PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	PG	WC	SC	GA	UT	PM
J	Kanauchi, N; Ookawara, S; Ito, K; Mogi, S; Yoshida, I; Kakei, M; Ishikawa, SE; Morishita, Y; Tabei, K				Kanauchi, Noriko; Ookawara, Susumu; Ito, Kiyonori; Mogi, Satsuki; Yoshida, Izumi; Kakei, Masafumi; Ishikawa, San-e; Morishita, Yoshiyuki; Tabei, Kaoru			Factors affecting the progression of renal dysfunction and the importance of salt restriction in patients with type 2 diabetic kidney disease	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						Type 2 diabetic kidney disease; Annual Ccr decline; Salt intake; Urinary protein excretion; Salt restriction	CREATININE CLEARANCE; NEPHROPATHY; RISK	Background Type 2 diabetic kidney disease (DKD) is the most common cause of end-stage renal failure, and the prevention of its progression has been a topic of discussion. Methods Sixty type 2 DKD patients were retrospectively evaluated for 1 year. Factors independently affecting the annual Ccr decline were examined by multivariable linear regression analysis. Patients were further divided into 2 groups based on their degree of renal function, and between-group differences at study initiation were evaluated. Results Ccr values were 21.0 +/- 11.8 mL/min/1.73 m(2) at study initiation, and 15.7 +/- 10.9 mL/min/1.73 m(2) after 1 year of observation. The multivariable linear regression analysis indicated salt intake (standardized coefficient: -0.34, P = 0.010) and urinary protein excretion (standardized coefficient: -0.33, P = 0.011) to be factors independently affecting the annual Ccr decline. Although decliners (-9.8 +/- 4.7 mL/min/1.73 m(2)/year) had a significantly higher salt intake than non-decliners (-1.1 +/- 3.8 mL/min/1.73 m(2)/year) at study initiation, this difference disappeared at the end of the study as a result of intensive dietary education. In 21 decliners with an additional year of follow-up, the annual Ccr decline significantly improved from -10.1 +/- 5.3 to -5.3 +/- 7.4 mL/min/1.73 m(2)/year (P = 0.02). Conclusion Salt intake and urinary protein excretion were associated with annual Ccr decline in type 2 DKD patients. Furthermore, dietary education covering salt intake may have positively affected the change in Ccr.	[Kanauchi, Noriko; Mogi, Satsuki] Jichi Med Univ, Saitama Med Ctr, Dept Nutr, Saitama, Japan; [Ookawara, Susumu; Ito, Kiyonori; Yoshida, Izumi; Morishita, Yoshiyuki; Tabei, Kaoru] Jichi Med Univ, Saitama Med Ctr, Dept Integrated Med 1, Div Nephrol, Saitama, Japan; [Kakei, Masafumi; Ishikawa, San-e] Jichi Med Univ, Saitama Med Ctr, Dept Integrated Med 1, Div Endocrinol, Saitama, Japan	Ookawara, S (reprint author), Jichi Med Univ, Saitama Med Ctr, Dept Integrated Med 1, Div Nephrol, Saitama, Japan.	su-ooka@hb.tp1.jp					American Diabetes Association, 2011, DIABETES CARE S1, V34, pS11, DOI DOI 10.2337/DC11-S011; Unsal A, 2012, EUR REV MED PHARMACO, V16, P878; Koya D, 2009, DIABETOLOGIA, V52, P2037, DOI 10.1007/s00125-009-1467-8; Hayashi K, 2007, CIRC RES, V100, P342, DOI 10.1161/01.RES.0000256155.31133.49; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Altemtam N, 2012, NEPHROL DIAL TRANSPL, V27, P1847, DOI 10.1093/ndt/gfr561; REMUZZI G, 1990, KIDNEY INT, V38, P384, DOI 10.1038/ki.1990.217; Pedrini MT, 1996, ANN INTERN MED, V124, P627; Zoppini G, 2012, CLIN J AM SOC NEPHRO, V7, P401, DOI 10.2215/CJN.07650711; Nakai S, 2012, THER APHER DIAL, V16, P483, DOI 10.1111/j.1744-9987.2012.01143.x; Kobori H, 2013, CURR PHARM DESIGN, V19, P3033; Dowling TC, 2010, PHARMACOTHERAPY, V30, P776, DOI 10.1592/phco.30.8.776; Mancia G, 2007, J HYPERTENS, V25, P1105, DOI 10.1097/HJH.0b013e3281fc975a; Suckling RJ, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006763.pub2; Diamandopoulos A, 2010, HIPPOKRATIA, V14, P98; Maeda CY, 2007, CLIN EXP PHARMACOL P, V34, P574, DOI 10.1111/j.1440-1681.2007.04625.x; Keane WF, 2003, KIDNEY INT, V63, P1499, DOI 10.1046/j.1523-1755.2003.00885.x; MARONI BJ, 1985, KIDNEY INT, V27, P58, DOI 10.1038/ki.1985.10; Rossing K, 2004, KIDNEY INT, V66, P1596, DOI 10.1111/j.1523-1755.2004.00925.x; Byme C, 2010, NEPHRON CLIN PRAC S1, V115, pc41; Dowling TC, 2013, PHARMACOTHERAPY, V33, P912, DOI 10.1002/phar.1282; GALL MA, 1993, DIABETOLOGIA, V36, P1071, DOI 10.1007/BF02374501; Japan Nephrology Society, 2012, NIHON JINZO GAKKAI S, V54, P1034; Rotz E, 1999, AM J KIDNEY DIS, V34, P795; Williams ME, 2013, NUTR MANAGEMENT RENA, P485	25	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	DEC	2015	19	6					1120	1126		10.1007/s10157-015-1118-y		7	Urology & Nephrology	Urology & Nephrology	CY7YS	WOS:000366626000016		
J	Kuriyama, S; Maruyama, Y; Nishio, S; Takahashi, Y; Kidoguchi, S; Kobayashi, C; Takahashi, D; Sugano, N; Hosoya, T; Yokoo, T				Kuriyama, Satoru; Maruyama, Yukio; Nishio, Shinichiro; Takahashi, Yasuhito; Kidoguchi, Satoshi; Kobayashi, Chisa; Takahashi, Daisuke; Sugano, Naoki; Hosoya, Tatsuo; Yokoo, Takashi			Serum uric acid and the incidence of CKD and hypertension	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						Uric acid; CKD; Hypertension; Estimated glomerular filtration rate	CARDIOVASCULAR-DISEASE; RISK-FACTOR; RENAL-DISEASE; KIDNEY-DISEASE; HYPERURICEMIA; PROGRESSION; COHORT; METAANALYSIS; MORTALITY; GOUT	Background Uric acid (UA) levels correlate positively with the prevalence of chronic kidney disease (CKD) and/or hypertension. We tested the hypothesis that UA may also have a link to a new incidence of CKD and hypertension. Methods Study design is a cohort study and the predictor is UA levels. Of the 15,470 screened cases, 8223 participants without CKD were eligible for the analysis of the incidence of CKD. Among these CKD candidates, 7569 participants were eligible for the analysis of the new development of hypertension. The observation period was 4 years. Results Relationship of UA with new cases of CKD. Higher UA levels had a closer association with the new development of CKD; 1.1 % (UA < 5 mg/dL), 1.5 % (5.0-5.9 mg/dL), 1.7 % (6.0-6.9 mg/dL), and 3.4 % (>= 7 mg/dL), respectively (p < 0.001 by the Chi-square test). Cox proportional hazard analysis showed that the estimates of the CKD development were eGFR [Hazard Ratio (HR) 0.816, 95 % confidence intervals (CI) 0.791-0.840] and male gender (HR 0.562, 95 % CI 0.322-0.982). UA levels and new development of hypertension. Higher UA levels had a closer association with the new development of hypertension; 5.0 % (UA < 5 mg/dL), 8.9 % (5.0-5.9 mg/dL), 10.6 % (6.0-6.9 mg/dL), and 11.8 % (>= 7 mg/dL), respectively (p < 0.001 by the Chi-square test). Cox proportional hazard analysis showed that the estimates of the hypertension development were BMI (HR 1.190, 95 % CI 1.155-1.226), age (HR 1.021, 95 % CI 1.010-1.032), HDL-cholesterol (HR 1.013, 95 % CI 1.007-1.019), male gender (HR 1.791, 95 % CI 1.338-2.395), UA level (HR 1.112, 95 % CI 1.024-1.207), and eGFR (HR 1008, 95 % CI 1.002-1.013). Furthermore, the logistic analysis showed that the odds ratio (OR) to estimate hypertension in the high UA group (UA >= 7 mg/dL; OR 1.33, 95 % CI 1.01-1.80) was greater than that in the low UA group (UA < 5 mg/dL). Kaplan-Meier analysis also confirmed the finding that the higher the UA levels the greater the hypertension development (p < 0.001 by the Log-rank test and Cox proportional hazard analysis). Conclusion High UA levels are associated with the new development of hypertension, but not with the incidence of CKD.	[Hosoya, Tatsuo] Jikei Univ, Sch Med, Dept Pathophysiol & Therapy Chron Kidney Dis, Tokyo 1058461, Japan; [Kuriyama, Satoru; Maruyama, Yukio; Nishio, Shinichiro; Takahashi, Yasuhito; Kidoguchi, Satoshi; Kobayashi, Chisa; Takahashi, Daisuke; Sugano, Naoki; Yokoo, Takashi] Jikei Univ, Div Nephrol & Hypertens, Dept Internal Med, Sch Med,Minato Ku, Tokyo 1058461, Japan	Kuriyama, S (reprint author), Jikei Univ, Div Nephrol & Hypertens, Dept Internal Med, Sch Med,Minato Ku, 3-25-8 Nishi Shinbashi, Tokyo 1058461, Japan.	kuriyamas218@yahoo.co.jp					Chonchol M, 2007, AM J KIDNEY DIS, V50, P239, DOI 10.1053/j.ajkd.2007.05.013; Feig DI, 2006, J AM SOC NEPHROL, V17, pS69, DOI 10.1681/ASN.2005121331; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; JOSSA F, 1994, J HUM HYPERTENS, V8, P677; Taniguchi Y, 2001, J HYPERTENS, V19, P1209, DOI 10.1097/00004872-200107000-00005; Zhang WL, 2009, CLIN CHEM, V55, P2026, DOI 10.1373/clinchem.2009.124891; Johnson RJ, 2005, J AM SOC NEPHROL, V16, P1909, DOI 10.1681/ASN.2005010063; Grayson PC, 2011, ARTHRIT CARE RES, V63, P102, DOI 10.1002/acr.20344; Syrjanen J, 2000, NEPHROL DIAL TRANSPL, V15, P34, DOI 10.1093/ndt/15.1.34; KINSEY D, 1961, CIRCULATION, V24, P972; FESSEL WJ, 1979, AM J MED, V67, P74, DOI 10.1016/0002-9343(79)90076-7; YU TF, 1982, AM J MED, V72, P95, DOI 10.1016/0002-9343(82)90593-9; Siu YP, 2006, AM J KIDNEY DIS, V47, P51, DOI 10.1053/j.ajkd.2005.10.006; Bo S, 2001, EUR J CLIN INVEST, V31, P318, DOI 10.1046/j.1365-2362.2001.00812.x; Nakagawa T, 2006, KIDNEY INT, V69, P1722, DOI 10.1038/sj.ki.5000391; Johnson RJ, 2005, HYPERTENSION, V45, P18, DOI 10.1161/01.HYP.0000150785.39055.e8; Mellen PB, 2006, HYPERTENSION, V48, P1037, DOI 10.1161/01.HYP.0000249768.26560.66; Iseki K, 2001, HYPERTENS RES, V24, P691, DOI 10.1291/hypres.24.691; Iseki K, 2004, AM J KIDNEY DIS, V44, P642, DOI 10.1053/j.ajkd.2004.06.006; Krishnan E, 2007, HYPERTENSION, V49, P298, DOI 10.1161/01.HYP.0000254480.64564.b6; Kawai T, 2012, HYPERTENS RES, V35, P1087, DOI 10.1038/hr.2012.99; KLEIN R, 1973, ARCH INTERN MED, V132, P401, DOI 10.1001/archinte.132.3.401; Kanellis J, 2004, NEPHROLOGY, V9, P394, DOI 10.1111/j.1440-1797.2004.00336.x; Fang J, 2000, JAMA-J AM MED ASSOC, V283, P2404, DOI 10.1001/jama.283.18.2404; CANNON PJ, 1966, NEW ENGL J MED, V275, P457, DOI 10.1056/NEJM196609012750902; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Tomita M, 2000, J Epidemiol, V10, P403; Wang JN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085982; Werner DE, 2008, J AM SOC NEPHROL, V19, P1204; Zhu P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100801	31	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	DEC	2015	19	6					1127	1134		10.1007/s10157-015-1120-4		8	Urology & Nephrology	Urology & Nephrology	CY7YS	WOS:000366626000017		
J	Hamasaki, Y; Ishikura, K; Uemura, O; Ito, S; Wada, N; Hattori, M; Ohashi, Y; Tanaka, R; Nakanishi, K; Kaneko, T; Honda, M				Hamasaki, Yuko; Ishikura, Kenji; Uemura, Osamu; Ito, Shuichi; Wada, Naohiro; Hattori, Motoshi; Ohashi, Yasuo; Tanaka, Ryojiro; Nakanishi, Koichi; Kaneko, Tetsuji; Honda, Masataka			Growth impairment in children with pre-dialysis chronic kidney disease in Japan	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						Child; Chronic kidney disease; Growth; Growth hormone; Japan	STAGE RENAL-DISEASE; YOUNG-CHILDREN; TRANSPLANT; ADOLESCENTS; DIALYSIS; HORMONE; PERSPECTIVE; NAPRTCS; HEIGHT	Background Growth impairment is a major complication of chronic kidney disease (CKD) in children. However, no cohort studies have examined the growth of Asian children with pre-dialysis CKD. Methods We sent cross-sectional surveys to 113 Japanese medical institutions that were treating 447 children with CKD stages 3-5 in 2010 and 2011. Of 447 children included in our survey conducted in 2010, height and CKD stage were evaluable for 297 children in 2011, and height standard deviation score (height SDS) was calculated in these children. Results Height SDS decreased with increasing CKD stage (P < 0.001) in boys and girls. Height SDS also decreased significantly with increasing CKD stage among patients with congenital anomalies of the kidney and urinary tract (P < 0.001). Risk factors for growth impairment included CKD stages 4 and 5 (relative to stage 3), being small-for-date, and asphyxia at birth. Among children with a height <= -2.0, growth hormone was used in 19.5, 31.0, and 25.0 % of children with CKD stages 3, 4, and 5, respectively. Conclusions This prospective cohort study revealed marked growth impairment in Japanese children with CKD stages 3-5 relative to healthy children. CKD-related risk factors for growth impairment included advanced CKD (stages 4 and 5), being small-for-date, and asphyxia at birth. Growth hormone was infrequently used in this cohort of children with pre-dialysis CKD.	[Hamasaki, Yuko] Toho Univ, Fac Med, Dept Pediat Nephrol, Ota Ku, Tokyo 1438541, Japan; [Ishikura, Kenji; Honda, Masataka] Tokyo Metropolitan Childrens Med Ctr, Dept Nephrol, Tokyo, Japan; [Ishikura, Kenji; Kaneko, Tetsuji] Tokyo Metropolitan Childrens Med Ctr, Div Clin Res Support Ctr, Tokyo, Japan; [Uemura, Osamu] Aichi Childrens Hlth & Med Ctr, Dept Pediat Nephrol, Aichi, Japan; [Ito, Shuichi] Yokohama City Univ, Dept Pediat, Grad Sch Med, Yokohama, Kanagawa 232, Japan; [Wada, Naohiro] Shizuoka Childrens Hosp, Dept Pediat Nephrol, Shizuoka, Japan; [Hattori, Motoshi] Tokyo Womens Med Univ, Dept Pediat Nephrol, Tokyo, Japan; [Ohashi, Yasuo] Chuo Univ, Dept Integrated Sci & Technol Sustainable Soc, Tokyo 112, Japan; [Tanaka, Ryojiro] Hyogo Prefectural Childrens Hosp, Dept Nephrol, Kobe, Hyogo, Japan; [Nakanishi, Koichi] Wakayama Med Univ, Dept Pediat, Wakayama, Japan	Hamasaki, Y (reprint author), Toho Univ, Fac Med, Dept Pediat Nephrol, Ota Ku, 6-11-1 Omori Nishi, Tokyo 1438541, Japan.	yuhamasaki@med.toho-u.ac.jp			'Research on Rare and Intractable Diseases, Health and Labour Sciences Research Grants' from Ministry of Health, Labour and Welfare, Japan	This work was supported by 'Research on Rare and Intractable Diseases, Health and Labour Sciences Research Grants' from the Ministry of Health, Labour and Welfare, Japan. The results presented in this paper have not been published previously in whole or part, except in abstract format. The authors would like to thank Drs. Takuhito Nagai (Aichi), Kenichi Satomura (Osaka), Midori Awazu (Tokyo), Toshiyuki Ohta (Hiroshima), Kazumoto Iijima (Hyogo), Takeshi Matsuyama (Tokyo), Mayumi Sako (Tokyo), Hidefumi Nakamura (Tokyo), Shuichiro Fujinaga (Saitama), Hiroshi Kitayama (Shizuoka), Naoya Fujita (Shizuoka), Masataka Hisano (Chiba), Yuko Akioka (Tokyo), Daishi Hirano (Tokyo), Hiroshi Hataya (Tokyo), Shunsuke Shinozuka (Tokyo), Ryoko Harada (Tokyo), Yoshinobu Nagaoka (Hokkaido), Takashi Sekine (Tokyo), Yoshimitsu Goto (Aichi), Takuji Yamada (Aichi), Yohei Ikezumi (Niigata), Takeshi Yamada (Niigata), and Akira Matsunaga (Yamagata) of The Pediatric CKD Study Group in Japan for their contributions to the study. The authors also thank the institutions listed in the Supplementary Table for participating in the surveys, and Mr. Masaaki Kurihara, Ms. Chie Matsuda and Ms. Naomi Miyamoto of the Japan Clinical Research Support Unit (Tokyo) for their help with data management.	Neu AM, 2002, PEDIATR NEPHROL, V17, P656, DOI 10.1007/s00467-002-0928-9; Fine RN, 2010, PEDIATR NEPHROL, V25, P739, DOI 10.1007/s00467-009-1387-3; Schwartz GJ, 2009, J AM SOC NEPHROL, V20, P629, DOI 10.1681/ASN.2008030287; Copelovitch L, 2011, CLIN J AM SOC NEPHRO, V6, P2047, DOI 10.2215/CJN.10751210; Ishikura K, 2014, NEPHROL DIAL TRANSPL, V29, P878, DOI 10.1093/ndt/gfu012; Vimalachandra D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003264.pub2; Fine RN, 2010, PEDIATR NEPHROL, V25, P725, DOI 10.1007/s00467-009-1409-1; Fine RN, 2001, PEDIATR NEPHROL, V16, P951; Chadha V, 2005, ADV CHRONIC KIDNEY D, V12, P343, DOI 10.1053/j.j.ackd.2005.07.013; Furth SL, 2011, CLIN J AM SOC NEPHRO, V6, P2132, DOI 10.2215/CJN.07100810; Ishikura K, 2013, NEPHROL DIAL TRANSPL, V28, P2345, DOI 10.1093/ndt/gfs611; Warady BA, 2007, PEDIATR NEPHROL, V22, P1999, DOI 10.1007/s00467-006-0410-1; Greenbaum LA, 2011, CLIN J AM SOC NEPHRO, V6, P14, DOI 10.2215/CJN.08481109; [Anonymous], 2010, ATL CKD ESRD 2010; Wuhl E, 1996, PEDIATR NEPHROL, V10, P294; Gil S, 2012, PEDIATR NEPHROL, V27, P1005, DOI 10.1007/s00467-011-2090-8; Rees L, 2011, J AM SOC NEPHROL, V22, P2303, DOI 10.1681/ASN.2010020192; Uemura O, 2014, CLIN EXP NEPHROL, V18, P626, DOI 10.1007/s10157-013-0856-y; Castaneda DA, 2011, TRANSPL P, V43, P3344, DOI 10.1016/j.transproceed.2011.10.034; Mahan JD, 2006, PEDIATR NEPHROL, V21, P917, DOI 10.1007/s00467-006-0020-y; Parekh RS, 2001, J AM SOC NEPHROL, V12, P2418; Harambat J, 2011, PEDIATR NEPHROL, V27, P363, DOI DOI 10.1007/S00467-011-1939-1; Tejani A, 1993, Kidney Int Suppl, V43, pS56	23	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	DEC	2015	19	6					1142	1148		10.1007/s10157-015-1098-y		7	Urology & Nephrology	Urology & Nephrology	CY7YS	WOS:000366626000019		
J	Matsushita, S; Ishikura, K; Okamoto, S; Okuda, Y; Nagaoka, Y; Harada, R; Hamada, R; Sakai, T; Hamasaki, Y; Hataya, H; Ando, T; Ogata, K; Honda, M				Matsushita, Shoko; Ishikura, Kenji; Okamoto, Shojiro; Okuda, Yusuke; Nagaoka, Yoshinobu; Harada, Ryoko; Hamada, Riku; Sakai, Tomoyuki; Hamasaki, Yuko; Hataya, Hiroshi; Ando, Takashi; Ogata, Kentaro; Honda, Masataka			Long-term morbidity of IgA nephropathy in children evaluated with newly proposed remission criteria in Japan	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						IgA nephropathy; Remission criteria; Children	RANDOMIZED CONTROLLED-TRIAL; IMMUNOGLOBULIN-A NEPHROPATHY; OXFORD CLASSIFICATION; PULSE THERAPY; ADULTS; PROTEINURIA; OUTCOMES	Background The long-term outcome of pediatric IgA nephropathy (IgAN) is unclear. Objective IgAN remission criteria were proposed by the Japanese Society of Nephrology in 2013. Methods Children with newly developed IgAN followed for > 5 years were analyzed. They were divided into two groups based on histological findings at initial kidney biopsy: the focal mesangial proliferation group (Focal group) and diffuse mesangial proliferation group (Diffuse group). The primary outcome was the remission rate according to the newly proposed IgAN remission criteria. Results The patients comprised 53 children (31 boys; mean age at IgAN onset, 10.0 years). The Focal and Diffuse groups comprised 21 and 32 patients, respectively. No significant differences in patient characteristics were found between the groups except for steroid administration. The median follow-up period from onset was 9.9 years. Sixteen patients in the Diffuse group and 10 in the Focal group had not achieved remission at the last observation. Patient conditions 2 years after the initial treatment were almost identical to those at the last observation. Multivariate analysis revealed that proteinuria, particularly < 0.5 g/g Cr at 2 years, was significantly associated with remission at the last observation regardless of proteinuria status at the start of treatment. Conclusions Pediatric IgAN has a prolonged course that is longer than expected regardless of severity at diagnosis. Patient conditions 2 years after initial treatment predicted their conditions at the last observation. Although the final renal function of these patients is presently unclear, children with IgAN should be followed beyond adolescence and further into adulthood.	[Matsushita, Shoko; Ishikura, Kenji; Okuda, Yusuke; Nagaoka, Yoshinobu; Harada, Ryoko; Hamada, Riku; Hataya, Hiroshi; Honda, Masataka] Tokyo Metropolitan Childrens Med Ctr, Dept Nephrol, Fuchu, Tokyo 1838561, Japan; [Matsushita, Shoko] Tokyo Metropolitan Childrens Med Ctr, Div Allergy, Fuchu, Tokyo 1838561, Japan; [Okamoto, Shojiro] Tokai Univ Hachioji Hosp, Dept Pediat, Hachioji, Tokyo 1920032, Japan; [Okuda, Yusuke; Sakai, Tomoyuki] Shiga Univ Med Sci, Dept Pediat, Otsu, Shiga 5202192, Japan; [Nagaoka, Yoshinobu] Natl Hosp Org, Dept Pediat, Hokkaido Med Ctr, Nishi Ku, Sapporo, Hokkaido 0630005, Japan; [Hamasaki, Yuko] Toho Univ, Fac Med, Dept Pediat Nephrol, Ota Ku, Tokyo 1438541, Japan; [Ando, Takashi] Japan Clin Res Support Unit, Bunkyo Ku, Tokyo 1130034, Japan; [Ogata, Kentaro] Federat Natl Publ Serv Personnel Mutual Aid Assoc, Tachikawa Hosp, Div Pathol, Tachikawa, Tokyo 1908531, Japan	Ishikura, K (reprint author), Tokyo Metropolitan Childrens Med Ctr, Dept Nephrol, 2-8-29 Musashidai, Fuchu, Tokyo 1838561, Japan.	kenzo@ii.e-mansion.com			Health and Labour Sciences Research Grant for Research on Rare and Intractable Diseases from Ministry of Health, Labour and Welfare, Japan	The authors would like to thank Dr. Emi Kawaguchi of Tokyo Metropolitan Children's Medical Center for her support in preparation of the manuscript. The authors also wish to thank Angela Morben, DVM, ELS, of Edanz Group Ltd, for providing editorial language support in the preparation of the manuscript. This work was partly supported by a Health and Labour Sciences Research Grant for Research on Rare and Intractable Diseases from the Ministry of Health, Labour and Welfare, Japan (H26-nanchitou(nan)-ip-pan-036).	Suzuki Y, 2014, CLIN EXP NEPHROL, V18, P481, DOI 10.1007/s10157-013-0849-x; Floege J, 2013, NAT REV NEPHROL, V9, P320, DOI 10.1038/nrneph.2013.59; Shima Y, 2012, PEDIATR NEPHROL, V27, P783, DOI 10.1007/s00467-011-2061-0; Shima Y, 2011, NEPHROL DIAL TRANSPL, V26, P163, DOI 10.1093/ndt/gfq387; Lv JC, 2012, J AM SOC NEPHROL, V23, P1108, DOI 10.1681/ASN.2011111112; Coppo R, 2005, J NEPHROL, V18, P503; Pozzi C, 2013, J NEPHROL, V26, P86, DOI 10.5301/jn.5000110; Kawasaki Y, 2006, PEDIATR NEPHROL, V21, P1701, DOI 10.1007/s00467-006-0272-6; Pozzi C, 2004, J AM SOC NEPHROL, V15, P157, DOI 10.1097/01.ASN.0000103869.08096.4F; Kamei K, 2011, CLIN J AM SOC NEPHRO, V6, P1301, DOI 10.2215/CJN.08630910; Reich HN, 2007, J AM SOC NEPHROL, V18, P3177, DOI 10.1681/ASN.2007050526; Gutierrez E, 2012, J AM SOC NEPHROL, V23, P1753, DOI 10.1681/ASN.2012010063; Roberts ISD, 2009, KIDNEY INT, V76, P546, DOI 10.1038/ki.2009.168; Coppo R, 2010, KIDNEY INT, V77, P921, DOI 10.1038/ki.2010.43; Haas M, 2008, NEPHROL DIAL TRANSPL, V23, P2537, DOI 10.1093/ndt/gfn014; Koyama A, 1997, AM J KIDNEY DIS, V29, P526, DOI 10.1016/S0272-6386(97)90333-4; Yoshikawa N, 2006, CLIN J AM SOC NEPHRO, V1, P511, DOI 10.2215/CJN.01120905; Yoshikawa N, 2001, PEDIATR NEPHROL, V16, P446; Matsuzaki K, 2013, CLIN EXP NEPHROL, V17, P827, DOI 10.1007/s10157-013-0779-7; Kawamura T, 2014, NEPHROL DIAL TRANSPL, V29, P1546, DOI 10.1093/ndt/gfu020; Yoshikawa N, 1999, J AM SOC NEPHROL, V10, P101; Ikezumi Y, 2006, NEPHROL DIAL TRANSPL, V21, P3466, DOI 10.1093/ndt/gfl455; Uemura O, 2014, CLIN EXP NEPHROL, V18, P626, DOI 10.1007/s10157-013-0856-y; Japanese Society of Nephrology, 2014, CLIN EXP NEPHROL, V18, P346; Tomino Yasuhiko, 2003, Clin Exp Nephrol, V7, P93, DOI 10.1007/s10157-003-0232-4	25	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	DEC	2015	19	6					1149	1156		10.1007/s10157-015-1105-3		8	Urology & Nephrology	Urology & Nephrology	CY7YS	WOS:000366626000020		
J	Nakazato, Y; Kurane, R; Hirose, S; Watanabe, A; Shimoyama, H				Nakazato, Yuichi; Kurane, Riichi; Hirose, Satoru; Watanabe, Akihisa; Shimoyama, Hiromi			Variability of laboratory parameters is associated with frailty markers and predicts non-cardiac mortality in hemodialysis patients	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						Blood urea nitrogen; Frailty; Hemodialysis; Homeostasis; Non-cardiovascular mortality; Variability	LEAN BODY-MASS; DIALYSIS PATIENTS; CREATININE INDEX; PROTEIN; SURVIVAL; PRESSURE; OUTCOMES; DISEASE	Background The levels of many laboratory parameters are associated with the outcomes of dialysis patients, but the significance of their variability has not been well studied. MethodsA total of 384 patients receiving stable hemodialysis treatment during 2002 were followed up for mortality until the end of 2013. The within-patient coefficients of variation (CV) were calculated for 13 laboratory parameters from 1 year of data. We defined variability as CV and analyzed the survival of the patients according to the baseline CV values of each parameter by proportional hazard modeling. ResultsDuring the 11-year observation period, 125 patients died. Higher CV levels for eight parameters, namely, blood urea nitrogen (BUN), sodium, hemoglobin, creatinine, total protein, albumin, potassium and phosphate, were significantly associated with all-cause mortality. The adjusted hazard ratios for a high BUN-CV (> 15 %) and a high Na-CV (> 1.3 %) against a lower CV were 1.92 (95 % CI 1.31-2.81) and 1.95 (1.36-2.80), respectively. The increased mortality risk associated with each variability was attributed to excess non-cardiac deaths. The CV values of most parameters were correlated with each other and often exhibited negative associations with age, diabetes, and mobility as well as the levels of hemoglobin, albumin, creatinine, Na, the protein catabolic rate, and the creatinine generation rate. Therefore, a high variability was generally associated with frailty-related adverse prognostic factors. ConclusionsThe variability of several blood parameters had a significant impact on all-cause and non-cardiac mortality. The levels of the variabilities were most likely related to poor physical conditions of the patients.	[Nakazato, Yuichi; Kurane, Riichi; Hirose, Satoru; Watanabe, Akihisa; Shimoyama, Hiromi] Hakuyukai Med Corp, Div Nephrol, Yuai Nisshin Clin, Kita Ku, Saitama, Saitama 3310823, Japan	Nakazato, Y (reprint author), Hakuyukai Med Corp, Div Nephrol, Yuai Nisshin Clin, Kita Ku, 2-1914-6 Nisshin Cho, Saitama, Saitama 3310823, Japan.	nkzt@hakuyukai.jp					van Dijk S, 2013, J PSYCHOSOM RES, V74, P511, DOI 10.1016/j.jpsychores.2013.03.001; Terrier N, 2008, NEPHROL DIAL TRANSPL, V23, P345, DOI 10.1093/ndt/gfm573; Shinzato T, 1997, ARTIF ORGANS, V21, P864; Scrucca L, 2007, BONE MARROW TRANSPL, V40, P381, DOI 10.1038/sj.bmt.1705727; Burrowes JD, 2002, J RENAL NUTR, V12, P87, DOI 10.1053/jren.2002.32209; Chmielewski M, 2011, NEPHROL DIAL TRANSPL, V26, P3325, DOI 10.1093/ndt/gfr008; Qureshi AR, 1998, KIDNEY INT, V53, P773, DOI 10.1046/j.1523-1755.1998.00812.x; Kovesdy CP, 2009, NEPHROLOGY, V14, P408, DOI 10.1111/j.1440-1797.2009.01119.x; Wiig H, 2013, J CLIN INVEST, V123, P2803, DOI 10.1172/JCI60113; Hermans MMH, 2007, KIDNEY INT, V72, P202, DOI 10.1038/sj.ki.5002178; Desai AA, 2009, HEMODIAL INT, V13, P347, DOI 10.1111/j.1542-4758.2009.00377.x; Canaud B, 2011, CLIN J AM SOC NEPHRO, V6, P1651, DOI 10.2215/CJN.03530410; Ebah LM, 2013, KIDNEY INT, V84, P980, DOI 10.1038/ki.2013.208; Desmeules S, 2004, NEPHROL DIAL TRANSPL, V19, P1182, DOI 10.1093/ndt/gfh016; Dahlmann A, 2014, KIDNEY INT, V87, P434; KESHAVIAH PR, 1994, J AM SOC NEPHROL, V4, P1475; Merlot AM, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00299; Moreau-Gaudry X, 2014, J RENAL NUTR, V24, P395, DOI 10.1053/j.jrn.2014.06.008	18	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	DEC	2015	19	6					1165	1178		10.1007/s10157-015-1108-0		14	Urology & Nephrology	Urology & Nephrology	CY7YS	WOS:000366626000022		
J	Inoue, K; Goto, A; Kishimoto, M; Tsujimoto, T; Yamamoto-Honda, R; Noto, H; Kajio, H; Terauchi, Y; Noda, M				Inoue, Kaori; Goto, Atsushi; Kishimoto, Miyako; Tsujimoto, Tetsuro; Yamamoto-Honda, Ritsuko; Noto, Hiroshi; Kajio, Hiroshi; Terauchi, Yasuo; Noda, Mitsuhiko			Possible discrepancy of HbA1c values and its assessment among patients with chronic renal failure, hemodialysis and other diseases	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						Glycated hemoglobin; Glycated albumin; Chronic renal failure	GLYCATED ALBUMIN; DIABETIC-PATIENTS; GLYCEMIC CONTROL; PLASMA-GLUCOSE; INDICATOR; ANEMIA	Background Glycated hemoglobin (HbA1c) and glycated albumin (GA) are frequently used as glycemic control markers. However, these markers are influenced by alterations in hemoglobin and albumin metabolism. Thus, conditions such as anemia, chronic renal failure, hypersplenism, chronic liver diseases, hyperthyroidism, hypoalbuminemia, and pregnancy need to be considered when interpreting HbA1c or GA values. Using data from patients with normal albumin and hemoglobin metabolism, we previously established a linear regression equation describing the GA value versus the HbA1c value to calculate an extrapolated HbA1c (eHbA1c) value for the accurate evaluation of glycemic control. In this study, we investigated the difference between the measured HbA1c and the eHbA1c values for patients with various conditions. MethodsData sets for a total of 2461 occasions were obtained from 731 patients whose HbA1c and GA values were simultaneously measured. We excluded patients with missing data or changeable HbA1c levels, and patients who had received transfusions or steroids within the previous 3 months. Finally, we included 44 patients with chronic renal failure (CRF), 10 patients who were undergoing hemodialysis (HD), 7 patients with hematological malignancies and a hemoglobin level of less than 10 g/dL (HM), and 12 patients with chronic liver diseases (CLD). ResultsIn all the groups, the eHbA1c values were significantly higher than the measured HbA1c values. The median difference was 0.75 % (95 % CI 0.40-1.10 %, P for the difference is < 0.001) in the CRF group, 0.80 % (95 % CI 0.30-1.65 %, P for the difference is 0.041) in the HD group, 0.90 % (95 % CI 0.90-1.30 %, P for the difference is 0.028) in the HM group, and 0.85 % (95 % CI 0.40-1.50 %, P for the difference is 0.009) in the CLD group. ConclusionsWe found that the measured HbA1c values were lower than the eHbA1c values in each of the groups.	[Inoue, Kaori; Kishimoto, Miyako; Tsujimoto, Tetsuro; Yamamoto-Honda, Ritsuko; Noto, Hiroshi; Kajio, Hiroshi] Natl Ctr Global Hlth & Med, Ctr Hosp, Dept Endocrinol Diabet & Metab, Tokyo 1628655, Japan; [Goto, Atsushi; Noda, Mitsuhiko] Natl Ctr Global Hlth & Med, Dept Diabet Res, Shinjuku Ku, Tokyo 1628655, Japan; [Inoue, Kaori; Goto, Atsushi; Terauchi, Yasuo] Yokohama City Univ, Dept Endocrinol & Metab, Grad Sch Med, Yokohama, Kanagawa 2360004, Japan	Noda, M (reprint author), Natl Ctr Global Hlth & Med, Dept Diabet Res, Shinjuku Ku, 1-21-1 Toyama, Tokyo 1628655, Japan.	mnoda@hosp.ncgm.go.jp			health sciences research grants (Comprehensive Research on Life-style Related Diseases Including Cardiovascular Diseases and Diabetes Mellitus) from Ministry of Health, Labour and Welfare of Japan [H22-019, H25-016]	This work was funded by health sciences research grants (Comprehensive Research on Life-style Related Diseases Including Cardiovascular Diseases and Diabetes Mellitus H22-019 and H25-016) from the Ministry of Health, Labour and Welfare of Japan.	Okada T, 2011, INTERNAL MED, V50, P23, DOI 10.2169/internalmedicine.50.4129; Koga M, 2011, CLIN CHIM ACTA, V412, P253, DOI 10.1016/j.cca.2010.10.014; TAHARA Y, 1995, DIABETES CARE, V18, P440, DOI 10.2337/diacare.18.4.440; Bando Y, 2009, ANN CLIN BIOCHEM, V46, P368, DOI 10.1258/acb.2009.008231; Inoue K, 2014, ENDOCR J, V61, P553; Shima K, 2012, ANN CLIN BIOCHEM, V49, P68, DOI 10.1258/acb.2011.011161; Koga M, 2008, DIABETES RES CLIN PR, V81, P258, DOI 10.1016/j.diabres.2008.04.012; Inaba M, 2007, J AM SOC NEPHROL, V18, P896, DOI 10.1681/ASN.2006070772; Coban E, 2004, ACTA HAEMATOL-BASEL, V112, P126, DOI 10.1159/000079722; Barry IF, 2008, PERITON DIALYSIS INT, V30, P72; Chujo Keiko, 2006, J Med Invest, V53, P223, DOI 10.2152/jmi.53.223; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Kashiwagi A, 2012, DIABETOL INT, V3, P8, DOI DOI 10.1007/S13340-012-0069-8; The Japanese Society for Dialysis Therapy, 2013, NIHON TOSEKI IGAKKAI, V46, P311	14	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	DEC	2015	19	6					1179	1183		10.1007/s10157-015-1110-6		5	Urology & Nephrology	Urology & Nephrology	CY7YS	WOS:000366626000023		
J	Nakai, K; Fujii, H; Yoshikawa, M; Kono, K; Yonekura, Y; Goto, S; Ishimura, T; Takeda, M; Fujisawa, M; Nishi, S				Nakai, Kentaro; Fujii, Hideki; Yoshikawa, Mikiko; Kono, Keiji; Yonekura, Yuriko; Goto, Shunsuke; Ishimura, Takeshi; Takeda, Masashi; Fujisawa, Masato; Nishi, Shinichi			Effect of cinacalcet cessation on hyperparathyroidism in kidney transcaplant patients after long-term dialysis therapy	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						Cinacalcet; Hyperparathyroidism; Kidney transplantation; Parathyroid hormone; Vitamin D	VITAMIN-D-RECEPTOR; SECONDARY HYPERPARATHYROIDISM; TRANSPLANT RECIPIENT; CALCIUM-METABOLISM; SINGLE-CENTER	Background Cinacalcet is a promising therapy widely used in dialysis patients with hyperparathyroidism resistant to conventional therapy. However, reports regarding the influence of cinacalcet cessation after long-term use on kidney transplantation patients are few. MethodsThis retrospective observational study included 40 dialysis patients who underwent kidney transplantation. Creatinine, corrected calcium, phosphorus, alkaline phosphatase, and intact parathyroid hormone levels were assessed before and after kidney transplantation according to pretransplant treatment of chronic kidney disease-mineral and bone disorder. ResultsUltrasonography revealed enlargement of the parathyroid in all patients treated with cinacalcet. Although the data at the time of kidney transplantation were comparable, the serum levels of calcium, alkaline phosphatase, and intact parathyroid hormone after kidney transplantation were higher in patients treated with cinacalcet than in those treated without. However, serum phosphate levels in the cinacalcet group were slightly higher at the time of kidney transplantation and significantly lower 3 months later. ConclusionsMineral abnormalities persisted in kidney transplant patients with enlarged parathyroid glands after discontinuation of cinacalcet treatment. Parathyroidectomy should be considered in kidney transplant candidates with the risk of developing refractory hyperparathyroidism after transplantation.	[Nakai, Kentaro; Fujii, Hideki; Yoshikawa, Mikiko; Kono, Keiji; Yonekura, Yuriko; Goto, Shunsuke; Nishi, Shinichi] Kobe Univ, Grad Sch Med, Div Nephrol, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Nakai, Kentaro; Fujii, Hideki; Yoshikawa, Mikiko; Kono, Keiji; Yonekura, Yuriko; Goto, Shunsuke; Nishi, Shinichi] Kobe Univ, Grad Sch Med, Kidney Ctr, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Ishimura, Takeshi; Takeda, Masashi; Fujisawa, Masato] Kobe Univ, Grad Sch Med, Dept Organs Therapeut, Div Urol, Kobe, Hyogo 6500017, Japan	Fujii, H (reprint author), Kobe Univ, Grad Sch Med, Div Nephrol, Chuo Ku, 7-5-2 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	fhideki@med.kobe-u.ac.jp			Kyowa Hakko Kirin Co. Ltd., Japan	SN received a research grant from Kyowa Hakko Kirin Co. Ltd., Japan. Others, none declared.	Evenepoel P, 2004, NEPHROL DIAL TRANSPL, V19, P1281, DOI 10.1093/ndt/gfh128; Hirai T, 2010, THER APHER DIAL, V14, P577, DOI 10.1111/j.1744-9987.2010.00843.x; Seikrit C, 2011, NAT REV NEPHROL, V7, P237, DOI 10.1038/nrneph.2010.169; Evenepoel P, 2012, CLIN TRANSPLANT, V26, P393, DOI 10.1111/j.1399-0012.2011.01524.x; Rodriguez ME, 2007, AM J PHYSIOL-RENAL, V292, pF1390, DOI 10.1152/ajprenal.00262.2006; Kawarazaki H, 2011, THER APHER DIAL, V15, P481, DOI 10.1111/j.1744-9987.2011.00932.x; Wada M, 1997, J CLIN INVEST, V100, P2977, DOI 10.1172/JCI119851; Torregrosa JV, 2009, TRANSPL P, V41, P2396, DOI 10.1016/j.transproceed.2009.06.073; Torres A, 2002, J AM SOC NEPHROL, V13, P551; Esposito L, 2007, CLIN NEPHROL, V68, P245; Evenepoel P, 2007, NEPHROL DIAL TRANSPL, V22, P1730, DOI 10.1093/ndt/gfm044; Bonarek H, 1999, KIDNEY INT, V56, P642, DOI 10.1046/j.1523-1755.1999.00589.x; Peng LW, 2007, AM J MED, V120, pE7, DOI 10.1016/j.amjmed.2005.09.041; Taniguchi M, 2006, KIDNEY INT, V70, P363, DOI 10.1038/sj.ki.5001549; Jadoul M., 2010, NDT Plus, V3, P37, DOI 10.1093/ndtplus/sfp167; Tanaka M, 2008, NDT PLUS, V1, piii49	16	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	DEC	2015	19	6					1184	1188		10.1007/s10157-015-1107-1		5	Urology & Nephrology	Urology & Nephrology	CY7YS	WOS:000366626000024		
J	Nakajima, A; Lu, Y; Kawano, H; Horie, S; Muto, S				Nakajima, Akiko; Lu, Yan; Kawano, Haruna; Horie, Shigeo; Muto, Satoru			Association of arginine vasopressin surrogate marker urinary copeptin with severity of autosomal dominant polycystic kidney disease (ADPKD)	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						Autosomal dominant polycystic kidney disease; Vasopressin; Copeptin; GFR; Total kidney volume; Marker	TRANSPLANT RECIPIENTS; FUNCTION DECLINE; PLASMA; HYPERTENSION; BIOMARKER; CHILDREN; VOLUME	Background Experimental studies suggest a detrimental role for cyclic adenosine monophosphate (cAMP) and vasopressin in the pathogenesis of autosomal dominant polycystic kidney disease (ADPKD). It is unknown, however, whether urinary cAMP and copeptin concentration are associated with disease severity in patients with ADPKD. Methods Urinary cAMP (u-cAMP) and copeptin concentration (u-copeptin) were measured by immunoassay in ADPKD patients with CKD stage a parts per thousand currency sign4. We compared our measurements with clinical parameters including estimated glomerular filtration rate (eGFR), total kidney volume (TKV), and height-adjusted TKV (htTKV). Logarithmic transformation of all variables was performed to fulfill the requirement of equal distribution of the residuals. Results We included 50 patients in this study (24 females and 26 males; mean age: 49.3 years). The median eGFR and TKV were 53.2 ml/min/1.73 m(2) (interquartile range: IQR; 29.4-68.45) and 1138.1 ml (IQR; 814.7-2065.0), respectively. The median u-copeptin level was 12.19 (IQR; 6.91-22.32) ng/ml. Although u-cAMP/u-Cr was not significantly correlated with TKV (R = -0.006, p = 0.967) and eGFR (R = 0.077, p = 0.602), urinary copeptin/u-Cr was statistically associated with the various markers of disease severity in ADPKD [positively with TKV (R = 0.351, p = 0.014), htTKV (R = 0.383, p = 0.008) and negatively with eGFR (R = -0.304, p = 0.036)]. Conclusions In ADPKD subjects, a higher u-copeptin is associated with disease progression, suggesting that u-copeptin may be a new surrogate marker to predict renal prognosis in ADPKD.	[Nakajima, Akiko; Lu, Yan; Muto, Satoru] Teikyo Univ, Sch Med, Dept Urol, Itabashi Ku, Tokyo 1738605, Japan; [Kawano, Haruna; Horie, Shigeo] Juntendo Univ, Dept Urol, Grad Sch Med, Tokyo, Japan	Muto, S (reprint author), Teikyo Univ, Sch Med, Dept Urol, Itabashi Ku, 2-11-1 Kaga, Tokyo 1738605, Japan.	muto@med.teikyo-u.ac.jp			Progressive Renal Diseases Research Project from Ministry of Health, Labour and Welfare of Japan	This work was supported in part by a grant for the Progressive Renal Diseases Research Project from the Ministry of Health, Labour and Welfare of Japan.	Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; FICK GM, 1994, J AM SOC NEPHROL, V4, P1654; Barash I, 2010, CLIN J AM SOC NEPHRO, V5, P693, DOI 10.2215/CJN.04180609; Przybylowski P, 2010, TRANSPL P, V42, P1808, DOI 10.1016/j.transproceed.2010.03.138; Szinnai G, 2007, J CLIN ENDOCR METAB, V92, P3973, DOI 10.1210/jc.2007-0232; de Bree FM, 1998, CELL MOL NEUROBIOL, V18, P173, DOI 10.1023/A:1022564803093; Tokiwa S, 2011, CLIN EXP NEPHROL, V15, P539, DOI 10.1007/s10157-011-0428-y; Meijer E, 2010, KIDNEY INT, V77, P29, DOI 10.1038/ki.2009.397; Zittema D, 2012, CLIN J AM SOC NEPHRO, V7, P906, DOI 10.2215/CJN.11311111; Fliser D, 2007, J AM SOC NEPHROL, V18, P1057, DOI 10.1681/ASN.2006090956; Hilzendeger AM, 2013, HYPERTENSION, V61, P716, DOI 10.1161/HYPERTENSIONAHA.111.00356; Morgenthaler NG, 2006, CLIN CHEM, V52, P112, DOI 10.1373/clinchem.2005.060038; Boertien WE, 2012, NEPHROL DIAL TRANSPL, V27, P4131, DOI 10.1093/ndt/gfs070; Littlejohn NK, 2013, AM J PHYSIOL-REG I, V304, pR818, DOI 10.1152/ajpregu.00082.2013; Morgenthaler NG, 2008, TRENDS ENDOCRIN MET, V19, P43, DOI 10.1016/j.tem.2007.11.001; Graffe CC, 2012, AM J PHYSIOL-RENAL, V302, pF917, DOI 10.1152/ajprenal.00616.2011; Torres VE, 2007, LANCET, V369, P1287, DOI 10.1016/S0140-6736(07)60601-1; RAVINE D, 1994, LANCET, V343, P824, DOI 10.1016/S0140-6736(94)92026-5; Chapman AB, 2012, CLIN J AM SOC NEPHRO, V7, P479, DOI 10.2215/CJN.09500911; Boertien WE, 2013, AM J KIDNEY DIS, V61, P420, DOI 10.1053/j.ajkd.2012.08.038; Meijer E, 2009, TRANSPLANTATION, V88, P561, DOI 10.1097/TP.0b013e3181b11ae4; Bhandari SS, 2009, CLIN SCI, V116, P257, DOI 10.1042/CS20080140; Meijer E, 2010, CLIN J AM SOC NEPHRO, V5, P1091, DOI 10.2215/CJN.00360110; Mochizuki T, 2013, CLIN EXP NEPHROL, V17, P317, DOI 10.1007/s10157-012-0741-0; Kluge M, 1999, CLIN CHEM, V45, P98; Kistler AD, 2013, PLOS ONE, V8, pe5301; Meijer E, 2010, CLIN J AM SOC NEPHRO, V6, P361; R Development Core Team, 2011, R LANG ENV STAT COMP; ROBERTSO.GL, 1973, J CLIN INVEST, V52, P2340, DOI 10.1172/JCI107423; Roussel R, 2014, J CLIN ENDOCR METAB, V99, P4656, DOI 10.1210/jc.2014-2295; Zittema D, 2014, CLIN J AM SOC NEPHOL, V9, P1533	31	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	DEC	2015	19	6					1199	1205		10.1007/s10157-015-1101-7		7	Urology & Nephrology	Urology & Nephrology	CY7YS	WOS:000366626000026		
J	Umehara, J; Ikezoe, T; Nishishita, S; Nakamura, M; Umegaki, H; Kobayashi, T; Fujita, K; Ichihashi, N				Umehara, Jun; Ikezoe, Tome; Nishishita, Satoru; Nakamura, Masatoshi; Umegaki, Hiroki; Kobayashi, Takuya; Fujita, Kosuke; Ichihashi, Noriaki			Effect of hip and knee position on tensor fasciae latae elongation during stretching: An ultrasonic shear wave elastography study	CLINICAL BIOMECHANICS			English	Article						Ultrasonic shear wave elastography; Tensor fasciae latae; Stretching	ILIOTIBIAL BAND FRICTION; GASTROCNEMIUS-MUSCLE; TRANSIENT ELASTOGRAPHY; ELASTIC PROPERTIES; SOFT-TISSUE; HARDNESS; TRACT; OBER; VIVO	Background: Decreased flexibility of the tensor fasciae latae is one factor that causes iliotibial band syndrome. Stretching has been used to improve flexibility or tightness of the muscle. However, no studies have investigated the effective stretching position for the tensor fasciae latae using an index to quantify muscle elongation in vivo. The aim of this study was to investigate the effects of hip rotation and knee angle on tensor fasciae latae elongation during stretching in vivo using ultrasonic shear wave elastography. Methods: Twenty healthy men participated in this study. The shear elastic modulus of the tensor fasciae latae was calculated using ultrasonic shear wave elastography. Stretching was performed at maximal hip adduction and maximal hip extension in 12 different positions with three hip rotation conditions (neutral, internal, and external rotations) and four knee angles (0 degrees, 45 degrees, 90 degrees, and 135 degrees). Findings: Two-way analysis of variance showed a significant main effect for knee angle, but not for hip rotation. The post-hoc test for knee angle indicated that the shear elastic modulus at 90 degrees and 135 degrees were significantly greater than those at 0 degrees and 45 degrees. Interpretation: Our results suggest that adding hip rotation to the stretching position with hip adduction and extension may have less effect on tensor fasciae latae elongation, and that stretching at >90 degrees of knee flexion may effectively elongate the tensor fasciae latae. (C) 2015 Elsevier Ltd. All rights reserved.	[Umehara, Jun; Ikezoe, Tome; Nishishita, Satoru; Nakamura, Masatoshi; Umegaki, Hiroki; Kobayashi, Takuya; Fujita, Kosuke; Ichihashi, Noriaki] Kyoto Univ, Grad Sch Med, Human Hlth Sci, Kyoto 6068507, Japan; [Nakamura, Masatoshi] Doshisha Univ, Fac Hlth & Sports Sci, Kyoto 602, Japan	Umehara, J (reprint author), Kyoto Univ, Grad Sch Med, Human Hlth Sci, Sakyo Ku, 53 Shogoin Kawahara Cho, Kyoto 6068507, Japan.	umehara.jun.77z@st.kyoto-u.ac.jp			 [15H03043]	The authors wish to thank Dr. Satoshi Hasegawa, Assistant Professor of Graduate School of Medicine, Kyoto University for the advice on experimental design. This work was supported by the Grant-in-Aid for Scientific Research (B) 15H03043.	Akagi R, 2014, SCAND J MED SCI SPOR, V24, P950, DOI 10.1111/sms.12111; PARE EB, 1981, J BONE JOINT SURG AM, V63, P1457; SPOOR CW, 1992, J BIOMECH, V25, P201, DOI 10.1016/0021-9290(92)90276-7; Bercoff J, 2004, IEEE T ULTRASON FERR, V51, P396, DOI 10.1109/TUFFC.2004.1295425; Baker RL, 2011, PM&R, V3, P550, DOI 10.1016/j.pmrj.2011.01.002; Akagi R, 2013, MED SCI SPORT EXER, V45, P1348, DOI 10.1249/MSS.0b013e3182850e17; Gajdosik RL, 2003, CLIN BIOMECH, V18, P77; Maisetti O, 2012, J BIOMECH, V45, P978, DOI 10.1016/j.jbiomech.2012.01.009; Wang TG, 2006, ARCH PHYS MED REHAB, V87, P1407, DOI 10.1016/j.apmr.2006.06.007; MANSOUR JM, 1987, J BIOMECH, V20, P51, DOI 10.1016/0021-9290(87)90266-1; Vieira ELC, 2007, ARTHROSCOPY, V23, P269, DOI 10.1016/j.arthro.2006.11.019; Nakamura M, 2014, ULTRASOUND MED BIOL, V40, P1991, DOI 10.1016/j.ultrasmedbio.2014.03.024; Maganaris CN, 2000, EUR J APPL PHYSIOL, V83, P363, DOI 10.1007/s004210000247; Ober FR, 1936, J BONE JOINT SURG, V18, P105; Nakamura M, 2013, MANUAL THER, V18, P211, DOI 10.1016/j.math.2012.09.010; Ellis R, 2007, MANUAL THER, V12, P200, DOI 10.1016/j.math.2006.08.004; Vasilevska V, 2009, SKELETAL RADIOL, V38, P871, DOI 10.1007/s00256-009-0704-z; Nordez A, 2008, J BIOMECH, V41, P2305, DOI 10.1016/j.jbiomech.2008.03.033; DOSTAL WF, 1986, PHYS THER, V66, P351; Gennisson JL, 2005, J BIOMECH, V38, P1543, DOI 10.1016/j.jbiomech.2004.07.013; Birnbaum K, 2004, SURG RADIOL ANAT, V26, P433, DOI 10.1007/s00276-004-0265-8; Eby SF, 2013, J BIOMECH, V46, P2381, DOI 10.1016/j.jbiomech.2013.07.033; Koo TK, 2013, J BIOMECH, V46, P2053, DOI 10.1016/j.jbiomech.2013.05.016; Fetto Joseph, 2002, J Orthop Sci, V7, P724, DOI 10.1007/s007760200130; Kendall H.O., 1970, POSTURE PAIN, P135; Koo TK, 2014, CLIN BIOMECH, V29, P33, DOI 10.1016/j.clinbiomech.2013.11.009; Leong HT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067199; Louw M, 2014, PHYS THER SPORT, V15, P64, DOI 10.1016/j.ptsp.2013.07.002; Taniguchi K, 2015, SCAND J MED SCI SPOR, V25, P32, DOI 10.1111/sms.12146; Umegaki H., 2014, MAN THER, P7	30	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0268-0033	1879-1271		CLIN BIOMECH	Clin. Biomech.	DEC	2015	30	10					1056	1059		10.1016/j.clinbiomech.2015.09.007		4	Engineering, Biomedical; Orthopedics; Sport Sciences	Engineering; Orthopedics; Sport Sciences	CZ0JF	WOS:000366790400006		
J	Koyama, Y; Tateuchi, H; Nishimura, R; Ji, X; Umegaki, H; Kobayashi, M; Ichihashi, N				Koyama, Yumiko; Tateuchi, Hiroshige; Nishimura, Riho; Ji, Xiang; Umegaki, Hiroki; Kobayashi, Masashi; Ichihashi, Noriaki			Relationships between performance and kinematic/kinetic variables of stair descent in patients with medial knee osteoarthritis: An evaluation of dynamic stability using an extrapolated center of mass	CLINICAL BIOMECHANICS			English	Article						Knee osteoarthritis; Stair descent; Dynamic stability	GAIT CHARACTERISTICS; WALKING; BALANCE; ARTHROPLASTY; POPULATION; KINETICS; ASCENT; COHORT; WOMEN; PAIN	Background: The ability to descend stairs independently is impaired from a relatively early stage in patients with knee osteoarthritis. The purpose of this study was to evaluate the performance in patients with knee osteoarthritis when stepping down a step by evaluating the dynamic stability using the extrapolated center of mass. Methods: Twenty-three individuals with medial knee osteoarthritis were evaluated during step descent without any assistance. Kinematic/kinetic data were collected using a three-dimensional motion analysis system and force platforms. The extrapolated center of mass and its deviation from the anterior boundary on the base of support (margin of stability) were calculated at the initiation of descent. joint angles and internal joint moments were collected at the stance limb. The relationship between patients dynamic stability control, which was measured by the timed up and go test, and the length of margin of stability was analyzed. Relationships between the length of the margin of stability and each kinematic/kinetic variable were also evaluated. Findings: The margin of stability positively correlated with the time taken for a timed up and go test. A positive correlation was additionally observed between the ankle dorsiflexion angle and the margin of stability. It was also found that a higher ratio of ankle plantar flexion moment by support moment was associated' with a larger margin of stability. Interpretation: Patients with knee osteoarthritis who had high ability in dynamic stability control were observed to move their center of mass anteriorly at the initiation of stepping down. It was also suggested that these patients could dorsiflex their ankle joint and generate sufficient ankle plantar flexor torque. (C) 2015 Elsevier Ltd. All rights reserved.	[Koyama, Yumiko; Tateuchi, Hiroshige; Nishimura, Riho; Ji, Xiang; Umegaki, Hiroki; Ichihashi, Noriaki] Kyoto Univ, Grad Sch Med, Human Hlth Sci, Kyoto 6068507, Japan; [Kobayashi, Masashi] Kobayashi Orthoped Clin, Tsubata, Ishikawa, Japan	Koyama, Y (reprint author), Kyoto Univ, Grad Sch Med, Human Hlth Sci, Dept Phys Therapy,Sakyo Ku, 53 Kawahara Cho, Kyoto 6068507, Japan.	koyama.yumiko.52c@st.kyoto-u.ac.jp					Yoshimura N, 2009, J BONE MINER METAB, V27, P620, DOI 10.1007/s00774-009-0080-8; Kaufman KR, 2001, J BIOMECH, V34, P907, DOI 10.1016/S0021-9290(01)00036-7; WINTER DA, 1980, J BIOMECH, V13, P923, DOI 10.1016/0021-9290(80)90162-1; Major MJ, 2013, GAIT POSTURE, V38, P858, DOI 10.1016/j.gaitpost.2013.04.012; Costigan PA, 2002, GAIT POSTURE, V16, P31, DOI 10.1016/S0966-6362(01)00201-6; Bosse I, 2012, HUM MOVEMENT SCI, V31, P1560, DOI 10.1016/j.humov.2012.05.003; Kito N, 2010, CLIN BIOMECH, V25, P914, DOI 10.1016/j.clinbiomech.2010.06.008; Lewek MD, 2004, J ORTHOPAED RES, V22, P110, DOI 10.1016/S0736-0266(03)00154-2; Hicks-Little CA, 2012, J ARTHROPLASTY, V27, P1183, DOI 10.1016/j.arth.2012.01.018; Hof AL, 2007, GAIT POSTURE, V25, P250, DOI 10.1016/j.gaitpost.2006.04.013; Bedson J, 2007, FAM PRACT, V24, P443, DOI 10.1093/fampra/cmm036; Zeni JA, 2010, J BONE JOINT SURG AM, V92A, P1130, DOI 10.2106/JBJS.I.00299; Hof AL, 2008, HUM MOVEMENT SCI, V27, P112, DOI 10.1016/j.humov.2007.08.003; Kuo AD, 2005, EXERC SPORT SCI REV, V33, P88, DOI 10.1097/00003677-200504000-00006; Startzell JK, 2000, J AM GERIATR SOC, V48, P567; Arampatzis A, 2008, J BIOMECH, V41, P1754, DOI 10.1016/j.jbiomech.2008.02.022; Hicks-Little CA, 2011, MED SCI SPORT EXER, V43, P516, DOI 10.1249/MSS.0b013e3181f257be; van Dijk GM, 2010, ARCH PHYS MED REHAB, V91, P58, DOI 10.1016/j.apmr.2009.08.147; Baert IAC, 2013, CLIN BIOMECH, V28, P40, DOI 10.1016/j.clinbiomech.2012.10.007; Botolfsen Pernille, 2008, Physiother Res Int, V13, P94, DOI 10.1002/pri.394; JEVSEVAR DS, 1993, PHYS THER, V73, P229; Marmon Adam R, 2014, Int J Sports Phys Ther, V9, P168; Muraki S, 2012, ARTHRITIS RHEUM-US, V64, P1447, DOI 10.1002/art.33508; Winter D.A., 2005, BIOMECHANICS MOTOR C	24	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0268-0033	1879-1271		CLIN BIOMECH	Clin. Biomech.	DEC	2015	30	10					1066	1070		10.1016/j.clinblomech.2015.09.005		5	Engineering, Biomedical; Orthopedics; Sport Sciences	Engineering; Orthopedics; Sport Sciences	CZ0JF	WOS:000366790400008		
J	Chino, K; Takahashi, H				Chino, Kentaro; Takahashi, Hideyuki			The association of muscle and tendon elasticity with passive joint stiffness: In vivo measurements using ultrasound shear wave elastography	CLINICAL BIOMECHANICS			English	Article						Gastrocnemius muscle; Achilles tendon; Ankle joint; Joint flexibility; Elasticity imaging technique; B-mode ultrasonography	GASTROCNEMIUS-MUSCLE; ACHILLES-TENDON; ANKLE STIFFNESS; CONTRACTION; APONEUROSIS; FLEXIBILITY; LENGTH; FALLS; AGE	Background: Passive joint stiffness is associated with various tissues, including muscles, tendons, ligaments, and joint capsules. The specific elasticity of muscles or tendons can be measured using ultrasound shear wave elastography. To examine the association of muscle and tendon elasticity with passive joint stiffness, in vivo measurements of muscle and tendon elasticity were performed using ultrasound shear wave elastography. Methods: In 25 subjects, passive ankle joint stiffness was determined using the joint angle-passive torque relationship. The stiffness index of the muscle belly of the medial gastrocnemius (MG) influenced by the muscle fascicles, its aponeuroses, and the proximal tendon was quantified by the displacement of the muscle-tendon junction, which was visualized using B-mode ultrasonography during passive dorsiflexion. The stiffness index of the Achilles tendon influenced by the tendon and the ligaments and joint capsule of the ankle was similarly determined. The MG and Achilles tendon elasticity was measured using ultrasound shear wave elastography. Findings: Simple regression indicated a significant correlation between passive joint stiffness and stiffness index of the MG muscle belly (r = 0.80) and Achilles tendon (r = 0.60), but no correlation with elasticity of the MG (r = 0.37) or Achilles tendon (r = 039). Interpretation: Individual variations in the elasticity of either the MG or Achilles tendon are not associated with variations in passive ankle joint stiffness; however, variations in the elasticity of other tissues, including MG aponeuroses or the ligaments and joint capsule of the ankle, would be associated with the variations in joint stiffness. (C) 2015 Elsevier Ltd. All rights reserved.	[Chino, Kentaro; Takahashi, Hideyuki] Japan Inst Sports Sci, Dept Sports Sci, Kita Ku, Tokyo 1150056, Japan	Chino, K (reprint author), Japan Inst Sports Sci, Kita Ku, 3-15-1 Nishigaoka, Tokyo 1150056, Japan.	kentaro.chino@jpnsport.go.jp			JSPS [24700695]	This study was supported by JSPS KAKENHI, Grant Number #24700695.	Arda K, 2011, AM J ROENTGENOL, V197, P532, DOI 10.2214/AJR.10.5449; GEHLSEN GM, 1990, ARCH PHYS MED REHAB, V71, P739; Kawakami Y, 2008, J ORTHOP SPORT PHYS, V38, P269, DOI 10.2519/jospt.2008.2632; Riemann BL, 2001, J ATHL TRAINING, V36, P369; Muraoka T, 2004, CELLS TISSUES ORGANS, V178, P197, DOI 10.1159/000083731; Gennisson JL, 2003, J ACOUST SOC AM, V114, P536, DOI 10.1121/1.1579008; Bercoff J, 2004, IEEE T ULTRASON FERR, V51, P396, DOI 10.1109/TUFFC.2004.1295425; Menz HB, 2006, J GERONTOL A-BIOL, V61, P866; Akagi R, 2013, MED SCI SPORT EXER, V45, P1348, DOI 10.1249/MSS.0b013e3182850e17; Maisetti O, 2012, J BIOMECH, V45, P978, DOI 10.1016/j.jbiomech.2012.01.009; Muramatsu T, 2002, J BIOMECH, V35, P217, DOI 10.1016/S0021-9290(01)00196-8; Riener R, 1999, J BIOMECH, V32, P539, DOI 10.1016/S0021-9290(99)00009-3; Shinohara M, 2010, MUSCLE NERVE, V42, P438, DOI 10.1002/mus.21723; Magnusson SP, 1998, SCAND J MED SCI SPOR, V8, P65; Salsich GB, 2000, PHYS THER, V80, P352; Muraoka T, 2002, CELLS TISSUES ORGANS, V171, P260, DOI 10.1159/000063128; CHESWORTH BM, 1989, PHYS THER, V69, P217; Hug F, 2013, J BIOMECH, V46, P2534, DOI 10.1016/j.jbiomech.2013.07.015; Kawakami Y, 1998, J APPL PHYSIOL, V85, P398; Gennisson J-L, 2013, Diagn Interv Imaging, V94, P487, DOI 10.1016/j.diii.2013.01.022; Gleim G W, 1997, Sports Med, V24, P289; Grieve D. W., 1978, BIOMECHANICS A, P405; Knudson DV, 2000, PRES COUNCIL PHYS FI, V3, P1; Muraoka T., 2005, IJSHS, V3, P303; Nitz JC, 2004, NZ J PHYSIOTHER, V32, P121; The American Orthopaedic Society for Sports Medicine, 2008, FLEX STRETCH AOSSM S	26	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0268-0033	1879-1271		CLIN BIOMECH	Clin. Biomech.	DEC	2015	30	10					1230	1235		10.1016/j.clinbiomech.2015.07.014		6	Engineering, Biomedical; Orthopedics; Sport Sciences	Engineering; Orthopedics; Sport Sciences	CZ0JF	WOS:000366790400033		
J	Dong, CH; Chen, YW; Foruzan, AH; Lin, LF; Han, XH; Tateyama, T; Wu, X; Xu, G; Jiang, HY				Dong, Chunhua; Chen, Yen-wei; Foruzan, Amir Hossein; Lin, Lanfen; Han, Xian-hua; Tateyama, Tomoko; Wu, Xing; Xu, Gang; Jiang, Huiyan			Segmentation of liver and spleen based on computational anatomy models	COMPUTERS IN BIOLOGY AND MEDICINE			English	Article						Multiple organs segmentation; Template matching; Organ bounding box; Iterative probabilistic atlas; Computational anatomy model	PROBABILISTIC ATLAS; CT IMAGES; AUTOMATED SEGMENTATION; ACTIVE CONTOURS; HUMAN BRAIN; GRAPH-CUTS; CONSTRUCTION; ALGORITHM; FORESTS; REGION	Accurate segmentation of abdominal organs is a key step in developing a computer-aided diagnosis (CAD) system. Probabilistic atlas based on human anatomical structure, used as a priori information in a Bayes framework, has been widely used for organ segmentation. How to register the probabilistic atlas to the patient volume is the main challenge. Additionally, there is the disadvantage that the conventional probabilistic atlas may cause a bias toward the specific patient study because of the single reference. Taking these into consideration, a template matching framework based on an iterative probabilistic atlas for liver and spleen segmentation is presented in this paper. First, a bounding box based on human anatomical localization, which refers to the statistical geometric location of the organ, is detected for the candidate organ. Then, the probabilistic atlas is used as a template to find the organ in this bounding box by using template matching technology. We applied our method to 60 datasets including normal and pathological cases. For the liver, the Dice/Tanimoto volume overlaps were 0.930/0.870, the root-mean-squared error (RMSE) was 2.906 mm. For the spleen, quantification led to 0.922 Dice/0.857 Tanimoto overlaps, 1.992 mm RMSE. The algorithm is robust in segmenting normal and abnormal spleens and livers, such as the presence of tumors and large morphological changes. Comparing our method with conventional and recently developed atlas-based methods, our results show an improvement in the segmentation accuracy for multi-organs (p < 0.00001). (C) 2015 Elsevier Ltd. All rights reserved.	[Dong, Chunhua; Chen, Yen-wei; Han, Xian-hua; Tateyama, Tomoko; Wu, Xing; Xu, Gang] Ritsumeikan Univ, Grad Sch Informat Sci & Engn, Kusatsu, Japan; [Foruzan, Amir Hossein] Shahed Univ, Dept Biomed Engn, Fac Engn, Tehran, Iran; [Chen, Yen-wei; Lin, Lanfen] Zhejiang Univ, Coll Comp Sci & Technol, Hangzhou, Zhejiang, Peoples R China; [Jiang, Huiyan] Northeastern Univ, Coll Software, Shenyang, Peoples R China	Chen, YW (reprint author), Ritsumeikan Univ, Grad Sch Informat Sci & Engn, Noji Higashi 1-1-1, Kusatsu, Japan.	dongchunhua89@gmail.com; chen@is.ritsumei.ac.jp			Japanese Ministry for Education, Science, Culture and Sports (MEXT) [2430076, 15H01130]; MEXT Support Program for the Strategic Research Foundation at Private Universities; R-GIRO Research Fund from Ritsumeikan University; National Science and Technology Support Program of China [2013BAF02B10]; Recruitment Program of Global Experts (HAIOU Program) from Zhejiang Province, China	This research was supported in part by the Grant-in Aid for Scientific Research from the Japanese Ministry for Education, Science, Culture and Sports (MEXT) under the Grant No. 2430076 and No. 15H01130, in part by the MEXT Support Program for the Strategic Research Foundation at Private Universities (2013-2017), in part by the R-GIRO Research Fund from Ritsumeikan University, in part by National Science and Technology Support Program of China under the Grant no. 2013BAF02B10, and in part by the Recruitment Program of Global Experts (HAIOU Program) from Zhejiang Province, China.	ADAMS R, 1994, IEEE T PATTERN ANAL, V16, P641, DOI 10.1109/34.295913; Andrews S., 2010, IEEE INT C MED IM CO, P9; Criminisi A, 2011, LECT NOTES COMPUT SC, V6533, P106, DOI 10.1007/978-3-642-18421-5_11; Lee M, 2012, COMPUT BIOL MED, V42, P523, DOI 10.1016/j.compbiomed.2012.01.005; Park H, 2003, IEEE T MED IMAGING, V22, P483, DOI 10.1109/TMI.2003.809139; Grady L, 2006, IEEE T PATTERN ANAL, V28, P1768, DOI 10.1109/TPAMI.2006.233; Karasev P, 2013, IEEE T MED IMAGING, V32, P2127, DOI 10.1109/TMI.2013.2274734; Gall J, 2009, PROC CVPR IEEE, P1022; Boykov Y, 2006, INT J COMPUT VISION, V70, P109, DOI 10.1007/s11263-006-7934-5; Peng JL, 2014, PATTERN RECOGN LETT, V43, P81, DOI 10.1016/j.patrec.2013.07.010; Li BN, 2011, COMPUT BIOL MED, V41, P1, DOI 10.1016/j.compbiomed.2010.10.007; Linguraru MG, 2010, MED PHYS, V37, P771, DOI 10.1118/1.3284530; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293; Xiong W, 2009, 2009 16TH IEEE INTERNATIONAL CONFERENCE ON IMAGE PROCESSING, VOLS 1-6, P1773; Zhang X, 2010, IEEE ENG MED BIO, P5351; Umetsu S, 2014, IEICE T INF SYST, VE97D, P951, DOI 10.1587/transinf.E97.D.951; Joshi S, 2004, NEUROIMAGE, V23, pS151, DOI 10.1016/j.neuroimage.2004.07.068; Lorenzo-Valdes M, 2004, MED IMAGE ANAL, V8, P255, DOI 10.1016/j.media.2004.06.005; Thompson PM, 2000, HUM BRAIN MAPP, V9, P81, DOI 10.1002/(SICI)1097-0193(200002)9:2<81::AID-HBM3>3.0.CO;2-8; Shimizu A, 2007, INT J COMPUT ASS RAD, V2, P135, DOI 10.1007/s11548-007-0135-z; Foruzan AH, 2013, IEICE T INF SYST, VE96D, P798, DOI 10.1587/transinf.E96.D.798; Peyrat JM, 2007, IEEE T MED IMAGING, V26, P1500, DOI 10.1109/TMI.2007.907286; Heimann T, 2009, IEEE T MED IMAGING, V28, P1251, DOI 10.1109/TMI.2009.2013851; Lu DF, 2015, COMPUT MED IMAG GRAP, V43, P1, DOI 10.1016/j.compmedimag.2015.01.006; Zhou X, 2005, INT CONGR SER, V1281, P1169, DOI 10.1016/j.ics.2005.03.079; Staal J, 2004, LECT NOTES COMPUT SC, V3117, P193; Caselles V, 1997, INT J COMPUT VISION, V22, P61, DOI 10.1023/A:1007979827043; Chen YW, 2010, LECT NOTES COMPUT SC, V6064, P162; Duay V., 2005, IEEE INT C IM PROC, V2, P1286; Heimann T., 2007, IEEE INT C MICCAI WO; Juszczyk J., 2015, J COMP IN PRESS 0302; Kainmuller D., 2007, IEEE INT C MICCAI WO, P109; Kasiri K., 2010, IEEE C IM PROC THEOR, P306; Lee J., 2007, IEEE INT C MICCAI WO, P189, DOI 10.1115/1.802655.paper29; Li C. Y., 2010, IEEE INT C IM PROC I, P1522; Okada T., 2008, J ACAD RADIOL, V63, P1390; Okada T., 2008, IEEE INT C MED IM CO, V5242, P502; Pan Z. G., 2004, J COMPUT SCI ENG, V9, P32; Saddi K. A., 2007, IEEE INT C MICCAI WO, P207; Torralba A., 2007, IEEE T PATTERN ANAL, V22, P859; van Rilcxoort Y. A. E., 2007, IEEE INT C MICCAI WO, P101; Yamaguchi S., 2014, J COMPUT BIOL MED, V55, P79; Zhang J., 2008, INT C COMP SCI SOFTW, V6, P105; Zhao K., 2010, IEEE ICHQP, P1; Zhou S., 2005, IEEE INT C COMP VIS, V1, P17; Zhou S. K., 2007, ICCV, P1; Zhou X, 2012, IEEE INT C SPIE MED, V8314, pE; Zhou X., 2006, IEEE INT C MED IM CO, P856	48	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0010-4825	1879-0534		COMPUT BIOL MED	Comput. Biol. Med.	DEC 1	2015	67						146	160		10.1016/j.compbiomed.2015.10.007		15	Biology; Computer Science, Interdisciplinary Applications; Engineering, Biomedical; Mathematical & Computational Biology	Life Sciences & Biomedicine - Other Topics; Computer Science; Engineering; Mathematical & Computational Biology	CY9ZY	WOS:000366766100015		
J	Giordano, D; Nichols, ARL; Potuzak, M; Di Genova, D; Romano, C; Russell, JK				Giordano, D.; Nichols, A. R. L.; Potuzak, M.; Di Genova, D.; Romano, C.; Russell, J. K.			Heat capacity of hydrous trachybasalt from Mt Etna: comparison with CaAl2Si2O8 (An)-CaMgSi2O6 (Di) as basaltic proxy compositions	CONTRIBUTIONS TO MINERALOGY AND PETROLOGY			English	Article						Specific heat; Etna trachybasalt; Anorthite-diopside; Hydrous silicate melts	GLASS-TRANSITION TEMPERATURES; SILICATE MELTS; CONFIGURATIONAL ENTROPY; ALUMINOSILICATE GLASSES; PHASE-RELATIONS; VISCOSITY; LIQUIDS; MAGMAS; WATER; MODEL	The specific heat capacity (C-p) of six variably hydrated (similar to 3.5 wt% H2O) iron-bearing Etna trachybasaltic glasses and liquids has been measured using differential scanning calorimetry from room temperature across the glass transition region. These data are compared to heat capacity measurements on thirteen melt compositions in the iron-free anorthite (An)-diopside (Di) system over a similar range of H2O contents. These data extend considerably the published C-p measurements for hydrous melts and glasses. The results for the Etna trachybasalts show nonlinear variations in, both, the heat capacity of the glass at the onset of the glass transition (i.e., C-p(g)) and the fully relaxed liquid (i.e., C-p(l)) with increasing H2O content. Similarly, the "configurational heat capacity" (i.e., C-p(c) = C-p(l) - C-p(g)) varies nonlinearly with H2O content. The An-Di hydrous compositions investigated show similar trends, with C-p values varying as a function of melt composition and H2O content. The results show that values in hydrous C-p(g), C-p(l) and C-p(c) in the depolymerized glasses and liquids are substantially different from those observed for more polymerized hydrous albitic, leucogranitic, trachytic and phonolitic multicomponent compositions previously investigated. Polymerized melts have lower C-p(l) and C-p(c) and higher C-p(g) with respect to more depolymerized compositions. The covariation between C-p values and the degree of polymerization in glasses and melts is well described in terms of SMhydrous and NBO/T-hydrous. Values of C-p(c) increase sharply with increasing depolymerization up to SMhydrous similar to 30-35 mol% (NBO/T-hydrous similar to 0.5) and then stabilize to an almost constant value. The partial molar heat capacity of H2O for both glasses (C-p(H2O)g) and liquids (C-p(l) (H2O)) appears to be independent of composition and, assuming ideal mixing, we obtain a value for C-p(l) (H2O) of 79 J mol(-1) K-1. However, we note that a range of values for C-p(H2O)l (i.e., similar to 78-87 J mol(-1) K-1) proposed by previous workers will reproduce the extended data to within experimental uncertainty. Our analysis suggests that more data are required in order to ascribe a compositional dependence (i.e., nonideal mixing) to C-p(l) (H2O).	[Giordano, D.] Univ Turin, Dipartimento Sci Terra, I-10125 Turin, Italy; [Nichols, A. R. L.] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Res & Dev Ctr Ocean Drilling Sci, Yokosuka, Kanagawa 2370061, Japan; [Potuzak, M.] Corning Inc, Div Sci & Technol, Corning, NY 14831 USA; [Di Genova, D.] Univ Munich, Dept Earth & Environm Sci, D-80333 Munich, Germany; [Romano, C.] Univ Roma Tre, Dipartimento Sci, I-00146 Rome, Italy; [Russell, J. K.] Univ British Columbia, Dept Earth Ocean & Atmospher Sci, Vancouver, BC V6T 1Z4, Canada	Giordano, D (reprint author), Univ Turin, Dipartimento Sci Terra, Via Valperga Caluso 35, I-10125 Turin, Italy.	daniele.giordano@unito.it					Avramov I, 2013, J NON-CRYST SOLIDS, V362, P120, DOI 10.1016/j.jnoncrysol.2012.11.008; PYLE DM, 1995, GEOPHYS RES LETT, V22, P563, DOI 10.1029/95GL00052; Di Muro A, 2009, CHEM GEOL, V259, P78, DOI 10.1016/j.chemgeo.2008.08.013; SACK RO, 1994, CONTRIB MINERAL PETR, V116, P287, DOI 10.1007/BF00306498; Russell JK, 2005, GEOCHIM COSMOCHIM AC, V69, P5333, DOI 10.1016/j.gca.2005.06.019; Russell JK, 2003, AM MINERAL, V88, P1390; Di Genova D, 2014, GEOCHIM COSMOCHIM AC, V142, P314, DOI 10.1016/j.gca.2014.07.012; GHIORSO MS, 1995, CONTRIB MINERAL PETR, V119, P197, DOI 10.1007/BF00307281; COURTIAL P, 1993, GEOCHIM COSMOCHIM AC, V57, P1267, DOI 10.1016/0016-7037(93)90063-3; LANGE RA, 1992, CONTRIB MINERAL PETR, V110, P311, DOI 10.1007/BF00310746; Bouhifd MA, 2013, CHEM GEOL, V346, P125, DOI 10.1016/j.chemgeo.2012.10.026; Navrotsky A, 1995, REV MINERAL, V32, P121; Mercier M, 2009, GEOCHIM COSMOCHIM AC, V73, P197, DOI 10.1016/j.gca.2008.09.030; Sahagian DL, 1996, J VOLCANOL GEOTH RES, V74, P19, DOI 10.1016/S0377-0273(96)00047-9; Whittington A, 2000, GEOCHIM COSMOCHIM AC, V64, P3725, DOI 10.1016/S0016-7037(00)00448-8; Webb SL, 2008, CHEM GEOL, V256, P92, DOI 10.1016/j.chemgeo.2008.04.003; Behrens H, 1996, CHEM GEOL, V128, P41, DOI 10.1016/0009-2541(95)00162-X; Toplis MJ, 1997, AM MINERAL, V82, P979; RICHET P, 1985, GEOCHIM COSMOCHIM AC, V49, P471, DOI 10.1016/0016-7037(85)90039-0; Toplis MJ, 1998, AM MINERAL, V83, P480; [Anonymous], 1990, REV MINERAL; [Anonymous], 1992, ADV PHYS GEOCHEM; Chevrel MO, 2013, CHEM GEOL, V346, P93, DOI 10.1016/j.chemgeo.2012.09.004; Stebbins JF, 2008, CHEM GEOL, V256, P80, DOI 10.1016/j.chemgeo.2008.03.011; Giordano D, 2008, EARTH PLANET SC LETT, V271, P123, DOI 10.1016/j.epsl.2008.03.038; Whittington A, 2001, CHEM GEOL, V174, P209, DOI 10.1016/S0009-2541(00)00317-X; CLEMENS JD, 1987, J GEOL, V95, P173; NAVROTSKY A, 1980, GEOCHIM COSMOCHIM AC, V44, P1409, DOI 10.1016/0016-7037(80)90107-6; Giordano D, 2009, GEOCHIM COSMOCHIM AC, V73, P6613, DOI 10.1016/j.gca.2009.07.033; Giordano D, 2005, J VOLCANOL GEOTH RES, V142, P105, DOI 10.1016/j.jvolgeores.2004.10.015; Giordano D, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/20/205148; Whittington AG, 2009, AM MINERAL, V94, P1, DOI 10.2138/am.2009.2892; Fulcher GS, 1925, J AM CERAM SOC, V8, P339, DOI 10.1111/j.1151-2916.1925.tb16731.x; STEBBINS JF, 1984, CONTRIB MINERAL PETR, V86, P131, DOI 10.1007/BF00381840; Behrens H, 2003, GLASS SCI TECHNOL, V76, P176; DINGWELL DB, 1991, AM MINERAL, V76, P1560; Perugini D, 2005, GEOLOGY, V33, P5, DOI 10.1130/G21075.1; Richet P, 1995, REV MINERAL, V32, P67; Giordano D, 2008, CHEM GEOL, V256, P203, DOI 10.1016/j.chemgeo.2008.06.027; Bowen NL, 1915, AM J SCI, V40, P161; Bouhifd MA, 2006, GEOCHIM COSMOCHIM AC, V70, P711, DOI 10.1016/j.gca.2005.09.012; RICHET P, 1987, CHEM GEOL, V62, P111, DOI 10.1016/0009-2541(87)90062-3; Russell JK, 2002, EUR J MINERAL, V14, P417, DOI 10.1127/0935-1221/2002/0014-0417; BURNHAM CW, 1974, AM J SCI, V274, P902; Toplis MJ, 2001, GEOCHIM COSMOCHIM AC, V65, P1985, DOI 10.1016/S0016-7037(01)00594-4; ADAM G, 1965, J CHEM PHYS, V43, P139, DOI 10.1063/1.1696442; Giordano D, 2003, B VOLCANOL, V65, P8, DOI 10.1007/s00445-002-0233-2; RICHET P, 1984, GEOCHIM COSMOCHIM AC, V48, P471, DOI 10.1016/0016-7037(84)90275-8; Potuzak M, 2008, EARTH PLANET SC LETT, V270, P54, DOI 10.1016/j.epsl.2008.03.018; Knoche R, 1993, THESIS; Kushiro I, 1973, CARNEGIE I WASHINGTO, V72, P502; Maier CG, 1932, J AM CHEM SOC, V54, P3243, DOI 10.1021/ja01347a029; Moynihan C.T., 1995, STRUCTURE DYNAMICS P, V32, P1; Mysen BO, 1988, STRUCTURE PROPERTIES; Press W H, 1986, NUMERICAL RECIPES AR; Weill DF, 1980, PHYSICS MAGMATIC PRO, P49	56	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0010-7999	1432-0967		CONTRIB MINERAL PETR	Contrib. Mineral. Petrol.	DEC	2015	170	5-6							48	10.1007/s00410-015-1196-6		23	Geochemistry & Geophysics; Mineralogy	Geochemistry & Geophysics; Mineralogy	CZ0OP	WOS:000366805800008		
J	Kato, H; Fujita, T				Kato, Hiroki; Fujita, Takashi			RIG-I-like receptors and autoimmune diseases	CURRENT OPINION IN IMMUNOLOGY			English	Review							SYSTEMIC-LUPUS-ERYTHEMATOSUS; AICARDI-GOUTIERES SYNDROME; SINGLETON-MERTEN SYNDROME; SELECTIVE IGA DEFICIENCY; DOUBLE-STRANDED-RNA; ANTIVIRAL RESPONSES; IFIH1; RECOGNITION; MDA5; ASSOCIATION	Type I interferon (IFN) plays an essential role in antiviral innate immune responses and also in adaptive immune responses. Defects in the production of IFN markedly increase susceptibility to viral invasion and attenuate the acquired immunity. Recently an increased expression of type I IFN, also termed IFN signature, has been reported in patients with autoimmune diseases such as systemic lupus erythematosus (SLE) and Aicardi-Goutieres syndrome (AGS). The evidence clearly shows that the initiation and termination of IFN production should be tightly controlled. RIG-I-like receptors (RLRs) are viral RNA sensors and are essential for type I IFN induction. We herein summarize recent reports on RLR mutations in patients and MDA5 mutant mice, and discuss possible mechanisms by which aberrant activation of RLRs can cause autoimmunity.	[Kato, Hiroki; Fujita, Takashi] Kyoto Univ, Inst Virus Res, Mol Genet Lab, Kyoto 606, Japan; [Kato, Hiroki; Fujita, Takashi] Kyoto Univ, Grad Sch Biostudies, Lab Mol & Cellular Immunol, Kyoto, Japan; [Kato, Hiroki] Sci & Technol Agcy JST, PRESTO, Kawaguchi, Saitama 3320012, Japan	Fujita, T (reprint author), Kyoto Univ, Inst Virus Res, Mol Genet Lab, Kyoto 606, Japan.	tfujita@virus.kyoto-u.ac.jp					Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; Rice GI, 2014, NAT GENET, V46, P503, DOI 10.1038/ng.2933; Nakashima R, 2010, RHEUMATOLOGY, V49, P433, DOI 10.1093/rheumatology/kep375; Dale RC, 2000, NEUROPEDIATRICS, V31, P155, DOI 10.1055/s-2000-7492; Peisley A, 2011, P NATL ACAD SCI USA, V108, P21010, DOI 10.1073/pnas.1113651108; Oda H, 2014, AM J HUM GENET, V95, P121, DOI 10.1016/j.ajhg.2014.06.007; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Ferreira RC, 2010, NAT GENET, V42, P777, DOI 10.1038/ng.644; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kell AM, 2015, VIROLOGY, V479, P110, DOI 10.1016/j.virol.2015.02.017; Cai X, 2014, MOL CELL, V54, P289, DOI 10.1016/j.molcel.2014.03.040; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Crow YJ, 2004, AM J MED GENET A, V129A, P303, DOI 10.1002/ajmg.a.30250; Napirei M, 2000, NAT GENET, V25, P177; Sato S, 2009, ARTHRITIS RHEUM-US, V60, P2193, DOI 10.1002/art.24621; Ferreira RC, 2014, DIABETES, V63, P2538, DOI 10.2337/db13-1777; Pisitkun P, 2006, SCIENCE, V312, P1669, DOI 10.1126/science.1124978; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zouk H, 2014, AUTOIMMUNITY, V47, P40, DOI 10.3109/08916934.2013.832758; Rehwinkel J, 2010, CELL, V140, P397, DOI 10.1016/j.cell.2010.01.020; Dou QY, 2014, IMMUNOL INVEST, V43, P627, DOI 10.3109/08820139.2014.909455; Jaidane H, 2008, DIABETES METAB, V34, P537, DOI 10.1016/j.diabet.2008.05.008; Satoh T, 2010, P NATL ACAD SCI USA, V107, P1512, DOI 10.1073/pnas.0912986107; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Davis ME, 2015, VIROLOGY, V479, P52, DOI 10.1016/j.virol.2015.02.033; Robinson T, 2011, J IMMUNOL, V187, P1298, DOI 10.4049/jimmunol.1100857; Crampton SP, 2012, J IMMUNOL, V188, P1451, DOI 10.4049/jimmunol.1102705; Mohan C, 2015, NAT REV NEPHROL, V11, P329, DOI 10.1038/nrneph.2015.33; Yoneyama M, 2005, J IMMUNOL, V175, P2851; Yoneyama M, 2015, CURR OPIN IMMUNOL, V32, P48, DOI 10.1016/j.coi.2014.12.012; Wu B, 2015, CURR OPIN VIROL, V12, P91, DOI 10.1016/j.coviro.2015.04.004; Schuberth-Wagner C, 2015, IMMUNITY, V43, P41, DOI 10.1016/j.immuni.2015.06.015; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Deane JA, 2007, IMMUNITY, V27, P801, DOI 10.1016/j.immuni.2007.09.009; Van Eyck L, 2015, ARTHRITIS RHEUMATOL, V67, P1592, DOI 10.1002/art.39110; Crow YJ, 2009, HUM MOL GENET, V18, pR130, DOI 10.1093/hmg/ddp293; Bruns AM, 2015, CYTOKINE, V74, P198, DOI 10.1016/j.cyto.2015.02.010; Bursztejn AC, 2015, BR J DERMATOL; Graham DSC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002341; Funabiki M, 2014, IMMUNITY, V40, P199, DOI 10.1016/j.immuni.2013.12.014; Goubau D, 2014, NATURE, V514, P372, DOI 10.1038/nature13590; Jakobsen MR, 2014, CYTOKINE GROWTH F R, V25, P649, DOI 10.1016/j.cytogfr.2014.06.004; Jang MA, 2015, AM J HUM GENET, V96, P266, DOI 10.1016/j.ajhg.2014.11.019; Liddicoat BJ, 2015, SCIENCE; Rutsch F, 2015, AM J HUM GENET, V96, P275, DOI 10.1016/j.ajhg.2014.12.014; Takeda K, 2015, CURR PROTOC IMMUNOL, V109; Varzari A, 2014, J NEUROIMMUNOL, V277, P140, DOI 10.1016/j.jneuroim.2014.09.015	47	0	0	CURRENT BIOLOGY LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0952-7915	1879-0372		CURR OPIN IMMUNOL	Curr. Opin. Immunol.	DEC	2015	37						40	45		10.1016/j.coi.2015.10.002		6	Immunology	Immunology	CZ0FK	WOS:000366780300008		
J	Asai, S; Shirasu, K				Asai, Shuta; Shirasu, Ken			Plant cells under siege: plant immune system versus pathogen effectors	CURRENT OPINION IN PLANT BIOLOGY			English	Review							CHITIN-TRIGGERED IMMUNITY; PHYTOPHTHORA-INFESTANS; SALICYLIC-ACID; INNATE IMMUNITY; COLLETOTRICHUM FUNGI; PROTEASE INHIBITOR; MAGNAPORTHE-ORYZAE; DOWNY MILDEW; ARABIDOPSIS; BACTERIAL	Pathogen-secreted effector proteins enable pathogens to manipulate plant immunity for successful infection. To penetrate host apoplastic space, pathogens reopen the stomata. Once the invasion into the apoplast occurs, pathogens deceive the host detection system by deploying apoplastic effectors. Pathogens also deliver an arsenal of cytosolic effectors into the host cells, which undermine host immunity such as salicylic acid (SA)-dependent immunity. Here we summarize recent findings that highlight the functions of the effectors from fungal, oomycete and bacterial pathogens in the key steps of infection at the stomata, in the apoplast, and inside the cell. We also discuss cell type-specific responses in the host during infection and the necessity of further investigation of plant pathogen interactions at spatial and temporal resolution.	[Asai, Shuta; Shirasu, Ken] RIKEN, Ctr Sustainable Resource Sci, Yokohama, Kanagawa 2300045, Japan	Asai, S (reprint author), RIKEN, Ctr Sustainable Resource Sci, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	shuta.asai@riken.jp; ken.shirasu@riken.jp			JSPS KAKENHI [15K18651, 24228008, 15H05959]; RIKEN Special Postdoctoral Research Fellowship	Our work is supported by JSPS KAKENHI 15K18651 (SA), 24228008 (KS) and 15H05959 (KS), and RIKEN Special Postdoctoral Research Fellowship (SA). We thank Tolga O Bozkurt, Alberto P. Macho, Simon B Saucet, Yasuhiro Kadota, Timothy Westlake, and Shigeyuki Tanaka for critically reading the manuscript.	Anderson RG, 2012, PLANT J; Mustroph A, 2009, P NATL ACAD SCI USA, V106, P18843, DOI 10.1073/pnas.0906131106; Grimmer MK, 2012, J EXP BOT, V63, P4321, DOI 10.1093/jxb/ers143; Tian MY, 2005, PLANT PHYSIOL, V138, P1785, DOI 10.1104/pp.105.061226; Jelenska J, 2007, CURR BIOL, V17, P499, DOI 10.1016/j.cub.2007.02.028; Naito K, 2008, MOL PLANT MICROBE IN, V21, P1165, DOI 10.1094/MPMI-21-9-1165; Rovenich H, 2014, CURR OPIN PLANT BIOL, V20, P96, DOI 10.1016/j.pbi.2014.05.001; Macho AP, 2015, CURR OPIN MICROBIOL, V23, P14, DOI 10.1016/j.mib.2014.10.009; Tian MY, 2007, PLANT PHYSIOL, V143, P364, DOI 10.1104/pp.106.090050; Mentlak TA, 2012, PLANT CELL, V24, P322, DOI 10.1105/tpc.111.092957; Deal RB, 2011, NAT PROTOC, V6, P56, DOI 10.1038/nprot.2010.175; Coates ME, 2010, ANNU REV PHYTOPATHOL, V48, P329, DOI 10.1146/annurev-phyto-080508-094422; van Esse HP, 2007, MOL PLANT MICROBE IN, V20, P1092, DOI 10.1094/MPMI-20-9-1092; Lo Presti L, 2015, ANNU REV PLANT BIOL, V66, P513, DOI 10.1146/annurev-arplant-043014-114623; Galan JE, 2014, ANNU REV MICROBIOL, V68, P415, DOI 10.1146/annurev-micro-092412-155725; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Zhou JG, 2014, PLANT J, V77, P235, DOI 10.1111/tpj.12381; Skibbe DS, 2010, SCIENCE, V328, P89, DOI 10.1126/science.1185775; DebRoy S, 2004, P NATL ACAD SCI USA, V101, P9927, DOI 10.1073/pnas.0401601101; Birnbaum K, 2005, NAT METHODS, V2, P615, DOI 10.1038/nmeth0805-615; van den Burg HA, 2006, MOL PLANT MICROBE IN, V19, P1420, DOI 10.1094/MPMI-19-1420; Shabab M, 2008, PLANT CELL, V20, P1169, DOI 10.1105/tpc.107.056325; van Damme M, 2008, PLANT J, V54, P785, DOI 10.1111/j.1365-313X.2008.03427.x; Nomura K, 2006, SCIENCE, V313, P220, DOI 10.1126/science.1129523; Ballare CL, 2011, TRENDS PLANT SCI, V16, P249, DOI 10.1016/j.tplants.2010.12.001; Mukhtar MS, 2011, SCIENCE, V333, P596, DOI 10.1126/science.1203659; Melotto M, 2006, CELL, V126, P969, DOI 10.1016/j.cell.2006.06.054; Wang YJ, 2010, PLANT CELL, V22, P2033, DOI 10.1105/tpc.110.075697; O'Connell RJ, 2012, NAT GENET, V44, P1060, DOI 10.1038/ng.2372; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; Marshall R, 2011, PLANT PHYSIOL, V156, P756, DOI 10.1104/pp.111.176347; Zhang KW, 2013, P NATL ACAD SCI USA, V110, P14807, DOI 10.1073/pnas.1302702110; Song J, 2009, P NATL ACAD SCI USA, V106, P1654, DOI 10.1073/pnas.0809201106; Kazan K, 2014, PLANT CELL, V26, P2285, DOI 10.1105/tpc.114.125419; de Jonge R, 2010, SCIENCE, V329, P953, DOI 10.1126/science.1190859; Win J, 2007, PLANT CELL, V19, P2349, DOI 10.1105/tpc.107.051037; Nomura K, 2011, P NATL ACAD SCI USA, V108, P10774, DOI 10.1073/pnas.1103338108; Lozano-Duran R, 2014, NEW PHYTOL, V202, P259, DOI 10.1111/nph.12651; Gan P, 2013, NEW PHYTOL, V197, P1236, DOI 10.1111/nph.12085; Doehlemann G, 2013, NEW PHYTOL, V198, P1001, DOI 10.1111/nph.12277; Djamei A, 2011, NATURE, V478, P395, DOI 10.1038/nature10454; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Khang CH, 2010, PLANT CELL, V22, P1388, DOI 10.1105/tpc.109.069666; Kaschani F, 2010, PLANT PHYSIOL, V154, P1794, DOI 10.1104/pp.110.158030; Jelenska J, 2010, P NATL ACAD SCI USA, V107, P13177, DOI 10.1073/pnas.0910943107; Tian MY, 2004, J BIOL CHEM, V279, P26370, DOI 10.1074/jbc.M400941200; Giraldo MC, 2013, NAT REV MICROBIOL, V11, P800, DOI 10.1038/nrmicro3119; Nelson T, 2006, ANNU REV PLANT BIOL, V57, P181, DOI 10.1146/annurev.arplant.56.032604.144138; Ustun S, 2015, PLANT PHYSIOL, V168, P107, DOI 10.1104/pp.15.00132; Bozkurt TO, 2011, P NATL ACAD SCI USA, V108, P20832, DOI 10.1073/pnas.1112708109; Zeng WQ, 2010, PLANT PHYSIOL, V153, P1188, DOI 10.1104/pp.110.157016; Caillaud MC, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001732; Dong SM, 2014, SCIENCE, V343, P552, DOI 10.1126/science.1246300; Gimenez-Ibanez S, 2014, PLOS BIOL, V12; Gimenez-Ibanez S, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00072; Giraldo M. C., 1996, NAT COMMUN, V4, P1996; Hurley B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114921; Jacobs JM, 2013, MBIO, V4; Jiang SS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003715; Kombrink A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003769; Kubicek CP, 2014, ANNU REV PHYTOPATHOL, V52, P427, DOI 10.1146/annurev-phyto-102313-045831; Liu TL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5686; Liu WD, 2014, ANNU REV PHYTOPATHOL, V52, P213, DOI 10.1146/annurev-phyto-102313-045926; Montillet JL, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001513; Mueller AN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003177; Sanchez-Vallet A, 2013, ELIFE, V2, DOI 10.7554/eLife.00790; Tanaka S, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00349; Ustun S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003427; Wessling R, 2014, CELL HOST MICROBE, V16, P364, DOI 10.1016/j.chom.2014.08.004; Zeilmaker T, 2015, PLANT J, V81, P210, DOI 10.1111/tpj.12719	70	0	0	CURRENT BIOLOGY LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1369-5266	1879-0356		CURR OPIN PLANT BIOL	Curr. Opin. Plant Biol.	DEC	2015	28						1	8		10.1016/j.pbi.2015.08.008		8	Plant Sciences	Plant Sciences	CZ0FN	WOS:000366780600002		
J	Fukuda, H; Yang, ZB				Fukuda, Hiroo; Yang, Zhenbiao			Editorial overview: Cell biology: From signals to cell shape and function	CURRENT OPINION IN PLANT BIOLOGY			English	Editorial Material									[Fukuda, Hiroo] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 1130033, Japan; [Yang, Zhenbiao] Univ Calif Riverside, Dept Bot & Plant Sci, Inst Integrated Genome Biol, Ctr Plant Cell Biol, Riverside, CA 92521 USA	Fukuda, H (reprint author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 1130033, Japan.	fukuda@bs.s.u-tokyo.ac.jp						0	0	0	CURRENT BIOLOGY LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1369-5266	1879-0356		CURR OPIN PLANT BIOL	Curr. Opin. Plant Biol.	DEC	2015	28						IV	VI		10.1016/j.pbi.2015.11.001		3	Plant Sciences	Plant Sciences	CZ0FN	WOS:000366780600001		
J	Torii, KU				Torii, Keiko U.			Stomatal differentiation: the beginning and the end	CURRENT OPINION IN PLANT BIOLOGY			English	Review							ASYMMETRIC CELL-DIVISION; LIGAND-RECEPTOR PAIRS; SECRETORY PEPTIDE; ARABIDOPSIS; SPEECHLESS; STOMAGEN; POLARITY; DENSITY; FAMA; GENE	Differentiation of stomata follows a series of stereotypical cell divisions and cell-state transitional steps specified by the master-regulatory transcription factors. The density and numbers of stomata are regulated by cell cell signaling and flexibly modulated by environmental and physiological inputs. This review focuses on the latest breakthroughs in Arabidopsis elucidating the mechanisms behind the initiation of stomatal precursors, asymmetric cell division and stem cell behavior, and terminal differentiation of guard cells. I discuss new insights emerging from these studies: (i) competitive actions of signals and regulatory circuits initiating stomatal precursor pattern; (ii) a subcellular partitioning of signaling components determining the stomatal lineage stem-cell divisions; and (iii) epigenetic regulation maintaining the differentiated guard cell state.	[Torii, Keiko U.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Torii, Keiko U.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Torii, Keiko U.] Nagoya Univ, Inst Transformat Biomol, Nagoya, Aichi 4648601, Japan	Torii, KU (reprint author), Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA.	ktorii@u.washington.edu			Gordon and Betty Moore Foundation [GBMF3035]; Japan MEXT;  [26113507];  [B-26291057]	This review article is dedicated to the memory of Prof. Fred Sack, who pioneered and led the field of stomatal development. I thank Soon-Ki Han, Aarthi Putarjunan and Robin Horst for crucial and helpful comments, and Julian Avila for the cartoon modified in Figure 1b. The work in my laboratory is supported by Gordon and Betty Moore Foundation (GBMF3035); and Japan MEXT, Grant-in-aid-Scientific Research (B-26291057) and Grant-in-Aid for Scientific Research on Innovative Areas (26113507). I am a GBMF investigator of Howard Hughes Medical Institute and a Principal Investigator of the Institute of Transformative Biomolecules, Nagoya University.	Torii KU, 2012, TRENDS PLANT SCI, V17, P711, DOI 10.1016/j.tplants.2012.06.013; Holroyd GH, 2002, NEW PHYTOL, V153, P433, DOI 10.1046/j.1469-8137.2002.00326.x; Pillitteri LJ, 2011, PLANT CELL, V23, P3260, DOI 10.1105/tpc.111.088583; Dong J, 2009, CELL, V137, P1320, DOI 10.1016/j.cell.2009.04.018; Nadeau JA, 2002, SCIENCE, V296, P1697, DOI 10.1126/science.1069596; Hara K, 2009, PLANT CELL PHYSIOL, V50, P1019, DOI 10.1093/pcp/pcp068; Bergmann DC, 2007, ANNU REV PLANT BIOL, V58, P163, DOI 10.1146/annurev.arplant.58.032806.104023; Lee E, 2014, PLANT J, V78, P555, DOI 10.1111/tpj.12489; Lee JS, 2012, GENE DEV, V26, P126, DOI 10.1101/gad.179895.111; Engineer CB, 2014, NATURE, V513, P246, DOI 10.1038/nature13452; Hunt L, 2009, CURR BIOL, V19, P864, DOI 10.1016/j.cub.2009.03.069; Pillitteri LJ, 2012, ANNU REV PLANT BIOL, V63, P591, DOI 10.1146/annurev-arplant-042811-105451; Lampard GR, 2008, SCIENCE, V322, P1113, DOI 10.1126/science.1162263; Lu PZ, 1996, PLANT CELL, V8, P2155, DOI 10.1105/tpc.8.12.2155; Sakai T, 2008, PLANT J, V53, P157, DOI 10.1111/j.1365-313X.2007.03327.x; Liu CY, 2010, ANNU REV PLANT BIOL, V61, P395, DOI 10.1146/annurev.arplant.043008.091939; Facette MR, 2012, CURR OPIN PLANT BIOL, V15, P585, DOI 10.1016/j.pbi.2012.09.013; Hara K, 2007, GENE DEV, V21, P1720, DOI 10.1101/gad.1550707; Pillitteri LJ, 2007, NATURE, V445, P501, DOI 10.1038/nature05467; Malcos JL, 2011, CYTOSKELETON, V68, P247, DOI 10.1002/cm.20508; Richardson LGL, 2013, J EXP BOT, V64, P5243, DOI 10.1093/jxb/ert246; Franks PJ, 2014, NEW PHYTOL, V201, P1079, DOI 10.1111/nph.12673; Lau OS, 2012, DEVELOPMENT, V139, P3683, DOI 10.1242/dev.080523; Ohashi-Ito K, 2006, PLANT CELL, V18, P2493, DOI 10.1105/tpc.106.046136; [Anonymous], 2014, NATURE COMMUNICATION; Kanaoka MM, 2008, PLANT CELL, V20, P1775, DOI 10.1105/tpc.108.060848; Lee E, 2014, PLANT J, V78, P566, DOI 10.1111/tpj.12516; Kim TW, 2012, NATURE, V482, P419, DOI 10.1038/nature10794; Zhang JY, 2014, P NATL ACAD SCI USA, V111, pE3015, DOI 10.1073/pnas.1400542111; Shpak ED, 2005, SCIENCE, V309, P290, DOI 10.1126/science.1109710; Peterson KM, 2013, DEVELOPMENT, V140, P1924, DOI 10.1242/dev.090209; Sugano SS, 2010, NATURE, V463, P241, DOI 10.1038/nature08682; Gudesblat GE, 2012, NAT CELL BIOL, V14, P548, DOI 10.1038/ncb2471; Gray JE, 2000, NATURE, V408, P713, DOI 10.1038/35047071; MacAlister CA, 2007, NATURE, V445, P537, DOI 10.1038/nature05491; Takada S, 2013, DEVELOPMENT, V140, P1919, DOI 10.1242/dev.094417; He JX, 2005, SCIENCE, V307, P1634, DOI 10.1126/science.1107580; Balcerowicz M, 2014, TRENDS PLANT SCI, V19, P747, DOI 10.1016/j.tplants.2014.10.006; Horst RJ, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005374; Hronkova M, 2015, J EXP BOT; Lau OS, 2014, SCIENCE, V345, P1605, DOI 10.1126/science.1256888; Lee Jin Suk, 2015, Nature, V522, P439, DOI 10.1038/nature14561; Lee JS, 2012, COLD SPRING HARB SYM, P83; Matos JL, 2014, ELIFE, V3; Nadeau JA, 2002, STOMATAL DEV ARABIDO; Ohki S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1520; Pillitteri Lynn Jo, 2013, Arabidopsis Book, V11, pe0162, DOI 10.1199/tab.0162; Zhang Y, 2015, DEV CELL, V33, P136, DOI 10.1016/j.devcel.2015.02.022	48	0	0	CURRENT BIOLOGY LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1369-5266	1879-0356		CURR OPIN PLANT BIOL	Curr. Opin. Plant Biol.	DEC	2015	28						16	22		10.1016/j.pbi.2015.08.005		7	Plant Sciences	Plant Sciences	CZ0FN	WOS:000366780600004		
J	Ueda, H; Tamura, K; Hara-Nishimura, I				Ueda, Haruko; Tamura, Kentaro; Hara-Nishimura, Ikuko			Functions of plant-specific myosin XI: from intracellular motility to plant postures	CURRENT OPINION IN PLANT BIOLOGY			English	Review							ENDOPLASMIC-RETICULUM MOTILITY; CULTURED BY-2 CELLS; ARABIDOPSIS-THALIANA; NUCLEAR MORPHOLOGY; ACTIN ORGANIZATION; TAIL DOMAIN; LEAF-CELLS; ROOT HAIR; MOVEMENT; DYNAMICS	The plant-specific protein motor class myosin XI is known to function in rapid bulk flow of the cytoplasm (cytoplasmic streaming) and in organellar movements. Recent studies unveiled a wide range of physiological functions of myosin XI motors, from intracellular motility to organ movements. Arabidopsis thaliana has 13 members of myosin XI class. In vegetative organs, myosins XIk, XI1, and XI2 primarily contribute to dynamics and spatial configurations of endoplasmic reticulum that develops a tubular network in the cell periphery and thick strand-like structures in the inner cell regions. Myosin XI-i forms a nucleocytoplasmic linker and is responsible for nuclear movement and shape. In addition to these intracellular functions, myosin XIf together with myosin XIk is involved in the fundamental nature of plants; the actin myosin XI cytoskeleton regulates organ straightening to adjust plant posture.	[Ueda, Haruko; Tamura, Kentaro; Hara-Nishimura, Ikuko] Kyoto Univ, Grad Sch Sci, Dept Bot, Kyoto 6068502, Japan	Hara-Nishimura, I (reprint author), Kyoto Univ, Grad Sch Sci, Dept Bot, Kyoto 6068502, Japan.	ihnishi@gr.bot.kyoto-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [25440132, 15KT0151, 15H05776, 15K14545, 26711017];  [22000014]	This work was supported by Specially Promoted Research of Grant-in-Aid for Scientific Research to IH-N (no. 22000014) and Grants-in-Aid for Scientific Research to HU (nos. 25440132 and 15KT0151), to IH-N (no. 15H05776), and to KT (nos. 15K14545 and 26711017) from the Japan Society for the Promotion of Science (JSPS).	Tamura K, 2010, PLANT CELL, V22, P4084, DOI 10.1105/tpc.110.079947; Diensthuber RP, 2015, FASEB J, V29, P81, DOI 10.1096/fj.14-254763; QUADER H, 1986, PROTOPLASMA, V131, P250, DOI 10.1007/BF01282989; Steffens A, 2014, PLANT PHYSIOL, V164, P1879, DOI 10.1104/pp.113.233031; Sattarzadeh A, 2009, MOL PLANT, V2, P1351, DOI 10.1093/mp/ssp094; Westrate LM, 2015, ANNU REV BIOCHEM, V84, P791, DOI 10.1146/annurev-biochem-072711-163501; Sakamoto Y, 2013, PLANT CELL PHYSIOL, V54, P622, DOI 10.1093/pcp/pct031; Nunokawa SY, 2007, PLANT CELL PHYSIOL, V48, P1558, DOI 10.1093/pcp/pcm126; Yokota E, 2009, J EXP BOT, V60, P197, DOI 10.1093/jxb/ern280; Avisar D, 2009, PLANT PHYSIOL, V150, P700, DOI 10.1104/pp.109.136853; Zhou X, 2012, J CELL BIOL, V196, P203, DOI 10.1083/jcb.201108098; Cai C, 2014, PLANT PHYSIOL, V166, P1359, DOI 10.1104/pp.114.244335; Avisar D, 2012, J EXP BOT, V63, P241, DOI 10.1093/jxb/err265; Bastien R, 2013, P NATL ACAD SCI USA, V110, P755, DOI 10.1073/pnas.1214301109; ALLEN NS, 1988, CELL MOTIL CYTOSKEL, V10, P153, DOI 10.1002/cm.970100120; Deeks MJ, 2007, J CELL SCI, V120, P2609, DOI 10.1242/jcs.007302; Oda Yoshihisa, 2011, Plant J, V66, P629, DOI 10.1111/j.1365-313X.2011.04523.x; Sparkes I, 2011, MOL PLANT, V4, P805, DOI 10.1093/mp/ssr063; Madison SL, 2013, CURR OPIN PLANT BIOL, V16, P710, DOI 10.1016/j.pbi.2013.10.004; Kandasamy MK, 2009, PLANT CELL, V21, P701, DOI 10.1105/tpc.108.061960; Higa T, 2014, J EXP BOT, V65, P2873, DOI 10.1093/jxb/ert414; Vidali L, 2010, PLANT CELL, V22, P1868, DOI 10.1105/tpc.109.073288; Boevink P, 1996, PLANT J, V10, P935, DOI 10.1046/j.1365-313X.1996.10050935.x; Zhao Q, 2008, PLANT CELL, V20, P1639, DOI 10.1105/tpc.108.059220; Dittmer TA, 2007, PLANT CELL, V19, P2793, DOI 10.1105/tpc.107.053231; Tominaga M, 2013, DEV CELL, V27, P345, DOI 10.1016/j.devcel.2013.10.005; Kato T, 2010, PLANT CELL PHYSIOL, V51, P333, DOI 10.1093/pcp/pcp189; Lanza M, 2012, DEV CELL, V22, P1275, DOI 10.1016/j.devcel.2012.04.008; Tamura K, 2013, CURR BIOL, V23, P1776, DOI 10.1016/j.cub.2013.07.035; Stankovic B, 1998, PHYSIOL PLANTARUM, V102, P328, DOI 10.1034/j.1399-3054.1998.1020222.x; Higa T, 2014, P NATL ACAD SCI USA, V111, P4327, DOI 10.1073/pnas.1317902111; Ueda H, 2010, P NATL ACAD SCI USA, V107, P6894, DOI 10.1073/pnas.0911482107; Wang GF, 2012, PLANT CELL, V24, P3447, DOI 10.1105/tpc.112.101360; Yang L, 2014, P NATL ACAD SCI USA, V111, P13996, DOI 10.1073/pnas.1405292111; Sparkes I, 2009, PLANT CELL, V21, P3937, DOI 10.1105/tpc.109.072249; Yokota E, 2011, PLANT PHYSIOL, V156, P129, DOI 10.1104/pp.111.175018; Iwabuchi K, 2007, PLANT CELL PHYSIOL, V48, P1291, DOI 10.1093/pcp/pcm095; Iwabuchi K, 2010, PLANT PHYSIOL, V152, P1309, DOI 10.1104/pp.109.149526; Hashimoto K, 2008, J EXP BOT, V59, P3523, DOI 10.1093/jxb/ern202; Goto C, 2014, PLANT CELL, V26, P2143, DOI 10.1105/tpc.113.122168; Prokhnevsky AI, 2008, P NATL ACAD SCI USA, V105, P19744, DOI 10.1073/pnas.0810730105; Hayakawa K, 2008, J CELL SCI, V121, P496, DOI 10.1242/jcs.022053; van der Honing HS, 2012, PLANT PHYSIOL, V158, P1426, DOI 10.1104/pp.111.192385; Ojangu EL, 2007, PROTOPLASMA, V230, P193, DOI 10.1007/s00709-006-0233-8; Buchnik L, 2015, J INTEGR PLANT BIOL, V57, P23, DOI 10.1111/jipb.12282; Darwin C, 1880, POWER MOVEMENTS PLAN; Gilroy S, 2008, PLANT TROPISMS, P1; Griffing LR, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00218; Griffis AHN, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00129; Hamada T, 2014, PLANT PHYSIOL, V166, P1869, DOI 10.1104/pp.114.252320; Hawes C, 2015, J INTEGR PLANT BIOL, V57, P50, DOI 10.1111/jipb.12297; Henn A, 2014, CURR OPIN PLANT BIOL, V22, P65, DOI 10.1016/j.pbi.2014.09.006; Joensuu M, 2015, EXP CELL RES; Klocko AL, 2012, FRONT PLANT SCI, V3, P184; Lichtscheidl IK, 2000, ACTIN DYNAMIC FRAMEW, P191; lino M, 2006, CURR OPIN PLANT BIOL, V9, P89; Muhlhausen S, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-202; Ojangu EL, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-81; Okamoto K, 2015, NATURE PLANTS, V1, P15031; Park E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076745; Peremyslov VV, 2011, PLANT PHYSIOL, V155, P1191; Peremyslov W, 2010, PLANT CELL, V22, P1883; Peremyslov W, 2013, PLANT CELL, V25, P3022; Peremyslov W, 2008, PLANT PHYSIOL, V146, P1109; Quader H, 2006, MORPHOLOGY DYNAMICS; Reddy A S, 2001, BMC Genomics, V2, P2, DOI 10.1186/1471-2164-2-2; Stefano G, 2014, CURR OPIN PLANT BIOL, V22, P30, DOI 10.1016/j.pbi.2014.09.001; Stefano G, 2014, J CELL SCI, V127, P947, DOI 10.1242/jcs.139907; Stephan O, 2014, PLANT CELL, V26, P4426, DOI 10.1105/tpc.114.131078; Suetsugu Noriyuki, 2010, Plant Signal Behav, V5, P1190; Tominaga M, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00211; Wang HY, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-200; Zhou X, 2015, NUCLEUS-PHILA, V6, P144, DOI 10.1080/19491034.2014.1003512	73	0	0	CURRENT BIOLOGY LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1369-5266	1879-0356		CURR OPIN PLANT BIOL	Curr. Opin. Plant Biol.	DEC	2015	28						30	38		10.1016/j.pbi.2015.08.006		9	Plant Sciences	Plant Sciences	CZ0FN	WOS:000366780600006		
J	Ikeuchi, M; Iwase, A; Sugimoto, K				Ikeuchi, Momoko; Iwase, Akira; Sugimoto, Keiko			Control of plant cell differentiation by histone modification and DNA methylation	CURRENT OPINION IN PLANT BIOLOGY			English	Review							POLYCOMB-GROUP PROTEINS; TRANSCRIPTION FACTOR GENES; KNOX HOMEOBOX GENES; ARABIDOPSIS-THALIANA; STOMATAL DEVELOPMENT; ROOT DEVELOPMENT; DOMAIN PROTEIN; COMPLEX; MAINTENANCE; CHROMATIN	How cells differentiate and acquire diverse arrays of determined states in multicellular organisms is a fundamental and yet unanswered question in biology. Molecular genetic studies over the last few decades have identified many transcriptional regulators that activate or repress gene expression to promote cell differentiation in plant development. What has recently emerged as an additional important regulatory layer is the control at the epigenetic level by which locus-specific DNA methylation and histone modification alter the chromatin state and limit the expression of key developmental regulators to specific windows of time and space. Accumulating evidence suggests that histone acetylation is commonly linked with active transcription and this mechanism is adopted to control sequential progression of cell differentiation. Histone H3 trimethylation at lysine 27 and DNA methylation are both associated with gene repression, and these mechanisms are often utilised to promote and/or maintain the differentiated status of plant cells.	[Ikeuchi, Momoko; Iwase, Akira; Sugimoto, Keiko] RIKEN, Ctr Sustainable Resource Sci, Yokohama, Kanagawa 2300045, Japan	Sugimoto, K (reprint author), RIKEN, Ctr Sustainable Resource Sci, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	keiko.sugimoto@riken.jp			Scientific Technique Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry; Ministry of Education, Culture, Sports and Technology of Japan [15K18564, 15K18565, 26291064, 15H05961]; RIKEN Special Postdoctoral Researcher Program	We thank Bart Rymen, Anna Franciosini, Natalie Clark and Lewis Watt for providing comments on the manuscript. Research in the authors' laboratory on the topic of this review is supported by a grant from Scientific Technique Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry and grants from the Ministry of Education, Culture, Sports and Technology of Japan to MI (15K18564), AT (15K18565) and to KS (26291064, 15H05961). MI is a recipient of the RIKEN Special Postdoctoral Researcher Program.	Goodrich J, 1997, NATURE, V386, P44, DOI 10.1038/386044a0; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/nmeth.2688, 10.1038/NMETH.2688]; Tricker PJ, 2012, J EXP BOT, V63, P3799, DOI 10.1093/jxb/ers076; Stone SL, 2001, P NATL ACAD SCI USA, V98, P11806, DOI 10.1073/pnas.201413498; Sugimoto-Shirasu K, 2005, P NATL ACAD SCI USA, V102, P18736, DOI 10.1073/pnas.0505883102; Yang C, 2013, CURR BIOL, V23, P1324, DOI 10.1016/j.cub.2013.05.050; Pandey R, 2002, NUCLEIC ACIDS RES, V30, P5036, DOI 10.1093/nar/gkf660; Sun B, 2009, GENE DEV, V23, P1791, DOI 10.1101/gad.1800409; Sugimoto K, 2010, DEV CELL, V18, P463, DOI 10.1016/j.devcel.2010.02.004; Beh LY, 2012, P NATL ACAD SCI USA, V109, pE1063, DOI 10.1073/pnas.1118678109; Alvarez-Venegas R, 2003, CURR BIOL, V13, P627, DOI 10.1016/S0960-9822(03)00243-4; Pillitteri LJ, 2012, ANNU REV PLANT BIOL, V63, P591, DOI 10.1146/annurev-arplant-042811-105451; Berr A, 2010, PLANT CELL, V22, P3232, DOI 10.1105/tpc.110.079962; Mayer KFX, 1998, CELL, V95, P805, DOI 10.1016/S0092-8674(00)81703-1; Roudier F, 2011, EMBO J, V30, P1928, DOI 10.1038/emboj.2011.103; Kornet N, 2009, PLANT CELL, V21, P1070, DOI 10.1105/tpc.108.065300; Napsucialy-Mendivil S, 2014, J EXP BOT, V65, P6373, DOI 10.1093/jxb/eru355; Pillitteri LJ, 2007, NATURE, V445, P501, DOI 10.1038/nature05467; Guo L, 2010, P NATL ACAD SCI USA, V107, P18557, DOI 10.1073/pnas.1010478107; Guilfoyle TJ, 2007, CURR OPIN PLANT BIOL, V10, P453, DOI 10.1016/j.pbi.2007.08.014; Ohashi-Ito K, 2006, PLANT CELL, V18, P2493, DOI 10.1105/tpc.106.046136; Xu L, 2008, CURR BIOL, V18, P1966, DOI 10.1016/j.cub.2008.11.019; Laux T, 2003, CELL, V113, P281, DOI 10.1016/S0092-8674(03)00312-X; Lee E, 2014, PLANT J, V78, P566, DOI 10.1111/tpj.12516; Ikeuchi M, 2013, PLANT CELL, V25, P3159, DOI 10.1105/tpc.113.116053; Liu XG, 2011, PLANT CELL, V23, P3654, DOI 10.1105/tpc.111.091538; Heo JB, 2013, CHROMOSOME RES, V21, P685, DOI 10.1007/s10577-013-9392-6; Hsieh TF, 2009, SCIENCE, V324, P1451, DOI [10.1126/science.1172417, 10.1126/science.112417]; Candaele J, 2014, PLANT PHYSIOL, V164, P1350, DOI 10.1104/pp.113.233312; Ikeuchi M, 2015, NAT PLANTS, V1, P1, DOI 10.1038/NPLANTS.2015.89; Kuwabara A, 2014, J EXP BOT, V65, P2667, DOI 10.1093/jxb/eru069; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; Lodha M, 2013, GENE DEV, V27, P596, DOI 10.1101/gad.211425.112; Holec S, 2012, PLANT PHYSIOL, V158, P35, DOI 10.1104/pp.111.186445; Chanvivattana Y, 2004, DEVELOPMENT, V131, P5263, DOI 10.1242/dev.01400; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Sarkar AK, 2007, NATURE, V446, P811, DOI 10.1038/nature05703; Long JA, 2006, SCIENCE, V312, P1520, DOI 10.1126/science.1123841; Kieffer M, 2006, PLANT CELL, V18, P560, DOI 10.1105/tpc.105.039107; Timmermans MCP, 1999, SCIENCE, V284, P151, DOI 10.1126/science.284.5411.151; La Rota C, 2011, PLANT CELL, V23, P4318, DOI 10.1105/tpc.111.092619; Carles CC, 2009, GENE DEV, V23, P2723, DOI 10.1101/gad.1812609; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Sinha N, 1999, ANNU REV PLANT PHYS, V50, P419, DOI 10.1146/annurev.arplant.50.1.419; MacAlister CA, 2007, NATURE, V445, P537, DOI 10.1038/nature05491; Atta R, 2009, PLANT J, V57, P626, DOI 10.1111/j.1365-313X.2008.03715.x; Iwase A, 2011, CURR BIOL, V21, P508, DOI 10.1016/j.cub.2011.02.020; Hay A, 2010, DEVELOPMENT, V137, P3153, DOI 10.1242/dev.030049; Baulcombe DC, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a019471; Bouyer D, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002014; Bruex A, 2012, PLOS GENET; Choi YH, 2002, CELL, V110, P33, DOI 10.1016/S0092-8674(02)00807-3; Dixon JR, 2015, NATURE, V518, DOI 10.1038/nature14222; He CS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002911; Kim S-Y, 2012, PLOS GENET; Lafos M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002040; Li W, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002243; Matos JL, 2014, ELIFE; Pi L, 2015, DEV CELL, V8, P576; Pires HR, 2014, PLANT CELL, V26, P4345, DOI 10.1105/tpc.114.131250; Rosa S, 2014, PLANT CELL, V26, P4821, DOI 10.1105/tpc.114.133793; Sun B, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00017; Sun B, 2014, SCIENCE, V343, P505, DOI 10.1126/science.1248559; Taylor-Teeples M., 2014, NATURE, V517, P571, DOI [10.1038/nature14099, DOI 10.1038/NATURE14099]; VALVEKENS D, 1988, P NATL ACAD SCI USA, V85, P5536, DOI 10.1073/pnas.85.15.5536; Weiste C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4883; Yamamuro C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5062; Yang HX, 2015, PLANT J, V81, P268, DOI 10.1111/tpj.12726; Yao XZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056537; Zhang XY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r62; Zhang XY, 2007, PLOS BIOL, V5, P1026, DOI 10.1371/journal.pbio.0050129	71	0	0	CURRENT BIOLOGY LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1369-5266	1879-0356		CURR OPIN PLANT BIOL	Curr. Opin. Plant Biol.	DEC	2015	28						60	67		10.1016/j.pbi.2015.09.004		8	Plant Sciences	Plant Sciences	CZ0FN	WOS:000366780600010		
J	Kondo, Y; Fukuda, H				Kondo, Yuki; Fukuda, Hiroo			The TDIF signaling network	CURRENT OPINION IN PLANT BIOLOGY			English	Review							XYLEM CELL-DIFFERENTIATION; ARABIDOPSIS-THALIANA; GENE-EXPRESSION; CLE PEPTIDES; RECEPTOR KINASES; ROOT-FORMATION; DIVISION; FAMILY; MERISTEM; WUSCHEL	Plant growth and development are coordinately controlled by intercellular signaling molecules. CLAVATA3 (CLV3)/EMBRYO SURROUNDING REGION-related (CLE) peptides are crucial intercellular signaling molecules that control plant meristem maintenance. CLE peptides are perceived by plasma membrane-located receptor-like kinases, followed by the initiation of intracellular signaling cascades. Recent studies have uncovered these intracellular signaling networks involving signal divergence and integration. This review summarizes recent advances in the study of TDIF peptide signaling pathway, a representative model of CLE peptide signaling, focusing on newly uncovered biological functions and unique signal transduction mechanisms.	[Kondo, Yuki; Fukuda, Hiroo] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan	Kondo, Y (reprint author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	p@bs.s.u-tokyo.ac.jp; fukuda@bs.s.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [15H01226, 15H05958]; Ministry of Education, Culture, Sports, Science and Technology of Japan (NC-CARP project); Japan Society for the Promotion of Science [26891005, 23227001]	This work was supported partly by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (15H01226 to Y.K., and 15H05958 and NC-CARP project to H.F.), and from the Japan Society for the Promotion of Science (26891005 to Y.K. and 23227001 to H.F.).	Gonzalez-Garcia MP, 2011, DEVELOPMENT, V138, P849, DOI 10.1242/dev.057331; Yamamoto R, 1997, PLANT CELL PHYSIOL, V38, P980; Okushima Y, 2007, PLANT CELL, V19, P118, DOI 10.1105/tpc.106.047761; Strabala TJ, 2006, PLANT PHYSIOL, V140, P1331, DOI 10.1104/pp.105.075515; Ikeda M, 2009, PLANT CELL, V21, P3493, DOI 10.1105/tpc.109.069997; Uchida N, 2013, J EXP BOT, V64, P5335, DOI 10.1093/jxb/ert196; Gish LA, 2011, PLANT J, V66, P117, DOI 10.1111/j.1365-313X.2011.04518.x; Li L, 2009, PLANT J, V58, P275, DOI 10.1111/j.1365-313X.2008.03778.x; Endo S, 2014, CURR OPIN PLANT BIOL, V21, P140, DOI 10.1016/j.pbi.2014.07.011; Qiang Y, 2013, J INTEGR PLANT BIOL, V55, P389, DOI 10.1111/jipb.12044; Ito Y, 2006, SCIENCE, V313, P842, DOI 10.1126/science.1128436; Ohmori Y, 2013, PLANT CELL, V25, P229, DOI 10.1105/tpc.112.103432; Yu XF, 2008, P NATL ACAD SCI USA, V105, P7618, DOI 10.1073/pnas.0802254105; Yin YH, 2002, CELL, V109, P181, DOI 10.1016/S0092-8674(02)00721-3; Haecker A, 2004, DEVELOPMENT, V131, P657, DOI 10.1242/dev.00963; Etchells JP, 2015, CURR BIOL, V25, P1050, DOI 10.1016/j.cub.2015.02.023; Etchells JP, 2013, DEVELOPMENT, V140, P2224, DOI 10.1242/dev.091314; Li JM, 2002, SCIENCE, V295, P1299; Schrader J, 2004, PLANT CELL, V16, P2278, DOI 10.1105/tpc.104.024190; Ohyama K, 2008, PLANT J, V55, P152, DOI 10.1111/j.1365-313X.2008.03464.x; Suer S, 2011, PLANT CELL, V23, P3247, DOI 10.1105/tpc.111.087874; Tang WQ, 2008, SCIENCE, V321, P557, DOI 10.1126/science.1156973; Whitford R, 2008, P NATL ACAD SCI USA, V105, P18625, DOI 10.1073/pnas.0809395105; Hirakawa Y, 2011, CURR OPIN PLANT BIOL, V14, P17, DOI 10.1016/j.pbi.2010.09.011; Vilarrasa-Blasi J, 2014, DEV CELL, V30, P36, DOI 10.1016/j.devcel.2014.05.020; De Rybel B, 2009, CHEM BIOL, V16, P594, DOI 10.1016/j.chembiol.2009.04.008; Fisher K, 2007, CURR BIOL, V17, P1061, DOI 10.1016/j.cub.2007.05.049; Etchells JP, 2010, DEVELOPMENT, V137, P767, DOI 10.1242/dev.044941; Hirakawa Y, 2010, PLANT CELL, V22, P2618, DOI 10.1105/tpc.110.076083; Love J, 2009, P NATL ACAD SCI USA, V106, P5984, DOI 10.1073/pnas.0811660106; Kubo M, 2005, GENE DEV, V19, P1855, DOI 10.1101/gad.1331305; Miyawaki K, 2013, CURR OPIN PLANT BIOL, V16, P598, DOI 10.1016/j.pbi.2013.08.008; Kim TW, 2009, NAT CELL BIOL, V11, P1254, DOI 10.1038/ncb1970; Hirakawa Y, 2008, P NATL ACAD SCI USA, V105, P15208, DOI 10.1073/pnas.0808444105; Cano-Delgado A, 2004, DEVELOPMENT, V131, P5341, DOI 10.1242/dev.01403; Yaginuma H, 2011, PLANT CELL PHYSIOL, V52, P1354, DOI 10.1093/pcp/pcr081; Aichinger E, 2012, ANNU REV PLANT BIOL, V63, P615, DOI 10.1146/annurev-arplant-042811-105555; Betsuyaku Shigeyuki, 2011, Arabidopsis Book, V9, pe0149, DOI 10.1199/tab.0149; Cho H, 2014, NAT CELL BIOL, V16, P66, DOI 10.1038/ncb2893; Etchells JP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002997; Katsir L, 2011, CURR BIOL, V21, P356; Kondo Y, 2014, ENZYMES, V35, P85, DOI 10.1016/B978-0-12-801922-1.00004-X; Kondo Y, 2015, MOL PLANT, V8, P612, DOI 10.1016/j.molp.2014.10.008; Kondo Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4504; Liu BB, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-296; Matsubayashi Yoshikatsu, 2011, Arabidopsis Book, V9, pe0150, DOI 10.1199/tab.0150; van der Graaff E, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-248; Zhou Y, 2015, NATURE, V517, P377, DOI 10.1038/nature13853	48	0	0	CURRENT BIOLOGY LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1369-5266	1879-0356		CURR OPIN PLANT BIOL	Curr. Opin. Plant Biol.	DEC	2015	28						106	110		10.1016/j.pbi.2015.10.002		5	Plant Sciences	Plant Sciences	CZ0FN	WOS:000366780600016		
J	Kanaoka, MM; Higashiyama, T				Kanaoka, Masahiro M.; Higashiyama, Tetsuya			Peptide signaling in pollen tube guidance	CURRENT OPINION IN PLANT BIOLOGY			English	Review							REPRODUCTIVE-TRACT DEVELOPMENT; GPI-ANCHORED PROTEIN; MALE-GAMETE DELIVERY; VITRO STYLAR MATRIX; ARABIDOPSIS-THALIANA; DOUBLE FERTILIZATION; SYNERGID CELL; IN-VITRO; MICROPYLAR GUIDANCE; TORENIA-FOURNIERI	Fertilization is an important life event for sexually reproductive plants. Part of this process involves precise regulation of a series of complicated cell-cell communications between male and female tissues. Through genetic and omics approaches, many genes and proteins involved in this process have been identified. Here we review our current understanding of signaling components during fertilization. We will especially focus on LURE peptides and related signaling events that are required for micropylar pollen tube guidance. We will also summarize signaling events required for termination of micropylar pollen tube guidance after fertilization.	[Kanaoka, Masahiro M.; Higashiyama, Tetsuya] Nagoya Univ, Grad Sch Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Higashiyama, Tetsuya] Nagoya Univ, JST, ERATO,Higashiyama Live Holon Project, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Higashiyama, Tetsuya] Nagoya Univ, Inst Transformat Biomol WPI ITbM, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Higashiyama, T (reprint author), Nagoya Univ, Grad Sch Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648602, Japan.	higashi@bio.nagoya-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [15H04385, 15H01231, 26113709]	We are grateful for Hiroko Uchida for illustration in Figure 1. This work was supported by Grant-in-Aid for Scientific Research to M.M.K. (nos. 15H04385, 15H01231, 26113709) from the Japan Society for the Promotion of Science (JSPS).	Amien S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000388; Mollet JC, 2000, PLANT CELL, V12, P1737, DOI 10.1105/tpc.12.9.1737; Matsubayashi Y, 2014, ANNU REV PLANT BIOL, V65, P385, DOI 10.1146/annurev-arplant-050312-120122; Rotman N, 2003, CURR BIOL, V13, P432, DOI 10.1016/S0960-9822(03)00093-9; Cheung AY, 2010, J EXP BOT, V61, P1907, DOI 10.1093/jxb/erq062; Crawford BCW, 2011, DEVELOPMENT, V138, P2999, DOI 10.1242/dev.067793; Komori R, 2009, P NATL ACAD SCI USA, V106, P15067, DOI 10.1073/pnas.0902801106; Tang WH, 2004, PLANT J, V39, P343, DOI 10.1111/j.1365-313X.2004.02139.x; Lee JS, 2012, GENE DEV, V26, P126, DOI 10.1101/gad.179895.111; Dai XR, 2014, PLANT PHYSIOL, V165, P1544, DOI 10.1104/pp.114.236133; Kanaoka MM, 2011, ANN BOT-LONDON, V108, P739, DOI 10.1093/aob/mcr111; Huang WJ, 2014, PLANT CELL, V26, P2505, DOI 10.1105/tpc.114.123281; Zhan HD, 2015, PLANT J, V82, P758, DOI 10.1111/tpj.12846; Takayama S, 2001, NATURE, V413, P534, DOI 10.1038/35097104; Brownfield L, 2009, PLANT CELL, V21, P1940, DOI 10.1105/tpc.109.066373; Mori T, 2006, NAT CELL BIOL, V8, P64, DOI 10.1038/ncb1345; Tsuchimatsu T, 2010, NATURE, V464, P1342, DOI 10.1038/nature08927; Okuda S, 2013, MOL PLANT, V6, P1074, DOI 10.1093/mp/sst050; Marton ML, 2010, BIOCHEM SOC T, V38, P627, DOI 10.1042/BST0380627; Kaya H, 2014, PLANT CELL, V26, P1069, DOI 10.1105/tpc.113.120642; Capron A, 2008, PLANT CELL, V20, P3038, DOI 10.1105/tpc.108.061713; Ngo QA, 2014, DEV CELL, V29, P491, DOI 10.1016/j.devcel.2014.04.008; Alandete-Saez M, 2008, MOL PLANT, V1, P586, DOI 10.1093/mp/ssn015; Ogawa-Ohnishi M, 2013, NAT CHEM BIOL, V9, P726, DOI [10.1038/nchembio.1351, 10.1038/NCHEMBIO.1351]; Leydon AR, 2013, CURR BIOL, V23, P1209, DOI 10.1016/j.cub.2013.05.021; Crawford BCW, 2007, CURR BIOL, V17, P1101, DOI 10.1016/j.cub.2007.05.079; Stuhrwohldt N, 2015, PHYSIOL PLANTARUM, V153, P643, DOI 10.1111/ppl.12270; Hamamura Y, 2011, CURR BIOL, V21, P497, DOI 10.1016/j.cub.2011.02.013; Maruyama D, 2013, DEV CELL, V25, P317, DOI 10.1016/j.devcel.2013.03.013; Higashiyama T, 2001, SCIENCE, V293, P1480, DOI 10.1126/science.1062429; Wang JZ, 2015, NATURE, V525, P265, DOI 10.1038/nature14858; Okuda S, 2009, NATURE, V458, P357, DOI 10.1038/nature07882; Kessler SA, 2010, SCIENCE, V330, P968, DOI 10.1126/science.1195211; Li HJ, 2011, PLANT CELL, V23, P3288, DOI 10.1105/tpc.111.088914; Volz R, 2013, DEV CELL, V25, P310, DOI 10.1016/j.devcel.2013.04.001; Chae K, 2009, PLANT CELL, V21, P3902, DOI 10.1105/tpc.109.070854; Horade M, 2013, RSC ADV, V3, P22301, DOI 10.1039/c3ra42804d; Shimizu KK, 2000, DEVELOPMENT, V127, P4511; Leshem Y, 2013, PLANT REPROD, V26, P93, DOI 10.1007/s00497-013-0211-1; Park SY, 2000, PLANT CELL, V12, P151, DOI 10.1105/tpc.12.1.151; Woriedh M, 2013, PLANT REPROD, V26, P255, DOI 10.1007/s00497-013-0221-z; Mizuta Y, 2015, PROTOPLASMA, V252, P1231, DOI 10.1007/s00709-014-0754-5; Lin SY, 2014, PLANT CELL, V26, P602, DOI 10.1105/tpc.113.121335; Zhou ZZ, 2015, PLANT CELL, V27, P1140, DOI 10.1105/tpc.114.135400; Tsukamoto T, 2010, PLANT J, V62, P571, DOI 10.1111/j.1365-313X.2010.04177.x; Dong J, 2005, PLANT PHYSIOL, V138, P778, DOI 10.1104/pp.105.063388; Gremski K, 2007, DEVELOPMENT, V134, P3593, DOI 10.1242/dev.011510; Lu YX, 2011, PLANT CELL, V23, P81, DOI 10.1105/tpc.110.080499; Higashiyama T, 2008, SEX PLANT REPROD, V21, P17, DOI 10.1007/s00497-007-0064-6; Hafidh S, 2014, BIOCHEM SOC T, V42, P388, DOI 10.1042/BST20130204; Heydlauff J, 2014, J EXP BOT, V65, P1323, DOI 10.1093/jxb/eru030; Escobar-Restrepo JM, 2007, SCIENCE, V317, P656, DOI 10.1126/science.1143562; Qu LJ, 2015, J EXP BOT, V66, P5139, DOI 10.1093/jxb/erv275; Kasahara RD, 2005, PLANT CELL, V17, P2981, DOI 10.1105/tpc.105.034603; Maruyama D, 2015, CELL, V161, P907, DOI 10.1016/j.cell.2015.03.018; Higashiyama T, 2006, PLANT PHYSIOL, V142, P481, DOI 10.1104/pp.106.083832; Wang HZ, 2008, PLANT CELL, V20, P3300, DOI 10.1105/tpc.108.062919; Beale KM, 2012, CURR BIOL, V22, P1090, DOI 10.1016/j.cub.2012.04.041; Alvarez J, 1999, DEVELOPMENT, V126, P2377; Kasahara RD, 2012, CURR BIOL, V22, P1084, DOI 10.1016/j.cub.2012.03.069; Marton ML, 2005, SCIENCE, V307, P573, DOI 10.1126/science.1104954; Sprunck S, 2012, SCIENCE, V338, P1093, DOI 10.1126/science.1223944; Mori T, 2014, CURR BIOL, V24, P170, DOI 10.1016/j.cub.2013.11.030; Boisson-Dernier A, 2009, DEVELOPMENT, V136, P3279, DOI 10.1242/dev.040071; Guan YF, 2014, PLANT PHYSIOL, V165, P528, DOI 10.1104/pp.113.231274; Li S, 2013, PLANT J, V74, P486, DOI 10.1111/tpj.12139; Huck N, 2003, DEVELOPMENT, V130, P2149, DOI 10.1242/dev.00458; Silverstein KAT, 2007, PLANT J, V51, P262, DOI 10.1111/j.1365-313X.2007.03136.x; Wolf S, 2014, PLANT CELL, V26, P1848, DOI 10.1105/tpc.114.125518; Shimizu KK, 2008, PLANT CELL PHYSIOL, V49, P1478, DOI 10.1093/pcp/pcn130; Kim S, 2003, P NATL ACAD SCI USA, V100, P16125, DOI 10.1073/pnas.2533800100; Liu JJ, 2013, CURR BIOL, V23, P993, DOI 10.1016/j.cub.2013.04.043; Lassig R, 2014, PLANT J, V78, P94, DOI 10.1111/tpj.12452; Rotman N, 2005, CURR BIOL, V15, P244, DOI 10.1016/j.cub.2005.01.013; Yang X, 2014, PLANT MOL BIOL, V86, P225, DOI 10.1007/s11103-014-0220-y; Higashiyama T, 2015, ANNU REV PLANT BIOL, V66, P393, DOI 10.1146/annurev-arplant-043014-115635; Boex-Fontvieille E, 2015, J EXP BOT; Boisson-Dernier A, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001719; Denninger P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5645; Duan QH, 2014, NAT COMMUN, P5; Endo S, 2013, CURR BIOL, V23, P1670, DOI 10.1016/j.cub.2013.06.060; Fang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019033; Gui CP, 2014, PLANT CELL, V26, P3538, DOI 10.1105/tpc.114.127381; Hamamura Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5722; Ichikawa M, 2015, PLANT REPROD; Lee Jin Suk, 2015, Nature, V522, P439, DOI 10.1038/nature14561; Li CX, 2015, ELIFE, V4, P4; Liang Y, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003933; Lindner H, 2015, PLOS BIOL, P13; Ling Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029470; Takeuchi H, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001449; Tsuchimatsu T, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002838; Uebler S, 2013, PLANT SIGNAL BEHAV, V8, DOI [10.4161/psb25682., DOI 10.4161/PSB25682]; Wang SS, 2015, PLANT CELL ENV	94	0	0	CURRENT BIOLOGY LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1369-5266	1879-0356		CURR OPIN PLANT BIOL	Curr. Opin. Plant Biol.	DEC	2015	28						127	136		10.1016/j.pbi.2015.10.006		10	Plant Sciences	Plant Sciences	CZ0FN	WOS:000366780600019		
J	Munemasa, S; Hauser, F; Park, J; Waadt, R; Brandt, B; Schroeder, JI				Munemasa, Shintaro; Hauser, Felix; Park, Jiyoung; Waadt, Rainer; Brandt, Benjamin; Schroeder, Julian I.			Mechanisms of abscisic acid-mediated control of stomata! aperture	CURRENT OPINION IN PLANT BIOLOGY			English	Review							ARABIDOPSIS GUARD-CELLS; S-TYPE ANION; DEPENDENT PROTEIN-KINASE; REDUCED AIR HUMIDITY; NADPH OXIDASE RBOHD; PLASMA-MEMBRANE; SIGNAL-TRANSDUCTION; DROUGHT TOLERANCE; STRESS RESPONSES; PHOSPHATASE PAIR	Drought stress triggers an increase in the level of the plant hormone abscisic acid (ABA), which initiates a signaling cascade to close stomata and reduce water loss. Recent studies have revealed that guard cells control cytosolic ABA concentration through the concerted actions of biosynthesis, catabolism as well as transport across membranes. Substantial progress has been made at understanding the molecular mechanisms of how the ABA signaling core module controls the activity of anion channels and thereby stomatal aperture. In this review, we focus on our current mechanistic understanding of ABA signaling in guard cells including the role of the second messenger Ca2+ as well as crosstalk with biotic stress responses.	[Munemasa, Shintaro] Okayama Univ, Grad Sch Environm & Life Sci, Kita Ku, Okayama 7008530, Japan; [Hauser, Felix; Park, Jiyoung; Schroeder, Julian I.] Univ Calif San Diego, Div Biol Sci, Cell & Dev Biol Sect, La Jolla, CA 92093 USA; [Waadt, Rainer] Heidelberg Univ, Ctr Organismal Studies, Plant Dev Biol, D-69120 Heidelberg, Germany; [Brandt, Benjamin] Univ Geneva, Dept Bot & Plant Biol, Struct Plant Biol Lab, CH-1211 Geneva, Switzerland	Schroeder, JI (reprint author), Univ Calif San Diego, Div Biol Sci, Cell & Dev Biol Sect, 9500 Gilman Dr, La Jolla, CA 92093 USA.	jischroeder@ucsd.edu			JSPS KAKENHI [26850233]; National Institutes of Health [GM060396-ES010337]; Human Frontier Science Program Long-Term fellowship; EMBO long term fellowship	The authors apologize to those colleagues whose relevant work could not be cited because of space limitations. Research in the authors' laboratories was supported by grants from JSPS KAKENHI Grant Number 26850233 (to S.M.), the National Institutes of Health (GM060396-ES010337) (to J.I.S.), a Human Frontier Science Program Long-Term fellowship (to J.P.), an EMBO long term fellowship (to B.B.).	Kanno Y, 2012, P NATL ACAD SCI USA, V109, P9653, DOI 10.1073/pnas.1203567109; Hubbard KE, 2012, ANN BOT-LONDON, V109, P5, DOI 10.1093/aob/mcr252; McAdam SAM, 2012, ECOL LETT, V15, P1, DOI 10.1111/j.1461-0248.2011.01700.x; Imes D, 2013, PLANT J, V74, P372, DOI 10.1111/tpj.12133; Ache P, 2000, FEBS LETT, V486, P93, DOI 10.1016/S0014-5793(00)02248-1; Nambara E, 2005, ANNU REV PLANT BIOL, V56, P165, DOI 10.1146/annurev.arplant.56.032604.144046; Kuromori T, 2011, PLANT J, V67, P885, DOI 10.1111/j.1365-313X.2011.04641.x; Kang J, 2010, P NATL ACAD SCI USA, V107, P2355, DOI 10.1073/pnas.0909222107; Munemasa S, 2011, PLANT PHYSIOL, V155, P553, DOI 10.1104/pp.110.162750; Haig D, 2013, ANN BOT-LONDON, V111, P337, DOI 10.1093/aob/mcs295; Liu Z, 2015, PLANT PHYSIOL, V167, P1659, DOI 10.1104/pp.15.00053; CORNISH K, 1986, PLANT PHYSIOL, V81, P1017, DOI 10.1104/pp.81.4.1017; Lee SC, 2009, P NATL ACAD SCI USA, V106, P21419, DOI 10.1073/pnas.0910601106; Hedrich R, 2012, PHYSIOL REV, V92, P1777, DOI 10.1152/physrev.00038.2011; Negi J, 2008, NATURE, V452, P483, DOI 10.1038/nature06720; Laanemets K, 2013, PLANT PHYSIOL, V163, P504, DOI 10.1104/pp.113.220343; Kwak JM, 2003, EMBO J, V22, P2623, DOI 10.1093/emboj/cdg277; Osakabe Y, 2013, PLANT CELL, V25, P609, DOI 10.1105/tpc.112.105700; Du MM, 2014, PLANT CELL, V26, P3167, DOI 10.1105/tpc.114.128272; Park SY, 2015, NATURE, V520, P545, DOI 10.1038/nature14123; Li L, 2014, CELL HOST MICROBE, V15, P329, DOI 10.1016/j.chom.2014.02.009; Kadota Y, 2014, MOL CELL, V54, P43, DOI 10.1016/j.molcel.2014.02.021; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; Chater C, 2015, CURR BIOL, V25, P2709, DOI 10.1016/j.cub.2015.09.013; McLachlan DH, 2014, NEW PHYTOL, V203, P1049, DOI 10.1111/nph.12916; Pressel S, 2014, J BRYOL, V36, P87, DOI 10.1179/1743282014Y.0000000103; Schwartz SH, 1997, PLANT PHYSIOL, V114, P161, DOI 10.1104/pp.114.1.161; Vlad F, 2009, PLANT CELL, V21, P3170, DOI 10.1105/tpc.109.069179; Boursiac Y, 2013, TRENDS PLANT SCI, V18, P325, DOI 10.1016/j.tplants.2013.01.007; RASCHKE K, 1975, PLANTA, V125, P243, DOI 10.1007/BF00385601; Vahisalu T, 2008, NATURE, V452, P487, DOI 10.1038/nature06608; Meyer S, 2010, PLANT J, V63, P1054, DOI 10.1111/j.1365-313X.2010.04302.x; Melotto M, 2006, CELL, V126, P969, DOI 10.1016/j.cell.2006.06.054; Murata Y, 2001, PLANT CELL, V13, P2513, DOI 10.1105/tpc.13.11.2513; Ye WX, 2013, PLANT PHYSIOL, V163, P591, DOI 10.1104/pp.113.224055; Ye WX, 2015, PLANT CELL PHYSIOL, V56, P1239, DOI 10.1093/pcp/pcv051; Geiger D, 2009, P NATL ACAD SCI USA, V106, P21425, DOI 10.1073/pnas.0912021106; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Kollist H, 2014, NEW PHYTOL, V203, P44, DOI 10.1111/nph.12832; Koers S, 2011, PLANT J, V68, P670, DOI 10.1111/j.1365-313X.2011.04719.x; Sasaki T, 2010, PLANT CELL PHYSIOL, V51, P354, DOI 10.1093/pcp/pcq016; Geiger D, 2010, P NATL ACAD SCI USA, V107, P8023, DOI 10.1073/pnas.0912030107; Zhu MM, 2014, PLANT J, V78, P491, DOI 10.1111/tpj.12490; Bauer H, 2013, CURR BIOL, V23, P53, DOI 10.1016/j.cub.2012.11.022; Merilo E, 2013, PLANT PHYSIOL, V162, P1652, DOI 10.1104/pp.113.220608; Kim TH, 2012, PLANT CELL, V24, P5177, DOI 10.1105/tpc.112.107235; Chen ZH, 2010, PLANT J, V61, P816, DOI 10.1111/j.1365-313X.2009.04108.x; Ligrone R, 2012, ANN BOT-LONDON, V109, P851, DOI 10.1093/aob/mcs017; Xue SW, 2011, EMBO J, V30, P1645, DOI 10.1038/emboj.2011.68; Weiner JJ, 2010, CURR OPIN PLANT BIOL, V13, P495, DOI 10.1016/j.pbi.2010.09.007; Wang YZ, 2013, PLANT PHYSIOL, V163, P566, DOI 10.1104/pp.113.219758; Hosy E, 2003, P NATL ACAD SCI USA, V100, P5549, DOI 10.1073/pnas.0733970100; Ruszala EM, 2011, CURR BIOL, V21, P1030, DOI 10.1016/j.cub.2011.04.044; Kim TH, 2010, ANNU REV PLANT BIOL, V61, P561, DOI 10.1146/annurev-arplant-042809-112226; Hauser F, 2011, CURR BIOL, V21, pR346, DOI 10.1016/j.cub.2011.03.015; McAdam SAM, 2015, PLANT PHYSIOL, V167, P833, DOI 10.1104/pp.114.252940; Kim TH, 2011, CURR BIOL, V21, P990, DOI 10.1016/j.cub.2011.04.045; Deger AG, 2015, NEW PHYTOL, V208, P162, DOI 10.1111/nph.13435; Lee KH, 2006, CELL, V126, P1109, DOI 10.1016/j.cell.2006.07.034; Hua DP, 2012, PLANT CELL, V24, P2546, DOI 10.1105/tpc.112.100107; Vahisalu T, 2010, PLANT J, V62, P442, DOI 10.1111/j.1365-313X.2010.04159.x; Murata Y, 2015, ANNU REV PLANT BIOL, V66, P369, DOI 10.1146/annurev-arplant-043014-114707; Dong T, 2014, PLANT PHYSIOL, V165, P277, DOI 10.1104/pp.114.239210; Okamoto M, 2009, PLANT PHYSIOL, V149, P825, DOI 10.1104/pp.108.130823; Roelfsema MRG, 2012, TRENDS PLANT SCI, V17, P221, DOI 10.1016/j.tplants.2012.01.009; Okamoto M, 2013, P NATL ACAD SCI USA, V110, P12132, DOI 10.1073/pnas.1305919110; Jin XF, 2013, PLANT CELL, V25, P4789, DOI 10.1105/tpc.113.119800; Brandt B, 2012, P NATL ACAD SCI USA, V109, P10593, DOI 10.1073/pnas.1116590109; Levchenko V, 2005, P NATL ACAD SCI USA, V102, P4203, DOI 10.1073/pnas.0500146102; Chater C, 2011, CURR BIOL, V21, P1025, DOI 10.1016/j.cub.2011.04.032; McAdam SAM, 2012, PLANT CELL, V24, P1510, DOI 10.1105/tpc.112.096404; Cao MJ, 2013, CELL RES, V23, P1043, DOI 10.1038/cr.2013.95; Umezawa T, 2009, P NATL ACAD SCI USA, V106, P17588, DOI 10.1073/pnas.0907095106; Siegel RS, 2009, PLANT J, V59, P207, DOI 10.1111/j.1365-313X.2009.03872.x; Brandt B, 2015, ELIFE, V4, DOI 10.7554/eLife.03599; Bueso E, 2014, PLANT J, V80, P1057, DOI 10.1111/tpj.12708; Finkelstein Ruth, 2013, Arabidopsis Book, V11, pe0166, DOI 10.1199/tab.0166; Jones AM, 2014, ELIFE, V3, DOI 10.7554/eLife.01741; Lim CW, 2014, PLANT CELL PHYSIOL, V55, P1691, DOI 10.1093/pcp/pcu100; Lind C, 2015, CURR BIOL, V25, P928, DOI 10.1016/j.cub.2015.01.067; Maierhofer T, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005703; Merilo E, 2015, MOL PLANT, V8, P657, DOI 10.1016/j.molp.2015.01.014; Montillet JL, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001513; Mori IC, 2006, PLOS BIOL, V4, P1749, DOI 10.1371/journal.pbio.0040327; Rodriguez L, 2014, PLANT CELL, V26, P4802, DOI 10.1105/tpc.114.129973; Waadt R, 2014, ELIFE, V3, DOI 10.7554/eLife.01739; Zhang HW, 2014, MOL PLANT, V7, P1522, DOI 10.1093/mp/ssu063	87	0	0	CURRENT BIOLOGY LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1369-5266	1879-0356		CURR OPIN PLANT BIOL	Curr. Opin. Plant Biol.	DEC	2015	28						154	162		10.1016/j.pbi.2015.10.010		9	Plant Sciences	Plant Sciences	CZ0FN	WOS:000366780600022		
J	Xiong, Y; Huang, SH; Shinno, Y; Furuya, Y; Imazato, S; Fok, A; Hayashi, M				Xiong, Yu; Huang, Shih-Hao; Shinno, Yuko; Furuya, Yu; Imazato, Satoshi; Fok, Alex; Hayashi, Mikako			The use of a fiber sleeve to improve fracture strength of pulpless teeth with flared root canals	DENTAL MATERIALS			English	Article						Dentin bonding; Fiber post; Finite element analysis; Flared root canal; Fracture strength; Root fracture; Stress distribution	COMPOSITE RESTORATIONS; STRESS-DISTRIBUTION; BOND STRENGTH; POSTS; RESISTANCE; DENTIN; CORE; RESIN; TOOTH; FEA	Objectives. This study aimed to investigate how use of a fiber sleeve may reduce interfacial debonding and improve fracture strength of pulpless teeth with flared root canals. Methods. Pulpless premolars with flared root canals were restored either with a fiber-reinforced post (FRP) alone or with an FRP wrapped in a hollow tubular fiber sleeve. A normal root restored with an FRP alone served as a control. The integrity of resin-dentin and resin-fiber interfaces in the restored roots was evaluated by a stereoscopic system after penetrating a dye. Four roots were tested for each experimental group. Fracture resistance in pulpless premolars with flared root canals restored with an FRP alone or with an FRP/sleeve combination were investigated under bonded and non-bonded conditions with static fracture testing (n = 8), and stress distribution in these restored premolars were tested by finite element analysis (FEA). Results. Flared root canals restored with an FRP/sleeve combination demonstrated superior integrity at the cervical resin-dentin interface to root canals with an FRP alone. Premolars with a flared root canal restored with an FRP/sleeve combination showed significantly greater fracture resistance compared with premolars restored with an FRP alone. FEA showed that once interfacial de-bonding extended to the cervical region of the root, stress concentration in the root dentin dramatically increased. Significance. The FRP/sleeve combination was effective in reducing debonding and, hence, improving the fracture strength of pulpless premolars with flared root canals. (C) 2015 Academy of Dental Materials. Published by Elsevier Ltd. All rights reserved.	[Xiong, Yu] Third Mil Med Univ, Dept Stomatol, Southwest Hosp, Beijing, Peoples R China; [Huang, Shih-Hao] Natl Taiwan Univ, Grad Inst Clin Dent, Sch Dent, Taipei, Taiwan; [Shinno, Yuko; Furuya, Yu; Hayashi, Mikako] Osaka Univ, Grad Sch Dent, Dept Restorat Dent & Endodontol, Suita, Osaka 5650871, Japan; [Imazato, Satoshi] Osaka Univ, Grad Sch Dent, Dept Biomat Sci, Suita, Osaka 5650871, Japan; [Fok, Alex] Univ Minnesota, Minnesota Dent Res Ctr Biomat & Biomechan, Sch Dent, Minneapolis, MN 55455 USA	Hayashi, M (reprint author), Osaka Univ, Grad Sch Dent, Dept Restorat Dent & Endodontol, 1-8 Yamadaoka, Suita, Osaka 5650871, Japan.	xytmmu@gmail.com; d97422003@ntu.edu.tw; y-takeda@dent.osaka-u.ac.jp; yfuruya@dent.osaka-u.ac.jp; imazato@dent.osaka-u.ac.jp; alexfok@umn.edu; mikarin@dent.oska-u.ac.jp			Japan-China Sasakawa Medical Fellowship from JSPS [25293387, 15K15700]; Chongqing NSF of China [cstc2013jcyjA10112]	This study was supported by the Japan-China Sasakawa Medical Fellowship, Grants-in-Aid for Scientific Research (25293387 and 15K15700) from JSPS, and Chongqing NSF of China (cstc2013jcyjA10112). The authors are grateful to Sun Medical for kindly providing some of the materials used. The authors deny any conflicts of interest related to this study.	Alonso RC, 2006, ACTA ODONTOL SCAND, V64, P141, DOI 10.1080/0016350500474565; Mezzomo LA, 2011, J PROSTHODONT, V20, P120, DOI 10.1111/j.1532-849X.2010.00669.x; Lanza A, 2005, DENT MATER, V21, P709, DOI 10.1016/j.dental.2004.09.010; Zicari F, 2008, DENT MATER, V24, P967, DOI 10.1016/j.dental.2007.11.011; Grandini S, 2003, J ADHES DENT, V5, P243; Clavijo VGR, 2009, J APPL ORAL SCI, V17, P574, DOI 10.1590/S1678-77572009000600007; Grandini S, 2005, J ADHES DENT, V7, P235; Macedo VC, 2010, J ENDODONT, V36, P1543, DOI 10.1016/j.joen.2010.04.014; Khan SIR, 2013, J ADHES DENT, V15, P167, DOI 10.3290/j.jad.a28731; Tait CME, 2005, BRIT DENT J, V198, P609, DOI 10.1038/sj.bdj.4812351; HO MH, 1994, J PROSTHET DENT, V72, P367, DOI 10.1016/0022-3913(94)90555-X; Braga RR, 2006, DENT MATER, V22, P818, DOI 10.1016/j.dental.2005.11.010; Teixeira CS, 2009, J ENDODONT, V35, P1034, DOI 10.1016/j.joen.2009.04.018; Cagidiaco MC, 2008, INT J PROSTHODONT, V21, P328; SANO H, 1994, J DENT RES, V73, P1205; Rundquist BD, 2006, INT ENDOD J, V39, P226, DOI 10.1111/j.1365-2591.2006.01078.x; Santos AFV, 2010, J DENT RES, V89, P587, DOI 10.1177/0022034510363382; Inaba Y, 2013, DENT MATER J, V32, P718, DOI 10.4012/dmj.2013-038; Mancebo JC, 2010, AM J DENT, V23, P351; Tay FR, 2007, J ENDODONT, V33, P391, DOI 10.1016/j.joen.2006.10.009; CARTER DR, 1977, J BONE JOINT SURG AM, V59, P954; Gomes GM, 2014, J ADHES DENT, V16, P267, DOI 10.3290/j.jad.a31940; Hayashi M, 2006, DENT MATER, V22, P477, DOI 10.1016/j.dental.2005.03.017; Lassila LVJ, 2004, DENT MATER, V20, P29, DOI 10.1016/S0109-5641(03)00065-4; Tay FR, 2005, J ENDODONT, V31, P584, DOI 10.1097/01.don.0000168891.23486.de; Faria-e-Silva André Luís, 2009, J Appl Oral Sci, V17, P600; Friedman C E, 1977, J Endod, V3, P304, DOI 10.1016/S0099-2399(77)80035-6; Hayashi M, 2008, JAP DENT SCI REV, V44, P22, DOI 10.1016/j.jdsr.2007.10.001; Hegde Jayshree, 2012, J Conserv Dent, V15, P223, DOI 10.4103/0972-0707.97942; Silva Gisele Rodrigues da, 2011, Braz. Dent. J., V22, P230, DOI 10.1590/S0103-64402011000300009; Zogheib Lucas Villaça, 2008, Braz Dent J, V19, P329, DOI 10.1590/S0103-64402008000400008	31	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0109-5641	1879-0097		DENT MATER	Dent. Mater.	DEC	2015	31	12					1427	1434		10.1016/j.dental.2015.09.005		8	Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials	Dentistry, Oral Surgery & Medicine; Materials Science	CY7EA	WOS:000366569800005		
J	Yoshihara, K; Nagaoka, N; Okihara, T; Kuroboshi, M; Hayakawa, S; Maruo, Y; Nishigawa, G; De Munck, J; Yoshida, Y; Van Meerbeek, B				Yoshihara, Kumiko; Nagaoka, Noriyuki; Okihara, Takumi; Kuroboshi, Manabu; Hayakawa, Satoshi; Maruo, Yukinori; Nishigawa, Goro; De Munck, Jan; Yoshida, Yasuhiro; Van Meerbeek, Bart			Functional monomer impurity affects adhesive performance	DENTAL MATERIALS			English	Article						Functional monomer; NMR; TEM; Impurity; Adhesion; Dentin	PHOSPHORIC-ACID ESTER; UNIVERSAL ADHESIVES; BOND STRENGTH; DENTIN; ENAMEL; DEGRADATION; PHOSPHATE; EFFICACY; SYSTEMS; MODES	Objective. The functional monomer 10-MDP has been considered as one of the best performing functional monomers for dental adhesives. Different adhesives containing 10-MDP are commercially available, among which many so-called 'universal' adhesives. We hypothesize that the quality of the functional monomer 10-MDP in terms of purity may affect bonding performance. Methods. We therefore characterized three different 10-MDP versions (10-MDP_KN provided by Kuraray Noritake; 10-MDP_PCM provided by PCM; 10-MDP_DMI provided by DMI) using NMR, and analyzed their ability to form 10-MDP_Ca salts on dentin using XRD. The 'immediate' and 'aged' micro-tensile bond strength (mu TBS) to dentin of three experimental 10-MDP primers was measured. The resultant interfacial adhesive-dentin ultra-structure was characterized using TEM. Results. NMR disclosed impurities and the presence of 10-MDP dimer in 10-MDP_PCM and 10-MDP_DMI. 10-MDP_PCM and 10-MDP_DMI appeared also sensitive to hydrolysis. 10-MDP_KN, on the contrary, contained less impurities and dimer, and did not undergo hydrolysis. XRD revealed more intense 10-MDP_Ca salt deposition on dentin induced by 10-MDP_KN. The adhesive based on the experimental 10-MDP_KN primer resulted in a significantly higher 'immediate' bond strength that remained stable upon aging; the mu TBS of the experimental 10-MDP_PCM and 10-MDP_DMI adhesives significantly dropped upon aging. TEM revealed thicker hybridization and more intense nano-layering for 10-MDP_KN. Significance. It was concluded that primer impurities and the presence of 10-MDP dimer affected not only hybridization, but also reduced the formation of 10-MDP_Ca salts and nano-layering. 10-MDP in a high purity grade is essential to achieve durable bonding. (C) 2015 Published by Elsevier Ltd on behalf of Academy of Dental Materials. All rights reserved.	[Yoshihara, Kumiko] Okayama Univ Hosp, Ctr Innovat Clin Med, Kita Ku, Okayama 7008558, Japan; [Nagaoka, Noriyuki] Okayama Univ, Sch Dent, Adv Res Ctr Oral & Craniofacial Sci, Kita Ku, Okayama 7008558, Japan; [Okihara, Takumi; Kuroboshi, Manabu] Okayama Univ, Div Chem & Biol Technol, Grad Sch Nat Sci & Technol, Kita Ku, Okayama 7008530, Japan; [Hayakawa, Satoshi] Okayama Univ, Biomat Lab, Grad Sch Nat Sci & Technol, Kita Ku, Okayama 7008530, Japan; [Maruo, Yukinori; Nishigawa, Goro] Okayama Univ, Dept Occlus & Removable Prosthodont, Kita Ku, Okayama 7008558, Japan; [De Munck, Jan; Van Meerbeek, Bart] Katholieke Univ Leuven, BIOMAT, Dept Oral Hlth Res, KU Leuven, B-3000 Leuven, Belgium; [De Munck, Jan; Van Meerbeek, Bart] Katholieke Univ Leuven Hosp, Dent, B-3000 Leuven, Belgium; [Yoshida, Yasuhiro] Hokkaido Univ, Grad Sch Dent Med, Dept Biomat & Bioengn, Kita Ku, Sapporo, Hokkaido 0608586, Japan	Van Meerbeek, B (reprint author), Katholieke Univ Leuven, BIOMAT, Dept Oral Hlth Res, KU Leuven, Kapucijnenvoer 7 Blok Bus 7001, B-3000 Leuven, Belgium.	k-yoshi@md.okayama-u.ac.jp; nagaoka@okayama-u.ac.jp; okihara@cc.okayama-u.ac.jp; mkurohos@cc.okayama-u.ac.jp; satoshi@okayama-u.ac.jp; ykmar@md.okayama-u.ac.jp; goro@md.okayama-u.ac.jp; jan.demunck@med.kuleuven.be; yasuhiro@den.hokudai.ac.jp; bart.vanmeerbeek@med.kuleuven.be			 [26893156]	The current research was supported by a Grant-in-Aid for Research Activity Start-up (26893156). We thank the respective manufacturers, Kuraray Noritake (Tokyo, Japan), PCM (Krefeld, Germany) and Designer Molecule (DMI, San Diego, CA) for providing the different 10-MDP monomers.	Walter R, 2012, J DENT, V40, P549, DOI 10.1016/j.jdent.2012.03.003; Wagner A, 2014, J DENT, V42, P800, DOI 10.1016/j.jdent.2014.04.012; Ogliari FA, 2008, J DENT, V36, P171, DOI 10.1016/j.jdent.2007.11.003; Aida M, 2009, J DENT RES, V88, P443, DOI 10.1177/0022034509337146; Zander-Grande C, 2011, AM J DENT, V24, P239; Yoshida Y, 2012, J DENT RES, V91, P1060, DOI 10.1177/0022034512460396; Yoshida Y, 2004, J DENT RES, V83, P454; Moszner N, 2005, DENT MATER, V21, P895, DOI 10.1016/j.dental.2005.05.001; Fukegawa D, 2006, J DENT RES, V85, P941; Zhou ZY, 2009, AM J DENT, V22, P235; Fujita K, 2011, J DENT RES, V90, P607, DOI 10.1177/0022034510397837; Yoshihara K, 2010, ACTA BIOMATER, V6, P3573, DOI 10.1016/j.actbio.2010.03.024; Van Meerbeek B, 1998, J DENT RES, V77, P50; Munoz MA, 2014, J DENT, V42, P595, DOI 10.1016/j.jdent.2014.01.013; Teshima I, 2010, J DENT RES, V89, P1281, DOI 10.1177/0022034510379018; Inoue S, 2005, J DENT RES, V84, P1160; Peumans M, 2010, DENT MATER, V26, P1176, DOI 10.1016/j.dental.2010.08.190; De Munck J, 2012, J DENT RES, V91, P351, DOI 10.1177/0022034511431251; Yoshihara K, 2011, ACTA BIOMATER, V7, P3187, DOI 10.1016/j.actbio.2011.04.026; Poitevin A, 2007, DENT MATER J, V26, P694; Yoshida Y, 2012, J DENT RES, V91, P376, DOI 10.1177/0022034512437375; Fujita K, 2006, J DENT, V34, P123, DOI 10.1016/j.jdent.2005.04.005; Omura I, US Patent, Patent No. 4537940	23	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0109-5641	1879-0097		DENT MATER	Dent. Mater.	DEC	2015	31	12					1493	1501		10.1016/j.dental.2015.09.019		9	Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials	Dentistry, Oral Surgery & Medicine; Materials Science	CY7EA	WOS:000366569800013		
J	Fukuda, A; Mitani, A; Miyashita, T; Umezawa, A; Akutsu, H				Fukuda, Atsushi; Mitani, Atsushi; Miyashita, Toshiyuki; Umezawa, Akihiro; Akutsu, Hidenori			Chromatin condensation of Xist genomic loci during oogenesis in mice	DEVELOPMENT			English	Article						Xist; Imprinted XCI; Chromatin condensation; Oogenesis; Histone methylation; Nuclear transfer	X-CHROMOSOME INACTIVATION; EMBRYONIC STEM-CELLS; EARLY MOUSE EMBRYOS; OOCYTE GROWTH; EPIGENETIC MODIFICATIONS; HISTONE METHYLATION; MAMMALIAN OOCYTES; EXPRESSION; HETEROCHROMATIN; TRANSCRIPTION	Repression of maternal Xist (Xm-Xist) during preimplantation in mouse embryos is essential for establishing imprinted X chromosome inactivation. Nuclear transplantation (NT) studies using nuclei derived from non-growing (ng) and full-grown (fg) oocytes have indicated that maternal-specific repressive modifications are imposed on Xm-Xist during oogenesis, as well as on autosomal imprinted genes. Recent studies have revealed that histone H3 lysine 9 trimethylation (H3K9me3) enrichments on Xm-Xist promoter regions are involved in silencing at the preimplantation stages. However, whether H3K9me3 is imposed on Xm-Xist during oogenesis is not known. Here, we dissected the chromatin states in ng and fg oocytes and early preimplantation stage embryos. Chromatin immunoprecipitation experiments against H3K9me3 revealed that there was no significant enrichment within the Xm-Xist region during oogenesis. However, NT embryos with ng nuclei (ngNT) showed extensive Xm-Xist derepression and H3K9me3 hypomethylation of the promoter region at the 4-cell stage, which corresponds to the onset of paternal Xist expression. We also found that the chromatin state at the Xist genomic locus became markedly condensed as oocyte growth proceeded. Although the condensed Xm-Xist genomic locus relaxed during early preimplantation phases, the extent of the relaxation across Xm-Xist loci derived from normally developed oocytes was significantly smaller than those of paternal-Xist and ngNT-Xistgenomic loci. Furthermore, Xm-Xistfrom 2-cell metaphase nuclei became derepressed following NT. We propose that chromatin condensation is associated with imprinted Xist repression and that skipping of the condensation step by NT leads to Xist activation during the early preimplantation phase.	[Fukuda, Atsushi; Mitani, Atsushi; Umezawa, Akihiro; Akutsu, Hidenori] Natl Res Inst Child Hlth & Dev, Ctr Regenerat Med, Setagaya Ku, Tokyo 1578535, Japan; [Mitani, Atsushi; Miyashita, Toshiyuki] Kitasato Univ, Grad Sch Med Sci, Dept Mol Genet, Minami Ku, Sagamihara, Kanagawa 2520374, Japan; [Akutsu, Hidenori] Fukushima Med Univ, Dept Stem Cell Res, Fukushima, Fukushima 9601295, Japan	Akutsu, H (reprint author), Natl Res Inst Child Hlth & Dev, Ctr Regenerat Med, Setagaya Ku, 2-10-1 Okura, Tokyo 1578535, Japan.	akutsu-h@ncchd.go.jp			Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; Ministry of Health, Labor, and Welfare (MHLW); JST-CREST; JSPS KAKENHI [26861350];  [21390456]	This work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; a grant from the Ministry of Health, Labor, and Welfare (MHLW) to H.A. and A.U.; a Grant-in-Aid for Scientific Research [21390456]; a grant from JST-CREST to H.A.; and a JSPS KAKENHI Grant-in-Aid for Young Scientists (B) to A.F. [26861350]. Deposited in PMC for immediate release.	Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Tada T, 2000, DEVELOPMENT, V127, P3101; Inoue K, 2010, SCIENCE, V330, P496, DOI 10.1126/science.1194174; Wen B, 2009, NAT GENET, V41, P246, DOI 10.1038/ng.297; Nakamura T, 2012, NATURE, V486, P415, DOI 10.1038/nature11093; Kono T, 1996, NAT GENET, V13, P91, DOI 10.1038/ng0596-91; Sado T, 2013, REPRODUCTION, V146, pR131, DOI 10.1530/REP-13-0173; Chambeyron S, 2004, GENE DEV, V18, P1119, DOI 10.1101/gad.292104; Shin J, 2010, NATURE, V467, P977, DOI 10.1038/nature09457; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Yoshida N, 2007, DEV BIOL, V301, P464, DOI 10.1016/k.ydbio.2006.08.006; Puschendorf M, 2008, NAT GENET, V40, P411, DOI 10.1038/ng.99; Kageyama S, 2007, REPRODUCTION, V133, P85, DOI 10.1530/REP-06-0025; Jonkers I, 2009, CELL, V139, P999, DOI 10.1016/j.cell.2009.10.034; Ma PP, 2012, P NATL ACAD SCI USA, V109, pE481, DOI 10.1073/pnas.1118403109; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Santos F, 2005, DEV BIOL, V280, P225, DOI 10.1016/j.ydbio.2005.01.025; TAKAGI N, 1975, NATURE, V256, P640, DOI 10.1038/256640a0; Augui S, 2011, NAT REV GENET, V12, P429, DOI 10.1038/nrg2987; KONO T, 1993, MOL REPROD DEV, V34, P43, DOI 10.1002/mrd.1080340107; Lee JT, 2011, NAT REV MOL CELL BIO, V12, P815, DOI 10.1038/nrm3231; Wang FC, 2007, BIOL REPROD, V77, P1007, DOI 10.1095/biolreprod.107.063149; Kawahara M, 2008, NAT PROTOC, V3, P197, DOI 10.1038/nprot.2007.531; Terranova R, 2008, DEV CELL, V15, P668, DOI 10.1016/j.devcel.2008.08.015; Matsui T, 2010, NATURE, V464, P927, DOI 10.1038/nature08858; Nesterova TB, 2001, DEV BIOL, V235, P343, DOI 10.1006/dbio.2001.0295; Egli D, 2009, CURR BIOL, V19, P1403, DOI 10.1016/j.cub.2009.06.065; De La Fuente R, 2006, DEV BIOL, V292, P1, DOI 10.1016/j.ydbio.2006.01.008; Eskeland R, 2010, MOL CELL, V38, P452, DOI 10.1016/j.molcel.2010.02.032; Fukuda A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011274; Fukuda A, 2015, SCI REP-UK, V5, DOI 10.1038/srep14101; Fukuda A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6464; Shirane K, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003439; Sugimoto M, 2007, PLOS GENET, V3, P1309, DOI 10.1371/journal.pgen.0030116	34	0	0	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0950-1991	1477-9129		DEVELOPMENT	Development	DEC 1	2015	142	23					4049	4055		10.1242/dev.127308		7	Developmental Biology	Developmental Biology	CY4FK	WOS:000366363800006		
J	Aldiri, I; Ajioka, I; Xu, BS; Zhang, JK; Chen, X; Benavente, C; Finkelstein, D; Johnson, D; Akiyama, J; Pennacchio, LA; Dyer, MA				Aldiri, Issam; Ajioka, Itsuki; Xu, Beisi; Zhang, Jiakun; Chen, Xiang; Benavente, Claudia; Finkelstein, David; Johnson, Dianna; Akiyama, Jennifer; Pennacchio, Len A.; Dyer, Michael A.			Brg1 coordinates multiple processes during retinogenesis and is a tumor suppressor in retinoblastoma	DEVELOPMENT			English	Article						SWI/SNF; Epigenetics; Retina development; Retinoblastoma; Mouse	CELL-CYCLE PROGRESSION; ROD DYSTROPHY CORD7; GENE-EXPRESSION; RETINAL DEVELOPMENT; MOUSE RETINA; DEVELOPMENTAL DEFECTS; CENTRIOLE DUPLICATION; FATE DETERMINATION; DNA-REPLICATION; GOLGI TRANSPORT	Retinal development requires precise temporal and spatial coordination of cell cycle exit, cell fate specification, cell migration and differentiation. When this process is disrupted, retinoblastoma, a developmental tumor of the retina, can form. Epigenetic modulators are central to precisely coordinating developmental events, and many epigenetic processes have been implicated in cancer. Studying epigenetic mechanisms in development is challenging because they often regulate multiple cellular processes; therefore, elucidating the primary molecular mechanisms involved can be difficult. Here we explore the role of Brg1 (Smarca4) in retinal development and retinoblastoma in mice using molecular and cellular approaches. Brg1 was found to regulate retinal size by controlling cell cycle length, cell cycle exit and cell survival during development. Brg1 was not required for cell fate specification but was required for photoreceptor differentiation and cell adhesion/polarity programs that contribute to proper retinal lamination during development. The combination of defective cell differentiation and lamination led to retinal degeneration in Brg1-deficient retinae. Despite the hypocellularity, premature cell cycle exit, increased cell death and extended cell cycle length, retinal progenitor cells persisted in Brg1-deficient retinae, making them more susceptible to retinoblastoma. ChIP-Seq analysis suggests that Brg1 might regulate gene expression through multiple mechanisms.	[Aldiri, Issam; Zhang, Jiakun; Benavente, Claudia; Dyer, Michael A.] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; [Ajioka, Itsuki] Tokyo Med & Dent Univ, Ctr Brain Integrat Res, Tokyo 1138510, Japan; [Xu, Beisi; Chen, Xiang; Finkelstein, David] St Jude Childrens Res Hosp, Dept Computat Biol, Memphis, TN 38105 USA; [Johnson, Dianna; Dyer, Michael A.] Univ Tennessee, Ctr Hlth Sci, Dept Ophthalmol, Memphis, TN 38163 USA; [Akiyama, Jennifer; Pennacchio, Len A.] Lawrence Berkeley Natl Lab, Genom Div, Berkeley, CA 94701 USA; [Akiyama, Jennifer; Pennacchio, Len A.] Joint Genome Inst, Dept Energy, Walnut Creek, CA 94598 USA; [Dyer, Michael A.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Dyer, MA (reprint author), St Jude Childrens Res Hosp, Dept Dev Neurobiol, 332 N Lauderdale St, Memphis, TN 38105 USA.	michael.dyer@stjude.org			Cancer Center Support from National Cancer Institute (NCI) [CA21765]; National Institutes of Health (NIH) [EY014867, EY018599, CA168875]; American Lebanese Syrian Associated Charities (ALSAC); Alex's Lemonade Stand Foundation for Childhood Cancer; National Institute of Dental and Craniofacial Research (NIDCR) [U01DE020060NIH]; National Human Genome Research Institute (NHGRI) [R01HG003988, U54HG006997]; Department of Energy [DE-AC02-05CH11231]	This work was supported, in part, by Cancer Center Support [CA21765] from the National Cancer Institute (NCI), grants to M.A.D. from the National Institutes of Health (NIH) [EY014867 and EY018599 and CA168875], and the American Lebanese Syrian Associated Charities (ALSAC). M.A.D. was also supported by a grant from Alex's Lemonade Stand Foundation for Childhood Cancer. L.A.P. was supported by a National Institute of Dental and Craniofacial Research (NIDCR) FaceBase grant [U01DE020060NIH] and by National Human Genome Research Institute (NHGRI) grants [R01HG003988 and U54HG006997], and research was conducted at the E. O. Lawrence Berkeley National Laboratory and performed under Department of Energy Contract DE-AC02-05CH11231. Deposited in PMC for immediate release.	Wells J, 2002, P NATL ACAD SCI USA, V99, P3890, DOI 10.1073/pnas.062047499; Hargreaves DC, 2011, CELL RES, V21, P396, DOI 10.1038/cr.2011.32; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Reisman D, 2009, ONCOGENE, V28, P1653, DOI 10.1038/onc.2009.4; Johnson S, 2003, GENOMICS, V81, P304, DOI 10.1016/S0888-7543(03)00010-7; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; Sun HF, 2006, MOL CELL BIOL, V26, P1527, DOI 10.1128/MCB.26.4.1527-1537.2006; Fu XY, 2006, DEV BIOL, V299, P424, DOI 10.1016/j.ydbio.2006.08.015; Yasumi M, 2003, BIOCHEM BIOPH RES CO, V302, P61, DOI 10.1016/S0006-291X(03)00106-2; Wen H, 2008, GENE DEV, V22, P601, DOI 10.1101/gad.1626308; Hu GQ, 2011, GENOME RES, V21, P1650, DOI 10.1101/gr.121145.111; Firat-Karalar EN, 2014, CURR BIOL, V24, P664, DOI 10.1016/j.cub.2014.01.067; Dyer MA, 2001, J COMP NEUROL, V429, P601; Sonnen KF, 2013, J CELL SCI, V126, P3223, DOI 10.1242/jcs.129502; Dyer MA, 2000, DEVELOPMENT, V127, P3593; Dyer MA, 2003, NAT GENET, V34, P53, DOI 10.1038/ng1144; Rowan S, 2004, DEV BIOL, V271, P388, DOI 10.1016/j.ydbio.2004.03.039; Kurimchak A, 2012, GENE, V499, P1, DOI 10.1016/j.gene.2012.02.015; Weinmann AS, 2001, MOL CELL BIOL, V21, P6820, DOI 10.1128/MCB.21.20.6820-6832.2001; Shingai T, 2003, J BIOL CHEM, V278, P35421, DOI 10.1074/jbc.M305387200; McEvoy J, 2011, CANCER CELL, V20, P260, DOI 10.1016/j.ccr.2011.07.005; Chi P, 2010, NAT REV CANCER, V10, P457, DOI 10.1038/nrc2876; Lachke SA, 2012, HUM GENET, V131, P235, DOI 10.1007/s00439-011-1064-z; Attanasio C, 2014, GENOME RES, V24, P920, DOI 10.1101/gr.168930.113; Mizeracka K, 2013, DEV DYNAM, V242, P1147, DOI 10.1002/dvdy.24006; Gregg RG, 2003, P NATL ACAD SCI USA, V100, P6535, DOI 10.1073/pnas.0631813100; Shain AH, 2012, P NATL ACAD SCI USA, V109, pE252, DOI 10.1073/pnas.1114817109; Robinson G, 2012, NATURE, V488, P43, DOI 10.1038/nature11213; Hoffman GR, 2014, P NATL ACAD SCI USA, V111, P3128, DOI 10.1073/pnas.1316793111; Trimarchi JM, 2009, DEV DYNAM, V238, P2327, DOI 10.1002/dvdy.21973; Glaros S, 2008, CANCER RES, V68, P3689, DOI 10.1158/0008-5472.CAN-07-6652; Takai Y, 2003, CANCER SCI, V94, P655, DOI 10.1111/j.1349-7006.2003.tb01499.x; Martins RAP, 2006, EUR J NEUROSCI, V24, P969, DOI 10.1111/j.1460-9568.2006.04966.x; Alexiades MR, 1996, DEV DYNAM, V205, P293, DOI 10.1002/(SICI)1097-0177(199603)205:3<293::AID-AJA9>3.0.CO;2-D; Link BA, 2000, DEVELOPMENT, V127, P2177; Parsons DW, 2011, SCIENCE, V331, P435, DOI 10.1126/science.1198056; Gonzalo S, 2005, CELL CYCLE, V4, P752; Cainarca S, 1999, HUM MOL GENET, V8, P1387, DOI 10.1093/hmg/8.8.1387; Zheng CL, 2010, BLOOD, V116, P5698, DOI [10.1182/blood-2010-04-278325, 10.1182/blood-201004-278325]; Hunter DD, 2004, MOL CELL NEUROSCI, V27, P477, DOI 10.1016/j.mcn.2004.08.003; Latta EJ, 2012, MECH DEVELOP, V128, P560, DOI 10.1016/j.mod.2012.01.002; Wang MM, 2003, J COMP NEUROL, V460, P106, DOI 10.1002/cne.10636; Iwanaga R, 2006, ONCOGENE, V25, P1786, DOI 10.1038/sj.onc.1209210; Malinauskas T, 2011, NAT STRUCT MOL BIOL, V18, P886, DOI 10.1038/nsmb.2081; Phillips MJ, 2010, J COMP NEUROL, V518, P2071, DOI 10.1002/cne.22322; Lu JR, 2007, P NATL ACAD SCI USA, V104, P9381, DOI 10.1073/pnas.0610279104; Love C, 2012, NAT GENET, V44, P1321, DOI 10.1038/ng.2468; Johnson DA, 2007, CANCER RES, V67, P2701, DOI 10.1158/0008-5472.CAN-06-3754; Zhang JH, 2012, NATURE, V481, P329, DOI 10.1038/nature10733; Mizeracka K, 2013, DEVELOPMENT, V140, P3188, DOI 10.1242/dev.090696; Ajioka I, 2007, CELL, V131, P378, DOI 10.1016/j.cell.2007.09.036; Joukov V, 2014, MOL CELL, V55, P578, DOI 10.1016/j.molcel.2014.06.016; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Wilson BG, 2014, MOL CELL BIOL, V34, P1136, DOI 10.1128/MCB.01372-13; Dyer MA, 2005, NAT REV CANCER, V5, P91, DOI 10.1038/nrc1545; Benetti R, 2008, NAT STRUCT MOL BIOL, V15, P998, DOI 10.1038/nsmb0908-998b; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; Muller H, 2001, GENE DEV, V15, P267, DOI 10.1101/gad.864201; Medina PP, 2008, HUM MUTAT, V29, P617, DOI 10.1002/humu.20730; Wurster AL, 2008, MOL CELL BIOL, V28, P7274, DOI 10.1128/MCB.00835-08; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Schimel AM, 2006, OPHTHALMIC GENET, V27, P9, DOI 10.1080/13816810500481758; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Alexander JM, 2015, DEVELOPMENT, V142, P1418, DOI 10.1242/dev.109496; Zhang JK, 2004, NAT GENET, V36, P351, DOI 10.1038/ng1318; Ishida S, 2001, MOL CELL BIOL, V21, P4684, DOI 10.1128/MCB.21.14.4684-4699.2001; Bourgo RJ, 2009, MOL BIOL CELL, V20, P3192, DOI 10.1091/mbc.E08-12-1224; Rodriguez-Nieto S, 2011, HUM MUTAT, V32, pE1999, DOI 10.1002/humu.21415; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; Dyer MA, 2001, NAT REV NEUROSCI, V2, P333, DOI 10.1038/35072555; Cherry TJ, 2009, P NATL ACAD SCI USA, V106, P9495, DOI 10.1073/pnas.0903264106; Trimarchi JM, 2007, J COMP NEUROL, V502, P1047, DOI 10.1002/cne.21368; Inagaki M, 2005, DEVELOPMENT, V132, P1525, DOI 10.1242/dev.01697; Donovan SL, 2004, VISION RES, V44, P3323, DOI 10.1016/j.visres.2004.08.007; Takai Y, 2003, CURR OPIN NEUROBIOL, V13, P520, DOI 10.1016/j.conb.2003.09.003; Zheng CL, 2013, J BIOL CHEM, V288, P20499, DOI 10.1074/jbc.M113.461434; Cam H, 2003, CANCER CELL, V3, P311, DOI 10.1016/S1535-6108(03)00080-1; Hang CT, 2010, NATURE, V466, P62, DOI 10.1038/nature09130; Matsumoto S, 2006, DEV BIOL, V289, P372, DOI 10.1016/j.ydbio.2005.10.044; Johnson DA, 2006, J COMP NEUROL, V498, P112, DOI 10.1002/cne.21059; Lamba DA, 2008, DEV DYNAM, V237, P3016, DOI 10.1002/dvdy.21697; Coelho D, 2012, NAT GENET, V44, P1152, DOI 10.1038/ng.2386; Quaderi NA, 1997, NAT GENET, V17, P285, DOI 10.1038/ng1197-285; Nunbhakdi-Craig V, 2002, J CELL BIOL, V158, P967, DOI 10.1083/jcb.200206114; Roesch K, 2008, J COMP NEUROL, V509, P225, DOI 10.1002/cne.21730; Michaelides M, 2005, BRIT J OPHTHALMOL, V89, P198, DOI 10.1136/bjo.2004.050773; Bultman SJ, 2008, ONCOGENE, V27, P460, DOI 10.1038/sj.onc.1210664; DUNAIEF JL, 1994, CELL, V79, P119, DOI 10.1016/0092-8674(94)90405-7; Takai Y, 2003, J CELL SCI, V116, P17, DOI 10.1242/jcs.00167; Inagaki M, 2003, J COMP NEUROL, V460, P514, DOI 10.1002/cne.10653; Benavente CA, 2014, ONCOTARGET, V5, P9594; Donovan SL, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-14; Dyer M., 2007, EYE RETINA IN PRESS; Hao H, 2014, ADV EXP MED BIOL, V801, P395, DOI 10.1007/978-1-4614-3209-8_50; Kim S, 2013, DEV CELL, V26, P325, DOI 10.1016/j.devcel.2013.08.001; Kurimchak Alison, 2012, Genes Cancer, V3, P739, DOI 10.1177/1947601912473479; Moser SC, 2013, DEV CELL, V26, P381, DOI 10.1016/j.devcel.2013.06.014; Nygaard V, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-258; Roesch Karin, 2012, Mol Vis, V18, P1197; Trimarchi JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001588	100	0	0	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0950-1991	1477-9129		DEVELOPMENT	Development	DEC 1	2015	142	23					4092	4106		10.1242/dev.124800		15	Developmental Biology	Developmental Biology	CY4FK	WOS:000366363800010		
J	Kurihara, D; Mizuta, Y; Sato, Y; Higashiyama, T				Kurihara, Daisuke; Mizuta, Yoko; Sato, Yoshikatsu; Higashiyama, Tetsuya			ClearSee: a rapid optical clearing reagent for whole-plant fluorescence imaging	DEVELOPMENT			English	Article						Clearing; Whole plant; Deep imaging; Confocal microscopy; Two-photon microscopy; Arabidopsis thaliana; Physcomitrella patens	SINGLE-CELL RESOLUTION; ARABIDOPSIS-THALIANA; GENE-EXPRESSION; 2-PHOTON MICROSCOPY; MOUSE-BRAIN; TISSUES; TOMOGRAPHY; EXCITATION; RECONSTRUCTION; TRANSFORMATION	Imaging techniques for visualizing and analyzing precise morphology and gene expression patterns are essential for understanding biological processes during development in all organisms. With the aid of chemical screening, we developed a clearing method using chemical solutions, termed ClearSee, for deep imaging of morphology and gene expression in plant tissues. ClearSee rapidly diminishes chlorophyll autofluorescence while maintaining fluorescent protein stability. By adjusting the refractive index mismatch, whole-organ and whole-plant imaging can be performed by both confocal and two-photon excitation microscopy in ClearSee-treated samples. Moreover, ClearSee is applicable to multicolor imaging of fluorescent proteins to allow structural analysis of multiple gene expression. Given that ClearSee is compatible with staining by chemical dyes, the technique is useful for deep imaging in conjunction with genetic markers and for plant species not amenable to transgenic approaches. This method is useful for whole imaging for intact morphology and will help to accelerate the discovery of new phenomena in plant biological research.	[Kurihara, Daisuke; Mizuta, Yoko; Higashiyama, Tetsuya] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Kurihara, Daisuke; Mizuta, Yoko; Higashiyama, Tetsuya] JST, ERATO, Higashiyama Live Holon Project, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Sato, Yoshikatsu; Higashiyama, Tetsuya] Nagoya Univ, Inst Transformat Biomol ITbM, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Kurihara, D (reprint author), Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648602, Japan.	kuri@bio.nagoya-u.ac.jp	Sato, Yoshikatsu/I-6129-2014		Japan Science and Technology Agency (ERATO); Ministry of Education, Culture, Sports, Science and Technology, Japan [26840104]; Research Foundation for Opto-Science and Technology	This work was supported by grants from the Japan Science and Technology Agency (ERATO project to T.H.); the Ministry of Education, Culture, Sports, Science and Technology, Japan [no. 26840104 to Y.M.]; and the Research Foundation for Opto-Science and Technology (to Y.M.). Deposited in PMC for immediate release.	Ulmasov T, 1997, PLANT CELL, V9, P1963; Drobizhev M, 2011, NAT METHODS, V8, P393, DOI [10.1038/nmeth.1596, 10.1038/NMETH.1596]; Cheung AY, 2010, J EXP BOT, V61, P1907, DOI 10.1093/jxb/erq062; Narusaka M, 2010, PLANT BIOTECHNOL-NAR, V27, P349, DOI 10.5511/plantbiotechnology.27.349; Gallagher KL, 2004, CURR BIOL, V14, P1847, DOI 10.1016/j.cub.2004.09.081; Haseloff J, 2003, BIOTECHNIQUES, V34, P1174; Miyawaki A, 2015, MICROSCOPY-JPN, V64, P5, DOI 10.1093/jmicro/dfu108; Oikawa K, 2003, PLANT CELL, V15, P2805, DOI 10.1105/tpc.016428; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; Susaki EA, 2014, CELL, V157, P726, DOI 10.1016/j.cell.2014.03.042; Feijo JA, 2004, PROTOPLASMA, V223, P1, DOI 10.1007/s00709-003-0026-2; Kwak SH, 2008, CURR BIOL, V18, P1949, DOI 10.1016/j.cub.2008.10.064; Thompson MV, 2008, PLANT PHYSIOL, V146, P1599, DOI 10.1104/pp.107.113274; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Crawford BCW, 2007, CURR BIOL, V17, P1101, DOI 10.1016/j.cub.2007.05.079; Simpson JLS, 1929, STAIN TECHNOL, V4, P131; KUMAR R, 1973, APPL OPTICS, V12, P2950, DOI 10.1364/AO.12.002950; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Bonke M, 2003, NATURE, V426, P181, DOI 10.1038/nature02100; Lee K, 2006, PLANT CELL, V18, P2145, DOI 10.1105/tpc.106.043042; Tomer R, 2014, NAT PROTOC, V9, P1682, DOI 10.1038/nprot.2014.123; Mizuta Y, 2015, PROTOPLASMA, V252, P1231, DOI 10.1007/s00709-014-0754-5; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; Bilsborough GD, 2011, P NATL ACAD SCI USA, V108, P3424, DOI 10.1073/pnas.1015162108; Centonze VE, 1998, BIOPHYS J, V75, P2015; Langhans M, 2014, PROTOPLASMA, V251, P277, DOI 10.1007/s00709-013-0601-0; Stuppy WH, 2003, TRENDS PLANT SCI, V8, P2, DOI 10.1016/S1360-1385(02)00004-3; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; Ke MT, 2013, NAT NEUROSCI, V16, P1154, DOI 10.1038/nn.3447; Truernit E, 2008, PLANT CELL, V20, P1494, DOI 10.1105/tpc.107.056069; Vogt N, 2015, NAT METHODS, V12, P11; Bougourd S, 2000, PLANT J, V24, P543, DOI 10.1046/j.1365-313x.2000.00892.x; Vogelmann TC, 1996, PHYSIOL PLANTARUM, V98, P43; Horton NG, 2013, NAT PHOTONICS, V7, P205, DOI [10.1038/nphoton.2012.336, 10.1038/NPHOTON.2012.336]; Heisler MG, 2005, CURR BIOL, V15, P1899, DOI 10.1016/j.cub.2005.09.052; Adachi S, 2011, P NATL ACAD SCI USA, V108, P10004, DOI 10.1073/pnas.1103584108; Bauby H, 2007, PLANT CELL PHYSIOL, V48, P97, DOI 10.1093/pcp/pcl045; HAJDUKIEWICZ P, 1994, PLANT MOL BIOL, V25, P989, DOI 10.1007/BF00014672; Nishiyama T, 2000, DNA RES, V7, P9, DOI 10.1093/dnares/7.1.9; Yang B, 2014, CELL, V158, P945, DOI 10.1016/j.cell.2014.07.017; Hoyer H., 1882, BIOL ZENTRALBLATT, V2, P23; Kawakami R, 2013, SCI REP-UK, V3, DOI 10.1038/srep01014; LERSTEN NELS R., 1967, IOWA STATE J SCI, V41, P481; Littlejohn GR, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00140; Metzner R, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00469; Müller Sara M, 2013, Front Plant Sci, V4, P413, DOI 10.3389/fpls.2013.00413; Notaguchi M, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00161; Tainaka K, 2014, CELL, V159, P911, DOI 10.1016/j.cell.2014.10.034; Turner Simon, 2003, Arabidopsis Book, V2, pe0073, DOI 10.1199/tab.0073; Vogelmann T. C., 1986, Photomorphogenesis in plants, P307; Warner CA, 2014, PLANT PHYSIOL, V166, P1684, DOI 10.1104/pp.114.244673	51	0	0	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0950-1991	1477-9129		DEVELOPMENT	Development	DEC 1	2015	142	23					4168	4179		10.1242/dev.127613		12	Developmental Biology	Developmental Biology	CY4FK	WOS:000366363800017		
J	Aso, Y; Fukushima, M; Sagara, M; Jojima, T; Iijima, T; Suzuki, K; Momobayashi, A; Kasai, K; Inukai, T				Aso, Yoshimasa; Fukushima, Maiko; Sagara, Masaaki; Jojima, Teruo; Iijima, Toshie; Suzuki, Kunihiro; Momobayashi, Atsushi; Kasai, Kikuo; Inukai, Toshihiko			Sitagliptin, a DPP-4 inhibitor, alters the subsets of circulating CD4+T cells in patients with type 2 diabetes	DIABETES RESEARCH AND CLINICAL PRACTICE			English	Article						DPP-4 inhibitor; CD4+T cell; T-helper 17 cell; Regulatory T cell	DIPEPTIDYL PEPTIDASE-IV; REGULATORY T-CELLS; SERUM-LEVEL; CD26; TH17; AUTOIMMUNE; CYTOKINE; PROLIFERATION; VILDAGLIPTIN; INFLAMMATION	Objective: CD26/DPP-4 is highly expressed by T cells, especially CD4+ T cells (T helper cells; Th) and may regulate the differentiation, maturation, or proliferation of these cells. We investigated the effects of sitagliptin, a DPP-4 inhibitor, on the absolute number and percentage of various subsets of circulating CD4+ T cells in patients with type 2 diabetes. Methods: We enrolled 30 consecutive patients (16 women and 14 men) with type 2 diabetes in a prospective, randomized, open-label, blinded endpoint study. Eligible participants were randomly assigned at a 2: 1 ratio to either a sitagliptin group (sitagliptin at 50 mg/day) or an active control group (glimepiride at 1 mg/day). Patients were followed for 12 weeks with monthly review. Peripheral blood mononuclear cells were examined by flow cytometry for intracellular expression of cytokines (IFN-gamma as a marker of Th1cells, IL-4 for Th2 cells, and IL-17 for Th17 cells) and for expression of CD4, CD25, and Foxp3 (regulatory T cells [Treg]). Results: Both groups showed similar improvement of glycemic control. The total number of CD4+ T cells was decreased by treatment with sitagliptin, while it did not change in the control group. The number and percentage of Th17 cells and Treg cells both decreased significantly in the sitagliptin group, but not in the control group. There was a significant positive correlation between changes in the percentage of Th17 cells and Treg cells after treatment with sitagliptin. Conclusions: Treatment with sitagliptin for 12 weeks reduced the number of circulating CD4+ T cells, especially Th17 and Treg cells, in patients with type 2 diabetes. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Aso, Yoshimasa; Sagara, Masaaki; Jojima, Teruo; Iijima, Toshie; Suzuki, Kunihiro] Dokkyo Med Univ, Dept Endocrinol & Metab, Mibu, Tochigi, Japan; [Fukushima, Maiko] LSI Medience Corp, Tokyo, Japan; [Kasai, Kikuo] Ishibashi Gen Hosp, Dept Med, Shimotsuke, Tochigi, Japan; [Inukai, Toshihiko] Dokkyo Med Univ, Koshigaya Hosp, Dept Internal Med, Koshigaya, Saitama, Japan	Aso, Y (reprint author), Dokkyo Med Univ, Dept Endocrinol & Metab, Mibu, Tochigi, Japan.	yaso@dokkyomed.ac.jp					Alunno A, 2015, MEDIAT INFLAMM, V2015; Yu DMT, 2011, SCAND J IMMUNOL, V73, P102, DOI 10.1111/j.1365-3083.2010.02488.x; Saito T, 2013, DIABETES RES CLIN PR, V102, pE8, DOI 10.1016/j.diabres.2013.07.010; Crickx E, 2014, RHEUMATOL INT, V34, P291, DOI 10.1007/s00296-013-2710-7; Ohnuma K, 2011, ADV CLIN CHEM, V53, P51, DOI 10.1016/S0065-2423(11)53003-3; TANAKA T, 1992, J IMMUNOL, V149, P481; Ruiz P, 1998, CLIN IMMUNOL IMMUNOP, V88, P156, DOI 10.1006/clin.1998.4550; TANAKA T, 1994, P NATL ACAD SCI USA, V91, P3082, DOI 10.1073/pnas.91.8.3082; Lambeir AM, 2003, CRIT REV CL LAB SCI, V40, P209, DOI 10.1080/713609354; DANG NH, 1991, J IMMUNOL, V147, P2825; Nistala K, 2009, RHEUMATOLOGY, V48, P602, DOI 10.1093/rheumatology/kep028; Amori RE, 2007, JAMA-J AM MED ASSOC, V298, P194, DOI 10.1001/jama.298.2.194; Aso Y, 2013, TRANSL RES, V162, P309, DOI 10.1016/j.trsl.2013.07.011; Kim W, 2008, PHARMACOL REV, V60, P470, DOI 10.1124/pr.108.000604; Noack M, 2014, AUTOIMMUN REV, V13, P668, DOI [10.1016/j.autrev.2013.12.004, 10.1016/jautrev2013.12.004]; Morimoto C, 1998, IMMUNOL REV, V161, P55, DOI 10.1111/j.1600-065X.1998.tb01571.x; Price JD, 2013, CLIN EXP IMMUNOL, V174, P120, DOI 10.1111/cei.12144; Zhu JF, 2010, CELL RES, V20, P4, DOI 10.1038/cr.2009.138; Yan SL, 2003, EUR J IMMUNOL, V33, P1519, DOI 10.1002/eji.200323469; Schmiedl A, 2010, CLIN EXP ALLERGY, V40, P1794, DOI 10.1111/j.1365-2222.2010.03547.x; Winer S, 2009, EUR J IMMUNOL, V39, P2629, DOI 10.1002/eji.200838893; Makdissi A, 2012, J CLIN ENDOCR METAB, V97, P3333, DOI 10.1210/jc.2012-1544; van Poppel PCM, 2014, DIABETES RES CLIN PR, V103, P395, DOI 10.1016/j.diabres.2013.12.039; Wagner NM, 2013, OBESITY, V21, P461, DOI 10.1002/oby.20087; Mallat Z, 2007, TRENDS CARDIOVAS MED, V17, P113, DOI 10.1016/j.tcm.2007.03.001; Durinx C, 2000, EUR J BIOCHEM, V267, P5608, DOI 10.1046/j.1432-1327.2000.01634.x; Bengsch B, 2012, J IMMUNOL, V188, P5438, DOI 10.4049/jimmunol.1103801; Anz D, 2014, DIABETES OBES METAB, V16, P569, DOI 10.1111/dom.12246; Aso Y, 2012, TRANSL RES, V159, P25, DOI 10.1016/j.trsl.2011.09.005; Cheng X, 2008, CLIN IMMUNOL, V127, P89, DOI 10.1016/j.clim.2008.01.009; Iwaki-Egawa S, 1998, J BIOCHEM-TOKYO, V124, P428; Tasic T, 2011, CLIN EXP ALLERGY, V41, P1098, DOI 10.1111/j.1365-2222.2011.03778.x; White PC, 2010, J DIABETES COMPLICAT, V24, P209, DOI 10.1016/j.jdiacomp.2009.09.001; Jagannathan-Bogdan M, 2011, J IMMUNOL, V186, P1162, DOI 10.4049/jimmunol.1002615; Richter Bernd, 2008, Vasc Health Risk Manag, V4, P753; Sasaki T, 2010, DIABETOL INT, V1, P90, DOI [10.1007/s13340-010-0010-y, DOI 10.1007/S13340-010-0010-Y]; Williams-Herman Debora, 2008, BMC Endocr Disord, V8, P14, DOI 10.1186/1472-6823-8-14; Zhao YI, 2014, DIABETES METAB RES R	38	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-8227	1872-8227		DIABETES RES CLIN PR	Diabetes Res. Clin. Pract.	DEC	2015	110	3					250	256		10.1016/j.diabres.2015.10.012		7	Endocrinology & Metabolism	Endocrinology & Metabolism	CY3OF	WOS:000366318400007		
J	Yamaguchi, M; Uemura, H; Arisawa, K; Katsuura-Kamano, S; Hamajima, N; Hishida, A; Suma, S; Oze, I; Nakamura, K; Takashima, N; Suzuki, S; Ibusuki, R; Mikami, H; Ohnaka, K; Kuriyama, N; Kubom, M; Tanaka, H				Yamaguchi, Miwa; Uemura, Hirokazu; Arisawa, Kokichi; Katsuura-Kamano, Sakurako; Hamajima, Nobuyuki; Hishida, Asahi; Suma, Shino; Oze, Isao; Nakamura, Kazuyo; Takashima, Naoyuki; Suzuki, Sadao; Ibusuki, Rie; Mikami, Haruo; Ohnaka, Keizo; Kuriyama, Nagato; Kubom, Michiaki; Tanaka, Hideo		J-MICC Study Grp	Association between brain-muscle-ARNT-like protein-2 (BMAL2) gene polymorphism and type 2 diabetes mellitus in obese Japanese individuals: A cross-sectional analysis of the Japan Multi-institutional Collaborative Cohort Study	DIABETES RESEARCH AND CLINICAL PRACTICE			English	Article						Brain-muscle-Arnt-like protein; Type 2 diabetes; Obesity; Single nucleotide polymorphisms; Gene-environment interaction	FOOD FREQUENCY QUESTIONNAIRE; GENOME-WIDE ASSOCIATION; CHROMOSOMAL LOCALIZATION; TRANSCRIPTION; POPULATION; SUSCEPTIBILITY; DISTRIBUTIONS; DISORDERS; CLONING	Aims: Brain-muscle-Arnt-like protein-1 (BMAL1) and BMAL2 genes are essential components of the circadian clock, and are considered to be involved in glucose homeostasis. We examined whether single nucleotide polymorphisms (SNPs) of BMAL1 and BMAL2 were associated with the prevalence of type 2 diabetes (T2DM) in the general Japanese population. Methods: We studied 2467 subjects (1232 men and 1235 women, 35-69 years old), including 105 men and 57 women with T2DM, from the participants of the Japan Multi-institutional Collaborative Cohort Study. The association between SNPs in the BMAL1 (rs11022775 and rs2290035) and BMAL2 (rs7958822) genes and T2DM were analyzed by multiple logistic regression after adjustment for potential confounders. Analysis was also performed after stratification by body mass index (>= 25 kg/m(2) and <25 kg/m(2)) to investigate an interaction between genotypes and obesity. Results: The A/G and A/A genotypes of BMAL2 rs7958822 showed significantly higher adjusted odds ratios (OR) for T2DM than the G/G genotype among obese men (OR = 2.2, 95% confidence intervals [CI] 1.1, 4.6, P for interaction = 0.0495) and obese women (OR = 2.7, 95% CI 1.1, 6.7, P for interaction = 0.199). There were no significant associations between BMAL1 rs11022775 or rs2290035 genotypes and T2DM. Conclusions: To the best of our knowledge, this is the first study to show the significant association between BMAL2 rs7958822 genotype and T2DM among obese subjects. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Yamaguchi, Miwa; Uemura, Hirokazu; Arisawa, Kokichi; Katsuura-Kamano, Sakurako] Univ Tokushima, Inst Biomed Sci, Dept Prevent Med, Grad Sch, Tokushima, Tokushima 7708503, Japan; [Hamajima, Nobuyuki] Nagoya Univ, Dept Healthcare Adm, Grad Sch Med, Showa Ku, Nagoya, Aichi 4668550, Japan; [Hishida, Asahi; Suma, Shino] Nagoya Univ, Dept Prevent Med, Grad Sch Med, Showa Ku, Nagoya, Aichi 4668550, Japan; [Suma, Shino] Natl Ctr Geriatr & Gerontol, Dept Oral Dis Res, Obu City, Aichi 4748511, Japan; [Oze, Isao; Tanaka, Hideo] Aichi Canc Ctr Res Inst, Div Epidemiol & Prevent, Chikusa Ku, Nagoya, Aichi 4648681, Japan; [Nakamura, Kazuyo] St Marys Coll, Fac Nursing, Kurume, Fukuoka 8308558, Japan; [Takashima, Naoyuki] Shiga Univ Med Sci, Dept Publ Hlth, Otsu, Shiga 5202192, Japan; [Suzuki, Sadao] Nagoya City Univ, Grad Sch Med Sci, Dept Publ Hlth, Mizuho Ku, Nagoya, Aichi 4678601, Japan; [Ibusuki, Rie] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Int Isl & Community Med, Kagoshima, Kagoshima 8908544, Japan; [Mikami, Haruo] Canc Prevent Ctr, Chiba Canc Ctr Res Inst, Chuo Ku, Chiba 2608717, Japan; [Ohnaka, Keizo] Kyushu Univ, Grad Sch Med Sci, Dept Geriatr Med, Higashi Ku, Fukuoka, Fukuoka 8128582, Japan; [Kuriyama, Nagato] Kyoto Prefectural Univ Med, Dept Epidemiol Community Hlth & Med, Kamigyo Ku, Kyoto, Kyoto 6028566, Japan; [Kubom, Michiaki] RIKEN, Ctr Integrat Med Sci, Lab Genotyping Dev, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan	Arisawa, K (reprint author), Univ Tokushima, Inst Biomed Sci, Dept Prevent Med, Grad Sch, 3-18-15 Kuramoto Cho, Tokushima, Tokushima 7708503, Japan.	karisawa@tokushima-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology [17015018, 221S0001]	This study was supported in part by Grants-in-Aid for Scientific Research on Priority Areas of Cancer (no. 17015018) and on Innovative Areas (no. 221S0001) from the Japanese Ministry of Education, Culture, Sports, Science and Technology.	Bass J, 2012, NATURE, V491, P348, DOI 10.1038/nature11704; Takeuchi F, 2009, DIABETES, V58, P1690, DOI 10.2337/db08-1494; Sipila T, 2010, BIOL PSYCHIAT, V67, P1163, DOI 10.1016/j.biopsych.2009.12.011; Pappa KI, 2013, DIABETES RES CLIN PR, V99, P151, DOI 10.1016/j.diabres.2012.10.015; Wakai K, 2011, J EPIDEMIOL, V21, P223, DOI 10.2188/jea.JE20100139; Poulton J, 2002, HUM MOL GENET, V11, P1581, DOI 10.1093/hmg/11.13.1581; Woon PY, 2007, P NATL ACAD SCI USA, V104, P14412, DOI 10.1073/pnas.0703247104; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Tokudome Y, 2005, J EPIDEMIOL, V15, P135, DOI 10.2188/jea.15.135; Seino Y, 2010, J DIABETES INVEST, V1, P1, DOI 10.1111/j.2040-1124.2010.00005.x; Ikeda M, 2000, BIOCHEM BIOPH RES CO, V275, P493, DOI 10.1006/bbrc.2000.3248; [Anonymous], 2014, DATABASE SHORT GENET; Sasaki M, 2009, J BIOL CHEM, V284, P25149, DOI 10.1074/jbc.M109.040758; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Rohlfs RV, 2008, GENETICS, V180, P1609, DOI 10.1534/genetics.108.088005; Ohnishi Y, 2001, J HUM GENET, V46, P471, DOI 10.1007/s100380170047; Rajeevan H, 2003, NUCLEIC ACIDS RES, V31, P270, DOI 10.1093/nar/gkg043; Kovanen L, 2010, ALCOHOL ALCOHOLISM, V45, P303, DOI 10.1093/alcalc/agq035; Hamajima N, 2007, ASIAN PAC J CANCER P, V8, P317; Shi SQ, 2013, CURR BIOL, V23, P372, DOI 10.1016/j.cub.2013.01.048; Bener A, 2005, CROAT MED J, V46, P302; Imaeda N, 2007, J EPIDEMIOL, V17, P100, DOI 10.2188/jea.17.100; Wolting CD, 1998, MAMM GENOME, V9, P463, DOI 10.1007/s003359900797; Chang YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069622; Kashiwagi A, 2012, J DIABETES INVEST, V3, P39, DOI 10.1111/j.2040-1124.2012.00207.x; Englund Ani, 2009, J Circadian Rhythms, V7, P5, DOI 10.1186/1740-3391-7-5; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; Kelly MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032670; Tokudome Shinkan, 2004, Asian Pac J Cancer Prev, V5, P40	29	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-8227	1872-8227		DIABETES RES CLIN PR	Diabetes Res. Clin. Pract.	DEC	2015	110	3					301	308		10.1016/j.diabres.2015.10.009		8	Endocrinology & Metabolism	Endocrinology & Metabolism	CY3OF	WOS:000366318400013		
J	Nonogaki, K; Kaji, T				Nonogaki, Katsunori; Kaji, Takao			Mosapride, a selective serotonin 5-HT4 receptor agonist, and alogliptin, a selective dipeptidyl peptidase-4 inhibitor, exert synergic effects on plasma active GLP-1 levels and glucose tolerance in mice	DIABETES RESEARCH AND CLINICAL PRACTICE			English	Article						Mosapride; 5-HT4 receptor agonist; Alogliptin; DPP-4 inhibitor; GLP-1; Glucose tolerance	GLYCEMIC CONTROL; INSULIN SENSITIVITY; DIABETES-MELLITUS; CITRATE	Pharmacologic stimulation of serotonin 5-HT4 receptors increased plasma active glucagon-like-peptide-1 (GLP-1) levels independent of feeding, and that pharmacologic stimulation of 5-HT4 receptors and pharmacologic inhibition of dipeptidyl peptidase-4 exerted synergic effects on plasma active GLP-1 levels and glucose tolerance in mice. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Nonogaki, Katsunori; Kaji, Takao] Tohoku Univ, Grad Sch Biomed Engn, Dept Diabet Technol, Sendai, Miyagi 9808579, Japan	Nonogaki, K (reprint author), Tohoku Univ, Grad Sch Biomed Engn, Dept Diabet Technol, Aoba Ku, 6-6-11 Aramakiaza, Sendai, Miyagi 9808579, Japan.	katsu@trc.med.tohoku.ac.jp					Ueno N, 2002, DIABETOLOGIA, V45, P792, DOI 10.1007/s00125-002-0835-4; Sanger GJ, 2008, TRENDS PHARMACOL SCI, V29, P465, DOI 10.1016/j.tips.2008.06.008; Mader R, 2006, EUR J GASTROEN HEPAT, V18, P945, DOI 10.1097/01.meg.0000228975.87645.27; Asakawa H, 2003, DIABETES RES CLIN PR, V61, P175, DOI 10.1016/S0168-8227(03)00121-9; Nam JS, 2010, DIABETES RES CLIN PR, V87, P329, DOI 10.1016/j.diabres.2009.12.021; Okubo H, 2015, AM J PHYSIOL-GASTR L, V308, pG151, DOI 10.1152/ajpgi.00198.2014; Nonogaki K, 2014, BIOMED RES INT, DOI 10.1155/2014/751930; Aoki K, 2013, ENDOCR J, V60, P493; Lovshin JA, 2005, NAT REV ENDOCRINOL, V5, P262; Moritoh Y, 2009, BRIT J PHARMACOL, V157, P415, DOI 10.1111/j.1476-5381.2009.00145.x	10	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-8227	1872-8227		DIABETES RES CLIN PR	Diabetes Res. Clin. Pract.	DEC	2015	110	3					E18	E21		10.1016/j.diabres.2015.10.011		4	Endocrinology & Metabolism	Endocrinology & Metabolism	CY3OF	WOS:000366318400002		
J	Shimura, Y; Hirose, Y; Misawa, N; Osana, Y; Katoh, H; Yamaguchi, H; Kawachi, M				Shimura, Yohei; Hirose, Yuu; Misawa, Naomi; Osana, Yasunori; Katoh, Hiroshi; Yamaguchi, Haruyo; Kawachi, Masanobu			Comparison of the terrestrial cyanobacterium Leptolyngbya sp NIES-2104 and the freshwater Leptolyngbya boryana PCC 6306 genomes	DNA RESEARCH			English	Article						comparative genomics; cyanobacteria; genome sequence; nitrogen fixation	PLECTONEMA-BORYANUM; PROTOCHLOROPHYLLIDE REDUCTASE; FILAMENTOUS CYANOBACTERIUM; CHLOROPHYLL BIOSYNTHESIS; EXTRACELLULAR POLYSACCHARIDES; DIFFERENTIAL OPERATION; TREHALOSE SYNTHASE; FREEZING TOLERANCE; GENE; OXYGEN	The cyanobacterial genus Leptolyngbya is widely distributed throughout terrestrial environments and freshwater. Because environmental factors, such as oxygen level, available water content, and light intensity, vary between soil surface and water bodies, terrestrial Leptolyngbya should have genomic differences with freshwater species to adapt to a land habitat. To study the genomic features of Leptolyngbya species, we determined the complete genome sequence of the terrestrial strain Leptolyngbya sp. NIES-2104 and compared it with that of the near-complete sequence of the freshwater Leptolyngbya boryana PCC 6306. The greatest differences between these two strains were the presence or absence of a nitrogen fixation gene cluster for anaerobic nitrogen fixation and several genes for tetrapyrrole synthesis, which can operate under micro-oxic conditions. These differences might reflect differences in oxygen levels where these strains live. Both strains have the genes for trehalose biosynthesis, but only Leptolyngbya sp. NIES-2104 has genetic capacity to produce a mycosporine-like amino acid, mycosporine-glycine. Mycosporine-glycine has an antioxidant action, which may contribute to adaptation to terrestrial conditions. These features of the genomes yielded additional insights into the classification and physiological characteristics of these strains.	[Shimura, Yohei; Yamaguchi, Haruyo; Kawachi, Masanobu] Natl Inst Environm Studies, Ctr Environm Biol & Ecosyst Studies, Tsukuba, Ibaraki 3058506, Japan; [Hirose, Yuu; Misawa, Naomi] Toyohashi Univ Technol, Dept Environm & Life Sci, Elect Inspired Interdisciplinary Res Inst EIIRIS, Toyohashi, Aichi 4418580, Japan; [Osana, Yasunori] Univ Ryukyus, Dept Elect & Elect Engn, Nishihara, Okinawa 9030213, Japan; [Katoh, Hiroshi] Mie Univ, Life Sci Res Ctr, Tsu, Mie 5148507, Japan	Shimura, Y (reprint author), Natl Inst Environm Studies, Ctr Environm Biol & Ecosyst Studies, Tsukuba, Ibaraki 3058506, Japan.	shimura.yohei@nies.go.jp			Japan Agency for Medical Research and Development (AMED); Ministry of Education, Culture, Sports, Science, and Technology of Japan	Funding to pay the Open Access publication charges for this articlewas provided by the Japan Agency for Medical Research and Development (AMED), and the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	ANAGNOSTIDIS K, 1988, Archiv fuer Hydrobiologie Supplement, V80, P327; Kada S, 2003, PLANT MOL BIOL, V51, P225, DOI 10.1023/A:1021195226978; Higo A, 2006, MICROBIOL-SGM, V152, P979, DOI 10.1099/mic.0.28583-0; Johansen JR, 2011, NOVA HEDWIGIA, V92, P283, DOI 10.1127/0029-5035/2011/0092-0283; GARCIAPICHEL F, 1993, APPL ENVIRON MICROB, V59, P163; Yoshida T, 2009, J GEN APPL MICROBIOL, V55, P135; Pfreundt U, 2012, ISME J, V6, P1367, DOI 10.1038/ismej.2011.199; Tamagnini P, 2002, MICROBIOL MOL BIOL R, V66, P1, DOI 10.1128/MMBR.66.1.1-20.2002; Aoki R, 2011, PLANT CELL PHYSIOL, V52, P1744, DOI 10.1093/pcp/pcr108; Hagemann M, 2013, ADV BOT RES, V65, P27, DOI 10.1016/B978-0-12-394313-2.00002-0; Bolhuis H, 2010, ISME J, V4, P121, DOI 10.1038/ismej.2009.99; Aoki R, 2012, J BIOL CHEM, V287, P13500, DOI 10.1074/jbc.M112.346205; FUJITA Y, 1993, PLANT CELL PHYSIOL, V34, P305; Taton A, 2011, POLAR BIOL, V34, P181, DOI 10.1007/s00300-010-0868-y; RIPPKA R, 1977, FEMS MICROBIOL LETT, V2, P83, DOI 10.1111/j.1574-6968.1977.tb00913.x; Yamazaki S, 2006, PLANT PHYSIOL, V142, P911, DOI 10.1104/pp.106.086090; Garcia-Pichel F, 2001, APPL ENVIRON MICROB, V67, P1902, DOI 10.1128/AEM.67.4.1902-1910.2001; Shih PM, 2013, P NATL ACAD SCI USA, V110, P1053, DOI 10.1073/pnas.1217107110; Gao QJ, 2011, J BACTERIOL, V193, P5923, DOI 10.1128/JB.05730-11; Gao Q, 2011, NAT REV MICROBIOL, V9, P791, DOI 10.1038/nrmicro2649; Kopf M, 2014, DNA RES, V21, P255, DOI 10.1093/dnares/dst055; Iteman I, 2000, MICROBIOL-SGM, V146, P1275; Maruta K, 2002, BIOSCI BIOTECH BIOCH, V66, P1976; Fujita Y, 1996, PLANT CELL PHYSIOL, V37, P313; STEWART WDP, 1970, ARCH MIKROBIOL, V73, P250, DOI 10.1007/BF00410626; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1; Dagan T, 2013, GENOME BIOL EVOL, V5, P31, DOI 10.1093/gbe/evs117; Kumar S, 2012, BIOINFORMATICS, V28, P2685, DOI 10.1093/bioinformatics/bts507; Minamizaki K, 2008, J BIOL CHEM, V283, P2684, DOI 10.1074/jbc.M708954200; LESLIE SB, 1995, APPL ENVIRON MICROB, V61, P3592; DUNLAP WC, 1995, COMP BIOCHEM PHYS B, V112, P105, DOI 10.1016/0305-0491(95)00086-N; Tamagnini P, 2000, CURR MICROBIOL, V40, P356, DOI 10.1007/s002840010070; Reyes-Prieto A, 2007, ANNU REV GENET, V41, P147, DOI 10.1146/annurev.genet.41.110306.130134; Bruno L, 2009, APPL ENVIRON MICROB, V75, P608, DOI 10.1128/AEM.01183-08; Casamatta DA, 2005, J PHYCOL, V41, P421, DOI 10.1111/j.1529-8817.2005.04062.x; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; NISHIMOTO T, 1995, BIOSCI BIOTECH BIOCH, V59, P2189; Knowles EJ, 2008, FEMS MICROBIOL ECOL, V66, P261, DOI 10.1111/j.1574-6941.2008.00568.x; Nishimoto T, 1996, BIOSCI BIOTECH BIOCH, V60, P640; Garcia-Pichel F, 1998, ARCH MICROBIOL, V169, P469, DOI 10.1007/s002030050599; Latifi A, 2009, FEMS MICROBIOL REV, V33, P258, DOI 10.1111/j.1574-6976.2008.00134.x; Yamamoto H, 2009, PLANT CELL PHYSIOL, V50, P1663, DOI 10.1093/pcp/pcp111; Balskus EP, 2010, SCIENCE, V329, P1653, DOI 10.1126/science.1193637; Tamaru Y, 2005, APPL ENVIRON MICROB, V71, P7327, DOI 10.1128/AEM.71.11.7327-7333.2005; HERSHKOVITZ N, 1991, APPL ENVIRON MICROB, V57, P645; JORGENSEN BB, 1979, APPL ENVIRON MICROB, V38, P46; Miah F, 2013, CHEM BIOL, V20, P487, DOI 10.1016/j.chembiol.2013.02.014; Komarek J, 2010, HYDROBIOLOGIA, V639, P245, DOI 10.1007/s10750-009-0031-3; Tsujimoto R, 2014, P NATL ACAD SCI USA, V111, P6762, DOI 10.1073/pnas.1323570111; Fujita Y, 1998, PLANT CELL PHYSIOL, V39, P177; Goto T, 2010, PLANT CELL PHYSIOL, V51, P650, DOI 10.1093/pcp/pcq023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Castenholz RW, 2001, BERGEYS MANUAL SYSTE, V1, P473; Chaen H, 1999, J APPL GLYCOSCI, V46, P399, DOI 10.5458/jag.46.399; Elbein AD, 2003, GLYCOBIOLOGY, V13, P17; FUJITA Y, 1992, PLANT CELL PHYSIOL, V33, P81; Katoh H., 2012, BIOCHIM BIOPHYS ACTA, V18, P1499; Katoh H., 2003, MICROB ENV, V18, P82; Ohtsubo Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-376; Page-Sharp M., 1999, BIOCHIM BIOPHYS ACTA, V14, P519; Popendorf K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012651; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846; Stucken K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009235	63	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1340-2838	1756-1663		DNA RES	DNA Res.	DEC	2015	22	6					403	412		10.1093/dnares/dsv022		10	Genetics & Heredity	Genetics & Heredity	CY8AV	WOS:000366631700002		
J	Kato, H; Mori, H; Maruyama, F; Toyoda, A; Oshima, K; Endo, R; Fuchu, G; Miyakoshi, M; Dozono, A; Ohtsubo, Y; Nagata, Y; Hattori, M; Fujiyama, A; Kurokawa, K; Tsuda, M				Kato, Hiromi; Mori, Hiroshi; Maruyama, Fumito; Toyoda, Atsushi; Oshima, Kenshiro; Endo, Ryo; Fuchu, Genki; Miyakoshi, Masatoshi; Dozono, Ayumi; Ohtsubo, Yoshiyuki; Nagata, Yuji; Hattori, Masahira; Fujiyama, Asao; Kurokawa, Ken; Tsuda, Masataka			Time-series metagenomic analysis reveals robustness of soil microbiome against chemical disturbance	DNA RESEARCH			English	Article						soil microbiome; metagenome; recalcitrant aromatic compounds; phage; robustness	RIBOSOMAL-RNA GENES; READ ALIGNMENT; GUT MICROBIOME; SEARCH TOOL; COMMUNITY; DEGRADATION; BIODEGRADATION; PHENANTHRENE; RESILIENCE; RESISTANCE	Soil microbial communities have great potential for bioremediation of recalcitrant aromatic compounds. However, it is unclear which taxa and genes in the communities, and how they contribute to the bioremediation in the polluted soils. To get clues about this fundamental question here, time-course (up to 24 weeks) metagenomic analysis of microbial community in a closed soil microcosm artificially polluted with four aromatic compounds, including phenanthrene, was conducted to investigate the changes in the community structures and gene pools. The pollution led to drastic changes in the community structures and the gene sets for pollutant degradation. Complete degradation of phenanthrene was strongly suggested to occur by the syntrophic metabolism by Mycobacterium and the most proliferating genus, Burkholderia. The community structure at Week 24 (similar to 12 weeks after disappearance of the pollutants) returned to the structure similar to that before pollution. Our time-course metagenomic analysis of phage genes strongly suggested the involvement of the 'kill-the-winner' phenomenon (i.e. phage predation of Burkholderia cells) for the returning of the microbial community structure. The pollution resulted in a decrease in taxonomic diversity and a drastic increase in diversity of gene pools in the communities, showing the functional redundancy and robustness of the communities against chemical disturbance.	[Kato, Hiromi; Endo, Ryo; Fuchu, Genki; Miyakoshi, Masatoshi; Ohtsubo, Yoshiyuki; Nagata, Yuji; Tsuda, Masataka] Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi 9808577, Japan; [Mori, Hiroshi; Dozono, Ayumi; Kurokawa, Ken] Tokyo Inst Technol, Dept Biol Informat, Grad Sch Biosci & Biotechnol, Tokyo 1528550, Japan; [Maruyama, Fumito] Kyoto Univ, Grad Sch Med, Kyoto 6068501, Japan; [Toyoda, Atsushi; Fujiyama, Asao] Natl Inst Genet, Ctr Informat Biol, Mishima, Shizuoka 4118540, Japan; [Oshima, Kenshiro; Hattori, Masahira] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol, Kashiwa, Chiba 2778561, Japan; [Fujiyama, Asao] Natl Inst Informat, Principles Informat Res Div, Kunitachi, Tokyo 1018430, Japan; [Kurokawa, Ken] Tokyo Inst Technol, Earth Life Sci Inst, Tokyo 1528550, Japan	Tsuda, M (reprint author), Tohoku Univ, Grad Sch Life Sci, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.	mtsuda@ige.tohoku.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [25292206]; Institute for Fermentation, Osaka (IFO); Global COE program 'Ecosystem Adaptability Science for the Future' at Tohoku University	This work was supported by Grants-in-Aid for Scientific Research (no. 25292206 and Innovative Area 'Genome Science') from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and by a grant from the Institute for Fermentation, Osaka (IFO) and a Global COE program 'Ecosystem Adaptability Science for the Future' at Tohoku University. Funding to pay the Open Access publication charges for this article was provided by the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Balashova NV, 2001, BIODEGRADATION, V12, P179, DOI 10.1023/A:1013126723719; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Oh S, 2011, APPL ENVIRON MICROB, V77, P6000, DOI 10.1128/AEM.00107-11; Leplae R, 2010, NUCLEIC ACIDS RES, V38, pD57, DOI 10.1093/nar/gkp938; Ogawa N, 2003, CHEM REC, V3, P158, DOI 10.1002/tcr.10059; Le Digabel Y, 2013, APPL MICROBIOL BIOT, V97, P10531, DOI 10.1007/s00253-013-4803-3; Fierer N, 2013, SCIENCE, V342, P621, DOI 10.1126/science.1243768; Rodriguez-Brito B, 2010, ISME J, V4, P739, DOI 10.1038/ismej.2010.1; Mackelprang R, 2011, NATURE, V480, P368, DOI 10.1038/nature10576; Korbel JO, 2002, TRENDS GENET, V18, P158, DOI 10.1016/S0168-9525(01)02597-5; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485; Vilchez-Vargas R, 2013, ENVIRON MICROBIOL, V15, P1016, DOI 10.1111/j.1462-2920.2012.02752.x; Delmont TO, 2012, ISME J, V6, P1677, DOI 10.1038/ismej.2011.197; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Ben Zakour N, 2004, NUCLEIC ACIDS RES, V32, P17, DOI 10.1093/nar/gkg928; Nagayama H, 2015, APPL MICROBIOL BIOT, V99, P4453, DOI 10.1007/s00253-014-6322-2; Luo CW, 2014, APPL ENVIRON MICROB, V80, P1777, DOI 10.1128/AEM.03712-13; Stingley RL, 2004, BIOCHEM BIOPH RES CO, V322, P133, DOI 10.1016/j.bbrc.2004.07.089; Chang HK, 1998, J BACTERIOL, V180, P6529; Summer EJ, 2007, CURR OPIN MICROBIOL, V10, P410, DOI 10.1016/j.mib.2007.05.016; Peng RH, 2008, FEMS MICROBIOL REV, V32, P927, DOI 10.1111/j.1574-6976.2008.00127.x; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Moody JD, 2001, APPL ENVIRON MICROB, V67, P1476, DOI 10.1128/AEM.67.4.1476-1483.2001; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Souza RC, 2015, APPL SOIL ECOL, V86, P106, DOI 10.1016/j.apsoil.2014.10.010; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Mori H, 2014, DNA RES, V21, P217, DOI 10.1093/dnares/dst052; Parales RE, 2003, J IND MICROBIOL BIOT, V30, P271, DOI 10.1007/s10295-003-0043-3; Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174; Hartmann M, 2014, ISME J, V8, P226, DOI 10.1038/ismej.2013.141; Stenuit B, 2015, CURR OPIN BIOTECH, V33, P305, DOI 10.1016/j.copbio.2015.03.012; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Kristensen DM, 2013, J BACTERIOL, V195, P941, DOI 10.1128/JB.01801-12; Silby MW, 2011, FEMS MICROBIOL REV, V35, P652, DOI 10.1111/j.1574-6976.2011.00269.x; Janssen PH, 2006, APPL ENVIRON MICROB, V72, P1719, DOI 10.1128/AEM.72.3.1719-1728.2006; Perez-Pantoja D, 2012, ENVIRON MICROBIOL, V14, P1091, DOI 10.1111/j.1462-2920.2011.02613.x; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Allison SD, 2008, P NATL ACAD SCI USA, V105, P11512, DOI 10.1073/pnas.0801925105; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Sharon I, 2013, GENOME RES, V23, P111, DOI 10.1101/gr.142315.112; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Gilbert JA, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0069-1; Guazzaroni M.-E., 2012, ISME J, V7, P122; Harabasz J., 1974, COMMUN STAT, V3, P1, DOI [DOI 10.1080/03610927408827101, 10.1080/03610928308827180]; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Kato H., 2015, GENOME ANNOUNC, V3; Leekitcharoenphon P., 2014, BURKHOLDERIA GENOMES, P31; Lynch K. H., 2014, BURKHOLDERIA GENOMES, P230; Morimoto S., 2005, MICROBES ENVIRON, V20, P151, DOI 10.1264/jsme2.20.151; Muller EEL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6603; Raes J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r10; Shade A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00417; Yergeau E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030058; Zhu WH, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq275	57	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1340-2838	1756-1663		DNA RES	DNA Res.	DEC	2015	22	6					413	424		10.1093/dnares/dsv023		12	Genetics & Heredity	Genetics & Heredity	CY8AV	WOS:000366631700003		
J	Shimada, S; Makita, Y; Kuriyama-Kondou, T; Kawashima, M; Mochizuki, Y; Hirakawa, H; Sato, S; Toyoda, T; Matsui, M				Shimada, Setsuko; Makita, Yuko; Kuriyama-Kondou, Tomoko; Kawashima, Mika; Mochizuki, Yoshiki; Hirakawa, Hideki; Sato, Shusei; Toyoda, Tetsuro; Matsui, Minami			Functional and expression analyses of transcripts based on full-length cDNAs of Sorghum bicolor	DNA RESEARCH			English	Article						Sorghum bicolor; full-length cDNA; RNA-Seq; transcriptome	NATURAL ANTISENSE TRANSCRIPTS; DISTINCT EXPRESSION; SUCROSE SYNTHASE; MAIZE; GENOME; GENES; IDENTIFICATION; ARABIDOPSIS; CLONING; STRESS	Sorghum bicolor is one of the most important crops for food and bioethanol production. Its small diploid genome and resistance to environmental stress make sorghum an attractive model for studying the functional genomics of the Saccharinae and other C-4 grasses. We analyzed the domain-based functional annotation of the cDNAs using the gene ontology (GO) categories for molecular function to characterize all the genes cloned in the full-length cDNA library of sorghum. The sorghum cDNA library successfully captured a wide range of cDNA-encoded proteins with various functions. To characterize the protein function of newly identified cDNAs, a search of their deduced domains and comparative analyses in the Oryza sativa and Zea mays genomes were carried out. Furthermore, genes on the sense strand corresponding to antisense transcripts were classified based on the GO of molecular function. To add more information about these genes, we have analyzed the expression profiles using RNA-Seq of three tissues (spikelet, seed and stem) during the starch-filling phase. We performed functional analysis of tissue-specific genes and expression analysis of genes of starch biosynthesis enzymes. This functional analysis of sorghum full-length cDNAs and the transcriptome information will facilitate further analysis of the Saccharinae and grass families.	[Shimada, Setsuko; Makita, Yuko; Kuriyama-Kondou, Tomoko; Kawashima, Mika; Matsui, Minami] RIKEN, Synthet Genom Res Grp, Ctr Sustainable Resource Sci, Biomass Engn Res Div, Yokohama, Kanagawa 2300045, Japan; [Mochizuki, Yoshiki; Toyoda, Tetsuro] RIKEN, ACCC, Wako, Saitama 3510198, Japan; [Hirakawa, Hideki; Sato, Shusei] Kazusa DNA Res Inst, Kisarazu, Chiba 2920818, Japan	Matsui, M (reprint author), RIKEN, Synthet Genom Res Grp, Ctr Sustainable Resource Sci, Biomass Engn Res Div, Yokohama, Kanagawa 2300045, Japan.	minami@riken.jp			RIKEN Biomass Engineering Program	This research was conducted under the research program of the RIKEN Biomass Engineering Program. Funding to pay the Open Access publication charges for this article was provided by RIKEN Biomass Engineering Program.	Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Chen J, 2014, PLANT PHYSIOL, V166, P252, DOI 10.1104/pp.114.240689; Blauth SL, 2002, PLANT MOL BIOL, V48, P287, DOI 10.1023/A:1013335217744; Pasini L, 2014, J PLANT PHYSIOL, V171, P537, DOI 10.1016/j.jplph.2013.12.014; Lapidot M, 2006, EMBO REP, V7, P1216, DOI 10.1038/sj.embor.7400857; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Ma J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r22; Dinges JR, 2001, PLANT PHYSIOL, V125, P1406, DOI 10.1104/pp.125.3.1406; Carninci P, 2001, GENOMICS, V77, P79, DOI 10.1006/geno.2001.6601; Edwards GE, 2004, ANNU REV PLANT BIOL, V55, P173, DOI 10.1146/annurev.arplant.55.031903.141725; Henz SR, 2007, PLANT PHYSIOL, V144, P1247, DOI 10.1104/pp.107.100396; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Salzman RA, 2005, PLANT PHYSIOL, V138, P352, DOI 10.1104/pp.104.058206; Datta R, 2001, SEX PLANT REPROD, V14, P127, DOI 10.1007/s00497-001-0105-5; Wang H, 2014, GENOME RES, V24, P444, DOI 10.1101/gr.165555.113; Duncan KA, 2006, PLANT CELL PHYSIOL, V47, P959, DOI 10.1093/pcp/pcj068; Carninci P, 1996, GENOMICS, V37, P327, DOI 10.1006/geno.1996.0567; STINARD PS, 1993, PLANT CELL, V5, P1555, DOI 10.1105/tpc.5.11.1555; Carlson SJ, 1996, MOL GEN GENET, V252, P303; Buchanan CD, 2005, PLANT MOL BIOL, V58, P699, DOI 10.1007/s11103-005-7876-2; Jeon JS, 2010, PLANT PHYSIOL BIOCH, V48, P383, DOI 10.1016/j.plaphy.2010.03.006; Pratt LH, 2005, PLANT PHYSIOL, V139, P869, DOI 10.1104/pp.105.066134; Davidson RM, 2012, PLANT J, V71, P492, DOI 10.1111/j.1365-313X.2012.05005.x; Benson DA, 2009, NUCLEIC ACIDS RES, V37, pD26, DOI 10.1093/nar/gkn723; Carninci P, 1998, P NATL ACAD SCI USA, V95, P520, DOI 10.1073/pnas.95.2.520; Alexandrov NN, 2006, PLANT MOL BIOL, V60, P69, DOI 10.1007/s11103-005-2564-9; Arumuganathan K., 1991, PLANT MOL BIOL REP, V9, P208, DOI DOI 10.1007/BF02672069; Dugas DV, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-514; Gelli M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-179; Jiang SY, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-18; Johnson SM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-456; Makita Y., 2015, PLANT CELL PHYSL, V56, P4; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Maunder AB, 2003, WORLD AGR S, P11, DOI 10.1002/9780470384923.ch2; Mizuno H, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-121; Osato Naoki, 2003, Genome Biol, V5, pR5, DOI 10.1186/gb-2003-5-1-r5; Perez-Rodrguez P, 2010, NUCLEIC ACIDS RES, V38, P822; Pillai L, 2012, DATABASE-OXFORD, DOI 10.1093/database/bas038; Shakoor N, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-35; Yazawa T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062460	40	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1340-2838	1756-1663		DNA RES	DNA Res.	DEC	2015	22	6					485	493		10.1093/dnares/dsv030		9	Genetics & Heredity	Genetics & Heredity	CY8AV	WOS:000366631700009		
J	Ochiai, M; Ichiyama, M; Iwayarna, M; Sakai, Y; Yoshida, K; Hara, T				Ochiai, Masayuki; Ichiyama, Masako; Iwayarna, Mariko; Sakai, Yasuanri; Yoshida, Keiko; Hara, Toshiro			Longitudinal study of very low birth weight infants until 9 years of age; attention deficit hyperactivity and autistic features are correlated with their cognitive functions	EARLY HUMAN DEVELOPMENT			English	Article						Preterm infant; Follow-up; School age; Neurodevelopmental outcome; Psychiatric symptom; Learning disability	PRETERM INFANTS; OUTCOMES; JAPAN; BORN; DISORDERS; MORTALITY; CHILDREN; PROFILES; ADHD; ADOLESCENTS	Background: Increasing attention has been given to neuro-developmental problems of very low birth weight infants (VLBWIs) at school age. However, it remains unknown whether their neuro-cognitive function and psychiatric symptoms are mutually associated. Aim: The aim of this study was to investigate the characteristics of neuro-cognitive functions in VLBWIs and their relationship with psychiatric symptoms. Methods: A total of 160 VLBWIs who were born at our institute between 2001 and 2005 were recruited consecutively and followed up until nine years of age. The developmental profiles were obtained from 77 children (45 males and 32 females) at six to nine years of age using the ADHD Rating Scale-Fourth edition (ADHD-RS), Autism Screening Questionnaire-Japanese version (ASQ-J) and the Wechsler Intelligence Scale for Children-Third edition (WISC-III). Results: The full-scale intelligence quotient did not significantly differ between the male and female VLBWIs (median: 91 vs. 99, p = 0.17). The males had higher total scores (median: 13 vs. 4, p < 0.01) and higher scores on the subscales of Inattention (8 vs. 2, p < 0.01) and Hyperactivity-Impulsivity (5 vs. 1, p < 0.01) of the ADHD-RS compared with the females. The Verbal Comprehension Index (VCI) of the WISC-III was inversely correlated with the total scores of the ASQ-J for all VLBVVIs (n = 77, rc: -032, 95% CI: -0.19 to -0.01, p = 0.04). We also observed that the Freedom from Distractibility Index (FDI) of the WISC-III was significantly correlated with the Inattentive scores of the ADHD-RS (n = 45, rc: -0.18, 95% CI: -0.35 to -0.02, p = 0.03) in male, but not female VLBWIs. Conclusions: We herein report that the VCI and FDI of the WISC-III were correlated with the autism spectrum disorder and attention deficit hyperactivity disorder symptoms, respectively, in male VLBWIs. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Ochiai, Masayuki; Ichiyama, Masako; Iwayarna, Mariko; Sakai, Yasuanri; Hara, Toshiro] Kyushu Univ Hosp, Comprehens Matern & Perinatal Care Ctr, Fukuoka 812, Japan; [Ochiai, Masayuki; Ichiyama, Masako; Iwayarna, Mariko; Hara, Toshiro] Kyushu Univ, Grad Sch Med Sci, Dept Pediat, Fukuoka 8128582, Japan; [Yoshida, Keiko] Kyushu Univ Hosp, Dept Child Psychiat, Fukuoka 812, Japan	Ochiai, M (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Pediat, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	ochimasa@pediatr.med.kyushu-u.ac.jp			Kyushu University Clinical Research Network Project; Takeda Science Foundation; Mother and Child Health Foundation; JSPS KAKENHI [15K09717]	The authors acknowledge Kinjo T, Kusuda T and Inoue H for the treatment of the patients, Abe T for the data management and statistic support, and Ishizaki Y, Sanefuji M and Yamashita H for the evaluation cognitive functions and psychiatric symptoms of the patients. This study was supported in part by the Kyushu University Clinical Research Network Project (M.O.), Takeda Science Foundation (Y.S.), the Mother and Child Health Foundation (Y.S.) and the JSPS KAKENHI Grant Number15K09717 (M.O.). The authors have no financial relationships relevant to this article to disclose.	Kono Y, 2011, PEDIATR INT, V53, P930, DOI 10.1111/j.1442-200X.2011.03424.x; LINCOLN AJ, 1988, J AUTISM DEV DISORD, V18, P505, DOI 10.1007/BF02211870; Stephens BE, 2012, J DEV BEHAV PEDIATR, V33, P535, DOI 10.1097/DBP.0b013e31825fd0af; Kono Y, 2011, PEDIATR INT, V53, P1051, DOI 10.1111/j.1442-200X.2011.03480.x; Zayat M, 2011, J AUTISM DEV DISORD, V41, P1743, DOI 10.1007/s10803-011-1207-z; Yoshida S, 2001, J OBSTET GYNAECOL RE, V27, P205; Dias TGC, 2013, REV BRAS PSIQUIATR, V35, pS40, DOI 10.1590/1516-4446-2013-S103; Kusuda S, 2012, PEDIATR RES, V72, P531, DOI 10.1038/pr.2012.114; Anderson P, 2003, JAMA-J AM MED ASSOC, V289, P3264, DOI 10.1001/jama.289.24.3264; Takayanagi T, 2013, PEDIATR INT, V55, P594, DOI 10.1111/ped.12156; Indredavik MS, 2004, ARCH DIS CHILD, V89, pF445, DOI 10.1136/adc.2003.038943; Hack M, 2004, PEDIATRICS, V114, P932, DOI 10.1542/peds.2003-1017-L; Langberg JM, 2010, PEDIATRICS, V126, pE1033, DOI 10.1542/peds.2010-1267; Msall ME, 2002, MENT RETARD DEV D R, V8, P258, DOI 10.1002/mrdd.10046; Gaub M, 1997, J AM ACAD CHILD PSY, V36, P1036, DOI 10.1097/00004583-199708000-00011; Johnson S, 2010, J AM ACAD CHILD PSY, V49, P453, DOI 10.1016/j.jaac.2010.02.002; Hahn WH, 2011, J KOREAN MED SCI, V26, P467, DOI [10.3346/jkms.2011.26.4.467, 10.3346/jkrns.2011.26.4.467]; Hack M, 2002, NEW ENGL J MED, V346, P149, DOI 10.1056/NEJMoa010856; Mayes SD, 2004, CLIN NEUROPSYCHOL, V18, P559, DOI 10.1080/13854040490888530; Berument SK, 1999, BRIT J PSYCHIAT, V175, P444, DOI 10.1192/bjp.175.5.444; Itabashi K, 2009, PEDIATRICS, V123, P445, DOI 10.1542/peds.2008-0763; Moura O, 2014, DYSLEXIA, V20, P19, DOI 10.1002/dys.1468; Matson JL, 2014, INT J DEV NEUROSCI, V39, P44, DOI 10.1016/j.ijdevneu.2014.02.003; Johnson S, 2010, J PEDIATR-US, V156, P525, DOI 10.1016/j.jpeds.2009.10.041; Siegel DJ, 1996, J AUTISM DEV DISORD, V26, P389, DOI 10.1007/BF02172825; Baron Ida Sue, 2005, Child Neuropsychol, V11, P471, DOI 10.1080/09297040590951587; Bloom B, 2012, VITAL HLTH STAT, V10, P10; Czamara D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063859; Dairoku H, 2004, KOKURITSU TOKUSHU KY, V7, P19; DuPaul G, 2008, ADHD RATING SCALE 4; DuPaul G. L., 1998, ADHD RATING SCALE 4; Kusuda S, 2006, PEDIATRICS, V118, pE1130, DOI 10.1542/peds.2005-2724; Mayes Susan Dickerson, 2006, J Atten Disord, V9, P486, DOI 10.1177/1087054705283616; Ochiai M, 2014, NEONATOLOGY, V105, P79, DOI 10.1159/000355818; Pinto-Martin JA, 2011, PEDIATRICS, V128, P883, DOI 10.1542/peds.2010-2846; Wechsler D., 1991, WISC 3 WECHSLER INTE; Yang P, 2014, CHILD PSYCHIAT HUM D, V46, P358	37	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0378-3782	1872-6232		EARLY HUM DEV	Early Hum. Dev.	DEC	2015	91	12					783	786		10.1016/j.earlhumdev.2015.09.005		4	Obstetrics & Gynecology; Pediatrics	Obstetrics & Gynecology; Pediatrics	CY5HZ	WOS:000366440000021		
J	Carrasco, L; Toquenaga, Y; Mashiko, M				Carrasco, Luis; Toquenaga, Yukihiko; Mashiko, Miyuki			Extrapolation of random forest models shows scale adaptation in egret colony site selection against landscape complexity	ECOLOGICAL COMPLEXITY			English	Article						Ardeids; Collective decision-making; Habitat selection; Heron; Landscape configuration	BREEDING HABITAT SELECTION; SPECIES DISTRIBUTION; PUBLIC INFORMATION; HERON COLONIES; BIRDS; SIZE; ATTRACTION; MOVEMENTS; PATTERNS; ECOLOGY	Availability of certain habitats or landscape configurations can cause differential habitat selection in animal species. Landscape complexity can affect foraging scales, home ranges and movement, but its effect on habitat selection is not well documented. We aimed to examine differences in colony site selection of herons and egrets in different regions. We studied whether landscape complexities could affect their scale of selection and habitat preferences. We used colony distribution data and land-use maps for two neighboring regions, Ibaraki and Chiba prefectures in Japan, to create random forest models for analyzing habitat preferences and important scales of selection. We did cross-validation of the models, adjusted for its respective region's land-use maps with changing scales. The scales that best explained colony distribution were 1-, 4-, 10- and 15-km in the Ibaraki region, and 1- and 10-km in the Chiba region. Evergreen forest was the most important variable for lbaraki at 4-km and for the Chiba at 1-km. The importance of other variables differed for other models. Cross-validation showed that herons and egrets had the same habitat preferences at a 4-km scale in Ibaraki and at a 1-km scale in Chiba. The scale of selection was reduced in Chiba, where the main foraging resources for herons and egrets was more complex. Differences in landscape complexities did not affect habitat preferences but resulted in differences in the scale of selection. Habitat selection models created at the landscape level can be useful to study behavioral aspects difficult to describe with direct observation in detail. (C) 2015 Elsevier B.V. All rights reserved.	[Carrasco, Luis; Toquenaga, Yukihiko; Mashiko, Miyuki] Univ Tsukuba, Grad Sch Life & Environm Sci, Ibaraki 3058572, Japan	Carrasco, L (reprint author), Univ Tsukuba, Grad Sch Life & Environm Sci, Ibaraki 3058572, Japan.	luis@pe.ska.life.tsukuba.ac.jp			MEXT [13740433, 19570014, 26440233]; JSPS	We thank S. Ikeno, T. Mikami, M. Seido, and K. Takeda for supplying information about the location of some colonies in Ibaraki region, and K. Ueda and Heron Research Group of the Approved Specified Nonprofit Corporation Friends of Gyotoku Bird Observatory for supplying their original colony data in Chiba prefecture. We also thank K. Ohashi and members of the Population Ecology Laboratory for their helpful discussions. This study was supported in part by Grant-in-Aids for Scientific Research (13740433, 19570014 and 26440233) to YT from the MEXT and JSPS. Additional financial support was provided through a Monbukagakusho scholarship to LC from MEXT.	McNett BJ, 2000, ECOL ENTOMOL, V25, P423, DOI 10.1046/j.1365-2311.2000.00279.x; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Doligez B, 2003, ANIM BEHAV, V66, P973, DOI 10.1006/anbe.2002.2270; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Lima SL, 1996, TRENDS ECOL EVOL, V11, P131, DOI 10.1016/0169-5347(96)81094-9; Parkes ML, 2012, WATERBIRDS, V35, P56; Tarvin KA, 2002, AUK, V119, P971, DOI 10.1642/0004-8038(2002)119[0971:HANSOB]2.0.CO;2; Mcnew LB, 2013, J WILDLIFE MANAGE, V77, P791, DOI 10.1002/jwmg.493; Thomson RL, 2003, OECOLOGIA, V134, P431, DOI 10.1007/s00442-002-1140-0; Mashiko M, 2013, FORKTAIL, P71; Petit LJ, 1996, ECOL MONOGR, V66, P367, DOI 10.2307/2963523; Kerth G, 2010, ANIMAL BEHAVIOUR: EVOLUTION AND MECHANISMS, P241, DOI 10.1007/978-3-642-02624-9_9; Schofield PJ, 2003, J EXP MAR BIOL ECOL, V288, P125, DOI 10.1016/S0022-0981(03)00004-2; FASOLA M, 1992, BIOL CONSERV, V62, P219, DOI 10.1016/0006-3207(92)91049-X; Campomizzi AJ, 2008, J WILDLIFE MANAGE, V72, P331, DOI 10.2193/2007-204; Herfindal I, 2009, ECOGRAPHY, V32, P849, DOI 10.1111/j.1600-0587.2009.05783.x; Austin M, 2007, ECOL MODEL, V200, P1, DOI 10.1016/j.ecolmodel.2006.07.005; Gibbs JP, 1997, COLON WATERBIRD, V20, P1, DOI 10.2307/1521757; Haskell JP, 2002, NATURE, V418, P527, DOI 10.1038/nature00840; Stensland E, 2003, MAMMAL REV, V33, P205, DOI 10.1046/j.1365-2907.2003.00022.x; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Paracuellos M, 2006, BIODIVERS CONSERV, V15, P4569, DOI 10.1007/s10531-005-5820-z; FAHRIG L, 1988, APPL MATH COMPUT, V27, P53, DOI 10.1016/0096-3003(88)90098-7; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Boisteau B, 2006, CR BIOL, V329, P208, DOI 10.1016/j.crvi.2006.01.001; ANDERSON SH, 1974, ECOLOGY, V55, P828, DOI 10.2307/1934418; Phelps SM, 2007, BEHAV ECOL, V18, P108, DOI 10.1093/beheco/ar1063; Carrasco L, 2014, ECOL RES, V29, P483, DOI 10.1007/s11284-014-1147-0; Danchin E, 1998, ECOLOGY, V79, P2415, DOI 10.1890/0012-9658(1998)079[2415:CRSABH]2.0.CO;2; Kelly JP, 2008, WETLANDS, V28, P257, DOI 10.1672/07-152.1; Leblond M, 2010, ECOGRAPHY, V33, P1102, DOI 10.1111/j.1600-0587.2009.06104.x; MORRIS DW, 1987, ECOLOGY, V68, P362, DOI 10.2307/1939267; Bustamante J, 1997, BIOL CONSERV, V80, P153, DOI 10.1016/S0006-3207(96)00136-X; BROWN CR, 1995, BEHAV ECOL SOCIOBIOL, V36, P221, DOI 10.1007/BF00165830; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Fasola M, 2010, POPUL ECOL, V52, P59, DOI 10.1007/s10144-009-0165-1; Ritchie ME, 1998, EVOL ECOL, V12, P309, DOI 10.1023/A:1006552200746; Stapp P, 1997, FUNCT ECOL, V11, P644, DOI 10.1046/j.1365-2435.1997.00133.x; Cody M.L., 1985, HABITAT SELECTION BI; de Jager M, 2011, SCIENCE, V332, P1551, DOI 10.1126/science.1201187; DENEUBOURG JL, 1989, ETHOL ECOL EVOL, V1, P295; Environmental Agency of Japan, 1994, DISTR POP STAT COL C; FRETWELL S D, 1969, Acta Biotheoretica, V19, P45, DOI 10.1007/BF01601955; Gneiting T., 2012, STAT SCI, V2, P247; Hancock J.A., 2005, THE HERONS; Immelmann K., 1972, Advances Study Behav, V4, P147, DOI 10.1016/S0065-3454(08)60009-1; Keister A.R., 1979, BEHAV ECOL SOCIOBIOL, V5, P323; Liaw A, 2002, R NEWS, V2, P18, DOI DOI 10.1016/J.MEMSCI.2010.02.036; MARTIN TE, 1993, BIOSCIENCE, V43, P523, DOI 10.2307/1311947; R Development Core Team, 2011, R LANG ENV STAT COMP; Sevcikova H., 2011, ESTIMATION FRACTAL D; Tourenq C., 2004, AUK, V121, P193; Ueda K., 2011, REPORTS WILD BIRD SO, V367, P3; Yamashina Institute for Ornithology, 2002, ATL JAP MIGR BIRDS 1	54	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1476-945X	1476-9840		ECOL COMPLEX	Ecol. Complex.	DEC	2015	24						29	36		10.1016/j.ecocom.2015.08.002		8	Ecology	Environmental Sciences & Ecology	CZ0GI	WOS:000366782700003		
J	Okamoto, H; Tsutsumi, Y; Watanabe, M; Yamakage, K; Ashida, M; Chen, P; Doi, H; Miura, H; Matsumura, M; Hanawa, T				Okamoto, Hiroyuki; Tsutsumi, Yusuke; Watanabe, Mika; Yamakage, Kohji; Ashida, Maki; Chen, Peng; Doi, Hisashi; Miura, Hiroyuki; Matsumura, Mitsuaki; Hanawa, Takao			Evaluation of Release and Accumulation of Metal Ions from Titanium and Nickel by Accelerated Dissolution Test in Simulated Body Environments	ELECTROCHEMISTRY			English	Article						Titanium; Metal Allergy; Corrosion; Body Fluid	SKIN SENSITIZATION TEST; TEST H-CLAT; IN-VITRO; CONTACT; ALLERGY	To study the allergenic properties of titanium (Ti), the corrosion behaviors and following metal ions release of Ti and nickel (Ni) in simulated physiological environments were investigated. Anodic polarization tests and accelerated dissolution tests were performed in artificial saliva with and without fluorine, and in artificial sweat. Ti showed good corrosion resistance in the artificial saliva without fluorine even when the passive film was physically destroyed by mechanical wear. The concentration of Ti ions released into the solution showed relatively higher values in artificial saliva with fluorine and in artificial sweat, however, it remained to be below 10 ppm. On the other hand, Ni was not passivated in these solutions and the concentrations of the released Ni ions were about 100 ppm. Thus, Ti can be regarded as a considerably safer material than Ni from the viewpoint of corrosion engineering. The large differences in the corrosion characteristics and metal ion solubility between Ti and Ni under the experimental conditions are discussed. (C) The Electrochemical Society of Japan, All rights reserved.	[Okamoto, Hiroyuki; Miura, Hiroyuki; Matsumura, Mitsuaki] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Restorat Sci, Fixed Prosthodont,Bunkyo Ku, Tokyo 1138549, Japan; [Tsutsumi, Yusuke; Ashida, Maki; Chen, Peng; Doi, Hisashi; Hanawa, Takao] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Dept Metall Biomat, Chiyoda Ku, Tokyo 1010062, Japan; [Tsutsumi, Yusuke] Univ Tokyo, Dept Mat Engn, Bunkyo Ku, Tokyo 1138656, Japan; [Watanabe, Mika; Yamakage, Kohji] Hatano Res Inst, Food & Drug Safety Ctr, Hadano, Kanagawa 2578523, Japan	Tsutsumi, Y (reprint author), Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Dept Metall Biomat, Chiyoda Ku, 2-3-10 Kanda Surugadai, Tokyo 1010062, Japan.	tsutsumi.met@tmd.ac.jp			JSPS KAKENHI [A25709064, 24650275]	This work was supported by JSPS KAKENHI Grant Number A25709064, and 24650275, Grant-in-Aid for challenging Exploratory Research.	Liden C, 2001, CONTACT DERMATITIS, V44, P160, DOI 10.1034/j.1600-0536.2001.044003160.x; [Anonymous], 2013, 105E042013 ISO; Wolf R, 2013, CLIN DERMATOL, V31, P479, DOI 10.1016/j.clindermatol.2013.01.015; Sakaguchi H, 2009, CELL BIOL TOXICOL, V25, P109, DOI 10.1007/s10565-008-9059-9; FUSAYAMA T, 1963, J DENT RES, V42, P1183, DOI 10.1177/00220345630420051301; BOERE G, 1995, J APPL BIOMATER, V6, P283, DOI 10.1002/jab.770060409; Tanaka Y, 2007, J MATER SCI-MATER M, V18, P797, DOI 10.1007/s10856-006-0004-2; PENDRYS DG, 1991, J AM DENT ASSOC, V122, P63; [Anonymous], 2004, L08482004 JIS; Leung VWH, 1997, J DENT, V25, P475, DOI 10.1016/S0300-5712(96)00068-1; [Anonymous], 1987, TEST METH COL FASTN; Reclaru L, 1998, BIOMATERIALS, V19, P85, DOI 10.1016/S0142-9612(97)00179-8; NIELSEN NH, 1992, ACTA DERM-VENEREOL, V72, P456; Ashikaga T, 2006, TOXICOL IN VITRO, V20, P767, DOI 10.1016/j.tiv.2005.10.012; Sicilia A, 2008, CLIN ORAL IMPLAN RES, V19, P823, DOI 10.1111/j.1600-0501.2008.01544.x; Sulzberger MB, 1931, ARCH DERMATOL SYPH, V23, P519; Schram SE, 2010, INT J DERMATOL, V49, P115, DOI 10.1111/j.1365-4632.2009.04307.x; Evrard L, 2010, Rev Med Brux, V31, P44; Garner Lisa A, 2004, Dermatol Ther, V17, P321, DOI 10.1111/j.1396-0296.2004.04034.x; Hanawa T, 2004, MAT SCI ENG C-BIO S, V24, P745, DOI 10.1016/j.msec.2004.08.018; Oda Y., 1996, JPN J DENT MAT DEV, V15, P317; Sulzberger M B, 1975, Contact Dermatitis, V1, P117, DOI 10.1111/j.1600-0536.1975.tb05337.x	22	0	0	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	DEC	2015	83	12					1048	1052		10.5796/electrochemistry.83.1048		5	Electrochemistry	Electrochemistry	CZ0IP	WOS:000366788700001		
J	Liu, Z; Luo, YW; Zhou, MJ; Wang, WQ; Gan, N; Okada, S; Yamaki, J				Liu, Zhen; Luo, Yuwen; Zhou, Mingjiong; Wang, Wenqin; Gan, Ning; Okada, Shigeto; Yamaki, Jun-ichi			Enhanced Performance of Yolk-Shell Structured Si-PPy Composite as an Anode for Lithium Ion Batteries	ELECTROCHEMISTRY			English	Article						Yolk-shell Structure; Nano-silicon Anode; Conductive Polymer; Lithium-ion Batteries	CARBON-COATED SILICON; FACILE SYNTHESIS; STORAGE; NANOPARTICLES; NANOCOMPOSITES; POLYTHIOPHENE; MICROSPHERES; ELECTROLYTE; IMPROVEMENT; EFFICIENCY	Yolk-shell structured silicon-polypyrrole (Si-PPy) composite has been prepared by an in situ chemical polymerization approach. The designed parcel method significantly improves the cycling stability and rate capability compared to those of bare silicon. The Si-PPy composite exhibits a high specific capacity of 1400 mAh g(-1) after 100 cycles, which is approximately 4 times higher than bare Si. Moreover, the Si-PPy composite delivers a high reversible capacity of similar to 1200 mAh g(-1) at a high current density of 10 A g(-1), while the bare Si only achieves a low capacity of similar to 490 mAh g(-1) at the same current density. The outstanding electrochemical properties of the Si-PPy composites are attributed to the stability and conductivity of the PPy shell and the nanoscale structure of the composite. (C) The Electrochemical Society of Japan, All rights reserved.	[Liu, Zhen; Luo, Yuwen; Zhou, Mingjiong; Wang, Wenqin; Gan, Ning] Ningbo Univ, Sch Mat Sci & Chem Engn, Ningbo 315211, Zhejiang, Peoples R China; [Okada, Shigeto; Yamaki, Jun-ichi] Kyushu Univ, Inst Mat Chem & Engn, Kasuga, Fukuoka 8168580, Japan	Zhou, MJ (reprint author), Ningbo Univ, Sch Mat Sci & Chem Engn, Fenghua Rd 818, Ningbo 315211, Zhejiang, Peoples R China.	zhoumingjiong@nbu.edu.cn			Scientific Research Foundation [ZX2013000556]; Natural Science Foundation of Ningbo [ZX2014000631]; School Scientific Research Foundations [ZX2014000114, ZX2014000391]; Education Foundation of Zhejiang Province [ZX2014000283]; K. C. Wong Magna Fund in Ningbo University	This work was financially supported by Scientific Research Foundation for Startup Researcher (ZX2013000556), Natural Science Foundation of Ningbo (ZX2014000631), School Scientific Research Foundations (ZX2014000114, ZX2014000391), Education Foundation of Zhejiang Province (ZX2014000283). This work was also sponsored by K. C. Wong Magna Fund in Ningbo University.	Lou XW, 2006, ADV MATER, V18, P2325, DOI 10.1002/adma.200600733; Xin X, 2012, J MATER CHEM, V22, P7724, DOI 10.1039/c2jm00120a; Dimov N, 2003, ELECTROCHIM ACTA, V48, P1579, DOI 10.1016/S0013-4686(03)00030-6; Wu H, 2012, NANO LETT, V12, P904, DOI 10.1021/nl203967r; Doi T, 2008, J POWER SOURCES, V185, P1380, DOI 10.1016/j.jpowsour.2008.08.062; Wang JY, 2013, ANGEW CHEM INT EDIT, V52, P6417, DOI 10.1002/anie.201301622; Gai LG, 2013, DALTON T, V42, P1820, DOI 10.1039/c2dt32164e; Aparicio M, 2000, J AM CERAM SOC, V83, P1351; Zhang H, 2008, LANGMUIR, V24, P13748, DOI 10.1021/la8028935; Chew SY, 2007, ELECTROCHEM COMMUN, V9, P941, DOI 10.1016/j.elecom.2006.11.028; Ng SH, 2006, ANGEW CHEM INT EDIT, V45, P6896, DOI 10.1002/anie.200601676; Zhao Y, 2012, J PHYS CHEM C, V116, P18612, DOI 10.1021/jp304095y; Kousik G, 2001, PROG ORG COAT, V43, P286, DOI 10.1016/S0300-9440(01)00211-9; Cao SQ, 2015, APPL SURF SCI, V342, P55, DOI 10.1016/j.apsusc.2015.02.139; Schmidt J, 2008, PROG PHOTOVOLTAICS, V16, P461, DOI 10.1002/pip.823; WANG HL, 1990, MACROMOLECULES, V23, P1053, DOI 10.1021/ma00206a024; Du ZJ, 2012, J MATER CHEM, V22, P11636, DOI 10.1039/c2jm31419c; Yoshio M, 2002, J ELECTROCHEM SOC, V149, pA1598, DOI 10.1149/1.1518988; Tao HC, 2012, ELECTROCHIM ACTA, V71, P194, DOI 10.1016/j.electacta.2012.03.139; Iwamura S, 2013, J POWER SOURCES, V222, P400, DOI 10.1016/j.jpowsour.2012.09.003; Si Q, 2011, J POWER SOURCES, V196, P9774, DOI 10.1016/j.jpowsour.2011.08.005; Mao Y, 2013, ELECTROCHIM ACTA, V105, P162, DOI 10.1016/j.electacta.2013.04.086; Liu XH, 2012, ACS NANO, V6, P1522, DOI 10.1021/nn204476h; Fu QG, 2005, SCRIPTA MATER, V52, P923, DOI 10.1016/j.scriptamat.2005.12.029; Wang HB, 2007, ELECTROCHIM ACTA, V52, P5102, DOI 10.1016/j.electacta.2007.02.004; Ren YR, 2012, J SOLID STATE ELECTR, V16, P1453, DOI 10.1007/s10008-011-1525-2; Szczech JR, 2011, ENERG ENVIRON SCI, V4, P56, DOI 10.1039/c0ee00281j; Guo ZP, 2005, J POWER SOURCES, V146, P448, DOI 10.1016/j.jpowsour.2005.03.112; Cuentas-Gallegos AK, 2006, J POWER SOURCES, V161, P580, DOI 10.1016/j.jpowsour.2006.04.138; Zhou XS, 2012, CHEM COMMUN, V48, P2198, DOI 10.1039/c2cc17061b; Kim H, 2010, ANGEW CHEM INT EDIT, V49, P2146, DOI 10.1002/anie.200906287; La HS, 2006, COLLOID SURFACE A, V272, P22, DOI 10.1016/j.colsurfa.2005.07.003; He Y, 2011, ADV MATER, V23, P4938, DOI 10.1002/adma.201102568; Dhawan SK, 2002, SYNTHETIC MET, V129, P261, DOI 10.1016/S0379-6779(02)00079-6; Gnanaraj J. S., 2001, J ELECTROCHEM SOC, V148, P525; Idota Y, 2002, SCIENCE, V296, P2012; Yamada M., 2011, J ELECTROCHEM SOC, V158, P417	37	0	0	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	DEC	2015	83	12					1067	1070		10.5796/electrochemistry.83.1067		4	Electrochemistry	Electrochemistry	CZ0IP	WOS:000366788700004		
J	Mori, D; Kobayashi, H; Okumura, T; Inaguma, Y				Mori, Daisuke; Kobayashi, Hironori; Okumura, Toyoki; Inaguma, Yoshiyuki			Relationship between Cyclic Properties and Charge-discharge Condition for Li2Mn0.4Ru0.6O3 and Li2RuO3	ELECTROCHEMISTRY			English	Article						Li-rich Manganese Layered Oxide; Li2RuO3; Local Structure; Voltage Fade	POSITIVE ELECTRODE MATERIAL; X-RAY-ABSORPTION; LI-ION BATTERIES; LAYERED-OXIDE ELECTRODES; HIGH-CAPACITY; LITHIUM INTERCALATION; RU SUBSTITUTION; VOLTAGE DECAY; RICH; CATHODE	Capacity and voltage retentions upon subsequent cycles for Li2RuO3 and Li2Mn0.4Ru0.6O3 (LMR) under various cutoff voltages have been investigated. The change in average and local structures upon electrochemical cycling were examined by ex-situ XRD and Ru L-3-edge XANES measurements, and the relationship between the cyclic capabilities and the structural changes is discussed. The deteriorations of discharge capacity and average discharge voltage in the subsequent cycles of LMR with a charge cut-off voltage of 4.8 V vs. Li/Li+ are remarkably smaller than that with the voltage of 4.2 V. Moreover, LMR exhibits higher average discharge voltage than Li2RuO3 under a charge cut-off voltage of 4.8V. The phase transition behavior of LMR was not similar to Li2RuO3 upon electrochemical cycling. Ru L-3-edge XANES spectra measurements reveal that RuO6 octahedra in LMR charged at 4.2V are much distorted. The local structure of RuO6 octahedra is associated with the cyclic capability of LMR and Li2RuO3. (C) The Electrochemical Society of Japan, All rights reserved.	[Mori, Daisuke; Inaguma, Yoshiyuki] Gakushuin Univ, Dept Chem, Fac Sci, Toshima Ku, Tokyo 1718588, Japan; [Kobayashi, Hironori; Okumura, Toyoki] Natl Inst Adv Ind Sci & Technol, Res Inst Electrochem Energy, Environm & Energy Dept, Ikeda, Osaka 5638577, Japan	Mori, D (reprint author), Gakushuin Univ, Dept Chem, Fac Sci, Toshima Ku, 1-5-1 Mejiro, Tokyo 1718588, Japan.	daisuke.mori@gakushuin.ac.jp			Japan Society for the Promotion of Science [25810137]	The synchrotron XRD measurements of SPring-8 were performed under the Priority Green/Life innovation program administrated by the Japan Synchrotron Radiation Research Institute (JASRI) (Proposal Nos. 2012A1658, 2013A1697, 2014B1492). The Ru L-edge XANES measurements were conducted under the Project for Creation of Research Platforms and Sharing of Advanced Research Infrastructure (Proposal No. R1301). This work was supported by a Grant-in-Aid for Young Scientists (B) (no. 25810137 to D. M.) of the Japan Society for the Promotion of Science. We are grateful to the reviewers for their useful advice and helpful comments.	SHAM TK, 1983, J AM CHEM SOC, V105, P2269, DOI 10.1021/ja00346a028; Tran N, 2008, CHEM MATER, V20, P4815, DOI 10.1021/cm070435m; Zheng YM, 2012, J POWER SOURCES, V208, P447, DOI 10.1016/j.jpowsour.2012.02.044; Song BH, 2012, ELECTROCHIM ACTA, V80, P187, DOI 10.1016/j.electacta.2012.06.118; Lu ZH, 2002, J ELECTROCHEM SOC, V149, pA815, DOI 10.1149/1.1480014; Oishi M, 2013, J POWER SOURCES, V222, P45, DOI 10.1016/j.jpowsour.2012.08.023; Yu HJ, 2012, J MATER CHEM, V22, P15507, DOI 10.1039/c2jm33484d; Johnson CS, 2004, ELECTROCHEM COMMUN, V6, P1085, DOI 10.1016/j.elecom.2004.08.002; Knight JC, 2015, J MATER CHEM A, V3, P2006, DOI 10.1039/c4ta05178e; Kobayashi H, 1996, SOLID STATE IONICS, V86-8, P859, DOI 10.1016/0167-2738(96)00194-4; Sathiya M, 2013, NAT MATER, V12, P827, DOI [10.1038/nmat3699, 10.1038/NMAT3699]; Wu Y, 2006, ELECTROCHEM SOLID ST, V9, pA221, DOI 10.1149/1.2180528; Sathiya M, 2013, CHEM MATER, V25, P1121, DOI 10.1021/cm400193m; Zheng YM, 2012, THIN SOLID FILMS, V520, P4889, DOI 10.1016/j.tsf.2012.03.029; Oishi M, 2015, J POWER SOURCES, V276, P89, DOI 10.1016/j.jpowsour.2014.11.104; Ebbinghaus S, 2001, J SOLID STATE CHEM, V156, P194, DOI 10.1006/jssc.2000.8981; Sarkar S, 2014, J ELECTROCHEM SOC, V161, pA934, DOI 10.1149/2.030406jes; Koga H, 2014, J PHYS CHEM C, V118, P5700, DOI 10.1021/jp412197z; Yabuuchi N, 2011, J AM CHEM SOC, V133, P4404, DOI 10.1021/ja108588y; Boulineau A, 2012, CHEM MATER, V24, P3558, DOI 10.1021/cm301140g; Tabuchi M, 2002, J ELECTROCHEM SOC, V149, pA509, DOI 10.1149/1.1462791; Lee ES, 2014, J MATER CHEM A, V2, P3932, DOI 10.1039/c3ta14975g; Mohanty D, 2014, CHEM MATER, V26, P6272, DOI 10.1021/cm5031415; Mori D, 2011, J POWER SOURCES, V196, P6934, DOI 10.1016/j.jpowsour.2010.11.150; Gallagher KG, 2013, ELECTROCHEM COMMUN, V33, P96, DOI 10.1016/j.elecom.2013.04.022; Taminato S, 2014, J MATER CHEM A, V2, P17875, DOI 10.1039/c4ta02795g; Koga H, 2013, J ELECTROCHEM SOC, V160, pA786, DOI 10.1149/2.038306jes; KOBAYASHI H, 1995, SOLID STATE IONICS, V82, P25, DOI 10.1016/0167-2738(95)00135-S; Mori D., 2015, SOLID STATE IN PRESS, DOI [10.1016/j.ssi.2015.09.025, DOI 10.1016/J.SSI.2015.09.025]; Sathiya M, 2015, NAT MATER, V14, P230, DOI [10.1038/nmat4137, 10.1038/NMAT4137]; Taminato S., 2013, FUNTAI OYOBI FUNMATS, V60, P24	31	0	0	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	DEC	2015	83	12					1071	1076		10.5796/electrochemistry.83.1071		6	Electrochemistry	Electrochemistry	CZ0IP	WOS:000366788700005		
J	Yanagishita, T; Masuda, H				Yanagishita, Takashi; Masuda, Hideki			High-Throughput Fabrication Process for Highly Ordered Through-Hole Porous Alumina Membranes Using Two-Layer Anodization	ELECTROCHIMICA ACTA			English	Article						Anodic Porous Alumina; Through-Hole; Ordered Hole Arrangement; Filtration	ANODIC ALUMINA; NANOWIRE ARRAYS; MORPHOLOGY	Alumina through-hole membranes with an ordered array of holes were obtained by the wet etching of two-layered anodic porous alumina, which was formed by the first anodization of Al in an acid solution under standard conditions and the subsequent anodization in concentrated H2SO4. In this process, the detachment of the porous alumina membrane and through-holing could be achieved simultaneously by etching in an appropriate acid solution. This is because the oxide layers formed in concentrated H2SO4 were more easily dissolved than the oxide layer formed in the standared acid solution. After the detachment of the membrane, the residual Al substrate could be repeatedly used for the preparation of ordered through-hole membranes. The obtained through-hole membranes are expected to be used in various applications. (C) 2015 Elsevier Ltd. All rights reserved.	[Yanagishita, Takashi; Masuda, Hideki] Tokyo Metropolitan Univ, Dept Appl Chem, Hachioji, Tokyo 1920397, Japan	Masuda, H (reprint author), Tokyo Metropolitan Univ, Dept Appl Chem, 1-1 Minamiosawa, Hachioji, Tokyo 1920397, Japan.	masuda-hideki@tmu.ac.jp					Lee W, 2008, NAT NANOTECHNOL, V3, P402, DOI 10.1038/nnano.2008.161; Thormann A, 2007, SMALL, V3, P1032, DOI 10.1002/smll.200600582; Yuan JH, 2006, ELECTROCHIM ACTA, V51, P4589, DOI 10.1016/j.electacta.2005.12.044; Osmanbeyoglu HU, 2009, J MEMBRANE SCI, V343, P1, DOI 10.1016/j.memsci.2009.07.027; Cao Y, 2008, CHEM MATER, V20, P5260, DOI 10.1021/cm801028a; Masuda H, 1997, J ELECTROCHEM SOC, V144, pL127, DOI 10.1149/1.1837634; Ekanayake EMIM, 2007, BIOSENS BIOELECTRON, V23, P107, DOI 10.1016/j.bios.2007.03.022; Li Y, 2000, J MATER RES, V15, P2305, DOI 10.1557/JMR.2000.0331; Schneider JJ, 2005, EUR J INORG CHEM, P2352, DOI 10.1002/ejic.200401046; HUBER CA, 1994, SCIENCE, V263, P800, DOI 10.1126/science.263.5148.800; Kolmakov A, 2003, ADV MATER, V15, P997, DOI 10.1002/adma.200304889; Jeong SH, 2001, APPL PHYS LETT, V78, P2052, DOI 10.1063/1.1359483; Lu QY, 2004, J AM CHEM SOC, V126, P8650, DOI 10.1021/ja0488378; FURNEAUX RC, 1989, NATURE, V337, P147, DOI 10.1038/337147a0; Belwalkar A, 2008, J MEMBRANE SCI, V319, P192, DOI 10.1016/j.memsci.2008.03.044; Masuda H., 1996, JPN J APPL PHYS, V35, P126; MASUDA H, 1995, SCIENCE, V268, P1466, DOI 10.1126/science.268.5216.1466; Mausda H., 2012, Japan patent, Patent No. [WO2014/020939, 2014020939]	18	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0013-4686	1873-3859		ELECTROCHIM ACTA	Electrochim. Acta	DEC 1	2015	184						80	85		10.1016/j.electacta.2015.10.019		6	Electrochemistry	Electrochemistry	CX9HU	WOS:000366016900011		
J	Sumi, H; Ohshiro, T; Nakayama, M; Suzuki, T; Fujishiro, Y				Sumi, Hirofumi; Ohshiro, Takayuki; Nakayama, Masanobu; Suzuki, Toshio; Fujishiro, Yoshinobu			Prevention of Reaction between (Ba,Sr)(Co,Fe)O-3 Cathodes and Yttria-stabilized Zirconica Electrolytes for Intermediate-temperature Solid Oxide Fuel Cells	ELECTROCHIMICA ACTA			English	Article						intermediate-temperature solid oxide fuel cell (IT-SOFC); cathode; perovskite oxide; mixed ionic and electronic conductor (MIEC)	BA0.5SR0.5CO0.8FE0.2O3-DELTA; DIFFUSION; KINETICS; SOFCS	Perovskite (Ba,Sr)(Co,Fe)O-3 (BSCF) cathodes are highly electrochemically active in the oxygen reduction process for intermediate-temperature solid oxide fuel cells (IT-SOFCs). However, the phase of perovskite zirconate is formed between the BSCF cathode and yttria-stabilized zirconia (YSZ) electrolyte, which increased the cathode polarization resistance. In the present work, the (Ba, Sr)ZrO3 formation was not prevented by the insertion of a porous gadolinia-doped ceria (GDC) interlayer between the cathode and the electrolyte, when the BSCF cathode was sintered at 1100 degrees C. Energy dispersive X-ray spectroscopy showed that the product of (Ba, Sr)ZrO3 formed between BSCF and YSZ was thicker than that of SrZrO3 formed between a conventional (La, Sr)(Co, Fe)O-3 (LSCF) and YSZ. When a BSCF cathode was sintered at 900 degrees C, no (Ba,Sr)ZrO3 formation was observed between the cathode and the electrolyte. The maximum power density at 650 degrees C was improved from 7.5 to 740 mW/cm(2) by decreasing the sintering temperature of BSCF cathode from 1100 degrees C to 900 degrees C. Distribution of relaxation times (DRT) analysis showed that the polarization resistance of the oxygen exchange process in the BSCF cathode sintered at 900 degrees C was lower than that in the LSCF cathode. The sintering temperature is important for obtaining high-performance BSCF cathodes for IT-SOFCs. (C) 2015 Elsevier Ltd. All rights reserved.	[Sumi, Hirofumi; Suzuki, Toshio; Fujishiro, Yoshinobu] Natl Inst Adv Ind Sci & Technol, Inorgan Funct Mat Res Inst, Nagoya, Aichi 4638560, Japan; [Ohshiro, Takayuki; Nakayama, Masanobu] Nagoya Inst Technol, Dept Mat Sci & Engn, Nagoya, Aichi 4558555, Japan	Sumi, H (reprint author), Natl Inst Adv Ind Sci & Technol, Inorgan Funct Mat Res Inst, Nagoya, Aichi 4638560, Japan.	h-sumi@aist.go.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI [25709059]	The present work was partially supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grants-in-Aid of for Young Scientists No. 25709059.	Kendall K, 1998, J POWER SOURCES, V71, P268, DOI 10.1016/S0378-7753(97)02761-4; Sumi H, 2012, ELECTROCHIM ACTA, V67, P159, DOI 10.1016/j.electacta.2012.02.021; Wang FF, 2014, J POWER SOURCES, V258, P281, DOI 10.1016/j.jpowsour.2014.02.046; Kao WX, 2010, J POWER SOURCES, V195, P2220, DOI 10.1016/j.jpowsour.2009.10.057; Ried P, 2007, ECS TRANSACTIONS, V7, P1217, DOI 10.1149/1.2729221; KINGSMITH RD, 1994, PHYS REV B, V49, P5828, DOI 10.1103/PhysRevB.49.5828; Yashiro K, 2002, ELECTROCHEMISTRY, V70, P958; Kendall K, 2000, ELECTROCHEMISTRY, V68, P403; Bucher E, 2008, SOLID STATE IONICS, V179, P1032, DOI 10.1016/j.ssi.2008.01.089; Chen DJ, 2013, ELECTROCHEM COMMUN, V35, P131, DOI 10.1016/j.elecom.2013.08.017; Yamanaka S, 2003, J ALLOY COMPD, V359, P109, DOI 10.1016/S0925-8388(03)00214-7; Tsoga A, 2000, SOLID STATE IONICS, V135, P403, DOI 10.1016/S0167-2738(00)00477-X; Shao ZP, 2004, NATURE, V431, P170, DOI 10.1038/nature02863; Leonide A, 2008, J ELECTROCHEM SOC, V155, pB36, DOI 10.1149/1.2801372; [Anonymous], 2007, 2007 IEEE S COMP; Adler SB, 1996, J ELECTROCHEM SOC, V143, P3554, DOI 10.1149/1.1837252; BOUKAMP BA, 1995, J ELECTROCHEM SOC, V142, P1885, DOI 10.1149/1.2044210; Kim YM, 2010, J POWER SOURCES, V195, P6420, DOI 10.1016/j.jpowsour.2010.03.095; Sun CW, 2010, J SOLID STATE ELECTR, V14, P1125, DOI 10.1007/s10008-009-0932-0; Shiiba H, 2013, J MATER CHEM A, V1, P10345, DOI 10.1039/c3ta10382j; Schichlein H, 2002, J APPL ELECTROCHEM, V32, P875, DOI 10.1023/A:1020599525160; Shao ZP, 2000, J MEMBRANE SCI, V172, P177, DOI 10.1016/S0376-7388(00)00337-9; Bouwmeester HJM, 2004, J SOLID STATE ELECTR, V8, P599, DOI 10.1007/s10008-003-0488-3; Duan ZS, 2006, J POWER SOURCES, V160, P57, DOI 10.1016/j.jpowsour.2006.01.092; Macdonald J. R., 1987, IMPEDANCE SPECTROSCO; Shi G. H., 2012, INT J HYDROGEN ENERG, V37, P13022; Sumi H., 2013, J POWER SOURCES, V229, P354; Sumi Hirofumi, 2014, ECS Transactions, V56, DOI 10.1149/05601.0063ecst; WEESE J, 1992, COMPUT PHYS COMMUN, V69, P99, DOI 10.1016/0010-4655(92)90132-I; Wu X. W., 2014, FUEL CELL, V14, P171; Yan M.A., 2008, J POWER SOURCES, V185, P76	31	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0013-4686	1873-3859		ELECTROCHIM ACTA	Electrochim. Acta	DEC 1	2015	184						403	409		10.1016/j.electacta.2015.10.092		7	Electrochemistry	Electrochemistry	CX9HU	WOS:000366016900051		
J	Lee, H; Honda, Y; Hashizume, M; Guo, YL; Wu, CF; Kan, HD; Jung, K; Lim, YH; Yi, S; Kim, H				Lee, Hyewon; Honda, Yasushi; Hashizume, Masahiro; Guo, Yue Leon; Wu, Chang-Fu; Kan, Haidong; Jung, Kweon; Lim, Youn-Hee; Yi, Seungmuk; Kim, Ho			Short-term exposure to fine and coarse particles and mortality: A multicity time-series study in East Asia	ENVIRONMENTAL POLLUTION			English	Article						Air pollution; Particulate matter; Fine particles; Coarse particles; Mortality	PARTICULATE AIR-POLLUTION; CHEMICAL-CONSTITUENTS; HOSPITAL ADMISSIONS; INDOOR EXPOSURE; CHINESE CITIES; OUTDOOR ORIGIN; UNITED-STATES; DUST STORMS; KOREA; ASSOCIATIONS	Few studies on size-specific health effects of particulate matter have been conducted in Asia. We examined the association between both fine and coarse particles (PM2.5 and PM10-2.5) and mortality across 11 East Asian cities from 4 countries (Korea, Japan, Taiwan, and China). We performed a two-stage analysis: we generated city-specific estimates using a time-series analysis with a generalized additive model (Quasi-Poisson distribution), and estimated the overall effects by conducting a meta-analysis. Each 10-mu g/m(3) increase in PM2.5 (lag01) was associated with an increase of 0.38% (95% confidence interval = 0.21%-0.55%) in all causes mortality, 0.96% (0.46%-1.46%) in cardiovascular mortality, and 1% (0.23%-1.78%) in respiratory mortality. Each 10-mu g/m(3) increase in PM10-2.5 (lag01) was associated with cardiovascular mortality (0.69%, [0.05%-1.33%]), although this association attenuated after controlling for other pollutants, especially PM2.5. Increased mortality was associated with increasing PM2.5 and PM10-2.5 concentrations over 11 East Asian cities. (C) 2015 Elsevier Ltd. All rights reserved.	[Lee, Hyewon; Yi, Seungmuk; Kim, Ho] Seoul Natl Univ, Grad Sch Publ Hlth, Seoul 151742, South Korea; [Honda, Yasushi] Univ Tsukuba, Fac Hlth & Sport Sci, Tsukuba, Ibaraki 305, Japan; [Hashizume, Masahiro] Nagasaki Univ, Inst Trop Med, Nagasaki, Japan; [Guo, Yue Leon] Natl Taiwan Univ, Dept Environm & Occupat Med, Inst Occupat Med & Ind Hyg, Taipei 10764, Taiwan; [Wu, Chang-Fu] Natl Taiwan Univ, Dept Publ Hlth, Taipei 10764, Taiwan; [Kan, Haidong] Fudan Univ, Sch Publ Hlth, Dept Environm Hlth, Shanghai 200032, Peoples R China; [Jung, Kweon] Seoul Metropolitan Govt Res Inst Publ Hlth & Envi, Seoul, South Korea; [Lim, Youn-Hee] Seoul Natl Univ, Med Res Ctr, Inst Environm Med, Seoul 151742, South Korea; [Lim, Youn-Hee] Seoul Natl Univ, Coll Med, Ctr Environm Hlth, Seoul 151742, South Korea; [Yi, Seungmuk; Kim, Ho] Seoul Natl Univ, Asian Inst Energy Environm & Sustainabil, Seoul 151742, South Korea	Kim, H (reprint author), Seoul Natl Univ, Grad Sch Publ Hlth, 1 Gwanak Ro, Seoul 151742, South Korea.	hokim@snu.ac.kr			Global Research Lab through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT (Information and Communication Technologies), and Future Planning [K21004000001-10A0500-00710]; Women Scientist Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT (Information and Communication Technologies), and Future Planning [2012R1A1A3005549]; Korean Ministry of Environment as "Climate Change Correspondence Program" [201400131010]	This study was supported by Global Research Lab (#K21004000001-10A0500-00710) and Women Scientist Research Program (#2012R1A1A3005549) through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT (Information and Communication Technologies), and Future Planning, and by the Korean Ministry of Environment as "Climate Change Correspondence Program" (#201400131010).	Woodruff TJ, 1997, ENVIRON HEALTH PERSP, V105, P608; Perez L, 2008, EPIDEMIOLOGY, V19, P800, DOI 10.1097/EDE.0b013e31818131cf; Peng RD, 2006, J ROY STAT SOC A STA, V169, P179, DOI 10.1111/j.1467-985X.2006.00410.x; Tsai SS, 2014, INT J ENV RES PUB HE, V11, P5081, DOI 10.3390/ijerph110505081; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Samoli E, 2014, ENVIRON INT, V67, P54, DOI [10.1016/j.envint.2014.02.013, 10.1016/j.envint2014.02.013]; Brunekreef B, 2002, LANCET, V360, P1233, DOI 10.1016/S0140-6736(02)11274-8; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Son JY, 2012, ENVIRON HEALTH PERSP, V120, P872, DOI 10.1289/ehp.1104316; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; POPE CA, 1991, AM REV RESPIR DIS, V144, P668; Sandstrom T, 2008, EPIDEMIOLOGY, V19, P808, DOI 10.1097/EDE.0b013e31818809e0; Asafu-Adjaye J, 2000, ENERG ECON, V22, P615, DOI 10.1016/S0140-9883(00)00050-5; Zanobetti A, 2000, ENVIRON HEALTH PERSP, V108, P841, DOI 10.2307/3434991; Dai LZ, 2014, ENVIRON HEALTH PERSP, V122, P837, DOI 10.1289/ehp.1307568; Zhou B, 2013, ATMOS ENVIRON, V75, P217, DOI 10.1016/j.atmosenv.2013.04.044; Armstrong BG, 1998, OCCUP ENVIRON MED, V55, P651; Medina-Ramon M, 2006, AM J EPIDEMIOL, V163, P579, DOI 10.1093/aje/kwj078; Lee JH, 2001, ATMOS ENVIRON, V35, P635, DOI 10.1016/S1352-2310(00)00378-2; Qiu H, 2012, ENVIRON HEALTH PERSP, V120, P572, DOI 10.1289/ehp.1104002; Yi O, 2010, ENVIRON RES, V110, P89, DOI 10.1016/j.envres.2009.09.009; Samoli E, 2013, ENVIRON HEALTH PERSP, V121, P932, DOI 10.1289/ehp.1206124; Kim HS, 2007, ATMOS ENVIRON, V41, P6762, DOI 10.1016/j.atmosenv.2007.04.060; Zanobetti A, 2003, ENVIRON HEALTH PERSP, V111, P1188, DOI 10.1289/ehp.5712; Chen RJ, 2011, SCI TOTAL ENVIRON, V409, P4934, DOI 10.1016/j.scitotenv.2011.08.058; Lei YC, 2004, ENVIRON RES, V95, P71, DOI 10.1016/S0013-9351(03)00136-1; Chan CK, 2008, ATMOS ENVIRON, V42, P1, DOI 10.1016/j.atmosenv.2007.09.003; Kan HD, 2008, ENVIRON HEALTH PERSP, V116, P1183, DOI 10.1289/ehp.10851; Samet JM, 2000, NEW ENGL J MED, V343, P1742, DOI 10.1056/NEJM200012143432401; Lee H, 2013, ATMOS ENVIRON, V79, P510, DOI 10.1016/j.atmosenv.2013.06.046; Kan HD, 2007, ENVIRON INT, V33, P376, DOI 10.1016/j.envint.2006.12.001; Nawahda A, 2012, WATER AIR SOIL POLL, V223, P3445, DOI 10.1007/s11270-012-1123-7; Youngsin C, 2004, METEOROL ATMOS PHYS, V87, P143, DOI 10.1007/s00703-003-0067-2; Castillejos M, 2000, INHAL TOXICOL, V12, P61, DOI 10.1080/089583700196392; Lee H, 2014, ATMOS ENVIRON, V89, P309, DOI 10.1016/j.atmosenv.2014.02.048; Ostro B, 2006, ENVIRON HEALTH PERSP, V114, P29, DOI 10.1289/ehp.8335; Bell ML, 2004, JAMA-J AM MED ASSOC, V292, P2372, DOI 10.1001/jama.292.19.2372; Zanobetti A, 2009, ENVIRON HEALTH PERSP, V117, P898, DOI 10.1289/ehp.0800108; Katsouyanni K, 1997, BMJ-BRIT MED J, V314, P1658; Chen RJ, 2012, AM J EPIDEMIOL, V175, P1173, DOI 10.1093/aje/kwr425; Lee JT, 2007, ENVIRON RES, V105, P409, DOI 10.1016/j.envres.2007.06.004; Chen RJ, 2013, ENVIRON POLLUT, V182, P278, DOI 10.1016/j.envpol.2013.07.024; EPA US, 2012, NAAQS NAT AMB AIR QU; European-Comission EU, 2008, AIR QUAL STAND; Franklin M, 2007, J EXPO SCI ENV EPID, V17, P279, DOI 10.1038/sj.jes.7500530; Meister K., 2011, ENV HLTH PERSPECT, V120, P431; Ostro B.D., 1999, J EXPO ANAL ENV EPID, V10, P412; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132	48	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0269-7491	1873-6424		ENVIRON POLLUT	Environ. Pollut.	DEC	2015	207						43	51		10.1016/j.envpol.2015.08.036		9	Environmental Sciences	Environmental Sciences & Ecology	CY7VN	WOS:000366617500005		
J	Wang, L; Pang, J; Feng, ZZ; Zhu, JG; Kobayashi, K				Wang, Liang; Pang, Jing; Feng, Zhaozhong; Zhu, Jianguo; Kobayashi, Kazuhiko			Diurnal variation of apoplastic ascorbate in winter wheat leaves in relation to ozone detoxification	ENVIRONMENTAL POLLUTION			English	Article						Apoplast; Ascorbate; Detoxification; Ozone; Triticum aestivum L	AIR FIELD CONDITIONS; 2 POPLAR CLONES; LEAF APOPLAST; PROTECT VEGETATION; RISK-ASSESSMENT; ACID CONTENT; DIEL TREND; FLUX; EXPOSURE; PLANTS	Besides stomatal closure, biological detoxification is an important protection mechanism for plants against ozone (O-3). This study investigated the diurnal changes of ascorbate (a major detoxification agent) in the apoplast and leaf tissues of winter wheat grown under ambient air field conditions. Results showed the reduced ascorbate in the apoplast (ASC(apo)) exhibited a peak in late morning or midday, mismatching with either the maximum external O-3 concentrations in mid-afternoon or the maximum stomatal O-3 uptake between late morning and mid-afternoon. In contrast, the ASC in leaf tissues remained stable throughout the day. The investigations conducted in a Free-Air Concentration Elevation of O-3 system confirmed that the diurnal variations of the ASC(apo) were induced more by the daily variations of O-3 concentrations rather than the cumulative O-3 effects. In conclusion, the O-3-stress detoxification should be a dynamic variable rather than a fixed threshold as assumed in the stomatal flux-based O-3 dose metrics. (C) 2015 Elsevier Ltd. All rights reserved.	[Wang, Liang; Feng, Zhaozhong] Chinese Acad Sci, Res Ctr Ecoenvironm Sci, State Key Lab Urban & Reg Ecol, Beijing 100085, Peoples R China; [Pang, Jing] Hubei Univ, Acad Resource & Environm, Wuhan 430064, Peoples R China; [Feng, Zhaozhong; Kobayashi, Kazuhiko] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Zhu, Jianguo] Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing 210008, Peoples R China	Feng, ZZ (reprint author), Chinese Acad Sci, Res Ctr Ecoenvironm Sci, State Key Lab Urban & Reg Ecol, Shuangqing Rd 18, Beijing 100085, Peoples R China.	fzz@rcees.ac.cn			Hundred Talents Program, Chinese Academy of Sciences; Japan Society for the Promotion of Science [P09120]; International S & T Cooperation Program of China [2009DFA31110]	This study has been funded by the Hundred Talents Program, Chinese Academy of Sciences, Fellowship of Japan Society for the Promotion of Science (P09120), The International S & T Cooperation Program of China (2009DFA31110). We are grateful to Prof. G. Liu and Dr. H. Y. Tang for their technical support in the free-air ozone release system.	Castagna A, 2015, ENVIRON SCI POLLUT R, V22, P2064, DOI 10.1007/s11356-014-3481-8; Mills G, 2011, ATMOS ENVIRON, V45, P5064, DOI 10.1016/j.atmosenv.2011.06.009; Kollist H, 2001, PHYSIOL PLANTARUM, V113, P377, DOI 10.1034/j.1399-3054.2001.1130311.x; Wilkinson S, 2012, J EXP BOT, V63, P527, DOI 10.1093/jxb/err317; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Plochl M, 2000, PLANTA, V210, P454, DOI 10.1007/PL00008153; Avnery S, 2011, ATMOS ENVIRON, V45, P2284, DOI 10.1016/j.atmosenv.2010.11.045; Burkey KO, 2003, PHYSIOL PLANTARUM, V117, P51, DOI 10.1034/j.1399-3054.2003.1170106.x; Dizengremel P, 2008, ENVIRON POLLUT, V156, P11, DOI 10.1016/j.envpol.2007.12.024; de la Torre D, 2008, THESCIENTIFICWORLDJO, V8, P1197, DOI 10.1100/tsw.2008.149; Kollist H, 2000, J PLANT PHYSIOL, V156, P645; Massman WJ, 2000, ATMOS ENVIRON, V34, P745, DOI 10.1016/S1352-2310(99)00395-7; Langebartels C, 2002, PLANT PHYSIOL BIOCH, V40, P567, DOI 10.1016/S0981-9428(02)01416-X; Castagna A, 2009, ENVIRON POLLUT, V157, P1461, DOI 10.1016/j.envpol.2008.09.029; Turcsanyi E, 2000, J EXP BOT, V51, P901, DOI 10.1093/jexbot/51.346.901; Tang HY, 2011, ATMOS ENVIRON, V45, P6276, DOI 10.1016/j.atmosenv.2011.08.059; D'Haese D, 2005, PLANT CELL ENVIRON, V28, P623, DOI 10.1111/j.1365-3040.2005.01308.x; CHAMEIDES WL, 1989, ENVIRON SCI TECHNOL, V23, P595, DOI 10.1021/es00063a013; Feng ZZ, 2014, ENVIRON POLLUT, V193, P296, DOI 10.1016/j.envpol.2014.06.004; Grantz DA, 2013, J EXP BOT, V64, P1703, DOI 10.1093/jxb/ert032; Frei M, 2010, J EXP BOT, V61, P1405, DOI 10.1093/jxb/erq007; Heath RL, 2008, ENVIRON POLLUT, V155, P453, DOI 10.1016/j.envpol.2008.03.010; Di Baccio D, 2008, TREE PHYSIOL, V28, P1761; Musselman RC, 2006, ATMOS ENVIRON, V40, P1869, DOI 10.1016/j.atmosenv.2005.10.064; Grantz DA, 2014, ATMOS ENVIRON, V98, P571, DOI 10.1016/j.atmosenv.2014.08.068; Zheng YB, 2000, PLANT PHYSIOL BIOCH, V38, P403, DOI 10.1016/S0981-9428(00)00755-5; Fares S, 2010, J EXP BOT, V61, P629, DOI 10.1093/jxb/erp336; LUWE M, 1995, PLANTA, V197, P448; Feng ZZ, 2010, ENVIRON POLLUT, V158, P3539, DOI 10.1016/j.envpol.2010.08.019; Booker FL, 2012, PLANT CELL ENVIRON, V35, P1456, DOI 10.1111/j.1365-3040.2012.02502.x; Schraudner M, 1997, PHYSIOL PLANTARUM, V100, P274, DOI 10.1034/j.1399-3054.1997.1000208.x; Heath RL, 2009, ATMOS ENVIRON, V43, P2919, DOI 10.1016/j.atmosenv.2009.03.011; Burkey KO, 2006, ENVIRON POLLUT, V143, P427, DOI 10.1016/j.envpol.2005.12.009; Feng ZZ, 2011, GLOBAL CHANGE BIOL, V17, P580, DOI 10.1111/j.1365-2486.2010.02184.x; Massman WJ, 2004, ATMOS ENVIRON, V38, P2323, DOI 10.1016/j.atmosenv.2003.09.079; Zhu XK, 2011, GLOBAL CHANGE BIOL, V17, P2697, DOI 10.1111/j.1365-2486.2011.02400.x; Tuzet A, 2011, AGR FOREST METEOROL, V151, P480, DOI 10.1016/j.agrformet.2010.12.004; Feng ZZ, 2012, ENVIRON POLLUT, V164, P16, DOI 10.1016/j.envpol.2012.01.014; Pignocchi C, 2003, CURR OPIN PLANT BIOL, V6, P379, DOI 10.1016/S1369-5266(03)00069-4; Feng ZZ, 2009, ATMOS ENVIRON, V43, P1510, DOI 10.1016/j.atmosenv.2008.11.033; Tang HY, 2013, GLOBAL CHANGE BIOL, V19, P2739, DOI 10.1111/gcb.12252; Wang JL, 2014, PLANT PHYSIOL BIOCH, V82, P183, DOI 10.1016/j.plaphy.2014.06.004; Buker P, 2007, ENVIRON POLLUT, V146, P726, DOI 10.1016/j.envpol.2006.04.007; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; Booker F, 2009, J INTEGR PLANT BIOL, V51, P337, DOI 10.1111/j.1744-7909.2008.00805.x; Horemans N, 2000, TRENDS PLANT SCI, V5, P263, DOI 10.1016/S1360-1385(00)01649-6; Calvete-Sogo H, 2014, ATMOS ENVIRON, V95, P197, DOI 10.1016/j.atmosenv.2014.05.073; Lyons T., 1999, ENV POLLUTION PLANT, P183	48	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0269-7491	1873-6424		ENVIRON POLLUT	Environ. Pollut.	DEC	2015	207						413	419		10.1016/j.envpol.2015.09.040		7	Environmental Sciences	Environmental Sciences & Ecology	CY7VN	WOS:000366617500047		
J	Erren, TC; Gross, JV; Steffany, F; Meyer-Rochow, VB				Erren, Thomas C.; Gross, J. Valerie; Steffany, Frank; Meyer-Rochow, V. Benno			"Plastic ocean": What about cancer?	ENVIRONMENTAL POLLUTION			English	Letter						Plastic; Synthetic polymer; Styrene; Vinyl chloride; Bisphenol A; IARC; Toxicology; Cancer; Public health; Fetal exposure; Neonatal exposure	BISPHENOL-A; WILDLIFE CANCER; POLLUTION		[Erren, Thomas C.; Gross, J. Valerie] Univ Cologne, Inst & Policlin Occupat Med Environm Med & Preven, Uniklin Koln, D-50931 Cologne, Germany; [Steffany, Frank] Univ Cologne, Inst Geophys & Meteorol, D-50923 Cologne, Germany; [Meyer-Rochow, V. Benno] Res Inst Luminous Organisms, Tokyo, Japan	Erren, TC (reprint author), Univ Cologne, Inst & Policlin Occupat Med Environm Med & Preven, Uniklin Koln, D-50931 Cologne, Germany.	thomas.erren@ndcn.ox.ac.uk					Thompson RC, 2004, SCIENCE, V304, P838, DOI 10.1126/science.1094559; Law KL, 2014, SCIENCE, V345, P144, DOI 10.1126/science.1254065; Jambeck JR, 2015, SCIENCE, V347, P768, DOI 10.1126/science.1260352; van Franeker JA, 2015, ENVIRON POLLUT, V203, P89, DOI 10.1016/j.envpol.2015.02.034; Glausiusz J, 2014, NATURE, V508, P306, DOI 10.1038/508306a; Maffini MV, 2006, MOL CELL ENDOCRINOL, V254, P179, DOI 10.1016/j.mce.2006.04.033; Weinhouse C, 2014, ENVIRON HEALTH PERSP, V122, P485, DOI 10.1289/ehp.1307449; OPPENHEIMER BS, 1953, SCIENCE, V118, P305, DOI 10.1126/science.118.3063.305; Acevedo N, 2013, ENVIRON HEALTH PERSP, V121, P1040, DOI 10.1289/ehp.1306734; Kwon BG, 2014, ENVIRON POLLUT, V188, P45, DOI 10.1016/j.envpol.2014.01.019; Lusher AL, 2015, ENVIRON POLLUT, V199, P185, DOI 10.1016/j.envpol.2015.01.023; Seltenrich N, 2015, ENVIRON HEALTH PERSP, V123, pA34, DOI 10.1289/ehp.123-A34; McAloose D, 2009, NAT REV CANCER, V9, P517, DOI 10.1038/nrc2665; Erren T, 2009, NAT REV CANCER, V9, DOI 10.1038/nrc2665-c1; Erren TC, 2014, REPROD TOXICOL, V50, P180, DOI 10.1016/j.reprotox.2014.07.079; IARC, 2002, SOM TRAD HERB MED, V82; IARC, 2012, CHEM AG REL OCC F, V100F	17	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0269-7491	1873-6424		ENVIRON POLLUT	Environ. Pollut.	DEC	2015	207						436	437		10.1016/j.envpol.2015.05.025		2	Environmental Sciences	Environmental Sciences & Ecology	CY7VN	WOS:000366617500053		
J	Song, K; Suenaga, T; Harper, WF; Hori, T; Riya, S; Hosomi, M; Terada, A				Song, Kang; Suenaga, Toshikazu; Harper, Willie F., Jr.; Hori, Tomoyuki; Riya, Shohei; Hosomi, Masaaki; Terada, Akihiko			Effects of aeration and internal recycle flow on nitrous oxide emissions from a modified Ludzak-Ettinger process fed with glycerol	ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH			English	Article						Nitrous oxide; Modified Ludzak-Ettinger processes; Glycerol; Aeration rate; Internal recycle flow ratio; Microbial community structure; N2O-reducing bacteria	WASTE-WATER TREATMENT; AMMONIA-OXIDIZING BACTERIA; N2O EMISSION; ACTIVATED-SLUDGE; RHODOBACTER-CAPSULATUS; MICROBIAL COMMUNITY; TREATMENT SYSTEM; REMOVAL SYSTEMS; CARBON SOURCE; DENITRIFICATION	Nitrous oxide (N2O) is emitted from a modified Ludzak-Ettinger (MLE) process, as a primary activated sludge system, which requires mitigation. The effects of aeration rates and internal recycle flow (IRF) ratios on N2O emission were investigated in an MLE process fed with glycerol. Reducing the aeration rate from 1.5 to 0.5 L/min increased gaseous the N2O concentration from the aerobic tank and the dissolved N2O concentration in the anoxic tank by 54.4 and 53.4 %, respectively. During the period of higher aeration, the N2O-N conversion ratio was 0.9 % and the potential N2O reducers were predominantly Rhodobacter, which accounted for 21.8 % of the total population. Increasing the IRF ratio from 3.6 to 7.2 decreased the N2O emission rate from the aerobic tank and the dissolved N2O concentration in the anoxic tank by 56 and 48 %, respectively. This study suggests effective N2O mitigation strategies for MLE systems.	[Song, Kang; Suenaga, Toshikazu; Riya, Shohei; Hosomi, Masaaki; Terada, Akihiko] Tokyo Univ Agr & Technol, Dept Chem Engn, Koganei, Tokyo 1848588, Japan; [Song, Kang] Japan Soc Promot Sci, Chiyoda Ku, Tokyo 1020083, Japan; [Harper, Willie F., Jr.] Air Force Inst Technol, Dept Syst Engn & Management, Dayton, OH 45433 USA; [Hori, Tomoyuki] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058568, Japan	Terada, A (reprint author), Tokyo Univ Agr & Technol, Dept Chem Engn, 2-24-16 Naka, Koganei, Tokyo 1848588, Japan.	akte@cc.tuat.ac.jp			New Energy and Industrial Technology Development Organization [11B13001d]; Kurita Water and Environment Foundation [13B188]; Japan Society for the Promotion of Science (JSPS) [268245];  [26630420]	This work was financially supported by the New Energy and Industrial Technology Development Organization (11B13001d), a Grant-in-Aid for Exploratory Research (26630420), Kurita Water and Environment Foundation (13B188), and a Grant-in-Aid for Scientific Research (No. 268245) from the Japan Society for the Promotion of Science (JSPS). The authors thank Ms. Kanako Mori (Tokyo University of Agriculture and Technology), Dr. Ronald R. Navarro, and Ms. Tomo Aoyagi for technical support with molecular analyses. The views expressed in this article are those of the authors and do not reflect the official policy or position of the Air Force Institute of Technology, United States Air Force, Department of Defense, or United States government.	Hu Z, 2010, J BIOSCI BIOENG, V109, P487, DOI 10.1016/j.jbiosc.2009.11.001; RICHARDSON DJ, 1991, EUR J BIOCHEM, V199, P677, DOI 10.1111/j.1432-1033.1991.tb16170.x; Bodik I, 2009, BIORESOURCE TECHNOL, V100, P2452, DOI 10.1016/j.biortech.2008.11.050; Noda N, 2003, WATER SCI TECHNOL, V48, P363; Leyva-Diaz JC, 2015, CHEM ENG J, V259, P692, DOI 10.1016/j.cej.2014.07.136; Louzeiro NR, 2002, WATER RES, V36, P2721, DOI 10.1016/S0043-1354(01)00494-8; Park H, 2010, ENVIRON SCI TECHNOL, V44, P6110, DOI 10.1021/es1002956; Jimenez J, 2011, WATER ENVIRON RES, V83, P26, DOI 10.2175/106143010X12609736967008; Wu GX, 2014, WATER-SUI, V6, P2978, DOI 10.3390/w6102978; Haselkorn R, 2001, PHOTOSYNTH RES, V70, P43, DOI 10.1023/A:1013883807771; Liu BB, 2013, ENVIRON MICROBIOL, V15, P2816, DOI 10.1111/1462-2920.12142; Lu HJ, 2014, WATER RES, V64, P237, DOI [10.1016/j.watres.2014.06.042, 10.1016/j.waters.2014.06.42]; Masih AMM, 2010, ENERG POLICY, V38, P1372, DOI 10.1016/j.enpol.2009.11.018; Tumendelger A, 2014, RAPID COMMUN MASS SP, V28, P1883, DOI 10.1002/rcm.6973; Kampschreur MJ, 2009, WATER RES, V43, P4093, DOI 10.1016/j.watres.2009.03.001; Lu HJ, 2011, ENVIRON MICROBIOL, V13, P2930, DOI 10.1111/j.1462-2920.2011.02568.x; Liang ZH, 2010, WATER RES, V44, P5432, DOI 10.1016/j.watres.2010.06.060; Chourey K, 2013, PROTEOMICS, V13, P2921, DOI 10.1002/pmic.201300155; Jones CM, 2013, ISME J, V7, P417, DOI 10.1038/ismej.2012.125; Park SM, 2004, WATER SCI TECHNOL, V49, P373; Pan M, 2014, BIOCHEM ENG J, V86, P62, DOI 10.1016/j.bej.2014.03.003; Wang XJ, 2014, J BIOSCI BIOENG, V117, P298, DOI 10.1016/j.jbiosc.2013.08.009; Poutiainen H, 2010, ENVIRON TECHNOL, V31, P617, DOI 10.1080/09593331003592246; Nishizawa T, 2014, BIOL FERT SOILS, V50, P1001, DOI 10.1007/s00374-014-0918-7; SMITH MPW, 1982, J APPL BACTERIOL, V53, P117, DOI 10.1111/j.1365-2672.1982.tb04741.x; Foley J, 2010, WATER RES, V44, P831, DOI 10.1016/j.watres.2009.10.033; Law YY, 2012, PHILOS T R SOC B, V367, P1265, DOI 10.1098/rstb.2011.0317; Henry S, 2006, APPL ENVIRON MICROB, V72, P5181, DOI 10.1128/AEM.00231-06; Jia WL, 2012, BIORESOURCE TECHNOL, V113, P232, DOI 10.1016/j.biortech.2011.10.095; Colliver BB, 2000, BIOTECHNOL ADV, V18, P219, DOI 10.1016/S0734-9750(00)00035-5; Igarashi N, 1997, NAT STRUCT BIOL, V4, P276, DOI 10.1038/nsb0497-276; Chandran K, 2011, BIOCHEM SOC T, V39, P1832, DOI 10.1042/BST20110717; Wang C, 2013, ENVIRON SCI TECHNOL, V47, P7341, DOI 10.1021/es305293h; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533; Terada A, 2013, BIOCHEM ENG J, V79, P153, DOI 10.1016/j.bej.2013.07.012; Desloover J, 2012, CURR OPIN BIOTECH, V23, P474, DOI 10.1016/j.copbio.2011.12.030; Adouani N, 2010, RESOUR CONSERV RECY, V54, P299, DOI 10.1016/j.resconrec.2009.07.011; APHA, 1992, STANDARD METHODS EXA; Cua LS, 2014, FRONT MICROBIOL, V5, P1; Hori T., 2014, J WATER ENV TECHNOL, V12, P357, DOI [10.2965/jwet.2014.357, DOI 10.2965/JWET.2014.357]; Kampschreur M. J., 2007, ENVIRON SCI TECHNOL, V42, P429; Metcalf E, 2003, WASTEWATER ENG TREAT; Schulthess R. V., 1995, Water Research, V29, P215, DOI 10.1016/0043-1354(94)E0108-I; Solomon S, 2007, CONTRIBUTION WORKING; Song K, 2014, J BIOSCI BIOENG, V118, P289, DOI 10.1016/j.jbiosc.2014.02.028	45	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0944-1344	1614-7499		ENVIRON SCI POLLUT R	Environ. Sci. Pollut. Res.	DEC	2015	22	24					19562	19570		10.1007/s11356-015-5129-8		9	Environmental Sciences	Environmental Sciences & Ecology	CY8CX	WOS:000366637300025		
J	Duong, HT; Kadokami, K; Chau, HTC; Nguyen, TQ; Nguyen, TT; Kong, LX				Hanh Thi Duong; Kadokami, Kiwao; Hong Thi Cam Chau; Trung Quang Nguyen; Thao Thanh Nguyen; Kong, Lingxiao			Groundwater screening for 940 organic micro-pollutants in Hanoi and Ho Chi Minh City, Vietnam	ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH			English	Article						GC-MS; Organic micro-pollutants; Comprehensive analysis; Groundwater; Occurrence	WASTE-WATER CONTAMINANTS; CHROMATOGRAPHY-MASS-SPECTROMETRY; PERSONAL CARE PRODUCTS; COMPREHENSIVE ANALYTICAL METHOD; SOLID-PHASE EXTRACTION; DRINKING-WATER; NATIONAL RECONNAISSANCE; ORGANOCHLORINE PESTICIDES; AUTOMATED IDENTIFICATION; DATABASE SYSTEM	Groundwater is the main source of drinking water for more than half of the residents of Hanoi (HN). It also provides about one third of the total water demand for residents of Ho Chi Minh City (HCM). However, due to rapid urbanization and frequent discharges of untreated urban wastewater to surface water, freshwater is widely contaminated by man-made chemicals, which may result in groundwater pollution. As part of an ongoing campaign to collect baseline information on the occurrence of organic micro-pollutants (OMPs) in the aquatic environment in Vietnam, 43 water samples were collected from 26 groundwater wells in HN (22) and HCM (4) in September 2013 and August 2014. Samples were analyzed by gas chromatography-mass spectrometry (GC-MS) and the resulting chromatograms were screened for 940 OMPs by an automated identification and quantification system (AIQS) within a GC-MS database. A total of 74 compounds were detected, with between 4 and 43 (median 18) compounds found at each site. Overall, contamination levels were low, with over 89 % of the detected concentrations that were less than 0.5 mu g L-1. Results suggest that most of the sampled aquifers have been impacted by non-point source pollution. Most of the contaminants detected are either currently not regulated in drinking water or are present at low levels. A health risk assessment for detected contaminants implied that there were no risks to humans. Since this study was based on a limited number of samples, especially in HCM, further, more detailed studies on the occurrence of OMPs in groundwater in HCM and a full risk assessment of detected contaminants should be prioritized.	[Hanh Thi Duong; Kadokami, Kiwao; Hong Thi Cam Chau; Kong, Lingxiao] Univ Kitakyushu, Grad Sch Environm Engn, Kitakyushu, Fukuoka 8080135, Japan; [Trung Quang Nguyen; Thao Thanh Nguyen] Vietnam Acad Sci & Technol, Inst Environm Technol, Hanoi, Vietnam	Kadokami, K (reprint author), Univ Kitakyushu, Grad Sch Environm Engn, I-1 Hibikino, Kitakyushu, Fukuoka 8080135, Japan.	dthanh.iet@gmail.com; kadokami@kitakyu-u.ac.jp; chauhong0914@gmail.com; nqt79@yahoo.com; thao7980@gmail.com; lingxiao.kong@gmail.com			Japanese Society for the Promotion of Science (JSPS) [12308030]; Vietnamese Academy of Science and Technology (VAST) [VAST.HTQT.NHAT.01/2012-2014]; Kitakyushu City, Japan	This study was supported by a bilateral joint research project between the Japanese Society for the Promotion of Science (JSPS, project no. 12308030) and the Vietnamese Academy of Science and Technology (VAST, project code VAST.HTQT.NHAT.01/2012-2014), and a research grant from Kitakyushu City, Japan. The authors also wish to thank the researchers in the Department of Environmental Toxicology Analysis, IET, VAST for their assistance in sample collection and analysis. We thank our laboratory members for their enthusiastic support of this work.	Hoai PM, 2010, ENVIRON POLLUT, V158, P913, DOI 10.1016/j.envpol.2009.09.018; Sanchez-Avila J, 2009, SCI TOTAL ENVIRON, V407, P4157, DOI 10.1016/j.scitotenv.2009.03.016; Kadokami K, 2012, ANAL SCI, V28, P1183; Drewes JE, 2009, GROUND WATER, V47, P502, DOI 10.1111/j.1745-6584.2009.00587_5.x; Kolpin DW, 2002, ENVIRON SCI TECHNOL, V36, P1202, DOI 10.1021/es011055j; Schaider LA, 2014, SCI TOTAL ENVIRON, V468, P384, DOI 10.1016/j.scitotenv.2013.08.067; Kim I, 2014, BIODEGRADATION, V25, P383, DOI 10.1007/s10532-013-9667-9; Lopez-Roldan P, 2004, ANAL BIOANAL CHEM, V378, P599, DOI 10.1007/s00216-003-2187-4; Kuch HM, 2001, ENVIRON SCI TECHNOL, V35, P3201, DOI 10.1021/es010034m; Jobling S, 1996, ENVIRON TOXICOL CHEM, V15, P194, DOI 10.1897/1551-5028(1996)015<0194:IOTGIR>2.3.CO;2; Duong HT, 2014, CHEMOSPHERE, V107, P462, DOI 10.1016/j.chemosphere.2014.01.064; Kishida M, 2007, J HEALTH SCI, V53, P291, DOI 10.1248/jhs.53.291; Berg M, 2001, ENVIRON SCI TECHNOL, V35, P2621, DOI 10.1021/es010027y; Belfroid AC, 1998, SCI TOTAL ENVIRON, V222, P167, DOI 10.1016/S0048-9697(98)00298-8; Boxall ABA, 2004, REV ENVIRON CONTAM T, V180, P1, DOI 10.1007/0-387-21729-0_1; Buschmann J, 2008, ENVIRON INT, V34, P756, DOI 10.1016/j.envint.2007.12.025; Cerejeira MJ, 2003, WATER RES, V37, P1055, DOI 10.1016/S0043-1354(01)00462-6; Jin XL, 2004, J ENVIRON SCI-CHINA, V16, P825; Swartz CH, 2006, ENVIRON SCI TECHNOL, V40, P4894, DOI 10.1021/es052595+; Minh NH, 2007, ARCH ENVIRON CON TOX, V52, P458, DOI 10.1007/s00244-006-0157-5; Seiler RL, 1999, GROUND WATER, V37, P405, DOI 10.1111/j.1745-6584.1999.tb01118.x; Vulliet E, 2008, J CHROMATOGR A, V1210, P84, DOI 10.1016/j.chroma.2008.09.034; Shukla G, 2006, ENVIRON INT, V32, P244, DOI 10.1016/j.envint.2005.08.027; Carrara C, 2008, ENVIRON SCI TECHNOL, V42, P2805, DOI 10.1021/es070344q; Jinya D, 2013, ANAL SCI, V29, P483; Akingbemi BT, 2004, P NATL ACAD SCI USA, V101, P775, DOI 10.1073/pnas.0305977101; Kummerer K, 2009, J ENVIRON MANAGE, V90, P2354, DOI 10.1016/j.jenvman.2009.01.023; Nhan DD, 2001, ENVIRON POLLUT, V112, P311, DOI 10.1016/S0269-7491(00)00149-4; Lapworth DJ, 2012, ENVIRON POLLUT, V163, P287, DOI 10.1016/j.envpol.2011.12.034; Meesters RJW, 2002, ANAL CHEM, V74, P3566, DOI 10.1021/ac011258q; SHAROM MS, 1981, J AGR FOOD CHEM, V29, P1122, DOI 10.1021/jf00108a005; Ellis JB, 2006, ENVIRON POLLUT, V144, P184, DOI 10.1016/j.envpol.2005.12.018; Nakada N, 2008, ENVIRON SCI TECHNOL, V42, P6347, DOI 10.1021/es7030856; Kadokami K, 2005, J CHROMATOGR A, V1089, P219, DOI 10.1016/j.chroma.2005.06.052; Buerge IJ, 2011, ENVIRON SCI TECHNOL, V45, P615, DOI 10.1021/es1031272; Fox CB, 2009, MOLECULES, V14, P3286, DOI 10.3390/molecules14093286; Stuart ME, 2014, SCI TOTAL ENVIRON, V468, P564, DOI 10.1016/j.scitotenv.2013.08.042; Focazio MJ, 2008, SCI TOTAL ENVIRON, V402, P201, DOI 10.1016/j.scitotenv.2008.02.021; Loos R, 2010, WATER RES, V44, P4115, DOI 10.1016/j.watres.2010.05.032; JABBAR A, 1993, B ENVIRON CONTAM TOX, V51, P268; Ying GG, 2003, WATER RES, V37, P3785, DOI 10.1016/S0043-1354(03)00261-6; Barnes KK, 2008, SCI TOTAL ENVIRON, V402, P192, DOI 10.1016/j.scitotenv.2008.04.028; Nhan DD, 1998, MAR POLLUT BULL, V36, P742, DOI 10.1016/S0025-326X(98)00025-3; Jurado A, 2012, SCI TOTAL ENVIRON, V440, P82, DOI 10.1016/j.scitotenv.2012.08.029; Daughton CG, 1999, ENVIRON HEALTH PERSP, V107, P907, DOI 10.2307/3434573; Duong HT, 2014, SE ASIAN WATER ENV, V5, P195; He J, 2011, PESTICIDES FORMULATI; IGES, 2007, SUST GROUNDW MAN AS; Jamal H. M., 2011, Agriculture and Biology Journal of North America, V2, P488, DOI 10.5251/abjna.2011.2.3.488.492; Lari SZ, 2014, J ENVIRON HEALTH SCI, V12, DOI 10.1186/2052-336X-12-11; Minnesota Department of Health - MDH, 2013, MDH DER HLTH RISK LI; Nga NV, 2006, 5 RES M SUST WAT MAN; Sankararamakrishnan N., 2005, INDIA ENV INT, V31, P113, DOI DOI 10.1016/J.ENVINT.2004.08.001; Stephenson J, 2009, GAO10292T; Takizawa S, 2008, GROUNDWATER MANAGEME, P61; United Nations Children's Fund-UNICEF, 2001, REP INV RES ARS GROU, P22; Vazquez-Sune E., 2010, HYDROL EARTH SYST SC, V7, P2543; World Bank, 1996, 15041VN FAO UNDP NGO, P151	58	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0944-1344	1614-7499		ENVIRON SCI POLLUT R	Environ. Sci. Pollut. Res.	DEC	2015	22	24					19835	19847		10.1007/s11356-015-5180-5		13	Environmental Sciences	Environmental Sciences & Ecology	CY8CX	WOS:000366637300050		
J	Gerber, R; Smit, NJ; van Vuren, JHJ; Nakayama, SMM; Yohannes, YB; Ikenaka, Y; Ishizuka, M; Wepener, V				Gerber, Ruan; Smit, Nico J.; van Vuren, Johan H. J.; Nakayama, Shouta M. M.; Yohannes, Yared B.; Ikenaka, Yoshinori; Ishizuka, Mayumi; Wepener, Victor			Application of a Sediment Quality Index for the assessment and monitoring of metals and organochlorines in a premier conservation area	ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH			English	Article						Multivariate analysis; Sediment quality; DDT; Lindane; Kruger National Park; Spatial distribution; Temporal variation	ECOLOGICAL RISK-ASSESSMENT; SOUTH-AFRICA; OLIFANTS RIVER; HEAVY-METALS; CLARIAS-GARIEPINUS; WATER; BIOACCUMULATION; COPPER; INDIA; ZINC	The physical and chemical characteristics of surface sediments from a leading conservation area, namely the Kruger National Park, were determined in order to identify potential stressors in the systems that may contribute to overall deterioration in sediment quality within the reserve, leading to potential threats to the aquatic biota conserved within these stretches of river. Sediment samples were collected during four surveys (two low flow and two high flow) from 2009 to 2011. Samples were analysed for organic content, grain size determination, metals and various organochlorine pesticides. Results indicated that the Olifants River sediments did not show any great improvement over the years and point towards the continued input of pollutants into this system. Sediment quality in the Luvuvhu and Letaba Rivers is better than that of sediments from the Olifants River in terms of metals, but metal concentrations are still comparable and point towards anthropogenic inputs of metals into these rivers. Even though the data indicate that these systems are being contaminated with both metals and organochlorine pesticides (OCPs), levels were still below contaminated sediments from around the globe. Sediment Quality Index scores showed that the sediment quality of these rivers is in a relatively good state. High metal concentrations were the drivers behind lowered sediment quality, and in some cases certain OCPs played a role. Both metals and OCP concentrations were highly correlated with finer grain sizes. Sediment assessments are not routinely applied in South Africa resulting in very little reference or background data available for the area. The metal concentrations for the study area were generally lower than those for other studies in more polluted regions. The study also contributes to the available knowledge on surrounding metal pollution in riverine sediments in South Africa.	[Gerber, Ruan; van Vuren, Johan H. J.] Univ Johannesburg, Dept Zool, ZA-2006 Auckland Pk, South Africa; [Smit, Nico J.; Wepener, Victor] North West Univ, Unit Environm Sci & Management, Potchefstroom, South Africa; [Nakayama, Shouta M. M.; Yohannes, Yared B.; Ikenaka, Yoshinori; Ishizuka, Mayumi] Hokkaido Univ, Grad Sch Vet Med, Dept Environm Vet Sci, Lab Toxicol,Kita Ku, Sapporo, Hokkaido 0600818, Japan	Gerber, R (reprint author), Univ Johannesburg, Dept Zool, Kingsway Campus,Box 524, ZA-2006 Auckland Pk, South Africa.	gerberrjl@gmail.com			Water Research Commission (WRC) of South Africa [K5-1922]; National Research Foundation (NRF); Ministry of Education, Culture, Sports, Science, and Technology of Japan [24248056, 26304043, 15H02825]; foundation of JSPS Core to Core Program; Bilateral Joint Research Project	The authors wish to thank the Zoology Department and Spectrum at the University of Johannesburg for the use of laboratories and equipment. The authors would like to thank the Water Research Commission (WRC) of South Africa (Project K5-1922, N.J. Smit, PI) for the financial support of this study. Views expressed are those of the authors and not those of the WRC. The authors also wish to thank SANParks for logistical support during the study and Dr. Wynand Malherbe, North-West University, for generating the study site map. The financial assistance of the National Research Foundation (NRF) towards this research is hereby acknowledged. Opinions expressed and conclusions arrived at are those of the authors and are not necessarily to be attributed to the NRF. This study was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan awarded to M. Ishizuka (No. 24248056) and Y. Ikenaka (Nos. 26304043 and 15H02825) as well as a foundation of JSPS Core to Core Program (AA Science Platforms) and Bilateral Joint Research Project.	Agency for Toxic Substances and Disease Registry - ATSDR, 2012, TOX PROF CADM; Agency for Toxic Substances and Disease Registry (ATSDR), 2013, TOX PROF HEX; Agency for Toxic Substances and Disease Registry (ATSDR), 2005, TOX PROF ALPH BET GA; Agency for Toxic Substances and Disease Registry (ATSDR), 2004, TOX PROF COPP; Agency for Toxic Substances and Disease Registry (ATSDR), 2008, TOX PROF AL; Agency for Toxic Substances and Disease Registry (ATSDR), 1994, TOX PROF CHLORD; Agency for Toxic Substances and Disease Registry (ATSDR), 2007, TOX PROF ARS; Agency for Toxic Substances and Disease Registry (ATSDR), 2012, TOX PROF CHROM; Agency for Toxic Substances and Disease Registry (ATSDR), 2004, TOX PROF COB; Angliss M, 2001, 16501 TT WRC; Chale FMM, 2002, SCI TOTAL ENVIRON, V299, P115, DOI 10.1016/S0048-9697(02)00252-8; SAKAI H, 1986, WATER RES, V20, P559, DOI 10.1016/0043-1354(86)90019-9; Kwon YT, 2001, MICROCHEM J, V70, P255, DOI 10.1016/S0026-265X(01)00122-9; Rath P, 2009, J HAZARD MATER, V163, P632, DOI 10.1016/j.jhazmat.2008.07.048; Coetzee L, 2002, WATER SA, V28, P433; Bouwman H, 2003, HANDB ENVIRON CHEM, V3, P297; Sibali LL, 2008, WATER SA, V34, P611; Alexander BW, 2008, GEOCHIM COSMOCHIM AC, V72, P378, DOI 10.1016/j.gca.2007.10.028; Amiard JC, 2007, ESTUAR COAST SHELF S, V72, P511, DOI 10.1016/j.ecss.2006.11.017; Wepener V, 2000, WATER SA, V26, P97; Ansara-Ross TM, 2012, AFR J AQUAT SCI, V37, P1, DOI 10.2989/16085914.2012.666336; MATHIS BJ, 1973, J WATER POLLUT CON F, V45, P1573; Jain CK, 2004, WATER RES, V38, P569, DOI 10.1016/j.watres.2003.10.042; Mabaso MLH, 2004, TROP MED INT HEALTH, V9, P846, DOI 10.1111/j.1365-3156.2004.01263.x; SEYMORE T, 1995, WATER SA, V21, P159; Filgueiras AV, 2004, SCI TOTAL ENVIRON, V330, P115, DOI 10.1016/j.scitotenv.2004.03.038; Malik A, 2007, B ENVIRON CONTAM TOX, V78, P335, DOI 10.1007/s00128-007-9188-5; Yohannes YB, 2013, ENVIRON SCI POLLUT R, V20, P8663, DOI 10.1007/s11356-013-1821-8; Kotze P, 1999, WATER SA, V25, P99; MARTIN JM, 1979, MAR CHEM, V7, P173, DOI 10.1016/0304-4203(79)90039-2; Naude Y, 1998, WATER SA, V24, P205; Van Dyk JC, 2010, SCI TOTAL ENVIRON, V408, P2745, DOI 10.1016/j.scitotenv.2010.03.002; Avenant-Oldewage Annemarie, 2000, Koedoe, V43, P17; Canadian Council of Ministers of the Environment (CCME), 2007, SOIL QUAL IND CALC; Canadian Council of Ministers of the Environment (CCME), 2002, CAN ENV QUAL GUID; Cyrus DP, 2000, 722199 WRC; Gerber R, 2015, AFR J AQUAT IN PRESS; Griscom HR, 2008, GEOJOURNAL, V75, P163; Kidd KA, 1998, WATER QUALITY UNPUB; Marx H. M., 1998, Koedoe, V41, P27; Quinn L, 2010, J ENVIRON MONITOR, V11, P1647; Seymore Tharina, 1994, Koedoe, V37, P1; SUBRAMANIAN V, 1985, CHEM GEOL, V48, P271, DOI 10.1016/0009-2541(85)90052-X; Ter Braak CJ, 2004, CANOCO WINDOWS VERSI; USEPA (United States Environmental Protection Agency), 2001, 823B01002 USEPA OFF; Van den Brink Paul J., 2003, Australasian Journal of Ecotoxicology, V9, P141; Wenning RJ, 2002, SETAC PELLST WORKSH; Wepener V., 1999, Koedoe, V42, P85; Wepener V, 2005, WATER SA, V34, P589	49	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0944-1344	1614-7499		ENVIRON SCI POLLUT R	Environ. Sci. Pollut. Res.	DEC	2015	22	24					19971	19989		10.1007/s11356-015-5206-z		19	Environmental Sciences	Environmental Sciences & Ecology	CY8CX	WOS:000366637300064		
J	Subramaniam, J; Murugan, K; Panneerselvam, C; Kovendan, K; Madhiyazhagan, P; Kumar, PM; Dinesh, D; Chandramohan, B; Suresh, U; Nicoletti, M; Higuchi, A; Hwang, JS; Kumar, S; Alarfaj, AA; Munusamy, MA; Messing, RH; Benelli, G				Subramaniam, Jayapal; Murugan, Kadarkarai; Panneerselvam, Chellasamy; Kovendan, Kalimuthu; Madhiyazhagan, Pari; Kumar, Palanisamy Mahesh; Dinesh, Devakumar; Chandramohan, Balamurugan; Suresh, Udaiyan; Nicoletti, Marcello; Higuchi, Akon; Hwang, Jiang-Shiou; Kumar, Suresh; Alarfaj, Abdullah A.; Munusamy, Murugan A.; Messing, Russell H.; Benelli, Giovanni			Eco-friendly control of malaria and arbovirus vectors using the mosquitofish Gambusia affinis and ultra-low dosages of Mimusops elengi-synthesized silver nanoparticles: towards an integrative approach?	ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH			English	Article						Aedes aegypti; Anopheles stephensi; Biological control; Dengue; Green-synthesis; Malaria; Nanobiotechnology; EDX; FTIR; TEM-EDX; XRD	QUINQUEFASCIATUS DIPTERA-CULICIDAE; FERONIA-ELEPHANTUM RUTACEAE; ANOPHELES-STEPHENSI; AEDES-AEGYPTI; CULEX-QUINQUEFASCIATUS; GREEN SYNTHESIS; LEAF EXTRACT; PREDATION EFFICIENCY; DENGUE VECTOR; ANTIBACTERIAL ACTIVITY	Mosquito-borne diseases represent a deadly threat for millions of people worldwide. However, the use of synthetic insecticides to control Culicidae may lead to high operational costs and adverse non-target effects. Plant-borne compounds have been proposed for rapid extracellular synthesis of mosquitocidal nanoparticles. Their impact against biological control agents of mosquito larval populations has been poorly studied. We synthesized silver nanoparticles (AgNP) using the aqueous leaf extract of Mimusops elengi as a reducing and stabilizing agent. The formation of AgNP was studied using different biophysical methods, including UV-vis spectrophotometry, TEM, XRD, EDX and FTIR. Low doses of AgNP showed larvicidal and pupicidal toxicity against the malaria vector Anopheles stephensi and the arbovirus vector Aedes albopictus. AgNP LC50 against A. stephensi ranged from 12.53 (I instar larvae) to 23.55 ppm (pupae); LC50 against A. albopictus ranged from 11.72 ppm (I) to 21.46 ppm (pupae). In the field, the application of M. elengi extract and AgNP (10 x LC50) led to 100 % larval reduction after 72 h. In adulticidal experiments, AgNP showed LC50 of 13.7 ppm for A. stephensi and 14.7 ppm for A. albopictus. The predation efficiency of Gambusia affinis against A. stephensi and A. albopictus III instar larvae was 86.2 and 81.7 %, respectively. In AgNP-contaminated environments, predation was 93.7 and 88.6 %, respectively. This research demonstrates that M. elengi-synthesized AgNP may be employed at ultra-low doses to reduce larval populations of malaria and arbovirus vectors, without detrimental effects on predation rates of mosquito natural enemies, such as larvivorous fishes.	[Subramaniam, Jayapal; Murugan, Kadarkarai; Panneerselvam, Chellasamy; Kovendan, Kalimuthu; Madhiyazhagan, Pari; Kumar, Palanisamy Mahesh; Dinesh, Devakumar; Chandramohan, Balamurugan; Suresh, Udaiyan] Bharathiar Univ, Sch Life Sci, Dept Zool, Div Entomol, Coimbatore 641046, Tamil Nadu, India; [Nicoletti, Marcello] Univ Roma La Sapienza, Dept Environm Biol, I-00185 Rome, Italy; [Higuchi, Akon] Natl Res Inst Child Hlth & Dev, Dept Reprod, Tokyo 1578535, Japan; [Hwang, Jiang-Shiou] Natl Taiwan Ocean Univ, Inst Marine Biol, Keelung 20224, Taiwan; [Kumar, Suresh] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Med Microbiol & Parasitol, Serdang 43400, Malaysia; [Alarfaj, Abdullah A.; Munusamy, Murugan A.] King Saud Univ, Coll Sci, Dept Bot & Microbiol, Riyadh 11451, Saudi Arabia; [Messing, Russell H.] Univ Hawaii Manoa, Kauai Agr Res Ctr, Kapaa, HI 96746 USA; [Benelli, Giovanni] Univ Pisa, Dept Agr Food & Environm, I-56124 Pisa, Italy	Benelli, G (reprint author), Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.	g.benelli@sssup.it			USDA National Institute of Food and Agriculture, Hatch [9023R]; University Grant Commission, New Delhi, India; King Saud University, Deanship of Scientific Research, and College of Sciences Research Center	Philippe Garrigues and three anonymous reviewers improved an earlier version of the manuscript. Russell H. Messing was supported by the USDA National Institute of Food and Agriculture, Hatch project 9023R. Jayapal Subramaniam is grateful to the University Grant Commission, New Delhi, India (UGC-BSR-RFSMS-Research Fellowship in Science for Meritorious Students) for providing financial support. This study was supported by King Saud University, Deanship of Scientific Research, and College of Sciences Research Center. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ahmad A, 2003, COLLOID SURFACE B, V28, P313, DOI 10.1016/S0927-7765(02)00174-1; Ali A.M.A., 2008, RES J AGR BIOL SCI, V4, P871; American Public Health Association, 2005, STANDARD METHODS EXA; Amerasan D, 2012, PARASITOL RES, V111, P1953, DOI 10.1007/s00436-012-3042-3; Arjunan NK, 2012, VECTOR-BORNE ZOONOT, V12, P262, DOI 10.1089/vbz.2011.0661; Patil CD, 2012, PARASITOL RES, V111, P555, DOI 10.1007/s00436-012-2867-0; Bar H, 2009, COLLOID SURFACE A, V339, P134, DOI 10.1016/j.colsurfa.2009.02.008; Subramaniam J, 2012, SAUDI J BIOL SCI, V19, P503, DOI 10.1016/j.sjbs.2012.07.003; Benelli G, 2015, PARASITOL RES, V114, P3201, DOI 10.1007/s00436-015-4656-z; Purnima A, 2010, INDIAN J PHARM SCI, V72, P480, DOI 10.4103/0250-474X.73908; Veerakumar K, 2014, PARASITOL RES, V113, P1775, DOI 10.1007/s00436-014-3823-y; Lees RS, 2014, ACTA TROP, V132, pS2, DOI 10.1016/j.actatropica.2013.11.005; Murugan K, 2015, EXP PARASITOL, V153, P129, DOI 10.1016/j.exppara.2015.03.017; Jensen M, 2009, PARASITOL RES, V105, P609, DOI 10.1007/s00436-009-1524-8; Panneerselvam C, 2013, PARASITOL RES, V112, P679, DOI 10.1007/s00436-012-3185-2; Rawani A, 2013, ACTA TROP, V128, P613, DOI 10.1016/j.actatropica.2013.09.007; Nicoletti M, 2012, PARASITOL RES, V111, P205, DOI 10.1007/s00436-012-2819-8; Baliga MS, 2011, FOOD RES INT, V44, P1823, DOI 10.1016/j.foodres.2011.01.063; Mukherjee P, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/7/075103; Jayapal Subramaniam, 2012, Journal of Biopesticides, V5, P163; Dinesh D, 2015, PARASITOL RES, V114, P1519, DOI 10.1007/s00436-015-4336-z; Griffin LF, 2012, WETL ECOL MANAG, V20, P243, DOI 10.1007/s11273-012-9248-4; Murugan K, 2012, PARASITOL RES, V111, P1757, DOI 10.1007/s00436-012-3021-8; Murugan K, 2015, PARASITOL RES, V114, P3657, DOI 10.1007/s00436-015-4593-x; Rajan R, 2015, IND CROP PROD, V70, P356, DOI 10.1016/j.indcrop.2015.03.015; Ruikar AD, 2012, J VECTOR DIS, V49, P111; Muthukumaran U, 2015, PARASITOL RES, V114, P1817, DOI 10.1007/s00436-015-4368-4; Mehlhorn H, 2012, PARASITOL RES, V110, P259, DOI 10.1007/s00436-011-2480-7; Murugan K, 2015, ENVIRON SCI POLLUT R, V22, P17053, DOI 10.1007/s11356-015-4920-x; Murugan K, 2015, PARASITOL RES, V114, P2243, DOI 10.1007/s00436-015-4417-z; Rao JV, 2010, Z NATURFORSCH C, V65, P303; Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371; Arokiyaraj S, 2015, ENVIRON SCI POLLUT R, V22, P9759, DOI 10.1007/s11356-015-4148-9; Magudapathy P, 2001, PHYSICA B, V299, P142, DOI 10.1016/S0921-4526(00)00580-9; Gratz NS, 1996, J AM MOSQUITO CONTR, V12, P160; Kamareddine L, 2012, TOXINS, V4, P748, DOI 10.3390/toxins4090748; Chandra G, 2008, INDIAN J MED RES, V127, P13; Santhoshkumar Thirunavukkarasu, 2011, Parasitol Res, V108, P693, DOI 10.1007/s00436-010-2115-4; Gong P, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/28/285604; Ohba SY, 2010, J MED ENTOMOL, V47, P783, DOI 10.1603/ME10051; Prakash P, 2013, COLLOID SURFACE B, V108, P255, DOI 10.1016/j.colsurfb.2013.03.017; Dubey M, 2009, DIG J NANOMATER BIOS, V4, P537; Pavela R, 2015, IND CROP PROD, V76, P174, DOI 10.1016/j.indcrop.2015.06.050; Sakthivadivel M, 2008, APPL ENTOMOL ZOOL, V43, P57, DOI 10.1303/aez.2008.57; Suresh U, 2015, PARASITOL RES, V114, P1551, DOI 10.1007/s00436-015-4339-9; Benelli G, 2015, PARASITOL RES, V114, P2801, DOI 10.1007/s00436-015-4586-9; Roni M, 2013, PARASITOL RES, V112, P981, DOI 10.1007/s00436-012-3220-3; Murugan K, 2015, PARASITOL RES, V114, P3601, DOI 10.1007/s00436-015-4582-0; Veerakumar K, 2014, PARASITOL RES, V113, P4085, DOI 10.1007/s00436-014-4077-4; Conti B, 2013, PARASITOL RES, V112, P991, DOI 10.1007/s00436-012-3221-2; Salunkhe RB, 2011, PARASITOL RES, V109, P823, DOI 10.1007/s00436-011-2328-1; Marimuthu S, 2011, PARASITOL RES, V108, P1541, DOI 10.1007/s00436-010-2212-4; Krishnan R, 2006, FOOD CHEM, V94, P331, DOI 10.1016/j.foodchem.2004.11.039; Veerakumar K, 2014, PARASITOL RES, V113, P2363, DOI 10.1007/s00436-014-3895-8; Amerasan D., 2015, Journal of Entomological and Acarological Research, V47, P31, DOI 10.4081/jear.2015.1986; Rupp HR, 1996, J AM MOSQUITO CONTR, V12, P155; Panneerselvam C, 2013, ASIAN PAC J TROP MED, V6, P102, DOI 10.1016/S1995-7645(13)60003-6; Fayaz AM, 2010, NANOMED-NANOTECHNOL, V6, P103, DOI 10.1016/j.nano.2009.04.006; Louca V, 2009, J MED ENTOMOL, V46, P546, DOI 10.1603/033.046.0320; Asmathunisha N, 2010, COLLOID SURFACE B, V79, P488; Benelli G, 2015, PARASITOL RES, V114, P391, DOI 10.1007/s00436-014-4286-x; Benelli G, 2015, PARASITOLOGY RES MON; Benelli G, 2015, PARASITOL RES, V114, P1011, DOI 10.1007/s00436-014-4267-0; Benelli G, 2015, PARASITOL RES, V114, P227, DOI 10.1007/s00436-014-4183-3; Chobu M, 2015, ACTA TROP, V142, P131, DOI 10.1016/j.actatropica.2014.11.012; DAS M K, 1991, Indian Journal of Malariology, V28, P171; Finney DJ, 1971, PROBIT ANAL, P68, DOI DOI 10.1007/BF02431962; Gadamsetty G., 2013, INT J PHARM PHARM SC, V5, P126; Ganu G. P., 2010, Research Journal of Pharmaceutical Biological and Chemical Sciences, V1, P67; Gayatri G., 2011, RES J PHARM BIOL CHE, V2, P405; Gerberich JB, 1985, INTEGRATED MOSQUITO, V2, P47; Goodsell DS, 2004, BIONANOTECHNOLOGY LE; JAHAN N, 1995, J NAT PRODUCTS, V58, P1244, DOI 10.1021/np50122a014; Kweka EJ, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-128; Mitra R., 1981, INDIAN J HIST SCI, V12, P169; Murugan K., 1996, Journal of Entomological Research (New Delhi), V20, P137; Murugan K, 2003, ANN MED ENTOMOL, V12, P11; Murugan K, 2015, PARASITOL RES; Naresh Kumar A, 2012, J ENTOMOL ACAROL RES, V44, P79; Noginov MA, 2006, APPL PHYS B, V86, P458; Payal J.S., 2003, J ETHNOPHARMACOL, V89, P305; Priyadarshini A, 2012, PARASITOL RES, V111, P997; Ramesh Kumar K, 2014, J NANOMED NANOTECHNO, V5, P1; Roni M, 2015, ECOTOX ENVIRON SAFE, V121, P31, DOI 10.1016/j.ecoenv.2015.07.005; Sathyavathi R., 2010, ADV SCI LETT, V3, P1; Schwarz D, 2000, WATER CLARIFICATION, P1; Sivapriyajothi S, 2014, J ENTOMOL ACAROL RES, V46, P1787; Tietze N. S., 1994, Journal of the Florida Mosquito Control Association, V65, P37; Voyadjoglou A, 2007, PREDATION ORGANISMS, P123, DOI DOI 10.1007/978-3-540-46046-6-7; Walton WE, 2007, AMCA B, P186; WHO, 1981, WHOVBC81807; WHO, 2012, HDB INT VECT MAN; YAP H H, 1985, Southeast Asian Journal of Tropical Medicine and Public Health, V16, P163	93	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0944-1344	1614-7499		ENVIRON SCI POLLUT R	Environ. Sci. Pollut. Res.	DEC	2015	22	24					20067	20083		10.1007/s11356-015-5253-5		17	Environmental Sciences	Environmental Sciences & Ecology	CY8CX	WOS:000366637300073		
J	Horiuchi, Y; Yamamoto, H; Ogura, R; Shimoda, N; Sato, H; Kato, K				Horiuchi, Yuki; Yamamoto, Hiroki; Ogura, Reina; Shimoda, Naomi; Sato, Hitoshi; Kato, Kiyoaki			Genetic analysis and molecular mapping of genes controlling seed coat colour in adzuki bean (Vigna angularis)	EUPHYTICA			English	Article						Adzuki bean; Seed quality; Seed coat colour; Natural variation; Molecular map	ANTIOXIDATIVE PROPERTIES; AZUKI-BEANS; PROANTHOCYANIDINS; PROCYANIDIN-B-1; DOMESTICATION; ANTHOCYANINS; LEGUMES; TRAITS	Seed coat colour is an important agronomic trait in adzuki bean (Vigna angularis). Here, we identified four genes controlling seed coat colour in this species. We conducted a quantitative trait locus (QTL) study of 133 recombinant inbred lines (F-6) derived from a cross between V. angularis Shumari (red) and landrace Acc2265 (olive buff), by using simple sequence repeat (SSR) markers. We identified a strong QTL, designated OLB1, which explained 54, 43, and 56 % of the total variance in the L* (lightness), a* (redness), and b* (yellowness) values, respectively. In addition, we identified a minor QTL, designated OLB2, which explained 6 % of the total variance in redness. OLB1 and OLB2 were located on linkage group (LG) 1, >80 cM apart. The F-1 phenotype was olive buff, implying that the red colour trait was recessive. Next, we crossed two spontaneous mutants, 'Shiro-shouzu' (ivory yellow) and 'TA230002' (pale olive buff), to the red-seeded 'Beni-shouzu'. Genetic analysis of the F-1, F-2, and F-3 progenies derived from each parental cross revealed that the ivory yellow and pale olive buff traits were recessive to the red trait. Molecular mapping studies indicated that the ivory yellow trait was controlled by a single Mendelian gene, designated IVY, located on LG 8. The pale olive buff trait was also controlled by a single Mendelian gene, designated POB, located on LG 10. Our findings will facilitate the development of novel red seed cultivars and the introgression of ivory yellow genes into desirable cultivars, via marker-assisted selection.	[Horiuchi, Yuki; Sato, Hitoshi] Hokkaido Res Org, Agr Res Dept, Tokachi Agr Expt Stn, Memuro, Hokkaido 0820081, Japan; [Yamamoto, Hiroki; Shimoda, Naomi; Kato, Kiyoaki] Obihiro Univ Agr & Vet Med, Dept Agroenvironm Sci, Obihiro, Hokkaido 0808555, Japan; [Ogura, Reina] Hokkaido Res Org, Cent Agr Expt Stn, Agr Res Dept, Naganuma, Hokkaido 0691395, Japan	Kato, K (reprint author), Obihiro Univ Agr & Vet Med, Dept Agroenvironm Sci, Obihiro, Hokkaido 0808555, Japan.	kiyoaki@obihiro.ac.jp			Japan Beans Fund Association; Obihiro University of Agriculture and Veterinary Medicine [10089]	This study was funded by the Japan Beans Fund Association and the Obihiro University of Agriculture and Veterinary Medicine (10089).	Sato S, 2005, J NUTR BIOCHEM, V16, P547, DOI 10.1016/j.jnutbio.2005.02.003; Suzuki T, 2012, BREEDING SCI, V62, P11, DOI 10.1270/jsbbs.62.11; Takahama U, 2013, FOOD CHEM, V141, P282, DOI 10.1016/j.foodchem.2013.02.113; PARIDA A, 1990, GENETICA, V82, P125, DOI 10.1007/BF00124642; Yoshida K, 1996, BIOSCI BIOTECH BIOCH, V60, P589; Isemura T, 2007, ANN BOT-LONDON, V100, P1053, DOI 10.1093/aob/mcm155; Yamada T, 2001, PLANT CELL TISS ORG, V64, P47, DOI 10.1023/A:1010635832468; Buckow R, 2010, J AGR FOOD CHEM, V58, P10076, DOI 10.1021/jf1015347; Kaga A, 2008, GENETICS, V178, P1013, DOI 10.1534/genetics.107.078451; Han OK, 2005, THEOR APPL GENET, V111, P1278, DOI 10.1007/s00122-005-0046-8; Patras A, 2010, TRENDS FOOD SCI TECH, V21, P3, DOI 10.1016/j.tifs.2009.07.004; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; ARIGA T, 1988, AGR BIOL CHEM TOKYO, V52, P2717; ARIGA T, 1990, AGR BIOL CHEM TOKYO, V54, P2499; Lumpkin TA, 1994, AZUKI BEAN BOT PRODU; Sasanuma S, 1996, BOT MAG TOKYO, V79, P807; Takahashi Y, 1917, 7 HOKK AGR EXP STAT; Van Ooijen JW, 2009, MAPQTL 4 SOFTWARE MA; Vaughan DA, 2005, GENETIC RESOURCES CH, V1, P341	20	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0014-2336	1573-5060		EUPHYTICA	Euphytica	DEC	2015	206	3					609	617		10.1007/s10681-015-1461-9		9	Agronomy; Plant Sciences; Horticulture	Agriculture; Plant Sciences	CY8BK	WOS:000366633200005		
J	Tasaki, K; Nakatsuka, A; Cheon, KS; Kobayashi, N				Tasaki, Keisuke; Nakatsuka, Akira; Cheon, Kyeong-Seong; Kobayashi, Nobuo			Inheritance of the narrow leaf mutation in traditional Japanese evergreen azaleas	EUPHYTICA			English	Article						Rhododendron; Cultivar; Choripetalous corolla; Recessive; Single gene mutation	RHODODENDRON-SIMSII-PLANCH; MAPLE-WILLOW MUTANT; GLORY IPOMOEA-NIL; MORNING GLORY; PETALED CULTIVARS; WILD-TYPE; FLOWERS; LEAVES	Morphological mutations have been admired and preserved in the classical cultivars of the Japanese evergreen azalea since the Edo era (1603-1867). One such mutation is the presence of narrow leaves and petals. In this study, we investigated the characteristics and inheritance patterns of the narrow leaf-type mutational form of Rhododendron macrosepalum 'Seigaiha', R. kaempferi 'Kin-kujyaku', and R. kiusianum Yanagi-ba mutant. The leaves of all cultivars showed weak development in the transverse plane and thickened margins. Subsequently, based on this qualitative character, the inheritance of the narrow leaf mutation was investigated. F1 seedlings of cross combinations between normal and narrow leaf-type plants had normal leaf-type. All F1 progenies of cross combinations between narrow leaf-type plants had narrow leaves like their parents. In addition, seedlings obtained from backcross and sib-cross tests using narrow leaf mutants segregated into normal and narrow leaf-types at a 1:1 and 3:1 ratio, respectively. These results indicate that the narrow leaf trait of three different azalea cultivars, 'Seigaiha', 'Kin-kujyaku', and R. kiusianum Yanagi-ba mutant, is probably a recessive mutation caused by a single, common gene.	[Tasaki, Keisuke] Shimane Univ, Dept Mol & Funct Genom, Ctr Integrated Res Sci, Matsue, Shimane 6908504, Japan; [Nakatsuka, Akira; Cheon, Kyeong-Seong; Kobayashi, Nobuo] Shimane Univ, Fac Life & Environm Sci, Matsue, Shimane 6908504, Japan	Kobayashi, N (reprint author), Shimane Univ, Fac Life & Environm Sci, Matsue, Shimane 6908504, Japan.	nkobayashi@life.shimane-u.ac.jp			KAKENHI from Japan Society for the Promotion of Science (JSPS) [23241076, 26292017]	This study was supported by Grant-in-Aid for Scientific Research (KAKENHI Nos. 23241076 and 26292017) from Japan Society for the Promotion of Science (JSPS).	Kobayashi N, 2013, ACTA HORTIC, V990, P213; HEURSEL J, 1977, Z PFLANZENZUCHT, V79, P238; Tasaki K, 2012, J JPN SOC HORTIC SCI, V81, P72; HEURSEL J, 1989, PLANT BREEDING, V103, P304, DOI 10.1111/j.1439-0523.1989.tb00390.x; Tasaki K, 2014, J JPN SOC HORTIC SCI, V83, P52, DOI 10.2503/jjshs1.CH-030; Michishita A, 2003, J FAC AGR KYUSHU U, V47, P283; De Riek J, 1999, THEOR APPL GENET, V99, P1155, DOI 10.1007/s001220051320; Kurashige Yuji, 2008, Horticultural Research (Japan), V7, P323, DOI 10.2503/hrj.7.323; Kajita Y, 2009, J JPN SOC HORTIC SCI, V78, P369, DOI 10.2503/jjshs1.78.369; Imai Y, 1925, J GENET, V16, P77, DOI 10.1007/BF02983989; Kobayashi N, 2010, ACTA HORTIC, V855, P165; Tasaki K, 2012, SCI HORTIC-AMSTERDAM, V134, P191, DOI 10.1016/j.scienta.2011.11.013; HEURSEL J, 1975, Z PFLANZENZUCHT, V74, P62; Kajita Y, 2009, J JPN SOC HORTIC SCI, V78, P469, DOI 10.2503/jjshs1.78.469; Galle FC, 1987, AZALEA REVISED ENLAR, P37; Heursel J, 1976, GARTENWELT, V76, P111; IMAI YOSHITAKA, 1930, GENETICA, V12, P297, DOI 10.1007/BF01508094; Ito I, 1984, BROCADE PILLOW AZALE; Kunishige M, 1980, CONTRIBUTIONS CLASSI, P277; Wilson EH, 1921, PUBLICATIONS ARNOLD, V9; Yamazaki T, 1993, FLORA JAPAN A, V3a, P16; Yamazaki T, 1996, REVISION GENUS RHODO	22	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0014-2336	1573-5060		EUPHYTICA	Euphytica	DEC	2015	206	3					649	656		10.1007/s10681-015-1479-z		8	Agronomy; Plant Sciences; Horticulture	Agriculture; Plant Sciences	CY8BK	WOS:000366633200008		
J	Lu, SJ; Li, Y; Wang, JL; Srinives, P; Nan, HY; Cao, D; Wang, YP; Li, JL; Li, XM; Fang, C; Shi, XY; Yuan, XH; Watanabe, S; Feng, XZ; Liu, BH; Abe, J; Kong, FJ				Lu, Sijia; Li, Ying; Wang, Jialin; Srinives, Peerasak; Nan, Haiyang; Cao, Dong; Wang, Yanping; Li, Jinliang; Li, Xiaoming; Fang, Chao; Shi, Xinyi; Yuan, Xiaohui; Watanabe, Satoshi; Feng, Xianzhong; Liu, Baohui; Abe, Jun; Kong, Fanjiang			QTL mapping for flowering time in different latitude in soybean	EUPHYTICA			English	Article						Additive effect; Epistatic effect; Flowering time; Long juvenile trait (LJ); Quantitative trait loci (QTLs)	GENETIC-LINKAGE MAP; QUANTITATIVE TRAIT LOCUS; LONG JUVENILE PERIOD; SEED QUALITY TRAITS; GLYCINE-MAX; PHOTOPERIOD INSENSITIVITY; LIGHT QUALITY; GROWTH HABIT; MATURITY; RESPONSES	Flowering represents the transition from the vegetative to reproductive phase and plays an important role in many agronomic traits. For soybean, a short day (SD) induced and photoperiod-sensitive plant, delaying flowering time under SD environments is very important and has been used by breeders to increase yields and enhance plant adaptabilities at lower latitudes. The purpose of this study was to identify quantitative trait loci (QTLs) associated with flowering time, especially QTLs underlying the long juvenile (LJ) trait which delays flowering time under SD environments. A population of 91 recombinant inbred lines derived from a cross between AGS292 and K3 was used for map construction and QTL analysis. The map covered 2546.7 cM and included 52 new promoter-specific indel and 9 new exon-specific indel markers. The phenotypic days-to-flowering data were examined in nine environments, including four short-day (SD, low latitude) and five long-day photoperiod (LD, high latitude) environments. For the SD environments, six QTLs were detected. Five of them were associated with the LJ trait. Among the five LJ QTLs, four QTLs may be attributed to the known flowering time genes, including qFT-J-1 for FT5a locus, qFT-J-2 for the FT2a locus, qFT-O for the E2 locus and qFT-L for the E3 locus. This is the first report that the E2, E3, FT2a and FT5a loci may be associated with the LJ trait. Under the five LD environments, as expected, qFT-O for the E2 locus and qFT-L for the E3 locus were identified, suggesting that E2 and E3 loci are very important for soybean adaptation in LD photoperiod. Conjoint analysis of multiple environments identified nine additive QTLs and nine pairs of epistatic QTLs, among which most were involved in interactions with the environments. In total, five QTLs (qFT-B2-1, qFT-C1-1, qFT-K, qFT-D2 and qFT-F) were identified that may represent novel flowering time genes. This provides a fundamental foundation for future studies of flowering time in soybean using fine mapping, map-based cloning, and molecular-assisted breeding.	[Lu, Sijia; Wang, Jialin; Nan, Haiyang; Cao, Dong; Li, Xiaoming; Fang, Chao; Shi, Xinyi; Yuan, Xiaohui; Feng, Xianzhong; Liu, Baohui; Kong, Fanjiang] Chinese Acad Sci, Northeast Inst Geog & Agroecol, Key Lab Soybean Mol Design Breeding, Harbin 150081, Peoples R China; [Lu, Sijia; Li, Xiaoming; Fang, Chao; Shi, Xinyi] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Li, Ying] Northeast Forestry Univ, State Key Lab Tree Genet & Breeding, Harbin 150040, Peoples R China; [Srinives, Peerasak] Kasetsart Univ, Ctr Agr Biotechnol, Nakhon Pathom 73140, Thailand; [Wang, Yanping] Heilongjiang Acad Agr Sci, Mudanjiang Branch, Mudanjiang 157041, Peoples R China; [Li, Jinliang] Heilongjiang Acad Agr Sci, Heihe Branch, Heihe 164399, Peoples R China; [Watanabe, Satoshi] Saga Univ, Fac Agr, Saga, Saga 8408502, Japan; [Abe, Jun] Hokkaido Univ, Res Fac Agr, Kita Ku, Sapporo, Hokkaido 0608589, Japan	Liu, BH (reprint author), Chinese Acad Sci, Northeast Inst Geog & Agroecol, Key Lab Soybean Mol Design Breeding, 138 Haping Rd, Harbin 150081, Peoples R China.	winglee.sakuraco@gmail.com; wangjialin@iga.ac.cn; agrpss@ku.ac.th; haiyang_mei@163.com; caodong@iga.ac.cn; wyping1981@126.com; hhfyljl@163.com; fuzzy1314@163.com; cubechao@gmail.com; 15804631612@163.com; yuanxh@iga.ac.cn; nabemame@cc.saga-u.ac.jp; fengxianzhong@iga.ac.cn; liubh@iga.ac.cn; jabe@res.agr.hokudai.ac.ip; kongfj@iga.ac.cn			National Natural Science Foundation of China [31430065, 31071445, 31171579, 31201222, 31230050, 31371651, 31371643]; Open Foundation of the Key Laboratory of Soybean Molecular Design Breeding, Chinese Academy of Sciences; Chinese Academy of Sciences; Strategic Action Plan for Science and Technology Innovation of Chinese Academy of Sciences [XDA08030108]; Heilongjiang Natural Science Foundation of China [ZD201001, JC201313]	This work was funded by the National Natural Science Foundation of China (31430065, 31071445, 31171579, 31201222, 31230050, 31371651 and 31371643); the Open Foundation of the Key Laboratory of Soybean Molecular Design Breeding, Chinese Academy of Sciences; "Hundred Talents" Program of Chinese Academy of Sciences; Strategic Action Plan for Science and Technology Innovation of Chinese Academy of Sciences (XDA08030108); and Heilongjiang Natural Science Foundation of China (ZD201001, JC201313).	Jannink JL, 2007, GENETICS, V176, P553, DOI 10.1534/genetics.106.062992; Cairo CA, 2002, EUPHYTICA, V124, P387, DOI 10.1023/A:1015767623038; Takahashi R, 1999, CROP SCI, V39, P1657; Chapman A, 2003, EUPHYTICA, V129, P387, DOI 10.1023/A:1022282726117; Li HY, 2010, THEOR APPL GENET, V120, P1405, DOI 10.1007/s00122-010-1264-2; CHURCHILL GA, 1994, GENETICS, V138, P963; Song QJ, 2004, THEOR APPL GENET, V109, P122, DOI 10.1007/s00122-004-1602-3; SINCLAIR TR, 1992, CROP SCI, V32, P1242; Xu YF, 2014, THEOR APPL GENET, V127, P59, DOI 10.1007/s00122-013-2201-y; Wang DL, 1999, THEOR APPL GENET, V99, P1255, DOI 10.1007/s001220051331; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Cober ER, 1996, CROP SCI, V36, P606; Lee SH, 1996, THEOR APPL GENET, V92, P516, DOI 10.1007/BF00224553; Liu W, 2011, THEOR APPL GENET, V123, P545, DOI 10.1007/s00122-011-1606-8; Funatsuki H, 2005, THEOR APPL GENET, V111, P851, DOI 10.1007/s00122-005-0007-2; RAY JD, 1995, CROP SCI, V35, P1001; Reinprecht Y, 2006, GENOME, V49, P1510, DOI 10.1039/G06-112; Hyten DL, 2010, CROP SCI, V50, P960, DOI 10.2135/cropsci2009.06.0360; Liu B, 2008, GENETICS, V180, P995, DOI 10.1534/genetics.108.092742; Cregan PB, 1999, CROP SCI, V39, P1464; KEIM P, 1990, GENETICS, V126, P735; Cheng LR, 2011, THEOR APPL GENET, V123, P421, DOI 10.1007/s00122-011-1594-8; FEHR WR, 1971, CROP SCI, V11, P929; Cober ER, 2011, CROP SCI, V51, P140, DOI 10.2135/cropsci2010.05.0262; Watanabe S, 2011, GENETICS, V188, P395, DOI 10.1534/genetics.110.125062; Thakare D, 2011, PLANTA, V234, P933, DOI 10.1007/s00425-011-1450-8; Tasma IM, 2001, MOL BREEDING, V8, P25, DOI 10.1023/A:1011998116037; MCBLAIN BA, 1987, J HERED, V78, P160; Cober ER, 2001, CROP SCI, V41, P698; DOYLE JJ, 1990, EVOLUTION, V44, P371, DOI 10.2307/2409415; BUZZELL RI, 1971, CAN J GENET CYTOL, V13, P703; Bonato ER, 1999, GENET MOL BIOL, V22, P229, DOI 10.1590/S1415-47571999000200016; Watanabe S, 2004, BREEDING SCI, V54, P399, DOI 10.1270/jsbbs.54.399; Cober ER, 2010, THEOR APPL GENET, V120, P1005, DOI 10.1007/s00122-009-1228-6; BERNARD RL, 1971, CROP SCI, V11, P242; Ha BK, 2012, EUPHYTICA, V186, P933, DOI 10.1007/s10681-012-0719-8; Cober ER, 2001, CROP SCI, V41, P1823; Watanabe S, 2009, GENETICS, V182, P1251, DOI 10.1534/genetics.108.098772; HARTWIG EE, 1979, FIELD CROP RES, V2, P145, DOI 10.1016/0378-4290(79)90017-0; Yang J, 2008, BIOINFORMATICS, V24, P721, DOI 10.1093/bioinformatics/btm494; Liu B, 2007, ANN BOT-LONDON, V100, P1027, DOI 10.1093/aob/mcm149; PARVEZ AQ, 1987, CROP SCI, V27, P305; Liu BH, 2010, J HERED, V101, P251, DOI 10.1093/jhered/esp113; Khan NA, 2008, THEOR APPL GENET, V117, P479, DOI 10.1007/s00122-008-0792-5; Githiri SM, 2007, J HERED, V98, P360, DOI 10.1093/jhered/esm042; Kong FJ, 2010, PLANT PHYSIOL, V154, P1220, DOI 10.1104/pp.110.160796; Xia ZJ, 2012, P NATL ACAD SCI USA, V109, pE2155, DOI 10.1073/pnas.1117982109; Levy YY, 1998, PLANT CELL, V10, P1973; Buzzell R, 1980, SOYBEAN GENET NEWSL, V7, P26; Cairo CA, 2009, WORLD SOYB RES C 8 B; Carpentieri-Pipolo V, 2000, EUPHYTICA, V112, P203, DOI 10.1023/A:1003927817278; Carpentleri-Pipolo V, 2002, GENET MOL BIOL, V25, P463, DOI 10.1590/S1415-47572002000400016; Gutierrez-Gonzalez JJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-105; Gutierrez-Gonzalez JJ, 2009, THEOR APPL GENET, V119, P1069, DOI 10.1007/s00122-009-1109-z; Jiang BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106042; Kong FJ, 2014, CROP SCI, V54, P2529, DOI 10.2135/cropsci2014.03.0228; Nan HY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097669; Pooprompan P., 2006, Kasetsart Journal, Natural Sciences, V40, P573; SPEHAR CR, 1995, FIELD CROP RES, V41, P141, DOI 10.1016/0378-4290(95)00007-D; Tsubokura Y, 2013, AGRONOMY, V3, P117, DOI DOI 10.3390/AGRONOMY3010117; Van Ooijen J, 2004, MAPQTL 5 SOFTWARE MA; Xu ML, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-91	62	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0014-2336	1573-5060		EUPHYTICA	Euphytica	DEC	2015	206	3					725	736		10.1007/s10681-015-1501-5		12	Agronomy; Plant Sciences; Horticulture	Agriculture; Plant Sciences	CY8BK	WOS:000366633200015		
J	Minami, Y; Ong, DS; Uemura, S; Wang, Z; Aguirre, AD; Mukhopadhyay, S; Soeda, T; Vergallo, R; Jia, HB; Tian, JW; Hu, SN; Kim, SJ; Park, CB; Dauerman, HL; Lee, S; Jang, IK				Minami, Yoshiyasu; Ong, Daniel S.; Uemura, Shiro; Wang, Zhao; Aguirre, Aaron D.; Mukhopadhyay, Shankha; Soeda, Tsunenari; Vergallo, Rocco; Jia, Haibo; Tian, Jinwei; Hu, Sining; Kim, Soo Joong; Park, Chang-Bum; Dauerman, Harold L.; Lee, Stephen; Jang, Ik-Kyung			Impacts of lesion angle on incidence and distribution of acute vessel wall injuries and strut malapposition after drug-eluting stent implantation assessed by optical coherence tomography	EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING			English	Article						Optical coherence tomography; Drug-eluting stent; Post-stent complication	THROMBUS FORMATION; CLINICAL-OUTCOMES; NATURAL-HISTORY; TISSUE PROLAPSE; CORONARY STENT; SHEAR-STRESS; FOLLOW-UP; PREDICTORS; DISSECTION; GEOMETRY	Aims To investigate the impact of lesion angle on the incidence and distribution of acute vessel wall injuries and incomplete stent apposition (ISA) following second-generation drug-eluting stent (DES) implantation using optical coherence tomography (OCT). Several ex vivo studies demonstrated that angled arterial walls are exposed to imbalanced mechanical stress from deployed stents. Methods and results We included 243 lesions treated with a single DES (148 everolimus-eluting stent and 95 zotarolimus-eluting stent). Angled lesions were defined as lesions with angle >= 45 degrees onan angiogram(n = 58). The vessel wall injuries and ISA were evaluated by OCT. The results were compared with non-angled lesions (<45 degrees, n = 185). The incidence of instent dissection, thrombus, and ISA was significantly higher in the angled group than in the non-angled group (84.5 vs. 63.2%, P < 0.01; 55.2 vs. 35.1%, P < 0.01; 75.9 vs. 44.9%, P < 0.001, respectively). In the angled group, the normalized tissue protrusion volume around the centreofangle(6.59 +/- 6.81, mm(3) x 10(2)) washigher than in the distal sub-segment (2.21 +/- 2.87, mm(3) x 10(2), P < 0.001), in the proximal sub-segment (4.14 +/- 5.34, mm(3) x 10(2), P = 0.02), and in the non-angled group (3.30 +/- 2.81, mm(3) x 10(2), P < 0.001). The incidence of major adverse cardiac events within 12 months was similar between the groups. Conclusions Angled coronary lesions had a higher incidence rate of OCT-detected vessel wall injuries and ISA compared with non-angled lesions following second-generation DES implantation. Further studies are needed to understand the long-term clinical significance of these findings.	[Minami, Yoshiyasu; Ong, Daniel S.; Mukhopadhyay, Shankha; Soeda, Tsunenari; Vergallo, Rocco; Jia, Haibo; Tian, Jinwei; Hu, Sining; Jang, Ik-Kyung] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Cardiol, Boston, MA 02114 USA; [Uemura, Shiro] Nara Med Univ, Dept Med 1, Nara, Japan; [Wang, Zhao] MIT, Cambridge, MA 02139 USA; [Aguirre, Aaron D.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiol, Boston, MA 02114 USA; [Jia, Haibo; Tian, Jinwei; Hu, Sining] Harbin Med Univ, Affiliated Hosp 2, Dept Cardiol, Harbin, Peoples R China; [Kim, Soo Joong; Jang, Ik-Kyung] Kyung Hee Univ Hosp, Seoul, South Korea; [Park, Chang-Bum] Kyung Hee Univ Hosp Gangdong, Seoul, South Korea; [Dauerman, Harold L.] Univ Vermont, Burlington, VT USA; [Lee, Stephen] Queen Mary Hosp, Pok Fu Lam, Hong Kong, Peoples R China	Jang, IK (reprint author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Cardiol, GRB 800,55 Fruit St, Boston, MA 02114 USA.	ijang@mgh.harvard.edu			Italian Society of Cardiology Award for Research Abroad; National Natural Science Foundation of China [81200076, 81300201]; China Postdoctoral Science Foundation [2013M531074]; Heilongjiang Postdoctoral Science Foundation [LBH-Z12180]	R.V. was funded in part by the 2013 Italian Society of Cardiology Award for Research Abroad. H.J. received a grant from the National Natural Science Foundation of China (81200076). J.T. has received a grant from the National Natural Science Foundation of China (81300201), a grant from China Postdoctoral Science Foundation (2013M531074), and a grant from Heilongjiang Postdoctoral Science Foundation (LBH-Z12180).	Matsumoto D, 2007, EUR HEART J, V28, P961, DOI 10.1093/eurheartj/ehl413; Mortier P, 2011, EUROINTERVENTION, V7, P369, DOI 10.4244/EIJV7I3A62; Kawamori H, 2013, EUR HEART J-CARD IMG, V14, P865, DOI 10.1093/ehjci/jes299; Kubo T, 2008, JACC-CARDIOVASC IMAG, V1, P475, DOI 10.1016/j.jcmg.2008.03.012; Sugiyama T, 2014, INT J CARDIOL, V176, P182, DOI 10.1016/j.ijcard.2014.07.005; Chamie D, 2013, JACC-CARDIOVASC INTE, V6, P800, DOI 10.1016/j.jcin.2013.03.019; Gonzalo N, 2009, HEART, V95, P1913, DOI 10.1136/hrt.2009.172072; Ino Y, 2011, CIRC J, V75, P1878, DOI 10.1253/circj.CJ-10-1182; Takano M, 2006, EUR HEART J, V27, P1763, DOI 10.1093/eurheartj/ehi744; Torguson R, 2008, AM J CARDIOL, V102, P1624, DOI 10.1016/j.amjcard.2008.08.013; Hanna EB, 2010, CLIN CARDIOL, V33, P476, DOI 10.1002/clc.20819; Kuramitsu S, 2012, CIRC-CARDIOVASC INTE, V5, P663, DOI 10.1161/CIRCINTERVENTIONS.112.969238; Wentzel JJ, 2000, J BIOMECH, V33, P1287, DOI 10.1016/S0021-9290(00)00066-X; Gyongyosi M, 2000, J AM COLL CARDIOL, V35, P1580, DOI 10.1016/S0735-1097(00)00570-2; De Cock D, 2014, EUR HEART J-CARD IMG, V15, P800, DOI 10.1093/ehjci/jeu003; Bouma BE, 2003, HEART, V89, P317, DOI 10.1136/heart.89.3.317; Mortier P, 2010, ANN BIOMED ENG, V38, P88, DOI 10.1007/s10439-009-9836-5; Turco MA, 2011, EXPERT REV MED DEVIC, V8, P303, DOI [10.1586/erd.11.2, 10.1586/ERD.11.2]; Ino Y, 2009, CIRC J, V73, P2036; Kume T, 2012, CIRC J, V76, P698, DOI 10.1253/circj.CJ-11-0845; Wu W, 2007, J BIOMECH, V40, P2580, DOI 10.1016/j.jbiomech.2006.11.009; Chatzizisis YS, 2007, J AM COLL CARDIOL, V49, P2379, DOI 10.1016/j.jacc.2007.02.059; Im E, 2014, CIRC-CARDIOVASC INTE, V7, P88, DOI 10.1161/CIRCINTERVENTIONS.113.000797; Gomez-Lara J, 2011, AM HEART J, V162, P1069, DOI 10.1016/j.ahj.2011.09.010; Barlis P, 2010, INT J CARDIOL, V141, P151, DOI 10.1016/j.ijcard.2008.11.204; Furie B, 2008, NEW ENGL J MED, V359, P938, DOI 10.1056/NEJMra0801082; Gutierrez-Chico JL, 2012, CIRC-CARDIOVASC INTE, V5, P20, DOI 10.1161/CIRCINTERVENTIONS.111.965301; Kim JS, 2010, AM HEART J, V159, DOI 10.1016/j.ahj.2009.11.029; Tanigawa Jun, 2007, EuroIntervention, V3, P128	29	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	2047-2404	2047-2412		EUR HEART J-CARD IMG	Eur. Heart J.-Cardiovasc. Imaging	DEC	2015	16	12					1390	1398		10.1093/ehjci/jev108		9	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CY7KD	WOS:000366586300018		
J	Kato, K; Sakai, Y; Ishibashi, I; Kobayashi, Y				Kato, Ken; Sakai, Yoshiaki; Ishibashi, Iwao; Kobayashi, Yoshio			Transient focal left ventricular ballooning: a new variant of Takotsubo cardiomyopathy	EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING			English	Editorial Material									[Kato, Ken; Kobayashi, Yoshio] Chiba Univ, Grad Sch Med, Dept Cardiovasc Med, Chuo Ku, Chiba, Japan; [Sakai, Yoshiaki; Ishibashi, Iwao] Chiba Emergency Med Ctr, Dept Cardiol, Chiba, Japan	Kato, K (reprint author), Chiba Univ, Grad Sch Med, Dept Cardiovasc Med, Chuo Ku, 1-8-1 Inohana, Chiba, Japan.	kkatou0424@yahoo.co.jp						0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	2047-2404	2047-2412		EUR HEART J-CARD IMG	Eur. Heart J.-Cardiovasc. Imaging	DEC	2015	16	12					1406	1406		10.1093/ehjci/jev218		1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CY7KD	WOS:000366586300021		
J	Xu, SA; Onishi, N; Tsurusaki, A; Manaka, Y; Wang, WH; Muckerman, JT; Fujita, E; Himeda, Y				Xu, Shaoan; Onishi, Naoya; Tsurusaki, Akihiro; Manaka, Yuichi; Wang, Wan-Hui; Muckerman, James T.; Fujita, Etsuko; Himeda, Yuichiro			Efficient Cp*Ir Catalysts with Imidazoline Ligands for CO2 Hydrogenation	EUROPEAN JOURNAL OF INORGANIC CHEMISTRY			English	Article						Homogeneous catalysis; Iridium; CO2 hydrogenation	CARBON-DIOXIDE HYDROGENATION; RUTHENIUM PINCER COMPLEX; FORMIC-ACID; AQUEOUS-MEDIA; FORMATE; STORAGE; WATER; DEHYDROGENATION; BICARBONATE; GENERATION	We report newly developed iridium catalysts with electron-donating imidazoline moieties as ligands for the hydrogenation of CO2 to formate in aqueous solution. Interestingly, these new complexes promote CO2 hydrogenation much more effectively than their imidazole analogues and exhibit a turnover frequency (TOF) of 1290 h(-1) for the bisimidazoline complex compared to that of 20 h(-1) for the bisimidazole complex at 1 MPa and 50 degrees C. In addition, the hydrogenation proceeds smoothly even under atmospheric pressure at room temperature. The TOF of 43 h(-1) for the bisimidazoline complex is comparable to that of a dinuclear complex (70 h(-1), highest TOF reported) [Nat. Chem. 2012, 4, 383], which in-corporates proton-responsive ligands with pendent-OH groups in the second coordination sphere. The catalytic activity of the complex with an N-methylated imidazoline moiety is much the same as that of the corresponding pyridyl-imidazoline analogue. This result and the UV/Vis titrations of the imidazoline complexes indicate that the high activity is not attributable to the deprotonation of NH on the imidazoline under the reaction conditions.	[Xu, Shaoan; Onishi, Naoya; Tsurusaki, Akihiro; Manaka, Yuichi; Himeda, Yuichiro] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058565, Japan; [Xu, Shaoan; Onishi, Naoya; Himeda, Yuichiro] Japan Sci & Technol Agcy, ACT C, Kawaguchi, Saitama 3320012, Japan; [Wang, Wan-Hui] Dalian Univ Technol, Sch Petr & Chem Engn, Panjin 124221, Peoples R China; [Muckerman, James T.; Fujita, Etsuko] Brookhaven Natl Lab, Dept Chem, Upton, NY 11973 USA	Onishi, N (reprint author), Natl Inst Adv Ind Sci & Technol, Tsukuba Cent 5,1-1-1 Higashi, Tsukuba, Ibaraki 3058565, Japan.	n.onishi@aist.go.jp; himeda.y@aist.go.jp			Japan Science and Technology Agency (JST), ACT-C; Dalian University of Technology [Fundamental Research Funds for the Central Universities] [DUT14RC(3)082, 844401]; National Natural Science Foundation of China [21402019]; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-SC00112704]	S. X., N. O., Y. M., and Y. H. thank the Japan Science and Technology Agency (JST), ACT-C for financial support. W.-H. W. is grateful for the financial support from Dalian University of Technology [the Fundamental Research Funds for the Central Universities, Grant No. DUT14RC(3)082; Grant No. 844401] and the National Natural Science Foundation of China (Grant No. 21402019). The work at BNL was carried out with the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences under contract DE-SC00112704.	Hull JF, 2012, NAT CHEM, V4, P383, DOI [10.1038/nchem.1295, 10.1038/NCHEM.1295]; Wang WH, 2015, ACS CATAL, V5, P5496, DOI 10.1021/acscatal.5b01090; Muller K, 2013, CHEMCATCHEM, V5, P1340, DOI 10.1002/cctc.201200818; Zhang YY, 2015, CHEM SCI, V6, P4291, DOI 10.1039/c5sc01467k; JESSOP PG, 1994, NATURE, V368, P231, DOI 10.1038/368231a0; Fong H, 2015, INORG CHEM, V54, P5124, DOI 10.1021/ic502508p; Jeletic MS, 2014, ACS CATAL, V4, P3755, DOI 10.1021/cs5009927; Ziebart C, 2012, J AM CHEM SOC, V134, P20701, DOI 10.1021/ja307924a; Onishi N, 2015, INORG CHEM, V54, P5114, DOI 10.1021/ic502904q; Schmeier TJ, 2011, J AM CHEM SOC, V133, P9274, DOI 10.1021/ja2035514; Maenaka Y, 2012, ENERG ENVIRON SCI, V5, P7360, DOI 10.1039/c2ee03315a; WILLIAMS R, 1978, APPL PHYS LETT, V33, P381, DOI 10.1063/1.90403; Lilio AM, 2015, J AM CHEM SOC, V137, P8251, DOI [10.1021/jacs.5b04291, 10.1021/jacs.5604291]; Wang WH, 2013, ACS CATAL, V3, P856, DOI 10.1021/cs400172j; Wang WH, 2014, ADV INORG CHEM, V66, P189, DOI 10.1016/B978-0-12-420221-4.00006-8; Huff CA, 2013, ACS CATAL, V3, P2412, DOI 10.1021/cs400609u; Fujita E, 2015, INORG CHEM, V54, P5040, DOI 10.1021/acs.inorgchem.5b00790; Sanz S, 2010, DALTON T, V39, P6339, DOI 10.1039/c003220d; Barnard JH, 2013, CHEM SCI, V4, P1234, DOI 10.1039/c2sc21923a; Manaka Y, 2014, CATAL SCI TECHNOL, V4, P34, DOI 10.1039/c3cy00830d; Tanaka R, 2009, J AM CHEM SOC, V131, P14168, DOI 10.1021/ja903574e; Kothandaraman J, 2015, CHEMSUSCHEM, V8, P1442, DOI 10.1002/cssc.201403458; Bertini F, 2015, ACS CATAL, V5, P1254, DOI 10.1021/cs501998t; Himeda Y, 2009, GREEN CHEM, V11, P2018, DOI 10.1039/b914442k; Watari R, 2015, ADV SYNTH CATAL, V357, P1369, DOI 10.1002/adsc.201500043; Filonenko GA, 2014, CHEMCATCHEM, V6, P1526, DOI 10.1002/cctc.201402119; Badiei YM, 2013, INORG CHEM, V52, P12576, DOI 10.1021/ic401707u; Himeda Y, 2007, ORGANOMETALLICS, V26, P702, DOI 10.1021/om060899e; Erlandsson M, 2008, EUR J INORG CHEM, P620, DOI 10.1002/ejic.200700792; GRAF E, 1992, J CHEM SOC CHEM COMM, P623, DOI 10.1039/c39920000623; Moret S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5017; Ogo S, 2006, DALTON T, P4657, DOI 10.1039/b607993h; Papp G., 2011, ANGEW CHEM INT EDIT, V50; Papp G., 2011, ANGEW CHEM, V123, P10617; Rivada-Wheelaghan O, 2015, INORG CHEM, V54, P4526, DOI 10.1021/acs.inorgchem.5b00366; Suna Y, 2014, ORGANOMETALLICS, V33, P6519, DOI 10.1021/om500832d; Wang W.-H., 2015, CHEM REV, DOI [10.1021/acs.chem-rev.1025b00197, DOI 10.1021/ACS.CHEMREV.1025B00197]; Zhu FX, 2015, CHEMSUSCHEM, V8, P609, DOI 10.1002/cssc.201403234; Zhu QL, 2015, ENERG ENVIRON SCI, V8, P478, DOI 10.1039/c4ee03690e	39	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1434-1948	1099-0682		EUR J INORG CHEM	Eur. J. Inorg. Chem.	DEC	2015		34					5591	5594		10.1002/ejic.201501030		4	Chemistry, Inorganic & Nuclear	Chemistry	CY5EZ	WOS:000366432200002		
J	Pradeep, EKC; Ohtani, M; Kobiro, K				Pradeep, Ellawala K. C.; Ohtani, Masataka; Kobiro, Kazuya			A Simple Synthetic Approach to Al2O3-TiO2 and ZnO-TiO2 Mesoporous Hollow Composite Assemblies Consisting of Homogeneously Mixed Primary Particles at the Nano Level	EUROPEAN JOURNAL OF INORGANIC CHEMISTRY			English	Article						Hollow composite nanoassemblies; Band gap energy tuning; Phase transitions; Nanoparticles; Mesoporous materials	RUTILE PHASE-TRANSFORMATION; LITHIUM STORAGE PROPERTIES; METAL OXIDE NANOPARTICLES; STABILIZED ANATASE TIO2; SENSITIZED SOLAR-CELLS; ONE-POT; HYDROTHERMAL METHOD; SUPERCRITICAL METHANOL; OPTICAL-PROPERTIES; ION BATTERIES	A simple synthetic approach to Al2O3-TiO2 and ZnO-TiO2 mesoporous hollow composite assemblies consisting of homogeneously mixed primary particles at the nano scale was demonstrated. The composites, Al2O3-TiO2 and ZnO-TiO2, have a large specific surface area (250-600 m(2)g(-1)) and were synthesized by high-temperature and high-pressure treatment of precursor solutions containing Al(OiPr)(3) or Zn(OAc)(2), Ti(OiPr)(4), and phthalic acid in methanol. Aggregated, fused spherical, and individual spherical morphologies of the hollow assemblies with amorphous Al2O3 and anatase TiO2 were obtained, depending on the Al/Ti ratio of the precursor solutions. Hollow spherical composite assemblies with amorphous ZnO and anatase TiO2 phases were obtained by treating precursor solutions with lower Zn contents (5-25%). A phase transition from anatase to rutile was not observed for the Al2O3-TiO2 composite assemblies (50% Al) even at 1000 degrees C. The band gap energies of the ZnO-TiO2 hollow assemblies were tuned (3.12-3.21 eV) by changing their Zn content.	[Pradeep, Ellawala K. C.; Ohtani, Masataka; Kobiro, Kazuya] Kochi Univ Technol, Sch Environm Sci & Engn, Kami, Kochi 7828502, Japan	Ohtani, M (reprint author), Kochi Univ Technol, Sch Environm Sci & Engn, 185 Miyanokuchi, Kami, Kochi 7828502, Japan.	ohtani.masataka@kochi-tech.ac.jp; kobiro.kazuya@kochi-tech.ac.jp			Creation of New Business and Industry Program through the Kochi Prefectural Industry-Academia-Government Collaboration Research Promotion Operation; Japan Society for the Promotion of Science (JSPS KAKENHI) [15K06560]	This work was partially supported by the Creation of New Business and Industry Program through the Kochi Prefectural Industry-Academia-Government Collaboration Research Promotion Operation and by the Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research (JSPS KAKENHI) (grant number 15K06560). We thank Dr. Toshiyuki Kawaharamura for fruitful discussions.	Bang JH, 2008, ADV MATER, V20, P2599, DOI 10.1002/adma.200703188; Li D, 2013, ACS APPL MATER INTER, V5, P9095, DOI 10.1021/am4024059; Lee K, 2010, J AM CHEM SOC, V132, P1478, DOI 10.1021/ja910045x; Manthina V, 2012, J PHYS CHEM C, V116, P23864, DOI 10.1021/jp304622d; Bayal N, 2014, CERAM INT, V40, P15463, DOI 10.1016/j.ceramint.2014.06.122; Dahl M, 2014, CHEM REV, V114, P9853, DOI 10.1021/cr400634p; Yang J, 1998, MATER LETT, V36, P320, DOI 10.1016/S0167-577X(98)00042-1; Kim JY, 2010, LANGMUIR, V26, P2864, DOI 10.1021/la902931w; Lou XW, 2008, ADV MATER, V20, P3987, DOI 10.1002/adma.200800854; Hu J, 2011, CHEM SOC REV, V40, P5472, DOI 10.1039/c1cs15103g; Wang PY, 2014, PURE APPL CHEM, V86, P785, DOI 10.1515/pac-2013-1117; Bousquet C, 2008, J EUR CERAM SOC, V28, P223, DOI 10.1016/j.jeurceramsoc.2007.06.005; Arun TA, 2014, DALTON T, V43, P4830, DOI 10.1039/c3dt52780h; Liu YD, 2013, CHEM SOC REV, V42, P2610, DOI 10.1039/c2cs35369e; Wang ST, 2012, ANAL CHEM, V84, P7763, DOI 10.1021/ac301258q; Joo JB, 2012, ADV FUNCT MATER, V22, P166, DOI 10.1002/adfm.201101927; Vlazan P, 2015, MATER CHARACT, V101, P153, DOI 10.1016/j.matchar.2015.01.017; Yu XY, 2015, ANGEW CHEM INT EDIT, V54, P4001, DOI 10.1002/anie.201411353; Pillai SC, 2007, J PHYS CHEM C, V111, P1605, DOI 10.1021/jp065933h; Wang JJ, 2014, J PHYS CHEM C, V118, P7451, DOI 10.1021/jp5004775; Zhou ZM, 2011, IND ENG CHEM RES, V50, P883, DOI 10.1021/ie101697t; Ihara T, 2014, RSC ADV, V4, P25148, DOI 10.1039/c4ra02877e; Huang RT, 2015, ACS APPL MATER INTER, V7, P3949, DOI 10.1021/am505989j; Li W, 2004, J APPL PHYS, V96, P6663, DOI 10.1063/1.1807520; Yu JG, 2010, DALTON T, V39, P5860, DOI 10.1039/c0dt00053a; Agrawal M, 2009, CHEM MATER, V21, P5343, DOI 10.1021/cm9028098; Luo S, 2015, J PHYS CHEM C, V119, P2669, DOI 10.1021/jp511986n; Wang PY, 2013, J SUPERCRIT FLUID, V80, P71, DOI 10.1016/j.supflu.2013.04.001; Wang PY, 2013, J SUPERCRIT FLUID, V78, P124, DOI 10.1016/j.supflu.2013.03.023; Attia A, 2005, J SOLID STATE ELECTR, V9, P138, DOI 10.1007/s10008-004-0564-3; Li YS, 2014, ADV MATER, V26, P3176, DOI 10.1002/adma.201305319; Hu H, 2015, ENERG ENVIRON SCI, V8, P1480, DOI 10.1039/c5ee00101c; Yan XD, 2013, J MATER CHEM A, V1, P5347, DOI 10.1039/c3ta01621h; Jiang J, 2012, ADV MATER, V24, P5166, DOI 10.1002/adma.201202146; Pedersen TG, 2005, PHYS STATUS SOLIDI C, V2, P4026, DOI 10.1002/pssc.200562222; Wang PY, 2012, CHEM LETT, V41, P264, DOI 10.1246/cl.2012.264; Xue GX, 2015, RSC ADV, V5, P13385, DOI 10.1039/c4ra12917b; Dejang N, 2010, SURF COAT TECH, V204, P1651, DOI 10.1016/j.surfcoat.2009.10.052; Ryu SY, 2010, J PHYS CHEM C, V114, P17440, DOI 10.1021/jp105496h; Bhaskar A, 2014, NANOSCALE, V6, P10762, DOI 10.1039/c4nr02505a; Pradeep EKC, 2015, J SUPERCRIT FLUID, V97, P217, DOI 10.1016/j.supflu.2014.12.004; Vyas R, 2013, J ALLOY COMPD, V554, P59, DOI 10.1016/j.jallcom.2012.11.059; Guo SJ, 2012, J COLLOID INTERF SCI, V387, P141, DOI 10.1016/j.jcis.2012.08.005; Hanaor DAH, 2011, J MATER SCI, V46, P855, DOI 10.1007/s10853-010-5113-0; Arunachalam A., 2012, ACTA A, V138, P105; Lee J, 2014, NANO TODAY, V9, P631, DOI 10.1016/j.nantod.2014.09.003; Perera S, 2005, CHEM COMMUN, P5988, DOI 10.1039/b512148e; TAUC J, 1966, PHYS STATUS SOLIDI, V15, P627, DOI 10.1002/pssb.19660150224; Wang P., 2014, EUR J INORG CHEM, V26, P4254; Xiong WL, 2012, ACTA CRYSTALLOGR C, V68, pM235, DOI 10.1107/S0108270112033045	50	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1434-1948	1099-0682		EUR J INORG CHEM	Eur. J. Inorg. Chem.	DEC	2015		34					5621	5627		10.1002/ejic.201500964		7	Chemistry, Inorganic & Nuclear	Chemistry	CY5EZ	WOS:000366432200006		
J	Kataoka, Y; Yano, N; Kawamoto, T; Handa, M				Kataoka, Yusuke; Yano, Natsumi; Kawamoto, Tatsuya; Handa, Makoto			Isolation of a Tetranuclear Intermediate Complex in the Synthesis of Paddlewheel-Type Dirhodium Tetraacetate	EUROPEAN JOURNAL OF INORGANIC CHEMISTRY			English	Article						Rhodium; Reaction intermediates; X-ray diffraction; Electronic structure; Density functional calculations	RHODIUM(II) CARBOXYLATES; COORDINATION POLYMER; CRYSTAL; ABSORPTION; CATALYSTS; DIMERS; BONDS; DNA	To investigate the detailed mechanism of formation of the paddlewheel-type dirhodium tetraacetate [Rh-2(O2CCH3)(4)-(L)(2)] ([1-(L)(2)]; L = axial-coordinated solvent ligand), we performed a step-by-step synthesis. The isolated red intermediate complex [Rh-4(mu-Cl)(4)(O2CCH3)(4)(L)(4)] ([2-(L)(4)]) was characterized by means of single-crystal X-ray diffraction, H-1 NMR spectroscopy, infrared spectroscopy, and elemental analysis. The crystal structure of [2-(MeOH)(4)], which was crystallized from MeOH solution, has a unique twisted-box Rh-4(mu-Cl)(4) core coordinated by four mu-carboxylato bridging ligands and four MeOH molecules as axially coordinated solvent molecules. The electronic structure and absorption properties of [2-(MeOH)(4)] in MeOH were also carefully investigated both experimentally and theoretically.	[Kataoka, Yusuke; Yano, Natsumi; Handa, Makoto] Shimane Univ, Interdisciplinary Grad Sch Sci & Engn, Dept Chem, Matsue, Shimane 6908504, Japan; [Kawamoto, Tatsuya] Kanagawa Univ, Fac Sci, Dept Chem, Hiratsuka, Kanagawa 2591293, Japan	Kataoka, Y (reprint author), Shimane Univ, Interdisciplinary Grad Sch Sci & Engn, Dept Chem, 1060 Nishikawatsu, Matsue, Shimane 6908504, Japan.	kataoka@riko.shimane-u.ac.jp			KAKENHI [15H00877, 15K17897, 25620145]; Strategic Research Base Development Program for Private Universities of the Ministry of Education, Culture, Sports and Technology (MEXT), Japan	This work was supported by Grants-in-Aid for Scientific Research (KAKENHI) (no. 15H00877, 15K17897, and 25620145) and the Strategic Research Base Development Program for Private Universities of the Ministry of Education, Culture, Sports and Technology (MEXT), Japan. Y. K. acknowledges the SEI Group CSR Foundation, the JAPAN PRIZE Foundation, and the Electronic Technology Research Foundation of Chugoku.	COTTON FA, 1971, ACTA CRYSTALL B-STRU, VB 27, P1664, DOI 10.1107/S0567740871004527; Majer Z, 2015, MICROCHEM J, V120, P51, DOI 10.1016/j.microc.2015.01.002; Kataoka Y, 2011, SUPRAMOL CHEM, V23, P329, DOI 10.1080/10610278.2010.534553; Miyasaka H, 2000, ANGEW CHEM INT EDIT, V39, P3831, DOI 10.1002/1521-3773(20001103)39:21<3831::AID-ANIE3831>3.0.CO;2-D; BEAR JL, 1991, INORG CHEM, V30, P336, DOI 10.1021/ic00002a036; Pruchnik FP, 2009, POLYHEDRON, V28, P769, DOI 10.1016/j.poly.2008.12.037; BOYAR EB, 1983, COORDIN CHEM REV, V50, P109, DOI 10.1016/0010-8545(83)85028-0; Fu PKL, 2001, INORG CHEM, V40, P2476, DOI 10.1021/ic010118w; Handa M, 1999, B CHEM SOC JPN, V72, P2681, DOI 10.1246/bcsj.72.2681; Takamizawa S, 2003, ANGEW CHEM INT EDIT, V42, P4331, DOI 10.1002/anie.200351368; AHSAN MQ, 1986, INORG CHEM, V25, P260, DOI 10.1021/ic00223a006; Kataoka Y, 2010, CHEM LETT, V39, P358, DOI 10.1246/cl.2010.358; NORMAN JG, 1978, J AM CHEM SOC, V100, P791, DOI 10.1021/ja00471a022; HOWARD RA, 1976, CANCER RES, V36, P4402; Kataoka Y, 2010, B CHEM SOC JPN, V83, P1481, DOI 10.1246/bcsj.20100128; Bradley PM, 2001, INORG CHEM, V40, P1376, DOI 10.1021/ic0009573; Hansen J, 2008, COORDIN CHEM REV, V252, P545, DOI 10.1016/j.ccr.2007.08.019; Pirrung MC, 2002, J AM CHEM SOC, V124, P1014, DOI 10.1021/ja011599l; Fuma Y, 2004, J AM CHEM SOC, V126, P12238, DOI 10.1021/ja047421r; COTTON FA, 1993, J AM CHEM SOC, V115, P8511, DOI 10.1021/ja00071a096; Tong LH, 2012, CHEM COMMUN, V48, P9891, DOI 10.1039/c2cc35206k; Chifotides H. T., 2005, MULTIPLE BONDS METAL, P465, DOI 10.1007/0-387-25829-9_12; Chifotides HT, 2005, ACCOUNTS CHEM RES, V38, P146, DOI 10.1021/ar0302078; Frisch MJ, 2009, GAUSSIAN 09 REVISION; LEGZDINS P, 1970, J CHEM SOC A, P3322, DOI 10.1039/j19700003322; Miyasaka H., 2000, ANGEW CHEM, V112, P3989, DOI 10.1002/1521-3757(20001103)112:21<3989::AID-ANGE3989>3.0.CO;2-0; Naito S, 2001, CHEM LETT, P1178; Sheu JT, 1996, CHEM COMMUN, P315, DOI 10.1039/cc9960000315; Takamizawa S., 2003, ANGEW CHEM, V115, P4467, DOI 10.1002/ange.200351368; Yang Z., 1998, J CHEM SOC DA, V14, P2277	30	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1434-1948	1099-0682		EUR J INORG CHEM	Eur. J. Inorg. Chem.	DEC	2015		34					5650	5655		10.1002/ejic.201500955		6	Chemistry, Inorganic & Nuclear	Chemistry	CY5EZ	WOS:000366432200009		
J	Toyota, S; Miyaji, R; Yamamoto, Y; Inoue, M; Wakamatsu, K; Iwanaga, T				Toyota, Shinji; Miyaji, Ryutaro; Yamamoto, Yuta; Inoue, Masataka; Wakamatsu, Kan; Iwanaga, Tetsuo			An Enantiopure 5,5-Bitetracene	EUROPEAN JOURNAL OF ORGANIC CHEMISTRY			English	Article						Biaryls; Chiral resolution; Circular dichroism; Density functional calculations; Absolute stereochemistry	THIN-FILM TRANSISTORS; CHIROPTICAL PROPERTIES; PENTACENE DERIVATIVES; CIRCULAR-DICHROISM; OPTICAL-ACTIVITY; STEREOCHEMISTRY; SEMICONDUCTORS; SEPARATION; BIARYLS	Two 5,5-bitetracene derivatives were synthesized from tetracenone in three steps as novel axially chiral biaryls. The enantiomers of 12,12-bis(phenylethynyl) derivative were successfully resolved by chiral HPLC. Their absolute stereochemistry was determined by theoretical calculations of the CD spectra using the time-dependent (TD) DFT method.	[Toyota, Shinji] Tokyo Inst Technol, Dept Chem & Mat Sci, Meguro Ku, Tokyo 1528551, Japan; [Miyaji, Ryutaro; Yamamoto, Yuta; Inoue, Masataka; Wakamatsu, Kan; Iwanaga, Tetsuo] Okayama Univ Sci, Dept Chem, Fac Sci, Kita Ku, Okayama 7000005, Japan	Toyota, S (reprint author), Tokyo Inst Technol, Dept Chem & Mat Sci, Meguro Ku, 2-12-1 Ookayama, Tokyo 1528551, Japan.	stoyota@cms.titech.ac.jp			JSPS KAKENHI [26410060]; MEXT-Supported Program for the Strategic Research Foundation at Private Universities	This work was partly supported by JSPS KAKENHI for Scientific Research (C) (Grant Number 26410060) and by a MEXT-Supported Program for the Strategic Research Foundation at Private Universities, 2009-2013.	Agranat I., 1979, J ORG CHEM, V44, P1979; Berthod M, 2005, CHEM REV, V105, P1801, DOI 10.1021/cr040652w; Shimizu H, 2007, ACCOUNTS CHEM RES, V40, P1385, DOI 10.1021/ar700101x; Greyson EC, 2010, J PHYS CHEM B, V114, P14168, DOI 10.1021/jp907392q; Diedrich C, 2003, J PHYS CHEM A, V107, P2524, DOI 10.1021/jp0275802; Feldmeier EJ, 2010, ADV MATER, V22, P3568, DOI 10.1002/adma.201000980; Tsubaki K, 2003, J AM CHEM SOC, V125, P16200, DOI 10.1021/ja038910e; SCHWARTZ LH, 1986, J ORG CHEM, V51, P995, DOI 10.1021/jo00357a008; Fudickar W, 2012, J AM CHEM SOC, V134, P15071, DOI 10.1021/ja306056x; Li S, 2011, J ORG CHEM, V76, P9983, DOI 10.1021/jo201659q; Zhang FP, 2013, ORG ELECTRON, V14, P888, DOI 10.1016/j.orgel.2013.01.003; Kitamura C, 2010, CHEM-EUR J, V16, P890, DOI 10.1002/chem.200901668; Katsuta S, 2011, ORG LETT, V13, P1454, DOI 10.1021/ol200145r; Toyota S, 2008, CHIRALITY, V20, P295, DOI 10.1002/chir.20437; Anthony JE, 2002, ORG LETT, V4, P15, DOI 10.1021/ol0167356; Tanaka K, 2013, RSC ADV, V3, P15310, DOI 10.1039/c3ra41914b; Okamoto T, 2012, CHEM-ASIAN J, V7, P105, DOI 10.1002/asia.201100590; Pereira MM, 2013, CHEM SOC REV, V42, P6990, DOI 10.1039/c3cs60116a; Zhang XJ, 2010, CHEM-EUR J, V16, P464, DOI 10.1002/chem.200902675; Takaishi K, 2010, ORG LETT, V12, P1832, DOI 10.1021/ol100582v; CZARNIECKI S, 1978, J MOL STRUCT, V47, P365, DOI 10.1016/0022-2860(78)87204-4; Toyota S, 2004, B CHEM SOC JPN, V77, P2065, DOI 10.1246/bcsj.77.2065; Brunel JM, 2005, CHEM REV, V105, P857, DOI 10.1021/cr040079g; Anthony JE, 2001, J AM CHEM SOC, V123, P9482, DOI 10.1021/ja0162459; Odom SA, 2003, ORG LETT, V5, P4245, DOI 10.1021/OL035415E; Autschbach J, 2011, TOP CURR CHEM, V298, P1, DOI 10.1007/128_2010_72; Meca L, 2003, J ORG CHEM, V68, P5677, DOI 10.1021/jo034344u; MASON SF, 1974, TETRAHEDRON, V30, P1671, DOI 10.1016/S0040-4020(01)90689-1; Adams R, 1933, CHEM REV, V12, P261, DOI 10.1021/cr60042a003; Zhang JJ, 2012, J MATER CHEM, V22, P6182, DOI 10.1039/c2jm16173g; Toyota S, 2003, TETRAHEDRON-ASYMMETR, V14, P1623, DOI 10.1016/S0957-4166(03)00252-0; BADGER GM, 1962, J CHEM SOC, P4268, DOI 10.1039/jr9620004268; Badger G. M., 1971, TETRAHEDRON, V27, P5999; Eliel E. L., 1993, STEREOCHEMISTRY ORGA; Harvey R. G., 1997, POLYCYCLIC AROMATIC; Hopf H., 2000, CLASSICS HYDROCARBON; Hughes D. L., 2014, ORG SYNTH, V91, P1; Kanno M., 2002, Jpn. Kokai Tokkyo Koho, Patent No. [JP 2002167578 A, CAN 137:13091, 2002167578]; Koslowski A., 2000, CIRCULAR DICHROISM P; Krow G., 1970, TOP STEREOCHEM, V5, P31, DOI 10.1002/9780470147146.ch2; Nori-shargh D, 2005, J MOL STRUC-THEOCHEM, V717, P41, DOI 10.1016/j.theochem.2004.11.022; OI S, 1990, CHEM LETT, P59, DOI 10.1246/cl.1990.59; Seyden-Penne J., 1995, CHIRAL AUXILIARIES L; Wolf C., 2008, DYNAMIC STEREOCHEMIS	44	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1434-193X	1099-0690		EUR J ORG CHEM	Eur. J. Org. Chem.	DEC	2015		35					7648	7651		10.1002/ejoc.201501135		4	Chemistry, Organic	Chemistry	CY5CW	WOS:000366426600003		
J	Tokoro, Y; Ohtsuka, N; Toh, A; Fukuzawa, S				Tokoro, Yuichiro; Ohtsuka, Nobuhiko; Toh, Ayumi; Fukuzawa, Shin-ichi			Synthesis and Structure of N-Hetero-ortho-phenylene Hexamers Containing 2,3-Substituted Pyridine Moieties	EUROPEAN JOURNAL OF ORGANIC CHEMISTRY			English	Article						Helical structures; Arenes; Nitrogen heterocycles; Stacking interactions; C-H activation	CATALYZED DIRECT ARYLATION; H BOND ACTIVATION; ASYMMETRIC CATALYSIS; HELICAL POLYMERS; CHIRAL RECOGNITION; SOLID-STATE; BASIS-SETS; OLIGOMERS; POLY(QUINOXALINE-2,3-DIYL)S; POLYACETYLENE	N-Hetero-ortho-phenylene hexamers with two 2,3-substituted pyridine moieties (i.e., 1a-c) were prepared by palladium-catalyzed homocoupling with pyridine-directed C-H cleavage as the key step. The conformations of the resulting hexamers in solution and in the solid state were investigated by computational methods, X-ray analysis, and H-1 NMR spectroscopy. Calculations at the SCS-MP2/def2-TZVPP//B97-D3(bj)/def2-SVP level suggested that helical folding of 1a as the pyridine moieties are stacked is thermally more stable than the equivalent folding in the unsubstituted ortho-phenylene hexamer. The conformations of single crystals of 1 were consistent with the optimized structures obtained by DFT calculations. Except for rotation of the terminal phenyl groups, only one set of signals corresponding to a helical conformation was observed by analysis of 1 by H-1 NMR spectroscopy in CDCl3 solution.	[Tokoro, Yuichiro; Ohtsuka, Nobuhiko; Toh, Ayumi; Fukuzawa, Shin-ichi] Chuo Univ, Inst Sci & Engn, Dept Appl Chem, Bunkyo Ku, Tokyo 1128551, Japan	Tokoro, Y (reprint author), Chuo Univ, Inst Sci & Engn, Dept Appl Chem, Bunkyo Ku, 1-13-27 Kasuga, Tokyo 1128551, Japan.	ytokoro@kc.chuo-u.ac.jp			Chuo University, Tokyo	This work was financially supported by the Chuo University, Tokyo through a Joint Research Grant.	Pan F, 2013, ANGEW CHEM INT EDIT, V52, P2063, DOI 10.1002/anie.201208362; Norinder J, 2008, J AM CHEM SOC, V130, P5858, DOI 10.1021/ja800818b; Grimme S, 2003, J CHEM PHYS, V118, P9095, DOI 10.1063/1.1569242; Geronimo I, 2010, J CHEM THEORY COMPUT, V6, P1931, DOI 10.1021/ct100182u; Iida H, 2013, J POLYM SCI POL CHEM, V51, P2869, DOI 10.1002/pola.26678; Berni E, 2007, CHEM-EUR J, V13, P8463, DOI 10.1002/chem.200700847; Weigend F, 2005, PHYS CHEM CHEM PHYS, V7, P3297, DOI 10.1039/b508541a; Hohenstein EG, 2009, J PHYS CHEM A, V113, P878, DOI 10.1021/jp809062x; He J, 2012, ORG BIOMOL CHEM, V10, P3398, DOI 10.1039/c2ob07146k; Kalyani D, 2005, J AM CHEM SOC, V127, P7330, DOI 10.1021/ja051402f; Yashima E, 2009, CHEM REV, V109, P6102, DOI 10.1021/cr900162q; Song C, 2013, POLYM CHEM-UK, V4, P645, DOI 10.1039/c2py20546g; Hartley CS, 2010, J ORG CHEM, V75, P8627, DOI 10.1021/jo1021025; Grimme S, 2006, J COMPUT CHEM, V27, P1787, DOI 10.1002/jcc.20495; Yamamoto T, 2009, ANGEW CHEM INT EDIT, V48, P539, DOI 10.1002/anie.200803719; Marsella MJ, 2007, ORG BIOMOL CHEM, V5, P391, DOI 10.1039/b613891h; Shinohara K, 2009, CHEM LETT, V38, P690, DOI 10.1246/cl.2009.690; Huang HJ, 2015, RSC ADV, V5, P26236, DOI 10.1039/c4ra16466k; Ito Y, 1996, J AM CHEM SOC, V118, P9188, DOI 10.1021/ja961818g; Ke YZ, 2015, ANGEW CHEM INT EDIT, V54, P9333, DOI 10.1002/anie.201502209; Zurro M, 2014, J AM CHEM SOC, V136, P13999, DOI 10.1021/ja507940k; He JA, 2010, J AM CHEM SOC, V132, P13848, DOI 10.1021/ja106050s; Zhang HY, 2015, J POLYM SCI POL CHEM, V53, P1816, DOI 10.1002/pola.27630; Azzarito V, 2015, CHEM SCI, V6, P2434, DOI 10.1039/c4sc03559c; Shimomura K, 2014, NAT CHEM, V6, P429, DOI [10.1038/nchem.1916, 10.1038/NCHEM.1916]; Marsella MJ, 2003, J AM CHEM SOC, V125, P13928, DOI 10.1021/ja038260e; Megens RP, 2011, CHEM-EUR J, V17, P8514, DOI 10.1002/chem.201100672; Mathew SM, 2013, J AM CHEM SOC, V135, P6714, DOI 10.1021/ja4026006; Zhao XD, 2008, J AM CHEM SOC, V130, P8136, DOI 10.1021/ja803154h; Ando S, 2012, J AM CHEM SOC, V134, P11084, DOI 10.1021/ja303117z; Grimme S, 2011, J COMPUT CHEM, V32, P1456, DOI 10.1002/jcc.21759; Bruno NC, 2014, J ORG CHEM, V79, P4161, DOI 10.1021/jo500355k; Suginome M, 2007, CHEM LETT, V36, P1036, DOI 10.1246/cl.2007.1036; Yamamoto T, 2011, ANGEW CHEM INT EDIT, V50, P8844, DOI 10.1002/anie.201103792; SCHAFER A, 1992, J CHEM PHYS, V97, P2571; Blake AJ, 1998, TETRAHEDRON LETT, V39, P9093, DOI 10.1016/S0040-4039(98)02003-6; Hull KL, 2006, J AM CHEM SOC, V128, P14047, DOI 10.1021/ja065718e; Mathew SM, 2011, MACROMOLECULES, V44, P8425, DOI 10.1021/ma201866p; Song WF, 2012, ANGEW CHEM INT EDIT, V51, P8251, DOI 10.1002/anie.201202466; Ohta E, 2011, NAT CHEM, V3, P68, DOI [10.1038/nchem.900, 10.1038/NCHEM.900]; Grimme S, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3382344; Ke Y.-Z., 2015, ANGEW CHEM, V127, P9465; Mathew S, 2014, J AM CHEM SOC, V136, P16666, DOI 10.1021/ja509902m; Neese F., ORCA VERSION 3 0; Okamoto Y, 2009, J POLYM SCI POL CHEM, V47, P1731, DOI 10.1002/pola.23215; Pan F., 2013, ANGEW CHEM, V125, P2117; Song W., 2012, ANGEW CHEM, V124, P8376; Yamamoto T., 2011, ANGEW CHEM, V123, P9006; Yamamoto T., 2009, ANGEW CHEM, V121, P547; Zhang CH, 2015, J POLYM SCI POL CHEM, V53, P809, DOI 10.1002/pola.27506	50	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1434-193X	1099-0690		EUR J ORG CHEM	Eur. J. Org. Chem.	DEC	2015		35					7666	7669		10.1002/ejoc.201501270		4	Chemistry, Organic	Chemistry	CY5CW	WOS:000366426600007		
J	Shigehisa, H; Kikuchi, H; Suzuki, T; Hiroya, K				Shigehisa, Hiroki; Kikuchi, Harue; Suzuki, Tsuyoshi; Hiroya, Kou			The Revised Structure of Trichodermatide A	EUROPEAN JOURNAL OF ORGANIC CHEMISTRY			English	Article						Trichodermatide A; Structure elucidation; Cobalt catalysis; X-ray crystallography; Natural products	COBALT-CATALYZED HYDROHYDRAZINATION; UNACTIVATED OLEFINS; MOLECULAR-OXYGEN; A-D; AZIDES; HYDROAZIDATION; COMPLEX; ALKENES; ACCESS	A revised structure for trichodermatide A, which is a C10 epimer of the originally reported structure, is proposed. The revision is supported by the X-ray structure of a synthetic intermediate synthesized according to our previous route for trichodermatide A. The revised stereochemistry was also supported by NOESY experiment. Finally, we synthesized Trauner's compound corresponding to the originally reported structure from our synthetic intermediate of trichodermatide A through a Mitsunobu reaction at C10.	[Shigehisa, Hiroki; Kikuchi, Harue; Suzuki, Tsuyoshi; Hiroya, Kou] Musashino Univ, Fac Pharm, Nishitokyo, Tokyo 2028585, Japan	Shigehisa, H (reprint author), Musashino Univ, Fac Pharm, 1-1-20 Shinmachi, Nishitokyo, Tokyo 2028585, Japan.	cgehisa@musashino-u.ac.jp			JSPS KAKENHI [26860017, 15K07872]; Society of Synthetic Organic Chemistry; Takeda Pharmaceutical Company; Uehara Memorial Foundation	We thank Dr. Takashi Fujiwara at Saitama University for the assistance with the X-ray analysis. The work was supported by JSPS KAKENHI Grant No. 26860017 (H. S.) and 15K07872 (K. H.), the Society of Synthetic Organic Chemistry, Takeda Pharmaceutical Company award, and the Uehara Memorial Foundation.	Shigehisa H, 2013, ORG LETT, V15, P5158, DOI 10.1021/ol402696h; Waser J, 2006, J AM CHEM SOC, V128, P11693, DOI 10.1021/ja062355+; Shigehisa H, 2013, J AM CHEM SOC, V135, P10306, DOI 10.1021/ja405219f; Wan X, 2008, J AM CHEM SOC, V130, P17236, DOI 10.1021/ja807011b; Li Q, 2013, TETRAHEDRON LETT, V54, P5567, DOI 10.1016/j.tetlet.2013.07.137; Gaspar B, 2008, ANGEW CHEM INT EDIT, V47, P5758, DOI 10.1002/anie.200801760; Tokuyasu T, 2002, ORG LETT, V4, P3595, DOI 10.1021/ol0201299; QianCutrone JF, 1996, J ANTIBIOT, V49, P990; Gaspar B, 2009, J AM CHEM SOC, V131, P13214, DOI 10.1021/ja904856k; Abe N, 2000, J AM CHEM SOC, V122, P12606, DOI 10.1021/ja003013l; Myers E, 2014, J ORG CHEM, V79, P9812, DOI 10.1021/jo501206k; Iwasaki K, 2014, J AM CHEM SOC, V136, P1300, DOI 10.1021/ja412342g; VISHWAKARMA LC, 1988, ORG SYNTH, V66, P203; UMBREIT MA, 1977, J AM CHEM SOC, V99, P5526, DOI 10.1021/ja00458a072; Shigehisa H, 2013, ANGEW CHEM INT EDIT, V52, P3646, DOI 10.1002/anie.201210099; Waser J, 2005, J AM CHEM SOC, V127, P8294, DOI 10.1021/ja052164r; Hosotani N, 2007, J ANTIBIOT, V60, P184; Seephonkai P, 2006, ORG LETT, V8, P3073, DOI 10.1021/ol061046l; Waser J, 2005, ORG LETT, V7, P4249, DOI 10.1021/ol0517473; Waser J, 2004, ANGEW CHEM INT EDIT, V43, P4099, DOI 10.1002/anie.200460811; Nicolaou KC, 2005, ANGEW CHEM INT EDIT, V44, P1012, DOI 10.1002/anie.200460864; Song FH, 2010, J NAT PROD, V73, P806, DOI 10.1021/np900642p; Waser J, 2004, J AM CHEM SOC, V126, P5676, DOI 10.1021/ja048698u; Sun Y, 2008, ORG LETT, V10, P393, DOI 10.1021/ol702674f; Shi J, 2011, J AM CHEM SOC, V133, P8014, DOI 10.1021/ja202103e; Gaspar B, 2007, ANGEW CHEM INT EDIT, V46, P4519, DOI 10.1002/anie.200700575; Gaspar B, 2007, SYNTHESIS-STUTTGART, P3839, DOI 10.1055/s-2007-1000817; Gaspar B., 2008, ANGEW CHEM, V120, P5842, DOI 10.1002/ange.200801760; Gaspar B., 2007, ANGEW CHEM, V119, P4603, DOI 10.1002/ange.200700575; ISAYAMA S, 1989, CHEM LETT, P1071, DOI 10.1246/cl.1989.1071; Mukherjee P. K., 2013, TRICHODERMA BIOL APP; Nicolaou K. C., 2005, ANGEW CHEM, V117, P1036, DOI 10.1002/ange.200460864; Shigehisa H., 2013, ANGEW CHEM INT EDIT, V125, P3734; Waser J., 2004, ANGEW CHEM, V116, P4191, DOI 10.1002/ange.200460811; Yabe K., 2000, J NAT PRODUCTS, V63, P1677	35	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1434-193X	1099-0690		EUR J ORG CHEM	Eur. J. Org. Chem.	DEC	2015		35					7670	7673		10.1002/ejoc.201501281		4	Chemistry, Organic	Chemistry	CY5CW	WOS:000366426600008		
J	Gon, M; Morisaki, Y; Chujo, Y				Gon, Masayuki; Morisaki, Yasuhiro; Chujo, Yoshiki			Highly Emissive Optically Active Conjugated Dimers Consisting of a Planar Chiral [2.2]Paracyclophane Showing Circularly Polarized Luminescence	EUROPEAN JOURNAL OF ORGANIC CHEMISTRY			English	Article						Luminescence; Cyclophanes; Chirality; Conjugation	SPACE CHARGE-TRANSFER; 2.2 PARACYCLOPHANE; POLYMERS; CHROMOPHORES; DERIVATIVES; CYCLOPHANES; RESOLUTION; PAIRS	Optically active X-shaped dimers based on the planar chiral [2.2]paracyclophane have been synthesized. The dimers consist of stacked p-arylene-ethynylenes with phenyl, naphthyl, and anthryl groups as terminal units. The optical and chiroptical properties of the dimers and the corresponding model compounds were investigated. The naphthalene-containing dimer exhibits an intense circularly polarized luminescence (CPL) signal with a high dissymmetry factor (g(lum)) in the order of 10(-3) in addition to a high E and good photoluminescence quantum efficiency, which indicates that this compound is a highly emissive CPL material.	[Gon, Masayuki; Chujo, Yoshiki] Kyoto Univ, Grad Sch Engn, Dept Polymer Chem, Nishikyo Ku, Kyoto 6158510, Japan; [Morisaki, Yasuhiro] Kwansei Gakuin Univ, Dept Appl Chem Environm, Sch Sci & Technol, Sanda, Hyogo 6691337, Japan	Morisaki, Y (reprint author), Kwansei Gakuin Univ, Dept Appl Chem Environm, Sch Sci & Technol, 2-1 Gakuen, Sanda, Hyogo 6691337, Japan.	ymo@kwansei.ac.jp; chujo@chujo.synchem.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [15H00992]; Japan Society for the Promotion of Science [14J02514]	This work was supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan for a Grant-in-Aid for Scientific Research on Innovative Areas (grant number 15H00992) "pi-Figuration". M. G. thanks the Japan Society for the Promotion of Science for Young Scientists for a research fellowship (grant number 14J02514). The authors are grateful to Professor Kazuo Akagi and Dr. Kazuyoshi Watanabe (Department of Polymer Chemistry, Graduate School of Engineering, Kyoto University) for CPL data analysis.	Rowlands GJ, 2008, ORG BIOMOL CHEM, V6, P1527, DOI 10.1039/b800698a; Gon M, 2015, J MATER CHEM C, V3, P521, DOI 10.1039/c4tc02339k; Seferos DS, 2004, J ORG CHEM, V69, P1110, DOI 10.1021/jo035664g; Keg P, 2010, J MATER CHEM, V20, P2448, DOI 10.1039/b921349j; Zyss J, 2000, J AM CHEM SOC, V122, P11956, DOI 10.1021/ja0022526; Gibson SE, 2003, ORG BIOMOL CHEM, V1, P1256, DOI 10.1039/b300717k; Morisaki Y, 2012, CHEM LETT, V41, P990, DOI 10.1246/cl.2012.990; Bartholomew GP, 2001, ACCOUNTS CHEM RES, V34, P30, DOI 10.1021/ar9901568; Morisaki Y, 2014, CHEM-EUR J, V20, P8386, DOI 10.1002/chem.201402930; KONIG B, 1993, CHEM BER-RECL, V126, P1643, DOI 10.1002/cber.19931260723; Morisaki Y, 2012, POLYM CHEM-UK, V3, P2727, DOI 10.1039/c2py20530k; CRAM DJ, 1955, J AM CHEM SOC, V77, P6289, DOI 10.1021/ja01628a067; Morisaki Y, 2014, J AM CHEM SOC, V136, P3350, DOI 10.1021/ja412197j; Bartholomew GP, 2004, J AM CHEM SOC, V126, P11529, DOI 10.1021/ja038743i; Hong JW, 2005, J AM CHEM SOC, V127, P7435, DOI 10.1021/ja044326+; BROWN CJ, 1949, NATURE, V164, P915, DOI 10.1038/164915b0; Bazan GC, 1998, J AM CHEM SOC, V120, P9188, DOI 10.1021/ja973816h; Bazan GC, 2007, J ORG CHEM, V72, P8615, DOI 10.1021/jo071176n; Bartholomew GP, 2002, J AM CHEM SOC, V124, P5183, DOI 10.1021/ja0121383; Morisaki Y, 2012, CHEM LETT, V41, P840, DOI 10.1246/cl.2012.840; Aly AA, 2009, TETRAHEDRON, V65, P8055, DOI 10.1016/j.tet.2009.06.034; Billingsley K, 2007, J AM CHEM SOC, V129, P3358, DOI 10.1021/ja068577p; Hinrichs H, 2006, CHEM-EUR J, V12, P7103, DOI 10.1002/chem.200600498; Morisaki Y, 2012, CHEM-EUR J, V18, P4216, DOI 10.1002/chem.201103653; CRAM DJ, 1951, J AM CHEM SOC, V73, P5691, DOI 10.1021/ja01156a059; Morisaki Y, 2006, ANGEW CHEM INT EDIT, V45, P6430, DOI 10.1002/anie.200600752; Bartholomew GP, 2002, SYNTHESIS-STUTTGART, P1245; Wang SJ, 2000, J AM CHEM SOC, V122, P1289, DOI 10.1021/ja991611y; Bondarenko L, 2004, SYNTHESIS-STUTTGART, P2751, DOI 10.1055/s-2004-834872; Brabec C., 2008, ORGANIC PHOTOVOLTAIC; Gleiter R., 2004, MODERN CYCLOPHANE CH; Groza J. R., 2007, ORGANIC FIELD EFFECT; Hopf H, 2008, ANGEW CHEM INT EDIT, V47, P9808, DOI 10.1002/anie.200800969; Hopf H., 2008, ANGEW CHEM, V120, P9954, DOI DOI 10.1002/ANGE.200800969; Morisaki Y., 2006, ANGEW CHEM, V118, P6580, DOI 10.1002/ange.200600752; Morisaki Y, 2011, POLYM CHEM-UK, V2, P1249, DOI 10.1039/c0py00421a; Morisaki Y, 2015, POLYM J, V47, P278; Muellen K., 2006, ORGANIC LIGHT EMITTI; Pangborn AB, 1996, ORGANOMETALLICS, V15, P1518, DOI 10.1021/om9503712; Paradies J, 2011, SYNTHESIS-STUTTGART, P3749, DOI 10.1055/s-0031-1289296; Rozenberg V., 2004, MODERN CYCLOPHANE CH, P435, DOI DOI 10.1002/3527603964.CH17; Skotheim T. A., 2006, HDB CONDUCTING POLYM; Sonogashira K., 2002, HDB ORGANOPALLADIUM, P493, DOI DOI 10.1002/04712I2466.CH22; TAKAHASHI S, 1980, SYNTHESIS-STUTTGART, P627; Tohda Y., 1975, TETRAHEDRON LETT, V16, P4467; Vogtle F., 1993, CYCLOPHANE CHEM SYNT	46	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1434-193X	1099-0690		EUR J ORG CHEM	Eur. J. Org. Chem.	DEC	2015		35					7756	7762		10.1002/ejoc.201501181		7	Chemistry, Organic	Chemistry	CY5CW	WOS:000366426600016		
J	Putra, AE; Oe, Y; Ohta, T				Putra, Anggi Eka; Oe, Yohei; Ohta, Tetsuo			Pd/C-Catalyzed Alkylation of Heterocyclic Nucleophiles with Alcohols through the "Borrowing Hydrogen" Process	EUROPEAN JOURNAL OF ORGANIC CHEMISTRY			English	Article						Heterogeneous catalysis; Palladium; Hydrogen transfer; Nitrogen heterocycles; Alkylation; Alcohols	MIYAURA COUPLING REACTION; BETA-AMINO ALCOHOLS; LIGAND-FREE; CHEMOSELECTIVE HYDROGENATION; ALPHA-ALKYLATION; BORONIC ESTERS; AQUEOUS-MEDIA; INDOLES; IRIDIUM; METHODOLOGY	The alkylation of heterocyclic compounds is important for the synthesis of various biologically active compounds. In this paper, we present the development of a Pd/C-catalyzed alkylation of heterocyclic compounds using alcohols as the alkylating agents. This method gives the corresponding alkylated heterocyclic compounds in high yields (up to 99%). The commercially available catalyst can be recovered and reused five times without significant loss of catalytic efficiency, and the turnover number (TON) was as high as 900. Moreover, the reaction could be scaled up.	[Putra, Anggi Eka; Oe, Yohei; Ohta, Tetsuo] Doshisha Univ, Grad Sch Life & Med Sci, Kyoto 6100394, Japan; [Oe, Yohei; Ohta, Tetsuo] Doshisha Univ, Dept Biomed Informat, Fac Life & Med Sci, Kyoto 6100394, Japan	Ohta, T (reprint author), Doshisha Univ, Grad Sch Life & Med Sci, 1-3 Tatara Miyakodani, Kyoto 6100394, Japan.	tota@mail.doshisha.ac.jp					Hamid MHSA, 2009, J AM CHEM SOC, V131, P1766, DOI 10.1021/ja807323a; Bahn S, 2011, CHEMCATCHEM, V3, P1853, DOI 10.1002/cctc.201100255; Grigg R, 2009, TETRAHEDRON, V65, P4375, DOI 10.1016/j.tet.2009.03.065; Zhang Y, 2014, ANGEW CHEM INT EDIT, V53, P1399, DOI 10.1002/anie.201307789; Cozzi PG, 2008, ANGEW CHEM INT EDIT, V47, P4162, DOI 10.1002/anie.200800622; Montagut-Romans A, 2014, NEW J CHEM, V38, P1794, DOI 10.1039/c3nj01517c; Jursic BS, 2001, TETRAHEDRON LETT, V42, P4103, DOI 10.1016/S0040-4039(01)00621-9; Putra AE, 2013, EUR J ORG CHEM, V2013, P6146, DOI 10.1002/ejoc.201300692; AMEMIYA Y, 1990, SYNTHETIC COMMUN, V20, P2483, DOI 10.1080/00397919008053197; Bartolucci S, 2015, J ORG CHEM, V80, P3217, DOI 10.1021/acs.joc.5b00195; Yamada YMA, 2006, ORG LETT, V8, P1375, DOI 10.1021/ol060166q; Tao YS, 2012, J ORG CHEM, V77, P2942, DOI 10.1021/jo2024812; Galliford CV, 2007, ANGEW CHEM INT EDIT, V46, P8748, DOI 10.1002/anie.200701342; Grigg R, 2009, TETRAHEDRON, V65, P7468, DOI 10.1016/j.tet.2009.07.027; Quinn JF, 2008, TETRAHEDRON LETT, V49, P6137, DOI 10.1016/j.tetlet.2008.08.023; Guillena G, 2010, CHEM REV, V110, P1611, DOI 10.1021/cr9002159; Corma A, 2012, CHEM-EUR J, V18, P14150, DOI 10.1002/chem.201201837; Putra AE, 2013, EUR J ORG CHEM, V2013, P6344, DOI 10.1002/ejoc.201300744; Maegawa T, 2007, CHEM PHARM BULL, V55, P837, DOI 10.1248/cpb.55.837; Matsuzawa H, 2007, ORG LETT, V9, P5561, DOI 10.1021/ol7025203; Ma WMJ, 2013, ORG LETT, V15, P4850, DOI 10.1021/ol402271a; Reddy CR, 2011, ORG BIOMOL CHEM, V9, P3940, DOI 10.1039/c0ob01144d; Hamid MHSA, 2007, ADV SYNTH CATAL, V349, P1555, DOI 10.1002/adsc.200600638; Maegawa T, 2007, CHEM-EUR J, V13, P5937, DOI 10.1002/chem.200601795; Shimizu K, 2015, CATAL SCI TECHNOL, V5, P1412, DOI 10.1039/c4cy01170h; Siddiki SMAH, 2015, GREEN CHEM, V17, P173, DOI 10.1039/c4gc01419g; Rong ZQ, 2015, J AM CHEM SOC, V137, P4944, DOI 10.1021/jacs.5b02212; Yang Q, 2015, CHEM SOC REV, V44, P2305, DOI 10.1039/c4cs00496e; Guo L, 2013, ORG LETT, V15, P1144, DOI 10.1021/ol400360g; Buil ML, 2013, ACS CATAL, V3, P2072, DOI 10.1021/cs4005375; Chaudhari C, 2013, TETRAHEDRON LETT, V54, P6490, DOI 10.1016/j.tetlet.2013.09.077; Volk B, 2008, J MED CHEM, V51, P2522, DOI 10.1021/jm070279v; Mandal PK, 2007, J ORG CHEM, V72, P6599, DOI 10.1021/jo0706123; Lubinu MC, 2011, CHEM-EUR J, V17, P82, DOI 10.1002/chem.201002704; Liu GH, 2011, CATAL COMMUN, V12, P655, DOI 10.1016/j.catcom.2010.12.021; Chaudhari C, 2014, CATAL SCI TECHNOL, V4, P1064, DOI 10.1039/c3cy00911d; Yu B, 2014, CHEM COMMUN, V50, P2330, DOI 10.1039/c3cc49365b; Sakurai H, 2002, J ORG CHEM, V67, P2721, DOI 10.1021/jo016342k; Kitamura Y, 2007, TETRAHEDRON, V63, P10596, DOI 10.1016/j.tet.2007.08.017; Mori A, 2006, ORG LETT, V8, P3279, DOI 10.1021/ol061147j; Kagata T, 2006, J NAT PROD, V69, P1517, DOI 10.1021/np0602968; Bandini M, 2005, SYNLETT, P1199, DOI 10.1055/s-2005-865210; Chaston J. C., 1961, PLATIN MET REV, V5, P122; Cozzi P. G., 2008, ANGEW CHEM, V120, P4230, DOI DOI 10.1002/ANGE.200800622; Dinges J., 2012, BIOACTIVE HETEROCYCL; Galliford C. V., 2007, ANGEW CHEM, V119, P8902, DOI 10.1002/ange.200701342; Katritzky A. R., 1985, HDB HETEROCYCLIC CHE; Kitamura Y, 2007, CHEM COMMUN, P5069, DOI 10.1039/b712207a; Pan H.-J., 2015, CHEM COMMUN, DOI [10.1039/C5CC03399C, DOI 10.1039/C5CC03399C;]; Reddy CR, 2010, SYNTHESIS-STUTTGART, P3715, DOI 10.1055/s-0030-1258214; Roth P. G., 1995, TETRAHEDRON LETT, V36, P2191; Rueping M, 2010, BEILSTEIN J ORG CHEM, V6, DOI 10.3762/bjoc.6.6; Rueping M, 2010, SYNLETT, P1549, DOI 10.1055/s-0029-1219936; Zhang Y., 2014, ANGEW CHEM, V126, P1423	54	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1434-193X	1099-0690		EUR J ORG CHEM	Eur. J. Org. Chem.	DEC	2015		35					7799	7805		10.1002/ejoc.201501030		7	Chemistry, Organic	Chemistry	CY5CW	WOS:000366426600020		
J	Yamada, K; Yoshida, S; Fujita, H; Kitamura, M; Kunishima, M				Yamada, Kohei; Yoshida, Saki; Fujita, Hikaru; Kitamura, Masanori; Kunishima, Munetaka			O-Benzylation of Carboxylic Acids Using 2,4,6-Tris(benzyloxy)-1,3,5-triazine (TriBOT) under Acidic or Thermal Conditions	EUROPEAN JOURNAL OF ORGANIC CHEMISTRY			English	Article						Synthetic methods; Alkylation; Carboxylic acids; Carbocations	ESTERS; CONFIGURATION; INVERSION; ALCOHOLS	Two methods for the synthesis of benzyl esters from carboxylic acids using the O-benzylating reagent 2,4,6-tris(benzyloxy)-1,3,5-triazine (TriBOT) have been developed. The reactions were conducted either in the presence of a catalytic amount of TfOH at room temperature (acidic conditions) or in the absence of TfOH at 180-230 degrees C (thermal conditions). Interestingly, the O-benzylation of hydroxy carboxylic acids under the two conditions afforded different products: The dibenzylated product under acidic conditions and the hydroxy ester under thermal conditions. In addition to these results, other evidence indicated that the former reaction proceeds through an S(N)1-type mechanism, and the latter by an S(N)2-type mechanism.	[Yamada, Kohei; Yoshida, Saki; Fujita, Hikaru; Kitamura, Masanori; Kunishima, Munetaka] Kanazawa Univ, Fac Pharmaceut Sci, Inst Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa 9201192, Japan	Kunishima, M (reprint author), Kanazawa Univ, Fac Pharmaceut Sci, Inst Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa 9201192, Japan.	kunisima@p.kanazawa-u.ac			Japan Society for the Promotion of Science (JSPS) KAKENHI [25460012]; Japan Science and Technology Agency [AS242Z03610M]	This work was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI (grant number 25460012) and by Japan Science and Technology Agency (Adaptable and Seamless Technology Transfer Program through Target-driven R&D, AS242Z03610M).	Rassias G, 2010, ORG PROCESS RES DEV, V14, P92, DOI 10.1021/op900188v; KOHNO Y, 1995, B CHEM SOC JPN, V68, P322, DOI 10.1246/bcsj.68.322; Chighine A, 2009, J ORG CHEM, V74, P4753, DOI 10.1021/jo900476y; Garcia LA, 2011, POLYMER, V52, P5326, DOI 10.1016/j.polymer.2011.09.029; Hager K, 2006, CHEM-EUR J, V12, P2663, DOI 10.1002/chem.200501300; KOLTHOFF IM, 1974, ANAL CHEM, V46, P1992, DOI 10.1021/ac60349a005; Yamada K, 2013, SYNTHESIS-STUTTGART, V45, P2989, DOI 10.1055/s-0033-1339713; Black PJ, 2006, ORG BIOMOL CHEM, V4, P116, DOI 10.1039/b511053j; Yamada K, 2012, ORG LETT, V14, P5026, DOI 10.1021/ol302222p; Ishihara K, 2008, ORG LETT, V10, P2187, DOI 10.1021/ol8005979; Baik JS, 2006, B KOREAN CHEM SOC, V27, P333; Tummatorn J, 2007, J ORG CHEM, V72, P8962, DOI 10.1021/jo7018625; Magens S, 2010, J ORG CHEM, V75, P3715, DOI 10.1021/jo1004636; Greene T. W., 2006, GREENES PROTECTIVE G; Henry-Riyad H, 2008, ARKIVOC, P113; KAULEN J, 1987, ANGEW CHEM INT EDIT, V26, P773, DOI 10.1002/anie.198707731; Kaulen J., 1987, ANGEW CHEM, V99, P800, DOI 10.1002/ange.19870990819; Kocienski P. J., 2003, PROTECTING GROUPS; Kokotos G, 1997, SYNTHESIS-STUTTGART, P168; Otera J., 2010, ESTERIFICATION METHO; Paoloni L., 1967, RIC SCI, V37, P258; Singh P. P., 2008, SYNTHETIC COMMUN, V38, P928; Yamamoto Y., 1991, J ORG CHEM, V56, P6737	23	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1434-193X	1099-0690		EUR J ORG CHEM	Eur. J. Org. Chem.	DEC	2015		36					7997	8002		10.1002/ejoc.201501172		6	Chemistry, Organic	Chemistry	CY7PD	WOS:000366599800014		
J	Inaba, H				Inaba, Hajime			The development of ensemble theory A new glimpse at the history of statistical mechanics	EUROPEAN PHYSICAL JOURNAL H			English	Article							THERMODYNAMICS; EINSTEIN; FOUNDATIONS; GIBBS	This paper investigates the history of statistical mechanics from the viewpoint of the development of the ensemble theory from 1871 to 1902. In 1871, Ludwig Boltzmann introduced a prototype model of an ensemble that represents a polyatomic gas. In 1879, James Clerk Maxwell defined an ensemble as copies of systems of the same energy. Inspired by H.W. Watson, he called his approach "statistical". Boltzmann and Maxwell regarded the ensemble theory as a much more general approach than the kinetic theory. In the 1880s, influenced by Hermann von Helmholtz, Boltzmann made use of ensembles to establish thermodynamic relations. In Elementary Principles in Statistical Mechanics of 1902, Josiah Willard Gibbs tried to get his ensemble theory to mirror thermodynamics, including thermodynamic operations in its scope. Thermodynamics played the role of a "blind guide". His theory of ensembles can be characterized as more mathematically oriented than Einstein's theory proposed in the same year. Mechanical, empirical, and statistical approaches to foundations of statistical mechanics are presented. Although it was formulated in classical terms, the ensemble theory provided an infrastructure still valuable in quantum statistics because of its generality.	[Inaba, Hajime] Univ Tokyo, Meguro Ku, Tokyo 1538902, Japan	Inaba, H (reprint author), Univ Tokyo, Meguro Ku, Komaba 3-8-1, Tokyo 1538902, Japan.	Hajime.Inaba@gmail.com					Abiko S., 2004, AINSYUTAIN SOUTAISEI; Navarro L, 1998, ARCH HIST EXACT SCI, V53, P147, DOI 10.1007/s004070050025; MEHRA J, 1975, PHYSICA A, V79, P447, DOI 10.1016/0378-4371(75)90100-4; BIERHALTER G, 1981, ARCH HIST EXACT SCI, V25, P71, DOI 10.1007/BF00357202; BIERHALTER G, 1987, ARCH HIST EXACT SCI, V37, P77, DOI 10.1007/BF00412330; Mehra J, 1998, FOUND PHYS, V28, P1785, DOI 10.1023/A:1018890903755; Badino M, 2011, EUR PHYS J H, V36, P353, DOI 10.1140/epjh/e2011-10048-5; Bordoni S, 2013, EUR PHYS J H, V38, P617, DOI 10.1140/epjh/e2013-40028-7; Uffink J, 2006, STUD HIST PHILOS M P, V37, P36, DOI 10.1016/j.shpsb.2005.07.004; Brown HR, 2009, STUD HIST PHILOS M P, V40, P174, DOI 10.1016/j.shpsb.2009.03.003; KLEIN MJ, 1967, SCIENCE, V157, P509, DOI 10.1126/science.157.3788.509; KLEIN MJ, 1990, PHYS TODAY, V43, P40, DOI 10.1063/1.881258; [Anonymous], 1885, SITZUNGSBERICHTE MN, V2, P201; Renn J, 1997, ARCH HIST EXACT SCI, V51, P315, DOI 10.1007/BF00518232; GALLAVOTTI G, 1995, J STAT PHYS, V78, P1571, DOI 10.1007/BF02180143; Baracca A., 1985, REV MEX FIS, V31, P695; Bernhardt H., 1971, NTM Z GESCH NATURWIS, V8, P13; Bierhalter G., 1993, H VONHELMHOLTZ FDN 1, P433; Blackmore J., 1995, L BOLTZMANN HIS LATE; Boltzmann L., 1898, VORLESUNGEN GASTHEOR; Boltzmann L., 1885, SITZUNGSBERICHTE MN, V2, P231; Boltzmann L., 1887, J REINE ANGEW MATH, V100, P201; Boltzmann L., 1964, TRANSLATORS INTRO LE; Boltzmann L., 1882, PHILOS MAG, V14, P299; Boltzmann L., 1871, MATH NATURWISSENSCHA, V63, P397; Boltzmann L., 1881, BEIBL ANN PHYS, V5, P403; Boltzmann L., 1885, J REINE ANGEW MATH, V98, P68; Boltzmann L., 1868, MATH NATURWISSENSCHA, V58, P517; Boltzmann L., 1871, MATH NATURWISSENSCHA, V63, P679; Broda E., 1957, L BOLTZMANN MENSCH P; Brush S.G., 1986, KIND MOTION WE CALL; Brush S.G., 1983, STAT PHYS ATOMIC THE; Brush S.G., 1964, LECT GAS THEORY; Cahan D., 1993, H VONHELMHOLTZ FDN 1, P403; Cercignani C, 1998, L BOLTZMANN MAN WHO; Conrad M., 1907, ENCYKLOPADIE MATH WI, V4.4; Dugas R., 1959, THEORIE PHYS SENS BO; Ehrenfest P., 1911, ENCY MATH WISSENSCHA, V4.4, P3; Einstein A, 1903, ANN PHYS-BERLIN, V11, P170; Einstein A, 1911, ANN PHYS-BERLIN, V34, P175; Einstein A, 1902, ANN PHYS-BERLIN, V9, P417; Ezawa H., 1979, JAPANESE STUDIES HIS, V18, P27; Fasol G. L., 2006, L BOLTZMANN 1844 190; Fowler R.H., 1938, STAT MECH THEORY PRO; Gallavotti G., 1999, STAT MECH SHORT TREA; Gallavotti G, 2014, THEOR MATH PHYS SER, P1, DOI 10.1007/978-3-319-06758-2; Garber E., 1966, THESIS; Garber E., 1973, CENTAURUS, V17, P11, DOI 10.1111/j.1600-0498.1973.tb00182.x; Garber E., 1995, MAXWELL HEAT STAT ME; Garber E., 1986, MAXWELL MOL GASES; GEARHART CA, 1983, AM J PHYS, V51, P81, DOI 10.1119/1.13399; GEARHART CA, 1990, AM J PHYS, V58, P468, DOI 10.1119/1.16478; Gibbs J.VV., 1889, P AM ACAD, V16, P458; Gibbs J.W., 1902, ELEMENTARY PRINCIPLE; Gibbs J.W., 1884, P AM ASS ADV SCI 33, P57; Haas A., 1936, COMMENTARY SCI WRITI, VI; Haas A., 1936, COMMENTARY SCI WRITI, VII, P461; Haas A., 1936, COMMENTARY SCI WRITI, VII; Helmholtz H. v., 1884, J REINE ANGEW MATH, V97, P111; Helmholtz H. v., 1884, J REINE ANGEW MATH, V97, P317; Helmholtz H.v, 1884, SITZUNGSBERICHTE KON, V1884, P311; Helmholtz H.v, 1884, SITZUNGSBERICHTE KON, V1884, P755; Helmholtz H.v, 1884, SITZUNGSBERICHTE KON, V1884, P159; Hiromasa N., 2006, B LIBERAL ARTS ED CT, V26, P49; Hiroshige T., 1968, BUTSURIGAKUSHI; Inaba H., 2010, KAGAKUSHI KENKYU, V49, P1; Inoue T., 1989, BUTSURIGAKU SHI SONO, V4, P1; Klein M.J., 1987, ANCIENT OMENS STAT M, P281; Klein M. B., 1974, 1974 International Electron Devices Meeting (IEDM), DOI 10.1109/IEDM.1974.6219661; Klein M.J., 1970, P EHRENFEST MAKING T; Klein M.J., 1978, HUMAN IMPLICATIONS S, P330; Klein M.J., 1990, P GIBBS S YALE U MAY, P1; Klein M.J., 1969, HIST STUD PHYS SCI, V1, P127; Klein M.J., 1972, CENTAURUS, V17, P58; Klein M.J., 1983, SPRINGS SCI CREATIVI, P142; Knudsen O., 1987, ANCIENT OMENS STAT M, P271; Kobayashi T., 1996, BUTSURIGAKU SHI SONO, V9, P36; Kox A., 2014, CAMBRIDGE COMPANION, P103; Kruger L., 1981, PROBABILISTIC THINKI, P147; Kuhn T.S., 1987, BLACK BODY THEORY QU; Landau L.D., 1980, COURSES THEORETICAL, V5; Lorentz H. A., 1907, ABHANDLUNGEN THEORET, P202; Maxwell J.C., 1879, NATURE, V18, P242; Maxwell J.C., 1879, T CAMBRIDGE PHILOS S, V12, P547; Plato J. v., 1992, ARCH HIST EXACT SCI, V44, P71; Putnam F.W., 1884, P AM ASS ADV SCI 33; Renn J., 2005, Annalen der Physik, DOI 10.1002/andp.200410131; Renn J., 2014, CAMBRIDGE COMPANION, P38; Schiemann G., 1997, WAHRHEITSGEWISSHEITS; Sklar L., 1993, PHYS CHANCE PHILOS I; Stachel J., 1989, COLLECTED PAPERS A E, V3, P41; Tolman R.C., 1938, PRINCIPLES STAT MECH; Watson H.W., 1876, TREATISE KINETIC THE; Wheeler L.P., 1951, JW GIBBS HIST GREAT; Wilson E B, 1945, Proc Natl Acad Sci U S A, V31, P34, DOI 10.1073/pnas.31.1.34; Holton G., 1980, Some strangeness in the proportion. Centennial symposium to celebrate the achievements of Albert Einstein; Yamamoto Y., 2009, NETSUGAKU SHISO NO S, V3	97	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	2102-6459	2102-6467		EUR PHYS J H	Eur. Phys. J. H	DEC	2015	40	4-5					489	526		10.1140/epjh/e2015-60034-2		38	History & Philosophy Of Science; Physics, Multidisciplinary	History & Philosophy of Science; Physics	CY7ZV	WOS:000366629100003		
J	Tamura, T; Kimura, K; Yui, K; Yoshida, S				Tamura, Takahiko; Kimura, Kazumi; Yui, Katsuyuki; Yoshida, Shigeto			Reduction of conventional dendritic cells during Plasmodium infection is dependent on activation induced cell death by type I and II interferons	EXPERIMENTAL PARASITOLOGY			English	Article						Malaria; Dendritic cells; Interferons	EXPERIMENTAL CEREBRAL MALARIA; BLOOD-STAGE; SIGNALING PATHWAYS; BERGHEI ANKA; FLT3 LIGAND; RECEPTOR; IMMUNITY; VIVO; PATHOGENESIS; ENHANCEMENT	Dendritic cells (DCs) play critical roles in innate and adaptive immunity and in pathogenesis during the blood stage of malaria infection. The mechanisms underlying DC homeostasis during malaria infection are not well understood. In this study, the numbers of conventional DCs (cDCs) and plasmacytoid DCs (pDCs) in the spleens after lethal rodent malaria infection were examined, and were found to be significantly reduced. Concomitant with up-regulation of maturation-associated molecules, activation of caspase-3 was significantly increased, suggesting induction of cell death. Studies using neutralizing antibody and gene-deficient mice showed that type I and II interferons were critically involved in activation induced cell death of cDCs during malaria infection. These results demonstrate that DCs rapidly disappeared following IFN-mediated DC activation, and that homeostasis of DCs was significantly impaired during malaria infection. (C) 2015 Elsevier Inc. All rights reserved.	[Tamura, Takahiko; Kimura, Kazumi; Yui, Katsuyuki] Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Microbiol & Immunol, Div Immunol, Nagasaki 8528523, Japan; [Tamura, Takahiko; Yui, Katsuyuki] Nagasaki Univ, Global COE Program, Nagasaki 8528523, Japan; [Tamura, Takahiko; Yoshida, Shigeto] Kanazawa Univ, Sch Pharm, Lab Vaccinol & Appl Immunol, Kanazawa, Ishikawa 9201192, Japan	Tamura, T (reprint author), Kanazawa Univ, Sch Pharm, Lab Vaccinol & Appl Immunol, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan.	tamura99@p.kanazawa-u.ac.jp			Japan Society for the Promotion of Science [21390125, 24590507]	We appreciate Dr. S. Akira and Dr. K. Takeda for donating MyD88<SUP>-/-</SUP> and Trif<SUP>-/-</SUP> mice, Dr. M. Toni for PyL, and Dr. Yuda for PbA. We also thank N. Kawamoto for technical assistance. This study was supported by grants-in-aid for scientific research from the Japan Society for the Promotion of Science to K.Y. (21390125) and T.T. (24590507). The authors declare no competing financial interests.	Wykes MN, 2011, P NATL ACAD SCI USA, V108, P11205, DOI 10.1073/pnas.1108579108; Belnoue E, 2002, J IMMUNOL, V169, P6369; Zander Ryan A., 2013, Current Immunology Reviews, V9, P179, DOI 10.2174/1573395509666131126230832; Watarai H, 2008, P NATL ACAD SCI USA, V105, P2993, DOI 10.1073/pnas.0710351105; Tamura T, 2014, PARASITE IMMUNOL, V36, P87, DOI 10.1111/pim.12085; Kushwah R, 2010, J IMMUNOL, V185, P795, DOI 10.4049/jimmunol.1000325; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Reizis B, 2011, ANNU REV IMMUNOL, V29, P163, DOI 10.1146/annurev-immunol-031210-101345; deWalick S, 2007, J IMMUNOL, V178, P6033; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Palomo J, 2013, EUR J IMMUNOL, V43, P2683, DOI 10.1002/eji.201343327; Franklin BS, 2009, P NATL ACAD SCI USA, V106, P5789, DOI 10.1073/pnas.0809742106; Pene F, 2009, INFECT IMMUN, V77, P5651, DOI 10.1128/IAI.00238-09; Gautier G, 2005, J EXP MED, V201, P1435, DOI 10.1081/jem.20011961; Gazzinelli RT, 2006, NAT REV IMMUNOL, V6, P895, DOI 10.1038/nri1978; Schofield L, 2005, NAT REV IMMUNOL, V5, P722, DOI 10.1038/nri1686; Guermonprez P, 2013, NAT MED, V19, P730, DOI 10.1038/nm.3197; Liu K, 2010, IMMUNOL REV, V234, P45, DOI 10.1111/j.0105-2896.2009.00879.x; de Souza JB, 2010, PARASITOLOGY, V137, P755, DOI 10.1017/S0031182009991715; Wu J, 2014, P NATL ACAD SCI USA, V111, pE511, DOI 10.1073/pnas.1316467111; McCall MBB, 2010, J LEUKOCYTE BIOL, V88, P1131, DOI 10.1189/jlb.0310137; Swiecki M, 2011, J EXP MED, V208, P2367, DOI 10.1084/jem.20110654; Kordes M, 2011, INFECT IMMUN, V79, P3633, DOI 10.1128/IAI.05459-11; Wang TH, 2009, BLOOD, V113, P2906, DOI 10.1182/blood-2008-08-176354; Wilson NS, 2006, NAT IMMUNOL, V7, P165, DOI 10.1038/ni1300; Tamura T, 2011, INFECT IMMUN, V79, P3947, DOI 10.1128/IAI.01337-10; Nopora A, 2002, J IMMUNOL, V169, P3006; Pinzon-Charry A, 2013, J EXP MED, V210, P1635, DOI [10.1084/jem.20121972, 10.1084/jem.]; Marraco SAF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020189; Gazzinelli RT, 2014, NAT REV IMMUNOL, V14, P744, DOI 10.1038/nri3742; Hague A, 2011, EUR J IMMUNOL, V41, P2688, DOI [10.1002/eji.201141539, DOI 10.1002/EJI.201141539]; Kim CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048126; Mattei F, 2009, EUR J IMMUNOL, V39, P1807, DOI 10.1002/eji.200939233	33	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4894	1090-2449		EXP PARASITOL	Exp. Parasitol.	DEC	2015	159						127	135		10.1016/j.exppara.2015.09.010		9	Parasitology	Parasitology	CY5JC	WOS:000366442900017		
J	Kouchi, T; Goyne, CP; Rockwell, RD; McDaniel, JC				Kouchi, Toshinori; Goyne, Christopher P.; Rockwell, Robert D.; McDaniel, James C.			Focusing-schlieren visualization in a dual-mode scramjet	EXPERIMENTS IN FLUIDS			English	Article							SUPERSONIC CROSS-FLOWS; TIME EVOLUTION; COMBUSTOR; JETS	Schlieren imaging is particularly suited to measuring density gradients in compressible flowfields and can be used to capture shock waves and expansion fans, as well as the turbulent structures of mixing and wake flows. Conventional schlieren imaging, however, has difficulty clearly capturing such structures in long-duration supersonic combustion test facilities. This is because the severe flow temperatures locally change the refractive index of the window glass that is being used to provide optical access. On the other hand, focusing-schlieren imaging presents the potential of reduced sensitivity to thermal distortion of the windows and to clearly capture the flow structures even during a combustion test. This reduced sensitivity is due the technique's ability to achieve a narrow depth of focus. As part of this study, a focusing-schlieren system was developed with a depth of focus near +/- 5 mm and was applied to a direct-connect, continuous-flow type, supersonic combustion test facility with a stagnation temperature near 1200 K. The present system was used to successfully visualize the flowfield inside a dual-mode scramjet. The imaging system captured combustion-induced volumetric expansion of the fuel jet and an anchored bifurcated shock wave at the trailing edge of the ramp fuel injector. This is the first time successful focusing-schlieren measurements have been reported for a dual-mode scramjet.	[Kouchi, Toshinori] Okayama Univ, Dept Mech & Syst Engn, Kita Ku, Okayama, Okayama 7008530, Japan; [Goyne, Christopher P.; Rockwell, Robert D.; McDaniel, James C.] Univ Virginia, Dept Mech & Aerosp Engn, Charlottesville, VA 22904 USA	Kouchi, T (reprint author), Okayama Univ, Dept Mech & Syst Engn, Kita Ku, Tsushimanaka 3-1-1, Okayama, Okayama 7008530, Japan.	kouchi@okayama-u.ac.jp			Japan Society for the Promotion of Science; National Center for Hypersonic Combined Cycle Propulsion [FA 9550-09-1-0611]	The authors appreciate the assistant of Dr. Roland Krauss and Mr. Roger Reynolds in operating the supersonic combustion facility. This work was supported by Young Researcher Oversea Study Program of the Japan Society for the Promotion of Science. This research was also supported by the National Center for Hypersonic Combined Cycle Propulsion Grant FA 9550-09-1-0611. The technical monitors on the Grant were Chiping Li (AFOSR), and Aaron Auslender and Rick Gaffney (NASA).	BROWN GL, 1974, J FLUID MECH, V64, P775, DOI 10.1017/S002211207400190X; Weinstein LM, 2010, EUR PHYS J-SPEC TOP, V182, P65, DOI 10.1140/epjst/e2010-01226-y; GARTENBERG E, 1994, AIAA J, V32, P1242, DOI 10.2514/3.12126; Rockwell RD, 2014, J PROPUL POWER, V30, P530, DOI 10.2514/1.B35021; Weiss A, 2010, EXP FLUIDS, V49, P355, DOI 10.1007/s00348-009-0764-9; Ben-Yakar A, 2002, EXP FLUIDS, V32, P652, DOI 10.1007/s00348-002-0405-z; Ben-Yakar A, 2006, PHYS FLUIDS, V18, DOI 10.1063/1.2139684; Fotia ML, 2012, J PROPUL POWER, V28, P83, DOI 10.2514/1.B34367; Matsuo K, 1999, PROG AEROSP SCI, V35, P33, DOI 10.1016/S0376-0421(98)00011-6; Babinsky H, 2011, SHOCK WAVE BOUNDARY, P55; Kouchi T, 2009, AIAA20097316, DOI [10.2514/6.2009-7316, DOI 10.2514/6.2009-7316]; Kouchi T, 2012, AIAA20124148, DOI [10.2514/6.2012-4148, DOI 10.2514/6.2012-4148]; Krauss RH, 1992, AIAA923912, DOI [10.2514/6.1992-3912, DOI 10.2514/6.1992-3912]; Laurence SJ, 2011, AIAA20112310, DOI [10.2514/6.2011-2310, DOI 10.2514/6.2011-2310]; Settles GS, 2001, SCHLIEREN SHADOWGRAP, P88; VanDercreek C, 2010, 27 AIAA AER MEAS TEC	16	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0723-4864	1432-1114		EXP FLUIDS	Exp. Fluids	DEC	2015	56	12							211	10.1007/s00348-015-2081-9		14	Engineering, Mechanical; Mechanics	Engineering; Mechanics	CY8DU	WOS:000366639800005		
J	Craige, SM; Kant, S; Reif, M; Chen, K; Pei, YM; Angoff, R; Sugamura, K; Fitzgibbons, T; Keaney, JF				Craige, Siobhan M.; Kant, Shashi; Reif, Michaella; Chen, Kai; Pei, Yongmei; Angoff, Rebecca; Sugamura, Koichi; Fitzgibbons, Timothy; Keaney, John F., Jr.			Endothelial NADPH oxidase 4 protects ApoE-/- mice from atherosclerotic lesions	FREE RADICAL BIOLOGY AND MEDICINE			English	Article						NADPH Oxidase 4; Reactive oxygen species; Atherosclerosis; T regulatory cells; CXCL9	REGULATORY T-CELLS; OXIDATIVE STRESS; NOX4; ACTIVATION; HYPERCHOLESTEROLEMIA; LOCALIZATION; SUPEROXIDE; INDUCTION; RESPONSES; REVEALS	Vascular reactive oxygen species (ROS) are known to be involved in atherosclerosis development and progression. NADPH oxidase 4 (Nox4) is a constitutively active ROS-producing enzyme that is highly expressed in the vascular endothelium. Nox4 is unique in its biology and has been implicated in vascular repair, however, the role of Nox4 in atherosclerosis is unknown. Therefore, to determine the effect of endothelial Nox4 on development of atherosclerosis, Apoe E-/- mice +/- endothelial Nox4 (ApoE-/- + EC Nox4) were fed a high cholesterol/high fat (Western) diet for 24 weeks. Significantly fewer atherosclerotic lesions were observed in the ApoE-/- + EC Nox4 mice as compared to the ApoE-/- littermates, which was most striking in the abdominal region of the aorta. In addition, markers of T cell populations were markedly different between the groups; T regulatory cell marker (FoxP3) was increased whereas T effector cell marker (T-bet) was decreased in aorta from ApoE-/- + EC Nox4 mice compared to ApoE-/- alone. We also observed decreased monokine induced by gamma interferon (MIG; CXCL9), a cytokine known to recruit and activate T cells, in plasma and tissue from ApoE-/- + EC Nox4 mice. To further investigate the link between endothelial Nox4 and MIG expression, we utilized cultured endothelial cells from our EC Nox4 transgenic mice and human cells with adenoviral overexpression of Nox4. In these cultured cells, upregulation of Nox4 attenuated endothelial cell MIG expression in response to interferon-gamma. Together these data suggest that endothelial Nox4 expression reduces MIG production and promotes a T cell distribution that favors repair over inflammation, leading to protection from atherosclerosis. (C) 2015 Elsevier Inc. All rights reserved.	[Craige, Siobhan M.; Kant, Shashi; Reif, Michaella; Chen, Kai; Pei, Yongmei; Angoff, Rebecca; Fitzgibbons, Timothy; Keaney, John F., Jr.] Univ Massachusetts, Sch Med, Dept Med, Div Cardiovasc Med, Worcester, MA 01605 USA; [Sugamura, Koichi] Kumamoto Univ Hosp, Dept Cardiovasc Med, Kumamoto, Japan	Craige, SM (reprint author), Univ Massachusetts, Sch Med, Albert Sherman Ctr, 363 Plantat St, Worcester, MA 01605 USA.	siobhan.craige@umassmed.edu			NHLBI [F32HL099282, R01HL092122, R01HL098407]	This work was supported by F32HL099282 (SMC), R01HL092122 (JFK), and R01HL098407 (JFK) from the NHLBI.	Amarnath S, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-57; Chen K, 2008, J CELL BIOL, V181, P1129, DOI 10.1083/jcb.200709049; Stocker R, 2005, J THROMB HAEMOST, V3, P1825, DOI 10.1111/j.1538-7836.2005.01370.x; Lassegue B, 2012, CIRC RES, V110, P1364, DOI 10.1161/CIRCRESAHA.111.243972; Veillard NR, 2005, CIRCULATION, V112, P870, DOI 10.1161/CIRCULATIONAHA.104.520718; Heller EA, 2006, CIRCULATION, V113, P2301, DOI 10.1161/CIRCULATIONAHA.105.605121; Maganto-Garcia E, 2011, CIRCULATION, V124, P185, DOI 10.1161/CIRCULATIONAHA.110.006411; Hecker L, 2009, NAT MED, V15, P1077, DOI 10.1038/nm.2005; Guzik B, 2013, INT J CARDIOL, V168, P2389, DOI 10.1016/j.ijcard.2013.01.278; Szocs K, 2002, ARTERIOSCL THROM VAS, V22, P21, DOI 10.1161/hq0102.102189; Kim HP, 2014, NANOSCALE RES LETT, V9, P1, DOI 10.1186/1556-276X-9-323; Kraaij MD, 2010, P NATL ACAD SCI USA, V107, P17686, DOI 10.1073/pnas.1012016107; Nisimoto Y, 2014, BIOCHEMISTRY-US, V53, P5111, DOI 10.1021/bi500331y; Takac I, 2011, J BIOL CHEM, V286, P13304, DOI 10.1074/jbc.M110.192138; Maloney E, 2009, ARTERIOSCL THROM VAS, V29, P1370, DOI 10.1161/ATVBAHA.109.188813; Schroder K, 2012, CIRC RES, V110, P1217, DOI 10.1161/CIRCRESAHA.112.267054; Pober JS, 2012, TRENDS IMMUNOL, V33, P49, DOI 10.1016/j.it.2011.09.006; Martyn KD, 2006, CELL SIGNAL, V18, P69, DOI 10.1016/j.cellsig.200503.023; Sirker A, 2011, BASIC RES CARDIOL, V106, P735, DOI 10.1007/s00395-011-0190-z; Klingenberg R, 2013, J CLIN INVEST, V123, P1323, DOI 10.1172/JCI63891; Serrander L, 2007, BIOCHEM J, V406, P105, DOI 10.1042/BJ20061903; Helmcke I, 2009, ANTIOXID REDOX SIGN, V11, P1279, DOI 10.1089/ARS.2008.2383; Lee K, 2011, P NATL ACAD SCI USA, V108, P9548, DOI 10.1073/pnas.1012645108; Ait-Oufella H, 2006, NAT MED, V12, P178, DOI 10.1038/nm1343; Nisimoto Y, 2010, BIOCHEMISTRY-US, V49, P2433, DOI 10.1021/bi9022285; Sorescu D, 2002, CIRCULATION, V105, P1429, DOI 10.1161/01.CIR.0000012917.74432.66; Craige SM, 2011, CIRCULATION, V124, P731, DOI 10.1161/CIRCULATIONAHA.111.030775	27	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0891-5849	1873-4596		FREE RADICAL BIO MED	Free Radic. Biol. Med.	DEC	2015	89						1	7		10.1016/j.freeradbiomed.2015.07.004		7	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Biochemistry & Molecular Biology; Endocrinology & Metabolism	CY4CI	WOS:000366355800001		
J	Wang, DP; Ma, Y; Yang, X; Xu, XG; Zhao, YY; Zhu, Z; Wang, XJ; Deng, HY; Li, CC; Gao, FF; Tong, J; Yamanaka, K; An, Y				Wang, Dapeng; Ma, Yuan; Yang, Xu; Xu, Xiguo; Zhao, Yingying; Zhu, Zhen; Wang, Xiaojuan; Deng, Hanyi; Li, Chunchun; Gao, Fenfang; Tong, Jian; Yamanaka, Kenzo; An, Yan			Hypermethylation of the Keap1 gene inactivates its function, promotes Nrf2 nuclear accumulation, and is involved in arsenite-induced human keratinocyte transformation	FREE RADICAL BIOLOGY AND MEDICINE			English	Article						Arsenite; Carcinogenesis; Keap1; Methylation; Nrf2; Free radicals	INDUCED MALIGNANT-TRANSFORMATION; DNA METHYLTRANSFERASE INHIBITORS; EPITHELIAL-CELLS; CANCER-CELLS; HUMAN-DISEASE; METHYLATION; EXPRESSION; ACTIVATION; RESISTANCE; TOXICITY	is well known that long-term exposure to arsenite leads to human skin cancer, but the underlying mechanisms of carcinogenesis remain obscure. The transcription factor Nrf2-mediated antioxidant response represents a critical cellular defense mechanism; however, emerging data suggest that constitutive activation of Nrf2 is associated with cancer development and chemotherapy resistance. The reasons Nrf2 continuously accumulates in cancer cells remain to be fully understood. By establishing transformed human keratinocyte cells via chronic arsenite treatment, we observed a continuous reduction in reactive oxygen species levels and enhanced levels of Nrf2 and its target antioxidant enzymes in the later stage of arsenite-induced cell transformation. We also revealed that hypermethylation of the Keap1 gene promoter region induced by DNA methyltransferase-3 leading to inactivation of its function was responsible for constitutive activation of Nrf2 and its target enzymes. To validate these observations, the expression of Keap1 protein was restored in arsenite-transformed cells by treatment with a DNA methyltransferase inhibitor, 5-aza-2'-deoxycytidine (5-Aza-dC), and protein levels of Nrf2 and colony formation were then determined after these treatments. Results showed that enhancement of Keap1 expression by 5-Aza-dC significantly reduced NO and its target antioxidant enzyme levels, and that in turn suppressed cell proliferation and colony formation of the transformed cells. Taken together, the present study strongly suggests that loss of Keap1 function by hypermethylation of its promoter region leading to NO nuclear accumulation appears to play a role in arsenite-induced human keratinocyte transformation. (C) 2015 Elsevier Inc. All rights reserved	[Wang, Dapeng; Ma, Yuan; Yang, Xu; Xu, Xiguo; Zhao, Yingying; Zhu, Zhen; Wang, Xiaojuan; Deng, Hanyi; Li, Chunchun; Gao, Fenfang; Tong, Jian; An, Yan] Soochow Univ, Coll Med, Jiangsu Key Lab Prevent & Translat Med Geriatr Di, Dept Toxicol,Sch Publ Hlth, Suzhou 215123, Jiangsu, Peoples R China; [Wang, Dapeng] Guizhou Med Univ, Sch Publ Hlth, Dept Toxicol, Guiyang 550025, Guizhou, Peoples R China; [Yamanaka, Kenzo] Nihon Univ, Sch Pharm, Lab Environm Toxicol & Carcinogenesis, Chiba, Japan	An, Y (reprint author), Soochow Univ, Coll Med, Jiangsu Key Lab Prevent & Translat Med Geriatr Di, Dept Toxicol,Sch Publ Hlth, Suzhou 215123, Jiangsu, Peoples R China.	dranyan@126.com			National Natural Science Foundation of China [81573173]; Research Fund for the Doctoral Program of Higher Education of China [20123201110012]; Graduate Innovation Project of Jiangsu Province [ZY32007613]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [26460176]; National Natural Science Foundation of China (NSFC) [Q3126982]; Projects of Key International Cooperation and Exchanges [NSFC 81020108028]; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported in part by the National Natural Science Foundation of China (81573173); the Research Fund for the Doctoral Program of Higher Education of China (20123201110012); the Graduate Innovation Project of Jiangsu Province (ZY32007613); a Grant-in-Aid for Scientific Research (C) (No. 26460176) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; a Pre-research of the National Natural Science Foundation of China (NSFC) research grant (Q3126982); the Projects of Key International Cooperation and Exchanges (NSFC 81020108028); and the Priority Academic Program Development of Jiangsu Higher Education Institutions.	Stacy DR, 2006, HEAD NECK-J SCI SPEC, V28, P813, DOI 10.1002/hed.20430; Shibata T, 2008, GASTROENTEROLOGY, V135, P1358, DOI 10.1053/j.gastro.2008.06.082; Li YA, 2010, TOXICOL SCI, V116, P174, DOI 10.1093/toxsci/kfq109; Zhao R, 2012, ENVIRON HEALTH PERSP, V120, P583, DOI 10.1289/ehp.1104580; Niture SK, 2013, FREE RADICAL BIO MED, V57, P119, DOI 10.1016/j.freeradbiomed.2012.12.014; Chang QS, 2010, CANCER RES, V70, P5127, DOI 10.1158/0008-5472.CAN-10-0007; Warnecke PM, 2000, CURR OPIN ONCOL, V12, P68, DOI 10.1097/00001622-200001000-00012; Pi JB, 2008, FREE RADICAL BIO MED, V45, P651, DOI 10.1016/j.freeradbiomed.2008.05.020; Achanzar WE, 2002, J NATL CANCER I, V94, P1888; Robertson KD, 2000, NAT REV GENET, V1, P11, DOI 10.1038/35049533; Stresemann C, 2008, INT J CANCER, V123, P8, DOI 10.1002/ijc.23607; Kitchin KT, 2010, CHEM RES TOXICOL, V23, P327, DOI 10.1021/tx900343d; Smeester L, 2011, CHEM RES TOXICOL, V24, P165, DOI 10.1021/tx1004419; Nioi P, 2007, BIOCHEM BIOPH RES CO, V362, P816, DOI 10.1016/j.bbrc.2007.08.051; JACOBSONKRAM D, 1985, ENVIRON MUTAGEN, V7, P787, DOI 10.1002/em.2860070515; Shin S, 2009, EUR J PHARMACOL, V620, P138, DOI 10.1016/j.ejphar.2009.08.022; Muscarella LA, 2011, EPIGENETICS-US, V6, P317; Du Y, 2008, ENVIRON HEALTH PERSP, V116, P1154, DOI 10.1289/ehp.11464; Wang L, 2012, ARCH TOXICOL, V86, P879, DOI 10.1007/s00204-012-0845-z; Reichard JF, 2007, BIOCHEM BIOPH RES CO, V352, P188, DOI 10.1016/j.bbrc.2006.11.001; Jing Y, 2012, TOXICOL SCI, V125, P10, DOI 10.1093/toxsci/kfr256; Lyko F, 2005, J NATL CANCER I, V97, P1498, DOI 10.1093/jnci/dji311; Reichard JF, 2010, EPIGENOMICS-UK, V2, P87, DOI [10.2217/epi.09.45, 10.2217/EPI.09.45]; Li B, 2013, ENVIRON TOXICOL, V28, P401, DOI 10.1002/tox.20731; Nekanti U, 2010, INT J BIOL SCI, V6, P499; Ren XF, 2011, ENVIRON HEALTH PERSP, V119, P11, DOI 10.1289/ehp.1002114; Jomova K, 2011, J APPL TOXICOL, V31, P95, DOI 10.1002/jat.1649; Jiang T, 2010, DIABETES, V59, P850, DOI 10.2337/db09-1342; Rossman TG, 2011, METALLOMICS, V3, P1135, DOI 10.1039/c1mt00074h; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Zhang P, 2010, MOL CANCER THER, V9, P336, DOI 10.1158/1535-7163.MCT-09-0589; Niture SK, 2012, J BIOL CHEM, V287, P9873, DOI 10.1074/jbc.M111.312694; Gueraud F, 2010, FREE RADICAL RES, V44, P1098, DOI 10.3109/10715762.2010.498477; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Wang XJ, 2008, CARCINOGENESIS, V29, P1235, DOI 10.1093/carcin/bgn095; Zhao CQ, 1997, P NATL ACAD SCI USA, V94, P10907, DOI 10.1073/pnas.94.20.10907; CULLEN WR, 1989, CHEM REV, V89, P713, DOI 10.1021/cr00094a002; Pi JB, 2003, EXP CELL RES, V290, P234, DOI 10.1016/S0014-4827(03)00341-0; Centeno JA, 2002, ENVIRON HEALTH PERSP, V110, P883; Cho HY, 2002, AM J RESP CELL MOL, V26, P175; Kobayashi M, 2006, ADV ENZYME REGUL, V46, P113, DOI 10.1016/j.advenzreg.2006.01.007; Ohta T, 2008, CANCER RES, V68, P1303, DOI 10.1158/0008-5472.CAN-07-5003; Lau A, 2008, PHARMACOL RES, V58, P262, DOI 10.1016/j.phrs.2008.09.003; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Zhang DD, 2006, DRUG METAB REV, V38, P769, DOI 10.1080/03602530600971974; Gopalakrishnan S, 2008, MUTAT RES-FUND MOL M, V647, P30, DOI 10.1016/j.mrfmmm.2008.08.006; Wang R, 2008, BIOCHEM BIOPH RES CO, V373, P151, DOI 10.1016/j.bbrc.2008.06.004; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Mitsuishi Y, 2012, CANCER CELL, V22, P66, DOI 10.1016/j.ccr.2012.05.016; Baylin SB, 1998, ADV CANCER RES, V72, P141; Chain C.W., 2004, ENV HLTH PERSPECT, V112, P1704; Hanada N, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-66; Rossman TG, 2003, MUTAT RES-FUND MOL M, V533, P37, DOI 10.1016/j.mrfmmm.2003.07.009; Singh A, 2006, PLOS MED, V3, P1865, DOI 10.1371/journal.pmed.0030420; Singh Amrit Pal, 2011, Toxicol Int, V18, P87, DOI 10.4103/0971-6580.84258; Watson J, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120144; Wen G., 2007, MOL MED, V14, P2; Working Group on the Evaluation of Carcinogenic Risks to Humans, 2012, IARC MON C, V100C, P36	58	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0891-5849	1873-4596		FREE RADICAL BIO MED	Free Radic. Biol. Med.	DEC	2015	89						209	219		10.1016/j.freeredbiomed.2015.07.153		11	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Biochemistry & Molecular Biology; Endocrinology & Metabolism	CY4CI	WOS:000366355800020		
J	Tanaka, Y; Kume, S; Araki, H; Nakazawa, J; Chin-Kanasaki, M; Araki, S; Nakagawa, F; Koya, D; Haneda, M; Maegawa, H; Uzu, T				Tanaka, Yuki; Kume, Shinji; Araki, Hisazumi; Nakazawa, Jun; Chin-Kanasaki, Masami; Araki, Shin-ichi; Nakagawa, Fumiyuki; Koya, Daisuke; Haneda, Masakazu; Maegawa, Hiroshi; Uzu, Takashi			1-Methylnicotinamide ameliorates lipotoxicity-induced oxidative stress and cell death in kidney proximal tubular cells	FREE RADICAL BIOLOGY AND MEDICINE			English	Article						Nicotinamide N-methyltransferase (NNMT); Nicotinamide adenine dinucleotide (NAD); Proteinuria; Lipotoxicity; Proximal tubular cell damage; Apoptosis Necrosis	FATTY-ACIDS; SIGNALING PATHWAYS; APOPTOSIS; NAD(+); PROTEINURIA; PALMITATE; MICE; INFLAMMATION; DISEASE; MNA	Free fatty acid-bound albumin (FFA-albumin)-related oxidative stress is involved in the pathogenesis of proximal tubular cell (PTC) damage and subsequent renal dysfunction in patients with refractory proteinuria. Nicotinamide adenine dinucleotide (NAD) metabolism has recently been focused on as a novel therapeutic target for several modern diseases, including diabetes. This study was designed to identify a novel molecule in NAD metabolism to protect PTCs from lipotoxicity-related oxidative stress. Among 19 candidate enzymes involved in mammalian NAD metabolism, the mRNA expression level of nicotinamide n-methyltransferase (NNMT) was significantly increased in both the kidneys of FFA-albumin-overloaded mice and cultured PTCs stimulated with palmitate-albumin. Knockdown of NNMT exacerbated palmitate-albumin-induced cell death in cultured PTCs, whereas overexpression of NNMT inhibited it. Intracellular concentration of 1-Methylnicotinamide (1-MNA), a metabolite of NNMT, increased and decreased in cultured NNMT-overexpressing and -knockdown PTCs, respectively. Treatment with 1-MNA inhibited palmitate-albumin-induced mitochondrial reactive oxygen species generation and cell death in cultured PTCs. Furthermore, oral administration of 1-MNA ameliorated oxidative stress, apoptosis, necrosis, inflammation, and fibrosis in the kidneys of FFA-albumin-overloaded mice. In conclusion, NNMT-derived 1-MNA can reduce lipotoxicity-mediated oxidative stress and cell damage in PTCs. Supplementation of 1-MNA may have potential as a new therapy in patients with refractory proteinuria. (C) 2015 Elsevier Inc. All rights reserved.	[Tanaka, Yuki; Kume, Shinji; Araki, Hisazumi; Nakazawa, Jun; Chin-Kanasaki, Masami; Araki, Shin-ichi; Nakagawa, Fumiyuki; Maegawa, Hiroshi; Uzu, Takashi] Shiga Univ Med Sci, Dept Med, Otsu, Shiga 5202192, Japan; [Nakagawa, Fumiyuki] CMIC Pharma Sci Co Ltd, Osaka Lab, Suita, Osaka, Japan; [Koya, Daisuke] Kanazawa Med Univ, Dept Diabetol & Endocrinol, Kanazawa, Ishikawa, Japan; [Haneda, Masakazu] Asahikawa Med Univ, Div Metab & Biosyst Sci, Asahikawa, Hokkaido, Japan	Kume, S (reprint author), Shiga Univ Med Sci, Dept Med, Tsukinowa Cho, Otsu, Shiga 5202192, Japan.	skume@belle.shiga-med.ac.jp			Japan Society for the Promotion of Science [25713033, 26461223]	This study was supported by Grants-in-Aid for Scientific Research (KAKENHI) from the Japan Society for the Promotion of Science (No. 25713033 to S.K., and No. 26461223 to H.A). We thank Takeshi Sugaya (St. Marianna University School of Medicine) for providing cultured proximal cell lines and Kazumasa Oka (Hyogo Prefectural Nishinomiya Hospital) for providing expertize on renal histopathology. We are grateful to Naoko Yamanaka (Shiga University of Medical Science) for her technical assistance.	Araki S, 2007, DIABETES, V56, P1727, DOI 10.2337/db06-1646; Burton C, 1996, AM J KIDNEY DIS, V27, P765, DOI 10.1016/S0272-6386(96)90512-0; Ruggiero C, 2014, AM J PHYSIOL-RENAL, V306, pF896, DOI 10.1152/ajprenal.00484.2013; Bryniarski K, 2008, EUR J PHARMACOL, V578, P332, DOI 10.1016/j.ejphar.2007.09.011; Deji N, 2009, AM J PHYSIOL-RENAL, V296, pF118, DOI 10.1152/ajprenal.00110.2008; Takaya K, 2003, AM J PHYSIOL-RENAL, V284, pF1037, DOI 10.1152/ajprenal.00230.2002; Lv JC, 2012, J AM SOC NEPHROL, V23, P1108, DOI 10.1681/ASN.2011111112; Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014; Watala C, 2009, PHARMACOL REP, V61, P86; Sternak M, 2010, PHARMACOL REP, V62, P483; Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006; Bhansali SG, 2006, TOXICOL MECH METHOD, V16, P173, DOI 10.1080/15376520500194726; Bartus M, 2008, PHARMACOL REP, V60, P127; Sarnak MJ, 2000, AM J KIDNEY DIS, V35, pS117, DOI 10.1016/S0272-6386(00)70239-3; Canto C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022; Kume S, 2006, FREE RADICAL BIO MED, V40, P2175, DOI 10.1016/j.freeradbiomed.2006.02.014; Yuzefovych L, 2010, AM J PHYSIOL-ENDOC M, V299, pE1096, DOI 10.1152/ajpendo.00238.2010; Koyama T, 2011, FREE RADICAL BIO MED, V51, P1258, DOI 10.1016/j.freeradbiomed.2011.05.028; Soumura M, 2010, BIOCHEM BIOPH RES CO, V402, P265, DOI 10.1016/j.bbrc.2010.10.012; Kamijo A, 2002, KIDNEY INT, V62, P1628, DOI 10.1046/j.1523-1755.2002.00618.x; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Thomas ME, 2002, AM J PHYSIOL-RENAL, V283, pF640, DOI 10.1152/ajprenal.00001.2002; Tanaka Y, 2011, KIDNEY INT, V79, P871, DOI 10.1038/ki.2010.530; Yamahara K, 2013, J AM SOC NEPHROL, V24, P1769, DOI 10.1681/ASN.2012111080; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Sparagna GC, 2000, AM J PHYSIOL-HEART C, V279, pH2124; REAVEN GM, 1988, DIABETES, V37, P1020, DOI 10.2337/diabetes.37.8.1020; Parsons RB, 2011, BIOCHEM J, V436, P145, DOI 10.1042/BJ20101685; Berger F, 2004, TRENDS BIOCHEM SCI, V29, P111, DOI 10.1016/j.tibs.2004.01.007; Tanifuji C, 2005, ANTIOXID REDOX SIGN, V7, P1261, DOI 10.1089/ars.2005.7.1261; Xie XY, 2014, ARCH BIOCHEM BIOPHYS, V564, P52, DOI 10.1016/j.abb.2014.08.017; Abbate M, 2006, J AM SOC NEPHROL, V17, P2974, DOI 10.1681/ASN.2006040377; Houtkooper RH, 2010, ENDOCR REV, V31, P194, DOI 10.1210/er.2009-0026; Crowley CL, 2000, CELL DEATH DIFFER, V7, P314, DOI 10.1038/sj.cdd.4400658; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Coggins C H, 1986, Trans Am Clin Climatol Assoc, V97, P18; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Linkermann A, 2014, NAT REV IMMUNOL, V14, P759, DOI 10.1038/nri3743	38	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0891-5849	1873-4596		FREE RADICAL BIO MED	Free Radic. Biol. Med.	DEC	2015	89						831	841		10.1016/j.freeradbiomed.2015.10.414		11	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Biochemistry & Molecular Biology; Endocrinology & Metabolism	CY4CI	WOS:000366355800078		
J	Eto, H; Hyodo, F; Kosem, N; Kobayashi, R; Yasukawa, K; Nakao, M; Kiniwa, M; Utsumi, H				Eto, Hinako; Hyodo, Fuminori; Kosem, Nutavutt; Kobayashi, Ryoma; Yasukawa, Keiji; Nakao, Motonao; Kiniwa, Mamoru; Utsumi, Hideo			Redox imaging of skeletal muscle using in vivo DNP-MRI and its application to an animal model of local inflammation	FREE RADICAL BIOLOGY AND MEDICINE			English	Article						Dynamic nuclear polarization magnetic resonance imaging; Oxidation reduction; Inflammation; Neutrophil activity; Nitroxyl radical; Skeletal muscle	OVERHAUSER-ENHANCED MRI; MYELOPEROXIDASE; BUPIVACAINE; REGENERATION; ROPIVACAINE; INHIBITION; MECHANISMS; RADICALS; RAT	Disorders of skeletal muscle are often associated with inflammation and alterations in redox status. A non-invasive technique that could localize and evaluate the severity of skeletal muscle inflammation based on its redox environment would be useful for disease identification and monitoring, and for the development of treatments; however, no such technique currently exists. We describe a method for redox imaging of skeletal muscle using dynamic nuclear polarization magnetic resonance imaging (DNP-MRI), and apply this method to an animal model of local inflammation. Female C57/BL6 mice received injections of 0.5% bupivacaine into their gastrocnemius muscles. Plasma biomarkers, myeloperoxidase activity, and histological sections were assessed at 4 and 24 h after bupivacaine injection to measure the inflammatory response. In vivo DNP-MRI was performed with the nitroxyl radicals carbamoyl-PROXYL (cell permeable) and carboxy-PROXYL (cell impermeable) as molecular imaging probes at 4 and 24 h after bupivacaine administration. The images obtained after carbamoyl-PROXYL administration were confirmed with the results of L-band EPR spectroscopy. The plasma biomarkers, myeloperoxidase activity, and histological findings indicated that bupivacaine injection caused acute muscle damage and inflammation. DNP-MRI images of mice treated with carbamoyl-PROXYL or carboxy-PROXYL at 4 and 24 h after bupivacaine injection showed similar increases in image intensity and decay rate was significantly increased at 24 h. In addition, reduction rates in individual mice at 4 h and 24 h showed faster trends with bupivacaine injection than in their contralateral sides by image-based analysis. These findings indicate that in vivo DNP-MRI with nitroxyl radicals can non-invasively detect changes in the focal redox status of muscle resulting from locally-induced inflammation. (C) 2015 Elsevier Inc. All rights reserved.	[Eto, Hinako; Hyodo, Fuminori; Kosem, Nutavutt; Kobayashi, Ryoma; Kiniwa, Mamoru; Utsumi, Hideo] Kyushu Univ, Innovat Ctr Med Redox Nav, Fukuoka 812, Japan; [Yasukawa, Keiji] Kyushu Univ, Fac Pharmaceut Sci, Fukuoka 812, Japan; [Yasukawa, Keiji] Daiichi Univ Pharm, Drug Innovat Res Ctr, Fukuoka, Japan; [Nakao, Motonao] Kyushu Univ, Div Metab, Res Ctr Trans Med, Med Inst Bioregulat, Fukuoka 812, Japan	Hyodo, F (reprint author), Kyushu Univ, Innovat Ctr Med Redox Nav, Fukuoka 812, Japan.	hyodof@redoxnavi.med.kyushu-u.ac.jp			Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program from the Ministry of Education, Culture, Sports, Science and Technology, Japan; Development of Advanced Measurement and Analysis Systems grant from the Japan Science and Technology Agency; KAKENHI [22249003, 25253005, 25713004]; Core-to-Core Program for Scientific Research from the Japan Society for the Promotion of Science	We thank Dr. T. Naganuma at Japan Redox Inc., and Dr. K Ichikawa at the Innovation Center for Medical Redox Navigation at Kyushu University, for providing the custom in vivo DNP-MRI system. This work was supported by the Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program from the Ministry of Education, Culture, Sports, Science and Technology, Japan; and by a Development of Advanced Measurement and Analysis Systems grant from the Japan Science and Technology Agency. This work was also supported by KAKENHI Grant Numbers 22249003, 25253005 and 25713004, and the Core-to-Core Program for Scientific Research from the Japan Society for the Promotion of Science.	Samouilov A, 2014, ANAL CHEM, V86, P1045, DOI 10.1021/ac402230h; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sztark F, 1998, ANESTHESIOLOGY, V88, P1340, DOI 10.1097/00000542-199805000-00026; Lagrota-Candido J, 2010, INT J EXP PATHOL, V91, P522, DOI 10.1111/j.1365-2613.2010.00737.x; Kim JH, 2013, J MUSCLE RES CELL M, V34, P1, DOI 10.1007/s10974-012-9330-9; KRAWISZ JE, 1984, GASTROENTEROLOGY, V87, P1344; Takeshita K, 1999, FREE RADICAL BIO MED, V26, P951, DOI 10.1016/S0891-5849(98)00278-0; Scutari G, 1998, BIOCHEM PHARMACOL, V56, P1633, DOI 10.1016/S0006-2952(98)00192-0; Hyodo F, 2014, ANAL CHEM, V86, P7234, DOI 10.1021/ac502150x; Valentine JS, 2002, FREE RADICAL BIO MED, V33, P1314, DOI 10.1016/S0891-5849(02)01080-8; Rees MD, 2009, BIOCHEM J, V421, P79, DOI 10.1042/BJ20090309; Krishna MC, 2002, P NATL ACAD SCI USA, V99, P2216, DOI 10.1073/pnas.042671399; Lurie DJ, 2005, MAGN RESON IMAGING, V23, P175, DOI 10.1016/j.mri.2004.11.051; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Yamato M, 2011, NEUROCHEM INT, V59, P804, DOI 10.1016/j.neuint.2011.08.010; Cela O, 2010, MITOCHONDRION, V10, P487, DOI 10.1016/j.mito.2010.05.005; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Soule BP, 2007, FREE RADICAL BIO MED, V42, P1632, DOI 10.1016/j.freeradbiomed.2007.02.030; OVERHAUSER AW, 1953, PHYS REV, V92, P411, DOI 10.1103/PhysRev.92.411; Ahn KH, 2011, MAGN RESON MED, V65, P1416, DOI 10.1002/mrm.22732; BENOIT PW, 1970, J ANAT, V107, P547; Queiroz RF, 2011, BIOCHEM J, V439, P423, DOI 10.1042/BJ20110555; LURIE DJ, 1988, J MAGN RESON, V76, P366, DOI 10.1016/0022-2364(88)90123-0; Utsumi H, 2006, P NATL ACAD SCI USA, V103, P1463, DOI 10.1073/pnas.0510670103; Tews DS, 1998, CLIN IMMUNOL IMMUNOP, V87, P240, DOI 10.1006/clin.1998.4527; Matsumoto S, 2007, MAGN RESON MED, V57, P806, DOI 10.1002/mrm.21198; Blankenbaker DG, 2004, APPL RADIOL, V33, P14; Duguez S, 2002, AM J PHYSIOL-ENDOC M, V282, pE802, DOI 10.1152/ajpendo.00343.2001; Koonjoo N, 2014, CONTRAST MEDIA MOL I, V9, P363, DOI 10.1002/cmmi.1586; Rasband W. S., 1997, IMAGE J; Ribeiro Paulo Domingos Jr, 2003, Anesth Prog, V50, P169; Wilcox CS, 2010, PHARMACOL THERAPEUT, V126, P119, DOI 10.1016/j.pharmthera.2010.01.003	32	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0891-5849	1873-4596		FREE RADICAL BIO MED	Free Radic. Biol. Med.	DEC	2015	89						1097	1104		10.1016/j.freeradbiomed.2015.10.418		8	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Biochemistry & Molecular Biology; Endocrinology & Metabolism	CY4CI	WOS:000366355800103		
J	Ichihashi, Y; Tsukaya, H				Ichihashi, Yasunori; Tsukaya, Hirokazu			Behavior of Leaf Meristems and Their Modification	FRONTIERS IN PLANT SCIENCE			English	Review						Arabidopsis thaliana; gene regulatory network; leaf development; leaf meristems; natural variation	ADAXIAL-ABAXIAL POLARITY; GENE REGULATORY NETWORKS; KNOX HOMEOBOX GENES; PLANT ORGAN SIZE; ARABIDOPSIS-THALIANA; CELL-PROLIFERATION; ASYMMETRIC LEAVES2; AUXIN-RESPONSE; TRANSCRIPTION FACTORS; FUNCTIONAL-ANALYSIS	A major source of diversity in flowering plant form is the extensive variability of leaf shape and size. Leaf formation is initiated by recruitment of a handful of cells flanking the shoot apical meristem (SAM) to develop into a complex three-dimensional structure. Leaf organogenesis depends on activities of several distinct meristems that are established and spatiotemporally differentiated after the initiation of leaf primordia. Here, we review recent findings in the gene regulatory networks that orchestrate leaf meristem activities in a model plant Arabidopsis thaliana. We then discuss recent key studies investigating the natural variation in leaf morphology to understand how the gene regulatory networks modulate leaf meristems to yield a substantial diversity of leaf forms during the course of evolution.	[Ichihashi, Yasunori] RIKEN Ctr Sustainable Resource Sci, Yokohama, Kanagawa, Japan; [Tsukaya, Hirokazu] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 113, Japan; [Tsukaya, Hirokazu] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Bionext Project, Okazaki, Aichi 4448787, Japan	Ichihashi, Y (reprint author), RIKEN Ctr Sustainable Resource Sci, Yokohama, Kanagawa, Japan.	yasunori.ichihashi@riken.jp			RIKEN from the Ministry of Education, Culture, Sports, Science and Technology, Japan [15K18589]; Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology, japan	We apologize to colleagues whose work could not be highlighted because of space limitations. This work was partially supported by the RIKEN Special Postdoctoral Researchers Program; Grantin-Aid for Young Scientists (B; grant no. 15K18589) from the Ministry of Education, Culture, Sports, Science and Technology, Japan to YI; and by the Japan Society for the Promotion of Science (Grants-in-Aid for Creative Scientific Research and Scientific Research A), the Ministry of Education, Culture, Sports, Science and Technology, japan (Scientific Research on Priority Areas and Scientific Research on Innovative Areas) to HT.	Agrios G. N., 2005, PLANT PATHOLOGY; Groszmann M, 2010, J EXP BOT, V61, P1495, DOI 10.1093/jxb/erq015; Nikovics K, 2006, PLANT CELL, V18, P2929, DOI 10.1105/tpc.106.045617; Li PH, 2010, NAT GENET, V42, P1060, DOI 10.1038/ng.703; Ueno Y, 2007, PLANT CELL, V19, P445, DOI 10.1105/tpc.106.042325; De Veylder L, 2001, PLANT CELL, V13, P1653, DOI 10.1105/tpc.13.7.1653; Wu G, 2008, P NATL ACAD SCI USA, V105, P16392, DOI 10.1073/pnas.0803997105; Ferjani A, 2007, PLANT PHYSIOL, V144, P988, DOI 10.1104/PP.107.099325; Iwakawa H, 2007, PLANT J, V51, P173, DOI 10.1111/j.1365-313X.2007.03132.x; Nardmann J, 2013, NEW PHYTOL, V199, P1081, DOI 10.1111/nph.12343; Bharathan G, 2002, SCIENCE, V296, P1858, DOI 10.1126/science.1070343; Kawade K, 2013, CURR BIOL, V23, P788, DOI 10.1016/j.cub.2013.03.044; Byrne ME, 2002, DEVELOPMENT, V129, P1957; Flood PJ, 2011, TRENDS PLANT SCI, V16, P327, DOI 10.1016/j.tplants.2011.02.005; Hu YX, 2003, PLANT CELL, V15, P1951, DOI 10.1105/tpc.013557; Nardmann J, 2004, DEVELOPMENT, V131, P2827, DOI 10.1242/dev.01164; Jun JH, 2010, PLANT CELL, V22, P62, DOI 10.1105/tpc.109.070763; White DWR, 2006, P NATL ACAD SCI USA, V103, P13238, DOI 10.1073/pnas.0604349103; Koyama T, 2010, PLANT CELL, V22, P3574, DOI 10.1105/tpc.110.075598; Kawamura E, 2010, PLANT J, V62, P429, DOI 10.1111/j.1365-313X.2010.04156.x; Lim PO, 2010, J EXP BOT, V61, P1419, DOI 10.1093/jxb/erq010; Hepworth SR, 2005, PLANT CELL, V17, P1434, DOI 10.1105/tpc.104.030536; Ha CM, 2007, PLANT CELL, V19, P1809, DOI 10.1105/tpc.107.051938; Gonzalez N, 2012, TRENDS PLANT SCI, V17, P332, DOI 10.1016/j.tplants.2012.02.003; Kuchen EE, 2012, SCIENCE, V335, P1092, DOI 10.1126/science.1214678; Chen XF, 2013, J EXP BOT, V64, P4895, DOI 10.1093/jxb/ert278; Ikezaki M, 2010, PLANT J, V61, P70, DOI 10.1111/j.1365-313X.2009.04033.x; Zgurski JM, 2005, PLANT CELL, V17, P77, DOI 10.1105/tpc.104.026898; Siegfried KR, 1999, DEVELOPMENT, V126, P4117; Toyokura K, 2015, PLANT CELL PHYSIOL, V56, P1229, DOI 10.1093/pcp/pcv050; Takahashi H, 2013, PLANT CELL PHYSIOL, V54, P418, DOI 10.1093/pcp/pct027; Fu YL, 2007, PLANT CELL PHYSIOL, V48, P724, DOI 10.1093/pcp/pcm040; Ha CM, 2010, GENETICS, V186, P197, DOI 10.1534/genetics.110.118703; Rebeiz M, 2009, SCIENCE, V326, P1663, DOI 10.1126/science.1178357; Ha CM, 2004, PLANT CELL PHYSIOL, V45, P1361, DOI 10.1093/pcp/pch201; Horiguchi G, 2011, PLANT J, V65, P724, DOI 10.1111/j.1365-313X.2010.04457.x; Vercruyssen L, 2014, PLANT CELL, V26, P210, DOI 10.1105/tpc.113.115907; Sawa S, 1999, GENE DEV, V13, P1079, DOI 10.1101/gad.13.9.1079; Horiguchi G, 2006, PLANT J, V48, P638, DOI 10.1111/j.1365-313X.2006.02896.x; Norberg M, 2005, DEVELOPMENT, V132, P2203, DOI 10.1242/dev.01815; Ikeuchi M, 2011, PLANT CELL PHYSIOL, V52, P59, DOI 10.1093/pcp/pcq138; Nath U, 2003, SCIENCE, V299, P1404, DOI 10.1126/science.1079354; Mizukami Y, 2000, P NATL ACAD SCI USA, V97, P942, DOI 10.1073/pnas.97.2.942; Vlad D, 2014, SCIENCE, V343, P780, DOI 10.1126/science.1248384; Garcia D, 2006, CURR BIOL, V16, P933, DOI 10.1016/j.cub.2006.03.064; Sicard A, 2014, CURR BIOL, V24, P1880, DOI 10.1016/j.cub.2014.06.061; Disch S, 2006, CURR BIOL, V16, P272, DOI 10.1016/j.cub.2005.12.026; Kim JH, 2004, P NATL ACAD SCI USA, V101, P13374, DOI 10.1073/pnas.0405450101; Kimura S, 2008, CURR BIOL, V18, P672, DOI 10.1016/j.cub.2008.04.008; Efroni I, 2013, DEV CELL, V24, P438, DOI 10.1016/j.devcel.2013.01.019; Iwasaki M, 2013, DEVELOPMENT, V140, P1958, DOI 10.1242/dev.085365; Ha CM, 2003, DEVELOPMENT, V130, P161, DOI 10.1242/dev.00196; Blein T, 2008, SCIENCE, V322, P1835, DOI 10.1126/science.1166168; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Nakata M, 2012, PLANT CELL, V24, P519, DOI 10.1105/tpc.111.092858; Nicotra AB, 2011, FUNCT PLANT BIOL, V38, P535, DOI 10.1071/FP11057; Guo P, 2015, J PLANT RES, V128, P497, DOI 10.1007/s10265-015-0703-1; Ichihashi Y, 2010, PLANT CELL PHYSIOL, V51, P252, DOI 10.1093/pcp/pcp184; Ichihashi Y, 2014, P NATL ACAD SCI USA, V111, pE2616, DOI 10.1073/pnas.1402835111; Rojas CA, 2009, PLANT MOL BIOL, V71, P307, DOI 10.1007/s11103-009-9525-7; Guo MJ, 2008, PLANT CELL, V20, P48, DOI 10.1105/tpc.107.056127; Eriksson S, 2010, CURR BIOL, V20, P527, DOI 10.1016/j.cub.2010.01.039; Loehlin DW, 2012, SCIENCE, V335, P943, DOI 10.1126/science.1215193; Rodriguez RE, 2010, DEVELOPMENT, V137, P103, DOI 10.1242/dev.043067; Yao Y, 2008, DEVELOPMENT, V135, P1325, DOI 10.1242/dev.017913; Fischer AHL, 2012, INTEGR COMP BIOL, V52, P842, DOI 10.1093/icb/ics112; Bilsborough GD, 2011, P NATL ACAD SCI USA, V108, P3424, DOI 10.1073/pnas.1015162108; Koyama T, 2007, PLANT CELL, V19, P473, DOI 10.1105/tpc.106.044792; Ohno CK, 2004, DEVELOPMENT, V131, P1111, DOI 10.1242/dev.00991; Kono A, 2007, PLANT CELL, V19, P1265, DOI 10.1105/tpc.106.046763; Krizek BA, 1999, DEV GENET, V25, P224, DOI 10.1002/(SICI)1520-6408(1999)25:3<224::AID-DVG5>3.3.CO;2-P; Donnelly PM, 1999, DEV BIOL, V215, P407, DOI 10.1006/dbio.1999.9443; Liu DM, 2009, PHYSIOL PLANTARUM, V136, P223, DOI 10.1111/j.1399-3054.2009.01229.x; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Yamaguchi T, 2010, PLANT CELL, V22, P2141, DOI 10.1105/tpc.110.076927; Andriankaja M, 2012, DEV CELL, V22, P64, DOI 10.1016/j.devcel.2011.11.011; Iwakawa H, 2002, PLANT CELL PHYSIOL, V43, P467, DOI 10.1093/pcp/pcf077; Beemster GTS, 2005, PLANT PHYSIOL, V138, P734, DOI 10.1104/pp.104.053884; Peter IS, 2011, CELL, V144, P970, DOI 10.1016/j.cell.2011.02.017; Autran D, 2002, EMBO J, V21, P6036, DOI 10.1093/emboj/cdf614; Pinon V, 2008, DEVELOPMENT, V135, P1315, DOI 10.1242/dev.016469; Eloy NB, 2011, PLANT J, V68, P351, DOI 10.1111/j.1365-313X.2011.04691.x; Toyokura K, 2011, PLANT CELL PHYSIOL, V52, P1340, DOI 10.1093/pcp/pcr079; Li YH, 2008, GENE DEV, V22, P1331, DOI 10.1101/gad.463608; Lodha M, 2013, GENE DEV, V27, P596, DOI 10.1101/gad.211425.112; Phelps-Durr TL, 2005, PLANT CELL, V17, P2886, DOI 10.1105/tpc.105.035477; Nakayama H, 2012, PLANT CELL, V24, P929, DOI 10.1105/tpc.111.092924; Narita NN, 2004, PLANT J, V38, P699, DOI 10.1111/j.1365-313X.2004.02078.x; Kanei M, 2012, DEVELOPMENT, V139, P2436, DOI 10.1242/dev.081547; McConnell JR, 2001, NATURE, V411, P709, DOI 10.1038/35079635; Sarojam R, 2010, PLANT CELL, V22, P2113, DOI 10.1105/tpc.110.075853; Kojima S, 2011, PLANT CELL PHYSIOL, V52, P1259, DOI 10.1093/pcp/pcr083; Efroni I, 2008, PLANT CELL, V20, P2293, DOI 10.1105/tpc.107.057521; Anastasiou E, 2007, DEV CELL, V13, P843, DOI 10.1016/j.devcel.2007.10.001; Lee BH, 2009, PLANT PHYSIOL, V151, P655, DOI 10.1104/pp.109.141838; Lin WC, 2003, PLANT CELL, V15, P2241, DOI 10.1105/tpc.014969; Horiguchi G, 2005, PLANT J, V43, P68, DOI 10.1111/j.1365-313X.2005.02429.x; Nole-Wilson S, 2005, PLANT MOL BIOL, V57, P613, DOI 10.1007/s11103-005-0955-6; Pick L, 2012, ANN NY ACAD SCI, V1256, P15, DOI 10.1111/j.1749-6632.2011.06385.x; MacAlister CA, 2012, NAT GENET, V44, P1393, DOI 10.1038/ng.2465; Schruff MC, 2006, DEVELOPMENT, V133, P251, DOI 10.1242/dev.02194; Kazama T, 2010, PLANT CELL PHYSIOL, V51, P1046, DOI 10.1093/pcp/pcq051; Ichihashi Y, 2011, PLANT PHYSIOL, V157, P1151, DOI 10.1104/pp.111.185066; Adamski NM, 2009, P NATL ACAD SCI USA, V106, P20115, DOI 10.1073/pnas.0907024106; Wenkel S, 2007, PLANT CELL, V19, P3379, DOI 10.1105/tpc.107.055772; Xu L, 2003, DEVELOPMENT, V130, P4097, DOI 10.1242/dev.00622; Semiarti E, 2001, DEVELOPMENT, V128, P1771; Mallory AC, 2004, EMBO J, V23, P3356, DOI 10.1038/sj.emboj.7600340; Tsukaya H, 2013, J PLANT RES, V126, P3, DOI 10.1007/s10265-012-0518-2; Makkena S, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-1; Hay A, 2010, DEVELOPMENT, V137, P3153, DOI 10.1242/dev.030049; Piazza P, 2010, CURR BIOL, V20, P2223, DOI 10.1016/j.cub.2010.11.037; Chitwood DH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029570; Esau K., 1977, ANATOMY SEED PLANTS; Fukushima K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7450; Ishibashi N, 2012, BIOL OPEN, V1, P197, DOI 10.1242/bio.2012406; Kalve S, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00362; Nakayama H, 2014, PLANT CELL, V26, P4733, DOI 10.1105/tpc.114.130229; Palmer NA, 2015, FUNCT INTEGR GENOMIC, V15, P1, DOI 10.1007/s10142-014-0393-0; Sack L, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1835; Steeves T. A., 1989, PATTERNS PLANT DEV; Tameshige T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003655; Tsukaya H., 2014, ATLAS PLANT CELL STR, P187; Tsukaya H, 2014, CURR OPIN PLANT BIOL, V17, P103, DOI 10.1016/j.pbi.2013.11.012	124	0	0	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-462X			FRONT PLANT SCI	Front. Plant Sci.	DEC 1	2015	6								1080	10.3389/fpls.2015.01060		8	Plant Sciences	Plant Sciences	CY7EJ	WOS:000366570800001		
J	Lin, C; Hare, A; Comparini, D; Bouteau, F; Kawano, T				Lin, Cun; Hare, Ayaka; Comparini, Diego; Bouteau, Francois; Kawano, Tomonori			Zinc-Dependent Protection of Tobacco and Rice Cells From Aluminum-Induced Superoxide-Mediated Cytotoxicity	FRONTIERS IN PLANT SCIENCE			English	Article						aluminum; zinc; BY-2; Nicotiana tabacum L.; Olyza sativa L.; ROS	SUSPENSION-CULTURE; PLANT-CELLS; BY-2 CELLS; CALCIUM; INHIBITION; ION; GENERATION; TOXICITY; CA2+; ELONGATION	Al3+ toxicity in growing plants is considered as one of the major factors limiting the production of crops on acidic soils worldwide. In the last 15 years, it has been proposed that Al3+ toxicity are mediated with distortion of the cellular signaling mechanisms such as calcium signaling pathways, and production of cytotoxic reactive oxygen species (ROS) causing oxidative damages. On the other hand, zinc is normally present in plants at high concentrations and its deficiency is one of the most widespread micronutrient deficiencies in plants. Earlier studies suggested that lack of zinc often results in ROS-mediated oxidative damage to plant cells. Previously, inhibitory action of Zn2+ against lanthanide-induced superoxide generation in tobacco cells have been reported, suggesting that Zn2+ interferes with the cation-induced ROS production via stimulation of NADPH oxidase. In the present study, the effect of Zn2+ on Al3+ -induced superoxide generation in the cell suspension cultures of tobacco (Nicotiana tabacum L. cell-line, BY-2) and rice (Ora sativa L., cv. Nipponbare), was examined. The Zn2+ -dependent inhibition of the AP- induced oxidative burst was observed in both model cells selected from the monocots and dicots (rice and tobacco), suggesting that this phenomenon (Al3+/Zn(2+)interaction) can be preserved in higher plants. Subsequently induced cell death in tobacco cells was analyzed by lethal cell staining with Evans blue. Obtained results indicated that presence of Zn2+ at physiological concentrations can protect the cells by preventing the Al3+ induced superoxide generation and cell death. Furthermore, the regulation of the Ca2+ signaling, i.e., change in the cytosolic Ca2+ ion concentration, and the cross talks among the elements which participate in the pathway were further explored.	[Lin, Cun; Hare, Ayaka; Comparini, Diego; Kawano, Tomonori] Univ Kitakyushu, Fac Environm Engn, Kitakyushu, Fukuoka, Japan; [Lin, Cun; Hare, Ayaka; Comparini, Diego; Kawano, Tomonori] Univ Kitakyushu, Grad Sch Environm Engn, Kitakyushu, Fukuoka, Japan; [Comparini, Diego; Bouteau, Francois; Kawano, Tomonori] Univ Kitakyushu, Int Photosynth Ind Res Ctr, Kitakyushu, Fukuoka, Japan; [Comparini, Diego; Bouteau, Francois; Kawano, Tomonori] Univ Florence LINV Kitakyushu Res Ctr, Kitakyushu, Fukuoka, Japan; [Comparini, Diego; Bouteau, Francois; Kawano, Tomonori] Univ Florence, Int Plant Neurobiol Lab, Sesto Fiorentino, Italy; [Bouteau, Francois] Univ Paris Diderot, Sorbonne Paris Cite, Inst Energies Demain, FRE3597, Paris, France; [Kawano, Tomonori] Univ Paris Diderot, Sorbonne Paris Cite, Paris Interdisciplinary Energy Res Inst 7, Paris, France	Kawano, T (reprint author), Univ Kitakyushu, Fac Environm Engn, Kitakyushu, Fukuoka, Japan.	kawanotom@kitakyu-u.ac.jp			Regional Innovation Cluster Program by Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	This work was supported by Regional Innovation Cluster Program by Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	Sanzonowicz C, 1998, J PLANT NUTR, V21, P785, DOI 10.1080/01904169809365442; Amenos M, 2009, PLANT CELL PHYSIOL, V50, P528, DOI 10.1093/pcp/pcp013; Rengel Z, 2003, NEW PHYTOL, V159, P295, DOI 10.1046/j.1469-8137.2003.00821.x; Poschenrieder C, 2008, SCI TOTAL ENVIRON, V400, P356, DOI 10.1016/j.scitotenv.2008.06.003; Kawano T, 2003, BIOCHEM BIOPH RES CO, V308, P35, DOI 10.1016/S0006-291X(03)01286-5; NAKANO M, 1986, ANAL BIOCHEM, V159, P363, DOI 10.1016/0003-2697(86)90354-4; Kawano T, 2001, PLANT CELL ENVIRON, V24, P1235, DOI 10.1046/j.1365-3040.2001.00766.x; Babourina O, 2009, ANN BOT-LONDON, V104, P189, DOI 10.1093/aob/mcp098; Achary VMM, 2013, MUTAT RES-GEN TOX EN, V751, P130, DOI 10.1016/j.mrgentox.2012.12.008; Lin C, 2006, Z NATURFORSCH C, V61, P74; Lukaszewski KM, 1996, PLANT PHYSIOL, V112, P1135; Cakmak I, 2000, NEW PHYTOL, V146, P185, DOI 10.1046/j.1469-8137.2000.00630.x; LAZOF DB, 1994, PLANT PHYSIOL, V106, P1107; Kawano T, 1998, PLANT CELL PHYSIOL, V39, P721; Kawano T, 2002, PHYSIOL PLANTARUM, V114, P395, DOI 10.1034/j.1399-3054.2002.1140309.x; Kawano T, 2004, BIOCHEM BIOPH RES CO, V324, P40, DOI 10.1016/j.bbrc.2004.09.015; LEVAN H, 1994, PLANT PHYSIOL, V106, P971; CALDWELL CR, 1989, PLANT PHYSIOL, V91, P233, DOI 10.1104/pp.91.1.233; LEDIG M, 1991, NEUROCHEM RES, V16, P591, DOI 10.1007/BF00974879; Ma JF, 1999, PLANT CELL PHYSIOL, V40, P549; Lin C, 2005, BIOCHEM BIOPH RES CO, V332, P823, DOI 10.1016/j.bbrc.2005.05.030; Takahashi K, 1997, PLANT PHYSIOL, V113, P587; Delhaize E, 1996, PLANT PHYSIOL, V111, P849, DOI 10.1104/pp.111.3.849; Cross AR, 1999, BIOCHEM J, V338, P229, DOI 10.1042/0264-6021:3380229; Yamamoto Y, 2002, PLANT PHYSIOL, V128, P63, DOI 10.1104/pp.128.1.63; PINTON R, 1994, J EXP BOT, V45, P45, DOI 10.1093/jxb/45.1.45; MOMOHARA I, 1990, FEBS LETT, V273, P159, DOI 10.1016/0014-5793(90)81074-X; Kadono Takashi, 2006, Plant Signal Behav, V1, P312, DOI 10.4161/psb.1.6.3518; Kawano N., 2003, ANN BOT, V91, P456; Kawano T., 2013, SALICYLIC ACID, P249; Kunihiro Shuta, 2011, Plant Signal Behav, V6, P611; Lin C., 2007, CRYOBIOL CRYOTECHNOL, V53, P7; Lin C., 2006, CRYOBIOLOGY CRYOTECH, V52, P83; Markich Scott J., 2002, Australasian Journal of Ecotoxicology, V8, P1; Panda Sanjib Kumar, 2009, Plant Signal Behav, V4, P592; Santa Maria G.E., 1988, J PLANT PHYSL, V132, P312; Yoshioka Hirofumi, 2008, Plant Signal Behav, V3, P153	37	0	0	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-462X			FRONT PLANT SCI	Front. Plant Sci.	DEC 1	2015	6								1079	10.3389/fpls.2015.01079		10	Plant Sciences	Plant Sciences	CY7EQ	WOS:000366571600001		
J	Takahashi, Y; Iseki, K; Kitazawa, K; Muto, C; Somta, P; Irie, K; Naito, K; Tomooka, N				Takahashi, Yu; Iseki, Kohtaro; Kitazawa, Kumiko; Muto, Chiaki; Somta, Prakit; Irie, Kenji; Naito, Ken; Tomooka, Norihiko			A Homoploid Hybrid Between Wild Vigna Species Found in a Limestone Karst	FRONTIERS IN PLANT SCIENCE			English	Article						genus Vigna; wild crop relatives; genetic resource; drought tolerance; stress tolerance; homoploid; hybrid speciation; introgressive hybridization; natural hybrid	WATER-STRESS; GENUS VIGNA; PLANT; SPECIATION; DOMESTICATION; REPRODUCTION; ADAPTATION; EVOLUTION; DROUGHT	Genus Vigna comprise several domesticated species including cowpea and mungbean, and diverse wild species. We found an introgressiye hybrid population derived from two wild species, Vigna umbellata and Vigna exilis, in Ratchaburi district, Thailand. The hybrid was morphologically similar to V umbellata but habituated in a limestone rock mountain, which is usually dominated by V exilis. Analyzing simple sequence repeat loci indicated the hybrid has undergone at least one round of backcross by V urnbellata. We found the hybrid acquired vigorous growth from V umbellata and drought tolerance plus early flowering from V exilis, and thus has taken over some habitats of V exilis in limestone karsts. Given the wide crossability of V umbellata, the hybrid can be a valuable genetic resource to improve drought tolerance of some domesticated species.	[Takahashi, Yu; Iseki, Kohtaro; Muto, Chiaki; Naito, Ken; Tomooka, Norihiko] Natl Inst Agrobiol Sci, Genet Resources Ctr, Tsukuba, Ibaraki, Japan; [Kitazawa, Kumiko; Irie, Kenji] Tokyo Univ Agr, Dept Int Agr Dev, Tokyo, Japan; [Somta, Prakit] Kasetsart Univ, Fac Agr Kamphaeng Saen, Dept Agron, Nakhon Pathom, Thailand	Naito, K (reprint author), Natl Inst Agrobiol Sci, Genet Resources Ctr, Tsukuba, Ibaraki, Japan.	knaito@affrc.go.jp			JSPS KAKENHI [13J09808, 26850006]	This work was supported by JSPS KAKENHI Grant Number 13J09808 and 26850006.	ANDERSON E., 1936, Ann. Mo. Bot. Gdn., V23, P159, DOI 10.2307/2394192; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; DAS ND, 1987, PLANT BREEDING, V98, P68, DOI 10.1111/j.1439-0523.1987.tb01093.x; Rieseberg LH, 2003, SCIENCE, V301, P1211, DOI 10.1126/science.1086949; Tomooka N, 2014, PLANT GENET RESOUR-C, V12, pS168, DOI 10.1017/S1479262114000483; Gupta VP, 2002, PLANT BREEDING, V121, P182, DOI 10.1046/j.1439-0523.2002.00675.x; McDowell N, 2008, NEW PHYTOL, V178, P719, DOI 10.1111/j.1469-8137.2008.02436.x; Doi K, 2002, GENETICA, V114, P129, DOI 10.1023/A:1015158408227; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Franks SJ, 2007, P NATL ACAD SCI USA, V104, P1278, DOI 10.1073/pnas.0608379104; Sanchez FJ, 1998, FIELD CROP RES, V59, P225, DOI 10.1016/S0378-4290(98)00125-7; Turkan I, 2005, PLANT SCI, V168, P223, DOI 10.1016/j.plantsci.2004.07.032; Chankaew S, 2014, THEOR APPL GENET, V127, P691, DOI 10.1007/s00122-013-2251-1; Clements R, 2006, BIOSCIENCE, V56, P733, DOI 10.1641/0006-3568(2006)56[733:LKOSAI]2.0.CO;2; Strasburg JL, 2012, PHILOS T R SOC B, V367, P364, DOI 10.1098/rstb.2011.0199; COHEN D, 1976, AM NAT, V110, P801, DOI 10.1086/283103; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Tian J, 2013, GENOME, V56, P717, DOI 10.1139/gen-2013-0118; KOZLOWSKI J, 1992, TRENDS ECOL EVOL, V7, P15, DOI 10.1016/0169-5347(92)90192-E; Arnold ML, 2012, HEREDITY, V108, P159, DOI 10.1038/hdy.2011.65; Kerstiens G, 2006, J EXP BOT, V57, P2493, DOI 10.1093/jxb/erl017; Mao JF, 2011, AM NAT, V177, P424, DOI 10.1086/658905; Paun O, 2009, NEW PHYTOL, V182, P507, DOI 10.1111/j.1469-8137.2009.02767.x; ANDERSON E, 1948, EVOLUTION, V2, P1, DOI 10.2307/2405610; Chankaew S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104990; Maxted N., 2004, AFRICAN VIGNA ECOGRA; Tateishi Y., 2002, Kew Bulletin, V57, P625, DOI 10.2307/4110990; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tomooka N, 2002, ASIAN VIGNA GENUS VI	30	0	0	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-462X			FRONT PLANT SCI	Front. Plant Sci.	DEC 1	2015	6								1050	10.3389/fpls.2015.01050		11	Plant Sciences	Plant Sciences	CY7EH	WOS:000366570600001		
J	Latos, PA; Sienerth, AR; Murray, A; Senner, CE; Muto, M; Ikawa, M; Oxley, D; Burge, S; Cox, BJ; Hemberger, M				Latos, Paulina A.; Sienerth, Arnold R.; Murray, Alexander; Senner, Claire E.; Muto, Masanaga; Ikawa, Masahito; Oxley, David; Burge, Sarah; Cox, Brian J.; Hemberger, Myriam			Elf5-centered transcription factor hub controls trophoblast stem cell self-renewal and differentiation through stoichiometry-sensitive shifts in target gene networks	GENES & DEVELOPMENT			English	Article						trophoblast stem cells; transcriptional networks; transcription factor complexes; self-renewal; control of differentiation	EARLY MOUSE DEVELOPMENT; EXTRAEMBRYONIC ECTODERM; TROPHECTODERM; CDX2; LINEAGES; FATE; PLURIPOTENCY; EMBRYO; TEAD4; ELF5	Elf5 is a transcription factor with pivotal roles in the trophoblast compartment, where it reinforces a trophoblast stem cell (TSC)-specific transcriptional circuit. However, Elf5 is also present in differentiating trophoblast cells that have ceased to express other TSC genes such as Cdx2 and Eomes. In the present study, we aimed to elucidate the context-dependent role of Elf5 at the interface between TSC self-renewal and the onset of differentiation. We demonstrate that precise levels of Elf5 are critical for normal expansion of the TSC compartment and embryonic survival, as Elf5 overexpression triggers precocious trophoblast differentiation. Through integration of protein interactome, transcriptome, and genome-wide chromatin immunoprecipitation data, we reveal that this abundance-dependent function is mediated through a shift in preferred Elf5-binding partners; in TSCs, Elf5 interaction with Eomes recruits Tfap2c to triply occupied sites at TSC-specific genes, driving their expression. In contrast, the Elf5 and Tfap2c interaction becomes predominant as their protein levels increase. This triggers binding to double-and single-occupancy sites that harbor the cognate Tfap2c motif, causing activation of the associated differentiation-promoting genes. These data place Elf5 at the center of a stoichiometry-sensitive transcriptional network, where it acts as a molecular switch governing the balance between TSC proliferation and differentiation.	[Latos, Paulina A.; Sienerth, Arnold R.; Murray, Alexander; Senner, Claire E.; Burge, Sarah; Hemberger, Myriam] Babraham Inst, Epigenet Programme, Cambridge CB22 3AT, England; [Latos, Paulina A.; Sienerth, Arnold R.; Murray, Alexander; Senner, Claire E.; Hemberger, Myriam] Univ Cambridge, Ctr Trophoblast Res, Cambridge CB2 3EG, England; [Muto, Masanaga; Ikawa, Masahito] Osaka Univ, Grad Sch Pharmaceut Sci, Anim Resource Ctr Infect Dis, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; [Oxley, David] Babraham Inst, Prote Grp, Cambridge CB22 3AT, England; [Cox, Brian J.] Univ Toronto, Fac Med, Dept Physiol, Toronto, ON M5S 1A8, Canada; [Cox, Brian J.] Univ Toronto, Fac Med, Dept Obstet & Gynaecol, Toronto, ON M5G 1E2, Canada	Hemberger, M (reprint author), Babraham Inst, Epigenet Programme, Cambridge CB22 3AT, England.	b.cox@utorono.ca; myriam.hemberger@babraham.ac.uk			Next-Generation Fellowship (Centre for Trophoblast Research, University of Cambridge); Biotechnology and Biological Sciences Research Council (BBSRC); Wellcome Trust; Canadian Institutes of Health Research; Canada Research Chair	We are grateful to Kristina Tabbada for Illumina high-throughput sequencing, Judith Webster for assistance with mass spectrometry experiments, Anne Segonds-Pichon for expert statistical help, and Oliver Tam, Simon Andrews, and Felix Krueger for help with the bioinformatic analysis. This work was supported by a Next-Generation Fellowship (awarded to P.A.L. by the Centre for Trophoblast Research, University of Cambridge), the Biotechnology and Biological Sciences Research Council (BBSRC), and the Wellcome Trust. B.J.C. is supported by a Canada Research Chair and an operating grant from the Canadian Institutes of Health Research.	Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Ralston A, 2008, DEV BIOL, V313, P614, DOI 10.1016/j.ydbio.2007.10.054; Walentin K, 2015, DEVELOPMENT, V142, P1125, DOI 10.1242/dev.113829; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Yang JC, 2008, P NATL ACAD SCI USA, V105, P19756, DOI 10.1073/pnas.0809321105; Webster J, 2009, SPRINGER PROTOC HAND, P1117, DOI 10.1007/978-1-59745-198-7_120; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481; Ralston A, 2010, DEVELOPMENT, V137, P395, DOI 10.1242/dev.038828; Goller T, 2008, MOL CELL BIOL, V28, P6819, DOI 10.1128/MCB.01058-08; Carey BW, 2011, CELL STEM CELL, V9, P588, DOI 10.1016/j.stem.2011.11.003; Ng RK, 2008, NAT CELL BIOL, V10, P1280, DOI 10.1038/ncb1786; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Kuckenberg P, 2010, MOL CELL BIOL, V30, P3310, DOI 10.1128/MCB.01215-09; Chuong EB, 2013, NAT GENET, V45, P325, DOI 10.1038/ng.2553; Shimokawa K, 2011, DEV CELL, V21, P257, DOI 10.1016/j.devcel.2011.06.027; Yamamoto H, 1998, GENE DEV, V12, P1315, DOI 10.1101/gad.12.9.1315; Okada Y, 2007, NAT BIOTECHNOL, V25, P233, DOI 10.1038/nbt1280; Tavares L, 2012, CELL, V148, P664, DOI 10.1016/j.cell.2011.12.029; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Werling U, 2002, MOL CELL BIOL, V22, P3149, DOI 10.1128/MCB.22.9.3149-3156.2002; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Tremblay GB, 2001, GENE DEV, V15, P833, DOI 10.1101/gad.873401; Rugg-Gunn PJ, 2010, P NATL ACAD SCI USA, V107, P10783, DOI 10.1073/pnas.0914507107; Home P, 2009, J BIOL CHEM, V284, P28729, DOI 10.1074/jbc.M109.016840; Radzisheuskaya A, 2013, NAT CELL BIOL, V15, P579, DOI 10.1038/ncb2742; Donnison M, 2005, DEVELOPMENT, V132, P2299, DOI 10.1242/dev.01819; Martello G, 2014, ANNU REV CELL DEV BI, V30, P647, DOI 10.1146/annurev-cellbio-100913-013116; Yu GC, 2015, BIOINFORMATICS, V31, P2382, DOI 10.1093/bioinformatics/btv145; Adachi K, 2013, MOL CELL, V52, P380, DOI 10.1016/j.molcel.2013.09.002; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Morioka Y, 2009, GENESIS, V47, P793, DOI 10.1002/dvg.20563; Yagi R, 2007, DEVELOPMENT, V134, P3827, DOI 10.1242/dev.010223; Auman HJ, 2002, DEVELOPMENT, V129, P2733; Kidder BL, 2010, GENOME RES, V20, P458, DOI 10.1101/gr.101469.109; Georgiades P, 2007, BIOTECHNIQUES, V42, P317, DOI 10.2144/000112341; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Russ AP, 2000, NATURE, V404, P95, DOI 10.1038/35003601; Cambuli F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6538; Donnison M, 2015, DEV BIOL, V397, P77, DOI 10.1016/j.ydbio.2014.10.011; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kunath T, 2014, PLACENTA, V35, P1079, DOI 10.1016/j.placenta.2014.09.008; Latos PA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8776; Nichols J, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008128; Nishioka N, 2008, MECH DEVELOP, V125, P270, DOI 10.1016/j.mod.2007.11.002; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	47	0	0	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	0890-9369	1549-5477		GENE DEV	Genes Dev.	DEC 1	2015	29	23					2435	2448		10.1101/gad.268821.115		14	Cell Biology; Developmental Biology; Genetics & Heredity	Cell Biology; Developmental Biology; Genetics & Heredity	CY9WW	WOS:000366758100003		
J	Stewart, KR; Veselovska, L; Kim, J; Huang, JH; Saadeh, H; Tomizawa, S; Smallwood, SA; Chen, TP; Kelsey, G				Stewart, Kathleen R.; Veselovska, Lenka; Kim, Jeesun; Huang, Jiahao; Saadeh, Heba; Tomizawa, Shin-ichi; Smallwood, Sebastien A.; Chen, Taiping; Kelsey, Gavin			Dynamic changes in histone modifications precede de novo DNA methylation in oocytes	GENES & DEVELOPMENT			English	Article						oocytes; DNA methylation; genomic imprinting; histone modifications; ChIP-seq	GERM-CELL DEVELOPMENT; CPG ISLANDS; H3K36 METHYLATION; GENE; TRANSCRIPTION; DOMAIN; H3; CHROMATIN; TRIMETHYLATION; DEMETHYLATION	Erasure and subsequent reinstatement of DNA methylation in the germline, especially at imprinted CpG islands (CGIs), is crucial to embryogenesis in mammals. The mechanisms underlying DNA methylation establishment remain poorly understood, but a number of post-translational modifications of histones are implicated in antagonizing or recruiting the de novo DNA methylation complex. In mouse oogenesis, DNA methylation establishment occurs on a largely unmethylated genome and in nondividing cells, making it a highly informative model for examining how histone modifications can shape the DNA methylome. Using a chromatin immunoprecipitation (ChIP) and genome-wide sequencing (ChIP-seq) protocol optimized for low cell numbers and novel techniques for isolating primary and growing oocytes, profiles were generated for histone modifications implicated in promoting or inhibiting DNA methylation. CGIs destined for DNA methylation show reduced protective H3K4 dimethylation (H3K4me2) and trimethylation (H3K4me3) in both primary and growing oocytes, while permissive H3K36me3 increases specifically at these CGIs in growing oocytes. Methylome profiling of oocytes deficient in H3K4 demethylase KDM1A or KDM1B indicated that removal of H3K4 methylation is necessary for proper methylation establishment at CGIs. This work represents the first systematic study performing ChIP-seq in oocytes and shows that histone remodeling in the mammalian oocyte helps direct de novo DNA methylation events.	[Stewart, Kathleen R.; Veselovska, Lenka; Huang, Jiahao; Saadeh, Heba; Smallwood, Sebastien A.; Kelsey, Gavin] Babraham Inst, Epigenet Programme, Cambridge CB22 3AT, England; [Kim, Jeesun; Chen, Taiping] Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, Smithville, TX 77030 USA; [Saadeh, Heba] Babraham Inst, Bioinformat Grp, Cambridge CB22 3AT, England; [Tomizawa, Shin-ichi] Yokohama City Univ, Sch Med, Yokohama, Kanagawa 2360027, Japan; [Kelsey, Gavin] Univ Cambridge, Ctr Trophoblast Res, Cambridge CB2 3EG, England	Kelsey, G (reprint author), Babraham Inst, Epigenet Programme, Cambridge CB22 3AT, England.	gavin.kelsey@babraham.ac.uk			Medical Research Council of the UK; Rising Star Award from the Cancer Prevention and Research Institute of Texas (CPRIT) [R1108]; People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7 under Research Executive Agency [290123]	We are grateful to Robert Klose for providing the H3K36me3 antibody. We thank Felix Krueger and Simon Andrews for bioinformatic support; the Babraham Biological Support Unit for mouse husbandry; Rebecca Newman, Rachael Walker, and Arthur Davies for FACS help; Kristina Tabbada for library sequencing; and Courtney Hanna and Wendy Dean for advice and critical reading of the manuscript. This work was supported by grants from the Medical Research Council of the UK (to G.K.), a Rising Star Award (R1108 to T.C.) from the Cancer Prevention and Research Institute of Texas (CPRIT), and funding from the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7/2007-2013 under Research Executive Agency grant agreement number 290123.	Henikoff S, 2011, TRENDS GENET, V27, P389, DOI 10.1016/j.tig.2011.06.006; Mikkelsen TS, 2010, CELL, V143, P156, DOI 10.1016/j.cell.2010.09.006; Cheng XD, 2010, BIOCHEMISTRY-US, V49, P2999, DOI 10.1021/bi100213t; Proudhon C, 2012, MOL CELL, V47, P909, DOI 10.1016/j.molcel.2012.07.010; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; Blackledge NP, 2010, MOL CELL, V38, P179, DOI 10.1016/j.molcel.2010.04.009; Chotalia M, 2009, GENE DEV, V23, P105, DOI 10.1101/gad.495809; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Thomson JP, 2010, NATURE, V464, P1082, DOI 10.1038/nature08924; Edmunds JW, 2008, EMBO J, V27, P406, DOI 10.1038/sj.emboj.7601967; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Smallwood SA, 2012, TRENDS GENET, V28, P33, DOI 10.1016/j.tig.2011.09.004; Kizer KO, 2005, MOL CELL BIOL, V25, P3305, DOI 10.1128/MCB.25.8.3305-3316.2005; Smallwood SA, 2011, NAT GENET, V43, P811, DOI 10.1038/ng.864; Rajkovic A, 2004, SCIENCE, V305, P1157, DOI 10.1126/science.1099755; Fang R, 2010, MOL CELL, V39, P222, DOI 10.1016/j.molcel.2010.07.008; Handel MA, 2010, NAT REV GENET, V11, P124, DOI 10.1038/nrg2723; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Schenk T, 2012, NAT MED, V18, P605, DOI 10.1038/nm.2661; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Yuan W, 2009, J BIOL CHEM, V284, P15701, DOI 10.1074/jbc.M808431200; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; Fang R, 2013, MOL CELL, V49, P558, DOI 10.1016/j.molcel.2012.11.019; Yoh SM, 2008, GENE DEV, V22, P3422, DOI 10.1101/gad.1720008; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Tomizawa S, 2011, DEVELOPMENT, V138, P811, DOI 10.1242/dev.061416; Hiura H, 2006, GENES CELLS, V11, P353, DOI 10.1111/j.1365-2443.2006.00943.x; Rosner M, 2013, NAT PROTOC, V8, P602, DOI 10.1038/nprot.2013.011; Pepling ME, 2006, GENESIS, V44, P622, DOI 10.1002/dvg.20258; Hata K, 2002, DEVELOPMENT, V129, P1983; Blackledge NP, 2011, EPIGENETICS-US, V6, P147, DOI 10.4161/epi.6.2.13640; Obata Y, 2002, J BIOL CHEM, V277, P5285, DOI 10.1074/jbc.M108586200; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Macfarlan TS, 2011, GENE DEV, V25, P594, DOI 10.1101/gad.2008511; Dhayalan A, 2010, J BIOL CHEM, V285, P26114, DOI 10.1074/jbc.M109.089433; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Noh KM, 2015, MOL CELL, V59, P89, DOI 10.1016/j.molcel.2015.05.017; Mosammaparast N, 2010, ANNU REV BIOCHEM, V79, P155, DOI 10.1146/annurev.biochem.78.070907.103946; Peat JR, 2014, CELL REP, V9, P1990, DOI 10.1016/j.celrep.2014.11.034; Suzumori N, 2002, MECH DEVELOP, V111, P137, DOI 10.1016/S0925-4773(01)00620-7; Tomizawa SI, 2012, INT J DEV BIOL, V56, P867, DOI 10.1387/ijdb.120152gk; Baubec T, 2015, NATURE, V520, P243, DOI 10.1038/nature14176; Ciccone DN, 2010, NATURE, V461, P415; Illingworth R, 2008, PLOS BIOL, V6, P37, DOI 10.1371/journal.pbio.0060022; Illingworth RS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001134; Kerenyi MA, 2013, ELIFE, V2, DOI 10.7554/eLife.00633; Kobayashi H, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002440; Krebs AR, 2014, ELIFE, V3, DOI [10.7554/eLife.04094, 10.7554/eLife.04094.001]; Miura F, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks454; Morselli M, 2015, ELIFE, V4, DOI 10.7554/eLife.06205; Pan YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017536; Shirane K, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003439; Smith EY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002422; Veselovska L, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0769-z; Wachter E, 2014, ELIFE, V3, DOI 10.7554/eLife.03397	60	0	0	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	0890-9369	1549-5477		GENE DEV	Genes Dev.	DEC 1	2015	29	23					2449	2462		10.1101/gad.271353.115		14	Cell Biology; Developmental Biology; Genetics & Heredity	Cell Biology; Developmental Biology; Genetics & Heredity	CY9WW	WOS:000366758100004		
J	Amankwah, EK; Lin, HY; Tyrer, JP; Lawrenson, K; Dennis, J; Chornokur, G; Aben, KKH; Anton-Culver, H; Antonenkova, N; Bruinsma, F; Bandera, EV; Bean, YT; Beckmann, MW; Bisogna, M; Bjorge, L; Bogdanova, N; Brinton, LA; Brooks-Wilson, A; Bunker, CH; Butzow, R; Campbell, IG; Carty, K; Chen, ZH; Chen, YA; Chang-Claude, J; Cook, LS; Cramer, DW; Cunningham, JM; Cybulski, C; Dansonka-Mieszkowska, A; Du Bois, A; Despierre, E; Dicks, E; Doherty, JA; Doerk, T; Duerst, M; Easton, DF; Eccles, DM; Edwards, RP; Ekici, AB; Fasching, PA; Fridley, BL; Gao, YT; Gentry-Maharaj, A; Giles, GG; Glasspool, R; Goodman, MT; Gronwald, J; Harrington, P; Harter, P; Hasmad, HN; Hein, A; Heitz, F; Hildebrandt, MAT; Hillemanns, P; Hogdall, CK; Hogdall, E; Hosono, S; Iversen, ES; Jakubowska, A; Jensen, A; Ji, BT; Karlan, BY; Jim, H; Kellar, M; Kiemeney, LA; Krakstad, C; Kjaer, SK; Kupryjanczyk, J; Lambrechts, D; Lambrechts, S; Le, ND; Lee, AW; Lele, S; Leminen, A; Lester, J; Levine, DA; Liang, D; Lim, BK; Lissowska, J; Lu, K; Lubinski, J; Lundvall, L; Massuger, LFAG; Matsuo, K; McGuire, V; McLaughlin, JR; McNeish, I; Menon, U; Milne, RL; Modugno, F; Moysich, KB; Ness, RB; Nevanlinna, H; Eilber, U; Odunsi, K; Olson, SH; Orlow, I; Orsulic, S; Weber, RP; Paul, J; Pearce, CL; Pejovic, T; Pelttari, LM; Permuth-Wey, J; Pike, MC; Poole, EM; Risch, HA; Rosen, B; Rossing, MA; Rothstein, JH; Rudolph, A; Runnebaum, IB; Rzepecka, IK; Salvesen, HB; Schernhammer, E; Schwaab, I; Shu, XO; Shvetsov, YB; Siddiqui, N; Sieh, W; Song, HL; Southey, MC; Spiewankiewicz, B; Sucheston-Campbell, L; Teo, SH; Terry, KL; Thompson, PJ; Thomsen, L; Tangen, IL; Tworoger, SS; Van Altena, AM; Vierkant, RA; Vergote, I; Walsh, CS; Wang-Gohrke, S; Wentzensen, N; Whittemore, AS; Wicklund, KG; Wilkens, LR; Wu, AH; Wu, XF; Woo, YL; Yang, H; Zheng, W; Ziogas, A; Kelemen, LE; Berchuck, A; Chenevix-Trench, G; Grp, AM; Schildkraut, JM; Ramus, SJ; Goode, EL; Monteiro, ANA; Gayther, SA; Narod, SA; Pharoah, PDP; Sellers, TA; Phelan, CM				Amankwah, Ernest K.; Lin, Hui-Yi; Tyrer, Jonathan P.; Lawrenson, Kate; Dennis, Joe; Chornokur, Ganna; Aben, Katja K. H.; Anton-Culver, Hoda; Antonenkova, Natalia; Bruinsma, Fiona; Bandera, Elisa V.; Bean, Yukie T.; Beckmann, Matthias W.; Bisogna, Maria; Bjorge, Line; Bogdanova, Natalia; Brinton, Louise A.; Brooks-Wilson, Angela; Bunker, Clareann H.; Butzow, Ralf; Campbell, Ian G.; Carty, Karen; Chen, Zhihua; Chen, Y. Ann; Chang-Claude, Jenny; Cook, Linda S.; Cramer, Daniel W.; Cunningham, Julie M.; Cybulski, Cezary; Dansonka-Mieszkowska, Agnieszka; Du Bois, Andreas; Despierre, Evelyn; Dicks, Ed; Doherty, Jennifer A.; Doerk, Thilo; Duerst, Matthias; Easton, Douglas F.; Eccles, Diana M.; Edwards, Robert P.; Ekici, Arif B.; Fasching, Peter A.; Fridley, Brooke L.; Gao, Yu-Tang; Gentry-Maharaj, Aleksandra; Giles, Graham G.; Glasspool, Rosalind; Goodman, Marc T.; Gronwald, Jacek; Harrington, Patricia; Harter, Philipp; Hasmad, Hanis N.; Hein, Alexander; Heitz, Florian; Hildebrandt, Michelle A. T.; Hillemanns, Peter; Hogdall, Claus K.; Hogdall, Estrid; Hosono, Satoyo; Iversen, Edwin S.; Jakubowska, Anna; Jensen, Allan; Ji, Bu-Tian; Karlan, Beth Y.; Jim, Heather; Kellar, Melissa; Kiemeney, Lambertus A.; Krakstad, Camilla; Kjaer, Susanne K.; Kupryjanczyk, Jolanta; Lambrechts, Diether; Lambrechts, Sandrina; Le, Nhu D.; Lee, Alice W.; Lele, Shashi; Leminen, Arto; Lester, Jenny; Levine, Douglas A.; Liang, Dong; Lim, Boon Kiong; Lissowska, Jolanta; Lu, Karen; Lubinski, Jan; Lundvall, Lene; Massuger, Leon F. A. G.; Matsuo, Keitaro; McGuire, Valerie; McLaughlin, John R.; McNeish, Ian; Menon, Usha; Milne, Roger L.; Modugno, Francesmary; Moysich, Kirsten B.; Ness, Roberta B.; Nevanlinna, Heli; Eilber, Ursula; Odunsi, Kunle; Olson, Sara H.; Orlow, Irene; Orsulic, Sandra; Weber, Rachel Palmieri; Paul, James; Pearce, Celeste L.; Pejovic, Tanja; Pelttari, Liisa M.; Permuth-Wey, Jennifer; Pike, Malcolm C.; Poole, Elizabeth M.; Risch, Harvey A.; Rosen, Barry; Rossing, Mary Anne; Rothstein, Joseph H.; Rudolph, Anja; Runnebaum, Ingo B.; Rzepecka, Iwona K.; Salvesen, Helga B.; Schernhammer, Eva; Schwaab, Ira; Shu, Xiao-Ou; Shvetsov, Yurii B.; Siddiqui, Nadeem; Sieh, Weiva; Song, Honglin; Southey, Melissa C.; Spiewankiewicz, Beata; Sucheston-Campbell, Lara; Teo, Soo-Hwang; Terry, Kathryn L.; Thompson, Pamela J.; Thomsen, Lotte; Tangen, Ingvild L.; Tworoger, Shelley S.; Van Altena, Anne M.; Vierkant, Robert A.; Vergote, Ignace; Walsh, Christine S.; Wang-Gohrke, Shan; Wentzensen, Nicolas; Whittemore, Alice S.; Wicklund, Kristine G.; Wilkens, Lynne R.; Wu, Anna H.; Wu, Xifeng; Woo, Yin-Ling; Yang, Hannah; Zheng, Wei; Ziogas, Argyrios; Kelemen, Linda E.; Berchuck, Andrew; Chenevix-Trench, Georgia; Grp, Aocs Management; Schildkraut, Joellen M.; Ramus, Susan J.; Goode, Ellen L.; Monteiro, Alvaro N. A.; Gayther, Simon A.; Narod, Steven A.; Pharoah, Paul D. P.; Sellers, Thomas A.; Phelan, Catherine M.			Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk	GENETIC EPIDEMIOLOGY			English	Article						ovarian cancer; epithelial-mesenchymal transition; single-nucleotide polymorphisms	SINGLE-NUCLEOTIDE POLYMORPHISMS; LUNG-CANCER; NEVER SMOKERS; SUSCEPTIBILITY; NEUROPILIN-1; SURVIVAL; DISEASE; METAANALYSIS; GLYPICANS; ONCOGENES	Epithelial-mesenchymal transition (EMT) is a process whereby epithelial cells assume mesenchymal characteristics to facilitate cancer metastasis. However, EMT also contributes to the initiation and development of primary tumors. Prior studies that explored the hypothesis that EMT gene variants contribute to epithelial ovarian carcinoma (EOC) risk have been based on small sample sizes and none have sought replication in an independent population. We screened 15,816 single-nucleotide polymorphisms (SNPs) in 296 genes in a discovery phase using data from a genome-wide association study of EOC among women of European ancestry (1,947 cases and 2,009 controls) and identified 793 variants in 278 EMT-related genes that were nominally (P < 0.05) associated with invasive EOC. These SNPs were then genotyped in a larger study of 14,525 invasive-cancer patients and 23,447 controls. A P-value < 0.05 and a false discovery rate (FDR) < 0.2 were considered statistically significant. In the larger dataset, GPC6/GPC5 rs17702471 was associated with the endometrioid subtype among Caucasians (odds ratio (OR) = 1.16, 95% CI = 1.07-1.25, P = 0.0003, FDR = 0.19), whereas F8 rs7053448 (OR = 1.69, 95% CI = 1.27-2.24, P = 0.0003, FDR = 0.12), F8 rs7058826 (OR = 1.69, 95% CI = 1.27-2.24, P = 0.0003, FDR = 0.12), and CAPN13 rs1983383 (OR = 0.79, 95% CI = 0.69-0.90, P = 0.0005, FDR = 0.12) were associated with combined invasive EOC among Asians. In silico functional analyses revealed that GPC6/GPC5 rs17702471 coincided with DNA regulatory elements. These results suggest that EMT gene variants do not appear to play a significant role in the susceptibility to EOC. (C) 2015 Wiley Periodicals, Inc.	[Amankwah, Ernest K.; Chornokur, Ganna; Permuth-Wey, Jennifer; Sellers, Thomas A.; Phelan, Catherine M.] H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Epidemiol, Tampa, FL 33612 USA; [Amankwah, Ernest K.] All Childrens Hosp Johns Hopkins Med, Clin & Translat Res Org, St Petersburg, FL USA; [Lin, Hui-Yi; Chen, Zhihua; Chen, Y. Ann; Monteiro, Alvaro N. A.] H Lee Moffitt Canc Ctr & Res Inst, Dept Biostat & Bioinformat, Tampa, FL USA; [Tyrer, Jonathan P.; Dennis, Joe] Univ Cambridge, Strangeways Res Lab, Dept Publ Hlth & Primary Care, Ctr Canc Epidemiol, Cambridge, England; [Lawrenson, Kate; Lee, Alice W.; Pearce, Celeste L.; Pike, Malcolm C.; Wu, Anna H.; Ramus, Susan J.; Gayther, Simon A.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA; [Aben, Katja K. H.; Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, Dept Hlth Evidence, NL-6525 ED Nijmegen, Netherlands; [Aben, Katja K. H.] Comprehens Canc Ctr Netherlands, Nijmegen, Netherlands; [Anton-Culver, Hoda; Ziogas, Argyrios] Univ Calif Irvine, Sch Med, Dept Epidemiol, UCI Ctr Canc Genet Res & Prevent,Genet Epidemiol, Irvine, CA 92717 USA; [Antonenkova, Natalia] Byelorussian Inst Oncol & Med Radiol Aleksandrov, Minsk, Byelarus; [Bruinsma, Fiona; Giles, Graham G.; Milne, Roger L.] Canc Council Victoria, Canc Epidemiol Ctr, Melbourne, Australia; [Bandera, Elisa V.] Rutgers Canc Inst New Jersey, Canc Prevent & Control, New Brunswick, NJ USA; [Bean, Yukie T.; Kellar, Melissa; Pejovic, Tanja] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97201 USA; [Bean, Yukie T.; Kellar, Melissa; Pejovic, Tanja] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA; [Beckmann, Matthias W.; Fasching, Peter A.; Hein, Alexander] Univ Erlangen Nurnberg, Univ Hosp Erlangen, Dept Gynecol & Obstet, Erlangen Nuremberg Comprehens Canc Ctr, Erlangen Emn, Germany; [Bisogna, Maria; Levine, Douglas A.] Mem Sloan Kettering Canc Ctr, Dept Surg, Gynecol Serv, New York, NY 10021 USA; [Bjorge, Line; Krakstad, Camilla; Salvesen, Helga B.; Tangen, Ingvild L.] Haukeland Hosp, Dept Gynecol & Obstet, N-5021 Bergen, Norway; [Bjorge, Line; Krakstad, Camilla; Salvesen, Helga B.; Tangen, Ingvild L.] Univ Bergen, Dept Clin Med, Ctr Canc Biomarkers, Bergen, Norway; [Bogdanova, Natalia; Doerk, Thilo; Hillemanns, Peter] Hannover Med Sch, Radiat Oncol Res Unit, Hannover, Germany; [Brinton, Louise A.; Ji, Bu-Tian; Wentzensen, Nicolas; Yang, Hannah] Natl Canc Inst, Div Canc Epidemiol & Genet, Bethesda, MD USA; [Brooks-Wilson, Angela] BC Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC, Canada; [Brooks-Wilson, Angela] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC V5A 1S6, Canada; [Bunker, Clareann H.; Modugno, Francesmary] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA; [Butzow, Ralf; Leminen, Arto; Nevanlinna, Heli; Pelttari, Liisa M.] Univ Helsinki, Cent Hosp, Dept Obstet & Gynecol, Helsinki, Hus, Finland; [Butzow, Ralf] Univ Helsinki, Cent Hosp, Dept Pathol, Helsinki, Finland; [Campbell, Ian G.] Peter MacCallum Canc Inst, Div Res, Canc Genet Lab, East Melbourne, Australia; [Campbell, Ian G.; Southey, Melissa C.] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia; [Campbell, Ian G.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3052, Australia; [Carty, Karen; Siddiqui, Nadeem] Glasgow Royal Infirm, Dept Gynaecol Oncol, Glasgow G4 0SF, Lanark, Scotland; [Carty, Karen; Glasspool, Rosalind; McNeish, Ian; Paul, James] Beatson West Scotland Canc Ctr, CRUK Clin Trials Unit, Glasgow, Lanark, Scotland; [Chang-Claude, Jenny; Eilber, Ursula; Rudolph, Anja; Wang-Gohrke, Shan] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany; [Cook, Linda S.] Univ New Mexico, Dept Internal Med, Div Epidemiol & Biostat, Albuquerque, NM 87131 USA; [Cramer, Daniel W.; Terry, Kathryn L.; Tworoger, Shelley S.] Brigham & Womens Hosp, Obstet & Gynecol Ctr, Boston, MA 02115 USA; [Cramer, Daniel W.; Terry, Kathryn L.; Tworoger, Shelley S.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Cunningham, Julie M.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [Cybulski, Cezary; Gronwald, Jacek; Jakubowska, Anna; Lubinski, Jan] Pomeranian Med Univ, Dept Genet & Pathol, Int Hereditary Canc Ctr, Szczecin, Poland; [Dansonka-Mieszkowska, Agnieszka; Kupryjanczyk, Jolanta; Rzepecka, Iwona K.] Maria Sklodowska Curie Mem Canc Ctr, Dept Pathol, Warsaw, Poland; [Dansonka-Mieszkowska, Agnieszka; Kupryjanczyk, Jolanta; Rzepecka, Iwona K.] Inst Oncol, Warsaw, Poland; [Du Bois, Andreas; Harter, Philipp; Heitz, Florian] Knappschaft GmbH, Evang Huyssens Stiftung, Kliniken Essen Mitte, Dept Gynaecol & Gynaecol Oncol, Essen, Germany; [Du Bois, Andreas; Harter, Philipp; Heitz, Florian] Dr Horst Schmidt Kliniken Wiesbaden, Dept Gynaecol & Gynaecol Oncol, Wiesbaden, Germany; [Despierre, Evelyn; Lambrechts, Sandrina; Vergote, Ignace] Katholieke Univ Leuven, Univ Hosp Leuven, Leuven Canc Inst, Div Gynecol, Leuven, Belgium; [Dicks, Ed; Harrington, Patricia; Song, Honglin] Univ Cambridge, Strangeways Res Lab, Dept Oncol, Ctr Canc Epidemiol, Cambridge, England; [Doherty, Jennifer A.] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Sect Biostat & Epidemiol,Dept Community & Family, Hanover, NH 03756 USA; [Doherty, Jennifer A.; Rossing, Mary Anne; Wicklund, Kristine G.] Univ Washington, Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Program Epidemiol, Seattle, WA 98195 USA; [Duerst, Matthias; Runnebaum, Ingo B.] Univ Jena, Dept Gynecol, Jena, Germany; [Easton, Douglas F.] Univ Cambridge, Dept Oncol, Ctr Canc Genet Epidemiol, Cambridge, England; [Easton, Douglas F.] Univ Cambridge, Dept Publ Hlth & Primary Care, Ctr Canc Genet Epidemiol, Cambridge, England; [Eccles, Diana M.] Princess Anne Hosp, Wessex Clin Genet Serv, Southampton, Hants, England; [Edwards, Robert P.] Univ Pittsburgh, Div Gynecol Oncol, Dept Obstet Gynecol RS, Ovarian Canc Ctr Excellence, Pittsburgh, PA USA; [Ekici, Arif B.] Univ Erlangen Nurnberg, Univ Hosp Erlangen, Inst Human Genet, Erlangen, Germany; [Fasching, Peter A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Hematol & Oncol, Los Angeles, CA 90095 USA; [Fridley, Brooke L.] Univ Kansas, Med Ctr, Biostat & Informat Shared Resource, Kansas City, KS 66103 USA; [Gao, Yu-Tang] Shanghai Canc Inst, Dept Epidemiol, Shanghai, Peoples R China; [Gentry-Maharaj, Aleksandra; Menon, Usha] UCL EGA Inst Womens Hlth, Womens Canc, London, England; [Giles, Graham G.; Milne, Roger L.] Univ Melbourne, Sch Populat & Global Hlth, Ctr Epidemiol & Biostat, Melbourne, Australia; [Goodman, Marc T.; Thompson, Pamela J.] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Canc Prevent & Control, Los Angeles, CA 90048 USA; [Goodman, Marc T.; Thompson, Pamela J.] Cedars Sinai Med Ctr, Dept Biomed Sci, Community & Populat Hlth Res Inst, Los Angeles, CA 90048 USA; [Hasmad, Hanis N.; Teo, Soo-Hwang] Sime Darby Med Ctr, Canc Res Initiat Fdn, Subang Jaya, Malaysia; [Hildebrandt, Michelle A. T.; Wu, Xifeng] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Hogdall, Claus K.; Kjaer, Susanne K.; Lundvall, Lene] Univ Copenhagen, Rigshosp, Dept Gynaecol, DK-2100 Copenhagen, Denmark; [Hogdall, Estrid; Jensen, Allan; Kjaer, Susanne K.] Danish Canc Soc Res Ctr, Dept Virus Lifestyle & Genes, Copenhagen, Denmark; [Hogdall, Estrid] Univ Copenhagen, Herlev Hosp, Dept Pathol, Mol Unit, Copenhagen, Denmark; [Hosono, Satoyo; Matsuo, Keitaro] Aichi Canc Ctr Res Inst, Div Epidemiol & Prevent, Nagoya, Aichi, Japan; [Iversen, Edwin S.] Duke Univ, Dept Stat, Durham, NC USA; [Karlan, Beth Y.; Lester, Jenny; Orsulic, Sandra; Walsh, Christine S.] Cedars Sinai Med Ctr, Inst Canc, Womens Canc Program Samuel Oschin Comprehens, Los Angeles, CA 90048 USA; [Jim, Heather] H Lee Moffitt Canc Ctr & Res Inst, Dept Hlth Outcomes & Behav, Tampa, FL USA; [Lambrechts, Diether] Univ Leuven, VIB, Vesalius Res Ctr, Leuven, Belgium; [Lambrechts, Diether] Univ Leuven, Dept Oncol, Lab Translat Genet, Leuven, Belgium; [Le, Nhu D.] BC Canc Agcy, Canc Control Res, Vancouver, BC, Canada; [Lele, Shashi; Moysich, Kirsten B.; Sucheston-Campbell, Lara] Roswell Pk Canc Inst, Dept Canc Prevent & Control, Buffalo, NY 14263 USA; [Liang, Dong] Texas So Univ, Coll Pharm & Hlth Sci, Houston, TX 77004 USA; [Lim, Boon Kiong; Woo, Yin-Ling] Univ Malaya, Med Ctr, Dept Obstet & Gynaecol, Kuala Lumpur, Malaysia; [Lissowska, Jolanta] M Sklodowska Curie Mem Canc Ctr, Dept Canc Epidemiol & Prevent, Warsaw, Poland; [Lissowska, Jolanta] Inst Oncol, Warsaw, Poland; [Lu, Karen] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol, Houston, TX 77030 USA; [Massuger, Leon F. A. G.; Van Altena, Anne M.] Radboud Inst Mol Life Sci, Radboud Univ Med Ctr, Nijmegen, Netherlands; [McGuire, Valerie; Rothstein, Joseph H.; Sieh, Weiva; Whittemore, Alice S.] Stanford Univ, Sch Med, Dept Hlth Res & Policy Epidemiol, Stanford, CA 94305 USA; [McLaughlin, John R.] Publ Hlth Ontario, Toronto, ON, Canada; [Modugno, Francesmary] Univ Pittsburgh, Inst Canc, Womens Canc Res Program, Magee Womens Res Inst, Pittsburgh, PA USA; [Modugno, Francesmary] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA; [Modugno, Francesmary] Univ Pittsburgh, Sch Med, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA USA; [Ness, Roberta B.] Univ Texas Houston, Sch Publ Hlth, Houston, TX USA; [Odunsi, Kunle] Roswell Pk Canc Inst, Dept Gynecol Oncol, Buffalo, NY 14263 USA; [Olson, Sara H.; Orlow, Irene; Pike, Malcolm C.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Weber, Rachel Palmieri] Duke Univ, Med Ctr, Dept Community & Family Med, Durham, NC USA; [Pearce, Celeste L.] Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Poole, Elizabeth M.; Schernhammer, Eva] Brigham & Womens Hosp, Channing Div Network Med, Boston, MA 02115 USA; [Poole, Elizabeth M.; Schernhammer, Eva] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Poole, Elizabeth M.; Schernhammer, Eva; Terry, Kathryn L.; Tworoger, Shelley S.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Risch, Harvey A.] Yale Univ, Sch Publ Hlth, Dept Chron Dis Epidemiol, New Haven, CT USA; [Rosen, Barry] Princess Margaret Hosp, Dept Gynecology Oncol, Toronto, ON M4X 1K9, Canada; [Rosen, Barry] Univ Toronto, Fac Med, Dept Obstet & Gynecol, Toronto, ON, Canada; [Lele, Shashi; Moysich, Kirsten B.; Sucheston-Campbell, Lara] Inst Human Genet & Anthropol, Wiesbaden, Germany; [Shu, Xiao-Ou] Vanderbilt Univ, Sch Med, Ingram Canc Ctr, Epidemiol Ctr & Vanderbilt, Nashville, TN 37235 USA; [Shvetsov, Yurii B.; Wilkens, Lynne R.] Univ Hawaii, Canc Epidemiol Program, Honolulu, HI 96822 USA; [Spiewankiewicz, Beata] Inst Oncol, Dept Gynecol Oncol, Warsaw, Poland; [Teo, Soo-Hwang] Univ Malaya, Med Ctr, Kuala Lumpur, Malaysia; [Thomsen, Lotte] Univ Copenhagen, Rigshosp, Dept Pathol, DK-2100 Copenhagen, Denmark; [Vierkant, Robert A.] Mayo Clin, Div Biomed Stat & Informat, Dept Hlth Sci Res, Rochester, MN USA; [Zheng, Wei] Vanderbilt Univ, Sch Med, Vanderbilt Epidemiol Ctr, Nashville, TN 37235 USA; [Kelemen, Linda E.] Med Univ S Carolina, Dept Publ Hlth Sci, Charleston, SC 29425 USA; [Berchuck, Andrew] Duke Univ, Med Ctr, Dept Obstet & Gynecol, Durham, NC USA; [Chenevix-Trench, Georgia; Grp, Aocs Management] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia; [Chenevix-Trench, Georgia; Grp, Aocs Management] Peter MacCallum Canc Ctr, East Melbourne, Australia; [Schildkraut, Joellen M.] Duke Canc Inst, Canc Prevent Detect & Control Res Program, Durham, NC USA; [Goode, Ellen L.] Mayo Clin, Div Epidemiol, Dept Hlth Sci Res, Rochester, MN USA; [Narod, Steven A.] Univ Toronto, Womens Coll Res Inst, Toronto, ON, Canada	Phelan, CM (reprint author), H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Epidemiol, 12902 Magnolia Dr, Tampa, FL 33612 USA.	catherine.phelan@moffitt.org					American Cancer Society, 2014, CANC FACTS FIG 2014; Zhang CW, 2011, MOL GENET METAB, V103, P104, DOI 10.1016/j.ymgme.2011.02.005; Lawrenson K, 2011, CARCINOGENESIS, V32, P1540, DOI 10.1093/carcin/bgr140; Prahst C, 2008, J BIOL CHEM, V283, P25110, DOI 10.1074/jbc.C800137200; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Liu L, 2014, CANCER EPIDEMIOL, V38, P66, DOI 10.1016/j.canep.2013.12.009; Hefler LA, 2002, GYNECOL ONCOL, V86, P134, DOI 10.1006/gyno.2002.6749; Puisieux A, 2014, NAT CELL BIOL, V16, P488, DOI 10.1038/ncb2976; Filmus J, 2001, J CLIN INVEST, V108, P497, DOI 10.1172/JCI13712; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Narod SA, 2004, NAT REV CANCER, V4, P665, DOI 10.1038/nrc1431; Galic V, 2007, GENE CHROMOSOME CANC, V46, P239, DOI 10.1002/gcc.20407; Quaye L, 2009, BRIT J CANCER, V100, P993, DOI 10.1038/sj.bjc.6604947; Li Y, 2008, GYNECOL ONCOL, V108, P409, DOI 10.1016/j.ygyno.2007.10.024; De Cat B, 2001, SEMIN CELL DEV BIOL, V12, P117, DOI 10.1006/scdb.2000.0240; Yang X, 2013, CANCER LETT, V341, P265, DOI 10.1016/j.canlet.2013.08.020; Schildkraut JM, 2009, CANCER RES, V69, P2349, DOI 10.1158/0008-5472.CAN-08-2902; Ralph S, 2007, CANCER SCI, V98, P844, DOI 10.1111/j.1349-7006.2007.00461.x; Auranen A, 1996, BRIT J CANCER, V74, P280, DOI 10.1038/bjc.1996.352; Polterauer S, 2007, GYNECOL ONCOL, V105, P385, DOI 10.1016/j.ygyno.2006.12.021; Schultheis AM, 2008, CLIN CANCER RES, V14, P7554, DOI 10.1158/1078-0432.CCR-08-0351; Sulpice E, 2008, BLOOD, V111, P2036, DOI 10.1182/blood-2007-04-084269; Stratton JF, 1998, BRIT J OBSTET GYNAEC, V105, P493, DOI 10.1111/j.1471-0528.1998.tb10148.x; Steffensen KD, 2010, GYNECOL ONCOL, V117, P109, DOI 10.1016/j.ygyno.2009.11.011; Quaye L, 2008, CLIN CANCER RES, V14, P5833, DOI 10.1158/1078-0432.CCR-08-0819; Goode EL, 2010, CLIN CANCER RES, V16, P995, DOI 10.1158/1078-0432.CCR-09-2553; Permuth-Wey J, 2011, CANCER RES, V71, P3896, DOI 10.1158/0008-5472.CAN-10-4167; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Sankararaman S, 2008, AM J HUM GENET, V82, P290, DOI [10.1016/j.ajhg.2007.09.022, 10.1016/i.ajhg.2007.09.022]; Soker S, 2002, J CELL BIOCHEM, V85, P357, DOI 10.1002/jcb.10140; Pharoah PDP, 2013, NAT GENET, V45, P362, DOI 10.1038/ng.2564; Li YF, 2010, LANCET ONCOL, V11, P321, DOI 10.1016/S1470-2045(10)70042-5; Davidson Ben, 2012, Front Oncol, V2, P33, DOI 10.3389/fonc.2012.00033; Grandclement C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020444; Nieto MA, 2013, SCIENCE, V342, P708, DOI 10.1126/science.1234850; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917	36	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0741-0395	1098-2272		GENET EPIDEMIOL	Genet. Epidemiol.	DEC	2015	39	8					689	697		10.1002/gepi.21921		9	Genetics & Heredity; Public, Environmental & Occupational Health	Genetics & Heredity; Public, Environmental & Occupational Health	CY7RA	WOS:000366605200009		
J	Kizaki, S; Hashimoto, K; Matsui, H; Usui, H; Shozu, M				Kizaki, Shoko; Hashimoto, Kazunori; Matsui, Hideo; Usui, Hirokazu; Shozu, Makio			Comparison of 5-day MTX and 5-day ETP treatment results and early predictors of drug resistance to 5-day MTX in patients with post-molar low-risk gestational trophoblastic neoplasia	GYNECOLOGIC ONCOLOGY			English	Article						Low-risk gestational trophoblastic neoplasia; Drug resistance; Chemotherapy	AGENT METHOTREXATE CHEMOTHERAPY; FOLINIC ACID; ACTINOMYCIN-D; DISEASE; TUMORS; COMBINATION; WOMEN	Objective. To determine the primary remission rates and predictors of drug resistance in patients with post-molar low-risk gestational trophoblastic neoplasia (GTN) who were treated with a 5-day intramuscular methotrexate (5-day IM MTX) or a 5-day drip infusion etoposide (5-day DIV ETP) regimen. Methods. Between 1980 and 2014, 166 consecutive patients with low-risk post-molar GTN were initially treated with a 5-day IM MTX or a 5-day DIV ETP regimen. The primary remission rates, changes in chemotherapy due to drug resistance or toxicity, and relapse rates were compared. Furthermore, we analyzed the factors that influenced the development of resistance to MTX. Results. Primary remission rates were significantly higher among the ETP-treated patients than among the MTX-treated patients. Among the 42 patients who required a change in chemotherapy, 23 patients (22.6%) and 4 patients (6.3%) were diagnosed as being resistant to MTX and EPT, respectively. Maternal age and the presence of metastasis did not significantly influence the development of MTX resistance, although higher FIGO scores and pre-treatment human chorionic gonadotropin (hCG) levels of >5 x 10(4) mIU/mL were significantly more common among patients who developed MTX resistance. Moreover, a <30% decrease in hCG after the first cycles of MIX chemotherapy was significantly associated with the development of MIX resistance. Conclusions. All patients with low-risk GTN eventually achieved complete remission, although several patients developed drug resistance to the first-line chemotherapy. A <30% decrease in hCG during the first chemotherapy cycle may be an early indicator of drug resistance after commencing a 5-day MTX regimen. (C) 2015 Elsevier Inc. All rights reserved.	[Kizaki, Shoko; Hashimoto, Kazunori; Matsui, Hideo] Tokyo Womens Med Univ, Dept Obstet & Gynecol, Shinnjuku Ku, Tokyo 1628666, Japan; [Usui, Hirokazu; Shozu, Makio] Chiba Univ, Grad Sch Med, Dept Reprod Med, Chuo Ku, Chiba 2608670, Japan	Matsui, H (reprint author), Tokyo Womens Med Univ, Dept Obstet & Gynecol, Shinnjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	matsui.hideo@twmu.ac.jp					Roberts JP, 1996, AM J OBSTET GYNECOL, V174, P1917, DOI 10.1016/S0002-9378(96)70229-6; Matsui H, 2005, GYNECOL ONCOL, V96, P616, DOI 10.1016/j.ygyno.2004.11.011; Aghajanian C, 2011, J CLIN ONCOL, V29, P786, DOI 10.1200/JCO.2010.31.0151; SOPER JT, 1994, GYNECOL ONCOL, V54, P76, DOI 10.1006/gyno.1994.1169; LURAIN JR, 1995, AM J OBSTET GYNECOL, V172, P574, DOI 10.1016/0002-9378(95)90575-8; McNeish IA, 2002, J CLIN ONCOL, V20, P1838, DOI 10.1200/JCO.2002.07.166; Osborne RJ, 2011, J CLIN ONCOL, V29, P825, DOI 10.1200/JCO.2010.30.4386; McGrath S, 2010, BRIT J CANCER, V102, P810, DOI 10.1038/sj.bjc.6605529; Chapman-Davis E, 2012, GYNECOL ONCOL, V125, P572, DOI 10.1016/j.ygyno.2012.03.039; Rustin GJS, 1996, J CLIN ONCOL, V14, P2769; Matsui H, 1998, GYNECOL OBSTET INVES, V46, P5, DOI 10.1159/000009987; SMITH EB, 1982, AM J OBSTET GYNECOL, V144, P88; WONG LC, 1985, AM J OBSTET GYNECOL, V152, P59; BERKOWITZ RS, 1986, GYNECOL ONCOL, V23, P111, DOI 10.1016/0090-8258(86)90123-X; Matsui H, 2000, GYNECOL ONCOL, V78, P28, DOI 10.1006/gyno.2000.5813; Cancer Therapy Evaluation Program (CTEP), COMM TERM CRIT ADV E	16	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0090-8258	1095-6859		GYNECOL ONCOL	Gynecol. Oncol.	DEC	2015	139	3					429	432		10.1016/j.ygyno.2015.10.007		4	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CY7WB	WOS:000366618900009		
J	Mikami, M; Tanabe, K; Matsuo, K; Miyazaki, Y; Miyazawa, M; Hayashi, M; Asai, S; Ikeda, M; Shida, M; Hirasawa, T; Kojima, N; Sho, R; Iijima, S				Mikami, Mikio; Tanabe, Kazuhiro; Matsuo, Koji; Miyazaki, Yuko; Miyazawa, Masaki; Hayashi, Masaru; Asai, Satoshi; Ikeda, Masae; Shida, Masako; Hirasawa, Takeshi; Kojima, Nozomi; Sho, Ryuichiro; Iijima, Sadayo			Fully-sialylated alpha-chain of complement 4-binding protein: Diagnostic utility for ovarian clear cell carcinoma	GYNECOLOGIC ONCOLOGY			English	Article						Complement 4-binding protein; Full sialylation; Ovarian clear cell carcinoma; Endometrioma: early detection	C4B-BINDING PROTEIN; SIALIC-ACID; CANCER; ENDOMETRIOSIS; CIRCULATION; BIOMARKERS; RISK	Objective. While a certain fraction of endometriomas can develop de novo epithelial ovarian cancer (EOC) such as clear cell carcinoma (OCCC), there is currently no useful biomarker available for early detection of OCCC from endometriomas. The aim of this study was to describe the diagnostic utility of a novel biomarker for EOC especially for OCCC to distinguish from endometrioma. Methods. More than 100,000 glycan structures of serum glycoproteins obtained from 134 pretreatment all stage EOC patients (including 45 OCCCs) and 159 non-cancer control women (including 36 endometriomas) were explored for a mass spectrum approach. Diagnostic accuracy of identified biomarker was compared to the one of CA-125 by comparing area under curve (AUC) and positive/negative predictive values (PPV and NPV). Results. A2160, a fully-sialylated alpha-chain of complement 4-binding protein, was identified as a candidate target marker. A2160 was significantly elevated in all stages of OCCC compared to with endometriomas. Diagnostic accuracy of A2160 (cutoff 1.6 U/mL) to distinguish early stage OCCC from endometrioma is significantly higher than that of CA-125 (cutoff 35 IU/L): AUC for A2160 versus CA-125;0.92 versus 0.67; PPV 95% versus 64%; and NPV 85% versus 58%. In addition, fully-sialylated glycans had a higher accuracy for diagnosing EOC as compared to partially-sialylated glycans of alpha-chain of complement 4-binding protein. Conclusion. Our study suggested that A2160 may be a useful biomarker to distinguish early-stage OCCC from endometrioma. This new biomarker can be potentially applied for the monitoring of endometrioma patients, making possible the early diagnosis of OCCC. (C) 2015 The Authors. Published by Elsevier Inc.	[Mikami, Mikio; Miyazawa, Masaki; Hayashi, Masaru; Asai, Satoshi; Ikeda, Masae; Shida, Masako; Hirasawa, Takeshi] Tokai Univ, Sch Med, Dept Obstet & Gynecol, Isehara, Kanagawa 2591193, Japan; [Tanabe, Kazuhiro; Miyazaki, Yuko] LSI Medience Corp, Med Solut Segment, Adv Technol Ctr, Tokyo 1748555, Japan; [Matsuo, Koji] Univ So Calif, Norris Comprehens Canc Ctr, Dept Obstet & Gynecol, Div Gynecol Oncol, Los Angeles, CA 90033 USA; [Kojima, Nozomi] Mitsubishi Chem Grp Sci & Technol Res Ctr Inc, Yokohama, Kanagawa 2278502, Japan; [Sho, Ryuichiro] Sho Hosp, Dept Obstet & Gynecol, Tokyo 1730004, Japan; [Iijima, Sadayo] LSI Medience Corp, Int Sales Dept, Tokyo 1018517, Japan	Mikami, M (reprint author), Tokai Univ, Sch Med, Dept Obstet & Gynecol, Isehara, Kanagawa 2591193, Japan.	mmikami@is.icc.u-tokai.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [26462538]; Ministry of Education, Culture, Sports, Science and Technology-Supported Program [S1201001]; Mr. Minoru Sano Memorial Fund; Tokai University Research Aid; Ensign Endowment for Ovarian Cancer Research	This work was supported in part by a Grant-in-aid for scientific research from Ministry of Education, Culture, Sports, Science and Technology (No. 26462538), Ministry of Education, Culture, Sports, Science and Technology-Supported Program (S1201001) for the Strategic Research Foundation at Private Universities, 2012-2014, grants from Mr. Minoru Sano Memorial Fund and Tokai University Research Aid and Ensign Endowment for Ovarian Cancer Research. We thank Dr. Brendan Grubbs for the technical support for the study.	Zhang Y, 2012, GLYCOCONJUGATE J, V29, P249, DOI 10.1007/s10719-012-9398-x; Sugiyama T, 2000, CANCER, V88, P2584, DOI 10.1002/1097-0142(20000601)88:11<2584::AID-CNCR22>3.0.CO;2-5; Sogabe M, 2014, J PROTEOME RES, V13, P1624, DOI 10.1021/pr401109n; Kobayashi H, 2007, INT J GYNECOL CANCER, V17, P37, DOI 10.1111/j.1525-1438.2006.00754.x; Miyoshi E, 2010, METHOD ENZYMOL, V478, P153, DOI 10.1016/S0076-6879(10)78006-X; Brinton LA, 1997, AM J OBSTET GYNECOL, V176, P572, DOI 10.1016/S0002-9378(97)70550-7; Kobayashi E, 2012, CANCER EPIDEM BIOMAR, V21, P1902, DOI 10.1158/1055-9965.EPI-12-0646; Pearce CL, 2012, LANCET ONCOL, V13, P385, DOI 10.1016/S1470-2045(11)70404-1; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Buys SS, 2011, JAMA-J AM MED ASSOC, V305, P2295, DOI 10.1001/jama.2011.766; MORELL AG, 1971, J BIOL CHEM, V246, P1461; Criado-Garcia O, 1999, EUR J CELL BIOL, V78, P657; Sorensen AL, 2009, BLOOD, V114, P1645, DOI 10.1182/blood-2009-01-199414; Holmberg MT, 2001, J IMMUNOL, V167, P935; Narimatsu H, 2010, FEBS J, V277, P95, DOI 10.1111/j.1742-4658.2009.07430.x; Bulun SE, 2009, NEW ENGL J MED, V360, P268, DOI 10.1056/NEJMra0804690; Clarke-Pearson D.L., 2009, NEW ENGL J MED, V61, P170; Nozaki H., 2012, Differential marker of epithelial ovarian cancer, Patent No. [JP 2012-145500, 2012145500]	18	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0090-8258	1095-6859		GYNECOL ONCOL	Gynecol. Oncol.	DEC	2015	139	3					520	528		10.1016/j.ygyno.2015.10.012		9	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CY7WB	WOS:000366618900024		
J	Kato, K; Matsuura, M; Takeshima, N				Kato, Kazuyoshi; Matsuura, Motoki; Takeshima, Nobuhiro			Secondary debulking surgery for isolated para-aortic nodal recurrence in endometrial cancer requiring partial resection of the inferior vena cava	GYNECOLOGIC ONCOLOGY			English	Article						Endometrial cancer; Para-aortic lymphadenectomy; Inferior vena cava	LYMPH-NODES; RENAL-VEIN	Objective. We report the details of a surgical technique for the cytoreduction of metastatic para-aortic lymph nodes with involvement of the inferior vena cava (IVC) requiring partial resection and repair of the IVC. Methods. A 52-year-old woman presented with endometrial cancer and isolated nodal recurrence involving the IVC. A vascular clamp was applied to the segment of the IVC that the metastatic lymph nodes had involved, and an en bloc resection of the para-aortic lymph nodes with the involved segment of the IVC was performed. Results and conclusion. In this case, a partial resection of the IVC was performed to enable a complete cytoreduction without encroaching on the tumor planes. No intraoperative or postoperative complications, including vascular complications, occurred. This surgical procedure can be adopted for the management of metastatic para-aortic lymph nodes in selected patients. (C) 2015 Elsevier Inc All rights reserved.	[Kato, Kazuyoshi; Matsuura, Motoki; Takeshima, Nobuhiro] Canc Inst Hosp, Dept Gynecol, Koutou Ku, Tokyo 1358550, Japan	Kato, K (reprint author), Canc Inst Hosp, Dept Gynecol, Koutou Ku, 3-8-31 Ariake, Tokyo 1358550, Japan.	kazuyosikato@gmail.com					Barlin JN, 2010, GYNECOL ONCOL, V118, P14, DOI 10.1016/j.ygyno.2010.04.005; Kato K, 2015, GYNECOL ONCOL, V137, P188, DOI 10.1016/j.ygyno.2015.02.007; Ozgul N, 2015, GYNECOL ONCOL, V138, P492, DOI 10.1016/j.ygyno.2015.05.012; Kato K, 2014, GYNECOL ONCOL, V134, P164, DOI 10.1016/j.ygyno.2014.04.054; Kato K, 2013, GYNECOL ONCOL, V130, P226, DOI 10.1016/j.ygyno.2013.03.025	5	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0090-8258	1095-6859		GYNECOL ONCOL	Gynecol. Oncol.	DEC	2015	139	3					580	581		10.1016/j.ygyno.2015.10.011		2	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CY7WB	WOS:000366618900033		
J	Saito, J; Keosada, N; Tomokawa, S; Akiyama, T; Kaewviset, S; Nonaka, D; Waikugul, J; Kobayashi, J; Souvanvixay, M; Jimba, M				Saito, Junko; Ngouay Keosada; Tomokawa, Sachi; Akiyama, Takeshi; Kaewviset, Sethavudh; Nonaka, Daisuke; Waikugul, Jitra; Kobayashi, Jun; Souvanvixay, Mithong; Jimba, Masamine			Factors influencing the National School Health Policy implementation in Lao PDR: a multi-level case study	HEALTH PROMOTION INTERNATIONAL			English	Article						school health services; health promotion; school health policy; developing countries	DEVELOPING-COUNTRIES; PROMOTION; PROGRAMS	In the last decade, a National School Health Policy (NSHP) has been formulated in several developing countries following the recommendations of the Global School Health Initiative. However, NSHP implementations across the country have not been fully shared. This study aimed to identify factors that have influenced implementation of the NSHP in Lao People's Democratic Republic (Lao PDR). We conducted key informant interviews with 20 NSHP implementers and document reviews. Data were collected at the national level and at three lower administrative levels (provincial, district and school) in three areas (north, central and south). Study areas were selected according to the history of NSHP interventions. We applied content analysis using 12 key components of successful policy implementation and a policy triangle framework. We found that scaling up to nationwide implementation was limited. Results showed the NSHP implementation in Lao PDR was influenced by nine interlinked factors, including extensive planning, resource management, monitoring cycle, the perception gap between national and lower administrative officers, national task-force ownership, ongoing coaching of district educational officers, management skills of school principals, priority of school health and decentralization. Furthermore, these nine factors could be integrated into the existing educational system. In conclusion, for sustainable and nationwide implementation of the NSHP in Lao PDR, the following three factors need to be embedded in the educational system: extensive planning with a clear long-term vision at national level, human resource management including well-organized training at each administrative level and a monitoring cycle to understand the real situation at school level.	[Saito, Junko; Jimba, Masamine] Univ Tokyo, Grad Sch Med, Dept Community & Global Hlth, Bunkyo Ku, Tokyo 1130033, Japan; [Ngouay Keosada] Natl Univ Laos, Fac Educ, Res Off, Viangchan, Laos; [Tomokawa, Sachi] Shinshu Univ, Fac Educ, Dept Sports & Hlth Sci, Nagano, Nagano 3808544, Japan; [Akiyama, Takeshi] Nagasaki Univ, Inst Trop Med, Nagasaki 8528523, Japan; [Kaewviset, Sethavudh] Mahidol Univ, Fac Trop Med, OIC, Bangkok 10400, Thailand; [Nonaka, Daisuke] Univ Ryukyus, Grad Sch Med, Dept Parasitol & Int Hlth, Nishihara, Okinawa 9030215, Japan; [Waikugul, Jitra] Mahidol Univ, Fac Trop Med, Dept Helminthol, Bangkok 10400, Thailand; [Kobayashi, Jun] Univ Ryukyus, Sch Hlth Sci, Dept Global Hlth, Nishihara, Okinawa 9030215, Japan; [Souvanvixay, Mithong] Minist Educ, Dept Primary & Preschool Educ, Viangchan, Laos	Jimba, M (reprint author), Univ Tokyo, Grad Sch Med, Dept Community & Global Hlth, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	mjimba@m.u-tokyo.ac.jp			Ministry of Health, Labour and Welfare of Japan [21S3, 24S2]	This work was supported by the Ministry of Health, Labour and Welfare of Japan [Kosei Kagaku Research Grant, International Cooperation Research Grant 21S3, 24S2]. The study sponsor did not have any specific role in any procedure of this study.	Hoelscher DM, 2004, PREV MED, V38, P594, DOI 10.1016/j.ypmed.2003.11.017; Shasha Y, 2011, DEV SO AFR, V28, P293, DOI 10.1080/0376835X.2011.570077; Kamuzora P, 2007, HEALTH POLICY PLANN, V22, P95, DOI 10.1093/heapol/czm001; Okabayashi H, 2006, PARASITOL INT, V55, P121, DOI 10.1016/j.parint.2005.11.056; Whitman CV, 2009, CASE STUDIES IN GLOBAL SCHOOL HEALTH PROMOTION: FROM RESEARCH TO PRACTICE, P35, DOI 10.1007/978-0-387-92269-0_3; Whitman CV, 2009, CASE STUDIES IN GLOBAL SCHOOL HEALTH PROMOTION: FROM RESEARCH TO PRACTICE, P19, DOI 10.1007/978-0-387-92269-0_2; Williams HA, 2004, HEALTH POLICY PLANN, V19, P356, DOI 10.1093/heapol/czh051; Jourdan D, 2011, HEALTH PROMOT INT, V26, P302, DOI 10.1093/heapro/daq076; Jimba M, 2005, LANCET, V365, P751; Deschesnes M, 2003, HEALTH PROMOT INT, V18, P387, DOI 10.1093/heapro/dag410; Lee K, 1998, SOC SCI MED, V47, P949, DOI 10.1016/S0277-9536(98)00168-3; Shiffman J, 2007, AM J PUBLIC HEALTH, V97, P796, DOI 10.2105/AJPH.2006.095455; Bui TTH, 2010, HEALTH POLICY, V98, P178, DOI 10.1016/j.healthpol.2010.06.015; Lee A, 2006, J EPIDEMIOL COMMUN H, V60, P530, DOI 10.1136/jech.2005.040121; Phoungkham S, 2009, CASE STUDIES IN GLOBAL SCHOOL HEALTH PROMOTION: FROM RESEARCH TO PRACTICE, P327, DOI 10.1007/978-0-387-92269-0_24; Green A, 2011, HEALTH POLICY, V100, P167, DOI 10.1016/j.healthpol.2010.11.016; Baker GR, 2011, BMJ QUAL SAF, V20, pI30, DOI 10.1136/bmjqs.2010.046490; Committee for Planning and Investment, 2007, STAT YB 2006; Federal Ministry of Education Nigeria, 2006, NAT SCH HLTH POL; Leger L. S., 1998, HEALTH PROMOT INT, V13, P223; Ministry of Education and Ministry of Health Lao PDR, 2005, NAT SCH HLTH POL; Ministry of Education Lao PDR, 2009, ED SECT DEV FRAM 200; Oldenburg B., 2008, HLTH BEHAV HLTH ED T, V4, P313; Oliveira-Cruz V., 2003, J INT DEV, V15, P41, DOI 10.1002/jid.965; Oseji M., 2011, International Journal of Collaborative Research on Internal Medicine and Public Health (IJCRIMPH), V3, P378; Republic of Kenya, 2011, NAT SCH HLTH STRAT I; Tomokawa S., 2006, J INT DEV COOPERATIO, V12, P87; United Nations Educational Scientific and Cultural Organization, 2012, MON EV GUID SCH HL 1; United States Agency for International Development, 2013, APPR PROM MEAS GEND; United States Agency for International Development, 2010, TAK PULS POL POL IMP; Waikagul Jitra, 2005, Southeast Asian J Trop Med Public Health, V36 Suppl 3, P13; WALT G, 1994, HEALTH POLICY PLANN, V9, P353, DOI 10.1093/heapol/9.4.353; World Health Organization, 2009, HLTH PROM SCH FRAM A; World Health Organization, 2011, NAT DEW PROGR KEN EX; World Health Organization, 1998, WHOS GLOB SCH HLTH I; Yin R., 2009, CASE STUDY RES DESIG	36	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0957-4824	1460-2245		HEALTH PROMOT INT	Health Promot. Int.	DEC	2015	30	4					843	854		10.1093/heapro/dau016		12	Health Policy & Services; Public, Environmental & Occupational Health	Health Care Sciences & Services; Public, Environmental & Occupational Health	CY7YN	WOS:000366625500004		
J	Nagashima, Y; Iijima, R; Nakamura, M; Sugi, K				Nagashima, Yoshinori; Iijima, Raisuke; Nakamura, Masato; Sugi, Kaoru			Utility of the SYNTAX score in predicting outcomes after coronary intervention for chronic total occlusion	HERZ			English	Article						Chronic total occlusion; SYNTAX score; J-CTO score; Percutaneous coronary intervention; Procedural failure	PROCEDURAL OUTCOMES; ARTERY-DISEASE; EXPERIENCE; REGISTRY; RECANALIZATION; SUCCESS; MULTICENTER	Chronic total occlusion (CTO) lesions are a challenging issue. When dealing with complex CTO lesions in patients undergoing percutaneous coronary intervention (PCI), it is important to evaluate not only the CTO lesion itself but also atherosclerotic lesions of the whole coronary artery tree. The utility of the SYNTAX (Synergy Between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery Trial) score in patients with CTO undergoing PCI is unclear. This retrospective study included 304 consecutive patients with CTO lesions who underwent PCI. Primary endpoints were procedural failure and major adverse cardiac events (MACE) within 30 days. The SYNTAX and J-CTO (Multicenter CTO Registry in Japan) scores were assessed before the procedures, and patients were divided into two groups according to SYNTAX criteria: high (> 22; n = 158) and low (a parts per thousand currency signaEuro parts per thousand 22; n = 146) SYNTAX scores. Procedural success was achieved in 252 patients (82.9 %). Patients with a high SYNTAX score had significantly lower procedural success than those with a low SYNTAX score (74.7 % versus 91.8 %, p < 0.0001). There were 13 MACE (8.2 %) in patients with high SYNTAX scores and two MACE (1.4 %) in those with low scores. The SYNTAX and J-CTO scores had odds ratios of 3.33 (95 %CI, 1.44-7.74) and 3.64 (95 %CI, 1.24-10.66) for procedural failure. A higher SYNTAX score (> 22) was also an independent predictor of 30-day MACE after PCI (odds ratio = 4.80, 95 %Cl 1.03-22.42). The SYNTAX score is predictive of procedural failure, as is the J-CTO score. Furthermore, a higher SYNTAX score is strongly associated with an increased risk of 30-day MACE. The SYNTAX score is useful for clinical decision making when treating patients with complex CTO lesions.	[Nagashima, Yoshinori; Iijima, Raisuke; Nakamura, Masato; Sugi, Kaoru] Toho Univ, Ohashi Med Ctr, Div Cardiovasc Med, Tokyo 1538515, Japan	Iijima, R (reprint author), Toho Univ, Ohashi Med Ctr, Div Cardiovasc Med, Meguro Ku, 2-17-6 Ohashi, Tokyo 1538515, Japan.	raisuke@live.jp					Serruys PW, 2009, NEW ENGL J MED, V360, P961, DOI 10.1056/NEJMoa0804626; Yamamoto E, 2013, AM J CARDIOL, V112, P767, DOI 10.1016/j.amjcard.2013.05.004; Suero JA, 2001, J AM COLL CARDIOL, V38, P409, DOI 10.1016/S0735-1097(01)01349-3; Tamburino C, 2013, AM HEART J, V165, P133, DOI 10.1016/j.ahj.2012.10.017; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Shiba M, 2014, INT J CARDIOL, V176, P1270, DOI 10.1016/j.ijcard.2014.07.189; Patel VG, 2013, JACC-CARDIOVASC INTE, V6, P128, DOI 10.1016/j.jcin.2012.10.011; Michael TT, 2013, AM J CARDIOL, V112, P488, DOI 10.1016/j.amjcard.2013.04.008; Kimura M, 2009, JACC-CARDIOVASC INTE, V2, P1135, DOI 10.1016/j.jcin.2009.09.008; Olivari Z, 2003, J AM COLL CARDIOL, V41, P1672, DOI 10.1016/S0735-1097(03)00312-7; Ikeda N, 2012, EUR HEART J, V33, P113, DOI 10.1093/eurheartj/ehr399; Noguchi T, 2000, CATHETER CARDIO INTE, V49, P258, DOI 10.1002/(SICI)1522-726X(200003)49:3<258::AID-CCD7>3.0.CO;2-L; Rittger H, 2014, HERZ, V39, P212, DOI 10.1007/s00059-013-3822-2; Prasad A, 2007, J AM COLL CARDIOL, V49, P1611, DOI 10.1016/j.jacc.2006.12.040; Hoye A, 2012, HEART, V98, P822, DOI 10.1136/heartjnl-2011-300616; Sahin DY, 2013, HERZ, V38, P922, DOI 10.1007/s00059-013-3767-5; Syrseloudis D, 2013, HEART, V99, P474, DOI 10.1136/heartjnl-2012-303205; Hoye A, 2005, EUR HEART J, V26, P2630, DOI 10.1093/eurheartj/ehi498; Lo N, 2014, JACC-CARDIOVASC INTE, V7, P47, DOI 10.1016/j.jcin.2013.07.011; Morino Y, 2001, JACC-CARDIOVASC INTE, V4, P213; Yamane M, 2013, EUROINTERVENTION, V9, P102, DOI 10.4244/EIJV9I1A15	21	0	0	URBAN & VOGEL	MUNICH	NEUMARKTER STRASSE 43, D-81673 MUNICH, GERMANY	0340-9937	1615-6692		HERZ	Herz	DEC	2015	40	8					1090	1096		10.1007/s00059-015-4323-2		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CY6GF	WOS:000366506000010		
J	Ohnishi, N; Ishii, A; Kuramitsu, Y; Morita, T; Sakawa, Y; Takabe, H				Ohnishi, Naofumi; Ishii, Ayako; Kuramitsu, Yasuhiro; Morita, Taichi; Sakawa, Youichi; Takabe, Hideaki			Numerical analysis of hydrodynamic instability in magnetized laser ablation flow	HIGH ENERGY DENSITY PHYSICS			English	Article						Radiation magneto-hydrodynamics; Laser ablation; Hydrodynamic instability; Laboratory astrophysics	RICHTMYER-MESHKOV INSTABILITY; FIELD AMPLIFICATION; ACCELERATION; MAGNETOHYDRODYNAMICS; SCHEME	We have conducted radiation magneto-hydrodynamics (RMHD) simulations of Richtmyer-Meshkov instability (RMI) in a magnetized counter flow produced by intense lasers. A jet-like plasma from a planar plastic target is formed and maintained in several-tens of nanoseconds by expanding plasma from rear side of two separated laser spots, and parallelly located another target is ablated by the radiation from the plasma, reproducing past experimental works. A planar shock driven by the radiation interacts with the jet as a nonuniform density structure, resulting in the RMI. The magnetic field is amplified up to similar to 40 times greater than the background value at the interface at which the instability occurs. However, a certain extent of the amplification results from the compression effect induced by the counter flow, and the obtained amplification level is difficult to be measured in the experiments. An experiment for observing a clear amplification must be designed through the RMHD simulations so that the RMI takes place in the low-density area between two targets. (C) 2014 Elsevier B.V. All rights reserved.	[Ohnishi, Naofumi; Ishii, Ayako] Tohoku Univ, Dept Aerosp Engn, Aoba Ku, Sendai, Miyagi 9808579, Japan; [Kuramitsu, Yasuhiro] Natl Cent Univ, Dept Phys, Taoyuan 320, Taiwan; [Morita, Taichi; Sakawa, Youichi; Takabe, Hideaki] Osaka Univ, Inst Laser Engn, Suita, Osaka 5650871, Japan	Ohnishi, N (reprint author), Tohoku Univ, Dept Aerosp Engn, Aoba Ku, 6-6-01 Aramaki Aza Aoba, Sendai, Miyagi 9808579, Japan.	ohnishi@rhd.mech.tohoku.ac.jp					BRIO M, 1988, J COMPUT PHYS, V75, P400, DOI 10.1016/0021-9991(88)90120-9; RICHTMYER RD, 1960, COMMUN PUR APPL MATH, V13, P297, DOI 10.1002/cpa.3160130207; Inoue T, 2009, ASTROPHYS J, V695, P825, DOI 10.1088/0004-637X/695/2/825; Uchiyama Y, 2007, NATURE, V449, P576, DOI 10.1038/nature06210; STONE JM, 1992, ASTROPHYS J SUPPL S, V80, P791, DOI 10.1086/191681; Ohnishi N, 2012, HIGH ENERG DENS PHYS, V8, P341, DOI 10.1016/j.hedp.2012.09.003; Giacalone J, 2009, ASTROPHYS J, V701, P1865, DOI 10.1088/0004-637X/701/2/1865; VANLEER B, 1979, J COMPUT PHYS, V32, P101, DOI 10.1016/0021-9991(79)90145-1; Kuramitsu Y, 2011, ASTROPHYS SPACE SCI, V336, P269, DOI 10.1007/s10509-010-0568-7; SPITZER L, 1953, PHYS REV, V89, P977, DOI 10.1103/PhysRev.89.977; Kuramitsu Y, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.195004; Kuramitsu Y., 2011, 7 INT C IN FUS SCI A; Meshkov E.E., 1969, FLUID DYNAM, V4, P101; Nishio K, 2013, EPJ WEB CONF, V59, DOI 10.1051/epjconf/20135915005; Ohnishi N, 2006, J PHYS IV, V133, P1193, DOI 10.1051/jp4:2006133244; Samtaney R, 2003, PHYS FLUIDS, V15, pL53, DOI 10.1063/1.1591188; Sano T, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.205001; Sano T, 2012, ASTROPHYS J, V758, DOI 10.1088/0004-637X/758/2/126; Wada Y., 1994, 940083 AIAA; Wheatley V, 2009, PHYS FLUIDS, V21, DOI 10.1063/1.3194303; Wheatley V, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.125002	21	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1574-1818	1878-0563		HIGH ENERG DENS PHYS	High Energy Density Phys.	DEC	2015	17		A		SI		18	23		10.1016/j.hedp.2014.11.006		6	Physics, Fluids & Plasmas	Physics	CY7ES	WOS:000366571800004		
J	Zhang, K; Zhong, JY; Wang, JQ; Pei, XX; Wei, HG; Yuan, DW; Yang, ZW; Wang, C; Li, F; Han, B; Yin, CL; Liao, GQ; Fang, Y; Yang, S; Yuan, XH; Sakawa, Y; Morita, T; Cao, ZR; Jiang, SE; Ding, YK; Kuramitsu, Y; Liang, GY; Wang, FL; Li, YT; Zhu, JQ; Zhang, J; Zhao, G				Zhang, K.; Zhong, J. Y.; Wang, J. Q.; Pei, X. X.; Wei, H. G.; Yuan, D. W.; Yang, Z. W.; Wang, C.; Li, F.; Han, B.; Yin, C. L.; Liao, G. Q.; Fang, Y.; Yang, S.; Yuan, X. H.; Sakawa, Y.; Morita, T.; Cao, Z. R.; Jiang, S. E.; Ding, Y. K.; Kuramitsu, Y.; Liang, G. Y.; Wang, F. L.; Li, Y. T.; Zhu, J. Q.; Zhang, J.; Zhao, G.			Modeling the interaction of solar wind with a dipole magnetic field with Shenguang II intense lasers	HIGH ENERGY DENSITY PHYSICS			English	Article						Magnetic reconnection; Laser plasmas	X-RAY SOURCE; SUPERNOVA HYDRODYNAMICS; RECONNECTION; CRITERIA	The interaction of solar wind with a dipole magnetic field is modeled in a laboratory setting with a small cylindrical permanent magnet and magnetized plasma driven by intense lasers. The result shows a potential application in the understanding of Earth's magnetosphere near the pole region. Some significant features are observed in our experiments, such as magnetic reconnection and repulsion, which agree well with magnetohydrodynamics (MHD) simulation results. (C) 2014 Elsevier B.V. All rights reserved.	[Zhang, K.; Pei, X. X.; Wei, H. G.; Yuan, D. W.; Li, F.; Han, B.; Liang, G. Y.; Wang, F. L.; Zhao, G.] Chinese Acad Sci, Natl Astron Observ, Key Lab Opt Astron, Beijing 100012, Peoples R China; [Zhang, K.] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Zhong, J. Y.] Beijing Normal Univ, Dept Astron, Beijing 100875, Peoples R China; [Wang, J. Q.] Sichuan Univ, Coll Phys Sci & Technol, Chengdu 610065, Peoples R China; [Yin, C. L.; Liao, G. Q.; Li, Y. T.] Chinese Acad Sci, Inst Phys, Beijing 100080, Peoples R China; [Yang, Z. W.; Cao, Z. R.; Jiang, S. E.; Ding, Y. K.] China Acad Engn Phys, Res Ctr Laser Fus, Mianyang 621900, Peoples R China; [Fang, Y.; Yang, S.; Yuan, X. H.; Zhang, J.] Shanghai Jiao Tong Univ, Dept Phys, Shanghai 200240, Peoples R China; [Wang, C.] Shanghai Inst Laser Plasma, Shanghai 201800, Peoples R China; [Zhu, J. Q.] Natl Lab High Power Lasers & Phys, Shanghai 201800, Peoples R China; [Sakawa, Y.; Morita, T.; Kuramitsu, Y.] Osaka Univ, Inst Laser Engn, Suita, Osaka 5650871, Japan	Zhong, JY (reprint author), Beijing Normal Univ, Dept Astron, Beijing 100875, Peoples R China.	jyzhong@bnu.edu.cn; gzhao@bao.ac.cn			National Basic Research Program of China (973 program) [2013CBA01500]; National Natural Science Foundation of China [11135012, 11220101002, 11273033, 11205015]; Beijing Nova Program [Z131109000413050]	The authors are very much grateful to the SG2 operation staffs and the target preparation staffs for valuable help and support. This work is supported by the National Basic Research Program of China (973 program) (Grant Nos. 2013CBA01500), and the National Natural Science Foundation of China (Grant Nos. 11135012, 11220101002, 11273033, 11205015) and Beijing Nova Program (Z131109000413050).	Li CK, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.205001; Hipp M, 2004, MEASUREMENT, V36, P53, DOI 10.1016/j.measurement.2004.04.003; Brady P, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3085786; YATES MA, 1982, PHYS REV LETT, V49, P1702, DOI 10.1103/PhysRevLett.49.1702; Ryutov DD, 2000, ASTROPHYS J SUPPL S, V127, P465, DOI 10.1086/313320; Zhong JY, 2010, NAT PHYS, V6, P984, DOI 10.1038/NPHYS1790; MASUDA S, 1994, NATURE, V371, P495, DOI 10.1038/371495a0; Yamada M, 2010, REV MOD PHYS, V82, P603, DOI 10.1103/RevModPhys.82.603; YAMADA M, 1994, PHYS PLASMAS, V1, P3269, DOI 10.1063/1.870479; Lubow SH, 1996, MON NOT R ASTRON SOC, V279, P1251; Yamada M, 2007, PHYS PLASMAS, V14, DOI 10.1063/1.2740595; McKinney JC, 2012, MON NOT R ASTRON SOC, V419, P573, DOI 10.1111/j.1365-2966.2011.19721.x; Kane J, 1999, PHYS PLASMAS, V6, P2065, DOI 10.1063/1.873497; Falize E, 2009, ASTROPHYS SPACE SCI, V322, P107, DOI 10.1007/s10509-009-9983-z; Ryutov D, 1999, ASTROPHYS J, V518, P821, DOI 10.1086/307293; Li CK, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.055001; Nilson PM, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.255001; Nilson PM, 2008, PHYS PLASMAS, V15, DOI 10.1063/1.2966115; Taylor J.B., 1986, REV MOD PHYS, V58, P74163; Xu X.Y., 2011, RES ASTRON ASTROPHYS, V11	20	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1574-1818	1878-0563		HIGH ENERG DENS PHYS	High Energy Density Phys.	DEC	2015	17		A		SI		32	37		10.1016/j.hedp.2014.11.001		6	Physics, Fluids & Plasmas	Physics	CY7ES	WOS:000366571800006		
J	Ishii, A; Ohnishi, N; Nagakura, H; Ito, H; Yamada, S				Ishii, Ayako; Ohnishi, Naofumi; Nagakura, Hiroki; Ito, Hirotaka; Yamada, Shoichi			Identical algorithm of radiative transfer across ultrarelativistic shock in different inertial frames	HIGH ENERGY DENSITY PHYSICS			English	Article						Radiative transfer; Gamma-ray burst; Relativistic shock	GAMMA-RAY BURSTS; PHOTOSPHERIC EMISSION; RELATIVISTIC JETS; STRATIFIED JETS; COMPTONIZATION; SUPERNOVAE; EFFICIENCY; COLLAPSARS; BREAKOUT; OUTFLOW	Some high-energy photons are thought to be produced by the inverse Compton scattering process in ultrarelativistic flows, and the high-energy component of spectra in gamma-ray bursts can be interpreted by the process. To examine numerically the trajectory of photons traveling in relativistic jets in detail, a coupled computation method of radiative transport with relativistic hydrodynamics is required. We have developed a three-dimensional code of radiative transport on a background with a relativistic flow using Monte Carlo method. Radiative transfer simulations have been implemented in different inertial frames which are described as a shock rest frame or shock moving frames, and obtained results are compared in the shock rest frame to identify a consistent transformation among different frames. Optical depth tau for every directions agrees among each frame if a time duration of the computation is small enough to resolve photon path close to a shock front with almost the speed of light. Although the obtained results of the direction distribution and the spectrum of the escaped photons from the computational domain in each frame show discrepancies due to different flow velocities, they are identical after Lorentz transforming to the shock rest frame. We found the second peak of energy in the high-energy side of the spectra if the simulation condition is determined to allow the scattering process in the upstream side of the shock, and this peak is formed by the inverse Compton scattering process. (C) 2014 Elsevier B.V. All rights reserved.	[Ishii, Ayako; Ohnishi, Naofumi] Tohoku Univ, Dept Aerosp Engn, Sendai, Miyagi 9808579, Japan; [Nagakura, Hiroki] Kyoto Univ, Yukawa Inst Theoret Phys, Kyoto 6068502, Japan; [Ito, Hirotaka] RIKEN, Astrophys Big Bang Lab, Wako, Saitama 3510198, Japan; [Yamada, Shoichi] Waseda Univ, Adv Res Inst Sci & Engn, Tokyo 1698555, Japan	Ishii, A (reprint author), Tohoku Univ, Dept Aerosp Engn, Sendai, Miyagi 9808579, Japan.	ishii@rhd.mech.tohoku.ac.jp					Aloy MA, 2000, ASTROPHYS J, V531, pL119, DOI 10.1086/312537; ANDERSON JL, 1972, ASTROPHYS J, V171, P127, DOI 10.1086/151265; Ishii A, 2013, HIGH ENERG DENS PHYS, V9, P280, DOI 10.1016/j.hedp.2013.01.002; Mizuta A, 2006, ASTROPHYS J, V651, P960, DOI 10.1086/507861; Suzuki A, 2010, ASTROPHYS J, V719, P881, DOI 10.1088/0004-637X/719/1/881; Maeda K, 2006, ASTROPHYS J, V644, P385, DOI 10.1086/503415; Briggs MS, 1999, ASTROPHYS J, V524, P82, DOI 10.1086/307808; Meszaros P, 2000, ASTROPHYS J, V530, P292, DOI 10.1086/308371; Eichler D, 2000, ASTROPHYS J, V529, P146, DOI 10.1086/308245; Ryde F, 2009, ASTROPHYS J, V702, P1211, DOI 10.1088/0004-637X/702/2/1211; Zhang WQ, 2003, ASTROPHYS J, V586, P356, DOI 10.1086/367609; Nakayama K, 2005, ASTROPHYS J, V627, P310, DOI 10.1086/430169; Sari R, 1997, ASTROPHYS J, V485, P270, DOI 10.1086/304428; REES MJ, 1994, ASTROPHYS J, V430, pL93, DOI 10.1086/187446; Beloborodov AM, 2011, ASTROPHYS J, V737, DOI 10.1088/0004-637X/737/2/68; Castor I.I., 1972, ASTROPHYS J, V178, P779; Ito H, 2013, ASTROPHYS J, V777, DOI 10.1088/0004-637X/777/1/62; Ito H, 2014, ASTROPHYS J, V789, DOI 10.1088/0004-637X/789/2/159; Lazzati D, 2009, ASTROPHYS J LETT, V700, pL47, DOI 10.1088/0004-637X/700/1/L47; Mizuta A, 2011, ASTROPHYS J, V732, DOI 10.1088/0004-637X/732/1/26; Nagakura H, 2011, ASTROPHYS J, V731, DOI 10.1088/0004-637X/731/2/80; Ohtani Y, 2013, ASTROPHYS J, V777, DOI 10.1088/0004-637X/777/2/113; Pe'er A, 2011, ASTROPHYS J, V732, DOI 10.1088/0004-637X/732/1/49; Schutz B., 2009, 1 COURSE GEN RELATIV; Shibata S, 2014, ASTROPHYS J LETT, V787, DOI 10.1088/2041-8205/787/1/L4; Takagi R, 2005, ASTROPHYS J, V622, pL25, DOI 10.1086/429587	26	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1574-1818	1878-0563		HIGH ENERG DENS PHYS	High Energy Density Phys.	DEC	2015	17		A		SI		85	91		10.1016/j.hedp.2014.11.002		7	Physics, Fluids & Plasmas	Physics	CY7ES	WOS:000366571800014		
J	Kuramitsu, Y; Chu, HH; Hau, LN; Chen, SH; Liu, YL; Hsieh, CY; Sakawa, Y; Hideaki, T; Wang, J				Kuramitsu, Yasuhiro; Chu, Hsu-Hsin; Hau, Lin-Ni; Chen, Shih-Hung; Liu, Yao-Li; Hsieh, Chia-Ying; Sakawa, Youichi; Hideaki, Takabe; Wang, Jyhpyng			Relativistic plasma astrophysics with intense lasers	HIGH ENERGY DENSITY PHYSICS			English	Article						Magnetic field; Plasmas; Laser; Relativity; Laboratory astrophysics	MAGNETIC-FIELD AMPLIFICATION; COUNTER-STREAMING PLASMAS; SUPERNOVA REMNANT; SHOCK; SIMULATIONS; INSTABILITY; GENERATION; WAVE	Recent progresses of laser technologies enable us to investigate space and astrophysical phenomena in laboratories. In space plasmas the local observations by spacecrafts provide us the microscopic information of the plasma and electric/magnetic fields, however, it is difficult to obtain the global structures of the phenomena. In astrophysical plasmas, in contrast, global images provide us the macroscopic information, although there is no local observation and thus no microscopic information. Laboratory experiments on space and astrophysical phenomena provide us the local and global information simultaneously. We have investigated so far mostly non-relativistic phenomena in the universe with long laser pulses. Now we extend our research from non-relativistic to relativistic regime with an ultra intense laser, the 100 TW laser facility at National Central University. We introduce our facility and model relativistic phenomena in laboratory, focusing on the magnetic field generation and the magnetic reconnection in the universe. (C) 2014 Elsevier B.V. All rights reserved.	[Kuramitsu, Yasuhiro; Chu, Hsu-Hsin; Chen, Shih-Hung; Liu, Yao-Li; Hsieh, Chia-Ying; Wang, Jyhpyng] Natl Cent Univ, Dept Phys, Taoyuan 320, Taiwan; [Hau, Lin-Ni] Natl Cent Univ, Grad Inst Space Sci, Taoyuan 320, Taiwan; [Sakawa, Youichi; Hideaki, Takabe] Osaka Univ, Inst Laser Engn, Suita, Osaka 5650871, Japan; [Wang, Jyhpyng] Acad Sinica, Inst Atom & Mol Sci, Taipei, Taiwan	Kuramitsu, Y (reprint author), Natl Cent Univ, Dept Phys, 300 Jhongda Rd, Taoyuan 320, Taiwan.	yasu@ncu.edu.tw			Asian Core Program for High energy density science Using intense Laser photons - Japan Society for the Promotion of Science (JSPS); Ministry of Science and Technology, Taiwan [MOST-103-2112 -M-008-001-MY2]	This work was partially supported by the Asian Core Program for High energy density science Using intense Laser photons commissioned by Japan Society for the Promotion of Science (JSPS). This work was supported by the Ministry of Science and Technology, Taiwan under Grant No. MOST-103-2112 -M-008-001-MY2.	Alves EP, 2012, ASTROPHYS J LETT, V746, DOI 10.1088/2041-8205/746/2/L14; Inoue T, 2009, ASTROPHYS J, V695, P825, DOI 10.1088/0004-637X/695/2/825; Uchiyama Y, 2007, NATURE, V449, P576, DOI 10.1038/nature06210; Ross JS, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.3694124; Kuramitsu Y, 2009, ASTROPHYS J LETT, V707, pL137, DOI 10.1088/0004-637X/707/2/L137; Gregori G, 2012, NATURE, V481, P480, DOI 10.1038/nature10747; Woolsey NC, 2004, PLASMA PHYS CONTR F, V46, pB397, DOI 10.1088/0741-3335/46/12B/034; Courtois C, 2004, PHYS PLASMAS, V11, P3386, DOI 10.1063/1.1752930; Davis SP, 2013, HIGH ENERG DENS PHYS, V9, P231, DOI 10.1016/j.hedp.2012.11.009; Kuramitsu Y, 2011, ASTROPHYS SPACE SCI, V336, P269, DOI 10.1007/s10509-010-0568-7; Zhong JY, 2010, NAT PHYS, V6, P984, DOI 10.1038/NPHYS1790; Woolsey NC, 2001, PHYS PLASMAS, V8, P2439, DOI 10.1063/1.1351831; Kugland NL, 2012, NAT PHYS, V8, P809, DOI [10.1038/nphys2434, 10.1038/NPHYS2434]; Kuramitsu Y, 2013, HIGH ENERG DENS PHYS, V9, P222, DOI 10.1016/j.hedp.2013.01.001; Chen BK, 2012, APPL PHYS B-LASERS O, V106, P817, DOI 10.1007/s00340-011-4810-y; Kuramitsu Y, 2012, PLASMA PHYS CONTR F, V54, DOI 10.1088/0741-3335/54/12/124049; Morita T, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3524269; Kuramitsu Y, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.175002; Davis S, 2010, J PHYS CONF SER, V244, DOI 10.1088/1742-6596/244/4/042006; Dong QL, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.215001; Gregory CD, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3431094; Hoshino M, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.135003; Hung TS, 2014, APPL PHYS B-LASERS O, V117, P1189, DOI 10.1007/s00340-014-5943-6; Korneev P, 2014, PHYS PLASMAS, V21, DOI 10.1063/1.4866598; Kuo CC, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.033901; Kuramitsu Y, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.026401; Kuramitsu Y, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3528434; Kuramitsu Y, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.195004; Li CK, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.055001; Mahajan SM, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.095005; Meinecke J., 2014, NAT PHYS; Morita T, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4821967; Nilson PM, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.255001; Nilson PM, 2008, PHYS PLASMAS, V15, DOI 10.1063/1.2966115; Sano T, 2012, ASTROPHYS J, V758, DOI 10.1088/0004-637X/758/2/126; Takabe H, 2008, PLASMA PHYS CONTR F, V50, DOI 10.1088/0741-3335/50/12/124057; Willingale L, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3377787; Yoneda H, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.125004	38	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1574-1818	1878-0563		HIGH ENERG DENS PHYS	High Energy Density Phys.	DEC	2015	17		A		SI		198	202		10.1016/j.hedp.2014.11.005		5	Physics, Fluids & Plasmas	Physics	CY7ES	WOS:000366571800031		
J	Iijima, O; Miyake, K; Watanabe, A; Miyake, N; Igarashi, T; Kanokoda, C; Nakamura-Takahashi, A; Kinoshita, H; Noguchi, T; Abe, S; Narisawa, S; Millan, JL; Okada, T; Shimada, T				Iijima, Osamu; Miyake, Koichi; Watanabe, Atsushi; Miyake, Noriko; Igarashi, Tsutomu; Kanokoda, Chizu; Nakamura-Takahashi, Aki; Kinoshita, Hideaki; Noguchi, Taku; Abe, Shinichi; Narisawa, Sonoko; Millan, Jose Luis; Okada, Takashi; Shimada, Takashi			Prevention of Lethal Murine Hypophosphatasia by Neonatal Ex Vivo Gene Therapy Using Lentivirally Transduced Bone Marrow Cells	HUMAN GENE THERAPY			English	Article							SEVERE COMBINED IMMUNODEFICIENCY; ENZYME-REPLACEMENT THERAPY; HEMATOPOIETIC STEM-CELLS; IN-UTERO TRANSPLANTATION; ALKALINE-PHOSPHATASE; INFANTILE HYPOPHOSPHATASIA; RETROVIRAL VECTORS; MICE; PATIENT; MODEL	Hypophosphatasia (HPP) is an inherited skeletal and dental disease caused by loss-of-function mutations in the gene that encodes tissue-nonspecific alkaline phosphatase (TNALP). The major symptoms of severe forms of the disease are bone defects, respiratory insufficiency, and epileptic seizures. In 2015, enzyme replacement therapy (ERT) using recombinant bone-targeted TNALP with deca-aspartate (D-10) motif was approved to treat pediatric HPP patients in Japan, Canada, and Europe. However, the ERT requires repeated subcutaneous administration of the enzyme because of the short half-life in serum. In the present study, we evaluated the feasibility of neonatal ex vivo gene therapy in TNALP knockout (Akp2(-/-)) HPP mice using lentivirally transduced bone marrow cells (BMC) expressing bone-targeted TNALP in which a D-10 sequence was linked to the C-terminus of soluble TNALP (TNALP-D-10). The Akp2(-/-) mice usually die within 20 days because of growth failure, epileptic seizures, and hypomineralization. However, an intravenous transplantation of BMC expressing TNALP-D-10 (ALP-BMC) into neonatal Akp2(-/-) mice prolonged survival of the mice with improved bone mineralization compared with untransduced BMC-transplanted Akp2(-/-) mice. The treated Akp2(-/-) mice were normal in appearance and experienced no seizures during the experimental period. The lentivirally transduced BMC were efficiently engrafted in the recipient mice and supplied TNALP-D-10 continuously at a therapeutic level for at least 3 months. Moreover, TNALP-D-10 overexpression did not affect multilineage reconstitution in the recipient mice. The plasma ALP activity was sustained at high levels in the treated mice, and tissue ALP activity was selectively detected on bone surfaces, not in the kidneys or other organs. No ectopic calcification was observed in the ALP-BMC-treated mice. These results indicate that lentivirally transduced BMC can serve as a reservoir for stem cell-based ERT to rescue the Akp2(-/-) phenotype. Neonatal ex vivo gene therapy thus appears to be a possible treatment option for treating severe HPP.	[Iijima, Osamu; Miyake, Koichi; Watanabe, Atsushi; Miyake, Noriko; Igarashi, Tsutomu; Kanokoda, Chizu; Nakamura-Takahashi, Aki; Okada, Takashi; Shimada, Takashi] Nippon Med Sch, Res Ctr Adv Med Technol, Div Gene Therapy, Dept Biochem & Mol Biol, Tokyo 1138602, Japan; [Watanabe, Atsushi] Nippon Med Coll Hosp, Div Clin Genet, Tokyo, Japan; [Igarashi, Tsutomu] Nippon Med Coll Hosp, Dept Ophthalmol, Tokyo, Japan; [Kinoshita, Hideaki] Tokyo Dent Coll, Dept Dent Mat Sci, Tokyo, Japan; [Noguchi, Taku; Abe, Shinichi] Tokyo Dent Coll, Dept Anat, Tokyo, Japan; [Narisawa, Sonoko; Millan, Jose Luis] Sanford Burnham Med Res Inst, Sanford Childrens Hlth Res Ctr, La Jolla, CA USA	Miyake, K (reprint author), Nippon Med Sch, Dept Biochem & Mol Biol, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138602, Japan.	kmiyake@nms.ac.jp			JSPS KAKENHI Grant [25461564]	We thank Dr. Seiko Yamamoto at the Nihon University Graduate School of Dentistry at Matsudo, and Dr. Tae Matsumoto and Dr. Hanako Sugano-Tajima at Nippon Medical School for valuable advice and support. This work was supported by JSPS KAKENHI Grant Number 25461564.	Kawamoto T, 2003, ARCH HISTOL CYTOL, V66, P123, DOI 10.1679/aohc.66.123; Persons DA, 2011, MOL THER, V19, P229, DOI 10.1038/mt.2010.305; Hacein-Bey-Abina S, 2010, NEW ENGL J MED, V363, P355, DOI 10.1056/NEJMoa1000164; Whyte MP, 2015, BONE, V75, P229, DOI 10.1016/j.bone.2015.02.022; Ciancaglini P, 2010, J BONE MINER RES, V25, P716, DOI 10.1359/jbmr.091023; Mukherjee S, 2013, GENE, V525, P174, DOI 10.1016/j.gene.2013.03.098; Millan JL, 2013, CALCIFIED TISSUE INT, V93, P299, DOI 10.1007/s00223-012-9672-8; Yoshimitsu M, 2007, GENE THER, V14, P256, DOI 10.1038/sj.gt.3302839; Narisawa S, 1997, DEV DYNAM, V208, P432, DOI 10.1002/(SICI)1097-0177(199703)208:3<432::AID-AJA13>3.0.CO;2-1; van Til NP, 2010, BLOOD, V115, P5329, DOI 10.1182/blood-2009-11-252874; Miyake N, 2006, STEM CELLS, V24, P653, DOI 10.1634/stemcells.2005-0328; Sugano H, 2012, HUM GENE THER, V23, P399, DOI 10.1089/hum.2011.148; WHYTE MP, 1995, J CLIN INVEST, V95, P1440, DOI 10.1172/JCI117814; KOZLOWSKI K, 1976, PEDIATR RADIOL, V5, P103, DOI 10.1007/BF00975316; Meza NW, 2009, MOL THER, V17, P2000, DOI 10.1038/mt.2009.200; Igarashi T, 2007, CURR EYE RES, V32, P543, DOI 10.1080/02713680701389333; Rio P, 2005, GENE THER, V12, P358, DOI 10.1038/sj.gt.3302419; Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046; Candotti F, 2012, BLOOD, V120, P3635, DOI 10.1182/blood-2012-02-400937; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; Kinoshita H, 2013, DENT MATER J, V32, P637, DOI 10.4012/dmj.2012-175; Oikawa H, 2014, J INHERIT METAB DIS, V37, P309, DOI 10.1007/s10545-013-9646-7; Hanawa H, 2009, MOL THER, V17, P667, DOI 10.1038/mt.2009.1; Hofling AA, 2004, MOL THER, V9, P856, DOI 10.1016/j.ymthe.2004.03.013; Yamamoto S, 2011, J BONE MINER RES, V26, P135, DOI 10.1002/jbmr.201; Narisawa S, 2001, J PATHOL, V193, P125, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH722>3.0.CO;2-Y; Flake AW, 1996, NEW ENGL J MED, V335, P1806, DOI 10.1056/NEJM199612123352404; Whyte MP, 2012, NEW ENGL J MED, V366, P904, DOI 10.1056/NEJMoa1106173; Matsumoto T, 2011, HUM GENE THER, V22, P1355, DOI 10.1089/hum.2010.210; Whyte MP, 2010, ANN NY ACAD SCI, V1192, P190, DOI 10.1111/j.1749-6632.2010.05387.x; Wu TL, 2012, MOL THER, V20, P572, DOI 10.1038/mt.2011.280; Demirbilek H, 2012, J CLIN RES PEDIATR E, V4, P34, DOI 10.4274/jcrpe.473; Taketani T, 2015, CELL TRANSPLANT, V24, P1931, DOI 10.3727/096368914X685410; SHOHAT M, 1991, PEDIATR RADIOL, V21, P421, DOI 10.1007/BF02026677; Porada CD, 2005, MOL THER, V12, P754, DOI 10.1016/j.ymthe.2005.05.011; Cahill RA, 2007, J CLIN ENDOCR METAB, V92, P2923, DOI 10.1210/jc.2006-2131; Charrier S, 2007, GENE THER, V14, P415, DOI 10.1038/sj.gt.3302863; Millan JL, 2008, J BONE MINER RES, V23, P777, DOI 10.1359/JBMR.071213; Wengler GS, 1996, LANCET, V348, P1484, DOI 10.1016/S0140-6736(96)09392-0; Whyte MP, 2003, J BONE MINER RES, V18, P624, DOI 10.1359/jbmr.2003.18.4.624; Watanabe Atsushi, 2007, Journal of Nippon Medical School, V74, P65, DOI 10.1272/jnms.74.65; Pacienza N, 2012, MOL THER, V20, P1454, DOI 10.1038/mt.2012.64; Scaramuzza S, 2013, MOL THER, V21, P175, DOI 10.1038/mt.2012.23; Tadokoro M, 2009, J PEDIATR-US, V154, P924, DOI 10.1016/j.jpeds.2008.12.021; Schuettrumpf J, 2006, MOL THER, V13, P1064, DOI 10.1016/j.ymthe.2006.03.002; FEDDE KN, 1988, ARCH BIOCHEM BIOPHYS, V264, P400, DOI 10.1016/0003-9861(88)90305-0; Katsube Y, 2010, GENE THER, V17, P494, DOI 10.1038/gt.2009.156; Biffi A, 2013, SCIENCE, V341, P864, DOI 10.1126/science.1233158; Gasque KCS, 2015, BONE, V72, P137, DOI 10.1016/j.bone.2014.11.017; Ginn S.L., 2012, J GENE MED, V15, P65, DOI DOI 10.1002/JGM.2698; Mornet E, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-40; Mornet E, 2014, EUR J HUM GENET, V22, pe1; Nakamura-Utsunomiya Akari, 2010, Clin Pediatr Endocrinol, V19, P7, DOI 10.1297/cpe.19.7	53	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1043-0342	1557-7422		HUM GENE THER	Hum. Gene Ther.	DEC 1	2015	26	12					801	812		10.1089/hum.2015.078		12	Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	CZ0YV	WOS:000366833500005		
J	Nelson, WC; Pyo, CW; Vogan, D; Wang, RH; Pyon, YS; Hennessey, C; Smith, A; Pereira, S; Ishitani, A; Geraghty, DE				Nelson, Wyatt C.; Pyo, Chul-Woo; Vogan, David; Wang, Ruihan; Pyon, Yoon-Soo; Hennessey, Carly; Smith, Anajane; Pereira, Shalini; Ishitani, Akiko; Geraghty, Daniel E.			An integrated genotyping approach for HLA and other complex genetic systems	HUMAN IMMUNOLOGY			English	Article						Single molecule sequencing; HLA genotyping; KIR haplotyping; High resolution; Multiplex PCR; System integration; Genotyping software	STEM-CELL TRANSPLANTATION; UNRELATED DONOR; HIGH-THROUGHPUT; HIGH-RESOLUTION; MARROW-TRANSPLANTATION; IMGT/HLA DATABASE; GENERATION; DNA; CHIMERISM; LEUKEMIA	Clinical immunogenetics laboratories performing routine sequencing of human leukocyte antigen (HLA) genes in support of hematopoietic cell transplantation are motivated to upgrade to next-generation sequencing (NGS) technology by its potential for cost savings as well as testing accuracy and flexibility. While NGS machines are available and simple to operate, there are few systems available that provide comprehensive sample preparation and data analysis workflows to complete the process. We report on the development and testing of the Integrated Genotyping System (IGS), which has been designed to specifically address the challenges associated with the adoption of NGS in clinical laboratories. To validate the system for a variety of sample DNA sources, we have tested 336 DNA specimens from whole blood, dried blood spots, buccal swabs, and lymphoblastoid cell lines. HLA class I and class II genotypes were derived from amplicon sequencing of HLA-A, -B, -C for exons 1-7 and HLA-DPA1, -DPB1, -DQA1, -DQB1, -DRB1, -DRB3, -DRB4, -DRB5 for exons 1-4. Additionally, to demonstrate the extensibility of the IGS to other genetic loci, KIR haplotyping of 93 samples was carried out in parallel with HLA typing using a workflow based on the HLA system. These results are discussed with respect to their applications in the clinical setting and consequent potential for advancing precision medicine. (C) 2015 The Authors. Published by Elsevier Inc. on behalf of American Society for Histocompatibility and Immunogenetics.	[Nelson, Wyatt C.; Pyo, Chul-Woo; Vogan, David; Wang, Ruihan; Pyon, Yoon-Soo; Hennessey, Carly; Geraghty, Daniel E.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; [Nelson, Wyatt C.; Pyo, Chul-Woo; Vogan, David; Wang, Ruihan; Smith, Anajane; Pereira, Shalini; Ishitani, Akiko; Geraghty, Daniel E.] Scisco Genet Inc, Seattle, WA 98115 USA; [Ishitani, Akiko; Geraghty, Daniel E.] Scisco Genet Inc, Kashihara, Nara 6340006, Japan	Geraghty, DE (reprint author), Fred Hutchinson Canc Res Ctr, 1100 Fairview Ave North,D4-100, Seattle, WA 98109 USA.	geraghty@fhcrc.org			National Institutes of Health [R42RR018669]	We are especially grateful for the support provided by the entire staff, past and present, of the FHCRC laboratory that have contributed to HLA typing over the past 9 years. This work was supported in part by the National Institutes of Health Grant No. R42RR018669.	Adey A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r119; Rothberg JM, 2011, NATURE, V475, P348, DOI 10.1038/nature10242; Lee SJ, 2007, BLOOD, V110, P4576, DOI 10.1182/blood-2007-06-097386; Lind C, 2010, HUM IMMUNOL, V71, P1033, DOI 10.1016/j.humimm.2010.06.016; Holcomb CL, 2011, TISSUE ANTIGENS, V77, P206, DOI 10.1111/j.1399-0039.2010.01606.x; Latham K, 2014, METHODS MOL BIOL, V1109, P73, DOI 10.1007/978-1-4614-9437-9_5; Petersdorf EW, 2013, INT J IMMUNOGENET, V40, P2, DOI 10.1111/iji.12022; Holcomb CL, 2014, TISSUE ANTIGENS, V83, P32, DOI 10.1111/tan.12269; Wang CL, 2012, P NATL ACAD SCI USA, V109, P8676, DOI 10.1073/pnas.1206614109; MacMillan ML, 2008, BIOL BLOOD MARROW TR, V14, P16, DOI 10.1016/j.bbmt.2008.05.019; De Santis D, 2013, INT J IMMUNOGENET, V40, P72, DOI 10.1111/iji.12024; Robinson J, 2015, NUCLEIC ACIDS RES, V43, pD423, DOI 10.1093/nar/gku1161; Aydin F, 2007, INT J LAB HEMATOL, V29, P208, DOI 10.1111/j.1751-553X.2007.00865.x; Venepalli N, 2010, BONE MARROW TRANSPL, V45, P1579, DOI 10.1038/bmt.2010.138; Moonsamy PV, 2013, TISSUE ANTIGENS, V81, P141, DOI 10.1111/tan.12071; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Gartland AJ, 2014, J VIROL, V88, P8242, DOI 10.1128/JVI.01164-14; Erlich H, 2012, TISSUE ANTIGENS, V80, P1, DOI 10.1111/j.1399-0039.2012.01881.x; Dehn J, 2008, BIOL BLOOD MARROW TR, V14, P1334, DOI 10.1016/j.bbmt.2008.09.009; Grumbt B, 2013, TRANSFUS MED HEMOTH, V40, P196, DOI 10.1159/000351267; Hansen JA, 1998, NEW ENGL J MED, V338, P962, DOI 10.1056/NEJM199804023381405; Spellman SR, 2012, BLOOD, V120, P259, DOI 10.1182/blood-2012-03-379032; Pohl M, 2013, BIOSYSTEMS, V114, P31, DOI 10.1016/j.biosystems.2013.07.003; Chang CXL, 2013, EUR J IMMUNOL, V43, P1109, DOI 10.1002/eji.201243088; Saavedra-Matiz CA, 2013, CLIN CHEM, V59, P1045, DOI 10.1373/clinchem.2012.198945; Kwon M, 2012, BIOL BLOOD MARROW TR, V18, P1235, DOI 10.1016/j.bbmt.2012.01.012; Voorter CEM, 2014, METHODS MOL BIOL, V1109, P101, DOI 10.1007/978-1-4614-9437-9_7; McCann SR, 2005, TRANSFUS APHER SCI, V32, P55, DOI 10.1016/j.transci.2004.10.006; Fernandez-Vina MA, 2014, BLOOD, V123, P1270, DOI 10.1182/blood-2013-10-532671; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Li SYS, 2014, J CLIN INVEST, V124, P3879, DOI 10.1172/JCI75539; Furst D, 2010, TISSUE ANTIGENS, V76, P57, DOI 10.1111/j.1399-0039.2010.01461.x; Lind C, 2013, HUM IMMUNOL, V74, P325, DOI 10.1016/j.humimm.2012.12.007; Sasazuki T, 1998, NEW ENGL J MED, V339, P1177, DOI 10.1056/NEJM199810223391701; Rieneck K, 2013, TRANSFUSION, V53, P2892, DOI 10.1111/trf.12172; Cox ST, 2003, TISSUE ANTIGENS, V61, P20, DOI 10.1034/j.1399-0039.2003.610103.x; Chen CY, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00305; Collins FS, 2015, N ENGL J MED; Danzer M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-221; Dommaraju K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111334; Ehrenberg PK, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-864; Erlich RL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-42; Gabriel C, 2014, TISSUE ANTIGENS, V83, P65, DOI 10.1111/tan.12298; Hosomichi K, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-355; Lange V, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-63; Niklas N, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-176; Pagani Ilaria S, 2014, Oncoscience, V1, P510; Pyo CW, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-89; Pyo CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015115; Siva N., 2014, LANCET; Smith AG, 2014, HUM IMMUNOL, V75, P1040, DOI 10.1016/j.humimm.2014.08.206; Torjesen I, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6690; Trachtenberg Elizabeth A, 2013, Methods Mol Biol, V1034, P197, DOI 10.1007/978-1-62703-493-7_10; UK catapults precision medicine, 2015, NAT BIOTECHNOL, V33, P119; Wittig M, 2015, NUCL ACIDS RES	55	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0198-8859	1879-1166		HUM IMMUNOL	Hum. Immunol.	DEC	2015	76	12			SI		928	938		10.1016/j.humimm.2015.05.001		11	Immunology	Immunology	CY5HE	WOS:000366437900009		
J	Matsuo, M				Matsuo, Makoto			A Framework for Facilitating Experiential Learning	HUMAN RESOURCE DEVELOPMENT REVIEW			English	Article						experiential learning; facilitator; work experience; manager development	POSITIVE PSYCHOLOGY; DEVELOPMENTAL NETWORKS; DELIBERATE PRACTICE; GOAL ORIENTATION; CRITICAL REFLECTION; EXPERT PERFORMANCE; LEADER DEVELOPMENT; WORK EXPERIENCES; JOB; ACQUISITION	Although learning from experience is recognized as important for the development of managers, there is no systematic model regarding how to facilitate experiential learning. This study was designed to develop a theoretical framework for the ability to learn from experience. Drawing on the literature, I have developed a model in which five facilitators (seeking challenging tasks, critical reflection, enjoyment of work, learning goal orientation, and developmental network) directly and indirectly facilitate performance of the four steps of Kolb's experiential learning process. The central contribution of this study is to propose a framework that integrates factors that facilitate experiential learning in various fields. The present research compensates for the shortcomings of Kolb's experiential learning cycle.	[Matsuo, Makoto] Hokkaido Univ, Sapporo, Hokkaido 0600809, Japan	Matsuo, M (reprint author), Hokkaido Univ, Management, Grad Sch Econ & Business Adm, Kita Ku, Kita9 Nishi7, Sapporo, Hokkaido 0600809, Japan.	mmatsuo@econ.hokudai.ac.jp			JSPS KAKENHI [26285078]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by JSPS KAKENHI Grant Numbers 26285078.	AMABILE TM, 1988, RES ORGAN BEHAV, V10, P123; Yamazaki Y, 2007, INT J HUM RESOUR MAN, V18, P1373, DOI 10.1080/09585190701502521; Seligman MEP, 2000, AM PSYCHOL, V55, P5, DOI 10.1037/0003-066X.56.1.89; DWECK CS, 1988, PSYCHOL REV, V95, P256, DOI 10.1037//0033-295X.95.2.256; Kayes DC, 2002, ACAD MANAG LEARN EDU, V1, P137; Macaskill A, 2013, STUD HIGH EDUC, V38, P124, DOI 10.1080/03075079.2011.566325; Graves LM, 2012, J MANAGE, V38, P1655, DOI 10.1177/0149206310363612; Lee FK, 2003, J APPL PSYCHOL, V88, P256, DOI 10.1037/0021-9010.88.2.256; Cunliffe AL, 2009, MANAGE LEARN, V40, P87, DOI 10.1177/1350507608099315; Quinones MA, 1995, PERS PSYCHOL, V48, P887, DOI 10.1111/j.1744-6570.1995.tb01785.x; de Janasz SC, 2003, ACAD MANAGE EXEC, V17, P78; Heslin PA, 2006, PERS PSYCHOL, V59, P871, DOI 10.1111/j.1744-6570.2006.00057.x; Higgins MC, 2001, ACAD MANAGE REV, V26, P264, DOI 10.5465/AMR.2001.4378023; Goldman EF, 2008, HUM RESOUR DEV Q, V19, P217, DOI 10.1002/hrdq.1237; Holman D, 1997, MANAGE LEARN, V28, P135, DOI 10.1177/1350507697282003; Higgins MC, 2001, J ORGAN BEHAV, V22, P595, DOI 10.1002/job.104; SPENCE JT, 1992, J PERS ASSESS, V58, P160, DOI 10.1207/s15327752jpa5801_15; Noordzij G, 2013, PERS PSYCHOL, V66, P723, DOI 10.1111/peps.12011; Reynolds M, 1998, MANAGE LEARN, V29, P183, DOI 10.1177/1350507698292004; Ghosh R, 2013, CAREER DEV INT, V18, P232, DOI 10.1108/CDI-09-2012-0084; Gable SL, 2005, REV GEN PSYCHOL, V9, P103, DOI 10.1037/1089-2680.9.2.103; Gray DE, 2007, MANAGE LEARN, V38, P495, DOI 10.1177/1350507607083204; Elliot AJ, 1997, J PERS SOC PSYCHOL, V72, P218, DOI 10.1037/0022-3514.72.1.218; McNulty JK, 2012, AM PSYCHOL, V67, P101, DOI 10.1037/a0024572; DWECK CS, 1986, AM PSYCHOL, V41, P1040, DOI 10.1037/0003-066X.41.10.1040; Mirvis P, 2008, ACAD MANAG LEARN EDU, V7, P173; De Pater IE, 2009, PERS PSYCHOL, V62, P297, DOI 10.1111/j.1744-6570.2009.01139.x; Murphy WM, 2010, CAREER DEV INT, V15, P637, DOI 10.1108/13620431011094069; Potosky D, 2010, HUM RESOUR DEV Q, V21, P273, DOI 10.1002/hrdq.20047; Cotton RD, 2011, ACAD MANAGE J, V54, P15; MCCAULEY CD, 1994, J APPL PSYCHOL, V79, P544, DOI 10.1037/0021-9010.79.4.544; Spreitzer GM, 1997, J APPL PSYCHOL, V82, P6, DOI 10.1037/0021-9010.82.1.6; Ng KY, 2009, ACAD MANAG LEARN EDU, V8, P511; Kolb AY, 2005, ACAD MANAG LEARN EDU, V4, P193, DOI 10.5465/AMLE.2005.17268566; MORRISON RF, 1992, J APPL PSYCHOL, V77, P926, DOI 10.1037/0021-9010.77.6.926; DeRue DS, 2009, J APPL PSYCHOL, V94, P859, DOI 10.1037/a0015317; Tesluk PE, 1998, PERS PSYCHOL, V51, P321, DOI 10.1111/j.1744-6570.1998.tb00728.x; Yanow D, 2009, J MANAGE STUD, V46, P1339, DOI 10.1111/j.1467-6486.2009.00859.x; Locke EA, 2002, AM PSYCHOL, V57, P705, DOI 10.1037//0003-066X.57.9.705; Dragoni L, 2009, ACAD MANAGE J, V52, P731; Porter COLH, 2010, J APPL PSYCHOL, V95, P935, DOI 10.1037/a0019637; ERICSSON KA, 1993, PSYCHOL REV, V100, P363, DOI 10.1037/0033-295X.100.3.363; Grant H, 2003, J PERS SOC PSYCHOL, V85, P541, DOI 10.1037/0022-3514.85.3.541; Runhaar P, 2010, TEACH TEACH EDUC, V26, P1154, DOI 10.1016/j.tate.2010.02.011; Ericsson KA, 2004, ACAD MED, V79, pS70, DOI 10.1097/00001888-200410001-00022; Payne SC, 2007, J APPL PSYCHOL, V92, P128, DOI 10.1037/0021-9010.92.1.128; Keith N, 2007, J EXP PSYCHOL-APPL, V13, P135, DOI 10.1037/1076-898X.13.3.135; Dragoni L, 2012, J APPL PSYCHOL, V97, P1032, DOI 10.1037/a0028405; Armstrong SJ, 2008, ACAD MANAG LEARN EDU, V7, P189; Pellegrini EK, 2005, EDUC PSYCHOL MEAS, V65, P323, DOI 10.1177/0013164404268665; Wasko MM, 2000, J STRATEGIC INF SYST, V9, P155; ARGYRIS C, 1991, HARVARD BUS REV, V69, P99; Beard C., 2002, POWER EXPERIENTIAL L; Berings M. G. M. C., 2005, HUMAN RESOURCE DEV R, V4, P373, DOI DOI 10.1177/1534484305281769; Boud D., 1993, USING EXPERIENCE LEA; Brutus S., 2000, HUMAN RESOURCE DEV Q, V11, P367, DOI DOI 10.1002/1532-1096(200024)11:4<LESS; Csikszentmihalyi M., 1990, FLOW PSYCHOL OPTIMAL; Csikszentmihalyi M., 1975, BOREDOM ANXIETY; Cunliffe AL, 2004, J MANAGEMENT ED, V28, P407, DOI 10.1177/1052562904264440; DAVIES J, 1984, J MANAGE STUD, V21, P169, DOI 10.1111/j.1467-6486.1984.tb00230.x; Dewey J., 1938, EXPERIENCE ED; Dixon N. M., 1999, ORG LEARNING CYCLE W; Dobrow S. R., 2011, J MANAGE, V38, P210; Egan T. M., 2005, ADV DEV HUMAN RESOUR, V7, P489, DOI DOI 10.1177/1523422305279679; Ericsson KA, 1996, ROAD TO EXCELLENCE, P1; Illeris K., 2007, HUMAN RESOURCE DEV R, V6, P84, DOI 10.1177/1534484306296828; Kolb D. A., 1984, EXPERIENTIAL LEARNIN; KRAM KE, 1983, ACAD MANAGE J, V26, P608, DOI 10.2307/255910; Littrell LN, 2006, HUMAN RESOURCE DEV R, V5, P355, DOI DOI 10.1177/1534484306290106; Locke E. A., 1990, THEORY GOAL SETTING; Lombardo M. M., 2010, CAREER ARCHITECT DEV; McCall M. W., 1998, HIGH FLYERS DEV NEXT; McCall M. W., 1988, LESSONS EXPERIENCE S; McCall M. W., 2002, DEV GLOBAL EXECUTIVE; McCauley C. D., 1998, CTR CREATIVE LEADERS; McGuire D., 2010, HUMAN RESOURCE DEV R, V9, P249; Mezirow J., 1990, FOSTERING CRITICAL R, P1; Molloy J. C, 2005, CAREER DEV INT, V10, P536, DOI 10.1108/13620430510620601; Nakamura Y. T., 2011, HUMAN RESOURCE DEV R, V10, P222; Nelson T. O., 1994, METACOGNITION KNOWIN, P1; Raelin J. A., 2002, REFLECTIONS, V4, P66, DOI DOI 10.1162/152417302320467571; Reynolds M., 2004, ORG REFLECTION, P1; Rodriguez-Sanchez AM, 2011, WORK STRESS, V25, P75, DOI 10.1080/02678373.2011.565619; Schon D, 1983, REFLECTIVE PRACTITIO; Sempowicz T., 2012, INT J EVIDENCE BASED, V10, P52; SIMS RR, 1983, ACAD MANAGE REV, V8, P501, DOI 10.2307/257838; Vince R., 1998, J MANAGEMENT ED, V22, P304, DOI DOI 10.1177/105256299802200304; Wenger E., 2002, CULTIVATING COMMUNIT; Daudelin MW, 1996, ORGAN DYN, V24, P36; Yamazaki Y., 2004, ACAD MANAG LEARN EDU, V3, P362, DOI DOI 10.5465/AMLE.2004.15112543	90	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1534-4843	1552-6712		HUM RESOUR DEV REV	Hum. Resour. Dev. Rev.	DEC	2015	14	4					442	461		10.1177/1534484315598087		20	Management	Business & Economics	CY7MY	WOS:000366594000005		
J	Yuniati, MD; Kitagawa, K; Hirajima, T; Miki, H; Okibe, N; Sasaki, K				Yuniati, Mutia Dewi; Kitagawa, Keitaro; Hirajima, Tsuyoshi; Miki, Hajime; Okibe, Naoko; Sasaki, Keiko			Suppression of pyrite oxidation in acid mine drainage by carrier microencapsulation using liquid product of hydrothermal treatment of low-rank coal, and electrochemical behavior of resultant encapsulating coatings	HYDROMETALLURGY			English	Article						Pyrite oxidation suppression; Hydrothermal treatment liquid; Si-Cat complex; Electrochemistry; Complex plane plots	ACIDITHIOBACILLUS-FERROOXIDANS; IMPEDANCE SPECTROSCOPY; DISSOLUTION; WATER; MECHANISM; CORROSION; CATECHOL; IRON	Pyrite is a mineral sulfide found extensively in acid mine drainage; this is one of the most serious environmental problems in the mining industry. Suppression of pyrite oxidation via carrier microencapsulation (CME) with silicon (Si) and organic carriers has been proposed. In the present study, use of the hydrothermal treatment liquid (HTL) produced from low-rank coal as a carrier in CME was investigated. In dissolution tests for 51 days with pyrite and iron-oxidizing bacteria, treatment with a mixture of HTL and a silicon reagent (Si-HTL) lowered the ferric ion concentration and limited bacterial attachment compared with untreated pyrite. This might be caused by catechol present in the HTL. A mixture of catechol and a silicon reagent (Si-Cat) was also used, and the coatings obtained using Si-HTL and Si-Cat were compared. The electrochemical behavior of the treated pyrite samples showed oxidative decomposition of the Si-Cat complex and formation of an encapsulating layer at 690 mV for Si-HTL and 550 mV for Si-Cat. The two semi-circular curves in the Nyquist plot simulations showed that the total impedances of the treated pyrite samples increased. Microscopic observations showed that the oxidative layer was silica rich. These data indicate that a silica-quinone coating is created and the pyrite oxidation rate can be suppressed by pretreatment with either Si-HTL or Si-Cat for 1 h. (C) 2015 Elsevier B.V. All rights reserved.	[Yuniati, Mutia Dewi; Kitagawa, Keitaro; Hirajima, Tsuyoshi; Miki, Hajime; Okibe, Naoko; Sasaki, Keiko] Kyushu Univ, Dept Earth Resources Engn, Fukuoka 8190395, Japan; [Yuniati, Mutia Dewi] Indonesian Inst Sci LIPI, Res Ctr Geotechnol, Jl Sangkuriang Bandung 40135, Indonesia	Yuniati, MD (reprint author), Indonesian Inst Sci LIPI, Res Ctr Geotechnol, Jl Sangkuriang Bandung 40135, Indonesia.	mutia@geotek.lipi.go.id			Ministry of Education, Culture, Sports, Science and Technology (MEXT) Japan; Japan Society for the Promotion of Science (JSPS) [24246149, 15H02333]	The authors would like to acknowledge the Ministry of Education, Culture, Sports, Science and Technology (MEXT) Japan and a Grant-in-Aid for Scientific Research (Nos. 24246149 and 15H02333) from Japan Society for the Promotion of Science (JSPS) for financial and other supports.	Alhberg E., 1996, ELECTROCHEMISTRY MIN, VIV, P119; BAKER GG, 1986, ENERGY, V11, P1267, DOI 10.1016/0360-5442(86)90064-2; Satur J, 2007, INT J MINER PROCESS, V83, P116, DOI 10.1016/j.minpro.2007.06.003; LALVANI SB, 1990, FUEL, V69, P1567, DOI 10.1016/0016-2361(90)90209-9; Lefebvre O, 2012, J HAZARD MATER, V241, P411, DOI 10.1016/j.jhazmat.2012.09.062; BACKES CA, 1993, SOIL USE MANAGE, V9, P30, DOI 10.1111/j.1475-2743.1993.tb00924.x; SILVERMAN MP, 1959, J BACTERIOL, V77, P642; PANG J, 1990, J ELECTROCHEM SOC, V137, P3447, DOI 10.1149/1.2086249; Zhang YL, 1998, SOIL SCI, V163, P53, DOI 10.1097/00010694-199801000-00008; Sheoran AS, 2006, MINER ENG, V19, P105, DOI 10.1016/j.mineng.2005.08.006; Jha RKT, 2008, MINER ENG, V21, P889, DOI 10.1016/j.mineng.2008.02.011; LALVANI SB, 1991, CORROSION, V47, P55; Perdicakis M, 2001, ELECTROCHIM ACTA, V47, P211, DOI 10.1016/S0013-4686(01)00553-9; Evangelou VP, 1998, ENVIRONM SCI, P197; Mursito AT, 2010, FUEL, V89, P3934, DOI 10.1016/j.fuel.2010.06.035; Murphy R, 2009, SURF SCI REP, V64, P1, DOI 10.1016/j.surfrep.2008.09.002; Crundwell FK, 2003, HYDROMETALLURGY, V71, P75, DOI 10.1016/S0304-386X(03)000175-0; Fowler TA, 2001, HYDROMETALLURGY, V59, P257, DOI 10.1016/S0304-386X(00)00172-9; Todd EC, 2003, GEOCHIM COSMOCHIM AC, V67, P881, DOI 10.1016/S0016-7037(02)00957-2; Bessho M, 2011, ENVIRON EARTH SCI, V64, P311, DOI 10.1007/s12665-010-0848-0; Sanchez-Andrea I, 2014, J HAZARD MATER, V269, P98, DOI 10.1016/j.jhazmat.2013.12.032; Gleisner M, 2006, CHEM GEOL, V225, P16, DOI 10.1016/j.chemgeo.2005.07.020; Akcil A, 2006, J CLEAN PROD, V14, P1139, DOI 10.1016/j.jclepro.2004.09.006; Liu Y, 2011, IONICS, V17, P169, DOI 10.1007/s11581-010-0492-4; Mackie AL, 2012, WATER RES, V46, P327, DOI 10.1016/j.watres.2011.10.030; Favas G, 2003, FUEL, V82, P59, DOI 10.1016/S0016-2361(02)00191-6; Hallberg KB, 2005, SCI TOTAL ENVIRON, V338, P53, DOI 10.1016/j.scitotenv.2004.09.005; Szczygiel B, 2005, ELECTROCHIM ACTA, V50, P4188, DOI 10.1016/j.electacta.2005.01.040; Liu Y, 2011, MINER ENG, V24, P833, DOI 10.1016/j.mineng.2011.03.002; SASAKI K, 1995, GEOCHIM COSMOCHIM AC, V59, P3155, DOI 10.1016/0016-7037(95)00203-C; Jha RKT, 2012, MINER PROCESS EXTR M, V33, P89, DOI 10.1080/08827508.2011.562946; Mursito AT, 2010, FUEL, V89, P635, DOI 10.1016/j.fuel.2009.07.004; Johnson DB, 2005, SCI TOTAL ENVIRON, V338, P3, DOI 10.1016/j.scitotenv.2004.09.002; Evangelou V.P., 1995, PYRITE OXIDATION ITS; Fytas K., 2002, CIM B, V95, P1063; Hutchison I.P.G., 1992, MINE WASTE MANAGEMEN, P654; Kitagawa K., 2010, P C MIN MAT PROC I J, P72; Kleinmann R.L.P., 1981, MINING ENG, V3, P300; Kollias K., 2014, GEOSCI ENV PROT, V2, P37; Li M.G., 1997, P 4 INT C AC ROCK DR, P115; Mehling P.E., 1997, P 4 INT C AC ROCK DR, P953; Mendiratta NK, 1996, ELEC SOC S, V96, P155; Peters E., 1984, ELECTROCHEMISTRY MIN, P343; Rimstidt D.J., 2003, GEOCHIM COSMOCHIM AC, V67, P873; Swanson DA, 1997, P 4 INT C AC ROCK DR, P1595; Totten G.E., 2003, HDB ALUMINUM ALLOY P; Zeng S., 2013, COMPUT WATER ENERGY, V2, P50	47	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-386X	1879-1158		HYDROMETALLURGY	Hydrometallurgy	DEC	2015	158						83	93		10.1016/j.hydromet.2015.09.028		11	Metallurgy & Metallurgical Engineering	Metallurgy & Metallurgical Engineering	CZ0AR	WOS:000366768000012		
J	Kondo, K; Takeda, M; Matsumoto, M				Kondo, Kazuo; Takeda, Masaya; Matsumoto, Michiaki			Separation of rare metals using silica gel modified with a surfactant micelle containing an extractant	HYDROMETALLURGY			English	Article						Extractant; Metal adsorption; Silica gel; Surfactant; Rare metal	SOLID-PHASE EXTRACTION; ATOMIC-ABSORPTION-SPECTROMETRY; SOLVENT-EXTRACTION; WATER SAMPLES; DIISOSTEARYLPHOSPHORIC ACID; ORGANOPHOSPHORUS COMPOUNDS; SELECTIVE SEPARATION; LIQUID-MEMBRANE; ICP-OES; PRECONCENTRATION	Solvent extraction is widely used as a universal method to extract and separate metals in industry. However solvent extraction has some disadvantages, for example, the use of a large amount of organic solvent which could be an environmental hazard. Therefore a solid-phase extraction method is proposed in this research. First of all, a silica gel modified with a nonionic surfactant (TritonX-100) micelle including 2-ethylhexyl phosphonic acid mono-2-ethylhexyl ester (EHPNA) as a metal extractant has been prepared. The amount of extractant contained in the modified silica gel was measured to evaluate the characteristics of the modified silica gel. Then the stability of the modified silica gel was examined. Next, the adsorption equilibrium and the adsorption rate of the metals (aluminum, gallium and indium) were measured to estimate the adsorption mechanism of the metals. Finally, the mutualseparation of aluminum, gallium and indium using the modified silica gel packed in a column was investigated. The amount of EHPNA impregnated in the modified silica gel was 0.205 mmol/g-silica gel. The modified silica gel can be used as a stable adsorbent below pH 2.0 without leaking EHPNA. The results of adsorption equilibrium showed that the higher the pH, the higher was the extent of metal adsorbed. And among aluminum, gallium and indium, only indium was recovered with a three-metal mixture solution ranging pH 1.0 to pH 1.5. In contrast, as a result of examination of the separation of each metal using the modified silica gel packed in a column, the mutual separation of aluminum, gallium and indium was achieved by repeating the adsorption and desorption processes. (C) 2015 Elsevier B.V. All rights reserved.	[Kondo, Kazuo; Takeda, Masaya; Matsumoto, Michiaki] Doshisha Univ, Dept Chem Engn & Mat Sci, Kyoto 6100321, Japan	Kondo, K (reprint author), Doshisha Univ, Dept Chem Engn & Mat Sci, Kyoto 6100321, Japan.	kkondo@mail.doshisha.ac.jp; mmatsumo@mail.doshisha.ac.jp					Aeungmaitrepirom W, 2009, ANAL SCI, V25, P1477; AKMAN S, 1991, ANAL SCI, V7, P799, DOI 10.2116/analsci.7.799; Alfantazi AM, 2003, MINER ENG, V16, P687, DOI 10.1016/S0892-6875(03)00168-7; Uezu K, 2006, SOLVENT EXTR RES DEV, V13, P161; Adhikari BB, 2011, ANALYST, V136, P4570, DOI 10.1039/c1an15398f; Abdel-Fattah TM, 2011, CHEM ENG J, V175, P117, DOI 10.1016/j.cej.2011.09.068; Cui YM, 2007, MICROCHEM J, V87, P20, DOI 10.1016/j.microc.2007.04.004; Liu JS, 2006, J APPL POLYM SCI, V100, P253, DOI 10.1002/app.23042; Repo E, 2009, J HAZARD MATER, V171, P1071, DOI 10.1016/j.jhazmat.2009.06.111; Zhu XB, 2007, MICROCHEM J, V86, P189, DOI 10.1016/j.microc.2007.03.002; Kamio E, 2002, J CHEM ENG JPN, V35, P178, DOI 10.1252/jcej.35.178; Madrakian T, 2008, J HAZARD MATER, V160, P468, DOI 10.1016/j.jhazmat.2008.03.021; Sharma RK, 2013, J ENVIRON SCI-CHINA, V25, P1252, DOI 10.1016/S1001-0742(12)60173-9; Wang WS, 2013, CHEM ENG RES DES, V91, P2759, DOI 10.1016/j.cherd.2013.05.006; Lee MS, 2002, HYDROMETALLURGY, V63, P269, DOI 10.1016/S0304-386X(02)00004-X; Nishihama S, 1998, J CHEM ENG JPN, V31, P818, DOI 10.1252/jcej.31.818; Filho NL, 2006, ELECTROCHIM ACTA, V52, P965, DOI 10.1016/j.electacta.2006.06.033; Tian YA, 2010, CHEM ENG J, V162, P573, DOI 10.1016/j.cej.2010.05.065; Pereira AS, 2010, J HAZARD MATER, V175, P399, DOI 10.1016/j.jhazmat.2009.10.018; Ngeontae W, 2007, TALANTA, V71, P1075, DOI 10.1016/j.talanta.2006.05.094; Martendal E, 2009, J HAZARD MATER, V161, P450, DOI 10.1016/j.jhazmat.2008.03.117; Sarkar SG, 2000, J RADIOANAL NUCL CH, V243, P803, DOI 10.1023/A:1010615629734; Qu RJ, 2008, APPL SURF SCI, V255, P3361, DOI 10.1016/j.apsusc.2008.09.055; Sadeghi S, 2009, J HAZARD MATER, V163, P861, DOI 10.1016/j.jhazmat.2008.07.053; Ezoddin M, 2010, J HAZARD MATER, V178, P900, DOI 10.1016/j.jhazmat.2010.02.023; Zhou ZX, 2001, J INCL PHENOM MACRO, V40, P29, DOI 10.1023/A:1011170621111; Kurahashi K, 2008, SOLVENT EXTR RES DEV, V15, P37; Kim SK, 2005, INORG CHEM, V44, P7866, DOI 10.1021/ic050702v; Afkhami A, 2010, J HAZARD MATER, V181, P836, DOI 10.1016/j.jhazmat.2010.05.089; Puanngam M, 2008, J HAZARD MATER, V154, P578, DOI 10.1016/j.jhazmat.2007.10.090; Donia AM, 2011, SEP SCI TECHNOL, V46, P1329, DOI 10.1080/01496395.2011.558036; Gidwani MS, 2002, REACT FUNCT POLYM, V53, P143, DOI 10.1016/S1381-5148(02)00169-4; Garcia-Valls R, 2001, ANAL CHIM ACTA, V439, P247, DOI 10.1016/S0003-2670(01)01044-3; Kondo K, 1997, J MEMBRANE SCI, V137, P9, DOI 10.1016/S0376-7388(97)00175-0; Kondo K, 1998, SEP PURIF TECHNOL, V13, P109, DOI 10.1016/S1383-5866(97)00064-6; Nishihama S, 1999, IND ENG CHEM RES, V38, P1032, DOI 10.1021/ie980510q; Ohashi A, 2006, SOLVENT EXTR RES DEV, V13, P147; Sharma RK, 2012, J HAZARD MATER, V209, P285, DOI 10.1016/j.jhazmat.2012.01.022; Mahmoud ME, 2010, DESALINATION, V250, P62, DOI 10.1016/j.desal.2009.09.009; Jal PK, 2001, TALANTA, V55, P233, DOI 10.1016/S0039-9140(00)00678-0; Gupta B., 2007, SEP PURIF TECHNOL, V374, P294; Kanazawa Y., 2011, THESIS; Kitahara A., 1979, KAIMENKASSEIZAI BUSS; Kondo K., 1996, SOLV EXTR RES DEV JA, V3, P178; Tokman N, 2003, TALANTA, V59, P201, DOI 10.1016/S0039-9140(02)00479-4	45	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-386X	1879-1158		HYDROMETALLURGY	Hydrometallurgy	DEC	2015	158						107	113		10.1016/j.hydromet.2015.09.030		7	Metallurgy & Metallurgical Engineering	Metallurgy & Metallurgical Engineering	CZ0AR	WOS:000366768000015		
J	Lin, HF; Ishibashi, K; Shin, WY; Fujii, T				Lin, Huifa; Ishibashi, Koji; Shin, Won-Yong; Fujii, Takeo			A Simple Random Access Scheme With Multilevel Power Allocation	IEEE COMMUNICATIONS LETTERS			English	Article						Decentralized power allocation; random access; successive interference cancellation (SIC)	SYSTEMS	This letter proposes a decentralized power allocation approach for random access with capabilities of multi-packet reception (MPR) and successive interference cancellation (SIC). Considering specific features of SIC, a bottom-up per-level algorithm is proposed to obtain discrete transmission power levels and the corresponding probabilities. Comparing with the conventional power allocation scheme with MPR and SIC, our approach significantly improves the system sum rate; this is confirmed by computer simulations.	[Lin, Huifa; Ishibashi, Koji; Fujii, Takeo] Univ Electrocommun, Adv Wireless & Commun Res Ctr AWCC, Tokyo 1828585, Japan; [Shin, Won-Yong] Dankook Univ, Dept Comp Sci & Engn, Yongin 448701, South Korea	Lin, HF (reprint author), Univ Electrocommun, Adv Wireless & Commun Res Ctr AWCC, Tokyo 1828585, Japan.	linhuifa@awcc.uec.ac.jp; koji@ieee.org; wyshin@dankook.ac.kr; fujii@awcc.uec.ac.jp			National Research Foundation of Korea - Ministry of Education [2014R1A1A2054577]	This work was supported in part by the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education (2014R1A1A2054577). The associate editor coordinating the review of this paper and approving it for publication was M. A. Imran.	Abramson N., 1970, P AFIPS C, P281; METZNER JJ, 1976, IEEE T COMMUN, V24, P447, DOI 10.1109/TCOM.1976.1093317; LaMaire RO, 1998, WIREL NETW, V4, P263, DOI 10.1023/A:1019164308540; COVER TM, 1972, IEEE T INFORM THEORY, V18, P2, DOI 10.1109/TIT.1972.1054727; Xu CB, 2013, IEEE J SEL AREA COMM, V31, P2387, DOI 10.1109/JSAC.2013.131113; Rimoldi B, 1996, IEEE T INFORM THEORY, V42, P364, DOI 10.1109/18.485709; Andrews JG, 2005, IEEE WIREL COMMUN, V12, P19, DOI 10.1109/MWC.2005.1421925; Bertsekas D. P., 1992, DATA NETWORKS	8	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1089-7798	1558-2558		IEEE COMMUN LETT	IEEE Commun. Lett.	DEC	2015	19	12					2118	2121		10.1109/LCOMM.2015.2489650		4	Telecommunications	Telecommunications	CY7TX	WOS:000366613300017		
J	Takamiya, M; Wu, JT; Ryynanen, J; Okada, K; Kim, J				Takamiya, Makoto; Wu, Jieh-Tsorng; Ryynanen, Jussi; Okada, Kenichi; Kim, Jaeha			Introduction to the December Special Issue on the 2015 IEEE International Solid-State Circuits Conference	IEEE JOURNAL OF SOLID-STATE CIRCUITS			English	Editorial Material									[Takamiya, Makoto] Univ Tokyo, Tokyo, Japan; [Wu, Jieh-Tsorng] Natl Chiao Tung Univ, Hsinchu, Taiwan; [Ryynanen, Jussi] Aalto Univ, Dept Micro & Nanosci, Sch Elect Engn, Espoo, Finland; [Okada, Kenichi] Tokyo Inst Technol, Tokyo 152, Japan; [Kim, Jaeha] Seoul Natl Univ, Seoul, South Korea	Takamiya, M (reprint author), Univ Tokyo, Tokyo, Japan.							0	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9200	1558-173X		IEEE J SOLID-ST CIRC	IEEE J. Solid-State Circuit	DEC	2015	50	12					2799	2803		10.1109/JSSC.2015.2496978		5	Engineering, Electrical & Electronic	Engineering	CY8LK	WOS:000366659700001		
J	Shirane, A; Fang, YM; Tan, HW; Ibe, T; Ito, H; Ishihara, N; Masu, K				Shirane, Atsushi; Fang, Yiming; Tan, Haowei; Ibe, Taiki; Ito, Hiroyuki; Ishihara, Noboru; Masu, Kazuya			RF-Powered Transceiver With an Energy- and Spectral-Efficient IF-Based Quadrature Backscattering Transmitter	IEEE JOURNAL OF SOLID-STATE CIRCUITS			English	Article						Batteryless; low power; quadrature modulation; radio frequency identification (RFID); radio-frequency integrated circuits; RF powering; transmitters; wireless sensor networks		This study introduces a 5.8 GHz RF-powered transceiver that includes a transmitter using an IF-based quadrature backscattering (IFQB) technique. The IFQB transmitter can produce a quadrature modulated signal without active RF circuits, such as PLL, local generation, and local distribution circuits. Thus, the IFQB technique can significantly reduce the power consumption while achieving denser constellations by the quadrature modulation. The RF-powered transceiver consists of the IFQB transmitter, an OOK receiver, and a power management unit (PMU) for RF powering. The transmitter and receiver operate under a 0.6 V power supply provided by the PMU to further reduce the power consumption. We fabricated a prototype RF-powered transceiver using a 65 nm Si CMOS process to confirm the validity of the proposed technique. During the measurements, the transmitter achieved 2.5 Mb/s with a 32-QAM modulation while consuming 113 mu W. In addition, a wireless temperature sensing demonstration was conducted using the prototype sensor node with the presented RF-powered transceiver.	[Shirane, Atsushi; Fang, Yiming; Tan, Haowei; Ibe, Taiki; Ito, Hiroyuki; Ishihara, Noboru; Masu, Kazuya] Tokyo Inst Technol, Yokohama, Kanagawa 2268503, Japan	Shirane, A (reprint author), Tokyo Inst Technol, Yokohama, Kanagawa 2268503, Japan.				STARC; KAKENHI; VDEC; Agilent Technologies Japan, Ltd.; Cadence Design Systems, Inc.; Mentor Graphics, Inc.; eShuttle Inc.; Fujitsu Semiconductor Ltd.	This paper was approved by Guest Editor Jussi Ryynanen. This work was supported in part by STARC, KAKENHI, and VDEC in collaboration with Agilent Technologies Japan, Ltd., Cadence Design Systems, Inc., Mentor Graphics, Inc., eShuttle Inc., and Fujitsu Semiconductor Ltd.	He X, 2009, IEEE J SOLID-ST CIRC, V44, P3448, DOI 10.1109/JSSC.2009.2032495; Nguyen TK, 2006, IEEE T MICROW THEORY, V54, P4062, DOI 10.1109/TMTT.2006.885556; Thomas SJ, 2012, IEEE T MICROW THEORY, V60, P1175, DOI 10.1109/TMTT.2012.2185810; Brown J. K., 2013, IEEE INT SOL STAT CI, P442; Chen F., 2014, IEEE INT SOL STAT CI, P162; Cheng S.-J., 2013, IEEE INT SOL STAT CI, P450; Chillara V. K., 2014, ISSCC, P172; Cisco, 2015, CISC VIS NETW IND GL; Flatscher M., 2009, IEEE INT SOL STAT CI, P286; Geng S., 2014, IEEE INT SOL STAT CI, P160; Huang X., 2012, IEEE INT SOL STAT CI, P454; Kim K., 2008, IEEE ISSCC FEB, P458; Liu Y.-H., 2013, ISSCC, P446; Nakamoto H., 2006, IEEE INT SOL STAT CI, P1201; Papotto G., 2012, IEEE INT SOL STAT CI, P452; Rai S., 2009, IEEE INT SOL STAT CI, P212, DOI DOI 10.1109/ISSCC.2009.4977383; Reinisch H., 2011, IEEE INT SOL STAT CI, P454, DOI DOI 10.1109/ISSCC.2011.5746394; Satoh Y., 2004, P 2 INT S AC WAV DEV, P141; Shirane A., 2015, IEEE INT SOL STAT CI, P248; Thomas S. J., 2012, 2012 IEEE International Conference on RFID (IEEE RFID 2012), DOI 10.1109/RFID.2012.6193049; TSensors Summit, TSENSORS SUMM TRILL; Vidojkovic M., 2011, IEEE INT SOL STAT CI, P458, DOI DOI 10.1109/ISSCC.2011.5746396; Vidojkovic M., 2014, ISSCC, P170; Wang X., 2012, IEEE ISSCC, P450; Wong A., 2012, ISSCC, P300; Zhang F., 2012, ISSCC, P298, DOI DOI 10.1109/ISSCC.2012.6177004	26	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9200	1558-173X		IEEE J SOLID-ST CIRC	IEEE J. Solid-State Circuit	DEC	2015	50	12					2975	2987		10.1109/JSSC.2015.2454235		13	Engineering, Electrical & Electronic	Engineering	CY8LK	WOS:000366659700017		
J	Sohgawa, M; Zhang, ZY; Akai, T; Takada, K; Yamashita, K; Noda, M				Sohgawa, Masayuki; Zhang, Ziyang; Akai, Toshio; Takada, Keisuke; Yamashita, Kaoru; Noda, Minoru			Detection of Amyloid Beta Fibril Growth by Liposome-Immobilized Micro-Cantilever With NiCr Thin-Film Strain Gauge	IEEE SENSORS JOURNAL			English	Article						Biological sensor; micro-cantilever; NiCr strain gauge; liposome; amyloid beta	ALZHEIMERS-DISEASE; MICROCANTILEVER SENSORS; MEDICINE; CELLS	A micro-cantilever with thermally stable strain gauge of a NiCr thin film and a self-assembled monolayer was fabricated by surface micromachining. Liposomes, as biosensing molecules, were immobilized on its surface. To prevent evaporation of the water solvent, a reservoir made of polydimethylsiloxane around the micro-cantilever was fabricated and covered with a glass plate. The resistance of the strain gauge increases with time in the amyloid beta (A beta) solution, because the cantilever is bent downward caused by interaction between A beta and liposomes immobilized on the micro-cantilever surface. Moreover, resistance change depends on the interaction ability of A beta proteins with liposomes. It is therefore indicated that the fabricated static mode micro-cantilever sensor with immobilized liposomes can be used to detect A beta proteins.	[Sohgawa, Masayuki] Niigata Univ, Fac Engn, Niigata 9502181, Japan; [Zhang, Ziyang; Akai, Toshio; Takada, Keisuke; Yamashita, Kaoru; Noda, Minoru] Kyoto Inst Technol, Kyoto 6068585, Japan	Sohgawa, M (reprint author), Niigata Univ, Fac Engn, Niigata 9502181, Japan.	sohgawa@eng.nigata-u.ac.jp; zhang-zy@kit.ac.jp; b9121501@edu.kit.ac.jp; m2621020@edu.kit.ac.jp; yamashita.kaoru@kit.ac.jp; noda@kit.ac.jp			Japan Society for the Promotion of Science [19360162, 20760539, 22360144, 25249048]	This work was supported by the Grants-in-Aid for Scientific Research through the Japan Society for the Promotion of Science under Grant 19360162, Grant 20760539, Grant 22360144, and Grant 25249048.	Alzheimer's Association, ALZH DIS DEM; WORTMAN JJ, 1965, J APPL PHYS, V36, P153, DOI 10.1063/1.1713863; Hyun SJ, 2006, SENSOR ACTUAT B-CHEM, V117, P415, DOI 10.1016/j.snb.2005.11.054; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Englund H, 2007, J NEUROCHEM, V103, P334, DOI 10.1111/j.1471-4159.2007.04759.x; Morita M, 2012, SOFT MATTER, V8, P2816, DOI 10.1039/c2sm07185a; Kotarek JA, 2010, ANAL BIOCHEM, V399, P30, DOI 10.1016/j.ab.2009.12.016; Boisen A, 2011, REP PROG PHYS, V74, DOI 10.1088/0034-4885/74/3/036101; Ban T, 2004, J MOL BIOL, V344, P757, DOI 10.1016/j.jmb.2004.09.078; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Noda M, 2009, 2009 IEEE SENSORS, VOLS 1-3, P836, DOI 10.1109/ICSENS.2009.5398264; Sohgawa M, 2012, SENSOR ACTUAT A-PHYS, V186, P32, DOI 10.1016/j.sna.2011.12.055; Park K, 2008, LAB CHIP, V8, P1034, DOI 10.1039/b803601b; Ohhashi Y, 2004, J BIOL CHEM, V279, P10814, DOI 10.1074/jbc.M310334200; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Shu WM, 2008, BIOSENS BIOELECTRON, V24, P233, DOI 10.1016/j.bios.2008.03.036; Shu WM, 2007, BIOSENS BIOELECTRON, V22, P2003, DOI 10.1016/j.bios.2006.08.047; Li X.X., 2012, MEAS SCI TECHNOL, V2, P22001; Nussbaum RL, 2003, NEW ENGL J MED, V348, P1356; Ogi H, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.07GF01; Onishi H., 2009, IEEJ T SENS MICROMAC, V129, P411; Sohgawa M., 2013, P IEEE SENSORS, P1	23	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1530-437X	1558-1748		IEEE SENS J	IEEE Sens. J.	DEC	2015	15	12					7135	7141		10.1109/JSEN.2015.2470108		7	Engineering, Electrical & Electronic; Instruments & Instrumentation; Physics, Applied	Engineering; Instruments & Instrumentation; Physics	CZ1EU	WOS:000366849500049		
J	Sakai, K; Sun, MT; Ku, WS; Lai, TH; Vasilakos, AV				Sakai, Kazuya; Sun, Min-Te; Ku, Wei-Shinn; Lai, Ten H.; Vasilakos, Athanasios V.			A Framework for the Optimal k-Coverage Deployment Patterns of Wireless Sensors	IEEE SENSORS JOURNAL			English	Article						Coverage; optimal deployment pattern; wireless sensor network topology	NETWORKS; LOCALIZATION	The strategy for node deployment to achieve multiple connectivity and coverage plays an important role in various wireless senor network applications. To alleviate the operational cost, the number of nodes to be deployed needs to be reduced. While the optimal k-connectivity deployment patterns (k <= 6) and the multiple k-coverage problem (k <= 3) have been extensively studied for 2-D networks, a general method to identify the optimal deployment pattern for any given sensor coverage requirement has yet to be found. Considering the ease of sensor deployment and operation, the deployment patterns should be identical and symmetric in the deployment region. This implies that the Voronoi diagram of the optimal deployment is a regular tessellation. Based on the fact that there exist only three regular tessellations, we propose a framework, namely, range elimination scheme (RES), to compute the optimal k-coverage deployment pattern for any given k value to accommodate various wireless sensor application requirements. We apply RES to show the optimal k-coverage deployment patterns for 4 <= k <= 9. Our analytical and simulation results show that our proposed framework successfully identifies the optimal deployment patterns and significantly reduces the number of sensors to be deployed.	[Sakai, Kazuya] Tokyo Metropolitan Univ, Dept Informat & Commun Syst, Tokyo 1910065, Japan; [Sun, Min-Te] Natl Cent Univ, Dept Comp Sci & Informat Engn, Taoyuan 320, Taiwan; [Ku, Wei-Shinn] Auburn Univ, Dept Comp Sci & Software Engn, Auburn, AL 36849 USA; [Lai, Ten H.] Ohio State Univ, Dept Comp Sci & Engn, Columbus, OH 43210 USA; [Vasilakos, Athanasios V.] Lulea Univ Technol, Dept Comp Sci Elect & Space Engn, S-97187 Lulea, Sweden	Sakai, K (reprint author), Tokyo Metropolitan Univ, Dept Informat & Commun Syst, Tokyo 1910065, Japan.	ksakai@tmu.ac.jp; msun@csie.ncu.edu.tw; weishinn@auburn.edu; lai@cse.ohiostate.edu; vasilako@ath.forthnet.gr					Cheng W, 2012, IEEE T PARALL DISTR, V23, P1267, DOI 10.1109/TPDS.2011.259; Wan PJ, 2010, IEEE T INFORM THEORY, V56, P2867, DOI 10.1109/TIT.2010.2046254; Bai XL, 2010, IEEE T MOBILE COMPUT, V9, P435, DOI 10.1109/TMC.2009.143; Yun ZQ, 2012, IEEE ACM T NETWORK, V20, P1964, DOI 10.1109/TNET.2012.2199515; Yu ZM, 2013, IEEE INFOCOM SER, P1195; Chen A, 2007, MOBICOM'07: PROCEEDINGS OF THE THIRTEENTH ACM INTERNATIONAL CONFERENCE ON MOBILE COMPUTING AND NETWORKING, P63; Bai XL, 2011, IEEE INFOCOM SER, P2498; [Anonymous], 2008, P 9 ACM INT S MOB AD, DOI 10.1145/1374618.1374672; Bai XL, 2009, MOBIHOC'09 PROCEEDINGS OF THE TENTH ACM INTERNATIONAL SYMPOSIUM ON MOBILE AD HOC NETWORKING AND COMPUTING, P145; Ku WS, 2011, J NETW COMPUT APPL, V34, P914, DOI 10.1016/j.jnca.2010.04.012; Kershner R, 1939, AM J MATH, V61, P665, DOI 10.2307/2371320; Teng J, 2014, IEEE ACM T NETWORK, V22, P1285, DOI 10.1109/TNET.2013.2274283; Li M, 2013, P IEEE, V101, P2538, DOI 10.1109/JPROC.2013.2257631; Britton J., 1999, SYMMETRY TESSELATION; Kumar S., 2005, P 11 ANN INT C MOB C, P284, DOI 10.1145/1080829.1080859; Li W.-X., 2012, LECT NOTES COMPUTER, V7529, P150; Miao Z., 2010, P IET INT C WIR SENS, P73; Saipulla A., 2008, P IEEE MILCOM 2008, P1; Yu ZM, 2014, ACM T SENSOR NETWORK, V10, DOI 10.1145/2594770; Zhang H., 2005, WIRELESS AD HOC SENS, V1, P89	20	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1530-437X	1558-1748		IEEE SENS J	IEEE Sens. J.	DEC	2015	15	12					7273	7283		10.1109/JSEN.2015.2474711		11	Engineering, Electrical & Electronic; Instruments & Instrumentation; Physics, Applied	Engineering; Instruments & Instrumentation; Physics	CZ1EU	WOS:000366849500064		
J	Yoda, D; Ochiai, H				Yoda, Daiki; Ochiai, Hideki			Multilevel Coded Modulation With Reduced Latency Decoding Based on Novel Set Partitioning for APSK	IEEE TRANSACTIONS ON BROADCASTING			English	Article						Amplitude phase-shift keying (APSK); digital video broadcasting-satellite-second generation (DVB-S2); in-phase and quadrature (I-Q) decomposition; multilevel coded modulation (MLC); turbo code	FADING CHANNELS; CONVOLUTIONAL-CODES; LDPC CODES; CONSTELLATION; BICM; PERFORMANCE; DESIGN; DVB-S2; QAM	We address the use of a multilevel coding (MLC) to the amplitude phase-shift keying (APSK) modulations that consist of multiple PSK rings of different radii with a distinct number of constellation points. Such modulations have been adopted in the satellite broadcasting standards since they have a significant advantage over commonly used square-type quadrature amplitude modulations; their signals exhibit lower peak-to-average power ratio and thus enhance the power amplifier efficiency at the transmitter. A common low-complexity approach for decoding of MLC is the multi-stage decoding (MSD). However, MSD in general leads to severe latency at the decoder since the binary decisions on the higher levels should wait for those of the lower levels. Furthermore, this latency issue is even more salient for APSK signaling due to its circular nature of constellations that does not allow its decomposition into in-phase and quadrature components (i.e., I-Q decomposition). Therefore, in this paper we introduce a new MLC design for APSK that enables the decoder to reduce its latency without any increase in terms of complexity. The proposed approach consists of a novel labeling with an unconventional set partitioning that allows the detector to make use of I-Q decomposition. Specifically, the proposed set partitioning results in a quadrature-PSK constellation at the penultimate level, which can be decomposed into a pair of separately decodable binary-PSK constellations at the final level. The resulting decoder consists of a combination of MSD and parallel independent decoding that can be implemented with lower latency. The simulation results together with the theoretical analyses demonstrate that the reduction of not only the decoding latency but also the complexity in bit metric calculation can be achieved without noticeable degradation in terms of error performance compared to the conventional set partitioning approach.	[Yoda, Daiki; Ochiai, Hideki] Yokohama Natl Univ, Dept Elect & Comp Engn, Yokohama, Kanagawa 2408501, Japan	Yoda, D (reprint author), Yokohama Natl Univ, Dept Elect & Comp Engn, Yokohama, Kanagawa 2408501, Japan.	d.yoda.jp@ieee.org; hideki@ynu.ac.jp			Strategic Information and Communications Research and Development Promotion Programme, the Ministry of Internal Affairs and Communications, Japan	This work was supported in part by the Strategic Information and Communications Research and Development Promotion Programme, the Ministry of Internal Affairs and Communications, Japan. A part of this paper was presented at the 2013 IEEE International Symposium on Information Theory, Istanbul, Turkey, in July 2013.	Caire G, 1998, IEEE T INFORM THEORY, V44, P927, DOI 10.1109/18.669123; Morello A, 2006, P IEEE, V94, P210, DOI 10.1109/JPROC.2005.861013; Valenti MC, 2012, IEEE T COMMUN, V60, P2960, DOI 10.1109/TCOMM.2012.070912.110533; Nagaraj S, 2008, IEEE T WIREL COMMUN, V7, P4404, DOI 10.1109/T-WC.2008.070927; Meric H, 2013, IEEE T BROADCAST, V59, P627, DOI 10.1109/TBC.2013.2268694; Martinez A, 2009, IEEE T WIREL COMMUN, V8, P38, DOI 10.1109/T-WC.2009.071300; Xie QL, 2012, IEEE T WIREL COMMUN, V11, P2649, DOI 10.1109/TWC.2012.051412.112055; Jang M, 2015, IEEE T BROADCAST, V61, P327, DOI 10.1109/TBC.2015.2400815; Gul G, 2011, IEEE T COMMUN, V59, P998, DOI 10.1109/TCOMM.2011.020411.090497; Liu ZS, 2011, IEEE COMMUN LETT, V15, P1271, DOI 10.1109/LCOMM.2011.101211.111825; Wachsmann U, 1999, IEEE T INFORM THEORY, V45, P1361, DOI 10.1109/18.771140; Papaharalabos S, 2008, IEEE T BROADCAST, V54, P120, DOI 10.1109/TBC.2007.911365; Gong L, 2011, IEEE T BROADCAST, V57, P263, DOI 10.1109/TBC.2011.2115010; DIVSALAR D, 1995, ICC '95 - 1995 IEEE INTERNATIONAL CONFERENCE ON COMMUNICATIONS, CONFERENCE RECORD, VOLS 1-3, P54, DOI 10.1109/ICC.1995.525138; Acikel OF, 1999, IEEE T COMMUN, V47, P1315, DOI 10.1109/26.789667; Hehn T, 2009, IEEE T COMMUN, V57, P1683, DOI 10.1109/TCOMM.2009.06.080014; IMAI H, 1977, IEEE T INFORM THEORY, V23, P371, DOI 10.1109/TIT.1977.1055718; Chindapol A, 2001, IEEE J SEL AREA COMM, V19, P944, DOI 10.1109/49.924878; [Anonymous], 2014, DVB BLUE BOOK; Maiya SV, 2012, IEEE T COMMUN, V60, P1215, DOI 10.1109/TCOMM.2012.042712.110189; Maunder RG, 2015, IEEE T COMMUN, V63, P2762, DOI 10.1109/TCOMM.2015.2450208; Gallager R. G., 1968, INFORM THEORY RELIAB; Gaudenzi R. D., 2006, INT J SATELL COMM N, V24, P261; Gaudenzi R. D., 2006, IEEE T WIREL COMMUN, V5, P2396; He D., 2014, P IEEE PES INN SMART, P1; Meloni A., 2014, P IEEE INT S BROADB, P1; UNGERBOECK G, 1982, IEEE T INFORM THEORY, V28, P55, DOI 10.1109/TIT.1982.1056454	27	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9316	1557-9611		IEEE T BROADCAST	IEEE Trans. Broadcast.	DEC	2015	61	4					674	684		10.1109/TBC.2015.2492471		11	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	CY8NU	WOS:000366666300011		
J	Dede, EM; Schmalenberg, P; Nomura, T; Ishigaki, M				Dede, Ercan M.; Schmalenberg, Paul; Nomura, Tsuyoshi; Ishigaki, Masanori			Design of Anisotropic Thermal Conductivity in Multilayer Printed Circuit Boards	IEEE TRANSACTIONS ON COMPONENTS PACKAGING AND MANUFACTURING TECHNOLOGY			English	Article						Composite; electrothermal; multilayer; printed wiring board; resistive heating	OPTIMIZATION; PLACEMENT	The design of anisotropic thermal conductivity in multilayer printed circuit boards (PCB) is studied, where the flow of heat is manipulated through the informed layout of circuit board electrothermal traces. Three representative circuit board configurations are considered to illustrate the basic method. A baseline circuit board (Configuration 1) comprising a heat-generating device in thermal communication with a heat sensitive device by the way of a standard electrical trace connection is studied first to characterize heat flow due to conduction and convection. Building off of this baseline structure, the thermal management advantages and disadvantages of a closed heat shield for anisotropic PCB thermal conductivity are explored using the second circuit board (Configuration 2). The design of the third multilayer circuit board (Configuration 3) with optimized anisotropic PCB thermal conductivity for enhanced heat flow control is simultaneously explored. It is experimentally shown that, for PCBs subject to free convection and power densities on the order of 1-10 W/cm(2), the design technique allows for noticeable (-10 degrees C) reduction in the temperature of the heat sensitive device without a significant (<3 degrees C) increase in the heat-generating device temperature. The experimental heat transfer results are verified through simulations that further confirm and explain the functionality and limitations of the heat flow control concept. The effect of Joule heating is also investigated numerically. A conceptual framework for electrothermal codesign of multilayer PCBs with integrated heat flow control and more device-dense packaging is proposed.	[Dede, Ercan M.; Schmalenberg, Paul; Ishigaki, Masanori] Toyota Res Inst North Amer, Elect Res Dept, Ann Arbor, MI 48105 USA; [Nomura, Tsuyoshi] Toyota Cent Res & Dev Labs Inc, Nagakute, Aichi 4801192, Japan	Dede, EM (reprint author), Toyota Res Inst North Amer, Elect Res Dept, Ann Arbor, MI 48105 USA.	eric.dede@tema.toyota.com; paul.schmalenberg@tema.toyota.com; nomu2@mosk.tytlabs.co.jp; masanori.ishigaki@tema.toyota.com					Altman D. H., 2012, ELECT COOLING, V3, P20; QUINN NR, 1979, IEEE T CIRCUITS SYST, V26, P377, DOI 10.1109/TCS.1979.1084652; Adam J, 2004, P IEEE SEMICOND THER, P292, DOI 10.1109/STHERM.2004.1291337; Wits WW, 2010, IEEE T COMPON PACK T, V33, P398, DOI 10.1109/TCAPT.2010.2041929; Chu CCN, 1998, IEEE T COMPUT AID D, V17, P1166, DOI 10.1109/43.736189; Chen TY, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2988181; He X, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4807920; Fan CZ, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2951600; Dede EM, 2010, COMP MATER SCI, V50, P510, DOI 10.1016/j.commatsci.2010.09.012; Narayana S, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.214303; Anflor CTM, 2014, INT J HEAT MASS TRAN, V78, P121, DOI 10.1016/j.ijheatmasstransfer.2014.06.032; [Anonymous], 2014, COMSOL MULT VERS 4 4; Dede EM, 2014, STRUCT MULTIDISCIP O, V49, P59, DOI 10.1007/s00158-013-0963-0; Boreyko JB, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3666818; Shi B, 2013, IET CIRC DEVICE SYST, V7, P223, DOI 10.1049/iet-cds.2013.0026; Li JY, 2010, J APPL PHYS, V108, DOI 10.1063/1.3490226; Queipo NV, 1998, IEEE T COMPON PACK A, V21, P142, DOI 10.1109/95.679044; Lee J, 2003, IEEE T COMPON PACK T, V26, P473, DOI 10.1109/TCAPT.2003.815091; Nojiri Y, 1998, IEEE POWER ELECTRON, P374, DOI 10.1109/PESC.1998.701926; Ariga Z.-N., 2012, P 7 INT C INT POW SY, P1; Bar-Cohen Avram, 2013, Computational Thermal Sciences, V5; Dede EM, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4816775; Dogruoz M. B., 2013, IEEE COMPON PACKAG M, V2, P1649; ELIASI R, 1990, IEEE T COMPON HYBR, V13, P953, DOI 10.1109/33.62568; Hong SJ, 2014, J NATUROPATHY, V3, P1; Incropera F. P., 2007, INTRO HEAT TRANSFER; Langer G., 2014, P NATL ACAD SCI USA, P1; Mandray Sylvain, 2009, Proceedings of the 2009 IEEE Energy Conversion Congress and Exposition. ECCE 2009, DOI 10.1109/ECCE.2009.5316092; Remsburg R., 1998, ADV THERMAL DESIGN E; Saums D. L., 2014, P 8 INT C INT POW SY, P1; Schweizer Electronic AG, 2014, POW EL COOL BOARD WW; Shook B. W., 2013, P 14 IEEE WORKSH CON, P1; Ying T. M., 2000, P 7 INT C THERM THER	33	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2156-3950	2156-3985		IEEE T COMP PACK MAN	IEEE Trans. Compon. Pack. Manuf. Technol.	DEC	2015	5	12					1763	1774		10.1109/TCPMT.2015.2473103		12	Engineering, Manufacturing; Engineering, Electrical & Electronic; Materials Science, Multidisciplinary	Engineering; Materials Science	CZ0XZ	WOS:000366831100006		
J	Than, PH; Uchida, K; Nozaki, S				Phuc Hong Than; Uchida, Kazuo; Nozaki, Shinji			Effects of Electrical Stress on the InGaP/GaAs Heterojunction Phototransistor	IEEE TRANSACTIONS ON DEVICE AND MATERIALS RELIABILITY			English	Article						Heterojunction phototransistor (HPT); InGaP/GaAs; emitter-ledge passivation; electrical stress; temperature dependence	BIPOLAR-TRANSISTORS; OFFSET VOLTAGE; RELIABILITY; PASSIVATION; ALGAAS/GAAS; GAINP/GAAS; TRANSPORT; GAASHBTS; HBTS	Although the effects of electrical stress on the performance of InGaP/GaAs heterojunction bipolar transistors (HBTs) have been widely studied and reported, few or no reports on the InGaP/GaAs heterojunction phototransistors (HPTs) have been published. In this paper, we discuss the phototransistor characteristics before and after the electrical stress applied at room temperature and at high temperature, and assess the effectiveness of the emitter- ledge passivation, which was found to keep the InGaP/GaAs HBTs from degrading at higher temperature or due to electrical stress. A room- temperature electrical stress was applied to the HPTs by maintaining a current density of 37 A/cm(2) for 1 h at room temperature. The electrical stress was lower by two to three orders than the stress usually applied to the HBTs for the stress study and did not cause significant decreases in the room- temperature current gain and photoresponse, but it significantly degraded the characteristics of the InGaP/GaAs HPTs at 420 K. In order to accelerate the degradation, the high- temperature stress was applied to both HPTs with and without the emitter- ledge passivation at 420 K. Although the current density was the same and the stress time was reduced to 15 min, the high- temperature stress significantly decreased the current gain and collector photocurrent of the HPT without the emitter- ledge passivation over the entire measurement temperature range of 300- 420 K. The emitter- ledge passivation suppresses the recombination via defects at the emitter perimeter and is found to be more effective than that in the HBTs.	[Phuc Hong Than; Uchida, Kazuo; Nozaki, Shinji] Univ Electrocommun, Grad Sch Informat & Engn, Dept Engn Sci, Tokyo 1828585, Japan	Than, PH (reprint author), Univ Electrocommun, Grad Sch Informat & Engn, Dept Engn Sci, Tokyo 1828585, Japan.	nozaki@ee.uec.ac.jp					Pan N, 1998, IEEE ELECTR DEVICE L, V19, P115, DOI 10.1109/55.663532; Adlerstein MG, 2000, IEEE T ELECTRON DEV, V47, P434, DOI 10.1109/16.822291; Kamitsuna H, 2001, IEEE T MICROW THEORY, V49, P1921, DOI 10.1109/22.954808; CHANDRASEKHAR S, 1993, IEEE PHOTONIC TECH L, V5, P1316, DOI 10.1109/68.250055; Ueda O, 1997, SOLID STATE ELECTRON, V41, P1605, DOI 10.1016/S0038-1101(97)00112-3; LIU W, 1993, IEEE ELECTR DEVICE L, V14, P301, DOI 10.1109/55.215205; LEE TW, 1993, IEEE T ELECTRON DEV, V40, P1390, DOI 10.1109/16.223697; HA KH, 1995, ELECTRON LETT, V31, P1386, DOI 10.1049/el:19950889; Song CK, 1999, MICROELECTRON RELIAB, V39, P1817, DOI 10.1016/S0026-2714(99)00190-0; LIU W, 1993, IEEE T ELECTRON DEV, V40, P1351, DOI 10.1109/16.216446; TIWARI S, 1987, IEEE T ELECTRON DEV, V34, P185, DOI 10.1109/T-ED.1987.22906; Tan SW, 2005, IEEE T ELECTRON DEV, V52, P204, DOI 10.1109/TED.2004.842537; McAlister SP, 2001, IEEE T ELECTRON DEV, V48, P1745, DOI 10.1109/16.936699; Song CK, 2001, IEEE ELECTR DEVICE L, V22, P315; Lin YS, 2009, IEEE T ELECTRON DEV, V56, P2945, DOI 10.1109/TED.2009.2033325; Kurokawa A., 2006, ED2005198 IEICE; Rezazadeh A. A., 2000, P 38 IEEE ANN INT RE, P250; Yang F-Y., 2008, ED2007217 IEICE	18	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1530-4388	1558-2574		IEEE T DEVICE MAT RE	IEEE Trans. Device Mater. Reliab.	DEC	2015	15	4					604	609		10.1109/TDMR.2015.2491338		6	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	CY8MK	WOS:000366662500018		
J	Nagayama, T; Sanada, A				Nagayama, Tsutomu; Sanada, Atsushi			Planar Distributed Full-Tensor Anisotropic Metamaterials for Transformation Electromagnetics	IEEE TRANSACTIONS ON MICROWAVE THEORY AND TECHNIQUES			English	Article						Carpet cloaks of invisibility; metamaterials; transformation electromagnetics	TRANSMISSION-LINE MATRIX; INVISIBILITY CLOAK; FIELDS; FREQUENCIES	Planar distributed full-tensor anisotropic metamaterials for cloaks of invisibility based on transformation electromagnetics are proposed. The proposed metamaterials are composed of nonresonant transmission lines and are advantageous in full control of the off-diagonal components of the permeability tensor as well as broadband and low-loss characteristics. The explicit design formulas for the metamaterials are given based on the equivalent circuit derived directly from Maxwell's equations. A carpet cloak of invisibility is designed and the validity of the design theory is confirmed by circuit simulations. In addition, the carpet cloak is implemented in microstrip line technology and its performance is demonstrated experimentally at microwave frequencies.	[Nagayama, Tsutomu; Sanada, Atsushi] Yamaguchi Univ, Dept Elect & Elect Engn, Yamaguchi 7558611, Japan	Nagayama, T (reprint author), Yamaguchi Univ, Dept Elect & Elect Engn, Yamaguchi 7558611, Japan.	t-nagayama@ieee.org; sanada@ieee.org			MEXT KAKENHI [22109002]	This work was supported in part by MEXT KAKENHI Grant-in-Aid for Scientific Research on Innovative Areas under Grant 22109002.	Alitalo P., 2009, PHYS REV LETT, V103; Alitalo P., 2008, P 2 INT C ADV EL MAT, P392; Lee JH, 2009, OPT EXPRESS, V17, P12922, DOI 10.1364/OE.17.012922; Schurig D, 2006, SCIENCE, V314, P977, DOI 10.1126/science.1133628; JOHNS PB, 1971, P I ELECTR ENG, V118, P1203; Silveirinha MG, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.036603; Schofield RS, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/6/063063; Gabrielli LH, 2009, NAT PHOTONICS, V3, P461, DOI 10.1038/NPHOTON.2009.117; Kante B, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.201104; Selvanayagam M, 2013, PHYS REV X, V3, DOI 10.1103/PhysRevX.3.041011; Alu A, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.245115; Liu R, 2009, SCIENCE, V323, P366, DOI 10.1126/science.1166949; Schittny R, 2014, SCIENCE, V345, P427, DOI 10.1126/science.1254524; Pendry JB, 2006, SCIENCE, V312, P1780, DOI 10.1126/science.1125907; Alitalo P, 2008, IEEE T ANTENN PROPAG, V56, P416, DOI 10.1109/TAP.2007.915469; Edwards B, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.153901; Sanada A, 2014, 2014 INTERNATIONAL CONFERENCE ON ELECTROMAGNETICS IN ADVANCED APPLICATIONS (ICEAA), P804, DOI 10.1109/ICEAA.2014.6903967; Ergin T, 2010, SCIENCE, V328, P337, DOI 10.1126/science.1186351; Valentine J, 2009, NAT MATER, V8, P568, DOI [10.1038/nmat2461, 10.1038/NMAT2461]; Schurig D, 2006, OPT EXPRESS, V14, P9794, DOI 10.1364/OE.14.009794; Zedler M, 2010, IEEE MTT S INT MICR, P33, DOI 10.1109/MWSYM.2010.5517976; Liu X, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3263149; Nagayama T, 2013, ASIA PACIF MICROWAVE, P1209, DOI 10.1109/APMC.2013.6695073; Alitalo P, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3068749; Selvanayagam M, 2013, OPT EXPRESS, V21, P14409, DOI 10.1364/OE.21.014409; Leonhardt U, 2006, SCIENCE, V312, P1777, DOI 10.1126/science.1126493; Padooru YR, 2012, J APPL PHYS, V112, DOI 10.1063/1.4745888; Sanada A, 2013, URSI INT SYM ELECT, P336; Christopoulos C., 1995, TRANSMISSION LINE MO; HOEFER WJR, 1985, IEEE T MICROW THEORY, V33, P882, DOI 10.1109/TMTT.1985.1133146; JOHNS PB, 1987, IEEE T MICROW THEORY, V35, P370, DOI 10.1109/TMTT.1987.1133658; Kron G., 1944, Proceedings of the Institute of Radio Engineers, V32, DOI 10.1109/JRPROC.1944.231021; Li JS, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.203901; Ma H. F., 2011, NATURE COMMUN, V1, P21; Nagayama T., 2013, IEEE INT MICR S 2013, P1; Sanada A., 2014, P EUR MICR C OCT, P965; Selvanayagam M, 2012, IEEE ANTENN WIREL PR, V11, P1226, DOI 10.1109/LAWP.2012.2224840; Shin D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2219	38	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9480	1557-9670		IEEE T MICROW THEORY	IEEE Trans. Microw. Theory Tech.	DEC	2015	63	12	1				3851	3861		10.1109/TMTT.2015.2487275		11	Engineering, Electrical & Electronic	Engineering	CY3OB	WOS:000366318000002		
J	Nakamura, T; Kitazawa, N; Kohira, K; Ishikuro, H				Nakamura, Takahiro; Kitazawa, Naoki; Kohira, Kaoru; Ishikuro, Hiroki			A Prototype SAW-Less LTE Transmitter With a High-Linearity Modulator Using BPF-Based I/Q Summing and a Triple-Layer Marchand Balun	IEEE TRANSACTIONS ON MICROWAVE THEORY AND TECHNIQUES			English	Article						Bandpass filter (BPF)-based in-phase/quadrature (I/Q) summing; long-term evolution (LTE); surface acoustic wave (SAW)-less; triple-layer Marchand balun	FILTER	A 65-nm CMOS-technology-based surface-acoustic-wave filterless transmitter (TX) for a long-term evolution (LTE) system was developed and performance tested. The TX incorporates both a passive quadrature modulator (QMOD) using bandpass filter (BPF)-based in-phase/quadrature (I/Q) signal summing and a small triple-layer Marchand balun. The passive operation and BPF-based I/Q summing, respectively, contribute to low noise performance and high input impedance (seen from the baseband signal), resulting in low receiver (RX) band noise and high linearity of the TX. The triple-layer Marchand balun contributes to the small area of the TX. A prototype LTE TX using the QMOD and the balun exhibits in-specification RX-band noise (< -161.6 dBc/Hz), a high output third-order intercept point (OIP3 = 20.5 dBm), and a small chip area (0.224 mm(2)).	[Nakamura, Takahiro; Kitazawa, Naoki; Kohira, Kaoru; Ishikuro, Hiroki] Keio Univ, Dept Elect & Elect Engn, Yokohama, Kanagawa 2238522, Japan	Nakamura, T (reprint author), Keio Univ, Dept Elect & Elect Engn, Yokohama, Kanagawa 2238522, Japan.	t_nakamura@iskr.elec.keio.ac.jp; kitazawa@iskr.elec.keio.ac.jp; Ko-hira@iskr.elec.keio.ac.jp; ishikuro@elec.keio.ac.jp					Farazian M, 2010, IEEE T MICROW THEORY, V58, P1349, DOI 10.1109/TMTT.2010.2042851; He X, 2009, IEEE J SOLID-ST CIRC, V44, P3448, DOI 10.1109/JSSC.2009.2032495; D'Souza S, 2011, IEEE INT SYMP CIRC S, P450; Mirzaei A, 2011, IEEE J SOLID-ST CIRC, V46, P950, DOI 10.1109/JSSC.2011.2109570; [Anonymous], 2014, IEEE EUR SOLID STAT; Feng WJ, 2011, ELECTRON LETT, V47, P198, DOI 10.1049/el.2010.7282; Ma TG, 2011, IEEE MICROW WIREL CO, V21, P188, DOI 10.1109/LMWC.2011.2109055; Tseng SC, 2006, IEEE T MICROW THEORY, V54, P4362, DOI 10.1109/TMTT.2006.884690; Craninckx J., 2011, P IEEE CUST INT CIRC, P1; Giannini V., 2011, IEEE INT SOL STAT CI, P374; Ingels M., 2013, IEEE ISSCC SAN FRANC, P338; Kihara T., 2012, IEEE RAD FREQ INT CI, P399; Olieri O., 2012, IEEE INT SOL STAT CI, P164; Sowlati T., 2009, IEEE ISSCC FEB, P116; Ueda K., 2012, P IEEE CUST INT CIRC, P1	15	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9480	1557-9670		IEEE T MICROW THEORY	IEEE Trans. Microw. Theory Tech.	DEC	2015	63	12	1				4090	4097		10.1109/TMTT.2015.2489214		8	Engineering, Electrical & Electronic	Engineering	CY3OB	WOS:000366318000026		
J	Uchida, G; Nakajima, A; Takenaka, K; Koga, K; Shiratani, M; Setsuhara, Y				Uchida, Giichiro; Nakajima, Atsushi; Takenaka, Kosuke; Koga, Kazunori; Shiratani, Masaharu; Setsuhara, Yuichi			Gas Flow Rate Dependence of the Discharge Characteristics of a Plasma Jet Impinging Onto the Liquid Surface	IEEE TRANSACTIONS ON PLASMA SCIENCE			English	Article						Gas flow pattern; plasma jet; plasma-liquid; interaction.	ATMOSPHERIC-PRESSURE; MEDICINE; NEEDLE	We present here an analysis of the discharge characteristics near the liquid surface in the plasma jet operated at a He gas flow rate of 1.5-10 slm. The plasma diameter on the liquid surface increases with an increase in He gas flow rate, which results in an increase in the total amount of charge particles transferred from the plasma to the liquid. We also analyzed the gas flow patterns using a Schlieren gas flow imaging system. The diameter of the laminar flow and the gas flow distance along the liquid surface increase with an increase in He gas flow rate, which well explains the increase in the plasma diameter on the liquid surface. Our experiments clearly demonstrate that high gas flow rate realizes the large reaction area between the water molecule and the plasma in the plasma jet system.	[Uchida, Giichiro; Nakajima, Atsushi; Takenaka, Kosuke; Setsuhara, Yuichi] Osaka Univ, Joining & Welding Res Inst, Osaka 5670047, Japan; [Koga, Kazunori; Shiratani, Masaharu] Kyushu Univ, Grad Sch Informat Sci & Elect Engn, Fukuoka 8190395, Japan	Uchida, G (reprint author), Osaka Univ, Joining & Welding Res Inst, Osaka 5670047, Japan.	uchida@jwri.osaka-u.ac.jp; a.nakajima@jwri.osaka-u.ac.jp; k_takenaka@jwri.osaka-u.ac.jp; koga@ed.kyushu-u.ac.jp; siratani@ed.kyushu-u.ac.jp; setsuhara@jwri.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [24108003]	This work was supported by the Grant-in-Aid for Scientific Research on Innovative Areas within Plasma Medical Innovation through the Ministry of Education, Culture, Sports, Science and Technology, Japan, under Grant 24108003. (Corresponding author: Giichiro Uchida.)	Teschke M, 2005, IEEE T PLASMA SCI, V33, P310, DOI 10.1109/TPS.2005.845377; Goree J, 2006, IEEE T PLASMA SCI, V34, P1317, DOI 10.1109/TPS.2006.878431; van Gessel AFH, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/26/265202; Uchida G, 2009, J APPL PHYS, V106, DOI 10.1063/1.3253723; Qayyum A, 2005, J APPL PHYS, V98, DOI 10.1063/1.2132514; Tresp H, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/43/435401; Srivastava N, 2011, J APPL PHYS, V110, DOI 10.1063/1.3632970; Dobrynin D, 2012, IEEE T PLASMA SCI, V40, P2163, DOI 10.1109/TPS.2012.2204780; Reuter S, 2009, PLASMA SOURCES SCI T, V18, DOI 10.1088/0963-0252/18/1/015006; Reuter S, 2012, PLASMA SOURCES SCI T, V21, DOI 10.1088/0963-0252/21/3/034015; van Gils CAJ, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/17/175203; Lu X, 2006, J APPL PHYS, V100, DOI 10.1063/1.2349475; Uchida G, 2015, J APPL PHYS, V117, DOI 10.1063/1.4918546; Oh JS, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/15/155206; Bruggeman P, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/5/053001; Kong MG, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115012; Stoffels E, 2002, PLASMA SOURCES SCI T, V11, P383, DOI 10.1088/0963-0252/11/4/304; Yonemori S, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/22/225202; Fridman G, 2008, PLASMA PROCESS POLYM, V5, P503, DOI 10.1002/ppap.200700154; Walsh JL, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2361274; Laroussi M, 2009, IEEE T PLASMA SCI, V37, P714, DOI 10.1109/TPS.2009.2017267; Walsh JL, 2010, J PHYS D APPL PHYS, V43, DOI 10.1088/0022-3727/43/7/075201; Robert E, 2014, PLASMA SOURCES SCI T, V23, DOI 10.1088/0963-0252/23/1/012003; Lukes P, 2014, PLASMA SOURCES SCI T, V23, DOI 10.1088/0963-0252/23/1/015019; Norberg SA, 2014, J PHYS D APPL PHYS, V47, DOI 10.1088/0022-3727/47/47/475203; Takenaka K, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.11NE04; Tanaka H, 2014, IEEE T PLASMA SCI, V42, P3760, DOI 10.1109/TPS.2014.2353659; Uchida G, 2015, IEEE T PLASMA SCI, V43, P737, DOI 10.1109/TPS.2014.2387064	28	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0093-3813	1939-9375		IEEE T PLASMA SCI	IEEE Trans. Plasma Sci.	DEC	2015	43	12	2				4081	4087		10.1109/TPS.2015.2488619		7	Physics, Fluids & Plasmas	Physics	CY5TN	WOS:000366470500003		
J	Sasamoto, R; Matsumoto, T; Izawa, Y; Nishijima, K				Sasamoto, Ryo; Matsumoto, Takao; Izawa, Yasuji; Nishijima, Kiyoto			Gas Heating and Streamer-to-Leader Transition of Impulse Surface Discharge on Quartz Glass in Atmospheric Air	IEEE TRANSACTIONS ON PLASMA SCIENCE			English	Article						Flashover; gas heating; leader; streamer; surface; discharges.	TEMPERATURE DETERMINATION; INCEPTION; CORONA; GAPS	Flashover on the surface of dielectric materials often causes extensive damage to the insulation system, resulting in reduced withstand voltage and system downtime as the damaged component is located and replaced. Therefore, understanding the flashover mechanism on dielectrics is of great significance to reduce incidences. In this work, the change in gas temperature in an impulse surface discharge during streamer-to-leader transition was measured in atmospheric air by the spectroscopic method. In the experiment, a quartz glass having a conductive indium tin oxide-coated back-surface was used as an insulation material having a back electrode. As a result, the increase in gas temperature in a discharge channel was confirmed when the discharge phase transformed into a leader.	[Sasamoto, Ryo; Matsumoto, Takao; Izawa, Yasuji; Nishijima, Kiyoto] Fukuoka Univ, Dept Elect Engn, Fukuoka 8140180, Japan	Sasamoto, R (reprint author), Fukuoka Univ, Dept Elect Engn, Fukuoka 8140180, Japan.	td151003@cis.fukuoka-u.ac.jp					Matsumoto T, 2015, ELECTR ENG JPN, V190, P10, DOI 10.1002/eej.22675; Bazavan M, 2008, ROM REP PHYS, V60, P671; GALLIMBERTI I, 1986, J PHYS D APPL PHYS, V19, P2351, DOI 10.1088/0022-3727/19/12/015; Gu SQ, 2010, IEEE T PLASMA SCI, V38, P214, DOI 10.1109/TPS.2009.2037004; RIZK FAM, 1989, IEEE T POWER DELIVER, V4, P596, DOI 10.1109/61.19251; ROUX F, 1993, J MOL SPECTROSC, V158, P270, DOI 10.1006/jmsp.1993.1071; Yubero C, 2013, SPECTROCHIM ACTA B, V90, P61, DOI 10.1016/j.sab.2013.10.004; Gallimberti I, 2002, CR PHYS, V3, P1335, DOI 10.1016/S1631-0705(02)01414-7; BONDIOU A, 1994, J PHYS D APPL PHYS, V27, P1252, DOI 10.1088/0022-3727/27/6/024; Gallimberti I., 1986, IEE P, V33; Gallimberti I., 1979, J PHYSIQUE C, V40, P193; Herzberg G., 1950, MOL SPECTRA MOL STRU; Kovacs I., 1969, ROTATIONAL STRUCTURE; Les Renardieres Group, 1974, ELECTRA, P149; Nishijima K, 2010, IEEJ T FUNDAMENT MAT, V130, P983; Phillips D. M., 1975, J PHYS D, V8, P507; RIZK FAM, 1989, IEEE T POWER DELIVER, V4, P2187, DOI 10.1109/61.35646; Vidal F., 2003, IEEE T PLASMA SCI, V30, P1339; Wake S., 2011, JPN J APPL PHYS, V50	19	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0093-3813	1939-9375		IEEE T PLASMA SCI	IEEE Trans. Plasma Sci.	DEC	2015	43	12	2				4210	4215		10.1109/TPS.2015.2494628		6	Physics, Fluids & Plasmas	Physics	CY5TN	WOS:000366470500020		
J	Kidokoro, H; Kanda, T; Brscic, D; Shiomi, M				Kidokoro, Hiroyuki; Kanda, Takayuki; Brscic, Drazen; Shiomi, Masahiro			Simulation-Based Behavior Planning to Prevent Congestion of Pedestrians Around a Robot	IEEE TRANSACTIONS ON ROBOTICS			English	Article						Behavior-based systems; behavior planning; pedestrian simulation; perspective-taking; social human-robot interaction	TRACKING; SENSORS; PEOPLE	Social robots working among pedestrians can attract crowds of people around them and consequently become bothersome entities causing congestion in narrow spaces. This in turn can affect the comfort of pedestrians who wish to pass through. To address this problem, our idea is to endow the robot with three capabilities: anticipating pedestrian crowding around the robot, understanding pedestrians' walking comfort, and planning to avoid congestions in advance. Combining several elementary pedestrian behavior models, the robot is able to simulate hypothetical situations where it navigates between pedestrians and anticipate the degree to which this would affect the pedestrians' walking comfort. During planning, the robot determines the best next navigation step based on the results of simulations. We tested the developed system in a real shopping mall and confirmed that it successfully reduces the robot's influence on pedestrian walking comfort due to congestions.	[Kidokoro, Hiroyuki; Kanda, Takayuki; Brscic, Drazen; Shiomi, Masahiro] Adv Telecommun Res Inst, Int Intelligent Robot & Commun Labs, Kyoto 6190288, Japan	Kidokoro, H (reprint author), Adv Telecommun Res Inst, Int Intelligent Robot & Commun Labs, Kyoto 6190288, Japan.	kanda@atr.jp; drazen@atr.jp; m-shiomi@atr.jp			Japan Science and Technology Agency, CREST; Ministry of Internal Affairs and Communications of Japan; Japan Society for the Promotion of Science	This paper was recommended for publication by Associate Editor A. Billard and Editor C. Torras upon evaluation of the reviewers' comments. This work was supported in part by the Japan Science and Technology Agency, CREST, the Ministry of Internal Affairs and Communications of Japan, and Japan Society for the Promotion of Science. Our early conference publication [1] presented the concept of our proposed method, while this paper reports an advanced system that can deal with dynamically changing situations. In addition, a new experimental evaluation of the system is presented.	Helbing D, 2000, NATURE, V407, P487, DOI 10.1038/35035023; Fox D, 1997, IEEE ROBOT AUTOM MAG, V4, P23, DOI 10.1109/100.580977; Garrell A, 2012, INT J ROBOT RES, V31, P1675, DOI 10.1177/0278364912459278; van Toll WG, 2012, COMPUT ANIMAT VIRT W, V23, P59, DOI 10.1002/cav.1424; Hoffman G, 2010, AUTON ROBOT, V28, P403, DOI 10.1007/s10514-009-9166-3; Henry P, 2010, IEEE INT CONF ROBOT, P981, DOI 10.1109/ROBOT.2010.5509772; Satake S, 2013, IEEE T ROBOT, V29, P508, DOI 10.1109/TRO.2012.2226387; Trafton JG, 2005, IEEE T SYST MAN CY A, V35, P460, DOI 10.1109/TSMCA.2005.850592; Treuille A, 2006, ACM T GRAPHIC, V25, P1160, DOI 10.1145/1141911.1142008; Ziebart BD, 2009, 2009 IEEE-RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, P3931, DOI 10.1109/IROS.2009.5354147; Hoogendoorn S, 2003, OPTIM CONTR APPL MET, V24, P153, DOI 10.1002/oca.727; Glas DF, 2009, ADV ROBOTICS, V23, P405, DOI 10.1163/156855309X408754; Colombo A, 2013, IEEE DECIS CONTR P, P3602, DOI 10.1109/CDC.2013.6760437; Kanda T, 2007, IEEE INT CONF ROBOT, P4846, DOI 10.1109/ROBOT.2007.364226; Gross HM, 2009, 2009 IEEE-RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, P2005, DOI 10.1109/IROS.2009.5354497; Bayazit OB, 2005, LECT NOTES COMPUT SC, V3342, P112; Berlin M., 2006, P 21 NAT C ART INT, P1444; Brscic D, 2015, IEEE T HUM-MACH SYST, V45, P228, DOI 10.1109/THMS.2014.2374172; Brscic D, 2013, IEEE T HUM-MACH SYST, V43, P522, DOI 10.1109/THMS.2013.2283945; Ferrer G., 2014, P IEEE INT C ROB AUT, P5940; Ferri G., 2011, P 2011 IEEE INT C RO, P655; Hall E. T., 1966, HIDDEN DIMENSION; Hayashi K., 2011, P ROB SCI SYST C, P121; Ikeda T., 2012, P ROB SCI SYST, P137; Kidokoro H, 2013, ACMIEEE INT CONF HUM, P259, DOI 10.1109/HRI.2013.6483597; Knepper R. A., 2012, P IEEE INT S ROB HUM, P94; Marin-Urias L. F., 2009, P 9 IEEE RAS INT C H, P331; Morales Y., 2012, P 7 ACM IEEE INT C H, P301; Moussaid M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010047; Shiomi M., 2012, P 3 INT C SIM MOD PR, P185; Thrun S., 2005, PROBABILISTIC ROBOTI; Trautman P., 2010, P IEEE RSJ INT C INT, P797; Zanlungo F, 2011, EPL-EUROPHYS LETT, V93, DOI 10.1209/0295-5075/93/68005; Zhou BL, 2015, INT J COMPUT VISION, V111, P50, DOI 10.1007/s11263-014-0735-3	34	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1552-3098	1941-0468		IEEE T ROBOT	IEEE Trans. Robot.	DEC	2015	31	6					1419	1431		10.1109/TRO.2015.2492862		13	Robotics	Robotics	CY8MR	WOS:000366663300012		
J	Ureche, ALP; Umezawa, K; Nakamura, Y; Billard, A				Ureche, Ana Lucia Pais; Umezawa, Keisuke; Nakamura, Yoshihiko; Billard, Aude			Task Parameterization Using Continuous Constraints Extracted From Human Demonstrations	IEEE TRANSACTIONS ON ROBOTICS			English	Article						Constraint extraction; learning and adaptive systems; motion control; programming by demonstration (PbD)	ROBOT; MOTION; REPRESENTATION	In this paper, we propose an approach for learning task specifications automatically, by observing human demonstrations. Using this approach allows a robot to combine representations of individual actions to achieve a high-level goal. We hypothesize that task specifications consist of variables that present a pattern of change that is invariant across demonstrations. We identify these specifications at different stages of task completion. Changes in task constraints allow us to identify transitions in the task description and to segment them into subtasks. We extract the following task-space constraints: 1) the reference frame in which to express the task variables; 2) the variable of interest at each time step, position, or force at the end effector; and 3) a factor that can modulate the contribution of force and position in a hybrid impedance controller. The approach was validated on a seven-degree-of-freedom Kuka arm, performing two different tasks: grating vegetables and extracting a battery from a charging stand.	[Ureche, Ana Lucia Pais; Billard, Aude] Ecole Polytech Fed Lausanne, Lab Learning Algorithms & Syst, CH-1015 Lausanne, Switzerland; [Umezawa, Keisuke] Univ Tokyo, Grad Sch Informat Sci & Technol, Tokyo 1138685, Japan; [Nakamura, Yoshihiko] Univ Tokyo, Grad Sch Informat Sci & Technol, Tokyo 1138685, Japan	Ureche, ALP (reprint author), Ecole Polytech Fed Lausanne, Lab Learning Algorithms & Syst, CH-1015 Lausanne, Switzerland.	lucia.pais@epfl.ch; keisuke.umezawa@gmail.com; nakamura@ynl.t.u-tokyo.ac.jp; aude.billard@epfl.ch			European Union Seventh Framework Programme FP7 [288533]	This paper was recommended for publication by Associate Editor A. Saxena and Editor C. Torras upon evaluation of the reviewers' comments. This work was supported by the European Union Seventh Framework Programme FP7/2007-2013 under Grant 288533 ROBOHOW.COG.	Kulic D, 2008, IEEE INT CONF ROBOT, P2591, DOI 10.1109/ROBOT.2008.4543603; Grollman DH, 2010, IEEE INT C INT ROBOT, P261; Kulic D, 2008, 2008 IEEE/RSJ INTERNATIONAL CONFERENCE ON ROBOTS AND INTELLIGENT SYSTEMS, VOLS 1-3, CONFERENCE PROCEEDINGS, P2860, DOI 10.1109/IROS.2008.4650619; Kormushev P, 2011, ADV ROBOTICS, V25, P581, DOI 10.1163/016918611X558261; Calinon S, 2007, IEEE T SYST MAN CY B, V37, P286, DOI 10.1109/TSMCB.2006.886952; Oriolo G, 2009, 2009 IEEE-RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, P297, DOI 10.1109/IROS.2009.5354287; Bennewitz M, 2005, INT J ROBOT RES, V24, P31, DOI 10.1177/0278364904048962; Beetz M, 2010, IEEE INT C INT ROBOT, P1012; Kulic D, 2012, INT J ROBOT RES, V31, P330, DOI 10.1177/0278364911426178; Howard M, 2009, AUTON ROBOT, V27, P105, DOI 10.1007/s10514-009-9129-8; Wang LA, 2003, PATTERN RECOGN, V36, P585, DOI 10.1016/S0031-3203(02)00100-0; Calinon S, 2006, IEEE INT CONF ROBOT, P2978; Calinon S, 2010, IEEE INT C INT ROBOT, P249; Dantam N, 2013, IEEE T ROBOT, V29, P704, DOI 10.1109/TRO.2013.2239553; Sukhoy V, 2012, 2012 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND AUTOMATION (ICRA), P2398, DOI 10.1109/ICRA.2012.6225358; Seth AK, 2010, J NEUROSCI METH, V186, P262, DOI 10.1016/j.jneumeth.2009.11.020; Muhlig M, 2009, 2009 IEEE-RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, P4996, DOI 10.1109/IROS.2009.5353894; Bobick AF, 1997, IEEE T PATTERN ANAL, V19, P1325, DOI 10.1109/34.643892; Konidaris G, 2012, INT J ROBOT RES, V31, P360, DOI 10.1177/0278364911428653; Shukla A, 2012, ROBOT AUTON SYST, V60, P424, DOI 10.1016/j.robot.2011.07.023; Arsenio A., 2004, P 2004 IEEE INT C CO, V1, P400; Jakel R., 2010, P IEEE INT C ROB AUT, P162; Lee S. H., 2011, P 6 INT C HUM ROB IN, P185, DOI 10.1145/1957656.1957723; Lin J., 2011, ROBOTICS NEUROLOGY R; Mangin O., 2012, P IROS 2012, P3268; Matsuo T., 2008, P IEEE 30 INT TEL EN, P1; Niekum S., 2013, ROB SCI SYST C BERL; Schutter J. D., 2007, INT J ROBOT RES, V26, P433; Shim J., 2011, P IEEE INT S ROB HUM, P455; Stilman M., 2007, P IEEE RSJ INT C INT, P3074; Takano W., 2006, P IEEE RAS INT C HUM, P425; Tao L., 2012, INFORM PROCESS COMPU, V7330, P167; Villani L., 2008, SPRINGER HDB ROBOTIC, P161, DOI 10.1007/978-3-540-30301-5_8; Ye Gu, 2011, INT S ROB RES ISRR, V5	34	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1552-3098	1941-0468		IEEE T ROBOT	IEEE Trans. Robot.	DEC	2015	31	6					1458	1471		10.1109/TRO.2015.2495003		14	Robotics	Robotics	CY8MR	WOS:000366663300015		
J	Zhuang, WH; Jamalipour, A; Bai, F; Vinel, A				Zhuang, Weihua; Jamalipour, Abbas; Bai, Fan; Vinel, Alexey			Emerging Technologies, Applications, and Standardizations for Connecting Vehicles	IEEE VEHICULAR TECHNOLOGY MAGAZINE			English	Article									[Zhuang, Weihua] Univ Waterloo, Dept Elect & Comp Engn, Waterloo, ON N2L 3G1, Canada; [Zhuang, Weihua] Canadian Acad Engn, Ottawa, ON, Canada; [Zhuang, Weihua] Engn Inst Canada, Kingston, ON, Canada; [Zhuang, Weihua] IEEE Vehicular Technol Soc, Mobile Radio, Ottawa, ON, Canada; [Zhuang, Weihua] Univ Waterloo, Wireless Commun Networks, Waterloo, ON N2L 3G1, Canada; [Jamalipour, Abbas] Univ Sydney, Ubiquitous Mobile Networking, Sydney, NSW 2006, Australia; [Jamalipour, Abbas] Inst Elect Informat & Commun Engineers, Tokyo, Japan; [Jamalipour, Abbas] Inst Engineers Australia, Barton, ACT, Australia; [Jamalipour, Abbas] Satellite & Space Commun Tech Comm, London, England; [Jamalipour, Abbas] Asia Pacific Board ComSoc, Tokyo, Japan; [Zhuang, Weihua; Jamalipour, Abbas; Bai, Fan] IEEE, New York, NY USA; [Vinel, Alexey] Inst Informat Transmiss Problems, Moscow, Russia; [Vinel, Alexey] Tampere Univ Technol, FIN-33101 Tampere, Finland	Zhuang, WH (reprint author), Univ Waterloo, Dept Elect & Comp Engn, Waterloo, ON N2L 3G1, Canada.							0	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1556-6072	1556-6080		IEEE VEH TECHNOL MAG	IEEE Veh. Technol. Mag.	DEC	2015	10	4					33	35		10.1109/MVT.2015.2481187		3	Engineering, Electrical & Electronic; Telecommunications; Transportation Science & Technology	Engineering; Telecommunications; Transportation	CY8NP	WOS:000366665800006		
J	Uysal, M; Ghassemlooy, Z; Bekkali, A; Kadri, A; Menouar, H				Uysal, Murat; Ghassemlooy, Zabih (Fary); Bekkali, Abdelmoula; Kadri, Abdullah; Menouar, Hamid			Visible Light Communication for Vehicular Networking Performance Study of a V2V System Using a Measured Headlamp Beam Pattern Model	IEEE VEHICULAR TECHNOLOGY MAGAZINE			English	Article							SYSTEMS	In this article, we discuss visible light communication (VLC) in the context of vehicular communication networks. With the omnipresence of light-emitting diodes (LEDs) in outdoor and automotive lightings, VLC emerges as a natural candidate for vehicle-to-vehicle (V2V) and vehicle-to-infrastructure (V2I) communications. We first provide an overview of this emerging research area highlighting recent advances and identifying open problems for further research. Then, we present the performance evaluation of a typical V2V VLC system with realistic automative light sources. Our evaluation takes into account the measured headlamp beam pattern and the impact of road reflected light. We demonstrate that depending on the photodetector (PD) position above the ground level, a data rate of 50 Mb/s can be achieved at 70 m.	[Uysal, Murat] Ozyegin Univ, Istanbul, Turkey; [Uysal, Murat] Univ Waterloo, Waterloo, ON N2L 3G1, Canada; [Ghassemlooy, Zabih (Fary)] Sheffield Hallam Univ, Opt Commun, Sheffield S1 1WB, S Yorkshire, England; [Ghassemlooy, Zabih (Fary)] Northumbria Univ, Newcastle Upon Tyne, Tyne & Wear, England; [Bekkali, Abdelmoula] NTT Labs, Tokyo, Japan; [Bekkali, Abdelmoula; Kadri, Abdullah; Menouar, Hamid] Qatar Mobil Innovat Ctr, Doha, Qatar	Uysal, M (reprint author), Ozyegin Univ, Istanbul, Turkey.	murat.uysal@ozyegin.edu.tr; z.ghassemlooy@northumbria.ac.uk; ab-bekkali@kddilabs.jp; abdullahk@qmic.com; hamidm@qmic.com			EU COST Action [IC1101]	The work of M. Uysal and Z. Ghassemlooy is supported by EU COST Action IC1101 "Optical Wireless Communications-An Emerging Technology."	Akanegawa M, 2001, IEEE T INTELL TRANSP, V2, P197, DOI 10.1109/6979.969365; Mesleh R, 2011, J OPT COMMUN NETW, V3, P620, DOI 10.1364/JOCN.3.000620; Papadimitratos P, 2009, IEEE COMMUN MAG, V47, P84, DOI 10.1109/MCOM.2009.5307471; Lee SJ, 2012, IEEE INT C INTELL TR, P463, DOI 10.1109/ITSC.2012.6338610; Kitano S, 2003, IEEE VTS VEH TECHNOL, P3346, DOI 10.1109/VETECF.2003.1286302; Morgan YL, 2010, IEEE COMMUN SURV TUT, V12, P504, DOI 10.1109/SURV.2010.033010.00024; Yu SH, 2013, IEEE COMMUN MAG, V51, P50; Kizilirmak RC, 2014, 2014 IEEE INTERNATIONAL BLACK SEA CONFERENCE ON COMMUNICATIONS AND NETWORKING (BLACKSEACOM), P11, DOI 10.1109/BlackSeaCom.2014.6848995; Chun S., 2015, VEHICULAR COMMUNICAT, P127; Karagiannis O., 2011, IEEE COMMUN SURV TUT, V13, P584; Liu C., 2011, P ACM INT WORKSH VEH, P41, DOI DOI 10.1145/2030698.2030705; Lourenco N., 2012, P IEEE RAD EFF DAT W, P1; Luo P., 2014, P 6 INT C WIR COMM S, P1; Takai I., 2014, IEEE PHOTON J, V6; Tomas B., 2014, P IEEE VEH NETW C, P222	15	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1556-6072	1556-6080		IEEE VEH TECHNOL MAG	IEEE Veh. Technol. Mag.	DEC	2015	10	4					45	53		10.1109/MVT.2015.2481561		9	Engineering, Electrical & Electronic; Telecommunications; Transportation Science & Technology	Engineering; Telecommunications; Transportation	CY8NP	WOS:000366665800008		
J	Nishiyama, H; Ngo, T; Oiyama, S; Kato, N				Nishiyama, Hiroki; Thuan Ngo; Oiyama, Shoki; Kato, Nei			Relay by Smart Device Innovative Communications for Efficient Information Sharing Among Vehicles and Pedestrians	IEEE VEHICULAR TECHNOLOGY MAGAZINE			English	Article							AD-HOC NETWORKS; RESOURCE-ALLOCATION; PROTOCOLS	The combination of vehicles and mobile computers, such as smartphones and wearable devices, has provided many applications in our daily life. However, it is still limited to the applications in personal use. In fact, by utilizing the device-to-device technologies, which make use of the mobile device resources, vehicle-to-pedestrian (V2P), vehicle-to-vehicle (V2V), and pedestrian-to-pedestrian (P2P) communications can be more effective and convenient. In this article, we present a concept of relay by smart device that aims at information dissemination by smart communication devices, which can contribute to efficient information sharing among vehicles and pedestrians. We propose a novel technique for effectively forming and disbanding the groups of vehicles and pedestrians for their communications. The proposed mechanism is based on three criteria, namely, the stability of the group, the activity of the group, and the qualification as a group leader. Procedures for group forming and disbanding are introduced. We develop a prototype as a smartphone application using Wi-Fi technology, referred to as the second generation of relay by smartphone, which is the smartphone type of relay by smart device. The results of the field experiment show that the proposed group-based information sharing technology has a good potential to be utilized in V2P, V2V, and P2P communications.	[Nishiyama, Hiroki; Kato, Nei] Tohoku Univ, Grad Sch Informat Sci, Sendai, Miyagi 980, Japan; [Thuan Ngo] Tohoku Univ, Informat Sci, Sendai, Miyagi 980, Japan	Nishiyama, H (reprint author), Tohoku Univ, Grad Sch Informat Sci, Sendai, Miyagi 980, Japan.	hiroki.nishiyama.1983@ieee.org; thuan.ngo@it.is.tohoku.ac.jp; shouki.oiyama@it.is.tohoku.ac.jp; kato@it.is.tohoku.ac.jp					Koukoumidis E, 2012, IEEE T MOBILE COMPUT, V11, P707, DOI 10.1109/TMC.2011.275; Pelusi L, 2006, IEEE COMMUN MAG, V44, P134, DOI 10.1109/MCOM.2006.248176; Xu C, 2013, IEEE J SEL AREA COMM, V31, P348, DOI 10.1109/JSAC.2013.SUP.0513031; Song LY, 2014, IEEE WIREL COMMUN, V21, P136; Menouar H, 2006, IEEE WIREL COMMUN, V13, P30, DOI 10.1109/WC-M.2006.250355; Perkins CE, 2001, IEEE PERS COMMUN, V8, P16, DOI 10.1109/98.904895; Harrysson F, 2013, IEEE T VEH TECHNOL, V62, P2532, DOI 10.1109/TVT.2013.2244623; Booysen MJ, 2011, IET COMMUN, V5, P1619, DOI 10.1049/iet-com.2011.0085; Nishiyama H, 2014, IEEE COMMUN MAG, V52, P56, DOI 10.1109/MCOM.2014.6807947; Skog I, 2014, IEEE T INSTRUM MEAS, V63, P3190, DOI 10.1109/TIM.2014.2315739; Sakano T, 2013, IEEE NETWORK, V27, P40, DOI 10.1109/MNET.2013.6574664; Karagiannis G, 2011, IEEE COMMUN SURV TUT, V13, P584, DOI 10.1109/SURV.2011.061411.00019; Fall K., 2003, P ACM SIGCOMM, P27, DOI DOI 10.1145/863955.863960; Han T., 2014, IEEE INTERNET THINGS, V1, P161; Yujin Li, 2013, IEEE Transactions on Vehicular Technology, V62, DOI 10.1109/TVT.2013.2264689	15	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1556-6072	1556-6080		IEEE VEH TECHNOL MAG	IEEE Veh. Technol. Mag.	DEC	2015	10	4					54	62		10.1109/MVT.2015.2481558		9	Engineering, Electrical & Electronic; Telecommunications; Transportation Science & Technology	Engineering; Telecommunications; Transportation	CY8NP	WOS:000366665800009		
J	Moriichi, K; Fujiya, M; Ijiri, M; Tanaka, K; Sakatani, A; Dokoshi, T; Fujibayashi, S; Ando, K; Nomura, Y; Ueno, N; Kashima, S; Gotoh, T; Sasajima, J; Inaba, Y; Ito, T; Tanabe, H; Saitoh, Y; Kohgo, Y				Moriichi, Kentaro; Fujiya, Mikihiro; Ijiri, Masami; Tanaka, Kazuyuki; Sakatani, Aki; Dokoshi, Tatsuya; Fujibayashi, Shugo; Ando, Katsuyoshi; Nomura, Yoshiki; Ueno, Nobuhiro; Kashima, Shin; Gotoh, Takuma; Sasajima, Junpei; Inaba, Yuhei; Ito, Takahiro; Tanabe, Hiroki; Saitoh, Yusuke; Kohgo, Yutaka			Quantification of autofluorescence imaging can accurately and objectively assess the severity of ulcerative colitis	INTERNATIONAL JOURNAL OF COLORECTAL DISEASE			English	Article						Autofluorescence imaging; Endoscopy; Ulcerative colitis	BIOPSY	No endoscopic examination has been able to evaluate severity of ulcerative colitis (UC) by quantification. This prospective study investigated the efficacy of quantifying autofluorescence imaging (AFI) to assess the severity of UC, which captures the fluorescence emitted from intestinal tissue and then quantifies the intensity using an image-analytical software program. Eleven endoscopists separately evaluated 135 images of conventional endoscopy (CE) and AFI from a same lesion. A CE image corresponding to Mayo endoscopic subscore 0 or 1 was defined as being inactive. The fluorescence intensities of AFI were quantified using an image-analytical software program (F index; FI). Active inflammation was defined when Matts' histological grade was 2 or more. A cut-off value of the FI for active inflammation was determined using a receiver operating characteristic (ROC) analysis. The inter-observer consistency was calculated by unweighted kappa statistics. The correlation coefficient for the FI was inversely related to the histological severity (r = -0.558, p < 0.0001). The ROC analysis showed that the optimal cut-off value for the FI for active inflammation was 0.906. The average diagnostic accuracy of the FI was significantly higher than those of the CE (84.7 vs 78.5 %, p < 0.01). The kappa values for the inter-observer consistency of CE and the FI were 0.60 and 0.95 in all participants, 0.53 and 0.97 in the less-experienced endoscopists group and 0.67 and 0.93 in the expert group, respectively. The quantified AFI is considered to be an accurate and objective indicator that can be used to assess the activity of ulcerative colitis, particularly for less-experienced endoscopists.	[Moriichi, Kentaro; Fujiya, Mikihiro; Ijiri, Masami; Tanaka, Kazuyuki; Sakatani, Aki; Dokoshi, Tatsuya; Fujibayashi, Shugo; Ando, Katsuyoshi; Nomura, Yoshiki; Ueno, Nobuhiro; Kashima, Shin; Gotoh, Takuma; Sasajima, Junpei; Inaba, Yuhei; Ito, Takahiro; Tanabe, Hiroki; Kohgo, Yutaka] Asahikawa Med Univ, Dept Med, Div Gastroenterol & Hematol Oncol, Asahikawa, Hokkaido 0788510, Japan; [Tanabe, Hiroki; Kohgo, Yutaka] Int Univ Hlth & Wealfare Hosp, Div Gastroenterol, Nasushiobara, Tochigi, Japan; [Inaba, Yuhei; Saitoh, Yusuke] Asahikawa City Hosp, Ctr Digest Dis, Asahikawa, Hokkaido, Japan	Fujiya, M (reprint author), Asahikawa Med Univ, Dept Med, Div Gastroenterol & Hematol Oncol, 2-1 Midorigaoka Higashi, Asahikawa, Hokkaido 0788510, Japan.	fjym@asahikawa-med.ac.jp					Rogler G, 2012, DIGEST DIS, V30, P48, DOI 10.1159/000341893; DICK AP, 1966, GUT, V7, P355, DOI 10.1136/gut.7.4.355; MATTS SG, 1961, Q J MED, V30, P393; RILEY SA, 1991, GUT, V32, P174, DOI 10.1136/gut.32.2.174; TRUELOVE SC, 1956, BRIT MED J, V1, P1315; D'Haens G, 2007, GASTROENTEROLOGY, V132, P763, DOI 10.1053/j.gastro.2006.12.038	6	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0179-1958	1432-1262		INT J COLORECTAL DIS	Int. J. Colorectal Dis.	DEC	2015	30	12					1639	1643		10.1007/s00384-015-2332-5		5	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CY3PW	WOS:000366323000005		
J	Shiga, H; Kuroha, M; Endo, K; Kimura, T; Kakuta, Y; Kinouchi, Y; Kayaba, S; Shimosegawa, T				Shiga, Hisashi; Kuroha, Masatake; Endo, Katsuya; Kimura, Tomoya; Kakuta, Yoichi; Kinouchi, Yoshitaka; Kayaba, Shoichi; Shimosegawa, Tooru			Colorectal endoscopic submucosal dissection (ESD) performed by experienced endoscopists with limited experience in gastric ESD	INTERNATIONAL JOURNAL OF COLORECTAL DISEASE			English	Article						Endoscopic submucosal dissection (ESD); Colorectal neoplasia; Novices; Enblocresection; Perforation	LEARNING-CURVE; EPITHELIAL NEOPLASMS; TUMORS; PERFORATION; JAPAN; MULTICENTER; RESECTION; EFFICACY; OUTCOMES; SAFETY	Since colorectal endoscopic submucosal dissection (ESD) requires higher-level skills than endoscopic mucosal resection (EMR), it is recommended to acquire sufficient experience in gastric ESD prior to attempting colorectal ESD. We evaluated the ability of experienced endoscopists with limited experience in gastric ESD to perform colorectal ESD. We retrospectively reviewed 120 colorectal ESDs performed by two endoscopists who had expertise in colonoscopy and colorectal EMR but experience of fewer than five gastric ESDs. Main outcomes were the en bloc resection rate with tumor-free margins (R0 resection rate) and adverse events rate. Using only clinical characteristics prior to ESD, we also identified factors affecting outcomes. A total of 113 patients (94.2 %) received en bloc resection, and the R0 resection rate was 80.0 % (96/120). Perforation and postoperative hemorrhage occurred in eight (6.7 %) and two (1.7 %) patients, respectively. Dividing the 120 cases into three learning phases, R0 resection and perforation rates improved from 77.5 % (31/40) and 12.5 % (5/40) in phase 1 to 85.0 % (34/40) and 2.5 % (1/40) in phase 3, respectively. Multivariate analysis revealed that lesions at junctions (dentate line, sigmoid-descending junction, splenic flexure, hepatic flexure, ileocecal valve) and lesions with factors reflecting fibrosis in the submucosal layer (based on endoscopic findings before ESD) were significantly correlated with R0 resection failure, with adjusted odds ratios of 10.5 (95 % CI 2.1-67.6) and 10.4 (2.7-48.6), respectively. Colorectal ESD is feasible for experienced endoscopists with limited experience in gastric ESD. Novices should avoid lesions at junctions or those with factors reflecting fibrosis.	[Shiga, Hisashi; Kuroha, Masatake; Endo, Katsuya; Kimura, Tomoya; Kakuta, Yoichi; Kinouchi, Yoshitaka; Shimosegawa, Tooru] Tohoku Univ, Grad Sch Med, Div Gastroenterol, Aoba Ku, Sendai, Miyagi 9808574, Japan; [Kayaba, Shoichi] Iwate Prefectural Isawa Hosp, Dept Gastroenterol, Oshu, Japan	Shiga, H (reprint author), Tohoku Univ, Grad Sch Med, Div Gastroenterol, Aoba Ku, 1-1 Seiryo, Sendai, Miyagi 9808574, Japan.	shiga@med.tohoku.ac.jp					Saito Y, 2007, GASTROINTEST ENDOSC, V66, P966, DOI 10.1016/j.gie.2007.02.053; Probst A, 2012, ENDOSCOPY, V44, P660, DOI 10.1055/s-0032-1309403; Oka S, 2010, DIGEST ENDOSC, V22, P376, DOI 10.1111/j.1443-1661.2010.01016.x; Tanaka S, 2007, GASTROINTEST ENDOSC, V66, P100, DOI 10.1016/j.gie.2007.02.032; Tanaka S, 2008, J GASTROENTEROL, V43, P641, DOI 10.1007/s00535-008-2223-4; Saito Y, 2010, GASTROINTEST ENDOSC, V72, P1217, DOI 10.1016/j.gie.2010.08.004; Taku K, 2007, J GASTROEN HEPATOL, V22, P1409, DOI 10.1111/j.1440-1746.2007.05022.x; Iacopini F, 2012, GASTROINTEST ENDOSC, V76, P1188, DOI 10.1016/j.gie.2012.08.024; Repici A, 2012, ENDOSCOPY, V44, P137, DOI 10.1055/s-0031-1291448; Fujishiro M, 2007, CLIN GASTROENTEROL H, V5, P678, DOI 10.1016/j.cgh.2007.01.006; Niimi K, 2012, DIGEST ENDOSC, V24, P154, DOI 10.1111/j.1443-1661.2012.01251.x; Shiga H, 2014, SURG ENDOSC, V28, P2120, DOI 10.1007/s00464-014-3443-8; Tamegai Y, 2007, ENDOSCOPY, V39, P418, DOI 10.1055/s-2007-966427; Yoshida N, 2009, ENDOSCOPY, V41, P758, DOI 10.1055/s-0029-1215028; Hotta K, 2010, DIGEST ENDOSC, V22, P302, DOI 10.1111/j.1443-1661.2010.01005.x; Hayashi N, 2014, GASTROINTEST ENDOSC, V79, P427, DOI 10.1016/j.gie.2013.09.014; Isomoto H, 2009, ENDOSCOPY, V41, P679, DOI 10.1055/s-0029-1214979; Terasaki M, 2014, INT J COLORECTAL DIS, V29, P877, DOI 10.1007/s00384-014-1901-3; Deprez PH, 2010, ENDOSCOPY, V42, P854, DOI 10.1055/s-0030-1255563; Fujishiro M., 2007, CLIN GASTROENTEROL H, V5, P645, DOI [10.1016/ j.cgh.2007.01.006, DOI 10.1016/J.CGH.2007.01.006]; Hori K, 2014, ENDOSCOPY, V46, P862, DOI 10.1055/s-0034-1377205; Mizushima T, 2015, SURG ENDOSC, V29, P133, DOI 10.1007/s00464-014-3665-9; Sato K, 2014, SURG ENDOSC, V28, P2959, DOI 10.1007/s00464-014-3558-y; Suzuki Haruhisa, 2006, Gastric Cancer, V9, P315, DOI 10.1007/s10120-006-0399-y; Tanaka S, 2010, DIGEST ENDOSC, V22, pS2, DOI 10.1111/j.1443-1661.2010.00952.x; Workshop. PitP, 2003, GASTROINTEST ENDOS S, V58, pS3	26	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0179-1958	1432-1262		INT J COLORECTAL DIS	Int. J. Colorectal Dis.	DEC	2015	30	12					1645	1652		10.1007/s00384-015-2334-3		8	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CY3PW	WOS:000366323000006		
J	Watanabe, J; Ota, M; Kawaguchi, D; Shima, H; Kaida, S; Osada, S; Kamimukai, N; Kamiya, N; Ishibe, A; Watanabe, K; Matsuyama, R; Akiyama, H; Ichikawa, Y; Oba, M; Endo, I				Watanabe, Jun; Ota, Mitsuyoshi; Kawaguchi, Daisuke; Shima, Hidetaka; Kaida, Shuhei; Osada, Shunichi; Kamimukai, Nobuyuki; Kamiya, Noriyuki; Ishibe, Atsushi; Watanabe, Kazuteru; Matsuyama, Ryusei; Akiyama, Hirotoshi; Ichikawa, Yasushi; Oba, Mari; Endo, Itaru			Incidence and risk factors for rectovaginal fistula after low anterior resection for rectal cancer	INTERNATIONAL JOURNAL OF COLORECTAL DISEASE			English	Article						Rectovaginal fistula; Rectal cancer; Anastomotic-vaginal fistula; Anastomotic leakage; Low anterior resection	ANASTOMOTIC-VAGINAL FISTULA; DOUBLE-STAPLING TECHNIQUE; OBSTETRIC FISTULA; FLAP REPAIR; COMPLICATION; SURGERY	The rectovaginal fistula (RVF) is a rare complication after low anterior resection (LAR) for rectal cancer. The aim of this study was to evaluate the risk factors for RVF after LAR for rectal cancer. This was a retrospective multi-institution study of 371 female rectal cancer patients who underwent LAR with anastomosis between January 2007 and December 2011. Patient-, tumor-, and surgery-related variables were examined by univariate and multivariate analyses. The overall RVF rate was 3.0 % (11/371). The RVF was diagnosed on median postoperative day 83 (15-766). In 81.8 % (9/11) of the patients, the diagnosis of RVF was made after hospital discharge. Multivariate analysis identified prognostic nutritional index (PNI; odds ratio (OR) 6.97; 95 % confidence interval (CI) 1.47-33.08; P = 0.015), preoperative chemotherapy (OR 27.31; CI 3.49-213.62; P = 0.002), tumor size (OR 5.90; CI 1.04-33.47; P = 0.045), intraoperative bleeding (OR 13.91; CI 1.34-144.42; P = 0.027), and lateral lymph node dissection (OR 4.92; CI 1.02-23.63; P = 0.045) as independent risk factors for RVF after LAR. Risk factors of RVF were PNI (< 45), preoperative chemotherapy, tumor size (a parts per thousand 50 mm), intraoperative bleeding (a parts per thousand 200 ml), and lateral lymph node dissection. Before an operation, obtaining the information about these risk factors is of great importance in LAR for rectal cancer.	[Watanabe, Jun; Kaida, Shuhei] Yokosuka Kyosai Hosp, Dept Surg, Yokosuka, Kanagawa 2388558, Japan; [Ota, Mitsuyoshi] Yokohama City Univ, Dept Surg, Gastroenterol Ctr, Yokohama, Kanagawa 232, Japan; [Kawaguchi, Daisuke] Yokohama Municipal Citizens Hosp, Dept Surg, Yokohama, Kanagawa, Japan; [Shima, Hidetaka] Yokosuka Municipal Citizens Hosp, Dept Surg, Yokosuka, Kanagawa, Japan; [Osada, Shunichi] Yokohama City Minato Red Cross Hosp, Dept Surg, Yokohama, Kanagawa, Japan; [Kamimukai, Nobuyuki] Yokohama Hodogaya Cent Hosp, Dept Surg, Yokohama, Kanagawa, Japan; [Kamiya, Noriyuki] Ito Municipal Hosp, Dept Surg, Ito, Japan; [Ishibe, Atsushi; Matsuyama, Ryusei; Akiyama, Hirotoshi; Ichikawa, Yasushi; Endo, Itaru] Yokohama City Univ, Grad Sch Med, Dept Surg Gastroenterol, Yokohama, Kanagawa 232, Japan; [Watanabe, Kazuteru] Nippon Telegraph & Tel Corp, Med Ctr, Dept Surg, Tokyo, Japan; [Oba, Mari] Yokohama City Univ, Dept Biostat & Epidemiol, Yokohama, Kanagawa 232, Japan	Watanabe, J (reprint author), Yokosuka Kyosai Hosp, Dept Surg, 1-16 Yonegahama St, Yokosuka, Kanagawa 2388558, Japan.	nabe-jun@comet.ocn.ne.jp					ANTONSEN HK, 1987, DIS COLON RECTUM, V30, P579, DOI 10.1007/BF02554801; REX JC, 1992, DIS COLON RECTUM, V35, P354, DOI 10.1007/BF02048113; FLESHNER PR, 1992, DIS COLON RECTUM, V35, P938, DOI 10.1007/BF02253495; Matthiessen P, 2010, COLORECTAL DIS, V12, P351, DOI 10.1111/j.1463-1318.2009.01798.x; Nakagoe T, 1999, J SURG ONCOL, V71, P196, DOI 10.1002/(SICI)1096-9098(199907)71:3<196::AID-JSO11>3.0.CO;2-R; Tsutsumi N, 2007, HEPATO-GASTROENTEROL, V54, P1682; BARAN JJ, 1992, AM SURGEON, V58, P270; ARBMAN G, 1993, DIS COLON RECTUM, V36, P310, DOI 10.1007/BF02053522; Sugarbaker PH, 1996, J SURG ONCOL, V61, P155, DOI 10.1002/(SICI)1096-9098(199602)61:2<155::AID-JSO12>3.0.CO;2-8; van Onkelen RS, 2014, DIS COLON RECTUM, V57, P1007, DOI 10.1097/DCR.0000000000000154; Kosugi C, 2005, SURGERY, V137, P329, DOI 10.1016/j.surg.2004.10.004; Bangser M, 2006, LANCET, V367, P535, DOI 10.1016/S0140-6736(06)68188-9; Gottgens KW, 2014, DIS COLON RECTUM, V57, P888, DOI 10.1097/DCR.0000000000000147; Cook RJ, 2004, INT J GYNECOL OBSTET, V87, P72, DOI 10.1016/j.ijgo.2004.07.005; Hotouras A, 2015, COLORECTAL DIS, V17, P104, DOI 10.1111/codi.12791; Kin Cindy, 2012, Pol Przegl Chir, V84, P601, DOI 10.2478/v10035-012-0099-8; Pata Giacomo, 2014, Int J Surg Case Rep, V5, P527, DOI 10.1016/j.ijscr.2014.04.014; Sobin L, 2009, TNM CLASSIFICATION M; Tozer PJ, 2013, COLORECTAL DIS, V15, P871, DOI 10.1111/codi.12114	19	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0179-1958	1432-1262		INT J COLORECTAL DIS	Int. J. Colorectal Dis.	DEC	2015	30	12					1659	1666		10.1007/s00384-015-2340-5		8	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CY3PW	WOS:000366323000008		
J	Okada, K; Sadahiro, S; Suzuki, T; Tanaka, A; Saito, G; Masuda, S; Haruki, Y				Okada, Kazutake; Sadahiro, Sotaro; Suzuki, Toshiyuki; Tanaka, Akira; Saito, Gota; Masuda, Shinobu; Haruki, Yasuo			The size of retrieved lymph nodes correlates with the number of retrieved lymph nodes and is an independent prognostic factor in patients with stage II colon cancer	INTERNATIONAL JOURNAL OF COLORECTAL DISEASE			English	Article						Colonic neoplasm; Adenocarcinoma; Lymph nodes; Survival analysis; Retrospective study	COLORECTAL-CANCER; CLINICAL-SIGNIFICANCE; MINIMUM NUMBER; SURVIVAL; METASTASES; RESECTION; ADENOCARCINOMA; DISSECTION; CARCINOMA	In stage II colon cancer, patients with many retrieved lymph nodes (LNs) have been reported to have better oncological outcomes. We tested the hypothesis that the greater number of retrieved LNs is related to a larger LN size. The subjects comprised 320 patients with stage II colon cancer who underwent curative resection. All operations were elective and were performed by the same surgeons. The maximum long axis and short axis diameters of LNs were measured on hematoxylin-eosin-stained specimens. A total of 4,744 LNs were evaluated. The number of retrieved LNs was 14.8 +/- 10.1 (mean +/- SD). The long axis diameter was 4.8 +/- 2.6 mm, with a median value of 4.3 mm, a maximum value of 20.4 mm, and a minimum value of 0.6 mm. The corresponding short axis diameters were 3.4 +/- 1.7, 3.0, 15.1, and 0.5 mm, respectively. The highest correlation coefficient for the association with the number of LNs was obtained for the maximum value of the long axis diameter (0.59). Multivariate analysis revealed that age, tumor location, pathological T stage, and the maximum long axis diameter were independent prognostic factors. The number of LNs was not a significant factor. Patients with less than 12 LNs and a maximum long axis diameter of less than 10 mm had significantly poorer outcomes (p < 0.001). In patients with stage II colon cancer, the maximum long axis diameter of LNs correlated with the number of LNs and was an independent prognostic factor.	[Okada, Kazutake; Sadahiro, Sotaro; Suzuki, Toshiyuki; Tanaka, Akira; Saito, Gota] Tokai Univ, Dept Surg, Isehara, Kanagawa 2591193, Japan; [Masuda, Shinobu] Nihon Univ, Dept Pathol, Tokyo, Japan; [Haruki, Yasuo] Tokai Univ, Dept Basic Med Sci, Isehara, Kanagawa, Japan	Sadahiro, S (reprint author), Tokai Univ, Dept Surg, 143 Shimokasuya Isehara, Isehara, Kanagawa 2591193, Japan.	sadahiro@is.icc.u-tokai.ac.jp					Le Voyer TE, 2003, J CLIN ONCOL, V21, P2912, DOI 10.1200/JCO.2003.05.062; Naito Y, 1998, CANCER RES, V58, P3491; West NP, 2012, J CLIN ONCOL, V30, P1763, DOI 10.1200/JCO.2011.38.3992; Brown HG, 2004, MODERN PATHOL, V17, P402, DOI 10.1038/modpathol.3800071; Swanson RS, 2003, ANN SURG ONCOL, V10, P65, DOI 10.1245/ASO.2003.03.058; Cserni G, 2002, J SURG ONCOL, V81, P63, DOI 10.1002/jso.10140; Kotake K, 2012, JPN J CLIN ONCOL, V42, P29, DOI 10.1093/jjco/hyr164; Kim YW, 2013, ANTICANCER RES, V33, P5143; Markl B, 2012, MODERN PATHOL, V25, P1413, DOI 10.1038/modpathol.2012.92; Perez RO, 2009, DIS COLON RECTUM, V52, P1278, DOI 10.1007/DCR.0b013e3181a0af4b; Chang GJ, 2007, J NATL CANCER I, V99, P433, DOI 10.1093/jnci/djk092; Murphy J, 2007, DIS COLON RECTUM, V50, P1526, DOI 10.1007/s10350-007-9024-3; Prall F, 2004, HUM PATHOL, V35, P808, DOI 10.1016/j.humpath.2004.01.022; RodriguezBigas MA, 1996, ANN SURG ONCOL, V3, P124, DOI 10.1007/BF02305790; HERRERA L, 1992, DIS COLON RECTUM, V35, P783, DOI 10.1007/BF02050329; Chen SL, 2006, ANN SURG, V244, P602, DOI 10.1097/01.sla.0000237655.11717.50; Sarli L, 2005, EUR J CANCER, V41, P272, DOI 10.1016/j.ejca.2004.10.010; Bjelovic M, 1998, HEPATO-GASTROENTEROL, V45, P433; HIDA J, 1994, J AM COLL SURGEONS, V178, P223; Sloothaak DAM, 2014, BRIT J SURG, V101, P701, DOI 10.1002/bjs.9451; Edler D, 2007, ACTA ONCOL, V46, P975, DOI 10.1080/02841860701203537; GRAHAM DM, 1990, MODERN PATHOL, V3, P332; Goldstein NS, 2002, AM J SURG PATHOL, V26, P179, DOI 10.1097/00000478-200202000-00004; FIELDING LP, 1991, J GASTROEN HEPATOL, V6, P325, DOI 10.1111/j.1440-1746.1991.tb00867.x; Schmucker Douglas L, 2003, Clin Dev Immunol, V10, P167, DOI 10.1080/10446670310001642168	25	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0179-1958	1432-1262		INT J COLORECTAL DIS	Int. J. Colorectal Dis.	DEC	2015	30	12					1685	1693		10.1007/s00384-015-2357-9		9	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CY3PW	WOS:000366323000011		
J	Yamashita, M				Yamashita, Masayuki			Electric axon guidance during development of retinal ganglion cells	INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE			English	Meeting Abstract	Joint Meeting of the 20th Biennial Meeting of the International-Society-for-Developmental-Neuroscience / 5th Annual NeuroDevNet Brain Development Conference	JUL 19-24, 2014	Montreal, CANADA	Int Soc Dev Neuroscience					[Yamashita, Masayuki] Int Univ Hlth & Welf, Ctr Med Sci, Tokyo, Japan							Yamashita M, 2013, BIOCHEM BIOPH RES CO, V431, P280, DOI 10.1016/j.bbrc.2012.12.115	1	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0736-5748	1873-474X		INT J DEV NEUROSCI	Int. J. Dev. Neurosci.	DEC	2015	47		A		SI		35	35		10.1016/j.ijdevneu.2015.04.100		1	Developmental Biology; Neurosciences	Developmental Biology; Neurosciences & Neurology	CY6QT	WOS:000366534600090		
J	Shimada, T; Yoshida, T; Yamagata, K				Shimada, Tadayuki; Yoshida, Tomoyuki; Yamagata, Kanato			Neuritin mediates activity-dependent axonal branching in hippocampal granule cells	INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE			English	Meeting Abstract	Joint Meeting of the 20th Biennial Meeting of the International-Society-for-Developmental-Neuroscience / 5th Annual NeuroDevNet Brain Development Conference	JUL 19-24, 2014	Montreal, CANADA	Int Soc Dev Neuroscience					[Shimada, Tadayuki; Yamagata, Kanato] Tokyo Metropolitan Inst Med Sci, Neural Plast Project, Tokyo 113, Japan; [Yoshida, Tomoyuki] Toyama Univ, Dept Mol Neurosci, Toyama 930, Japan								0	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0736-5748	1873-474X		INT J DEV NEUROSCI	Int. J. Dev. Neurosci.	DEC	2015	47		A		SI		38	38		10.1016/j.ijdevneu.2015.04.110		1	Developmental Biology; Neurosciences	Developmental Biology; Neurosciences & Neurology	CY6QT	WOS:000366534600100		
J	Hayashi, K; Kitazawa, A; Kubo, KI; Matsunaga, Y; Ishii, K; Nakajima, K				Hayashi, Kanehiro; Kitazawa, Ayako; Kubo, Ken-ichiro; Matsunaga, Yuki; Ishii, Kazuhiro; Nakajima, Kazunori			Climbing mode of migration: A novel migration mode of pyramidal neurons in the developing hippocampus	INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE			English	Meeting Abstract	Joint Meeting of the 20th Biennial Meeting of the International-Society-for-Developmental-Neuroscience / 5th Annual NeuroDevNet Brain Development Conference	JUL 19-24, 2014	Montreal, CANADA	Int Soc Dev Neuroscience					[Hayashi, Kanehiro; Kitazawa, Ayako; Kubo, Ken-ichiro; Matsunaga, Yuki; Ishii, Kazuhiro; Nakajima, Kazunori] Keio Univ, Dept Anat, Sch Med, Tokyo 108, Japan								0	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0736-5748	1873-474X		INT J DEV NEUROSCI	Int. J. Dev. Neurosci.	DEC	2015	47		A		SI		49	49		10.1016/j.ijdevneu.2015.04.138		1	Developmental Biology; Neurosciences	Developmental Biology; Neurosciences & Neurology	CY6QT	WOS:000366534600128		
J	Deguchi, K; Kubo, K; Armstrong, DL; Nakajima, K; Inoue, K				Deguchi, K.; Kubo, K.; Armstrong, D. L.; Nakajima, K.; Inoue, K.			Abnormal neuronal migration with ischemic brain injury in extremely preterm infants underlies subsequent cognitive impairment	INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE			English	Meeting Abstract	Joint Meeting of the 20th Biennial Meeting of the International-Society-for-Developmental-Neuroscience / 5th Annual NeuroDevNet Brain Development Conference	JUL 19-24, 2014	Montreal, CANADA	Int Soc Dev Neuroscience					[Deguchi, K.] Deguchi Pediat Clin, Tokyo, Japan; [Deguchi, K.; Inoue, K.] Natl Ctr Neurol & Psychiat, Tokyo, Japan; [Deguchi, K.; Kubo, K.; Nakajima, K.] Keio Univ, Sch Med, Tokyo 108, Japan; [Armstrong, D. L.] Baylor Coll Med, Houston, TX 77030 USA		kimikod118@gmail.com						0	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0736-5748	1873-474X		INT J DEV NEUROSCI	Int. J. Dev. Neurosci.	DEC	2015	47		A		SI		58	59		10.1016/j.ijdevneu.2015.04.164		2	Developmental Biology; Neurosciences	Developmental Biology; Neurosciences & Neurology	CY6QT	WOS:000366534600154		
J	Azuma, R; Deeley, Q; Campbell, LE; Daly, EM; Stevens, AF; Brammer, MJ; Ambery, FZ; Owen, MJ; Murphy, KC; Murphy, DGM				Azuma, Rayna; Deeley, Quinton; Campbell, Linda E.; Daly, Eileen M.; Stevens, Angela F.; Brammer, Michael J.; Ambery, Fiona Z.; Owen, Michael J.; Murphy, Kieran C.; Murphy, Declan G. M.			An fMRI study of facial emotion processing in children and adolescents with 22q11.2 deletion syndrome	INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE			English	Meeting Abstract	Joint Meeting of the 20th Biennial Meeting of the International-Society-for-Developmental-Neuroscience / 5th Annual NeuroDevNet Brain Development Conference	JUL 19-24, 2014	Montreal, CANADA	Int Soc Dev Neuroscience					[Azuma, Rayna] Waseda Univ, Tokyo, Japan; [Azuma, Rayna; Deeley, Quinton; Campbell, Linda E.; Daly, Eileen M.; Stevens, Angela F.; Brammer, Michael J.; Ambery, Fiona Z.; Murphy, Declan G. M.] Kings Coll London, Inst Psychiat, London WC2R 2LS, England; [Campbell, Linda E.] Univ Newcastle, Ctr Brain & Mental Hlth Res, Callaghan, NSW 2308, Australia; [Owen, Michael J.] Cardiff Univ, Dept Psychol Med, Cardiff CF10 3AX, S Glam, Wales; [Murphy, Kieran C.] Beaumont Hosp, Royal Coll Surg Ireland, Dept Psychiat, Dublin 9, Ireland								0	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0736-5748	1873-474X		INT J DEV NEUROSCI	Int. J. Dev. Neurosci.	DEC	2015	47		A		SI		63	63		10.1016/j.ijdevneu.2015.04.175		1	Developmental Biology; Neurosciences	Developmental Biology; Neurosciences & Neurology	CY6QT	WOS:000366534600165		
J	Hoshino, M; Seto, Y; Nakatani, T; Kawaguchi, Y; Ikenaka, K; Takebayashi, H; Ono, Y; Yamada, M				Hoshino, Mikio; Seto, Yusuke; Nakatani, Tomoya; Kawaguchi, Yoshiya; Ikenaka, Kazuhiro; Takebayashi, Hirohide; Ono, Yuichi; Yamada, Mayumi			Spatiotemporal regulation of neural progenitor identities by transcription factors	INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE			English	Meeting Abstract	Joint Meeting of the 20th Biennial Meeting of the International-Society-for-Developmental-Neuroscience / 5th Annual NeuroDevNet Brain Development Conference	JUL 19-24, 2014	Montreal, CANADA	Int Soc Dev Neuroscience					[Hoshino, Mikio; Seto, Yusuke; Yamada, Mayumi] Natl Ctr Neurol & Psychiat, Tokyo, Japan; [Nakatani, Tomoya; Ono, Yuichi] KAN Res Inst, Tokyo, Japan; [Kawaguchi, Yoshiya] Kyoto Univ, Kyoto 6068501, Japan; [Ikenaka, Kazuhiro] Natl Inst Physiol Sci, Tokyo, Japan; [Takebayashi, Hirohide] Niigata Univ, Niigata 95021, Japan		hoshino@ncnp.go.jp						0	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0736-5748	1873-474X		INT J DEV NEUROSCI	Int. J. Dev. Neurosci.	DEC	2015	47		A		SI		70	71		10.1016/j.ijdevneu.2015.04.193		2	Developmental Biology; Neurosciences	Developmental Biology; Neurosciences & Neurology	CY6QT	WOS:000366534600183		
J	Kim, J; Son, Y; Kim, J; Lee, S; Kang, S; Park, K; Kim, SH; Kim, JC; Kim, J; Takayama, C; Im, HI; Yang, M; Shin, T; Moon, C				Kim, Jinwook; Son, Yeonghoon; Kim, Juhwan; Lee, Sueun; Kang, Sohi; Park, Kyunghwan; Kim, Sung-Ho; Kim, Jong-Choon; Kim, Jeongtae; Takayama, Chitoshi; Im, Heh-In; Yang, Miyoung; Shin, Taekyun; Moon, Changjong			Developmental and degenerative modulation of GABAergic transmission in the mouse hippocampus	INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE			English	Article						GABAergic transmission; Hippocampus; Neurodegeneration; Postnatal development; Trimethyltin	GAMMA-AMINOBUTYRIC-ACID; VESICULAR GABA TRANSPORTER; TEMPORAL-LOBE EPILEPSY; SUBUNIT MESSENGER-RNAS; INDUCED NEURONAL DAMAGE; TIME QUANTITATIVE PCR; POSTNATAL-DEVELOPMENT; RECEPTOR SUBUNITS; DENTATE GYRUS; RAT-BRAIN	gamma-Aminobutyric acid (GABA) is the main inhibitory neurotransmitter involved in synaptic plasticity. GABAergic transmission is also implicated in developmental and degenerative processes in the brain. The goal of the present study was to understand the developmental and degenerative regulation of GABAergic transmission in the mouse hippocampus by examining changes in GABA receptor subunit mRNA levels and GABA-related protein expression during postnatal development of the hippocampus and trimethyltin (TMT)-induced neurodegeneration in the juvenile (postnatal day [PD] 24) and adult hippocampus (PD 56). During postnatal development, the mRNA levels of GABA A receptor (GABA(A)R) subunits, including alpha 1, alpha 4, beta 1, beta 2, and delta; GABA B receptor (GABA(B)R) subunit 2; and the expression of GABA-related proteins, including glutamic acid decarboxylase, vesicular GABA transporter (VGAT), and potassium chloride cotransporter 2 increased gradually in the mouse hippocampus. The results of seizure scoring and histopathological findings in the hippocampus revealed a more pronounced response to the same administered TMT dose in juvenile mice, compared with that in adult mice. The mRNA levels of most GABA receptor subunits in the juvenile hippocampus, excluding GABA(A)R subunit beta 3, were dynamically altered after TMT treatment. The mRNA levels of GABA(A)R subunits gamma 2 and delta decreased significantly in the adult hippocampus following TMT treatment, whereas the level of GABA(B)R subunit 1 mRNA increased significantly. Among the GABA-related proteins, only VGAT decreased significantly in the juvenile and adult mouse hippocampus after TMT treatment. In conclusion, regulation of GABAergic signaling in the mouse hippocampus may be related to maturation of the central nervous system and the degree of neurodegeneration during postnatal development and TMT-induced neurodegeneration in the experimental animals. (C) 2015 Elsevier Ltd. All rights reserved.	[Kim, Jinwook; Son, Yeonghoon; Kim, Juhwan; Lee, Sueun; Kang, Sohi; Park, Kyunghwan; Kim, Sung-Ho; Kim, Jong-Choon; Moon, Changjong] Chonnam Natl Univ, Dept Vet Anat, Coll Vet Med, Kwangju 500757, South Korea; [Kim, Jinwook; Son, Yeonghoon; Kim, Juhwan; Lee, Sueun; Kang, Sohi; Park, Kyunghwan; Kim, Sung-Ho; Kim, Jong-Choon; Moon, Changjong] Chonnam Natl Univ, Dept Vet Toxicol, Coll Vet Med, Kwangju 500757, South Korea; [Kim, Jinwook; Son, Yeonghoon; Kim, Juhwan; Lee, Sueun; Kang, Sohi; Park, Kyunghwan; Kim, Sung-Ho; Kim, Jong-Choon; Moon, Changjong] Chonnam Natl Univ, Anim Med Inst, Kwangju 500757, South Korea; [Kim, Juhwan; Im, Heh-In] Korea Inst Sci & Technol, Ctr Neurosci, Seoul 136791, South Korea; [Kim, Jeongtae; Takayama, Chitoshi] Univ Ryukyus, Fac Med, Dept Mol Anat, Okinawa 9030215, Japan; [Yang, Miyoung] Wonkwang Univ, Sch Med, Dept Anat, Iksan 570749, Jeonbuk, South Korea; [Shin, Taekyun] Jeju Natl Univ, Coll Vet Med, Dept Vet Anat, Jeju 690756, South Korea	Moon, C (reprint author), Chonnam Natl Univ, Dept Vet Anat, Coll Vet Med, Kwangju 500757, South Korea.	shint@jejunu.ac.kr; moonc@chonnam.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning, Republic of Korea [NRF-2012R1A1B4001262]; Animal Medical Institute of Chonnam National University	The animal experiment in this study was supported by the Animal Medical Institute of Chonnam National University. This work was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning, Republic of Korea (NRF-2012R1A1B4001262).	GUNTHER U, 1995, P NATL ACAD SCI USA, V92, P7749, DOI 10.1073/pnas.92.17.7749; POULTER MO, 1992, J NEUROSCI, V12, P2888; Ghose S, 2011, BRIT J PHARMACOL, V162, P1, DOI 10.1111/j.1476-5381.2010.01004.x; Nishimura T, 2001, MOL BRAIN RES, V97, P1, DOI 10.1016/S0169-328X(01)00278-9; Takayama C, 2006, NEUROSCIENCE, V143, P757, DOI 10.1016/j.neuroscience.2006.08.044; ERLANDER MG, 1991, NEURON, V7, P91, DOI 10.1016/0896-6273(91)90077-D; Chaudhry FA, 1998, J NEUROSCI, V18, P9733; Whiting PJ, 2003, DRUG DISCOV TODAY, V8, P445, DOI 10.1016/S1359-6446(03)02703-X; Bruccoleri A, 1999, J NEUROSCI RES, V57, P916, DOI 10.1002/(SICI)1097-4547(19990915)57:6<916::AID-JNR17>3.0.CO;2-J; Martin SC, 2004, J COMP NEUROL, V473, P16, DOI 10.1002/cne.20094; Fritschy JM, 2004, J COMP NEUROL, V477, P235, DOI 10.1002/cne.20188; Kuner R, 1999, SCIENCE, V283, P74, DOI 10.1126/science.283.5398.74; BERTRAM EH, 1994, BRAIN RES, V661, P157, DOI 10.1016/0006-8993(94)91192-4; Zuo ZH, 2009, AQUAT TOXICOL, V92, P44, DOI 10.1016/j.aquatox.2009.01.008; Brooks-Kayal AR, 2001, J NEUROCHEM, V77, P1266, DOI 10.1046/j.1471-4159.2001.00329.x; Asada H, 1997, P NATL ACAD SCI USA, V94, P6496, DOI 10.1073/pnas.94.12.6496; Fritschy JM, 1999, NEUROCHEM INT, V34, P435, DOI 10.1016/S0197-0186(99)00040-6; Lee S, 2014, ACTA HISTOCHEM, V116, P1276, DOI 10.1016/j.acthis.2014.07.009; FRITSCHY JM, 1995, J COMP NEUROL, V359, P154, DOI 10.1002/cne.903590111; Walls AB, 2010, J NEUROCHEM, V115, P1398, DOI 10.1111/j.1471-4159.2010.07043.x; Behar TN, 1996, J NEUROSCI, V16, P1808; Lattanzi W, 2013, INT J MOL SCI, V14, P16817, DOI 10.3390/ijms140816817; Asada H, 1996, BIOCHEM BIOPH RES CO, V229, P891, DOI 10.1006/bbrc.1996.1898; Pathak HR, 2007, J NEUROSCI, V27, P14012, DOI 10.1523/JNEUROSCI.4390-07.2007; Dupuy ST, 1996, J NEUROSCI, V16, P6919; Galanopoulou AS, 2008, CURR NEUROPHARMACOL, V6, P1, DOI 10.2174/157015908783769653; Patel AB, 2006, J NEUROCHEM, V97, P385, DOI 10.1111/j.1471-4159.2006.03741.x; Taketo M, 2000, NEUROSCIENCE, V96, P507, DOI 10.1016/S0306-4522(99)00574-6; Furtinger S, 2003, MOL BRAIN RES, V113, P107, DOI 10.1016/S0169-328X(03)00097-4; Rudolph U, 2006, CURR OPIN PHARMACOL, V6, P18, DOI 10.1016/j.coph.2005.10.003; GREIF KF, 1991, NEUROCHEM RES, V16, P235, DOI 10.1007/BF00966086; CULIAT CT, 1994, P NATL ACAD SCI USA, V91, P2815, DOI 10.1073/pnas.91.7.2815; Houser CR, 2007, PROG BRAIN RES, V163, P217, DOI 10.1016/S0079-6123(07)63013-1; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; O'Toole KK, 2014, EPILEPSY RES, V108, P29, DOI 10.1016/j.eplepsyres.2013.10.013; BESSER R, 1987, NEUROLOGY, V37, P945; Berg DA, 2013, DEVELOPMENT, V140, P2548, DOI 10.1242/dev.088005; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; FREEMAN JH, 1994, BRAIN RES, V634, P85, DOI 10.1016/0006-8993(94)90261-5; Ikonomidou C, 2001, BIOCHEM PHARMACOL, V62, P401, DOI 10.1016/S0006-2952(01)00696-7; Son Y, 2015, NEUROBIOL LEARN MEM, V121, P12, DOI 10.1016/j.nlm.2015.03.002; Kang TC, 2003, NEUROSCI LETT, V335, P207, DOI 10.1016/S0304-3940(02)01166-7; FRITSCHY JM, 1994, J NEUROSCI, V14, P5302; Ganguly K, 2001, CELL, V105, P521, DOI 10.1016/S0092-8674(01)00341-5; Stein V, 2004, J COMP NEUROL, V468, P57, DOI 10.1002/cne.10983; GREIF KF, 1992, DEV BIOL, V153, P158, DOI 10.1016/0012-1606(92)90100-U; Ishida N, 1997, NEUROSCIENCE, V81, P1183, DOI 10.1016/S0306-4522(97)00220-0; Barnard EA, 1998, PHARMACOL REV, V50, P291; Ben-Ari Y, 2006, LANCET NEUROL, V5, P1055, DOI 10.1016/S1474-4422(06)70626-3; Owens DF, 2002, NAT REV NEUROSCI, V3, P715, DOI 10.1038/nrn919; RICE JE, 1981, ANN NEUROL, V9, P131, DOI 10.1002/ana.410090206; Ben-Ari Y, 2007, PHYSIOL REV, V87, P1215, DOI 10.1152/physrev.00017.2006; Minelli A, 2003, NEUROSCIENCE, V117, P337, DOI 10.1016/S0306-4522(02)00864-3; Tretter V, 1997, J NEUROSCI, V17, P2728; NITECKA L, 1984, NEUROSCIENCE, V13, P1073, DOI 10.1016/0306-4522(84)90289-6; Yang M, 2012, NEUROCHEM INT, V61, P955, DOI 10.1016/j.neuint.2012.09.015; Sieghart W, 1999, NEUROCHEM INT, V34, P379, DOI 10.1016/S0197-0186(99)00045-5; Plotkin MD, 1997, J NEUROBIOL, V33, P781, DOI 10.1002/(SICI)1097-4695(19971120)33:6<781::AID-NEU6>3.0.CO;2-5; McIntire SL, 1997, NATURE, V389, P870; NAALSUND LU, 1985, NEUROTOXICOLOGY, V6, P145; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Yoneyama M, 2008, NEUROCHEM INT, V52, P761, DOI 10.1016/j.neuint.2007.09.003; Bovetti S, 2011, J CHEM NEUROANAT, V42, P304, DOI 10.1016/j.jchemneu.2011.05.006; HENDRICKSON AE, 1994, J COMP NEUROL, V343, P566, DOI 10.1002/cne.903430407; MARTIN DL, 1993, J NEUROCHEM, V60, P395, DOI 10.1111/j.1471-4159.1993.tb03165.x; Takayama C, 2004, NEUROSCI RES, V50, P447, DOI 10.1016/j.neures.2004.08.012; Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348; Olsen RW, 1997, EPILEPSIA, V38, P399, DOI 10.1111/j.1528-1157.1997.tb01728.x; BARBIN G, 1993, NEUROSCI LETT, V152, P150, DOI 10.1016/0304-3940(93)90505-F; Gambardella A, 2003, NEUROLOGY, V60, P560; Tian N, 1999, P NATL ACAD SCI USA, V96, P12911, DOI 10.1073/pnas.96.22.12911; SAXENA NC, 1994, J NEUROSCI, V14, P7077; Liu YJ, 1997, ANNU REV NEUROSCI, V20, P125; Watanabe M, 2009, J BIOL CHEM, V284, P27980, DOI 10.1074/jbc.M109.043620; BALABAN CD, 1988, NEUROSCIENCE, V26, P337, DOI 10.1016/0306-4522(88)90150-9; Haas KZ, 1996, J NEUROSCI, V16, P4250; Rudolph U, 2004, ANNU REV PHARMACOL, V44, P475, DOI 10.1146/annurev.pharmtox.44.101802.121429; Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8; Bettler B, 2004, PHYSIOL REV, V84, P835, DOI 10.1152/physrev.00036.2003.; Eiden LE, 2000, FASEB J, V14, P2396, DOI 10.1096/fj.00-0817rev; LAURIE DJ, 1992, J NEUROSCI, V12, P4151; Brooks-Kayal AR, 1998, NAT MED, V4, P1166, DOI 10.1038/2661; SMITH GB, 1995, TRENDS PHARMACOL SCI, V16, P162, DOI 10.1016/S0165-6147(00)89009-4; Kruger K, 2005, BRIT J PHARMACOL, V144, P283, DOI 10.1038/sj.bjp.0706083; Ben-Ari Y, 2012, NEUROSCIENTIST, V18, P467, DOI 10.1177/1073858412438697; Hortnagl H, 2013, NEUROSCIENCE, V236, P345, DOI 10.1016/j.neuroscience.2013.01.008; Rivera C, 1999, NATURE, V397, P251; Vinay L, 2008, BRAIN RES REV, V57, P103, DOI 10.1016/j.brainresrev.2007.09.003; Kim J, 2014, ACTA HISTOCHEM, V116, P1490, DOI 10.1016/j.acthis.2014.09.003; Arslan A., 2014, J INTEGR NEUROSCI, P1; BENARI Y, 1989, J PHYSIOL-LONDON, V416, P303; Briggs S.W., 2011, NEURAL PLAST, V2011; Egawa K, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00170; Kim J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070356; Kim J, 2014, INT J DEV NEUROSCI, V38, P68, DOI 10.1016/j.ijdevneu.2014.08.001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Pallotto M, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00166; Sieghart W., 2002, Current Topics in Medicinal Chemistry, V2, P795, DOI 10.2174/1568026023393507; Van Liefferinge J., 2013, FRONT CELL NEUROSCI, V7	100	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0736-5748	1873-474X		INT J DEV NEUROSCI	Int. J. Dev. Neurosci.	DEC	2015	47		B				320	332		10.1016/j.ijdevneu.2015.08.009		13	Developmental Biology; Neurosciences	Developmental Biology; Neurosciences & Neurology	CY6QU	WOS:000366534700021		
J	Shimizu, M; Usui, H; Yamane, K; Sakata, T; Nokami, T; Itoh, T; Sakaguchi, H				Shimizu, Masahiro; Usui, Hiroyuki; Yamane, Kazuya; Sakata, Takuma; Nokami, Toshiki; Itoh, Toshiyuki; Sakaguchi, Hiroki			Electrochemical Na-Insertion/Extraction Properties of Phosphorus Electrodes in Ionic Liquid Electrolytes	INTERNATIONAL JOURNAL OF ELECTROCHEMICAL SCIENCE			English	Article						Phosphorus; Na-ion battery; Thick-film electrode; Ionic liquid electrolyte; Gas deposition	THICK-FILM ANODES; HIGH-CAPACITY; GAS-DEPOSITION; HARD-CARBON; NEGATIVE ELECTRODES; BATTERIES; COMPOSITE; STORAGE; BIS(FLUOROSULFONYL)AMIDE; TEMPERATURES	The electrochemical Na-insertion/extraction properties of phosphorus as a Na-ion battery anode in ionic liquid electrolytes were investigated by using a thick film without any binder or conductive additive. The ionic liquid with more electrochemically-stable cation structure, 1-((2-methoxyethoxy) methyl)-1-methylpyrrolidinium bis(fluorosulfonyl) amide (PylMEM-FSA), delivered a high reversible capacity of 310 mA h g(-1) at the 100th cycle, whereas the phosphorus electrode in 1-ethyl-3-methylimidazolium bis(fluorosulfonyl) amide (EMI-FSA) showed a low capacity of only 110 mA h g(-1). It was revealed that disintegration of the electrode after cycling was effectively suppressed by applying PylMEM-FSA instead of an organic electrolyte including propylene carbonate (PC), and that a surface layer induced by the decomposition of EMI-FSA hindered Na-insertion into the active material layer. The performance obtained in PylMEM-FSA was very superior to that in PC. We applied for the first time a closed-system fire-resistance test to the ionic liquid electrolyte for quantitatively evaluating its non-flammability. The PylMEM-FSA-based electrolyte exhibited an excellent fire resistance in comparison with the PC-based organic electrolyte, which can be an advantage for realizing a Na-ion battery with a high-energy density and a high safety.	[Shimizu, Masahiro; Usui, Hiroyuki; Yamane, Kazuya; Sakata, Takuma; Nokami, Toshiki; Itoh, Toshiyuki; Sakaguchi, Hiroki] Tottori Univ, Grad Sch Engn, Dept Chem & Biotechnol, Koyama, Tottori 6808552, Japan; [Shimizu, Masahiro; Usui, Hiroyuki; Yamane, Kazuya; Sakata, Takuma; Nokami, Toshiki; Itoh, Toshiyuki; Sakaguchi, Hiroki] Tottori Univ, Ctr Res Green Sustainable Chem, Koyama, Tottori 6808552, Japan	Shimizu, M (reprint author), Tottori Univ, Grad Sch Engn, Dept Chem & Biotechnol, 4-101 Minami, Koyama, Tottori 6808552, Japan.	sakaguch@chem.tottori-u.ac.jp			Adaptable and Seamless Technology Transfer Program from Japan Science and Technology Agency (JST); Japan Society for the Promotion of Science (JSPS) [2611485]	This work was supported in part by the Adaptable and Seamless Technology Transfer Program through target-driven R&D funding from the Japan Science and Technology Agency (JST). M. Shimizu thanks Japan Society for the Promotion of Science (JSPS) for research fellowship (No. 2611485). The authors appreciate Dr. H. Furutani (KANEKA Co., Japan) and Mr. K. Matsumoto for supplying chemicals and synthesis of ionic liquids, respectively.	Tsunashima K, 2007, ELECTROCHEM COMMUN, V9, P2353, DOI 10.1016/j.elecom.2007.07.003; Shimizu M, 2015, J PHYS CHEM C, V119, P2975, DOI 10.1021/jp5121965; Fukunaga A, 2014, J POWER SOURCES, V246, P387, DOI 10.1016/j.jpowsour.2013.07.112; Yamagata M, 2013, ELECTROCHIM ACTA, V110, P181, DOI 10.1016/j.electacta.2013.03.018; Dahbi M, 2014, PHYS CHEM CHEM PHYS, V16, P15007, DOI 10.1039/c4cp00826j; Ellis LD, 2014, J ELECTROCHEM SOC, V161, pA416, DOI 10.1149/2.080403jes; VANDERBORGH CA, 1989, PHYS REV B, V40, P9595, DOI 10.1103/PhysRevB.40.9595; Kim Y, 2013, ADV MATER, V25, P3045, DOI 10.1002/adma.201204877; Kosters J, 2013, J PHYS CHEM B, V117, P2527, DOI 10.1021/jp311563h; Shimizu M, 2014, J ELECTROCHEM SOC, V161, pA1765, DOI 10.1149/2.0021412jes; Usui H, 2012, CHEM LETT, V41, P521, DOI 10.1246/cl.2012.521; Darwiche A, 2012, J AM CHEM SOC, V134, P20805, DOI 10.1021/ja310347x; Matsumoto H, 2006, J POWER SOURCES, V160, P1308, DOI 10.1016/j.jpowsour.2006.02.018; Datta MK, 2013, J POWER SOURCES, V225, P316, DOI 10.1016/j.jpowsour.2012.10.014; Cao YL, 2012, NANO LETT, V12, P3783, DOI 10.1021/nl3016957; Ponrouch A, 2012, ENERG ENVIRON SCI, V5, P8572, DOI 10.1039/c2ee22258b; Yamamoto T, 2012, J POWER SOURCES, V217, P479, DOI 10.1016/j.jpowsour.2012.05.110; Ponrouch A, 2013, ELECTROCHEM COMMUN, V27, P85, DOI 10.1016/j.elecom.2012.10.038; Qian JF, 2013, ANGEW CHEM INT EDIT, V52, P4633, DOI 10.1002/anie.201209689; Monti D, 2014, J POWER SOURCES, V245, P630, DOI 10.1016/j.jpowsour.2013.06.153; Usui H, 2013, J POWER SOURCES, V235, P29, DOI 10.1016/j.jpowsour.2013.01.188; Usui H, 2012, THIN SOLID FILMS, V520, P7006, DOI 10.1016/j.tsf.2012.07.093; Buzzeo MC, 2004, CHEMPHYSCHEM, V5, P1106, DOI 10.1002/cphc.200301017; Shimizu M, 2014, J POWER SOURCES, V248, P378, DOI 10.1016/j.jpowsour.2013.09.046; Matsushita T, 2013, MATER EXPRESS, V3, P30, DOI 10.1166/mex.2013.1095; Li WJ, 2013, NANO LETT, V13, P5480, DOI 10.1021/nl403053v; Komaba S, 2011, ADV FUNCT MATER, V21, P3859, DOI 10.1002/adfm.201100854; Wongittharom N, 2014, ACS APPL MATER INTER, V6, P17564, DOI 10.1021/am5033605; Sakaguchi H, 2007, ELECTROCHEM SOLID ST, V10, pJ146, DOI 10.1149/1.2772409; Sun Q, 2011, ELECTROCHEM COMMUN, V13, P1462, DOI 10.1016/j.elecom.2011.09.020; Kubota K, 2012, ELECTROCHIM ACTA, V66, P320, DOI 10.1016/j.electacta.2012.01.097; Qian JF, 2012, CHEM COMMUN, V48, P7070, DOI 10.1039/c2cc32730a; Lombardo L, 2013, J POWER SOURCES, V227, P8, DOI 10.1016/j.jpowsour.2012.11.017; Nokami T, 2014, ORG PROCESS RES DEV, V18, P1367, DOI 10.1021/op500131u	34	0	0	ESG	BELGRADE	BORIVOJA STEVANOVICA 25-7, BELGRADE, 11000, SERBIA	1452-3981			INT J ELECTROCHEM SC	Int. J. Electrochem. Sci.	DEC	2015	10	12					10132	10144				13	Electrochemistry	Electrochemistry	CY3KA	WOS:000366307100029		
J	Murayama, M; Sasaki, K; Shibahara, T				Murayama, M.; Sasaki, K.; Shibahara, T.			Electrophysiological evaluation of nerve function in inferior alveolar nerve injury: relationship between nerve action potentials and histomorphometric observations	INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Article						inferior alveolar nerve injury; nerve injury; action potential (SNAP); conduction velocity (SCV)	SAGITTAL SPLIT OSTEOTOMY; PERIPHERAL-NERVES; CONDUCTION-VELOCITY; DORSAL ROOTS; RATS	The objective of this study was to improve the accuracy of diagnosis of inferior alveolar nerve (IAN) injury by determining degrees of nerve disturbance using the sensory nerve action potential (SNAP) and sensory nerve conduction velocity (SCV). Crush and partial and complete nerve amputation injuries were applied to the IAN of rabbits, then SNAPs and histomorphometric observations were recordedat 1, 5, and 10 weeks. For crush injury, most nerves were smaller in diameter at 5 weeks than at 1 week, however after 10 weeks, extensive nerve regeneration was observed. The SNAP showed a decrease in SCV at weeks 1 and 5, followed by an increase at week 10. For partial nerve amputation, small to medium-sized nerve fibres were observed at weeks 1 and 5, then larger nerves were seen at week 10. Minimal changes in SCV were observed at weeks 1 and 5, however SCV increased at week 10. For complete nerve amputation, nerve fibres were sparse at week 1, but gradual nerve regeneration was observed at weeks 5 and 10. SNAPs were detectable from week 10, however the SCV was extremely low. This study showed SCV to be an effective factor in the evaluation of nerve injury and regeneration.	[Murayama, M.; Sasaki, K.; Shibahara, T.] Tokyo Dent Coll, Dept Oral & Maxillofacial Surg, Tokyo, Japan; [Sasaki, K.] Sasaki Dent Oral & Maxillofacial Care Clin, Chiba, Japan	Murayama, M (reprint author), Tokyo Dent Coll, Dept Oral & Maxillofacial Surg, Chiyoda Ku, 2-9-18 Misakichou, Tokyo, Japan.	murayamamasato@tdc.ac.jp					BENECKE R, 1980, J NEUROL, V223, P231, DOI 10.1007/BF00313337; Mazzer PYCN, 2008, J NEUROSCI METH, V173, P249, DOI 10.1016/j.jneumeth.2008.06.019; NORDIN M, 1984, PAIN, V20, P231, DOI 10.1016/0304-3959(84)90013-7; WALL PD, 1974, EXP NEUROL, V43, P580, DOI 10.1016/0014-4886(74)90197-6; Jaaskelainen SK, 1999, MUSCLE NERVE, V22, P455, DOI 10.1002/(SICI)1097-4598(199904)22:4<455::AID-MUS5>3.0.CO;2-A; Poort LJ, 2009, J ORAL MAXIL SURG, V67, P292, DOI 10.1016/j.joms.2008.06.076; Antonarakis GS, 2012, J ORAL MAXIL SURG, V70, P2752, DOI 10.1016/j.joms.2012.08.002; Teerijoki-Oksa T, 2003, INT J ORAL MAX SURG, V32, P15, DOI 10.1054/ijom.2002.0325; Sugimoto Y, 2002, J PERIPHER NERV SYST, V7, P104, DOI 10.1046/j.1529-8027.2002.02017.x; YAMAZAKI Y, 1983, J ORAL MAXIL SURG, V41, P34; ZUNIGA JR, 1987, INT J ORAL MAX SURG, V16, P465, DOI 10.1016/S0901-5027(87)80086-3; OLSSON Y, 1973, ACTA NEUROPATHOL, V23, P105; Mambelli E, 2012, CLIN NEPHROL, V77, P468, DOI 10.5414/CN107188; Barron KD, 1989, FRONTIERS CLIN NEURO, V6, P79; Cravioto H, 1966, Bull Los Angeles Neurol Soc, V31, P196; DEVOR M, 1990, J NEUROPHYSIOL, V64, P1733; Donoff RB, 1995, REV ORAL BIOL MED, V6, P18; Gordon T., 1983, SOMATIC AUTONOMIC NE, P289; Hursh JB, 1939, AM J PHYSIOL, V127, P131; Kamei T, 1988, JPN J ORAL MAXILLOFA, V34, P1584; Lundborg G, 1988, NERVE INJURY REPAIR, P149; MATSUDA Y, 1980, Shikwa Gakuho, V80, P1267; MATSUDA Y, 1980, Shikwa Gakuho, V80, P1591; Mondelli M, 2012, CLIN NEUROPHYSIOL, V17, P551; SASAKI K, 1983, Shikwa Gakuho, V83, P249; Sasaki K, 1986, JAPAN J ORAL SURG, V32, P1139; Seil FJ, 1989, FRONTIERS CLIN NEURO, V6, P123; Sugiyama Noriko, 1999, Shikwa Gakuho, V99, P983; Tsukagoshi T, 2004, J SHOWA MED ASS, V64, P456; Zuniga JR, 1989, J ORAL MAXILLOFAC S, V47, P102, DOI 10.1016/0278-2391(89)90621-6	30	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0901-5027	1399-0020		INT J ORAL MAX SURG	Int. J. Oral Maxillofac. Surg.	DEC	2015	44	12					1529	1539		10.1016/j.ijom.2015.09.004		11	Dentistry, Oral Surgery & Medicine; Surgery	Dentistry, Oral Surgery & Medicine; Surgery	CY7VT	WOS:000366618100015		
J	Kakehashi, H; Ando, T; Minamizato, T; Nakatani, Y; Kawasaki, T; Ikeda, H; Kuroshima, S; Kawakami, A; Asahina, I				Kakehashi, H.; Ando, T.; Minamizato, T.; Nakatani, Y.; Kawasaki, T.; Ikeda, H.; Kuroshima, S.; Kawakami, A.; Asahina, I.			Administration of teriparatide improves the symptoms of advanced bisphosphonate-related osteonecrosis of the jaw: preliminary findings	INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Article						teriparatide; bisphosphonate; osteonecrosis; jaw; osteoporosis	CANCER-TREATMENT; BONE METASTASES; RISK-FACTORS; OSTEOPOROSIS; MANAGEMENT; THERAPY; ALENDRONATE; PTH	Teriparatide is a synthetic polypeptide hormone that contains the 1-34 amino acid fragment of the recombinant human parathyroid hormone that stimulates bone formation. Currently, it is approved only for the treatment of osteoporosis. The outcomes of daily teriparatide injections for the treatment of bisphosphonate-related osteonecrosis of the jaw in 10 patients are reported here. Two of the 10 cases dropped out due to adverse events. Of the remaining eight cases, seven exhibited clinical improvement of the jaw-related symptoms of osteonecrosis and progression of the sequestration, while one case did not show improvement of the symptoms. Administration of teriparatide in patients with osteonecrosis of the jaw promotes bone formation and subsequent sequestration over a short period of time. These results suggest that adjunctive teriparatide therapy is a viable and effective option for treating osteonecrosis of the jaw.	[Kakehashi, H.; Minamizato, T.; Nakatani, Y.; Kawasaki, T.; Ikeda, H.; Asahina, I.] Nagasaki Univ, Grad Sch Biomed Sci, Dept Regenerat Oral Surg, Nagasaki 8528588, Japan; [Ando, T.; Kawakami, A.] Nagasaki Univ, Grad Sch Biomed Sci, Dept Endocrinol & Metab, Nagasaki 8528588, Japan; [Kuroshima, S.] Nagasaki Univ, Grad Sch Biomed Sci, Dept Appl Prosthodont, Nagasaki 8528588, Japan	Asahina, I (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Regenerat Oral Surg, 1-7-1 Sakamoto, Nagasaki 8528588, Japan.	asahina@nagasaki-u.ac.jp			 [26463016]	This study was supported in part by a Grant-in-Aid from Scientific Research (C) (Research number 26463016).	Abu-Id MH, 2008, J CRANIO MAXILL SURG, V36, P95, DOI 10.1016/j.jcms.2007.06.008; Mauri D, 2009, BREAST CANCER RES TR, V116, P433, DOI 10.1007/s10549-009-0432-z; Oxlund H, 2006, BONE, V39, P244, DOI 10.1016/j.bone.2006.01.142; Marx RE, 2005, J ORAL MAXIL SURG, V63, P1567, DOI 10.1016/j.joms.2005.07.010; Khan AA, 2008, J RHEUMATOL, V35, P1391; Russell RGG, 2008, OSTEOPOROSIS INT, V19, P733, DOI 10.1007/s00198-007-0540-8; Miyauchi A, 2010, BONE, V47, P493, DOI 10.1016/j.bone.2010.05.022; Hayashi K, 2009, BIOCHEM BIOPH RES CO, V379, P261, DOI 10.1016/j.bbrc.2008.12.035; Harper RP, 2007, J ORAL MAXIL SURG, V65, P573, DOI 10.1016/j.joms.2006.10.076; Stanton DC, 2009, J ORAL MAXIL SURG, V67, P943, DOI 10.1016/j.joms.2008.12.057; Clemons M, 2012, CURR ONCOL, V19, P259, DOI 10.3747/co.19.1011; Hasegawa T, 2013, J CRANIO MAXILL SURG, V41, P558, DOI 10.1016/j.jcms.2012.11.023; Wilde F, 2011, ORAL SURG ORAL MED O, V111, P153, DOI 10.1016/j.tripleo.2010.04.015; Blick SKA, 2008, DRUGS, V68, P2709, DOI 10.2165/0003495-200868180-00012; McKeage K, 2008, PHARMACOECONOMICS, V26, P251; Cheung A, 2010, NEW ENGL J MED, V363, P2473, DOI 10.1056/NEJMc1002684; Kwon YD, 2012, OSTEOPOROSIS INT, V23, P2721, DOI 10.1007/s00198-011-1882-9; Subbiah V, 2010, OSTEOPOROSIS INT, V21, P1041, DOI 10.1007/s00198-009-1004-0; Marx RE, 2003, J ORAL MAXIL SURG, V61, P1115, DOI 10.1016/S0278-2391(03)00720-1; Coleman R, 2011, BREAST CANCER RES TR, V127, P429, DOI 10.1007/s10549-011-1429-y; [Anonymous], 2014, MED PACKAGE INSERT T; Coleman R, 2011, ANN NY ACAD SCI, V1218, P3, DOI 10.1111/j.1749-6632.2010.05766.x; Jiang YB, 2003, J BONE MINER RES, V18, P1932, DOI 10.1359/jbmr.2003.18.11.1932; Watts NB, 2010, J CLIN ENDOCR METAB, V95, P1555, DOI 10.1210/jc.2009-1947; Carlson ER, 2009, J ORAL MAXIL SURG, V67, P85, DOI 10.1016/j.joms.2009.01.006; Kwon YD, 2009, J ORAL MAXILLOFAC S, V67, P2; Lee JJ, 2010, HEAD NECK-J SCI SPEC, V33, P1366; Murphy DR, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-213; Tawfeek H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012290; Woo SB, 2006, ANN INTERN MED, V144, P753	30	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0901-5027	1399-0020		INT J ORAL MAX SURG	Int. J. Oral Maxillofac. Surg.	DEC	2015	44	12					1558	1564		10.1016/j.ijom.2015.07.018		7	Dentistry, Oral Surgery & Medicine; Surgery	Dentistry, Oral Surgery & Medicine; Surgery	CY7VT	WOS:000366618100018		
J	Bhawal, UK; Lee, HJ; Arikawa, K; Shimosaka, M; Suzuki, M; Toyama, T; Sato, T; Kawamata, R; Taguchi, C; Hamada, N; Nasu, I; Arakawa, H; Shibutani, K				Bhawal, Ujjal K.; Lee, Hye-Jin; Arikawa, Kazumune; Shimosaka, Michiharu; Suzuki, Masatoshi; Toyama, Toshizo; Sato, Takenori; Kawamata, Ryota; Taguchi, Chieko; Hamada, Nobushiro; Nasu, Ikuo; Arakawa, Hirohisa; Shibutani, Koh			Micromolar sodium fluoride mediates anti-osteoclastogenesis in Porphyromonas gingivalis-induced alveolar bone loss	INTERNATIONAL JOURNAL OF ORAL SCIENCE			English	Article						alveolar bone loss; osteoclasts; Porphyromonas gingivalis; sodium fluoride	PARATHYROID-HORMONE; CELL-CULTURES; CATHEPSIN K; IN-VITRO; DIFFERENTIATION; OSTEOPROTEGERIN; ACTIVATION; PERIODONTITIS; DEGRADATION; RESORPTION	Osteoclasts are bone-specific multinucleated cells generated by the differentiation of monocyte/macrophage lineage precursors. Regulation of osteoclast differentiation is considered an effective therapeutic approach to the treatment of bone-lytic diseases. Periodontitis is an inflammatory disease characterized by extensive bone resorption. In this study, we investigated the effects of sodium fluoride (NaF) on osteoclastogenesis induced by Porphyromonas gingivalis, an important colonizer of the oral cavity that has been implicated in periodontitis. NaF strongly inhibited the P. gingivalis-induced alveolar bone loss. That effect was accompanied by decreased levels of cathepsin K, interleukin (IL)-1 beta, matrix metalloproteinase 9 (MMP9), and tartrate-resistant acid phosphatase, which were up-regulated during P. gingivalis-induced osteoclastogenesis. Consistent with the in vivo anti-osteoclastogenic effect, NaF inhibited osteoclast formation caused by the differentiation factor RANKL (receptor activator of nuclear factor kappa B ligand) and macrophage colony-stimulating factor (M-CSF). The RANKL-stimulated induction of the transcription factor nuclear factor of activated T cells (NFAT) c1 was also abrogated by NaF. Taken together, our data demonstrate that NaF inhibits RANKL-induced osteoclastogenesis by reducing the induction of NFATc1, ultimately leading to the suppressed expression of cathepsin K and MMP9. The in vivo effect of NaF on the inhibition of P. gingivalis-induced osteoclastogenesis strengthens the potential usefulness of NaF for treating periodontal diseases.	[Bhawal, Ujjal K.] Nihon Univ, Sch Dent Matsudo, Dept Biochem & Mol Biol, Matsudo, Chiba 2718587, Japan; [Bhawal, Ujjal K.; Arikawa, Kazumune; Shimosaka, Michiharu; Suzuki, Masatoshi; Taguchi, Chieko; Nasu, Ikuo; Shibutani, Koh] Nihon Univ, Sch Dent Matsudo, Res Inst Oral Hlth, Matsudo, Chiba 2718587, Japan; [Bhawal, Ujjal K.; Arakawa, Hirohisa] Kanagawa Dent Univ, Grad Sch Dent, Dept Oral Hlth, Yokosuka, Kanagawa, Japan; [Lee, Hye-Jin] Howon Univ, Dept Dent Hyg, Gunsan, South Korea; [Arikawa, Kazumune; Taguchi, Chieko; Nasu, Ikuo; Shibutani, Koh] Nihon Univ, Sch Dent Matsudo, Dept Prevent & Publ Oral Hlth, Matsudo, Chiba 2718587, Japan; [Shimosaka, Michiharu; Suzuki, Masatoshi] Nihon Univ, Sch Dent Matsudo, Dept Anesthesiol, Matsudo, Chiba 2718587, Japan; [Toyama, Toshizo; Sato, Takenori; Hamada, Nobushiro] Kanagawa Dent Univ, Div Microbiol, Dept Infect Control, Yokosuka, Kanagawa, Japan; [Kawamata, Ryota] Kanagawa Dent Univ, Dept Radiopraxis Sci, Yokosuka, Kanagawa, Japan	Bhawal, UK (reprint author), Nihon Univ, Sch Dent Matsudo, Dept Biochem & Mol Biol, Nishi Ku, 2-870-1 Sakae Cho, Matsudo, Chiba 2718587, Japan.	bhawal.ujjal.kumar@nihon-u.ac.jp					KENWORTHY R, 1981, J CLIN PERIODONTOL, V8, P349, DOI 10.1111/j.1600-051X.1981.tb02044.x; Assuma R, 1998, J IMMUNOL, V160, P403; Drake FH, 1996, J BIOL CHEM, V271, P12511; Hall TJ, 1996, INFLAMM RES, V45, P1, DOI 10.1007/BF02263497; GEDALIA I, 1970, CALC TISS RES, V5, P146, DOI 10.1007/BF02017544; RICH C, 1961, NATURE, V191, P184, DOI 10.1038/191184a0; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Graves DT, 2003, J PERIODONTOL, V74, P391, DOI 10.1902/jop.2003.74.3.391; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; LEVY BM, 1970, J DENT RES, V49, P816, DOI 10.1177/00220345700490041901; MESSER HH, 1973, CALC TISS RES, V13, P227, DOI 10.1007/BF02015412; Gowen M, 1999, J BONE MINER RES, V14, P1654, DOI 10.1359/jbmr.1999.14.10.1654; Song I, 2009, FEBS LETT, V583, P2435, DOI 10.1016/j.febslet.2009.06.047; Oshita K, 2011, ARTHRITIS RHEUM-US, V63, P1658, DOI 10.1002/art.30309; Arakawa Y, 2009, BIOMED RES-TOKYO, V30, P271; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; ZIPKIN I, 1965, PERIODONTICS, V3, P111; Oguro A, 2003, IN VITRO CELL DEV-AN, V39, P243; Haffajee AD, 2006, PERIODONTOL 2000, V42, P7, DOI 10.1111/j.1600-0757.2006.00190.x; Liu R, 2006, J DENT RES, V85, P510; FARLEY JR, 1988, METABOLISM, V37, P988, DOI 10.1016/0026-0495(88)90158-8; DenBesten PK, 2002, ARCH ORAL BIOL, V47, P763, DOI 10.1016/S0003-9969(02)00117-6; Everts V, 2006, J BONE MINER RES, V21, P1399, DOI 10.1359/JBMR.060614; ENGLANDER HR, 1963, AM J PUBLIC HEALTH N, V53, P1233, DOI 10.2105/AJPH.53.8.1233; TAYLOR ML, 1989, ANAT EMBRYOL, V180, P427, DOI 10.1007/BF00305117; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Bellows CG, 1990, J BONE MINER RES, V5, P101; BOIVIN G, 1989, BONE, V10, P89, DOI 10.1016/8756-3282(89)90004-5; Debiński Andrzej, 2004, Ann Acad Med Stetin, V50 Suppl 1, P23; HOLT SC, 1988, SCIENCE, V239, P55, DOI 10.1126/science.3336774; OKUDA A, 1990, Journal of Bone and Mineral Research, V5, pS115; Teng YT, 2000, J CLIN INVEST, V106, P59; Turner CH, 1997, CALCIFIED TISSUE INT, V61, P77, DOI 10.1007/s002239900299; WERGEDAL JE, 1988, CLIN ORTHOP RELAT R, P274	34	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1674-2818	2049-3169		INT J ORAL SCI	Int. J. Oral Sci.	DEC	2015	7	4					242	249		10.1038/ijos.2015.28		8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CZ0NW	WOS:000366803000006		
J	Nagata, Y; Hiraoka, M; Shibata, T; Onishi, H; Kokubo, M; Karasawa, K; Shioyama, Y; Onimaru, R; Kozuka, T; Kunieda, E; Saito, T; Nakagawa, K; Hareyama, M; Takai, Y; Hayakawa, K; Mitsuhashi, N; Ishikura, S				Nagata, Yasushi; Hiraoka, Masahiro; Shibata, Taro; Onishi, Hiroshi; Kokubo, Masaki; Karasawa, Katsuyuki; Shioyama, Yoshiyuki; Onimaru, Rikiya; Kozuka, Takuyo; Kunieda, Etsuo; Saito, Tsutomu; Nakagawa, Keiichi; Hareyama, Masato; Takai, Yoshihiro; Hayakawa, Kazushige; Mitsuhashi, Norio; Ishikura, Satoshi			Prospective Trial of Stereotactic Body Radiation Therapy for Both Operable and Inoperable T1N0M0 Non-Small Cell Lung Cancer: Japan Clinical Oncology Group Study JCOG0403	INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS			English	Article							PROSPECTIVE PHASE-II; ABLATIVE RADIOTHERAPY; LOBECTOMY; OUTCOMES; RESECTION; TUMORS	Purpose: To evaluate, in Japan Clinical Oncology Group study 0403, the safety and efficacy of stereotactic body radiation therapy (SBRT) in patients with T1N0M0 non-small cell lung cancer (NSCLC). Methods and Materials: Eligibility criteria included histologically or cytologically proven NSCLC, clinical T1N0M0. Prescribed dose was 48 Gy at the isocenter in 4 fractions. The primary endpoint was the percent (%) 3-year overall survival. The threshold % 3-year survival to be rejected was set at 35% for inoperable patients, whereas the expected % 3-year survival was 80% for operable patients. Results: Between July 2004 and November 2008, 169 patients from 15 institutions were registered. One hundred inoperable and 64 operable patients (total 164) were eligible. Patients' characteristics were 122 male, 47 female; median age 78 years (range, 50-91 years); adenocarcinomas, 90; squamous cell carcinomas, 61; others, 18. Of the 100 inoperable patients, the % 3-year OS was 59.9% (95% confidence interval 49.6%-68.8%). Grade 3 and 4 toxicities were observed in 10 and 2 patients, respectively. No grade 5 toxicity was observed. Of the 64 operable patients, the % 3-year OS was 76.5% (95% confidence interval 64.0%-85.1%). Grade 3 toxicities were observed in 5 patients. No grade 4 and 5 toxicities were observed. Conclusions: Stereotactic body radiation therapy for stage I NSCLC is effective, with low incidences of severe toxicity. This treatment can be considered a standard treatment for inoperable stage I NSCLC. This treatment is promising as an alternative to surgery for operable stage I NSCLC. (C) 2015 Elsevier Inc. All rights reserved.	[Nagata, Yasushi] Hiroshima Univ, Dept Radiat Oncol, Hiroshima 7348551, Japan; [Hiraoka, Masahiro] Kyoto Univ, Dept Radiat Oncol & Image Appl Therapy, Kyoto, Japan; [Shibata, Taro] Natl Canc Ctr, Ctr Res Adm & Support, Japan Clin Oncol Grp, Ctr Data, Tokyo 104, Japan; [Onishi, Hiroshi] Univ Yamanashi, Dept Radiol, Chuo Ku, Yamanashi, Japan; [Kokubo, Masaki] Inst Biomed Res & Innovat, Dept Image Based Med, Kobe, Hyogo, Japan; [Karasawa, Katsuyuki] Tokyo Metropolitan Komagome Hosp, Dept Radiat Oncol, Tokyo, Japan; [Shioyama, Yoshiyuki] Kyushu Univ, Dept Clin Radiol, Fukuoka, Japan; [Onimaru, Rikiya] Hokkaido Univ, Dept Radiol, Sapporo, Hokkaido, Japan; [Kozuka, Takuyo] Canc Inst Hosp, Dept Radiat Oncol, Tokyo, Japan; [Kunieda, Etsuo] Keio Univ, Dept Radiat Oncol, Tokyo, Japan; [Saito, Tsutomu] Nihon Univ, Itabashi Hosp, Dept Radiol, Tokyo, Japan; [Nakagawa, Keiichi] Tokyo Univ Hosp, Dept Radiol, Tokyo 113, Japan; [Hareyama, Masato] Sapporo Med Univ, Dept Radiol, Sapporo, Hokkaido, Japan; [Takai, Yoshihiro] Tohoku Univ, Dept Radiat Oncol, Sendai, Miyagi 980, Japan; [Hayakawa, Kazushige] Kitasato Univ, Dept Radiol & Radiat Oncol, Sagamihara, Kanagawa 228, Japan; [Mitsuhashi, Norio] Tokyo Womens Med Univ, Dept Radiat Oncol, Tokyo, Japan; [Ishikura, Satoshi] Koshigaya Municipal Hosp, Dept Radiol, Koshigaya, Japan	Nagata, Y (reprint author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Radiat Oncol, Kasumi 1-2-3, Hiroshima 7348551, Japan.	nagat@hiroshima-u.ac.jp			National Cancer Center Research and Development Fund [23-A-16, 23-A-21, 26-A-4]; Health and Labor Sciences Research Grant for Clinical Cancer Research from the Japanese Ministry of Health, Labor and Welfare [H15-41, H18-014];  [14S-4];  [17S-5];  [20S-5];  [20S-6]	This work was supported in part by the National Cancer Center Research and Development Fund (23-A-16, 23-A-21, and 26-A-4); a Grant-in-Aid for Cancer Research (14S-4, 17S-5, 20S-5, and 20S-6); and a Health and Labor Sciences Research Grant for Clinical Cancer Research (H15-41, H18-014) from the Japanese Ministry of Health, Labor and Welfare. The principal investigator of this study is Masahiro Hiraoka.	Nishio T, 2006, PHYS MED BIOL, V51, P5409, DOI 10.1088/0031-9155/51/21/002; Nagata Y, 2002, INT J RADIAT ONCOL, V52, P1041, DOI 10.1016/S0360-3016(01)02731-6; Aoki T, 2004, RADIOLOGY, V230, P101, DOI 10.1148/radiol.2301021226; Onimaru R, 2003, INT J RADIAT ONCOL, V56, P126, DOI 10.1016/S0630-3016(03)00095-6; Baumann P, 2009, J CLIN ONCOL, V27, P3290, DOI 10.1200/JCO.2008.21.5681; Timmerman R, 2003, CHEST, V124, P1946, DOI 10.1378/chest.124.5.1946; Matsuoka H, 2005, EUR J CARDIO-THORAC, V28, P380, DOI 10.1016/j.ejcts.2005.06.010; Fakiris AJ, 2009, INT J RADIAT ONCOL, V75, P677, DOI 10.1016/j.ijrobp.2008.11.042; Uematsu M, 2001, INT J RADIAT ONCOL, V51, P666, DOI 10.1016/S0360-3016(01)01703-5; Ricardi U, 2010, LUNG CANCER, V68, P72, DOI 10.1016/j.lungcan.2009.05.007; Timmerman R, 2010, JAMA-J AM MED ASSOC, V303, P1070, DOI 10.1001/jama.2010.261; Wulf J, 2004, INT J RADIAT ONCOL, V60, P186, DOI 10.1016/j.ijrobp.2004.06.060; Asamura H, 2008, J THORAC ONCOL, V3, P46, DOI 10.1097/JTO.0b013e31815e8577; Verstegen NE, 2013, ANN ONCOL, V24, P1543, DOI 10.1093/annonc/mdt026; Graham MV, 1997, INT J RADIAT ONCOL, V39, P561, DOI 10.1016/S0360-3016(97)00353-2; Grutters JPC, 2010, RADIOTHER ONCOL, V95, P32, DOI 10.1016/j.radonc.2009.08.003; Onishi H, 2011, INT J RADIAT ONCOL, V81, P1352, DOI 10.1016/j.ijrobp.2009.07.1751; Shirvani SM, 2012, INT J RADIAT ONCOL, V84, P1060, DOI 10.1016/j.ijrobp.2012.07.2354; Chang JY, 2015, LANCET ONCOL, V16, P630, DOI 10.1016/S1470-2045(15)70168-3; Arimoto T, 1998, CAR 98 COMPUTER ASSI; Blomgren H, 1998, J RADIOSURGERY, V1, P63, DOI 10.1023/B:JORA.0000010880.40483.c4; HOLMES CE, 1995, ANN THORAC SURG, V60, P615; Lax I, 1998, J RADIOSURG, V1, P135, DOI 10.1023/B:JORA.0000010898.87146.2e; Shirakusa K, 2002, JPN J LUNG CANC, V42, P555; Timmerman RD, 2014, INT J RADIAT ONCOL, V90, pS30	25	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0360-3016	1879-355X		INT J RADIAT ONCOL	Int. J. Radiat. Oncol. Biol. Phys.	DEC 1	2015	93	5					989	996		10.1016/j.ijrobp.2015.07.2278		8	Oncology; Radiology, Nuclear Medicine & Medical Imaging	Oncology; Radiology, Nuclear Medicine & Medical Imaging	CY7FC	WOS:000366572800011		
J	Sonobe, N; Fukiba, K; Sato, S; Yoshimura, Y				Sonobe, Nobuki; Fukiba, Katsuyoshi; Sato, Sota; Yoshimura, Yusuke			Method for defrosting heat exchangers using an air-particle jet	INTERNATIONAL JOURNAL OF REFRIGERATION-REVUE INTERNATIONALE DU FROID			English	Article						Defrosting; Cryogenic heat exchanger; Jet; Particles	FROST FORMATION; FLUIDIZED-BED; ARRAY	We report test results on a method for defrosting heat exchangers in which solid particles accelerated by an air jet impinge on heat exchange surfaces. This study was motivated by the development of a cryogenic heat exchanger for a hypersonic aircraft engine. We conducted experiments to remove frost from a single-row heat exchanger cooled with liquid nitrogen as the refrigerant. In the experiments, particle-jet defrosting was conducted for 1 s at intervals of 50-300 s over total experimental durations of 600 s. The experiments were performed using different intervals between defrost cycles, different particle diameters, and different numbers of particles. The effects of these parameters on the performance of the heat exchanger were evaluated by measuring pressure losses and heat transfer rates. The results show that the method prevents buildup of frost and is more effective than defrosting with only an air jet. (C) 2015 Elsevier Ltd and International Institute of Refrigeration. All rights reserved.	[Sonobe, Nobuki; Fukiba, Katsuyoshi; Sato, Sota] Shizuoka Univ, Grad Sch Engn, Naka Ku, Hamamatsu, Shizuoka 4328561, Japan; [Yoshimura, Yusuke] Shizuoka Univ, Fac Engn, Naka Ku, Hamamatsu, Shizuoka 4328561, Japan	Fukiba, K (reprint author), Shizuoka Univ, Grad Sch Engn, Naka Ku, 3-5-1 Johoku, Hamamatsu, Shizuoka 4328561, Japan.	tkfukib@shizuoka.ac.jp			Hamamatsu Foundation for Science and Technology Promotion	This research has been supported by Hamamatsu Foundation for Science and Technology Promotion.	Aihara T., 1996, T JPN SOC MECH ENG-B, V62, P2406; Fukiba K, 2009, J THERMOPHYS HEAT TR, V23, P533, DOI 10.2514/1.40491; Harada K, 2001, J PROPUL POWER, V17, P1233, DOI 10.2514/2.5869; Aihara T, 1997, INT J HEAT MASS TRAN, V40, P1807, DOI 10.1016/S0017-9310(96)00258-X; TAKEUCHI H, 1990, KAGAKU KOGAKU RONBUN, V16, P859; AIHARA T, 1989, EXP THERM FLUID SCI, V2, P65, DOI 10.1016/0894-1777(89)90050-2; Fukiba Katsuyoshi, 2008, Transactions of the Japan Society of Refrigerating and Air Conditioning Engineers, V25; Jiang YQ, 2014, ENERG BUILDINGS, V68, P707, DOI 10.1016/j.enbuild.2013.08.055; Moffat RJ, 1998, EXP THERM FLUID SCI, V1, P3; Sato S., 2014, T JPN SOC REFRIG AIR, V31, P169; Sato T., 2006, J JPN SOC AERONAUT S, V51, P597	11	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0140-7007	1879-2081		INT J REFRIG	Int. J. Refrig.-Rev. Int. Froid	DEC	2015	60						261	269		10.1016/j.ijrefrig.2015.08.017		9	Thermodynamics; Engineering, Mechanical	Thermodynamics; Engineering	CY3HE	WOS:000366299000024		
J	Kobayashi, R; Kimizuka, N; Watanabe, M; Suzuki, T				Kobayashi, Rika; Kimizuka, Norihito; Watanabe, Manabu; Suzuki, Toru			The effect of supercooling on ice structure in tuna meat observed by using X-ray computed tomography	INTERNATIONAL JOURNAL OF REFRIGERATION-REVUE INTERNATIONALE DU FROID			English	Article						Ice crystal; Supercooling; Freezing method; X-ray CT; Tuna meat	FROZEN BEEF; CRYSTALS; STORAGE; TISSUE	Several studies have reported that freezing a homogeneous food such as soy bean curd with deep supercooling (supercooled freezing) results in the formation of many particle ice and homogenous ice structure. However, ice crystal morphology may be affected by the cellular structure of the food. In this study, the ice crystal structure in tuna meat, a cellular food, frozen by the supercooled freezing method was investigated by X-ray computed tomography and compared with ice structures in tuna meat frozen by conventional freezing methods. The results showed that rod-like ice crystals grew parallel with the myofibers, and inhomogeneous ice structures formed in tuna meat frozen by the supercooled freezing method regardless of the degree of supercooling, in contrast to the ice structure in frozen soy bean curds. These ice crystals linked with each other to form rod-like ice structures due to mobility limitations imposed by the cellular structure. (C) 2015 Elsevier Ltd and International Institute of Refrigeration. All rights reserved.	[Kobayashi, Rika; Watanabe, Manabu; Suzuki, Toru] Tokyo Univ Marine Sci & Technol, Grad Sch, Dept Food Sci & Technol, Minato Ku, Tokyo 1088477, Japan; [Kimizuka, Norihito] Miyagi Univ, Sch Food Agr & Environm Sci, Taihaku Ku, Sendai, Miyagi 9820215, Japan	Suzuki, T (reprint author), Tokyo Univ Marine Sci & Technol, Grad Sch, Dept Food Sci & Technol, Minato Ku, 4-5-7 Konan, Tokyo 1088477, Japan.	toru@kaiyodai.ac.jp			Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science, and Technology of Japan "MEXT Revitalization Project for the creation of Fisheries Research and Education Center in Sanriku"	This work was partly supported by the Japan Science and Technology Agency and the Ministry of Education, Culture, Sports, Science, and Technology of Japan "MEXT Revitalization Project for the creation of Fisheries Research and Education Center in Sanriku".	Andou H., 2006, Transactions of the Japan Society of Refrigerating and Air Conditioning Engineers, V23; MIYAWAKI O, 1992, BIOSCI BIOTECH BIOCH, V56, P953; Ishiguro H, 2008, INT J HEAT MASS TRAN, V51, P5642, DOI 10.1016/j.ijheatmasstransfer.2008.04.019; Mousavi R, 2005, J FOOD SCI, V70, pE437, DOI 10.1111/j.1365-2621.2005.tb11473.x; Kaale LD, 2013, FOOD CONTROL, V31, P491, DOI 10.1016/j.foodcont.2012.11.047; Van Dyck T, 2014, J FOOD ENG, V123, P67, DOI 10.1016/j.jfoodeng.2013.09.017; BEVILACQUA AE, 1980, J FOOD TECHNOL, V15, P589, DOI 10.1108/09534810210449550; Do GS, 2004, INT J REFRIG, V27, P184, DOI 10.1016/S0140-7007(03)00042-2; Mousavi R, 2007, INT J FOOD SCI TECH, V42, P714, DOI 10.1111/j.1365-2621.2007.01514.x; Nakamura YN, 2005, FISHERIES SCI, V71, P605, DOI 10.1111/j.1444-2906.2005.01004.x; Chevalier D, 2000, J FOOD ENG, V46, P277, DOI 10.1016/S0260-8774(00)00089-3; Mendoza F, 2010, J FOOD ENG, V99, P206, DOI 10.1016/j.jfoodeng.2010.02.021; Ngapo TM, 1999, MEAT SCI, V53, P159, DOI 10.1016/S0309-1740(99)00051-0; Frisullo P, 2012, J FOOD ENG, V108, P232, DOI 10.1016/j.jfoodeng.2011.07.036; Ando H, 2009, BIOSCI BIOTECH BIOCH, V73, P1257, DOI 10.1271/bbb.80681; Fennema O.R., 1973, LOW TEMPERATURE PRES, P151; Hagiwara T., 2003, JPN J FOOD ENG, V4, P11; Kobayashi R., 2014, T JSRAE, V31, P297; Kobayashi R., 2014, P 3 IIR INT C SUST C; Love R.M., 1968, LOW TEMPERATURE BIOL, P105; Sanguansri Charoenrein, 2010, Journal of Food Engineering, V100, P310; Simoyamada M., 1999, FOOD SCI TECHNOL RES, V5, P284; Sun D., 2006, HDB FROZEN FOOD PROC, P175; Viriyarattanasak C., 2007, T JAPAN SOC REFRIGER, V24, P227	24	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0140-7007	1879-2081		INT J REFRIG	Int. J. Refrig.-Rev. Int. Froid	DEC	2015	60						270	277		10.1016/j.ijrefrig.2015.07.011		8	Thermodynamics; Engineering, Mechanical	Thermodynamics; Engineering	CY3HE	WOS:000366299000025		
J	Inoue, M; Imura, J; Kashima, K; Suzuki, M; Aihara, K				Inoue, Masaki; Imura, Jun-ichi; Kashima, Kenji; Suzuki, Masayasu; Aihara, Kazuyuki			Absolute instability of Lur'e systems and its application to oscillation analysis of uncertain genetic networks	INTERNATIONAL JOURNAL OF ROBUST AND NONLINEAR CONTROL			English	Article						absolute instability; Lur'e systems; uncertain systems; biological systems	NONLINEAR-SYSTEMS; ESCHERICHIA-COLI; TOGGLE SWITCH; ROBUSTNESS; STABILITY; CRITERION; MODELS	We derive instability criteria for Lur'e systems with sector-bounded nonlinearities and uncertain external signals. First, we define absolute instability of an equilibrium and derive an absolute instability condition for a fixed equilibrium point in terms of a linear matrix inequality, which is analogous to the well-known circle stability criterion. Then, the condition is extended to a parametric absolute instability condition, which is applicable to the instability test of a Lur'e system with an equilibrium point whose location is affected by uncertain nonlinearities and uncertain external signals. Finally, we show that the proposed analysis method is useful through the oscillation analysis of an uncertain genetic network model. Copyright (C) 2014 John Wiley & Sons, Ltd.	[Inoue, Masaki] Keio Univ, Fac Sci & Technol, Yokohama, Kanagawa 2238522, Japan; [Imura, Jun-ichi] Tokyo Inst Technol, Grad Sch Informat Sci & Engn, Tokyo 1528552, Japan; [Kashima, Kenji] Kyoto Univ, Grad Sch Informat, Kyoto 6068501, Japan; [Suzuki, Masayasu] Utsunomiya Univ, Grad Sch Engn, Utsunomiya, Tochigi 3218585, Japan; [Aihara, Kazuyuki] Univ Tokyo, Inst Ind Sci, Tokyo 1538505, Japan	Inoue, M (reprint author), Keio Univ, Fac Sci & Technol, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	minoue@appi.keio.ac.jp			Aihara Innovative Mathematical Modelling Project; Japan Society for the Promotion of Science (JSPS) through Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program); Council for Science and Technology Policy (CSTP); JSPS [26820163]	This research is supported by the Aihara Innovative Mathematical Modelling Project, the Japan Society for the Promotion of Science (JSPS) through the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program), initiated by the Council for Science and Technology Policy (CSTP) and the Grant-in-Aid for Young Scientists (B), No.26820163 from JSPS.	Alon U, 2007, INTRO SYSTEMS BIOL D; Chesi G, 2013, INT J ROBUST NONLIN, V23, P137, DOI 10.1002/rnc.1819; ANDERSON BD, 1966, J FRANKLIN I, V282, P155, DOI 10.1016/0016-0032(66)90317-6; TOMBERG EA, 1989, SIBERIAN MATH J+, V30, P641; Wada T, 2000, AUTOMATICA, V36, P1365, DOI 10.1016/S0005-1098(00)00052-2; Atkinson MR, 2003, CELL, V113, P597, DOI 10.1016/S0092-8674(03)00346-5; Pogromsky A, 1999, INT J BIFURCAT CHAOS, V9, P629, DOI 10.1142/S0218127499000444; Hasenauer J, 2010, J PROCESS CONTR, V20, P1076, DOI 10.1016/j.jprocont.2010.06.004; IBRAHIM ES, 1964, IEEE T AUTOMAT CONTR, VAC 9, P154, DOI 10.1109/TAC.1964.1105666; Wada T, 1998, IEEE T AUTOMAT CONTR, V43, P1649, DOI 10.1109/9.728889; Sepulchre R, 2005, SYST CONTROL LETT, V54, P809, DOI 10.1016/j.sysconle.2004.12.004; BROCKETT RW, 1967, PR INST ELECTR ELECT, V55, P604, DOI 10.1109/PROC.1967.5626; Ma L, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-38; Inoue M, 2013, P AMER CONTR CONF, P4080; Waldherr S, 2011, AUTOMATICA, V47, P1139, DOI 10.1016/j.automatica.2011.01.012; Angeli D, 2004, P NATL ACAD SCI USA, V101, P1822, DOI 10.1073/pnas.0308265100; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; TAUSSKY O, 1961, J SOC IND APPL MATH, V9, P640, DOI 10.1137/0109053; Rantzer A, 1996, SYST CONTROL LETT, V28, P7, DOI 10.1016/0167-6911(95)00063-1; Hori Y, 2011, AUTOMATICA, V47, P1203, DOI 10.1016/j.automatica.2011.02.042; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Gardner TS, 2000, NATURE, V403, P339; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Stan GB, 2007, IEEE T AUTOMAT CONTR, V52, P256, DOI 10.1109/TAC.2006.890471; Athans M, 1966, OPTIMAL CONTROL INTR; Boyd S, 1994, LINEAR MATRIX INEQUA; Ghaemi R, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-95; IKEDA M, 1991, PROG SYST C, V7, P1; Khalil H. K., 2002, NONLINEAR SYSTEMS; Ostrowski A, 1962, J MATH ANAL APPL, V4, P72, DOI 10.1016/0022-247X(62)90030-6; Popov VM, 1962, AUTOMAT REM CONTR+, V22, P857; Robinson C., 1998, DYNAMICAL SYSTEMS ST; Yakubovich VA, 1973, SIBERIAN MATH J, V14, P768; Yakubovich VA, 1970, AUTOMAT REM CONTR, V31, P1903; YAKUBOVI.VA, 1971, AUTOMAT REM CONTR+, V32, P876	35	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1049-8923	1099-1239		INT J ROBUST NONLIN	Int. J. Robust Nonlinear Control	DEC	2015	25	18					3746	3762		10.1002/rnc.3294		17	Automation & Control Systems; Engineering, Electrical & Electronic; Mathematics, Applied	Automation & Control Systems; Engineering; Mathematics	CY9JQ	WOS:000366723600013		
J	Suzuki, K; Tagami, K				Suzuki, K.; Tagami, K.			Role of Nasal Staphylococcus aureus Carriage in Transmission among Contact Athletes	INTERNATIONAL JOURNAL OF SPORTS MEDICINE			English	Article						physical contact; transmission; genotyping	FOOTBALL TEAM; SKIN; INFECTIONS; OUTBREAK; RECOVERY; PLAYERS; JAPAN; MRSA	Among athletes, Staphylococcus aureus is thought to be transmitted by close physical contact with carriers. Nevertheless, evidence is limited with regard to both the tracking of individual strains and the role of S. aureus on the skin's surface. We investigated its transmission using molecular genotyping and the presence of S. aureus on the skin during exercise. In the first study, nasal samples were obtained from 172 athletes over a period of up to one year. The 200 strains of S. aureus collected from these athletes were genotyped, and transmission of S. aureus was detected by phage open reading frame typing (POT). In the second study, the presence of S. aureus on the skin's surface was compared between nasal carriers (n = 9) and non-nasal carriers (n = 9), who had participated in the first study. In the first study, 10 cases of transmission were confirmed. In the second study, exercise-induced sweating increased S. aureus isolates from the skin's surface (before vs. after exercise: 5.2+/-5.4 vs. 41.7+/-40.6 CFU/ml) in nasal carriers. In 5 of 9 nasal carriers, S. aureus isolates from the skin's surface were clonally identical to those from the nares. These results identify a major route of S. aureus transmission among athletes and provide insight into the role played by exercise-induced sweating in nasal carriers.	[Suzuki, K.; Tagami, K.] Univ Tsukuba, Fac Hlth & Sport Sci, Tsukuba, Ibaraki 3058574, Japan	Suzuki, K (reprint author), Univ Tsukuba, Fac Hlth & Sport Sci, 1-1-1 Tenoudai, Tsukuba, Ibaraki 3058574, Japan.	Ksuzuki@taiiku.tsukuba.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [KAKENHI24700748]	We are grateful to Saori Yamamoto, Katsunobu Nakagawa, Tomiya Takahiro, Hiroshi Kushiyama, Sotaro Okawa and Yasunori Katagiri for excellent technical assistance. This study was funded by the Ministry of Education, Culture, Sports, Science and Technology, grant number (KAKENHI24700748) Grant-in-Aid for Young Scientists (B).	Harriss DJ, 2013, INT J SPORTS MED, V34, P1025, DOI 10.1055/s-0033-1358756; Stacey AR, 1998, BRIT J SPORT MED, V32, P153; Kazakova SV, 2005, NEW ENGL J MED, V352, P468, DOI 10.1056/NEJMoa042859; Begier EM, 2004, CLIN INFECT DIS, V39, P1446, DOI 10.1086/425313; Creech CB, 2010, ARCH PEDIAT ADOL MED, V164, P615, DOI 10.1001/archpediatrics.2010.93; Maeda T, 2012, J INFECT CHEMOTHER, V18, P906, DOI 10.1007/s10156-012-0506-4; Kong HH, 2012, J INVEST DERMATOL, V132, P933, DOI 10.1038/jid.2011.417; Suzuki M, 2006, J APPL MICROBIOL, V101, P938, DOI 10.1111/j.1365-2672.2006.02932.x; Teramura H, 2010, BIOCONTROL SCI, V15, P149, DOI 10.4265/bio.15.149; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Turbeville SD, 2006, AM J SPORT MED, V34, P1860, DOI 10.1177/0363546505285385; Redziniak DE, 2009, INT J SPORTS MED, V30, P557, DOI 10.1055/s-0029-1214382; Romano R, 2006, J ATHL TRAINING, V41, P141; Oller AR, 2010, J ATHL TRAINING, V45, P222, DOI 10.4085/1062-6050-45.3.222; Oller AR, 2009, J INFECT DEV COUNTR, V3, P224; Larkin-Thier Susan M, 2010, J Chiropr Med, V9, P32, DOI 10.1016/j.jcm.2009.12.001	16	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0172-4622	1439-3964		INT J SPORTS MED	Int. J. Sports Med.	DEC	2015	36	14					1186	1191		10.1055/s-0035-1555856		6	Sport Sciences	Sport Sciences	CY9OZ	WOS:000366737500010		
J	Arents, T; Tsuneishi, N				Arents, Tom; Tsuneishi, Norihiko			The Uneven Recruitment of Korean Miners in Japan in the 1910s and 1920s: Employment Strategies of the Miike and Chikuho Coalmining Companies	INTERNATIONAL REVIEW OF SOCIAL HISTORY			English	Article								After Japan's colonization of Korea in 1910, many Korean peasants lost their land owing to the changes imposed in agriculture, and several Japanese coalmining companies started to recruit them as a colonial surplus population. Despite the low wages they offered, not all of the companies relied on Korean miners - the distribution of this workforce was strikingly uneven. Focusing on the mines of Chikuho and Miike in the Fukuoka prefecture during the 1910s and 1920s, this article argues that the distribution of Koreans was a consequence of uneven capital accumulation among different mining companies. This unevenness reflected the differing wages and recruitment policies of these companies. Correlating earlier groups of cheap labourers, such as convict workers, to this history, we suggest some explanations as to why some mining companies brought Korean workers into the coal-production process as an immediately available, cheap, and disposable workforce, while others did not.	[Arents, Tom] Sapporo Gakuin Univ, Grad Sch Reg Management, Ebetsu, Hokkaido 0698555, Japan; [Tsuneishi, Norihiko] Columbia Univ, Grad Sch Architecture Planning & Preservat, New York, NY 10027 USA	Arents, T (reprint author), Sapporo Gakuin Univ, Grad Sch Reg Management, Bunkyodai 11, Ebetsu, Hokkaido 0698555, Japan.	tom_arents@hotmail.com; nt2296@columbia.edu					[Anonymous], 1999, THESIS, P76; Bunko Mitsui, 1994, MITSUI JIGYO SHI 2, VIII, P95; Chikuho Sekitan Kogyo-shi Nenpyo Hensan Iinkai [Committee for the Compilation of a Historical Chronology of the Chikuho Coal Industry], 1973, CHIK SEK KOG SHI NEN, P168; Hashimoto Tetsuya, 1966, SHAKAI KEIZAIGAKU SH, V32, P398; Hashimoto Tetsuya, 1966, SHAKAI KEIZAIGAKU SH, V32, P403; Hatakeyama Hideki, 2000, KINDAI NIHON KYODAI, P7; Hayashi Eidai, 2011, CHIKUHO GUNKANJIMA C, P53; Kawashima K, 2009, PROCEEDINGS OF INTERNATIONAL CONFERENCE ON EARTHQUAKE ENGINEERING - THE FIRST ANNIVERSARY OF WENCHUAN EARTHQUAKE, P25; Kozan Mitsui, 1943, MIIKE KOGYOSHO ENKAK, VIII, P637; Kozan Mitsui, 1943, GOJUNEN SHI KO IOHEN, P147; Kozan Mitsui, 1943, SHUTO SAITAN YURAI, P4; Marx Karl, 1990, CAPITAL, VI, P342; Nishinarita Yutaka, 1985, GIJUTSU KAKUSHIN JOS, P71; Noshomu Sho Kozan Kyoku [Mining Division of the Ministry of Agriculture and Commerce], 1918, HONP JUYO KOZ YOR, P907; Ogino Yoshihiro, 1993, CHIKUHO TANKO ROSHI, P144; Shindo Toyoo, 1985, AKAI BOTAYAMA HI CHI, P154; Sumiya Mikio, 1968, NIHON SEKITAN SANGY; Takeuchi Yasuto, 2013, CHOSA CHOSENJIN KYOS; Tanaka Naoki, 1984, KINDAI NIHON TANKO R, P269	19	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0020-8590	1469-512X		INT REV SOC HIST	Int. Rev. Soc. Hist.	DEC	2015	60			1	SI		121	143		10.1017/S0020859015000437		23	History	History	CY3AW	WOS:000366281200006		
J	Inohara, T; Miyata, H; Ueda, I; Maekawa, Y; Fukuda, K; Kohsaka, S				Inohara, Taku; Miyata, Hiroaki; Ueda, Ikuko; Maekawa, Yuichiro; Fukuda, Keiichi; Kohsaka, Shun			Use of Intra-aortic Balloon Pump in a Japanese Multicenter Percutaneous Coronary Intervention Registry	JAMA INTERNAL MEDICINE			English	Letter							MORTALITY		[Inohara, Taku; Ueda, Ikuko; Maekawa, Yuichiro; Fukuda, Keiichi; Kohsaka, Shun] Keio Univ, Sch Med, Dept Cardiol, Tokyo 1608582, Japan; [Miyata, Hiroaki] Keio Univ, Sch Med, Dept Hlth Policy & Management, Tokyo 1608582, Japan	Kohsaka, S (reprint author), Keio Univ, Sch Med, Dept Cardiol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	kohsaka@cpnet.med.keio.ac.jp					Peterson ED, 2010, J AM COLL CARDIOL, V55, P1923, DOI 10.1016/j.jacc.2010.02.005; Ahmad Y, 2015, JAMA INTERN MED, V175, P931, DOI 10.1001/jamainternmed.2015.0569; Inohara T, 2014, JACC-CARDIOVASC INTE, V7, P1000, DOI 10.1016/j.jcin.2014.06.006; Nallamothu BK, 2015, LANCET, V385, P1114, DOI 10.1016/S0140-6736(14)61932-2; Watanabe H, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.001962	5	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6106	2168-6114		JAMA INTERN MED	JAMA Intern. Med.	DEC	2015	175	12					1980	+		10.1001/jamainternmed.2015.5119		3	Medicine, General & Internal	General & Internal Medicine	CY3TE	WOS:000366332000024		
J	Ohtake, J; Kaneumi, S; Tanino, M; Kishikawa, T; Terada, S; Sumida, K; Masuko, K; Ohno, Y; Kita, T; Iwabuchi, S; Shinohara, T; Tanino, Y; Takemura, T; Tanaka, S; Kobayashi, H; Kitamura, H				Ohtake, Junya; Kaneumi, Shun; Tanino, Mishie; Kishikawa, Takuto; Terada, Satoshi; Sumida, Kentaro; Masuko, Kazutaka; Ohno, Yosuke; Kita, Toshiyuki; Iwabuchi, Sadahiro; Shinohara, Toshiya; Tanino, Yoshinori; Takemura, Tamiko; Tanaka, Shinya; Kobayashi, Hiroya; Kitamura, Hidemitsu			Neuropeptide signaling through neurokinin-1 and neurokinin-2 receptors augments antigen presentation by human dendritic cells	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							IMMUNE-RESPONSES; ASTHMA; IL-12		[Ohtake, Junya; Kaneumi, Shun; Kishikawa, Takuto; Terada, Satoshi; Sumida, Kentaro; Masuko, Kazutaka; Ohno, Yosuke; Kita, Toshiyuki; Kitamura, Hidemitsu] Hokkaido Univ, Div Immunoregulat, Sect Dis Control, Inst Genet Med, Sapporo, Hokkaido, Japan; [Tanino, Mishie; Tanaka, Shinya] Hokkaido Univ, Grad Sch Med, Dept Canc Pathol, Sapporo, Hokkaido, Japan; [Iwabuchi, Sadahiro] Univ Iowa, Carver Coll Med, Dept Mol Physiol & Biophys, Iowa City, IA USA; [Shinohara, Toshiya] Teine Keijinkai Hosp, Dept Pathol, Sapporo, Hokkaido, Japan; [Tanino, Yoshinori] Fukushima Med Univ, Dept Pulm Med, Fukushima, Japan; [Takemura, Tamiko] Japanese Red Cross Med Ctr, Dept Pathol, Tokyo, Japan; [Kobayashi, Hiroya] Asahikawa Med Univ, Dept Pathol, Asahikawa, Hokkaido, Japan	Ohtake, J (reprint author), Hokkaido Univ, Div Immunoregulat, Sect Dis Control, Inst Genet Med, Sapporo, Hokkaido, Japan.	kitamura@igm.hokudai.ac.jp					Janelsins BM, 2013, BLOOD, V121, P2923, DOI 10.1182/blood-2012-07-446054; Nagato T, 2007, J IMMUNOL, V178, P1189; Ohtake J, 2014, IMMUNOL LETT, V161, P20, DOI 10.1016/j.imlet.2014.04.010; Kobayashi M, 2012, EUR J IMMUNOL, V42, P393, DOI 10.1002/eji.201141845; Holgate ST, 2012, NAT MED, V18, P673, DOI 10.1038/nm.2731; Kitamura H, 1999, J EXP MED, V189, P1121, DOI 10.1084/jem.189.7.1121; Kitamura H, 2012, J IMMUNOL, V188, P4200, DOI 10.4049/jimmunol.1102521; Lacasse Y, 2012, CHEST, V142, P208, DOI 10.1378/chest.11-2479; Ramalho R, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-41	9	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2015	136	6					1690	1694		10.1016/j.jaci.2015.06.050		7	Allergy; Immunology	Allergy; Immunology	CX9RZ	WOS:000366044300035		
J	Okado, Y; Shigetomi, K; Mitsuhashi, S; Ubukata, M				Okado, Yuji; Shigetomi, Kengo; Mitsuhashi, Shinya; Ubukata, Makoto			First total synthesis of (+)-epogymnolactam, a novel autophagy inducer	JOURNAL OF ANTIBIOTICS			English	Article							FATTY-ACID SYNTHESIS; STEREOSELECTIVE-SYNTHESIS; D-GLUCOSE; CERULENIN; (+)-CERULENIN; INHIBITION; SYNTHETASE; DISEASE; TARGET	A novel autophagy inducer, (+)-epogymnolactam (1), was first synthesized from cis-4-benzyloxy-2-butene-1-ol (2) in eight steps. A reliable preparation of optically pure epoxy alcohol (+)-3 from monobenzyl derivative (2) was established by a tandem strategy, Sharpless epoxidation/lipase kinetic resolution.	[Okado, Yuji; Shigetomi, Kengo; Mitsuhashi, Shinya; Ubukata, Makoto] Hokkaido Univ, Grad Sch Agr, Div Appl Biosci, Res Fac Agr, Sapporo, Hokkaido 0608589, Japan	Ubukata, M (reprint author), Hokkaido Univ, Grad Sch Agr, Div Appl Biosci, Res Fac Agr, Kita 9,Nishi 9, Sapporo, Hokkaido 0608589, Japan.	m-ub@for.agr.hokudai.ac.jp			Institute for Fermentation, Osaka (IFO), Japan; Japan Society for the Promotion of Science (JSPS) [26450135]	This work was supported by a grant from the Institute for Fermentation, Osaka (IFO), Japan, and a Grant-in-Aid for Scientific Research (C) (No. 26450135) from the Japan Society for the Promotion of Science (JSPS). We are grateful to Dr E Fukushi (Graduate School of Agriculture, Hokkaido University) for NMR measurements of synthetic (+)-epogymnolactam.	Mani NS, 1997, J ORG CHEM, V62, P636, DOI 10.1021/jo9618177; Rawat V, 2012, ORG BIOMOL CHEM, V10, P3988, DOI 10.1039/c2ob25635e; DESS DB, 1991, J AM CHEM SOC, V113, P7277, DOI 10.1021/ja00019a027; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Nixon RA, 2011, NEUROBIOL DIS, V43, P38, DOI 10.1016/j.nbd.2011.01.021; FURUKAWA J, 1988, CHEM PHARM BULL, V36, P1229; KUHAJDA FP, 1994, P NATL ACAD SCI USA, V91, P6379, DOI 10.1073/pnas.91.14.6379; Shen LL, 2008, TETRAHEDRON-ASYMMETR, V19, P1647, DOI 10.1016/j.tetasy.2008.05.021; Sarkar S, 2005, J CELL BIOL, V170, P1101, DOI 10.1083/jcb.200504035; Rubinsztein DC, 2012, NAT REV DRUG DISCOV, V11, P709, DOI 10.1038/nrd3802; Jeong JK, 2012, NEUROSCI RES, V73, P99, DOI 10.1016/j.neures.2012.03.005; SANO Y, 1967, J ANTIBIOT, V20, P344; Yoshino T, 1997, TETRAHEDRON, V53, P10239, DOI 10.1016/S0040-4020(97)00651-0; Chin RM, 2014, NATURE, V510, P397, DOI 10.1038/nature13264; Faigl F, 2005, TETRAHEDRON-ASYMMETR, V16, P3841, DOI 10.1016/j.tetasy.2005.09.029; SUEDA N, 1979, TETRAHEDRON LETT, P2039; Jimenez RE, 2014, BRIT J PHARMACOL, V171, P1907, DOI 10.1111/bph.12477; Gupta VK, 2013, NAT NEUROSCI, V16, P1453, DOI 10.1038/nn.3512; Nakashima T, 2013, SYNTHESIS-STUTTGART, V45, P2417, DOI 10.1055/s-0033-1338503; YODA H, 1991, TETRAHEDRON LETT, V32, P6771, DOI 10.1016/S0040-4039(00)93599-8; MORI K, 1988, TETRAHEDRON, V44, P1035, DOI 10.1016/S0040-4020(01)85883-X; DAGNOLO G, 1973, BIOCHIM BIOPHYS ACTA, V326, P155, DOI 10.1016/0005-2760(73)90241-5; Cuervo AM, 2004, TRENDS CELL BIOL, V14, P70, DOI 10.1016/j.tcb.2003.12.002; Williams A, 2008, NAT CHEM BIOL, V4, P295, DOI 10.1038/nchembio.79; Shoji-Kawata S, 2013, NATURE, V494, P201, DOI 10.1038/nature11866; Yadav RN, 2011, TETRAHEDRON LETT, V52, P1942, DOI 10.1016/j.tetlet.2011.02.054; FUNABASHI H, 1989, J BIOCHEM-TOKYO, V105, P751; Mitsuhashi S., 2015, PHYTOCHEMISTRY, V114, P155; PIETRASZKIEWICZ M, 1979, TETRAHEDRON LETT, P4741	29	0	0	JAPAN ANTIBIOTICS RESEARCH ASSOC	TOKYO	2 20 8 KAMIOSAKI SHINAGAWA KU, TOKYO, 141, JAPAN	0021-8820			J ANTIBIOT	J. Antibiot.	DEC	2015	68	12					721	724		10.1038/ja.2015.63		4	Biotechnology & Applied Microbiology; Immunology; Microbiology; Pharmacology & Pharmacy	Biotechnology & Applied Microbiology; Immunology; Microbiology; Pharmacology & Pharmacy	CY9MQ	WOS:000366731400001		
J	Sasaki, K; Kobayashi, Y; Kurihara, T; Yamashita, Y; Takahashi, Y; Miyake, T; Akamatsu, Y				Sasaki, Kazushige; Kobayashi, Yoshihiko; Kurihara, Takashi; Yamashita, Yohei; Takahashi, Yoshiaki; Miyake, Toshiaki; Akamatsu, Yuzuru			Synthesis and antibacterial activity of 4 '' or 6 ''-alkanoylamino derivatives of arbekacin	JOURNAL OF ANTIBIOTICS			English	Article							16S RIBOSOMAL-RNA; PSEUDOMONAS-AERUGINOSA; TOXICITY RELATIONSHIPS; CRYSTAL-STRUCTURE; RESISTANCE; MRSA; ANTIBIOTICS; ENZYME	Arbekacin, an aminoglycoside antibiotic, is an important drug because it shows a potent efficacy against methicillin-resistant Staphylococcus aureus. However, resistance to arbekacin, which is caused mainly by the bifunctional aminoglycoside-modifying enzyme, has been observed, becoming a serious problem in medical practice. To create new arbekacin derivatives active against resistant bacteria, we modified the C-4 '' and 6 '' positions of its 3-aminosugar portion. Regioselective amination of the 6 ''-position gave 6 ''-amino-6 ''-deoxyarbekacin (1), and it was converted to a variety of 6 ''-N-alkanoyl derivatives (6a-z). Furthermore, regioselective modifications of the 4 ''-hydroxyl group were performed to give 4 ''-deoxy-4 ''-epiaminoarbekacin (2) and its 4 ''-N-alkanoyl derivatives (12 and 13). Their antibacterial activity against S. aureus, including arbekacin-resistant bacteria, was evaluated. It was observed that 6 ''-amino-6 ''-N-[(S)-4-amino-2-hydroxybutyryl]-6 ''-deoxyarbekacin (6o) showed excellent antibacterial activity, even better than arbekacin.	[Sasaki, Kazushige; Kobayashi, Yoshihiko; Kurihara, Takashi; Yamashita, Yohei; Takahashi, Yoshiaki; Miyake, Toshiaki] Inst Microbial Chem BIKAKEN, Kawasaki, Kanagawa, Japan; [Akamatsu, Yuzuru] Inst Microbial Chem BIKAKEN, Tokyo, Japan	Sasaki, K (reprint author), Inst Microbial Chem BIKAKEN, Nakahara Ku, 3-34-17 Ida, Kawasaki, Kanagawa, Japan.	sasakik@bikaken.or.jp					Anderson W. G., 1964, J AM CHEM SOC, V86, P1839; Takahashi Y, 1998, CARBOHYD RES, V306, P349, DOI 10.1016/S0008-6215(97)10080-5; KONDO S, 1973, J ANTIBIOT, V26, P412; KONDO S, 1973, J ANTIBIOT, V26, P705; Aghazadeh M, 2013, MICROB DRUG RESIST, V19, P282, DOI 10.1089/mdr.2012.0223; Hiraiwa Y, 2007, BIOORG MED CHEM LETT, V17, P6369, DOI 10.1016/j.bmcl.2007.08.059; TAKAHASHI Y, 1993, CARBOHYD RES, V249, P57, DOI 10.1016/0008-6215(93)84060-J; Kondo J, 2006, ANGEW CHEM INT EDIT, V45, P3310, DOI 10.1002/anie.200600354; Vicens Q, 2003, J MOL BIOL, V326, P1175, DOI 10.1016/S0022-2836(02)01435-3; Magnet S, 2005, CHEM REV, V105, P477, DOI 10.1021/cr0301088; Chow JW, 2001, ANTIMICROB AGENTS CH, V45, P2691, DOI 10.1128/AAC.45.10.2691-2694.2001; MOAZED D, 1987, NATURE, V327, P389, DOI 10.1038/327389a0; Ishino K, 2004, J ANTIBIOT, V57, P679; Zhang JJ, 2010, BIOORGAN MED CHEM, V18, P1396, DOI 10.1016/j.bmc.2010.01.027; Shigemura K, 2013, J ANTIBIOT, V66, P273, DOI 10.1038/ja.2013.14; Shaul P, 2011, ORG BIOMOL CHEM, V9, P4057, DOI 10.1039/c0ob01133a; Suga T, 2012, J ANTIBIOT, V65, P527, DOI 10.1038/ja.2012.53; Chen W, 2014, MEDCHEMCOMM, V5, P1179, DOI 10.1039/c4md00119b; NAITO T, 1974, J ANTIBIOT, V27, P851; Kunishima M, 2001, TETRAHEDRON, V57, P1551, DOI 10.1016/S0040-4020(00)01137-6; Hiraiwa Y, 2007, BIOORG MED CHEM LETT, V17, P3540, DOI 10.1016/j.bmcl.2007.04.065; Deguchi Koichi, 1993, Japanese Journal of Antibiotics, V46, P794; KAWAGUCH.H, 1972, J ANTIBIOT, V25, P695; Minowa N., 2005, PCT Int. Appl., Patent No. [WO 2005070945, 2005070945, 2005070945A1]; Perez-Fernandez D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4112; Staudinger H, 1919, HELV CHIM ACTA, V2, P635, DOI 10.1002/hlca.19190020164	26	0	0	JAPAN ANTIBIOTICS RESEARCH ASSOC	TOKYO	2 20 8 KAMIOSAKI SHINAGAWA KU, TOKYO, 141, JAPAN	0021-8820			J ANTIBIOT	J. Antibiot.	DEC	2015	68	12					741	747		10.1038/ja.2015.61		7	Biotechnology & Applied Microbiology; Immunology; Microbiology; Pharmacology & Pharmacy	Biotechnology & Applied Microbiology; Immunology; Microbiology; Pharmacology & Pharmacy	CY9MQ	WOS:000366731400004		
J	Seki, T; Matsumoto, A; Omura, S; Takahashi, Y				Seki, Tamae; Matsumoto, Atsuko; Omura, Satoshi; Takahashi, Yoko			Distribution and isolation of strains belonging to the order Solirubrobacterales	JOURNAL OF ANTIBIOTICS			English	Article							SP-NOV.; GEN-NOV; EMENDED DESCRIPTION; GINSENG FIELD; SOIL; BACTERIUM; PATULIBACTER; CULTIVATION; PROPOSAL		[Seki, Tamae; Matsumoto, Atsuko; Omura, Satoshi; Takahashi, Yoko] Kitasato Univ, Kitasato Inst Life Sci, Tokyo 1088641, Japan; [Matsumoto, Atsuko] Kitasato Univ, Grad Sch Infect Control Sci, Tokyo 1088641, Japan	Matsumoto, A (reprint author), Kitasato Univ, Kitasato Inst Life Sci, Minato Ku, 5-9-1 Shirokane, Tokyo 1088641, Japan.	amatsu@lisci.kitasato-u.ac.jp					Chen MY, 2004, INT J SYST EVOL MICR, V54, P1849, DOI 10.1099/ijs.0.63109-0; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Kim KK, 2012, INT J SYST EVOL MICR, V62, P563, DOI 10.1099/ijs.0.032052-0; Stevenson BS, 2004, APPL ENVIRON MICROB, V70, P4748, DOI 10.1128/AEM.70.8.4748-4755.2004; Reddy GSN, 2009, INT J SYST EVOL MICR, V59, P87, DOI 10.1099/ijs.0.64185-0; Sung MH, 2003, J MICROBIOL BIOTECHN, V13, P1013; Seki T, 2012, INT J SYST EVOL MICR, V62, P2400, DOI 10.1099/ijs.0.036095-0; Sait M, 2002, ENVIRON MICROBIOL, V4, P654, DOI 10.1046/j.1462-2920.2002.00352.x; Sangwan P, 2005, APPL ENVIRON MICROB, V71, P8402, DOI 10.1128/AEM.71.12.8402-8410.2005; Takahashi Y, 2006, INT J SYST EVOL MICR, V56, P401, DOI 10.1099/ijs.0.63796-0; Wei LF, 2014, INT J SYST EVOL MICR, V64, P858, DOI 10.1099/ijs.0.057554-0; Nakashima T, 2010, J BIOSCI BIOENG, V110, P304, DOI 10.1016/j.jbiosc.2010.03.003; Monciardini P, 2003, INT J SYST EVOL MICR, V53, P569, DOI 10.1099/ijs.0.02400-0; ZARILLA KA, 1986, INT J SYST BACTERIOL, V36, P13; ZARILLA KA, 1984, ARCH MICROBIOL, V137, P286, DOI 10.1007/BF00410723; Kim MK, 2007, INT J SYST EVOL MICR, V57, P1453, DOI 10.1099/ijs.0.64715-0; Carreto L, 1996, INT J SYST BACTERIOL, V46, P460; Singleton DR, 2003, INT J SYST EVOL MICR, V53, P485, DOI 10.1099/ijs.0.02438-0; SUZUKI K, 1988, FEMS MICROBIOL LETT, V52, P33, DOI 10.1111/j.1574-6968.1988.tb02568.x; Davis E. R. K., 2005, APPL ENVIRON MICROB, V71, P826; Hugenholtz P, 2002, GENOME BIOL, V3; Yu L, 2002, ACTINOMYCETOLOGICA, V16, P1, DOI 10.3209/saj.16_1	22	0	0	JAPAN ANTIBIOTICS RESEARCH ASSOC	TOKYO	2 20 8 KAMIOSAKI SHINAGAWA KU, TOKYO, 141, JAPAN	0021-8820			J ANTIBIOT	J. Antibiot.	DEC	2015	68	12					763	766		10.1038/ja.2015.67		4	Biotechnology & Applied Microbiology; Immunology; Microbiology; Pharmacology & Pharmacy	Biotechnology & Applied Microbiology; Immunology; Microbiology; Pharmacology & Pharmacy	CY9MQ	WOS:000366731400009		
J	Komaki, H; Tamura, T; Ichikawa, N; Oguchi, A; Hamada, M; Suzuki, K; Fujita, N				Komaki, Hisayuki; Tamura, Tomohiko; Ichikawa, Natsuko; Oguchi, Akio; Hamada, Moriyuki; Suzuki, Ken-ichiro; Fujita, Nobuyuki			Genome-based analysis of type-I polyketide synthase and nonribosomal peptide synthetase gene clusters in a novel strain taxonomically close to the genus Salinispora	JOURNAL OF ANTIBIOTICS			English	Article							TROPICA		[Komaki, Hisayuki; Tamura, Tomohiko; Hamada, Moriyuki; Suzuki, Ken-ichiro] Natl Inst Technol & Evaluat, Biol Resource Ctr, Kisarazu, Chiba 2920818, Japan; [Ichikawa, Natsuko; Oguchi, Akio; Fujita, Nobuyuki] Natl Inst Technol & Evaluat, Biol Resource Ctr, Tokyo, Japan	Komaki, H (reprint author), Natl Inst Technol & Evaluat, Biol Resource Ctr, 2-5-8 Kazusakamatari, Kisarazu, Chiba 2920818, Japan.	komaki-hisayuki@nite.go.jp					Udwary DW, 2007, P NATL ACAD SCI USA, V104, P10376, DOI 10.1073/pnas.0700962104; Ziemert N, 2014, P NATL ACAD SCI USA, V111, pE1130, DOI 10.1073/pnas.1324161111; Horsman GR, 2009, METHOD ENZYMOL, V459, P97, DOI 10.1016/S0076-6879(09)04605-9; Blin K, 2013, NUCLEIC ACIDS RES, V41, pW204, DOI 10.1093/nar/gkt449; Maldonado LA, 2005, INT J SYST EVOL MICR, V55, P1759, DOI 10.1099/ijs.0.63625-0; Ohtsubo Y, 2012, J BACTERIOL, V194, P6970, DOI 10.1128/JB.01848-12; Komaki H, 2012, J GEN APPL MICROBIOL, V58, P363; Nett M, 2009, NAT PROD REP, V26, P1362, DOI 10.1039/b817069j; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Trujillo ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108522	10	0	0	JAPAN ANTIBIOTICS RESEARCH ASSOC	TOKYO	2 20 8 KAMIOSAKI SHINAGAWA KU, TOKYO, 141, JAPAN	0021-8820			J ANTIBIOT	J. Antibiot.	DEC	2015	68	12					767	770		10.1038/ja.2015.69		4	Biotechnology & Applied Microbiology; Immunology; Microbiology; Pharmacology & Pharmacy	Biotechnology & Applied Microbiology; Immunology; Microbiology; Pharmacology & Pharmacy	CY9MQ	WOS:000366731400010		
J	Fujimoto, A; Morishima, K; Harada, M; Hirata, T; Osuga, Y; Fujii, T				Fujimoto, Akihisa; Morishima, Kaoru; Harada, Miyuki; Hirata, Tetsuya; Osuga, Yutaka; Fujii, Tomoyuki			Elective single-embryo transfer improves cumulative pregnancy outcome in young patients but not in women of advanced reproductive age	JOURNAL OF ASSISTED REPRODUCTION AND GENETICS			English	Article						eSET; Age; Cumulative live birth rate; Multivariate logistic regression analyses	FREEZE-ALL POLICY; PREVENTION; CYCLES; FRESH	The purpose of the present study is to assess the significance of elective single-embryo transfer (eSET) in older women. The outcomes of assisted reproductive technology between 2001 and 2013 at single institution were retrospectively evaluated. Cumulative live birth rates (CLBRs) in one oocyte retrieval cycle were compared between those who underwent eSET and multiple embryo transfer (MET) in fresh cycles. The outcomes of 429 eSET cycles and 965 MET cycles were compared. CLBRs in eSET were higher than those of MET in women under 37 and were comparable in women aged 37 and over. The analysis of the outcomes separately in three age subgroups showed a significantly higher CLBR in young eSET (aged under 37) than that in young MET and similar CLBR between older (aged 37-40 and over 40) eSET and MET. Multiple birth rates were lower in eSET in all age groups. Multivariate logistic regression analyses showed that, in women aged under 37, number of frozen embryos, presence of good-quality embryos, and eSET were significantly related to cumulative live birth. In women aged between 37 and 40, age and number of frozen embryos were significantly related, while eSET was not. eSET in women under 37 resulted in increased CLBR compared with MET. In women aged between 37 and 40, CLBR in eSET group was similar with that in MET group. In both age groups, eSET reduced multiple birth rates. The significance of eSET in older women is limited presently, and further research on the strategy to improve cumulative outcomes is necessary.	[Fujimoto, Akihisa] Sanraku Hosp, Dept Obstet & Gynecol, Chiyoda Ku, Tokyo 1018326, Japan; [Fujimoto, Akihisa; Morishima, Kaoru; Harada, Miyuki; Hirata, Tetsuya; Osuga, Yutaka; Fujii, Tomoyuki] Univ Tokyo, Fac Med, Dept Obstet & Gynecol, Bunkyo Ku, Tokyo 1138655, Japan	Fujimoto, A (reprint author), Sanraku Hosp, Dept Obstet & Gynecol, Chiyoda Ku, 2-5 Kanda Surugadai, Tokyo 1018326, Japan.	fujimoto-tky@umin.ac.jp					Bianco A, 1996, OBSTET GYNECOL, V87, P917, DOI 10.1016/0029-7844(96)00045-2; Veleva Z, 2006, HUM REPROD, V21, P2098, DOI 10.1093/humprep/del137; Roque M, 2015, FERTIL STERIL, V103, P1190, DOI 10.1016/j.fertnstert.2015.01.045; Strandell A, 2000, HUM REPROD, V15, P2520, DOI 10.1093/humrep/15.12.2520; Pinborg A, 2005, HUM REPROD UPDATE, V11, P575, DOI 10.1093/humupd/dmi027; Bourgain C, 2003, HUM REPROD UPDATE, V9, P515, DOI 10.1093/humupd/dmg045; Fauque P, 2010, FERTIL STERIL, V94, P927, DOI 10.1016/j.fertnstert.2009.03.105; Gerris J, 1999, HUM REPROD, V14, P2581, DOI 10.1093/humrep/14.10.2581; Niinimaki M, 2013, HUM REPROD, V28, P331, DOI 10.1093/humrep/des399; McLernon DJ, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c6945; Min Jason K, 2010, J Obstet Gynaecol Can, V32, P363; Roque M, 2015, J ASSIST REPROD GEN, V32, P171, DOI 10.1007/s10815-014-0391-0; Veeck LL, 1999, ATLAS HUMAN GAMATES	13	0	0	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1058-0468	1573-7330		J ASSIST REPROD GEN	J. Assist. Reprod. Genet.	DEC	2015	32	12					1773	1779		10.1007/s10815-015-0598-8		7	Genetics & Heredity; Obstetrics & Gynecology; Reproductive Biology	Genetics & Heredity; Obstetrics & Gynecology; Reproductive Biology	CY8FE	WOS:000366643400010		
J	Hiraoka, K; Kitamura, S				Hiraoka, Kenichiro; Kitamura, Seiji			Clinical efficiency of Piezo-ICSI using micropipettes with a wall thickness of 0.625 mu m	JOURNAL OF ASSISTED REPRODUCTION AND GENETICS			English	Article						Fertilization; Human; ICSI; Piezo; Lysis; Wall thickness	INTRACYTOPLASMIC SPERM INJECTION; OVARIAN STIMULATION; OOCYTE; MICROMANIPULATION	The purposes of the present study are to assess the clinical efficiency of Piezo-intracytoplasmic sperm injection (ICSI) and to improve the Piezo-ICSI method for human oocytes. We examined three ICSI methods to determine their clinical efficiency by comparing the survival, fertilization, good-quality day-3 embryo, pregnancy, and live birth rates. The three ICSI methods tested were conventional ICSI (CI) (using beveled spiked micropipettes with a wall thickness of 1 mu m), conventional Piezo-ICSI (CPI) (using flat-tipped micropipettes with a wall thickness of 0.925 mu m), and improved Piezo-ICSI (IPI) (using flat-tipped micropipettes with a wall thickness of 0.625 mu m). We collectively investigated 2020 mature oocytes retrieved from 437 patients between October 2010 and January 2014. The survival rates after CI, CPI, and IPI were 90, 95, and 99 %, respectively. The fertilization rates after CI, CPI, and IPI were 68, 75, and 89 %, respectively. The good-quality day-3 embryo rates after CI, CPI, and IPI were 37, 43, and 55 %, respectively. The pregnancy rates after the transfer of good-quality day-3 embryo of CI, CPI, and IPI were 19, 21, and 31 %, respectively. The live birth rates of CI, CPI, and IPI were 15, 16, and 25 %, respectively. Significantly higher survival, fertilization, good-quality day-3 embryo, pregnancy, and live birth rates were obtained using IPI. When comparing the IPI to the CI and CPI, the results revealed that the Piezo-ICSI using flat-tipped micropipettes with a wall thickness of 0.625 mu m significantly improves survival, fertilization, good-quality day-3 embryo, pregnancy, and live birth rates.	[Hiraoka, Kenichiro] Kameda Med Ctr, Kamogawa, Chiba 2968602, Japan; [Kitamura, Seiji] Ogikubo Hosp, Niji Clin, Suginami Ku, Tokyo 1670051, Japan	Hiraoka, K (reprint author), Kameda Med Ctr, 929 Higashi Cho, Kamogawa, Chiba 2968602, Japan.	hiraoka@oct.email.ne.jp					Dumoulin JCM, 2001, HUM REPROD, V16, P306, DOI 10.1093/humrep/16.2.306; Huang T, 1996, J ASSIST REPROD GEN, V13, P320, DOI 10.1007/BF02070146; Kuwayama M, 2005, REPROD BIOMED ONLINE, V11, P608; Yanagida K, 1999, HUM REPROD, V14, P448, DOI 10.1093/humrep/14.2.448; Abdelmassih S, 2002, HUM REPROD, V17, P2694, DOI 10.1093/humrep/17.10.2694; DIEDRICH K, 1994, HUM REPROD, V9, P788; Hiraoka K, 2009, J ASSIST REPROD GEN, V26, P515, DOI 10.1007/s10815-009-9350-6; Ferraretti AP, 2015, FERTIL STERIL, V104, P333, DOI 10.1016/j.fertnstert.2015.05.006; Ebner T, 2004, HUM REPROD, V19, P1837, DOI 10.1093/humrep/deh325; De Vos A, 2008, HUM REPROD, V23, P1815, DOI 10.1093/humrep/den212; Takeuchi S, 2001, GYNECOL OBSTET INVES, V52, P158, DOI 10.1159/000052965; PALERMO G, 1992, LANCET, V340, P17, DOI 10.1016/0140-6736(92)92425-F; KIMURA Y, 1995, BIOL REPROD, V52, P709, DOI 10.1095/biolreprod52.4.709; Richter Kevin S, 2006, J Exp Clin Assist Reprod, V3, P5, DOI 10.1186/1743-1050-3-5	14	0	0	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1058-0468	1573-7330		J ASSIST REPROD GEN	J. Assist. Reprod. Genet.	DEC	2015	32	12					1827	1833		10.1007/s10815-015-0597-9		7	Genetics & Heredity; Obstetrics & Gynecology; Reproductive Biology	Genetics & Heredity; Obstetrics & Gynecology; Reproductive Biology	CY8FE	WOS:000366643400017		
J	Daduang, R; Kitani, S; Sudoh, Y; Pait, IGU; Thamchaipenet, A; Ikeda, H; Igarashi, Y; Nihira, T				Daduang, Ratama; Kitani, Shigeru; Sudoh, Yuri; Pait, Ivy Grace Umadhay; Thamchaipenet, Arinthip; Ikeda, Haruo; Igarashi, Yasuhiro; Nihira, Takuya			29-Deoxymaklamicin, a new maklamicin analogue produced by a genetically engineered strain of Micromonospora sp NBRC 110955	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Micromonospora; Spirotetronate-class antibiotics; Maklamicin; Cytochrome P450; Hydroxylation	STREPTOMYCES-COELICOLOR A3(2); GENE-CLUSTER; BIOSYNTHESIS; CYTOCHROME-P450; AVERMITILIS; AVERMECTIN; ENZYME	Maklamicin is a spirotetronate-class antibiotic produced by Micromonospora sp. NBRC 110955, and a polyketide assembly line and a glycerate utilization system are involved in its biosynthesis. One tailoring step in the biosynthesis is predicted to be post-polyketide synthase (PKS) modification, which seems to be catalysed by putative cytochrome P450 monooxygenases, MakC2 and/or MakC3. In this study, we characterized makC2 and makC3 in the biosynthesis of maklamicin and identified a new maklamicin analogue from a makC2 disruptant. Gene deletion of makC2 resulted in the complete loss of maklamicin production with concomitant accumulation of a new compound (29-deoxymaklamicin), while gene deletion of makC3 did not affect the maklamicin production, indicating that 29-deoxymaklamicin is an intermediate in the biosynthetic pathway of maklamicin and should serve as the substrate of MakC2. 29-Deoxymaklamicin showed strong-to-modest anti-microbial activity against gram-positive bacteria. The fact that Streptomyces avermitilis heterologously expressing makC2 successfully converted 29-deoxymaklamicin into maklamicin confirmed that MakC2 is the final-step hydroxylase in the formation of mature maklamicin. (c) 2015, The Society for Biotechnology, Japan. All rights reserved.	[Daduang, Ratama; Kitani, Shigeru; Pait, Ivy Grace Umadhay; Nihira, Takuya] Osaka Univ, Int Ctr Biotechnol, Suita, Osaka 5650871, Japan; [Sudoh, Yuri] Hyphagenesis Inc, Machida, Tokyo 1940041, Japan; [Thamchaipenet, Arinthip] Kasetsart Univ, Fac Sci, Dept Genet, Bangkok 10900, Thailand; [Ikeda, Haruo] Kitasato Univ, Kitasato Inst Life Sci, Sagamihara, Kanagawa 2520373, Japan; [Igarashi, Yasuhiro] Toyama Prefectural Univ, Biotechnol Res Ctr, Imizu, Toyama 9390398, Japan; [Nihira, Takuya] Mahidol Univ, Fac Sci, MU OU Collaborat Res Ctr Biosci & Biotechnol, Bangkok 10400, Thailand	Nihira, T (reprint author), Osaka Univ, Int Ctr Biotechnol, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.	nihira@icb.osaka-u.ac.jp			JSPS [24310157, 24651243, 24780071]; Ministry of Education, Culture, Sports, and Technology of Japan	This work was supported in part by a Grant-in-Aid for Scientific Research (B) (No. 24310157) and a Grant-in-Aid for Challenging Exploratory Research (No. 24651243) from JSPS to T.N. and S.K.; by a Grant-in-Aid for Young Scientists (B) (No. 24780071) from JSPS to S.K.; and by a scholarship from the Ministry of Education, Culture, Sports, and Technology of Japan to R.D.	Lamb DC, 2003, BIOCHEM BIOPH RES CO, V307, P610, DOI 10.1016/S0006-291X(03)01231-2; Igarashi Y, 2011, J NAT PROD, V74, P670, DOI 10.1021/np100727h; Olano C, 2010, NAT PROD REP, V27, P571, DOI 10.1039/b911956f; Jia XY, 2006, CHEM BIOL, V13, P575, DOI 10.1016/j.chembiol.2006.03.008; Lamb DC, 2013, EXPERT OPIN DRUG MET, V9, P1279, DOI 10.1517/17425255.2013.806485; Li SM, 2013, ORG LETT, V15, P1374, DOI 10.1021/ol400342e; Pulsawat N, 2007, GENE, V393, P31, DOI 10.1016/j.gene.2006.12.035; Wietzorrek A, 1997, MOL MICROBIOL, V25, P1181, DOI 10.1046/j.1365-2958.1997.5421903.x; Kitani S, 2009, APPL MICROBIOL BIOT, V82, P1089, DOI 10.1007/s00253-008-1850-2; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; Staunton J, 2001, NAT PROD REP, V18, P380, DOI 10.1039/a909079g; Hashimoto T, 2015, J AM CHEM SOC, V137, P572, DOI 10.1021/ja510711x; Yoshigae Y, 2013, BIOCHEMISTRY-US, V52, P4636, DOI 10.1021/bi4004843; Zhang H, 2007, J AM CHEM SOC, V129, P14670, DOI 10.1021/ja0744854; Paget MSB, 1999, J BACTERIOL, V181, P204; Choi KY, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-81; Sambrook J., 2001, MOL CLONING LAB MANU; Vieweg L, 2014, NAT PROD REP, V31, P1554, DOI 10.1039/c4np00015c; Werck-Reichhart D, 2000, GENOME BIOL, V1, P1, DOI DOI 10.1186/GB-2000-1-6-REVIEWS3003	19	0	0	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	DEC	2015	120	6					608	613		10.1016/j.jbiosc.2015.04.004		6	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CY9ZP	WOS:000366765200002		
J	Kudo, K; Watanabe, A; Ujiie, S; Shintani, T; Gomi, K				Kudo, Kanako; Watanabe, Akira; Ujiie, Seiryu; Shintani, Takahiro; Gomi, Katsuya			Purification and enzymatic characterization of secretory glycoside hydrolase family 3 (GH3) aryl beta-glucosidases screened from Aspergillus oryzae genome	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Aspergillus oryzae; beta-Glucosidase; Glycoside hydrolase family 3 (GH3); Aryl beta-glucoside; Isoflavone aglycone	HIGH HYDROLYTIC ACTIVITY; HIGHLY GLUCOSE-TOLERANT; YEAST-CELL SURFACE; ISOFLAVONE GLYCOSIDES; SUBSTRATE-SPECIFICITY; TRANSGLYCOSYLATION ACTIVITY; TRICHODERMA-REESEI; CRYSTAL-STRUCTURES; SOY ISOFLAVONE; BIOAVAILABILITY	By a global search of the genome database of Aspergillus oryzae, we found 23 genes encoding putative beta-glucosidases, among which 10 genes with a signal peptide belonging to glycoside hydrolase family 3 (GH3) were overexpressed in A. oryzae using the improved glaA gene promoter. Consequently, crude enzyme preparations from three strains, each harboring the genes AO090038000223 (bglA), AO090103000127 (bglF), and AO090003001511 (bglJ), showed a substrate preference toward p-nitrophenyl-beta-D-glucopyranoside (pNPGlc) and thus were purified to homogeneity and enzymatically characterized. All the purified enzymes (BglA, BglF, and BglJ) preferentially hydrolyzed aryl beta-glycosides, including pNPGlc, rather than cellobiose, and these enzymes were proven to be aryl beta-glucosidases. Although the specific activity of BglF toward all the substrates tested was significantly low, BglA and BglJ showed appreciably high activities toward pNPGlc and arbutin. The kinetic parameters of BglA and BglJ for pNPGlc suggested that both the enzymes had relatively higher hydrolytic activity toward pNPGlc among the fungal beta-glucosidases reported. The thermal and pH stabilities of BglA were higher than those of Bel, and BglA was particularly stable in a wide pH range (pH 4.5-10). In contrast, BA was the most heat- and alkaline-labile among the three beta-glucosidases. Furthermore, BglA was more tolerant to ethanol than BglJ; as a result, it showed much higher hydrolytic activity toward isoflavone glycosides in the presence of ethanol than BglJ. This study suggested that the mining of novel beta-glucosidases exhibiting higher activity from microbial genome sequences is of great use for the production of beneficial compounds such as isoflavone aglycones. (c) 2015, The Society for Biotechnology, Japan. All rights reserved.	[Kudo, Kanako; Watanabe, Akira; Ujiie, Seiryu; Shintani, Takahiro; Gomi, Katsuya] Tohoku Univ, Grad Sch Agr Sci, Dept Bioind Informat & Genom, Lab Bioind Genom,Aoba Ku, Sendai, Miyagi 9818555, Japan	Gomi, K (reprint author), Tohoku Univ, Grad Sch Agr Sci, Dept Bioind Informat & Genom, Lab Bioind Genom,Aoba Ku, 1-1 Tsutsumidori Amamiyamachi, Sendai, Miyagi 9818555, Japan.	gomi@biochem.tohoku.ac.jp			Ministry of Economy, Trade and Industry, Japan	This study was financially supported in part by the Ministry of Economy, Trade and Industry, Japan.	Suzuki K, 2013, BIOCHEM J, V452, P211, DOI 10.1042/BJ20130054; Machida M, 2008, DNA RES, V15, P173, DOI 10.1093/dnares/dsn020; Uchiyama T, 2013, J BIOL CHEM, V288, P18325, DOI 10.1074/jbc.M113.471342; ROJAS A, 1995, BIOCHEM MOL BIOL INT, V35, P1223; Kaya M, 2008, APPL MICROBIOL BIOT, V79, P51, DOI 10.1007/s00253-008-1393-6; He HY, 2013, APPL BIOCHEM BIOTECH, V169, P870, DOI 10.1007/s12010-012-9936-9; Kono H, 1999, GLYCOCONJUGATE J, V16, P415, DOI 10.1023/A:1007034728857; Hendrich S, 2002, J CHROMATOGR B, V777, P203, DOI 10.1016/S1570-0232(02)00347-1; Kobayashi T, 2007, BIOSCI BIOTECH BIOCH, V71, P646, DOI 10.1271/bbb.60550; Kitamoto N, 1996, APPL MICROBIOL BIOT, V46, P538, DOI 10.1007/s002530050857; Riou C, 1998, APPL ENVIRON MICROB, V64, P3607; Setchell KDR, 2002, AM J CLIN NUTR, V76, P447; KUDOU S, 1991, AGR BIOL CHEM TOKYO, V55, P2227; Hancock SM, 2005, CHEMBIOCHEM, V6, P866, DOI 10.1002/cbic.200400341; Hancock SM, 2006, CURR OPIN CHEM BIOL, V10, P509, DOI 10.1016/j.cbpa.2006.07.015; SOMOGYI M, 1952, J BIOL CHEM, V195, P19; CHEN HZ, 1992, BIOCHIM BIOPHYS ACTA, V1121, P54, DOI 10.1016/0167-4838(92)90336-C; Horii K, 2009, J MOL CATAL B-ENZYM, V59, P297, DOI 10.1016/j.molcatb.2008.11.013; Kawakami Y, 2005, J NUTR BIOCHEM, V16, P205, DOI 10.1016/j.jnutbio.2004.11.005; Ito J, 2008, J MOL CATAL B-ENZYM, V55, P69, DOI 10.1016/j.molcatb.2008.01.003; Lineweaver H, 1934, J AM CHEM SOC, V56, P658, DOI 10.1021/ja01318a036; Langston J, 2006, BBA-PROTEINS PROTEOM, V1764, P972, DOI 10.1016/j.bbapap.2006.03.009; Wang YX, 2011, J AGR FOOD CHEM, V59, P11219, DOI 10.1021/jf203693v; Matsumura K, 2004, J BIOSCI BIOENG, V98, P77, DOI 10.1263/jbb.98.77; Ravindranath MH, 2004, ADV EXP MED BIOL, V546, P121; GOMI K, 1987, AGR BIOL CHEM TOKYO, V51, P2549; Ducret A, 2002, BIOTECHNOL BIOENG, V77, P752, DOI 10.1002/bit.10156; Yang L, 2004, J AGR FOOD CHEM, V52, P1940, DOI 10.1021/jf030476c; XU X, 1995, J NUTR, V125, P2307; Miura T, 2002, BIOSCI BIOTECH BIOCH, V66, P2626, DOI 10.1271/bbb.66.2626; Kuo LC, 2008, J AGR FOOD CHEM, V56, P119, DOI 10.1021/jf072287q; Bhatia Y, 2005, APPL MICROBIOL BIOT, V66, P527, DOI 10.1007/s00253-004-1754-8; Murray P, 2004, PROTEIN EXPRES PURIF, V38, P248, DOI 10.1016/j.pep.2004.08.006; Bhatia Y, 2002, CRIT REV BIOTECHNOL, V22, P375, DOI 10.1080/07388550290789568; Sato H, 2011, APPL MICROBIOL BIOT, V92, P961, DOI 10.1007/s00253-011-3422-0; Machida M, 2005, NATURE, V438, P1157, DOI 10.1038/nature04300; Saha BC, 1996, APPL ENVIRON MICROB, V62, P3165; Decker CH, 2001, APPL MICROBIOL BIOT, V55, P157, DOI 10.1007/s002530000462; Brown J. P., 1998, ROLE GUT FLORA TOXIC, P109; Cappelletti V, 2000, J CELL BIOCHEM, V79, P594, DOI 10.1002/1097-4644(20001215)79:4<594::AID-JCB80>3.0.CO;2-4; Eyzaguirre J, 2005, HANDBOOK OF CARBOHYDRATE ENGINEERING, P645; Karkehabadi S, 2014, J BIOL CHEM, V289, P31624, DOI 10.1074/jbc.M114.587766; Ketudat CJR, 2010, CELL MOL LIFE SCI, V67, P3389, DOI DOI 10.1007/S00018-010-0399-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Messina M., 1999, AM J CLIN NUTR S, V70, P439; Minetoki T., 2003, J BIOL MACROMOL, V3, P89; Nelson N, 1944, J BIOL CHEM, V153, P375; Odoux E, 2003, J AGR FOOD CHEM, V51, P3168, DOI 10.1021/jf0260388; Siegel D., 2000, J BIOL CHEM, V275, P4973; Winterhalter P, 1997, Adv Biochem Eng Biotechnol, V55, P73	50	0	0	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	DEC	2015	120	6					614	623		10.1016/j.jbiosc.2015.03.019		10	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CY9ZP	WOS:000366765200003		
J	Shimafuji, C; Noguchi, M; Nishie, M; Nagao, J; Shioya, K; Zendo, T; Nakayama, J; Sonomoto, K				Shimafuji, Chinatsu; Noguchi, Megumi; Nishie, Mami; Nagao, Jun-ichi; Shioya, Kouki; Zendo, Takeshi; Nakayama, Jiro; Sonomoto, Kenji			In vitro catalytic activity of N-terminal and C-terminal domains in NukM, the post-translational modification enzyme of nukacin ISK-1	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Lantibiotic; Nukacin ISK-1; Unusual amino acids; Modification enzyme; Peptide engineering	STAPHYLOCOCCUS-WARNERI ISK-1; NONPROTEINOGENIC AMINO-ACIDS; LACTICIN 481 SYNTHETASE; NISIN LEADER PEPTIDE; LANTIBIOTIC BIOSYNTHESIS; LACTOCOCCUS-LACTIS; SUBSTRATE; IDENTIFICATION; SPECIFICITY; CYCLIZATION	Lantibiotics are antibacterial peptides containing unique thioether cross-links termed lanthionine and methyllanthionine. NukM, the modifying enzyme of nukacin ISK-1, which is produced by Staphylococcus warneri ISK-1, catalyzes the dehydration of specific Ser/Thr residues in a precursor peptide, followed by conjugative addition of intramolecular Cys to dehydrated residues to generate a cyclic structure. By contrast, the precursor peptide of nisin is modified by 2 enzymes, NisB and NisC, which mediate dehydration and cyclization, respectively. While the C-terminal domain of NukM is homologous to NisC, the N-terminal domain has no homology with other known proteins. We expressed and characterized the N- and C-terminal domains of NukM, NukM(N), and NukM(C) separately. In vitro reconstitution revealed that full-length NukM fully modified the substrate peptide NukA. NukM(N) partially phosphorylated, dehydrated, and cyclized NukA. By contrast, NukM(C) did not catalyze dehydration, phosphorylation, or cyclization reactions. Interaction studies using surface plasmon resonance analysis indicated that NukM and NukM(N) can bind NukA with high affinity, whereas NukM(C) has low substrate-recognition activity. These results suggest that NukM(N) is mainly responsible for substrate recognition and dehydration and that the whole NukM structure, including the C-terminal domain, is required for the complete modification of NukA. To the best of our knowledge, this is the first report providing insights into the in vitro catalytic activity of individual domains of a LanM-type modification enzyme. (c) 2015, The Society for Biotechnology, Japan. All rights reserved.	[Shimafuji, Chinatsu; Noguchi, Megumi; Nishie, Mami; Shioya, Kouki; Zendo, Takeshi; Nakayama, Jiro; Sonomoto, Kenji] Kyushu Univ, Grad Sch, Lab Microbial Technol,Fac Agr, Div Syst Bioengn,Dept Biosci & Biotechnol,Higashi, Fukuoka 8128581, Japan; [Nagao, Jun-ichi] Fukuoka Dent Coll, Sect Infect Biol, Dept Funct Biosci, Sawara Ku, Fukuoka 8140193, Japan; [Sonomoto, Kenji] Kyushu Univ, Lab Funct Food Design, Dept Funct Metab Design, Bioarchitecture Ctr,Higashi Ku, Fukuoka 8128581, Japan	Sonomoto, K (reprint author), Kyushu Univ, Grad Sch, Lab Microbial Technol,Fac Agr, Div Syst Bioengn,Dept Biosci & Biotechnol,Higashi, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	momiwo94@gmail.com; n.megumi3224@gmail.com; mami.nishie@gmail.com; jungao@college.fdcnet.ac.jp; raleigh.blackpearl@gmail.com; zendo@agr.kyushu-u.ac.jp; nakayama@agr.kyushu-u.ac.jp; sonomoto@agr.kyushu-u.ac.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI [26292040]; Novartis Foundation (Japan) for the Promotion of Science; Novozymes Japan Research Fund; Nagase Science and Technology Foundation	This work was partially supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Number 26292040, and grants from the Novartis Foundation (Japan) for the Promotion of Science, the Novozymes Japan Research Fund, and the Nagase Science and Technology Foundation.	Shioya K, 2010, APPL MICROBIOL BIOT, V86, P891, DOI 10.1007/s00253-009-2334-8; Patton GC, 2005, CURR OPIN MICROBIOL, V8, P543, DOI 10.1016/j.mib.2005.08.008; Bierbaum G, 2009, CURR PHARM BIOTECHNO, V10, P2; Chatterjee C, 2005, J AM CHEM SOC, V127, P15332, DOI 10.1021/ja0543043; Nagao JI, 2006, J BIOSCI BIOENG, V102, P139, DOI 10.1263/jbb.102.139; Nagao J, 2005, BIOCHEM BIOPH RES CO, V336, P507, DOI 10.1016/j.bbrc.2005.08.125; Rink R, 2007, BIOCHEMISTRY-US, V46, P13179, DOI 10.1021/bi700106z; van Saparoea HBV, 2008, APPL ENVIRON MICROB, V74, P5541, DOI 10.1128/AEM.00342-08; You YO, 2009, ACS CHEM BIOL, V4, P379, DOI 10.1021/cb800309v; Nagao J, 2009, PEPTIDES, V30, P1412, DOI 10.1016/j.peptides.2009.05.021; Li B, 2006, SCIENCE, V311, P1464, DOI 10.1126/science.1121422; Levengood MR, 2009, J AM CHEM SOC, V131, P12024, DOI 10.1021/ja903239s; Mavaro A, 2011, J BIOL CHEM, V286, P30552, DOI 10.1074/jbc.M111.263210; Sashihara T, 2000, BIOSCI BIOTECH BIOCH, V64, P2420, DOI 10.1271/bbb.64.2420; Rea MC, 2011, PROKARYOTIC ANTIMICROBIAL PEPTIDES: FROM GENES TO APPLICATIONS, P29, DOI 10.1007/978-1-4419-7692-5_3; You YO, 2007, BIOCHEMISTRY-US, V46, P5991, DOI 10.1021/bi602663x; Levengood MR, 2009, CHEMBIOCHEM, V10, P911, DOI 10.1002/cbic.200800752; Levengood MR, 2007, J AM CHEM SOC, V129, P10314, DOI 10.1021/ja072967+; Khusainov R, 2013, FEBS OPEN BIO, V3, P237, DOI 10.1016/j.fob.2013.05.001; Aso Y, 2004, BIOSCI BIOTECH BIOCH, V68, P1663, DOI 10.1271/bbb.68.1663; Aso Y, 2005, BIOSCI BIOTECH BIOCH, V69, P1403, DOI 10.1271/bbb.69.1403; Paul M, 2007, BIOCHEMISTRY-US, V46, P6268, DOI 10.1021/bi7000104; VANDERMEER JR, 1994, J BIOL CHEM, V269, P3555; Patton GC, 2008, BIOCHEMISTRY-US, V47, P7342, DOI 10.1021/bi800277d; Kuipers A, 2004, J BIOL CHEM, V279, P22176, DOI 10.1074/jbc.M312789200; Uguen P, 2000, J BACTERIOL, V182, P5262, DOI 10.1128/JB.182.18.5262-5266.2000; Sambrook J., 2001, MOL CLONING LAB MANU	27	0	0	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	DEC	2015	120	6					624	629		10.1016/j.jbiosc.2015.03.020		6	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CY9ZP	WOS:000366765200004		
J	Minamihata, K; Maeda, Y; Yamaguchi, S; Ishihara, W; Ishiwatari, A; Takamori, S; Yamahira, S; Nagamune, T				Minamihata, Kosuke; Maeda, Yasukazu; Yamaguchi, Satoshi; Ishihara, Wataru; Ishiwatari, Akira; Takamori, Satoshi; Yamahira, Shinya; Nagamune, Teruyuki			Photosensitizer and polycationic peptide-labeled streptavidin as a nano-carrier for light-controlled protein transduction	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Protein transduction; Photosensitizer; Cell-permeable peptides; Nano-carrier; Streptavidin	CELL-PENETRATING PEPTIDES; DELIVERY	Transductions of exogenous proteins into cells enable the precise study of the effect of the transduced proteins on cellular functions. Accordingly, the protein transduction technique, which can control the release of proteins into the cytosol with certainty and high-throughput, is highly desired in various research fields. In this study, streptavidin (SA) labeled with a photosensitizer and cell-permeable peptides (CPP) was proposed as a nano-carrier for light-controlled protein transduction. SA was modified with biotinylated oligo-arginine peptides (R-pep), which were functionalized with Alexa Fluor 546 (AF546), to achieve cell penetrating and endosomal escape functionalities. The SA-R-pep complex was efficiently internalized into living HeLa cells corresponding to the length and the modification number of R-pep. SA conjugated with more than three equimolar AF546-modified R-pep consisting of fifteen arginine residues was achieved to diffuse throughout the cytosol without cytotoxicity by irradiation of the excitation light for AF546. The optimized nanocarrier was confirmed to transduce a biotinylated model cargo protein, enhanced green fluorescent protein fused with thioredoxin (tEGFP) into the cytosol at the light-irradiated area. The results provided proof-of-principle that SA possessing multiple AF546-modified R-pep has the potential to be a versatile and facile carrier for light-controlled protein transduction into the cytosol of mammalian cells. (C) 2015, The Society for Biotechnology, Japan. All rights reserved.	[Minamihata, Kosuke; Maeda, Yasukazu; Yamaguchi, Satoshi; Ishihara, Wataru; Ishiwatari, Akira; Takamori, Satoshi; Yamahira, Shinya; Nagamune, Teruyuki] Univ Tokyo, Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan; [Nagamune, Teruyuki] Univ Tokyo, Sch Engn, Dept Bioengn, Bunkyo Ku, Tokyo 1138656, Japan	Nagamune, T (reprint author), Univ Tokyo, Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	nagamune@bio.t.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan; Center for NanoBio Integration at The University of Tokyo;  [21760634]	This work was supported in part by the Ministry of Education, Culture, Sports, Science and Technology, Japan, a Grant-in-Aid for Young Scientists (B) No. 21760634, and the Center for NanoBio Integration at The University of Tokyo.	Copolovici DM, 2014, ACS NANO, V8, P1972, DOI 10.1021/nn4057269; Zhang Y, 2008, CURR OPIN BIOTECH, V19, P506, DOI 10.1016/j.copbio.2008.07.005; Brooks H, 2005, ADV DRUG DELIVER REV, V57, P559, DOI 10.1016/j.addr.2004.12.001; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005; Rols MP, 1998, NAT BIOTECHNOL, V16, P168, DOI 10.1038/nbt0298-168; Leader B, 2008, NAT REV DRUG DISCOV, V7, P21, DOI 10.1038/nrd2399; Heng BC, 2005, MED HYPOTHESES, V64, P1105, DOI 10.1016/j.mehy.2005.01.011; Berg K, 1999, CANCER RES, V59, P1180; Behr JP, 1997, CHIMIA, V51, P34; Vermonden T, 2012, CHEM REV, V112, P2853, DOI 10.1021/cr200157d; Futami J, 2005, J BIOSCI BIOENG, V99, P95, DOI 10.1263/jbb.99.095; Varkouhi AK, 2011, J CONTROL RELEASE, V151, P220, DOI 10.1016/j.jconrel.2010.11.004; Wu J, 2006, ULTRASONICS, V44, pE21, DOI 10.1016/j.ultras.2006.06.033; Futaki S, 2001, J BIOL CHEM, V276, P5836, DOI 10.1074/jbc.M007540200; Hasadsri L, 2009, J BIOL CHEM, V284, P6972, DOI 10.1074/jbc.M805956200; Endoh T, 2008, BIOCONJUGATE CHEM, V19, P1017, DOI 10.1021/bc800020n; Torchilin VP, 2005, NAT REV DRUG DISCOV, V4, P145, DOI 10.1038/nrd1632; Matsushita M, 2004, FEBS LETT, V572, P221, DOI 10.1016/j.febslet.2004.07.033; Thompson DB, 2012, CHEM BIOL, V19, P831, DOI 10.1016/j.chembiol.2012.06.014; Milletti F, 2012, DRUG DISCOV TODAY, V17, P850, DOI 10.1016/j.drudis.2012.03.002; Patel LN, 2007, PHARM RES, V24, P1977, DOI 10.1007/s11095-007-9303-7; Hapala I, 1997, CRIT REV BIOTECHNOL, V17, P105, DOI 10.3109/07388559709146609; Miller D. S., 1985, P NATL ACAD SCI USA, V81, P1426	23	0	0	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	DEC	2015	120	6					630	636		10.1016/j.jbiosc.2015.04.001		7	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CY9ZP	WOS:000366765200005		
J	Treebupachatsakul, T; Shioya, K; Nakazawa, H; Kawaguchi, T; Morikawa, Y; Shida, Y; Ogasawara, W; Okada, H				Treebupachatsakul, Treesukon; Shioya, Koki; Nakazawa, Hikaru; Kawaguchi, Takashi; Morikawa, Yasushi; Shida, Yosuke; Ogasawara, Wataru; Okada, Hirofumi			Utilization of recombinant Trichoderma reesei expressing Aspergillus aculeatus beta-glucosidase I (JN11) for a more economical production of ethanol from lignocellulosic biomass	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Trichoderma reesei; Aspergillus aculeatus BGL I; Simultaneous saccharification and fermentation; Separate hydrolysis and fermentation; Ethanol	SACCHAROMYCES-CEREVISIAE; ENZYMATIC-HYDROLYSIS; SIMULTANEOUS SACCHARIFICATION; CELLOBIOHYDROLASE I; FUEL ETHANOL; FERMENTATION; CELLULOSE; INHIBITION; CELLULASES; ADSORPTION	The capacity of Trichoderma reesei cellulase to degrade lignocellulosic biomass has been enhanced by the construction of a recombinant T. reesei strain expressing Aspergillus aculeatus beta-glucosidase I. We have confirmed highly efficient ethanol production from converge-milled Japanese cedar by recombinant T. reesei expressing A. aculeatus beta-glucosidase I (JN11). We investigated the ethanol productivity of JN11 and compared it with the cocktail enzyme T. reesei PC-3-7 with reinforced cellobiase activity by the commercial Novozyme 188. Results showed that the ethanol production efficiency under enzymatic hydrolysis of JN11 was comparable to the cocktail enzyme both on simultaneous saccharification and fermentation (SSF) or separate hydrolysis and fermentation (SHF) processes. Moreover, the cocktail enzyme required more protein loading for attaining similar levels of ethanol conversion as JN11. We propose that JN11 is an intrinsically economical enzyme that can eliminate the supplementation of BGL for PC-3-7, thereby reducing the cost of industrial ethanol production from lignocellulosic biomass. (c) 2015, The Society for Biotechnology, Japan. All rights reserved.	[Treebupachatsakul, Treesukon; Shioya, Koki; Nakazawa, Hikaru; Morikawa, Yasushi; Shida, Yosuke; Ogasawara, Wataru; Okada, Hirofumi] Nagaoka Univ Technol, Dept Bioengn, Nagaoka, Niigata 9402188, Japan; [Kawaguchi, Takashi] Osaka Prefecture Univ, Grad Sch Agr & Biol Sci, Sakai, Osaka 5998531, Japan; [Kawaguchi, Takashi] Osaka Prefecture Univ, Res Inst Adv Sci & Technol, Sakai, Osaka 5998531, Japan	Ogasawara, W (reprint author), Nagaoka Univ Technol, Dept Bioengn, Kamitomioka Cho 1603-1, Nagaoka, Niigata 9402188, Japan.	owataru@vos.nagaokaut.ac.jp					Adney B., 1996, NRELTP51042628; Zhang YHP, 2004, BIOTECHNOL BIOENG, V88, P797, DOI 10.1002/bit.20282; Kang HW, 2012, BIOPROC BIOSYST ENG, V35, P115, DOI 10.1007/s00449-011-0621-0; Vasquez MP, 2007, APPL BIOCHEM BIOTECH, V137, P141, DOI 10.1007/s12010-007-9046-2; Wang MY, 2012, ADV BIOCHEM ENG BIOT, V128, P1, DOI 10.1007/10_2011_131; Gusakov AV, 2011, TRENDS BIOTECHNOL, V29, P419, DOI 10.1016/j.tibtech.2011.04.004; Mussatto SI, 2010, BIOTECHNOL ADV, V28, P817, DOI 10.1016/j.biotechadv.2010.07.001; Galbe M, 2002, APPL MICROBIOL BIOT, V59, P618, DOI 10.1007/s00253-002-1058-9; Gray KA, 2006, CURR OPIN CHEM BIOL, V10, P141, DOI 10.1016/j.cbpa.2006.02.035; Du FY, 2010, APPL BIOCHEM BIOTECH, V161, P313, DOI 10.1007/s12010-009-8796-4; Sun Y, 2002, BIORESOURCE TECHNOL, V83, P1, DOI 10.1016/S0960-8524(01)00212-7; PHILIPPIDIS GP, 1993, BIOTECHNOL BIOENG, V41, P846, DOI 10.1002/bit.260410903; Xiao ZZ, 2004, APPL BIOCHEM BIOTECH, V113, P1115; Stanley D, 2010, J APPL MICROBIOL, V109, P13, DOI 10.1111/j.1365-2672.2009.04657.x; Medve J, 1998, BIOTECHNOL BIOENG, V59, P621, DOI 10.1002/(SICI)1097-0290(19980905)59:5<621::AID-BIT13>3.0.CO;2-C; SOMOGYI M, 1952, J BIOL CHEM, V195, P19; Sugimoto N, 2012, LANGMUIR, V28, P14323, DOI 10.1021/la302352k; Boer H, 2000, BIOTECHNOL BIOENG, V69, P486, DOI 10.1002/1097-0290(20000905)69:5<486::AID-BIT3>3.0.CO;2-N; Mansfield SD, 1999, BIOTECHNOL PROGR, V15, P804, DOI 10.1021/bp9900864; Xu F, 2008, J MOL CATAL B-ENZYM, V51, P42, DOI 10.1016/j.molcatb.2007.10.004; Lee WH, 2013, J BIOTECHNOL, V167, P316, DOI 10.1016/j.jbiotec.2013.06.016; de Souza CJA, 2012, BIORESOURCE TECHNOL, V109, P63, DOI 10.1016/j.biortech.2012.01.024; Berlin A, 2007, BIOTECHNOL BIOENG, V97, P287, DOI 10.1002/bit.21238; Merino ST, 2007, ADV BIOCHEM ENG BIOT, V108, P95, DOI 10.1007/10_2007_066; NEVADO J, 1993, YEAST, V9, P111, DOI 10.1002/yea.320090202; Demain AL, 2009, J IND MICROBIOL BIOT, V36, P319, DOI 10.1007/s10295-008-0521-8; KAWAMORI M, 1986, APPL MICROBIOL BIOT, V24, P449; Palmqvist E, 2000, BIORESOURCE TECHNOL, V74, P17, DOI 10.1016/S0960-8524(99)00160-1; Kawai T, 2012, J IND MICROBIOL BIOT, V39, P1741, DOI 10.1007/s10295-012-1195-9; Lynd LR, 2005, CURR OPIN BIOTECH, V16, P577, DOI 10.1016/j.copbio.2005.08.009; Arantes V, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-3; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lau MW, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-11; Nakazawa H., 2011, BIOTECHNOL BIOENG, V109, P92; Olofsson K, 2008, BIOTECHNOL BIOFUELS, V1, P1, DOI DOI 10.1186/1754-6834-1-7.PMCID:PMC2397418; Palonen H, 2004, J BIOTECHNOL, V107, P65, DOI 10.1016/j.jbiotec.2003.09.011; Rana V, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-516; Rosgaard J., 2007, BIOTECHNOL PROGR, V23, P1270; Sanchez OJ, 2008, BIORESOURCE TECHNOL, V99, P5270, DOI 10.1016/j.biortech.2007.11.013; Shuster A, 2010, APPL MICROBIOL BIOT, V87, P787; Timell T. E., 1967, Wood Science and Technology, V1, P45; TOMME P, 1988, EUR J BIOCHEM, V170, P575, DOI 10.1111/j.1432-1033.1988.tb13736.x; van Maris AJA, 2006, ANTON LEEUW INT J G, V90, P391, DOI 10.1007/s10482-006-9085-7	43	0	0	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	DEC	2015	120	6					657	665		10.1016/j.jbiosc.2015.04.015		9	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CY9ZP	WOS:000366765200009		
J	Funahashi, E; Saiki, K; Honda, K; Sugiura, Y; Kawano, Y; Ohtsu, I; Watanabe, D; Wakabayashi, Y; Abe, T; Nakanishi, T; Suematsu, M; Takagi, H				Funahashi, Eri; Saiki, Kyohei; Honda, Kurara; Sugiura, Yuki; Kawano, Yusuke; Ohtsu, Iwao; Watanabe, Daisuke; Wakabayashi, Yukari; Abe, Tetsuya; Nakanishi, Tsuyoshi; Suematsu, Makoto; Takagi, Hiroshi			Finding of thiosulfate pathway for synthesis of organic sulfur compounds in Saccharomyces cerevisiae and improvement of ethanol production	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Saccharomyces cerevisiae; Thiosulfate assimilation; Ethanol production; Pentose phoshate pathway; Sulfur metabolism; Sulfur metabolome	L-CYSTEINE PRODUCTION; ESCHERICHIA-COLI; METABOLISM; METHYLGLYOXAL; BIOSYNTHESIS; ASSIMILATION; ENHANCEMENT; YEAST; YCIW; GENE	We found that Saccharomyces cerevisiae utilizes thiosulfate as a sole sulfur source. The energetically-favored thiosulfate rather than sulfate as sulfur sources is also more effective for improving growth and ethanol-production rate in S. cerevisiae due to high levels of intracellular NADPH during thiosulfate utilization. (c) 2015, The Society for Biotechnology, Japan. All rights reserved.	[Funahashi, Eri; Saiki, Kyohei; Kawano, Yusuke; Ohtsu, Iwao; Watanabe, Daisuke; Takagi, Hiroshi] Nara Inst Sci & Technol, Grad Sch Biol Sci, Ikoma, Nara 6300192, Japan; [Wakabayashi, Yukari; Abe, Tetsuya] Kyowa Hakko Bio Co Ltd, Tech Res Labs, Hofu, Yamaguchi 7478522, Japan; [Nakanishi, Tsuyoshi] Shimadzu Co, MS Business Unit, Nakagyo Ku, Kyoto 6048511, Japan; [Honda, Kurara; Sugiura, Yuki; Suematsu, Makoto] Keio Univ, Sch Med, Dept Biochem, Shinjyuku Ku, Tokyo 1608582, Japan	Ohtsu, I (reprint author), Nara Inst Sci & Technol, Grad Sch Biol Sci, 8916-5 Takayama Cho, Ikoma, Nara 6300192, Japan.	iohtsu@bs.naist.jp			Kyowa Hakko Bio Co., Ltd; KAKENHI from the Japan Society for the Promotion of Science [26450091]; Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry [26027AB]	Metabolomic analyses were supported partly by Biobank Japan Project from MEXT, Japan. This work was supported in part by a grant from Kyowa Hakko Bio Co., Ltd to I.O. This work was also supported by KAKENHI [Grant-in-Aid for Scientific Research (C) (26450091)] from the Japan Society for the Promotion of Science, and by Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry (26027AB) to I.O.	Ohtsu I, 2010, J BIOL CHEM, V285, P17479, DOI 10.1074/jbc.M109.081356; YAMAGATA S, 1974, J BIOCHEM-TOKYO, V75, P1221; KREDICH NM, 1966, J BIOL CHEM, V241, P4955; Sugiura Y, 2014, PROTEOMICS, V14, P829, DOI 10.1002/pmic.201300047; Ravilious GE, 2012, NAT PROD REP, V29, P1138, DOI 10.1039/c2np20009k; CHEREST H, 1969, J BACTERIOL, V97, P328; Ingenbleek Y, 2013, NUTR REV, V71, P413, DOI 10.1111/nure.12050; KERJAN P, 1986, NUCLEIC ACIDS RES, V14, P7861, DOI 10.1093/nar/14.20.7861; Marzluf GA, 1997, ANNU REV MICROBIOL, V51, P73, DOI 10.1146/annurev.micro.51.1.73; Martins AMTBS, 2001, FEBS LETT, V499, P41, DOI 10.1016/S0014-5793(01)02519-4; Kalapos MP, 1999, TOXICOL LETT, V110, P145, DOI 10.1016/S0378-4274(99)00160-5; Jez JM, 2013, CURR OPIN STRUC BIOL, V23, P302, DOI 10.1016/j.sbi.2013.02.011; Kawano Y, 2015, J BIOSCI BIOENG, V119, P310, DOI 10.1016/j.jbiosc.2014.08.012; Kawano Y, 2015, J BIOSCI BIOENG, V119, P176, DOI 10.1016/j.jbiosc.2014.07.006; Nakatani T, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-62; Ohtsu I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120619; Wiriyathanawudhiwong N, 2009, APPL MICROBIOL BIOT, V81, P903, DOI 10.1007/s00253-008-1686-9	17	0	0	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	DEC	2015	120	6					666	669		10.1016/j.jbiosc.2015.04.011		4	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CY9ZP	WOS:000366765200010		
J	Sato, Y; Sugimoto, N; Higashiyama, T; Arata, H				Sato, Yoshikatsu; Sugimoto, Nagisa; Higashiyama, Tetsuya; Arata, Hideyuki			Quantification of pollen tube attraction in response to guidance by female gametophyte tissue using artificial microscale pathway	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Plant reproduction; Pollen tube; Ovule; Pollen tube guidance; Torenia fournieri; Purification; Polydimethylsiloxane; Microchip; Microchannel; Micro-electro-mechanical system	TORENIA-FOURNIERI; SYNERGID CELL; IN-VITRO; DEVICES; FABRICATION; ARRAYS; MEMS; DNA	We developed two types of artificial platforms, T-junction and crossroad microchannel devices, and obtained guidance response ratio of pollen tubes to the female tissue as 56-57%. The crossroad device was also able to collect the attracted pollen tubes with high purity, which is useful for future omics analysis. (c) 2015, The Society for Biotechnology, Japan. All rights reserved.	[Sato, Yoshikatsu; Sugimoto, Nagisa; Higashiyama, Tetsuya] Nagoya Univ, Inst Transformat Biomol ITbM, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Higashiyama, Tetsuya; Arata, Hideyuki] Nagoya Univ, JST, ERATO, Higashiyama Live Holon Project,Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Higashiyama, Tetsuya; Arata, Hideyuki] Nagoya Univ, Grad Sch Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Sato, Y (reprint author), Nagoya Univ, Inst Transformat Biomol ITbM, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648602, Japan.	sato.yoshikatsu@i.mbox.nagoya-u.ac.jp	Sato, Yoshikatsu/I-6129-2014		Japan Advanced Plant Science Network; Exploratory Research for Advanced Technology (ERATO), the Japan Science and Technology Agency (JST); Japan Society for the Promotion of Science [25706013, 25650075]	We thank Mr. Motoki Kuzuya for sample preparation and Dr. Mitsuhiro Horade for technical support in fabricating microchannel devices. Part of this work was conducted at the Institute of Transformative Bio-Molecules (ITbM) at Nagoya University, supported by the Japan Advanced Plant Science Network. This work was partly supported by Exploratory Research for Advanced Technology (ERATO), the Japan Science and Technology Agency (JST), and grants from the Japan Society for the Promotion of Science (25706013 to H.A. and 25650075 to Y.S.).	Judy JW, 2001, SMART MATER STRUCT, V10, P1115, DOI 10.1088/0964-1726/10/6/301; Agudelo CG, 2013, PLANT J, V73, P1057, DOI 10.1111/tpj.12093; Arata HF, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2177374; Higashiyama T, 2001, SCIENCE, V293, P1480, DOI 10.1126/science.1062429; Okuda S, 2009, NATURE, V458, P357, DOI 10.1038/nature07882; Hosokawa K, 2004, LAB CHIP, V4, P181, DOI 10.1039/b403930k; Arata HF, 2009, INTEGR BIOL, V1, P363, DOI 10.1039/b901902b; Horade M, 2013, RSC ADV, V3, P22301, DOI 10.1039/c3ra42804d; Arata H, 2012, ANALYST, V137, P3234, DOI 10.1039/c2an16154k; Arata H, 2009, P NATL ACAD SCI USA, V106, P19239, DOI 10.1073/pnas.0902234106; Yetisen AK, 2011, J MICROMECH MICROENG, V21, DOI 10.1088/0960-1317/21/5/054018; Higashiyama T, 1998, PLANT CELL, V10, P2019; Yager P, 2006, NATURE, V442, P412, DOI 10.1038/nature05064; Park J, 2014, SENSOR ACTUAT B-CHEM, V191, P178, DOI 10.1016/j.snb.2013.09.060; Higashiyama T, 2006, PLANT PHYSIOL, V142, P481, DOI 10.1104/pp.106.083832; Horade M, 2014, MICROELECTRON ENG, V118, P25, DOI 10.1016/j.mee.2014.01.017; Arata H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048329; Palanivelu R, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-7; Rondelez Y, 2005, NAT BIOTECHNOL, V23, P361, DOI 10.1038/nbt1072; Sanati Nezhad Amir, 2013, Proc Natl Acad Sci U S A, V110, P8093, DOI 10.1073/pnas.1221677110	20	0	0	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	DEC	2015	120	6					697	700		10.1016/j.jbiosc.2015.03.021		4	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CY9ZP	WOS:000366765200015		
J	Matsuyama, R; Tsutsui, T; Lee, KH; Onitsuka, M; Omasa, T				Matsuyama, Rima; Tsutsui, Tomomi; Lee, Kyoung Ho; Onitsuka, Masayoshi; Omasa, Takeshi			Improved gene amplification by cell-cycle engineering combined with the Cre-loxP system in Chinese hamster ovary cells	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Chinese hamster ovary cells; Gene amplification; Bispecific antibody; Cre-loxP system; Cell cycle	CHO-CELLS; CHROMOSOME REARRANGEMENT; MAMMALIAN-CELLS; 25 HOMOLOG; CDC25B; EXPRESSION; TRANSGENE; LINES; DNA; INTEGRATION	The dihydrofolate reductase gene amplification system is widely used in Chinese hamster ovary (CHO) cells for the industrial production of therapeutic proteins. To enhance the efficiency of conventional gene amplification systems, we previously presented a novel method using cell-cycle checkpoint engineering. Here, we constructed high-producing and stable cells by the conditional expression of mutant cell division cycle 25 homolog B (CDC25B) using the Cre-loxP system. A bispecific antibody-producing CHO DG44-derived cell line was transfected with foxed mutant CDC25B. After inducing gene amplification in the presence of 250 nM methotrexate, mutant CDC25B sequence was removed by Cre recombinase protein expression. Overexpression of the foxed mutant CDC25B significantly enhanced the efficiency of transgene amplification and productivity. Moreover, the specific production rate of the isolated clone CHO Cre-1 and Cre-2 were approximately 11-fold and 15-fold higher than that of mock-transfected clone CHO Mock-S. Chromosomal aneuploidy was increased by mutant CDC25B overexpression, but Cre-1 and Cre-2 did not show any changes in chromosome number during long-term cultivation, as is the case with CHO Mock-S. Our results suggest that high-producing and stable cells can be constructed by conditionally controlling a cell-cycle checkpoint integrated in conventional gene amplification systems. (c) 2015, The Society for Biotechnology, Japan. All rights reserved.	[Matsuyama, Rima; Tsutsui, Tomomi; Onitsuka, Masayoshi; Omasa, Takeshi] Univ Tokushima, Inst Sci & Technol, Tokushima 7708506, Japan; [Lee, Kyoung Ho; Omasa, Takeshi] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan	Omasa, T (reprint author), Osaka Univ, Grad Sch Engn, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.	omasa@bio.eng.osaka-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [26630433, 26249125]; Ministry of Economy, Trade and Industry, Japan	This work was partially supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS) (nos. 26630433 and 26249125) and a grant for the project focused on developing key technology of discovering and manufacturing drug for next-generation treatment and diagnosis from Ministry of Economy, Trade and Industry, Japan.	Gandor C, 1995, FEBS LETT, V377, P290, DOI 10.1016/0014-5793(95)01328-8; Lattenmayer C, 2006, CYTOTECHNOLOGY, V51, P171, DOI 10.1007/s10616-006-9029-0; Lee KH, 2013, J BIOSCI BIOENG, V116, P754, DOI 10.1016/j.jbiosc.2013.05.032; RENNER WA, 1995, BIOTECHNOL BIOENG, V47, P476, DOI 10.1002/bit.260470409; Bi JX, 2004, BIOTECHNOL BIOENG, V85, P741, DOI 10.1002/bit.20025; Sunley K, 2010, BIOTECHNOL ADV, V28, P385, DOI 10.1016/j.biotechadv.2010.02.003; Kameyama Y, 2010, BIOTECHNOL BIOENG, V105, P1106, DOI 10.1002/bit.22619; Kim WD, 2010, APPL MICROBIOL BIOT, V85, P535, DOI 10.1007/s00253-009-2152-z; Walsh G, 2006, NAT BIOTECHNOL, V24, P1241, DOI 10.1038/nbt1252; Obayashi H, 2012, J BIOSCI BIOENG, V113, P381, DOI 10.1016/j.jbiosc.2011.10.027; WILSON C, 1990, ANNU REV CELL BIOL, V6, P679, DOI 10.1146/annurev.cb.06.110190.003335; Omasa T, 2002, J BIOSCI BIOENG, V94, P600, DOI 10.1016/S1389-1723(02)80201-8; Boutros R, 2007, NAT REV CANCER, V7, P495, DOI 10.1038/nrc2169; Davezac N, 2000, ONCOGENE, V19, P2179, DOI 10.1038/sj.onc.1203545; Cao YH, 2012, BIOTECHNOL BIOENG, V109, P1357, DOI 10.1002/bit.24347; Weikert S, 1999, NAT BIOTECHNOL, V17, P1116; Cacciatore JJ, 2010, BIOTECHNOL ADV, V28, P673, DOI 10.1016/j.biotechadv.2010.04.003; Aressy B, 2008, CELL CYCLE, V7, P2234; Bugler B, 2006, MOL CANCER THER, V5, P1446, DOI 10.1158/1535-7163.MCT-06-0099; Onitsuka M, 2012, APPL MICROBIOL BIOT, V94, P69, DOI 10.1007/s00253-011-3814-1; Forrest A, 2001, ONCOGENE, V20, P4393, DOI 10.1038/sj.onc.1204574; Mutskov V, 2004, EMBO J, V23, P138, DOI 10.1038/sj.emboj.7600013; Ishii Y, 2014, J BIOSCI BIOENG, V118, P223, DOI 10.1016/j.jbiosc.2014.01.013; Paredes V, 2013, BIOTECHNOL LETT, V35, P987, DOI 10.1007/s10529-013-1168-8; Coquelle A, 1997, CELL, V89, P215, DOI 10.1016/S0092-8674(00)80201-9; Kieffer I, 2007, ONCOGENE, V26, P7847, DOI 10.1038/sj.onc.1210596; Kaneko E, 2012, J BIOSCI BIOENG, V113, P641, DOI 10.1016/j.jbiosc.2011.12.005; Lee KH, 2013, CYTOTECHNOLOGY, V65, P1017, DOI 10.1007/s10616-013-9662-3; Garrick D, 1998, NAT GENET, V18, P56, DOI 10.1038/ng0198-56; Cao YH, 2012, METHODS, V56, P418, DOI 10.1016/j.ymeth.2011.11.002; Lee KH, 2013, APPL MICROBIOL BIOT, V97, P5731, DOI 10.1007/s00253-013-4923-9; Dorer DR, 1997, GENETICS, V147, P1181; Giles N, 2003, J BIOL CHEM, V278, P28580, DOI 10.1074/jbc.M304027200; KAUFMAN RJ, 1990, METHOD ENZYMOL, V185, P537; Wurm FM, 2004, NAT BIOTECHNOL, V22, P1393, DOI 10.1038/nbt1026; Kim JY, 2012, APPL MICROBIOL BIOT, V93, P917, DOI 10.1007/s00253-011-3758-5; Matsuoka M, 2007, NAT REV CANCER, V7, P270, DOI 10.1038/nrc2111; Yin Z, 2012, GENET MOL RES, V11, P355, DOI 10.4238/2012.February.16.1; Yang YS, 2010, J BIOTECHNOL, V147, P180, DOI 10.1016/j.jbiotec.2010.04.004; Boutros R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067822; Bugler B, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-29; Karlsson-Rosenthal Christina, 2006, Trends Cell Biol, V16, P285, DOI 10.1016/j.tcb.2006.04.002; Kuystermans D, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-76; Lodish H., 2012, MOL CELL BIOL	44	0	0	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	DEC	2015	120	6					701	708		10.1016/j.jbiosc.2015.04.009		8	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CY9ZP	WOS:000366765200016		
J	Ogawa, Y; Kim, MH; Kino-Oka, M				Ogawa, Yuuki; Kim, Mee-Hae; Kino-Oka, Masahiro			Changes in human mesenchymal stem cell behaviors on dendrimer-immobilized surfaces due to mediation of fibronectin adsorption and assembly	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Dendrimer-immobilized surface; Human mesenchymal stem cells; Cell behaviors; Fibronectin adsorption on surface; Fibronectin assembly	D-GLUCOSE DISPLAY; TYROSINE PHOSPHORYLATION; MATRIX ADHESIONS; MIGRATION; CHEMISTRY; MT1-MMP; FIBRILLOGENESIS; POLYMERIZATION; EXPRESSION; SUBSTRATE	Dynamic changes of morphologies in human mesenchymal stem cells (hMSCs) were investigated on dendrimer surfaces with different capacities for fibronectin adsorption by changing the polymeric generation numbers of first (G1), third (G3), and fifth (G5) generations. The amount of adsorbed fibronectin on dendrimer surfaces increased with the generation number. Time-lapse observations revealed that cells on the G1 surface maintained their shape with formation of fibronectin fibrils in the bodies, introducing to the stabilization of focal adhesion with enriched stress fibers. Cells on the G3 surface showed partial contraction with degradation of fibril structures in the trailing edge. Cells on the G5 surface changed the shape by active extension and strong contracting without stabilization of focal adhesion through the formation of fibronectin aggregates and immature stress fibers. In addition, the paxillin which is a focal adhesion protein at lamellipodia was phosphorylated, leading to active lamellipodium protrusions. These results indicate that the amount and structure of fibronectin affects dynamic hMSC behaviors through the formation of cytoskeletons and focal adhesions. (c) 2015, The Society for Biotechnology, Japan. All rights reserved.	[Ogawa, Yuuki; Kim, Mee-Hae; Kino-Oka, Masahiro] Osaka Univ, Grad Sch Engn, Dept Biotechnol, Suita, Osaka 5650871, Japan	Kino-Oka, M (reprint author), Osaka Univ, Grad Sch Engn, Dept Biotechnol, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.	kino-oka@bio.eng.osaka-u.ac.jp			Japan Science and Technology Agency (JST); Ministry of Education, Culture, Sports, Science and Technology of Japan [21360402]; MEXT; Japan Society for the Promotion of Science (JSPS) through Japanese-German Graduate Externship	This work was partially supported by the Japan Science and Technology Agency (JST), Grants-in-Aid for Scientific Research (B) (no. 21360402) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, by the MEXT project, "Creating Hybrid Organs of the future" at Osaka University, and by the Japan Society for the Promotion of Science (JSPS) through Japanese-German Graduate Externship.	Pellenc D, 2006, J COLLOID INTERF SCI, V298, P132, DOI 10.1016/j.jcis.2005.11.059; Ballestrem C, 2001, J CELL BIOL, V155, P1319, DOI 10.1083/jcb.200107107; Takino T, 2011, FEBS LETT, V585, P3378, DOI 10.1016/j.febslet.2011.09.039; Gilles C, 2001, J CELL SCI, V114, P2967; Faucheux N, 2006, BIOMATERIALS, V27, P234, DOI 10.1016/j.biomaterials.2005.05.076; Lawson C, 2012, CELL ADHES MIGR, V6, P302, DOI 10.4161/cam.20488; Shi F, 2011, J CELL SCI, V124, P4039, DOI 10.1242/jcs.087858; Huveneers S, 2008, J CELL SCI, V121, P2452, DOI 10.1242/jcs.033001; Kim MH, 2010, J BIOSCI BIOENG, V109, P55, DOI 10.1016/j.jbiosc.2009.06.020; Esparza J, 1999, BLOOD, V94, P2754; Zaidel-Bar R, 2007, J CELL SCI, V120, P137, DOI 10.1242/jcs.03314; Kim MH, 2007, J BIOSCI BIOENG, V103, P192, DOI 10.1263/jbb.103.192; Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537; Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008; Worthylake RA, 2001, J CELL BIOL, V154, P147, DOI 10.1083/jcb.200103048; Hocking DC, 2000, J BIOL CHEM, V275, P10673, DOI 10.1074/jbc.275.14.10673; Friedl P, 2009, CANCER METAST REV, V28, P129, DOI 10.1007/s10555-008-9174-3; Kim MH, 2010, BIOMATERIALS, V31, P7666, DOI 10.1016/j.biomaterials.2010.06.034; Higuchi A, 2013, CHEM REV, V113, P3297, DOI 10.1021/cr300426x; Rico P, 2009, TISSUE ENG PT A, V15, P3271, DOI 10.1089/ten.TEA.2009.0141; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Gardel ML, 2010, ANNU REV CELL DEV BI, V26, P315, DOI 10.1146/annurev.cellbio.011209.122036; Bacakova L, 2004, PHYSIOL RES, V53, pS35; Kim MH, 2014, BIOMATERIALS, V35, P5670, DOI 10.1016/j.biomaterials.2014.03.085; Sottile J, 2002, MOL BIOL CELL, V13, P3546, DOI 10.1091/mbc.E02-01-0048; Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1; Li D, 2009, TUMORI, V95, P769; Dolatshahi-Pirouz A, 2011, COLLOID SURFACE B, V84, P18, DOI 10.1016/j.colsurfb.2010.12.004; Jiao Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041591	29	0	0	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	DEC	2015	120	6					709	714		10.1016/j.jbiosc.2015.04.024		6	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CY9ZP	WOS:000366765200017		
J	Yoshimoto, M; Otsuki, T; Itagaki, K; Kato, T; Kohsaka, T; Matsumoto, Y; Ike, K; Park, EY				Yoshimoto, Mai; Otsuki, Takahiro; Itagaki, Kohei; Kato, Tatsuya; Kohsaka, Tetsuya; Matsumoto, Yumino; Ike, Kazunori; Park, Enoch Y.			Evaluation of recombinant Neospora caninum antigens purified from silkworm larvae for the protection of N. caninum infection in mice	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Neospora caninum; Antigen; Subunit vaccine; BmNPV bacmid; Silkworm	MICRONEME PROTEIN NCMIC3; SURFACE PROTEIN; SUBCELLULAR-LOCALIZATION; LIVE TACHYZOITES; FUSION PROTEIN; VACCINATION; VACCINES; NCSRS2; CATTLE; CELLS	Three antigens (NcSAG1, NcSRS2 and NcMIC3) from Neospora caninum were expressed using the BmNPV bacmid system in silkworm larvae and purified from the hemolymph. From 20 silkworm larvae, 1.5, 1.2 and 1.4 mg of purified recombinant NcSAG1, NcSRS2 and NcMIC3 were obtained, respectively. When each purified recombinant antigen was immunized with Freund's incomplete adjuvant (FIA) to mice, recombinant NcSAG1 induced a Th2 immune response in immunized mice and produced a SAG1-specific antibody. In the experiment where NcSAG1-immunized mice were challenged with N. caninum, the cerebral N. caninum burden was significantly reduced compared with that of either the FIA- or PBS-immunized mice. Recombinant NcSRS2 or NcMIC3 induced both Th1 and Th2 immune responses, but NcMIC3-immunization did not induce significant production of NcMIC3-specific antibodies. These results suggest that the silkworm can produce recombinant antigens of N. caninum, which can be used as a recombinant vaccine against N. caninum. (C) 2015, The Society for Biotechnology, Japan. All rights reserved.	[Yoshimoto, Mai; Otsuki, Takahiro; Itagaki, Kohei; Kato, Tatsuya; Park, Enoch Y.] Shizuoka Univ, Fac Agr, Dept Appl Biol Chem, Biotechnol Lab,Suruga Ku, Shizuoka 4228529, Japan; [Kato, Tatsuya; Park, Enoch Y.] Shizuoka Univ, Res Inst Green Sci & Technol, Biotechnol Lab, Suruga Ku, Shizuoka 4228529, Japan; [Kohsaka, Tetsuya] Shizuoka Univ, Lab Anim Reprod & Physiol, Dept Appl Biol Chem, Fac Agr, Shizuoka 4228529, Japan; [Matsumoto, Yumino; Ike, Kazunori] Nippon Vet & Life Univ, Lab Vet Parasitol, Musashino, Tokyo 1808602, Japan	Park, EY (reprint author), Shizuoka Univ, Res Inst Green Sci & Technol, Biotechnol Lab, Suruga Ku, 836 Ohya, Shizuoka 4228529, Japan.	park.enoch@shizuoka.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [22248009]	This work was supported by Grant-in-Aid for Scientific Research (A) Grant No. 22248009 from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Hemphill A, 1996, PARASITOLOGY, V112, P183; Williams DJL, 2007, INFECT IMMUN, V75, P1343, DOI 10.1128/IAI.00777-06; Park EY, 2007, J BIOTECHNOL, V129, P681, DOI 10.1016/j.jbiotec.2007.01.028; Naguleswaran A, 2001, INFECT IMMUN, V69, P6483, DOI 10.1128/IAI.69.10.6483-6494.2001; Sharman PA, 2010, PARASITE IMMUNOL, V32, P590, DOI 10.1111/j.1365-3024.2010.01209.x; Haldorson GJ, 2005, INT J PARASITOL, V35, P1407, DOI 10.1016/j.ijpara.2005.05.013; Deo VK, 2013, J BIOTECHNOL, V165, P69, DOI 10.1016/j.jbiotec.2013.02.013; Nishikawa Y, 2000, INT J PARASITOL, V30, P51, DOI 10.1016/S0020-7519(99)00162-9; Monney T, 2014, EXP PARASITOL, V140, P52, DOI 10.1016/j.exppara.2014.02.015; Goodswen SJ, 2013, INFECT GENET EVOL, V13, P133, DOI 10.1016/j.meegid.2012.08.012; BUXTON D, 1993, PARASITOL TODAY, V9, P335, DOI 10.1016/0169-4758(93)90236-9; Uchida M, 2013, PARASITOL RES, V112, P655, DOI 10.1007/s00436-012-3182-5; Hemphill A, 1996, INFECT IMMUN, V64, P4279; Cannas A, 2003, J PARASITOL, V89, P44, DOI 10.1645/0022-3395(2003)089[0044:RCIONC]2.0.CO;2; Weber FH, 2013, CLIN VACCINE IMMUNOL, V20, P99, DOI 10.1128/CVI.00225-12; Romero JJ, 2004, VET PARASITOL, V123, P149, DOI 10.1016/j.vetpar.2004.06.016; Cannas A, 2003, PARASITOLOGY, V126, P303, DOI 10.1017/S0031182002002895; Park EY, 2008, BIOTECHNOL APPL BIOC, V49, P135, DOI 10.1042/BA20070098; Zhang GH, 2010, VACCINE, V28, P7243, DOI 10.1016/j.vaccine.2010.08.096; Regidor-Cerrillo J, 2008, PARASITOLOGY, V135, P1651, DOI 10.1017/S003118200800509X; Otsuki T, 2013, VET PARASITOL, V192, P284, DOI 10.1016/j.vetpar.2012.09.038; Nishikawa Y, 2002, VET PARASITOL, V109, P191, DOI 10.1016/S0304-4017(02)00256-X; Dubey JP, 2007, CLIN MICROBIOL REV, V20, P323, DOI 10.1128/CMR.00031-06; Debache K., 2010, INT J PARASITOL, V39, P1373; Hecker YP, 2014, VET IMMUNOL IMMUNOP, V162, P142, DOI 10.1016/j.vetimm.2014.11.001; Hemphill Andrew, 2013, Front Biosci (Elite Ed), V5, P23; Monney Thierry, 2011, Animals (Basel), V1, P306, DOI 10.3390/ani1030306; Pinitkiatisakul S, 2007, VACCINE, V25, P3658, DOI 10.1016/j.vaccine.2007.01.074	28	0	0	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	DEC	2015	120	6					715	719		10.1016/j.jbiosc.2015.04.002		5	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CY9ZP	WOS:000366765200018		
J	Maruyama, T; Izaki, S; Kurinomaru, T; Handa, K; Kimoto, T; Shiraki, K				Maruyama, Takuya; Izaki, Shunsuke; Kurinomaru, Takaaki; Handa, Kenji; Kimoto, Tomoaki; Shiraki, Kentaro			Protein-poly(amino acid) precipitation stabilizes a therapeutic protein L-asparaginase against physicochemical stress	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						L-Asparaginase; Precipitation; Protein-polyelectrolyte complex; Redissolution; Stabilization	PREVENT THERMAL INACTIVATION; AGGREGATION; LYSOZYME; POLYELECTROLYTE; PURIFICATION; CLASSIFICATION; FORMULATIONS; INHIBITION; PAIR	Long-term storage in aqueous solution has been demanded for the practical application of therapeutic proteins. Recently, a precipitation-redissolution method was proposed to prepare salt-dissociable protein polyelectrolyte complex (PPC). To elucidate the utility of the complex for storage of proteins, we investigated the stress tolerance of PPC precipitates containing L-asparaginase (ASNase) and poly-L-lysine (polyK). PPC precipitate containing ASNase and polyK was prepared by precipitation-redissolution method. The sample was treated to three types of stress, i.e., heat, shaking, and oxidation. The protein concentration, enzyme activity, and CD spectrum of the supernatants of samples were measured after stressed. PPC precipitate consisting of ASNase and polyK showed tolerance against thermal and shaking stress compared to the native solution. In addition, PPC precipitate protected ASNase from inactivation by oxidation. PPC precipitate of ASNase/polyK complex successfully stabilized ASNase against physicochemical stresses. These results suggest that the PPC precipitate has great potential as a storage method in aqueous solution for unstable proteins. (c) 2015, The Society for Biotechnology, Japan. All rights reserved.	[Maruyama, Takuya; Kurinomaru, Takaaki; Shiraki, Kentaro] Univ Tsukuba, Fac Pure & Appl Sci, Tsukuba, Ibaraki 3058573, Japan; [Izaki, Shunsuke; Handa, Kenji; Kimoto, Tomoaki] Terumo Co Ltd, Ctr Res & Dev, Nakai, Kanagawa 2590151, Japan	Shiraki, K (reprint author), Univ Tsukuba, Fac Pure & Appl Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058573, Japan.	shiraki@bk.tsukuba.ac.jp			University of Tsukuba; Terumo Corp.	This study was supported financially by University of Tsukuba and Terumo Corp.	Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; Leader B, 2008, NAT REV DRUG DISCOV, V7, P21, DOI 10.1038/nrd2399; Tomita S, 2011, J POLYM SCI POL CHEM, V49, P3835, DOI 10.1002/pola.24822; Wang W, 2008, INT J PHARM, V347, P31, DOI 10.1016/j.ijpharm.2007.06.042; Joubert MK, 2011, J BIOL CHEM, V286, P25118, DOI 10.1074/jbc.M110.160457; Okanojo M, 2005, J BIOSCI BIOENG, V100, P556, DOI 10.1263/jbb.100.556; Remmele RL, 2012, CURR PHARM BIOTECHNO, V13, P471; Kurinomaru T, 2012, LANGMUIR, V28, P4334, DOI 10.1021/la2043312; Shiraki K, 2005, BIOTECHNOL PROGR, V21, P640, DOI 10.1021/bp049769w; Ganguli S, 2009, J AM CHEM SOC, V131, P6549, DOI 10.1021/ja900786z; Allison SD, 1999, ARCH BIOCHEM BIOPHYS, V365, P289, DOI 10.1006/abbi.1999.1175; Peram T, 2010, BIOTECHNOL PROGR, V26, P1322, DOI 10.1002/btpr.437; Rajagopal K, 2013, J PHARM SCI-US, V102, P2655, DOI 10.1002/jps.23634; Boeris V, 2009, PROCESS BIOCHEM, V44, P1260, DOI 10.1016/j.procbio.2009.07.001; Carpenter John F, 2002, Pharm Biotechnol, V13, P109; Tomita S, 2010, SOFT MATTER, V6, P5320, DOI 10.1039/c000930j; Soares AL, 2002, INT J PHARMACEUT, V237, P163, DOI 10.1016/S0378-5173(02)00046-7; Hirano A, 2008, PROTEIN J, V27, P253, DOI 10.1007/s10930-008-9132-5; Zhang CM, 2005, J CHROMATOGR A, V1069, P107, DOI 10.1016/j.chroma.2004.10.018; Kudou M, 2003, EUR J BIOCHEM, V270, P4547, DOI 10.1046/j.1432-1033.2003.03850.x; Wang YF, 1996, BIOTECHNOL PROGR, V12, P356, DOI 10.1021/bp960013+; Arakawa T, 2003, BIOCHEM BIOPH RES CO, V304, P148, DOI 10.1016/S0006-291X(03)00578-3; McDonald P, 2009, BIOTECHNOL BIOENG, V102, P1141, DOI 10.1002/bit.22127; Kayitmazer AB, 2013, SOFT MATTER, V9, P2553, DOI 10.1039/c2sm27002a; SLUZKY V, 1992, BIOTECHNOL BIOENG, V40, P895, DOI 10.1002/bit.260400805; Kurinomaru T, 2014, LANGMUIR, V30, P3826, DOI 10.1021/la500575c; Shiraki K, 2002, J BIOCHEM, V132, P591; Sasahara K, 2003, J MOL BIOL, V326, P1227, DOI 10.1016/S0022-2836(02)01443-2; Bhambhani A, 2010, AM PHARM REV, V13, P31; Kurinomaru T., 2014, J PHARM SCI, V8, P2248; Kurinomaru T, 2015, J PHARM SCI-US, V104, P587, DOI 10.1002/jps.24217; PACE CN, 1995, PROTEIN SCI, V4, P2411; Stecher A. L., 1999, PHARM ACTA HELV, P1; Wang W, 2005, INT J PHARM, V289, P1, DOI 10.1016/j.ijpharm.2004.11.014	34	0	0	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	DEC	2015	120	6					720	724		10.1016/j.jbiosc.2015.04.010		5	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CY9ZP	WOS:000366765200019		
J	Okahashi, N; Kohno, S; Kitajima, S; Matsuda, F; Takahashi, C; Shimizu, H				Okahashi, Nobuyuki; Kohno, Susumu; Kitajima, Shunsuke; Matsuda, Fumio; Takahashi, Chiaki; Shimizu, Hiroshi			Metabolic characterization of cultured mammalian cells by mass balance analysis, tracer labeling experiments and computer-aided simulations	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Metabolic engineering; Cultured mammalian cell; C-13-tracer experiment; p53; Soft tissue sarcoma; Reductive glutamine metabolism	REDUCTIVE GLUTAMINE-METABOLISM; FLUX ANALYSIS; CHO-CELLS; B-CELLS; CANCER; C-13; PROLIFERATION; SURVIVAL; HYPOXIA; GROWTH	Studying metabolic directions and flow rates in cultured mammalian cells can provide key information for understanding metabolic function in the fields of cancer research, drug discovery, stem cell biology, and antibody production. In this work, metabolic engineering methodologies including medium component analysis, C-13-labeling experiments, and computer-aided simulation analysis were applied to characterize the metabolic phenotype of soft tissue sarcoma cells derived from p53-null mice. Cells were cultured in medium containing [1-C-13] glutamine to assess the level of reductive glutamine metabolism via the reverse reaction of isocitrate dehydrogenase (IDH). The specific uptake and production rates of glucose, organic acids, and the 20 amino acids were determined by time-course analysis of cultured media. Gas chromatography-mass spectrometry analysis of the C-13-labeling of citrate, succinate, fumarate, malate, and aspartate confirmed an isotopically steady state of the cultured cells. After removing the effect of naturally occurring isotopes, the direction of the IDH reaction was determined by computer-aided analysis. The results validated that metabolic engineering methodologies are applicable to soft tissue sarcoma cells derived from p53-null mice, and also demonstrated that reductive glutamine metabolism is active in p53-null soft tissue sarcoma cells under normoxia. (c) 2015, The Society for Biotechnology, Japan. All rights reserved.	[Okahashi, Nobuyuki; Matsuda, Fumio; Shimizu, Hiroshi] Osaka Univ, Grad Sch Informat Sci & Technol, Dept Bioinformat Engn, Suita, Osaka 5650871, Japan; [Kohno, Susumu; Kitajima, Shunsuke; Takahashi, Chiaki] Kanazawa Univ, Div Oncol & Mol Biol, Canc Res Inst, Kanazawa, Ishikawa 9201192, Japan	Shimizu, H (reprint author), Osaka Univ, Grad Sch Informat Sci & Technol, Dept Bioinformat Engn, 1-5 Yamadaoka, Suita, Osaka 5650871, Japan.	n-okahashi@ist.osaka-u.ac.jp; skohno@staff.kanazawa-u.ac.jp; skitajim@staff.kanazawa-u.ac.jp; fmatsuda@ist.osaka-u.ac.jp; chtakaha@staff.kanazawa-u.ac.jp; shimizu@ist.osaka-u.ac.jp			Cancer Research Institute, Kanazawa University [26-13, 27-02]	We thank Dr. Katsunori Yoshikawa and Dr. Yoshihiro Toya for their helpful comments on this manuscript. This work was partly supported by Extramural Collaborative Research Grant of Cancer Research Institute, Kanazawa University (Grant Nos. 26-13 and 27-02).	Metallo CM, 2009, J BIOTECHNOL, V144, P167, DOI 10.1016/j.jbiotec.2009.07.010; Omasa T, 2010, BIOPROC BIOSYST ENG, V33, P117, DOI 10.1007/s00449-009-0351-8; Dauner M, 2000, BIOTECHNOL PROGR, V16, P642, DOI 10.1021/bp000058h; Folmes CDL, 2012, CELL STEM CELL, V11, P596, DOI 10.1016/j.stem.2012.10.002; Mueller D, 2013, CURR OPIN BIOTECH, V24, P54, DOI 10.1016/j.copbio.2012.10.015; Sengupta N, 2011, BIOTECHNOL BIOENG, V108, P82, DOI 10.1002/bit.22890; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; Armenta JM, 2010, ANAL CHEM, V82, P548, DOI 10.1021/ac901790q; Orman Mehmet A., 2011, Critical Reviews in Biomedical Engineering, V39, P511; Suzuki S, 2010, P NATL ACAD SCI USA, V107, P7461, DOI 10.1073/pnas.1002459107; Kajihata S, 2014, BIOMED RES INT, DOI 10.1155/2014/627014; Le A, 2012, CELL METAB, V15, P110, DOI 10.1016/j.cmet.2011.12.009; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Murphy TA, 2013, METAB ENG, V15, P206, DOI 10.1016/j.ymben.2012.07.008; Quek LE, 2010, METAB ENG, V12, P161, DOI 10.1016/j.ymben.2009.09.002; Sims JK, 2013, CURR OPIN BIOTECH, V24, P933, DOI 10.1016/j.copbio.2013.07.001; Vousden KH, 2009, NAT REV CANCER, V9, P691, DOI 10.1038/nrc2715; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Yoshii Y, 2009, CANCER SCI, V100, P821, DOI 10.1111/j.1349-7006.2009.01099.x; Yoo H, 2008, J BIOL CHEM, V283, P20621, DOI 10.1074/jbc.M706494200; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Jung JY, 2015, J CHROMATOGR B, V974, P101, DOI 10.1016/j.jchromb.2014.10.033; van Winden WA, 2002, BIOTECHNOL BIOENG, V80, P477, DOI 10.1002/bit.10393; Deshpande Rahul, 2009, Biotechnology Journal, V4, P247, DOI 10.1002/biot.200800143; Ahn WS, 2012, BIOTECHNOL J, V7, P61, DOI 10.1002/biot.201100052; Sheikh K, 2005, BIOTECHNOL PROGR, V21, P112, DOI 10.1021/bp0498138; TSUKADA T, 1993, ONCOGENE, V8, P3313; Ahn WS, 2011, METAB ENG, V13, P598, DOI 10.1016/j.ymben.2011.07.002; Cheung EC, 2010, CURR OPIN CELL BIOL, V22, P186, DOI 10.1016/j.ceb.2009.12.006; Goudar C, 2010, METAB ENG, V12, P138, DOI 10.1016/j.ymben.2009.10.007; Boros L. G., 2004, DRUG DISCOV TODAY, V1, P435, DOI 10.1016/j.ddstr.2004.11.016; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Fendt SM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3236; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Mullen AR, 2011, NATURE, V481, P385, DOI DOI 10.1038/NATURE10642; Okahashi Nobuyuki, 2014, Metabolites, V4, P408, DOI 10.3390/metabo4020408; Turner J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112757; Vander Heiden MG, 2009, SCIENCE, V324, P1029, DOI DOI 10.1126/SCIENCE.1160809; Wiechert W, 2001, METAB ENG, V3, P195, DOI 10.1006/mben.2001.0187	39	0	0	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	DEC	2015	120	6					725	731		10.1016/j.jbiosc.2015.04.003		7	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CY9ZP	WOS:000366765200020		
J	Masuda, M; Hatashita, M; Fujihara, S; Suzuki, Y; Sakurai, A				Masuda, Mina; Hatashita, Masanori; Fujihara, Shinya; Suzuki, Yu; Sakurai, Akihiko			Simple and efficient isolation of cordycepin from culture broth of a Cordyceps militaris mutant	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Cordycepin; Cordyceps militaris mutant; Proton beam irradiation; Crystallization; Purification	LIQUID CULTURE; CELLS; INHIBITION; LINK; AKT	Isolation of cordycepin from the culture broth of Cordyceps militaris mutant was investigated. Based on the solubility curve, three crystallizing processes, temperature shift (process I), pH shift (process II), and pH shift followed by temperature shift (process III) were carried out. Process III was the most promising method regarding both purity and yield. (c) 2015, The Society for Biotechnology, Japan. All rights reserved.	[Masuda, Mina; Fujihara, Shinya; Sakurai, Akihiko] Univ Fukui, Dept Appl Chem & Biotechnol, Grad Sch Engn, Fukui, Fukui 9108507, Japan; [Hatashita, Masanori] Wakasa Wan Res Ctr, Dept Res & Dev, Tsuruga, Fukui 9140192, Japan; [Suzuki, Yu] Univ Fukui, Tenure Track Program Innovat Res, Fukui, Fukui 9108507, Japan; [Sakurai, Akihiko] Univ Fukui, Translat Res Ctr, Org Life Sci Adv Programs, Fukui 9101193, Japan	Sakurai, A (reprint author), Univ Fukui, Dept Appl Chem & Biotechnol, Grad Sch Engn, 3-9-1 Bunkyo, Fukui, Fukui 9108507, Japan.	a_sakura@u-fukui.ac.jp					Kim HG, 2006, EUR J PHARMACOL, V545, P192, DOI 10.1016/j.ejphar.2006.06.047; Masuda M, 2014, PROCESS BIOCHEM, V49, P181, DOI 10.1016/j.procbio.2013.10.017; Ni H, 2009, J CHROMATOGR B, V877, P2135, DOI 10.1016/j.jchromb.2009.06.009; Shin YK, 2014, J FUNCT FOODS, V6, P331, DOI 10.1016/j.jff.2013.10.024; Chen ZG, 2013, BIORESOURCE TECHNOL, V133, P82, DOI 10.1016/j.biortech.2013.01.117; FURUYA T, 1983, PHYTOCHEMISTRY, V22, P2509, DOI 10.1016/0031-9422(83)80150-2; Das SK, 2008, LETT APPL MICROBIOL, V47, P534, DOI 10.1111/j.1472-765X.2008.02456.x; KREDICH NM, 1960, BIOCHIM BIOPHYS ACTA, V41, P363, DOI 10.1016/0006-3002(60)90027-5; Lee SY, 2013, FOOD CHEM TOXICOL, V60, P439, DOI 10.1016/j.fct.2013.07.068; Song H, 2007, J BIOTECHNOL, V132, P445, DOI 10.1016/j.jbiotec.2007.07.496; Jeong MH, 2012, J MICROBIOL BIOTECHN, V22, P1161, DOI 10.4014/jmb.1203.03039; CUNNINGHAM KG, 1950, NATURE, V166, P949, DOI 10.1038/166949a0; Ahn YJ, 2000, J AGR FOOD CHEM, V48, P2744, DOI 10.1021/jf990862n; Kodama EN, 2000, BIOCHEM PHARMACOL, V59, P273, DOI 10.1016/S0006-2952(99)00325-1; Jeong JW, 2012, INT J ONCOL, V40, P1697, DOI 10.3892/ijo.2012.1332; FREDERIK.S, 1965, BIOCHIM BIOPHYS ACTA, V95, P189, DOI 10.1016/0005-2787(65)90483-1; Promraksa A., 2009, J CRYST GROWTH, V31, P3667	17	0	0	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	DEC	2015	120	6					732	735		10.1016/j.jbiosc.2015.04.008		4	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CY9ZP	WOS:000366765200021		
J	Ishii, Y; Murakami, J; Sasaki, K; Tsukahara, M; Wakamatsu, K				Ishii, Yoichi; Murakami, Junko; Sasaki, Kazue; Tsukahara, Masayoshi; Wakamatsu, Kaori			Efficient folding/assembly in CHO cells is critical for high quality (low aggregate content) of secreted trastuzumab as well as for high production: Stepwise multivariate regression analyses (vol 118, pg 223, 2014)	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Correction									[Ishii, Yoichi; Murakami, Junko; Sasaki, Kazue] Kyowa Hakko Kirin Co Ltd, Bioproc Res & Dev Labs, Takasaki, Gumma 3700013, Japan; [Tsukahara, Masayoshi] Kyowa Hakko Kirin Co Ltd, Div Planning Dept, Prod Div, Chiyoda Ku, Tokyo 1008185, Japan; [Ishii, Yoichi; Wakamatsu, Kaori] Gunma Univ, Grad Sch Engn, Kiryu, Gumma 3768515, Japan	Ishii, Y (reprint author), Kyowa Hakko Kirin Co Ltd, Bioproc Res & Dev Labs, 100-1 Hagiwara Machi, Takasaki, Gumma 3700013, Japan.	yoichi.ishii@kyowa-kirin.co.jp					Ishii Y, 2014, J BIOSCI BIOENG, V118, P223, DOI 10.1016/j.jbiosc.2014.01.013	1	0	0	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	DEC	2015	120	6					736	736		10.1016/j.jbiosc.2015.07.012		1	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CY9ZP	WOS:000366765200022		
J	Amino, M; Inokuchi, S; Nagao, K; Nakagawa, Y; Yoshioka, K; Ikari, Y; Funakoshi, H; Hayakawa, K; Matsuzaki, M; Sakurai, A; Tahara, Y; Yonemoto, N; Yaguchi, A; Morimura, N				Amino, Mari; Inokuchi, Sadaki; Nagao, Ken; Nakagawa, Yoshihide; Yoshioka, Koichiro; Ikari, Yuji; Funakoshi, Hiraku; Hayakawa, Katsura; Matsuzaki, Masakazu; Sakurai, Atsushi; Tahara, Yoshio; Yonemoto, Naohiro; Yaguchi, Arino; Morimura, Naoto		SOS-KANTO 2012 Study Grp	Nifekalant Hydrochloride and Amiodarone Hydrochloride Result in Similar Improvements for 24-Hour Survival in Cardiopulmonary Arrest Patients: The SOS-KANTO 2012 Study	JOURNAL OF CARDIOVASCULAR PHARMACOLOGY			English	Article							HOSPITAL CARDIAC-ARREST; RESISTANT VENTRICULAR-FIBRILLATION; PUBLIC-ACCESS DEFIBRILLATION; INTRAVENOUS AMIODARONE; ANTIARRHYTHMIC-DRUG; RESUSCITATION; LIDOCAINE; ASSOCIATION; MYOCYTES; OUTCOMES		[Amino, Mari; Inokuchi, Sadaki; Nakagawa, Yoshihide; Yoshioka, Koichiro; Ikari, Yuji] Tokai Univ, Sch Med, Hiratsuka, Kanagawa 25912, Japan; [Nagao, Ken; Matsuzaki, Masakazu] Nihon Univ, Surugadai Hosp, Tokyo, Japan; [Funakoshi, Hiraku] Tokyo Bay Urayasu Ichikawa Med Ctr, Chiba, Japan; [Hayakawa, Katsura] Saitama Red Cross Maebashi Hosp, Saitama, Japan; [Sakurai, Atsushi] Nihon Univ, Sch Med, Tokyo, Japan; [Tahara, Yoshio] Natl Cerebral & Cardiovasc Ctr Hosp, Osaka, Japan; [Yonemoto, Naohiro] Natl Ctr Neurol & Psychiat, Tokyo, Japan; [Yaguchi, Arino] Tokyo Womens Med Univ Hosp, Tokyo, Japan; [Morimura, Naoto] Yokohama City Univ, Med Ctr, Yokohama, Kanagawa, Japan	Amino, M (reprint author), Tokai Univ, Sch Med, Dept Cardiovasc Med, Shimokasuya 143, Isehara, Kanagawa 2591193, Japan.	mariam@is.icc.u-tokai.ac.jp			Japanese Association for Acute Medicine of Kanto; Sanofy K.K; Comprehensive Research on Cardiovascular and Life-Style Related Diseases from the Ministry from Health, Labor and Welfare, Japan [H24-001]	Supported by the Japanese Association for Acute Medicine of Kanto.; All members who were involved in the execution of the current study are members of the Japanese Association for Acute Medicine of Kanto. The co-author of this publication Dr Y. Ikari receives a research grant for investigation about the effect for the polyvascular disease of antiplatelet agent from Sanofy K.K and royalty of IKARI-catheter from the TERUMO Corporation. Dr Y. Ikari was not developing products related to the research described in this study. The other co-author Dr K. Nagao was supported by research grants for the Comprehensive Research on Cardiovascular and Life-Style Related Diseases (H24-001) from the Ministry from Health, Labor and Welfare, Japan.	Amino M, 2014, J ARRHYTHMIA, V30, P180; Amino Mari, 2003, J Cardiol, V41, P127; Shiga T, 2010, RESUSCITATION, V81, P47, DOI 10.1016/j.resuscitation.2009.09.027; Nagao K, 2010, CIRC J, V74, P2285, DOI 10.1253/circj.CJ-10-0936; Mitani Y, 2014, CIRC J, V78, P701, DOI 10.1253/circj.CJ-13-1162; Kudenchuk PJ, 1999, NEW ENGL J MED, V341, P871, DOI 10.1056/NEJM199909163411203; Yoshioka K, 2006, CIRC J, V70, P21, DOI 10.1253/circj.70.21; Sakamoto T, 2014, RESUSCITATION, V85, P762, DOI 10.1016/j.resuscitation.2014.01.031; Yoshioka K, 2009, J CARDIOL, V54, P460, DOI 10.1016/j.jjcc.2009.02.002; Abe T, 2009, RESUSCITATION, V80, P431, DOI 10.1016/j.resuscitation.2008.12.010; Field JM, 2010, CIRCULATION, V122, pS640, DOI 10.1161/CIRCULATIONAHA.110.970889; Hasegawa K, 2013, JAMA-J AM MED ASSOC, V309, P257, DOI 10.1001/jama.2012.187612; Soga T, 2012, CIRC J, V76, P2579, DOI 10.1253/circj.CJ-12-0448; Tamura A, 2009, J PHARMACOL SCI, V110, P150, DOI 10.1254/jphs.08312FP; VELTRI EP, 1986, AM J CARDIOL, V58, P1110, DOI 10.1016/0002-9149(86)90126-8; HOHNLOSER SH, 1991, AM HEART J, V121, P89, DOI 10.1016/0002-8703(91)90960-P; Sugiyama A, 2001, JPN J PHARMACOL, V87, P74, DOI 10.1254/jjp.87.74; Amino M, 2010, J CARDIOVASC PHARM, V55, P391, DOI 10.1097/FJC.0b013e3181d3dcc7; Kitamura T, 2010, NEW ENGL J MED, V362, P994, DOI 10.1056/NEJMoa0906644; Kudenchuk PJ, 2014, AM HEART J, V167, P653, DOI 10.1016/j.ahj.2014.02.010; NAKAYA H, 1993, BRIT J PHARMACOL, V109, P157; Dorian P, 2002, NEW ENGL J MED, V346, P884, DOI 10.1056/NEJMoa013029; Kotake Y, 2015, J CARDIOL, V66, P161, DOI 10.1016/j.jjcc.2014.10.004; Harayama N, 2014, J ANESTH, V28, P587, DOI 10.1007/s00540-013-1775-5; Shirakabe A, 2013, CIRC J, V77, P2064, DOI 10.1253/circj.CJ-12-1326; Hagihara A, 2012, JAMA-J AM MED ASSOC, V307, P1161, DOI 10.1001/jama.2012.294; Cheng JH, 1996, CARDIOVASC RES, V31, P963; Boyett MR, 2000, CARDIOVASC RES, V47, P658, DOI 10.1016/S0008-6363(00)00135-8; Tahara Y, 2006, CIRC J, V70, P442, DOI 10.1253/circj.70.442; Ando S, 2009, CIRC J, V73, P1361; Katoh T, 2007, J ARRHYTHMIA, V23, P131; Kodama I, 1999, AM J CARDIOL, V84, p20R, DOI 10.1016/S0002-9149(99)00698-0; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; SOS-KANTO 2012 Study group, ACUTE MED SURG, DOI [10.1002/ams2.102, DOI 10.1002/AMS2.102]; SOS-KANTO Committee, 2005, CIRC J, V69, P1157; Nagao K, 2012, AM J EMERG MED, V30, P770, DOI 10.1016/j.ajem.2011.03.031; Nagao K, 2007, LANCET, V369, P920; Nagao K, 2009, CIRC J, V73, P490; Nagao K, 2011, CIRC J, V75, P580, DOI 10.1253/circj.CJ-10-0485	39	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0160-2446	1533-4023		J CARDIOVASC PHARM	J. Cardiovasc. Pharmacol.	DEC	2015	66	6					600	609				10	Cardiac & Cardiovascular Systems; Pharmacology & Pharmacy	Cardiovascular System & Cardiology; Pharmacology & Pharmacy	CY9FS	WOS:000366713400011		
J	Kanemoto, S; Kobayashi, Y; Yamashita, T; Miyamoto, T; Cui, M; Asada, R; Cui, X; Hino, K; Kaneko, M; Takai, T; Matsuhisa, K; Takahashi, N; Imaizumi, K				Kanemoto, Soshi; Kobayashi, Yasuhiro; Yamashita, Teruhito; Miyamoto, Takeshi; Cui, Min; Asada, Rie; Cui, Xiang; Hino, Kenta; Kaneko, Masayuki; Takai, Tomoko; Matsuhisa, Koji; Takahashi, Naoyuki; Imaizumi, Kazunori			Luman is involved in osteoclastogenesis through the regulation of DC-STAMP expression, stability and localization	JOURNAL OF CELL SCIENCE			English	Article						Osteoclastogenesis; Cell-cell fusion; Endoplasmic reticulum; Transcription factor	CELL-CELL FUSION; BODY GIANT-CELLS; ENDOPLASMIC-RETICULUM; ER STRESS; TRANSMEMBRANE PROTEIN; SIGNALING MECHANISMS; BONE-FORMATION; TRANSCRIPTION; ACTIVATION; NFATC1	Luman (also known as CREB3) is a type-II transmembrane transcription factor belonging to the OASIS family that localizes to the endoplasmic reticulum (ER) membrane under normal conditions. In response to ER stress, OASIS-family members are subjected to regulated intramembrane proteolysis (RIP), following which the cleaved N-terminal fragments translocate to the nucleus. In this study, we show that treatment of bone marrow macrophages (BMMs) with cytokines - macrophage colony-stimulating factor (M-CSF) and RANKL (also known as TNFSF11) - causes a time-dependent increase in Luman expression, and that Luman undergoes RIP and becomes activated during osteoclast differentiation. Small hairpin (sh) RNA-mediated knockdown of Luman in BMMs prevented the formation of multinucleated osteoclasts, concomitant with the suppression of DC-STAMP, a protein that is essential for cell-cell fusion in osteoclastogenesis. The N-terminus of Luman facilitates promoter activity of DC-STAMP, resulting in upregulation of DC-STAMP expression. Furthermore, Luman interacts with DC-STAMP, and controls its stability and localization. These results suggest that Luman regulates the multinucleation of osteoclasts by promoting cell fusion of mononuclear osteoclasts through DC-STAMP induction and intracellular distribution during osteoclastogenesis.	[Kanemoto, Soshi; Cui, Min; Asada, Rie; Cui, Xiang; Hino, Kenta; Kaneko, Masayuki; Takai, Tomoko; Matsuhisa, Koji; Imaizumi, Kazunori] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Biochem, Minami Ku, Hiroshima 7348553, Japan; [Kobayashi, Yasuhiro; Yamashita, Teruhito; Takahashi, Naoyuki] Matsumoto Dent Univ, Inst Oral Sci, Nagano 3990781, Japan; [Miyamoto, Takeshi] Keio Univ, Sch Med, Dept Orthoped Surg, Shinjuku Ku, Tokyo 1608582, Japan	Kanemoto, S (reprint author), Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Biochem, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan.	soshikanemoto@hiroshima-u.ac.jp; imaizumi@hiroshima-u.ac.jp			Japan Society for the Promotion of Science KAKENHI grant [25251014, 15K15067, 25861324, 15K20001, 25-677, 15K19516, 26460099, 15K18377]; Takeda Science Foundation; Kobayashi International Scholarship Foundation; Mitsubishi Foundation	This study was supported by the Japan Society for the Promotion of Science KAKENHI grant [grant numbers 25251014 and 15K15067 to K.I.; 25861324 and 15K20001 to S.K.; 25-677 and 15K19516 to R.A.; 26460099 to M.K.; and 15K18377 to T.T.]; and also supported in part by Takeda Science Foundation; Kobayashi International Scholarship Foundation; and The Mitsubishi Foundation (to K.I.). Deposited in PMC for immediate release.	Murakami T, 2009, NAT CELL BIOL, V11, P1205, DOI 10.1038/ncb1963; Kondo S, 2012, CELL DEATH DIFFER, V19, P1939, DOI 10.1038/cdd.2012.77; Liang GQ, 2006, MOL CELL BIOL, V26, P7999, DOI 10.1128/MCB.01046-06; Matsumoto M, 2004, J BIOL CHEM, V279, P45969, DOI 10.1074/jbc.M408795200; Lu R, 1997, MOL CELL BIOL, V17, P5117; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; Lee SH, 2006, NAT MED, V12, P1403, DOI 10.1038/nm1514; Asada R, 2011, J BIOCHEM, V149, P507, DOI 10.1093/jb/mvr041; Miyamoto H, 2012, J BONE MINER RES, V27, P1289, DOI 10.1002/jbmr.1575; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050615; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Miyamoto H, 2012, J BIOL CHEM, V287, P32479, DOI 10.1074/jbc.M112.358226; Yagi M, 2007, J BONE MINER RES, V22, P992, DOI 10.1359/JBMR.070401; Zhao BH, 2009, NAT MED, V15, P1066, DOI 10.1038/nm.2007; Kudo T, 2008, CELL DEATH DIFFER, V15, P364, DOI 10.1038/sj.cdd.4402276; Rawson RB, 2003, NAT REV MOL CELL BIO, V4, P631, DOI 10.1038/nrm1174; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Hayman AR, 2008, AUTOIMMUNITY, V41, P218, DOI 10.1080/08916930701694667; Saito A, 2009, NAT CELL BIOL, V11, P1197, DOI 10.1038/ncb1962; Kim K, 2008, MOL ENDOCRINOL, V22, P176, DOI 10.1210/me.2007-0237; Islam R, 2014, J CELL PHYSIOL, V229, P2166, DOI 10.1002/jcp.24679; Hartgers FC, 2000, EUR J IMMUNOL, V30, P3585, DOI 10.1002/1521-4141(200012)30:12<3585::AID-IMMU3585>3.0.CO;2-Y; Sawatani Y, 2008, INT IMMUNOL, V20, P1259, DOI 10.1093/intimm/dxn082; Raggo C, 2002, MOL CELL BIOL, V22, P5639, DOI 10.1128/MCB.22.16.5639-5649.2002; Hobolt-Pedersen AS, 2014, CALCIFIED TISSUE INT, V95, P73, DOI 10.1007/s00223-014-9864-5; Nakashima T, 2012, TRENDS ENDOCRIN MET, V23, P582, DOI 10.1016/j.tem.2012.05.005; Eleveld-Trancikova D, 2010, MOL IMMUNOL, V47, P1963, DOI 10.1016/j.molimm.2010.04.019; Eleveld-Trancikova D, 2005, J LEUKOCYTE BIOL, V77, P337, DOI 10.1189/jlb.0804441	29	0	0	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0021-9533	1477-9137		J CELL SCI	J. Cell Sci.	DEC 1	2015	128	23					4353	4365		10.1242/jcs.176057		13	Cell Biology	Cell Biology	CY3NL	WOS:000366316400013		
J	Eino, A; Kageyama, S; Uemura, T; Annoh, H; Saito, T; Narita, I; Waguri, S; Komatsu, M				Eino, Atsushi; Kageyama, Shun; Uemura, Takefumi; Annoh, Hiromichi; Saito, Tetsuya; Narita, Ichiei; Waguri, Satoshi; Komatsu, Masaaki			Sqstm1-GFP knock-in mice reveal dynamic actions of Sqstm1 during autophagy and under stress conditions in living cells	JOURNAL OF CELL SCIENCE			English	Article						Sqstm1; Autophagy; Selective autophagy; Nrf2; Knock-in mice	TRANSCRIPTION FACTOR NRF2; SELECTIVE AUTOPHAGY; DEFICIENT MICE; P62; P62/SQSTM1; PHOSPHORYLATION; DEGRADATION; PROTEINS; KEAP1; DISSECTION	Sqstm1 serves as a signaling hub and receptor for selective autophagy. Consequently, dysregulation of Sqstm1 causes imbalances in signaling pathways and disrupts proteostasis, thereby contributing to the development of human diseases. Environmental stresses influence the level of Sqstm1 by altering its expression and/or autophagic degradation, and also changes the localization of Sqstm1, making it difficult to elucidate the actions and roles of this protein. In this study, we developed knock-in mice expressing Sqstm1 fused to GFP (Sqstm1-GFP(KI/+)). Using these Sqstm1-GFP(KI/+) mice, we revealed for the first time the dynamics of endogenous Sqstm1 in living cells. Sqstm1-GFP was translocated to a restricted area of LC3-positive structures, which primarily correspond to the inside of autophagosomes, and then degraded. Moreover, exposure to arsenite induced expression of Sqstm1-GFP, followed by accumulation of the fusion protein in large aggregates that were degraded by autophagy. Furthermore, suppression of autophagy in Sqstm1-GFP(KI/+) mouse livers caused accumulation of Sqstm1-GFP and formation of GFP-positive aggregate structures, leading to severe hepatic failure. These results indicate that Sqstm1-GFP(KI/+) mice are a useful tool for analyzing Sqstm1 in living cells and intact animals.	[Eino, Atsushi; Kageyama, Shun; Saito, Tetsuya; Komatsu, Masaaki] Niigata Univ, Grad Sch Med & Dent Sci, Dept Biochem, Chuo Ku, Niigata 9518510, Japan; [Eino, Atsushi; Narita, Ichiei] Niigata Univ, Grad Sch Med & Dent Sci, Div Clin Nephrol & Rheumatol, Chuo Ku, Niigata 9518510, Japan; [Uemura, Takefumi; Annoh, Hiromichi; Waguri, Satoshi] Fukushima Med Univ, Sch Med, Dept Anat & Histol, Fukushima 9601295, Japan	Komatsu, M (reprint author), Niigata Univ, Grad Sch Med & Dent Sci, Dept Biochem, Chuo Ku, Niigata 9518510, Japan.	waguri@fmu.ac.jp; komatsu-ms@med.niigata-u.ac.jp			Human Frontier Scientific Program [RGP0055/2014]; Takeda Science Foundation;  [25111006];  [26253019]	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas [grant number 25111006]; a Grant-in-Aid for Scientific Research (A) [grant number 26253019]; a Human Frontier Scientific Program [grant number RGP0055/2014]; and the Takeda Science Foundation. Deposited in PMC for immediate release.	Matsumoto G, 2015, HUM MOL GENET, V24, P4429, DOI 10.1093/hmg/ddv179; Matsumoto G, 2011, MOL CELL, V44, P279, DOI 10.1016/j.molcel.2011.07.039; Moscat J, 2011, CELL, V147, P724, DOI 10.1016/j.cell.2011.10.021; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Jain A, 2010, J BIOL CHEM, V285, P22576, DOI 10.1074/jbc.M110.118976; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Taguchi K, 2012, P NATL ACAD SCI USA, V109, P13561, DOI 10.1073/pnas.1121572109; Lau A, 2010, MOL CELL BIOL, V30, P3275, DOI 10.1128/MCB.00248-10; Rogov V, 2014, MOL CELL, V53, P167, DOI 10.1016/j.molcel.2013.12.014; Ciuffa R, 2015, CELL REP, V11, P748, DOI 10.1016/j.celrep.2015.03.062; Rea SL, 2014, EXP CELL RES, V325, P27, DOI 10.1016/j.yexcr.2014.01.020; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Li LJ, 2013, CANCER CELL, V24, P738, DOI 10.1016/j.ccr.2013.10.025; Lamark T, 2003, J BIOL CHEM, V278, P34568, DOI 10.1074/jbc.M303221200; Shvets E, 2008, J CELL SCI, V121, P2685, DOI 10.1242/jcs.026005; Ishii T, 2013, FREE RADICAL BIO MED, V65, P102, DOI 10.1016/j.freeradbiomed.2013.06.019; Ni HM, 2014, J HEPATOL, V61, P617, DOI 10.1016/j.jhep.2014.04.043; Jiang T, 2015, FREE RADICAL BIO MED, V88, P199, DOI 10.1016/j.freeradbiomed.2015.06.014; Waguri S, 2009, METHOD ENZYMOL, V453, P181, DOI 10.1016/S0076-6879(08)04009-3; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Itakura E, 2011, J CELL BIOL, V192, P17, DOI 10.1083/jcb.201009067; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Zatloukal K, 2002, AM J PATHOL, V160, P255, DOI 10.1016/S0002-9440(10)64369-6; Jain A, 2015, J BIOL CHEM, V290, P14945, DOI 10.1074/jbc.M115.656116; Pilli M, 2012, IMMUNITY, V37, P223, DOI 10.1016/j.immuni.2012.04.015; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Takamura A, 2011, GENE DEV, V25, P795, DOI 10.1101/gad.2016211; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Bitto A, 2014, AGE, V36, P1123, DOI 10.1007/s11357-014-9626-3; Ichimura Y, 2013, MOL CELL, V51, P618, DOI 10.1016/j.molcel.2013.08.003; Ishimura R, 2014, FEBS LETT, V588, P822, DOI 10.1016/j.febslet.2014.01.045; Lim J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004987; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200	35	0	0	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0021-9533	1477-9137		J CELL SCI	J. Cell Sci.	DEC 1	2015	128	23					4453	4461		10.1242/jcs.180174		9	Cell Biology	Cell Biology	CY3NL	WOS:000366316400021		
J	Moryama, CT; Sugahara, T; Franco, DYY; Mimachi, H				Moryama, Caroline T.; Sugahara, Takeshi; Franco, Danilo Y. Yatabe; Mimachi, Hiroko			In Situ Raman Spectroscopic Studies on Small-Cage Occupancy of Methane in the Simple Methane and Methane plus Deuterated Tetrahydrofuran Mixed Hydrates	JOURNAL OF CHEMICAL AND ENGINEERING DATA			English	Article							PHASE-EQUILIBRIUM; ETHANE; DISSOCIATION; SYSTEM; WATER; NONSTOICHIOMETRY; TRANSITION; STABILITY; MIXTURES; ENTHALPY	To investigate the small-cage occupancies of methane (CH4) in the structure-I and structure-II hydrates, under the three-phase equilibrium conditions of dathrate hydrate, aqueous solution, and fluid CH4 phases, in situ Raman spectra of the guest molecules in the simple CH4 hydrate and the CH4 + deuterated tetrahydrofuran (THF-d(8)) mixed hydrate with the stoichiometric THF-d(8) composition were measured. The three-phase equilibrium conditions of CH4 + THF-d(8) mixed hydrate phase, THF-d(8) aqueous solution phase, and fluid CH4 phase were measured in a temperature range of (278 to 294) K and pressure range up to 2.6 MPa. The small-cage occupancy of CH4 in the structure-II CH4 + THF-d(8) hydrate increases with increasing pressure (and also temperature) up to 3 MPa. At pressures higher than 3 MPa, the small-cages of structure-II hydrate are mostly filled up with the CH4 molecules. In the simple CH4 hydrate, the small-cage occupancy is almost independent of the pressures of (5 to 60) MPa measured in the present study. The three-phase equilibrium pressures at which the small cages are filled up with the CH4 molecules would be lower than ever expected by the statistic-thermodynamic model.	[Moryama, Caroline T.; Sugahara, Takeshi; Franco, Danilo Y. Yatabe] Osaka Univ, Grad Sch Engn Sci, Dept Mat Engn Sci, Div Chem Engn, Toyonaka, Osaka 5608531, Japan; [Moryama, Caroline T.] Univ Estadual Maringa, Dept Chem Engn, BR-87020900 Maringa, Parana, Brazil; [Franco, Danilo Y. Yatabe] Univ Fed Rio de Janeiro, Sch Chem, Dept Chem Engn, BR-21945970 Rio De Janeiro, RJ, Brazil; [Mimachi, Hiroko] Mitsui Engn & Shipbldg Co Ltd, Res & Dev Headquarters, Chiba Technol Ctr, Ichihara, Chiba 2908531, Japan	Sugahara, T (reprint author), Osaka Univ, Grad Sch Engn Sci, Dept Mat Engn Sci, Div Chem Engn, 1-3 Machikaneyama, Toyonaka, Osaka 5608531, Japan.	sugahara@cheng.es.osaka-u.ac.jp			CAPES Foundation, Ministry of Education of Brazil [88888.068169/2013-00, 88888.058098/2013-00]	The authors (C.T.M. and D.Y.Y.F.) sincerely thank the CAPES Foundation, Ministry of Education of Brazil, for the scholarship (No. 88888.068169/2013-00 and 88888.058098/2013-00, respectively).	SLOAN ED, 1992, FLUID PHASE EQUILIBR, V76, P123, DOI 10.1016/0378-3812(92)85082-J; Nakano S, 1998, J CHEM ENG DATA, V43, P807, DOI 10.1021/je9800555; [Anonymous], 1994, J MOL STRUC-THEOCHEM, DOI 10.1016/0166-1280(94)03793-K; Subramanian S, 2000, CHEM ENG SCI, V55, P1981, DOI 10.1016/S0009-2509(99)00389-9; Morita K, 2000, FLUID PHASE EQUILIBR, V169, P167, DOI 10.1016/S0378-3812(00)00320-4; Hashimoto S, 2006, CHEM ENG SCI, V61, P7884, DOI 10.1016/j.ces.2006.09.039; Shimada N, 2003, FLUID PHASE EQUILIBR, V205, P17, DOI 10.1016/S0378-3812(02)00186-3; de Deugd RM, 2001, AICHE J, V47, P693, DOI 10.1002/aic.690470316; Yoon JH, 2012, KOREAN J CHEM ENG, V29, P1670, DOI 10.1007/s11814-012-0137-6; Seo YT, 2001, FLUID PHASE EQUILIBR, V189, P99, DOI 10.1016/S0378-3812(01)00580-5; Lee H, 2005, NATURE, V434, P743, DOI 10.1038/nature03457; Huo ZX, 2003, AICHE J, V49, P1300, DOI 10.1002/aic.690490521; Huo ZX, 2002, CHEM ENG SCI, V57, P705, DOI 10.1016/S0009-2509(01)00437-7; Sugahara T, 2009, J AM CHEM SOC, V131, P14616, DOI 10.1021/ja905819z; VANDERWAALS JH, 1959, ADV CHEM PHYS, V2, P1; KVENVOLDEN KA, 1988, CHEM GEOL, V71, P41, DOI 10.1016/0009-2541(88)90104-0; Subramanian S, 2002, J PHYS CHEM B, V106, P4348, DOI 10.1021/jp013644h; HANDA YP, 1986, J CHEM THERMODYN, V18, P915, DOI 10.1016/0021-9614(86)90149-7; Makino T, 2005, J CHEM ENG DATA, V50, P2058, DOI 10.1021/je0502694; Takeya S, 2003, CAN J PHYS, V81, P479, DOI 10.1139/P03-038; Lee YJ, 2012, J CHEM ENG DATA, V57, P3543, DOI 10.1021/je300850q; Sugahara K, 2006, J CHEM ENG DATA, V51, P301, DOI 10.1021/je050447t; Zhang Q, 2005, J CHEM ENG DATA, V50, P234, DOI 10.1021/je0497146; Sum AK, 1997, J PHYS CHEM B, V101, P7371, DOI 10.1021/jp970768e; Takeya S, 2010, J AM CHEM SOC, V132, P524, DOI 10.1021/ja905426e; Hashimoto S., 2008, OPEN THERMODYN J, V2, P100, DOI 10.2174/1874396X00802010100; Papadimitriou N. I., 2009, J CHEM PHYS, V131; Sloan ED, 2008, CHEM IND-SER, V119, pXIX; Udachin K. A., 2002, J SUPRAMOL CHEM, V2, P405, DOI 10.1016/S1472-7862(03)00049-2	29	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0021-9568			J CHEM ENG DATA	J. Chem. Eng. Data	DEC	2015	60	12					3581	3587		10.1021/acs.jced.5b00533		7	Thermodynamics; Chemistry, Multidisciplinary; Engineering, Chemical	Thermodynamics; Chemistry; Engineering	CY3WE	WOS:000366339800014		
J	Tanaka, H; Fujiwara, N; Sato, H				Tanaka, Hiroshi; Fujiwara, Naoki; Sato, Haruki			Isobaric Heat Capacity of Liquid 1,1,1,3,3-Pentafluoropropane (R245fa) by Flow Calorimeter from 278 K to 343 K	JOURNAL OF CHEMICAL AND ENGINEERING DATA			English	Article							HCFC-123	Isobaric heat capacity of liquid 1,1,1,3,3-pentafluoropropane (R245fa) was measured. Since our group constructed a flow-calorimeter in 1985, specific isobaric heat capacity of liquid refrigerants have been measured for R32, R123, R125, R134a, R142b, and R152a. In 2014, the authors modified the apparatus of flow calorimetry with an improvement for achieving a stable mass-flow-rate by introducing plastic accumulators and two parallel needle valves. The apparatus is able to measure isobaric heat capacity with unmeasurable level small heat loss and good repeatability mostly within 0.4 % (80 % of the data) and the largest 1.5 % from the maximum scatter. The measurements were obtained at 15 points of state parameters, along two pressures of 500 kPa and 800 kPa in a temperature range from 278 K to 343 K. The expanded uncertainty (coverage factor of k = 2) for the heat capacity value is predicted for each datum as being between 0.36 and 1.12 %. The purity of the sample liquid R245fa is analyzed as being better than 99.99 in mass fraction by the manufacture.	[Tanaka, Hiroshi; Fujiwara, Naoki] Keio Univ, Grad Sch Sci & Technol, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan; [Sato, Haruki] Keio Univ, Dept Syst Design Engn, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan	Sato, H (reprint author), Keio Univ, Dept Syst Design Engn, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	hsato@sd.keio.ac.jp					Defibaugh DR, 1997, J CHEM ENG DATA, V42, P160, DOI 10.1021/je960266e; SAITOH A, 1990, J CHEM ENG DATA, V35, P107, DOI 10.1021/je00060a002; HWANG SH, 1992, J THERM ANAL, V38, P2515, DOI 10.1007/BF01974629; [Anonymous], 2008, 1002008 JCGM, P1; SAITOH A, 1989, INT J THERMOPHYS, V10, P649, DOI 10.1007/BF00507986; Lemmon EW, 2006, J CHEM ENG DATA, V51, P785, DOI 10.1021/je050186n; NAKAGAWA S, 1993, J CHEM ENG DATA, V38, P70, DOI 10.1021/je00009a017; Miyazawa T, 2012, J CHEM ENG DATA, V57, P1700, DOI 10.1021/je2013473; Kondo S., 2013, P AS THERM PROP C KO; Nakagawa S., 1991, HIGH TEMP HIGH PRESS, V23, P191; NAKAGAWA S, 1991, J CHEM ENG DATA, V36, P156, DOI 10.1021/je00002a007; NAKAGAWA S, 1990, THERMOCHIM ACTA, V163, P203, DOI 10.1016/0040-6031(90)80398-I; Yamashita S., 2014, J JPN SOC ENERGY RES, V35, P21; Yomo M., 1994, HIGH TEMP HIGH PRESS, V26, P267	14	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0021-9568			J CHEM ENG DATA	J. Chem. Eng. Data	DEC	2015	60	12					3594	3599		10.1021/acs.jced.5b00597		6	Thermodynamics; Chemistry, Multidisciplinary; Engineering, Chemical	Thermodynamics; Chemistry; Engineering	CY3WE	WOS:000366339800016		
J	Matsuura, H; Iwaasa, S; Nagasaka, Y				Matsuura, Hiroaki; Iwaasa, Shintaro; Nagasaka, Yuji			Mass Diffusion Coefficient and Soret Coefficient of o-Dichlorobenzene Solutions of PCBM and [60]Fullerene by the Soret Forced Rayleigh Scattering Method	JOURNAL OF CHEMICAL AND ENGINEERING DATA			English	Article							POLYMER PHOTOVOLTAIC CELLS; ORGANIC LIQUID-MIXTURES; THERMAL-DIFFUSION; BENCHMARK TEST; TEMPERATURE-DEPENDENCE; SOLAR-CELLS; PRECISE DETERMINATION; HYDROCARBON MIXTURES; OPTICAL MEASUREMENT; SELF-ORGANIZATION	We measured the binary diffusion coefficient and the Soret coefficient in the fabrication system of organic photovoltaics (OPVs) by the holographic grating technique we call Soret forced Rayleigh scattering (SFRS). To test the validity of the apparatus we built, we here performed measurements on binary benchmark mixtures: three types of binary solutions (50 wt %) composed of n-dodecane, isobutylbenzene, and 1,2,3,4-tetrahydronaphthalene, at 298.2 K. Our experimental results for the diffusion coefficient and the Soret coefficient agree with the benchmark values within +/- 10 %. The uncertainties estimated based on the Guide to the Expression of Uncertainty in Measurement (GUM) for the Soret coefficient on the benchmark mixtures are within 16 % with the coverage factor of k = 2. For OPV systems, our measurements were performed on [60]fullerene or [6,6]-phenyl-C61-butyric acid methyl ester (PCBM) solved in o-dichlorobenzene. We evaluated the Soret coefficient and the diffusion coefficient across a wide concentration range ([60]fullerene/o-dichlorobenzene; (5 to 30) mg-mL(-1) and PCBM/o-dichlorobenzene; (10 to 40) mg-mL(-1)) at 298.2 K and the temperature range (288.2 to 333.2) K.	[Matsuura, Hiroaki; Iwaasa, Shintaro; Nagasaka, Yuji] Keio Univ, Dept Syst Design Engn, Yokohama, Kanagawa 2238522, Japan	Nagasaka, Y (reprint author), Keio Univ, Dept Syst Design Engn, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	nagasaka@sd.keio.ac.jp			Japan Society for the Promotion of Science (JSPS) [24226006]	The work described in this paper was carried out under a Grant-in Aid for Scientific Research (S) (No. 24226006) from the Japan Society for the Promotion of Science (JSPS).	Chen DA, 2011, NANO LETT, V11, P561, DOI 10.1021/nl103482n; YU G, 1995, SCIENCE, V270, P1789, DOI 10.1126/science.270.5243.1789; KOHLER W, 1995, J PHYS CHEM-US, V99, P5838; Dutrieux JF, 2002, J PHYS CHEM B, V106, P6104, DOI 10.1021/jp013945r; Leppla C, 2003, PHILOS MAG, V83, P1989, DOI 10.1080/0141861031000108222; Costeseque P, 2003, PHILOS MAG, V83, P2017, DOI 10.1080/0141861031000108187; Yang XN, 2005, NANO LETT, V5, P579, DOI 10.1021/nl048120i; Bou-Ali MM, 1998, J PHYS-CONDENS MAT, V10, P3321, DOI 10.1088/0953-8984/10/15/009; Rahman MA, 2014, INT J HEAT MASS TRAN, V73, P693, DOI 10.1016/j.ijheatmasstransfer.2014.02.057; Liu F, 2012, J POLYM SCI POL PHYS, V50, P1018, DOI 10.1002/polb.23063; KOLODNER P, 1988, J CHEM PHYS, V88, P6512, DOI 10.1063/1.454436; Rossmanith P, 1996, MACROMOLECULES, V29, P3203, DOI 10.1021/ma9516302; Li G, 2005, NAT MATER, V4, P864, DOI 10.1038/nmat1500; Niwa M, 2009, J CHEM ENG DATA, V54, P2708, DOI 10.1021/je900242e; Zhang Y, 2014, NANO LETT, V14, P5547, DOI 10.1021/nl501933q; Treat ND, 2011, ADV ENERGY MATER, V1, P82, DOI 10.1002/aenm.201000023; Wittko G, 2003, PHILOS MAG, V83, P1973, DOI 10.1080/0141861031000108213; Platten JK, 2003, PHILOS MAG, V83, P2001, DOI 10.1080/0141861031000108196; RUOFF RS, 1993, J PHYS CHEM-US, V97, P3379, DOI 10.1021/j100115a049; Sondergaard RR, 2013, J POLYM SCI POL PHYS, V51, P16, DOI 10.1002/polb.23192; Kishikawa Y, 2010, BIOMACROMOLECULES, V11, P740, DOI 10.1021/bm9013149; Rauch J, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.185901; Zhang KJ, 1996, J CHEM PHYS, V104, P6881, DOI 10.1063/1.471355; Fischer F, 2014, ADV FUNCT MATER, V24, P6172, DOI 10.1002/adfm.201401153; GRIFFING V, 1954, J PHYS CHEM-US, V58, P1054, DOI 10.1021/j150521a032; KOHLER W, 1993, J CHEM PHYS, V98, P660; Martin A, 2011, CR MECANIQUE, V339, P329, DOI 10.1016/j.crme.2011.03.010; NAGASAKA Y, 1988, REV SCI INSTRUM, V59, P1156, DOI 10.1063/1.1139743; Brabec CJ, 2010, ADV MATER, V22, P3839, DOI 10.1002/adma.200903697; Yahya M, 2015, J CHEM ENG DATA, V60, P2329, DOI 10.1021/acs.jced.5b00251; Kohler W, 2000, ADV POLYM SCI, V151, P1; Machui F, 2012, SOL ENERG MAT SOL C, V100, P138, DOI 10.1016/j.solmat.2012.01.005; Campoy-Quiles M, 2008, NAT MATER, V7, P158, DOI 10.1038/nmat2102; Ruelle P, 1996, J AM CHEM SOC, V118, P1777, DOI 10.1021/ja953467w; Bou-Ali MM, 2003, PHILOS MAG, V83, P2011, DOI 10.1080/0141861031000113299; Thompson BC, 2008, ANGEW CHEM INT EDIT, V47, P58, DOI 10.1002/anie.200702506; Platten JK, 2003, PHILOS MAG, V83, P1965, DOI 10.1080/0141861031000108204; Treat ND, 2013, MACROMOLECULES, V46, P1002, DOI 10.1021/ma302337p; THYAGARAJAN K, 1978, OPT COMMUN, V26, P54, DOI 10.1016/0030-4018(78)90340-1; Krebs FC, 2009, SOL ENERG MAT SOL C, V93, P394, DOI 10.1016/j.solmat.2008.10.004; KOHLER W, 1995, J CHEM PHYS, V103, P4367; Cussler E. L., 2009, CAMBRIDGE SERIES CHE; Eichler H. J., 1986, LASER INDUCED DYNAMI; GHAI RK, 1974, J PHYS CHEM-US, V78, P2283, DOI 10.1021/j100615a022; Hayashida K., 1997, NIPPON KIKAI GAKKA B, VB63, P276; Wittko G, 2007, EPL-EUROPHYS LETT, V78, DOI 10.1209/0295-5075/78/46007; Yamamoto Y., 2006, NIPPON KIKAI GAKKA B, VB72, P715; Yamamoto Y., 2006, NIPPON KIKAI GAKKA B, VB72, P709; You JB, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2411	49	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0021-9568			J CHEM ENG DATA	J. Chem. Eng. Data	DEC	2015	60	12					3621	3630		10.1021/acs.jced.5b00609		10	Thermodynamics; Chemistry, Multidisciplinary; Engineering, Chemical	Thermodynamics; Chemistry; Engineering	CY3WE	WOS:000366339800019		
J	Matsudaira, T; Gow, RV; Kelly, J; Murphy, C; Potts, L; Sumich, A; Ghebremeskel, K; Crawford, MA; Taylor, E				Matsudaira, Toshiko; Gow, Rachel V.; Kelly, Joanna; Murphy, Caroline; Potts, Laura; Sumich, Alexander; Ghebremeskel, Kebreab; Crawford, Michael A.; Taylor, Eric			Biochemical and Psychological Effects of Omega-3/6 Supplements in Male Adolescents with Attention-Deficit/Hyperactivity Disorder: A Randomized, Placebo-Controlled, Clinical Trial	JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY			English	Article							DEFICIT HYPERACTIVITY DISORDER; POLYUNSATURATED FATTY-ACIDS; BRAIN DOCOSAHEXAENOIC ACID; YOUNG-ADULT PRISONERS; DOUBLE-BLIND; LINOLENIC ACID; CHILDREN; BEHAVIOR; ADHD; RATS	Background: An abnormality in long chain-polyunsaturated fatty acid (LC-PUFA) levels has been implicated in attention-deficit/hyperactivity disorder (ADHD). Studies evaluating LC-PUFA supplementation for therapeutic efficacy in ADHD have shown mixed and, therefore, inconclusive results. Methods: Seventy-six male adolescents (age 12-16 years, mean=13.7) with ADHD were assessed for the effects of 12 weeks omega-3 and omega-6 supplements on biochemical and psychological outcomes in a randomized, placebo-controlled, clinical trial. The primary outcome measure was change in the Conners' Teacher Rating Scales (CTRS) following 12 weeks of supplementation of LC-PUFA or placebo. At baseline, the placebo and treatment groups had comparable levels of LC-PUFA as measured by red blood cell phosphatidylcholine. In the treatment group, supplementation enhanced eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), and total omega-3 fatty acid levels. Results: No superiority of LC-PUFAs to placebo was observed on the primary outcome. Further, there were no reliable treatment effects on aggression, impulsivity, depression, and anxiety. Conclusions: Future studies should use larger sample sizes and longer supplementation period to detect small-modest effects for clinical recommendations in ADHD.	[Matsudaira, Toshiko; Taylor, Eric] Inst Psychiat Psychol & Neurosci, Dept Adolescent & Child Psychiat, London, England; [Gow, Rachel V.] NIH, Sect Nutr Neurosci, Bethesda, MD 20892 USA; [Kelly, Joanna; Murphy, Caroline; Potts, Laura] Inst Psychiat, Dept Biostat, Kings Clin Trials Unit, London, England; [Sumich, Alexander] Nottingham Trent Univ, Sch Social Sci, Div Psychol, Nottingham, England; [Ghebremeskel, Kebreab] London Metropolitan Univ, Lipid & Nutr Res Ctr, London, England; [Crawford, Michael A.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Reprod Physiol, London, England	Matsudaira, T (reprint author), 1-15-9 Sekiguchi,Bunkyo Ku, Tokyo 1120014, Japan.	toshimatsudaira@yahoo.co.jp					American Psychiatric Association, 2013, DIAGN STAT MAN MENT; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Song C, 2008, J NUTR, V138, P954; Yavin E, 2009, NEUROSCIENCE, V162, P1011, DOI 10.1016/j.neuroscience.2009.05.012; McQuade JD, 2008, DEV DISABIL RES REV, V14, P320, DOI 10.1002/ddrr.35; Voigt RG, 2001, J PEDIATR-US, V139, P189, DOI 10.1067/mpd.2001.116050; Moriguchi T, 2000, J NEUROCHEM, V75, P2563, DOI 10.1046/j.1471-4159.2000.0752563.x; BOURRE JM, 1992, ADV EXP MED BIOL, V318, P211; Gesch CB, 2002, BRIT J PSYCHIAT, V181, P22, DOI 10.1192/bjp.181.1.22; Hibbeln JR, 2007, LANCET, V369, P578, DOI 10.1016/S0140-6736(07)60277-3; FOLCH J, 1957, J BIOL CHEM, V226, P497; Tapert SF, 2002, J AM ACAD CHILD PSY, V41, DOI 10.1097/00004583-200206000-00007; de Boo GM, 2007, CLIN PSYCHOL REV, V27, P78, DOI 10.1016/j.cpr.2006.03.006; Johnson M, 2009, J ATTEN DISORD, V12, P394, DOI 10.1177/1087054708316261; Bloch MH, 2011, J AM ACAD CHILD PSY, V50, P991, DOI 10.1016/j.jaac.2011.06.008; Richardson AJ, 2002, PROG NEURO-PSYCHOPH, V26, P233, DOI 10.1016/S0278-5846(01)00254-8; SINCLAIR AJ, 1972, FEBS LETT, V26, P127, DOI 10.1016/0014-5793(72)80557-X; Young G, 2005, REPROD NUTR DEV, V45, P1, DOI 10.1051/rnd:2005001; Solanto MV, 2009, J ATTEN DISORD, V13, P27, DOI 10.1177/1087054708320403; Peet M, 2002, J PSYCHIAT RES, V36, P7, DOI 10.1016/S0022-3956(01)00048-6; Zimmer L, 2000, J LIPID RES, V41, P32; Crawford MA, 2009, ANN NUTR METAB, V55, P202, DOI 10.1159/000229003; Nemets H, 2006, AM J PSYCHIAT, V163, P1098, DOI 10.1176/appi.ajp.163.6.1098; Antalis CJ, 2006, PROSTAG LEUKOTR ESS, V75, P299, DOI 10.1016/j.plefa.2006.07.004; Green P, 1999, J LIPID RES, V40, P960; Salem N, 2001, LIPIDS, V36, P945, DOI 10.1007/s11745-001-0805-6; Cao DH, 2009, J NEUROCHEM, V111, P510, DOI 10.1111/j.1471-4159.2009.06335.x; Sublette ME, 2006, AM J PSYCHIAT, V163, P1100, DOI 10.1176/appi.ajp.163.6.1100; Sinn N, 2007, J DEV BEHAV PEDIATR, V28, P82, DOI 10.1097/01.DBP.0000267558.88457.a5; Fedorova I, 2006, PROSTAG LEUKOTR ESS, V75, P271, DOI 10.1016/j.plefa.2006.07.006; Chalon S, 2006, PROSTAG LEUKOTR ESS, V75, P259, DOI 10.1016/j.plefa.2006.07.005; Conners CK, 1998, J ABNORM CHILD PSYCH, V26, P279, DOI 10.1023/A:1022606501530; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Zimmer L, 2000, NEUROSCI LETT, V284, P25, DOI 10.1016/S0304-3940(00)00950-2; STEVENS LJ, 1995, AM J CLIN NUTR, V62, P761; Zaalberg A, 2010, AGGRESSIVE BEHAV, V36, P117, DOI 10.1002/ab.20335; Salem N, 2001, J MOL NEUROSCI, V16, P299, DOI 10.1385/JMN:16:2-3:299; Freeman MP, 2006, J CLIN PSYCHIAT, V67, P1954; Richardson AJ, 2005, PEDIATRICS, V115, P1360, DOI 10.1542/peds.2004-2164; Marszalek JR, 2005, ANNU REV CELL DEV BI, V21, P633, DOI 10.1146/annurev.cellbio.21.122303.120624; Barkley RA, 2003, BRAIN DEV-JPN, V25, P77, DOI 10.1016/S0387-7604(02)00152-3; Stevens LJ, 1996, PHYSIOL BEHAV, V59, P915, DOI 10.1016/0031-9384(95)02207-4; Levant B, 2004, BEHAV BRAIN RES, V152, P49, DOI 10.1016/j.bbr.2003.09.029; Chen JR, 2004, J NUTR BIOCHEM, V15, P467, DOI 10.1016/j.jnutbio.2004.01.008; Hamazaki T, 2004, EUR J CLIN NUTR, V58, P838, DOI 10.1038/sj.ejcn.1601888; Barragan E BD, 2014, J ATTEN DISORD; Faraone Stephen V, 2003, World Psychiatry, V2, P104; FIENNES RNT, 1973, J MED PRIMATOL, V2, P155; Frick Paul J, 2006, Curr Psychiatry Rep, V8, P59, DOI 10.1007/s11920-006-0082-3; Gilles D, 2012, COCHRANE DB SYST REV, V7; Kaufman AS, 2004, KAUFMAN BRIEF INTELL; Reisbick M, 1994, PHYSIOL BEHAV, V55, P231; Richardson AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043909; Rooney MT, 1999, ADM MANUAL CHIPS CHI; Strathdee A, 1994, J FORENSIC PSYCHIATR, V5, P83, DOI 10.1080/09585189408410899; Taylor E, 2004, EUR CHILD ADOLESC S1, V13, P17, DOI DOI 10.1007/s00787-004-1002-x; Tercyak KP, 2002, J AM ACAD CHILD ADOL, V41, P79; World Health Organization, 1992, ICD 10 ICD 10 CLASS	58	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1044-5463	1557-8992		J CHILD ADOL PSYCHOP	J. Child Adolesc. Psychopharmacol.	DEC 1	2015	25	10					775	782		10.1089/cap.2015.0052		8	Pediatrics; Pharmacology & Pharmacy; Psychiatry	Pediatrics; Pharmacology & Pharmacy; Psychiatry	CY9JT	WOS:000366723900006		
J	Shimura, T; Mori, N; Mase, H				Shimura, Tomoya; Mori, Nobuhito; Mase, Hajime			Future Projections of Extreme Ocean Wave Climates and the Relation to Tropical Cyclones: Ensemble Experiments of MRI-AGCM3.2H	JOURNAL OF CLIMATE			English	Article						Circulation; Dynamics; Wind waves; Physical Meteorology and Climatology; Climate change	WESTERN NORTH PACIFIC; HEIGHTS; WIND; REANALYSIS; TRENDS; SIMULATIONS; VARIABILITY; PERFORMANCE; INTERIM; SYSTEM	Future projections of extreme ocean surface wave climates were carried out with single-model ensemble experiments of the atmospheric global climate model MRI-AGCM3.2H. The ensemble experiments of MRI-AGCM3.2H consist of four future sea surface temperature (SST) ensembles and three perturbed physics (PP) ensembles. This study showed that future changes in extreme wave heights strongly depend on the global climate model (GCM) performance to simulate tropical cyclones (TCs), indicating a need to acknowledge that results in a study that employs a low-performance model are not able to account for extreme waves associated with TCs (TC waves). The spatial distribution of future changes in non-TC extreme wave heights on the global scale was similar to that for mean wave heights; namely, wave heights increase over the middle-to-high latitudes in the Southern Ocean and central North Pacific and decrease over midlatitudes and the North Atlantic, although the magnitude of future changes for extreme wave heights is greater than for mean wave heights. The variance of future changes mainly depends on differences in physics among PP ensemble experiments rather than differences in SST ensembles. The 10-yr return wave heights of TC waves over the western North Pacific showed either an increase or a decrease of 30% for different regions, maximally. The spatial distribution of future changes in TC waves can be explained by an eastward shift of TC tracks.	[Shimura, Tomoya; Mori, Nobuhito; Mase, Hajime] Kyoto Univ, Disaster Prevent Res Inst, Uji, Kyoto 6110011, Japan	Shimura, T (reprint author), Kyoto Univ, Disaster Prevent Res Inst, Uji, Kyoto 6110011, Japan.	shimura@storm.dpri.kyoto-u.ac.jp			Japan Society for the Promotion of Science (JSPS); SOUSEI Program by the Ministry of Education, Culture, Sports, Science, and Technology (MEXT)	The authors were supported by the Japan Society for the Promotion of Science (JSPS) Fellowships for Young Scientists and Grant-in-Aid for JSPS Fellows. This research was supported under the SOUSEI Program by the Ministry of Education, Culture, Sports, Science, and Technology (MEXT).	Bromirski PD, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004706; Hemer MA, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044595; Wang XLL, 2001, J CLIMATE, V14, P2204, DOI 10.1175/1520-0442(2001)014<2204:COEWHI>2.0.CO;2; Slott JM, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027445; Menendez M, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035394; Chao YY, 2010, WEATHER FORECAST, V25, P1543, DOI 10.1175/2010WAF2222309.1; Young IR, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007753; Wu LG, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022937; Fan YL, 2013, J CLIMATE, V26, P6046, DOI 10.1175/JCLI-D-12-00410.1; Komar PD, 2008, J COASTAL RES, V24, P479, DOI 10.2112/07-0894.1; Mizuta R, 2012, J METEOROL SOC JPN, V90A, P233, DOI 10.2151/jmsj.2012-A12; Ardhuin F, 2010, J PHYS OCEANOGR, V40, P1917, DOI 10.1175/2010JPO4324.1; Murakami H, 2014, GEOPHYS RES LETT, V41, P2133, DOI 10.1002/2014GL059519; Shimura T, 2015, J CLIMATE, V28, P3171, DOI 10.1175/JCLI-D-14-00187.1; Tolman HL, 1996, J PHYS OCEANOGR, V26, P2497, DOI 10.1175/1520-0485(1996)026<2497:STIATG>2.0.CO;2; Kobayashi S, 2015, J METEOROL SOC JPN, V93, P5, DOI 10.2151/jmsj.2015-001; Yokoi S, 2013, J CLIMATE, V26, P4096, DOI 10.1175/JCLI-D-12-00218.1; Murakami H, 2010, SOLA, V6, P73, DOI 10.2151/sola.2010-019; Murakami H, 2012, CLIM DYNAM, V39, P2569, DOI 10.1007/s00382-011-1223-x; Wang XLL, 2014, GEOPHYS RES LETT, V41, P1026, DOI 10.1002/2013GL058650; Graham NE, 2001, B AM METEOROL SOC, V82, P1869, DOI 10.1175/1520-0477(2001)082<1869:EFIONP>2.3.CO;2; Moore LJ, 2013, GEOPHYS RES LETT, V40, P5867, DOI 10.1002/2013GL057311; Wang XLL, 2009, CLIM DYNAM, V32, P189, DOI 10.1007/s00382-008-0442-2; Sasaki W, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023722; Young IR, 2011, SCIENCE, V332, P451, DOI 10.1126/science.1197219; Ruggiero P, 2010, COAST ENG, V57, P539, DOI 10.1016/j.coastaleng.2009.12.005; Endo H, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2012JD017874; Wang XLL, 2006, CLIM DYNAM, V26, P109, DOI 10.1007/s00382-005-0080-x; Sterl A, 2005, INT J CLIMATOL, V25, P963, DOI 10.1002/joc.1175; Meehl GA, 2007, B AM METEOROL SOC, V88, P1383, DOI 10.1175/BAMS-88-9-1383; Wu LG, 2004, J CLIMATE, V17, P1686, DOI 10.1175/1520-0442(2004)017<1686:AIOGWO>2.0.CO;2; Cooley D, 2007, J AM STAT ASSOC, V102, P824, DOI 10.1198/016214506000000780; Bromirski PD, 2013, J GEOPHYS RES-OCEANS, V118, P6329, DOI 10.1002/2013JC009189; Yong H, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2008JC004732; Hemer MA, 2013, NAT CLIM CHANGE, V3, P471, DOI [10.1038/nclimate1791, 10.1038/NCLIMATE1791]; Stopa JE, 2014, OCEAN MODEL, V75, P65, DOI 10.1016/j.ocemod.2013.12.006; Tolman HL, 2005, OCEAN MODEL, V9, P305, DOI 10.1016/j.ocemod.2004.09.003; Colbert AJ, 2015, J CLIMATE, V28, P1806, DOI 10.1175/JCLI-D-14-00100.1; Emanuel K, 2005, NATURE, V436, P686, DOI 10.1038/nature03906; Manganello JV, 2012, J CLIMATE, V25, P3867, DOI 10.1175/JCLI-D-11-00346.1; Ardhuin F., 2011, P 12 INT WORKSH WAV; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Hosking J.R.M., 1997, REGIONAL FREQUENCY A; Mori Nobuhito, 2010, Hydrological Research Letters, V4, DOI 10.3178/HRL.4.15; Stocker T. F., 2013, CLIM CHANG 2013 PHYS, P1535, DOI DOI 10.1017/CBO9781107415324; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Tolman H. L., 2014, USER MANUAL SYSTEM D; Tolman H. L., 2009, 276 MMAB; Von Storch H., 1999, STAT ANAL CLIMATE RE	49	0	0	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0894-8755	1520-0442		J CLIMATE	J. Clim.	DEC	2015	28	24					9838	9856		10.1175/JCLI-D-14-00711.1		19	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CY9IO	WOS:000366720800017		
J	Hosono, T; Alvarez, K; Lin, IT; Shimada, J				Hosono, Takahiro; Alvarez, Kelly; Lin, In-Tian; Shimada, Jun			Nitrogen, carbon, and sulfur isotopic change during heterotrophic (Pseudomonas aureofaciens) and autotrophic (Thiobacillus denitrificans) denitrification reactions	JOURNAL OF CONTAMINANT HYDROLOGY			English	Article						Heterotrophic denitrification; Autotrophic denitrification; Isotope fractionation; C, N, S isotopes; Batch culture experiments	ZERO-VALENT IRON; IN-GROUND WATER; NITRATE REDUCTION; N2O PRODUCTION; FRESH-WATER; ACIDITHIOBACILLUS-FERROOXIDANS; BIOLOGICAL DENITRIFICATION; MICROBIAL DENITRIFICATION; NATURAL DENITRIFICATION; DENITRIFYING BACTERIA	In batch culture experiments, we examined the isotopic change of nitrogen in nitrate (delta N-15(NO3)), carbon in dissolved inorganic carbon (delta C-13(DIC)), and sulfur in sulfate (delta S-34(SO4)) during heterotrophic and autotrophic denitrification of two bacterial strains (Pseudomonas aureofaciens and Thiobacillus denitrificans). Heterotrophic denitrification (HD) experiments were conducted with trisodium citrate as electron donor, and autotrophic denitrification (AD) experiments were carried out with iron disulfide (FeS2) as electron donor. For heterotrophic denitrification experiments, a complete nitrate reduction was accomplished, however bacterial denitrification with T. denitrificans is a slow process in which, after seventy days nitrate was reduced to 40% of the initial concentration by denitrification. In the HD experiment, systematic change of delta C-13(DIC) (from -7.7 parts per thousand to -12.2 parts per thousand) with increase of DIC was observed during denitrification (enrichment factor epsilon N was -4.7 parts per thousand), suggesting the contribution of C of trisodium citrate (delta C-13 = -12.4 parts per thousand). No SO42- and delta S-34(SO4) changes were observed. In the AD experiment, clear fractionation of delta C-13(DIC) during DIC consumption (epsilon C = -7.8 parts per thousand) and delta S-34(SO4) during sulfur use of FeS2-S (around 2 parts per thousand), were confirmed through denitrification (epsilon N = -12.5 parts per thousand). Different pattern in isotopic change between HD and AD obtained on laboratory-scale are useful to recognize the type of denitrification occurring in the field. (C) 2015 Elsevier B.V. All rights reserved.	[Hosono, Takahiro; Alvarez, Kelly] Kumamoto Univ, Prior Org Innovat & Excellence, Kumamoto 8608555, Japan; [Lin, In-Tian; Shimada, Jun] Kumamoto Univ, Grad Sch Sci & Technol, Kumamoto 8608555, Japan	Hosono, T (reprint author), Kumamoto Univ, Prior Org Innovat & Excellence, 2-39-1 Kurokami, Kumamoto 8608555, Japan.	hosono@kumamoto-u.ac.jp			CREST Project (JST: Japan Science and Technology Agency);  [24681007]	This study was funded by a Grant-in-Aid for Young Scientist (A) (No. 24681007) and by the CREST Project (JST: Japan Science and Technology Agency).	Alcunna J.C., 1993, WATER RES, V27, P1303; Volokita M, 1996, WATER SCI TECHNOL, V34, P379, DOI 10.1016/0273-1223(96)00527-6; Molenat J, 2002, HYDROL PROCESS, V16, P479, DOI 10.1002/hyp.328; Casciotti KL, 2002, ANAL CHEM, V74, P4905, DOI 10.1021/ac020113w; CHRISTENSSON M, 1994, WATER SCI TECHNOL, V30, P83; ANDERSON IC, 1993, APPL ENVIRON MICROB, V59, P3525; Bottrell SH, 2006, EARTH-SCI REV, V75, P59, DOI 10.1016/j.earscirev.2005.10.004; DELWICHE CC, 1970, ENVIRON SCI TECHNOL, V4, P929, DOI 10.1021/es60046a004; Wunderlich A, 2012, ENVIRON SCI TECHNOL, V46, P4861, DOI 10.1021/es204075b; Schreiber ME, 2000, HYDROGEOL J, V8, P161; [Anonymous], APPL ENV MICROBIOL, V62, P2286; Pisapia C, 2007, GEOCHIM COSMOCHIM AC, V71, P2474, DOI 10.1016/j.gca.2007.02.021; Soares MIM, 2000, WATER AIR SOIL POLL, V123, P183, DOI 10.1023/A:1005242600186; Rickard D, 2007, CHEM REV, V107, P514, DOI 10.1021/cr0503658; KOROM SF, 1992, WATER RESOUR RES, V28, P1657, DOI 10.1029/92WR00252; Jorgensen CJ, 2009, ENVIRON SCI TECHNOL, V43, P4851, DOI 10.1021/es803417s; Benz M, 1998, ARCH MICROBIOL, V169, P159, DOI 10.1007/s002030050555; Schulte P, 2011, EARTH-SCI REV, V109, P20, DOI 10.1016/j.earscirev.2011.07.003; Barford CC, 1999, APPL ENVIRON MICROB, V65, P989; Lewicka-Szczebak D, 2014, GEOCHIM COSMOCHIM AC, V134, P55, DOI 10.1016/j.gca.2014.03.010; SINGER PC, 1970, SCIENCE, V167, P1121, DOI 10.1126/science.167.3921.1121; Granger J, 2008, LIMNOL OCEANOGR, V53, P2533, DOI 10.4319/lo.2008.53.6.2533; Brabec MY, 2012, GEOCHIM COSMOCHIM AC, V83, P234, DOI 10.1016/j.gca.2011.12.008; Schippers A, 1996, APPL ENVIRON MICROB, V62, P3424; Knoller K, 2011, BIOGEOCHEMISTRY, V103, P371, DOI 10.1007/s10533-010-9483-9; Carrey R, 2013, APPL GEOCHEM, V32, P142, DOI 10.1016/j.apgeochem.2012.10.009; Sigman DM, 2001, ANAL CHEM, V73, P4145, DOI 10.1021/ac010088e; MARIOTTI A, 1988, GEOCHIM COSMOCHIM AC, V52, P1869, DOI 10.1016/0016-7037(88)90010-5; Aravena R, 1998, GROUND WATER, V36, P975, DOI 10.1111/j.1745-6584.1998.tb02104.x; Puig R, 2013, APPL GEOCHEM, V32, P129, DOI 10.1016/j.apgeochem.2012.10.014; Kusian B, 2002, J BACTERIOL, V184, P5018, DOI 10.1128/JB.184.18.5018-5026.2002; WELLMAN RP, 1968, SCIENCE, V161, P269, DOI 10.1126/science.161.3838.269; Heidel C, 2011, CHEM GEOL, V281, P305, DOI 10.1016/j.chemgeo.2010.12.017; Aslan S, 2005, PROCESS BIOCHEM, V40, P935, DOI 10.1016/j.procbio.2004.02.020; Well R, 2012, GEOCHIM COSMOCHIM AC, V90, P265, DOI 10.1016/j.gca.2012.04.045; Sutka RL, 2006, APPL ENVIRON MICROB, V72, P638, DOI 10.1128/AEM.72.1.638-644.2006; Volokita M, 1996, WATER RES, V30, P965, DOI 10.1016/0043-1354(95)00242-1; Hosono T, 2014, WATER RES, V54, P284, DOI 10.1016/j.watres.2014.02.005; BOTTCHER J, 1990, J HYDROL, V114, P413, DOI 10.1016/0022-1694(90)90068-9; Torrento C, 2010, CHEM GEOL, V278, P80, DOI 10.1016/j.chemgeo.2010.09.003; Schipper LA, 2004, J CONTAM HYDROL, V69, P263, DOI 10.1016/S0169-7722(03)00157-8; Button DK, 1998, MICROBIOL MOL BIOL R, V62, P636; Mohammadi AS, 2011, FRESEN ENVIRON BULL, V20, P2427; BATCHELOR B, 1978, J WATER POLLUT CON F, V50, P1986; Thullner M, 2008, ENVIRON SCI TECHNOL, V42, P6544, DOI 10.1021/es702782c; BUTTON DK, 1991, APPL ENVIRON MICROB, V57, P2033; Biswas S, 2005, J ENVIRON ENG-ASCE, V131, P1212, DOI 10.1061/(ASCE)0733-9372(2005)131:8(1212); Nascimento C, 1997, GEOPHYS RES LETT, V24, P1511, DOI 10.1029/97GL01404; Heidel C, 2013, CHEM GEOL, V342, P29, DOI 10.1016/j.chemgeo.2013.01.016; SASAKI K, 1995, GEOCHIM COSMOCHIM AC, V59, P3155, DOI 10.1016/0016-7037(95)00203-C; POSTMA D, 1991, WATER RESOUR RES, V27, P2027, DOI 10.1029/91WR00989; Mengis M, 1999, GROUND WATER, V37, P448, DOI 10.1111/j.1745-6584.1999.tb01124.x; Thurston RS, 2010, CHEM GEOL, V269, P252, DOI 10.1016/j.chemgeo.2009.10.001; Soares MIM, 2002, WATER RES, V36, P1392, DOI 10.1016/S0043-1354(01)00326-8; Choe SH, 2004, APPL GEOCHEM, V19, P335, DOI 10.1016/j.apgeochem.2003.08.001; Nyberg U, 1996, WATER SCI TECHNOL, V33, P109, DOI 10.1016/0273-1223(96)00464-7; Fukada T, 2003, WATER RES, V37, P3070, DOI 10.1016/S0043-1354(03)00176-3; Welch AH, 2000, GROUND WATER, V38, P589, DOI 10.1111/j.1745-6584.2000.tb00251.x; Otero N, 2009, AGR ECOSYST ENVIRON, V133, P103, DOI 10.1016/j.agee.2009.05.007; Meckenstock RU, 2004, J CONTAM HYDROL, V75, P215, DOI 10.1016/j.jconhyd.2004.06.003; Haaijer SCM, 2007, GEOMICROBIOL J, V24, P391, DOI 10.1080/01490450701436489; MARIOTTI A, 1981, PLANT SOIL, V62, P413, DOI 10.1007/BF02374138; Bald N., 2007, GEOCHIM COSMOCHIM AC, V71, P3796; KINNIBURGH DG, 1994, APPL GEOCHEM, V9, P175, DOI 10.1016/0883-2927(94)90006-X; Komor A., 2002, P WATER ENV FEDERATI, P496; Krouse H.R., 1991, STABLE ISOTOPES NATU; Lasaga A.C., 1998, KINETIC THEORY EARTH, P728	67	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0169-7722	1873-6009		J CONTAM HYDROL	J. Contam. Hydrol.	DEC	2015	183						72	81		10.1016/j.jconhyd.2015.10.009		10	Environmental Sciences; Geosciences, Multidisciplinary; Water Resources	Environmental Sciences & Ecology; Geology; Water Resources	CY6SQ	WOS:000366539500006		
J	Hibi, Y; Tomigashi, A; Hirose, M				Hibi, Yoshihiko; Tomigashi, Akira; Hirose, Masafumi			Evaluation of a numerical simulation model for a system coupling atmospheric gas, surface water and unsaturated or saturated porous medium	JOURNAL OF CONTAMINANT HYDROLOGY			English	Article						Multiphase flow; Global pressure; Saturation equation; Porous medium; Surface fluid; Coupling, Numerical simulation	HYDRAULIC CONDUCTIVITY; FLOW; EQUATIONS; SEEPAGE	Numerical simulations that couple flow in a surface fluid with that in a porous medium are useful for examining problems of pollution that involve interactions among the atmosphere, surface water and groundwater, including, for example, saltwater intrusion along coasts. We previously developed a numerical simulation method for simulating a coupled atmospheric gas, surface water, and groundwater system (called the ASG method) that employs a saturation equation for flow in a porous medium; this equation allows both the void fraction of water in the surface system and water saturation in the porous medium to be solved simultaneously. It remained necessary, however, to evaluate how global pressure, including gas pressure, water pressure, and capillary pressure, should be specified at the boundary between the surface and the porous medium. Therefore, in this study, we derived a new equation for global pressure and integrated it into the ASG method. We then simulated water saturation in a porous medium and the void fraction of water in a surface system by the ASG method and reproduced fairly well the results of two column experiments. Next, we simulated water saturation in a porous medium (sand) with a bank, by using both the ASG method and a modified Picard (MP) method. We found only a slight difference in water saturation between the ASG and MP simulations. This result cohfirmed that the derived equation for global pressure was valid for a porous medium, and that the global pressure value could thus be used with the saturation equation for porous media. Finally, we used the ASG method to simulate a system coupling atmosphere, surface water, and a porous medium (110 m wide and 50 m high) with a trapezoidal bank. The ASG method was able to simulate the complex flow of fluids in this system and the interaction between the porous medium and the surface water or the atmosphere. (C) 2015 Elsevier B.V. All rights reserved.	[Hibi, Yoshihiko; Hirose, Masafumi] Meijo Univ, Fac Sci & Technol, Tenpaku Ku, Nagoya, Aichi 4688502, Japan; [Tomigashi, Akira] Yachiyo Engn Co Ltd, Engn Management & Coordinat Div, Tech Dev Dept, Shinjuku Ku, Tokyo 1618575, Japan	Hibi, Y (reprint author), Meijo Univ, Fac Sci & Technol, Tenpaku Ku, 1-501 Shiogamaguchi, Nagoya, Aichi 4688502, Japan.	hibiy@meijo-u.ac.jp					Amsden A. A., 1970, Journal of Computational Physics, V6, DOI 10.1016/0021-9991(70)90029-X; Groen J, 2000, J HYDROL, V234, P1, DOI 10.1016/S0022-1694(00)00235-3; Delfs JO, 2013, ENVIRON EARTH SCI, V69, P395, DOI 10.1007/s12665-013-2420-1; Maxwell RM, 2008, ADV WATER RESOUR, V31, P807, DOI 10.1016/j.advwatres.2008.01.020; HARLOW FH, 1965, PHYS FLUIDS, V8, P2182, DOI 10.1063/1.1761178; Discacciati M, 2002, APPL NUMER MATH, V43, P57, DOI 10.1016/S0168-9274(02)00125-3; YABE T, 1991, COMPUT PHYS COMMUN, V66, P233, DOI 10.1016/0010-4655(91)90072-S; SMOLARKIEWICZ PK, 1992, J ATMOS SCI, V49, P2082, DOI 10.1175/1520-0469(1992)049<2082:ACOSLA>2.0.CO;2; Chen ZX, 1997, J COMPUT PHYS, V132, P362, DOI 10.1006/jcph.1996.5641; Robinson C, 2007, ADV WATER RESOUR, V30, P851, DOI 10.1016/j.advwatres.2006.07.006; CELIA MA, 1990, WATER RESOUR RES, V26, P1483, DOI 10.1029/90WR00196; Hill AA, 2009, ADV WATER RESOUR, V32, P1609, DOI 10.1016/j.advwatres.2009.08.007; THOMSON NR, 1992, J CONTAM HYDROL, V10, P197, DOI 10.1016/0169-7722(92)90061-I; MUALEM Y, 1976, WATER RESOUR RES, V12, P513, DOI 10.1029/WR012i003p00513; BROCK TD, 1982, WATER RES, V16, P1255, DOI 10.1016/0043-1354(82)90144-0; PARKER JC, 1987, WATER RESOUR RES, V23, P2187, DOI 10.1029/WR023i012p02187; CHORIN AJ, 1968, MATH COMPUT, V22, P745, DOI 10.2307/2004575; VANGENUCHTEN MT, 1980, SOIL SCI SOC AM J, V44, P892; BELANGER TV, 1985, WATER RESOUR BULL, V21, P265; Chavent G., 1986, MATH MODELS FINITE E; Chen Z., 1994, MULTIPHASE FLOW SIMU, P925; Dahle H.K., 2002, TOTAL PRESSURE SATUR, P1067; Hibi Y., 2010, J GROUNDW HYDROL, V52, P169; Onda S., 2013, J HYDROSCI HYDRAUL E, V69, P11207; Peaceman D.W, 1977, FUNDAMENTALS NUMERIC; Tosaka T, 2000, J GROUNDW HYDROL, V44, P45; Weill S., 2011, ADV WATER RESOUR, V34, P28	27	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0169-7722	1873-6009		J CONTAM HYDROL	J. Contam. Hydrol.	DEC	2015	183						121	134		10.1016/j.jconhyd.2015.10.010		14	Environmental Sciences; Geosciences, Multidisciplinary; Water Resources	Environmental Sciences & Ecology; Geology; Water Resources	CY6SQ	WOS:000366539500010		
J	Urabe, S; Akazawa, Y; Takeshima, F				Urabe, Shigetoshi; Akazawa, Yuko; Takeshima, Fuminao			A Case of Cronkhite-Canada Syndrome with a Colitis-mimicking Endoscopic Presentation	JOURNAL OF CROHNS & COLITIS			English	Letter									[Urabe, Shigetoshi; Akazawa, Yuko; Takeshima, Fuminao] Nagasaki Univ Hosp, Dept Gastroenterol & Hepatol, Nagasaki 8528501, Japan	Akazawa, Y (reprint author), Nagasaki Univ Hosp, Dept Gastroenterol & Hepatol, Sakamoto 1-7-1, Nagasaki 8528501, Japan.	akazaway@nagasaki-u.ac.jp					Chadalavada R, 2003, AM J GASTROENTEROL, V98, P1444; CRONKHITE LW, 1955, NEW ENGL J MED, V252, P1011, DOI 10.1056/NEJM195506162522401; DANIEL ES, 1982, MEDICINE, V61, P293; Kopacova M, 2013, GASTROENT RES PRACT, V2013; Watanabe C, 2015, J GASTROENTEROL, DOI [10.1007/s00535-015-1107-7, DOI 10.1007/S00535-015-1107-7]	5	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1873-9946	1876-4479		J CROHNS COLITIS	J. Crohns Colitis	DEC 1	2015	9	12					1179	1180		10.1093/ecco-jcc/jjv154		2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CY5YF	WOS:000366483000019		
J	Takamizawa, T; Barkmeier, WW; Tsujimoto, A; Scheidel, DD; Watanabe, H; Erickson, RL; Latta, MA; Miyazaki, M				Takamizawa, Toshiki; Barkmeier, Wayne W.; Tsujimoto, Akimasa; Scheidel, Donal D.; Watanabe, Hidehiko; Erickson, Robert L.; Latta, Mark A.; Miyazaki, Masashi			Influence of water storage on fatigue strength of self-etch adhesives	JOURNAL OF DENTISTRY			English	Article						Fatigue strength; Self-etch adhesive; Long-term water storage; Phosphoric acid pre-etching	SINGLE-STEP ADHESIVES; RESIN-DENTIN BONDS; HYDROLYTIC DEGRADATION; RESTORATIVE MATERIALS; ENAMEL; DURABILITY; INTERFACE; STABILITY; SYSTEMS; LIMITS	Objectives: The purpose of this study was to determine enamel and dentin bond durability after long-term water storage using self-etch adhesives. Methods: Two single step self-etch adhesives (SU, Scotchbond Universal and GB, G-aenial Bond) and a two-step self-etch adhesive (OX, OptiBond XTR) were used. The shear bond strength (SBS) and shear fatigue strength (FS) of the enamel and dentin were obtained with and without phosphoric acid pre-etching prior to application of the adhesives. The specimens were stored in distilled water at 37 degrees C for 24 h, 6 months, and one year. A staircase method was used to determine the FS using a frequency of 10 Hz for 50,000 cycles or until failure occurred. Results: The SBS and FS of enamel bonds were significantly higher with pre-etching, when compared to no pre-etching for the same water storage period. The FS of dentin bonds with pre-etching tended to decrease relative to no pre-etching at the same storage period. For the one year storage period, SU and GB with pre-etching showed significantly lower FS values than the groups without pre-etching. Conclusions: The influence of water storage on FS of the self-etch adhesives was dependent on the adhesive material, storage period and phosphoric acid pre-etching of the bonding site. Clinical significance: Phosphoric acid pre-etching of enamel improves the effectiveness of self-etch adhesive systems. Inadvertent contact of phosphoric acid on dentin appears to reduce the ability of self-etch adhesives to effectively bond resin composite materials. (C) 2015 Elsevier Ltd. All rights reserved.	[Takamizawa, Toshiki; Tsujimoto, Akimasa; Miyazaki, Masashi] Nihon Univ, Sch Dent, Dept Operat Dent, Chiyoda Ku, Tokyo 1018310, Japan; [Barkmeier, Wayne W.; Erickson, Robert L.; Latta, Mark A.] Creighton Univ, Sch Dent, Dept Gen Dent, Omaha, NE 68178 USA; [Scheidel, Donal D.] Creighton Univ, Sch Dent, Dept Diagnost Sci, Omaha, NE 68178 USA; [Watanabe, Hidehiko] Univ Nebraska, Sect Operat Dent, Lincoln, NE USA	Takamizawa, T (reprint author), Nihon Univ, Sch Dent, Dept Operat Dent, Chiyoda Ku, 1-8-13 Kanda Surugadai, Tokyo 1018310, Japan.	takamizawa.toshiki@nihon-u.ac.jp					Mazzoni A, 2013, J DENT RES, V92, P82, DOI 10.1177/0022034512467034; Erickson RL, 2009, DENT MATER, V25, P716, DOI [10.1016/j.dental.2008.12.001, 10.1016/j.denta1.2008.12.001]; Hashimoto M, 2007, DENT MATER J, V26, P677; Baran G, 2001, CRIT REV ORAL BIOL M, V12, P350; Frankenberger R, 2008, J ADHES DENT, V10, P339; Hanabusa M, 2012, J DENT, V40, P475, DOI 10.1016/j.jdent.2012.02.012; Karl M, 2009, DENT MATER, V25, P1426, DOI 10.1016/j.dental.2009.06.015; Sheets JL, 2012, J PROSTHET DENT, V107, P102, DOI 10.1016/S0022-3913(12)60033-X; Tay FR, 2003, AM J DENT, V16, P6; Tjaderhane L, 2013, DENT MATER, V29, P999, DOI 10.1016/j.dental.2013.07.016; Yoshihara K, 2011, J DENT RES, V90, P602, DOI 10.1177/0022034510397197; Nassar M, 2014, J DENT, V42, P312, DOI 10.1016/j.jdent.2013.11.023; Kappert PF, 2013, DENT MATER, V29, P1012, DOI 10.1016/j.dental.2013.07.001; Hashimoto M, 2002, J BIOMED MATER RES, V63, P306, DOI 10.1002/jbm.10208; De Munck J, 2011, DENT MATER J, V30, P7, DOI 10.4012/dmj.2010-085; Miyazaki M, 2014, J ORAL SCI, V56, P1, DOI 10.2334/josnusd.56.1; De Munck J, 2005, J DENT RES, V84, P118; Erickson RL, 2009, DENT MATER, V25, P1187, DOI 10.1016/j.dental.2009.04.004; Armstrong SR, 2004, OPER DENT, V29, P705; Barkmeier WW, 2009, OPER DENT, V34, P217, DOI 10.2341/08-72; Maeda T, 2008, J DENT, V36, P606, DOI 10.1016/j.jdent.2008.04.009; Watanabe T, 2008, OPER DENT, V33, P426, DOI 10.2341/07-110; Ikeda M, 2008, OPER DENT, V33, P702, DOI 10.2341/08-26; Erickson RL, 2009, DENT MATER, V25, P1459, DOI 10.1016/j.dental.2009.07.002; Peumans M, 2010, DENT MATER, V26, P1176, DOI 10.1016/j.dental.2010.08.190; Van Landuyt KL, 2006, J DENT, V34, P77, DOI 10.1016/j.jdent.2005.04.001; Peumans M, 2014, DENT MATER, V30, P1089, DOI 10.1016/j.dental.2014.07.007; Mazzoni A, 2012, J DENT RES, V91, P467, DOI 10.1177/0022034512439210; Hashimoto M, 2009, EUR J ORAL SCI, V117, P611, DOI 10.1111/j.1600-0722.2009.00664.x; Stanislawczuk R, 2014, J DENT, V42, P39, DOI 10.1016/j.jdent.2013.11.002; DRAUGHN RA, 1979, J DENT RES, V58, P1093, DOI 10.1177/00220345790580031101; Takamizawa T, 2015, OPER DENT, V40, P379, DOI 10.2341/13-252-L; Breschi L, 2008, DENT MATER, V24, P90, DOI 10.1016/j.dental.2007.02.009; Feitosa VP, 2012, J DENT, V40, P1134, DOI 10.1016/j.jdent.2012.09.011; Cardoso MV, 2011, AUST DENT J, V56, P31, DOI 10.1111/j.1834-7819.2011.01294.x; Van Landuyt KL, 2010, J DENT RES, V89, P1045, DOI 10.1177/0022034510375285; Sauro S, 2009, DENT MATER, V25, P1392, DOI 10.1016/j.dental.2009.06.010; Marchesi G, 2013, EUR J ORAL SCI, V121, P43, DOI 10.1111/eos.12009; De Munck J, 2005, OPER DENT, V30, P39; Hashimoto M, 2011, JPN DENT SCI REV, V47, P5, DOI 10.1016/j.jdsr.2010.02.001; Rosa W.L.O., 2015, J DENT, V45, P765; Scheidel D.D., 2014, J DENT RES A, V93A; Sezinando A., 2012, J ESTHET RESTOR DENT, V2, P345; Tay Franklin R, 2002, J Adhes Dent, V4, P255; Van Landuyt K.L., 2005, DENT MATER, V22, P533	45	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0300-5712	1879-176X		J DENT	J. Dent.	DEC	2015	43	12					1416	1427		10.1016/j.jdent.2015.10.018		12	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CY5PO	WOS:000366459800005		
J	Kitasako, Y; Sasaki, Y; Takagaki, T; Sadr, A; Tagami, J				Kitasako, Yuichi; Sasaki, Yoshiyuki; Takagaki, Tomohiro; Sadr, Alireza; Tagami, Junji			Age-specific prevalence of erosive tooth wear by acidic diet and gastroesophageal reflux in Japan (vol 43, pg 418, 2015)	JOURNAL OF DENTISTRY			English	Correction									[Kitasako, Yuichi; Takagaki, Tomohiro; Tagami, Junji] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Restorat Sci, Cariol & Operat Dent, Tokyo, Japan; [Sasaki, Yoshiyuki] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Maxillofacial & Neck Reconstruct, Maxillofacial Orthognath, Tokyo, Japan; [Sadr, Alireza] Tokyo Med & Dent Univ, Int Exchange Ctr, Tokyo, Japan	Kitasako, Y (reprint author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Restorat Sci, Cariol & Operat Dent, Tokyo, Japan.	kitasako.ope@tmd.ac.jp					Kitasako Y, 2015, J DENT, V43, P418, DOI 10.1016/j.jdent.2015.02.004	1	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0300-5712	1879-176X		J DENT	J. Dent.	DEC	2015	43	12					1596	1596		10.1016/j.jdent.2015.10.005		1	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CY5PO	WOS:000366459800028		
J	Nutahara, K				Nutahara, Kengo			Do credit market imperfections justify a central bank's response to asset price fluctuations?	JOURNAL OF ECONOMIC DYNAMICS & CONTROL			English	Article						Asset prices; Credit market imperfections; Collateral constraints; Equilibrium indeterminacy; Monetary policy; Taylor principle	FRICTIONS; CYCLES	Do credit market imperfections justify a central bank's response to asset price fluctuations? This study addresses this question from the perspective of equilibrium determinacy. In the model we use, prices are sticky and the working capital of firms is subject to asset values because of a lack of commitment. If credit market imperfections exist to a small degree, the Taylor principle is a necessary and sufficient condition for equilibrium determinacy, and monetary policy response to asset price fluctuations is good from the perspective of equilibrium determinacy. However, if credit market imperfections exist to a large degree such that the collateral constraint is binding, then the Taylor principle no longer guarantees equilibrium determinacy, and monetary policy response to asset price fluctuations becomes a source of equilibrium indeterminacy. We find that the existence of credit market imperfections makes it unsuitable to initiate a monetary policy response to deal with asset price fluctuations. We also find that reductions in credit market imperfections can enlarge the indeterminacy region of the model parameters. (C) 2015 Elsevier B.V. All rights reserved.	[Nutahara, Kengo] Senshu Univ, Tama Ku, Kawasaki, Kanagawa 2148580, Japan; [Nutahara, Kengo] Canon Inst Global Studies, Chiyoda Ku, Tokyo 1006511, Japan	Nutahara, K (reprint author), Senshu Univ, Tama Ku, 2-1-1 Higashimita, Kawasaki, Kanagawa 2148580, Japan.	nutti@isc.senshu-u.ac.jp			Senshu University fellowship; JSPS KAKENHI [15H05389]	The author would like to thank Naohito Abe, Hiroki Arato, Takeo Hori, Masaru Inaba, Takashi Kano, Ryo Kato, Keiichiro Kobayashi, Kiminori Matsuyama, Keisuke Otsu, Morten Ravn, Katsuyuki Shibayama, Etsuro Shioji, Daichi Shirai, and seminar participants at University of Kent, Aoyama Gakuin University, Bank of Japan, Hitotsubashi University, the 2012 Meeting of the Royal Economic Society, the 2012 European Meeting of the Econometric Society, the 2012 Fall Meeting of the Japanese Economic Association, the 2014 Macro, Money, and Finance Conference, and the 2015 Singapore Economic Review Conference for their helpful comments. Ichiro Muto, who is the discussant at the 2012 Fall Meeting of the Japanese Economic Association, is especially aknowledged for his valuable comments and suggestions. The author is also grateful to James Bullard (Editor) and an anomymous referee for helpful comments. Of course, all errors are the author's own. This work was supported by a Senshu University fellowship for research abroad ("Asset prices and macroeconomic policy") in 2013, and a Grant-in-Aid for Young Scientists (A) (JSPS KAKENHI Grant Number 15H05389).	Mendoza EG, 2010, AM ECON REV, V100, P1941, DOI 10.1257/aer.100.5.1941; Carlstrom CT, 2005, J ECON THEORY, V123, P4, DOI 10.1016/j.jet.2004.05.002; Kobayashi K, 2012, MACROECON DYN, V16, P752, DOI 10.1017/S1365100510000829; Nutahara K, 2014, J MONEY CREDIT BANK, V46, P817, DOI 10.1111/jmcb.12126; Monacelli T, 2009, J MONETARY ECON, V56, P242, DOI 10.1016/j.jmoneco.2008.09.013; Faia E, 2007, J ECON DYN CONTROL, V31, P3228, DOI 10.1016/j.jedc.2006.11.006; Brooks BP, 2004, APPL MATH LETT, V17, P463, DOI 10.1016/s0893-9659(04)00054-0; Benhabib J, 2013, J MONETARY ECON, V60, P789, DOI 10.1016/j.jmoneco.2013.06.004; Harrison SG, 2013, MACROECON DYN, V17, P1055, DOI 10.1017/S1365100511000836; Iacoviello M., 2005, AM ECON REV, V95, P739; Liu A, 2013, ECONOMETRICA, V81, P1147; Yun T, 1996, J MONETARY ECON, V37, P345, DOI 10.1016/S0304-3932(96)90040-9	12	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-1889	1879-1743		J ECON DYN CONTROL	J. Econ. Dyn. Control	DEC	2015	61						81	94		10.1016/j.jedc.2015.09.008		14	Economics	Business & Economics	CY2IU	WOS:000366232900005		
J	Frank, B; Enkawa, T; Schvaneveldt, SJ				Frank, Bjoern; Enkawa, Takao; Schvaneveldt, Shane J.			The role of individualism vs. collectivism in the formation of repurchase intent: A cross-industry comparison of the effects of cultural and personal values	JOURNAL OF ECONOMIC PSYCHOLOGY			English	Article						Repurchase intent; Customer loyalty; Public brand image; Culture; Individualism; Collectivism	CUSTOMER SATISFACTION INDEX; CONSUMER RESPONSES; NATIONAL CULTURE; LOYAL CUSTOMERS; CONSEQUENCES; DIMENSIONS; COUNTRY; IMPACT; PERFORMANCE; VALIDATION	As repurchase intent drives profitability and firms are facing culturally diverse customers, managers should know how individualism (vs. collectivism) influences the formation of repurchase intent. This research models individualism as a dimension of both national culture and personal values. Based on HLM of data from six countries and ten industries, study 1 shows that cultural individualism is more influential than personal individualism. Individualism positively moderates the effect of customer satisfaction and negatively moderates the effects of public brand image and relational switching costs on repurchase intent. While the effects of customer satisfaction and relational switching costs are moderated more strongly for services, the effect of public brand image is moderated more strongly for products. Study 2 illuminates psychological processes operating behind these moderating effects: importance of relational switching costs - reliance on salespeople; importance of public brand image - meeting social preferences (impressing others, expressing group identify), but not trustworthiness; importance of customer satisfaction - customization, distinctiveness, but not functional benefits. This research also tests extant theories about the main effect of individualism on repurchase intent. The results provide valuable, novel suggestions for cross-cultural adaptation of marketing strategy. (C) 2015 The Authors. Published by Elsevier B.V.	[Frank, Bjoern] Sophia Univ, Grad Sch Global Environm Studies, Chiyoda Ku, Tokyo 1028554, Japan; [Enkawa, Takao] Tokyo Inst Technol, Dept Ind Engn & Management, Meguro Ku, Tokyo 1528552, Japan; [Schvaneveldt, Shane J.] Weber State Univ, Goddard Sch Business & Econ, Ogden, UT 84408 USA	Frank, B (reprint author), Sophia Univ, Grad Sch Global Environm Studies, Chiyoda Ku, 7-1 Kioi Cho, Tokyo 1028554, Japan.				JSPS KAKENHI	The authors extend their gratitude to Editors-in-Chief Erik Holzl and Erich Kirchler, Associate Editor Ayse Onculer, and two anonymous reviewers for their valuable and constructive comments on previous versions of this article and to JSPS KAKENHI for financial support. They also thank Gulmire Ablat, Tanyanuparb Anantana, Laurent Burte, Zhuo Chen, Sou Ezawa, Boris Herbas Torrico, Yousuke Sekikawa, Gene Sessions, Naoki Yajima, and all survey participants for their contribution to the data collection.	Abulaiti G., 2010, J JAPANESE SOC QUALI, V40, P225; Hennig-Thurau T, 2005, ADV INT MARKETING, V15, P11, DOI 10.1016/S1474-7979(04)15002-3; Choi JY, 2004, J ECON PSYCHOL, V25, P821, DOI 10.1016/j.joep.2003.08.006; Reinartz WJ, 2003, J MARKETING, V67, P77, DOI 10.1509/jmkg.67.1.77.18589; Erdem T, 2006, J MARKETING, V70, P34, DOI 10.1509/jmkg.2006.70.1.34; Burnham TA, 2003, J ACAD MARKET SCI, V31, P109, DOI 10.1177/0092070302250897; Frank B, 2012, MARKET LETT, V23, P683, DOI 10.1007/s11002-012-9171-8; Kramer T, 2007, MARKET SCI, V26, P246, DOI 10.1287/mksc.1060.0223; ARMSTRONG JS, 1977, J MARKETING RES, V14, P396, DOI 10.2307/3150783; Lee JA, 2000, J CONSUM PSYCHOL, V9, P117, DOI 10.1207/S15327663JCP0902_6; Bolton RN, 2000, J ACAD MARKET SCI, V28, P95, DOI 10.1177/0092070300281009; Lehmann DR, 2011, J MARKETING, V75, P155; Taras V, 2009, J INT MANAG, V15, P357, DOI 10.1016/j.intman.2008.08.005; Auh SY, 2005, J ECON PSYCHOL, V26, P35, DOI 10.1016/j.joep.2003.10.002; Diamantopoulos A, 1999, INT MARKET REV, V16, P444, DOI 10.1108/02651339910300422; Triandis HC, 2002, ANNU REV PSYCHOL, V53, P133, DOI 10.1146/annurev.psych.53.100901.135200; Fischer M, 2010, J MARKETING RES, V47, P823; Turkyilmaz A, 2007, IND MANAGE DATA SYST, V107, P672, DOI 10.1108/02635570710750426; Stryker S, 2000, SOC PSYCHOL QUART, V63, P284, DOI 10.2307/2695840; Soares AM, 2007, J BUS RES, V60, P277, DOI 10.1016/j.jbusres.2006.10.018; Steenkamp JBEM, 2006, J MARKETING, V70, P136, DOI 10.1509/jmkg.70.3.136; Hewett K, 2006, J ACAD MARKET SCI, V34, P386, DOI 10.1177/0092070305285370; Jin B, 2008, INT MARKET REV, V25, P324, DOI 10.1108/02651330810877243; Frank B, 2014, J ACAD MARKET SCI, V42, P171, DOI 10.1007/s11747-013-0344-7; Johnson MD, 2001, J ECON PSYCHOL, V22, P217, DOI 10.1016/S0167-4870(01)00030-7; ROTH MS, 1995, J MARKETING RES, V32, P163, DOI 10.2307/3152045; Melnyk V, 2009, J MARKETING, V73, P82; Paul M, 2009, J ACAD MARKET SCI, V37, P215, DOI 10.1007/s11747-008-0118-9; Lindell MK, 2001, J APPL PSYCHOL, V86, P114, DOI 10.1037//0021-9010.86.1.114; Taras V, 2010, J APPL PSYCHOL, V95, P405, DOI 10.1037/a0018938; Tian KT, 2001, J CONSUM RES, V28, P50, DOI 10.1086/321947; AlbersMiller ND, 1996, J ADVERTISING, V25, P57; Johnson MD, 2002, J ECON PSYCHOL, V23, P749, DOI 10.1016/S0167-4870(02)00137-X; Reynolds KE, 1999, J RETAILING, V75, P11, DOI 10.1016/S0022-4359(99)80002-5; BELK RW, 1988, J CONSUM RES, V15, P139, DOI 10.1086/209154; Benet-Martinez V., 2008, HDB PERSONALITY THEO, P542; Bliese P. D., 2000, MULTILEVEL THEORY RE, P349; Coelho Pedro S., 2004, EUR J MARKETING, V38, P1272, DOI 10.1108/03090560410548979; Enkawa T., 2015, SCI CUSTOMER SATISFA; Fornell C, 1996, J MARKETING, V60, P7, DOI 10.2307/1251898; Frank B, 2014, J CONTING CRISIS MAN, V22, P197, DOI 10.1111/1468-5973.12058; Funder D. C., 2012, PERSONALITY PUZZLE; Hair J. F., 2010, MULTIVARIATE DATA AN; Hofstede G., 2005, CULTURES ORG SOFTWAR; Hofstede G., 2001, CULTURES CONSEQUENCE; Homburg C., 2009, MARKETING MANAGEMENT; Kreft I., 1998, INTRO MULTILEVEL MOD; Kumar V., 2006, CUSTOMER RELATIONSHI; Lam D., 2007, J INT CONSUMER MARKE, V19, P7, DOI 10.1300/J046v19n03_02; Lindzey G., 2010, HDB SOCIAL PSYCHOL, V2, P1423; Nasif E. G., 1991, MANAGE INT REV, V31, P79; Ngobo P. V., 2004, EUR J MARKETING, V38, P1129, DOI 10.1108/03090560410548906; Ogikubo M., 2008, J JAPANESE SOC QUALI, V38, P231; REICHHELD FF, 1990, HARVARD BUS REV, V68, P105; Bergkvist L, 2007, J MARKETING RES, V44, P175, DOI 10.1509/jmkr.44.2.175; Sharma P, 2010, J ACAD MARKET SCI, V38, P787, DOI 10.1007/s11747-009-0184-7; Singelis T. M., 1995, CROSS-CULT RES, V29, P240, DOI DOI 10.1177/106939719502900302; Triandis HC, 1996, AM PSYCHOL, V51, P407, DOI 10.1037/0003-066X.51.4.407; Varki S., 2003, EUR J MARKETING, V37, P169, DOI DOI 10.1108/03090560310454037; Vazquez-Carrasco R., 2006, J CONSUM BEHAV, V5, P367, DOI 10.1002/cb.187; Yaveroglu I., 2002, J INT CONSUMER MARKE, V14, P49, DOI DOI 10.1300/J046V14N04_	61	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-4870	1872-7719		J ECON PSYCHOL	J. Econ. Psychol.	DEC	2015	51						261	278		10.1016/j.joep.2015.08.008		18	Economics; Psychology, Multidisciplinary	Business & Economics; Psychology	CY9ZZ	WOS:000366766200019		
J	Qin, J				Qin, Jie			A model of regret, investor behavior, and market turbulence	JOURNAL OF ECONOMIC THEORY			English	Article						Regret over inaction; Regret aversion; Bubble; Herd; Market participation; Order imbalance	DECISION-MAKING; COUNTERFACTUAL THOUGHT; ANTICIPATED REGRET; BUBBLES; UNCERTAINTY; CHOICE; DISAPPOINTMENT; EXPERIENCE; CRASHES; PARTICIPATION	This study examines the effects of regret on investor behavior and market turbulence by using a model where investors not only regret wrong actions but also regret inaction. We demonstrate that regret aversion can cause investors to ride a bubble, exit and reenter the market, or choose not to trade. Further, herds and partial herds can occur in the market, and we show that the stronger regret over inaction, the easier it is for herds to occur. The model presented herein also predicts that during the formation of a bubble (crash), bearish (bullish) traders tend to exit and reenter the market, thereby causing a positive (negative) correlation between order volume and order imbalance. (C) 2015 Elsevier Inc. All rights reserved.	[Qin, Jie] Ritsumeikan Univ, Dept Econ, Kusatsu, Siga 5258577, Japan	Qin, J (reprint author), Ritsumeikan Univ, Dept Econ, Nojihigashi 1-1-1, Kusatsu, Siga 5258577, Japan.	khata@ec.ritsumei.ac.jp			Japan Society for the Promotion of Science [25590069]	I would like to thank an anonymous referee, an associate editor, and Xavier Vives for extensive comments that greatly improved this study. I also thank Yuichi Fukuta, Rainer Grundmann, Jarrad Harford, Keiichi Hori, Shinsuke Ikeda, Avraham Kamara, Satoshi Kawanishi, Wenjie Ma, Colin McKenzie, Kazuhiko Nishina, Masao Ogaki, Yoshiaki Ogura, Masamitsu Ohnishi, Wataru Ohta, Kei Sakata, Shunichiro Sasaki, Stephan Siegel, Yoshiro Tsutsui, and seminar participants for helpful comments. This research is supported by Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research 25590069.	Zhou ZH, 2010, NEUROPSYCHOLOGIA, V48, P3606, DOI 10.1016/j.neuropsychologia.2010.08.010; Barberis N, 2006, AM ECON REV, V96, P1069, DOI 10.1257/aer.96.4.1069; Filiz-Ozbay E, 2007, AM ECON REV, V97, P1407, DOI 10.1257/aer.97.4.1407; Coricelli G, 2007, TRENDS COGN SCI, V11, P258, DOI 10.1016/j.tics.2007.04.003; Chandrasekhar PVS, 2008, NEUROIMAGE, V39, P1472, DOI 10.1016/j.neuroimage.2007.10.027; DeMarzo PM, 2008, REV FINANC STUD, V21, P19, DOI 10.1093/rfs/hhm032; KAHNEMAN D, 1986, PSYCHOL REV, V93, P136, DOI 10.1037/0033-295X.93.2.136; Michenaud S, 2008, J INT MONEY FINANC, V27, P677, DOI 10.1016/j.jimonfin.2008.03.001; QUIGGIN J, 1994, J RISK UNCERTAINTY, V8, P153, DOI 10.1007/BF01065370; Hayashi T, 2008, J ECON THEORY, V139, P242, DOI 10.1016/j.jet.2007.07.001; LANDMAN J, 1987, J THEOR SOC BEHAV, V17, P135, DOI 10.1111/j.1468-5914.1987.tb00092.x; LOOMES G, 1982, ECON J, V92, P805, DOI 10.2307/2232669; DELONG JB, 1990, J FINANC, V45, P379, DOI 10.2307/2328662; Barlevy G, 2003, J ECON THEORY, V110, P234, DOI 10.1016/S0022-0531(03)00039-5; Gilovich T, 1998, PSYCHOL REV, V105, P602, DOI 10.1037//0033-295X.105.3.602; Matsushima H, 2013, J ECON THEORY, V148, P858, DOI 10.1016/j.jet.2012.08.002; Kaustia M, 2012, J FINANC ECON, V104, P321, DOI 10.1016/j.jfineco.2011.01.010; Zeelenberg M, 1999, J BEHAV DECIS MAKING, V12, P93, DOI 10.1002/(SICI)1099-0771(199906)12:2<93::AID-BDM311>3.0.CO;2-S; Abreu D, 2003, ECONOMETRICA, V71, P173, DOI 10.1111/1468-0262.00393; Sarver T, 2008, ECONOMETRICA, V76, P263, DOI 10.1111/j.0012-9682.2008.00834.x; ALLEN F, 1993, J ECON THEORY, V61, P206, DOI 10.1006/jeth.1993.1067; BELL DE, 1982, OPER RES, V30, P961, DOI 10.1287/opre.30.5.961; Hong H, 2004, J FINANC, V59, P137, DOI 10.1111/j.1540-6261.2004.00629.x; Brown JR, 2008, J FINANC, V63, P1509, DOI 10.1111/j.1540-6261.2008.01364.x; Anderson CJ, 2003, PSYCHOL BULL, V129, P139, DOI 10.1037//0033-2909.129.1.139; Shleifer A, 1997, J FINANC, V52, P35, DOI 10.2307/2329555; Barbey AK, 2009, PHILOS T R SOC B, V364, P1291, DOI 10.1098/rstb.2008.0315; BELL DE, 1983, MANAGE SCI, V29, P1156, DOI 10.1287/mnsc.29.10.1156; Muermann A, 2006, INSUR MATH ECON, V39, P219, DOI 10.1016/j.insmatheco.2006.02.006; Doblas-Madrid A, 2012, ECONOMETRICA, V80, P1845, DOI 10.3982/ECTA7887; Camille N, 2004, SCIENCE, V304, P1167, DOI 10.1126/science.1094550; Roese NJ, 1997, PSYCHOL BULL, V121, P133, DOI 10.1037/0033-2909.121.1.133; ALLEN F, 1993, REV ECON STUD, V60, P813, DOI 10.2307/2298101; Conlon JR, 2004, ECONOMETRICA, V72, P927, DOI 10.1111/j.1468-0262.2004.00516.x; Kumar A, 2006, J FINANC, V61, P2451, DOI 10.1111/j.1540-6261.2006.01063.x; Coricelli G, 2005, NAT NEUROSCI, V8, P1255, DOI 10.1038/nn1514; Ku G, 2008, ORGAN BEHAV HUM DEC, V105, P221, DOI 10.1016/j.obhdp.2007.08.002; Skiadas C, 1997, ECONOMETRICA, V65, P347, DOI 10.2307/2171896; Zeelenberg M, 1998, ORGAN BEHAV HUM DEC, V75, P117, DOI 10.1006/obhd.1998.2784; LANDMAN J, 1987, PERS SOC PSYCHOL B, V13, P524, DOI 10.1177/0146167287134009; De Bondt WFM, 1998, EUR ECON REV, V42, P831, DOI 10.1016/S0014-2921(98)00009-9; Reb J, 2008, ORGAN BEHAV HUM DEC, V105, P169, DOI 10.1016/j.obhdp.2007.08.006; BELL DE, 1985, OPER RES, V33, P1, DOI 10.1287/opre.33.1.1; BIKHCHANDANI S, 1992, J POLIT ECON, V100, P992, DOI 10.1086/261849; Bikhchandani S, 2014, J ECON THEORY, V152, P237, DOI 10.1016/j.jet.2014.05.001; Blume E., 1989, J FINANC, V44, P827; Brunnermeier M.K., 2013, HDB EC FINANCE B, V2B, P1221; Crespi C., 2012, NEUROSCIENCE EC DECI, P3; Fogel S. O., 2006, J BEHAV FINANC, V7, P107, DOI 10.1207/s15427579jpfm0702_5; GENNOTTE G, 1990, AM ECON REV, V80, P999; GILOVICH T, 1995, PSYCHOL REV, V102, P379, DOI 10.1037//0033-295X.102.2.379; GLOSTEN LR, 1985, J FINANC ECON, V14, P71, DOI 10.1016/0304-405X(85)90044-3; Guiso L., 2013, HDB EC FINANCE B, V2B, P1397; Hirshleifer D., 2003, EUROPEAN FINANCIAL M, V9, P25, DOI 10.1111/1468-036X.00207; Kahneman D., 1982, JUDGMENT UNCERTAINTY, P201, DOI DOI 10.1017/CBO9780511809477.015; Kahneman D., 1995, WHAT MIGHT HAVE BEEN, P375; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kindleberger CP, 2005, MANIAS, PANICS AND CRASHES: A HISTORY OF FINANCIAL CRISES, 5TH EDITION, P1, DOI 10.1057/9780230628045; LANDMAN J, 1992, BRIT J PSYCHOL, V83, P473; Landman J., 1993, REGRET PERSISTENCE P; Lee I.H., 1998, REV ECON STUD, V65, P395; LOOMES G, 1986, REV ECON STUD, V53, P271, DOI 10.2307/2297651; LOOMES G, 1987, J ECON THEORY, V41, P270, DOI 10.1016/0022-0531(87)90020-2; Malmendier U, 2011, Q J ECON, V126, P373, DOI 10.1093/qje/qjq004; GILOVICH T, 1994, J PERS SOC PSYCHOL, V67, P357, DOI 10.1037//0022-3514.67.3.357; Savage L. J., 1954, FDN STAT; Sharma S, 2001, IMF STAFF PAPERS, V47, P279; Strahilevitz MA, 2011, J MARKETING RES, V48, pS102; Zeelenberg M, 2000, COGNITION EMOTION, V14, P521; Zweig J., 2007, YOU MONEY YOUR BRAIN	70	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-0531	1095-7235		J ECON THEORY	J. Econ. Theory	DEC	2015	160						150	174		10.1016/j.jet.2015.08.010		25	Economics	Business & Economics	CY5JX	WOS:000366445000009		
J	Nakamura, Y				Nakamura, Yutaka			Mean-variance utility	JOURNAL OF ECONOMIC THEORY			English	Article						Mean-variance analysis; Mean-variance utility; Decision making under risk; Constant risk aversion	RISK; AVERSION	The mean-variance utility postulates that random variables with the same mean and variance should be equally desirable. This paper presents and discusses necessary and sufficient preference-based axioms for the existence of mean-variance utility in which any condition on variances but mean-values is not explicitly specified. Furthermore, we investigate necessary and sufficient axioms for four types of additively separable forms of mean and variance in the utility representation. (C) 2015 Elsevier Inc. All rights reserved.	[Nakamura, Yutaka] Univ Tsukuba, Grad Sch Syst & Informat Engn, Div Social Syst & Management, Tsukuba, Ibaraki 3058573, Japan	Nakamura, Y (reprint author), Univ Tsukuba, Grad Sch Syst & Informat Engn, Div Social Syst & Management, 1-1-1 Tennnoudai, Tsukuba, Ibaraki 3058573, Japan.	nakamura@sk.tsukuba.ac.jp					Nakamura Y, 2002, J MATH ECON, V37, P157, DOI 10.1016/S0304-4068(02)00014-9; FARQUHAR PH, 1987, OPER RES, V35, P206, DOI 10.1287/opre.35.2.206; EPSTEIN LG, 1985, ECONOMETRICA, V53, P945, DOI 10.2307/1912662; Loffler A, 1996, J ECON THEORY, V69, P532, DOI 10.1006/jeth.1996.0067; Markowitz H, 1952, J FINANC, V7, P77, DOI 10.2307/2975974; Bailey R.E., 2005, EC FINANCIAL MARKETS; Barbera S., 2004, HDB UTILITY THEORY, V2; Barbera S., 1998, HDB UTILITY THEORY, V1; Duffle D., 1988, SECURITY MARKETS; Eeckhoudt L., 2005, EC FINANCIAL DECISIO; Fishburn P.C., 1980, RES FINANCE, V2, P69; Fishburn P.C., 1982, FDN EXPECTED UTILITY; FISHBURN PC, 1979, THEOR DECIS, V10, P99, DOI 10.1007/BF00126333; Krantz D.H., 1971, FDN MEASUREMENT, V1; Markowitz H.M., 1959, PORTFOLIO SELECTION; Morgenstern O., 1947, THEORY GAMES EC BEHA; POLLATSE.A, 1970, J MATH PSYCHOL, V7, P540, DOI 10.1016/0022-2496(70)90039-8; Qu X., 2015, WORKING PAPER; Safra U., 1998, J ECON THEORY, V83, P19; Savage L. J., 1954, FDN STAT; von Neumann J., 1944, THEORY GAMES EC BEHA; von Neumann J., 1953, THEORY GAMES EC BEHA	22	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-0531	1095-7235		J ECON THEORY	J. Econ. Theory	DEC	2015	160						536	556		10.1016/j.jet.2015.10.001		21	Economics	Business & Economics	CY5JX	WOS:000366445000023		
J	Fukutomi, M; Someya, M; Ogawa, H				Fukutomi, Matasaburo; Someya, Makoto; Ogawa, Hiroto			Auditory modulation of wind-elicited walking behavior in the cricket Gryllus bimaculatus	JOURNAL OF EXPERIMENTAL BIOLOGY			English	Article						Escape behavior; Multisensory integration; Directionality; Context dependence; Cricket; Cercal system	COROLLARY DISCHARGE INHIBITION; PRIMARY SENSORY INTERNEURONS; ESCAPE BEHAVIOR; GIANT INTERNEURONS; FIELD CRICKET; REACTION-TIME; CAMPESTRIS L; NEURONS; INFORMATION; STIMULUS	Animals flexibly change their locomotion triggered by an identical stimulus depending on the environmental context and behavioral state. This indicates that additional sensory inputs in different modality from the stimulus triggering the escape response affect the neuronal circuit governing that behavior. However, how the spatio-temporal relationships between these two stimuli effect a behavioral change remains unknown. We studied this question, using crickets, which respond to a short air-puff by oriented walking activity mediated by the cercal sensory system. In addition, an acoustic stimulus, such as conspecific 'song' received by the tympanal organ, elicits a distinct oriented locomotion termed phonotaxis. In this study, we examined the cross-modal effects on wind-elicited walking when an acoustic stimulus was preceded by an air-puff and tested whether the auditory modulation depends on the coincidence of the direction of both stimuli. A preceding 10 kHz pure tone biased the wind-elicited walking in a backward direction and elevated a threshold of the wind-elicited response, whereas other movement parameters, including turn angle, reaction time, walking speed and distance were unaffected. The auditory modulations, however, did not depend on the coincidence of the stimulus directions. A preceding sound consistently altered the wind-elicited walking direction and response probability throughout the experimental sessions, meaning that the auditory modulation did not result from previous experience or associative learning. These results suggest that the cricket nervous system is able to integrate auditory and air-puff stimuli, and modulate the wind-elicited escape behavior depending on the acoustic context.	[Fukutomi, Matasaburo; Someya, Makoto] Hokkaido Univ, Grad Sch Life Sci, Biosyst Sci Course, Sapporo, Hokkaido 0600810, Japan; [Ogawa, Hiroto] Japan Sci & Technol Agcy JST, PREST, Kawaguchi, Saitama 3320012, Japan; [Ogawa, Hiroto] Hokkaido Univ, Fac Sci, Dept Biol Sci, Sapporo, Hokkaido 0600810, Japan	Ogawa, H (reprint author), Japan Sci & Technol Agcy JST, PREST, Kawaguchi, Saitama 3320012, Japan.	hogawa@sci.hokudai.ac.jp			Japan Science and Technology Agency (JST); Precursory Research for Embryonic Science and Technology (PRESTO); JSPS; MEXT [24120502, 26119501, 26440176]	This work was supported by funding to H.O. from Japan Science and Technology Agency (JST), Precursory Research for Embryonic Science and Technology (PRESTO), and JSPS and MEXT KAKENHI grants 24120502, 26119501 and 26440176 to H.O.	Casas J, 2010, ANNU REV ENTOMOL, V55, P505, DOI 10.1146/annurev-ento-112408-085342; Domenici P, 2010, J EXP ZOOL PART A, V313A, P59, DOI 10.1002/jez.580; HIROTA K, 1993, ZOOL SCI, V10, P705; SCHILDBERGER K, 1984, J COMP PHYSIOL, V154, P71, DOI 10.1007/BF00605392; Domenici P, 1997, MAR BIOL, V128, P29, DOI 10.1007/s002270050065; Jacobs GA, 2000, J NEUROSCI, V20, P2934; VAUGHAN HG, 1966, VISION RES, V6, P645, DOI 10.1016/0042-6989(66)90076-9; McDonald JJ, 2000, NATURE, V407, P906, DOI 10.1038/35038085; EATON RC, 1991, J EXP BIOL, V161, P469; Domenici P, 2011, J EXP BIOL, V214, P2474, DOI 10.1242/jeb.053801; HUBER F, 1985, SCI AM, V253, P60; Hedwig B, 2006, J COMP PHYSIOL A, V192, P677, DOI 10.1007/s00359-006-0115-8; MOISEFF A, 1978, P NATL ACAD SCI USA, V75, P4052, DOI 10.1073/pnas.75.8.4052; Jacobs GA, 2008, J EXP BIOL, V211, P1819, DOI 10.1242/jeb.016402; Wyttenbach RA, 1996, SCIENCE, V273, P1542, DOI 10.1126/science.273.5281.1542; Gras H, 1998, J COMP PHYSIOL A, V182, P351, DOI 10.1007/s003590050185; Pollack GS, 2007, J EXP BIOL, V210, P3160, DOI 10.1242/jeb.008136; THEUNISSEN FE, 1991, J NEUROPHYSIOL, V66, P1690; RITZMANN RE, 1991, BRAIN RES, V563, P175, DOI 10.1016/0006-8993(91)91531-5; Card GM, 2012, CURR OPIN NEUROBIOL, V22, P180, DOI 10.1016/j.conb.2011.12.009; Bidaye SS, 2014, SCIENCE, V344, P97, DOI 10.1126/science.1249964; GRAS H, 1992, J EXP BIOL, V171, P189; EIBL E, 1979, ZOOMORPHOLOGIE, V92, P1, DOI 10.1007/BF00999832; Domenici P, 2011, J EXP BIOL, V214, P2463, DOI 10.1242/jeb.029652; Poulet JFA, 2005, J COMP PHYSIOL A, V191, P979, DOI 10.1007/s00359-005-0027-z; SCHILDBERGER K, 1984, J COMP PHYSIOL, V155, P171, DOI 10.1007/BF00612635; Eilam D, 2005, NEUROSCI BIOBEHAV R, V29, P1181, DOI 10.1016/j.neubiorev.2005.03.027; Domenici P, 2008, CURR BIOL, V18, P1792, DOI 10.1016/j.cub.2008.09.062; Preuss T, 2003, J NEUROSCI, V23, P5617; Stein BE, 1996, J COGNITIVE NEUROSCI, V8, P497, DOI 10.1162/jocn.1996.8.6.497; Turesson H, 2009, J EXP BIOL, V212, P2925, DOI 10.1242/jeb.032953; HOY R, 1989, J EXP BIOL, V146, P287; MILLER JP, 1991, J NEUROPHYSIOL, V66, P1680; BRODFUEHRER PD, 1990, J COMP PHYSIOL A, V166, P651; WOHLERS DW, 1982, J COMP PHYSIOL, V146, P161; Ogawa H, 2008, J NEUROSCI, V28, P4592, DOI 10.1523/JNEUROSCI.5354-07.2008; HENNIG RM, 1988, J COMP PHYSIOL A, V163, P135, DOI 10.1007/BF00612003; ter Hofstede HM, 2009, J COMP PHYSIOL A, V195, P769, DOI 10.1007/s00359-009-0454-3; NOLEN TG, 1984, SCIENCE, V226, P992, DOI 10.1126/science.6505681; Diederich A, 2004, PERCEPT PSYCHOPHYS, V66, P1388, DOI 10.3758/BF03195006; Theunissen F, 1996, J NEUROPHYSIOL, V75, P1345; Rowland BA, 2007, J NEUROSCI, V27, P5879, DOI 10.1523/JNEUROSCI.4986-06.2007; Baba Y, 1997, ZOOL SCI, V14, P587, DOI 10.2108/zsj.14.587; GRAS H, 1990, J COMP PHYSIOL A, V166, P901; HUMPHRIE.DA, 1970, OECOLOGIA, V5, P285, DOI 10.1007/BF00815496; Oe M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080184; Schildberger K., 1989, P423; Schoneich S, 2015, J NEUROPHYSIOL, V113, P390, DOI 10.1152/jn.00520.2014; TAUBER E, 1995, J EXP BIOL, V198, P1895; YDENBERG RC, 1986, ADV STUD BEHAV, V16, P229, DOI 10.1016/S0065-3454(08)60192-8	50	0	0	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0022-0949	1477-9145		J EXP BIOL	J. Exp. Biol.	DEC	2015	218	24					3968	3977		10.1242/jeb.128751		10	Biology	Life Sciences & Biomedicine - Other Topics	CY8FZ	WOS:000366645500016		
J	Du, L; Yang, YH; Wang, YM; Xue, CH; Kurihara, H; Takahashi, K				Du, Lei; Yang, Yu-Hong; Wang, Yu-Ming; Xue, Chang-Hu; Kurihara, Hideyuki; Takahashi, Koretaro			Antitumour activity of EPA-enriched phospholipids liposomes against S180 ascitic tumour-bearing mice	JOURNAL OF FUNCTIONAL FOODS			English	Article						EPA-enriched phospholipids; Liposomes; S180 ascitic tumour; Antioxidant; Mitochondrial apoptotic pathways	N-3 FATTY-ACIDS; SWISS ALBINO MICE; OXIDATIVE STRESS; EICOSAPENTAENOIC ACID; DOCOSAHEXAENOIC ACID; FISH-OIL; CANCER; APOPTOSIS; CELLS; PERMEABILITY	The health benefits of eicosapentaenoic acid (EPA)-enriched phospholipids (PL) have witnessed a recent upsurge. In the present study, PL from starfish Asterias amurensis (SFP) and sea cucumber Cucumaria frondosa (SCP) were extracted and the liposomes were prepared. Both SFP and SCP liposomes showed antitumour effects in vitro and exhibited high transport and uptake effects in small intestinal epithelial cell models. The results also demonstrated that dietary SFP and SCP liposomes prolonged the life span and ameliorated oxidative stress status of S180 ascitic tumour-bearing mice. Results also showed that dietary SFP and SCP liposomes up-regulated the expression of Bax and down-regulated Bcl-2 level in tumour cells, then induced release of cytochrome c from mitochondria to cytosol, thus the activation of caspase 9 and caspase 3. Taken together, these findings suggest that SFP and SCP liposomes exert antitumour effects mainly via activation of mitochondrial apoptotic pathways in tumour-bearing mice. (C) 2015 Elsevier Ltd. All rights reserved.	[Du, Lei; Yang, Yu-Hong; Kurihara, Hideyuki; Takahashi, Koretaro] Hokkaido Univ, Fac Fisheries Sci, Hakodate, Hokkaido 0418611, Japan; [Du, Lei; Yang, Yu-Hong; Wang, Yu-Ming; Xue, Chang-Hu] Ocean Univ China, Coll Food Sci & Engn, Qingdao 266003, Shandong, Peoples R China	Wang, YM (reprint author), Ocean Univ China, Coll Food Sci & Engn, 5 Yu Shan Rd, Qingdao 266003, Shandong, Peoples R China.	wangyuming@ouc.edu.cn; kore@fish.hokudai.ac.jp			NSFC-Shandong Joint Fund for Marine Science Research Centers [U1406402]; National Natural Science Foundation of China [31371757, 31201329]; Program for New Century Excellent Talents in University [NCET-13-0534]; Towa Foundation for Food Science Research; China Scholarship Council [201206330082]	This work was supported by the grants from NSFC-Shandong Joint Fund for Marine Science Research Centers (U1406402), National Natural Science Foundation of China (31371757, 31201329), the Program for New Century Excellent Talents in University (NCET-13-0534) and the Towa Foundation for Food Science & Research. The author Lei Du also thanks the China Scholarship Council (No. 201206330082) for supporting his study in Hokkaido University.	Wang W, 2006, BIOL PHARM BULL, V29, P1132, DOI 10.1248/bpb.29.1132; Zhang Y, 2015, J FUNCT FOODS, V15, P151, DOI 10.1016/j.jff.2015.03.025; Alam B, 2015, ONCOL LETT, V9, P863, DOI 10.3892/ol.2014.2738; Rein DT, 2001, ANTI-CANCER DRUG, V12, P787, DOI 10.1097/00001813-200111000-00001; Liu XF, 2014, EUR J LIPID SCI TECH, V116, P255, DOI 10.1002/ejlt.201300407; Lu FSH, 2011, LIPIDS, V46, P3, DOI 10.1007/s11745-010-3496-y; Tu HL, 2014, CURR PHARM DESIGN, V20, P1917; Takahashi M, 2002, AM J PHYSIOL-GASTR L, V282, pG338; Mizoguchi K, 2014, ANTICANCER RES, V34, P7145; Bartsch H, 2006, LANGENBECK ARCH SURG, V391, P499, DOI 10.1007/s00423-006-0073-1; Kucharzik T, 2000, ANN NY ACAD SCI, V915, P171; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Zhang YY, 2015, BIOCHEM BIOPH RES CO, V456, P926, DOI 10.1016/j.bbrc.2014.12.036; Calviello G, 2009, NUTR CANCER, V61, P287, DOI 10.1080/01635580802582777; Visconti R, 2009, IDRUGS, V12, P240; Larsson SC, 2004, AM J CLIN NUTR, V79, P935; STILLWELL W, 1993, LIPIDS, V28, P103, DOI 10.1007/BF02535772; Lowe SW, 2000, CARCINOGENESIS, V21, P485, DOI 10.1093/carcin/21.3.485; Wijendran V, 2002, PEDIATR RES, V51, P265, DOI 10.1203/00006450-200203000-00002; BANGHAM AD, 1965, J MOL BIOL, V13, P238; Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006; Klaunig JE, 2010, TOXICOL PATHOL, V38, P96, DOI 10.1177/0192623309356453; Gullberg E, 2000, BIOCHEM BIOPH RES CO, V279, P808, DOI 10.1006/bbrc.2000.4038; Finocchiaro C, 2012, BRIT J NUTR, V108, P327, DOI 10.1017/S0007114511005551; Perin N, 1999, J PEDIATR GASTR NUTR, V28, P46, DOI 10.1097/00005176-199901000-00012; Hossain Z, 2006, MOL CELL BIOCHEM, V285, P155, DOI 10.1007/s11010-005-9074-6; Bozzuto G, 2015, INT J NANOMED, V10, P975, DOI 10.2147/IJN.S68861; Colomer R, 2007, BRIT J NUTR, V97, P823, DOI 10.1017/S000711450765795X; Goustard-Langelier B, 1999, LIPIDS, V34, P5, DOI 10.1007/s11745-999-331-6; Gupta M, 2004, J PHARMACOL SCI, V94, P177, DOI 10.1254/jphs.94.177; Murakawa Kentaro, 2007, J Oleo Sci, V56, P179; Nag Okhil K, 2013, Pharmaceutics, V5, P542, DOI 10.3390/pharmaceutics5040542; Prevot A. F., 1976, Revue Francaise des Corps Gras, V23, P409; Rahman A. H. M. M., 2012, International Journal of Biosciences (IJB), V2, P1; Ray S, 2014, J ENVIRON PATHOL TOX, V33, P295; van Breemen Richard B, 2005, Expert Opin Drug Metab Toxicol, V1, P175, DOI 10.1517/17425255.1.2.175	36	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1756-4646			J FUNCT FOODS	J. Funct. Food.	DEC	2015	19		B				970	982		10.1016/j.jff.2015.06.061		13	Food Science & Technology	Food Science & Technology	CY2LT	WOS:000366240900019		
J	Takakuwa, K; Hamanaka, T; Mori, K; Chin, S; Shinmei, Y; Funaki, T; Ebihara, N; Ono, K; Murakami, A; Matsuda, A				Takakuwa, Kanae; Hamanaka, Teruhiko; Mori, Kazuhiko; Chin, Shinki; Shinmei, Yasuhiro; Funaki, Toshinari; Ebihara, Nobuyuki; Ono, Koichi; Murakami, Akira; Matsuda, Akira			Atopic Glaucoma: Clinical and Pathophysiological Analysis	JOURNAL OF GLAUCOMA			English	Article							OPEN-ANGLE GLAUCOMA; MULTIPLEX CYTOKINE ANALYSIS; AQUEOUS-HUMOR; DERMATITIS; EYES; TRABECULECTOMY; MITOMYCIN; MESHWORK; JAPANESE		[Takakuwa, Kanae; Funaki, Toshinari; Ebihara, Nobuyuki; Ono, Koichi; Murakami, Akira; Matsuda, Akira] Juntendo Univ, Dept Ophthalmol, Grad Sch Med, Tokyo 1138431, Japan; [Hamanaka, Teruhiko] Japan Red Cross Soc, Med Ctr, Dept Ophthalmol, Tokyo, Japan; [Mori, Kazuhiko] Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, Japan; [Chin, Shinki; Shinmei, Yasuhiro] Hokkaido Univ, Sch Med, Dept Ophthalmol, Sapporo, Hokkaido 060, Japan	Matsuda, A (reprint author), Juntendo Univ, Sch Med, Dept Ophthalmol, Lab Ocular Atop Dis,Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138431, Japan.	akimatsu@juntendo.ac.jp			MEXT Japan [24592652]	Supported by Grants-in-Aid from MEXT Japan (No. 24592652 to A.M.).	HARRIS JL, 1960, AM J OPHTHALMOL, V49, P351; Hamanaka T, 2002, AM J OPHTHALMOL, V134, P17, DOI 10.1016/S0002-9394(02)01507-6; Hori K, 2012, INVEST OPHTH VIS SCI, V53, P1846, DOI 10.1167/iovs.11-8380; Kuchtey J, 2010, INVEST OPHTH VIS SCI, V51, P6441, DOI 10.1167/iovs.10-5216; FOSTER CS, 1990, OPHTHALMOLOGY, V97, P992; ROHEN JW, 1981, INVEST OPHTH VIS SCI, V21, P574; Iwao K, 2011, AM J OPHTHALMOL, V151, P1047, DOI 10.1016/j.ajo.2010.11.028; Johnson D, 1997, ARCH OPHTHALMOL-CHIC, V115, P375; Iwase A, 2004, OPHTHALMOLOGY, V111, P1641, DOI 10.1016/j.ophtha.2004.03.029; Hida T, 2000, JPN J OPHTHALMOL, V44, P407, DOI 10.1016/S0021-5155(00)00174-X; Bindlish R, 2002, OPHTHALMOLOGY, V109, P1336, DOI 10.1016/S0161-6420(02)01069-2; Jonas JB, 2005, OPHTHALMOLOGY, V112, P593, DOI 10.1016/j.ophtha.2004.10.042; Takai Y, 2012, INVEST OPHTH VIS SCI, V53, P241, DOI 10.1167/iovs.11-8434; Katayama Ichiro, 2011, Allergology International, V60, P205, DOI [10.2332/allergolint. 11-RAI-0333, 10.2332/allergolint.11-RAI-0333]; DeBry PW, 2002, ARCH OPHTHALMOL-CHIC, V120, P297; Ghadially F, 1997, ULTRASTRUCT PATHOL, P1352; Ritch R, 1996, GLAUCOMAS, P993	17	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1057-0829	1536-481X		J GLAUCOMA	J. Glaucoma	DEC	2015	24	9					662	668				7	Ophthalmology	Ophthalmology	CY8XI	WOS:000366691600005		
J	Ohba, C; Haginoya, K; Osaka, H; Kubota, K; Ishiyama, A; Hiraide, T; Komaki, H; Sasaki, M; Miyatake, S; Nakashima, M; Tsurusaki, Y; Miyake, N; Tanaka, F; Saitsu, H; Matsumoto, N				Ohba, Chihiro; Haginoya, Kazuhiro; Osaka, Hitoshi; Kubota, Kazuo; Ishiyama, Akihiko; Hiraide, Takuya; Komaki, Hirofumi; Sasaki, Masayuki; Miyatake, Satoko; Nakashima, Mitsuko; Tsurusaki, Yoshinori; Miyake, Noriko; Tanaka, Fumiaki; Saitsu, Hirotomo; Matsumoto, Naomichi			De novo KIF1A mutations cause intellectual deficit, cerebellar atrophy, lower limb spasticity and visual disturbance	JOURNAL OF HUMAN GENETICS			English	Article							DE-NOVO MUTATIONS; KIF1A; NEUROPATHY; KINESIN; NEURODEGENERATION; ENCEPHALOPATHY; CHILDHOOD; TRANSPORT; MOTORS; SPG30	Recently, de novo KIF1A mutations were identified in patients with intellectual disability, spasticity and cerebellar atrophy and/or optic nerve atrophy. In this study, we analyzed a total of 62 families, including 68 patients with genetically unsolved childhood cerebellar atrophy, by whole-exome sequencing (WES). We identified five de novo missense KIF1A mutations, including only one previously reported mutation (p.Arg316Trp). All the mutations are located in the motor domain of KIF1A. In all patients, initial symptom onset was during the infantile period, and included developmental delay in three patients and gait disturbance in two. Thereafter, they showed gait disturbances, exaggerated deep tendon reflexes, cerebellar symptoms and cerebellar atrophy on brain magnetic resonance imaging. Four patients showed lower limb spasticity, upper limb clumsiness and visual disturbances. Nerve conduction study revealed peripheral neuropathy in three patients. This study further delineates clinical features of de novo KIF1A mutations. Genetic testing of KIF1A should be considered in children with developmental delay, cerebellar atrophy and pyramidal features.	[Ohba, Chihiro; Miyatake, Satoko; Nakashima, Mitsuko; Tsurusaki, Yoshinori; Miyake, Noriko; Saitsu, Hirotomo; Matsumoto, Naomichi] Yokohama City Univ, Grad Sch Med, Dept Human Genet, Yokohama, Kanagawa 2360004, Japan; [Ohba, Chihiro; Tanaka, Fumiaki] Yokohama City Univ, Dept Clin Neurol & Stroke Med, Yokohama, Kanagawa 2360004, Japan; [Haginoya, Kazuhiro] Takuto Rehabil Ctr Children, Dept Pediat Neurol, Sendai, Miyagi, Japan; [Osaka, Hitoshi] Kanagawa Childrens Med Ctr, Clin Res Inst, Div Neurol, Yokohama, Kanagawa, Japan; [Osaka, Hitoshi] Jichi Med Univ, Dept Pediat, Shimotsuke, Tochigi, Japan; [Kubota, Kazuo; Ishiyama, Akihiko; Hiraide, Takuya; Komaki, Hirofumi; Sasaki, Masayuki] Natl Ctr Neurol & Psychiat, Dept Child Neurol, Tokyo, Japan	Saitsu, H (reprint author), Yokohama City Univ, Grad Sch Med, Dept Human Genet, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	hsaitsu@yokohama-cu.ac.jp; naomat@yokohama-cu.ac.jp			Ministry of Health, Labour and Welfare of Japan; Japan Society for the Promotion of Science [25293085, 25293235, 26670505, 13313587, 26461549, 24591500, 26330331]; Takeda Science Foundation; Fund for Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program in the Project for Developing Innovation Systems from the Japan Science and Technology Agency; Strategic Research Program for Brain Sciences [11105137]; Ministry of Education, Culture, Sports, Science and Technology of Japan [12024421]	We are grateful to the patients and their families for their participation in this study. We thank Nobuko Watanabe, Kiyomi Masuko, Sayaka Sasamoto and Mai Satoh for their excellent technical assistance. This work was supported by the Ministry of Health, Labour and Welfare of Japan; the Japan Society for the Promotion of Science (Grant-in-Aid for Scientific Research (B) (25293085, 25293235), Grant-in-Aid for Challenging Exploratory Research (26670505), Grant-in-Aid for Scientific Research (A) (13313587) and Grant-in-Aid for Scientific Research (C) (26461549, 24591500, 26330331)); the Takeda Science Foundation; the Fund for Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program in the Project for Developing Innovation Systems from the Japan Science and Technology Agency; the Strategic Research Program for Brain Sciences (11105137); and a Grant-in-Aid for Scientific Research on Innovative Areas (Transcription Cycle) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (12024421).	Ohba C, 2013, NEUROGENETICS, V14, P225, DOI 10.1007/s10048-013-0375-8; Klebe S, 2012, EUR J HUM GENET, V20, P645, DOI 10.1038/ejhg.2011.261; Hamdan FF, 2011, AM J HUM GENET, V88, P306, DOI 10.1016/j.ajhg.2011.02.001; Saitsu H, 2013, NAT GENET, V45, P445, DOI 10.1038/ng.2562; Nitta R, 2008, NAT STRUCT MOL BIOL, V15, P1067, DOI 10.1038/nsmb.1487; Klebe S, 2006, BRAIN, V129, P1456, DOI 10.1093/brain/awl012; Saitsu H, 2008, NAT GENET, V40, P782, DOI 10.1038/ng.150; Kikkawa M, 2001, NATURE, V411, P439, DOI 10.1038/35078000; Nitta R, 2004, SCIENCE, V305, P678, DOI 10.1126/science.1096621; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Hirokawa N, 2010, NEURON, V68, P610, DOI 10.1016/j.neuron.2010.09.039; Riviere JB, 2011, AM J HUM GENET, V89, P219, DOI 10.1016/j.ajhg.2011.06.013; Lee JR, 2015, HUM MUTAT, V36, P69, DOI 10.1002/humu.22709; Okamoto N, 2014, J HUM GENET, V59, P639, DOI 10.1038/jhg.2014.80	14	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1434-5161	1435-232X		J HUM GENET	J. Hum. Genet.	DEC	2015	60	12					739	742		10.1038/jhg.2015.108		4	Genetics & Heredity	Genetics & Heredity	CY9MJ	WOS:000366730700002		
J	Perera, EDP; Lahat, L				Perera, Edangodage Duminda Pradeep; Lahat, Livia			Fuzzy logic based flood forecasting model for the Kelantan River basin, Malaysia	JOURNAL OF HYDRO-ENVIRONMENT RESEARCH			English	Article						Fuzzy logic; Flood forecasting; Kelantan river; Mamdani method; Water level	RAINFALL-RUNOFF MODELS; RESERVOIR OPERATION; NEURAL-NETWORK; SYSTEM; PREDICTION	Among other flood forecasting tools, fuzzy logic is one of a simple and flexible approach which can be implemented in river basins where adequate hydrologic data is available and not good enough to use in a more sophisticated model. This paper assesses the potential of fuzzy logic approach for real time flood forecasting using the minimum implication function type Mamdani fuzzy inference system by applying the model to the Kelantan River basin in Malaysia. The developed models were tested for forecasting the downstream water levels of Guilemard and Kuala Krai stations using upstream hourly telemetric water levels of Dabong and Tualang stations. The membership functions (MFs) of triangular shapes with several fuzzy rule sets were utilized to check the efficiency of the fuzzy logic approach for the Kelantan River flood forecasting. For the Guilemard station, models of 8, 10 and 15 rules' sets were tested. In the calibration and validation events, the Guilemard station models' achieved MAE, ranges 0.35-0.45 m, N-S coefficient, ranges 0.87 - 0.89 and Coefficient of Determination ranges, R-2 ranges 0.91-0.95. The water level prediction model developed for the Kuala Krai station consisted of 19 rules with triangular shape MFs. It shows the ranges for MAE: 0.26-0.76 m, N-S coefficient: 0.78-0.93 and R-2: 0.91-0.96 in calibration and validation periods. The efficiencies of the developed models show acceptable levels according to the tested performance indicators implying the potential of establishing a flood forecasting system by using the fuzzy logic approach in the Kelantan River basin, Malaysia. (C) 2014 International Association for Hydro-environment Engineering and Research, Asia Pacific Division. Published by Elsevier B.V. All rights reserved.	[Perera, Edangodage Duminda Pradeep; Lahat, Livia] Publ Works Res Inst, UNESCO, Int Ctr Water Hazard & Risk Management Auspices, Tsukuba, Ibaraki, Japan	Perera, EDP (reprint author), Publ Works Res Inst, UNESCO, Int Ctr Water Hazard & Risk Management Auspices, 1-6 Minamihara, Tsukuba, Ibaraki, Japan.	perera55@pwri.go.jp			UNESCO at Public Works Research Institute (PWRI) of Japan; National Graduate Institute for Policy Studies (GRIPS) of Japan; Japan International Cooperation Agency (JICA)	The authors acknowledge the academic and material support given by the International Centre for Water Hazards and Risk Management (ICHARM) under the auspices of UNESCO at Public Works Research Institute (PWRI) of Japan, National Graduate Institute for Policy Studies (GRIPS) of Japan and Japan International Cooperation Agency (JICA) who provided the financial support for the second author to study for her postgraduate degree in Japan. The authors are very grateful to the anonymous reviewers for their valuable comments and suggestions to improve the manuscript to the present level.	Nayak PC, 2005, HYDROL PROCESS, V19, P955, DOI 10.1002/hyp.5553; Casper M, 2007, HYDROLOG SCI J, V52, P478, DOI 10.1623/hysj.52.3.478; Panigrahi DP, 2000, WATER RESOUR MANAG, V14, P89, DOI 10.1023/A:1008170632582; Xiong LH, 2001, J HYDROL, V245, P196, DOI 10.1016/S0022-1694(01)00349-3; Sen Z, 1998, SOL ENERGY, V63, P39, DOI 10.1016/S0038-092X(98)00043-7; Tayfur G, 2006, J HYDRAUL ENG-ASCE, V132, P1321, DOI 10.1061/(ASCE)0733-9429(2006)132:12(1321); BARDOSSY A, 1993, WATER RESOUR RES, V29, P373, DOI 10.1029/92WR02330; Lohani AK, 2012, J HYDROL, V442, P23, DOI 10.1016/j.jhydrol.2012.03.031; MAMDANI EH, 1975, INT J MAN MACH STUD, V7, P1, DOI 10.1016/S0020-7373(75)80002-2; Barreto-Neto AA, 2008, ENVIRON MODELL SOFTW, V23, P244, DOI [10.1016/j.envsoft.2007.07.006, 10.1016/j.envsoft.2007.05.005]; Sasikumar K, 2000, INT J SYST SCI, V31, P575, DOI 10.1080/002077200290894; Samanta S, 2003, WATER RESOUR RES, V39, DOI 10.1029/2002WR001349; Jacquin AP, 2006, J HYDROL, V329, P154, DOI 10.1016/j.jhydrol.2006.02.009; Altunkaynak A, 2005, WATER RESOUR MANAG, V19, P641, DOI 10.1007/s11269-005-7371-1; Luchetta A, 2003, COMPUT GEOSCI-UK, V29, P1111, DOI 10.1016/S0098-3004(03)00137-7; Tilmant A, 2002, WATER RESOUR MANAG, V16, P1, DOI 10.1023/A:1015523901205; Fontane DG, 1997, J WATER RES PL-ASCE, V123, P154, DOI 10.1061/(ASCE)0733-9496(1997)123:3(154); See L, 2000, HYDROLOG SCI J, V45, P523, DOI 10.1080/02626660009492354; Alvisi S, 2006, HYDROL EARTH SYST SC, V10, P1; Chen CS, 2013, J HYDROL, V490, P134, DOI 10.1016/j.jhydrol.2013.03.033; See L, 1999, HYDROLOG SCI J, V44, P763, DOI 10.1080/02626669909492272; Jayawardena AW, 2014, J HYDROL, V514, P85, DOI [10.1016/j.jhydro1.2014.03.064, 10.1016/j.jhydrol.2014.03.064]; Hundecha Y, 2001, HYDROLOG SCI J, V46, P363, DOI 10.1080/02626660109492832; Basarudin Z, 2014, IOP C SER EARTH ENV, V18, DOI 10.1088/1755-1315/18/1/012084; Yu PS, 2005, HYDROLOG SCI J, V50, P265, DOI 10.1623/hysj.50.2.265.61796; Hazalizah H., 2005, ROAD MAP EFFECTIVE F; Hong H.K., 2001, THESIS, P1; Hoong C.C., 2007, DEV FLOOD FORECASTIN, P1; Ibrahim Noraini, 2014, WSEAS Transactions on Mathematics, V13; Math Works Inc, 2012, MATL US MAN MATL FUZ; Negnevitsky M., 2005, ARTIF INTELL, P1; Russell SO, 1996, J WATER RES PL-ASCE, V122, P165, DOI 10.1061/(ASCE)0733-9496(1996)122:3(165); Sugeno M., 1974, IEE P, V12, P1585; TAKAGI T, 1985, IEEE T SYST MAN CYB, V15, P116; Tareghian R., 2007, Journal of Applied Sciences, V7, P3451; ZADEH LA, 1965, INFORM CONTROL, V8, P338, DOI 10.1016/S0019-9958(65)90241-X	36	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1570-6443	1876-4444		J HYDRO-ENVIRON RES	J. Hydro-environ. Res.	DEC	2015	9	4					542	553		10.1016/j.jher.2014.12.001		12	Engineering, Civil; Environmental Sciences; Water Resources	Engineering; Environmental Sciences & Ecology; Water Resources	CZ0FH	WOS:000366780000007		
J	Zha, YY; Yeh, TCJ; Illman, WA; Tanaka, T; Bruines, P; Onoe, H; Saegusa, H				Zha, Yuanyuan; Yeh, Tian-Chyi J.; Illman, Walter A.; Tanaka, Tatsuya; Bruines, Patrick; Onoe, Hironori; Saegusa, Hiromitsu			What does hydraulic tomography tell us about fractured geological media? A field study and synthetic experiments	JOURNAL OF HYDROLOGY			English	Article						Hydraulic tomography; Inverse modeling; Fracture and fault hydrogeology; Fracture connectivity	CROSS-HOLE TESTS; INVERSE METHOD; POROUS-MEDIA; TRAVEL-TIME; FLOW; ZONE; AQUIFER; CONNECTIVITY; TRANSPORT; RADAR	Between 2005 and 2010, Japan Atomic Energy Agency conducted four long-term, independent pumping tests in a fractured granite formation at the Mizunami Underground Research Laboratory (MIU) site in Mizunami city, central Japan. During these tests, drawdowns were monitored at different depths along several deep boreholes. These tests become one of the few, if not the only, hydraulic tomographic survey conducted in the world over thousands of meters in a fractured geologic medium with several fault zones. We analyzed the drawdown-time data set associated with each pumping test independently, and then the data sets from all pumping tests jointly to derive the spatial distributions of hydraulic conductivity (K) and specific storage (S-s) of the medium. These estimated distributions revealed some large-scale high K and low K zones. While the low K zones corroborated well with known low permeable layers and fault based on geological investigations, there were no clear geological features that can be related to the large-scale high K zones. In order to understand and substantiate these high and low K zones, we simulated a hydraulic tomographic survey in a synthetic fractured aquifer, which bears similar geologic features (i.e., formations, fractures, and faults) at the MIU site, with exception that the hydraulic properties, fracture and fault distributions were known exactly. Results of the simulation show that not only are the identified high K zones related to fracture networks connected with pumping and observation locations of each pumping test but also their values reflect the degree of connectivity of the network. Afterward, we investigated the extent of the improvement of characterization of the fault and fractures through the use of deploying dense monitoring intervals and late-time flux measurements. (C) 2015 Elsevier B.V. All rights reserved.	[Zha, Yuanyuan; Yeh, Tian-Chyi J.] Univ Arizona, Dept Hydrol & Water Resources, Tucson, AZ 85721 USA; [Zha, Yuanyuan] Wuhan Univ, State Key Lab Water Resources & Hydropower Engn S, Wuhan 430072, Peoples R China; [Illman, Walter A.] Univ Waterloo, Dept Earth & Environm Sci, Waterloo, ON N2L 3G1, Canada; [Tanaka, Tatsuya; Bruines, Patrick] Obayashi Corp, Tokyo, Japan; [Onoe, Hironori; Saegusa, Hiromitsu] Japan Atom Energy Agcy, Mizunami, Japan	Yeh, TCJ (reprint author), Univ Arizona, Dept Hydrol & Water Resources, Tucson, AZ 85721 USA.	ybiem@mac.hwr.arizona.edu			U.S. Environmental Security Technology Certification Program (ESTCP) [ER-201212]; NSF EAR [1014594]; China Scholarship Council; Discovery Grant from Natural Sciences & Engineering Research Council of Canada (NSERC)	The work was supported by the U.S. Environmental Security Technology Certification Program (ESTCP) Grant ER-201212. This research was supported in part by the NSF EAR Grant 1014594. The first author acknowledges the support of "China Scholarship Council". Tian-Chyi Jim Yeh also acknowledges the Outstanding Oversea Professorship award through Jilin University from Department of Education, China. Walter A. Illman was supported in part by the Discovery Grant from Natural Sciences & Engineering Research Council of Canada (NSERC). The constructive suggestions and comments from the Associate Editor and two anonymous reviewers are appreciated.	Huang SY, 2011, WATER RESOUR RES, V47, DOI 10.1029/2011WR010698; Mao DQ, 2013, ADV WATER RESOUR, V52, P50, DOI 10.1016/j.advwatres.2012.08.001; Illman WA, 2001, WATER RESOUR RES, V37, P583, DOI 10.1029/2000WR900273; Meier PM, 2001, GROUND WATER, V39, P10, DOI 10.1111/j.1745-6584.2001.tb00346.x; Ni CF, 2008, ADV WATER RESOUR, V31, P1708, DOI 10.1016/j.advwatres.2008.08.007; SRIVASTAVA R, 1992, ADV WATER RESOUR, V15, P275, DOI 10.1016/0309-1708(92)90014-S; Yeh TCJ, 2000, WATER RESOUR RES, V36, P2095, DOI 10.1029/2000WR900114; Xiang JW, 2009, WATER RESOUR RES, V45, DOI 10.1029/2008WR007180; Day-Lewis FD, 2000, WATER RESOUR RES, V36, P1707, DOI 10.1029/2000WR900073; Cardiff M, 2013, WATER RESOUR RES, V49, P5395, DOI 10.1002/wrcr.20356; Guiltinan E, 2015, J HYDROL, V521, P100, DOI 10.1016/j.jhydrol.2014.11.066; Castagna M, 2011, WATER RESOUR RES, V47, DOI 10.1029/2010WR009262; He Z, 2006, WATER RESOUR RES, V42, DOI 10.1029/2004WR003783; Hao YH, 2008, GROUND WATER, V46, P183, DOI 10.1111/j.1745-6584.2007.00388.x; Brauchler R, 2003, WATER RESOUR RES, V39, DOI 10.1029/2003WR002262; Tiedeman CR, 2010, GROUND WATER, V48, P401, DOI 10.1111/j.1745-6584.2009.00651.x; Sharmeen R, 2012, WATER RESOUR RES, V48, DOI 10.1029/2012WR012216; Zha YY, 2014, ADV WATER RESOUR, V71, P162, DOI 10.1016/j.advwatres.2014.06.008; Sun RL, 2013, WATER RESOUR RES, V49, P3881, DOI 10.1002/wrcr.20337; Lavenue M, 2001, WATER RESOUR RES, V37, P2659, DOI 10.1029/2000WR900289; Bense VF, 2013, EARTH-SCI REV, V127, P171, DOI 10.1016/j.earscirev.2013.09.008; Day-Lewis FD, 2006, HYDROGEOL J, V14, P1, DOI 10.1007/s10040-004-0372-y; Yeh TCJ, 1996, WATER RESOUR RES, V32, P85, DOI 10.1029/95WR02869; Vesselinov VV, 2001, WATER RESOUR RES, V37, P3019, DOI 10.1029/2000WR000135; Klepikova MV, 2013, WATER RESOUR RES, V49, P7255, DOI 10.1002/2013WR013722; Day-Lewis FD, 2003, WATER RESOUR RES, V39, DOI 10.1029/2002WR001722; Boyle E.J., 2012, SPE W REG M; Bruines P., 2014, 8 AS ROCK MECH S SAP; Hsieh P.A., 1996, PROCEEDINGS OF THE T, P127; Hsieh P.A., 1985, WATER RESOUR RES; Hsieh P.A., 1999, US GEOLOGICAL SURVEY, P777; Illman WA, 2009, WATER RESOUR RES, V45, DOI 10.1029/2007WR006715; Illman WA, 2014, GROUNDWATER, V52, P659, DOI 10.1111/gwat.12119; Illman W.A., 1999, SINGLE CROSS HOLE PN; Japan Atomic Energy Agency, 2010, JAEA REV; Saegusa H., 2011, JAEA RES; Yeh T.-C.J., 2011, WELL DEFINEDNESS SCA; Zhu J, 2005, WATER RESOUR RES, V41, P1, DOI DOI 10.1029/2004WR003790	38	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-1694	1879-2707		J HYDROL	J. Hydrol.	DEC	2015	531		1		SI		17	30		10.1016/j.jhydrol.2015.06.013		14	Engineering, Civil; Geosciences, Multidisciplinary; Water Resources	Engineering; Geology; Water Resources	CZ0BD	WOS:000366769200003		
J	Yu, W; Nakakita, E; Kim, S; Yamaguchi, K				Yu, Wansik; Nakakita, Eiichi; Kim, Sunmin; Yamaguchi, Kosei			Improvement of rainfall and flood forecasts by blending ensemble NWP rainfall with radar prediction considering orographic rainfall	JOURNAL OF HYDROLOGY			English	Article						Radar prediction; Orographic rainfall; Ensemble NWP; Blending; Hybrid flood forecast	HYDROLOGICAL ENSEMBLE; DATA ASSIMILATION; MODEL; SYSTEM; EXTRAPOLATION; ECMWF	Many basins in Japan are characterized by steep mountainous regions, generating orographic rainfall events. Orographic rainfall may cause localized heavy rainfall to induce flash floods and sediment disasters. However, the accuracy of radar-based rainfall prediction was not enough because of the complex geographical pattern of the mountainous areas. In order to reduce damage due to localized heavy rainfall, characteristics of orographic rainfall must be identified into a short-term rainfall prediction procedure. The accuracy of radar-based rainfall prediction performs best for very short lead time, however the accuracy of radar prediction rapidly decreases with increasing lead times. At longer lead times, higher accuracy QPFs are produced by Numerical Weather Prediction (NWP) models, which solve the dynamics and physics of the atmosphere. This study proposes hybrid blending system of ensemble information from radar-based prediction and numerical weather prediction (NWP) to improve the accuracy of rainfall and flood forecasting. First, an improved radar image extrapolation method, which is comprised of the orographic rainfall identification and the error ensemble scheme, is introduced. Then, ensemble NWP outputs are updated based on mean bias of the error fields considering error structure. Finally, the improved radar-based prediction and updated NWP rainfall considering bias correction are blended dynamically with changing weight functions, which are computed from the expected skill of each radar prediction and updated NWP rainfall. The proposed method is verified temporally and spatially through a target event and is applied to the hybrid flood forecasting for updating with 1 h intervals. The newly proposed method shows sufficient reproducibility in peak discharge value, and could reduce the width of ensemble spread, which is expressed as the uncertainty, in the flood forecasting. Our study is carried out and verified using the largest flood event by typhoon 'Talas' of 2011 over the two catchments, which are Futatsuno (356.1 km(2)) and Nanairo (182.1 km(2)) dam catchments of Shingu river basin (2360 km(2)), which is located in the Kii peninsula, Japan. (C) 2015 Elsevier B.V. All rights reserved.	[Yu, Wansik; Nakakita, Eiichi; Yamaguchi, Kosei] Kyoto Univ, Disaster Prevent Res Inst, Uji, Kyoto, Japan; [Kim, Sunmin] Kyoto Univ, Dept Civil & Earth Resources Engn, Uji, Kyoto, Japan	Yu, W (reprint author), Kyoto Univ, Disaster Prevent Res Inst, Uji, Kyoto, Japan.	yuwansik@gmail.com; nakakita@hmd.dpri.kyoto-u.ac.jp; kim.sunmin.6x@kyoto-u.ac.jp; yamaguchi.kosei.5r@kyo-to-u.ac.jp			sub-project of the field 3 on Next Generation Supercomputer Project	This study was partly supported by the sub-project of the field 3 on Next Generation Supercomputer Project, 'Prediction of heavy rainfalls by a cloud-resolving NWP system', and was based on data from the Ministry of Land, Infrastructure, Transport and Tourism (MLIT) and J-POWER CO., Ltd. I am grateful for their support. We would like to thank the anonymous reviewers for their valuable comments that improved the paper.	Cuo L, 2011, J HYDROMETEOROL, V12, P713, DOI 10.1175/2011JHM1347.1; Buizza R, 1999, Q J ROY METEOR SOC, V125, P2887, DOI 10.1256/smsqj.56005; Roulin E, 2005, J HYDROMETEOROL, V6, P729, DOI 10.1175/JHM436.1; Bowler NE, 2006, Q J ROY METEOR SOC, V132, P2127, DOI 10.1256/qj.04.100; Noh SJ, 2014, J HYDROL, V519, P2707, DOI 10.1016/j.jhydrol.2014.07.049; Buizza R, 2005, MON WEATHER REV, V133, P1076, DOI 10.1175/MWR2905.1; Toth E, 2000, J HYDROL, V239, P132, DOI 10.1016/S0022-1694(00)00344-9; Golding BW, 2009, METEOROL APPL, V16, P3, DOI 10.1002/met.123; Fan FM, 2014, J HYDROL, V519, P2906, DOI 10.1016/j.jhydrol.2014.04.038; Seo DJ, 2014, J HYDROL, V519, P2661, DOI 10.1016/j.jhydro1.2014.11.035; Kim S, 2009, HYDROL PROCESS, V23, P597, DOI 10.1002/hyp.7188; Gneiting T, 2005, SCIENCE, V310, P248, DOI 10.1126/science.1115255; Lin C, 2005, GEOPHYS RES LETT, V32, DOI [10.1029/2005GL023451, 10.1029/2005GL022861]; Saito K, 2006, MON WEATHER REV, V134, P1266, DOI 10.1175/MWR3120.1; Atencia A, 2010, NAT HAZARD EARTH SYS, V10, P1443, DOI 10.5194/nhess-10-1443-2010; TAKASAO T, 1988, J HYDROL, V102, P301, DOI 10.1016/0022-1694(88)90104-7; Xuan Y, 2009, HYDROL EARTH SYST SC, V13, P293; Bennett JC, 2014, J HYDROL, V519, P2832, DOI 10.1016/j.jhydrol.2014.08.010; Brown J.D., 2014, J HYDROL D, V519, P2848; Demeritt D., 2007, Environmental Hazards, V7, P115, DOI 10.1016/j.envhaz.2007.05.001; Golding BW, 1998, METEOROL APPL, V5, P1, DOI DOI 10.1017/S1350482798000577; Hamm A.J., 2004, SESS 7 VER STUD 20 2; Honda Y., 2008, CAS JSC WGNE RES ACT, V38; Matsubara T., 2013, ANN J HYDRAUL ENG, V69; Nakakita E., 2012, IAHS PUBL, V351, P311; Nakakita E., 2008, ANN J HYDRAUL ENG JS, V52, P331; Palmer T., 2007, ECMWF NEWSLETTER, V114, P14; Pierce C., 2001, METEOROLOGICAL APPL, V7, P341; Saito K., 2012, ATMOSPHERIC MODEL AP, P85, DOI [DOI 10.5772/35368, dx.doi.org/10.5772/35368]; Sayama T., 2006, P 3 APHW C WIS WAT R; Shiiba M., 1984, ANN J HYDRAULIC ENG, V28, P423; Tachikawa Y, 2004, ANN J HYDRAULIC ENG, V48, P7; Tatehira R., 1976, TENKI, V23, P95; Yu W., 2014, J JPN SOC CIV ENG B1, V70; Yu W., 2013, ADV RIVER ENG JSCE, V19, P235	35	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-1694	1879-2707		J HYDROL	J. Hydrol.	DEC	2015	531		2		SI		494	507		10.1016/j.jhydrol.2015.04.055		14	Engineering, Civil; Geosciences, Multidisciplinary; Water Resources	Engineering; Geology; Water Resources	CZ0BF	WOS:000366769400020		
J	Noritake, H; Kobayashi, Y; Ooba, Y; Matsunaga, E; Ohta, K; Shimoyama, S; Yamazaki, S; Chida, T; Kawata, K; Sakaguchi, T; Suda, T				Noritake, Hidenao; Kobayashi, Yoshimasa; Ooba, Yukimasa; Matsunaga, Erika; Ohta, Kazuyoshi; Shimoyama, Shin; Yamazaki, Satoru; Chida, Takeshi; Kawata, Kazuhito; Sakaguchi, Takanori; Suda, Takafumi			Successful Interferon Therapy Reverses Enhanced Hepatic Progenitor Cell Activation in Patients with Chronic Hepatitis C	JOURNAL OF INTERFERON AND CYTOKINE RESEARCH			English	Article							HEPATOCELLULAR-CARCINOMA; VIRUS-INFECTION; LIVER-REGENERATION; DUCTULAR REACTION; STEM-CELLS; FIBROSIS; EXPRESSION; ALPHA; INITIATION; STEATOSIS	The enhanced accumulation of hepatic progenitor cells (HPCs) is related to the risk of progression to hepatocellular carcinoma (HCC). Interferon (IFN) treatment reduces HCC risk in patients with chronic hepatitis C virus (HCV) infection. However, the underlying mechanisms remain unclear. The aim of this study was to examine the effects of IFN treatment on HPC activation in HCV patients. Immunohistochemical detection and computer-assisted quantitative image analyses of cytokeratin 7 (CK7) were performed to evaluate HPC activation in paired pre- and post-treatment liver biopsies from 18 HCV patients with sustained virological response (SVR) to IFN-based therapy and from 23 patients without SVR, as well as normal liver tissues obtained from surgical resection specimens of 10 patients. Pretreatment HCV livers showed increased CK7 immunoreactivity, compared with normal livers (HCV: median, 1.38%; normal: median, 0.69%, P=0.006). IFN treatment reduced hepatic CK7 immunoreactivity (median, 1.57% pre-IFN vs. 0.69% post-IFN, P=0.006) in SVR patients, but not in non-SVR patients. The development of HCC following IFN treatment was encountered in 3 non-SVR patients who showed high post-IFN treatment CK7 immunoreactivity (>4%). Successful IFN therapy can reverse enhanced HPC activation in HCV patients, which may contribute to the reduced risk of HCC development in these patients.	[Noritake, Hidenao; Kobayashi, Yoshimasa; Ooba, Yukimasa; Matsunaga, Erika; Ohta, Kazuyoshi; Shimoyama, Shin; Yamazaki, Satoru; Chida, Takeshi; Kawata, Kazuhito] Hamamatsu Univ Sch Med, Dept Internal Med, Hepatol Div, Hamamatsu, Shizuoka 4313192, Japan; [Sakaguchi, Takanori] Hamamatsu Univ Sch Med, Dept Surg, Hamamatsu, Shizuoka 4313192, Japan; [Suda, Takafumi] Hamamatsu Univ Sch Med, Dept Internal Med, Respiratol Div, Hamamatsu, Shizuoka 4313192, Japan	Kobayashi, Y (reprint author), Hamamatsu Univ Sch Med, Dept Internal Med, Hepatol Div, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	yoshi@hama-med.ac.jp					Hajarizadeh B, 2013, NAT REV GASTRO HEPAT, V10, P553, DOI 10.1038/nrgastro.2013.107; Chiba T, 2007, GASTROENTEROLOGY, V133, P937, DOI 10.1053/j.gasrtro.2007.06.016; Libbrecht L, 2002, SEMIN CELL DEV BIOL, V13, P389, DOI 10.1016/S1084-9521(02)00125-8; Napoli J, 1996, HEPATOLOGY, V24, P759; Gochee PA, 2003, J GASTROEN HEPATOL, V18, P386, DOI 10.1046/j.1440-1746.2003.02984.x; Roskams TA, 2004, HEPATOLOGY, V39, P1739, DOI 10.1002/hep.20130; Roskams T, 2003, AM J PATHOL, V163, P1301, DOI 10.1016/S0002-9440(10)63489-X; Fotiadu A, 2004, LIVER INT, V24, P268, DOI 10.1111/j.1478-3231.2004.0908.x; Asahina Y, 2013, HEPATOLOGY, V58, P1253, DOI 10.1002/hep.26442; Marshall A, 2005, GASTROENTEROLOGY, V128, P33, DOI 10.1053/j.gastro.2004.09.076; Ziol M, 2010, GASTROENTEROLOGY, V139, P335, DOI 10.1053/j.gastro.2010.04.012; Lowes KN, 1999, AM J PATHOL, V154, P537, DOI 10.1016/S0002-9440(10)65299-6; Fausto N, 2004, HEPATOLOGY, V39, P1477, DOI 10.1002/hep.20214; Morgan RL, 2013, ANN INTERN MED, V158, P329, DOI 10.7326/0003-4819-158-5-201303050-00005; Tang Y, 2008, P NATL ACAD SCI USA, V105, P2445, DOI 10.1073/pnas.0705395105; D'Ambrosio R, 2012, HEPATOLOGY, V56, P532, DOI 10.1002/hep.25606; Clouston AD, 2005, HEPATOLOGY, V41, P809, DOI 10.1002/hep.20650; Cardoso AC, 2010, J HEPATOL, V52, P652, DOI 10.1016/j.jhep.2009.12.028; Dumble ML, 2002, CARCINOGENESIS, V23, P435, DOI 10.1093/carcin/23.3.435; Kannan RP, 2011, J VIROL, V85, P7989, DOI 10.1128/JVI.00280-11; Dolle L, 2010, J HEPATOL, V52, P117, DOI 10.1016/j.jhep.2009.10.009; Zhang HQ, 2009, AM J RESP CELL MOL, V41, P509, DOI 10.1165/rcmb.2009-0169TR; Libbrecht L, 2000, J HEPATOL, V33, P76, DOI 10.1016/S0168-8278(00)80162-2; Kuramitsu K, 2013, AM J PATHOL, V183, P182, DOI 10.1016/j.ajpath.2013.03.018; Chobert MN, 2012, LAB INVEST, V92, P135, DOI 10.1038/labinvest.2011.143; Ravuri C, 2011, FREE RADICAL RES, V45, P600, DOI 10.3109/10715762.2011.564164; Lim R, 2006, HEPATOLOGY, V43, P1074, DOI 10.1002/hep.21170; Chougule P, 2012, CYTOKERATINS TOOLS O, P15; DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1016/0270-9139(94)90250-X; Lo Regina Cheuk-Lam, 2013, Liver Cancer, V2, P84, DOI 10.1159/000343844; Williams MJ, 2014, GASTROENTEROLOGY, V146, P349, DOI 10.1053/j.gastro.2013.11.034	31	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1079-9907	1557-7465		J INTERF CYTOK RES	J. Interferon Cytokine Res.	DEC 1	2015	35	12					956	962		10.1089/jir.2014.0197		7	Biochemistry & Molecular Biology; Cell Biology; Immunology	Biochemistry & Molecular Biology; Cell Biology; Immunology	CY7QS	WOS:000366604400004		
J	Fujiogi, M; Tanaka, Y; Kawashima, H; Toma, M; Suzuki, K; Amano, H; Morita, K; Uchida, H; Iwanaka, T				Fujiogi, Michimasa; Tanaka, Yujiro; Kawashima, Hiroshi; Toma, Miki; Suzuki, Keisuke; Amano, Hizuru; Morita, Kaori; Uchida, Hiroo; Iwanaka, Tadashi			An Easy and Safe Technique for Laparoscopic Pyloromyotomy: Using a Vascular Clamp for Stabilization of the Pylorus	JOURNAL OF LAPAROENDOSCOPIC & ADVANCED SURGICAL TECHNIQUES			English	Article							INCISION	Background: Laparoscopic pyloromyotomy (LP) is a well-established approach for treating hypertrophic pyloric stenosis. Although grasping the pylorus with forceps is important in LP, it requires a high level of surgical skill. To make this approach easier, in 2008 we introduced the method of Dozier and Kim, in which a vascular clamp (VC) is used for grasping the pylorus (LP with VC). Here, we retrospectively compared results between traditional LP (TLP) and LP with VC. Materials and Methods: Forty-three patients underwent LP with VC, whereas 194 patients underwent TLP. Two ports in the umbilicus and the left flank are common in both procedures. Instead of a right flank port, however, in LP with VC, we directly insert a VC to grasp the pylorus. Results: Patients' characteristics were not different between the two groups. There was only one wound infection and no major complication associated with LP with VC, whereas there were three major complications in TLP. Our hospital is a pediatric teaching institution in Japan where many surgeons perform their first LP. Twenty-eight surgeons performed their first LP in our hospital in the past 17 years, and LP with VC was the first LP for nine. The operative time for surgeons' first LP was significantly shorter with LP with VC than with TLP, based on Welch's t test (42.8 versus 54.4 minutes; P=.048). Conclusions: Our results suggest that LP with VC is an easy and safe technique, and it is recommended for beginners in laparoscopic surgery.	[Fujiogi, Michimasa; Tanaka, Yujiro; Kawashima, Hiroshi; Toma, Miki; Suzuki, Keisuke; Amano, Hizuru; Morita, Kaori] Saitama Childrens Med Ctr, Dept Pediat Surg, Iwatsuki, Saitama 3398551, Japan; [Uchida, Hiroo] Nagoya Univ, Grad Sch Med, Dept Pediat Surg, Nagoya, Aichi 4648601, Japan; [Iwanaka, Tadashi] Tokyo Univ Hosp, Dept Pediat Surg, Tokyo 113, Japan	Fujiogi, M (reprint author), Saitama Childrens Med Ctr, Dept Pediat Surg, 2100 Magome, Iwatsuki, Saitama 3398551, Japan.	fujiogi-stm@umin.ac.jp					Durkin ET, 2008, SURG CLIN N AM, V88, P1101, DOI 10.1016/j.suc.2008.05.014; Dozier K, 2007, PEDIATR SURG INT, V23, P1237, DOI 10.1007/s00383-007-1913-y; Haricharan RN, 2008, J PEDIATR SURG, V43, P97, DOI 10.1016/j.jpedsurg.2007.09.028; Leinwand MJ, 1999, J AM COLL SURGEONS, V189, P362, DOI 10.1016/S1072-7515(99)00136-2; Hall NJ, 2004, ANN SURG, V240, P774, DOI 10.1097/01.sla.0000143250.48265.d6; Harmon CM, 2011, SEMIN PEDIATR SURG, V20, P208, DOI 10.1053/j.sempedsurg.2011.05.009; Campbell BT, 2002, J PEDIATR SURG, V37, P1068, DOI 10.1053/jpsu.2002.33846; ALAIN JL, 1991, J PEDIATR SURG, V26, P1191, DOI 10.1016/0022-3468(91)90331-M; Lemoine C, 2011, J PEDIATR SURG, V46, P870, DOI 10.1016/j.jpedsurg.2011.02.019; Muensterer OJ, 2011, SURG ENDOSC, V25, P3414, DOI 10.1007/s00464-011-1677-2; St Peter SD, 2006, ANN SURG, V244, P363, DOI 10.1097/01.sla.0000234647.03466.27; Kim SS, 2005, J LAPAROENDOSC ADV S, V15, P474, DOI 10.1089/lap.2005.15.474; Arai M, 2004, PEDIAT ENDOSC INN TE, V8, P13, DOI 10.1089/109264104773513089; Ramstedt C, 1912, MED KLIN, V26, P1191; Ranells Judith D, 2011, Adv Pediatr, V58, P195, DOI 10.1016/j.yapd.2011.03.005; TAN KC, 1986, BRIT J SURG, V73, P399, DOI 10.1002/bjs.1800730529	16	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1092-6429	1557-9034		J LAPAROENDOSC ADV S	J. Laparoendosc. Adv. Surg. Tech.	DEC 1	2015	25	12					1036	1039		10.1089/lap.2015.0109		4	Surgery	Surgery	CY8NC	WOS:000366664400014		
J	Tsuji, Y; Widayati, KA; Nila, S; Hadi, I; Suryobroto, B; Watanabe, K				Tsuji, Yamato; Widayati, Kanthi Arum; Nila, Sarah; Hadi, Islamul; Suryobroto, Bambang; Watanabe, Kunio			"Deer" friends: feeding associations between colobine monkeys and deer	JOURNAL OF MAMMALOGY			English	Article						feeding association; Indonesia; nutritional analysis; Pangandaran; primates; Rusa timorensis; Trachypithecus auratus; ungulates	TRACHYPITHECUS-AURATUS-SONDAICUS; MACAQUES MACACA-FUSCATA; JAPANESE MACAQUES; SIKA-DEER; CALIFORNIA; PHENOLOGY; INDONESIA; BEHAVIOR; DOLPHINS; MAMMALS	We observed an interspecies association between wild Javan lutungs (Trachypithecus auratus) and rusa deer (Rusa timorensis). In this association, the former drops plant items that the latter subsequently consumes (glean). We investigated whether the association is beneficial for deer that inhabit tropical regions characterized by drastic seasonal changes. Between 2011 and 2013, we conducted field surveys in the Pangandaran Nature Reserve, Indonesia. We observed 248 gleaning events; the total duration (60.1 h) of these gleaning events corresponded to approximately 4% of the lutung observation time. Deer consumed 39 items dropped by lutungs; these items belonged to 28 plant species and included leaves, fruits, and flowers. Gleaning events occurred more frequently during months when rainfall was low and few herbaceous plants grew in grassland patches. Gleaned foods were significantly heavier than non-gleaned foods. Our findings imply that the lutung-deer association is beneficial to deer, by improving nutritional condition during seasons with low food resources.	[Tsuji, Yamato; Watanabe, Kunio] Kyoto Univ, Primate Res Inst, Dept Ecol & Behav, Inuyama, Aichi 4848506, Japan; [Widayati, Kanthi Arum; Nila, Sarah; Hadi, Islamul; Suryobroto, Bambang] Bogor Agr Univ, Dept Biol, Fac Math & Nat Sci, Bogor 16680, West Java, Indonesia; [Hadi, Islamul] Mataram Univ, Fac Math & Nat Sci, Biol Study Program, Mataram 83125, Nusa Tenggara B, Indonesia	Tsuji, Y (reprint author), Kyoto Univ, Primate Res Inst, Dept Ecol & Behav, 41-2 Kanrin, Inuyama, Aichi 4848506, Japan.	ytsuji1002@gmail.com			AS-HOPE of the Japan Society for the Promotion of Science; ITP-HOPE of the Japan Society for the Promotion of Science; Department of Academy and Technology of Japan [23780160, 24405018]; John Mung Program from Kyoto University	We thank the forest rangers of the Pangandaran Nature Reserve, especially Y. Hendrayana, for access to their facilities. We are grateful to B. Prayitno for assistance during our fieldwork and to K. Monteith, M. A. Huffman, and 2 anonymous reviewers for constructive comments and suggestions. We thank the staff of the Department of Biology, Bogor Agricultural University for technical help. This study was funded by a grant from AS-HOPE and ITP-HOPE of the Japan Society for the Promotion of Science, by Grants-in-Aid from the Department of Academy and Technology of Japan (Nos. 23780160 and 24405018), and by a grant from the John Mung Program from Kyoto University.	Asada M, 1996, ECOL RES, V11, P89, DOI 10.1007/BF02347823; Marshal JP, 2004, SOUTHWEST NAT, V49, P501, DOI 10.1894/0038-4909(2004)049<0501:SFUBDM>2.0.CO;2; DIAMOND JM, 1981, NATURE, V292, P408, DOI 10.1038/292408a0; Agoramoorthy G, 1997, MAMMALIA, V61, P271; Taylor WA, 2000, MAMMAL REV, V30, P141, DOI 10.1046/j.1365-2907.2000.00062.x; Anderwald P, 2011, MAR ECOL PROG SER, V424, P219, DOI 10.3354/meps08947; Majolo B, 2004, ETHOL ECOL EVOL, V16, P33; BOINSKI S, 1988, BIOTROPICA, V20, P136, DOI 10.2307/2388186; NEWTON PN, 1989, ETHOLOGY, V83, P89; MINTA SC, 1992, J MAMMAL, V73, P814, DOI 10.2307/1382201; Tsuji Y, 2013, PRIMATES, V54, P27, DOI 10.1007/s10329-012-0334-2; Stensland E, 2003, MAMMAL REV, V33, P205, DOI 10.1046/j.1365-2907.2003.00022.x; KOOL KM, 1992, FOLIA PRIMATOL, V58, P210, DOI 10.1159/000156631; ROBINSON JG, 1985, J MAMMAL, V66, P153, DOI 10.2307/1380972; Monteith KL, 2013, J ANIM ECOL, V82, P377, DOI 10.1111/1365-2656.12016; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Bearzi M, 2006, J MAMMAL, V87, P606, DOI 10.1644/04-MAMM-A-115R4.1; Tsuji Y, 2007, ACTA THERIOL, V52, P427, DOI 10.1007/BF03194240; Hanya G, 2013, PRIMATES, V54, P101, DOI 10.1007/s10329-012-0341-3; Brager S, 1998, CONDOR, V100, P560, DOI 10.2307/1369725; Tsuji Y, 2008, PRIMATES, V49, P157, DOI 10.1007/s10329-007-0070-1; Brotoisworo E., 1991, COMP PRIMATOLOGY MON, V3, P45; de Garin-Wichetitsky M., 2005, J ZOOL, V32, P117; ELDER W H, 1970, Mammalia, V34, P356, DOI 10.1515/mamm.1970.34.3.356; Heymann E. W., 2014, BIOL REV, V90, P142; Kangiras G. E., 2009, THESIS; KOOL KM, 1993, INT J PRIMATOL, V14, P667, DOI 10.1007/BF02192186; LIEBERMAN D, 1982, J ECOL, V70, P791, DOI 10.2307/2260105; Maynard L. A., 1979, ANIMAL NUTR; Mitani M., 2009, HUMANS NATURE, V20, P113; Morgan-Davies A. M, 1960, J E AFRICAN NATURAL, V23, P297; Newton P. N, 2001, NEW ENCY MAMMALS, P506; Ramesh Tharmalingam, 2012, Zoos' Print, V27, P15; RINEY THANE, 1960, JOUR WILDLIFE MANAGEMENT, V24, P92, DOI 10.2307/3797362; SENZOTA R B M, 1983, Mammalia, V47, P421; Sumardja E. A., 1977, BIOTROP B, V18, P1; Tsuji Y, 2015, MAMM STUDY, V40, P35; Tsuji Yamato, 2008, Primate Research, V24, P3; Tsuji Y., 2014, HUMANS NATURE, V25, P105; Zar J.H., 1999, BIOSTATISTICAL ANAL	40	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0022-2372	1545-1542		J MAMMAL	J. Mammal.	DEC	2015	96	6					1152	1161		10.1093/jmammal/gyv123		10	Zoology	Zoology	CY4PF	WOS:000366389800006		
J	Kim, M; Min, T; Kwon, OK; Kim, H; Seto, T; Kim, Y; Kim, JA; Kim, T				Kim, Myunjoon; Min, Taegee; Kwon, O-Ki; Kim, Hojoong; Seto, Takafumi; Kim, Yeongseok; Kim, Jang Ah; Kim, Taesung			Numerical study on proximal ischemia	JOURNAL OF MECHANICAL SCIENCE AND TECHNOLOGY			English	Article						Proximal ischemia; Non-newtonian model; Computational fluid dynamics; Shear rate	BLOOD-CELL AGGREGATION; SHEAR RATE; VERTEBRAL ARTERY; CORONARY-ARTERY; FLOW; VISCOSITY; SIMULATION; ANEURYSMS; SEDIMENTATION; HEMODYNAMICS	Brain artery occlusion is a major cause of cerebral stroke. During a stroke, perfusion decreases at tissues distal to the occlusion, but ischemia or hypoperfusion at tissues supplied by arterial branches proximal to the occlusion is not expected. However, ischemia proximal to the occlusion site has been observed without mechanical occlusion of the proximal branches. The mechanism of this unexpected 'proximal ischemia' is not well understood yet. In this study, transient three-dimensional computational fluid dynamics simulations of hemodynamic flow were performed to investigate 'proximal ischemia' using three non-Newtonian models and Newtonian model of a simple blood vessel consisting of an artery with one branch. Blood velocity of the artery dropped sharply after occlusion, resulting in shear rates low enough to cause red blood cell aggregation. The average shear rate in a cross-section of the artery during diastole was around 0.1 s(-1), resulting in large red blood cell clots. Large aggregates formed in the artery have the potential to block the artery or the entrance of the branch.	[Kim, Myunjoon; Kim, Yeongseok; Kim, Taesung] Sungkyunkwan Univ, Sch Mech Engn, Suwon 440746, South Korea; [Min, Taegee] S&H Co Ltd, R&B Ctr, Suwon 441813, South Korea; [Kwon, O-Ki] Seoul Natl Univ, Bundang Hosp, Dept Neurosurg, Songnam 463707, South Korea; [Kim, Hojoong; Kim, Jang Ah; Kim, Taesung] Sungkyunkwan Univ, SKKU Adv Inst Nano Technol SAINT, Suwon 440746, South Korea; [Seto, Takafumi] Kanazawa Univ, Dept Chem & Mat Engn, Kanazawa, Ishikawa 9201192, Japan	Kim, T (reprint author), Sungkyunkwan Univ, Sch Mech Engn, Suwon 440746, South Korea.	tkim@skku.edu			Ministry for Health&Welfare Affairs, Republic of Korea [HI14C0517]; MOTIE/KEIT [10043971]	This study was partly supported by a grant of the Korea Healthcare technology R&D Project, Ministry for Health&Welfare Affairs, Republic of Korea (HI14C0517) and the Industrial R&D program of MOTIE/KEIT (10043971, Development of plate stent with high elasticity and conformity for neuroaneurysm treatment).	Sims NR, 2010, BBA-MOL BASIS DIS, V1802, P80, DOI 10.1016/j.bbadis.2009.09.003; Kakalis NMP, 2008, IEEE T MED IMAGING, V27, P814, DOI 10.1109/TMI.2008.915549; Cebral JR, 2003, J ENG MATH, V47, P369, DOI 10.1023/B:ENGI.0000007977.02652.02; Fenech M, 2009, ANN BIOMED ENG, V37, P2299, DOI 10.1007/s10439-009-9775-1; CHEN SQ, 1994, CLIN HEMORHEOL, V14, P497; Lee BK, 2007, BIORHEOLOGY, V44, P29; BEDERSON JB, 1986, STROKE, V17, P472; Arbia G, 2014, J SURG RES, V186, P44, DOI 10.1016/j.jss.2013.07.037; Ajmani RS, 1997, CLIN HEMORHEOL MICRO, V17, P397; Berger SA, 2000, ANNU REV FLUID MECH, V32, P347, DOI 10.1146/annurev.fluid.32.1.347; Evju O, 2013, J BIOMECH, V46, P2802, DOI 10.1016/j.jbiomech.2013.09.004; FUKUSHIMA T, 1982, J BIOMECH ENG-T ASME, V104, P143; Pereira VM, 2013, J BIOMECH, V46, P1531, DOI [10.1016/j.jbiomech.2013.03.024, 10.1016/j.jbidmech.2013.03.024]; Bishop JJ, 2001, BIORHEOLOGY, V38, P263; REINKE W, 1987, AM J PHYSIOL, V253, pH540; De Gruttola S, 2005, ARTIF ORGANS, V29, P949, DOI 10.1111/j.1525-1594.2005.00164.x; Jung JW, 2006, J BIOMECH, V39, P2064, DOI 10.1016/j.jbiomech.2005.06.023; CHIEN S, 1970, SCIENCE, V168, P977, DOI 10.1126/science.168.3934.977; Kim YH, 2008, INT J NUMER METH FL, V58, P803, DOI 10.1002/fld.1768; Shin S, 2002, BIOSENS BIOELECTRON, V17, P383, DOI 10.1016/S0956-5663(01)00314-1; Buckenham TM, 2004, BRIT J RADIOL, V77, P15, DOI 10.1259/bjr/70447093; Eckmann DM, 2000, ANESTH ANALG, V91, P539; Morales HG, 2013, J BIOMECH, V46, P2158, DOI 10.1016/j.jbiomech.2013.06.034; COPLEY AL, 1976, BIORHEOLOGY, V13, P281; Almog B, 2005, SEX TRANSM DIS, V32, P484, DOI 10.1097/01.olq.0000161183.43732.53; Chen B, 2011, J BIOL PHYS, V37, P429, DOI 10.1007/s10867-011-9224-x; Caro C. G., 2012, MECH CIRCULATION; Kanaris A. G., 2010, P 7 EUR C CHEM ENG P; SCHMIDSC.H, 1968, J CLIN INVEST, V47, P1447, DOI 10.1172/JCI105836; SIRS JA, 1991, J PHYSIOL-LONDON, V442, P569	30	0	0	KOREAN SOC MECHANICAL ENGINEERS	SEOUL	KSTC NEW BLD. 7TH FLOOR, 635-4 YEOKSAM-DONG KANGNAM-KU, SEOUL 135-703, SOUTH KOREA	1738-494X	1976-3824		J MECH SCI TECHNOL	J. Mech. Sci. Technol.	DEC	2015	29	12					5523	5529		10.1007/s12206-015-1153-3		7	Engineering, Mechanical	Engineering	CY4HG	WOS:000366368600055		
J	Kawatsu, K; Sakata, J; Yonekita, T; Kumeda, Y				Kawatsu, Kentaro; Sakata, Junko; Yonekita, Taro; Kumeda, Yuko			Evaluation of an immunochromatographic assay for direct identification of thermostable direct hemolysin-producing Vibrio parahaemolyticus colonies on selective agar plates	JOURNAL OF MICROBIOLOGICAL METHODS			English	Article						TDH-producing Vibtio parahaemolyticus; Diarrhea; Food-borne pathogen; Immunochromatographic assay	TDH GENE; HOLLISAE; STRAINS; TRH	We evaluated the utility of an immunochromatographic assay (NH IC TDH) in identifying thermostable direct hemolysin (TDH)-producing Vibrio parahaemolyticus colonies on selective agar plates. The sensitivity of the NH IC TDH assay was 100% (189 samples) and its specificity was 100% (41 samples) compared with the presence of tdh. (C) 2015 Elsevier B.V. All rights reserved.	[Kawatsu, Kentaro; Sakata, Junko; Kumeda, Yuko] Osaka Prefectural Inst Publ Hlth, Div Bacteriol, Higashinari Ku, Osaka 5370025, Japan; [Yonekita, Taro] NH Foods Ltd, R&D Ctr, Tsukuba, Ibaraki 3002646, Japan	Kawatsu, K (reprint author), Osaka Prefectural Inst Publ Hlth, Div Bacteriol, Higashinari Ku, 3-69,Nakamichi 1-Chome, Osaka 5370025, Japan.	kawatu@iph.pref.osaka.jp					DePaola A, 2003, APPL ENVIRON MICROB, V69, P3999, DOI 10.1128/AEM.69.7.3999-4005.2003; Sakata J, 2015, J MICROBIOL METH, V116, P23, DOI 10.1016/j.mimet.2015.06.009; HONDA T, 1980, J CLIN MICROBIOL, V11, P600; Bhuiyan NA, 2002, J CLIN MICROBIOL, V40, P284, DOI 10.1128/JCM.40.1.284-286.2002; Matsumoto C, 2000, J CLIN MICROBIOL, V38, P578; Nemoto J, 2009, J FOOD PROTECT, V72, P748; Okuda J, 1997, J CLIN MICROBIOL, V35, P1965; Thompson FL, 2003, INT J SYST EVOL MICR, V53, P1615, DOI 10.1099/ijs.0.02660-0; NISHIBUCHI M, 1995, INFECT IMMUN, V63, P2093; NISHIBUCHI M, 1990, FEMS MICROBIOL LETT, V67, P251, DOI 10.1016/0378-1097(90)90004-A; Hara-Kudo Y, 2001, APPL ENVIRON MICROB, V67, P5819, DOI 10.1128/AEM.67.12.5819-5823.2001; YOH M, 1988, CAN J MICROBIOL, V34, P1321; Kawatsu K, 2006, J CLIN MICROBIOL, V44, P1821, DOI 10.1128/JCM.44.5.1821-1827.2006; Suzuki N, 1997, Kansenshogaku Zasshi, V71, P1221; TADA J, 1992, MOL CELL PROBE, V6, P477, DOI 10.1016/0890-8508(92)90044-X; Yoshida H, 1991, FEMS Microbiol Lett, V68, P249	16	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-7012	1872-8359		J MICROBIOL METH	J. Microbiol. Methods	DEC	2015	119						4	6		10.1016/j.mimet.2015.09.020		3	Biochemical Research Methods; Microbiology	Biochemistry & Molecular Biology; Microbiology	CY5IX	WOS:000366442400002		
J	Matsumura, Y; Yamamoto, M; Nagao, M; Tanaka, M; Takakura, S; Ichiyama, S				Matsumura, Yasufumi; Yamamoto, Masaki; Nagao, Miki; Tanaka, Michio; Takakura, Shunji; Ichiyama, Satoshi			Detection of Escherichia coli sequence type 131 clonal group among extended-spectrum beta-lactamase-producing E. coli using VITEK MS Plus matrix-assisted laser desorption ionization-time of flight mass spectrometry	JOURNAL OF MICROBIOLOGICAL METHODS			English	Article						MALDI-TOF MS; ESBL; Sequence types; Clone	ST131; ST405; B2	We investigated the performance of the VITEK MS Plus system for the detection of Escherichia coil sequence type 131 (ST131) among extended-spectrum beta-lactamase-producing E. coil isolates. The SARAMIS software could discriminate the 67 ST131 isolates from 82 non-ST131 isolates with a sensitivity of 86.6% and a specificity of 95.1%. (C) 2015 Elsevier B.V. All rights reserved.	[Matsumura, Yasufumi; Yamamoto, Masaki; Nagao, Miki; Tanaka, Michio; Takakura, Shunji; Ichiyama, Satoshi] Kyoto Univ, Grad Sch Med, Dept Clin Lab Med, Sakyo Ku, Kyoto 6068507, Japan	Matsumura, Y (reprint author), Kyoto Univ, Grad Sch Med, Dept Clin Lab Med, Sakyo Ku, 54 Shogoin Kawaharacho, Kyoto 6068507, Japan.	yazblood@kuhp.kyoto-u.ac.jp; masakiy@kuhp.kyoto-u.ac.jp; mnagao@kuhp.kyoto-u.ac.jp; mbac@kuhp.kyoto-u.ac.jp; stakalcr@kuhp.kyoto-u.ac.jp; sichiyam@kuhp.kyoto-u.ac.jp		Matsumura, Yasufumi/0000-0001-8595-8944			Clark AE, 2013, CLIN MICROBIOL REV, V26, P547, DOI 10.1128/CMR.00072-12; Novais A, 2014, EUR J CLIN MICROBIOL, V33, P1391, DOI 10.1007/s10096-014-2071-5; Peirano G, 2014, EMERG INFECT DIS, V20, P1928, DOI 10.3201/eid2011.141388; Matsumura Y, 2013, ANTIMICROB AGENTS CH, V57, P4736, DOI 10.1128/AAC.00641-13; Banerjee R, 2014, ANTIMICROB AGENTS CH, V58, P4997, DOI 10.1128/AAC.02824-14; Matsumura Y, 2014, J CLIN MICROBIOL, V52, P1034, DOI 10.1128/JCM.03196-13; Sauget M, 2014, INT J MED MICROBIOL, V304, P977, DOI 10.1016/j.ijmm.2014.06.004	7	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-7012	1872-8359		J MICROBIOL METH	J. Microbiol. Methods	DEC	2015	119						7	9		10.1016/j.mimet.2015.09.016		3	Biochemical Research Methods; Microbiology	Biochemistry & Molecular Biology; Microbiology	CY5IX	WOS:000366442400003		
J	Ojima-Kato, T; Yamamoto, N; Iijima, Y; Tamura, H				Ojima-Kato, Teruyo; Yamamoto, Naomi; Iijima, Yoshio; Tamura, Hiroto			Assessing the performance of novel software Strain Solution on automated discrimination of Escherichia coli serotypes and their mixtures using matrix-assisted laser desorption ionization-time of flight mass spectrometry	JOURNAL OF MICROBIOLOGICAL METHODS			English	Article						MALDI-TOF MS; Strain Solution; Escherichia coli; S10-GERMS	MALDI-TOF MS; RAPID IDENTIFICATION; S10-SPC-ALPHA OPERON; MULTIPLEX PCR; SPC OPERONS; BACTERIA; SPECTRUM; O157/H7; LEVEL; CLASSIFICATION	O157, O26, and O111 are the most important O serogroups of enterohemorrhagic Escherichia coli worldwide. Recently we reported a strategy for discriminating these serotypes from the others using matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) based on the S10-spc-alpha operon gene-encoded ribosomal protein mass spectrum (S10-GERMS) method. To realize the fully automated identification of microorganisms at species- or serotype-level with the concept of SW-GERMS method, novel software named Strain Solution for MALDI-TOF MS was developed. In this study, the Strain Solution was evaluated with a total of 45 E. coli isolates including O26, O91, O103, O111, O115, O121, O128, O145, O157, O159, and untyped serotypes. The Strain Solution could accurately discriminate 92% (11/12) of O157 strains, 100% (13/13) of O26 and O111 strains from the others with three biomarkers in an automated manner. In addition, this software could identify 2 different E. coli strains (K-12 as a non-O157 representative and O157) in mixed samples. The results suggest that Strain Solution will be useful for species- or serotype-level classification of microorganisms in the fields of food safety and diagnostics. (C) 2015 The Authors. Published by Elsevier B.V.	[Ojima-Kato, Teruyo; Tamura, Hiroto] Aichi Sci & Technol Fdn, Knowledge Hub Aichi, Toyota, Aichi 4700356, Japan; [Yamamoto, Naomi; Tamura, Hiroto] Meijo Univ, Sch Agr, Tenpaku Ku, Nagoya, Aichi 4680073, Japan; [Iijima, Yoshio] Kobe Inst Hlth, Chuo Ku, Kobe, Hyogo 6500046, Japan	Ojima-Kato, T (reprint author), Aichi Sci & Technol Fdn, Knowledge Hub Aichi, Toyota, Aichi 4700356, Japan.	teruyo.ojima@gmail.com; hiroto@meijo-u.ac.jp			Aichi Science and Technology Foundation (Japan)	This work was financially supported by the Aichi Science and Technology Foundation (Japan) in a part of 'Technological Development Project for Food Safety and Security' under Knowledge Hub Aichi. We would like to thank Mrs. Akiko Ito (Meijo University) and Mrs. Junko Nakayama (Meijo University) for providing technical assistance in sample preparation.	Josten M, 2013, J CLIN MICROBIOL, V51, P1809, DOI 10.1128/JCM.00518-13; Tamura H, 2013, J AM SOC MASS SPECTR, V24, P1185, DOI 10.1007/s13361-013-0627-8; WHITTAM TS, 1993, INFECT IMMUN, V61, P1619; Hotta Y, 2011, J AGR FOOD CHEM, V59, P5222, DOI 10.1021/jf2004095; Carter MQ, 2012, APPL ENVIRON MICROB, V78, P1004, DOI 10.1128/AEM.07033-11; Cherkaoui A, 2010, J CLIN MICROBIOL, V48, P1169, DOI 10.1128/JCM.01881-09; CEBULA TA, 1995, J CLIN MICROBIOL, V33, P248; Mahe P, 2014, BIOINFORMATICS, V30, P1280, DOI 10.1093/bioinformatics/btu022; Diaz S, 2011, FOODBORNE PATHOG DIS, V8, P1313, DOI 10.1089/fpd.2011.0923; Hotta Y, 2012, FEMS MICROBIOL LETT, V330, P23, DOI 10.1111/j.1574-6968.2012.02525.x; LIN Z, 1993, MICROBIOL IMMUNOL, V37, P543; Khot PD, 2013, J CLIN MICROBIOL, V51, P3711, DOI 10.1128/JCM.01526-13; Lagace-Wiens PRS, 2012, J CLIN MICROBIOL, V50, P3324, DOI 10.1128/JCM.01479-12; Maurer JJ, 1999, APPL ENVIRON MICROB, V65, P2954; Kawasaki S, 2005, J FOOD PROTECT, V68, P551; Hotta Y, 2010, J PROTEOME RES, V9, P6722, DOI 10.1021/pr100868d; Sato H, 2012, SYST APPL MICROBIOL, V35, P447, DOI 10.1016/j.syapm.2012.08.008; Feng P, 1998, J INFECT DIS, V177, P1750, DOI 10.1086/517438; Onnerfjord P, 1999, RAPID COMMUN MASS SP, V13, P315; Jarman KH, 2000, ANAL CHEM, V72, P1217, DOI 10.1021/ac990832j; Fothergill A, 2013, J CLIN MICROBIOL, V51, P805, DOI 10.1128/JCM.02326-12; Claydon MA, 1996, NAT BIOTECHNOL, V14, P1584, DOI 10.1038/nbt1196-1584; Benagli C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048441; Christner M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101924; Cook J.R., 1965, IMMUNOLOGY, V8, P74; Gannon P., 1997, J CLIN MICROBIOL, V35, P656; Kallow W., 2000, European patent, Patent No. [EP 1253622., 1253622]; Kok J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023285; Ojima-Kato T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113458; Teramoto K., 2007, ANAL CHEM, P8712	30	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-7012	1872-8359		J MICROBIOL METH	J. Microbiol. Methods	DEC	2015	119						233	238		10.1016/j.mimet.2015.11.005		6	Biochemical Research Methods; Microbiology	Biochemistry & Molecular Biology; Microbiology	CY5IX	WOS:000366442400037		
J	Tetsurou, S; Kuribayashi, T; Fukuyama, M; Yamaguchi, S; Yamamoto, S				Tetsurou, Seita; Kuribayashi, Takashi; Fukuyama, Masafumi; Yamaguchi, Seiji; Yamamoto, Shizuo			Inhibition of verotoxin (VT) 2 absorption into systemic blood from intestine by repeated administration of bovine immune colostral antibody against VT2 in mice	JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION			English	Article						absorption; bovine colostral antibody; intestine; mice; VT2	ESCHERICHIA-COLI O157-H7; HEMOLYTIC-UREMIC SYNDROME; O157H7; OUTBREAK; INFECTIONS	Background/Purpose: Whether absorption of verotoxin (VT) 2 from the intestine in mice is inhibited by administration bovine immune colostral antibody against VT2 was investigated. Methods: Three-week-old mice were administered VT2 solution at 477.8 ng/mL or 955.6 ng/mL, and bovine immune colostral antibody against VT2 was then administered three times. Whey without antibody against VT2 was administered to control mice. Serum levels of VT2 were measured by fluorescence enzyme immunoassay. Results: Serum levels of VT2 in mice administered VT2 solution at 477.8 ng/mL and bovine immune colostral antibody against VT2 scarcely changed. By contrast, serum levels of VT2 in control mice increased and peaked 12 hours after administration. Peak values were 15.4 +/- 5.04 ng/mL. Furthermore, serum levels of VT2 at 12 hours and 16 hours in control mice were significantly higher than in mice administered bovine colostral antibody against VT2. Serum levels of VT2 in mice administered antibody at 955.6 ng/mL showed no significant differences between repeated administration of bovine immune colostral antibody and controls. Conclusion: These results suggest that absorption of VT2 from the intestine was inhibited by repeated administration of bovine immune colostral antibody against VT2 at early stages of Escherichia coli O157: H7 infection, whereas VT2 in the intestine remained at low levels. Copyright (C) 2014, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights reserved.	[Tetsurou, Seita; Kuribayashi, Takashi; Yamamoto, Shizuo] Azabu Univ, Grad Sch Environm & Hlth Sci, Chou Ku, Sagamihara, Kanagawa 2525201, Japan; [Fukuyama, Masafumi] Azabu Univ, Microbiol Lab, Fac Life & Environm Sci, Sagamihara, Kanagawa 2525201, Japan; [Yamaguchi, Seiji] Shimane Univ, Sch Med, Dept Pediat, Izumo, Shimane 6938501, Japan	Yamamoto, S (reprint author), Azabu Univ, Grad Sch Environm & Hlth Sci, Chou Ku, 1-17-71 Fuchinobe, Sagamihara, Kanagawa 2525201, Japan.	yamamoto@azabu-u.ac.jp			Azabu University	This research was partially supported by a research project grant awarded by Azabu University.	Phillips B, 2005, BRIT MED J, V330, P409, DOI 10.1136/bmj.330.7488.409; Asano Y, 2013, JPN J INFECT DIS, V66, P201; CARTER AO, 1987, NEW ENGL J MED, V317, P1496, DOI 10.1056/NEJM198712103172403; Koseki S, 2011, J FOOD PROTECT, V74, P1543, DOI 10.4315/0362-028X.JFP-10-424; Karch H, 2005, INT J MED MICROBIOL, V295, P405, DOI 10.1016/j.ijmm.2005.06.009; Kuribayashi T, 2009, COMPARATIVE MED, V59, P163; Kita E, 2000, INFECT IMMUN, V68, P1207, DOI 10.1128/IAI.68.3.1207-1214.2000; Wong CS, 2000, NEW ENGL J MED, V342, P1930, DOI 10.1056/NEJM200006293422601; Kuribayashi Takashi, 2006, Journal of Infection and Chemotherapy, V12, P251, DOI 10.1007/s10156-006-0470-y; Tarr PI, 2005, LANCET, V365, P1073, DOI 10.1016/S0140-6736(05)71144-2; Baum HV, 2005, INT J MED MICROBIOL, V295, P503; Clary TG, 2004, SEMIN PEDIAT INFECT, V14, P260; Ito T, 1997, Kansenshogaku Zasshi, V71, P130; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P142; PAVIA AT, 1990, J PEDIATR-US, V116, P544, DOI 10.1016/S0022-3476(05)81600-2; Sawamura S, 1999, Kansenshogaku Zasshi, V73, P1054; Seita T, 2013, J MICROBIOL IMMUNOL, V46, P73, DOI 10.1016/j.jmii.2012.01.002; Takata Toshihiko, 2003, Japanese Journal of Antibiotics, V56, P691	18	0	0	ELSEVIER TAIWAN	TAIPEI	RM N-412, 4F, CHIA HSIN BUILDING 11, NO 96, ZHONG SHAN N ROAD SEC 2, TAIPEI, 10449, TAIWAN	1684-1182	1995-9133		J MICROBIOL IMMUNOL	J. Microbiol. Immunol. Infect.	DEC	2015	48	6					583	587		10.1016/j.jmii.2014.05.013		5	Immunology; Infectious Diseases; Microbiology	Immunology; Infectious Diseases; Microbiology	CY6QR	WOS:000366534400001		
J	Guo, DJ; Warisawa, S; Ishihara, S; Kometani, R				Guo, Dengji; Warisawa, Shin'ichi; Ishihara, Sunao; Kometani, Reo			Mechanical characteristics of ultra-long horizontal nanocantilevers grown by real-time feedback control on focused-ion-beam chemical vapour deposition	JOURNAL OF MICROMECHANICS AND MICROENGINEERING			English	Article						focused ion beam-chemical vapour deposition; real-time feedback control; ultra-long horizontal nanocantilever; mechanical characteristics; diamond-like carbon	3-DIMENSIONAL NANOSTRUCTURE FABRICATION; YOUNGS MODULUS	Focused-ion-beam chemical vapour deposition (FIB-CVD) has been repeatedly proved to be a useful tool for the growth of three-dimensional (3D) micro- and nano-structures. The strategy of real-time feedback control on FIB-CVD was previously proposed and experimentally demonstrated to be effective for growing ultra-long horizontal nanocantilevers. To fabricate various nanoelectromechanical systems that consist of such types of nanocantilever structures, the mechanical characteristics of ultra-long horizontal nanocantilevers should be investigated. In this study, nanocantilevers with an overhang length of up to 35 mu m were grown by using a 30 kV Ga+ FIB, a beam current of 0.50 pA and phenanthrene (C14H10) as the gas source to deposit a diamond-like carbon structure. The Young's modulus of each nanocantilever was measured by bending the nanocantilever with a nanopillar whose Young's modulus was known. The average density of each nanocantilever was calculated from the Young's modulus and the measured resonant frequency. We found that the mechanical characteristics of each nanocantilever depended on the length of the nanocantilever if the strategy of real-time feedback control was applied in fabrication. The Young's moduli and the averaged densities of the nanocantilevers with a length of 11 to 34 mu m were found to be 86 to 254 GPa and 1950 to 5750 kg m(-3), respectively. With the increase of the overhang length, the Young's modulus and the average density were found to gradually increase.	[Guo, Dengji] Shenzhen Univ, Shenzhen Key Lab Adv Mfg Technol Mould & Die, Shenzhen 518060, Guangdong, Peoples R China; [Guo, Dengji; Warisawa, Shin'ichi; Ishihara, Sunao; Kometani, Reo] Univ Tokyo, Grad Sch Engn, Tokyo 1138656, Japan	Guo, DJ (reprint author), Shenzhen Univ, Shenzhen Key Lab Adv Mfg Technol Mould & Die, Shenzhen 518060, Guangdong, Peoples R China.	guodj@szu.edu.cn; kometani@mech.t.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [26709005]; Japanese Society for Promotion of Science [25-4726]; Fundamental Research Funds for Shenzhen University [2015-27]	The authors gratefully acknowledge the support of the Grant-in-Aid for Young Scientists (A) (Grant No 26709005) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, the support of the Japanese Society for the Promotion of Science (Project No 25-4726) and the support of the Fundamental Research Funds for Shenzhen University (Grant No 2015-27).	Ishida M, 2002, J VAC SCI TECHNOL B, V20, P2784, DOI 10.1116/1.1526699; Morita T, 2003, JPN J APPL PHYS 1, V42, P3874, DOI 10.1143/JJAP.42.3874; Hoshino T, 2006, J VAC SCI TECHNOL B, V24, P2538, DOI 10.1116/1.2359730; Fujita J, 2001, J VAC SCI TECHNOL B, V19, P2834, DOI 10.1116/1.1417545; Nonaka K, 2008, JPN J APPL PHYS, V47, P5116, DOI 10.1143/JJAP.47.5116; Kometani R, 2009, SCI TECHNOL ADV MAT, V10, DOI 10.1088/1468-6996/10/3/034501; Guo DJ, 2013, J VAC SCI TECHNOL B, V31, DOI 10.1116/1.4824170; Igaki JY, 2006, MICROELECTRON ENG, V83, P1221, DOI 10.1016/j.mee.2005.12.022; Kometani R, 2004, J VAC SCI TECHNOL B, V22, P257, DOI 10.1116/1.1643056; [Anonymous], 2001, PHYS REV B; Igaki J, 2006, J VAC SCI TECHNOL B, V24, P2911, DOI 10.1116/1.2357960; Li XX, 2003, APPL PHYS LETT, V83, P3081, DOI 10.1063/1.1618369; Kometani R, 2009, J VAC SCI TECHNOL B, V27, P2698, DOI 10.1116/1.3250240; Morita T, 2004, J VAC SCI TECHNOL B, V22, P3137, DOI 10.1116/1.1826063; Matsui S, 2000, J VAC SCI TECHNOL B, V18, P3181, DOI 10.1116/1.1319689; Ashiba H, 2012, J VAC SCI TECHNOL B, V30, DOI 10.1116/1.4766315; Dai J, 2014, J MICROMECH MICROENG, V24, DOI 10.1088/0960-1317/24/5/055015; Kometani R, 2011, J VAC SCI TECHNOL B, V29, DOI 10.1116/1.3662493; Nonaka K, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.06FG07	19	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0960-1317	1361-6439		J MICROMECH MICROENG	J. Micromech. Microeng.	DEC	2015	25	12							125028	10.1088/0960-1317/25/12/125028		6	Engineering, Electrical & Electronic; Nanoscience & Nanotechnology; Instruments & Instrumentation; Materials Science, Multidisciplinary; Mechanics	Engineering; Science & Technology - Other Topics; Instruments & Instrumentation; Materials Science; Mechanics	CZ1LX	WOS:000366868400031		
J	Ishizuka, H; Miki, N				Ishizuka, Hiroki; Miki, Norihisa			Fabrication of hemispherical liquid encapsulated structures based on droplet molding	JOURNAL OF MICROMECHANICS AND MICROENGINEERING			English	Article						MEMS; liquid encapsulation; smart fluid; tactile display		We have developed and demonstrated a method for forming spherical structures of a thin polydimethylsiloxane (PDMS) membrane encapsulating a liquid. Liquid encapsulation can enhance the performance of microelectromechanical systems (MEMS) devices by providing deformability and improved dielectric properties. Parylene deposition and wafer bonding are applied to encapsulate liquid into a MEMS device. In parylene deposition, a parylene membrane is directly formed onto a liquid droplet. However, since the parylene membrane is stiff, the membrane is fragile. Although wafer bonding can encapsulate liquid between two substrates, the surface of the fabricated structure is normally flat. We propose a new liquid encapsulation method by dispensing liquid droplets. At first, a 20 mu l PDMS droplet is dispensed on ethylene glycol. A 70 mu l glycerin droplet is dispensed into a PDMS casting solution layer. The droplet forms a layer on heated ethylene glycol. Glycerin and ethylene glycol are chosen for their high boiling points. Additionally, a glycerin droplet is dispensed on the layer and surrounded by a thin PDMS casting solution film. The film is baked for 1 h at 75 degrees C. As the result, a structure encapsulating a liquid in a flexible PDMS membrane is obtained. We investigate the effects of the volume, surface tension, and guide thickness on the shape of the formed structures. We also evaluated the effect of the structure diameter on miniaturization. The structure can be adapted for various functions by changing the encapsulated liquid. We fabricated a stiffness-tunable structure by dispensing a magnetorheoligical fluid droplet with a stiffness that can be changed by an external magnetic field. We also confirmed that the proposed structure can produce stiffness differences that are distinguishable by humans.	[Ishizuka, Hiroki; Miki, Norihisa] Keio Univ, Dept Mech Engn, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan	Ishizuka, H (reprint author), Keio Univ, Dept Mech Engn, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	ishizuka1314@a3.keio.jp					Kameyama T, 2014, 2014 IEEE HAPTICS SYMPOSIUM (HAPTICS), P283, DOI 10.1109/HAPTICS.2014.6775468; Roberts DC, 2003, J MICROELECTROMECH S, V12, P81, DOI 10.1109/JMEMS.2002.807471; Berge B, 2005, PROC IEEE MICR ELECT, P227; Kwok NM, 2007, ISA T, V46, P167, DOI 10.1016/j.isatra.2006.08.005; Ninomiya T, 2011, SENSOR ACTUAT A-PHYS, V166, P277, DOI 10.1016/j.sna.2009.07.002; CONNOR CE, 1990, J NEUROSCI, V10, P3823; Goff CM, 2012, MICROFLUID NANOFLUID, V13, P891, DOI 10.1007/s10404-012-0997-4; Okayama Y, 2010, J MICROMECH MICROENG, V20, DOI 10.1088/0960-1317/20/9/095018; Li PY, 2010, J MICROELECTROMECH S, V19, P215, DOI 10.1109/JMEMS.2009.2032670; Nakahara K, 2011, PROC IEEE MICR ELECT, P1083, DOI 10.1109/MEMSYS.2011.5734617; Antelius M, 2011, PROC IEEE MICR ELECT, P356, DOI 10.1109/MEMSYS.2011.5734435; Yang TH, 2012, J INTEL MAT SYST STR, V23, P1025, DOI 10.1177/1045389X12447983; Takesue N, 2003, IEEE INT CONF ROBOT, P202; Li ZA, 2014, ANAL METHODS-UK, V6, P4716, DOI 10.1039/c4ay00798k; Zhu XY, 2015, OPT LASER TECHNOL, V68, P23, DOI 10.1016/j.optlastec.2014.11.003; Krogmann F, 2006, J OPT A-PURE APPL OP, V8, pS330, DOI 10.1088/1464-4258/8/7/S06; Tanaka Y, 2007, LAB CHIP, V7, P207, DOI 10.1039/b612082b; Bilotkach K, 2008, P 12 INT C MIN SYST, P1483; Cheng C, 2001, T JSME, V67, P1926; Hotta Y, 2012, MICROMACHINES-BASEL, V3, P137, DOI 10.3390/mi3010137; Hu H, 2007, P IEEE SENSORS, P815; Ishizuka H, 2001, P INT C EL PACK 2015, V2015, P409; Ishizuka H., 2014, MECH ENG J, V1, P1; Ko U, 2011, LECT NOTES COMPUT SC, V6851, P22; Kosemura Y, 2014, JPN J APPL PHYS, V11, P1; Lapisa M A, 2009, P 15 INT C SOL STAT, P833; Miki N, 2013, ADV MICRONANOELECTRO, P41; Nakadegawa T, 2015, P INT C EL PACK 2015, P405; Nguyen B, 2007, P MEMS07, P305; Nicholson L L, J MANIPULATIVE PHYSL, V26, P365; Park Y, 2011, P IEEE SENSORS, V2011, P81; Ponce Wong Ruben D., 2012, Sensors and Actuators: A Physical, V179, DOI 10.1016/j.sna.2012.03.023; Takamatsu S., 2010, IEEJ T ELECTR ELECTR, V130, P562, DOI 10.1541/ieejsmas.130.562; Zheng L, 2015, P INT C MICR SYST, P18	34	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0960-1317	1361-6439		J MICROMECH MICROENG	J. Micromech. Microeng.	DEC	2015	25	12							125010	10.1088/0960-1317/25/12/125010		8	Engineering, Electrical & Electronic; Nanoscience & Nanotechnology; Instruments & Instrumentation; Materials Science, Multidisciplinary; Mechanics	Engineering; Science & Technology - Other Topics; Instruments & Instrumentation; Materials Science; Mechanics	CZ1LX	WOS:000366868400013		
J	Yagyu, H; Kikitsu, T				Yagyu, Hiromasa; Kikitsu, Takeshi			Particle size dependence of the laser microfabrication of gold nanoparticles dispersed in polymer resists	JOURNAL OF MICROMECHANICS AND MICROENGINEERING			English	Article						2D micropattern; Au nanoparticle; TEM; visible ray absorption; liquid-phase reduction	EVOLUTION	A laser microfabrication technique for a polymer film based on the absorbance of Au nanoparticles for realizing a nano-microstructure was proposed. The polymer films were made of ethylcellulose wherein Au nanoparticles were dispersed. Since the absorption spectrum, which influences laser processing ability, depends on the size of the Au nanoparticles in the polymer, four sizes of Au nanoparticles were prepared using a liquid-phase reduction method and a newly developed size control technique. The polymer films with Au nanoparticles of different sizes were processed using a Nd: YVO4-SHG laser. The results confirmed that the laser processing ability was unrelated to the absorption coefficient of the polymer film but the increase of the processed depth can be explained by the decrease of full width at half maximum of the absorption peak, indicated by the sharpness of the peak.	[Yagyu, Hiromasa; Kikitsu, Takeshi] Kanto Gakuin Univ, Dept Mech Engn, Kanazawa Ku, Yokohama, Kanagawa 2368501, Japan	Yagyu, H (reprint author), Kanto Gakuin Univ, Dept Mech Engn, Kanazawa Ku, 1-50-1 Mutsuura Higashi, Yokohama, Kanagawa 2368501, Japan.	yagyu@kanto-gakuin.ac.jp			'Nanotechnology Platform' of Ministry of Education, Culture, Sports, Science and Technology, Japan [12024046]	Part of this work was supported by 'Nanotechnology Platform' (project No. 12024046) of the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Salleo A, 2000, APPL PHYS A-MATER, V71, P601, DOI 10.1007/s003390000546; Zhou WH, 2002, SCIENCE, V296, P1106, DOI 10.1126/science.296.5570.1106; Maye MM, 2000, LANGMUIR, V16, P490, DOI 10.1021/la990892k; Yagyu H, 2004, J MICROELECTROMECH S, V13, P1, DOI 10.1109/JMEMS.2003.823217; Slocombe A, 2000, APPL SURF SCI, V154, P617, DOI 10.1016/S0169-4332(99)00391-8; Yagyu H, 2008, APPL SURF SCI, V255, P2237, DOI 10.1016/j.apsusc.2008.07.075; Shimizu T, 2003, J PHYS CHEM B, V107, P2719, DOI 10.1021/jp026920g; BRUST M, 1994, J CHEM SOC CHEM COMM, P801, DOI 10.1039/c39940000801; Dyson R W, 1987, SPECIALTY POLYM; Hui A P, 2002, IEEE INT C MICROELEC, P156; Illy E K, 2000, SPIE INT SOC OPTICAL, P608; Junjun D, 2010, 5 IEEE INT C NAN MOL, P1074; Li L, 2010, J PHYS CHEM C, V114, P7774; Yagyu H, 2003, 12 INT C SOL STAT SE, P762; Yagyu H, 2006, IEEJ T SM, V126, P7, DOI 10.1541/ieejsmas.126.7; Yang L, 2010, 2 INT C NAN NANOMAN2, DOI 10.13140/2.1.3838.6568	16	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0960-1317	1361-6439		J MICROMECH MICROENG	J. Micromech. Microeng.	DEC	2015	25	12							125018	10.1088/0960-1317/25/12/125018		7	Engineering, Electrical & Electronic; Nanoscience & Nanotechnology; Instruments & Instrumentation; Materials Science, Multidisciplinary; Mechanics	Engineering; Science & Technology - Other Topics; Instruments & Instrumentation; Materials Science; Mechanics	CZ1LX	WOS:000366868400021		
J	Hayashi, K; Kawachi, I; Ohira, T; Kondo, K; Shirai, K; Kondo, N				Hayashi, Kei; Kawachi, Ichiro; Ohira, Tetsuya; Kondo, Katsunori; Shirai, Kokoro; Kondo, Naoki			Laughter and Subjective Health Among Community-Dwelling Older People in Japan Cross-Sectional Analysis of the Japan Gerontological Evaluation Study Cohort Data	JOURNAL OF NERVOUS AND MENTAL DISEASE			English	Article						Laughter; subjective health; depression; social participation; Japan	HUMOR THERAPY; EVOLUTION; LIFE	The aim of this study was to evaluate the association of laughter with subjective health independent of socioeconomic status and social participation among older people in Japan. We used the data of 26,368 individuals (men, 12,174; women, 14,194) 65 years or older who participated in the Japan Gerontological Evaluation Study (JAGES) in 2013. Participants provided information on laughter and self-rated health, depression, socioeconomic, and psychosocial factors. We evaluated laughter from three perspectives: frequency, opportunities, and interpersonal interactions. Even after adjustment for depression, sociodemographic factors, and social participation, the prevalence ratio for poor subjective health among women who never or almost never laugh was 1.78 (95% confidence interval, 1.48-2.15) compared with those who reported laughing every day. Similar associations were observed among men. Laughter may be an important factor for the promotion of general and mental health of older adults. The mechanisms linking laughter and health warrant further study.	[Hayashi, Kei] Univ Tokyo, Fac Med, Tokyo 113, Japan; [Kawachi, Ichiro] Harvard Univ, Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA; [Ohira, Tetsuya] Fukushima Med Univ, Dept Epidemiol, Fukushima, Japan; [Kondo, Katsunori] Chiba Univ, Ctr Prevent Med Sci, Chiba, Japan; [Shirai, Kokoro] Univ Ryukyus, Dept Human Sci, Sch Law & Letters, Okinawa, Japan; [Kondo, Naoki] Univ Tokyo, Sch Publ Hlth, Dept Hlth Educ & Hlth Sociol, Dept Hlth & Social Behav, Tokyo, Japan	Kondo, N (reprint author), Med Bldg 3 S310,7-3-1 Hongo,Bunkyo Ku, Tokyo 1130033, Japan.	naoki-kondo@umin.ac.jp			Health Labour Sciences Research Grant, Comprehensive Research on Aging and Health from the Ministry of Health, Labour, and Welfare, Japan [H26-Choju-Ippan-006, H25-Choju-Ippan-003, H25-Kenki-Wakate-015, H25-Irryo-Shitei-003(Fukkou), H24-Junkanki(Syosyu)-Ippan-007]; Japan Society for the Promotion of Science [20319338, 22390400, 23243070, 23590786, 23790710, 24140701, 24390469, 24530698, 24653150, 24683018, 25253052, 25870573, 25870881]; National Center for Geriatrics and Gerontology, Japan [24-17, 24-23, J09KF00804]	This study used data from the JAGES, conducted by the Center for Well-Being and Society, Nihon Fukushi University, as one of their research projects, which was supported by Health Labour Sciences Research Grant, Comprehensive Research on Aging and Health (H26-Choju-Ippan-006, H25-Choju-Ippan-003, H25-Kenki-Wakate-015, H25-Irryo-Shitei-003(Fukkou), H24-Junkanki(Syosyu)-Ippan-007) from the Ministry of Health, Labour, and Welfare, Japan; Grant-in-Aid for Scientific Research (20319338, 22390400, 23243070, 23590786, 23790710, 24140701, 24390469, 24530698, 24653150, 24683018, 25253052, 25870573, and 25870881) from the Japan Society for the Promotion of Science; and a grant from National Center for Geriatrics and Gerontology, Japan (24-17, 24-23, J09KF00804).	Gervais M, 2005, Q REV BIOL, V80, P395, DOI 10.1086/498281; Dolgoff-Kaspar R, 2012, ALTERN THER HEALTH M, V18, P61; Martin RA, 2002, CURR DIR PSYCHOL SCI, V11, P216, DOI 10.1111/1467-8721.00204; Schimmack U, 2002, J PERS SOC PSYCHOL, V82, P582, DOI 10.1037//0022-3514.82.4.582; Ramachandran VS, 1998, MED HYPOTHESES, V51, P351, DOI 10.1016/S0306-9877(98)90061-5; LaFrance M, 2003, PSYCHOL BULL, V129, P305, DOI 10.1037/0033-2909.129.2.305; PROVINE RR, 1993, ETHOLOGY, V95, P291; Bennett MP, 2009, EVID-BASED COMPL ALT, V6, P159, DOI 10.1093/ecam/nem149; Alpass FM, 2003, AGING MENT HEALTH, V7, P212, DOI 10.1080/1360786031000101193; Hirsch RD, 2010, Z GERONTOL GERIATR, V43, P42, DOI 10.1007/s00391-009-0086-9; BERK LS, 1989, AM J MED SCI, V298, P390, DOI 10.1097/00000441-198912000-00006; Hasan H, 2009, INT J MED SCI, V6, P200; Bennett PN, 2014, SEMIN DIALYSIS, V27, P488, DOI 10.1111/sdi.12194; Donkor ES, 2014, CLIN INTERV AGING, V9, P1701, DOI 10.2147/CIA.S62371; Hooff J, 1972, COMP APPROACH PHYLOG; Kubzansky LD, 2011, CLEVE CLIN J MED S1, V78, P65; Sakai Yoshinori, 2013, Jpn Hosp, P53; Takeda M, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-28; Wongpakaran Nahathai, 2013, J Clin Med Res, V5, P101, DOI 10.4021/jocmr1239w	19	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-3018	1539-736X		J NERV MENT DIS	J. Nerv. Ment. Dis.	DEC	2015	203	12					934	942		10.1097/NMD.0000000000000399		9	Clinical Neurology; Psychiatry	Neurosciences & Neurology; Psychiatry	CY7KM	WOS:000366587300009		
J	Fu, YX; Takahashi, EJ; Zhang, QB; Lu, PX; Midorikawa, K				Fu, Yuxi; Takahashi, Eiji J.; Zhang, Qingbin; Lu, Peixiang; Midorikawa, Katsumi			Optimization and characterization of dual-chirped optical parametric amplification	JOURNAL OF OPTICS			English	Article						high-energy; optical parametric amplification; infrared; femtosecond laser; dispersion	1.6 MU-M; NONLINEAR OPTICS; EXTREME-ULTRAVIOLET; PULSE AMPLIFIER; GENERATION; LIGHT; INTERFEROMETRY; PHOTOEMISSION; SUB-2-CYCLE; IONIZATION	We report optimization and characterization of a dual-chirped optical parametric amplification (DC-OPA) scheme (2011 Opt. Express 19 7190). By increasing a pump pulse energy to 100 mJ, a total (signal + idler) output energy exceeding 30 mJ was recorded with higher than 30% conversion efficiency. The feasibility of further increasing the output energy to a higher scale using the DC-OPA scheme was confirmed by a proof-of-principle experiment, in which 30%-40% conversion efficiency was observed. The signal pulse with the center wavelength of 1.4 mu m was compressed to 27 fs (FWHM), which was very close to a transform-limited pulse duration of 25 fs. Since the DC-OPA scheme is efficient for generating high-energy infrared (IR) pulses with excellent scaling ability, the design parameters for obtaining hundred-mJ-level and even joule-level IR pulses are discussed and presented in detail.	[Fu, Yuxi; Takahashi, Eiji J.; Midorikawa, Katsumi] RIKEN, RIKEN Ctr Adv Photon, Attosecond Sci Res Team, Wako, Saitama 3510198, Japan; [Zhang, Qingbin; Lu, Peixiang] Huazhong Univ Sci & Technol, Sch Phys, Wuhan 430074, Peoples R China	Fu, YX (reprint author), RIKEN, RIKEN Ctr Adv Photon, Attosecond Sci Res Team, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	yxfu@riken.jp; ejtak@riken.jp			Ministry of Education, Culture, Sports, Science, and Technology (MEXT) through a grant for Extreme Photonics Research; Japan Society for the Promotion of Science; MEXT [25286074, 26600122]	This work was supported by the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) through a grant for Extreme Photonics Research, by the Japan Society for the Promotion of Science through a Grant-in-Aid for Scientific Research, and by the MEXT through a Grant-in-Aid for Scientific Research (B) No. 25286074, and a Grant-in-Aid for Exploratory Research No. 26600122. This work was also part of the Advanced Photon Science Alliance Project commissioned by the MEXT of Japan.	Nagata Y, 2007, OPT LETT, V32, P722, DOI 10.1364/OL.32.000722; Stockman MI, 2007, NAT PHOTONICS, V1, P539, DOI 10.1038/nphoton.2007.169; LEE PA, 1981, REV MOD PHYS, V53, P769, DOI 10.1103/RevModPhys.53.769; Tang Y, 2008, OPT LETT, V33, P2386, DOI 10.1364/OL.33.002386; Goulielmakis E, 2008, SCIENCE, V320, P1614, DOI 10.1126/science.1157846; Huang SW, 2011, NAT PHOTONICS, V5, P475, DOI 10.1038/NPHOTON.2011.140; Ravasio A, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.028104; Gu X, 2009, OPT EXPRESS, V17, P62, DOI 10.1364/OE.17.000062; Midorikawa K, 2011, NAT PHOTONICS, V5, P640, DOI 10.1038/nphoton.2011.265; CORKUM PB, 1993, PHYS REV LETT, V71, P1994, DOI 10.1103/PhysRevLett.71.1994; Rudd JV, 2005, OPT LETT, V30, P1974, DOI 10.1364/OL.30.001974; Moses J, 2009, OPT EXPRESS, V17, P5540, DOI 10.1364/OE.17.005540; FEDER R, 1977, SCIENCE, V197, P259, DOI 10.1126/science.406670; Takahashi EJ, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.253901; Li CA, 2011, OPT EXPRESS, V19, P6783, DOI 10.1364/OE.19.006783; Colosimo P, 2008, NAT PHYS, V4, P386, DOI 10.1038/nphys914; Takahashi E, 2002, OPT LETT, V27, P1920, DOI 10.1364/OL.27.001920; KRAUSE JL, 1992, PHYS REV LETT, V68, P3535, DOI 10.1103/PhysRevLett.68.3535; Mucke OD, 2009, OPT LETT, V34, P2498, DOI 10.1364/OL.34.002498; Johnson SL, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.037203; Cerullo G, 2003, REV SCI INSTRUM, V74, P1, DOI 10.1063/1.1523642; Sansone G, 2010, NATURE, V465, P763, DOI 10.1038/nature09084; Takahashi EJ, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2960352; TOMIE T, 1991, SCIENCE, V252, P691, DOI 10.1126/science.2024121; Takahashi E, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.021802; Sekikawa T, 2004, NATURE, V432, P605, DOI 10.1038/nature03108; Wang H, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.143002; Fu YX, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.013802; Schultze M, 2010, SCIENCE, V328, P1658, DOI 10.1126/science.1189401; Nabekawa Y, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.153904; Mansson EP, 2014, NAT PHYS, V10, P207, DOI 10.1038/NPHYS2880; Zhang QB, 2011, OPT EXPRESS, V19, P7190, DOI 10.1364/OE.19.007190; Vozzi C, 2007, OPT LETT, V32, P2957, DOI 10.1364/OL.32.002957; Locher R, 2015, OPTICA, V2, P405, DOI 10.1364/OPTICA.2.000405; Tate J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.013901; Tzallas P, 2003, NATURE, V426, P267, DOI 10.1038/nature02091; NAKATANI H, 1988, APPL PHYS LETT, V53, P2587, DOI 10.1063/1.100535; Seres E, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2364126; Schmidt BE, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3359458; Brida D, 2008, OPT LETT, V33, P741, DOI 10.1364/OL.33.000741; Andriukaitis G, 2011, OPT LETT, V36, P2755, DOI 10.1364/OL.36.002755; Ishii N, 2012, OPT LETT, V37, P4182, DOI 10.1364/OL.37.004182; Krausz F, 2009, REV MOD PHYS, V81, P163, DOI 10.1103/RevModPhys.81.163; NISOLI M, 1994, OPT LETT, V19, P1973, DOI 10.1364/OL.19.001973; Stuart BC, 1996, PHYS REV B, V53, P1749, DOI 10.1103/PhysRevB.53.1749; Miao JW, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.088303; Du D, 1994, PHYS LETT, V64, P3071; Fu Y, 2015, OPT LETT IN PRESS; Limpert J, 2005, OPT EXPRESS, V13, P7386, DOI 10.1364/OPEX.13.007386; Mashiko H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6599; Neutze R, 2000, NATURE, V406, P752, DOI 10.1038/35021099; Schmidt BE, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4643; Shan B., 2001, PHYS REV A, V65, DOI DOI 10.1103/PHYSREVA.65.011804; Shutherland R L, 2003, HDB NONLINEAR OPTICS, P129; Takahashi E J, 2015, IEEE J SEL TOP QUANT, V21; Takahashi EJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3691; Vaupel A, 2014, OPT ENG, V53, DOI 10.1117/1.OE.53.5.051507	57	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	2040-8978	2040-8986		J OPTICS-UK	J. Opt.	DEC	2015	17	12							124001	10.1088/2040-8978/17/12/124001		9	Optics	Optics	CY4JZ	WOS:000366375700003		
J	Mori, Y; Fukuoka, T; Nomura, T				Mori, Yutaka; Fukuoka, Takahiko; Nomura, Takanori			Extended focused imaging in digital holography by spatial-domain mask method	JOURNAL OF OPTICS			English	Article						interference; image forming and processing; holography; beam trapping; self-focusing and defocusing; self-phase modulation	NUMERICAL RECONSTRUCTION; MICROSCOPY; OBJECTS; REDUCTION; DEPTH	In a digital holographic reconstruction, only images located at the reconstruction distance are in focus. A speckle reduction technique is proposed to improve digital holographic in-focus imaging. The extended focused image is obtained from a depth map created by evaluating the edge sharpness of object images. In order to show the performance and effectiveness of the proposed technique for extended focused imaging, we conducted the demonstration experiments using two objects, which are a resolution chart and two screws.	[Mori, Yutaka] Kagawa Univ, Fac Engn, Takamatsu, Kagawa 7610396, Japan; [Fukuoka, Takahiko] Wakayama Univ, Grad Sch Syst Engn, Wakayama 6408510, Japan; [Nomura, Takanori] Wakayama Univ, Fac Syst Engn, Wakayama 6408510, Japan	Mori, Y (reprint author), Kagawa Univ, Fac Engn, 2217-20 Hayashi Cho, Takamatsu, Kagawa 7610396, Japan.	mori@eng.kagawa-u.ac.jp; s142067@center.wakayama-u.ac.jp; nom@sys.wakayama-u.ac.jp					Awatsuji Y, 2004, APPL PHYS LETT, V85, P1069, DOI 10.1063/1.1777796; Matsushima K, 2009, OPT EXPRESS, V17, P19662, DOI 10.1364/OE.17.019662; Claus D, 2010, APPL OPTICS, V49, P3187, DOI 10.1364/AO.49.003187; Tachiki ML, 2008, APPL OPTICS, V47, pD144, DOI 10.1364/AO.47.00D144; Nomura T, 2010, OPT LETT, V35, P2281, DOI 10.1364/OL.35.002281; Langehanenberg P, 2008, APPL OPTICS, V47, pD176, DOI 10.1364/AO.47.00D176; Cuche E, 2000, APPL OPTICS, V39, P4070, DOI 10.1364/AO.39.004070; Geusebroek JM, 2000, CYTOMETRY, V39, P1; Yamaguchi I, 1997, OPT LETT, V22, P1268, DOI 10.1364/OL.22.001268; Jiang XY, 2013, J OPTICS-UK, V15, DOI 10.1088/2040-8978/15/12/125402; [Anonymous], 2005, INTRO FOURIER OPTICS; Barada D, 2011, APPL OPTICS, V50, pH237, DOI 10.1364/AO.50.00H237; Tajahuerce E, 2000, APPL OPTICS, V39, P6595, DOI 10.1364/AO.39.006595; Sun Y, 2004, MICROSC RES TECHNIQ, V65, P139, DOI 10.1002/jemt.20118; Maycock J, 2007, J OPT SOC AM A, V24, P1617, DOI 10.1364/JOSAA.24.001617; SCHNARS U, 1994, APPL OPTICS, V33, P179, DOI 10.1364/AO.33.000179; Mori Y, 2013, APPL OPTICS, V52, P3838, DOI 10.1364/AO.52.003838; GOODMAN JW, 1967, APPL PHYS LETT, V11, P77, DOI 10.1063/1.1755043; Ferraro P, 2005, OPT EXPRESS, V13, P6738, DOI 10.1364/OPEX.13.006738; Tahara T, 2014, OPT EXPRESS, V22, P29594, DOI 10.1364/OE.22.029594; McElhinney CP, 2008, APPL OPTICS, V47, pD71, DOI 10.1364/AO.47.000D71; Ma LH, 2004, J OPT A-PURE APPL OP, V6, P396, DOI 10.1088/1464-4258/6/4/016; GROEN FCA, 1985, CYTOMETRY, V6, P81, DOI 10.1002/cyto.990060202; Memmolo P, 2011, OPT LETT, V36, P1945, DOI 10.1364/OL.36.001945; Bianco V, 2013, OPT LETT, V38, P619, DOI 10.1364/OL.38.000619; Fukuoka T, 2014, 4 JAP KOR WORKSH DIG, P12; Goodman J. W., 2007, SPECKLE PHENOMENA OP; Hilaire P S, 1994, Appl Opt, V33, P768, DOI 10.1364/AO.33.000768; Mori Y, 2013, OPT ENG, V52, DOI 10.1117/1.OE.52.12.123101	29	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	2040-8978	2040-8986		J OPTICS-UK	J. Opt.	DEC	2015	17	12							125706	10.1088/2040-8978/17/12/125706		8	Optics	Optics	CY4JZ	WOS:000366375700051		
J	Tahara, T; Mori, R; Arai, Y; Takaki, Y				Tahara, Tatsuki; Mori, Ryota; Arai, Yasuhiko; Takaki, Yasuhiro			Four-step phase-shifting digital holography simultaneously sensing dual-wavelength information using a monochromatic image sensor	JOURNAL OF OPTICS			English	Article						digital holography; holography; interferometry; multiwavelength imaging; phase-division multiplexing of wavelengths	MICROSCOPY; INTERFEROMETRY	Four-step phase-shifting digital holography simultaneously sensing dual-wavelength information from wavelength-multiplexed holograms is presented. Specific phase shifts for respective wavelengths are introduced to remove the crosstalk components and extract only the object wave at the desired wavelength from the holograms. Object waves at multiple wavelengths are selectively extracted by utilizing 2 pi ambiguity and the subtraction procedures based on phase-shifting interferometry. Two-step phase-shifting interferometry is merged into the procedures to decrease the number of the recorded holograms. The proposed technique is numerically investigated and experimentally demonstrated. The applicability to the case where the number of wavelengths is more than two and possible noise when using two-step phase-shifting interferometry are discussed.	[Tahara, Tatsuki; Mori, Ryota; Arai, Yasuhiko] Kansai Univ, Fac Engn Sci, Suita, Osaka 5648680, Japan; [Takaki, Yasuhiro] Tokyo Univ Agr & Technol, Inst Engn, Koganei, Tokyo 1848588, Japan	Tahara, T (reprint author), Kansai Univ, Fac Engn Sci, 3-3-35 Yamate Cho, Suita, Osaka 5648680, Japan.	tahara@kansai-u.ac.jp			Okawa Foundation; Research Foundation for Opt-Science and Technology; Japan Society for the Promotion of Science (JSPS) [15K17474]; MEXT Supported Program for the Strategic Research Foundation at Private Universities	This study was partially supported by The Okawa Foundation, Research Foundation for Opt-Science and Technology, Grant-in-Aid for Young Scientists (B) 15K17474 of the Japan Society for the Promotion of Science (JSPS), and MEXT Supported Program for the Strategic Research Foundation at Private Universities.	Liu JP, 2009, OPT LETT, V34, P250; POON TC, 1995, OPT ENG, V34, P1338, DOI 10.1117/12.201662; Tahara T, 2015, OPT LETT, V40, P2810, DOI 10.1364/OL.40.002810; Gass J, 2003, OPT LETT, V28, P1141, DOI 10.1364/OL.28.001141; Kato J, 2002, OPT LETT, V27, P1403, DOI 10.1364/OL.27.001403; Meng XF, 2006, OPT LETT, V31, P1414, DOI 10.1364/OL.31.001414; Yamaguchi I, 2002, OPT LETT, V27, P1108, DOI 10.1364/OL.27.001108; Kim MK, 2006, J OPT A-PURE APPL OP, V8, pS518, DOI 10.1088/1464-4258/8/7/S33; Yamaguchi I, 1997, OPT LETT, V22, P1268, DOI 10.1364/OL.22.001268; Xia P, 2011, APPL OPTICS, V50, pH177, DOI 10.1364/AO.50.00H177; Watanabe E, 2013, OPT LETT, V38, P1319, DOI 10.1364/OL.38.001319; LEITH EN, 1962, J OPT SOC AM, V52, P1123, DOI 10.1364/JOSA.52.001123; Ferraro P, 2006, OPT LETT, V31, P1405, DOI 10.1364/OL.31.001405; Wada A, 2008, J OPT SOC AM A, V25, P3013, DOI 10.1364/JOSAA.25.003013; GOODMAN JW, 1967, APPL PHYS LETT, V11, P77, DOI 10.1063/1.1755043; Desse JM, 2011, MEAS SCI TECHNOL, V22, DOI 10.1088/0957-0233/22/6/064005; Tahara T, 2014, OPT EXPRESS, V22, P29594, DOI 10.1364/OE.22.029594; Takaki Y, 1999, APPL OPTICS, V38, P4990, DOI 10.1364/AO.38.004990; GABOR D, 1948, NATURE, V161, P777, DOI 10.1038/161777a0; Shimobaba T, 2010, J OPTICS-UK, V12, DOI 10.1088/2040-8978/12/6/065402; Murata S, 2000, OPT LASER TECHNOL, V32, P567, DOI 10.1016/S0030-3992(00)00088-8; Kubota T, 2007, OPT EXPRESS, V15, P14348, DOI 10.1364/OE.15.014348; Kiire T, 2009, APPL OPTICS, V48, P1308, DOI 10.1364/AO.48.001308; Pavillon N, 2014, J INNOV OPT HEAL SCI, V7, DOI 10.1142/S1793545813300097; Tahara T, 2014, DM3B4 OSA	25	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	2040-8978	2040-8986		J OPTICS-UK	J. Opt.	DEC	2015	17	12							125707	10.1088/2040-8978/17/12/125707		10	Optics	Optics	CY4JZ	WOS:000366375700052		
J	Wang, N; Kobayashi, T				Wang, Nan; Kobayashi, Takayoshi			Subtraction threshold for an isotropic fluorescence emission difference microscope	JOURNAL OF OPTICS			English	Article						subtraction microscopy; image processing; 3D imaging	STRUCTURED ILLUMINATION; STIMULATED-EMISSION; RESOLUTION LIMIT; DIFFRACTION; BEAMS; ENHANCEMENT; BREAKING; SYSTEM; FIELD	Isotropic fluorescence emission difference microscopy proposed recently provides a simple method to enhance the spatial resolution in three-dimensions (3D) for fluorescence imaging. However, the subtraction threshold to achieve the condition for appropriately resolving the sample in 3D have not been studied. Then the subtraction factors used in this type of microscopes are still experientially chosen. Based on vector diffraction theory and a 3D numerical model developed here, the subtraction threshold is numerically investigated for the isotropic fluorescence subtraction microscopy. The subtraction factors and peak intensities at the threshold are obtained and comparied both in lateral and axial planes for achieving most appropriate subtraction and inspecting the isotropic characteristic. The effects of radius ratios of implemented 0-pi annular phase plate for generating three dimensional donut spot on the subtracted resolution, peak intensity and negative sidebands are also discussed.	[Wang, Nan; Kobayashi, Takayoshi] Univ Electrocommun, Adv Ultrafast Laser Res Ctr, Chofu, Tokyo 1828585, Japan; [Wang, Nan; Kobayashi, Takayoshi] JST, CREST, Chiyoda Ku, Tokyo 1020075, Japan; [Kobayashi, Takayoshi] Natl Chiao Tung Univ, Dept Electrophys, Adv Ultrafast Laser Res Ctr, Hsinchu 300, Taiwan; [Kobayashi, Takayoshi] Osaka Univ, Insitute Laser Engn, Suita, Osaka 5650971, Japan	Wang, N (reprint author), Univ Electrocommun, Adv Ultrafast Laser Res Ctr, 1-5-1 Chofugaoka, Chofu, Tokyo 1828585, Japan.	kobayashi@ils.uec.ac.jp					You ST, 2015, AIP ADV, V5, DOI 10.1063/1.4915132; Dehez H, 2013, OPT EXPRESS, V21, P15912, DOI 10.1364/OE.21.015912; Wang N, 2014, OPT EXPRESS, V22, P28819, DOI 10.1364/OE.22.028819; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Jia S, 2014, NAT PHOTONICS, V8, P302, DOI 10.1038/NPHOTON.2014.13; Miyazaki J, 2014, OPT EXPRESS, V22, P9024, DOI 10.1364/OE.22.009024; Sharonov A, 2006, P NATL ACAD SCI USA, V103, P18911, DOI 10.1073/pnas.0609643104; Fujita K, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.228105; Hao XA, 2010, J OPT-UK, V12, DOI 10.1088/2040-8978/12/11/115707; Segawa S, 2014, OPT LETT, V39, P3118, DOI 10.1364/OL.39.003118; Vaziri A, 2008, P NATL ACAD SCI USA, V105, P20221, DOI 10.1073/pnas.0810636105; Wei JS, 2014, OPT LETT, V39, P6387, DOI 10.1364/OL.39.006387; Ganic D, 2003, OPT EXPRESS, V11, P2747, DOI 10.1364/OE.11.002747; Wang N, 2015, OPT EXPRESS, V23, P13410, DOI 10.1364/OE.23.013410; Iketaki Y, 2015, OPT LETT, V40, P1057, DOI 10.1364/OL.40.001057; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Yew EYS, 2007, OPT LETT, V32, P3417, DOI 10.1364/OL.32.003417; Han KY, 2009, NANO LETT, V9, P3323, DOI 10.1021/nl901597v; Wang N, 2015, OPT COMMUN, V343, P28, DOI 10.1016/j.optcom.2014.12.072; Yao JJ, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.014302; Fiolka R, 2012, P NATL ACAD SCI USA, V109, P5311, DOI 10.1073/pnas.1119262109; Gordon MP, 2004, P NATL ACAD SCI USA, V101, P6462, DOI 10.1073/pnas.0401638101; Wang N, 2015, OPT EXPRESS, V23, P13704, DOI 10.1364/OE.23.013704; Dertinger T, 2009, P NATL ACAD SCI USA, V106, P22287, DOI 10.1073/pnas.0907866106; Gustafsson MGL, 2000, J MICROSC-OXFORD, V198, P82, DOI 10.1046/j.1365-2818.2000.00710.x; RICHARDS B, 1959, PROC R SOC LON SER-A, V253, P358, DOI 10.1098/rspa.1959.0200; He JP, 2015, OPT LETT, V40, P1141, DOI 10.1364/OL.40.001141; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; Kuang CF, 2013, SCI REP-UK, V3, DOI 10.1038/srep01441; You ST, 2014, APPL OPTICS, V53, P7838, DOI 10.1364/AO.53.007838	30	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	2040-8978	2040-8986		J OPTICS-UK	J. Opt.	DEC	2015	17	12							125302	10.1088/2040-8978/17/12/125302		8	Optics	Optics	CY4JZ	WOS:000366375700024		
J	Zhang, L; Tuan, TH; Liu, L; Gao, WQ; Kawamura, H; Suzuki, T; Ohishi, Y				Zhang, Lei; Tuan, Tong-Hoang; Liu, Lai; Gao, Wei-Qing; Kawamura, Harutaka; Suzuki, Takenobu; Ohishi, Yasutake			Widely tunable dispersive wave generation and soliton self-frequency shift in a tellurite microstructured optical fiber pumped near the zero dispersion wavelength	JOURNAL OF OPTICS			English	Article						nonlinear optics; Raman soliton; Cherenkov radiation; microstructured optical fiber	PHOTONIC CRYSTAL FIBERS; CHERENKOV RADIATION; SUPERCONTINUUM GENERATION; OPTIMIZATION; EFFICIENT	Widely tunable dispersive waves (DW) and Raman solitons are generated in a tellurite microstructured optical fiber (TMOF) by pumping in the anomalous dispersion regime, close to the zero dispersion wavelength (ZDW). The DW can be generated from 1518.3 nm to 1315.5 nm, and the soliton can be shifted from the pump wavelength of 1570 nm to 1828.7 nm, by tuning the average pump power from 3 dBm to 17.5 dBm. After the average pump power is increased to 18.8 dBm, two DW peaks (centered at 1323 nm and 1260 nm) and three soliton peaks (centered at 1762 nm, 1825 nm, and 1896 nm) can be observed simultaneously. When the average pump power is greater than 23.4 dBm, a flat and broadband supercontinuum (SC) can be formed by the combined nonlinear effects of soliton self-frequency shift (SSFS), DW generation, and cross phase modulation (XPM).	[Zhang, Lei; Tuan, Tong-Hoang; Liu, Lai; Gao, Wei-Qing; Kawamura, Harutaka; Suzuki, Takenobu; Ohishi, Yasutake] Toyota Technol Inst, Res Ctr Adv Photon Technol, Tempaku Ku, Nagoya, Aichi 4688511, Japan	Zhang, L (reprint author), Toyota Technol Inst, Res Ctr Adv Photon Technol, Tempaku Ku, 2-12-1 Hisakata, Nagoya, Aichi 4688511, Japan.	leizhang080@gmail.com			Ministry of Education, Culture, Sports, Science and Technology (MEXT)	This work is supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) under the Support Program for Forming Strategic Research Infrastructure (2011-2015).	GORDON JP, 1986, OPT LETT, V11, P662, DOI 10.1364/OL.11.000662; Efimov A, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.213902; Erkintalo M, 2010, OPT LETT, V35, P658, DOI 10.1364/OL.35.000658; Tu HH, 2013, OPT EXPRESS, V21, P23188, DOI 10.1364/OE.21.023188; Arteaga-Sierra FR, 2014, OPT EXPRESS, V22, P23686, DOI 10.1364/OE.22.023686; Skryabin DV, 2010, REV MOD PHYS, V82, P1287, DOI 10.1103/RevModPhys.82.1287; Al-kadry AM, 2012, J OPT SOC AM B, V29, P1347; Travers JC, 2009, OPT LETT, V34, P115, DOI 10.1364/OL.34.000115; MITSCHKE FM, 1986, OPT LETT, V11, P659, DOI 10.1364/OL.11.000659; AKHMEDIEV N, 1995, PHYS REV A, V51, P2602, DOI 10.1103/PhysRevA.51.2602; Choudhary A, 2012, OPT EXPRESS, V20, P5538, DOI 10.1364/OE.20.005538; Gao WQ, 2012, OPT COMMUN, V285, P3809, DOI 10.1016/j.optcom.2012.05.059; Masip ME, 2009, OPT LETT, V34, P842, DOI 10.1364/OL.34.000842; Arteaga-Sierra FR, 2014, OPT EXPRESS, V22, P2451, DOI 10.1364/OE.22.002451; Hult J, 2007, J LIGHTWAVE TECHNOL, V25, P3770, DOI 10.1109/JLT.2007.909373; Driben R, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.063808; Petersen CR, 2014, NAT PHOTONICS, V8, P830, DOI 10.1038/NPHOTON.2014.213; Chang GQ, 2011, OPT EXPRESS, V19, P6635, DOI 10.1364/OE.19.006635; Qiu P, 2014, PHYS REV A, V90, DOI 10.1103/PhysRevA.90.043813; Washburn BR, 2001, ELECTRON LETT, V37, P1510, DOI 10.1049/el:20011047; Judge AC, 2009, J OPT SOC AM B, V26, P2064, DOI 10.1364/JOSAB.26.002064; Dekker SA, 2011, OPT EXPRESS, V19, P17766, DOI 10.1364/OE.19.017766; Cheng TL, 2014, OPT EXPRESS, V22, P3740, DOI 10.1364/OE.22.003740; Zhang L, 2015, IEEE PHOTONIC TECH L, V27, P1547, DOI 10.1109/LPT.2015.2429735; Barviau B, 2011, J OPT SOC AM B, V28, P1152; Mak KF, 2013, OPT EXPRESS, V21, P10942, DOI 10.1364/OE.21.010942; [Anonymous], 2015, IEEE PHOTONICS J; Feng X., 2005, J LIGHTWAVE TECHNOL, V23, P2046, DOI DOI 10.1109/JLT.2005.849945; Zhang L, 2013, J OPTICS-UK, V15, DOI 10.1088/2040-8978/15/7/075201	29	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	2040-8978	2040-8986		J OPTICS-UK	J. Opt.	DEC	2015	17	12							125501	10.1088/2040-8978/17/12/125501		7	Optics	Optics	CY4JZ	WOS:000366375700029		
J	Shigehara, S; Ohba, S; Nakashima, K; Takanashi, Y; Asahina, I				Shigehara, Satoshi; Ohba, Seigo; Nakashima, Ken; Takanashi, Yoshiaki; Asahina, Izumi			Immediate Loading of Dental Implants Inserted in Edentulous Maxillas and Mandibles: 5-Year Results of a Clinical Study	JOURNAL OF ORAL IMPLANTOLOGY			English	Article						immediate loading; completely edentulous jaw; survival rate	SUBMERGED ITI IMPLANTS; FOLLOW-UP; PROSPECTIVE MULTICENTER; FIXED PROSTHESES; DENTURES	The aim of the present study was to evaluate the long-term outcome of immediately loaded full-arch, fixed, one-piece prostheses supported by dental implants inserted in completely edentulous maxillae and mandibles. Twenty-eight completely edentulous jaws in 27 patients were treated with screw-fixed provisional prostheses on the same day as implant insertion. A total of 189 implants were inserted into the jaws of the patients. All provisional prostheses were the one-piece bridge type and were made with acrylic resin. Final restoration was performed more than 2 months after surgery. Implant survival rate, prosthesis success rate, and complications during the follow-up period were evaluated. Implant size (diameter and length) and bone quality (Hounsfield units) of the region of the implant were also analyzed. Mean follow-up time was 77.9 months. The cumulative survival rate of the implants was 100%, and the success rate of the prostheses was also 100% during the observation time. Although 3 types of minor complications occurred in 10 jaws (10/28; 35.7%), no major complications were found. Immediate loading of dental implants produces an equivalent outcome as that reported in previous studies using conventional loading. We believe this study not only adds to the immediate loading data but also confirms that the immediate loading technique may be most advantageous strategy for edentulous patients.	[Shigehara, Satoshi] Shonan Dent Care Implant Clin, Ninomiya, Japan; [Ohba, Seigo; Asahina, Izumi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Regenerat Oral Surg, Nagasaki 852, Japan; [Ohba, Seigo] Univ Fukui, Fac Med, Dept Sensory & Locomotor Med, Div Dent & Oral Surg, Fukui 910, Japan; [Nakashima, Ken] Takanashi Dent Clin, Chuou Ku, Nihon Bashi, Japan; [Takanashi, Yoshiaki] Shonan Dent Care Implant Clin, City, Japan; [Takanashi, Yoshiaki] Takanashi Dent Clin, City, Japan	Ohba, S (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Regenerat Oral Surg, Nagasaki 852, Japan.	sohba@nagasaki-u.ac.jp					Ferrigno N, 2002, CLIN ORAL IMPLAN RES, V13, P260, DOI 10.1034/j.1600-0501.2002.130305.x; Gallucci GO, 2009, INT J ORAL MAX IMPL, V24, P132; Bergkvist G, 2004, CLIN ORAL IMPLAN RES, V15, P351, DOI 10.1111/j.1600-0501.2004.01017.x; Arvidson K, 1998, CLIN ORAL IMPLAN RES, V9, P225, DOI 10.1034/j.1600-0501.1998.090403.x; Moberg LE, 2001, CLIN ORAL IMPLAN RES, V12, P450, DOI 10.1034/j.1600-0501.2001.120504.x; Ganeles J, 2008, CLIN ORAL IMPLAN RES, V19, P1119, DOI 10.1111/j.1600-0501.2008.01626.x; Bergkvist G, 2009, CLIN IMPLANT DENT R, V11, P1, DOI 10.1111/j.1708-8208.2008.00094.x; Piattelli A, 1997, J PERIODONTOL, V68, P591; Testori T, 2004, CLIN ORAL IMPLAN RES, V15, P278, DOI 10.1111/j.1600-0501.2004.01013.x; Agliardi E, 2010, QUINTESSENCE INT, V41, P285; Rasmusson L, 2005, CLIN IMPLANT DENT R, V7, P36, DOI 10.1111/j.1708-8208.2005.tb00045.x; Degidi M, 2005, J PERIODONTOL, V76, P1016, DOI 10.1902/jop.2005.76.6.1016; Allen PF, 2003, CLIN ORAL IMPLAN RES, V14, P173, DOI 10.1034/j.1600-0501.2003.140206.x; Tealdo T, 2008, J PROSTHET DENT, V99, P351, DOI 10.1016/S0022-3913(08)60082-7; Ibanez JC, 2005, J PERIODONTOL, V76, P1972, DOI 10.1902/jop.2005.76.11.1972; Li W, 2005, J ORAL MAXILLOFAC SU, V67, P2653; Maló Paulo, 2003, Clin Implant Dent Relat Res, V5 Suppl 1, P2, DOI 10.1111/j.1708-8208.2003.tb00010.x; Misch C E, 1990, Int J Oral Implantol, V6, P23	18	0	0	ALLEN PRESS INC	LAWRENCE	810 E 10TH ST, LAWRENCE, KS 66044 USA	0160-6972	1548-1336		J ORAL IMPLANTOL	J. Oral Implant.	DEC	2015	41	6					701	705		10.1563/AAID-JOI-D-14-00018		5	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CY9JN	WOS:000366723300022		
J	Ogino, Y; Kihara, M; Yamada, J; Toriya, K; Koyano, K				Ogino, Yoichiro; Kihara, Masafumi; Yamada, Junichi; Toriya, Kohei; Koyano, Kiyoshi			Implant Treatments for Edentulous Maxilla With Anterior Hyperfunction	JOURNAL OF ORAL IMPLANTOLOGY			English	Article							DENTAL IMPLANTS; SUPPORTED PROSTHESES; STRESS-DISTRIBUTION; TREATMENT OUTCOMES; PATIENT		[Ogino, Yoichiro; Kihara, Masafumi; Yamada, Junichi; Toriya, Kohei; Koyano, Kiyoshi] Kyushu Univ, Fac Dent Sci, Div Oral Rehabil, Sect Implant & Rehabilitat Dent, Fukuoka 812, Japan	Ogino, Y (reprint author), Kyushu Univ, Fac Dent Sci, Div Oral Rehabil, Sect Implant & Rehabilitat Dent, Fukuoka 812, Japan.	ogino@dent.kyushu-u.ac.jp					ADELL R, 1990, International Journal of Oral and Maxillofacial Implants, V5, P347; Herford AS, 2015, J ORAL IMPLANTOL, V41, P196, DOI 10.1563/AAID-JOI-D-12-00218; Sagat G, 2010, IMPLANT DENT, V19, P498, DOI 10.1097/ID.0b013e3181fa4267; Bergkvist G, 2008, CLIN IMPLANT DENT R, V10, P40, DOI 10.1111/j.1708-8208.2007.00059.x; Zitzmann NU, 2000, J PROSTHET DENT, V83, P424, DOI 10.1016/S0022-3913(00)70037-0; Att W, 2009, J ORAL MAXIL SURG, V67, P60, DOI 10.1016/j.joms.2009.07.007; Zitzmann NU, 2000, J PROSTHET DENT, V83, P434, DOI 10.1016/S0022-3913(00)70038-2; Tolstunov L, 2009, J ORAL MAXIL SURG, V67, P178, DOI 10.1016/j.joms.2008.09.013; Brito C, 2014, J BIOMED MATER RES B, V102, P643, DOI 10.1002/jbm.b.33042; Cibirka RM, 1997, J PROSTHET DENT, V78, P574, DOI 10.1016/S0022-3913(97)70008-8; Rossetti PHO, 2010, J PROSTHODONT, V19, P449, DOI 10.1111/j.1532-849X.2010.00615.x; KELLY E, 1972, J PROSTHET DENT, V27, P140, DOI 10.1016/0022-3913(72)90190-4; Lambert FE, 2009, J PERIODONTOL, V80, P1220, DOI 10.1902/jop.2009.090109; Drago C, 2011, J PROSTHODONT, V20, P336, DOI 10.1111/j.1532-849X.2011.00717.x; Carlsson G E, 1967, Odontol Tidskr, V75, P193; Jivraj S, 2006, Br Dent J, V201, P261, DOI 10.1038/sj.bdj.4813952; Shanaman R H, 1992, Int J Periodontics Restorative Dent, V12, P256; Speroni Stefano, 2010, Indian J Dent Res, V21, P474, DOI 10.4103/0970-9290.74208; Tolstunov Len, 2007, J Oral Implantol, V33, P139, DOI 10.1563/1548-1336(2007)33[139:CSCACR]2.0.CO;2; Watzek G, 1995, Int J Oral Maxillofac Implants, V10, P561; Werbitt M J, 1992, Int J Periodontics Restorative Dent, V12, P206	21	0	0	ALLEN PRESS INC	LAWRENCE	810 E 10TH ST, LAWRENCE, KS 66044 USA	0160-6972	1548-1336		J ORAL IMPLANTOL	J. Oral Implant.	DEC	2015	41	6					731	736		10.1563/AAID-JOI-D-13-00123		6	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CY9JN	WOS:000366723300027		
J	Sumida, T; Nakano, H; Hamakawa, H; Mori, Y				Sumida, Tomoki; Nakano, Hiroyuki; Hamakawa, Hiroyuki; Mori, Yoshihide			Dental Implants in Oral Rehabilitation of A Maxillary Cancer Reconstruction: A Case Report	JOURNAL OF ORAL IMPLANTOLOGY			English	Article									[Sumida, Tomoki; Nakano, Hiroyuki; Mori, Yoshihide] Kyushu Univ, Sch Dent, Dept Maxillofacial Diagnost & Surg Sci, Div Oral & Maxillofacial Surg, Fukuoka 812, Japan; [Sumida, Tomoki; Hamakawa, Hiroyuki] Ehime Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Matsuyama, Ehime 790, Japan	Sumida, T (reprint author), Kyushu Univ, Sch Dent, Dept Maxillofacial Diagnost & Surg Sci, Div Oral & Maxillofacial Surg, Fukuoka 812, Japan.	tomoki@dent.kyushu-u.ac.jp			Amada Foundation	This work was supported by a Grant for Scientific Research from the Amada Foundation, awarded to T. Sumida.	Anne-Gaelle B, 2011, ORAL ONCOL, V47, P1099, DOI 10.1016/j.oraloncology.2011.07.016; Bianchi B, 2010, J ORAL MAXIL SURG, V68, P2706, DOI 10.1016/j.joms.2010.01.008; Korfage A, 2011, HEAD NECK-J SCI SPEC, V33, P831, DOI 10.1002/hed.21544; Deng H, 2011, AUST DENT J, V56, P244, DOI 10.1111/j.1834-7819.2011.01349.x; Bidra AS, 2013, J ORAL IMPLANTOL, V39, P91, DOI 10.1563/AAID-JOI-D-10-00181; BAKER SR, 1984, HEAD NECK SURG, V6, P828, DOI 10.1002/hed.2890060405; Bodard A-G, 2011, Rev Stomatol Chir Maxillofac, V112, pe1, DOI 10.1016/j.stomax.2011.01.008; D'Agostino Antonio, 2013, J Craniofac Surg, V24, pe159, DOI 10.1097/SCS.0b013e31827c836e; Lin PY, 2011, ISRN SURG, V2011	9	0	0	ALLEN PRESS INC	LAWRENCE	810 E 10TH ST, LAWRENCE, KS 66044 USA	0160-6972	1548-1336		J ORAL IMPLANTOL	J. Oral Implant.	DEC	2015	41	6					737	739		10.1563/AAID-JOI-D-13-00136		3	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CY9JN	WOS:000366723300028		
J	Shimada, K; Kai, M				Shimada, K.; Kai, M.			Calculating disability-adjusted life years (DALY) as a measure of excess cancer risk following radiation exposure	JOURNAL OF RADIOLOGICAL PROTECTION			English	Article						DALY; radiation risk; cancer; Japan; ICRP; detriment	MORTALITY	This paper has proposed that disability-adjusted life year (DALY) can be used as a measure of radiation health risk. DALY is calculated as the sum of years of life lost (YLL) and years lived with disability (YLD). This multidimensional concept can be expressed as a risk index without a probability measure to avoid the misuse of the current radiation detriment at low doses. In this study, we calculated YLL and YLD using Japanese population data by gender. DALY for all cancers in Japan per 1 Gy per person was 0.84 year in men and 1.34 year in women. The DALY for all cancers in the Japanese baseline was 4.8 in men and 3.5 in women. When we calculated the ICRP detriment from the same data, DALYs for the cancer sites were similar to the radiation detriment in the cancer sites, excluding leukemia, breast and thyroid cancer. These results suggested that the ICRP detriment overestimate the weighting fraction of leukemia risk and underestimate the weighting fraction of breast and thyroid cancer. A big advantage over the ICRP detriment is that DALY can calculate the risk components for non-fatal diseases without the data of lethality. This study showed that DALY is a practical tool that can compare many types of diseases encountered in public health.	[Shimada, K.] Japan Atom Energy Agcy, Tokai, Ibaraki 3191195, Japan; [Kai, M.] Oita Univ Nursing & Hlth Sci, Oita City, Oita Prefecture 8701201, Japan	Shimada, K (reprint author), Japan Atom Energy Agcy, 2-4 Shirakata Shirane, Tokai, Ibaraki 3191195, Japan.	shimada.kazumasa@jaea.go.jp					Gonzalez AJ, 2013, J RADIOL PROT, V33, P497, DOI 10.1088/0952-4746/33/3/497; THOMAS D, 1992, HEALTH PHYS, V63, P259, DOI 10.1097/00004032-199209000-00001; Preston DL, 2004, RADIAT RES, V162, P377, DOI 10.1667/RR3232; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Logue JM, 2012, ENVIRON HEALTH PERSP, V120, P216, DOI 10.1289/ehp.1104035; Murray CJL, 2012, LANCET, V380, P2055, DOI 10.1016/S0140-6736(12)62134-5; EPA, 2011, EPA RAD CANC RISK MO; International Commission on Radiation Protection (ICRP), 2007, ANN ICRP, V37, P2, DOI DOI 10.1016/J.ICRP.2007.10.003; International Commission on Radiological Protection (ICRP), 1991, ANN ICRP, V21, P1, DOI 10.1016/0146-6453(91)90009-6; Matsuda A, 2013, JPN J CLIN ONCOL, V44, P388; Ministry of Health Labor and Welfare, 2013, VIT STAT JAP 2010; Murray CJ, 1996, GLOBAL BURDEN DIS CO; NCC, 2013, MON CANC INC JAP SUR; PRESTON DL, 1994, RADIAT RES, V137, pS68, DOI 10.2307/3578893; WHO, 2003, INTR METH ASS ENV BU; WHO, 2004, GLOB BURD DIS 2004 U	16	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0952-4746	1361-6498		J RADIOL PROT	J. Radiol. Prot.	DEC	2015	35	4					763	775		10.1088/0952-4746/35/4/763		13	Environmental Sciences; Public, Environmental & Occupational Health; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	Environmental Sciences & Ecology; Public, Environmental & Occupational Health; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	CY4OU	WOS:000366388500005		
J	Shahien, M; Yamada, M; Fukumoto, M; Egota, K; Okamoto, K				Shahien, Mohammed; Yamada, Motohiro; Fukumoto, Masahiro; Egota, Kazumi; Okamoto, Kenji			Reactive Plasma-Sprayed Aluminum Nitride-Based Coating Thermal Conductivity	JOURNAL OF THERMAL SPRAY TECHNOLOGY			English	Article						alumnum nitride; arc current; N-2 plasma gas; reactive plasma spray; thermal conductivity	AL2O3 POWDER; ALN COATINGS; DIFFUSIVITY; FABRICATION; ZIRCONIA; SIZE	Recently, thick aluminum nitride/alumina (AlN/Al2O3) composite coatings were successfully fabricated through the reactive plasma spraying of fine Al2O3/AlN mixture in the N-2/H-2 atmospheric plasma. The coatings consist of AlN, Al5O6N, gamma-Al2O3, and alpha-Al2O3 phases. This study will evaluate the thermal conductivity of these complicated plasma-sprayed coatings and optimize the controlling aspects. Furthermore, the influence of the process parameters on the coatings thermal conductivity will be investigated. The fabricated coatings showed very low thermal conductivity (2.43 W/m K) compared to the AlN sintered compacts. It is attributed to the phase composition of the fabricated coatings, oxide content, and porosity. The presence of Al2O3, Al5O6N and the high coating porosity decreased its thermal conductivity. The presence of oxygen in the AlN lattice creates Al vacancies which lead to phonon scattering and therefore suppressed the thermal conductivity. The formation of gamma-Al2O3 phase in the coating leads to further decrease in its conductivity, due to its lower density compared to the alpha-phase. Moreover, the high porosity of the coating strongly suppressed the conductivity. This is due to the complicated microstructure of plasma spray coatings (splats, porosity, and interfaces, particularly in case of reactive spray process), which obviously lowered the conductivity. Furthermore, the measured coating density was lower than the AlN value and suppressed the coating conductivity. In addition, the spraying parameter showed a varied effect on the coating phase composition, porosity, density, and therefore on its conductivity. Although the N-2 gas flow improved the nitride content, it suppressed the thermal conductivity gradually. It is attributed to the further increase in the porosity and further decrease in the density of the coatings with the N-2 gas. Furthermore, increasing the arc did not show a significant change on the coating thermal conductivity. On the other hand, the influence of spray parameters was optimized by investigating the effect of simple heat treatment (at 1100 A degrees C) as a function of the arc current and N-2 gas flow. The heat treatment improved the coating thermal conductivity at the different spray parameters. Thus, after heat treatment, the coating porosity, gamma-Al2O3, Al5O6N strongly decreased and therefore the conductivity improved. On the other hand, the N-2 gas flow and/or arc current did not show any difference on the conductivity after heat treatment. Therefore, using higher N-2 gas flow and higher arc current is economically useless. Finally, although the obtained conductivity of the coating was not so high (compared to the AlN value), the main factors that govern the conductivity of such complicated plasma-spraying composite coating was realized. Herein, in order to fabricate high thermal conductivity AlN plasma spray coating, adjusting the phase composition, oxide content, porosity, and microstructure (at low N-2 gas flow rate and low arc current) through the post-heat treatment is the key factor.	[Shahien, Mohammed; Yamada, Motohiro; Fukumoto, Masahiro] Toyohashi Univ Technol, Toyohashi, Aichi 4418580, Japan; [Shahien, Mohammed] Cent Met R&D Inst CMRDI, Adv Mat Dept, Cairo, Egypt; [Egota, Kazumi; Okamoto, Kenji] Fuji Elect Co Ltd, Hino, Tokyo, Japan	Shahien, M (reprint author), Toyohashi Univ Technol, 1-1 Tempaku Cho, Toyohashi, Aichi 4418580, Japan.	mo.shahien@yahoo.com			Japan Society for the Promotion of Science (JSPS) [232575]	This research was supported by the Grants-in-Aid for JSPS Fellows (232575) of Japan Society for the Promotion of Science (JSPS).	PARKER WJ, 1961, J APPL PHYS, V32, P1679, DOI 10.1063/1.1728417; Raghavan S, 1998, SCRIPTA MATER, V39, P1119, DOI 10.1016/S1359-6462(98)00290-5; Ravichandran KS, 1999, J AM CERAM SOC, V82, P673; MELETIS EI, 1991, J VAC SCI TECHNOL A, V9, P2279, DOI 10.1116/1.577309; AULT NN, 1957, J AM CERAM SOC, V40, P69, DOI 10.1111/j.1151-2916.1957.tb12578.x; Fauchais P, 2001, J THERM SPRAY TECHN, V10, P44, DOI 10.1361/105996301770349510; HURLEY GF, 1979, AM CERAM SOC BULL, V58, P509; [Anonymous], 2006, R1672 JIS; SLACK GA, 1973, J PHYS CHEM SOLIDS, V34, P321, DOI 10.1016/0022-3697(73)90092-9; Shahien M, 2013, MATER TRANS, V54, P207, DOI 10.2320/matertrans.T-M2012831; SUNDGREN JE, 1985, THIN SOLID FILMS, V128, P21, DOI 10.1016/0040-6090(85)90333-5; Shahien M, 2013, J THERM SPRAY TECHN, V22, P1283, DOI 10.1007/s11666-013-9992-x; Damani RJ, 2000, J EUR CERAM SOC, V20, P867, DOI 10.1016/S0955-2219(99)00217-4; Shahien M, 2010, J THERM SPRAY TECHN, V19, P635, DOI 10.1007/s11666-010-9469-0; VIRKAR AV, 1989, J AM CERAM SOC, V72, P2031, DOI 10.1111/j.1151-2916.1989.tb06027.x; SELVADURAY G, 1993, MATER SCI TECH SER, V9, P463; ONEILL MJ, 1966, ANAL CHEM, V38, P1331, DOI 10.1021/ac60242a011; Shahien M, 2011, KEY ENG MATER, V484, P166, DOI 10.4028/www.scientific.net/KEM.484.166; Shahien M, 2010, MATER TRANS, V51, P957, DOI 10.2320/matertrans.T-M2010804; [Anonymous], 2005, 18755 ISO; Shahien M, 2013, SURF COAT TECH, V216, P308, DOI 10.1016/j.surfcoat.2012.11.062; [Anonymous], 2010, R1611 JIS; Shahien M, 2011, J THERM SPRAY TECHN, V20, P205, DOI 10.1007/s11666-010-9584-y; Shahien M, 2011, J THERM SPRAY TECHN, V20, P580, DOI 10.1007/s11666-010-9582-0; [Anonymous], 1987, K7123 JIS; BOIRELAVIGNE S, 1995, J THERM SPRAY TECHN, V4, P261, DOI 10.1007/BF02646969; Boey F. Y. C., 1999, Journal of Materials Processing Technology, V89-90, DOI 10.1016/S0924-0136(99)00134-X; Cao L. H., 1999, Journal of Materials Processing Technology, V89-90, DOI 10.1016/S0924-0136(99)00063-1; Kingery W.D., 1976, INTRO CERAMICS, P583; Pierson H.O., 1996, HDB REFRACTORY CARBI, P237; Schiefler Filho M. F. O., 2004, J. Braz. Soc. Mech. Sci. & Eng., V26, P98, DOI 10.1590/S1678-58782004000100016; Shahien Mohammed, 2011, Coatings, V1, DOI 10.3390/coatings1020088; Shahien M., 2010, IND APPL PLASMA PROC, V3, P1; Slack G. A., 1987, PHYS CHEM SOLIDS, V48, P641; Wemer A.W., 1997, CARBIDE NITRIDE BORI, P6	35	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1059-9630	1544-1016		J THERM SPRAY TECHN	J. Therm. Spray Technol.	DEC	2015	24	8					1385	1398		10.1007/s11666-015-0314-3		14	Materials Science, Coatings & Films	Materials Science	CY4HS	WOS:000366369800009		
J	Adachi, S; Ueda, N				Adachi, Shinichiro; Ueda, Nobuhiro			Formation of Expanded Austenite on a Cold-Sprayed AISI 316L Coating by Low-Temperature Plasma Nitriding	JOURNAL OF THERMAL SPRAY TECHNOLOGY			English	Article						cold spray; corrosion resistance; laser remelting; plasma nitriding; wear resistance	STAINLESS-STEEL; LAYERS; DIFFRACTION	Low-temperature plasma nitriding at temperatures below 450 A degrees C is commonly applied to austenitic stainless steels to enhance wear resistance, while maintaining corrosion resistance, by forming expanded austenite (known as the S-phase). In this work, low-temperature plasma nitriding of cold-sprayed AISI 316L coatings was examined. A cold-spray technique was developed to produce metal coatings with less oxidation. However, the cold-sprayed AISI 316L coating obtained by use of nitrogen gas as propellant contained many interconnected pores and cracks, and was, consequently, unsuitable as an anticorrosive coating. Therefore, laser post-treatment was used to modify the coating and increase its density to similar to that of bulk steel. The anticorrosive performance of this coating on a carbon steel substrate in NaCl solution was substantially improved. Subsequent low-temperature plasma nitriding enhanced the wear resistance by two orders of magnitude. It is concluded that cold-sprayed AISI 316L coatings treated by laser post-treatment and subsequent low-temperature plasma nitriding could be used as protective coatings under severe wear and corrosion conditions.	[Adachi, Shinichiro; Ueda, Nobuhiro] Technol Res Inst Osaka Prefecture, Izumi 5941157, Japan	Adachi, S (reprint author), Technol Res Inst Osaka Prefecture, 2-7-1 Ayumino, Izumi 5941157, Japan.	shinadachi@tri-osaka.jp			KAKENHI [25420747]	This work was supported financially by KAKENHI (25420747).	MENTHE E, 1995, SURF COAT TECH, V74-5, P412, DOI 10.1016/0257-8972(95)08246-8; Chemkhi M, 2013, SURF COAT TECH, V221, P191, DOI 10.1016/j.surfcoat.2013.01.047; Zeng Z, 2006, J THERM SPRAY TECHN, V15, P431, DOI 10.1361/105996306X124446; Mingolo N, 2006, SURF COAT TECH, V201, P4215, DOI 10.1016/j.surfcoat.2006.08.060; Larisch B, 1999, SURF COAT TECH, V116, P205, DOI 10.1016/S0257-8972(99)00084-5; Poza P, 2014, SURF COAT TECH, V243, P51, DOI 10.1016/j.surfcoat.2012.03.018; He H, 2003, SURF COAT TECH, V163, P331, DOI 10.1016/S0257-8972(02)00611-4; Moller W, 2001, SURF COAT TECH, V136, P73, DOI 10.1016/S0257-8972(00)01015-X; Sun Y, 1999, J MATER SCI, V34, P4793, DOI 10.1023/A:1004647423860; Adachi S, 2012, THIN SOLID FILMS, V523, P11, DOI 10.1016/j.tsf.2012.05.062; Hamdy AS, 2011, MATER CHEM PHYS, V126, P507, DOI 10.1016/j.matchemphys.2011.01.037; Riviere JP, 2002, SURF COAT TECH, V158, P99, DOI 10.1016/S0257-8972(02)00227-X; Schmidt T, 2006, J THERM SPRAY TECHN, V15, P488, DOI 10.1361/105996306X147144; Gontijo LC, 2006, MAT SCI ENG A-STRUCT, V431, P315, DOI 10.1016/j.msea.2006.06.023; Bielawski J, 2006, SURF COAT TECH, V200, P6572, DOI 10.1016/j.surfcoat.2005.11.037; Sova A, 2013, SURF COAT TECH, V235, P283, DOI 10.1016/j.surfcoat.2013.07.052; Adachi S, 2014, SURF COAT TECH, V259, P44, DOI 10.1016/j.surfcoat.2014.07.010; Spencer K, 2011, SURF COAT TECH, V205, P5135, DOI 10.1016/j.surfcoat.2011.05.020; Stinville JC, 2010, SURF COAT TECH, V204, P1947, DOI 10.1016/j.surfcoat.2009.09.052; Adachi S, 2013, ADV POWDER TECHNOL, V24, P818, DOI 10.1016/j.apt.2012.12.011; Koster K, 2013, SURF COAT TECH, V228, pS615, DOI 10.1016/j.surfcoat.2011.10.059; Baranowska J, 2004, SURF COAT TECH, V180, P145, DOI 10.1016/j.surfcoat.2003.10.056; Ichii K., 1986, Technology Reports of Kansai University; Liang W., 2000, Surface and Coatings Technology, V130, DOI 10.1016/S0257-8972(00)00713-1; SAKER A, 1991, MAT SCI ENG A-STRUCT, V140, P702, DOI 10.1016/0921-5093(91)90500-M; Sun Y., 1999, HEAT TREAT MET, V1, P9; Zhang Z. L., 1985, SURF ENG, V1, P131	27	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1059-9630	1544-1016		J THERM SPRAY TECHN	J. Therm. Spray Technol.	DEC	2015	24	8					1399	1407		10.1007/s11666-015-0278-3		9	Materials Science, Coatings & Films	Materials Science	CY4HS	WOS:000366369800010		
J	Ando, Y; Noda, Y; Adachi, S				Ando, Yasutaka; Noda, Yoshimasa; Adachi, Shin-ichiro			Rapid Diamond Deposition on Ni and Co Coatings by Using Twin Acetylene/Oxygen Gas Welding Torches	JOURNAL OF THERMAL SPRAY TECHNOLOGY			English	Article						APS cobalt coating; APS nickel coating; combustion flame method; CVD; diamond deposition	COMBUSTION-FLAME; CERMET COATINGS; WEAR-RESISTANCE; SUBSTRATE; NICKEL; AREA	Cermet coatings have been widely used because of their high hardness and excellent wear resistance even under high-temperature conditions. However, since cermet coatings include expensive materials such as WC, TiC, TiN and so on, low-cost hard particles as a dispersing agent need to be developed. In this study, in order to develop a low-cost diamond dispersion system for the creation of diamond/thermal sprayed metal hybrid coatings, diamond deposition on thermal sprayed Ni and Co coatings and Mo and Ni metal substrates by the combustion flame method using twin acetylene/oxygen gas welding torches was carried out. Consequently, even in cases of thermal sprayed Ni and Co coatings, diamond particles could be deposited within only 5 min. From these results, this technique is proved to have a high potential for rapid diamond deposition in order to create diamond/thermal sprayed metal hybrid coatings.	[Ando, Yasutaka] Ashikaga Inst Technol, Dept Mech Engn, Fac Engn, Ashikaga, Tochigi 3268558, Japan; [Noda, Yoshimasa] Ashikaga Inst Technol, Collaborat Res Ctr, Ashikaga, Tochigi 3268558, Japan; [Adachi, Shin-ichiro] Tech Res Inst Osaka Prefecture, Met Finishing & Anal Sect, Osaka, Osaka 5941157, Japan	Ando, Y (reprint author), Ashikaga Inst Technol, Dept Mech Engn, Fac Engn, 268-1 Omae, Ashikaga, Tochigi 3268558, Japan.	yando@ashitech.ac.jp					HAUBNER R, 1993, DIAM RELAT MATER, V2, P1505, DOI 10.1016/0925-9635(93)90021-S; Shi MG, 2005, MATER TRANS, V46, P84, DOI 10.2320/matertrans.46.84; Mohanty M, 1995, J THERM SPRAY TECHN, V4, P384, DOI 10.1007/BF02648640; Legoux JG, 2002, J THERM SPRAY TECHN, V11, P86, DOI 10.1361/105996302770349014; Stoica V, 2004, J THERM SPRAY TECHN, V13, P93, DOI 10.1361/10599630418077; MURAKAWA M, 1990, SURF COAT TECH, V43-4, P22, DOI 10.1016/0257-8972(90)90056-I; MURAKAWA M, 1989, SURF COAT TECH, V39, P235, DOI 10.1016/0257-8972(89)90057-1; Ando Y, 2004, THIN SOLID FILMS, V457, P217, DOI 10.1016/j.tsf.2003.12.042; Ando Y, 2009, J THERM SPRAY TECHN, V18, P483, DOI 10.1007/s11666-009-9400-8; Richardson AF, 2003, WEAR, V255, P593, DOI 10.1016/S0043-1648(03)00049-8; Ishikawa Y, 2005, J THERM SPRAY TECHN, V14, P384, DOI 10.1361/105996305X59378; Sitar Z, 1998, DIAM RELAT MATER, V7, P276, DOI 10.1016/S0925-9635(97)00244-6; [Anonymous], 1992, J THERM SPRAY TECHN, DOI 10.1007/BF02659010; Gawne DT, 2001, J THERM SPRAY TECHN, V10, P599, DOI 10.1361/105996301770349114; Lanzutti A., 2013, TRIBOL IND, V35, P113; Matsumoto S., 1982, JPN J APPL PHYS, V21, P183; Takahashi M., 2007, J SOLID MECH MAT ENG, V1, P223, DOI 10.1299/jmmp.1.223	17	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1059-9630	1544-1016		J THERM SPRAY TECHN	J. Therm. Spray Technol.	DEC	2015	24	8					1408	1414		10.1007/s11666-015-0323-2		7	Materials Science, Coatings & Films	Materials Science	CY4HS	WOS:000366369800011		
J	Molak, RM; Araki, H; Watanabe, M; Katanoda, H; Ohno, N; Kuroda, S				Molak, R. M.; Araki, H.; Watanabe, M.; Katanoda, H.; Ohno, N.; Kuroda, S.			Effects of Spray Parameters and Heat Treatment on the Microstructure and Mechanical Properties of Titanium Coatings Formed by Warm Spraying	JOURNAL OF THERMAL SPRAY TECHNOLOGY			English	Article						mechanical properties; microstructure; miniature specimen; porosity; warm spraying	GAS-DYNAMIC SPRAY; COLD-SPRAY; TI-6AL-4V; TI; TECHNOLOGY; DEPOSITS; ELIMINATION; TEMPERATURE; OXIDATION; VELOCITY	The microstructure and mechanical properties of Ti coatings deposited by warm spraying were investigated with the aim to find a set of optimum parameters for the spray process as well as for the subsequent heat treatment. Titanium powder was deposited with different nitrogen flow rates in a range from 0.5 to 1.5 m(3)/min. It was shown that spray parameters, which affect the temperature and velocity of in-flight particles, have significant influence on the fabricated coatings properties. Especially the increase of the warm spraying combustion pressure from 1 to 4 MPa resulted in an increase in the particle velocity to above 1100 m/s. This modification significantly increased the density and was beneficial for controlling the oxygen level in Ti coatings. Miniature tensile specimens with a total length of 9 mm were used to perform tensile tests for the Ti deposits. The optimal mechanical properties were achieved for specimens formed at a middle range of nitrogen flow rate (0.75 m(3)/min). Subsequently, several heat treatments were performed in order to enhance the mechanical properties of the as-sprayed coatings. It was found that the post-spray heat treatment significantly enhanced the strength and elongation of the Ti deposits determined by miniature specimen tensile test.	[Molak, R. M.; Araki, H.; Watanabe, M.; Kuroda, S.] Natl Inst Mat Sci, Tsukuba, Ibaraki, Japan; [Katanoda, H.] Kagoshima Univ, Kagoshima 890, Japan; [Ohno, N.] Plasma Giken Co Ltd, Toda, Saitama, Japan	Molak, RM (reprint author), Natl Inst Mat Sci, Tsukuba, Ibaraki, Japan.	Rafal.Molak@inmat.pw.edu.pl					Jahedi M, 2009, MATER SCI FORUM, V618-619, P505; Sundararajan G, 2013, J THERM SPRAY TECHN, V22, P1348, DOI 10.1007/s11666-013-0034-5; Li WY, 2007, ADV ENG MATER, V9, P418, DOI 10.1002/adem.200700022; Wong W, 2011, J THERM SPRAY TECHN, V20, P213, DOI 10.1007/s11666-010-9568-y; Kim K, 2009, SCRIPTA MATER, V60, P710, DOI 10.1016/j.scriptamat.2008.12.050; Vo P, 2013, J THERM SPRAY TECHN, V22, P954, DOI 10.1007/s11666-013-9945-4; Lima RS, 2002, J MATER SCI LETT, V21, P1687, DOI 10.1023/A:1020833011448; Bae G, 2009, ACTA MATER, V57, P5654, DOI 10.1016/j.actamat.2009.07.061; Kim K, 2010, SCRIPTA MATER, V63, P215, DOI 10.1016/j.scriptamat.2010.03.061; Huang R, 2012, J THERM SPRAY TECHN, V21, P541, DOI 10.1007/s11666-011-9707-0; [Anonymous], 1997, E140908 ASTM; Sova A, 2013, INT J ADV MANUF TECH, V69, P2269, DOI 10.1007/s00170-013-5166-8; Kim K, 2008, SCRIPTA MATER, V59, P768, DOI 10.1016/j.scriptamat.2008.06.020; Kuroda S, 2011, J THERM SPRAY TECHN, V20, P653, DOI 10.1007/s11666-011-9648-7; Fukumoto M, 2010, J THERM SPRAY TECHN, V19, P89, DOI 10.1007/s11666-009-9426-y; Gartner F, 2006, J THERM SPRAY TECHN, V15, P223, DOI 10.1361/105996306X108110; Lee JC, 2007, CIRP ANN-MANUF TECHN, V56, P577, DOI 10.1016/j.cirp.2007.05.138; Kim K, 2010, J THERM SPRAY TECHN, V19, P1244, DOI 10.1007/s11666-010-9532-x; Wong W, 2013, J THERM SPRAY TECHN, V22, P1140, DOI 10.1007/s11666-013-9951-6; Bae G, 2010, MAT SCI ENG A-STRUCT, V527, P6313, DOI 10.1016/j.msea.2010.06.037; Kim K, 2009, J THERM SPRAY TECHN, V18, P392, DOI 10.1007/s11666-009-9303-8; Zahiri SH, 2009, J THERM SPRAY TECHN, V18, P16, DOI 10.1007/s11666-008-9212-2; Marrocco T, 2006, J THERM SPRAY TECHN, V15, P263, DOI 10.1361/105996306X108219; Papyrin A, 2001, ADV MATER PROCESS, V159, P49; Molak RM, 2014, J THERM SPRAY TECHN, V23, P197, DOI 10.1007/s11666-013-0024-7; AL-Mangour B, 2014, J THERM SPRAY TECHN, V23, P641, DOI 10.1007/s11666-013-0053-2; Watanabe M, 2013, SURF COAT TECH, V232, P587, DOI 10.1016/j.surfcoat.2013.06.034; Kawakita J, 2008, SURF COAT TECH, V202, P4369, DOI 10.1016/j.surfcoat.2008.04.011; Wong W, 2012, MATER SCI FORUM, V706-709, P258, DOI 10.4028/www.scientific.net/MSF.706-709.258; Wong W, 2010, ADV MATER RES-SWITZ, V89-91, P639, DOI 10.4028/www.scientific.net/AMR.89-91.639; Meng XM, 2011, APPL SURF SCI, V258, P700, DOI 10.1016/j.apsusc.2011.07.107; Jazi HRS, 2007, METALL MATER TRANS A, V38A, P476, DOI 10.1007/s11661-006-9075-4; Stoltenhoff T, 2006, SURF COAT TECH, V200, P4947, DOI 10.1016/j.surfcoat.2005.05.011; Binder K, 2011, J THERM SPRAY TECHN, V20, P234, DOI 10.1007/s11666-010-9557-1; Morgan RH, 2003, MATER RES SOC SYMP P, V758, P73; [Anonymous], 2003, B26503 ASTM; Bae G, 2008, ACTA MATER, V56, P4858, DOI 10.1016/j.actamat.2008.06.003; Zahiri SH, 2009, J MATER PROCESS TECH, V209, P922, DOI 10.1016/j.jmatprotec.2008.03.005; Wong W, 2013, J THERM SPRAY TECHN, V22, P413, DOI 10.1007/s11666-012-9827-1; ASM Handbook, 1987, METALS HDB, V12; Blose R. E., 2006, Metal Powder Report, V61, DOI 10.1016/S0026-0657(06)70713-5; Champagne Victor K., 2008, Journal of Failure Analysis and Prevention, V8, DOI 10.1007/s11668-008-9116-y; Goldbaum D, 2011, MAT SCI ENG A-STRUCT, V530, P253, DOI 10.1016/j.msea.2011.09.083; Hussain T, 2011, J THERM SPRAY TECHN, V20, P260, DOI 10.1007/s11666-010-9540-x; Jacobs M.H., 1995, P 1995 INT C EXH POW; Katanoda H., 2013, P INT THERM SPRAY C; Kuroda S, 2008, SCI TECHNOL ADV MAT, V9, DOI 10.1088/1468-6996/9/3/033002; Kim K, 2012, J THERM SPRAY TECHN, V21, P550, DOI 10.1007/s11666-011-9703-4; Lugscheider E., 2005, THERMAL SPRAY CONNEC; Williams J.C., 2007, TITANIUM; Yu JS, 2013, ADV MATER RES-SWITZ, V602-604, P1604, DOI 10.4028/www.scientific.net/AMR.602-604.1604; Yua M., 2011, APPL SURF SCI, V257, P5972	52	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1059-9630	1544-1016		J THERM SPRAY TECHN	J. Therm. Spray Technol.	DEC	2015	24	8					1459	1479		10.1007/s11666-015-0343-y		21	Materials Science, Coatings & Films	Materials Science	CY4HS	WOS:000366369800016		
J	Kaneko, M; Watashi, K; Kamisuki, S; Matsunaga, H; Iwamoto, M; Kawai, F; Ohashi, H; Tsukuda, S; Shimura, S; Suzuki, R; Aizaki, H; Sugiyama, M; Park, SY; Ito, T; Ohtani, N; Sugawara, F; Tanaka, Y; Mizokami, M; Sureau, C; Wakita, T				Kaneko, Manabu; Watashi, Koichi; Kamisuki, Shinji; Matsunaga, Hiroki; Iwamoto, Masashi; Kawai, Fumihiro; Ohashi, Hirofumi; Tsukuda, Senko; Shimura, Satomi; Suzuki, Ryosuke; Aizaki, Hideki; Sugiyama, Masaya; Park, Sam-Yong; Ito, Takayoshi; Ohtani, Naoko; Sugawara, Fumio; Tanaka, Yasuhito; Mizokami, Masashi; Sureau, Camille; Wakita, Takaji			A Novel Tricyclic Polyketide, Vanitaracin A, Specifically Inhibits the Entry of Hepatitis B and D Viruses by Targeting Sodium Taurocholate Cotransporting Polypeptide	JOURNAL OF VIROLOGY			English	Article							LARGE ENVELOPE PROTEIN; C-VIRUS; NATURAL-PRODUCTS; DELTA VIRUS; MEMBRANE TRANSPORTER; SURFACE PROTEIN; CYCLOSPORINE-A; PRE-S1 DOMAIN; INFECTION; HEPATOCYTES	Anti-hepatitis B virus (HBV) drugs are currently limited to nucleos(t)ide analogs (NAs) and interferons. A challenge of drug development is the identification of small molecules that suppress HBV infection from new chemical sources. Here, from a fungus-derived secondary metabolite library, we identify a structurally novel tricyclic polyketide, named vanitaracin A, which specifically inhibits HBV infection. Vanitaracin A inhibited the viral entry process with a submicromolar 50% inhibitory concentration (IC50) (IC50 = 0.61 +/- 0.23 mu M), without evident cytotoxicity (50% cytotoxic concentration of >256 mu M; selectivity index value of >419) in primary human hepatocytes. Vanitaracin A did not affect the HBV replication process. This compound was found to directly interact with the HBV entry receptor sodium taurocholate cotransporting polypeptide (NTCP) and impaired its bile acid transport activity. Consistent with this NTCP targeting, antiviral activity of vanitaracin A was observed with hepatitis D virus (HDV) but not hepatitis C virus. Importantly, vanitaracin A inhibited infection by all HBV genotypes tested (genotypes A to D) and clinically relevant NA-resistant HBV isolate. Thus, we identified a fungal metabolite, vanitaracin A, which was a potent, well-tolerated, and broadly active inhibitor of HBV and HDV entry. This compound, or its related analogs, could be part of an antiviral strategy for preventing reinfection with HBV, including clinically relevant nucleos(t) ide analog-resistant virus. IMPORTANCE For achieving better treatment and prevention of hepatitis B virus (HBV) infection, anti-HBV agents targeting a new molecule are in great demand. Although sodium taurocholate cotransporting polypeptide (NTCP) has recently been reported to be an essential host factor for HBV entry, there is a limited number of reports that identify new compounds targeting NTCP and inhibiting HBV entry. Here, from an uncharacterized chemical library, we isolated a structurally new compound, named vanitaracin A, which inhibited the process of entry of HBV and hepatitis D virus (HDV). This compound was suggested to directly interact with NTCP and inhibit its transporter activity. Importantly, vanitaracin A inhibited the entry of all HBV genotypes examined and of a clinically relevant nucleos(t) ide analog-resistant HBV isolate.	[Kaneko, Manabu; Watashi, Koichi; Iwamoto, Masashi; Ohashi, Hirofumi; Tsukuda, Senko; Shimura, Satomi; Suzuki, Ryosuke; Aizaki, Hideki; Wakita, Takaji] Natl Inst Infect Dis, Dept Virol 2, Tokyo, Japan; [Kaneko, Manabu; Watashi, Koichi; Kamisuki, Shinji; Matsunaga, Hiroki; Iwamoto, Masashi; Ohashi, Hirofumi; Ohtani, Naoko; Sugawara, Fumio] Tokyo Univ Sci, Dept Appl Biol Sci, Noda, Chiba 278, Japan; [Kawai, Fumihiro; Park, Sam-Yong] Yokohama City Univ, Prot Design Lab, Yokohama, Kanagawa 232, Japan; [Tsukuda, Senko] RIKEN Ctr Life Sci Technol, Microsignaling Regulat Technol Unit, Wako, Saitama, Japan; [Shimura, Satomi] Scynexis Inc, Durham, NC USA; [Sugiyama, Masaya; Mizokami, Masashi] Natl Ctr Global Hlth & Med, Res Ctr Hepatitis & Immunol, Ichikawa, Japan; [Ito, Takayoshi] Showa Univ, Koto Toyosu Hosp, Ctr Digest Dis, Tokyo, Japan; [Tanaka, Yasuhito] Nagoya City Univ, Grad Sch Med Sci, Dept Virol, Nagoya, Aichi, Japan; [Tanaka, Yasuhito] Nagoya City Univ, Grad Sch Med Sci, Liver Unit, Nagoya, Aichi, Japan; [Sureau, Camille] Inst Natl Transfus Sanguine, Lab Virol Mol, F-75015 Paris, France	Wakita, T (reprint author), Natl Inst Infect Dis, Dept Virol 2, Tokyo, Japan.	kwatashi@nih.go.jp			Ministry of Health, Labor, and Welfare, Japan; Ministry of Education, Culture, Sports, Science, and Technology, Japan; Japan Society for the Promotion of Science KAKENHI [26460565, 26102747]; Research Program on Hepatitis from the Japan Agency for Medical Research and Development, AMED	This study was partly supported by grants-in-aid from the Ministry of Health, Labor, and Welfare, Japan; the Ministry of Education, Culture, Sports, Science, and Technology, Japan; Japan Society for the Promotion of Science KAKENHI grants 26460565 and 26102747; and the Research Program on Hepatitis from the Japan Agency for Medical Research and Development, AMED.	Myobatake Y, 2014, J NAT PROD, V77, P1236, DOI 10.1021/np401017g; Watashi K, 2014, HEPATOLOGY, V59, P1726, DOI 10.1002/hep.26982; Tenney DJ, 2004, ANTIMICROB AGENTS CH, V48, P3498, DOI 10.1128/AAC.48.9.3498-3507.2004; Nakajima S, 2013, BIOCHEM BIOPH RES CO, V440, P515, DOI 10.1016/j.bbrc.2013.09.100; KUO MYP, 1989, J VIROL, V63, P1945; Schulze A, 2007, HEPATOLOGY, V46, P1759, DOI 10.1002/hep.21896; Stieger B, 2011, HANDB EXP PHARMACOL, V201, P205, DOI 10.1007/978-3-642-14541-4_5; Taylor JM, 2013, WORLD J GASTROENTERO, V19, P6730, DOI 10.3748/wjg.v19.i40.6730; Matsunaga H, 2015, BIOORG MED CHEM LETT, V25, P4325, DOI 10.1016/j.bmcl.2015.07.067; Petersen J, 2008, NAT BIOTECHNOL, V26, P335, DOI 10.1038/nbt1389; Ciancio A, 2014, NAT REV GASTRO HEPAT, V11, P68, DOI 10.1038/nrgastro.2013.164; Nkongolo S, 2014, J HEPATOL, V60, P723, DOI 10.1016/j.jhep.2013.11.022; Wang XJ, 2015, ANTIVIR RES, V120, P140, DOI 10.1016/j.antiviral.2015.06.007; Calland N, 2012, VIRUSES-BASEL, V4, P2197, DOI 10.3390/v4102197; Klaassen CD, 2010, PHARMACOL REV, V62, P1, DOI 10.1124/pr.109.002014; Iwamoto M, 2014, BIOCHEM BIOPH RES CO, V443, P808, DOI 10.1016/j.bbrc.2013.12.052; Sun FD, 2014, CURR DRUG TARGETS, V15, P175; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102; Leistner CM, 2008, CELL MICROBIOL, V10, P122, DOI 10.1111/j.1462-5822.2007.01023.x; Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756; Cragg GM, 2013, BBA-GEN SUBJECTS, V1830, P3670, DOI 10.1016/j.bbagen.2013.02.008; Belloni L, 2012, J CLIN INVEST, V122, P529, DOI 10.1172/JCI58847; Lindenbach BD, 2013, NAT REV MICROBIOL, V11, P688, DOI 10.1038/nrmicro3098; Tscherne DM, 2006, J VIROL, V80, P1734, DOI 10.1128/JVI.80.4.1734-1741.2006; Zeisel MB, 2015, GUT, V64, P1314, DOI 10.1136/gutjnl-2014-308943; Levrero M, 2009, J HEPATOL, V51, P581, DOI 10.1016/j.jhep.2009.05.022; Ott JJ, 2012, VACCINE, V30, P2212, DOI 10.1016/j.vaccine.2011.12.116; SUREAU C, 1994, J VIROL, V68, P4063; Son M, 2013, J MICROBIOL, V51, P545, DOI 10.1007/s12275-013-3450-9; Taylor JM, 2012, SEMIN LIVER DIS, V32, P195, DOI 10.1055/s-0032-1323623; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Lucifora J, 2013, ANTIVIR RES, V97, P195, DOI 10.1016/j.antiviral.2012.12.008; Barrera A, 2005, J VIROL, V79, P9786, DOI 10.1128/JVI.79.15.9786-9798.2005; Fofana I, 2014, ANTIVIR RES, V104, P136, DOI 10.1016/j.antiviral.2014.02.001; Ogura N, 2014, BIOCHEM BIOPH RES CO, V452, P315, DOI 10.1016/j.bbrc.2014.08.029; Pawlotsky JM, 2008, GASTROENTEROLOGY, V134, P405, DOI 10.1053/j.gastro.2007.11.036; Gudima S, 2007, J VIROL, V81, P4343, DOI 10.1128/JVI.02478-06; Urban S, 2014, GASTROENTEROLOGY, V147, P48, DOI 10.1053/j.gastro.2014.04.030; Wedemeyer H, 2010, NAT REV GASTRO HEPAT, V7, P31, DOI 10.1038/nrgastro.2009.205; Blanchet M, 2014, ANTIVIR RES, V106, P111, DOI 10.1016/j.antiviral.2014.03.017; Gripon P, 2005, J VIROL, V79, P1613, DOI 10.1128/JVI.79.3.1616-1622.2005; Jiang Y, 2010, MINI-REV MED CHEM, V10, P1331, DOI 10.2174/138955710793564133; Glebe D, 2005, GASTROENTEROLOGY, V129, P234, DOI 10.1053/j.gastro.2005.03.090; Le Seyec J, 1999, J VIROL, V73, P2052; Zhou XF, 2013, CURR MED CHEM, V20, P953; Baumert TF, 2014, CURR OPIN VIROL, V4, P58, DOI 10.1016/j.coviro.2013.12.002; Anwer MS, 2014, PFLUG ARCH EUR J PHY, V466, P77, DOI 10.1007/s00424-013-1367-0; Huang HC, 2014, ANTIVIR RES, V111, P100, DOI [10.1016/j.antiviral.2014.09.009, 10.1016/j.antivira1.2014.09.009]; Ko C, ANTIVIR THER; Ni Y, 2014, GASTROENTEROLOGY, V146, P1070, DOI 10.1053/j.gastro.2013.12.024; Tong SP, 2014, GASTROENTEROLOGY, V146, P902, DOI 10.1053/j.gastro.2014.02.024; Tsukuda S, 2015, J BIOL CHEM, V290, P5673, DOI 10.1074/jbc.M114.602540; Watashi Koichi, 2013, J Biol Chem, V288, P31715, DOI 10.1074/jbc.M113.501122; Yan H, 2012, ELIFE, V1, DOI 10.7554/eLife.00049	54	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0022-538X	1098-5514		J VIROL	J. Virol.	DEC	2015	89	23					11945	11953		10.1128/JVI.01855-15		9	Virology	Virology	CZ1WM	WOS:000366896600018		
J	Rujas, E; Gulzar, N; Morante, K; Tsumoto, K; Scott, JK; Nieva, JL; Caaveiro, JMM				Rujas, Edurne; Gulzar, Naveed; Morante, Koldo; Tsumoto, Kouhei; Scott, Jamie K.; Nieva, Jose L.; Caaveiro, Jose M. M.			Structural and Thermodynamic Basis of Epitope Binding by Neutralizing and Nonneutralizing Forms of the Anti-HIV-1 Antibody 4E10	JOURNAL OF VIROLOGY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; PROXIMAL EXTERNAL REGION; HUMAN MONOCLONAL-ANTIBODY; X-RAY CRYSTALLOGRAPHY; HIV-1 GP41; TRANSMEMBRANE DOMAIN; VACCINE DESIGN; MEMBRANE; RECOGNITION; 2F5	The 4E10 antibody recognizes the membrane-proximal external region (MPER) of the HIV-1 Env glycoprotein gp41 transmembrane subunit, exhibiting one of the broadest neutralizing activities known to date. The neutralizing activity of 4E10 requires solvent-exposed hydrophobic residues at the apex of the complementarity-determining region (CDR) H3 loop, but the molecular basis for this requirement has not been clarified. Here, we report the cocrystal structures and the energetic parameters of binding of a peptide bearing the 4E10-epitope sequence (4E10ep) to nonneutralizing versions of the 4E10 Fab. Nonneutralizing Fabs were obtained by shortening and decreasing the hydrophobicity of the CDR-H3 loop (termed Delta Loop) or by substituting the two tryptophan residues of the CDR-H3 apex with Asp residues (termed WDWD), which also decreases hydrophobicity but preserves the length of the loop. The analysis was complemented by the first crystal structure of the 4E10 Fab in its ligand-free state. Collectively, the data ruled out major conformational changes of CDR-H3 at any stage during the binding process (equilibrium or transition state). Although these mutations did not impact the affinity of wild-type Fab for the 4E10ep in solution, the two nonneutralizing versions of 4E10 were deficient in binding to MPER inserted in the plasma membrane (mimicking the environment faced by the antibody in vivo). The conclusions of our structure-function analysis strengthen the idea that to exert effective neutralization, the hydrophobic apex of the solvent-exposed CDR-H3 loop must recognize an antigenic structure more complex than just the linear alpha-helical epitope and likely constrained by the viral membrane lipids. IMPORTANCE The broadly neutralizing anti-HIV-1 4E10 antibody blocks infection caused by nearly all viral strains and isolates examined thus far. However, 4E10 (or 4E10-like) antibodies are rarely found in HIV-1-infected individuals or elicited through vaccination. Impediments to the design of successful 4E10 immunogens are partly attributed to an incomplete understanding of the structural and binding characteristics of this class of antibodies. Since the broadly neutralizing activity of 4E10 is abrogated by mutations of the tip of the CDR-H3, we investigated their impact on binding of the MPER-epitope at the atomic and energetic levels. We conclude that the difference between neutralizing and nonneutralizing antibodies of 4E10 is neither structural nor energetic but is related to the capacity to recognize the HIV-1 gp41 epitope inserted in biological membranes. Our findings strengthen the idea that to elicit similar neutralizing antibodies, the suitable MPER vaccine must be "delivered" in a membrane environment.	[Rujas, Edurne; Morante, Koldo; Tsumoto, Kouhei; Caaveiro, Jose M. M.] Univ Tokyo, Grad Sch Engn, Dept Bioengn, Tokyo, Japan; [Rujas, Edurne; Nieva, Jose L.] Univ Basque Country UPV EHU, UPV EHU, CSIC, Biophys Unit, Bilbao, Spain; [Rujas, Edurne; Nieva, Jose L.] Univ Basque Country UPV EHU, Dept Biochem & Mol Biol, Bilbao, Spain; [Gulzar, Naveed; Scott, Jamie K.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada; [Scott, Jamie K.] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada	Caaveiro, JMM (reprint author), Univ Tokyo, Grad Sch Engn, Dept Bioengn, Tokyo, Japan.	joseluis.nieva@ehu.es; jose@bioeng.t.u-tokyo.ac.jp			National Institutes of Health [1R01AI097051-01]; Japan Society for the Promotion of Science [25249115, 15K06962]; Basque Government	We acknowledge financial support by the National Institutes of Health (1R01AI097051-01 to J.K.S. and J.L.N.). This study was also supported by a Grant-in-Aid for Scientific Research A (grant 25249115 to K.T.) and a Grant-in-Aid for Scientific Research C (grant 15K06962 to J.M.M.C.) from the Japan Society for the Promotion of Science. E.R. is a recipient of a predoctoral fellowship from the Basque Government. Access to Beam-line BL-5A was granted by the Photon Factory Advisory Committee (proposals 2014G190 and 2013G738).	Cardoso RMF, 2005, IMMUNITY, V22, P163, DOI 10.1016/j.immuni.2004.12.011; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Klein JS, 2009, P NATL ACAD SCI USA, V106, P7385, DOI 10.1073/pnas.0811427106; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Apellaniz B, 2011, BIOPHYS J, V101, P2426, DOI 10.1016/j.bpj.2011.10.005; PURTSCHER M, 1994, AIDS RES HUM RETROV, V10, P1651, DOI 10.1089/aid.1994.10.1651; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Alam SM, 2009, P NATL ACAD SCI USA, V106, P20234, DOI 10.1073/pnas.0908713106; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Miyafusa T, 2013, FEBS LETT, V587, P3824, DOI 10.1016/j.febslet.2013.10.009; Gore S, 2012, ACTA CRYSTALLOGR D, V68, P478, DOI 10.1107/S0907444911050359; Lorizate M, 2006, J BIOL CHEM, V281, P39598, DOI 10.1074/jbc.M605998200; Salzwedel K, 1999, J VIROL, V73, P2469; Huarte N, 2008, J VIROL, V82, P8986, DOI 10.1128/JVI.00846-08; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; van den Bedem H, 2013, NAT METHODS, V10, P896, DOI [10.1038/nmeth.2592, 10.1038/NMETH.2592]; MUSTER T, 1993, J VIROL, V67, P6642; Cardoso RMF, 2007, J MOL BIOL, V365, P1533, DOI 10.1016/j.jmb.2006.10.088; Fraser JS, 2009, NATURE, V462, P669, DOI 10.1038/nature08615; Montero M, 2012, J VIROL, V86, P2930, DOI 10.1128/JVI.06349-11; Kunert R, 1998, AIDS RES HUM RETROV, V14, P1115, DOI 10.1089/aid.1998.14.1115; Sakamoto S, 2009, J MOL BIOL, V389, P880, DOI 10.1016/j.jmb.2009.04.050; Burton DR, 2015, NAT IMMUNOL, V16, P571, DOI 10.1038/ni.3158; Cleland WW, 1999, METHOD ENZYMOL, V308, P3; MUSTER T, 1994, J VIROL, V68, P4031; Apellaniz B, 2015, J BIOL CHEM, V290, P12999, DOI 10.1074/jbc.M115.644351; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Zwick MB, 2005, AIDS, V19, P1725, DOI 10.1097/01.aids.0000189850.83322.41; Leaman DP, 2015, J VIROL, V89, P6725, DOI 10.1128/JVI.03738-14; Lang PT, 2010, PROTEIN SCI, V19, P1420, DOI 10.1002/pro.423; Klein F, 2013, SCIENCE, V341, P1199, DOI 10.1126/science.1241144; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Sun ZYJ, 2008, IMMUNITY, V28, P52, DOI 10.1016/j.immuni.2007.11.018; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Xu HY, 2010, J VIROL, V84, P1076, DOI 10.1128/JVI.02113-09; Sanchez-Martinez S, 2006, AIDS RES HUM RETROV, V22, P998, DOI 10.1089/aid.2006.22.998; Scherer EM, 2010, P NATL ACAD SCI USA, V107, P1529, DOI 10.1073/pnas.0909680107; Ofek G, 2010, J VIROL, V84, P2955, DOI 10.1128/JVI.02257-09; Julien JP, 2010, J VIROL, V84, P4136, DOI 10.1128/JVI.02357-09; Brunel FM, 2006, J VIROL, V80, P1680, DOI 10.1128/JVI.80.4.1680-1687.2006; Montero M, 2008, MICROBIOL MOL BIOL R, V72, P54, DOI 10.1128/MMBR.00020-07; Apellaniz B, 2014, J VIROL, V88, P13367, DOI 10.1128/JVI.02151-14; Bird GH, 2014, NAT STRUCT MOL BIOL, V21, P1058, DOI 10.1038/nsmb.2922; Finton KAK, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004403; Finton KAK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003639; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kiyoshi M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7866; Kiyoshi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087099; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127	57	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0022-538X	1098-5514		J VIROL	J. Virol.	DEC	2015	89	23					11975	11989		10.1128/JVI.01793-15		15	Virology	Virology	CZ1WM	WOS:000366896600021		
J	Katoh, H; Nakatsu, Y; Kubota, T; Sakata, M; Takeda, M; Kidokoro, M				Katoh, Hiroshi; Nakatsu, Yuichiro; Kubota, Toru; Sakata, Masafumi; Takeda, Makoto; Kidokoro, Minoru			Mumps Virus Is Released from the Apical Surface of Polarized Epithelial Cells, and the Release Is Facilitated by a Rab11-Mediated Transport System	JOURNAL OF VIROLOGY			English	Article							RESPIRATORY SYNCYTIAL VIRUS; MEASLES-VIRUS; BASOLATERAL SURFACE; PARTICLE-PRODUCTION; PANTROPIC MUTANT; SENDAI-VIRUS; PROTEIN; ENTRY; INFECTION; MEMBRANE	Mumps virus (MuV) is an airborne virus that causes a systemic infection in patients. In vivo, the epithelium is a major replication site of MuV, and thus, the mode of MuV infection of epithelial cells is a subject of interest. Our data in the present study showed that MuV entered polarized epithelial cells via both the apical and basolateral surfaces, while progeny viruses were predominantly released from the apical surface. In polarized cells, intracellular transport of viral ribonucleoprotein (vRNP) complexes was dependent on Rab11-positive endosomes, and vRNP complexes were transported to the apical membrane. Expression of a dominant negative form of Rab11 (Rab11S25N) reduced the progeny virus release in polarized cells but not in nonpolarized cells. Although in this way these effects were correlated with cell polarity, Rab11S25N did not modulate the direction of virus release from the apical surface. Therefore, our data suggested that Rab11 is not a regulator of selective apical release of MuV, although it acts as an activator of virus release from polarized epithelial cells. In addition, our data and previous studies on Sendai virus, respiratory syncytial virus, and measles virus suggested that selective apical release from epithelial cells is used by many paramyxoviruses, even though they cause either a systemic infection or a local respiratory infection. IMPORTANCE Mumps virus (MuV) is the etiological agent of mumps and causes a systemic infection. However, the precise mechanism by which MuV breaks through the epithelial barriers and achieves a systemic infection remains unclear. In the present study, we show that the entry of MuV is bipolar, while the release is predominantly from the apical surface in polarized epithelial cells. In addition, the release of progeny virus was facilitated by a Rab11-positive recycling endosome and microtubule network. Our data provide important insights into the mechanism of transmission and pathogenesis of MuV.	[Katoh, Hiroshi; Nakatsu, Yuichiro; Kubota, Toru; Sakata, Masafumi; Takeda, Makoto; Kidokoro, Minoru] Natl Inst Infect Dis, Dept Virol 3, Tokyo, Japan	Katoh, H (reprint author), Natl Inst Infect Dis, Dept Virol 3, Tokyo, Japan.	kato0704@nih.go.jp			Ministry of Health, Labour and Welfare of Japan	This work was supported in part by a grant from the Ministry of Health, Labour and Welfare of Japan to Hiroshi Katoh.	Tahara M, 2008, J VIROL, V82, P4630, DOI 10.1128/JVI.02691-07; TUCKER SP, 1993, ADV VIRUS RES, V42, P187, DOI 10.1016/S0065-3527(08)60086-X; Eisfeld AJ, 2011, J VIROL, V85, P6117, DOI 10.1128/JVI.00378-11; FLEISCHER B, 1982, INFECT IMMUN, V35, P25; Bruce EA, 2010, J VIROL, V84, P5848, DOI 10.1128/JVI.00307-10; Brock SC, 2003, P NATL ACAD SCI USA, V100, P15143, DOI 10.1073/pnas.2434327100; Hviid A, 2008, LANCET, V371, P932, DOI 10.1016/S0140-6736(08)60419-5; OWENS RJ, 1991, P NATL ACAD SCI USA, V88, P3987, DOI 10.1073/pnas.88.9.3987; Naim HY, 2000, EMBO J, V19, P3576, DOI 10.1093/emboj/19.14.3576; Excoffon KJDA, 2008, J INFECT DIS, V197, P1189, DOI 10.1086/529515; Mostov KE, 2000, CURR OPIN CELL BIOL, V12, P483, DOI 10.1016/S0955-0674(00)00120-4; FOY HM, 1971, AM J EPIDEMIOL, V94, P467; Schlie K, 2010, J VIROL, V84, P3178, DOI 10.1128/JVI.02240-09; Lamb RA, 2007, CURR OPIN STRUC BIOL, V17, P427, DOI 10.1016/j.sbi.2007.08.016; Shannon-Lowe CD, 2006, P NATL ACAD SCI USA, V103, P7065, DOI 10.1073/pnas.0510512103; Tseng CTK, 2005, J VIROL, V79, P9470, DOI 10.1128/JVI.79.15.9470-9479.2005; Yu XZ, 2007, EUR J CELL BIOL, V86, P25, DOI 10.1016/j.ejcb.2006.10.002; Stamataki Z, 2009, BLOOD, V113, P585, DOI 10.1182/blood-2008-05-158824; Kolesnikova L, 2007, J INFECT DIS, V196, pS232, DOI 10.1086/520584; Saito H, 1996, MICROBIOL IMMUNOL, V40, P271; El Najjar F, 2014, VIRUSES-BASEL, V6, P3019, DOI 10.3390/v6083019; TANABAYASHI K, 1990, VIROLOGY, V177, P124, DOI 10.1016/0042-6822(90)90466-5; Yeaman C, 1999, PHYSIOL REV, V79, P73; HENLE G, 1948, J EXP MED, V88, P223, DOI 10.1084/jem.88.2.223; Amorim MJ, 2011, J VIROL, V85, P4143, DOI 10.1128/JVI.02606-10; Goldenring JR, 1996, AM J PHYSIOL-GASTR L, V270, pG515; ROBERTS SR, 1995, J VIROL, V69, P2667; Nakatsu Y, 2013, J VIROL, V87, P4683, DOI 10.1128/JVI.02189-12; UTZ JP, 1958, P SOC EXP BIOL MED, V99, P259; Wilcke M, 2000, J CELL BIOL, V151, P1207, DOI 10.1083/jcb.151.6.1207; Krautkramer E, 2008, J VIROL, V82, P4257, DOI 10.1128/JVI.02210-07; Schmitt PT, 2010, J VIROL, V84, P12810, DOI 10.1128/JVI.01885-10; TASHIRO M, 1990, J VIROL, V64, P4672; TSURUDOME M, 1986, J GEN VIROL, V67, P2259, DOI 10.1099/0022-1317-67-10-2259; SIMONS K, 1990, CELL, V62, P207, DOI 10.1016/0092-8674(90)90357-K; Tashiro M, 1996, J VIROL, V70, P5990; Muhlebach MD, 2011, NATURE, V480, P530, DOI 10.1038/nature10639; Whelan SPJ, 2004, CURR TOP MICROBIOL, V283, P61; MORITA M, 1977, ARCH VIROL, V53, P197, DOI 10.1007/BF01314664; Li M, 2009, J VIROL, V83, P7261, DOI 10.1128/JVI.00421-09; Lamp B, 2013, J VIROL, V87, P3143, DOI 10.1128/JVI.02696-12; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Villar E, 2006, GLYCOCONJUGATE J, V23, P5, DOI 10.1007/s10719-006-5433-0; Chambers R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010994; Izquierdo-Useros N, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000740; Katoh H, 2015, J VIROL, V89, P3188, DOI 10.1128/JVI.03343-14; Lamb RA, 2006, FIELDS VIROLOGY, P1449; Lemon K, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001263; Momose F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021123; Rodriguez Boulan E, 1978, P NATL ACAD SCI USA, V75, P5071, DOI 10.1073/pnas.75.10.5071; Rubin S, 2015, J PATHOL, V235, P242, DOI 10.1002/path.4445	51	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0022-538X	1098-5514		J VIROL	J. Virol.	DEC	2015	89	23					12026	12034		10.1128/JVI.02048-15		9	Virology	Virology	CZ1WM	WOS:000366896600025		
J	Tsurudome, M; Ito, M; Ohtsuka, J; Hara, K; Komada, H; Nishio, M; Nosaka, T				Tsurudome, Masato; Ito, Morihiro; Ohtsuka, Junpei; Hara, Kenichiro; Komada, Hiroshi; Nishio, Machiko; Nosaka, Tetsuya			The Fusion Protein Specificity of the Parainfluenza Virus Hemagglutinin-Neuraminidase Protein Is Not Solely Defined by the Primary Structure of Its Stalk Domain	JOURNAL OF VIROLOGY			English	Article							NEWCASTLE-DISEASE VIRUS; CELL-FUSION; TYPE-2 VIRUS; PARAMYXOVIRUS FUSION; SENDAI-VIRUS; IDENTIFICATION; GLYCOPROTEIN; MECHANISM; ENTRY; HN	Virus-specific interaction between the attachment protein (HN) and the fusion protein (F) is prerequisite for the induction of membrane fusion by parainfluenza viruses. This HN-F interaction presumably is mediated by particular amino acids in the HN stalk domain and those in the F head domain. We found in the present study, however, that a simian virus 41 (SV41) F-specific chimeric HPIV2 HN protein, SCA, whose cytoplasmic, transmembrane, and stalk domains were derived from the SV41 HN protein, could not induce cell-cell fusion of BHK-21 cells when coexpressed with an SV41 HN-specific chimeric PIV5 F protein, no. 36. Similarly, a headless form of the SV41 HN protein failed to induce fusion with chimera no. 36, whereas it was able to induce fusion with the SV41 F protein. Interestingly, replacement of 13 amino acids of the SCA head domain, which are located at or around the dimer interface of the head domain, with SV41 HN counterparts resulted in a chimeric HN protein, SCA-RII, which induced fusion with chimera no. 36 but not with the SV41 F protein. More interestingly, retroreplacement of 11 out of the 13 amino acids of SCA-RII with the SCA counterparts resulted in another chimeric HN protein, IM18, which induced fusion either with chimera no. 36 or with the SV41 F protein, similar to the SV41 HN protein. Thus, we conclude that the F protein specificity of the HN protein that is observed in the fusion event is not solely defined by the primary structure of the HN stalk domain. IMPORTANCE It is appreciated that the HN head domain initially conceals the HN stalk domain but exposes it after the head domain has bound to the receptors, which allows particular amino acids in the stalk domain to interact with the F protein and trigger it to induce fusion. However, other regulatory roles of the HN head domain in the fusion event have been ill defined. We have shown in the current study that removal of the head domain or amino acid substitutions in a particular region of the head domain drastically change the F protein specificity of the HN protein, suggesting that the ability of a given HN protein to interact with an F protein is defined not only by the primary structure of the HN stalk domain but also by its conformation. This notion seems to account for the unidirectional substitutability among rubulavirus HN proteins in triggering noncognate F proteins.	[Tsurudome, Masato; Ohtsuka, Junpei; Hara, Kenichiro; Nosaka, Tetsuya] Mie Univ, Grad Sch Med, Dept Microbiol & Mol Genet, Tsu, Mie 514, Japan; [Ito, Morihiro] Chubu Univ, Dept Biomed Sci, Coll Life & Hlth Sci, Kasugai, Aichi 487, Japan; [Ohtsuka, Junpei; Hara, Kenichiro] Biocomo Inc, Mie, Mie, Japan; [Komada, Hiroshi] Suzuka Univ Med Sci, Dept Microbiol, Suzuka, Mie, Japan; [Nishio, Machiko] Wakayama Med Univ, Dept Microbiol, Wakayama, Japan	Tsurudome, M (reprint author), Mie Univ, Grad Sch Med, Dept Microbiol & Mol Genet, Tsu, Mie 514, Japan.	turudome@doc.medic.mie-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [26460552]	This work was supported by a Grant-in-Aid for Scientific Research (grant 26460552) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	TSURUDOME M, 1995, VIROLOGY, V213, P190, DOI 10.1006/viro.1995.1559; Bose S, 2014, J VIROL, V88, P3925, DOI 10.1128/JVI.03741-13; YUASA T, 1995, VIROLOGY, V206, P1117, DOI 10.1006/viro.1995.1035; Brindley MA, 2013, J VIROL, V87, P11693, DOI 10.1128/JVI.01945-13; Connolly SA, 2009, J VIROL, V83, P10857, DOI 10.1128/JVI.01191-09; Lamb RA, 2007, CURR OPIN STRUC BIOL, V17, P427, DOI 10.1016/j.sbi.2007.08.016; THOMPSON SD, 1987, VIROLOGY, V160, P1, DOI 10.1016/0042-6822(87)90037-7; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Yuan P, 2005, STRUCTURE, V13, P803, DOI 10.1016/j.str.2005.02.019; TSURUDOME M, 1989, VIROLOGY, V171, P38, DOI 10.1016/0042-6822(89)90508-4; Bose S, 2012, P NATL ACAD SCI USA, V109, pE2625, DOI 10.1073/pnas.1213813109; Bose S, 2013, J VIROL, V87, P13520, DOI 10.1128/JVI.02123-13; Ito M, 1997, J VIROL, V71, P9855; MIRZA AM, 1993, J BIOL CHEM, V268, P21425; Tsurudome M, 1998, J GEN VIROL, V79, P279; Bose S, 2015, VIROLOGY, V479, P518, DOI 10.1016/j.virol.2015.02.037; Porotto M, 2012, J BIOL CHEM, V287, P778, DOI 10.1074/jbc.M111.298059; Iorio RM, 2009, FUTURE VIROL, V4, P335, DOI 10.2217/FVL.09.17; Morrison TG, 2003, BBA-BIOMEMBRANES, V1614, P73, DOI 10.1016/S0005-2736(03)00164-0; TSURUDOME M, 1990, VIROLOGY, V179, P738, DOI 10.1016/0042-6822(90)90141-D; HU XL, 1992, J VIROL, V66, P1528; Tsurudome M, 2013, J VIROL, V87, P8342, DOI 10.1128/JVI.03549-12; Melanson VR, 2006, J VIROL, V80, P623, DOI 10.1128/JVI.80.2.623-633.2006; Tanabayashi K, 1996, J VIROL, V70, P6112; Bose S, 2011, J VIROL, V85, P12855, DOI 10.1128/JVI.06350-11; Deng R, 1997, ARCH VIROL, P115; Gui L, 2015, MBIO, V6, DOI 10.1128/mBio.02393-14; Heminway BR, 1994, VIRUS RES, V32, P1; Karron RA, 2013, FIELDS VIROLOGY, V1, P996; Lamb RA, 2013, FIELDS VIROLOGY, V1, P957; Tsurudome M, 2011, J VIROL, V85, P3253; Welch BD, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003534	32	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0022-538X	1098-5514		J VIROL	J. Virol.	DEC	2015	89	24					12374	12387		10.1128/JVI.01448-15		14	Virology	Virology	CZ1WS	WOS:000366897200015		
J	Nishioka, C; Ikezoe, T; Takeuchi, A; Nobumoto, A; Tsuda, M; Yokoyama, A				Nishioka, C.; Ikezoe, T.; Takeuchi, A.; Nobumoto, A.; Tsuda, M.; Yokoyama, A.			The novel function of CD82 and its impact on BCL2L12 via AKT/STAT5 signal pathway in acute myelogenous leukemia cells	LEUKEMIA			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; METASTASIS SUPPRESSOR GENE; ACUTE MYELOID-LEUKEMIA; APOPTOSIS-RELATED GENES; EXPRESSION ANALYSIS; STEM-CELLS; SELF-RENEWAL; COLON-CANCER; CONSTITUTIVE ACTIVATION; MOLECULAR-CLONING	The aim of this study was to explore the biological functions of a tetraspanin family protein CD82 expressed aberrantly in chemotherapy-resistant CD34(+)/CD38(-) acute myelogenous leukemia (AML) cells. Microarray analysis of patient-isolated CD34(+)/CD38(-) AML cells revealed that the levels of anti-apoptotic protein BCL2L12 were downregulated after CD82 depletion by specific short hairpin RNA (shRNA). Western blot analysis indicated that BCL2L12 was aberrantly expressed in patient-isolated AML cells and AML cell lines. Furthermore, CD82 blockade by a specific antibody downregulated BCL2L12 in parallel with dephosphorylation of signal transducer and activator of transcription 5 (STAT5) and AKT, whereas pharmacological inhibition of STAT5 and AKT activation decreased BCL2L12 expression in leukemia cells. In addition, shRNA-mediated downregulation of BCL2L12 increased the levels of cleaved caspase-3 and suppressed proliferation of leukemia cells, impairing their engraftment in immunodeficient mice. Taken together, our results indicate that CD82 regulated BCL2L12 expression via STAT5A and AKT signaling and stimulated proliferation and engrafting of leukemia cells, suggesting that CD82 and BCL2L12 may be promising therapeutic targets in AML.	[Nishioka, C.; Ikezoe, T.; Takeuchi, A.; Yokoyama, A.] Kochi Univ, Dept Hematol & Resp Med, Nankoku, Kochi 7838505, Japan; [Nobumoto, A.; Tsuda, M.] Kochi Univ, Kochi Med Sch, Facil Anim Res, Nankoku, Kochi 7838505, Japan	Ikezoe, T (reprint author), Kochi Univ, Dept Hematol & Resp Med, Oko Cho, Nankoku, Kochi 7838505, Japan.	ikezoet@kochi-u.ac.jp			Takeda Science Foundation; JSPS KAKENHI [14446690]	This work was supported in part by Takeda Science Foundation (to CN) and JSPS KAKENHI Grant Number 14446690 (to CN).	Schuringa JJ, 2004, J EXP MED, V200, P623, DOI 10.1084/jem.20041024; Kitada S, 1998, BLOOD, V91, P3379; Knoener M, 2012, DIS MARKERS, V32, P337, DOI 10.3233/DMA-2012-0896; Maurer CA, 1999, SURGERY, V126, P869, DOI 10.1067/msy.2099.100381; Nishioka C, 2014, INT J CANCER, V134, P55, DOI 10.1002/ijc.28348; Yang J, 2010, MOL CANCER THER, V9, P3386, DOI 10.1158/1535-7163.MCT-10-0416; Florou D, 2010, BIOCHEM BIOPH RES CO, V391, P214, DOI 10.1016/j.bbrc.2009.11.034; Sarry JE, 2011, J CLIN INVEST, V121, P384, DOI 10.1172/JCI41495; Nishioka C, 2013, INT J CANCER, V132, P2006, DOI 10.1002/ijc.27904; Adachi M, 1996, CANCER RES, V56, P1751; Gebhard C, 2006, CANCER RES, V66, P6118, DOI 10.1158/0008-5472.CAN-06-0376; Stegh AH, 2010, GENE DEV, V24, P2194, DOI 10.1101/gad.1924710; Schepers H, 2007, BLOOD, V110, P2880, DOI 10.1182/blood-2006-08-039073; Scorilas A, 2001, GENOMICS, V72, P217, DOI 10.1006/geno.2000.6455; Matsuo Y, 1997, LEUKEMIA, V11, P1469, DOI 10.1038/sj.leu.2400768; Taussig DC, 2008, BLOOD, V112, P568, DOI [10.1182/blood-2007-10-118331, 10.1182/blood-2008-10-118331]; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Stegh AH, 2008, P NATL ACAD SCI USA, V105, P10703, DOI 10.1073/pnas.0712034105; Nishioka C, 2015, CANCER MED-US, V4, P1426, DOI 10.1002/cam4.482; Gattenloehner S, 2007, BLOOD, V110, P2027, DOI 10.1182/blood-2007-01-074203; Papageorgiou SG, 2011, ONCOLOGIST, V16, P1280, DOI 10.1634/theoncologist.2010-0349; Stegh AH, 2007, GENE DEV, V21, P98, DOI 10.1101/gad.1480007; DONG JT, 1995, SCIENCE, V268, P884, DOI 10.1126/science.7754374; Ikezoe T, 2011, INT J CANCER, V128, P2317, DOI 10.1002/ijc.25806; Thomadaki H, 2012, CLIN BIOCHEM, V45, P1362, DOI 10.1016/j.clinbiochem.2012.06.012; Floros KV, 2006, ANN NY ACAD SCI, V1090, P89, DOI 10.1196/annals.1378.009; Mathioudaki K, 2004, BIOL CHEM, V385, P779, DOI 10.1515/BC.2004.101; Ishikawa F, 2007, NAT BIOTECHNOL, V25, P1315, DOI 10.1038/nbt1350; Moore MAS, 2007, EXP HEMATOL, V35, P105, DOI 10.1016/j.exphem.2007.01.018; Liu FS, 2001, AM J PATHOL, V159, P1629, DOI 10.1016/S0002-9440(10)63009-X; Kontos CK, 2008, BIOL CHEM, V389, P1467, DOI 10.1515/BC.2008.173; Kontos CK, 2012, GENE, V505, P153, DOI 10.1016/j.gene.2012.04.084; Nishioka C, 2011, LEUKEMIA RES, V35, P932, DOI 10.1016/j.leukres.2011.04.004; Perry JM, 2011, GENE DEV, V25, P1928, DOI 10.1101/gad.17421911; Stegh AH, 2008, CELL CYCLE, V7, P2833, DOI 10.4161/cc.7.18.6759; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Karan-Djurasevic T, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0405-7; Nishioka C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125017; Riva Laura, 2012, Front Oncol, V2, P40, DOI 10.3389/fonc.2012.00040; Yamamoto M, 2015, MOL CLIN ONCOL, V3, P449	42	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0887-6924	1476-5551		LEUKEMIA	Leukemia	DEC	2015	29	12					2296	2306		10.1038/leu.2015.219		11	Oncology; Hematology	Oncology; Hematology	CY4QS	WOS:000366393900004		
J	Fujiwara, H; Ochi, T; Ochi, F; Miyazaki, Y; Asai, H; Narita, M; Okamoto, S; Mineno, J; Kuzushima, K; Shiku, H; Yasukawa, M				Fujiwara, H.; Ochi, T.; Ochi, F.; Miyazaki, Y.; Asai, H.; Narita, M.; Okamoto, S.; Mineno, J.; Kuzushima, K.; Shiku, H.; Yasukawa, M.			Antileukemia multifunctionality of CD4(+) T cells genetically engineered by HLA class I-restricted and WT1-specific T-cell receptor gene transfer	LEUKEMIA			English	Article							ACUTE MYELOID-LEUKEMIA; ADOPTIVE IMMUNOTHERAPY; LYMPHOCYTES; ANTIGEN; CD8(+); TCR; GENERATION; EXPRESSION; REACTIVITY; MELANOMA	To develop gene-modified T-cell-based antileukemia adoptive immunotherapy, concomitant administration of CD4(+) and CD8(+) T cells that have been gene modified using identical HLA class I-restricted leukemia antigen-specific T-cell receptor (TCR) gene transfer has not yet been fully investigated. Here, using CD4(+) and CD8(+) T cells that had been gene modified with a retroviral vector expressing HLA-A*24:02-restricted and Wilms' tumor 1 (WT1)-specific TCR-alpha/beta genes and siRNAs for endogenous TCRs (WT1-siTCR/CD4(+) T cells and WT1-siTCR/CD8(+) T cells), we examined the utility of this strategy. WT1-siTCR/CD4(+) T cells sufficiently recognized leukemia cells in an HLA class I-restricted manner and provided target-specific Th1 help for WT1-siTCR/CD8(+) T cells. By using a xenografted mouse model, we found that WT1-siTCR/CD4(+) T cells migrated to leukemia sites and subsequently attracted WT1-siTCR/CD8(+) T cells via chemotaxis. Therapy-oriented experiments revealed effective enhancement of leukemia suppression mediated by concomitant administration of WT1-siTCR/CD4(+) T cells and WT1-siTCR/CD8(+) T cells. Importantly, this augmented efficacy in the presence of WT1-siTCR/CD4(+) T cells was correlated with longer survival and enhanced formation of memory T cells by WT1-siTCR/CD8(+) T cells. Collectively, our experimental findings strongly suggest that this strategy would be clinically advantageous for the treatment of human leukemia.	[Fujiwara, H.; Ochi, T.; Ochi, F.; Miyazaki, Y.; Asai, H.; Yasukawa, M.] Ehime Univ, Sch Med, Dept Hematol Clin Immunol & Infect Dis, Toon, Ehime, Japan; [Ochi, T.] Ontario Canc Inst, Princess Margaret Canc Ctr, Toronto, ON M4X 1K9, Canada; [Ochi, F.] Ehime Univ, Sch Med, Dept Pediat, Toon, Ehime, Japan; [Narita, M.] Niigata Univ, Grad Sch Hlth Sci, Lab Hematol & Oncol, Niigata, Japan; [Okamoto, S.; Mineno, J.] Takara Bio Inc, Ctr Cell & Gene Therapy, Otsu, Shiga, Japan; [Kuzushima, K.] Aichi Canc Ctr, Div Immunol, Nagoya, Aichi 464, Japan; [Shiku, H.] Mie Univ, Grad Sch Med, Dept Canc Vaccine & Immunogene Therapy, Tsu, Mie 514, Japan	Fujiwara, H (reprint author), Ehime Univ, Sch Med, Dept Hematol Clin Immunol & Infect Dis, Toon, Ehime, Japan.	yunarief@m.ehime-u.ac.jp; yasukawa@m.ehime-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labor and Welfare; Takeda Science Foundation; Uehara Memorial Foundation; Princess Takamatsu Cancer Research Fund	We thank Dr Kenji Kameda, Ehime University for technical assistance. We also thank Dr Yoshiki Akatsuka, Department of Hematology, Fujita Health University for supplying the K562-A24 and Dr Hiroo Saji, HLA Laboratory, Japan for HLA typing. This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (HF and MY); a Grant-in-Aid for Cancer Research from the Ministry of Health, Labor and Welfare (MY); a grant from Takeda Science Foundation (MY); a grant from the Uehara Memorial Foundation (MY); and a grant from the Princess Takamatsu Cancer Research Fund (MY).	Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; June CH, 2007, J CLIN INVEST, V117, P1204, DOI 10.1172/JCI31446; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; STEIMLE V, 1994, SCIENCE, V265, P106, DOI 10.1126/science.8016643; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Klebanoff CA, 2011, CLIN CANCER RES, V17, P5343, DOI 10.1158/1078-0432.CCR-11-0503; Morgan RA, 2013, J IMMUNOTHER, V36, P133, DOI 10.1097/CJI.0b013e3182829903; Yang SC, 2011, CANCER IMMUNOL IMMUN, V60, P739, DOI 10.1007/s00262-011-0977-7; Okamoto S, 2009, CANCER RES, V69, P9003, DOI 10.1158/0008-5472.CAN-09-1450; Colmone A, 2008, SCIENCE, V322, P1861, DOI 10.1126/science.1164390; Frankel TL, 2010, J IMMUNOL, V184, P5988, DOI 10.4049/jimmunol.1000189; Legoux F, 2013, EUR J IMMUNOL, V43, P3244, DOI 10.1002/eji.201343726; Wetzler M, 2003, LEUKEMIA, V17, P707, DOI 10.1038/sj.leu.2402865; Anguille S, 2012, LEUKEMIA, V26, P2186, DOI 10.1038/leu.2012.145; Tsuji T, 2005, BLOOD, V106, P470, DOI 10.1182/blood-2004-09-3663; Roszkowski JJ, 2005, CANCER RES, V65, P1570, DOI 10.1158/0008-5472.CAN-04-2076; Muranski P, 2009, CURR OPIN IMMUNOL, V21, P200, DOI 10.1016/j.coi.2009.02.004; Antony PA, 2005, J IMMUNOL, V174, P2591; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Linette GP, 2013, BLOOD, V122, P863, DOI 10.1182/blood-2013-03-490565; Kessels HWHG, 2006, J IMMUNOL, V177, P976; Muranski P, 2008, BLOOD, V112, P362, DOI 10.1182/blood-2007-11-120998; Franciszkiewicz K, 2012, CANCER RES, V72, P6325, DOI 10.1158/0008-5472.CAN-12-2027; Park TS, 2011, TRENDS BIOTECHNOL, V29, P550, DOI 10.1016/j.tibtech.2011.04.009; Rambaldi A, 2015, LEUKEMIA, V29, P1, DOI 10.1038/leu.2014.189; Kharfan-Dabaja MA, 2014, LEUKEMIA, V28, P507, DOI 10.1038/leu.2013.311; Ochi T, 2011, EXPERT OPIN BIOL TH, V11, P699, DOI 10.1517/14712598.2011.566853; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Ossendorp F, 1998, J EXP MED, V187, P693, DOI 10.1084/jem.187.5.693; Suemori K, 2008, CANCER SCI, V99, P1414, DOI 10.1111/j.1349-7006.2008.00823.x; Ochi T, 2011, BLOOD, V118, P1495, DOI 10.1182/blood-2011-02-337089; Li Y, 2005, NAT BIOTECHNOL, V23, P349, DOI 10.1038/nbt1070; Ochi T, 2009, BLOOD, V113, P66, DOI 10.1182/blood-2008-06-164889; Nagai K, 2012, BLOOD, V119, P368, DOI 10.1182/blood-2011-06-360354; Ohkura N, 2012, IMMUNITY, V37, P785, DOI 10.1016/j.immuni.2012.09.010; Ohminami H, 2000, BLOOD, V95, P286; Asai H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056820; Davila ML, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008226; Miyawaki Shuichi, 2005, Rinsho Ketsueki, V46, P1279; van Loenen MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065212; Xue SA, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.22590	41	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0887-6924	1476-5551		LEUKEMIA	Leukemia	DEC	2015	29	12					2393	2401		10.1038/leu.2015.155		9	Oncology; Hematology	Oncology; Hematology	CY4QS	WOS:000366393900015		
J	Tokumasu, M; Murata, C; Shimada, A; Ohki, K; Hayashi, Y; Saito, AM; Fujimoto, J; Horibe, K; Nagao, M; Itoh, H; Kamikubo, Y; Nakayama, H; Kinoshita, A; Tomizawa, D; Taga, T; Tawa, A; Tanaka, S; Heike, T; Adachi, S				Tokumasu, M.; Murata, C.; Shimada, A.; Ohki, K.; Hayashi, Y.; Saito, A. M.; Fujimoto, J.; Horibe, K.; Nagao, M.; Itoh, H.; Kamikubo, Y.; Nakayama, H.; Kinoshita, A.; Tomizawa, D.; Taga, T.; Tawa, A.; Tanaka, S.; Heike, T.; Adachi, S.			Adverse prognostic impact of KIT mutations in childhood CBF-AML: the results of the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 trial	LEUKEMIA			English	Letter							ACUTE MYELOID-LEUKEMIA; GENETIC LESIONS; RELAPSE; FLT3; RAS		[Tokumasu, M.; Heike, T.] Kyoto Univ, Dept Pediat, Kyoto, Japan; [Murata, C.; Ohki, K.; Hayashi, Y.] Gunma Childrens Med Ctr, Dept Hematol Oncol, Shibukawa, Japan; [Shimada, A.] Okayama Univ, Dept Pediat, Okayama, Japan; [Saito, A. M.; Horibe, K.] Natl Hosp Org, Nagoya Med Ctr, Clin Res Ctr, Nagoya, Aichi, Japan; [Fujimoto, J.] Natl Ctr Child Hlth & Dev, Clin Res Ctr, Tokyo, Japan; [Nagao, M.; Itoh, H.; Kamikubo, Y.; Adachi, S.] Kyoto Univ, Human Hlth Sci, Kyoto, Japan; [Nakayama, H.] Natl Hosp Org, Fukuoka Higashi Med Ctr, Dept Pediat, Koga, Japan; [Kinoshita, A.] St Marianna Univ, Sch Med, Dept Pediat, Kawasaki, Kanagawa, Japan; [Tomizawa, D.] Natl Ctr Child Hlth & Dev, Childrens Canc Ctr, Div Leukemia & Lymphoma, Tokyo, Japan; [Taga, T.] Shiga Univ Med Sci, Dept Pediat, Otsu, Shiga 52021, Japan; [Tawa, A.] Natl Hosp Org, Osaka Med Ctr, Dept Pediat, Osaka, Japan; [Tanaka, S.] Kyoto Univ, Dept Pharmacoepidemiol, Kyoto, Japan	Tokumasu, M (reprint author), Kyoto Univ, Dept Pediat, Kyoto, Japan.	adachiso@kuhp.kyoto-u.ac.jp					Nick HJ, 2012, BLOOD, V119, P1522, DOI 10.1182/blood-2011-02-338228; Wang YY, 2011, P NATL ACAD SCI USA, V108, P2450, DOI 10.1073/pnas.1019625108; Paschka P, 2013, BLOOD, V121, P170, DOI 10.1182/blood-2012-05-431486; Manara E, 2014, LEUKEMIA, V28, P1132, DOI 10.1038/leu.2013.339; Kaspers GJL, 2013, J CLIN ONCOL, V31, P599, DOI 10.1200/JCO.2012.43.7384; Allen C, 2013, LEUKEMIA, V27, P1891, DOI 10.1038/leu.2013.186; Schnittger S, 2006, BLOOD, V107, P1791, DOI 10.1182/blood-2005-04-1466; Pollard JA, 2010, BLOOD, V115, P2372, DOI 10.1182/blood-2009-09-241075; Cairoli R, 2006, BLOOD, V107, P3463, DOI 10.1182/blood-2005-09-3640; Lennartsson J, 2012, PHYSIOL REV, V92, P1619, DOI 10.1152/physrev.00046.2011; Shih LY, 2008, LEUKEMIA, V22, P303, DOI 10.1038/sj.leu.2404995; Goemans BF, 2005, LEUKEMIA, V19, P1536, DOI 10.1038/sj.leu.2403870; Krauth MT, 2014, LEUKEMIA, V28, P1449, DOI 10.1038/leu.2014.4; Tomizawa D, 2013, LEUKEMIA, V27, P2413, DOI 10.1038/leu.2013.153; Shimada A, 2006, BLOOD, V107, P1806, DOI 10.1182/blood-2005-08-3408; Mpakou VE, 2013, LEUKEMIA RES, V37, P175, DOI 10.1016/j.leukres.2012.10.011	16	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0887-6924	1476-5551		LEUKEMIA	Leukemia	DEC	2015	29	12					2438	2441		10.1038/leu.2015.121		5	Oncology; Hematology	Oncology; Hematology	CY4QS	WOS:000366393900031		
J	Gocho, Y; Kiyokawa, N; Ichikawa, H; Nakabayashi, K; Osumi, T; Ishibashi, T; Ueno, H; Terada, K; Oboki, K; Sakamoto, H; Shioda, Y; Imai, M; Noguchi, Y; Arakawa, Y; Kojima, Y; Toyama, D; Hata, K; Yoshida, T; Matsumoto, K; Kato, M; Fukushima, T; Koh, K; Manabe, A; Ohara, A				Gocho, Y.; Kiyokawa, N.; Ichikawa, H.; Nakabayashi, K.; Osumi, T.; Ishibashi, T.; Ueno, H.; Terada, K.; Oboki, K.; Sakamoto, H.; Shioda, Y.; Imai, M.; Noguchi, Y.; Arakawa, Y.; Kojima, Y.; Toyama, D.; Hata, K.; Yoshida, T.; Matsumoto, K.; Kato, M.; Fukushima, T.; Koh, K.; Manabe, A.; Ohara, A.		Tokyo Children's Canc Study Grp	A novel recurrent EP300-ZNF384 gene fusion in B-cell precursor acute lymphoblastic leukemia	LEUKEMIA			English	Letter							P300; TRANSCRIPTION; PROTEIN; KINASE		[Gocho, Y.; Kiyokawa, N.; Ishibashi, T.; Ueno, H.; Terada, K.] Natl Res Inst Child Hlth & Dev, Dept Pediat Hematol & Oncol Res, Setagaya Ku, Tokyo, Japan; [Gocho, Y.] Nippon Med Sch, Dept Pediat, Bunkyo Ku, Tokyo 113, Japan; [Ichikawa, H.; Sakamoto, H.; Yoshida, T.] Natl Canc Ctr, Div Genet, Chuo Ku, Tokyo, Japan; [Nakabayashi, K.; Hata, K.] Natl Res Inst Child Hlth & Dev, Dept Maternal Fetal Biol, Setagaya Ku, Tokyo, Japan; [Osumi, T.; Shioda, Y.] Natl Ctr Child Hlth & Dev, Childrens Canc Ctr, Div Leukemia & Lymphoma, Setagaya Ku, Tokyo, Japan; [Ishibashi, T.] Juntendo Univ, Sch Med, Dept Pediat & Adolescent Med, Bunkyo Ku, Tokyo 113, Japan; [Terada, K.; Noguchi, Y.] Japanese Red Cross Narita Hosp, Dept Pediat, Chiba, Japan; [Oboki, K.] Tokyo Metropolitan Inst Med Sci, Dept Mol Med Res, Setagaya Ku, Tokyo 113, Japan; [Imai, M.] Japanese Red Cross Musashino Hosp, Dept Pediat, Musashino, Tokyo, Japan; [Arakawa, Y.; Koh, K.] Saitama Childrens Med Ctr, Dept Hematol Oncol, Saitama, Japan; [Kojima, Y.; Ohara, A.] Toho Univ, Omori Med Ctr, Dept Pediat, Ota Ku, Tokyo, Japan; [Toyama, D.] Showa Univ, Fujigaoka Hosp, Dept Pediat, Yokohama, Kanagawa 227, Japan; [Matsumoto, K.] Natl Res Inst Child Hlth & Dev, Dept Allergy & Immunol, Setagaya Ku, Tokyo, Japan; [Kato, M.] Univ Tokyo, Dept Pediat, Bunkyo Ku, Tokyo, Japan; [Fukushima, T.] Univ Tsukuba, Fac Med, Dept Pediat, Tsukuba, Ibaraki, Japan; [Manabe, A.] St Lukes Int Hosp, Dept Pediat, Chuo Ku, Tokyo, Japan	Gocho, Y (reprint author), Natl Res Inst Child Hlth & Dev, Dept Pediat Hematol & Oncol Res, Setagaya Ku, Tokyo, Japan.	kiyokawa-n@ncchd.go.jp					Bidwell JP, 2001, CRIT REV EUKAR GENE, V11, P279; Roberts KG, 2014, NEW ENGL J MED, V371, P1005, DOI 10.1056/NEJMoa1403088; Pui CH, 2012, BLOOD, V120, P1165, DOI 10.1182/blood-2012-05-378943; Pasqualucci L, 2011, NATURE, V471, P189, DOI 10.1038/nature09730; Blobel GA, 2000, BLOOD, V95, P745; Delvecchio M, 2013, NAT STRUCT MOL BIOL, V20, P1040, DOI 10.1038/nsmb.2642; Kimbrel EA, 2009, BLOOD, V114, P4804, DOI 10.1182/blood-2009-04-217794; Ida K, 1997, BLOOD, V90, P4699; Manabe A, 2008, HAEMATOL-HEMATOL J, V93, P1155, DOI 10.3324/haematol.12365; Roberts KG, 2012, CANCER CELL, V22, P153, DOI 10.1016/j.ccr.2012.06.005; Martini A, 2002, CANCER RES, V62, P5408; Chaffanet M, 2000, GENE CHROMOSOME CANC, V28, P138, DOI 10.1002/(SICI)1098-2264(200006)28:2<138::AID-GCC2>3.0.CO;2-2; Zhong CH, 2008, LEUKEMIA, V22, P723, DOI 10.1038/sj.leu.2405084; Inaba H, 2013, LANCET, V381, P1943, DOI 10.1016/S0140-6736(12)62187-4; Lilljebjorn H, 2013, LEUKEMIA, V28, P977	15	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0887-6924	1476-5551		LEUKEMIA	Leukemia	DEC	2015	29	12					2445	2448		10.1038/leu.2015.111		5	Oncology; Hematology	Oncology; Hematology	CY4QS	WOS:000366393900033		
J	Kumasaka, T; Hoshika, Y; Kobayashi, E; Mitani, K; Okura, MK; Hong, YK; Takahashi, K; Seyama, K				Kumasaka, Toshio; Hoshika, Yoshito; Kobayashi, Etsuko; Mitani, Keiko; Okura, Makiko K.; Hong, Young Kwon; Takahashi, Kazuhisa; Seyama, Kuniaki			A Model of Lymphangioleiomyomatosis in a Three-Dimensional Culture System	LYMPHATIC RESEARCH AND BIOLOGY			English	Article							CELL CLUSTERS; MMPS; LAM		[Kumasaka, Toshio] Japanese Red Cross Med Ctr, Dept Pathol, Tokyo 1508935, Japan; [Hoshika, Yoshito; Kobayashi, Etsuko; Okura, Makiko K.; Takahashi, Kazuhisa; Seyama, Kuniaki] Juntendo Univ, Fac Med, Div Resp Med, Tokyo, Japan; [Mitani, Keiko] Juntendo Univ, Fac Med, Div Human Pathol, Tokyo, Japan; [Mitani, Keiko] Grad Sch Med, Tokyo, Japan; [Hong, Young Kwon] Univ So Calif, Norris Comprehens Canc Ctr, Dept Surg, Los Angeles, CA 90089 USA; [Hong, Young Kwon] Univ So Calif, Norris Comprehens Canc Ctr, Dept Biochem & Mol Biol, Los Angeles, CA 90089 USA; [Kumasaka, Toshio; Hoshika, Yoshito; Kobayashi, Etsuko; Mitani, Keiko; Okura, Makiko K.; Seyama, Kuniaki] Study Grp Pneumothorax & Cyst Lung Dis, Tokyo, Japan	Kumasaka, T (reprint author), Japanese Red Cross Med Ctr, Dept Pathol, Shibuya Ku, 4-1-22 Hiro O, Tokyo 1508935, Japan.	kumasaka_toshio@med.jrc.or.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan [21659210]; Ministry of Health, Labour and Welfare, Japan; High Technology Research Center Grant from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; Institute for Environmental and Gender-Specific Medicine, Juntendo University Graduate School of Medicine, Tokyo Japan	Sources of Support: This study was supported in part by Grant-in-Aid for Scientific Research No. 21659210 (Seyama K) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; a grant to the Respiratory Failure Research Group (Seyama K) from the Ministry of Health, Labour and Welfare, Japan; the High Technology Research Center Grant from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; and the Institute for Environmental and Gender-Specific Medicine, Juntendo University Graduate School of Medicine, Tokyo Japan.	Hayashi T, 1997, HUM PATHOL, V28, P1071, DOI 10.1016/S0046-8177(97)90061-7; Kumasaka T, 2005, AM J SURG PATHOL, V29, P1356, DOI 10.1097/01.pas.0000172192.25295.45; Seyama K, 2010, LYMPHAT RES BIOL, V8, P21, DOI 10.1089/lrb.2009.0018; Hirakawa S, 2003, AM J PATHOL, V162, P575, DOI 10.1016/S0002-9440(10)63851-5; Moses MA, 2006, NEW ENGL J MED, V354, P2621, DOI 10.1056/NEJMc053410; Seyama Kuniaki, 2006, Lymphatic Research and Biology, V4, P143, DOI 10.1089/lrb.2006.4.143; Mitani K, 2009, ACTA CYTOL, V53, P402, DOI 10.1159/000325340; Henske EP, 2012, J CLIN INVEST, V122, P3807, DOI 10.1172/JCI58709	8	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1539-6851	1557-8585		LYMPHAT RES BIOL	Lymphat. Res. Biol.	DEC 1	2015	13	4					248	252				5	Medicine, Research & Experimental; Physiology	Research & Experimental Medicine; Physiology	CY9IB	WOS:000366719500003		
J	Nagase, K				Nagase, K.			Wave analysis and control of double cascade-connected damped mass-spring systems	MECHANICS RESEARCH COMMUNICATIONS			English	Article						Vibration control; Wave analysis; Damped mass-spring; Tensegrity; Impedance matching	POWER-FLOW; DEPLOYABLE STRUCTURES; STRUCTURAL NETWORKS; PERIODIC STRUCTURES; RECTANGULAR PANEL; FLEXIBLE SYSTEMS; FEEDBACK-CONTROL; FLEXURAL WAVES; PROPAGATION; BEAM	This paper presents wave analysis and control for double cascade-connected damped mass-spring systems, whose mass is connected beyond the adjacent masses. The system is motivated by a cantilevered tensegrity beam supporting tensile and compressive forces. The wave solution is derived from a recurrent formula, and the properties of the propagation constants are precisely investigated. Elimination of reflected waves provides the impedance matching controller. We show that the impedance matching controller can be constructed from a similarity transformation of the characteristic impedance matrix by a matrix composed of the propagation constants. A numerical example of vibration control of a tensegrity beam is shown. (C) 2015 Elsevier Ltd. All rights reserved.	[Nagase, K.] Wakayama Univ, Dept Optomechatron, Wakayama 6408510, Japan	Nagase, K (reprint author), Wakayama Univ, Dept Optomechatron, Wakayama 6408510, Japan.	nagase@sys.wakayama-u.ac.jp					Ahlfors L., 1979, COMPLEX ANAL; Aldrich J.B., 2004, THESIS; Iwamoto H, 2012, MECH SYST SIGNAL PR, V32, P216, DOI 10.1016/j.ymssp.2012.06.013; Sultan C, 2003, INT J SOLIDS STRUCT, V40, P4637, DOI 10.1016/S0020-7683(03)00267-1; VONFLOTOW AH, 1986, J GUID CONTROL DYNAM, V9, P673, DOI 10.2514/3.20163; Iwamoto H, 2013, MECH SYST SIGNAL PR, V39, P3, DOI 10.1016/j.ymssp.2012.06.012; Fraternali F, 2012, J MECH PHYS SOLIDS, V60, P1137, DOI 10.1016/j.jmps.2012.02.007; Puig L, 2010, ACTA ASTRONAUT, V67, P12, DOI 10.1016/j.actaastro.2010.02.021; Mei C, 2009, J SOUND VIB, V322, P29, DOI 10.1016/j.jsv.2008.11.003; BALAS MJ, 1978, J OPTIMIZ THEORY APP, V25, P415, DOI 10.1007/BF00932903; You Z, 1996, AIAA J, V34, P813, DOI 10.2514/3.13144; MIURA K, 1990, AIAA J, V28, P1098, DOI 10.2514/3.25172; Vera C, 2005, ANN BIOMED ENG, V33, P1387, DOI 10.1007/s10439-005-4698-y; CAI GQ, 1991, AIAA J, V29, P450, DOI 10.2514/3.10599; MILLER DW, 1989, J SOUND VIB, V128, P145, DOI 10.1016/0022-460X(89)90686-X; Fraternali F, 2011, J MECH PHYS SOLIDS, V59, P89, DOI 10.1016/j.jmps.2010.09.004; Mei C, 2001, J SOUND VIB, V247, P765, DOI 10.1006/jsvi.2001.3795; Mei C, 2005, J VIB ACOUST, V127, P382, DOI 10.1115/1.1924647; Ingber DE, 1998, SCI AM, V278, P48; Ruzzene M, 2000, J VIB ACOUST, V122, P151, DOI 10.1115/1.568452; ELLIOTT SJ, 1993, J SOUND VIB, V163, P295, DOI 10.1006/jsvi.1993.1166; Leonard A, 2013, EXP MECH, V53, P327, DOI 10.1007/s11340-011-9544-6; Blesgen T, 2012, MECH RES COMMUN, V45, P58, DOI 10.1016/j.mechrescom.2012.07.006; VAUGHAN DR, 1968, J BASIC ENG-T ASME, V90, P157; Nagase K, 2014, MECH RES COMMUN, V59, P14, DOI 10.1016/j.mechrescom.2014.03.007; Ojima H, 2001, IEEE DECIS CONTR P, P2574, DOI 10.1109/CDC.2001.980652; Svensson JL, 2008, J SOUND VIB, V313, P418, DOI 10.1016/j.jsv.2007.12.011; MESTER SS, 1995, SHOCK VIB, V2, P69; Paul C, 2006, IEEE T ROBOT, V22, P944, DOI 10.1109/TRO.2006.878980; MACMARTIN DG, 1991, J GUID CONTROL DYNAM, V14, P521, DOI 10.2514/3.20671; de Oliveira M.C., 2009, TENSEGRITY SYSTEMS; Fuller R.B., 1962, United States Patent, Patent No. [3,063,521, 3063521]; MACE BR, 1984, J SOUND VIB, V97, P237, DOI 10.1016/0022-460X(84)90320-1; Masic M., 1998, P SOC PHOTO-OPT INS, P298; Matsuda K., 1995, GUID NAV CONTR C, P112; MEIROVITCH L, 1983, J GUID CONTROL DYNAM, V6, P302, DOI 10.2514/3.19833; MILLER DW, 1990, J SOUND VIB, V140, P475, DOI 10.1016/0022-460X(90)90762-O; Motro R., 2003, TENSEGRITY STRUCTURA; Nagase K., 1996, P 3 INT C MOT VIBR C, P81; Nagase K., 2000, P 5 INT C MOT VIBR C, P121; Nagase K., 2014, J INT ASS SHELL SPAT, V55, P37; Ngo D, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.036602; Pellegrino S., 2001, DEPLOYABLE STRUCTURE; Sadao S., 1996, INT J SPACE STRUCTUR, V11, P37; Schmit L, 1981, IALAA J, V19, P1249, DOI [10.2514/3.7859, DOI 10.2514/3.7859]; VONFLOTOW AH, 1986, J SOUND VIB, V106, P433, DOI 10.1016/0022-460X(86)90190-2; VONFLOTOW AH, 1986, J GUID CONTROL DYNAM, V9, P462, DOI 10.2514/3.20133; Vongpanitlerd S., 1973, NETWORK ANAL SYNTHES; WANG Q, 1995, COMPUT STRUCT, V57, P177, DOI 10.1016/0045-7949(94)00591-P	49	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0093-6413			MECH RES COMMUN	Mech. Res. Commun.	DEC	2015	70						49	57		10.1016/j.mechrescom.2015.09.004		9	Mechanics	Mechanics	CY9ZM	WOS:000366764900007		
J	Sugita, N; Matsuoka, N; Yoshizawa, M; Abe, M; Homma, N; Otake, H; Kim, J; Ohtaki, Y				Sugita, Norihiro; Matsuoka, Narumi; Yoshizawa, Makoto; Abe, Makoto; Homma, Noriyasu; Otake, Hideharu; Kim, Junghyun; Ohtaki, Yukio			Estimation of heart rate variability using a compact radiofrequency motion sensor	MEDICAL ENGINEERING & PHYSICS			English	Article						Pocketable sensor; Contactless; Heart rate variability; Coefficient of variation of R-R intervals	SPECTRAL-ANALYSIS; KA-BAND; NONCONTACT; POWER; HYPERTENSION; PRESSURE	Physiological indices that reflect autonomic nervous activity are considered useful for monitoring peoples' health on a daily basis. A number of such indices are derived from heart rate variability, which is obtained by a radiofrequency (RE) motion sensor without making physical contact with the user's body. However, the bulkiness of RF motion sensors used in previous studies makes them unsuitable for home use. In this study, a new method to measure heart rate variability using a compact RF motion sensor that is sufficiently small to fit in a user's shirt pocket is proposed. To extract a heart rate related component from the sensor signal, an algorithm that optimizes a digital filter based on the power spectral density of the signal is proposed. The signals of the RF motion sensor were measured for 29 subjects during the resting state and their heart rate variability was estimated from the measured signals using the proposed method and a conventional method. A correlation coefficient between true heart rate and heart rate estimated from the proposed method was 0.69. Further, the experimental results showed the viability of the RF sensor for monitoring autonomic nervous activity. However, some improvements such as controlling the direction of sensing were necessary for stable measurement. (C) 2015 IPEM. Published by Elsevier Ltd. All rights reserved.	[Sugita, Norihiro; Matsuoka, Narumi; Abe, Makoto] Tohoku Univ, Grad Sch Engn, Sendai, Miyagi 9808579, Japan; [Yoshizawa, Makoto] Tohoku Univ, Cybersci Ctr, Sendai, Miyagi 9808578, Japan; [Homma, Noriyasu] Tohoku Univ, Grad Sch Med, Sendal, Miyagi 9808575, Japan; [Otake, Hideharu; Kim, Junghyun; Ohtaki, Yukio] ALPS Elect Co Ltd, Osaki, Miyagi 9896181, Japan	Sugita, N (reprint author), Tohoku Univ, Grad Sch Engn, Sendai, Miyagi 9808579, Japan.	sugita@yoshizawa.ecei.tohoku.ac.jp			ALPS Electric Co., Ltd.	This study was funded by ALPS Electric Co., Ltd.	Jonathan E, 2011, J BIOPHOTONICS, V4, P293, DOI 10.1002/jbio.201000050; PAGANI M, 1988, HYPERTENSION, V12, P600; MURATA K, 1992, J AUTONOM NERV SYST, V37, P199, DOI 10.1016/0165-1838(92)90041-E; Lu GH, 2009, SENSORS-BASEL, V9, P9572, DOI 10.3390/s91209572; Li CZ, 2006, IEEE T MICROW THEORY, V54, P4464, DOI 10.1109/TMTT.2006.884652; BIGGER JT, 1993, CIRCULATION, V88, P927; Ramaekers D, 1998, EUR HEART J, V19, P1334, DOI 10.1053/euhj.1998.1084; Bland JM, 2007, J BIOPHARM STAT, V17, P571, DOI 10.1080/10543400701329422; Moak JP, 2007, HEART RHYTHM, V4, P1523, DOI 10.1016/j.hrthm.2007.07.019; Poh MZ, 2011, IEEE T BIO-MED ENG, V58, P7, DOI 10.1109/TBME.2010.2086456; Poh MZ, 2010, OPT EXPRESS, V18, P10762, DOI 10.1364/OE.18.010762; Scully CG, 2012, IEEE T BIO-MED ENG, V59, P303, DOI 10.1109/TBME.2011.2163157; PAGANI M, 1986, CIRC RES, V59, P178; Varanini M, 2008, COMPUTERS IN CARDIOLOGY 2008, VOLS 1 AND 2, P149; MANCIA G, 1983, LANCET, V2, P695; SIEGEL WC, 1990, HYPERTENSION, V16, P140; Suzuki S, 2008, MED BIOL ENG COMPUT, V46, P709, DOI 10.1007/s11517-007-0298-3; Nagae D, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3478017; Obeid D, 2010, IEEE ENG MED BIO, P658, DOI 10.1109/IEMBS.2010.5627214; Obeid D, 2009, MICROW OPT TECHN LET, V51, P666, DOI 10.1002/mop.24110; Xiao YM, 2006, IEEE T MICROW THEORY, V54, P2023, DOI 10.1109/TMTT.2006.873625; Zakrzewski M, 2012, IEEE SENS J, V12, P627, DOI 10.1109/JSEN.2011.2119299; EWING DJ, 1984, BRIT HEART J, V52, P396; Lucini D, 2002, CIRCULATION, V106, P2673, DOI 10.1161/01.CIR.0000039106.89299.AB; Shioiri T, 2005, EUR ARCH PSY CLIN N, V255, P293, DOI 10.1007/s00406-005-0561-2; Takano C, 2007, MED ENG PHYS, V29, P853, DOI 10.1016/j.medengphy.2006.09.006; MALLIANI A, 1991, CIRCULATION, V84, P482; Pelegris P, 2010, IEEE ENG MED BIO, P5488, DOI 10.1109/IEMBS.2010.5626580; FUJIMOTO J, 1987, Journal of the Japan Diabetes Society, V30, P167; HAYANO J, 1991, AM J CARDIOL, V67, P199, DOI 10.1016/0002-9149(91)90445-Q; Sun Y, 2012, J BIOMED OPT, V17; Tavakolian K, 2008, INT J TELEMED APPL, V2008	32	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1350-4533	1873-4030		MED ENG PHYS	Med. Eng. Phys.	DEC	2015	37	12					1146	1151		10.1016/j.medengphy.2015.09.008		6	Engineering, Biomedical	Engineering	CZ0CG	WOS:000366772100004		
J	Furuse, M; Nonoguchi, N; Kawabata, S; Miyatake, SI; Kuroiwa, T				Furuse, Motomasa; Nonoguchi, Naosuke; Kawabata, Shinji; Miyatake, Shin-Ichi; Kuroiwa, Toshihiko			Delayed brain radiation necrosis: pathological review and new molecular targets for treatment	MEDICAL MOLECULAR MORPHOLOGY			English	Review						Angiogenesis; Cytokines; Inflammation; Radiation injuries; Vascular endothelial growth factors	ENDOTHELIAL GROWTH-FACTOR; NEWLY-DIAGNOSED GLIOBLASTOMA; CORD BARRIER BREAKDOWN; CENTRAL-NERVOUS-SYSTEM; SPINAL-CORD; VEGF EXPRESSION; PDGF-C; BEVACIZUMAB; INJURY; ANGIOGENESIS	Delayed radiation necrosis is a well-known adverse event following radiotherapy for brain diseases and has been studied since the 1930s. The primary pathogenesis is thought to be the direct damage to endothelial and glial cells, particularly oligodendrocytes, which causes vascular hyalinization and demyelination. This primary pathology leads to tissue inflammation and ischemia, inducing various tissue protective responses including angiogenesis. Macrophages and lymphocytes then infiltrate the surrounding areas of necrosis, releasing inflammatory cytokines such as interleukin (IL)-1 alpha, IL-6, and tumor necrosis factor (TNF)-alpha. Microglia also express these inflammatory cytokines. Reactive astrocytes play an important role in angiogenesis, expressing vascular endothelial growth factor (VEGF). Some chemokine networks, like the CXCL12/CXCR4 axis, are upregulated by tissue inflammation. Hypoxia may mediate the cell-cell interactions among reactive astrocytes, macrophages, and microglial cells around the necrotic core. Recently, bevacizumab, an anti-VEGF antibody, has demonstrated promising results as an alternative treatment for radiation necrosis. The importance of VEGF in the pathophysiology of brain radiation necrosis is being recognized. The discovery of new molecular targets could facilitate novel treatments for radiation necrosis. This literature review will focus on recent work characterizing delayed radiation necrosis in the brain.	[Furuse, Motomasa; Nonoguchi, Naosuke; Kawabata, Shinji; Miyatake, Shin-Ichi; Kuroiwa, Toshihiko] Osaka Med Coll, Dept Neurosurg, Takatsuki, Osaka 5698686, Japan	Furuse, M (reprint author), Osaka Med Coll, Dept Neurosurg, 2-7 Daigakumachi, Takatsuki, Osaka 5698686, Japan.	neu054@poh.osaka-med.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology [26462222]	This work was partly supported by a Grant-in-Aid for Scientific Research (C) (26462222) given to M.F. from the Japanese Ministry of Education, Culture, Sports, Science and Technology.	Yang SX, 2005, BIOCHEM BIOPH RES CO, V335, P523, DOI 10.1016/j.bbrc.2005.07.113; Furuse M, 2013, JPN J CLIN ONCOL, V43, P337, DOI 10.1093/jjco/hys231; BURGER PC, 1979, CANCER, V44, P1256, DOI 10.1002/1097-0142(197910)44:4<1256::AID-CNCR2820440415>3.0.CO;2-T; MARTINS AN, 1977, J NEUROSURG, V47, P336, DOI 10.3171/jns.1977.47.3.0336; Wong ET, 2008, J CLIN ONCOL, V26, P5649, DOI 10.1200/JCO.2008.19.1866; RUSSELL DS, 1949, J NEUROL NEUROSUR PS, V12, P187, DOI 10.1136/jnnp.12.3.187; Ruben JD, 2006, INT J RADIAT ONCOL, V65, P499, DOI 10.1016/j.ijrobp.2005.12.002; O'Connor MM, 2000, NEUROSURGERY, V46, P138; Iuchi T, 2006, INT J RADIAT ONCOL, V64, P1317, DOI 10.1016/j.ijrobp.2005.12.005; Li YQ, 2001, CANCER RES, V61, P3348; ARNOLD A, 1954, NEUROLOGY, V4, P165; Matuschek C, 2011, STRAHLENTHER ONKOL, V187, P135, DOI 10.1007/s00066-010-2184-4; Kawabata S, 2009, J RADIAT RES, V50, P51, DOI 10.1269/jrr.08043; Tsao MN, 1999, J NEUROPATH EXP NEUR, V58, P1051, DOI 10.1097/00005072-199910000-00003; Wang DG, 1999, CANCER RES, V59, P1464; Mizumoto M, 2010, INT J RADIAT ONCOL, V77, P98, DOI 10.1016/j.ijrobp.2009.04.054; Jeyaretna DS, 2011, J CLIN ONCOL, V29, pE159, DOI 10.1200/JCO.2010.31.4815; Yoshii Y, 2008, BRAIN TUMOR PATHOL, V25, P51, DOI 10.1007/s10014-008-0233-9; Heldin CH, 1999, PHYSIOL REV, V79, P1283; Ping YF, 2011, J PATHOL, V224, P344, DOI 10.1002/path.2908; Jagannathan J, 2004, AM J CLIN ONCOL-CANC, V27, P441, DOI 10.1097/01.coc.0000128721.94095.e4; Reigstad LJ, 2005, FEBS J, V272, P5723, DOI 10.1111/j.1742-4658.2005.04989.x; STRIETER RM, 1992, AM J PATHOL, V141, P1279; MASTAGLIA FL, 1976, BRAIN, V99, P101, DOI 10.1093/brain/99.1.101; GLANTZ MJ, 1994, NEUROLOGY, V44, P2020; SCHULTHEISS TE, 1995, INT J RADIAT ONCOL, V31, P1093, DOI 10.1016/0360-3016(94)00655-5; PENNYBACKER J, 1948, J NEUROL NEUROSUR PS, V11, P183, DOI 10.1136/jnnp.11.3.183; GLASS JP, 1984, CANCER, V54, P1966, DOI 10.1002/1097-0142(19841101)54:9<1966::AID-CNCR2820540930>3.0.CO;2-4; Pore N, 2006, CANCER RES, V66, P3197, DOI 10.1158/0008-5472.CAN-05-3090; Yoritsune E, 2014, J RADIAT RES, V55, P803, DOI 10.1093/jrr/rru017; Rempel SA, 2000, CLIN CANCER RES, V6, P102; Li XR, 2010, ONCOTARGET, V1, P309; KURESHI SA, 1994, NEUROSURGERY, V35, P822; Brandsma D, 2008, LANCET ONCOL, V9, P453, DOI 10.1016/S1470-2045(08)70125-6; Pizzi M, 2004, MOL CELL NEUROSCI, V25, P301, DOI 10.1016/j.mcn.2003.10.022; ARNOLD A, 1954, RADIOLOGY, V62, P37; Benoit A, 2011, J NEUROL, V258, P328, DOI 10.1007/s00415-010-5747-5; Pore N, 2004, MOL BIOL CELL, V15, P4841, DOI 10.1091/mbc.E04-05-0374; MCDONALD LW, 1967, AM J PATHOL, V50, P745; Liu AK, 2009, INT J RADIAT ONCOL, V75, P1148, DOI 10.1016/j.ijrobp.2008.12.032; Brandes AA, 2008, J CLIN ONCOL, V26, P2192, DOI 10.1200/JCO.2007.14.8163; MAIONE TE, 1990, SCIENCE, V247, P77, DOI 10.1126/science.1688470; McPherson CM, 2004, J NEURO-ONCOL, V68, P41, DOI 10.1023/B:NEON.0000024744.16031.e9; KONDZIOLKA D, 1992, NEUROSURGERY, V31, P271; Gonzalez J, 2007, INT J RADIAT ONCOL, V67, P323, DOI 10.1016/j.ijrobp.2006.10.010; Levin VA, 2011, INT J RADIAT ONCOL, V79, P1487, DOI 10.1016/j.ijrobp.2009.12.061; Nonoguchi N, 2011, J NEURO-ONCOL, V105, P423, DOI 10.1007/s11060-011-0610-9; Ohguri T, 2007, INT J RADIAT ONCOL, V67, P248, DOI 10.1016/j.ijrobp.2006.08.009; Mizukami Y, 2004, CANCER RES, V64, P1765, DOI 10.1158/0008-5472.CAN-03-3017; KOCH AE, 1992, SCIENCE, V258, P1798, DOI 10.1126/science.1281554; Furuse M, 2011, J NEURO-ONCOL, V102, P471, DOI 10.1007/s11060-010-0333-3; Torcuator R, 2009, J NEURO-ONCOL, V94, P63, DOI 10.1007/s11060-009-9801-z; Nordal RA, 2004, CLIN CANCER RES, V10, P3342, DOI 10.1158/1078-0432.CCR-03-0426; Bui Quoc-Chuong, 2004, International Journal of Radiation Oncology Biology Physics, V60, P871, DOI 10.1016/j.ijrobp.2004.04.019; Fischer AW, 1930, DTSCH Z CHIR, V227, P475; Furuse M, 2015, RADIAT ONCOL, V10, DOI 10.1186/s13014-015-0446-0; KONDZIOLKA D, 1992, NEUROSURGERY, V31, P280; Miyata T, 2014, RADIAT ONCOL, V9, DOI 10.1186/1748-717X-9-51; Miyatake SI, 2015, NEUROL MED-CHIR, V55, P50, DOI 10.2176/nmc.ra.2014-0188; VALK PE, 1991, AM J NEURORADIOL, V12, P45	60	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1860-1480	1860-1499		MED MOL MORPHOL	Med. Mol. Morphol.	DEC	2015	48	4					183	190		10.1007/s00795-015-0123-2		8	Biology; Microscopy; Pathology	Life Sciences & Biomedicine - Other Topics; Microscopy; Pathology	CY7MV	WOS:000366593700001		
J	Wu, H; Iwai, N; Nakano, T; Ooi, Y; Ishihara, S; Sano, K				Wu, Hong; Iwai, Noritaka; Nakano, Takashi; Ooi, Yukimasa; Ishihara, Sonoko; Sano, Kouichi			Route of intrabacterial nanotransportation system for CagA in Helicobacter pylori	MEDICAL MOLECULAR MORPHOLOGY			English	Article						Helicobacter pylori; MreB; A22; CagA; Urease; Localization; Shift; Intrabacterial nanotransportation system; Acidic pH; Immunoelectron microscopy	S-BENZYLISOTHIOUREA COMPOUND; GASTRIC EPITHELIAL-CELLS; ACTIN-LIKE PROTEIN; ESCHERICHIA-COLI; BACTERIAL CYTOSKELETON; SPHERICAL CELLS; UREA CHANNEL; ROD-SHAPE; IN-VIVO; MREB	Helicobacter pylori (H. pylori) possesses an intrabacterial nanotransportation system (ibNoTS) for transporting CagA and urease within the bacterial cytoplasm; this system is controlled by the extrabacterial environment. The transportation routes of the system have not yet been studied in detail. In this study, we demonstrated by immunoelectron microscopy that CagA localizes closely with the MreB filament in the bacterium, and MreB polymerization inhibitor A22 obstructs ibNoTS for CagA. These findings indicate that the route of ibNoTS for CagA is closely associated with the MreB filament. Because these phenomena were not observed in ibNoTS for urease, the route of ibNoTS for CagA is different from that of ibNoTS for urease as previously suggested. We propose that the route of ibNoTS for CagA is associated with the MreB filament in H. pylori.	[Wu, Hong; Iwai, Noritaka; Nakano, Takashi; Sano, Kouichi] Osaka Med Coll, Cent Res Ctr, Project Team Study Nanotransportat Syst, Takatsuki, Osaka 5698686, Japan; [Wu, Hong; Nakano, Takashi; Ooi, Yukimasa; Ishihara, Sonoko; Sano, Kouichi] Osaka Med Coll, Dept Microbiol & Infect Control, Takatsuki, Osaka 5698686, Japan; [Iwai, Noritaka] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa 2268501, Japan	Wu, H (reprint author), Osaka Med Coll, Dept Microbiol & Infect Control, 2-7 Daigaku Machi, Takatsuki, Osaka 5698686, Japan.	wuhong@art.osaka-med.ac.jp					DOI M, 1988, J BACTERIOL, V170, P4619; Cudmore S, 1997, TRENDS MICROBIOL, V5, P142, DOI 10.1016/S0966-842X(97)01011-1; Errington J, 2003, ASM NEWS, V69, P608; Shih YL, 2006, MICROBIOL MOL BIOL R, V70, P729, DOI 10.1128/MMBR.00017-06; Wu H, 2005, J MED MICROBIOL, V54, P1117, DOI 10.1099/jmm.0.46158-0; Beier D, 1997, J BACTERIOL, V179, P4676; BOHN W, 1986, VIROLOGY, V149, P91, DOI 10.1016/0042-6822(86)90090-5; ABHAYAWARDHANE Y, 1995, J BACTERIOL, V177, P765; Weeks DL, 2001, MOL MICROBIOL, V40, P1249, DOI 10.1046/j.1365-2958.2001.02466.x; Skouloubris S, 1998, INFECT IMMUN, V66, P4517; Scott DR, 2000, INFECT IMMUN, V68, P470, DOI 10.1128/IAI.68.2.470-477.2000; van den Ent F, 2001, NATURE, V413, P39, DOI 10.1038/35092500; Hehnly H, 2007, FEBS LETT, V581, P2112, DOI 10.1016/j.febslet.2007.01.094; Celler K, 2013, J BACTERIOL, V195, P1627, DOI 10.1128/JB.02194-12; Greber UF, 2005, P NATL ACAD SCI USA, V102, P5639, DOI 10.1073/pnas.0501696102; Dauty E, 2005, J BIOL CHEM, V280, P7823, DOI 10.1074/jbc.M412374200; Divakaruni AV, 2007, MOL MICROBIOL, V66, P174, DOI 10.1111/j.1365-2958.2007.05910.x; Aoki H, 2009, MED MOL MORPHOL, V42, P40, DOI 10.1007/s00795-008-0431-x; McGowan CC, 1996, GASTROENTEROLOGY, V110, P926, DOI 10.1053/gast.1996.v110.pm8608904; Weeks DL, 2000, SCIENCE, V287, P482, DOI 10.1126/science.287.5452.482; Mizote T, 1997, INFECT IMMUN, V65, P1519; Noguchi N, 2008, BIOL PHARM BULL, V31, P1327, DOI 10.1248/bpb.31.1327; Covacci A, 1999, SCIENCE, V284, P1328, DOI 10.1126/science.284.5418.1328; DE BP, 1993, J BIOL CHEM, V268, P5703; Backert S, 2000, CELL MICROBIOL, V2, P155, DOI 10.1046/j.1462-5822.2000.00043.x; Nakamura H, 1998, INFECT IMMUN, V66, P4832; Hong W, 2003, J MED MICROBIOL, V52, P211, DOI 10.1099/jmm.0.05072-0; Madabhushi R, 2009, MOL CELL, V33, P171, DOI 10.1016/j.molcel.2009.01.001; Iwai N, 2007, BIOSCI BIOTECH BIOCH, V71, P246, DOI 10.1271/bbb.60443; Gerits N, 2007, J BIOL CHEM, V282, P37232, DOI 10.1074/jbc.M704873200; Iwai N, 2004, BIOSCI BIOTECH BIOCH, V68, P2265, DOI 10.1271/bbb.68.2265; Srivastava P, 2007, J BACTERIOL, V189, P7450, DOI 10.1128/JB.00362-07; Iwai N, 2002, BIOSCI BIOTECH BIOCH, V66, P2658; BUCHER D, 1989, J VIROL, V63, P3622; Scott DR, 2007, P NATL ACAD SCI USA, V104, P7235, DOI 10.1073/pnas.0702300104; Schweinitzer T, 2008, J BACTERIOL, V190, P3244, DOI 10.1128/JB.01940-07; Backert S, 2001, MOL MICROBIOL, V42, P631, DOI 10.1046/j.1365-2958.2001.02649.x; Hong W, 2000, J MICROBIOL METH, V42, P121, DOI 10.1016/S0167-7012(00)00165-2; Popp D, 2010, J BIOL CHEM, V285, P15858, DOI 10.1074/jbc.M109.095901; Dempwolff F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027035; Gahlmann A, 2014, NAT REV MICROBIOL, V12, P9, DOI 10.1038/nrmicro3154; Isenberg HD, 2004, CLIN MICROBIOLOGY PR; Jones LJ, 2001, CELL, V23, P913; Kurner J, 2005, SCIENCE, V307, P436, DOI 10.1126/science.1104031; Mollenhauer-Rektorschek M, 2002, RES MICROBIOL, V153, P659, DOI 10.1016/S0923-2508(02)01380-3; Nakano T, 2012, J MICROBIOL MEHOTDS, V60, P60; Scott DR, 1998, GASTROENTEROLOGY, V114, P8; Shaevitz JW, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000364; Soufo CD, 2009, DEV CELL, V15, P935; Wu H, 2014, MED MOL MORPHOL, V47, P224, DOI 10.1007/s00795-013-0068-2	50	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1860-1480	1860-1499		MED MOL MORPHOL	Med. Mol. Morphol.	DEC	2015	48	4					191	203		10.1007/s00795-015-0097-0		13	Biology; Microscopy; Pathology	Life Sciences & Biomedicine - Other Topics; Microscopy; Pathology	CY7MV	WOS:000366593700002		
J	Suzuki, H; Kanchiku, T; Imajo, Y; Yoshida, Y; Nishida, N; Gondo, T; Yoshii, S; Taguchi, T				Suzuki, Hidenori; Kanchiku, Tsukasa; Imajo, Yasuaki; Yoshida, Yuichiro; Nishida, Norihiro; Gondo, Toshikazu; Yoshii, Satoru; Taguchi, Toshihiko			Artificial collagen-filament scaffold promotes axon regeneration and long tract reconstruction in a rat model of spinal cord transection	MEDICAL MOLECULAR MORPHOLOGY			English	Article						Spinal cord injury; Collagen filament; Axonal regeneration; Long tract; Motor evoked potential	MARROW STROMAL CELLS; EVOKED POTENTIALS; SCHWANN-CELLS; INJURY; DELIVERY; MOTOR; REPAIR; TRANSPLANTATION; RECOVERY; GROWTH	Traumatically injured spinal cord (SC) displays structural damage that includes discontinuity of long tracts and cavitations. Axonal regrowth beyond the lesion is necessary to achieve functional recovery following SC injury. We report here the development of an artificial collagen-filament (CF) scaffold to replace the SC in 8-week-old female Fisher rats. Axonal sprouting and regrowth was very rapid following grafting of the CF. One week after implantation, the scaffold was filled with cells of host origin and with regenerated axons. Histological examination of SC adjacent to the scaffold showed little cavity formation or fibrous scarring. Eight weeks after implantation, myelinated nerve fibers were found in the scaffold and 10-25 % of rubrospinal tracts were repaired. Four to six weeks after transplantation, motor evoked potentials were recorded in CF-grafted rats but were not detectable in non-grafted rats. Electrophysiological and histological examinations revealed the grafted CF was likely to function as a nerve tract. In addition, these results suggest that collagen fibers may provide a permissive microenvironment for the elongation of SC axons and to support the process of spinal cord regeneration.	[Suzuki, Hidenori; Kanchiku, Tsukasa; Imajo, Yasuaki; Yoshida, Yuichiro; Nishida, Norihiro; Taguchi, Toshihiko] Yamaguchi Univ, Grad Sch Med, Dept Orthoped Surg, Ube, Yamaguchi 7558505, Japan; [Gondo, Toshikazu] Fujisawa City Hosp, Dept Surg Pathol, Fujisawa, Kanagawa, Japan; [Yoshii, Satoru] Osaka Red Cross Hosp, Dept Rehabil, Osaka, Japan	Suzuki, H (reprint author), Yamaguchi Univ, Grad Sch Med, Dept Orthoped Surg, 1-1-1 Minami Kogushi, Ube, Yamaguchi 7558505, Japan.	hsuzuki@yamaguchi-u.ac.jp			Ministry of Education, Science and Culture of Japan [20791045]	We thank Jun Kawano (Kagoshima University, Kagoshima, Japan) for insightful discussions and for technical advice on the analysis of tracing study results. This work was supported by grants-in-aid for Young Scientific Research B (20791045) from the Ministry of Education, Science and Culture of Japan.	Furutani T, 2006, GASTROENTEROLOGY, V130, P2087, DOI 10.1053/j.gastro.2006.02.060; Kaneko K, 2001, CLIN NEUROPHYSIOL, V112, P1035, DOI 10.1016/S1388-2457(01)00533-8; Jain A, 2006, BIOMATERIALS, V27, P497, DOI 10.1016/j.biomaterials.2005.07.008; Blesch A, 2003, J COMP NEUROL, V467, P403, DOI 10.1002/cne.10934; Yoshii S, 2004, J BIOMED MATER RES A, V70A, P569, DOI 10.1002/jbm.a.30120; Rossignol S, 2007, J NEUROSCI, V27, P11782, DOI 10.1523/JNEUROSCI.3444-07.2007; Novikova LN, 2003, CURR OPIN NEUROL, V16, P711, DOI 10.1097/01.wco.0000102620.38669.3e; Suzuki H, 2004, BIOCHEM BIOPH RES CO, V322, P918, DOI 10.1016/j.bbrc.2004.07.201; Ragnarsson KT, 2008, SPINAL CORD, V46, P255, DOI 10.1038/sj.sc.3102091; Friedman JA, 2002, NEUROSURGERY, V51, P742, DOI 10.1097/00006123-200209000-00024; Huang YC, 2006, ARTIF ORGANS, V30, P514, DOI 10.1111/j.1525-1594.2006.00253.x; Onose G, 2009, SPINAL CORD, V47, P716, DOI 10.1038/sc.2009.52; Stokic DS, 2010, SPINAL CORD, V48, P649, DOI 10.1038/sc.2009.187; Suzuki H, 2011, MED MOL MORPHOL, V44, P131, DOI 10.1007/s00795-010-0519-y; Wright KT, 2008, SPINAL CORD, V46, P811, DOI 10.1038/sc.2008.77; Tuszynski MH, 1996, EXP NEUROL, V137, P157, DOI 10.1006/exnr.1996.0016; Tator CH, 2006, NEUROSURGERY, V59, P957, DOI 10.1227/01.NEU.0000245591.16087.89; YAMADA H, 1995, ZOOL SCI, V12, P325; Tsai EC, 2006, BIOMATERIALS, V27, P519, DOI 10.1016/j.biomaterials.2005.07.025; Guo SZ, 2010, SPINAL CORD, V48, P576, DOI 10.1038/sc.2009.170; DELATORRE JC, 1981, LAB ANIM SCI, V31, P701; Yoshii S, 2003, SPINE, V28, P2346, DOI 10.1097/01.BRS.0000085302.95413.16; McDonald JW, 2002, LANCET, V359, P417, DOI 10.1016/S0140-6736(02)07603-1; Fujiki M, 2004, EXP NEUROL, V187, P468, DOI 10.1016/j.expneurol.2004.03.009; Chhabra HS, 2009, SPINAL CORD, V47, P887, DOI 10.1038/sc.2009.54; Wakabayashi Y, 2001, SPINE, V26, P1215, DOI 10.1097/00007632-200106010-00009; Novikova LN, 2008, BIOMATERIALS, V29, P1198, DOI 10.1016/j.biomaterials.2007.11.033; Moore MJ, 2006, BIOMATERIALS, V27, P419, DOI 10.1016/j.biomaterials.2005.07.045; Yara T, 2009, MED MOL MORPHOL, V42, P150, DOI 10.1007/s00795-009-0454-y; Hurtado A, 2006, BIOMATERIALS, V27, P430, DOI 10.1016/j.biomaterials.2005.07.014; Cao Q, 2005, EXP NEUROL, V191, P3; Geisler S, 2002, HISTOCHEM CELL BIOL, V117, P69, DOI 10.1007/s00418-001-0357-z; Geller M, 2002, EXP NEUROL, V174, P125	33	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1860-1480	1860-1499		MED MOL MORPHOL	Med. Mol. Morphol.	DEC	2015	48	4					214	224		10.1007/s00795-015-0104-5		11	Biology; Microscopy; Pathology	Life Sciences & Biomedicine - Other Topics; Microscopy; Pathology	CY7MV	WOS:000366593700004		
J	Matsuzaki, Y; Wu, H; Nakano, T; Nakahari, T; Sano, K				Matsuzaki, Yuji; Wu, Hong; Nakano, Takashi; Nakahari, Takashi; Sano, Kouichi			ATP-association to intrabacterial nanotransportation system in Vibrio cholerae	MEDICAL MOLECULAR MORPHOLOGY			English	Article						Vibrio cholerae; Nanotransportation; ATP; Immunoelectron microscopy; Cholera toxin	HELICOBACTER-PYLORI; BACTERIAL CYTOSKELETON; SECRETION; COMPLEX; CELL; 8-AMINO-ADENOSINE; TOXIN	Vibrio cholerae colonizes the lumen of the proximal small intestine, which has an alkaline environment, and secretes cholera toxin (CT) through a type II secretion machinery. V. cholerae possesses the intrabacterial nanotransportation system (ibNoTS) for transporting CT from the inner portion toward the peripheral portion of the cytoplasm, and this system is controlled by extrabacterial pH. Association of ATP with ibNoTS has not yet been examined in detail. In this study, we demonstrated by immunoelectron microscopy that ibNoTS of V. cholerae under the extrabacterial alkaline condition was inhibited by ATP inhibitors, 2,4-dinitrophenol (DNP), a protonophore, or 8-amino-adenosine which produces inactive form of ATP. The inhibition of CT transport can be reversed by neutralization of DNP. Those inhibitions were associated with decrease of CT secretion by which ibNoTS followed. We propose that ATP closely associates with V. cholerae ibNoTS for transporting CT.	[Matsuzaki, Yuji; Wu, Hong; Nakano, Takashi; Sano, Kouichi] Osaka Med Coll, Dept Microbiol & Infect Control, Takatsuki, Osaka 5698686, Japan; [Nakahari, Takashi] Osaka Med Coll, Dept Physiol, Takatsuki, Osaka 5698686, Japan	Sano, K (reprint author), Osaka Med Coll, Dept Microbiol & Infect Control, 2-7 Daigaku Machi, Takatsuki, Osaka 5698686, Japan.	ksano@art.osaka-med.ac.jp					Alberts B, 2007, MOL BIOL CELL; Sandkvist M, 2000, INT J MED MICROBIOL, V290, P345; Saville RM, 2011, J BACTERIOL, V193, P3257, DOI 10.1128/JB.00251-11; Shih YL, 2006, MICROBIOL MOL BIOL R, V70, P729, DOI 10.1128/MMBR.00017-06; Wu H, 2005, J MED MICROBIOL, V54, P1117, DOI 10.1099/jmm.0.46158-0; HOBOT JA, 1984, J BACTERIOL, V160, P143; Yamada H, 2010, J MICROBIOL METH, V80, P14, DOI 10.1016/j.mimet.2009.09.022; GRAHAM LL, 1991, J BACTERIOL, V173, P1623; van den Ent F, 2001, NATURE, V413, P39, DOI 10.1038/35092500; Gschwantler M, 1998, EUR J GASTROEN HEPAT, V10, P579, DOI 10.1097/00042737-199807000-00010; Hehnly H, 2007, FEBS LETT, V581, P2112, DOI 10.1016/j.febslet.2007.01.094; Meno Y, 1998, ARCH MICROBIOL, V170, P339, DOI 10.1007/s002030050651; Papanikou E, 2007, NAT REV MICROBIOL, V5, P839, DOI 10.1038/nrmicro1771; Matson JS, 2007, INFECT IMMUN, V75, P5542, DOI 10.1128/IAI.01094-07; Aoki H, 2009, MED MOL MORPHOL, V42, P40, DOI 10.1007/s00795-008-0431-x; Randall LL, 2002, CELL MOL LIFE SCI, V59, P1617, DOI 10.1007/PL00012488; Luirink J, 2004, BBA-MOL CELL RES, V1694, P17, DOI 10.1016/j.bbamcr.2004.03.013; Ataide SF, 2011, SCIENCE, V331, P881, DOI 10.1126/science.1196473; Frey JA, 2010, MOL CANCER THER, V9, P236, DOI 10.1158/1535-7163.MCT-09-0767; Hong W, 2003, J MED MICROBIOL, V52, P211, DOI 10.1099/jmm.0.05072-0; BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0; KONDO K, 1993, MICROBIOL IMMUNOL, V37, P149; Ausmees N, 2003, CELL, V115, P705, DOI 10.1016/S0092-8674(03)00935-8; HOPFER U, 1968, P NATL ACAD SCI USA, V59, P484, DOI 10.1073/pnas.59.2.484; HOBOT JA, 1985, J BACTERIOL, V162, P960; Du Plessis DJF, 2011, BBA-BIOMEMBRANES, V1808, P851, DOI 10.1016/j.bbamem.2010.08.016; Korotkov KV, 2012, NAT REV MICROBIOL, V10, P336, DOI 10.1038/nrmicro2762; Krett NL, 2004, MOL CANCER THER, V3, P1411; Hong W, 2000, J MICROBIOL METH, V42, P121, DOI 10.1016/S0167-7012(00)00165-2; Johnson XL, 2012, NATURE, V483, P489; Klann M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029645; Lamers CBHW, 1996, EUR J GASTROEN HEPAT, V8, pS3, DOI 10.1097/00042737-199610001-00002; Oison ER, 1993, MOL MICROBIOL, V8, P5; Sack DA, 2004, LANCET, V233, P323; Wu H, 2014, MED MOL MORPHOL, V47, P224, DOI 10.1007/s00795-013-0068-2; Wu H, 2015, MED MOL MORPHOL, V48, P191, DOI 10.1007/s00795-015-0097-0	36	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1860-1480	1860-1499		MED MOL MORPHOL	Med. Mol. Morphol.	DEC	2015	48	4					225	234		10.1007/s00795-015-0105-4		10	Biology; Microscopy; Pathology	Life Sciences & Biomedicine - Other Topics; Microscopy; Pathology	CY7MV	WOS:000366593700005		
J	Ohtsuki, Y; Mori, K; Ohnishi, H; Enzan, H; Iguchi, M; Lee, GH; Furihata, M				Ohtsuki, Yuji; Mori, Kousuke; Ohnishi, Hirozo; Enzan, Hideaki; Iguchi, Mitsuko; Lee, Gang-Hong; Furihata, Mutsuo			Investigation of aluminum and iron deposition on metaplastic bones in three patients with diffuse pulmonary ossification	MEDICAL MOLECULAR MORPHOLOGY			English	Article						Diffuse pulmonary ossification; Histochemistry; Metaplastic bone; Aluminum; Iron	INTERSTITIAL LUNG-DISEASE; FIBROSIS	Diffuse pulmonary ossification (DPO) is a rare pulmonary lesion. DPO is typically detected at autopsy rather than premortem. Recently, however, several cases were diagnosed antemortem using computed tomography, high-resolution computed tomography, or video-assisted thoracic surgery. In the present study, we evaluated DPO at autopsy from two patients with post-myocardial infarction (cases 1 and 3) and one patient with duodenal cancer (case 2). Multiple metaplastic bones (nodular in case 1 and 3 or dendriform in case 2) were detected in these three cases. In an attempt to detect aluminum and iron deposition in these metaplastic bones, histochemical investigations were performed. The two nodular types of one and three cases were positive for aluminum and iron, but the dendriform type of case 2 was positive only for aluminum. The depositions occurred in a linear pattern along the calcifying front. It is of great interest that these deposition patterns were similar to those of bones from three previously reported DPO cases and from the bones of hemodialysis patients. It is suggested that these abnormal metal depositions in the calcifying front might disturb the normal mineralization processes of the metaplastic bones, although no morphological abnormality was detected, except for dense black color of calcifying front lines. Further investigations are needed in more patients with DPO to obtain more information on this topic.	[Ohtsuki, Yuji] Matsuyama Shimin Hosp, Dept Diagnost Pathol, Matsuyama, Ehime 7900067, Japan; [Mori, Kousuke] Murakami Mem Hosp, Dept Internal Med, Imabari, Ehime, Japan; [Ohnishi, Hirozo] Ehime Rosai Hosp, Dept Pathol, Niihama, Ehime, Japan; [Enzan, Hideaki] Chikamori Hosp, Dept Diagnost Pathol, Kochi, Japan; [Iguchi, Mitsuko; Lee, Gang-Hong; Furihata, Mutsuo] Kochi Univ, Kochi Med Sch, Dept Pathol, Kochi 780, Japan	Ohtsuki, Y (reprint author), Matsuyama Shimin Hosp, Dept Diagnost Pathol, Matsuyama, Ehime 7900067, Japan.	y.ohtsuki@matsuyama-shimin-hsp.or.jp					Abe J, 2014, THORAX, V69, P97, DOI 10.1136/thoraxjnl-2012-203024; Ohtsuki Y, 2008, HISTOL HISTOPATHOL, V23, P137; OHTSUKI Y, 1989, STAIN TECHNOL, V64, P55; Crisosto CAF, 2004, ARCH BRONCONEUMOL, V40, P595; Konoglou M, 2013, J THORAC DIS, V5, P101, DOI 10.3978/j.issn.2072-1439.2013.01.09; Burkett A, 2014, CAN RESPIR J, V21, P23; Lara JF, 2005, ARCH PATHOL LAB MED, V129, P348; Harvey NT, 2012, PATHOLOGY, V44, P363, DOI 10.1097/PAT.0b013e328353be01; Reddy TL, 2012, J THORAC IMAG, V27, pW108, DOI 10.1097/RTI.0b013e3182326c38; Kim TS, 2005, EUR RADIOL, V15, P1581, DOI 10.1007/s00330-005-2671-7; Tseung J, 2006, PATHOLOGY, V38, P45, DOI 10.1080/00313020500464912; Peros-Golubicic T, 2008, CURR OPIN PULM MED, V14, P488, DOI 10.1097/MCP.0b013e3283043e1b; Rajwani NA, 2014, CAN RESPIR J, V21, P83; Trejo O, 2002, ARCH BRONCONEUMOL, V38, P399; Mizushina Y, 2012, INTERNAL MED, V51, P2923, DOI 10.2169/internalmedicine.51.7520; Jamjoom Lamia, 2013, Indian J Radiol Imaging, V23, P15, DOI 10.4103/0971-3026.113613; Ohtsuki Y, 1992, KIDNEY METAB BONE DI, V5, P87	17	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1860-1480	1860-1499		MED MOL MORPHOL	Med. Mol. Morphol.	DEC	2015	48	4					235	238		10.1007/s00795-015-0096-1		4	Biology; Microscopy; Pathology	Life Sciences & Biomedicine - Other Topics; Microscopy; Pathology	CY7MV	WOS:000366593700006		
J	Matsuzaki, Y; Wu, H; Nakano, T; Nakahari, T; Sano, K				Matsuzaki, Yuji; Wu, Hong; Nakano, Takashi; Nakahari, Takashi; Sano, Kouichi			ATP-association to intrabacterial nanotransportation system in Vibrio cholerae (vol 48, pg 225, 2015)	MEDICAL MOLECULAR MORPHOLOGY			English	Correction									[Matsuzaki, Yuji; Wu, Hong; Nakano, Takashi; Sano, Kouichi] Osaka Med Coll, Dept Microbiol & Infect Control, Takatsuki, Osaka 5698686, Japan; [Nakahari, Takashi] Osaka Med Coll, Dept Physiol, Takatsuki, Osaka 5698686, Japan	Sano, K (reprint author), Osaka Med Coll, Dept Microbiol & Infect Control, 2-7 Daigaku Machi, Takatsuki, Osaka 5698686, Japan.	ksano@art.osaka-med.ac.jp					Matsuzaki Y, 2015, MED MOL MORPHOL, V48, P225, DOI 10.1007/s00795-015-0105-4	1	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1860-1480	1860-1499		MED MOL MORPHOL	Med. Mol. Morphol.	DEC	2015	48	4					239	240		10.1007/s00795-015-0113-4		2	Biology; Microscopy; Pathology	Life Sciences & Biomedicine - Other Topics; Microscopy; Pathology	CY7MV	WOS:000366593700007		
J	Shoji, K; Akiyama, Y; Suzuki, M; Nakamura, N; Ohno, H; Morishima, K				Shoji, Kan; Akiyama, Yoshitake; Suzuki, Masato; Nakamura, Nobuhumi; Ohno, Hiroyuki; Morishima, Keisuke			Insect biofuel cell using an electrode with gold nanoparticles deposited by sputtering	MICRO & NANO LETTERS			English	Article						biofuel; fuel cells; gold; nanoparticles; sputter deposition; catalysts; sugar; oxidation; enzymes; electrochemical electrodes; insect biofuel cell; gold nanoparticle; sputter deposition; high-stability living battery; metallic catalyst; glucose oxidation; enzyme; insect haemolymph; battery anode; carbon cloth; vacuum state; cockroach haemolymph; CHL; electrocatalytic stability; bilirubin oxidase-modified electrode; Au	BEHAVIOR	A high-stability living battery that uses a metallic catalyst for glucose oxidation instead of enzymes is investigated. In this battery, glucose in insect haemolymph is oxidised by a gold nanoparticle (AuNP)-modified electrode, which is utilised as the anode of the battery. The AuNP-modified electrode was fabricated by sputtering gold onto a carbon cloth in a low-vacuum state. First, the oxidation performance values of glucose were evaluated and the oxidation current of glucose was obtained by the AuNP-modified electrode from cockroach haemolymph (CHL). Then, the electrocatalytic stability of the AuNP-modified electrode was compared with an enzymatic electrode. Furthermore, a glucose biofuel cell consisting of the AuNP-modified electrode and a bilirubin oxidase-modified electrode was constructed; the respective power densities obtained from 100 mM glucose solution and CHL were 22.4 and 15.1 mu W/cm(2), respectively. It is concluded that AuNPs are a useful catalyst for living batteries.	[Shoji, Kan; Akiyama, Yoshitake; Morishima, Keisuke] Osaka Univ, Dept Mech Engn, Suita, Osaka 5650871, Japan; [Shoji, Kan] Japan Soc Promot Sci, Tokyo 1020083, Japan; [Suzuki, Masato; Nakamura, Nobuhumi; Ohno, Hiroyuki] Tokyo Univ Agr & Technol, Dept Biotechnol & Life Sci, Koganei, Tokyo, Japan	Shoji, K (reprint author), Osaka Univ, Dept Mech Engn, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	morishima@mech.eng.osaka-u.ac.jp			Industrial Research Program of New Energy and Industrial Technology Development Organization (NEDO); Ministry of Education, Culture, Sports, Science and Technology in Japan [20034017, 21676002, 21225007, 21111503, 23111705, 26249027]; Tokyo Energy Power Company (TEPCO) Memorial Foundation; Japan Society for the Promotion of Science (JSPS)	This work was partly supported by the Industrial Research Program of New Energy and Industrial Technology Development Organization (NEDO), Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology in Japan (nos. 20034017, 21676002, 21225007, 21111503, 23111705 and 26249027), the Tokyo Energy Power Company (TEPCO) Memorial Foundation and the Japan Society for the Promotion of Science (JSPS) Research Fellow Program.	Shoji K, 2012, BIOMED MICRODEVICES, V14, P1063, DOI 10.1007/s10544-012-9706-z; Miyake T, 2011, J AM CHEM SOC, V133, P5129, DOI 10.1021/ja111517e; Falk M, 2012, BIOSENS BIOELECTRON, V37, P38, DOI 10.1016/j.bios.2012.04.030; Coman V, 2010, FUEL CELLS, V10, P9, DOI 10.1002/fuce.200900121; Szczupak A, 2012, ENERG ENVIRON SCI, V5, P8891, DOI 10.1039/c2ee21626d; Cinquin P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010476; Wang CL, 2004, ELECTROCHEM SOLID ST, V7, pA435, DOI 10.1149/1.1798151; Kuwana Y, 1999, BIOSENS BIOELECTRON, V14, P195, DOI 10.1016/S0956-5663(98)00106-7; Zebda A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01516; Naruse J, 2011, BIOSENS BIOELECTRON, V30, P204, DOI 10.1016/j.bios.2011.09.012; Tominaga M, 2007, ELECTROCHEM COMMUN, V9, P1892, DOI 10.1016/j.elecom.2007.04.024; Kanzaki R, 1996, ROBOT AUTON SYST, V18, P33, DOI 10.1016/0921-8890(95)00081-X; Bozkurt A, 2009, IEEE T BIO-MED ENG, V56, P2304, DOI 10.1109/TBME.2009.2022551; Rasmussen M, 2012, J AM CHEM SOC, V134, P1458, DOI 10.1021/ja210794c; Falk M, 2013, CHEMPHYSCHEM, V14, P2045, DOI 10.1002/cphc.201300044; Halamkova L, 2012, J AM CHEM SOC, V134, P5040, DOI 10.1021/ja211714w; Wang XJ, 2012, BIOSENS BIOELECTRON, V31, P219, DOI 10.1016/j.bios.2011.10.020; Katz E, 2013, ENERG ENVIRON SCI, V6, P2791, DOI 10.1039/c3ee42126k; Sato Hirotaka, 2009, Front Integr Neurosci, V3, P24, DOI 10.3389/neuro.07.024.2009	19	0	0	INST ENGINEERING TECHNOLOGY-IET	HERTFORD	MICHAEL FARADAY HOUSE SIX HILLS WAY STEVENAGE, HERTFORD SG1 2AY, ENGLAND	1750-0443			MICRO NANO LETT	Micro Nano Lett.	DEC	2015	10	12					674	677		10.1049/mnl.2015.0374		4	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary	Science & Technology - Other Topics; Materials Science	CY7PS	WOS:000366601400002		
J	Uesugi, A; Hirai, Y; Sugano, K; Tsuchiya, T; Tabata, O				Uesugi, Akio; Hirai, Yoshikazu; Sugano, Koji; Tsuchiya, Toshiyuki; Tabata, Osamu			Effect of crystallographic orientation on tensile fractures of (100) and (110) silicon microstructures fabricated from silicon-on-insulator wafers	MICRO & NANO LETTERS			English	Article						crystal orientation; tensile strength; fracture toughness; silicon; surface morphology; crystal defects; crystal microstructure; microfabrication; crystallographic orientation effect; tensile fractures; (100) silicon microstructures; (110) silicon microstructures; silicon-on-insulator wafers; surface orientations; surface morphology; tensile testing; average strength; pit-like defects; bottom surfaces; SOI bonding processes; intrinsic SOI defects; high-strength structures; size 5 mum; pressure 3; 62 GPa to 3; 14 GPa; Si	SINGLE-CRYSTAL SILICON; THIN-FILMS; ANISOTROPY; STRENGTH; AFM	This Letter investigates the effect of crystallographic orientation on tensile fractures of silicon microstructures. Specimens 5 m wide and 5 m thick were fabricated on (100) and (110) wafers with 100, 110, and 111 tensile axes. To explore the effects of different surface orientations and morphologies, these specimens were patterned from (100) and (110) silicon-on-insulator (SOI) wafers using the Bosch process under identical fabrication conditions, while other specimens were fabricated from (110) wafers under different conditions. Tensile tests of specimens prepared under the identical fabrication conditions showed that (100) specimens had lower strength than (110) specimens along the 100 and 110 axes; the average strength decreased from 3.62 to 3.14 GPa for 110. This decrease in strength is related to differences in damage that ultimately causes fractures. While (110) specimens fractured due to fabrication damage at top corners, fractures of (100) specimens were due to pit-like defects on bottom surfaces. Since these defects were introduced during SOI bonding processes, the fractures of (100) specimens were dominated by intrinsic SOI defects rather than damage introduced during specimen fabrication processes. To realise higher-strength structures on SOI wafers, both the damage caused during fabrication and the intrinsic defects need to be controlled.	[Uesugi, Akio; Hirai, Yoshikazu; Sugano, Koji; Tsuchiya, Toshiyuki; Tabata, Osamu] Kyoto Univ, Dept Micro Engn, Kyoto 6158540, Japan	Uesugi, A (reprint author), Kyoto Univ, Dept Micro Engn, Kyoto 6158540, Japan.	a_uesugi@nms.me.kyoto-u.ac.jp					Tsuchiya T, 2010, SENSOR MATER, V22, P1; Tsuchiya T, 1998, J MICROELECTROMECH S, V7, P106, DOI 10.1109/84.661392; Gaither MS, 2013, J MICROELECTROMECH S, V22, P589, DOI 10.1109/JMEMS.2012.2234724; Namazu T, 2000, J MICROELECTROMECH S, V9, P450, DOI 10.1109/84.896765; Aga H, 1999, JPN J APPL PHYS 1, V38, P2694, DOI 10.1143/JJAP.38.2694; HESKETH PJ, 1993, J ELECTROCHEM SOC, V140, P1080, DOI 10.1149/1.2056201; Hajika R, 2014, J MICROMECH MICROENG, V24, DOI 10.1088/0960-1317/24/10/105014; Yi TC, 2000, SENSOR ACTUAT A-PHYS, V83, P172, DOI 10.1016/S0924-4247(00)00350-2; Tsuchiya T, 2010, EXP MECH, V50, P509, DOI 10.1007/s11340-009-9258-1; Nakao S, 2008, J MICROMECH MICROENG, V18, DOI 10.1088/0960-1317/18/1/015026; Tsuchiya T, 2005, J MICROELECTROMECH S, V14, P1178, DOI 10.1109/JMEMS.2005.851820; Li XP, 2005, SENSOR ACTUAT A-PHYS, V117, P143, DOI 10.1016/j.sna.2004.06.003; Shikida M, 2015, MICROSYST TECHNOL, V21, P661, DOI 10.1007/s00542-014-2075-1; Izumi S., 2007, ZAIRYO J SOC MAT SCI, V56, P920, DOI [10.2472/jsms.56.920, DOI 10.2472/JSMS.56.920]; Mitwally M. E., 2015, MICROSYST TECHNOL; Perez R, 2000, ACTA MATER, V48, P4517, DOI 10.1016/S1359-6454(00)00238-X; Uesugi A., 2013, T JSME A, V79, P1191, DOI [10.1299/kikaia.79.1191, DOI 10.1299/KIKAIA.79.1191]; WEIBULL W, 1951, J APPL MECH-T ASME, V18, P293	18	0	0	INST ENGINEERING TECHNOLOGY-IET	HERTFORD	MICHAEL FARADAY HOUSE SIX HILLS WAY STEVENAGE, HERTFORD SG1 2AY, ENGLAND	1750-0443			MICRO NANO LETT	Micro Nano Lett.	DEC	2015	10	12					678	682		10.1049/mnl.2015.0334		5	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary	Science & Technology - Other Topics; Materials Science	CY7PS	WOS:000366601400003		
J	Kubota, M; Takamizawa, H; Shimizu, Y; Nozawa, Y; Ebisawa, N; Toyama, T; Ishida, Y; Yanagiuchi, K; Inoue, K; Nagai, Y				Kubota, Masaki; Takamizawa, Hisashi; Shimizu, Yasuo; Nozawa, Yasuko; Ebisawa, Naoki; Toyama, Takeshi; Ishida, Yoichi; Yanagiuchi, Katsuaki; Inoue, Koji; Nagai, Yasuyoshi			Elemental Distribution in Multilayer Systems by Laser-Assisted Atom Probe Tomography with Various Analysis Directions	MICROSCOPY AND MICROANALYSIS			English	Article						magnetic multilayers; atom probe tomography; field evaporation; artifact	SPECIMEN PREPARATION; ROOM-TEMPERATURE; TUNNEL-JUNCTIONS; MAGNETORESISTANCE; RECONSTRUCTION	Elemental distributions in a magnetic multilayer system with the structure Si substrate/Ta/NiFe/Ru/CoFeB/Ru/NiFe were studied using atom probe tomography (APT) along different analysis directions. The distributions of Ru and B atoms, which require a high evaporation field, were strongly influenced by the APT analysis direction. In particular, B in the CoFeB layer appeared near the interface with the lower Ru layer when the analysis was anti-parallel to the film growth direction, while B atoms were observed at the other side of the CoFeB layer when the analysis was parallel to the film growth direction. Moreover, when the analysis was perpendicular to the film growth direction, a homogenous distribution of B atoms was found within the CoFeB layer. Owing to this B behavior, the underlying Ru layer was affected in both of these analysis directions. In APT measurements of such a multilayer system composed of a stack of different evaporation field materials, evaluation of the elemental distribution around interfaces should be performed from more than one analysis direction.	[Kubota, Masaki; Ishida, Yoichi; Yanagiuchi, Katsuaki] TDK Corp, Saku, Nagano 3858555, Japan; [Takamizawa, Hisashi; Shimizu, Yasuo; Nozawa, Yasuko; Ebisawa, Naoki; Toyama, Takeshi; Inoue, Koji; Nagai, Yasuyoshi] Tohoku Univ, Inst Mat Res, Oarai Ctr, Oarai, Ibaraki 3111313, Japan	Yanagiuchi, K (reprint author), TDK Corp, 543 Otai, Saku, Nagano 3858555, Japan.	kyanagi@jp.tdk.com					Parkin SSP, 2004, NAT MATER, V3, P862, DOI 10.1038/nmat1256; Vurpillot F, 2004, MICROSC MICROANAL, V10, P384, DOI 10.1017/S1431927604040486; Larson DJ, 1999, ULTRAMICROSCOPY, V79, P287, DOI 10.1016/S0304-3991(99)00055-8; Koelling S, 2011, ULTRAMICROSCOPY, V111, P540, DOI 10.1016/j.ultramic.2011.01.004; Inoue K, 2009, ULTRAMICROSCOPY, V109, P1479, DOI 10.1016/j.ultramic.2009.08.002; Vurpillot F, 2013, ULTRAMICROSCOPY, V132, P19, DOI 10.1016/j.ultramic.2013.03.010; TSONG TT, 1978, SURF SCI, V70, P211, DOI 10.1016/0039-6028(78)90410-7; Larson DJ, 1999, NANOTECHNOLOGY, V10, P45, DOI 10.1088/0957-4484/10/1/010; Kagami T, 2006, IEEE T MAGN, V42, P93, DOI 10.1109/TMAG.2005.861796; Ikeda S, 2010, NAT MATER, V9, P721, DOI [10.1038/nmat2804, 10.1038/NMAT2804]; Kambham AK, 2011, ULTRAMICROSCOPY, V111, P535, DOI 10.1016/j.ultramic.2011.01.017; Larson DJ, 2011, SCRIPTA MATER, V64, P673, DOI 10.1016/j.scriptamat.2010.12.021; Prosa TJ, 2009, MICROSC MICROANAL, V15, P298, DOI 10.1017/S1431927609093295; Larson DJ, 2012, MICROSC MICROANAL, V18, P953, DOI 10.1017/S1431927612001523; Larson DJ, 2013, CURR OPIN SOLID ST M, V17, P236, DOI 10.1016/j.cossms.2013.09.002; Larson DJ, 2011, ULTRAMICROSCOPY, V111, P506, DOI 10.1016/j.ultramic.2010.12.010; Hono K, 2011, ULTRAMICROSCOPY, V111, P576, DOI 10.1016/j.ultramic.2010.11.020; Bae JY, 2006, J APPL PHYS, V99, DOI 10.1063/1.2170591; Bouchikhaoui H, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4824033; Brandon D. G., 1964, SURF SCI, V3, P1; Butler W. H., 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.054416; Cha JJ, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2769753; Djayaprawira DD, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1871344; Gault B, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2194089; Gault B, 2010, J APPL PHYS, V108, DOI 10.1063/1.3462399; Geiser BP, 2009, MICROSC MICROANAL, V15, P292, DOI 10.1017/S1431927609098249; Ibusuki T, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3080208; Karthik SV, 2009, J APPL PHYS, V106, DOI 10.1063/1.3182817; Karthik SV, 2012, J APPL PHYS, V111, DOI 10.1063/1.4707964; Kelly TF, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2709758; Kim DJ, 2007, J APPL PHYS, V101, DOI 10.1063/1.2713431; Larson DJ, 2011, J PHYS CONF SER, V326, DOI 10.1088/1742-6596/326/1/012030; Larson D. J., 2010, J MICROSC-OXFORD, V243, P15; Marquis EA, 2011, J MICROSC-OXFORD, V241, P225, DOI 10.1111/j.1365-2818.2010.03421.x; Mathon J, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.220403; Miller M. K., 1996, ATOM PROBE FIELD ION, P83; Miller MK, 2007, MICROSC MICROANAL, V13, P428, DOI 10.1017/S1431927607070845; Miller M. K., 2000, ATOM PROBE TOMOGRAPH, P222; Miyajima T, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3106624; Pinitsoontorn S, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2973045; Schreiber DK, 2011, J APPL PHYS, V109, DOI 10.1063/1.3583569; Shimizu Y, 2011, J APPL PHYS, V109, DOI 10.1063/1.3544496; Takamizawa H, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3644960; Takamizawa H, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3690864; Yuasa S, 2004, NAT MATER, V3, P868, DOI 10.1038/nmat1257; Yuasa S, 2004, JPN J APPL PHYS 2, V43, pL588, DOI 10.1143/JJAP.43.L588	46	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1431-9276	1435-8115		MICROSC MICROANAL	Microsc. microanal.	DEC	2015	21	6					1373	1378		10.1017/S1431927615015160		6	Materials Science, Multidisciplinary; Microscopy	Materials Science; Microscopy	CY8LS	WOS:000366660500001		
J	Kubo, Y; Kuramochi, K				Kubo, Yugo; Kuramochi, Koji			Observation of Fine Distribution of Minor Dopants in an Erbium-Doped Fiber Core using a Sample Thinning Technique for Field Emission Electron Probe Microanalysis	MICROSCOPY AND MICROANALYSIS			English	Article						erbium-doped fiber; sample thinning technique; field emission electron probe microanalysis; minor dopants	MINIMUM DETECTION LIMIT; SPATIAL-RESOLUTION; SPECIMENS	To observe the fine distribution of minor aluminum and germanium dopants in the erbium-doped fiber (EDF) core of an optical amplifier, a sample thinning technique was applied for field emission electron probe microanalysis (FE-EPMA) together with wavelength-dispersive X-ray spectrometry. This technique significantly improved the spatial resolution without much degradation of the minimum detection limit for FE-EPMA. As such, this enabled us to observe the distribution of minor dopants in EDF. Moreover, we propose a very simple sample preparation to prevent electron-beam radiation damage, a problem involved with FE-EPMA of low-conductivity materials such as SiO2 glass, which is the main component of EDF.	[Kubo, Yugo; Kuramochi, Koji] Sumitomo Elect Ind Ltd, Anal Technol Res Ctr, Osaka, Osaka 5540024, Japan	Kubo, Y (reprint author), Sumitomo Elect Ind Ltd, Anal Technol Res Ctr, 1-1-3 Shimaya, Osaka, Osaka 5540024, Japan.	kubo-yugo@sei.co.jp					NAMAE T, 1975, J ELECTRON MICROSC, V24, P1; BRUGGER K, 1971, APPL OPTICS, V10, P437, DOI 10.1364/AO.10.000437; Kubo Y, 2013, ULTRAMICROSCOPY, V135, P64, DOI 10.1016/j.ultramic.2013.05.011; Kimura T, 2006, MICROCHIM ACTA, V155, P175, DOI 10.1007/s00604-006-0538-5; Rinaldi R, 2015, MICROSC MICROANAL, V21, P1053, DOI 10.1017/S1431927615000409; KANAYA K, 1972, J PHYS D APPL PHYS, V5, P43, DOI 10.1088/0022-3727/5/1/308; FRENCH WG, 1973, APPL PHYS LETT, V23, P338, DOI 10.1063/1.1654910; Hovington P, 1997, SCANNING, V19, P1; Haruna T, 2006, OPT EXPRESS, V14, P11036, DOI 10.1364/OE.14.011036; Kubo Y, 2015, ULTRAMICROSCOPY, V157, P48, DOI 10.1016/j.ultramic.2015.05.019; YOSHIDA S, 1995, ELECTRON LETT, V31, P1765, DOI 10.1049/el:19951226; Berger D, 2014, IOP CONF SER-MAT SCI, V55, DOI 10.1088/1757-899X/55/1/012002; Cao C. K., 1982, OPTICAL FIBER SYSTEM; Castaing R., 1960, ADV ELECTRONICS ELEC, V13, P317, DOI 10.1016/S0065-2539(08)60212-7; DUNCUMB P, 1963, BRIT J APPL PHYS, V14, P617, DOI 10.1088/0508-3443/14/10/306; Goldstein J. I., 1992, SCANNING ELECT MICRO; Goldstein J. I., 1979, INTRO ANAL ELECT MIC; Hashimoto T., 2005, J SURFACE ANAL, V12, P405; Jenkins R., 1981, QUANTITATIVE XRAY SP; Kamino T, 2005, INTRODUCTION TO FOCUSED ION BEAMS: INSTRUMENTATION, THEORY, TECHNIQUES AND PRACTICE, P229, DOI 10.1007/0-387-23313-X_11; Kimura T., 2003, J SURFACE ANAL, V10, P203; Lorimer G. W., 1975, DEV ELECTRON MICROSC, P153; Reed S. J. B., 1993, ELECT MICROPROBE ANA; Soejima H., 1979, THESIS; Takahashi H., 2004, HYOMEN KAGAKU, V24, P224; Weast R. C., 1967, HDB CHEM PHYS	26	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1431-9276	1435-8115		MICROSC MICROANAL	Microsc. microanal.	DEC	2015	21	6					1398	1405		10.1017/S1431927615015445		8	Materials Science, Multidisciplinary; Microscopy	Materials Science; Microscopy	CY8LS	WOS:000366660500004		
J	Kanbayashi, T; Miyafuji, H				Kanbayashi, Toru; Miyafuji, Hisashi			Anatomical and Topochemical Aspects of Japanese beech (Fagus crenata) Cell Walls After Treatment with the Ionic Liquid, 1-Ethylpyridinium Bromide	MICROSCOPY AND MICROANALYSIS			English	Article						ionic liquid; 1-ethylpyridinium bromide; cell wall; wood; Japanese beech	1-ETHYL-3-METHYLIMIDAZOLIUM CHLORIDE; ULTRAVIOLET MICROSCOPY; MORPHOLOGICAL-CHANGES; ENZYMATIC-HYDROLYSIS; RAMAN-SPECTROSCOPY; REACTION BEHAVIOR; PICEA-MARIANA; BIRCH WOOD; LIGNIN; DISSOLUTION	Changes in the ultrastructure and chemical components, and their distribution in Japanese beech (Fagus crenata), during the ionic liquid 1-ethylpyridinium bromide ([EtPy][Br]) treatment were examined at the cellular level by light microscopy, scanning electron microscopy, and confocal Raman microscopy. Each of the tissues, including wood fibers, vessels and parenchyma cells treated with [EtPy][Br] showed specific morphological characteristics. Furthermore, lignin can be preferentially liquefied and eluted in [EtPy][Br] from the cell walls when compared to polysaccharides. However, the delignification was heterogeneous on the cell walls as lignin maintained a relatively high-concentration at the compound middle lamella, cell corners, inner surface of the secondary wall, and pits after [EtPy][Br] treatment.	[Kanbayashi, Toru; Miyafuji, Hisashi] Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Div Environm Sci, Sakyo Ku, Kyoto 6068522, Japan	Miyafuji, H (reprint author), Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Div Environm Sci, Sakyo Ku, Hangi Cho, Kyoto 6068522, Japan.	miyafuji@kpu.ac.jp			"Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry" from Ministry of Agriculture, Forestry and Fisheries of Japan [26052A]; Japan Society for the Promotion of Science (JSPS) [25450246, 15J05592]	This work was partly supported by the "Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry" (No. 26052A) from the Ministry of Agriculture, Forestry and Fisheries of Japan, a Grant-in-Aid for Scientific Research (C) (No. 25450246) from the Japan Society for the Promotion of Science (JSPS), and a Grant-in-Aid for JSPS Fellows (No. 15J05592). The authors wish to thank the Kyoto Municipal Institute of Industrial Technology and Culture for assistance with the Raman microscopy analyses.	Agarwal U. P., 1999, ADV LIGNOCELLULOSICS, P201; Miyafuji H, 2012, J WOOD SCI, V58, P222, DOI 10.1007/s10086-011-1245-3; Donohoe BS, 2008, BIOTECHNOL BIOENG, V101, P913, DOI 10.1002/bit.21959; Roder T, 2004, HOLZFORSCHUNG, V58, P480, DOI 10.1515/HF.2004.072; Kanbayashi T, 2013, J WOOD SCI, V59, P410, DOI 10.1007/s10086-013-1343-5; Agarwal UP, 1997, APPL SPECTROSC, V51, P1648, DOI 10.1366/0003702971939316; Agarwal UP, 2006, PLANTA, V224, P1141, DOI 10.1007/s00425-006-0295-z; Miyafuji H, 2011, J WOOD SCI, V57, P459, DOI 10.1007/s10086-011-1190-1; SAKA S, 1982, WOOD SCI TECHNOL, V16, P167; Nakamura A, 2010, J WOOD SCI, V56, P256, DOI 10.1007/s10086-009-1081-x; Nakamura A, 2010, HOLZFORSCHUNG, V64, P289, DOI 10.1515/HF.2010.042; Kanbayashi T, 2015, PLANTA, V242, P509, DOI 10.1007/s00425-014-2235-7; Oasmaa A, 2010, ENERG FUEL, V24, P1380, DOI 10.1021/ef901107f; Miyafuji H, 2009, J WOOD SCI, V55, P215, DOI 10.1007/s10086-009-1020-x; Viell J, 2011, HOLZFORSCHUNG, V65, P519, DOI 10.1515/HF.2011.072; Fukaya Y, 2008, GREEN CHEM, V10, P44, DOI 10.1039/b713289a; Sun N, 2009, GREEN CHEM, V11, P646, DOI 10.1039/b822702k; Pu YQ, 2007, J WOOD CHEM TECHNOL, V27, P23, DOI 10.1080/02773810701282330; Xu CB, 2008, FUEL, V87, P335, DOI 10.1016/j.fuel.2007.05.013; Swatloski RP, 2002, J AM CHEM SOC, V124, P4974, DOI 10.1021/ja025790m; [Anonymous], 2005, MODERN RAMAN SPECTRO; Selig MJ, 2007, BIOTECHNOL PROGR, V23, P1333, DOI 10.1021/bp0702018; Zhang H, 2005, MACROMOLECULES, V38, P8272, DOI 10.1021/ma0505676; Zhao YL, 2008, BIOTECHNOL BIOENG, V99, P1320, DOI 10.1002/bit.21712; FERGUS BJ, 1969, WOOD SCI TECHNOL, V3, P117; Agarwal UP, 2011, J WOOD CHEM TECHNOL, V31, P324, DOI 10.1080/02773813.2011.562338; SAKA S, 1988, HOLZFORSCHUNG, V42, P149, DOI 10.1515/hfsg.1988.42.3.149; Fort DA, 2007, GREEN CHEM, V9, P63, DOI 10.1039/b607614a; Zhang X, 2014, MICROSC RES TECHNIQ, V77, P609, DOI 10.1002/jemt.22379; FERGUS BJ, 1970, HOLZFORSCHUNG, V24, P118, DOI 10.1515/hfsg.1970.24.4.118; Jansen S, 1998, IAWA J, V19, P347; Kilpelainen I, 2007, J AGR FOOD CHEM, V55, P9142, DOI 10.1021/jf071692e; Taherzadeh MJ, 1997, IND ENG CHEM RES, V36, P4659, DOI 10.1021/ie9700831; MUSHA Y, 1975, WOOD SCI TECHNOL, V9, P45; Kanbayashi T, 2014, J WOOD SCI, V60, P152, DOI 10.1007/s10086-014-1389-z; Gierlinger N., 2013, CELLULOSE BIOMASS CO, P159; Harada H., 1965, CELLULAR ULTRASTRUCT, P235; Kanbayashi T, 2015, HOLZFORSCHUNG, V69, P273, DOI 10.1515/hf-2014-0060; Lucas M, 2011, BIORESOURCE TECHNOL, V102, P4518, DOI 10.1016/j.biortech.2010.12.087; Seddon KR, 1997, J CHEM TECHNOL BIOT, V68, P351, DOI 10.1002/(SICI)1097-4660(199704)68:4<351::AID-JCTB613>3.0.CO;2-4; Sheldon R, 2001, CHEM COMMUN, P2399, DOI 10.1039/b107270f; Tsoumis G., 1991, SCI TECHNOLOGY WOOD, P34; Yokoo T, 2014, J WOOD SCI, V60, P339, DOI 10.1007/s10086-014-1409-z	43	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1431-9276	1435-8115		MICROSC MICROANAL	Microsc. microanal.	DEC	2015	21	6					1562	1572		10.1017/S1431927615015275		11	Materials Science, Multidisciplinary; Microscopy	Materials Science; Microscopy	CY8LS	WOS:000366660500020		
J	Shioya, H; Russo, S; Yamamoto, M; Craciun, MF; Tarucha, S				Shioya, Hiroki; Russo, Saverio; Yamamoto, Michihisa; Craciun, Monica F.; Tarucha, Seigo			Electron States of Uniaxially Strained Graphene	NANO LETTERS			English	Article						Graphene; uniaxial strain; straintronics; planar device structures; strain induced potentials; Landau-fan diagram	TRANSPORT; STRESS	We report an experimental study of electron states and the resulting electronic transport properties of uniaxially strained graphene. For this study we developed a novel strain application method that is compatible with the planar device technology. We identify the value of the strain induced in graphene by Raman spectroscopy and show with atomic force microscopy that its topography consists of wrinkles up to 4 nm height aligned along the direction of the applied strain. Transport experiments reveal a broadening of the charge neutrality region and the convergence of Landau levels to multiple Dirac points in Landau-fan diagrams. These observations are consistent with large fluctuations of the scalar potential via the strain-induced wrinkles, which is experimentally observed for the first time.	[Shioya, Hiroki; Yamamoto, Michihisa; Tarucha, Seigo] Univ Tokyo, Dept Appl Phys, Tokyo 113, Japan; [Russo, Saverio; Craciun, Monica F.] Univ Exeter, Coll Engn Math & Phys Sci, Ctr Graphene Sci, Exeter EX4 4QF, Devon, England; [Tarucha, Seigo] RIKEN, CEMS, Wako, Saitama, Japan	Shioya, H (reprint author), Osaka Univ, Inst Sci & Ind Res, Osaka, Japan.	shioya@meso.t.u-tokyo.ac.jp			GCOE for Phys. Sci. Frontier; Project for Developing Innovation Systems, MEXT, Japan; EPSRC [EP/J000396/1, EP/K017160/1, EP/K010050/1, EPG036101/1, EP/M001024/1, EPM002438/1]; Royal Society [2012/R3, 2013/R2]; JSPS; Canon Foundation; JST Strategic International Cooperative Program (DFG-JST); JST Strategic International Cooperative Program (EPSRC-JST);  [26220710]	The authors would like to acknowledge useful discussion with Prof. T. Osada on our experimental results. H.S. acknowledges financial support from GCOE for Phys. Sci. Frontier and from Project for Developing Innovation Systems, MEXT, Japan. S.R. and M.F.C acknowledge financial support from EPSRC (Grant no. EP/J000396/1, EP/K017160/1, EP/K010050/1, EPG036101/1, EP/M001024/1, EPM002438/1) and from Royal Society International Exchanges Scheme 2012/R3 and 2013/R2. M.Y. acknowledges financial support from JSPS Grant-in-Aid for Scientific Research on Innovative Areas "Science of Atomic Layers" and Canon Foundation. S.T. acknowledges financial support from JST Strategic International Cooperative Programs (DFG-JST and EPSRC-JST) and Grants-in-Aid for Scientific Research S (No. 26220710).	Das Sarma S, 2011, REV MOD PHYS, V83, P407, DOI 10.1103/RevModPhys.83.407; Vozmediano MAH, 2010, PHYS REP, V496, P109, DOI 10.1016/j.physrep.2010.07.003; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; Cerda E, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.074302; Kvashnin AG, 2015, J PHYS CHEM LETT, V6, P2740, DOI 10.1021/acs.jpclett.5b01041; Guinea F, 2010, NAT PHYS, V6, P30, DOI 10.1038/NPHYS1420; Guinea F, 2012, SOLID STATE COMMUN, V152, P1437, DOI 10.1016/j.ssc.2012.04.019; Montambaux G, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.153412; Pereira VM, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.045401; Lee C, 2008, SCIENCE, V321, P385, DOI 10.1126/science.1157996; Tombros N, 2007, NATURE, V448, P571, DOI 10.1038/nature06037; Shioya H, 2014, NANO LETT, V14, P1158, DOI 10.1021/nl403679f; Mohiuddin TMG, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.205433; Ferrari AC, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.187401; Zhang YB, 2005, NATURE, V438, P201, DOI 10.1038/nature04235; Bao WZ, 2009, NAT NANOTECHNOL, V4, P562, DOI [10.1038/nnano.2009.191, 10.1038/NNANO.2009.191]; Peres NMR, 2010, REV MOD PHYS, V82, P2673, DOI 10.1103/RevModPhys.82.2673; Blake P., 2007, APPL PHYS LETT, V91; Gibertini M., 2012, PHYS REV B, VR; Huertas-Hernando D, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.146801; Liu F, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.064120; Manes JL, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.045430; MURBACH HP, 1953, P PHYS SOC LOND B, V66, P905, DOI 10.1088/0370-1301/66/11/301; Pereira VM, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.046801; STORY HS, 1957, P PHYS SOC LOND B, V70, P950, DOI 10.1088/0370-1301/70/10/305; Suzuura H, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.235412; WILMAN H, 1955, P PHYS SOC LOND B, V68, P474, DOI 10.1088/0370-1301/68/7/110; Zhou Y.-B., 2011, APPL PHYS LETT, V98	28	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1530-6984	1530-6992		NANO LETT	Nano Lett.	DEC	2015	15	12					7943	7948		10.1021/acs.nanolett.5b03027		6	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CY3WC	WOS:000366339600024		
J	Hu, J; Hoshi, N; Uosaki, K; Ikeda, K				Hu, Jian; Hoshi, Nagahiro; Uosaki, Kohei; Ikeda, Katsuyoshi			Vibrational Spectroscopic Observation of Atomic-Scale Local Surface Sites Using Site-Selective Signal Enhancement	NANO LETTERS			English	Article						Atomic-scale surface defects; surface enhanced Raman scattering; localized surface plasmon resonance; metal molecule interactions	RAMAN-SCATTERING; INFRARED-ABSORPTION; SINGLE-MOLECULE; GOLD SURFACES; AU(111); PLASMON; SERS; ELECTROCATALYSIS; REACTIVITY; MONOLAYERS	Molecule substrate interactions are sensitively affected by atomic-scale surface structures. Unique activity in heterogeneous catalysts or electrocatalysts is often related with local surface sites with specific structures. We demonstrate that adsorption geometry of a model molecule with an isocyanide anchor is drastically varied among one-fold atop, two-fold bridge, and three-fold hollow configurations with increasing the size of atomic-scale local surface sites of Pd islands on an Au(111) model surface. The vibrational spectroscopic observation of such local information is realized by site-selective and self-assembled formation of hotspots, where Raman scattering intensity is significantly enhanced via excitation of localized surface plasmons.	[Hu, Jian; Ikeda, Katsuyoshi] Hokkaido Univ, Grad Sch Sci, Div Chem, Sapporo, Hokkaido 0600810, Japan; [Hu, Jian; Uosaki, Kohei; Ikeda, Katsuyoshi] Natl Inst Mat Sci, Global Res Ctr Environm & Energy Based Nanomat Sc, Tsukuba, Ibaraki 3050044, Japan; [Hoshi, Nagahiro] Chiba Univ, Grad Sch Engn, Dept Appl Chem & Biotechnol, Inage Ku, Chiba 2638522, Japan; [Uosaki, Kohei] Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton WPI MANA, Tsukuba, Ibaraki 3050044, Japan; [Ikeda, Katsuyoshi] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan	Ikeda, K (reprint author), Nagoya Inst Technol, FRIMS, Showa Ku, Nagoya, Aichi 4668555, Japan.	kikeda@nitech.ac.jp			Japan Society for the Promotion of Science (JSPS) [24681018]; World Premier International Research Center (WPI) Initiative on Materials Nanoarchitectonics; Program for Development of Environmental Technology using Nanotechnology of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	This research was supported in part by a Grant-in-Aid for Young Scientists (A) (No. 24681018) from the Japan Society for the Promotion of Science (JSPS), World Premier International Research Center (WPI) Initiative on Materials Nanoarchitectonics, and the Program for Development of Environmental Technology using Nanotechnology of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	Alkire R. C., 2006, DIFFRACTION SPECTROS; Hu J, 2014, J AM CHEM SOC, V136, P10299, DOI 10.1021/ja502008t; ZHU XD, 1987, PHYS REV B, V35, P3047, DOI 10.1103/PhysRevB.35.3047; Hammer B, 2000, ADV CATAL, V45, P71; Hoshi N, 2002, J PHYS CHEM B, V106, P9107, DOI 10.1021/jp020898+; Steidtner J, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.236101; ARAVIND PK, 1982, J PHYS CHEM-US, V86, P5076, DOI 10.1021/j100223a007; OSAWA M, 1991, J PHYS CHEM-US, V95, P9914, DOI 10.1021/j100177a056; Ikeda K, 2011, NANO LETT, V11, P1716, DOI 10.1021/nl200251a; Hartschuh A, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.095503; Maroun F, 2001, SCIENCE, V293, P1811, DOI 10.1126/science.1061696; Ikeda K, 2008, CHEM PHYS LETT, V460, P205, DOI 10.1016/j.cplett.2008.05.093; Naohara H, 2000, ELECTROCHIM ACTA, V45, P3305, DOI 10.1016/S0013-4686(00)00440-0; Zhang R, 2013, NATURE, V498, P82, DOI 10.1038/nature12151; Nordlander P, 2004, NANO LETT, V4, P2209, DOI 10.1021/nl0486160; Hill RT, 2010, NANO LETT, V10, P4150, DOI 10.1021/nl102443p; Feng M, 2014, ACS NANO, V8, P8644, DOI 10.1021/nn5035026; LECOEUR J, 1982, SURF SCI, V114, P320, DOI 10.1016/0039-6028(82)90474-5; Ikeda K, 2013, J AM CHEM SOC, V135, P17387, DOI 10.1021/ja407459t; Kibler LA, 2006, CHEMPHYSCHEM, V7, P985, DOI 10.1002/cphc.200500646; Stamenkovic VR, 2007, NAT MATER, V6, P241, DOI 10.1038/nmat1840; HARTSTEIN A, 1980, PHYS REV LETT, V45, P201, DOI 10.1103/PhysRevLett.45.201; Kim K, 2011, ANAL SCI, V27, P775; Li JF, 2010, NATURE, V464, P392, DOI 10.1038/nature08907; Butcher DP, 2012, J PHYS CHEM C, V116, P5128, DOI 10.1021/jp211884s; Ikeda K, 2009, J PHYS CHEM C, V113, P11816, DOI 10.1021/jp901858t; Kibler LA, 2005, ANGEW CHEM INT EDIT, V44, P2080, DOI 10.1002/anie.200462127; Ikeda K, 2011, J PHOTOCH PHOTOBIO A, V221, P175, DOI 10.1016/j.jphotochem.2011.02.022; Kibler LA, 1999, SURF SCI, V443, P19, DOI 10.1016/S0039-6028(99)00968-1; Bjorketun ME, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.045407; FLEISCHMANN M, 1974, CHEM PHYS LETT, V26, P163, DOI 10.1016/0009-2614(74)85388-1; Liu Z, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1310; Markovic N. M., 2002, SURF SCI REP, V45, P117, DOI DOI 10.1016/S0167-5729(01)00022-X; Wieckowski A, 1999, INTERFACIAL ELECTROC	34	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1530-6984	1530-6992		NANO LETT	Nano Lett.	DEC	2015	15	12					7982	7986		10.1021/acs.nanolett.5603093		5	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CY3WC	WOS:000366339600030		
J	Muruganathan, M; Sun, J; Imamura, T; Mizuta, H				Muruganathan, Manoharan; Sun, Jian; Imamura, Tomonori; Mizuta, Hiroshi			Electrically Tunable van der Waals Interaction in Graphene Molecule Complex	NANO LETTERS			English	Article						van der Waals complex; electrical tunability of vdW interaction; graphene-molecule vdW complexes; field-dependent charge transfer	SURFACES; FORCES; LAYERS	van der Waals (vdW) interactions play a central role in the surface-related physics and chemistry. Tuning of the correlated charge fluctuation in a vdW complex is a plausible way of modulating the molecules interaction at the atomic surface. Here, we report the vdW interaction tunability of the graphene CO, complex by combining the first-principles calculations with the vdW density functionals and the time evaluation measurements of CO, molecules adsorption/desorption on graphene under an external electric field. The field-dependent charge transfer within the complex unveils the controllable tuning of CO, from acceptor to donor. Meanwhile, the configuration of the adsorbed molecule, the equilibrium distance from graphene and O C-O bonding angle, is modified accordingly. The range of electrical tunability is a unique feature for each type of molecule.	[Muruganathan, Manoharan; Sun, Jian; Imamura, Tomonori; Mizuta, Hiroshi] Japan Adv Inst Sci & Technol, Sch Mat Sci, Nomi 9231211, Japan; [Mizuta, Hiroshi] Univ Southampton, Fac Phys Sci & Engn, Nanoelect & Nanotechnol Res Grp, Southampton SO17 1BJ, Hants, England	Muruganathan, M (reprint author), Japan Adv Inst Sci & Technol, Sch Mat Sci, Nomi 9231211, Japan.	mano@jaist.ac.jp			Japan Society for the Promotion of Science [25220904]	This work was supported by Grant-in-Aid for Scientific Research (No. 25220904) from Japan Society for the Promotion of Science. The authors thank M. E. Schmidt and X. Wang for their helpful discussions.	Kushima A, 2015, NANO LETT, V15, P1302, DOI 10.1021/nl5045082; Chen SS, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/12/125011; MULLIKEN RS, 1955, J CHEM PHYS, V23, P1833, DOI 10.1063/1.1740588; Muller-Dethlefs K, 2000, CHEM REV, V100, P143, DOI 10.1021/cr9900331; Soler JM, 2002, J PHYS-CONDENS MAT, V14, P2745, DOI 10.1088/0953-8984/14/11/302; Bartels L, 2010, NAT CHEM, V2, P87, DOI [10.1038/nchem.517, 10.1038/NCHEM.517]; Schedin F, 2007, NAT MATER, V6, P652, DOI 10.1038/nmat1967; [Anonymous], 2012, ADV PHYS, V61, P155; Zhang YH, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/18/185504; Geim AK, 2013, NATURE, V499, P419, DOI 10.1038/nature12385; Kim S, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3077021; [Anonymous], 2004, SCIENCE, DOI DOI 10.1126/SCIENCE.1102896; Zhou J, 2010, P NATL ACAD SCI USA, V107, P2801, DOI 10.1073/pnas.0905571107; Lalatonne Y, 2004, NAT MATER, V3, P121, DOI 10.1038/nmat1054; Clark SJ, 2005, Z KRISTALLOGR, V220, P567, DOI 10.1524/zkri.220.5.567.65075; Delrio FW, 2005, NAT MATER, V4, P629, DOI 10.1038/nmat1431; Aradhya SV, 2012, NAT MATER, V11, P872, DOI [10.1038/nmat3403, 10.1038/NMAT3403]; Bogani L, 2008, NAT MATER, V7, P179, DOI 10.1038/nmat2133; Sato Y, 2011, NANO LETT, V11, P3468, DOI 10.1021/nl202002p; Berland K, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.035412; Berland K, 2015, REP PROG PHYS, V78, DOI 10.1088/0034-4885/78/6/066501; Chakarova-Kack S. D., 2006, PHYS REV LETT, V96, P96; Dion M., 2004, PHYS REV LETT, V92, P92; Dzyaloshinskii I E, 1961, SOV PHYS USP, V4, p[153, 381], DOI DOI 10.1070/PU1961V004N02ABEH003330; Foroutan-Nejad C., 2014, PHYS CHEM CHEM PHYS, V16, P2508; Huttmann F., 2015, ARXIV150902020CONDMA; Lessel M., 2013, PHYS REV LETT, V111, P111; Roman-Perez G, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.096102; TROULLIER N, 1991, PHYS REV B, V43, P1993, DOI 10.1103/PhysRevB.43.1993; Wiley, WILEY PRINCIPLES ADS	30	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1530-6984	1530-6992		NANO LETT	Nano Lett.	DEC	2015	15	12					8176	8180		10.1021/acs.nanolett.5b03653		5	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CY3WC	WOS:000366339600058		
J	Withers, F; Del Pozo-Zamudio, O; Schwarz, S; Dufferwiel, S; Walker, PM; Godde, T; Rooney, AP; Gholinia, A; Woods, CR; Blake, P; Haigh, SJ; Watanabe, K; Taniguchi, T; Aleiner, IL; Geim, AK; Fal'ko, VI; Tartakovskii, AI; Novoselov, KS				Withers, F.; Del Pozo-Zamudio, O.; Schwarz, S.; Dufferwiel, S.; Walker, P. M.; Godde, T.; Rooney, A. P.; Gholinia, A.; Woods, C. R.; Blake, P.; Haigh, S. J.; Watanabe, K.; Taniguchi, T.; Aleiner, I. L.; Geim, A. K.; Fal'ko, V. I.; Tartakovskii, A. I.; Novoselov, K. S.			WSe2 Light-Emitting Tunneling Transistors with Enhanced Brightness at Room Temperature	NANO LETTERS			English	Article						Electroluminescence; photoluminescence; transition metal dichalcogenides; tungsten diselenide; hexagonal boron nitride; graphene; van der Waals heterostructure	DER-WAALS HETEROSTRUCTURES; TRANSITION-METAL DICHALCOGENIDES; 2-DIMENSIONAL ATOMIC CRYSTALS; P-N-JUNCTIONS; PHOTOCURRENT GENERATION; MONOLAYER WSE2; THIN-FILMS; DIODES; ELECTROLUMINESCENCE; MOS2	Monolayers of molybdenum and tungsten dichalcogenides are direct bandgap semiconductors, which makes them promising for optoelectronic applications. In particular, van der Waals heterostructures consisting of monolayers of MoS2 sandwiched between atomically thin hexagonal boron nitride (hBN) and graphene electrodes allows one to obtain light emitting quantum wells (LEQWs) with low-temperature external quantum efficiency (EQE) of 1%. However, the EQE of MoS2- and MoSe2- based LEQWs shows behavior common for many other materials: it decreases fast from cryogenic conditions to room temperature, undermining their practical applications. Here we compare MoSe2- and WSe2 LEQWs. We show that the EQE of WSe, devices grows with temperature, with room temperature EQE reaching 5%, which is 250X more than the previous best performance of MoS, and MoSe2 quantum wells in ambient conditions. We attribute such different temperature dependences to the inverted sign of spin-orbit splitting of conduction band states in tungsten and molybdenum dichalcogenides, which makes the lowest-energy exciton in WSe2 dark.	[Withers, F.; Woods, C. R.; Blake, P.; Geim, A. K.; Fal'ko, V. I.; Novoselov, K. S.] Univ Manchester, Sch Phys & Astron, Manchester M13 9PL, Lancs, England; [Withers, F.; Blake, P.; Aleiner, I. L.; Fal'ko, V. I.; Novoselov, K. S.] Univ Manchester, Natl Graphene Inst, Manchester M13 9PL, Lancs, England; [Del Pozo-Zamudio, O.; Schwarz, S.; Dufferwiel, S.; Walker, P. M.; Godde, T.; Tartakovskii, A. I.] Univ Sheffield, Sch Phys & Astron, Sheffield S3 7R11, S Yorkshire, England; [Rooney, A. P.; Gholinia, A.; Haigh, S. J.] Univ Manchester, Sch Mat, Manchester M13 9PL, Lancs, England; [Watanabe, K.; Taniguchi, T.] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050044, Japan; [Aleiner, I. L.] Columbia Univ, Dept Phys, New York, NY 10027 USA	Withers, F (reprint author), Univ Manchester, Sch Phys & Astron, Oxford Rd, Manchester M13 9PL, Lancs, England.	freddie.withers@manchester.ac.uk; a.tartakovskii@sheffield.ac.uk; kostya@manchester.ac.uk	Del Pozo-Zamudio, Osvaldo/G-7768-2014; Novoselov, Kostya/G-9581-2014	Novoselov, Kostya/0000-0003-4972-5371	European Research Council Synergy Grant Hetero2D; EC-FET European Graphene Flagship; Royal Society; Royal Academy of Engineering; U.S. Army; European Science Foundation (ESF) under the EUROCORES Programme EuroGRAPHENE (GOSPEL); Engineering and Physical Sciences Research Council (U.K.); Leverhulme Trust (U.K.); U.S. Office of Naval Research; U.S. Defence Threat Reduction Agency; U.S. Air Force Office of Scientific Research; FP7 ITN S3NANO; SEP-Mexico; CONACYT	This work was supported by European Research Council Synergy Grant Hetero2D, EC-FET European Graphene Flagship, The Royal Society, Royal Academy of Engineering, U.S. Army, European Science Foundation (ESF) under the EUROCORES Programme EuroGRAPHENE (GOSPEL), Engineering and Physical Sciences Research Council (U.K.), the Leverhulme Trust (U.K.), U.S. Office of Naval Research, U.S. Defence Threat Reduction Agency, U.S. Air Force Office of Scientific Research, FP7 ITN S3NANO, SEP-Mexico, and CONACYT.	Zhu CR, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.161302; Xu XD, 2014, NAT PHYS, V10, P343, DOI 10.1038/NPHYS2942; Lee CH, 2014, NAT NANOTECHNOL, V9, P676, DOI [10.1038/nnano.2014.150, 10.1038/NNANO.2014.150]; Zhang YJ, 2014, SCIENCE, V344, P725, DOI 10.1126/science.1251329; Novoselov KS, 2005, P NATL ACAD SCI USA, V102, P10451, DOI 10.1073/pnas.0502848102; Britnell L, 2012, SCIENCE, V335, P947, DOI 10.1126/science.1218461; Pospischil A, 2014, NAT NANOTECHNOL, V9, P257, DOI [10.1038/nnano.2014.14, 10.1038/NNANO.2014.14]; Withers F, 2015, NAT MATER, V14, P301, DOI 10.1038/nmat4205; Haigh SJ, 2012, NAT MATER, V11, P764, DOI [10.1038/nmat3386, 10.1038/NMAT3386]; You YM, 2015, NAT PHYS, V11, P477, DOI [10.1038/nphys3324, 10.1038/NPHYS3324]; Britnell L, 2013, SCIENCE, V340, P1311, DOI 10.1126/science.1235547; Splendiani A, 2010, NANO LETT, V10, P1271, DOI 10.1021/nl903868w; Kretinin AV, 2014, NANO LETT, V14, P3270, DOI 10.1021/nl5006542; Ye ZL, 2014, NATURE, V513, P214, DOI 10.1038/nature13734; Jo S, 2014, NANO LETT, V14, P2019, DOI 10.1021/nl500171v; Wang L, 2013, SCIENCE, V342, P614, DOI 10.1126/science.1244358; Yu WJ, 2013, NAT NANOTECHNOL, V8, P952, DOI [10.1038/nnano.2013.219, 10.1038/NNANO.2013.219]; Geim AK, 2013, NATURE, V499, P419, DOI 10.1038/nature12385; Cheng R, 2014, NANO LETT, V14, P5590, DOI 10.1021/nl502075n; Xiao D, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.196802; Schwarz S, 2014, NANO LETT, V14, P7003, DOI 10.1021/nl503312x; Mak KF, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.136805; Arora A, 2015, NANOSCALE, V7, P10421, DOI 10.1039/c5nr01536g; Mak KF, 2014, SCIENCE, V344, P1489, DOI 10.1126/science.1250140; Withers F, 2014, NANO LETT, V14, P3987, DOI 10.1021/nl501355j; Ross JS, 2014, NAT NANOTECHNOL, V9, P268, DOI [10.1038/nnano.2014.26, 10.1038/NNANO.2014.26]; Britnell L, 2012, NANO LETT, V12, P1707, DOI 10.1021/nl3002205; Piprek J, 2010, PHYS STATUS SOLIDI A, V207, P2217, DOI 10.1002/pssa.201026149; Baugher BWH, 2014, NAT NANOTECHNOL, V9, P262, DOI [10.1038/nnano.2014.25, 10.1038/NNANO.2014.25]; Sundaram RS, 2013, NANO LETT, V13, P1416, DOI 10.1021/nl400516a; Wang QH, 2012, NAT NANOTECHNOL, V7, P699, DOI [10.1038/nnano.2012.193, 10.1038/NNANO.2012.193]; Chernikov A, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.076802; Dery H., 2015, ARXIV150606686; Dufferwiel S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9579; Ganchev B, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.107401; He KL, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.026803; Kang K., 2015, NATURE, V520, P656; Kormanyos A, 2015, 2D MATER, V2, DOI 10.1088/2053-1583/2/2/022001; Lee GH, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3662043; Li DH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8509; Lin YC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8311; Wu SF, 2015, NATURE, V520, P69, DOI 10.1038/nature14290; Xie JQ, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2988324; Yu HY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4876	44	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1530-6984	1530-6992		NANO LETT	Nano Lett.	DEC	2015	15	12					8223	8228		10.1021/acs.nanolett.5b03740		6	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CY3WC	WOS:000366339600065		
J	Kushima, A; Koido, T; Fujiwara, Y; Kuriyama, N; Kusumi, N; Li, J				Kushima, Akihiro; Koido, Tetsuya; Fujiwara, Yoshiya; Kuriyama, Nariaki; Kusumi, Nobuhiro; Li, Ju			Charging/Discharging Nanomorphology Asymmetry and Rate-Dependent Capacity Degradation in Li-Oxygen Battery	NANO LETTERS			English	Article						in situ; transmission electron microscopy (TEM); liquid cell; electrochemistry; three-phase boundary	RECHARGEABLE LITHIUM BATTERIES; IN-SITU TEM; AIR BATTERIES; ELECTROCHEMICAL LITHIATION; ELECTRON-MICROSCOPY; LI-O-2 BATTERIES; GROWTH; CATALYST; DENSITY; CHARGE	Liquid-cell in situ transmission electron microscopy (TEM) observations of the charge/discharge reactions of nonaqueous Li oxygen battery cathode were performed with similar to 5 nm spatial resolution. The discharging reaction occurred at the interface between the electrolyte and the reaction product, whereas in charging, the reactant was decomposed at the contact with the gold current collector, indicating that the lithium ion diffusivity/electronic conductivity is the limiting factor in discharging/charging, respectively, which is a root cause for the asymmetry in discharging/charging overpotential. Detachments of lithium oxide particles from the current collector into the liquid electrolyte are frequently seen when the cell was discharged at high overpotentials, with loss of active materials into liquid electrolyte ("flotsam") under minute liquid flow agitation, as the lithium peroxide dendritic trees are shown to be fragile mechanically and electrically. Our result implies that enhancing the binding force between the reaction products and the current collector to maintain robust electronic conduction is a key for improving the battery performance. This work demonstrated for the first time the in situ TEM observation of a threephase-reaction involving gold electrode, lithium oxides, DMSO electrolyte and lithium salt, and O-2 gas. The technique described in this work is not limited to Li oxygen battery but also can be potentially used in other applications involving gas/liquid/solid electrochemical reactions.	[Kushima, Akihiro; Li, Ju] MIT, Dept Nucl Sci & Engn, Cambridge, MA 02139 USA; [Koido, Tetsuya; Fujiwara, Yoshiya; Kusumi, Nobuhiro] Honda Res & Dev Co Ltd, Automobile R&D Ctr, Wako, Saitama 3510193, Japan; [Kuriyama, Nariaki] Honda Res & Dev Co Ltd, Fundamental Technol Res Ctr, Wako, Saitama 3510188, Japan; [Li, Ju] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA	Li, J (reprint author), MIT, Dept Nucl Sci & Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	liju@mit.edu			Honda RD Co. Ltd.	We acknowledge financial support from Honda R&D Co. Ltd. We are also grateful for discussions with Prof. Sanjeev Mukerjee.	Debart A, 2007, J POWER SOURCES, V174, P1177, DOI 10.1016/j.jpowsour.2007.06.180; Zeng ZY, 2014, NANO LETT, V14, P1745, DOI 10.1021/nl403922u; Radin MD, 2013, ENERG ENVIRON SCI, V6, P2370, DOI 10.1039/c3ee41632a; Abraham KM, 1996, J ELECTROCHEM SOC, V143, P1, DOI 10.1149/1.1836378; Cheng H, 2010, J POWER SOURCES, V195, P1370, DOI 10.1016/j.jpowsour.2009.09.030; Sacci RL, 2015, NANO LETT, V15, P2011, DOI 10.1021/nl5048626; Liu XH, 2012, ADV ENERGY MATER, V2, P722, DOI 10.1002/aenm.201200024; Bruce PG, 2012, NAT MATER, V11, P19, DOI [10.1038/nmat3191, 10.1038/NMAT3191]; Liao HG, 2012, SCIENCE, V336, P1011, DOI 10.1126/science.1219185; Girishkumar G, 2010, J PHYS CHEM LETT, V1, P2193, DOI 10.1021/jz1005384; Radin MD, 2012, J MATER SCI, V47, P7564, DOI 10.1007/s10853-012-6552-6; Wen R, 2013, J AM CHEM SOC, V135, P10870, DOI 10.1021/ja405188g; Lu YC, 2010, J AM CHEM SOC, V132, P12170, DOI 10.1021/ja1036572; Huang JY, 2010, SCIENCE, V330, P1515, DOI 10.1126/science.1195628; Viswanathan V, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3663385; Read J, 2002, J ELECTROCHEM SOC, V149, pA1190, DOI 10.1149/1.1498256; Debart A, 2008, ANGEW CHEM INT EDIT, V47, P4521, DOI 10.1002/anie.200705648; de Jonge N, 2011, NAT NANOTECHNOL, V6, P695, DOI [10.1038/nnano.2011.161, 10.1038/NNANO.2011.161]; Zhang SS, 2010, J POWER SOURCES, V195, P1235, DOI 10.1016/j.jpowsour.2009.08.088; Zhong L, 2013, NANO LETT, V13, P2209, DOI 10.1021/nl400731w; Zheng JP, 2008, J ELECTROCHEM SOC, V155, pA432, DOI 10.1149/1.2901961; McCloskey BD, 2011, J AM CHEM SOC, V133, P18038, DOI 10.1021/ja207229n; Guo W, 2015, NANO LETT, V15, P6582, DOI 10.1021/acs.nanolett.5b02306; Wen R, 2014, CHEM COMMUN, V50, P2628, DOI 10.1039/c3cc49625b; Scrosati B, 2010, J POWER SOURCES, V195, P2419, DOI 10.1016/j.jpowsour.2009.11.048; Radisic A, 2006, J PHYS CHEM B, V110, P7862, DOI 10.1021/jp057549a; Zhang GQ, 2010, J ELECTROCHEM SOC, V157, pA953, DOI 10.1149/1.3446852; Adams BD, 2013, ENERG ENVIRON SCI, V6, P1772, DOI 10.1039/c3ee40697k; Johnson L, 2014, NAT CHEM, V6, P1091, DOI [10.1038/nchem.2101, 10.1038/NCHEM.2101]; Kreidler E., 2013, ECS M ABSTR, P456; Li S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8872; Peng ZQ, 2011, ANGEW CHEM INT EDIT, V50, P6351, DOI 10.1002/anie.201100879; Sun MH, 2013, SCI REP-UK, V3, DOI 10.1038/srep03227	33	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1530-6984	1530-6992		NANO LETT	Nano Lett.	DEC	2015	15	12					8260	8265		10.1021/acs.nanolett.5b03812		6	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CY3WC	WOS:000366339600071		
J	Pradhan, NR; McCreary, A; Rhodes, D; Lu, ZG; Feng, SM; Manousakis, E; Smirnov, D; Namburu, R; Dubey, M; Walker, ARH; Terrones, H; Terrones, M; Dobrosavljevic, V; Balicas, L				Pradhan, Nihar R.; McCreary, Amber; Rhodes, Daniel; Lu, Zhengguang; Feng, Simin; Manousakis, Efstratios; Smirnov, Dmitry; Namburu, Raju; Dubey, Madan; Walker, Angela R. Hight; Terrones, Humberto; Terrones, Mauricio; Dobrosavljevic, Vladimir; Balicas, Luis			Metal to Insulator Quantum-Phase Transition in Few-Layered ReS2	NANO LETTERS			English	Article						Transition metal dichalcogenides; rhenium disulfide; Raman scattering; field-effect transistor; field-effect mobilities; metal-insulator transition	FIELD-EFFECT TRANSISTORS; 2 DIMENSIONS; MOS2 TRANSISTORS; MOLYBDENUM-DISULFIDE; SINGLE-LAYER; WS2; LOCALIZATION; MONOLAYER; HALL; MOBILITIES	In ReS2, a layer-independent direct band gap of 1.5 eV implies a potential for its use in optoelectronic applications. ReS2 crystallizes in the 1T'-structure, which leads to anisotropic physical properties and whose concomitant electronic structure might host a nontrivial topology. Here, we report an overall evaluation of the anisotropic Raman response and the transport properties of few-layered ReS2 field-effect transistors. We find that ReS2 exfoliated on SiO2 behaves as an n-type semiconductor with an intrinsic carrier mobility surpassing mu(i) similar to 30 cm(2)/(V s) at T = 300 K, which increases up to similar to 350 cm(2)/(V s) at 2 K. Semiconducting behavior is observed at low electron densities n, but at high values of n the resistivity decreases by a factor of >7 upon cooling to 2 K and displays a metallic T-2-dependence. This suggests that the band structure of 1T'-ReS2 is quite susceptible to an electric field applied perpendicularly to the layers. The electric-field induced metallic state observed in transition metal dichalcogenides was recently claimed to result from a percolation type of transition. Instead, through a scaling analysis of the conductivity as a function of T and n, we find that the metallic state of ReS2 results from a second-order metal-to-insulator transition driven by electronic correlations. This gate-induced metallic state offers an alternative to phase engineering for producing ohmic contacts and metallic interconnects in devices based on transition metal dichalcogenides.	[Pradhan, Nihar R.; Rhodes, Daniel; Lu, Zhengguang; Manousakis, Efstratios; Smirnov, Dmitry; Dobrosavljevic, Vladimir; Balicas, Luis] Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32310 USA; [McCreary, Amber; Feng, Simin; Terrones, Mauricio] Penn State Univ, Dept Phys, State Coll, PA 16802 USA; [McCreary, Amber; Feng, Simin; Terrones, Mauricio] Penn State Univ, Ctr Dimens & Layered Mat 2, State Coll, PA 16802 USA; [McCreary, Amber; Namburu, Raju] US Army, Res Lab, Computat & Informat Sci Directorate, Adelphi, MD 20783 USA; [McCreary, Amber; Dubey, Madan] US Army, Res Lab, Sensor & Electron Devices Directorate, Adelphi, MD 20783 USA; [Rhodes, Daniel; Lu, Zhengguang; Manousakis, Efstratios; Dobrosavljevic, Vladimir] Florida State Univ, Dept Phys, Tallahassee, FL 32306 USA; [Walker, Angela R. Hight] NIST, Div Engn Phys, Phys Lab, Gaithersburg, MD 20899 USA; [Terrones, Humberto] Rensselaer Polytech Inst, Dept Phys Appl Phys & Astron, Troy, NY 12180 USA; [Terrones, Mauricio] Penn State Univ, Dept Chem, State Coll, PA 16802 USA; [Terrones, Mauricio] Penn State Univ, Dept Mat Sci & Engn, State Coll, PA 16802 USA; [Terrones, Mauricio] Shinshu Univ, Carbon Inst Sci & Technol, Nagano 3808553, Japan	Balicas, L (reprint author), Florida State Univ, Natl High Magnet Field Lab, 1800 East Paul Dirac Dr, Tallahassee, FL 32310 USA.	balicas@magnet.fsu.edu			U.S. Army Research Office MURI [W911NF-11-1-0362]; NHMFL UCGP [5087]; DOE BES Division [DE-FG02-07ER46451]; NSF [NSF-DMR-0084173, DMR-1410132]; State of Florida; National Science Foundation [EFRI-1433311]; US Army Research Laboratory (ARL) Director's Strategic Initiative (DSI)	This work was supported by the U.S. Army Research Office MURI Grant No. W911NF-11-1-0362. J.L. acknowledges the support by NHMFL UCGP No. 5087. Z.L. and D.S. acknowledge the support by DOE BES Division under Grant No. DE-FG02-07ER46451. The NHMFL is supported by NSF through NSF-DMR-0084173 and the State of Florida. H.T. acknowledges the support from the National Science Foundation (EFRI-1433311). A.M., R.R.N., and M.D. acknowledge the support from the US Army Research Laboratory (ARL) Director's Strategic Initiative (DSI) program on interfaces in stacked 2D atomic layered materials. V.D. is supported by the NSF through Grant No. DMR-1410132. The views and conclusions contained in this document are those of the authors and should not be interpreted as representing official policies, either expressed or implied, of the Army Research Laboratory or the U.S. Government. The U.S. Government is authorized to reproduce and distribute reprints for Government purposes notwithstanding any copyright notation herein.	Zhang E, 2015, ADV FUNCT MATER, V25, P4076, DOI 10.1002/adfm.201500969; BELITZ D, 1994, REV MOD PHYS, V66, P261, DOI 10.1103/RevModPhys.66.261; Peimyoo N, 2013, ACS NANO, V7, P10985, DOI 10.1021/nn4046002; Kravchenko SV, 1996, PHYS REV LETT, V77, P4938, DOI 10.1103/PhysRevLett.77.4938; Pradhan NR, 2014, ACS NANO, V8, P5911, DOI 10.1021/nn501013c; Gutierrez HR, 2013, NANO LETT, V13, P3447, DOI 10.1021/nl3026357; Baugher BWH, 2013, NANO LETT, V13, P4212, DOI 10.1021/nl401916s; Radisavljevic B, 2011, NAT NANOTECHNOL, V6, P147, DOI [10.1038/nnano.2010.279, 10.1038/NNANO.2010.279]; Braga D, 2012, NANO LETT, V12, P5218, DOI 10.1021/nl302389d; Pradhan NR, 2014, ACS NANO, V8, P7923, DOI 10.1021/nn501693d; Das S, 2013, NANO LETT, V13, P100, DOI 10.1021/nl303583v; Meric I, 2011, NANO LETT, V11, P1093, DOI 10.1021/nl103993z; CASTELLANI C, 1984, PHYS REV B, V30, P527, DOI 10.1103/PhysRevB.30.527; Elias AL, 2013, ACS NANO, V7, P5235, DOI 10.1021/nn400971k; Jo S, 2014, NANO LETT, V14, P2019, DOI 10.1021/nl500171v; Qian XF, 2014, SCIENCE, V346, P1344, DOI 10.1126/science.1256815; FINKELSTEIN AM, 1984, Z PHYS B CON MAT, V56, P189, DOI 10.1007/BF01304171; ABRAHAMS E, 1979, PHYS REV LETT, V42, P673, DOI 10.1103/PhysRevLett.42.673; Corbett CM, 2015, ACS NANO, V9, P363, DOI 10.1021/nn505354a; Popovic D, 1997, PHYS REV LETT, V79, P1543, DOI 10.1103/PhysRevLett.79.1543; Pradhan NR, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4799172; Mak KF, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.136805; Cho S, 2015, SCIENCE, V349, P625, DOI 10.1126/science.aab3175; Radisavljevic B, 2013, NAT MATER, V12, P815, DOI [10.1038/nmat3687, 10.1038/NMAT3687]; Kappera R, 2014, NAT MATER, V13, P1128, DOI [10.1038/nmat4080, 10.1038/NMAT4080]; Wu W, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4801861; Jariwala D, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4803920; Chhowalla M, 2013, NAT CHEM, V5, P263, DOI [10.1038/nchem.1589, 10.1038/NCHEM.1589]; Abrahams E, 2001, REV MOD PHYS, V73, P251, DOI 10.1103/RevModPhys.73.251; Chen XL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7088; Dobrosavljevic V., 2012, CONDUCTOR INSULATOR; Donos A, 2013, NAT PHYS, V9, P648, DOI 10.1038/NPHYS2701; Kaasbjerg K, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.115317; Lin PV, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.166401; Liu EF, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7991; Ong ZY, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.165316; Pradhan NR, 2015, SCI REP-UK, V5, DOI 10.1038/srep08979; Qiu H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3642; Tongay S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4252; Wang H. Q., 2012, NAT NANOTECHNOL, V7, P699; Yoon J., 2013, SMALL, V9, P3185; Zhou J.-C., 2013, NANO LETT, V13, P2615	42	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1530-6984	1530-6992		NANO LETT	Nano Lett.	DEC	2015	15	12					8377	8384		10.1021/acs.nanolett.5b04100		8	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CY3WC	WOS:000366339600091		
J	Sandner, A; Preis, T; Schell, C; Giudici, P; Watanabe, K; Taniguchi, T; Weiss, D; Eroms, J				Sandner, Andreas; Preis, Tobias; Schell, Christian; Giudici, Paula; Watanabe, Kenji; Taniguchi, Takashi; Weiss, Dieter; Eroms, Jonathan			Ballistic Transport in Graphene Antidot Lattices	NANO LETTERS			English	Article						Graphene; boron nitride; ballistic transport; nanopatterning antidots	CARBON NANOTUBES; SUPERLATTICES; NANORIBBONS; ARRAYS; FABRICATION; PRESSURE; PERIODS; ORBITS	The bulk carrier mobility in graphene was shown to be enhanced in graphene boron nitride heterostructures. However, nanopatterning graphene can add extra damage and drastically degrade the intrinsic properties by edge disorder. Here we show that graphene embedded into a heterostructure with hexagonal boron nitride (hBN) on both sides is protected during a nanopatterning step. In this way, we can prepare graphene-based antidot lattices where the high mobility is preserved. We report magnetotransport experiments in those antidot lattices with lattice periods down to SO nm. We observe pronounced commensurability features stemming from ballistic orbits around one or several antidots. Due to the short lattice period in our samples, we can also explore the boundary between the classical and the quantum transport regime, as the Fermi wavelength of the electrons approaches the smallest length scale of the artificial potential.	[Sandner, Andreas; Preis, Tobias; Schell, Christian; Giudici, Paula; Weiss, Dieter; Eroms, Jonathan] Univ Regensburg, Inst Expt & Appl Phys, D-93040 Regensburg, Germany; [Watanabe, Kenji; Taniguchi, Takashi] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050044, Japan	Eroms, J (reprint author), Univ Regensburg, Inst Expt & Appl Phys, D-93040 Regensburg, Germany.	jonathan.eroms@ur.de			Deutsche Forschungsgemeinschaft (DFG) [GRK 1570, GI 539/4-1]	The authors thank A. Geim and R. Jalil for sharing details of the graphene transfer procedure, R. Fleischmann, T. Geisel and K. Richter for helpful discussions, and the Deutsche Forschungsgemeinschaft (DFG) for funding through projects GRK 1570 and GI 539/4-1.	Pedersen JG, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.235404; Dean CR, 2013, NATURE, V497, P598, DOI 10.1038/nature12186; FLEISCHMANN R, 1992, PHYS REV LETT, V68, P1367, DOI 10.1103/PhysRevLett.68.1367; Taychatanapat T, 2013, NAT PHYS, V9, P225, DOI [10.1038/nphys2549, 10.1038/NPHYS2549]; WEISS D, 1993, PHYS REV LETT, V70, P4118, DOI 10.1103/PhysRevLett.70.4118; TAKAHARA J, 1995, JPN J APPL PHYS 1, V34, P4325, DOI 10.1143/JJAP.34.4325; Kim M, 2010, NANO LETT, V10, P1125, DOI 10.1021/nl9032318; Ponomarenko LA, 2013, NATURE, V497, P594, DOI 10.1038/nature12187; Calado VE, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4861627; Eroms J, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/9/095021; Kosynkin DV, 2009, NATURE, V458, P872, DOI 10.1038/nature07872; Cai JM, 2010, NATURE, V466, P470, DOI 10.1038/nature09211; McCann E, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.146805; Kubota Y, 2007, SCIENCE, V317, P932, DOI 10.1126/science.1144216; WEISS D, 1991, PHYS REV LETT, V66, P2790, DOI 10.1103/PhysRevLett.66.2790; Ishizaka S, 1997, PHYS REV B, V55, P16331, DOI 10.1103/PhysRevB.55.16331; Wang L, 2013, SCIENCE, V342, P614, DOI 10.1126/science.1244358; SCHUSTER R, 1994, PHYS REV B, V49, P8510, DOI 10.1103/PhysRevB.49.8510; Minke S, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.195432; Ishizaka S, 1999, PHYS LOW-DIMENS STR, V5-6, P5; Bai JW, 2010, NAT NANOTECHNOL, V5, P190, DOI [10.1038/nnano.2010.8, 10.1038/NNANO.2010.8]; Stampfer C, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.056403; Kozlov DA, 2010, JETP LETT+, V91, P134, DOI 10.1134/S0021364010030070; Poumirol JM, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.041413; Dean CR, 2010, NAT NANOTECHNOL, V5, P722, DOI 10.1038/nnano.2010.172; Shen T, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2988725; Jiao LY, 2009, NATURE, V458, P877, DOI 10.1038/nature07919; Dean CR, 2011, NAT PHYS, V7, P693, DOI [10.1038/nphys2007, 10.1038/NPHYS2007]; Pedersen TG, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.136804; Taniguchi T, 2007, J CRYST GROWTH, V303, P525, DOI 10.1016/j.jcrysgro.2006.12.061; Bischoff D, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4765345; Brack M., 1997, SEMICLASSICAL PHYS; NIHEY F, 1993, PHYSICA B, V184, P398, DOI 10.1016/0921-4526(93)90388-M; Sakurai J. J., 1994, MODERN QUANTUM MECH; Yagi R, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.195406	35	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1530-6984	1530-6992		NANO LETT	Nano Lett.	DEC	2015	15	12					8402	8406		10.1021/acs.nanolett.5b04414		5	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CY3WC	WOS:000366339600095		
J	Hayashi, T; Joki, N; Tanaka, Y; Hase, H				Hayashi, Toshihide; Joki, Nobuhiko; Tanaka, Yuri; Hase, Hiroki			Anaemia and early phase cardiovascular events on haemodialysis	NEPHROLOGY			English	Review						anaemia; cardiovascular disease; chronic kidney disease; haemodialysis; left ventricular hypertrophy	CHRONIC KIDNEY-DISEASE; CORONARY-ARTERY-DISEASE; LEFT-VENTRICULAR MASS; TYPE-2 MYOCARDIAL-INFARCTION; SYMPATHETIC-NERVE ACTIVITY; ISCHEMIC-HEART-DISEASE; STAGE RENAL-DISEASE; PRESSURE-OVERLOAD; DIALYSIS PATIENTS; ERYTHROPOIETIN DEFICIENCY	Although the mechanism of the cardio-renal anaemia syndrome (CRAS) has been elucidated in considerable detail over the past decade, cardiovascular disease (CVD) remains a leading cause of death among patients with end-stage kidney disease (ESKD) undergoing haemodialysis, and these patients' cardiovascular mortality is greater than that of the general population. Recent studies have reported that the CVD risk increases with advancing chronic kidney disease (CKD) stage. Furthermore, the incidence of cardiovascular events is highest during the first week after dialysis initiation, with increased risk in incident haemodialysis patients. This accumulated evidence demonstrates that how patients are managed during the pre-dialysis phase may have important implications on long-term outcomes in ESKD. Anaemia, a non-traditional risk factor for CVD, advances exponentially along with declining kidney function due to insufficient erythropoietin production. Anaemia causes functional abnormalities of the heart, as represented by cardiac hypertrophy, which results from increased cardiac workload induced by an increased preload. Left ventricular hypertrophy (LVH), a traditional risk factor for CVD, is especially associated with advanced CKD stage and could be a major risk factor for cardiovascular complications such as ischaemic heart disease, heart failure, and sudden cardiac death. In ESKD, anaemia develops more severely and requires a higher amount of erythropoiesis-stimulating agent (ESA) therapy before dialysis initiation. This suggests that improvement in anaemia management during the pre-dialysis phase may have a beneficial effect on cardiac hypertrophy and contribute to reducing the CVD risk after initiating haemodialysis.	[Hayashi, Toshihide; Joki, Nobuhiko; Tanaka, Yuri; Hase, Hiroki] Toho Univ, Div Nephrol, Ohashi Med Ctr, Tokyo 1538515, Japan	Joki, N (reprint author), Toho Univ, Div Nephrol, Ohashi Med Ctr, Meguro Ku, 2-17-6 Ohashi, Tokyo 1538515, Japan.	jokinobuhiko@gmail.com					Ronco C, 2010, EUR HEART J, V31, P703, DOI 10.1093/eurheartj/ehp507; Zoccali C, 2004, SEMIN DIALYSIS, V17, P299, DOI 10.1111/j.0894-0959.2004.17331.x; Asaumi Y, 2007, CIRCULATION, V115, P2022, DOI 10.1161/CIRCULATIONAHA.106.659037; Ohtake T, 2005, J AM SOC NEPHROL, V16, P1141, DOI 10.1681/ASN.2004090765; Bradbury BD, 2007, CLIN J AM SOC NEPHRO, V2, P89, DOI 10.2215/CJN.01170905; Iwasaki M, 2014, J ATHEROSCLER THROMB, V21, P593; Kiyosue A, 2010, CIRC J, V74, P786, DOI 10.1253/circj.CJ-09-0715; DUKE M, 1969, CIRCULATION, V39, P503; Vlagopoulos PT, 2005, MED CLIN N AM, V89, P587, DOI 10.1016/j.mcna.2004.11.003; MCGONIGLE RJS, 1984, KIDNEY INT, V25, P437, DOI 10.1038/ki.1984.36; HORINA JH, 1993, NEPHROL DIAL TRANSPL, V8, P1219; Franchitto N, 2013, INT J CARDIOL, V168, P2352, DOI 10.1016/j.ijcard.2013.01.023; Cai ZQ, 2003, CIRCULATION, V108, P79, DOI 10.1161/01.CIR.0000078635.89229.8A; ANAGNOSTOU A, 1994, P NATL ACAD SCI USA, V91, P3974, DOI 10.1073/pnas.91.9.3974; Franchitto N, 2010, HYPERTENSION, V55, P1012, DOI 10.1161/HYPERTENSIONAHA.109.146779; De Vriese AS, 2012, KIDNEY INT, V81, P143, DOI 10.1038/ki.2011.340; Moon C, 2003, P NATL ACAD SCI USA, V100, P11612, DOI 10.1073/pnas.1930406100; Xue JL, 2002, AM J KIDNEY DIS, V40, P1153, DOI 10.1053/ajkd.2002.36861; Sano M, 2007, NATURE, V446, P444, DOI 10.1038/nature05602; Eckardt KU, 2015, KIDNEY INT, V88, P1117, DOI 10.1038/ki.2015.117; Amann K, 1998, J AM SOC NEPHROL, V9, P1018; Parfrey PS, 1996, KIDNEY INT, V49, P1428, DOI 10.1038/ki.1996.201; Shiojima I, 2005, J CLIN INVEST, V115, P2108, DOI 10.1172/JCI24682; Goodkin DA, 2003, J AM SOC NEPHROL, V14, P3270, DOI 10.1097/01.ASN.0000100127.54107.57; ROSTAND SG, 1984, KIDNEY INT, V25, P653, DOI 10.1038/ki.1984.70; Cerasola G, 2011, J NEPHROL, V24, P1, DOI 10.5301/JN.2010.2030; Saaby L, 2013, AM J MED, V126, P789, DOI 10.1016/j.amjmed.2013.02.029; Izumiya Y, 2006, HYPERTENSION, V47, P887, DOI 10.1161/01.HYP.0000215207.54689.31; Levin A, 1999, AM J KIDNEY DIS, V34, P125, DOI 10.1016/S0272-6386(99)70118-6; Collins AJ, 2001, J AM SOC NEPHROL, V12, P2465; Joki N, 1997, NEPHROL DIAL TRANSPL, V12, P718, DOI 10.1093/ndt/12.4.718; Thygesen K, 2012, NAT REV CARDIOL, V9, P620, DOI 10.1038/nrcardio.2012.122; Astor BC, 2002, ARCH INTERN MED, V162, P1401, DOI 10.1001/archinte.162.12.1401; Naito Y, 2009, AM J PHYSIOL-HEART C, V296, pH585, DOI 10.1152/ajpheart.00463.2008; Moroi M, 2013, AM J KIDNEY DIS, V61, P466, DOI 10.1053/j.ajkd.2012.09.017; Herzog CA, 2011, KIDNEY INT, V80, P572, DOI 10.1038/ki.2011.223; Silverberg D, 2003, NEPHROL DIAL TRANSPL, V18, P7, DOI [10.1093/ndt//gfg1084, 10.1093/ndt/gfg1056]; Glassock RJ, 2009, CLIN J AM SOC NEPHRO, V4, pS79, DOI 10.2215/CJN.04860709; Jungers P, 2000, NEPHROL DIAL TRANSPL, V15, P2000, DOI 10.1093/ndt/15.12.2000; Kazory A, 2009, J AM COLL CARDIOL, V53, P639, DOI 10.1016/j.jacc.2008.10.046; Zoccali C, 2004, KIDNEY INT, V65, P1492, DOI 10.1111/j.1523-1755.2004.00530.x; Wang H, 2012, NEPHROL DIAL TRANSPL, V27, P4422, DOI 10.1093/ndt/gfs090; Parsa CJ, 2003, J CLIN INVEST, V112, P999, DOI 10.1172/JCI200318200; Bosman DR, 2001, DIABETES CARE, V24, P495, DOI 10.2337/diacare.24.3.495; Asakawa T, 2014, CARDIORENAL MED, V4, P189, DOI 10.1159/000368200; Baron T, 2015, HEART, V101, P101, DOI 10.1136/heartjnl-2014-306093; Foley R N, 1998, J Am Soc Nephrol, V9, pS16; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; K/DOQI Workgroup, 2005, AM J KIDNEY DIS S, V45, pS1, DOI DOI 10.1053/J.AJKD.2005.02.002; Lopez B, 2008, KIDNEY INT S, V111, pS19	50	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5358	1440-1797		NEPHROLOGY	Nephrology	DEC	2015	20			4	SI		1	6		10.1111/nep.12642		6	Urology & Nephrology	Urology & Nephrology	CZ1IC	WOS:000366858400001		
J	Io, H; Aizawa, M; Funabiki, K; Horikoshi, S; Tomino, Y				Io, Hiroaki; Aizawa, Masashi; Funabiki, Kazuhiko; Horikoshi, Satoshi; Tomino, Yasuhiko			Impact of anaemia treatment for left ventricular remodelling prior to initiation of dialysis in chronic kidney disease patients: Efficacy and stability of long acting erythropoietin stimulating agents	NEPHROLOGY			English	Article						anaemia; chronic kidney disease; left ventricular hypertrophy; left ventricular mass index; remodelling	HEMODIALYSIS-PATIENTS; CARDIOVASCULAR EVENTS; HEMOGLOBIN LEVEL; RENAL-FUNCTION; MASS INDEX; HYPERTROPHY; ECHOCARDIOGRAPHY; ASSOCIATION; GUIDELINES; THERAPY	AimAnaemia is a common complication in patients with chronic kidney disease (CKD), which may initiate or accelerate left ventricular (LV) hypertrophy (LVH). The present study is a retrospective analysis to assess whether anaemia treatment is independently associated with LV remodelling prior to initiation of dialysis in CKD patients. MethodsBiochemical and physical values were collected over a period of more than 120 days prior to the initiation of dialysis in 27 patients with CKD. The left ventricular mass index (LVMI) was evaluated by echocardiography twice (at the baseline and the follow-up at the initiation of the dialysis period). ResultsPatients using long-acting erythropoietin stimulating agents (L-ESA) had the tendency of maintaining higher levels of haemoglobin (Hb) than those using short-acting ESA (S-ESA). Patients using L-ESA showed a more significant improvement in the erythropoietin resistance index (ERI) than those of using S-ESA. In a multivariate regression analysis, the average Hb level for the observational period, the level of Hb at the initiation of dialysis and the use of L-ESA were independently associated factors for the LVMI at the initiation of dialysis. A lower LVMI at the initiation of dialysis and an improvement of the LVMI during the observational period were detected in the highest tertile of average Hb (10.4 g/dL). ConclusionLong-acting ESA was effective and stable when treating anaemia until the start of dialysis. It is important to treat anaemia for the prevention of LV remodelling in CKD patients. These findings have some therapeutic implications for treatment strategies for pre-dialysis patients.	[Io, Hiroaki; Horikoshi, Satoshi; Tomino, Yasuhiko] Juntendo Univ, Div Nephrol, Dept Internal Med, Fac Med, Tokyo 1138421, Japan; [Aizawa, Masashi; Funabiki, Kazuhiko] Juntendo Tokyo Koto Geriatr Med Ctr, Div Nephrol & Hypertens, Tokyo, Japan; [Tomino, Yasuhiko] Med Corp Showakai, Tokyo, Japan	Io, H (reprint author), Juntendo Univ, Div Nephrol, Dept Internal Med, Fac Med,Bunkyo ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	hiroaki@juntendo.ac.jp			Kidney Foundation, Japan [JKFB11-29]	We are indebted to the nephrologists and patients at the Juntendo University Hospital for their collaboration in this study. This study was supported in part by grant from The Kidney Foundation, Japan (JKFB11-29).	Padulles-Zamora N, 2012, NEFROLOGIA, V32, P221, DOI 10.3265/Nefrologia.pre2012.Jan.10946; Matsumoto M, 2012, J NEPHROL, V25, P794, DOI 10.5301/jn.5000066; Minutolo R, 2014, CLIN J AM SOC NEPHRO, V9, P1586, DOI 10.2215/CJN.10481013; Drueke TB, 2006, NEW ENGL J MED, V355, P2071, DOI 10.1056/NEJMoa062276; Chang JM, 2014, AM J MED SCI, V347, P183, DOI 10.1097/MAJ.0b013e31827981be; Rossert J, 2007, NEPHROL DIAL TRANSPL, V22, P794, DOI 10.1093/ndt/gf1716; Tsubakihara Y, 2010, THER APHER DIAL, V14, P240, DOI 10.1111/j.1744-9987.2010.00836.x; Foley RN, 1998, KIDNEY INT, V54, P1720, DOI 10.1046/j.1523-1755.1998.00154.x; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Vanholder R, 2005, NEPHROL DIAL TRANSPL, V20, P1048, DOI 10.1093/ndt/gfh813; Panichi V, 2011, NEPHROL DIAL TRANSPL, V26, P2641, DOI 10.1093/ndt/gfq802; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; Io H, 2011, SEMIN DIALYSIS, V24, P349, DOI 10.1111/j.1525-139X.2010.00759.x; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; HARNETT JD, 1993, NEPHRON, V65, P212; Gouva C, 2004, KIDNEY INT, V66, P753, DOI 10.1111/j.1523-1755.2004.00797.x; Moon SJ, 2011, J NEPHROL, V24, P50, DOI 10.5301/JN.2010.353; Cianciaruso B, 2008, J NEPHROL, V21, P861; Hayashi T, 2000, AM J KIDNEY DIS, V35, P250, DOI 10.1016/S0272-6386(00)70334-9; Okumura K, 2013, CLIN NEPHROL, V79, P7, DOI 10.5414/CN107569; Asakawa T, 2014, CARDIORENAL MED, V4, P189, DOI 10.1159/000368200; Eckhardt K-U, 2009, J AM SOC NEPHROL, V20, P2651; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Kuwahara M, 2014, CLIN EXP NEPHROL, V18, P755, DOI 10.1007/s10157-013-0919-0; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5358	1440-1797		NEPHROLOGY	Nephrology	DEC	2015	20			4	SI		7	13		10.1111/nep.12640		7	Urology & Nephrology	Urology & Nephrology	CZ1IC	WOS:000366858400002		
J	Kataoka, H; Tsuchiya, K; Naganuma, T; Okazaki, M; Komatsu, M; Kimura, T; Shiohira, S; Kawaguchi, H; Nitta, K				Kataoka, Hiroshi; Tsuchiya, Ken; Naganuma, Toshiaki; Okazaki, Masayuki; Komatsu, Mizuki; Kimura, Tomonori; Shiohira, Shunji; Kawaguchi, Hiroshi; Nitta, Kosaku			Relationship between anaemia management at haemodialysis initiation and patient prognosis	NEPHROLOGY			English	Article						chronic kidney disease; cardiovascular disease; haemodialysis initiation; pre-dialysis; renal anaemia	CHRONIC KIDNEY-DISEASE; STARTING HEMODIALYSIS; DIALYSIS INITIATION; HEMOGLOBIN LEVEL; RENAL-FAILURE; PROGRESSION; OUTCOMES; STROKE; COHORT	AimIt has been suggested that anaemia management during a transition period to haemodialysis could influence prognosis. In this paper, we have conducted a retrospective investigation on how Hb levels at haemodialysis initiation in patients with chronic kidney disease (CKD) influence the risk of cerebral infarction and cardiovascular events. MethodsSeventy-two patients who underwent initial haemodialysis between May 2012 and April 2014 were designated as subjects of the study and the patients were divided into a cohort with Hb levels 8 g/dL and a cohort with <8 g/dL at haemodialysis initiation. The occurrence of cardiovascular events was analyzed using the Kaplan-Meier method and Cox proportional hazards model. ResultsThe cohort with <8 g/dL Hb levels at haemodialysis initiation demonstrated a tendency toward low dosage of ESA or iron preparation in the pre-haemodialysis (maintenance) phase. Significant incidence of cardiovascular (log rank, P=0.002) and cerebrovascular (log rank, P=0.02) events was observed. The results of multivariate analysis of the Cox proportional hazards model indicated that anaemia with <8 g/dL Hb levels at haemodialysis initiation was a significant risk factor for coronary artery (hazard ratio = 12.85, P=0.003) and cerebrovascular (hazard ratio = 5.11, P=0.04) diseases post-haemodialysis. ConclusionThe results of this investigation indicate the possible involvement of low Hb levels at haemodialysis initiation as a factor in cardio- and cerebrovascular events. There, our results suggested that the administration of adequate dosage of iron preparations and ESA in the pre-haemodialysis period could help prevent cardio- and cerebrovascular events.	[Kataoka, Hiroshi; Tsuchiya, Ken; Shiohira, Shunji; Nitta, Kosaku] Tokyo Womens Med Univ, Dept Med 4, Tokyo 1628666, Japan; [Naganuma, Toshiaki; Okazaki, Masayuki; Komatsu, Mizuki; Kimura, Tomonori; Shiohira, Shunji; Kawaguchi, Hiroshi] Jyoban Hosp, Dept Nephrol, Fukushima, Japan	Tsuchiya, K (reprint author), Tokyo Womens Med Univ, Dept Med 4, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	tsuchiya@kc.twmu.ac.jp			Ministry of Health, Labour and Welfare of Japan	This study was supported in part by a Grant-in-Aid for Progressive Renal Diseases Research, from the Ministry of Health, Labour and Welfare of Japan.	Joki N, 2003, AM J NEPHROL, V23, P458, DOI 10.1159/000074538; Go AS, 2006, CIRCULATION, V113, P2713, DOI 10.1161/CIRCULATIONHA.105.577577; Tsubakihara Y, 2010, THER APHER DIAL, V14, P240, DOI 10.1111/j.1744-9987.2010.00836.x; Hao ZL, 2013, J CLIN NEUROSCI, V20, P37, DOI 10.1016/j.jocn.2012.05.020; Robinson BM, 2014, KIDNEY INT, V85, P158, DOI 10.1038/ki.2013.252; Eckardt KU, 2015, KIDNEY INT, V88, P1117, DOI 10.1038/ki.2015.117; Akizawa T, 2008, NEPHROL DIAL TRANSPL, V23, P3643, DOI 10.1093/ndt/gfn346; Kuriyama S, 1997, NEPHRON, V77, P176; Heidenreich S, 2012, CLIN DRUG INVEST, V32, P99, DOI 10.2165/11594040-000000000-00000; Mohanram A, 2008, KIDNEY INT, V73, P630, DOI 10.1038/sj.ki.5002746; De Nicola L, 2007, CLIN J AM SOC NEPHRO, V2, P938, DOI 10.2215/CJN.01690407; Power A, 2013, BLOOD PURIFICAT, V36, P179, DOI 10.1159/000356086; Akizawa T, 2011, CLIN EXP NEPHROL, V15, P248, DOI 10.1007/s10157-010-0396-7; Silverberg D, 2003, NEPHROL DIAL TRANSPL, V18, P7, DOI [10.1093/ndt//gfg1084, 10.1093/ndt/gfg1056]; Akizawa T, 2014, THER APHER DIAL, V18, P140, DOI 10.1111/1744-9987.12066; Joki N, 2001, CLIN NEPHROL, V55, P109; Link DK, 2014, ADV CHRONIC KIDNEY D, V21, P360, DOI 10.1053/j.ackd.2014.02.013; Zoccali C, 2004, KIDNEY INT, V65, P1492, DOI 10.1111/j.1523-1755.2004.00530.x; Kitai Y, 2013, INT J CARDIOL, V168, P5221, DOI 10.1016/j.ijcard.2013.08.029; Asakawa T, 2014, CARDIORENAL MED, V4, P189, DOI 10.1159/000368200; Kuwahara M, 2014, CLIN EXP NEPHROL, V18, P755, DOI 10.1007/s10157-013-0919-0; Leurs P, 2015, J RENAL NUTR, V25, P238, DOI 10.1053/j.jrn.2014.10.015; London G M, 1991, Adv Nephrol Necker Hosp, V20, P249; Murray AM, 2013, J AM SOC NEPHROL, V24, P1166, DOI 10.1681/ASN.2012080841; Nakai S, 2014, THER APHER DIAL, V18, P535, DOI 10.1111/1744-9987.12281	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5358	1440-1797		NEPHROLOGY	Nephrology	DEC	2015	20			4	SI		14	21		10.1111/nep.12639		8	Urology & Nephrology	Urology & Nephrology	CZ1IC	WOS:000366858400003		
J	Koibuchi, K; Miyagi, M; Arai, T; Aoki, T; Aikawa, A; Sakai, K				Koibuchi, Kiyoto; Miyagi, Moriatsu; Arai, Taichi; Aoki, Toshiyuki; Aikawa, Atsushi; Sakai, Ken			Comparing the efficacy of continuous erythropoietin receptor activator and darbepoetin Alfa treatments in Japanese patients with chronic kidney disease during the predialysis period: A propensity-matched analysis	NEPHROLOGY			English	Article						anaemia; chronic kidney disease; continuous erythropoietin receptor activator; darbepoetin alfa; erythropoiesis-stimulating agents	ANEMIA CORRECTION; HEMOGLOBIN LEVEL; HEMODIALYSIS-PATIENTS; EPOETIN BETA; DIALYSIS; HEPCIDIN; IRON; CERA; ASSOCIATION; SUPPRESSION	AimErythropoiesis-stimulating agent (ESA) treatment during the predialysis period can be a strategy to reduce cardiac mortality soon after initiation of dialysis. In this study, we compared the efficacy of continuous erythropoietin receptor activator (CERA) and darbepoetin alfa (DA) in patients with chronic kidney disease (CKD) over 6 months prior to initiation of dialysis. MethodsThis study was a retrospective propensity score-matched study conducted at a single center in Japan that analyzed the effects of CERA and DA therapy on haemoglobin (Hb) changes, ESA resistance index (ERI) changes, and interval of ESA administration during a 6-month observation period prior to initiation of dialysis. Propensity scores were used for matching the patients included in the CERA and DA groups. ResultsAmong 680 screened, 74 pairs of patients (one in each group) were included in the present analysis after propensity score matching. Mean Hb significantly decreased over 6 months in the DA group compared to that in the CERA group (-0.700.23 vs. -0.33 +/- 0.22). In the DA group, mean ERI was significantly increased at 4, 3, 2, and 1 month before dialysis and initiation of dialysis, while in the CERA group, mean ERI was significantly increased only at 1 month before dialysis and initiation of dialysis. Moreover, patients administered CERA were required to visit the hospital significantly less frequently for ESA administration than those administered DA. ConclusionOur study showed that CERA may be more effective than DA for management of anaemia during the predialysis period in CKD patients.	[Koibuchi, Kiyoto; Miyagi, Moriatsu; Arai, Taichi; Aoki, Toshiyuki] Saiseikai Yokohama City Eastern Hosp, Dept Nephrol & Dialysis, Yokohama, Kanagawa 2300012, Japan; [Aikawa, Atsushi; Sakai, Ken] Toho Univ, Sch Med, Dept Nephrol, Fac Med, Tokyo, Japan	Koibuchi, K (reprint author), Saiseikai Yokohama City Eastern Hosp, Dept Nephrol & Dialysis, Tsurumi Ku, 3-6-1 Shimosueyoshi, Yokohama, Kanagawa 2300012, Japan.	k_koibuchi@tobu.saiseikai.or.jp					Alsalimy N, 2014, INT J CLIN PHARM-NET, V36, P1115, DOI 10.1007/s11096-014-0023-x; Sasaki Y, 2014, INT J HEMATOL, V99, P561, DOI 10.1007/s12185-014-1554-6; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Laine F, 2012, EUR J APPL PHYSIOL, V112, P1391, DOI 10.1007/s00421-011-2097-7; Drueke TB, 2006, NEW ENGL J MED, V355, P2071, DOI 10.1056/NEJMoa062276; Shoji S, 2013, EUR J HAEMATOL, V90, P237, DOI 10.1111/ejh.12067; Robinson BM, 2014, KIDNEY INT, V85, P158, DOI 10.1038/ki.2013.252; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; Alexander M, 2007, CURR MED RES OPIN, V23, P2997, DOI 10.1185/030079907X242502; Parfrey PS, 2009, CLIN J AM SOC NEPHRO, V4, P755, DOI 10.2215/CJN.02730608; Akaishi M, 2013, J CARDIOL, V62, P249, DOI 10.1016/j.jjcc.2013.04.008; Vega A, 2014, HIPPOKRATIA, V18, P315; Minutolo R, 2010, BLOOD PURIFICAT, V30, P186, DOI 10.1159/000321486; Suzuki M, 2012, INT HEART J, V53, P238; Akizawa T, 2014, THER APHER DIAL, V18, P140, DOI 10.1111/1744-9987.12066; Nemeth E, 2009, ACTA HAEMATOL-BASEL, V122, P78, DOI 10.1159/000243791; Hayashi T, 2000, AM J KIDNEY DIS, V35, P250, DOI 10.1016/S0272-6386(00)70334-9; Pfeffer MA, 2009, NEW ENGL J MED, V361, P2019, DOI 10.1056/NEJMoa0907845; Macdougall IC, 2002, NEPHROL DIAL TRANSPL, V17, P66, DOI 10.1093/ndt/17.suppl_5.66; Asakawa T, 2014, CARDIORENAL MED, V4, P189, DOI 10.1159/000368200; De Lurdes Agostinho Cabrita A, 2011, INT UROL NEPHROL, V43, P835; Kakimoto-Shino M, 2014, THER APHER DIAL, V18, P421, DOI 10.1111/1744-9987.12161; Lopez-Gomez JM, 2008, KIDNEY INT, V74, pS75, DOI 10.1038/ki.2008.523; Nakai S, 2014, THER APHER DIAL, V18, P535, DOI 10.1111/1744-9987.12281; Ohashi Naro, 2012, Int J Nephrol Renovasc Dis, V5, P53, DOI 10.2147/IJNRD.S23447; Palmer SC, 2014, COCHRANE DB SYST REV, V12; Washida N, 2015, THER APHER DIAL, P450	27	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5358	1440-1797		NEPHROLOGY	Nephrology	DEC	2015	20			4	SI		22	28		10.1111/nep.12641		7	Urology & Nephrology	Urology & Nephrology	CZ1IC	WOS:000366858400004		
J	Kawahara, K; Minakuchi, J; Yokota, N; Suekane, H; Tsuchida, K; Kawashima, S				Kawahara, Kazuhiko; Minakuchi, Jun; Yokota, Narushi; Suekane, Hiroto; Tsuchida, Kenji; Kawashima, Shu			Treatment of renal anaemia with erythropoiesis-stimulating agents in predialysis chronic kidney disease patients: Haemoglobin profile during the 6 months before initiation of dialysis	NEPHROLOGY			English	Article						chronic kidney disease; continuous erythropoietin receptor activator; erythropoiesis-stimulating agent; initiation of dialysis; renal anaemia	CORRECTS ANEMIA	AimErythropoiesis-stimulating agents (ESAs) are all effective for renal anaemia in patients with chronic kidney disease (CKD). However, it was reported that the haemoglobin (Hb) concentration decreases to 8.4 g/dL during the initial phase of dialysis despite treatment with recombinant human erythropoietin (rHuEPO). This study compared Hb at the initiation of dialysis among patients treated with three different ESAs (rHuEPO, darbepoetin alfa [DA], and a continuous erythropoietin receptor activator [CERA]). MethodsThe subjects were 82 CKD patients who started dialysis at Kawashima Hospital between 1 January 2009 and 28 February 2015 and who received only one kind of ESA for at least 6 months before initiation of dialysis. Baseline characteristics and laboratory data at initiation of dialysis were compared among the three groups. Then changes of the Hb, ESA dose, and erythropoiesis resistance index were assessed over time during the 6 months before initiation of dialysis. Differences of Hb at the initiation of dialysis were also assessed. ResultsAmong the 82 patients, 36 received rHuEPO, 13 received DA, and 33 received CERA. Baseline characteristics and laboratory data of the patients showed no significant differences among the three groups. The monthly Hb decreased gradually during the 6-month period before initiation of dialysis in all three groups. Hb was significantly higher in the CERA group than the rHuEPO group at the initiation of dialysis. ConclusionLong-acting ESAs may be more useful for predialysis patients with CKD because they do not attend hospital frequently, unlike haemodialysis patients.	[Kawahara, Kazuhiko] Kamojima Kawashima Clin, Tokushima, Tokushima 7700037, Japan; [Minakuchi, Jun; Yokota, Narushi; Suekane, Hiroto; Kawashima, Shu] Kawashima Hosp, Tokushima, Japan; [Tsuchida, Kenji] Kawashima Dialysis Clin, Tokushima, Japan	Kawahara, K (reprint author), Kamojima Kawashima Clin, 1-9 Minamisako 7 Bancho, Tokushima, Tokushima 7700037, Japan.	kazukawahara@mac.com					Robinson BM, 2014, KIDNEY INT, V85, P158, DOI 10.1038/ki.2013.252; Eckardt KU, 2015, KIDNEY INT, V88, P1117, DOI 10.1038/ki.2015.117; Macdougall IC, 2008, CLIN J AM SOC NEPHRO, V3, P337, DOI 10.2215/CJN.00480107; Roger SD, 2011, NEPHROL DIAL TRANSPL, V26, P3980, DOI 10.1093/ndt/gfr160; Akizawa T, 2014, THER APHER DIAL, V18, P140, DOI 10.1111/1744-9987.12066; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Asakawa T, 2014, CARDIORENAL MED, V4, P189, DOI 10.1159/000368200	7	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5358	1440-1797		NEPHROLOGY	Nephrology	DEC	2015	20			4	SI		29	32		10.1111/nep.12647		4	Urology & Nephrology	Urology & Nephrology	CZ1IC	WOS:000366858400005		
J	Krichmar, JL; Conradt, J; Asada, M				Krichmar, Jeffrey L.; Conradt, Joerg; Asada, Minoru			Neurobiologically Inspired Robotics: Enhanced Autonomy through Neuromorphic Cognition	NEURAL NETWORKS			English	Editorial Material									[Krichmar, Jeffrey L.] Univ Calif Irvine, Dept Comp Sci, Dept Cognit Sci, Irvine, CA 92623 USA; [Conradt, Joerg] Tech Univ Munich, Ctr Competence NeuroEngn, Dept Elect & Comp Engn, D-80290 Munich, Germany; [Asada, Minoru] Osaka Univ, Grad Sch Engn, Dept Adapt Machine Syst, Suita, Osaka, Japan	Krichmar, JL (reprint author), Univ Calif Irvine, Dept Comp Sci, Dept Cognit Sci, Irvine, CA 92623 USA.	jkrichma@uci.edu; conradt@tum.de; asada@ams.eng.osaka-u.ac.jp					Barros P, 2015, NEURAL NETWORKS, V72, P140, DOI 10.1016/j.neunet.2015.09.009; Beyeler M, 2015, NEURAL NETWORKS, V72, P75, DOI 10.1016/j.neunet.2015.09.005; Chen Z, 2015, NEURAL NETWORKS, V72, P48, DOI 10.1016/j.neunet.2015.10.002; Fard FS, 2015, NEURAL NETWORKS, V72, P13, DOI 10.1016/j.neunet.2015.10.003; Llofriu M, 2015, NEURAL NETWORKS, V72, P62, DOI 10.1016/j.neunet.2015.09.006; Maffei G, 2015, NEURAL NETWORKS, V72, P88, DOI 10.1016/j.neunet.2015.10.004; Park G, 2015, NEURAL NETWORKS, V72, P109, DOI 10.1016/j.neunet.2015.09.004; Seepanomwan K, 2015, NEURAL NETWORKS, V72, P31, DOI 10.1016/j.neunet.2015.09.010; Sousa E, 2015, NEURAL NETWORKS, V72, P123, DOI 10.1016/j.neunet.2015.09.002; Strauss S, 2015, NEURAL NETWORKS, V72, P3, DOI 10.1016/j.neunet.2015.10.005; Walter F, 2015, NEURAL NETWORKS, V72, P152, DOI 10.1016/j.neunet.2015.07.004	11	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0893-6080	1879-2782		NEURAL NETWORKS	Neural Netw.	DEC	2015	72						1	2		10.1016/j.neunet.2015.11.004		2	Computer Science, Artificial Intelligence; Neurosciences	Computer Science; Neurosciences & Neurology	CY9BF	WOS:000366701700001		
J	Nakajima, S; Numakawa, T; Adachi, N; Ooshima, Y; Odaka, H; Yoshimura, A; Kunugi, H				Nakajima, Shingo; Numakawa, Tadahiro; Adachi, Naoki; Ooshima, Yoshiko; Odaka, Haruki; Yoshimura, Aya; Kunugi, Hiroshi			Self-amplified BDNF transcription is a regulatory system for synaptic maturation in cultured cortical neurons	NEUROCHEMISTRY INTERNATIONAL			English	Article						BDNF; ERK; CREB; TrkB	MESSENGER-RNA EXPRESSION; NEUROTROPHIC FACTOR; PLASTICITY; BRAIN; EXERCISE; STIMULATION; INCREASES; MEMORY; CELLS	Neuronal cell survival and synaptic plasticity are controlled through expression of various neurotrophic factors including brain-derived neurotrophic factor (BDNF). In the present study, we examined the mechanism behind BDNF-induced Bdnf mRNA production and the physiological role of its amplification system using cortical neurons. Exogenous BDNF was applied to the cultured cortical neurons at days in vitro (DIV) 3 and DIV 7 with or without inhibitors for intracellular signaling. Expression levels of total Bdnf and Bdnf variants (exon I, exon IV, and exon VI) were biphasically increased after the BDNF application in different developing stage of neurons. Inhibitor for extracellular signal-regulated kinase, calmodulin dependent protein kinase II, or protein kinase A repressed the BDNF-induced Bdnf mRNA expression. Furthermore, we found that application of TrkB-Fc, which scavenges produced endogenous BDNF, resulted in weakened BDNF/TrkB signaling and decreased expression of postsynaptic proteins, suggesting that newly synthesized BDNF induced by the self-amplification system contributes to the synaptic maturation and function. (C) 2015 Elsevier Ltd. All rights reserved.	[Nakajima, Shingo; Numakawa, Tadahiro; Adachi, Naoki; Ooshima, Yoshiko; Odaka, Haruki; Yoshimura, Aya; Kunugi, Hiroshi] NCNP, Natl Inst Neurosci, Dept Mental Disorder Res, Kodaira, Tokyo 1878502, Japan; [Nakajima, Shingo] Hokkaido Univ, Fac Hlth Sci, Sapporo, Hokkaido, Japan; [Numakawa, Tadahiro] Kumamoto Univ, Dept Cell Modulat, Inst Mol Embryol & Genet, Kumamoto, Japan; [Adachi, Naoki] Kwansei Gakuin Univ, Dept Biomed Chem, Sanda, Japan; [Ooshima, Yoshiko] NCNP, Natl Inst Neurosci, Dept Mol Pharmacol, Kodaira, Tokyo 1878502, Japan; [Odaka, Haruki] Waseda Univ, Sch Adv Sci & Engn, Dept Life Sci & Med Biosci, Tokyo, Japan	Numakawa, T (reprint author), NCNP, Natl Inst Neurosci, Dept Mental Disorder Res, 4-1-1 Ogawa Higashi, Kodaira, Tokyo 1878502, Japan.	numakawa.yyrmk@gmail.com			Takeda Science Foundation; JSPS KAKENHI in the Ministry of Education, Culture, Sports, Science, and Technology of Japan [24300139]; JSPS KAKENHI Grant [25640019]; Health and Labor Sciences Research Grants; Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP; CREST, Japan Science and Technology Agency (JST)	This study was supported by grants from Takeda Science Foundation (T.N.), the Grant-in-Aid for Challenging Exploratory Research (JSPS KAKENHI Grant Number 25640019) (T. N.), and the Grant-in-Aid for Scientific Research (B) (JSPS KAKENHI 24300139) (T. N.) in the Ministry of Education, Culture, Sports, Science, and Technology of Japan. This study also supported by the Health and Labor Sciences Research Grants (H. K.), Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP (H.K.) and CREST, Japan Science and Technology Agency (JST) (T.N., N.A. and H.K.).	Andreska T, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00107; Park H, 2013, NAT REV NEUROSCI, V14, P7, DOI 10.1038/nrn3379; Numakawa T, 2009, P NATL ACAD SCI USA, V106, P647, DOI 10.1073/pnas.0800888106; Katanuma Y, 2014, SYNAPSE, V68, P257, DOI 10.1002/syn.21735; Kim SY, 2004, EUR J BIOCHEM, V271, P3470, DOI 10.1111/j.1432-1033.2004.04242.x; Kuczewski N, 2010, EUR J NEUROSCI, V32, P1239, DOI 10.1111/j.1460-9568.2010.07378.x; Cheng PL, 2011, P NATL ACAD SCI USA, V108, P18430, DOI 10.1073/pnas.1115907108; Garza AA, 2004, PHARMACOL BIOCHEM BE, V77, P209, DOI 10.1016/j.pbb.2003.10.020; Zheng F, 2009, NEUROCHEM INT, V54, P385, DOI 10.1016/j.neuint.2009.01.006; Jakawich SK, 2010, NEURON, V68, P1143, DOI 10.1016/j.neuron.2010.11.034; Yoshii A, 2010, DEV NEUROBIOL, V70, P304, DOI 10.1002/dneu.20765; Bechara RG, 2013, BEHAV BRAIN RES, V245, P96, DOI 10.1016/j.bbr.2013.02.018; Nakanishi S, 2006, J PHYSIOL-LONDON, V575, P389, DOI 10.1113/jphysiol.2006.113340; Vaynman S, 2003, NEUROSCIENCE, V122, P647, DOI 10.1016/j.neuroscience.2003.08.001; Ma J, 2013, NEUROCHEM INT, V62, P84, DOI 10.1016/j.neuint.2012.11.010; ZAFRA F, 1990, EMBO J, V9, P3545; Bambah-Mukku D, 2014, J NEUROSCI, V34, P12547, DOI 10.1523/JNEUROSCI.0324-14.2014; Ji YY, 2010, NAT NEUROSCI, V13, P302, DOI 10.1038/nn.2505; Yasuda M, 2007, J NEUROCHEM, V103, P626, DOI 10.1111/j.1471-4159.2007.04851.x; Guo W, 2014, J CELL SCI, V127, P2249, DOI 10.1242/jcs.139964; Li Y, 2014, NEUROCHEM INT, V75, P96, DOI 10.1016/j.neuint.2014.06.004; Pruunsild P, 2011, J NEUROSCI, V31, P3295, DOI 10.1523/JNEUROSCI.4540-10.2011; Leal G, 2014, NEUROPHARMACOLOGY, V76, P639, DOI 10.1016/j.neuropharm.2013.04.005; Ray MT, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.26; Zheng F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028441	25	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186	1872-9754		NEUROCHEM INT	Neurochem. Int.	DEC	2015	91						55	61		10.1016/j.neuint.2015.10.009		7	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	CZ0FL	WOS:000366780400006		
J	Chaki, S; Fukumoto, K; Iijima, M				Chaki, Shigeyuki; Fukumoto, Kenichi; Iijima, Michihiko			Role of AMPA Receptor Stimulation in the mPFC and Subsequent Serotonin Neuron Activation in Antidepressant Effects of an mGlu2/3 Receptor Antagonist and Ketamine	NEUROPSYCHOPHARMACOLOGY			English	Meeting Abstract	54th Annual Meeting of the American-College-of-Neuropsychopharmacology (ACNP)	DEC 06-10, 2015	Hollywood, FL	Amer Coll Neuropsychopharmacol		mGlu2/3 receptor; Antidepressant; Ketamine; ampa receptor; Serotonin			[Chaki, Shigeyuki; Fukumoto, Kenichi; Iijima, Michihiko] Taisho Pharmaceut Co, Saitama, Japan								0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0893-133X	1740-634X		NEUROPSYCHOPHARMACOL	Neuropsychopharmacology	DEC	2015	40			1		M77	S155	S155				1	Neurosciences; Pharmacology & Pharmacy; Psychiatry	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	CY7OI	WOS:000366597700285		
J	Hashimoto, K; Yang, C; Zhang, JC; Ren, Q; Ma, M; Yao, W; Chao, D; Shirayama, Y				Hashimoto, Kenji; Yang, Chun; Zhang, Ji-Chun; Ren, Qian; Ma, Min; Yao, Wei; Chao, Dong; Shirayama, Yukihiko			R-Ketamine: A Rapid Onset and Sustained Antidepressant Without Psychotomimetic Side Effects	NEUROPSYCHOPHARMACOLOGY			English	Meeting Abstract	54th Annual Meeting of the American-College-of-Neuropsychopharmacology (ACNP)	DEC 06-10, 2015	Hollywood, FL	Amer Coll Neuropsychopharmacol		Ketamine; Esketamine; Antidepressant; NMDA Receptor; BDNF			[Hashimoto, Kenji; Yang, Chun; Zhang, Ji-Chun; Ren, Qian; Ma, Min; Yao, Wei; Chao, Dong; Shirayama, Yukihiko] Chiba Univ, Ctr Forens Mental Hlth, Chiba, Japan								0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0893-133X	1740-634X		NEUROPSYCHOPHARMACOL	Neuropsychopharmacology	DEC	2015	40			1		M62	S145	S145				1	Neurosciences; Pharmacology & Pharmacy; Psychiatry	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	CY7OI	WOS:000366597700270		
J	Hikida, T; Morita, M; Kuroiwa, M; Macpherson, T; Itou, T; Shuto, T; Sotogaku, N; Niwa, M; Sawa, A; Nishi, A				Hikida, Takatoshi; Morita, Makiko; Kuroiwa, Mahomi; Macpherson, Tom; Itou, Taichi; Shuto, Takahide; Sotogaku, Naoki; Niwa, Minae; Sawa, Akira; Nishi, Akinori			Social Isolated DISC1 Mutant Mice Displayed High Sensitivity to Chronic Cocaine Exposure and Rolipram Treatment	NEUROPSYCHOPHARMACOLOGY			English	Meeting Abstract	54th Annual Meeting of the American-College-of-Neuropsychopharmacology (ACNP)	DEC 06-10, 2015	Hollywood, FL	Amer Coll Neuropsychopharmacol		addiction; DISC1; Gene environment interaction; PDE4			[Hikida, Takatoshi; Morita, Makiko; Kuroiwa, Mahomi; Macpherson, Tom; Itou, Taichi; Shuto, Takahide; Sotogaku, Naoki; Niwa, Minae; Sawa, Akira; Nishi, Akinori] Kyoto Univ, Grad Sch Med, Med Inovat Ctr, Kyoto, Japan								0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0893-133X	1740-634X		NEUROPSYCHOPHARMACOL	Neuropsychopharmacology	DEC	2015	40			1		M228	S249	S249				1	Neurosciences; Pharmacology & Pharmacy; Psychiatry	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	CY7OI	WOS:000366597700436		
J	Ikeda, K; Hagino, Y; Kasai, S; Yamamoto, H; Mishina, M				Ikeda, Kazutaka; Hagino, Yoko; Kasai, Shinya; Yamamoto, Hideko; Mishina, Masayoshi			NMDA Receptor GluN2D Subunit is Indispensable in Phencyclidine (PCP) Effects	NEUROPSYCHOPHARMACOLOGY			English	Meeting Abstract	54th Annual Meeting of the American-College-of-Neuropsychopharmacology (ACNP)	DEC 06-10, 2015	Hollywood, FL	Amer Coll Neuropsychopharmacol		NMDA Receptor; Dopamine; c-Fos; psychosis; NMDA channel blocker			[Ikeda, Kazutaka; Hagino, Yoko; Kasai, Shinya; Yamamoto, Hideko; Mishina, Masayoshi] Tokyo Metropolitan Inst Med Sci, Addict Subst Project, Tokyo 113, Japan								0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0893-133X	1740-634X		NEUROPSYCHOPHARMACOL	Neuropsychopharmacology	DEC	2015	40			1		M212	S239	S240				2	Neurosciences; Pharmacology & Pharmacy; Psychiatry	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	CY7OI	WOS:000366597700420		
J	Kida, S; Ishikawa, R				Kida, Satoshi; Ishikawa, Rie			Erasure of Recent and Remote Fear Memory by Enhancing Forgetting Through Increase in Adult Hippocampal Neurogenesis	NEUROPSYCHOPHARMACOLOGY			English	Meeting Abstract	54th Annual Meeting of the American-College-of-Neuropsychopharmacology (ACNP)	DEC 06-10, 2015	Hollywood, FL	Amer Coll Neuropsychopharmacol		PTSD; Fear conditioning; Fear extinction; mice; Neurogenesis			[Kida, Satoshi; Ishikawa, Rie] Tokyo Univ Agr, Tokyo, Japan								0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0893-133X	1740-634X		NEUROPSYCHOPHARMACOL	Neuropsychopharmacology	DEC	2015	40			1		M138	S194	S194				1	Neurosciences; Pharmacology & Pharmacy; Psychiatry	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	CY7OI	WOS:000366597700346		
J	Matsumoto, M				Matsumoto, Mickey			Neural Functions of SREB - The Most Evolutionarily Conserved G-Protein Coupled Receptor Family Associated with Psychiatric Disorders	NEUROPSYCHOPHARMACOLOGY			English	Meeting Abstract	54th Annual Meeting of the American-College-of-Neuropsychopharmacology (ACNP)	DEC 06-10, 2015	Hollywood, FL	Amer Coll Neuropsychopharmacol					[Matsumoto, Mickey] Astellas Phrama Inc, Tsukuba, Ibaraki, Japan								0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0893-133X	1740-634X		NEUROPSYCHOPHARMACOL	Neuropsychopharmacology	DEC	2015	40			1		50.4	S88	S89				2	Neurosciences; Pharmacology & Pharmacy; Psychiatry	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	CY7OI	WOS:000366597700177		
J	Mihara, T; Honda, S; Takahasi, Y; Yamada, H; Matsumoto, M				Mihara, Takuma; Honda, Sokichi; Takahasi, Yuko; Yamada, Hiroshi; Matsumoto, Mickey			Bi-Phasic Effect of Ketamine on Auditory Steady-State Response in Awaking Rats	NEUROPSYCHOPHARMACOLOGY			English	Meeting Abstract	54th Annual Meeting of the American-College-of-Neuropsychopharmacology (ACNP)	DEC 06-10, 2015	Hollywood, FL	Amer Coll Neuropsychopharmacol		ketamine; ASSR; ERPs; electroencephalography; NMDA Antagonists			[Mihara, Takuma; Honda, Sokichi; Takahasi, Yuko; Yamada, Hiroshi; Matsumoto, Mickey] Astellas Pharma Inc, Tsukuba, Ibaraki, Japan								0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0893-133X	1740-634X		NEUROPSYCHOPHARMACOL	Neuropsychopharmacology	DEC	2015	40			1		M160	S208	S208				1	Neurosciences; Pharmacology & Pharmacy; Psychiatry	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	CY7OI	WOS:000366597700368		
J	Miyakawa, T; Hagihara, H; Hattori, S; Takamiya, Y; Kameyama, T; Ouchi, Y; Inagaki, H; Kurahashi, H; Huang, F; Huang, KP				Miyakawa, Tsuyoshi; Hagihara, Hideo; Hattori, Satoko; Takamiya, Yoshihiro; Kameyama, Toshiki; Ouchi, Yuya; Inagaki, Hidehito; Kurahashi, Hiroki; Huang, Freesia; Huang, Kuo-Ping			Deficiency of Neurogranin, a Susceptibility Gene for Schizophrenia, Confers Multiple Molecular and Behavioral Phenotypes Related to Schizophrenia	NEUROPSYCHOPHARMACOLOGY			English	Meeting Abstract	54th Annual Meeting of the American-College-of-Neuropsychopharmacology (ACNP)	DEC 06-10, 2015	Hollywood, FL	Amer Coll Neuropsychopharmacol		schizophrenia; neurogranin; animal model; inflammation; parvalbumin			[Miyakawa, Tsuyoshi; Hagihara, Hideo; Hattori, Satoko; Takamiya, Yoshihiro; Kameyama, Toshiki; Ouchi, Yuya; Inagaki, Hidehito; Kurahashi, Hiroki; Huang, Freesia; Huang, Kuo-Ping] Fujita Hlth Univ, Toyoake, Aichi, Japan								0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0893-133X	1740-634X		NEUROPSYCHOPHARMACOL	Neuropsychopharmacology	DEC	2015	40			1		T160	S374	S375				2	Neurosciences; Pharmacology & Pharmacy; Psychiatry	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	CY7OI	WOS:000366597700627		
J	Nakamura, K; Thanseem, I; Mori, N; Tsujii, M; Matsumoto, N				Nakamura, Kazuhiko; Thanseem, Ismail; Mori, Norio; Tsujii, Masatsugu; Matsumoto, Naomich			CNV Analysis and Exome Sequencing in Japanese Autism Spectrum Disorder Subjects	NEUROPSYCHOPHARMACOLOGY			English	Meeting Abstract	54th Annual Meeting of the American-College-of-Neuropsychopharmacology (ACNP)	DEC 06-10, 2015	Hollywood, FL	Amer Coll Neuropsychopharmacol		autism spectrum disorders; copy number variation; de novo; exome sequencing			[Nakamura, Kazuhiko; Thanseem, Ismail; Mori, Norio; Tsujii, Masatsugu; Matsumoto, Naomich] Hirosaki Univ, Grad Sch Med, Aomori, Japan								0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0893-133X	1740-634X		NEUROPSYCHOPHARMACOL	Neuropsychopharmacology	DEC	2015	40			1		M37	S129	S130				2	Neurosciences; Pharmacology & Pharmacy; Psychiatry	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	CY7OI	WOS:000366597700245		
J	Nishikawa, T				Nishikawa, Toru			Calcium-Permeable Ampa Receptor and Asc-1 Transporter Regulate the Cortical Extracellular D-Serine Concentration: Potential Targets for Development of Novel Pharmacotherapy for NMDA Receptor Dysfunction in Schizophrenia	NEUROPSYCHOPHARMACOLOGY			English	Meeting Abstract	54th Annual Meeting of the American-College-of-Neuropsychopharmacology (ACNP)	DEC 06-10, 2015	Hollywood, FL	Amer Coll Neuropsychopharmacol					[Nishikawa, Toru] Tokyo Med & Dent Univ, Tokyo, Japan								0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0893-133X	1740-634X		NEUROPSYCHOPHARMACOL	Neuropsychopharmacology	DEC	2015	40			1		29.2	S50	S50				1	Neurosciences; Pharmacology & Pharmacy; Psychiatry	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	CY7OI	WOS:000366597700099		
J	Okada, G; Okamoto, Y; Takamura, M; Toki, S; Yamamoto, T; Yamawaki, S				Okada, Go; Okamoto, Yasumasa; Takamura, Masahiro; Toki, Shigeru; Yamamoto, Tetsuya; Yamawaki, Shigeto			Functional Connectivity of Striatum and SSRI Treatment in Major Depressive Disorder	NEUROPSYCHOPHARMACOLOGY			English	Meeting Abstract	54th Annual Meeting of the American-College-of-Neuropsychopharmacology (ACNP)	DEC 06-10, 2015	Hollywood, FL	Amer Coll Neuropsychopharmacol		Major Depressive Disorder (MDD); SSRI; resting state fMRI; functional connectivity; striatum			[Okada, Go; Okamoto, Yasumasa; Takamura, Masahiro; Toki, Shigeru; Yamamoto, Tetsuya; Yamawaki, Shigeto] Hiroshima Univ, Hiroshima, Japan								0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0893-133X	1740-634X		NEUROPSYCHOPHARMACOL	Neuropsychopharmacology	DEC	2015	40			1		T69	S315	S315				1	Neurosciences; Pharmacology & Pharmacy; Psychiatry	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	CY7OI	WOS:000366597700538		
J	Sora, I; Arime, Y; Hall, F; Uhl, GR; Kasahara, Y				Sora, Ichiro; Arime, Yosefu; Hall, Frank; Uhl, George R.; Kasahara, Yoshiyuki			Region-Specific Dendritic Spine Loss of Pyramidal Neurons in Dopamine Transporter Knockout Mice	NEUROPSYCHOPHARMACOLOGY			English	Meeting Abstract	54th Annual Meeting of the American-College-of-Neuropsychopharmacology (ACNP)	DEC 06-10, 2015	Hollywood, FL	Amer Coll Neuropsychopharmacol		transgenic mice; medial prefrontal cortex; pyramidal neuron			[Sora, Ichiro; Arime, Yosefu; Hall, Frank; Uhl, George R.; Kasahara, Yoshiyuki] Kobe Univ, Grad Sch Med, Kobe, Hyogo 657, Japan								0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0893-133X	1740-634X		NEUROPSYCHOPHARMACOL	Neuropsychopharmacology	DEC	2015	40			1		M185	S222	S222				1	Neurosciences; Pharmacology & Pharmacy; Psychiatry	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	CY7OI	WOS:000366597700393		
J	Uchida, H; Nakajima, S; Bies, R; Caravaggio, F; Suzuki, T; Plitman, E; Mar, W; Gerretsen, P; Pollock, B; Mulsant, B; Mamo, D; Graff, A				Uchida, Hiroyuki; Nakajima, Shinichiro; Bies, Robert; Caravaggio, Fernando; Suzuki, Takefumi; Plitman, Eric; Mar, Wanna; Gerretsen, Philip; Pollock, Bruce; Mulsant, Benoit; Mamo, David; Graff, Ariel			Central Dopamine D2/3 Receptor Occupancy Following Dose Reduction is Predictable with Minimal Plasma Antipsychotic Concentrations: An Open-Label Clinical Trial	NEUROPSYCHOPHARMACOLOGY			English	Meeting Abstract	54th Annual Meeting of the American-College-of-Neuropsychopharmacology (ACNP)	DEC 06-10, 2015	Hollywood, FL	Amer Coll Neuropsychopharmacol		schizophrenia; Antipsychotic; Dopamine (D2, D3) receptors; PET			[Uchida, Hiroyuki; Nakajima, Shinichiro; Bies, Robert; Caravaggio, Fernando; Suzuki, Takefumi; Plitman, Eric; Mar, Wanna; Gerretsen, Philip; Pollock, Bruce; Mulsant, Benoit; Mamo, David; Graff, Ariel] Keio Univ, Sch Med, Tokyo, Japan								0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0893-133X	1740-634X		NEUROPSYCHOPHARMACOL	Neuropsychopharmacology	DEC	2015	40			1		M159	S207	S208				2	Neurosciences; Pharmacology & Pharmacy; Psychiatry	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	CY7OI	WOS:000366597700367		
J	Fukuizumi, R; Selem, FH; Kikuchi, H				Fukuizumi, Reika; Selem, Fouad Hadj; Kikuchi, Hiroaki			Stationary problem related to the nonlinear Schrodinger equation on the unit ball (vol 25, pg 2271, 2012)	NONLINEARITY			English	Correction									[Fukuizumi, Reika] Tohoku Univ, Grad Sch Informat Sci, Aoba Ku, Sendai, Miyagi 9808579, Japan; [Selem, Fouad Hadj] CEA Saclay, Neurospin, I2BM, CEA, F-91191 Gif Sur Yvette, France; [Kikuchi, Hiroaki] Tsuda Coll, Dept Math, Kodaira, Tokyo 1878577, Japan	Fukuizumi, R (reprint author), Tohoku Univ, Grad Sch Informat Sci, Aoba Ku, 6-3-09 Aramaki Aza Aoba, Sendai, Miyagi 9808579, Japan.	hiroaki@tsuda.ac.jp					Fukuizumi R, 2012, NONLINEARITY, V25, P2271, DOI 10.1088/0951-7715/25/8/2271; Cazenave T, 2003, COURANT LECT NOTES M, V10	2	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0951-7715	1361-6544		NONLINEARITY	Nonlinearity	DEC	2015	28	12					C3	C7		10.1088/0951-7715/28/11/C3		5	Mathematics, Applied; Physics, Mathematical	Mathematics; Physics	CZ0LX	WOS:000366797700001		
J	Nakamura, M; Tobita, K; Someya, Y; Utoh, H; Sakamoto, Y; Gulden, W				Nakamura, M.; Tobita, K.; Someya, Y.; Utoh, H.; Sakamoto, Y.; Gulden, W.			Thermohydraulic responses of a water-cooled tokamak fusion DEMO to loss-of-coolant accidents	NUCLEAR FUSION			English	Article						fusion DEMO; safety; loss-of-coolant accident; thermohydraulics	BROADER APPROACH; SAFETY DESIGN; REACTOR; MELCOR	Major in- and ex-vessel loss-of-coolant accidents (LOCAs) of a water-cooled tokamak fusion DEMO reactor have been analysed. Analyses have identified responses of the DEMO systems to these accidents and pressure loads to confinement barriers for radioactive materials. As for the in-VV LOCA, we analysed the multiple double-ended break of the first wall cooling pipes around the outboard toroidal circumference. As for the ex-VV LOCA, we analysed the doubleended break of the primary cooling pipe. The thermohydraulic analysis results suggest that the in- and ex-vessel LOCAs crucially threaten integrity of the primary and final confinement barriers, respectively. Mitigations of the loads to the confinement barriers are also discussed.	[Nakamura, M.; Tobita, K.; Someya, Y.; Utoh, H.; Sakamoto, Y.] Japan Atom Energy Agcy, Rokkasho 0393212, Japan; [Gulden, W.] Fus Energy, D-85748 Garching, Germany	Nakamura, M (reprint author), Japan Atom Energy Agcy, Rokkasho 0393212, Japan.	nakamura.makoto@jaea.go.jp			Broader Approach (BA); Japan Society for the Promotion of Science; KAKENHI [25420898]	This work is partially supported by the Broader Approach (BA) and by a Grant-in-Aid for Scientific Research from Japan Society for the Promotion of Science; KAKENHI Grant number 25420898. M.N. and K.T. thank Dr. B. Merrill (Idaho National Laboratory, INL) for kindly providing us with MELCOR with the fusion modifications and his hospitality during their visit to INL. They also thank Mrs. Takao Araki (Toshiba Corporation) and Kazuhito Watanabe (Toshiba Corporation) for supporting MELCOR modeling, and Professor Tomoaki Kunugi (Kyoto University) and Dr. Takehiko Yokomine (Kyoto University) for their comments about the interpretation of the MELCOR calculation results.	Gulden W, 2007, NUCL FUSION, V47, pS415, DOI 10.1088/0029-5515/47/7/S01; Nishitani T, 2012, FUSION ENG DES, V87, P535, DOI 10.1016/j.fusengdes.2012.01.018; Petti DA, 2006, FUSION ENG DES, V80, P111, DOI 10.1016/j.fusengdes.2005.06.351; Nakamura M, 2014, FUSION ENG DES, V89, P2028, DOI 10.1016/j.fusengdes.2014.04.062; Enoeda M, 2012, FUSION ENG DES, V87, P1363, DOI 10.1016/j.fusengdes.2012.03.007; Taylor N, 2011, FUSION ENG DES, V86, P619, DOI 10.1016/j.fusengdes.2010.11.037; [Anonymous], 2002, ITER TECHN BAS ITER, V24; Tsuchiya K, 2007, NUCL FUSION, V47, P1300, DOI 10.1088/0029-5515/47/9/029; Merrill BJ, 2010, FUSION ENG DES, V85, P1479, DOI 10.1016/j.fusengdes.2010.04.017; Merrill BJ, 2000, FUSION ENG DES, V51-52, P555, DOI 10.1016/S0920-3796(00)00220-9; Tobita K, 2014, FUSION ENG DES, V89, P1870, DOI 10.1016/j.fusengdes.2014.02.077; Gauntt R. O., 2000, NUREGCR6119 USNRC SA, V1; Humrickhouse PW, 2015, FUSION SCI TECHNOL, V67, P167; ITER, 1997, NSSR2 ITER; ITER, 2011, PREL SAF REP RPRS VE; Merrill BJ, 2008, FUSION SCI TECHNOL, V54, P838; Nakamura M., 2014, PLASMA FUSION RES, V9; Raeder J., 1995, 1221795 EURFUBRU; Sakamoto Y., 2014, 25 IAEA INT C FUS EN; Summers R. M., 1991, NUREGCR5531 USNRC SA	20	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0029-5515	1741-4326		NUCL FUSION	Nucl. Fusion	DEC	2015	55	12							123008	10.1088/0029-5515/55/12/123008		7	Physics, Fluids & Plasmas; Physics, Nuclear	Physics	CY6QS	WOS:000366534500010		
J	Shaing, KC; Ida, K; Sabbagh, SA				Shaing, K. C.; Ida, K.; Sabbagh, S. A.			Neoclassical plasma viscosity and transport processes in non-axisymmetric tori	NUCLEAR FUSION			English	Review						tokamak; non-asymmetric tori; plasma transport	RADIAL ELECTRIC-FIELD; LARGE HELICAL DEVICE; ION THERMAL-CONDUCTIVITY; NONAXISYMMETRIC TOROIDAL PLASMAS; L-H TRANSITION; COLLISIONAL TOKAMAK PLASMA; RATIONAL MAGNETIC-SURFACES; DRIFT-KINETIC-EQUATION; FINITE ASPECT RATIO; QUASI-LINEAR THEORY	Neoclassical transport processes are important to the understanding of plasma confinement physics in doubly periodic magnetized toroidal plasmas, especially, after the impact of the momentum confinement on the particle and energy confinement is recognized. Real doubly periodic tori in general are non-axisymmetric, with symmetric tori as a special case. An eight-moment approach to transport theory with plasma density N, plasma pressure p, mass flow velocity V and heat flow q as independent variables is adopted. Transport processes are dictated by the solutions of the momentum and heat flux balance equations. For toroidal plasma confinement devices, the first order (in the gyro-radius ordering) plasma flows are on the magnetic surface to guarantee good plasma confinement and are thus two-dimensional. Two linearly independent components of the momentum equation are required to determine the flows completely. Once this two-dimensional flow is relaxed, i.e. the momentum equation reaches a steady state, plasmas become ambipolar, and all the transport fluxes are determined through the flux-force relation. The flux-force relation is derived both from the kinetic definitions for the transport fluxes and from the manipulation of the momentum and heat flux balance equations to illustrate the nature of the transport fluxes by examining their corresponding driven forces and their roles in the momentum and heat flux balance equations. Steady-state plasma flows are determined by the components of the stress and heat stress tensors in the momentum and heat flux balance equations. This approach emphasizes the pivotal role of the momentum equation in the transport processes and is particularly useful in modelling plasma flows in experiments. The methodology for neoclassical transport theory is applied to fluctuation-driven transport fluxes in the quasilinear theory to unify these two theories. Experimental observations in tokamaks and stellarators for the physics discussed are presented.	[Shaing, K. C.] Natl Cheng Kung Univ, Tainan 70101, Taiwan; [Ida, K.] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Sabbagh, S. A.] Columbia Univ, New York, NY 10027 USA	Shaing, KC (reprint author), Natl Cheng Kung Univ, Tainan 70101, Taiwan.	kcs@plasma.pssc.ncku.edu.tw			Ministry of Science and Technology, Taiwan [100-2112-M-006-004-MY3]; Foundation for the Advancement of Outstanding Scholarship, Taiwan; JSPS, Japan [21224014, 23246164]; US Department of Energy [DE-FG02-99ER54524]	The authors would like to thank Dr M S Chu for carefully reading section 3. They would like to thank Dr W H Ko for charge exchange recombination spectroscopy measurements and analysis of toroidal plasma rotation in KSTAR. The work by KCS was supported by the Ministry of Science and Technology, Taiwan, under Grant No. 100-2112-M-006-004-MY3, and Foundation for the Advancement of Outstanding Scholarship, Taiwan. The work by KI was supported in part by a Grant-in-Aid for Specially-Promoted Research (No. 21224014) and a Grant-in-Aid for Scientific Research (No. 23246164) of JSPS, Japan. The work by SAS was supported by the US Department of Energy under Grant No. DE-FG02-99ER54524.	Abramowitz M, 1965, HDB MATH FUNCTIONS; GIBSON A, 1969, PLASMA PHYSICS, V11, P121, DOI 10.1088/0032-1028/11/2/004; Fujisawa A, 1997, PHYS REV LETT, V79, P1054, DOI 10.1103/PhysRevLett.79.1054; Wang WX, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.055002; HENDER TC, 1992, NUCL FUSION, V32, P2091, DOI 10.1088/0029-5515/32/12/I02; Hinton FL, 1999, PLASMA PHYS CONTR F, V41, pA653, DOI 10.1088/0741-3335/41/3A/059; SHAING KC, 1990, PHYS FLUIDS B-PLASMA, V2, P1492, DOI 10.1063/1.859473; SHAING KC, 1993, PHYS FLUIDS B-PLASMA, V5, P3596, DOI 10.1063/1.860831; Stroth U, 2001, PHYS REV LETT, V86, P5910, DOI 10.1103/PhysRevLett.86.5910; SHAING KC, 1989, PHYS FLUIDS B-PLASMA, V1, P1663, DOI 10.1063/1.858945; Beidler CD, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/7/076001; HIRSHMAN SP, 1983, PHYS FLUIDS, V26, P3553, DOI 10.1063/1.864116; Shaing KC, 2010, NUCL FUSION, V50, DOI 10.1088/0029-5515/50/12/125008; Shaing KC, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.3682044; LIN Z, 1995, PHYS PLASMAS, V2, P2975, DOI 10.1063/1.871196; Shaing KC, 1998, PHYS PLASMAS, V5, P953, DOI 10.1063/1.872663; MYNICK HE, 1982, PHYS REV LETT, V48, P322, DOI 10.1103/PhysRevLett.48.322; WATANABE KY, 1995, NUCL FUSION, V35, P335, DOI 10.1088/0029-5515/35/3/I07; Shaing KC, 2008, PHYS PLASMAS, V15, DOI 10.1063/1.2969434; Houlberg WA, 1997, PHYS PLASMAS, V4, P3230, DOI 10.1063/1.872465; Kitajima S, 2006, NUCL FUSION, V46, P200, DOI 10.1088/0029-5515/46/2/002; BERK HL, 1967, PHYS FLUIDS, V10, P441, DOI 10.1063/1.1762126; Shaing KC, 1997, PHYS PLASMAS, V4, P771, DOI 10.1063/1.872171; Shaing KC, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/7/073043; Buttery R J, 2008, Physics of Plasmas, V15, DOI 10.1063/1.2894215; MATTOR N, 1988, PHYS FLUIDS, V31, P1180, DOI 10.1063/1.866747; HINTON FL, 1985, PHYS FLUIDS, V28, P3082, DOI 10.1063/1.865350; Gerhardt SP, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.015002; NOCENTINI A, 1975, NUCL FUSION, V15, P359, DOI 10.1088/0029-5515/15/3/001; Coppi B, 2002, NUCL FUSION, V42, P1, DOI 10.1088/0029-5515/42/1/301; TSANG KT, 1977, NUCL FUSION, V17, P557, DOI 10.1088/0029-5515/17/3/014; Morita S, 2007, NUCL FUSION, V47, P1033, DOI 10.1088/0029-5515/47/8/038; Sauter O, 1999, PHYS PLASMAS, V6, P2834, DOI 10.1063/1.873240; HIRSHMAN SP, 1986, COMPUT PHYS COMMUN, V43, P143, DOI 10.1016/0010-4655(86)90058-5; Peng YKM, 2009, FUSION SCI TECHNOL, V56, P957; CORONADO M, 1987, PHYS FLUIDS, V30, P3171, DOI 10.1063/1.866492; NAKAJIMA N, 1992, J PHYS SOC JPN, V61, P833, DOI 10.1143/JPSJ.61.833; Aydemir AY, 2012, NUCL FUSION, V52, DOI 10.1088/0029-5515/52/6/063026; Terry PW, 2000, REV MOD PHYS, V72, P109, DOI 10.1103/RevModPhys.72.109; SHAING KC, 1983, PHYS FLUIDS, V26, P3315, DOI 10.1063/1.864108; CHEW GF, 1956, PROC R SOC LON SER-A, V236, P112, DOI 10.1098/rspa.1956.0116; JAEGER EF, 1978, PHYS REV LETT, V40, P866, DOI 10.1103/PhysRevLett.40.866; Shaing KC, 2012, PLASMA PHYS CONTR F, V54, DOI 10.1088/0741-3335/54/12/124033; SHAING KC, 1994, PHYS PLASMAS, V1, P1168, DOI 10.1063/1.870713; Sabbagh SA, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/10/104007; SU CH, 1968, PHYS REV LETT, V20, P427, DOI 10.1103/PhysRevLett.20.427; CHANKIN AV, 1993, NUCL FUSION, V33, P1459, DOI 10.1088/0029-5515/33/10/I05; Shaing KC, 2009, PLASMA PHYS CONTR F, V51, DOI 10.1088/0741-3335/51/7/075015; Garofalo AM, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.195005; Helander P, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3633940; Ware AS, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.125003; Evans TE, 2008, NUCL FUSION, V48, DOI 10.1088/0029-5515/48/2/024002; FITZPATRICK R, 1993, NUCL FUSION, V33, P1049, DOI 10.1088/0029-5515/33/7/I08; Shaing KC, 1996, PHYS REV LETT, V76, P4364, DOI 10.1103/PhysRevLett.76.4364; Inagaki S, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.055002; Aydemir AY, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.225002; STRINGER TE, 1972, NUCL FUSION, V12, P689, DOI 10.1088/0029-5515/12/6/010; DUPREE TH, 1972, PHYS FLUIDS, V15, P334, DOI 10.1063/1.1693911; GALEEV AA, 1968, SOV PHYS JETP-USSR, V26, P233; Park YS, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/8/083029; Gerhardt SP, 2010, PLASMA PHYS CONTR F, V52, DOI 10.1088/0741-3335/52/10/104003; Xia H, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.255003; Shaing KC, 2005, PHYS PLASMAS, V12, DOI 10.1063/1.2001327; Cole AJ, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.065001; CORONADO M, 1986, PHYS FLUIDS, V29, P527, DOI 10.1063/1.865440; SHAING KC, 1983, PHYS FLUIDS, V26, P2136, DOI 10.1063/1.864395; HINTON FL, 1976, REV MOD PHYS, V48, P239, DOI 10.1103/RevModPhys.48.239; Shaing KC, 2002, PHYS PLASMAS, V9, P1654, DOI 10.1063/1.1468856; ISAEV MY, 1994, PLASMA PHYS REP, V20, P319; Yavorskij V, 2010, NUCL FUSION, V50, DOI 10.1088/0029-5515/50/8/084022; SHAING KC, 1986, PHYS FLUIDS, V29, P521, DOI 10.1063/1.865439; Sano F, 2005, NUCL FUSION, V45, P1557, DOI 10.1088/0029-5515/45/12/011; Estrada T, 2007, NUCL FUSION, V47, P305, DOI 10.1088/0029-5515/47/4/009; Park JK, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.065002; Yavorskij VA, 1999, PHYS PLASMAS, V6, P3853, DOI 10.1063/1.873649; Hirsch M, 2008, PLASMA PHYS CONTR F, V50, DOI 10.1088/0741-3335/50/5/053001; Liang Y, 2010, NUCL FUSION, V50, DOI 10.1088/0029-5515/50/2/025013; Cole AJ, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3590933; SHAING KC, 1989, PHYS FLUIDS B-PLASMA, V1, P148, DOI 10.1063/1.859093; Shaing KC, 1997, PHYS PLASMAS, V4, P3928, DOI 10.1063/1.872513; IDA K, 1994, PHYS PLASMAS, V1, P116, DOI 10.1063/1.870944; Sabbagh SA, 2006, NUCL FUSION, V46, P635, DOI 10.1088/0029-5515/46/5/014; Liu YQ, 2008, PHYS PLASMAS, V15, DOI 10.1063/1.3008045; Belli EA, 2008, PLASMA PHYS CONTR F, V50, DOI 10.1088/0741-3335/50/9/095010; HIRSHMAN SP, 1986, PHYS FLUIDS, V29, P2951, DOI 10.1063/1.865495; Shaing KC, 2002, PHYS PLASMAS, V9, P3470, DOI 10.1063/1.1491533; HSU CT, 1990, PLASMA PHYS CONTR F, V32, P499, DOI 10.1088/0741-3335/32/7/002; FRIEMAN EA, 1970, PHYS FLUIDS, V13, P490, DOI 10.1063/1.1692944; Gerhardt SP, 2005, PHYS PLASMAS, V12, DOI [10.1063/1.1876293, 10.1063/1./1876293]; HITCHCOCK DA, 1979, PLASMA PHYS CONTR F, V21, P741, DOI 10.1088/0032-1028/21/8/007; Ida K, 2004, PHYS PLASMAS, V11, P2551, DOI [10.1063/1.1688787, 10.1063/1.1668787]; Hu B, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.105002; CONNOR JW, 1973, NUCL FUSION, V13, P221, DOI 10.1088/0029-5515/13/2/011; BOLTON C, 1983, PHYS FLUIDS, V26, P459, DOI 10.1063/1.864159; KAUFMAN AN, 1972, J PLASMA PHYS, V8, P1; ITOH SI, 1988, PHYS LETT A, V127, P267, DOI 10.1016/0375-9601(88)90694-9; Vargas VI, 2007, NUCL FUSION, V47, P1367, DOI 10.1088/0029-5515/47/9/039; SIGMAR DJ, 1973, NUCL FUSION, V13, P17, DOI 10.1088/0029-5515/13/1/003; MASE A, 1991, NUCL FUSION, V31, P1725, DOI 10.1088/0029-5515/31/9/010; Gott YV, 1999, PLASMA PHYS REP, V25, P363; Shaing KC, 1997, PHYS REV LETT, V79, P3652, DOI 10.1103/PhysRevLett.79.3652; Sabbagh SA, 2002, PHYS PLASMAS, V9, P2085, DOI 10.1063/1.1468230; Kaye SM, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/4/045010; Finken KH, 1999, NUCL FUSION, V39, P637, DOI 10.1088/0029-5515/39/5/306; Miyamoto K, 1996, NUCL FUSION, V36, P927, DOI 10.1088/0029-5515/36/7/I09; CRUME EC, 1988, PHYS FLUIDS, V31, P11, DOI 10.1063/1.866559; SHAING KC, 1992, PHYS FLUIDS B-PLASMA, V4, P2547, DOI 10.1063/1.860170; GALEEV AA, 1969, PHYS REV LETT, V22, P511, DOI 10.1103/PhysRevLett.22.511; Sugama H, 2002, PHYS PLASMAS, V9, P4637, DOI 10.1063/1.1512917; HASTINGS DE, 1985, PHYS FLUIDS, V28, P1402, DOI 10.1063/1.864974; Berkery JW, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.035003; Kwak JG, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/10/104005; SHAING KC, 1983, PHYS FLUIDS, V26, P1526, DOI 10.1063/1.864329; Shaing KC, 2002, PHYS PLASMAS, V9, P736, DOI 10.1063/1.1430746; STRINGER TE, 1969, PHYS REV LETT, V22, P770, DOI 10.1103/PhysRevLett.22.770; Shaing KC, 2001, PHYS PLASMAS, V8, P193, DOI 10.1063/1.1332986; TANG WM, 1978, NUCL FUSION, V18, P1089, DOI 10.1088/0029-5515/18/8/006; DOMINGUEZ RR, 1987, NUCL FUSION, V27, P65, DOI 10.1088/0029-5515/27/1/006; MYNICK HE, 1983, NUCL FUSION, V23, P1053, DOI 10.1088/0029-5515/23/8/006; Ida K, 2004, NUCL FUSION, V44, P290, DOI 10.1088/0029-5515/44/2/010; SNIPES JA, 1988, NUCL FUSION, V28, P1085, DOI 10.1088/0029-5515/28/6/010; Schaffer MJ, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/10/103028; NAGASHIMA K, 1994, NUCL FUSION, V34, P449, DOI 10.1088/0029-5515/34/3/I12; Isaev MY, 2006, FUSION SCI TECHNOL, V50, P440; Park JK, 2008, NUCL FUSION, V48, DOI 10.1088/0029-5515/48/4/045006; ROME JA, 1976, NUCL FUSION, V16, P55, DOI 10.1088/0029-5515/16/1/006; Yokoyama M, 1996, NUCL FUSION, V36, P1307, DOI 10.1088/0029-5515/36/10/I04; Shaing KC, 2003, PHYS PLASMAS, V10, P1443, DOI 10.1063/1.1567285; HIRSHMAN SP, 1977, PHYS FLUIDS, V20, P589, DOI 10.1063/1.861917; Shaing KC, 2000, PHYS PLASMAS, V7, P5081, DOI 10.1063/1.1322560; Sun Y, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.145002; Shaing KC, 1997, PHYS PLASMAS, V4, P1371, DOI 10.1063/1.872312; Wang SJ, 1998, PHYS PLASMAS, V5, P3319, DOI 10.1063/1.872999; Shaing KC, 1997, PHYS PLASMAS, V4, P3341, DOI 10.1063/1.872475; Waelbroeck FL, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/10/104025; Sun Y, 2010, PLASMA PHYS CONTR F, V52, DOI 10.1088/0741-3335/52/10/105007; DEWAR RL, 1973, PHYS FLUIDS, V16, P1102, DOI 10.1063/1.1694473; Spong DA, 2001, NUCL FUSION, V41, P711, DOI 10.1088/0029-5515/41/6/305; HAMADA S, 1962, NUCL FUSION, V2, P23, DOI 10.1088/0029-5515/2/1-2/005; Park JK, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3122862; Ida K, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.015002; Ida K, 2001, PHYS REV LETT, V86, P5297, DOI 10.1103/PhysRevLett.86.5297; Dinklage A, 2007, NUCL FUSION, V47, P1265, DOI 10.1088/0029-5515/47/9/025; TSANG KT, 1976, PHYS FLUIDS, V19, P747, DOI 10.1063/1.861533; Claassen HA, 1999, CZECH J PHYS, V49, P69; Nowak S, 2012, J PHYS CONF SER, V401, DOI 10.1088/1742-6596/401/1/012017; PORCELLI F, 1992, PHYS FLUIDS B-PLASMA, V4, P3017, DOI 10.1063/1.860461; SHAING KC, 1988, PHYS FLUIDS, V31, P8, DOI 10.1063/1.866581; NUHRENBERG J, 1988, PHYS LETT A, V129, P113, DOI 10.1016/0375-9601(88)90080-1; Reimerdes H, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/11/115001; Ida K, 2005, NUCL FUSION, V45, P391, DOI 10.1088/0029-5515/45/5/010; SHAING KC, 1992, PHYS FLUIDS B-PLASMA, V4, P404, DOI 10.1063/1.860290; STACEY WM, 1985, PHYS FLUIDS, V28, P2800, DOI 10.1063/1.865240; Solomon WM, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.065004; Taguchi M, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4789619; Stacey WM, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4775601; Callen JD, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/9/094026; Shaing KC, 2009, PLASMA PHYS CONTR F, V51, DOI 10.1088/0741-3335/51/3/035009; Shaing KC, 2010, NUCL FUSION, V50, DOI 10.1088/0029-5515/50/2/025022; Pustovitov VD, 1998, PLASMA PHYS REP, V24, P279; HIRSHMAN SP, 1978, NUCL FUSION, V18, P917, DOI 10.1088/0029-5515/18/7/004; CHANG CS, 1982, PHYS FLUIDS, V25, P1493, DOI 10.1063/1.863934; Zhang YZ, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.3676597; Shaing KC, 2010, NUCL FUSION, V50, DOI 10.1088/0029-5515/50/12/125012; Zhu W, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.225002; Shaing KC, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.245003; Aydemir AY, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/6/065001; WARE AA, 1970, PHYS REV LETT, V25, P916, DOI 10.1103/PhysRevLett.25.916; Miller RL, 1997, PHYS PLASMAS, V4, P1062, DOI 10.1063/1.872193; Shaing KC, 2001, PHYS REV LETT, V86, P640, DOI 10.1103/PhysRevLett.86.640; Lazzaro E, 2003, PHYS PLASMAS, V10, P2399, DOI 10.1063/1.1574814; Garbet X, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3454365; Kikuchi M, 2012, REV MOD PHYS, V84, P1807, DOI 10.1103/RevModPhys.84.1807; Wilson HR, 2004, NUCL FUSION, V44, P917, DOI 10.1088/0029-5515/44/8/010; Lazzaro E, 2002, PHYS PLASMAS, V9, P3906, DOI 10.1063/1.1499495; Shaing KC, 2014, NUCL FUSION, V54, DOI 10.1088/0029-5515/54/3/033012; STRINGER TE, 1970, PHYS FLUIDS, V13, P810, DOI 10.1063/1.1692992; Ida K, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.085003; Hinton FL, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.4748138; KOLESNICHENKO YI, 1984, PHYS REV LETT, V53, P1825, DOI 10.1103/PhysRevLett.53.1825; BOOZER AH, 1983, PHYS FLUIDS, V26, P496, DOI 10.1063/1.864166; Castejon F, 2004, NUCL FUSION, V44, P593, DOI 10.1088/0029-5515/44/5/003; Horton W, 1999, REV MOD PHYS, V71, P735, DOI 10.1103/RevModPhys.71.735; VANMILLIGEN BP, 1993, NUCL FUSION, V33, P1119, DOI 10.1088/0029-5515/33/8/I03; BEIDLER CD, 1987, J COMPUT PHYS, V72, P220, DOI 10.1016/0021-9991(87)90079-9; Garofalo AM, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3129164; Lee H, 2013, PLASMA PHYS CONTR F, V55, DOI 10.1088/0741-3335/55/3/035012; Ida K, 2001, PHYS REV LETT, V86, P3040, DOI 10.1103/PhysRevLett.86.3040; Sabbagh SA, 2010, NUCL FUSION, V50, DOI 10.1088/0029-5515/50/2/025020; SHAING KC, 1984, PHYS FLUIDS, V27, P1567, DOI 10.1063/1.864810; PYTTE A, 1981, PHYS FLUIDS, V24, P88, DOI 10.1063/1.863250; SMOLYAKOV AI, 1995, PHYS PLASMAS, V2, P1581, DOI 10.1063/1.871308; SHAING KC, 1986, PHYS FLUIDS, V29, P2548, DOI 10.1063/1.865546; SHAING KC, 1994, PHYS PLASMAS, V1, P3365, DOI 10.1063/1.870484; Chatthong B, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/1/013007; Shaing KC, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/4/043013; Tribaldos V, 2001, PHYS PLASMAS, V8, P1229, DOI 10.1063/1.1353812; Sun Y, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/7/073026; Allmaier K, 2008, PHYS PLASMAS, V15, DOI 10.1063/1.2918659; ZHANG YZ, 1992, PHYS FLUIDS B-PLASMA, V4, P1385, DOI 10.1063/1.860095; Spong DA, 2005, PHYS PLASMAS, V12, DOI 10.1063/1.1887172; Shaing KC, 1996, PHYS PLASMAS, V3, P965, DOI 10.1063/1.871801; SHAING KC, 1986, PHYS FLUIDS, V29, P2231, DOI 10.1063/1.865561; HIRSHMAN SP, 1979, PHYS FLUIDS, V22, P731, DOI 10.1063/1.862654; Yokoyama M, 2007, NUCL FUSION, V47, P1213, DOI 10.1088/0029-5515/47/9/018; IDA K, 1991, PHYS REV LETT, V67, P58, DOI 10.1103/PhysRevLett.67.58; HASSAM AB, 1978, PHYS FLUIDS, V21, P2271, DOI 10.1063/1.862166; Boozer AH, 2006, PHYS PLASMAS, V13, DOI 10.1063/1.2192511; GREENE JM, 1971, PHYS FLUIDS, V14, P1258, DOI 10.1063/1.1693593; HIRSHMAN SP, 1976, PHYS FLUIDS, V19, P1532, DOI 10.1063/1.861356; SHAING KC, 1988, PHYS FLUIDS, V31, P2249, DOI 10.1063/1.866626; ROZHANSKY V, 1992, PHYS FLUIDS B-PLASMA, V4, P1877, DOI 10.1063/1.860463; WATANABE K, 1992, NUCL FUSION, V32, P1499, DOI 10.1088/0029-5515/32/9/I01; SHAING KC, 1995, PHYS PLASMAS, V2, P1801, DOI 10.1063/1.871332; Shaing KC, 2015, J PLASMA PHYS, V81, DOI 10.1017/S0022377814001068; La Haye RJ, 2002, PHYS PLASMAS, V9, P2051, DOI 10.1063/1.1456066; Cole AJ, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.225002; HASTIE RJ, 1967, ANN PHYS-NEW YORK, V41, P302, DOI 10.1016/0003-4916(67)90237-0; Ida K, 1997, PHYS PLASMAS, V4, P310, DOI 10.1063/1.872091; KOIDE Y, 1994, PHYS REV LETT, V72, P3662, DOI 10.1103/PhysRevLett.72.3662; Berkery JW, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3474925; LIU CS, 1971, PHYS REV LETT, V27, P399; SHAING KC, 1989, PHYS REV LETT, V63, P2369, DOI 10.1103/PhysRevLett.63.2369; Shaing KC, 2009, PLASMA PHYS CONTR F, V51, DOI 10.1088/0741-3335/51/3/035004; ITOH SI, 1988, PHYS REV LETT, V60, P2276, DOI 10.1103/PhysRevLett.60.2276; Yoshinuma M, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/7/075036; LINLIU YR, 1995, PHYS PLASMAS, V2, P1666, DOI 10.1063/1.871315; SHAING KC, 1993, PHYS FLUIDS B-PLASMA, V5, P666, DOI 10.1063/1.860511; SHAING KC, 1995, PHYS PLASMAS, V2, P349, DOI 10.1063/1.870961; Shaing KC, 2003, PHYS PLASMAS, V10, P1530, DOI 10.1063/1.1566747; Shaing KC, 2005, PHYS PLASMAS, V12, DOI 10.1063/1.2100187; Sugama H, 1997, PHYS PLASMAS, V4, P405, DOI 10.1063/1.872099; SHAING KC, 1989, PHYS FLUIDS B-PLASMA, V1, P705, DOI 10.1063/1.859134; Catto PJ, 2005, PHYS PLASMAS, V12, DOI 10.1063/1.1819372; WARE AA, 1984, PHYS FLUIDS, V27, P1215, DOI 10.1063/1.864729; Tsypin VS, 1998, PHYS PLASMAS, V5, P3358, DOI 10.1063/1.873049; HAZELTINE RD, 1978, PLASMA PHYS CONTR F, V20, P673, DOI 10.1088/0032-1028/20/7/005; HIRSHMAN SP, 1976, PHYS FLUIDS, V19, P155, DOI 10.1063/1.861313; Shaing KC, 1996, PHYS PLASMAS, V3, P4276, DOI 10.1063/1.871557; Seol J, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.195003; Kikuchi M, 1995, PLASMA PHYS CONTR F, V37, P1215, DOI 10.1088/0741-3335/37/11/003; Fujisawa A, 1998, PHYS REV LETT, V81, P2256, DOI 10.1103/PhysRevLett.81.2256; GRAD H, 1967, PHYS FLUIDS, V10, P137, DOI 10.1063/1.1761965; Shaing KC, 2009, PLASMA PHYS CONTR F, V51, DOI 10.1088/0741-3335/51/5/055003; GRAD H, 1970, PHYS REV LETT, V24, P1337, DOI 10.1103/PhysRevLett.24.1337; TAYLOR RJ, 1989, PHYS REV LETT, V63, P2365, DOI 10.1103/PhysRevLett.63.2365; Kasilov SV, 2014, PHYS PLASMAS, V21, DOI 10.1063/1.4894479; CHU MS, 1977, PHYS FLUIDS, V20, P127, DOI 10.1063/1.861701; Sabbagh SA, 2004, NUCL FUSION, V44, P560, DOI 10.1088/0029-5515/44/4/011; Sun Y, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/5/053015; Belli EA, 2012, PLASMA PHYS CONTR F, V54, DOI 10.1088/0741-3335/54/1/015015; Nemov VV, 1999, PHYS PLASMAS, V6, P4622, DOI 10.1063/1.873749; ARTSIMOV.LA, 1972, NUCL FUSION, V12, P215, DOI 10.1088/0029-5515/12/2/012; Beidler C. D., 1996, THEORY FUSION PLASMA; BICKERTO.RJ, 1971, NATURE-PHYS SCI, V229, P110; BIGLARI H, 1990, PHYS FLUIDS B-PLASMA, V2, P1, DOI 10.1063/1.859529; Braginskii S.I., 1965, Reviews of Plasma Physics; Briesemeister A, 2010, CONTRIB PLASM PHYS, V50, P741, DOI 10.1002/ctpp.200900057; Cahyna P., 2008, PHYS PLASMAS, V15; Coloborod'ko V. Ya., 1984, NUCL FUSION, V23, P399; Cooper W. A., 2002, PLASMA PHYS CONTROL, V44, P357; COPPI B, 1994, PLASMA PHYS CONTR F, V36, pB107, DOI 10.1088/0741-3335/36/12B/008; Davidson J. N., 1975, NUCL FUSION, V16, P731; Dominguez R. R., 1993, PHYS FLUIDS B-PLASMA, V5, P387; Drummond W. E., 1962, NUCL FUSION S, V2, P1049; Ferrando I. M. S., 2004, FUSION SCI TECHNOL, V46, P44; Figarella CF, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.015002; Fujisawa A, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.165002; Furukawa M., 1999, J PLASMA FUSION RES, V75, P481, DOI 10.1585/jspf.75.481; Galeev A. A., 1979, REV PLASMA PHYS, V7, P257; GALEEV AA, 1971, SOV PHYS JETP-USSR, V32, P752; Gerhardt S. P., 2009, NUCL FUSION, V49; Glasser A. H., 1997, B AM PHYS SOC, V42, P1960; Gott Yu. V., 2014, PLASMA PHYS REP, V49, P243; Grad H., 1958, P 2 INT C PEAC US AT, V31, P190; Gradshteyn I.S., 1980, TABLE INTEGRALS SERI; HAZELTIN.RD, 1973, PLASMA PHYS CONTR F, V15, P77, DOI 10.1088/0032-1028/15/1/009; HAZELTIN.RD, 1974, PHYS FLUIDS, V17, P961, DOI 10.1063/1.1694838; HAZELTIN.RD, 1971, PHYS FLUIDS, V14, P361, DOI 10.1063/1.1693436; HAZELTIN.RD, 1973, PHYS FLUIDS, V16, P1645, DOI 10.1063/1.1694191; Hinton F. L., 1969, NUCL FUSION, V9, P119; Hirsch M, 2000, PLASMA PHYS CONTR F, V42, pA231, DOI 10.1088/0741-3335/42/5A/327; Hogweij G. M. D., 1996, PHYS REV LETT, V76, P632; Ida K, 2004, PLASMA PHYS CONTR F, V46, pA45, DOI 10.1088/0741-3335/46/5A/004; Ida K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6816; Ida K, 2002, PLASMA PHYS CONTR F, V44, P361, DOI 10.1088/0741-3335/44/3/306; Ida K., 1999, NUCL FUSION, V39, P1849; Perkins FW, 1999, NUCL FUSION, V39, P2137, DOI 10.1088/0029-5515/39/12/301; Itoh K, 1996, PLASMA PHYS CONTR F, V38, P1, DOI 10.1088/0741-3335/38/1/001; ITOH SI, 1982, J PHYS SOC JPN, V51, P3345, DOI 10.1143/JPSJ.51.3345; KADOMTSE.BB, 1971, NUCL FUSION, V11, P67, DOI 10.1088/0029-5515/11/1/010; Kernbichler W., 2008, PLASMA FUSION RES, V3, pS1061; Kikuchi M., 2011, 38 EPS C PLASM PHYS, P4115; KOVRIZHN.LM, 1969, SOV PHYS JETP-USSR, V29, P475; Landau L., 1946, Journal of Physics, V10; Maassberg H, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3175328; Mikhailovskii A. B., 1984, Soviet Journal of Plasma Physics, V10; Morita S, 2006, PLASMA PHYS CONTR F, V48, pA269, DOI 10.1088/0741-3335/48/5A/S25; Nakajima N., 1992, J PLASMA FUSION RES, V68, P503; OKABAYAS.M, 1972, PHYS REV LETT, V29, P1725, DOI 10.1103/PhysRevLett.29.1725; Peng YKM, 2005, PLASMA PHYS CONTR F, V47, pB263, DOI 10.1088/0741-3335/47/12B/S20; Rodriguez-Solano Ribeiro E, 1987, PHYS FLUIDS, V30, P8; Rome J. A., 1979, NUCL FUSION, V19, P1293, DOI 10.1088/0029-5515/19/9/003; ROSENBLU.MN, 1972, PHYS FLUIDS, V15, P116, DOI 10.1063/1.1693728; Rosenbluth M. N., 1971, PLASMA PHYS CONTROLL, V1, P495; RUTHERFO.PH, 1973, PHYS FLUIDS, V16, P1903, DOI 10.1063/1.1694232; RUTHERFO.PH, 1970, PHYS FLUIDS, V13, P482, DOI 10.1063/1.1692943; Ryutov D. D., 1987, REV PLASMA PHYS, P93; Sabbagh S. A., 2010, P 23 IAEA FUS EN C F; Sabbagh S. A., 2014, P 25 IAEA FUS EN C S; SHAFRANOV VD, 1958, SOV PHYS JETP-USSR, V6, P545; SHAING KC, 1992, PHYS FLUIDS B-PLASMA, V4, P171, DOI 10.1063/1.860430; SHAING KC, 1992, PHYS FLUIDS B-PLASMA, V4, P290, DOI 10.1063/1.860276; SHAING KC, 1992, PHYS FLUIDS B-PLASMA, V4, P3310, DOI 10.1063/1.860385; SHAING KC, 1993, PHYS FLUIDS B-PLASMA, V5, P3841, DOI 10.1063/1.860605; SHAING KC, 1990, PHYS FLUIDS B-PLASMA, V2, P2847, DOI 10.1063/1.859354; SHAING KC, 1990, PHYS FLUIDS B-PLASMA, V2, P764, DOI 10.1063/1.859576; Shaing K. C., 1989, PLASMA PHYS CONTROLL, V2, P13; Soel J., 2012, PHYS PLASMAS, V19; STIX TH, 1972, PLASMA PHYSICS, V14, P367, DOI 10.1088/0032-1028/14/4/002; Stix T. H., 1962, THEORY PLASMA WAVES, P207; STRINGER TE, 1993, NUCL FUSION, V33, P1249, DOI 10.1088/0029-5515/33/9/I01; STRINGER TE, 1974, PLASMA PHYS CONTR F, V16, P651, DOI 10.1088/0032-1028/16/7/008; TAGUCHI M, 1992, PHYS FLUIDS B-PLASMA, V4, P3638, DOI 10.1063/1.860372; Taguchi M., 2014, PHYS PLASMAS, V24; TAGUCHI M, 1988, PLASMA PHYS CONTR F, V30, P1897, DOI 10.1088/0741-3335/30/13/009; Takahashi S., 2006, PLASMA PHYS CONTROL, V48, P39; TANIUTI T, 1992, J PHYS SOC JPN, V61, P568, DOI 10.1143/JPSJ.61.568; Vedenov A., 1962, NUCL FUSION       S2, V2, P465; Wagner F, 2007, PLASMA PHYS CONTR F, V49, pB1, DOI 10.1088/0741-3335/49/12B/S01; Wakasa A., 2001, J PLASMA FUSION RES, V4, P408; Yokoyama M., 2002, NUCL FUSION, V35, P153; YOSHIKAW.S, 1973, NUCL FUSION, V13, P433, DOI 10.1088/0029-5515/13/3/015; Yoshinuma M, 2004, PLASMA PHYS CONTR F, V46, P1021, DOI 10.1088/0741-3335/46/7/002; Yushmanov P. N., 1990, REV PLASMA PHYS, V16; Zarnstorff MC, 2001, PLASMA PHYS CONTR F, V43, pA237, DOI 10.1088/0741-3335/43/12A/318	336	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0029-5515	1741-4326		NUCL FUSION	Nucl. Fusion	DEC	2015	55	12							125001	10.1088/0029-5515/55/12/125001		104	Physics, Fluids & Plasmas; Physics, Nuclear	Physics	CY6QS	WOS:000366534500031		
J	Tsujimura, TI; Kubo, S; Takahashi, H; Makino, R; Seki, R; Yoshimura, Y; Igami, H; Shimozuma, T; Ida, K; Suzuki, C; Emoto, M; Yokoyama, M; Kobayashi, T; Moon, C; Nagaoka, K; Osakabe, M; Kobayashi, S; Ito, S; Mizuno, Y; Okada, K; Ejiri, A; Mutoh, T				Tsujimura, T. Ii; Kubo, S.; Takahashi, H.; Makino, R.; Seki, R.; Yoshimura, Y.; Igami, H.; Shimozuma, T.; Ida, K.; Suzuki, C.; Emoto, M.; Yokoyama, M.; Kobayashi, T.; Moon, C.; Nagaoka, K.; Osakabe, M.; Kobayashi, S.; Ito, S.; Mizuno, Y.; Okada, K.; Ejiri, A.; Mutoh, T.		LHD Expt Grp	Development and application of a ray-tracing code integrating with 3D equilibrium mapping in LHD ECH experiments	NUCLEAR FUSION			English	Article						electron cyclotron resonance heating; 3D equilibrium mapping; large helical device; experiment; 1D full-wave equation; mode contents analyses; ray-tracing code	ELECTRON-CYCLOTRON WAVES; STEADY-STATE OPERATION; PLASMAS; TOKAMAK; POWER	The central electron temperature has successfully reached up to 7.5 keV in large helical device (LHD) plasmas with a central high-ion temperature of 5 keV and a central electron density of 1.3 x 10(19) m(-3). This result was obtained by heating with a newly-installed 154 GHz gyrotron and also the optimisation of injection geometry in electron cyclotron heating (ECH). The optimisation was carried out by using the ray-tracing code 'LHDGauss', which was upgraded to include the rapid post-processing three-dimensional (3D) equilibrium mapping obtained from experiments. For ray-tracing calculations, LHDGauss can automatically read the relevant data registered in the LHD database after a discharge, such as ECH injection settings (e.g. Gaussian beam parameters, target positions, polarisation and ECH power) and Thomson scattering diagnostic data along with the 3D equilibrium mapping data. The equilibrium map of the electron density and temperature profiles are then extrapolated into the region outside the last closed flux surface. Mode purity, or the ratio between the ordinary mode and the extraordinary mode, is obtained by calculating the 1D full-wave equation along the direction of the rays from the antenna to the absorption target point. Using the virtual magnetic flux surfaces, the effects of the modelled density profiles and the magnetic shear at the peripheral region with a given polarisation are taken into account. Power deposition profiles calculated for each Thomson scattering measurement timing are registered in the LHD database. The adjustment of the injection settings for the desired deposition profile from the feedback provided on a shot-by-shot basis resulted in an effective experimental procedure.	[Tsujimura, T. Ii; Kubo, S.; Takahashi, H.; Makino, R.; Seki, R.; Yoshimura, Y.; Igami, H.; Shimozuma, T.; Ida, K.; Suzuki, C.; Emoto, M.; Yokoyama, M.; Kobayashi, T.; Moon, C.; Nagaoka, K.; Osakabe, M.; Kobayashi, S.; Ito, S.; Mizuno, Y.; Okada, K.; Mutoh, T.; LHD Expt Grp] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Takahashi, H.; Ida, K.; Kobayashi, T.; Nagaoka, K.; Osakabe, M.; Mutoh, T.] Grad Univ Adv Studies, SOKENDAI, Toki, Gifu 5095292, Japan; [Ejiri, A.] Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba 2778561, Japan	Tsujimura, TI (reprint author), Natl Inst Nat Sci, Natl Inst Fus Sci, 322-6 Oroshicho, Toki, Gifu 5095292, Japan.	tsujimura.tohru@nifs.ac.jp			National Institute for Fusion Science [ULRR701, ULRR804, ULHH007]	The authors thank the LHD Experiment Group for their assistance. This work has been supported by the National Institute for Fusion Science under ULRR701, ULRR804, and ULHH007.	Balakin AA, 2008, NUCL FUSION, V48, DOI 10.1088/0029-5515/48/6/065003; HIRSHMAN SP, 1983, PHYS FLUIDS, V26, P3553, DOI 10.1063/1.864116; Takahashi H, 2014, PHYS PLASMAS, V21, DOI 10.1063/1.4884365; Yoshimura Y, 2010, FUSION SCI TECHNOL, V58, P551; Poli E, 2001, COMPUT PHYS COMMUN, V136, P90, DOI 10.1016/S0010-4655(01)00146-1; Komori A, 2014, J PHYS CONF SER, V565, DOI 10.1088/1742-6596/565/1/012017; Prater R, 2008, NUCL FUSION, V48, DOI 10.1088/0029-5515/48/3/035006; Ida K, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/1/013061; Marushchenko NB, 2014, COMPUT PHYS COMMUN, V185, P165, DOI 10.1016/j.cpc.2013.09.002; Shimozuma T, 2010, FUSION SCI TECHNOL, V58, P530; Nagasaki K, 1999, PHYS PLASMAS, V6, P556, DOI 10.1063/1.873200; PETTY CC, 1994, NUCL FUSION, V34, P121, DOI 10.1088/0029-5515/34/1/I09; Ida K, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.085003; BORNATICI M, 1983, NUCL FUSION, V23, P1153, DOI 10.1088/0029-5515/23/9/005; Shimozuma T, 2008, J PHYS CONF SER, V123, DOI 10.1088/1742-6596/123/1/012022; Emoto M, 2014, FUSION ENG DES, V89, P758, DOI 10.1016/j.fusengdes.2014.02.014; NOWAK S, 1993, PHYS FLUIDS B-PLASMA, V5, P1945, DOI 10.1063/1.860782; Ii T, 2015, REV SCI INSTRUM, V86, DOI 10.1063/1.4907355; Igami H., 2012, PLASMA FUSION RES, V7; Inagaki S, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/11/113006; Kirov KK, 2002, PLASMA PHYS CONTR F, V44, P2583, DOI 10.1088/0741-3335/44/12/307; Kubo S., 2002, AIP C P, V669, P187; Kubo S, 2005, PLASMA PHYS CONTR F, V47, pA81, DOI 10.1088/0741-3335/47/5A/008; Makino R., 2014, JPS C P, V1; Marushchenko N. B., 2007, PLASMA FUSION RES, V2, pS1129, DOI 10.1585/pfr.2.S1129; Nagaoka K., 2015, NUCL FUSION, V55; Sakakibara S, 2010, FUSION SCI TECHNOL, V58, P471; Shimozuma Takashi, 2009, J Microw Power Electromagn Energy, V43, P60; Tokuzawa T., 2010, Fusion Science and Technology, V58; Yokoyama M., 2013, PLASMA FUSION RES, V8; Yoshimura Y., 2005, Journal of Physics: Conference Series, V25, DOI 10.1088/1742-6596/25/1/024	31	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0029-5515	1741-4326		NUCL FUSION	Nucl. Fusion	DEC	2015	55	12							123019	10.1088/0029-5515/55/12/123019		12	Physics, Fluids & Plasmas; Physics, Nuclear	Physics	CY6QS	WOS:000366534500021		
J	Shinozaki, K; Pisarski, W; Affatigato, M; Honma, T; Komatsu, T				Shinozaki, Kenji; Pisarski, Wojciech; Affatigato, Mario; Honma, Tsuyoshi; Komatsu, Takayuki			Glass structure and NIR emission of Er3+ at 1.5 mu m in oxyfluoride BaF2-Al2O3-B2O3 glasses	OPTICAL MATERIALS			English	Article						Glass structure; Oxyfluoride; Rare earth; Judd-Ofelt analysis; NIR emission	RARE-EARTH IONS; SPECTROSCOPIC PROPERTIES; FLUORIDE GLASSES; SILICATE-GLASSES; ENERGY-TRANSFER; EU3+; NAF-NA2O-B2O3; FLUORESCENCE; INTENSITIES; ABSORPTION	The glass structure, photoluminescence properties of Eu3+, Judd-Ofelt analysis, and near infrared emissions of Er3+ at 1.5 mu m in the oxyfluoride glasses and glass-ceramics of 1Eu(2)O(3)- or 1Er(2)O(3)-doped 50BaF2(-x)Al(2)O(3)-(50 - x)B2O3 (x = 0-25 mol%) were investigated. It was clarified on the ground of Raman scattering spectroscopy and F1s and 01s XPS measurements that the glass with no Al2O3 (1Er(2)O(3)-50BaF(2)-50B(2)O(3)) is composed of BO3, BO2F and BO3F units with F-Ba bonds. The glasses with 25Al(2)O(3) (1Er(2)O(3)-50BaF(2)-25Al(2)O(3)-25B(2)O(3)) is mainly composed of BO3- and Al(O,F)(x) units. Existence of non-bridging oxygen was not detected by Ols-XPS spectra. It was proposed that these structures are largely affected on crystallization behavior, e.g., the glass with no Al2O3 forms BaF2 and beta-BaB2O4 due to Ba-F bonds and the glass with 25Al(2)O(3) forms BaAlBO3F2 because the glass structure composed of BO3 and Al (O,F) units is similar to the BaAlBO3F2 crystal structure. Judd-Ofelt parameters of Er3+ and Eu3+ in the glasses showed almost the same values in Omega(4) and Omega(6) for each glass, on the other hand Omega(2) decreased with addition of Al2O3. The emission spectra of Er3+ at 1.5 mu m in the glasses and glass-ceramics with BaAlBO3F2 crystals showed broad peaks. It is proposed that oxyfluoride glasses and glass-ceramics based on the BaF2-Al2O3-B2O3 system have a high potential for optical device applications such as broadband optical amplifiers. (C) 2015 Elsevier B.V. All rights reserved.	[Shinozaki, Kenji; Honma, Tsuyoshi; Komatsu, Takayuki] Nagaoka Univ Technol, Dept Mat Sci & Technol, Nagaoka, Niigata 9402188, Japan; [Pisarski, Wojciech] Univ Silesia, Inst Chem, PL-40007 Katowice, Poland; [Affatigato, Mario] Coe Coll, Dept Phys, Cedar Rapids, IA 52402 USA	Shinozaki, K (reprint author), Nagaoka Univ Technol, Dept Mat Sci & Technol, 1603-1 Kamitomioka Cho, Nagaoka, Niigata 9402188, Japan.	kshinozaki@mst.nagaokaut.ac.jp			Ministry of Education, Science, Sport, Culture, and Technology, Japan [23246114]; Program for High Reliable Materials Design and Manufacturing in Nagaoka University of Technology	This study was supported by the Grant-in-Aid for Scientific Research from the Ministry of Education, Science, Sport, Culture, and Technology, Japan (No. 23246114), and by Program for High Reliable Materials Design and Manufacturing in Nagaoka University of Technology.	Kawamoto Y, 1998, J PHYS-CONDENS MAT, V10, P9711, DOI 10.1088/0953-8984/10/43/014; Dimitrov V, 2005, J SOLID STATE CHEM, V178, P831, DOI 10.1016/j.jssc.2004.12.013; Peters PM, 1998, J NON-CRYST SOLIDS, V239, P162, DOI 10.1016/S0022-3093(98)00733-9; Kawamoto Y, 1999, J FLUORINE CHEM, V96, P135, DOI 10.1016/S0022-1139(99)00068-8; Shinozaki K, 2011, OPT MATER, V33, P1350, DOI 10.1016/j.optmat.2011.03.037; Stamboulis A, 2004, J NON-CRYST SOLIDS, V333, P101, DOI [10.1016/j.jnoncrysol.2003.09.049, 10.1016/j.noncrysol.2003.09.049]; OFELT GS, 1962, J CHEM PHYS, V37, P511, DOI 10.1063/1.1701366; Vijaya N, 2013, J MOL STRUCT, V1036, P42, DOI 10.1016/j.molstruc.2012.09.037; JUDD BR, 1962, PHYS REV, V127, P750, DOI 10.1103/PhysRev.127.750; Jlassi I, 2010, J LUMIN, V130, P2394, DOI 10.1016/j.jlumin.2010.07.026; Dejneka M, 1995, J LUMIN, V65, P227, DOI 10.1016/0022-2313(95)00073-9; Bocker C, 2009, ACTA MATER, V57, P5956, DOI 10.1016/j.actamat.2009.08.021; Babushkina O, 1999, ACTA CHEM SCAND, V53, P320, DOI 10.3891/acta.chem.scand.53-0320; Shen SX, 2004, OPT MATER, V25, P321, DOI 10.1016/j.optmat.2003.08.006; Shinozaki K, 2014, OPT MATER, V36, P1384, DOI 10.1016/j.optmat.2014.03.037; Miura Y, 2001, J NON-CRYST SOLIDS, V290, P1, DOI 10.1016/S0022-3093(01)00720-7; WANG YH, 1993, APPL PHYS LETT, V63, P3268, DOI 10.1063/1.110170; Wang J. S., 1994, Optical Materials, V3, DOI 10.1016/0925-3467(94)90004-3; Ebendorff-Heidepriem H, 1999, J NON-CRYST SOLIDS, V248, P247, DOI 10.1016/S0022-3093(99)00243-4; Huang FF, 2014, SCI REP-UK, V4, DOI 10.1038/srep05053; JAGER C, 1985, PHYS CHEM GLASSES, V26, P152; KLINE D, 1966, PHYS CHEM GLASSES, V7, P41; Miniscalco W.J., 1993, RARE EARTH DOPED FIB, P78; Narendran N, 2004, J CRYST GROWTH, V268, P449, DOI 10.1016/j.jcrysgro.2004.04.071; Nikitin A.V., 1977, FIZ KHIM STEKLA, V3, P284; TAKEBE H, 1995, J AM CERAM SOC, V78, P1161, DOI 10.1111/j.1151-2916.1995.tb08463.x	26	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-3467	1873-1252		OPT MATER	Opt. Mater.	DEC	2015	50		B				238	243		10.1016/j.optmat.2015.10.035		6	Materials Science, Multidisciplinary; Optics	Materials Science; Optics	CY2KJ	WOS:000366237200027		
J	Kakuma, S				Kakuma, Seiichi			Frequency scanning interferometry with nanometer precision using a vertical-cavity surface-emitting laser diode under scanning speed control	OPTICAL REVIEW			English	Article						VCSEL; Block gauge measurement; Frequency scanning interferometry	GAUGE BLOCK MEASUREMENT; DISTANCE MEASUREMENT; SHAPE MEASUREMENT; WAVELENGTH; RANGE; LIGHT	Frequency scanning interferometry technique with a nanometer precision using a vertical-cavity surface-emitting laser diode (VCSEL) is presented. Since the frequency scanning of the VCSEL is linearized by the phase-locked-loop technique, the gradient of the interference fringe order can be precisely determined using linear least squares fitting. This enables a length measurement with a precision better than a quarter wavelength, and the absolute fringe number including the integer part at the atomic transition spectrum (rubidium-D-2 line) is accurately determined. The validity of the method is demonstrated by excellent results of block gauge measurement with a root mean square error better than 5 nm.	[Kakuma, Seiichi] Hokkaido Univ, Div Appl Phys, Grad Sch Engn, Kita Ku, Sapporo, Hokkaido 0608628, Japan	Kakuma, S (reprint author), Hokkaido Univ, Div Appl Phys, Grad Sch Engn, Kita Ku, N13W8, Sapporo, Hokkaido 0608628, Japan.	kakuma@eng.hokudai.ac.jp					Bitou Y, 2000, JPN J APPL PHYS 1, V39, P6084, DOI 10.1143/JJAP.39.6084; BARWOOD GP, 1991, APPL PHYS B-PHOTO, V53, P142, DOI 10.1007/BF00330229; Ishii Y, 1999, OPT REV, V6, P273, DOI 10.1007/s10043-999-0273-3; Tsai M, 1999, OPT REV, V6, P449, DOI 10.1007/s10043-999-0449-x; Dai XL, 1998, MEAS SCI TECHNOL, V9, P1031, DOI 10.1088/0957-0233/9/7/004; Hibino K, 2011, APPL OPTICS, V50, P962, DOI 10.1364/AO.50.000962; Davila A, 2012, OPT LASER ENG, V50, P1089, DOI 10.1016/j.optlaseng.2012.02.005; Kuwamura S, 1997, APPL OPTICS, V36, P4473, DOI 10.1364/AO.36.004473; Kakuma S, 2012, OPT REV, V19, P376, DOI 10.1007/s10043-012-0061-3; Kakuma S, 2004, OPT COMMUN, V239, P445, DOI 10.1016/j.optcom.2004.05.060; Yamamoto A, 2001, OPT REV, V8, P59, DOI 10.1007/s10043-001-0059-8; KIKUTA H, 1986, APPL OPTICS, V25, P2976; Decker JE, 2003, APPL OPTICS, V42, P5670, DOI 10.1364/AO.42.005670; Bitou Y, 2002, JPN J APPL PHYS 1, V41, P384, DOI 10.1143/JJAP.41.3841; Kakuma S, 2010, OPT REV, V17, P481, DOI 10.1007/s10043-010-0087-3; Ciddor PE, 1996, APPL OPTICS, V35, P1566, DOI 10.1364/AO.35.001566; Liu S.H., 2002, APPL OPTICS, V41, P5866	17	0	0	OPTICAL SOC JAPAN	TOKYO	KUDAN-KITA BLDG 5F, 1-12-3, KUDAN-KITA CHIYODA-KU, TOKYO, 102, JAPAN	1340-6000	1349-9432		OPT REV	Opt. Rev.	DEC	2015	22	6					869	874		10.1007/s10043-015-0140-3		6	Optics	Optics	CZ0WQ	WOS:000366827500001		
J	Hashimoto, M; Yoshiki, K; Kurihara, M; Hashimoto, N; Araki, T				Hashimoto, Mamoru; Yoshiki, Keisuke; Kurihara, Makoto; Hashimoto, Nobuyuki; Araki, Tsutomu			Orientation detection of a single molecule using pupil filter with electrically controllable polarization pattern	OPTICAL REVIEW			English	Article						Single molecule detection; Molecular orientation; Fluorescence microscopy	LIGHT; BEAM	We have developed a system for measuring the orientation of single molecules using a conventional wide-field fluorescence microscope with a polarization filter consisting of a polarizer and a compact polarization mode converter. The polarization filter electrically controls the pattern of polarization filtering. Since the polarization of the fluorescence from a single molecule highly depends on the angle between the observation direction and the molecular direction, polarization pattern filtering at the pupil plane of the objective lens allows the orientation of a single molecule to be visualized. Using this system, we demonstrated the orientation detection of single molecules.	[Hashimoto, Mamoru; Araki, Tsutomu] Osaka Univ, Grad Sch Engn Sci, Toyonaka, Osaka 5608531, Japan; [Yoshiki, Keisuke] Univ Hyogo, Grad Sch Engn, Himeji, Hyogo 6712201, Japan; [Kurihara, Makoto; Hashimoto, Nobuyuki] Citizen Holdings Co Ltd, Dev Div, Tokorozawa, Saitama 3598511, Japan	Hashimoto, M (reprint author), Osaka Univ, Grad Sch Engn Sci, 1-3 Machikaneyama, Toyonaka, Osaka 5608531, Japan.	mamoru@me.es.osaka-u.ac.jp					Neil MAA, 2000, J MICROSC-OXFORD, V197, P219; Novotny L, 2001, PHYS REV LETT, V86, P5251, DOI 10.1103/PhysRevLett.86.5251; Fourkas JT, 2001, OPT LETT, V26, P211, DOI 10.1364/OL.26.000211; Yoshiki K, 2007, OPT LETT, V32, P1680, DOI 10.1364/OL.32.001680; Ishitobi H, 2010, J PHYS CHEM B, V114, P2565, DOI 10.1021/jp905719b; Abouraddy AF, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.153901; Hashimoto M, 2005, OPT REV, V12, P37, DOI 10.1007/s10043-005-0037-7; Jares-Erijman EA, 2003, NAT BIOTECHNOL, V21, P1387, DOI 10.1038/nbt896; Yoshiki K, 2005, JPN J APPL PHYS 2, V44, pL1066, DOI 10.1143/JJAP.44.L1066; Patra D, 2004, J PHYS CHEM A, V108, P6836, DOI 10.1021/jp048188m; Quabis S, 2000, OPT COMMUN, V179, P1, DOI 10.1016/S0030-4018(99)00729-4; Backer AS, 2013, OPT LETT, V38, P1521, DOI 10.1364/OL.38.001521; Pavania S.R.P., 2009, P NATL ACAD SCI USA, V106, P2997	13	0	0	OPTICAL SOC JAPAN	TOKYO	KUDAN-KITA BLDG 5F, 1-12-3, KUDAN-KITA CHIYODA-KU, TOKYO, 102, JAPAN	1340-6000	1349-9432		OPT REV	Opt. Rev.	DEC	2015	22	6					875	881		10.1007/s10043-015-0143-0		7	Optics	Optics	CZ0WQ	WOS:000366827500002		
J	Egashira, K				Egashira, Kazuhiro			Optimal mirror reflectivity for transparency of a thin-film absorbent in a Fabry-Perot cavity	OPTICAL REVIEW			English	Article						Reflectivity; Cavity mirror; Fabry-Perot cavity; Thin film; Standing wave; Transmittance	INTERPOLATION PROFILE METHOD; CIP METHOD; GRAPHENE; WAVE	We could make a thin-film absorbent virtually transparent by enclosing it in a Fabry-Perot cavity. One requirement to realize the phenomenon is that the cavity consists of a pair of mirrors with optimal reflectivity. We calculate the reflectivity to give the highest transmittance through the cavity for various kinds of thin films. An empirical equation to reproduce the optimal reflectivity is given, in which the first term inversely depends on the film thickness and the second term is related to multiplication of the thickness and the dielectric constant of the thin film.	[Egashira, Kazuhiro] Genesis Res Inst Inc, East Tokyo Lab, Ichikawa, Chiba 2720001, Japan	Egashira, K (reprint author), Genesis Res Inst Inc, East Tokyo Lab, 717-86 Futamata, Ichikawa, Chiba 2720001, Japan.	egashira@clusterlab.jp			Special Cluster Research Project of Genesis Research Institute, Inc.	The present study has been supported by the Special Cluster Research Project of Genesis Research Institute, Inc.	Nair RR, 2008, SCIENCE, V320, P1308, DOI 10.1126/science.1156965; Pu MB, 2012, OPT EXPRESS, V20, P2246, DOI 10.1364/OE.20.002246; Yabe T, 2001, J COMPUT PHYS, V169, P556, DOI 10.1006/jcph.2000.6625; Terasaki A, 2005, J OPT SOC AM B, V22, P675, DOI 10.1364/JOSAB.22.000675; Kim KS, 2009, NATURE, V457, P706, DOI 10.1038/nature07719; Lee C, 2008, SCIENCE, V321, P385, DOI 10.1126/science.1157996; Okubo K, 2007, IEEE T ANTENN PROPAG, V55, P485, DOI 10.1109/TAP.2006.889984; Kats MA, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4767646; Egashira K, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2748747; Chong YD, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.053901; Egashira K, 2010, APPL OPTICS, V49, P1151, DOI 10.1364/AO.49.001151; TAKEWAKI H, 1985, J COMPUT PHYS, V61, P261, DOI 10.1016/0021-9991(85)90085-3; Li SC, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.220301; Born M., 1980, PRINCIPLES OPTICS; Egashira K, 2012, EUR PHYS J D, V66, DOI 10.1140/epjd/e2012-20587-5; Macleod H.A., 1986, THIN FILM OPTICAL FI; Watanabe S, 2006, IEICE T ELECTRON, VE89C, P51, DOI 10.1093/ietele/e89-c.1.51	17	0	0	OPTICAL SOC JAPAN	TOKYO	KUDAN-KITA BLDG 5F, 1-12-3, KUDAN-KITA CHIYODA-KU, TOKYO, 102, JAPAN	1340-6000	1349-9432		OPT REV	Opt. Rev.	DEC	2015	22	6					888	892		10.1007/s10043-015-0144-z		5	Optics	Optics	CZ0WQ	WOS:000366827500004		
J	Shibuya, K; Nakae, K; Mizutani, Y; Iwata, T				Shibuya, Kyuki; Nakae, Katsuhiro; Mizutani, Yasuhiro; Iwata, Tetsuo			Comparison of reconstructed images between ghost imaging and Hadamard transform imaging	OPTICAL REVIEW			English	Article								We compared images reconstructed by three methods: ghost imaging (GI), Hadamard transform imaging (HTI), and scan-based imaging. Although GI and HTI use a bucket (or single channel) detector, GI has attracted more attention than HTI in recent years. Nevertheless, a direct comparison between them has not yet been conducted to the best of our knowledge. In the present work, we evaluate contrast ratios of images obtained from computational GI (CGI) and HTI under various signal-to-noise ratio (SNR) conditions. Our results indicate that HTI and CGI are useful in high-and low-SNR situations, respectively, although both methods have a similar performance.	[Shibuya, Kyuki; Nakae, Katsuhiro] Univ Tokushima, Grad Sch Adv Technol & Sci, Tokushima, Tokushima 7708506, Japan; [Mizutani, Yasuhiro] Osaka Univ, Dept Mech Engn, Suita, Osaka 5650871, Japan; [Iwata, Tetsuo] Univ Tokushima, Inst Sci & Technol, Tokushima, Tokushima 7708506, Japan	Mizutani, Y (reprint author), Osaka Univ, Dept Mech Engn, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	mizutani@mech.eng.osaka-u.ac.jp					Duan DY, 2013, PHYS REV A, V88, DOI 10.1103/PhysRevA.88.053842; Bromberg Y, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.053840; Meyers RE, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3567931; Gatti A, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.093602; Shapiro JH, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.061802; PRATT WK, 1969, P IEEE, V57, P58, DOI 10.1109/PROC.1969.6869; TREADO PJ, 1989, APPL SPECTROSC, V43, P190, DOI 10.1366/0003702894203093; Duarte MF, 2008, IEEE SIGNAL PROC MAG, V25, P83, DOI 10.1109/MSP.2007.914730; Chan KWC, 2010, OPT EXPRESS, V18, P5562, DOI 10.1364/OE.18.005562; Chen XH, 2009, OPT LETT, V34, P695; Mei EW, 1996, FRESEN J ANAL CHEM, V354, P250, DOI 10.1007/PL00012722; Sun B, 2013, SCIENCE, V340, P844, DOI 10.1126/science.1234454; Ferri F, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.183602; Bennink RS, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.113601; Belinsky A. V., 1994, SOV PHYS JETP, V78, P259; Harwit M., 1979, HADAMARD TRANSFORM O; PITTMAN TB, 1995, PHYS REV A, V52, pR3429; Takhar D., 2006, P SOC PHOTO-OPT INS, V6065; Welsh S.S., 2013, P SOC PHOTO-OPT INS, V8618	19	0	0	OPTICAL SOC JAPAN	TOKYO	KUDAN-KITA BLDG 5F, 1-12-3, KUDAN-KITA CHIYODA-KU, TOKYO, 102, JAPAN	1340-6000	1349-9432		OPT REV	Opt. Rev.	DEC	2015	22	6					897	902		10.1007/s10043-015-0138-x		6	Optics	Optics	CZ0WQ	WOS:000366827500006		
J	Iwata, Y; Handa, T; Ishikawa, H; Shoji, N; Shimizu, K				Iwata, Yo; Handa, Tomoya; Ishikawa, Hitoshi; Shoji, Nobuyuki; Shimizu, Kimiya			Attempt of quantitative determination of ocular deviation using a pupillometer	OPTICAL REVIEW			English	Article						Ophthalmology; Strabismus operation; Ocular deviation; Pupillometer; Phorometer		Purpose To measure the ocular deviation using a binocular open-view type pupillometer. Methods Ocular deviation was measured using a phorometer, a binocular open-view type pupillometer, and the alternate prism cover test (APCT). The mean and confidence interval, and the difference between the two measurements were evaluated using a Bland-Altman Plot. Agreement between them was assessed using the intraclass coefficient (ICC). Results The ocular deviation was -1.34 +/- 1.54 degrees for the phorometer and -2.46 +/- 1.77 degrees for APCT. The two measurements showed moderate agreement (ICC = 0.89). Conclusion Binocular open-view type pupillometer can measure ocular deviation which is not influenced by the examiner.	[Iwata, Yo] Kitasato Univ, Grad Sch, Masters Program Med Sci, Sagamihara, Kanagawa 2520373, Japan; [Handa, Tomoya; Ishikawa, Hitoshi; Shoji, Nobuyuki] Kitasato Univ, Dept Rehabil Orthopt & Visual Sci Course, Sch Allied Hlth Sci, Sagamihara, Kanagawa 2520373, Japan; [Ishikawa, Hitoshi; Shoji, Nobuyuki; Shimizu, Kimiya] Kitasato Univ, Sch Med, Dept Ophthalmol, Sagamihara, Kanagawa 2520373, Japan	Iwata, Y (reprint author), Kitasato Univ, Grad Sch, Masters Program Med Sci, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520373, Japan.	mm14004q@st.kitasato-u.ac.jp					Handa T, 2012, J REFRACT SURG, V28, P672, DOI 10.3928/1081597X-20120830-01	1	0	0	OPTICAL SOC JAPAN	TOKYO	KUDAN-KITA BLDG 5F, 1-12-3, KUDAN-KITA CHIYODA-KU, TOKYO, 102, JAPAN	1340-6000	1349-9432		OPT REV	Opt. Rev.	DEC	2015	22	6					928	930		10.1007/s10043-015-0145-y		3	Optics	Optics	CZ0WQ	WOS:000366827500010		
J	Ichihara, S; Hidalgo-Diaz, JJ; Facca, S; Liverneaux, P				Ichihara, S.; Hidalgo-Diaz, J. J.; Facca, S.; Liverneaux, P.			Unicompartmental isoelastic resurfacing prosthesis for malignant tumor of the distal radius: A case report with a 3-year follow-up	ORTHOPAEDICS & TRAUMATOLOGY-SURGERY & RESEARCH			English	Article						Unicompartmental isoelastic resurfacing prosthesis; Hemiprosthesis; Malignant tumor; Distal radius	GIANT-CELL TUMOR; OSTEOARTICULAR ALLOGRAFT; WRIST PROSTHESIS; BONE; RECONSTRUCTION; RESECTION; EXCISION	We report a case of 74-year-old man in whom a unicompartmental isoelastic resurfacing prosthesis was used to reconstruct the distal radius after en-bloc resection of a malignant tumor. Thirty-nine months after the operation, on a visual analogic scale, pain score was 0110 and range of motion was 25 degrees of flexion, 5 of extension, 70 of pronation, 45 of supination, 20 of radial deviation, and 30 of ulnar deviation. The Quick DASH functional score was 72.72/100. With radiographic finding, the prosthesis was well-aligned, with no evidence of loosening but with slightly implant conflict with the lunate. This case report indicates that unicompartmental isoelastic resurfacing prosthesis seems a simple and reliable technique for distal radius reconstruction after en-bloc resection of malignant tumor. (C) 2015 Elsevier Masson SAS. All rights reserved.	[Ichihara, S.; Hidalgo-Diaz, J. J.; Facca, S.; Liverneaux, P.] Univ Strasbourg, FMTS, Strasbourg Univ Hosp, Hand Surg Dept,Icube CNRS 7357, F-67403 Illkirch Graffenstaden, France; [Ichihara, S.] Juntendo Univ, Dept Orthoped Surg, Tokyo, Japan	Liverneaux, P (reprint author), Univ Strasbourg, FMTS, Strasbourg Univ Hosp, Hand Surg Dept,Icube CNRS 7357, 10 Ave Baumann, F-67403 Illkirch Graffenstaden, France.	philippe.liverneaux@chru-strasbourg.fr					Adams Brian D, 2004, Tech Hand Up Extrem Surg, V8, P130, DOI 10.1097/01.bth.0000131199.39073.2a; Hatano H, 2006, J BONE JOINT SURG BR, V88B, P1656, DOI 10.1302/0301-620X.88B12.17989; SHETH DS, 1995, J HAND SURG-AM, V20A, P432, DOI 10.1016/S0363-5023(05)80102-9; Damert HG, 2013, ARCH ORTHOP TRAUM SU, V133, P713, DOI 10.1007/s00402-013-1692-y; Innocenti M, 2004, J BONE JOINT SURG AM, V86A, P1504; Minami A, 2002, PLAST RECONSTR SURG, V110, P112, DOI 10.1097/00006534-200207000-00020; Hariri A, 2013, ORTHOP TRAUMATOL-SUR, V99, P635, DOI 10.1016/j.otsr.2013.04.001; GOLD AM, 1957, J BONE JOINT SURG AM, V39, P1374; Herzberg G, 2011, CHIR MAIN, V30, P20, DOI 10.1016/j.main.2011.01.017; Roux JL, 2009, CHIR MAIN, V28, P10, DOI 10.1016/j.main.2008.11.009; Vergnenegre G, 2014, CHIR MAIN, V33, P112, DOI 10.1016/j.main.2014.01.007; Bianchi G, 2005, J HAND SURG-BRIT EUR, V30B, P369, DOI 10.1016/j.jhsb.2005.04.006; Kocher MS, 1998, J BONE JOINT SURG AM, V80A, P407; Szendroi M, 2004, J BONE JOINT SURG BR, V86B, P5, DOI 10.1302/0301-620X.86B1.14053; Chantelot C, 2006, Chir Main, V25, P271, DOI 10.1016/j.main.2006.10.003; ECKARDT JJ, 1986, CLIN ORTHOP RELAT R, P45; GOLDENBE.RR, 1970, J BONE JOINT SURG AM, VA 52, P619; Ichihara Satoshi, 2015, J Wrist Surg, V4, P150, DOI 10.1055/s-0035-1556855; Roux JL, 2000, HAND ARTHROPLASTICS, P183; Roux JL, 2011, REV CHIR ORTHOP RE S, V97S, P46; SERADGE H, 1982, J BONE JOINT SURG AM, V64, P67	21	0	0	ELSEVIER MASSON	MILANO	VIA PALEOCAPA 7, 20121 MILANO, ITALY	1877-0568			ORTHOP TRAUMATOL-SUR	Orthop. Traumatol.-Surg. Res.	DEC	2015	101	8					969	971		10.1016/j.otsr.2015.09.020		3	Orthopedics; Surgery	Orthopedics; Surgery	CY3GX	WOS:000366298200015		
J	Ichihara, S; Vaiss, L; Acciaro, AL; Facca, S; Liverneaux, P				Ichihara, S.; Vaiss, L.; Acciaro, A. L.; Facca, S.; Liverneaux, P.			External bone remodeling after injectable calcium-phosphate cement in benign bone tumor: two cases in the hand	ORTHOPAEDICS & TRAUMATOLOGY-SURGERY & RESEARCH			English	Article						Bone remodeling; Bone tumor; Calcium-phosphate cement	HYDROXYAPATITE; RECONSTRUCTION; DEFECT; MODEL	Bone remodeling commonly occurred after fracture and curettage benign bone tumor. A lot of previous articles reported "internal" trabecular bone remodeling. There were no previous clinical reports about "external" cortical bone remodeling. We present here 2 clinical cases of "external" bone remodeling after injectable calcium-phosphate in benign bone tumor in the hand. In two cases of benign bone tumor, we performed complete removal of the tumor and immediate filling of the metacarpal bone with injectable calcium-phosphate cement Arexbone (R) from the mechanical viewpoint. With respect to the shape of the calcium-phosphate, by using an injection-type, calcium-phosphate is adhered uniformly to the bone cortex by injecting, remodeling has been promoted. After 5 and 8 years, both cases were no recurrences, and the shape of the metacarpal looked close to the contralateral side. These findings supposed to be concerned with potential self-healing and self-protection mechanism in human body. (C) 2015 Elsevier Masson SAS. All rights reserved.	[Ichihara, S.; Vaiss, L.; Facca, S.; Liverneaux, P.] Univ Strasbourg, Dept Hand Surg, Univ Hosp Strasbourg, SOS Main,CCOM,FMTS,Icube CNRS 7357, F-67400 Illkirch Graffenstaden, France; [Ichihara, S.] Juntendo Univ, Dept Orthoped Surg, Tokyo, Japan; [Acciaro, A. L.] CS Hand & Microsurg, Modena, Italy	Liverneaux, P (reprint author), Univ Strasbourg, Dept Hand Surg, Univ Hosp Strasbourg, SOS Main,CCOM,FMTS,Icube CNRS 7357, 10 Ave Baumann, F-67400 Illkirch Graffenstaden, France.	philippe.liverneaux@chru-strasbourg.fr			Newclip Technics; Integra; Argomedical; iiN medical	Philippe Liverneaux has conflicts of interest with Newclip Technics, Integra, Argomedical, iiN medical.	Yano K, 2012, J ORTHOP SCI, V17, P484, DOI 10.1007/s00776-012-0235-7; Taleb C, 2010, CHIR MAIN, V29, P78, DOI 10.1016/j.main.2009.12.001; Hadjidakis DJ, 2006, ANN NY ACAD SCI, V1092, P385, DOI 10.1196/annals.1365.035; Crockett JC, 2011, J CELL SCI, V124, P991, DOI 10.1242/jcs.063032; Khosla S, 2008, J CLIN INVEST, V118, P421, DOI [10.1172/JCI33612, 10.1172/JC133612]; Pasquier G, 1998, B ACAD NAT MED PARIS, V182, P1851; Todtmann N, 2013, J BIOMED MATER RES B, V101, P1410, DOI 10.1002/jbm.b.32960; Tamai N, 2010, J ORTHOP SCI, V15, P560, DOI 10.1007/s00776-010-1479-8; Raisz LG, 1999, CLIN CHEM, V45, P1353; Yoshikawa M, 2000, J BIOMED MATER RES, V53, P430, DOI 10.1002/1097-4636(2000)53:4<430::AID-JBM18>3.0.CO;2-E; Hirano S, 1997, PLAST RECONSTR SURG, V100, P86, DOI 10.1097/00006534-199707000-00015; Fu Kun, 2008, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V33, P421; Kini U, 2012, RADIONUCLIDE HYBRID, P29; Landi A, 2014, J HAND SURG-EUR VOL, V39, P994, DOI 10.1177/1753193414529046; Liang Xi, 2007, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V21, P785; Liverneaux P, 2003, REV CHIR ORTHOP, V89, P532; Myoui A, 2002, ORTHOP CERAMIC IMPLA, V21, P103; Noda H, 2003, BLOOD IMMUN CANC, V8, P52; Pianta Teresa J, 2013, Hand (N Y), V8, P86, DOI 10.1007/s11552-012-9476-3	19	0	0	ELSEVIER MASSON	MILANO	VIA PALEOCAPA 7, 20121 MILANO, ITALY	1877-0568			ORTHOP TRAUMATOL-SUR	Orthop. Traumatol.-Surg. Res.	DEC	2015	101	8					983	986		10.1016/j.otsr.2015.09.019		4	Orthopedics; Surgery	Orthopedics; Surgery	CY3GX	WOS:000366298200019		
J	Bernal, MA; Bordage, MC; Brown, JMC; Davidkova, M; Delage, E; El Bitar, Z; Enger, SA; Francis, Z; Guatelli, S; Ivanchenko, VN; Karamitros, M; Kyriakou, I; Maigne, L; Meylan, S; Murakami, K; Okada, S; Payno, H; Perrot, Y; Petrovic, I; Pham, QT; Ristic-Fira, A; Sasaki, T; Stepan, V; Tran, HN; Villagrasa, C; Incerti, S				Bernal, M. A.; Bordage, M. C.; Brown, J. M. C.; Davidkova, M.; Delage, E.; El Bitar, Z.; Enger, S. A.; Francis, Z.; Guatelli, S.; Ivanchenko, V. N.; Karamitros, M.; Kyriakou, I.; Maigne, L.; Meylan, S.; Murakami, K.; Okada, S.; Payno, H.; Perrot, Y.; Petrovic, I.; Pham, Q. T.; Ristic-Fira, A.; Sasaki, T.; Stepan, V.; Tran, H. N.; Villagrasa, C.; Incerti, S.			Track structure modeling in liquid water: A review of the Geant4-DNA very low energy extension of the Geant4 Monte Carlo simulation toolkit	PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS			English	Review						Monte Carlo; Geant4-DNA; Radiolysis; Radiobiology; Ionizing radiation	INELASTIC CROSS-SECTIONS; HEAVY-ATOM NANOPARTICLES; RADIATION-INDUCED SPURS; PROTEIN DATA-BANK; QUANTITATIVE MODEL; ELECTRON-TRANSPORT; STOCHASTIC-MODELS; PHYSICS PROCESSES; ION IRRADIATION; STRUCTURE CODE	Understanding the fundamental mechanisms involved in the induction of biological damage by ionizing radiation remains a major challenge of today's radiobiology research. The Monte Carlo simulation of physical, physicochemical and chemical processes involved may provide a powerful tool for the simulation of early damage induction. The Geant4-DNA extension of the general purpose Monte Carlo Geant4 simulation toolkit aims to provide the scientific community with an open source access platform for the mechanistic simulation of such early damage. This paper presents the most recent review of the Geant4-DNA extension, as available to Geant4 users since June 2015 (release 10.2 Beta). In particular, the review includes the description of new physical models for the description of electron elastic and inelastic interactions in liquid water, as well as new examples dedicated to the simulation of physicochemical and chemical stages of water radiolysis. Several implementations of geometrical models of biological targets are presented as well, and the list of Geant4-DNA examples is described. (C) 2015 Associazione Italiana di Fisica Medica. Published by Elsevier Ltd. All rights reserved.	[Bernal, M. A.] Univ Estadual Campinas, Inst Fis Gleb Wataghin, BR-13081970 Campinas, SP, Brazil; [Bordage, M. C.] Univ Toulouse 3, CRCT, UMR 1037, INSERM, F-31062 Toulouse, France; [Bordage, M. C.] Univ Toulouse III Paul Sabatier, UMR 1037, CRCT, F-31000 Toulouse, France; [Brown, J. M. C.] Monash Univ, Sch Phys & Astron, Melbourne, Vic 3004, Australia; [Brown, J. M. C.] Queens Univ Belfast, Sch Math & Phys, Belfast BT7 1NN, Antrim, North Ireland; [Davidkova, M.; Stepan, V.] CAS, Dept Radiat Dosimetry, Inst Nucl Phys, Prague, Czech Republic; [Delage, E.; Maigne, L.; Payno, H.; Perrot, Y.; Pham, Q. T.] Clermont Univ, CNRS, IN2P3, Lab Phys Corpusculaire, Aubiere, France; [El Bitar, Z.] Inst Pluridisciplinaire Hubert Curien, Strasbourg, France; [Enger, S. A.] McGill Univ, Dept Oncol, Med Phys Unit, Montreal, PQ, Canada; [Francis, Z.] Uni St Jeseph, Dept Phys, Fac Sci, Beirut, Lebanon; [Guatelli, S.] Univ Wollongong, Ctr Med Radiat Phys, Wollongong, NSW 2522, Australia; [Ivanchenko, V. N.] Geant4 Associates Int Ltd, Hebden Bridge, W Yorkshire, England; [Ivanchenko, V. N.] Ecoanalytica, Moscow 119899, Russia; [Karamitros, M.] Univ Notre Dame, Notre Dame Radiat Lab, Notre Dame, IN 46556 USA; [Kyriakou, I.] Univ Ioannina, Sch Med, Med Phys Lab, GR-45110 Ioannina, Greece; [Meylan, S.; Villagrasa, C.] IRSN, BP17, F-92962 Fontenay Aux Roses, France; [Murakami, K.; Okada, S.; Sasaki, T.] Natl Lab High Energy Phys, KEK, Tsukuba, Ibaraki 305, Japan; [Petrovic, I.; Ristic-Fira, A.] Univ Belgrade, Vinca Inst Nucl Sci, Belgrade, Serbia; [Tran, H. N.; Incerti, S.] Ton Duc Thang Univ, Div Nucl Phys, Ho Chi Minh City, Vietnam; [Tran, H. N.; Incerti, S.] Ton Duc Thang Univ, Fac Sci Appl, Ho Chi Minh City, Vietnam; [Incerti, S.] Univ Bordeaux, CENBG, UMR 5797, F-33170 Gradignan, France; [Incerti, S.] CNRS, IN2P3, CENBG, UMR 5797, F-33170 Gradignan, France	Incerti, S (reprint author), CNRS, IN2P3, CENBG, UMR 5797, F-33170 Gradignan, France.	sebastien.incerti@tdt.edu.vn			FAPESP foundation in Brazil [2011/51594-2]; European Space Agency through the BioRadII [4000107387/12/NL/AK]	We would like to acknowledge Pr Paolo Russo for kindly inviting us to submit this review to the "Physica Medica - European Journal of Medical Physics". M.A. Bernal thanks the FAPESP foundation in Brazil for financing his research activities through the 2011/51594-2 project. Geant4-DNA receives funding from the European Space Agency through the BioRadII contract (contract number: 4000107387/12/NL/AK).	Agostinelli S, 2003, NUCL INSTRUM METH A, V506, P250, DOI 10.1016/S0168-9002(03)01368-8; Allison J, 2006, NUCL SCI IEEE T, V53, P270, DOI DOI 10.1109/TNS.2006.869826; Andre T, 2014, NUCL INSTRUM METH B, V319, P87, DOI 10.1016/j.nimb.2013.11.005; Lazarakis P, 2012, INT J RADIAT BIOL, V88, P183, DOI 10.3109/09553002.2011.641436; Sokhansanj BA, 2002, NUCLEIC ACIDS RES, V30, P1817, DOI 10.1093/nar/30.8.1817; TERRISSOL M, 1990, RADIAT PROT DOSIM, V31, P175; Villagrasa C, 2011, RADIAT PROT DOSIM, V143, P214, DOI 10.1093/rpd/ncq537; Francis Z, 2011, APPL RADIAT ISOTOPES, V69, P220, DOI 10.1016/j.apradiso.2010.08.011; Emfietzoglou D, 2012, INT J RADIAT BIOL, V88, P22, DOI 10.3109/09553002.2011.588061; Liamsuwan T, 2012, INT J RADIAT BIOL, V88, P899, DOI 10.3109/09553002.2012.699136; Kyriakou I, 2015, MED PHYS, V42, P3870, DOI 10.1118/1.4921613; Kase Y, 2008, PHYS MED BIOL, V53, P37, DOI 10.1088/0031-9155/53/1/003; Plante I, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/6/063047; Emfietzoglou D, 2003, RADIAT PHYS CHEM, V66, P373, DOI 10.1016/S0969-806X(02)00504-2; Toulemonde M, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.031913; Wang H, 2014, PHYS MED BIOL, V59, P3657, DOI 10.1088/0031-9155/59/14/3657; Sefl M, 2015, APPL RADIAT ISOTOPES, V104, P113, DOI 10.1016/j.apradiso.2015.06.027; Karr JR, 2012, CELL, V150, P389, DOI 10.1016/j.cell.2012.05.044; BERNSTEIN FC, 1978, ARCH BIOCHEM BIOPHYS, V185, P584, DOI 10.1016/0003-9861(78)90204-7; Nikjoo H, 2006, RADIAT MEAS, V41, P1052, DOI 10.1016/j.radmeas.2006.02.001; Karamitros M, 2014, J COMPUT PHYS, V274, P841, DOI 10.1016/j.jcp.2014.06.011; Plante I, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/12/125020; Schalch T, 2005, NATURE, V436, P138, DOI 10.1038/nature03686; Wilson WE, 2004, RADIAT RES, V161, P591, DOI 10.1667/RR3179; Dingfelder M, 2008, RADIAT RES, V169, P584, DOI 10.1667/RR1099.1; GROSSWENDT B, 1978, NUCL INSTRUM METHODS, V155, P145, DOI 10.1016/0029-554X(78)90198-2; Cucinotta FA, 2000, INT J RADIAT BIOL, V76, P1463; Bug MU, 2010, EUR PHYS J D, V60, P85, DOI 10.1140/epjd/e2010-00145-1; Garcia-Molina R, 2011, PHYS MED BIOL, V56, P6475, DOI 10.1088/0031-9155/56/19/019; Michalik V, 1998, RADIAT RES, V149, P224, DOI 10.2307/3579955; UEHARA S, 1993, PHYS MED BIOL, V38, P1841, DOI 10.1088/0031-9155/38/12/010; Francis Z, 2012, PHYS MED BIOL, V57, P209, DOI 10.1088/0031-9155/57/1/209; Emfietzoglou D, 2003, PHYS MED BIOL, V48, P2355, DOI 10.1088/0031-9155/48/15/308; Nikjoo H, 2012, INT J RADIAT BIOL, V88, P87, DOI 10.3109/09553002.2011.640860; Perl J, 2012, MED PHYS, V39, P6818, DOI 10.1118/1.4758060; Vassiliev ON, 2012, PHYS MED BIOL, V57, P1087, DOI 10.1088/0031-9155/57/4/1087; Bernal MA, 2013, COMPUT PHYS COMMUN, V184, P2840, DOI 10.1016/j.cpc.2013.07.015; Semenenko VA, 2003, RADIAT ENVIRON BIOPH, V42, P213, DOI 10.1007/s00411-003-0201-z; Munoz A, 2008, INT J MASS SPECTROM, V277, P175, DOI 10.1016/j.ijms.2008.04.028; Stia CR, 2010, EUR PHYS J D, V60, P77, DOI 10.1140/epjd/e2010-00013-0; Emfietzoglou D, 2005, RADIAT RES, V163, P98, DOI 10.1667/RR3281; Emfietzoglou D, 2013, RADIAT RES, V180, P499, DOI 10.1667/RR13362.1; Incerti S, 2010, MED PHYS, V37, P4692, DOI 10.1118/1.3476457; MICHAUD M, 1987, PHYS REV A, V36, P4672, DOI 10.1103/PhysRevA.36.4672; Fourie H, 2015, PHYS MED BIOL, V60, P3333, DOI 10.1088/0031-9155/60/8/3333; Friedland W, 2003, RADIAT RES, V159, P401, DOI 10.1667/0033-7587(2003)159[0401:SODDAP]2.0.CO;2; Cucinotta FA, 2008, RADIAT RES, V169, P214, DOI 10.1667/RR1035.1; KIM YK, 1994, PHYS REV A, V50, P3954, DOI 10.1103/PhysRevA.50.3954; Kreipl MS, 2009, RADIAT ENVIRON BIOPH, V48, P11, DOI 10.1007/s00411-008-0194-8; Francis Z, 2011, COMPUT METH PROG BIO, V101, P265, DOI 10.1016/j.cmpb.2010.12.012; Walzlein C, 2014, PHYS MED BIOL, V59, P1441, DOI 10.1088/0031-9155/59/6/1441; Jan S, 2011, PHYS MED BIOL, V56, P881, DOI 10.1088/0031-9155/56/4/001; Fernandez-Varea JM, 2012, INT J RADIAT BIOL, V88, P66, DOI 10.3109/09553002.2011.598209; Emfietzoglou D, 2013, J APPL PHYS, V114, DOI 10.1063/1.4824541; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Delage E, 2015, COMPUT PHYS COMMUN, V192, P282, DOI 10.1016/j.cpc.2015.02.026; Peudon A, 2006, RADIAT PROT DOSIM, V122, P128, DOI [10.1093/rpd/ncl452, 10.1093/rpd/nc1452]; Belov OV, 2015, J THEOR BIOL, V366, P115, DOI 10.1016/j.jtbi.2014.09.024; Bourret S, 2014, NUCL INSTRUM METH B, V325, P27, DOI 10.1016/j.nimb.2014.02.004; Brun R, 1997, NUCL INSTRUM METH A, V389, P81, DOI 10.1016/S0168-9002(97)00048-X; Champion C, 2014, APPL RADIAT ISOTOPES, V83, P137, DOI 10.1016/j.apradiso.2013.01.037; Chauvie S, 2007, NUCL SCI IEEE T, V54, P2619; CLIFFORD P, 1985, J PHYS CHEM-US, V89, P925, DOI 10.1021/j100252a008; CLIFFORD P, 1987, J PHYS CHEM-US, V91, P4417, DOI 10.1021/j100300a043; Cullen D.E., 1997, UCRL50400, V6, P1997; Dingfelder M., 1999, RADIAT PHYS CHEM, V53, P1, DOI 10.1016/S0969-806X(97)00317-4; Dos Santos M, 2013, NUCL INSTRUM METH B, V298, P47, DOI 10.1016/j.nimb.2013.01.009; Edel S, 2006, THESIS; Emfietzoglou D, 2009, NUCL INSTRUM METH B, V267, P45, DOI 10.1016/j.nimb.2008.11.008; Ester M, 1996, P 2 INT C KNOWL DISC, P226; Francis Z, 2011, NUCL INSTRUM METH B, V269, P2307, DOI 10.1016/j.nimb.2011.02.031; Gaigeot MP, 2010, MUTAT RES-REV MUTAT, V704, P45, DOI 10.1016/j.mrrev.2010.01.004; Incerti S, 2010, INT J MODEL SIMUL SC, V1, P157, DOI DOI 10.1142/S1793962310000122; Incerti Sébastien, 2014, Phys Med Biol, V59, P7565, DOI 10.1088/0031-9155/59/24/7565; Incerti S, 2014, NUCL INSTRUM METH B, V333, P92, DOI 10.1016/j.nimb.2014.04.025; Incerti S, 2013, NUCL INSTRUM METH B, V306, P158, DOI 10.1016/j.nimb.2012.12.054; Ivanchenko VN, 2014, SNA MC 2013 JOINT IN; Ivanchenko VN, 2012, NUCL INSTRUM METH B, V273, P95, DOI 10.1016/j.nimb.2011.07.048; Mantero A, 2011, X-RAY SPECTROM, V40, P135, DOI 10.1002/xrs.1301; McMahon SJ, 2011, SCI REP-UK, V1, DOI 10.1038/srep00018; Michaud M, 2003, RADIAT RES, V159, P3; Mott N. F., 1965, THEORY ATOMIC COLLIS; Naqa IE, 2012, PHYS MED BIOL, V57, pR75; Okada S, 2015, INNOVATION MED HEALT, P323; Pham QT, 2015, NUCL INSTRUM METH B, V353, P46, DOI 10.1016/j.nimb.2015.04.024; Raine M, 2014, NUCL INSTRUM METH B, V325, P97, DOI 10.1016/j.nimb.2014.01.014; Stepan V, 2014, EUR PHYS J D, V68, P1; Stepan V, 20 KEV ELECT 200 KEV; Stepan V, 20 KEV ELECT 20 MEV; Stepan V, 50 MEV 100 MEV 1 GEV; Stepan V, 2014, GEANT4 DNA VISUALIZA; Taleei R, 2013, RADIAT RES, V179, P540, DOI 10.1667/RR3124.1; Taleei R., 2012, J MOL ENG SYST BIOL, V1, P1; Tran HN, 2015, NUCL INSTRUM METH B, V343, P132, DOI 10.1016/j.nimb.2014.10.016; Walck C, 2007, SUFPFY9601 U STOCKH; Yuting Lin, 2014, Physics in Medicine and Biology, V59, DOI 10.1088/0031-9155/59/24/7675; Zaidi H, 2002, THERAPEUTIC APPL MON	97	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1120-1797	1724-191X		PHYS MEDICA	Phys. Medica	DEC	2015	31	8					861	874		10.1016/j.ejmp.2015.10.087		14	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CY8LR	WOS:000366660400003		
J	Nakamura, M; Takamiya, M; Akimoto, M; Ueki, N; Yamada, M; Tanabe, H; Mukumoto, N; Yokota, K; Matsuo, Y; Mizowaki, T; Kokubo, M; Hiraoka, M				Nakamura, Mitsuhiro; Takamiya, Masanori; Akimoto, Mami; Ueki, Nami; Yamada, Masahiro; Tanabe, Hiroaki; Mukumoto, Nobutaka; Yokota, Kenji; Matsuo, Yukinori; Mizowaki, Takashi; Kokubo, Masaki; Hiraoka, Masahiro			Target localization errors from fiducial markers implanted around a lung tumor for dynamic tumor tracking	PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS			English	Article						Dynamic tumor tracking; Target localization error; Implanted fiducial markers; Multiple regression analysis	BODY RADIATION-THERAPY; GIMBAL MOUNTED LINAC; ACCURACY; RADIOTHERAPY; SYSTEM; PLACEMENT; STABILITY; ONCOLOGY; PRECISION; CANCER	Purpose: To assess target localization errors (TLEs) from implanted fiducial markers by three different centers of gravity (CG) and three different multiple regression analysis (MRA) approaches. Methods: The three-dimensional (3D) positions of the markers were detected on the fluoroscopic images of 15 lung cancer patients, and the marker closest to the tumor was then assumed to be the target (P-t). The estimated target position (P-e) was calculated from three markers adjacent to the target (P-i, 1 <= i <= 3) using the equation P-e = aP(1) + bP(2) + cP(3) + d.P-e was then calculated using three different CGs and three different MRAs. The TLE was calculated as the root-mean-square error of the difference between Pt and Pe calculated for each fraction. First, we compared the TLE of the first fraction to assess the intrafraction TLE of the six approaches tested. Second, interfraction TLEs were calculated to evaluate the robustness of the coefficients obtained in the first fraction. The interfraction TLE was defined as the difference between the TLE of a later and the first fraction. Results: The mean plus two times the standard deviation of the intrafraction TLE was up to 4.3 mm in the CG approaches, while the MRA approaches provided TLEs within 1.5 mm. The mean plus two times the standard deviation of the interfraction TLE did not exceed 1.7 mm in any direction using either approach. Conclusions: The MRA approach was superior to the CG approach in terms of estimating the target position based on the implanted fiducial markers. (C) 2015 Associazione Italiana di Fisica Medica. Published by Elsevier Ltd. All rights reserved.	[Nakamura, Mitsuhiro; Takamiya, Masanori; Akimoto, Mami; Ueki, Nami; Yamada, Masahiro; Mukumoto, Nobutaka; Yokota, Kenji; Matsuo, Yukinori; Mizowaki, Takashi; Hiraoka, Masahiro] Kyoto Univ, Grad Sch Med, Dept Radiat Oncol & Image Appl Therapy, Kyoto 6068507, Japan; [Takamiya, Masanori] Kyoto Univ, Grad Sch Engn, Engn Div Course, Kyoto 6068507, Japan; [Tanabe, Hiroaki; Kokubo, Masaki] Inst Biomed Res & Innovat, Div Radiat Oncol, Kobe, Hyogo, Japan; [Kokubo, Masaki] Kobe City Med Ctr, Gen Hosp, Dept Radiat Oncol, Kobe, Hyogo, Japan	Nakamura, M (reprint author), Kyoto Univ, Grad Sch Med, Sakyo Ku, 54 Kawahara Cho, Kyoto 6068507, Japan.	m_nkmr@kuhp.kyoto-u.ac.jp			Practical Research for Innovative Cancer Control from the Japan Agency for Medical Research and development, AMED [15ck0106035h0002]	This research is partially supported by the Practical Research for Innovative Cancer Control (15ck0106035h0002) from the Japan Agency for Medical Research and development, AMED.	Akimoto M, 2013, MED PHYS, V40; Benedict SH, 2010, MED PHYS, V37, P4078, DOI 10.1118/1.3438081; De Ruysscher D, 2010, J CLIN ONCOL, V28, P5301, DOI 10.1200/JCO.2010.30.3271; Timmerman R, 2006, ACTA ONCOL, V45, P779, DOI 10.1080/02841860600902213; Ueki N, 2014, RADIOTHER ONCOL, V110, P523, DOI 10.1016/j.radonc.2014.01.014; Murphy MJ, 2002, MED PHYS, V29, P334, DOI 10.1118/1.1448823; Mukumoto N, 2014, RADIOTHER ONCOL, V111, P301, DOI 10.1016/j.radonc.2014.02.018; Dieterich S, 2008, MED PHYS, V35, P5684, DOI 10.1118/1.3020593; Wunderink W, 2010, INT J RADIAT ONCOL, V77, P1573, DOI 10.1016/j.ijrobp.2009.10.040; Kupelian PA, 2007, INT J RADIAT ONCOL, V69, P777, DOI 10.1016/j.ijrobp.2007.03.040; West JB, 2001, NEUROSURGERY, V48, P810, DOI 10.1097/00006123-200104000-00023; Liu HS, 2003, MED PHYS, V30, P103, DOI 10.1118/1.1533748; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Hoogeman M, 2009, INT J RADIAT ONCOL, V74, P297, DOI 10.1016/j.ijrobp.2008.12.041; Depuydt T, 2013, RADIOTHER ONCOL, V106, P236, DOI 10.1016/j.radonc.2012.12.015; Seppenwoolde Y, 2011, PHYS MED BIOL, V56, P5445, DOI 10.1088/0031-9155/56/17/001; Garibaldi C, 2015, PHYS MEDICA, V31, P501, DOI 10.1016/j.ejmp.2015.04.001; Persson GF, 2013, J APPL CLIN MED PHYS, V14, P187, DOI 10.1120/jacmp.v14i5.4337; Seppenwoolde Y, 2002, INT J RADIAT ONCOL, V53, P822, DOI 10.1016/S0360-3016(02)02803-1; Keall PJ, 2006, MED PHYS, V33, P3874, DOI 10.1118/1.2349696; International Commission on Radiation Units and Measurements, 1993, 50 ICRU; Matsuo Y, 2014, RADIOTHER ONCOL, V112, P360, DOI 10.1016/j.radonc.2014.08.003; Nakamura M, 2015, PHYS MEDICA, V31, P204, DOI 10.1016/j.ejmp.2015.01.004; Potters L, 2004, INT J RADIAT ONCOL, V60, P1026, DOI 10.1016/j.ijrobp.2004.07.701; van Zyp NCV, 2011, INT J RADIAT ONCOL, V81, pE75, DOI 10.1016/j.ijrobp.2010.12.026	25	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1120-1797	1724-191X		PHYS MEDICA	Phys. Medica	DEC	2015	31	8					934	941		10.1016/j.ejmp.2015.06.012		8	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CY8LR	WOS:000366660400012		
J	Fujii, K; Takahashi, Y; Nakai, Y; Kato, D; Goto, M; Morita, S; Hasuo, M				Fujii, K.; Takahashi, Y.; Nakai, Y.; Kato, D.; Goto, M.; Morita, S.; Hasuo, M.		LHD Expt Grp	Visible emission spectroscopy of highly charged tungsten ions in LHD: II. Evaluation of tungsten ion temperature	PHYSICA SCRIPTA			English	Article						Zeeman effect; ion temperature measurement; highly charged ion	LARGE HELICAL DEVICE; DIAGNOSTIC NEUTRAL BEAM	We demonstrated a polarization-resolved high resolution spectroscopy of a visible emission line of highly charged tungsten ions (lambda(0) = 668.899 nm, Shinohara et al Phys. Scr. 90 125402) for the large helical device (LHD) plasma, where the tungsten ions were introduced by a pellet injection. Its spectral profile shows broadening and polarization dependence, which are attributed to the Doppler and Zeeman effects, respectively. The tungsten ion temperature was evaluated for the first time from the broadening of visible the emission line, with its emission location determined by the Abel inversion of the chord-integrated emission intensities observed with multiple chords. The tungsten ion temperature was found to be close to the helium-like argon ion temperature, which is used as an ion temperature monitor in LHD.	[Fujii, K.; Takahashi, Y.; Nakai, Y.; Hasuo, M.] Kyoto Univ, Grad Sch Engn, Dept Mech Engn & Sci, Kyoto 6158540, Japan; [Kato, D.; Goto, M.; Morita, S.] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Kato, D.; Goto, M.; Morita, S.] Grad Univ Adv Studies, Dept Fus Sci, Toki, Gifu 5095292, Japan	Fujii, K (reprint author), Kyoto Univ, Grad Sch Engn, Dept Mech Engn & Sci, Kyoto 6158540, Japan.	fujii@me.kyoto-u.ac.jp			National Institute for Fusion Science [NIFS13KLPH021, NIFS14KLPH023, NIFS12KOAH028]; JSPS-NRF-NSFC A3 Foresight Program in field of Plasma Physics (NSFC) [11261140328]; JSPS-NRF-NSFC A3 Foresight Program in field of Plasma Physics (NRF) [2012K2A2A6000443]	This work was supported by the National Institute for Fusion Science (NIFS13KLPH021, NIFS14KLPH023, and NIFS12KOAH028). SM and MH acknowledge the support by the JSPS-NRF-NSFC A3 Foresight Program in the field of Plasma Physics (NSFC: No. 11261140328, NRF: No. 2012K2A2A6000443).	Thomas DM, 1999, REV SCI INSTRUM, V70, P886, DOI 10.1063/1.1149408; FONCK RJ, 1982, PHYS REV LETT, V49, P737, DOI 10.1103/PhysRevLett.49.737; Charbonnier P, 1997, IEEE T IMAGE PROCESS, V6, P298, DOI 10.1109/83.551699; Borgia GC, 1998, J MAGN RESON, V132, P65, DOI 10.1006/jmre.1998.1387; Nozato H, 2004, PHYS PLASMAS, V11, P1920, DOI 10.1063/1.1695355; Fujii K, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4863650; Masuzaki S, 2002, NUCL FUSION, V42, P750, DOI 10.1088/0029-5515/42/6/313; SCHILLING G, 1992, REV SCI INSTRUM, V63, P4937, DOI 10.1063/1.1143555; Nakano T, 2015, J PHYS B-AT MOL OPT, V48, DOI 10.1088/0953-4075/48/14/144023; Sasaki A, 2013, J PHYS B-AT MOL OPT, V46, DOI 10.1088/0953-4075/46/17/175701; Narihara K, 2001, REV SCI INSTRUM, V72, P1122, DOI 10.1063/1.1319368; Morita S, 2003, REV SCI INSTRUM, V74, P2375, DOI 10.1063/1.1556942; Crosswhite H M, 1968, HYDROGEN MOL WAVELEN; Ding X B, 2012, PLASMA FUSION RES RE, V7; Qiu ML, 2014, J PHYS B-AT MOL OPT, V47, DOI 10.1088/0953-4075/47/17/175002; Shinohara M, PHYS SCR, V90	16	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0031-8949	1402-4896		PHYS SCRIPTA	Phys. Scr.	DEC	2015	90	12							125403	10.1088/0031-8949/90/12/125403		7	Physics, Multidisciplinary	Physics	CZ1ND	WOS:000366871600007		
J	Shinohara, M; Fujii, K; Kato, D; Nakamura, N; Goto, M; Morita, S; Hasuo, M				Shinohara, M.; Fujii, K.; Kato, D.; Nakamura, N.; Goto, M.; Morita, S.; Hasuo, M.		LHD Expt Grp	Visible emission spectroscopy of highly charged tungsten ions in LHD: I. Survey of new visible emission lines	PHYSICA SCRIPTA			English	Article						echelle spectrometer; forbidden line; highly charged ion	PLASMA; COMPONENTS; RADIATION; REGION	We found 12 unknown visible emission lines from the core plasma of large helical device with highly charged tungsten ions accumulated. The observation was made with our home-built echelle spectrometer, which covers the wavelength range of 450-715 nm with a wavelength resolution of <0.05 nm for two lines of sight; one line passes both the core and edge plasmas and the other passes only the edge plasma. These emission lines are attributed to highly charged tungsten ions because (1) they were observed only after a tungsten pellet was injected into the plasma, (2) they were observed only from the core plasma where the electron temperature is 1 keV, (3) they show line broadenings that are close to the Doppler widths of tungsten ions with 1 keV temperature and (4) the wavelengths of some of these emission lines are close to the calculation results for tungsten ions in the charge state of 25-28.	[Shinohara, M.; Fujii, K.; Hasuo, M.] Kyoto Univ, Grad Sch Engn, Dept Mech Engn & Sci, Kyoto 6158540, Japan; [Kato, D.; Goto, M.; Morita, S.] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Kato, D.; Goto, M.; Morita, S.] Grad Univ Adv Studies, Dept Fus Sci, Toki, Gifu 5095292, Japan; [Nakamura, N.] Univ Electrocommun, Inst Laser Sci, Tokyo 1828585, Japan	Shinohara, M (reprint author), Kyoto Univ, Grad Sch Engn, Dept Mech Engn & Sci, Kyoto 6158540, Japan.	fujii@me.kyoto-u.ac.jp	NAKAMURA, Nobuyuki/B-4945-2011		National Institute for Fusion Science [NIFS13KLPH021, NIFS14KLPH023, NIFS12KOAH028]; JSPS-NRF-NSFC A3 Foresight Program in field of Plasma Physics (NSFC) [11261140328]; JSPS-NRF-NSFC A3 Foresight Program in field of Plasma Physics (NRF) [2012K2A2A6000443]	This work was supported by the National Institute for Fusion Science (NIFS13KLPH021, NIFS14KLPH023, and NIFS12KOAH028). SM and MH acknowledge the support by the JSPS-NRF-NSFC A3 Foresight Program in the field of Plasma Physics (NSFC: No. 11261140328, NRF: No. 2012K2A2A6000443).	Porto JV, 2000, PHYS REV A, V61, part. no., DOI 10.1103/PhysRevA.61.054501; Nozato H, 2006, PHYS PLASMAS, V13, DOI 10.1063/1.2337790; Sasaki A, 2013, HIGH ENERG DENS PHYS, V9, P325, DOI 10.1016/j.hedp.2013.01.009; Zhao ZZ, 2015, J PHYS B-AT MOL OPT, V48, DOI 10.1088/0953-4075/48/11/115004; HINNOV E, 1978, PHYS LETT A, V66, P109, DOI 10.1016/0375-9601(78)90010-5; Yanagibayashi J, 2010, J PHYS B-AT MOL OPT, V43, DOI 10.1088/0953-4075/43/14/144013; Hirai T, 2013, FUSION ENG DES, V88, P1798, DOI 10.1016/j.fusengdes.2013.05.010; ISLER RC, 1977, PHYS LETT A, V63, P295, DOI 10.1016/0375-9601(77)90908-2; Nozato H, 2004, PHYS PLASMAS, V11, P1920, DOI 10.1063/1.1695355; FELDMAN U, 1991, J OPT SOC AM B, V8, P3, DOI 10.1364/JOSAB.8.000003; Clementson J, 2010, J PHYS B-AT MOL OPT, V43, DOI 10.1088/0953-4075/43/14/144009; Sakaue HA, 2011, J APPL PHYS, V109, DOI 10.1063/1.3549707; GAUSTER WB, 1990, NUCL FUSION, V30, P1897, DOI 10.1088/0029-5515/30/9/013; Ding XB, 2012, J PHYS B-AT MOL OPT, V45, DOI 10.1088/0953-4075/45/3/035003; Putterich T, 2008, PLASMA PHYS CONTR F, V50, DOI 10.1088/0741-3335/50/8/085016; Nakano T, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/11/115024; Merola M, 2014, FUSION ENG DES, V89, P890, DOI 10.1016/j.fusengdes.2014.01.055; Narihara K, 2001, REV SCI INSTRUM, V72, P1122, DOI 10.1063/1.1319368; Watanabe H, 2012, CAN J PHYS, V90, P497, DOI 10.1139/P2012-045; Neu R, 2005, NUCL FUSION, V45, P209, DOI 10.1088/0029-5515/45/3/007; Asmussen K, 1998, NUCL FUSION, V38, P967, DOI 10.1088/0029-5515/38/7/302; Ding XB, 2011, J PHYS B-AT MOL OPT, V44, DOI 10.1088/0953-4075/44/14/145004; Fei Z, 2014, PHYS REV A, V90, DOI 10.1103/PhysRevA.90.052517; Chowdhuri M B, 2007, PLASMA FUSION RES, V2, pS1060, DOI DOI 10.1585/PFR.2.S1060; Ding X B, 2012, PLASMA FUSION RES RE, V7; Fujii K, PHYS SCR, V90; Gu MF, 2008, CAN J PHYS, V86, P675, DOI 10.1139/P07-197; Kato D, 2013, PHYS SCR T, V156; Komatsu A, 2012, PLASMA FUSION RES, V7; Nakamura N, 2011, ASTROPHYS J, V739, DOI 10.1088/0004-637X/739/1/17; Qiu ML, 2015, J PHYS B-AT MOL OPT, V48, DOI 10.1088/0953-4075/48/14/144029	31	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0031-8949	1402-4896		PHYS SCRIPTA	Phys. Scr.	DEC	2015	90	12							125402	10.1088/0031-8949/90/12/125402		10	Physics, Multidisciplinary	Physics	CZ1ND	WOS:000366871600006		
J	Hironiwa, D; Matsuo, N; Chantana, J; Sakai, N; Kato, T; Sugimoto, H; Minemoto, T				Hironiwa, Daisuke; Matsuo, Nobuki; Chantana, Jakapan; Sakai, Noriyuki; Kato, Takuya; Sugimoto, Hiroki; Minemoto, Takashi			Annealing effect on Cu2ZnSn(S,Se)(4) solar cell with Zn1-xMgxO buffer layer	PHYSICA STATUS SOLIDI A-APPLICATIONS AND MATERIALS SCIENCE			English	Article						(Zn,Mg)O; annealing; buffer layers; Cu2ZnSn(S,Se)(4); solar cells status solidi physica	CONDUCTION-BAND OFFSET	(Zn,Mg)O buffer layer has attracted attention with the potential to control the conduction-band offset (CBO) at the interface between the buffer layer and the Cu2ZnSn(S,Se)(4) (CZTSSe) absorber, where the (Zn, Mg) O buffer layer is deposited by sputtering. The bandgap energy (E-g) of (Zn, Mg) O layers is tunable from 3.3 to 7.7 eV by changing the Mg/(Zn+Mg) ratio. Thus, short-wavelength response of solar cells with a (Zn,Mg)O buffer layer is higher than that with a CdS buffer layer. Nevertheless, the solar-cell performances with a (Zn,Mg)O buffer layer is significantly lower than that with a CdS buffer layer. The low performances are attributed to the sputtering damage on the CZTSSe absorber. To recover sputtering damage, the annealing treatment was conducted on CZTSSe solar cells. However, after the annealing treatment, the performances of CZTSSe solar cells decreased. Photoluminescence (PL) spectra of the CZTSSe absorbers without and with the annealing treatment were measured to evaluate the (Zn, Mg) O/CZTSSe junction quality. From the results, the PL intensity presents a slight variation, while the Eg of the CZTSSe absorbers decreases. Thus, the defects near the space-charge region activate. Consequently, the decrease of the sputtering damage was not confirmed by the annealing treatment. Therefore, a damage-free method for the deposition of (Zn,Mg) O layer is necessary. (C) 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim	[Hironiwa, Daisuke] Ritsumeikan Univ, Global Innovat Res Org, Kusatsu, Shiga 5258577, Japan; [Matsuo, Nobuki; Chantana, Jakapan; Minemoto, Takashi] Ritsumeikan Univ, Dept Elect & Elect Engn, Kusatsu, Shiga 5258577, Japan; [Sakai, Noriyuki; Kato, Takuya; Sugimoto, Hiroki] Solar Frontier KK, Atsugi Res Ctr, Atsugi, Kanagawa 2430206, Japan	Hironiwa, D (reprint author), Ritsumeikan Univ, Global Innovat Res Org, Kusatsu, Shiga 5258577, Japan.	hironiwa@fc.ritsumei.ac.jp					Minemoto T, 2003, SOL ENERG MAT SOL C, V75, P121, DOI 10.1016/S0927-0248(02)00120-4; Shimakawa S, 2008, SOL ENERG MAT SOL C, V92, P1086, DOI 10.1016/j.solmat.2008.03.014; Kobayashi T, 2014, PROG PHOTOVOLTAICS, V22, P115, DOI 10.1002/pip.2339; Green MA, 2014, PROG PHOTOVOLTAICS, V22, P701, DOI 10.1002/pip.2525; Hironiwa D, 2015, THIN SOLID FILMS, V582, P151, DOI 10.1016/j.tsf.2014.11.016; Shin B, 2013, PROG PHOTOVOLTAICS, V21, P72, DOI 10.1002/pip.1174; Hariskos D, 2009, PROG PHOTOVOLTAICS, V17, P479, DOI 10.1002/pip.897; Rey G, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4896315; Hironiwa D, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.106502; Minemoto T, 2000, THIN SOLID FILMS, V372, P173, DOI 10.1016/S0040-6090(00)01009-9; Yan C, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4873715; Siebentritt S, 2013, THIN SOLID FILMS, V535, P1, DOI 10.1016/j.tsf.2012.12.089; Tajima S, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4894858; Minemoto T, 2001, J APPL PHYS, V89, P8327, DOI 10.1063/1.1366655; Hironiwa D, 2015, CURR APPL PHYS, V15, P383, DOI 10.1016/j.cap.2015.01.011; Chen SY, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4768215; Gokmen T, 2013, J APPL PHYS, V114, DOI 10.1063/1.4821841; Haight R, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3600776; Huang D., 2014, APPL PHYS LETT, V105; Kato T., 2013, P 28 EUR PHOT SOL EN, P2125; Kim J., 2014, ADV ENERGY MATER, V10, P7427; Mizumoto Y, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.125503; Okuda K, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.05FW04; Terada T., 2014, EUR MAT RES SOC SPRI; Wang W., 2013, ADV ENERGY MATER, V10	25	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1862-6300	1862-6319		PHYS STATUS SOLIDI A	Phys. Status Solidi A-Appl. Mat.	DEC	2015	212	12					2766	2771		10.1002/pssa.201532217		6	Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Materials Science; Physics	CY7LM	WOS:000366589900017		
J	Kelgenbaeva, Z; Omurzak, E; Ihara, H; Iwamoto, C; Sulaimankulova, S; Mashimo, T				Kelgenbaeva, Zhazgul; Omurzak, Emil; Ihara, Hirotaka; Iwamoto, Chihiro; Sulaimankulova, Saadat; Mashimo, Tsutomu			Sn and SnO2 nanoparticles by pulsed plasma in liquid: Synthesis, characterization and applications	PHYSICA STATUS SOLIDI A-APPLICATIONS AND MATERIALS SCIENCE			English	Article						nanoparticles; pulsed plasma in liquid; synthesis; tin; tin dioxide	DEPENDENT MELTING PROPERTIES; SOL-GEL METHOD; TIN NANOPARTICLES; SILVER NANOPARTICLES; ASSISTED SYNTHESIS; TEMPERATURE; PURE; DECOMPOSITION; DISPERSION; GOLD	In this work, spherical Sn and SnO2 nanoparticles smaller than 5 and 20 nm, respectively, were synthesized using pulsed plasma in deionized water, simply and environmentally friendly. The tetragonal Sn nanoparticles showed good crystallinity and slight increase in lattice parameters. Thermo-gravimetric analysis revealed insignificant weight loss from the particles, indicating their thermal stability up to 500 degrees C. The Sn nanoparticles then were annealed at 800 degrees C; in result, cassiterite phase of SnO2 nanoparticles were successfully obtained. Structural and morphological analysis indicated the full oxidation of Sn and size growth of SnO2 nanoparticles upto 20-25 nm. The SnO2 nanoparticles showed good photocatalytic activity in degradation of organic dyes, such as methylene blue and methyl orange. (C) 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim	[Kelgenbaeva, Zhazgul; Mashimo, Tsutomu] Kumamoto Univ, Inst Pulsed Power Sci, Kumamoto 8608555, Japan; [Omurzak, Emil] Kumamoto Univ, Prior Org Innovat & Excellence, Kumamoto 8608555, Japan; [Ihara, Hirotaka] Kumamoto Univ, Dept Appl Chem & Biochem, Kumamoto 8608555, Japan; [Iwamoto, Chihiro] Ibaraki Univ, Fac Mat Sci & Engn, Ibaraki 3168511, Japan; [Sulaimankulova, Saadat] Natl Acad Sci, Inst Chem & Chem Technol, Bishkek 720072, Kyrgyzstan	Mashimo, T (reprint author), Kumamoto Univ, Inst Pulsed Power Sci, Kurokami 2-39-1, Kumamoto 8608555, Japan.	mashimo@gpo.kumamoto-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) Scholarship; Institute of Pulsed Power Science of Kumamoto University, Japan	We thank our colleagues Mr. S. Takebe, Mr. T. Okamoto, and Mrs. N. Watanabe for their collaboration in performing experiments and analysis. This work was supported by the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) Scholarship and the Institute of Pulsed Power Science of Kumamoto University, Japan.	Abdullaeva Z., 2012, CARBON, V20, P1776; [Anonymous], MDI JAD 5 PDF 41 144; Patterson AL, 1939, PHYS REV, V56, P978, DOI 10.1103/PhysRev.56.978; Sharma VK, 2009, ADV COLLOID INTERFAC, V145, P83, DOI 10.1016/j.cis.2008.09.002; Zhong XH, 2012, PARTICUOLOGY, V10, P365, DOI 10.1016/j.partic.2011.09.005; Hou LR, 2014, MATER RES BULL, V60, P1, DOI 10.1016/j.materresbull.2014.08.006; Rashad MM, 2014, CLEAN-SOIL AIR WATER, V42, P657, DOI 10.1002/clen.201300032; Kaur J, 2013, PHYSICA B, V416, P33, DOI 10.1016/j.physb.2013.02.005; Ye HC, 2004, LANGMUIR, V20, P2915, DOI 10.1021/la0361060; Valvo M, 2009, J POWER SOURCES, V189, P297, DOI 10.1016/j.jpowsour.2008.09.019; Zou CD, 2010, T NONFERR METAL SOC, V20, P248, DOI 10.1016/S1003-6326(09)60130-8; Li YX, 2007, MAT SCI ENG A-STRUCT, V458, P235, DOI 10.1016/j.msea.2006.12.075; Li ZW, 2007, ULTRASON SONOCHEM, V14, P89, DOI 10.1016/j.ultsonch.2005.11.008; Jiang HJ, 2006, CHEM PHYS LETT, V429, P492, DOI 10.1016/j.cplett.2006.08.027; Chen L, 2010, J PHYS CHEM C, V114, P12909, DOI 10.1021/jp1031465; Zhao YB, 2003, MAT SCI ENG A-STRUCT, V359, P405, DOI 10.1016/S0921-5093(03)00395-2; Saito G, 2014, ADV POWDER TECHNOL, V25, P728, DOI 10.1016/j.apt.2013.11.001; Chen LL, 2011, J PHYS CHEM C, V115, P9370, DOI 10.1021/jp111367k; Omurzak E, 2007, J NANOSCI NANOTECHNO, V7, P3157, DOI 10.1166/jnn.2007.804; Krishnakumar T, 2008, J NANO RES, V4, P91, DOI 10.4028/www.scientific.net/JNanoR.4.91; Lee SD, 2012, PHYSCS PROC, V32, P320, DOI 10.1016/j.phpro.2012.03.563; Kong J, 2009, MATER CHEM PHYS, V114, P854, DOI 10.1016/j.matchemphys.2008.10.049; Mott D, 2007, LANGMUIR, V23, P5740, DOI 10.1021/la0635092; Ila D, 1998, NUCL INSTRUM METH B, V141, P289, DOI 10.1016/S0168-583X(98)00072-X; Melendrez MF, 2013, REV MEX FIS, V59, P39; Elghanian R, 1997, SCIENCE, V277, P1078, DOI 10.1126/science.277.5329.1078; Sun YG, 2002, SCIENCE, V298, P2176, DOI 10.1126/science.1077229; Bagheri-Mohagheghi MM, 2008, PHYSICA B, V403, P2431, DOI 10.1016/j.physb.2008.01.004; Balan L., 2005, MATER LETT, V59, P1008; Caballero A, 2005, ELECTROCHEM SOLID ST, V8, pA464, DOI [10.1149/1.1993388, 10.1149/1993388]; Chee S., 2012, T NONFERR METAL SOC, V22, P707; Chee S., 2012, ELECTRON MATER LETT, V6, P587; Kelgenbaeva Z., 2013, JPN J APPL PHYS, V52; Kelgenbaeva Z, 2014, J NANOPART RES, V16, DOI 10.1007/s11051-014-2603-z; Long N., 2010, NANOTECHNOLOGY, V21; Patil GE, 2012, INT NANO LETT, V2, P17; Tran QH, 2013, ADV NAT SCI-NANOSCI, V4, DOI 10.1088/2043-6262/4/3/033001	37	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1862-6300	1862-6319		PHYS STATUS SOLIDI A	Phys. Status Solidi A-Appl. Mat.	DEC	2015	212	12					2951	2957		10.1002/pssa.201532502		7	Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Materials Science; Physics	CY7LM	WOS:000366589900043		
J	Inoue, R; Takahashi, S; Kitanaka, Y; Oguchi, T; Noguchi, Y; Miyayama, M				Inoue, Ryotaro; Takahashi, Shusuke; Kitanaka, Yuuki; Oguchi, Takeshi; Noguchi, Yuji; Miyayama, Masaru			Enhanced photovoltaic currents in strained Fe-doped LiNbO3 films	PHYSICA STATUS SOLIDI A-APPLICATIONS AND MATERIALS SCIENCE			English	Article						density functional theory; ferroelectric materials; LiNbO3; photovoltaic effect; thin films	CHARGE-TRANSPORT PROCESSES; LITHIUM-NIOBATE CRYSTALS; PULSED-LASER DEPOSITION; PHOTOREFRACTIVE CRYSTALS; 2ND-HARMONIC GENERATION; MODULATORS; POSITION; OPTICS; LITAO3; SITE	We investigate the impact of strain on photovoltaic current (J(z)) characteristics for iron-doped LiNbO3 (Fe-LN) under visible light illumination by thin-film experiments. The J(z) values are demonstrated to be dramatically enhanced for the film with a tensile strain along the P-s direction, which is over 500 times as large as that of the bulk (strain-free) Fe-LN crystals. Density functional theory (DFT) calculations show that the tensile strain increases an off-center displacement of Fe2+ that is opposite to the P-s direction. Our experimental and DFT study demonstrates that the control of the lattice strain is effective in enhancing the photovoltaic effect in the Fe-LN system. (C) 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim	[Inoue, Ryotaro] Nihon Univ, Div Phys, Sch Med, Inst Liberal Educ,Itabashi Ku, Tokyo 1738601, Japan; [Takahashi, Shusuke; Kitanaka, Yuuki; Oguchi, Takeshi; Noguchi, Yuji; Miyayama, Masaru] Univ Tokyo, Sch Engn, Dept Appl Chem, Bunkyo Ku, Tokyo 1138654, Japan	Inoue, R (reprint author), Nihon Univ, Div Phys, Sch Med, Inst Liberal Educ,Itabashi Ku, 31-10 Ooyaguchi Kamicho, Tokyo 1738601, Japan.	inoue.ryotaro@nihon-u.ac.jp; ynoguchi@fmat.t.u-tokyo.ac.jp			Japan Society for the Promotion of Science (JSPS); JSPS	This research is partly granted by the Japan Society for the Promotion of Science (JSPS) through the Funding Program for Next Generation World-Leading Researchers (NEXT Program), initiated by the Council for Science and Technology Policy (CSTP). This research is partly granted by JSPS.	ALFERNESS RC, 1982, IEEE T MICROW THEORY, V30, P1121; KEUNE W, 1975, J APPL PHYS, V46, P3914, DOI 10.1063/1.322139; PETERSON GE, 1964, APPL PHYS LETT, V5, P62, DOI 10.1063/1.1754053; JUPPE S, 1990, SOLID STATE COMMUN, V76, P299, DOI 10.1016/0038-1098(90)90841-X; CHEN FS, 1968, APPL PHYS LETT, V13, P223, DOI 10.1063/1.1652580; Nahm HH, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.184108; GOLDBERG L, 1995, APPL PHYS LETT, V67, P2910, DOI 10.1063/1.114839; TSAI CS, 1992, IEEE T ULTRASON FERR, V39, P529, DOI 10.1109/58.156172; PRUNERI V, 1995, OPT LETT, V20, P2375, DOI 10.1364/OL.20.002375; PETERSON GE, 1971, APPL PHYS LETT, V19, P130, DOI 10.1063/1.1653854; Yang SY, 2010, NAT NANOTECHNOL, V5, P143, DOI [10.1038/nnano.2009.451, 10.1038/NNANO.2009.451]; TIEN PK, 1977, REV MOD PHYS, V49, P361, DOI 10.1103/RevModPhys.49.361; FESTL HG, 1982, PHYS STATUS SOLIDI B, V113, P157, DOI 10.1002/pssb.2221130115; DHAR A, 1990, J APPL PHYS, V68, P5804, DOI 10.1063/1.346951; CHEN FS, 1969, J APPL PHYS, V40, P3389, DOI 10.1063/1.1658195; GLASS AM, 1974, APPL PHYS LETT, V25, P233, DOI 10.1063/1.1655453; GOG T, 1995, J PHYS-CONDENS MAT, V7, P6971, DOI 10.1088/0953-8984/7/35/004; MALOVICHKO GI, 1994, SOLID STATE COMMUN, V89, P195, DOI 10.1016/0038-1098(94)90681-5; FENG D, 1980, APPL PHYS LETT, V37, P607, DOI 10.1063/1.92035; SHIBATA Y, 1995, J APPL PHYS, V77, P1498, DOI 10.1063/1.358900; ASHKIN A, 1966, APPL PHYS LETT, V9, P72, DOI 10.1063/1.1754607; Wang H, 2005, PHYSICA B, V367, P53, DOI 10.1016/j.physb.2005.05.049; Wooten EL, 2000, IEEE J SEL TOP QUANT, V6, P69, DOI 10.1109/2944.826874; ABRAHAMS SC, 1966, J PHYS CHEM SOLIDS, V27, P997, DOI 10.1016/0022-3697(66)90072-2; Dudarev SL, 1998, PHYS REV B, V57, P1505, DOI 10.1103/PhysRevB.57.1505; REBOUTA L, 1991, EUROPHYS LETT, V14, P557, DOI 10.1209/0295-5075/14/6/010; Arizmendi L, 2004, PHYS STATUS SOLIDI A, V201, P253, DOI 10.1002/pssa.200303911; Bhatnagar A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3835; BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; BURNS WK, 1994, IEEE PHOTONIC TECH L, V6, P252, DOI 10.1109/68.275441; Buse K, 1997, APPL PHYS B-LASERS O, V64, P273, DOI 10.1007/s003400050175; Buse K, 1997, APPL PHYS B-LASERS O, V64, P391, DOI 10.1007/s003400050190; de Miguel-Sanz EM, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.165101; Higuchi S, 2003, JPN J APPL PHYS 2, V42, pL1066, DOI 10.1143/JJAP.42.L1066; Keune W., 1991, MAT SCI ENG B, V9, P505; KOHN W, 1965, PHYS REV, V140, P1133, DOI 10.1103/PhysRev.140.A1133; KRESSE G, 1994, PHYS REV B, V49, P14251, DOI 10.1103/PhysRevB.49.14251; Oliner A. A., 1978, ACOUSTIC SURFACE WAV; Sanson A, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.094109; Schirmer OF, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.165106; Schirmer O. F., 2009, J PHYS CONDENS MATT, V21; Seidel J, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.126805; SOTHE H, 1992, J PHYS-CONDENS MAT, V4, P9901, DOI 10.1088/0953-8984/4/49/017; Sturman B., 1990, PHOTOVOLTAIC PHOTORE; Tsukada I., 2004, JPN J APPL PHYS, V43, P5307; Wang L, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.014431; Xu HX, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.184109; Yang DS, 2009, J PHYS SOC JPN, V78, DOI 10.1143/JPSJ.78.114605; Young SM, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.116601; Zenkevich A, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.161409	50	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1862-6300	1862-6319		PHYS STATUS SOLIDI A	Phys. Status Solidi A-Appl. Mat.	DEC	2015	212	12					2968	2974		10.1002/pssa.201532398		7	Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Materials Science; Physics	CY7LM	WOS:000366589900046		
J	Widyowati, R; Sugimoto, S; Yamano, Y; Sukardiman; Otsuka, H; Matsunami, K				Widyowati, Retno; Sugimoto, Sachiko; Yamano, Yoshi; Sukardiman; Otsuka, Hideaki; Matsunami, Katsuyoshi			New cis-ent-clerodanes from Linaria japonica	PHYTOCHEMISTRY LETTERS			English	Article						Linaria japonica; Linarenone; Cytotoxicity; Leishmania; cis-ent-Clerodane	IRIDOID GLUCOSIDE; DITERPENE DIALDEHYDE; MIQ; CONSTITUENTS; LEAVES	Five new cis-ent-clerodanes, linarenones A-E (1-5) and two known compounds (6 and 7) were isolated from whole plant of Linaria japonica. The structures of these compounds were determined by various spectroscopic analyses (UV, IR, HR-ESI-MS, 1D and 2D NMR). The absolute configuration of five new diterpenoids was confirmed by circular dichroism (CD) analysis and chemical conversion. Cytotoxicity of the isolated compounds against A549 cell lines and Leishmania major were evaluated. The new cis-ent-clerodane 3 was found to be moderately active against A549 cell lines, and new cis-ent-clerodanes 1,6 and desacetyl-linarienone (7) were active against L. major. (C) 2015 Phytochemical Society of Europe. Published by Elsevier B.V. All rights reserved.	[Widyowati, Retno; Sugimoto, Sachiko; Yamano, Yoshi; Matsunami, Katsuyoshi] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Hiroshima 730, Japan; [Widyowati, Retno; Sukardiman] Airlangga Univ, Fac Pharm, Surabaya, Indonesia; [Otsuka, Hideaki] Yasuda Womens Univ, Grad Sch Pharm, Hiroshima, Japan	Matsunami, K (reprint author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Hiroshima 730, Japan.	matunami@hiroshima-u.ac.jp			JSPS KAKENHI [26460122, 00107385, 60549012]; Indonesian Directorate General of Higher Education (DIKTI)	This work was supported by JSPS KAKENHI Grant Number 26460122, 00107385 and 60549012. The authors are grateful for access to the superconducting NMR instrument, UV and ESI-MS at the Analytical Center of Molecular Medicine, the Analysis Center of Life Science and the Natural Science Center for Basic Research and Development of the Graduate School of Biomedical and Health Sciences, Hiroshima University. The authors would like to express their sincere thanks to Indonesian Directorate General of Higher Education (DIKTI) for doctoral scholarships.	Andres G., 1997, J NAT PRODUCTS, V60, P13; Wang F, 2010, CHEM PHARM BULL, V58, P1267; OTSUKA H, 1993, PHYTOCHEMISTRY, V32, P979, DOI 10.1016/0031-9422(93)85239-N; KITAGAWA I, 1980, CHEM PHARM BULL, V28, P2403; OTSUKA H, 1993, PHYTOCHEMISTRY, V33, P617, DOI 10.1016/0031-9422(93)85459-5; OTSUKA H, 1994, J NAT PROD, V57, P357, DOI 10.1021/np50105a004; Yang NY, 2010, PHYTOCHEMISTRY, V71, P1528, DOI 10.1016/j.phytochem.2010.06.008; Wang B, 2013, J NAT PROD, V76, P1573, DOI 10.1021/np400212d; MORITA N, 1974, YAKUGAKU ZASSHI, V94, P913; KITAGAWA I, 1975, TETRAHEDRON LETT, P23; MANABE S, 1986, TETRAHEDRON, V42, P3461, DOI 10.1016/S0040-4020(01)87313-0; OTSUKA H, 1992, J NAT PROD, V55, P1252, DOI 10.1021/np50087a011; KITAGAWA I, 1976, CHEM PHARM BULL, V24, P294; KITAGAWA I, 1978, CHEM PHARM BULL, V26, P79; KITAGAWA I, 1973, CHEM PHARM BULL, V21, P1978; OTSUKA H, 1994, PHYTOCHEMISTRY, V37, P461, DOI 10.1016/0031-9422(94)85080-1; OTSUKA H, 1995, PHYTOCHEMISTRY, V39, P1111, DOI 10.1016/0031-9422(95)00101-C; Kabir S, 2010, NAT PROD COMMUN, V5, P1543; Macahig RA, 2010, J NAT MED-TOKYO, V64, P1, DOI 10.1007/s11418-009-0354-4; KITAGAWA I, 1977, TETRAHEDRON LETT, P1221; KITAGAWA I, 1972, TETRAHEDRON LETT, P419; Nikolas F., 2006, BIOL PHARM BULL, V29, P1775; Wang T., 2012, J MED PLANTS RES, V26, P4259	23	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1874-3900	1876-7486		PHYTOCHEM LETT	Phytochem. Lett.	DEC	2015	14						56	62		10.1016/j.phytol.2015.09.002		7	Biochemistry & Molecular Biology; Plant Sciences	Biochemistry & Molecular Biology; Plant Sciences	CY7DV	WOS:000366569300012		
J	Pimjuk, P; Phosri, C; Wauke, T; McCloskey, S				Pimjuk, Preeyanuch; Phosri, Cherdchai; Wauke, Tsuyoshi; McCloskey, Sirirath			The isolation of two new lanostane triterpenoid derivatives from the edible mushroom Astraeus asiaticus	PHYTOCHEMISTRY LETTERS			English	Article						Astraeus asiaticus; Lanostane triterpenoid; Cytotoxic activity; Biogenesis	GENUS ASTRAEUS	Two lanostane triterpenoid derivatives, astrasiaone (2), (22S, 25R, 26R)-26-methoxy-22-26-epoxylanost-8- en-3-one, and astrasiate (3), (3 alpha, 22S, 25R)-3, 22-dihydroxylanost-8-en-26 -oate, together with six known compounds, astraodorol (1), artabotryol B (4), artabotryol C1 (5), 6-dehydrocerevisterol (6), ergosterol (7) and hypaphorine (8) were isolated from the edible mushroom Astraeus asiaticus. 3 and 4 exhibited weak cytotoxicity against KB and NCI-H187 cancer cell lines. A comparison of the structures of 2 and 3 to that of 1,4 and 5 suggest that these two new compounds could be the intermediate form that occurs during biogenesis. (C) 2015 Phytochemical Society of Europe. Published by Elsevier B.V. All rights reserved.	[Pimjuk, Preeyanuch; McCloskey, Sirirath] Khon Kaen Univ, Fac Sci, Dept Chem, Nat Prod Res Unit,Ctr Excellence Innovat Chem PER, Bangkok 40002, Thailand; [Phosri, Cherdchai] Nakhon Phanom Univ, Fac Liberal Arts & Sci, Div Sci, Nakhon Phanom 48000, Thailand; [Wauke, Tsuyoshi] Univ Ryukyus, Fac Sci, Dept Chem Biol & Marine Sci, Okinawa, Japan	McCloskey, S (reprint author), Khon Kaen Univ, Fac Sci, Dept Chem, Bangkok 40002, Thailand.	sirsod@kku.ac.th			Development and Promotion of Science and Technology Talents Project (DPST); office of the National Research Council of Thailand (NRCT); Centre of Excellence for Innovation in Chemistry (PERCH-CIC), Office of the Higher Education Commission, Ministry of Education	This work was supported by the Development and Promotion of Science and Technology Talents Project (DPST), an office of the National Research Council of Thailand (NRCT) and the Centre of Excellence for Innovation in Chemistry (PERCH-CIC), Office of the Higher Education Commission, Ministry of Education.	Andrew W.W., 2012, NEW PHYTOL, V194, P1079; Gupta C, 2010, HELV CHIM ACTA, V93, P1925, DOI 10.1002/hlca.201000102; Stanikunaite R, 2008, J NAT PROD, V71, P2077, DOI 10.1021/np800577p; Phosri C, 2007, MYCOL RES, V111, P275, DOI 10.1016/j.mycres.2007.01.004; KOPE HH, 1991, CAN J MICROBIOL, V37, P258; Fangfuk W, 2010, MYCOSCIENCE, V51, P291, DOI 10.1007/s10267-010-0039-6; Arpha K, 2012, J AGR FOOD CHEM, V60, P9834, DOI 10.1021/jf302433r; Phosri C, 2004, MYCOTAXON, V89, P453; Brien JO, 2000, EUR J BIOCHEM, V267, P5421, DOI DOI 10.1046/J.1432-1327.2000.01606.X; Dewick P.M., 2009, MED NATURAL PRODUCTS; Lee S.Y., 2010, NAT PROD RES, V25, P1304; Nasomjai P, 2014, ARCH PHARM RES, V37, P1538, DOI 10.1007/s12272-014-0393-6; Phosri C., 2014, PLOS ONE, V9, P1; Tapan K.L., 2012, CHEM BIODIVERS, V9, P1517; Phosri Cherdchai, 2013, IMA Fungus, V4, P347, DOI 10.5598/imafungus.2013.04.02.13	15	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1874-3900	1876-7486		PHYTOCHEM LETT	Phytochem. Lett.	DEC	2015	14						79	83		10.1016/j.phytol.2015.09.009		5	Biochemistry & Molecular Biology; Plant Sciences	Biochemistry & Molecular Biology; Plant Sciences	CY7DV	WOS:000366569300015		
J	Hung, LD; Hirayama, M; Ly, BM; Hori, K				Le Dinh Hung; Hirayama, Makoto; Bui Minh Ly; Hori, Kanji			Biological activity, cDNA cloning and primary structure of lectin KSA-2 from the cultivated red alga Kappaphycus striatum (Schmitz) Doty ex Silva	PHYTOCHEMISTRY LETTERS			English	Review						cDNA cloning; Kappaphucus striatum; Lectin; Antibacterial activity; Primary structure	MANNOSE-BINDING LECTIN; ANTI-HIV ACTIVITY; OSCILLATORIA-AGARDHII; CARBOHYDRATE-BINDING; INFLUENZA-VIRUSES; EUCHEUMA-SERRA; SPECIFICITY; CYANOBACTERIUM; HEMAGGLUTININ; AGGLUTININ	The red alga (Kappaphycus striatum) has been widely cultivated as a source of carrageenophytes for industry. Previously, lectin KSA-2 from this alga has been isolated and evaluated for the strictly highmannose N-glycan binding specificity. In this study, we have determined the antibacterial activities and cDNA cloning encoding lectin KSA-2. Complementary DNA (cDNA) cloning based on the rapid amplification of cDNA ends (RACE) elucidated the full-length sequence of KSA-2, which encoded a polypeptide of 269 amino acids including initiating methionine, with four tandemly repeated domains of about 67 amino acids, and sharing 45% sequence identity. The calculated molecular mass from the deduced sequence was consistent with that of natural KSA-2 (28,021.5 Da), which was determined by electron spray ionization-mass spectrometry. The primary structure of KSA-2 is highly similar to those of the high-mannose N-glycan specific lectins in lower organisms including Burkholderia oklahomensis EO147 (BOA), Myxococcus xanthus (MBHA) and Pseudomonas fluorescens Pf0-1 (PFL) from proteobacteria, Oscillatoria agardhii NIES-240 (OAA) from cyanobacterium, Eucheuma serra (ESA-2) and Eucheuma denticulatum (EDA-2) from macro red algae, indicating that they were closely related to each other. The active fraction KSA-2 inhibited the growth of human and shrimp pathogenic bacteria Enterobacter cloacae and Vibrio alginolyticus, respectively, although it did not affect the growth of Staphylococcus aureus, Escherichia coli, Vibrio parahaemolyticus and Vibrio harveyi, suggesting that KSA-2 caused the activity through binding to the target receptor(s) on the cell surface of E. cloacae and V. alginolyticus. These results indicate that the cultivated K. striatum is a good source of a lectin that may be useful as an antibacterial agents. (C) 2015 Phytochemical Society of Europe. Published by Elsevier B.V. All rights reserved.	[Le Dinh Hung; Bui Minh Ly] Vietnam Acad Sci & Technol, NhaTrang Inst Technol Res & Applicat, Nhatrang City, Vietnam; [Hirayama, Makoto; Hori, Kanji] Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima 7398528, Japan	Hung, LD (reprint author), Vietnam Acad Sci & Technol, NhaTrang Inst Technol Res & Applicat, 2A HungVuong St, Nhatrang City, Vietnam.	ledinhhungims@yahoo.co.uk			Vietnam National Foundation for Science and Technology Development (NAFOSTED) [106.05-2011.35]; Laboratory of Marine Bioresource Chemistry, Graduate School of Biosphere Sciences, Hiroshima University	This research is supported by Vietnam National Foundation for Science and Technology Development (NAFOSTED) under grant number 106.05-2011.35, and Grant-in-Aid for Scientific Research from Laboratory of Marine Bioresource Chemistry, Graduate School of Biosphere Sciences, Hiroshima University.	Sato Y, 2007, J BIOL CHEM, V282, P11021, DOI 10.1074/jbc.M701252200; Hung LD, 2015, J APPL PHYCOL, V27, P1657, DOI 10.1007/s10811-014-0441-0; Sato Y, 2011, BIOCHEM BIOPH RES CO, V405, P291, DOI 10.1016/j.bbrc.2011.01.031; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Chisholm JRM, 1996, NATURE, V381, P382, DOI 10.1038/381382a0; Cavalier-Smith T, 2000, TRENDS PLANT SCI, V5, P174, DOI 10.1016/S1360-1385(00)01598-3; Charungchitrak S, 2011, FOOD CHEM, V126, P1025, DOI 10.1016/j.foodchem.2010.11.114; Liao WR, 2003, J IND MICROBIOL BIOT, V30, P433, DOI 10.1007/s10295-003-0068-7; Hori K, 2007, GLYCOBIOLOGY, V17, P479, DOI 10.1093/glycob/cwm007; Sato Y, 2011, J BIOL CHEM, V286, P19446, DOI 10.1074/jbc.M110.216655; Koharudin LMI, 2012, J BIOL CHEM, V287, P33796, DOI 10.1074/jbc.M112.388579; Whitley MJ, 2013, FEBS J, V280, P2056, DOI 10.1111/febs.12229; Sato Y, 2015, MAR DRUGS, V13, P3454, DOI 10.3390/md13063454; Hung LD, 2011, PHYTOCHEMISTRY, V72, P855, DOI 10.1016/j.phytochem.2011.03.009; ROMEO JM, 1986, P NATL ACAD SCI USA, V83, P6332, DOI 10.1073/pnas.83.17.6332; Moreira D, 2000, NATURE, V405, P69, DOI 10.1038/35011054; Koharudin LMI, 2011, J BIOL CHEM, V286, P1588, DOI 10.1074/jbc.M110.173278; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Ask EI, 2002, AQUACULTURE, V206, P257, DOI 10.1016/S0044-8486(01)00724-4; Sato T, 2009, FISHERIES SCI, V75, P743, DOI 10.1007/s12562-009-0074-4; Santi-Gadelha T, 2006, BIOCHEM BIOPH RES CO, V350, P1050, DOI 10.1016/j.bbrc.2006.09.149; Riera AS, 2003, BIOCELL, V27, P37; Fourans A, 2004, FEMS MICROBIOL ECOL, V51, P55, DOI 10.1016/j.femsec.2004.07.012; Hung L.D., 2009, FISHERIES SCI, V75, P723; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Sato Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045922; Sharon N., 2003, LECTINS	28	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1874-3900	1876-7486		PHYTOCHEM LETT	Phytochem. Lett.	DEC	2015	14						99	105		10.1016/j.phytol.2015.09.012		7	Biochemistry & Molecular Biology; Plant Sciences	Biochemistry & Molecular Biology; Plant Sciences	CY7DV	WOS:000366569300018		
J	Shiono, Y; Koyama, H; Murayama, T; Koseki, T				Shiono, Yoshihito; Koyama, Hiromasa; Murayama, Tetsuya; Koseki, Takuya			New sesquiterpenes from the endophyte Microdiplodia sp TT-12 and their antimicrobial activity	PHYTOCHEMISTRY LETTERS			English	Article						Endophyte; Raffaelea quercivora; Microdiplodia sp TT-12; Phomadecalin; Macrophorin A	FUNGUS; WILT	Four new compounds, phomadecalin F (1), 8 alpha-monoacetoxyphomadecalin D (2), 3-epi-phomadecalin D (3), and 13-hydroxylmacrophorin A (4), were isolated from the endophyte, Microdiplodia sp. TT-12 together with two known compounds, phomadecalins C (5) and D (6). The structures of the compounds were elucidated by NMR spectroscopic and mass spectrometric analyses in combination with chemical means. The antibacterial activities of the isolated compounds were evaluated. Compound 4 was weakly active against Raffaelea quercivora. (C) 2015 Phytochemical Society of Europe. Published by Elsevier B.V. All rights reserved.	[Shiono, Yoshihito; Koyama, Hiromasa; Murayama, Tetsuya; Koseki, Takuya] Yamagata Univ, Fac Agr, Dept Food Life & Environm Sci, Tsuruoka, Yamagata 9978555, Japan	Shiono, Y (reprint author), Yamagata Univ, Fac Agr, Dept Food Life & Environm Sci, Tsuruoka, Yamagata 9978555, Japan.	yshiono@tds1.tr.yamagata-u.ac.jp			JSPS KAKENHI [24580154]	We would like to thank Professor Dr. Masaru Hashimoto and Mr. Atsushi Ito, Hirosaki University, for CD measurement. Financial assistance from 'JSPS KAKENHI Grant Numbers (24580154)' has gratefully been acknowledged.	Fang SM, 2012, MAR DRUGS, V10, P1266, DOI 10.3390/md10061266; Che YS, 2002, J NAT PROD, V65, P399, DOI 10.1021/np010519o; Kuroda K, 2001, J WOOD SCI, V47, P425, DOI 10.1007/BF00767893; Shiono Y, 2005, BIOSCI BIOTECH BIOCH, V69, P287, DOI 10.1271/bbb.69.287; BROOKS DS, 1994, BIOL CONTROL, V4, P373, DOI 10.1006/bcon.1994.1047; O'Hanlon KA, 2012, BIOL CONTROL, V63, P69, DOI 10.1016/j.biocontrol.2012.08.007; Takahashi Y, 2010, PHYTOPATHOLOGY, V100, P747, DOI 10.1094/PHYTO-100-8-0747; Fu Y, 2014, J NAT PROD, V77, P1791, DOI 10.1021/np500142g; OHTANI I, 1991, J AM CHEM SOC, V113, P4092, DOI 10.1021/ja00011a006; Haggag W.M., 2010, LIFE SCI J, V7, P69; Kubono Takanori, 2002, Mycoscience, V43, P255, DOI 10.1007/s102670200037; Zhang QH, 2014, BIOL CONTROL, V72, P98, DOI 10.1016/j.biocontrol.2014.02.018	12	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1874-3900	1876-7486		PHYTOCHEM LETT	Phytochem. Lett.	DEC	2015	14						143	147		10.1016/j.phytol.2015.10.004		5	Biochemistry & Molecular Biology; Plant Sciences	Biochemistry & Molecular Biology; Plant Sciences	CY7DV	WOS:000366569300025		
J	McGillivray, S; Murayama, K; Castel, AD				McGillivray, Shannon; Murayama, Kou; Castel, Alan D.			Thirst for Knowledge: The Effects of Curiosity and Interest on Memory in Younger and Older Adults	PSYCHOLOGY AND AGING			English	Article						memory; curiosity; interest; older adults	AGE-DIFFERENCES; EMOTIONAL MEMORY; ENHANCES MEMORY; INFORMATION; HIPPOCAMPUS; MOTIVATION; ATTENTION; RESOURCE	Given age-related memory impairments, one's level of curiosity or interest could enhance memory for certain information. In the current study, younger and older adults read trivia questions, rated how curious they were to learn each answer, provided confidence and interest ratings, and judgments of learning after learning the answer. No age-related differences in memory were found. Analyses indicated that curiosity and interest contributed to the formation of judgments of learning. Additionally, interest had a unique increasing relationship with older, but not younger, adults' memory performance after a one-week delay. The results suggest that subjective interest may serve to enhance older adults' memory.	[McGillivray, Shannon] Weber State Univ, Dept Psychol, Ogden, UT 84408 USA; [McGillivray, Shannon; Castel, Alan D.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA; [Murayama, Kou] Univ Reading, Dept Psychol, Reading RG6 2AH, Berks, England; [Murayama, Kou] Kochi Univ Technol, Res Unit Psychol Educ & Technol, Kami, Kochi, Japan	McGillivray, S (reprint author), Weber State Univ, Dept 1202, 1299 Edvalson St, Ogden, UT 84408 USA.	smcgillivray@weber.edu			National Institutes of Health (National Institute on Aging) [R01AG044335]; Marie Curie Career Integration Grant [CIG630680]; Japan Society for the Promotion of Science Kakenhi [15H05401]	We thank Kevin Pho, Alex Muro, Jenna Joske, and Michael Friedman for help with data collection. Portions of this work were presented at the 14th Biennial Cognitive Aging Conference in Atlanta, Georgia. This research was supported in part by the National Institutes of Health (National Institute on Aging), Award Number R01AG044335 (Alan D. Castel); the Marie Curie Career Integration Grant, Award Number CIG630680 (Kou Murayama); and Japan Society for the Promotion of Science Kakenhi, Grant Number 15H05401 (Kou Murayama). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Stine-Morrow EAL, 2006, PSYCHOL BULL, V132, P582, DOI 10.1037/0033-2909.132.4.582; HIDI S, 1990, REV EDUC RES, V60, P549, DOI 10.3102/00346543060004549; Isaacowitz DM, 2006, PSYCHOL AGING, V21, P40, DOI 10.1037/0882-7974.21.1.40; Kang MJ, 2009, PSYCHOL SCI, V20, P963, DOI 10.1111/j.1467-9280.2009.02402.x; Castel AD, 2013, PSYCHOL AGING, V28, P232, DOI 10.1037/a0030678; Germain CM, 2007, AGING NEUROPSYCHOL C, V14, P462, DOI 10.1080/13825580600611302; HULTSCH DF, 1983, EXP AGING RES, V9, P17; Hamann S, 2001, TRENDS COGN SCI, V5, P394, DOI 10.1016/S1364-6613(00)01707-1; Hines JC, 2009, PSYCHOL AGING, V24, P462, DOI 10.1037/a0014417; Mather M, 2005, PSYCHOL AGING, V20, P554, DOI 10.1037/0882-7974.20.4.554; Murayama K, 2011, COGNITION, V119, P120, DOI 10.1016/j.cognition.2011.01.001; Mather M, 2005, TRENDS COGN SCI, V9, P496, DOI 10.1016/j.tics.2005.08.005; Hess TM, 2001, PSYCHOL AGING, V16, P629, DOI 10.1037//0882-7974.16.4.629; Meyer BJF, 1998, EDUC GERONTOL, V24, P747, DOI 10.1080/0360127980240803; Murayama K, 2014, J EXP PSYCHOL LEARN, V40, P1287, DOI 10.1037/a0036914; Hess TM, 2009, J GERONTOL B-PSYCHOL, V64, P447, DOI 10.1093/geronb/gbp020; Higgins ET, 2010, J PERS SOC PSYCHOL, V98, P559, DOI 10.1037/a0018833; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Hertzog C, 2010, DEV PSYCHOL, V46, P939, DOI 10.1037/a0019812; Hertzog C, 2011, CURR DIR PSYCHOL SCI, V20, P167, DOI 10.1177/0963721411409026; McDaniel MA, 2000, J EDUC PSYCHOL, V92, P492, DOI 10.1037//0022-0663.92.3.492; Stine-Morrow EAL, 2006, PSYCHOL AGING, V21, P790, DOI 10.1037/0882-7974.21.4.790; Hidi S, 2001, EDUC PSYCHOL REV, V13, P191, DOI 10.1023/A:1016667621114; Mather M, 2003, PSYCHOL SCI, V14, P409, DOI 10.1111/1467-9280.01455; Butterfield B, 2006, METACOGNITION LEARNI, V1, P69, DOI DOI 10.1007/S11409-006-6894-Z; Castel A. D., 2008, PSYCHOL LEARN MOTIV, V48, P225, DOI DOI 10.1016/S0079-7421(07)48006-9; Craik F. I. M., 1982, AGING COGNITIVE PROC, V191-211; Craik F. I. M., 2008, HDB AGING COGNITION; Gruber MJ, 2014, NEURON, V84, P486, DOI 10.1016/j.neuron.2014.08.060; KENNY DA, 1985, J PERS SOC PSYCHOL, V48, P339, DOI 10.1037//0022-3514.48.2.339; Middlebrooks C. D., J GERONTOLOGY PSYCHO; Raudenbush S. W., 2002, HIERARCHICAL LINEAR; Renninger A., 2011, ED PSYCHOL, V46, P168; Spaniol J., 2014, PSYCHOL SCI, V69, P730; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Zacks R. T., 2006, LIFESPAN COGNITION M, P162, DOI DOI 10.1093/ACPROF:OSO/9780195169539.003.0011	36	0	0	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0882-7974	1939-1498		PSYCHOL AGING	Psychol. Aging	DEC	2015	30	4					835	841		10.1037/a0039801		7	Gerontology; Psychology, Developmental	Geriatrics & Gerontology; Psychology	CZ0TY	WOS:000366820100009		
J	Hayes, T; Usami, S; Jacobucci, R; McArdle, JJ				Hayes, Timothy; Usami, Satoshi; Jacobucci, Ross; McArdle, John J.			Using Classification and Regression Trees (CART) and Random Forests to Analyze Attrition: Results From Two Simulations	PSYCHOLOGY AND AGING			English	Article						missing data analysis; attrition; machine learning; classification and regression trees (CART); longitudinal data analysis	STRUCTURAL EQUATION MODELS; MAXIMUM-LIKELIHOOD-ESTIMATION; MISSING-DATA; WEIGHTS; LONELINESS; INFERENCE	In this article, we describe a recent development in the analysis of attrition: using classification and regression trees (CART) and random forest methods to generate inverse sampling weights. These flexible machine learning techniques have the potential to capture complex nonlinear, interactive selection models, yet to our knowledge, their performance in the missing data analysis context has never been evaluated. To assess the potential benefits of these methods, we compare their performance with commonly employed multiple imputation and complete case techniques in 2 simulations. These initial results suggest that weights computed from pruned CART analyses performed well in terms of both bias and efficiency when compared with other methods. We discuss the implications of these findings for applied researchers.	[Hayes, Timothy; Jacobucci, Ross; McArdle, John J.] Univ So Calif, Dept Psychol, Los Angeles, CA 90089 USA; [Usami, Satoshi] Univ Tsukuba, Dept Psychol, Tsukuba, Ibaraki 305, Japan	McArdle, JJ (reprint author), Univ So Calif, Dept Psychol, 3620 South McClintock Ave,Seeley G Mudd SGM 501, Los Angeles, CA 90089 USA.	jmcardle@usc.edu					Aiken L. S., 1991, MULTIPLE REGRESSION; ANDERSON TW, 1957, J AM STAT ASSOC, V52, P200, DOI 10.2307/2280845; Stapleton LA, 2002, STRUCT EQU MODELING, V9, P475, DOI 10.1207/S15328007SEM0904_2; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581; MORGAN JN, 1963, J AM STAT ASSOC, V58, P415, DOI 10.2307/2283276; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; MUTHEN B, 1987, PSYCHOMETRIKA, V52, P431, DOI 10.1007/BF02294365; Enders CK, 2001, PSYCHOL METHODS, V6, P352, DOI 10.1037//1082-989X.6.4.352; Asparouhov T, 2005, STRUCT EQU MODELING, V12, P411, DOI 10.1207/s15328007sem1203_4; POTTHOFF RF, 1992, J AM STAT ASSOC, V87, P383, DOI 10.2307/2290269; Hawkley LC, 2011, PSYCHOPHYSIOLOGY, V48, P1134, DOI 10.1111/j.1469-8986.2011.01185.x; Enders CK, 2001, STRUCT EQU MODELING, V8, P128, DOI 10.1207/S15328007SEM0801_7; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1023/A:1018054314350; Strobl C, 2009, PSYCHOL METHODS, V14, P323, DOI 10.1037/a0016973; Lee BK, 2010, STAT MED, V29, P337, DOI 10.1002/sim.3782; BRODLEY CE, 1995, MACH LEARN, V19, P45, DOI 10.1007/BF00994660; Collins LM, 2001, PSYCHOL METHODS, V6, P330, DOI 10.1037//1082-989X.6.4.330; De'Ath G, 2002, ECOLOGY, V83, P1105, DOI 10.2307/3071917; MCARDLE JJ, 1992, EXP AGING RES, V18, P145; Hawkley LC, 2010, PSYCHOL AGING, V25, P132, DOI 10.1037/a0017805; Graham JW, 2003, STRUCT EQU MODELING, V10, P80, DOI 10.1207/S15328007SEM1001_4; Arbuckle J. N, 1996, ADV STRUCTURAL EQUAT, P243; Berk R. A, 2009, STAT LEARNING REGRES; Breiman L., 1984, CLASSIFICATION REGRE, V19; COHEN S, 1988, CLAR SYMP, P31; Cohen S., 2008, BASIC PSYCHOMETRICS; Enders C. K., 2010, APPL MISSING DATA AN; Graham J. W., 1999, STAT STRATEGIES SMAL, V1, P1; van Buuren S, 2011, J STAT SOFTW, V45, P1; Hallquist M., 2014, MPLUSAUTOMATION AUTO; Hastie T, 2009, ELEMENTS STAT LEARNI; Hawkley LC, 2008, J GERONTOL B-PSYCHOL, V63, pS375; Kish L, 1995, J OFF STAT, V11, P55; Liaw A., 2002, R NEWS, V2, P12; Louppe G., 2014, THESIS; McArdle J. J., 2013, CONT ISSUES EXPLORAT, P282; Muthen L. K., 2011, MPLUS USERS GUIDE; Ripley B., 2014, PACKAGE TREE; Rogosa D., 1995, ANAL CHANGE, P3; Rubin D. B., 1987, MULTIPLE IMPUTATION; Shadish W. R., 2002, EXPT QUASIEXPERIMENT; Therneau T., 2014, RPART RECURSIVE PART	42	0	0	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0882-7974	1939-1498		PSYCHOL AGING	Psychol. Aging	DEC	2015	30	4					911	929		10.1037/pag0000046		19	Gerontology; Psychology, Developmental	Geriatrics & Gerontology; Psychology	CZ0TY	WOS:000366820100016		
J	Kobayashi, E; Liang, J; Sugawara, I; Fukaya, T; Shinkai, S; Akiyama, H				Kobayashi, Erika; Liang, Jersey; Sugawara, Ikuko; Fukaya, Taro; Shinkai, Shoji; Akiyama, Hiroko			Associations Between Social Networks and Life Satisfaction Among Older Japanese: Does Birth Cohort Make a Difference?	PSYCHOLOGY AND AGING			English	Article						birth cohort; age differences; subjective well-being; social relationship; gender	UNITED-STATES; GENDER-DIFFERENCES; AGE; SUPPORT; DEPRESSION; HEALTH; PERIOD; ADULTS; MODERATOR; HAPPINESS	Japanese older people experienced drastic changes in family structure and values after World War II at different life stages by birth cohorts. We examined how linkages between different types of social ties and life satisfaction (LS) vary across cohorts, in conjunction with age and survey year differences. Data from face-to-face interviews conducted in 1987, 1999, and 2012 with a nationally representative sample of older Japanese (N = 4,917) were analyzed. The participants were members of 4 birth cohorts (C1: 1901-1912, C2: 1913-1924, C3: 1925-1936, C4: 1937-1949), categorized into 6 groups based on cohort and age at time of measurement (young-old [YO]: 63-74; old-old [OO]: 75-86): C1OO, C2YO, C2OO, C3YO, C3OO, and C4YO. Effects of social networks on LS among the 6 groups were compared simultaneously and separately by gender using the Amos software. There were significant cohort variations in the linkages between family network and LS. The positive association between being married and LS was stronger for later cohorts (C3, C4) among men, whereas that of co-residence with a child and LS was stronger for the earlier cohorts (C1, C2) among women. Moreover, the positive association between meeting with nonfamily members and LS increased from 1987 to 2012 among women, indicating a period effect over a cohort effect. The effects of being married and participation in community groups on LS also changed with age. Our results suggest that linkages between social relations and LS should be interpreted within the context of individual and social changes over time.	[Kobayashi, Erika; Fukaya, Taro; Shinkai, Shoji] Tokyo Metropolitan Inst Gerontol, Tokyo, Japan; [Liang, Jersey] Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA; [Sugawara, Ikuko; Akiyama, Hiroko] Univ Tokyo, Inst Gerontol, Tokyo 1138654, Japan	Kobayashi, E (reprint author), Tokyo Metropolitan Inst Gerontol, Itabashi Ku, 35-2 Sakae Cho, Tokyo, Japan.	erikak@tmig.or.jp			JSPS (Japan Society for the Promotion of Science) KAKENHI [23243062]	This research was supported by JSPS (Japan Society for the Promotion of Science) KAKENHI Grant 23243062.	Ajrouch K. J., 2007, NEW DYNAMICS OLD AGE, P43; Blanchflower DG, 2008, SOC SCI MED, V66, P1733, DOI 10.1016/j.socscimed.2008.01.030; ROSS CE, 1990, J MARRIAGE FAM, V52, P1059, DOI 10.2307/353319; Li LW, 2007, PSYCHOL AGING, V22, P386, DOI 10.1037/0882-7974.22.2.386; Yang Y, 2008, AM SOCIOL REV, V73, P204; LEE GR, 1987, RES AGING, V9, P459, DOI 10.1177/0164027587094001; UMBERSON D, 1992, J HEALTH SOC BEHAV, V33, P10, DOI 10.2307/2136854; Okabayashi H, 2014, AGING MENT HEALTH, V18, P59, DOI 10.1080/13607863.2013.788997; Yang Y, 2007, J HEALTH SOC BEHAV, V48, P16; McPherson M, 2006, AM SOCIOL REV, V71, P353; Gerstorf D, 2010, PSYCHOL AGING, V25, P477, DOI 10.1037/a0017543; Koyano W, 1996, AUST J AGEING, V15, P51, DOI 10.1111/j.1741-6612.1996.tb00203.x; Gana K, 2013, J GERONTOL B-PSYCHOL, V68, P540, DOI 10.1093/geronb/gbs093; Suanet B, 2013, J GERONTOL B-PSYCHOL, V68, P633, DOI 10.1093/geronb/gbt043; RYDER NB, 1965, AM SOCIOL REV, V30, P843, DOI 10.2307/2090964; PALMORE E, 1978, SOC FORCES, V57, P282; Okabayashi H, 2004, SOC SCI MED, V59, P2259, DOI 10.1016/j.socscimed.2004.02.024; Diener E, 1999, PSYCHOL BULL, V125, P276, DOI 10.1037/0033-2909.125.2.276; Sugisawa H, 2002, J SOC ISSUES, V58, P785, DOI 10.1111/1540-4560.00290; Gerstorf D, 2008, PSYCHOL AGING, V23, P154, DOI 10.1037/0882-7974.23.1.154; DEAN A, 1990, J HEALTH SOC BEHAV, V31, P148, DOI 10.2307/2137169; Stone AA, 2010, P NATL ACAD SCI USA, V107, P9985, DOI 10.1073/pnas.1003744107; NEUGARTEN BL, 1961, J GERONTOL, V16, P134; Pinquart M, 2000, PSYCHOL AGING, V15, P187, DOI 10.1037//0882-7974.15.2.187; Takagi E, 2011, DEMOGRAPHY, V48, P1559, DOI 10.1007/s13524-011-0053-0; RILEY MW, 1978, DAEDALUS, V107, P39; Litwin H, 2013, AGEING SOC, V33, P1263, DOI 10.1017/S0144686X12000645; Oishi S, 1999, J PERS, V67, P157, DOI 10.1111/1467-6494.00051; Ryan RM, 2001, ANNU REV PSYCHOL, V52, P141, DOI 10.1146/annurev.psych.52.1.141; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; PETERS GR, 1987, RES AGING, V9, P392, DOI 10.1177/0164027587093004; GEORGE LK, 1985, RES AGING, V7, P209, DOI 10.1177/0164027585007002004; BLANCHARD RD, 1977, SOCIO ECON PLAN SCI, V11, P137, DOI 10.1016/0038-0121(77)90032-5; Goss KA, 1999, NONPROF VOLUNT SEC Q, V28, P378, DOI 10.1177/0899764099284002; Mroczek DK, 2005, J PERS SOC PSYCHOL, V88, P189, DOI 10.1037/0022-3514.88.1.189; Yang Y, 2009, SOC FORCES, V87, P2093; Huxhold O, 2014, J GERONTOL B-PSYCHOL, V69, P366, DOI 10.1093/geronb/gbt029; Baird BM, 2010, SOC INDIC RES, V99, P183, DOI 10.1007/s11205-010-9584-9; Van Groenou MB, 2010, AGEING SOC, V30, P445, DOI 10.1017/S0144686X09990638; ANTONUCCI TC, 1987, SEX ROLES, V17, P737, DOI 10.1007/BF00287685; ARLING G, 1976, J MARRIAGE FAM, V38, P757, DOI 10.2307/350695; Burgess E. W., 1971, FAMILY TRADITIONAL C; Cabinet Office Government of Japan, 2011, DAI 7 KAI KOUR SHA S; Cabinet Office Government of Japan, 2013, SHOUSH KA TAIS HAK; Cantor M. H., 1979, RES AGING, V1, P434, DOI 10.1177/016402757914002; Carstensen L., 1991, ANN REV GERONTOLOGY, V11, P195; CARSTENSEN L, 1997, ANN REV GERONTOLOGY, V0017; Fischer C. S., 1982, DWELL FRIENDS PERSON; George L. K., 1981, ANN REV GERONTOLOGY, V2, P345; Goode W. J., 1963, WORLD REVOLUTION FAM; Hareven T. K., 1996, ENCY GERONTOLOGY, V2, P31; HARINGHIDORE M, 1985, J MARRIAGE FAM, V47, P947, DOI 10.2307/352338; Kobayashi E., 2011, SHAKAIGAKU HYORON, V62, P356; LARSON R, 1978, J GERONTOL, V33, P109; Larson R, 1986, Psychol Aging, V1, P117, DOI 10.1037//0882-7974.1.2.117; LIANG J, 1984, J GERONTOL, V39, P613; Ministry of Health Labor and Welfare, 2014, HEIS 25 NEN KOK SEIK; Ogburn W. F., 1933, RECENT SOCIAL TRENDS, V1, P661; Oshio Takashi, 2012, J Cross Cult Gerontol, V27, P259, DOI 10.1007/s10823-012-9169-y; POHJOLAINEN P, 1991, Journal of Cross-Cultural Gerontology, V6, P109, DOI 10.1007/BF00117115; Putnam Robert D., 2000, BOWLING ALONE COLLAP; Raymo J. M., 2003, DEMOGRAPHIC CHANGE F, P27; Raymo JM, 2008, J POPUL RES CANBERRA, V25, P379, DOI [10.1007/bf03033896, DOI 10.1007/BF03033896]; Shishido K., 2011, SHAKAIGAKU HYORON, V62, P336; Siedlecki K. L., 2008, J POSIT PSYCHOL, V<IT>3</IT>, P153, DOI DOI 10.1080/17439760701834602; Statistics Bureau Ministry of Internal Affairs and Communications, 2012, HIST STAT JAP; Statistics Bureau Ministry of Internal Affairs and Communications, 2011, HEIS 22 NEN KOK CHOS; Sugihara Y, 2008, J GERONTOL B-PSYCHOL, V63, P227, DOI DOI 10.1093/GERONB/63.4.P227; Yamada M., 1998, JAPANESE FAMILY TRAN	69	0	0	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0882-7974	1939-1498		PSYCHOL AGING	Psychol. Aging	DEC	2015	30	4					952	966		10.1037/pag0000053		15	Gerontology; Psychology, Developmental	Geriatrics & Gerontology; Psychology	CZ0TY	WOS:000366820100019		
J	Takamizawa, S; Gomi, H; Shimizu, Y; Isono, H; Shirokawa, T; Kato, M				Takamizawa, S.; Gomi, H.; Shimizu, Y.; Isono, H.; Shirokawa, T.; Kato, M.			Leptospirosis and Jarisch-Herxheimer reaction	QJM-AN INTERNATIONAL JOURNAL OF MEDICINE			English	Editorial Material									[Takamizawa, S.; Shimizu, Y.; Isono, H.; Shirokawa, T.; Kato, M.] Univ Tsukuba, Mito Kyodo Gen Hosp, Dept Med, Mito, Ibaraki 3100015, Japan; [Gomi, H.; Shirokawa, T.] Univ Tsukuba, Mito Kyodo Gen Hosp, Ctr Global Hlth, Mito, Ibaraki 3100015, Japan	Gomi, H (reprint author), Univ Tsukuba, Mito Kyodo Gen Hosp, Ctr Global Hlth, 3-2-7 Miyamachi, Mito, Ibaraki 3100015, Japan.	hgomi-oky@umin.org					Narita M, 2005, AM J TROP MED HYG, V73, P652; Guerrier G, 2013, PLOS ONE; Infectious Disease Surveillance Center Okinawa, INC LEPT	3	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1460-2725	1460-2393		QJM-INT J MED	QJM-An Int. J. Med.	DEC 1	2015	108	12					967	968		10.1093/qjmed/hcv077		2	Medicine, General & Internal	General & Internal Medicine	CY7KO	WOS:000366587500009		
J	Okamoto, T; Fujii, M; Furusawa, H; Tsuchiya, K; Miyazaki, Y; Inase, N				Okamoto, Tsukasa; Fujii, Mayumi; Furusawa, Haruhiko; Tsuchiya, Kimitake; Miyazaki, Yasunari; Inase, Naohiko			The usefulness of KL-6 and SP-D for the diagnosis and management of chronic hypersensitivity pneumonitis	RESPIRATORY MEDICINE			English	Article						Hypersensitivity pneumonitis; Idiopathic pulmonary fibrosis; Krebs von den Lungen-6; Surfactant protein D; Acute exacerbation	IDIOPATHIC PULMONARY-FIBROSIS; BIRD FANCIERS LUNG; SURFACTANT-PROTEIN-D; HUMAN MUC1 MUCIN; ACUTE EXACERBATION; INTERSTITIAL PNEUMONIA; CIRCULATING KL-6; CLINICAL-FEATURES; DISEASES; CLASSIFICATION	Background: It is believed that Krebs von den Lungen-6 (KL-6) and surfactant protein D (SP-D) are useful biomarkers for the diagnosis of various types of interstitial lung diseases, including hypersensitivity pneumonitis (HP). The clinical features of chronic HP are similar to those of idiopathic interstitial pneumonias, especially idiopathic pulmonary fibrosis (IPF). Objective: We sought to clarify the usefulness of serum KL-6 and SP-D for the diagnosis and management of chronic HP. Methods: We examined serum KL-6 and SP-D levels and retrospectively evaluated the clinical parameters of acute HP (n = 35), chronic HP (n = 57), IPF (n = 54), collagen vascular disease-associated interstitial pneumonia (CVD-IP) (n = 67), and sarcoidosis (n = 47). We analyzed the relations between the two biomarkers and clinical data in chronic HP. Results: Serum KL-6 and SP-D levels in acute HP (2710 U/ml and 338 ng/ml, median) and chronic HP (1500 U/ml and 264 ng/ml, median) were significantly higher than in IPF, CVD-IP, and sarcoidosis. The area under the curve (AUC) values for serum KL-6 and SP-D between chronic HP and IPF were 0.771 and 0.729, respectively. Serum KL-6 levels in chronic HP were significantly higher during episodes of acute exacerbation than 1 month before acute exacerbation. The serum KL-6 levels had correlations with serum SP-D and the percentage of lymphocytes in bronchoalveolar lavage fluid. Conclusions: Serum KL-6 and SP-D levels are useful for the diagnosis and management of chronic HP. (C) 2015 Elsevier Ltd. All rights reserved.	[Okamoto, Tsukasa; Furusawa, Haruhiko; Tsuchiya, Kimitake; Miyazaki, Yasunari; Inase, Naohiko] Tokyo Med & Dent Univ, Dept Resp Med, Bunkyo Ku, Tokyo 1138519, Japan; [Fujii, Mayumi] Soka Municipal Hosp, Dept Resp Med, Soka City, Saitama 3408560, Japan	Okamoto, T (reprint author), Tokyo Med & Dent Univ, Dept Resp Med, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	tokamoto.pulm@tmd.ac.jp; mayumi-f@fk9.so-net.ne.jp; hfurusawa.pulm@tmd.ac.jp; tsucpulm@tmd.ac.jp; miyazaki.pilm@tmd.ac.jp; ninase.pulm@tmd.ac.jp			Practical Research Project for Rare Intractable Diseases from Japan Agency for Medical Research and Development, AMED [15Aek0109064H0002]; Ministry of Health, Labour and Welfare of Japan [H26-065]	This research is partially supported by the Practical Research Project for Rare Intractable Diseases from Japan Agency for Medical Research and Development (15Aek0109064H0002), AMED. This study is partially supported by a grant from the Ministry of Health, Labour and Welfare of Japan (H26-065) awarded to the Study Group on Diffuse Pulmonary Disorders, Scientific Research/Research on intractable diseases.	American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias, 2002, AM J RESP CRIT CARE, V165, P277; Fukaya S, 2000, RHEUMATOL INT, V19, P223, DOI 10.1007/s002960000064; Park IN, 2007, CHEST, V132, P214, DOI 10.1378/chest.07-0323; Kim DS, 2006, EUR RESPIR J, V27, P143, DOI 10.1183/00936.06.00114004; Takahashi T, 2000, CHEST, V118, P445, DOI 10.1378/chest.118.2.445; Janssen R, 2005, SARCOIDOSIS VASC DIF, V22, P51; Trahan S, 2008, CHEST, V134, P126, DOI 10.1378/chest.08-0033; Lacasse Y, 2009, INT ARCH ALLERGY IMM, V149, P161, DOI 10.1159/000189200; Satoh H, 2006, J INTERN MED, V260, P429, DOI 10.1111/j.1365-2796.2006.01704.x; Ohtani Y, 2003, ANN ALLERG ASTHMA IM, V90, P604; Collard HR, 2010, AM J PHYSIOL-LUNG C, V299, pL3, DOI 10.1152/ajplung.90637.2008; [Anonymous], 1999, SARCOIDOSIS VASC DIF; Inase N, 2007, SARCOIDOSIS VASC DIF, V24, P141; Takemura T, 2012, HISTOPATHOLOGY, V61, P1026, DOI 10.1111/j.1365-2559.2012.04322.x; Churg A, 2006, AM J SURG PATHOL, V30, P201, DOI 10.1097/01.pas.0000184806.38037.3c; Miyazaki Y, 2008, CHEST, V134, P1265, DOI 10.1378/chest.08-0866; Collard HR, 2007, AM J RESP CRIT CARE, V176, P636, DOI 10.1164/rccm.200703-463PP; Ohtani Y, 2005, THORAX, V60, P665, DOI 10.1136/thx.2004.027326; Ohtani Y, 2002, AM J MED, V112, P588, DOI 10.1016/S0002-9343(02)01030-6; Kakugawa T, 2013, CELL STRESS CHAPERON, V18, P581, DOI 10.1007/s12192-013-0411-5; Hirasawa Y, 1997, AM J RESP CELL MOL, V17, P501; Parambil JG, 2005, CHEST, V128, P3310, DOI 10.1378/chest.128.5.3310; Yoshizawa Y, 1999, J ALLERGY CLIN IMMUN, V103, P315, DOI 10.1016/S0091-6749(99)70507-5; Oyama T, 1997, LUNG, V175, P379, DOI 10.1007/PL00007584; BRAUN SR, 1979, AM REV RESPIR DIS, V119, P185; Ohnishi H, 2003, THORAX, V58, P872, DOI 10.1136/thorax.58.10.872; HONDA Y, 1995, AM J RESP CRIT CARE, V152, P1860; Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST; Yokoyama A, 2006, RESPIROLOGY, V11, P164, DOI 10.1111/j.1440-1843.2006.00834.x; Takahashi H, 2006, RESPIROLOGY, V11, pS51, DOI 10.1111/j.1440-1843.2006.00809.x; Yokoyama A, 1998, AM J RESP CRIT CARE, V158, P1680; Ohnishi H, 2002, AM J RESP CRIT CARE, V165, P378; Yoshikawa S, 2006, INTERNAL MED, V45, P537, DOI 10.2169/internalmedicine.45.1646; Takahashi H, 2000, AM J RESP CRIT CARE, V162, P1109; KOHNO N, 1989, CHEST, V96, P68, DOI 10.1378/chest.96.1.68; Ohnishi H, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-129; Okamoto T., 2015, SARCOIDOSIS VASC DIF, V31, P364; Okamoto Tsukasa, 2013, Respir Investig, V51, P191, DOI 10.1016/j.resinv.2013.03.004; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL	39	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0954-6111	1532-3064		RESP MED	Respir. Med.	DEC	2015	109	12					1576	1581		10.1016/j.rmed.2015.10.005		6	Cardiac & Cardiovascular Systems; Respiratory System	Cardiovascular System & Cardiology; Respiratory System	CY7EL	WOS:000366571000012		
J	Rubtsov, NB; Karamysheva, TV; Bogdanov, AS; Kartavtseva, IV; Bochkarev, MN; Iwasa, MA				Rubtsov, N. B.; Karamysheva, T. V.; Bogdanov, A. S.; Kartavtseva, I. V.; Bochkarev, M. N.; Iwasa, M. A.			Comparative analysis of DNA homology in pericentric regions of chromosomes of wood mice from genera Apodemus and Sylvaemus	RUSSIAN JOURNAL OF GENETICS			English	Article						fluorescent in situ hybridization (FISH); heterochromatin; DNA repeats; evolution; pericentric chromosomal regions	COMPARATIVE FISH ANALYSIS; FIELD-MOUSE; PENINSULAE RODENTIA; GENUS APODEMUS; URALENSIS RODENTIA; GENETIC-VARIATION; B-CHROMOSOMES; MURIDAE; ARGENTEUS; EVOLUTION	In the present study, an analysis of the DNA homology of the pericentric chromosomal regions and pericentric heterochromatin in distantly related species of wood mice (species from the Apodemus genus, as well as from the Apodemus and Sylvaemus genera) was conducted by fluorescent in situ hybridization (FISH) of microdissected DNA probes obtained from the corresponding chromosomal regions of these species. Cross-hybridization of microdissected DNA probes obtained from pericentric C-positive blocks of chromosomes of Sylvaemus species with chromosomes of Apodemus species, as well as DNA probes from pericentric C-positive blocks of chromosomes of Apodemus species with chromosomes of Apodemus and Sylvaemus species, showed that DNA repeats homologous to the pericentric regions in other species represented dispersed repeats in C-negative chromosomal regions, as well as in several regions bordering pericentric Cpositive and C-negative regions in sex chromosomes and autosomes and in distal regions of the long arms of several autosomes. The results indicate that the level of DNA homology in pericentric chromosomal regions decreases with an increase in the differentiation level and a decrease in the relationship between the compared forms and species of wood mice. Most likely, degeneration of the DNA repeats is accompanied by a gradual destruction of repeat clusters and their replacement by new, nonhomologous repeats in almost all pericentric regions (some old repetitive sequences might be "extruded" into interstitial or telomeric regions of chromosomes). These processes, which are observed in some species from Sylvaemus genus, in distantly related species of Sylvaemus and Apodemus genera have almost achieved the final stages.	[Rubtsov, N. B.; Karamysheva, T. V.; Bochkarev, M. N.] Russian Acad Sci, Siberian Branch, Inst Cytol & Genet, Novosibirsk 630090, Russia; [Rubtsov, N. B.] Novosibirsk State Univ, Dept Cytol & Genet, Novosibirsk 630090, Russia; [Bogdanov, A. S.] Russian Acad Sci, NK Koltsov Dev Biol Inst, Moscow 119334, Russia; [Kartavtseva, I. V.] Russian Acad Sci, Inst Biol & Soil Sci, Far Eastern Branch, Vladivostok 690022, Russia; [Iwasa, M. A.] Nihon Univ, Fujisawa, Kanagawa 2528510, Japan	Rubtsov, NB (reprint author), Russian Acad Sci, Siberian Branch, Inst Cytol & Genet, Novosibirsk 630090, Russia.	rubt@bionet.nsc.ru; bogdalst@yahoo.com; irina-kar52@rambler.ru; iwasa.masahiro@nihon-u.ac.jp			Russian Foundation for Basic Research [14-04-00086a, 14-04-00785a, 15-04-03871a];  [VI.53.1.4]	This study was supported by the Russian Foundation for Basic Research (project no. 14-04-00086a, 14-04-00785a, 15-04-03871a), as well as by the budget project VI.53.1.4.	Abe Syuiti, 1997, Chromosome Science, V1, P7; HIRAI H, 1980, J FAC AGR KYUSHU U, V25, P1; Kartavtseva IV, 2000, RUSS J GENET+, V36, P162; Suzuki H, 2003, BIOL J LINN SOC, V80, P469, DOI 10.1046/j.1095-8312.2003.00253.x; Karamysheva TV, 2010, RUSS J GENET+, V46, P712, DOI 10.1134/S1022795410060128; Fukushi D, 2001, CYTOGENET CELL GENET, V92, P254, DOI 10.1159/000056913; FUKUOKA H, 1979, P JPN ACAD B-PHYS, V55, P492, DOI 10.2183/pjab.55.492; Michaux JR, 2002, MOL PHYLOGENET EVOL, V23, P123, DOI 10.1016/S1055-7903(02)00007-6; SAITOH M, 1986, ZOOL SCI, V3, P785; RADZHABLI SI, 1979, DOKL AKAD NAUK SSSR+, V248, P979; Matsubara K, 2004, CHROMOSOME RES, V12, P383, DOI 10.1023/B:CHRO.0000034103.05528.83; Bogdanov AS, 2005, RUSS J GENET+, V41, P1123, DOI 10.1007/s11177-005-0209-3; Rubtsov NB, 2005, BIOL MEMBRANY, V22, P196; Filippucci MG, 2002, BIOL J LINN SOC, V75, P395, DOI 10.1046/j.1095-8312.2002.00032.x; VOLOBUEV VT, 1980, GENETIKA+, V16, P1277; SAITOH M, 1989, ZOOL SCI, V6, P1005; HIRNING U, 1989, CHROMOSOMA, V98, P450, DOI 10.1007/BF00292791; YOSHIDA MC, 1975, GENETICA, V45, P397, DOI 10.1007/BF01772867; Serizawa K, 2000, BIOCHEM GENET, V38, P27, DOI 10.1023/A:1001828203201; Rubtsov NB, 2011, RUSS J GENET+, V47, P1096, DOI 10.1134/S1022795411090158; Kuznetsova I, 2006, CYTOGENET GENOME RES, V112, P248, DOI 10.1159/000089878; Bogdanov AS, 2012, RUSS J GENET+, V48, P186, DOI 10.1134/S1022795412020044; BORISOV YM, 1990, GENETIKA+, V26, P1484; VUJOSEVIC M, 1984, Z SAUGETIERKD, V49, P234; Borisov Yu.M., 1980, IZV SIB OTD AKAD N B, V15, P61; Chelomina G.N., 2005, LESNYE POLEVYE MYSHI; Corbet G.B., 1992, MAMMALS INDOMALAYAN; Corbet G.B., 1978, MAMMALS PALAEARCTIC; Kartavtseva I.V., 2002, KARIOSISTEMATIKA LES; KOBAYASHI T, 1971, Annotationes Zoologicae Japonenses, V44, P236; LUNGEANU A, 1986, Travaux du Museum d'Histoire Naturelle "Grigore Antipa", V28, P267; MEZHZHERIN S V, 1991, Tsitologiya i Genetika, V25, P51; Mezhzherin S.V., 1997, RUSS J GENET, V33, P65; Mezhzherin S.V., 1997, Vestnik Zoologii, V31, P29; Musser G. G., 1996, BONNER ZOOL BEITR, V46, P143; Musser G.G., 2005, MAMMAL SPECIES WORLD, P894; Obara Yoshitaka, 1997, Chromosome Science, V1, P1; Ostromyshenskii D.I., 2015, CELL TISSUE BIOL, V9, P217; Pavlinov I.Ya., 1995, MLEKOPITAYUSHCHIE EV, V1; Pavlinov I.Ya., 2012, MLEKOPITAYUSHCHIE RO; Rubtsov NB, 2015, RUSS J GENET+, V51, P278, DOI 10.1134/S1022795415030114	41	0	0	MAIK NAUKA/INTERPERIODICA/SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013-1578 USA	1022-7954	1608-3369		RUSS J GENET+	Russ. J. Genet.	DEC	2015	51	12					1233	1242		10.1134/S1022795415120091		10	Genetics & Heredity	Genetics & Heredity	CY8EF	WOS:000366640900010		
J	Sugime, Y; Ogawa, K; Watanabe, D; Shimoji, H; Koshikawa, S; Miura, T				Sugime, Yasuhiro; Ogawa, Kota; Watanabe, Dai; Shimoji, Hiroyuki; Koshikawa, Shigeyuki; Miura, Toru			Expansion of presoldier cuticle contributes to head elongation during soldier differentiation in termites	SCIENCE OF NATURE			English	Article						Termite; Soldier differentiation; Presoldier; Cuticle; Intermoult	DAMP-WOOD TERMITE; HODOTERMOPSIS-JAPONICA ISOPTERA; ZOOTERMOPSIS-NEVADENSIS ISOPTERA; PRORHINOTERMES-SIMPLEX ISOPTERA; JUVENILE-HORMONE ANALOG; CASTE DIFFERENTIATION; NASUTE TERMITE; FRONTAL GLAND; TERMOPSIDAE; MORPHOGENESIS	In termites, the soldier caste possesses morphological features suitable for colony defence, despite some exceptions. Soldiers are differentiated via two moultings through a presoldier stage with dramatic morphogenesis. While a number of morphological modifications are known to occur during the presoldier moult, growth and morphogenesis seem to continue even after the moult. The present study, using the damp-wood termite Hodotermopsis sjostedti, carried out morphological and histological investigations on the developmental processes during the presoldier stage that is artificially induced by the application of a juvenile hormone analogue. Measurements of five body parameters indicated that head length significantly increased during the 14-day period after the presoldier moult, while it did not increase subsequently to the stationary moult (pseudergate moult as control). Histological observations also showed that the cuticular development played a role in the presoldier head elongation, suggesting that the soft and flexible presoldier cuticle contributed to the soldier morphogenesis in termites.	[Sugime, Yasuhiro; Ogawa, Kota; Watanabe, Dai; Shimoji, Hiroyuki; Miura, Toru] Hokkaido Univ, Grad Sch Environm Sci, Sapporo, Hokkaido 0600810, Japan; [Ogawa, Kota] Natl Inst Basic Biol, NIBB Core Res Facil, Okazaki, Aichi 4448585, Japan; [Koshikawa, Shigeyuki] Kyoto Univ, Hakubi Ctr Adv Res, Kyoto 6068502, Japan; [Koshikawa, Shigeyuki] Kyoto Univ, Grad Sch Sci, Kyoto 6068502, Japan	Miura, T (reprint author), Hokkaido Univ, Grad Sch Environm Sci, Sapporo, Hokkaido 0600810, Japan.	miu@ees.hokudai.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan;  [25251041]	We would like to express our gratitude to Tetsuo Kohyama for his advice regarding our statistical analysis. We would also like to thank Thomas Bourguignon, Kei Tanabe, Run Minoura, Masaru K. Hojo, and Chifune Sasa for their assistance in conducting the fieldwork. This work was supported by a Grant-in-Aid for Scientific Research A (No. 25251041) for TM and by Grant-in-Aid for JSPS Fellows for YS, from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Miura T, 2000, ECOL RES, V15, P83, DOI 10.1046/j.1440-1703.2000.00320.x; Xing L, 2013, ANN ENTOMOL SOC AM, V106, P619, DOI 10.1603/AN13007; Koshikawa S, 2002, INSECT SOC, V49, P245, DOI 10.1007/s00040-002-8309-8; Miura T, 2011, BIOLOGY OF TERMITES: A MODERN SYNTHESIS, P211, DOI 10.1007/978-90-481-3977-4_9; Miura T, 2000, P ROY SOC B-BIOL SCI, V267, P1185, DOI 10.1098/rspb.2000.1127; Hanus R, 2006, INSECT SOC, V53, P249, DOI 10.1007/s00040-006-0865-x; Miura T, 2004, INSECT SOC, V51, P247, DOI 10.1007/s00040-003-0736-2; Koshikawa S, 2005, FEBS LETT, V579, P1365, DOI 10.1016/j.febslet.2005.01.031; Bordereau C, 1997, INSECT SOC, V44, P289, DOI 10.1007/s000400050049; Lo N, 2007, BIOL LETTERS, V3, P562, DOI 10.1098/rsbl.2007.0264; Miura T, 2005, EVOL DEV, V7, P122, DOI 10.1111/j.1525-142X.2005.05014.x; PRESTWICH GD, 1984, J CHEM ECOL, V10, P1219, DOI 10.1007/BF00988550; Masuoka Y, 2015, INSECT BIOCHEM MOLEC, V64, P25, DOI 10.1016/j.ibmb.2015.07.013; Sobotnik J, 2004, EUR J ENTOMOL, V101, P153; Cornette R, 2008, INSECT SOC, V55, P407, DOI 10.1007/s00040-008-1031-4; Miura T, 1999, P NATL ACAD SCI USA, V96, P13874, DOI 10.1073/pnas.96.24.13874; Koshikawa S, 2003, NATURWISSENSCHAFTEN, V90, P180, DOI 10.1007/s00114-003-0408-5; Cornette R, 2008, J INSECT PHYSIOL, V54, P922, DOI 10.1016/j.jinsphys.2008.04.017; OGINO K, 1993, ZOOL SCI, V10, P361; Charles JP, 2010, INSECT BIOCHEM MOLEC, V40, P205, DOI 10.1016/j.ibmb.2009.12.005; Korb J, 2008, BIOL REV, V83, P295, DOI 10.1111/j.1469-185X.2008.00044.x; HOPKINS TL, 1992, ANNU REV ENTOMOL, V37, P273; NOIROT C, 1991, ETHOL ECOL EVOL, P3; ANDERSEN SO, 1995, INSECT BIOCHEM MOLEC, V25, P153, DOI 10.1016/0965-1748(94)00052-J; Toga K, 2009, ZOOL SCI, V26, P382, DOI 10.2108/zsj.26.382; NOIROT C, 1987, EXPERIENTIA, V43, P851, DOI 10.1007/BF01951642; Hattori A, 2013, J EXP ZOOL PART B, V320B, P295, DOI 10.1002/jez.b.22501; Bordereau C, 1985, CASTE DIFFERENTIATIO, P221, DOI DOI 10.1016/B978-0-08-030783-1.50021-5; Deligne J., 1981, SOCIAL INSECTS, VII, P1; Hackman RH, 1984, BIOL INTEGUMENT, VI, P583; Hare L, 1937, ANN ENTOMOLOGICAL SO, V30, P459; Holmgren N, 1911, K SVENSKA VETENSK AK, V46, P1; Ishikawa Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002617; Matsumoto T., 1985, Scientific Papers of the College of Arts and Sciences University of Tokyo, V35, P211; Miller E. M., 1969, P283; NIJHOUT HF, 1982, Q REV BIOL, V57, P109, DOI 10.1086/412671; Noirot C, 1969, BIOL TERMITES, VI, P311; PRESTWICH GD, 1984, ANNU REV ENTOMOL, V29, P201; Roisin Y, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P95; Sobotnik J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015761; Sobotnik J, 2012, SCIENCE, V337, P436, DOI 10.1126/science.1219129; Weesner FM, 1969, BIOL TERMITES, VI, P19	42	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0028-1042	1432-1904		SCI NAT-HEIDELBERG	Sci. Nat.	DEC	2015	102	11-12							71	10.1007/s00114-015-1322-3		8	Multidisciplinary Sciences	Science & Technology - Other Topics	CZ0WZ	WOS:000366828400006		
J	Otobe, K; Watanabe, S; Harada, K				Otobe, Kazunori; Watanabe, Satoshi; Harada, Kyuya			Analysis of QTLs for the micromorphology on the seed coat surface of soybean using recombinant inbred lines	SEED SCIENCE RESEARCH			English	Article						Glycine max (L.) Merrill; linkage map; micromorphology; quantitative trait loci; recombinant inbred lines; seed coat; topography microscope	IMPERMEABLE SEED; WATER-ABSORPTION; HARD SEEDEDNESS; GLYCINE-MAX; PERMEABILITY; RESISTANCE; IMBIBITION; INFECTION; PHOMOPSIS; QUALITY	The seed coat of soybean (Glycine max (L.) Merrill) must protect the seed but allow water intake. Overprotection, causing impermeability, is assumed to be due to the presence of an impermeable layer in the seed coat, although validation of this assumption has relied on imbibition testing, which tends to be influenced by microfractures in the seed coat. Recent micromorphological analyses using laser-assisted topography microscopy revealed links to the surface roughness (SR) of the seed coat. To verify genetic links between hardseededness and SR, we analysed quantitative trait loci (QTLs) governing SR formation using 148 recombinant inbred lines (RILs) with a genetic linkage map covering 2663.6cM of all 20 linkage groups of soybean, with 355 DNA markers and 5 phenotype markers. Five QTLs were detected, including previously identified hardseededness QTLs for ratio of seeds absorbing water, namely RAS1 and RAS2, which accounted for 20% of the phenotypic variance, and one near a locus inhibiting seed coat colour (I). These results indicate that the impermeability of soybean seed is genetically related to the reduction of SR.	[Otobe, Kazunori] NARO Agr Res Ctr, Ibaraki 3058666, Japan; [Watanabe, Satoshi] Saga Univ, Fac Agr, Saga 8408502, Japan; [Harada, Kyuya] Natl Inst Agrobiol Sci, Ibaraki 3058602, Japan	Otobe, K (reprint author), NARO Agr Res Ctr, Tsukuba 3-1-1, Ibaraki 3058666, Japan.	otobek@affrc.go.jp			Ministry of Agriculture, Forestry, and Fisheries, Japan	This work was supported by the Ministry of Agriculture, Forestry, and Fisheries, Japan.	Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Shao SQ, 2007, J EXP BOT, V58, P1071, DOI 10.1093/jxb/erl268; Kebede H, 2014, THEOR APPL GENET, V127, P1991, DOI 10.1007/s00122-014-2355-2; CALERO E, 1981, CROP SCI, V21, P926; Song QJ, 2004, THEOR APPL GENET, V109, P122, DOI 10.1007/s00122-004-1602-3; Koizumi M, 2008, ANN BOT-LONDON, V102, P343, DOI 10.1093/aob/mcn095; ROY KW, 1994, CAN J PLANT PATHOL, V16, P122; YAKLICH RW, 1984, SCAN ELECTRON MICROS, P991; Meyer CJ, 2007, J EXP BOT, V58, P717, DOI 10.1093/jxb/erl244; HARTWIG EE, 1987, CROP SCI, V27, P506; KEIM P, 1990, THEOR APPL GENET, V79, P465, DOI 10.1007/BF00226154; Qutob D, 2008, BOTANY, V86, P219, DOI 10.1139/B08-002; MARBACH I, 1974, PLANT PHYSIOL, V54, P817, DOI 10.1104/pp.54.6.817; Mullin WJ, 2001, J AGR FOOD CHEM, V49, P5331, DOI 10.1021/jf010303s; YAKLICH RW, 1986, CROP SCI, V26, P616; Watanabe S, 2004, BREEDING SCI, V54, P399, DOI 10.1270/jsbbs.54.399; KULIK MM, 1991, CROP SCI, V31, P108; Liu B, 2007, ANN BOT-LONDON, V100, P1027, DOI 10.1093/aob/mcm149; Ma FS, 2004, ANN BOT-LONDON, V94, P213, DOI 10.1093/aob/mch133; Sakamoto SI, 2004, BREEDING SCI, V54, P133, DOI 10.1270/jsbbs.54.133; HEATHERLY LG, 1995, FIELD CROP RES, V40, P57, DOI 10.1016/0378-4290(94)00075-N; Chachalis D, 2001, SEED SCI TECHNOL, V29, P401; KILEN TC, 1978, FIELD CROP RES, V1, P65, DOI 10.1016/0378-4290(78)90007-2; Argel P. J., 1999, TROPICAL SUBTROPICAL, V2, P247; Baskin CC, 2014, SEEDS: ECOLOGY, BIOGEOGRAPHY, AND EVOLUTION OF DORMANCY AND GERMINATION, 2ND EDITION, P1; Baskin Jerry M., 2000, Plant Species Biology, V15, P139, DOI 10.1046/j.1442-1984.2000.00034.x; Otobe K., 2008, Japanese Journal of Crop Science, V77, P69, DOI 10.1626/jcs.77.69; Scala Jr N. L., 1999, SEED SCI TECHNOL, V27, P371; Senda M, 2011, BREEDING SCI, V61, P523, DOI 10.1270/jsbbs.61.523; Smykal P, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00351; Tyler J. M., 1997, Seed Technology, V19, P45	31	0	0	CAMBRIDGE UNIV PRESS	CAMBRIDGE	EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND	0960-2585	1475-2735		SEED SCI RES	Seed Sci. Res.	DEC	2015	25	4					409	415		10.1017/S0960258515000318		7	Plant Sciences	Plant Sciences	CY6US	WOS:000366544900005		
J	Amin, ARMR; Karpowicz, PA; Carey, TE; Arbiser, J; Nahta, R; Chen, ZG; Dong, JT; Kucuk, O; Khan, GN; Huang, GS; Mi, SJ; Lee, HY; Reichrath, J; Honoki, K; Georgakilas, AG; Amedei, A; Amin, A; Helferich, B; Boosani, CS; Ciriolo, MR; Chen, S; Mohammed, SI; Azmis, AS; Keith, WN; Bhakta, D; Halicka, D; Niccolai, E; Fujii, H; Aquilano, K; Ashraf, SS; Nowsheen, S; Yang, XJ; Bilsland, A; Shin, DM				Amin, A. R. M. Ruhul; Karpowicz, Phillip A.; Carey, Thomas E.; Arbiser, Jack; Nahta, Rita; Chen, Zhuo G.; Dong, Jin-Tang; Kucuk, Omer; Khan, Gazala N.; Huang, Gloria S.; Mi, Shijun; Lee, Ho-Young; Reichrath, Joerg; Honoki, Kanya; Georgakilas, Alexandros G.; Amedei, Amedeo; Amin, Amr; Helferich, Bill; Boosani, Chandra S.; Ciriolo, Maria Rosa; Chen, Sophie; Mohammed, Sulma I.; Azmis, Asfar S.; Keith, W. Nicol; Bhakta, Dipita; Halicka, Dorota; Niccolai, Elena; Fujii, Hiromasa; Aquilano, Katia; Ashraf, S. Salman; Nowsheen, Somaira; Yang, Xujuan; Bilsland, Alan; Shin, Dong M.			Evasion of anti-growth signaling: A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds	SEMINARS IN CANCER BIOLOGY			English	Review						Tumor suppressor; Anti-growth signaling; Reversible and irreversible evasion; Cancer prevention; Hallmark of cancer	FACTOR-I RECEPTOR; MACROPHAGE-INHIBITORY CYTOKINE-1; BREAST-CANCER CELLS; KRUPPEL-LIKE FACTOR-5; TUMOR-SUPPRESSOR GENE; HUMAN PROSTATE-CANCER; FACTOR-BINDING PROTEIN-3; GREEN TEA POLYPHENOL; FACTOR-KAPPA-B; DIFFERENTIATION FACTOR 15	The evasion of anti-growth signaling is an important characteristic of cancer cells. In order to continue to proliferate, cancer cells must somehow uncouple themselves from the many signals that exist to slow down cell growth. Here, we define the anti-growth signaling process, and review several important pathways involved in growth signaling: p53, phosphatase and tensin homolog (PTEN), retinoblastoma protein (Rb), Hippo, growth differentiation factor 15 (GDF15), AT-rich interactive domain 1A (ARID1A), Notch, insulin-like growth factor (IGF), and Krfippel-like factor 5 (KLF5) pathways. Aberrations in these processes in cancer cells involve mutations and thus the suppression of genes that prevent growth, as well as mutation and activation of genes involved in driving cell growth. Using these pathways as examples, we prioritize molecular targets that might be leveraged to promote anti-growth signaling in cancer cells. Interestingly, naturally occurring phytochemicals found in human diets (either singly or as mixtures) may promote anti-growth signaling, and do so without the potentially adverse effects associated with synthetic chemicals. We review examples of naturally occurring phytochemicals that may be applied to prevent cancer by antagonizing growth signaling, and propose one phytochemical for each pathway. These are: epigallocatechin-3-gallate (EGCG) for the Rb pathway, luteolin for p53, curcumin for PTEN, porphyrins for Hippo, genistein for GDF15, resveratrol for ARID1A, withaferin A for Notch and diguelin for the IGF1-receptor pathway. The coordination of anti-growth signaling and natural compound studies will provide insight into the future application of these compounds in the clinical setting. (C) 2015 Elsevier Ltd.	[Amin, A. R. M. Ruhul; Arbiser, Jack; Nahta, Rita; Chen, Zhuo G.; Dong, Jin-Tang; Kucuk, Omer; Shin, Dong M.] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA; [Karpowicz, Phillip A.] Univ Windsor, Dept Biol Sci, Windsor, ON N9B 3P4, Canada; [Carey, Thomas E.] Univ Michigan, Ann Arbor, MI 48109 USA; [Arbiser, Jack] Atlanta Vet Adm Hlth Ctr, Atlanta, GA USA; [Khan, Gazala N.] Henry Ford Hosp, Detroit, MI 48202 USA; [Huang, Gloria S.; Mi, Shijun] Albert Einstein Coll Med, New York, NY USA; [Lee, Ho-Young] Seoul Natl Univ, Coll Pharm, Seoul, South Korea; [Reichrath, Joerg] Univ Saarland, D-66123 Saarbrucken, Germany; [Honoki, Kanya; Fujii, Hiromasa] Nara Med Univ, Nara, Japan; [Georgakilas, Alexandros G.] Natl Tech Univ Athens, Athens, Greece; [Amedei, Amedeo] Univ Florence, Florence, Italy; [Amin, Amr; Ashraf, S. Salman] UAE Univ, Al Ain, U Arab Emirates; [Amin, Amr] Cairo Univ, Fac Sci, Cairo, Egypt; [Helferich, Bill; Yang, Xujuan] Univ Illinois, Urbana, IL 61801 USA; [Boosani, Chandra S.] Creighton Univ, Omaha, NE 68178 USA; [Ciriolo, Maria Rosa; Aquilano, Katia] Univ Roma Tor Vergata, Rome, Italy; [Chen, Sophie] Ovarian & Prostate Canc Res Lab, Guildford, Surrey, England; [Mohammed, Sulma I.] Purdue Univ, W Lafayette, IN 47907 USA; [Azmis, Asfar S.] Wayne State Univ, Detroit, MI USA; [Keith, W. Nicol; Bilsland, Alan] Univ Glasgow, Glasgow, Lanark, Scotland; [Bhakta, Dipita] SASTRA Univ, Sch Chem & Bio Technol, Thanjavur, India; [Halicka, Dorota] New York Med Coll, Valhalla, NY 10595 USA; [Nowsheen, Somaira] Mayo Clin, Mayo Grad Sch, Mayo Med Sch, Med Scientist Training Program, Rochester, MN USA	Shin, DM (reprint author), Emory Univ, Winship Canc Inst, 1365-C Clifton Rd, Atlanta, GA 30322 USA.	dmshin@emory.edu					Akhurst RJ, 2001, TRENDS CELL BIOL, V11, pS44, DOI 10.1016/S0962-8924(01)82259-5; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; Wallace JA, 2011, CANCER RES, V71, P1203, DOI 10.1158/0008-5472.CAN-10-3263; Dell'Eva R, 2007, CARCINOGENESIS, V28, P404, DOI 10.1093/carcin/bgl162; Peacock CD, 2008, J CLIN ONCOL, V26, P2883, DOI 10.1200/JCO.2007.15.2702; Wynne S, 2010, MOL CANCER RES, V8, P1656, DOI 10.1158/1541-7786.MCR-10-0342; Rizzo P, 2008, ONCOGENE, V27, P5124, DOI 10.1038/onc.2008.226; Reisman D, 2009, ONCOGENE, V28, P1653, DOI 10.1038/onc.2009.4; Zlotogorski A, 2013, ORAL ONCOL, V49, P187, DOI 10.1016/j.oraloncology.2012.09.015; Dudas J, 2013, EXP CELL RES, V319, P800, DOI 10.1016/j.yexcr.2012.12.001; Moll UM, 2003, MOL CANCER RES, V1, P1001; Brown DA, 2003, CLIN CANCER RES, V9, P2642; Maxwell JH, 2010, CLIN CANCER RES, V16, P1226, DOI 10.1158/1078-0432.CCR-09-2350; Maillard I, 2004, BLOOD, V104, P1696, DOI 10.1182/blood-2004-02-0514; Wang TT, 2012, ASIAN PAC J CANCER P, V13, P5455, DOI 10.7314/APJCP.2012.13.11.5455; Mankame TP, 2012, NEOPLASIA, V14, P1213, DOI 10.1593/neo.121422; Tan MJ, 2000, P NATL ACAD SCI USA, V97, P109, DOI 10.1073/pnas.97.1.109; Ichimiya S, 1999, ONCOGENE, V18, P1061, DOI 10.1038/sj.onc.1202390; Nandan MO, 2005, FEBS LETT, V579, P4757, DOI 10.1016/j.febslet.2005.07.053; Chen FP, 2014, CLIMACTERIC, V17, P385, DOI 10.3109/13697137.2013.869671; Samani AA, 2007, ENDOCR REV, V28, P20, DOI 10.1210/er.2006-0001; Varelas X, 2012, TRENDS CELL BIOL, V22, P88, DOI 10.1016/j.tcb.2011.10.002; Tsui KH, 2012, INT J CANCER, V130, P2812, DOI 10.1002/ijc.26284; Guan B, 2011, AM J SURG PATHOL, V35, P625, DOI 10.1097/PAS.0b013e318212782a; Bracken AP, 2004, TRENDS BIOCHEM SCI, V29, P409, DOI 10.1016/j.tibs.2004.06.006; Welsh JB, 2003, P NATL ACAD SCI USA, V100, P3410, DOI 10.1073/pnas.0530278100; Mizuno T, 2012, ONCOGENE, V31, P5117, DOI 10.1038/onc.2012.5; Chen YB, 2007, CANCER RES, V67, P7954, DOI 10.1158/0008-5472.CAN-07-1229; Di X, 2008, HUM REPROD, V23, P1873, DOI 10.1093/humrep/den087; Youns M, 2011, EUR J PHARMACOL, V650, P170, DOI 10.1016/j.ejphar.2010.10.026; Hoffmann J, 2011, BIOCHEM PHARMACOL, V82, P1153, DOI 10.1016/j.bcp.2011.07.063; Li YY, 2009, INT J CANCER, V125, P286, DOI 10.1002/ijc.24398; Sarkar FH, 2009, CELL SIGNAL, V21, P1541, DOI 10.1016/j.cellsig.2009.03.009; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Belletti B, 2001, J BIOL CHEM, V276, P13867; Evans DGR, 2009, GENET MED, V11, P599, DOI 10.1097/GIM.0b013e3181ac9a27; Reed AL, 1996, CANCER RES, V56, P3630; Kohno T, 1999, CARCINOGENESIS, V20, P1403, DOI 10.1093/carcin/20.8.1403; Oh SH, 2012, CANCER SCI, V103, P1259, DOI 10.1111/j.1349-7006.2012.02301.x; Joshi JP, 2011, BIOCHEM PHARMACOL, V82, P1090, DOI 10.1016/j.bcp.2011.07.082; Staal FJT, 2008, HAEMATOL-HEMATOL J, V93, P493, DOI 10.3324/haematol.12917; Kong L, 2012, CARCINOGENESIS, V33, P751, DOI 10.1093/carcin/bgs022; Lanzilli G, 2006, INT J ONCOL, V28, P641; Pinnix CC, 2007, PIGM CELL RES, V20, P458, DOI 10.1111/j.1600-0749.2007.00410.x; Haddad RI, 2008, NEW ENGL J MED, V359, P1143, DOI 10.1056/NEJMra0707975; Baek SJ, 2006, GASTROENTEROLOGY, V131, P1553, DOI 10.1053/j.gastro.2006.09.015; Hahm ER, 2013, JNCI-J NATL CANCER I, V105, P1111, DOI 10.1093/jnci/djt153; Deng YT, 2011, J AGR FOOD CHEM, V59, P13318, DOI 10.1021/jf204149c; Hahm ER, 2007, MOL CANCER THER, V6, P2686, DOI 10.1158/1535-7163.MCT-07-0217; Okuyama R, 2008, J DERMATOL SCI, V49, P187, DOI 10.1016/j.jdermsci.2007.05.017; Farabegoli F, 2011, BIOSCIENCE REP, V31, P99, DOI 10.1042/BSR20090143; Ding SX, 2014, TUMOR BIOL, V35, P3053, DOI 10.1007/s13277-013-1396-5; Riedemann J, 2006, ENDOCR-RELAT CANCER, V13, pS33, DOI 10.1677/erc.1.01280; Lee H, 2010, ONCOL REP, V24, P957, DOI 10.3892/or_00000942; Suh YA, 2013, CANCER LETT, V332, P102, DOI 10.1016/j.canlet.2013.01.022; Apelqvist A, 1999, NATURE, V400, P877; Yamaguchi K, 2004, J BIOL CHEM, V279, P49617, DOI 10.1074/jbc.M408796200; Sur I, 2006, J CELL SCI, V119, P3593, DOI 10.1242/jcs.03070; Kahlert S, 2000, J BIOL CHEM, V275, P18447, DOI 10.1074/jbc.M910345199; Nair AS, 2006, J IMMUNOL, V177, P5612; Wang ZW, 2010, J CELL BIOCHEM, V109, P726, DOI 10.1002/jcb.22451; Lin CL, 2012, NEUROSCI LETT, V529, P60, DOI 10.1016/j.neulet.2012.09.022; Ng SW, 2000, ONCOGENE, V19, P1885, DOI 10.1038/sj.onc.1203512; Trimboli AJ, 2009, NATURE, V461, P1084, DOI 10.1038/nature08486; Bhattacharyya S, 2010, CELL MOL IMMUNOL, V7, P306, DOI 10.1038/cmi.2010.11; Xu Y, 2012, MOL ONCOL, V6, P405, DOI 10.1016/j.molonc.2012.03.005; Wallin U, 2011, BRIT J CANCER, V104, P1619, DOI 10.1038/bjc.2011.112; Osada M, 2007, BIOCHEM BIOPH RES CO, V354, P913, DOI 10.1016/j.bbrc.2007.01.089; Shankar S, 2007, INT J ONCOL, V30, P905; Lin Y, 2008, CURR CANCER DRUG TAR, V8, P634, DOI 10.2174/156800908786241050; Zhang N, 2013, FEBS LETT, V587, P2346, DOI 10.1016/j.febslet.2013.05.059; Konishi J, 2007, CANCER RES, V67, P8051, DOI 10.1158/0008-5472.CAN-07-1022; MIYAKE K, 1989, BRIT J PHARMACOL, V98, P389; Murga C, 1998, J BIOL CHEM, V273, P19080, DOI 10.1074/jbc.273.30.19080; Sunahara M, 1998, INT J ONCOL, V13, P319; Bagli E, 2004, CANCER RES, V64, P7936, DOI 10.1158/0008-5472.CAN-03-3104; Medema JP, 2011, NATURE, V474, P318, DOI 10.1038/nature10212; Liu BR, 2000, J BIOL CHEM, V275, P33607, DOI 10.1074/jbc.M002547200; Li YW, 2006, CANCER RES, V66, P4816, DOI 10.1158/0008-5472.CAN-05-3752; Kennedy DO, 2002, CANCER LETT, V179, P25, DOI 10.1016/S0304-3835(01)00856-4; Guo P, 2009, J BIOL CHEM, V284, P6071, DOI 10.1074/jbc.M806270200; Fuggetta MP, 2006, J EXP CLIN CANC RES, V25, P189; Sun RG, 2001, J BIOL CHEM, V276, P6897, DOI 10.1074/jbc.C000870200; Dallas PB, 1998, MOL CELL BIOL, V18, P3596; Amin ARMR, 2007, P NATL ACAD SCI USA, V104, P5419, DOI 10.1073/pnas.0700642104; Lichner Z, 2013, AM J PATHOL, V182, P1163, DOI 10.1016/j.ajpath.2013.01.007; Kang JX, 1999, CELL GROWTH DIFFER, V10, P591; Wang ZW, 2009, CANCER RES, V69, P2757, DOI 10.1158/0008-5472.CAN-08-3060; Rosenfeldt MT, 2013, NATURE, V504, P296, DOI 10.1038/nature12865; Valenti D, 2013, BBA-MOL BASIS DIS, V1832, P2085, DOI 10.1016/j.bbadis.2013.07.014; Christofori G, 2006, NATURE, V441, P444, DOI 10.1038/nature04872; Ulbricht U, 2013, BREAST CANCER RES TR, V138, P437, DOI 10.1007/s10549-013-2472-7; Bock AJ, 2010, INT J GYNECOL CANCER, V20, P1448, DOI 10.1111/IGC.0b013e3181f7d6be; Wen SH, 2001, P NATL ACAD SCI USA, V98, P4622, DOI 10.1073/pnas.081063798; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Huang GS, 2010, CLIN CANCER RES, V16, P2999, DOI 10.1158/1078-0432.CCR-09-3233; Chen CS, 2005, ONCOGENE, V24, P3319, DOI 10.1038/sj.onc.1208497; Nian WQ, 2013, ONCOL LETT, V6, P359, DOI 10.3892/ol.2013.1375; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Sausen M, 2013, NAT GENET, V45, P12, DOI 10.1038/ng.2493; Hayes VM, 2006, CANCER EPIDEM BIOMAR, V15, P1223, DOI 10.1158/1055-9965.EPI-06-0063; Kovalev S, 1998, CELL GROWTH DIFFER, V9, P897; Lindmark F, 2004, J NATL CANCER I, V96, P1248, DOI 10.1093/jnci/djh227; Zheng HQ, 2009, ONCOGENE, V28, P3702, DOI 10.1038/onc.2009.235; Stupack DG, 2002, J CELL SCI, V115, P3729, DOI 10.1242/jcs.00071; Bahr C, 2005, GROWTH FACTORS, V23, P1, DOI 10.1080/08977190400020229; Miyamoto Y, 2003, CANCER CELL, V3, P565, DOI 10.1016/S1535-6108(03)00140-5; Kwak MK, 2008, J CANCER RES CLIN, V134, P163, DOI 10.1007/s00432-007-0265-2; Holy JM, 2002, MUTAT RES-GEN TOX EN, V518, P71, DOI 10.1016/S1383-5718(02)00076-1; Wang X, 2013, CARCINOGENESIS, V34, P1323, DOI 10.1093/carcin/bgt058; Sharma C, 2012, ASIAN PAC J CANCER P, V13, P4815, DOI 10.7314/APJCP.2012.13.9.4815; Chen Y, 2007, BASIC CLIN PHARMACOL, V101, P427, DOI 10.1111/j.1742-7843.2007.00142.x; Stockhausen MT, 2005, EXP CELL RES, V310, P218, DOI 10.1016/j.yexcr.2005.07.011; Vanhara P, 2009, DIFFERENTIATION, V78, P213, DOI 10.1016/j.diff.2009.07.008; Zhao DZ, 2011, J BIOL CHEM, V286, P6092, DOI 10.1074/jbc.M110.192534; Shin DH, 2011, MOL CANCER THER, V10, P2437, DOI 10.1158/1535-7163.MCT-11-0235; Tan EH, 2014, ONCOGENE, V33, P3325, DOI 10.1038/onc.2013.287; Ishida T, 2013, ONCOL LETT, V6, P1201, DOI 10.3892/ol.2013.1549; Garofalo C, 2012, MOL ENDOCRINOL, V26, P1603, DOI 10.1210/me.2012-1142; Wiklund FE, 2010, AGING CELL, V9, P1057, DOI 10.1111/j.1474-9726.2010.00629.x; Wang X, 2009, ARCH PHARM RES, V32, P1263, DOI 10.1007/s12272-009-1912-8; Hwa V, 1999, ENDOCR REV, V20, P761, DOI 10.1210/er.20.6.761; Daniels LB, 2011, CIRCULATION, V123, P2101, DOI 10.1161/CIRCULATIONAHA.110.979740; Friday BB, 2008, CLIN CANCER RES, V14, P342, DOI 10.1158/1078-0432.CCR-07-4790; Miele L, 2006, CURR CANCER DRUG TAR, V6, P313, DOI 10.2174/156800906777441771; Jogie-Brahim S, 2009, ENDOCR REV, V30, P417, DOI 10.1210/er.2008-0028; Karpowicz P, 2010, DEVELOPMENT, V137, P4135, DOI 10.1242/dev.060483; van der Veeken J, 2009, CURR CANCER DRUG TAR, V9, P748; Zhu WZ, 2012, NUTR CANCER, V64, P393, DOI 10.1080/01635581.2012.654926; Charles C, 2014, MUTAT RES-GEN TOX EN, V768, P33, DOI 10.1016/j.mrgentox.2014.04.014; Costa VL, 2010, CLIN CANCER RES, V16, P5842, DOI 10.1158/1078-0432.CCR-10-1312; Ehebauer M, 2006, SCIENCE, V314, P1414, DOI 10.1126/science.1134042; Sinha P, 2013, CANCER IMMUNOL IMMUN, V62, P1663, DOI 10.1007/s00262-013-1470-2; Majumdar D, 2014, CANCER PREV RES, V7, P65, DOI 10.1158/1940-6207.CAPR-13-0230; Yonekura S, 2013, ANTICANCER RES, V33, P3099; Moore AB, 2007, HUM REPROD, V22, P2623, DOI 10.1093/humrep/dem185; Reedijk M, 2008, BREAST CANCER RES TR, V111, P439, DOI 10.1007/s10549-007-9805-3; Hardcastle IR, 2006, J MED CHEM, V49, P6209, DOI 10.1021/jm0601194; Guo G, 2013, CANCER RES, V73, P1668, DOI 10.1158/0008-5472.CAN-12-3810; Debeb BG, 2012, BREAST CANCER RES TR, V134, P495, DOI 10.1007/s10549-012-2075-8; Cornen S, 2012, ONCOGENE, V31, P4255, DOI 10.1038/onc.2011.598; Wu M, 2010, J BIOL CHEM, V285, P12055, DOI 10.1074/jbc.M109.088781; Hollander MC, 2011, NAT REV CANCER, V11, P289, DOI 10.1038/nrc3037; Nihal M, 2010, PHARM RES-DORDR, V27, P1103, DOI 10.1007/s11095-010-0054-5; Mendivil A, 2011, REPROD SCI, V18, P832, DOI 10.1177/1933719111398501; Choudhuri T, 2002, FEBS LETT, V512, P334, DOI 10.1016/S0014-5793(02)02292-5; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Siddiqui IA, 2009, CANCER RES, V69, P1712, DOI 10.1158/0008-5472.CAN-08-3978; Yang YZ, 2005, CANCER BIOL THER, V4, P1216, DOI 10.4161/cbt.4.11.2090; Shim M, 2008, MOL CANCER THER, V7, P961, DOI 10.1158/1535-7163.MCT-07-0470; Zhang LL, 2014, CELL SIGNAL, V26, P1011, DOI 10.1016/j.cellsig.2014.01.025; Lam EWF, 2013, NAT REV CANCER, V13, P482, DOI 10.1038/nrc3539; Lundberg AS, 2002, ONCOGENE, V21, P4577, DOI 10.1038/sj.onc.1205550; Wong TS, 2010, ANTICANCER RES, V30, P2851; Koduru S, 2010, MOL CANCER THER, V9, P202, DOI 10.1158/1535-7163.MCT-09-0771; Maor S, 2006, J ENDOCRINOL, V191, P605, DOI 10.1677/joe.1.07016; Martinez-Garcia M, 2012, CLIN CANCER RES, V18, P4806, DOI 10.1158/1078-0432.CCR-12-0742; Shammas MA, 2006, BLOOD, V108, P2804, DOI 10.1182/blood-2006-05-022814; Liu TM, 2013, STEM CELLS DEV, V22, P268, DOI 10.1089/scd.2012.0222; Yang YZ, 2007, FASEB J, V21, P543, DOI 10.1096/fj.06-6694com; Moon SH, 2013, INT J ONCOL, V42, P921, DOI 10.3892/ijo.2013.1765; Lai D, 2011, CANCER RES, V71, P2728, DOI 10.1158/0008-5472.CAN-10-2711; Hardtner C, 2012, EUR J PHARMACOL, V684, P36, DOI 10.1016/j.ejphar.2012.03.039; Hartog H, 2012, ANTICANCER RES, V32, P1309; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Albertoni M, 2002, ONCOGENE, V21, P4212, DOI 10.1038/sj.onc.1205610; Tannapfel A, 1999, J NATL CANCER I, V91, P1154, DOI 10.1093/jnci/91.13.1154; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Tian BQ, 2008, CANCER LETT, V264, P299, DOI 10.1016/j.canlet.2008.01.041; Nallet-Staub F, 2014, J INVEST DERMATOL, V134, P123, DOI 10.1038/jid.2013.319; Shimizu S, 2013, BIOCHEM BIOPH RES CO, V430, P1277, DOI 10.1016/j.bbrc.2012.11.137; Pal D, 2012, CARCINOGENESIS, V33, P2424, DOI 10.1093/carcin/bgs276; Zhang SY, 2014, NUTR CANCER, V66, P315, DOI 10.1080/01635581.2014.868909; Dardousis K, 2007, MOL THER, V15, P94, DOI 10.1038/sj.mt.6300003; Baek SJ, 2005, MOL PHARMACOL, V67, P356, DOI 10.1124/mol.104.005108; Cordero-Espinoza L, 2013, J BIOL CHEM, V288, P36020, DOI 10.1074/jbc.M113.510289; Wang XY, 2013, BIOCHEM PHARMACOL, V85, P597, DOI 10.1016/j.bcp.2012.11.025; Ponnurangam S, 2012, MOL CANCER THER, V11, P963, DOI 10.1158/1535-7163.MCT-11-0999; Koopmann J, 2006, CLIN CANCER RES, V12, P442, DOI 10.1158/1078-0432.CCR-05-0564; Guo P, 2009, J BIOL CHEM, V284, P28243, DOI 10.1074/jbc.M109.036160; Kim WY, 2009, CANCER RES, V69, P7439, DOI 10.1158/0008-5472.CAN-08-3792; Premkumar DR, 2012, J PHARMACOL EXP THER, V341, P859, DOI 10.1124/jpet.112.191536; Shi ZM, 2013, RNA, V19, P552, DOI 10.1261/rna.035972.112; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Shangary S, 2008, MOL CANCER THER, V7, P1533, DOI 10.1158/1535-7163.MCT-08-0140; Shindo T, 2002, NAT MED, V8, P856, DOI 10.1038/nm738; Shim M, 2005, J BIOL CHEM, V280, P18636, DOI 10.1074/jbc.M414613200; Jacque E, 2013, ONCOGENE, V32, P2661, DOI 10.1038/onc.2012.282; Kopelovich L, 2003, J NATL CANCER I, V95, P1747, DOI 10.1093/jnci/dig109; Lin SY, 2013, INT J ONCOL, V43, P1817, DOI 10.3892/ijo.2013.2109; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Indovina P, 2013, J CELL PHYSIOL, V228, P525, DOI 10.1002/jcp.24170; Murtaugh LC, 2003, P NATL ACAD SCI USA, V100, P14920, DOI 10.1073/pnas.2436557100; HUMBEL RE, 1990, EUR J BIOCHEM, V190, P445, DOI 10.1111/j.1432-1033.1990.tb15595.x; Zhang DL, 2004, J BIOL CHEM, V279, P19683, DOI 10.1074/jbc.M313145200; McClatchey AI, 2005, GENE DEV, V19, P2265, DOI 10.1101/gad.1335605; Whitson RJ, 2013, J CELL BIOCHEM, V114, P1424, DOI 10.1002/jcb.24484; Chen KC, 2013, LIFE SCI, V93, P924, DOI 10.1016/j.lfs.2013.10.004; Ogawara Y, 2002, J BIOL CHEM, V277, P21843, DOI 10.1074/jbc.M109745200; Cheng I, 2007, CANCER EPIDEM BIOMAR, V16, P1309, DOI 10.1158/1055-9965.EPI-07-0165; Schmidt F, 2008, ONCOL REP, V19, P1061; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Zheng JJ, 2014, FEBS J, V281, P88, DOI 10.1111/febs.12574; Khaw AK, 2013, J CELL BIOCHEM, V114, P1257, DOI 10.1002/jcb.24466; Hald J, 2003, DEV BIOL, V260, P426, DOI 10.1016/S0012-1606(03)00326-9; Santoro R, 2012, ONCOGENE, V31, P2931, DOI 10.1038/onc.2011.469; Volate SR, 2009, MOL CARCINOGEN, V48, P920, DOI 10.1002/mc.20542; Ulanet DB, 2010, P NATL ACAD SCI USA, V107, P10791, DOI 10.1073/pnas.0914076107; Classon M, 2002, NAT REV CANCER, V2, P910, DOI 10.1038/nrc950; Chen C, 2007, ONCOGENE, V26, P2386, DOI 10.1038/sj.onc.1210021; Johnson JL, 2012, CANCER RES, V72, P516, DOI 10.1158/0008-5472.CAN-11-2647; LeRoith D, 2003, CANCER LETT, V195, P127, DOI 10.1016/S0304-3835(03)00159-9; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Licitra L, 2006, J CLIN ONCOL, V24, P5630, DOI 10.1200/JCO.2005.04.6136; Faridoni-Laurens L, 2008, CELL CYCLE, V7, P1587, DOI 10.4161/cc.7.11.5894; Pollak MN, 2004, NAT REV CANCER, V4, P505, DOI 10.1038/nrc1387; Min KW, 2012, TOXICOL APPL PHARM, V263, P225, DOI 10.1016/j.taap.2012.06.014; Goldstein BG, 2007, AM J PHYSIOL-GASTR L, V292, pG1784, DOI 10.1152/ajpgi.00541.2006; Bateman NW, 2004, J BIOL CHEM, V279, P12093, DOI 10.1074/jbc.M311532200; Hastak K, 2005, FASEB J, V19, P789, DOI 10.1096/fj.04-2226fje; King HA, 2012, BBA-GENE REGUL MECH, V1819, P716, DOI 10.1016/j.bbagrm.2012.02.019; FISCHBACH F, 1988, EUR J CLIN MICROBIOL, V7, P588, DOI 10.1007/BF01962627; Werner H, 2012, ONCOGENE, V31, P2703, DOI 10.1038/onc.2011.447; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Kan CY, 2013, J BIOL CHEM, V288, P12032, DOI 10.1074/jbc.M112.447821; Brown DA, 2006, CLIN CANCER RES, V12, P89, DOI 10.1158/1078-0432.CCR-05-1331; Amin ARMR, 2010, J BIOL CHEM, V285, P34557, DOI 10.1074/jbc.M110.141135; Senapati S, 2010, ONCOGENE, V29, P1293, DOI 10.1038/onc.2009.420; DAMERON KM, 1994, COLD SPRING HARB SYM, V59, P483; Yin P, 2004, J BIOL CHEM, V279, P32660, DOI 10.1074/jbc.M401378200; Grogan PT, 2014, INVEST NEW DRUG, V32, P604, DOI 10.1007/s10637-014-0084-7; Jiang P, 2013, CELL CYCLE, V12, P3720, DOI 10.4161/cc.27267; Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015; Bauskin AR, 2005, CANCER RES, V65, P2330, DOI 10.1158/0008-5472.CAN-04-3827; Tao L, 2014, MOL NUTR FOOD RES, V58, P665, DOI 10.1002/mnfr.201300427; Ouchi H, 2005, INT J UROL, V12, P73, DOI 10.1111/j.1442-2042.2004.00973.x; Oh SH, 2008, INT J CANCER, V122, P5, DOI 10.1002/ijc.23075; Xue Q, 2008, CANCER RES, V68, P9551, DOI 10.1158/0008-5472.CAN-08-2058; Heyninck K, 2014, BIOCHEM PHARMACOL, V91, P501, DOI 10.1016/j.bcp.2014.08.004; Kim SY, 2009, B CANCER, V96, pE52, DOI 10.1684/bdc.2009.0915; Staff AC, 2010, GYNECOL ONCOL, V118, P237, DOI 10.1016/j.ygyno.2010.05.032; Choi NM, 2011, CURR OPIN IMMUNOL, V23, P81, DOI 10.1016/j.coi.2010.09.007; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; Bunney TD, 2010, NAT REV CANCER, V10, P342, DOI 10.1038/nrc2842; Wang ZY, 2014, P NATL ACAD SCI USA, V111, pE89, DOI 10.1073/pnas.1319190110; Liu-Chittenden Y, 2012, GENE DEV, V26, P1300, DOI 10.1101/gad.192856.112; Chen C, 2003, PROSTATE, V55, P81, DOI 10.1002/pros.10205; Yasaei H, 2013, ONCOGENE, V32, P171, DOI 10.1038/onc.2012.45; Griner SE, 2013, BIOCHEM PHARMACOL, V85, P46, DOI 10.1016/j.bcp.2012.10.007; Chen C, 2002, ONCOGENE, V21, P6567, DOI 10.1038/sj.onc.1205817; Ma YW, 2006, ENDOCRINOLOGY, V147, P1256; WEINBERG RA, 1991, SCIENCE, V254, P1138, DOI 10.1126/science.1659741; DeCristofaro MF, 2001, J CELL PHYSIOL, V186, P136; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Berletch JB, 2008, J CELL BIOCHEM, V103, P509, DOI 10.1002/jcb.21417; Shnaper S, 2009, INT J CANCER, V125, P2624, DOI 10.1002/ijc.24639; Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Zhang Y, 2014, TUMOR BIOL, V35, P5701, DOI 10.1007/s13277-014-1755-x; Chen CS, 2005, J BIOL CHEM, V280, P41553, DOI 10.1074/jbc.M5061873200; Negi A, 2013, MINI-REV MED CHEM, V13, P653; Nandan MO, 2008, GASTROENTEROLOGY, V134, P120, DOI 10.1053/j.gastro.2007.10.023; Mamo A, 2012, ONCOGENE, V31, P2090, DOI 10.1038/onc.2011.386; Chen Y, 2007, IN VIVO, V21, P365; Mimeault M, 2010, J CELL PHYSIOL, V224, P626, DOI 10.1002/jcp.22196; Barry ER, 2013, NATURE, V493, P106, DOI 10.1038/nature11693; Kunnumakkara AB, 2008, CANCER LETT, V269, P199, DOI 10.1016/j.canlet.2008.03.009; Gupta S, 2003, ARCH BIOCHEM BIOPHYS, V410, P177, DOI 10.1016/S0003-9861(02)00668-9; Damera G, 2009, BRIT J PHARMACOL, V158, P1429, DOI 10.1111/j.1476-5381.2009.00428.x; Ren FF, 2010, P NATL ACAD SCI USA, V107, P21064, DOI 10.1073/pnas.1012759107; Sjolund J, 2005, EUR J CANCER, V41, P2620, DOI 10.1016/j.ejca.2005.06.025; Du LP, 2012, NUTR CANCER, V64, P1228, DOI 10.1080/01635581.2012.717682; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Leao M, 2013, J NAT PROD, V76, P774, DOI 10.1021/np400049j; Nefedova Y, 2008, DRUG RESIST UPDATE, V11, P210, DOI 10.1016/j.drup.2008.09.002; Reinmuth N, 2002, CLIN CANCER RES, V8, P3259; Wetterau LA, 2003, J CLIN ENDOCR METAB, V88, P3354, DOI 10.1210/jc.2002-021326; Zaika AI, 1999, CANCER RES, V59, P3257; Chen L, 2013, WORLD J GASTROENTERO, V19, P6814, DOI 10.3748/wjg.v19.i40.6814; Zhong Y, 2010, EUR J CANCER, V46, P3365, DOI 10.1016/j.ejca.2010.07.007; Gui YT, 2011, NAT GENET, V43, P875, DOI 10.1038/ng.907; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Abraham J, 2011, MOL CANCER THER, V10, P697, DOI 10.1158/1535-7163.MCT-10-0695; Weng CJ, 2012, CANCER METAST REV, V31, P323, DOI 10.1007/s10555-012-9347-y; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Sadava D, 2007, BIOCHEM BIOPH RES CO, V360, P233, DOI 10.1016/j.bbrc.2007.06.030; Koopmann J, 2004, CLIN CANCER RES, V10, P2386, DOI 10.1158/1078-0432.CCR-03-0165; Pankov R, 2003, J BIOL CHEM, V278, P18671, DOI 10.1074/jbc.M300879200; Gualberto A, 2009, CURR DRUG TARGETS, V10, P923; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Brown DA, 2009, CLIN CANCER RES, V15, P6658, DOI 10.1158/1078-0432.CCR-08-3126; Jerome L, 2003, ENDOCR-RELAT CANCER, V10, P561, DOI 10.1677/erc.0.0100561; Chen CH, 2006, INT J CANCER, V118, P1346, DOI 10.1002/ijc.21533; Malaguarnera R, 2007, ENDOCR-RELAT CANCER, V14, P43, DOI 10.1677/erc.1.01223; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Lamar JM, 2012, P NATL ACAD SCI USA, V109, pE2441, DOI 10.1073/pnas.1212021109; Li YG, 2013, CARCINOGENESIS, V34, P1601, DOI 10.1093/carcin/bgt065; Wang ZW, 2006, CANCER RES, V66, P2778, DOI 10.1158/0008-5472.CAN-05-4281; Heallen T, 2011, SCIENCE, V332, P458, DOI 10.1126/science.1199010; Park W, 2013, CANCER PREV RES, V6, P387, DOI 10.1158/1940-6207.CAPR-12-0410; Nasiri M, 2013, ASIAN PAC J CANCER P, V14, P3449, DOI 10.7314/APJCP.2013.14.6.3449; Baek SJ, 2001, J BIOL CHEM, V276, P33384, DOI 10.1074/jbc.M101814200; FERNANDEZ D, 1988, J HYPERTENS, V6, pS145; Park JH, 2006, EMBO J, V25, P3986, DOI 10.1038/sj.emboj.7601291; Kim JH, 2011, BLOOD, V118, P2622, DOI 10.1182/blood-2010-08-299784; McGrath M, 2011, GYNECOL ONCOL, V120, P174, DOI 10.1016/j.ygyno.2010.10.012; Baek SJ, 2002, CARCINOGENESIS, V23, P425, DOI 10.1093/carcin/23.3.425; Werner H, 2006, TRENDS ENDOCRIN MET, V17, P236, DOI 10.1016/j.tem.2006.06.007; William WN, 2009, NAT REV DRUG DISCOV, V8, P213, DOI 10.1038/nrd2663; HARPER JW, 1993, CELL, V75, P805; Banerjee S, 2008, CANCER LETT, V269, P226, DOI 10.1016/j.canlet.2008.03.052; Bolos V, 2009, CLIN TRANSL ONCOL, V11, P11, DOI 10.1007/s12094-009-0305-2; Freed-Pastor WA, 2012, GENE DEV, V26, P1268, DOI 10.1101/gad.190678.112; Reedijk M, 2005, CANCER RES, V65, P8530, DOI 10.1158/0008-5472.CAN-05-1069; Stoeltzing O, 2003, AM J PATHOL, V163, P1001, DOI 10.1016/S0002-9440(10)63460-8; Wang H, 2011, CARCINOGENESIS, V32, P1881, DOI 10.1093/carcin/bgr218; Dickson BC, 2007, MODERN PATHOL, V20, P685, DOI 10.1038/modpathol.3800785; Levine AJ, 2006, GENE DEV, V20, P267, DOI 10.1101/gad.1363206; Martinez JM, 2006, J PHARMACOL EXP THER, V318, P899, DOI 10.1124/jpet.105.100081; Menendez D, 2013, CURR OPIN ONCOL, V25, P85, DOI 10.1097/CCO.0b013e32835b6386; Varelas X, 2010, DEV CELL, V18, P579, DOI 10.1016/j.devcel.2010.03.007; Zgheib A, 2013, J BIOL CHEM, V288, P13378, DOI 10.1074/jbc.M113.456533; Zang ZJ, 2012, NAT GENET, V44, P570, DOI 10.1038/ng.2246; Arbiser JL, 1998, MOL MED, V4, P376; Shankar S, 2007, MOL CELL BIOCHEM, V304, P273, DOI 10.1007/s11010-007-9510-x; Su CC, 2010, INT J MOL MED, V26, P217, DOI 10.3892/ijmm_00000455; Wu B, 2008, MOL CELL BIOCHEM, V313, P125, DOI 10.1007/s11010-008-9749-x; Knuutila S, 1999, AM J PATHOL, V155, P683, DOI 10.1016/S0002-9440(10)65166-8; Fang MZ, 2003, CANCER RES, V63, P7563; Garcia A, 2008, CLIN CANCER RES, V14, P4267, DOI 10.1158/1078-0432.CCR-08-0102; Hussain A, 2012, CANCER EPIDEMIOL, V36, pE387, DOI 10.1016/j.canep.2012.07.005; Ono M, 2013, ANTICANCER RES, V33, P1861; Lee H, 2012, P NATL ACAD SCI USA, V109, P7765, DOI 10.1073/pnas.1205132109; Wilson LC, 2003, INT J CANCER, V105, P747, DOI 10.1002/ijc.11173; Kim KK, 2008, CARCINOGENESIS, V29, P704, DOI 10.1093/carcin/bgn031; Wang K, 2011, NAT GENET, V43, P1219, DOI 10.1038/ng.982; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Hudson JD, 1999, J EXP MED, V190, P1375, DOI 10.1084/jem.190.10.1375; Selander KS, 2007, CANCER EPIDEM BIOMAR, V16, P532, DOI 10.1158/99965.EPI-06-0841; Wolf I, 2008, ONCOGENE, V27, P7094, DOI 10.1038/onc.2008.292; Chen CS, 2007, INT J CANCER, V121, P80, DOI 10.1002/ijc.22653; Cui H, 2013, CANCER RES, V73, P3451, DOI 10.1158/0008-5472.CAN-12-3902; Yokomizo A, 1999, PROSTATE, V39, P94; Ahmad N, 2002, ARCH BIOCHEM BIOPHYS, V398, P125, DOI 10.1006/abbi.2001.2704; Denissova NG, 2012, CARCINOGENESIS, V33, P149, DOI 10.1093/carcin/bgr236; Amin ARMR, 2009, J CLIN ONCOL, V27, P2712, DOI 10.1200/JCO.2008.20.6235; Douc-Rasy S, 2002, AM J PATHOL, V160, P631, DOI 10.1016/S0002-9440(10)64883-3; Zhang JW, 2013, CANCER LETT, V339, P279, DOI 10.1016/j.canlet.2012.10.037; Luo HT, 2011, FOOD CHEM, V128, P513, DOI 10.1016/j.foodchem.2011.03.073; Ting HJ, 2012, CANCER RES, V72, P958, DOI 10.1158/0008-5472.CAN-11-0042; Liang H, 2012, GENOME RES, V22, P2120, DOI 10.1101/gr.137596.112; Kooijman R, 2003, CELL SIGNAL, V15, P1091, DOI 10.1016/S0898-6568(03)00069-X; Mitra A, 2006, J ENVIRON PATHOL TOX, V25, P679; Kim YM, 2008, CANCER GENET CYTOGEN, V186, P78, DOI 10.1016/j.cancergencyto.2008.06.010; Hendrickson AW, 2009, CURR OPIN INVEST DR, V10, P1032; DENNIS PA, 1991, P NATL ACAD SCI USA, V88, P580, DOI 10.1073/pnas.88.2.580; Bootcov MR, 1997, P NATL ACAD SCI USA, V94, P11514, DOI 10.1073/pnas.94.21.11514; Gabellini C, 2006, ONCOGENE, V25, P5326, DOI 10.1038/sj.onc.1209631; Giovannini M, 2000, GENE DEV, V14, P1617; Ying L, 2007, CANCER RES, V67, P9286, DOI 10.1158/0008-5472.CAN-07-2238; Ryan PD, 2008, ONCOLOGIST, V13, P16, DOI 10.1634/theoncologist.2007-0199; Nagl NG, 2006, CANCER RES, V66, P1289, DOI 10.1158/0008-5472.CAN-05-3427; Santer FR, 2006, CANCER RES, V66, P3024, DOI 10.1158/0008-5472.CAN-05-2013; Lambert JR, 2006, J CELL PHYSIOL, V208, P566, DOI 10.1002/jcp.20692; Li M, 2007, CANCER RES, V67, P1988, DOI 10.1158/0008-5472.CAN-06-3066; Yamamoto S, 2012, VIRCHOWS ARCH, V460, P77, DOI 10.1007/s00428-011-1169-8; Bian Y, 2012, ONCOGENE, V31, P3322, DOI 10.1038/onc.2011.494; Cekanova M, 2009, CANCER PREV RES, V2, P450, DOI 10.1158/1940-6207.CAPR-09-0057; Wang YH, 2009, MOL CELL BIOCHEM, V327, P257, DOI 10.1007/s11010-009-0064-y; Wesolowska O, 2010, ANTICANCER RES, V30, P4587; Khaw AK, 2012, GENE CHROMOSOME CANC, V51, P961, DOI 10.1002/gcc.21979; Morgillo F, 2007, CLIN CANCER RES, V13, P2795, DOI 10.1158/1078-0432.CCR-06-2077; Cantero G, 2006, MUTAGENESIS, V21, P321, DOI 10.1093/mutage/ge1033; Wang QF, 2014, INT J ONCOL, V44, P1277, DOI 10.3892/ijo.2014.2271; Buck E, 2010, MOL CANCER THER, V9, P2652, DOI 10.1158/1535-7163.MCT-10-0318; Aster JC, 2008, ANNU REV PATHOL-MECH, V3, P587, DOI 10.1146/annurev.pathol.3.121806.154300; Zhang YK, 2013, CARCINOGENESIS, V34, P1756, DOI 10.1093/carcin/bgt129; Guo P, 2009, J BIOL CHEM, V284, P18184, DOI 10.1074/jbc.M109.007096; Yee D, 2012, J NATL CANCER I, V104, P975, DOI 10.1093/jnci/djs258; Roy AM, 2005, MOL CANCER THER, V4, P81; Shrimali D, 2013, CANCER LETT, V341, P139, DOI 10.1016/j.canlet.2013.08.023; Bolos V, 2007, ENDOCR REV, V28, P339, DOI 10.1210/er.2006-0046; Huang CS, 1999, CARCINOGENESIS, V20, P237, DOI 10.1093/carcin/20.2.237; Singh S, 2010, BBA-GENE REGUL MECH, V1799, P788, DOI 10.1016/j.bbagrm.2010.07.004; Wu JN, 2013, CANCER DISCOV, V3, P35, DOI 10.1158/2159-8290.CD-12-0361; Reidy DL, 2010, J CLIN ONCOL, V28, P4240, DOI 10.1200/JCO.2010.30.4154; Katagiri A, 2012, MODERN PATHOL, V25, P282, DOI 10.1038/modpathol.2011.161; Rao PS, 2012, INT J CANCER, V130, P2703, DOI 10.1002/ijc.26308; Rogler G, 2014, CANCER LETT, V345, P235, DOI 10.1016/j.canlet.2013.07.032; Thaiparambil JT, 2011, INT J CANCER, V129, P2744, DOI 10.1002/ijc.25938; Murillo G, 2009, CANCER PREV RES, V2, P942, DOI 10.1158/1940-6207.CAPR-08-0232; Balasubramanyam K, 2004, J BIOL CHEM, V279, P51163, DOI 10.1074/jbc.M409024200; Guha M, 2013, NAT REV DRUG DISCOV, V12, P250, DOI 10.1038/nrd3992; Liu ZF, 2009, BIOORG MED CHEM LETT, V19, P706, DOI 10.1016/j.bmcl.2008.12.041; Hossain MM, 2012, NEUROCHEM INT, V61, P1102, DOI 10.1016/j.neuint.2012.08.002; Sasiela CA, 2008, J BIOMOL SCREEN, V13, P229, DOI 10.1177/1087057108315038; Yavari K, 2010, ACTA ONCOL, V49, P70, DOI 10.3109/02841860903334429; Zhao B, 2011, GENE DEV, V25, P51, DOI 10.1101/gad.2000111; Lee DH, 2003, CANCER RES, V63, P4648; Jung YD, 2001, INT J EXP PATHOL, V82, P309, DOI 10.1046/j.1365-2613.2001.00205.x; Athar M, 2009, ARCH BIOCHEM BIOPHYS, V486, P95, DOI 10.1016/j.abb.2009.01.018; Dickinson Douglas, 2014, Inflammation & Allergy Drug Targets, V13, P15; Yu LL, 2011, ONCOL REP, V26, P1197, DOI 10.3892/or.2011.1410; Li JL, 2005, CANCER CELL, V8, P1, DOI 10.1016/j.ccr.2005.06.013; Sotoca AM, 2008, J STEROID BIOCHEM, V112, P171, DOI 10.1016/j.jsbmb.2008.10.002; Shamim U, 2012, J CELL PHYSIOL, V227, P1493, DOI 10.1002/jcp.22865; Maher DM, 2011, MOL CARCINOGEN, V50, P47, DOI 10.1002/mc.20695; FOTSIS T, 1993, P NATL ACAD SCI USA, V90, P2690, DOI 10.1073/pnas.90.7.2690; Clem BF, 2013, MOL CANCER THER, V12, P1461, DOI 10.1158/1535-7163.MCT-13-0097; Nandakumar V, 2011, CARCINOGENESIS, V32, P537, DOI 10.1093/carcin/bgq285; Loukopoulos P, 2007, CANCER SCI, V98, P392, DOI 10.1111/j.1349-7006.2007.00395.x; Subbaramaiah K, 2013, CANCER PREV RES, V6, P886, DOI 10.1158/1940-6207.CAPR-13-0140; Yokomizo A, 1999, ONCOGENE, V18, P1629, DOI 10.1038/sj.onc.1202474; Thamilselvan V, 2011, INT J CANCER, V129, P2916, DOI 10.1002/ijc.25949; Xie F, 2012, EUR J PHARM SCI, V46, P388, DOI 10.1016/j.ejps.2012.03.002; Fang LY, 2013, CANCER RES, V73, P5633, DOI 10.1158/0008-5472.CAN-12-3228; Nandan MO, 2004, ONCOGENE, V23, P3404, DOI 10.1038/sj.onc.1207397; Guan B, 2011, CANCER RES, V71, P6718, DOI 10.1158/0008-5472.CAN-11-1562; Aronchik I, 2014, MOL CANCER RES, V12, P1621, DOI 10.1158/1541-7786.MCR-14-0018; Bean GR, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003483; Beckerman R, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000935; Bray SJ, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-11; Breen MJ, 2013, PLOS ONE, V8; Chen SJ, 2007, PROSTATE, V67, P557, DOI 10.1002/pros.20551; Chen Sophie S, 2012, Discov Med, V13, P7; Chen WT, 2013, ONCOGENE, V33, P4997; Chintharlapalli S, 2007, CARCINOGENESIS, V28, P2337, DOI 10.1093/carcin/bgm189; Covey TM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013545; Dai W, 2013, MOL CARCINOG; Dai XZ, 2013, ASIAN PAC J CANCER P, V14, P3855; D'Angelo L, 2014, CARCINOGENESIS, V35, P2314, DOI 10.1093/carcin/bgu173; Dhar S, 2015, BBA-MOL CELL RES, V1853, P265, DOI 10.1016/j.bbamcr.2014.11.004; Dominguez G, 2006, J CLIN ONCOL, V24, P805, DOI 10.1200/JCO.2005.02.2350; Dotsch V, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004887; Durfort T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029213; Enderle L, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004208; Fox Melissa M, 2013, Genes Cancer, V4, P3, DOI 10.1177/1947601913486346; Gao R, 2014, MOL CANCER THER, V13, P2930, DOI 10.1158/1535-7163.MCT-14-0324; Gudkov Andrei V, 2011, Genes Cancer, V2, P503, DOI 10.1177/1947601911409747; Gullett Norleena P, 2010, Semin Oncol, V37, P258, DOI 10.1053/j.seminoncol.2010.06.014; Hahn WC, 2002, NEW ENGL J MED, V347, P1593, DOI 10.1056/NEJMra021902; Hebert E, 2006, BIOSCIENCE REP, V26, P7, DOI 10.1007/s10540-006-9002-3; Herman-Antosiewicz A, 2007, MOL CANCER THER, V6, P1249, DOI 10.1158/1535-7163.MCT-06-0477; Huang AC, 2013, IN VIVO, V27, P627; Husaini Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043833; Jang JY, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-421; Ji Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078700; Jia CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027008; Kandoth C, 2013, NATURE, V497, P67, DOI DOI 10.1038/NATURE12113; Kaushik G, 2014, MOL CARCINOG; Khan R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056020; Kim KJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080590; Lamonte Gregory, 2013, Cancer Metab, V1, P23, DOI 10.1186/2049-3002-1-23; Leupin N, 2004, LEUKEMIA LYMPHOMA, V45, P1205, DOI 10.1080/10298190310001623829; Li J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065549; Massi D, 2006, MODERN PATHOL, V19, P246, DOI 10.1038/modpathol.3800526; Mohan Royce, 2004, Angiogenesis, V7, P115, DOI 10.1007/s10456-004-1026-3; Nahta R, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1612; Nakamura H, 2011, PLOS ONE, V6; Pons DG, 2014, J CELL BIOCHEM, V155, P949; Pratheeshkumar P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052279; Rufini Alessandro, 2011, Genes Cancer, V2, P491, DOI 10.1177/1947601911408890; Serrano I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3976; Sharif T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032526; Szic KSV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087850; The Cancer Genome Atlas Research Network, 2013, NATURE, V499, P43; Van HB, 2014, CARCINOGENESIS, V35, P867; Wang BY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047053; Wang DD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040364; Wang LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065539; Wang T, 2007, CANCER RES, V67, P1879; Xing CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065538; Yang YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054736; Yu JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055934; Zanotto A, 2012, J NUTR BIOCHEM, V23, P591, DOI 10.1016/j.jnutbio.2011.02.015; Zhang L, 2014, HEPATOLOGY, V59, P178, DOI 10.1002/hep.26628; Zhang X, 2013, J SHANDONG U ENG SCI, V1, P1; Zhang YY, 2014, ONCOL REP, V31, P1445, DOI 10.3892/or.2013.2951; Zilfou JT, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001883	481	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1044-579X			SEMIN CANCER BIOL	Semin. Cancer Biol.	DEC	2015	35			S			S55	S77		10.1016/j.semcancer.2015.02.005		23	Oncology	Oncology	CY7WG	WOS:000366619400004		
J	Block, KI; Gyllenhaal, C; Lowe, L; Amedei, A; Amin, ARMR; Amin, A; Aquilano, K; Arbiser, J; Arreola, A; Arzumanyan, A; Ashraf, SS; Azmi, AS; Benencia, F; Bhakta, D; Bilsland, A; Bishayeen, A; Blain, SW; Block, PB; Boosani, CS; Carey, TE; Carnero, A; Carotenuto, M; Casey, SC; Chakrabarti, M; Chaturvedi, R; Chen, GZ; Chenx, H; Chen, S; Chen, YC; Choi, BK; Ciriolo, MR; Coley, HM; Collins, AR; Connell, M; Crawford, S; Curran, CS; Dabrosin, C; Damia, G; Dasgupta, S; DeBerardinis, RJ; Decker, WK; Dhawan, P; Diehl, AME; Dong, JT; Dou, QP; Drew, JE; Elkord, E; El-Rayes, B; Feitelson, MA; Felsher, DW; Ferguson, LR; Fimognari, C; Firestone, GL; Frezza, C; Fujii, H; Fuster, MM; Generali, D; Georgakilas, AG; Gieseler, F; Gilbertson, M; Green, MF; Grue, B; Guha, G; Halicka, D; Helferich, WG; Heneberg, P; Hentosh, P; Hirschey, MD; Hofseth, LJ; Holcombe, RF; Honoki, K; Hsu, HY; Huang, GS; Jensen, LD; Jiang, WG; Jones, LW; Karpowicz, PA; Keith, WN; Kerkar, SP; Khan, GN; Khatami, M; Ko, YH; Kucuk, O; Kulathinal, RJ; Kumar, NB; Kwon, BS; Le, A; Lea, MA; Lee, HY; Lichtor, T; Lin, LT; Locasale, JW; Lokeshwar, BL; Longo, VD; Lyssiotis, CA; MacKenzie, KL; Malhotra, M; Marino, M; Martinez-Chantar, ML; Matheu, A; Maxwell, C; McDonnell, E; Meeker, AK; Mehrmohamadi, M; Mehta, K; Michelotti, GA; Mohammad, RM; Mohammed, SI; Morre, DJ; Muqbil, I; Muralidhar, V; Murphy, MP; Nagaraju, GP; Nahta, R; Niccolai, E; Nowsheen, S; Panis, C; Pantano, F; Parslow, VR; Pawelec, G; Pedersen, PL; Poore, B; Poudyal, D; Prakash, S; Prince, M; Raffaghello, L; Rathmell, JC; Rathmell, WK; Ray, SK; Reichrath, J; Rezazadeh, S; Ribatti, D; Ricciardiello, L; Robey, RB; Rodier, F; Rupasinghe, HPV; Russo, GL; Ryan, EP; Samadi, AK; Sanchez-Garcia, I; Sanders, AJ; Santini, D; Sarkar, M; Sasada, T; Saxena, NK; Shackelford, RE; Kumara, HMCS; Sharma, D; Shin, DM; Sidransky, D; Siegelin, MD; Signori, E; Singh, N; Sivanand, S; Sliva, D; Smythe, C; Spagnuolo, C; Stafforini, DM; Stagg, J; Subbarayan, PR; Sundin, T; Talib, WH; Thompson, SK; Tran, PT; Ungefroren, H; Vander Heiden, MG; Venkateswaran, V; Vinay, DS; Vlachostergios, PJ; Wang, ZW; Wellendx, KE; Whelan, RL; Yang, ES; Yang, HJ; Yang, XJ; Yaswen, P; Yedjou, C; Yin, X; Zhu, JY; Zollo, M				Block, Keith I.; Gyllenhaal, Charlotte; Lowe, Leroy; Amedei, Amedeo; Amin, A. R. M. Ruhul; Amin, Amr; Aquilano, Katia; Arbiser, Jack; Arreola, Alexandra; Arzumanyan, Alla; Ashraf, S. Salman; Azmi, Asfar S.; Benencia, Fabian; Bhakta, Dipita; Bilsland, Alan; Bishayeen, Anupam; Blain, Stacy W.; Block, Penny B.; Boosani, Chandra S.; Carey, Thomas E.; Carnero, Amancio; Carotenuto, Marianeve; Casey, Stephanie C.; Chakrabarti, Mrinmay; Chaturvedi, Rupesh; Chen, Georgia Zhuo; Chenx, Helen; Chen, Sophie; Chen, Yi Charlie; Choi, Beom K.; Ciriolo, Maria Rosa; Coley, Helen M.; Collins, Andrew R.; Connell, Marisa; Crawford, Sarah; Curran, Colleen S.; Dabrosin, Charlotta; Damia, Giovanna; Dasgupta, Santanu; DeBerardinis, Ralph J.; Decker, William K.; Dhawan, Punita; Diehl, Anna Mae E.; Dong, Jin-Tang; Dou, Q. Ping; Drew, Janice E.; Elkord, Eyad; El-Rayes, Bassel; Feitelson, Mark A.; Felsher, Dean W.; Ferguson, Lynnette R.; Fimognari, Carmela; Firestone, Gary L.; Frezza, Christian; Fujii, Hiromasa; Fuster, Mark M.; Generali, Daniele; Georgakilas, Alexandros G.; Gieseler, Frank; Gilbertson, Michael; Green, Michelle F.; Grue, Brendan; Guha, Gunjan; Halicka, Dorota; Helferich, William G.; Heneberg, Petr; Hentosh, Patricia; Hirschey, Matthew D.; Hofseth, Lorne J.; Holcombe, Randall F.; Honoki, Kanya; Hsu, Hsue-Yin; Huang, Gloria S.; Jensen, Lasse D.; Jiang, Wen G.; Jones, Lee W.; Karpowicz, Phillip A.; Keith, W. Nicol; Kerkar, Sid P.; Khan, Gazala N.; Khatami, Mahin; Ko, Young H.; Kucuk, Omer; Kulathinal, Rob J.; Kumar, Nagi B.; Kwon, Byoung S.; Le, Anne; Lea, Michael A.; Lee, Ho-Young; Lichtor, Terry; Lin, Liang-Tzung; Locasale, Jason W.; Lokeshwar, Bal L.; Longo, Valter D.; Lyssiotis, Costas A.; MacKenzie, Karen L.; Malhotra, Meenakshi; Marino, Maria; Martinez-Chantar, Maria L.; Matheu, Ander; Maxwell, Christopher; McDonnell, Eoin; Meeker, Alan K.; Mehrmohamadi, Mahya; Mehta, Kapil; Michelotti, Gregory A.; Mohammad, Ramzi M.; Mohammed, Sulma I.; Morre, D. James; Muqbil, Irfana; Muralidhar, Vinayak; Murphy, Michael P.; Nagaraju, Ganji Purnachandra; Nahta, Rita; Niccolai, Elena; Nowsheen, Somaira; Panis, Carolina; Pantano, Francesco; Parslow, Virginia R.; Pawelec, Graham; Pedersen, Peter L.; Poore, Brad; Poudyal, Deepak; Prakash, Satya; Prince, Mark; Raffaghello, Lizzia; Rathmell, Jeffrey C.; Rathmell, W. Kimryn; Ray, Swapan K.; Reichrath, Joerg; Rezazadeh, Sarallah; Ribatti, Domenico; Ricciardiello, Luigi; Robey, R. Brooks; Rodier, Francis; Rupasinghe, H. P. Vasantha; Russo, Gian Luigi; Ryan, Elizabeth P.; Samadi, Abbas K.; Sanchez-Garcia, Isidro; Sanders, Andrew J.; Santini, Daniele; Sarkar, Malancha; Sasada, Tetsuro; Saxena, Neeraj K.; Shackelford, Rodney E.; Kumara, H. M. C. Shantha; Sharma, Dipali; Shin, Dong M.; Sidransky, David; Siegelin, Markus David; Signori, Emanuela; Singh, Neetu; Sivanand, Sharanya; Sliva, Daniel; Smythe, Carl; Spagnuolo, Carmela; Stafforini, Diana M.; Stagg, John; Subbarayan, Pochi R.; Sundin, Tabetha; Talib, Wamidh H.; Thompson, Sarah K.; Tran, Phuoc T.; Ungefroren, Hendrik; Vander Heiden, Matthew G.; Venkateswaran, Vasundara; Vinay, Dass S.; Vlachostergios, Panagiotis J.; Wang, Zongwei; Wellendx, Kathryn E.; Whelan, Richard L.; Yang, Eddy S.; Yang, Huanjie; Yang, Xujuan; Yaswen, Paul; Yedjou, Clement; Yin, Xin; Zhu, Jiyue; Zollo, Massimo			Designing a broad-spectrum integrative approach for cancer prevention and treatment	SEMINARS IN CANCER BIOLOGY			English	Review						Multi-targeted; Cancer hallmarks; Phytochemicals; Targeted therapy; Integrative medicine	RANDOMIZED CONTROLLED-TRIALS; TEA POLYPHENOL (-)-EPIGALLOCATECHIN-3-GALLATE; BOTANICAL DIETARY-SUPPLEMENTS; TRADITIONAL CHINESE MEDICINE; CONTROLLED CLINICAL-TRIAL; METASTATIC BREAST-CANCER; ENDOTHELIAL-CELL-GROWTH; III COLON-CANCER; PHASE-I TRIAL; LOW-FAT DIETS	Targeted therapies and the consequent adoption of "personalized" oncology have achieved notable successes in some cancers; however, significant problems remain with this approach. Many targeted therapies are highly toxic, costs are extremely high, and most patients experience relapse after a few disease-free months. Relapses arise from genetic heterogeneity in tumors, which harbor therapy-resistant immortalized cells that have adopted alternate and compensatory pathways (i.e., pathways that are not reliant upon the same mechanisms as those which have been targeted). To address these limitations, an international task force of 180 scientists was assembled to explore the concept of a low-toxicity "broadspectrum" therapeutic approach that could simultaneously target many key pathways and mechanisms. Using cancer hallmark phenotypes and the tumor microenvironment to account for the various aspects of relevant cancer biology, interdisciplinary teams reviewed each hallmark area and nominated a wide range of high-priority targets (74 in total) that could be modified to improve patient outcomes. For these targets, corresponding low-toxicity therapeutic approaches were then suggested, many of which were phytochemicals. Proposed actions on each target and all of the approaches were further reviewed for known effects on other hallmark areas and the tumor microenvironment Potential contrary or procarcinogenic effects were found for 3.9% of the relationships between targets and hallmarks, and mixed evidence of complementary and contrary relationships was found for 7.1%. Approximately 67% of the relationships revealed potentially complementary effects, and the remainder had no known relationship. Among the approaches, 1.1% had contrary, 2.8% had mixed and 62.1% had complementary relationships. These results suggest that a broad-spectrum approach should be feasible from a safety standpoint. This novel approach has potential to be relatively inexpensive, it should help us address stages and types of cancer that lack conventional treatment, and it may reduce relapse risks. A proposed agenda for future research is offered. (C) 2015 The Authors. Published by Elsevier Ltd.	[Block, Keith I.; Gyllenhaal, Charlotte; Block, Penny B.] Block Ctr Integrat Canc Treatment, Skokie, IL 60077 USA; [Lowe, Leroy] Getting Know Canc, Truro, NS, Canada; [Amedei, Amedeo] Univ Florence, Dept Expt & Clin Med, Florence, Italy; [Amin, Amr] Univ Florence, Dept Expt & Clin Med, Florence, Italy; [Aquilano, Katia; Ciriolo, Maria Rosa] United Arab Emirates Univ, Coll Sci, Dept Biol, Al Ain, U Arab Emirates; [Arreola, Alexandra; Rathmell, W. Kimryn] Univ Roma Tor Vergata, Dept Biol, Rome, Italy; [Arzumanyan, Alla; Feitelson, Mark A.; Kulathinal, Rob J.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Ashraf, S. Salman] Temple Univ, Dept Biol, Philadelphia, PA 19122 USA; [Azmi, Asfar S.; Dou, Q. Ping; Mohammad, Ramzi M.; Muqbil, Irfana] United Arab Emirates Univ, Coll Sci, Dept Chem, Al Ain, U Arab Emirates; [Benencia, Fabian] Wayne State Univ, Karmanos Canc Inst, Dept Oncol, Detroit, MI USA; [Bhakta, Dipita; Guha, Gunjan] Ohio Univ, Dept Biomed Sci, Athens, OH 45701 USA; [Bilsland, Alan; Keith, W. Nicol] SASTRA Univ, Sch Chem & Bio Technol, Thanjavur, Tamil Nadu, India; [Bishayeen, Anupam] Univ Glasgow, Glasgow, Lanark, Scotland; [Blain, Stacy W.] Larkin Hlth Sci Inst, Coll Pharm, Dept Pharmaceut Sci, Miami, FL USA; [Boosani, Chandra S.] Suny Downstate Med Ctr, Dept Pediat, Brooklyn, NY USA; [Carey, Thomas E.] Creighton Univ, Sch Med, Dept Biomed Sci, Omaha, NE 68178 USA; [Carnero, Amancio] Univ Michigan, Head & Neck Canc Biol Lab, Ann Arbor, MI USA; [Carotenuto, Marianeve; Zollo, Massimo] CSIC, Inst Biomed Sevilla, Seville, Spain; [Carotenuto, Marianeve; Zollo, Massimo] Ctr Ingn Genet & Biotecnol Avanzate, Naples, Italy; [Casey, Stephanie C.; Felsher, Dean W.] Univ Naples Federico II, Dept Mol Med & Med Biotechnol, I-80131 Naples, Italy; [Chakrabarti, Mrinmay; Ray, Swapan K.] Stanford Univ, Div Oncol, Dept Pathol & Med, Stanford, CA 94305 USA; [Chaturvedi, Rupesh] Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC USA; [Chenx, Helen; Connell, Marisa; Maxwell, Christopher] Jawaharlal Nehru Univ, Sch Biotechnol, New Delhi 110067, India; [Chen, Sophie] Univ British Columbia, Dept Pediat, Michael Cuccione Childhood Canc Res Program, Child & Family Res Inst, Vancouver, BC V6T 1W5, Canada; [Chen, Yi Charlie] Ovarian & Prostate Canc Res Lab, Guildford, Surrey, England; [Chen, Yi Charlie] Alderson Broaddus Univ, Dept Biol, Philadelphia, PA USA; [Gyllenhaal, Charlotte; Choi, Beom K.; Kwon, Byoung S.] Natl Canc Ctr, Div Canc Biol, Canc Immunol Branch, Goyang, Gyeonggi, South Korea; [Coley, Helen M.] Univ Surrey, Fac Hlth & Med Sci, Guildford GU2 5XH, Surrey, England; [Collins, Andrew R.] Univ Oslo, Fac Med, Dept Nutr, Oslo 3, Norway; [Crawford, Sarah] So Connecticut State Univ, Canc Biol Res Lab, New Haven, CT 06515 USA; [Curran, Colleen S.] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA; [Dabrosin, Charlotta] Linkoping Univ, Dept Oncol, Linkoping, Sweden; [Dabrosin, Charlotta] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden; [Damia, Giovanna] Ist Ric Farmacol Mario Negri, Ist Ricovero Cura Carattere Sci, Dept Oncol, Milan, Italy; [Dasgupta, Santanu] Univ Texas Hlth Sci Ctr Tyler, Dept Cellular & Mol Biol, Tyler, TX USA; [Vinay, Dass S.] Tulane Univ, Hlth Sci Ctr, Dept Med, Sect Clin Immunol Allergy & Rheumatol, New Orleans, LA USA; [DeBerardinis, Ralph J.] Univ Texas SW Med Ctr Dallas, Childrens Med Ctr Res Inst, Dallas, TX 75390 USA; [Decker, William K.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Dhawan, Punita] Vanderbilt Univ, Sch Med, Div Surg Oncol, Dept Surg & Canc Biol, Nashville, TN 37212 USA; [Diehl, Anna Mae E.; Michelotti, Gregory A.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Drew, Janice E.] Univ Aberdeen, Rowett Inst Nutr & Hlth, Aberdeen, Scotland; [Elkord, Eyad] United Arab Emirates Univ, Coll Med & Hlth Sci, Al Ain, U Arab Emirates; [El-Rayes, Bassel; Nagaraju, Ganji Purnachandra] Emory Univ, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA; [Ferguson, Lynnette R.; Parslow, Virginia R.] Univ Auckland, Discipline Nutr, Auckland 1, New Zealand; [Fimognari, Carmela] Univ Auckland, Auckland Canc Soc Res Ctr, Auckland 1, New Zealand; [Firestone, Gary L.] Univ Bologna, Dipartimento Sci Qualita Vita Alma Mater Studioru, Rimini, Italy; [Frezza, Christian] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Fujii, Hiromasa] Univ Cambridge, Hutchison MRC Res Ctr, Med Res Council Canc Unit, Cambridge, England; [Fuster, Mark M.; Yin, Xin] Nara Med Univ, Dept Orthoped Surg, Kashihara, Nara 634, Japan; [Generali, Daniele] Univ Calif San Diego, Med & Res Serv, Vet Affairs San Diego Healthcare Syst, San Diego, CA 92103 USA; [Generali, Daniele] Univ Calif San Diego, San Diego, CA 92103 USA; [Georgakilas, Alexandros G.] Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy; [Gieseler, Frank; Ungefroren, Hendrik] Azienda Osped Ist Ospitalieri Cremona, Mol Therapy & Pharrnacogen Unit, Cremona, Italy; [Gilbertson, Michael] Natl Tech Univ Athens, Sch Appl Math & Phys Sci, Dept Phys, Athens, Greece; [Green, Michelle F.; Hirschey, Matthew D.; McDonnell, Eoin; Rathmell, Jeffrey C.] Univ Hosp Schleswig Holstein, Dept Med 1, Lubeck, Germany; [Grue, Brendan] Getting Know Canc, Guelph, ON, Canada; [Halicka, Dorota] Duke Univ, Med Ctr, Duke Mol Physiol Inst, Durham, NC USA; [Helferich, William G.; Yang, Xujuan] Dalhousie Univ, Dept Environm Sci Microbiol & Immunol, Halifax, NS, Canada; [Heneberg, Petr] New York Med Coll, Dept Pathol, Valhalla, NY 10595 USA; [Hentosh, Patricia] Univ Illinois, Champaign, IL 61820 USA; [Hofseth, Lorne J.; Poudyal, Deepak] Charles Univ Prague, Fac Med 3, Prague, Czech Republic; [Holcombe, Randall F.] Old Domin Univ, Sch Med Lab & Radiat Sci, Norfolk, VA USA; [Hsu, Hsue-Yin] Univ S Carolina, Coll Pharm, Columbia, SC 29208 USA; [Huang, Gloria S.] Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USA; [Jensen, Lasse D.] Tzu Chi Univ, Dept Life Sci, Hualien, Taiwan; [Jensen, Lasse D.] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Jensen, Lasse D.] Montefiore Med Ctr, Bronx, NY 10467 USA; [Jensen, Lasse D.] Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden; [Jensen, Lasse D.] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Jiang, Wen G.; Sanders, Andrew J.] Cardiff Univ, Sch Med, Heath Pk, Cardiff, Wales; [Jones, Lee W.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Karpowicz, Phillip A.] Univ Windsor, Windsor, ON N9B 3P4, Canada; [Kerkar, Sid P.] Mayo Clin, Lab Med & Pathol, Rochester, MN USA; [Khan, Gazala N.] Henry Ford Hosp, Detroit, MI 48202 USA; [Khatami, Mahin] Natl Inst Hlth, Natl Canc Inst, Inflammat & Canc Res, Bethesda, MD USA; [Ko, Young H.] Univ Maryland BioPark, Innovat Ctr, KoDiscovery, Baltimore, MD USA; [Kumar, Nagi B.] Univ S Florida, Coll Med, Moffitt Canc Ctr, Tampa, FL USA; [Kumara, H. M. C. Shantha; Whelan, Richard L.] St Lukes Roosevelt Hosp, Dept Surg, New York, NY 10025 USA; [Kwon, Byoung S.] Tulane Univ, Dept Med, Hlth Sci Ctr, New Orleans, LA 70118 USA; [Le, Anne; Poore, Brad] Johns Hopkins Univ, Sch Med, Dept Pathol, Sol Goldman Pancreat Canc Res Ctr, Baltimore, MD USA; [Lea, Michael A.] Rutgers State Univ, New Jersey Med Sch, Newark, NJ USA; [Lee, Ho-Young] Seoul Natl Univ, Coll Pharm, Seoul 151, South Korea; [Lichtor, Terry] Rush Univ, Med Ctr, Dept Neurosurg, Chicago, IL 60612 USA; [Lin, Liang-Tzung] Taipei Med Univ, Coll Med, Sch Med, Dept Microbiol & Immunol, Taipei, Taiwan; [Locasale, Jason W.] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Lokeshwar, Bal L.] Georgia Regents Univ, Ctr Canc, Dept Med, Augusta, GA USA; [Longo, Valter D.] Univ So Calif, Div Biogerontol, Andrus Gerontol Ctr, Los Angeles, CA USA; [Lyssiotis, Costas A.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI USA; [Lyssiotis, Costas A.] Univ Michigan, Dept Internal Med, Div Gastroenterol, Ann Arbor, MI USA; [MacKenzie, Karen L.] Childrens Canc Inst Australia, Kensington, NSW, Australia; [Malhotra, Meenakshi; Prakash, Satya] McGill Univ, Dept Biomed Engn, Montreal, PQ, Canada; [Marino, Maria] Univ Rome Tre, Dept Sci, I-00146 Rome, Italy; [Martinez-Chantar, Maria L.] Technol Pk Bizkaia, Ctr Invest Biomed Red Enfermedades Hepat Digest, Metabol Unit, Bizkaia, Spain; [Matheu, Ander] Biodonostia Inst, Gipuzkoa, Spain; [Meeker, Alan K.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Mehrmohamadi, Mahya] Cornell Univ, Dept Mol Biol & Genet, Field Genet Gen & Dev, Ithaca, NY USA; [Mehta, Kapil] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Mohammed, Sulma I.] Purdue Univ, Ctr Canc Res, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA; [Morre, D. James] Mor NuCo Inc, Purdue Res Pk, W Lafayette, IN USA; [Muralidhar, Vinayak] Harvard Univ, Sch Med, Harvard MIT Div Hlth Sci & Technol, Boston, MA USA; [Muralidhar, Vinayak; Vander Heiden, Matthew G.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Murphy, Michael P.] MRC Mitochondrial Biol Unit, Cambridge, England; [Niccolai, Elena] Univ Florence, Florence, Italy; [Nowsheen, Somaira] Mayo Clin, Mayo Med Sch, Mayo Grad Sch, Med Sci Training Program, Rochester, MN USA; [Panis, Carolina] State Univ West Parana, UNIOESTE, Lab Inflammatory Mediators, Parana, Brazil; [Pantano, Francesco; Santini, Daniele] Univ Campus Bio Med, Dept Med Oncol, Rome, Italy; [Pawelec, Graham] Univ Tubingen, Med Res Ctr, Tubingen, Germany; [Pedersen, Peter L.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Dept Biol Chem & Oncol Member Large, Baltimore, MD USA; [Prince, Mark] Univ Michigan, Sch Med, Dept Otolaryngol Head & Neck, Ann Arbor, MI USA; [Raffaghello, Lizzia] Ist Giannina Gaslini, Lab Oncol, I-16148 Genoa, Italy; [Reichrath, Joerg] Saarland Univ Hosp, Clin Dermatol Venerol & Allergol, Ctr Clin & Expt Photodermatol, Homburg, Germany; [Rezazadeh, Sarallah] Univ Rochester, Dept Biol, Rochester, NY 14627 USA; [Ribatti, Domenico] Univ Bari, Sch Med, Dept Basic Med Sci Neurosci & Sensory Organs, Bari, Italy; [Ricciardiello, Luigi] Natl Canc Inst Giovanni Paolo II, Bari, Italy; [Robey, R. Brooks] Univ Bologna, Dept Med & Surg Sci, Bologna, Italy; [Robey, R. Brooks] White River Junct Vet Affairs Med Ctr, White River Jct, VT USA; [Rodier, Francis] Geisel Sch Med Dartmouth, Hanover, NH USA; [Rodier, Francis] Univ Montreal, Ctr Rech Ctr Hosp, Montreal, PQ, Canada; [Rupasinghe, H. P. Vasantha] Inst Canc Montreal, Montreal, PQ, Canada; [Russo, Gian Luigi; Spagnuolo, Carmela] Univ Montreal, Dept Radiol, Radio Oncol & Med Nucl, Montreal, PQ, Canada; [Ryan, Elizabeth P.] Dalhousie Univ, Dept Environm Sci, Fac Agr, Halifax, NS, Canada; [Samadi, Abbas K.] Dalhousie Univ, Dept Pathol, Fac Med, Halifax, NS, Canada; [Sanchez-Garcia, Isidro] CNR, Inst Food Sci, Avellino, Italy; [Sarkar, Malancha] Colorado State Univ, Dept Environm & Radiol Hlth Sci, Ft Collins, CO 80523 USA; [Sasada, Tetsuro] Sanus Biosci, San Diego, CA USA; [Saxena, Neeraj K.] Univ Salamanca, CSIC, Inst Biol Mol & Celular Canc, Expt Therapeut & Translat Oncol Program, E-37008 Salamanca, Spain; [Shackelford, Rodney E.] Univ Miami, Dept Biol, Miami, FL USA; [Sharma, Dipali] Kurume Univ, Sch Med, Dept Immunol, Kurume, Fukuoka 830, Japan; [Sidransky, David] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Siegelin, Markus David] Louisiana State Univ, Hlth Shreveport, Dept Pathol, Shreveport, LA 71105 USA; [Signori, Emanuela] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Signori, Emanuela] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA; [Singh, Neetu] Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD USA; [Sivanand, Sharanya; Wellendx, Kathryn E.] Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY USA; [Sliva, Daniel] Inst Translat Pharmacol, Natl Res Council, Rome, Italy; [Singh, Neetu] King Georges Med Univ, Adv Mol Sci Res Ctr, Ctr Adv Res, Lucknow, Uttar Pradesh, India; [Sivanand, Sharanya; Wellendx, Kathryn E.] Univ Penn, Perelman Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA; [Sliva, Daniel] Purdue Res Pk, DSTest Labs, Indianapolis, IN USA; [Smythe, Carl] Univ Sheffield, Dept Biomed Sci, Sheffield Canc Res Ctr, Sheffield S10 2TN, S Yorkshire, England; [Stafforini, Diana M.] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA; [Stagg, John] Univ Utah, Dept Internal Med, Salt Lake City, UT USA; [Subbarayan, Pochi R.] Univ Montreal, Ctr Rech Ctr Hosp, Faculte Pharmacie, Inst Canc Montreal, Montreal, PQ, Canada; [Sundin, Tabetha] Univ Miami, Sch Med, Dept Med, Miami, FL USA; [Talib, Wamidh H.] Sentara Healthcare, Dept Mol Diagnost, Norfolk, VA USA; [Thompson, Sarah K.] Appl Sci Univ, Dept Clin Pharm & Therapeut, Amman, Jordan; [Tran, Phuoc T.] Royal Adelaide Hosp, Dept Surg, Adelaide, SA 5000, Australia; [Venkateswaran, Vasundara] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Vlachostergios, Panagiotis J.] Johns Hopkins Univ, Dept Radiat Oncol, Baltimore, MD USA; [Wang, Zongwei] Johns Hopkins Univ, Dept Mol Radiat Sci Oncol & Urol, Baltimore, MD USA; [Venkateswaran, Vasundara] Univ Toronto, Dept Surg, Div Urol, Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada; [Vlachostergios, Panagiotis J.] New York Univ, Lutheran Med Ctr, Dept Internal Med, Brooklyn, NY USA; [Wang, Zongwei] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Urol, Boston, MA USA; [Yang, Eddy S.] Univ Alabama Birmingham, Med Sch Birmingham, Dept Radiat Oncol, Birmingham, AL USA; [Yang, Huanjie] Harbin Inst Technol, Sch Life Sci & Technol, Harbin 150006, Heilongjiang, Peoples R China; [Yaswen, Paul] Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA USA; [Yedjou, Clement] Jackson State Univ, Dept Biol, Jackson, MS USA; [Zhu, Jiyue] Washington State Univ, Coll Pharm, Spokane, WA USA; [Arbiser, Jack] Atlanta Vet Adm Med Ctr, Atlanta, GA USA; [Arbiser, Jack] Emory Univ, Emory Univ Sch Med, Dept Dermatol, Atlanta, GA USA; [Lowe, Leroy] Univ Lancaster, Lancaster Environm Ctr, Lancaster, England	Block, KI (reprint author), Block Ctr Integrat Canc Treatment, Skokie, IL 60077 USA.	drblock@blockmedical.com; Leroy.lowe@gettingtoknowcancer.org	Keith, Nicol/D-3325-2009	Keith, Nicol/0000-0001-7862-3580	Terry Fox Foundation Grant [TF-13-20]; UAEU Program for Advanced Research (UPAR) [31S118]; NIH [AR47901, R21CA188818, R15 CA137499-01, F32CA177139, P20RR016477, P20GM103434, R01CA170378, U54CA149145, U54CA143907, R01-HL107652, R01CA166348, R01GM071725, R01 CA109335-04A1, <LF>109511<LF>R01CA151304<LF>CA168997 <LF> A1110613<LF>1R03CA1711326<LF> 1P01AT003961<LF>RO1 CA100816<LF>P01AG034906 <LF> R01AG020642<LF>P01AG034906-01A1<LF>R01HL108006]; NIH NRSA Grant [F31CA154080]; NIH (NIAID) R01: Combination therapies for chronic HBV, liver disease, and cancer [AI076535]; Sky Foundation Inc. Michigan; University of Glasgow; Beatson Oncology Centre Fund; Spanish Ministry of Economy and Competitivity, ISCIII [PI12/00137, RTICC: RD12/0036/0028]; FEDER from Regional Development European Funds (European Union), Consejeria de Ciencia e Innovacion [CTS-6844, CTS-1848]; Consejeria de Salud of the Junta de Andalucia [PI-0135-2010, PI-0306-2012]; ISCIII [PIE13/0004]; FEDER funds; United Soybean Board; NIH NCCAM Grant [K01AT007324]; NIH NCI Grant [R33 CA161873-02]; Michael Cuccione Childhood Cancer Foundation Graduate Studentship; Ovarian and Prostate Cancer Research Trust, UK; West Virginia Higher Education Policy Commission/Division of Science Research; National Institutes of Health; Italian Association for Cancer Research (AIRC) [IG10636, 15403]; GRACE Charity, UK; Breast Cancer Campaign, UK; Michael Cuccione Childhood Cancer Foundation Postdoctoral Fellowship; Connecticut State University; Swedish Research Council; Swedish Research Society; University of Texas Health Science Centre at Tyler, Elsa U. Pardee Foundation; CPRIT; Cancer Prevention and Research Institute of Texas; NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH National Institute on Alcohol Abuse and Alcoholism (NIAAA); Gilead and Shire Pharmaceuticals; NIH/NCI [1R01CA20009, 5R01CAl27258-05, R21CA184788, NIH P30 CA22453, NCI RO1 28704]; Scottish Government's Rural and Environment Science and Analytical Services Division; National Research Foundation; United Arab Emirates University; Terry Fox Foundation; Novartis Pharmaceutical; Aveo Pharmaceutical; Roche; Bristol Myers Squibb; Bayer Pharmaceutical; Pfizer; Kyowa Kirin; NIH/NIAID Grant [A1076535]; Auckland Cancer Society; Cancer Society of New Zealand; NIH Public Service Grant from the National Cancer Institute [CA164095]; Medical Research Council CCU-Program Grant on cancer metabolism; EU Marie Curie Reintegration Grant [MC-CIG-303514]; Greek National funds through the Operational Program 'Educational and Lifelong Learning of the National Strategic Reference Framework (NSRF)-Research Funding Program THALES [MIS 379346]; COST Action CM1201 `Biomimetic Radical Chemistry'; Duke University Molecular Cancer Biology T32 Training Grant; National Sciences Engineering and Research Council Undergraduate Student Research Award in Canada; Charles University in Prague projects [UNCE 204015, PRVOUK P31/2012]; Czech Science Foundation projects [15-03834Y, P301/12/1686]; Czech Health Research Council AZV project [15-32432A]; Internal Grant Agency of the Ministry of Health of the Czech Republic project [NT13663-3/2012]; National Institute of Aging [P30AG028716-01]; NIH/NCI training grants to Duke University [T32-CA059365-19, 5T32-CA059365]; Ministry of Education, Culture, Sports, Science and Technology, Japan [24590493]; Ministry of Health and Welfare [CCMP101-RD-031, CCMP102-RD-112]; Tzu-Chi University of Taiwan [61040055-10]; Svenska Sallskapet for Medicinsk Forskning; Cancer Research Wales; Albert Hung Foundation; Fong Family Foundation; Welsh Government A4B scheme; NIH NCI; University of Glasgow, Beatson Oncology Centre Fund, CRUK [C301/A14762]; NIH Intramural Research Program; National Science Foundation; American Cancer Society; National Cancer Center [NCC-1310430-2]; National Research Foundation [NRF-2005-0093837]; Sol Goldman Pancreatic Cancer Research Fund Grant [80028595]; Lustgarten Fund Grant [90049125, NIHR21CA169757]; Alma Toorock Memorial for Cancer Research; National Research Foundation of Korea (NRF); Ministry of Science, ICT & Future Planning (MSIP), Republic of Korea [2011-0017639, 2011-0030001]; Ministry of Education of Taiwan [TMUTOP103005-4]; International Life Sciences Institute; United States' Public Health Services Grants [NIH R01CA156776]; VA-BLR&D Merit Review Grant [5101-BX001517-02]; V Foundation; Pancreatic Cancer Action Network; Damon Runyon Cancer Research Foundation; Children's Cancer Institute Australia; University Roma Tre; Italian Association for Cancer Research (AIRC-Grant) [IG15221]; Carlos III Health Institute; Feder funds [AM: CP10/00539, PI13/02277]; Basque Foundation for Science (IKERBASQUE); Marie Curie CIG Grant [2012/712404]; Canadian Institutes of Health Research; Avon Foundation for Women [OBC-134038]; Canadian Institutes of Health [MSH-136647, MOP 64308]; Bayer Healthcare System G4T (Grants4Targets); NIH NIDDK; NIH NIAAA; Shire Pharmaceuticals; Harvard-MIT Health Sciences and Technology Research Assistantship Award; Italian Ministry of University; University of Italy; Auckland Cancer Society Research Centre (ACSRC); German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, BMBF) [16SV5536K]; European Commission [FP7 259679 "IDEAL"]; Cinque per Mille dell'IRPEF-Finanziamento della Ricerca Sanitaria; European Union Seventh Framework Programme (FP7) [278570]; AIRC [10216, 13837]; European Community's Seventh Framework Program FP7 [311876]; Canadian Institute for Health Research [MOP114962, MOP125857]; Fonds de Recherche Quebec Sante [22624]; Terry Fox Research Institute [1030]; FEDER; MICINN [SAF2012-32810]; Junta de Castilla y Leon [BIO/SA06/13]; ARIMMORA project [FP7-ENV-2011]; European Union; NIH NIDDK [K01DK077137, R03DK089130]; NIH NCI grants [R01CA131294, R21 CA155686]; Avon Foundation; Breast Cancer Research Foundation Grant [90047965]; National Institute of Health, NINDS Grant [K08NS083732]; AACR-National Brain Tumor Society Career Development Award for Translational Brain Tumor Research [13-20-23-SIEG]; Department of Science and Technology, New Delhi, India [SR/FT/LS-063/2008]; Yorkshire Cancer Research; Wellcome Trust, UK; Italian Ministry of Economy and Finance Project CAMPUS-QUARC, within program FESR Campania Region; National Cancer Institute [5P01CA073992]; IDEA Award from the Department of Defense [W81XWH-12-1-0515]; Huntsman Cancer Foundation; University of Miami Clinical and Translational Science Institute (CTSI) Pilot Research Grant [CTSI-2013-P03]; SEEDS You Choose Awards; DoD [W81XVVH-11-1-0272, W81XWH-13-1-0182]; Kimmel Translational Science Award [SKF-13-021]; ACS Scholar award [122688-RSG-12-196-01-TBG]; National Cancer Institute, Pancreatic Cancer Action Network, Pew Charitable Trusts; American Diabetes Association; Elsa U. Pardee Foundation; Scientific Research Foundation for the Returned Oversea Scholars, State Education Ministry and Scientific and Technological Innovation Project, Harbin [2012RFLX5011]; United States National Institutes of Health [ES019458]; California Breast Cancer Research Program [17UB-8708]; National Institutes of Health through the RCMI-Center for Environmental Health [G1200MD007581]; NIH/National Heart, Lung, and Blood Institute Training Grant [T32HL098062]; European FP7-TuMIC [HEALTH-F2-2008-201662]; Italian Association for Cancer research (AIRC) Grant IG [11963]; Regione Campania L.R:N.5; European National Funds [PON01-02388/1 2007-2013]	Amr Amin was funded by Terry Fox Foundation Grant # TF-13-20 and UAEU Program for Advanced Research (UPAR) #31S118; Jack Arbiser was funded by NIH AR47901; Alexandra Arreola was funded by NIH NRSA Grant F31CA154080; Alla Arzumanyan was funded by NIH (NIAID) R01: Combination therapies for chronic HBV, liver disease, and cancer (AI076535); Work in the lab of Asfar S. Azmi is supported by NIH R21CA188818 as well as from Sky Foundation Inc. Michigan; Fabian Benencia was supported by NIH Grant R15 CA137499-01; Alan Bilsland was supported by the University of Glasgow, Beatson Oncology Centre Fund, CRUK (www. cancerresearchuk.org) Grant C301/A14762; Amancio Carnero was supported by grants from the Spanish Ministry of Economy and Competitivity, ISCIII (Fis: PI12/00137, RTICC: RD12/0036/0028) co-funded by FEDER from Regional Development European Funds (European Union), Consejeria de Ciencia e Innovacion (CTS-6844 and CTS-1848) and Consejeria de Salud of the Junta de Andalucia (PI-0135-2010 and PI-0306-2012). His work on this project has also been made possible thanks to the Grant PIE13/0004 co-funded by the ISCIII and FEDER funds; Stephanie C. Casey was supported by NIH Grant F32CA177139; Mrinmay Chakrabarti was supported by the United Soybean Board; Rupesh Chaturvedi was supported by an NIH NCCAM Grant (K01AT007324); Georgia Zhuo Chen was supported by an NIH NCI Grant (R33 CA161873-02); Helen Chen acknowledges financial support from the Michael Cuccione Childhood Cancer Foundation Graduate Studentship; Sophie Chen acknowledges financial support from the Ovarian and Prostate Cancer Research Trust, UK; Yi Charlie Chen acknowledges financial support from the West Virginia Higher Education Policy Commission/Division of Science Research, his research was also supported by NIH grants (P20RR016477 and P20GM103434) from the National Institutes of Health awarded to the West Virginia IDeA Network of Biomedical Research Excellence; Maria Rosa Ciriolo was partially supported by the Italian Association for Cancer Research (AIRC) Grants #IG10636 and #15403; Helen M. Coley acknowledges financial support from the GRACE Charity, UK and the Breast Cancer Campaign, UK; Marisa Connell was supported by a Michael Cuccione Childhood Cancer Foundation Postdoctoral Fellowship; Sarah Crawford was supported by a research grant from Connecticut State University; Charlotta Dabrosin acknowledges financial support from the Swedish Research Council and the Swedish Research Society; Giovanna Damia gratefully acknowledges the generous contributions of The Italian Association for Cancer Research (IG14536 to G.D.); Santanu Dasgupta gratefully acknowledges the support of the University of Texas Health Science Centre at Tyler, Elsa U. Pardee Foundation; William K. Decker was supported in part by CPRIT, the Cancer Prevention and Research Institute of Texas; Anna Mae E. Diehl was supported by NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the NIH National Institute on Alcohol Abuse and Alcoholism (NIAAA), Gilead and Shire Pharmaceuticals; Q. Ping Dou was partially supported by NIH/NCI (1R01CA20009, 5R01CAl27258-05 and R21CA184788), and NIH P30 CA22453 (to Karmanos Cancer Institute); Janice E.; Drew was supported by the Scottish Government's Rural and Environment Science and Analytical Services Division; Eyad Elkord thanks the National Research Foundation, United Arab Emirates University and the Terry Fox Foundation for supporting research projects in his lab; Bassel El-Rayes was supported by Novartis Pharmaceutical, Aveo Pharmaceutical, Roche, Bristol Myers Squibb, Bayer Pharmaceutical, Pfizer, and Kyowa Kirin; Mark A. Feitelson was supported by NIH/NIAID Grant A1076535; Dean W. Felsher was supported by NIH grants (R01CA170378, U54CA149145, and U54CA143907); Lynnette R Ferguson was financially supported by the Auckland Cancer Society and the Cancer Society of New Zealand; Gary L. Firestone was supported by NIH Public Service Grant CA164095 awarded from the National Cancer Institute; Christian Frezza "would like to acknowledge funding from a Medical Research Council CCU-Program Grant on cancer metabolism, and a unique applicant AICR project grant"; Mark M. Fuster was supported by NIH Grant R01-HL107652; Alexandros G. Georgakilas was supported by an EU Marie Curie Reintegration Grant MC-CIG-303514, Greek National funds through the Operational Program 'Educational and Lifelong Learning of the National Strategic Reference Framework (NSRF)-Research Funding Program THALES (Grant number MIS 379346) and COST Action CM1201 `Biomimetic Radical Chemistry'; Michelle F. Green was supported by a Duke University Molecular Cancer Biology T32 Training Grant; Brendan Grue was supported by a National Sciences Engineering and Research Council Undergraduate Student Research Award in Canada; Dorota Halicka was supported by by NIH NCI grant NCI RO1 28704; Petr Heneberg was supported by the Charles University in Prague projects UNCE 204015 and PRVOUK P31/2012, by the Czech Science Foundation projects 15-03834Y and P301/12/1686, by the Czech Health Research Council AZV project 15-32432A, and by the Internal Grant Agency of the Ministry of Health of the Czech Republic project NT13663-3/2012; Matthew D. Hirschey wishes to acknowledge Duke University Institutional Support, the Duke Pepper Older Americans Independence Center (OAIC) Program in Aging Research supported by the National Institute of Aging (P30AG028716-01) and NIH/NCI training grants to Duke University (T32-CA059365-19 and 5T32-CA059365); Lorne J. Hofseth was supported by NIH grants (1R01CA151304,1R03CA1711326, and 1P01AT003961); Kanya Honoki was supported in part by the grant from the Ministry of Education, Culture, Sports, Science and Technology, Japan (No. 24590493); Hsue-Yin Hsu was supported in part by grants from the Ministry of Health and Welfare (CCMP101-RD-031 and CCMP102-RD-112) and Tzu-Chi University (61040055-10) of Taiwan; Lasse D. Jensen was supported by Svenska Sallskapet for Medicinsk Forskning, Gosta Fraenkels Stiftelse, Ak.e Wibergs Stiftelse, kopings Universitet and the Karolinska Institute, Sweden; Wen G. Jiang wishes to ackOllie och Elof Ericssons Stiftelse, Linnowledge the support by Cancer Research Wales, the Albert Hung Foundation, the Fong Family Foundation, and Welsh Government A4B scheme; Lee W. Jones was supported in part by grants from the NIH NCI; W Nicol Keith was supported by the University of Glasgow, Beatson Oncology Centre Fund, CRUK (www. cancerresearchuk.org) Grant C301/A14762; Sid P. Kerkar was supported by the NIH Intramural Research Program; Rob J. Kulathinal was supported by the National Science Foundation, and the American Cancer Society; Byoung S.; Kwon was supported in part by National Cancer Center (NCC-1310430-2) and National Research Foundation (NRF-2005-0093837); Anne Le was supported by Sol Goldman Pancreatic Cancer Research Fund Grant 80028595, a Lustgarten Fund Grant 90049125 and Grant NIHR21CA169757 (to Anne Le); Michael A. Lea was funded by the The Alma Toorock Memorial for Cancer Research; Ho-Young Lee This work was supported by grants from the National Research Foundation of Korea (NRF), the Ministry of Science, ICT & Future Planning (MSIP), Republic of Korea (Nos. 2011-0017639 and 2011-0030001) and by a NIH Grant RO1 CA100816; Liang-Tzung Lin was supported in part by a grant from the Ministry of Education of Taiwan (TMUTOP103005-4); Jason W. Locasale acknowledges support from NIH awards (CA168997 and A1110613) and the International Life Sciences Institute; Bal L. Lokeshwar was supported in part by United States' Public Health Services Grants: NIH R01CA156776 and VA-BLR&D Merit Review Grant No. 5101-BX001517-02; Valter D. Longo acknowleages support from NIH awards (P01AG034906 and R01AG020642) and from the V Foundation; Costas A. Lyssiotis was funded in part by the Pancreatic Cancer Action Network as a Pathway to Leadership Fellow and through a Dale F. Frey Breakthrough award from the Damon Runyon Cancer Research Foundation; Karen L. MacKenzie wishes to acknowledge the support from the Children's Cancer Institute Australia (affiliated with the University of New South Wales, Australia and the Sydney Children's Hospital Network); Maria Marino was supported by grant from University Roma Tre to M.M. (CLA 2013) and by the Italian Association for Cancer Research (AIRC-Grant #IG15221); Ander Matheu is funded by Carlos III Health Institute and Feder funds (AM: CP10/00539, PI13/02277), Basque Foundation for Science (IKERBASQUE) and Marie Curie CIG Grant (AM: 2012/712404); Christopher Maxwell was supported by funding from the Canadian Institutes of Health Research, in partnership with the Avon Foundation for Women (OBC-134038) and the Canadian Institutes of Health Research New Investigator Salary Award (MSH-136647); Eoin McDonnell received Duke University Institutional Support; Kapil Mehta was supported by Bayer Healthcare System G4T (Grants4Targets); Gregory A. Michelotti received support from NIH NIDDK, NIH NIAAA, and Shire Pharmaceuticals; Vinayak Muralidhar was supported by the Harvard-MIT Health Sciences and Technology Research Assistantship Award; Elena Niccolai was supported by the Italian Ministry of University and the University of Italy; Virginia R. Parslow gratefully acknowledges the financial support of the Auckland Cancer Society Research Centre (ACSRC); Graham Pawelec was supported by the German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, BMBF) Grant number 16SV5536K, and by the European Commission (FP7 259679 "IDEAL"); Peter L. Pedersen was supported by NIH Grant CA-10951; Brad Poore was supported by Sol Goldman Pancreatic Cancer Research Fund Grant 80028595, the Lustgarten Fund Grant 90049125, and Grant NIHR21CA169757 (to Anne Le); Satya Prakash was supported by a Canadian Institutes of Health Research Grant (MOP 64308); Lizzia Raffaghello was supported by an NIH Grant (P01AG034906-01A1) and Cinque per Mille dell'IRPEF-Finanziamento della Ricerca Sanitaria; Jeffrey C. Rathmell was supported by an NIH Grant (R01HL108006); Swapan K.; Ray was supported by the United Soybean Board; Domenico Ribatti received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under Grant agreement no 278570; Luigi Ricciardiello was supported by the AIRC Investigator Grants 10216 and 13837, and the European Community's Seventh Framework Program FP7/2007-2013 under Grant agreement 311876; Francis Rodier acknowledges the support of the Canadian Institute for Health Research (FR: MOP114962, MOP125857), Fonds de Recherche Quebec Sante (FR: 22624), and the Terry Fox Research Institute (FR: 1030); Gian Luigi Russo contributed to this effort while participating in the Fulbright Research Scholar Program 2013-14; Isidro Sanchez-Garcia is partially supported by FEDER and by MICINN (SAF2012-32810), by NIH Grant (R01 CA109335-04A1), by Junta de Castilla y Leon (BIO/SA06/13) and by the ARIMMORA project (FP7-ENV-2011, European Union Seventh Framework Program). Isidro SanchezGarcia's lab is also a member of the EuroSyStem and the DECIDE Network funded by the European Union under the FP7 program; Andrew J. Sanders wishes to acknowledge the support by Cancer Research Wales, the Albert Hung Foundation, the Fong Family Foundation, and Welsh Government A4B scheme; Neeraj K. Saxena was supported by grant funding from NIH NIDDK (K01DK077137, R03DK089130); Dipali Sharma was partially funded by NIH NCI grants (R01CA131294, R21 CA155686), the Avon Foundation and a Breast Cancer Research Foundation Grant (90047965); Markus David Siegelin received funding from National Institute of Health, NINDS Grant K08NS083732, and the 2013 AACR-National Brain Tumor Society Career Development Award for Translational Brain Tumor Research, Grant Number 13-20-23-SIEG; Neetu Singh was supported by funds from the Department of Science and Technology (SR/FT/LS-063/2008), New Delhi, India; Carl Smythe was supported by Yorkshire Cancer Research and The Wellcome Trust, UK; Carmela Spagnuolo was supported by funding from Project C.I.S.I.A., act n. 191/2009 from the Italian Ministry of Economy and Finance Project CAMPUS-QUARC, within program FESR Campania Region 2007/2013, objectives 2.1, 2.2; Diana M. Stafforini was supported by grants from the National Cancer Institute (5P01CA073992), IDEA Award W81XWH-12-1-0515 from the Department of Defense, and by the Huntsman Cancer Foundation; John Stagg was supported by the Canadian Institutes of Health Research; Pochi R. Subbarayan was supported by the University of Miami Clinical and Translational Science Institute (CTSI) Pilot Research Grant (CTSI-2013-P03) and SEEDS You Choose Awards; Phuoc T. Tran was funded by the DoD (W81XVVH-11-1-0272 and W81XWH-13-1-0182), a Kimmel Translational Science Award (SKF-13-021), an ACS Scholar award (122688-RSG-12-196-01-TBG) and the NIH (R01CA166348); Kathryn E. Wellen receives funding from the National Cancer Institute, Pancreatic Cancer Action Network, Pew Charitable Trusts, American Diabetes Association, and Elsa U.; Pardee Foundation; Huanjie Yang was partially supported by the Scientific Research Foundation for the Returned Oversea Scholars, State Education Ministry and Scientific and Technological Innovation Project, Harbin (2012RFLX5011); Paul Yaswen was supported by funding from the United States National Institutes of Health (ES019458) and the California Breast Cancer Research Program (17UB-8708); Clement Yedjou was supported by a grant from the National Institutes of Health (Grant # G1200MD007581), through the RCMI-Center for Environmental Health; Xin Yin was supported by NIH/National Heart, Lung, and Blood Institute Training Grant T32HL098062.; Jiyue Zhu was supported by NIH Grant R01GM071725; Massimo Zollo was supported by the European FP7-TuMIC HEALTH-F2-2008-201662, the Italian Association for Cancer research (AIRC) Grant IG # 11963 and the Regione Campania L.R:N.5, the European National Funds PON01-02388/1 2007-2013.	Academic Consortium for Integrative Medicine, 2015, DEF INT MED; Mousa SA, 2010, METHODS MOL BIOL, V663, P229, DOI 10.1007/978-1-60761-803-4_9; Xiong F, 2014, INTEGR CANCER THER, V13, P152, DOI 10.1177/1534735413503544; Madabushi R, 2006, EUR J CLIN PHARMACOL, V62, P225, DOI 10.1007/s00228-006-0096-0; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Aggarwal BB, 2006, BIOCHEM PHARMACOL, V72, P1605, DOI 10.1016/j.bcp.2006.06.029; Lutgendorf SK, 2010, BRAIN BEHAV IMMUN, V24, P1231, DOI 10.1016/j.bbi.2010.06.014; Khan N, 2006, CANCER RES, V66, P2500, DOI 10.1158/0008-5472.CAN-05-3636; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Montonen J, 2013, EUR J NUTR, V52, P337, DOI 10.1007/s00394-012-0340-6; Mantovani A, 2009, NATURE, V457, P36, DOI 10.1038/457036b; Ranjan AP, 2013, ANTICANCER RES, V33, P3603; EGGERMONT AMM, 1988, CANCER DETECT PREV, V12, P421; Ciociola AA, 2014, AM J GASTROENTEROL, V109, P620, DOI 10.1038/ajg.2013.407; Pendyala S, 2011, AM J CLIN NUTR, V93, P234, DOI 10.3945/ajcn.110.002683; Lee SC, 2010, CANCER LETT, V288, P36, DOI 10.1016/j.canlet.2009.06.020; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Bishayee A, 2012, CURR CANCER DRUG TAR, V12, P1191; Kim IY, 2012, J SURG RES, V174, P284, DOI 10.1016/j.jss.2010.12.021; Kanai M, 2013, CANCER CHEMOTH PHARM, V71, P1521, DOI 10.1007/s00280-013-2151-8; Davis NJ, 2011, J DIABETES COMPLICAT, V25, P371, DOI 10.1016/j.jdiacomp.2011.08.001; Kristal AR, 2010, AM J EPIDEMIOL, V172, P566, DOI 10.1093/aje/kwq148; Kumara HMCS, 2011, SURG ENDOSC, V25, P2153, DOI 10.1007/s00464-010-1514-z; Xu J, 2009, GENE THER MOL BIOL, V13, P36; Friedenreich CM, 2010, J CLIN ONCOL, V28, P1458, DOI 10.1200/JCO.2009.24.9557; Heymach JV, 2011, CANCER PREV RES, V4, P1590, DOI 10.1158/1940-6207.CAPR-10-0136; Yan XH, 2012, SURG ENDOSC, V26, P1856, DOI 10.1007/s00464-011-2114-2; Block KI, 2008, INT J CANCER, V123, P1227, DOI 10.1002/ijc.23754; Kumara HMCS, 2012, SURG ENDOSC, V26, P1759, DOI 10.1007/s00464-011-2112-4; Karlsen A, 2007, J NUTR, V137, P1951; Harley CB, 2008, NAT REV CANCER, V8, P167, DOI 10.1038/nrc2275; Thompson CB, 2009, NEW ENGL J MED, V360, P813, DOI 10.1056/NEJMe0810213; Carter JJ, 2006, SURG INNOV, V13, P41, DOI 10.1177/155335060601300107; Panis C, 2012, BREAST CANCER RES TR, V133, P89, DOI 10.1007/s10549-011-1693-x; Mencalha A, 2014, ANTICANCER RES, V34, P1127; Baguley BC, 2010, MOL BIOTECHNOL, V46, P308, DOI 10.1007/s12033-010-9321-2; Zhang XH, 2013, WORLD J GASTROENTERO, V19, P1005, DOI 10.3748/wjg.v19.i7.1005; Sporn MB, 1997, ANN NY ACAD SCI, V833, P137, DOI 10.1111/j.1749-6632.1997.tb48599.x; Weber JS, 1999, J IMMUNOTHER, V22, P431, DOI 10.1097/00002371-199909000-00007; Courtice MN, 2012, INT J OCCUP ENV HEAL, V18, P247, DOI 10.1179/1077352512Z.00000000021; Russo GL, 2014, CANCER TREAT RES, V159, P185, DOI 10.1007/978-3-642-38007-5_11; Ferguson LR, 2012, MOL NUTR FOOD RES, V56, P126, DOI 10.1002/mnfr.201100507; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Stein GH, 1999, MOL CELL BIOL, V19, P2109; Weber JS, 2013, J CLIN ONCOL, V31, P4311, DOI 10.1200/JCO.2013.51.4802; Zanella F, 2010, CURR CANCER DRUG TAR, V10, P135; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Ohnishi K, 2014, BIOCHEM BIOPH RES CO, V455, P10, DOI 10.1016/j.bbrc.2014.07.020; Coussens LM, 2013, SCIENCE, V339, P286, DOI 10.1126/science.1232227; Shivappa N, 2015, BRIT J NUTR, V113, P665, DOI 10.1017/S000711451400395X; Niraula S, 2012, J CLIN ONCOL, V30, P3012, DOI 10.1200/JCO.2011.40.3824; Crawford SE, 1998, HUM PATHOL, V29, P1039, DOI 10.1016/S0046-8177(98)90410-5; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; GODBOUT R, 1983, NATURE, V304, P451, DOI 10.1038/304451a0; Cao YH, 2004, SEMIN CANCER BIOL, V14, P139, DOI 10.1016/j.semcancer.2003.09.018; Russo M, 2010, TOXINS, V2, P517, DOI 10.3390/toxins2040517; Jiang JH, 2013, INTEGR CANCER THER, V12, P145, DOI 10.1177/1534735412442369; Bohn T, 2014, NUTR REV, V72, P429, DOI 10.1111/nure.12114; Weber J, 2007, ONCOLOGIST, V12, P864, DOI 10.1634/theoncoloost.12-7-864; Shiao SL, 2011, GENE DEV, V25, P2559, DOI 10.1101/gad.169029.111; Thakur VS, 2012, CURR PHARM BIOTECHNO, V13, P191; Chen Y, 2007, PHARMACOGENET GENOM, V17, P571, DOI 10.1097/01.fpc.0000236339.79916.07; Chlebowski RT, 2006, J NATL CANCER I, V98, P1767, DOI 10.1093/jnci/djj494; Marks C, 2009, DIS MODEL MECH, V2, P111, DOI 10.1242/dmm.002725; Backos DS, 2012, BIOCHEM PHARMACOL, V83, P1005, DOI 10.1016/j.bcp.2011.11.016; Vicente-Duenas C, 2009, CELL CYCLE, V8, P1314, DOI 10.4161/cc.8.9.8217; Bensinger SJ, 2012, SEMIN CELL DEV BIOL, V23, P352, DOI 10.1016/j.semcdb.2012.02.003; Alcorta DA, 1996, P NATL ACAD SCI USA, V93, P13742, DOI 10.1073/pnas.93.24.13742; Kruse V, 2011, ACTA CLIN BELG, V66, P2, DOI 10.2143/ACB.66.1.2062507; McCarty MF, 2006, INTEGR CANCER THER, V5, P150, DOI 10.1177/1534735406288443; Motzer RJ, 2009, J CLIN ONCOL, V27, P3584, DOI 10.1200/JCO.2008.20.1293; Eremin O, 2009, BREAST, V18, P17, DOI 10.1016/j.breast.2008.09.002; Costantini S, 2014, CANCER TREAT RES, V159, P311, DOI 10.1007/978-3-642-38007-5_18; Sovak M, 2002, J NATL CANCER I, V94, P1275, DOI 10.1093/jnci/94.17.1275; Kumara HMCS, 2012, SURG ENDOSC, V26, P790, DOI 10.1007/s00464-011-1953-1; Feitelson MA, 2006, CANCER LETT, V239, P10, DOI 10.1016/j.canlet.2005.07.009; Golombick T, 2012, AM J HEMATOL, V87, P455, DOI 10.1002/ajh.23159; Ullah MF, 2013, CELL BIOCHEM BIOPHYS, V67, P431, DOI 10.1007/s12013-011-9303-4; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Talmadge JE, 2010, CANCER RES, V70, P5649, DOI 10.1158/0008-5472.CAN-10-1040; Paul SM, 2010, NAT REV DRUG DISCOV, V9, P203, DOI 10.1038/nrd3078; Block KI, 2007, CANCER TREAT REV, V33, P407, DOI 10.1016/j.ctrv.2007.01.005; He SM, 2010, EXPERT OPIN DRUG MET, V6, P1195, DOI 10.1517/17425255.2010.510132; Darvesh AS, 2013, NUTR CANCER, V65, P329, DOI 10.1080/01635581.2013.767367; Du Toit A, 2013, NAT REV MOL CELL BIO, V14, P546, DOI 10.1038/nrm3637; Tradtrantip L, 2010, MOL PHARMACOL, V77, P69, DOI 10.1124/mol.109.061051; Farnsworth NR, 2009, PHARM BIOL, V47, P755, DOI 10.1080/13880200902988637; Weaver CM, 2009, PHARM BIOL, V47, P768, DOI 10.1080/13880200902988603; Kelley DS, 2006, J NUTR, V136, P981; Wang P, 2010, INTEGR CANCER THER, V9, P50, DOI 10.1177/1534735409359179; Pan MH, 2011, FOOD FUNCT, V2, P101, DOI 10.1039/c0fo00174k; Setchell KDR, 2011, AM J CLIN NUTR, V94, P1284, DOI 10.3945/ajcn.111.019638; Kenny PA, 2007, FRONT BIOSCI, V12, P3468, DOI 10.2741/2327; Chu ESM, 2013, INTEGR CANCER THER, V12, P336, DOI 10.1177/1534735412464519; Schwarze SR, 2005, NEOPLASIA, V7, P816, DOI 10.1593/neo.05250; Kumara HMCS, 2009, ANN SURG, V249, P973, DOI 10.1097/SLA.0b013e3181a6cd72; [Anonymous], 2014, ESMO 2014 FINAL SURV; Hopkins MH, 2011, CANCER PREV RES, V4, P1645, DOI 10.1158/1940-6207.CAPR-11-0105; Schmeiser HH, 2014, INT J CANCER, V135, P502, DOI 10.1002/ijc.28681; Lu YH, 2013, FOOD CHEM TOXICOL, V62, P707, DOI 10.1016/j.fct.2013.09.025; Panis C, 2012, BREAST CANCER RES TR, V133, P881, DOI 10.1007/s10549-011-1851-1; Fuentes E, 2013, EVID-BASED COMPL ALT, DOI 10.1155/2013/861786; Saif MW, 2014, CANCER CHEMOTH PHARM, V73, P373, DOI 10.1007/s00280-013-2359-7; Gagnier JJ, 2006, ANN INTERN MED, V144, P364; Meyerhardt JA, 2006, J CLIN ONCOL, V24, P3535, DOI 10.1200/JCO.2006.06.0863; LANGE PH, 1980, CANCER, V45, P1498, DOI 10.1002/1097-0142(19800315)45:6<1498::AID-CNCR2820450633>3.0.CO;2-7; Sharp L, 2013, J NUTR, V143, P1966, DOI 10.3945/jn.113.174664; Kinghorn AD, 2009, PURE APPL CHEM, V81, P1051, DOI 10.1351/PAC-CON-08-10-16; Chen T, 2012, CANCER PREV RES, V5, P41, DOI 10.1158/1940-6207.CAPR-11-0469; Ringash J, 2014, CANCER-AM CANCER SOC, V120, P181, DOI 10.1002/cncr.28410; Hu J, 2012, CELL, V148, P651, DOI 10.1016/j.cell.2011.12.028; Fry DW, 2004, MOL CANCER THER, V3, P1427; Gescher A, 2013, ANN NY ACAD SCI, V1290, P12, DOI 10.1111/nyas.12205; Vinay DS, 2014, BMB REP, V47, P122, DOI 10.5483/BMBRep.2014.47.3.283; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Peeters CFJM, 2006, INT J CANCER, V119, P1249, DOI 10.1002/ijc.21928; Kondo A, 2013, INT J CLIN ONCOL, V18, P380, DOI 10.1007/s10147-012-0387-7; Urpi-Sarda M, 2012, PHARMACOL RES, V65, P577, DOI 10.1016/j.phrs.2012.03.006; Neuhouser ML, 2012, J NUTR, V142, P369, DOI 10.3945/jn.111.149807; McVeigh TP, 2014, EUR J CANCER, V50, P2763, DOI 10.1016/j.ejca.2014.08.002; Fan TP, 2012, J ETHNOPHARMACOL, V140, P568, DOI 10.1016/j.jep.2012.02.029; Rugo H, 2007, BREAST CANCER RES TR, V105, P17, DOI 10.1007/s10549-006-9430-6; Shergis JL, 2013, AM J CHINESE MED, V41, P231, DOI 10.1142/S0192415X13500171; Rusin M, 2009, MECH AGEING DEV, V130, P528, DOI 10.1016/j.mad.2009.06.005; Xu JD, 2013, J CHROMATOGR A, V1304, P154, DOI 10.1016/j.chroma.2013.07.023; Donkena KV, 2010, MINI-REV MED CHEM, V10, P1385; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Kamba T, 2007, BRIT J CANCER, V96, P1788, DOI 10.1038/sj.bjc.6603813; Ramakrishnan R, 2013, CANCER IMMUNOL IMMUN, V62, P405, DOI 10.1007/s00262-012-1390-6; Semenza GL, 2003, ANNU REV MED, V54, P17, DOI 10.1146/annurev.med.54.101601.152418; Goel A, 2010, NUTR CANCER, V62, P919, DOI 10.1080/01635581.2010.509835; Jolad SD, 2004, PHYTOCHEMISTRY, V65, P1937, DOI 10.1016/j.phytochem.2004.06.008; Liu XG, 2012, INTEGR CANCER THER, V11, P337, DOI 10.1177/1534735410392579; Khatami M, 2009, CELL BIOCHEM BIOPHYS, V55, P55, DOI 10.1007/s12013-009-9059-2; Ji RC, 2014, CANCER LETT, V346, P6, DOI 10.1016/j.canlet.2013.12.001; Lv QW, 2015, ANN RHEUM DIS, V74, P1078, DOI 10.1136/annrheumdis-2013-204807; Du MY, 2012, CARCINOGENESIS, V33, P895, DOI 10.1093/carcin/bgs017; Kundu JK, 2008, MUTAT RES-REV MUTAT, V659, P15, DOI 10.1016/j.mrrev.2008.03.002; Daviglus ML, 2005, J AM DIET ASSOC, V105, P1735, DOI 10.1016/j.jada.2005.08.008; Fang MZ, 2003, CANCER RES, V63, P7563; Krishnan AV, 2007, J BONE MINER RES, V22, pV74, DOI [10.1359/jbmr.07s213, 10.1359/JBMR.07S213]; Lee H, 2012, P NATL ACAD SCI USA, V109, P7765, DOI 10.1073/pnas.1205132109; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Malaney P, 2014, CANCER LETT, V344, P1, DOI 10.1016/j.canlet.2013.10.010; Meyerhardt JA, 2007, JAMA-J AM MED ASSOC, V298, P754, DOI 10.1001/jama.298.7.754; Artandi SE, 2000, CURR OPIN GENET DEV, V10, P39, DOI 10.1016/S0959-437X(99)00047-7; Shehzad A, 2014, J NANOSCI NANOTECHNO, V14, P803, DOI 10.1166/jnn.2014.9103; Kiecolt-Glaser JK, 2011, BRAIN BEHAV IMMUN, V25, P1725, DOI 10.1016/j.bbi.2011.07.229; Lee C, 2011, ONCOGENE, V30, P3305, DOI 10.1038/onc.2011.91; Amin ARMR, 2009, J CLIN ONCOL, V27, P2712, DOI 10.1200/JCO.2008.20.6235; Pereira AGB, 2013, CARBOHYD POLYM, V98, P711, DOI 10.1016/j.carbpol.2013.06.013; Trbusek M, 2013, ADV EXP MED BIOL, V792, P109, DOI 10.1007/978-1-4614-8051-8_5; Kast RE, 2013, ONCOTARGET, V4, P502; Wang Y, 2012, CURR TOP MED CHEM, V12, P1356; Perez AT, 2010, BREAST CANCER RES TR, V120, P111, DOI 10.1007/s10549-009-0678-5; Muller PAJ, 2014, CANCER CELL, V25, P304, DOI 10.1016/j.ccr.2014.01.021; ALLENDORF JDF, 1995, ARCH SURG-CHICAGO, V130, P649; Luo DJ, 2014, BIOMED RES INT, DOI 10.1155/2014/409272; Ramasamy K, 2008, CANCER LETT, V269, P352, DOI 10.1016/j.canlet.2008.03.053; Block KI, 2009, BREAST J, V15, P357, DOI 10.1111/j.1524-4741.2009.00739.x; Kruijsen-Jaarsma M, 2013, EXERC IMMUNOL REV, V19, P120; Komarova NL, 2005, P NATL ACAD SCI USA, V102, P9714, DOI 10.1073/pnas.0501870102; Hussain SP, 2003, NAT REV CANCER, V3, P276, DOI 10.1038/ncr1046; Morin PJ, 2003, DRUG RESIST UPDATE, V6, P169, DOI 10.1016/S1368-7646(03)00059-1; Daniel FI, 2011, CANCER-AM CANCER SOC, V117, P677, DOI 10.1002/cncr.25482; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Chin K, 2004, NAT GENET, V36, P984, DOI 10.1038/ng1409; Ge J, 2011, J MOL MED, V89, P595, DOI 10.1007/s00109-011-0737-3; Balasubramanyam K, 2004, J BIOL CHEM, V279, P51163, DOI 10.1074/jbc.M409024200; Liu ZF, 2009, BIOORG MED CHEM LETT, V19, P706, DOI 10.1016/j.bmcl.2008.12.041; Dudhatra GB, 2012, SCI WORLD J, DOI 10.1100/2012/637953; Demaria S, 2010, J IMMUNOTHER, V33, P335, DOI 10.1097/CJI.0b013e3181d32e74; Hanahan D, 2014, LANCET, V383, P558, DOI 10.1016/S0140-6736(13)62226-6; Morris ME, 2014, AAPS J, V16, P705, DOI 10.1208/s12248-014-9610-y; Topalian SL, 2012, CURR OPIN IMMUNOL, V24, P207, DOI 10.1016/j.coi.2011.12.009; Nandakumar V, 2011, CARCINOGENESIS, V32, P537, DOI 10.1093/carcin/bgq285; Han R, 2012, BRIT J CLIN PHARMACO, V74, P424, DOI 10.1111/j.1365-2125.2012.04221.x; Wildbrett P, 2002, SURG ENDOSC, V16, P1162, DOI 10.1007/s00464-001-8158-y; Easwaran H, 2014, MOL CELL, V54, P716, DOI 10.1016/j.molcel.2014.05.015; Aravindan S, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-46; Azmi Asfar S, 2013, F1000Res, V2, P135, DOI 10.12688/f1000research.2-135.v1; Barton DL, 2013, JNCI-J NATL CANCER I, V105, P1230, DOI 10.1093/jnci/djt181; Bastos LFS, 2014, CNS DRUGS, V28, P45, DOI 10.1007/s40263-013-0128-0; Bishayee A, 2014, ADV EXP MED BIOL, V816, P401, DOI 10.1007/978-3-0348-0837-8_16; Block KI, 2014, INTEGRATIVE ONCOLOGY, P120; Block KI, 2012, ADVANCING MEDICINE WITH FOOD AND NUTRIENTS, 2ND EDITION, P727; Block KI, 2015, INTEGR CANCER THER, V14, P113, DOI 10.1177/1534735414567473; Block KI, 2009, LIFE OVER CANC, P594; Capodice Jillian L, 2009, J Soc Integr Oncol, V7, P43; Casey Stephanie C, 2014, J Immunother Cancer, V2, P24, DOI 10.1186/2051-1426-2-24; Chatterjee Subhojyoti, 2012, Bioinformation, V8, P1249, DOI 10.6026/97320630081249; Cramer H, 2013, EVID-BASED COMPL ALT, V2013, DOI DOI 10.1155/2013/383142; Crawford S., 2014, THER ADV MED ONCOL, V6, P52068; Deocaris CC, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-14; Ding XW, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-271; Dwivedi V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037113; Ermolaeva MA, 2014, TRENDS GENET, V30, P95, DOI 10.1016/j.tig.2013.12.001; Abboud C, 2013, BLOOD, V121, P4439, DOI 10.1182/blood-2013-03-490003; Ferarrelli LK, 2013, SCI SIGNAL, V6, peg5; Ferlay J, 2014, GLOBOCAN 2012 V1 0; Fong DYT, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e70; Fritz H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081968; Gao J J, 2012, Drug Discov Ther, V6, P1; Gordon I, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000161; Goshima H, 1989, J JPN SURG SOC, V90, P1245; Guyen DX, 2007, NAT REV GENET, V8, P341; Hanhineva K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039322; Hasima Noor, 2012, Int J Biochem Mol Biol, V3, P328; Health Canada, 2014, PATHW LIC NAT HLTH P; Hollebecque A, 2013, J CLIN ONCOL S; Horwitz KB, 2015, EPIGENOMICS, V17, P1; Hu Q-N, 2014, CPT Pharmacometrics Syst Pharmacol, V3, pe105, DOI 10.1038/psp.2014.1; Huang EC, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-68; Huq F, 2014, ANTICANCER RES, V34, P541; Iyoke Chukwuemeka Anthony, 2014, Int J Womens Health, V6, P123, DOI 10.2147/IJWH.S55797; Jochems C, 2014, CANCER IMMUNOL IMMUN, V63, P407, DOI 10.1007/s00262-014-1524-0; Kamba T, 2006, AM J PHYSIOL-HEART C, V290, pH560, DOI 10.1152/ajpheart.00133.2005; Kefford R, 2014, J CLIN ONCOL, V32; Krattiger A, 2007, INTELLECTUAL PROPERT; Lamson D W, 2000, Altern Med Rev, V5, P196; Li S, 2013, CHIN J NAT MEDICINES, V11, P110, DOI [10.1016/S1875-5364(13)60037-0, 10.3724/SP.J.1009.2013.00110]; Li X T, 2013, SCI MANAGEMENT RES, V8, P90; Ishikawa H, 2006, J NUTR, V136, p816S; Manello F, 2007, INT J CANCER, V120, P1971; Marrone M, 2014, GENET MED; McCarty Mark F, 2005, Integr Cancer Ther, V4, P301, DOI 10.1177/1534735405282475; Medicines and Healthcare Products Regulatory Agency, 2014, PERM IND DIR TRAD HE; Meltzer SM, 2009, AM J OBSTET GYNECOL, V200, DOI DOI 10.1016/J.AJOG.2008.07.064; Muqbil I., 2012, J STEM CELL RES TH S; Ohnishi S, 2013, OXID MED CELL LONGEV, V2013; Palumbo MO, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00057; Patyar S, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-21; Peairs AT, 2008, OBESITY SILVER SPRIN, V6, P1573; Quaranta V, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004715; Rao S, 2014, INTEGR CANCER THER, V13, P201, DOI 10.1177/1534735413503549; Rees L, 2001, BRIT MED J, V322, P119, DOI 10.1136/bmj.322.7279.119; Ribas A, 2014, CLIN CANCER RES, V20, P4982, DOI 10.1158/1078-0432.CCR-14-0933; Rock CL, 2012, CA-CANCER J CLIN, V62, P243, DOI 10.3322/caac.21142; Sachan V, 2010, REG ISS HERB PROD RE; Sage J, 2010, GENE DEV, V241, P329; Santana R, 2013, CLIN NUTR, V32, P503; Scalbert A, 2001, J NUTR S, p2073S; Stoner GD, 2009, CANCER PREV RES, P187; Subbarayan PR, 2013, EVID-BASED COMPL ALT, V2013; Tabung F, 2014, CANCER CAUSE CONTROL, V26, P399; Trejo-Solis C, 2013, EVID-BASED COMPL ALT, V2013, DOI [10.1155/2013/705121, DOI 10.1155/2013/705121]; U. S. Food and Drug Administration, 2015, HEM ONC CANC APPR SA; van Breemen RB, 2008, AM J CLIN NUTR, V87, p509S; Vander Heiden MG, 2009, SCIENCE, V324, P1029, DOI DOI 10.1126/SCIENCE.1160809; Verhoeff JJC, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-444; Watson J, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120144; Weiss GJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076438; Wong AYT, 2014, CHIN MED-UK, V9, DOI 10.1186/1749-8546-9-17; World Cancer Research Fund/American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; World Health Organization, 2005, NAT POL TRAD MED REG; Wu P, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-112; Yanga YL, 2013, P NATL ACAD SCI USA, V110, P12018, DOI 10.1073/pnas.1301331110; Zahreddine H, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00028; Zaric GS, 2009, HARVARD BUSINESS REV; Zhai Bo, 2013, World J Hepatol, V5, P345, DOI 10.4254/wjh.v5.i7.345; Zhu HI, 2013, DRUG METAB DISPOS, V419, P1679	261	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1044-579X			SEMIN CANCER BIOL	Semin. Cancer Biol.	DEC	2015	35			S			S276	S304		10.1016/j.semcancer.2015.09.007		29	Oncology	Oncology	CY7WG	WOS:000366619400013		
J	Casey, SC; Amedei, A; Aquilano, K; Azmi, AS; Benencia, F; Bhakta, D; Bilsland, AE; Boosani, CS; Chen, S; Ciriolo, MR; Crawford, S; Fujii, H; Georgakilas, AG; Guha, G; Halicka, D; Helferich, WG; Heneberg, P; Honoki, K; Keith, WN; Kerkar, SP; Mohammed, SI; Niccolai, E; Nowsheen, S; Rupasinghe, HPV; Samadi, A; Singh, N; Talib, WH; Venkateswaran, V; Whelan, RL; Yang, XJ; Felsher, DW				Casey, Stephanie C.; Amedei, Amedeo; Aquilano, Katia; Azmi, Asfar S.; Benencia, Fabian; Bhakta, Dipita; Bilsland, Alan E.; Boosani, Chandra S.; Chen, Sophie; Ciriolo, Maria Rosa; Crawford, Sarah; Fujii, Hiromasa; Georgakilas, Alexandros G.; Guha, Gunjan; Halicka, Dorota; Helferich, William G.; Heneberg, Petr; Honoki, Kanya; Keith, W. Nicol; Kerkar, Sid P.; Mohammed, Sulma I.; Niccolai, Elena; Nowsheen, Somaira; Rupasinghe, H. P. Vasantha; Samadi, Abbas; Singh, Neetu; Talib, Wamidh H.; Venkateswaran, Vasundara; Whelan, Richard L.; Yang, Xujuan; Felsher, Dean W.			Cancer prevention and therapy through the modulation of the tumor microenvironment	SEMINARS IN CANCER BIOLOGY			English	Review						Tumor microenvironment; Cancer biology; Cancer therapy; Cancer prevention	ENDOTHELIAL GROWTH-FACTOR; CELL-CYCLE ARREST; NF-KAPPA-B; REGULATORY T-CELLS; HUMAN PROSTATE-CANCER; HUMAN COLON-CANCER; INDOLEAMINE 2,3-DIOXYGENASE EXPRESSION; EPITHELIAL-MESENCHYMAL TRANSITION; CARCINOMA-ASSOCIATED FIBROBLASTS; BERBERINE INDUCES APOPTOSIS	Cancer arises in the context of an in vivo tumor microenvironment This microenvironment is both a cause and consequence of tumorigenesis. Tumor and host cells co-evolve dynamically through indirect and direct cellular interactions, eliciting multiscale effects on many biological programs, including cellular proliferation, growth, and metabolism, as well as angiogenesis and hypoxia and innate and adaptive immunity. Here we highlight specific biological processes that could be exploited as targets for the prevention and therapy of cancer. Specifically, we describe how inhibition of targets such as cholesterol synthesis and metabolites, reactive oxygen species and hypoxia, macrophage activation and conversion, indoleamine 2,3-dioxygenase regulation of dendritic cells, vascular endothelial growth factor regulation of angiogenesis, fibrosis inhibition, endoglin, and Janus kinase signaling emerge as examples of important potential nexuses in the regulation of tumorigenesis and the tumor microenvironment that can be targeted. We have also identified therapeutic agents as approaches, in particular natural products such as berberine, resveratrol, onionin A, epigallocatechin gallate, genistein, curcumin, naringenin, desoxyrhapontigenin, piperine, and zerumbone, that may warrant further investigation to target the tumor microenvironment for the treatment and/or prevention of cancer. (C) 2015 Elsevier Ltd.	[Casey, Stephanie C.; Felsher, Dean W.] Stanford Univ, Div Oncol, Dept Med, Sch Med, Stanford, CA 94305 USA; [Casey, Stephanie C.; Felsher, Dean W.] Stanford Univ, Div Oncol, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Amedei, Amedeo] Univ Florence, Dept Expt & Clin Med, Florence, Italy; [Aquilano, Katia; Ciriolo, Maria Rosa] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy; [Azmi, Asfar S.] Wayne State Univ, Sch Med, Dept Oncol, Detroit, MI USA; [Benencia, Fabian] Ohio Univ, Dept Biomed Sci, Athens, OH 45701 USA; [Bhakta, Dipita] SASTRA Univ, Sch Chem & Biotechnol, Thanjavur 613401, Tamil Nadu, India; [Bilsland, Alan E.] Univ Glasgow, Inst Canc Sci, Glasgow, Lanark, Scotland; [Boosani, Chandra S.] Creighton Univ, Sch Med, Dept Biomed Sci, Omaha, NE 68178 USA; [Chen, Sophie] Ovarian & Prostate Canc Res Lab, Guildford, Surrey, England; [Crawford, Sarah] So Connecticut State Univ, Dept Biol, New Haven, CT 06515 USA; [Fujii, Hiromasa] Nara Med Univ, Dept Orthoped Surg, Kashihara, Nara 634, Japan; [Georgakilas, Alexandros G.] Natl Tech Univ Athens, Dept Phys, Sch Appl Math & Phys Sci, GR-15773 Athens, Greece; [Halicka, Dorota] New York Med Coll, Valhalla, NY 10595 USA; [Helferich, William G.] Univ Illinois, Champaign, IL USA; [Helferich, William G.] Univ Illinois, Urbana, IL USA; [Heneberg, Petr] Charles Univ Prague, Fac Med 3, Prague, Czech Republic; [Kerkar, Sid P.] NCI, NIH, Ctr Canc Res, Bethesda, MD 20892 USA; [Mohammed, Sulma I.] Purdue Univ, Ctr Canc Res, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA; [Niccolai, Elena] Univ Florence, Florence, Italy; [Nowsheen, Somaira] Mayo Clin, Mayo Med Sch, Mayo Grad Sch, Med Sci Training Program, Rochester, MN USA; [Rupasinghe, H. P. Vasantha] Dalhousie Univ, Fac Agr, Dept Environm Sci, Halifax, NS B3H 3J5, Canada; [Samadi, Abbas] Sanus Biosci, San Diego, CA USA; [Singh, Neetu] King Georges Med Univ, Adv Mol Sci Res Ctr, Ctr Adv Res, Lucknow, Uttar Pradesh, India; [Talib, Wamidh H.] Appl Sci Univ, Dept Clin Pharm & Therapeut, Amman, Jordan; [Venkateswaran, Vasundara] Sunnybrook Hlth Sci Ctr, Div Urol, Toronto, ON M4N 3M5, Canada; [Whelan, Richard L.] Icahn Sch Med Mt Sinai, Mt Sinai Roosevelt Hosp, New York, NY 10029 USA	Felsher, DW (reprint author), Stanford Univ, Div Oncol, Dept Med, Stanford, CA 94305 USA.	dfelsher@stanford.edu	Keith, Nicol/D-3325-2009	Keith, Nicol/0000-0001-7862-3580	Ohio University; EU [MC-CIG-303514]; Greek National funds through the Operational Program 'Educational and Lifelong Learning of the National Strategic Reference Framework (NSRF)-Research Funding Program: THALES [MIS 379346]; Charles University in Prague [UNCE 204015, PRVOUK P31/2012]; Czech Science Foundation [P301/12/1686]; Internal Grant Agency of the Ministry of Health of the Czech Republic [NT13663-3/2012]; CRU [C301/A14762]; Heritage College of Osteopathic Medicine at OU [RP1206]; Ministry of Education, Culture, Sports, Science and Technology, Japan [24590493]	R.L.W. is conducting a Phase I trial for EGCG. The authors thank the Italian Ministry of University and Research (2009FZZ4XM_002 to E.N., A.A.), the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research (S.P.K.), the National Institutes of Health (R01CA128704 to D.H.), National Institutes of Health F32CA177139, R01CA170378, U54CA149145, P50CA114747, R01CA184384, and R21CA169964 (to S.C.C., D.W.F.), an NIH R15 CA137499-01 (F.B.), a startup fund from Ohio University, an RSAC grant (RP1206) from the Heritage College of Osteopathic Medicine at OU (to F.B.), Prostate and Ovarian Cancer Research Trust in Surrey, UK (S. Chen), a Connecticut State University Research grant (S. Crawford), an EU Marie Curie Reintegration Grant MC-CIG-303514, Greek National funds through the Operational Program 'Educational and Lifelong Learning of the National Strategic Reference Framework (NSRF)-Research Funding Program: THALES (Grant number MIS 379346) and COST Action CM1201 'Biomimetic Radical Chemistry' (to A.G.G.), the Charles University in Prague projects UNCE 204015 and PRVOUK P31/2012, by the Czech Science Foundation project P301/12/1686, and by the Internal Grant Agency of the Ministry of Health of the Czech Republic project NT13663-3/2012 (to P.H.), the Ministry of Education, Culture, Sports, Science and Technology, Japan (No. 24590493) (to K.H.), and private donations (R.L.W.). W.N.K. and A.E.B. acknowledge the University of Glasgow, Beatson Oncology Centre Fund, CRU (www.cancerresearchuk.org/) grant C301/A14762. Study sponsors had no involvement in the study. The authors also acknowledge the efforts of Leroy Lowe and the Getting to Know Cancer team.	Ando K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102436; Masuda M, 2003, CLIN CANCER RES, V9, P3486; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Khan MK, 2011, FOOD FUNCT, V2, P617, DOI 10.1039/c1fo10077g; Cui GL, 2009, J BIOL CHEM, V284, P28420, DOI 10.1074/jbc.M109.012674; Fonsatti E, 2001, J CELL PHYSIOL, V188, P1, DOI 10.1002/jcp.1095; Autiero M, 2003, NAT MED, V9, P936, DOI 10.1038/nm884; Lee S, 2007, BIOCHEM BIOPH RES CO, V362, P853, DOI 10.1016/j.bbrc.2007.08.060; Keunen O, 2011, P NATL ACAD SCI USA, V108, P3749, DOI 10.1073/pnas.1014480108; Kim HG, 2012, FOOD CHEM TOXICOL, V50, P2342, DOI 10.1016/j.fct.2012.04.024; Lakshman M, 2011, CLIN EXP METASTAS, V28, P39, DOI 10.1007/s10585-010-9356-6; Egler RA, 2008, CLIN CANCER RES, V14, P7028, DOI 10.1158/1078-0432.CCR-07-5017; Graziani SR, 2002, GYNECOL ONCOL, V85, P493, DOI 10.1006/gyno.2002.6654; Flavin R, 2011, J PATHOL, V223, P283, DOI 10.1002/path.2809; Li ZC, 2014, TUMOR BIOL, V35, P111, DOI 10.1007/s13277-013-1013-7; Kusmartsev S, 2006, CANCER IMMUNOL IMMUN, V55, P237, DOI 10.1007/s00262-005-0048-z; Murtola TJ, 2011, EUR J PHARMACOL, V673, P96, DOI 10.1016/j.ejphar.2011.10.022; Saidi A, 2009, INT J CANCER, V125, P1054, DOI 10.1002/ijc.24380; Cao YH, 1999, NATURE, V398, P381, DOI 10.1038/18793; Mitsunaga S, 2013, BRIT J CANCER, V108, P2063, DOI 10.1038/bjc.2013.174; Bishayee A, 2009, CANCER PREV RES, V2, P409, DOI 10.1158/1940-6207.CAPR-08-0160; Deeb D, 2013, MOLECULES, V18, P3250, DOI 10.3390/molecules18033250; El-Aasr M, 2010, J NAT PROD, V73, P1306, DOI 10.1021/np100105u; Bishayee A, 2010, CANCER PREV RES, V3, P753, DOI 10.1158/1940-6207.CAPR-09-0171; Kudo M, 2009, J NEUROSURG, V111, P219, DOI 10.3171/2008.12.JNS081284; Eruslanov E, 2009, J IMMUNOL, V182, P7548, DOI 10.4049/jimmunol.0802358; Barbu I, 2013, ROM J MORPHOL EMBRYO, V54, P519; Kerkar SP, 2012, CANCER RES, V72, P3125, DOI 10.1158/0008-5472.CAN-11-4094; AMES BN, 1983, SCIENCE, V221, P1256, DOI 10.1126/science.6351251; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; Lutz MB, 2002, TRENDS IMMUNOL, V23, P445, DOI 10.1016/S1471-4906(02)02281-0; Chang Q, 2013, NEOPLASIA, V15, P848, DOI 10.1593/neo.13706; Heneberg P, 2011, CURR PHARM DESIGN, V17, P3753; Balachandran VP, 2011, NAT MED, V17, P1094, DOI 10.1038/nm.2438; Akbay EA, 2013, CANCER DISCOV, V3, P1355, DOI 10.1158/2159-8290.CD-13-0310; Knupfer H, 2010, BREAST CARE, V5, P177, DOI [000314248, 10.1159/000314248]; Qiu F, 2008, DRUG METAB DISPOS, V36, P2159, DOI 10.1124/dmd.108.021659; Fang F, 2010, BIOCHEM BIOPH RES CO, V397, P163, DOI 10.1016/j.bbrc.2010.05.065; Cao ZW, 2011, CANCER RES, V71, P2286, DOI 10.1158/0008-5472.CAN-10-3367; Latendresse JR, 2009, REPROD TOXICOL, V28, P342, DOI 10.1016/j.reprotox.2009.04.006; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Inai T, 2004, AM J PATHOL, V165, P35, DOI 10.1016/S0002-9440(10)63273-7; Serafini P, 2006, SEMIN CANCER BIOL, V16, P53, DOI 10.1016/j.semcancer.2005.07.005; Inaba T, 2010, GYNECOL ONCOL, V117, P423, DOI 10.1016/j.ygyno.2010.02.028; Maeng HJ, 2002, J PHARM SCI, V91, P2614, DOI 10.1002/jps.10268; Atmaca N, 2014, BIOMED RES INT, DOI 10.1155/2014/698628; Du GJ, 2009, CANCER RES, V69, P3205, DOI 10.1158/0008-5472.CAN-08-3393; Chalaris A, 2011, EUR J CELL BIOL, V90, P484, DOI 10.1016/j.ejcb.2010.10.007; Lanzilli G, 2006, INT J ONCOL, V28, P641; Huang CH, 2009, MOL NUTR FOOD RES, V53, P1156, DOI 10.1002/mnfr.200800592; Deng YT, 2011, J AGR FOOD CHEM, V59, P13318, DOI 10.1021/jf204149c; Escudero-Lopez B, 2014, BIOFACTORS, V40, P327, DOI 10.1002/biof.1152; Sehrawat A, 2012, BREAST CANCER RES TR, V136, P429, DOI 10.1007/s10549-012-2280-5; Gao YH, 2013, BIOCHEM BIOPH RES CO, V435, P46, DOI 10.1016/j.bbrc.2013.04.034; Hideshima T, 2001, CANCER RES, V61, P3071; Kinoshita K, 2010, INT J ONCOL, V37, P869, DOI 10.3892/ijo_00000738; Jang JW, 2012, CYTOKINE, V60, P686, DOI 10.1016/j.cyto.2012.07.017; Habibi D, 2010, J CELL PHYSIOL, V225, P196, DOI 10.1002/jcp.22220; Guo YQ, 2010, CLIN CANCER RES, V16, P5759, DOI 10.1158/1078-0432.CCR-10-1095; Ghaemi A, 2012, IRAN J IMMUNOL, V9, P119, DOI IJIv9i2A5; Hess D, 2011, EXP BIOL MED, V236, P707, DOI 10.1258/ebm.2011.010265; Gavalas NG, 2012, BRIT J CANCER, V107, P1869, DOI 10.1038/bjc.2012.468; Ogrunc M, 2014, CELL DEATH DIFFER, V21, P998, DOI 10.1038/cdd.2014.16; Bhattacharyya S, 2010, CELL MOL IMMUNOL, V7, P306, DOI 10.1038/cmi.2010.11; Negretto GW, 2014, MOL GENET METAB, V111, P205, DOI 10.1016/j.ymgme.2013.11.011; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Pradeep CR, 2004, INT IMMUNOPHARMACOL, V4, P1795, DOI 10.1016/j.intimp.2004.08.005; Limaverde-Sousa G, 2014, CANCER TREAT REV, V40, P548, DOI 10.1016/j.ctrv.2013.11.009; O'Shea JJ, 2002, CELL, V109, pS121, DOI 10.1016/S0092-8674(02)00701-8; Bergers G, 2003, J CLIN INVEST, V111, P1287, DOI 10.1172/JCI200317929; Fuggetta MP, 2006, J EXP CLIN CANC RES, V25, P189; Derenzini E, 2013, EXPERT OPIN INV DRUG, V22, P775, DOI 10.1517/13543784.2013.775244; Do MT, 2013, FOOD CHEM, V141, P2591, DOI 10.1016/j.foodchem.2013.04.125; Choi RJ, 2014, REDOX BIOL, V2, P504, DOI 10.1016/j.redox.2014.02.001; CHU CY, 1994, FOOD CHEM TOXICOL, V32, P373, DOI 10.1016/0278-6915(94)90076-0; Duncan RE, 2005, CANCER LETT, V224, P221, DOI 10.1016/j.canlet.2004.11.031; Kasiotis KM, 2013, FOOD CHEM TOXICOL, V61, P112, DOI 10.1016/j.fct.2013.03.038; Sica A, 2006, EUR J CANCER, V42, P717, DOI 10.1016/j.ejca.2006.01.003; Moreira L, 2013, EXP CELL RES, V319, P1784, DOI 10.1016/j.yexcr.2013.05.001; Abdelwahab SI, 2010, EXP TOXICOL PATHOL, V62, P461, DOI 10.1016/j.etp.2009.06.005; Grun F, 2006, ENDOCRINOLOGY, V147, pS50, DOI 10.1210/en.2005-1129; Sassano A, 2008, CANCER LETT, V260, P11, DOI 10.1016/j.canlet.2007.11.036; Murakami A, 2003, CANCER LETT, V195, P17, DOI 10.1016/S0304-3835(03)00058-2; Hurchla MA, 2005, J IMMUNOL, V174, P3377; Romero D, 2011, CANCER RES, V71, P3482, DOI 10.1158/0008-5472.CAN-10-2665; Lee MH, 2004, BIOL PHARM BULL, V27, P72, DOI 10.1248/bpb.27.72; Dang CV, 2012, GENE DEV, V26, P877, DOI 10.1101/gad.189365.112; Lee-Chang C, 2013, J IMMUNOL, V191, P4141, DOI 10.4049/jimmunol.1300606; Brusq JM, 2006, J LIPID RES, V47, P1281, DOI 10.1194/jlr.M600020-JLR200; Espenshade PJ, 2007, ANNU REV GENET, V41, P401, DOI 10.1146/annurev.genet.41.110306.130315; Rocha KKR, 2009, FOOD CHEM TOXICOL, V47, P1362, DOI 10.1016/j.fct.2009.03.010; Padilla-Banks E, 2006, ENDOCRINOLOGY, V147, P4871, DOI 10.1210/en.2006-0389; Aluyen Julia Khristine, 2012, Journal of Dietary Supplements, V9, P45, DOI 10.3109/19390211.2011.650842; Ji XH, 2012, NUCLEIC ACID THER, V22, P127, DOI 10.1089/nat.2012.0342; Lai LH, 2012, ACTA PHARMACOL SIN, V33, P523, DOI 10.1038/aps.2011.209; Adjakly M, 2013, ANTICANCER RES, V33, P39; Olivieri F, 2012, CURR VASC PHARMACOL, V10, P216; Notarnicola M, 2008, GENES NUTR, V3, P35, DOI 10.1007/s12263-008-0082-5; Silver JS, 2010, J LEUKOCYTE BIOL, V88, P1145, DOI 10.1189/jlb.0410217; Lin YG, 2007, CLIN CANCER RES, V13, P3423, DOI 10.1158/1078-0432.CCR-06-3072; Liu XD, 2010, BLOOD, V115, P3520, DOI 10.1182/blood-2009-09-246124; Frumento G, 2002, J EXP MED, V196, P459, DOI 10.1084/jem.20020121; Kageura T, 2001, BIOORGAN MED CHEM, V9, P1887, DOI 10.1016/S0968-0896(01)00093-1; Na HK, 2012, BIOCHEM PHARMACOL, V84, P1241, DOI 10.1016/j.bcp.2012.08.024; Hsu YC, 2011, J CELL PHYSIOL, V226, P2721, DOI 10.1002/jcp.22623; Goldwasser J, 2011, J HEPATOL, V55, P963, DOI 10.1016/j.jhep.2011.02.011; DIEBOLD TJ, 1988, AM ANN DEAF, V133, P30; Prabhu AV, 2014, BBA-MOL CELL BIOL L, V1841, P1431, DOI 10.1016/j.bbalip.2014.07.006; Qian F, 2009, CANCER RES, V69, P5498, DOI 10.1158/0008-5472.CAN-08-2106; Salgado R, 2003, INT J CANCER, V103, P642, DOI 10.1002/ijc.10833; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; Jeong YI, 2007, BIOCHEM BIOPH RES CO, V354, P1004, DOI 10.1016/j.bbrc.2007.01.076; Ji Y, 2014, BRIT J DERMATOL, V170, P78, DOI 10.1111/bjd.12592; Hay N, 2005, CANCER CELL, V8, P179, DOI 10.1016/j.ccr.2005.08.008; Fan QM, 2014, CANCER LETT, V352, P160, DOI 10.1016/j.canlet.2014.05.008; Ogawa K, 2012, ONCOL LETT, V4, P546, DOI 10.3892/ol.2012.761; Hybertson BM, 2011, MOL ASPECTS MED, V32, P234, DOI 10.1016/j.mam.2011.10.006; Mosieniak G, 2012, MECH AGEING DEV, V133, P444, DOI 10.1016/j.mad.2012.05.004; Ogiwara H, 2013, CARCINOGENESIS, V34, P2486, DOI 10.1093/carcin/bgt240; Shain KH, 2009, CANCER RES, V69, P1009, DOI 10.1158/0008-5472.CAN-08-2419; Sebastian C, 2009, J IMMUNOL, V183, P2356, DOI 10.4049/jimmunol.0901131; Liu XX, 2013, MOLECULES, V18, P13200, DOI 10.3390/molecules181113200; Lin JK, 2000, J AGR FOOD CHEM, V48, P2736, DOI 10.1021/jf000066d; Mo WH, 2011, PANCREATOLOGY, V11, P601, DOI 10.1159/000333542; Hsu WH, 2007, ARCH TOXICOL, V81, P719, DOI 10.1007/s00204-006-0169-y; Kortylewski M, 2008, CURR OPIN IMMUNOL, V20, P228, DOI 10.1016/j.coi.2008.03.010; Matsuda H, 2000, BIOORG MED CHEM LETT, V10, P323, DOI 10.1016/S0960-894X(99)00702-7; KIUCHI F, 1993, CHEM PHARM BULL, V41, P1640; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Schreiner CE, 2011, CARDIOVASC RES, V90, P140, DOI 10.1093/cvr/cvq355; HALLIWELL B, 1991, AM J MED, V91, pS14, DOI 10.1016/0002-9343(91)90279-7; Heinrich PC, 1998, BIOCHEM J, V334, P297; Powolny AA, 2008, CANCER LETT, V269, P305, DOI 10.1016/j.canlet.2008.05.027; Abdelwahab SI, 2012, INT IMMUNOPHARMACOL, V12, P594, DOI 10.1016/j.intimp.2012.01.014; Liu XJ, 2006, PHARM RES, V23, P82, DOI 10.1007/s11095-005-9043-5; Hwang JM, 2006, ARCH TOXICOL, V80, P62, DOI 10.1007/s00204-005-0014-8; Lin CY, 2013, J CELL BIOCHEM, V114, P2061, DOI 10.1002/jcb.24553; Shiao SL, 2011, GENE DEV, V25, P2559, DOI 10.1101/gad.169029.111; Chen WF, 2004, J CLIN ENDOCR METAB, V89, P2351, DOI 10.1210/jc.2003-032065; Schmatz R, 2012, BIOCHIMIE, V94, P374, DOI 10.1016/j.biochi.2011.08.005; Hu LM, 2005, CLIN CANCER RES, V11, P6966, DOI 10.1158/1078-0432.CCR-05-0910; Galeone C, 2006, AM J CLIN NUTR, V84, P1027; Leon CG, 2010, PROSTATE, V70, P390, DOI 10.1002/pros.21072; Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Ichikawa M, 2005, FRONT BIOSCI, V10, P2856, DOI 10.2741/1742; Choi BH, 2006, EXP MOL MED, V38, P599; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Simon I, 2006, CANCER RES, V66, P1570, DOI 10.1158/0008-5472.CAN-04-3550; Filomeni G, 2007, GENES NUTR, V2, P295, DOI 10.1007/s12263-007-0059-9; Pelicano H, 2004, DRUG RESIST UPDATE, V7, P97, DOI 10.1016/j.drup.2004.01.004; BRADY JF, 1991, CHEM RES TOXICOL, V4, P642, DOI 10.1021/tx00024a008; Greenhough A, 2009, CARCINOGENESIS, V30, P377, DOI 10.1093/carcin/bgp014; Shinriki S, 2009, CLIN CANCER RES, V15, P5426, DOI 10.1158/1078-0432.CCR-09-0287; Doucette CD, 2013, J NUTR BIOCHEM, V24, P231, DOI 10.1016/j.jnutbio.2012.05.009; Kuppers R, 2012, HEMATOL-AM SOC HEMAT, P328, DOI 10.1182/asheducation-2012.1.328; Leal SM, 2002, TRENDS ENDOCRIN MET, V13, P319, DOI 10.1016/S1043-2760(02)00675-6; Karkera J, 2011, PROSTATE, V71, P1455, DOI 10.1002/pros.21362; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20020407; Coward J, 2011, CLIN CANCER RES, V17, P6083, DOI 10.1158/1078-0432.CCR-11-0945; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Shon MY, 2004, FOOD CHEM TOXICOL, V42, P659, DOI 10.1016/j.fct.2003.12.002; Gossner G, 2007, GYNECOL ONCOL, V105, P23, DOI 10.1016/j.ygyno.2006.11.009; Kim HK, 2006, J LEUKOCYTE BIOL, V79, P686, DOI 10.1189/jlb.0805436; Ki DH, 2007, INT J CANCER, V121, P2005, DOI 10.1002/ijc.22975; Mittal D, 2013, J INVEST DERMATOL, V133, P2686, DOI 10.1038/jid.2013.222; Choudhury SR, 2010, INVEST NEW DRUG, V28, P812, DOI 10.1007/s10637-009-9324-7; Poynter JN, 2005, NEW ENGL J MED, V352, P2184, DOI 10.1056/NEJMoa043792; Belleri M, 2005, MOL PHARMACOL, V67, P1451, DOI 10.1124/mol.104.009043; Giannoni E, 2010, CANCER RES, V70, P6945, DOI 10.1158/0008-5472.CAN-10-0785; Huang B, 2006, CANCER RES, V66, P1123, DOI 10.1158/0008-5472CAN-05-1299; Hurt EM, 2007, BLOOD, V109, P3953, DOI 10.1182/blood-2006-07-035162; Scheinman EJ, 2013, MOL CELL ENDOCRINOL, V374, P101, DOI 10.1016/j.mce.2013.04.011; Rahimi N, 2006, FRONT BIOSCI, V11, P818; Lu TY, 2012, CLIN CANCER RES, V18, P4877, DOI 10.1158/1078-0432.CCR-11-2939; Lotfi R, 2011, EUR J IMMUNOL, V41, P2021, DOI 10.1002/eji.201041324; Nair RR, 2012, LEUKEMIA RES, V36, P756, DOI 10.1016/j.leukres.2011.12.002; Ribatti D, 2005, BRIT J HAEMATOL, V128, P303, DOI 10.1111/j.1365-2141.2004.05291.x; Kim SM, 2008, PHYTOMEDICINE, V15, P749, DOI 10.1016/j.phymed.2007.11.004; Kim KJ, 2014, IMMUNOLOGY, V143, P21, DOI 10.1111/imm.12283; Brackett CM, 2011, LASER SURG MED, V43, P676, DOI 10.1002/lsm.21107; Shoba G, 1998, PLANTA MED, V64, P353, DOI 10.1055/s-2006-957450; Huang GC, 2005, PLANTA MED, V71, P219, DOI 10.1055/s-2005-837820; Djonov V, 2003, CELL TISSUE RES, V314, P107, DOI 10.1007/s00441-003-0784-3; Kurzrock R, 2013, CLIN CANCER RES, V19, P3659, DOI 10.1158/1078-0432.CCR-12-3349; Cao JX, 2009, EMBO J, V28, P1505, DOI 10.1038/emboj.2009.101; Hiratsuka S, 2002, CANCER CELL, V2, P289, DOI 10.1016/S1535-6108(02)00153-8; Finley SD, 2013, JNCI-J NATL CANCER I, V105, P802, DOI 10.1093/jnci/djt093; Bulzomi P, 2012, IUBMB LIFE, V64, P690, DOI 10.1002/iub.1049; He W, 2012, J PHARMACOL SCI, V119, P341, DOI 10.1254/jphs.12052FP; Paauwe M, 2013, EXPERT OPIN THER TAR, V17, P421, DOI 10.1517/14728222.2013.758716; Dalwadi H, 2005, CLIN CANCER RES, V11, P7674, DOI 10.1158/1078-0432.CCR-05-1205; Oguro T, 2013, EUR J CANCER, V49, P1715, DOI 10.1016/j.ejca.2012.11.038; D'Arena G, 2013, INT J IMMUNOPATH PH, V26, P117; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Pisanti S, 2014, PHARMACOL RES, V88, P84, DOI 10.1016/j.phrs.2014.06.013; Denoyelle C, 2001, CARCINOGENESIS, V22, P1139, DOI 10.1093/carcin/22.8.1139; Chen YS, 2013, INT J ONCOL, V42, P1325, DOI 10.3892/ijo.2013.1833; Elsawa SF, 2011, BLOOD, V118, P5540, DOI 10.1182/blood-2011-04-351742; Gaya A, 2012, CANCER TREAT REV, V38, P484, DOI 10.1016/j.ctrv.2011.12.008; Sinha P, 2005, CANCER IMMUNOL IMMUN, V54, P1137, DOI 10.1007/s00262-005-0703-4; Pan JF, 2002, ACTA PHARMACOL SIN, V23, P77; Mo HB, 2004, EXP BIOL MED, V229, P567; Finley LWS, 2011, CANCER CELL, V19, P416, DOI 10.1016/j.ccr.2011.02.014; Murakami A, 2009, FORUM NUTR, V61, P193, DOI 10.1159/000212751; Eck SM, 2009, MOL CANCER RES, V7, P1033, DOI 10.1158/1541-7786.MCR-09-0015; Park KS, 2012, YONSEI MED J, V53, P346, DOI 10.3349/ymj.2012.53.2.346; Cheng CW, 2010, J AGR FOOD CHEM, V58, P887, DOI 10.1021/jf903377e; Santer FR, 2010, ENDOCR-RELAT CANCER, V17, P241, DOI 10.1677/ERC-09-0200; Kalemci S, 2013, EUR REV MED PHARMACO, V17, P3334; Linde N, 2012, J PATHOL, V227, P17, DOI 10.1002/path.3989; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ravasco P, 2010, CLIN NUTR, V29, P42, DOI 10.1016/j.clnu.2009.06.006; Lin JP, 2006, WORLD J GASTROENTERO, V12, P21; Munn DH, 2004, J CLIN INVEST, V114, P280, DOI 10.1172/JCI200421583; Naugler WE, 2008, TRENDS MOL MED, V14, P109, DOI 10.1016/j.molmed.2007.12.007; Maruyama T, 2014, ONCOL REP, V31, P625, DOI 10.3892/or.2013.2925; Kenny PA, 2007, FRONT BIOSCI, V12, P3468, DOI 10.2741/2327; Athar M, 2007, TOXICOL APPL PHARM, V224, P274, DOI 10.1016/j.taap.2006.12.025; Harmon AW, 2004, BREAST CANCER RES TR, V85, P103, DOI 10.1023/B:BREA.0000025397.56192.e2; Keuser B, 2013, MUTAGENESIS, V28, P569, DOI 10.1093/mutage/get034; Liu J, 2013, CELL PHYSIOL BIOCHEM, V32, P1213, DOI 10.1159/000354520; Bhattaram VA, 2002, PHYTOMEDICINE, V9, P1; Abidi P, 2005, ARTERIOSCL THROM VAS, V25, P2170, DOI 10.1161/01.ATV.0000181761.16341.2b; Menegazzi M, 2001, FASEB J, V15, P1309; Pradeep CR, 2002, CLIN EXP METASTAS, V19, P703, DOI 10.1023/A:1021398601388; Chainani-Wu N, 2003, J ALTERN COMPLEM MED, V9, P161, DOI 10.1089/107555303321223035; Nassiri F, 2011, ANTICANCER RES, V31, P2283; Gomez LS, 2013, BIOCHIMIE, V95, P1336, DOI 10.1016/j.biochi.2013.02.013; El Roz A, 2012, ANTICANCER RES, V32, P3007; Ghosh AK, 2009, CLIN CANCER RES, V15, P1250, DOI 10.1158/1078-0432.CCR-08-1511; Kara S, 2014, SCI WORLD J, DOI 10.1155/2014/797824; Huang B, 2005, CANCER RES, V65, P5009, DOI 10.1158/0008-5472.CAN-05-0784; Koblish HK, 2010, MOL CANCER THER, V9, P489, DOI 10.1158/1535-7163.MCT-09-0628; Shamoto T, 2014, PANCREAS, V43, P396, DOI 10.1097/MPA.0000000000000039; Mittal R, 2000, METHOD FIND EXP CLIN, V22, P271, DOI 10.1358/mf.2000.22.5.796644; Berletch JB, 2008, J CELL BIOCHEM, V103, P509, DOI 10.1002/jcb.21417; Chen W, 2011, AAPS PHARMSCITECH, V12, P705, DOI 10.1208/s12249-011-9632-z; Eguchi A, 2007, BIOSCI BIOTECH BIOCH, V71, P935, DOI 10.1271/bbb.60596; Boros LG, 2001, PANCREAS, V22, P1, DOI 10.1097/00006676-200101000-00001; Maier JAM, 1997, ANTI-CANCER DRUG, V8, P238, DOI 10.1097/00001813-199703000-00004; Kim SK, 2011, JOINT BONE SPINE, V78, P471, DOI 10.1016/j.jbspin.2011.01.004; Kim M, 2009, INT J CANCER, V124, P264, DOI 10.1002/ijc.23923; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Sato N, 2012, ONCOL REP, V28, P1574, DOI 10.3892/or.2012.1984; Chien YC, 2011, GENE DEV, V25, P2125, DOI 10.1101/gad.17276711; Liu Y, 2011, EUR J PHARMACOL, V650, P130, DOI 10.1016/j.ejphar.2010.10.009; Lee BH, 2013, CANCER RES, V73, P1211, DOI 10.1158/0008-5472.CAN-12-3128; She XW, 2004, INT J CANCER, V108, P251, DOI 10.1002/ijc.11551; Frombaum M, 2012, BIOCHIMIE, V94, P269, DOI 10.1016/j.biochi.2011.11.001; Hussain T, 2005, INT J CANCER, V113, P660, DOI 10.1002/ijc.20629; Adini A, 2002, CANCER RES, V62, P2749; Kunze D, 2008, INT J ONCOL, V32, P1049; Hwang YP, 2011, TOXICOL LETT, V203, P9, DOI 10.1016/j.toxlet.2011.02.013; Nardo G, 2011, CANCER RES, V71, P4214, DOI 10.1158/0008-5472.CAN-11-0242; KNEKT P, 1988, J CLIN EPIDEMIOL, V41, P519, DOI 10.1016/0895-4356(88)90056-X; Mantena SK, 2006, MOL CANCER THER, V5, P296, DOI 10.1158/1535-7163.MCT-05-0448; Borriello A, 2013, CURR PHARM DESIGN, V19, P5384; Schimanski S, 2010, HORM METAB RES, V42, P102, DOI 10.1055/s-0029-1241859; Prasad DVR, 2004, J IMMUNOL, V173, P2500; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Pierini R, 2008, BRIT J NUTR, V99, pES53, DOI 10.1017/S0007114508965764; PIYACHATURAWAT P, 1983, TOXICOL LETT, V16, P351, DOI 10.1016/0378-4274(83)90198-4; Fruehauf JP, 2007, CLIN CANCER RES, V13, P789, DOI 10.1158/1078-0432.CCR-06-2082; Sharma MD, 2007, J CLIN INVEST, V117, P2570, DOI 10.1172/JCI31911; Ivanovska N, 1999, IMMUNOPHARM IMMUNOT, V21, P771, DOI 10.3109/08923979909007141; Bayir H, 2005, CRIT CARE MED, V33, pS498, DOI 10.1097/01.CCM.0000186787.64500.12; Bloch K, 1942, J BIOL CHEM, V143, P297; Hunsucker SA, 2011, BRIT J HAEMATOL, V152, P579, DOI 10.1111/j.1365-2141.2010.08533.x; Rios-Marco P, 2013, BBA-MOL CELL BIOL L, V1831, P1322, DOI 10.1016/j.bbalip.2013.05.004; Hua YQ, 2011, J PROTEOME RES, V10, P3513, DOI 10.1021/pr200147g; Kansara M, 2013, J CLIN INVEST, V123, P5351, DOI 10.1172/JCI70559; Ozdemir BC, 2014, CANCER CELL, V25, P719, DOI 10.1016/j.ccr.2014.04.005; Newbold RR, 2009, MOL CELL ENDOCRINOL, V304, P84, DOI 10.1016/j.mce.2009.02.024; Hu ZL, 2011, ARTHRITIS RHEUM-US, V63, P949, DOI 10.1002/art.30202; GRISHAM MB, 1990, BIOCHEM PHARMACOL, V39, P2060, DOI 10.1016/0006-2952(90)90630-4; Ji YN, 2014, TUMOR BIOL, V35, P2787, DOI 10.1007/s13277-013-1371-1; Selvendiran K, 2004, CLIN CHIM ACTA, V350, P73, DOI 10.1016/j.cccn.2004.07.004; Piha-Paul SA, 2014, ANTICANCER RES, V34, P1939; Lin SS, 2009, CANCER LETT, V285, P127, DOI 10.1016/j.canlet.2009.04.037; Aldinucci D, 2010, J PATHOL, V221, P248, DOI 10.1002/path.2711; Shibuya M, 2006, J BIOCHEM MOL BIOL, V39, P469; Lyford-Pike S, 2013, CANCER RES, V73, P1733, DOI 10.1158/0008-5472.CAN-12-2384; HANUKOGLU I, 1992, J STEROID BIOCHEM, V43, P779, DOI 10.1016/0960-0760(92)90307-5; Lohr J, 2004, J IMMUNOL, V173, P5028; Lee J, 2006, BIOCHEM BIOPH RES CO, V339, P748, DOI 10.1016/j.bbrc.2005.11.075; Gu HY, 2014, BIOMARKERS, V19, P252, DOI 10.3109/1354750X.2014.902997; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Kim S, 2008, PHYTOMEDICINE, V15, P340, DOI 10.1016/j.phymed.2007.09.011; Lee WY, 2014, TOXICOL APPL PHARM, V274, P55, DOI 10.1016/j.taap.2013.10.027; Eom KS, 2008, BIOL PHARM BULL, V31, P558, DOI 10.1248/bpb.31.558; Bell EL, 2011, MOL CELL, V42, P561, DOI 10.1016/j.molcel.2011.05.008; Hosoki A, 2012, J RADIAT RES, V53, P58, DOI 10.1269/jrr.11034; Guterres FADB, 2013, EXP CELL RES, V319, P2977, DOI 10.1016/j.yexcr.2013.07.026; [Anonymous], 2007, CHIN TRADIT HERBAL D, V38, P1476; HALLIWELL B, 1991, DRUGS, V42, P569, DOI 10.2165/00003495-199142040-00003; Hong DS, 2007, CANCER, V110, P1911, DOI 10.1002/cncr.22999; Jiang XG, 2008, ENDOCRINOLOGY, V149, P5366, DOI 10.1210/en.2008-0857; Chung DJ, 2009, BLOOD, V114, P555, DOI 10.1182/blood-2008-11-191197; Kim BH, 2011, BRIT J PHARMACOL, V164, P106, DOI 10.1111/j.1476-5381.2011.01353.x; Chen HP, 2013, EXP CELL RES, V319, P697, DOI 10.1016/j.yexcr.2012.12.026; Dank M, 2014, ANTICANCER RES, V34, P1275; Islam M, 2013, ORAL ONCOL, V49, P778, DOI 10.1016/j.oraloncology.2013.04.003; Ono M, 2013, ANTICANCER RES, V33, P1861; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Fouad MA, 2013, HUM EXP TOXICOL, V32, P1067, DOI 10.1177/0960327113475679; Nonaka H, 2011, INT J ONCOL, V38, P113, DOI 10.3892/ijo_00000830; Qin L, 2011, PROTEIN CELL, V2, P507, DOI 10.1007/s13238-011-1056-8; Hendrayani SF, 2013, NEOPLASIA, V15, P631, DOI 10.1593/neo.13478; Rakhra K, 2010, CANCER CELL, V18, P485, DOI 10.1016/j.ccr.2010.10.002; LeCouter J, 2003, SCIENCE, V299, P890, DOI 10.1126/science.1079562; Munn DH, 2013, TRENDS IMMUNOL, V34, P137, DOI 10.1016/j.it.2012.10.001; Macha MA, 2013, CANCER LETT, V341, P166, DOI 10.1016/j.canlet.2013.07.037; Fizazi K, 2012, EUR J CANCER, V48, P85, DOI 10.1016/j.ejca.2011.10.014; Noh KT, 2013, BIOCHEM BIOPH RES CO, V431, P348, DOI 10.1016/j.bbrc.2012.12.093; Prietsch RF, 2014, MOL CELL BIOCHEM, V390, P235, DOI 10.1007/s11010-014-1974-x; [Anonymous], 2000, ALTERN MED REV, V5, P175; Shachaf CM, 2007, BLOOD, V110, P2674, DOI 10.1182/blood-2006-09-048033; Arul D, 2013, PATHOL ONCOL RES, V19, P763, DOI 10.1007/s12253-013-9641-1; Bae GS, 2012, PHYTOTHER RES, V26, P1893, DOI 10.1002/ptr.4649; Chakraborty G, 2008, MOL MED REP, V1, P641, DOI 10.3892/mmr_00000005; Diogo CV, 2011, CURR DRUG TARGETS, V12, P850; Caruso MG, 2002, J GASTROENTEROL, V37, P504, DOI 10.1007/s005350200078; Ogawa K, 2012, CANCER SCI, V103, P951, DOI 10.1111/j.1349-7006.2012.02237.x; Fisher DT, 2011, J CLIN INVEST, V121, P3846, DOI 10.1172/JCI44952; Patan S, 2000, J NEURO-ONCOL, V50, P1, DOI 10.1023/A:1006493130855; Kasibhatta Ravisekhar, 2007, Drugs R D, V8, P383; Goswami KK, 2014, MOL IMMUNOL, V59, P119, DOI 10.1016/j.molimm.2014.01.015; Malhotra A, 2012, ULTRASTRUCT PATHOL, V36, P179, DOI 10.3109/01913123.2011.652765; Sanchez-Correa B, 2013, CYTOKINE, V61, P885, DOI 10.1016/j.cyto.2012.12.023; Masuda M, 2001, CLIN CANCER RES, V7, P4220; Cheng Z, 2006, BBA-GEN SUBJECTS, V1760, P1682, DOI 10.1016/j.bbagen.2006.09.007; Kobayashi CI, 2012, J CELL PHYSIOL, V227, P421, DOI 10.1002/jcp.22764; Fan LX, 2013, BBA-GEN SUBJECTS, V1830, P5175, DOI 10.1016/j.bbagen.2013.07.010; Regev-Shoshani G, 2003, BIOCHEM J, V374, P157, DOI 10.1042/BJ20030141; Han L, 2012, CHINESE MED J-PEKING, V125, P2032, DOI 10.3760/cma.j.issn.0366-6999.2012.11.034; Jang DS, 1999, BIOCHEM PHARMACOL, V57, P705, DOI 10.1016/S0006-2952(98)00350-5; Nogueira V, 2013, CLIN CANCER RES, V19, P4309, DOI 10.1158/1078-0432.CCR-12-1424; Karnevi E, 2014, IMMUNOL CELL BIOL, V92, P543, DOI 10.1038/icb.2014.22; Mantena SK, 2006, CARCINOGENESIS, V27, P2018, DOI 10.1093/carcin/bgl043; Lin Y, 2014, TUMOR BIOL, V35, P3305, DOI 10.1007/s13277-013-1433-4; Shan BE, 2009, CANCER INVEST, V27, P604, DOI 10.1080/07357900802337191; Keong YS, 2010, PAK J PHARM SCI, V23, P75; Hu XJ, 2014, MOL MED REP, V9, P1883, DOI 10.3892/mmr.2014.1999; Nelson ER, 2013, SCIENCE, V342, P1094, DOI 10.1126/science.1241908; Han MH, 2013, FOOD CHEM TOXICOL, V62, P382, DOI 10.1016/j.fct.2013.08.085; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Khaw AK, 2012, GENE CHROMOSOME CANC, V51, P961, DOI 10.1002/gcc.21979; Fang HY, 2011, PHYTOMEDICINE, V18, P697, DOI 10.1016/j.phymed.2010.11.012; Litzenburger UM, 2014, ONCOTARGET, V5, P1038; Pan CC, 2012, BIOCHEM BIOPH RES CO, V424, P620, DOI 10.1016/j.bbrc.2012.06.163; Shimizu M, 2008, CANCER LETT, V262, P10, DOI 10.1016/j.canlet.2007.11.026; Paul S, 2010, EUR J MED CHEM, V45, P3702, DOI 10.1016/j.ejmech.2010.05.019; Jung KH, 2013, J NUCL MED, V54, P2161, DOI 10.2967/jnumed.112.115436; Silva A, 2008, J CLIN INVEST, V118, P3762, DOI 10.1172/JCI34616; Riboldi E, 2005, J IMMUNOL, V175, P2788; Rahman HS, 2014, BIOMED RES INT, DOI 10.1155/2014/920742; Abdelwahab SI, 2011, LEUKEMIA RES, V35, P268, DOI 10.1016/j.leukres.2010.07.025; Rattigan YL, 2012, EXP CELL RES, V318, P326, DOI 10.1016/j.yexcr.2011.11.014; Anand P, 2008, CANCER LETT, V267, P133, DOI 10.1016/j.canlet.2008.03.025; Raza H, 2008, ANN NY ACAD SCI, V1138, P358, DOI 10.1196/annals.1414.037; Peng G, 2006, MOL CARCINOGEN, V45, P309, DOI 10.1002/mc.20166; Osmak M, 2012, CANCER LETT, V324, P1, DOI 10.1016/j.canlet.2012.04.011; Papadopoulos G, 2011, EUR J CANCER, V47, P819, DOI 10.1016/j.ejca.2011.01.005; Nonn L, 2007, CARCINOGENESIS, V28, P1188, DOI 10.1093/carcin/bgl241; ARUOMA OI, 1987, BIOCHEM PHARMACOL, V36, P3739, DOI 10.1016/0006-2952(87)90028-1; Halliwell B, 2013, BRIT J CLIN PHARMACO, V75, P637, DOI 10.1111/j.1365-2125.2012.04272.x; Sidler D, 2011, ONCOGENE, V30, P2411, DOI 10.1038/onc.2010.629; DESSI S, 1994, CANCER, V73, P253, DOI 10.1002/1097-0142(19940115)73:2<253::AID-CNCR2820730204>3.0.CO;2-F; Chuchawankul S, 2012, GENET MOL RES, V11, P617, DOI 10.4238/2012.March.14.5; Pan Q, 2007, CANCER CELL, V11, P53, DOI 10.1016/j.ccr.2006.10.018; Bavaresco L, 2003, DRUG EXP CLIN RES, V29, P181; Miyamoto S, 2010, CHEM-BIOL INTERACT, V183, P276, DOI 10.1016/j.cbi.2009.11.002; Morris K, 2013, VET IMMUNOL IMMUNOP, V153, P159, DOI 10.1016/j.vetimm.2013.02.008; Pfeifer S, 2012, J CANCER RES CLIN, V138, P1821, DOI 10.1007/s00432-012-1259-2; Cieslewicz M, 2013, P NATL ACAD SCI USA, V110, P15919, DOI 10.1073/pnas.1312197110; Hwang KA, 2013, TOXICOL APPL PHARM, V272, P637, DOI 10.1016/j.taap.2013.07.027; Hudes G, 2013, INVEST NEW DRUG, V31, P669, DOI 10.1007/s10637-012-9857-z; Jagadeesh S, 2006, CANCER RES, V66, P2107, DOI 10.1158/0008-5472.CAN-05-2494; Lee H, 2013, BRIT J NUTR, V110, P69, DOI 10.1017/S0007114512004734; Sahu SC, 1997, FOOD CHEM TOXICOL, V35, P443, DOI 10.1016/S0278-6915(97)00011-2; Laurent A, 2005, CANCER RES, V65, P948; Athar M, 2009, ARCH BIOCHEM BIOPHYS, V486, P95, DOI 10.1016/j.abb.2009.01.018; Purushotham A, 2009, MOL NUTR FOOD RES, V53, P300, DOI 10.1002/mnfr.200700514; de Jong RA, 2012, GYNECOL ONCOL, V126, P474, DOI 10.1016/j.ygyno.2012.05.034; Ouyang DY, 2013, FOOD CHEM TOXICOL, V60, P424, DOI 10.1016/j.fct.2013.08.007; Liu YQ, 2005, CANCER RES, V65, P4955, DOI 10.1158/0008-5472.CAN-04-3957; Conejo-Garcia JR, 2003, CANCER BIOL THER, V2, P446; Kerkar SP, 2011, J CLIN INVEST, V121, P4746, DOI 10.1172/JCI58814; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Guseva NV, 2011, CANCER BIOL THER, V12, P80, DOI 10.4161/cbt.12.1.15721; Qiu B, 2013, CLIN EXP METASTAS, V30, P1009, DOI 10.1007/s10585-013-9599-0; Lee W, 2013, BIOCHEM BIOPH RES CO, V430, P406, DOI 10.1016/j.bbrc.2012.11.030; Bell EL, 2011, ONCOGENE, V30, P2986, DOI 10.1038/onc.2011.37; Notarnicola M, 2004, ANTICANCER RES, V24, P3837; Arago F, 1816, ANN CHIMIE PHYS; Arias-Pulido H, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-298; Ashizawa Tatsuto, 2005, Gastric Cancer, V8, P124, DOI 10.1007/s10120-005-0315-x; Atal Navin, 2010, J Ayurveda Integr Med, V1, P96, DOI 10.4103/0975-9476.65073; Bao B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043726; Bao B, 2012, PLOS ONE, V7; Basu Gargi D, 2006, J Immunol, V177, P2391; Bo Li Z., 2012, J CELL SCI, V125, P3957; Breen MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072407; Buttari B., 2013, OXIDATIVE MED CELLUL, V2013; Cao HL, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-163; Cardin Romilda, 2012, BMC Cancer, V12, P177, DOI 10.1186/1471-2407-12-177; Casey Stephanie C, 2014, J Immunother Cancer, V2, P24, DOI 10.1186/2051-1426-2-24; Cesaratto L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070909; Chakraborty A, 2011, CANC RES S, V71; Chen MF, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-26; Chen MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061901; Chen QY, 2014, J NUTR BIOCHEM, V25, P177, DOI 10.1016/j.jnutbio.2013.10.004; Chiyomaru T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070372; Choi RJ, 2014, INT IMMUNOPHARMACOL, V18, P182, DOI 10.1016/j.intimp.2013.11.022; Dai W., 2013, NFAT MOL CARCINOG, V54, P301; Dang CV, 2013, COLD SPRING HARB PER, V3; Das L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099583; DeNardo DG, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1746; [邓意辉 Deng Yihui], 2004, [中国药学杂志, Chinese Pharmaceutical Journal], V39, P40; Dengler MA, 2011, PLOS ONE, V6; Diaz T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018856; Dong Y, 2015, MOL CARCINOG; dos Santos CR, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-16; Fan SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089961; FEIG DI, 1994, CANCER RES, V54, pS1890; FIORENTINO DF, 1991, J IMMUNOL, V146, P3444; Fu LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069240; Ganapathy S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015627; Godugu C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089919; Goyne HE, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00382; Guerreiro S, 2007, FASEB J, V21, P848; Gupta Aditi, 2013, Cancers (Basel), V5, P617, DOI 10.3390/cancers5020617; Ha SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099955; Han X, 2014, BIOMEDICAL REPORTS, V2, P183; Han YY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015420; HANO K, 1957, Gan, V48, P443; Hawinkels U, 2010, CANCER RES, V70, P4141; Hollborn M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059603; Hou JZS, 2008, CHINA PHARM, V19, P1150; Huang AC, 2013, IN VIVO, V27, P627; Iwasaki K, 2013, BIOCHEMISTRY-US, V52, P5075, DOI 10.1021/bi400399f; Ji Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078700; Jie SH, 2011, J GASTROEN HEPATOL, V26, P179, DOI 10.1111/j.1440-1746.2010.06389.x; Jorvig JE, 2015, ANTI-CANCER DRUG, V26, P160, DOI 10.1097/CAD.0000000000000171; Kalinski T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099296; Khan AW, 2014, DRUG DELIV; Kiao CW, 2008, FRONT BIOSCI, V13, P2660; Kim J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039448; Kojima M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088018; Konner Jason, 2004, Clin Colorectal Cancer, V4 Suppl 2, pS81, DOI 10.3816/CCC.2004.s.013; LEE HP, 1991, LANCET, V337, P1197; Lee Jung-Yun, 2012, J Tradit Complement Med, V2, P96; Li Mengmeng, 2013, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V29, P581; Li SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081657; Li Y, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-62; Liu K, 2014, MOL CELL BIOCHEM, V386, P117, DOI 10.1007/s11010-013-1850-0; Liu W, 2014, MEDIAT INFLAMM, V2014; Liu YM, 2014, INVEST NEW DRUG, V32, P851, DOI 10.1007/s10637-014-0129-y; Lo TF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075628; Lou CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050956; Lu LDY, 2013, SCI REP-UK, V3, DOI 10.1038/srep03169; Mace TA, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.24891; Madeddu C, 2014, J CELL MOL MED, V18, P2519, DOI 10.1111/jcmm.12413; Maitra R, 2009, J INFLAMM-LOND, V6, DOI 10.1186/1476-9255-6-15; Makuuchi V., 2013, CANCER SCI, V104, P1045; Malki Ahmed, 2009, Cancer Biol Ther, V8, P2175; Martin DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004531; Martinez-Outschoorn UE, 2010, CELL CYCLE, V9, P3515, DOI 10.4161/cc.9.17.12928; Martinez-Outschoorn UE, 2010, CELL CYCLE, V9, P3256, DOI 10.4161/cc.9.16.12553; McClellan JL, 2012, AM J PHYSIOL-GASTR L, V303, pG1087, DOI 10.1152/ajpgi.00252.2012; Medrek C, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-306; MESSINA MJ, 1994, NUTR CANCER, V21, P113; Michielsen AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027944; Middleton K, 2014, CRIT REV ONCOL HEMAT, V89, P129, DOI 10.1016/j.critrevonc.2013.08.004; Milano Francesca, 2013, Front Oncol, V3, P137, DOI 10.3389/fonc.2013.00137; Modem Suhasini, 2012, Genes Cancer, V3, P177, DOI 10.1177/1947601912458581; Mohapatra P, 2014, TOXICOL APPL PHARM, V275, P221, DOI 10.1016/j.taap.2014.01.011; Murakami A., 2005, J NUTR, V135, P2987; Orlando L, 2011, CANCER BIOL THER, V11, P883; Pan Guo-Yu, 2003, Yaoxue Xuebao, V38, P911; Pan ZQ, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-7; Papa Luena, 2014, Genes Cancer, V5, P15; Papetti M, 2002, AM J PHYSIOL-CELL PH, V282, pC947, DOI 10.1152/ajpcell.00389.2001; Pavese JM, 2014, AM J CLIN NUTR, V100, P431; Pervaiz S, 2003, FASEB J, V17, P1975, DOI 10.1096/fj.03-0168rev; Potluri R, 2014, FRONT CARD BIOL M; Priceman SJ, 2014, CELL REP, V6, P992, DOI 10.1016/j.celrep.2014.02.016; Pund S, 2014, PHYTOMEDICINE, V21, P307, DOI 10.1016/j.phymed.2013.09.013; Qi HW, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-22; Qi WT, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-219; Rahman HS, 2014, INT J NANOMED, V9, P527, DOI 10.2147/IJN.S54346; Rahman Heshu Sulaiman, 2013, Int J Nanomedicine, V8, P2769, DOI 10.2147/IJN.S45313; Rhodes CM, 1995, BIOCHEMISTRY; Rosen LS, 2014, CURR ONCOL REP, V16, DOI 10.1007/s11912-013-0365-x; Sakinah SAS, 2007, CANCER CELL INT, V7, DOI 10.1186/1475-2867-7-4; Samykutty A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065889; Sayeed A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067191; Shanmugam MK, 2014, MOL CARCINOG; Singhapol C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052989; Tillhon M, 2012, BIOCHEM PHARMACOL, V84, P1260, DOI 10.1016/j.bcp.2012.07.018; Sunila ES, 2004, J ETHNOPHARMACOL, V90, P339, DOI 10.1016/j.jep.2003.10.016; Yang XH, 2010, CARCINOGENESIS, V31, P695, DOI 10.1093/carcin/bgq007; Zhuang LY, 2005, J CLIN INVEST, V115, P959; Ziogas AC, 2012, INT J CANCER, V130, P857, DOI 10.1002/ijc.26094; Vollmer P, 1999, EUR J BIOCHEM, V263, P438, DOI 10.1046/j.1432-1327.1999.00511.x; Tedeschi E, 2002, ANN NY ACAD SCI, V973, P435; Zhang YQ, 2013, CANCER RES, V73, P6359, DOI 10.1158/0008-5472.CAN-13-1558-T; Sun W, 2014, INT J ONCOL, V44, P1551, DOI 10.3892/ijo.2014.2323; Yu XP, 2012, MED ONCOL, V29, P349, DOI 10.1007/s12032-010-9770-2; Vitrac X, 2003, LIFE SCI, V72, P2219, DOI 10.1016/S0024-3205(03)00096-1; Sulfikkarali N, 2013, PATHOL ONCOL RES, V19, P287, DOI 10.1007/s12253-012-9581-1; Ziebarth AJ, 2013, CLIN CANCER RES, V19, P170, DOI 10.1158/1078-0432.CCR-12-1045; Voorhees PM, 2013, BRIT J HAEMATOL, V161, P357, DOI 10.1111/bjh.12266; Tzeng HE, 2013, BIOCHEM PHARMACOL, V85, P531, DOI 10.1016/j.bcp.2012.11.021; Sun Y, 2013, PHARMAZIE, V68, P141, DOI 10.1691/ph.2013.2654; Suh WK, 2003, NAT IMMUNOL, V4, P899, DOI 10.1038/ni967; Yoshioka Y, 2000, NMR BIOMED, V13, P377, DOI 10.1002/1099-1492(200011)13:7<377::AID-NBM658>3.0.CO;2-E; SIPERSTEIN MD, 1964, CANCER RES, V24, P1108; Slimestad R, 2007, J AGR FOOD CHEM, V55, P10067, DOI 10.1021/jf0712503; Whitfield JR, 2012, CELL MOL LIFE SCI, V69, P931, DOI 10.1007/s00018-011-0860-x; Yu JP, 2013, J IMMUNOL, V190, P3783, DOI 10.4049/jimmunol.1201449; Xin H, 2011, CANCER RES, V71, P6601, DOI 10.1158/0008-5472.CAN-11-1217; Valenti D, 2013, BBA-MOL BASIS DIS, V1832, P2085, DOI 10.1016/j.bbadis.2013.07.014; Zulli A, 2009, HYPERTENSION, V53, P1017, DOI 10.1161/HYPERTENSIONAHA.109.129924; Xu Y, 2012, TOXICOL APPL PHARM, V259, P395, DOI 10.1016/j.taap.2011.09.028; Voorzanger N, 1996, CANCER RES, V56, P5499; Yamada O, 2012, MOL CANCER THER, V11, P1112, DOI 10.1158/1535-7163.MCT-11-0850; Suzuki T, 2014, BIOCHEM BIOPH RES CO, V444, P248, DOI 10.1016/j.bbrc.2014.01.058; Siwak DR, 2005, CANCER, V104, P879, DOI 10.1002/cncr.21216; Wang ZW, 2006, INT J CANCER, V118, P1930, DOI 10.1002/ijc.21589; Wang HY, 2013, TOXICOLOGY, V303, P139, DOI 10.1016/j.tox.2012.09.017; Smith C, 2012, CANCER DISCOV, V2, P722, DOI 10.1158/2159-8290.CD-12-0014; Sun ZK, 2014, EXP THER MED, V7, P843, DOI 10.3892/etm.2014.1542; Wang X, 2009, ARCH PHARM RES, V32, P1263, DOI 10.1007/s12272-009-1912-8; Takahashi S, 2011, BIOL PHARM BULL, V34, P1785; Yan S, 2013, ONCOTARGET, V4, P433; Zang J, 2013, HEAD NECK-J SCI SPEC, V35, P1507, DOI 10.1002/hed.23156; Wang TH, 2004, NAT MED, V10, P48, DOI 10.1038/nm976; Wikberg ML, 2013, TUMOR BIOL, V34, P1013, DOI 10.1007/s13277-012-0638-2; Tanaka M, 2013, BIOORGAN MED CHEM, V21, P1159, DOI 10.1016/j.bmc.2012.12.028; Zhang HY, 2011, AM J PHYSIOL-GASTR L, V300, pG454, DOI 10.1152/ajpgi.00458.2010; Zierau O, 2004, J STEROID BIOCHEM, V92, P107, DOI 10.1016/j.jsbmb.2004.06.001; Yadav A, 2011, MOL CANCER RES, V9, P1658, DOI 10.1158/1541-7786.MCR-11-0271; SUNDARAM SG, 1993, CANCER LETT, V74, P85, DOI 10.1016/0304-3835(93)90048-E; Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995; Steidl C, 2010, NEW ENGL J MED, V362, P875, DOI 10.1056/NEJMoa0905680; Stechishin OD, 2013, NEURO-ONCOLOGY, V15, P198, DOI 10.1093/neuonc/nos302; Zheng M, 2013, INT IMMUNOPHARMACOL, V15, P517, DOI 10.1016/j.intimp.2013.02.002; Wei LH, 2003, ONCOGENE, V22, P1517, DOI 10.1038/sj.onc.1206226; Yu XW, 2014, TUMOR BIOL, V35, P155, DOI 10.1007/s13277-013-1019-1; Xia C, 2007, CANCER RES, V67, P10823, DOI 10.1158/0008-5472.CAN-07-0783; Ye J, 2013, VIRCHOWS ARCH, V462, P73, DOI 10.1007/s00428-012-1340-x; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422; Yu JP, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/469135; Uyttenhove C, 2003, NAT MED, V9, P1269, DOI 10.1038/nm934; Wang J, 2012, INT J MOL MED, V30, P1166, DOI 10.3892/ijmm.2012.1095; Stagos D, 2007, FREE RADICAL RES, V41, P357, DOI 10.1080/10715760601064714; Waldner M, 2006, WORLD J GASTROENTERO, V12, P7233; Takada Y, 2005, ONCOGENE, V24, P6957, DOI 10.1038/sj.onc.1208845; Wang YX, 2012, BIOORGAN MED CHEM, V20, P6552, DOI 10.1016/j.bmc.2012.09.029; Zamanakou M, 2007, IMMUNOL LETT, V111, P69, DOI 10.1016/j.imlet.2007.06.001; Zhang G, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/384726; Wartenberg M, 2003, LAB INVEST, V83, P87, DOI 10.1097/01.LAB.0000049348.51663.2F; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Wang Y, 2012, CYTOKINE, V59, P228, DOI 10.1016/j.cyto.2012.04.020; Yodkeeree S, 2009, CANCER RES, V69, P6581, DOI 10.1158/0008-5472.CAN-09-1161; Song B, 2012, CELL IMMUNOL, V276, P91, DOI 10.1016/j.cellimm.2012.04.006; Wang TTY, 2010, MOL NUTR FOOD RES, V54, P335, DOI 10.1002/mnfr.200900143; Vellaichamy L, 2009, ENVIRON TOXICOL PHAR, V28, P11, DOI 10.1016/j.etap.2009.01.008; WEI HC, 1993, CARCINOGENESIS, V14, P1195, DOI 10.1093/carcin/14.6.1195; Xian MJ, 2007, CANCER SCI, V98, P118, DOI 10.1111/j.1349-7006.2007.00362.x; Zhou FL, 2013, J LEUKOCYTE BIOL, V94, P423, DOI 10.1189/jlb.0113006; Yamagiwa Y, 2006, LIFE SCI, V78, P2494, DOI 10.1016/j.lfs.2005.10.015; Svejda B, 2010, CANCER-AM CANCER SOC, V116, P2902, DOI 10.1002/cncr.25049; Xiao HB, 2012, PHARMACOL REP, V64, P889; Song X, 2014, BBA-MOL CELL RES, V1843, P894, DOI 10.1016/j.bbamcr.2014.02.002; Wietrzyk J, 2004, MED SCI MONITOR, V10, pBR414; Wong WWL, 2002, LEUKEMIA, V16, P508, DOI 10.1038/sj.leu.2402476; Vaughan RA, 2013, INT J CANCER, V133, P2504, DOI 10.1002/ijc.28264; Tarhini AA, 2011, CLIN CANCER RES, V17, P6574, DOI 10.1158/1078-0432.CCR-11-1463; Yi H, 2012, INT J ONCOL, V41, P310, DOI 10.3892/ijo.2012.1447; Zahid M, 2010, FREE RADICAL BIO MED, V48, P318, DOI 10.1016/j.freeradbiomed.2009.11.002; Yang CS, 2009, NAT REV CANCER, V9, P429, DOI 10.1038/nrc2641; Wang SD, 2000, BLOOD, V96, P2808; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177; Weiss JM, 2007, EXPERT OPIN BIOL TH, V7, P1705, DOI 10.1517/14712598.7.11.1705; Yang CP, 2012, J ASIAN NAT PROD RES, V14, P68, DOI 10.1080/10286020.2011.632369; Zikaki K, 2014, APOPTOSIS, V19, P958, DOI 10.1007/s10495-014-0979-y; Talmadge JE, 2007, CANCER METAST REV, V26, P373, DOI 10.1007/s10555-007-9072-0; Zhang GJ, 1999, ANTICANCER RES, V19, P1427; Sumimoto H, 2006, J EXP MED, V203, P1651, DOI 10.1084/jem.20051848; Tong NN, 2012, ONCOL LETT, V3, P1263, DOI 10.3892/ol.2012.644; Wang H, 2011, CARCINOGENESIS, V32, P1881, DOI 10.1093/carcin/bgr218; Soleas GJ, 2001, J CHROMATOGR B, V757, P161, DOI 10.1016/S0378-4347(01)00142-6; Tan GH, 2004, INT J CANCER, V112, P701, DOI 10.1002/ijc.20449; Yang CM, 2012, J NUTR BIOCHEM, V23, P8, DOI 10.1016/j.jnutbio.2010.10.006; Wong CP, 2011, IMMUNOL LETT, V139, P7, DOI 10.1016/j.imlet.2011.04.009; Yang Z, 2012, ANTI-CANCER AGENT ME, V12, P1264; Wang B, 2013, NUTR RES, V33, P971, DOI 10.1016/j.nutres.2013.07.016; Xiao CW, 2008, FRONT BIOSCI-LANDMRK, V13, P2660, DOI 10.2741/2873; Wang GH, 2012, BIOORG MED CHEM LETT, V22, P2114, DOI 10.1016/j.bmcl.2011.12.095; WALTENBERGER J, 1994, J BIOL CHEM, V269, P26988; Zhang J, 2013, INT J BIOCHEM CELL B, V45, P745, DOI 10.1016/j.biocel.2012.11.001; Timmerman JM, 1999, ANNU REV MED, V50, P507; Zahid M, 2007, FREE RADICAL BIO MED, V43, P1534, DOI 10.1016/j.fteeradbiomed.2007.08.005; Wang HK, 2012, J AGR FOOD CHEM, V60, P2171, DOI 10.1021/jf204625y; Turner N, 2008, DIABETES, V57, P1414, DOI 10.2337/db07-1552; Suresh D, 2007, FOOD CHEM TOXICOL, V45, P1437, DOI 10.1016/j.fct.2007.02.002; Yoo MY, 2007, PHYTOTHER RES, V21, P186, DOI 10.1002/ptr.2042; Wang JP, 2012, AM J PATHOL, V180, P221, DOI 10.1016/j.ajpath.2011.09.007; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Zhang H, 2013, BLOOD, V122, P1105, DOI 10.1182/blood-2012-08-449413; Wang ZG, 2012, CLIN EXP PHARMACOL P, V39, P227, DOI 10.1111/j.1440-1681.2011.05660.x; Tran E, 2013, J EXP MED, V210, P1125, DOI 10.1084/jem.20130110; Takahashi A, 2014, BIOCHEM BIOPH RES CO, V443, P1, DOI 10.1016/j.bbrc.2013.10.094; Smith B, 2012, CELL REP, V2, P580, DOI 10.1016/j.celrep.2012.08.011; Zhang MH, 2013, INT J MOL MED, V31, P621, DOI 10.3892/ijmm.2013.1237; Yamamoto M, 2006, CANCER GENE THER, V13, P194, DOI 10.1038/sj.cgt.7700873; Sung B, 2008, CANCER RES, V68, P8938, DOI 10.1158/0008-5472.CAN-08-2155; Zhang BC, 2012, CLINICS, V67, P901, DOI 10.6061/clinics/2012(08)08; Wainwright DA, 2012, CLIN CANCER RES, V18, P6110, DOI 10.1158/1078-0432.CCR-12-2130; Xu J, 2013, MOL CANCER THER, V12, P717, DOI 10.1158/1535-7163.MCT-12-1016-T; Siperstein M D, 1972, Trans Am Clin Climatol Assoc, V83, P156; SIPERSTE.MD, 1966, J BIOL CHEM, V241, P602; Siperstein M D, 1970, Trans Am Clin Climatol Assoc, V81, P107; Sisson TH, 2012, ADV BIOSCI BIOTECHNO, V3, P657; Sobhan PK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059350; Su D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054505; Sung BH, 2004, BIOSCI BIOTECH BIOCH, V68, P428; Surampalli G, 2014, DRUG DEV IND PHARM, P1; Tang SN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031067; Tewari KS, 2014, NEW ENGL J MED, V370, P734, DOI 10.1056/NEJMoa1309748; Thysell E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014175; Valluru M, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00089; Yan J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024705; Vanamala J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-238; von Bergwelt-Baildon MS, 2006, BLOOD, V108, P228, DOI 10.1182/blood-2005-08-3507; Walle T, 2004, DRUG METAB DISPOS, V32, P1377; Wang JP, 2013, NUTR METAB, V10, DOI 10.1186/1743-7075-10-29; Wang J, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.474; Wang LF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029432; Wang LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056666; Wang Y., 2013, ADV CIV ENG, V2013, P8, DOI DOI 10.1186/2193-1801-2-324; Waris Gulam, 2006, J Carcinog, V5, P14, DOI 10.1186/1477-3163-5-14; Wilken R, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-12; Wilson Mark A., 2008, BMC Pharmacology, V8, P15, DOI 10.1186/1471-2210-8-15; Wu CM, 2013, EVID-BASED COMPL ALT, V2013; Wu XF, 2013, J TOXICOL PATHOL, V26, P385, DOI 10.1293/tox.2013-0020; Xu WW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034406; Yamagishi N, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-229; Yamazaki K, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000387; YANG CS, 1993, J NATL CANCER I, V85, P1038, DOI 10.1093/jnci/85.13.1038; Yang EJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086062; Yao LB, 2013, BLOOD, V122, P3832, DOI 10.1182/blood-2012-12-473835; Yao X, 2014, PHARMACOL THERAPEUT, V141, P125, DOI 10.1016/j.pharmthera.2013.09.004; Yu Y, 2014, APOPTOSIS, V19, P1, DOI 10.1007/s10495-013-0908-5; Yuan X, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.334; Zhang Feng, 2012, World J Biol Chem, V3, P167, DOI 10.4331/wjbc.v3.i8.167; Zhang L, 2014, HEPATOLOGY, V59, P178, DOI 10.1002/hep.26628; ZHANG RX, 1990, CHINESE MED J-PEKING, V103, P658; Zhou DX, 2014, CELL SIGNAL, V26, P192, DOI 10.1016/j.cellsig.2013.11.004; Zhou Jun, 2014, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V39, P142, DOI 10.11817/j.issn.1672-7347.2014.02.006	664	4	4	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1044-579X			SEMIN CANCER BIOL	Semin. Cancer Biol.	DEC	2015	35			S			S199	S223		10.1016/j.semcancer.2015.02.007		25	Oncology	Oncology	CY7WG	WOS:000366619400010		
J	Feitelson, MA; Arzumanyan, A; Kulathinal, RJ; Blain, SW; Holcombe, RF; Mahajna, J; Marino, M; Martinez-Chantar, ML; Nawroth, R; Sanchez-Garcia, I; Sharma, D; Saxena, NK; Singh, N; Vlachostergios, PJ; Guo, SC; Honoki, K; Fujii, H; Georgakilas, AG; Bilsland, A; Amedei, A; Niccolai, E; Amin, A; Ashraf, SS; Boosani, CS; Guha, G; Ciriolo, MR; Aquilano, K; Chen, S; Mohammed, SI; Azmi, AS; Bhakta, D; Halicka, D; Keith, WN; Nowsheen, S				Feitelson, Mark A.; Arzumanyan, Alla; Kulathinal, Rob J.; Blain, Stacy W.; Holcombe, Randall F.; Mahajna, Jamal; Marino, Maria; Martinez-Chantar, Maria L.; Nawroth, Roman; Sanchez-Garcia, Isidro; Sharma, Dipali; Saxena, Neeraj K.; Singh, Neetu; Vlachostergios, Panagiotis J.; Guo, Shanchun; Honoki, Kanya; Fujii, Hiromasa; Georgakilas, Alexandros G.; Bilsland, Alan; Amedei, Amedeo; Niccolai, Elena; Amin, Amr; Ashraf, S. Salman; Boosani, Chandra S.; Guha, Gunjan; Ciriolo, Maria Rosa; Aquilano, Katia; Chen, Sophie; Mohammed, Sulma I.; Azmi, Asfar S.; Bhakta, Dipita; Halicka, Dorota; Keith, W. Nicol; Nowsheen, Somaira			Sustained proliferation in cancer: Mechanisms and novel therapeutic targets	SEMINARS IN CANCER BIOLOGY			English	Review						Proliferation; Natural products; Therapeutic targets; Cancer stem cells; Cancer hallmarks	NF-KAPPA-B; HUMAN BREAST-CANCER; CELL-CYCLE ARREST; GROWTH-FACTOR-I; ESTROGEN-RECEPTOR-ALPHA; EPITHELIAL-MESENCHYMAL TRANSITION; TELOMERASE-REVERSE-TRANSCRIPTASE; DEPENDENT KINASE INHIBITOR; HEDGEHOG-SIGNALING PATHWAY; ACTIVATED PROTEIN-KINASE	Proliferation is an important part of cancer development and progression. This is manifest by altered expression and/or activity of cell cycle related proteins. Constitutive activation of many signal transduction pathways also stimulates cell growth. Early steps in tumor development are associated with a fibrogenic response and the development of a hypoxic environment which favors the survival and proliferation of cancer stem cells. Part of the survival strategy of cancer stem cells may manifested by alterations in cell metabolism. Once tumors appear, growth and metastasis may be supported by overproduction of appropriate hormones (in hormonally dependent cancers), by promoting angiogenesis, by undergoing epithelial to mesenchymal transition, by triggering autophagy, and by taking cues from surrounding stromal cells. A number of natural compounds (e.g., curcumin, resveratrol, indole-3-carbinol, brassinin, sulforaphane, epigallocatechin-3-gallate, genistein, ellagitannins, lycopene and quercetin) have been found to inhibit one or more pathways that contribute to proliferation (e.g., hypoxia inducible factor 1, nuclear factor kappa B, phosphoinositide 3 kinase/Akt, insulin-like growth factor receptor 1, Wnt, cell cycle associated proteins, as well as androgen and estrogen receptor signaling). These data, in combination with bioinformatics analyses, will be very important for identifying signaling pathways and molecular targets that may provide early diagnostic markers and/or critical targets for the development of new drugs or drug combinations that block tumor formation and progression. (C) 2015 Elsevier Ltd.	[Feitelson, Mark A.; Arzumanyan, Alla; Kulathinal, Rob J.] Temple Univ, Dept Biol, Philadelphia, PA 19122 USA; [Blain, Stacy W.] Suny Downstate Med Ctr, Dept Pediat, Brooklyn, NY 11203 USA; [Holcombe, Randall F.] Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USA; [Mahajna, Jamal] MIGAL Galilee Technol Ctr, Canc Drug Discovery Program, Kityat Shmona, Israel; [Marino, Maria] Univ Rome Tre, Dept Sci, I-00146 Rome, Italy; [Martinez-Chantar, Maria L.] Ctr Invest Biomed Red Enfermedades Hepat & Digest, CIC bioGUNE, Metabol Unit, Technol Pk Bizkaia, Bizkaia, Spain; [Nawroth, Roman] Tech Univ Munich, Klinikum Rechts Isar, Dept Urol, D-80290 Munich, Germany; [Sanchez-Garcia, Isidro] Univ Salamanca, CSIC, Inst Biol Mol & Celular Canc, Expt Therapeut & Translat Oncol, E-37008 Salamanca, Spain; [Sharma, Dipali] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Saxena, Neeraj K.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Singh, Neetu] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA; [Vlachostergios, Panagiotis J.] CSIR, Cent Drug Res Inst, Council Sci & Ind Res, Tissue & Cell Culture Unit, Lucknow, Uttar Pradesh, India; [Guo, Shanchun] NYU, Lutheran Med Ctr, Dept Med, Brooklyn, NY USA; [Honoki, Kanya] Morehouse Sch Med, Dept Microbiol Biochem & Immunol, Atlanta, GA USA; [Fujii, Hiromasa] Nara Med Univ, Dept Orthoped Surg, Kashihara, Nara 634, Japan; [Georgakilas, Alexandros G.] Natl Tech Univ Athens, Sch Appl Math & Phys Sci, Dept Phys, Athens 15780, Greece; [Bilsland, Alan; Keith, W. Nicol] Univ Glasgow, Inst Canc Sci, Glasgow G12 8QQ, Lanark, Scotland; [Amedei, Amedeo; Niccolai, Elena] Univ Florence, Dept Expt & Clin Med, I-50134 Florence, Italy; [Amin, Amr] UAE Univ, Coll Sci, Dept Biol, Al Ain, U Arab Emirates; [Ashraf, S. Salman] UAE Univ, Coll Sci, Dept Chem, Al Ain, U Arab Emirates; [Boosani, Chandra S.] Creighton Univ, Dept Biomed Sci, Omaha, NE 68178 USA; [Guha, Gunjan; Bhakta, Dipita] SASTRA Univ, Sch Chem & Bio Technol, Thanjavur, India; [Ciriolo, Maria Rosa; Aquilano, Katia] Univ Roma Tor Vergata, Dept Biol, I-00133 Rome, Italy; [Chen, Sophie] Ovarian & Prostate Canc Res Trust Lab, Dept Res & Dev, Guildford GU2 7YG, Surrey, England; [Mohammed, Sulma I.] Purdue Univ, Ctr Canc Res, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA; [Azmi, Asfar S.] Wayne State Univ, Sch Med, Karmonas Canc Inst, Dept Pathol, Detroit, MI USA; [Halicka, Dorota] New York Med Coll, Dept Pathol, Brander Canc Res Inst, Valhalla, NY 10595 USA; [Nowsheen, Somaira] Mayo Clin, Med Scientist Training Program, Mayo Med Sch, Mayo Grad Sch, Rochester, MN USA	Feitelson, MA (reprint author), Temple Univ, Dept Biol Coll Sci & Technol, Suite 409 BioLIfe Bldg,1900N 12th St, Philadelphia, PA 19122 USA.	feitelso@temple.edu	Keith, Nicol/D-3325-2009	Keith, Nicol/0000-0001-7862-3580	NIH [AI076535, R01 CA109335-04A1, R01CA131294, CA155686, K01DK077137, R03DK089130]; Temple University; National Science Foundation; American Cancer Society; University Roma Tre (CLA); Italian Association for Cancer Research [IG15221]; EU [MC-CIG-303514]; Greek National funds through the Operational Program 'Educational and Lifelong Learning of the National Strategic Reference Framework (NSRF)-Research Funding Program: THALES [MIS 379346]; COST Action CM1201 'Biomimetic Radical Chemistry'; Italian Ministry of University; University of Italy; Terry Fox Foundation [TF-36]; UAEU Program for Advanced Research [UPAR25183]; Al-Jalila Foundation [AJF201454]; Zayed Center for Health Sciences [ZCHS2014]; FEDER; MICINN [SAF2012-32810]; Junta de Castilla y Leon [BIO/SA06/13]; ARIMMORA project (FP7-ENV, EU 7th Framework Program); EuroSyStem; DECIDE Network (EU FP7); Avon Foundation; Breast Cancer Research Foundation [90047965]; Fast Track Scheme for Young Scientists, Department of Science and Technology, India [SR/FT/LS-063/2008]; Ministry of Education, Culture, Sports, Science and Technology, Japan [24590493]; Italian Association for Cancer Research (AIRC) [IG10636]; MIUR-PRIN [20125S38FA_002]; Ministero della Salute [GR-2011-02348047]; Ovarian; Purdue University Center for Cancer Research; University of Glasgow; Beatson Oncology Centre Fund; Cancer Research UK [C301/A14762]; Prostate Cancer Research Trust, UK	Authors 1-13 contributed to the bulk of the work while the remaining authors contributed to cross-validation activities. Drs. Feitelson and Arzumanyan were supported by NIH (AI076535) and by Temple University. Dr. Rob J. Kulathinal was supported by the National Science Foundation, and by the American Cancer Society. Dr. Marino was supported by grant from University Roma Tre (CLA 2013) and by the Italian Association for Cancer Research (no. IG15221). Dr. Georgakilas was supported by the EU Marie Curie Reintegration Grant (MC-CIG-303514), Greek National funds through the Operational Program 'Educational and Lifelong Learning of the National Strategic Reference Framework (NSRF)-Research Funding Program: THALES (MIS 379346) and COST Action CM1201 'Biomimetic Radical Chemistry.' Dr. Amedei was supported by the Italian Ministry of University and University of Italy. Dr. Amin was supported by the Terry Fox Foundation (TF-36), UAEU Program for Advanced Research (UPAR25183), Al-Jalila Foundation (AJF201454) and Zayed Center for Health Sciences (ZCHS2014). Dr. Sanchez-Garcia was supported by FEDER, by MICINN (SAF2012-32810), by NIH (R01 CA109335-04A1), by Junta de Castilla y Leon (BIO/SA06/13), by the ARIMMORA project (FP7-ENV-2011, EU 7th Framework Program) and by the EuroSyStem and the DECIDE Network (EU FP7). Dr. Sharma was funded by NIH grants (R01CA131294, CA155686), the Avon Foundation and a Breast Cancer Research Foundation grant (90047965). Dr. Saxena was supported by a grant from NIH (K01DK077137 and R03DK089130). Dr. Singh was supported by the Fast Track Scheme for Young Scientists, Department of Science and Technology, India (SR/FT/LS-063/2008). Dr. Honoki was supported by a grant from the Ministry of Education, Culture, Sports, Science and Technology, Japan (no. 24590493). Dr. Ciriolo was supported by the Italian Association for Cancer Research (AIRC - grant #IG10636). Dr. Aquilano was supported by MIUR-PRIN (20125S38FA_002) and Ministero della Salute (GR-2011-02348047). Dr. Chen was funded from the Ovarian and Prostate Cancer Research Trust, UK. Dr. Mohammed is supported by the Purdue University Center for Cancer Research. W. Nicol Keith & Alan Bilsland were supported by the University of Glasgow, Beatson Oncology Centre Fund, and Cancer Research UK (http://www.cancerresearchuk.org) grant C301/A14762.	Abel EV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091983; Acconcia F, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00030; Agbalya A, 2014, J SAGE OPEN MED, V2, P1; Bulzomi P, 2012, J CELL PHYSIOL, V227, P1891, DOI 10.1002/jcp.22917; Melo JV, 2007, NAT REV CANCER, V7, P441, DOI 10.1038/nrc2147; Bhatia D, 2013, EVID-BASED COMPL ALT, DOI 10.1155/2013/371813; Hung CF, 2008, EUR J PHARMACOL, V586, P275, DOI 10.1016/j.ejphar.2008.03.001; Guo LD, 2013, PHYTOTHER RES, V27, P422, DOI 10.1002/ptr.4731; Ma HK, 2013, CURR TOP MED CHEM, V13, P2208; Escriva M, 2008, MOL CELL BIOL, V28, P1528, DOI 10.1128/MCB.02061-07; Jobin C, 1999, J IMMUNOL, V163, P3474; Aggarwal S, 2006, MOL PHARMACOL, V69, P195, DOI 10.1124/mol.105.017400; Oishi N, 2011, INT J BIOL SCI, V7, P517; Polyak K, 2009, TRENDS GENET, V25, P30, DOI 10.1016/j.tig.2008.10.012; Bross PF, 2004, CLIN CANCER RES, V10, P3954, DOI 10.1158/1078-0432.CCR-03-0781; Chen FP, 2014, CLIMACTERIC, V17, P385, DOI 10.3109/13697137.2013.869671; Knutson MD, 2008, NUTR REV, V66, P591, DOI 10.1111/j.1753-4887.2008.00109.x; Bell EL, 2005, MITOCHONDRION, V5, P322, DOI 10.1016/j.mito.2005.06.005; Linsalata M, 2005, NUTR CANCER, V52, P84, DOI 10.1207/s15327914nc5201_11; Chen LG, 2010, STEM CELLS, V28, P57, DOI 10.1002/stem.251; Nerurkar P, 2010, PHARM RES-DORDR, V27, P1049, DOI 10.1007/s11095-010-0057-2; Khan N, 2006, CANCER RES, V66, P2500, DOI 10.1158/0008-5472.CAN-05-3636; LaBarge MA, 2010, CLIN CANCER RES, V16, P3121, DOI 10.1158/1078-0432.CCR-09-2933; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Jagtap S, 2009, CURR MED CHEM, V16, P1451; Huynh H, 2003, INT J ONCOL, V23, P821; Qazi A, 2010, TRANSL ONCOL, V3, P389, DOI 10.1593/tlo.10235; Kajita M, 2004, MOL CELL BIOL, V24, P7559, DOI 10.1128/MCB.24.17.7559-7566.2004; Levine B, 2008, AUTOPHAGY, V4, P600; Bishayee A, 2009, CANCER PREV RES, V2, P409, DOI 10.1158/1940-6207.CAPR-08-0160; Jacks T, 1998, SCIENCE, V280, P1035, DOI 10.1126/science.280.5366.1035; Park CH, 2005, BIOCHEM BIOPH RES CO, V331, P1222, DOI 10.1016/j.bbrc.2005.03.242; Gao Z, 2009, ANTICANCER RES, V29, P2025; Brechbiel J, 2014, CANCER TREAT REV, V40, P750, DOI 10.1016/j.ctrv.2014.02.003; Leow PC, 2010, INVEST NEW DRUG, V28, P766, DOI 10.1007/s10637-009-9311-z; Jedinak A, 2010, IMMUNOBIOLOGY, V215, P242, DOI 10.1016/j.imbio.2009.03.004; Galluzzo P, 2009, MOL NUTR FOOD RES, V53, P699, DOI 10.1002/mnfr.200800239; Kuhl SJ, 2013, BBA-GEN SUBJECTS, V1830, P2297, DOI 10.1016/j.bbagen.2012.08.010; Curran EM, 2006, CLIN CANCER RES, V12, P5641, DOI 10.1158/1078-0432.CCR-05-1117; Mimeault M, 2007, ANN ONCOL, V18, P1605, DOI 10.1093/annonc/mdm070; Kawaguchi T, 2011, INT J ONCOL, V38, P643, DOI 10.3892/ijo.2010.882; Nadal-Serrano M, 2013, INT J BIOCHEM CELL B, V45, P2045, DOI 10.1016/j.biocel.2013.07.002; Rajala MW, 2003, ENDOCRINOLOGY, V144, P3765, DOI 10.1210/en.2003-0580; Boggess JF, 2006, GYNECOL ONCOL, V103, P417, DOI 10.1016/j.ygyno.2006.03.032; Maeyama Y, 2011, INT J ONCOL, V39, P41, DOI 10.3892/ijo.2011.1026; Li YW, 2005, CANCER RES, V65, P6934, DOI 10.1158/0008-5472.CAN-04-4604; Lee SC, 2010, CANCER LETT, V288, P36, DOI 10.1016/j.canlet.2009.06.020; Mani SA, 2007, P NATL ACAD SCI USA, V104, P10069, DOI 10.1073/pnas.0703900104; McCubrey JA, 2012, ONCOTARGET, V3, P954; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Mueller MT, 2009, GASTROENTEROLOGY, V137, P1102, DOI 10.1053/j.gastro.2009.05.053; Dituri F, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/947858; Hassan KA, 2013, CLIN CANCER RES, V19, P1972, DOI 10.1158/1078-0432.CCR-12-0370; KINSELL LW, 1948, J CLIN INVEST, V27, P677, DOI 10.1172/JCI102016; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; Hartman J, 2006, CANCER RES, V66, P11207, DOI 10.1158/0008-5472.CAN-06-0017; Imbert A, 2001, J CELL BIOL, V153, P555, DOI 10.1083/jcb.153.3.555; Perl AK, 1998, NATURE, V392, P190; Patel BB, 2008, INT J CANCER, V122, P267, DOI 10.1002/ijc.23097; Lissa D, 2014, P NATL ACAD SCI USA, V111, P3020, DOI 10.1073/pnas.1318440111; Ali FR, 2013, BRIT J DERMATOL, V169, P53, DOI 10.1111/bjd.12311; Delmas D, 2004, ONCOGENE, V23, P8979, DOI 10.1038/sj.onc.1208086; Carew JS, 2011, J BIOL CHEM, V286, P6602, DOI 10.1074/jbc.M110.151324; Han JB, 2013, MOL CANCER RES, V11, P207, DOI 10.1158/1541-7786.MCR-12-0670; Janes MR, 2010, NAT MED, V16, P205, DOI 10.1038/nm.2091; Bos R, 2004, BREAST CANCER RES, V6, pR450, DOI 10.1186/bcr813; Lanzilli G, 2006, INT J ONCOL, V28, P641; Gallahan D, 1996, CANCER RES, V56, P1775; Monroe DG, 2005, MOL ENDOCRINOL, V19, P1555, DOI 10.1210/me.2004-0381; Guo JY, 2011, GENE DEV, V25, P460, DOI 10.1101/gad.2016311; Chen C, 2013, FEBS LETT, V587, P3327, DOI 10.1016/j.febslet.2013.08.022; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Perez-Mancera PA, 2005, ONCOGENE, V24, P3073, DOI 10.1038/sj.onc.1208505; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Kwon JS, 2012, ATHEROSCLEROSIS, V225, P41, DOI 10.1016/j.atherosclerosis.2012.07.040; Lacorazza HD, 2006, CANCER CELL, V9, P175, DOI 10.1016/j.ccr.2006.02.017; Panchal HD, 2008, NEUROCHEM RES, V33, P1701, DOI 10.1007/s11064-008-9608-x; Maiuri MC, 2009, CELL CYCLE, V8, P1571; Cassinelli G, 2013, CURR MED CHEM, V20, P1923; Kaikkonen S, 2013, MOL ENDOCRINOL, V27, P212, DOI 10.1210/me.2012-1313; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Bhattacharyya S, 2010, CELL MOL IMMUNOL, V7, P306, DOI 10.1038/cmi.2010.11; Crews LA, 2013, CANCER LETT, V338, P15, DOI 10.1016/j.canlet.2012.08.006; Pedersen MW, 2005, BRIT J CANCER, V93, P915, DOI 10.1038/sj.bjc.6602793; Martelli AM, 2011, CURR MED CHEM, V18, P2715; Marconett CN, 2012, MOL CELL ENDOCRINOL, V363, P74, DOI 10.1016/j.mce.2012.07.008; Fan YJ, 2010, J BIOL CHEM, V285, P7324, DOI 10.1074/jbc.M109.035584; Basnet P, 2011, MOLECULES, V16, P4567, DOI 10.3390/molecules16064567; O'Hare T, 2009, CANCER CELL, V16, P401, DOI 10.1016/j.ccr.2009.09.028; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Caamano J, 2002, CLIN MICROBIOL REV, V15, P414, DOI 10.1128/CMR.15.3.414-429.2002; Lee SR, 2002, J BIOL CHEM, V277, P20336, DOI 10.1074/jbc.M111899200; Benitez DA, 2007, J ANDROL, V28, P282, DOI 10.2164/jandrol.106.000968; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Prasad S, 2010, MOL CELL BIOCHEM, V336, P25, DOI 10.1007/s11010-009-0267-2; Leong KG, 2007, J EXP MED, V204, P2935, DOI 10.1084/jem.20071082; Fiorentini D, 2001, FREE RADICAL BIO MED, V31, P923, DOI 10.1016/S0891-5849(01)00678-5; Brouty-Boye D, 2005, PROG MOLEC, V40, P55; Fuggetta MP, 2006, J EXP CLIN CANC RES, V25, P189; Bendinelli P, 2013, EUR J CANCER, V49, P2608, DOI 10.1016/j.ejca.2013.03.002; Chim CS, 2007, HUM PATHOL, V38, P1849, DOI 10.1016/j.humpath.2007.05.009; Farnie G, 2007, STEM CELL REV, V3, P169, DOI 10.1007/s12015-007-0023-5; Hadad SM, 2008, CRIT REV ONCOL HEMAT, V67, P1, DOI 10.1016/j.critrevonc.2008.01.007; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; He X, 2011, CANCER LETT, V301, P168, DOI 10.1016/j.canlet.2010.11.012; Li L, 2004, CANCER, V101, P2351, DOI 10.1002/cncr.20605; Koehl GE, 2010, ONCOGENE, V29, P1553, DOI 10.1038/onc.2009.435; Bar-Sela G, 2010, CURR MED CHEM, V17, P190; Knopeke MT, 2011, FEBS LETT, V585, P3159, DOI 10.1016/j.febslet.2011.09.007; Diaz-Moralli S, 2013, PHARMACOL THERAPEUT, V138, P255, DOI 10.1016/j.pharmthera.2013.01.011; Burgess LC, 2008, TOXICOL IN VITRO, V22, P1297, DOI 10.1016/j.tiv.2008.03.001; Heber D, 2008, CANCER LETT, V269, P262, DOI 10.1016/j.canlet.2008.03.043; Lao YZ, 2014, AUTOPHAGY, V10, P736, DOI 10.4161/auto.28034; Lee-Chang C, 2013, J IMMUNOL, V191, P4141, DOI 10.4049/jimmunol.1300606; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Avila MA, 2000, J HEPATOL, V33, P907, DOI 10.1016/S0168-8278(00)80122-1; Li Y, 2008, J BIOL CHEM, V283, P27707, DOI 10.1074/jbc.M802759200; Levy JMM, 2011, PHARMACOL THERAPEUT, V131, P130, DOI 10.1016/j.pharmthera.2011.03.009; Luka Z, 2006, TRANSGENIC RES, V15, P393, DOI 10.1007/s11248-006-0008-1; Marconett CN, 2011, CARCINOGENESIS, V32, P1315, DOI 10.1093/carcin/bgr116; Eder IE, 2013, INT J MOL SCI, V14, P11942, DOI 10.3390/ijms140611942; Gupta SC, 2010, CANCER METAST REV, V29, P405, DOI 10.1007/s10555-010-9235-2; Pece S, 2004, J CELL BIOL, V167, P215, DOI 10.1083/jcb.200406140; Holy JM, 2002, MUTAT RES-GEN TOX EN, V518, P71, DOI 10.1016/S1383-5718(02)00076-1; Lin YG, 2007, CLIN CANCER RES, V13, P3423, DOI 10.1158/1078-0432.CCR-06-3072; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; DUCE AM, 1988, HEPATOLOGY, V8, P65, DOI 10.1002/hep.1840080113; Cecchinato V, 2007, BIOCHEM PHARMACOL, V74, P1568, DOI 10.1016/j.bcp.2007.08.001; Eramo A, 2010, ONCOGENE, V29, P4625, DOI 10.1038/onc.2010.207; Metivier R, 2002, MOL CELL, V10, P1019, DOI 10.1016/S1097-2765(02)00746-3; Garrido C, 2006, CELL DEATH DIFFER, V13, P1423, DOI 10.1038/sj.cdd.4401950; Marra F, 2008, TRENDS MOL MED, V14, P72, DOI 10.1016/j.molmed.2007.12.003; Gonzalez-Perez RR, 2010, CELL SIGNAL, V22, P1350, DOI 10.1016/j.cellsig.2010.05.003; Dierks C, 2008, CANCER CELL, V14, P238, DOI 10.1016/j.ccr.2008.08.003; Marino M, 2008, STEROIDS, V73, P853, DOI 10.1016/j.steroids.2007.12.003; Izutani Y, 2012, INT J ONCOL, V40, P816, DOI 10.3892/ijo.2011.1246; Kawamori T, 1999, CANCER RES, V59, P597; Frasor J, 2009, CANCER RES, V69, P8918, DOI 10.1158/0008-5472.CAN-09-2608; Bao B, 2012, CANCER RES, V72, P335, DOI 10.1158/0008-5472.CAN-11-2182; Charles C, 2014, MUTAT RES-GEN TOX EN, V768, P33, DOI 10.1016/j.mrgentox.2014.04.014; Eskelinen EL, 2009, BBA-MOL CELL RES, V1793, P664, DOI 10.1016/j.bbamcr.2008.07.014; Palozza P, 2005, APOPTOSIS, V10, P1445, DOI 10.1007/s10495-005-1393-2; Peacock CD, 2007, P NATL ACAD SCI USA, V104, P4048, DOI 10.1073/pnas.0611682104; Hall M, 1996, ADV CANCER RES, V68, P67, DOI 10.1016/S0065-230X(08)60352-8; HAMBURGER A, 1977, J CLIN INVEST, V60, P846, DOI 10.1172/JCI108839; Oyama T, 2011, DEVELOPMENT, V138, P5235, DOI 10.1242/dev.062802; Lacorazza HD, 2003, BLOOD CELL MOL DIS, V31, P342, DOI 10.1016/S1079-9796(03)00162-1; Kakarala M, 2007, CANCER J, V13, P271, DOI 10.1097/PPO.0b013e318156da4e; Mosieniak G, 2012, MECH AGEING DEV, V133, P444, DOI 10.1016/j.mad.2012.05.004; Huang CS, 2007, J NUTR BIOCHEM, V18, P449, DOI 10.1016/j.jnutbio.2006.08.007; DeNardo D, 2010, CANCER METAST REV, V29, P309, DOI 10.1007/s10555-010-9223-6; Bose M, 2007, J AGR FOOD CHEM, V55, P7695, DOI 10.1021/jf071004r; Fuster JJ, 2010, CARDIOVASC RES, V86, P254, DOI 10.1093/cvr/cvp363; Carew JS, 2007, BLOOD, V110, P313, DOI 10.1182/blood-2006-10-050260; Mendivil A, 2011, REPROD SCI, V18, P832, DOI 10.1177/1933719111398501; Mato JM, 1999, J HEPATOL, V30, P1081, DOI 10.1016/S0168-8278(99)80263-3; Bao B, 2012, BBA-REV CANCER, V1826, P272, DOI 10.1016/j.bbcan.2012.04.008; Kumar S, 2009, CANCER METAST REV, V28, P113, DOI 10.1007/s10555-008-9173-4; Mo WH, 2011, PANCREATOLOGY, V11, P601, DOI 10.1159/000333542; Imamov O, 2004, P NATL ACAD SCI USA, V101, P9375, DOI 10.1073/pnas.0403041101; Guo SC, 2012, BBA-REV CANCER, V1825, P207, DOI 10.1016/j.bbcan.2012.01.002; Kozuki Y, 2001, CANCER LETT, V167, P151, DOI 10.1016/S0304-3835(01)00476-1; Pequeux C, 2012, CANCER RES, V72, P3010, DOI 10.1158/0008-5472.CAN-11-3768; Holmes-McNary M, 2000, CANCER RES, V60, P3477; Feng Y, 2012, CELL PROLIFERAT, V45, P413, DOI 10.1111/j.1365-2184.2012.00837.x; Nair JS, 2013, ANTICANCER RES, V33, P1307; Du JW, 2014, STEM CELLS DEV, V23, P83, DOI 10.1089/scd.2013.0370; Khuda-Bukhsh AR, 2014, NUTR CANCER, V66, P194, DOI 10.1080/01635581.2014.864420; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Prakobwong S, 2011, CARCINOGENESIS, V32, P1372, DOI 10.1093/carcin/bgr032; Liu Y, 2009, CELL STEM CELL, V4, P37, DOI 10.1016/j.stem.2008.11.006; Ma Y, 2005, CANCER RES, V65, P6476, DOI 10.1158/0008-5472.CAN-05-0370; Cheng J, 2007, ENDOCRINOLOGY, V148, P2066, DOI 10.1210/en.2006-1465; Beltz Lisa Ann, 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P389; Kumar R, 2003, CELL, V113, P142, DOI 10.1016/S0092-8674(03)00274-5; Baumgarten SC, 2012, MOL ENDOCRINOL, V26, P360, DOI 10.1210/me.2011-1302; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Kapitsinou PP, 2008, CELL DEATH DIFFER, V15, P650, DOI 10.1038/sj.cdd.4402313; Imaoka T, 2012, J ENDOCRINOL INVEST, V35, P828, DOI 10.3275/8189; Beachy PA, 2004, NATURE, V432, P324, DOI 10.1038/nature03100; Jacques TS, 2010, EMBO J, V29, P222, DOI 10.1038/emboj.2009.327; Nagahata T, 2003, CANCER SCI, V94, P515, DOI 10.1111/j.1349-7006.2003.tb01475.x; Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Ikegawa T, 2000, CANCER LETT, V160, P21, DOI 10.1016/S0304-3835(00)00549-8; Nyquist MD, 2013, HORM CANCER-US, V4, P61, DOI 10.1007/s12672-013-0131-4; Palomero T, 2006, P NATL ACAD SCI USA, V103, P18261, DOI 10.1073/pnas.0606108103; Palmer HG, 2001, J CELL BIOL, V154, P369, DOI 10.1083/jcb.200102028; Gabellini C, 2013, CARCINOGENESIS, V34, P2558, DOI 10.1093/carcin/bgt242; Memmott RM, 2010, CANCER PREV RES, V3, P1066, DOI 10.1158/1940-6207.CAPR-10-0055; Kabil A, 2008, CARCINOGENESIS, V29, P1862, DOI 10.1093/carcin/bgn138; Leitch AE, 2009, BRIT J PHARMACOL, V158, P1004, DOI 10.1111/j.1476-5381.2009.00402.x; Fang JS, 2008, SEMIN CANCER BIOL, V18, P330, DOI 10.1016/j.semcancer.2008.03.011; Pai R, 2008, CANCER RES, V68, P5086, DOI 10.1158/0008-5472.CAN-07-2325; Iida H, 2012, INT J ONCOL, V40, P71, DOI 10.3892/ijo.2011.1207; Jin YC, 2011, MOL CELL BIOCHEM, V358, P345, DOI 10.1007/s11010-011-0985-0; Blechschmidt K, 2008, BRIT J CANCER, V98, P489, DOI 10.1038/sj.bjc.6604115; Perkins ND, 2004, TRENDS CELL BIOL, V14, P64, DOI 10.1016/j.tcb.2003.12.004; Barone M, 2010, SCAND J GASTROENTERO, V45, P1320, DOI 10.3109/00365521.2010.487915; Narayanan BA, 2006, CURR CANCER DRUG TAR, V6, P711, DOI 10.2174/156800906779010218; Cao JX, 2009, EMBO J, V28, P1505, DOI 10.1038/emboj.2009.101; BUCHDUNGER E, 1995, P NATL ACAD SCI USA, V92, P2558, DOI 10.1073/pnas.92.7.2558; Dorai T, 2000, PROSTATE CANCER P D, V3, P84, DOI 10.1038/sj.pcan.4500399; Liu SA, 2010, MOL CANCER THER, V9, P2016, DOI 10.1158/1535-7163.MCT-09-0924; Brahimi-Horn MC, 2011, CURR OPIN GENET DEV, V21, P67, DOI 10.1016/j.gde.2010.10.006; Nogueira L, 2011, ONCOGENE, V30, P3537, DOI 10.1038/onc.2011.74; Dotan N, 2011, NUTR CANCER, V63, P1316, DOI 10.1080/01635581.2011.607542; Ischenko I, 2013, P NATL ACAD SCI USA, V110, P3937, DOI 10.1073/pnas.1219592110; Kim HD, 2012, BIOCHEM BIOPH RES CO, V422, P213, DOI 10.1016/j.bbrc.2012.04.086; Chai F, 2013, ONCOTARGETS THER, V6, P1643, DOI 10.2147/OTT.S51914; Galien R, 1997, NUCLEIC ACIDS RES, V25, P2424, DOI 10.1093/nar/25.12.2424; Kanadzu M, 2006, CANCER LETT, V241, P250, DOI 10.1016/j.canlet.2005.10.021; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Li XQ, 2010, CANCER RES, V70, P5942, DOI 10.1158/0008-5472.CAN-10-0157; Martinez-Chantar ML, 2002, FASEB J, V16, P1292, DOI 10.1096/fj.02-0078fje; Bishayee A, 2010, PHARM RES-DORDR, V27, P1080, DOI 10.1007/s11095-010-0144-4; Kimura A, 2004, ONCOGENE, V23, P4505, DOI 10.1038/sj.onc.1207582; Axanova LS, 2010, PROSTATE, V70, P1658, DOI 10.1002/pros.21201; Kim JY, 2006, J BIOL CHEM, V281, P10865, DOI 10.1074/jbc.M513378200; Jeng KS, 2012, ONCOL LETT, V4, P1158, DOI 10.3892/ol.2012.935; Park SJ, 2010, CANCER LETT, V292, P54, DOI 10.1016/j.canlet.2009.11.004; Cai YY, 2013, ASIAN PAC J CANCER P, V14, P4267, DOI 10.7314/APJCP.2013.14.7.4267; Perez-Mancera PA, 2005, HUM MOL GENET, V14, P3449, DOI 10.1093/hmg/ddi373; Hirota K, 2006, CRIT REV ONCOL HEMAT, V59, P15, DOI 10.1016/j.citrevonc.2005.12.003; Kim KH, 2011, J INVEST DERMATOL, V131, P195, DOI 10.1038/jid.2010.250; Dejana E, 2010, CIRC RES, V107, P943, DOI 10.1161/CIRCRESAHA.110.223750; Fan X, 2006, CANCER RES, V66, P7445, DOI 10.1158/0008-5472.CAN-06-0858; Acconcia F, 2006, CANCER LETT, V238, P1, DOI 10.1016/j.canlet.2005.06.018; Rangarajan A, 2001, EMBO J, V20, P3427, DOI 10.1093/emboj/20.13.3427; Liao D, 2007, CANCER RES, V67, P563, DOI 10.1158/0008-5472.CAN-06-2701; Bishayee A, 2013, J NUTR BIOCHEM, V24, P178, DOI 10.1016/j.jnutbio.2012.04.009; Jaiswal AS, 2002, ONCOGENE, V21, P8414, DOI 10.1038/sj.onc.1205947; Kaewpiboon C, 2014, INT J ONCOL, V44, P1233, DOI 10.3892/ijo.2014.2297; Chen YY, 1997, J BIOL CHEM, V272, P14110, DOI 10.1074/jbc.272.22.14110; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Lin HY, 2002, J UROLOGY, V168, P748, DOI 10.1016/S0022-5347(05)64739-8; Heavey S, 2014, CANCER TREAT REV, V40, P445, DOI 10.1016/j.ctrv.2013.08.006; Bao SD, 2006, CANCER RES, V66, P7843, DOI 10.1158/0008-5472.CAN-06-1010; Bardin A, 2004, ENDOCR-RELAT CANCER, V11, P537, DOI 10.1677/erc.1.00800; Fox CJ, 2003, GENE DEV, V17, P1841, DOI 10.1101/gad.1105003; Mimeault M, 2006, STEM CELLS, V24, P2319, DOI 10.1634/stemcells.2006-0066; Mudd SH, 2001, J INHERIT METAB DIS, V24, P448, DOI 10.1023/A:1010577512912; Chang C, 2014, ONCOGENE, V33, P3225, DOI 10.1038/onc.2013.274; Lu Z, 2008, J CLIN INVEST, V118, P3917, DOI 10.1172/JCI35512; Curtin JC, 2010, ONCOTARGET, V1, P563; Farahi N, 2011, CLIN EXP ALLERGY, V41, P673, DOI 10.1111/j.1365-2222.2010.03680.x; Keen JC, 2003, CANCER, V97, P825, DOI 10.1002/cncr.11126; Gomez LS, 2013, BIOCHIMIE, V95, P1336, DOI 10.1016/j.biochi.2013.02.013; Qiang L, 2012, CELL DEATH DIFFER, V19, P284, DOI 10.1038/cdd.2011.95; Perez-Losada J, 2002, BLOOD, V100, P1274; Parker LP, 2009, EUR J GYNAECOL ONCOL, V30, P616; Brunt EM, 2005, HEPATOL RES, V33, P68, DOI 10.1016/j.hepres.2005.09.006; Kim R, 2006, ANN ONCOL, V17, P1213, DOI 10.1093/annonc/mdl118; Bhuiyan MMR, 2006, CANCER RES, V66, P10064, DOI 10.1158/0008-5472.CAN-06-2011; Fang J, 2007, CELL SIGNAL, V19, P2487, DOI 10.1016/j.cellsig.2007.07.025; Ding G, 2013, FEBS LETT, V587, P930, DOI 10.1016/j.febslet.2013.02.020; Bae MK, 2006, ONCOL REP, V15, P1557; Leontieva OV, 2013, CELL CYCLE, V12, P3063, DOI 10.4161/cc.26130; Nishi M, 2014, ONCOGENE, V33, P643, DOI 10.1038/onc.2012.614; Hsieh TC, 2008, INT J ONCOL, V33, P851, DOI 10.3892/ijo_00000073; Fukushima T, 2012, J BIOL CHEM, V287, P29713, DOI 10.1074/jbc.M112.393074; Negi A, 2013, MINI-REV MED CHEM, V13, P653; Korkaya H, 2009, CLIN CANCER RES, V15, P1845, DOI 10.1158/1078-0432.CCR-08-3087; Chen A, 2008, BRIT J PHARMACOL, V153, P557, DOI 10.1038/sj.bjp.0707542; Moyer JD, 1997, CANCER RES, V57, P4838; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Chen Y, 2004, SURGERY, V136, P57, DOI 10.1016/j.surg.2004.01.017; Kunnumakkara AB, 2008, CANCER LETT, V269, P199, DOI 10.1016/j.canlet.2008.03.009; Heeg S, 2011, CANCER SCI, V102, P351, DOI 10.1111/j.1349-7006.2010.01796.x; Johnson GE, 2008, APOPTOSIS, V13, P790, DOI 10.1007/s10495-008-0212-y; Bishayee A, 2009, CHEM-BIOL INTERACT, V179, P131, DOI 10.1016/j.cbi.2008.11.015; Leiser SF, 2010, MOL CELL, V38, P779, DOI 10.1016/j.molcel.2010.06.015; Long HX, 2012, STEM CELLS, V30, P2309, DOI 10.1002/stem.1194; Krop I, 2012, J CLIN ONCOL, V30, P2307, DOI 10.1200/JCO.2011.39.1540; Choo AY, 2009, CELL CYCLE, V8, P567; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Li SH, 2013, MOL CELL BIOCHEM, V373, P217, DOI 10.1007/s11010-012-1493-6; Johnson SM, 2009, ANTICANCER RES, V29, P3185; Bansal T, 2009, J PHARM PHARM SCI, V12, P46; Aoki H, 2007, MOL PHARMACOL, V72, P29, DOI 10.1124/mol.106.033167; Berube M, 2005, INT J ONCOL, V26, P405; Kennedy SG, 1997, GENE DEV, V11, P701, DOI 10.1101/gad.11.6.701; He WA, 2013, J CLIN INVEST, V123, P4821, DOI 10.1172/JCI68523; Aggarwal BB, 2005, CLIN CANCER RES, V11, P7490, DOI 10.1158/1078-0432.CCR-05-1192; Mineharu Y, 2012, NEUROTHERAPEUTICS, V9, P827, DOI 10.1007/s13311-012-0144-7; Park MJ, 2002, INT J ONCOL, V21, P379; Giovannucci E, 2007, J NATL CANCER I, V99, P1060, DOI 10.1093/jnci/djm048; Juan ME, 2012, PHARMACOL RES, V65, P584, DOI 10.1016/j.phrs.2012.03.010; Guo WM, 2009, NUTR CANCER, V61, P807, DOI 10.1080/01635580903285098; Henderson BE, 2000, CARCINOGENESIS, V21, P427, DOI 10.1093/carcin/21.3.427; Brahimi-Horn MC, 2007, J MOL MED-JMM, V85, P1301, DOI 10.1007/s00109-007-0281-3; Mazzanti G, 2009, EUR J CLIN PHARMACOL, V65, P331, DOI 10.1007/s00228-008-0610-7; Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; Kumar SM, 2012, ONCOGENE, V31, P4898, DOI 10.1038/onc.2011.656; Kuhad A, 2007, J AGR FOOD CHEM, V55, P10150, DOI 10.1021/jf0723965d; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; Pan H, 2012, INT J MOL MED, V30, P337, DOI 10.3892/ijmm.2012.990; Kang NH, 2013, FOOD CHEM TOXICOL, V59, P373, DOI 10.1016/j.fct.2013.06.029; Manna SK, 2000, J IMMUNOL, V164, P6509; Li YW, 2009, CANCER RES, V69, P6704, DOI 10.1158/0008-5472.CAN-09-1298; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Park W, 2013, CANCER PREV RES, V6, P387, DOI 10.1158/1940-6207.CAPR-12-0410; Butler MS, 2008, NAT PROD REP, V25, P475, DOI 10.1039/b514294f; Kucuk O, 2002, EXP BIOL MED, V227, P881; Kundu JK, 2006, BIOCHEM PHARMACOL, V72, P1506, DOI 10.1016/j.bcp.2006.08.005; Mahajna J, 2009, NUTR CANCER, V61, P16, DOI 10.1080/01635580802379323; Mardis ER, 2012, CURR OPIN GENET DEV, V22, P245, DOI 10.1016/j.gde.2012.03.005; Chen HJ, 2012, BIOCHEM PHARMACOL, V84, P1143, DOI 10.1016/j.bcp.2012.08.011; Perdigoto CN, 2013, BBA-GEN SUBJECTS, V1830, P2307, DOI 10.1016/j.bbagen.2012.08.009; Kimura T, 2013, CANCER RES, V73, P3, DOI 10.1158/0008-5472.CAN-12-2464; Agarwal C, 2004, NEOPLASIA, V6, P646, DOI 10.1593/neo.04232; Liao HF, 2012, BIOMED PHARMACOTHER, V66, P378, DOI 10.1016/j.biopha.2011.12.008; Pons DG, 2014, J CELL BIOCHEM, V115, P949, DOI 10.1002/jcb.24737; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Chiba S, 2006, STEM CELLS, V24, P2437, DOI 10.1634/stemcells.2005-0661; KINSELL LW, 1947, SCIENCE, V106, P589, DOI 10.1126/science.106.2763.589; Myoung H, 2003, CANCER SCI, V94, P215, DOI 10.1111/j.1349-7006.2003.tb01422.x; Divya CS, 2006, MOL CARCINOGEN, V45, P320, DOI 10.1002/mc.20170; Niu YJ, 2008, P NATL ACAD SCI USA, V105, P12182, DOI 10.1073/pnas.0804700105; Macheda ML, 2008, CURR CANCER DRUG TAR, V8, P454, DOI 10.2174/156800908785699324; Bryant CS, 2010, ARCH GYNECOL OBSTET, V282, P677, DOI 10.1007/s00404-010-1381-9; Galluzzo P, 2007, ENDOCR-RELAT CANCER, V14, P153, DOI 10.1677/ERC-06-0020; Hershko DD, 2008, CANCER-AM CANCER SOC, V112, P1415, DOI 10.1002/cncr.23317; Akiyama M, 2003, CANCER RES, V63, P18; Choi EJ, 2014, EXP THER MED, V8, P454, DOI 10.3892/etm.2014.1771; Mailander PC, 2006, J STEROID BIOCHEM, V101, P204, DOI 10.1016/j.jsbmb.2006.06.019; Liu XX, 2008, CARCINOGENESIS, V29, P816, DOI 10.1093/carcin/bgn011; Galluzzo P, 2006, GENES NUTR, V1, P161, DOI 10.1007/BF02829966; Li S, 2012, CANCER RES, V72, P865, DOI 10.1158/0008-5472.CAN-11-1357; Fodde R, 2007, CURR OPIN CELL BIOL, V19, P150, DOI 10.1016/j.ceb.2007.02.007; Marino M, 2003, MOL BIOL CELL, V14, P2583, DOI 10.1091/mbc.E02-09-0621; Kamdje AHN, 2014, CELL SIGNAL, V26, P2843, DOI 10.1016/j.cellsig.2014.07.034; Arbiser JL, 1998, MOL MED, V4, P376; Hedvat CV, 2004, J BIOL CHEM, V279, P6395, DOI 10.1074/jbc.M307524200; Fang MZ, 2003, CANCER RES, V63, P7563; Mato JM, 2002, FASEB J, V16, P15, DOI 10.1096/fj.01-0401rev; Fouad MA, 2013, HUM EXP TOXICOL, V32, P1067, DOI 10.1177/0960327113475679; Nagy JA, 2010, SEMIN THROMB HEMOST, V36, P321, DOI 10.1055/s-0030-1253454; Li YY, 2010, CLIN CANCER RES, V16, P2580, DOI 10.1158/1078-0432.CCR-09-2937; Killian PH, 2012, CARCINOGENESIS, V33, P2507, DOI 10.1093/carcin/bgs312; Peretz S, 2002, RADIAT RES, V158, P174, DOI 10.1667/0033-7587(2002)158[0174:IREPAM]2.0.CO;2; Mintz PJ, 2008, CANCER, V113, P1489, DOI 10.1002/cncr.23699; Prasad CP, 2009, CHEM-BIOL INTERACT, V181, P263, DOI 10.1016/j.cbi.2009.06.012; Hendrayani SF, 2013, NEOPLASIA, V15, P631, DOI 10.1593/neo.13478; Pernicova Z, 2011, NEOPLASIA, V13, P526, DOI 10.1593/neo.11182; Liu Y, 2014, EUR J IMMUNOL, V44, P521, DOI 10.1002/eji.201243291; Elamin MH, 2010, MOL CARCINOGEN, V49, P302, DOI 10.1002/mc.20604; Noh KT, 2013, BIOCHEM BIOPH RES CO, V431, P348, DOI 10.1016/j.bbrc.2012.12.093; Denissova NG, 2012, CARCINOGENESIS, V33, P149, DOI 10.1093/carcin/bgr236; Clarke JD, 2008, CANCER LETT, V269, P291, DOI 10.1016/j.canlet.2008.04.018; Catalano A, 2004, J BIOL CHEM, V279, P46706, DOI 10.1074/jbc.M406696200; Narayanan BA, 2004, CARCINOGENESIS, V25, P2443, DOI 10.1093/carcin/bgh252; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Grimberg A, 2003, CANCER BIOL THER, V2, P630; Platet N, 2004, CRIT REV ONCOL HEMAT, V51, P55, DOI 10.1016/j.critevonc.2004.02.001; Han J, 2008, J BIOL CHEM, V283, P19665, DOI 10.1074/jbc.M710169200; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Franci C, 2006, ONCOGENE, V25, P5134, DOI 10.1038/sj.onc.1209519; Fulda S, 2006, CANCER DETECT PREV, V30, P217, DOI 10.1016/j.cdp.2006.03.007; Leone M, 2003, CANCER RES, V63, P8118; Hede K, 2006, J NATL CANCER I, V98, P808, DOI 10.1093/jnci/djj270; Nishinakagawa T, 2010, INT J MOL MED, V25, P717, DOI 10.3892/ijmm_00000396; Dotan N, 2011, INTEGR CANCER THER, V10, P148, DOI 10.1177/1534735410383169; Li Y, 2006, APPL BIOCHEM BIOTECH, V135, P181, DOI 10.1385/ABAB:135:3:181; Parekh P, 2011, EXP TOXICOL PATHOL, V63, P167, DOI 10.1016/j.etp.2009.11.005; Malhotra A, 2012, ULTRASTRUCT PATHOL, V36, P179, DOI 10.3109/01913123.2011.652765; Cobaleda C, 2007, ANNU REV GENET, V41, P41, DOI 10.1146/annurev.genet.41.110306.130146; Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033; Durban VM, 2014, AM J PATHOL, V184, P86, DOI 10.1016/j.ajpath.2013.10.003; Ascenzi Paolo, 2006, Molecular Aspects of Medicine, V27, P299, DOI 10.1016/j.mam.2006.07.001; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; Li M, 2007, CANCER RES, V67, P1988, DOI 10.1158/0008-5472.CAN-06-3066; Lattrich C, 2011, ANTI-CANCER DRUG, V22, P253, DOI 10.1097/CAD.0b013e3283427bb5; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Khaw AK, 2012, GENE CHROMOSOME CANC, V51, P961, DOI 10.1002/gcc.21979; Berman DM, 2002, SCIENCE, V297, P1559, DOI 10.1126/science.1073733; Osipo C, 2008, ONCOGENE, V27, P5019, DOI 10.1038/onc.2008.149; Deshpande A, 2005, ONCOGENE, V24, P2909, DOI 10.1038/sj.onc.1208618; Adams LS, 2010, CANCER PREV RES, V3, P108, DOI 10.1158/1940-6207.CAPR-08-0225; Jaitner S, 2012, CELL CYCLE, V11, P3331, DOI 10.4161/cc.21790; CULIG Z, 1994, CANCER RES, V54, P5474; Larriba MJ, 2007, ENDOCR-RELAT CANCER, V14, P141, DOI 10.1677/ERC-06-0028; Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444; Feldmann G, 2007, CANCER RES, V67, P2187, DOI 10.1158/0008-5472.CAN-06-3281; Abdelwahab SI, 2011, LEUKEMIA RES, V35, P268, DOI 10.1016/j.leukres.2010.07.025; Li Z, 2009, CANCER CELL, V15, P501, DOI 10.1016/j.ccr.2009.03.018; Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502; Amin A, 2007, RECENT PAT ANTI-CANC, V2, P109; Gillies RJ, 2007, CANCER METAST REV, V26, P311, DOI 10.1007/s10555-007-9065-z; Pratt MAC, 2009, ONCOGENE, V28, P2710, DOI 10.1038/onc.2009.131; Aguirre-Ghiso JA, 2013, NAT MED, V19, P276, DOI 10.1038/nm.3120; Nonn L, 2007, CARCINOGENESIS, V28, P1188, DOI 10.1093/carcin/bgl241; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Huber MA, 2004, J CLIN INVEST, V114, P569, DOI 10.1172/JCI200421358; Acker T, 2002, J MOL MED-JMM, V80, P562, DOI 10.1007/s00109-002-0355-1; Osakada F, 2011, CNS NEUROL DISORD-DR, V10, P419; Qing GL, 2009, CURR OPIN GENET DEV, V19, P60, DOI 10.1016/j.gde.2008.12.001; Jagadeesh S, 2006, CANCER RES, V66, P2107, DOI 10.1158/0008-5472.CAN-05-2494; Imtiyaz HZ, 2010, J CLIN INVEST, V120, P2699, DOI 10.1172/JCI39506; MILLS PK, 1989, CANCER, V64, P598, DOI 10.1002/1097-0142(19890801)64:3<598::AID-CNCR2820640306>3.0.CO;2-6; Meng Q, 2006, CELL SIGNAL, V18, P2262, DOI 10.1016/j.cellsig.2006.05.019; HAN XL, 1994, CANCER RES, V54, P5515; Oswald F, 1998, MOL CELL BIOL, V18, P2077; Kim JW, 2007, CANCER METAST REV, V26, P291, DOI 10.1007/s10555-007-9060-4; Gort EH, 2008, ONCOGENE, V27, P1501, DOI 10.1038/sj.onc.1210795; Listerman I, 2014, MOL CELL BIOL, V34, P280, DOI 10.1128/MCB.00844-13; Moore JD, 2013, NAT REV CANCER, V13, P201, DOI 10.1038/nrc3468; Martinez-Chantar ML, 2006, GASTROENTEROLOGY, V131, P223, DOI 10.1053/j.gastro.2006.04.019; Gao P, 2007, CANCER CELL, V12, P230, DOI 10.1016/j.ccr.2007.08.004; Korkaya H, 2007, BIODRUGS, V21, P299, DOI 10.2165/00063030-200721050-00002; Fan X, 2008, J CLIN ONCOL, V26, P2821, DOI 10.1200/JCO.2007.15.2264; Fan X, 2010, STEM CELLS, V28, P5, DOI 10.1002/stem.254; FOTSIS T, 1993, P NATL ACAD SCI USA, V90, P2690, DOI 10.1073/pnas.90.7.2690; Leotoing L, 2007, J MOL ENDOCRINOL, V39, P151, DOI 10.1677/JME-07-0021; Kane RC, 2007, CLIN CANCER RES, V13, P5291, DOI 10.1158/1078-0432.CCR-07-0871; Choi JS, 2004, EUR J PHARM BIOPHARM, V57, P313, DOI 10.1016/j.ejpb.2003.11.002; Bulzomi P, 2010, IUBMB LIFE, V62, P51, DOI 10.1002/iub.279; Liu JJ, 2012, CELL BIOCHEM BIOPHYS, V62, P19, DOI 10.1007/s12013-011-9253-x; Bar EE, 2007, STEM CELLS, V25, P2524, DOI DOI 10.1634/STEMCELLS.2007-0166; BARNES S, 1995, J CELL BIOCHEM, P181; Bathe E, 2000, NAT CELL BIOL, V2, P84; Bauer JA, 2006, NAT REV DRUG DISCOV, V5, P493; Baychelier F, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00325; Bermejo-Rodriguez C, 2006, GENOMICS, V87, P113, DOI 10.1016/j.ygeno.2005.09.014; Bilir B, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-280; Bishayee A., 2013, CANCER BIOMARK, P51; Bolli Alessandro, 2011, Recent Pat Endocr Metab Immune Drug Discov, V5, P210; Breen MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072407; Buehler P., 2004, CANCER, V100, P201; Buttari B, 2013, OXID MED CELL LONGEV, V2013; Cal Q, 2013, ONCOGENE, V32, P2079; Chang KH, 2014, BRIT J CANCER, V111, P1249, DOI 10.1038/bjc.2014.268; Chen Jiao-wen, 2011, Hua Xi Kou Qiang Yi Xue Za Zhi, V29, P83; Chen Sophie S, 2012, Discov Med, V13, P7; Cheng Haiying, 2011, JOP, V12, P334; Cloonan SM, 2010, INT J CANCER, V128, P1712; Criswell L, 2007, J BIOL CHEM, V282, P32491; Dai W, 2013, MOL CARCINOG; Danovi SA, 2008, NAT REV CANCER, V8, P572, DOI 10.1038/nrc2448; De Wever O, 2008, INT J CANCER, V123, P2229, DOI 10.1002/ijc.23925; Dey P., 2013, ONCOGENE; Durfort T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029213; Fan QW, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001017; Fang Baijun, 2011, Case Rep Oncol, V4, P192, DOI 10.1159/000327512; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Fu YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102535; Georgescu Maria-Magdalena, 2010, Genes Cancer, V1, P1170, DOI 10.1177/1947601911407325; Ghayad SE, 2010, RECENT PAT ANTI-CANC, V5, P29; Greenhough A, 2008, BIOCHEM J, V410, P225; Gun S., 2011, BIOCHIM BIOPHYS ACTA, V1815, P197; Guruvayoorappan Chandrasekharan, 2008, J Exp Ther Oncol, V7, P173; Hasima N, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.467; He CC, 2010, CURR OPIN CELL BIOL, V22, P140, DOI 10.1016/j.ceb.2010.01.001; Hirata H, 2013, BRIT J CANCER, V108, P2070, DOI 10.1038/bjc.2013.173; Hope C, 2008, MOL NUTR FOOD RES, V52, pS52, DOI 10.1002/mnfr.200700448; Hu Y, 2011, CELL RES, V22, P399; Hu Yu, 2007, Chin Med J (Engl), V120, P1672; Ilic N, 2011, P NATL ACAD SCI USA, V108, pE699, DOI 10.1073/pnas.1108237108; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Iwasaki K, 2013, BIOCHEMISTRY-US, V52, P5075, DOI 10.1021/bi400399f; JHAPPAN C, 1992, GENE DEV, V6, P345, DOI 10.1101/gad.6.3.345; Ji Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078700; Jin QH, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-12; Kang J, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-32; Karin M, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000141; Keerthivasan S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007607; Korkaya H, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000121; Krishnan V, 2013, CANCER METAST REV, V31, P605; Kuijjer ML, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-245; Larsson O, 2005, BRIT J CANCER, V92, P2097; Lenz HJ, 2014, CANCER SCI, V105, P1087, DOI 10.1111/cas.12471; Li V., 2003, P NATL ACAD SCI USA, V100, P15853; Liao Wen-Ting, 2014, Am J Stem Cells, V3, P46; Luke Z, 2002, HUM GENET, V110, P68; Luoto Kaisa R, 2013, Genome Integr, V4, P5, DOI 10.1186/2041-9414-4-5; Malanchi I, 2012, NATURE, V481, P85, DOI 10.1038/nature10694; Martinez-Chantar ML, 2008, HEPATOLOGY, V47, P1191, DOI [10.1002/hep.22159, 10.1002/bep.22159]; Martinez-Outschoorn UE, 2013, CELL CYCLE, V12, P2580, DOI 10.4161/cc.25510; Mowla SN, 2013, ONCOTARGETS THER, V6, P1221, DOI 10.2147/OTT.S36160; Nakamura A, 2012, BMC CELL BIOL, V13, DOI 10.1186/1471-2121-13-24; Nakamura H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020034; Nakamura Y, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-100; Nakshatri H, 1997, MOL CELL BIOL, V17, P3629; Nguyen Anthony V, 2009, Cancer Manag Res, V1, P25; Ohtani Naoko, 2004, J Med Invest, V51, P146, DOI 10.2152/jmi.51.146; Ostyn P, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/s12964-014-0052-z; Paggliaci MC, 1994, EUR J CANCER, V30A, P1675; Palazon A, 2014, IMMUNITY, V41, P518, DOI 10.1016/j.immuni.2014.09.008; Polakis P, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008052; Pratheeshkumar P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047516; Qi WT, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-219; Quoc TL, 2013, PLOS ONE, V8; Pattingre S, 2008, BIOCHIMIE, V90, P313, DOI 10.1016/j.biochi.2007.08.014; Verga Falzacappa MV, 2012, FEBS J, V279, P3559; Wang ZW, 2010, DRUG RESIST UPDATE, V13, P109, DOI 10.1016/j.drup.2010.07.001; Zhao C, 2009, NATURE, V458, P776, DOI 10.1038/nature07737; Salpeter SJ, 2011, ENDOCRINOLOGY, V152, P2589, DOI 10.1210/en.2010-1372; Wang Y, 2010, HUM MOL GENET, V19, P4319, DOI 10.1093/hmg/ddq354; Tan JX, 2011, INT J DEV BIOL, V55, P851, DOI 10.1387/ijdb.113365jt; Su Y, 2009, CARCINOGENESIS, V30, P331, DOI 10.1093/carcin/bgn279; Shih JY, 2005, CLIN CANCER RES, V11, P8070, DOI 10.1158/1078-0432.CCR-05-0687; Weisberg E, 2007, BLOOD, V109, P2112, DOI 10.1182/BLOOD-2006-06-026377; Ugolini F, 1999, ONCOGENE, V18, P1903, DOI 10.1038/sj.onc.1202739; Zaidman BZ, 2005, APPL MICROBIOL BIOT, V67, P453, DOI 10.1007/s00253-004-1787-z; Squires MS, 2003, BIOCHEM PHARMACOL, V65, P361, DOI 10.1016/S0006-2952(02)01517-4; Singh SK, 2004, ONCOGENE, V23, P7267, DOI 10.1038/sj.onc.1207946; Sasaki H, 1999, DEVELOPMENT, V126, P3915; Xie ZG, 2014, MOL MED REP, V10, P1103, DOI 10.3892/mmr.2014.2281; Smith SC, 2010, CANCER RES, V70, P1753, DOI 10.1158/0008-5472.CAN-09-3562; Sehrawat A, 2012, BREAST CANCER RES TR, V136, P429, DOI 10.1007/s10549-012-2280-5; Zheng MZ, 2004, MELANOMA RES, V14, P165, DOI 10.1097/01.cmr.0000129374.76399.19; Wang YL, 2013, BIOCHEM BIOPH RES CO, V434, P352, DOI 10.1016/j.bbrc.2013.03.077; Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x; Tsang JS, 2010, MOL CELL, V38, P140, DOI 10.1016/j.molcel.2010.03.007; Tseng SH, 2004, CLIN CANCER RES, V10, P2190, DOI 10.1158/1078-0432.CCR-03-0105; Temraz S, 2013, INT J MOL SCI, V14, P17279, DOI 10.3390/ijms140917279; Talero E, 2012, CURR PHARM DESIGN, V18, P3939, DOI 10.2174/138161212802083725; Sethi T, 1999, NAT MED, V5, P662, DOI 10.1038/9511; Rietjens IMCM, 2013, MOL NUTR FOOD RES, V57, P100, DOI 10.1002/mnfr.201200439; Xu Y, 2012, MOL ONCOL, V6, P405, DOI 10.1016/j.molonc.2012.03.005; Zhou JB, 2007, P NATL ACAD SCI USA, V104, P16158, DOI 10.1073/pnas.0702596104; Shacka JJ, 2006, AUTOPHAGY, V2, P228; Rapisarda A, 2012, NAT REV CLIN ONCOL, V9, P378, DOI 10.1038/nrclinonc.2012.64; Singh SK, 2003, CANCER RES, V63, P5821; Wang LM, 2013, ONCOTARGET, V4, P1158; Wen JP, 2010, MOLECULES, V15, P4401, DOI 10.3390/molecules15064401; Ye MX, 2012, PHYTOMEDICINE, V19, P779, DOI 10.1016/j.phymed.2012.03.005; Weng AP, 2006, GENE DEV, V20, P2096, DOI 10.1101/gad.1450406; Weljie AM, 2011, INT J BIOCHEM CELL B, V43, P981, DOI 10.1016/j.biocel.2010.08.009; Xia YQ, 2007, LIFE SCI, V80, P2161, DOI 10.1016/j.lfs.2007.04.008; Shan JJ, 2012, HEPATOLOGY, V56, P1004, DOI 10.1002/hep.25745; Slusarz A, 2010, CANCER RES, V70, P3382, DOI 10.1158/0008-5472.CAN-09-3012; Ronchini C, 2001, MOL CELL BIOL, V21, P5925, DOI 10.1128/MCB.21.17.5925-5934.2001; Yalcin A, 2009, J BIOL CHEM, V284, P24223, DOI 10.1074/jbc.M109.016816; Wang XR, 2007, MOL CELL BIOL, V27, P7405, DOI 10.1128/MCB.00760-07; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Sansone P, 2007, J CLIN INVEST, V117, P3988, DOI 10.1172/JCI32533; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shinojima N, 2007, AUTOPHAGY, V3, P635; Tang GQ, 2010, J CANCER RES CLIN, V136, P1179, DOI 10.1007/s00432-010-0765-3; Rao CV, 2000, CARCINOGENESIS, V21, P617, DOI 10.1093/carcin/21.4.617; Talks KL, 2000, AM J PATHOL, V157, P411, DOI 10.1016/S0002-9440(10)64554-3; Whitehead J, 2012, STAT MED, V31, P1931, DOI 10.1002/sim.5331; Rosich L, 2013, HAEMATOLOGICA, V98, P1739, DOI 10.3324/haematol.2013.088849; Salim T, 2014, EXP CELL RES, V321, P255, DOI 10.1016/j.yexcr.2013.10.021; Zhang YK, 2011, EXP BIOL MED, V236, P714, DOI 10.1258/ebm.2011.010347; Shin SC, 2006, INT J PHARM, V313, P144, DOI 10.1016/j.ijpharm.2006.01.028; Wu HZ, 2008, BIOMED PHARMACOTHER, V62, P613, DOI 10.1016/j.biopha.2008.06.036; Wang L, 2013, MOL CELL BIOCHEM, V379, P7, DOI 10.1007/s11010-013-1621-y; Russo M, 2010, TOXINS, V2, P517, DOI 10.3390/toxins2040517; Zumsteg A, 2012, MOL CANCER RES, V10, P800, DOI 10.1158/1541-7786.MCR-11-0522; Yamaguchi Y, 2009, ENDOCR J, V56, P1; Wong CP, 2009, CANCER LETT, V276, P38, DOI 10.1016/j.canlet.2008.10.025; Shehzad A, 2011, EUR J NUTR, V50, P151, DOI 10.1007/s00394-011-0188-1; Zhang JH, 2011, J BIOL CHEM, V286, P8055, DOI 10.1074/jbc.M110.192641; Tyagi A, 2011, CLIN CANCER RES, V17, P5402, DOI 10.1158/1078-0432.CCR-11-1072; Vicente-Duenas C, 2009, CELL CYCLE, V8, P1314, DOI 10.4161/cc.8.9.8217; Smith DA, 2013, MOL CANCER RES, V11, P1159, DOI 10.1158/1541-7786.MCR-13-0238; Zhong XS, 2004, BIOCHEM BIOPH RES CO, V324, P471, DOI 10.1016/j.bbrc.2004.09.082; Rossi M, 2009, J CELL SCI, V122, P3330, DOI 10.1242/jcs.048181; Sanchez-Garcia I, 2009, NEW ENGL J MED, V360, P297, DOI 10.1056/NEJMcibr0808031; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111; Shim HY, 2007, ANTI-CANCER DRUG, V18, P649, DOI 10.1097/CAD.0b013e3280825573; Wang J, 2004, MOL CELL ENDOCRINOL, V219, P171, DOI 10.1016/j.mce.2003.12.018; Shao ZM, 1998, J CELL BIOCHEM, V69, P44, DOI 10.1002/(SICI)1097-4644(19980401)69:1<44::AID-JCB5>3.3.CO;2-B; Takada Y, 2006, J IMMUNOL, V176, P3127; Zou HY, 2007, CANCER RES, V67, P4408, DOI 10.1158/0008-5472.CAN-06-4443; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Zhu H, 2012, MOL BIOL REP, V39, P4971, DOI 10.1007/s11033-011-1293-1; Wong KK, 2010, CURR OPIN GENET DEV, V20, P87, DOI 10.1016/j.gde.2009.11.002; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wolanin K, 2006, MOL CANCER RES, V4, P457, DOI 10.1158/1541-7786.MCR-05-0172; Uckun FM, 1998, CLIN CANCER RES, V4, P1125; Sethi G, 2006, J BIOL CHEM, V281, P23425, DOI 10.1074/jbc.M602627200; Su CC, 2006, ANTICANCER RES, V26, P1281; Signorelli P, 2005, J NUTR BIOCHEM, V16, P449, DOI 10.1016/j.jnutbio.2005.01.017; Zaidman BZ, 2008, MOL BIOL REP, V35, P107, DOI 10.1007/s11033-007-9059-5; UCKUN FM, 1995, SCIENCE, V267, P886, DOI 10.1126/science.7531365; Sarkar FH, 2010, CANCER METAST REV, V29, P383, DOI 10.1007/s10555-010-9233-4; Trosko JE, 2004, ANN NY ACAD SCI, V1028, P192, DOI 10.1196/annals.1322.023; Zhang YK, 2013, BRIT J NUTR, V109, P33, DOI 10.1017/S0007114512000876; Takeuchi H, 2005, CANCER RES, V65, P3336; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; Tang SN, 2012, INT J CANCER, V131, P30, DOI 10.1002/ijc.26323; Whitehead SA, 2006, BEST PRACT RES CL EN, V20, P45, DOI 10.1016/j.beem.2005.09.003; Tang FY, 2008, MOL NUTR FOOD RES, V52, P646, DOI 10.1002/mnfr.200700272; Shioiri M, 2006, BRIT J CANCER, V94, P1816, DOI 10.1038/sj.bjc.6603193; Sen M, 2008, J IMMUNOL, V181, P4441; Yoshida S, 2013, CIRCULATION, V128, P60, DOI 10.1161/CIRCULATIONAHA.113.001533; Wolter F, 2001, J NUTR, V131, P2197; Sachdev D, 2010, ONCOGENE, V29, P251, DOI 10.1038/onc.2009.316; Xiao K, 2013, J PHARMACOL SCI, V123, P102, DOI 10.1254/jphs.13085FP; Tabruyn SP, 2007, CELL DEATH DIFFER, V14, P1393, DOI 10.1038/sj.cdd.4402156; Tran B, 2012, J CLIN ONCOL, V30, P647, DOI 10.1200/JCO.2011.39.2316; Tetsu O, 1999, NATURE, V398, P422; Sun CY, 2006, CANCER GENET CYTOGEN, V165, P9, DOI 10.1016/j.cancergencyto.2005.06.016; Reinmuth N, 2002, CLIN CANCER RES, V8, P3259; Wetterau LA, 2003, J CLIN ENDOCR METAB, V88, P3354, DOI 10.1210/jc.2002-021326; Zhu ML, 2010, FASEB J, V24, P769, DOI 10.1096/fj.09-136994; Sanchez-Garcia I, 2007, BIOESSAYS, V29, P1269, DOI 10.1002/bies.20679; Shiota M, 2012, J UROLOGY, V188, P276, DOI 10.1016/j.juro.2012.02.2554; Rausch V, 2010, CANCER RES, V70, P5004, DOI 10.1158/0008-5472.CAN-10-0066; Westphalen CB, 2014, J CLIN INVEST, V124, P1283, DOI 10.1172/JCI73434; Yan CH, 2005, MOL CANCER THER, V4, P233; Spiotto MT, 2000, PROSTATE, V42, P186, DOI 10.1002/(SICI)1097-0045(20000215)42:3<186::AID-PROS4>3.0.CO;2-E; Sun M, 2003, J BIOL CHEM, V278, P42992, DOI 10.1074/jbc.M306295200; Watkins DN, 2003, NATURE, V422, P313, DOI 10.1038/nature01493; White E, 2009, CLIN CANCER RES, V15, P5308, DOI 10.1158/1078-0432.CCR-07-5023; Wang H, 2010, CURR CANCER DRUG TAR, V10, P593; Yang L, 2010, ONCOGENE, V29, P469, DOI 10.1038/onc.2009.392; Srivastava RK, 2007, CELL CYCLE, V6, P2953; Rusnak DW, 2001, MOL CANCER THER, V1, P85; Wang H, 2011, CARCINOGENESIS, V32, P1881, DOI 10.1093/carcin/bgr218; Sabbah M, 2008, DRUG RESIST UPDATE, V11, P123, DOI 10.1016/j.drup.2008.07.001; Seccareccia E, 2012, GROWTH HORM IGF RES, V22, P193, DOI 10.1016/j.ghir.2012.09.003; Tang FY, 2008, MOL NUTR FOOD RES, V52, P683, DOI 10.1002/mnfr.200700325; Saito Y, 2010, NAT BIOTECHNOL, V28, P275, DOI 10.1038/nbt.1607; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Zhang X, 2011, EUR J PHARM SCI, V42, P540, DOI 10.1016/j.ejps.2011.02.009; Sartippour MR, 2008, INT J ONCOL, V32, P475; Shukla S, 2007, CANCER RES, V67, P6925, DOI 10.1158/0008-5472.CAN-07-0717; Wen XY, 2009, PHYTOTHER RES, V23, P778, DOI 10.1002/ptr.2616; Zeng X, 2008, DEVELOPMENT, V135, P367, DOI 10.1242/dev.013540; Thomas SL, 2008, CELL CYCLE, V7, P2409; Shan B, 2012, J ENDOCRINOL, V214, P389, DOI 10.1530/JOE-12-0207; Vega S, 2004, GENE DEV, V18, P1131, DOI 10.1101/gad.294104; Wang HJ, 2012, TECHNOLOGICAL ENTREPRENEURSHIP IN CHINA: HOW DOES IT WORK, P1; Wesolowska O, 2010, ANTICANCER RES, V30, P4587; Schneider Y, 2001, NUTR CANCER, V39, P102, DOI 10.1207/S15327914nc391_14; Vicente-Duenas C, 2013, EMBO J, V32, P1502, DOI 10.1038/emboj.2013.97; Takahashi A, 2006, NAT CELL BIOL, V8, P1291, DOI 10.1038/ncb1491; Trumpp A, 2010, NAT REV IMMUNOL, V10, P201, DOI 10.1038/nri2726; Zhang YK, 2013, CARCINOGENESIS, V34, P1756, DOI 10.1093/carcin/bgt129; Wander SA, 2011, CLIN CANCER RES, V17, P12, DOI 10.1158/1078-0432.CCR-10-0752; Sansone P, 2007, STEM CELLS, V25, P807, DOI 10.1634/stemcells.2006-0442; Virgili F, 2008, FREE RADICAL BIO MED, V45, P1205, DOI 10.1016/j.freeradbiomed.2008.08.001; Wray J, 2012, TRENDS CELL BIOL, V22, P159, DOI 10.1016/j.tcb.2011.11.004; Shay JES, 2012, SEMIN CELL DEV BIOL, V23, P389, DOI 10.1016/j.semcdb.2012.04.004; Yang ZNJ, 2011, MOL CANCER THER, V10, P1533, DOI 10.1158/1535-7163.MCT-11-0047; Wertz K, 2009, NUTR CANCER, V61, P775, DOI 10.1080/01635580903285023; Rosenfeldt MT, 2011, CARCINOGENESIS, V32, P955, DOI 10.1093/carcin/bgr031; Yeh SY, 1999, P NATL ACAD SCI USA, V96, P5458, DOI 10.1073/pnas.96.10.5458; Wilkinson S, 2010, CURR OPIN GENET DEV, V20, P57, DOI 10.1016/j.gde.2009.12.004; Yang J, 2010, MED ONCOL, V27, P1114, DOI 10.1007/s12032-009-9344-3; Rasanen K, 2010, EXP CELL RES, V316, P2713, DOI 10.1016/j.yexcr.2010.04.032; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Yokoyama K, 2003, INT J ONCOL, V22, P891; Wang ZG, 2010, ANTICANCER RES, V30, P4537; Yu LL, 2011, ONCOL REP, V26, P1197, DOI 10.3892/or.2011.1410; Warner M, 2010, BIOCHEM BIOPH RES CO, V396, P63, DOI 10.1016/j.bbrc.2010.02.144; Zhang YJ, 2012, CELL CYCLE, V11, P594, DOI 10.4161/cc.11.3.19096; Vergara D, 2012, MOL BIOSYST, V8, P1078, DOI 10.1039/c2mb05486h; Ruoslahti E, 2002, NAT REV CANCER, V2, P83, DOI 10.1038/nrc724; Sotoca AM, 2008, J STEROID BIOCHEM, V112, P171, DOI 10.1016/j.jsbmb.2008.10.002; Shamim U, 2012, J CELL PHYSIOL, V227, P1493, DOI 10.1002/jcp.22865; Steelman LS, 2008, EXPERT OPIN THER TAR, V12, P1139, DOI [10.1517/14728222.12.9.1139 , 10.1517/14728220802351707]; Subbaramaiah K, 2013, CANCER PREV RES, V6, P886, DOI 10.1158/1940-6207.CAPR-13-0140; Ren ZH, 2013, PHARMAZIE, V68, P689, DOI 10.1691/ph.2013.2916; Reguart Noemi, 2005, Future Oncol, V1, P787, DOI 10.2217/14796694.1.6.787; Ren ZG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074322; Rodova M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046083; Roper J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025132; Ruiz I, 2007, TRENDS CELL BIOL, V17, P438, DOI DOI 10.1016/J.TCB.2007.06.007; Sandhiya Selvarajan, 2013, J Pharmacol Pharmacother, V4, P4, DOI 10.4103/0976-500X.107628; Sasaki T, 2013, PATHOBIOLOGY, V81, P36, DOI 10.1159/000351721; Saud SM, 2014, CARCINOGENESIS, V35, P2778, DOI 10.1093/carcin/bgu209; Sayeed A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067191; Schiff R., 2003, CLIN CANCER RES, V9, P447; Shah Manasvi S., 2012, Frontiers in Genetics, V3, P305, DOI 10.3389/fgene.2012.00305; Shakibaei M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057218; Sheth S., 2012, PLOS ONE, V7; Shostak K, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2886; Song RX, 2004, P NATL ACAD SCI USA, V101, P2076, DOI 10.1073/pnas.0308334100; Song Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017687; Tamari K, 2014, INT J ONCOL, V45, P2349, DOI 10.3892/ijo.2014.2671; Thakur Archana, 2013, Cancers (Basel), V5, P569, DOI 10.3390/cancers5020569; Tirkey Naveen, 2005, BMC Pharmacology, V5, P15, DOI 10.1186/1471-2210-5-15; Tobin NP, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-417; Tomellini E, 2014, STEM CELLS; Tortorella SM, 2014, ANTIOXID REDOX SIGNA; Vanamala J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-238; Vanamala J, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-49; Vander Broek R, 2013, ORAL ONCOL, VS1368-8375, P00714; Vander Heiden MG, 2009, SCIENCE, V324, P1029, DOI DOI 10.1126/SCIENCE.1160809; Velasco-Velazquez MA, 2011, FUTURE ONCOL, V7, P753, DOI [10.2217/fon.11.56, 10.2217/FON.11.56]; Vera-Badillo FE, 2014, JNCI-J NATL CANCER I, V106, P319; VLEMINCKX K, 1991, CELL, V66, P107, DOI 10.1016/0092-8674(91)90143-M; Wang SD, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-26; Wang YP, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-12; Wickenden JA, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2558; Wilken R, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-12; Xia YF, 2014, CANCER IMMUNOL RES, V2, P823, DOI 10.1158/2326-6066.CIR-14-0112; Xu N, 2012, J ONCOL, V2012, DOI DOI 10.1155/2012/951724; Yaguchi I, 2012, J IMMUNOL, V189, P2110; Yan M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-437; Yeh CT, 2011, EVID-BASED COMPL ALT, V2011; Yuasa Shinsuke, 2008, Expert Rev Cardiovasc Ther, V6, P803, DOI 10.1586/14779072.6.6.803; Zeuner A, 2014, CELL DEATH DIFFER, V21, P1877, DOI 10.1038/cdd.2014.105; Zhang C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004881; Zhou CX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055730; Zimmerman ZF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069593	708	2	2	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1044-579X			SEMIN CANCER BIOL	Semin. Cancer Biol.	DEC	2015	35			S			S25	S54		10.1016/j.semcancer.2015.02.006		30	Oncology	Oncology	CY7WG	WOS:000366619400003		
J	Ferguson, LR; Chen, H; Collins, AR; Connell, M; Damia, G; Dasgupta, S; Malhotra, M; Meeker, AK; Amedei, A; Amin, A; Ashraf, SS; Aquilano, K; Azmi, AS; Bhakta, D; Bilsland, A; Boosani, CS; Chen, S; Ciriolo, MR; Fujii, H; Guha, G; Halicka, D; Helferich, WG; Keith, WN; Mohammed, SI; Niccolai, E; Yang, XJ; Honoki, K; Parslow, VR; Prakash, S; Rezazadeh, S; Shackelford, RE; Sidransky, D; Tran, PT; Yang, ES; Maxwell, CA				Ferguson, Lynnette R.; Chen, Helen; Collins, Andrew R.; Connell, Marisa; Damia, Giovanna; Dasgupta, Santanu; Malhotra, Meenakshi; Meeker, Alan K.; Amedei, Amedeo; Amin, Amr; Ashraf, S. Salman; Aquilano, Katia; Azmi, Asfar S.; Bhakta, Dipita; Bilsland, Alan; Boosani, Chandra S.; Chen, Sophie; Ciriolo, Maria Rosa; Fujii, Hiromasa; Guha, Gunjan; Halicka, Dorota; Helferich, William G.; Keith, W. Nicol; Mohammed, Sulma I.; Niccolai, Elena; Yang, Xujuan; Honoki, Kanya; Parslow, Virginia R.; Prakash, Satya; Rezazadeh, Sarallah; Shackelford, Rodney E.; Sidransky, David; Tran, Phuoc T.; Yang, Eddy S.; Maxwell, Christopher A.			Genomic instability in human cancer: Molecular insights and opportunities for therapeutic attack and prevention through diet and nutrition	SEMINARS IN CANCER BIOLOGY			English	Review						Genomic instability; Cancer therapy; Cancer prevention; DNA damage; Nutraceutical	DNA MISMATCH-REPAIR; BASE-EXCISION-REPAIR; CELLS IN-VITRO; TELOMERASE REVERSE-TRANSCRIPTASE; HUMAN PROSTATE-CANCER; POLY(ADP-RIBOSE) POLYMERASE INHIBITION; NONPOLYPOSIS COLORECTAL-CANCER; ISLAND METHYLATOR PHENOTYPE; CYCLIN-DEPENDENT KINASE; HUMAN OVARIAN-CARCINOMA	Genomic instability can initiate cancer, augment progression, and influence the overall prognosis of the affected patient. Genomic instability arises from many different pathways, such as telomere damage, centrosome amplification, epigenetic modifications, and DNA damage from endogenous and exogenous sources, and can be perpetuating, or limiting, through the induction of mutations or aneuploidy, both enabling and catastrophic. Many cancer treatments induce DNA damage to impair cell division on a global scale but it is accepted that personalized treatments, those that are tailored to the particular patient and type of cancer, must also be developed. In this review, we detail the mechanisms from which genomic instability arises and can lead to cancer, as well as treatments and measures that prevent genomic instability or take advantage of the cellular defects caused by genomic instability. In particular, we identify and discuss five priority targets against genomic instability: (1) prevention of DNA damage; (2) enhancement of DNA repair; (3) targeting deficient DNA repair; (4) impairing centrosome clustering; and, (5) inhibition of telomerase activity. Moreover, we highlight vitamin D and B, selenium, carotenoids, PARP inhibitors, resveratrol, and isothiocyanates as priority approaches against genomic instability. The prioritized target sites and approaches were cross validated to identify potential synergistic effects on a number of important areas of cancer biology. (C) 2015 The Authors. Published by Elsevier Ltd.	[Ferguson, Lynnette R.; Parslow, Virginia R.] Univ Auckland, Discipline Nutr, Auckland 1, New Zealand; [Chen, Helen; Connell, Marisa; Maxwell, Christopher A.] Univ British Columbia, Dept Pediat, Michael Cuccione Childhood Canc Res Program, Child & Family Res Inst, Vancouver, BC V6T 1W5, Canada; [Collins, Andrew R.] Univ Oslo, Fac Med, Dept Nutr, Oslo, Norway; [Damia, Giovanna] Cura Carattere Sci Ist Ric Farmacol Mario Negri, Inst Ricovero, Dept Oncol, Milan, Italy; [Dasgupta, Santanu] Univ Texas Hlth Sci Ctr Tyler, Dept Cellular & Mol Biol, Tyler, TX USA; [Malhotra, Meenakshi; Prakash, Satya] Univ Coll Cork, Sch Pharm, Cork, Ireland; [Meeker, Alan K.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Amedei, Amedeo; Niccolai, Elena] Univ Florence, Dept Expt & Clin Med, Florence, Italy; [Amin, Amr] United Arab Emirates Univ, Coll Sci, Dept Biol, Al Ain, U Arab Emirates; [Amin, Amr] Cairo Univ, Fac Sci, Cairo, Egypt; [Ashraf, S. Salman] United Arab Emirates Univ, Coll Sci, Dept Chem, Al Ain, U Arab Emirates; [Aquilano, Katia; Ciriolo, Maria Rosa] Univ Roma Tor Vergata, Dept Biol, Rome, Italy; [Azmi, Asfar S.; Rezazadeh, Sarallah] Univ Rochester, Dept Biol, Rochester, NY USA; [Bhakta, Dipita; Guha, Gunjan] SASTRA Univ, Sch Chem & BioTechnol, Thanjavur, Tamil Nadu, India; [Bilsland, Alan; Keith, W. Nicol] Univ Glasgow, Inst Canc Sci, Glasgow, Lanark, Scotland; [Boosani, Chandra S.] Creighton Univ, Dept Biomed Sci, Omaha, NE 68178 USA; [Chen, Sophie] Ovarian & Prostate Canc Res Trust Lab, Dept Res & Dev, Guildford, Surrey, England; [Fujii, Hiromasa; Honoki, Kanya] Nara Med Univ, Dept Orthopaed Surg, Kashihara, Nara 634, Japan; [Halicka, Dorota] New York Med Coll, Valhalla, NY 10595 USA; [Helferich, William G.; Yang, Xujuan] Univ Illinois, Dept Food Sci & Human Nutr, Champaign, IL USA; [Mohammed, Sulma I.] Purdue Univ, Dept Comparat Patho Biol, W Lafayette, IN USA; [Mohammed, Sulma I.] Purdue Univ, Ctr Canc Res, W Lafayette, IN USA; [Shackelford, Rodney E.] Louisiana State Univ Hlth Shreveport, Dept Pathol, Shreveport, LA USA; [Sidransky, David] Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD USA; [Tran, Phuoc T.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Dept Radiat Oncol & Mol Radiat Sci Oncol & Urol, Baltimore, MD USA; [Yang, Eddy S.] Univ Alabama Birmingham, Med Sch Birmingham, Dept Radiat Oncol, Birmingham, AL USA	Ferguson, LR (reprint author), Univ Auckland, Discipline Nutr, Private Bag 92019, Auckland 1, New Zealand.	l.ferguson@auckland.ac.nz; cmaxwell@cfri.ca	Keith, Nicol/D-3325-2009	Keith, Nicol/0000-0001-7862-3580	Italian Ministry of University and Research; University of Florence; Terry Fox Foundation; UAEU Program for Advanced Research; Al-Jalila Foundation; Zayed Center for Health Sciences; Italia Ministry of Education, University and Research- Miur [PRIN 20125S38FA_002]; University of Glasgow; Child and Family Research Institute PhD studentship; Michael Cuccione childhood cancer research foundation fellowship; Ovarian Prostate Cancer Research Trust Laboratory; University of Oslo; Italian Association for Cancer Research [AIRC IG 10636]; Elsa U Pardee Foundation; Auckland Cancer Society Research Centre, University of Auckland; National Institutes of Health; Ministry of Education, Culture, Sports, Science and Technology, Japan [24590493]; CIHR; Avon Foundation for Women [OBC 134038]; NIH/NCI [RO1CA172380, P30CA006973, RCI RFA0D09009, 5R01 CA132996-03]; DOD [W81WH1210545, W81XWH12PCRPTIA]; Italian Ministry of University; University of Italy; CIHR [MOP 64308]; Department of Biology, University of Rochester; Patrick C. Walsh Prostate Cancer Research Fund; Department of Defense [W81XWH-11-1-0272, W81XWH-13-1-0182]; Commonwealth Foundation; Uniting Against Lung Cancer; Sidney Kimmel Translational Scholar award [SKF-13-021]; ACS Scholar award [122688-RSG-12-196-01-TBG]; NIH [1R01CA166348]; Susan G. Komen Foundation; AACR; Gabrielle's Angel Foundation; Eli Lilly; Bristol Myers Squibb; Beatson Oncology Centre Fund; CRUK grant [C301/A14762]	The following funding agencies supported the research: Italian Ministry of University and Research and the University of Florence (A. Amedia); Terry Fox Foundation, UAEU Program for Advanced Research, Al-Jalila Foundation and Zayed Center for Health Sciences (A. Amin); Italia Ministry of Education, University and Research- Miur, PRIN 20125S38FA_002 (K. Aquilano); University of Glasgow, Beatson Oncology Centre Fund, CRUK grant C301/A14762 (A. Bilsland and W.N. Keith); Child and Family Research Institute PhD studentship (H. Chen); Michael Cuccione childhood cancer research foundation fellowship (M. Connell); Ovarian Prostate Cancer Research Trust Laboratory (S. Chen); University of Oslo (A.R. Collins); Italian Association for Cancer Research AIRC IG 10636 (M.R. Ciriolo); Elsa U Pardee Foundation (S. Dasgupta); Auckland Cancer Society Research Centre, University of Auckland (L. Ferguson and V. Parslow); National Institutes of Health (H.D. Halicka); Ministry of Education, Culture, Sports, Science and Technology, Japan, No. 24590493 (K. Honoki); CIHR, in partnership with the Avon Foundation for Women, OBC 134038 (C.A. Maxwell); NIH/NCI RO1CA172380, DOD W81WH1210545, DOD W81XWH12PCRPTIA, NIH/NCI P30CA006973, NIH/NCI RCI RFA0D09009, NIH/NCI 5R01 CA132996-03 (A. Meeker); Italian Ministry of University and University of Italy (E. Niccolai); CIHR MOP 64308 (S. Prakash); Department of Biology, University of Rochester (S. Rezazadeh); Patrick C. Walsh Prostate Cancer Research Fund, the Department of Defense (W81XWH-11-1-0272 and W81XWH-13-1-0182), Commonwealth Foundation, Uniting Against Lung Cancer, a Sidney Kimmel Translational Scholar award (SKF-13-021), an ACS Scholar award (122688-RSG-12-196-01-TBG) and the NIH (1R01CA166348) (P.T. Tran); Susan G. Komen Foundation, AACR, Gabrielle's Angel Foundation, Eli Lilly, and Bristol Myers Squibb (E.S. Yang).	Kuklin AI, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-17; Anand P, 2003, CANCER CELL, V3, P51; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Damm K, 2001, EMBO J, V20, P6958, DOI 10.1093/emboj/20.24.6958; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Tischkowitz MD, 2009, GASTROENTEROLOGY, V137, P1183, DOI 10.1053/j.gastro.2009.06.055; Fong PC, 2010, J CLIN ONCOL, V28, P2512, DOI 10.1200/JCO.2009.26.9589; Wright WE, 2005, J AM GERIATR SOC, V53, pS292, DOI 10.1111/j.1532-5415.2005.53492.x; Meeker AK, 2004, CLIN CANCER RES, V10, P3317, DOI 10.1158/1078-0432.CCR-0984-03; Kontek R, 2010, TOXICOL IN VITRO, V24, P417, DOI 10.1016/j.tiv.2009.10.013; Sproul D, 2005, NAT REV GENET, V6, P775, DOI 10.1038/nrg1688; El-Bayoumy K, 2001, MUTAT RES-FUND MOL M, V475, P123, DOI 10.1016/S0027-5107(01)00075-6; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Shinmura K, 2004, CARCINOGENESIS, V25, P2311, DOI 10.1093/carcin/bgh267; Liu L, 2004, MOL CANCER THER, V3, P1003; Alter BP, 2002, RADIOTHER ONCOL, V62, P345, DOI 10.1016/S0167-8140(01)00474-1; Reddy L, 2006, BIOL CHEM, V387, P87, DOI 10.1515/BC.2006.012; Masutani M, 2013, MOL ASPECTS MED, V34, P1202, DOI 10.1016/j.mam.2013.05.003; Kramer A, 2011, MOL ONCOL, V5, P324, DOI 10.1016/j.molonc.2011.05.003; Hager G, 2001, ACTA OTO-LARYNGOL, V121, P103; Rudolph KL, 2001, NAT GENET, V28, P155, DOI 10.1038/88871; Hansen LA, 1998, CARCINOGENESIS, V19, P1837, DOI 10.1093/carcin/19.10.1837; Heaphy CM, 2007, CLIN CANCER RES, V13, P7037, DOI 10.1158/1078-0432.CCR-07-0432; Wong G, 2004, J STEROID BIOCHEM, V89-90, P567, DOI 10.1016/j.jsbmb.2004.03.072; Ghosh A, 2012, NAT CELL BIOL, V14, P1270, DOI 10.1038/ncb2621; Tebbs RS, 1999, DEV BIOL, V208, P513, DOI 10.1006/dbio.1999.9232; Olaussen KA, 2006, NEW ENGL J MED, V355, P983, DOI 10.1056/NEJMoa060570; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Hardy PA, 2005, CELL BIOL INT, V29, P983, DOI 10.1016/j.cellbi.2005.10.001; Li RW, 2013, MOL CARCINOGEN, V52, P426, DOI 10.1002/mc.21873; Li YY, 2010, FASEB J, V24, P1442, DOI 10.1096/fj.09-149328; COLLINS N, 1995, ONCOGENE, V10, P1673; Aroni K, 2008, ACTA DERM-VENEREOL, V88, P191, DOI 10.2340/00015555-0377; Kee Y, 2010, GENE DEV, V24, P1680, DOI 10.1101/gad.1955310; Cunningham JM, 1998, CANCER RES, V58, P3455; Krishnan AV, 2013, J STEROID BIOCHEM, V136, P289, DOI 10.1016/j.jsbmb.2012.08.005; Park EY, 2007, NUTR CANCER, V57, P66; Lee SC, 2010, CANCER LETT, V288, P36, DOI 10.1016/j.canlet.2009.06.020; Pra D, 2012, MUTAT RES-FUND MOL M, V733, P92, DOI 10.1016/j.mrfmmm.2012.02.001; Li YY, 2009, INT J CANCER, V125, P286, DOI 10.1002/ijc.24398; Larsen E, 2003, MOL CELL BIOL, V23, P5346, DOI 10.1128/MCB.23.15.5346-5353.2003; Kim SH, 2011, CARCINOGENESIS, V32, P359, DOI 10.1093/carcin/bgq267; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Sasaki M, 2012, J NUTR BIOCHEM, V23, P423, DOI 10.1016/j.jnutbio.2011.01.006; Fahey JW, 2012, CANCER PREV RES, V5, P603, DOI 10.1158/1940-6207.CAPR-11-0538; Duthie SJ, 2007, MOL NUTR FOOD RES, V51, P665, DOI 10.1002/mnfr.200600257; McClintock B, 1939, P NATL ACAD SCI USA, V25, P405, DOI 10.1073/pnas.25.8.405; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Schabath MB, 2004, J NUTR, V134, P3362; Nam HJ, 2010, CARCINOGENESIS, V31, P1531, DOI 10.1093/carcin/bgq133; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; Weaver BAA, 2007, CANCER CELL, V11, P25, DOI 10.1016/j.ccr.2006.12.003; Thoms KM, 2007, EXP DERMATOL, V16, P532, DOI 10.1111/j.1600-0625.2007.00559.x; McManus KJ, 2009, P NATL ACAD SCI USA, V106, P3276, DOI 10.1073/pnas.0813414106; Trejo-Solis C, 2013, EVID-BASED COMPL ALT, DOI 10.1155/2013/705121; Kloor M, 2010, INT J CANCER, V127, P1001, DOI 10.1002/ijc.25283; MORRISON A, 1993, EMBO J, V12, P1467; Soares NDP, 2013, NUTR CANCER, V65, P1076, DOI 10.1080/01635581.2013.812225; Amiri F, 2013, EUR J PHARMACOL, V718, P34, DOI 10.1016/j.ejphar.2013.09.020; Poulsen MM, 2013, ANN NY ACAD SCI, V1290, P74, DOI 10.1111/nyas.12141; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Nigg EA, 2002, NAT REV CANCER, V2, P815, DOI 10.1038/nrg924; Lanzilli G, 2006, INT J ONCOL, V28, P641; LIVINGSTONE LR, 1992, CELL, V70, P923, DOI 10.1016/0092-8674(92)90243-6; Maxwell CA, 2003, MOL BIOL CELL, V14, P2262, DOI 10.1091/mbc.E02-07-0377; Ulaner GA, 2003, CANCER RES, V63, P1759; Lens SMA, 2010, NAT REV CANCER, V10, P825, DOI 10.1038/nrc2964; Vilar E, 2013, CANCER DISCOV, V3, P502, DOI 10.1158/2159-8290.CD-12-0471; Nakajima Y, 2008, J PHARM PHARMACOL, V60, P1365, DOI 10.1211/jpp/60.10.0013; Lamy E, 2013, PHYTOTHER RES, V27, P1036, DOI 10.1002/ptr.4798; Kristal AR, 2010, AM J EPIDEMIOL, V172, P566, DOI 10.1093/aje/kwq148; Chen PC, 2013, ONCOL REP, V30, P1157, DOI 10.3892/or.2013.2563; Rankin EB, 2009, CANCER CELL, V15, P459, DOI 10.1016/j.ccr.2009.05.004; Scolastici C, 2008, EXP TOXICOL PATHOL, V60, P59, DOI 10.1016/j.etp.2008.01.010; Jiang C, 1999, MOL CARCINOGEN, V26, P213, DOI 10.1002/(SICI)1098-2744(199912)26:4<213::AID-MC1>3.0.CO;2-Z; Pawlik TM, 2004, DIS MARKERS, V20, P199; Batra S, 2010, MOL CANCER THER, V9, P1596, DOI 10.1158/1535-7163.MCT-09-1146; HilakiviClarke L, 1997, P NATL ACAD SCI USA, V94, P9372, DOI 10.1073/pnas.94.17.9372; Sram RJ, 2009, MUTAT RES-GEN TOX EN, V672, P129, DOI 10.1016/j.mrgentox.2008.11.005; Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI 10.1053/j.gastro.2009.12.064; Galipeau PC, 1996, P NATL ACAD SCI USA, V93, P7081, DOI 10.1073/pnas.93.14.7081; Andreassen PR, 2001, MOL BIOL CELL, V12, P1315; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Martin SA, 2010, CLIN CANCER RES, V16, P5107, DOI 10.1158/1078-0432.CCR-10-0821; Chen MC, 2012, INNATE IMMUN-LONDON, V18, P685, DOI 10.1177/1753425912436589; Fukasawa K, 2008, BBA-REV CANCER, V1786, P15, DOI 10.1016/j.bbcan.2008.04.002; BUNIN GR, 1993, NEW ENGL J MED, V329, P536, DOI 10.1056/NEJM199308193290804; Ogden A, 2012, CELL DEATH DIFFER, V19, P1255, DOI 10.1038/cdd.2012.61; Ikura T, 2007, MOL CELL BIOL, V27, P7028, DOI 10.1128/MCB.00579-07; Wang Z, 2013, J INT MED RES, V41, P1577, DOI 10.1177/0300060513480913; Fuggetta MP, 2006, J EXP CLIN CANC RES, V25, P189; Gergely F, 2008, GENE DEV, V22, P2291, DOI 10.1101/gad.1715208; Cao AY, 2009, BREAST CANCER RES TR, V114, P457, DOI 10.1007/s10549-008-0036-z; Martin SA, 2011, CANCER RES, V71, P1836, DOI 10.1158/0008-5472.CAN-10-2836; Sajesh BV, 2013, GENETICS, V195, P757, DOI 10.1534/genetics.113.156836; He X, 2011, CANCER LETT, V301, P168, DOI 10.1016/j.canlet.2010.11.012; Ghadimi BM, 2000, GENE CHROMOSOME CANC, V27, P183, DOI 10.1002/(SICI)1098-2264(200002)27:2<183::AID-GCC10>3.0.CO;2-P; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Liu W, 2002, AM J PATHOL, V160, P511, DOI 10.1016/S0002-9440(10)64870-5; Tennstedt P, 2013, INT J CANCER, V132, P2118, DOI 10.1002/ijc.27907; Shay JW, 2012, SCIENCE, V336, P1388, DOI 10.1126/science.1222394; Lee-Chang C, 2013, J IMMUNOL, V191, P4141, DOI 10.4049/jimmunol.1300606; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022; Karunasinghe N, 2012, GENES NUTR, V7, P179, DOI 10.1007/s12263-011-0259-1; Stone JG, 2000, CANCER LETT, V149, P15, DOI 10.1016/S0304-3835(99)00324-9; Berger SL, 2009, GENE DEV, V23, P781, DOI 10.1101/gad.1787609; Kelvin EA, 2009, CANCER EPIDEM BIOMAR, V18, P2262, DOI 10.1158/1055-9965.EPI-09-0316; Ooi LL, 2010, CANCER RES, V70, P1835, DOI 10.1158/0008-5472.CAN-09-3194; Sinicrope FA, 2011, JNCI-J NATL CANCER I, V103, P863, DOI 10.1093/jnci/djr153; Vilar E, 2011, CANCER RES, V71, P2632, DOI 10.1158/0008-5472.CAN-10-1120; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Chew BP, 2011, VET IMMUNOL IMMUNOP, V140, P199, DOI 10.1016/j.vetimm.2010.12.004; Luijsterburg MS, 2007, J CELL SCI, V120, P2706, DOI 10.1242/jcs.008367; Tripathi DN, 2009, CHEM-BIOL INTERACT, V180, P398, DOI 10.1016/j.cbi.2009.03.017; Davoli T, 2010, CELL, V141, P81, DOI 10.1016/j.cell.2010.01.031; Wei K, 2002, TRENDS MOL MED, V8, P346, DOI 10.1016/S1471-4914(02)02359-6; Melchini A, 2013, NUTR CANCER, V65, P132, DOI 10.1080/01635581.2013.741747; Ozten N, 2010, CANCER PREV RES, V3, P371, DOI 10.1158/1940-6207.CAPR-09-0152; Papoutsis AJ, 2012, J NUTR BIOCHEM, V23, P1324, DOI 10.1016/j.jnutbio.2011.08.001; Tutt A, 2010, LANCET, V376, P235, DOI 10.1016/S0140-6736(10)60892-6; Ferguson LR, 2012, MOL NUTR FOOD RES, V56, P126, DOI 10.1002/mnfr.201100507; Gadau S, 2006, DIABETOLOGIA, V49, P405, DOI 10.1007/s00125-005-0103-5; Hockemeyer D, 2005, EMBO J, V24, P2667, DOI 10.1038/sj.emboj.7600733; Kusmartsev S, 2003, CANCER RES, V63, P4441; Pellegrino R, 2010, HEPATOLOGY, V51, P857, DOI 10.1002/hep.23467; Fukasawa K, 2005, CANCER LETT, V230, P6, DOI 10.1016/j.canlet.2004.12.028; Aguilera A, 2008, NAT REV GENET, V9, P204, DOI 10.1038/nrg2268; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Cho S, 2010, DERMATOLOGY, V221, P160, DOI 10.1159/000305548; Baylin SB, 2001, HUM MOL GENET, V10, P687, DOI 10.1093/hmg/10.7.687; Ohshima S, 2012, OXID MED CELL LONGEV, DOI 10.1155/2012/217594; Sharif R, 2012, MUTAT RES-FUND MOL M, V733, P111, DOI 10.1016/j.mrfmmm.2011.08.009; Turner SD, 2002, MOL CELL BIOL, V22, P4011, DOI 10.1128/MCB.22.12.4011-4019.2002; Nigg EA, 2011, NAT CELL BIOL, V13, P1154, DOI 10.1038/ncb2345; Gorrini C, 2007, NATURE, V448, P1063, DOI 10.1038/nature06055; O'Sullivan JN, 2002, NAT GENET, V32, P280, DOI 10.1038/ng989; Huang CS, 2011, FOOD CHEM TOXICOL, V49, P1381, DOI 10.1016/j.fct.2011.03.023; Bajpai S, 2011, BIOL TRACE ELEM RES, V144, P327, DOI 10.1007/s12011-011-9097-7; Kolodner RD, 1999, CURR OPIN GENET DEV, V9, P89, DOI 10.1016/S0959-437X(99)80013-6; NISHIKAWA K, 1992, CANCER RES, V52, P4758; GLOVER DM, 1995, CELL, V81, P95, DOI 10.1016/0092-8674(95)90374-7; Maynard S, 2009, CARCINOGENESIS, V30, P2, DOI 10.1093/carcin/bgn250; Robertson KD, 2002, ONCOGENE, V21, P5361, DOI 10.1038/sj.onc.1205609; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; Rayalam S, 2007, J NUTR, V137, P2668; Meeker AK, 2004, J MAMMARY GLAND BIOL, V9, P285, DOI 10.1023/B:JOMG.0000048775.04140.92; Farrington SM, 2005, AM J HUM GENET, V77, P112, DOI 10.1086/431213; Cha HJ, 2013, TUMOR BIOL, V34, P3293, DOI 10.1007/s13277-013-1038-y; PFEIFER GP, 1990, P NATL ACAD SCI USA, V87, P8252, DOI 10.1073/pnas.87.21.8252; Liu C, 2011, CANCER PREV RES, V4, P1255, DOI 10.1158/1940-6207.CAPR-10-0384; Moyal L, 2011, MOL CELL, V41, P529, DOI 10.1016/j.molcel.2011.02.015; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Shiau RJ, 2010, EUR J NUTR, V49, P19, DOI 10.1007/s00394-009-0044-8; Goel A, 2007, GASTROENTEROLOGY, V132, P127, DOI 10.1053/j.gastro.2006.09.018; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Tripathi DN, 2010, MUTAT RES-GEN TOX EN, V696, P69, DOI 10.1016/j.mrgentox.2009.12.014; Avilion AA, 1996, CANCER RES, V56, P645; Khuda-Bukhsh AR, 2014, NUTR CANCER, V66, P194, DOI 10.1080/01635581.2014.864420; Rajesh M, 2006, BIOCHEM BIOPH RES CO, V350, P352, DOI 10.1016/j.bbrc.2006.09.049; Gryfe R, 2000, NEW ENGL J MED, V342, P69, DOI 10.1056/NEJM200001133420201; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231; Jin BL, 2013, ADV EXP MED BIOL, V754, P3, DOI 10.1007/978-1-4419-9967-2_1; Vilar E, 2010, NAT REV CLIN ONCOL, V7, P153, DOI 10.1038/nrclinonc.2009.237; Barnetson RA, 2007, CLIN GENET, V72, P551, DOI 10.1111/j.1399-0004.2007.00900.x; Lin SY, 2012, ANGIOGENESIS, V15, P671, DOI 10.1007/s10456-012-9289-6; Park EY, 2012, NUTR CANCER, V64, P732, DOI 10.1080/01635581.2012.687425; Chirnomas D, 2006, MOL CANCER THER, V5, P952, DOI 10.1158/1535-7163.MCT-05-0493; GREIDER CW, 1989, NATURE, V337, P331, DOI 10.1038/337331a0; Cardnell RJ, 2013, CLIN CANCER RES, V19, P6322, DOI 10.1158/1078-0432.CCR-13-1975; Filomeni G, 2007, GENES NUTR, V2, P295, DOI 10.1007/s12263-007-0059-9; Miquel C, 2007, ONCOGENE, V26, P5919, DOI 10.1038/sj.onc.1210419; Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220; Chen TF, 2009, INT J BIOCHEM CELL B, V41, P666, DOI [10.1016/j.biocel.2008.07.014, 10.1016/j.bioce1.2008.07.014]; Dasgupta S, 2012, J CELL PHYSIOL, V227, P2451, DOI 10.1002/jcp.22980; Choi KC, 2009, CANCER RES, V69, P583, DOI 10.1158/0008-5472.CAN-08-2442; Chatterjee A, 2011, CANCER PREV RES, V4, P638, DOI 10.1158/1940-6207.CAPR-10-0326; Puduvalli VK, 2005, APOPTOSIS, V10, P233, DOI 10.1007/s10495-005-6078-3; Sun YL, 2005, P NATL ACAD SCI USA, V102, P13182, DOI 10.1073/pnas.0504211102; Etchegaray JP, 2013, CURR TOP MED CHEM, V13, P2991; Kasiappan R, 2012, J BIOL CHEM, V287, P41297, DOI 10.1074/jbc.M112.407189; Rosignoli P, 2008, EUR J NUTR, V47, P301, DOI 10.1007/s00394-008-0725-8; Taniguchi T, 2003, NAT MED, V9, P568, DOI 10.1038/nm852; Astley SB, 2002, NUTR CANCER, V43, P202, DOI 10.1207/S15327914NC432_11; Hoang JM, 1997, CANCER RES, V57, P300; Mahjabeen I, 2012, FAM CANCER, V11, P587, DOI 10.1007/s10689-012-9554-2; Rengarajan T, 2013, NUTRIENTS, V5, P4978, DOI 10.3390/nu5124978; Ting HJ, 2007, CANCER LETT, V247, P122, DOI 10.1016/j.canlet.2006.03.025; ARENSMAN RM, 1979, J PEDIATR SURG, V14, P809, DOI 10.1016/S0022-3468(79)80271-7; Smyth JF, 1997, ANN ONCOL, V8, P569, DOI 10.1023/A:1008211226339; HIYAMA E, 1992, JPN J CANCER RES, V83, P159; Dasgupta S, 2008, CANCER RES, V68, P700, DOI 10.1158/0008-5472.CAN-07-5532; Nassani N, 2013, CLIN BIOCHEM, V46, P1701, DOI 10.1016/j.clinbiochem.2013.07.018; Reid S, 2007, NAT GENET, V39, P162, DOI 10.1038/ng1947; Helleday T, 2007, DNA REPAIR, V6, P923, DOI 10.1016/j.dnarep.2007.02.006; Ferguson LR, 2012, MUTAT RES-FUND MOL M, V733, P100, DOI 10.1016/j.mrfmmm.2011.12.011; Economopoulou M, 2009, NAT MED, V15, P553, DOI 10.1038/nm.1947; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Lacey KR, 1999, P NATL ACAD SCI USA, V96, P2817, DOI 10.1073/pnas.96.6.2817; Deeb D, 2012, BIOCHEM BIOPH RES CO, V422, P561, DOI 10.1016/j.bbrc.2012.05.024; Dietmaier W, 1997, CANCER RES, V57, P4749; Ikeda N, 2003, MOL CANCER THER, V2, P739; Venturini L, 2012, NEURO-ONCOLOGY, V14, P736, DOI 10.1093/neuonc/nos083; Foksinski M, 2007, EUR J NUTR, V46, P174, DOI 10.1007/s00394-006-0642-7; Arnold RS, 2009, PROSTATE, V69, P1, DOI 10.1002/pros.20854; van Ommen B, 2010, GENES NUTR, V5, P285, DOI 10.1007/s12263-010-0192-8; Swisher EM, 2008, CANCER RES, V68, P2581, DOI 10.1158/0008-5472.CAN-08-0088; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0; Sun DD, 2013, BIOMATERIALS, V34, P171, DOI 10.1016/j.biomaterials.2012.09.031; Konishi A, 2008, GENE DEV, V22, P1221, DOI 10.1101/gad.1634008; Ferreira ALA, 2007, MUTAT RES-GEN TOX EN, V631, P26, DOI 10.1016/j.mrgentox.2007.04.003; Butturini AM, 2007, J CLIN ONCOL, V25, P2063, DOI 10.1200/JCO.2006.07.7792; Moon DO, 2010, CANCER LETT, V295, P260, DOI 10.1016/j.canlet.2010.03.009; Konijeti R, 2010, PROSTATE, V70, P1547, DOI 10.1002/pros.21190; Dasgupta S, 2012, INT J CANCER, V131, P158, DOI 10.1002/ijc.26357; Lara-Gonzalez P, 2012, CURR BIOL, V22, pR966, DOI 10.1016/j.cub.2012.10.006; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; LEVY MZ, 1992, J MOL BIOL, V225, P951, DOI 10.1016/0022-2836(92)90096-3; Xie W, 2009, MOL CELL, V33, P417, DOI 10.1016/j.molcel.2009.02.004; Kim KH, 2011, J INVEST DERMATOL, V131, P195, DOI 10.1038/jid.2010.250; Glei M, 2002, TOXICOL APPL PHARM, V179, P65, DOI 10.1006/taap.2001.9329; Storz P, 2005, FRONT BIOSCI, V10, P1881, DOI 10.2741/1667; Tischkowitz M, 2010, CANCER RES, V70, P7353, DOI 10.1158/0008-5472.CAN-10-1012; CASTILLA LH, 1994, NAT GENET, V8, P387, DOI 10.1038/ng1294-387; Briviba K, 2008, NUTR CANCER, V60, P164, DOI 10.1080/01635580701621346; Gatz SA, 2008, CARCINOGENESIS, V29, P321, DOI 10.1093/carcin/bgm276; Bao BY, 2006, CARCINOGENESIS, V27, P32, DOI 10.1093/carcin/bgi170; van Helden YGJ, 2009, CARCINOGENESIS, V30, P2070, DOI 10.1093/carcin/bgp186; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Chan N, 2010, CANCER RES, V70, P8045, DOI 10.1158/0008-5472.CAN-10-2352; Chen SN, 2007, J CLIN ONCOL, V25, P1329, DOI 10.1200/JCO.2006.09.1066; Grabsch H, 2003, J PATHOL, V200, P16, DOI 10.1002/path.1324; La Terra S, 2005, J CELL BIOL, V168, P713, DOI 10.1083/jcb.200411126; Petros JA, 2005, P NATL ACAD SCI USA, V102, P719, DOI 10.1073/pnas.0408894102; Moon AF, 2007, DNA REPAIR, V6, P1709, DOI 10.1016/j.dnarep.2007.05.009; Tamae D, 2011, BIOCHEMISTRY-US, V50, P2321, DOI 10.1021/bi101933p; Szabo G, 2012, DIGEST DIS, V30, P243, DOI 10.1159/000336913; Hamilton EE, 2006, J AM CHEM SOC, V128, P3388, DOI 10.1021/ja056568v; Holysz H, 2013, TUMOR BIOL, V34, P1371, DOI 10.1007/s13277-013-0757-4; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Hollander MC, 2005, P NATL ACAD SCI USA, V102, P13200, DOI 10.1073/pnas.0503133102; Tarapore P, 2002, ONCOGENE, V21, P6234, DOI 10.1038/sj.onc.1205707; MORIN GB, 1989, CELL, V59, P521, DOI 10.1016/0092-8674(89)90035-4; King-Batoon A, 2008, ENVIRON MOL MUTAGEN, V49, P36, DOI 10.1002/em.20363; Hopkins MH, 2011, CANCER PREV RES, V4, P1645, DOI 10.1158/1940-6207.CAPR-11-0105; Slater EP, 2010, CLIN GENET, V78, P490, DOI 10.1111/j.1399-0004.2010.01425.x; Gomez LS, 2013, BIOCHIMIE, V95, P1336, DOI 10.1016/j.biochi.2013.02.013; Caliskan-Can E, 2008, CLIN CHEM LAB MED, V46, P107, DOI 10.1515/CCLM.2008.010; Kao CF, 2004, GENE DEV, V18, P184, DOI 10.1101/gad.1149604; LaTulippe E, 2002, CANCER RES, V62, P4499; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Aguilera A, 2013, ANNU REV GENET, V47, P1, DOI 10.1146/annurev-genet-111212-133232; Wong KK, 2003, NATURE, V421, P643, DOI 10.1038/nature01385; Rouleau M, 2010, NAT REV CANCER, V10, P293, DOI 10.1038/nrc2812; Doxsey S, 2001, NAT REV MOL CELL BIO, V2, P688, DOI 10.1038/35089575; Tomlinson I, 2002, J PATHOL, V197, P6, DOI 10.1002/path.1071; McClintock B, 1941, GENETICS, V26, P234; Lingle WL, 2002, P NATL ACAD SCI USA, V99, P1978, DOI 10.1073/pnas.032479999; DIRE F, 1990, CANCER CHEMOTH PHARM, V25, P355; Mishra A, 2012, CANCER CELL, V22, P645, DOI 10.1016/j.ccr.2012.09.009; Sharp L, 2013, J NUTR, V143, P1966, DOI 10.3945/jn.113.174664; van Heek NT, 2002, AM J PATHOL, V161, P1541, DOI 10.1016/S0002-9440(10)64432-X; Chun JY, 2006, MOL CANCER THER, V5, P913, DOI 10.1158/1535-7163.MCT-05-0389; Love WK, 2008, INT J ONCOL, V32, P625; Rahman N, 2007, NAT GENET, V39, P165, DOI 10.1038/ng1959; PAPADOPOULOS N, 1994, SCIENCE, V263, P1625, DOI 10.1126/science.8128251; Palozza P, 2001, IUBMB LIFE, V52, P77, DOI 10.1080/15216540252774810; Chen Y, 2007, IN VIVO, V21, P365; Kwon M, 2008, GENE DEV, V22, P2189, DOI 10.1101/gad.1700908; Khodjakov A, 2002, J CELL BIOL, V158, P1171, DOI 10.1083/jcb.200205102; Osley Mary Ann, 2006, Briefings in Functional Genomics & Proteomics, V5, P179, DOI 10.1093/bfgp/ell022; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; Raynaud CM, 2008, ANN ONCOL, V19, P1875, DOI 10.1093/annonc/mdn405; Rayet B, 1999, ONCOGENE, V18, P6938, DOI 10.1038/sj.onc.1203221; Sobol RW, 1996, NATURE, V379, P183, DOI 10.1038/379183a0; Hassa PO, 2008, FRONT BIOSCI-LANDMRK, V13, P3046, DOI 10.2741/2909; Moreno FS, 2007, CHEM-BIOL INTERACT, V168, P221, DOI 10.1016/j.cbi.2007.04.011; Borel F, 2002, P NATL ACAD SCI USA, V99, P9819, DOI 10.1073/pnas.152205299; Dikmen ZG, 2009, BBA-MOL BASIS DIS, V1792, P240, DOI 10.1016/j.bbadis.2009.01.018; Lorenzo Y, 2009, CARCINOGENESIS, V30, P308, DOI 10.1093/carcin/bgn270; Efimova EV, 2010, CANCER RES, V70, P6277, DOI 10.1158/0008-5472.CAN-09-4224; Bera S, 2013, MUTAGENESIS, V28, P127, DOI 10.1093/mutage/ges064; Al-Tassan N, 2002, NAT GENET, V30, P227, DOI 10.1038/ng828; Nair-Shalliker V, 2012, MUTAT RES-FUND MOL M, V733, P50, DOI 10.1016/j.mrfmmm.2012.02.005; Xia XJ, 2013, CELL REP, V5, P1243, DOI 10.1016/j.celrep.2013.10.046; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Imai K, 2008, CARCINOGENESIS, V29, P673, DOI 10.1093/carcin/bgm228; Sanmartin C, 2012, INT J MOL SCI, V13, P9649, DOI 10.3390/ijms13089649; Chuang HC, 2012, BREAST CANCER RES TR, V134, P649, DOI 10.1007/s10549-012-2106-5; Umar A, 2004, J NATL CANCER I, V96, P261, DOI 10.1093/jnci/djh034; Huang PH, 2012, ANGIOGENESIS, V15, P377, DOI 10.1007/s10456-012-9267-z; Quintyne NJ, 2005, SCIENCE, V307, P127, DOI 10.1126/science.1104905; Aubert G, 2008, PHYSIOL REV, V88, P557, DOI 10.1152/physrev.00026.2007; Donkena KV, 2010, MINI-REV MED CHEM, V10, P1385; Jones S, 2009, SCIENCE, V324, P217, DOI 10.1126/science.1171202; Boland CR, 1998, CANCER RES, V58, P5248; Kakar S, 2003, CANCER, V97, P1421, DOI 10.1002/cncr.11206; Kang NH, 2013, FOOD CHEM TOXICOL, V59, P373, DOI 10.1016/j.fct.2013.06.029; Thomson SJ, 2006, CANCER RES, V66, P6772, DOI 10.1158/0008-5472.CAN-05-3809; Calvert P, 1998, CHEM-BIOL INTERACT, V112, P213; Shay JW, 2003, CLIN CANCER RES, V9, P3521; Taylor SM, 2010, BLOOD, V116, P3108, DOI 10.1182/blood-2010-01-266197; Sram RJ, 2012, MUTAT RES-FUND MOL M, V733, P39, DOI 10.1016/j.mrfmmm.2011.12.001; BRONNER CE, 1994, NATURE, V368, P258, DOI 10.1038/368258a0; Falchetti ML, 2008, INT J CANCER, V122, P1236, DOI 10.1002/ijc.23193; Foley EA, 2013, NAT REV MOL CELL BIO, V14, P25, DOI 10.1038/nrm3494; Estrela JM, 2006, CRIT REV CL LAB SCI, V43, P143, DOI 10.1080/10408360500523878; Kang LG, 2010, J CELL MOL MED, V14, P1485, DOI 10.1111/j.1582-4934.2009.00877.x; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Srinivasan M, 2009, TOXICOLOGY, V262, P43, DOI 10.1016/j.tox.2009.05.004; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; Irshad S, 2011, EXPERT REV ANTICANC, V11, P1243, DOI [10.1586/era.11.52, 10.1586/ERA.11.52]; Farazi PA, 2003, CANCER RES, V63, P5021; Martin SA, 2009, EMBO MOL MED, V1, P323, DOI 10.1002/emmm.200900040; Fowke JH, 2011, LUNG CANCER, V73, P18, DOI 10.1016/j.lungcan.2010.10.024; Jakubikova J, 2011, HAEMATOL-HEMATOL J, V96, P1170, DOI 10.3324/haematol.2010.029363; Greider CW, 1991, CURR OPIN CELL BIOL, V3, P444, DOI 10.1016/0955-0674(91)90072-7; Heaphy CM, 2011, AM J PATHOL, V179, P1608, DOI 10.1016/j.ajpath.2011.06.018; MEHLE C, 1994, CANCER RES, V54, P236; Fang X, 2011, SEMIN CELL DEV BIOL, V22, P595, DOI 10.1016/j.semcdb.2011.03.002; Nguyen HG, 2009, FASEB J, V23, P2741, DOI 10.1096/fj.09-130963; Merdes A, 1996, CELL, V87, P447, DOI 10.1016/S0092-8674(00)81365-3; Hanks S, 2004, NAT GENET, V36, P1159, DOI 10.1038/ng1449; Nicassio F, 2007, CURR BIOL, V17, P1972, DOI 10.1016/j.cub.2007.10.034; Premkumar VG, 2008, VASC PHARMACOL, V48, P191, DOI 10.1016/j.vph.2008.02.003; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Astley SB, 2004, BRIT J NUTR, V91, P63, DOI 10.1079/BJN20031001; Ding YC, 2011, BREAST CANCER RES TR, V126, P227, DOI 10.1007/s10549-010-1271-7; Chen HP, 2013, EXP CELL RES, V319, P697, DOI 10.1016/j.yexcr.2012.12.026; Krishnan AV, 2007, J BONE MINER RES, V22, pV74, DOI [10.1359/jbmr.07s213, 10.1359/JBMR.07S213]; Martin SA, 2010, CANCER CELL, V17, P235, DOI 10.1016/j.ccr.2009.12.046; Das PM, 2004, J CLIN ONCOL, V22, P4632, DOI 10.1200/JCO.2004.07.151; Silk AD, 2009, J CELL BIOL, V184, P677, DOI 10.1083/jcb.200810091; Dolinoy DC, 2007, P NATL ACAD SCI USA, V104, P13056, DOI 10.1073/pnas.0703739104; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Fouad MA, 2013, HUM EXP TOXICOL, V32, P1067, DOI 10.1177/0960327113475679; Artandi SE, 2000, CURR OPIN GENET DEV, V10, P39, DOI 10.1016/S0959-437X(99)00047-7; Peel N, 2007, CURR BIOL, V17, P834, DOI 10.1016/j.cub.2007.04.036; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Srinivasan M, 2007, BBA-GEN SUBJECTS, V1770, P659, DOI 10.1016/j.bbagen.2006.11.008; Hitchins MP, 2010, ADV GENET, V70, P201, DOI [10.1016/B978-0-12-380866-0.60008-3, 10.1016/S0065-2660(10)70008-0]; Noh KT, 2013, BIOCHEM BIOPH RES CO, V431, P348, DOI 10.1016/j.bbrc.2012.12.093; Serpeloni JM, 2010, ARCH TOXICOL, V84, P811, DOI 10.1007/s00204-010-0576-y; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Santocono M, 2007, J PHOTOCH PHOTOBIO B, V88, P1, DOI 10.1016/j.jphotobiol.2007.04.007; Tripathi DN, 2008, TOXICOLOGY, V248, P96, DOI 10.1016/j.tox.2008.03.015; Tischkowitz M, 2012, HUM MUTAT, V33, P674, DOI 10.1002/humu.22022; Neeha VS, 2013, J FOOD SCI TECH MYS, V50, P415, DOI 10.1007/s13197-012-0775-z; Collins AR, 2012, EUR J NUTR, V51, P261, DOI 10.1007/s00394-012-0318-4; Nishino H, 2002, CANCER METAST REV, V21, P257, DOI 10.1023/A:1021206826750; Morin B, 2008, FOOD CHEM TOXICOL, V46, P787, DOI 10.1016/j.fct.2007.10.011; Albertson TM, 2009, P NATL ACAD SCI USA, V106, P17101, DOI 10.1073/pnas.0907147106; Wong KK, 2003, J NATL CANCER I, V95, P1184, DOI 10.1093/jnci/djg028; Thejass P, 2007, NITRIC OXIDE-BIOL CH, V16, P247, DOI 10.1016/j.niox.2006.09.006; Meeker AK, 2002, CANCER RES, V62, P6405; Kim YM, 2008, CANCER GENET CYTOGEN, V186, P78, DOI 10.1016/j.cancergencyto.2008.06.010; Griffith JK, 1999, BREAST CANCER RES TR, V54, P59, DOI 10.1023/A:1006128228761; Kowalczyk MC, 2009, CARCINOGENESIS, V30, P1008, DOI 10.1093/carcin/bgp069; Bjelakovic G, 2007, JAMA-J AM MED ASSOC, V297, P842, DOI 10.1001/jama.297.8.842; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; FORD D, 1994, LANCET, V343, P692, DOI 10.1016/S0140-6736(94)91578-4; McDonald KL, 2010, J NEUROPATH EXP NEUR, V69, P729, DOI 10.1097/NEN.0b013e3181e576cf; McCabe N, 2006, CANCER RES, V66, P8109, DOI 10.1158/0008-5472.CAN-06-0140; Campisi J, 2000, IN VIVO, V14, P183; Scolastici C, 2007, TOXICOL IN VITRO, V21, P840, DOI 10.1016/j.tiv.2007.01.020; Lowe L, 2003, RECENT RES CANCER, V164, P99; Coleman ML, 2009, NAT MED, V15, P491, DOI 10.1038/nm0509-491; Poynter KR, 2009, MOL CANCER THER, V8, P1319, DOI 10.1158/1535-7163.MCT-08-0849; LEACH FS, 1993, CELL, V75, P1215, DOI 10.1016/0092-8674(93)90330-S; Wesolowska O, 2010, ANTICANCER RES, V30, P4587; Wang RH, 2008, MOL CELL, V32, P11, DOI 10.1016/j.molcel.2008.09.011; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Park E, 2009, J CLIN BIOCHEM NUTR, V45, P341, DOI 10.3164/jcbn.09-44; Wachsman JT, 1997, MUTAT RES-FUND MOL M, V375, P1, DOI 10.1016/S0027-5107(97)00003-1; Lee YC, 2003, J BIOL CHEM, V278, P39615, DOI 10.1074/jbc.M304095200; Tenesa A, 2005, J NATL CANCER I, V97, P320, DOI 10.1093/jnci/jdi051; Chavakis T, 2009, CELL CYCLE, V8, P3438, DOI 10.4161/cc.8.21.9750; Chan LY, 2009, GENE DEV, V23, P1639, DOI 10.1101/gad.1804609; Baerlocher GM, 2003, CYTOM PART A, V55A, P1, DOI 10.1002/cyto.a.10064; Otsuki T, 1998, INT J HEMATOL, V67, P243; FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0; Popat S, 2005, J CLIN ONCOL, V23, P609, DOI 10.1200/JCO.2005.01.186; Ferguson LR, 2001, MUTAT RES-FUND MOL M, V475, P89, DOI 10.1016/S0027-5107(01)00073-2; Velanganni AAJ, 2007, INDIAN J BIOCHEM BIO, V44, P157; Birkbak NJ, 2011, CANCER RES, V71, P3447, DOI 10.1158/0008-5472.CAN-10-3667; Costa A, 2006, CANCER RES, V66, P8918, DOI 10.1158/0008-5472.CAN-06-0273; FRIEDMAN LS, 1994, NAT GENET, V8, P399, DOI 10.1038/ng1294-399; Taketo MM, 2009, GASTROENTEROLOGY, V136, P780, DOI 10.1053/j.gastro.2008.12.049; Dasgupta S, 2010, CANCER PREV RES, V3, P1205, DOI 10.1158/1940-6207.CAPR-10-0018; Villarreal-Garza C, 2012, EXP DIABETES RES, DOI 10.1155/2012/732027; Arnold RS, 2013, BIOMED RES INT, DOI 10.1155/2013/239257; Dent P, 2011, MOL INTERV, V11, P133, DOI 10.1124/mi.11.2.11; SMITH JK, 1992, AM J OBSTET GYNECOL, V167, P1883; Grotsky DA, 2013, J CELL BIOL, V200, P187, DOI 10.1083/jcb.201204053; Sargent DJ, 2010, J CLIN ONCOL, V28, P3219, DOI 10.1200/JCO.2009.27.1825; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; German JB, 2011, ANNU REV FOOD SCI T, V2, P97, DOI 10.1146/annurev.food.102308.124147; Jang SH, 2009, ANN NY ACAD SCI, V1171, P156, DOI 10.1111/j.1749-6632.2009.04711.x; MCAUSLAN BR, 1986, MICROVASC RES, V32, P112, DOI 10.1016/0026-2862(86)90047-6; Wertz K, 2009, NUTR CANCER, V61, P775, DOI 10.1080/01635580903285023; Hager G, 2004, ACTA OTO-LARYNGOL, V124, P90, DOI 10.1080/00016480310015353; Harley CB, 1997, CANCER SURV, V29, P263; Riha K, 2006, ANNU REV GENET, V40, P237, DOI 10.1146/annurev.genet.39.110304.095755; De Lange T, 2005, COLD SH Q B, V70, P197, DOI 10.1101/sqb.2005.70.032; PETO R, 1981, NATURE, V290, P201, DOI 10.1038/290201a0; DENKO NC, 1994, P NATL ACAD SCI USA, V91, P5124, DOI 10.1073/pnas.91.11.5124; Ko MA, 2005, NAT GENET, V37, P883, DOI 10.1038/ng1605; Felsher DW, 1999, P NATL ACAD SCI USA, V96, P3940, DOI 10.1073/pnas.96.7.3940; Stoehlmacher J, 2002, J NATL CANCER I, V94, P936; Bergstrom T, 2011, MUTAGENESIS, V26, P735, DOI 10.1093/mutage/ger041; O'Hagan RC, 2002, CANCER CELL, V2, P149, DOI 10.1016/S1535-6108(02)00094-6; Artandi SE, 2000, NATURE, V406, P641; Bryan TM, 1997, NAT MED, V3, P1271, DOI 10.1038/nm1197-1271; Rao L, 2001, J NUTR, V131, P3175; AliOsman F, 1997, J BIOL CHEM, V272, P10004; Shamim U, 2012, J CELL PHYSIOL, V227, P1493, DOI 10.1002/jcp.22865; Mai W, 2009, CLIN CANCER RES, V15, P6810, DOI 10.1158/1078-0432.CCR-09-0973; Ren ZH, 2013, PHARMAZIE, V68, P689, DOI 10.1691/ph.2013.2916; El Sayed SM, 2013, MED HYPOTHESES, V81, P866, DOI 10.1016/j.mehy.2013.08.024; Alderton GK, 2013, NAT REV CANCER, V13, P77, DOI 10.1038/nrc3455; Barrett C, 2013, PLOS ONE, V8; Baylin SB, 1998, ADV CANCER RES, V72, P141; Blackburn E H, 2000, Keio J Med, V49, P59; Blasiak J, 2002, TERATOGEN CARCIN MUT, V22, P73, DOI 10.1002/tcm.1040; Boreddy S, 2011, PLOS ONE, V6; Buttari B., 2013, OXIDATIVE MED CELLUL, V2013; Castiel A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-412; Chen L, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.553; Collins AR, 2003, CARCINOGENESIS, V24, P511, DOI 10.1093/carcin/24.3.511; Cook CC, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.141; COUNTER CM, 1994, P NATL ACAD SCI USA, V91, P2900, DOI 10.1073/pnas.91.8.2900; Dai CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063054; D'Andrea AD, 2010, NEW ENGL J MED, V362, P1909, DOI 10.1056/NEJMra0809889; Dasgupta S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006533; de Lange T, 2010, Cold Spring Harb Symp Quant Biol, V75, P167, DOI 10.1101/sqb.2010.75.017; Devaraj S, 2008, J AM COLL NUTR, V27, P267; Ermolaeva MA, 2014, TRENDS GENET, V30, P95, DOI 10.1016/j.tig.2013.12.001; Fishel R, 1994, CELL, V77, P166; Friedenson Bernard, 2005, MedGenMed, V7, P60; FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630; Ghosald G., 2013, TRANSL CANC RES, V2, P107, DOI DOI 10.3978/J.ISSN.2218-676X.2013.04.01; Gupta P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067278; Haddad NF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062773; Haren Laurence, 2009, BMC Res Notes, V2, P64, DOI 10.1186/1756-0500-2-64; HARLEY CB, 1991, MUTAT RES, V256, P271, DOI 10.1016/0921-8734(91)90018-7; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Houtgraaf Jaco H, 2006, Cardiovasc Revasc Med, V7, P165, DOI 10.1016/j.carrev.2006.02.002; Iwasaki K, 2013, BIOCHEMISTRY-US, V52, P5075, DOI 10.1021/bi400399f; Ji Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078700; Karlseder J, 2004, PLOS BIOL, V2, P1150, DOI 10.1371/journal.pbio.0020240; Keith M, 2013, MOL CARCINOG; Kloss-Brandstatter A, 2010, AM J HUM GENET, V87, P802, DOI 10.1016/j.ajhg.2010.11.001; Kobayashi H, 2013, ONCOL REP; Krishnan A, 2007, J BONE MIN RES S2, V22, P80; Kunkel T A, 2009, Cold Spring Harb Symp Quant Biol, V74, P91, DOI 10.1101/sqb.2009.74.027; Lagadu S, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-157; Lamy E, 2013, PLOS ONE, V8; Lanni JS, 1998, MOL CELL BIOL, V18; Lerebours F, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-41; Liang YL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012860; Lim U, 2012, DIETARY LIFESTYLE FA, P359; Liu W, 2002, AM J PATHOL; Lopez R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079708; Luca MD, 2006, CELL CYCLE, V5; Marthiens V, 2012, J CELL SCI, V125, P3281, DOI 10.1242/jcs.094797; Martin DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004531; Maxwell CA, 2005, CANCER RES, V65, P850; Muller HJ, 1938, COLLECTING NET, V13, P181; Najjar Yana G, 2013, Front Oncol, V3, P49, DOI 10.3389/fonc.2013.00049; NICOLAIDES NC, 1994, NATURE, V371, P75, DOI 10.1038/371075a0; Nowsheen S, 2012, CANC LETT, DOI 10.1016/j.canlet.2012.05.015; OIKAWA T, 1990, EUR J PHARMACOL, V178, P247, DOI 10.1016/0014-2999(90)90483-M; OLOVNIKO.AM, 1971, DOKL AKAD NAUK SSSR+, V201, P1496; Omenn GS, 1996, J NATL CANCER I, V88, P1550, DOI 10.1093/jnci/88.21.1550; Otten JJ, 2006, DRI DIETARY REFERENC; Park JS, 2010, NUTR METAB, V7; Phalon C, 2010, EXPERT REV MOL MED, V2010; Raffoul J, 2012, J ONCOL, V2012; Sajesh Babu V, 2013, Cancers (Basel), V5, P739, DOI 10.3390/cancers5030739; Sayeed A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067191; Sessa C, 2011, ANN ONCOL S8, V22, pviii72; SHACKNEY SE, 1989, CANCER RES, V49, P3344; Shen S, 2014, MOL PHARM; Simone RE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019652; Stan SD, 2013, NUTR CANC; Stracker Travis H., 2013, Frontiers in Genetics, V4, P37, DOI 10.3389/fgene.2013.00037; Swindall Amanda F, 2013, Cancers (Basel), V5, P943, DOI 10.3390/cancers5030943; Telli Melinda L, 2010, Clin Adv Hematol Oncol, V8, P629; van Helden YGJ, 2009, FREE RADICAL BIO MED, V46, P299, DOI 10.1016/j.freeradbiomed.2008.10.038; van Pel DM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003254; Vanamala J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-238; Vander Heiden MG, 2009, SCIENCE, V324, P1029, DOI DOI 10.1126/SCIENCE.1160809; WATSON JD, 1972, NATURE-NEW BIOL, V239, P197; Watson MM, 2014, BR J CANC; Willers H, 2011, TARGETING HOMOLOGOUS, P119; Zini A, 2010, FERTIL STERIL, V94, P1033, DOI 10.1016/j.fertnstert.2009.04.004; Yurtcu E, 2011, MOL BIOL REP, V38, P4265, DOI 10.1007/s11033-010-0549-5; Zhang XH, 2013, WORLD J GASTROENTERO, V19, P1005, DOI 10.3748/wjg.v19.i7.1005; Zhou GD, 2010, TOXICOL APPL PHARM, V249, P224, DOI 10.1016/j.taap.2010.09.019; Xu XL, 1999, MOL CELL, V3, P389, DOI 10.1016/S1097-2765(00)80466-9; Zhang XH, 2006, CURR CANCER DRUG TAR, V6, P229, DOI 10.2174/156800906776842939; Zhou XP, 1997, ONCOGENE, V15, P1713, DOI 10.1038/sj.onc.1201337; Yang CM, 2012, J NUTR BIOCHEM, V23, P1155, DOI 10.1016/j.jnutbio.2011.06.009; Zheng YL, 2012, CANCER-AM CANCER SOC, V118, P1362, DOI 10.1002/cncr.26388; Yang MD, 2010, ANTICANCER RES, V30, P2135; Yang ES, 2012, CANCER RES, V72, P5547, DOI 10.1158/0008-5472.CAN-12-0934; Zhang MH, 2013, INT J MOL MED, V31, P621, DOI 10.3892/ijmm.2013.1237; Yun UJ, 2012, CANCER LETT, V323, P155, DOI 10.1016/j.canlet.2012.04.003; Yao H, 2013, PLOS ONE, V8; Zastre Jason A, 2013, Cancer Metab, V1, P16, DOI 10.1186/2049-3002-1-16; Zhang JJ, 2013, INDIAN J MED RES, V137, P527; Zhang S., 2013, J NANOMATER, V2013, P8, DOI DOI 10.1371/J0URNAL.P0NE.0083699; Zhu W Y, 1994, Zhonghua Bing Li Xue Za Zhi, V23, P347	518	1	1	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1044-579X			SEMIN CANCER BIOL	Semin. Cancer Biol.	DEC	2015	35			S			S5	S24		10.1016/j.semcancer.2015.03.005		20	Oncology	Oncology	CY7WG	WOS:000366619400002		
J	Jiang, WG; Sanders, AJ; Katoh, M; Ungefroren, H; Gieseler, F; Prince, M; Thompson, SK; Zollo, M; Spano, D; Dhawan, P; Sliva, D; Subbarayan, PR; Sarkar, M; Honoki, K; Fujii, H; Georgakilas, AG; Amedei, A; Niccolai, E; Amin, A; Ashraf, SS; Ye, L; Helferich, WG; Yang, X; Boosani, CS; Guha, G; Ciriolo, MR; Aquilano, K; Chen, S; Azmi, AS; Keith, WN; Bilsland, A; Bhakta, D; Halicka, D; Nowsheen, S; Pantano, F; Santini, D				Jiang, W. G.; Sanders, A. J.; Katoh, M.; Ungefroren, H.; Gieseler, F.; Prince, M.; Thompson, S. K.; Zollo, M.; Spano, D.; Dhawan, P.; Sliva, D.; Subbarayan, P. R.; Sarkar, M.; Honoki, K.; Fujii, H.; Georgakilas, A. G.; Amedei, A.; Niccolai, E.; Amin, A.; Ashraf, S. S.; Ye, L.; Helferich, W. G.; Yang, X.; Boosani, C. S.; Guha, G.; Ciriolo, M. R.; Aquilano, K.; Chen, S.; Azmi, A. S.; Keith, W. N.; Bilsland, A.; Bhakta, D.; Halicka, D.; Nowsheen, S.; Pantano, F.; Santini, D.			Tissue invasion and metastasis: Molecular, biological and clinical perspectives	SEMINARS IN CANCER BIOLOGY			English	Review						Cancer metastasis; Invasion; Cancer therapy	GROWTH-FACTOR-BETA; NF-KAPPA-B; BREAST-CANCER CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; ISOLATED TUMOR-CELLS; POLYUNSATURATED FATTY-ACIDS; GANODERMA-LUCIDUM-POLYSACCHARIDES; LYMPH-NODE MICROMETASTASIS; FOCAL ADHESION KINASE; ANTITUMOR NATURAL-PRODUCT	Cancer is a key health issue across the world, causing substantial patient morbidity and mortality. Patient prognosis is tightly linked with metastatic dissemination of the disease to distant sites, with metastatic diseases accounting for a vast percentage of cancer patient mortality. While advances in this area have been made, the process of cancer metastasis and the factors governing cancer spread and establishment at secondary locations is still poorly understood. The current article summarizes recent progress in this area of research, both in the understanding of the underlying biological processes and in the therapeutic strategies for the management of metastasis. This review lists the disruption of E-cadherin and tight junctions, key signaling pathways, including urokinase type plasminogen activator (uPA), phosphatidylinositol 3-kinase/v-alct murine thymoma viral oncogene (PI3K/AKT), focal adhesion kinase (FAK), beta-catenin/zinc finger E-box binding homeobox 1 (ZEB-1) and transforming growth factor beta (TGF-beta), together with inactivation of activator protein-1 (AP-1) and suppression of matrix metalloproteinase-9 (MMP-9) activity as key targets and the use of phytochemicals, or natural products, such as those from Agaricus blazei, Albatrellus confluens, Cordyceps militaris, Ganoderma lucidum, Poria cocos and Silybum marianum, together with diet derived fatty acids gamma linolenic acid (GLA) and eicosapentanoic acid (EPA) and inhibitory compounds as useful approaches to target tissue invasion and metastasis as well as other hallmark areas of cancer. Together, these strategies could represent new, inexpensive, low toxicity strategies to aid in. the management of cancer metastasis as well as having holistic effects against other cancer hallmarks. (C) 2015 Elsevier Ltd.	[Jiang, W. G.; Sanders, A. J.; Ye, L.] Cardiff Univ, Cardiff CF14 4XN, S Glam, Wales; [Katoh, M.] Natl Canc Ctr, Tokyo 104, Japan; [Ungefroren, H.; Gieseler, F.] Univ Hosp Schleswig Holstein, Lubeck, Germany; [Prince, M.] Univ Michigan, Ann Arbor, MI 48109 USA; [Thompson, S. K.] Royal Adelaide Hosp, Adelaide, SA 5000, Australia; [Zollo, M.] Univ Naples Federico II, Dept Mol Med & Med Biotechnol DMMBM, Naples, Italy; [Zollo, M.; Spano, D.] CEINGE Biotecnol Avanzate, Naples, Italy; [Dhawan, P.] Univ Nebraska Med Ctr, Omaha, NE USA; [Sliva, D.] Purdue Res Pk, Indianapolis, IN USA; [Subbarayan, P. R.; Sarkar, M.] Univ Miami, Miami, FL USA; [Honoki, K.; Fujii, H.] Nara Med Univ, Kashihara, Nara 634, Japan; [Georgakilas, A. G.] NTUA, Dept Phys, Sch Appl Math & Phys Sci, Athens, Greece; [Amedei, A.; Niccolai, E.] Univ Florence, Florence, Italy; [Amin, A.; Ashraf, S. S.] United Arab Emirates Univ, Al Ain, U Arab Emirates; [Amin, A.; Ashraf, S. S.] Cairo Univ, Fac Sci, Giza, Egypt; [Helferich, W. G.; Yang, X.] Univ Illinois, Urbana, IL USA; [Boosani, C. S.] Creighton Univ, Omaha, NE 68178 USA; [Guha, G.; Bhakta, D.] SASTRA Univ, Thanjavur, India; [Ciriolo, M. R.; Aquilano, K.] Univ Roma Tor Vergata, Rome, Italy; [Chen, S.] Ovarian & Prostate Canc Res Trust Lab, Surrey, England; [Azmi, A. S.] Wayne State Univ, Detroit, MI USA; [Keith, W. N.; Bilsland, A.] Univ Glasgow, Glasgow, Lanark, Scotland; [Halicka, D.] New York Med Coll, Valhalla, NY 10595 USA; [Nowsheen, S.] Mayo Clin, Coll Med, Rochester, MN USA; [Pantano, F.; Santini, D.] Univ Campus Biomed, Rome, Italy	Jiang, WG (reprint author), Cardiff Univ, Sch Med, Cardiff Peking Canc Inst, Henry Wellcome Bldg,Heath Pk, Cardiff CF14 4XN, S Glam, Wales.	jiangw@cf.ac.uk	Keith, Nicol/D-3325-2009; Jiang, Wen G./B-1293-2010	Keith, Nicol/0000-0001-7862-3580; Jiang, Wen G./0000-0002-3283-1111	Cancer Research Wales; National Research Network in Health and Life Sciences; Albert Hung Foundation; AIRC (Associazione Italaliana per la Ricerca sul Cancro); University of Miami Clinical and Translational Science Institute (CTSI) Pilot Research Grant [CTSI-2013-P03]; Greek National funds through the Operational Program 'Educational and Lifelong Learning of the National Strategic Reference Framework (NSRF)-Research Funding Program: THALES [MIS 379346]; COST Action CM1201 'Biomimetic Radical Chemistry'; EU Marie Curie Reintegration Grant [MC-CIG-303514];  [EU-FP7-TUMIC-HEALTH-F2-2008-2016662]	The following are acknowledged for their support: Cancer Research Wales (WGJ and AJS), the National Research Network in Health and Life Sciences (WGJ), The Albert Hung Foundation (WGJ), AIRC (Associazione Italaliana per la Ricerca sul Cancro) 2012-2014 (MZ), EU-FP7-TUMIC-HEALTH-F2-2008-2016662 (MZ), University of Miami Clinical and Translational Science Institute (CTSI) Pilot Research Grant (CTSI-2013-P03) (PRS), SEEDS You Choose Awards (PRS). AGG was supported by an EU Marie Curie Reintegration Grant MC-CIG-303514, Greek National funds through the Operational Program 'Educational and Lifelong Learning of the National Strategic Reference Framework (NSRF)-Research Funding Program: THALES (Grant number MIS 379346) and COST Action CM1201 'Biomimetic Radical Chemistry'.	Akhurst RJ, 2001, TRENDS CELL BIOL, V11, pS44, DOI 10.1016/S0962-8924(01)82259-5; Amadori D., 1997, Frontiers in Bioscience (online), V2, pG8; Toole BP, 2008, DRUG RESIST UPDATE, V11, P110, DOI 10.1016/j.drup.2008.04.002; Sadeghi B, 2000, CANCER, V88, P358, DOI 10.1002/(SICI)1097-0142(20000115)88:2<358::AID-CNCR16>3.0.CO;2-O; Smith MR, 2009, NEW ENGL J MED, V361, P745, DOI 10.1056/NEJMoa0809003; Martinez-Estrada OM, 2006, BIOCHEM J, V394, P449, DOI 10.1042/BJ20050591; Sanchez-Tillo E, 2014, CELL DEATH DIFFER, V21, P247, DOI 10.1038/cdd.2013.123; Botkjaer KA, 2012, MOL CANCER RES, V10, P1532, DOI 10.1158/1541-7786.MCR-12-0349; Liggins RT, 2000, BIOMATERIALS, V21, P1959, DOI 10.1016/S0142-9612(00)00080-6; Scheri RP, 2007, ANN SURG ONCOL, V14, P2861, DOI 10.1245/s10434-007-9472-y; Peng SB, 2005, BIOCHEMISTRY-US, V44, P2293, DOI 10.1021/bi048851x; Kumar VB, 2011, MUTAT RES-FUND MOL M, V707, P42, DOI 10.1016/j.mrfmmm.2010.12.009; Maritz MF, 2011, BIOL CHEM, V392, P439, DOI 10.1515/BC.2011.036; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; Thelen P, 2004, J UROLOGY, V171, P1934, DOI 10.1097/01.ju.0000121329.37206.1b; Loser K, 2006, NAT MED, V12, P1372, DOI 10.1038/nm1518; Cai J, 2006, CLIN CANCER RES, V12, P3510, DOI 10.1158/1078-0432.CCR-06-0094; Chen NH, 2011, PHYTOMEDICINE, V18, P719, DOI 10.1016/j.phymed.2011.01.011; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Gottardi CJ, 1996, P NATL ACAD SCI USA, V93, P10779, DOI 10.1073/pnas.93.20.10779; Mankertz J, 2004, BIOCHEM BIOPH RES CO, V314, P1001, DOI 10.1016/j.bbrc.2003.12.185; Thompson SK, 2011, J GASTROINTEST SURG, V15, P1762, DOI 10.1007/s11605-011-1634-3; Spencer GJ, 2006, J CELL SCI, V119, P1283, DOI 10.1242/jcs.02883; Buijs JT, 2009, CANCER LETT, V273, P177, DOI 10.1016/j.canlet.2008.05.044; Wu KJ, 2013, CELL SIGNAL, V25, P2625, DOI 10.1016/j.cellsig.2013.08.028; ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Jiang WG, 2005, CRIT REV ONCOL HEMAT, V53, P35, DOI 10.1016/j.critrevonc.2004.09.004; Harisinghani MG, 2003, NEW ENGL J MED, V348, P2491, DOI 10.1056/NEJMoa022749; Smith DC, 2013, J CLIN ONCOL, V31, P412, DOI 10.1200/JCO.2012.45.0494; Devine SM, 2004, J CLIN ONCOL, V22, P1095, DOI 10.1200/JCO.2004.07.13; Glickman JN, 1999, CANCER, V85, P769, DOI 10.1002/(SICI)1097-0142(19990215)85:4<769::AID-CNCR3>3.0.CO;2-I; Li JH, 2009, CANCER BIOL THER, V8, P1806; Hemon P, 2011, J IMMUNOL, V186, P5173, DOI 10.4049/jimmunol.1002050; Chiappori AA, 2007, CLIN CANCER RES, V13, P2091, DOI 10.1158/1078-0432.CCR-06-1586; Connelly L, 2011, ONCOGENE, V30, P1402, DOI 10.1038/onc.2010.521; Su ZY, 2011, J AGR FOOD CHEM, V59, P5109, DOI 10.1021/jf104700j; Li J, 2011, BASIC CLIN PHARMACOL, V108, P84, DOI 10.1111/j.1742-7843.2010.00613.x; Mullin JM, 1996, EXP CELL RES, V227, P12, DOI 10.1006/excr.1996.0244; Mineta K, 2011, FEBS LETT, V585, P606, DOI 10.1016/j.febslet.2011.01.028; Shiou SR, 2007, CANCER RES, V67, P1571, DOI 10.1158/0008-5472.CAN-06-1680; Clarke H, 2000, ADV DRUG DELIVER REV, V41, P283, DOI 10.1016/S0169-409X(00)00047-8; Shibata A, 2002, BREAST CANCER RES TR, V73, P237, DOI 10.1023/A:1015872531675; Xi LQ, 2005, CLIN CANCER RES, V11, P1099; Ling H, 2010, MOL CARCINOGEN, V49, P271, DOI 10.1002/mc.20597; Tsai WC, 2010, BIOORG MED CHEM LETT, V20, P6145, DOI 10.1016/j.bmcl.2010.08.006; Thierry Benjamin, 2009, Current Drug Delivery, V6, P391; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Jiang WG, 2012, INT J ONCOL, V41, P1635, DOI 10.3892/ijo.2012.1627; Klein CA, 2009, CANCER RES, V69, P5285, DOI 10.1158/0008-5472.CAN-08-4586; Dong LL, 2012, ACTA PHARMACOL SIN, V33, P817, DOI 10.1038/aps.2012.30; Jiang JH, 2011, BIOCHEM BIOPH RES CO, V415, P325, DOI 10.1016/j.bbrc.2011.10.055; Fang YZ, 2013, JNCI-J NATL CANCER I, V105, P47, DOI 10.1093/jnci/djs485; Huang CY, 2010, J AGR FOOD CHEM, V58, P8798, DOI 10.1021/jf1020158; Kikuchi T, 2011, J NAT PROD, V74, P137, DOI 10.1021/np100402b; Liu XH, 2005, ENDOCRINOLOGY, V146, P1991, DOI 10.1210/en.2004-1167; Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200; Fasano A, 2011, PHYSIOL REV, V91, P151, DOI 10.1152/physrev.00003.2008; Nacht M, 1999, CANCER RES, V59, P5464; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Shiozawa Y, 2011, J CLIN INVEST, V121, P1298, DOI 10.1172/JCI43414; Gonzalez ME, 2011, CANCER RES, V71, P2360, DOI 10.1158/0008-5472.CAN-10-1933; Komukai S, 2000, SURGERY, V127, P40, DOI 10.1067/msy.2000.102754; Gassmann P, 2009, NEOPLASIA, V11, P651, DOI 10.1593/neo.09272; Jiang JH, 2008, INT J MOL MED, V21, P577; Chang YM, 2008, ONCOGENE, V27, P6365, DOI 10.1038/onc.2008.250; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Soini Y, 2006, J CLIN PATHOL, V59, P250, DOI 10.1136/jcp.2005.028589; Kang JH, 2005, PEDIATR NEPHROL, V20, P1490, DOI 10.1007/s00467-005-1969-7; Tan C, 2004, CANCER CELL, V5, P79, DOI 10.1016/S1535-6108(03)00281-2; Kobayashi H, 2005, J CANCER RES CLIN, V131, P527, DOI 10.1007/s00432-005-0672-1; PASSLICK B, 1994, J CLIN ONCOL, V12, P1827; Tran TT, 2007, NEURO-ONCOLOGY, V9, P259, DOI 10.1215/15228517-2007-010; Ting H, 2013, AAPS J, V15, P707, DOI 10.1208/s12248-013-9486-2; Cassinelli G, 2013, CURR MED CHEM, V20, P1923; Doki Y, 2002, J SURG RES, V107, P75, DOI 10.1006/jsre.2002.6506; Brubaker KD, 2003, J BONE MINER RES, V18, P222, DOI 10.1359/jbmr.2003.18.2.222; Waterman TA, 2004, ANN THORAC SURG, V78, P1161, DOI 10.1016/j.athoracsur.2004.04.045; Scheuemann P, 2001, DIS ESOPHAGUS, V14, P85, DOI 10.1046/j.1442-2050.2001.00161.x; Spano D, 2012, SEMIN CANCER BIOL, V22, P234, DOI 10.1016/j.semcancer.2012.03.006; Ikari A, 2006, J CELL SCI, V119, P1781, DOI 10.1242/jcs.02901; Deep G, 2013, CURR CANCER DRUG TAR, V13, P486; Lin SB, 2003, LIFE SCI, V72, P2381, DOI 10.1016/S0024-3205(03)00124-3; Soini Y, 2005, HISTOPATHOLOGY, V46, P551, DOI 10.1111/j.1365-2559.2005.02127.x; Clarhaut J, 2009, NEOPLASIA, V11, P157, DOI 10.1593/neo.81074; SEGREDO V, 1990, ANESTHESIOLOGY, V72, P566, DOI 10.1097/00000542-199003000-00030; Wong YY, 2010, J BIOL CHEM, V285, P2610, DOI 10.1074/jbc.M109.071159; Lee SJ, 2009, ARCH BIOCHEM BIOPHYS, V490, P103, DOI 10.1016/j.abb.2009.09.001; Lee SB, 2009, MOL CELLS, V28, P583, DOI 10.1007/s10059-009-0152-6; Cheng SJ, 2013, INT J ONCOL, V42, P1869, DOI 10.3892/ijo.2013.1902; Matsumoto S, 2009, IMMUNOLOGY, V128, pe170, DOI 10.1111/j.1365-2567.2008.02942.x; Rosivatz E, 2002, AM J PATHOL, V161, P1881, DOI 10.1016/S0002-9440(10)64464-1; Harikumar KB, 2010, MOL CANCER RES, V8, P751, DOI 10.1158/1541-7786.MCR-09-0565; Prasad S, 2005, LAB INVEST, V85, P1139, DOI 10.1038/labinvest.3700316; Chung JY, 1999, CANCER RES, V59, P4610; Thyagarajan A, 2010, NUTR CANCER, V62, P630, DOI 10.1080/01635580903532390; Swenson WG, 2011, MOL CARCINOGEN, V50, P668, DOI 10.1002/mc.20775; Spano D, 2013, CLIN EXP METASTAS, V30, P47, DOI 10.1007/s10585-012-9506-0; Jing KP, 2013, ANTI-CANCER AGENT ME, V13, P1162; Peter Y, 2009, MOL CARCINOGEN, V48, P488, DOI 10.1002/mc.20485; Henry DH, 2011, J CLIN ONCOL, V29, P1125, DOI 10.1200/JCO.2010.31.3304; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Blanco MJ, 2002, ONCOGENE, V21, P3241, DOI 10.1038/sj.onc.1205416; Lavi I, 2006, CANCER LETT, V244, P61, DOI 10.1016/j.canlet.2005.12.007; Collares-Buzato CB, 1998, EUR J CELL BIOL, V76, P85; Weilbaecher KN, 2011, NAT REV CANCER, V11, P411, DOI 10.1038/nrc3055; Dhawan P, 2005, J CLIN INVEST, V115, P1765, DOI 10.1172/JCI24543; Jin FS, 2005, CANCER RES, V65, P6354, DOI 10.1158/0008-5472.CAN-04-4061; de Boer M, 2009, NEW ENGL J MED, V361, P653, DOI 10.1056/NEJMoa0904832; Wang YX, 2014, ASIAN PAC J CANCER P, V15, P6791, DOI 10.7314/APJCP.2014.15.16.6791; Ge RR, 2006, CLIN CANCER RES, V12, P4315, DOI 10.1158/1078-0432.CCR-06-0162; Tyagi A, 2002, PROSTATE, V53, P211, DOI 10.1002/pros.10146; Mateen S, 2010, MOL CARCINOGEN, V49, P247, DOI 10.1002/mc.20595; Balkovetz DF, 2004, AM J PHYSIOL-RENAL, V286, pF702, DOI 10.1152/ajprenal.00270.2003; Jensen AB, 2010, CLIN BREAST CANCER, V10, P452, DOI 10.3816/CBC.2010.n.059; Uhl M, 2004, CANCER RES, V64, P7954, DOI 10.1158/0008-5472.CAN-04-1013; Pang R, 2010, CELL STEM CELL, V6, P603, DOI 10.1016/j.stem.2010.04.001; Wang Y, 2014, PHYTOMEDICINE, V21, P1310, DOI 10.1016/j.phymed.2014.06.018; Xie J. T., 2006, Experimental Oncology, V28, P25; JIANG WG, 1995, CANCER RES, V55, P5043; Ono Y, 2012, CANCER SCI, V103, P317, DOI 10.1111/j.1349-7006.2011.02133.x; Chien MH, 2009, CARCINOGENESIS, V30, P2005, DOI 10.1093/carcin/bgp244; Jiang WG, 1998, BRIT J CANCER, V77, P731, DOI 10.1038/bjc.1998.120; Sporn MB, 1997, ANN NY ACAD SCI, V833, P137, DOI 10.1111/j.1749-6632.1997.tb48599.x; Turksen K, 2011, BBA-REV CANCER, V1816, P73, DOI 10.1016/j.bbcan.2011.04.001; Liu HN, 2012, MOL BIOL REP, V39, P10665, DOI 10.1007/s11033-012-1956-6; Li CG, 2001, J NATL CANCER I, V93, P555, DOI 10.1093/jnci/93.7.555; Akhurst RJ, 2006, CURR OPIN INVESTIG D, V7, P513; Kominsky SL, 2003, ONCOGENE, V22, P2021, DOI 10.1038/sj.onc.1206199; Thompson SK, 2010, ANN SURG, V252, P299, DOI 10.1097/SLA.0b013e3181e61e15; Kim H, 2011, MOL MED, V17, P893, DOI 10.2119/molmed.2011.00032; Lazaro G, 2013, ENDOCR-RELAT CANCER, V20, P691, DOI 10.1530/ERC-13-0019; Leifler KS, 2013, J IMMUNOL, V190, P4420, DOI 10.4049/jimmunol.1202610; Koenig AM, 2009, ANN SURG ONCOL, V16, P454, DOI 10.1245/s10434-008-0169-7; Vousden KH, 2009, AGING-US, V1, P275; Itoh M, 1999, J CELL BIOL, V147, P1351, DOI 10.1083/jcb.147.6.1351; Eitsuka T, 2004, BIOFACTORS, V21, P19; Bonavina L, 1999, J GASTROINTEST SURG, V3, P468, DOI 10.1016/S1091-255X(99)80099-7; de Vries TJ, 2009, MOL CANCER RES, V7, P476, DOI 10.1158/1541-7786.MCR-08-0219; Katakura Y, 1999, BIOCHEM BIOPH RES CO, V255, P110, DOI 10.1006/bbrc.1999.0129; Tafreshi NK, 2012, CLIN CANCER RES, V18, P207, DOI 10.1158/1078-0432.CCR-11-0238; Li J, 2008, EJSO-EUR J SURG ONC, V34, P857, DOI 10.1016/j.ejso.2007.07.009; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; St Croix B, 1998, J CELL BIOL, V142, P557, DOI 10.1083/jcb.142.2.557; Bogenrieder T, 2003, ONCOGENE, V22, P6524, DOI 10.1038/sj.onc.1206757; Ma JF, 2013, EUR REV MED PHARMACO, V17, P1102; Hau P, 2007, OLIGONUCLEOTIDES, V17, P201, DOI 10.1089/oli.2006.0053; Rosich L, 2013, HAEMATOLOGICA, V98, P1739, DOI 10.3324/haematol.2013.088849; Osanai M, 2007, CANCER SCI, V98, P1557, DOI 10.1111/j.1349-7006.2007.00569.x; Soares R, 2011, J MED FOOD, V14, P563, DOI 10.1089/jmf.2010.0095; Bausch D, 2011, ANGIOGENESIS, V14, P235, DOI 10.1007/s10456-011-9207-3; Salim T, 2014, EXP CELL RES, V321, P255, DOI 10.1016/j.yexcr.2013.10.021; Andjilani M, 2006, INT J ONCOL, V28, P535; Scheunemann P, 2009, LANGENBECK ARCH SURG, V394, P105, DOI 10.1007/s00423-008-0369-4; Connolly EC, 2011, CANCER RES, V71, P2339, DOI 10.1158/0008-5472.CAN-10-2941; Ghosh SC, 2012, EXPERT OPIN THER TAR, V16, P635, DOI 10.1517/14728222.2012.687374; Jakowlew SB, 2006, CANCER METAST REV, V25, P435, DOI 10.1007/s10555-006-9006-2; Jiang WG, 1996, BRIT J SURG, V83, P437, DOI 10.1002/bjs.1800830404; Hough CD, 2000, CANCER RES, V60, P6281; Morin C, 2013, PROSTAG LEUKOTR ESS, V89, P203, DOI 10.1016/j.plefa.2013.07.004; Portanova P, 2013, INT J ONCOL, V43, P121, DOI 10.3892/ijo.2013.1945; Han L, 2013, CURR MED CHEM, V20, P4142; Migita T, 2008, INT J ONCOL, V33, P41; Auvinen P, 2013, INT J CANCER, V132, P531, DOI 10.1002/ijc.27707; Vincent J, 2010, CANCER RES, V70, P3052, DOI 10.1158/0008-5472.CAN-09-3690; Sakurai H, 2012, TRENDS PHARMACOL SCI, V33, P522, DOI 10.1016/j.tips.2012.06.007; Choi S, 2011, TOXICOL APPL PHARM, V257, P165, DOI 10.1016/j.taap.2011.08.030; da Silva AF, 2013, HUM EXP TOXICOL, V32, P647, DOI 10.1177/0960327112468173; Singh RP, 2004, CLIN CANCER RES, V10, P8641, DOI 10.1158/1078-0432.CCR-04-1435; Mizushina Y, 2004, CANCER SCI, V95, P354, DOI 10.1111/j.1349-7006.2004.tb03215.x; Akiyama H, 2011, BBA-GEN SUBJECTS, V1810, P519, DOI 10.1016/j.bbagen.2011.02.010; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mazzocca A, 2010, HEPATOLOGY, V51, P523, DOI 10.1002/hep.23285; Morgan TM, 2009, CLIN CANCER RES, V15, P677, DOI 10.1158/1078-0432.CCR-08-1754; Tan W, 2011, NATURE, V470, P548, DOI 10.1038/nature09707; Cordero-Espinoza L, 2013, J BIOL CHEM, V288, P36020, DOI 10.1074/jbc.M113.510289; Mullin JM, 1997, CARCINOGENESIS, V18, P2339, DOI 10.1093/carcin/18.12.2339; Cheung ST, 2005, CLIN CANCER RES, V11, P551; Smith DA, 2013, MOL CANCER RES, V11, P1159, DOI 10.1158/1541-7786.MCR-13-0238; Bonafoux D, 2009, EXPERT OPIN THER PAT, V19, P1759, DOI 10.1517/13543770903397400; Itoh S, 2010, J CLIN BIOCHEM NUTR, V47, P81, DOI 10.3164/jcbn.10-24; Jin TR, 2008, CELL SIGNAL, V20, P1697, DOI 10.1016/j.cellsig.2008.04.014; Chen JY, 2013, TUMOR BIOL, V34, P1381, DOI 10.1007/s13277-013-0746-7; Trimboli AJ, 2008, CANCER RES, V68, P937, DOI 10.1158/0008-5472.CAN-07-2148; Botta C, 2012, J IMMUNOTHER, V35, P440, DOI 10.1097/CJI.0b013e31825943aa; Mima S, 2005, CANCER RES, V65, P1868, DOI 10.1158/0008-5472.CAN-04-2770; Escaffit F, 2005, J CELL PHYSIOL, V203, P15, DOI 10.1002/jcp.20189; MacGuill MJ, 2007, J CLIN PATHOL, V60, P1108, DOI 10.1136/jcp.2006.044149; Mon NN, 2009, METHODS MOL BIOL, V512, P279, DOI 10.1007/978-1-60327-530-9_15; Niu YC, 2009, ONCOL REP, V21, P145, DOI 10.3892/or_0000201; Lee SY, 2013, FOOD CHEM TOXICOL, V60, P439, DOI 10.1016/j.fct.2013.07.068; Takakura M, 2005, MOL CELL BIOL, V25, P8037, DOI 10.1128/MCB.25.18.8037-8043.2005; Ip YC, 2007, MOL CANCER THER, V6, P2858, DOI 10.1158/1535-7163.MCT-07-0453; Sun LX, 2012, J DRUG TARGET, V20, P582, DOI 10.3109/1061186X.2012.697167; Li L, 2008, CANCER LETT, V272, P61, DOI 10.1016/j.canlet.2008.06.033; Becker-Weimann S, 2013, ONCOTARGET, V4, P2010; Mira E, 2004, J CELL SCI, V117, P1847, DOI 10.1242/jcs.01035; Medici D, 2008, MOL BIOL CELL, V19, P4875, DOI 10.1091/mbc.E08-05-0506; Nogueira L, 2011, ONCOGENE, V30, P3537, DOI 10.1038/onc.2011.74; Kim HD, 2012, BIOCHEM BIOPH RES CO, V422, P213, DOI 10.1016/j.bbrc.2012.04.086; Niu YC, 2009, AM J CHINESE MED, V37, P909; Mateen S, 2013, NUTR CANCER, V65, P3, DOI 10.1080/01635581.2013.785004; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Talmadge JE, 2010, CANCER RES, V70, P5649, DOI 10.1158/0008-5472.CAN-10-1040; Rangel LBA, 2003, CLIN CANCER RES, V9, P2567; Xu PF, 2013, INT J PHARMACEUT, V454, P21, DOI 10.1016/j.ijpharm.2013.06.053; Stopeck AT, 2010, J CLIN ONCOL, V28, P5132, DOI 10.1200/JCO.2010.29.7101; Axanova LS, 2010, PROSTATE, V70, P1658, DOI 10.1002/pros.21201; Harnack U, 2010, ANTICANCER RES, V30, P3959; Ren ZH, 2012, INT IMMUNOPHARMACOL, V14, P698, DOI 10.1016/j.intimp.2012.10.008; Gaspar NJ, 2007, MOL PHARMACOL, V72, P152, DOI 10.1124/mol.106.029025; Ardalan B, 2010, CLIN CANCER RES, V16, P3019, DOI 10.1158/1078-0432.CCR-09-2590; Luo XJ, 2011, EUR J PHARMACOL, V670, P427, DOI 10.1016/j.ejphar.2011.08.026; Lavi I, 2012, J GASTROENTEROL, V47, P504, DOI 10.1007/s00535-011-0514-7; Lahn M, 2005, EXPERT OPIN INV DRUG, V14, P629, DOI 10.1517/13543784.14.6.629; Bukholm IRK, 2003, EUR J SURG ONCOL, V29, P862, DOI 10.1016/j.ejso.2003.09.007; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Lai IR, 2010, AM J PATHOL, V177, P1629, DOI 10.2353/ajpath.2010.100172; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Heinrich MC, 2000, BLOOD, V96, P925; Serini S, 2009, APOPTOSIS, V14, P135, DOI 10.1007/s10495-008-0298-2; Lee JW, 2005, GYNECOL ONCOL, V97, P53, DOI 10.1016/j.ygyno.2004.11.058; Horstmann O, 2004, J CANCER RES CLIN, V130, P733, DOI 10.1007/s00432-004-0609-0; Ji Z, 2011, ONCOL LETT, V2, P565, DOI 10.3892/ol.2011.275; Chan WI, 2008, SEMIN ONCOL, V35, P326, DOI 10.1053/j.seminoncol.2008.04.003; Liu TQ, 2013, CANCER LETT, V328, P271, DOI 10.1016/j.canlet.2012.09.024; Bhola NE, 2013, J CLIN INVEST, V123, P1348, DOI 10.1172/JCI65416; Heavey S, 2014, CANCER TREAT REV, V40, P445, DOI 10.1016/j.ctrv.2013.08.006; Niu RF, 2007, J EXP CLIN CANC RES, V26, P385; Ho BY, 2011, INT J BIOL SCI, V7, P869, DOI 10.7150/ijbs.7.869; Schley PD, 2007, J NUTR, V137, P548; Heeren PAM, 2005, EJSO, V31, P270, DOI 10.1016/j.ejso.2004.12.001; Iclozan C, 2013, CANCER IMMUNOL IMMUN, V62, P909, DOI 10.1007/s00262-013-1396-8; Simon GR, 2011, CANCER CHEMOTH PHARM, V68, P1233, DOI 10.1007/s00280-011-1593-0; Hocevar BA, 1998, MINER ELECTROL METAB, V24, P131, DOI 10.1159/000057360; Eitsuka T, 2005, BBA-MOL CELL BIOL L, V1737, P1, DOI 10.1016/j.bbalip.2005.08.017; McGuill MJ, 2008, DIS ESOPHAGUS, V21, P236, DOI 10.1111/j.1442-2050.2007.00765.x; Fransvea E, 2009, HEPATOLOGY, V49, P839, DOI 10.1002/hep.22731; Cragg GM, 2013, BBA-GEN SUBJECTS, V1830, P3670, DOI 10.1016/j.bbagen.2013.02.008; Jiang WG, 1997, CLIN EXP METASTAS, V15, P593, DOI 10.1023/A:1018435229087; Rabbani SA, 2010, NEOPLASIA, V12, P778, DOI 10.1593/neo.10296; Ling H, 2011, BREAST CANCER RES TR, V126, P609, DOI 10.1007/s10549-010-0929-5; Paland N, 2013, ATHEROSCLEROSIS, V231, P29, DOI 10.1016/j.atherosclerosis.2013.08.016; Buijs JT, 2007, CLIN EXP METASTAS, V24, P609, DOI 10.1007/s10585-007-9118-2; Ling H, 2009, MOL CARCINOGEN, V48, P498, DOI 10.1002/mc.20487; Mueller JD, 2000, CANCER, V89, P1874, DOI 10.1002/1097-0142(20001101)89:9<1874::AID-CNCR2>3.3.CO;2-D; Roberts AB, 2003, P NATL ACAD SCI USA, V100, P8621, DOI 10.1073/pnas.1633291100; Kleer CG, 2001, MODERN PATHOL, V14, P458, DOI 10.1038/modpathol.3880334; Kubota H, 2013, ANTICANCER RES, V33, P4319; Novitskiy SV, 2012, J LEUKOCYTE BIOL, V92, P641, DOI 10.1189/jlb.1211639; Krause G, 2008, BBA-BIOMEMBRANES, V1778, P631, DOI 10.1016/j.bbamem.2007.10.018; Marutsuka T, 2003, CLIN CANCER RES, V9, P678; Forghani P, 2014, CANCER MED-US, V3, P215, DOI 10.1002/cam4.186; Xie YM, 2009, EXPERT OPIN DRUG DEL, V6, P785, DOI 10.1517/17425240903085128; Tatarov O, 2009, CLIN CANCER RES, V15, P3540, DOI 10.1158/1078-0432.CCR-08-1857; Shu LM, 2010, CANCER METAST REV, V29, P483, DOI 10.1007/s10555-010-9239-y; Raina K, 2013, MOL CARCINOGEN, V52, P195, DOI 10.1002/mc.21843; Apte SM, 2004, CLIN CANCER RES, V10, P897, DOI 10.1158/1078-0432.CCR-1151-3; Nagaraj NS, 2010, EXPERT OPIN INV DRUG, V19, P77, DOI 10.1517/13543780903382609; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Fransvea E, 2008, HEPATOLOGY, V47, P1557, DOI 10.1002/hep.22201; Mantel PY, 2011, METHODS MOL BIOL, V677, P303, DOI 10.1007/978-1-60761-869-0_21; Noori S, 2013, IRAN J IMMUNOL, V10, P10, DOI IJIv10i1A2; Myal Y, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/956897; Hong SH, 2013, INT J ONCOL, V42, P277, DOI 10.3892/ijo.2012.1683; Joseph S, 2011, ACTA PHARMACEUT, V61, P335, DOI 10.2478/v10007-011-0030-6; Clezardin P, 2009, CURR CANCER DRUG TAR, V9, P801; Jiang WG, 2000, PROSTAG LEUKOTR ESS, V62, P119, DOI 10.1054/plef.1999.0131; Jiang WG, 1998, CRIT REV ONCOL HEMAT, V27, P179, DOI 10.1016/S1040-8428(98)00003-1; Jin S, 2007, APOPTOSIS, V12, P1317, DOI 10.1007/s10495-007-0062-z; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Ghosh-Choudhury T, 2009, BREAST CANCER RES TR, V118, P213, DOI 10.1007/s10549-008-0227-7; Lee EJ, 2010, PHYTOTHER RES, V24, P1755, DOI 10.1002/ptr.3132; Mohammad KS, 2011, CANCER RES, V71, P175, DOI 10.1158/0008-5472.CAN-10-2651; Du YC, 2012, PHYTOMEDICINE, V19, P788, DOI 10.1016/j.phymed.2012.03.014; Li FN, 2012, INT J CLIN PHARM TH, V50, P712, DOI 10.5414/CP201663; Mazzocca A, 2009, HEPATOLOGY, V50, P1140, DOI 10.1002/hep.23118; Weng CJ, 2012, CANCER METAST REV, V31, P323, DOI 10.1007/s10555-012-9347-y; Kennedy SG, 1997, GENE DEV, V11, P701, DOI 10.1101/gad.11.6.701; Won SY, 2005, J ETHNOPHARMACOL, V96, P555, DOI 10.1016/j.pep.2004.10.009; He WA, 2013, J CLIN INVEST, V123, P4821, DOI 10.1172/JCI68523; Spano D, 2012, CLIN EXP METASTAS, V29, P381, DOI 10.1007/s10585-012-9457-5; Bogdahn U, 2011, NEURO-ONCOLOGY, V13, P132, DOI 10.1093/neuonc/noq142; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Mineharu Y, 2012, NEUROTHERAPEUTICS, V9, P827, DOI 10.1007/s13311-012-0144-7; Al Moustafa AE, 1999, CLIN CANCER RES, V5, P681; Kohno T, 2008, BIOCHEM J, V410, P513, DOI 10.1042/BJ20070665; Suzuki E, 2007, CANCER RES, V67, P2351, DOI 10.1158/0008-5472.CAN-06-2389; Usami Y, 2006, HUM PATHOL, V37, P569, DOI 10.1016/j.humpath.2005.12.018; Wang L, 2007, CELL DEATH DIFFER, V14, P306, DOI 10.1038/sj.cdd.4401996; Jedinak A, 2011, INT J ONCOL, V38, P761, DOI 10.3892/ijo.2011.898; Garrison K, 2012, CANCER IMMUNOL IMMUN, V61, P511, DOI 10.1007/s00262-011-1119-y; GUNTHERT U, 1991, CELL, V65, P13, DOI 10.1016/0092-8674(91)90403-L; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Jeong MH, 2013, ONCOL REP, V30, P1996, DOI 10.3892/or.2013.2660; Wu XY, 2000, P NATL ACAD SCI USA, V97, P4233, DOI 10.1073/pnas.97.8.4233; JONES LMH, 1995, CLIN EXP METASTAS, V13, P373; Cao QZ, 2006, LIFE SCI, V78, P1457, DOI 10.1016/j.lfs.2005.07.017; Davis SJ, 2010, ARCH OTOLARYNGOL, V136, P1260, DOI 10.1001/archoto.2010.219; Agarwal R, 2005, CANCER RES, V65, P7378, DOI 10.1158/0008-5472.CAN-05-1036; Michl P, 2003, CANCER RES, V63, P6265; Miwa N, 2001, ONCOL RES, V12, P469; Cao QZ, 2004, ACTA PHARMACOL SIN, V25, P833; Burgess T, 2006, CANCER RES, V66, P1721, DOI 10.1158/0008-5472.CAN-05-3329; Kortlever RM, 2006, CELL CYCLE, V5, P2697, DOI 10.4161/cc.5.23.3510; Fransvea E, 2011, CANCER CHEMOTH PHARM, V68, P79, DOI 10.1007/s00280-010-1459-x; Singh RP, 2008, CLIN CANCER RES, V14, P7773, DOI 10.1158/1078-0432.CCR-08-1309; Nasiri M, 2013, ASIAN PAC J CANCER P, V14, P3449, DOI 10.7314/APJCP.2013.14.6.3449; Domanska UM, 2012, NEOPLASIA, V14, P709, DOI 10.1593/neo.12324; Martin TA, 2005, ANN SURG ONCOL, V12, P488, DOI 10.1245/ASO.2005.04.010; Jiang WG, 2000, SURG ONCOL, V9, P151, DOI 10.1016/S0960-7404(01)00010-X; Reichert M, 2000, J BIOL CHEM, V275, P9492, DOI 10.1074/jbc.275.13.9492; Wang H, 2010, CURR CANCER DRUG TAR, V10, P593; Chu K, 2013, ONCOTARGET, V4, P446; Katakura Y, 2003, BIOSCI BIOTECH BIOCH, V67, P815; Ochiai K, 2012, BIOORGAN MED CHEM, V20, P1644, DOI 10.1016/j.bmc.2012.01.033; Qiao B, 2010, INT J ONCOL, V37, P663, DOI 10.3892/ijo_00000715; Hawkins RA, 1998, J PATHOL, V185, P61; Dieter SM, 2011, CELL STEM CELL, V9, P357, DOI 10.1016/j.stem.2011.08.010; Weng CJ, 2008, CARCINOGENESIS, V29, P147, DOI 10.1093/carcin/bgm261; Stockinger A, 2001, J CELL BIOL, V154, P1185, DOI 10.1083/jcb.200104036; Sakaguchi T, 2002, J BIOL CHEM, V277, P21361, DOI 10.1074/jbc.M110261200; D'Souza T, 2005, J BIOL CHEM, V280, P26233, DOI 10.1074/jbc.M502003200; Krishnan M, 2010, ONCOGENE, V29, P305, DOI 10.1038/onc.2009.324; Loo D, 2012, CLIN CANCER RES, V18, P3834, DOI 10.1158/1078-0432.CCR-12-0715; Garnero P, 1998, J BIOL CHEM, V273, P32347, DOI 10.1074/jbc.273.48.32347; Akiyama M, 2003, CANCER RES, V63, P18; Ungefroren H, 2011, CURR CANCER DRUG TAR, V11, P524; Singh RP, 2004, MUTAT RES-FUND MOL M, V555, P21, DOI 10.1016/j.mrfmmm.2004.05.017; Kirkwood JM, 2011, CANCER-AM CANCER SOC, V117, P4732, DOI 10.1002/cncr.26068; Rubin MA, 2001, HUM PATHOL, V32, P690, DOI 10.1053/hupa.2001.25902; Wang JH, 2012, J ETHNOPHARMACOL, V139, P582, DOI 10.1016/j.jep.2011.11.055; Calone I., 2012, Experimental Oncology, V34, P9; Gapter L, 2005, BIOCHEM BIOPH RES CO, V332, P1153, DOI 10.1016/j.bbrc.2005.05.044; Van Cutsem E, 2014, CLIN CANCER RES, V20, P4240, DOI 10.1158/1078-0432.CCR-13-2752; Mescoli C, 2006, J CLIN PATHOL, V59, P870, DOI 10.1136/jcp.2005.036350; Shrimali RK, 2010, CANCER RES, V70, P6171, DOI 10.1158/0008-5472.CAN-10-0153; Wu GS, 2012, FITOTERAPIA, V83, P408, DOI 10.1016/j.fitote.2011.12.004; Tang W, 2006, LIFE SCI, V80, P205, DOI 10.1016/j.lfs.2006.09.001; Melisi D, 2008, MOL CANCER THER, V7, P829, DOI 10.1158/1535-7163.MCT-07-0337; Pardini RS, 2006, CHEM-BIOL INTERACT, V162, P89, DOI 10.1016/j.cbi.2006.05.012; Rausch MP, 2009, ANTICANCER RES, V29, P2099; Hsieh YC, 2011, J AGR FOOD CHEM, V59, P10943, DOI 10.1021/jf202771d; Tsai YM, 2011, INTEGR CANCER THER, V10, P341, DOI 10.1177/1534735410384860; Wang JG, 2009, J AGR FOOD CHEM, V57, P10565, DOI 10.1021/jf902597w; Natsugoe S, 1998, CANCER, V83, P858, DOI 10.1002/(SICI)1097-0142(19980901)83:5<858::AID-CNCR9>3.0.CO;2-E; Cintron JR, 1996, SEMIN SURG ONCOL, V12, P267, DOI 10.1002/(SICI)1098-2388(199607/08)12:4<267::AID-SSU6>3.0.CO;2-3; Kim KJ, 2006, CLIN CANCER RES, V12, P1292, DOI 10.1158/1078-0432.CCR-05-1793; Liu Y, 2014, EUR J IMMUNOL, V44, P521, DOI 10.1002/eji.201243291; Schurr PG, 2006, J SURG ONCOL, V94, P307, DOI 10.1002/jso.20582; Li J, 2013, CARCINOGENESIS, V34, P1343, DOI 10.1093/carcin/bgt063; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Sironen RK, 2011, EXP CELL RES, V317, P383, DOI 10.1016/j.yexcr.2010.11.017; Hjelmeland MD, 2004, MOL CANCER THER, V3, P737; Bauerle T, 2011, INT J CANCER, V128, P2453, DOI 10.1002/ijc.25563; Tanaka M, 2005, J BIOL CHEM, V280, P42375, DOI 10.1074/jbc.M503786200; Karagiannis GS, 2014, MOL ONCOL, V8, P178, DOI 10.1016/j.molonc.2013.10.008; Liang CY, 2012, ONCOL REP, V27, P1079, DOI 10.3892/or.2011.1593; Sato F, 2001, BRIT J SURG, V88, P426, DOI 10.1046/j.1365-2168.2001.01687.x; Ilkovitch D, 2009, BLOOD, V113, P4729, DOI 10.1182/blood-2008-08-176438; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Fizazi K, 2011, LANCET, V377, P813, DOI 10.1016/S0140-6736(10)62344-6; Le Gall C, 2007, CANCER RES, V67, P9894, DOI 10.1158/0008-5472.CAN-06-3940; Eynard AR, 1998, PROSTAG LEUKOTR ESS, V59, P371, DOI 10.1016/S0952-3278(98)90098-9; Clay MR, 2010, HEAD NECK-J SCI SPEC, V32, P1195, DOI 10.1002/hed.21315; Wu MH, 2012, J NUTR BIOCHEM, V23, P1434, DOI 10.1016/j.jnutbio.2011.09.004; Jiang JH, 2004, INT J ONCOL, V24, P1093; Kim SA, 2011, CANCER LETT, V306, P197, DOI 10.1016/j.canlet.2011.03.006; Veltman JD, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-464; Vajkoczy P, 2000, INT J CANCER, V87, P261, DOI 10.1002/1097-0215(20000715)87:2<261::AID-IJC18>3.0.CO;2-6; Bachi ALL, 2009, MOL CANCER RES, V7, P1417, DOI 10.1158/1541-7786.MCR-09-0038; Hara T, 2009, N-S ARCH PHARMACOL, V380, P247, DOI 10.1007/s00210-009-0425-9; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Hsieh YC, 2010, CHEM RES TOXICOL, V23, P1256, DOI 10.1021/tx100116a; Dong W, 2012, NUCLEIC ACIDS RES, V40, P2940, DOI 10.1093/nar/gkr1216; Cavallaro U, 2004, ANN NY ACAD SCI, V1014, P58, DOI 10.1196/annals.1294.006; Luo XJ, 2011, EUR J CANCER, V47, P316, DOI 10.1016/j.ejca.2010.09.021; Kauntz H, 2012, APOPTOSIS, V17, P797, DOI 10.1007/s10495-012-0731-4; Ryden L, 2007, EJSO-EUR J SURG ONC, V33, P33, DOI 10.1016/j.ejso.2006.11.007; Cui FJ, 2007, TOXICOL IN VITRO, V21, P417, DOI 10.1016/j.tiv.2006.10.004; Piva MR, 2013, ONCOL LETT, V5, P1909, DOI 10.3892/ol.2013.1302; Hwang YP, 2011, MOL NUTR FOOD RES, V55, P594, DOI 10.1002/mnfr.201000292; Chao YC, 2009, AM J RESP CRIT CARE, V179, P123, DOI 10.1164/rccm.200803-456OC; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Pecheur I, 2002, FASEB J, V16, P1266, DOI 10.1096/fj.01-0911fje; Kantak SS, 1998, J BIOL CHEM, V273, P16953, DOI 10.1074/jbc.273.27.16953; HILDENBRAND R, 1995, PATHOL RES PRACT, V191, P403; Ponnala S, 2011, CELL SIGNAL, V23, P2065, DOI 10.1016/j.cellsig.2011.08.001; Lee SY, 2012, CANCER RES, V72, P3607, DOI 10.1158/0008-5472.CAN-12-0006; Chen JZ, 2013, ANTI-CANCER AGENT ME, V13, P725; Sweeney P, 2002, CLIN CANCER RES, V8, P2714; French AD, 2009, INT J MED SCI, V6, P93; Ward KK, 2013, CLIN EXP METASTAS, V30, P579, DOI 10.1007/s10585-012-9562-5; Singh RP, 2008, CANCER RES, V68, P2043, DOI 10.1158/0008-5472.CAN-07-6247; CUNLIFFE WJ, 1989, BRIT J SURG, V76, P1082, DOI 10.1002/bjs.1800761030; Baik JS, 2012, INDIAN J BIOCHEM BIO, V49, P86; Rubin JB, 2003, P NATL ACAD SCI USA, V100, P13513, DOI 10.1073/pnas.2235846100; Gottardi CJ, 2001, J CELL BIOL, V153, P1049, DOI 10.1083/jcb.153.5.1049; Chen NH, 2008, J PHARMACOL SCI, V108, P212, DOI 10.1254/jphs.SC0080019; Gopalakrishnan S, 2008, MUTAT RES-FUND MOL M, V647, P30, DOI 10.1016/j.mrfmmm.2008.08.006; Morita K, 1999, J CELL BIOL, V145, P579, DOI 10.1083/jcb.145.3.579; Ebihara C, 2006, J PHARMACOL EXP THER, V316, P255, DOI 10.1124/jpet.105.093351; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Dastpeyman M, 2012, MED ONCOL, V29, P2512, DOI 10.1007/s12032-011-0113-8; Lee HH, 2013, INT J ONCOL, V42, P1036, DOI 10.3892/ijo.2013.1762; Tedelind S, 2003, EUR J ENDOCRINOL, V149, P215, DOI 10.1530/eje.0.1490215; Lv ZD, 2012, INT J MOL MED, V29, P373, DOI 10.3892/ijmm.2011.852; Schittenhelm MM, 2006, CANCER RES, V66, P473, DOI 10.1158/0008-5472.CAN-05-2050; Lu KH, 2004, CLIN CANCER RES, V10, P3291, DOI 10.1158/1078-0432.CCR-03-0409; Santini D, 2011, J CELL PHYSIOL, V226, P780, DOI 10.1002/jcp.22402; Dizaji MZ, 2012, NEUROCHEM RES, V37, P370, DOI 10.1007/s11064-011-0620-1; Liu J, 2007, BIOORGAN MED CHEM, V15, P4966, DOI 10.1016/j.bmc.2007.04.036; Chen Y, 2010, J AGR FOOD CHEM, V58, P11645, DOI 10.1021/jf1028976; Shin DY, 2011, ONCOL REP, V25, P567, DOI 10.3892/or.2010.1104; Rao YK, 2011, CHEM RES TOXICOL, V24, P238, DOI 10.1021/tx100318m; Jiang WG, 2013, ONCOL REP, V30, P1405, DOI 10.3892/or.2013.2586; Liu RM, 2011, PHYTOMEDICINE, V18, P349, DOI 10.1016/j.phymed.2010.08.019; Miyamori H, 2001, J BIOL CHEM, V276, P28204, DOI 10.1074/jbc.M103083200; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Mittendorf EA, 2008, ANN SURG ONCOL, V15, P3369, DOI 10.1245/s10434-008-0153-2; Jeong JW, 2011, TOXICOL IN VITRO, V25, P817, DOI 10.1016/j.tiv.2011.02.001; Rosenberg R, 2004, INT J COLORECTAL DIS, V19, P430, DOI 10.1007/s00384-003-0559-z; Tamura A, 2008, GASTROENTEROLOGY, V134, P523, DOI 10.1053/j.gastro.2007.11.040; Rosano L, 2011, CLIN CANCER RES, V17, P2350, DOI 10.1158/1078-0432.CCR-10-2325; Sauer T, 2005, CYTOPATHOLOGY, V16, P193, DOI 10.1111/j.1365-2303.2005.00257.x; Gilmore AP, 1996, MOL BIOL CELL, V7, P1209; Mon NN, 2006, ANN NY ACAD SCI, V1086, P199, DOI 10.1196/annals.1377.019; Singh AB, 2004, J BIOL CHEM, V279, P3543, DOI 10.1074/jbc.M308682200; Findley MK, 2009, IUBMB LIFE, V61, P431, DOI 10.1002/iub.175; Manzoni M, 2010, ONCOLOGY-BASEL, V79, P187, DOI 10.1159/000320609; Veshnyakova A, 2012, J BIOL CHEM, V287, P1698, DOI 10.1074/jbc.M111.312165; Park S, 2010, CANCER CELL, V18, P160, DOI 10.1016/j.ccr.2010.06.014; Jeong JW, 2012, INT J ONCOL, V40, P1697, DOI 10.3892/ijo.2012.1332; Battle E., 2000, NAT CELL BIOL, V2, P84; Cheng KC, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-411; Chinn SB, 2014, HEAD NECK; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Creighton Chad J, 2013, Cancer Manag Res, V5, P187, DOI 10.2147/CMAR.S35171; Deep G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034630; DELCASTILLO CF, 1993, HEPATO-GASTROENTEROL, V40, P430; Dong YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083789; Ebrahimnezhad Zohreh, 2013, Bioimpacts, V3, P67, DOI 10.5681/bi.2013.005; Edge SB, 2009, ESOPHAGUS ESOPHAGOGA; Ganapathy V, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-122; GARRISON RN, 1986, ANN SURG, V203, P644, DOI 10.1097/00000658-198606000-00009; Geng LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059918; Georgopoulos NT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013621; Gonzalez-Mariscal L, 2007, PROG HISTOCHEM CYTO, V42, P1, DOI 10.1016/j.proghi.2007.01.001; Guarino M, 2007, INT J BIOCHEM CELL B, V39, P2153, DOI 10.1016/j.biocel.2007.07.011; Haider SK, 2005, NEOPLASIA, V7, P509; Hallett MA, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3385; Han Sung-Soo Ronald, 2009, J Acupunct Meridian Stud, V2, P218, DOI 10.1016/S2005-2901(09)60058-3; Harada K, 2012, INT J ONCOL, V37, P623; Hsu JW, 2011, EVID-BASED COMPL ALT, V2011; Hull Mark A, 2013, Recent Results Cancer Res, V191, P143, DOI 10.1007/978-3-642-30331-9_8; Ivina A A, 2014, Stomatologiia (Mosk), V93, P31; Izbicki JR, 1997, NEW ENGL J MED, V337, P1188, DOI 10.1056/NEJM199710233371702; Jean C, 2014, J CELL BIOL, V204, P247, DOI 10.1083/jcb.201307067; Jing Y, 2011, CELL BIOSCI, V1, P29; Junxia Wei, 2010, Cancer Sci, V101, P1790, DOI 10.1111/j.1349-7006.2010.01594.x; Kang Moon-Il, 2012, Genes Cancer, V3, P37, DOI 10.1177/1947601912448820; Le NH, 2008, BRIT J CANCER, V98, P1886, DOI 10.1038/sj.bjc.6604401; Lee SJ, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-99; Lirdprapamongkol K, 2009, J AGR FOOD CHEM, V57, P3055, DOI 10.1021/jf803366f; Lu J, 2014, PHYTOTHER RES, V28, P200, DOI 10.1002/ptr.4980; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Miyake JA, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-8; MORTON DL, 1992, ARCH SURG-CHICAGO, V127, P392; Mowla SN, 2013, ONCOTARGETS THER, V6, P1221, DOI 10.2147/OTT.S36160; Nakabayashi H, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-339; Ridolfi L, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-135; Nikolakopoulou Zacharoula, 2013, Carcinogenesis, V34, P2716, DOI 10.1093/carcin/bgt257; O'Sullivan S, 2014, BBA-MOL CELL RES, V1843, P603, DOI 10.1016/j.bbamcr.2013.12.006; Oh Jung Young, 2008, J Microbiol Biotechnol, V18, P512; Paget S, 1889, LANCET, V133, P571, DOI DOI 10.1016/S0140-6736(00)49915-0; Pyo P, 2008, J HEMATOL ONCOL, V1, DOI 10.1186/1756-8722-1-25; Radwan FF, 2011, J CLIN CELL IMMUNO S, VS3, P4; Resnick MB, 2005, MODERN PATHOL, V18, P511, DOI 10.1038/modpathol.3800301; Santini D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019234; Sasaki T, 2013, PATHOBIOLOGY, V81, P36, DOI 10.1159/000351721; Shi XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064266; Shiozaki A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038049; Sliva D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047873; Soini Y, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-70; Su RJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-20; Suarez-Arroyo IJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057431; Tafreshi NK, 2010, CANCER RES, V71, P1050; Turner CE, 2000, NAT CELL BIOL, V2, pE231, DOI 10.1038/35046659; Vander B. R., 2014, ORAL ONCOL, V50, P930; Vazquez-Sequeiros E, 2002, GASTROENTEROLOGY, V122, P1815, DOI 10.1053/gast.2002.33665; Wang Z, 2015, SEMIN CANC BIOL; Watanabe T, 2012, J OVARIAN RES, V5, DOI 10.1186/1757-2215-5-7; Wells A, 2013, TRENDS PHARMACOL SCI, V34, P283, DOI 10.1016/j.tips.2013.03.001; Wu Jian Yong, 2007, Phytomedicine, V14, P43, DOI 10.1016/j.phymed.2005.11.005; Xu WW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034406; Meng HZ, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-160; Yang L, 2010, CANCER METAST REV, V29, P263, DOI 10.1007/s10555-010-9226-3; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yang SP, 1998, J CELL PHYSIOL, V176, P342, DOI 10.1002/(SICI)1097-4652(199808)176:2<342::AID-JCP12>3.0.CO;2-5; Ye M, 2007, CANCER LETT, V258, P199, DOI 10.1016/j.canlet.2007.09.001; Zhang HR, 2013, J INT MED RES, V41, P584, DOI 10.1177/0300060513480920; Yao WL, 2014, ANTI-CANCER AGENT ME, V14, P29; Yao XY, 2012, PLANTA MED, V78, P1740, DOI 10.1055/s-0032-1315303; Xu YB, 2013, EUR REV MED PHARMACO, V17, P2486; Yaccoby S, 2007, BLOOD, V109, P2106, DOI 10.1182/blood-2006-09-047712; Ye M, 2005, FEBS LETT, V579, P3437, DOI 10.1016/j.febslet.2005.05.013; Zaidi SK, 2004, EMBO J, V23, P790, DOI 10.1038/sj.emboj.7600073; Zschiesche W, 1997, ANTICANCER RES, V17, P561; Yoshikawa N, 2008, N-S ARCH PHARMACOL, V377, P591, DOI 10.1007/s00210-007-0218-y; Yakymovych I, 2002, BIOCHEMISTRY-US, V41, P11000, DOI 10.1021/bi025936u; Zhang M, 2006, ONCOL REP, V15, P637; Yamauchi K, 2004, P NATL ACAD SCI USA, V101, P4690, DOI 10.1073/pnas.0306924101; Zhang BX, 2009, CANCER LETT, V277, P114, DOI 10.1016/j.canlet.2008.11.035; Zollo M, 2012, CLIN EXP METASTAS, V29, P585, DOI 10.1007/s10585-012-9473-5; Ye L, 2012, ANTICANCER RES, V32, P2537; Zhao ZQ, 2014, CANCER LETT, V342, P150, DOI 10.1016/j.canlet.2013.08.042; Yukawa H, 2012, BIOL PHARM BULL, V35, P1014, DOI 10.1248/bpb.b110657; Zingg U, 2009, EJSO-EUR J SURG ONC, V35, P593, DOI 10.1016/j.ejso.2008.12.001; Zubeldia IG, 2013, EXP CELL RES, V319, P12, DOI 10.1016/j.yexcr.2012.11.004; Yu CC, 2012, J NUTR BIOCHEM, V23, P900, DOI 10.1016/j.jnutbio.2011.04.015; Yang JC, 2009, CANCER RES, V69, P151, DOI 10.1158/0008-5472.CAN-08-0442; Zhang HF, 2004, LEUKEMIA LYMPHOMA, V45, P1887, DOI 10.1080/10428190410001712225; Yeh CT, 2009, CANCER LETT, V285, P73, DOI 10.1016/j.canlet.2009.05.002; Zhu XL, 2005, ACTA PHARMACOL SIN, V26, P1130, DOI 10.1111/j.1745-7254.2005.00171.x; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Zhang MX, 2011, NEOPLASIA, V13, P537, DOI 10.1593/neo.11258; Yingling JM, 2004, NAT REV DRUG DISCOV, V3, P1011, DOI 10.1038/nrd1580; Yang JY, 2005, PATHOL RES PRACT, V201, P745, DOI 10.1016/j.prp.2005.08.007; Yeh CT, 2013, CARCINOGENESIS, V34, P2918, DOI 10.1093/carcin/bgt255; Zhang JA, 2011, NEOPLASIA, V13, P23, DOI 10.1593/neo.10728; Yoo YD, 1999, INT J CANCER, V83, P512, DOI 10.1002/(SICI)1097-0215(19991112)83:4<512::AID-IJC13>3.0.CO;2-Z; Zhao SF, 2011, INT J ONCOL, V38, P1319, DOI 10.3892/ijo.2011.965; Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023; Yousefi M, 2012, NEUROCHEM RES, V37, P2053, DOI 10.1007/s11064-012-0827-9; Yang YJ, 2014, CANCER BIOL THER, V15, P99, DOI 10.4161/cbt.26718; Yekebas EF, 2006, J SURG ONCOL, V93, P541, DOI 10.1002/jso.20544; Zhao YY, 2011, BBA-GEN SUBJECTS, V1810, P384, DOI 10.1016/j.bbagen.2010.12.005; Zimmerman ZF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069593	542	2	2	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1044-579X			SEMIN CANCER BIOL	Semin. Cancer Biol.	DEC	2015	35			S			S244	S275		10.1016/j.semcancer.2015.03.008		32	Oncology	Oncology	CY7WG	WOS:000366619400012		
J	Mohammad, RM; Muqbil, I; Lowe, L; Yedjou, C; Hsu, HY; Lin, LT; Siegelin, MD; Fimognari, C; Kumar, NB; Dou, QP; Yang, HJ; Samadi, AK; Russo, GL; Spagnuolo, C; Ray, SK; Chakrabarti, M; Morre, JD; Coley, HM; Honoki, K; Fujii, H; Georgakilas, AG; Amedei, A; Niccolai, E; Amin, A; Ashraf, SS; Helferich, WG; Yang, XJ; Boosani, CS; Guha, G; Bhakta, D; Ciriolo, MR; Aquilano, K; Chen, S; Mohammed, SI; Keith, WN; Bilsland, A; Halicka, D; Nowsheen, S; Azmi, AS				Mohammad, Ramzi M.; Muqbil, Irfana; Lowe, Leroy; Yedjou, Clement; Hsu, Hsue-Yin; Lin, Liang-Tzung; Siegelin, Markus David; Fimognari, Carmela; Kumar, Nagi B.; Dou, Q. Ping; Yang, Huanjie; Samadi, Abbas K.; Russo, Gian Luigi; Spagnuolo, Carmela; Ray, Swapan K.; Chakrabarti, Mrinmay; Morre, James D.; Coley, Helen M.; Honoki, Kanya; Fujii, Hiromasa; Georgakilas, Alexandros G.; Amedei, Amedeo; Niccolai, Elena; Amin, Amr; Ashraf, S. Salman; Helferich, William G.; Yang, Xujuan; Boosani, Chandra S.; Guha, Gunjan; Bhakta, Dipita; Ciriolo, Maria Rosa; Aquilano, Katia; Chen, Sophie; Mohammed, Sulma I.; Keith, W. Nicol; Bilsland, Alan; Halicka, Dorota; Nowsheen, Somaira; Azmi, Asfar S.			Broad targeting of resistance to apoptosis in cancer	SEMINARS IN CANCER BIOLOGY			English	Review						Apoptosis; Necrosis; Autophagy; Apoptosis evasion; Nuclear transporters, natural chemopreventive agents	CHRONIC LYMPHOCYTIC-LEUKEMIA; GROWTH-FACTOR-RECEPTOR; AUTOPHAGIC CELL-DEATH; GREEN TEA POLYPHENOLS; MALIGNANT GLIOMA-CELLS; HUMAN-MELANOMA CELLS; HUMAN BREAST-CANCER; SHOCK-PROTEIN 90; EPITHELIAL-MESENCHYMAL TRANSITION; PANCREATIC ADENOCARCINOMA CELLS	Apoptosis or programmed cell death is natural way of removing aged cells from the body. Most of the anticancer therapies trigger apoptosis induction and related cell death networks to eliminate malignant cells. However, in cancer, de-regulated apoptotic signaling, particularly the activation of an anti-apoptotic systems, allows cancer cells to escape this program leading to uncontrolled proliferation resulting in tumor survival, therapeutic resistance and recurrence of cancer. This resistance is a complicated phenomenon that emanates from the interactions of various molecules and signaling pathways. In this comprehensive review we discuss the various factors contributing to apoptosis resistance in cancers. The key resistance targets that are discussed include (1) BcI-2 and Mcl-1 proteins; (2) autophagy processes; (3) necrosis and necroptosis; (4) heat shock protein signaling; (5) the proteasome pathway; (6) epigenetic mechanisms; and (7) aberrant nuclear export signaling. The shortcomings of current therapeutic modalities are highlighted and a broad spectrum strategy using approaches including (a) gossypol; (b) epigallocatechin-3-gallate; (c) UMI-77 (d) triptolide and (e) selinexor that can be used to overcome cell death resistance is presented. This review provides a roadmap for the design of successful anti-cancer strategies that overcome resistance to apoptosis for better therapeutic outcome in patients with cancer. (C) 2015 Elsevier Ltd.	[Mohammad, Ramzi M.; Muqbil, Irfana; Dou, Q. Ping; Azmi, Asfar S.] Wayne State Univ, Karmanos Canc Inst, Dept Oncol, Detroit, MI 48201 USA; [Mohammad, Ramzi M.] Hamad Med Corp, Interim translat Res Inst, Doha, Qatar; [Lowe, Leroy] Getting Know Canc, Truro, NS, Canada; [Yedjou, Clement] Jackson State Univ, C SET, Jackson, MS USA; [Hsu, Hsue-Yin] Tzu Chi Univ, Dept Life Sci, Hualien, Taiwan; [Lin, Liang-Tzung] Taipei Med Univ, Coll Med, Sch Med, Dept Microbiol & Immunol, Taipei, Taiwan; [Siegelin, Markus David] Columbia Univ, Dept Pathol & Cell Biol, New York, NY USA; [Fimognari, Carmela] Univ Bologna, Dipartimento Sci Qualita Vita Alma Mater Studioru, I-40126 Bologna, Italy; [Kumar, Nagi B.] Univ S Florida, Coll Med, Moffit Canc Ctr, Tampa, FL USA; [Dou, Q. Ping] Karmanos Canc Inst, Dept Pharmacol & Pathol, Detroit, MI USA; [Yang, Huanjie] Harbin Inst Technol, Sch Life Sci & Technol, Harbin 150006, Heilongjiang, Peoples R China; [Samadi, Abbas K.] Sanus Biosci, San Diego, CA USA; [Russo, Gian Luigi; Spagnuolo, Carmela] CNR, Inst Food Sci, Avellino, Italy; [Ray, Swapan K.; Chakrabarti, Mrinmay] Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC USA; [Morre, James D.] Mor NuCo Inc, Purdue Res Pk, W Lafayette, IN USA; [Coley, Helen M.] Univ Surrey, Fac Hlth & Med Sci, Guildford GU2 5XH, Surrey, England; [Honoki, Kanya; Fujii, Hiromasa] Nara Med Univ, Dept Orthopaed Surg, Kashihara, Nara 634, Japan; [Georgakilas, Alexandros G.] Natl Tech Univ Athens, Sch Appl Math & Phys Sci, Dept Phys, Athens 15780, Greece; [Amedei, Amedeo; Niccolai, Elena] Univ Florence, Dept Expt & Clin Med, I-50121 Florence, Italy; [Amin, Amr] UAE Univ, Coll Sci, Dept Biol, Al Ain, U Arab Emirates; [Amin, Amr] Cairo Univ, Fac Sci, Cairo, Egypt; [Ashraf, S. Salman] UAE Univ, Coll Sci, Dept Chem, Al Ain, U Arab Emirates; [Helferich, William G.; Yang, Xujuan] Univ Illinois, Dept Food Sci & Human Nutr, Urbana, IL 61801 USA; [Boosani, Chandra S.] Creighton Univ, Sch Med, Dept Biomed Sci, Omaha, NE USA; [Guha, Gunjan; Bhakta, Dipita] SASTRA Univ, Sch Chem & Bio Technol, Thanjavur, India; [Ciriolo, Maria Rosa; Aquilano, Katia] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy; [Chen, Sophie] Ovarian & Prostate Canc Res Trust Lab, Guildford, Surrey, England; [Mohammed, Sulma I.] Dept Comparat Pathobiol, W Lafayette, IN USA; [Mohammed, Sulma I.] Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA; [Keith, W. Nicol; Bilsland, Alan] Univ Glasgow, Inst Canc Sci, Glasgow, Lanark, Scotland; [Halicka, Dorota] New York Med Coll, Dept Pathol, Valhalla, NY 10595 USA; [Nowsheen, Somaira] Mayo Clin, Med Scientist Training Program, Mayo Med Sch, Mayo Grad Sch, Rochester, MN USA	Mohammad, RM (reprint author), Wayne State Univ, Karmanos Canc Inst, Dept Oncol, 732 HWCRC Bldg, Detroit, MI 48201 USA.	mohammar@karmanos.org	Keith, Nicol/D-3325-2009	Keith, Nicol/0000-0001-7862-3580	NIH [R21 1R21CA16984801, 1R21CA17597401, 1 R21 CA188818 01A1]; Scientific Research Foundation for the Returned Oversea Scholars; State Education Ministry and Scientific and Technological Innovation Project, Harbin [2012RFLXS011]; NIH/NCI [1R01CA20009, 5R01CA127258-05, R21CA184788, NIH P30 CA22453]; Ministry of Science and Technology of Taiwan [NSC93-2314-B-320-006, NSC94-2314-B-320-002]; Taipei Medical University NIH Grant [TMU101-AE3-Y19, K08 NS083732]; Ministero dell'Istruzione dell'Universita e della Ricerca [200974K3JC]; EU [MC-CIG-303514]; Greek National funds through the Operational Program 'Educational and Lifelong Learning of the National Strategic Reference Framework (NSRF)-Research Funding Program: THALES [MIS 379346]; COST Action CM1201 'Biomimetic Radical Chemistry'; National Institute of Health - National Cancer Institute [R01 CA12060-01A1]; United Soybean Board (USB Chesterfield, M, United States); AI-Jalila Foundation; Zayed Center for Health Sciences; Terry Fox Foundation; NIH grant through the RCMI-Center for Environmental Health at Jackson State University [5G12RR013459-13]	NIH Grants R21 1R21CA16984801 and 1R21CA17597401 to RMM is acknowledged. This work was partially supported by the Scientific Research Foundation for the Returned Oversea Scholars and State Education Ministry and Scientific and Technological Innovation Project, Harbin (2012RFLXS011 to HJ Yang), and NIH/NCI (1R01CA20009, 5R01CA127258-05 and R21CA184788 to Q.P. Dou, and NIH P30 CA22453 to Karmanos Cancer Institute). HY Hsu was funded by grants from the Ministry of Science and Technology of Taiwan (NSC93-2314-B-320-006 and NSC94-2314-B-320-002) and LT Lin was supported by a grant from Taipei Medical University (TMU101-AE3-Y19) NIH Grant K08 NS083732 to MDS is acknowledged. Dr. Gian Luigi Russo acknowledges the Fulbright Research Scholar program 2013-14. Work in CF's lab described here was supported by Ministero dell'Istruzione dell'Universita e della Ricerca (grant number: 200974K3JC). Dr. Clement G. Yedjou acknowledges NIH grant 5G12RR013459-13 through the RCMI-Center for Environmental Health at Jackson State University. Dr. Georgakilas was supported by an EU Marie Curie Reintegration Grant MC-CIG-303514, Greek National funds through the Operational Program 'Educational and Lifelong Learning of the National Strategic Reference Framework (NSRF)-Research Funding Program: THALES (Grant number MIS 379346) and COST Action CM1201 'Biomimetic Radical Chemistry'. The work reported by Nagi B. Kumar was funded by the National Institute of Health - National Cancer Institute R01 CA12060-01A1. Work in Carmela Famignori's lab described here was supported by Ministero dell'Istruzione dell'Universita e della Ricerca (grant number: 200974K3JC). Dr. Swapan K Ray and Mrinmay Chakrabarti acknowledge the support by United Soybean Board (USB Chesterfield, M, United States). The USB had no involvement in the writing of the manuscript or the decision to submit the manuscript for publication. Amr Amin was supported partially by Ai-Jalila Foundation 2015, Zayed Center for Health Sciences 2015, and Terry Fox Foundation 2014. NIH grant 1 R21 CA188818 01A1 to Asfar Azmi is acknowledged.	ADHAMI V. M., 2003, J NUTR, V133, P2417; Ajabnoor GMA, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.139; Wu PP, 2011, ONCOL REP, V25, P551, DOI 10.3892/or.2010.1080; Wanka C, 2012, ONCOGENE, V31, P3764, DOI 10.1038/onc.2011.530; Choan E, 2005, UROL ONCOL-SEMIN ORI, V23, P108, DOI 10.1016/j.urolonc.2004.10.008; Moon DO, 2008, FEBS LETT, V582, P3367, DOI 10.1016/j.febslet.2008.08.029; Huang TT, 2009, NEUROTHERAPEUTICS, V6, P500, DOI 10.1016/j.nurt.2009.04.008; Chen S, 2002, J DENT RES, V81, P98; Grossman SA, 2010, CLIN CANCER RES, V16, P2443, DOI 10.1158/1078-0432.CCR-09-3106; Zhang XQ, 2010, ASIAN J ANDROL, V12, P697, DOI 10.1038/aja.2010.57; Sha WX, 2013, INT J CANCER, V133, P1578, DOI 10.1002/ijc.28181; Yang SM, 2003, MOL CANCER THER, V2, P65; Capparelli C, 2012, CELL CYCLE, V11, P2285, DOI 10.4161/cc.20718; Barkla DH, 1999, PATHOLOGY, V31, P230; Das A, 2008, CANCER INVEST, V26, P352, DOI 10.1080/07357900701788080; Coley HM, 2012, BRIT J CANCER, V106, P482, DOI 10.1038/bjc.2011.566; Gray-Schopfer VC, 2005, CANCER METAST REV, V24, P165, DOI 10.1007/s10555-005-5865-1; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Lenardo MJ, 2002, J VIROL, V76, P5082, DOI 10.1128/JVI.76.10.5082-5093.2002; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Kang BH, 2007, CELL, V131, P257, DOI 10.1016/j.cell.2007.08.028; Xu DR, 2010, CURR OPIN STRUC BIOL, V20, P782, DOI 10.1016/j.sbi.2010.09.008; Siegelin MD, 2013, CANCER LETT, V333, P133, DOI 10.1016/j.canlet.2013.01.045; Roach HI, 2000, J BONE JOINT SURG BR, V82B, P601, DOI 10.1302/0301-620X.82B4.9846; Bushunow P, 1999, J NEURO-ONCOL, V43, P79, DOI 10.1023/A:1006267902186; Panischeva LA, 2011, BIOCHEMISTRY-MOSCOW+, V76, P1009, DOI 10.1134/S0006297911090045; He CC, 2013, CELL, V154, P1085, DOI 10.1016/j.cell.2013.07.035; Souers AJ, 2013, NAT MED, V19, P202, DOI 10.1038/nm.3048; Chang CM, 2012, ONCOL REP, V28, P1799, DOI 10.3892/or.2012.1991; Fimognari C, 2006, MUTAT RES-FUND MOL M, V601, P92, DOI 10.1016/j.mrfmmm.2006.06.001; Fischer DC, 2004, ONCOL REP, V11, P1085; Qin JZ, 2010, BIOCHEM BIOPH RES CO, V401, P293, DOI 10.1016/j.bbrc.2010.09.054; Nakagami H, 2002, ARTERIOSCL THROM VAS, V22, P238, DOI 10.1161/hq0202.104001; Chang CP, 2013, AUTOPHAGY, V9, P619, DOI 10.4161/auto.23546; Shin EA, 2014, ONCOTARGET, V5, P5624; Hoffmann J, 2011, BIOCHEM PHARMACOL, V82, P1153, DOI 10.1016/j.bcp.2011.07.063; Yin Y, 2013, INT J ONCOL, V42, P253, DOI 10.3892/ijo.2012.1691; Zhu S, 2013, ASIAN PAC J CANCER P, V14, P5687, DOI 10.7314/APJCP.2013.14.10.5687; Edmond V, 2011, EMBO J, V30, P510, DOI 10.1038/emboj.2010.333; Deng J, 2007, CANCER RES, V67, P11867, DOI 10.1158/0008-5472.CAN-07-1961; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; Balakumaran BS, 2010, AUTOPHAGY, V6, P281, DOI 10.1158/0008-5472.CAN-09-0910; Nor JE, 2001, CANCER RES, V61, P2183; Edmond V, 2011, CELL CYCLE, V10, P1968, DOI 10.4161/cc.10.12.15825; Marquez RT, 2012, AM J CANCER RES, V2, P214; Jiang JH, 2004, ANTICANCER RES, V24, P91; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Geisler S, 2001, CANCER RES, V61, P2505; Deng YT, 2011, J AGR FOOD CHEM, V59, P13318, DOI 10.1021/jf204149c; Farrand L, 2013, J BIOL CHEM, V288, P23740, DOI 10.1074/jbc.M113.487686; Pang XF, 2011, MOL CANCER THER, V10, P795, DOI 10.1158/1535-7163.MCT-10-0936; Lopez PLC, 2012, ONCOLOGY-BASEL, V83, P75, DOI 10.1159/000337978; Robertson LE, 1996, LEUKEMIA, V10, P456; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chandarlapaty S, 2010, ONCOGENE, V29, P325, DOI 10.1038/onc.2009.337; Etchin J, 2013, LEUKEMIA, V27, P66, DOI 10.1038/leu.2012.219; Laurie SA, 2005, CANCER CHEMOTH PHARM, V55, P33, DOI 10.1007/s00280-004-0859-1; Fornerod Maarten, 2002, Results Probl Cell Differ, V35, P67; Glasspool RM, 2006, BRIT J CANCER, V94, P1087, DOI 10.1038/sj.bjc.6603024; Newlands ES, 1996, BRIT J CANCER, V74, P648, DOI 10.1038/bjc.1996.415; Murdoch W J, 1999, J Reprod Fertil Suppl, V54, P353; Jesenberger V, 2002, NAT REV MOL CELL BIO, V3, P112, DOI 10.1038/nrm731; Zhang KJ, 2013, EXP HEMATOL, V41, P67, DOI 10.1016/j.exphem.2012.09.002; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Qi XJ, 2006, J BIOL CHEM, V281, P813, DOI 10.1074/jbc.M505546200; Sharma N, 2012, CANCER LETT, V326, P143, DOI 10.1016/j.canlet.2012.07.029; Jodoin J, 2002, BBA-MOL CELL RES, V1542, P149, DOI 10.1016/S0167-4889(01)00175-6; Boldogh I, 2003, TOXICOLOGY, V193, P137, DOI 10.1016/j.tox.2003.08.013; Dodou K, 2005, EXPERT OPIN INV DRUG, V14, P1419, DOI 10.1517/13543784.14.11.1419; Karami H, 2014, ASIAN PAC J CANCER P, V15, P629, DOI 10.7314/APJCP.2014.15.2.629; Tsuruo T, 2003, CANCER SCI, V94, P15, DOI 10.1111/j.1349-7006.2003.tb01345.x; Fimognari C, 2012, MUTAT RES-REV MUTAT, V750, P107, DOI 10.1016/j.mrrev.2011.12.001; Quinn BA, 2011, EXPERT OPIN INV DRUG, V20, P1397, DOI 10.1517/13543784.2011.609167; Chung JY, 1999, CANCER RES, V59, P4610; Xu N, 2012, BIOCHEM BIOPH RES CO, V423, P826, DOI 10.1016/j.bbrc.2012.06.048; Schneider R, 2007, GENE DEV, V21, P3027, DOI 10.1101/gad.1604607; Haas-Kogan DA, 2005, J NATL CANCER I, V97, P880, DOI 10.1093/jnci/dji161; Azmi AS, 2013, HAEMATOLOGICA, V98, P1098, DOI 10.3324/haematol.2012.074781; Oikawa T, 1998, BIOCHEM BIOPH RES CO, V246, P243, DOI 10.1006/bbrc.1998.8604; Kareva I, 2013, CANCER RES, V73, P2737, DOI 10.1158/0008-5472.CAN-12-3696; Lowman HB, 1996, J BIOL CHEM, V271, P14344; Chen N, 2013, ONCOGENE, V32, P2543, DOI 10.1038/onc.2012.277; Sprouse AA, 2014, ANTICANCER RES, V34, P5363; Wang ZW, 2009, CANCER RES, V69, P2757, DOI 10.1158/0008-5472.CAN-08-3060; Rosenfeldt MT, 2013, NATURE, V504, P296, DOI 10.1038/nature12865; Gupta SC, 2013, BIOFACTORS, V39, P2, DOI 10.1002/biof.1079; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Valenti D, 2013, BBA-MOL BASIS DIS, V1832, P2085, DOI 10.1016/j.bbadis.2013.07.014; Forman HJ, 2014, FREE RADICAL BIO MED, V66, P24, DOI 10.1016/j.freeradbiomed.2013.05.045; Kaminskyy VO, 2012, AUTOPHAGY, V8, P1032, DOI 10.4161/auto.20123; Mayer P, 2012, ENDOCR-RELAT CANCER, V19, P217, DOI 10.1530/ERC-11-0227; Davenport A, 2010, INT J MOL MED, V25, P465, DOI 10.3892/ijmm_00000366; Shen M, 2013, EXPERT OPIN THER TAR, V17, P1091, DOI 10.1517/14728222.2013.815728; Chook YM, 2011, BBA-MOL CELL RES, V1813, P1593, DOI 10.1016/j.bbamcr.2010.10.014; Pacak K, 2012, INT J CANCER, V131, P2445, DOI 10.1002/ijc.27524; Marfori M, 2012, TRAFFIC, V13, P532, DOI 10.1111/j.1600-0854.2012.01329.x; Billard C, 2002, LEUKEMIA LYMPHOMA, V43, P1991, DOI 10.1080/1042819021000015952; Baguley BC, 2010, MOL BIOTECHNOL, V46, P308, DOI 10.1007/s12033-010-9321-2; Wolter KG, 2006, NEOPLASIA, V8, P163, DOI 10.1593/neo.05691; Tinhofer I, 1998, BLOOD, V91, P4273; Azmi AS, 2009, J CELL PHYSIOL, V218, P13, DOI 10.1002/jcp.21567; Zhang XN, 2012, J MED VIROL, V84, P272, DOI 10.1002/jmv.22267; Roman V, 2002, BRIT J HAEMATOL, V117, P842, DOI 10.1046/j.1365-2141.2002.03520.x; Garcia-Caballero M, 2014, MAR DRUGS, V12, P279, DOI 10.3390/md12010279; Masuda Y, 2004, J BIOL CHEM, V279, P42503, DOI 10.1074/jbc.M404256200; Hsu A, 2011, J NUTR BIOCHEM, V22, P502, DOI 10.1016/j.jnutbio.2010.04.006; Trisciuoglio D, 2005, MOL BIOL CELL, V16, P4153, DOI 10.1091/mbc.E04-12-1087; Liang M, 2008, CANCER LETT, V270, P337, DOI 10.1016/j.canlet.2008.05.025; Hsu YC, 2011, J CELL PHYSIOL, V226, P2721, DOI 10.1002/jcp.22623; Skandalis SS, 2012, CURR MOL MED, V12, P1068; Russo GL, 2014, CANCER TREAT RES, V159, P185, DOI 10.1007/978-3-642-38007-5_11; Smit LA, 2007, BLOOD, V109, P1660, DOI 10.1182/blood-2006-05-021683; Walde S, 2010, TRENDS CELL BIOL, V20, P461, DOI 10.1016/j.tcb.2010.05.001; Goncalves AMMN, 2014, MAR DRUGS, V12, P4361, DOI 10.3390/md12084361; Azmi AS, 2013, CURR CANCER DRUG TAR, V13, P906; Wang X, 2009, ARCH PHARM RES, V32, P1263, DOI 10.1007/s12272-009-1912-8; FERGUSON LR, 1993, MUTAT RES, V285, P79, DOI 10.1016/0027-5107(93)90054-J; Arthur JC, 2007, J IMMUNOL, V179, P6291; Brandes AA, 2009, CANCER, V115, P3512, DOI 10.1002/cncr.24406; Shimamura T, 2012, CLIN CANCER RES, V18, P4973, DOI 10.1158/1078-0432.CCR-11-2967; Marelli M, 2001, BIOCHEM CELL BIOL, V79, P603; Veronese L, 2008, LEUKEMIA, V22, P1291, DOI 10.1038/sj.leu.2405052; Liang YC, 1997, J CELL BIOCHEM, V67, P55, DOI 10.1002/(SICI)1097-4644(19971001)67:1<55::AID-JCB6>3.0.CO;2-V; Kitano H, 2003, NATURE, V426, P125, DOI 10.1038/426125a; BOTTAZZI B, 1992, J IMMUNOL, V148, P1280; Alt JR, 2000, GENE DEV, V14, P3102, DOI 10.1101/gad.854900; Sherr CJ, 2000, CURR OPIN GENET DEV, V10, P94, DOI 10.1016/S0959-437X(99)00038-6; Dimmeler S, 1999, J EXP MED, V189, P1815, DOI 10.1084/jem.189.11.1815; Knauer SK, 2007, FASEB J, V21, P207, DOI 10.1096/fj.06-8741com; Schwartz PS, 2007, MOL CANCER THER, V6, P2073, DOI 10.1158/1535-7163.MCT-06-0767; Tarnow J, 1999, ANASTH INTENSIV NOTF, V34, P723, DOI 10.1055/s-1999-224; Chang DJ, 2012, J MED CHEM, V55, P10863, DOI 10.1021/jm301488q; Longo PG, 2008, BLOOD, V111, P846, DOI 10.1182/blood-2007-05-089037; Hung FM, 2013, ONCOL REP, V29, P1053, DOI 10.3892/or.2013.2230; Dighiero G, 2008, LANCET, V371, P1017, DOI 10.1016/S0140-6736(08)60456-0; Cai J, 2003, DIABETES, V52, P2959, DOI 10.2337/diabetes.52.12.2959; Shi XP, 2013, INT J MOL SCI, V14, P15655, DOI 10.3390/ijms140815655; Damle RN, 2010, BEST PRACT RES CL HA, V23, P33, DOI 10.1016/j.beha.2010.02.001; Mutka SC, 2009, CANCER RES, V69, P510, DOI 10.1158/0008-5472.CAN-08-0858; Chow HHS, 2003, CLIN CANCER RES, V9, P3312; Dutta S, 2012, BRIT J CANCER, V106, P702, DOI 10.1038/bjc.2011.610; Tan BJ, 2013, INT J ONCOL, V42, P1605, DOI 10.3892/ijo.2013.1843; Wang J, 2013, MOL BIOSYST, V9, P1489, DOI 10.1039/c3mb25461e; BERCHEM GJ, 1995, CANCER RES, V55, P735; An B, 1998, CELL DEATH DIFFER, V5, P1062, DOI 10.1038/sj.cdd.4400436; Russo M, 2010, TOXINS, V2, P517, DOI 10.3390/toxins2040517; Zhang HY, 2011, AM J PHYSIOL-GASTR L, V300, pG454, DOI 10.1152/ajpgi.00458.2010; Elter T, 2011, LANCET ONCOL, V12, P1204, DOI 10.1016/S1470-2045(11)70242-X; HAMAMOTO T, 1983, J ANTIBIOT, V36, P639; Molinari M, 2006, LIVER TRANSPLANT, V12, P1892, DOI 10.1002/lt.21021; Pimkina JS, 2011, CANCER BIOL THER, V12, P503, DOI 10.4161/cbt.12.6.15976; Hardtner C, 2012, EUR J PHARMACOL, V684, P36, DOI 10.1016/j.ejphar.2012.03.039; Haste NM, 2011, MAR DRUGS, V9, P680, DOI 10.3390/md9040680; Murdoch WJ, 1999, J REPROD FERTIL, V117, P325, DOI 10.1530/jrf.0.1170325; Vogler M, 2009, CELL DEATH DIFFER, V16, P360, DOI 10.1038/cdd.2008.137; Lai A, 2011, J CLIN ONCOL, V29, P142, DOI 10.1200/JCO.2010.30.2729; Phelps MA, 2009, BLOOD, V113, P2637, DOI 10.1182/blood-2008-07-168583; Chautan M, 1999, CURR BIOL, V9, P967, DOI 10.1016/S0960-9822(99)80425-4; Salminen A, 2013, AGEING RES REV, V12, P520, DOI 10.1016/j.arr.2012.11.004; Kim SM, 2013, MOL CANCER THER, V12, P2145, DOI 10.1158/1535-7163.MCT-12-1188; Wang XT, 2011, MOL NUTR FOOD RES, V55, P1572, DOI 10.1002/mnfr.201000560; Socinski MA, 2013, CLIN CANCER RES, V19, P3068, DOI 10.1158/1078-0432.CCR-12-3381; Huang Q, 2009, CELL DEATH DIFFER, V16, P264, DOI 10.1038/cdd.2008.151; Sun JX, 2004, ARTERIOSCL THROM VAS, V24, P2238, DOI 10.1161/01.ATV.0000147894.22300.4c; Tahmatzopoulos A, 2004, AKTUEL UROL, V35, P491, DOI 10.1055/s-2004-830048; Huang WY, 2009, CLIN INVEST MED, V32, pE315; Mandal M, 1997, J BIOL CHEM, V272, P14183, DOI 10.1074/jbc.272.22.14183; Lestini BJ, 2009, CANCER BIOL THER, V8, P1587, DOI 10.4161/cbt.8.16.8964; Chen Y, 2009, CELL DEATH DIFFER, V16, P1040, DOI 10.1038/cdd.2009.49; Torres CA, 2008, FREE RADICAL BIO MED, V44, P403, DOI 10.1016/j.fi-ceradbiomed.2007.10.002; Azad MB, 2008, AUTOPHAGY, V4, P195; Jackson RS, 2012, NEOPLASIA, V14, P656, DOI 10.1593/neo.12640; SHAULSKY G, 1991, ONCOGENE, V6, P2055; Zhang XQ, 2010, ASIAN J ANDROL, V12, P390, DOI 10.1038/aja.2009.87; Nana-Sinkam SP, 2010, CANCER GENET CYTOGEN, V203, P127, DOI 10.1016/j.cancergencyto.2010.09.007; Rengarajan T, 2013, NUTRIENTS, V5, P4978, DOI 10.3390/nu5124978; Jiang JH, 2009, INT J MOL MED, V24, P69, DOI 10.3892/ijmm_00000208; Anai S, 2011, UROL ONCOL-SEMIN ORI, V29, P421, DOI 10.1016/j.urolonc.2009.04.009; Boots AW, 2008, EUR J PHARMACOL, V585, P325, DOI 10.1016/j.ejphar.2008.03.008; Mathew R, 2007, GENE DEV, V21, P1367, DOI 10.1101/gad.1545107; Mihaljevic AL, 2010, LANGENBECK ARCH SURG, V395, P295, DOI 10.1007/s00423-010-0622-5; Jaattela M, 2003, NAT IMMUNOL, V4, P416, DOI 10.1038/ni0503-416; Russo M, 2012, BIOCHEM PHARMACOL, V83, P6, DOI 10.1016/j.bcp.2011.08.010; Azmi AS, 2011, EXPERT OPIN EMERG DR, V16, P59, DOI 10.1517/14728214.2010.515210; Lee MP, 1997, CANCER RES, V57, P3131; Cascone T, 2008, J CELL PHYSIOL, V216, P698, DOI 10.1002/jcp.21444; Russo M, 2010, BRIT J CANCER, V103, P642, DOI 10.1038/sj.bjc.6605794; Tucker CA, 2008, MOL CANCER THER, V7, P749, DOI 10.1158/1535-7163.MCT-07-0302; Karmakar S, 2008, CANCER, V112, P596, DOI 10.1002/cncr.23223; KORSMEYER SJ, 1993, SEMIN CANCER BIOL, V4, P327; Syed N, 2011, CANCER RES, V71, P3317, DOI 10.1158/0008-5472.CAN-10-2048; Sahin F, 2010, HEMATOLOGY, V15, P144, DOI 10.1179/102453309X12583347113771; Deveraux QL, 1997, NATURE, V388, P300; MacFarlane M, 2005, CELL DEATH DIFFER, V12, P773, DOI 10.1038/sj.cdd.4401649; Bredberg A, 2007, EUR J CANCER, V43, P947, DOI 10.1016/j.ejca.2006.12.003; Kazi A, 2003, BIOCHEM PHARMACOL, V66, P965, DOI 10.1016/S0006-2952(03)00414-3; Bruel A, 1997, EXP CELL RES, V233, P281, DOI 10.1006/excr.1997.3594; Mei YY, 2004, J PHARM PHARMACOL, V56, P1307, DOI 10.1211/0022357044364; Chen LS, 2010, BIOCHEM PHARMACOL, V80, P1936, DOI 10.1016/j.bcp.2010.07.039; Kumar P, 2008, LAB INVEST, V88, P740, DOI 10.1038/labinvest.2008.46; Hinz M, 2000, NUCLEOS NUCLEOT NUCL, V19, P1543, DOI 10.1080/15257770008045445; Adams J, 2004, CANCER INVEST, V22, P304, DOI 10.1081/CNV-120030218; Borissenko L, 2007, CHEM REV, V107, P687, DOI 10.1021/cr0502504; Dewaele M, 2010, AUTOPHAGY, V6, P838, DOI 10.4161/auto.6.7.12113; Fortugno P, 2003, P NATL ACAD SCI USA, V100, P13791, DOI 10.1073/pnas.2434345100; Anai S, 2007, UROLOGY, V70, P832, DOI 10.1016/j.urology.2007.06.1118; Wang Zhiwei, 2011, Nat Rev Gastroenterol Hepatol, V8, P27, DOI 10.1038/nrgastro.2010.188; Zheng L, 2011, CANCER LETT, V309, P27, DOI 10.1016/j.canlet.2011.05.011; Zhong Y, 2014, LEUKEMIA, V28, P1158, DOI 10.1038/leu.2014.9; HAMAMOTO T, 1983, J ANTIBIOT, V36, P646; Shimamura T, 2005, CANCER RES, V65, P6401, DOI 10.1158/0008-5472.CAN-05-0933; Chowdhury D, 2006, MOL CELL, V23, P133, DOI 10.1016/j.molcel.2006.06.005; Chakravarti A, 2002, CANCER RES, V62, P200; Nicolau-Galmes F, 2011, APOPTOSIS, V16, P1253, DOI 10.1007/s10495-011-0640-y; Voorhees PM, 2006, ANNU REV PHARMACOL, V46, P189, DOI 10.1146/annurev.pharmtox.46.120604.141300; Srinivasula SM, 2008, MOL CELL, V30, P123, DOI 10.1016/j.molcel.2008.03.008; Bernard D, 2001, J BIOL CHEM, V276, P27322, DOI 10.1074/jbc.M011183200; Inoue H, 2013, J UROLOGY, V189, P2317, DOI 10.1016/j.juro.2012.10.018; Nagano A, 2000, CURR OPIN NEUROL, V13, P533, DOI 10.1097/00019052-200010000-00005; Beeram M, 2005, J CLIN ONCOL, V23, P6771, DOI 10.1200/JCO.2005.08.036; Kazi A, 2004, ANTICANCER RES, V24, P943; Oeffinger M, 2012, BBA-GENE REGUL MECH, V1819, P494, DOI 10.1016/j.bbagrm.2012.02.011; Oakes SR, 2012, P NATL ACAD SCI USA, V109, P2766, DOI 10.1073/pnas.1104778108; Voelkel-Johnson C, 2011, NAT REV UROL, V8, P417, DOI 10.1038/nrurol.2011.81; Mrowietz U, 1999, BRIT J CANCER, V79, P1025, DOI 10.1038/sj.bjc.6690164; Johnson VL, 1999, EXP CELL RES, V251, P175, DOI 10.1006/excr.1999.4557; Lee Y, 2012, FOOD CHEM TOXICOL, V50, P2397, DOI 10.1016/j.fct.2012.04.014; Chow SE, 2014, APOPTOSIS, V19, P527, DOI 10.1007/s10495-013-0945-0; Balaburski GM, 2010, TRENDS CELL BIOL, V20, P363, DOI 10.1016/j.tcb.2010.02.007; Moore BS, 2008, CURR OPIN CHEM BIOL, V12, P434, DOI 10.1016/j.cbpa.2008.06.033; Haugk B, 2010, HISTOPATHOLOGY, V57, P503, DOI 10.1111/j.1365-2559.2010.03610.x; Gokbulut AA, 2013, HEMATOLOGY, V18, P144, DOI 10.1179/1607845412Y.0000000042; Ghosh AK, 2009, CLIN CANCER RES, V15, P1250, DOI 10.1158/1078-0432.CCR-08-1511; Wang JYJ, 2005, CELL RES, V15, P43, DOI 10.1038/sj.cr.7290263; Shankar S, 2008, FRONT BIOSCI-LANDMRK, V13, P440, DOI 10.2741/2691; Berletch JB, 2008, J CELL BIOCHEM, V103, P509, DOI 10.1002/jcb.21417; Soderquist R, 2013, LEUKEMIA, V27, P2262, DOI 10.1038/leu.2013.138; Hwang KC, 2002, J CARDIOVASC PHARM, V39, P271, DOI 10.1097/00005344-200202000-00014; Yang Y, 2004, CANCER SCI, V95, P176, DOI 10.1111/j.1349-7006.2004.tb03200.x; Marubayashi S, 2010, J CLIN INVEST, V120, P3578, DOI 10.1172/JCI42442; Kraehn GM, 2001, BRIT J CANCER, V84, P72, DOI 10.1054/bjoc.2000.1535; Everett PC, 2007, AM J HEMATOL, V82, P23, DOI 10.1002/ajh.20757; Angelo LS, 2009, CLIN CANCER RES, V15, P1123, DOI 10.1158/1078-0432.CCR-08-2791; Carter BZ, 2012, LEUKEMIA, V26, P443, DOI 10.1038/leu.2011.246; Kumar SR, 2013, MAR DRUGS, V11, P5130, DOI 10.3390/md11125130; Adhami VM, 2007, CLIN CANCER RES, V13, P1611, DOI 10.1158/1078-0432.CCR-06-2269; Ringash J, 2014, CANCER-AM CANCER SOC, V120, P181, DOI 10.1002/cncr.28410; Van der Watt PJ, 2009, INT J CANCER, V124, P1829, DOI 10.1002/ijc.24146; Chen TC, 2011, CANCER LETT, V302, P100, DOI 10.1016/j.canlet.2010.11.008; Iwado E, 2007, INT J ONCOL, V31, P1087; Nguyen VT, 2014, MAR DRUGS, V12, P69, DOI 10.3390/md12010069; BREM S, 1992, CANCER, V70, P2673, DOI 10.1002/1097-0142(19921201)70:11<2673::AID-CNCR2820701118>3.0.CO;2-F; Gyurkocza B, 2006, J NATL CANCER I, V98, P1068, DOI 10.1093/jnci/djj300; Akgul C, 2009, CELL MOL LIFE SCI, V66, P1326, DOI 10.1007/s00018-008-8637-6; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Tai YT, 2014, LEUKEMIA, V28, P155, DOI 10.1038/leu.2013.115; Fulda S, 2002, NAT MED, V8, P808, DOI 10.1038/nm735; Shanafelt TD, 2009, J CLIN ONCOL, V27, P3808, DOI 10.1200/JCO.2008.21.1284; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Mozzicafreddo M, 2009, J CHEM INF MODEL, V49, P401, DOI 10.1021/ci800235m; Duval M, 2007, MOL BIOL CELL, V18, P4659, DOI 10.1091/mbc.E07-05-0467; Manero F, 2006, CANCER RES, V66, P2757, DOI 10.1158/0008-5472.CAN-05-2097; Wang SY, 2011, INT J BIOCHEM CELL B, V43, P1263, DOI 10.1016/j.biocel.2011.05.010; Vogler M, 2012, CELL DEATH DIFFER, V19, P67, DOI 10.1038/cdd.2011.158; Merdzhanova G, 2008, CELL DEATH DIFFER, V15, P1815, DOI 10.1038/cdd.2008.135; Stommel JM, 2007, SCIENCE, V318, P287, DOI 10.1126/science.1142946; Papandreou CN, 2004, CANCER RES, V64, P5036, DOI 10.1158/0008-5472.CAN-03-2707; Le YY, 2002, IN VIVO, V16, P1; Jain MV, 2013, J CELL MOL MED, V17, P12, DOI 10.1111/jcmm.12001; Balakrishnan K, 2008, BLOOD, V112, P1971, DOI 10.1182/blood-2007-12-126946; Hirose Y, 2001, CANCER RES, V61, P1957; Durig J, 2011, LEUKEMIA, V25, P638, DOI 10.1038/leu.2010.322; Deveraux QL, 1998, EMBO J, V17, P2215, DOI 10.1093/emboj/17.8.2215; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nmb1209; Messmer BT, 2005, J CLIN INVEST, V115, P755, DOI 10.1172/JCI23409; Yecies D, 2010, BLOOD, V115, P3304, DOI 10.1182/blood-2009-07-233304; Hallaert DYH, 2008, BLOOD, V112, P5141, DOI 10.1182/blood-2008-03-146704; Ramalingam S, 2004, EXPERT OPIN PHARMACO, V5, P1771, DOI 10.1517/14656566.5.8.1771; Mao L, 2013, CURR PHARM DESIGN, V19, P2318; Voss V, 2010, MOL CANCER RES, V8, P1002, DOI 10.1158/1541-7786.MCR-09-0562; Chen LM, 2012, INT J ONCOL, V40, P1066, DOI 10.3892/ijo.2011.1278; Wang GP, 2006, J MED CHEM, V49, P6139, DOI 10.1021/jm060460o; Vellanki S, 2009, NEOPLASIA, V11, P743, DOI 10.1593/neo.09436; Kaminski BM, 2011, CANCER CHEMOTH PHARM, V67, P1167, DOI 10.1007/s00280-010-1413-y; Mo J, 2013, PATHOL RES PRACT, V209, P640, DOI 10.1016/j.prp.2013.07.004; Christophorou MA, 2006, NATURE, V443, P214, DOI 10.1038/nature05077; Brennan MA, 2000, MOL MICROBIOL, V38, P31, DOI 10.1046/j.1365-2958.2000.02103.x; Pradelli LA, 2010, ONCOGENE, V29, P1641, DOI 10.1038/onc.2009.448; Bolesta E, 2012, MOL CELL BIOL, V32, P1879, DOI 10.1128/MCB.06214-11; Matthew EM, 2009, CELL CYCLE, V8, P4168, DOI 10.4161/cc.8.24.10800; Smith DM, 2002, MOL MED, V8, P382; Hayun R, 2009, LEUKEMIA LYMPHOMA, V50, P625, DOI 10.1080/10428190902789181; Mi LX, 2009, J BIOL CHEM, V284, P17039, DOI 10.1074/jbc.M901789200; Carew JS, 2010, J CELL MOL MED, V14, P2448, DOI 10.1111/j.1582-4934.2009.00832.x; Pepper C, 2008, BLOOD, V112, P3807, DOI 10.1182/blood-2008-05-157131; Yashiroda Y, 2003, CURR MED CHEM, V10, P741, DOI 10.2174/0929867033457791; Basu A, 2013, CELL, V154, P1151, DOI 10.1016/j.cell.2013.08.003; Park B, 2011, BIOCHEM PHARMACOL, V82, P1134, DOI 10.1016/j.bcp.2011.07.062; Wang H, 2011, CARCINOGENESIS, V32, P1881, DOI 10.1093/carcin/bgr218; Turkson J, 2004, EXPERT OPIN THER TAR, V8, P409, DOI 10.1517/14728222.8.5.409; Singh SK, 2005, CLIN EXP RHEUMATOL, V23, P311; Patel MP, 2009, CURR OPIN ONCOL, V21, P516, DOI 10.1097/CCO.0b013e328331a7a4; ELFadl D, 2011, BREAST, V20, P334, DOI 10.1016/j.breast.2011.02.017; Ewen CL, 2012, CELL DEATH DIFFER, V19, P28, DOI 10.1038/cdd.2011.153; Zgheib A, 2013, J BIOL CHEM, V288, P13378, DOI 10.1074/jbc.M113.456533; Beck R, 2009, BIOCHEM PHARMACOL, V77, P375, DOI 10.1016/j.bcp.2008.10.019; Sakakibara K, 2011, BLOOD, V118, P3922, DOI 10.1182/blood-2011-01-333138; Liu DL, 2011, MED ONCOL, V28, P105, DOI 10.1007/s12032-009-9397-3; Baguley BC, 2010, METHODS MOL BIOL, V596, P1, DOI 10.1007/978-1-60761-416-6_1; Gandhi L, 2011, J CLIN ONCOL, V29, P909, DOI 10.1200/JCO.2010.31.6208; Chio CC, 2013, ARCH TOXICOL, V87, P459, DOI 10.1007/s00204-012-0965-5; Booy EP, 2011, ONCOGENE, V30, P2367, DOI 10.1038/onc.2010.616; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Nair S, 2010, ACTA PHARMACOL SIN, V31, P1223, DOI 10.1038/aps.2010.147; Sheikh R, 2010, EXPERT REV ANTICANC, V10, P1647, DOI [10.1586/era.10.148, 10.1586/ERA.10.148]; Balakumaran BS, 2009, CANCER RES, V69, P7803, DOI 10.1158/0008-5472.CAN-09-0910; Joo KM, 2008, LAB INVEST, V88, P808, DOI 10.1038/labinvest.2008.57; Hu LG, 2010, CANCER CHEMOTH PHARM, V66, P467, DOI 10.1007/s00280-009-1182-7; Buggins AGS, 2010, LEUKEMIA RES, V34, P837, DOI 10.1016/j.leukres.2010.03.011; Kitagawa S, 2004, J PHARM PHARMACOL, V56, P1001, DOI 10.1211/0022357044003; Li BY, 2000, P NATL ACAD SCI USA, V97, P3850, DOI 10.1073/pnas.070047997; Mortenson MM, 2007, J CELL BIOCHEM, V102, P1171, DOI 10.1002/jcb.21343; Chondrogianni N, 2003, J BIOL CHEM, V278, P28026, DOI 10.1074/jbc.M301048200; Reef S, 2006, MOL CELL, V22, P463, DOI 10.1016/j.molcel.2006.04.014; Muqbil I, 2013, CURR DRUG TARGETS, V14, P1094; Slocum SL, 2011, ARCH TOXICOL, V85, P273, DOI 10.1007/s00204-011-0675-4; Bennett HL, 2013, BJU INT, V111, P672, DOI 10.1111/j.1464-410X.2012.11409.x; Yoneda Y, 1996, ARCH HISTOL CYTOL, V59, P97, DOI 10.1679/aohc.59.97; Edwards JG, 2003, CHEST, V124, P1916, DOI 10.1378/chest.124.5.1916; Pepper C, 1997, BRIT J CANCER, V76, P935, DOI 10.1038/bjc.1997.487; George J, 2010, NEURO-ONCOLOGY, V12, P1088, DOI 10.1093/neuonc/noq079; Walsby E, 2012, ONCOTARGET, V3, P525; Wood TE, 2008, MOL CANCER THER, V7, P3546, DOI 10.1158/1535-7163.MCT-08-0569; Bono C, 2012, HAEMATOL-HEMATOL J, V97, P1101, DOI 10.3324/haematol.2011.049981; Tomic J, 2013, EXP HEMATOL, V41, P675, DOI 10.1016/j.exphem.2013.04.004; Hutten S, 2007, TRENDS CELL BIOL, V17, P193, DOI 10.1016/j.tcb.2007.02.003; Giampietri C, 2012, APOPTOSIS, V17, P1210, DOI 10.1007/s10495-012-0752-z; Kiviharju TM, 2002, CLIN CANCER RES, V8, P2666; Lin TS, 2009, J CLIN ONCOL, V27, P6012, DOI 10.1200/JCO.2009.22.6944; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Awan FT, 2009, BLOOD, V113, P535, DOI 10.1182/blood-2008-08-173450; Wang WY, 2013, MOL MED REP, V7, P1501, DOI 10.3892/mmr.2013.1379; Aoki H, 2007, FASEB J, V21, P2918, DOI 10.1096/fj.06-6941com; Billard C, 2012, LEUKEMIA, V26, P2032, DOI 10.1038/leu.2012.88; Buggins AGS, 2010, CANCER RES, V70, P7523, DOI 10.1158/0008-5472.CAN-10-1634; Hippert MM, 2006, CANCER RES, V66, P9349, DOI 10.1158/0008-5472.CAN-06-1597; Russo M, 2013, BIOCHEM PHARMACOL, V85, P927, DOI 10.1016/j.bcp.2013.01.011; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Etchin J, 2013, BRIT J HAEMATOL, V161, P117, DOI 10.1111/bjh.12231; Fukuda M, 1997, NATURE, V390, P308; Chandra A, 2013, J BIOL CHEM, V288, P20488, DOI 10.1074/jbc.M112.447250; Ivanov VN, 2003, MOL CELL BIOL, V23, P3623, DOI 10.1128/MCB.23.10.3623-3635.2003; Singh M, 2011, J BIOMED NANOTECHNOL, V7, P202, DOI 10.1166/jbn.2011.1268; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Balakrishnan K, 2009, BLOOD, V113, P149, DOI 10.1182/blood-2008-02-138560; Ciechanover A, 2005, NAT REV MOL CELL BIO, V6, P79, DOI 10.1038/nrm1552; Koga F, 2009, ANTICANCER RES, V29, P797; Rosenbluh J, 2012, CELL, V151, P1457, DOI 10.1016/j.cell.2012.11.026; Oya M, 2001, ONCOGENE, V20, P3888, DOI 10.1038/sj.onc.1204525; Zhang C, 2011, MOL CANCER THER, V10, P1264, DOI 10.1158/1535-7163.MCT-10-1091; Choi HN, 2013, BIOCHEM BIOPH RES CO, V432, P123, DOI 10.1016/j.bbrc.2013.01.074; Morin PJ, 2003, DRUG RESIST UPDATE, V6, P169, DOI 10.1016/S1368-7646(03)00059-1; SNOW BJ, 1990, ARCH NEUROL-CHICAGO, V47, P870; Yan WJ, 2013, TUMOR BIOL, V34, P1391, DOI 10.1007/s13277-012-0584-z; Spagnuolo C, 2012, ANN NY ACAD SCI, V1259, P95, DOI 10.1111/j.1749-6632.2012.06599.x; Ziparo E, 2013, INT J MOL SCI, V14, P12090, DOI 10.3390/ijms140612090; Kisselev AF, 2000, J BIOL CHEM, V275, P14831, DOI 10.1074/jbc.275.20.14831; Liang G, 2010, INT J ONCOL, V37, P111, DOI 10.3892/ijo_00000659; Junttila MR, 2010, NATURE, V468, P567, DOI 10.1038/nature09526; MacFarlane M, 2012, CELL CYCLE, V11, P3919, DOI 10.4161/cc.21804; Kalid O, 2012, J COMPUT AID MOL DES, V26, P1217, DOI 10.1007/s10822-012-9611-9; CaligarisCappio F, 1996, BLOOD, V87, P2615; Brohem CA, 2012, PIGM CELL MELANOMA R, V25, P354, DOI 10.1111/j.1755-148X.2012.00992.x; Videira M, 2014, BBA-REV CANCER, V1846, P312, DOI 10.1016/j.bbcan.2014.07.011; RICHMOND A, 1985, CANCER RES, V45, P6390; Mi LX, 2007, CANCER RES, V67, P6409, DOI 10.1158/0008-5472.CAN-07-0340; Shanafelt TD, 2013, CANCER-AM CANCER SOC, V119, P363, DOI 10.1002/cncr.27719; Raices M, 2012, NAT REV MOL CELL BIO, V13, P687, DOI 10.1038/nrm3461; Liu JJ, 2012, PHYTOMEDICINE, V19, P756, DOI 10.1016/j.phymed.2012.02.014; Diekmann Y, 2013, BIOCHEM J, V449, P319, DOI 10.1042/BJ20120957; Grossman E, 2012, ANNU REV BIOPHYS, V41, P557, DOI [10.1146/annurev-biophys-050511-102328, 10.1146/annurev-biophys-850511-102328]; Shimamura T, 2008, CANCER RES, V68, P5827, DOI 10.1158/0008-5472.CAN-07-5428; Kang BH, 2009, J CLIN INVEST, V119, P454, DOI 10.1172/JCI37613; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; SATO T, 1995, SCIENCE, V268, P411, DOI 10.1126/science.7536343; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Liang YC, 1999, J CELL BIOCHEM, V75, P1; Bonkhoff H, 1998, PROSTATE, V34, P251, DOI 10.1002/(SICI)1097-0045(19980301)34:4<251::AID-PROS2>3.0.CO;2-K; Stearns ME, 2010, AM J PATHOL, V177, P3169, DOI 10.2353/ajpath.2010.100330; Xi GM, 2011, CANCER LETT, V307, P141, DOI 10.1016/j.canlet.2011.03.026; Lord SJ, 2003, IMMUNOL REV, V193, P31, DOI 10.1034/j.1600-065X.2003.00044.x; Zuo JH, 2010, MOL CANCER RES, V8, P170, DOI 10.1158/1541-7786.MCR-09-0354; Jatoi A, 2003, CANCER, V97, P1442, DOI 10.1002/cncr.11200; Garcia-Caballero M, 2013, BIOCHEM PHARMACOL, V85, P1727, DOI 10.1016/j.bcp.2013.04.007; Abulwerdi F, 2014, MOL CANCER THER, V13, P565, DOI 10.1158/1535-7163.MCT-12-0767; Liu EY, 2012, J CELL SCI, V125, P2349, DOI 10.1242/jcs.093708; Farnaes L, 2014, J NAT PROD, V77, P15, DOI 10.1021/np400466j; LaCasse EC, 2008, ONCOGENE, V27, P6252, DOI 10.1038/onc.2008.302; Li X, 2011, TOXICOL APPL PHARM, V251, P146, DOI 10.1016/j.taap.2010.12.007; Gozuacik D, 2001, ONCOGENE, V20, P6233, DOI 10.1038/sj.onc.1204835; Seki N, 2003, CANCER RES, V63, P207; Yuan SJ, 2013, STRUCTURE, V21, P501, DOI 10.1016/j.str.2013.02.024; Nam S, 2001, J BIOL CHEM, V276, P13322, DOI 10.1074/jbc.M004209200; Turner JG, 2008, CURR MED CHEM, V15, P2648, DOI 10.2174/092986708786242859; Etxebarria A, 2008, BIOCHEM PHARMACOL, V76, P1563, DOI 10.1016/j.bcp.2008.08.003; Warr MR, 2008, CURR MOL MED, V8, P138; Hallek M, 2010, BEST PRACT RES CL HA, V23, P85, DOI 10.1016/j.beha.2009.12.002; Farabegoli F, 2010, PHYTOMEDICINE, V17, P356, DOI 10.1016/j.phymed.2010.01.001; McBrayer SK, 2012, BLOOD, V119, P4686, DOI 10.1182/blood-2011-09-377846; Lv Q, 2012, CANCER RES, V72, P3238, DOI 10.1158/0008-5472.CAN-11-3832; Du YH, 2007, J BIOMOL SCREEN, V12, P915, DOI 10.1177/1087057107306067; Pan JX, 2010, CANCER LETT, V292, P149, DOI 10.1016/j.canlet.2009.11.018; Ayshamgul H, 2011, CHIN MED J, V124, P341; Azmi AS, 2012, GASTROENTEROLOGY, V144, P447; Beeram Muralidhar, 2003, Clin Adv Hematol Oncol, V1, P476; Beesoo R, 2014, MUTAT RES FUNDAM MOL; bou-Nassar K, 2010, CLIN ADV HEMATOL ONC, V8, P886; Busacca S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065489; Carew Jennifer S, 2012, Cancer Manag Res, V4, P357, DOI 10.2147/CMAR.S26133; Carew Jennifer S, 2008, Biologics, V2, P201; Chan KC, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-128; Chang PC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088556; Chen S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.380; Cheng P, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.17; Cheng V, 2014, MOL CANCER THER, V13, P675; Cho V, 2011, PLOS ONE, V6; Chopra M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075737; Cortes S. M., 2008, CLIN TRANSL ONCOL, V10, P143, DOI [10.1007/s12094-008-0171-3, DOI 10.1007/S12094-008-0171-3]; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; Dalla Via L, 2012, FUTURE MED CHEM, V4, P525; Dangi-Garimella S, 2012, EPITHELIALMESENCHYMA; Das A, 2008, J NEURO-ONCOL, V87, P9, DOI 10.1007/s11060-007-9485-1; Diaz-Chavez J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064378; Dreyfuss JM, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-71; Du TA, 2013, NAT REV MOL CELL BIO, V14, P546; Dupere-Richer D, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.210; Farnaes L, 2014, ORG BIOMOL CHEM, V12, P418, DOI 10.1039/c3ob41355a; Filipova A, 2014, TUMORI, V100, P363, DOI 10.1700/1636.17886; Giampietri C, 2014, INT J CELL BIOL, V2014; Gundala SR, 2014, TOXICOL APPL PHARM, V280, P86, DOI 10.1016/j.taap.2014.07.012; Gupta P, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-80; Hu T, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-251; Huang KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033615; Huang W., 2012, EVID-BASED COMPL ALT, V2012, P1; Huq F, 2014, ANTICANCER RES, V34, P541; Hui B, 2012, CANCER-AM CANCER SOC, V118, P5560, DOI 10.1002/cncr.27586; It Garcia, 1997, CELL GROWTH DIFFER, V8, P1267; Jang JY, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-421; Jentsch S, 1992, Trends Cell Biol, V2, P98, DOI 10.1016/0962-8924(92)90013-D; Karantanos T, 2015, EUR UROL, V67, P470, DOI 10.1016/j.eururo.2014.09.049; Klarer Alden C, 2014, Cancer Metab, V2, P2, DOI 10.1186/2049-3002-2-2; Krakstad C, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-135; Kumar N, 2012, TRANSL MED SUNNYV S2, P005; Kumar N, 2012, J CLIN TRIALS, P2; KUTTAN R, 1985, CANCER LETT, V29, P197, DOI 10.1016/0304-3835(85)90159-4; Likui Wang, 2009, J Surg Oncol, V100, P396, DOI 10.1002/jso.21344; Luo T, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2473; Ma JX, 2012, ONCOL RES, V20, P359, DOI 10.3727/096504013X13657689382932; Masood Ashiq, 2011, Cancers (Basel), V3, P1527, DOI 10.3390/cancers3021527; Munoz-Gomez JA, 2009, AUTOPHAGY, V5, P61; Niebler M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003536; O'Connell J, 2000, ANN NY ACAD SCI, V910, P178; Okuhashi V, 2011, ANTICANCER RES, V31, P893; Op den Kamp C M, 2012, Lung Cancer, V76, P112, DOI 10.1016/j.lungcan.2011.09.012; Pal K, 2014, MOL CANCER THER, V13, P285, DOI 10.1158/1535-7163.MCT-13-0681; Pan XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056679; Parrondo R, 2013, PEERJ, V1, DOI 10.7717/peerj.144; Pedros C, 2003, MED CLIN-BARCELONA, V121, P598, DOI 10.1157/13053801; Piekielko-Witkowska A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013690; Pignochino V, 2009, MOL CANCER, V8, P118; Rasheed ZA, 2012, PATHOLOGY PANCREATIC; Restall IJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011076; Richardson Paul G, 2003, Cancer Control, V10, P361; Robert Mc, 2008, Biomed Imaging Interv J, V4, pe3, DOI 10.2349/biij.4.1.e3; Sagar S, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-344; Shi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051076; Singh T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027444; Spiegl-Kreinecker S, 2010, NEURO-ONCOLOGY, V12, P28, DOI 10.1093/neuonc/nop003; Tagscherer KE, 2008, ONCOGENE, V27, P6646; Tai WT, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.18; Van BK, 2012, ANNU REV CELL DEV BI, V28, P163; Van CS, 2002, ANAT HISTOL EMBRYOL, V31, P214; Vitagliano O, 2013, EXPERT REV HEMATOL, V6, P587, DOI 10.1586/17474086.2013.827415; Volkova Maria, 2011, Curr Cardiol Rev, V7, P214; Walker N I, 1988, Methods Achiev Exp Pathol, V13, P18; WYLLIE AH, 1994, PHILOS T ROY SOC B, V345, P237, DOI 10.1098/rstb.1994.0099; Zhang Q, 2010, PHARM RES-DORDR, V27, P1066, DOI 10.1007/s11095-010-0056-3; Zhao F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080784; Zhao M, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-104; Zhen Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.376; Zheng Jun-meng, 2005, Di Yi Jun Yi Da Xue Xue Bao, V25, P1537; Zhu HT, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-119	496	4	4	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1044-579X			SEMIN CANCER BIOL	Semin. Cancer Biol.	DEC	2015	35			S			S78	S103		10.1016/j.semcancer.2015.03.001		26	Oncology	Oncology	CY7WG	WOS:000366619400005		
J	Samadi, AK; Bilsland, A; Georgakilas, AG; Amedei, A; Amin, A; Bishayee, A; Azmi, AS; Lokeshwar, BL; Grue, B; Panis, C; Boosani, CS; Poudyal, D; Stafforini, DM; Bhakta, D; Niccolai, E; Guha, G; Rupasinghe, HPV; Fujii, H; Honoki, K; Mehta, K; Aquilano, K; Lowe, L; Hofseth, LJ; Ricciardiello, L; Ciriolo, MR; Singh, N; Whelan, RL; Chaturvedi, R; Ashraf, SS; Kumara, HMCS; Nowsheen, S; Mohammed, SI; Keith, WN; Helferich, WG; Yang, XJ				Samadi, Abbas K.; Bilsland, Alan; Georgakilas, Alexandros G.; Amedei, Amedeo; Amin, Amr; Bishayee, Anupam; Azmi, Asfar S.; Lokeshwar, Bal L.; Grue, Brendan; Panis, Carolina; Boosani, Chandra S.; Poudyal, Deepak; Stafforini, Diana M.; Bhakta, Dipita; Niccolai, Elena; Guha, Gunjan; Rupasinghe, H. P. Vasantha; Fujii, Hiromasa; Honoki, Kanya; Mehta, Kapil; Aquilano, Katia; Lowe, Leroy; Hofseth, Lorne J.; Ricciardiello, Luigi; Ciriolo, Maria Rosa; Singh, Neetu; Whelan, Richard L.; Chaturvedi, Rupesh; Ashraf, S. Salman; Kumara, H. M. C. Shantha; Nowsheen, Somaira; Mohammed, Sulma I.; Keith, W. Nicol; Helferich, William G.; Yang, Xujuan			A multi-targeted approach to suppress tumor-promoting inflammation	SEMINARS IN CANCER BIOLOGY			English	Review						Cancer; Tumor; Inflammation; Hallmarks; Phytochemicals	NF-KAPPA-B; NITRIC-OXIDE SYNTHASE; NECROSIS-FACTOR-ALPHA; MIGRATION-INHIBITORY FACTOR; PROSTATE-CANCER CELLS; GREEN TEA POLYPHENOL; HUMAN BREAST-CANCER; EPITHELIAL OVARIAN-CANCER; ACTIVATED PROTEIN-KINASE; CHEMOPREVENTIVE AGENT CURCUMIN	Cancers harbor significant genetic heterogeneity and patterns of relapse following many therapies are due to evolved resistance to treatment. While efforts have been made to combine targeted therapies, significant levels of toxicity have stymied efforts to effectively treat cancer with multi-drug combinations using currently approved therapeutics. We discuss the relationship between tumor-promoting inflammation and cancer as part of a larger effort to develop a broad-spectrum therapeutic approach aimed at a wide range of targets to address this heterogeneity. Specifically, macrophage migration inhibitory factor, cyclooxygenase-2, transcription factor nuclear factor-kappa B, tumor necrosis factor alpha, inducible nitric oxide synthase, protein kinase B, and CXC chemokines are reviewed as important antiinflammatory targets while curcumin, resveratrol, epigallocatechin gallate, genistein, lycopene, and anthocyanins are reviewed as low-cost, low toxicity means by which these targets might all be reached simultaneously. Future translational work will need to assess the resulting synergies of rationally designed antiinflammatory mixtures (employing low-toxicity constituents), and then combine this with similar approaches targeting the most important pathways across the range of cancer hallmark phenotypes. (C) 2015 Elsevier Ltd.	[Samadi, Abbas K.] Sanus Biosci, San Diego, CA USA; [Bilsland, Alan; Keith, W. Nicol] Univ Glasgow, Inst Canc Sci, Glasgow, Lanark, Scotland; [Georgakilas, Alexandros G.] Natl Tech Univ Athens, Dept Phys, Sch Appl Math & Phys Sci, GR-15773 Athens, Greece; [Amedei, Amedeo] Univ Florence, Dept Expt & Clin Med, Florence, Italy; [Amin, Amr] United Arab Emirates Univ, Coll Sci, Dept Biol, Al Ain, U Arab Emirates; [Amin, Amr] Cairo Univ, Fac Sci, Cairo, Egypt; [Bishayee, Anupam] Larkin Hlth Sci Inst, Coll Pharm, Dept Pharmaceut Sci, Miami, FL USA; [Azmi, Asfar S.] Wayne State Univ, Dept Pathol, Karmanos Canc Ctr, Detroit, MI 48202 USA; [Lokeshwar, Bal L.] Univ Miami, Miller Sch Med, Dept Urol, Miami, FL 33136 USA; [Lokeshwar, Bal L.] Miami Vet Adm Med Ctr, Miami, FL USA; [Grue, Brendan] Dalhousie Univ, Dept Environm Sci, Halifax, NS, Canada; [Grue, Brendan] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada; [Panis, Carolina] State Univ West Parana, UNIOESTE, Lab Inflammatory Mediators, Curitiba, Parana, Brazil; [Boosani, Chandra S.] Creighton Univ, Dept Biomed Sci, Sch Med, Omaha, NE 68178 USA; [Poudyal, Deepak; Hofseth, Lorne J.] Univ S Carolina, South Carolina Coll Pharm, Dept Drug Discovery & Biomed Sci, Columbia, SC 29208 USA; [Stafforini, Diana M.] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA; [Stafforini, Diana M.] Univ Utah, Dept Internal Med, Salt Lake City, UT 84112 USA; [Bhakta, Dipita; Guha, Gunjan] SASTRA Univ, Sch Chem & Biotechnol, Thanjavur, Tamil Nadu, India; [Niccolai, Elena] Univ Florence, Florence, Italy; [Rupasinghe, H. P. Vasantha] Dalhousie Univ, Dept Environm Sci, Fac Agr, Halifax, NS, Canada; [Rupasinghe, H. P. Vasantha] Dalhousie Univ, Dept Pathol, Fac Med, Halifax, NS, Canada; [Fujii, Hiromasa; Honoki, Kanya] Nara Med Univ, Dept Orthoped Surg, Kashihara, Nara 634, Japan; [Mehta, Kapil] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Aquilano, Katia; Ciriolo, Maria Rosa] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy; [Lowe, Leroy] Getting Know Canc, Truro, NS, Canada; [Ricciardiello, Luigi] Univ Bologna, Dept Med & Surg Sci, Bologna, Italy; [Singh, Neetu] King Georges Med Univ, Adv Mol Sci Res Ctr, Ctr Adv Res, Lucknow, Uttar Pradesh, India; [Whelan, Richard L.; Kumara, H. M. C. Shantha] St Lukes Roosevelt Hosp, Dept Surg, New York, NY 10025 USA; [Chaturvedi, Rupesh] Jawaharlal Nehru Univ, Sch Biotechnol, New Delhi 110067, India; [Ashraf, S. Salman] United Arab Emirates Univ, Coll Sci, Dept Chem, Al Ain, U Arab Emirates; [Nowsheen, Somaira] Mayo Clin, Mayo Med Sch, Mayo Grad Sch, Med Sci Training Program, Rochester, MN USA; [Mohammed, Sulma I.] Purdue Univ, Ctr Canc Res, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA; [Helferich, William G.; Yang, Xujuan] Univ Illinois, Champaign, IL 61820 USA	Lowe, L (reprint author), Getting Know Canc, Room 229A Forrester Hall,36 Arthur St, Truro, NS, Canada.	leroy.lowe@gettingtoknowcancer.org	Keith, Nicol/D-3325-2009	Keith, Nicol/0000-0001-7862-3580	EU [MC-CIG-303514]; Greek National funds through the Operational Program 'Educational and Lifelong Learning of the National Strategic Reference Framework (NSRF)-Research Funding Program: THALES [MIS 379346]; COST Action CM1201 'Biomimetic Radical Chemistry'; Terry Fox Foundation (TF); UAEU Program for Advanced Research (UPAR); Al-Jalila Foundation (ALF); Zayed Center for Health Sciences (ZCHS); NIH [R21 CA188818 01A1, R01 CA 156776-01]; VA Merit Award [BLR&D 1 01-BX001517-01]; National Cancer Institute [5P01CA073992]; DOD IDEA Award [W81XWH-12-1-0515]; Huntsman Cancer Foundation; Ministry of Education, Culture, Sports, Science and Technology, Japan [24590493]; Bayer Healthcare System G4T (Grants4Targets); US NIH National Cancer Institute [1R01CA151304, 1R03CA1711326, 1P01AT003961]; Associazione Italiana per la Ricerca sul Cancro (AIRC) [10216, 14218]; European Community [311876]; Fast Track Scheme for Young Scientists, Department of Science and Technology, India [SR/FT/LS-063/2008]; philanthropy (grateful patients); US NIH National Center for Complementary and Alternative Medicine [K01AT007324]; University of Glasgow; Beatson Oncology Centre Fund; Cancer Research UK [C301/A14762]	Alexandros G. Georgakilas was supported by an EU Marie Curie Reintegration Grant MC-CIG-303514, Greek National funds through the Operational Program 'Educational and Lifelong Learning of the National Strategic Reference Framework (NSRF)-Research Funding Program: THALES (Grant number MIS 379346) and COST Action CM1201 'Biomimetic Radical Chemistry'; Amr Amin was supported in part by the Terry Fox Foundation (TF2014), UAEU Program for Advanced Research (UPAR2014), Al-Jalila Foundation (ALF2015) and Zayed Center for Health Sciences (ZCHS 2015); Asfar S Azmi was supported by a grants from NIH (R21 CA188818 01A1); Bal L. Lokeshwar was supported by NIH Grant NO. R01 CA 156776-01; VA Merit Award NO. BLR&D 1 01-BX001517-01; Diana M. Stafforini was supported by grant 5P01CA073992 from the National Cancer Institute, by DOD IDEA Award W81XWH-12-1-0515 and by the Huntsman Cancer Foundation; Kanya Honoki was supported in part by a grant from the Ministry of Education, Culture, Sports, Science and Technology, Japan (No. 24590493); Kapil Mehta was supported by Bayer Healthcare System G4T (Grants4Targets); Lorne Hofseth was supported by US NIH National Cancer Institute grants: 1R01CA151304 (LJH), 1R03CA1711326 (LJH), and 1P01AT003961 (LJH); Luigi Ricciardiello was supported by the Associazione Italiana per la Ricerca sul Cancro (AIRC) under investigator grants 10216 and 14218, and by the European Community's Seventh Framework Program FP7/2007-2013 under Grant Agreement 311876; Neetu Singh was supported in part by the Fast Track Scheme for Young Scientists, Department of Science and Technology, India (SR/FT/LS-063/2008); Richard L. Whelan was supported in part by philanthropy (grateful patients) and Hospital Start-up funds; Rupesh Chaturvedi was supported by a grant from US NIH National Center for Complementary and Alternative Medicine (K01AT007324). W. Nicol Keith & Alan Bilsland were supported by the University of Glasgow, Beatson Oncology Centre Fund, and Cancer Research UK (http://www.cancerresearchuk.org) grant C301/A14762.	Abu-Eid R, 2014, CANCER IMMUNOL RES, V2, P1080, DOI 10.1158/2326-6066.CIR-14-0095; Administration. USFaD, 2009, FOOD ADD STAT LIST; Almeida L, 2009, MOL NUTR FOOD RES, V53, pS7, DOI 10.1002/mnfr.200800177; Etminan M, 2004, CANCER EPIDEM BIOMAR, V13, P340; El-Rayes BF, 2011, INVEST NEW DRUG, V29, P694, DOI 10.1007/s10637-010-9386-6; Guo LD, 2013, PHYTOTHER RES, V27, P422, DOI 10.1002/ptr.4731; Beck JT, 2014, CANCER TREAT REV, V40, P980, DOI 10.1016/j.ctrv.2014.06.006; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Balkwill F, 2010, CLIN PHARMACOL THER, V87, P401, DOI 10.1038/clpt.2009.312; Friberg C, 2006, J INVEST DERMATOL, V126, P998, DOI 10.1038/sj.jid.5700194; Aggarwal BB, 2009, CURR OPIN PHARMACOL, V9, P351, DOI 10.1016/j.coph.2009.06.020; Aggarwal BB, 2006, BIOCHEM PHARMACOL, V72, P1605, DOI 10.1016/j.bcp.2006.06.029; Aggarwal S, 2006, MOL PHARMACOL, V69, P195, DOI 10.1124/mol.105.017400; Kim DC, 2005, BIOL PHARM BULL, V28, P2220, DOI 10.1248/bpb.28.2220; Giliano NY, 2010, B EXP BIOL MED+, V149, P78; Li RJ, 2014, J HUAZHONG U SCI-MED, V34, P234, DOI 10.1007/s11596-014-1264-6; Afaq F, 2005, PHOTOCHEM PHOTOBIOL, V81, P38, DOI 10.1562/2004-08-06-RA-264.1; Gu SC, 2011, MOL MED, V17, P48, DOI 10.2119/molmed.2010.00120; Min JW, 2013, BIOCHEM BIOPH RES CO, V440, P137, DOI 10.1016/j.bbrc.2013.09.041; Goto T, 1999, CLIN CANCER RES, V5, P1411; Mantovani A, 2009, NATURE, V457, P36, DOI 10.1038/457036b; Lazennec G, 2010, TRENDS MOL MED, V16, P133, DOI 10.1016/j.molmed.2010.01.003; Ma Y, 2011, CANCER LETT, V301, P75, DOI 10.1016/j.canlet.2010.10.022; Karius T, 2012, BIOCHEM PHARMACOL, V83, P1591, DOI 10.1016/j.bcp.2012.02.004; Bishayee A, 2009, CANCER PREV RES, V2, P409, DOI 10.1158/1940-6207.CAPR-08-0160; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Hussain SP, 2007, INT J CANCER, V121, P2373, DOI 10.1002/ijc.23173; Bishayee A, 2010, CANCER PREV RES, V3, P753, DOI 10.1158/1940-6207.CAPR-09-0171; Falchetti R, 2001, LIFE SCI, V70, P81, DOI 10.1016/S0024-3205(01)01367-4; Jin Z, 2009, INT J CANCER, V125, P2229, DOI 10.1002/ijc.24612; FUJISAWA H, 1995, J NEUROCHEM, V64, P85; Krieg C, 2009, SEMIN CANCER BIOL, V19, P76, DOI 10.1016/j.semcancer.2008.10.011; Korkaya H, 2011, CLIN CANCER RES, V17, P6125, DOI 10.1158/1078-0432.CCR-10-2743; Chen WS, 2001, INT J CANCER, V91, P894, DOI 10.1002/1097-0215(200102)9999:9999<894::AID-IJC1146>3.0.CO;2-#; Connelly L, 2011, ONCOGENE, V30, P1402, DOI 10.1038/onc.2010.521; Liu Q, 2003, CARCINOGENESIS, V24, P637, DOI 10.1093/carcin/bgg014; Li J, 2011, BASIC CLIN PHARMACOL, V108, P84, DOI 10.1111/j.1742-7843.2010.00613.x; Jendrossek V, 2013, CANCER LETT, V332, P313, DOI 10.1016/j.canlet.2011.01.012; Chang CM, 2012, ONCOL REP, V28, P1799, DOI 10.3892/or.2012.1991; Di X, 2008, HUM REPROD, V23, P1873, DOI 10.1093/humrep/den087; Clark PE, 2006, UROLOGY, V67, P1257, DOI 10.1016/j.urology.2005.12.035; Faurschou A, 2008, J INVEST DERMATOL, V128, P2069, DOI 10.1038/jid.2008.19; Choe YJ, 2012, ONCOL REP, V28, P2049, DOI 10.3892/or.2012.2034; Anand P, 2007, MOL PHARM, V4, P807, DOI 10.1021/mp700113r; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Fujita Y, 2012, INVEST NEW DRUG, V30, P1878, DOI 10.1007/s10637-011-9749-7; Drenckhan A, 2013, J SURG RES, V182, P250, DOI 10.1016/j.jss.2012.09.035; Bishayee A, 2012, CURR CANCER DRUG TAR, V12, P1191; Ahmed S, 2002, FREE RADICAL BIO MED, V33, P1097, DOI 10.1016/S0891-5849(02)01004-3; Amiri F, 2013, EUR J PHARMACOL, V718, P34, DOI 10.1016/j.ejphar.2013.09.020; Jiang JM, 2006, GENE CHROMOSOME CANC, V45, P103, DOI 10.1002/gcc.20264; Lanzilli G, 2006, INT J ONCOL, V28, P641; Isbrucker RA, 2006, FOOD CHEM TOXICOL, V44, P636, DOI 10.1016/j.fct.2005.11.003; Gil M, 2013, P NATL ACAD SCI USA, V110, pE1291, DOI 10.1073/pnas.1220580110; Deng YT, 2011, J AGR FOOD CHEM, V59, P13318, DOI 10.1021/jf204149c; Hadad N, 2012, FREE RADICAL BIO MED, V53, P1381, DOI 10.1016/j.freeradbiomed.2012.07.078; He H, 2006, CANCER, V106, P1243, DOI 10.1002/cncr.21694; Lu YP, 2005, CARCINOGENESIS, V26, P1465, DOI 10.1093/carcin/bgi086; Jonker D, 2003, REGUL TOXICOL PHARM, V37, P396, DOI 10.1016/S0273-2300(03)00013-8; Lee J, 2012, NUTR CANCER, V64, P153, DOI 10.1080/01635581.2012.630161; Mantovani A, 2010, CYTOKINE GROWTH F R, V21, P27, DOI 10.1016/j.cytogfr.2009.11.007; COFFER PJ, 1991, EUR J BIOCHEM, V201, P475, DOI 10.1111/j.1432-1033.1991.tb16305.x; Juarez J, 2003, LEUKEMIA, V17, P1294, DOI 10.1038/sj.leu.2402998; Hara E, 1996, BIOCHEM BIOPH RES CO, V224, P153, DOI 10.1006/bbrc.1996.0999; Huang X, 2009, MOL CELL, V35, P856, DOI 10.1016/j.molcel.2009.09.006; Junker A, 2009, BRAIN, V132, P3342, DOI 10.1093/brain/awp300; JONES PF, 1991, P NATL ACAD SCI USA, V88, P4171, DOI 10.1073/pnas.88.10.4171; Cassinelli G, 2013, CURR MED CHEM, V20, P1923; Ghaemi A, 2012, IRAN J IMMUNOL, V9, P119, DOI IJIv9i2A5; Hu HY, 2013, J BIOL CHEM, V288, P10973, DOI 10.1074/jbc.M112.434340; Aggarwal BB, 2006, BIOCHEM PHARMACOL, V71, P1397, DOI 10.1016/j.bcp.2006.02.009; Chow HHS, 2005, CLIN CANCER RES, V11, P4627, DOI 10.1158/1078-0432.CCR-04-2549; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Banerjee S, 2002, CANCER RES, V62, P4945; Bhattacharyya S, 2010, CELL MOL IMMUNOL, V7, P306, DOI 10.1038/cmi.2010.11; Lai KN, 2003, J PATHOL, V199, P496, DOI 10.1002/path.1291; Klotz T, 1998, CANCER, V82, P1897, DOI 10.1002/(SICI)1097-0142(19980515)82:10<1897::AID-CNCR12>3.3.CO;2-P; Eigner D, 1999, J ETHNOPHARMACOL, V67, P1, DOI 10.1016/S0378-8741(98)00234-7; Asaumi H, 2006, EUR J CLIN INVEST, V36, P113, DOI 10.1111/j.1365-2362.2006.01599.x; Hwang ES, 2004, J MED FOOD, V7, P284, DOI 10.1089/jmf.2004.7.284; Liu M, 2009, CELL RES, V19, P828, DOI 10.1038/cr.2009.72; Berasain C, 2009, ANN NY ACAD SCI, V1155, P206, DOI 10.1111/j.1749-6632.2009.03704.x; Bogatcheva NV, 2005, MICROVASC RES, V69, P107, DOI 10.1016/j.mvr.2005.01.007; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Lee W, 2012, FOOD CHEM TOXICOL, V50, P1826, DOI 10.1016/j.fct.2012.03.003; Kunter I, 2014, ONCOL REP, V31, P573, DOI 10.3892/or.2013.2932; Lev-Ari S, 2005, CLIN CANCER RES, V11, P6738, DOI 10.1158/1078-0432.CCR-05-0171; Caamano J, 2002, CLIN MICROBIOL REV, V15, P414, DOI 10.1128/CMR.15.3.414-429.2002; Goldmann T, 2008, VIRCHOWS ARCH, V452, P347, DOI 10.1007/s00428-008-0579-8; Harikumar KB, 2010, MOL CANCER RES, V8, P751, DOI 10.1158/1541-7786.MCR-09-0565; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Aravindaram K, 2010, PLANTA MED, V76, P1103, DOI 10.1055/s-0030-1249859; Howell JC, 2013, MOL VIS, V19, P544; Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009; Fuggetta MP, 2006, J EXP CLIN CANC RES, V25, P189; Amin ARMR, 2007, P NATL ACAD SCI USA, V104, P5419, DOI 10.1073/pnas.0700642104; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; He X, 2011, CANCER LETT, V301, P168, DOI 10.1016/j.canlet.2010.11.012; Almeida MI, 2010, CELL RES, V20, P603, DOI 10.1038/cr.2010.70; Chen YK, 2002, HEAD NECK-J SCI SPEC, V24, P925, DOI 10.1002/hed.10131; Inoue K, 2001, ONCOL REP, V8, P955; Jin FS, 2005, CANCER RES, V65, P6354, DOI 10.1158/0008-5472.CAN-04-4061; Guo DL, 2014, CURR PHARM DESIGN, V20, P2619; Barlow M, 2012, J PEDIATR SURG, V47, P1223, DOI 10.1016/j.jpedsurg.2012.03.031; Altamemi I, 2014, J PHARMACOL EXP THER, V350, P99, DOI 10.1124/jpet.114.213306; Hajri A, 1998, BRIT J CANCER, V78, P841, DOI 10.1038/bjc.1998.591; Guo R, 2014, DIABETES VASC DIS RE, V11, P92, DOI 10.1177/1479164113520332; Balkwill F, 2005, CANCER CELL, V7, P211, DOI 10.1016/j.ccr.2005.02.013; Giese NA, 2002, CANCER GENE THER, V9, P432, DOI 10.1038/sj/cgt/7700457; Lee-Chang C, 2013, J IMMUNOL, V191, P4141, DOI 10.4049/jimmunol.1300606; Marienfeld R, 2003, J BIOL CHEM, V278, P19852, DOI 10.1074/jbc.M301945200; Chen G, 2012, J BIOL CHEM, V287, P12132, DOI 10.1074/jbc.M111.302299; Hushmendy S, 2009, NUTR RES, V29, P568, DOI 10.1016/j.nutres.2009.08.003; Askling J, 2009, ANN RHEUM DIS, V68, P648, DOI 10.1136/ard.2007.085852; Li W, 2013, CURR MED CHEM, V20, P4185; Fosslien E, 2000, ANN CLIN LAB SCI, V30, P3; Benetou V, 2008, CANCER EPIDEM BIOMAR, V17, P387, DOI 10.1158/1055-9965.EPI-07-2665; Maheshwari RK, 2006, LIFE SCI, V78, P2081, DOI 10.1016/j.lfs.2005.12.007; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Gupta SC, 2010, CANCER METAST REV, V29, P405, DOI 10.1007/s10555-010-9235-2; Haas P, 2009, INT J FOOD SCI NUTR, V60, P1, DOI 10.1080/09637480802183380; May MJ, 1997, SEMIN CANCER BIOL, V8, P63, DOI 10.1006/scbi.1997.0057; Lee HJ, 2014, WORLD J GASTROENTERO, V20, P1681, DOI 10.3748/wjg.v20.i7.1681; Ireson C, 2001, CANCER RES, V61, P1058; Kane AJ, 2001, BRIT J PHARMACOL, V132, P1631, DOI 10.1038/sj.bjp.0703944; Chen SF, 2013, MINI-REV MED CHEM, V13, P1272; Kundu JK, 2010, PHARM RES-DORDR, V27, P999, DOI 10.1007/s11095-010-0096-8; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Dubois RN, 1998, FASEB J, V12, P1063; Johnson JJ, 2011, CANCER LETT, V305, P1, DOI 10.1016/j.canlet.2011.02.005; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Biswas S, 2004, PROSTAG LEUKOTR ESS, V71, P277, DOI 10.1016/j.plefa.2004.03.021; Mavrakis KJ, 2010, NAT CELL BIOL, V12, P372, DOI 10.1038/ncb2037; Bao B, 2012, CANCER RES, V72, P335, DOI 10.1158/0008-5472.CAN-11-2182; Mohamad NA, 2009, WORLD J GASTROENTERO, V15, P1065, DOI 10.3748/wjg.15.1065; Donovan JL, 2004, DRUG METAB DISPOS, V32, P906, DOI 10.1124/dmd.104.000083; Farghali H, 2009, NITRIC OXIDE-BIOL CH, V21, P216, DOI 10.1016/j.niox.2009.09.004; Chun KS, 2003, CARCINOGENESIS, V24, P1515, DOI 10.1093/carcin/bgg107; Bandi N, 2009, CANCER RES, V69, P5553, DOI 10.1158/0008-5472.CAN-08-4277; Brindicci C, 2009, CHEST, V135, P353, DOI 10.1378/chest.08-0964; Chen EP, 2011, PROSTAG OTH LIPID M, V96, P14, DOI 10.1016/j.prostaglandins.2011.08.005; Bellocq A, 1998, AM J PATHOL, V152, P83; Lee YG, 2011, FRONT BIOSCI-LANDMRK, V16, P517, DOI 10.2741/3702; Ganiger S, 2007, FOOD CHEM TOXICOL, V45, P64, DOI 10.1016/j.fct.2006.07.016; Huang CS, 2007, J NUTR BIOCHEM, V18, P449, DOI 10.1016/j.jnutbio.2006.08.007; Li B, 2009, CANCER RES, V69, P338, DOI 10.1158/0008-5472.CAN-08-1565; DeNardo D, 2010, CANCER METAST REV, V29, P309, DOI 10.1007/s10555-010-9223-6; Disis ML, 2010, J CLIN ONCOL, V28, P4531, DOI 10.1200/JCO.2009.27.2146; Ji C, 2012, BIOCHEM BIOPH RES CO, V421, P462, DOI 10.1016/j.bbrc.2012.04.012; Melo SA, 2014, SEMIN CANCER BIOL, V27, P46, DOI 10.1016/j.semcancer.2014.02.012; Carrasco C, 2014, MOL CELL BIOCHEM, V387, P217, DOI 10.1007/s11010-013-1887-0; Coussens LM, 2013, SCIENCE, V339, P286, DOI 10.1126/science.1232227; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; Chen PN, 2006, CHEM-BIOL INTERACT, V163, P218, DOI 10.1016/j.cbi.2006.08.003; Greathouse KL, 2012, MOL CANCER RES, V10, P546, DOI 10.1158/1541-7786.MCR-11-0605; Kulbe H, 2007, CANCER RES, V67, P585, DOI 10.1158/0008-5472.CAN-06-2941; Bach JP, 2009, CANCER, V115, P2031, DOI 10.1002/cncr.24245; Li HX, 2013, MOL CELL BIOCHEM, V382, P137, DOI 10.1007/s11010-013-1728-1; Feng WY, 2006, CURR DRUG METAB, V7, P755; Lerner M, 2009, EXP CELL RES, V315, P2941, DOI 10.1016/j.yexcr.2009.07.001; Cho KS, 2013, ONCOL LETT, V6, P933, DOI 10.3892/ol.2013.1515; Ma N, 2001, INT J RADIAT ONCOL, V50, P1041, DOI 10.1016/S0360-3016(01)01596-6; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Li YY, 2014, CANCER LETT, V346, P197, DOI 10.1016/j.canlet.2014.01.012; Gharib A, 2013, SKIN PHARMACOL PHYS, V26, P68, DOI 10.1159/000345761; Matysiak M, 2013, J IMMUNOL, V190, P5102, DOI 10.4049/jimmunol.1202397; Mariette X, 2010, ANN RHEUM DIS, V69, P400, DOI 10.1136/ard.2009.117762; Ferenc P, 2010, J PHOTOCH PHOTOBIO B, V98, P25, DOI 10.1016/j.jphotobiol.2009.10.004; Kuo PL, 2003, J BIOMED SCI, V10, P219, DOI 10.1159/000068711; Li WT, 2014, CANCER INVEST, V32, P409, DOI 10.3109/07357907.2014.933235; Burn J, 2011, CANCER PREV RES, V4, P655, DOI 10.1158/1940-6207.CAPR-11-0106; Martin AR, 2004, BIOCHEM PHARMACOL, V67, P1399, DOI 10.1016/j.bcp.2003.12.024; Moghaddam SJ, 2009, CARCINOGENESIS, V30, P1949, DOI 10.1093/carcin/bgp229; DiDonato JA, 2012, IMMUNOL REV, V246, P379, DOI 10.1111/j.1600-065X.2012.01099.x; Almeida A, 2004, NAT CELL BIOL, V6, P45, DOI 10.1038/ncb1080; Jones SW, 2009, OSTEOARTHR CARTILAGE, V17, P464, DOI 10.1016/j.joca.2008.09.012; Gong LJ, 2003, ONCOGENE, V22, P4702, DOI 10.1038/sj.onc.1206583; Baumgarten SC, 2012, MOL ENDOCRINOL, V26, P360, DOI 10.1210/me.2011-1302; Liang CZ, 2012, ANTI-CANCER AGENT ME, V12, P554; Mittelbronn M, 2011, ACTA NEUROPATHOL, V122, P353, DOI 10.1007/s00401-011-0858-3; Lo MC, 2013, CANCER LETT, V335, P81, DOI 10.1016/j.canlet.2013.01.052; Giovannucci E, 1999, J NATL CANCER I, V91, P317, DOI 10.1093/jnci/91.4.317; Greenhough A, 2009, CARCINOGENESIS, V30, P377, DOI 10.1093/carcin/bgp014; Bhaumik D, 2008, ONCOGENE, V27, P5643, DOI 10.1038/onc.2008.171; Carroll RE, 2011, CANCER PREV RES, V4, P354, DOI 10.1158/1940-6207.CAPR-10-0098; Ling L, 1998, P NATL ACAD SCI USA, V95, P3792, DOI 10.1073/pnas.95.7.3792; Khor TO, 2008, PLANTA MED, V74, P1540, DOI 10.1055/s-0028-1088303; Flores MBS, 2012, GASTROENTEROLOGY, V143, P741, DOI 10.1053/j.gastro.2012.05.045; Ju J, 2005, CANCER RES, V65, P10623, DOI 10.1158/0008-5472-05-1949; Lopez-Rivera E, 2014, CANCER RES, V74, P1067, DOI 10.1158/0008-5472.CAN-13-0588; Boldin MP, 2011, J EXP MED, V208, P1189, DOI 10.1084/jem.20101823; Gowda R, 2013, MOL CANCER THER, V12, P3, DOI 10.1158/1535-7163.MCT-12-0492; Lev-Ari S, 2014, J NUTR BIOCHEM, V25, P843, DOI 10.1016/j.jnutbio.2014.03.014; Binder C, 1999, LAB INVEST, V79, P1703; Messing E, 2012, CANCER PREV RES, V5, P621, DOI 10.1158/1940-6207.CAPR-11-0455; Brest P, 2011, NAT GENET, V43, P242, DOI 10.1038/ng.762; Kim D, 2001, FASEB J, V15, P1953, DOI 10.1096/fj.01-0198com; BELLACOSA A, 1991, SCIENCE, V254, P274, DOI 10.1126/science.1833819; Lee B, 2005, J NUTR, V135, P2767; Linsley PS, 2007, MOL CELL BIOL, V27, P2240, DOI 10.1128/MCB.02005-06; Kitano H, 1999, THYROID, V9, P113, DOI 10.1089/thy.1999.9.113; Hill MM, 2002, PHARMACOL THERAPEUT, V93, P243, DOI 10.1016/S0163-7258(02)00193-6; Jeong YI, 2009, J BIOL CHEM, V284, P3700, DOI 10.1074/jbc.M807328200; Makrygiannakis D, 2006, ANN RHEUM DIS, V65, P1219, DOI 10.1136/ard.2005.049403; Kojima M, 1999, J SURG ONCOL, V70, P222, DOI 10.1002/(SICI)1096-9098(199904)70:4<222::AID-JSO5>3.0.CO;2-G; Hussain F, 2013, MOL CANCER THER, V12, P1223, DOI 10.1158/1535-7163.MCT-12-0988; Dolcet X, 2005, VIRCHOWS ARCH, V446, P475, DOI 10.1007/s00428-005-1264-9; Hojo S, 2007, CANCER RES, V67, P4725, DOI 10.1158/0008-5472.CAN-06-3424; Kundu JK, 2006, CARCINOGENESIS, V27, P1465, DOI 10.1093/carcin/bgi349; Kirsh VA, 2006, CANCER EPIDEM BIOMAR, V15, P92, DOI 10.1158/1055-9965.EPI-05-0563; GAO YT, 1994, J NATL CANCER I, V86, P855, DOI 10.1093/jnci/86.11.855; Meyer-Siegler KL, 2006, J IMMUNOL, V177, P8730; Kim YS, 2009, CANCER PREV RES, V2, P200, DOI 10.1158/1940-6207.CAPR-08-0141; Keystone EC, 2009, ANN RHEUM DIS, V68, P789, DOI 10.1136/ard.2008.099010; Asare Y, 2013, THROMB HAEMOSTASIS, V109, P391, DOI 10.1160/TH12-11-0831; Lee YK, 2010, ONCOL REP, V24, P1471, DOI 10.3892/or_00001007; Luthra R, 2008, ONCOGENE, V27, P6667, DOI 10.1038/onc.2008.256; Li L, 2014, FOOD CHEM TOXICOL, V63, P166, DOI 10.1016/j.fct.2013.08.036; Kim GY, 2004, IMMUNOLOGY, V113, P203, DOI 10.1046/j.1365-2567.2004.01945.x; Bielecki A, 2011, NUTR CANCER, V63, P139, DOI 10.1080/01635581.2010.516867; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Li Q, 2014, J AGR FOOD CHEM, V62, P10928, DOI 10.1021/jf502950u; Freedman ND, 2008, INT J CANCER, V122, P2330, DOI 10.1002/ijc.23319; Dhawan P, 2002, J LEUKOCYTE BIOL, V72, P9; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Balkwill F, 2006, CANCER METAST REV, V25, P409, DOI 10.1007/s10555-006-9005-3; Bishayee A, 2010, PHARM RES-DORDR, V27, P1080, DOI 10.1007/s11095-010-0144-4; Laveti Durgaprasad, 2013, Inflammation & Allergy Drug Targets, V12, P349; Miyazawa T, 1999, J AGR FOOD CHEM, V47, P1083, DOI 10.1021/jf9809582; Grosch S, 2001, FASEB J, V15, P2742, DOI 10.1096/fj.01-0299fje; FEINSTEIN DL, 1994, J NEUROCHEM, V62, P811; Allred CD, 2001, CANCER RES, V61, P5045; Cai CK, 2012, ONCOL REP, V28, P1764, DOI 10.3892/or.2012.1995; Lutz NW, 2003, FEBS LETT, V544, P123, DOI 10.1016/S0014-5793(03)00489-7; Gagliano N, 2005, BIOMED PHARMACOTHER, V59, P359, DOI 10.1016/j.biopha.2005.06.001; HAVELL EA, 1988, J EXP MED, V167, P1067, DOI 10.1084/jem.167.3.1067; Arber N, 2006, NEW ENGL J MED, V355, P885, DOI 10.1056/NEJMoa061652; Krystal GW, 2002, MOL CANCER THER, V1, P913; Kim KH, 2011, J INVEST DERMATOL, V131, P195, DOI 10.1038/jid.2010.250; Kundu JK, 2005, MUTAT RES-FUND MOL M, V591, P123, DOI 10.1016/j.mrfmmm.2005.04.019; Kim SH, 2009, ANN NY ACAD SCI, V1171, P495, DOI 10.1111/j.1749-6632.2009.04899.x; Bell D, 1999, J EXP MED, V190, P1417, DOI 10.1084/jem.190.10.1417; Bernard MP, 2010, VACCINE, V28, P1363, DOI 10.1016/j.vaccine.2009.11.005; Lavon I, 2000, NAT MED, V6, P573; Marks F, 2000, EUR J CANCER, V36, P314, DOI 10.1016/S0959-8049(99)00318-4; Marcotorchino J, 2012, MOL NUTR FOOD RES, V56, P725, DOI 10.1002/mnfr.201100623; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Cheng AL, 2001, ANTICANCER RES, V21, P2895; Aggarwal BB, 2009, CLIN CANCER RES, V15, P425, DOI 10.1158/1078-0432.CCR-08-0149; Ireson CR, 2002, CANCER EPIDEM BIOMAR, V11, P105; Ellie E, 1995, NEUROREPORT, V7, P294, DOI 10.1097/00001756-199512000-00070; Bifulco C, 2008, CURR PHARM DESIGN, V14, P3790; Gironella M, 2007, P NATL ACAD SCI USA, V104, P16170, DOI 10.1073/pnas.0703942104; de Nigris F, 2012, RECENT PAT ANTI-CANC, V7, P251; Brindicci C, 2007, CHEST, V132, P581, DOI 10.1378/chest.06-3046; Hasegawa K, 2005, INT J ONCOL, V26, P1419; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Bazzoni F, 2009, P NATL ACAD SCI USA, V106, P5282, DOI 10.1073/pnas.0810909106; Chainani-Wu N, 2003, J ALTERN COMPLEM MED, V9, P161, DOI 10.1089/107555303321223035; Jiang SA, 2010, CANCER RES, V70, P3119, DOI 10.1158/0008-5472.CAN-09-4250; Dhillon N, 2008, CLIN CANCER RES, V14, P4491, DOI 10.1158/1078-0432.CCR-08-0024; Lodish HF, 2008, NAT REV IMMUNOL, V8, P120, DOI 10.1038/nri2252; Gomez LS, 2013, BIOCHIMIE, V95, P1336, DOI 10.1016/j.biochi.2013.02.013; Biswas S, 2010, P NATL ACAD SCI USA, V107, P6976, DOI 10.1073/pnas.1001653107; Chen PN, 2006, CANCER LETT, V235, P248, DOI 10.1016/j.canlet.2005.04.033; Ganster RW, 2001, P NATL ACAD SCI USA, V98, P8638, DOI 10.1073/pnas.151239498; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; Howells LM, 2011, INT J CANCER, V129, P476, DOI 10.1002/ijc.25670; Chakrabarti M, 2012, BRAIN RES, V1454, P1, DOI 10.1016/j.brainres.2012.03.017; Dong R, 2007, BRAZ J MED BIOL RES, V40, P1071, DOI 10.1590/S0100-879X2007000800007; Garcea G, 2005, CANCER EPIDEM BIOMAR, V14, P120; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Mestdagh P, 2010, MOL CELL, V40, P762, DOI 10.1016/j.molcel.2010.11.038; Berletch JB, 2008, J CELL BIOCHEM, V103, P509, DOI 10.1002/jcb.21417; Hwang KC, 2002, J CARDIOVASC PHARM, V39, P271, DOI 10.1097/00005344-200202000-00014; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Chung S, 2011, BBA-MOL BASIS DIS, V1812, P581, DOI 10.1016/j.bbadis.2011.02.003; Goo YA, 2007, PROTEOM CLIN APPL, V1, P513, DOI 10.1002/prca.200600511; Knop FK, 2013, DIABETIC MED, V30, P1214, DOI 10.1111/dme.12231; Liu B, 2014, MOL MED REP, V10, P1697, DOI 10.3892/mmr.2014.2406; Madka V, 2013, CURR CANCER DRUG TAR, V13, P542; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Franciszkiewicz K, 2012, CANCER RES, V72, P6325, DOI 10.1158/0008-5472.CAN-12-2027; Cerella C, 2010, BIOCHEM PHARMACOL, V80, P1801, DOI 10.1016/j.bcp.2010.06.050; Ahuja KDK, 2006, NUTRITION, V22, P259, DOI 10.1016/j.nut.2005.07.015; Bachmeier BE, 2008, CARCINOGENESIS, V29, P779, DOI 10.1093/carcin/bgm248; Chen Y, 2007, IN VIVO, V21, P365; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; De Ledinghen V, 2001, INT J ONCOL, V19, P83; Gescher A, 2013, ANN NY ACAD SCI, V1290, P12, DOI 10.1111/nyas.12205; Guo TL, 2007, CARCINOGENESIS, V28, P2560, DOI 10.1093/carcin/bgm223; Bishayee A, 2009, CHEM-BIOL INTERACT, V179, P131, DOI 10.1016/j.cbi.2008.11.015; Liu CY, 1998, BRIT J CANCER, V78, P534, DOI 10.1038/bjc.1998.528; Bluestone JA, 2009, NAT REV IMMUNOL, V9, P811, DOI 10.1038/nri2654; Bertazza L, 2010, CURR MED CHEM, V17, P3337; Choi S, 2012, J IMMUNOL, V189, P3905, DOI 10.4049/jimmunol.1102152; Hussain T, 2005, INT J CANCER, V113, P660, DOI 10.1002/ijc.20629; Cobb JP, 1999, SURGERY, V126, P438, DOI 10.1016/S0039-6060(99)70189-3; Eck M, 2003, CLIN EXP IMMUNOL, V134, P508, DOI 10.1046/j.1365-2249.2003.02305.x; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Gupta SC, 2010, BBA-GENE REGUL MECH, V1799, P775, DOI 10.1016/j.bbagrm.2010.05.004; Goel A, 2001, CANCER LETT, V172, P111, DOI 10.1016/S0304-3835(01)00655-3; Ginestier C, 2010, J CLIN INVEST, V120, P485, DOI [10.1172/JCI39397, 10.1172/JC139397]; Andreasson K, 2010, PROSTAG OTH LIPID M, V91, P104, DOI 10.1016/j.prostaglandins.2009.04.003; LINGEN C, 1959, EXP CELL RES, V16, P384, DOI 10.1016/0014-4827(59)90267-8; Dryden GW, 2013, INFLAMM BOWEL DIS, V19, P1904, DOI 10.1097/MIB.0b013e31828f5198; He WA, 2013, J CLIN INVEST, V123, P4821, DOI 10.1172/JCI68523; Hansel TT, 2003, FASEB J, V17, P1298, DOI 10.1096/fj.02-0633fje; Anttila MA, 2007, GYNECOL ONCOL, V105, P97, DOI 10.1016/j.ygyno.2006.10.049; Mineharu Y, 2012, NEUROTHERAPEUTICS, V9, P827, DOI 10.1007/s13311-012-0144-7; Borghese F, 2011, EXPERT OPIN THER TAR, V15, P237, DOI 10.1517/14728222.2011.550879; Grivennikov SI, 2010, CURR OPIN GENET DEV, V20, P65, DOI 10.1016/j.gde.2009.11.004; Chen ML, 2012, MOL NUTR FOOD RES, V56, P889, DOI 10.1002/mnfr.201100683; Jadeski LC, 1999, AM J PATHOL, V155, P1381, DOI 10.1016/S0002-9440(10)65240-6; Mazzanti G, 2009, EUR J CLIN PHARMACOL, V65, P331, DOI 10.1007/s00228-008-0610-7; Ishigami S, 2000, CANCER, V88, P577, DOI 10.1002/(SICI)1097-0142(20000201)88:3<577::AID-CNCR13>3.0.CO;2-V; Koh E, 1999, CANCER LETT, V146, P173, DOI 10.1016/S0304-3835(99)00265-7; [Anonymous], 1999, TOX PROF LYC; Ishizaki T, 2006, INT J MOL MED, V17, P357; Lombardi L, 2013, CRIT REV ONCOL HEMAT, V88, P696, DOI 10.1016/j.critrevonc.2013.08.005; Li YW, 2009, CANCER RES, V69, P6704, DOI 10.1158/0008-5472.CAN-09-1298; Bucala R, 1996, FASEB J, V10, P1607; Billottet C, 2013, BBA-REV CANCER, V1836, P287, DOI 10.1016/j.bbcan.2013.08.002; KITAJIMA I, 1994, BIOCHEM BIOPH RES CO, V204, P244, DOI 10.1006/bbrc.1994.2451; Goulet AC, 2003, CANCER BIOL THER, V2, P713; Lee KY, 1999, J BIOL CHEM, V274, P13451, DOI 10.1074/jbc.274.19.13451; Hidaka H, 2002, CANCER, V95, P1206, DOI 10.1002/cncr.10812; Baek SJ, 2002, CARCINOGENESIS, V23, P425, DOI 10.1093/carcin/23.3.425; Borm PJA, 1996, TOXICOL LETT, V88, P109; Cui XL, 2010, CANCER PREV RES, V3, P549, DOI 10.1158/1940-6207.CAPR-09-0117; Kundu JK, 2012, FREE RADICAL BIO MED, V52, P2013, DOI 10.1016/j.freeradbiomed.2012.02.035; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Banerjee S, 2008, CANCER LETT, V269, P226, DOI 10.1016/j.canlet.2008.03.052; Boosani CS, 2007, BLOOD, V110, P1168, DOI 10.1182/blood-2007-01-066282; Babu SN, 2012, ASIAN PAC J CANCER P, V13, P1737, DOI 10.7314/APJCP.2012.13.5.1737; Beyne-Rauzy O, 2004, ONCOGENE, V23, P7507, DOI 10.1038/sj.onc.1208024; Akiyama M, 2003, CANCER RES, V63, P18; Khatami M, 2009, CELL BIOCHEM BIOPHYS, V55, P55, DOI 10.1007/s12013-009-9059-2; Duda DG, 2011, CLIN CANCER RES, V17, P2074, DOI 10.1158/1078-0432.CCR-10-2636; Abboud PA, 2008, EUR J PHARMACOL, V579, P411, DOI 10.1016/j.ejphar.2007.10.053; Hsu CP, 2012, J AGR FOOD CHEM, V60, P3686, DOI 10.1021/jf204619n; Huang JH, 2013, CLIN IMMUNOL, V149, P156, DOI 10.1016/j.clim.2013.07.006; Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Kogiso M, 2006, NUTRITION, V22, P802, DOI 10.1016/j.nut.2006.04.003; Kundu JK, 2008, MUTAT RES-REV MUTAT, V659, P15, DOI 10.1016/j.mrrev.2008.03.002; Arbiser JL, 1998, MOL MED, V4, P376; Jiang XG, 2008, ENDOCRINOLOGY, V149, P5366, DOI 10.1210/en.2008-0857; He ZY, 2011, CANCER INVEST, V29, P208, DOI 10.3109/07357907.2010.550592; Conroy H, 2010, QJM-INT J MED, V103, P831, DOI 10.1093/qjmed/hcq148; Brown VA, 2010, CANCER RES, V70, P9003, DOI 10.1158/0008-5472.CAN-10-2364; Lin A, 2003, SEMIN CANCER BIOL, V13, P107, DOI 10.1016/S1044-579X(02)00128-1; Lippitz BE, 2013, LANCET ONCOL, V14, pE218, DOI 10.1016/S1470-2045(12)70582-X; Fouad MA, 2013, HUM EXP TOXICOL, V32, P1067, DOI 10.1177/0960327113475679; Ali S, 2010, CANCER RES, V70, P3606, DOI 10.1158/0008-5472.CAN-09-4598; Karin M, 2009, IMMUNOL REV, V228, P225, DOI 10.1111/j.1600-065X.2008.00755.x; Maru DM, 2009, AM J PATHOL, V174, P1940, DOI 10.2353/ajpath.2009.080718; Cruz-Correa M, 2006, CLIN GASTROENTEROL H, V4, P1035, DOI 10.1016/j.cgh.2006.03.020; Li HQ, 2012, MINI-REV MED CHEM, V12, P350; Gaballah HE, 2001, MED ONCOL, V18, P171, DOI 10.1385/MO:18:3:171; Macarthur M, 2004, AM J PHYSIOL-GASTR L, V286, pG515, DOI 10.1152/ajpgi.00475.2003; FAJARDO LF, 1992, AM J PATHOL, V140, P539; Marczylo TH, 2007, CANCER CHEMOTH PHARM, V60, P171, DOI 10.1007/s00280-006-0355-x; Ahmad N, 2002, ARCH BIOCHEM BIOPHYS, V398, P125, DOI 10.1006/abbi.2001.2704; Calandra T, 1997, CRIT REV IMMUNOL, V17, P77; CALANDRA T, 1995, NATURE, V377, P68, DOI 10.1038/377068a0; Lin BQ, 2013, LUNG CANCER, V79, P111, DOI 10.1016/j.lungcan.2012.11.001; Marathe SA, 2011, EXPERT OPIN BIOL TH, V11, P1485, DOI 10.1517/14712598.2011.623124; Bishayee A, 2013, MOL CARCINOGEN, V52, P304, DOI 10.1002/mc.21860; DeClerck K, 2010, FRONT BIOSCI, V15, P213, DOI 10.2741/3616; Feldmann M, 1997, ADV IMMUNOL, V64, P283, DOI 10.1016/S0065-2776(08)60891-3; Aktas O, 2004, J IMMUNOL, V173, P5794; Fasanaro P, 2008, J BIOL CHEM, V283, P15878, DOI 10.1074/jbc.M800731200; Addison CL, 2000, HUM GENE THER, V11, P247, DOI 10.1089/10430340050015996; Jin Z, 2011, ONCOGENE, V30, P1577, DOI 10.1038/onc.2010.534; Matsunaga K, 2002, J INFECT DIS, V185, P229, DOI 10.1086/338449; Kim JM, 2013, MICROBIOL IMMUNOL, V57, P366, DOI 10.1111/1348-0421.12049; Malhotra A, 2012, ULTRASTRUCT PATHOL, V36, P179, DOI 10.3109/01913123.2011.652765; Di Tomo P, 2012, MOL NUTR FOOD RES, V56, P217, DOI 10.1002/mnfr.201100500; Bansal SS, 2011, PHARM RES-DORDR, V28, P1121, DOI 10.1007/s11095-011-0375-z; Faria A, 2010, PHYTOTHER RES, V24, P1862, DOI 10.1002/ptr.3213; Degterev A, 2003, ONCOGENE, V22, P8543, DOI 10.1038/sj.onc.1207107; du Rieu MC, 2010, CLIN CHEM, V56, P603, DOI 10.1373/clinchem.2009.137364; Giannakakis A, 2008, CANCER BIOL THER, V7, P255, DOI 10.4161/cbt.7.2.5297; Arumugam A, 2012, BIOCHEM BIOPH RES CO, V425, P177, DOI 10.1016/j.bbrc.2012.07.062; Marczylo TH, 2009, CANCER CHEMOTH PHARM, V64, P1261, DOI 10.1007/s00280-009-0996-7; Hattermann K, 2010, CANCER RES, V70, P3299, DOI 10.1158/0008-5472.CAN-09-3642; Haasch D, 2002, CELL IMMUNOL, V217, P78, DOI 10.1016/S0008-8749(02)00506-3; Jha RK, 2012, CELL BIOCHEM BIOPHYS, V62, P397, DOI 10.1007/s12013-011-9313-2; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Khaw AK, 2012, GENE CHROMOSOME CANC, V51, P961, DOI 10.1002/gcc.21979; Liu PP, 2014, CELL DEATH DIFFER, V21, P124, DOI 10.1038/cdd.2013.131; Hussain SP, 2003, NAT REV CANCER, V3, P276, DOI 10.1038/ncr1046; Cassileth B, 2010, ONCOLOGY-NY, V24, P296; Axelsson H, 2010, INT J ONCOL, V37, P1143, DOI 10.3892/ijo_00000766; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Loffler D, 2007, BLOOD, V110, P1330, DOI 10.1182/blood-2007-03-081133; Klein U, 2010, CANCER CELL, V17, P28, DOI 10.1016/j.ccr.2009.11.019; Huang CS, 1999, CARCINOGENESIS, V20, P237, DOI 10.1093/carcin/20.2.237; Doi K, 1996, CANCER-AM CANCER SOC, V77, P1598, DOI 10.1002/(SICI)1097-0142(19960415)77:8<1598::AID-CNCR27>3.0.CO;2-U; Burn J, 2011, LANCET, V378, P2081, DOI 10.1016/S0140-6736(11)61049-0; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Bongartz T, 2006, JAMA-J AM MED ASSOC, V295, P2275, DOI 10.1001/jama.295.19.2275; Hofmann CS, 2003, FASEB J, V17, P702, DOI 10.1096/fj.02-0665fje; Hwang KA, 2013, TOXICOL APPL PHARM, V272, P637, DOI 10.1016/j.taap.2013.07.027; Garcea G, 2004, BRIT J CANCER, V90, P1011, DOI 10.1038/sj.bjc.6601623; Huang HY, 2012, ONCOL REP, V27, P2050, DOI 10.3892/or.2012.1715; Jagadeesh S, 2006, CANCER RES, V66, P2107, DOI 10.1158/0008-5472.CAN-05-2494; Gantier MP, 2012, NUCLEIC ACIDS RES, V40, P8048, DOI 10.1093/nar/gks521; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Demaria S, 2010, J IMMUNOTHER, V33, P335, DOI 10.1097/CJI.0b013e3181d32e74; Cottart CH, 2014, MOL NUTR FOOD RES, V58, P7, DOI 10.1002/mnfr.201200589; Jung YD, 2001, INT J EXP PATHOL, V82, P309, DOI 10.1046/j.1365-2613.2001.00205.x; Hussain T, 2003, CANCER LETT, V191, P125, DOI 10.1016/S0304-3835(02)00524-4; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Howells LM, 2011, CANCER PREV RES, V4, P1419, DOI 10.1158/1940-6207.CAPR-11-0148; Grieb G, 2010, DRUG NEWS PERSPECT, V23, P257, DOI 10.1358/dnp.2010.23.4.1453629; Mann J, 2013, INT J DERMATOL, V52, P471, DOI 10.1111/j.1365-4632.2011.05336.x; Abraham AG, 2014, BIOCHEM SOC T, V42, P798, DOI 10.1042/BST20140070; Bureyko T, 2009, BRIT J NUTR, V101, P990, DOI 10.1017/S0007114508051684; Hamed EA, 2012, J CANCER RES CLIN, V138, P999, DOI 10.1007/s00432-012-1176-4; Li YW, 2010, CANCER RES, V70, P1486, DOI 10.1158/0008-5472.CAN-09-2792; Bonci D, 2008, NAT MED, V14, P1271, DOI 10.1038/nm.1880; FOTSIS T, 1993, P NATL ACAD SCI USA, V90, P2690, DOI 10.1073/pnas.90.7.2690; Ciesek S, 2011, HEPATOLOGY, V54, P1947, DOI 10.1002/hep.24610; Kristal AR, 2011, CANCER EPIDEM BIOMAR, V20, P638, DOI 10.1158/1055-9965.EPI-10-1221; Delhalle S, 2002, ONCOGENE, V21, P3917, DOI 10.1038/sj.onc.1205489; Herrera ACSA, 2012, CANCER IMMUNOL IMMUN, V61, P2193, DOI 10.1007/s00262-012-1283-8; Balkwill FR, 2012, J PATHOL, V226, P148, DOI 10.1002/path.3029; Baniyash M, 2014, CANCER IMMUNOL IMMUN, V63, P11, DOI 10.1007/s00262-013-1468-9; Baoping Yu, 2004, Dig Dis Sci, V49, P948, DOI 10.1023/B:DDAS.0000034553.58554.ab; Bentz BG, 2004, J CARCINOG, V3, P16, DOI DOI 10.1186/1477-3163-3-16; Bertagnolli MM, 2006, NEW ENGL J MED, V355, P873, DOI 10.1056/NEJMoa061355; Bishayee A, 2014, ADV EXP MED BIOL, V816, P401, DOI 10.1007/978-3-0348-0837-8_16; Bobanga Iuliana D, 2013, Vaccines (Basel), V1, P444, DOI 10.3390/vaccines1040444; Bocca C, 2014, EXPERT OPIN THER TAR, V18, P121, DOI 10.1517/14728222.2014.860447; Bonvissuto G., 2011, UROLOGY, V77, P248; Borsig I, 2014, ONCOGENE, V33, P3217; Buttari B, 2013, OXID MED CELL LONGEV, DOI 10.1155/2013/574029; Chang Yuan-hong, 2013, Zhongguo Zhong Xi Yi Jie He Za Zhi, V33, P1102; Chen JY, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0410-1; Chen L, 2015, CELL BIOCH BIOPHY; Cheng H, 2014, CANC LETT; Cho WCS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-60; Choudhary S, 2013, CARCINOGENESIS, V34, P2891, DOI 10.1093/carcin/bgt239; Chu HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018108; Cichocki M, 2008, MOL NUTR FOOD RES, V52, pS62, DOI 10.1002/mnfr.200700466; Ciruelos G, 2014, CANC TREAT REV, V40, P862, DOI [10.1016/j.ctrv.2014.03.004, DOI 10.1016/J.CTRV.2014.03.004]; Cui XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053791; Dahiya N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002436; Dai W., 2013, NFAT MOL CARCINOG, V54, P301; Das R, 2013, P NATL ACAD SCI USA, V110, pE2997, DOI 10.1073/pnas.1301128110; Das UN, 2006, MED SCI MONITOR, V12, pRA79; White RWD, 2004, UROLOGY, V63, P259, DOI 10.1016/j.urology.2003.09.061; EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS), 2013, EFSA J, P11; Erasalo H, 2014, BASIC CLIN PHARMACOL, V116, P53; Feller I, 2013, ORAL ONCOL, V49, P887; Fernando TR, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-7; Fouad TM, 2014, ADV EXP MED BIOL, V816, P53, DOI 10.1007/978-3-0348-0837-8_3; Garufi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048342; Gatz SA, 2008, CARCINOGENESIS, V3, P3; Georgakilas AG, 2014, CANCER LETT, V353, P248, DOI 10.1016/j.canlet.2014.07.030; Grosz P, 1993, J EXP MED, V177, P1391; Ha Tai-You, 2011, Immune Netw, V11, P11, DOI 10.4110/in.2011.11.1.11; Haddad NF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062773; Han YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018286; Hasima Noor, 2012, Int J Biochem Mol Biol, V3, P328; Houede N, 2014, PHARM THER C, V145C, P1; Huang AC, 2013, IN VIVO, V27, P627; Institute NC, 1996, J CELL BIOCHEM, V26, P72; Ioannou K, 2014, INT J ONCOL, V45, P1457, DOI 10.3892/ijo.2014.2551; Iwasaki K, 2013, BIOCHEMISTRY-US, V52, P5075, DOI 10.1021/bi400399f; Jang JY, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-421; Jeon J, 2014, ANN DERMATOL, V26, P564, DOI 10.5021/ad.2014.26.5.564; Ji Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078700; Jiang JW, 2014, HUM IMMUNOL, V75, P1128, DOI 10.1016/j.humimm.2014.09.025; Jiao SF, 2014, J BIOMED SCI, V21, DOI 10.1186/1423-0127-21-1; Kanzler I, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-012-0310-4; Karadayi N, 2013, DIAGN PATHOL, V8, DOI [10.1186/1746-1596-8-151, 10.1186/1746-1596-8-152]; Karar J, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00051; Kumar S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049321; KUROSE I, 1995, J GASTROEN HEPATOL, V10, pS68, DOI 10.1111/j.1440-1746.1995.tb01803.x; Lao Christopher D, 2006, BMC Complement Altern Med, V6, P10, DOI 10.1186/1472-6882-6-10; Lee SJ, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-44; Lee SJ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-144; Lee Yong Soo, 2002, Journal of Environmental Pathology Toxicology and Oncology, V21, P113; Leibovich-Rivkin T, 2013, NEOPLASIA, V15, P1330, DOI 10.1593/neo.131688; Li HX, 2014, ARCH GYNECOL OBSTET, V290, P1067, DOI 10.1007/s00404-014-3377-3; Li XL, 2014, SCI REP-UK, V4, DOI 10.1038/srep04885; Liu LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073038; Itzkowitz SH, 2004, AM J PHYSIOL-GASTR L, V287, pG7, DOI 10.1152/ajpgi.00079.2004; Lu MS, 2014, EUR J NUTR; Lu Y, 2014, IN VITRO CELL DEV BI; Luanpitpong S., 2012, IMMUNOPATHOL DIS THE, V3, P141; lzzotti A, 2012, MUTAT RES; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Ma YT, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.27663; Maru GB, 2014, ADV EXP MED BIOL, V816, P437, DOI 10.1007/978-3-0348-0837-8_17; World Cancer Research Fund/American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; Sharma RA, 2001, CLIN CANCER RES, V7, P1894; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Obermajer N, 2012, IMMUNOL INVEST, V41, P635, DOI 10.3109/08820139.2012.695417; Murphy C, 2005, CLIN CANCER RES, V11, P4117, DOI 10.1158/1078-0432.CCR-04-1518; RAVINDRANATH V, 1980, TOXICOLOGY, V16, P259, DOI 10.1016/0300-483X(80)90122-5; Tokuhiro S, 2003, NAT GENET, V35, P341, DOI 10.1038/ng1267; Wu K, 2000, MOL CELL BIOL, V20, P1382, DOI 10.1128/MCB.20.4.1382-1393.2000; Xie KP, 1998, CANCER METAST REV, V17, P55, DOI 10.1023/A:1005956721457; Vickers SM, 1999, ARCH SURG-CHICAGO, V134, P245, DOI 10.1001/archsurg.134.3.245; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Pan MH, 1999, DRUG METAB DISPOS, V27, P486; Yang FJ, 2001, MOL PHARMACOL, V60, P528; Shi Q, 1999, CLIN CANCER RES, V5, P3711; Stanczyk J, 2008, ARTHRITIS RHEUM, V58, P1001, DOI 10.1002/art.23386; Tan PL, 1999, MOL CELL, V3, P527, DOI 10.1016/S1097-2765(00)80481-5; Woo CH, 2000, J BIOL CHEM, V275, P32357, DOI 10.1074/jbc.M005638200; PARK SK, 1994, J NEUROSCI RES, V39, P405, DOI 10.1002/jnr.490390407; Yu ZH, 2014, TUMOR BIOL, V35, P4637, DOI 10.1007/s13277-014-1607-8; Watanabe T, 2014, INT J CANCER, V134, P2373, DOI 10.1002/ijc.28582; Wei DY, 2004, CANCER RES, V64, P2030, DOI 10.1158/0008-5472.CAN-03-1945; RISCH HA, 1995, CANCER EPIDEM BIOMAR, V4, P447; Sarkar FH, 2009, CELL SIGNAL, V21, P1541, DOI 10.1016/j.cellsig.2009.03.009; Uppala PT, 2013, PHYTOTHER RES, V27, P595, DOI 10.1002/ptr.4764; Orlowski RZ, 2002, TRENDS MOL MED, V8, P385, DOI 10.1016/S1471-4914(02)02375-4; Palapattu GS, 2005, CARCINOGENESIS, V26, P1170, DOI 10.1093/carcin/bgh317; Tschugguel W, 1999, BREAST CANCER RES TR, V56, P145; Yoshida A, 1999, INVEST OPHTH VIS SCI, V40, P1624; van den Berg A, 2003, GENE CHROMOSOME CANC, V37, P20, DOI 10.1002/gcc.10186; Soares NDP, 2013, NUTR CANCER, V65, P1076, DOI 10.1080/01635581.2013.812225; Yoshida S, 1997, MOL CELL BIOL, V17, P4015; Scarpino S, 2000, AM J PATHOL, V156, P831, DOI 10.1016/S0002-9440(10)64951-6; Wang Y, 2012, CURR MOL MED, V12, P153; Rissland OS, 2011, MOL CELL, V43, P993, DOI 10.1016/j.molcel.2011.08.021; Waters JP, 2013, J PATHOL, V230, P241, DOI 10.1002/path.4188; Shen XY, 2014, INT J ONCOL, V44, P791, DOI 10.3892/ijo.2014.2251; Moreland LW, 1997, NEW ENGL J MED, V337, P141, DOI 10.1056/NEJM199707173370301; Zhang R, 2014, DIGEST DIS SCI, V59, P89, DOI 10.1007/s10620-013-2877-5; Sartor L, 2004, INT J CANCER, V112, P823, DOI 10.1002/ijc.20496; Xu Y, 2012, MOL ONCOL, V6, P405, DOI 10.1016/j.molonc.2012.03.005; Niwa R, 2007, CURR OPIN GENET DEV, V17, P145, DOI 10.1016/j.gde.2007.02.004; Vishvakarma NK, 2011, TOXICOL APPL PHARM, V252, P298, DOI 10.1016/j.taap.2011.03.002; Van Raemdonck K, 2014, ANGIOGENESIS, V17, P631, DOI 10.1007/s10456-014-9417-6; Woodall CE, 2009, ANTI-CANCER DRUG, V20, P437, DOI 10.1097/CAD.0b013e32832afb95; Porkka KP, 2011, GENE CHROMOSOME CANC, V50, P499, DOI 10.1002/gcc.20873; Peiffer DS, 2014, CANCER PREV RES, V7, P574, DOI 10.1158/1940-6207.CAPR-14-0003; Williams GM, 2008, EUR J CANCER PREV, V17, P169, DOI 10.1097/CEJ.0b013e3282b6fcff; Shachar I, 2011, LEUKEMIA LYMPHOMA, V52, P1446, DOI 10.3109/10428194.2011.565437; Valenti D, 2013, BBA-MOL BASIS DIS, V1832, P2085, DOI 10.1016/j.bbadis.2013.07.014; Wu CT, 2014, TUMOR BIOL, V35, P195, DOI 10.1007/s13277-013-1024-4; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; Wiens A, 2010, RHEUMATOL INT, V30, P1063, DOI 10.1007/s00296-009-1111-4; Yan LX, 2008, RNA, V14, P2348, DOI 10.1261/rna.1034808; Xu J, 2008, ANTIVIR RES, V78, P242, DOI 10.1016/j.antiviral.2007.11.011; Takano K, 2004, J AGR FOOD CHEM, V52, P4571, DOI 10.1021/jf0355194; Oh HY, 2010, BIOCHEM BIOPH RES CO, V393, P319, DOI 10.1016/j.bbrc.2010.01.133; Nishiya T, 1997, FEBS LETT, V408, P33, DOI 10.1016/S0014-5793(97)00383-9; Rahman MA, 2001, CLIN CANCER RES, V7, P1325; Sharma RA, 2004, CLIN CANCER RES, V10, P6847, DOI 10.1158/1078-0432.CCR-04-0744; Subbaramaiah K, 2000, J BIOL CHEM, V275, P14838, DOI 10.1074/jbc.275.20.14838; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Targownik LE, 2013, AM J GASTROENTEROL, V108, P1835, DOI 10.1038/ajg.2013.294; Tang YJ, 2009, ARTHRITIS RHEUM, V60, P1065, DOI 10.1002/art.24436; Schioppa T, 2011, P NATL ACAD SCI USA, V108, P10662, DOI 10.1073/pnas.1100994108; Wang F, 2009, BMB REP, V42, P725; Noh KH, 2009, MOL THER, V17, P439, DOI 10.1038/mt.2008.255; Paplomata E, 2014, THER ADV MED ONCOL, V6, P154, DOI 10.1177/1758834014530023; Wang X, 2009, ARCH PHARM RES, V32, P1263, DOI 10.1007/s12272-009-1912-8; Plummer SM, 1999, ONCOGENE, V18, P6013, DOI 10.1038/sj.onc.1202980; Wirleitner B, 2005, IMMUNOL LETT, V100, P159, DOI 10.1016/j.imlet.2005.03.008; Pavese JM, 2010, CANCER METAST REV, V29, P465, DOI 10.1007/s10555-010-9238-z; Sonkoly E, 2008, CLIN EXP DERMATOL, V33, P312, DOI 10.1111/j.1365-2230.2008.02804.x; Zhu GD, 2006, BIOORG MED CHEM LETT, V16, P3424, DOI 10.1016/j.bmcl.2006.04.005; Wang JH, 2008, J BIOL CHEM, V283, P4283, DOI 10.1074/jbc.M707465200; Tschugguel W, 1999, BRIT J CANCER, V79, P1609, DOI 10.1038/sj.bjc.6690256; Symonds EL, 2013, BRIT J NUTR, V109, P2117, DOI 10.1017/S0007114512004333; Ogawa K, 2012, ONCOL LETT, V4, P546, DOI 10.3892/ol.2012.761; PUSZTAI L, 1993, BRIT J CANCER, V67, P290, DOI 10.1038/bjc.1993.55; Moore AB, 2007, HUM REPROD, V22, P2623, DOI 10.1093/humrep/dem185; Montales MTE, 2012, CARCINOGENESIS, V33, P652, DOI 10.1093/carcin/bgr317; Mosieniak G, 2012, MECH AGEING DEV, V133, P444, DOI 10.1016/j.mad.2012.05.004; Palozza P, 2010, CARCINOGENESIS, V31, P1813, DOI 10.1093/carcin/bgq157; Shimizu M, 2005, CLIN CANCER RES, V11, P2735, DOI 10.1158/1078-0432.CCR-04-2014; Wei XC, 2012, EUR J MED CHEM, V53, P235, DOI 10.1016/j.ejmech.2012.04.005; Swana HS, 1999, J UROLOGY, V161, P630, DOI 10.1016/S0022-5347(01)61985-2; Mukhopadhyay A, 2001, ONCOGENE, V20, P7597, DOI 10.1038/sj.onc.1204997; Weitberg AB, 1999, J EXP CLIN CANC RES, V18, P433; Noh SU, 2008, INT IMMUNOPHARMACOL, V8, P1172, DOI 10.1016/j.intimp.2008.04.002; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Romagnani P, 2004, TRENDS IMMUNOL, V25, P201, DOI 10.1016/j.it.2004.02.006; Rieder J, 2001, GYNECOL ONCOL, V82, P172, DOI 10.1006/gyno.2001.6242; Tornatore L, 2012, TRENDS CELL BIOL, V22, P557, DOI 10.1016/j.tcb.2012.08.001; Wang LS, 2008, CANCER LETT, V269, P281, DOI 10.1016/j.canlet.2008.05.020; Rajaram MVS, 2006, J IMMUNOL, V177, P6317; Tamamura H, 2003, FEBS LETT, V550, P79, DOI 10.1016/S0014-5793(03)00824-X; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Shimizu M, 2008, CANCER EPIDEM BIOMAR, V17, P3020, DOI 10.1158/1055-9965.EPI-08-0528; Zhao HX, 1998, BLOOD, V92, P1031; Wallach D, 2008, CELL DEATH DIFFER, V15, P1533, DOI 10.1038/cdd.2008.41; Zhang SY, 2014, NUTR CANCER, V66, P315, DOI 10.1080/01635581.2014.868909; Privat M, 2010, ANTICANCER RES, V30, P2049; Szabolcs A, 2006, EUR J PHARMACOL, V532, P187, DOI 10.1016/j.ejphar.2006.01.055; Sampath D, 2013, LEUKEMIA RES, V37, P1461, DOI 10.1016/j.leukres.2013.07.034; Tsai SH, 1999, BRIT J PHARMACOL, V126, P673, DOI 10.1038/sj.bjp.0702357; Rioux JD, 2001, NAT GENET, V29, P223, DOI 10.1038/ng1001-223; Tili E, 2010, CARCINOGENESIS, V31, P1561, DOI 10.1093/carcin/bgq143; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; Shim HY, 2007, ANTI-CANCER DRUG, V18, P649, DOI 10.1097/CAD.0b013e3280825573; Mudduluru G, 2011, BIOSCIENCE REP, V31, P185, DOI 10.1042/BSR20100065; Wang ZW, 2011, J CELL BIOCHEM, V112, P78, DOI 10.1002/jcb.22770; Oshima H, 2014, ONCOGENE, V33, P3820, DOI 10.1038/onc.2013.356; Wang J, 2004, MOL CELL ENDOCRINOL, V219, P171, DOI 10.1016/j.mce.2003.12.018; Witte AV, 2014, J NEUROSCI, V34, P7862, DOI 10.1523/JNEUROSCI.0385-14.2014; Molnar J, 2004, IN VIVO, V18, P237; Zintzaras E, 2005, ARCH INTERN MED, V165, P2337, DOI 10.1001/archinte.165.20.2337; Rasyid A, 2002, ASIA PAC J CLIN NUTR, V11, P314, DOI 10.1046/j.1440-6047.2002.00296.x; Zhu H, 2012, MOL BIOL REP, V39, P4971, DOI 10.1007/s11033-011-1293-1; Polivka J, 2014, PHARMACOL THERAPEUT, V142, P164, DOI 10.1016/j.pharmthera.2013.12.004; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Yoon Y, 2007, CANCER RES, V67, P7518, DOI 10.1158/0008-5472.CAN-06-2263; Parker RS, 1996, FASEB J, V10, P542; Siddiqui IA, 2011, FASEB J, V25, P1198, DOI 10.1096/fj.10-167924; Song ZM, 2011, J COLLOID INTERF SCI, V354, P116, DOI 10.1016/j.jcis.2010.10.024; Sang SM, 2011, PHARMACOL RES, V64, P87, DOI 10.1016/j.phrs.2011.02.007; Mutamba JT, 2011, DNA REPAIR, V10, P1282, DOI 10.1016/j.dnarep.2011.10.008; Nogueira L, 2011, ONCOGENE, V30, P3537, DOI 10.1038/onc.2011.74; Tazzyman S, 2009, INT J EXP PATHOL, V90, P222, DOI 10.1111/j.1365-2613.2009.00641.x; Zhao JL, 2011, P NATL ACAD SCI USA, V108, P9184, DOI 10.1073/pnas.1105398108; Tili E, 2007, J IMMUNOL, V179, P5082; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Rasyid A, 1999, ALIMENT PHARM THERAP, V13, P245; Zhao ZQ, 2014, CANCER LETT, V342, P150, DOI 10.1016/j.canlet.2013.08.042; Tam W, 2001, GENE, V274, P157, DOI 10.1016/S0378-1119(01)00612-6; Sukhthankar M, 2008, GASTROENTEROLOGY, V134, P1972, DOI 10.1053/j.gastro.2008.02.095; Shaikh J, 2009, EUR J PHARM SCI, V37, P223, DOI 10.1016/j.ejps.2009.02.019; Schetter AJ, 2010, CARCINOGENESIS, V31, P37, DOI 10.1093/carcin/bgp272; Qiu X, 2013, CANCER PREV RES, V6, P419, DOI 10.1158/1940-6207.CAPR-12-0364; Rolle CE, 2012, ADV EXP MED BIOL, V746, P53, DOI 10.1007/978-1-4614-3146-6_5; Park SJ, 2010, CANCER LETT, V292, P54, DOI 10.1016/j.canlet.2009.11.004; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Olive V, 2009, GENE DEV, V23, P2839, DOI 10.1101/gad.1861409; Villegas FR, 2002, LUNG CANCER-J IASLC, V35, P23, DOI 10.1016/S0169-5002(01)00292-6; Toh ML, 2006, J IMMUNOL, V177, P4818; Schetter AJ, 2009, CLIN CANCER RES, V15, P5878, DOI 10.1158/1078-0432.CCR-09-0627; Weisburger JH, 1998, P SOC EXP BIOL MED, V218, P140; She QB, 2001, CANCER RES, V61, P1604; Villegas I, 2011, MOL NUTR FOOD RES, V55, P259, DOI 10.1002/mnfr.201000225; Vogt TM, 2002, AM J EPIDEMIOL, V155, P1023, DOI 10.1093/aje/155.11.1023; Schmid JA, 2008, CYTOKINE GROWTH F R, V19, P157, DOI 10.1016/j.cytogfr.2008.01.006; Odemis V, 2010, J CELL SCI, V123, P1081, DOI 10.1242/jcs.062810; Sies H, 1998, P SOC EXP BIOL MED, V218, P121; Tao L, 2014, MOL NUTR FOOD RES, V58, P665, DOI 10.1002/mnfr.201300427; Wilson KT, 1998, CANCER RES, V58, P2929; Schulz R, 2014, CURR OPIN ONCOL, V26, P108, DOI 10.1097/CCO.0000000000000036; Yuan JM, 2007, INT J CANCER, V120, P1344, DOI 10.1002/ijc.22460; Vaidyanathan JB, 2003, J PHARMACOL EXP THER, V307, P745, DOI 10.1124/jpet.103.054296; Tan J, 2013, CHIN J CANCER, V32, P376, DOI 10.5732/cjc.012.10287; Panis C, 2012, BREAST CANCER RES TR, V133, P881, DOI 10.1007/s10549-011-1851-1; Tsubaki M, 2013, EUR J CANCER, V49, P3708, DOI 10.1016/j.ejca.2013.07.010; Zhang F, 1999, CARCINOGENESIS, V20, P445, DOI 10.1093/carcin/20.3.445; Vandercappellen J, 2008, CANCER LETT, V267, P226, DOI 10.1016/j.canlet.2008.04.050; Singh B, 2008, J SURG RES, V147, P240, DOI 10.1016/j.jss.2008.02.026; Wen S, 2011, J NEURO-ONCOL, V104, P169, DOI 10.1007/s11060-010-0496-y; Nakasa T, 2008, ARTHRITIS RHEUM, V58, P1284, DOI 10.1002/art.23429; Punathil T, 2008, BIOCHEM BIOPH RES CO, V375, P162, DOI 10.1016/j.bbrc.2008.07.157; Vona-Davis L, 2013, J MAMMARY GLAND BIOL, V18, P291, DOI 10.1007/s10911-013-9299-z; Tili E, 2008, NAT CLIN PRACT RHEUM, V4, P534, DOI 10.1038/ncprheum0885; Sun SC, 2011, CELL RES, V21, P71, DOI 10.1038/cr.2010.177; Ringash J, 2014, CANCER-AM CANCER SOC, V120, P181, DOI 10.1002/cncr.28410; PENNICA D, 1984, NATURE, V312, P724, DOI 10.1038/312724a0; Steinbach G, 2000, NEW ENGL J MED, V342, P1946, DOI 10.1056/NEJM200006293422603; Salerno E, 2009, MOL CANCER THER, V8, P2684, DOI 10.1158/1535-7163.MCT-09-0127; Nesbitt A, 2007, INFLAMM BOWEL DIS, V13, P1323, DOI 10.1002/ibd.20225; Vaughan RA, 2013, INT J CANCER, V133, P2504, DOI 10.1002/ijc.28264; TAMIR S, 1995, CANCER RES, V55, P4391; Samuels TL, 2013, ANN OTO RHINOL LARYN, V122, P632; Xia LM, 2012, CARCINOGENESIS, V33, P2250, DOI 10.1093/carcin/bgs249; Yang LL, 2012, J EXP MED, V209, P1655, DOI 10.1084/jem.20112218; Tang L, 2014, GYNECOL ONCOL, V132, P241, DOI 10.1016/j.ygyno.2013.10.020; SRIVASTAVA KC, 1995, PROSTAG LEUKOTR ESS, V52, P223, DOI 10.1016/0952-3278(95)90040-3; Woo JH, 2004, ONCOGENE, V23, P1845, DOI 10.1038/sj.onc.1207307; Young LE, 2012, MOL CANCER RES, V10, P167, DOI 10.1158/1541-7786.MCR-11-0337; Zlotogorski A, 2013, ORAL ONCOL, V49, P502, DOI 10.1016/j.oraloncology.2013.02.011; Yang CM, 2012, J NUTR BIOCHEM, V23, P1155, DOI 10.1016/j.jnutbio.2011.06.009; Wislez M, 2004, INFLAMM RES, V53, P4, DOI 10.1007/s00011-003-1215-3; Wu G, 2011, BRIT J CANCER, V105, P146, DOI 10.1038/bjc.2011.190; Pan MH, 2009, J AGR FOOD CHEM, V57, P4467, DOI 10.1021/jf900612n; Zhang Y, 2012, J CELL PHYSIOL, V227, P35, DOI 10.1002/jcp.22722; Pallavicini FB, 2010, AUTOIMMUN REV, V9, P175, DOI 10.1016/j.autrev.2009.07.006; Ozkan E, 2012, J SURG RES, V176, P232, DOI 10.1016/j.jss.2011.09.005; Yang Y, 2008, INT IMMUNOPHARMACOL, V8, P542, DOI 10.1016/j.intimp.2007.12.006; Thomsen LL, 1998, CANCER METAST REV, V17, P107, DOI 10.1023/A:1005912906436; Neto CC, 2008, MOL NUTR FOOD RES, V52, pS18, DOI 10.1002/mnfr.200700433; Wang H, 2010, CURR CANCER DRUG TAR, V10, P593; Rakib MA, 2013, EVID-BASED COMPL ALT, DOI 10.1155/2013/429393; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Pons DG, 2014, J CELL BIOCHEM, V115, P949, DOI 10.1002/jcb.24737; Verbeke H, 2011, CYTOKINE GROWTH F R, V22, P345, DOI 10.1016/j.cytogfr.2011.09.002; Pichiorri F, 2008, P NATL ACAD SCI USA, V105, P12885, DOI 10.1073/pnas.0806202105; Murugaiyan G, 2011, J IMMUNOL, V187, P2213, DOI 10.4049/jimmunol.1003952; Wang H, 2011, CARCINOGENESIS, V32, P1881, DOI 10.1093/carcin/bgr218; Xie TX, 2010, ONCOL REP, V23, P725, DOI 10.3892/or_00000690; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zgheib A, 2013, J BIOL CHEM, V288, P13378, DOI 10.1074/jbc.M113.456533; Ogura T, 1996, NEUROREPORT, V7, P853, DOI 10.1097/00001756-199603220-00003; Yang CM, 2012, J NUTR BIOCHEM, V23, P8, DOI 10.1016/j.jnutbio.2010.10.006; Park SA, 2012, FREE RADICAL RES, V46, P1051, DOI 10.3109/10715762.2012.671940; MURATA J, 1995, INT J CANCER, V62, P743, DOI 10.1002/ijc.2910620616; Ono M, 2013, ANTICANCER RES, V33, P1861; TARTAGLIA LA, 1992, IMMUNOL TODAY, V13, P151, DOI 10.1016/0167-5699(92)90116-O; Rodrigo KA, 2006, NUTR CANCER, V54, P58, DOI 10.1207/s15327914nc5401_7; Park JY, 2006, CLIN IMMUNOL, V119, P229, DOI 10.1016/j.clim.2006.01.016; O'Connell RM, 2010, IMMUNITY, V33, P607, DOI 10.1016/j.immuni.2010.09.009; Tao HY, 2004, CELL MOL IMMUNOL, V1, P50; NISHIYA T, 1995, FEBS LETT, V371, P333, DOI 10.1016/0014-5793(95)00933-Z; Zhu SM, 2007, J BIOL CHEM, V282, P14328, DOI 10.1074/jbc.M611393200; Thoppil RJ, 2012, CURR CANCER DRUG TAR, V12, P1244; Noh KT, 2013, BIOCHEM BIOPH RES CO, V431, P348, DOI 10.1016/j.bbrc.2012.12.093; Sambandam Y, 2013, ONCOGENE, V32, P97, DOI 10.1038/onc.2012.24; Stambolic V, 2006, TRENDS CELL BIOL, V16, P461, DOI 10.1016/j.tcb.2006.07.001; Zhong M, 1999, PHYTOMEDICINE, V6, P79; Tili E, 2011, P NATL ACAD SCI USA, V108, P4908, DOI 10.1073/pnas.1101795108; Shah BH, 1999, BIOCHEM PHARMACOL, V58, P1167, DOI 10.1016/S0006-2952(99)00206-3; Takeshita F, 2010, MOL THER, V18, P181, DOI 10.1038/mt.2009.207; Wang Y, 2006, CLIN EXP IMMUNOL, V145, P485, DOI 10.1111/j.1365-2249.2006.03137.x; Sun CL, 2006, CARCINOGENESIS, V27, P1301, DOI 10.1093/carcin/bgl024; Oyagbemi AA, 2010, INDIAN J CANCER, V47, P53, DOI 10.4103/0019-509X.58860; Mukaida N, 2014, MEDIAT INFLAMM, DOI 10.1155/2014/170381; Nakano H, 1998, P NATL ACAD SCI USA, V95, P3537, DOI 10.1073/pnas.95.7.3537; Weichselbaum RR, 2002, LANCET ONCOL, V3, P665, DOI 10.1016/S1470-2045(02)00900-2; Sartor L, 2002, BIOCHEM PHARMACOL, V64, P229, DOI 10.1016/S0006-2952(02)01069-9; Winner M, 2007, METHOD ENZYMOL, V435, P355, DOI 10.1016/S0076-6879(07)35018-0; Narvaiza I, 2000, J IMMUNOL, V164, P3112; Pan JA, 2010, ONCOL REP, V24, P105, DOI 10.3892/or_00000834; Rath PC, 1999, J CLIN IMMUNOL, V19, P350, DOI 10.1023/A:1020546615229; Tam W, 2006, GENE CHROMOSOME CANC, V45, P211, DOI 10.1002/gcc.20282; Wu F, 2008, GASTROENTEROLOGY, V135, P1624, DOI 10.1053/j.gastro.2008.07.068; Neergheen VS, 2010, TOXICOLOGY, V278, P229, DOI 10.1016/j.tox.2009.10.010; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Weigmann B, 2008, J EXP MED, V205, P2099, DOI 10.1084/jem.20072484; Singh BN, 2011, BIOCHEM PHARMACOL, V82, P1807, DOI 10.1016/j.bcp.2011.07.093; Wesolowska O, 2010, ANTICANCER RES, V30, P4587; Walle T, 2011, ANN NY ACAD SCI, V1215, P9, DOI 10.1111/j.1749-6632.2010.05842.x; XIE KP, 1995, J EXP MED, V181, P1333, DOI 10.1084/jem.181.4.1333; Qin J, 2009, BIOMED PHARMACOTHER, V63, P241, DOI 10.1016/j.biopha.2008.04.007; Mu P, 2009, GENE DEV, V23, P2806, DOI 10.1101/gad.1872909; Shishodia S, 2013, BIOFACTORS, V39, P37, DOI 10.1002/biof.1041; Rubin JB, 2003, P NATL ACAD SCI USA, V100, P13513, DOI 10.1073/pnas.2235846100; Singh S, 2009, CLIN CANCER RES, V15, P2380, DOI 10.1158/1078-0432.CCR-08-2387; Peng G, 2006, MOL CARCINOGEN, V45, P309, DOI 10.1002/mc.20166; Peters U, 2007, CANCER EPIDEM BIOMAR, V16, P962, DOI 10.1158/1055-9965.EPI-06-0861; Welford SM, 2006, GENE DEV, V20, P3366, DOI 10.1101/gad.1471106; Reddy MK, 2005, J AGR FOOD CHEM, V53, P9268, DOI 10.1021/jf051399j; Xu L, 2009, J NATL CANCER I, V101, P1141, DOI 10.1093/jnci/djp227; Ofir M, 2011, MOL CANCER RES, V9, P440, DOI 10.1158/1541-7786.MCR-10-0344; Singh S, 2011, CANCER CHEMOTH PHARM, V67, P1211, DOI 10.1007/s00280-011-1654-4; Sarkar FH, 2004, MUTAT RES-FUND MOL M, V555, P53, DOI 10.1016/j.mrfmmm.2004.04.015; Taylor CK, 2009, NUTR REV, V67, P398, DOI 10.1111/j.1753-4887.2009.00213.x; Szewczuk LM, 2004, J BIOL CHEM, V279, P22727, DOI 10.1074/jbc.M314302200; Nakachi K, 2000, BIOFACTORS, V13, P49; Zhang B, 2010, ANTI-CANCER DRUG, V21, P288, DOI 10.1097/CAD.0b013e328334da17; Wang LS, 2009, CANCER PREV RES, V2, P84, DOI 10.1158/1940-6207.CAPR-08-0155; Yu LL, 2011, ONCOL REP, V26, P1197, DOI 10.3892/or.2011.1410; Vaughan RA, 2013, PROSTATE, V73, P1538, DOI 10.1002/pros.22703; Zhang MH, 2013, INT J MOL MED, V31, P621, DOI 10.3892/ijmm.2013.1237; Qin S, 2013, ASIAN PAC J CANCER P, V14, P835, DOI 10.7314/APJCP.2013.14.2.835; Salazar N, 2013, CRIT REV EUKAR GENE, V23, P77; Yun JH, 2004, J PERIODONTAL RES, V39, P300, DOI 10.1111/j.1600-0765.2004.00743.x; Palmer LJ, 1998, AM J RESP CRIT CARE, V158, P1825; Vergara D, 2012, MOL BIOSYST, V8, P1078, DOI 10.1039/c2mb05486h; Natoli G, 1997, SCIENCE, V275, P200, DOI 10.1126/science.275.5297.200; Subbaramaiah K, 1998, J BIOL CHEM, V273, P21875, DOI 10.1074/jbc.273.34.21875; Shamim U, 2012, J CELL PHYSIOL, V227, P1493, DOI 10.1002/jcp.22865; O'Connell RM, 2012, ANNU REV IMMUNOL, V30, P295, DOI 10.1146/annurev-immunol-020711-075013; Wang YH, 2012, J CELL MOL MED, V16, P496, DOI 10.1111/j.1582-4934.2011.01337.x; Takada H, 2003, MOL CELL BIOL, V23, P4026, DOI 10.1128/MCB.23.11.4026-4033.2003; Singh RK, 2011, CANCER RES, V71, P3268, DOI 10.1158/0008-5472.CAN-10-2769; SYAPIN PJ, 1995, ALCOHOL CLIN EXP RES, V19, P262, DOI 10.1111/j.1530-0277.1995.tb01501.x; Perkins ND, 2006, CELL DEATH DIFFER, V13, P759, DOI 10.1038/sj.cdd.4401838; Rao CV, 2002, CANCER RES, V62, P165; Wang R, 2013, CURR PHARM DESIGN, V19, P115; Struyf S, 2007, CANCER RES, V67, P5940, DOI 10.1158/0008-5472.CAN-06-4682; Orucevic A, 1999, INT J CANCER, V81, P889, DOI 10.1002/(SICI)1097-0215(19990611)81:6<889::AID-IJC9>3.0.CO;2-2; Morris KT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098656; Mowla SN, 2013, ONCOTARGETS THER, V6, P1221, DOI 10.2147/OTT.S36160; Nakamura H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020034; Nakamura Y, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-100; Neilsen PM, 2012, ONCOGENE, V32, P2992; Noguchi M, 2014, BIOCH BIOPHYS ACTA; Ohnishi S, 2013, OXID MED CELL LONGEV, V2013; Pan Hongzhi, 2004, Wei Sheng Yan Jiu, V33, P456; Papagiannakopoulos T, 2008, CANCER RES, V68, P8164, DOI 10.1158/0008-5472.CAN-08-1305; Pendleton JM, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-132; Persky L., 1977, FORTSCHRITTE KREBSFO, P97; Philippe L, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00070; Ponzo V, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-158; Porta Camillo, 2014, Front Oncol, V4, P64, DOI 10.3389/fonc.2014.00064; Pouchieu C, 2014, NUTR CANC, P1; Qi WT, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-219; Ramon S, 2013, CURR ANGIOGENESIS, V2, P135; Rasheed Z, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2700; Resch U, 2014, J BIOL CHEM, V289, P25088, DOI 10.1074/jbc.M114.563312; Rivas MA, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3187; Rothwell PM, 2010, LANCET, V376, P1741, DOI 10.1016/S0140-6736(10)61543-7; Sahin K, 2012, J ONCOL, V2012; Sakai Tohru, 2008, J Med Invest, V55, P167, DOI 10.2152/jmi.55.167; Saleh F, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-322; Schneider SL, 2014, EXP DERMATOL, V24, P86; Schols D, 1997, J EXP MED, V186, P1383, DOI 10.1084/jem.186.8.1383; Shimizu Masahito, 2005, J Exp Ther Oncol, V5, P69; Silva AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091406; Simone RE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019652; Simpson KD, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.23337; Singh RK, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-57; Slaby O, 2007, ONCOLOGY-BASEL, V72, P397, DOI 10.1159/000113489; Soini Y, 2000, BRIT J CANCER, V83, P880, DOI 10.1054/bjoc.2000.1384; STAHL W, 1992, J NUTR, V122, P2161; Straus DS, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-78; Subramaniam KS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068923; Sundin T, 2012, EXPERT REV MOL MED, V14, DOI 10.1017/erm.2012.1; Teodoro AJ, 2012, CANCER CELL INT, V12, DOI 10.1186/1475-2867-12-36; Till E., 2013, IMMUNOL REV, V253, P167; Till E, 2011, J NUCL ACIDS, V2011; Hannelien V, 2012, BBA-REV CANCER, V1825, P117, DOI 10.1016/j.bbcan.2011.10.008; Volden PA, 2013, BRAIN BEHAV IMMUN, V30, pS26, DOI 10.1016/j.bbi.2012.10.022; Wang H, 2014, MOL CARCINOGEN, V53, pE107, DOI 10.1002/mc.22052; Whitcomb DC, 2004, AM J PHYSIOL-GASTR L, V287, pG315, DOI 10.1152/ajpgi.00115.2004; Whyte J, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2361; Wietrzykl J, 2004, MED SCI MONITOR, V10; Wilken R, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-12; Wong D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r70; Wong D, 2014, BMC UROL, V14, DOI 10.1186/1471-2490-14-12; Wu KK, 2014, J BIOMED SCI, V21, DOI 10.1186/1423-0127-21-17; Xie YF, 2013, J INFLAMM-LOND, V10, DOI 10.1186/1476-9255-10-20; Xu P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081767; Xu X, 2014, CARCINOGENESIS; Yan M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-437; Yi CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099943; Yoshie Osamu, 2013, Nihon Rinsho Meneki Gakkai Kaishi, V36, P189; Yu H, 2007, BIOMED PHARMACOTHER, V22, P22; Zhang L, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-60	840	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1044-579X			SEMIN CANCER BIOL	Semin. Cancer Biol.	DEC	2015	35			S			S151	S184		10.1016/j.semcancer.2015.03.006		34	Oncology	Oncology	CY7WG	WOS:000366619400008		
J	Vinay, DS; Ryan, EP; Pawelec, G; Talib, WH; Stagg, J; Elkord, E; Lichtor, T; Decker, WK; Whelan, RL; Kumara, HMCS; Signori, E; Honoki, K; Georgakilas, AG; Amin, A; Helferich, WG; Boosani, CS; Guha, G; Ciriolo, MR; Chen, S; Mohammed, SI; Azmi, AS; Keith, WN; Bilsland, A; Bhakta, D; Halicka, D; Fujii, H; Aquilano, K; Ashraf, SS; Nowsheen, S; Yang, XJ; Choi, BK; Kwon, BS				Vinay, Dass S.; Ryan, Elizabeth P.; Pawelec, Graham; Talib, Wamidh H.; Stagg, John; Elkord, Eyad; Lichtor, Terry; Decker, William K.; Whelan, Richard L.; Kumara, H. M. C. Shantha; Signori, Emanuela; Honoki, Kanya; Georgakilas, Alexandros G.; Amin, Amr; Helferich, William G.; Boosani, Chandra S.; Guha, Gunjan; Ciriolo, Maria Rosa; Chen, Sophie; Mohammed, Sulma I.; Azmi, Asfar S.; Keith, W. Nicol; Bilsland, Alan; Bhakta, Dipita; Halicka, Dorota; Fujii, Hiromasa; Aquilano, Katia; Ashraf, S. Salman; Nowsheen, Somaira; Yang, Xujuan; Choi, Beom K.; Kwon, Byoung S.			Immune evasion in cancer: Mechanistic basis and therapeutic strategies	SEMINARS IN CANCER BIOLOGY			English	Review						Cancer; Immune evasion; T cells; Therapy	REGULATORY T-CELLS; TUMOR-INFILTRATING LYMPHOCYTES; NATURAL-KILLER-CELLS; NF-KAPPA-B; GROWTH-FACTOR-BETA; GANODERMA-LUCIDUM POLYSACCHARIDES; INTRACEREBRAL BREAST-CANCER; GAMMA-DELTA; DENDRITIC CELLS; METASTATIC MELANOMA	Cancer immune evasion is a major stumbling block in designing effective anticancer therapeutic strategies. Although considerable progress has been made in understanding how cancers evade destructive immunity, measures to counteract tumor escape have not kept pace. There are a number of factors that contribute to tumor persistence despite having a normal host immune system. Immune editing is one of the key aspects why tumors evade surveillance causing the tumors to lie dormant in patients for years through "equilibrium" and "senescence" before re-emerging. In addition, tumors exploit several immunological processes such as targeting the regulatory T cell function or their secretions, antigen presentation, modifying the production of immune suppressive mediators, tolerance and immune deviation. Besides these, tumor heterogeneity and metastasis also play a critical role in tumor growth. A number of potential targets like promoting Th1, NK cell, gamma delta T cell responses, inhibiting Treg functionality, induction of IL-12, use of drugs including phytochemicals have been designed to counter tumor progression with much success. Some natural agents and phytochemicals merit further study. For example, use of certain key polysaccharide components from mushrooms and plants have shown to possess therapeutic impact on tumor-imposed genetic instability, anti-growth signaling, replicative immortality, dysregulated metabolism etc. In this review, we will discuss the advances made toward understanding the basis of cancer immune evasion and summarize the efficacy of various therapeutic measures and targets that have been developed or are being investigated to enhance tumor rejection. (C) 2015 Elsevier Ltd.	[Vinay, Dass S.; Kwon, Byoung S.] Tulane Univ, Hlth Sci Ctr, Sect Clin Immunol Allergy & Rheumatol, Dept Med, New Orleans, LA 70118 USA; [Ryan, Elizabeth P.] Colorado State Univ, Dept Environm & Radiol Hlth Sci, Ft Collins, CO 80523 USA; [Pawelec, Graham] Univ Tubingen, Med Res Ctr, Tubingen, Germany; [Talib, Wamidh H.] Appl Sci Univ, Dept Clin Pharm & Therapeut, Amman, Jordan; [Stagg, John] Univ Montreal, Ctr Rech Ctr Hosp, Fac Pharm, Montreal, PQ, Canada; [Stagg, John] Univ Montreal, Inst Canc Montreal, Montreal, PQ H2L 4M1, Canada; [Elkord, Eyad] United Arab Emirates Univ, Coll Med & Hlth Sci, Al Ain, U Arab Emirates; [Lichtor, Terry] Rush Univ, Med Ctr, Dept Neurosurg, Chicago, IL 60612 USA; [Decker, William K.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Whelan, Richard L.; Kumara, H. M. C. Shantha] St Lukes Roosevelt Hosp, Dept Surg, New York, NY 10025 USA; [Signori, Emanuela] CNR, Inst Translat Pharmacol, Rome, Italy; [Honoki, Kanya; Fujii, Hiromasa] Nara Med Univ, Kashihara, Nara 634, Japan; [Georgakilas, Alexandros G.] Natl Tech Univ Athens, Dept Phys, Sch Appl Math & Phys Sci, GR-15773 Athens, Greece; [Amin, Amr] United Arab Emirates Univ, Dept Biol, Coll Sci, Al Ain, U Arab Emirates; [Amin, Amr] Cairo Univ, Fac Sci, Cairo, Egypt; [Helferich, William G.; Yang, Xujuan] Univ Illinois, Urbana, IL 61801 USA; [Boosani, Chandra S.] Creighton Univ, Omaha, NE 68178 USA; [Guha, Gunjan; Bhakta, Dipita] SASTRA Univ, Sch Chem & Bio Technol, Thanjavur, India; [Ciriolo, Maria Rosa] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy; [Chen, Sophie] Ovarian & Prostate Canc Res Trust Lab, Guildford, Surrey, England; [Mohammed, Sulma I.] Purdue Univ Canc Canc Res, W Lafayette, IN USA; [Azmi, Asfar S.] Wayne State Univ, Karmanos Canc Inst, Detroit, MI USA; [Keith, W. Nicol; Bilsland, Alan] Univ Glasgow, Glasgow, Lanark, Scotland; [Halicka, Dorota] New York Med Coll, Valhalla, NY 10595 USA; [Ashraf, S. Salman] United Arab Emirates Univ, Coll Sci, Dept Chem, Al Ain, U Arab Emirates; [Nowsheen, Somaira] Mayo Clin, Mayo Med Sch, Mayo Grad Sch, Rochester, MN USA; [Choi, Beom K.; Kwon, Byoung S.] Natl Canc Ctr, Div Canc Biol, Canc Immunol Branch, Goyang, Gyeonggi, South Korea	Kwon, BS (reprint author), R&D Ctr Canc Therapeut, Natl Canc Ctr, Goyang 410769, Gyeonggi Do, South Korea.	bskwon@ncc.re.kr	Keith, Nicol/D-3325-2009	Keith, Nicol/0000-0001-7862-3580	National Cancer Center, Korea [NCC-1310430-2]; National Research Foundation [NRF-2005-0093837]; University of Glasgow; Beatson Oncology Centre Fund; Cancer Research UK [C301/A14762]	This work was supported by grants from the National Cancer Center, Korea (NCC-1310430-2) and the National Research Foundation (NRF-2005-0093837). W. Nicol Keith & Alan Bilsland were supported by the University of Glasgow, Beatson Oncology Centre Fund, and Cancer Research UK (http://www.cancerresearchuk.org) grant C301/A14762.	Albulescu R, 2013, MEDIAT INFLAMM, DOI 10.1155/2013/979748; Allard B, 2013, CLIN CANCER RES, V19, P5626, DOI 10.1158/1078-0432.CCR-13-0545; Tanaka T, 1995, CARCINOGENESIS, V16, P2957, DOI 10.1093/carcin/16.12.2957; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Bisen PS, 2010, CURR MED CHEM, V17, P2419; LENNARD TWJ, 1985, BRIT J SURG, V72, P771, DOI 10.1002/bjs.1800721002; Vinay DS, 2012, MOL CANCER THER, V11, P1062, DOI 10.1158/1535-7163.MCT-11-0677; Strauss L, 2007, CLIN CANCER RES, V13, P6301, DOI 10.1158/1078-0432.CCR-07-1403; Nagendraprabhu P, 2011, INVEST NEW DRUG, V29, P207, DOI 10.1007/s10637-009-9342-5; French LE, 2002, SEMIN CANCER BIOL, V12, P51, DOI 10.1006/scbi.2001.0405; Drake CG, 2012, CURR OPIN UROL, V22, P197, DOI 10.1097/MOU.0b013e3283519ad5; Lamagna C, 2006, J LEUKOCYTE BIOL, V80, P705, DOI 10.1189/jlb.1105656; Lichtor T, 2005, CANCER GENE THER, V12, P708, DOI 10.1038/sj.cgt.7700832; Mackall CL, 2000, STEM CELLS, V18, P10, DOI 10.1634/stemcells.18-1-10; Polonini HC, 2013, BIOORGAN MED CHEM, V21, P964, DOI 10.1016/j.bmc.2012.11.052; Sylla P, 2005, SURG CLIN N AM, V85, P1, DOI 10.1016/j.suc.2004.09.005; Zhang L, 2011, PHARMAZIE, V66, P144, DOI 10.1691/ph.2011.0738; McBride WH, 2004, RADIAT RES, V162, P1, DOI 10.1667/RR3196; Jacobs JFM, 2012, LANCET ONCOL, V13, pE32, DOI 10.1016/S1470-2045(11)70155-3; ROSENBERG SA, 1994, J NATL CANCER I, V86, P1159, DOI 10.1093/jnci/86.15.1159; Nagorsen D, 2003, CLIN CANCER RES, V9, P4296; Whelan RL, 2003, SURG ENDOSC, V17, P972, DOI 10.1007/s00464-001-8263-y; Rankin EB, 2003, CANCER BIOL THER, V2, P687; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806; van Kempen LCLT, 2003, EUR J CELL BIOL, V82, P539, DOI 10.1078/0171-9335-00346; Stagg J, 2010, ONCOGENE, V29, P5346, DOI 10.1038/onc.2010.292; Lin EY, 2002, J MAMMARY GLAND BIOL, V7, P147, DOI 10.1023/A:1020399802795; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Wu X, 2013, CANCER LETT, V340, P124, DOI 10.1016/j.canlet.2013.07.038; BOUTARD V, 1995, J IMMUNOL, V155, P2077; Barten R, 2001, TRENDS IMMUNOL, V22, P52, DOI 10.1016/S1471-4906(00)01802-0; Pasche B, 2001, J CELL PHYSIOL, V186, P153, DOI 10.1002/1097-4652(200002)186:2<153::AID-JCP1016>3.0.CO;2-J; Lutsiak MEC, 2005, BLOOD, V105, P2862, DOI 10.1182/blood-2004-06-2410; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Kavitha K, 2013, BBA-GEN SUBJECTS, V1830, P4433, DOI 10.1016/j.bbagen.2013.05.032; Erler JT, 2009, CANCER CELL, V15, P35, DOI 10.1016/j.ccr.2008.11.012; Muller AJ, 2005, CANCER RES, V65, P8065, DOI 10.1158/0008-5472.CAN-05-2213; Speranza L, 2012, MAR DRUGS, V10, P890, DOI 10.3390/md10040890; RIVOLTINI L, 1995, J IMMUNOL, V154, P2257; Fang NB, 2006, J ALTERN COMPLEM MED, V12, P125, DOI 10.1089/acm.2006.12.125; Xu J, 2009, GENE THER MOL BIOL, V13, P36; Calder PC, 2002, BRIT J NUTR, V88, pS165, DOI 10.1079/BJN2002682; Mir LM, 1999, P NATL ACAD SCI USA, V96, P4262, DOI 10.1073/pnas.96.8.4262; Merlo LMF, 2006, NAT REV CANCER, V6, P924, DOI 10.1038/nrc2013; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; Kim DH, 2013, INT J ONCOL, V43, P1915, DOI 10.3892/ijo.2013.2116; Zhao L, 2013, TUMOR BIOL, V34, P1531, DOI 10.1007/s13277-013-0680-8; Nefedova Y, 2004, J IMMUNOL, V172, P464; Sonoda K, 2008, FRONT BIOSCI-LANDMRK, V13, P1106, DOI 10.2741/2748; Yang JC, 2007, J IMMUNOTHER, V30, P825; Shen F, 2013, ONCOTARGETS THER, V6, P523, DOI 10.2147/OTT.S44161; Rosenberg SA, 2003, CLIN CANCER RES, V9, P2973; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Bogen B, 1996, EUR J IMMUNOL, V26, P2671, DOI 10.1002/eji.1830261119; Lind MH, 2004, P NATL ACAD SCI USA, V101, P4972, DOI 10.1073/pnas.0307106101; Kashiwagi S, 2005, J CLIN INVEST, V115, P1816, DOI 10.1172/JCI124015; Yokokawa J, 2008, CLIN CANCER RES, V14, P1032, DOI 10.1158/1078-0432.CCR-07-2056; Cormier JN, 1997, CANCER J SCI AM, V3, P37; Bernstein MB, 2014, CANCER BIOTHER RADIO, V29, P153, DOI 10.1089/cbr.2013.1578; Schietinger A, 2012, SCIENCE, V335, P723, DOI 10.1126/science.1214277; Gu J, 2000, CANCER RES, V60, P5359; Seliger B, 1997, IMMUNOL TODAY, V18, P292, DOI 10.1016/S0167-5699(97)01052-9; Stagg J, 2010, P NATL ACAD SCI USA, V107, P1547, DOI 10.1073/pnas.0908801107; Sceneay J, 2012, CANCER RES, V72, P3906, DOI 10.1158/0008-5472.CAN-11-3873; Minn AJ, 2005, J CLIN INVEST, V115, P44, DOI 10.1172/JC1200522320; Kasid U, 1996, NATURE, V382, P813, DOI 10.1038/382813a0; BUTLER TP, 1975, CANCER RES, V35, P512; Parmiani G, 2002, J NATL CANCER I, V94, P805; Loi S, 2013, P NATL ACAD SCI USA, V110, P11091, DOI 10.1073/pnas.1222251110; Facciabene A, 2011, NATURE, V475, P226, DOI 10.1038/nature10169; Ono Y, 2012, CANCER SCI, V103, P317, DOI 10.1111/j.1349-7006.2011.02133.x; Maeda H, 1996, J IMMUNOL, V156, P73; Coussens LM, 2001, J EXP MED, V193, pF23, DOI 10.1084/jem.193.6.F23; Jeff IB, 2013, INT J BIOL MACROMOL, V52, P99, DOI 10.1016/j.ijbiomac.2012.10.007; Lander HM, 1997, J BIOL CHEM, V272, P17810, DOI 10.1074/jbc.272.28.17810; Munder M, 2009, BRIT J PHARMACOL, V158, P638, DOI 10.1111/j.1476-5381.2009.00291.x; Zamarron BF, 2011, INT J BIOL SCI, V7, P651; Weber JS, 1999, J IMMUNOTHER, V22, P431, DOI 10.1097/00002371-199909000-00007; Kim YS, 2007, ONCOL REP, V18, P1189; Gasparoto TH, 2010, CANCER IMMUNOL IMMUN, V59, P819, DOI 10.1007/s00262-009-0803-7; Andersen MH, 2012, CANCER IMMUNOL IMMUN, V61, P1289, DOI 10.1007/s00262-012-1234-4; Schepetkin IA, 2006, INT IMMUNOPHARMACOL, V6, P317, DOI 10.1016/j.intimp.2005.10.005; Ren L, 2012, FOOD FUNCT, V3, P1118, DOI 10.1039/c2fo10279j; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Palucka K, 2012, NAT REV CANCER, V12, P265, DOI 10.1038/nrc3258; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Stewart CA, 2013, J CLIN INVEST, V123, P4859, DOI 10.1172/BCI65180; Fu ZX, 2013, ACTA ONCOL, V52, P1760, DOI 10.3109/0284186X.2012.760847; Koga S, 2000, HUM GENE THER, V11, P1397, DOI 10.1089/10430340050057477; Day SD, 2013, CYTOKINE, V64, P454, DOI 10.1016/j.cyto.2013.04.031; HOTTA T, 1994, J NEURO-ONCOL, V21, P135, DOI 10.1007/BF01052897; HEPPNER GH, 1984, CANCER RES, V44, P2259; Wakita D, 2010, EUR J IMMUNOL, V40, P1927, DOI 10.1002/eji.200940157; SEUNG LP, 1995, P NATL ACAD SCI USA, V92, P6254, DOI 10.1073/pnas.92.14.6254; Liu L, 2004, GENE, V340, P1, DOI 10.1016/j.gene.2004.06.011; Sliva D, 2002, BIOCHEM BIOPH RES CO, V298, P603, DOI 10.1016/S0006-291X(02)02496-8; Russo M, 2010, TOXINS, V2, P517, DOI 10.3390/toxins2040517; Weber J, 2007, ONCOLOGIST, V12, P864, DOI 10.1634/theoncoloost.12-7-864; Lichtor T, 2008, J IMMUNOTHER, V31, P18; TARIN D, 1984, CANCER RES, V44, P3584; Beavis PA, 2013, P NATL ACAD SCI USA, V110, P14711, DOI 10.1073/pnas.1308209110; Jia YM, 2012, PHYTOTHER RES, V26, P812, DOI 10.1002/ptr.3637; Yang B, 2013, INT J BIOL MACROMOL, V62, P287, DOI 10.1016/j.ijbiomac.2013.09.016; Rosenberg SA, 2011, CLIN CANCER RES, V17, P4550, DOI 10.1158/1078-0432.CCR-11-0116; Rice J, 2008, NAT REV CANCER, V8, P108, DOI 10.1038/nrc2326; RotemYehudar R, 1996, J EXP MED, V183, P499, DOI 10.1084/jem.183.2.499; Elkabets M, 2010, EUR J IMMUNOL, V40, P3347, DOI 10.1002/eji.201041037; Thakur A, 2012, CANCER IMMUNOL IMMUN, V61, P497, DOI 10.1007/s00262-011-1116-1; Fowler DW, 2012, CANCER IMMUNOL IMMUN, V61, P535, DOI 10.1007/s00262-011-1121-4; Marusyk A, 2010, BBA-REV CANCER, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; Tsung K, 2002, CANCER RES, V62, P5069; Chen YT, 1997, P NATL ACAD SCI USA, V94, P1914, DOI 10.1073/pnas.94.5.1914; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Zhang PS, 2007, CANCER RES, V67, P6468, DOI 10.1158/0008-5472.CAN-07-1264; Branco-Price C, 2012, CANCER CELL, V21, P52, DOI 10.1016/j.ccr.2011.11.017; de Martel C, 2009, CRIT REV ONCOL HEMAT, V70, P183, DOI 10.1016/j.critrevonc.2008.07.021; Dunn GP, 2004, ANNU REV IMMUNOL, V22, P329, DOI 10.1146/annurev.immunol.22.012703.104803; Chakraborty M, 2004, CANCER RES, V64, P4328, DOI 10.1158/0008-5472.CAN-04-0073; Chiarella P, 2008, EXPERT OPIN BIOL TH, V8, P1645, DOI [10.1517/14712598.8.11.1645 , 10.1517/14712590802472606]; Xia YF, 2012, NAT CELL BIOL, V14, P257, DOI 10.1038/ncb2428; VandenEynde BJ, 1997, CURR OPIN IMMUNOL, V9, P684, DOI 10.1016/S0952-7915(97)80050-7; Auyeung KKW, 2009, INT J MOL MED, V23, P189, DOI 10.3892/ijmm_00000116; Ogasawara M, 2007, BIOL PHARM BULL, V30, P200, DOI 10.1248/bpb.30.200; Ohta A, 2006, P NATL ACAD SCI USA, V103, P13132, DOI 10.1073/pnas.0605251103; ROSENBERG SA, 1988, NEW ENGL J MED, V319, P1676, DOI 10.1056/NEJM198812223192527; Iannello A, 2013, J EXP MED, V210, P2057, DOI 10.1084/jem.20130783; Munn DH, 2002, SCIENCE, V297, P1867, DOI 10.1126/science.1073514; FERGUSON RM, 1981, TRANSPLANT P, V13, P1673; Meraviglia S, 2010, CLIN EXP IMMUNOL, V161, P290, DOI 10.1111/j.1365-2249.2010.04167.x; Gao YH, 2004, J MED FOOD, V7, P417, DOI 10.1089/jmf.2004.7.417; Sano B, 2002, SURG TODAY, V32, P503; Pahl JHW, 2012, CLIN CANCER RES, V18, P432, DOI 10.1158/1078-0432.CCR-11-2277; Wakshlag JJ, 2010, AM J VET RES, V71, P89, DOI 10.2460/ajvr.71.1.89; Hsieh TC, 2011, INT J MOL MED, V28, P1065, DOI 10.3892/ijmm.2011.788; Kim HJ, 2006, CELL DEATH DIFFER, V13, P738, DOI 10.1038/sj.cdd.4401877; Choi YJ, 2012, EXP THER MED, V3, P592, DOI 10.3892/etm.2012.472; Melancon MP, 2010, BIOMATERIALS, V31, P6567, DOI 10.1016/j.biomaterials.2010.05.001; Mundy GR, 1997, CANCER, V80, P1546, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1546::AID-CNCR4>3.0.CO;2-I; Oka Y, 2006, CURR MED CHEM, V13, P2345, DOI 10.2174/092986706777935104; Kim YS, 2012, J IMMUNOL, V188, P4226, DOI 10.4049/jimmunol.1103040; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Garrido F, 1997, IMMUNOL TODAY, V18, P89, DOI 10.1016/S0167-5699(96)10075-X; Slavin-Chiorini DC, 2004, CANCER GENE THER, V11, P665, DOI 10.1038/sj.cgt.7700741; Chiarella P, 2013, CURR DRUG METAB, V14, P291; Rosenberg SA, 1999, IMMUNITY, V10, P281, DOI 10.1016/S1074-7613(00)80028-X; Shay JW, 2004, ONCOGENE, V23, P2919, DOI 10.1038/sj.onc.1207518; Wang KP, 2013, J AGR FOOD CHEM, V61, P9849, DOI 10.1021/jf403291w; Rosenberg SA, 2008, NAT REV CANCER, V8, P299, DOI 10.1038/nrc2355; Calder PC, 2007, PROSTAG LEUKOTR ESS, V77, P327, DOI 10.1016/j.plefa.2007.10.015; Maeurer MJ, 1996, J CLIN INVEST, V98, P1633, DOI 10.1172/JCI118958; Jiang JH, 2004, NUTR CANCER, V49, P209, DOI 10.1207/s15327914nc4902_13; Goodnow CC, 2005, NATURE, V435, P590, DOI 10.1038/nature03724; Birkle S, 2003, BIOCHIMIE, V85, P455, DOI 10.1016/S0300-9084(03)00006-3; Li N, 2014, EUR REV MED PHARMACO, V18, P78; Matsumura S, 2010, RADIAT RES, V173, P418, DOI 10.1667/RR1860.1; Singh AK, 2014, HUM IMMUNOL, V75, P250, DOI 10.1016/j.humimm.2013.12.004; Joseph S, 2011, ACTA PHARMACEUT, V61, P335, DOI 10.2478/v10007-011-0030-6; Belanich M, 1996, CANCER CHEMOTH PHARM, V37, P547, DOI 10.1007/s002800050427; Stagg J, 2011, CANCER RES, V71, P2892, DOI 10.1158/0008-5472.CAN-10-4246; Chouaib S, 2009, CLIN IMMUNOL, V130, P34, DOI 10.1016/j.clim.2008.08.020; Gabrilovich DI, 1996, NAT MED, V2, P1096, DOI 10.1038/nm1096-1096; Kalos M, 2012, CANCER IMMUNOL IMMUN, V61, P127, DOI 10.1007/s00262-011-1173-5; Woodhouse EC, 1997, CANCER, V80, P1529, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1529::AID-CNCR2>3.3.CO;2-#; RESTIFO NP, 1993, J EXP MED, V177, P265, DOI 10.1084/jem.177.2.265; Ardiani A, 2014, CANCER RES, V74, P1945, DOI 10.1158/0008-5472.CAN-13-2045; MATSUDA M, 1994, J EXP MED, V180, P2371, DOI 10.1084/jem.180.6.2371; Hayakawa Y, 2011, CANCER SCI, V102, P1967, DOI 10.1111/j.1349-7006.2011.02042.x; Ikeda H, 1997, IMMUNITY, V6, P199, DOI 10.1016/S1074-7613(00)80426-4; Nestle FO, 2000, ONCOGENE, V19, P6673, DOI 10.1038/sj.onc.1204095; Yuen JWM, 2008, NUTR CANCER, V60, P109, DOI 10.1080/01635580701525869; Palozza P, 2009, CANCER LETT, V283, P108, DOI 10.1016/j.canlet.2009.03.031; Lee PP, 1999, NAT MED, V5, P677; Cooke VG, 2012, CANCER CELL, V21, P66, DOI 10.1016/j.ccr.2011.11.024; Cao QZ, 2004, ACTA PHARMACOL SIN, V25, P833; Yasui Y, 2011, CHEM-BIOL INTERACT, V193, P79, DOI 10.1016/j.cbi.2011.05.006; Galluzzi L, 2012, NAT REV DRUG DISCOV, V11, P215, DOI 10.1038/nrd3626; Ferrarini M, 2002, TRENDS IMMUNOL, V23, P14, DOI 10.1016/S1471-4906(01)02110-X; Byrne WL, 2011, CANCER RES, V71, P6915, DOI 10.1158/0008-5472.CAN-11-1156; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Naldini A, 2003, CURR PHARM DESIGN, V9, P511, DOI 10.2174/1381612033391423; Jameson J, 2003, CURR OPIN IMMUNOL, V15, P349, DOI 10.1016/S0952-7915(03)00045-1; Smyth MJ, 2001, J EXP MED, V193, P661, DOI 10.1084/jem.193.6.661; Garnett CT, 2004, CANCER RES, V64, P7985, DOI 10.1158/0008-5472.CAN-04-1525; Wang XC, 2012, INT J ONCOL, V41, P1181, DOI 10.3892/ijo.2012.1568; Hodge JW, 2009, VACCINE, V27, P4475, DOI 10.1016/j.vaccine.2009.05.017; Hodge JW, 2013, INT J CANCER, V133, P624, DOI 10.1002/ijc.28070; George TC, 1999, J IMMUNOL, V163, P1859; NICOLSON GL, 1984, CANCER METAST REV, V3, P25, DOI 10.1007/BF00047691; DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; Budhu A, 2006, CANCER CELL, V10, P99, DOI 10.1016/j.ccr.2006.06.016; Schoppmann SF, 2002, AM J PATHOL, V161, P947, DOI 10.1016/S0002-9440(10)64255-1; Cole BF, 2007, JAMA-J AM MED ASSOC, V297, P2351, DOI 10.1001/jama.297.21.2351; Lee I, 2005, J EXP MED, V201, P1037, DOI 10.1084/jem.20041709; Umansky V, 2012, CANCER IMMUNOL IMMUN, V61, P275, DOI 10.1007/s00262-011-1164-6; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Whiteside TL, 2012, EXPERT OPIN BIOL TH, V12, P1383, DOI 10.1517/14712598.2012.707184; McKallip R, 1999, J IMMUNOL, V163, P3718; Beavis PA, 2012, TRENDS IMMUNOL, V33, P231, DOI 10.1016/j.it.2012.02.009; KLEIN SC, 1995, HEMATOL ONCOL, V13, P121, DOI 10.1002/hon.2900130302; NOONAN FP, 1977, CANCER RES, V37, P2473; Nakashima M, 1999, NAT MED, V5, P938; Melero I, 2013, CLIN CANCER RES, V19, P997, DOI 10.1158/1078-0432.CCR-12-2214; Dudley ME, 2002, SCIENCE, V298, P850, DOI 10.1126/science.1076514; Becker JC, 2013, CANCER IMMUNOL IMMUN, V62, P1137, DOI 10.1007/s00262-013-1434-6; Driessens G, 2009, IMMUNOL REV, V229, P126, DOI 10.1111/j.1600-065X.2009.00771.x; Hicklin DJ, 1999, MOL MED TODAY, V5, P178, DOI 10.1016/S1357-4310(99)01451-3; Cheng C, 2014, TOXICOL LETT, V225, P488, DOI 10.1016/j.toxlet.2013.12.023; Wesolowska O, 2010, ANTICANCER RES, V30, P4587; SALGALLER ML, 1995, CANCER RES, V55, P4972; EHLERS G, 1973, BRIT J RADIOL, V46, P220; Kawabe K, 2012, IMMUNOBIOLOGY, V217, P118, DOI 10.1016/j.imbio.2011.07.018; Sleeman J, 2010, EUR J CANCER, V46, P1177, DOI 10.1016/j.ejca.2010.02.039; FIDLER IJ, 1977, SCIENCE, V197, P893, DOI 10.1126/science.887927; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Sica A, 2008, SEMIN CANCER BIOL, V18, P349, DOI 10.1016/j.semcancer.2008.03.004; Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444; Lynch TJ, 2012, J CLIN ONCOL, V30, P2046, DOI 10.1200/JCO.2011.38.4032; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Gao YH, 2005, IMMUNOL INVEST, V34, P171, DOI 10.1081/IMM-200055813; Marchand M, 1999, INT J CANCER, V80, P219, DOI 10.1002/(SICI)1097-0215(19990118)80:2<219::AID-IJC10>3.0.CO;2-S; Gomes AQ, 2010, CANCER RES, V70, P10024, DOI 10.1158/0008-5472.CAN-10-3236; Caccamo N, 2010, CURR CANCER DRUG TAR, V10, P27; King C, 2004, CELL, V117, P265, DOI 10.1016/S0092-8674(04)00335-6; Choi BK, 2014, J IMMUNOTHER, V37, P225, DOI 10.1097/CJI.0000000000000027; MILLS CD, 1992, J IMMUNOL, V149, P2709; UZAWA A, 1994, RADIAT RES, V137, P25, DOI 10.2307/3578787; Liu X, 2010, J GASTROEN HEPATOL, V25, P420, DOI 10.1111/j.1440-1746.2009.05981.x; Lauritzsen GF, 1998, INT J CANCER, V78, P216, DOI 10.1002/(SICI)1097-0215(19981005)78:2<216::AID-IJC16>3.3.CO;2-E; Johnsen AK, 1999, J IMMUNOL, V163, P4224; Demaria S, 2004, INT J RADIAT ONCOL, V58, P862, DOI 10.1016/j.ijrobp.2003.09.012; Gilboa E, 2007, J CLIN INVEST, V117, P1195, DOI 10.1172/JCI31205; Ye J, 2013, CANCER RES, V73, P6137, DOI 10.1158/0008-5472.CAN-13-0348; Jing WQ, 2011, BLOOD, V117, P6952, DOI 10.1182/blood-2010-12-326108; Kerkar SP, 2011, J CLIN INVEST, V121, P4746, DOI 10.1172/JCI58814; Topalian SL, 2012, CURR OPIN IMMUNOL, V24, P207, DOI 10.1016/j.coi.2011.12.009; Oka Y, 2000, IMMUNOGENETICS, V51, P99, DOI 10.1007/s002510050018; Garnett CT, 2008, CLIN CANCER RES, V14, P3536, DOI 10.1158/1078-0432.CCR-07-4025; June CH, 2007, J CLIN INVEST, V117, P1466, DOI 10.1172/JCI32446; Yao L, 1999, BLOOD, V93, P1612; Nakabayashi H, 2007, CANCER LETT, V246, P182, DOI 10.1016/j.canlet.2006.02.021; Kim J, 2012, BRIT J HAEMATOL, V158, P336, DOI 10.1111/j.1365-2141.2012.09154.x; Bidwell BN, 2012, NAT MED, V18; Blackwill F, 2002, LANCET, V357, P539; Campbell LL, 2007, CELL CYCLE, V6, P2322; Chambers A F, 2001, Surg Oncol Clin N Am, V10, P243; Dardenne M, 2002, EUR J CLIN NUTR, V56, P520; Durante M, 2013, TRENDS MOL MED, P00096; Fiddler IJ, 1982, SCIENCE, V217, P998; Fiddler IJ, 1999, CANC CHEMOTHER PHA S, V43, pS3; Folkman J, 1992, Semin Cancer Biol, V3, P65; Gabay C, 1999, NEW ENGL J MED, V340, P448; Gabrilovich D, 2004, NAT REV IMMUNOL, V4, P941, DOI 10.1038/nri1498; Gulley JL, 2013, CANCER IMMUNOL RES, V2, P133; Hsieh Tze-chen, 2006, BMC Complement Altern Med, V6, P30, DOI 10.1186/1472-6882-6-30; Hughes DA, 2001, NUTRITION, V17, P823, DOI 10.1016/S0899-9007(01)00638-4; Hunter KW, 2008, BREAST CANC RES, V10; Ifeadi V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031762; ISHIHARA H, 1995, J RADIAT RES, V36, P112, DOI 10.1269/jrr.36.112; Ito Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078191; Itok K, 2006, CANCER SCI, V97, P970; Kodama Noriko, 2003, Journal of Medicinal Food, V6, P371, DOI 10.1089/109662003772519949; Kumari A, 2013, J IMMUNOTHER CANC, V1, P1; Larsen H, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3934; Li Q, 2012, CHINESE MED J-PEKING, V125, P786, DOI 10.3760/cma.j.issn.0366-6999.2012.05.012; Lin MA, 2011, IMMUNOL REV, V239, P62; Lu J, 2014, PHYTOTHER RES, V28, P200, DOI 10.1002/ptr.4980; Mango I, 2008, IMMUNOL REV, V222, P162; Martinet W, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-012-0321-1; Melief CJ, 2002, ADV IMMUNOL, V75, P235; MIDDLETON E, 1992, BIOCHEM PHARMACOL, V43, P1167, DOI 10.1016/0006-2952(92)90489-6; Mikstacka Renata, 2010, Pol Merkur Lekarski, V28, P496; Miller F R, 1982, Cancer Metastasis Rev, V1, P319, DOI 10.1007/BF00124215; Nishitani Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062441; Oji V, 1999, JPN J CANCER RES, V90, P194; Ostrand-Rosenberg S, 2010, CANCER IMMUNOL IMMUN, V59, P1593, DOI 10.1007/s00262-010-0855-8; Ostrand-Rosenberg S, 2012, CANCER IMMUNOL IMMUN, V61, P1319, DOI 10.1007/s00262-012-1269-6; Pakala Rajbabu, 2002, Cardiovasc Radiat Med, V3, P95, DOI 10.1016/S1522-1865(02)00159-2; Palucka K, 2013, IMMUNITY, V39, P38, DOI 10.1016/j.immuni.2013.07.004; Patyar S, 2010, J BIOMED SCI, V17; Prendergast GC, 2008, ONCOGENE, V27, P3889, DOI 10.1038/onc.2008.35; Rakoff-Nahoum Seth, 2006, Yale J Biol Med, V79, P123; Rasku MA, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-12; Rock CL, 2007, AM J CLIN NUTR, V85, P2775; Sawnn JB, 2007, J CLIN INVEST, V117, P1137; Schmidt SV, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00274; Scholm J, 2014, ADV CANCER RES, V121, P67; Shashidharamurthy R, 2012, MED RES REV, V32, P1197, DOI 10.1002/med.20237; Shozaei F, 2008, TRENDS CELL BIOL, V18, P372; Sliva D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047873; SOTOMAYOR EM, 1991, J IMMUNOL, V147, P2816; Staveley-O'Carroll K, 1998, P NATL ACAD SCI USA, V95, P1179; VOEST EE, 1995, J NATL CANCER I, V87, P581, DOI 10.1093/jnci/87.8.581; Walter S, 2012, NAT MED, P1254; Wang T, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-179; Wolchok J, 2012, ANN ONCOL, V23, pviii5; Zong A, 2012, CARBOHYD POLYM, V904, P1395	301	4	4	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1044-579X			SEMIN CANCER BIOL	Semin. Cancer Biol.	DEC	2015	35			S			S185	S198		10.1016/j.semcancer.2015.03.004		14	Oncology	Oncology	CY7WG	WOS:000366619400009		
J	Wang, ZW; Dabrosin, C; Yin, X; Fuster, MM; Arreola, A; Rathmell, WK; Generali, D; Nagaraju, GP; El-Rayes, B; Ribatti, D; Chen, YC; Honoki, K; Fujii, H; Georgakilas, AG; Nowsheen, S; Amedei, A; Niccolai, E; Amin, A; Ashraf, SS; Helferich, B; Yang, XJ; Guha, G; Bhakta, D; Ciriolo, MR; Aquilano, K; Chen, S; Halicka, D; Mohammed, SI; Azmi, AS; Bilsland, A; Keith, WN; Jensen, LD				Wang, Zongwei; Dabrosin, Charlotta; Yin, Xin; Fuster, Mark M.; Arreola, Alexandra; Rathmell, W. Kimryn; Generali, Daniele; Nagaraju, Ganji P.; El-Rayes, Bassel; Ribatti, Domenico; Chen, Yi Charlie; Honoki, Kanya; Fujii, Hiromasa; Georgakilas, Alexandros G.; Nowsheen, Somaira; Amedei, Amedeo; Niccolai, Elena; Amin, Amr; Ashraf, S. Salman; Helferich, Bill; Yang, Xujuan; Guha, Gunjan; Bhakta, Dipita; Ciriolo, Maria Rosa; Aquilano, Katia; Chen, Sophie; Halicka, Dorota; Mohammed, Sulma I.; Azmi, Asfar S.; Bilsland, Alan; Keith, W. Nicol; Jensen, Lasse D.			Broad targeting of angiogenesis for cancer prevention and therapy	SEMINARS IN CANCER BIOLOGY			English	Review						Angiogenesis; Cancer; Phytochemicals; Treatment; Anti-angiogenic	CELL-CYCLE ARREST; HUMAN BREAST-CANCER; ENDOTHELIAL GROWTH-FACTOR; NF-KAPPA-B; INTERSTITIAL FLUID PRESSURE; INHIBITS TUMOR-GROWTH; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; LYMPH-NODE METASTASIS; LEWIS LUNG-CARCINOMA; RETINOBLASTOMA (PRB)-E2F/DP PATHWAY	Deregulation of angiogenesis - the growth of new blood vessels from an existing vasculature is a main driving force in many severe human diseases including cancer. As such, tumor angiogenesis is important for delivering oxygen and nutrients to growing tumors, and therefore considered an essential pathologic feature of cancer, while also playing a key role in enabling other aspects of tumor pathology such as metabolic deregulation and tumor dissemination/metastasis. Recently, inhibition of tumor angiogenesis has become a clinical anti-cancer strategy in line with chemotherapy, radiotherapy and surgery, which underscore the critical importance of the angiogenic switch during early tumor development. Unfortunately the clinically approved anti-angiogenic drugs in use today are only effective in a subset of the patients, and many who initially respond develop resistance overtime. Also, some of the anti-angiogenic drugs are toxic and it would be of great importance to identify alternative compounds, which could overcome these drawbacks and limitations of the currently available therapy. Finding "the most important target" may, however, prove a very challenging approach as the tumor environment is highly diverse, consisting of many different cell types, all of which may contribute to tumor angiogenesis. Furthermore, the tumor cells themselves are genetically unstable, leading to a progressive increase in the number of different angiogenic factors produced as the cancer progresses to advanced stages. As an alternative approach to targeted therapy, options to broadly interfere with angiogenic signals by a mixture of nontoxic natural compound with pleiotropic actions were viewed by this team as an opportunity to develop a complementary anti-angiogenesis treatment option. As a part of the "Halifax Project" within the "Getting to know cancer" framework, we have here, based on a thorough review of the literature, identified 10 important aspects of tumor angiogenesis and the pathological tumor vasculature which would be well suited as targets for anti-angiogenic therapy: (1) endothelial cell migration/tip cell formation, (2) structural abnormalities of tumor vessels, (3) hypoxia, (4) lymphangiogenesis, (5) elevated interstitial fluid pressure, (6) poor perfusion, (7) disrupted circadian rhythms, (8) tumor promoting inflammation, (9) tumor promoting fibroblasts and (10) tumor cell metabolism/acidosis. Following this analysis, we scrutinized the available literature on broadly acting anti-angiogenic natural products, with a focus on finding qualitative information on phytochemicals which could inhibit these targets and came up with 10 prototypical phytochemical compounds: (1) oleanolic acid, (2) tripterine, (3) silibinin, (4) curcumin, (5) epigallocatechin-gallate, (6) kaempferol, (7) melatonin, (8) enterolactone, (9) withaferin A and (10) resveratrol. We suggest that these plant-derived compounds could be combined to constitute a broader acting and more effective inhibitory cocktail at doses that would not be likely to cause excessive toxicity. All the targets and phytochemical approaches were further cross-validated against their effects on other essential tumorigenic pathways (based on the "hallmarks" of cancer) in order to discover possible synergies or potentially harmful interactions, and were found to generally also have positive involvement in/effects on these other aspects of tumor biology. The aim is that this discussion could lead to the selection of combinations of such anti-angiogenic compounds which could be used in potent anti-tumor cocktails, for enhanced therapeutic efficacy, reduced toxicity and circumvention of single-agent anti-angiogenic resistance, as well as for possible use in primary or secondary cancer prevention strategies. (C) 2015 The Authors. Published by Elsevier Ltd.	[Wang, Zongwei] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Urol, Boston, MA USA; [Dabrosin, Charlotta] Linkoping Univ, Dept Oncol, SE-58185 Linkoping, Sweden; [Dabrosin, Charlotta] Linkoping Univ, Dept Clin & Expt Med, SE-58185 Linkoping, Sweden; [Yin, Xin; Fuster, Mark M.] Vet Affairs San Diego Healthcare Syst, Med & Res Serv, San Diego, CA USA; [Yin, Xin; Fuster, Mark M.] Univ Calif San Diego, San Diego, CA 92103 USA; [Arreola, Alexandra; Rathmell, W. Kimryn] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Generali, Daniele] AO Isituti Ospitalieri Cremona, Mol Therapy & Pharmacogen Unit, Cremona, Italy; [Nagaraju, Ganji P.; El-Rayes, Bassel] Emory Univ, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA; [Ribatti, Domenico] Univ Bari, Sch Med, Dept Basic Med Sci Neurosci & Sensory Organs, Bari, Italy; [Ribatti, Domenico] Natl Canc Inst Giovanni Paolo II, Bari, Italy; [Chen, Yi Charlie] Alderson Broaddus Univ, Dept Biol, Philippi, WV USA; [Honoki, Kanya; Fujii, Hiromasa] Nara Med Univ, Dept Orthoped Surg Arthroplasty & Regenerat Med, Nara, Japan; [Georgakilas, Alexandros G.] Natl Tech Univ Athens, Dept Phys, Sch Appl Math & Phys Sci, GR-15773 Athens, Greece; [Nowsheen, Somaira] Mayo Clin, Coll Med, Mayo Grad Sch, Rochester, MN USA; [Amedei, Amedeo; Niccolai, Elena] Univ Florence, Dept Expt & Clin Med, Florence, Italy; [Amin, Amr] United Arab Emirates Univ, Coll Sci, Dept Biol, Al Ain, U Arab Emirates; [Amin, Amr] Cairo Univ, Fac Sci, Cairo, Egypt; [Ashraf, S. Salman] United Arab Emirates Univ, Coll Sci, Dept Chem, Al Ain, U Arab Emirates; [Helferich, Bill; Yang, Xujuan] Univ Illinois, Urbana, IL USA; [Guha, Gunjan; Bhakta, Dipita] SASTRA Univ, Sch Chem & Bio Technol, Thanjavur, India; [Ciriolo, Maria Rosa; Aquilano, Katia] Univ Roma Tor Vergata, Dept Biol, Rome, Italy; [Chen, Sophie] Ovarian & Prostate Canc Res Trust Lab, Surrey, England; [Halicka, Dorota] New York Med Coll, New York, NY USA; [Mohammed, Sulma I.] Purdue Univ, Ctr Canc Res, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA; [Azmi, Asfar S.] Wayne State Univ, Sch Med, Detroit, MI USA; [Bilsland, Alan; Keith, W. Nicol] Univ Glasgow, Inst Canc Sci, Glasgow, Lanark, Scotland; [Jensen, Lasse D.] Linkoping Univ, Dept Med & Hlth Sci, SE-58185 Linkoping, Sweden; [Jensen, Lasse D.] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden	Jensen, LD (reprint author), Linkoping Univ, Dept Med & Hlth Sci, Farmakologen Ingang 68 Pl 08, SE-58185 Linkoping, Sweden.	zwang0@partners.org; lasse.jensen@liu.se			Swedish Society for Medical Research; Goesta Fraenkel Foundation; Ake Wiberg's Foundation; Ollie och Elof Ericsson's Foundation; Karolinska Institute; Linkoping University; University of Glasgow; Beatson Oncology Center Fund; Cancer Research UK grant [C301/A14762]; NIH NRSA grant [F31CA154080]; EU grant [MC-CIG-303514]; National Strategic Reference Framework grant [MIS-379346]; COST action [CM1201]; University of Florence; Italian Ministry of Research; Terry Fox Foundation; UAEU Program for Advanced Research; West Virginia Experimental Program; NIH [5P20RR016477, 8P20GM104434]; Swedish Research Council; Swedish Research Society; EU [278570]; University of Italy; Japanese Ministry of Science grant [24590493]; Galaxo Smith Kline; AIRC; NIH/NHLBI grant [R01HL107652, T32HL098062]; Eisai Healthcare Investigator grant; Ovarian and Prostate Cancer Research Trust	We would like to thank Mr. Leroy Lowe for his vision and initiative in the GettingToKnowCancer organization. Dr. Jensen was funded by the Swedish Society for Medical Research, the Goesta Fraenkel Foundation, Ake Wiberg's Foundation, Ollie och Elof Ericsson's Foundation, the Karolinska Institute and Linkoping University. Drs Keith and Bilsland were funded by the University of Glasgow, Beatson Oncology Center Fund and Cancer Research UK grant C301/A14762. Dr. Arreola was funded by NIH NRSA grant F31CA154080. Dr. Georgakilas was funded by EU grant MC-CIG-303514, the National Strategic Reference Framework grant MIS-379346 and COST action CM1201. Dr. Amedei was funded by the University of Florence and the Italian Ministry of Research. Dr. Amin was partially funded by the Terry Fox Foundation, 2013 and the UAEU Program for Advanced Research 2013. Dr. Yi Charlie Chen was funded by the West Virginia Experimental Program to Stimulate Competitive Research and NIH grants 5P20RR016477 and 8P20GM104434. Dr. Dabrosin was funded by the Swedish Research Council and the Swedish Research Society. Dr. Generali was funded by the EU Seventh Framework Program grant 278570. Dr. Halicka was funded by the NIH. Dr. Niccolai was funded by the Italian Ministry of Research and the University of Italy. Dr. Honoki was funded by the Japanese Ministry of Science grant 24590493. Dr. Rathmell was funded by Galaxo Smith Kline for an investigator-initiated clinical trial. Dr. Ciriolo was funded by the AIRC. Dr. Fuster was funded by the NIH/NHLBI grant R01HL107652 and an Eisai Healthcare Investigator grant. Dr. Sophie Chen was funded by the Ovarian and Prostate Cancer Research Trust. Dr. Yin was funded by NIH/NHLBI grant T32HL098062.	Estrella V, 2013, CANCER RES, V73, P1524, DOI 10.1158/0008-5472.CAN-12-2796; Penel N, 2012, CRIT REV ONCOL HEMAT, V82, P40, DOI 10.1016/j.critrevonc.2011.04.009; Huang YL, 2008, CANCER LETT, V264, P101, DOI 10.1016/j.canlet.2008.01.043; Oshima T, 2011, ONCOL REP, V25, P1439, DOI 10.3892/or.2011.1207; Ochi N, 2007, PANCREAS, V34, P444, DOI 10.1097/mpa.0b13e31803dd307; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Hudson CC, 2002, MOL CELL BIOL, V22, P7004, DOI 10.1128/MCB.22.20.7004-7014.2002; Thelen P, 2004, J UROLOGY, V171, P1934, DOI 10.1097/01.ju.0000121329.37206.1b; Hua H, 2006, CANCER SCI, V97, P589, DOI 10.1111/j.1349-7006.2006.00225.x; Kim YH, 2010, BIOCHEM PHARMACOL, V80, P1152, DOI 10.1016/j.bcp.2010.07.006; Wang WB, 2012, J CELL PHYSIOL, V227, P2196, DOI 10.1002/jcp.22956; Forssell J, 2007, CLIN CANCER RES, V13, P1472, DOI 10.1158/1078-0432.CCR-06-2073; Schluep T, 2009, CLIN CANCER RES, V15, P181, DOI 10.1158/1078-0432.CCR-08-1848; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Jung YD, 2001, BRIT J CANCER, V84, P844, DOI 10.1054/bjoc.2000.1691; Wang BQ, 2013, CHINESE MED J-PEKING, V126, P4724, DOI 10.3760/cma.j.issn.0366-6999.20131965; Singh RP, 2003, CANCER EPIDEM BIOMAR, V12, P933; Cao YH, 1999, NATURE, V398, P381, DOI 10.1038/18793; Luo HT, 2012, INT J NANOMED, V7, P3951, DOI 10.2147/IJN.S33670; Bishayee A, 2009, CANCER PREV RES, V2, P409, DOI 10.1158/1940-6207.CAPR-08-0160; Deeb D, 2013, MOLECULES, V18, P3250, DOI 10.3390/molecules18033250; Gaddameedhi S, 2012, CELL CYCLE, V11, P3481, DOI 10.4161/cc.21771; Lim TG, 2014, CANCER PREV RES, V7, P466, DOI 10.1158/1940-6207.CAPR-13-0387; Ni HW, 2014, ACTA HAEMATOL-BASEL, V131, P102, DOI 10.1159/000354770; Hofmann M, 2006, NEOPLASIA, V8, P89, DOI 10.1593/neo.05469; Tyagi A, 2009, CANCER PREV RES, V2, P74, DOI 10.1158/1940-6207.CAPR-08-0095; Singh BN, 2009, CHEM-BIOL INTERACT, V181, P20, DOI 10.1016/j.cbi.2009.05.007; Kelly CJ, 2014, RADIOTHER ONCOL, V111, P72, DOI 10.1016/j.radonc.2014.02.007; Rupertus K, 2009, ANN SURG ONCOL, V16, P2629, DOI 10.1245/s10434-009-0564-8; Busik JV, 2009, J EXP MED, V206, P2897, DOI 10.1084/jem.20090889; van Meeteren ME, 2004, BIOCHEM PHARMACOL, V67, P967, DOI 10.1016/j.bcp.2003.10.018; Martinez-Campa CM, 2008, CANCER LETT, V268, P272, DOI 10.1016/j.canlet.2008.04.001; Yamanda S, 2009, BLOOD, V113, P3631, DOI 10.1182/blood-2008-07-170381; Schernhammer ES, 2003, J NATL CANCER I, V95, P825; Alitalo K, 2011, NAT MED, V17, P1371, DOI 10.1038/nm.2545; Skobe M, 2001, NAT MED, V7, P192, DOI 10.1038/84643; Sleeman JP, 2000, RECENT RES CANCER, V157, P55; Bussink J, 1998, BRIT J CANCER, V77, P57, DOI 10.1038/bjc.1998.9; Qu Y, 2003, PEPTIDES, V24, P363, DOI 10.1016/S0196-9781(03)00050-0; Anderson CJ, 2006, ONCOGENE, V25, P61, DOI 10.1038/sj.onc.1209011; Sogno I, 2009, RECENT RES CANCER, V181, P209; Lanzilli G, 2006, INT J ONCOL, V28, P641; Huang CH, 2009, MOL NUTR FOOD RES, V53, P1156, DOI 10.1002/mnfr.200800592; Guzy RD, 2006, EXP PHYSIOL, V91, P807, DOI 10.1113/expphysiol.2006.033506; Gombos Z, 2005, CLIN CANCER RES, V11, P8364, DOI 10.1158/1078-0432.CCR-05-1238; Saldanha SN, 2014, EXP CELL RES, V324, P40, DOI 10.1016/j.yexcr.2014.01.024; Renyi-Vamos F, 2005, CLIN CANCER RES, V11, P7344, DOI 10.1158/1078-0432.2005.CCR-05-1077; Hahm ER, 2013, JNCI-J NATL CANCER I, V105, P1111, DOI 10.1093/jnci/djt153; Singhal S, 1999, NEW ENGL J MED, V341, P1565, DOI 10.1056/NEJM199911183412102; Hamano Y, 2003, CANCER CELL, V3, P589, DOI 10.1016/S1535-6108(03)00133-8; Helfrich I, 2009, CLIN CANCER RES, V15, P1384, DOI 10.1158/1078-0432.CCR-08-1615; Voss MJ, 2010, CURR MOL MED, V10, P381; Shen XY, 2014, INT J ONCOL, V44, P791, DOI 10.3892/ijo.2014.2251; Cao ZX, 2004, CLIN CANCER RES, V10, P5253, DOI 10.1158/1078-0432.CCR-03-0588; Maeda-Yamamoto M, 1999, J AGR FOOD CHEM, V47, P2350, DOI 10.1021/jf9811525; Padera TP, 2002, SCIENCE, V296, P1883, DOI 10.1126/science.1071420; Bisacchi D, 2003, CANCER DETECT PREV, V27, P229, DOI 10.1016/S0361-090X(03)00030-8; Xue Y, 2012, NAT MED, V18, P100, DOI 10.1038/nm.2575; Deeb D, 2011, CARCINOGENESIS, V32, P757, DOI 10.1093/carcin/bgr030; Raina K, 2013, AUTOPHAGY, V9, P697, DOI 10.4161/auto.23960; Shin JY, 2009, CELL IMMUNOL, V256, P72, DOI 10.1016/j.cellimm.2009.01.006; Browder T, 2000, CANCER RES, V60, P1878; Rath S, 2012, BRIT J PHARMACOL, V167, P1048, DOI 10.1111/j.1476-5381.2012.02037.x; Jayaprakasam B, 2003, LIFE SCI, V74, P125, DOI 10.1016/j.lfs.2003.07.007; Kaur M, 2009, MOL CANCER THER, V8, P2366, DOI 10.1158/1535-7163.MCT-09-0304; Klintman M, 2010, BREAST CANCER RES TR, V121, P365, DOI 10.1007/s10549-009-0483-1; Bhattacharyya S, 2010, CELL MOL IMMUNOL, V7, P306, DOI 10.1038/cmi.2010.11; Hill SM, 2011, J MAMMARY GLAND BIOL, V16, P235, DOI 10.1007/s10911-011-9222-4; Xu Y, 2012, MOL ONCOL, V6, P405, DOI 10.1016/j.molonc.2012.03.005; Thomasset SC, 2007, INT J CANCER, V120, P451, DOI 10.1002/ijc.22419; Klauber N, 1997, CANCER RES, V57, P81; Mazur W, 1996, ANAL BIOCHEM, V233, P169, DOI 10.1006/abio.1996.0025; Siekmann AF, 2007, NATURE, V445, P781, DOI 10.1038/nature05577; Jankun J, 1997, NATURE, V387, P561, DOI 10.1038/42381; Goda N, 2003, MOL CELL BIOL, V23, P359, DOI 10.1128/MCB.23.1.359-369.2003; Tosetti F, 2009, INT J CANCER, V125, P1997, DOI 10.1002/ijc.24677; Villalba M, 2013, INT J BIOCHEM CELL B, V45, P106, DOI 10.1016/j.biocel.2012.04.024; Sartippour MR, 2002, J NUTR, V132, P2307; Xiang LS, 2014, J MOL MED, V92, P151, DOI 10.1007/s00109-013-1102-5; Kang N, 2014, FOOD CHEM TOXICOL, V67, P193, DOI 10.1016/j.fct.2014.02.024; Trapp V, 2010, ANGIOGENESIS, V13, P305, DOI 10.1007/s10456-010-9187-8; Casazza A, 2013, CANCER CELL, V24, P695, DOI 10.1016/j.ccr.2013.11.007; Craig DH, 2008, CELL MOL BIOL LETT, V13, P260, DOI 10.2478/s11658-007-0054-6; Bono P, 2004, CLIN CANCER RES, V10, P7144, DOI 10.1158/1078-0432.CCR-03-0826; Sotak M, 2013, INT J CANCER, V132, P1032, DOI 10.1002/ijc.27760; Moreira L, 2013, EXP CELL RES, V319, P1784, DOI 10.1016/j.yexcr.2013.05.001; Valenti D, 2013, BBA-MOL BASIS DIS, V1832, P2085, DOI 10.1016/j.bbadis.2013.07.014; Islam N, 2002, J CELL BIOCHEM, V87, P266, DOI 10.1002/jcb.10317; Schrohl AS, 2003, MOL CELL PROTEOMICS, V2, P164, DOI 10.1074/mcp.M300019-MCP200; Martinive P, 2006, CANCER RES, V66, P11736, DOI 10.1158/0008-5472.CAN-06-2056; Zhou JR, 2004, INT J CANCER, V108, P8, DOI 10.1002/ijc.11549; Khan N, 2009, NUTR CANCER, V61, P836, DOI 10.1080/01635580903285056; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Lindahl G, 2011, CANCER RES, V71, P51, DOI 10.1158/0008-5472.CAN-10-2289; Koyanagi S, 2003, CANCER RES, V63, P7277; Kinugasa Y, 2014, STEM CELLS, V32, P145, DOI 10.1002/stem.1556; Li XM, 2010, CANCER RES, V70, P3351, DOI 10.1158/0008-5472.CAN-09-4235; Ribatti D, 2012, CANCER LETT, V316, P126, DOI 10.1016/j.canlet.2011.10.040; Guba M, 2002, NAT MED, V8, P128, DOI 10.1038/nm0202-128; Huang YH, 2012, P NATL ACAD SCI USA, V109, P17561, DOI 10.1073/pnas.1215397109; Hushmendy S, 2009, NUTR RES, V29, P568, DOI 10.1016/j.nutres.2009.08.003; Wang W, 2009, CLIN CANCER RES, V15, P6630, DOI 10.1158/1078-0432.CCR-09-1001; Gillies RJ, 2012, NAT REV CANCER, V12, P487, DOI 10.1038/nrc3298; Wang X, 2013, CARCINOGENESIS, V34, P1323, DOI 10.1093/carcin/bgt058; Lin YG, 2007, CLIN CANCER RES, V13, P3423, DOI 10.1158/1078-0432.CCR-06-3072; Sharma C, 2012, ASIAN PAC J CANCER P, V13, P4815, DOI 10.7314/APJCP.2012.13.9.4815; Sanchez-Sanchez AM, 2011, FREE RADICAL RES, V45, P1333, DOI 10.3109/10715762.2011.623700; Yang HJ, 2007, MOL PHARMACOL, V71, P426, DOI 10.1124/mol.106.030015; Ghajar CM, 2013, NAT CELL BIOL, V15, P807, DOI 10.1038/ncb2767; Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387; Wang X, 2009, ARCH PHARM RES, V32, P1263, DOI 10.1007/s12272-009-1912-8; Madhok BM, 2010, BRIT J CANCER, V102, P1746, DOI 10.1038/sj.bjc.6605701; Jensen LD, 2011, BIRTH DEFECTS RES C, V93, P182, DOI 10.1002/bdrc.20203; Li JL, 2007, CANCER RES, V67, P11244, DOI 10.1158/0008-5472.CAN-07-0969; Wang CY, 2008, CIRCULATION, V118, P2166, DOI 10.1161/CIRCULATIONAHA.108.790469; Tae N, 2011, ANTICANCER RES, V31, P2179; Sinha P, 2013, CANCER IMMUNOL IMMUN, V62, P1663, DOI 10.1007/s00262-013-1470-2; JAMES SE, 1974, CANCER RES, V34, P839; Xu W, 2008, CANCER LETT, V264, P229, DOI 10.1016/j.canlet.2008.01.044; McCann MJ, 2008, MOL NUTR FOOD RES, V52, P567, DOI 10.1002/mnfr.200700052; Vangestel C, 2011, J NUCL MED, V52, P1786, DOI 10.2967/jnumed.111.092650; Kimura Y, 2013, PHYTOMEDICINE, V20, P328, DOI 10.1016/j.phymed.2012.10.016; Lin JK, 1999, BIOCHEM PHARMACOL, V58, P911, DOI 10.1016/S0006-2952(99)00112-4; Gardner LB, 2001, J BIOL CHEM, V276, P7919, DOI 10.1074/jbc.M010189200; Meeran SM, 2006, CLIN CANCER RES, V12, P2272, DOI 10.1158/1078-0432.CCR-05-2672; Lipton A, 2007, CANCER, V109, P1933, DOI 10.1002/cncr.22637; Adhami VM, 2001, BIOCHEM BIOPH RES CO, V288, P579, DOI 10.1006/bbrc.2001.5819; Yu T, 2014, CLIN TRANSL ONCOL, V16, P539, DOI 10.1007/s12094-013-1115-0; Suh Y, 2009, CARCINOGENESIS, V30, P300, DOI 10.1093/carcin/bgn269; Crawford Y, 2009, CANCER CELL, V15, P21, DOI 10.1016/j.ccr.2008.12.004; Thomas P, 2009, MUTAT RES-FUND MOL M, V661, P25, DOI 10.1016/j.mrfmmm.2008.10.016; Guo H, 2013, PHARMAZIE, V68, P431, DOI 10.1691/ph.2013.2861; Shanmugam MK, 2014, CANCER LETT, V346, P206, DOI 10.1016/j.canlet.2014.01.016; Hastak K, 2003, ONCOGENE, V22, P4851, DOI 10.1038/sj.onc.1206708; Mumprecht V, 2009, J CELL MOL MED, V13, P1405, DOI 10.1111/j.1582-4934.2009.00834.x; Luo HT, 2008, NUTR CANCER, V60, P800, DOI 10.1080/01635580802100851; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Siddiqui IA, 2009, CANCER RES, V69, P1712, DOI 10.1158/0008-5472.CAN-08-3978; Thiele W, 2013, CARCINOGENESIS, V34, P2804, DOI 10.1093/carcin/bgt291; Willett CG, 2004, NAT MED, V10, P145, DOI 10.1038/nm988; Kulbe H, 2012, CANCER RES, V72, P66, DOI 10.1158/0008-5472.CAN-11-2178; Roy S, 2012, CARCINOGENESIS, V33, P629, DOI 10.1093/carcin/bgr299; Tyagi A, 2004, CARCINOGENESIS, V25, P1711, DOI 10.1093/carcin/bgh180; Malik F, 2007, APOPTOSIS, V12, P2115, DOI 10.1007/s10495-007-0129-x; Shukla Y, 2011, ANN NY ACAD SCI, V1215, P1, DOI 10.1111/j.1749-6632.2010.05870.x; Saarinen NM, 2010, INT J CANCER, V127, P737, DOI 10.1002/ijc.25052; Tomei AA, 2009, J IMMUNOL, V183, P4273, DOI 10.4049/jimmunol.0900835; Grothey A, 2013, LANCET, V381, P303, DOI 10.1016/S0140-6736(12)61900-X; Onodera Y, 2014, J CLIN INVEST, V124, P367, DOI 10.1172/JCI63146; Seront E, 2013, BRIT J CANCER, V109, P2597, DOI 10.1038/bjc.2013.644; Roy RV, 2013, J NAT PROD, V76, P1909, DOI 10.1021/np400441f; Ferrara N, 2010, CURR OPIN HEMATOL, V17, P219, DOI 10.1097/MOH.0b013e3283386660; Chang LK, 2004, P NATL ACAD SCI USA, V101, P11658, DOI 10.1073/pnas.0404272101; Kajiya K, 2005, EMBO J, V24, P2885, DOI 10.1038/sj.emboj.7600763; Qu Y, 2008, MOL CELL BIOCHEM, V313, P11, DOI 10.1007/s11010-008-9736-2; Moghaddam SJ, 2009, CARCINOGENESIS, V30, P1949, DOI 10.1093/carcin/bgp229; Rofstad EK, 2002, CANCER RES, V62, P661; Jung DB, 2011, BIOL PHARM BULL, V34, P850, DOI 10.1248/bpb.34.850; Rao S, 2013, NATURE, V494, P243, DOI 10.1038/nature11823; Filomeni G, 2007, GENES NUTR, V2, P295, DOI 10.1007/s12263-007-0059-9; Park SY, 2007, CANCER LETT, V258, P63, DOI 10.1016/j.canlet.2007.08.011; Bendrik C, 2008, CANCER RES, V68, P3405, DOI 10.1158/0008-5472.CAN-08-0295; Corsini E, 2010, J AGR FOOD CHEM, V58, P6678, DOI 10.1021/jf100471n; Slivova V, 2005, NUTR CANCER, V52, P66, DOI 10.1207/s15327914nc5201_9; Banziger-Tobler NE, 2008, AM J PATHOL, V173, P586, DOI 10.2353/ajpath.2008.080060; Kumareswaran R, 2012, J CELL SCI, V125, P189, DOI 10.1242/jcs.092262; Rofstad EK, 2006, CANCER RES, V66, P6699, DOI 10.1158/008-5472.CAN-06-0983; Bishayee A, 2011, FRONT BIOSCI-LANDMRK, V16, P980, DOI 10.2741/3730; Pozzi A, 2002, ONCOGENE, V21, P272; Lofstedt T, 2004, J BIOL CHEM, V279, P39223, DOI 10.1074/jbc.M402904200; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Rana S, 2014, MOL BIOL REP, V41, P95, DOI 10.1007/s11033-013-2841-7; Otalora BB, 2008, J PINEAL RES, V44, P307, DOI 10.1111/j.1600-079X.2007.00531.x; Masferrer JL, 2000, CANCER RES, V60, P1306; Yang HJ, 2010, CANCER LETT, V292, P48, DOI 10.1016/j.canlet.2009.11.006; Tripathi C, 2014, ONCOTARGET, V5, P5350; Lekli I, 2010, J CELL MOL MED, V14, P2506, DOI 10.1111/j.1582-4934.2009.00921.x; Kubisch R, 2014, J NAT PROD, V77, P536, DOI 10.1021/np4008014; Thors L, 2008, BRIT J PHARMACOL, V155, P244, DOI 10.1038/bjp.2008.237; Huh SW, 2004, GYNECOL ONCOL, V94, P760, DOI 10.1016/j.ygyno.2004.05.031; Makinen T, 2005, GENE DEV, V19, P397, DOI 10.1101/gad.330105; Chen AY, 2013, FOOD CHEM, V138, P2099, DOI 10.1016/j.foodchem.2012.11.139; Khaw AK, 2013, J CELL BIOCHEM, V114, P1257, DOI 10.1002/jcb.24466; Hedlund EME, 2013, P NATL ACAD SCI USA, V110, P654, DOI 10.1073/pnas.1209310110; Ribatti D, 2009, LEUKEMIA RES, V33, P638, DOI 10.1016/j.leukres.2008.11.019; Yashiro M, 2009, BRIT J CANCER, V101, P1100, DOI 10.1038/sj.bjc.6605296; Li W, 2013, ARCH PHARM RES, V36, P768, DOI 10.1007/s12272-013-0042-5; Deeb D, 2012, BIOCHEM BIOPH RES CO, V422, P561, DOI 10.1016/j.bbrc.2012.05.024; Kieda C, 2013, J MOL MED, V91, P883, DOI 10.1007/s00109-013-0992-6; Yoysungnoen P, 2006, CLIN HEMORHEOL MICRO, V34, P109; Bishayee A, 2012, CURR PHARM BIOTECHNO, V13, P115; Fukumura D, 2007, J CELL BIOCHEM, V101, P937, DOI 10.1002/jcb.21187; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Abusnina A, 2015, THROMB HAEMOSTASIS, V113, P319, DOI 10.1160/TH14-05-0454; Thompson LU, 2006, NUTR CANCER, V54, P184, DOI 10.1207/s15327914nc5402_5; Karagiannis GS, 2012, MOL CANCER RES, V10, P1403, DOI 10.1158/1541-7786.MCR-12-0307; Stan SD, 2008, NUTR CANCER, V60, P51, DOI 10.1080/01635580802381477; Lin H, 2013, HEPATOLOGY, V57, P171, DOI 10.1002/hep.25991; Xu PF, 2013, INT J PHARMACEUT, V454, P21, DOI 10.1016/j.ijpharm.2013.06.053; Belkin DA, 2013, JAMA DERMATOL, V149, P178, DOI 10.1001/jamadermatol.2013.1609; Ridgway J, 2006, NATURE, V444, P1083, DOI 10.1038/nature05313; Cao YH, 2005, NAT REV CANCER, V5, P735, DOI 10.1038/nrc1693; Kimura Y, 2008, CANCER SCI, V99, P2083, DOI 10.1111/j.1349-7006.2008.00948.x; van der Schaft DWJ, 2004, J NATL CANCER I, V96, P1473, DOI 10.1093/jnci/djh267; Klein EA, 2011, JAMA-J AM MED ASSOC, V306, P1549, DOI 10.1001/jama.2011.1437; Mukhopadhyay A, 2002, ONCOGENE, V21, P8852, DOI 10.1038/sj.onc.1206048; Singh RP, 2005, ONCOGENE, V24, P1188, DOI 10.1038/sj.onc.1208276; Li H, 2011, CANCER-AM CANCER SOC, V117, P3135, DOI 10.1002/cncr.25893; Ishii H, 2010, ORAL ONCOL, V46, P373, DOI 10.1016/j.oraloncology.2010.02.014; Macpherson H, 2013, AM J CLIN NUTR, V97, P437, DOI 10.3945/ajcn.112.049304; Hong JH, 2006, PROSTATE CANCER P D, V9, P147, DOI 10.1038/sj.pcan.4500856; Decock J, 2011, J CELL MOL MED, V15, P1254, DOI 10.1111/j.1582-4934.2011.01302.x; Hamzah J, 2008, NATURE, V453, P410, DOI 10.1038/nature06868; Jensen LD, 2013, CELL CYCLE, V12, P405, DOI 10.4161/cc.23596; Hirakawa S, 2005, J EXP MED, V201, P1089, DOI 10.1084/jem.20041896; Maruyama T, 2014, ONCOL REP, V31, P625, DOI 10.3892/or.2013.2925; Surh YJ, 2003, NAT REV CANCER, V3, P768, DOI 10.1038/nrc1189; Hernandez-Luna MA, 2013, LEUKEMIA LYMPHOMA, V54, P1048, DOI 10.3109/10428194.2012.733874; Naksuriya O, 2014, BIOMATERIALS, V35, P3365, DOI 10.1016/j.biomaterials.2013.12.090; Ivan M, 2008, J CELL MOL MED, V12, P1426, DOI 10.1111/j.1582-4934.2008.00398.x; Marden A, 2006, FEMS YEAST RES, V6, P716, DOI 10.1111/j.1567-1364.2006.00092.x; Kim CH, 2010, KOREAN J PHYSIOL PHA, V14, P365, DOI 10.4196/kjpp.2010.14.6.365; Srivastava RK, 2010, MOL CELL BIOCHEM, V337, P201, DOI 10.1007/s11010-009-0300-5; Cao RH, 2004, CANCER CELL, V6, P333, DOI 10.1016/j.ccr.2004.08.034; Kerbel RS, 2011, BREAST, V20, pS56, DOI 10.1016/S0960-9776(11)70295-8; Gomez LS, 2013, BIOCHIMIE, V95, P1336, DOI 10.1016/j.biochi.2013.02.013; Schernhammer ES, 2001, J NATL CANCER I, V93, P1563; Bandyopadhyay S, 2008, MOL CELL ENDOCRINOL, V287, P57, DOI 10.1016/j.mce.2008.01.015; Forghani P, 2014, CANCER MED-US, V3, P215, DOI 10.1002/cam4.186; Park JS, 1998, J NUTR, V128, P1650; Wolter F, 2001, J NUTR, V131, P2197; Berletch JB, 2008, J CELL BIOCHEM, V103, P509, DOI 10.1002/jcb.21417; Jeong D, 2013, BIOL PHARM BULL, V36, P152, DOI 10.1248/bpb.b12-00871; Schafer H, 2013, ONCOGENE, V32, P180, DOI 10.1038/onc.2012.44; Sen T, 2009, LIFE SCI, V84, P194, DOI 10.1016/j.lfs.2008.11.018; RAPOZZI V, 1992, PHARMACOL RES, V25, P71, DOI 10.1016/1043-6618(92)90545-M; Matsuda H, 1997, BIOL PHARM BULL, V20, P1092; Touillaud MS, 2007, J NATL CANCER I, V99, P475, DOI 10.1093/jnci/djk096; Fotsis T, 1997, CANCER RES, V57, P2916; Nilsson UW, 2006, CANCER RES, V66, P4789, DOI 10.1158/0008-5472.CAN-05-4012; Heeg S, 2011, CANCER SCI, V102, P351, DOI 10.1111/j.1349-7006.2010.01796.x; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Miller KD, 2001, J CLIN ONCOL, V19, P1195; Sabins NC, 2013, MOL THER, V21, P1958, DOI 10.1038/mt.2013.133; Vaughan RA, 2013, INT J CANCER, V133, P2504, DOI 10.1002/ijc.28264; Ohashi T, 2013, INT J CANCER, V133, P1107, DOI 10.1002/ijc.28114; Jiang C, 2000, BIOCHEM BIOPH RES CO, V276, P371, DOI 10.1006/bbrc.2000.3474; Deng W, 2009, CHEM BIODIVERS, V6, P1243, DOI 10.1002/cbdv.200800187; Parrett ML, 1997, INT J ONCOL, V10, P503; Ravindranath MH, 2004, ADV EXP MED BIOL, V546, P121; Sadava D, 2007, BIOCHEM BIOPH RES CO, V360, P233, DOI 10.1016/j.bbrc.2007.06.030; Yang CS, 2009, NAT REV CANCER, V9, P429, DOI 10.1038/nrc2641; Rofstad EK, 2010, INT J CANCER, V127, P1535, DOI 10.1002/ijc.25176; Maxwell PH, 1999, NATURE, V399, P271; Lee JH, 2011, P NATL ACAD SCI USA, V108, P12036, DOI 10.1073/pnas.1108125108; Mihaly Z, 2012, CURR CANCER DRUG TAR, V12, P857; Grogan PT, 2013, INVEST NEW DRUG, V31, P545, DOI 10.1007/s10637-012-9888-5; Wu PK, 2009, LIFE SCI, V85, P113, DOI 10.1016/j.lfs.2009.04.025; Gotink KJ, 2010, ANGIOGENESIS, V13, P1, DOI 10.1007/s10456-009-9160-6; Yu T, 2013, INT J MOL MED, V32, P1093, DOI 10.3892/ijmm.2013.1496; Karpanen T, 2001, CANCER RES, V61, P1786; Kubo H, 2002, P NATL ACAD SCI USA, V99, P8868, DOI 10.1073/pnas.062040199; Mazzone M, 2009, CELL, V136, P839, DOI 10.1016/j.cell.2009.01.020; Lee SLC, 2009, P NATL ACAD SCI USA, V106, P19485, DOI 10.1073/pnas.0909228106; Yang Y, 2008, INT IMMUNOPHARMACOL, V8, P542, DOI 10.1016/j.intimp.2007.12.006; Trock BJ, 2006, J NATL CANCER I, V98, P459, DOI 10.1093/jnci/djj102; Baronzio G, 2012, ANTICANCER RES, V32, P405; Singh RP, 2008, CLIN CANCER RES, V14, P7773, DOI 10.1158/1078-0432.CCR-08-1309; Mo J, 2013, PATHOL RES PRACT, V209, P640, DOI 10.1016/j.prp.2013.07.004; Nasiri M, 2013, ASIAN PAC J CANCER P, V14, P3449, DOI 10.7314/APJCP.2013.14.6.3449; Kim AL, 2006, EXP DERMATOL, V15, P538, DOI 10.1111/j.1600-0625.2006.00445.x; Chen W, 2007, EUR SURG RES, V39, P332, DOI 10.1159/000104837; Kopitz C, 2007, CANCER RES, V67, P8615, DOI 10.1158/0008-5472.CAN-07-0232; Partridge JJ, 2007, J BIOL CHEM, V282, P35964, DOI 10.1074/jbc.M705993200; Banerjee S, 2008, CANCER LETT, V269, P226, DOI 10.1016/j.canlet.2008.03.052; Wang L, 2014, AAPS PHARMSCITECH, V15, P834, DOI 10.1208/s12249-014-0112-0; Daurkin I, 2011, CANCER RES, V71, P6400, DOI 10.1158/0008-5472.CAN-11-1261; Gonzalez A, 2011, J PINEAL RES, V50, P250, DOI 10.1111/j.1600-079X.2010.00834.x; Lee WY, 2014, TOXICOL APPL PHARM, V274, P55, DOI 10.1016/j.taap.2013.10.027; Nicolini A, 2006, CYTOKINE GROWTH F R, V17, P325, DOI 10.1016/j.cytogfr.2006.07.002; Singh BN, 2014, CANCER METAST REV, V33, P41, DOI 10.1007/s10555-013-9457-1; Land SC, 2007, J BIOL CHEM, V282, P20534, DOI 10.1074/jbc.M611782200; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; GREF R, 1994, SCIENCE, V263, P1600, DOI 10.1126/science.8128245; Chen HJ, 2013, ONCOL REP, V30, P925, DOI 10.3892/or.2013.2490; Martin S, 2013, BRIT J CANCER, V109, P433, DOI 10.1038/bjc.2013.325; Stanley G, 2005, BIOCHEM BIOPH RES CO, V330, P46, DOI 10.1016/j.bbrc.2005.02.116; Campbell NE, 2010, NEOPLASIA, V12, P275, DOI 10.1593/neo.91880; Zgheib A, 2013, J BIOL CHEM, V288, P13378, DOI 10.1074/jbc.M113.456533; Luo Y, 2011, CANCER PREV RES, V4, P2083, DOI 10.1158/1940-6207.CAPR-11-0319; Tsai SH, 1999, J CELL BIOCHEM, V74, P606, DOI 10.1002/(SICI)1097-4644(19990915)74:4<606::AID-JCB10>3.0.CO;2-W; Wojtkowiak JW, 2012, CANCER RES, V72, P3938, DOI 10.1158/0008-5472.CAN-11-3881; Jeong SK, 2014, INT IMMUNOPHARMACOL, V22, P303, DOI 10.1016/j.intimp.2014.07.004; Garvin S, 2006, CANCER LETT, V231, P113, DOI 10.1016/j.canlet.2005.01.031; Pratheeshkumar P, 2011, J ENVIRON PATHOL TOX, V30, P21; Arbiser JL, 1998, MOL MED, V4, P376; Kuang X, 2006, BRAIN RES, V1102, P145, DOI 10.1016/j.brainres.2006.04.110; Helferich W. G., 2008, Inflammopharmacology, V16, P219, DOI 10.1007/s10787-008-8020-0; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.13.5675-5686.2005; Wang B, 2013, NUTR RES, V33, P971, DOI 10.1016/j.nutres.2013.07.016; Tosetti F, 2002, FASEB J, V16, P2, DOI 10.1096/fj.01-0300rev; Fouad MA, 2013, HUM EXP TOXICOL, V32, P1067, DOI 10.1177/0960327113475679; Mace TA, 2013, CANCER RES, V73, P3007, DOI 10.1158/0008-5472.CAN-12-4601; Nagaraj S, 2010, CLIN CANCER RES, V16, P1812, DOI 10.1158/1078-0432.CCR-09-3272; Maione F, 2012, J CLIN INVEST, V122, P1832, DOI 10.1172/JCI58976; Hirakawa S, 2007, BLOOD, V109, P1010, DOI 10.1182/blood-2006-05-021758; Ahmad N, 2002, ARCH BIOCHEM BIOPHYS, V398, P125, DOI 10.1006/abbi.2001.2704; Lissoni P, 1996, ONCOL REP, V3, P947; Denissova NG, 2012, CARCINOGENESIS, V33, P149, DOI 10.1093/carcin/bgr236; Milder IEJ, 2005, BRIT J NUTR, V93, P393, DOI 10.1079/BJN20051371; Jakobsson L, 2010, NAT CELL BIOL, V12, P943, DOI 10.1038/ncb2103; Lockhart AC, 2010, J CLIN ONCOL, V28, P207, DOI 10.1200/JCO.2009.22.9237; Ricci-Vitiani L, 2010, NATURE, V468, P824, DOI 10.1038/nature09557; Alvarez-Garcia V, 2013, MICROVASC RES, V87, P25, DOI 10.1016/j.mvr.2013.02.008; Casagrande F, 2001, BIOCHEM PHARMACOL, V61, P1205, DOI 10.1016/S0006-2952(01)00583-4; Beveridge THJ, 2002, J AGR FOOD CHEM, V50, P744, DOI 10.1021/jf010701v; Aggarwal BB, 2013, BRIT J PHARMACOL, V169, P1672, DOI 10.1111/bph.12131; Ge PF, 2010, NEUROL RES, V32, P94, DOI 10.1179/016164109X12518779082273; Roenneberg T, 2013, NATURE, V498, P427, DOI 10.1038/498427a; Iliopoulos O, 1996, P NATL ACAD SCI USA, V93, P10595, DOI 10.1073/pnas.93.20.10595; Miyazaki K, 2010, GENES CELLS, V15, P351, DOI 10.1111/j.1365-2443.2010.01384.x; Noguera-Troise I, 2006, NATURE, V444, P1032, DOI 10.1038/nature05355; Wood J, 2002, J PHARMACOL EXP THER, V302, P1055, DOI 10.1124/jpet.102.035295; Apte RN, 2006, EUR J CANCER, V42, P751, DOI 10.1016/j.ejca.2006.01.010; Calcinotto A, 2012, CANCER RES, V72, P2746, DOI 10.1158/0008-5472.CAN-11-1272; Cortes JR, 2007, J IMMUNOL, V179, P3881; Kwon GT, 2009, J NUTR BIOCHEM, V20, P663, DOI 10.1016/j.jnutbio.2008.06.005; Lund AW, 2012, CELL REP, V1, P191, DOI 10.1016/j.celrep.2012.01.005; Zhou JR, 2003, J NUTR, V133, P516; Wu MW, 2012, ONCOL REP, V27, P1417, DOI 10.3892/or.2012.1688; Miyagi M, 2007, INT J CLIN ONCOL, V12, P17, DOI 10.1007/s10147-006-0616-z; Zhong H, 2000, CANCER RES, V60, P1541; Singh BN, 2011, BIOCHEM PHARMACOL, V82, P1807, DOI 10.1016/j.bcp.2011.07.093; Wesolowska O, 2010, ANTICANCER RES, V30, P4587; Nishi H, 2004, MOL CELL BIOL, V24, P6076, DOI 10.1128/MCB.24.13.6076-6083.2004; Lee KM, 2010, BIOCHEM PHARMACOL, V80, P2042, DOI 10.1016/j.bcp.2010.06.042; Krueger J, 2011, DEVELOPMENT, V138, P2111, DOI 10.1242/dev.063933; Peppicelli S, 2014, CLIN EXP METASTAS, V31, P423, DOI 10.1007/s10585-014-9637-6; Fang HY, 2011, PHYTOMEDICINE, V18, P697, DOI 10.1016/j.phymed.2010.11.012; Nagy JA, 2012, CLIN EXP METASTAS, V29, P657, DOI 10.1007/s10585-012-9500-6; Wang XH, 2008, VASC PHARMACOL, V49, P158, DOI 10.1016/j.vph.2008.07.005; Huang LL, 2011, INT J MOL MED, V27, P407, DOI 10.3892/ijmm.2011.600; Chirasani SR, 2013, INT J CANCER, V132, P843, DOI 10.1002/ijc.27712; Ramos S, 2007, J NUTR BIOCHEM, V18, P427, DOI 10.1016/j.jnutbio.2006.11.004; Jensen LD, 2012, CELL REP, V2, P231, DOI 10.1016/j.celrep.2012.07.005; Cos S, 1998, CANCER RES, V58, P4383; [Anonymous], 2002, TUMORI S; Yousefi M, 2012, NEUROCHEM RES, V37, P2053, DOI 10.1007/s11064-012-0827-9; Preise D, 2011, PHOTOCH PHOTOBIO SCI, V10, P681, DOI 10.1039/c0pp00315h; Pontiggia O, 2012, BREAST CANCER RES TR, V133, P459, DOI 10.1007/s10549-011-1766-x; Rattigan YL, 2012, EXP CELL RES, V318, P326, DOI 10.1016/j.yexcr.2011.11.014; Anea CB, 2012, CIRC RES, V111, P1157, DOI 10.1161/CIRCRESAHA.111.261750; Liu ZH, 2012, ONCOL LETT, V4, P837, DOI 10.3892/ol.2012.824; Santini D, 2003, CLIN CANCER RES, V9, P2893; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Huang WW, 2013, INT J ONCOL, V42, P2069, DOI 10.3892/ijo.2013.1909; Sethi G, 2007, BLOOD, V109, P2727, DOI 10.1182/blood-2006-10-050807; Dizaji MZ, 2012, NEUROCHEM RES, V37, P370, DOI 10.1007/s11064-011-0620-1; Zhang DF, 2011, P NATL ACAD SCI USA, V108, P4117, DOI 10.1073/pnas.1016220108; Jiang HL, 2013, MOL BIOL REP, V40, P4203, DOI 10.1007/s11033-013-2501-y; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Brakenhielm E, 2001, FASEB J, V15, P1798, DOI 10.1096/fj.01-0028fje; Golding JP, 2013, BRIT J CANCER, V109, P976, DOI 10.1038/bjc.2013.391; Tyagi A, 2002, MOL CANCER THER, V1, P525; Danbara N, 2005, ANTICANCER RES, V25, P2269; Park JH, 2010, ONCOL REP, V23, P585, DOI 10.3892/or_00000673; Thaiparambil JT, 2011, INT J CANCER, V129, P2744, DOI 10.1002/ijc.25938; Elshazley M, 2012, INT J CANCER, V131, P2820, DOI 10.1002/ijc.27598; Mattila MMT, 2002, INT J CANCER, V98, P946, DOI 10.1002/ijc.10283; Agarwal C, 2003, ONCOGENE, V22, P8271, DOI 10.1038/sj.onc.1207158; Miura D, 2007, NUTR CANCER, V58, P49; Mao LL, 2012, MOL ENDOCRINOL, V26, P1808, DOI 10.1210/me.2012-1071; Zhang YA, 2011, CANCER LETT, V303, P47, DOI 10.1016/j.canlet.2011.01.011; Wu JH, 2011, CANCER RES, V71, P2622, DOI 10.1158/0008-5472.CAN-10-3837; Gou ML, 2011, NANOSCALE, V3, P1558, DOI 10.1039/c0nr00758g; Aung KZ, 2012, J ORTHOP RES, V30, P2038, DOI 10.1002/jor.22154; Leong SPL, 2006, CANCER METAST REV, V25, P221, DOI 10.1007/s10555-006-8502-8; Garcia-Maceira P, 2009, ONCOGENE, V28, P313, DOI 10.1038/onc.2008.398; Mamlouk S, 2013, INT J CANCER, V132, P2721, DOI 10.1002/ijc.27901; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Jensen LD, 2009, CURR MOL MED, V9, P982; Shamim U, 2012, J CELL PHYSIOL, V227, P1493, DOI 10.1002/jcp.22865; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Filomeni G, 2010, AUTOPHAGY, V6, P202; Astin JW, 2014, MOL CANCER THER, V13, P2450, DOI 10.1158/1535-7163.MCT-14-0469-T; Bertl E, 2006, MOL CANCER THER, V5, P575, DOI 10.1158/1535-7163.MCT-05-0324; Bishayee A, 2010, J CARCINOG MUTAGEN, P1; Cao Y, 2011, SCI TRANSL MED, V3, DOI DOI 10.1126/SCITRANSLMED.3003149; Chatterjee Subhojyoti, 2012, Bioinformation, V8, P1249, DOI 10.6026/97320630081249; Choi Eun Jeong, 2008, Nutr Res Pract, V2, P322, DOI 10.4162/nrp.2008.2.4.322; Christiansen Ailsa, 2011, Genes Cancer, V2, P1146, DOI 10.1177/1947601911423028; Dabrosin C., 2007, CLIN CANCER RES, V13, P1061, DOI DOI 10.1158/1078-0432.CCR-06-1651; Dai CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063054; Dayan D, 2012, CANCER MED-US, V1, P128, DOI 10.1002/cam4.24; Deep G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034630; Deng B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063777; Duong T, 2012, J ONCOL, DOI DOI 10.1155/2012/204946; Duthie G, 2000, Curr Opin Clin Nutr Metab Care, V3, P447, DOI 10.1097/00075197-200011000-00006; Ebrahimnezhad Zohreh, 2013, Bioimpacts, V3, P67, DOI 10.5681/bi.2013.005; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; FOTSIS T, 1995, J NUTR, V125, pS790; Garaude J, 2012, SCI TRANSL MED, V4, P120; Garcia-Mediavilla V, 2007, EUR J PHARMACOL, V557, P221, DOI 10.1016/j.ejphar.2006.11.014; Garufi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048342; Gershon TR, 2013, CANC METAB, V1, P1; Gullett Norleena P, 2010, Semin Oncol, V37, P258, DOI 10.1053/j.seminoncol.2010.06.014; Guo GC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072079; Hahm ER, 2013, MOL CARCINOG, V53, P907; Hahm ER, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023354; Hasima Noor, 2012, Int J Biochem Mol Biol, V3, P328; Hasmeda M, 1999, PLANTA MED, V65, P14, DOI 10.1055/s-1999-13954; Hosaka K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3129; Hsiao YW, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003648; Huang YT, 1999, BRIT J PHARMACOL, V128, P999, DOI 10.1038/sj.bjp.0702879; Jang JY, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-421; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Ji Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078700; Jia CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063243; Kaelin WG, 2004, CLIN CANCER RES, V10, p6290S, DOI 10.1158/1078-0432.CCR-sup-040025; Krinsky Norman I., 2005, Molecular Aspects of Medicine, V26, P459, DOI 10.1016/j.mam.2005.10.001; Lamonte Gregory, 2013, Cancer Metab, V1, P23, DOI 10.1186/2049-3002-1-23; Landskroner-Eiger S, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a006643; Leelahavanichkul K, 2014, MOL ONCOL, V8, P105, DOI 10.1016/j.molonc.2013.10.003; Leffler KS, 2013, J IMMUNOL, V190, P4420; Liao JQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084941; Lickliter JD, 2010, BRIT J CANCER, V103, P597, DOI 10.1038/sj.bjc.6605841; Liu J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091606; Liu R, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-1; Lu KV, 2012, CANCER CELL, V22, P21, DOI 10.1016/j.ccr.2012.05.037; Lu LDY, 2013, SCI REP-UK, V3, DOI 10.1038/srep03169; Lunt SJ, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-2; Mabjeesh NJ, 2002, CANCER RES, V62, P2478; Mamede AC, 2013, ISRN ONCOL, V2013; Marti-Centelles R, 2013, BIOORGAN MED CHEM, V21, P3010, DOI 10.1016/j.bmc.2013.03.072; Masuda Muneyuki, 2002, J Exp Ther Oncol, V2, P350, DOI 10.1046/j.1359-4117.2002.01062.x; Matsubara Takao, 2013, Front Oncol, V3, P199, DOI 10.3389/fonc.2013.00199; Mineva ND, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073464; Mohan Royce, 2004, Angiogenesis, V7, P115, DOI 10.1007/s10456-004-1026-3; Nagy JA, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006544; Nakamura Y, 2005, BREAST CANCER RES TR, V91, P125, DOI 10.1007/s10549-004-5783-x; Okazaki H, 2014, CANCER RES, V74, P543, DOI 10.1158/0008-5472.CAN-12-3241; Parikh NR, 2014, PHYTOCHEM REV, V13, P793, DOI 10.1007/s11101-014-9337-5; Ran Sophia, 2010, Pathophysiology, V17, P229, DOI 10.1016/j.pathophys.2009.11.003; Riemann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022445; Ryder M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054302; Salado C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-59; Schrohl AS, 2009, BMC CANCER, P9; Sheth S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051655; Shi SJ, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0698-1; Singh Madhulika, 2012, Front Biosci (Elite Ed), V4, P426; Sohn Kyung-Hee, 1995, Cancer Letters, V94, P213, DOI 10.1016/0304-3835(95)03856-R; Sommer A, 2012, AM J CLIN NUTR, V96, P1204; Song WB, 2014, ONCOL REP, V31, P1350, DOI 10.3892/or.2014.2965; Sun RC, 2014, CELL METAB, V19, P285, DOI 10.1016/j.cmet.2013.11.022; Surh YJ, 2001, MUTAT RES-FUND MOL M, V480, P243, DOI 10.1016/S0027-5107(01)00183-X; Szic KSV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087850; Tang SN, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/23/235102; Thoppil Roslin J, 2011, World J Hepatol, V3, P228, DOI 10.4254/wjh.v3.i9.228; Wang XL, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-299; Wang YH, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-51; Yang CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037960; Yang Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070627; Yang WS, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-r92; Yanga YL, 2013, P NATL ACAD SCI USA, V110, P12018, DOI 10.1073/pnas.1301331110; Yeh CB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056661	465	1	1	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1044-579X			SEMIN CANCER BIOL	Semin. Cancer Biol.	DEC	2015	35			S			S224	S243		10.1016/j.semcancer.2015.01.001		20	Oncology	Oncology	CY7WG	WOS:000366619400011		
J	Yaswen, P; MacKenzie, KL; Keith, WN; Hentosh, P; Rodier, F; Zhu, JY; Firestone, GL; Matheu, A; Carnero, A; Bilsland, A; Sundin, T; Honoki, K; Fujii, H; Georgakilas, AG; Amedei, A; Amin, A; Helferich, B; Boosani, CS; Guha, G; Ciriolo, MR; Chen, S; Mohammed, SI; Azmi, AS; Bhakta, D; Halicka, D; Niccolai, E; Aquilano, K; Ashraf, SS; Nowsheen, S; Yang, XJ				Yaswen, Paul; MacKenzie, Karen L.; Keith, W. Nicol; Hentosh, Patricia; Rodier, Francis; Zhu, Jiyue; Firestone, Gary L.; Matheu, Ander; Carnero, Amancio; Bilsland, Alan; Sundin, Tabetha; Honoki, Kanya; Fujii, Hiromasa; Georgakilas, Alexandros G.; Amedei, Amedeo; Amin, Amr; Helferich, Bill; Boosani, Chandra S.; Guha, Gunjan; Ciriolo, Maria Rosa; Chen, Sophie; Mohammed, Sulma I.; Azmi, Asfar S.; Bhakta, Dipita; Halicka, Dorota; Niccolai, Elena; Aquilano, Katia; Ashraf, S. Salman; Nowsheen, Somaira; Yang, Xujuan			Therapeutic targeting of replicative immortality	SEMINARS IN CANCER BIOLOGY			English	Review						Senescence; Telomerase; Oncogenic stress; p53; pRB	TELOMERASE-REVERSE-TRANSCRIPTASE; PROSTATE-CANCER CELLS; ONCOGENE-INDUCED SENESCENCE; DNA-DAMAGE RESPONSE; CHRONIC LYMPHOCYTIC-LEUKEMIA; DEPENDENT KINASE INHIBITOR; HUMAN BREAST-CANCER; MAMMARY EPITHELIAL-CELLS; NORMAL HUMAN FIBROBLASTS; NF-KAPPA-B	One of the hallmarks of malignant cell populations is the ability to undergo continuous proliferation. This property allows clonal lineages to acquire sequential aberrations that can fuel increasingly autonomous growth, invasiveness, and therapeutic resistance. Innate cellular mechanisms have evolved to regulate replicative potential as a hedge against malignant progression. When activated in the absence of normal terminal differentiation cues, these mechanisms can result in a state of persistent cytostasis. This state, termed "senescence," can be triggered by intrinsic cellular processes such as telomere dysfunction and oncogene expression, and by exogenous factors such as DNA damaging agents or oxidative environments. Despite differences in upstream signaling, senescence often involves convergent interdependent activation of tumor suppressors p53 and p16/pRB, but can be induced, albeit with reduced sensitivity, when these suppressors are compromised. Doses of conventional genotoxic drugs required to achieve cancer cell senescence are often much lower than doses required to achieve outright cell death. Additional therapies, such as those targeting cyclin dependent kinases or components of the PI3K signaling pathway, may induce senescence specifically in cancer cells by circumventing defects in tumor suppressor pathways or exploiting cancer cells' heightened requirements for telomerase. Such treatments sufficient to induce cancer cell senescence could provide increased patient survival with fewer and less severe side effects than conventional cytotoxic regimens. This positive aspect is countered by important caveats regarding senescence reversibility, genomic instability, and paracrine effects that may increase heterogeneity and adaptive resistance of surviving cancer cells. Nevertheless, agents that effectively disrupt replicative immortality will likely be valuable components of new combinatorial approaches to cancer therapy. (C) 2015 The Authors. Published by Elsevier Ltd.	[Yaswen, Paul] Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [MacKenzie, Karen L.] Childrens Canc Inst Australia, Kensington, NSW, Australia; [Keith, W. Nicol; Bilsland, Alan] Univ Glasgow, Glasgow, Lanark, Scotland; [Hentosh, Patricia] Old Dominion Univ, Norfolk, VA USA; [Rodier, Francis] Univ Montreal, Montreal, PQ, Canada; [Zhu, Jiyue] Washington State Univ, Coll Pharm, Pullman, WA 99164 USA; [Firestone, Gary L.] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Matheu, Ander] Biodonostia Inst, Gipuzkoa, Spain; [Carnero, Amancio] Univ Seville, Consejo Super Invest Cient, HUVR, Inst Biomed Sevilla, Seville, Spain; [Sundin, Tabetha] Sentara Healthcare, Norfolk, VA USA; [Honoki, Kanya; Fujii, Hiromasa] Nara Med Univ, Kashihara, Nara 634, Japan; [Georgakilas, Alexandros G.] Natl Tech Univ Athens, Athens, Greece; [Amedei, Amedeo; Niccolai, Elena] Univ Florence, Florence, Italy; [Amin, Amr; Ashraf, S. Salman] United Arab Emirates Univ, Al Ain, U Arab Emirates; [Amin, Amr; Ashraf, S. Salman] Cairo Univ, Cairo, Egypt; [Helferich, Bill; Yang, Xujuan] Univ Illinois, Champaign, IL 61820 USA; [Boosani, Chandra S.] Creighton Univ, Omaha, NE 68178 USA; [Guha, Gunjan; Bhakta, Dipita] SASTRA Univ, Thanjavur, Tamil Nadu, India; [Ciriolo, Maria Rosa; Aquilano, Katia] Univ Roma Tor Vergata, Rome, Italy; [Chen, Sophie] Ovarian & Prostate Canc Res Trust, Guildford, Surrey, England; [Mohammed, Sulma I.] Purdue Univ, W Lafayette, IN 47907 USA; [Azmi, Asfar S.] Wayne State Univ, Karmanos Canc Inst, Detroit, MI USA; [Halicka, Dorota] New York Med Coll, Valhalla, NY 10595 USA; [Nowsheen, Somaira] Mayo Clin, Rochester, MN USA	Yaswen, P (reprint author), Lawrence Berkeley Natl Lab, 1 Cyclotron Rd, Berkeley, CA 94720 USA.	p_yaswen@lbl.gov; k.mackenzie@unsw.edu.au; nicol.keith@glasgow.ac.uk; hentoshp@hotmail.com; rodierf@mac.com; jiyue.zhu@wsu.edu; glfire@berkeley.edu; ander.matheu@biodonostia.org; acarnero@us.es; Alan.Bilsland@glasgow.ac.uk; trsundin@sentara.com	Keith, Nicol/D-3325-2009	Keith, Nicol/0000-0001-7862-3580	United States National Institutes of Health [ES019458, CA164095, GM071725]; California Breast Cancer Research Program [17UB-8708]; Cancer Research UK [C301/A14762]; University of Glasgow; Canadian Institute for Health Research [MOP114962]; Fonds de Recherche Quebec Sante [22624]; W.W. Smith Charitable Trust; Carlos III Health Institute [CP10/00539]; Basque Foundation for Science (IKERBASQUE); Spanish Ministry of Economy and Competitivity, ISCIII [PI12/00137, RD12/0036/0028]; Regional Development European Funds; Consejeria de Ciencia e Innovacion [CTS-1848]; Consejeria de Salud of the Junta de Andalucia [PI-0306-2012]; EU [MC-CIG-303514]; Greek National funds [MIS 379346]; COST Action grant [CM1201]; Italian Ministry of University; Japan Ministry of Education Culture Sports Science and Technology [24590493]; Italian Ministry of Education Universities and Research grant [MIUR-PRIN 20125S38FA_002]; Italian Ministry of Health [GR-2011-02348047]; Italian Association for Cancer Research; Ovarian and Prostate Cancer Research Trust in the United Kingdom; Terry Fox Foundation; Zayed Center for Health Sciences; Al-Jalila Foundation; University of Italy; Marie Curie CIG grant [2012/712404]	The authors thank members of Getting to Know Cancer for insightful discussion. Funding was provided by the United States National Institutes of Health (PY: ES019458, GF: CA164095, JZ: GM071725), California Breast Cancer Research Program (PY: 17UB-8708), Cancer Research UK (WNK: C301/A14762), University of Glasgow (WNK), Canadian Institute for Health Research (FR: MOP114962), Fonds de Recherche Quebec Sante (FR: 22624), W.W. Smith Charitable Trust (JZ), Carlos III Health Institute (AM: CP10/00539), Basque Foundation for Science (IKERBASQUE) and Marie Curie CIG grant (AM: 2012/712404), the Spanish Ministry of Economy and Competitivity, ISCIII (AC: PI12/00137, RTICC: RD12/0036/0028), Regional Development European Funds (AC), Consejeria de Ciencia e Innovacion (AC: CTS-1848), and Consejeria de Salud of the Junta de Andalucia (AC: PI-0306-2012). Children's Cancer Institute Australia is affiliated with the University of New South Wales and Sydney Children's Hospital Network (KM).; Funding for the cross-validation team was provided by EU Marie Curie Reintegration grant MC-CIG-303514 (AGG), Greek National funds grant MIS 379346 (AGG), COST Action grant CM1201 (AGG), Italian Ministry of University and the University of Italy (AA, EN), Japan Ministry of Education Culture Sports Science and Technology grant 24590493 (KH), Italian Ministry of Education Universities and Research grant MIUR-PRIN 20125S38FA_002 (KA), Italian Ministry of Health grant GR-2011-02348047 (KA), Italian Association for Cancer Research (MRC), Ovarian and Prostate Cancer Research Trust in the United Kingdom (SC), Terry Fox Foundation (AA), Zayed Center for Health Sciences (AA), and Al-Jalila Foundation (AA).	Damm K, 2001, EMBO J, V20, P6958, DOI 10.1093/emboj/20.24.6958; Strock CJ, 2006, CANCER RES, V66, P7509, DOI 10.1158/0008-5472.CAN-05-3048; Ruzankina Y, 2008, MECH AGEING DEV, V129, P460, DOI 10.1016/j.mad.2008.03.009; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; te Poele RH, 2002, CANCER RES, V62, P1876; Bringold F, 2000, EXP GERONTOL, V35, P317, DOI 10.1016/S0531-5565(00)00083-8; Samaila D, 2004, ANTICANCER RES, V24, P3089; Meyerson M, 1997, CELL, V90, P785, DOI 10.1016/S0092-8674(00)80538-3; Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070; Capparelli C, 2012, CELL CYCLE, V11, P2285, DOI 10.4161/cc.20718; Soder AI, 1998, ONCOGENE, V16, P979, DOI 10.1038/sj.onc.1201620; Soung YH, 2011, MOL CANCER THER, V10, P883, DOI 10.1158/1535-7163.MCT-10-1053; Coppe JP, 2011, J BIOL CHEM, V286, P36396, DOI 10.1074/jbc.M111.257071; Ohtani N, 2012, EXP DERMATOL, V21, P1, DOI 10.1111/j.1600-0625.2012.01493.x; Rudolph KL, 2001, NAT GENET, V28, P155, DOI 10.1038/88871; Ramachandran C, 2002, CANCER LETT, V184, P1, DOI 10.1016/S0304-3835(02)00192-1; Khan N, 2006, CANCER RES, V66, P2500, DOI 10.1158/0008-5472.CAN-05-3636; Ewald JA, 2009, J BIOMOL SCREEN, V14, P853, DOI 10.1177/1087057109340314; Serrano M, 2001, CURR OPIN CELL BIOL, V13, P748, DOI 10.1016/S0955-0674(00)00278-7; Ghosh A, 2012, NAT CELL BIOL, V14, P1270, DOI 10.1038/ncb2621; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Kondo S, 1998, FASEB J, V12, P801; Stewart SA, 2002, P NATL ACAD SCI USA, V99, P12606, DOI 10.1073/pnas.182407599; Darbro BW, 2005, J INVEST DERMATOL, V125, P499, DOI 10.1111/j.0022-202X.2005.23844.x; Tauchi T, 2003, ONCOGENE, V22, P5338, DOI 10.1038/sj.onc.1206833; Tauchi T, 2006, ONCOGENE, V25, P5719, DOI 10.1038/sj.onc.1209577; Hemon P, 2011, J IMMUNOL, V186, P5173, DOI 10.4049/jimmunol.1002050; Dai L, 2013, CANCER LETT, V333, P103, DOI 10.1016/j.canlet.2013.01.025; Ezhevsky SA, 2001, MOL CELL BIOL, V21, P4773, DOI 10.1128/MCB.21.14.4773-4784.2001; Jackson SR, 2007, CANCER RES, V67, P1121, DOI 10.1158/0008-5472.CAN-06-2306; Freund A, 2010, TRENDS MOL MED, V16, P238, DOI 10.1016/j.molmed.2010.03.003; Ge J, 2013, BIOMED ENVIRON SCI, V26, P902, DOI 10.3967/bes2013.019; Meeran SM, 2011, CANCER PREV RES, V4, P1243, DOI 10.1158/1940-6207.CAPR-11-0009; Hoffmann J, 2011, BIOCHEM PHARMACOL, V82, P1153, DOI 10.1016/j.bcp.2011.07.063; Carnero A, 2004, ONCOGENE, V23, P6006, DOI 10.1038/sj.onc.1207839; Guo YP, 2007, J NUTR BIOCHEM, V18, P408, DOI 10.1016/j.jnutbio.2006.08.006; Gilbert LA, 2010, CELL, V143, P355, DOI 10.1016/j.cell.2010.09.043; Gisselsson D, 2001, P NATL ACAD SCI USA, V98, P12683, DOI 10.1073/pnas.211357798; Atkinson SP, 2005, CANCER RES, V65, P7585, DOI 10.1158/0008-5472.CAN-05-1715; COUNTER CM, 1992, EMBO J, V11, P1921; Anderson CJ, 2006, ONCOGENE, V25, P61, DOI 10.1038/sj.onc.1209011; Nam HJ, 2010, CARCINOGENESIS, V31, P1531, DOI 10.1093/carcin/bgq133; Ho JSL, 2005, MOL CELL BIOL, V25, P7423, DOI 10.1128/MCB.25.17.7423-7431.2005; Horikawa I, 1999, CANCER RES, V59, P826; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Courtois-Cox S, 2008, ONCOGENE, V27, P2801, DOI 10.1038/sj.onc.1210950; Lanzilli G, 2006, INT J ONCOL, V28, P641; Shehzad A, 2013, BIOFACTORS, V39, P27, DOI 10.1002/biof.1065; Schwarze SR, 2002, J BIOL CHEM, V277, P14877, DOI 10.1074/jbc.M200373200; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Dai CY, 2000, ONCOGENE, V19, P1613, DOI 10.1038/sj.onc.1203438; Stratton SP, 2010, CANCER PREV RES, V3, P160, DOI 10.1158/1940-6207.CAPR-09-0183; Pugalendhi P, 2009, PHARMACOL REP, V61, P296; Roberson RS, 2005, CANCER RES, V65, P2795, DOI 10.1158/0008-5472.CAN-04-1270; Filaci G, 2006, BLOOD, V107, P1505, DOI 10.1182/blood-2005-01-0258; Tokcaer-Keskin Z, 2010, STEM CELL REV REP, V6, P224, DOI 10.1007/s12015-010-9124-7; Chen PC, 2013, ONCOL REP, V30, P1157, DOI 10.3892/or.2013.2563; Markey MP, 2002, CANCER RES, V62, P6587; Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Kang TH, 2007, CANCER RES, V67, P802, DOI 10.1158/0008-5472.CAN-06-2638; Cassinelli G, 2013, CURR MED CHEM, V20, P1923; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Bhattacharyya S, 2010, CELL MOL IMMUNOL, V7, P306, DOI 10.1038/cmi.2010.11; Djojosubroto MW, 2005, HEPATOLOGY, V42, P1127, DOI 10.1002/hep.20822; Chang YF, 2012, CANCER PREV RES, V5, P444, DOI 10.1158/1940-6207.CAPR-11-0308; Delhommeau FO, 2002, ONCOGENE, V21, P8262, DOI 10.1038/sj.onc.1206054; Vishvakarma NK, 2011, TOXICOL APPL PHARM, V252, P298, DOI 10.1016/j.taap.2011.03.002; Kunter I, 2014, ONCOL REP, V31, P573, DOI 10.3892/or.2013.2932; Nair SK, 2000, NAT MED, V6, P1011; Cai XZ, 2009, CANCER BIOL THER, V8, P1360, DOI 10.4161/cbt.8.14.8720; Fuggetta MP, 2006, J EXP CLIN CANC RES, V25, P189; Harley CB, 2008, NAT REV CANCER, V8, P167, DOI 10.1038/nrc2275; Berberich N, 2011, BRIT J PHARMACOL, V163, P1086, DOI 10.1111/j.1476-5381.2011.01309.x; Nakajima A, 2003, LEUKEMIA, V17, P560, DOI 10.1038/sj.leu.2402825; Singh M, 2009, MOL CELL BIOCHEM, V325, P107, DOI 10.1007/s11010-009-0025-5; Chen X, 2013, FOOD CHEM TOXICOL, V59, P325, DOI 10.1016/j.fct.2013.06.016; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Chang S, 2003, GENE DEV, V17, P88, DOI 10.1101/gad.1029903; Doi T, 2006, ORG LETT, V8, P4165, DOI 10.1021/ol061793i; Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831; Moreira L, 2013, EXP CELL RES, V319, P1784, DOI 10.1016/j.yexcr.2013.05.001; Tchkonia T, 2013, J CLIN INVEST, V123, P966, DOI 10.1172/JCI64098; Shay JW, 2002, CANCER CELL, V2, P257, DOI 10.1016/S1535-6108(02)00159-9; Logan JE, 2013, ANTICANCER RES, V33, P2997; Fu W, 2011, MOL CANCER THER, V10, P1018, DOI 10.1158/1535-7163.MCT-11-0167; Hayakawa N, 1999, BIOCHEMISTRY-US, V38, P11501, DOI 10.1021/bi982829k; Carnero A, 2000, NAT CELL BIOL, V2, P148; Um HJ, 2010, INT J ONCOL, V36, P1007, DOI 10.3892/ijo_00000581; Elson CE, 1999, P SOC EXP BIOL MED, V221, P294, DOI 10.1046/j.1525-1373.1999.d01-87.x; Lou DS, 2012, MED HYPOTHESES, V79, P430, DOI 10.1016/j.mehy.2012.06.012; Loutrari H, 2004, J PHARMACOL EXP THER, V311, P568, DOI 10.1124/jpet.104.070516; Ewald JA, 2010, J NATL CANCER I, V102, P1536, DOI 10.1093/jnci/djq364; Michaloglou C, 2008, ONCOGENE, V27, P877, DOI 10.1038/sj.onc.1210704; Sprouse AA, 2012, J CELL MOL MED, V16, P1, DOI 10.1111/j.1582-4934.2011.01460.x; Collins K, 2000, CURR OPIN CELL BIOL, V12, P378, DOI 10.1016/S0955-0674(00)00103-4; Braig M, 2006, CANCER RES, V66, P2881, DOI 10.1158/0008-5472.CAN-05-4006; Saab R, 2006, MOL CANCER THER, V5, P1299, DOI 10.1158/1535-7163.MCT-05-0383; Durgo K, 2011, ARH HIG RADA TOKSIKO, V62, P139, DOI 10.2478/10004-1254-62-2011-2105; Herbert BS, 1999, P NATL ACAD SCI USA, V96, P14276, DOI 10.1073/pnas.96.25.14276; Chou WC, 2001, J CLIN INVEST, V108, P1541, DOI 10.1172/JCI14064; Marconett CN, 2011, CARCINOGENESIS, V32, P1315, DOI 10.1093/carcin/bgr116; Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Narayanan NK, 2009, INT J CANCER, V125, P1, DOI 10.1002/ijc.24336; de Magalhaes JP, 2004, EXP GERONTOL, V39, P1379, DOI 10.1016/j.exger.2004.06.004; Beuvink I, 2005, CELL, V120, P747, DOI 10.1016/j.cell.2004.12.040; Liston BW, 2003, CANCER RES, V63, P2399; Thakur VS, 2012, INT J ONCOL, V41, P353, DOI 10.3892/ijo.2012.1449; Lee JH, 2010, CANCER LETT, V290, P76, DOI 10.1016/j.canlet.2009.08.026; Ressler S, 2006, AGING CELL, V5, P379, DOI 10.1111/j.1474-9726.2006.00231.x; Phillips JM, 2011, OTOLARYNG HEAD NECK, V145, P58, DOI 10.1177/0194599811400711; Vernell R, 2003, J BIOL CHEM, V278, P46124, DOI 10.1074/jbc.M304930200; Stein GH, 1999, MOL CELL BIOL, V19, P2109; Smith S, 1998, SCIENCE, V282, P1484, DOI 10.1126/science.282.5393.1484; Noh KH, 2012, J CLIN INVEST, V122, P4077, DOI 10.1172/JCI64057; Shammas MA, 2004, CLIN CANCER RES, V10, P770, DOI 10.1158/1078-0432.CCR-0793-03; Takuma Y, 2004, J GASTROEN HEPATOL, V19, P1300, DOI 10.1111/j.1400-1746.2004.03447.x; Jeyapalan JC, 2007, MECH AGEING DEV, V128, P36, DOI 10.1016/j.mad.2006.11.008; Krizhanovsky V, 2008, COLD SH Q B, V73, P513, DOI 10.1101/sqb.2008.73.048; Chandeck C, 2010, ADV ANAT PATHOL, V17, P42, DOI 10.1097/PAP.0b013e3181c66f4e; Farazuddin M, 2012, INT J NANOMED, V7, P35, DOI 10.2147/IJN.S24920; Nonet GH, 2001, CANCER RES, V61, P1250; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Napier CE, 2010, BBA-MOL CELL RES, V1803, P1142, DOI 10.1016/j.bbamcr.2010.06.010; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Kote-Jarai Z, 2013, HUM MOL GENET, V22, P2520, DOI 10.1093/hmg/ddt086; Hochreiter AE, 2006, CLIN CANCER RES, V12, P3184, DOI 10.1158/1078-0432.CCR-05-2760; Shin-ya K, 2001, J AM CHEM SOC, V123, P1262, DOI 10.1021/ja005780q; Pascolo E, 2002, J BIOL CHEM, V277, P15566, DOI 10.1074/jbc.M201266200; Magkouta S, 2009, NUTR CANCER, V61, P640, DOI 10.1080/01635580902825647; Chen YH, 2006, CANCER RES, V66, P8749, DOI 10.1158/0008-5472.CAN-06-0581; Cozzi SJ, 2006, CANCER RES, V66, P10083, DOI 10.1158/0008-5472.CAN-06-0348; Plo I, 2009, ONCOGENE, V28, P2231, DOI 10.1038/onc.2009.85; Kraemer K, 2006, INT J CANCER, V119, P1276, DOI 10.1002/ijc.21975; Lazarevic B, 2011, NUTR CANCER, V63, P889, DOI 10.1080/01635581.2011.582221; Mosieniak G, 2012, MECH AGEING DEV, V133, P444, DOI 10.1016/j.mad.2012.05.004; Ogiwara H, 2013, CARCINOGENESIS, V34, P2486, DOI 10.1093/carcin/bgt240; O'Sullivan JN, 2002, NAT GENET, V32, P280, DOI 10.1038/ng989; Liu LL, 2013, MOL CANCER RES, V11, P1326, DOI 10.1158/1541-7786.MCR-13-0172; Thomas P, 2009, MUTAT RES-FUND MOL M, V661, P25, DOI 10.1016/j.mrfmmm.2008.10.016; Huang C, 2009, NAT CELL BIOL, V11, P624, DOI 10.1038/ncb1868; Feldmann G, 2011, CANCER BIOL THER, V12, P598, DOI 10.4161/cbt.12.7.16475; Cohen SB, 2007, SCIENCE, V315, P1850, DOI 10.1126/science.1138596; RAY FA, 1990, J CELL BIOCHEM, V42, P13, DOI 10.1002/jcb.240420103; Chandra T, 2012, MOL CELL, V47, P203, DOI 10.1016/j.molcel.2012.06.010; Counter CM, 1998, P NATL ACAD SCI USA, V95, P14723, DOI 10.1073/pnas.95.25.14723; Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1; Rodier F, 2011, J CELL SCI, V124, P68, DOI 10.1242/jcs.071340; Rosich L, 2013, HAEMATOLOGICA, V98, P1739, DOI 10.3324/haematol.2013.088849; Mukherjee S, 2009, J ENVIRON PATHOL TOX, V28, P269; Pirker C, 2003, MELANOMA RES, V13, P483, DOI 10.1097/01.cmr.0000056264.56735.73; Deeley J, 2008, ORG BIOMOL CHEM, V6, P1994, DOI 10.1039/b802477d; Bazarov AV, 2009, CELL CYCLE, V8, P3373; Rowland BD, 2002, CANCER CELL, V2, P55, DOI 10.1016/S1535-6108(02)00085-5; Folini M, 2005, EUR J CANCER, V41, P624, DOI 10.1016/j.ejca.2004.12.002; Chiu CP, 1996, STEM CELLS, V14, P239; Mergny JL, 2001, P NATL ACAD SCI USA, V98, P3062, DOI 10.1073/pnas.051620698; Gowan SM, 2002, MOL PHARMACOL, V61, P1154, DOI 10.1124/mol.61.5.1154; Bagheri S, 2006, P NATL ACAD SCI USA, V103, P11306, DOI 10.1073/pnas.0510085103; Gomez-Contreras PC, 2006, CHEMOTHERAPY, V52, P308, DOI 10.1159/000096003; Shammas MA, 2008, LEUKEMIA, V22, P1410, DOI 10.1038/leu.2008.81; Gupta S, 2004, ONCOGENE, V23, P2507, DOI 10.1038/sj.onc.1207353; Ducray C, 1999, ONCOGENE, V18, P4211, DOI 10.1038/sj.onc.1202797; Plumb JA, 2001, ONCOGENE, V20, P7797, DOI 10.1038/sj.onc.1204954; Hardtner C, 2012, EUR J PHARMACOL, V684, P36, DOI 10.1016/j.ejphar.2012.03.039; Seger YR, 2002, CANCER CELL, V2, P401, DOI 10.1016/S1535-6108(02)00183-6; Denchi EL, 2005, MOL CELL BIOL, V25, P2660, DOI 10.1128/MCB.25.7.2660-2672.2005; Chaudhary SC, 2009, CHEM-BIOL INTERACT, V179, P145, DOI 10.1016/j.cbi.2008.12.016; Ludwig A, 2001, CANCER RES, V61, P3053; Mao CQ, 2014, MOL THER, V22, P964, DOI 10.1038/mt.2014.18; Akiyama M, 2003, CANCER RES, V63, P6187; Kawai K, 2004, J ALLERGY CLIN IMMUN, V113, P1211, DOI 10.1016/j.jaci.2004.02.044; Pajalunga D, 2007, J CELL BIOL, V176, P807, DOI 10.1083/jcb.200608109; Jiang BH, 2008, DRUG RESIST UPDATE, V11, P63, DOI 10.1016/j.drup.2008.03.001; Johnson AJ, 2012, LEUKEMIA, V26, P2554, DOI 10.1038/leu.2012.144; Cao Y, 2008, CANCER SCI, V99, P1092, DOI 10.1111/j.1349-7006.2008.00815.x; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Alcorta DA, 1996, P NATL ACAD SCI USA, V93, P13742, DOI 10.1073/pnas.93.24.13742; Asai A, 2003, CANCER RES, V63, P3931; Carroll RE, 2011, CANCER PREV RES, V4, P354, DOI 10.1158/1940-6207.CAPR-10-0098; Sherman MY, 2011, AGING CELL, V10, P949, DOI 10.1111/j.1474-9726.2011.00736.x; Roger L, 2013, JNCI-J NATL CANCER I, V105, P1202, DOI 10.1093/jnci/djt191; Smith DA, 2013, MOL CANCER RES, V11, P1159, DOI 10.1158/1541-7786.MCR-13-0238; Robles SJ, 1998, ONCOGENE, V16, P1113, DOI 10.1038/sj.onc.1201862; Cho HY, 2012, MOL CANCER THER, V11, P2462, DOI 10.1158/1535-7163.MCT-12-0321; Gonzalo S, 2005, CELL CYCLE, V4, P752; Suram A, 2012, EMBO J, V31, P2839, DOI 10.1038/emboj.2012.132; Tang J, 2008, NUCLEIC ACIDS RES, V36, P1200, DOI 10.1093/nar/gkm1137; Gosselin K, 2009, CANCER RES, V69, P7917, DOI 10.1158/0008-5472.CAN-08-2510; Jiang Y, 2013, ONCOL LETT, V6, P75, DOI 10.3892/ol.2013.1344; Lin GY, 2014, EUR J PHARMACOL, V729, P45, DOI 10.1016/j.ejphar.2014.02.011; Nakamura H, 2013, PROSTATE, V73, P1747, DOI 10.1002/pros.22712; Bartek J, 2007, ONCOGENE, V26, P7773, DOI 10.1038/sj.onc.1210881; Lim YC, 2011, J SURG ONCOL, V104, P776, DOI 10.1002/jso.21999; Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; Bosco EE, 2007, J CLIN INVEST, V117, P218, DOI 10.1172/JCI28803; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784; da Fonseca CO, 2008, SURG NEUROL, V70, P259, DOI 10.1016/j.surneu.2007.07.040; Chen Z, 2014, ONCOGENE, V33, P4548, DOI 10.1038/onc.2013.402; Hubackova S, 2012, AGING-US, V4, P932; Henderson YC, 2000, HEAD NECK-J SCI SPEC, V22, P347, DOI 10.1002/1097-0347(200007)22:4<347::AID-HED6>3.0.CO;2-J; Polivka J, 2014, PHARMACOL THERAPEUT, V142, P164, DOI 10.1016/j.pharmthera.2013.12.004; Kollmann K, 2013, CANCER CELL, V24, P167, DOI 10.1016/j.ccr.2013.07.012; Bilsland AE, 2003, ONCOGENE, V22, P370, DOI 10.1038/sj.onc.1206168; Hoenicke L, 2012, CARCINOGENESIS, V33, P1123, DOI 10.1093/carcin/bgs124; Bettuzzi S, 2006, CANCER RES, V66, P1234, DOI 10.1158/0008-5472.CAN-05-1145; Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599; Narita M, 2006, CELL, V126, P503, DOI 10.1016/j.cell.2006.05.052; Jia WW, 2011, FASEB J, V25, P979, DOI 10.1096/fj.10-173989; Folini M, 2000, J INVEST DERMATOL, V114, P259, DOI 10.1046/j.1523-1747.2000.00870.x; Seimiya H, 2002, MOL CANCER THER, V1, P657; Shay JW, 2010, FEBS LETT, V584, P3819, DOI 10.1016/j.febslet.2010.05.026; McLarty J, 2009, CANCER PREV RES, V2, P673, DOI 10.1158/1940-6207.CAPR-08-0167; Moon DO, 2010, CANCER LETT, V295, P260, DOI 10.1016/j.canlet.2010.03.009; Liu F, 2012, MOL CANCER THER, V11, P2138, DOI 10.1158/1535-7163.MCT-12-0562; Cristofari G, 2006, EMBO J, V25, P565, DOI 10.1038/sj.emboj.7600952; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Mo HB, 2004, EXP BIOL MED, V229, P567; Podlevsky JD, 2012, MUTAT RES-FUND MOL M, V730, P3, DOI 10.1016/j.mrfmmm.2011.11.002; Davalos AR, 2010, CANCER METAST REV, V29, P273, DOI 10.1007/s10555-010-9220-9; El Touny LH, 2009, CANCER RES, V69, P3695, DOI 10.1158/0008-5472.CAN-08-2958; Blaydes JP, 1998, ONCOGENE, V16, P3317, DOI 10.1038/sj.onc.1201880; Lundberg AS, 2000, CURR OPIN CELL BIOL, V12, P705, DOI 10.1016/S0955-0674(00)00155-1; Gisselsson D, 2002, BRIT J CANCER, V87, P202, DOI 10.1038/sj.bjc.6600438; Deng PB, 2013, CHIN J NAT MEDICINES, V11, P245, DOI [10.1016/S1875-5364(13)60023-0, 10.3724/SP.J.1009.2013.00245]; Chatzistamou I, 2011, CELL ONCOL, V34, P483, DOI 10.1007/s13402-011-0044-6; Lu R, 2014, ONCOGENE, V33, P1495, DOI 10.1038/onc.2013.103; FENG JL, 1995, SCIENCE, V269, P1236, DOI 10.1126/science.7544491; Moreno-Aspitia A, 2009, CLIN THER, V31, P1619, DOI 10.1016/j.clinthera.2009.08.005; Tuntiwechapikul W, 2010, J MED FOOD, V13, P1347, DOI 10.1089/jmf.2010.1191; Maruyama T, 2014, ONCOL REP, V31, P625, DOI 10.3892/or.2013.2925; Ouchi H, 2005, INT J UROL, V12, P73, DOI 10.1111/j.1442-2042.2004.00973.x; Li JJ, 2013, ONCOL LETT, V5, P101, DOI 10.3892/ol.2012.972; Izbicka E, 1999, ANTI-CANCER DRUG DES, V14, P355; Schwarze SR, 2005, NEOPLASIA, V7, P816, DOI 10.1593/neo.05250; Jahangir T, 2007, EVID-BASED COMPL ALT, V4, P439, DOI 10.1093/ecam/nel104; Vergel M, 2010, CLIN TRANSL ONCOL, V12, P410, DOI 10.1007/s12094-010-0528-2; Li CL, 2012, INT J GYNECOL CANCER, V22, P15, DOI 10.1097/IGC.0b013e3182322834; Holysz H, 2013, TUMOR BIOL, V34, P1371, DOI 10.1007/s13277-013-0757-4; McClendon AK, 2012, CELL CYCLE, V11, P2747, DOI 10.4161/cc.21127; Engelhardt M, 1997, BLOOD, V90, P182; MORIN GB, 1989, CELL, V59, P521, DOI 10.1016/0092-8674(89)90035-4; Patel KR, 2010, CANCER RES, V70, P7392, DOI 10.1158/0008-5472.CAN-10-2027; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Dhillon N, 2008, CLIN CANCER RES, V14, P4491, DOI 10.1158/1078-0432.CCR-08-0024; HARA E, 1991, BIOCHEM BIOPH RES CO, V179, P528, DOI 10.1016/0006-291X(91)91403-Y; Dong S, 2012, CANCER CHEMOTH PHARM, V70, P707, DOI 10.1007/s00280-012-1946-3; Coppe JP, 2006, J BIOL CHEM, V281, P29568, DOI 10.1074/jbc.M603307200; Ghosh AK, 2009, CLIN CANCER RES, V15, P1250, DOI 10.1158/1078-0432.CCR-08-1511; Rea S, 2000, NATURE, V406, P593; Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Beevers CS, 2009, CANCER RES, V69, P1000, DOI 10.1158/0008-5472.CAN-08-2367; Boros LG, 2001, PANCREAS, V22, P1, DOI 10.1097/00006676-200101000-00001; Chou CK, 2009, MOL CARCINOGEN, V48, P1048, DOI 10.1002/mc.20557; Konecny GE, 2011, CLIN CANCER RES, V17, P1591, DOI 10.1158/1078-0432.CCR-10-2307; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; Murnane JP, 2004, BIOESSAYS, V26, P1164, DOI 10.1002/bies.20125; Lin AW, 2001, P NATL ACAD SCI USA, V98, P5025, DOI 10.1073/pnas.091100298; da Fonseca CO, 2011, J CANCER RES CLIN, V137, P287, DOI 10.1007/s00432-010-0873-0; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Ezhevsky SA, 1997, P NATL ACAD SCI USA, V94, P10699, DOI 10.1073/pnas.94.20.10699; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Cairney CJ, 2012, DRUG DISCOV TODAY, V17, P269, DOI 10.1016/j.drudis.2012.01.019; Herbert BS, 2005, ONCOGENE, V24, P5262, DOI 10.1038/sj.onc.1208760; Hu J, 2012, CELL, V148, P651, DOI 10.1016/j.cell.2011.12.028; Viatour P, 2008, CELL STEM CELL, V3, P416, DOI 10.1016/j.stem.2008.07.009; Shelton DN, 1999, CURR BIOL, V9, P939, DOI 10.1016/S0960-9822(99)80420-5; Fry DW, 2004, MOL CANCER THER, V3, P1427; Strobeck MW, 2000, P NATL ACAD SCI USA, V97, P7748, DOI 10.1073/pnas.97.14.7748; Bazarov AV, 2012, CELL CYCLE, V11, P1008, DOI 10.4161/cc.11.5.19492; Parrinello S, 2005, J CELL SCI, V118, P485, DOI 10.1242/jcs.01635; Stewenius Y, 2005, P NATL ACAD SCI USA, V102, P5541, DOI 10.1073/pnas.0408454102; Shanafelt TD, 2009, J CLIN ONCOL, V27, P3808, DOI 10.1200/JCO.2008.21.1284; Kanai M, 2011, CANCER CHEMOTH PHARM, V68, P157, DOI 10.1007/s00280-010-1470-2; Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446; Majid S, 2008, CANCER RES, V68, P2736, DOI 10.1158/0008-5472.CAN-07-2290; Vaughan RA, 2013, INT J CANCER, V133, P2504, DOI 10.1002/ijc.28264; Gray-Schopfer VC, 2006, BRIT J CANCER, V95, P496, DOI 10.1038/sj.bjc.6603283; Corey DR, 2002, ONCOGENE, V21, P631, DOI 10.1038/sj.onc.1205063; El-Daly H, 2005, BLOOD, V105, P1742, DOI 10.1182/blood-2003-12-4322; Tauchi T, 2002, CLIN CANCER RES, V8, P3341; Naylor RM, 2013, CLIN PHARMACOL THER, V93, P105, DOI 10.1038/clpt.2012.193; Nielsen GP, 1999, LAB INVEST, V79, P1137; Abusnina A, 2011, MOL NUTR FOOD RES, V55, P1677, DOI 10.1002/mnfr.201100307; Phan V, 2013, J DRUG TARGET, V21, P1001, DOI 10.3109/1061186X.2013.847099; Aoki H, 2007, MOL PHARMACOL, V72, P29, DOI 10.1124/mol.106.033167; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Novakova Z, 2010, ONCOGENE, V29, P273, DOI 10.1038/onc.2009.318; Gowan SM, 2001, MOL PHARMACOL, V60, P981; Seguin J, 2013, INT J PHARMACEUT, V444, P146, DOI 10.1016/j.ijpharm.2013.01.050; Vonderheide RH, 2002, ONCOGENE, V21, P674, DOI 10.1038/sj.onc.1205074; Sun Y, 2012, NAT MED, V18, P1359, DOI 10.1038/nm.2890; Binz N, 2005, EUR J CANCER, V41, P2873, DOI 10.1016/j.ecja.2005.08.025; Juan ME, 2012, PHARMACOL RES, V65, P584, DOI 10.1016/j.phrs.2012.03.010; Colin D, 2011, CANCER PREV RES, V4, P1095, DOI 10.1158/1940-6207.CAPR-10-0274; Cookson JC, 2005, MOL PHARMACOL, V68, P1551, DOI 10.1124/mol.105.013300; Bojesen SE, 2013, NAT GENET, V45, P371, DOI 10.1038/ng.2566; BRYAN TM, 1995, EMBO J, V14, P4240; Castro ME, 2008, CARCINOGENESIS, V29, P491, DOI 10.1093/carcin/bgm246; Cheng TS, 2013, CANCER PREV RES, V6, P495, DOI 10.1158/1940-6207.CAPR-12-0293-T; Soder AI, 1997, ONCOGENE, V14, P1013, DOI 10.1038/sj.onc.1201066; Bilsland AE, 2011, J CELL MOL MED, V15, P179, DOI 10.1111/j.1582-4934.2010.01253.x; Bond J, 1996, ONCOGENE, V13, P2097; Rader J, 2013, CLIN CANCER RES, V19, P6173, DOI 10.1158/1078-0432.CCR-13-1675; Chan NLS, 2006, TOXICOL APPL PHARM, V213, P98, DOI 10.1016/j.taap.2005.10.002; Al-Ansari MM, 2013, ONCOGENE, V32, P2356, DOI 10.1038/onc.2012.270; Khan AQ, 2012, TOXICOLOGY, V302, P266, DOI 10.1016/j.tox.2012.08.008; Hsin IL, 2010, MUTAT RES-FUND MOL M, V688, P72, DOI 10.1016/j.mrfmmm.2010.03.011; Chau MN, 2007, CARCINOGENESIS, V28, P2282, DOI 10.1093/carcin/bgm148; Kipling D, 1999, NAT BIOTECHNOL, V17, P313, DOI 10.1038/7827; Falchetti ML, 2008, INT J CANCER, V122, P1236, DOI 10.1002/ijc.23193; Feldser DM, 2007, CANCER CELL, V11, P461, DOI 10.1016/j.ccr.2007.02.026; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Van Aller GS, 2011, BIOCHEM BIOPH RES CO, V406, P194, DOI 10.1016/j.bbrc.2011.02.010; Abedin ZR, 2010, CELL CYCLE, V9, P2456; Naasani I, 2003, CANCER RES, V63, P824; Dai WQ, 2015, MOL CARCINOGEN, V54, P301, DOI 10.1002/mc.22100; HARPER JW, 1993, CELL, V75, P805; Bayet-Robert M, 2010, CANCER BIOL THER, V9, P8; Beyne-Rauzy O, 2004, ONCOGENE, V23, P7507, DOI 10.1038/sj.onc.1208024; Lin SC, 2006, CANCER LETT, V236, P80, DOI 10.1016/j.canlet.2005.05.003; Lu YZ, 2014, J CLIN INVEST, V124, P1672, DOI 10.1172/JCI63139; Handschick K, 2014, MOL CELL, V53, P193, DOI 10.1016/j.molcel.2013.12.002; Kosciolek BA, 2003, MOL CANCER THER, V2, P209; Dikmen ZG, 2005, CANCER RES, V65, P7866, DOI 10.1158/0008-5472.CAN-05-1215; BLASCO MA, 1995, SCIENCE, V269, P1267, DOI 10.1126/science.7544492; Arbiser JL, 1998, MOL MED, V4, P376; Sharpless NE, 2004, J CLIN INVEST, V113, P160, DOI 10.1172/JCI200420761; Jackson JG, 2006, MOL CELL BIOL, V26, P2501, DOI 10.1128/MCB.26.7.2501-2510.2006; Melin BS, 2012, GENET EPIDEMIOL, V36, P368, DOI 10.1002/gepi.21630; Ono M, 2013, ANTICANCER RES, V33, P1861; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Bilsland AE, 2006, CANCER RES, V66, P1363, DOI 10.1158/0008-5472.CAN-05-1941; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Killian PH, 2012, CARCINOGENESIS, V33, P2507, DOI 10.1093/carcin/bgs312; Jackson JG, 2012, CANCER CELL, V21, P793, DOI 10.1016/j.ccr.2012.04.027; Gellert GC, 2006, BREAST CANCER RES TR, V96, P73, DOI 10.1007/s10549-005-9043-5; Chicas A, 2010, CANCER CELL, V17, P376, DOI 10.1016/j.ccr.2010.01.023; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Prietsch RF, 2014, MOL CELL BIOCHEM, V390, P235, DOI 10.1007/s11010-014-1974-x; Hughes BT, 2013, P NATL ACAD SCI USA, V110, P8954, DOI 10.1073/pnas.1302927110; Li S, 2004, CANCER RES, V64, P4833, DOI 10.1158/0008-5472.CAN-04-0953; Lebedeva IV, 2008, MOL CANCER THER, V7, P2042, DOI 10.1158/1535-7163.MCT-08-0245; Lin BQ, 2013, LUNG CANCER, V79, P111, DOI 10.1016/j.lungcan.2012.11.001; Harrington L, 1997, SCIENCE, V275, P973, DOI 10.1126/science.275.5302.973; Hall JM, 2013, MOL CARCINOGEN, V52, P715, DOI 10.1002/mc.21913; Fischer JDD, 2010, J PROTEOMICS, V73, P1018, DOI 10.1016/j.jprot.2010.01.003; Sundin T, 2013, MOL CELL BIOCHEM, V375, P97, DOI 10.1007/s11010-012-1532-3; Liu D, 2007, CANCER RES, V67, P3117, DOI 10.1158/0008-5472.CAN-06-3452; Maida Y, 2002, ONCOGENE, V21, P4071, DOI 10.1038/sj.onc.1205509; Kim MY, 2002, J AM CHEM SOC, V124, P2098, DOI 10.1021/ja017308q; Seimiya H, 2005, CANCER CELL, V7, P25, DOI 10.1016/j.ccr.2004.11.021; Pitiyage GN, 2011, J PATHOL, V223, P604, DOI 10.1002/path.2839; Roth A, 2003, LEUKEMIA, V17, P2410, DOI 10.1038/sj.leu.2403177; Gisselsson D, 2000, P NATL ACAD SCI USA, V97, P5357, DOI 10.1073/pnas.090013497; Tobi SE, 2002, INT J CANCER, V102, P439, DOI 10.1002/ijc.10730; Kim YM, 2008, CANCER GENET CYTOGEN, V186, P78, DOI 10.1016/j.cancergencyto.2008.06.010; Varna M, 2009, INT J CANCER, V124, P991, DOI 10.1002/ijc.24049; Brehm A, 1998, NATURE, V391, P597; Codd V, 2013, NAT GENET, V45, P422, DOI 10.1038/ng.2528; Pavletich NP, 1999, J MOL BIOL, V287, P821, DOI 10.1006/jmbi.1999.2640; Masutomi K, 2003, CELL, V114, P241, DOI 10.1016/S0092-8674(03)00550-6; Saunders WS, 2000, P NATL ACAD SCI USA, V97, P303, DOI 10.1073/pnas.97.1.303; Lahtela J, 2013, CELL CYCLE, V12, P625, DOI 10.4161/cc.23515; Freund A, 2011, EMBO J, V30, P1536, DOI 10.1038/emboj.2011.69; Liebl J, 2011, ANGIOGENESIS, V14, P281, DOI 10.1007/s10456-011-9212-6; Bavik C, 2006, CANCER RES, V66, P794, DOI 10.1158/0008-5472.CAN-05-1716; Garbers C, 2013, CELL CYCLE, V12, P3421, DOI 10.4161/cc.26431; Singh BN, 2011, BIOCHEM PHARMACOL, V82, P1807, DOI 10.1016/j.bcp.2011.07.093; Pallini R, 2001, J NEUROSURG, V94, P961, DOI 10.3171/jns.2001.94.6.0961; Liu PP, 2014, CELL DEATH DIFFER, V21, P124, DOI 10.1038/cdd.2013.131; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; Pantoja C, 1999, ONCOGENE, V18, P4974, DOI 10.1038/sj.onc.1202880; Kanazawa Y, 1996, BIOCHEM BIOPH RES CO, V225, P570, DOI 10.1006/bbrc.1996.1213; Nelson AC, 2010, MOL CELL ENDOCRINOL, V319, P129, DOI 10.1016/j.mce.2010.01.019; Jaitner S, 2012, CELL CYCLE, V11, P3331, DOI 10.4161/cc.21790; Cao AL, 2013, APOPTOSIS, V18, P1391, DOI 10.1007/s10495-013-0871-1; Naasani I, 1999, CANCER RES, V59, P4004; Sundin T, 2012, BIOCHIMIE, V94, P2639, DOI 10.1016/j.biochi.2012.07.028; Crowe DL, 2001, BBA-GENE STRUCT EXPR, V1518, P1, DOI 10.1016/S0167-4781(00)00296-7; Ashcroft M, 2000, MOL CELL BIOL, V20, P3224, DOI 10.1128/MCB.20.9.3224-3233.2000; Kang XM, 2009, J FOOD SCI, V74, pH237, DOI 10.1111/j.1750-3841.2009.01278.x; Chiang YJ, 2004, MOL CELL BIOL, V24, P7024, DOI 10.1128/MCB.24.16.7024-7031.2004; Venteicher AS, 2009, SCIENCE, V323, P644, DOI 10.1126/science.1165357; Keith WN, 2004, NAT CLIN PRACT ONCOL, V1, P88, DOI 10.1038/ncponc0044; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Jacobs JJL, 2004, CURR BIOL, V14, P2302, DOI 10.1016/j.cub.2004.12.025; Masutomi K, 2005, P NATL ACAD SCI USA, V102, P8222, DOI 10.1073/pnas.0503095102; Kraemer K, 2003, CLIN CANCER RES, V9, P3794; Beck S, 2011, MOL CELLS, V31, P9, DOI 10.1007/s10059-011-0008-8; Nonn L, 2007, CARCINOGENESIS, V28, P1188, DOI 10.1093/carcin/bgl241; Collado M, 2006, NAT REV CANCER, V6, P472, DOI 10.1038/nrc1884; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Mantena SK, 2005, PHOTOCHEM PHOTOBIOL, V81, P1174, DOI 10.1562/2005-04-11-RA-487; Chin K, 2004, NAT GENET, V36, P984, DOI 10.1038/ng1409; Vonderheide RH, 1999, IMMUNITY, V10, P673, DOI 10.1016/S1074-7613(00)80066-7; Morgan-Meadows S, 2003, CANCER CHEMOTH PHARM, V52, P361, DOI 10.1007/s00280-003-0684-y; Cottart CH, 2010, MOL NUTR FOOD RES, V54, P7, DOI 10.1002/mnfr.200900437; Lujambio A, 2013, CELL, V153, P449, DOI 10.1016/j.cell.2013.03.020; Manohar M, 2013, J NUTR BIOCHEM, V24, P940, DOI 10.1016/j.jnutbio.2012.06.013; De Leon G, 2010, INT J ONCOL, V36, P1269, DOI 10.3892/ijo_00000611; Chiron D, 2013, CELL CYCLE, V12, P1892, DOI 10.4161/cc.24928; Shanafelt TD, 2013, CANCER-AM CANCER SOC, V119, P363, DOI 10.1002/cncr.27719; Cairney CJ, 2008, BIOCHIMIE, V90, P13, DOI 10.1016/j.biochi.2007.07.025; Pitts AE, 1998, P NATL ACAD SCI USA, V95, P11549, DOI 10.1073/pnas.95.20.11549; Mender I, 2013, INT J ONCOL, V42, P1709, DOI 10.3892/ijo.2013.1865; Takahashi A, 2014, BIOCHEM BIOPH RES CO, V443, P1, DOI 10.1016/j.bbrc.2013.10.094; Norton JC, 1996, NAT BIOTECHNOL, V14, P615, DOI 10.1038/nbt0596-615; Danet-Desnoyers GAH, 2005, EXP HEMATOL, V33, P1275, DOI 10.1016/j.exphem.2005.07.011; Franco N, 2005, RADIAT RES, V163, P623, DOI 10.1667/RR3391; Jagadeesh S, 2006, CANCER RES, V66, P2107, DOI 10.1158/0008-5472.CAN-05-2494; Gogolin S, 2013, CELL CYCLE, V12, P1091, DOI 10.4161/cc.24091; Jung YD, 2001, INT J EXP PATHOL, V82, P309, DOI 10.1046/j.1365-2613.2001.00205.x; Smith LL, 2003, NAT CELL BIOL, V5, P474, DOI 10.1038/ncb985; Hoffmeyer K, 2012, SCIENCE, V336, P1549, DOI 10.1126/science.1218370; Held JM, 2012, MOL CANCER RES, V10, P1120, DOI 10.1158/1541-7786.MCR-12-0099; Liu Z, 2013, ONCOGENE, V32, P4203, DOI 10.1038/onc.2012.441; Suzuki Y, 2013, BIOMED RES-TOKYO, V34, P301; Chakravarti N, 2010, CANCER PREV RES, V3, P331, DOI 10.1158/1940-6207.CAPR-09-0076; Cotrim CZ, 2013, ONCOGENE, V32, P2390, DOI 10.1038/onc.2012.261; Romanov SR, 2001, NATURE, V409, P633, DOI 10.1038/35054579; Kenyon J, 2007, NUCLEIC ACIDS RES, V35, P7557, DOI 10.1093/nar/gkm1064; Artandi SE, 2000, NATURE, V406, P641; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Bryan TM, 1997, NAT MED, V3, P1271, DOI 10.1038/nm1197-1271; Sumi M, 2004, INT J ONCOL, V24, P1481; Hahn WC, 1999, NATURE, V400, P464; Melk A, 2004, KIDNEY INT, V65, P510, DOI 10.1111/j.1523-1755.2004.00438.x; FOTSIS T, 1993, P NATL ACAD SCI USA, V90, P2690, DOI 10.1073/pnas.90.7.2690; Dahiya A, 2001, MOL CELL, V8, P557, DOI 10.1016/S1097-2765(01)00346-X; Kleideiter Elke, 2007, V405, P167, DOI 10.1007/978-1-60327-070-0_13; Marzec M, 2006, BLOOD, V108, P1744, DOI 10.1182/blood-2006-04-016634; Gannage M, 2005, J IMMUNOL, V174, P8210; Liu Z, 2014, ANTI-CANCER DRUG, V25, P447, DOI 10.1097/CAD.0000000000000081; Jiao P, 2013, MOL CELL BIOCHEM, V382, P217, DOI 10.1007/s11010-013-1737-0; Barrette K, 2014, Br J Dermatol, V171, P1014, DOI 10.1111/bjd.12967; Bayet-Robert M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057971; Bilsland AE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006459; Blanco-Aparicio C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009305; Bodo J, 2013, BRIT J HAEMATOL, V163, P72, DOI 10.1111/bjh.12498; Bu XX, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-208; Carnero A., 2003, RES ADV CANC, V3, P183; Chiyomaru T, 2013, PLOS ONE, V8; Coppe JP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009188; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI [10.1146/annurev-pathol-121808-102144, 10.1140/annurev-pathol-121808-102144]; Cortez-Gonzalez X, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-12; da Fonseca CO, 2008, SURG NEUROL, V70, P66; d'Adda di Fagagna F, 2003, NATURE, V426, P194; D'Alessandro T, 2003, J NUTR, V133, p3773S; Deb G, 2014, MOL CARCINOG; Desai BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059588; Di Leonardo A., 1994, GENE DEV, V8, P2540; Dong YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083789; Du JH, 2009, AM J PHYSIOL-CELL PH, V297, pC742, DOI 10.1152/ajpcell.00138.2009; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Finn RS, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2419; Gershon Timothy R, 2013, Cancer Metab, V1, P2, DOI 10.1186/2049-3002-1-2; Grabinski N, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-85; Gun TL, 2007, CARCINOGENESIS, V28, P2560; Hasima Noor, 2012, Int J Biochem Mol Biol, V3, P328; He ZY, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-2; Herbert Brittney-Shea, 2002, Oncogene, V21, P638; Hou XX, 2014, ONCOL REP, V31, P1175, DOI 10.3892/or.2013.2944; Karar J, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00051; Khan N, 2011, INT J CANCER, V130, P1695; Khaw AK, 2012, J CELL BIOCHEM, V114, P1257; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Leontieva OV, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.202; Li YQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051701; Ma Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033835; Ma YC, 2014, ONCOL REP, V31, P1343, DOI 10.3892/or.2013.2933; Malumbres Marcos, 2003, Prog Cell Cycle Res, V5, P5; Mukherjee N. C. S., 2007, MOL CELL BIOCHEM, V297, P31; Nakamura H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020034; Narlik-Grassow M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060277; Nguyen Anthony V, 2009, Cancer Manag Res, V1, P25; Peffley D, 2012, NATURAL COMPOUNDS IN; Pefey DM, 2007, ARCH BIOCHEM BIOPHYS, V465, P266, DOI 10.1016/j.abb.2007.05.022; Rea K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.353; Relat J, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-280; Rodier Francis, 2013, Methods Mol Biol, V965, P165, DOI 10.1007/978-1-62703-239-1_10; Royt Madhumita, 2011, Ther Deliv, V2, P1275; Saito K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049456; Sea JH, 2010, CANC LETT, V288, P50; Shammas MA, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-24; SHAY JW, 1991, EXP CELL RES, V196, P33, DOI 10.1016/0014-4827(91)90453-2; SHIPPENLENTZ D, 1990, SCIENCE, V247, P546, DOI 10.1126/science.1689074; Subramaniam KS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068923; Sundin T, 2012, EXPERT REV MOL MED, V14, DOI 10.1017/erm.2012.1; Syed DN, 2012, ANTI-CANCER AGENT ME, V13, P995; Tang SN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031067; Uziel O, 2008, BRIT J HAEMATOL, V142, P82, DOI 10.1111/j.1365-2141.2008.07137.x; Zhang Y, 2012, J BIOL CHEM, V287, P32494, DOI 10.1074/jbc.M112.368282; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Zhu JY, 1999, P NATL ACAD SCI USA, V96, P3723, DOI 10.1073/pnas.96.7.3723; Wang YP, 2014, CANCER RES, V74, P2217, DOI 10.1158/0008-5472.CAN-13-2928; Wright WE, 1996, DEV GENET, V18, P173; Weng NP, 1996, J EXP MED, V183, P2471, DOI 10.1084/jem.183.6.2471; Yokoyama Y, 2000, BIOCHEM BIOPH RES CO, V273, P316, DOI 10.1006/bbrc.2000.2939; Zhang RG, 2007, MOL CELL BIOL, V27, P2343, DOI 10.1128/MCB.02019-06; Xie WY, 2014, INT J BIOL SCI, V10, P192, DOI 10.7150/ijbs.7770; Zhao YM, 2008, ACTA PHARMACOL SIN, V29, P481, DOI 10.1111/j.1745-7254.2008.00767.x; Ye XF, 2007, MOL CELL BIOL, V27, P2452, DOI 10.1128/MCB.01592-62; Zhang XL, 1999, GENE DEV, V13, P2388, DOI 10.1101/gad.13.18.2388; Yu D, 2014, ONCOL REP, V31, P673, DOI 10.3892/or.2013.2893; Zhang HS, 2000, CELL, V101, P79, DOI 10.1016/S0092-8674(00)80625-X; Wei S, 1999, CANCER RES, V59, P1539; Yalcin A, 2009, J BIOL CHEM, V284, P24223, DOI 10.1074/jbc.M109.016816; Xue Y, 2010, ONCOL REP, V24, P1551, DOI 10.3892/or_00001017; ZAHLER AM, 1991, NATURE, V350, P718, DOI 10.1038/350718a0; Wang X, 2009, ARCH PHARM RES, V32, P1263, DOI 10.1007/s12272-009-1912-8; Woo RA, 2004, GENE DEV, V18, P1317, DOI 10.1101/gad.1165204; Wu KJ, 1999, NAT GENET, V21, P220; Yu ST, 2009, INT J ONCOL, V35, P329, DOI 10.3892/ijo_00000344; Zhou CX, 2003, MOL CANCER THER, V2, P789; Wick M, 1999, GENE, V232, P97, DOI 10.1016/S0378-1119(99)00108-0; Yaswen P, 2002, INT J BIOCHEM CELL B, V34, P1382, DOI 10.1016/S1357-2725(02)00047-X; Zhang ZY, 2013, INT J ONCOL, V43, P289, DOI 10.3892/ijo.2013.1946; Webb LMC, 2005, J IMMUNOL, V175, P2783; Zhang RG, 2005, DEV CELL, V8, P19, DOI 10.1016/j.devcel.2004.10.019; Warabi K, 2005, J AM CHEM SOC, V127, P13262, DOI 10.1021/ja052688r; Yasumoto S, 1996, ONCOGENE, V13, P433; Wang T, 2012, ONCOL REP, V28, P1153, DOI 10.3892/or.2012.1952; Wu XP, 2012, BBA-MOL CELL RES, V1823, P2130, DOI 10.1016/j.bbamcr.2012.08.003; Zhang AJ, 2000, CANCER RES, V60, P6230; Zong HJ, 2014, MOL BIOL REP, V41, P4507, DOI 10.1007/s11033-014-3321-4; Wang J, 1998, GENE DEV, V12, P1769, DOI 10.1101/gad.12.12.1769; WynfordThomas D, 1996, J PATHOL, V180, P118, DOI 10.1002/(SICI)1096-9896(199610)180:2<118::AID-PATH673>3.0.CO;2-I; Zhao JQ, 2000, NEOPLASIA, V2, P531, DOI 10.1038/sj.neo.7900114; Xu NH, 2010, J CELL BIOL, V190, P297, DOI 10.1083/jcb.201003004; Young AP, 2004, ONCOGENE, V23, P814, DOI 10.1038/sj.onc.1207187; Zou CP, 2010, INT J GYNECOL CANCER, V20, P617, DOI 10.1111/IGC.0b013e3181c7ca5c; Yuan J, 2009, ONCOGENE, V28, P2678, DOI 10.1038/onc.2009.136; Wu SQ, 2009, EXP CELL RES, V315, P3099, DOI 10.1016/j.yexcr.2009.09.009; Zhang Y, 2012, J CELL PHYSIOL, V227, P35, DOI 10.1002/jcp.22722; Wong LH, 2013, CHEM BIOL, V20, P333, DOI 10.1016/j.chembiol.2012.12.008; Yuri T, 2004, BREAST CANCER RES TR, V84, P251, DOI 10.1023/B:BREA.0000019966.97011.4d; Zhao JQ, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-6; Wen VW, 2006, CANCER RES, V66, P10691, DOI 10.1158/0008-5472.CAN-06-0979; Zhang XB, 2012, J CANCER RES CLIN, V138, P2051, DOI 10.1007/s00432-012-1276-1; Wu HJ, 2012, EXP THER MED, V3, P650, DOI 10.3892/etm.2012.448; Wang ES, 2004, BLOOD, V103, P258, DOI 10.1182/blood-2003-02-0546; Zhang XH, 2013, CANCER BIOL THER, V14, P597, DOI 10.4161/cbt.24592; Yuan HY, 2013, CANCER RES, V73, P4349, DOI 10.1158/0008-5472.CAN-13-0322; Wall M, 2013, CANCER DISCOV, V3, P82, DOI 10.1158/2159-8290.CD-12-0404; Zhao YJ, 2009, GENE CHROMOSOME CANC, V48, P963, DOI 10.1002/gcc.20698; Zhang AJ, 2002, GENE CHROMOSOME CANC, V34, P269, DOI 10.1002/gcc.10071; Zanuy M, 2012, METABOLOMICS, V8, P454, DOI 10.1007/s11306-011-0328-x; Zhang C, 2008, MOL CANCER THER, V7, P818, DOI 10.1158/1535-7163.MCT-07-0440; Yu LL, 2011, ONCOL REP, V26, P1197, DOI 10.3892/or.2011.1410; WRIGHT WE, 1995, TRENDS CELL BIOL, V5, P293, DOI 10.1016/S0962-8924(00)89044-3; Wang YH, 2012, J CELL MOL MED, V16, P496, DOI 10.1111/j.1582-4934.2011.01337.x; Wang SW, 2007, MOL BIOL CELL, V18, P669, DOI 10.1091/mbc.E06-09-0840; Warfel NA, 2013, CELL CYCLE, V12, P3689, DOI 10.4161/cc.26930; Witkiewicz AK, 2013, ONCOGENE, V33, P3980; Wu AB, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-38; Xu XF, 2014, ENDOCRINOLOGY, V155, P1510, DOI 10.1210/en.2013-1929; Yeruva Laxmi, 2007, Cancer Lett, V257, P216, DOI 10.1016/j.canlet.2007.07.020; Yuan Zhang, 2002, Hematol J, V3, P201, DOI 10.1038/sj.thj.6200177; Zolnierczyk JD, 2009, ANN NY ACAD SCI, V1171, P124, DOI 10.1111/j.1749-6632.2009.04903.x	568	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1044-579X			SEMIN CANCER BIOL	Semin. Cancer Biol.	DEC	2015	35			S			S104	S128		10.1016/j.semcancer.2015.03.007		25	Oncology	Oncology	CY7WG	WOS:000366619400006		
J	Chikuda, H				Chikuda, Hirotaka			RE: Ischemic stroke after cervical spine injury: analysis of 11,005 patients using the Japanese Diagnosis Procedure Combination database Response	SPINE JOURNAL			English	Letter							CORD-INJURY		[Chikuda, Hirotaka] Univ Tokyo, Fac Med, Dept Orthopaed Surg, Bunkyo Ku, Tokyo 1138655, Japan	Chikuda, H (reprint author), Univ Tokyo, Fac Med, Dept Orthopaed Surg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.						Chikuda H, 2011, SPINE, V36, P1453, DOI 10.1097/BRS.0b013e3181f49718; Katoh S, 2014, SPINAL CORD, V52, P264, DOI 10.1038/sc.2014.13; Koyanagi I, 2000, J NEUROSURG, V93, P15, DOI 10.3171/spi.2000.93.1.0015; Kato H, 2008, J TRAUMA, V65, P373, DOI 10.1097/TA.0b013e31817db11d; Shingu H, 1995, J JPN MED SOC PARAPL, V8, P26	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1529-9430	1878-1632		SPINE J	Spine Journal	DEC 1	2015	15	12					2593	2594		10.1016/j.spinee.2015.08.051		3	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CY8JQ	WOS:000366655100055		
J	Teraguchi, M; Yoshimura, N; Hashizume, H; Yoshida, M				Teraguchi, Masatoshi; Yoshimura, Noriko; Hashizume, Hiroshi; Yoshida, Munehito			Response to "Revisiting the nomenclature and grading schemes for disc degeneration: issues to be solved"	SPINE JOURNAL			English	Letter									[Teraguchi, Masatoshi; Hashizume, Hiroshi; Yoshida, Munehito] Wakayama Med Univ, Dept Orthopaed Surg, Wakayama 6418509, Japan; [Yoshimura, Noriko] Univ Tokyo, Fac Med, Dept Joint Dis Res, 22nd Century Med & Res Ctr, Tokyo 1138655, Japan	Teraguchi, M (reprint author), Wakayama Med Univ, Dept Orthopaed Surg, 811-1 Kimiidera, Wakayama 6418509, Japan.							0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1529-9430	1878-1632		SPINE J	Spine Journal	DEC 1	2015	15	12					2595	2596		10.1016/j.spinee.2015.08.046		3	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CY8JQ	WOS:000366655100057		
J	Uehara, M; Takahashi, J; Kuraishi, S; Shimizu, M; Ikegami, S; Futatsugi, T; Kato, H				Uehara, Masashi; Takahashi, Jun; Kuraishi, Shugo; Shimizu, Masayuki; Ikegami, Shota; Futatsugi, Toshimasa; Kato, Hiroyuki			Osteoid osteoma presenting as thoracic scoliosis	SPINE JOURNAL			English	Article						Osteoid osteoma; Scoliosis; Spinal deformity; Tumor excision; Vertebral rotation; CT myelogram	PERCUTANEOUS RADIOFREQUENCY ABLATION; SPINE; OSTEOBLASTOMA	BACKGROUND CONTEXT: Osteoid osteoma of the thoracic spine is relatively uncommon and is often difficult to diagnose, especially when patients do not complain of pain. PURPOSE: This study aims to describe an unusual case of scoliosis caused by osteoid osteoma of the thoracic spine that was challenging to diagnose. STUDY DESIGN/SETTING: Acase report of a 12-year-old girl who presented with scoliosis caused by osteoid osteoma of the thoracic spine without apparent pain was carried out. METHODS: Diagnosis of the lesion was made using computed tomography (CT) and magnetic resonance imaging as well as the Scoliosis Research Society-22 (SRS-22) patient-based questionnaire. RESULTS: A preoperative CT myelogram revealed a mass lesion in the lamina of the 10th thoracic vertebra that was considered to be osteoid osteoma. This diagnosis was histologically confirmed following tumor excision. The patient's spinal deformity and SRS-22 scores were both improved at 5 months postoperatively. CONCLUSIONS: Osteoid osteoma of the thoracic spine may present as non-painful scoliosis. Tumor resection is effective. Clinicians should bear this uncommon lesion in mind during recommended CT examination before scoliosis surgery. (C) 2015 Elsevier Inc. All rights reserved.	[Uehara, Masashi; Takahashi, Jun; Kuraishi, Shugo; Shimizu, Masayuki; Ikegami, Shota; Futatsugi, Toshimasa; Kato, Hiroyuki] Shinshu Univ, Sch Med, Dept Orthpaed Surg, Matsumoto, Nagano 3908621, Japan	Takahashi, J (reprint author), Shinshu Univ, Sch Med, Dept Orthpaed Surg, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	jtaka@shinshu-u.ac.jp					Aergerter EE, 1968, ORTHOPEDIC DIS; FOUNTAIN EM, 1961, J NEUROSURG, V18, P380, DOI 10.3171/jns.1961.18.3.0380; Jaffe HL, 1935, ARCH SURG-CHICAGO, V31, P709; KIRWAN EO, 1984, J BONE JOINT SURG BR, V66, P21; SPONSELLER PD, 1995, J BONE JOINT SURG AM, V77A, P867; McDermott MB, 1996, CANCER, V77, P1442, DOI 10.1002/(SICI)1097-0142(19960415)77:8<1442::AID-CNCR4>3.3.CO;2-N; KEIM HA, 1975, J BONE JOINT SURG AM, VA 57, P159; AZOUZ EM, 1986, PEDIATR RADIOL, V16, P25, DOI 10.1007/BF02387501; JANIN Y, 1981, NEUROSURGERY, V8, P31; Atesok KI, 2011, J AM ACAD ORTHOP SUR, V19, P678; Lindner NJ, 2001, J BONE JOINT SURG BR, V83B, P391, DOI 10.1302/0301-620X.83B3.11679; Barei DP, 2000, CLIN ORTHOP RELAT R, P115; CROUZET G, 1989, J NEURORADIOLOGY, V16, P145; Boriani S, 1997, ADULT SPINE, P950; JACKSON RP, 1977, CLIN ORTHOP RELAT R, P303; MARCOVE RC, 1991, CLIN ORTHOP RELAT R, P197; MEHTA MH, 1978, CLIN ORTHOP RELAT R, P58; Singh Kern, 2005, Spine J, V5, P461, DOI 10.1016/j.spinee.2004.09.015; Unni KK, 1996, DAHLINS BONE TUMORS; Wu L, 2010, SPINE, V15, P182; Zileli Mehmet, 2003, Neurosurg Focus, V15, pE5	21	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1529-9430	1878-1632		SPINE J	Spine Journal	DEC 1	2015	15	12					E77	E81		10.1016/j.spinee.2015.08.064		5	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CY8JQ	WOS:000366655100035		
J	Nakata, T				Nakata, Tatsuya			EFFECTS OF EXPANDING AND EQUAL SPACING ON SECOND LANGUAGE VOCABULARY LEARNING Does Gradually Increasing Spacing Increase Vocabulary Learning?	STUDIES IN SECOND LANGUAGE ACQUISITION			English	Article							PAIRED-ASSOCIATE PARADIGM; LONG-TERM RETENTION; RETRIEVAL PRACTICE; SPACED RETRIEVAL; PHYSIOLOGY INFORMATION; DISTRIBUTED PRACTICE; OLDER-ADULTS; ACQUISITION; INTERVAL; RECALL	Although expanding spacing is often regarded as the most effective practice schedule, studies comparing equal and expanding spacing have yielded mixed results. The present study set out to examine whether the amount of spacing and the retention interval may influence the effects of expanding and equal spacing on second language (L2) vocabulary learning. One hundred and twenty-eight Japanese college students studied 20 English-Japanese word pairs. The type of spacing (expanding and equal) and the amount of spacing (massed, short, medium, and long) were manipulated. Results demonstrated a limited, yet statistically significant, advantage of expanding spacing. The finding is significant because this is the first L2 study to find the superiority of expanding over equal spacing. The main effect of the amount of spacing was also significant, producing large effect sizes. Taken together, the results suggest that expanding spacing may facilitate vocabulary learning, although introducing spacing may have a larger effect.	[Nakata, Tatsuya] Victoria Univ Wellington, Wellington, New Zealand	Nakata, T (reprint author), Kansai Univ, Fac Foreign Language Studies, 3-3-35 Yamate Cho, Suita, Osaka 5648680, Japan.	nakata@kansai-u.ac.jp			Student Exchange Support Program Scholarship from Japan Student Services Organization; Victoria PhD Scholarship from Victoria University of Wellington;  [109605];  [200314]	This research was supported by faculty research grants (#109605 and #200314) and a Victoria PhD Scholarship from Victoria University of Wellington as well as a Student Exchange Support Program Scholarship from the Japan Student Services Organization. Earlier versions of this article were presented at the 22nd Annual Conference of the European Second Language Association (EuroSLA), Poznan, Poland, 2012, and at the Vocab@Vic Conference, Wellington, New Zealand, 2013. This article is based on part of the author's doctoral dissertation, which was submitted to Victoria University of Wellington in 2013. I am very grateful to Stuart Webb, Paul Nation, and four SSLA reviewers for their invaluable advice. I would also like to extend my special thanks to Atsushi Mizumoto and Tomohiro Tsuchiya for their cooperation with data collection.	Al-Qarni I., 2008, LANGUAGE LEARNING J, V36, P239, DOI DOI 10.1080/09571730802390759; Maddox GB, 2011, PSYCHOL AGING, V26, P661, DOI 10.1037/a0022942; Cull WL, 2000, APPL COGNITIVE PSYCH, V14, P215, DOI 10.1002/(SICI)1099-0720(200005/06)14:3<215::AID-ACP640>3.0.CO;2-1; Schuetze U, 2015, LANG TEACH RES, V19, P28, DOI 10.1177/1362168814541726; SHAUGHNESSY JJ, 1992, B PSYCHONOMIC SOC, V30, P125; Balota DA, 2006, PSYCHOL AGING, V21, P19, DOI 10.1037/0882-7974.21.1.19; Son LK, 2012, EDUC PSYCHOL REV, V24, P379, DOI 10.1007/s10648-012-9206-y; Karpicke JD, 2011, J EXP PSYCHOL LEARN, V37, P1250, DOI 10.1037/a0023436; Pyc MA, 2009, J MEM LANG, V60, P437, DOI 10.1016/j.jml.2009.01.004; Nation ISP, 2006, CAN MOD LANG REV, V63, P59; Steinel MP, 2007, STUD SECOND LANG ACQ, V29, P449, DOI 10.1017/S0272263107070271; Dobson JL, 2011, ADV PHYSIOL EDUC, V35, P378, DOI 10.1152/advan.00039.2011; Metcalfe J, 2007, PSYCHON B REV, V14, P225, DOI 10.3758/BF03194056; Storm BC, 2010, MEM COGNITION, V38, P244, DOI 10.3758/MC.38.2.244; SCHMIDT RA, 1992, PSYCHOL SCI, V3, P207, DOI 10.1111/j.1467-9280.1992.tb00029.x; Griffin G, 1996, APPL PSYCHOLINGUIST, V17, P443, DOI 10.1017/S0142716400008195; Cepeda NJ, 2006, PSYCHOL BULL, V132, P354, DOI 10.1037/0033-2909.132.3.354; Elgort I, 2011, LANG LEARN, V61, P367, DOI 10.1111/j.1467-9922.2010.00613.x; Pashler H, 2003, J EXP PSYCHOL LEARN, V29, P1051, DOI 10.1037/0278-7393.29.6.1051; Carpenter SK, 2005, APPL COGNITIVE PSYCH, V19, P619, DOI 10.1002/acp.1101; Dobson JL, 2012, ADV PHYSIOL EDUC, V36, P6, DOI 10.1152/advan.00090.2011; Barcroft J, 2007, LANG LEARN, V57, P35, DOI 10.1111/j.1467-9922.2007.00398.x; Pyc MA, 2007, MEM COGNITION, V35, P1917, DOI 10.3758/BF03192925; Barcroft J, 2002, LANG LEARN, V52, P323, DOI 10.1111/0023-8333.00186; Logan JM, 2008, AGING NEUROPSYCHOL C, V15, P257, DOI 10.1080/13825580701322171; Webb SA, 2009, CAN MOD LANG REV, V65, P441, DOI 10.3138/cmlr.65.3.441; Nakata T, 2011, COMPUT ASSIST LANG L, V24, P17, DOI 10.1080/09588221.2010.520675; Cull WL, 1996, J EXP PSYCHOL-APPL, V2, P365, DOI 10.1037/1076-898X.2.4.365; Cepeda NJ, 2009, EXP PSYCHOL, V56, P236, DOI 10.1027/1618-3169.56.4.236; Karpicke JD, 2010, MEM COGNITION, V38, P116, DOI 10.3758/MC.38.1.116; Schneider VI, 2002, J MEM LANG, V46, P419, DOI 10.1006/jmla.2001.2813; Karpicke JD, 2007, J EXP PSYCHOL LEARN, V33, P704, DOI 10.1037/0278-7393.33.4.704; Baddeley A. D., 1997, HUMAN MEMORY THEORY; Barcroft J., 2013, VOC VIC C WELL NZ; Bjork R. A., 1994, METACOGNITION KNOWIN, P185; Cohen J., 1988, STAT POWER ANAL BEHA; Ellis N. C., 1995, Computer Assisted Language Learning, V8, DOI 10.1080/0958822940080202; Hulstijn J. H., 2001, COGNITION 2 LANGUAGE, P258; Kang SHK, 2014, PSYCHON B REV, V21, P1544, DOI 10.3758/s13423-014-0636-z; Landauer T. K., 1978, PRACTICAL ASPECTS ME, P625; Laufer B., 2012, ENCY APPL LINGUISTIC, P5151; Mondria J. A., 2003, STUDIES 2 LANGUAGE A, V25, P473, DOI DOI 10.1017/S0272263103000202; Nakata T., 2013, THESIS; Nation I. S. P., 2007, LANGUAGE TEACHER, V31, P9; Nation I. S. P., 2000, TESOL J, V9, P6; Nation I. S. P., 2001, LEARNING VOCABULARY; Nation I. S. P., 2011, RES ANAL VOCABULARY; Roediger H. L., 2010, SUCCESSFUL REMEMBERI, P23; Schmitt N., 2007, INT HDB ENGLISH LA 2, P827; Schmitt N., 1997, VOCABULARY DESCRIPTI, P199; Suppes P., 1967, EXPT 2 LANGUAGE LEAR; Wiersma B., 2004, VOCABULARY 2 LANGUAG, P79	52	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0272-2631	1470-1545		STUD SECOND LANG ACQ	Stud. Second Lang. Acquis.	DEC	2015	37	4					677	711		10.1017/S0272263114000825		35	Linguistics	Linguistics	CY8KC	WOS:000366656300004		
J	Kawamura, H; Shibasaki, S; Yoshida, T; Homma, S; Takahashi, M; Taketomi, A				Kawamura, Hideki; Shibasaki, Susumu; Yoshida, Tadashi; Homma, Shigenori; Takahashi, Masahiro; Taketomi, Akinobu			Strategy of Laparoscopic Partial Resection for Gastric Gastrointestinal Stromal Tumors According to the Growth Pattern	SURGICAL LAPAROSCOPY ENDOSCOPY & PERCUTANEOUS TECHNIQUES			English	Article							ESOPHAGOGASTRIC JUNCTION; STOMACH; DISSECTION; SURGERY; GIST; SAFE		[Kawamura, Hideki; Shibasaki, Susumu; Yoshida, Tadashi; Homma, Shigenori; Taketomi, Akinobu] Hokkaido Univ, Grad Sch Med, Dept Gastroenterol Surg 1, Sapporo, Hokkaido 0608638, Japan; [Takahashi, Masahiro] JA Sapporo Kosei Hosp, Dept Surg, Sapporo, Hokkaido, Japan	Kawamura, H (reprint author), Hokkaido Univ, Grad Sch Med, Dept Gastroenterol Surg 1, Kita Ku, N15,W7, Sapporo, Hokkaido 0608638, Japan.	h.kawamura@med.hokudai.ac.jp					De Vogelaere K, 2012, SURG ENDOSC, V26, P2339, DOI 10.1007/s00464-012-2186-7; Song KY, 2007, SURG ENDOSC, V21, P2272, DOI 10.1007/s00464-007-9369-7; Sakamoto Y, 2012, SURG TODAY, V42, P708, DOI 10.1007/s00595-012-0121-0; Karakousis GC, 2011, ANN SURG ONCOL, V18, P1599, DOI 10.1245/s10434-010-1517-y; Krajinovic K, 2010, DIGEST SURG, V27, P313, DOI 10.1159/000280022; Tanabe K, 2010, DIGEST SURG, V27, P461, DOI 10.1159/000320458; Fletcher CDM, 2002, HUM PATHOL, V33, P459, DOI 10.1053/hupa.2002.123545; Privette A, 2008, SURG ENDOSC, V22, P487, DOI 10.1007/s00464-007-9493-4; Silberhumer GR, 2009, J GASTROINTEST SURG, V13, P1213, DOI 10.1007/s11605-009-0872-0; Basu S, 2007, SURG ENDOSC, V21, P1685, DOI 10.1007/s00464-007-9445-z; Ma JJ, 2011, SURG LAPARO ENDO PER, V21, P101, DOI 10.1097/SLE.0b013e3182139546; Nakamori M, 2008, AM J SURG, V196, P425, DOI 10.1016/j.amjsurg.2007.10.012; Sasaki A, 2010, SURGERY, V147, P516, DOI 10.1016/j.surg.2009.10.035; Sujendran V, 2007, SURG-J R COLL SURG E, V5, P149; Hiki N, 2008, SURG ENDOSC, V22, P1729, DOI 10.1007/s00464-007-9696-8	15	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1530-4515	1534-4908		SURG LAPARO ENDO PER	Surg. Laparosc. Endosc. Pct. Tech.	DEC	2015	25	6					E175	E179				5	Surgery	Surgery	CY8XU	WOS:000366692800003		
J	Miyasaka, M; Nakata, H; Hao, J; Kim, YK; Kasugai, S; Kuroda, S				Miyasaka, Munemitsu; Nakata, Hidemi; Hao, Jia; Kim, You-Kyoung; Kasugai, Shohei; Kuroda, Shinji			Low-Intensity Pulsed Ultrasound Stimulation Enhances Heat-Shock Protein 90 and Mineralized Nodule Formation in Mouse Calvaria-Derived Osteoblasts	TISSUE ENGINEERING PART A			English	Article							OSTEOGENIC DIFFERENTIATION; STRESS-PROTEINS; BONE-GROWTH; CELLS; INDUCTION; HEAT-SHOCK-PROTEIN-27; IMMUNOLOCALIZATION; STABILIZATION; ACCELERATION; HYPERTHERMIA	Low-intensity pulsed ultrasound (LIPUS) has demonstrated its positive effects on osteogenic differentiation of mesenchymal stem cells and the proliferation and differentiation of osteoblasts, negative effects on osteoclast growth, and promotion of angiogenesis, leading to improvement of the tissue perfusion. Heat-shock proteins (HSPs) are initially identified as molecules encouraged and expressed by heat stress or chemical stress to cells and involved in the balance between differentiation and apoptosis of osteoblasts. However, it remains unclear if the effect of LIPUS on osteoblast differentiation could involve HSP expression and contribution. In this study, mouse calvarial osteoblasts were exposed to LIPUS at a frequency of 3.0MHz by 30mW/cm(2) for 15min or to 42 degrees C heat shock for 20min at day 3 of cell culture and examined for osteogenesis with pursuing induction of HSP27, HSP70, and HSP90. LIPUS as well as heat shock initially upregulated HSP90 and phosphorylation of Smad1 and Smad5, encouraging cell viability and proliferation at 24h, enhancing mineralized nodule formation stronger by LIPUS after 10 days. However, HSP27, associated with BMP2-stimulated p38 mitogen-activated protein kinase during osteoblast differentiation, was downregulated by both stimulations at this early time point. Notably, these two stimuli maintained Smad1 phosphorylation with mineralized nodule formation even under BMP2 signal blockage. Therefore, LIPUS might be a novel inducer of osteoblastic differentiation through a noncanonical signal pathway. In conclusion, LIPUS stimulation enhanced cell viability and proliferation as early as 24h after treatment, and HSP90 was upregulated, leading to dense mineralization in the osteoblast cell culture after 10 days.	[Miyasaka, Munemitsu; Nakata, Hidemi; Hao, Jia; Kim, You-Kyoung; Kasugai, Shohei; Kuroda, Shinji] Tokyo Med & Dent Univ, Dept Oral Implantol & Regenerat Dent Med, Div Oral Hlth Sci, Grad Sch Med & Dent Sci, Tokyo 1138510, Japan	Kuroda, S (reprint author), Tokyo Med & Dent Univ, Dept Oral Implantol & Regenerat Dent Med, Div Oral Hlth Sci, Grad Sch Med & Dent Sci,Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.	skuroda.mfc@tmd.ac.jp					Maddi A, 2006, BONE, V39, P283, DOI 10.1016/j.bone.2006.01.162; Kozawa O, 2002, J CELL BIOCHEM, V86, P357, DOI 10.1002/jcb.10221; Zylicz M, 2001, IUBMB LIFE, V51, P283; Yang Z, 2014, J ULTRAS MED, V33, P865, DOI 10.7863/ultra.33.5.865; Sena K, 2005, ULTRASOUND MED BIOL, V31, P703, DOI 10.1016/j.ultrasmedbio.2005.01.013; NOVER L, 1991, NEW BIOL, V3, P855; Mayr E, 2002, UNFALLCHIRURG, V105, P108, DOI 10.1007/s001130100301; Naruse K, 2000, BIOCHEM BIOPH RES CO, V268, P216, DOI 10.1006/bbrc.2000.2094; Tanzer M, 1996, J ORTHOPAED RES, V14, P901, DOI 10.1002/jor.1100140609; Sena K, 2011, ULTRASONICS, V51, P639, DOI 10.1016/j.ultras.2011.01.007; LAVOIE JN, 1993, J BIOL CHEM, V268, P3420; Tiffee JC, 2000, TISSUE CELL, V32, P141, DOI 10.1054/tice.2000.0097; PRATT WB, 1992, J STEROID BIOCHEM, V41, P223, DOI 10.1016/0960-0760(92)90348-M; Gebauer D, 2005, ULTRASOUND MED BIOL, V31, P1391, DOI 10.1016/j.ultrasmedbio.2005.06.002; Li L, 2012, BIOCHEM BIOPH RES CO, V418, P296, DOI 10.1016/j.bbrc.2012.01.014; Warden SJ, 2001, BIOCHEM BIOPH RES CO, V286, P443, DOI 10.1006/bbrc.2001.5412; Hedges JC, 1999, J BIOL CHEM, V274, P24211, DOI 10.1074/jbc.274.34.24211; Kristiansen TK, 1997, J BONE JOINT SURG AM, V79A, P961; Cook SD, 1997, CLIN ORTHOP RELAT R, P198; Leonardi R, 2004, CALCIFIED TISSUE INT, V75, P509, DOI 10.1007/s00223-004-0077-1; Chen PY, 2010, NUTR RES, V30, P191, DOI 10.1016/j.nutres.2010.03.004; Zhang HG, 2008, CANCER LETT, V271, P191, DOI 10.1016/j.canlet.2008.05.026; Blackburn RV, 1997, INT J CANCER, V72, P871, DOI 10.1002/(SICI)1097-0215(19970904)72:5<871::AID-IJC26>3.0.CO;2-A; WELCH WJ, 1992, PHYSIOL REV, V72, P1063; Ciocca DR, 2005, CELL STRESS CHAPERON, V10, P86, DOI 10.1379/CSC-99r.1; HECKMAN JD, 1994, J BONE JOINT SURG AM, V76A, P26; ERLEBACHER A, 1995, CELL, V80, P371, DOI 10.1016/0092-8674(95)90487-5; Issels RD, 2008, EUR J CANCER, V44, P2546, DOI 10.1016/j.ejca.2008.07.038; Takayama T, 2007, LIFE SCI, V80, P965, DOI 10.1016/j.lfs.2006.11.037; Kato K, 2011, ENDOCRINOLOGY, V152, P1872, DOI 10.1210/en.2010-1062; Suzuki A, 2009, ACTA BIOCH BIOPH SIN, V41, P108, DOI 10.1093/abbs/gmn012; KLUG W, 1986, EUR J NUCL MED, V11, P494; Angle SR, 2011, ULTRASONICS, V51, P281, DOI 10.1016/j.ultras.2010.09.004; Pockley AG, 2002, CIRCULATION, V105, P1012, DOI 10.1161/hc0802.103729; Yamada P, 2008, SPORTS MED, V38, P715, DOI 10.2165/00007256-200838090-00002; Leung KS, 2004, ULTRASOUND MED BIOL, V30, P389, DOI 10.1016/j.ultrasmedbio.2003.11.008; Naito H, 2001, MED SCI SPORT EXER, V33, P729; Mathew A, 1998, ANN NY ACAD SCI, V851, P99, DOI 10.1111/j.1749-6632.1998.tb08982.x; Nolte PA, 2001, J TRAUMA, V51, P693, DOI 10.1097/00005373-200110000-00012; Azuma Y, 2001, J BONE MINER RES, V16, P671, DOI 10.1359/jbmr.2001.16.4.671; Chung E, 2012, CELL STRESS CHAPERON, V17, P203, DOI 10.1007/s12192-011-0300-8; Unsworth J, 2007, ULTRASOUND MED BIOL, V33, P1468, DOI 10.1016/j.ultrasmedbio.2006.12.003; Menoret A, 2002, INT J HYPERTHER, V18, P490, DOI 10.1080/02656730210146926; Takikawa S, 2001, J ULTRAS MED, V20, P197; Wang XD, 2003, ARCH BIOCHEM BIOPHYS, V415, P6, DOI 10.1016/S0003-9861(03)00213-3; Garrido C, 2001, BIOCHEM BIOPH RES CO, V286, P433, DOI 10.1006/bbrc.2001.5427; Benisch P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045142; COWIN SC, 1991, J BIOMECH ENG-T ASME, V113, P191, DOI 10.1115/1.2891234; DUARTE LR, 1983, ARCH ORTHOP TRAUM SU, V101, P153, DOI 10.1007/BF00436764; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; Kregel KC, 2002, J APPL PHYSIOL, V92, P2177, DOI 10.1152/japplphysiol.01267.2001; Nover L, 1991, Results Probl Cell Differ, V17, P1; Pilla A A, 1990, J Orthop Trauma, V4, P246, DOI 10.1097/00005131-199004030-00002; Styrkarsdottir U, 2003, PLOS BIOL, V1, P351, DOI 10.1371/journal.pbio.0000069	54	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	DEC 1	2015	21	23-24					2829	2839		10.1089/ten.tea.2015.0234		11	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CY8NV	WOS:000366666400010		
J	Kaji, R				Kaji, Ryuji			Clinical differences between A1 and A2 botulinum toxin subtypes	TOXICON			English	Article						A2NTX; Subtype A2 botulinum toxin; Subtype A1; Less spread; Higher efficacy and safety; Lower limb spasticity	NEUROTOXIN; INHIBITION; SPASTICITY	All the type A botulinum toxins that have been clinically used are of subtype A1. We have developed low-molecular weight (150 k Dal) subtype A2 preparation (A2NDC) for clinical use. In the first-in-man study, the clinical efficacy of A2NTX was 1.5 times that of onabotulinumtoxinA (subtype A1) with similar time course and less spread of its action to a neighboring muscle. We have recently performed a comparative study of A1LL (onabotulinumtoxinA) and A2NTX toxins for post-stroke spasticity (Study of a New Generation Botulinum Toxin A2NTX to Treat Spasticity After Stroke; NCT01910363 at ClinicalTrials.gov). This double blinded randomized controlled study used 300u of each subtype. In this study, A2NTX showed significantly higher efficacy 30 days after injection (Fig. 2), and less spread of the effect as measured by the hand grip of the unaffected side than A1a. Functional independence measure (FIM) was also significantly improved for A2NTX, but not for A1LL. Additional large-scale clinical trials are warranted to further evaluate this promising new treatment. (C) 2015 Elsevier Ltd. All rights reserved.	[Kaji, Ryuji] Univ Tokushima, Inst Hlth Biosci, Dept Neurol, Tokushima 7708503, Japan	Kaji, R (reprint author), Univ Tokushima, Inst Hlth Biosci, Dept Neurol, 2-50-1 Kuramoto Cho, Tokushima 7708503, Japan.	rkaji@tokushima-u.ac.jp					LANCE JW, 1990, LANCET, V335, P606, DOI 10.1016/0140-6736(90)90389-M; Pier CL, 2011, FEBS LETT, V585, P199, DOI 10.1016/j.febslet.2010.11.045; Shin MC, 2013, TOXICON, V64, P12, DOI 10.1016/j.toxicon.2012.12.011; Kaji R, 2013, J PHYSIOL-LONDON, V591, P749, DOI 10.1113/jphysiol.2012.246322; Arndt JW, 2006, J MOL BIOL, V362, P733, DOI 10.1016/j.jmb.2006.07.040; Marchand-Pauvert V, 2013, J PHYSIOL-LONDON, V591, P1017, DOI 10.1113/jphysiol.2012.239178; Kato K, 2013, TOXICON, V74, P109, DOI 10.1016/j.toxicon.2013.07.027; Whitemarsh RCM, 2013, INFECT IMMUN, V81, P3894, DOI 10.1128/IAI.00536-13; Mukai Y, 2014, TOXICON, V81, P32, DOI 10.1016/j.toxicon.2013.12.012; Gracies JM, 2004, MOVEMENT DISORD, V19, pS120, DOI 10.1002/mds.20065; Caleo M, 2009, J NEUROCHEM, V109, P15, DOI 10.1111/j.1471-4159.2009.05887.x; Caleo M, 2009, TOXICON, V54, P593, DOI 10.1016/j.toxicon.2008.12.026; Akaike N, 2013, J PHYSIOL-LONDON, V591, P1031, DOI 10.1113/jphysiol.2012.242131; Kaji R., 2015, NEUROLOGY; Kaji R, 2015, NEUROLOGY, V84, P1051, DOI 10.1212/WNL.0000000000001328; Karaca B., 2015, J CHILD NEUROL; Koizumi Hidetaka, 2014, Front Neurol, V5, P98, DOI 10.3389/fneur.2014.00098; Torii Y., 2014, BASIC CLIN PHARM TOX; Torii Y, 2014, TOXICON, V77, P114, DOI 10.1016/j.toxicon.2013.11.006; Torii Y, 2013, TOXICON, V73, P9, DOI 10.1016/j.toxicon.2013.06.020	20	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0041-0101			TOXICON	Toxicon	DEC 1	2015	107		A		SI		85	88		10.1016/j.toxicon.2015.09.025		4	Pharmacology & Pharmacy; Toxicology	Pharmacology & Pharmacy; Toxicology	CY6SP	WOS:000366539400014		
J	Yamaguchi, K; Chijiwa, T; Yamamura, T; Ikeda, N; Yatsui, T; Hayama, S; Hattori, S; Oda-Ueda, N; Ohno, M				Yamaguchi, Kazuaki; Chijiwa, Takahito; Yamamura, Takeshi; Ikeda, Naoki; Yatsui, Takayo; Hayama, Setsuko; Hattori, Shosaku; Oda-Ueda, Naoko; Ohno, Motonori			Interisland variegation of venom [Lys(49)]phospholipase A(2) isozyme genes in Protobothrops genus snakes in the southwestern islands of Japan	TOXICON			English	Article						Protobothrops tokarensis; Venom; Phospholipase A(2) isozymes; Genome; LINE-1; APOBEC	TRIMERESURUS-FLAVOVIRIDIS VENOM; AMINO-ACID-SEQUENCE; PHOSPHOLIPASE A(2); ACCELERATED EVOLUTION; MOLECULAR EVOLUTION; PANCREATIC PHOSPHOLIPASE-A2; STRUCTURAL CHARACTERISTICS; HABU SNAKE; RESOLUTION; PROTEINS	Protobothrops tokarensis (Pt), a Crotalinae snake, inhabits only Takarajima and Kodakarajima islands of the Tokara Islands located in the immediate north of Amami-Oshima island of Japan. Kodakarajima P. tokarensis venom gland cDNA library gave four types of phospholipase A(2) (PLA(2)) cDNAs encoding neutral [Asp(49)]PLA(2), basic [Asp(49)]PLA(2), highly basic [Asp(49)]PLA(2), and [Lys(49)]PLA(2). As the amino acid sequences encoded by their open reading frames (ORFs) were identical to those of PLA(2), PLA-B, PLA-N, and BPI (a [Lys(49)]PLA(2)), respectively, from Amami-Oshima P. flavoviridis (Pf) venom, they were named PtPLA2, PtPLA-B, PtPLA-N, and PtBPI. Chromatography of P. tokarensis venom gave three PLA(2) isozymes, PtPLA2, PtPLA-B, and PtBPI. However, BPII and BPIII ([Lys(49)]PLA(2)s) expressed in Amami-Oshima P. flavoviridis venom were not found in P. tokarensis venom. Genomic polymerase chain reaction (PCR) for P. tokarensis liver DNAs with the unique primers gave PtBPI gene. Notably it was found that LINE (long interspersed nuclear element)-1 fragment is inserted into second intron of PtBPI gene. The LINE-1 fragment may prevent duplication of PtBPI gene and thus formation of plural [Lys(49)]PLA(2) genes in P. tokarensis genome. The interisland variegation of venom [Lys(49)]PLA(2) isozyme genes in Protobothrops genus snakes in the southwestern islands of japan is discussed. (C) 2015 Elsevier Ltd. All rights reserved.	[Yamaguchi, Kazuaki; Chijiwa, Takahito; Yamamura, Takeshi; Ikeda, Naoki; Yatsui, Takayo; Hayama, Setsuko; Ohno, Motonori] Sojo Univ, Fac Biosci, Dept Appl Life Sci, Kumamoto 8600082, Japan; [Hattori, Shosaku] Univ Tokyo, Inst Med Sci, Ooshima, Kagoshima 8941531, Japan; [Oda-Ueda, Naoko] Sojo Univ, Fac Pharmaceut Sci, Dept Biochem, Kumamoto 8600082, Japan	Chijiwa, T (reprint author), Sojo Univ, Fac Biosci, Dept Appl Life Sci, Kumamoto 8600082, Japan.	chijiwa@life.sojo-u.ac.jp			Ministry of Land, Infrastructure, Transport and Tourism of Japan; Ministry of Education, Science, Sports and Culture [26340095]	We thank to Bio-Rad Laboratories Japan (Osaka) who contributed in part to polymorphism analysis. This work was supported by the Ministry of Land, Infrastructure, Transport and Tourism of Japan, Grant-in-Aid (5% to Takahito Chijiwa), and the Ministry of Education, Science, Sports and Culture, Grant-Aid for Science Research (C), 2014-2016 (26340095, Takahito Chijiwa).	BLIN N, 1976, NUCLEIC ACIDS RES, V3, P2303; DIJKSTRA BW, 1981, J MOL BIOL, V147, P97, DOI 10.1016/0022-2836(81)90081-4; DIJKSTRA BW, 1983, J MOL BIOL, V168, P163, DOI 10.1016/S0022-2836(83)80328-3; Tsai IH, 2004, BBA-PROTEINS PROTEOM, V1702, P111, DOI 10.1016/j.bbapap.2004.08.006; Belanger K, 2013, NUCLEIC ACIDS RES, V41, P7438, DOI 10.1093/nar/gkt527; DUFTON MJ, 1983, EUR J BIOCHEM, V137, P545, DOI 10.1111/j.1432-1033.1983.tb07860.x; Osozawa S, 2012, INT GEOL REV, V54, P1369, DOI 10.1080/00206814.2011.639954; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Ohno M, 1998, PROG NUCLEIC ACID RE, V59, P307; KIMURA M, 1969, P NATL ACAD SCI USA, V63, P1181, DOI 10.1073/pnas.63.4.1181; Ikeda T, 2011, NUCLEIC ACIDS RES, V39, P5538, DOI 10.1093/nar/gkr124; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Malik HS, 1999, MOL BIOL EVOL, V16, P793; Yamaguchi Y, 2001, TOXICON, V39, P1069, DOI 10.1016/S0041-0101(00)00250-6; Kordis D, 1998, TOXICON, V36, P1585, DOI 10.1016/S0041-0101(98)00150-0; NAKASHIMA KI, 1995, P NATL ACAD SCI USA, V92, P5605, DOI 10.1073/pnas.92.12.5605; SUZUKI A, 1995, J BIOCHEM-TOKYO, V117, P730; CAVINS JF, 1970, ANAL BIOCHEM, V35, P489, DOI 10.1016/0003-2697(70)90211-3; Kordis D, 1997, EUR J BIOCHEM, V246, P772, DOI 10.1111/j.1432-1033.1997.00772.x; Conticello SG, 2005, MOL BIOL EVOL, V22, P367, DOI 10.1093/molbev/msi026; LIU SY, 1990, J BIOCHEM-TOKYO, V107, P400; YOSHIZUMI K, 1990, TOXICON, V28, P43, DOI 10.1016/0041-0101(90)90005-R; Murakami T, 2009, TOXICON, V54, P399, DOI 10.1016/j.toxicon.2009.05.003; Kinomoto M, 2007, NUCLEIC ACIDS RES, V35, P2955, DOI 10.1093/nar/gkm181; Ikeda N, 2010, GENE, V461, P15, DOI 10.1016/j.gene.2010.04.001; Chijiwa T, 2012, BIOSCI BIOTECH BIOCH, V76, P551, DOI 10.1271/bbb.110848; NAKASHIMA K, 1993, P NATL ACAD SCI USA, V90, P5964, DOI 10.1073/pnas.90.13.5964; Chijiwa T, 2000, BIOCHEM J, V347, P491, DOI 10.1042/0264-6021:3470491; OGAWA T, 1992, P NATL ACAD SCI USA, V89, P8557, DOI 10.1073/pnas.89.18.8557; MARAGANORE JM, 1986, J BIOL CHEM, V261, P4797; Ohno M, 2003, TOXICON, V42, P841, DOI 10.1016/j.toxicon.2003.11.003; KIHARA H, 1992, BIOCHEM INT, V28, P895; Chijiwa T, 2003, J MOL EVOL, V57, P546, DOI 10.1007/s00239-003-2508-4; Castoe TA, 2013, P NATL ACAD SCI USA, V110, P20645, DOI 10.1073/pnas.1314475110; Chijiwa T, 2003, J MOL EVOL, V56, P286, DOI 10.1007/s00239-002-2400-7; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.2307/2408678; Hutchison III C.A, 1989, MOBILE DNA, P593; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lindic N, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-156; Lovin N, 2001, MOL BIOL EVOL, V18, P2213; Naville M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114382; ODA N, 1990, J BIOCHEM-TOKYO, V108, P816; Ohno M, 2002, PERSPECTIVES IN MOLECULAR TOXINOLOGY, P387; RENETSEDER R, 1985, J BIOL CHEM, V260, P1627; SAMBROOK J, 1989, MOL CLONING LAB MANU; Smit A., 1996, REPEATMASKER OPEN 3; Stone K.L., 1989, PRACTICAL GUIDE PROT, P33; Suh A, 2014, GENOME BIOL EVOL, V7, P205	50	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0041-0101			TOXICON	Toxicon	DEC 1	2015	107		B		SI		210	216		10.1016/j.toxicon.2015.08.024		7	Pharmacology & Pharmacy; Toxicology	Pharmacology & Pharmacy; Toxicology	CY6SR	WOS:000366539600006		
J	Choi, H; Ahn, Y				Choi, Hyunsu; Ahn, Yoongho			A study on possibility of commuting trip using private motorized modes in cities around the world: Application of multilevel model	TRANSPORTATION RESEARCH PART D-TRANSPORT AND ENVIRONMENT			English	Article						Commuting trip possibility; Private motorized modes; Disaggregated traffic data in the world; Hierarchical logistic regression model; Principle component analysis	GREAT-BRITAIN; LAND-USE; TRAVEL; CONSUMPTION; OWNERSHIP; EMISSIONS; TRANSPORT; PATTERNS; POLICY; CAR	The focus of the current research was to evaluate how the individual's social characteristics and urban infrastructure impacts the usage of Private Motorized Modes (PMM). Based on individual and urban characteristics a multilevel analysis was conducted on the possibility of commuting trip by private motorized modes on the rush time of 78 cities around the world. Also the selected cities were classified through a principal component analysis, and based on the classification the impact of and urban variables on the possibility of commuting trips made by private motorized modes (POP) was verified. Results showed a diverse range of variables related to the usage of PMM, as well as the urban structure and railway lengths being an important variable in travel behavior. (C) 2015 Elsevier Ltd. All rights reserved.	[Choi, Hyunsu] Korean Railrd Res Inst, Global Mkt Div, Uiwang Si, Gyeonggi Do, South Korea; [Ahn, Yoongho] Ritsumeikan Univ, Coll Sci & Engn, Dept Civil Engn, Kusatsu, Shiga, Japan	Choi, H (reprint author), Korean Railrd Res Inst, Global Mkt Div, 176 Cheoldo Bangmulgwan Ro, Uiwang Si, Gyeonggi Do, South Korea.	hs_choi424@krri.re.kr; ahnyh@fc.ritsumei.ac.jp					KAISER HF, 1974, PSYCHOMETRIKA, V39, P31, DOI 10.1007/BF02291575; Sun X, 1998, TRANSPORT RES REC, P10; Ewing R, 2001, TRANSPORT RES REC, P87; Suryo R, 2007, SOC SCI J, V44, P253, DOI 10.1016/j.soscij.2007.03.012; Kenworthy JR, 1999, TRANSPORT RES A-POL, V33, P691, DOI 10.1016/S0965-8564(99)00006-3; Dargay J, 1999, TRANSPORT RES A-POL, V33, P101, DOI 10.1016/S0965-8564(98)00026-3; Winston C, 2006, J URBAN ECON, V60, P463, DOI 10.1016/j.jue.2006.04.003; Givoni M, 2007, TRANSPORT POLICY, V14, P357, DOI 10.1016/j.tranpol.2007.04.004; George LK, 1996, GERONTOLOGIST, V36, P248; Wang R, 2011, TRANSPORT POLICY, V18, P631, DOI 10.1016/j.tranpol.2011.03.005; He KB, 2005, ENERG POLICY, V33, P1499, DOI 10.1016/j.enpol.2004.01.007; Pucher J, 2005, TRANSP POLICY, V12, P185, DOI 10.1016/j.tranpol.2005.02.008; Giuliano G, 2003, URBAN STUD, V40, P2295, DOI 10.1080/0042098032000123303; Schmocker JD, 2005, TRANSPORT RES REC, P9; Schafer A, 1999, ENERGY, V24, P657, DOI 10.1016/S0360-5442(99)00019-5; Yannis G, 2008, SAFETY SCI, V46, P738, DOI 10.1016/j.ssci.2007.01.014; Guo G, 2000, ANNU REV SOCIOL, V26, P441, DOI 10.1146/annurev.soc.26.1.441; Giuliano G, 2006, TRANSPORT RES A-POL, V40, P106, DOI 10.1016/j.tra.2005.03.002; Litman T, 2007, TRANSPORT POLICY, V14, P94, DOI 10.1016/j.tranpol.2006.09.003; Crane R, 1998, TRANSPORT RES D-TR E, V3, P225, DOI 10.1016/S1361-9209(98)00001-7; Babalik-Sutcliffe E., 2003, J TRANSP GEOGR, V11, P151, DOI 10.1016/S0966-6923(03)00003-6; Baum-Snow N., 2005, BROOKINGS PAPERS URB; Bryk A. S., 1992, HIERARCHICAL LINEAR; Bussiere Y., 1996, REV POPUL LINED, V50, P955; Choi H., 2013, INT J RAILWAY, V6, P33; Choi Hyunsu, 2013, [International Journal of Urban Sciences, 도시과학국제저널], V17, P362, DOI 10.1080/12265934.2013.795754; Choi H., 2011, J INT CITY PLAN, V2011, P263; Chu X., 1994, DOTT9512; Elder G. H., 1985, LIFE COURSE DYNAMICS, P23; Holz-Rau C., 1997, SIEDLUNGSSTRUKTUREN; HOX JJ, 1994, SOCIOL METHOD RES, V22, P283, DOI 10.1177/0049124194022003001; Jang W., 2008, ANN REP 2008; Kenworthy J. R., 1999, INT SOURCEBOOK AUTOM; Kreft I., 1998, INTRO MULTILEVEL MOD; McCann B., 2000, DRIVEN SPEND IMPACT; Morimoto A., 1995, J CITY PLAN I JPN, V30, P685; NEWMAN PWG, 1989, J AM PLANN ASSOC, V55, P24, DOI 10.1080/01944368908975398; Pickup L., 1984, BUILT ENV, V10, P61; Raudenbush S. W., 2002, APPL STAT, V39, P205; Rosenbloom S., 1995, DEMOGRAPHIC SPECIAL; Roux S., 2010, 12 WORLD C TRANSP RE; Stradling S. G., 2005, SOCOTTISH HOUSEHOLD; Suzuki T., 2009, PAP CITY PLAN, V44, P73; Suzuki T., 2011, J CITY PLAN I JPN, V1, P13; Vance C., 2007, 86 ANN M TRANSP RES	45	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1361-9209			TRANSPORT RES D-TR E	Transport. Res. Part D-Transport. Environ.	DEC	2015	41						228	243		10.1016/j.trd.2015.10.008		16	Environmental Studies; Transportation; Transportation Science & Technology	Environmental Sciences & Ecology; Transportation	CY0ET	WOS:000366079900019		
J	Yue, Y; Wang, T; Liang, S; Yang, J; Hou, P; Qu, S; Zhou, J; Jia, XP; Wang, HT; Xu, M				Yue, Ye; Wang, Tao; Liang, Sai; Yang, Jie; Hou, Ping; Qu, Shen; Zhou, Jun; Jia, Xiaoping; Wang, Hongtao; Xu, Ming			Life cycle assessment of High Speed Rail in China	TRANSPORTATION RESEARCH PART D-TRANSPORT AND ENVIRONMENT			English	Article						High Speed Rail; Life cycle assessment; China	FREIGHT TRANSPORTATION; SYSTEMS; LCA	China has built the world's largest High Speed Rail (HSR) network. Its environmental impacts have been examined by the means of life cycle assessment (LCA) which describes the whole picture of the HSR system instead of single stages, with a case study for the highspeed railway that links Beijing and Shanghai. The research employs the China-specific life cycle inventory database Chinese Core Life Cycle Database (CLCD). Vehicle operation dominates most impact categories, while vehicle manufacturing/maintenance/disposal and infrastructure construction contribute mostly to mineral consumption (43% and 38%) and organic compounds in water (54% for infrastructure construction). Several scenarios are developed to explore effects of changes in HSR development, utilization, electricity mix, and infrastructure planning and construction. Suggestions are provided for improving the life cycle environmental performance of China's HSR systems. (C) 2015 Elsevier Ltd. All rights reserved.	[Yue, Ye; Liang, Sai; Hou, Ping; Qu, Shen; Xu, Ming] Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA; [Wang, Tao] Ritsumeikan Univ, Res Org Sci & Engn, Kyoto 5258577, Japan; [Yang, Jie; Wang, Hongtao] Sichuan Univ, Coll Architecture & Environm, Chengdu 610065, Peoples R China; [Zhou, Jun] Cent Univ Finance & Econ, Sch Management Sci & Engn, Beijing 100081, Peoples R China; [Jia, Xiaoping] Qingdao Univ Sci & Technol, Sch Environm & Safety Engn, Qingdao 266042, Peoples R China; [Xu, Ming] Univ Michigan, Dept Civil & Environm Engn, Ann Arbor, MI 48109 USA	Liang, S (reprint author), Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA.	yeyue@umich.edu; a.t.wang@gmail.com; liangsai@umich.edu; yangjie207@gmail.com; pinghou@umich.edu; shenquin@umich.edu; cufezhouj@126.com; jiaxp@qust.edu.cn; wanght.scu@gmail.com; mingxu@umich.edu			Environment Research and Technology Development Fund of the Ministry of the Environment, Japan [S-6-4, 1-1402]; Dow Sustainability Fellows Program	This research was partially supported by the Environment Research and Technology Development Fund (S-6-4 and 1-1402) of the Ministry of the Environment, Japan. Sai Liang and Shen Qu thank the support of the Dow Sustainability Fellows Program.	Lee CK, 2008, WIT TRANS BUILT ENV, V101, P367, DOI 10.2495/UT080361; von Rozycki C, 2003, INT J LIFE CYCLE ASS, V8, P83, DOI 10.1065/lca2003.02.107; Facanha C, 2007, ENVIRON SCI TECHNOL, V41, P7138, DOI 10.1021/es070989q; Spielmann M, 2005, INT J LIFE CYCLE ASS, V10, P325, DOI 10.1065/lca2004.10.188; Facanha C, 2006, INT J LIFE CYCLE ASS, V11, P229, DOI 10.1065/lca2006.02.244; Chang B, 2011, TRANSPORT RES D-TR E, V16, P429, DOI 10.1016/j.trd.2011.04.004; Recchioni M, 2015, INT J LIFE CYCLE ASS, V20, P895, DOI 10.1007/s11367-015-0907-6; Akerman J, 2011, TRANSPORT RES D-TR E, V16, P208, DOI 10.1016/j.trd.2010.12.004; Spielmann M, 2005, INT J LIFE CYCLE ASS, V10, P85, DOI 10.1065/lca.10.181.10; Chester MV, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/2/024008; Chester M, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/3/034012; Chester M, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/1/014003; Chester M.V., 2008, THESIS; Greenhouse Gas Protocol, 2012, CHIN LIF CYCL DAT CL; IKE, 2012, CHIN LIF CYCL DAT; IKE, 2011, CHIN LCA DAT SOFTW D; IKE, 2012, INTR LIF CYCL EN CON; Li Q., 2011, DESIGN ELECT MULTIPL; Li Y., 2007, BEIJING SHANGHAI HSR; Lu Y., 2012, CHINAS HIGH SPEED RA; Miyauchi T., 1999, Q REP RAILWAY TECH I, V40, P204, DOI DOI 10.2219/RTRIQR.40.204; National Bureau of Statistics of China, 2015, ENV STAT DAT; Siemens, 2005, HIGH SPEED TRAIN SET; Ueda H., 1999, Q REP RTRI, V40, P210, DOI 10.2219/rtriqr.40.210; Wang Tao, 2014, J IND ECOL IN PRESS; [杨洁 Yang Jie], 2013, [环境科学研究, Research of Environmental Sciences], V26, P1029	26	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1361-9209			TRANSPORT RES D-TR E	Transport. Res. Part D-Transport. Environ.	DEC	2015	41						367	376		10.1016/j.trd.2015.10.005		10	Environmental Studies; Transportation; Transportation Science & Technology	Environmental Sciences & Ecology; Transportation	CY0ET	WOS:000366079900028		
J	Esfandiari, F; Mashinchian, O; Ashtiani, MK; Ghanian, MH; Hayashi, K; Saei, AA; Mahmoudi, M; Baharvand, H				Esfandiari, Fereshteh; Mashinchian, Omid; Ashtiani, Mohammad Kazemi; Ghanian, Mohammad Hossein; Hayashi, Katsuhiko; Saei, Amir Ata; Mahmoudi, Morteza; Baharvand, Hossein			Possibilities in Germ Cell Research: An Engineering Insight	TRENDS IN BIOTECHNOLOGY			English	Review							PLURIPOTENT STEM-CELLS; RETINOIC ACID; DNA METHYLATION; C-KIT; GROWTH-FACTORS; MOUSE EMBRYOS; IN-VITRO; DIFFERENTIATION; MICE; FATE	Germ cells (GCs) are responsible for fertility and disruptions in their development or function cause infertility. However, current knowledge about the diverse mechanisms involved in GC development and function is still in its infancy. This is mainly because there are low numbers of GCs, especially during embryonic development. A deeper understanding of GCs would enhance our ability to produce them from stem cells. In addition, such information would enable the production of healthy gametes for infertile couples. In this regard, pluripotent stem cells (PSCs) demonstrated a promising ability to produce GCs in vitro. In this review, we highlight recent advances in the field of tissue engineering that suggest novel strategies to enhance GC research.	[Esfandiari, Fereshteh; Ashtiani, Mohammad Kazemi; Ghanian, Mohammad Hossein; Baharvand, Hossein] Royan Inst Stem Cell Biol & Technol, ACECR, Dept Stem Cells, Tehran, Iran; [Esfandiari, Fereshteh; Ashtiani, Mohammad Kazemi; Ghanian, Mohammad Hossein; Baharvand, Hossein] Royan Inst Stem Cell Biol & Technol, ACECR, Dev Biol Cell Sci Res Ctr, Tehran, Iran; [Esfandiari, Fereshteh; Baharvand, Hossein] Univ Sci & Culture, ACECR, Dept Dev Biol, Tehran, Iran; [Mashinchian, Omid] Nestle Inst Hlth Sci, Lausanne, Switzerland; [Mashinchian, Omid] Ecole Polytech Fed Lausanne, Sch Life Sci, Inst Bioengn, CH-1015 Lausanne, Switzerland; [Hayashi, Katsuhiko] Kyushu Univ, Fac Med Sci, Dept Dev Stem Cell Biol, Fukuoka 812, Japan; [Saei, Amir Ata] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden; [Mahmoudi, Morteza] Univ Tehran Med Sci, Fac Pharm, Nanotechnol Res Ctr, Tehran, Iran; [Mahmoudi, Morteza] Univ Tehran Med Sci, Fac Pharm, Dept Nanotechnol, Tehran, Iran; [Mahmoudi, Morteza] Stanford Univ, Sch Med, Cardiovasc Inst, Stanford, CA 94305 USA; [Mahmoudi, Morteza] Stanford Univ, Sch Med, Div Cardiovasc Med, Stanford, CA 94305 USA	Baharvand, H (reprint author), Royan Inst Stem Cell Biol & Technol, ACECR, Dept Stem Cells, Tehran, Iran.	baharvand@royaninstitute.org			Royan Institute; Iranian Council of Stem Cell Research and Technology; Iran National Science Foundation (INSF)	This work was supported by a grant provided from Royan Institute, Iranian Council of Stem Cell Research and Technology, the Iran National Science Foundation (INSF).	Richardson BE, 2010, NAT REV MOL CELL BIO, V11, P37, DOI 10.1038/nrm2815; Kirby GTS, 2011, POLYMERS-BASEL, V3, P571, DOI 10.3390/polym3010571; Huang GY, 2012, BIOFABRICATION, V4, DOI 10.1088/1758-5082/4/4/042001; Frum T, 2015, TRENDS GENET, V31, P402, DOI 10.1016/j.tig.2015.04.002; Easley CA, 2012, CELL REP, V2, P440, DOI 10.1016/j.celrep.2012.07.015; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; Kurimoto K, 2008, CELL CYCLE, V7, P3514, DOI 10.4161/cc.7.22.6979; Maia J, 2011, ACS NANO, V5, P97, DOI 10.1021/nn101724r; Yun H, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/2/022001; Flaim CJ, 2008, STEM CELLS DEV, V17, P29, DOI 10.1089/scd.2007.0085; Saitou M, 2010, REPRODUCTION, V139, P931, DOI 10.1530/REP-10-0043; Singh SR, 2011, J CELL MOL MED, V15, P468, DOI 10.1111/j.1582-4934.2010.01242.x; Masters KS, 2011, MACROMOL BIOSCI, V11, P1149, DOI 10.1002/mabi.201000505; Santos T, 2012, ACS NANO, V6, P10463, DOI 10.1021/nn304541h; Aguilar CA, 2013, NAT NANOTECHNOL, V8, P709, DOI 10.1038/nnano.2013.195; Eguizabal C, 2009, DIFFERENTIATION, V78, P116, DOI 10.1016/j.diff.2009.07.001; Barrios F, 2010, J CELL SCI, V123, P871, DOI 10.1242/jcs.057968; Li MWM, 2009, CYTOKINE GROWTH F R, V20, P329, DOI 10.1016/j.cytogfr.2009.07.007; Bratt-Leal AM, 2013, BIOMATERIALS, V34, P7227, DOI 10.1016/j.biomaterials.2013.05.079; Qian Y, 2013, DEVELOPMENT, V140, P1751, DOI 10.1242/dev.093641; Lee NPY, 2004, HUM REPROD UPDATE, V10, P349, DOI 10.1093/humupd/dmh026; Aramaki S, 2013, DEV CELL, V27, P516, DOI 10.1016/j.devcel.2013.11.001; Rivera RM, 2013, PROG BIOPHYS MOL BIO, V113, P423, DOI 10.1016/j.pbiomolbio.2013.02.001; Hayashi Y, 2012, FERTIL STERIL, V97, P1250, DOI 10.1016/j.fertnstert.2012.04.037; Ku B, 2013, LANGMUIR, V29, P9857, DOI 10.1021/la4015543; Schrans-Stassen BHGJ, 1999, ENDOCRINOLOGY, V140, P5894, DOI 10.1210/en.140.12.5894; Guibert S, 2012, GENOME RES, V22, P633, DOI 10.1101/gr.130997.111; Pellegrini M, 2008, CELL CYCLE, V7, P3878, DOI 10.4161/cc.7.24.7262; Paulo CSO, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/49/494002; Flaim CJ, 2005, NAT METHODS, V2, P119, DOI 10.1038/NMETH736; Duester G, 2013, SEMIN CELL DEV BIOL, V24, P694, DOI 10.1016/j.semcdb.2013.08.001; Sachlos E, 2008, BIOMATERIALS, V29, P4471, DOI 10.1016/j.biomaterials.2008.08.012; Sackmann EK, 2014, NATURE, V507, P181, DOI 10.1038/nature13118; Kubota H, 2004, P NATL ACAD SCI USA, V101, P16489, DOI 10.1073/pnas.0407063101; Ma XS, 2014, GENET MOL RES, V13, P8632, DOI 10.4238/2014.October.27.2; Bowles J, 2006, SCIENCE, V312, P596, DOI 10.1126/science.1125691; Richards M, 2010, FERTIL STERIL, V93, P986, DOI 10.1016/j.fertnstert.2008.10.030; Sugimoto R, 2012, MECH DEVELOP, V128, P610, DOI 10.1016/j.mod.2011.12.003; Hubner K, 2003, SCIENCE, V300, P1251, DOI 10.1126/science.1083452; Carpenedo RL, 2010, J BIOMED MATER RES A, V94A, P466, DOI 10.1002/jbm.a.32710; Kee K, 2006, STEM CELLS DEV, V15, P831, DOI 10.1089/scd.2006.15.831; Hayashi K, 2007, SCIENCE, V316, P394, DOI 10.1126/science.1137545; Seisenberger S, 2012, MOL CELL, V48, P849, DOI 10.1016/j.molcel.2012.11.001; Wylie RG, 2011, NAT MATER, V10, P799, DOI [10.1038/nmat3101, 10.1038/NMAT3101]; Toyooka Y, 2003, P NATL ACAD SCI USA, V100, P11457, DOI 10.1073/pnas.1932826100; Oana H, 2014, LAB CHIP, V14, P696, DOI 10.1039/c3lc51111a; Pontani LL, 2012, P NATL ACAD SCI USA, V109, P9839, DOI 10.1073/pnas.1201499109; Ramathal C, 2014, CELL REP, V7, P1284, DOI 10.1016/j.celrep.2014.03.067; BRANNAN CI, 1992, GENE DEV, V6, P1832, DOI 10.1101/gad.6.10.1832; Wilkinson AE, 2014, J BIOMED MATER RES A, V102, P3419, DOI 10.1002/jbm.a.35001; Solorio LD, 2012, J CONTROL RELEASE, V158, P224, DOI 10.1016/j.jconrel.2011.11.003; Carpenedo RL, 2009, BIOMATERIALS, V30, P2507, DOI 10.1016/j.biomaterials.2009.01.007; Sabour D, 2012, CURR OPIN CELL BIOL, V24, P716, DOI 10.1016/j.ceb.2012.08.006; Beaujean N, 2014, MOL REPROD DEV, V81, P100, DOI 10.1002/mrd.22268; Lane N, 2003, GENESIS, V35, P88, DOI 10.1002/gene.10168; Bratt-Leal AM, 2011, BIOMATERIALS, V32, P48, DOI 10.1016/j.biomaterials.2010.08.113; Geens M, 2011, J ASSIST REPROD GEN, V28, P471, DOI 10.1007/s10815-011-9541-9; Saitou M, 2012, DEVELOPMENT, V139, P15, DOI 10.1242/dev.050849; Zhao GQ, 2002, DEV CELL, V2, P537, DOI 10.1016/S1534-5807(02)00173-9; Anderson R, 2000, MECH DEVELOP, V91, P61, DOI 10.1016/S0925-4773(99)00271-3; Chen C, 2005, NATURE, V436, P1030, DOI 10.1038/nature03894; Wang F, 2011, ACS NANO, V5, P3679, DOI 10.1021/nn200007z; Raverdeau M, 2012, P NATL ACAD SCI USA, V109, P16582, DOI 10.1073/pnas.1214936109; Ikami K, 2015, DEVELOPMENT, V142, P1582, DOI 10.1242/dev.118695; Albanesi C, 1996, DEVELOPMENT, V122, P1291; Hayashi K, 2012, SCIENCE, V338, P971, DOI 10.1126/science.1226889; Park TS, 2009, STEM CELLS, V27, P783, DOI 10.1002/stem.13; Ronen M, 2014, LAB CHIP, V14, P2354, DOI 10.1039/c4lc00150h; Qutachi O, 2013, J CONTROL RELEASE, V168, P18, DOI 10.1016/j.jconrel.2013.02.029; Ertl P, 2014, TRENDS BIOTECHNOL, V32, P245, DOI 10.1016/j.tibtech.2014.03.004; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Perry JM, 2007, CELL, V129, P1045, DOI 10.1016/j.cell.2007.05.053; West FD, 2008, STEM CELLS, V26, P2768, DOI 10.1634/stemcells.2008-0124; Guo F, 2013, LAB CHIP, V13, P3152, DOI 10.1039/c3lc90067c; JEGOU B, 1993, INT REV CYTOL, V147, P25, DOI 10.1016/S0074-7696(08)60766-4; De A, 2014, BIOMICROFLUIDICS, V8, DOI 10.1063/1.4899059; Geljsen N., 2004, NATURE, V427, P148; Gu Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025984; Irie N, 2015, CELL, V160, P253, DOI 10.1016/j.cell.2014.12.013; Kador KE, 2014, ACTA BIOMATER, V10, P4939, DOI 10.1016/j.actbio.2014.08.032; Kerr GE, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.112.105809; Kobel S., 2010, BIOTECHNIQUES, V48, P9; Nayernia K, 2006, DEV CELL, V11, P125, DOI 10.1016/j.devcel.2006.05.010; Saiz N, 2013, REPRODUCTION, V145, pR65, DOI 10.1530/REP-12-0381; Soen Y, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100076; Sun Y, 2015, NAT METHODS, V12, P134, DOI 10.1038/nmeth.3210; Tabata Y, 2014, BIOMATER SCI-UK, V2, P176, DOI 10.1039/c3bm60183h; Yoshlhiro I., 2008, SOFT MATTER, V4, P46; Zhang L, 2013, BMC DEV BIOL, V13, DOI 10.1186/1471-213X-13-38; Zhang L, 2011, SPERMATOGENESIS, V1, P186, DOI DOI 10.4161/SPMG.1.3.17760; Zou JJ, 2011, J CARDIOTHORAC SURG, V6, DOI 10.1186/1749-8090-6-69	91	0	0	ELSEVIER SCIENCE LONDON	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0167-7799			TRENDS BIOTECHNOL	Trends Biotechnol.	DEC	2015	33	12					735	746		10.1016/j.tibtech.2015.09.004		12	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CZ0AV	WOS:000366768400004		
J	Kondo, H				Kondo, Hiroyuki			A Review of Research on Chou-I in Japan During the Past Fifty Years	UNIVERSITAS-MONTHLY REVIEW OF PHILOSOPHY AND CULTURE			Chinese	Article						I Ching; Chou-I; Formation of Chou-I; Research on Chou-I in Japan; Mawangdui Zhouyi; "Yao"		Since the middle of the twentieth century, "formation of Chou-I as confucian canon" has become a major topic among Japanese scholars. This topic was firstly discussed by Naito Konan, followed by Takeuchi Yoshio, Kanaya Osamu Honda Wataru, Uchiyama Toshihiko other famous scholars. On this issue, the Japanese scholars tends to hold similar views: Formation of Chou-I as confucian canon was proceeded in Qin and Han dynasties, and its formation was subserved by "to burn books and bury scholars". Since the discovery of the Mawangdui Silk Books in 1973, new historical materials were made public in succession, and gave rise to a new perspective on the "formation of Chou-I as confucian canon", that caused confrontation, for example, between Japanese two famous scholar Ikeda Tomohisa and AsanoYuichi.	[Kondo, Hiroyuki] Hokkaido Univ, Grad Sch Letters, Sapporo, Hokkaido 060, Japan	Kondo, H (reprint author), Hokkaido Univ, Grad Sch Letters, Sapporo, Hokkaido 060, Japan.	kondohy@let.hokudai.ac.jp						0	0	0	UNIVERSITAS	TAIPEI	106 NO 96 LE-LI RD, DA AN DISTRICT, TAIPEI, 10668, TAIWAN	1015-8383			UNIVERSITAS-TAIWAN	UNIVERSITAS-Mon. Rev. Philos. Cult.	DEC	2015	42	12					55	74				20	Philosophy	Philosophy	CZ1PE	WOS:000366877000005		
J	Li, GY; Nie, X; Chen, JY; Jiang, Q; An, TC; Wong, PK; Zhang, HM; Zhao, HJ; Yamashita, H				Li, Guiying; Nie, Xin; Chen, Jiangyao; Jiang, Qi; An, Taicheng; Wong, Po Keung; Zhang, Haimin; Zhao, Huijun; Yamashita, Hiromi			Enhanced visible-light-driven photocatalytic inactivation of Escherichia coli using g-C3N4/TiO2 hybrid photocatalyst synthesized using a hydrothermal-calcination approach	WATER RESEARCH			English	Article						Water disinfection; Photocatalytic inactivation; g-C3N4/TiO2; Escherichia coli K-12; Visible light irradiation	GRAPHITIC CARBON NITRIDE; DISINFECTION BY-PRODUCTS; DOMESTIC WASTE-WATER; PHOTOELECTROCATALYTIC DEGRADATION; BACTERIAL INACTIVATION; HYDROGEN EVOLUTION; E.-COLI; TIO2; IRRADIATION; UV	Biohazards are widely present in wastewater, and contaminated water can arouse various waterborne diseases. Therefore, effectively removing biohazards from water is a worldwide need. In this study, a novel visible-light-driven (VLD) graphitic carbon nitride (g-C3N4)/TiO2 hybrid photocatalyst with high photocatalytic bacterial inactivation activity was successfully synthesized using a facile hydrothermal-calcination approach. The optimum synthesized hybrid photocatalyst is composed of micron-sized TiO2 spheres (average diameter: ca. 2 mu m) and wrapped with lamellar g-C3N4 (thickness: ca. 2 nm), with narrowing bandgap (ca. 2.48 eV), leading to a significant improvement of visible light (VL) absorption and effective separation of photo-generated electron-hole pairs. This greatly enhances VL photocatalytic inactivation activity towards bacteria in water. Using this hybrid photocatalyst, 10(7) cfu mL(-1) of Escherichia coli K-12 could be completely inactivated within 180 min under VL irradiation. SEM images indicate that bacterial cells were greatly damaged, leading to a severe leakage of intracellular components during photocatalytic inactivation processes. The study concludes that bacterial cell destruction and water disinfection can be achieved using this newly fabricated VLD hybrid photocatalyst (c) 2015 Elsevier Ltd. All rights reserved.	[Li, Guiying; Nie, Xin; Chen, Jiangyao; Jiang, Qi; An, Taicheng] Chinese Acad Sci, Guangzhou Inst Geochem, State Key Lab Organ Geochem, Guangzhou 510640, Guangdong, Peoples R China; [Li, Guiying; Nie, Xin; Chen, Jiangyao; Jiang, Qi; An, Taicheng] Chinese Acad Sci, Guangzhou Inst Geochem, Guangdong Key Lab Environm Protect & Resources Ut, Guangzhou 510640, Guangdong, Peoples R China; [Wong, Po Keung] Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China; [Zhang, Haimin; Zhao, Huijun] Griffith Univ, Ctr Clean Environm & Energy, Southport, Qld 4222, Australia; [Yamashita, Hiromi] Osaka Univ, Grad Sch Engn, Div Mat & Mfg Sci, Suita, Osaka 5650871, Japan; [Nie, Xin; Jiang, Qi] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	An, TC (reprint author), Chinese Acad Sci, Guangzhou Inst Geochem, State Key Lab Organ Geochem, Guangzhou 510640, Guangdong, Peoples R China.	antc99@gig.ac.cn	An, Taicheng/F-5128-2013; Li, Guiying/I-1370-2014	An, Taicheng/0000-0001-6918-8070; Li, Guiying/0000-0002-6777-4786	National Natural Science Funds for Distinguished Young Scholars [41425015]; NSFC [21077104, 41373103]; Research Grant Council; Hong Kong SAR Government [476811]; Earmarked Fund of SKLOG [SKLOG2011A02]	This is contribution No. IS-2064 from GIGCAS. This work was supported by National Natural Science Funds for Distinguished Young Scholars (41425015), NSFC (21077104 and 41373103), Research Grant Council, Hong Kong SAR Government (476811) and Earmarked Fund of SKLOG (SKLOG2011A02).	Munoz-Batista MJ, 2015, APPL CATAL B-ENVIRON, V164, P261, DOI 10.1016/j.apcatb.2014.09.037; Wang XC, 2009, NAT MATER, V8, P76, DOI [10.1038/nmat2317, 10.1038/NMAT2317]; Rietveld LC, 2011, WATER SCI TECHNOL, V64, P1540, DOI 10.2166/wst.2011.037; Yan SC, 2010, DALTON T, V39, P1488, DOI 10.1039/b914110c; Haaken D, 2014, WATER RES, V52, P20, DOI 10.1016/j.watres.2013.12.029; Dobrowsky PH, 2014, APPL ENVIRON MICROB, V80, P2307, DOI 10.1128/AEM.04130-13; An TC, 2015, APPL CATAL B-ENVIRON, V164, P279, DOI 10.1016/j.apcatb.2014.09.009; Zhang L, 2014, J MATER CHEM A, V2, P2071, DOI 10.1039/c3ta14047d; Li YG, 2010, J PHYS CHEM B, V114, P9429, DOI 10.1021/jp103729c; Sun JX, 2012, DALTON T, V41, P6756, DOI 10.1039/c2dt12474b; Wang WJ, 2012, ENVIRON SCI TECHNOL, V46, P4599, DOI 10.1021/es2042977; Eischeid AC, 2011, CRIT REV ENV SCI TEC, V41, P1375, DOI 10.1080/10643381003608268; Cui YJ, 2011, J MATER CHEM, V21, P13032, DOI 10.1039/c1jm11961c; Sun HW, 2014, ENVIRON SCI TECHNOL, V48, P9412, DOI 10.1021/es502471h; Rodriguez C, 2009, INT J ENV RES PUB HE, V6, P1174, DOI 10.3390/ijerph6031174; Boonprakob N, 2014, J COLLOID INTERF SCI, V417, P402, DOI 10.1016/j.jcis.2013.11.072; Anastasi EM, 2013, WATER RES, V47, P6670, DOI 10.1016/j.watres.2013.09.008; Ge SX, 2011, ENVIRON SCI TECHNOL, V45, P3027, DOI 10.1021/es103773g; Ge L, 2012, J PHYS CHEM C, V116, P13708, DOI 10.1021/jp3041692; Zhou XS, 2011, CHEM COMMUN, V47, P10323, DOI 10.1039/c1cc13862f; Zhang JS, 2012, ANGEW CHEM INT EDIT, V51, P3183, DOI 10.1002/anie.201106656; Zuluaga S, 2015, PHYS CHEM CHEM PHYS, V17, P957, DOI 10.1039/c4cp05164e; Dorevitch S, 2012, ENVIRON HEALTH PERSP, V120, P192, DOI 10.1289/ehp.1103934; Fang HS, 2013, ENVIRON SCI TECHNOL, V47, P2704, DOI 10.1021/es304898r; Mitoraj D, 2008, ANGEW CHEM INT EDIT, V47, P9975, DOI 10.1002/anie.200800304; Xiong LB, 2015, ELECTROCHIM ACTA, V153, P583, DOI 10.1016/j.electacta.2014.11.169; Parker KM, 2014, ENVIRON SCI TECHNOL, V48, P11161, DOI 10.1021/es5028184; Rengifo-Herrera JA, 2008, APPL CATAL B-ENVIRON, V84, P448, DOI 10.1016/j.apcatb.2008.04.030; Ruales-Lonfat C, 2014, APPL CATAL B-ENVIRON, V160, P286, DOI 10.1016/j.apcatb.2014.05.001; Su FZ, 2010, J AM CHEM SOC, V132, P16299, DOI 10.1021/ja102866p; Wang WJ, 2013, ENVIRON SCI TECHNOL, V47, P8724, DOI 10.1021/es4013504; Zhang YJ, 2010, J AM CHEM SOC, V132, P6294, DOI 10.1021/ja101749y; Chen YM, 2011, ENVIRON SCI TECHNOL, V45, P5689, DOI 10.1021/es200778p; Santaella C, 2014, ENVIRON SCI TECHNOL, V48, P5245, DOI 10.1021/es500216t; Ong WJ, 2015, CHEM COMMUN, V51, P858, DOI 10.1039/c4cc08996k; Shi HX, 2015, J PHYS CHEM B, V119, P3104, DOI 10.1021/jp511201w; Zhao HX, 2014, APPL CATAL B-ENVIRON, V152, P46, DOI 10.1016/j.apcatb.2014.01.023; Yan SC, 2010, LANGMUIR, V26, P3894, DOI 10.1021/la904023j; Huang JH, 2014, CHEM COMMUN, V50, P4338, DOI 10.1039/c3cc48374f; Foster HA, 2011, APPL MICROBIOL BIOT, V90, P1847, DOI 10.1007/s00253-011-3213-7; Nie X, 2013, J CHEM TECHNOL BIOT, V88, P1488, DOI 10.1002/jctb.3992; Wang YJ, 2011, ENERG ENVIRON SCI, V4, P2922, DOI 10.1039/c0ee00825g; Wu DH, 2011, J PHOTOCH PHOTOBIO A, V217, P177, DOI 10.1016/j.jphotochem.2010.10.006; Wang Y, 2012, ANGEW CHEM INT EDIT, V51, P68, DOI 10.1002/anie.201101182; Li GY, 2013, APPL CATAL B-ENVIRON, V140, P225, DOI 10.1016/j.apcatb.2013.04.004; Wang PH, 2011, WATER RES, V45, P5015, DOI 10.1016/j.watres.2011.07.002; Chowdhury S, 2013, J WATER REUSE DESAL, V3, P297, DOI 10.2166/wrd.2013.082; AWWA, 1995, WAT TREATM PRINC PRA; Kubacka A., 2014, SCI REP, V4, P9; Li GY, 2015, CATAL TODAY, V242, P363, DOI 10.1016/j.cattod.2014.04.029; Sharma VK, 2014, J ENVIRON SCI HEAL B, V49, P212, DOI 10.1080/03601234.2014.858576; Soller JA, 2014, WATER RES, V66, P254, DOI 10.1016/j.watres.2014.08.026	52	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0043-1354			WATER RES	Water Res.	DEC 1	2015	86				SI		17	24		10.1016/j.watres.2015.05.053		8	Engineering, Environmental; Environmental Sciences; Water Resources	Engineering; Environmental Sciences & Ecology; Water Resources	CY7VV	WOS:000366618300004		
J	Hao, XD; Furumai, H; Chen, GH				Hao, Xiaodi; Furumai, Hiroaki; Chen, Guanghao			Resource recovery: Efficient approaches to sustainable water and wastewater treatment	WATER RESEARCH			English	Editorial Material									[Hao, Xiaodi] Beijing Univ Civil Engn & Architecture, Beijing, Peoples R China; [Furumai, Hiroaki] Univ Tokyo, Tokyo 1138654, Japan; [Chen, Guanghao] Hong Kong Univ Sci & Technol, Hong Kong, Hong Kong, Peoples R China	Hao, XD (reprint author), Beijing Univ Civil Engn & Architecture, Beijing, Peoples R China.	haoxiaodi@bucea.edu.cn						0	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0043-1354			WATER RES	Water Res.	DEC 1	2015	86				SI		83	84		10.1016/j.watres.2015.10.063		2	Engineering, Environmental; Environmental Sciences; Water Resources	Engineering; Environmental Sciences & Ecology; Water Resources	CY7VV	WOS:000366618300011		
J	An, KJ; Lam, YF; Hao, S; Morakinyo, TE; Furumai, H				An, Kyoung Jin; Lam, Yun Fat; Hao, Song; Morakinyo, Tobi Eniolu; Furumai, Hiroaki			Multi-purpose rainwater harvesting for water resource recovery and the cooling effect	WATER RESEARCH			English	Article						Rainwater harvesting; Miscellaneous water supplies; Toilet flushing; Rain garden; Cooling effect	URBAN; MODEL	The potential use of rainwater harvesting in conjunction with miscellaneous water supplies and a rooftop garden with rainwater harvesting facility for temperature reduction have been evaluated in this study for Hong Kong. Various water applications such as toilet flushing and areal climate controls have been systematically considered depending on the availability of seawater toilet flushing using the Geographic Information System (GIS). For water supplies, the district Area Precipitation per Demand Ratio (APDR) has been calculated to quantify the rainwater utilization potential of each administrative district in Hong Kong. Districts with freshwater toilet flushing prove to have higher potential for rainwater harvest and utilization compared to the areas with seawater toilet flushing. Furthermore, the effectiveness of using rainwater harvesting for miscellaneous water supplies in Hong Kong and Tokyo has been analyzed and compared; this revives serious consideration of diurnal and seasonal patterns of rainfall in applying such technology. In terms of the cooling effect, the implementation of a rooftop rainwater harvesting garden has been evaluated using the ENVI-met model. Our results show that a temperature drop of 1.3 degrees C has been observed due to the rainwater layer in the rain garden. This study provides valuable insight into the applicability of the rainwater harvesting for sustainable water management practice in a highly urbanized city. (c) 2015 Elsevier Ltd. All rights reserved.	[An, Kyoung Jin; Lam, Yun Fat; Hao, Song; Morakinyo, Tobi Eniolu] City Univ Hong Kong, Sch Energy & Environm, Kowloon, Hong Kong, Peoples R China; [Lam, Yun Fat] City Univ Hong Kong, Guy Carpenter Asia Pacific Climate Impact Ctr, Kowloon, Hong Kong, Peoples R China; [Furumai, Hiroaki] Univ Tokyo, Res Ctr Water Environm Technol, Tokyo 1138656, Japan	An, KJ (reprint author), City Univ Hong Kong, Sch Energy & Environm, Tat Chee Ave, Kowloon, Hong Kong, Peoples R China.	alicia.kjan@cityu.edu.hk		An, Kyoung Jin/0000-0003-0041-2817	Guy Carpenter Asia-Pacific Climate Impact Centre [9360126]; City University of Hong Kong	The work described in this paper is partly funded by the Guy Carpenter Asia-Pacific Climate Impact Centre (project no. 9360126) and the Research Studentship of City University of Hong Kong.	Zhang Y, 2009, J ENVIRON MANAGE, V91, P222, DOI 10.1016/j.jenvman.2009.08.008; Ahmed W, 2014, WATER RES, V53, P361, DOI 10.1016/j.watres.2013.12.021; Marlow DR, 2013, WATER RES, V47, P7150, DOI 10.1016/j.watres.2013.07.046; Willuweit L, 2013, WATER RES, V47, P7206, DOI 10.1016/j.watres.2013.09.060; Agudelo-Vera CM, 2013, WATER RES, V47, P7287, DOI 10.1016/j.watres.2013.10.040; Bruse M, 1998, ENVIRON MODELL SOFTW, V13, P373, DOI 10.1016/S1364-8152(98)00042-5; Tian YH, 2012, URBAN FOR URBAN GREE, V11, P223, DOI 10.1016/j.ufug.2012.03.003; van Roon M, 2007, J ENVIRON MANAGE, V83, P437, DOI 10.1016/j.jenvman.2006.04.008; Peng LLH, 2013, ENERGIES, V6, P598, DOI 10.3390/en6020598; Ng E, 2012, BUILD ENVIRON, V47, P256, DOI 10.1016/j.buildenv.2011.07.014; Booth CA, 2014, WATER RESOURCES IN THE BUILT ENVIRONMENT: MANAGEMENT ISSUES AND SOLUTIONS, P1, DOI 10.1002/9781118809167; Bureau of Waterworks Tokyo Metropolitan Government, 2014, WAT SUPPL TOK PROV E; Hong Kong Observatory, CLIM HONG KONG; Huttner S., 2009, 7 INT C URB CLIM, V29; Japan Meteorological Agency, CLIM JAP; Kim J, 2013, CASE REPORT MED, V2013, P1; Moavenzadeh E, 2002, FUTURE CITIES DYNAMI; Patterson T., 2014, NOT DROP DRINK HONG; Water Suppliy Department, 2008, TOT WAT MAN HONG KON	19	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0043-1354			WATER RES	Water Res.	DEC 1	2015	86				SI		116	121		10.1016/j.watres.2015.07.040		6	Engineering, Environmental; Environmental Sciences; Water Resources	Engineering; Environmental Sciences & Ecology; Water Resources	CY7VV	WOS:000366618300015		
J	Hana, T; Tanaka, S; Shin, M; Mukasa, A; Kugasawa, K; Saito, N				Hana, Taijun; Tanaka, Shota; Shin, Masahiro; Mukasa, Akitake; Kugasawa, Kazuha; Saito, Nobuhito			Neuroendoscopic Ventriculocisternostomy with Stent Placement for Trapped Temporal Horn After the Resection of Glioblastoma	WORLD NEUROSURGERY			English	Article						Glioblastoma; Hydrocephalus; Neuroendoscope; Stent placement; Trapped temporal horn; Ventriculostomy	HYDROCEPHALUS; SHUNT; 4TH-VENTRICLE; FENESTRATION; ENTRAPMENT	BACKGROUND: Endoscopic ventriculostomy is an attractive surgical alternative to ventriculoperitoneal shunt in the treatment of focal hydrocephalus, including trapped temporal horn (TTH). The major concern of this surgical approach is closure of a stoma, the risk of which may be minimized by placement of a stent after ventriculostomy. CASE DESCRIPTION: The authors report a case of a 60-year-old man with glioblastoma in the corpus callosum and the parietal lobe who developed TTH after partial tumor resection. After the failure of a ventriculoperitoneal shunt, endoscopic ventriculocisternostomy was chosen over the revision of the shunt. A stoma was placed at the medial wall of the dilated temporal horn. Endoscopic inspection confirmed communication with the interpeduncular cistern, but the collapsed lateral ventricle after fenestration suggested the risk of stoma closure. Therefore, a ventricular tube was placed through the stoma as a stent to secure its flow. No further surgical intervention was needed, and the patient was able to complete radiochemotherapy without cessation. CONCLUSIONS: The risk of recurrence of TTH after endoscopic ventriculocisternostomy may be minimized by combining ventriculostomy with stent placement. This surgical procedure would be beneficial, particularly in cases of TTH associated with malignant brain tumors, where the risk of delay or interruption of adjuvant oncologic treatments may negatively impact patient prognosis.	[Hana, Taijun; Tanaka, Shota; Shin, Masahiro; Mukasa, Akitake; Kugasawa, Kazuha; Saito, Nobuhito] Tokyo Univ Hosp, Fac Med, Dept Neurosurg, Tokyo 113, Japan	Tanaka, S (reprint author), Tokyo Univ Hosp, Fac Med, Dept Neurosurg, Tokyo 113, Japan.	tanakas-tky@umin.ac.jp					Hervey-Jumper SL, 2010, J NEUROSURG, V112, P410, DOI 10.3171/2009.3.JNS081423; Shin M, 2000, J NEUROSURG, V92, P1036, DOI 10.3171/jns.2000.92.6.1036; Aldana PR, 2003, PEDIATR NEUROSURG, V38, P286, DOI 10.1159/000070412; MAURICEWILLIAMS RS, 1986, J NEUROL NEUROSUR PS, V49, P238, DOI 10.1136/jnnp.49.3.238; Krahenbuhl AK, 2013, J NEUROSURG-PEDIATR, V11, P568, DOI 10.3171/2013.2.PEDS12417; Gliemroth J, 2014, CLIN NEUROL NEUROSUR, V122, P92, DOI 10.1016/j.clineuro.2014.03.022; Parrent AG, 2000, J NEUROSURG, V93, P891, DOI 10.3171/jns.2000.93.5.0891; Sagan LM, 2006, J NEUROSURG, V105, P275, DOI 10.3171/ped.2006.105.4.275; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Teo C, 2004, NEUROSURG CLIN N AM, V15, P89, DOI 10.1016/S1042-3680(03)00068-8; Schroeder HWS, 2008, NEUROSURGERY, V62, P1084, DOI [10.1227/01.neu.0000333774.81563.d8, 10.1227/01.NEU.0000249242.17805.E3]; Fritsch MJ, 2004, CHILD NERV SYST, V20, P137, DOI 10.1007/s00381-003-0860-8; Chen CC, 2013, WORLD NEUROSURG, V79; Schroeder HW, 2013, WORLD NEUROSURG, V79; Teo C, 1999, NEUROSURGERY, V44, P1261; Teo C, 1999, NEUROSURGERY, V44, P1257	16	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	DEC	2015	84	6							2078.e5	10.1016/j.wneu.2015.08.019		4	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CY3CQ	WOS:000366286300111		
J	Murai, Y; Ishisaka, E; Tsukiyama, A; Matano, F; Morita, A				Murai, Yasuo; Ishisaka, Eitaro; Tsukiyama, Atsushi; Matano, Fumihiro; Morita, Akio			Internal Carotid Artery Aneurysm Anomalously Originating from the Posterior Communicating Artery	WORLD NEUROSURGERY			English	Article						Carotid artery; Cerebral aneurysm; Paraclinoid aneurysm; Posterior communicating artery	UNRUPTURED INTRACRANIAL ANEURYSMS; ENDOVASCULAR TREATMENT; PARACLINOID ANEURYSMS; NATURAL-HISTORY	BACKGROUND: We report a case of an internal carotid artery (ICA) aneurysm anomalously originating from the posterior communicating artery (PComA). CASE DESCRIPTION: Preoperative radiologic findings revealed a paraclinoid carotid artery aneurysm at the level of the distal dural ring. Because of the low rupture risk, there are no treatment indications for small paraclinoid or ICA-superior hypophyseal artery unruptured aneurysms. In this case, because of the patient's age and the irregular shape of the aneurysm, treatment was considered necessary. Intraoperative findings using microscopic and endoscopic angiography showed that the aneurysm originated from the proximal branched PComA. The PComA originated from the same level as the ophthalmic artery, and the superior hypophyseal artery originated from the distal side of the PComA. CONCLUSIONS: According to numerous reports, small incidental paraclinoid aneurysms have a lower risk of rupture and growth than PComA aneurysms. Preoperative radiologic examination of unruptured small aneurysms was performed using magnetic resonance angiography and three-dimensional computed tomography angiography. Because the ability of magnetic resonance angiography and three-dimensional computed tomography angiography to detect small branches of the ICA is inferior to digital subtraction angiography, the location of an unruptured ICA aneurysm should be evaluated with other diagnostic modalities besides magnetic resonance angiography and three-dimensional computed tomography angiography.	[Murai, Yasuo; Ishisaka, Eitaro; Tsukiyama, Atsushi; Matano, Fumihiro; Morita, Akio] Nippon Med Sch, Dept Neurol Surg, Tokyo 113, Japan	Murai, Y (reprint author), Nippon Med Sch, Dept Neurol Surg, 1-1-5 Sendagi, Tokyo 113, Japan.	ymurai@nms.ac.jp					Hoh BL, 2001, NEUROSURGERY, V48, P78, DOI 10.1097/00006123-200101000-00014; Lee HW, 2013, J KOREAN NEUROSURG S, V54, P14, DOI 10.3340/jkns.2013.54.1.14; He WZ, 2010, J NEUROSURG, V112, P611, DOI 10.3171/2009.8.JNS08731; Wiebers D, 2003, LANCET, V362, P103, DOI 10.1016/S0140-6736(03)13860-3; Jeon JS, 2014, J NEUROL NEUROSUR PS, V85, P289, DOI 10.1136/jnnp-2013-305019; Thompson BG, 2015, STROKE, V46, P2368, DOI 10.1161/STR.0000000000000070; Bouthillier A, 1996, NEUROSURGERY, V38, P425, DOI 10.1097/00006123-199603000-00001; Liu J, 2014, J NEUROINTERV SURG, V6, P658, DOI 10.1136/neurintsurg-2013-010946; Morita A, 2012, NEW ENGL J MED, V366, P2474; Park SK, 2009, NEUROSURGERY, V65, P285; Park SK, 2009, NEUROSURGERY, V65, P281, DOI 10.1227/01.NEU.0000348296.09722.2F	11	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	DEC	2015	84	6							UNSP 2078.e9	10.1016/j.wneu.2015.08.026		3	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CY3CQ	WOS:000366286300112		
J	Sato, Y; Kashimura, H; Takeda, M; Chida, K; Kubo, Y; Ogasawara, K				Sato, Yuiko; Kashimura, Hiroshi; Takeda, Masaru; Chida, Kohei; Kubo, Yoshitaka; Ogasawara, Kuniaki			Aneurysm of the A1 Segment of the Anterior Cerebral Artery Associated with the Persistent Primitive Olfactory Artery	WORLD NEUROSURGERY			English	Article						Anterior cerebral artery; Olfactory artery; Persistent primitive aneurysm	ANGIOGRAPHY; DIAGNOSIS	BACKGROUND: The persistent primitive artery constitutes the anterior cerebral artery proper. When the persistent primitive artery keeps its embryologic course along the olfactory bulb, it is called the persistent primitive olfactory artery (PPOA). CASE DESCRIPTION: A 69-year-old man presented with an incidentally discovered unruptured aneurysm at the origin of the PPOA. The PPOA originated at the A1 segment of the anterior cerebral artery, coursed anteromedially along the olfactory tract, made a hairpin turn posterosuperior to the midline, and formed the callosomarginal branch of the anterior cerebral artery. The anomalous artery was interpreted as a PPOA (type 3). Type 3 PPOA associated with an unruptured aneurysm is rare. CONCLUSIONS: There is a high incidence of aneurysms associated with a PPOA. Follow-up studies are necessary in the present case to monitor for the development of another aneurysm at the hairpin bend.	[Sato, Yuiko; Kashimura, Hiroshi; Takeda, Masaru; Chida, Kohei] Iwate Prefectural Chubu Hosp, Dept Neurosurg, Kitakami, Iwate, Japan; [Kubo, Yoshitaka; Ogasawara, Kuniaki] Iwate Med Univ, Sch Med, Dept Neurosurg, Morioka, Iwate 020, Japan	Kashimura, H (reprint author), Iwate Prefectural Chubu Hosp, Dept Neurosurg, Kitakami, Iwate, Japan.	h-kashimura@pref.iwate.jp					Kaneko T, 1999, NEUROL SURG TOKYO, V27, P933; Nozaki K, 1998, ACTA NEUROCHIR, V140, P397, DOI 10.1007/s007010050114; Yamamoto T, 2009, NEUROL MED-CHIR, V49, P303; Lin WC, 2009, BRAIN DEV-JPN, V31, P318, DOI 10.1016/j.braindev.2008.05.008; Komiyama M, 2012, SURG RADIOL ANAT, V34, P97, DOI 10.1007/s00276-011-0861-3; Kim MS, 2011, J KOREAN NEUROSURG S, V49, P290, DOI 10.3340/jkns.2011.49.5.290; TSUJI T, 1995, J NEUROSURG, V83, P138, DOI 10.3171/jns.1995.83.1.0138; Horie N, 2012, J NEUROSURG, V117, P26, DOI 10.3171/2012.3.JNS111932; YAMAURA A, 1979, SURG NEUROL, V12, P425; Uchino A, 2001, CLIN IMAG, V25, P258, DOI 10.1016/S0899-7071(01)00294-7; Uchino A, 2011, SURG RADIOL ANAT, V33, P197, DOI 10.1007/s00276-010-0743-0; ENOMOTO H, 1986, Neurological Surgery, V14, P203; HANAKITA J, 1988, Neurological Surgery, V16, P781; MOFFAT D B, 1967, Anatomischer Anzeiger, V121, P477; Padget Dorcas Hager, 1948, CONTRIBUTIONS TO EMBRYOLOGY [CARNEGIE INST OF WASHINGTON PUBL], V32, P205	15	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	DEC	2015	84	6							2079.e7	10.1016/j.wneu.2015.08.017		3	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CY3CQ	WOS:000366286300114		
J	Sugiyama, T; Kazumata, K; Asaoka, K; Osanai, T; Shimbo, D; Uchida, K; Yokoyama, Y; Nakayama, N; Itamoto, K; Houkin, K				Sugiyama, Taku; Kazumata, Ken; Asaoka, Katsuyuki; Osanai, Toshiya; Shimbo, Daisuke; Uchida, Kazuki; Yokoyama, Yuka; Nakayama, Naoki; Itamoto, Kouji; Houkin, Kiyohiro			Reappraisal of Microsurgical Revascularization for Anterior Circulation Ischemia in Patients with Progressive Stroke	WORLD NEUROSURGERY			English	Article						Acute ischemic stroke; EC-IC bypass; Embolectomy; Progressive stroke; STA-MCA bypass	MIDDLE-CEREBRAL-ARTERY; INTRACRANIAL BYPASS-SURGERY; RANDOMIZED-TRIAL; ENDOVASCULAR THERAPY; DIFFUSION MISMATCH; INFARCT GROWTH; OCCLUSION; DETERIORATION; THROMBECTOMY; EMBOLECTOMY	BACKGROUND: Intravenous thrombolysis using tissue plasminogen activator and endovascular treatment for acute ischemic stroke is becoming an established standard therapy. However, there is no consensus in the treatment of patients who are suffering from progressive neurologic symptoms in the later stages. The purpose of this study was to evaluate the safety and efficacy of microsurgical revascularization in such patients with progressive stroke. METHODS: We retrospectively reviewed the clinical and radiological records of 14 consecutive patients with progressive stroke who underwent emergency open surgery for anterior circulation occlusion within 7 days after onset. Surgical candidates were carefully selected on the basis of symptom severity, diffusion-weighted imaging, and perfusion study. Superficial temporal artery to middle cerebral artery bypass was applied for atherosclerotic occlusion, and microsurgical embolectomy was applied for embolic occlusion. RESULTS: Superficial temporal artery to middle cerebral artery bypass was performed in 12 patients, microsurgical embolectomy in 1, and the combination of these modalities in 1. As a result, complete revascularization was achieved in all patients. The National Institutes of Health Stroke Scale scores significantly improved after surgery (at third postoperative day, P < 0.05; at 14th postoperative day, P < 0.01). A favorable outcome (modified Rankin Scale 0-2) was achieved in 12 of the 14 (85.7%) patients. Minor intracerebral hemorrhage occurred in 1 patient and hyperperfusion syndrome occurred in 1 patients; however, the patients subsequently recovered without additional treatment. CONCLUSIONS: Microsurgical revascularization is a feasible treatment option for patients with progressive stroke due to anterior circulation major vessel occlusion.	[Sugiyama, Taku; Asaoka, Katsuyuki; Shimbo, Daisuke; Uchida, Kazuki; Yokoyama, Yuka; Itamoto, Kouji] Teine Keijinkai Med Ctr, Dept Neurosurg, Sapporo, Hokkaido, Japan; [Kazumata, Ken; Osanai, Toshiya; Nakayama, Naoki; Houkin, Kiyohiro] Hokkaido Univ, Grad Sch Med, Dept Neurosurg, Sapporo, Hokkaido, Japan	Sugiyama, T (reprint author), Teine Keijinkai Med Ctr, Dept Neurosurg, Sapporo, Hokkaido, Japan.	taku-s@yk9.so-net.ne.jp					WELCH K, 1956, J NEUROSURG, V13, P73, DOI 10.3171/jns.1956.13.1.0073; Barrett KM, 2009, STROKE, V40, P2422, DOI 10.1161/STROKEAHA.109.548933; Jovin TG, 2011, STROKE, V42, P2206, DOI 10.1161/STROKEAHA.110.604223; Schaefer PW, 2002, AM J NEURORADIOL, V23, P1785; Smith WS, 2008, STROKE, V39, P1205, DOI 10.1161/STROKEAHA.107.497115; Horiuchi T, 2007, J NEUROSURG, V106, P257, DOI 10.3171/jns.2007.106.2.257; Inoue T, 2013, BRIT J NEUROSURG, V27, P783, DOI 10.3109/02688697.2013.793286; Barreto AD, 2009, STROKE, V40, P827, DOI 10.1161/STROKEAHA.108.528034; Ogawa A, 2007, STROKE, V38, P2633, DOI 10.1161/STROKEAHA.107.488551; Ferrero E, 2010, ANN VASC SURG, V24, P890, DOI 10.1016/j.avsg.2010.03.014; Natarajan SK, 2009, STROKE, V40, P3269, DOI 10.1161/STROKEAHA.109.555102; Karonen JO, 2000, J NUCL MED, V41, P788; DICKSON CS, 1991, J VASC SURG, V14, P181; Janjua N, 2009, AM J NEURORADIOL, V30, P1024, DOI 10.3174/ajnr.A1474; Yamaguchi T, 2006, STROKE, V37, P1810, DOI 10.1161/01.STR.0000227191.01792e3; Horiuchi T, 2013, NEUROSURG REV, V36, P559, DOI 10.1007/s10143-013-0487-5; Powers WJ, 2011, JAMA-J AM MED ASSOC, V306, P1983, DOI 10.1001/jama.2011.1610; Uchino H, 2012, STROKE, V43, P2610, DOI 10.1161/STROKEAHA.112.654723; Hong CT, 2012, CLIN NEUROL NEUROSUR, V114, P376, DOI 10.1016/j.clineuro.2011.11.019; Birschel P, 2004, CEREBROVASC DIS, V17, P242, DOI 10.1159/000076161; Kwan J, 2006, QJM-INT J MED, V99, P625, DOI 10.1093/qjmed/hcl082; Nussbaum ES, 2010, J NEUROSURG, V112, P666, DOI 10.3171/2009.5.JNS081556; Nogueira RG, 2012, LANCET, V380, P1231, DOI 10.1016/S0140-6736(12)61299-9; Petty GW, 2000, STROKE, V31, P1062; Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587; Campbell BCV, 2015, NEW ENGL J MED, V372, P1009, DOI 10.1056/NEJMoa1414792; Goyal M, 2015, NEW ENGL J MED, V372, P1019, DOI 10.1056/NEJMoa1414905; Duckworth EA, 2013, NEUROSURGERY, V73; Duckworth EA, 2013, NEUROSURGERY, V73; Horiuchi T, 2013, NEUROSURG REV, V36, P564; Hwang G, 2011, NEUROSURGERY, V68, P729; Hwang G, 2011, NEUROSURGERY, V68, P723, DOI 10.1227/NEU.0b013e318207a9de; Kuroda S, 2014, ACTA NEUROCHIR, V156, P77, DOI 10.1007/s00701-013-1961-0; Meerwaldt Robbert, 2010, Surg Technol Int, V20, P283; Minematsu K, 2012, J STROKE CEREBROVASC, V22, P571; MARLER JR, 1995, NEW ENGL J MED, V333, P1581; Penumbra Pivotal Stroke Trial Investigators, 2009, STROKE, V40, P2761, DOI DOI 10.1161/STR0KEAHA.108.544957; Ustrell Xavier, 2010, Curr Cardiol Rev, V6, P175, DOI 10.2174/157340310791658721; Yasargil M G, 1977, Neurosurgery, V1, P22	39	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	DEC	2015	84	6					1579	1588		10.1016/j.wneu.2015.07.053		10	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CY3CQ	WOS:000366286300028		
J	Matsukawa, H; Tanikawa, R; Kamiyama, H; Tsuboi, T; Noda, K; Ota, N; Miyata, S; Suzuki, G; Takeda, R; Tokuda, S				Matsukawa, Hidetoshi; Tanikawa, Rokuya; Kamiyama, Hiroyasu; Tsuboi, Toshiyuki; Noda, Kosumo; Ota, Nakao; Miyata, Shiro; Suzuki, Go; Takeda, Rihei; Tokuda, Sadahisa			Effects of Clot Removal by Meticulous Irrigation and Continuous Low-Dose Intravenous Nicardipine on Symptomatic Cerebral Vasospasm in Patients with Aneurysmal Subarachnoid Hemorrhage Treated by Clipping	WORLD NEUROSURGERY			English	Article						Clipping; Clot irrigation; Nicardipine; Subarachnoid hemorrhage; Symptomatic cerebral vasospasm	PROLONGED-RELEASE IMPLANTS; CASE-FATALITY; FISHER SCALE; PREDICTION; ISCHEMIA; BLOOD; OXYHEMOGLOBIN; EPIDEMIOLOGY; METAANALYSIS; PREVENTION	BACKGROUND: Symptomatic cerebral vasospasm (SCV) is the second most common of morbidity and mortality in aneurysmal subarachnoid hemorrhage (aSAH) after rebleeding. Blood breakdown products are one of the leading causes of vasospasm. We hypothesized that meticulous subarachnoid clot removal in addition to continuous low-dose intravenous nicardipine (CLIN) could reduce the incidence of SCV. METHODS: SCV was defined as new focal neurologic signs, consciousness deterioration, or both when the cause was believed to be ischemia attributable to vasospasm after other possible causes of worsening were excluded. Initial brain damage was defined as continued consciousness disturbance after clipping without acute hydrocephalus, ischemic lesions, or focal sign before clipping. Poor outcome was defined as a Glasgow Outcome Scale score of 3e5 at 30 days. We compared the variables for 460 aSAH patients with and without SCV, and with and without poor outcome by multivariate analysis. RESULTS: All patients underwent clipping with meticulous irrigation for clot removal, and SCV was observed in 56 patients (12%). SCV was observed in 2 patients (2.9%) among 70 patients treated with CLIN. There was a higher proportion of patients who were older than 65 years (P = 0.032) and female (P = 0.038), and a lower proportion of patients with CLIN (P = 0.026) among patients with SCV. The outcomes for 109 patients (27%) were poor; age greater than 65 years (P < 0.0001) and initial brain damage (P = 0.008) were related to the poor outcomes. CONCLUSIONS: The present study showed that meticulous irrigation for clot removal and CLIN might reduce the incidence of SCV in patients with aSAH.	[Matsukawa, Hidetoshi; Tanikawa, Rokuya; Kamiyama, Hiroyasu; Tsuboi, Toshiyuki; Noda, Kosumo; Ota, Nakao; Miyata, Shiro; Suzuki, Go; Takeda, Rihei; Tokuda, Sadahisa] Teishinkai Hosp, Stroke Ctr, Dept Neurosurg, Sapporo, Hokkaido, Japan	Matsukawa, H (reprint author), Teishinkai Hosp, Stroke Ctr, Dept Neurosurg, Sapporo, Hokkaido, Japan.	nowornever1982@gmail.com					FUJITA S, 1985, NEUROSURGERY, V17, P609; Kramer AH, 2008, J NEUROSURG, V109, P199, DOI 10.3171/JNS/2008/109/8/0199; Laher I, 2001, J CEREBR BLOOD F MET, V21, P887; Dietrich HH, 2000, NEUROSURGERY, V46, P517, DOI 10.1097/00006123-200003000-00001; HIJDRA A, 1988, STROKE, V19, P1250; Rosengart AJ, 2007, STROKE, V38, P2315, DOI 10.1161/STROKEAHA.107.484360; Barth M, 2007, STROKE, V38, P330, DOI 10.1161/01.STR.0000254601.74596.0f; Claassen J, 2001, STROKE, V32, P2012, DOI 10.1161/hs0901.095677; TODA N, 1990, AM J PHYSIOL, V258, pH57; MIZUKAMI M, 1982, NEUROSURGERY, V10, P301; Anderson C, 2000, STROKE, V31, P1843; Hop JW, 1997, STROKE, V28, P660; BUCKELL M, 1964, J NEUROL NEUROSUR PS, V27, P198, DOI 10.1136/jnnp.27.3.198; JENNETT B, 1975, LANCET, V1, P480; HUNT WE, 1968, J NEUROSURG, V28, P14, DOI 10.3171/jns.1968.28.1.0014; Barker FG, 1996, J NEUROSURG, V84, P405, DOI 10.3171/jns.1996.84.3.0405; KASSELL NF, 1985, STROKE, V16, P562; Nakagawa I, 2013, CEREBROVASC DIS, V35, P131, DOI 10.1159/000346586; Tejada JG, 2007, AM J NEURORADIOL, V28, P844; SABBATINI M, 1995, CLIN EXP HYPERTENS, V17, P719, DOI 10.3109/10641969509033632; Reilly C, 2004, J NEUROSURG, V101, P255, DOI 10.3171/jns.2004.101.2.0255; HALEY EC, 1993, J NEUROSURG, V78, P537, DOI 10.3171/jns.1993.78.4.0537; Rosengart AJ, 2007, J NEUROSURG, V107, P253, DOI 10.3171/JNS-07/08/0253; TODA N, 1980, J NEUROSURG, V53, P312, DOI 10.3171/jns.1980.53.3.0312; Frontera JA, 2009, STROKE, V40, P1963, DOI 10.1161/STROKEAHA.108.544700; Jeon JS, 2012, J KOREAN NEUROSURG S, V52, P75, DOI 10.3340/jkns.2012.52.2.75; MACDONALD RL, 1991, J NEUROSURG, V75, P415, DOI 10.3171/jns.1991.75.3.0415; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Schubert GA, 2009, J NEUROTRAUM, V26, P2225, DOI 10.1089/neu.2009.0924; Wartenberg KE, 2011, NEUROCRIT CARE, V14, P407, DOI 10.1007/s12028-010-9488-1; FISHER CM, 1980, NEUROSURGERY, V6, P1; Hussein HM, 2014, J STROKE CEREBROVASC, V23, P2687, DOI 10.1016/j.jstrokecerebrovasdis.2014.06.013; Weir B, 1999, ACT NEUR S, V72, P27; Schmidt JM, 2007, NEUROCRIT CARE, V7, P10, DOI 10.1007/s12028-007-0003-2; MACDONALD RL, 1991, STROKE, V22, P971; MACDONALD RL, 1991, BLOOD VESSELS, V28, P498; Linn FHH, 1996, STROKE, V27, P625; Hop JW, 1998, STROKE, V29, P798; Budohoski KP, 2014, J NEUROL NEUROSUR PS, V85, P1343, DOI 10.1136/jnnp-2014-307711; Frontera JA, 2006, NEUROSURGERY, V59, P21, DOI 10.1227/01.NEU.0000218821.34014.1B; Frontera JA, 2006, NEUROSURGERY, V59, P21; Harrod CG, 2005, NEUROSURGERY, V56, P633; Harrod CG, 2005, NEUROSURGERY, V56, P633, DOI 10.1227/01.NEU.0000156644.45384.92; KASSELL NF, 1990, J NEUROSURG, V73, P18, DOI 10.3171/jns.1990.73.1.0018; Kasuya H, 2005, NEUROSURGERY, V56, P895; Kasuya H, 2005, NEUROSURGERY, V56, P895; Niikawa S, 1998, NEUROL MED CHIR TOKY, V38, P849, DOI DOI 10.2176/NMC.38.844; Niikawa S, 1998, NEUROL MED CHIR TOKY, V38, P844; Pasqualin A, 1992, NEUROSURGERY, V31, P703; Pasqualin A, 1992, NEUROSURGERY, V31; Tanikawa Rokuya, 2007, No Shinkei Geka, V35, P17	51	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	DEC	2015	84	6					1798	1803		10.1016/j.wneu.2015.07.069		6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CY3CQ	WOS:000366286300056		
J	Hara, T; Akutsu, H; Yamamoto, T; Tanaka, S; Takano, S; Ishikawa, E; Matsuda, M; Matsumura, A				Hara, Takuma; Akutsu, Hiroyoshi; Yamamoto, Tetsuya; Tanaka, Shuho; Takano, Shingo; Ishikawa, Eiichi; Matsuda, Masahide; Matsumura, Akira			Cranial Base Repair Using Suturing Technique Combined with a Mucosal Flap for Cerebrospinal Fluid Leakage During Endoscopic Endonasal Surgery	WORLD NEUROSURGERY			English	Article						Cerebrospinal fluid leak; Endoscopic endonasal surgery; Postoperative complication; Skull base repair	TRANSSPHENOIDAL SURGERY; SKULL BASE; NASOSEPTAL FLAP; RECONSTRUCTION; MENINGIOMAS; RESECTION	OBJECTIVE: To evaluate a cranial base repair method using the dural suturing technique in combination with a mucosal flap in the endoscopic endonasal approach. METHODS: We analyzed 190 patients (mean age, 52.3 years; age range, 3-86 years) who underwent 194 endoscopic endonasal approaches. The degree of intraoperative cerebrospinal fluid (CSF) leakage was graded based on previously published criteria: grade 0, absent; grade 1, small; grade 2, moderate; and grade 3, large. Cranial base repair using the dural suturing technique was performed according to the grade of CSF leakage: grades 1 and 2, autologous fat graft anchored by dural suturing covered with a sphenoid sinus mucosal flap, and grade 3, multilayered, inlay sutured and onlay nonsutured fascial grafts covered with a nasoseptal flap. RESULTS: Intraoperative CSF leakage was observed in 125 of 194 cases (64.4%). The degree of CSF leakage was grade 0 in 69 cases, grade 1 in 51 cases, grade 2 in 30 cases, and grade 3 in 44 cases. A postoperative CSF leak was encountered in 2 of 125 repaired cases (1.6%). Both cases with CSF leak involved grade 3 CSF leak (4.5%), and both were successfully treated with lumbar drainage. CONCLUSION: Our graded cranial base repair method using the dural suturing technique is simple and reliable.	[Hara, Takuma; Akutsu, Hiroyoshi; Yamamoto, Tetsuya; Takano, Shingo; Ishikawa, Eiichi; Matsuda, Masahide; Matsumura, Akira] Univ Tsukuba, Dept Neurosurg, Tsukuba, Ibaraki, Japan; [Tanaka, Shuho] Univ Tsukuba, Dept Otolaryngol, Tsukuba, Ibaraki, Japan	Akutsu, H (reprint author), Univ Tsukuba, Dept Neurosurg, Tsukuba, Ibaraki, Japan.	akutsuh@md.tsukuba.ac.jp					Iacoangeli M, 2014, BRIT J NEUROSURG, V28, P241, DOI 10.3109/02688697.2013.835375; Cavallo LM, 2009, J NEUROSURG, V111, P578, DOI 10.3171/2009.2.JNS081026; Zanation AM, 2009, AMJ RHINOL ALLERGY, V23, P518, DOI 10.2500/ajra.2009.23.3378; Nishioka H, 2009, ACTA NEUROCHIR, V151, P1427, DOI 10.1007/s00701-009-0406-2; Gondim JA, 2011, PITUITARY, V14, P174, DOI 10.1007/s11102-010-0280-1; Kassam AB, 2011, J NEUROSURG, V114, P1544, DOI 10.3171/2010.10.JNS09406; Cappabianca P, 2008, ADV TECH STAND NEURO, V33, P151, DOI 10.1007/978-3-211-72283-1_4; Yamada S, 2010, WORLD NEUROSURG, V74, P320, DOI 10.1016/j.wneu.2010.06.014; Kitano M, 2009, SURG NEUROL, V71, P290, DOI 10.1016/j.surneu.2007.11.014; Ceylan S, 2010, J NEUROSURG, V112, P99, DOI 10.3171/2009.4.JNS09182; Gardner PA, 2008, NEUROSURGERY, V63, P36, DOI [10.1227/01.NEU.0000335069.30319.1E, 10.1227/01.NEU.0000316852.01820.45]; Kitano M, 2007, J NEUROSURG, V107, P337, DOI 10.2171/JNS-07/08/0337; Koutourousiou M, 2014, J NEUROSURG, V120, P1326, DOI 10.3171/2014.2.JNS13767; Esposito F, 2007, NEUROSURGERY, V60, P295, DOI 10.1227/01.NEU.0000255354.64077.66; Kassam AB, 2008, NEUROSURGERY, V63, P44, DOI 10.1227/01.NEU.0000297074.13423.F5; Catapano D, 2006, J NEUROSURG, V104, P419, DOI 10.3171/jns.2006.104.3.419; Cavallo LM, 2007, J NEUROSURG, V107, P713, DOI 10.3171/JNS-07/10/0713; Kelly DF, 2001, NEUROSURGERY, V49, P885, DOI 10.1097/00006123-200110000-00020; de Divitiis E, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.12.E8; Garcia-Navarro V, 2013, WORLD NEUROSURG, V80, P563, DOI 10.1016/j.wneu.2011.08.034; Jakimovski D, 2014, WORLD NEUROSURG, V82, pE513, DOI 10.1016/j.wneu.2013.06.005; Sakamoto Noriaki, 2013, Surg Neurol Int, V4, P19, DOI 10.4103/2152-7806.107546; Takeyama I, 1995, PRACT OTOL, V88, P407	23	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	DEC	2015	84	6					1887	1893		10.1016/j.wneu.2015.08.025		7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CY3CQ	WOS:000366286300068		
J	Aihara, N; Murakami, S				Aihara, Noritaka; Murakami, Shingo			Enlargement of the Internal Auditory Canal and Hearing Preservation in the Middle Fossa Approach for Intracanalicular Vestibular Schwannomas	WORLD NEUROSURGERY			English	Article						Hearing preservation; Internal auditory canal; Intracanalicular vestibular schwannoma; Middle fossa approach	ACOUSTIC NEUROMA SURGERY; PROGNOSTIC-FACTORS; TUMOR; RADIOSURGERY; MANAGEMENT; NERVE; ORIGIN	OBJECTIVE: The middle fossa (MF) approach is one of the treatment options for patients with intracanalicular vestibular schwannomas. This study investigated whether enlargement of the internal auditory canal (IAC) represents a risk factor for hearing loss in the MF approach. METHODS: Participants comprised 48 patients who underwent resection of intracanalicular vestibular schwannoma using the MF approach at Nagoya City University Hospital. In this retrospective case review, the shape of the IAC on the affected side was compared with the normal side by coronal reconstruction computed tomography images. A difference of >1 mm was judged as IAC enlargement. Patients were classified into 4 groups: NE, no enlargement; SE, superior enlargement; IE, inferior enlargement; and BE, both superior and inferior enlargement. In addition, pure-tone average (PTA) and speech discrimination score (SDS) were estimated before and after surgery to evaluate hearing. - RESULTS: Hearing preservation (PTA <= 50 dB; SDS >= 50%) was seen in 96% (21/22), 100% (3/3), 50% (8/16), and 29% (2/7) in the NE, SE, IE, and BE groups, respectively. A significant difference in hearing preservation was seen between cases without IE (NE and SE) and cases with IE (IE and BE) (P < 0.0001). IE of the IAC was identified as an independent risk factor for hearing loss by logistic regression analysis (odds ratio, 32.0; 95% confidence interval, 4.2-783.6). CONCLUSIONS: Enlargement of the IAC on coronal reconstruction computed tomography scan before surgery can predict hearing preservation using the MF approach. Patients without IE may represent good surgical candidates for the MF approach.	[Aihara, Noritaka] Nagoya City Univ, Sch Med, Dept Neurosurg, Nagoya, Aichi 467, Japan; [Murakami, Shingo] Nagoya City Univ, Sch Med, Dept Otorhinolaryngol, Nagoya, Aichi 467, Japan	Aihara, N (reprint author), Nagoya City Univ, Sch Med, Dept Neurosurg, Nagoya, Aichi 467, Japan.	aihara@med.nagoya-cu.ac.jp					American Academy of Otolaryngology-Head and Neck Surgery Foundation, 1995, OTOLARYNGOL HEADNECK, V113, P179; Wang AC, 2013, J NEUROSURG, V119, P131, DOI 10.3171/2013.1.JNS1297; Niranjan A, 2008, NEUROSURGERY, V63, P1054, DOI 10.1227/01.NEU.0000335783.70079.85; BROOKES GB, 1994, CLIN OTOLARYNGOL, V19, P204, DOI 10.1111/j.1365-2273.1994.tb01216.x; Irving RM, 1998, J NEUROSURG, V88, P840, DOI 10.3171/jns.1998.88.5.0840; Khrais T, 2008, J LARYNGOL OTOL, V122, P128, DOI 10.1017/S0022215107001028; DORNHOFFER JL, 1995, LARYNGOSCOPE, V105, P184, DOI 10.1288/00005537-199502000-00014; Samii M, 2006, J NEUROSURG, V105, P527, DOI 10.3171/jns.2006.105.4.527; Brackmann DE, 2000, AM J OTOL, V21, P417, DOI 10.1016/S0196-0709(00)80054-X; Colletti V, 1997, OTOLARYNG HEAD NECK, V117, P596, DOI 10.1016/S0194-5998(97)70039-1; Slattery WH, 1997, AM J OTOL, V18, P596; Phillips DJ, 2010, OTOL NEUROTOL, V31, P1463, DOI 10.1097/MAO.0b013e3181f6c8d2; Rachinger J, 2011, J NEUROSURG, V115, P900, DOI 10.3171/2011.7.JNS102092; Yamakami I, 2014, J NEUROSURG, V121, P554, DOI 10.3171/2014.6.JNS132471; Matthies C, 1997, NEUROSURGERY, V40, P469, DOI 10.1097/00006123-199703000-00009; Matthies C, 1997, NEUROSURGERY, V40, P919, DOI 10.1097/00006123-199705000-00007; Kim YH, 2013, INT J RADIAT ONCOL, V85, P61, DOI 10.1016/j.ijrobp.2012.03.036; Moriyama T, 2002, J NEUROSURG, V97, P337, DOI 10.3171/jns.2002.97.2.0337; Kutz JW, 2012, NEUROSURGERY, V70, P334, DOI 10.1227/NEU.0b013e31823110f1; Iwai Y, 2008, J CLIN NEUROSCI, V15, P993, DOI 10.1016/j.jocn.2007.09.008; Stangerup SE, 2008, J LARYNGOL OTOL, V122, P673, DOI 10.1017/S0022215107001077; DeMonte F, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.7.FOCUS12172; Kobayashi H, 1987, Nihon Jibiinkoka Gakkai Kaiho, V90, P1023; Roche Pierre-Hugues, 2008, Prog Neurol Surg, V21, P83, DOI 10.1159/000156710; Rohit Piccirllo E, 2006, ANN OTO RHINOL LARYN, V115, P41; Thakur JD, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.6.FOCUS12144	26	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	DEC	2015	84	6					1950	1955		10.1016/j.wneu.2015.08.041		6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CY3CQ	WOS:000366286300077		
J	Maekawa, H; Hadeishi, H				Maekawa, Hidetsugu; Hadeishi, Hiromu			Venous-Preserving Sylvian Dissection	WORLD NEUROSURGERY			English	Article						Superficial Sylvian vein; Surgical technique; Sylvian fissure dissection; Transsylvian approach; Venous sacrifice	TRANSLAMINA TERMINALIS APPROACH; LARGE BRIDGING VEINS; TRANSSYLVIAN APPROACH; DRAINING VEINS; CRANIOPHARYNGIOMA; PRESERVATION; ANEURYSMS; REMOVAL; PITFALL	OBJECTIVE: The Sylvian fissure has been dissected through the frontal side of the superficial Sylvian veins with sacrifice of the tributaries of the frontal superficial Sylvian vein, which may lead to venous infarction. In addition, disturbed venous drainage makes the brain susceptible to brain retraction. Therefore, preservation of the vein is essential in modern neurosurgery to decrease morbidity. METHODS: We describe the technical nuances of Sylvian dissection with an emphasis on preserving the veins. RESULTS: The arachnoid between the frontal and temporal superficial Sylvian veins is divided as to enter the fissure. After the deep part in the Sylvian fissure is reached, the inside of the fissure is dissected along the "microvascular Sylvian fissure," the temporal side of the frontal vessels or the frontal side of the temporal vessels. The Sylvian fissure is dissected in a deep-to-superficial and posterior-to-anterior fashion ("paperknife technique") up to the skull base. The frontal superficial Sylvian vein usually tethers the brain to the dura, restricting the surgical corridor when approaching deep lesions. Peeling off the arachnoid that wraps this vein ("denude technique") allows the vein to stretch. CONCLUSIONS: Keeping the proper dissection plane ("microvascular Sylvian fissure") is crucial to preserve the veins. The "paperknife technique" makes the division of the frontal and temporal lobe easier. The "denude technique" provides a wider space between the frontal lobe and the skull base. These techniques make it possible to obtain a sufficiently wide surgical corridor to the basal cistern without sacrificing the veins and their tributaries.	[Maekawa, Hidetsugu; Hadeishi, Hiromu] Kameda Med Ctr, Dept Neurosurg, Chiba, Japan	Hadeishi, H (reprint author), Kameda Med Ctr, Dept Neurosurg, Chiba, Japan.	hade@kameda.jp					Dean BL, 2005, AM J NEURORADIOL, V26, P2019; Figueiredo EG, 2006, NEUROSURGERY, V59, P263, DOI 10.1227/01.NEU.0000233691.23208.9C; Randell T, 2006, SURG NEUROL, V66, P382, DOI 10.1016/j.surneu.2006.04.014; Hernesniemi J, 2005, ACT NEUR S, V94, P17; Kyoshima K, 2001, NEUROSURGERY, V48, P447, DOI 10.1097/00006123-200102000-00047; Chyatte D, 2001, NEUROSURGERY, V48, P339, DOI 10.1097/00006123-200102000-00020; Rhoton AL, 2002, NEUROSURGERY, V51, pS159, DOI 10.1227/01.NEU.0000028228.51706.2D; Inoue K, 2009, NEUROSURGERY, V65, P644, DOI 10.1227/01.NEU.0000351774.81674.32; SUGITA K, 1982, J NEUROSURG, V57, P856, DOI 10.3171/jns.1982.57.6.0856; Kivisaari RP, 2000, NEUROSURGERY, V46, P1070, DOI 10.1097/00006123-200005000-00008; KASAMA A, 1989, SURG NEUROL, V32, P116, DOI 10.1016/0090-3019(89)90198-5; KANNO T, 1989, SURG NEUROL, V32, P111, DOI 10.1016/0090-3019(89)90197-3; Schaller C, 2002, NEUROSURGERY, V51, P971, DOI 10.1227/01.NEU.0000028830.90768.B8; Elsharkawy A, 2014, ACTA NEUROCHIR, V156, P17, DOI 10.1007/s00701-013-1894-7; Hasegawa H, 2013, NEUROSURGERY, V73; Hasegawa H, 2013, NEUROSURGERY, V73; Hsu Frank P K, 2005, Neurosurgery, V56, P172; Kivisaari RP, 2000, NEUROSURGERY, V46, P1074; Lawton MT, 2011, 7 ANEURYSMS TENETS T, P65; Sakata Y, 2010, SURG CEREB STROKE JP, V38, P387; Scballer C, 2002, NEUROSURGERY, V51, P976; Yasargil MG, 1984, MICRONEUROSURGERY, V1, P215	22	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	DEC	2015	84	6					2043	2052		10.1016/j.wneu.2015.07.050		10	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CY3CQ	WOS:000366286300091		
J	Shibata, D				Shibata, Daisuke			Hemerology, Extispicy and Ili-pada's Illness	ZEITSCHRIFT FUR ASSYRIOLOGIE UND VORDERASIATISCHE ARCHAOLOGIE			English	Article								A Middle Assyrian letter from Tell Taban, Tab T05A-134, was written when Ili-pada, a well-known figure in the very late 13th and the early 12th centuries B. C., had become ill while staying in Adalishu, a town in the Land of Mari located in the Middle Habur region. While the letter focuses primarily on medicine for Ili-pada, it also deals with extispicy and hemerology. Furthermore, the letter provides new insights into the Middle Assyrian terms for 'propitious day' and 'extispicy'.	[Shibata, Daisuke] Univ Tsukuba, Tsukuba, Ibaraki 305, Japan	Shibata, D (reprint author), Univ Tsukuba, Tsukuba, Ibaraki 305, Japan.	shibata.daisuke.fu@u.tsukuba.ac.jp					Borger R., 1998, BIBLIOTHECA ORIENTAL, V55, P817; Brunke H., 2010, WHY SHOULD SEMEONE W, P41; Cancik-Kirschbaum E., 1996, BATSH, V4; Cancik-Kirschbaum E., 1999, AOF, V26, P210; Cardascia G., 1969, LES LOIS ASSYRIENNES; Casaburi M. C., 2003, HANES, V8; Deller K., 1987, AFO, V34, P58; Donbaz V., 1976, NINURTA TUKULTI ASSU; Driver G. R., 1935, THE ASSYRIAN LAWS; Ebeling E., 1926, ALTORIENTALISCHE TEX, P412; Ehelolf H., 1922, ALTASSYRISCHES RECHT; Farber W., 1977, IRAQ, V39, P223, DOI 10.2307/4200070; Frahm E., 2011, GMTR, V5; Freydank H., 2009, STIRONE TIGRI DAL TE, P149; Freydank H., 1979, NUOVE ATTESTAZIONI D; Heessel N. P., 2000, AOAT, V43; Ismail B. K., 2008, IRAQ, V70, P147; Jakob, 2009, MITTELASSYRISCHEN TE; Jakob S., 2003, CUMMON, V29; Jastrow M., 1921, J AM ORIENTAL SOC, V41, P1, DOI 10.2307/593702; Kataja L., 1987, SAAB, V1, P65; Koch U. S., 2005, AOAT, V326; Koch-Westenholz U., 2002, FESTSCHRIFT C WALKER, V1, P131; Kuhne H., 2013, STUDIA ORONTICA, V11, P143; Kuhne H., 2008, STUDIA CHABURENSIA, V1, P115; Lambert W. G., 1991, STUDIES ASSYRIAN HIS, P314; Livingstone A., 2013, CUSAS, V25; Livingstone A., 1993, OFFICIAL CULT POPULA, P97; Llop J., 2005, MDOG, V137, P41; Llop J., 2014, FAMILLE PROCHE ORIEN, P443; Llop J., ROYAL JOURN IN PRESS; Llop J, 2012, AULA ORIENT, V30, P289; Luukko M., 2004, SAAS, V16; Macgregor S. L., 2012, SAAS, V21; Maul S. M., 1992, BBVOT, V2; Maul S. M., 2005, ASJ 2 S, V2; Maul S. M., 2005, RLA, V10, P45; Maul S. M., 2013, WAHRSAGEKUNST ALTEN; Meinhold W., 2009, AOAT, V367; Pedersen O., 1985, ARCH LIB CITY ASSU 1; Pongratz-Leisten B., 1999, SAAS, V10; Postgate N, 2013, BRONZE AGE BUREAUCRACY: WRITING AND THE PRACTICE OF GOVERNMENT IN ASSYRIA, P1, DOI 10.1017/CBO9781107338937; Postgate J. N., 1973, IRAQ, V35, P13, DOI 10.2307/4199949; Radnler K., 2005, SANTAG, V8; Rollig W., 2008, FUNDSTELLEN GESAMMEL, P189; Roth M., 1997, LAW COLLECTIONS MESO; Sallaberger W., 2012, ORG REPRESENTATION S, P1; Saporetti C., 1970, STPOHL, V6; Shibata D., 2009, EXCAVATIONS TELL TAB; Shibata D., 2012, ORG REPRESENTATION S, P489; Shibata D., 2015, PIHANS, V125, P235; Shibata D., 2007, RAFIDAN, V28, P63; Shibata D., STUDIES HONOUR N POS; Shibata D., 2011, RA, V105, P165; Shibata D., 2011, RA, V105, P95; Shibata D., 2010, STUDIA CHABURENSIA, V1, P217; Streck M. P., 2009, ZA, V99, P135; Tallqvist K., 1921, OLD ASSYRIAN LAWS; Tsukimoto A., 1992, WDO, V23, P21; Weidner E., 1936, ARCH ORIENTFORSCHUNG, V10, P1; Wiggermann F. A. M., 2004, 60 RENC ASS INT WARS; Wiggermann F. A. M., 2006, ICONOGRAPHY CYLINDER, P92	62	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0084-5299	1613-1150		Z ASSYRIOL VORDERASI	Z. Assyriol. Vorderasiat. Archaeol.	DEC	2015	105	2					139	153		10.1515/za-2015-0014		15	Archaeology; History; Language & Linguistics	Archaeology; History; Linguistics	CY7CI	WOS:000366565200002		
J	Iwai, T; Konishi, S; Miyazaki, T; Kawamorita, S; Yokokawa, N; Ohmiya, H; Sawamura, M				Iwai, Tomohiro; Konishi, Shota; Miyazaki, Tatsuya; Kawamorita, Soichiro; Yokokawa, Natsumi; Ohmiya, Hirohisa; Sawamura, Masaya			Silica-Supported Triptycene-Type Phosphine. Synthesis, Characterization, and Application to Pd-Catalyzed Suzuki-Miyaura Cross-Coupling of Chloroarenes	ACS CATALYSIS			English	Article						silica-supported catalyst; phosphine; triptycene; palladium; chloroarene	DIRECTED ORTHO BORYLATION; ARYL CHLORIDES; FUNCTIONALIZED ARENES; HINDERED KETONES; IRIDIUM COMPLEX; OXIDE SUPPORTS; IR CATALYSTS; LIGANDS; SYSTEM; TRIPHENYLPHOSPHANE	A silica-supported triptycene-type phosphine, Silica-TRIP, comprising a 9-phospha-10-silatriptycene (TRIP) and silica gel as a P-coordination center and a solid support, respectively, was synthesized and structurally characterized by nitrogen absorption measurements and solid-state CP/MAS NMR spectroscopy. Silica-TRIP exhibited a mono-P-ligating feature toward a Pd(II) complex, resulting in selective formation of a 1/1 Pd-P species even with an excess amount of the ligand. As a result, Silica-TRIP enabled Pd-catalyzed Suzuki-Miyaura cross-coupling reactions of chloroarenes under mild conditions, regardless of the moderate electrondonating nature of the triarylphosphine-based ligand.	[Iwai, Tomohiro; Konishi, Shota; Miyazaki, Tatsuya; Kawamorita, Soichiro; Yokokawa, Natsumi; Ohmiya, Hirohisa; Sawamura, Masaya] Hokkaido Univ, Dept Chem, Fac Sci, Sapporo, Hokkaido 0600810, Japan	Sawamura, M (reprint author), Hokkaido Univ, Dept Chem, Fac Sci, Sapporo, Hokkaido 0600810, Japan.	sawamura@sci.hokudai.ac.jp			JSPS;  [25810056]	This work was supported in part by Grants-in-Aid for Young Scientists (B) (No. 25810056). JSPS, to T.I. and by CREST and ACT-C, JST, to M.S. S.K. thanks the JSPS for scholarship support.	Kantchev EAB, 2007, ANGEW CHEM INT EDIT, V46, P2768, DOI 10.1002/anie.200601663; Iwai T, 2013, ANGEW CHEM INT EDIT, V52, P12322, DOI 10.1002/anie.201306769; Iwasawa T, 2006, ORGANOMETALLICS, V25, P4665, DOI 10.1021/om060615q; Kawamorita S, 2010, J ORG CHEM, V75, P3855, DOI 10.1021/jo100352b; Iwai T, 2014, CHEM-EUR J, V20, P1057, DOI 10.1002/chem.201304081; Opanasenko M, 2014, RSC ADV, V4, P65137, DOI 10.1039/c4ra11963k; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Beckmann J, 2004, ORGANOMETALLICS, V23, P4630, DOI 10.1021/om049620p; Yamazaki K, 2010, ORG LETT, V12, P3978, DOI 10.1021/ol101493m; [Anonymous], 1999, CRYSTALCLEAR; Crabtree RH, 2012, CHEM REV, V112, P1536, DOI 10.1021/cr2002905; Phan NTS, 2006, ADV SYNTH CATAL, V348, P609, DOI 10.1002/adsc.200505473; Kawamorita S, 2012, J AM CHEM SOC, V134, P12924, DOI 10.1021/ja305694r; Kawamorita S, 2011, J AM CHEM SOC, V133, P19310, DOI 10.1021/ja208364a; Kawamorita S, 2013, J AM CHEM SOC, V135, P2947, DOI 10.1021/ja3126239; Ochida A, 2003, ORG LETT, V5, P2671, DOI 10.1021/ol0349099; Martin R, 2008, ACCOUNTS CHEM RES, V41, P1461, DOI 10.1021/ar800036s; Wight AP, 2002, CHEM REV, V102, P3589, DOI 10.1021/cr010334m; Kawamorita S, 2011, ANGEW CHEM INT EDIT, V50, P8363, DOI 10.1002/anie.201103224; Konishi S, 2014, CHEM-ASIAN J, V9, P434, DOI 10.1002/asia.201301423; Kowada T, 2010, ORG LETT, V12, P296, DOI 10.1021/ol902631d; Snelders DJM, 2009, J AM CHEM SOC, V131, P11407, DOI 10.1021/ja904042h; Ochida A, 2006, CHEM LETT, V35, P294, DOI 10.1246/cl.2006.294; Beele B, 2010, NEW J CHEM, V34, P2729, DOI 10.1039/c0nj00482k; Fortman GC, 2011, CHEM SOC REV, V40, P5151, DOI 10.1039/c1cs15088j; Reinhard S, 2003, ADV SYNTH CATAL, V345, P589, DOI 10.1002/adsc.200202206; Suzuki A, 2011, ANGEW CHEM INT EDIT, V50, P6722, DOI 10.1002/anie.201101379; Li BY, 2012, ADV MATER, V24, P3390, DOI 10.1002/adma.201200804; Ochida A, 2008, ORGANOMETALLICS, V27, P5494, DOI 10.1021/om8005728; Tsuji H, 2006, ORGANOMETALLICS, V25, P6142, DOI 10.1021/om060681s; Corma A, 2006, ADV SYNTH CATAL, V348, P1391, DOI 10.1002/adsc.200606192; Hoffmann F, 2006, ANGEW CHEM INT EDIT, V45, P3216, DOI 10.1002/anie.200503075; Yang Y, 2008, J AM CHEM SOC, V130, P3771, DOI 10.1021/ja800541c; Iwai T, 2014, CHEM LETT, V43, P584, DOI 10.1246/cl.131161; Kawamorita S, 2008, ORG LETT, V10, P4697, DOI 10.1021/ol801996r; Burla MC, 2005, J APPL CRYSTALLOGR, V38, P381, DOI 10.1107/S002188980403225X; Hu QS, 2003, J AM CHEM SOC, V125, P2856, DOI 10.1021/ja029021e; Fleckenstein CA, 2010, CHEM SOC REV, V39, P694, DOI 10.1039/b903646f; Krogul A, 2012, DALTON T, V41, P658, DOI 10.1039/c1dt11412c; Kawamorita S, 2012, ADV SYNTH CATAL, V354, P3440, DOI 10.1002/adsc.201200555; Kawamorita S, 2009, J AM CHEM SOC, V131, P5058, DOI 10.1021/ja9008419; [Anonymous], 2000, CRYSTALSTRUCTURE 4 0, P2000; Hamasaka G, 2008, ORGANOMETALLICS, V27, P6495, DOI 10.1021/om800683g; [Anonymous], 2000, CRYSTALCLEAR SOFTW U; Ohta H, 2007, ORG LETT, V9, P89, DOI 10.1021/ol0626138; Zhang JD, 2014, J AM CHEM SOC, V136, P6276, DOI 10.1021/ja411855d; Chow WK, 2012, J ORG CHEM, V77, P3543, DOI 10.1021/jo202472k; Yamamoto T, 2011, ANGEW CHEM INT EDIT, V50, P8844, DOI 10.1002/anie.201103792; Zhou YB, 2015, ADV SYNTH CATAL, V357, P2503, DOI 10.1002/adsc.201500070; Fujihara T, 2008, ANGEW CHEM INT EDIT, V47, P8310, DOI 10.1002/anie.200802683; Murakami R, 2014, CHEM-EUR J, V20, P13127, DOI 10.1002/chem.201404362; Littke AF, 2002, ANGEW CHEM INT EDIT, V41, P4176, DOI 10.1002/1521-3773(20021115)41:22<4176::AID-ANIE4176>3.0.CO;2-U; Barbaro P, 2010, CATAL MET COMPLEXES, V33, P1, DOI 10.1007/978-90-481-3696-4; Benaglia M., 2009, RECOVERABLE RECYCLAB; Blumel J, 2008, COORDIN CHEM REV, V252, P2410, DOI 10.1016/j.ccr.2008.06.013; Fu GC, 2008, ACCOUNTS CHEM RES, V41, P1555, DOI 10.1021/ar800148f; Harnasaka G., 2007, ANGEW CHEM INT EDIT, V46, P5381; Kawakami Y, 2015, J ORGANOMET CHEM, V799-800, P265, DOI 10.1016/j.jorganchem.2015.09.041; Lindner E., 1999, ANGEW CHEM INT EDIT, V38, P2154, DOI 10.1002/(SICI)1521-3773(19990802)38:15<2154::AID-ANIE2154>3.3.CO;2-K; Lundgren RJ, 2011, SYNLETT, P2443, DOI 10.1055/s-0030-1260321; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Tsuji H, 2006, ACTA CRYSTALLOGR E, V62, pM535, DOI 10.1107/S1600536806004958; Wong SM, 2012, SYNLETT, P1132, DOI 10.1055/s-0031-1290672	63	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2155-5435			ACS CATAL	ACS Catal.	DEC	2015	5	12					7254	7264		10.1021/acscatal.5b00904		11	Chemistry, Physical	Chemistry	CY1FY	WOS:000366153300025		
J	Sauer, DF; Himiyama, T; Tachikawa, K; Fukumoto, K; Onoda, A; Mizohata, E; Inoue, T; Bocola, M; Schwaneberg, U; Hayashi, T; Okuda, J				Sauer, Daniel F.; Himiyama, Tomoki; Tachikawa, Kengo; Fukumoto, Kazuki; Onoda, Akira; Mizohata, Eiichi; Inoue, Tsuyoshi; Bocola, Marco; Schwaneberg, Ulrich; Hayashi, Takashi; Okuda, Jun			A Highly Active Biohybrid Catalyst for Olefin Metathesis in Water: Impact of a Hydrophobic Cavity in a beta-Barrel Protein	ACS CATALYSIS			English	Article						biohybrid catalysis; chemogenetic approach; metalloenzymes; ruthenium; metathesis	BIOTIN-STREPTAVIDIN TECHNOLOGY; ARTIFICIAL METALLOENZYMES; RUTHENIUM CATALYSTS; METALLOPROTEINS; POLYMERIZATION; ENZYMES; DESIGN; ROMP	A series of Grubbs-Hoveyda type catalyst precursors for olefin metathesis containing a maleimide moiety in the backbone of the NHC ligand was covalently incorporated in the cavity of the beta-barrel protein nitrobindin. By using two protein mutants with different cavity sizes and choosing the suitable spacer length, an artificial metalloenzyme for olefin metathesis reactions in water in the absence of any organic cosolvents was obtained. High efficiencies reaching TON > 9000 in the ROMP of a water-soluble 7-oxanorbornene derivative and TON > 100 in ring-closing metathesis (RCM) of 4,4-bis(hydroxymethyl)-1,6-heptadiene in water under relatively mild conditions (pH 6, T = 25-40 degrees C) were observed.	[Sauer, Daniel F.; Okuda, Jun] Rhein Westfal TH Aachen, Inst Inorgan Chem, D-52056 Aachen, Germany; [Himiyama, Tomoki; Tachikawa, Kengo; Fukumoto, Kazuki; Onoda, Akira; Mizohata, Eiichi; Inoue, Tsuyoshi; Hayashi, Takashi] Osaka Univ, Grad Sch Engn, Dept Appl Chem, Suita, Osaka 5650871, Japan; [Bocola, Marco; Schwaneberg, Ulrich] Rhein Westfal TH Aachen, Inst Biotechnol, D-52056 Aachen, Germany	Hayashi, T (reprint author), Osaka Univ, Grad Sch Engn, Dept Appl Chem, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.	thayashi@chem.eng.osaka-u.ac.jp; jun.okuda@ac.rwth-aachen.de			Deutsche Forschungsgemeinschaft through the International Research Training Group "Selectivity in Chemo- and Biocatalysis" (SeleCa); JSPS Japanese-German Graduate Externship; MEXT of Japan [2204]	We gratefully acknowledge financial support by the Deutsche Forschungsgemeinschaft through the International Research Training Group "Selectivity in Chemo- and Biocatalysis" (SeleCa) and the JSPS Japanese-German Graduate Externship. Umicore, Frankfurt, Germany (Dr. A. Doppiu), is thanked for a generous gift of ruthenium. We appreciate the financial support provided by a Grant-in-Aid for Scientific Research (Innovative Areas "Molecular Activation", area 2204) from the MEXT of Japan. We thank Dr. T. Tsujimoto and Prof. H. Uyama for their assistance with GPC measurements at Osaka University and the staff of the SPring-8 BL44XU for technical support during diffraction data collection.	Hong SH, 2006, J AM CHEM SOC, V128, P3508, DOI 10.1021/ja058451c; Steinreiber J, 2008, COORDIN CHEM REV, V252, P751, DOI 10.1016/j.ccr.2007.09.016; Lu Y, 2009, NATURE, V460, P855, DOI 10.1038/nature08304; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; Koh MJ, 2015, NATURE, V517, P181, DOI 10.1038/nature14061; P'Pool SJ, 2007, J AM CHEM SOC, V129, P14200, DOI 10.1021/ja071938w; Keitz BK, 2012, J AM CHEM SOC, V134, P693, DOI 10.1021/ja210225e; Onoda A, 2014, ACS CATAL, V4, P2645, DOI 10.1021/cs500392e; Onoda A, 2012, CHEM COMMUN, V48, P9756, DOI 10.1039/c2cc35165j; Jordan JP, 2007, ANGEW CHEM INT EDIT, V46, P5152, DOI 10.1002/anie.200701258; Lo C, 2011, CHEM COMMUN, V47, P12065, DOI 10.1039/c1cc15004a; Lynn DM, 2000, J AM CHEM SOC, V122, P6601, DOI 10.1021/ja0003167; Zhao JM, 2015, ORG BIOMOL CHEM, V13, P5652, DOI 10.1039/c5ob00428d; Zhang C, 2014, TETRAHEDRON, V70, P4245, DOI 10.1016/j.tet.2014.03.008; LEVINE HL, 1977, BIOCHEM BIOPH RES CO, V76, P64, DOI 10.1016/0006-291X(77)91668-0; Skowerski K, 2012, CATAL SCI TECHNOL, V2, P2424, DOI 10.1039/c2cy20320k; Bianchetti CM, 2010, PROTEINS, V78, P917, DOI 10.1002/prot.22617; Mayer C, 2011, CHEM COMMUN, V47, P12068, DOI 10.1039/c1cc15005g; Philippart F, 2013, CHEM-EUR J, V19, P13865, DOI 10.1002/chem.201301515; Ueno T, 2013, CHEM-ASIAN J, V8, P1646, DOI 10.1002/asia.201300347; Robles VM, 2014, J AM CHEM SOC, V136, P15676, DOI 10.1021/ja508258t; WILSON ME, 1978, J AM CHEM SOC, V100, P306, DOI 10.1021/ja00469a064; Zimbron JM, 2013, J AM CHEM SOC, V135, P5384, DOI 10.1021/ja309974s; Fukumoto K, 2014, CHEMCATCHEM, V6, P1229, DOI 10.1002/cctc.201301055; Gawin R, 2010, TETRAHEDRON, V66, P1051, DOI 10.1016/j.tet.2009.11.009; Collot J, 2003, J AM CHEM SOC, V125, P9030, DOI 10.1021/ja035545i; Khan RKM, 2013, J AM CHEM SOC, V135, P10258, DOI 10.1021/ja404208a; Trnka TM, 2001, ACCOUNTS CHEM RES, V34, P18, DOI 10.1021/ar000114f; Matsuo T, 2012, CHEM COMMUN, V48, P1662, DOI 10.1039/c2cc16898g; Hayashi T, 2015, ISR J CHEM, V55, P76, DOI 10.1002/ijch.201400123; Jordan J. P., 2007, ANGEW CHEM, V119, P5244, DOI 10.1002/ange.200701258; Lu Y., 2006, ANGEW CHEM, V118, P5714, DOI 10.1002/ange.200600168; Lu Y, 2006, ANGEW CHEM INT EDIT, V45, P5588, DOI 10.1002/anie.200600168; Matsuo T, 2014, BIOORGAN MED CHEM, V22, P5638, DOI 10.1016/j.bmc.2014.06.021; Sauer DF, 2015, CHEM-ASIAN J, V10, P177, DOI 10.1002/asia.201403005; YAMAMURA K, 1976, J CHEM SOC CHEM COMM, P830, DOI 10.1039/c39760000830	36	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2155-5435			ACS CATAL	ACS Catal.	DEC	2015	5	12					7519	7522		10.1021/acscatal.5b01792		4	Chemistry, Physical	Chemistry	CY1FY	WOS:000366153300052		
J	Oyama, HT; Abe, S				Oyama, Hideko T.; Abe, Saki			Stereocomplex Poly(lactic acid) Alloys with Superb Heat Resistance and Toughness	ACS SUSTAINABLE CHEMISTRY & ENGINEERING			English	Article						Poly(lactic acid); Stereocomplex; Interfacial reaction; Toughness; Heat resistance	MOLECULAR-WEIGHT; REACTIVE COMPATIBILIZATION; CRYSTALLIZATION BEHAVIOR; MECHANICAL-PROPERTIES; POLY(L-LACTIC ACID); BLENDS; POLYLACTIDE; COMPOSITES; MORPHOLOGY; COPOLYMER	Biobased, biocompatible, and biodegradable poly(lactic acid), PLA, possesses unique properties that give it high potential for a wide range of applications. However, its low thermal stability and brittleness are major obstacles for its use. In this study, both the thermal stability and toughness of PLA were simultaneously improved via stereocomplexation and reactive blending, by generating alloys composed of two PLA enantiomers, PLLA and PDLA, together with poly(ethylene-ran-methylacrylate ran-glycidyl methacrylate), EMA-GMA. It was found that reactive blending at 200 degrees C was very effective in generating alloys with high degrees of stereocomplex (sc) crystallinity and that the interfacial reaction between PLA and EMA-GMA contributed to a significant improvement in toughness. Most importantly, a (40/40/20)PLLA/PDLA/EMA-GMA film with high sc crystallinity exhibited both much higher tensile impact strength and thermal stability than neat PLLA, retaining high storage modulus up to 210 degrees C. The scPLA alloys also exhibited superior chemical resistance to neat PLA. Thus, it was demonstrated that simultaneous complexation and the interfacial reaction transform PLA to the level of high performance materials.	[Oyama, Hideko T.; Abe, Saki] Rikkyo Univ, Dept Chem, Toshima Ku, Tokyo 1718501, Japan; [Oyama, Hideko T.] Fuzhou Univ, Sch Chem Engn, Fuzhou 350116, Peoples R China	Oyama, HT (reprint author), Rikkyo Univ, Dept Chem, Toshima Ku, 3-34-1 Nishi Ikebukuro, Tokyo 1718501, Japan.	hidekooyama@rikkyo.ac.jp			MEXT-Supported Program for the Strategic Research Foundation at Private Universities	The authors are grateful to the MEXT-Supported Program for the Strategic Research Foundation at Private Universities, 2013-2017 for financial support. The authors also acknowledge Daisuke Tanishima for his assistance in the experiments.	Pan PP, 2009, ACS APPL MATER INTER, V1, P402, DOI 10.1021/am800106f; Kanno T, 2014, EUR POLYM J, V54, P62, DOI 10.1016/j.eurpolymj.2014.02.006; Purnama P, 2010, MACROMOLECULES, V43, P1137, DOI 10.1021/ma902536p; Xu HJ, 2012, POLYM BULL, V68, P1135, DOI 10.1007/s00289-011-0673-y; Ogata N, 1997, J POLYM SCI POL PHYS, V35, P389, DOI 10.1002/(SICI)1099-0488(19970130)35:2<389::AID-POLB14>3.0.CO;2-E; Oyama HI, 2009, POLYMER, V50, P747, DOI 10.1016/j.polymer.2008.12.025; Bai HW, 2013, POLYMER, V54, P5257, DOI 10.1016/j.polymer.2013.07.051; WU SH, 1990, POLYM ENG SCI, V30, P753, DOI 10.1002/pen.760301302; Gramlich WM, 2010, MACROMOLECULES, V43, P2313, DOI 10.1021/ma902449x; Anderson KS, 2008, POLYM REV, V48, P85, DOI 10.1080/15583720701834216; Liu HZ, 2011, J POLYM SCI POL PHYS, V49, P1051, DOI 10.1002/polb.22283; IKADA Y, 1987, MACROMOLECULES, V20, P904, DOI 10.1021/ma00170a034; TSUJI H, 1992, MACROMOLECULES, V25, P5719, DOI 10.1021/ma00047a024; Urayama H, 2003, POLYMER, V44, P5635, DOI 10.1016/S0032-3861(03)00583-4; Juntuek P, 2012, J APPL POLYM SCI, V125, P745, DOI 10.1002/app.36263; Liu HZ, 2011, MACROMOLECULES, V44, P1513, DOI 10.1021/ma1026934; Fukushima K, 2006, POLYM INT, V55, P626, DOI 10.1002/pi.2010; Li YJ, 2009, EUR POLYM J, V45, P738, DOI 10.1016/j.eurpolymj.2008.12.010; Schmidt SC, 2001, J POLYM SCI POL PHYS, V39, P300, DOI 10.1002/1099-0488(20010201)39:3<300::AID-POLB1002>3.0.CO;2-M; Garlotta D, 2001, J POLYM ENVIRON, V9, P63, DOI 10.1023/A:1020200822435; Li YJ, 2007, MACROMOL BIOSCI, V7, P921, DOI 10.1002/mabi.200700027; TSUJI H, 1993, MACROMOLECULES, V26, P6918, DOI 10.1021/ma00077a032; Harada M, 2008, POLYM ENG SCI, V48, P1359, DOI 10.1002/pen.21088; Oyama HT, 2011, J POLYM SCI POL PHYS, V49, P342, DOI 10.1002/polb.22193; Tsuji H, 2006, MACROMOL MATER ENG, V291, P325, DOI 10.1002/mame.200500371; Wu DF, 2013, IND ENG CHEM RES, V52, P6731, DOI 10.1021/ie4004199; Yamane H, 2003, POLYMER, V44, P2569, DOI 10.1016/S0032-3861(03)00092-2; Perego G, 1996, J APPL POLYM SCI, V59, P37, DOI 10.1002/(SICI)1097-4628(19960103)59:1<37::AID-APP6>3.0.CO;2-N; Bucknall CB, 2009, POLYMER, V50, P5539, DOI 10.1016/j.polymer.2009.09.059; Zeng JB, 2015, RSC ADV, V5, P32546, DOI 10.1039/c5ra01655j; Bai HW, 2011, MACROMOLECULES, V44, P1233, DOI 10.1021/ma102439t; Tsuji H, 1999, POLYMER, V40, P6699, DOI 10.1016/S0032-3861(99)00004-X; Tsuji H, 2005, MACROMOL BIOSCI, V5, P569, DOI 10.1002/mabi.200500062; TSUJI H, 1991, MACROMOLECULES, V24, P5651, DOI 10.1021/ma00020a026; Charoensirisomboon P, 2000, POLYMER, V41, P6907, DOI 10.1016/S0032-3861(00)00025-2; Keskkula H., 1989, ADV CHEM SER, V222, P289; Oyama HT, 2011, J MACROMOL SCI B, V50, P463, DOI 10.1080/00222341003780996; WU SH, 1985, POLYMER, V26, P1855, DOI 10.1016/0032-3861(85)90015-1	38	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2168-0485			ACS SUSTAIN CHEM ENG	ACS Sustain. Chem. Eng.	DEC	2015	3	12					3245	3252		10.1021/acssuschemeng.5b00832		8	Chemistry, Multidisciplinary; Engineering, Chemical	Chemistry; Engineering	CY1GC	WOS:000366153700028		
J	Mori, M; Yamanaka, K; Sato, S; Tsubaki, S; Satoh, K; Kumagai, M; Imafuku, M; Shobu, T; Chiba, A				Mori, Manami; Yamanaka, Kenta; Sato, Shigeo; Tsubaki, Shinki; Satoh, Kozue; Kumagai, Masayoshi; Imafuku, Muneyuki; Shobu, Takahisa; Chiba, Akihiko			Strengthening of biomedical Ni-free Co-Cr-Mo alloy by multipass "low-strain-per-pass" thermomechanical processing	ACTA BIOMATERIALIA			English	Article						Biomedical Co-Cr-Mo alloy; Thermomechanical processing; Materials design; Strengthening mechanism; Dislocation structures	MECHANICAL-PROPERTIES; DISLOCATION CONTRAST; CO-29CR-6MO ALLOYS; PROFILE ANALYSIS; MICROSTRUCTURE; DEFORMATION; EVOLUTION; BEHAVIOR; COPPER; TRANSFORMATION	Further strengthening of biomedical Co-Cr-Mo alloys is desired, owing to the demand for improvements to their durability in applications such as artificial hip joints, spinal rods, bone plates, and screws. Here, we present a strategy multipass "low-strain-per-pass" thermomechanical processing for achieving high-strength biomedical Co-Cr-Mo alloys with sufficient ductility. The process primarily consists of multipass hot deformation, which involves repeated introduction of relatively small amounts of strain to the alloy at elevated temperatures. The concept was verified by performing hot rolling of a Co-28Cr-6Mo-0.13N (mass%) alloy and its strengthening mechanisms were examined. Strength increased monotonically with hot-rolling reduction, eventually reaching 1400 MPa in 0.2% proof stress, an exceptionally high value. Synchrotron X-ray diffraction (XRD) line-profile analysis revealed a drastic increase in the dislocation density with an increase in hot-rolling reduction and proposed that the significant strengthening was primarily driven by the increased dislocation density, while the contributions of grain refinement were minor. In addition, extra strengthening, which originates from contributions of planar defects (stacking faults/deformation twins), became apparent for greater hot-rolling reductions. The results obtained in this work help in reconsidering the existing strengthening strategy for the alloys, and thus, a novel feasible manufacturing route using conventional hot deformation processing, such as forging, rolling, swaging, and drawing, is realized. Statement of significance The results obtained in this work suggested a novel microstructural design concept/feasible manufacturing route of high-strength Co-Cr-Mo alloys using conventional hot deformation processing. The present strategy focuses on the strengthening due to the introduction of a high density of lattice defects rather than grain refinement using dynamic recrystallization (DRX). The hot-rolled samples obtained by our process exhibited exceptional strength, which is comparable to the highest strength reported for biomedical Co-Cr-Mo alloys. It was also found that the acceptable ductility can be obtained even in such highly distorted Co-Cr-Mo alloys. We described the strengthening mechanisms in detail; this will be helpful for further investigations or industrial realization of the proposed strategy. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.	[Mori, Manami; Yamanaka, Kenta; Satoh, Kozue; Chiba, Akihiko] Tohoku Univ, Inst Mat Res, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Mori, Manami] Sendai Natl Coll Technol, Dept Mat & Environm Engn, Natori, Miyagi 9811239, Japan; [Sato, Shigeo] Ibaraki Univ, Grad Sch Sci & Engn, Hitachi, Ibaraki 3168511, Japan; [Tsubaki, Shinki; Kumagai, Masayoshi; Imafuku, Muneyuki] Tokyo City Univ, Fac Engn, Setagaya Ku, Tokyo 1588557, Japan; [Shobu, Takahisa] Japan Atom Energy Agcy, Sayo, Hyogo 6795148, Japan	Yamanaka, K (reprint author), Tohoku Univ, Inst Mat Res, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.	k_yamanaka@imr.tohoku.ac.jp			Cooperative Research and Development Center for Advanced Materials, Institute for Materials Research, Tohoku University [14G0429]; "Nanotechnology Platform" of the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan at the Center for Integrated Nanotechnology Support, Tohoku University; Inter-University Cooperative Research Program; Innovative Research for Biosis-Abiosis Intelligent Interface, from the MEXT; Project for the Promotion of Indigenous Creation and Development of Innovative Medical Devices in the Tohoku Area from the Ministry of Health, Labour and Welfare, Japan;  [13J10932];  [26870050]	Professors Mitsuo Niinomi, Tadashi Furuhara, and Yuichiro Koizumi at the Institute for Materials Research, Tohoku University, are gratefully acknowledged for their fruitful discussion. The authors would like to thank Koji Kuramoto, Fumiya Sato, and Kimio Wako for sample preparation, Professor Kazuhisa Sato, Shun Ito, and Yuichiro Hayasaka for TEM observations, and Dr. Ayumi Shiro for synchrotron XRD measurements. This research was supported by the Grant-in-Aid for JSPS Fellows (No. 13J10932); the Grant-in-Aid for Young Scientists (B) (No. 26870050); the cooperative program (No. 14G0429) of the Cooperative Research and Development Center for Advanced Materials, Institute for Materials Research, Tohoku University; "Nanotechnology Platform" of the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan, at the Center for Integrated Nanotechnology Support, Tohoku University; the Inter-University Cooperative Research Program; the Innovative Research for Biosis-Abiosis Intelligent Interface, from the MEXT; and the Project for the Promotion of Indigenous Creation and Development of Innovative Medical Devices in the Tohoku Area from the Ministry of Health, Labour and Welfare, Japan. The synchrotron radiation experiments were performed at the BL22XU in SPring-8 with the approval of the Japan Synchrotron Radiation Research Institute (JASRI) and Japan Atomic Energy Agency (JAEA) (Proposal No. 2014A3781_2014A-E18).	Okazaki Y, 2008, MATER TRANS, V49, P817, DOI 10.2320/matertrans.MRA2007274; Shen YF, 2005, SCRIPTA MATER, V52, P989, DOI 10.1016/j.scriptamat.2005.01.033; Yamanaka K, 2014, J MECH BEHAV BIOMED, V29, P417, DOI 10.1016/j.jmbbm.2013.10.006; Lu K, 2012, SCRIPTA MATER, V66, P878, DOI 10.1016/j.scriptamat.2011.12.044; Yamanaka K, 2015, SPINE, V40, pE767, DOI 10.1097/BRS.0000000000000881; Schinhammer M, 2013, MAT SCI ENG C-MATER, V33, P1882, DOI 10.1016/j.msec.2012.10.013; Wang HT, 2012, ACTA MATER, V60, P4027, DOI 10.1016/j.actamat.2012.03.035; Kurosu S, 2010, MATER LETT, V64, P49, DOI 10.1016/j.matlet.2009.10.001; Yan FK, 2012, ACTA MATER, V60, P1059, DOI 10.1016/j.actamat.2011.11.009; Niinomi M, 2012, ACTA BIOMATER, V8, P3888, DOI 10.1016/j.actbio.2012.06.037; Lee SH, 2008, MATER TRANS, V49, P260, DOI 10.2320/matertrans.MRA2007220; Ungar T, 1996, APPL PHYS LETT, V69, P3173; Lu K, 2009, SCIENCE, V324, P349, DOI 10.1126/science.1159610; Yamanaka K, 2012, METALL MATER TRANS A, V43A, P4875, DOI 10.1007/s11661-012-1303-5; REMY L, 1976, MATER SCI ENG, V26, P123, DOI 10.1016/0025-5416(76)90234-2; Yamanaka K, 2013, ACTA BIOMATER, V9, P6259, DOI 10.1016/j.actbio.2012.12.013; Ungar T, 2001, J APPL CRYSTALLOGR, V34, P298, DOI 10.1107/S0021889801003715; Mori M, 2010, MAT SCI ENG A-STRUCT, V528, P614, DOI 10.1016/j.msea.2010.09.002; Tsuji N, 2009, SCRIPTA MATER, V60, P1044, DOI 10.1016/j.scriptamat.2009.02.028; Shaw LL, 2008, SCRIPTA MATER, V58, P951, DOI 10.1016/j.scriptamat.2008.01.025; Lu L, 2004, SCIENCE, V304, P422, DOI 10.1126/science.1092905; Mani A, 2011, MAT SCI ENG A-STRUCT, V528, P3037, DOI 10.1016/j.msea.2010.12.024; Kurosu S, 2010, METALL MATER TRANS A, V41A, P2613, DOI 10.1007/s11661-010-0273-8; Ungar T, 1999, PHYS STATUS SOLIDI A, V171, P425, DOI 10.1002/(SICI)1521-396X(199902)171:2<425::AID-PSSA425>3.0.CO;2-W; Yoshihara H, 2013, SPINE J, V13, P1350, DOI 10.1016/j.spinee.2013.04.022; Yamanaka K, 2012, METALL MATER TRANS A, V43A, P5243, DOI 10.1007/s11661-012-1288-0; Chiba A, 2007, ACTA MATER, V55, P1309, DOI 10.1016/j.actamat.2006.10.005; Mori M, 2015, J MECH BEHAV BIOMED, V51, P205, DOI 10.1016/j.jmbbm.2015.06.034; Chiba A, 2005, MATER SCI FORUM, V475-479, P2317; Yamanaka K, 2011, MAT SCI ENG A-STRUCT, V528, P5961, DOI 10.1016/j.msea.2011.04.027; Mori M, 2012, METALL MATER TRANS A, V43A, P3108, DOI 10.1007/s11661-012-1156-y; Yamanaka K, 2009, METALL MATER TRANS A, V40A, P1980, DOI 10.1007/s11661-009-9879-0; Lu L, 2005, ACTA MATER, V53, P2169, DOI 10.1016/j.actamat.2005.01.031; Kamikawa N, 2009, ACTA MATER, V57, P4198, DOI 10.1016/j.actamat.2009.05.017; Hermawan H, 2010, ACTA BIOMATER, V6, P1852, DOI 10.1016/j.actbio.2009.11.025; Tsuji N, 2008, ISIJ INT, V48, P1114, DOI 10.2355/isijinternational.48.1114; Cao Y, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4769216; Gutierrez-Urrutia I., 2011, ACTA MAT, V59, P6449; Jian W. W., 2014, APPL PHYS LETT, V103; Jian WW, 2013, MAT RES LETT, V1, P61, DOI DOI 10.1080/21663831.2013.765927; SalinasRodriguez A, 1996, J BIOMED MATER RES, V31, P409, DOI 10.1002/(SICI)1097-4636(199607)31:3<409::AID-JBM16>3.0.CO;2-D; Schinhammer M., 2010, ACTA BIOMATER, V6, P1705; Slivka M. A., 2013, SPINE DEFORM, V1, P395; Yamanaka K., 2013, J MECH BEHAV BIOMED, V32, P52	44	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1742-7061	1878-7568		ACTA BIOMATER	Acta Biomater.	DEC	2015	28						215	224		10.1016/j.actbio.2015.09.016		10	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	CY0AS	WOS:000366069000021		
J	Hori, S; Taminato, S; Suzuki, K; Hirayama, M; Kato, Y; Kanno, R				Hori, Satoshi; Taminato, Sou; Suzuki, Kota; Hirayama, Masaaki; Kato, Yuki; Kanno, Ryoji			Structure-property relationships in lithium superionic conductors having a Li10GeP2S12-type structure	ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE CRYSTAL ENGINEERING AND MATERIALS			English	Article						superionic conductor; MEM analysis; lithium battery; solid state battery	MAXIMUM-ENTROPY-METHOD; BATTERY; DIFFUSION	The crystal structures of the superionic conductors Li9.81Sn0.81P2.19S12 and Li10.35Si1.35P1.65S12, both having a Li10GeP2S12 (LGPS)-type structure, were determined by neutron diffraction analysis over the temperature range 12-800 K. The maximum entropy method was also employed to clarify the lithium distribution in these materials. The Sn system showed one-dimensional diffusion in the c direction over a wide temperature range, even though the Ge-based system typically exhibits three-dimensional conduction at higher temperatures. The ionic conduction mechanisms of analogous Si, Ge and Sn phases with LGPS-type structures are discussed on the basis of the observed structural parameter changes.	[Hori, Satoshi; Taminato, Sou; Suzuki, Kota; Hirayama, Masaaki; Kato, Yuki; Kanno, Ryoji] Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Elect Chem, Midori Ku, Yokohama, Kanagawa 2268502, Japan; [Kato, Yuki] Toyota Motor Co Ltd, Battery Res Div, Higashifuji Tech Ctr, Susono, Shizuoka 4101193, Japan; [Kato, Yuki] TOYOTA MOTOR EUROPE NV SA, Adv Technol 1, Battery AT, B-1930 Zaventem, Belgium	Kanno, R (reprint author), Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Elect Chem, Midori Ku, 4259 Nagatsuta, Yokohama, Kanagawa 2268502, Japan.	kanno@echem.titech.ac.jp			Post-LiEAD project of the New Energy and Industry Technology Development Organization (NEDO), Japan	This study was supported by the Post-LiEAD project of the New Energy and Industry Technology Development Organization (NEDO), Japan. The computer program used for MEM analysis was developed through the NEDO RISING project. The neutron radiation experiments were carried out as projects approved by the Japan Proton Research Complex (J-Parc) (proposal Nos. 2014AM1004 and 2014PM0001).	Adams S, 2012, J MATER CHEM, V22, P7687, DOI 10.1039/c2jm16688g; Mo YF, 2012, CHEM MATER, V24, P15, DOI 10.1021/cm203303y; Kuhn A, 2013, PHYS CHEM CHEM PHYS, V15, P11620, DOI 10.1039/c3cp51985f; Kwon O, 2015, J MATER CHEM A, V3, P438, DOI 10.1039/c4ta05231e; Fujimura K, 2013, ADV ENERGY MATER, V3, P980, DOI 10.1002/aenm.201300060; Nishimura S, 2008, NAT MATER, V7, P707, DOI 10.1038/nmat2251; Du FM, 2014, J PHYS CHEM C, V118, P10590, DOI 10.1021/jp5000039; Hori S, 2014, FARADAY DISCUSS, V176, P83, DOI 10.1039/c4fd00143e; Kamaya N, 2011, NAT MATER, V10, P682, DOI [10.1038/nmat3066, 10.1038/NMAT3066]; Wang Y, 2015, NAT MATER, V14, P1026, DOI [10.1038/nmat4369, 10.1038/NMAT4369]; Ong SP, 2013, ENERG ENVIRON SCI, V6, P148, DOI 10.1039/c2ee23355j; Yashima M, 2005, J AM CHEM SOC, V127, P3491, DOI 10.1021/ja0449224; Hori S, 2015, J AM CERAM SOC, V98, P3352, DOI 10.1111/jace.13694; Xu M, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4737397; Oishi R, 2009, NUCL INSTRUM METH A, V600, P94, DOI 10.1016/j.nima.2008.11.056; Goodenough JB, 2010, CHEM MATER, V22, P587, DOI 10.1021/cm901452z; Whiteley JM, 2014, J ELECTROCHEM SOC, V161, pA1812, DOI 10.1149/2.0501412jes; Kato Y, 2012, ELECTROCHEMISTRY, V80, P749, DOI 10.5796/electrochemistry.80.749; Dunn B, 2011, SCIENCE, V334, P928, DOI 10.1126/science.1212741; SAKATA M, 1990, ACTA CRYSTALLOGR A, V46, P263, DOI 10.1107/S0108767389012377; SAKATA M, 1993, J APPL CRYSTALLOGR, V26, P159, DOI 10.1107/S0021889892010793; SHANNON RD, 1969, ACTA CRYSTALL B-STRU, VB 25, P925, DOI 10.1107/S0567740869003220; Bron P, 2013, J AM CHEM SOC, V135, P15694, DOI 10.1021/ja407393y; Armand M, 2008, NATURE, V451, P652, DOI 10.1038/451652a; Ishikawa Y., 2014, ICANS 21 IB JAP 29 S; Ishikawa Y., 2014, Z 3D TXB Z CODE POWD	26	1	1	INT UNION CRYSTALLOGRAPHY	CHESTER	2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND	2052-5206			ACTA CRYSTALLOGR B	Acta Crystallogr. Sect. B-Struct. Sci.Cryst. Eng. Mat.	DEC	2015	71	6			SI		727	736		10.1107/S2052520615022283		10	Chemistry, Multidisciplinary; Crystallography	Chemistry; Crystallography	CY3PF	WOS:000366321100017		
J	Matsushita, N; Taira, A				Matsushita, Nobuyuki; Taira, Ayako			A one-dimensional chloride- bridged Pt-II/Pt-IV mixed-valence complex with a 4-[(4-hydroxyphenyl)diazenyl]benzenesulfonate counter-ion	ACTA CRYSTALLOGRAPHICA SECTION C-STRUCTURAL CHEMISTRY			English	Article						platinum coordination polymer; mixed-valence compound; halogen-bridged complex; one-dimensional chain complex; amphiphilic azobenzene; crystal structure	PLATINUM COMPLEXES; MX CHAIN; CL; TEMPERATURE; CRYSTAL; STATE; BR	The title compound, catena-poly[[[bis(ethylenediamine-kappa N-2,N')platinum(II)]-mu-chlorido-[bis(ethylenediamine)platinum(IV)]-mu-chlorido] tetrakis{4-[(4-hydroxyphenyl)diazenyl]benzenesulfonate} dihydrate], {[(PtPtCl2)-Pt-II-Cl-IV(C2H8N2)(4)](HOC6H4N=NC6H4SO3)(4)center dot 2H(2)O}(n), has a linear chain structure composed of square-planar [Pt(en)(2)](2+) (en is ethylenediamine) and elongated octahedral trans-[PtCl2(en)(2)](2+) cations stacked alternately, bridged by Cl atoms, along the b axis. The Pt atoms are located on an inversion centre, while the Cl atoms are disordered over two sites and form a zigzag center dot center dot center dot Cl-Pt-IV-Cl center dot center dot center dot Pt-II center dot center dot center dot chain, with a Pt-IV-Cl bond length of 2.3140 (14) angstrom, an interatomic Pt-II center dot center dot center dot Cl distance of 3.5969 (15) angstrom and a Pt-IV-Cl center dot center dot center dot Pt-II angle of 170.66 (6)degrees. The structural parameter indicating the mixed-valence state of the Pt atom, expressed by delta = (Pt-IV-Cl)/(Pt-II center dot center dot center dot Cl), is 0.643.	[Matsushita, Nobuyuki] Rikkyo Univ, Dept Chem, Toshima Ku, Tokyo 1718501, Japan; [Matsushita, Nobuyuki] Rikkyo Univ, Res Ctr Smart Mol, Toshima Ku, Tokyo 1718501, Japan; [Taira, Ayako] Univ Tokyo, Grad Sch Arts & Sci, Dept Chem, Meguro Ku, Tokyo 1538902, Japan	Matsushita, N (reprint author), Rikkyo Univ, Dept Chem, Toshima Ku, Nishi Ikebukuro 3-34-1, Tokyo 1718501, Japan.	cnmatsu@rikkyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [471, S1311027]	This work was partly supported by a Grant-in-Aid for Scientific Research 'New Frontiers in Photochromism (No. 471)' and MEXT-Supported Program for the Strategic Research Foundation at Private Universities (project No. S1311027) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	MATSUSHITA N, 1992, ACTA CRYSTALLOGR C, V48, P1936, DOI 10.1107/S0108270192003457; Westrip SP, 2010, J APPL CRYSTALLOGR, V43, P920, DOI 10.1107/S0021889810022120; BEAUCHAMP AL, 1982, ACTA CRYSTALLOGR B, V38, P1158, DOI 10.1107/S0567740882005202; Ichimura K, 2000, CHEM REV, V100, P1847, DOI 10.1021/cr980079e; Matsushita N, 1999, SYNTHETIC MET, V102, P1787, DOI 10.1016/S0379-6779(98)01161-8; YAMASHITA M, 1985, ACTA CRYSTALLOGR C, V41, P876, DOI 10.1107/S0108270185005820; HUCKETT SC, 1993, INORG CHEM, V32, P2137, DOI 10.1021/ic00062a044; MATSUSHITA N, 1995, SYNTHETIC MET, V71, P1933, DOI 10.1016/0379-6779(94)03113-K; Einaga Y, 2005, THIN SOLID FILMS, V493, P230, DOI 10.1016/j.tsf.2004.06.198; TORIUMI K, 1993, ACTA CRYSTALLOGR B, V49, P497, DOI 10.1107/S0108768192009480; Brandenburg K., 2006, DIAMOND; Higashi T., 1995, ABSCOR; Keller H. J., 1982, EXTENDED LINEAR CHAI, P357; Matsushita N., 2003, ACTA CRYSTALLOGR E, VE59, pm26, DOI 10.1107/S1600536802022584; MATSUSHITA N, 1993, SYNTHETIC MET, V56, P3401, DOI 10.1016/0379-6779(93)90135-J; Matsushita N, 2005, ACTA CRYSTALLOGR E, V61, pM514, DOI 10.1107/S1600536805004113; Matsushita N, 2006, ACTA CRYSTALLOGR C, V62, pM33, DOI 10.1107/S0108270105041247; Matsushita N, 2005, ACTA CRYSTALLOGR E, V61, pM1301, DOI 10.1107/S1600536805017873; Rigaku, 2006, RAPID AUTO; Robin M. B., 1967, ADV INORG CHEM RAD, V10, P247, DOI DOI 10.1016/S0065-2792(08)60179-X; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930	21	0	0	INT UNION CRYSTALLOGRAPHY	CHESTER	2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND	2053-2296			ACTA CRYSTALLOGR C	Acta Crystallogr. Sect. C-Struct. Chem.	DEC	2015	71		12				1033	+		10.1107/S2053229615019877		9	Chemistry, Multidisciplinary; Crystallography	Chemistry; Crystallography	CY3JN	WOS:000366305600001		
J	Onoshima, D; Yukawa, H; Baba, Y				Onoshima, Daisuke; Yukawa, Hiroshi; Baba, Yoshinobu			Multifunctional nanobiodevices in medical sciences	ADVANCED DRUG DELIVERY REVIEWS			English	Editorial Material									[Onoshima, Daisuke] Nagoya Univ, Inst Innovat Future Soc, Nagoya, Aichi 4648601, Japan; [Yukawa, Hiroshi] Nagoya Univ, Impact Res Ctr Adv Nanobiodevices, Nagoya, Aichi 4648601, Japan; [Baba, Yoshinobu] Nagoya Univ, Dept Appl Chem, Sch Engn, Dept Adv Med Sci,Sch Med, Nagoya, Aichi 4648603, Japan	Onoshima, D (reprint author), Nagoya Univ, Inst Innovat Future Soc, Nagoya, Aichi 4648601, Japan.	onoshima-d@nanobio.nagoya-u.ac.jp; hiroshiy@med.nagoya-u.ac.jp; babaymtt@apchem.nagoya-u.ac.jp						0	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0169-409X	1872-8294		ADV DRUG DELIVER REV	Adv. Drug Deliv. Rev.	DEC 1	2015	95						1	1		10.1016/j.addr.2015.11.006		1	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CY2FM	WOS:000366224200001		
J	Onoshima, D; Yukawa, H; Baba, Y				Onoshima, Daisuke; Yukawa, Hiroshi; Baba, Yoshinobu			Multifunctional quantum dots-based cancer diagnostics and stem cell therapeutics for regenerative medicine	ADVANCED DRUG DELIVERY REVIEWS			English	Review						Quantum dots; FRET; Microfluidic device; Cancer diagnosis; Stem cell labeling; Cationic liposomes; Cell-penetrating peptides; Cell transplantation	RESONANCE ENERGY-TRANSFER; IN-VIVO; ADIPOSE-TISSUE; SEMICONDUCTOR NANOCRYSTALS; INTRACELLULAR TRAFFICKING; PROTEIN TRANSDUCTION; BIOLOGICAL DETECTION; OPTICAL-DETECTION; DNA NANOSENSOR; BREAST-CANCER	A field of recent diagnostics and therapeutics has been advanced with quantum dots (QDs). QDs have developed into new formats of biomolecular sensing to push the limits of detection in biology and medicine. QDs can be also utilized as bio-probes or labels for biological imaging of living cells and tissues. More recently, QDs has been demonstrated to construct a multifunctional nanoplatform, where the QDs serve not only as an imaging agent, but also a nanoscaffold for diagnostic and therapeutic modalities. This review highlights the promising applications of multi-functionalized QDs as advanced nanosensors for diagnosing cancer and as innovative fluorescence probes for in vitro or in vivo stem cell imaging in regenerative medicine. (C) 2015 Elsevier B.V. All rights resrved.	[Onoshima, Daisuke; Baba, Yoshinobu] Nagoya Univ, Inst Innovat Future Soc, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Onoshima, Daisuke; Yukawa, Hiroshi; Baba, Yoshinobu] Nagoya Univ, ImPACT Res Ctr Adv Nanobiodevices, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Yukawa, Hiroshi; Baba, Yoshinobu] Nagoya Univ, Dept Appl Chem, Grad Sch Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Baba, Yoshinobu] Natl Inst Adv Ind Sci & Technol, Takamatsu, Kagawa 7610395, Japan	Onoshima, D (reprint author), Nagoya Univ, Inst Innovat Future Soc, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648603, Japan.	onoshima-d@nanobio.nagoya-u.ac.jp; hiroshiy@med.nagoya-u.ac.jp					Algar W. R., 2008, LANGMUIR, V25, P633; Alivisatos P., 2005, ANNU REV BIOMED ENG, V7, P55; Alivisatos P, 2004, NAT BIOTECHNOL, V22, P47, DOI 10.1038/nbt927; Amariglio N, 2009, PLOS MED, V6, P221, DOI 10.1371/journal.pmed.1000029; Bakalova R, 2005, J AM CHEM SOC, V127, P11328, DOI 10.1021/ja051089h; Barua S, 2009, SMALL, V5, P370, DOI 10.1002/smll.200800972; Seo MJ, 2005, BIOCHEM BIOPH RES CO, V328, P258, DOI 10.1016/j.bbrc.2004.12.158; Jain KK, 2007, CLIN CHEM, V53, P2002, DOI 10.1373/clinchem.2007.090795; Yukawa H, 2012, BIOMATERIALS, V33, P2177, DOI 10.1016/j.biomaterials.2011.12.009; Han MY, 2001, NAT BIOTECHNOL, V19, P631, DOI 10.1038/90228; Srivastava S, 2005, J PROTEOME RES, V4, P1098, DOI 10.1021/pr050016u; Yukawa H, 2010, CELL TRANSPLANT, V19, P901, DOI 10.3727/096368910X509031; Elliott G, 1997, CELL, V88, P223, DOI 10.1016/S0092-8674(00)81843-7; Takasaki Y, 2011, ANAL CHEM, V83, P8252, DOI 10.1021/ac202053y; Lidke DS, 2004, NAT BIOTECHNOL, V22, P198, DOI 10.1038/nbt929; Rosenzweig A, 2006, NEW ENGL J MED, V355, P1274, DOI 10.1056/NEJMe068172; Yukawa H, 2010, BIOMATERIALS, V31, P4094, DOI 10.1016/j.biomaterials.2010.01.134; Chu TC, 2006, BIOSENS BIOELECTRON, V21, P1859, DOI 10.1016/j.bios.2005.12.015; Li SC, 2010, STEM CELL REV REP, V6, P317, DOI 10.1007/s12015-010-9130-9; Zhang CY, 2005, NAT MATER, V4, P826, DOI 10.1038/nmat1508; Lee JA, 2007, ADV MATER, V19, P3113, DOI 10.1002/adma.200701955; Chan WCW, 2002, CURR OPIN BIOTECH, V13, P40, DOI 10.1016/S0958-1669(02)00282-3; Yang HN, 2014, BIOMATERIALS, V35, P8439, DOI 10.1016/j.biomaterials.2014.06.024; Chen XC, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/23/235105; Gorman J, 2010, NAT STRUCT MOL BIOL, V17, P932, DOI 10.1038/nsmb.1858; Zhang TT, 2006, NANO LETT, V6, P800, DOI 10.1021/nl0603350; Rejman J, 2004, BIOCHEM J, V377, P159, DOI 10.1042/BJ20031253; Kirchhausen T, 2000, NAT REV MOL CELL BIO, V1, P187, DOI 10.1038/35043117; Schwarze SR, 2000, TRENDS CELL BIOL, V10, P290, DOI 10.1016/S0962-8924(00)01771-2; Correa-Duarte MA, 1998, CHEM PHYS LETT, V286, P497, DOI 10.1016/S0009-2614(98)00012-8; Delehanty JB, 2006, BIOCONJUGATE CHEM, V17, P920, DOI 10.1021/bc060044i; Nguyen PK, 2010, ADV DRUG DELIVER REV, V62, P1175, DOI 10.1016/j.addr.2010.08.008; Delehanty JB, 2009, ANAL BIOANAL CHEM, V393, P1091, DOI 10.1007/s00216-008-2410-4; Dittrich PS, 2005, ANAL BIOANAL CHEM, V382, P1771, DOI 10.1007/s00216-005-3335-9; FAWELL S, 1994, P NATL ACAD SCI USA, V91, P664, DOI 10.1073/pnas.91.2.664; Dabbousi BO, 1997, J PHYS CHEM B, V101, P9463, DOI 10.1021/jp971091y; Smith AM, 2006, EXPERT REV MOL DIAGN, V6, P231, DOI 10.1586/14737159.6.2.231; Alivisatos AP, 1996, J PHYS CHEM-US, V100, P13226, DOI 10.1021/jp9535506; Menasche P, 2009, CIRCULATION, V119, P2735, DOI 10.1161/CIRCULATIONAHA.108.812693; Hsieh SC, 2006, J BIOMED MATER RES B, V79B, P95, DOI 10.1002/jbm.30517; Powles R, 2010, LANCET ONCOL, V11, P305, DOI 10.1016/S1470-2045(10)70001-2; Chan WCW, 1998, SCIENCE, V281, P2016, DOI 10.1126/science.281.5385.2016; Bakalova R, 2004, NAT BIOTECHNOL, V22, P1360, DOI 10.1038/nbt1104-1360; Deng ZT, 2007, J PHYS CHEM B, V111, P12024, DOI 10.1021/jp074609z; Narazaki G, 2008, CIRCULATION, V118, P498, DOI 10.1161/CIRCULATIONAHA.108.769562; Joo C, 2008, ANNU REV BIOCHEM, V77, P51, DOI 10.1146/annurev.biochem.77.070606.101543; Yeo LY, 2011, SMALL, V7, P12, DOI 10.1002/smll.201000946; Rivet C, 2011, CHEM ENG SCI, V66, P1490, DOI 10.1016/j.ces.2010.08.015; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; ZABNER J, 1995, J BIOL CHEM, V270, P18997; Yukawa H, 2009, CELL TRANSPLANT, V18, P591; Medintz IL, 2009, PHYS CHEM CHEM PHYS, V11, P17, DOI 10.1039/b813919a; Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/nmat2442, 10.1038/NMAT2442]; Chang JC, 2008, BIOMATERIALS, V29, P925, DOI 10.1016/j.biomaterials.2007.10.046; Lee H, 2010, BIOCONJUGATE CHEM, V21, P289, DOI 10.1021/bc900342p; Derfus AM, 2004, ADV MATER, V16, P961, DOI 10.1002/adma.200306111; Chithrani BD, 2006, NANO LETT, V6, P662, DOI 10.1021/nl052396o; Subramaniam P, 2012, ADV MATER, V24, P4014, DOI 10.1002/adma.201201019; Ozturk SS, 2010, J NANOSCI NANOTECHNO, V10, P2479, DOI 10.1166/jnn.2010.1438; Zhang Y, 2006, J AM CHEM SOC, V128, P13396, DOI 10.1021/ja061225y; Shinchi H, 2014, BIOCONJUGATE CHEM, V25, P286, DOI 10.1021/bc400425w; Biju V, 2010, CHEM SOC REV, V39, P3031, DOI 10.1039/b926512k; Seleverstov O, 2006, NANO LETT, V6, P2826, DOI 10.1021/nl0619711; Wen XH, 2014, BIOMATERIALS, V35, P4627, DOI 10.1016/j.biomaterials.2014.02.042; Hsieh YH, 2010, ANAL BIOANAL CHEM, V396, P1135, DOI 10.1007/s00216-009-3323-6; Kim S, 2012, ANGEW CHEM INT EDIT, V51, P3578, DOI 10.1002/anie.201107714; Choi S, 2011, MICROFLUID NANOFLUID, V10, P231, DOI 10.1007/s10404-010-0638-8; Medintz IL, 2008, INT J NANOMED, V3, P151; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Liu KK, 2010, SENSORS-BASEL, V10, P6623, DOI 10.3390/s100706623; Slotkin JR, 2007, DEV DYNAM, V236, P3393, DOI 10.1002/dvdy.21235; Jares-Erijman EA, 2003, NAT BIOTECHNOL, V21, P1387, DOI 10.1038/nbt896; Liu W, 2008, J AM CHEM SOC, V130, P1274, DOI 10.1021/ja076069p; Wu AM, 2000, P NATL ACAD SCI USA, V97, P8495, DOI 10.1073/pnas.150228297; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996; Akerman ME, 2002, P NATL ACAD SCI USA, V99, P12617, DOI 10.1073/pnas.152463399; Lei Y, 2008, BIOCONJUGATE CHEM, V19, P421, DOI 10.1021/bc0700685; Cissell KA, 2008, ANAL CHEM, V80, P2319, DOI 10.1021/ac702577a; Resch-Genger U, 2008, NAT METHODS, V5, P763, DOI [10.1038/nmeth.1248, 10.1038/NMETH.1248]; Michalet X, 2005, SCIENCE, V307, P538, DOI 10.1126/science.1104274; Strong M, 2009, BIOLOGICALS, V37, P103, DOI 10.1016/j.biologicals.2009.01.003; Wang HZ, 2004, ACTA BIOCH BIOPH SIN, V36, P681; Noguchi H, 2006, ACTA MED OKAYAMA, V60, P1; Michaeli Y, 2013, CHEM COMMUN, V49, P8599, DOI 10.1039/c3cc42543f; Chen C, 2009, BIOMATERIALS, V30, P2912, DOI 10.1016/j.biomaterials.2009.02.010; Verma A, 2008, NAT MATER, V7, P588, DOI 10.1038/nmat2202; Silver J, 2005, NANO LETT, V5, P1445, DOI 10.1021/nl050808n; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105; Parak WJ, 2002, ADV MATER, V14, P882, DOI 10.1002/1521-4095(20020618)14:12<882::AID-ADMA882>3.0.CO;2-Y; Erogbogbo F, 2008, ACS NANO, V2, P873, DOI 10.1021/nn700319z; Onoshima D, 2008, ANAL SCI, V24, P181, DOI 10.2116/analsci.24.181; Chen B, 2008, LANGMUIR, V24, P11866, DOI 10.1021/la802048s; Gao XH, 2004, NAT BIOTECHNOL, V22, P969, DOI 10.1038/nbt994; Algar WR, 2010, ANAL BIOANAL CHEM, V398, P2439, DOI 10.1007/s00216-010-3837-y; Norris DJ, 1996, PHYS REV B, V53, P16338, DOI 10.1103/PhysRevB.53.16338; Wang GP, 2015, BIOMED PAP, V159, P227, DOI 10.5507/bp.2014.045; MULLIGAN RC, 1993, SCIENCE, V260, P926, DOI 10.1126/science.8493530; Seydack M, 2005, BIOSENS BIOELECTRON, V20, P2454, DOI 10.1016/j.bios.2004.11.003; Qian ZS, 2014, BIOSENS BIOELECTRON, V60, P64, DOI 10.1016/j.bios.2014.04.006; Lagerholm BC, 2004, NANO LETT, V4, P2019, DOI 10.1021/nl049295v; Chang JC, 2009, BIOMATERIALS, V30, P1937, DOI 10.1016/j.biomaterials.2008.12.039; Wu XY, 2003, NAT BIOTECHNOL, V21, P41, DOI 10.1038/nbt764; Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058; Wagner MK, 2010, ANAL BIOANAL CHEM, V397, P3213, DOI 10.1007/s00216-010-3847-9; Algar WR, 2009, ANAL CHEM, V81, P4113, DOI 10.1021/ac900421p; Jiang W, 2008, NAT NANOTECHNOL, V3, P145, DOI 10.1038/nnano.2008.30; Kawashima N, 2010, CHEM-EUR J, V16, P1186, DOI 10.1002/chem.200902963; Toita S, 2008, J NANOSCI NANOTECHNO, V8, P2279, DOI 10.1166/jnn.2008.240; Zhang Y, 2012, ANAL CHEM, V84, P224, DOI 10.1021/ac202405q; Algar WR, 2008, ANAL BIOANAL CHEM, V391, P1609, DOI 10.1007/s00216-007-1703-3; Hsieh SC, 2006, BIOMATERIALS, V27, P1656, DOI 10.1016/j.biomaterials.2005.09.004; Clapp AR, 2006, CHEMPHYSCHEM, V7, P47, DOI 10.1002/cphc.200500217; Sun C, 2014, ANAL CHEM, V86, P11403, DOI 10.1021/ac503363m; Chen L, 2011, ANAL BIOANAL CHEM, V399, P133, DOI 10.1007/s00216-010-4309-0; Biju V., 2014, CHEM SOC REV, V43, P737; Bruchez M, 1998, SCIENCE, V281, P2013, DOI 10.1126/science.281.5385.2013; Burns A. A., 2008, NANO LETT, V9, P442; Feigner P. L., 1987, P NATL ACAD SCI USA, V84, P7413; Gang Y., 2007, NAT NANOTECHNOL, V2, P249; Kim You-Sun, 2014, Tuberc Respir Dis (Seoul), V77, P116, DOI 10.4046/trd.2014.77.3.116; Lagerholm B Christoffer, 2007, Methods Mol Biol, V374, P105; Lin S, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-67; Miyazaki Y., 2013, CELL MED, V6, P91; Narayanan K, 2013, SCI REP-UK, V3, DOI 10.1038/srep02184; Nirmal M, 1999, ACCOUNTS CHEM RES, V32, P407, DOI 10.1021/ar9700320; Onoshima D., 2014, BIOPHYS J, V103, p699a; Phelps ME, 2000, P NATL ACAD SCI USA, V97, P9226, DOI 10.1073/pnas.97.16.9226; Prasuhn DE, 2010, ACS NANO, V4, P267, DOI 10.1021/nn901393v; Sapsford KE, 2006, SENSORS-BASEL, V6, P925, DOI 10.3390/s6080925; Shah LS, 2007, NANO LETT, V7, P3071, DOI 10.1021/nl071547f; Tian JN, 2012, TALANTA, V92, P72, DOI 10.1016/j.talanta.2012.01.051; Wang Y., 2013, THERANOSTICS, V3; Yukawa H., 2013, CELL MED, V2013, P83	134	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0169-409X	1872-8294		ADV DRUG DELIVER REV	Adv. Drug Deliv. Rev.	DEC 1	2015	95						2	14		10.1016/j.addr.2015.08.004		13	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CY2FM	WOS:000366224200002		
J	Morimoto, Y; Hsiao, AY; Takeuchi, S				Morimoto, Yuya; Hsiao, Amy Y.; Takeuchi, Shoji			Point-, line-, and plane-shaped cellular constructs for 3D tissue assembly	ADVANCED DRUG DELIVERY REVIEWS			English	Review						Microfluidic techniques; Bottom-up tissue engineering; 3D tissue fabrication; Cellular building blocks; Clinical treatments	MONODISPERSE DOUBLE EMULSIONS; ALGINATE-BASED MICROCAPSULES; MICROFLUIDIC DEVICE; 3-DIMENSIONAL TISSUES; HYDROGEL MICROBEADS; LADEN MICROFIBERS; FLOW LITHOGRAPHY; BLOOD-VESSELS; AQUEOUS-PHASE; LIVING CELLS	Microsized cellular constructs such as cellular aggregates and cell-laden hydrogel blocks are attractive cellular building blocks to reconstruct 3D macroscopic tissues with spatially ordered cells in bottom-up tissue engineering. In this regard, microfluidic techniques are remarkable methods to form microsized cellular constructs with high production rate and control of their shapes such as point, line, and plane. The fundamental shapes of the cellular constructs allow for the fabrication of larger arbitrary-shaped tissues by assembling them. This review introduces microfluidic formation methods of microsized cellular constructs and manipulation techniques to assemble them with control of their arrangements. Additionally, we show applications of the cellular constructs to biological studies and clinical treatments and discuss future trends as their potential applications. (C) 2015 Elsevier B.V. All rights reserved.	[Takeuchi, Shoji] Univ Tokyo, Ctr Int Res Integrat Biomed Syst CIBiS, IIS, Meguro Ku, Tokyo 1538505, Japan; KOL, Takeuchi Biohybrid Innovat Project, Exploratory Res Adv Technol ERATO, JST, Tokyo 1538904, Japan	Takeuchi, S (reprint author), Univ Tokyo, Ctr Int Res Integrat Biomed Syst CIBiS, IIS, Meguro Ku, 4-6-1 Komaba, Tokyo 1538505, Japan.	takeuchi@iis.u-tokyo.ac.jp					Huang SB, 2010, SENSOR ACTUAT B-CHEM, V147, P755, DOI 10.1016/j.snb.2010.04.021; Jun Y, 2013, BIOMATERIALS, V34, P8122, DOI 10.1016/j.biomaterials.2013.07.079; Matsunaga YT, 2011, ADV MATER, V23, pH90, DOI 10.1002/adma.201004375; Nichol JW, 2009, SOFT MATTER, V5, P1312, DOI 10.1039/b814285h; Kang E, 2011, NAT MATER, V10, P877, DOI [10.1038/nmat3108, 10.1038/NMAT3108]; Ota H, 2010, SENSOR ACTUAT B-CHEM, V147, P359, DOI 10.1016/j.snb.2009.11.061; Zhang SM, 2010, NAT MATER, V9, P594, DOI [10.1038/nmat2778, 10.1038/NMAT2778]; Kim LN, 2011, LAB CHIP, V11, P48, DOI [10.1039/c0lc00369g, 10.1039/c01c00369g]; O'Brien FJ, 2011, MATER TODAY, V14, P88, DOI 10.1016/S1369-7021(11)70058-X; Utada AS, 2005, SCIENCE, V308, P537, DOI 10.1126/science.1109164; McGuigan AP, 2006, P NATL ACAD SCI USA, V103, P11461, DOI 10.1073/pnas.0602740103; Chung SE, 2008, NAT MATER, V7, P581, DOI 10.1038/nmat2208; Okushima S, 2004, LANGMUIR, V20, P9905, DOI 10.1021/la0480336; Leng L, 2012, ADV MATER, V24, P3650, DOI 10.1002/adma.201201442; Matsusaki M, 2014, ADV DRUG DELIVER REV, V74, P95, DOI 10.1016/j.addr.2014.01.003; Ma SH, 2013, J MATER CHEM B, V1, P5128, DOI 10.1039/c3tb20851f; Nakamura M, 2008, J IMAGING SCI TECHN, V52, DOI 10.2352/J.ImagingSci.Technol.(2008)52:6(060201); Norotte C, 2009, BIOMATERIALS, V30, P5910, DOI 10.1016/j.biomaterials.2009.06.034; Griffiths AD, 2006, TRENDS BIOTECHNOL, V24, P395, DOI 10.1016/j.tibtech.2006.06.009; Morimoto Y, 2009, BIOMED MICRODEVICES, V11, P369, DOI 10.1007/s10544-008-9243-y; Onoe H, 2014, RSC ADV, V4, P30480, DOI 10.1039/c4ra02773f; Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Tan WH, 2007, ADV MATER, V19, P2696, DOI 10.1002/adma.200700433; Liu K, 2012, MICROFLUID NANOFLUID, V13, P761, DOI 10.1007/s10404-012-0998-3; Deng YL, 2011, LAB CHIP, V11, P4117, DOI 10.1039/c1lc20494g; Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5; Aikawa T, 2012, LANGMUIR, V28, P2145, DOI 10.1021/la2037586; Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6; Lee KH, 2010, LAB CHIP, V10, P1328, DOI 10.1039/b924987g; Sakai S, 2008, BIOMACROMOLECULES, V9, P2036, DOI 10.1021/bm800286v; Tsuda Y, 2010, LANGMUIR, V26, P2645, DOI [10.1021/la902827y, 10.1021/la002827y]; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Tottori S, 2015, RSC ADV, V5, P33691, DOI 10.1039/c5ra01037c; Bhat ZF, 2011, J FOOD SCI TECH MYS, V48, P125, DOI 10.1007/s13197-010-0198-7; Wu LY, 2008, BIOMED MICRODEVICES, V10, P197, DOI 10.1007/s10544-007-9125-8; Selimovic S, 2012, POLYMERS-BASEL, V4, P1554, DOI 10.3390/polym4031554; Yamada M, 2012, BIOMATERIALS, V33, P8304, DOI 10.1016/j.biomaterials.2012.07.068; Nakamura M, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/1/014110; Panda P, 2008, LAB CHIP, V8, P1056, DOI 10.1039/b804234a; Zamanian B, 2010, SMALL, V6, P937, DOI 10.1002/smll.200902326; Morimoto Y, 2013, ADV HEALTHC MATER, V2, P261, DOI 10.1002/adhm.201200189; Albrecht DR, 2006, NAT METHODS, V3, P369, DOI 10.1038/NMETH873; Mazzitelli S, 2013, ADV DRUG DELIVER REV, V65, P1533, DOI 10.1016/j.addr.2013.07.021; Lin Ruei-Zhen, 2008, Biotechnology Journal, V3, P1172, DOI 10.1002/biot.200700228; Luca G, 2007, TISSUE ENG, V13, P641, DOI 10.1089/ten.2006.0137; Torisawa YS, 2007, BIOMATERIALS, V28, P559, DOI 10.1016/j.biomaterials.2006.08.054; Chan V, 2014, LAB CHIP, V14, P653, DOI 10.1039/c3lc50989c; Miyama A, 2013, RSC ADV, V3, P12299, DOI 10.1039/c3ra41747f; Liu CY, 2014, RSC ADV, V4, P46141, DOI 10.1039/c4ra09085c; Dendukuri D, 2006, NAT MATER, V5, P365, DOI 10.1038/nmat1617; Shimizu T, 2002, CIRC RES, V90, pE40, DOI 10.1161/hh0302.105722; Huh D, 2010, SCIENCE, V328, P1662, DOI 10.1126/science.1188302; Rivron NC, 2012, P NATL ACAD SCI USA, V109, P6886, DOI 10.1073/pnas.1201626109; Kato-Negishi M, 2010, BIOMATERIALS, V31, P8939, DOI 10.1016/j.biomaterials.2010.08.008; Hwang CM, 2008, LANGMUIR, V24, P6845, DOI 10.1021/la800253b; Onoe H, 2013, NAT MATER, V12, P584, DOI [10.1038/nmat3606, 10.1038/NMAT3606]; Hirayama K, 2013, BIOMATERIALS, V34, P2421, DOI 10.1016/j.biomaterials.2012.12.013; Maeda K, 2012, ADV MATER, V24, P1340, DOI 10.1002/adma.201102560; Tavana H, 2010, ADV MATER, V22, P2628, DOI 10.1002/adma.200904271; Kang E, 2012, ADV MATER, V24, P4271, DOI 10.1002/adma.201201232; Huang SB, 2014, BIOMED MICRODEVICES, V16, P345, DOI 10.1007/s10544-014-9837-5; Kato-Negishi M, 2013, ADV HEALTHC MATER, V2, P1564, DOI 10.1002/adhm.201300052; Morimoto Y, 2009, LAB CHIP, V9, P2217, DOI 10.1039/b900035f; Du YA, 2008, P NATL ACAD SCI USA, V105, P9522, DOI 10.1073/pnas.0801866105; Akiyama Y, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3581883; Elliott RB, 2007, XENOTRANSPLANTATION, V14, P157, DOI 10.1111/j.1399-3089.2007.00384.x; Wieduwild R, 2015, ANGEW CHEM INT EDIT, V54, P3962, DOI 10.1002/anie.201411400; Mironov V, 2009, BIOMATERIALS, V30, P2164, DOI 10.1016/j.biomaterials.2008.12.084; Luo HY, 2014, J TISSUE ENG REGEN M, V8, P493, DOI 10.1002/term.1554; Hong SM, 2012, LAB CHIP, V12, P3277, DOI 10.1039/c2lc40558j; Taguchi T, 2011, SCI TECHNOL ADV MAT, V12, DOI 10.1088/1468-6996/12/6/064703; Khademhosseini A, 2007, BIOMATERIALS, V28, P5087, DOI 10.1016/j.biomaterials.2007.07.021; Harimoto M, 2002, J BIOMED MATER RES, V62, P464, DOI 10.1002/jbm.10228; Allazetta S, 2013, BIOMACROMOLECULES, V14, P1122, DOI 10.1021/bm4000162; Anna SL, 2003, APPL PHYS LETT, V82, P364, DOI 10.1063/1.1537519; Thorsen T, 2001, PHYS REV LETT, V86, P4163, DOI 10.1103/PhysRevLett.86.4163; Yeo M, 2014, J MATER CHEM B, V2, P314, DOI 10.1039/c3tb21163k; Lee KH, 2009, SMALL, V5, P1264, DOI 10.1002/smll.200801667; Liu VA, 2002, BIOMED MICRODEVICES, V4, P257, DOI 10.1023/A:1020932105236; Teshima T, 2010, LAB CHIP, V10, P2443, DOI 10.1039/c004986g; Chen MQ, 2011, BIOMATERIALS, V32, P7532, DOI 10.1016/j.biomaterials.2011.06.054; Matsusaki M, 2007, ANGEW CHEM INT EDIT, V46, P4689, DOI 10.1002/anie.20070108; Matsusaki M, 2013, ADV HEALTHC MATER, V2, P534, DOI 10.1002/adhm.201200299; Bruzewicz DA, 2008, LAB CHIP, V8, P663, DOI 10.1039/b719806j; Takeuchi S, 2005, ADV MATER, V17, P1067, DOI 10.1002/adma.200401738; Yamada M, 2012, SOFT MATTER, V8, P3122, DOI 10.1039/c2sm07263g; Morimoto Y, 2011, J MICROMECH MICROENG, V21, DOI 10.1088/0960-1317/21/5/054031; Fukuda J, 2005, TISSUE ENG, V11, P1254, DOI 10.1089/ten.2005.11.1254; Sato K, 2014, ANGEW CHEM INT EDIT, V53, P11798, DOI 10.1002/anie.201404720; Morimoto Y, 2013, BIOMATER SCI-UK, V1, P257, DOI 10.1039/c2bm00117a; Tung YC, 2011, ANALYST, V136, P473, DOI 10.1039/c0an00609b; Yuan B, 2012, ADV MATER, V24, P890, DOI 10.1002/adma.201104589; Shi XT, 2013, ADV HEALTHC MATER, V2, P846, DOI 10.1002/adhm.201200333; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Mazzitelli S, 2011, LAB CHIP, V11, P1776, DOI [10.1039/c1lc20082h, 10.1039/c11c20082h]; Hsiao AY, 2009, BIOMATERIALS, V30, P3020, DOI 10.1016/j.biomaterials.2009.02.047; L'Heureux N, 2006, NAT MED, V12, P361, DOI 10.1038/nm1364; Misawa N, 2010, P NATL ACAD SCI USA, V107, P15340, DOI 10.1073/pnas.1004334107; Sugiura S, 2008, LAB CHIP, V8, P1255, DOI 10.1039/b803850c; Matsuda N, 2007, ADV MATER, V19, P3089, DOI 10.1002/adma.200701978; de Vos P, 2006, BIOMATERIALS, V27, P5603, DOI 10.1016/j.biomaterials.2006.07.010; Yang J, 2005, BIOMATERIALS, V26, P6415, DOI 10.1016/j.biomaterials.2005.04.061; Caldwell DJ, 2013, ADV HEALTHC MATER, V2, P673, DOI 10.1002/adhm.201200346; Chung B.G., 2011, LAB CHIP, V12, P45; Elbert D.L., 2011, CURR OPIN BIOTECH, V22, P1; Frey O, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5250; McGuigan AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002258; Hsiao AY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119010; Illa X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111864; Kang AhRan, 2014, Biomaterials, V35, P2651, DOI 10.1016/j.biomaterials.2013.12.073; Khan OF, 2015, ADV HEALTHC MATER, V4, DOI 10.1002/adhm.201400150; Lee DH, 2014, BIOTECHNOL J, V9, P1233, DOI 10.1002/biot.201400319; Lee WG, 2010, TISSUE ENG PART C-ME, V16, P249, DOI 10.1089/ten.TEC.2009.0248; Neto AI, 2014, ADV FUNCT MATER, V24, P5096, DOI 10.1002/adfm.201400503; Onoe H, 2015, DRUG DISCOV TODAY, V20, P236, DOI 10.1016/j.drudis.2014.10.018; Ruppen J, 2014, LAB CHIP, V14, P1198, DOI 10.1039/c3lc51093j; Sekine H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2406; Shimizu K, 2015, J BIOSCI BIOENG, V119, P212, DOI 10.1016/j.jbiosc.2014.07.003; Takahashi K., 2007, NAT REV MOL CELL BIO, V8, P839; Yang J., 2006, J CONTROL RELEASE, V116, P199; Yue T, 2014, LAB CHIP, V14, P1151, DOI 10.1039/c3lc51134k	122	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0169-409X	1872-8294		ADV DRUG DELIVER REV	Adv. Drug Deliv. Rev.	DEC 1	2015	95						29	39		10.1016/j.addr.2015.09.003		11	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CY2FM	WOS:000366224200004		
J	Tominaga, N; Yoshioka, Y; Ochiya, T				Tominaga, Naoomi; Yoshioka, Yusuke; Ochiya, Takahiro			A novel platform for cancer therapy using extracellular vesicles	ADVANCED DRUG DELIVERY REVIEWS			English	Review						Drug delivery system; Cancer; Exosome; Extracellular vesicles; Biodistribution; Cell-cell communication; microRNA	TUMOR-DERIVED EXOSOMES; DRUG-DELIVERY SYSTEM; CD8(+) CTL RESPONSES; BLOOD-BRAIN-BARRIER; CELLS; BIODISTRIBUTION; METASTASIS; MICROVESICLES; NANOPARTICLE; ACTIVATION	Extracellular vesicles (EVs) are nanometer-sized membranous vesicles and are involved in cell-to-cell communication. EVs contain several types of functional molecules, such as proteins, mRNAs, and microRNAs (miRNAs). Over the past several years, EVs have emerged as potential tools for a drug delivery system (DDS) that can target organs or cells. EVs have a function of organ tropism and are naturally occurring from cells. Therefore, EVs have expected as naturally DDSs, which have the organ tropism and a low side effect. Actually, some reports showed that EVs delivered drugs to specific organ. However, despite observed the organ tropism, the mechanisms of organ tropism of EVs are still unclear. Moreover, preservation and efficient collection of EVs are desired to be investigated. Here, we provide an overview of the methods for using EVs as DDSs. (C) 2015 The Authors. Published by Elsevier B.V.	[Tominaga, Naoomi; Yoshioka, Yusuke; Ochiya, Takahiro] Natl Canc Ctr, Res Inst, Div Mol & Cellular Med, Tokyo 1040045, Japan; [Tominaga, Naoomi] Univ Tokyo, Grad Sch Med, Tokyo, Japan; [Tominaga, Naoomi] JSPS, Tokyo, Japan	Ochiya, T (reprint author), Natl Canc Ctr, Res Inst, Div Mol & Cellular Med, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	tochiya@ncc.go.jp			Ministry of Education, Culture, Sports, Science and Technology; Japanese Ministry of Education, Culture, Sports, Science and Technology; Center of Open Innovation Network for Smart Health (COINS) - Council for Science and Technology Policy	This work was supported in part by a Grant-in-Aid for the third term of a comprehensive 10-year strategy for cancer control; a Grant-in-Aid for scientific research on priority areas in cancer from the Ministry of Education, Culture, Sports, Science and Technology; a Grant-in-Aid for the Japan Society for the Promotion of Science (JSPS) fellows; a Grant-in-Aid for the Japan Science and Technology Agency (JST) through the Center of Open Innovation Network for Smart Health (COINS) initiated by the Council for Science and Technology Policy; a Grant-in-Aid for the Japan Agency for Medical Research and Development (A-MED); a Grant-in-Aid for Basic Science and Platform Technology Program for Innovative Biological Medicine; a Grant-in-Aid for a research program of the Project for Development of Innovative Research on Cancer Therapeutics (P-Direct); and a Grant-in-Aid for Scientific Research on Innovative Areas (functional machinery for non-coding RNAs) from the Japanese Ministry of Education, Culture, Sports, Science and Technology.	Aliotta J. M., 2011, CELL, V38, P233; Nanjundappa RH, 2011, VACCINE, V29, P3538, DOI 10.1016/j.vaccine.2011.02.095; Veronese FM, 2005, DRUG DISCOV TODAY, V10, P1451, DOI 10.1016/S1359-6446(05)03575-0; Akers JC, 2013, J NEURO-ONCOL, V113, P1, DOI 10.1007/s11060-013-1084-8; Kooijmans SAA, 2012, INT J NANOMED, V7, P1525, DOI 10.2147/IJN.S29661; Tian YH, 2014, BIOMATERIALS, V35, P2383, DOI 10.1016/j.biomaterials.2013.11.083; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Grange C, 2014, INT J MOL MED, V33, P1055, DOI 10.3892/ijmm.2014.1663; van Dommelen SM, 2012, J CONTROL RELEASE, V161, P635, DOI 10.1016/j.jconrel.2011.11.021; Zitvogel L, 1998, NAT MED, V4, P594, DOI 10.1038/nm0598-594; Al-Jamal WT, 2011, ACCOUNTS CHEM RES, V44, P1094, DOI 10.1021/ar200105p; Rupert DLM, 2014, ANAL CHEM, V86, P5929, DOI 10.1021/ac500931f; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Sun DM, 2010, MOL THER, V18, P1606, DOI 10.1038/mt.2010.105; Haney MJ, 2015, J CONTROL RELEASE, V207, P18, DOI 10.1016/j.jconrel.2015.03.033; Jang SC, 2013, ACS NANO, V7, P7698, DOI 10.1021/nn402232g; Natasha G, 2014, CLIN THER, V36, P820, DOI 10.1016/j.clinthera.2014.04.019; Rana S, 2011, INT J BIOCHEM CELL B, V43, P106, DOI [10.1016/j.biocel.2010.10.002, 10.1016/j.bioce1.2010.10.002]; Lattanzi L, 2012, VACCINE, V30, P7229, DOI 10.1016/j.vaccine.2012.10.010; Fong MY, 2015, NAT CELL BIOL, V17, P183, DOI 10.1038/ncb3094; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Zhou H, 2006, KIDNEY INT, V69, P1471, DOI 10.1038/sj.ki.5000273; Akao Y, 2011, MOL THER, V19, P395, DOI 10.1038/mt.2010.254; Shen C, 2011, J INT MED RES, V39, P740; Cho KJ, 2008, CLIN CANCER RES, V14, P1310, DOI 10.1158/1078-0432.CCR-07-1441; Dai S, 2008, MOL THER, V16, P782, DOI 10.1038/mt.2008.1; Wolfers J, 2001, NAT MED, V7, P297, DOI 10.1038/85438; Zhuang XY, 2011, MOL THER, V19, P1769, DOI 10.1038/mt.2011.164; Hood JL, 2011, CANCER RES, V71, P3792, DOI 10.1158/0008-5472.CAN-10-4455; Yang TZ, 2015, PHARM RES-DORDR, V32, P2003, DOI 10.1007/s11095-014-1593-y; Tominaga N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7716; Takahashi Y, 2013, J BIOTECHNOL, V165, P77, DOI 10.1016/j.jbiotec.2013.03.013; Lai CP, 2014, ACS NANO, V8, P483, DOI 10.1021/nn404945r; Kosaka N, 2013, J BIOL CHEM, V288, P10849, DOI 10.1074/jbc.M112.446831; Pan SF, 2014, J CELL PHYSIOL, V229, P631, DOI 10.1002/jcp.24486; Pap E, 2009, INFLAMM RES, V58, P1, DOI 10.1007/s00011-008-8210-7; Tominaga N, 2015, SEMIN CELL DEV BIOL, V40, P52, DOI [10.1016/j.semcdb.2015.02.016, 10.1016/j.semedb.2015.02.016]; Kalani A, 2014, LIFE SCI, V107, P1, DOI 10.1016/j.lfs.2014.04.018; Rountree RB, 2011, CANCER RES, V71, P5235, DOI 10.1158/0008-5472.CAN-10-4076; Brannon-Peppas L, 2012, ADV DRUG DELIVER REV, V64, P206, DOI 10.1016/j.addr.2012.09.033; Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; Munoz JL, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.60; Hao SG, 2007, J LEUKOCYTE BIOL, V82, P829, DOI 10.1189/jlb.0407249; Zomer A, 2015, CELL, V161, P1046, DOI 10.1016/j.cell.2015.04.042; Hao SG, 2007, J IMMUNOL, V179, P2731; Rana S, 2012, INT J BIOCHEM CELL B, V44, P1574, DOI 10.1016/j.biocel.2012.06.018; Koga K, 2005, ANTICANCER RES, V25, P3703; Nordin JZ, 2015, NANOMED-NANOTECHNOL, V11, P879, DOI 10.1016/j.nano.2015.01.003; Chow A, 2014, SCI REP-UK, V4, DOI 10.1038/srep05750; EL Andaloussi S, 2013, NAT REV DRUG DISCOV, V12, P348, DOI 10.1038/nrd3978; Enriti I. L., 2012, NAT PROTOC, V7, P2112; Escudier B., 2005, J TRANSL MED, V3, P10, DOI DOI 10.1186/1479-5876-3-10; Farokhzad O. C., 2009, ACS NANO, V3, P16, DOI DOI 10.1021/NN900002M; Federici C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088193; Gould S.J., 2013, J EXTRACELL VESICLES, V2, P3; Grapp M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3123; Inder K. L, 2014, J EXTRACELL VESICLES, V3, P1; Irina Nazarenko P. A., 2013, METHOD MOL BIOL, V1049, P495; Maas SLN, 2015, J CONTROL RELEASE, V200, P87, DOI 10.1016/j.jconrel.2014.12.041; Morse MA, 2005, J TRANSL MED, V3, P9, DOI DOI 10.1186/1479-5876-3-9; Ohno S.-I., 2012, MOL THER, V21, P185, DOI DOI 10.1038/MT.2012.180; Pascucci L, 2014, J CONTROL RELEASE, V192, P262, DOI 10.1016/j.jconrel.2014.07.042; Smyth T, 2015, J CONTROL RELEASE, V199, P145, DOI 10.1016/j.jconrel.2014.12.013; Wiklander OPB, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.26316; Zech D, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-37; Zhao YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106867	66	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0169-409X	1872-8294		ADV DRUG DELIVER REV	Adv. Drug Deliv. Rev.	DEC 1	2015	95						50	55		10.1016/j.addr.2015.10.002		6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CY2FM	WOS:000366224200006		
J	Shinjo, K; Kondo, Y				Shinjo, Keiko; Kondo, Yutaka			Targeting cancer epigenetics: Linking basic biology to clinical medicine	ADVANCED DRUG DELIVERY REVIEWS			English	Review						DNA methylation; Histone modification; Biomarker; Liquid biopsy; Epigenetic therapy	ISLAND METHYLATOR PHENOTYPE; BET BROMODOMAIN INHIBITION; EMBRYONIC STEM-CELLS; MLL-FUSION LEUKEMIA; DNA METHYLATION; HIGH-THROUGHPUT; LUNG-CANCER; COLORECTAL-CANCER; BREAST-CANCER; SELECTIVE-INHIBITION	Recent studies provide compelling evidence that epigenetic dysregulation is involved in almost every step of tumor development and progression. Differences in tumor behavior, which ultimately reflects clinical outcome, can be explained by variations in gene expression patterns generated by epigenetic mechanisms, such as DNA methylation. Therefore, epigenetic abnormalities are considered potential biomarkers and therapeutic targets. DNA methylation is stable at certain specific loci in cancer cells and predominantly reflects the characteristic clinicopathological features. Thus, it is an ideal biomarker for cancer screening, classification and prognostic purposes. Epigenetic treatment for cancers is based on the pharmacologic targeting of various core transcriptional programs that sustains cancer cell identity. Therefore, targeting aberrant epigenetic modifiers may be effective for multiple processes compared with using a selective inhibitor of aberrant single signaling pathway. This review provides an overview of the epigenetic alterations in human cancers and discusses about novel therapeutic strategies targeting epigenetic alterations. (C) 2015 Elsevier B.V. All rights reserved.	[Shinjo, Keiko; Kondo, Yutaka] Nagoya City Univ, Grad Sch Med Sci, Dept Epigen, Mizuho Ku, Nagoya, Aichi 4678601, Japan	Kondo, Y (reprint author), Nagoya City Univ, Grad Sch Med Sci, Dept Epigen, Mizuho Ku, 1 Kawasumi, Nagoya, Aichi 4678601, Japan.	ykondo@med.nagoya-cu.ac.jp					Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Daigle SR, 2013, BLOOD, V122, P1017, DOI 10.1182/blood-2013-04-497644; Shinjo K, 2012, CARCINOGENESIS, V33, P1277, DOI 10.1093/carcin/bgs154; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Li M, 2009, NAT BIOTECHNOL, V27, P858, DOI 10.1038/nbt.1559; Van de Voorde L, 2012, MUTAT RES-REV MUTAT, V751, P304, DOI 10.1016/j.mrrev.2012.06.001; Arrowsmith CH, 2012, NAT REV DRUG DISCOV, V11, P384, DOI 10.1038/nrd3674; Qi W, 2012, P NATL ACAD SCI USA, V109, P21360, DOI 10.1073/pnas.1210371110; Vaca-Paniagua F, 2015, EPIGENOMICS-UK, V7, P353, DOI 10.2217/epi.14.94; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; O'Connor OA, 2015, J CLIN ONCOL, V33, P2492, DOI 10.1200/JCO.2014.59.2782; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Kneip C, 2011, J THORAC ONCOL, V6, P1632, DOI 10.1097/JTO.0b013e318220ef9a; Song MS, 2013, PROG NEURO-PSYCHOPH, V44, P118, DOI 10.1016/j.pnpbp.2013.02.001; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Wu T, 2011, BRIT J CANCER, V105, P65, DOI 10.1038/bjc.2011.143; Issa JPJ, 2009, CLIN CANCER RES, V15, P3938, DOI 10.1158/1078-0432.CCR-08-2783; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Dedeurwaerder S, 2011, EPIGENOMICS-UK, V3, P771, DOI [10.2217/epi.11.105, 10.2217/EPI.11.105]; Lee EJ, 2013, CANCER LETT, V340, P171, DOI 10.1016/j.canlet.2012.10.040; McCabe MT, 2012, P NATL ACAD SCI USA, V109, P2989, DOI 10.1073/pnas.1116418109; French CA, 2003, CANCER RES, V63, P304; [Anonymous], 2015, CANC DISCOV, V5, P4; Piekarz RL, 2009, J CLIN ONCOL, V27, P5410, DOI 10.1200/JCO.2008.21.6150; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; Rauch T, 2006, CANCER RES, V66, P7939, DOI 10.1158/0008-5472.CAN-06-1888; Dombret H, 2015, BLOOD, V126, P291, DOI 10.1182/blood-2015-01-621664; Toyooka S, 2001, CANCER RES, V61, P5727; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Puissant A, 2013, CANCER DISCOV, V3, P308, DOI 10.1158/2159-8290.CD-12-0418; Cairns P, 2001, CLIN CANCER RES, V7, P2727; deVos T, 2009, CLIN CHEM, V55, P1337, DOI 10.1373/clinchem.2008.115808; Federico M, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/475641; Fiegl H, 2005, CANCER RES, V65, P1141, DOI 10.1158/0008-5472.CAN-04-2438; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Okada Y, 2005, CELL, V121, P167, DOI 10.1016/j.cell.2005.02.020; Chan MWY, 2002, CLIN CANCER RES, V8, P464; Laird PW, 2010, NAT REV GENET, V11, P191, DOI 10.1038/nrg2732; Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066; Grady WM, 2007, GUT, V56, P1498, DOI 10.1136/gut.2007.125732; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Brock MV, 2008, NEW ENGL J MED, V358, P1118, DOI 10.1056/NEJMoa0706550; Chen JJ, 2010, NAT REV CANCER, V10, P23, DOI 10.1038/nrc2765; Ohnishi K, 2014, CELL, V156, P663, DOI 10.1016/j.cell.2014.01.005; Dang L, 2010, NATURE, V465, P966, DOI 10.1038/nature09132; Mottamal M, 2015, MOLECULES, V20, P3898, DOI 10.3390/molecules20033898; Imperiale TF, 2014, NEW ENGL J MED, V370, P1287, DOI 10.1056/NEJMoa1311194; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; Konze KD, 2013, ACS CHEM BIOL, V8, P1324, DOI [10.1021/cb400133j, 10.1021/cb400133J]; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Flusberg BA, 2010, NAT METHODS, V7, P461, DOI [10.1038/nmeth.1459, 10.1038/NMETH.1459]; Kisiel JB, 2012, CANCER-AM CANCER SOC, V118, P2623, DOI 10.1002/cncr.26558; Meyer C, 2013, LEUKEMIA, V27, P2165, DOI 10.1038/leu.2013.135; Jones PA, 1999, NAT GENET, V21, P163, DOI 10.1038/5947; Wang F, 2013, SCIENCE, V340, P622, DOI 10.1126/science.1234769; Timp W, 2013, NAT REV CANCER, V13, P497, DOI 10.1038/nrc3486; Juergens RA, 2011, CANCER DISCOV, V1, P598, DOI 10.1158/2159-8290.CD-11-0214; Gu HC, 2011, NAT PROTOC, V6, P468, DOI 10.1038/nprot.2010.190; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; De Braekeleer M, 2005, ANTICANCER RES, V25, P1931; Knutson SK, 2014, MOL CANCER THER, V13, P842, DOI 10.1158/1535-7163.MCT-13-0773; Branton D, 2008, NAT BIOTECHNOL, V26, P1146, DOI 10.1038/nbt.1495; Belinsky SA, 2004, NAT REV CANCER, V4, P707, DOI 10.1038/nrc1432; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Kim W, 2013, NAT CHEM BIOL, V9, P643, DOI [10.1038/nchembio.1331, 10.1038/NCHEMBIO.1331]; FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0; Thress KS, 2015, NAT MED, V21, P560, DOI 10.1038/nm.3854; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Paschka P, 2010, J CLIN ONCOL, V28, P3636, DOI 10.1200/JCO.2010.28.3762; Hayami S, 2011, INT J CANCER, V128, P574, DOI 10.1002/ijc.25349; Laird PW, 2003, NAT REV CANCER, V3, P253, DOI 10.1038/nrc1045; Fleischhacker M, 2007, BBA-REV CANCER, V1775, P181, DOI 10.1016/j.bbcan.2006.10.001; Harris WJ, 2012, CANCER CELL, V21, P473, DOI 10.1016/j.ccr.2012.03.014; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Mikeska T, 2011, METHODS MOL BIOL, V791, P33, DOI 10.1007/978-1-61779-316-5_4; Campan M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028141; Church TR, 2014, GUT, V63, P317, DOI 10.1136/gutjnl-2012-304149; Coolen MW, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm662; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Eads CA, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.8.e32; Fang F., 2011, SCI TRANSL MED, V3, DOI DOI 10.1126/SCITRANSLMED.3001875; Hill J.M., 2014, SCI TRANSL MED, V6; Hogue MO, 2006, JNCI-J NATL CANCER I, V98, P996; Johnson DA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098238; Jung M., 2015, EPIGENOMICS, P1; Kristensen LS, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn113; McCabe M.T., 2012, NATURE, V492, P108; Mohammad H, 2014, EUR J CANCER, V50, P72; Ned R.M., 2011, PLOS CURR, V3, DOI DOI 10.1371/CURRENTS.RRN1220; Olsen E.A., 2007, J CLIN ONCOL OFF J A, V25, P3109; Romanoski Casey E, 2015, Nature, V518, P314, DOI 10.1038/518314a; Ruike Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-137; Schmidt B, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-600; Toiyarna Y, 2014, BIOCHEM BIOPH RES CO, V455, P43, DOI 10.1016/j.bbrc.2014.08.001; Yan H., 2009, NEW ENGL J MED, V360, P765	104	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0169-409X	1872-8294		ADV DRUG DELIVER REV	Adv. Drug Deliv. Rev.	DEC 1	2015	95						56	64		10.1016/j.addr.2015.10.006		9	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CY2FM	WOS:000366224200007		
J	Tahara, Y; Akiyoshi, K				Tahara, Yoshiro; Akiyoshi, Kazunari			Current advances in self-assembled nanogel delivery systems for immunotherapy	ADVANCED DRUG DELIVERY REVIEWS			English	Review						Nanogel; Cancer vaccine; Cytokine delivery; Nasal vaccine; siRNA delivery	INTRACELLULAR PROTEIN DELIVERY; LINKED POLYSACCHARIDE NANOGELS; CHOLESTEROL-BEARING PULLULAN; ESOPHAGEAL CANCER-PATIENTS; CELLULAR IMMUNE-RESPONSES; CD4 T-CELLS; DENDRITIC CELLS; HYDROPHOBIZED POLYSACCHARIDE; DRUG-DELIVERY; NY-ESO-1 PROTEIN	Since nanogels (nanometer-sized gels) were developed two decades ago, they were utilized as carriers of innovative drug delivery systems. In particular, immunological drug delivery via self-assembled nanogels (self-nanogels) owing to their nanometer size and molecular chaperon-like ability to encapsulate large biomolecules is one of the most well studied and successful applications of nanogels. In the present review, we focus on self-nanogel applications as immunological drug delivery systems for cancer vaccines, cytokine delivery, nasal vaccines, and nucleic acid delivery, including several clinical trials. Cancer vaccines were the first practical application of self-nanogels as vehicles for drug delivery. After successful pre-clinical studies, phase I clinical trials were conducted, and it was found that vaccines consisting of self-nanogels could be administered repeatedly to humans without serious adverse effects, and self-nanogel vaccines induced antigen-specific cellular and humoral immunity. Cytokine delivery via self-nanogels led to the sustained release of IL-12, suppressed tumor growth, and increased Th1-type immune responses. Cationic self-nanogels were effective in penetrating the nasal mucosa and resulted in successful nasal vaccines in mice and nonhuman primates. Cationic self-nanogels were also used for the intracellular delivery of proteins and nucleic acids, and were successfully used to knockdown tumor growth factor expression using short interfering RNA with the immunological effect. These studies suggest that self-nanogels are currently one of the most unique and attractive immunological drug delivery systems and are edging closer to practical use. (C) 2015 Elsevier B.V. All rights reserved.	[Akiyoshi, Kazunari] Kyoto Univ, Grad Sch Engn, Dept Polymer Chem, Nishikyo Ku, Kyoto 6158510, Japan; Kyoto Univ, Japan Sci & Technol Agcy JST, ERATO Bionanotransporter Project, Nishikyo Ku, Kyoto 6158510, Japan	Akiyoshi, K (reprint author), Kyoto Univ, Grad Sch Engn, Dept Polymer Chem, Nishikyo Ku, Kyoto 6158510, Japan.	akiyoshi@bio.polym.kyoto-u.ac.jp					Akiyoshi K., 1996, SUPRAMOL SCI, V3, P157, DOI 10.1016/0968-5677(96)00031-4; de Titta A, 2013, P NATL ACAD SCI USA, V110, P19902, DOI 10.1073/pnas.1313152110; Akiyama E, 2007, BIOMACROMOLECULES, V8, P2366, DOI 10.1021/bm070136q; Hayashi C, 2009, J CELL PHYSIOL, V220, P1, DOI 10.1002/jcp.21760; Tsuji K, 2008, CANCER IMMUNOL IMMUN, V57, P1429, DOI 10.1007/s00262-008-0478-5; Muraoka D, 2014, ACS NANO, V8, P9209, DOI 10.1021/nn502975r; Cho JK, 2009, J APPL POLYM SCI, V113, P2209, DOI 10.1002/app.30049; AKIYOSHI K, 1993, MACROMOLECULES, V26, P3062, DOI 10.1021/ma00064a011; Aoki M, 2009, VACCINE, V27, P6854, DOI 10.1016/j.vaccine.2009.09.018; Gu XG, 1998, CANCER RES, V58, P3385; Nishikawa T, 1996, J AM CHEM SOC, V118, P6110, DOI 10.1021/ja953843c; Moon JJ, 2011, NAT MATER, V10, P243, DOI [10.1038/nmat2960, 10.1038/NMAT2960]; Tahara Y, 2013, REACT FUNCT POLYM, V73, P958, DOI 10.1016/j.reactfunctpolym.2013.02.002; Miyai K, 2009, J BIOL CHEM, V284, P10593, DOI 10.1074/jbc.M807677200; Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673; NISHIKAWA T, 1994, MACROMOLECULES, V27, P7654, DOI 10.1021/ma00104a021; Ozawa Y, 2009, MACROMOL BIOSCI, V9, P694, DOI 10.1002/mabi.200800288; Nakamura Y, 2009, LUNG CANCER, V65, P119, DOI 10.1016/j.lungcan.2008.12.020; Kataoka K, 2001, ADV DRUG DELIVER REV, V47, P113, DOI 10.1016/S0169-409X(00)00124-1; Shimizu T, 2008, BIOCHEM BIOPH RES CO, V367, P330, DOI 10.1016/j.bbrc.2007.12.112; Miyahara T, 2012, J TISSUE ENG REGEN M, V6, P666, DOI 10.1002/term.475; Batrakova EV, 2008, J CONTROL RELEASE, V130, P98, DOI 10.1016/j.jconrel.2008.04.013; Ayame H, 2008, BIOCONJUGATE CHEM, V19, P882, DOI 10.1021/bc700422s; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; Ferreira SA, 2011, MATERIALS, V4, P601, DOI 10.3390/ma4040601; Hasegawa K, 2006, CLIN CANCER RES, V12, P1921, DOI 10.1158/1078-0432.CCR-05-1900; Akiyoshi K, 1998, CHEM LETT, P93; Lesterhuis WJ, 2011, NAT REV DRUG DISCOV, V10, P591, DOI 10.1038/nrd3500; Danesh-Bahreini MA, 2011, INT J NANOMED, V6, P835, DOI 10.2147/IJN.S16805; Krishnamachari Y, 2011, PHARM RES-DORDR, V28, P215, DOI 10.1007/s11095-010-0241-4; Li P, 2013, J CONTROL RELEASE, V168, P271, DOI 10.1016/j.jconrel.2013.03.025; Zhu Q, 2012, NAT MED, V18, P1291, DOI 10.1038/nm.2866; Kwon S, 2003, LANGMUIR, V19, P10188, DOI 10.1021/la0350608; Watanabe K, 2011, BIOMATERIALS, V32, P5900, DOI 10.1016/j.biomaterials.2011.04.058; Takahashi H, 2013, BIOMATER SCI-UK, V1, P842, DOI 10.1039/c3bm00178d; Siegwart DJ, 2012, PROG POLYM SCI, V37, P18, DOI 10.1016/j.progpolymsci.2011.08.001; Bontha S, 2006, J CONTROL RELEASE, V114, P163, DOI 10.1016/j.jconrel.2006.06.015; Sasaki Y, 2011, CHEM LETT, V40, P182, DOI 10.1246/cl.2011.182; Mundargi RC, 2008, J CONTROL RELEASE, V125, P193, DOI 10.1016/j.jconrel.2007.09.013; Kageyama S, 2008, CANCER SCI, V99, P601, DOI 10.1111/j.1349-7006.2007.00705.x; Ferreira SA, 2013, NANOMED-NANOTECHNOL, V9, P159, DOI 10.1016/j.nano.2012.06.001; Kurosaki T, 2012, PHARM RES-DORDR, V29, P483, DOI 10.1007/s11095-011-0571-x; Ariga K, 2011, ADV DRUG DELIVER REV, V63, P762, DOI 10.1016/j.addr.2011.03.016; AKIYOSHI K, 1992, CHEM LETT, P1727, DOI 10.1246/cl.1992.1727; Kobiyama K, 2014, P NATL ACAD SCI USA, V111, P3086, DOI 10.1073/pnas.1319268111; Demento SL, 2012, BIOMATERIALS, V33, P4957, DOI 10.1016/j.biomaterials.2012.03.041; Debache K, 2011, PARASITE IMMUNOL, V33, P81, DOI 10.1111/j.1365-3024.2010.01255.x; Morimoto N, 2009, SOFT MATTER, V5, P1597, DOI 10.1039/b817603e; Kawabata R, 2007, INT J CANCER, V120, P2178, DOI 10.1002/ijc.22583; Terech P, 1997, CHEM REV, V97, P3133, DOI 10.1021/cr9700282; Akiyoshi K, 1999, BIOCONJUGATE CHEM, V10, P321, DOI 10.1021/bc9801272; Roy K, 1999, NAT MED, V5, P387; Chen YT, 1997, P NATL ACAD SCI USA, V94, P1914, DOI 10.1073/pnas.94.5.1914; Akiyoshi K, 1997, MACROMOLECULES, V30, P857, DOI 10.1021/ma960786e; Na K, 2006, BIOTECHNOL BIOPROC E, V11, P262, DOI 10.1007/BF02932041; Fukuyama Y, 2015, MUCOSAL IMMUNOL, V8, P1144, DOI 10.1038/mi.2015.5; Lee S, 2014, ACS NANO, V8, P2048, DOI 10.1021/nn406584y; Wada H, 2008, INT J CANCER, V123, P2362, DOI 10.1002/ijc.23810; Naeye B, 2011, BIOMATERIALS, V32, P9120, DOI 10.1016/j.biomaterials.2011.08.015; Sangha R, 2007, CLIN CANCER RES, V13, p4652S, DOI 10.1158/1078-0432.CCR-07-0213; [Anonymous], 2014, PHARM RES; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Sasaki Y, 2011, POLYM CHEM-UK, V2, P1267, DOI 10.1039/c1py00100k; Tahara Y, 2015, BIOMATER SCI-UK, V3, P256, DOI 10.1039/c4bm00293h; Prego C, 2010, VACCINE, V28, P2607, DOI 10.1016/j.vaccine.2010.01.011; Toita S, 2009, CHEM LETT, V38, P1114, DOI 10.1246/cl.2009.1114; Stano A, 2013, BIOMATERIALS, V34, P4339, DOI 10.1016/j.biomaterials.2013.02.024; Kabanov AV, 2009, ANGEW CHEM INT EDIT, V48, P5418, DOI 10.1002/anie.200900441; Nochi T, 2010, NAT MATER, V9, P572, DOI [10.1038/nmat2784, 10.1038/NMAT2784]; Hu YH, 2009, BIOMACROMOLECULES, V10, P756, DOI 10.1021/bm801199z; Na JH, 2011, BIOMATERIALS, V32, P5252, DOI 10.1016/j.biomaterials.2011.03.076; Shimoda A, 2011, MACROMOL BIOSCI, V11, P882, DOI 10.1002/mabi.201000491; Mizote Y, 2014, VACCINE, V32, P957, DOI 10.1016/j.vaccine.2013.12.042; Hubbell JA, 2013, NAT MATER, V12, P963, DOI 10.1038/nmat3788; Standley SM, 2004, BIOCONJUGATE CHEM, V15, P1281, DOI 10.1021/bc049956f; Kitano S, 2006, CLIN CANCER RES, V12, P7397, DOI 10.1158/1078-0432.CCR-06-1546; Hashimoto Y, 2015, BIOMATERIALS, V37, P107, DOI 10.1016/j.biomaterials.2014.10.045; Kumar M, 2002, HUM GENE THER, V13, P1415, DOI 10.1089/10430340260185058; Hasegawa U, 2009, J CONTROL RELEASE, V140, P312, DOI 10.1016/j.jconrel.2009.06.025; Aleman J, 2007, PURE APPL CHEM, V79, P1801, DOI 10.1351/pac200779101801; Ikuta Y, 2002, BLOOD, V99, P3717, DOI 10.1182/blood.V99.10.3717; Schutz CA, 2011, BIOMACROMOLECULES, V12, P4153, DOI 10.1021/bm201231x; Nakai T, 2012, MACROMOL BIOSCI, V12, P475, DOI 10.1002/mabi.201100352; Reddy ST, 2007, NAT BIOTECHNOL, V25, P1159, DOI 10.1038/nbtl332; Hu Y, 2007, NANO LETT, V7, P3056, DOI 10.1021/nl071542i; Yuba E, 2015, BIOMATERIALS, V67, P214, DOI 10.1016/j.biomaterials.2015.07.031; Cohen JA, 2009, BIOCONJUGATE CHEM, V20, P111, DOI 10.1021/bc800338n; Khatri K, 2008, INT J PHARM, V354, P235, DOI 10.1016/j.ijpharm.2007.11.027; Sakurai K, 2001, BIOMACROMOLECULES, V2, P641, DOI 10.1021/bm000121r; Kamolratanakul P, 2011, ARTHRITIS RHEUM-US, V63, P1021, DOI 10.1002/art.30151; Bronich TK, 2005, J AM CHEM SOC, V127, P8236, DOI 10.1021/ja043042m; Akiyoshi K, 1998, J CONTROL RELEASE, V54, P313, DOI 10.1016/S0168-3659(98)00017-0; Hasegawa U, 2005, BIOCHEM BIOPH RES CO, V331, P917, DOI 10.1016/j.bbrc.2005.03.228; Toita S, 2010, BIOMACROMOLECULES, V11, P397, DOI 10.1021/bm901109z; Moon JJ, 2012, ADV MATER, V24, P3724, DOI 10.1002/adma.201200446; Gu Z, 2011, CHEM SOC REV, V40, P3638, DOI 10.1039/c0cs00227e; Oh JK, 2009, PROG POLYM SCI, V34, P1261, DOI 10.1016/j.progpolymsci.2009.08.001; Akagi T, 2005, J CONTROL RELEASE, V108, P226, DOI 10.1016/j.jconrel.2005.08.003; Hu CMJ, 2011, P NATL ACAD SCI USA, V108, P10980, DOI 10.1073/pnas.1106634108; Akagi T, 2007, BIOMATERIALS, V28, P3427, DOI 10.1016/j.biomaterials.2007.04.023; Discher DE, 2006, ANNU REV BIOMED ENG, V8, P323, DOI 10.1146/annurev.bioeng.8.061505.095838; Sasaki Y, 2010, CHEM REC, V10, P366, DOI 10.1002/tcr.201000008; Xu W, 2004, VACCINE, V22, P3603, DOI 10.1016/j.vaccine.2004.03.033; Kawada J, 2012, INT J CANCER, V130, P584, DOI 10.1002/ijc.26074; Yamane S, 2008, CHEM LETT, V37, P1282, DOI 10.1246/cl.2008.1282; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Shimoda A, 2012, COLLOID SURFACE B, V99, P38, DOI 10.1016/j.colsurfb.2011.09.025; Scanlan MJ, 2002, IMMUNOL REV, V188, P22, DOI 10.1034/j.1600-065X.2002.18803.x; Miyamoto N, 2014, CHEM LETT, V43, P991, DOI 10.1246/cl.140164; Pack DW, 2005, NAT REV DRUG DISCOV, V4, P581, DOI 10.1038/nrd1775; Ignatius R, 2000, BLOOD, V96, P3505; Shiku H, 2000, CANCER CHEMOTH PHARM, V46, pS77, DOI 10.1007/s002800000179; Mizote Y, 2010, VACCINE, V28, P5338, DOI 10.1016/j.vaccine.2010.05.044; Borges O., 2008, EUR J PHARM BIOPHARM, V69, P405; Calvo P, 1997, J APPL POLYM SCI, V63, P125, DOI 10.1002/(SICI)1097-4628(19970103)63:1<125::AID-APP13>3.0.CO;2-4; Demoulins T, 2013, NANOMED-NANOTECHNOL, V9, P806, DOI 10.1016/j.nano.2013.01.002; Flory P. J., 1974, FARADAY DISCUSS, V57, P7, DOI 10.1039/dc9745700007; Fujii H, 2014, CANCER SCI, V105, P1616, DOI 10.1111/cas.12547; Fujioka-Kobayashi M, 2012, BIOMATERIALS, V33, P7613, DOI 10.1016/j.biomaterials.2012.06.075; Hermans P. H., 1949, COLLOID SCIENCE, V2, P483; Hirakura T, 2004, BIOMACROMOLECULES, V5, P1804, DOI 10.1021/bm049860o; Hu CMJ, 2013, NAT NANOTECHNOL, V8, P933, DOI [10.1038/nnano.2013.254, 10.1038/NNANO.2013.254]; Isobe Midori, 2009, Cancer Immun, V9, P8; Kageyama S, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-246; Kong IG, 2013, INFECT IMMUN, V81, P1625, DOI 10.1128/IAI.00240-13; Li A. V., 2013, SCI TRANSL MED, V5; Lloyd D. J., 1926, COLLOID CHEM, V1, P767; Saito T, 2014, VACCINE, V32, P5901, DOI 10.1016/j.vaccine.2014.09.002; Tahara Y., 2014, ENCY POLYM NANOMATER, P1; Takahashi H, 2011, ACS NANO, V5, P337, DOI 10.1021/nn101447m; Uenaka Akiko, 2007, Cancer Immun, V7, P9; Wu W, 2015, BIOMATERIALS, V39, P260, DOI 10.1016/j.biomaterials.2014.11.005	132	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0169-409X	1872-8294		ADV DRUG DELIVER REV	Adv. Drug Deliv. Rev.	DEC 1	2015	95						65	76		10.1016/j.addr.2015.10.004		12	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CY2FM	WOS:000366224200008		
J	Somiya, M; Kuroda, S				Somiya, Masaharu; Kuroda, Shun'ichi			Development of a virus-mimicking nanocarrier for drug delivery systems: The bio-nanocapsule	ADVANCED DRUG DELIVERY REVIEWS			English	Review						Active targeting; Biomimicking; Hepatitis B virus; Liposome; Membrane fusion; Virus-like particle	HEPATITIS-B-VIRUS; MODIFIED TIO2 NANOPARTICLES; HUMAN-SERUM-ALBUMIN; L-PROTEIN PARTICLES; ANTIGEN L PROTEIN; GENE-DELIVERY; SURFACE-ANTIGEN; IN-VIVO; CANCER-THERAPY; DISPLAYING BIONANOCAPSULES	As drug delivery systems, nanocarriers should be capable of executing the following functions: evasion of the host immune system, targeting to the diseased site, entering cells, escaping from endosomes, and releasing payloads into the cytoplasm. Since viruses perform some or all of these functions, they are considered naturally occurring nanocarriers. To achieve biomimicry of the hepatitis B virus (HBV), we generated the "bio-nanocapsule" (BNC)-which deploys the human hepatocyte-targeting domain, fusogenic domain, and polymerized-albumin receptor domain of HBV envelope L protein on its surface-by overexpressing the L protein in yeast cells. BNCs are capable of delivering various payloads to the cytoplasm of human hepatic cells specifically in vivo, which is achieved via formation of complexes with various materials (e.g., drugs, nucleic acids, and proteins) by electroporation, fusion with liposomes, or chemical modification. In this review, we describe BNC-related technology, discuss retargeting strategies for BNCs, and outline other virus-inspired nanocarriers. (C) 2015 Elsevier B.V. All rights reserved.	[Somiya, Masaharu; Kuroda, Shun'ichi] Osaka Univ, Inst Sci & Ind Res, Ibaraki, Osaka 5670047, Japan; [Somiya, Masaharu; Kuroda, Shun'ichi] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Somiya, Masaharu] Japan Soc Promot Sci, Tokyo 1020083, Japan	Kuroda, S (reprint author), Osaka Univ, Inst Sci & Ind Res, Mihogaoka 8-1, Ibaraki, Osaka 5670047, Japan.	skuroda@sanken.osaka-u.ac.jp			Naito Foundation; Okawa Foundation; KAKENHI [25242043, 25003835]; Health Labor Sciences Research Grant from the Ministry of Health Labor and Welfare	This work was supported in part by The Naito Foundation (to S.K.), The Okawa Foundation (to S.K.), KAKENHI (Grant-in-Aid for Scientific Research [A], 25242043, to S.K.; Grant-in-Aid for JSPS Fellows, 25003835, to M.S.), and a Health Labor Sciences Research Grant from the Ministry of Health Labor and Welfare (to S.K.).	ALMEIDA JD, 1975, LANCET, V2, P899; KANEDA Y, 1989, SCIENCE, V243, P375, DOI 10.1126/science.2911748; Khalil IA, 2006, PHARMACOL REV, V58, P32, DOI 10.1124/pr.58.1.8; KRONE B, 1990, HEPATOLOGY, V11, P1050, DOI 10.1002/hep.1840110622; KURODA S, 1992, J BIOL CHEM, V267, P1953; Barenholz Y, 2012, J CONTROL RELEASE, V160, P117, DOI 10.1016/j.jconrel.2012.03.020; Kurata N, 2008, J BIOCHEM, V144, P701, DOI 10.1093/jb/mvn131; KURODA S, 1991, VACCINE, V9, P163, DOI 10.1016/0264-410X(91)90148-Y; Watashi K, 2014, INT J MOL SCI, V15, P2892, DOI 10.3390/ijms15022892; Akinc A, 2005, J GENE MED, V7, P657, DOI 10.1002/jgm.696; Schulze A, 2007, HEPATOLOGY, V46, P1759, DOI 10.1002/hep.21896; Maeda H, 2001, ADV ENZYME REGUL, V41, P189, DOI 10.1016/S0065-2571(00)00013-3; VALENZUELA P, 1982, NATURE, V298, P347, DOI 10.1038/298347a0; Waelti E, 2002, CANCER RES, V62, P437; Murata M, 2012, INT J NANOMED, V7, P4353, DOI 10.2147/IJN.S31365; Deshane J, 2003, J BIOL CHEM, V278, P4135, DOI 10.1074/jbc.M205662200; Katayama Y, 2002, BIOMACROMOLECULES, V3, P905, DOI 10.1021/bm025532h; Kasuya T, 2009, METHOD ENZYMOL, V464, P147, DOI 10.1016/S0076-6879(09)64008-8; Somiya M, 2012, BIOORGAN MED CHEM, V20, P3873, DOI 10.1016/j.bmc.2012.04.031; Teng LS, 2012, EXPERT OPIN DRUG DEL, V9, P901, DOI 10.1517/17425247.2012.694863; Somiya M, 2015, J CONTROL RELEASE, V212, P10, DOI 10.1016/j.jconrel.2015.06.012; Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387; Tacken PJ, 2007, NAT REV IMMUNOL, V7, P790, DOI 10.1038/nri2173; Salisse J, 2009, J VIROL, V83, P9321, DOI 10.1128/JVI.00678-09; Ohno M, 2014, ONCOTARGET, V5, P5581; Hama S, 2006, MOL THER, V13, P786, DOI 10.1016/j.ymthe.2005.10.007; Ludwig C, 2007, CURR OPIN BIOTECH, V18, P537, DOI 10.1016/j.copbio.2007.10.013; Somiya M, 2015, INT J PHARMACEUT, V490, P316, DOI 10.1016/j.ijpharm.2015.05.072; Nagaoka T, 2007, J CONTROL RELEASE, V118, P348, DOI 10.1016/j.jconrel.2006.12.020; Ninomiya K, 2012, ULTRASON SONOCHEM, V19, P607, DOI 10.1016/j.ultsonch.2011.09.009; Ogino C, 2010, BIOORG MED CHEM LETT, V20, P5320, DOI 10.1016/j.bmcl.2010.06.124; NEURATH AR, 1986, CELL, V46, P429, DOI 10.1016/0092-8674(86)90663-X; Oess S, 2000, GENE THER, V7, P750, DOI 10.1038/sj.gt.3301154; Enomoto T, 2011, VIROLOGY, V420, P1, DOI 10.1016/j.virol.2011.08.014; Iwamoto M, 2014, BIOCHEM BIOPH RES CO, V443, P808, DOI 10.1016/j.bbrc.2013.12.052; GLUCK R, 1992, J CLIN INVEST, V90, P2491, DOI 10.1172/JCI116141; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Li H, 2014, CELL MOL IMMUNOL, V11, P175, DOI 10.1038/cmi.2013.66; Tsutsui Y, 2007, J CONTROL RELEASE, V122, P159, DOI 10.1016/j.jconrel.2007.06.019; Matsuo H, 2012, INT J NANOMED, V7, P3341, DOI 10.2147/IJN.S32813; Shishido T, 2009, BIOORG MED CHEM LETT, V19, P1473, DOI 10.1016/j.bmcl.2009.01.049; Kasuya T, 2008, HUM GENE THER, V19, P887, DOI 10.1089/hum.2008.037; Kasuya T, 2008, FEBS J, V275, P5714, DOI 10.1111/j.1742-4658.2008.06698.x; Yamada T, 2001, VACCINE, V19, P3154, DOI 10.1016/S0264-410X(01)00017-2; Kusumoto K, 2014, INT J PHARMACEUT, V473, P144, DOI 10.1016/j.ijpharm.2014.07.007; Miyata T, 2013, MICROBIOL IMMUNOL, V57, P470, DOI 10.1111/1348-0421.12055; Heidel JD, 2007, P NATL ACAD SCI USA, V104, P5715, DOI 10.1073/pnas.0701458104; Iijima M, 2011, BIOMATERIALS, V32, P1455, DOI 10.1016/j.biomaterials.2010.10.057; Yamada T, 2003, NAT BIOTECHNOL, V21, P885, DOI 10.1038/nbt843; NEURATH AR, 1989, VACCINE, V7, P234; Kitai Y, 2011, J BIOTECHNOL, V155, P251, DOI 10.1016/j.jbiotec.2011.06.030; Shishido T, 2009, J BIOCHEM, V146, P867, DOI 10.1093/jb/mvp134; Yan H, 2013, J VIROL, V87, P7977, DOI 10.1128/JVI.03540-12; TIOLLAIS P, 1985, NATURE, V317, P489, DOI 10.1038/317489a0; Felnerova D, 2004, CURR OPIN BIOTECH, V15, P518, DOI 10.1016/j.copbio.2004.10.005; ITOH Y, 1992, J BIOTECHNOL, V23, P71, DOI 10.1016/0168-1656(92)90100-N; Zhang XM, 2014, BIOMATERIALS, V35, P6130, DOI 10.1016/j.biomaterials.2014.04.037; Meier A, 2013, HEPATOLOGY, V58, P31, DOI 10.1002/hep.26181; Oishi J, 2010, INT J PHARMACEUT, V396, P174, DOI 10.1016/j.ijpharm.2010.06.012; Kaneda Y, 2012, ADV DRUG DELIVER REV, V64, P730, DOI 10.1016/j.addr.2011.03.007; Hyodo M, 2014, J CONTROL RELEASE, V193, P316, DOI 10.1016/j.jconrel.2014.04.023; Maeda H, 2015, ADV DRUG DELIVER REV, V91, P3, DOI 10.1016/j.addr.2015.01.002; Yu DW, 2005, FEBS J, V272, P3651, DOI 10.1111/j.1742-4658.2005.04790.x; Kanesashi SN, 2003, J GEN VIROL, V84, P1899, DOI 10.1099/vir.0.19067-0; COSSART YE, 1970, LANCET, V1, P848; GABIZON A, 1994, CANCER RES, V54, P987; Qian ZM, 2002, PHARMACOL REV, V54, P561, DOI 10.1124/pr.54.4.561; Mastrobattista E, 2006, NAT REV DRUG DISCOV, V5, P115, DOI 10.1038/nrd1960; Cabral H, 2014, J CONTROL RELEASE, V190, P465, DOI 10.1016/j.jconrel.2014.06.042; Matsuura Y, 2011, EUR SURG RES, V46, P65, DOI 10.1159/000322491; Brannon-Peppas L, 2012, ADV DRUG DELIVER REV, V64, P206, DOI 10.1016/j.addr.2012.09.033; Torchilin VP, 2005, NAT REV DRUG DISCOV, V4, P145, DOI 10.1038/nrd1632; ISHIHARA K, 1987, J MED VIROL, V21, P89, DOI 10.1002/jmv.1890210112; Germershaus O, 2006, BIOCONJUGATE CHEM, V17, P1190, DOI 10.1021/bc0601119; Jung J, 2008, J CONTROL RELEASE, V126, P255, DOI [10.1016/j.jconrel.2007.12.002, 10.1016/j.jconret.2007.12.002]; Zhen ZP, 2013, ACS NANO, V7, P4830, DOI 10.1021/nn305791q; Kanasty R, 2013, NAT MATER, V12, P967, DOI [10.1038/nmat3765, 10.1038/NMAT3765]; Ara MN, 2014, BIOMATERIALS, V35, P7110, DOI 10.1016/j.biomaterials.2014.04.087; Seow Y, 2009, MOL THER, V17, P767, DOI 10.1038/mt.2009.41; Inoue T, 2008, J BIOTECHNOL, V134, P181, DOI 10.1016/j.jbiotec.2007.12.006; Khalil IA, 2007, GENE THER, V14, P682, DOI 10.1038/sj.gt.3302910; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; MATSUMURA Y, 1986, CANCER RES, V46, P6387; Whitehead KA, 2009, NAT REV DRUG DISCOV, V8, P129, DOI 10.1038/nrd2742; Kang JH, 2010, NANOMED-NANOTECHNOL, V6, P583, DOI 10.1016/j.nano.2010.01.007; Dams ETM, 2000, J PHARMACOL EXP THER, V292, P1071; Touze A, 1998, NUCLEIC ACIDS RES, V26, P1317, DOI 10.1093/nar/26.5.1317; Yamada M, 2012, J CONTROL RELEASE, V160, P322, DOI 10.1016/j.jconrel.2011.11.004; Toita R, 2013, INT J NANOMED, V8, P1989, DOI 10.2147/IJN.S40239; Liu QS, 2015, INT J NANOMED, V10, P4159, DOI 10.2147/IJN.S84295; Jung J, 2011, PROTEIN EXPRES PURIF, V78, P149, DOI 10.1016/j.pep.2011.04.008; Zhang Y, 2013, ADV DRUG DELIVER REV, V65, P104, DOI 10.1016/j.addr.2012.10.003; Davis ME, 2010, NATURE, V464, P1067, DOI 10.1038/nature08956; Maeda H, 2001, J CONTROL RELEASE, V74, P47, DOI 10.1016/S0168-3659(01)00309-1; Baumert TF, 2014, CURR OPIN VIROL, V4, P58, DOI 10.1016/j.coviro.2013.12.002; KOBAYASHI M, 1988, J BIOTECHNOL, V8, P1, DOI 10.1016/0168-1656(88)90064-8; Iwasaki Y, 2007, CANCER GENE THER, V14, P74, DOI 10.1038/sj.cgt.7700990; ITOH Y, 1986, BIOCHEM BIOPH RES CO, V141, P942, DOI 10.1016/S0006-291X(86)80134-6; Shishido T, 2010, BIOORG MED CHEM LETT, V20, P5726, DOI 10.1016/j.bmcl.2010.08.011; Bernfield M., 1999, ANNU REV BIOCHEM, V68, P729; Hamada Hiroki, 2013, Clin Med Insights Womens Health, V6, P71, DOI 10.4137/CMWH.S8213; Iijima M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00790; Jain R.K., 1990, CANC RES, V50; Kasai T., 2012, J DRUG DELIV, V2012; Nishimura Y, 2013, J NANOBIOTECHNOL, V11, DOI 10.1186/1477-3155-11-19; Murata M., 2014, PROTEIN EXPR PURIF; Nishimura Y, 2014, J NANOBIOTECHNOL, V12, DOI 10.1186/1477-3155-12-11; RODRIQUEZCRESPO I, 1994, J GEN VIROL, V75, P637, DOI 10.1099/0022-1317-75-3-637; Schneider-Schaulies J, 2000, J GEN VIROL, V81, P1413; Yamada T., 2012, COLD SPRING HARB PRO; Yan H, 2012, ELIFE, V1, DOI 10.7554/eLife.00049	111	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0169-409X	1872-8294		ADV DRUG DELIVER REV	Adv. Drug Deliv. Rev.	DEC 1	2015	95						77	89		10.1016/j.addr.2015.10.003		13	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CY2FM	WOS:000366224200009		
J	Fuse, T; Nakada, TA; Taniguchi, M; Mizushima, Y; Matsuoka, T				Fuse, Takashi; Nakada, Taka-aki; Taniguchi, Masashi; Mizushima, Yasuaki; Matsuoka, Tetsuya			Cardiac arrest due to airway obstruction in hereditary angioedema	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article							C1 INHIBITOR DEFICIENCY; ESTERASE INHIBITOR; ATTACKS; EDEMA	Hereditary angioedema (HAE) is a rare genetic disease caused by a deficiency of functional C1 esterase inhibitor that causes swelling attacks in various body tissues. We hereby report a case of out-of-hospital cardiac arrest due to airway obstruction in HAE. Cutaneous swelling and abdominal pain attacks caused by gastrointestinal wall swelling are common symptoms in HAE, whereas laryngeal swelling is rare. Emergency physicians may have few chances to experience cases of life-threatening laryngeal edema resulting in a delay from symptom onset to the diagnosis of HAE. Hereditary angioedema is diagnosed by performing complement blood tests. Because safe and effective treatment options are available for the life-threatening swellings in HAE, the diagnosis potentially reduces the risk of asphyxiation in patients and their blood relatives.	[Fuse, Takashi; Nakada, Taka-aki; Taniguchi, Masashi; Mizushima, Yasuaki; Matsuoka, Tetsuya] Senshu Trauma & Crit Care Ctr, Osaka 5988577, Japan; [Nakada, Taka-aki] Chiba Univ, Grad Sch Med, Chuo Ku, Chiba 2608677, Japan	Nakada, TA (reprint author), Senshu Trauma & Crit Care Ctr, 2-23 Rinku Orai Kita, Osaka 5988577, Japan.	taka.nakada@nifty.com					Bork K, 2000, MAYO CLIN PROC, V75, P349; Roche O, 2005, ANN ALLERG ASTHMA IM, V94, P498; Cicardi M, 2010, NEW ENGL J MED, V363, P523, DOI 10.1056/NEJMoa0905079; Bork K, 2003, ARCH INTERN MED, V163, P1229, DOI 10.1001/archinte.163.10.1229; Gompels MM, 2002, J CLIN PATHOL, V55, P145; Craig TJ, 2010, J CLIN IMMUNOL, V30, P823, DOI 10.1007/s10875-010-9442-1; Cicardi M, 2010, NEW ENGL J MED, V363, P532, DOI 10.1056/NEJMoa0906393; Longhurst H, 2012, LANCET, V379, P474, DOI 10.1016/S0140-6736(11)60935-5; Cicardi M, 2014, ALLERGY, V69, P602, DOI 10.1111/all.12380; Bhardwaj N, 2014, TRANSFUSION, V54, P2989, DOI 10.1111/trf.12674	10	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	DEC	2015	33	12							1840.e1	10.1016/j.ajem.2015.04.003		2	Emergency Medicine	Emergency Medicine	CY1IC	WOS:000366158900035		
J	Kishino, F; Inokuchi, R; Komaru, Y; Takaya, N; Yamamoto, M; Nakajima, S; Yahagi, N				Kishino, Fumiaki; Inokuchi, Ryota; Komaru, Yohei; Takaya, Nobuhiro; Yamamoto, Miyuki; Nakajima, Susumu; Yahagi, Naoki			A healthy young woman with massive hemorrhagic ascites	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article							PERITONEAL-FLUID; ABDOMINAL-PAIN; ENDOMETRIOSIS	Retrograde menstruation is the backward movement of menstrual fluids. The underlying mechanisms remain unknown. The converse current itself is benign, but the result can be abdominal pain caused by peritoneal irritation and, eventually, endometriosis. The case was of a 25-year-old woman with lower abdominal pain accompanied by significant hemoperitoneum. Physical examination and inspection using abdominal ultrasonography and computed tomography failed to reveal a differential diagnosis. Detailed history taking revealed sexual activities during her menstrual period, which allowed for a diagnosis of retrograde menstruation. These findings emphasize the importance of extensive history taking.	[Kishino, Fumiaki; Inokuchi, Ryota; Komaru, Yohei; Takaya, Nobuhiro] JR Tokyo Gen Hosp, Dept Emergency & Crit Care Med, Shibuya Ku, Tokyo, Japan; [Inokuchi, Ryota; Yamamoto, Miyuki; Nakajima, Susumu; Yahagi, Naoki] Tokyo Univ Hosp, Dept Emergency & Crit Care Med, Bunkyo Ku, Tokyo 1138655, Japan	Inokuchi, R (reprint author), Tokyo Univ Hosp, Dept Emergency & Crit Care Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	inokuchir-icu@h.u-tokyo.ac.jp					MAATHUIS JB, 1978, J ENDOCRINOL, V76, P123, DOI 10.1677/joe.0.0760123; SYROP CH, 1987, OBSTET GYNECOL, V69, P416; Tse KC, 2002, PERITON DIALYSIS INT, V22, P488; Jang T, 2014, AM J EMERG MED, V32, P457, DOI 10.1016/j.ajem.2014.01.004; Stoker J, 2009, RADIOLOGY, V253, P31, DOI 10.1148/radiol.2531090302; Young VJ, 2013, HUM REPROD UPDATE, V19, P558, DOI 10.1093/humupd/dmt024; HALME J, 1984, OBSTET GYNECOL, V64, P151	7	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	DEC	2015	33	12							1841.e1	10.1016/j.ajem.2015.04.039		2	Emergency Medicine	Emergency Medicine	CY1IC	WOS:000366158900037		
J	Miya, K; Shimojo, N; Koyama, Y; Enomoto, Y; Hagiya, K; Yamasaki, Y; Nishino, T; Kawano, S; Mizutani, T				Miya, Ken; Shimojo, Nobutake; Koyama, Yasuaki; Enomoto, Yuki; Hagiya, Keiichi; Yamasaki, Yuichiro; Nishino, Tomofumi; Kawano, Satoru; Mizutani, Taro			Efficacy of concomitant use of dexmedetomidine and propofol in tetanus	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article							MANAGEMENT; PATIENT	Tetanus is an infectious disease caused by Clostridium tetani, which manifests systemic convulsion and autonomic instability associated with high case fatality. Despite proper medical intervention, management of those symptoms is often difficult. We report a case of 67-year-old man with tetanus in which a concomitant use of dexmedetomidine, an adrenaline alpha-2 receptor agonist, and propofol, a GABA(A) receptor binding agent, was successful in the management of systemic convulsion and autonomic instability without necessitating conventional anticonvulsant, neuromuscular blocking agents, or tracheostomy.	[Miya, Ken; Shimojo, Nobutake; Koyama, Yasuaki; Enomoto, Yuki; Hagiya, Keiichi; Yamasaki, Yuichiro; Nishino, Tomofumi; Kawano, Satoru; Mizutani, Taro] Univ Tsukuba, Dept Emergency & Crit Care Med, Tsukuba, Ibaraki 3058575, Japan	Mizutani, T (reprint author), Univ Tsukuba, Dept Emergency & Crit Care Med, Tsukuba, Ibaraki 3058575, Japan.	mizutani@md.tsukuba.ac.jp					Murray MJ, 2002, CRIT CARE MED, V30, P142, DOI 10.1097/00003246-200201000-00021; Tarvainen MP, 2012, ANN BIOMED ENG, V40, P1802, DOI 10.1007/s10439-012-0544-1; Girgin NK, 2007, BRIT J ANAESTH, V99, P599, DOI 10.1093/bja/aem251; Gregorakos L, 1997, INTENS CARE MED, V23, P893, DOI 10.1007/s001340050428; Barr J, 2013, CRIT CARE MED, V41, P263, DOI 10.1097/CCM.0b013e3182783b72; BORGEAT A, 1991, CRIT CARE MED, V19, P295, DOI 10.1097/00003246-199102000-00032; Peduto V A, 1993, Minerva Anestesiol, V59, P171; Rodrigo C, 2014, CRIT CARE, V18, DOI 10.1186/cc13797	8	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	DEC	2015	33	12							1848.e3	10.1016/j.ajem.2015.04.069		2	Emergency Medicine	Emergency Medicine	CY1IC	WOS:000366158900052		
J	Nishizawa, M; Hoshide, S; Okawara, Y; Shimpo, M; Matsuo, T; Kario, K				Nishizawa, Masafumi; Hoshide, Satoshi; Okawara, Yukie; Shimpo, Masahisa; Matsuo, Takefumi; Kario, Kazuomi			Aftershock Triggers Augmented Pressor Effects in Survivors: Follow-Up of the Great East Japan Earthquake	AMERICAN JOURNAL OF HYPERTENSION			English	Article						aftershock; blood pressure; earthquake; hypertension; temporary housing	BLOOD-PRESSURE; DISASTER HYPERTENSION; MORNING SURGE; ORGAN DAMAGE; DISEASE	BACKGROUND Previous reports focused on the significant acute effects immediately after an earthquake on an increase in blood pressure (BP) assessed by ambulatory BP monitoring. However, there have been no data on the impact of environmental triggers on the long-term response to earthquake. METHODS We analyzed the ambulatory BP monitoring data of 8 patients who lived in the disaster area of the 11 March 2011 Great East Japan Earthquake on the day of the largest aftershock with a first tsunami warming (sirens) on 7 December 2012. RESULTS There was no significant difference in the BP in either the period 1 hour before (median (range): 126.5 (121.5-138.0) vs. 137.8 (129.5-177.0) mm Hg, P = 0.07) or that 1 hour after (139.3 (113.0-143.5) vs. 137.5 (125.0-192.0) mm Hg, P = 0.27) the aftershock between those living at home and those who had been living in temporary housing. After the time of aftershock, the systolic BP levels at that night (124.9 (113.2-137.9) vs. 107.0 (101.9-110.1) mm Hg, P = 0.021) and systolic BP levels at the following morning (149.3 (131.0-196.2) vs. 129.5 (128.8-131.0) mm Hg, P = 0.029) were also significantly higher in those living in temporary housing at the time compared to those living in their own homes. CONCLUSION Our data suggest that the stress of a change in living conditions following the disaster might have contributed an increased risk of cardiovascular events.	[Nishizawa, Masafumi] Minamisanriku Publ Med Clin, Dept Med, Minamisanriku, Miyagi, Japan; [Nishizawa, Masafumi; Hoshide, Satoshi; Okawara, Yukie; Shimpo, Masahisa; Kario, Kazuomi] Jichi Med Univ, Sch Med, Dept Med, Div Cardiovasc Med, Shimotsuke, Tochigi, Japan; [Matsuo, Takefumi] Hyogo Prefectural Awaji Med Ctr, Sumoto Shi, Hyogo, Japan	Kario, K (reprint author), Jichi Med Univ, Sch Med, Dept Med, Div Cardiovasc Med, Shimotsuke, Tochigi, Japan.	kkario@jichi.ac.jp			Banyu Life Science Foundation International; Japanese Circulation Society	This work was financially supported in part by a grant from Banyu Life Science Foundation International (2012-14) and grants from the Japanese Circulation Society (2011-13).	Spruill TM, 2010, CURR HYPERTENS REP, V12, P10, DOI 10.1007/s11906-009-0084-8; Hoshide S, 2014, AM J HYPERTENS, V27, P939, DOI 10.1093/ajh/hpt290; Armenian HK, 1998, AM J EPIDEMIOL, V148, P1077; Kario K, 2012, CIRC J, V76, P553, DOI 10.1253/circj.CJ-11-1510; Kario K, 2001, AM J MED, V111, P379, DOI 10.1016/S0002-9343(01)00832-4; Kario K, 2003, CIRCULATION, V107, P1401, DOI 10.1161/01.CIR.0000056521.67546.AA; Bland SH, 2000, AM J EPIDEMIOL, V151, P1086; Nishizawa M, 2012, CURR HYPERTENS REP, V14, P375, DOI 10.1007/s11906-012-0298-z; KARIO K, 1995, LANCET, V345, P1365, DOI 10.1016/S0140-6736(95)92561-9; Parati G, 2001, HYPERTENSION, V38, P1093, DOI 10.1161/hy1101.095334; Saito K, 2013, ENVIRON HEALTH PREV, V18, P72, DOI 10.1007/s12199-012-0284-8; Kario K, 2001, HYPERTENSION, V38, P852, DOI 10.1161/hy1001.092640; Petrazzi L, 2010, AM J MED, V123, pE1, DOI 10.1016/j.amjmed.2010.01.038; Hoshide S, 2003, AM J HYPERTENS, V16, P434, DOI 10.1016/S0895-7061(03)00567-3; Chen YC, 2009, HYPERTENS RES, V32, P797, DOI 10.1038/hr.2009.98; Gerin W, 2006, PSYCHOSOM MED, V68, P64, DOI 10.1097/01.psy.0000195747.12404.aa; Kario K, 2010, HYPERTENSION, V56, P765, DOI 10.1161/HYPERTENSIONAHA.110.157149	17	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0895-7061	1941-7225		AM J HYPERTENS	Am. J. Hypertens.	DEC	2015	28	12					1405	1408		10.1093/ajh/hpv044		4	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CY4IX	WOS:000366372900004		
J	Kusaka, H; Sueta, D; Koibuchi, N; Hasegawa, Y; Nakagawa, T; Lin, BW; Ogawa, H; Kim-Mitsuyama, S				Kusaka, Hiroaki; Sueta, Daisuke; Koibuchi, Nobutaka; Hasegawa, Yu; Nakagawa, Takashi; Lin, BoWen; Ogawa, Hisao; Kim-Mitsuyama, Shokei			LCZ696, Angiotensin II Receptor-Neprilysin Inhibitor, Ameliorates High-Salt-Induced Hypertension and Cardiovascular Injury More Than Valsartan Alone	AMERICAN JOURNAL OF HYPERTENSION			English	Article						angiotensin; blood pressure; cardiovascular protection; dual inhibition; hypertension; neprilysin	NEUTRAL ENDOPEPTIDASE INHIBITOR; PRESERVED EJECTION FRACTION; NATRIURETIC PEPTIDE SYSTEM; HEART-FAILURE; METABOLIC SYNDROME; DOUBLE-BLIND; ANGIOEDEMA; EFFICACY; BIOLOGY; RATS	BACKGROUND LCZ696, an angiotensin receptor-neprilysin inhibitor, has recently been demonstrated to exert more beneficial effects on hypertensive or heart failure patients than conventional renin-angiotensin system blockers. However, the mechanism underlying the benefit of LCZ696 remains to be understood. The present study was undertaken to examine the effect of LCZ696 compared with valsartan on hypertension and cardiovascular injury. METHODS (i) Using telemetry, we compared the hypotensive effect of LCZ696 and valsartan in spontaneously hypertensive rats (SHR) that were fed a high-salt diet followed by a low-salt diet. (ii) We also examined the comparative effect of LCZ696 and valsartan on salt loaded SHRcp, a model of metabolic syndrome. RESULTS (i) LCZ696 exerted a greater blood pressure (BP) lowering effect than valsartan in SHR regardless of high-salt or low-salt intake. Additive BP reduction by LCZ696 was associated with a significant increase in urinary sodium excretion and sympathetic activity suppression. (ii) LCZ696 significantly ameliorated cardiac hypertrophy and inflammation, coronary arterial remodeling, and vascular endothelial dysfunction in high-salt loaded SHRcp compared with valsartan. CONCLUSIONS LCZ696 caused greater BP reduction than valsartan in SHR regardless of the degree of salt intake, which was associated with a significant enhancement in urinary sodium excretion and sympathetic activity suppression. Furthermore, an additive BP lowering effect of LCZ696 led to greater cardiovascular protection in hypertensive rats.	[Kusaka, Hiroaki; Sueta, Daisuke; Koibuchi, Nobutaka; Hasegawa, Yu; Nakagawa, Takashi; Lin, BoWen; Kim-Mitsuyama, Shokei] Kumamoto Univ, Grad Sch Med Sci, Dept Pharmacol & Mol Therapeut, Kumamoto, Japan; [Ogawa, Hisao] Kumamoto Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Kumamoto, Japan	Kim-Mitsuyama, S (reprint author), Kumamoto Univ, Grad Sch Med Sci, Dept Pharmacol & Mol Therapeut, Kumamoto, Japan.	mitsuyam@gpo.kumamoto-u.ac.jp			Novartis	This work was supported in part by Novartis.	Levin ER, 1998, NEW ENGL J MED, V339, P321; Pandey KN, 2005, PEPTIDES, V26, P901, DOI 10.1016/j.peptides.2004.09.024; von Lueder TG, 2013, CIRC-HEART FAIL, V6, P594, DOI 10.1161/CIRCHEARTFAILURE.112.000289; Ruilope LM, 2010, LANCET, V375, P1255, DOI 10.1016/S0140-6736(09)61966-8; Campbell DJ, 2003, HYPERTENSION, V41, P383, DOI 10.1161/01.HYP.0000054215.71691.16; Gu J, 2010, J CLIN PHARMACOL, V50, P401, DOI 10.1177/0091270009343932; Fryer RM, 2008, BRIT J PHARMACOL, V153, P947, DOI 10.1038/sj.bjp.0707641; Toh S, 2012, ARCH INTERN MED, V172, P1582, DOI 10.1001/2013.jamainternmed.34; BEVAN EG, 1992, J HYPERTENS, V10, P607; Takaya K, 1996, NAT GENET, V14, P130, DOI 10.1038/ng1096-130; Sueta D, 2014, AM J HYPERTENS, V27, P1464, DOI 10.1093/ajh/hpu076; Hegde LG, 2011, J CARDIOVASC PHARM, V57, P495, DOI 10.1097/FJC.0b013e318210fc7e; Cleland JGF, 1998, LANCET, V351, P1657, DOI 10.1016/S0140-6736(05)77712-6; Solomon SD, 2012, LANCET, V380, P1387, DOI 10.1016/S0140-6736(12)61227-6; Gardner DG, 2007, HYPERTENSION, V49, P419, DOI 10.1161/01.HYP.0000258532.07418.fa; Cicardi M, 2004, ARCH INTERN MED, V164, P910, DOI 10.1001/archinte.164.8.910; Vardeny O, 2013, CLIN PHARMACOL THER, V94, P445, DOI 10.1038/clpt.2013.146; Sueta D, 2012, AM J HYPERTENS, V25, P704, DOI 10.1038/ajh.2012.26; Jhund PS, 2014, CIRC-HEART FAIL, V7, P953, DOI 10.1161/CIRCHEARTFAILURE.114.001427; Kostis John B., 2004, American Journal of Hypertension, V17, P103, DOI 10.1016/j.amjhyper.2003.09.014; McMurray JJV, 2014, NEW ENGL J MED, V371, P993, DOI 10.1056/NEJMoa1409077; Packer M, 2015, J AM COLL CARDIOL, V131, P54; Sueta D, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000035; von Lueder TG, 2015, CIRC-HEART FAIL, V8, P71, DOI 10.1161/CIRCHEARTFAILURE.114.001785	24	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0895-7061	1941-7225		AM J HYPERTENS	Am. J. Hypertens.	DEC	2015	28	12					1409	1417		10.1093/ajh/hpv015		9	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CY4IX	WOS:000366372900005		
J	Hasegawa, N; Kurihara, T; Sato, K; Homma, T; Fujie, S; Fujita, S; Sanada, K; Hamaoka, T; Iemitsu, M				Hasegawa, Natsuki; Kurihara, Toshiyuki; Sato, Koji; Homma, Toshiyuki; Fujie, Shumpei; Fujita, Satoshi; Sanada, Kiyoshi; Hamaoka, Takafumi; Iemitsu, Motoyuki			Intramyocellular and Extramyocellular Lipids Are Associated With Arterial Stiffness	AMERICAN JOURNAL OF HYPERTENSION			English	Article						adipose tissue; blood pressure; muscle; hypertension; magnetic resonance spectroscopy; pulse wave velocity	CENTRAL FAT MASS; INSULIN SENSITIVITY; SKELETAL-MUSCLE; ADIPOSE-TISSUE; VASCULAR STIFFNESS; AMSTERDAM GROWTH; PERIPHERAL FAT; VISCERAL FAT; OLDER-ADULTS; RISK-FACTORS	BACKGROUND Obese and overweight patients are at increased risk of arterial stiffness, and visceral, epicardial and hepatic fat accumulation is associated with cardiovascular disease risk. In general, muscular lipids are stored either in interstitial adipose tissue (extramyocellular lipid (EMCL)) or in lipid droplets within muscle cells (intramyocellular lipid (IMCL)). However, the association between IMCL or EMCL content and arterial stiffness remains unclear. This cross-sectional study aimed to clarify this association. METHODS A total of 237 subjects (18-81 years) were enrolled in this study. The IMCL and EMCL contents of the right vastus lateralis muscle were evaluated by proton magnetic resonance spectroscopy. Arterial stiffness was estimated using brachial-ankle pulse wave velocity (baPWV). RESULTS There were significant correlations between baPWV and the contents of both IMCL (R = -0.23, P < 0.001) and EMCL (R = 0.53, P < 0.001) in all subjects. The baPWV negatively correlated with IMCL content (R = -0.45, P < 0.001) in females only. In contrast, significant positive correlations were observed between baPWV and EMCL content in both males (R = 0.59, P < 0.001) and females (R = 0.55, P < 0.001). IMCL and EMCL contents contributed independently to baPWV variation after adjustment for age, sex, body mass index, visceral and subcutaneous abdominal fat, upper and lower limb fat, blood pressure, heart rate, and lipid profiles. CONCLUSION These results suggest that IMCL and EMCL contents may be a risk factor for arterial stiffness, and this association differed with gender and age.	[Hasegawa, Natsuki; Kurihara, Toshiyuki; Sato, Koji; Homma, Toshiyuki; Fujie, Shumpei; Fujita, Satoshi; Sanada, Kiyoshi; Hamaoka, Takafumi; Iemitsu, Motoyuki] Ritsumeikan Univ, Fac Sport & Hlth Sci, Shiga, Japan	Iemitsu, M (reprint author), Ritsumeikan Univ, Fac Sport & Hlth Sci, Shiga, Japan.	iemitsu@fc.ritsumei.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan (KAKENHI) [26282199, 25560378]	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (KAKENHI: #26282199 and #25560378 for M.I.).	Choi TY, 2013, ATHEROSCLEROSIS, V229, P118, DOI 10.1016/j.atherosclerosis.2013.03.003; Schouten F, 2011, AM J CLIN NUTR, V94, P40, DOI 10.3945/ajcn.111.013532; Orr JS, 2008, HYPERTENSION, V51, P1519, DOI 10.1161/HYPERTENSIONAHA.108.112946; Orshal JM, 2004, AM J PHYSIOL-REG I, V286, pR233, DOI 10.1152/ajpregu.00338.2003; Thamer C, 2003, J CLIN ENDOCR METAB, V88, P1785, DOI 10.1210/jc.2002-021674; Pruchnic R, 2004, AM J PHYSIOL-ENDOC M, V287, pE857, DOI 10.1152/ajpendo.00459.2003; Williams MJ, 1997, AM J CLIN NUTR, V65, P855; Ferreira I, 2004, J CLIN ENDOCR METAB, V89, P2632, DOI 10.1210/jc.2003-031619; Motoshima H, 2002, J CLIN ENDOCR METAB, V87, P5662, DOI 10.1210/JC.2002-020635; Okamoto Y, 2000, HORM METAB RES, V32, P47, DOI 10.1055/s-2007-978586; Iemitsu M, 2006, HYPERTENSION, V47, P928, DOI 10.1161/01.HYP.0000217520.44176.73; Liu JK, 2011, ARTERIOSCL THROM VAS, V31, P2715, DOI 10.1161/ATVBAHA.111.234062; Eriksson P, 2000, THROMB HAEMOSTASIS, V83, P545; Lim S, 2013, INT J CARDIOL, V169, P166, DOI 10.1016/j.ijcard.2013.08.077; Chen JY, 2012, J AM SOC HYPERTENS, V6, P253, DOI 10.1016/j.jash.2012.04.003; Goodpaster BH, 2001, J CLIN ENDOCR METAB, V86, P5755, DOI 10.1210/jc.86.12.5755; Krssak M, 1999, DIABETOLOGIA, V42, P113, DOI 10.1007/s001250051123; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; Yudkin JS, 1999, ARTERIOSCL THROM VAS, V19, P972; Weis J, 2009, J MAGN RESON IMAGING, V30, P1124, DOI 10.1002/jmri.21900; Zebekakis PE, 2005, J HYPERTENS, V23, P1839, DOI 10.1097/01.hjh.0000179511.93889.e9; Yim JE, 2008, J APPL PHYSIOL, V104, P700, DOI 10.1152/japplphysiol.01035.2007; Soliman EZ, 2010, J STROKE CEREBROVASC, V19, P58, DOI 10.1016/j.jstrokecerebrovasdis.2009.03.008; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Snijder MB, 2005, DIABETOLOGIA, V48, P301, DOI 10.1007/s00125-004-1637-7; Sinha R, 2002, DIABETES, V51, P1022, DOI 10.2337/diabetes.51.4.1022; Oosthuyse T, 2012, CURR OPIN PHARMACOL, V12, P363, DOI 10.1016/j.coph.2012.02.008; Wildman RP, 2003, HYPERTENSION, V42, P468, DOI 10.1161/01.HYP.0000090360.78539.CD; Boesch C, 1997, MAGN RESON MED, V37, P484, DOI 10.1002/mrm.1910370403; Provencher SW, 2001, NMR BIOMED, V14, P260, DOI 10.1002/nbm.698; Wildman RP, 2011, AM J CLIN NUTR, V93, P719, DOI 10.3945/ajcn.110.007153; Roepstorff C, 2002, AM J PHYSIOL-ENDOC M, V282, pE435; Cree MG, 2004, J CLIN ENDOCR METAB, V89, P3864, DOI 10.1210/jc.2003-031986; Hattori M, 2006, JPN J PHYS FIT SPORT, V55, pS43	34	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0895-7061	1941-7225		AM J HYPERTENS	Am. J. Hypertens.	DEC	2015	28	12					1473	1479		10.1093/ajh/hpv041		7	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CY4IX	WOS:000366372900012		
J	Tsuda, K				Tsuda, Kazushi			Plasma Homocysteine Levels and Endothelial Dysfunction in Cerebro- and Cardiovascular Diseases in the Metabolic Syndrome	AMERICAN JOURNAL OF HYPERTENSION			English	Letter							STROKE		[Tsuda, Kazushi] Kansai Univ Hlth Sci, Cardiovasc & Metab Res Ctr, Cardiovasc Med, Osaka, Japan	Tsuda, K (reprint author), Kansai Univ Hlth Sci, Cardiovasc & Metab Res Ctr, Cardiovasc Med, Osaka, Japan.	tsudak@mail.wakayama-med.ac.jp					Catena C, 2015, AM J HYPERTENS, V28, P943, DOI 10.1093/ajh/hpu248; Abdulle AM, 2010, NUTR NEUROSCI, V13, P2, DOI 10.1179/147683010X12611460763562; Stuhlinger MC, 2003, CIRCULATION, V108, P933, DOI 10.1161/01.CIR.0000085067.55901.89; Tsuda K, 2007, CLIN EXP PHARMACOL P, V34, pS70, DOI 10.1111/j.1440-1681.2007.04784.x; Knottnerus ILH, 2009, CEREBROVASC DIS, V27, P519, DOI 10.1159/000212672	5	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0895-7061	1941-7225		AM J HYPERTENS	Am. J. Hypertens.	DEC	2015	28	12					1489	1489		10.1093/ajh/hpv112		1	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CY4IX	WOS:000366372900014		
J	Kokai, S; Kanno, Z; Koike, S; Uesugi, S; Takahashi, Y; Ono, T; Soma, K				Kokai, Satoshi; Kanno, Zuisei; Koike, Sarina; Uesugi, Shunsuke; Takahashi, Yuzo; Ono, Takashi; Soma, Kunimichi			Retrospective study of 100 autotransplanted teeth with complete root formation and subsequent orthodontic treatment	AMERICAN JOURNAL OF ORTHODONTICS AND DENTOFACIAL ORTHOPEDICS			English	Article							LONG-TERM; FOLLOW-UP; TOOTH TRANSPLANTATION; PERMANENT INCISORS; DONOR TEETH; PREMOLARS; RESORPTION; IMPLANTS; SURVIVAL; SUCCESS	Introduction: Autotransplantation has become a major therapeutic option for replacing missing teeth in adult orthodontic patients. However, little systematic information is available about the long-term stability of autotransplanted teeth with complete root formation after the application of an orthodontic force. The objective of this study was to investigate the outcomes of autotransplanted teeth with complete root formation that underwent orthodontic treatment. Methods: One hundred teeth, autotransplanted in 89 patients, were examined over a mean observation period of 5.8 years. Orthodontic force was applied with nickel-titanium wires 4 to 8 weeks after autotransplantation. Root resorption, ankylosis, mobility, pocket depth, and inflammation at the recipient site were investigated clinically and with radiographs. Results: The survival rate of the autotransplanted teeth was 93.0%. Abnormal findings were found in 29 teeth, including 7 lost teeth, for a success rate of 71.0%. Donor tooth type and occlusal condition of the donor tooth before transplantation were associated with abnormal findings. Conclusions: The early application of orthodontic force may increase the success rate of autotransplanted teeth, and the type and presurgical occlusal condition of donor teeth affect the success rate.	[Kokai, Satoshi; Kanno, Zuisei; Koike, Sarina; Uesugi, Shunsuke; Takahashi, Yuzo; Ono, Takashi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Oral Hlth Sci, Orthodont Sci, Tokyo 1138549, Japan; [Soma, Kunimichi] Tokyo Med & Dent Univ, Tokyo 1138549, Japan	Ono, T (reprint author), Tokyo Med & Dent Univ, Grad Sch, Dept Oral Hlth Sci, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138549, Japan.	t.ono.orts@tmd.ac.jp					Andreasen JO, 1992, ATLAS REPLANTATION T; Andreasen J O, 1970, Scand J Dent Res, V78, P512; Czochrowska EM, 2000, AM J ORTHOD DENTOFAC, V118, P592, DOI 10.1067/mod.2000.110521; Choi YJ, 2013, AM J ORTHOD DENTOFAC, V144, P268, DOI 10.1016/j.ajodo.2012.08.031; Yoshino K, 2012, J ORAL REHABIL, V39, P37, DOI 10.1111/j.1365-2842.2011.02234.x; Diaz JA, 2008, DENT TRAUMATOL, V24, P320, DOI 10.1111/j.1600-9657.2008.00566.x; Zachrisson BU, 2004, AM J ORTHOD DENTOFAC, V126, P284, DOI 10.1016/j.ajodo.2004.06.007; Chung WC, 2014, J CLIN PERIODONTOL, V41, P412, DOI 10.1111/jcpe.12228; Mine K, 2005, ANGLE ORTHOD, V75, P637; Paulsen HU, 1995, AM J ORTHOD DENTOFAC, V108, P630, DOI 10.1016/S0889-5406(95)70009-9; Sugai T, 2010, INT J ORAL MAX SURG, V39, P1193, DOI 10.1016/j.ijom.2010.06.018; Thilander B, 1999, CLIN ORAL IMPLAN RES, V10, P346, DOI 10.1034/j.1600-0501.1999.100502.x; Kallu R, 2005, INT J ORAL MAX SURG, V34, P745, DOI 10.1016/j.ijom.2005.03.009; Czochrowska EM, 2002, AM J ORTHOD DENTOFAC, V121, P110, DOI 10.1067/mod.2002.119979; Levin L, 2013, J AM DENT ASSOC, V144, P1119; Denys D, 2013, EUR J ORTHODONT, V35, P680, DOI 10.1093/ejo/cjs112; Mejare B, 2004, ORAL SURG ORAL MED O, V97, P231, DOI 10.1016/S1079-2104(03)00461-X; Tanaka T, 2008, ANGLE ORTHOD, V78, P12, DOI 10.2319/120706-495.1; ANDREASEN JO, 1980, SWED DENT J, V4, P101; Kvint S, 2010, ANGLE ORTHOD, V80, P446, DOI 10.2319/062509-354.1; Watanabe Y, 2010, AM J ORTHOD DENTOFAC, V138, P720, DOI 10.1016/j.ajodo.2009.03.043; ANDREASEN JO, 1990, EUR J ORTHODONT, V12, P3; Aslan BI, 2010, ANGLE ORTHOD, V80, P396, DOI 10.2319/033109-184.1; Thilander B, 2001, EUR J ORTHODONT, V23, P715, DOI 10.1093/ejo/23.6.715; Paulsen HU, 1998, EUR J ORTHODONT, V20, P45, DOI 10.1093/ejo/20.1.45; Suzaki Y, 2008, ANGLE ORTHOD, V78, P495, DOI 10.2319/020207-51.1; Josefsson E, 1999, ACTA ODONTOL SCAND, V57, P111; Kaneko S, 2001, J PERIODONTAL RES, V36, P9, DOI 10.1034/j.1600-0765.2001.00607.x; Tsukiboshi M, 2002, DENT TRAUMATOL, V18, P157, DOI 10.1034/j.1600-9657.2002.00118.x; Bae JH, 2010, J ENDODONT, V36, P1422, DOI 10.1016/j.joen.2010.04.028; Kim E, 2005, ORAL SURG ORAL MED O, V100, P112, DOI 10.1016/j.tripleo.2004.09.007; Finucane D, 2003, DENT TRAUMATOL, V19, P170, DOI 10.1034/j.1600-9657.2003.00154.x; Aoyama S, 2012, ORAL SURG ORAL MED O, V114, P216; Fujita K, 2008, ORTHOD WAVES, V67, P128, DOI 10.1016/j.odw.2008.02.003; Hamamoto Y, 1997, J ORAL MAXILLOFAC SU, V43, P733; Hayashi Y, 2001, ORTHOD WAVES, V60, P373; KRISTERSON L, 1991, European Journal of Orthodontics, V13, P486; MUHLEMAN.HR, 1971, HELV ODONTOL ACTA, V15, P107; Tanaka AI, 1998, ORTHOD WAVES, V57, P180; Valderhaug J, 1997, J DENT, V3, P21	40	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0889-5406	1097-6752		AM J ORTHOD DENTOFAC	Am. J. Orthod. Dentofac. Orthop.	DEC	2015	148	6					982	989		10.1016/j.ajodo.2015.06.018		8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CY1XX	WOS:000366202800017		
J	Nakata, H; Oshiro, M; Namba, M; Shibasaki, M				Nakata, Hiroki; Oshiro, Misaki; Namba, Mari; Shibasaki, Manabu			Effects of passive heat stress on human somatosensory processing	AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY			English	Article						hyperthermia; somatosensory evoked potentials; conduction velocity; central fatigue; tactile	TRIGGERING VOLUNTARY MOVEMENT; CEREBRAL-BLOOD-FLOW; REACTION-TIME-TASK; EVOKED-POTENTIALS; SHORT-LATENCY; MEDIAN NERVE; CENTRIFUGAL REGULATION; BODY-TEMPERATURE; INTERSTIMULUS-INTERVAL; CORTICAL ACTIVITIES	Herein, we investigated the effects of passive heat stress on human somatosensory processing recorded by somatosensory-evoked potentials (SEPs). Fifteen healthy subjects received a median nerve stimulation at the left wrist under two thermal conditions: Heat Stress and normothermic Time Control. The latencies and amplitudes of P14, N20, P25, N35, P45, and N60 at C4' and P14, N18, P22, and N30 at Fz were evaluated. Under the Heat Stress condition, SEPs were recorded at normothermic baseline (1st), early in heat stress (2nd), when esophageal temperature had increased by similar to 1.0 degrees C (3rd) and similar to 2.0 degrees C (4th), and after heat stress (5th). In the Time Control condition, SEPs were measured at the same time intervals as those in the Heat Stress condition. The peak latencies and amplitudes of SEPs did not change early in heat stress. However, the latencies of P14, N20, and N60 at C4' and P14, N18, and P22 at Fz were significantly shorter in the 4th session than in the 1st session. Furthermore, the peak amplitudes of P25 and N60 at C4', and P22 and N30 at Fz decreased with increases in body temperature. On the other hand, under the Time Control condition, no significant differences were observed in the amplitudes or latencies of any component of SEPs. These results suggested that the conduction velocity of the ascending somatosensory input was accelerated by increases in body temperature, and hyperthermia impaired the neural activity of cortical somatosensory processing.	[Nakata, Hiroki; Shibasaki, Manabu] Nara Womens Univ, Fac Human Life & Environm, Dept Hlth Sci, Nara 6308506, Japan; [Oshiro, Misaki; Namba, Mari] Nara Womens Univ, Grad Sch Humanities & Sci, Nara 6308506, Japan	Shibasaki, M (reprint author), Nara Womens Univ, Fac Human Life & Environm, Dept Hlth Sci, Kitauoya Nishi Machi, Nara 6308506, Japan.	shiba@cc.nara-wu.ac.jp			Japan Society for the Promotion of Science [A-15H05361]	This study was supported by Japan Society for the Promotion of Science Grant-in-Aid for young Scientists A-15H05361 (to H. Nakata).	Cebolla AM, 2011, NEUROIMAGE, V54, P1297, DOI 10.1016/j.neuroimage.2010.08.060; [Anonymous], 1986, CEREB CORTEX; KAKIGI R, 1985, ELECTROEN CLIN NEURO, V62, P252, DOI 10.1016/0168-5597(85)90003-6; Inui K, 2004, CEREB CORTEX, V14, P851, DOI 10.1093/cercor/bhh043; Hocking C, 2001, COMP BIOCHEM PHYS A, V128, P719, DOI 10.1016/S1095-6433(01)00278-1; Nybo L, 2001, J APPL PHYSIOL, V91, P1055; CHERON G, 1992, ELECTROEN CLIN NEURO, V84, P288, DOI 10.1016/0168-5597(92)90010-9; Kida T, 2006, EXP BRAIN RES, V173, P733, DOI 10.1007/s00221-006-0448-0; Sun G, 2011, NEUROSCI LETT, V502, P94, DOI 10.1016/j.neulet.2011.07.029; Inui K, 2003, NEUROSCIENCE, V120, P235, DOI 10.1016/S0306-4522(03)00261-6; TAYLOR WF, 1989, J APPL PHYSIOL, V66, P1586; Hamada Y, 2003, CLIN NEUROPHYSIOL, V114, P548, DOI 10.1016/S1388-2457(02)00384-X; Legon W, 2008, NEUROREPORT, V19, P87, DOI 10.1097/WNR.0b013e3282f36f5f; Hoshiyama M, 1998, COGNITIVE BRAIN RES, V7, P137, DOI 10.1016/S0926-6410(98)00018-4; JONES EG, 1978, J COMP NEUROL, V181, P291, DOI 10.1002/cne.901810206; Brothers RM, 2009, J PHYSIOL-LONDON, V587, P3921, DOI 10.1113/jphysiol.2009.172023; MARSHALL NK, 1981, SCIENCE, V212, P356, DOI 10.1126/science.7209538; CHERON G, 1991, ELECTROEN CLIN NEURO, V80, P522, DOI 10.1016/0168-5597(91)90134-J; Wilson TE, 2006, AM J PHYSIOL-REG I, V291, pR1443, DOI 10.1152/ajpregu.00712.2005; Nybo L, 2008, J APPL PHYSIOL, V104, P871, DOI 10.1152/japplphysiol.00910.2007; Periard JD, 2014, EXP PHYSIOL, V99, P136, DOI 10.1113/expphysiol.2013.074583; NOGUCHI Y, 1995, NEUROLOGY, V45, P154; ALLISON T, 1991, BRAIN, V114, P2465, DOI 10.1093/brain/114.6.2465; HARI R, 1993, EUR J NEUROSCI, V5, P724, DOI 10.1111/j.1460-9568.1993.tb00536.x; Jiang QJ, 2013, INT J HYPERTHER, V29, P219, DOI 10.3109/02656736.2013.786141; PANJWANI GD, 1991, ELECTROEN CLIN NEURO, V80, P384, DOI 10.1016/0168-5597(91)90086-D; Nakata H, 2003, BRAIN TOPOGR, V15, P211, DOI 10.1023/A:1023908707851; KAZIS A, 1982, J NEUROL, V227, P1, DOI 10.1007/BF00313541; ALLISON T, 1989, J NEUROPHYSIOL, V62, P711; Wasaka T, 2012, EXP BRAIN RES, V219, P227, DOI 10.1007/s00221-012-3082-z; Ross EZ, 2012, J APPL PHYSIOL, V112, P748, DOI 10.1152/japplphysiol.00988.2011; Kida T, 2004, CLIN NEUROPHYSIOL, V115, P2223, DOI 10.1016/j.clinph.2004.04.017; Martin PG, 2005, EXP PHYSIOL, V90, P225, DOI 10.1113/expphysiol.2004.028977; Urushihara R, 2006, NEUROIMAGE, V31, P699, DOI 10.1016/j.neuroimage.2005.12.027; CHERON G, 1987, ELECTROEN CLIN NEURO, V67, P537, DOI 10.1016/0013-4694(87)90056-3; Kida T, 2006, NEUROIMAGE, V32, P1355, DOI 10.1016/j.neuroimage.2006.05.015; Madhok J, 2012, J NEUROSURG ANESTH, V24, P197, DOI 10.1097/ANA.0b013e31824ac36c; Arngrimsson SA, 2003, J APPL PHYSIOL, V94, P1162, DOI 10.1152/japplphysiol.00508.2002; Nakamura K, 2011, AM J PHYSIOL-REG I, V301, pR1207, DOI 10.1152/ajpregu.00109.2011; Liu K, 2013, BEHAV BRAIN RES, V243, P220, DOI 10.1016/j.bbr.2013.01.013; ALLISON T, 1989, J NEUROPHYSIOL, V62, P694; Sun G, 2012, INT J HYPERTHER, V28, P605, DOI 10.3109/02656736.2012.720345; Fierstra J, 2013, J PHYSIOL-LONDON, V591, P5809, DOI 10.1113/jphysiol.2013.259150; JONES SJ, 1981, ELECTROEN CLIN NEURO, V52, P517, DOI 10.1016/0013-4694(81)91427-9; Inoue K, 2002, CLIN NEUROPHYSIOL, V113, P1573, DOI 10.1016/S1388-2457(02)00162-1; Morrison S, 2004, EUR J APPL PHYSIOL, V91, P729, DOI 10.1007/s00421-004-1063-z; Szabo K, 2011, J NEUROL SCI, V309, P58, DOI 10.1016/j.jns.2011.07.026; Nakata H, 2011, NEUROREPORT, V22, P1000, DOI 10.1097/WNR.0b013e32834dc296; Mima T, 1998, J NEUROPHYSIOL, V80, P2215; Kida T, 2006, EXP BRAIN RES, V169, P289, DOI 10.1007/s00221-005-0141-8; Wikstrom H, 1996, EVOKED POTENTIAL, V100, P479; Todd G, 2005, J PHYSIOL-LONDON, V563, P621, DOI 10.1113/jphysiol.2004.077115; DESMEDT JE, 1989, ELECTROEN CLIN NEURO, V74, P321, DOI 10.1016/0168-5597(89)90001-4; Romo R, 2002, NAT NEUROSCI, V5, P1217, DOI 10.1038/nn950; Bain AR, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00092; MAUGUIERE F, 1983, BRAIN, V106, P271, DOI 10.1093/brain/106.2.271; ORO J, 1992, SPINE, V17, P498, DOI 10.1097/00007632-199205000-00005; Sato D, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-13	58	0	0	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0363-6119	1522-1490		AM J PHYSIOL-REG I	Am. J. Physiol.-Regul. Integr. Comp. Physiol.	DEC 1	2015	309	11					R1387	R1396		10.1152/ajpregu.00280.2015		10	Physiology	Physiology	CX7KN	WOS:000365880700008		
J	Paull, G; Dervis, S; McGinn, R; Haqani, B; Flouris, AD; Kondo, N; Kenny, GP				Paull, Gabrielle; Dervis, Sheila; McGinn, Ryan; Haqani, Baies; Flouris, Andreas D.; Kondo, Narihiko; Kenny, Glen P.			Muscle metaboreceptors modulate postexercise sweating, but not cutaneous blood flow, independent of baroreceptor loading status	AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY			English	Article						thermoregulation; postexercise; metaboreflex; baroreflex; heat loss responses	HEAT-LOSS RESPONSES; SEX-DIFFERENCES; DYNAMIC EXERCISE; VASCULAR CONDUCTANCE; TEMPERATURE RESPONSE; SYMPATHETIC OUTFLOW; HANDGRIP EXERCISE; PRESSURE; HUMANS; HYPERTHERMIA	We examined whether sustained changes in baroreceptor loading status during prolonged postexercise recovery can alter the metaboreceptors' influence on heat loss. Thirteen young males performed a 1-min isometric handgrip exercise (IHG) at 60% maximal voluntary contraction followed by 2 min of forearm ischemia (to activate metaboreceptors) before and 15, 30, 45, and 60 min after a 15-min intense treadmill running exercise (>90% maximal heart rate) in the heat (35 degrees C). This was repeated on three separate days with continuous lower body positive (LBPP, +40 mmHg), negative (LBNP, -20 mmHg), or no pressure (Control) from 13- to 65-min postexercise. Sweat rate (ventilated capsule; forearm, chest, upper back) and cutaneous vascular conductance (CVC; forearm, upper back) were measured. Relative to pre-IHG levels, sweating at all sites increased during IHG and remained elevated during ischemia at baseline and similarly at 30, 45, and 60 min postexercise (site average sweat rate increase during ischemia: Control, 0.13 +/- 0.02; LBPP, 0.12 +/- 0.02; LBNP, 0.15 +/- 0.02 mg.min(-1).cm(-2); all P < 0.01), but not at 15 min (all P > 0.10). LBPP and LBNP did not modulate the pattern of sweating to IHG and ischemia (all P > 0.05). At 15-min postexercise, forearm CVC was reduced from pre-IHG levels during both IHG and ischemia under LBNP only (ischemia: 3.9 +/- 0.8% CVCmax; P < 0.02). Therefore, we show metaboreceptors increase postexercise sweating in the middle to late stages of recovery (30-60 min), independent of baroreceptor loading status and similarly between skin sites. In contrast, metaboreflex modulation of forearm but not upper back CVC occurs only in the early stages of recovery (15 min) and is dependent upon baroreceptor unloading.	[Paull, Gabrielle; Dervis, Sheila; McGinn, Ryan; Haqani, Baies; Flouris, Andreas D.; Kenny, Glen P.] Univ Ottawa, Sch Human Kinet, Human & Environm Physiol Res Unit, Ottawa, ON K1N 6N5, Canada; [Flouris, Andreas D.] Univ Thessaly, Dept Exercise Sci, FAME Lab, Trikala, Greece; [Kondo, Narihiko] Kobe Univ, Grad Sch Human Dev & Environm, Lab Appl Human Physiol, Kobe, Hyogo 657, Japan	Kenny, GP (reprint author), Univ Ottawa, Sch Human Kinet, 125 Univ Private,Rm 367,Montpetit Hall, Ottawa, ON K1N 6N5, Canada.	gkenny@uottawa.ca			Natural Sciences and Engineering Research Council Discovery Grant [RGPIN-06313-2014]; Discovery Grants Program - Accelerator Supplements [RGPAS-462252-2014]; Canada Foundation for Innovation [22529]; University of Ottawa Research Chair Award; Ontario Graduate Scholarship; Human and Environmental Physiology Research Unit; Queen Elizabeth II Graduate Scholarship in Science and Technology	This study was supported by the Natural Sciences and Engineering Research Council Discovery Grant (RGPIN-06313-2014), Discovery Grants Program - Accelerator Supplements (RGPAS-462252-2014), and by Leaders Opportunity Fund from the Canada Foundation for Innovation (Grant 22529) (funds held by G. P. Kenny). G. P. Kenny was supported by a University of Ottawa Research Chair Award. G. Paull was supported by an Ontario Graduate Scholarship. S. Dervis was supported by the Human and Environmental Physiology Research Unit. R. McGinn. was supported by a Queen Elizabeth II Graduate Scholarship in Science and Technology.	Halliwill JR, 2013, EXP PHYSIOL, V98, P7, DOI 10.1113/expphysiol.2011.058065; Binder K, 2013, EUR J APPL PHYSIOL, V113, P183, DOI 10.1007/s00421-012-2428-3; Binder K, 2012, AM J PHYSIOL-REG I, V302, pR417, DOI 10.1152/ajpregu.00463.2011; Kenny GP, 2013, COMPR PHYSIOL, V3, P1689, DOI 10.1002/cphy.c130011; Kondo N, 1999, J PHYSIOL-LONDON, V515, P591, DOI 10.1111/j.1469-7793.1999.591ac.x; Christou DD, 2005, CIRCULATION, V111, P494, DOI 10.1161/01.CIR.0000153864.24034.A6; NISHIYASU T, 1994, ACTA PHYSIOL SCAND, V151, P143, DOI 10.1111/j.1748-1716.1994.tb09731.x; Kenny GP, 2008, APPL PHYSIOL NUTR ME, V33, P682, DOI 10.1139/H08-053; Kondo N, 2003, J APPL PHYSIOL, V94, P1829, DOI 10.1152/japplphysiol.00810.2002; THODEN J, 1994, EUR J APPL PHYSIOL O, V68, P170, DOI 10.1007/BF00244031; Gizdulich P, 1997, CARDIOVASC RES, V33, P698, DOI 10.1016/S0008-6363(97)00003-5; Hardy JD, 1938, J NUTR, V15, P461; WALLIN BG, 1989, AM J PHYSIOL, V256, pH105; Gizdulich P, 1996, J HYPERTENS, V14, P243, DOI 10.1097/00004872-199602000-00014; Kenny GP, 2007, AM J PHYSIOL-REG I, V292, pR1632, DOI 10.1152/ajpregu.00638.2006; Journeay WS, 2004, AVIAT SPACE ENVIR MD, V75, P841; McInnis NH, 2006, J APPL PHYSIOL, V101, P840, DOI 10.1152/japplphysiol.00382.2006; Kenny GP, 2002, EUR J APPL PHYSIOL, V86, P342, DOI 10.1007/s00421-001-0538-4; Shibasaki M, 2001, J PHYSIOL-LONDON, V534, P605, DOI 10.1111/j.1469-7793.2001.00605.x; Convertino VA, 1998, AM J PHYSIOL-REG I, V275, pR1909; Wilkins BW, 2004, J APPL PHYSIOL, V97, P2071, DOI 10.1152/japplphysiol.00466.2004; Kenny GP, 2006, AM J PHYSIOL-REG I, V291, pR580, DOI 10.1152/ajpregu.00918.2005; Bos WJW, 1996, CIRCULATION, V94, P1870; Gagnon D, 2013, J APPL PHYSIOL, V114, P394, DOI 10.1152/japplphysiol.00877.2012; Halliwill JR, 1996, J PHYSIOL-LONDON, V495, P279; Gagnon D, 2008, MED SCI SPORT EXER, V40, P513, DOI [10.1249/MSS.0b013e31815eb7b8, 10.1249/mss.0b013e31815eb7b8]; Jackson DN, 2003, J APPL PHYSIOL, V95, P121, DOI 10.1152/japplphysiol.01006.2002; Gagnon D, 2012, J APPL PHYSIOL, V113, P746, DOI 10.1152/japplphysiol.00637.2012; Journeay WS, 2004, J APPL PHYSIOL, V96, P2207, DOI 10.1152/japplphysiol.01201.2003; Amano T, 2011, J APPL PHYSIOL, V111, P524, DOI 10.1152/japplphysiol.00212.2011; Jarvis SS, 2011, AM J PHYSIOL-REG I, V301, pR193, DOI 10.1152/ajpregu.00562.2010; Larose J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083148; McGinn R, 2014, PHYSL REP, V2; McGinn R, 2014, AM J PHYSIOL-REG I, V306, pR82, DOI 10.1152/ajpregu.00364.2013; Penaz J., 1973, 10 INT C MED BIOL EN, P104; Stapleton JM, 2014, PHYSL REP, V2; WESSELING KH, 1995, HOMEOSTASIS HLTH DIS, V36, P67	37	0	0	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0363-6119	1522-1490		AM J PHYSIOL-REG I	Am. J. Physiol.-Regul. Integr. Comp. Physiol.	DEC 1	2015	309	11					R1415	R1424		10.1152/ajpregu.00287.2015		10	Physiology	Physiology	CX7KN	WOS:000365880700011		
J	Sato, T; Ishii, H				Sato, Toshiya; Ishii, Hisayoshi			Differences in control of parasympathetic vasodilation between submandibular and sublingual glands in the rat	AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY			English	Article						salivary gland; hemodynamics; muscarinic receptor; noncholinergic; vasoactive intestinal polypeptide	INTESTINAL POLYPEPTIDE VIP; BLOOD-FLOW; COMPLEMENTARY ROLE; MASSETER MUSCLE; CAT; SECRETION; ACETYLCHOLINE; STIMULATION; RELEASE; SALIVA	We examined blood flow in the submandibular gland (SMGBF) and sublingual gland (SLGBF) during electrical stimulation of the central cut end of the lingual nerve (LN) in the urethane-anesthetized rats using a laser speckle imaging flow meter. LN stimulation elicited intensity- and frequency-dependent SMGBF and SLGBF increases, and the magnitude of the SMGBF increase was higher than that of the SLGBF increase. The increase in both glands was significantly inhibited by intravenous administration of the autonomic cholinergic ganglion blocker hexamethonium. The antimuscarinic agent atropine markedly inhibited the SMGBF increase and partly inhibited the SLGBF increase. The atropine-resistant SLGBF increase was significantly inhibited by infusion of vasoactive intestinal peptide (VIP) receptor antagonist, although administration of VIP receptor antagonist alone had no effect. The recovery time to the basal blood flow level was shorter after LN stimulation than after administration of VIP. However, the recovery time after LN stimulation was significantly delayed by administration of atropine in a dose-dependent manner to the same level as after administration of VIP. Our results indicate that 1) LN stimulation elicits both a parasympathetic SMGBF increase mainly evoked by cholinergic fibers and a parasympathetic SLGBF increase evoked by cholinergic and noncholinergic fibers, and 2) VIP-ergic mechanisms are involved in the noncholinergic SLGBF increase and are activated when muscarinic mechanisms are deactivated.	[Sato, Toshiya; Ishii, Hisayoshi] Hlth Sci Univ Hokkaido, Sch Dent, Dept Oral Biol, Div Physiol, Ishikari, Hokkaido 0610293, Japan	Ishii, H (reprint author), Hlth Sci Univ Hokkaido, 1757 Kanazawa, Ishikari, Hokkaido 0610293, Japan.	hisayosh@hoku-iryo-u.ac.jp			MEXT KAKENHI [26861557, 25462896]	This study was partly supported by MEXT KAKENHI (Grant 26861557 to T. Sato and Grant 25462896 to H. Ishii).	Dawes C, 2015, ARCH ORAL BIOL, V60, P863, DOI 10.1016/j.archoralbio.2015.03.004; DUNERENGSTROM M, 1992, ACTA PHYSIOL SCAND, V146, P357, DOI 10.1111/j.1748-1716.1992.tb09430.x; Niioka T, 2009, ARCH ORAL BIOL, V54, P1022, DOI 10.1016/j.archoralbio.2009.08.006; Niioka T, 2009, ARCH ORAL BIOL, V54, P909, DOI 10.1016/j.archoralbio.2009.06.009; Ishii H, 2014, J COMP PHYSIOL B, V184, P385, DOI 10.1007/s00360-014-0807-2; IZUMI H, 1992, J PHYSIOL-LONDON, V450, P191; Anderson LC, 1998, EUR J MORPHOL, V36, P213; IZUMI H, 1994, AM J PHYSIOL, V267, pR747; Proctor GB, 2007, AUTON NEUROSCI-BASIC, V133, P3, DOI 10.1016/j.autneu.2006.10.006; LUNDBERG JM, 1981, ACTA PHYSIOL SCAND, V113, P329, DOI 10.1111/j.1748-1716.1981.tb06903.x; TAKAHASHI H, 1995, JPN J PHYSIOL, V45, P475, DOI 10.2170/jjphysiol.45.475; PLESCHKA K, 1984, REV PHYSIOL BIOCH P, V100, P75; Mizuta K, 2000, AM J PHYSIOL-REG I, V279, pR677; Stojic D, 2007, J DENT RES, V86, P565; Ishii H, 2005, J PHYSIOL-LONDON, V569, P617, DOI 10.1113/jphysiol.2005.087643; MIAO FJP, 1991, J CARDIOVASC PHARM, V18, P369, DOI 10.1097/00005344-199109000-00010; LUNDBERG JM, 1981, ACTA PHYSIOL SCAND, V113, P317, DOI 10.1111/j.1748-1716.1981.tb06902.x; Basak K, 2012, MED BIOL ENG COMPUT, V50, P547, DOI 10.1007/s11517-012-0902-z; Carpenter GH, 2013, ANNU REV FOOD SCI T, V4, P267, DOI 10.1146/annurev-food-030212-182700; Yasui T, 1997, INVEST OPHTH VIS SCI, V38, P2476; Izumi H, 1999, PHARMACOL THERAPEUT, V81, P141, DOI 10.1016/S0163-7258(98)00040-0; Ferguson DB, 1975, APPL PHYSL MOUTH; Lundblad L, 1984, Acta Physiol Scand Suppl, V529, P1	23	0	0	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0363-6119	1522-1490		AM J PHYSIOL-REG I	Am. J. Physiol.-Regul. Integr. Comp. Physiol.	DEC 1	2015	309	11					R1432	R1438		10.1152/ajpregu.00306.2015		7	Physiology	Physiology	CX7KN	WOS:000365880700013		
J	Turner, MJ; Kawada, T; Shimizu, S; Fukumitsu, M; Sugimachi, M				Turner, Michael J.; Kawada, Toru; Shimizu, Shuji; Fukumitsu, Masafumi; Sugimachi, Masaru			Differences in the dynamic baroreflex characteristics of unmyelinated and myelinated central pathways are less evident in spontaneously hypertensive rats	AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY			English	Article						baroreceptor; baroreflex; sympathetic nerve activity; hypertension	LOWERS BLOOD-PRESSURE; RHEOS PIVOTAL TRIAL; ACTIVATION THERAPY; RESISTANT HYPERTENSION; AORTIC BARORECEPTORS; SYMPATHETIC OUTFLOW; REFLEX; RABBITS; MECHANISMS; FIBERS	The aim of the study was to identify the contribution of myelinated (A-fiber) and unmyelinated (C-fiber) baroreceptor central pathways to the baroreflex control of sympathetic nerve activity (SNA) and arterial pressure (AP) in anesthetized Wistar-Kyoto (WKY; n = 8) and spontaneously hypertensive rats (SHR; n = 8). The left aortic depressor nerve (ADN) was electrically stimulated with two types of binary white noise signals designed to preferentially activate A-fibers (A-BRx protocol) or C-fibers (C-BRx protocol). In WKY, the central arc transfer function from ADN stimulation to SNA estimated by A-BRx showed strong derivative characteristics with the slope of dynamic gain between 0.1 and 1 Hz (Gslope) of 14.63 +/- 0.89 dB/decade. In contrast, the central arc transfer function estimated by C-BRx exhibited nonderivative characteristics with Gslope of 0.64 +/- 1.13 dB/decade. This indicates that A-fibers are important for rapid baroreflex regulation, whereas C-fibers are likely important for more sustained regulation of SNA and AP. In SHR, the central arc transfer function estimated by A-BRx showed higher Gslope (18.46 +/- 0.75 dB/decade, P < 0.01) and that estimated by C-BRx showed higher Gslope (8.62 +/- 0.64 dB/decade, P < 0.001) with significantly lower dynamic gain at 0.01 Hz (6.29 +/- 0.48 vs. 2.80 +/- 0.36%/Hz, P < 0.001) compared with WKY. In conclusion, the dynamic characteristics of the A-fiber central pathway are enhanced in the high-modulation frequency range (0.1-1 Hz) and those of the C-fiber central pathway are attenuated in the low-modulation frequency range (0.01-0.1 Hz) in SHR.	[Turner, Michael J.; Kawada, Toru; Shimizu, Shuji; Fukumitsu, Masafumi; Sugimachi, Masaru] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Dynam, Suita, Osaka 5658565, Japan; [Fukumitsu, Masafumi; Sugimachi, Masaru] Osaka Univ, Dept Artificial Organ Med, Fac Med, Grad Sch Med, Osaka, Japan	Turner, MJ (reprint author), Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Dynam, 5-7-1 Fujishirodai, Suita, Osaka 5658565, Japan.	michaeljturner@icloud.com			Support Program to Break the Bottlenecks at R&D Systems for accelerating the practical use of Health Research Outcome from Japan Science and Technology Agency; National Cerebral and Cardiovascular Center [26750153, 26-6-21, 26-6-24]	This study was supported partly by the Support Program to Break the Bottlenecks at R&D Systems for accelerating the practical use of Health Research Outcome from Japan Science and Technology Agency, Grant-in-Aid for Scientific Research (JSPS KAKENHI Grant 26750153), and Intramural Research Fund (26-6-21, 26-6-24) of the National Cerebral and Cardiovascular Center.	JONES JV, 1977, ACTA PHYSIOL SCAND, V101, P286, DOI 10.1111/j.1748-1716.1977.tb06010.x; Thoren P, 1999, ACTA PHYSIOL SCAND, V166, P167; Kawada T, 2015, AM J PHYSIOL-REG I, V308, pR957, DOI 10.1152/ajpregu.00525.2014; BROWN AM, 1978, CIRC RES, V42, P694; Morrison SF, 2001, AM J PHYSIOL-REG I, V281, pR683; Bakris GL, 2012, J AM SOC HYPERTENS, V6, P152, DOI 10.1016/j.jash.2012.01.003; Turner MJ, 2014, LIFE SCI, V106, P40, DOI 10.1016/j.lfs.2014.04.016; Kawada T, 2011, AM J PHYSIOL-REG I, V300, pR155, DOI 10.1152/ajpregu.00540.2010; Turner MJ, 2013, IEEE ENG MED BIO, P3809, DOI 10.1109/EMBC.2013.6610374; Yamamoto H, 2013, LIFE SCI, V92, P1202, DOI 10.1016/j.lfs.2013.05.004; Lohmeier TE, 2012, J APPL PHYSIOL, V113, P1652, DOI 10.1152/japplphysiol.00552.2012; Petiot E, 2001, J PHYSIOL-LONDON, V537, P949; Thrasher TN, 2005, AM J PHYSIOL-REG I, V288, pR819, DOI 10.1152/ajpregu.00813.2004; Kawada T, 2009, J PHYSIOL SCI, V59, P447, DOI 10.1007/s12576-009-0055-5; Fazan VPS, 2001, AM J PHYSIOL-HEART C, V280, pH1560; Lohmeier TE, 2007, HYPERTENSION, V49, P1307, DOI 10.1161/HYPERTENSIONAHA.107.087874; COWLEY AW, 1973, CIRC RES, V32, P564; Ramchandra R, 2006, AM J PHYSIOL-REG I, V290, pR701, DOI 10.1152/ajpregu.00504.2005; Bisognano JD, 2011, J AM COLL CARDIOL, V58, P765, DOI 10.1016/j.jacc.2011.06.008; Fan W, 1999, AM J PHYSIOL-REG I, V277, pR748; Sun H, 2009, J PHARMACOL EXP THER, V331, P851, DOI 10.1124/jpet.109.160473; Victor RG, 2015, NAT REV CARDIOL, V12, P451, DOI 10.1038/nrcardio.2015.96; Iliescu R, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-014-0453-9; Kawada T, 2010, J PHYSIOL SCI, V60, P283, DOI 10.1007/s12576-010-0096-9; Hoppe UC, 2012, J AM SOC HYPERTENS, V6, P270, DOI 10.1016/j.jash.2012.04.004; NUMAO Y, 1985, J AUTONOM NERV SYST, V13, P65, DOI 10.1016/0165-1838(85)90006-2; Kubo T, 1996, AM J PHYSIOL-HEART C, V270, pH1054; Bendat JS, 2010, RANDOM DATA ANAL MEA; Fan W, 1998, AM J PHYSIOL-HEART C, V275, pH632; Reynolds Patrick J, 2006, J Negat Results Biomed, V5, P6, DOI 10.1186/1477-5751-5-6	30	0	0	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0363-6119	1522-1490		AM J PHYSIOL-REG I	Am. J. Physiol.-Regul. Integr. Comp. Physiol.	DEC 1	2015	309	11					R1397	R1405		10.1152/ajpregu.00315.2015		9	Physiology	Physiology	CX7KN	WOS:000365880700009		
J	Benza, RL; Gomberg-Maitland, M; Demarco, T; Frost, AE; Torbicki, A; Langleben, D; Pulido, T; Correa-Jaque, P; Passineau, MJ; Wiener, HW; Tamari, M; Hirota, T; Kubo, M; Tiwari, HK				Benza, Raymond L.; Gomberg-Maitland, Mardi; Demarco, Teresa; Frost, Adaani E.; Torbicki, Adam; Langleben, David; Pulido, Tomas; Correa-Jaque, Priscilla; Passineau, Michael J.; Wiener, Howard W.; Tamari, Mayumi; Hirota, Tomomitsu; Kubo, Michiaki; Tiwari, Hemant K.			Endothelin-1 Pathway Polymorphisms and Outcomes in Pulmonary Arterial Hypertension	AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE			English	Article						pulmonary arterial hypertension; endothelin receptor antagonists; pharmacogenetics; polymorphisms	GENOME-WIDE ASSOCIATION; VASCULAR SMOOTH-MUSCLE; PROTEIN-COUPLED RECEPTORS; RIGHT-VENTRICULAR FAILURE; MALIGNANT MELANOMA-CELLS; BOSENTAN THERAPY; GENE-EXPRESSION; PLASMA ENDOTHELIN-1; BLOOD-PRESSURE; GROWTH-FACTOR	Rationale: Pulmonary arterial hypertension (PAH) is a progressive fatal disease. Variable response and tolerability to PAH therapeutics suggests that genetic differences may influence outcomes. The endothelin pathway is central to pulmonary vascular function, and several polymorphisms and/or mutations in the genes coding for endothelin ET)-1 and its receptors correlate with the clinical manifestations of other diseases. Objectives: To examine the interaction of ET-1 pathway polymorphisms and treatment responses of patients with PAH treated with ET receptor antagonists ERAs). Methods: A total of 1,198 patients with PAH were prospectively enrolled from 45 U.S. and Canadian pulmonary hypertension centers or retrospectively from global sites participating in the STRIDE Sitaxsentan To Relieve Impaired Exercise) trials. Comprehensive objective measures including a 6-minute-walk test, Borg dyspnea score, functional class, and laboratory studies were completed at baseline, before the initiation of ERAs, and repeated serially. Single-nucleotide polymorphisms from ET-1 pathway candidate genes were selected from a completed genome-wide association study performed on the study cohort. Measurements and Main Results: Patient efficacy outcomes were analyzed for a relationship between ET-1 pathway polymorphisms and clinical efficacy using predefined, composite positive and negative outcome measures in 715 European descent samples. A single-nucleotide polymorphism (rs11157866) in the G-protein alpha and gamma subunits gene was significantly associated, accounting for multiple testing, with a combined improvement in functional class and 6-minute-walk distance at 12 and 18 months and marginally significant at 24 months. Conclusions: ET-1 pathway associated polymorphisms may influence the clinical efficacy of ERA therapy for PAH. Further prospective studies are needed.	[Benza, Raymond L.; Correa-Jaque, Priscilla; Passineau, Michael J.] Allegheny Gen Hosp, Dept Med, Div Cardiovasc Dis, Pittsburgh, PA 15212 USA; [Gomberg-Maitland, Mardi] Univ Chicago, Dept Med, Div Cardiovasc Dis, Chicago, IL 60637 USA; [Demarco, Teresa] Univ Calif San Francisco, Dept Med, Div Cardiovasc Dis, San Francisco, CA 94143 USA; [Frost, Adaani E.] Baylor Coll Med, Houston, TX 77030 USA; [Torbicki, Adam] ECZ, Ctr Postgrad Med Educ, Dept Pulm Circulat & Thromboembol Dis, Otwock, Poland; [Langleben, David] McGill Univ, Dept Med, Sir Mortimer B Davis Jewish Gen Hosp, Montreal, PQ, Canada; [Pulido, Tomas] Natl Heart Inst, Cardiopulm Dept, Mexico City, DF, Mexico; [Wiener, Howard W.] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL USA; [Tiwari, Hemant K.] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA; [Tamari, Mayumi; Hirota, Tomomitsu; Kubo, Michiaki] RIKEN, Inst Phys & Chem Res, Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan	Benza, RL (reprint author), Allegheny Gen Hosp, 320 East North Ave,16th Floor,South Tower, Pittsburgh, PA 15212 USA.	rbenza@wpahs.org			NHLBI [5R01HL478946]; National Institutes of Health-Pharmacogenomics Research Network-Riken Center for Genomic Medicine Collaborative Studies: RIKEN VI	Supported by NHLBI 5R01HL478946 (R.L.B., Principal Investigator [PI]); and National Institutes of Health-Pharmacogenomics Research Network-Riken Center for Genomic Medicine Collaborative Studies: RIKEN VI (M.G.-M., PI).	Alakus H, 2014, ANN SURG ONCOL, V21, P4375, DOI 10.1245/s10434-014-3843-y; Matsuura A, 1998, HYPERTENSION, V32, P89; Mathai SC, 2012, AM J RESP CRIT CARE, V186, P428, DOI 10.1164/rccm.201203-0480OC; Yajima I, 2012, AM J CANCER RES, V2, P322; Nakajima M, 2014, NAT GENET, V46, P1012, DOI 10.1038/ng.3045; Yajima I, 2012, J DERMATOL SCI, V68, P172, DOI 10.1016/j.jdermsci.2012.09.009; Freidlin B, 2002, HUM HERED, V53, P146, DOI 10.1159/000064976; ITO H, 1991, CIRC RES, V69, P209; Germain M, 2013, NAT GENET, V45, P518, DOI 10.1038/ng.2581; Mulligan T, 2011, CELL SIGNAL, V23, P1617, DOI 10.1016/j.cellsig.2011.05.015; Abramovitch R, 2004, CANCER RES, V64, P1338, DOI 10.1158/0008-5472.CAN-03-2089; Brown MJ, 2000, J CARDIOVASC PHARM, V35, pS41, DOI 10.1097/00005344-200000002-00010; Yang M, 2009, BIOCHEM J, V417, P287, DOI 10.1042/BJ20081561; Peng J, 2014, GENET MOL RES, V13, P5463, DOI 10.4238/2014.July.24.26; Rasheed SAK, 2013, J BIOL CHEM, V288, P7986, DOI 10.1074/jbc.M112.437749; Sitbon O, 2002, J AM COLL CARDIOL, V40, P780, DOI 10.1016/S0735-1097(02)02012-0; Galie N, 2006, CIRCULATION, V114, P48, DOI 10.1161/CIRCULATIONAHA.106.630715; DALONZO GE, 1991, ANN INTERN MED, V115, P343; Barst RJ, 2006, J AM COLL CARDIOL, V47, P2049, DOI 10.1016/j.jacc.2006.01.057; Rubin LJ, 2002, NEW ENGL J MED, V346, P896, DOI 10.1056/NEJMoa012212; Matsuda K, 2015, HUM MOL GENET, V24, P1177, DOI 10.1093/hmg/ddu512; Growcott EJ, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-9; SHUBEITA HE, 1990, J BIOL CHEM, V265, P20555; Galie N, 2005, J AM COLL CARDIOL, V46, P529, DOI 10.1016/j.jacc.2005.04.050; Follin-Arbelet V, 2013, CANCER LETT, V335, P323, DOI 10.1016/j.canlet.2013.02.042; Michelakis ED, 2014, CIRC RES, V115, P109, DOI 10.1161/CIRCRESAHA.115.301132; Voelkel NF, 2012, EUR RESPIR J, V40, P1555, DOI 10.1183/09031936.00046612; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; Yajima I, 2014, AM J CANCER RES, V4, P182; Biasin V, 2014, INT J BIOCHEM CELL B, V54, P137, DOI 10.1016/j.biocel.2014.06.020; STEVENS PA, 1995, J CARDIOVASC PHARM, V26, pS9; Gabler NB, 2012, CHEST, V141, P20, DOI 10.1378/chest.11-0404; NOOTENS M, 1995, J AM COLL CARDIOL, V26, P1581, DOI 10.1016/0735-1097(95)00399-1; Galie N, 2008, CIRCULATION, V117, P3010, DOI 10.1161/CIRCULATIONAHA.107.742510; Laurie CC, 2010, GENET EPIDEMIOL, V34, P591, DOI 10.1002/gepi.20516; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Herrmann SM, 2001, EUR HEART J, V22, P1948, DOI 10.1053/euhj.2001.2626; YOSHIBAYASHI M, 1991, CIRCULATION, V84, P2280; Benza RL, 2007, J HEART LUNG TRANSPL, V26, P63, DOI 10.1016/j.healun.2006.10.019; Nicaud V, 1999, AM J HYPERTENS, V12, P304, DOI 10.1016/S0895-7061(98)00255-6; Leung T, 2006, BLOOD, V108, P160, DOI 10.1182/blood-2005-09-3706; Benza RL, 2012, CHEST, V142, P448, DOI 10.1378/chest.11-1460; Langleben D, 2004, J CARDIOVASC PHARM, V44, pS80, DOI 10.1097/01.fjc.0000166207.74178.d0; STEWART DJ, 1991, ANN INTERN MED, V114, P464; WEISSBERG PL, 1990, ATHEROSCLEROSIS, V85, P257, DOI 10.1016/0021-9150(90)90118-3; Yang ZH, 1999, CIRCULATION, V100, P5; Hayashi S, 2000, HYPERTENSION, V35, P237; Benza RL, 2008, CHEST, V134, P775, DOI 10.1378/chest.07-0767; Sandoval J, 2012, PULM PHARMACOL THER, V25, P33, DOI 10.1016/j.pupt.2011.10.002; Kawashiri S, 2014, RHEUMATOL INT, V34, P221, DOI 10.1007/s00296-013-2861-6; NEWBY AC, 1992, HERZ, V17, P291; McLaughlin VV, 2005, EUR RESPIR J, V25, P244, DOI 10.1183/09031936.05.00054804; Modarressi MH, 2000, BIOCHEM BIOPH RES CO, V272, P610, DOI 10.1006/bbrc.2000.2832; Shi CS, 2001, J BIOL CHEM, V276, P24293, DOI 10.1074/jbc.M100089200; Pulido T, 2013, NEW ENGL J MED, V369, P809, DOI 10.1056/NEJMoa1213917; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Weinstein LS, 2004, ENDOCRINOLOGY, V145, P5459, DOI 10.1210/en.2004-0865; Garcia-Murillas I, 2014, ONCOGENE, V33, P2478, DOI 10.1038/onc.2013.202; Peifley KA, 1998, BIOCHEM BIOPH RES CO, V242, P202, DOI 10.1006/bbrc.1997.7940; Wilkins MR, 2013, AM J RESP CRIT CARE, V188, P23, DOI 10.1164/rccm.201303-0470UP; Simonneau G, 2014, INT J CARDIOL, V172, P332, DOI 10.1016/j.ijcard.2013.12.179; Vaque JP, 2013, MOL CELL, V49, P94, DOI 10.1016/j.molcel.2012.10.018; Benza RL, 2010, CIRCULATION, V122, P164, DOI 10.1161/CIRCULATIONAHA.109.898122; GIAID A, 1993, NEW ENGL J MED, V328, P1732, DOI 10.1056/NEJM199306173282402; da Cunha JM, 2004, EUR J PHARMACOL, V501, P87, DOI 10.1016/j.ejphar.2004.08.004; Turcic K, 2014, J MOL ENDOCRINOL, V52, P321, DOI 10.1530/JME-13-0297; Torella D, 2009, AM J PHYSIOL-HEART C, V297, pH2015, DOI 10.1152/ajpheart.00738.2009; Klinger JR, 2013, AM J RESP CRIT CARE, V188, P639, DOI 10.1164/rccm.201304-0686PP; Matimba A, 2014, PHARMACOGENOMICS, V15, P433, DOI 10.2217/pgs.13.226; Castellanos-Rubio A, 2012, AUTOIMMUNITY, V45, P264, DOI 10.3109/08916934.2011.637531; Doaei Saeid, 2014, ARYA Atheroscler, V10, P169; Galie N, 2013, J AM COLL CARDIOL, V62, pD60, DOI 10.1016/j.jacc.2013.10.031; Hong Wei, 2014, Zhongguo Fei Ai Za Zhi, V17, P321, DOI 10.3779/j.issn.1009-3419.2014.04.06; Ikuta Kozo, 2014, Gastroenterology, V146, P1417, DOI 10.1053/j.gastro.2014.03.025; Narumi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060525; Olschewski H, 2013, HANDB EXP PHARMACOL, V218, P177, DOI 10.1007/978-3-642-38664-0_8; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Takano S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098718; Thompson MD, 2014, METHODS MOL BIOL, V1175, P189, DOI 10.1007/978-1-4939-0956-8_9; Thompson MD, 2014, METHODS MOL BIOL, V1175, P121, DOI 10.1007/978-1-4939-0956-8_7; Waxman AB, 2013, AM J CARDIOL, V111, p1A, DOI 10.1016/j.amjcard.2012.12.002; Waxman AB, 2013, AM J CARDIOL, V111, p17A; Yao Ai-Min, 2013, Zhongguo Dang Dai Er Ke Za Zhi, V15, P718	83	1	1	AMER THORACIC SOC	NEW YORK	25 BROADWAY, 18 FL, NEW YORK, NY 10004 USA	1073-449X	1535-4970		AM J RESP CRIT CARE	Am. J. Respir. Crit. Care Med.	DEC 1	2015	192	11					1345	1354		10.1164/rccm.201501-0196OC		10	Critical Care Medicine; Respiratory System	General & Internal Medicine; Respiratory System	CX6RU	WOS:000365829900015		
J	Murayama, S; Jo, J; Arai, K; Nishikido, F; Bakalova, R; Yamaya, T; Saga, T; Kato, M; Aoki, I				Murayama, Shuhei; Jo, Jun-ichiro; Arai, Kazutaka; Nishikido, Fumihiko; Bakalova, Rumiana; Yamaya, Taiga; Saga, Tsuneo; Kato, Masaru; Aoki, Ichio			gamma-PARCEL: Control of Molecular Release Using gamma-Rays	ANALYTICAL CHEMISTRY			English	Article							HYDROGEL; DELIVERY; PROTEIN; CELLS; NANOPARTICLES; PHOTOCONTROL; RADIOTHERAPY; LIGHT; RNA	We previously have developed the photo responsive tetra-gel and nanoparticles for controlling the function of the encapsulated substance by UV irradiation. However, the penetration ability of the UV is not high enough. Here, we developed a radiation-responsive tetra-gel and nanoparticle based on gamma-ray-responsive X-shaped polyethylene glycol (PEG) linker with a disulfide bond. The nanoparticle could retain small molecules and biomacromolecules. gamma-Rays were used as a trigger signal because of their higher penetrating ability. This allowed a spatiotemporal release and control of the encapsulated substances from the nanoparticle in the deeper region which is impossible by using light exposure (ultraviolet, visible, and near-infrared).	[Murayama, Shuhei; Jo, Jun-ichiro; Arai, Kazutaka; Nishikido, Fumihiko; Bakalova, Rumiana; Yamaya, Taiga; Saga, Tsuneo; Aoki, Ichio] Natl Inst Radiol Sci, Mol Imaging Ctr, Inage Ku, Chiba 2638555, Japan; [Kato, Masaru] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Kato, Masaru] Univ Tokyo, GPLLI Program, Bunkyo Ku, Tokyo 1130033, Japan	Aoki, I (reprint author), Natl Inst Radiol Sci, Mol Imaging Ctr, Inage Ku, 4-9-1 Anagawa, Chiba 2638555, Japan.	aoki@nirs.go.jp			JSPS KAKENHI [26860032]; Core-to-Core Program; A. Advanced Research Networks; NIRS; Center of Innovation Program (COI stream from JST)	This work was supported by JSPS KAKENHI Grant Number 26860032, Core-to-Core Program, A. Advanced Research Networks, an internal grant of NIRS, and the Center of Innovation Program (COI stream from JST).	SCHNAAR RL, 1985, ANAL BIOCHEM, V151, P268, DOI 10.1016/0003-2697(85)90175-7; THOMAS KR, 1986, CELL, V44, P419, DOI 10.1016/0092-8674(86)90463-0; Murayama S, 2010, ANAL CHEM, V82, P2186, DOI 10.1021/ac1003757; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; SMITHIES O, 1985, NATURE, V317, P230, DOI 10.1038/317230a0; Kunishima M, 1999, TETRAHEDRON LETT, V40, P5327, DOI 10.1016/S0040-4039(99)00968-5; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Yazawa M, 2009, NAT BIOTECHNOL, V27, P941, DOI 10.1038/nbt.1569; Murayama S, 2012, CHEM COMMUN, V48, P11461, DOI 10.1039/c2cc35567a; Murayama S, 2013, J MATER CHEM B, V1, P4932, DOI 10.1039/c3tb20828a; Cao W, 2014, CHEM-ASIAN J, V9, P48, DOI 10.1002/asia.201301294; Tanabe K, 2012, BIOCONJUGATE CHEM, V23, P1909, DOI 10.1021/bc3002985; Murayama S, 2012, CHEM COMMUN, V48, P8380, DOI 10.1039/c2cc32718j; Takagi K, 2014, SOFT MATTER, V10, P3553, DOI 10.1039/c3sm52908h; Cornelissen B, 2013, MOL CANCER THER, V12, P2472, DOI 10.1158/1535-7163.MCT-13-0369; Murayama S, 2012, ANAL CHEM, V84, P1374, DOI 10.1021/ac2023603; Murayama S, 2014, MACROMOL BIOSCI, V14, P626, DOI 10.1002/mabi.201300393; Chang CY, 1998, J AM CHEM SOC, V120, P7661, DOI 10.1021/ja981649v; Endo M., 2004, ANGEW CHEM, V116, P5761, DOI 10.1002/ange.200460889; Hahn E. M., 2004, ANGEW CHEM INT EDIT, V43, P5800	20	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0003-2700	1520-6882		ANAL CHEM	Anal. Chem.	DEC 1	2015	87	23					11625	11629		10.1021/acs.analchem.5b03030		5	Chemistry, Analytical	Chemistry	CX8CV	WOS:000365931100005		
J	Kuwata, T; Uchida, A; Takano, E; Kitayama, Y; Takeuchi, T				Kuwata, Takahiro; Uchida, Akane; Takano, Eri; Kitayama, Yukiya; Takeuchi, Toshifumi			Molecularly Imprinted Polymer Arrays as Synthetic Protein Chips Prepared by Transcription-type Molecular Imprinting by Use of Protein-Immobilized Dots as Stamps	ANALYTICAL CHEMISTRY			English	Article							LIQUID-PHASE DEPOSITION; ANTIBODY MICROARRAYS; PROSTHETIC GROUPS; DNA MICROARRAYS; PROTEOMICS; RECOGNITION; LYSOZYME; MONOMERS; DESIGN	Molecularly imprinted polymer (MIP) arrays were demonstrated for the recognition of proteins. They were prepared via transcription-type molecular imprinting where patterned dots composed of biotinylated nanoparticles were first immobilized on a glass substrate followed by the immobilization of versatile biotinylated proteins via avidin-biotin interactions, yielding a multiple protein-immobilized stamp as a mold that could be transcribed. MIPs were prepared between the stamp and a methacrylated glass substrate, and after the stamp was peeled off, MIP dots were able to be prepared on the methacrylated glass substrate according to the positions of the immobilized proteins on the stamp. We confirmed that the prepared MIP array showed the expected selective binding toward the corresponding template proteins by conducting competitive binding assays using the fluorescently labeled proteins as corresponding competitors. The binding behaviors were consistent with those obtained by a surface plasmon resonance sensing system. We believe that the proposed platform involving the easily handled nanoparticle-based protein stamps for the preparation of MIP arrays can provide a new type of pattern recognition-based protein chip, which can be adopted as a substitute for the use of conventional protein arrays in various research and industrial fields in the life sciences.	[Kuwata, Takahiro; Uchida, Akane; Takano, Eri; Kitayama, Yukiya; Takeuchi, Toshifumi] Kobe Univ, Grad Sch Engn, Nada Ku, Kobe, Hyogo 6578501, Japan	Takeuchi, T (reprint author), Kobe Univ, Grad Sch Engn, Nada Ku, 1-1 Rokkodai Cho, Kobe, Hyogo 6578501, Japan.	takeuchi@gold.kobe-u.ac.jp			JSPS Kakenhi [24651261, 15K14943]; System Instruments (Tokyo, Japan)	The authors thank Dr. Tooru Ooya (Kobe University) for his kind suggestion. This work was partially supported by JSPS Kakenhi Grants 24651261 and 15K14943. We also appreciate System Instruments (Tokyo, Japan) for their technical assistance and financial support.	Cutivet A, 2009, J AM CHEM SOC, V131, P14699, DOI 10.1021/ja901600e; MOSBACH K, 1994, TRENDS BIOCHEM SCI, V19, P9, DOI 10.1016/0968-0004(94)90166-X; Takeuchi T, 2007, ANALYST, V132, P101, DOI 10.1039/b614532a; Haruki M, 2007, BIOTECHNOL PROGR, V23, P1254, DOI 10.1021/bp070130c; Suga Y, 2013, CHEM COMMUN, V49, P8450, DOI 10.1039/c3cc40484f; Borrebaeck CAK, 2009, J PROTEOMICS, V72, P928, DOI 10.1016/j.jprot.2009.01.027; Babine RE, 1997, CHEM REV, V97, P1359, DOI 10.1021/cr960370z; Turner NW, 2006, BIOTECHNOL PROGR, V22, P1474, DOI 10.1021/bp060122g; Takeuchi T, 2008, ORG BIOMOL CHEM, V6, P2459, DOI 10.1039/b715737c; Hoshino Y, 2010, J AM CHEM SOC, V132, P6644, DOI 10.1021/ja102148f; Tatemichi M, 2007, J AM CHEM SOC, V129, P10906, DOI 10.1021/ja071890m; Rusmini F, 2007, BIOMACROMOLECULES, V8, P1775, DOI 10.1021/bm061197b; STENBERG E, 1991, J COLLOID INTERF SCI, V143, P513, DOI 10.1016/0021-9797(91)90284-F; Hu XB, 2007, ADV MATER, V19, P4327, DOI 10.1002/adma.200701084; Brown PO, 1999, NAT GENET, V21, P33, DOI 10.1038/4462; Ramsay G, 1998, NAT BIOTECHNOL, V16, P40, DOI 10.1038/nbt0198-40; Cheung WC, 2012, NAT BIOTECHNOL, V30, P447, DOI 10.1038/nbt.2167; Sunayama H, 2014, CHEM COMMUN, V50, P1347, DOI 10.1039/c3cc47759b; Zhu H, 2003, CURR OPIN CHEM BIOL, V7, P55, DOI 10.1016/S1367-5931(02)00005-4; Cai D, 2010, NAT NANOTECHNOL, V5, P597, DOI [10.1038/nnano.2010.114, 10.1038/NNANO.2010.114]; Lin HY, 2006, BIOSENS BIOELECTRON, V22, P534, DOI 10.1016/j.bios.2006.07.038; WULFF G, 1995, ANGEW CHEM INT EDIT, V34, P1812, DOI 10.1002/anie.199518121; Whitcombe MJ, 2011, CHEM SOC REV, V40, P1547, DOI 10.1039/c0cs00049c; Borrebaeck CAK, 2007, EXPERT REV MOL DIAGN, V7, P673, DOI 10.1586/14737159.7.5.673; Inoue J, 2011, SOFT MATTER, V7, P9681, DOI 10.1039/c1sm05088e; Hansen DE, 2007, BIOMATERIALS, V28, P4178, DOI 10.1016/j.biomaterials.2007.06.017; Takeda K, 2009, J AM CHEM SOC, V131, P8833, DOI 10.1021/ja9004317; Takeuchi T, 1999, ANAL CHEM, V71, P285, DOI 10.1021/ac980858v; Matsunaga T, 2006, CHEM LETT, V35, P1030, DOI 10.1246/cl.2006.1030; Brennan DJ, 2010, NAT REV CANCER, V10, P605, DOI 10.1038/nrc2902; Chen YW, 2009, ORG BIOMOL CHEM, V7, P488, DOI 10.1039/b813361a; Debouck C, 1999, NAT GENET, V21, P48, DOI 10.1038/4475; Green N. M., 1965, BIOCHEM J, V94, p23C; Haupt K., 2012, MOL IMPRINTING; Kamon Y, 2014, POLYM CHEM-UK, V5, P4764, DOI 10.1039/c4py00350k; Komiyama M., 2002, MOL IMPRINTING FUNDA, DOI [10.1002/352760202X, DOI 10.1002/352760202X]; Lee SW, 2013, HANDBOOK OF MOLECULAR IMPRINTING: ADVANCED SENSOR APPLICATIONS, P1; Liu J. X., 2014, SCI REP, V4; MacBeath G, 2002, NAT GENET, V32, P526, DOI 10.1038/ng1037; McNiven S, 1997, CHEM LETT, P1297, DOI 10.1246/cl.1997.1297; Sasaki S, 2015, J BIOSCI BIOENG, V119, P200, DOI 10.1016/j.jbiosc.2014.06.019; Sassolas A., 2008, J CHEM REV, V108, P109, DOI DOI 10.1021/CR0684467; Sellergren B, 2001, MOL IMPRINTED POLYM; Takeuchi T, 2014, ANGEW CHEM INT EDIT, V53, P12765, DOI 10.1002/anie.201406852; Yan M., 2005, MOL IMPRINTED MAT SC	45	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0003-2700	1520-6882		ANAL CHEM	Anal. Chem.	DEC 1	2015	87	23					11784	11791		10.1021/acs.analchem.5b03134		8	Chemistry, Analytical	Chemistry	CX8CV	WOS:000365931100027		
J	Ogata, S; Shimizu, K; Nakanishi, K				Ogata, Sho; Shimizu, Ken; Nakanishi, Kuniaki			Human intestinal spirochetosis: right-side preference in the large intestine	ANNALS OF DIAGNOSTIC PATHOLOGY			English	Article						Adenoma; Brachyspira; Location; Spirochetosis	JAPAN	Human intestinal spirochetosis (HIS) is a colorectal bacterial infection, and its clinicopathologic features remain unclear. The aim of this study was to examine its characteristics. We histologically reviewed paraffin-embedded section slides made in 2001, 2006, and 2011 at a single institution in Japan. Cases histologically exhibiting a distinct fringe formation were considered to have HIS. Information was obtained from pathology request forms. We identified 85 HIS cases among 4930 patients (7 cases [0.5%) in 2001, 29 [1.7%] in 2006, and 49 [2.8%] in 2011]. Gastrointestinal symptoms were observed in 7.1% of HIS cases. Human intestinal spirochetosis was more frequent in the right-side large intestine than in the left side. Among 224 samples from HIS cases, conventional (tubular, tubulovillous, and villous) adenomas were found in 148 samples. These adenomas were more frequent in the right side than in the left side, although neither their size nor morphology differed between the sides. Histopathologic evaluation suggested a year-upon-year increasing prevalence of HIS in Japan. A small number exhibited gastrointestinal symptoms. Both histologic sign of HIS and conventional adenomas were more frequent in the right-side large intestine. Therefore, a right-side preference may be a characteristic of HIS. (C) 2015 Elsevier Inc. All rights reserved.	[Ogata, Sho; Nakanishi, Kuniaki] Natl Def Med Coll Hosp, Dept Lab Med, Tokorozawa, Saitama 3598513, Japan; [Ogata, Sho; Shimizu, Ken] JCHO Saitama Med Ctr, Dept Diagnost Pathol, Saitama, Saitama 3300074, Japan; [Nakanishi, Kuniaki] Natl Def Med Coll, Dept Pathol & Lab Med, Tokorozawa, Saitama 3598513, Japan	Ogata, S (reprint author), Natl Def Med Coll Hosp, Dept Lab Med, Tokorozawa, Saitama 3598513, Japan.	sogata@ndmc.ac.jp					Weisheit B, 2007, SCAND J GASTROENTERO, V42, P1422, DOI 10.1080/00365520701245629; HARLAND WA, 1967, BRIT MED J, V3, P718; Korner M, 2003, INFECTION, V31, P341, DOI 10.1007/s15010-003-3145-y; Nakamura S, 1998, PATHOL INT, V48, P58, DOI 10.1111/j.1440-1827.1998.tb03829.x; Sato H, 2010, J MED MICROBIOL, V59, P791, DOI 10.1099/jmm.0.017376-0; Munshi MA, 2004, EPIDEMIOL INFECT, V132, P137, DOI 10.1017/S095026880300116X; Higashiyama M, 2009, ACTA MED OKAYAMA, V63, P217; Li SC, 2007, ARCH PATHOL LAB MED, V131, P440; Tanahashi J, 2008, MODERN PATHOL, V21, P76, DOI 10.1038/modpathol.3800987; SUEYOSHI M, 1990, INFECT IMMUN, V58, P3348; Ogata S, 2010, HUM PATHOL, V41, P249, DOI 10.1016/j.humpath.2009.07.020; SURAWICZ CM, 1987, AM J MED, V82, P587, DOI 10.1016/0002-9343(87)90104-5; Iwamoto J, 2014, INTERNAL MED, V53, P2067, DOI 10.2169/internalmedicine.53.2386; Koerner M, 2003, INFECTION, V31, P341; Rotterdam H., 1997, PATHOLOGY INFECT DIS, P583	15	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1092-9134	1532-8198		ANN DIAGN PATHOL	Ann. Diagn. Pathol.	DEC	2015	19	6					414	417		10.1016/j.anndiagpath.2015.10.004		4	Pathology	Pathology	CY2LW	WOS:000366241200009		
J	Lee, CY; Johnson, AL				Lee, Chia-Yen; Johnson, Andrew L.			Effective production: measuring of the sales effect using data envelopment analysis	ANNALS OF OPERATIONS RESEARCH			English	Article						Data envelopment analysis; Effectiveness measure; Sales effect; Effective production; Strategic position	MEASURING EFFICIENCY; DEA; PERFORMANCE; MODELS; DECOMPOSITION; INDUSTRY	Sales fluctuations lead to variations in the output levels affecting technical efficiency measures of operations when units sold are used at an output measure. The present study uses the concept of "effective production" and "effectiveness" to account for the effect of sales on operational performance measurements in a production system. The effectiveness measure complements the efficiency measure which does not account for the sales effect. The Malmquist productivity index is used to measure the sales effects characterized as the difference between the production function associated with efficiency and the sales-truncated production function associated with effectiveness. The proposed profit effectiveness is distinct from profit efficiency in that it accounts for sales. An empirical study of US airlines demonstrates the proposed method which describes the strategic position of a firm and a productivity-change analysis. These results demonstrate the concept of effectiveness and quantifies the effect of using sales as output.	[Lee, Chia-Yen] Natl Cheng Kung Univ, Inst Mfg Informat & Syst, Tainan 701, Taiwan; [Lee, Chia-Yen] Natl Cheng Kung Univ, Res Ctr Energy Technol & Strategy, Tainan 701, Taiwan; [Johnson, Andrew L.] Texas A&M Univ, Dept Ind & Syst Engn, College Stn, TX 77840 USA; [Johnson, Andrew L.] Osaka Univ, Grad Sch Informat Sci & Technol, Osaka 5650871, Japan	Lee, CY (reprint author), Natl Cheng Kung Univ, Inst Mfg Informat & Syst, Tainan 701, Taiwan.	cylee@mail.ncku.edu.tw; ajohnson@tamu.edu			National Science Council [NSC101-2218-E-006-023]; National Cheng Kung University Research Center for Energy Technology and Strategy (NCKU RCETS), Taiwan	This research was funded by National Science Council (NSC101-2218-E-006-023) and National Cheng Kung University Research Center for Energy Technology and Strategy (NCKU RCETS), Taiwan.	Althin R, 1996, ANN OPER RES, V66, P219, DOI 10.1007/BF02187592; Talluri S, 2006, INT J PROD ECON, V100, P212, DOI 10.1016/j.ijpe.2004.11.012; GOLANY B, 1993, IIE TRANS, V25, P2, DOI 10.1080/07408179308964322; Kuosmanen T, 2008, ECONOMET J, V11, P308, DOI 10.1111/j.1368-423X.2008.00239.x; Alam IMS, 2000, INT ECON REV, V41, P203; GOLANY B, 1995, MANAGE SCI, V41, P1172, DOI 10.1287/mnsc.41.7.1172; CHARNES A, 1978, EUR J OPER RES, V2, P429, DOI 10.1016/0377-2217(78)90138-8; BANKER RD, 1984, MANAGE SCI, V30, P1078, DOI 10.1287/mnsc.30.9.1078; DIEWERT WE, 1980, AM ECON REV, V70, P260; FARE R, 1994, AM ECON REV, V84, P66; Kuosmanen T, 2010, OPER RES, V58, P149, DOI 10.1287/opre.1090.0722; Kuosmanen T, 2012, ENERG ECON, V34, P2189, DOI 10.1016/j.eneco.2012.03.005; Asmild M, 2007, EUR J OPER RES, V178, P305, DOI 10.1016/j.ejor.2006.01.014; Barros CP, 2009, INT J PROD ECON, V122, P525, DOI 10.1016/j.ijpe.2009.04.016; Bureau of Transportation Statistics, 2011, AIRL DAT STAT; Byrnes P., 1999, PUBLIC PRODUCTIVITY, V23, P210, DOI 10.2307/3380779; CAVES DW, 1982, ECONOMETRICA, V50, P1393, DOI 10.2307/1913388; Chen WC, 2007, EUR J OPER RES, V178, P277, DOI 10.1016/j.ejor.2005.06.071; Coelli T., 2005, INTRO EFFICIENCY PRO; Diewert W. E., 1992, B ECON RES, V44, P163, DOI 10.1111/j.1467-8586.1992.tb00542.x; Fare R., 1992, J PROD ANAL, V3, P85, DOI DOI 10.1007/BF00158770; FARRELL MJ, 1957, J R STAT SOC SER A-G, V120, P253, DOI 10.2307/2343100; FIELDING GJ, 1985, TRANSPORT RES A-POL, V19, P73, DOI 10.1016/0191-2607(85)90009-3; GOLANY B, 1988, J OPER RES SOC, V39, P725; Graf M, 2013, INT J PROD ECON, V145, P281, DOI 10.1016/j.ijpe.2013.04.049; GrifellTatje E, 1997, ANN OPER RES, V73, P177, DOI 10.1023/A:1018925127385; HILDRETH C, 1954, J AM STAT ASSOC, V49, P598, DOI 10.2307/2281132; IATA, 2010, 2009 WORST DEM DECL; Lee CY, 2012, EUR J OPER RES, V216, P584, DOI 10.1016/j.ejor.2011.08.004; Lee CY, 2014, EUR J OPER RES, V232, P537, DOI 10.1016/j.ejor.2013.07.043; Lee CY, 2015, J OPTIMIZ THEORY APP, V164, P702, DOI 10.1007/s10957-014-0557-z; Lee CY, 2011, INT J PROD RES, V49, P4761, DOI 10.1080/00207543.2010.497507; Lovell CAK, 2003, J OPER RES SOC, V54, P101, DOI 10.1057/palgrave.jors.2601483; Nerlove M., 1965, ESTIMATION IDENTIFIC; Ouellette P, 2010, ANN OPER RES, V173, P57, DOI 10.1007/s10479-008-0477-0; Vaz CB, 2010, ANN OPER RES, V173, P5, DOI 10.1007/s10479-008-0397-z; Yu MM, 2008, OMEGA-INT J MANAGE S, V36, P1005, DOI 10.1016/j.omega.2007.06.003	37	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0254-5330	1572-9338		ANN OPER RES	Ann. Oper. Res.	DEC	2015	235	1					453	486		10.1007/s10479-015-1932-3		34	Operations Research & Management Science	Operations Research & Management Science	CX7FH	WOS:000365867100021		
J	Mackie, SL; Pease, CT; Fukuba, E; Harris, E; Emery, P; Hodgson, R; Freeston, J; McGonagle, D				Mackie, Sarah Louise; Pease, Colin Thomas; Fukuba, Eiji; Harris, Emma; Emery, Paul; Hodgson, Richard; Freeston, Jane; McGonagle, Dennis			Whole-body MRI of patients with polymyalgia rheumatica identifies a distinct subset with complete patient-reported response to glucocorticoids	ANNALS OF THE RHEUMATIC DISEASES			English	Article							ARTHRITIS; CRITERIA; TOMOGRAPHY; MANAGEMENT; ARTERITIS; OUTCOMES; PMR	Objectives To determine whether whole-body MRI defines clinically relevant subgroups within polymyalgia rheumatica (PMR) including glucocorticoid responsiveness. Methods 22 patients with PMR and 16 with rheumatoid arthritis (RA), untreated and diagnosed by consultant rheumatologists, underwent whole-body, multiple-joint MRI, scored by two experts. Patients with PMR reported whether they felt 'back to normal' on glucocorticoid therapy and were followed for a median of 2 years. Results All patients with PMR were deemed to respond to glucocorticoids clinically. A characteristic pattern of symmetrical, extracapsular inflammation, adjacent to greater trochanter, acetabulum, ischial tuberosity and/or symphysis pubis, was observed in 14/22 of the PMR cases. In PMR, this pattern was associated with complete glucocorticoid response (p=0.01), higher pretreatment C-reactive protein (CRP) and serum interleukin-6 (IL-6), and better post-treatment fatigue and function. Only 1/14 in the extracapsular group could stop glucocorticoids within 1 year, compared with 4/7 of the others. A score derived from the five sites discriminating best between PMR and RA correlated with IL-6 (p<0.002). IL-6 levels = 16.8 pg/mL had 86% sensitivity and 86% specificity for the extracapsular MRI pattern. Conclusions A subset of patients with rheumatologist-diagnosed PMR had a characteristic, extracapsular pattern of MRI inflammation, associated with elevated IL-6/CRP and with complete patient-reported glucocorticoid responsiveness.	[Mackie, Sarah Louise; Harris, Emma; Emery, Paul; Hodgson, Richard; Freeston, Jane; McGonagle, Dennis] Leeds Inst Rheumat & Musculoskeletal Med, Leeds, W Yorkshire, England; [Mackie, Sarah Louise; Emery, Paul; Hodgson, Richard; Freeston, Jane; McGonagle, Dennis] NIHR Leeds Musculoskeletal Biomed Res Unit, Leeds, W Yorkshire, England; [Pease, Colin Thomas] Leeds Teaching Hosp NHS Trust, Leeds, W Yorkshire, England; [Fukuba, Eiji] Shimane Univ, Dept Radiol, Izumo, Shimane, Japan; [Hodgson, Richard] Univ Manchester, Ctr Imaging Sci, Manchester, Lancs, England	Mackie, SL (reprint author), Chapel Allerton Hosp, Leeds Inst Rheumat & Musculoskeletal Med, Leeds LS7 4SA, W Yorkshire, England.	s.l.mackie@leeds.ac.uk			National Institute for Health Research Academic Clinical Lecturer Award; National Institute for Health Research Clinician Scientist Award; NIHR Leeds Musculoskeletal Biomedical Research Unit; Leeds Teaching Hospitals Charitable Trustees; National Institute for Health Research (NIHR)	SLM was funded by a National Institute for Health Research Academic Clinical Lecturer Award during the data collection and is currently funded by a National Institute for Health Research Clinician Scientist Award. MRI scans were funded by the NIHR Leeds Musculoskeletal Biomedical Research Unit. Biomarker analyses were funded by a grant to SLM from the Leeds Teaching Hospitals Charitable Trustees. This article presents independent research supported by the National Institute for Health Research (NIHR). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. An earlier version of this work was presented in poster form at the American College of Rheumatology Annual Meeting in November 2014.	Hutchings A, 2007, ARTHRIT RHEUM-ARTHR, V57, P803, DOI 10.1002/art.22777; Weyand CM, 1999, ARCH INTERN MED, V159, P577, DOI 10.1001/archinte.159.6.577; McGonagle D, 2001, J RHEUMATOL, V28, P1837; Spiera R, 2012, ARTHRITIS RHEUM-US, V64, P955, DOI 10.1002/art.34389; Matteson EL, 2012, J RHEUMATOL, V39, P795, DOI 10.3899/jrheum.110977; Freeston J, 2012, RHEUMATOLOGY, V51, P68; Dasgupta B, 2012, ANN RHEUM DIS, V71, P484, DOI 10.1136/annrheumdis-2011-200329; Kalke S, 2000, RHEUMATOLOGY, V39, P883, DOI 10.1093/rheumatology/39.8.883; Mackie SL, 2010, RHEUMATOLOGY, V49, P716, DOI 10.1093/rheumatology/kep395; Takahashi H, 2015, MOD RHEUMATOL, V25, P546, DOI 10.3109/14397595.2014.978936; Cimmino MA, 2013, RHEUMATOLOGY, V52, P1865, DOI 10.1093/rheumatology/ket229; Dasgupta B, 2010, RHEUMATOLOGY, V49, P186, DOI 10.1093/rheumatology/kep303a; Leeb BF, 2004, ANN RHEUM DIS, V63, P1279, DOI 10.1136/ard.2003.011379; BIRD HA, 1979, ANN RHEUM DIS, V38, P434, DOI 10.1136/ard.38.5.434; Dejaco C, 2014, ANN RHEUM DIS, V73, P553, DOI 10.1136/annrheumdis-2014-eular.2316; Pease CT, 2005, J RHEUMATOL, V32, P1043; Twohig H, 2015, PATIENT EDUC COUNS, V98, P645, DOI 10.1016/j.pec.2014.12.013; Mackie SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126758; Mori Shunsuke, 2007, Mod Rheumatol, V17, P369, DOI 10.1007/s10165-007-0595-6	19	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0003-4967	1468-2060		ANN RHEUM DIS	Ann. Rheum. Dis.	DEC	2015	74	12					2188	2192		10.1136/annrheumdis-2015-207395		5	Rheumatology	Rheumatology	CX6YA	WOS:000365846400021		
J	Sasada, S; Miyata, Y; Mimae, T; Mimura, T; Okada, M				Sasada, Shinsuke; Miyata, Yoshihiro; Mimae, Takahiro; Mimura, Takeshi; Okada, Morihito			Impact of Lepidic Component Occupancy on Effects of Adjuvant Chemotherapy for Lung Adenocarcinoma	ANNALS OF THORACIC SURGERY			English	Article							RESPIRATORY SOCIETY CLASSIFICATION; VINORELBINE PLUS CISPLATIN; INTERNATIONAL ASSOCIATION; IASLC/ATS/ERS CLASSIFICATION; SUBLOBAR RESECTION; CANCER; RECURRENCE; PROGNOSIS; SURVIVAL; REVISION	Background. The prognosis of lepidic predominant lung adenocarcinoma is favorable. We postulated that lepidic predominant tumors might not require postoperative adjuvant chemotherapy. The present study aims to determine whether lepidic component occupancy affects overall survival after postoperative adjuvant chemotherapy for lung adenocarcinoma. Methods. Clinical and pathologic data were collected from a database and from the medical records of 964 patients with completely resected lung adenocarcinoma. We assessed the influence of lepidic component occupancy in the tumor on the outcomes of adjuvant chemotherapy. Results. Among the patients, 270 received adjuvant chemotherapy and 694 did not, and 415 and 549 had lepidic predominant and non-lepidic predominant tumors, respectively. Adjuvant chemotherapy contributed to better overall survival compared with observation in non-lepidic predominant tumors (p = 0.025). Multivariate analyses revealed age, sex, stage, lepidic component occupancy, and adjuvant chemotherapy as independent prognostic factors for overall survival. The overall survival was significantly longer for patients with non-lepidic predominant tumors at stages IA, IB, and II-III under adjuvant chemotherapy compared with observation (p = 0.040, p = 0.007, and p = 0.012, respectively), whereas survival rates were similar for patients with all stages of lepidic predominant tumors even after propensity score matching study. Conclusions. Lepidic component occupancy reflected the effect of adjuvant chemotherapy for lung adenocarcinoma. Adjuvant chemotherapy did not have much impact for lepidic predominant tumors and could be considered for non-lepidic predominant tumors even at stage IA. (C) 2015 by The Society of Thoracic Surgeons	[Sasada, Shinsuke; Miyata, Yoshihiro; Mimae, Takahiro; Mimura, Takeshi; Okada, Morihito] Hiroshima Univ, Dept Surg Oncol, Hiroshima 7348551, Japan	Okada, M (reprint author), Hiroshima Univ, Dept Surg Oncol, Res Inst Radiat Biol & Med, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	morihito@hiroshima-u.ac.jp					Goldstraw P, 2007, J THORAC ONCOL, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Arriagada R, 2010, J CLIN ONCOL, V28, P35, DOI 10.1200/JCO.2009.23.2272; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Pignon JP, 2008, J CLIN ONCOL, V26, P3552, DOI 10.1200/JCO.2007.13.9030; Hung JJ, 2013, ANN SURG, V258, P1079, DOI 10.1097/SLA.0b013e31828920c0; Strauss GM, 2008, J CLIN ONCOL, V26, P5043, DOI 10.1200/JCO.2008.16.4855; Douillard JY, 2006, LANCET ONCOL, V7, P719, DOI 10.1016/S1470-2045(06)70804-X; Hamada C, 2005, J CLIN ONCOL, V23, P4999, DOI 10.1200/JCO.2005.09.017; Okada M, 2013, THORAC SURG CLIN, V23, P179, DOI 10.1016/j.thorsurg.2013.01.001; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Asamura H, 2008, J THORAC ONCOL, V3, P46, DOI 10.1097/JTO.0b013e31815e8577; Yoshizawa A, 2011, MODERN PATHOL, V24, P653, DOI 10.1038/modpathol.2010.232; Sasada S, 2014, ANN THORAC SURG, V98, P417, DOI 10.1016/j.athoracsur.2014.04.080; Okada M, 2006, J THORAC CARDIOV SUR, V132, P769, DOI 10.1016/j.jtcvs.2006.02.063; Winton T, 2005, NEW ENGL J MED, V352, P2589, DOI 10.1056/NEJMoa043623; Warth A, 2012, J CLIN ONCOL, V30, P1438, DOI 10.1200/JCO.2011.37.2185; Kato H, 2004, NEW ENGL J MED, V350, P1713, DOI 10.1056/NEJMoa032792; Hung JJ, 2014, J CLIN ONCOL, V32, P2357, DOI 10.1200/JCO.2013.50.1049; Bennouna J, 2011, LUNG CANCER, V74, P30, DOI 10.1016/j.lungcan.2011.02.004; Tsutani Y, 2013, J THORAC CARDIOV SUR, V146, P580, DOI 10.1016/j.jtcvs.2013.04.032; Le Chevalier T, 2004, NEW ENGL J MED, V350, P351; Iwata Hisashi, 2013, Gen Thorac Cardiovasc Surg, V61, P449, DOI 10.1007/s11748-013-0260-2; Nakagiri Tomoyuki, 2014, Gen Thorac Cardiovasc Surg, V62, P671, DOI 10.1007/s11748-014-0429-3; Ohtaki Yoichi, 2014, Gen Thorac Cardiovasc Surg, V62, P586, DOI 10.1007/s11748-014-0409-7; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI DOI 10.3322/CAAC.21208; Tsutani Y, 2014, CHEST, V145, P66, DOI 10.1378/chest.13-1094; Ueda Kazuhiro, 2014, Gen Thorac Cardiovasc Surg, V62, P24, DOI 10.1007/s11748-013-0346-x	27	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	DEC	2015	100	6					2079	2086		10.1016/j.athoracsur.2015.05.102		8	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CX6QD	WOS:000365824700026		
J	Suzuki, T; Asai, T; Nota, H; Kinoshita, T; Fujino, S				Suzuki, Tomoaki; Asai, Tohru; Nota, Hiromitsu; Kinoshita, Takeshi; Fujino, Susumu			Impact of Total Arterial Reconstruction on Long-Term Mortality and Morbidity: Off-Pump Total Arterial Reconstruction Versus Non-Total Arterial Reconstruction	ANNALS OF THORACIC SURGERY			English	Article							INTERNAL THORACIC ARTERY; SKELETONIZED GASTROEPIPLOIC ARTERY; DIABETIC-PATIENTS; MAMMARY ARTERIES; FOLLOW-UP; BYPASS; SURVIVAL; REVASCULARIZATION; GRAFTS; SURGERY	Background. We were interested in how favorable an influence total arterial reconstruction has on the clinical outcome of patients undergoing off-pump coronary artery bypass graft surgery. Methods. From January 2002 to December 2013, a total of 1,064 patients underwent isolated off-pump coronary artery bypass graft surgery at our institution. Of these 1,064 patients, 763 underwent total arterial revascularization (AR) and 301 underwent a combination of artery and vein revascularization (AVR). We compared the clinical results between the two groups using the propensity score matching technique. Results. In all, 260 cases from the AVR group and 520 from the AR group were successfully matched. All procedures were performed using the off-pump technique without conversion to on-pump. Eight patients in the AVR group (3.1%) and 5 in the AR group (1.0%) died in hospital. Multivariate analysis revealed that chronic kidney disease (odds ratio 6.9, p < 0.001), urgency (odds ratio 7.3, p < 0.001), and body mass index (odds ratio 1.3, p = 0.02) were independent risk factors for hospital death. Follow-up was complete for 97.6% of the patients to a maximum of 13 years. According to the Kaplan-Meier method, the rate of 12-year freedom from all causes of death was 69.7% for the AVR group and 72.6% for the AR group (p = 0.002), and the corresponding rates for major adverse cardiac events were 83.9% and 87.7% (p = 0.009). By multivariate Cox regression analysis, total arterial reconstruction was identified as a preventive factor for late cardiac events. Conclusions. Total arterial revascularization has some degree of favorable effect on the long-term clinical outcome of patients undergoing off-pump coronary artery bypass graft surgery. (C) 2015 by The Society of Thoracic Surgeons	[Suzuki, Tomoaki; Asai, Tohru; Nota, Hiromitsu; Kinoshita, Takeshi; Fujino, Susumu] Shiga Univ Med Sci, Dept Cardiovasc Surg, Otsu, Shiga 5202192, Japan	Suzuki, T (reprint author), Shiga Univ Med Sci, Dept Cardiovasc Surg, Otsu, Shiga 5202192, Japan.	suzukit@belle.shiga-med.ac.jp					Suzuki T, 2011, ANN THORAC SURG, V91, P1159, DOI 10.1016/j.athoracsur.2010.12.031; Rizzoli G, 2002, EUR J CARDIO-THORAC, V22, P781, DOI 10.1016/S1010-7940(02)00470-0; Lytle BW, 2004, ANN THORAC SURG, V78, P2005, DOI 10.1016/j.athoracsur.2004.05.070; Suzuki T, 2013, ANN THORAC SURG, V96, P90, DOI 10.1016/j.athoracsur.2013.04.018; Renner A, 2013, ANN THORAC SURG, V96, P528, DOI 10.1016/j.athoracsur.2013.04.063; Tavilla G, 2004, ANN THORAC SURG, V77, P794, DOI 10.1016/S0003-4975(03)01659-X; Bonacchi M, 2003, J THORAC CARDIOV SUR, V126, P1302, DOI 10.1016/S0022-5223(03)01277-7; Chavanon O, 2002, ANN THORAC SURG, V73, P499, DOI 10.1016/S0003-4975(01)03335-5; Hirotani T, 1999, J AM COLL CARDIOL, V34, P532, DOI 10.1016/S0735-1097(99)00215-6; Emmert MY, 2011, EUR J CARDIO-THORAC, V40, P233, DOI 10.1016/j.ejcts.2010.11.003; Puskas JD, 2012, CIRCULATION, V126, P2915, DOI 10.1161/CIRCULATIONAHA.112.150383; Lytle BW, 1999, J THORAC CARDIOV SUR, V117, P855, DOI 10.1016/S0022-5223(99)70365-X; Taggart DP, 2010, EUR HEART J, V31, P2470, DOI 10.1093/eurheartj/ehq318; Puskas JD, 2012, ANN THORAC SURG, V94, P710, DOI 10.1016/j.athoracsur.2012.03.082; Schmidt SE, 1997, ANN THORAC SURG, V64, P9, DOI 10.1016/S0003-4975(97)00473-6; Esaki J, 2007, ANN THORAC SURG, V83, P1024, DOI 10.1016/j.athoracsur.2006.10.020; Dorman MJ, 2012, CIRCULATION, V126, P2935, DOI 10.1161/CIRCULATIONAHA.112.117606; Magee MJ, 2001, ANN THORAC SURG, V72, P776, DOI 10.1016/S0003-4975(01)02840-5; Raja SG, 2014, J THORAC CARDIOV SUR, V148, P1275, DOI 10.1016/j.jtcvs.2013.11.045; Taggart DP, 2001, LANCET, V358, P870, DOI 10.1016/S0140-6736(01)06069-X; Lev-Ran O, 2003, ANN THORAC SURG, V75, P88, DOI 10.1016/S0003-4975(02)04158-9; Higami T, 2001, ANN THORAC SURG, V71, P1224, DOI 10.1016/S0003-4975(00)02660-6; Benedetto U, 2014, J THORAC CARDIOV SUR, V148, P2699, DOI 10.1016/j.jtcvs.2014.08.021; Buxton BF, 1998, CIRCULATION, V98, pII1; Freemantle N, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6409; Raza S, 2014, J THORAC CARDIOV SUR, V148, P1257, DOI 10.1016/j.jtcvs.2014.06.058; Suzuki T, 2015, ANN THORAC SURG, V100, P2244, DOI 10.1016/j.athoracsur.2015.05.034; Suzuki T, 2008, HEART SURG FORUM, V11, P196; Taggart DP, 2010, EUR HEART J, V31, P2444	29	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	DEC	2015	100	6					2244	2250		10.1016/j.athoracsur.2015.05.034		8	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CX6QD	WOS:000365824700047		
J	Takagi, H; Umemoto, T				Takagi, Hisato; Umemoto, Takuya		ALICE Grp	Coexisting Mitral Regurgitation Impairs Survival After Transcatheter Aortic Valve Implantation	ANNALS OF THORACIC SURGERY			English	Article							PERCUTANEOUS TREATMENT; STENOSIS; REPLACEMENT; MORTALITY; MODERATE; OUTCOMES; METAANALYSIS; IMPACT; GUIDELINES; EXPERIENCE	Background. It remains unclear whether coexisting and untreated mitral regurgitation (MR) affects survival after transcatheter aortic valve implantation (TAVI) for aortic stenosis (AS). To summarize contemporary evidence, we performed the first metaanalysis of adjusted observational studies reporting post-TAVI mortality in patients with various grades of MR. Methods. MEDLINE and EMBASE were searched until February 2015, with a bibliographic review of secondary sources. Eligible studies were observational studies enrolling patients undergoing TAVI for AS and reporting adjusted odds ratios (ORs), hazard ratios (HRs), or both for early (30-day or in-hospital) all-cause mortality, overall all-cause mortality, or both in patients with apparent (significant) versus unapparent (nonsignificant) MR as outcomes. Results. Sixteen eligible studies enrolling a total of 13,672 patients undergoing TAVI for AS were identified and included. Pooled analyses of eight studies (representing 9,356 patients) and 14 studies (representing 7,405 patients) respectively demonstrated a statistically significant increase in early (OR 2.17; 95% confidence interval [CI] 1.50 to 3.14; p < 0.0001) and overall all-cause mortality (HR 1.81; 95% CI 1.37 to 2.40; p < 0.0001) in patients with apparent relative to unapparent MR. The exclusion of any single study from the analyses did not substantively alter the overall results of our analyses, and there was no evidence of significant publication bias. Conclusions. Coexisting and untreated apparent (usually moderate or severe) MR appears to be associated with an increase in both early and overall mortality after TAVI for AS. (C) 2015 by The Society of Thoracic Surgeons	[Takagi, Hisato; Umemoto, Takuya; ALICE Grp] Shizuoka Med Ctr, Dept Cardiovasc Surg, Shimizu, Shizuoka 4118611, Japan	Takagi, H (reprint author), Shizuoka Med Ctr, Dept Cardiovasc Surg, 762-1 Nagasawa, Shimizu, Shizuoka 4118611, Japan.	kfgth973@ybb.ne.jp					Zahn R, 2013, AM J CARDIOL, V112, P272, DOI 10.1016/j.amjcard.2013.03.024; Puls M, 2013, CATHETER CARDIO INTE, V81, P896, DOI 10.1002/ccd.24448; Ong SH, 2011, AM J CARDIOL, V108, P893, DOI 10.1016/j.amjcard.2011.05.017; Alghamdi AA, 2010, J CARDIAC SURG, V25, P182, DOI 10.1111/j.1540-8191.2009.00965.x; Aung N, 2013, HEART, V99, P1261, DOI 10.1136/heartjnl-2013-303910; Surder D, 2011, EUR HEART J, V32, P636, DOI 10.1093/eurheartj/ehq378; Borz B, 2014, INT J CARDIOL, V173, P436, DOI 10.1016/j.ijcard.2014.03.011; Di Mario C, 2013, EUROINTERVENTION, V8, P1362, DOI 10.4244/EIJV8I12A209; Rodes-Cabau J, 2010, J AM COLL CARDIOL, V55, P1080, DOI 10.1016/j.jacc.2009.12.014; Nuis RJ, 2013, CIRC-CARDIOVASC INTE, V6, P625, DOI 10.1161/CIRCINTERVENTIONS.113.000409; Sabate M, 2013, REV ESP CARDIOL, V66, P949, DOI 10.1016/j.rec.2013.07.003; Egger M, 1997, BRIT MED J, V315, P629; Toggweiler S, 2012, J AM COLL CARDIOL, V59, P2068, DOI 10.1016/j.jacc.2012.02.020; Nombela-Franco L, 2014, J AM COLL CARDIOL, V63, P2643, DOI 10.1016/j.jacc.2014.02.573; Rudolph V, 2013, INT J CARDIOL, V167, P716, DOI 10.1016/j.ijcard.2012.03.060; Barbanti M, 2013, CIRCULATION, V128, P2776, DOI 10.1161/CIRCULATIONAHA.113.003885; Harling L, 2011, EUR J CARDIO-THORAC, V40, P1087, DOI 10.1016/j.ejcts.2011.03.036; Hutter A, 2013, ANN THORAC SURG, V95, P77, DOI 10.1016/j.athoracsur.2012.08.030; Barbanti M, 2011, CATHETER CARDIO INTE, V78, P650, DOI 10.1002/ccd.23015; Bedogni F, 2013, CIRCULATION, V128, P2145, DOI 10.1161/CIRCULATIONAHA.113.001822; Madder RD, 2011, JACC-CARDIOVASC INTE, V4, P824, DOI 10.1016/j.jcin.2011.05.009; Tamburino C, 2011, CIRCULATION, V123, P299, DOI 10.1161/CIRCULATIONAHA.110.946533; Nishimura RA, 2014, CIRCULATION, V129, P2440, DOI 10.1161/CIR.0000000000000029; Sannino A, 2014, AM J CARDIOL, V114, P875, DOI 10.1016/j.amjcard.2014.06.022; Kische S, 2013, CATHETER CARDIO INTE, V82, pE552, DOI 10.1002/ccd.24809; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Chakravarty T, 2015, AM J CARDIOL, V115, P942, DOI 10.1016/j.amjcard.2015.01.022; Evalve; Abbott Vascular, 2000, EV ABB VASC CARD OUT; Haensig M, 2014, ANN THORAC SURG, V97, P1247, DOI 10.1016/j.athoracsur.2013.11.025; Haensig M, 2014, ANN THORAC SURG, V97, P1253; Khawaja MZ, 2014, HEART, V100, P1799, DOI 10.1136/heartjnl-2014-305775; O'Sullivan CJ, 2015, CIRC-CARDIOVASC INTE, V8, DOI 10.1161/CIRCINTERVENTIONS.114.001895; Ramakrishna H, 2014, J CARDIOTHOR VASC AN, V28, P417, DOI 10.1053/j.jvca.2013.11.003; Reeves B.C., 2011, COCHRANE HDB SYSTEMA; Ribeiro HB, 2014, AM J CARDIOL, V113, P851, DOI 10.1016/j.amjcard.2013.11.038; Smith PK, 2014, NEW ENGL J MED, V371, P2178, DOI 10.1056/NEJMoa1410490; Takagi H, 2015, ANN THORAC SURG, V100, P2270, DOI 10.1016/j.athoracsur.2015.05.094	37	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	DEC	2015	100	6					2270	2277		10.1016/j.athoracsur.2015.05.094		9	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CX6QD	WOS:000365824700050		
J	Tanaka, T; Tao, H; Hayashi, T; Yoshiyama, K; Furukawa, M; Yoshida, K; Okabe, K				Tanaka, Toshiki; Tao, Hiroyuki; Hayashi, Tatsuro; Yoshiyama, Koichi; Furukawa, Masashi; Yoshida, Kumiko; Okabe, Kazunori			Disseminated Pleural Siliconoma Mimicking Malignant Pleural Mesothelioma	ANNALS OF THORACIC SURGERY			English	Article							RUPTURE	A 48-year-old woman with a 3-month history of back pain was admitted for further examination of multiple left pleural nodules. She had undergone bilateral breast augmentation with silicone implants 10 years previously. Nine years after the operation, both ruptured implants were removed, and autologous fat was injected. Computed tomography revealed multiple pleural nodules suggestive of malignant pleural mesothelioma. Thoracoscopic exploration revealed multiple pleural nodules with massive pleural adhesions. The nodules were filled with viscous liquid and were histologically determined to be siliconomas. Disseminated pleural siliconoma should be recognized as a late adverse event of silicone breast implantation. (C) 2015 by The Society of Thoracic Surgeons	[Tanaka, Toshiki; Tao, Hiroyuki; Hayashi, Tatsuro; Yoshiyama, Koichi; Furukawa, Masashi; Yoshida, Kumiko; Okabe, Kazunori] Yamaguchi Ube Med Ctr, Div Thorac Surg, Dept Surg, Ube, Yamaguchi 7550241, Japan	Tanaka, T (reprint author), Yamaguchi Ube Med Ctr, Div Thorac Surg, Dept Surg, 685 Higashikiwa, Ube, Yamaguchi 7550241, Japan.	tanakat@yamaguchi-hosp.jp					Brown SL, 1997, LANCET, V350, P1531, DOI 10.1016/S0140-6736(97)03164-4; STEVENS WMR, 1987, THORAX, V42, P825, DOI 10.1136/thx.42.10.825; Dragu A, 2009, BREAST J, V15, P496, DOI 10.1111/j.1524-4741.2009.00765.x; Parks CG, 1999, ENVIRON HEALTH PERSP, V107, P793, DOI 10.2307/3434342; Kappel RM, 2012, EUR J PLAST SURG, V35, P229; Karnatovskaia LV, 2014, CHEST, V146, P138	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	DEC	2015	100	6					2339	2340		10.1016/j.athoracsur.2015.03.043		3	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CX6QD	WOS:000365824700062		
J	Okada, N; Oshima, H; Narita, Y; Usui, A				Okada, Noritaka; Oshima, Hideki; Narita, Yuji; Usui, Akihiko			Nonanastomotic Rupture of a Woven Polyester Graft Caused by a Tacking Stitch After Aortic Arch Replacement	ANNALS OF THORACIC SURGERY			English	Editorial Material									[Okada, Noritaka; Oshima, Hideki; Narita, Yuji; Usui, Akihiko] Nagoya Univ, Grad Sch Med, Dept Cardiac Surg, Nagoya, Aichi 4668550, Japan	Okada, N (reprint author), Nagoya Univ, Grad Sch Med, Dept Cardiac Surg, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	cvsoka@gmail.com						0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	DEC	2015	100	6					2370	2370		10.1016/j.athoracsur.2015.09.007		1	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CX6QD	WOS:000365824700076		
J	Kataoka, Y				Kataoka, Yuki			Meta-Analysis of Survival in Mesothelioma: Can We Mix Apples and Oranges?	ANNALS OF THORACIC SURGERY			English	Letter									[Kataoka, Yuki] Hyogo Kenritsu Amagasaki Hosp, Dept Resp Med, Amagasaki, Hyogo, Japan	Kataoka, Y (reprint author), Hyogo Kenritsu Amagasaki Hosp, Dept Resp Med, Higashidaimotsu Cho 1-1-1, Amagasaki, Hyogo, Japan.	youkiti@gmail.com					Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Salas M, 1999, AM J EPIDEMIOL, V149, P981; Taioli E, 2015, ANN THORAC SURG, V99, P472, DOI 10.1016/j.athoracsur.2014.09.056; Wells G, 2014, NEWCASTLE OTTAWA SCA	4	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	DEC	2015	100	6					2412	2412				1	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CX6QD	WOS:000365824700086		
J	Sakurai, H				Sakurai, Hiroyuki			When and How Should Subcentimetric Lung Nodules Be Referred for Operation? Reply	ANNALS OF THORACIC SURGERY			English	Letter							PULMONARY NODULES; FLEISCHNER-SOCIETY; MANAGEMENT; GUIDELINES; STATEMENT; CANCER; CT		[Sakurai, Hiroyuki] Natl Canc Ctr, Div Thorac Surg, Chuo Ku, Tokyo 1040045, Japan	Sakurai, H (reprint author), Natl Canc Ctr, Div Thorac Surg, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	hsakurai@ncc.go.jp					Sakurai H, 2015, ANN THORAC SURG, V99, P1731, DOI 10.1016/j.athoracsur.2015.01.034; MacMahon H, 2005, RADIOLOGY, V237, P395, DOI 10.1148/radiol.2372041887; Swensen SJ, 1997, ARCH INTERN MED, V157, P849, DOI 10.1001/archinte.157.8.849; [Anonymous], 2013, CHEST S, DOI DOI 10.1378/CHEST.12-2351; Naidich DP, 2013, RADIOLOGY, V266, P304, DOI 10.1148/radiol.12120628; Suzuki K, 2015, INTERACT CARDIOV TH, V21, P218, DOI 10.1093/icvts/ivv124; Baisi A, 2015, ANN THORAC SURG, V100, P2412	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	DEC	2015	100	6					2413	2413				1	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CX6QD	WOS:000365824700089		
J	Sano, A; Yotsumoto, T				Sano, Atsushi; Yotsumoto, Takuma			Right Lower Lobe Superior Segmentectomy in a Patient With a Displaced Bronchus	ANNALS OF THORACIC SURGERY			English	Article								An 81-year-old woman with adenocarcinoma in the lower superior segment of the right lung underwent superior segmentectomy of the right lower lobe through a thoracotomy. Preoperatively, we detected an anomalous B10c bronchus branching from the right lower superior segment bronchus with multiplanar reconstruction computed tomography and virtual bronchoscopy. Intraoperatively, we stapled and cut the right lower superior segment bronchus at the level of the peripheral anomalous B10c bronchus under bronchoscopic visualization. Precise anatomic understanding is very important for segmentectomy, especially in patients with anomalous bronchi. Multiplanar reconstruction computed tomography and virtual bronchoscopy are useful for preoperative planning. (C) 2015 by The Society of Thoracic Surgeons	[Sano, Atsushi; Yotsumoto, Takuma] Chigasaki Municipal Hosp, Dept Thorac Surg, Chigasaki, Kanagawa 2530042, Japan	Sano, A (reprint author), Chigasaki Municipal Hosp, Dept Thorac Surg, Honson 5-15-1, Chigasaki, Kanagawa 2530042, Japan.	sanoa-tky@umin.ac.jp					Akiba T, 2014, ANN THORAC CARDIOVAS, V20, P659, DOI 10.5761/atcs.cr.13-00189; Masuda M, 2014, GEN THORAC CARDIOVAS, V62, P734; Sano Atsushi, 2014, J Bronchology Interv Pulmonol, V21, P113, DOI 10.1097/LBR.0000000000000051; Tsutani Y, 2014, EUR J CARDIO-THORAC, V46, P637, DOI 10.1093/ejcts/ezt645; Xu XF, 2014, ANN THORAC SURG, V98, pE127, DOI 10.1016/j.athoracsur.2014.09.059	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	DEC	2015	100	6					E121	E122		10.1016/j.athoracsur.2015.07.085		2	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CX6QD	WOS:000365824700001		
J	Watanabe, T; Adachi, O; Suzuki, Y; Notsuda, H; Niikawa, H; Matsuda, Y; Noda, M; Sado, T; Hoshikawa, Y; Akiba, M; Tatebe, S; Saiki, Y; Okada, Y				Watanabe, Tatsuaki; Adachi, Osamu; Suzuki, Yasuto; Notsuda, Hirotsugu; Niikawa, Hiromichi; Matsuda, Yasushi; Noda, Masafumi; Sado, Tetsu; Hoshikawa, Yasushi; Akiba, Miki; Tatebe, Shunsuke; Saiki, Yoshikatsu; Okada, Yoshinori			Lung Transplant for Pulmonary Arterial Hypertension After Arterial Switch Operation	ANNALS OF THORACIC SURGERY			English	Article							CONGENITAL HEART-DISEASE	Pulmonary arterial hypertension after arterial switch operation for transposition of the great arteries is an infrequent but life-threatening complication. We report successful lung transplantation in a case of pulmonary hypertension after arterial switch operation. Cardiopulmonary bypass outflow was established through the right subclavian and femoral arteries because of the previous arterial switch operation. Abnormal anatomy and severe pleural and pericardial adhesions as a result of previous operations resulted in prolonged graft ischemic and operation times. Despite delayed left heart adaptation and primary graft dysfunction requiring prolonged extracorporeal membrane oxygenation, the recipient was eventually discharged without activity limitations. (C) 2015 by The Society of Thoracic Surgeons	Tohoku Univ, Dept Thorac Surg, Inst Dev Aging & Canc, Sendai, Miyagi 9808575, Japan; Tohoku Univ, Grad Sch Med, Dept Cardiovasc Surg, Sendai, Miyagi 9808575, Japan; Tohoku Univ, Grad Sch Med, Dept Cardiovasc Med, Sendai, Miyagi 9808575, Japan; Kushiro Red Cross Hosp, Dept Pediat, Kushiro, Hokkaido, Japan; Tohoku Univ Hosp, Div Organ Transplantat, Sendai, Miyagi, Japan	Watanabe, T (reprint author), Tohoku Univ, Dept Thorac Surg, Inst Dev Aging & Canc, Aoba Ku, 4-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	tatsuaki_watanabe@yahoo.co.jp					Alonso-Gonzalez R, 2015, INT J CARDIOL, V184, P717, DOI 10.1016/j.ijcard.2015.02.031; Cordina R, 2010, PEDIATR CARDIOL, V31, P238, DOI 10.1007/s00246-009-9597-9; Yehya A, 2010, INT J CARDIOL, V143, P271, DOI 10.1016/j.ijcard.2009.02.039; Shiina Y, 2011, INT J CARDIOL, V146, P13, DOI 10.1016/j.ijcard.2009.05.032; Okada Y, 2004, J THORAC CARDIOV SUR, V128, P793, DOI 10.1016/j.jtcvs.2004.03.005; Kasimir MT, 2004, EUR J CARDIO-THORAC, V26, P776, DOI 10.1016/j.ejcts.2004.05.057; Oishi H, 2015, SURG TODAY, V45, P630, DOI 10.1007/s00595-014-0931-3; Tudorache I, 2015, TRANSPLANTATION, V99, P451, DOI 10.1097/TP.0000000000000348	8	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	DEC	2015	100	6					E133	E134		10.1016/j.athoracsur.2015.08.046		2	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CX6QD	WOS:000365824700005		
J	Ji, S; Eto, K; Yoshida, S; Kojima, K; Ishida, Y; Saito, S; Tsuchida, H; Okumura, H				Ji, Shiyang; Eto, Kazuma; Yoshida, Sadafumi; Kojima, Kazutoshi; Ishida, Yuuki; Saito, Shingo; Tsuchida, Hidekazu; Okumura, Hajime			Hopping conduction range of heavily Al-doped 4H-SiC thick epilayers grown by CVD	APPLIED PHYSICS EXPRESS			English	Article							CHEMICAL-VAPOR-DEPOSITION; IMPURITY CONDUCTION; LOW-RESISTIVITY; ALUMINUM; BORON; 6H; IMPLANTATION; TEMPERATURE; DEPENDENCE; ACTIVATION	To outline the hopping conduction range, the electrical characteristics of CVD-grown heavily Al-doped 4H-SiC thick epilayers (2.0 x 10(19)-4.0 x 10(20) cm(-3)) were investigated in a wide temperature regime (20-900 K). It is found that, below 100 K, hopping conduction dominates the carrier transport for all epilayers, and the corresponding hopping conduction activation energy shows a maximum of similar to 30 meV at around 1.1 x 10(20) cm(-3). With increasing doping level, the temperature dependence of resistivity evolves and finally obeys the similar to 1/T-1/4 law in the entire temperature regime, which gives direct evidence of variable-range hopping conduction. (C) 2015 The Japan Society of Applied Physics	[Ji, Shiyang; Eto, Kazuma; Yoshida, Sadafumi; Kojima, Kazutoshi; Ishida, Yuuki; Saito, Shingo; Okumura, Hajime] Natl Inst Adv Ind Sci & Technol, Adv Power Elect Res Ctr, Tsukuba, Ibaraki 3058568, Japan; [Tsuchida, Hidekazu] Cent Res Inst Elect Power Ind, Yokosuka, Kanagawa 2400196, Japan	Ji, S (reprint author), Natl Inst Adv Ind Sci & Technol, Adv Power Elect Res Ctr, Tsukuba, Ibaraki 3058568, Japan.	aist-ki@aist.go.jp			Japan Society for the Promotion of Science (JSPS)	This research was partially supported by the Japan Society for the Promotion of Science (JSPS) through its "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)".	Pernot J, 2005, J APPL PHYS, V98, DOI 10.1063/1.1978987; YAMANAKA M, 1987, J APPL PHYS, V61, P599, DOI 10.1063/1.338211; Achatz P, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2885081; MASSARANI B, 1978, PHYS REV B, V17, P1758, DOI 10.1103/PhysRevB.17.1758; Matsuura H, 2004, J APPL PHYS, V96, P2708, DOI 10.1063/1.1775298; Giannazzo F, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2813022; Miyazawa T, 2014, MATER SCI FORUM, V778-780, P135, DOI 10.4028/www.scientific.net/MSF.778-780.135; Mitchel WC, 1997, J ELECTRON MATER, V26, P113, DOI 10.1007/s11664-997-0135-3; MILLER A, 1960, PHYS REV, V120, P745, DOI 10.1103/PhysRev.120.745; Wang XK, 2010, IEEE T ELECTRON DEV, V57, P511, DOI 10.1109/TED.2009.2037379; Nipoti R, 2013, J MATER RES, V28, P17, DOI 10.1557/jmr.2012.207; Linnarsson MK, 2001, APPL PHYS LETT, V79, P2016, DOI 10.1063/1.1402160; Kimoto T, 2015, JPN J APPL PHYS, V54, DOI 10.7567/JJAP.54.040103; Saks NS, 2001, J APPL PHYS, V90, P2796, DOI 10.1063/1.1392958; Nordell N, 1996, J ELECTROCHEM SOC, V143, P2910, DOI 10.1149/1.1837126; Matsuura H, 2006, MICROELECTRON ENG, V83, P17, DOI 10.1016/j.mee.2005.10.015; Ji SY, 2013, MATER SCI FORUM, V740-742, P181, DOI 10.4028/www.scientific.net/MSF.740-742.181; Troffer T, 1997, PHYS STATUS SOLIDI A, V162, P277, DOI 10.1002/1521-396X(199707)162:1<277::AID-PSSA277>3.0.CO;2-C; Persson C, 2001, PHYS REV B, V63; Miyazawa T, 2015, J APPL PHYS, V118, DOI 10.1063/1.4929456; Evwaraye AO, 1996, APPL PHYS LETT, V68, P3159, DOI 10.1063/1.115810; Wirth H, 1999, APPL PHYS LETT, V74, P979, DOI 10.1063/1.123429; IKEDA M, 1980, PHYS REV B, V22, P2842, DOI 10.1103/PhysRevB.22.2842; Bluet JM, 2000, J APPL PHYS, V88, P1971, DOI 10.1063/1.1305904; Sato T, 2000, PHYS REV B, V61, P12970, DOI 10.1103/PhysRevB.61.12970; Ji SY, 2013, J CRYST GROWTH, V380, P85, DOI 10.1016/j.jcrysgro.2013.05.039; Koizumi A, 2009, J APPL PHYS, V106, DOI 10.1063/1.3158565; Krieger M, 2004, MATER SCI FORUM, V457-460, P685; Krieger M., 2005, THESIS; Matsumoto T, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.05FP05; Oyama K, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3120560; Parisini A, 2015, J APPL PHYS, V118, DOI 10.1063/1.4926751; Schoner A, 1999, MAT SCI ENG B-SOLID, V61-2, P389, DOI 10.1016/S0921-5107(98)00540-6; Shklovskii B. I., 1984, SPRINGER SERIES SOLI, V45, P183; Yonezawa Y., 2013, IEDM	35	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1882-0778	1882-0786		APPL PHYS EXPRESS	Appl. Phys. Express	DEC	2015	8	12							121302	10.7567/APEX.8.121302		4	Physics, Applied	Physics	CY1TX	WOS:000366191900005		
J	Kojima, H; Abe, R; Ito, M; Tomatsu, Y; Fujiwara, F; Matsubara, R; Yoshimoto, N; Nakamura, M				Kojima, Hirotaka; Abe, Ryo; Ito, Mitsuhiro; Tomatsu, Yasuyuki; Fujiwara, Fumiya; Matsubara, Ryosuke; Yoshimoto, Noriyuki; Nakamura, Masakazu			Giant Seebeck effect in pure fullerene thin films	APPLIED PHYSICS EXPRESS			English	Article							THERMAL-CONDUCTIVITY; ORDERING TRANSITION; SINGLE-CRYSTAL; C-60; PENTACENE; PHASE	The small thermal conductivity of molecular solids is beneficial for their thermoelectric applications. If Seebeck coefficients were sufficiently large to compensate for the relatively small electrical conductivity, these materials would be promising candidates for thermoelectric devices. In this work, the thermoelectric properties of C-60 were studied by in situ measurements under ultrahigh vacuum after the deposition of a pure C-60 thin film. An exceptionally large Seebeck coefficient of more than 150mV/K was observed as a steady-state thermoelectromotive force. Even considering several extreme but realistic conditions, conventional semiclassical thermoelectric theories cannot explain this giant Seebeck effect. (C) 2015 The Japan Society of Applied Physics	[Kojima, Hirotaka; Abe, Ryo; Ito, Mitsuhiro; Tomatsu, Yasuyuki; Fujiwara, Fumiya; Matsubara, Ryosuke; Nakamura, Masakazu] Nara Inst Sci & Technol, Grad Sch Mat Sci, Nara 6300192, Japan; [Yoshimoto, Noriyuki] Iwate Univ, Grad Sch Engn, Morioka, Iwate 0208551, Japan	Nakamura, M (reprint author), Nara Inst Sci & Technol, Grad Sch Mat Sci, Nara 6300192, Japan.	mnakamura@ms.naist.jp			JSPS KAKENHI Grant [25888016, 15K21163, 15H01000]; NAIST Green Photonics Research Project of the Ministry of Education, Culture, Sports, Science and Technology (MEXT)	This work was supported by JSPS KAKENHI Grant Numbers 25888016, 15K21163, and 15H01000 and NAIST Green Photonics Research Project of the Ministry of Education, Culture, Sports, Science and Technology (MEXT). The synchrotron radiation experiments were performed at the BL19B2 of SPring-8 with the approval of the Japan Synchrotron Radiation Research Institute (JASRI) (Proposal No. 2014A1590). The authors gratefully thank to Drs. T. Koganezawa, I. Hirosawa, and T. Watanabe (JASRI), and Messrs. M. Kikuchi and T. Oguri (Iwate University) for 2D-GIXD experiments and helpful discussions.	CUTLER M, 1969, PHYS REV, V181, P1336, DOI 10.1103/PhysRev.181.1336; DAVID WIF, 1992, EUROPHYS LETT, V18, P219, DOI 10.1209/0295-5075/18/3/006; PURI SM, 1965, PHYS REV, V139, pA995, DOI 10.1103/PhysRev.139.A995; Mikhal'chenko VP, 2010, PHYS SOLID STATE+, V52, P1549, DOI 10.1134/S1063783410070334; HEINEY PA, 1992, J PHYS CHEM SOLIDS, V53, P1333, DOI 10.1016/0022-3697(92)90231-2; Barbot A, 2013, J MATER SCI, V48, P2785, DOI 10.1007/s10853-012-6824-1; Menke T, 2012, ORG ELECTRON, V13, P3319, DOI 10.1016/j.orgel.2012.09.024; Yue RR, 2012, SYNTHETIC MET, V162, P912, DOI 10.1016/j.synthmet.2012.04.005; Lu ND, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.195205; Menke T, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3689778; VANDEWAAL BW, 1993, CHEM PHYS LETT, V202, P341, DOI 10.1016/0009-2614(93)85289-Z; Horiuchi K, 2003, PHYSICA B, V329, P1538, DOI 10.1016/S0921-4526(02)02282-2; Wang D, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3270161; Shimada T, 2011, APPL PHYS EXPRESS, V4, DOI 10.1143/APEX.4.061601; Efimov VB, 1997, JETP LETT+, V65, P687, DOI 10.1134/1.567407; YU RC, 1992, PHYS REV LETT, V68, P2050, DOI 10.1103/PhysRevLett.68.2050; Watanabe T, 2012, MOL CRYST LIQ CRYST, V566, P18, DOI 10.1080/15421406.2012.701111; DEBRUIJN J, 1993, EUROPHYS LETT, V24, P551; Matsubara R, 2011, ORG ELECTRON, V12, P195, DOI 10.1016/j.orgel.2010.10.024; HEINEY PA, 1991, PHYS REV LETT, V66, P2911, DOI 10.1103/PhysRevLett.66.2911; Sumino M, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3631633; Ito M, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.065102; Dragoman D, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2814080; Kanbara T, 2003, CHEM PHYS LETT, V379, P223, DOI 10.1016/j.cplett.2003.07.025; Fukumaru T, 2015, SCI REP-UK, V5, DOI 10.1038/srep07951; Hayashi N., 2006, MATER RES SOC S P, V965; Mott N. F., 1936, THEORY PROPERTIES ME, P308; Nakamura M., 2009, MRS P, V1197; Zhang Q, 2014, ADV MATER, V26, P6829, DOI 10.1002/adma.201305371	29	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1882-0778	1882-0786		APPL PHYS EXPRESS	Appl. Phys. Express	DEC	2015	8	12							121301	10.7567/APEX.8.121301		4	Physics, Applied	Physics	CY1TX	WOS:000366191900004		
J	Murugan, V; Ogomi, Y; Pandey, SS; Toyoda, T; Shen, Q; Hayase, S				Murugan, Vigneshwaran; Ogomi, Yuhei; Pandey, Shyam S.; Toyoda, Taro; Shen, Qing; Hayase, Shuzi			Effects of different chloride precursors on crystal growth of lead halide perovskites	APPLIED PHYSICS EXPRESS			English	Article							HETEROJUNCTION SOLAR-CELLS; THIN-FILMS; CH3NH3PBI3; EFFICIENCY; SIZE	The optimized quantity and nature of a chloride precursor used for the formation of large perovskite crystals with minimal disorder were explored. The effect of the alkyl chain length of an alkyl ammonium chloride precursor on the crystal growth of CH3NH3PbI3 was systematically investigated. It was found that the addition of ethyl ammonium chloride (EACl) increased the crystal size, which is almost twice (88 nm) the size of standard perovskite crystals (47 nm) having a preferential orientation towards the (110) plane. Photoacoustic studies demonstrated that the disorder in the perovskite crystals was highly reduced by the addition of the EACl precursor. (C) 2015 The Japan Society of Applied Physics	[Murugan, Vigneshwaran; Ogomi, Yuhei; Pandey, Shyam S.; Hayase, Shuzi] Kyushu Inst Technol, Dept Biol Funct & Syst, Grad Sch Life Sci & Syst Engn, Kitakyushu, Fukuoka 8080196, Japan; [Toyoda, Taro; Shen, Qing] Univ Electrocommun, Fac Informat & Engn, Dept Engn Sci, Chofu, Tokyo 1828585, Japan	Murugan, V (reprint author), Kyushu Inst Technol, Dept Biol Funct & Syst, Grad Sch Life Sci & Syst Engn, Kitakyushu, Fukuoka 8080196, Japan.	vicky04waran@gmail.com; hayase@life.kyutech.ac.jp					KEIL TH, 1966, PHYS REV, V144, P582, DOI 10.1103/PhysRev.144.582; Jeon NJ, 2014, J AM CHEM SOC, V136, P7837, DOI 10.1021/ja502824c; Xiao ZG, 2014, ENERG ENVIRON SCI, V7, P2619, DOI 10.1039/c4ee01138d; Kojima A, 2009, J AM CHEM SOC, V131, P6050, DOI 10.1021/ja809598r; Eperon GE, 2014, ENERG ENVIRON SCI, V7, P982, DOI 10.1039/c3ee43822h; ZAMMIT U, 1994, PHYS REV B, V49, P14322, DOI 10.1103/PhysRevB.49.14322; Docampo P, 2014, ADV ENERGY MATER, V4, DOI 10.1002/aenm.201400355; Koh TM, 2014, J PHYS CHEM C, V118, P16458, DOI 10.1021/jp411112k; Zuo CT, 2014, NANOSCALE, V6, P9935, DOI 10.1039/c4nr02425g; Zheng F, 2015, J PHYS CHEM LETT, V6, P31, DOI 10.1021/jz502109e; URBACH F, 1953, PHYS REV, V92, P1324, DOI 10.1103/PhysRev.92.1324; Jeon NJ, 2014, NAT MATER, V13, P897, DOI [10.1038/nmat4014, 10.1038/NMAT4014]; Williams ST, 2014, ACS NANO, V8, P10640, DOI 10.1021/nn5041922; Im JH, 2014, NAT NANOTECHNOL, V9, P927, DOI [10.1038/nnano.2014.181, 10.1038/NNANO.2014.181]; Wehrenfennig C, 2014, J PHYS CHEM LETT, V5, P1300, DOI 10.1021/jz500434p; Liang PW, 2014, ADV MATER, V26, P3748, DOI 10.1002/adma.201400231; Abrusci A, 2013, NANO LETT, V13, P3124, DOI 10.1021/nl401044q; Wang D, 2014, CHEM MATER, V26, P7145, DOI 10.1021/cm5037869; Pedesseau L, 2014, OPT QUANT ELECTRON, V46, P1225, DOI 10.1007/s11082-013-9823-9; Dar MI, 2014, NANO LETT, V14, P6991, DOI 10.1021/nl503279x; Zhao YX, 2014, J PHYS CHEM C, V118, P9412, DOI 10.1021/jp502696w; Shen Q, 1999, JPN J APPL PHYS 1, V38, P3163, DOI 10.1143/JJAP.38.3163; Kim HS, 2014, J PHYS CHEM LETT, V5, P2927, DOI 10.1021/jz501392m; Luo JS, 2014, SCIENCE, V345, P1593, DOI 10.1126/science.1258307	24	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1882-0778	1882-0786		APPL PHYS EXPRESS	Appl. Phys. Express	DEC	2015	8	12							125501	10.7567/APEX.8.125501		4	Physics, Applied	Physics	CY1TX	WOS:000366191900015		
J	Nagata, M; Moriyama, T; Tanabe, K; Tanaka, K; Chiba, D; Ohe, J; Hisamatsu, Y; Niizeki, T; Yanagihara, H; Kita, E; Ono, T				Nagata, Masaki; Moriyama, Takahiro; Tanabe, Kenji; Tanaka, Kensho; Chiba, Daichi; Ohe, Jun-ichiro; Hisamatsu, Yuki; Niizeki, Tomohiko; Yanagihara, Hideto; Kita, Eiji; Ono, Teruo			Spin motive force induced in Fe3O4 thin films with negative spin polarization	APPLIED PHYSICS EXPRESS			English	Article							MAGNETIC TUNNEL-JUNCTIONS; TRANSFER-TORQUE; PHASE	Spin motive force (SMF) is induced by a time and spatial derivative of magnetizations and is dependent on spin polarization. We compare the SMF in FeNi with positive spin polarization with that in a magnetite (Fe3O4) with negative spin polarization. We observe the SMF induced by a nonuniform ferromagnetic resonance in Fe3O4 and find that the SMF in Fe3O4 is opposite to that in FeNi. This result originates from the negative spin polarization of Fe3O4. Our clear observation of the SMF depending on the sign of the spin polarization agrees well with the framework of the SMF theory. (C) 2015 The Japan Society of Applied Physics	[Nagata, Masaki; Moriyama, Takahiro; Tanabe, Kenji; Tanaka, Kensho; Ono, Teruo] Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan; [Chiba, Daichi] Univ Tokyo, Dept Appl Phys, Bunkyo Ku, Tokyo 1138654, Japan; [Ohe, Jun-ichiro] Toho Univ, Dept Phys, Chiba 2748510, Japan; [Hisamatsu, Yuki; Niizeki, Tomohiko; Yanagihara, Hideto; Kita, Eiji] Univ Tsukuba, Inst Appl Phys, Tsukuba, Ibaraki 3058573, Japan	Nagata, M (reprint author), Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan.				Japan Society for the Promotion of Science (JSPS)	This work was partly supported by a Grant-in-Aid for Scientific Research (S), a Grant-in-Aid for Young Scientists (B), and a Research Fellowship for Young Scientists from the Japan Society for the Promotion of Science (JSPS).	YANASE A, 1984, J PHYS SOC JPN, V53, P312, DOI 10.1143/JPSJ.53.312; Bunce C, 2008, IEEE T MAGN, V44, P2970, DOI 10.1109/TMAG.2008.2001337; Huang DJ, 2002, J MAGN MAGN MATER, V239, P261, DOI 10.1016/S0304-8853(01)00591-1; STERN A, 1992, PHYS REV LETT, V68, P1022, DOI 10.1103/PhysRevLett.68.1022; Dedkov YS, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.064417; Yang SYA, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.054410; Uchida K, 2008, NATURE, V455, P778, DOI 10.1038/nature07321; Sankey JC, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.227601; Hu G, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.276601; Kubota H, 2008, NAT PHYS, V4, P37, DOI 10.1038/nphys784; Yanagihara H, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/17/175004; ZHANG Z, 1991, PHYS REV B, V44, P13319, DOI 10.1103/PhysRevB.44.13319; Seki T, 2008, NAT MATER, V7, P125, DOI 10.1038/nmat2098; Bakker FL, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.136601; BICKFORD LR, 1950, PHYS REV, V78, P449, DOI 10.1103/PhysRev.78.449; ARAGON R, 1986, J MAGN MAGN MATER, V54-7, P1335, DOI 10.1016/0304-8853(86)90844-9; Hai PN, 2009, NATURE, V458, P489, DOI 10.1038/nature07879; Mosendz O, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.214403; Yamane Y, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.236602; Barnes SE, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.246601; Sankey JC, 2008, NAT PHYS, V4, P67, DOI 10.1038/nphys783; Hayashi M, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.147202; ALVARADO SF, 1975, PHYS REV LETT, V34, P319, DOI 10.1103/PhysRevLett.34.319; FRAIT Z, 1977, PHYSICA B & C, V86, P1241, DOI 10.1016/0378-4363(77)90863-4; Liu LQ, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.036601; Nagata M, 2014, IEEE T MAGN, V50, DOI 10.1109/TMAG.2013.2274270; Soulen RJ, 1998, SCIENCE, V282, P85, DOI 10.1126/science.282.5386.85; Tanabe K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1824; VOLOVIK GE, 1987, J PHYS C SOLID STATE, V20, pL83, DOI 10.1088/0022-3719/20/7/003	29	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1882-0778	1882-0786		APPL PHYS EXPRESS	Appl. Phys. Express	DEC	2015	8	12							123001			4	Physics, Applied	Physics	CY1TX	WOS:000366191900012		
J	Okubo, S; Gunji, K; Onae, A; Schramm, M; Nakamura, K; Hong, FL; Hattori, T; Hosaka, K; Inaba, H				Okubo, Sho; Gunji, Kenta; Onae, Atsushi; Schramm, Malte; Nakamura, Keisuke; Hong, Feng-Lei; Hattori, Toshiaki; Hosaka, Kazumoto; Inaba, Hajime			All-optically stabilized frequency comb	APPLIED PHYSICS EXPRESS			English	Article							INTRACAVITY ELECTROOPTIC MODULATOR; LOCKED FIBER LASER; RELATIVE LINEWIDTHS; RING LASER; GENERATION; LEVEL; NOISE	We present an all-optically stabilized, erbium-doped mode-locked fiber laser with an optically pumped ytterbium-doped fiber. The mode-locked fiber laser has two frequency-control actuators that are pump laser powers for erbium-doped and ytterbium-doped fibers. We investigate the frequency-control characteristics of the mode-locked laser and find that the fixed points for the two actuators are sufficiently apart from each other, realizing the simultaneous phase locking of the repetition and carrier envelope offset frequencies. We describe a long-term frequency measurement of an acetylene-stabilized laser at 1542 nm using an all-optically stabilized frequency comb. (C) 2015 The Japan Society of Applied Physics	[Okubo, Sho; Gunji, Kenta; Onae, Atsushi; Schramm, Malte; Nakamura, Keisuke; Hosaka, Kazumoto; Inaba, Hajime] Natl Inst Adv Ind Sci & Technol, NMIJ, Tsukuba, Ibaraki 3058563, Japan; [Gunji, Kenta; Hattori, Toshiaki] Univ Tsukuba, Grad Sch Pure & Appl Sci, Tsukuba, Ibaraki 3058577, Japan; [Hong, Feng-Lei] Yokohama Natl Univ, Grad Sch Engn, Dept Phys, Yokohama, Kanagawa 2408501, Japan; [Okubo, Sho; Onae, Atsushi; Schramm, Malte; Nakamura, Keisuke; Hong, Feng-Lei; Hosaka, Kazumoto; Inaba, Hajime] JST, MINOSHIMA Intelligent Opt Synthesizer Project, ERATO, Tsukuba, Ibaraki 3058563, Japan	Inaba, H (reprint author), Natl Inst Adv Ind Sci & Technol, NMIJ, Tsukuba, Ibaraki 3058563, Japan.	h.inaba@aist.go.jp					Minoshima K, 2000, APPL OPTICS, V39, P5512, DOI 10.1364/AO.39.005512; Hong FL, 2003, OPT LETT, V28, P2324, DOI 10.1364/OL.28.002324; Schibli TR, 2008, NAT PHOTONICS, V2, P355, DOI 10.1038/nphoton.2008.79; Nakajima Y, 2010, OPT EXPRESS, V18, P1667, DOI 10.1364/OE.18.001667; Okuno T, 1999, IEEE J SEL TOP QUANT, V5, P1385, DOI 10.1109/2944.806765; Keilmann F, 2004, OPT LETT, V29, P1542, DOI 10.1364/OL.29.001542; Nakajima Y, 2008, OPT COMMUN, V281, P4484, DOI 10.1016/j.optcom.2008.04.062; Hellwig T, 2014, OPT LETT, V39, P525, DOI 10.1364/OL.39.000525; Felder R, 2005, METROLOGIA, V42, P323, DOI 10.1088/0026-1394/42/4/018; Briles TC, 2010, OPT EXPRESS, V18, P9739, DOI 10.1364/OE.18.009739; Wu TH, 2011, OPT EXPRESS, V19, P5313, DOI 10.1364/OE.19.005313; Steinmetz T, 2008, SCIENCE, V321, P1335, DOI 10.1126/science.1161030; Buckley JR, 2005, OPT LETT, V30, P1888, DOI 10.1364/OL.30.001888; TAMURA K, 1993, OPT LETT, V18, P1080, DOI 10.1364/OL.18.001080; TAMURA K, 1992, ELECTRON LETT, V28, P2226, DOI 10.1049/el:19921430; Swann WC, 2011, OPT EXPRESS, V19, P24387, DOI 10.1364/OE.19.024387; Nicolodi D, 2014, NAT PHOTONICS, V8, P219, DOI 10.1038/NPHOTON.2013.361; Zhang W, 2012, IEEE T ULTRASON FERR, V59, P432, DOI 10.1109/TUFFC.2012.2212; MATSAS VJ, 1992, ELECTRON LETT, V28, P1391, DOI 10.1049/el:19920885; Onae A, 1999, IEEE T INSTRUM MEAS, V48, P563, DOI 10.1109/19.769658; PREVEDELLI M, 1995, APPL PHYS B-LASERS O, V60, pS241; Swann WC, 2006, OPT LETT, V31, P3046, DOI 10.1364/OL.31.003046; Iwakuni K, 2012, OPT EXPRESS, V20, P13769, DOI 10.1364/OE.20.013769; Telle HR, 2002, APPL PHYS B-LASERS O, V74, P1, DOI 10.1007/s003400100735	24	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1882-0778	1882-0786		APPL PHYS EXPRESS	Appl. Phys. Express	DEC	2015	8	12							122701	10.7567/APEX.8.122701		4	Physics, Applied	Physics	CY1TX	WOS:000366191900011		
J	Shioya, H; Shoji, Y; Seiki, N; Nakano, M; Fukushima, T; Iwasa, Y				Shioya, Hiroki; Shoji, Yoshiaki; Seiki, Noriya; Nakano, Masaki; Fukushima, Takanori; Iwasa, Yoshihiro			Raising the metal-insulator transition temperature of VO2 thin films by surface adsorption of organic polar molecules	APPLIED PHYSICS EXPRESS			English	Article							SELF-ASSEMBLED MONOLAYERS; VANADIUM DIOXIDE; MOTT TRANSITION; SEMICONDUCTORS	We report a molecular adsorption effect on the first-order metal-insulator transition of vanadium dioxide (VO2) thin films. The phase transition temperature is shifted higher by the adsorption of particular polar and rigid tripodal molecules on the film surfaces. The shift becomes larger with increasing dipole moment magnitude, which ranges from 0 to 20D. The orientation of polar molecules aligned on the surface is most likely responsible for the higher shift of the transition temperature. Coating the surfaces with polar molecules, as demonstrated in this work, might provide a unique way of controlling the phase transition of materials. (C) 2015 The Japan Society of Applied Physics	[Shioya, Hiroki; Nakano, Masaki; Iwasa, Yoshihiro] Univ Tokyo, Quantum Phase Elect Ctr, Bunkyo Ku, Tokyo 1138656, Japan; [Shioya, Hiroki; Nakano, Masaki; Iwasa, Yoshihiro] Univ Tokyo, Dept Appl Phys, Bunkyo Ku, Tokyo 1138656, Japan; [Shoji, Yoshiaki; Seiki, Noriya; Fukushima, Takanori] Tokyo Inst Technol, Chem Resources Lab, Yokohama, Kanagawa 2268503, Japan; [Iwasa, Yoshihiro] RIKEN, Ctr Emergent Matter Sci CEMS, Wako, Saitama 3510198, Japan	Shioya, H (reprint author), Osaka Univ, Inst Sci & Ind Res, Ibaraki, Osaka 5670047, Japan.	shioya@sanken.osaka-u.ac.jp; iwasa@ap.t.u-tokyo.ac.jp			MEXT [25000003, 24350055, 26102001];  [25708040]	This work was supported in part by a Grant-in-Aid for Specially Promoted Research (No. 25000003), KAKENHI (No. 24350055), and a Grant-in-Aid for Scientific Research on Innovative Areas "pi-Figuration" (No. 26102001) from MEXT. MN was supported by a Grant-in-Aid for Young Scientists (A) (No. 25708040).	Kreutz TC, 2003, APPL PHYS LETT, V83, P4211, DOI 10.1063/1.1625422; Liu K, 2012, NANO LETT, V12, P6272, DOI 10.1021/nl303379t; Nakano M, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4824621; Shibuya K, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3291053; Calhoun MF, 2008, NAT MATER, V7, P84, DOI 10.1038/nmat2059; Liu MK, 2012, NATURE, V487, P345, DOI 10.1038/nature11231; Ji H, 2012, NANO LETT, V12, P2988, DOI 10.1021/nl300741h; BARKER AS, 1966, PHYS REV LETT, V17, P1286, DOI 10.1103/PhysRevLett.17.1286; Kobayashi S, 2004, NAT MATER, V3, P317, DOI 10.1038/nmat1105; Muraoka Y, 2002, APPL PHYS LETT, V80, P583, DOI 10.1063/1.1446215; Park JH, 2013, NATURE, V500, P431, DOI 10.1038/nature12425; Kawatani K, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.054203; Cavalleri A, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.237401; Carmeli I, 2012, ANGEW CHEM INT EDIT, V51, P7162, DOI 10.1002/anie.201201606; Nakano M, 2012, NATURE, V487, P459, DOI 10.1038/nature11296; Shibuya K, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.165108; Qazilbash MM, 2007, SCIENCE, V318, P1750, DOI 10.1126/science.1150124; Kim HT, 2004, NEW J PHYS, V6, DOI 10.1088/1367-2630/6/1/052; Vilan A, 2000, NATURE, V404, P166; MORIN FJ, 1959, PHYS REV LETT, V3, P34, DOI 10.1103/PhysRevLett.3.34; Jeong J, 2013, SCIENCE, V339, P1402, DOI 10.1126/science.1230512; Hu B, 2010, ADV MATER, V22, P5134, DOI 10.1002/adma.201002868; Aetukuri NB, 2013, NAT PHYS, V9, P661, DOI 10.1038/NPHYS2733; BERGLUND CN, 1969, PHYS REV, V185, P1022, DOI 10.1103/PhysRev.185.1022; GOODENOU.JB, 1971, J SOLID STATE CHEM, V3, P490, DOI 10.1016/0022-4596(71)90091-0; Okuyama D, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4861901; Suda M, 2015, SCIENCE, V347, P743, DOI 10.1126/science.1256783	27	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1882-0778	1882-0786		APPL PHYS EXPRESS	Appl. Phys. Express	DEC	2015	8	12							121101	10.7567/APEX.8.121101		4	Physics, Applied	Physics	CY1TX	WOS:000366191900001		
J	Shirotori, S; Hashimoto, S; Takagishi, M; Kamiguchi, Y; Iwasaki, H				Shirotori, Satoshi; Hashimoto, Susumu; Takagishi, Masayuki; Kamiguchi, Yuzo; Iwasaki, Hitoshi			High-output tri-magnetic terminal-based non-local spin valves	APPLIED PHYSICS EXPRESS			English	Article							ROOM-TEMPERATURE; ACCUMULATION; PRECESSION; INJECTION; MAGNETORESISTANCE	We propose tri-magnetic terminal-based non-local spin valves (TM-NLSVs) for lateral structures. A lateral structure has dual spin injector terminals with an anti-parallel spin configuration. The accumulated spin is detected as the voltage between the free layer and one side of the spin injector. Numerical investigation revealed that the output voltage of the TM-NLSV is 2.4-fold higher than that of the conventional four-terminal structure. A further 3.7-fold increase is expected by increasing the injector area by a factor of 9. These results indicate the possibility of obtaining an output voltage that is almost the same as that of conventional (non-lateral) spin valves. (C) 2015 The Japan Society of Applied Physics	[Shirotori, Satoshi; Hashimoto, Susumu; Takagishi, Masayuki; Kamiguchi, Yuzo; Iwasaki, Hitoshi] Toshiba Co Ltd, Corp R&D Ctr, Kawasaki, Kanagawa 2128582, Japan	Shirotori, S (reprint author), Toshiba Co Ltd, Corp R&D Ctr, Kawasaki, Kanagawa 2128582, Japan.				NEDO Strategic Innovation Program for Energy Conservation Technologies	This study was partially supported by the NEDO Strategic Innovation Program for Energy Conservation Technologies.	Shirotori S, 2015, APPL PHYS EXPRESS, V8, DOI 10.7567/APEX.8.023103; Jedema FJ, 2002, NATURE, V416, P713, DOI 10.1038/416713a; Takahashi S, 2008, J PHYS SOC JPN, V77, DOI 10.1143/JPSJ.77.031009; Idzuchi H, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4824897; Kimura T, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/16/165216; Ji Y, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2170138; Takahashi YK, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3681804; Valenzuela SO, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.196601; VALET T, 1993, PHYS REV B, V48, P7099, DOI 10.1103/PhysRevB.48.7099; Valenzuela SO, 2004, APPL PHYS LETT, V85, P5914, DOI 10.1063/1.1830685; Yamada M, 2013, IEEE T MAGN, V49, P713, DOI 10.1109/TMAG.2012.2226871; JOHNSON M, 1985, PHYS REV LETT, V55, P1790, DOI 10.1103/PhysRevLett.55.1790; Jedema FJ, 2001, NATURE, V410, P345, DOI 10.1038/35066533; Laczkowski P, 2011, APPL PHYS EXPRESS, V4, DOI 10.1143/APEX.4.063007; Takagishi M, 2010, IEEE T MAGN, V46, P2086, DOI 10.1109/TMAG.2010.2045739; Kimura T, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.014461; Oki S, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4832480; Fert A, 1996, PHYS REV B, V53, P6554, DOI 10.1103/PhysRevB.53.6554; Fukuma Y, 2011, NAT MATER, V10, P527, DOI [10.1038/nmat3046, 10.1038/NMAT3046]; Idzuchi H, 2012, SCI REP-UK, V2, DOI 10.1038/srep00628; Ikhtiar, 2014, INT 2014 C, pEB; Jaffres H, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.140408; Takahashi S, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.052409	23	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1882-0778	1882-0786		APPL PHYS EXPRESS	Appl. Phys. Express	DEC	2015	8	12							123003	10.7567/APEX.8.123003		4	Physics, Applied	Physics	CY1TX	WOS:000366191900014		
J	Taniguchi, T				Taniguchi, Tomohiro			Magnetization switching by microwaves initially rotating in opposite direction to precession	APPLIED PHYSICS EXPRESS			English	Article							CIRCULARLY-POLARIZED FIELD; DYNAMICS	A common understanding of magnetization switching in microwave-assisted magnetization reversal is that the rotation direction of the microwaves should be the same as the precession direction of the magnetization. In this letter, however, we show that microwaves initially rotating opposite to the magnetization precession destabilize the magnetization at an equilibrium and induce switching more efficiently when the microwave frequency depends on time. This argument is analytically deduced from an energy balance equation. We also establish a model satisfying this condition and confirm magnetization switching solely by microwaves by using numerical simulation. (C) 2015 The Japan Society of Applied Physics	[Taniguchi, Tomohiro] Natl Inst Adv Ind Sci & Technol, Spintron Res Ctr, Tsukuba, Ibaraki 3058568, Japan	Taniguchi, T (reprint author), Natl Inst Adv Ind Sci & Technol, Spintron Res Ctr, Tsukuba, Ibaraki 3058568, Japan.		Taniguchi, Tomohiro/J-6501-2012		JSPS [25790044]	The author expresses gratitude to Shinji Yuasa, Kay Yakushiji, Hitoshi Kubota, Akio Fukushima, Takehiko Yorozu, Yoichi Shiota, Sumito Tsunegi, Satoshi Iba, Aurelie Spiesser, Hiroki Maehara, and Ai Emura for their support and encouragement. This work was supported by JSPS KAKENHI Grant-in-Aid for Young Scientists (B) 25790044.	Kudo K, 2015, APPL PHYS EXPRESS, V8, DOI 10.7567/APEX.8.103001; Bertotti G, 2001, J APPL PHYS, V89, P6710, DOI 10.1063/1.1362640; Wang ZH, 2009, J APPL PHYS, V105, DOI 10.1063/1.3121075; Slonczewski JC, 1996, J MAGN MAGN MATER, V159, pL1, DOI 10.1016/0304-8853(96)00062-5; Okamoto S, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2977474; Thirion C, 2003, NAT MATER, V2, P524, DOI 10.1038/nmat946; Zhu JG, 2008, IEEE T MAGN, V44, P125, DOI 10.1109/TMAG.2007.911031; Rivkin K, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2405855; Igarashi M, 2009, IEEE T MAGN, V45, P3711, DOI 10.1109/TMAG.2009.2023424; Sun ZZ, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.132401; Bertotti G, 2001, PHYS REV LETT, V86, P724, DOI 10.1103/PhysRevLett.86.724; Okamoto S, 2010, J APPL PHYS, V107, DOI 10.1063/1.3436570; Taniguchi T, 2015, APPL PHYS EXPRESS, V8, DOI [10.7567/APEX.8.083004, 10.7567/APEX.8.073004]; Nozaki Y, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2775047; Berger L, 1996, PHYS REV B, V54, P9353, DOI 10.1103/PhysRevB.54.9353; Taniguchi T, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.024424; Okamoto S, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.237209; Barros N, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.014421; Barros N, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.144418; Bertotti G., 2009, NONLINEAR MAGNETIZAT; Bertotti G, 2009, J APPL PHYS, V105, DOI 10.1063/1.3072075; Denisov SI, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.104406; Klughertz G, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.104433; Suto H, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/24/245501; Tanaka T, 2013, J APPL PHYS, V113, DOI 10.1063/1.4801888	25	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1882-0778	1882-0786		APPL PHYS EXPRESS	Appl. Phys. Express	DEC	2015	8	12							123002	10.7567/APEX.8.123002		4	Physics, Applied	Physics	CY1TX	WOS:000366191900013		
J	Taninaka, A; Ochiai, T; Kanazawa, K; Takeuchi, O; Shigekawa, H				Taninaka, Atsushi; Ochiai, Takahiro; Kanazawa, Ken; Takeuchi, Osamu; Shigekawa, Hidemi			Probing of electronic structures of La@C-82 superatoms upon clustering realized using glycine nanocavities	APPLIED PHYSICS EXPRESS			English	Article							SCANNING TUNNELING MICROSCOPY/SPECTROSCOPY; ENDOHEDRAL METALLOFULLERENES; ATOM	We have succeeded in the first direct probe of the change in the electronic structures of La@C-82 superatoms upon clustering by scanning tunneling microscopy/spectroscopy (STM/STS). An array of similar to 1.3-nm-diameter glycine nanocavities self-assembled on a Cu(111) surface was used as a template. Isolated La@C-82 superatoms were stably observed on terraces without diffusion to step edges, which enabled us to observe the change in the electronic structures associated with single, dimer, and clustered La@C-82. A cluster with four La@C-82 superatoms showed electronic structures similar to those obtained for thin films in previous works. (C) 2015 The Japan Society of Applied Physics	[Taninaka, Atsushi; Ochiai, Takahiro; Kanazawa, Ken; Takeuchi, Osamu; Shigekawa, Hidemi] Univ Tsukuba, Fac Pure & Appl Sci, Tsukuba, Ibaraki 3058573, Japan; [Ochiai, Takahiro] TAKANO Co Ltd, Nagano 3994301, Japan	Shigekawa, H (reprint author), Univ Tsukuba, Fac Pure & Appl Sci, Tsukuba, Ibaraki 3058573, Japan.	hidemi@ims.tsukuba.ac.jp			Japan Society for the Promotion of Science [15H05734]	H.S. acknowledges the support from the Japan Society for the Promotion of Science (Grant-in-Aid for Scientific Research, 15H05734).	Kato H, 2003, J AM CHEM SOC, V125, P4391, DOI 10.1021/ja027555+; Huang T, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.085434; Sakurai T, 1996, PROG SURF SCI, V51, P263, DOI 10.1016/0079-6816(96)00005-6; Ton-That C, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.045419; Kanazawa K, 2011, CHEM COMMUN, V47, P11312, DOI 10.1039/c1cc11829c; Shinohara H, 2000, REP PROG PHYS, V63, P843, DOI 10.1088/0034-4885/63/6/201; Taninaka A, 2003, NANO LETT, V3, P337, DOI 10.1021/nl025975r; Brown RM, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.033410; Muthukumar K, 2013, J PHYS CHEM C, V117, P1656, DOI 10.1021/jp305438h; Grobis M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.136802; Ton-That C, 2003, SURF SCI, V522, pL15, DOI 10.1016/S0039-6028(02)02399-3; Iwamoto M, 2010, J PHYS CHEM C, V114, P14704, DOI 10.1021/jp1023394; Nishibori E, 2000, CHEM PHYS LETT, V330, P497, DOI 10.1016/S0009-2614(00)01079-4; Wang KD, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.185504; Feng M, 2008, SCIENCE, V320, P359, DOI 10.1126/science.1155866; Feng M, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.075417; Ito Y, 2010, PHYS CHEM CHEM PHYS, V12, P1618, DOI 10.1039/b913593f; Zhao J., COORD CHEM REV, V289-290, P315	18	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1882-0778	1882-0786		APPL PHYS EXPRESS	Appl. Phys. Express	DEC	2015	8	12							125503	10.7567/APEX.8.125503		4	Physics, Applied	Physics	CY1TX	WOS:000366191900017		
J	Tanoue, H; Taniguchi, T; Wada, S; Yamamoto, S; Nakamura, S; Naka, Y; Yoshikawa, H; Munekata, M; Nagaoka, S; Nakamura, Y				Tanoue, Hironobu; Taniguchi, Takuya; Wada, Shohei; Yamamoto, Shinya; Nakamura, Shohei; Naka, Yoshihiro; Yoshikawa, Hiroyuki; Munekata, Mizue; Nagaoka, Shoji; Nakamura, Yusui			Uniform ZnO epitaxial films formed at atmospheric pressure by high-speed rotation-type mist chemical vapor deposition	APPLIED PHYSICS EXPRESS			English	Article							THIN-FILMS; GROWTH; DISK; TRANSITION	Uniform ZnO epitaxial films were formed on 2-in.-diameter m-plane sapphire substrates by high-speed rotation-type mist chemical vapor deposition at atmospheric pressure, without using any vacuum equipment. The ZnO films were characterized by scanning electron microscopy, X-ray diffraction in theta-2 theta and phi scanning modes, electron backscatter diffraction, and room-temperature photoluminescence measurements. Experimental results show that m-plane ZnO films were epitaxially grown on the m-plane sapphire substrates with high uniformity of not only thickness but also crystallinity and optical properties. These results will promote the progress of ZnO-based devices such as light-emitting diodes. (C) 2015 The Japan Society of Applied Physics	[Tanoue, Hironobu; Taniguchi, Takuya; Wada, Shohei; Yamamoto, Shinya; Nakamura, Shohei; Naka, Yoshihiro; Yoshikawa, Hiroyuki; Munekata, Mizue; Nakamura, Yusui] Kumamoto Univ, Grad Sch Sci & Technol, Kumamoto 8608555, Japan; [Nagaoka, Shoji] Kumamoto Ind Res Inst, Kumamoto 8620901, Japan; [Naka, Yoshihiro; Nagaoka, Shoji; Nakamura, Yusui] Kumamoto Inst Photoelectro Organ, Kumamoto 8620901, Japan	Tanoue, H (reprint author), Kumamoto Univ, Grad Sch Sci & Technol, Kumamoto 8608555, Japan.						Ahn CH, 2009, J APPL PHYS, V105, DOI 10.1063/1.3054175; Nakamura S, 1996, JPN J APPL PHYS 2, V35, pL74, DOI 10.1143/JJAP.35.L74; Nakahara K, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3459139; Lu JG, 2007, J CRYST GROWTH, V299, P1, DOI 10.1016/j.jcrysgro.2006.10.251; Itagaki N, 2014, OPT ENG, V53, DOI 10.1117/1.OE.53.8.087109; OHMINE T, 1990, J ELECTRON MATER, V19, P429, DOI 10.1007/BF02658002; Okamoto K, 2008, APPL PHYS EXPRESS, V1, DOI 10.1143/APEX.1.072201; Moriyama T, 2005, JPN J APPL PHYS 1, V44, P7919, DOI 10.1143/JJAP.44.7919; SUGAWARA K, 1972, J ELECTROCHEM SOC, V119, P1749, DOI 10.1149/1.2404093; Akasaki I, 1997, JPN J APPL PHYS 1, V36, P5393, DOI 10.1143/JJAP.36.5393; MALIK MR, 1981, AIAA J, V19, P1131, DOI 10.2514/3.7849; Yamamoto K, 2010, J CRYST GROWTH, V312, P1703, DOI 10.1016/j.jcrysgro.2010.02.029; Kawaharamura T, 2008, JPN J APPL PHYS, V47, P4669, DOI 10.1143/JJAP.47.4669; Cochran WG, 1934, P CAMB PHILOS SOC, V30, P365; KOBAYASHI R, 1980, ACTA MECH, V35, P71, DOI 10.1007/BF01190058; OLANDER DR, 1967, IND ENG CHEM FUND, V6, P178, DOI 10.1021/i160022a004; Tsukazaki A, 2005, NAT MATER, V4, P42, DOI 10.1038/nmat1284; Kawaharamura T, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.05FF08; Schlichting H., 1955, BOUNDARY LAYER THEOR, P83	19	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1882-0778	1882-0786		APPL PHYS EXPRESS	Appl. Phys. Express	DEC	2015	8	12							125502	10.7567/APEX.8.125502		3	Physics, Applied	Physics	CY1TX	WOS:000366191900016		
J	Tomita, K; Sato, Y; Nishikawa, K; Uchino, K; Yanagida, T; Tomuro, H; Wada, Y; Kunishima, M; Kodama, T; Mizoguchi, H; Sunahara, A				Tomita, Kentaro; Sato, Yuta; Nishikawa, Kazutaka; Uchino, Kiichiro; Yanagida, Tatsuya; Tomuro, Hiroaki; Wada, Yasunori; Kunishima, Masahito; Kodama, Takeshi; Mizoguchi, Hakaru; Sunahara, Atsushi			Development of a collective Thomson scattering system for laser-produced tin plasmas for extreme-ultraviolet light sources	APPLIED PHYSICS EXPRESS			English	Article							LITHOGRAPHY	Spatial profiles of electron density (n(e)) and electron temperature (T-e) of laser-produced Sn plasmas for extreme-ultraviolet (EUV) light sources have been obtained using a new collective Thomson scattering system, which has been optimized for the measurement of the ion feature spectrum. The system has an 18 pm spectral resolution, a 5 ns temporal resolution, a 50 mu m spatial resolution, and sufficient stray-light rejection near the probing laser wavelength. With this system, measurements of the laser-produced Sn plasmas in the parameter ranges of 3 x 10(23) < n(e) < 10(25) m(-3) and 10 < T-e < 20 eV have been performed. (C) 2015 The Japan Society of Applied Physics	[Tomita, Kentaro; Sato, Yuta; Nishikawa, Kazutaka; Uchino, Kiichiro] Kyushu Univ, Interdisciplinary Grad Sch Engn & Sci, Kasuga, Fukuoka 8168580, Japan; [Yanagida, Tatsuya; Tomuro, Hiroaki; Wada, Yasunori; Kunishima, Masahito; Kodama, Takeshi; Mizoguchi, Hakaru] Gigaphoton Inc, Oyama, Tochigi 3238558, Japan; [Sunahara, Atsushi] Inst Laser Technol, Suita, Osaka 5650871, Japan	Tomita, K (reprint author), Kyushu Univ, Interdisciplinary Grad Sch Engn & Sci, Kasuga, Fukuoka 8168580, Japan.	tomita@ence.kyushu-u.ac.jp					Hassaballa S, 2004, IEEE T PLASMA SCI, V32, P127, DOI 10.1109/TPS.2004.823980; Kono A, 2000, REV SCI INSTRUM, V71, P2716, DOI 10.1063/1.1150680; Kieft ER, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.056413; Nishihara K, 2008, PHYS PLASMAS, V15, DOI 10.1063/1.2907154; Banine V, 2004, J PHYS D APPL PHYS, V37, P3207, DOI 10.1088/0022-3727/37/23/001; Tao Y, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1931825; Fujioka S, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.235004; Kieft ER, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.036402; Fujioka S, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2948874; Tallents G, 2010, NAT PHOTONICS, V4, P809, DOI 10.1038/nphoton.2010.277; Muraoka K, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/4/043001; Kieft ER, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.026415; Tomita K, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.076101; LAFONTAINE B, 1994, PHYS PLASMAS, V1, P2329, DOI 10.1063/1.870630; Sasaki A, 2009, HIGH ENERG DENS PHYS, V5, P147, DOI 10.1016/j.hedp.2009.04.002; Froula D. H., 2011, PLASMA SCATTERING EL; Mizoguchi H, 2015, PROC SPIE, V9422, DOI 10.1117/12.2086347; Morita T, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4821967; Sunahara A, 2008, PLASMA FUSION RES, V3, P043; Tomita K, 2009, J PLASMA FUSION RES, V8, P488; Tomita K, 2012, J INSTRUM, V7, DOI 10.1088/1748-0221/7/02/C02057; Yamazaki T, 2015, PROC SPIE, V9422, DOI 10.1117/12.2180269	22	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1882-0778	1882-0786		APPL PHYS EXPRESS	Appl. Phys. Express	DEC	2015	8	12							126101	10.7567/APEX.8.126101		4	Physics, Applied	Physics	CY1TX	WOS:000366191900018		
J	Genkawa, T; Shinzawa, H; Kato, H; Ishikawa, D; Murayama, K; Komiyama, M; Ozaki, Y				Genkawa, Takuma; Shinzawa, Hideyuki; Kato, Hideaki; Ishikawa, Daitaro; Murayama, Kodai; Komiyama, Makoto; Ozaki, Yukihiro			Baseline Correction of Diffuse Reflection Near-Infrared Spectra Using Searching Region Standard Normal Variate (SRSNV)	APPLIED SPECTROSCOPY			English	Article						Near-infrared spectroscopy; NIR spectroscopy; Standard normal variate; SNV; Searching Region SNV; SRSNV; Baseline correction; Moving window partial least squares regression; MWPLSR	PARTIAL LEAST-SQUARES; SCATTER-CORRECTION; SPECTROSCOPY; NIR; SPECTROMETER; REGRESSION; SELECTION; MODEL; IMPROVEMENT; GLUCOSE	An alternative baseline correction method for diffuse reflection near-infrared (NIR) spectra, searching region standard normal variate (SRSNV), was proposed. Standard normal variate (SNV) is an effective pretreatment method for baseline correction of diffuse reflection NIR spectra of powder and granular samples; however, its baseline correction performance depends on the NIR region used for SNV calculation. To search for an optimal NIR region for baseline correction using SNV, SRSNV employs moving window partial least squares regression (MWPLSR), and an optimal NIR region is identified based on the root mean square error (RMSE) of cross-validation of the partial least squares regression (PLSR) models with the first latent variable (LV). The performance of SRSNV was evaluated using diffuse reflection NIR spectra of mixture samples consisting of wheat flour and granular glucose (0-100% glucose at 5% intervals). From the obtained NIR spectra of the mixture in the 10 000-4000 cm(-1) region at 4 cm intervals (1501 spectral channels), a series of spectral windows consisting of 80 spectral channels was constructed, and then SNV spectra were calculated for each spectral window. Using these SNV spectra, a series of PLSR models with the first LV for glucose concentration was built. A plot of RMSE versus the spectral window position obtained using the PLSR models revealed that the 8680-8364 cm(-1) region was optimal for baseline correction using SNV. In the SNV spectra calculated using the 8680-8364 cm(-1) region (SRSNV spectra), a remarkable relative intensity change between a band due to wheat flour at 8500 cm(-1) and that due to glucose at 8364 cm(-1) was observed owing to successful baseline correction using SNV. A PLSR model with the first LV based on the SRSNV spectra yielded a determination coefficient (R-2) of 0.999 and an RMSE of 0.70%, while a PLSR model with three LVs based on SNV spectra calculated in the full spectral region gave an R-2 of 0.995 and an RMSE of 2.29%. Additional evaluation of SRSNV was carried out using diffuse reflection NIR spectra of marzipan and corn samples, and PLSR models based on SRSNV spectra showed good prediction results. These evaluation results indicate that SRSNV is effective in baseline correction of diffuse reflection NIR spectra and provides regression models with good prediction accuracy.	[Genkawa, Takuma; Kato, Hideaki] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Shinzawa, Hideyuki] AIST, Res Inst Instrumentat Frontier, Moriyama Ku, Nagoya, Aichi 4638560, Japan; [Ishikawa, Daitaro] Tohoku Univ, Grad Sch Agr Sci, Aoba Ku, Sendai, Miyagi 9818555, Japan; [Ishikawa, Daitaro; Ozaki, Yukihiro] Kwansei Gakuin Univ, Sch Sci & Technol, Dept Chem, Sanda, Hyogo 6691337, Japan; [Murayama, Kodai; Komiyama, Makoto] Yokogawa Elect Corp, Innovat Headquarters, Musashino, Tokyo 1808750, Japan	Genkawa, T (reprint author), Univ Tsukuba, Fac Life & Environm Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058572, Japan.	genkawa.takuma.fm@u.tsukuba.ac.jp			MEXT, Japan	This work was supported, in part, by the Program to Disseminate Tenure Tracking System, MEXT, Japan.	Murayama K, 2013, REV SCI INSTRUM, V84, DOI 10.1063/1.4790413; Ishikawa D, 2013, ANAL BIOANAL CHEM, V405, P9401, DOI 10.1007/s00216-013-7355-6; GELADI P, 1985, APPL SPECTROSC, V39, P491, DOI 10.1366/0003702854248656; Pi FW, 2009, J NEAR INFRARED SPEC, V17, P33, DOI 10.1255/jnirs.824; Kasemsumran S, 2004, ANAL CHIM ACTA, V512, P223, DOI 10.1016/j.aca.2004.02.045; Hu Y, 2006, J NEAR INFRARED SPEC, V14, P103; ISAKSSON T, 1988, APPL SPECTROSC, V42, P1273, DOI 10.1366/0003702884429869; Shinzawa H, 2006, J CHEMOMETR, V20, P436, DOI 10.1002/cem.1018; Pomerantsev AL, 2012, J CHEMOMETR, V26, P299, DOI 10.1002/cem.2445; Du YP, 2004, ANAL CHIM ACTA, V501, P183, DOI 10.1016/j.aca.2003.09.041; Ishikawa D, 2014, J NEAR INFRARED SPEC, V22, P189, DOI 10.1255/jnirs.1116; Watari M, 2007, APPL SPECTROSC, V61, P397, DOI 10.1366/000370207780466244; Ishikawa D, 2013, APPL SPECTROSC, V67, P1441, DOI 10.1366/13-07103; Nishii T, 2012, ANAL SCI, V28, P1165; Guo Q, 1999, ANAL CHIM ACTA, V382, P87, DOI 10.1016/S0003-2670(98)00737-5; Genkawa T, 2012, APPL SPECTROSC, V66, P773, DOI 10.1366/11-06499; de Groot PJ, 2001, APPL SPECTROSC, V55, P173, DOI 10.1366/0003702011951470; [Anonymous], 2004, US FOOD DRUG ADM GUI; Rinnan A, 2009, TRAC-TREND ANAL CHEM, V28, P1201, DOI 10.1016/j.trac.2009.07.007; Genkawa T, 2013, APPL SPECTROSC, V67, P724, DOI 10.1366/12-06871; Roggo Y, 2007, J PHARMACEUT BIOMED, V44, P683, DOI 10.1016/j.jpba.2007.03.023; BARNES RJ, 1989, APPL SPECTROSC, V43, P772, DOI 10.1366/0003702894202201; Kasemsumran S, 2006, CHEMOMETR INTELL LAB, V82, P97, DOI 10.1016/j.chemolab.2005.08.014; Martens H, 2003, ANAL CHEM, V75, P394, DOI 10.1021/ac020194w; Norgaard L, 2000, APPL SPECTROSC, V54, P413, DOI 10.1366/0003702001949500; Christensen J, 2004, J NEAR INFRARED SPEC, V12, P63; ISAKSSON T, 1993, APPL SPECTROSC, V47, P702, DOI 10.1366/0003702934066839; NODA I, 1993, APPL SPECTROSC, V47, P1329, DOI 10.1366/0003702934067694; Jiang JH, 2002, ANAL CHEM, V74, P3555, DOI 10.1021/ac011177u; Doherty SJ, 2005, PROCESS ANALYTICAL TECHNOLOGY: SPECTROSCOPIC TOOLS AND IMPLEMENTATION STRATEGIES FOR THE CHEMICAL AND PHARMACEUTICAL INDUSTRIES, P329, DOI 10.1002/9780470988459.ch9; Ozaki Y, 2012, ANAL SCI, V28, P545; [Anonymous], 2000, APPL SPECTROSC, DOI DOI 10.1366/0003702001950454; Dhanoa M. S., 1994, J NEAR INFRARED SPEC, V2, P43, DOI DOI 10.1255/JNIRS.30; Lee K, 2007, NEW TECHNOLOGIES, MOBILITY AND SECURITY, P361, DOI 10.1007/978-1-4020-6270-4_30; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Xiaobo Zou, 2010, Anal Chim Acta, V667, P14, DOI 10.1016/j.aca.2010.03.048	36	0	0	SOC APPLIED SPECTROSCOPY	FREDERICK	5320 SPECTRUM DRIVE SUITE C, FREDERICK, MD 21703 USA	0003-7028	1943-3530		APPL SPECTROSC	Appl. Spectrosc.	DEC	2015	69	12					1432	1441		10.1366/15-07905		10	Instruments & Instrumentation; Spectroscopy	Instruments & Instrumentation; Spectroscopy	CY1DG	WOS:000366146300010		
J	Zhang, Y; Liu, TM; Hao, JH; Lin, LY; Zeng, W; Peng, XH; Wang, ZC				Zhang, Yu; Liu, Tianmo; Hao, Jinghua; Lin, Liyang; Zeng, Wen; Peng, Xianghe; Wang, Zhongchang			Enhancement of NH3 sensing performance in flower-like ZnO nanostructures and their growth mechanism	APPLIED SURFACE SCIENCE			English	Article						ZnO; Nanoflowers; Single crystalline; Gas sensor	SOLAR-CELLS; HYDROTHERMAL SYNTHESIS; GAS SENSORS; LUMINESCENCE; NANOFIBERS; NANORODS; QUANTUM; ARRAYS; HOLLOW	ZnO nanostructures hold substantial promise for gas-sensing applications owing to their outstanding ethanol sensing performance, yet their sensing performance toward NH3 has rarely been reported. Here, we report on a successful preparation of sunflower-like ZnO nanostructures and ZnO nanoparticle via a facile hydrothermal method, and demonstrate that the ZnO nanoflowers have high gas-sensing performances toward NH3 under a low concentration of 10-50 ppm. Further structural characterization reveals that the sunflower-like nanostructure comprises six triangles-like and one sphere-like nanostructures, and the triangle-like nanostructure is single crystalline with {001} crystal face. As a consequence of their unique morphology, the nanoflowers show much improved NH3 sensing performances than the nanoparticles with a high sensitivity of 49.5. (C) 2015 Elsevier B.V. All rights reserved.	[Zhang, Yu; Liu, Tianmo; Hao, Jinghua; Lin, Liyang; Zeng, Wen] Chongqing Univ, Coll Mat Sci & Engn, Chongqing 400044, Peoples R China; [Zhang, Yu; Liu, Tianmo; Hao, Jinghua; Zeng, Wen] Chongqing Univ, Natl Engn Res Ctr Mg Alloys, Chongqing 400044, Peoples R China; [Peng, Xianghe] Chongqing Univ, Chongqing Key Lab Heterogeneous Mat Mech, Chongqing 400044, Peoples R China; [Lin, Liyang; Wang, Zhongchang] Tohoku Univ, Adv Inst Mat Res, Aoba Ku, Sendai, Miyagi 9808577, Japan	Liu, TM (reprint author), Chongqing Univ, Coll Mat Sci & Engn, Chongqing 400044, Peoples R China.	tmliu@cqu.edu.cn; zcwang@wpi-aimr.tohoku.ac.jp			National Natural Science Foundation of China [11332013]; Fundamental Research Funds for Central Universities [106112015CDJXY130013]; Challenging Exploratory Research [15K14117]; JSPS; CAS under Japan-China Scientific Cooperation Program; Shorai Foundation for Science and Technology;  [15H04114]	The authors gratefully acknowledge the financial support to this work from the National Natural Science Foundation of China under grant no. 11332013 and Fundamental Research Funds for Central Universities under grant no. 106112015CDJXY130013. Z.C.W. thanks supports from the Scientific Research (B) (grant no. 15H04114), Challenging Exploratory Research (grant no. 15K14117), JSPS and CAS under Japan-China Scientific Cooperation Program, and Shorai Foundation for Science and Technology.	Katoch A, 2015, SENSOR ACTUAT B-CHEM, V214, P111, DOI 10.1016/j.snb.2015.03.012; Alenezi MR, 2014, NANOSCALE, V6, P235, DOI 10.1039/c3nr04519f; Xie JA, 2011, APPL SURF SCI, V257, P6358, DOI 10.1016/j.apsusc.2011.01.105; Akhtar MS, 2008, ELECTROCHIM ACTA, V53, P7869, DOI 10.1016/j.electacta.2008.05.055; Ramadoss A, 2015, ACS NANO, V9, P4337, DOI 10.1021/acsnano.5b00759; Qurashi A, 2015, RSC ADV, V5, P22570, DOI 10.1039/c4ra15497e; Guo WW, 2013, SENSOR ACTUAT B-CHEM, V178, P53, DOI 10.1016/j.snb.2012.12.073; Hussain S, 2014, MATER LETT, V128, P35, DOI 10.1016/j.matlet.2014.04.115; Xu XB, 2012, CRYST GROWTH DES, V12, P4829, DOI 10.1021/cg3005773; Chen XS, 2013, MATER LETT, V112, P23, DOI 10.1016/j.matlet.2013.08.118; Kale RB, 2013, J ALLOY COMPD, V579, P444, DOI 10.1016/j.jallcom.2013.05.118; Yi S, 2014, SENSOR ACTUAT B-CHEM, V204, P351, DOI 10.1016/j.snb.2014.07.076; Cheng B, 2008, MATER LETT, V62, P3099, DOI 10.1016/j.matlet.2008.01.115; Lian JB, 2011, CRYSTENGCOMM, V13, P4820, DOI 10.1039/c1ce05301a; Zhao JG, 2013, J ALLOY COMPD, V579, P45, DOI 10.1016/j.jallcom.2013.05.052; Dalvand R, 2015, MATER LETT, V146, P65, DOI 10.1016/j.matlet.2015.02.003; Wang ZL, 2009, MAT SCI ENG R, V64, P33, DOI 10.1016/j.mser.2009.02.001; Srivastava A, 2007, MATER CHEM PHYS, V105, P385, DOI 10.1016/j.matchemphys.2007.05.003; Anantachaisilp S, 2014, J PHYS CHEM C, V118, P27150, DOI 10.1021/jp5085857; Kilic B, 2014, APPL SURF SCI, V318, P32, DOI 10.1016/j.apsusc.2013.12.065; Mao YZ, 2014, APPL SURF SCI, V298, P109, DOI 10.1016/j.apsusc.2014.01.133; Kaneva NV, 2011, APPL SURF SCI, V257, P8113, DOI 10.1016/j.apsusc.2011.04.119; Vignesh K, 2015, RSC ADV, V5, P30120, DOI 10.1039/c5ra02042e; Hasan MR, 2015, ACS APPL MATER INTER, V7, P5768, DOI 10.1021/am5085379; Zeng W, 2015, MATER RES BULL, V65, P157, DOI 10.1016/j.materresbull.2015.01.054; Zhao YY, 2015, NANOSCALE, V7, P1904, DOI 10.1039/c4nr06461e; Lare Y, 2009, APPL SURF SCI, V255, P6615, DOI 10.1016/j.apsusc.2009.02.054; Santra PK, 2013, J AM CHEM SOC, V135, P877, DOI 10.1021/ja310737m; Chee WK, 2015, ELECTROCHIM ACTA, V157, P88, DOI 10.1016/j.electacta.2015.01.080; Sun LW, 2015, NANOSCALE, V7, P7299, DOI 10.1039/c5nr00567a; Zhang Y., 2014, J MATER SCI-MATER EL, V26, P191; Zhang Y., 2013, J MATER SCI-MATER EL, V25, P376	32	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0169-4332	1873-5584		APPL SURF SCI	Appl. Surf. Sci.	DEC 1	2015	357		A				31	36		10.1016/j.apsusc.2015.08.170		6	Chemistry, Physical; Materials Science, Coatings & Films; Physics, Applied; Physics, Condensed Matter	Chemistry; Materials Science; Physics	CY2CR	WOS:000366216900005		
J	Hattori, M; Noda, K				Hattori, Masashi; Noda, Kei			All electrochemical fabrication of a bilayer membrane composed of nanotubular photocatalyst and palladium toward high-purity hydrogen production	APPLIED SURFACE SCIENCE			English	Article						Photocatalysis; High purity hydrogen production; Anodized TiO2 nanotube array; Hydrogen permeable metal; Electroless plating	NICKEL-BASED COCATALYSTS; VISIBLE-LIGHT; METAL MEMBRANES; TIO2 NANOTUBES; LIQUID WATER; DECOMPOSITION; H-2; ARRAYS; FILM; TEMPERATURE	We developed an all-electrochemical technique for fabricating a bilayer structure of a titanium dioxide (TiO2) nanotube array (TNA) and a palladium film (TNA/Pd membrane), which works for photocatalytic high-purity hydrogen production. Electroless plating was used for depositing the Pd film on the TNA surface prepared by anodizing a titanium foil. A 3-mu m-thick TNA/Pd membrane without any pinholes in a 1.5-cm-diameter area was fabricated by transferring a 1- mu m-thick TNA onto an electroless-plated 2-mu m-thick Pd Pd film with a mechanical peel-off process. This ultrathin membrane with sufficient mechanical robustness showed photocatalytic H-2 production via methanol reforming under ultraviolet illumination on the TNA side, immediately followed by the purification of the generated H2 gas through the Pd layer. The hydrogen production rate and the apparent quantum yield for high-purity H2 production from methanol/water mixture with the TNA/Pd membrane were also examined. This work suggests that palladium electroless plating is more suitable and practical for preparing a well-organized TNA/Pd heterointerface than palladium sputter deposition. (C) 2015 Elsevier B.V. All rights reserved.	[Hattori, Masashi] Kyushu Univ, Inst Mat Chem & Engn, Kasuga, Fukuoka 8168580, Japan; [Noda, Kei] Keio Univ, Dept Elect & Elect Engn, Yokohama, Kanagawa 2238522, Japan	Noda, K (reprint author), Keio Univ, Dept Elect & Elect Engn, Yokohama, Kanagawa 2238522, Japan.	nodakei@elec.keio.ac.jp			Japan Society for the Promotion of Science (JSPS) [25709024]	This study was partly supported by a Grant-in-Aid for Young Scientists (A) (KAKENHI No. 25709024) from the Japan Society for the Promotion of Science (JSPS). The authors are grateful to Mr. Takahiro Ohta (Keio University) for his help in the XPS measurements.	Takata T, 1997, J PHOTOCH PHOTOBIO A, V106, P45, DOI 10.1016/S1010-6030(97)00037-3; Maeda K, 2007, J PHYS CHEM C, V111, P7851, DOI 10.1021/jp070911w; Cheng YS, 2001, J MEMBRANE SCI, V182, P195, DOI 10.1016/S0376-7388(00)00563-9; Cao SW, 2014, J PHYS CHEM LETT, V5, P2101, DOI 10.1021/jz500546b; Lin JD, 2014, APPL SURF SCI, V309, P188, DOI 10.1016/j.apsusc.2014.05.008; Gong D, 2001, J MATER RES, V16, P3331, DOI 10.1557/JMR.2001.0457; Lv J, 2015, APPL SURF SCI, V351, P225, DOI 10.1016/j.apsusc.2015.05.139; Ran JR, 2014, CHEMSUSCHEM, V7, P3426, DOI 10.1002/cssc.201402574; Ogura S, 1997, APPL SURF SCI, V121, P521, DOI 10.1016/S0169-4332(97)00358-9; Lu ZD, 2011, APPL SURF SCI, V257, P10715, DOI 10.1016/j.apsusc.2011.07.085; Kato H, 2003, J AM CHEM SOC, V125, P3082, DOI 10.1021/ja027751g; KUDO A, 1989, J CATAL, V120, P337, DOI 10.1016/0021-9517(89)90274-1; Chiarello GL, 2009, CATAL TODAY, V144, P69, DOI 10.1016/j.cattod.2009.01.023; KUDO A, 1987, CHEM PHYS LETT, V133, P517, DOI 10.1016/0009-2614(87)80070-2; Li X, 2015, J MATER CHEM A, V3, P2485, DOI 10.1039/c4ta04461d; Macak JM, 2005, ANGEW CHEM INT EDIT, V44, P7463, DOI 10.1002/anie.200502781; Xu Y, 2015, APPL SURF SCI, V351, P779, DOI 10.1016/j.apsusc.2015.05.171; Paulose M, 2007, J PHYS CHEM C, V111, P14992, DOI 10.1021/jp075258r; Peachey NM, 1996, J MEMBRANE SCI, V111, P123, DOI 10.1016/0376-7388(95)00298-7; Moss TS, 1998, INT J HYDROGEN ENERG, V23, P99, DOI 10.1016/S0360-3199(97)00030-X; Tsuchiya H, 2005, ELECTROCHEM COMMUN, V7, P576, DOI 10.1016/j.elecom.2005.04.008; Yeung KL, 1999, J MEMBRANE SCI, V159, P107, DOI 10.1016/S0376-7388(99)00041-1; Liu X, 2014, APPL SURF SCI, V288, P513, DOI 10.1016/j.apsusc.2013.10.062; Palo DR, 2007, CHEM REV, V107, P3992, DOI 10.1021/cr050198b; Villarreal TL, 2004, J PHYS CHEM B, V108, P15172, DOI 10.1021/jp049447a; Mukaida M, 2010, J MEMBRANE SCI, V365, P378, DOI 10.1016/j.memsci.2010.09.025; Wang C, 2014, APPL SURF SCI, V292, P161, DOI 10.1016/j.apsusc.2013.11.105; O'Kelly JP, 2000, MICROELECTRON ENG, V50, P473, DOI 10.1016/S0167-9317(99)00317-2; Tahir B, 2015, APPL SURF SCI, V338, P1, DOI 10.1016/j.apsusc.2015.02.126; Zhang JF, 2014, PHYS CHEM CHEM PHYS, V16, P20382, DOI 10.1039/c4cp02201g; JAYARAMAN V, 1995, J MEMBRANE SCI, V99, P89, DOI 10.1016/0376-7388(94)00212-H; Hattori M, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3643052; Sayama K, 1997, J CHEM SOC FARADAY T, V93, P1647, DOI 10.1039/a607662i; SAYAMA K, 1994, J PHOTOCH PHOTOBIO A, V77, P243, DOI 10.1016/1010-6030(94)80049-9; Wang Y, 2014, J MATER CHEM A, V2, P3847, DOI 10.1039/c3ta14908k; Wang MY, 2014, RENEW SUST ENERG REV, V29, P573, DOI 10.1016/j.rser.2013.08.090; Albu SP, 2007, NANO LETT, V7, P1286, DOI 10.1021/nl070264k; Baudrand D., 1995, MET FINISH, V93, P55, DOI 10.1016/0026-0576(95)99502-2; Chao Y., 2008, INT J HYDROGEN ENERG, V33, P664; Hattori M, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4789763; KAWAI T, 1980, J CHEM SOC CHEM COMM, P694, DOI 10.1039/c39800000694; Knapton A.G., 1977, PLATIN MET REV, V21, P44; Li Q., 2015, ADV ENERGY MAT, V5; Li X., 2014, SCI CHINA MAT, V57, P70; McLeod LS, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2751597; Naumkin A.V., 2012, NIST STANDARD REFERE; Ran JR, 2014, CHEM SOC REV, V43, P7787, DOI 10.1039/c3cs60425j; Rothenberger KS, 2004, J MEMBRANE SCI, V244, P55, DOI 10.1016/j.memsci.2004.06.036; Tsui L.-K., 2014, ELECTROCHIM ACTA, V128, P341; Tsui L.-K., 2013, ELECTROCHIM ACTA, V100, P220; Varghese O.K., 2009, NAT NANOTECHNOL, V226, P592; Xiang Q., 2015, ANGEW CHEM INT ED	52	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0169-4332	1873-5584		APPL SURF SCI	Appl. Surf. Sci.	DEC 1	2015	357		A				214	220		10.1016/j.apsusc.2015.08.236		7	Chemistry, Physical; Materials Science, Coatings & Films; Physics, Applied; Physics, Condensed Matter	Chemistry; Materials Science; Physics	CY2CR	WOS:000366216900028		
J	Chao, BK; Cheng, HH; Nien, LW; Chen, MJ; Nagao, T; Li, JH; Hsueh, CH				Chao, Bo-Kai; Cheng, Hsin-Hung; Nien, Li-Wei; Chen, Miin-Jang; Nagao, Tadaaki; Li, Jia-Han; Hsueh, Chun-Hway			Anti-reflection textured structures by wet etching and island lithography for surface-enhanced Raman spectroscopy	APPLIED SURFACE SCIENCE			English	Article						Surface-enhanced Raman scattering; Anti reflection; Wet etching; Island lithography; Nanostructure; Textured substrate; Finite-difference time domain method	SINGLE-MOLECULE FLUORESCENCE; SOLAR-CELLS; ULTRASENSITIVE DETECTION; SILICON NANOSTRUCTURES; BOWTIE NANOANTENNAS; FIELD ENHANCEMENT; AU NANOPARTICLES; AT-AG; SERS; FABRICATION	A high surface area and low reflection textured surface-enhanced Raman scattering (SERS) substrate with plasmonic gold nanodroplets fabricated by wet etching and island lithography was reported in the present study. Specifically, four textured substrates, planar, pyramid, nanopillar, and nanopillar-on-pyramid, were fabricated. The fabricated structures were simulated using the finite-difference time-domain method and the results agreed with the reflection and dark-field scattering measurements. Although the SERS signals varied in different measured regions because of the random nanostructure, the SERS substrates with nanopillar-on-pyramid structure always have the stronger enhancement factor than the SERS substrates with only pyramids or nanopillars. Based on the atomic force microscope and reflection measurements, the nanopillar-on-pyramid structure provided a large surface area and multiple reflections for SERS enhancement, which was about 3 orders of magnitude larger than that of the planar substrate. Our results can be applied to fabricate the inexpensive, large surface area, and high SERS enhancement substrates. (C) 2015 Elsevier B.V. All rights reserved.	[Chao, Bo-Kai; Nien, Li-Wei; Chen, Miin-Jang; Hsueh, Chun-Hway] Natl Taiwan Univ, Dept Mat Sci & Engn, Taipei 10617, Taiwan; [Cheng, Hsin-Hung] Taipei Coll Maritime Technol, Dept Marine Engn, Taipei 11174, Taiwan; [Nagao, Tadaaki] Natl Inst Mat Sci, Ctr Mat Nanoarchitecton, Tsukuba, Ibaraki 3050044, Japan; [Li, Jia-Han] Natl Taiwan Univ, Dept Engn Sci & Ocean Engn, Taipei 10617, Taiwan	Hsueh, CH (reprint author), Natl Taiwan Univ, Dept Mat Sci & Engn, Taipei 10617, Taiwan.	hsuehc@ntu.edu.tw			Ministry of Science and Technology, Taiwan [MOST 103-2221-E-002-076-MY3]; Excellent Research Projects of National Taiwan University [103R8918]	The work was jointly supported by the Ministry of Science and Technology, Taiwan under Contract no. MOST 103-2221-E-002-076-MY3 and Excellent Research Projects of National Taiwan University under Project no. 103R8918. We are also grateful to the National Center for High-Performance Computing, Taiwan, for providing us with the computation time and facilities. Portion of experiments in this work were performed at the National Taiwan University NEMS Research Center and is gratefully acknowledged.	Chen K, 2012, ACS NANO, V6, P7998, DOI 10.1021/nn3026468; De Angelis F, 2013, NANO LETT, V13, P3553, DOI 10.1021/nl401100x; Kinkhabwala A, 2009, NAT PHOTONICS, V3, P654, DOI 10.1038/NPHOTON.2009.187; Panarin AY, 2010, APPL SURF SCI, V256, P6969, DOI 10.1016/j.apsusc.2010.05.008; Siddhanta S, 2012, ACS APPL MATER INTER, V4, P5807, DOI 10.1021/am302102p; Miele E, 2014, ADV MATER, V26, P4179, DOI 10.1002/adma.201400310; GUERRISI M, 1975, PHYS REV B, V12, P557, DOI 10.1103/PhysRevB.12.557; Liu XJ, 2011, ACS APPL MATER INTER, V3, P2944, DOI 10.1021/am200737b; Chang TW, 2014, J PHYS CHEM C, V118, P18693, DOI 10.1021/jp503191y; Yang X, 2014, J MATER CHEM A, V2, P14798, DOI 10.1039/c4ta03178d; Liu DQ, 2014, SMALL, V10, P2564, DOI 10.1002/smll.201303857; Green M, 1999, J VAC SCI TECHNOL B, V17, P2074, DOI 10.1116/1.590875; Liu J, 2013, SOL ENERG MAT SOL C, V108, P93, DOI 10.1016/j.solmat.2012.09.016; Taminiau TH, 2007, NANO LETT, V7, P28, DOI 10.1021/nl061726h; Liu J, 2014, APPL SURF SCI, V289, P300, DOI 10.1016/j.apsusc.2013.10.154; Huang ZP, 2011, ADV MATER, V23, P285, DOI 10.1002/adma.201001784; Habouti S, 2011, J MATER CHEM, V21, P6269, DOI 10.1039/c0jm03459b; Hatab NA, 2010, NANO LETT, V10, P4952, DOI 10.1021/nl102963g; Lu LH, 2006, LANGMUIR, V22, P2605, DOI 10.1021/la052659u; Yang Y, 2012, NANOSCALE, V4, P2663, DOI 10.1039/c2nr12110g; Han YB, 2014, RSC ADV, V4, P2776, DOI 10.1039/c3ra44377a; Xu ZD, 2012, J PHYS CHEM C, V116, P24161, DOI 10.1021/jp308162c; Fromm DP, 2004, NANO LETT, V4, P957, DOI 10.1021/nl049951r; Chen K, 2007, NANO LETT, V7, P254, DOI 10.1021/nl062090x; Huang YF, 2007, NAT NANOTECHNOL, V2, P770, DOI 10.1038/nnano.2007.389; Nien LW, 2013, J PHYS CHEM C, V117, P25004, DOI 10.1021/jp408610q; Yang F, 2014, APPL SURF SCI, V292, P256, DOI 10.1016/j.apsusc.2013.11.126; Anker JN, 2008, NAT MATER, V7, P442, DOI 10.1038/nmat2162; Huang YF, 2013, RSC ADV, V3, P16080, DOI 10.1039/c3ra43044h; Sonnichsen C, 2000, APPL PHYS LETT, V77, P2949, DOI 10.1063/1.1323553; Liu J, 2014, APPL PHYS A-MATER, V114, P1175, DOI 10.1007/s00339-013-7743-y; Wi JS, 2013, ADV OPT MATER, V1, P814, DOI 10.1002/adom.201300284; Xu H, 2011, ACS APPL MATER INTER, V3, P22, DOI 10.1021/am100781n; Brolo AG, 2004, LANGMUIR, V20, P4813, DOI 10.1021/la0493621; Jain PK, 2007, NANO LETT, V7, P2080, DOI 10.1021/nl071008a; Nagel PM, 2013, CHEM PHYS, V414, P106, DOI 10.1016/j.chemphys.2012.03.013; Cheng HH, 2011, OPT EXPRESS, V19, P22125, DOI 10.1364/OE.19.022125; Vernon KC, 2010, J RAMAN SPECTROSC, V41, P1106, DOI 10.1002/jrs.2557; Cheng HF, 2015, J MATER CHEM A, V3, P5244, DOI 10.1039/c4ta06484d; Dodson S, 2013, J PHYS CHEM LETT, V4, P496, DOI 10.1021/jz302018x; Green M, 2003, J PHYS CHEM B, V107, P13015, DOI 10.1021/jp030751y; Liu ZX, 2015, APPL SURF SCI, V334, P110, DOI 10.1016/j.apsusc.2014.08.077; Cheng H. H., 2012, APPL PHYS LETT, P101; Fang X., 2014, APPL PHYS LETT, P104; Hsueh Chun-Hway, 2011, Opt Express, V19, P19660, DOI 10.1364/OE.19.019660; Intartaglia R, 2015, LAB CHIP, V15, P1343, DOI 10.1039/c4lc01293c; Johnson P. B., 1972, PHYS REV B, P6; Lesuffleur A., 2007, APPL PHYS LETT, P90; Palik E. D., 1985, HDB OPTICAL CONSTANT; Zhu W. M., 2012, NAT COMMUN, P3	50	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0169-4332	1873-5584		APPL SURF SCI	Appl. Surf. Sci.	DEC 1	2015	357		A				615	621		10.1016/j.apsusc.2015.09.047		7	Chemistry, Physical; Materials Science, Coatings & Films; Physics, Applied; Physics, Condensed Matter	Chemistry; Materials Science; Physics	CY2CR	WOS:000366216900080		
J	Fu, T; Peng, XH; Huang, C; Yin, DQ; Li, QB; Wang, ZC				Fu, Tao; Peng, Xianghe; Huang, Cheng; Yin, Deqiang; Li, Qibin; Wang, Zhongchang			Molecular dynamics simulation of VN thin films under indentation	APPLIED SURFACE SCIENCE			English	Article						VN film; Indentation; MD simulation; Dislocation slip; Stacking fault	TIN/ALN MULTILAYERED COATINGS; 1ST PRINCIPLES; FCC METALS; TIN/VN INTERFACE; STACKING-FAULTS; SURFACE-ENERGY; NANOINDENTATION; FRACTURE; HARDNESS; SILICON	We investigated with molecular dynamics simulation the mechanical responses of VN (0 0 1) thin films subjected to indentation with a diamond columnar indenter. We calculated the generalized stacking-fault energies as a function of the displacement in the < 1 1 0> directions on the {0 0 1}, {1 1 0}, and {1 1 1} planes, and analyzed systematically the microstructures and their evolution during the indentation with the centro-symmetry parameters and the slices of the VN films. We found the slips on {1 1 0}< 11 0> of the VN film under indentation at the initial stage. With the increase of indentation depth, slips are also activated on {1 1 1}< 1 1 0> and {1 00}< 0 1 1> systems. We further found that the slip system is determined by the stacking-fault energy rather than the layer spacing. The indentations with other different parameters were also performed, and the results further prove the validity of the conclusion. (C) 2015 Elsevier B.V. All rights reserved.	[Fu, Tao; Peng, Xianghe; Huang, Cheng; Li, Qibin] Chongqing Univ, Coll Aerosp Engn, Chongqing 400044, Peoples R China; [Peng, Xianghe] Chongqing Univ, State Key Lab Coal Mine Disaster Dynam & Control, Chongqing 400044, Peoples R China; [Yin, Deqiang] Sichuan Univ, Sch Mfg Sci & Engn, Chengdu 610065, Peoples R China; [Wang, Zhongchang] Tohoku Univ, Adv Inst Mat Res, Aoba Ku, Sendai, Miyagi 9808577, Japan	Peng, XH (reprint author), Chongqing Univ, Coll Aerosp Engn, Chongqing 400044, Peoples R China.	xhpeng@cqu.edu.cn; zcwang@wpi-aimr.tohoku.ac.jp			National Natural Science Foundation of China [11332013, 11272364]; Chongqing Graduate Student Research Innovation Project [CYB15029]; Challenging Exploratory Research [15K14117]; JSPS; CAS under Japan-China Scientific Cooperation Program; Shorai Foundation for Science and Technology; National Natural Science Foundation of Chongqing [cstc2015jcyjA50008];  [15H04114]	The authors acknowledge the financial supports from National Natural Science Foundation of China (grant nos. 11332013 and 11272364), the Chongqing Graduate Student Research Innovation Project (grant no. CYB15029), the Scientific Research (B) (grant no. 15H04114), the Challenging Exploratory Research (grant no. 15K14117), the JSPS and CAS under Japan-China Scientific Cooperation Program, the Shorai Foundation for Science and Technology, and National Natural Science Foundation of Chongqing (grant no. cstc2015jcyjA50008).	SCHNEIDER T, 1978, PHYS REV B, V17, P1302, DOI 10.1103/PhysRevB.17.1302; BASKES MI, 1989, PHYS REV B, V40, P6085, DOI 10.1103/PhysRevB.40.6085; [Anonymous], 2015, APPL SURF SCI; HELMERSSON U, 1987, J APPL PHYS, V62, P481, DOI 10.1063/1.339770; Fu T, 2015, CERAM INT, V41, P14078, DOI 10.1016/j.ceramint.2015.07.027; Alam M, 2015, J PHYS CHEM SOLIDS, V82, P1, DOI 10.1016/j.jpcs.2015.02.007; CHU X, 1995, J APPL PHYS, V77, P4403, DOI 10.1063/1.359467; Mesli F, 2011, ARAB J CHEM, V4, P211, DOI 10.1016/j.arabjc.2010.06.039; ANDERSON PM, 1995, NANOSTRUCT MATER, V5, P349, DOI 10.1016/0965-9773(95)00250-I; Yin DQ, 2014, PHYSICA E, V63, P125, DOI 10.1016/j.physe.2014.05.017; Wang ZC, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.045318; Zhang JM, 2004, APPL SURF SCI, V229, P34, DOI 10.1016/j.apsusc.2003.09.050; Zhu B, 2014, COMP MATER SCI, V86, P200, DOI 10.1016/j.commatsci.2014.01.046; Lee YM, 2005, MECH MATER, V37, P1035, DOI 10.1016/j.mechmat.2005.01.004; KOEHLER JS, 1970, PHYS REV B, V2, P547, DOI 10.1103/PhysRevB.2.547; Xu ZH, 2011, COMP MATER SCI, V50, P1432, DOI 10.1016/j.commatsci.2010.11.030; Yin DQ, 2012, PHYSICA E, V44, P1838, DOI 10.1016/j.physe.2012.05.008; Kim YM, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.014101; Wei XM, 2007, APPL SURF SCI, V254, P1489, DOI 10.1016/j.apsusc.2007.07.078; Kelchner CL, 1998, PHYS REV B, V58, P11085, DOI 10.1103/PhysRevB.58.11085; Fu T, 2015, PHYSICA E, V69, P224, DOI 10.1016/j.physe.2015.01.046; Goel S, 2015, INT J MACH TOOL MANU, V88, P131, DOI 10.1016/j.ijmachtools.2014.09.013; Xu SZ, 2011, COMP MATER SCI, V50, P2411, DOI 10.1016/j.commatsci.2011.03.019; Lee BJ, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.184102; Gao Y, 2015, J MECH PHYS SOLIDS, V75, P58, DOI 10.1016/j.jmps.2014.11.005; Yin DQ, 2012, SURF INTERFACE ANAL, V44, P1261, DOI 10.1002/sia.4998; Cheng SF, 2010, TRIBOL LETT, V39, P329, DOI 10.1007/s11249-010-9682-5; Wen YN, 2007, SOLID STATE COMMUN, V144, P163, DOI 10.1016/j.ssc.2007.07.012; VITEK V, 1968, PHILOS MAG, V18, P773, DOI 10.1080/14786436808227500; KATO M, 1980, ACTA METALL MATER, V28, P285, DOI 10.1016/0001-6160(80)90163-7; Yin DQ, 2014, CERAM INT, V40, P14453, DOI 10.1016/j.ceramint.2014.07.016; Kim SH, 2004, SURF COAT TECH, V187, P47, DOI 10.1016/j.surfcoat.2004.01.011; Baowan D, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/9/093011; Yin DQ, 2015, CERAM INT, V41, P10095, DOI 10.1016/j.ceramint.2015.04.104; Fulcher BD, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.184106; Peng P, 2010, APPL SURF SCI, V256, P6284, DOI 10.1016/j.apsusc.2010.04.005; CAMMARATA RC, 1986, SCRIPTA METALL MATER, V20, P479, DOI 10.1016/0036-9748(86)90239-5; CHU X, 1992, J VAC SCI TECHNOL A, V10, P1604, DOI 10.1116/1.578030; Ivashchenko Turchi, 2013, CONDENS MATTER PHYS, V16, P33602; Jonathan A. Z., 2000, MODEL SIMUL MATER SC, V8, P103; Merkel S, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000920; Wang ZC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4239; Yadav SK, 2014, PHILOS MAG, V94, P464, DOI 10.1080/14786435.2013.856525; Yin DQ, 2010, J APPL PHYS, V108, DOI 10.1063/1.3466958; Zhao YB, 2015, PHYSICA E, V74, P481, DOI 10.1016/j.physe.2015.08.020	45	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0169-4332	1873-5584		APPL SURF SCI	Appl. Surf. Sci.	DEC 1	2015	357		A				643	650		10.1016/j.apsusc.2015.09.024		8	Chemistry, Physical; Materials Science, Coatings & Films; Physics, Applied; Physics, Condensed Matter	Chemistry; Materials Science; Physics	CY2CR	WOS:000366216900084		
J	Umeda, J; Fugetsu, B; Nishida, E; Miyaji, H; Kondoh, K				Umeda, Junko; Fugetsu, Bunshi; Nishida, Erika; Miyaji, Hirofumi; Kondoh, Katsuyoshi			Friction behavior of network-structured CNT coating on pure titanium plate	APPLIED SURFACE SCIENCE			English	Article						Carbon nanotubes; Friction coefficient; Ti plate; TiC interlayer; Abrasive wear; Carbon solid-solution strengthening	MULTIWALLED CARBON NANOTUBES; TRIBOLOGICAL PROPERTIES; LUBRICATION	Friction behavior of the network-structured CNTs coated pure Ti plate was evaluated by ball-on-disk wear test using SUS304 ball specimen under dry condition. The friction coefficient was significantly low and stable compared to the as-received Ti plate with no coating film. CNTs coating film had two important roles; self-lubrication and bearing effects to reduce the friction coefficient and carbon solid-solution hardening to improve the abrasive wear property of Ti plate. The annealing treatment at higher temperature (1123 K) was more effective to reduce the friction coefficient than that at lower temperature (973 K) because the Ti plate surface was uniformly covered with CNTs film even after sliding wear test. This is due to TiC interlayer formation via a reaction between Ti plate and carbon elements originated from CNTs during annealing. As a result, a strong interface bonding between CNTs film and Ti plate surface was obtained by higher temperature annealing treatment, and obstructed the detachment of CNTs film during wear test. (C) 2015 Elsevier B.V. All rights reserved.	[Umeda, Junko; Kondoh, Katsuyoshi] Osaka Univ, Joining & Welding Res Inst, Osaka 5670047, Japan; [Fugetsu, Bunshi] Hokkaido Univ, Grad Sch Environm Sci, Sapporo, Hokkaido 0600810, Japan; [Nishida, Erika; Miyaji, Hirofumi] Hokkaido Univ, Grad Sch Dent Med, Dept Periodontol & Endodontol, Sapporo, Hokkaido 0608586, Japan	Umeda, J (reprint author), Osaka Univ, Joining & Welding Res Inst, Osaka 5670047, Japan.	umedaj@jwri.osaka-u.ac.jp					Akita S., 2005, J SURF SCI NANOTECHN, V3, P86; Kondoh K, 2014, CARBON, V72, P15, DOI 10.1016/j.carbon.2014.01.013; Miyoshi K, 2005, TRIBOL LETT, V19, P191, DOI 10.1007/s11249-005-6146-4; Savalani MM, 2012, APPL SURF SCI, V258, P3173, DOI 10.1016/j.apsusc.2011.11.058; Fugetsu B, 2005, CHEM LETT, V34, P1218, DOI 10.1246/cl.2005.1218; Hu JJ, 2005, TRIBOL LETT, V19, P119, DOI 10.1007/s11249-005-5091-6; Platon F, 2001, WEAR, V250, P227, DOI 10.1016/S0043-1648(01)00651-2; Jiang LY, 2006, J MECH PHYS SOLIDS, V54, P2436, DOI 10.1016/j.jmps.2006.04.009; Miyoshi K, 2008, TRIBOL INT, V41, P24, DOI 10.1016/j.triboint.2007.04.006; Cumings J, 2000, SCIENCE, V289, P602, DOI 10.1126/science.289.5479.602; BUDINSKI KG, 1991, WEAR, V151, P203, DOI 10.1016/0043-1648(91)90249-T; Yamamoto G, 2008, J NANOSCI NANOTECHNO, V8, P2665, DOI 10.1166/jnn.2008.295; Hertel T, 1998, PHYS REV B, V58, P13870, DOI 10.1103/PhysRevB.58.13870; Kondoh K, 2010, MAT SCI ENG A-STRUCT, V527, P4103, DOI 10.1016/j.msea.2010.03.049; Cook EH, 2013, J MECH PHYS SOLIDS, V61, P652, DOI 10.1016/j.jmps.2012.08.004; Yu MF, 2000, J PHYS CHEM B, V104, P8764, DOI 10.1021/jp002828d; Moghadam AD, 2015, COMPOS PART B-ENG, V77, P402, DOI 10.1016/j.compositesb.2015.03.014; Zhang W, 2014, REV ADV MATER SCI, V36, P75; Barin I., 1989, THERMOCHEMICAL DATA, P1528; Church A.H., 2012, ADV SCI LETT, V5, P188; Rosenqvist T., 1983, PRINCIPLES EXTRACTIV, P492	21	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0169-4332	1873-5584		APPL SURF SCI	Appl. Surf. Sci.	DEC 1	2015	357		A				721	727		10.1016/j.apsusc.2015.09.063		7	Chemistry, Physical; Materials Science, Coatings & Films; Physics, Applied; Physics, Condensed Matter	Chemistry; Materials Science; Physics	CY2CR	WOS:000366216900095		
J	Tesfamichael, T; Cetin, C; Piloto, C; Arita, M; Bell, J				Tesfamichael, T.; Cetin, C.; Piloto, C.; Arita, M.; Bell, J.			The effect of pressure and W-doping on the properties of ZnO thin films for NO2 gas sensing	APPLIED SURFACE SCIENCE			English	Article						Nanostructure; ZnO thin films; W-doping Sputtering pressure; NO2 gas sensors	RAY PHOTOELECTRON-SPECTROSCOPY; OPTICAL BAND-GAP; DOPED ZNO; PHOTOLUMINESCENCE PROPERTIES; STRUCTURAL-PROPERTIES; ROOM-TEMPERATURE; ZINC-OXIDE; NANORODS; FABRICATION; NANOSTRUCTURES	Pure and W-doped ZnO thin films were obtained using magnetron sputtering at working pressures of 0.4 Pa and 1.33 Pa. The films were deposited on glass and alumina substrates at room temperature and subsequently annealed at 400 degrees C for 1 h in air. The effects of pressure and W-doping on the structure, chemical, optical and electronic properties of the ZnO films for gas sensing were examined. From AFM, the doped film deposited at higher pressure (1.33 Pa) has spiky morphology with much lower grain density and porosity compared to the doped film deposited at 0.4 Pa. The average gain size and roughness of the annealed films were estimated to be 65 nm and 2.2 nm, respectively with slightly larger grain size and roughness appeared in the doped films. From XPS the films deposited at 1.33 Pa favoured the formation of adsorbed oxygen on the film surface and this has been more pronounced in the doped film which created active sites for OH adsorption. As a consequence the W-doped film deposited at 1.33 Pa was found to have lower oxidation state of W (35.1 eV) than the doped film deposited at 0.4 Pa (35.9 eV). Raman spectra indicated that doping modified the properties of the ZnO film and induced free-carrier defects. The transmittance of the samples also reveals an enhanced free-carrier density in the W-doped films. The refractive index of the pure film was also found to increase from 1.7 to 2.2 after W-doping whereas the optical band gap only slightly increased. The W-doped ZnO film deposited at 0.4 Pa appeared to have favourable properties for enhanced gas sensing. This film showed significantly higher sensing performance towards 5-10 ppm NO2 at lower operating temperature of 150 degrees C most dominantly due to increased free-carrier defects achieved by W-doping. (C) 2015 Elsevier B.V. All rights reserved.	[Tesfamichael, T.; Piloto, C.; Bell, J.] Queensland Univ Technol, Fac Sci & Engn, Brisbane, Qld 4000, Australia; [Cetin, C.] Istanbul Tech Univ, Dept Mech Engn, TR-80626 Istanbul, Turkey; [Arita, M.] Hokkaido Univ, Lab Nanosci & Mat, Kita Ku, Sapporo, Hokkaido 0600814, Japan	Tesfamichael, T (reprint author), Queensland Univ Technol, Fac Sci & Engn, 2 George St, Brisbane, Qld 4000, Australia.	t.tesfamichael@qut.edu.au			Japanese Society for the Promotion of Science (JSPS)	This work has financially supported by Japanese Society for the Promotion of Science (JSPS). AFM characterization has been made at the Laboratory of Nanosciences and Materials at Hokkaido University Uapan). This research was done at IFE Central Analytical Research Facility at QUT.	Ahsan M, 2011, SENSOR LETT, V9, P759, DOI 10.1166/sl.2011.1610; Jia XH, 2011, J HAZARD MATER, V193, P194, DOI 10.1016/j.jhazmat.2011.07.049; Kim WM, 2013, THIN SOLID FILMS, V531, P430, DOI 10.1016/j.tsf.2013.01.078; Ismail A., 2013, Journal of King Saud University Science, V25, P209, DOI 10.1016/j.jksus.2012.12.004; LeGore LJ, 2002, THIN SOLID FILMS, V406, P79, DOI 10.1016/S0040-6090(02)00047-0; Bhatt V, 2005, SURF COAT TECH, V198, P304, DOI 10.1016/j.surfcoat.2004.10.118; Flickyngerova S, 2008, APPL SURF SCI, V254, P3643, DOI 10.1016/j.apsusc.2007.10.105; Water W, 2002, MATER LETT, V55, P67, DOI 10.1016/S0167-577X(01)00621-8; Shirazi M, 2014, J ALLOY COMPD, V602, P108, DOI 10.1016/j.jallcom.2014.03.029; Xu MM, 2014, SENSOR ACTUAT B-CHEM, V199, P403, DOI 10.1016/j.snb.2014.03.108; Duygulu NE, 2014, J CRYST GROWTH, V394, P116, DOI 10.1016/j.jcrysgro.2014.02.028; Zhang HF, 2010, VACUUM, V85, P184, DOI 10.1016/j.vacuum.2010.05.010; Kang SJ, 2007, APPL SURF SCI, V253, P7330, DOI 10.1016/j.apsusc.2007.03.020; Mihailova I, 2013, J NON-CRYST SOLIDS, V377, P212, DOI 10.1016/j.jnoncrysol.2013.05.003; Drmosh QA, 2013, APPL SURF SCI, V270, P104, DOI 10.1016/j.apsusc.2012.12.126; Can MM, 2012, J MAGN MAGN MATER, V324, P4054, DOI 10.1016/j.jmmm.2012.07.014; Barshilia HC, 2011, APPL SURF SCI, V257, P4410, DOI 10.1016/j.apsusc.2010.12.075; Choi CH, 2005, J CRYST GROWTH, V283, P170, DOI 10.1016/j.jcrysgro.2005.05.050; Zhang JJ, 2014, T NONFERR METAL SOC, V24, P736, DOI 10.1016/S1003-6326(14)63119-8; Wang XB, 2007, APPL SURF SCI, V253, P6905, DOI 10.1016/j.apsusc.2007.02.013; Kenanakis G, 2014, MATER RES BULL, V60, P752, DOI 10.1016/j.materresbull.2014.09.060; Lupan O, 2007, MICROELECTRON J, V38, P1211, DOI 10.1016/j.mejo.2007.09.004; Chen M, 2000, APPL SURF SCI, V158, P134, DOI 10.1016/S0169-4332(99)00601-7; Manjon FJ, 2005, J APPL PHYS, V97, DOI 10.1063/1.1856222; Axelevitch A, 2010, THIN SOLID FILMS, V518, P4520, DOI 10.1016/j.tsf.2009.12.021; Zhao XQ, 2009, APPL SURF SCI, V255, P5861, DOI 10.1016/j.apsusc.2009.01.022; Chu J, 2014, MATER RES BULL, V54, P73, DOI 10.1016/j.materresbull.2014.03.005; Minh VA, 2013, APPL SURF SCI, V265, P458, DOI 10.1016/j.apsusc.2012.11.028; Zhang C, 2013, APPL SURF SCI, V274, P371, DOI 10.1016/j.apsusc.2013.03.069; Shan FK, 2004, J EUR CERAM SOC, V24, P1869, DOI 10.1016/S0955-2219(03)00490-4; Heredia E, 2014, APPL SURF SCI, V317, P19, DOI 10.1016/j.apsusc.2014.08.046; Al-Salman HS, 2013, MEASUREMENT, V46, P1698, DOI 10.1016/j.measurement.2013.01.004; Ngom BD, 2009, APPL SURF SCI, V255, P7314, DOI 10.1016/j.apsusc.2009.03.089; Phan TL, 2010, J LUMIN, V130, P1142, DOI 10.1016/j.jlumin.2010.02.010; Gottardi G, 2011, MATER CHEM PHYS, V127, P364, DOI 10.1016/j.matchemphys.2011.02.020; MENG LJ, 1994, APPL SURF SCI, V78, P57, DOI 10.1016/0169-4332(94)90031-0; Yang LL, 2010, APPL SURF SCI, V256, P3592, DOI 10.1016/j.apsusc.2009.12.160; Bedia FZ, 2014, J ALLOY COMPD, V616, P312, DOI 10.1016/j.jallcom.2014.07.086; Tesfamichael T, 2007, APPL SURF SCI, V253, P4853, DOI 10.1016/j.apsusc.2006.10.065; Ayadi Z. B., 2008, MAT SCI ENG C, V28, P613, DOI 10.1016/j.msec.2007.10.006; Bai SL, 2014, SENSOR ACTUAT B-CHEM, V195, P657, DOI 10.1016/j.snb.2014.01.083; Bari A.R., 2014, PROCEDIA MAT SCI, V6, P1798; BEKMAN HHPT, 1993, APPL SURF SCI, V70-1, P347, DOI 10.1016/0169-4332(93)90455-K; Berger O, 2004, J MATER SCI-MATER EL, V15, P483, DOI 10.1023/B:JMSE.0000031602.73321.fe; Daniel GP, 2010, PHYSICA B, V405, P1782, DOI 10.1016/j.physb.2010.01.039; He JQ, 2013, SENSOR ACTUAT B-CHEM, V182, P170, DOI 10.1016/j.snb.2013.02.085; Moshfegh AZ, 2005, THIN SOLID FILMS, V484, P124, DOI 10.1016/j.tsf.2005.02.019; Saravanakumar K., 2011, ADV STUD THEOR PHYS, V5, P155; Stankova M, 2006, SENSOR ACTUAT B-CHEM, V113, P241, DOI 10.1016/j.snb.2005.02.056; Tauc J., 1974, AMORPHOUS LIQUID SEM; Tesfamichael T, 2015, SENSOR ACTUAT B-CHEM, V221, P393, DOI 10.1016/j.snb.2015.06.090	51	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0169-4332	1873-5584		APPL SURF SCI	Appl. Surf. Sci.	DEC 1	2015	357		A				728	734		10.1016/j.apsusc.2015.08.248		7	Chemistry, Physical; Materials Science, Coatings & Films; Physics, Applied; Physics, Condensed Matter	Chemistry; Materials Science; Physics	CY2CR	WOS:000366216900096		
J	Choi, J; Hatta, T				Choi, Junho; Hatta, Tetsuya			Structural changes of hydrogenated amorphous carbon films deposited on steel rods	APPLIED SURFACE SCIENCE			English	Article						Amorphous carbon film; Microstructure; Steel rod; Plasma based ion implantation; Raman spectroscopy	DIAMOND-LIKE CARBON; ION-IMPLANTATION TECHNIQUE; BIPOLAR PULSES; DLC COATINGS; PLASMA	In this study, hydrogenated amorphous carbon (a-C:H) films were deposited on steel rods of various radii by using bipolar-type plasma based ion implantation and deposition, and the film structure and mechanical properties have been investigated. Furthermore, the behavior of plasma surrounding the steel rods (i.e., flux and energy of incident ions and electrons) was investigated using the particle-in-cell Monte Carlo collision (PIC-MCC) method to examine the mechanism behind the structural changes of the a-C:H films. Three kinds of amorphous carbon films with different microstructures were prepared by changing the negative pulse voltages from 1 kV to 5 kV: one polymer-like carbon film and two diamond-like carbon films that possess the maximum FWHM(G) (full width at half maximum of Raman G-peak) and maximum hardness. The structure of the a-C:H films was evaluated through Raman spectroscopy, and the hardness of the films was measured using nanoindentation. It was found that the structures of a-C:H films deposited on the steel-rod surfaces are quite different from those on flat surfaces, and the film structures are directly affected by the curvature of the rod. It was also determined from the plasma simulation that the incident electron flux and ion flux become more intense as the curvature increases, resulting in the structural changes of the a-C:H films due to hydrogen evolution and thermal relaxation in the films. (C) 2015 Elsevier B.V. All rights reserved.	[Choi, Junho; Hatta, Tetsuya] Univ Tokyo, Dept Mech Engn, Bunkyo Ku, Tokyo 1138656, Japan	Choi, J (reprint author), Univ Tokyo, Dept Mech Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	choi@mech.t.u-tokyo.ac.jp			JSPS KAKENHI [23360072, 26289024]	This work was supported by JSPS KAKENHI (23360072 and 26289024).	TAMOR MA, 1994, J APPL PHYS, V76, P3823, DOI 10.1063/1.357385; Baba K, 2014, APPL SURF SCI, V310, P262, DOI 10.1016/j.apsusc.2014.03.064; Casiraghi C, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.085401; Ikeyama M, 2007, NUCL INSTRUM METH B, V257, P741, DOI 10.1016/j.nimb.2007.01.075; Choi J, 2011, DIAM RELAT MATER, V20, P845, DOI 10.1016/j.diamond.2011.04.003; GRILL A, 1993, WEAR, V168, P143, DOI 10.1016/0043-1648(93)90210-D; Miyagawa Y, 2005, SURF COAT TECH, V196, P155, DOI 10.1016/j.surfcoat.2004.08.180; Ferrari AC, 2000, PHYS REV B, V61, P14095, DOI 10.1103/PhysRevB.61.14095; CONRAD JR, 1987, J APPL PHYS, V62, P4591, DOI 10.1063/1.339055; Nanbu K, 2000, IEEE T PLASMA SCI, V28, P971, DOI 10.1109/27.887765; Xu JQ, 2008, DIAM RELAT MATER, V17, P194, DOI 10.1016/j.diamond.2007.12.010; Choi J, 2007, DIAM RELAT MATER, V16, P1361, DOI 10.1016/j.diamond.2006.11.088; Choi J, 2006, DIAM RELAT MATER, V15, P948, DOI 10.1016/j.diamond.2005.11.013; Robertson J, 2002, MAT SCI ENG R, V37, P129, DOI 10.1016/S0927-796X(02)00005-0; Miyagawa S, 2002, SURF COAT TECH, V156, P322, DOI 10.1016/S0257-8972(02)00101-9; Casiraghi C, 2005, DIAM RELAT MATER, V14, P1098, DOI 10.1016/j.diamond.2004.10.030; Ding Q, 2011, TRIBOL LETT, V41, P439, DOI 10.1007/s11249-010-9730-1; Miura K., 2008, HYOMEN GIJUTSU, V59, P203; Park W., 2014, J PHYS D	19	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0169-4332	1873-5584		APPL SURF SCI	Appl. Surf. Sci.	DEC 1	2015	357		A				814	818		10.1016/j.apsusc.2015.09.102		5	Chemistry, Physical; Materials Science, Coatings & Films; Physics, Applied; Physics, Condensed Matter	Chemistry; Materials Science; Physics	CY2CR	WOS:000366216900108		
J	Lei, YH; Ohtsuka, T; Sheng, N				Lei, Yanhua; Ohtsuka, Toshiaki; Sheng, Nan			Corrosion protection of copper by polypyrrole film studied by electrochemical impedance spectroscopy and the electrochemical quartz microbalance	APPLIED SURFACE SCIENCE			English	Article						Copper; Polymer; EIS; EQCM; Polymer coating	ELECTROACTIVE CONDUCTING POLYMERS; PHYTIC ACID; COATINGS; ELECTROPOLYMERIZATION; BEHAVIOR; DEGRADATION; ELECTRODE; PYRROLE; SURFACE; METALS	Polypyrrole (PPy) films were synthesized on copper in solution of sodium di-hydrogen phosphate and phytate for corrosion protection. The protection properties of PPy films were comparatively investigated in NaCl solution. During two months immersion, the PPy film doped with phytate anions, working as a cationic perm-selective membrane, inhibited the dissolution of copper to 1% of bare copper. Differently, the PPy film doped with di-hydrogen phosphate anions, possessing anionic perm-selectivity, was gradually reduced, and inhibited the dissolution to 7.8% of bare copper. Degradation of the PPy films was studied by comparing the electrochemical impedance spectroscopy change at different immersion time and Raman spectra change after immersion. (C) 2015 Elsevier B.V. All rights reserved.	[Lei, Yanhua; Ohtsuka, Toshiaki; Sheng, Nan] Hokkaido Univ, Div Mat Sci & Engn, Fac Engn, Kita Ku, Sapporo, Hokkaido 0608628, Japan; [Lei, Yanhua] Ocean Univ China, Inst Mat Sci & Engn, Qingdao 266100, Peoples R China	Lei, YH (reprint author), Hokkaido Univ, Ctr Adv Res Energy & Mat, Fac Engn, Kita Ku, Kita 13 Nishi 8, Sapporo, Hokkaido 0608628, Japan.	yhualei@gmail.com					Lei YH, 2013, CORROS SCI, V76, P302, DOI 10.1016/j.corsci.2013.07.003; Santos MJL, 2007, ELECTROCHIM ACTA, V52, P6141, DOI 10.1016/j.electacta.2007.03.070; Kowalski D, 2008, CORROS SCI, V50, P286, DOI 10.1016/j.corsci.2007.05.027; Deshpande PP, 2014, J COAT TECHNOL RES, V11, P473, DOI 10.1007/s11998-014-9586-7; Chen F, 2003, SYNTHETIC MET, V132, P125, DOI 10.1016/S0379-6779(02)00197-2; Fenelon AM, 2003, CORROS SCI, V45, P2837, DOI 10.1016/S0010-938X(03)00104-5; Annibaldi V, 2012, CORROS SCI, V59, P179, DOI 10.1016/j.corsci.2012.03.014; Liu YC, 2000, SYNTHETIC MET, V113, P203, DOI 10.1016/S0379-6779(00)00188-0; DOBLHOFER K, 1988, ELECTROCHIM ACTA, V33, P453, DOI 10.1016/0013-4686(88)80162-2; Lei YH, 2014, PROG ORG COAT, V77, P339, DOI 10.1016/j.porgcoat.2013.10.009; Egli I, 2003, J FOOD SCI, V68, P1855, DOI 10.1111/j.1365-2621.2003.tb12342.x; FURUKAWA Y, 1988, SYNTHETIC MET, V24, P329, DOI 10.1016/0379-6779(88)90309-8; Patil S, 2004, APPL SURF SCI, V225, P204, DOI [10.1016/j.apsusc.2003.10.050, 10.1016/j.apsusc.20093.10.050]; [Anonymous], 2015, PARADAY DISCUSS, DOI DOI 10.1039/C4FD00232F; Liu YC, 2000, THIN SOLID FILMS, V374, P85, DOI 10.1016/S0040-6090(00)01061-0; Tallman DE, 2002, J SOLID STATE ELECTR, V6, P73, DOI 10.1007/s100080100212; Redondo MI, 2007, CORROS SCI, V49, P1765, DOI 10.1016/j.corsci.2006.10.014; MERMILLIOD N, 1986, J ELECTROCHEM SOC, V133, P1073, DOI 10.1149/1.2108788; Prissanaroon W, 2004, SYNTHETIC MET, V142, P25, DOI 10.1016/j.synthmet.2003.07.010; Nielsen MM, 2007, EUR FOOD RES TECHNOL, V225, P173, DOI 10.1007/s00217-006-0397-7; Kear G, 2004, CORROS SCI, V46, P109, DOI 10.1016/S0010-938X(03)00257-3; Tallman DE, 2008, APPL SURF SCI, V254, P5452, DOI 10.1016/j.apsusc.2008.02.099; Efimov I, 2001, J ELECTROANAL CHEM, V499, P169, DOI 10.1016/S0022-0728(00)00358-2; Sheng N, 2012, PROG ORG COAT, V75, P59, DOI 10.1016/j.porgcoat.2012.03.008; Lei YH, 2014, PROG ORG COAT, V77, P774, DOI 10.1016/j.porgcoat.2014.01.002; Spinks GM, 2002, J SOLID STATE ELECTR, V6, P85, DOI 10.1007/s100080100211; Weidlich C, 2005, ELECTROCHIM ACTA, V50, P1547, DOI 10.1016/j.electacta.2004.10.032; Shinde V, 2006, APPL SURF SCI, V253, P1037, DOI 10.1016/j.apsusc.2006.02.007; Cascalheira AC, 2003, ELECTROCHIM ACTA, V48, P2523, DOI 10.1016/S0013-4686(03)00295-0; Liu T, 2007, ELECTROCHIM ACTA, V52, P8003, DOI 10.1016/j.electacta.2007.06.072; DEBERRY DW, 1985, J ELECTROCHEM SOC, V132, P1022, DOI 10.1149/1.2114008; Kowalshi D., 2007, CORROS SCI, V49, P3442; Nagiub A. M., 2005, PORT ELECTROCHIM ACT, V22, P301; Ohtsuka T., 2012, INT J CORROS, V2012, P7; Otmacic Curkovic H., 2009, CORROS SCI, V51, P2342; Ray H., 2012, CORROS SCI, V56, P67; Shinde V, 2005, CORROS SCI, V47, P1352, DOI 10.1016/j.corsci.2004.07.041; Tanguy J., 1987, J ELECTROCHEM SOC, V134, P795	38	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0169-4332	1873-5584		APPL SURF SCI	Appl. Surf. Sci.	DEC 1	2015	357		A				1122	1132		10.1016/j.apsusc.2015.09.053		11	Chemistry, Physical; Materials Science, Coatings & Films; Physics, Applied; Physics, Condensed Matter	Chemistry; Materials Science; Physics	CY2CR	WOS:000366216900146		
J	Jaworska, JS; Natsch, A; Ryan, C; Strickland, J; Ashikaga, T; Miyazawa, M				Jaworska, Joanna S.; Natsch, Andreas; Ryan, Cindy; Strickland, Judy; Ashikaga, Takao; Miyazawa, Masaaki			Bayesian integrated testing strategy (ITS) for skin sensitization potency assessment: a decision support system for quantitative weight of evidence and adaptive testing strategy	ARCHIVES OF TOXICOLOGY			English	Article						Integrated testing strategy; Skin sensitization; Bayesian network; LLNA potency class	IN-VITRO DATA; TEST H-CLAT; SCREENING CONTACT ALLERGENS; DATA ASSESSMENT PARADIGM; NEURAL-NETWORK ANALYSIS; NONANIMAL TEST METHODS; RISK-ASSESSMENT; CELL-LINE; CHEMICAL SENSITIZERS; PEPTIDE REACTIVITY	The presented Bayesian network Integrated Testing Strategy (ITS-3) for skin sensitization potency assessment is a decision support system for a risk assessor that provides quantitative weight of evidence, leading to a mechanistically interpretable potency hypothesis, and formulates adaptive testing strategy for a chemical. The system was constructed with an aim to improve precision and accuracy for predicting LLNA potency beyond ITS-2 (Jaworska et al., J Appl Toxicol 33(11):1353-1364, 2013) by improving representation of chemistry and biology. Among novel elements are corrections for bioavailability both in vivo and in vitro as well as consideration of the individual assays' applicability domains in the prediction process. In ITS-3 structure, three validated alternative assays, DPRA, KeratinoSens and h-CLAT, represent first three key events of the adverse outcome pathway for skin sensitization. The skin sensitization potency prediction is provided as a probability distribution over four potency classes. The probability distribution is converted to Bayes factors to: 1) remove prediction bias introduced by the training set potency distribution and 2) express uncertainty in a quantitative manner, allowing transparent and consistent criteria to accept a prediction. The novel ITS-3 database includes 207 chemicals with a full set of in vivo and in vitro data. The accuracy for predicting LLNA outcomes on the external test set (n = 60) was as follows: hazard (two classes)-100 %, GHS potency classification (three classes)-96 %, potency (four classes)-89 %. This work demonstrates that skin sensitization potency prediction based on data from three key events, and often less, is possible, reliable over broad chemical classes and ready for practical applications.	[Jaworska, Joanna S.] Procter & Gamble Co, B-1853 Strombeek Bever, Belgium; [Natsch, Andreas] Givaudan Schweiz AG, CH-8600 Dubendorf, Switzerland; [Ryan, Cindy] Procter & Gamble Co, Mason, OH 45040 USA; [Strickland, Judy] ILS Contractor Supporting NICEATM, Res Triangle Pk, NC 27709 USA; [Ashikaga, Takao] Shisheido Co Ltd, Tokyo, Japan; [Miyazawa, Masaaki] Kao Corp, R&D Safety Sci Res, Haga, Tochigi 3213497, Japan	Jaworska, JS (reprint author), Procter & Gamble Co, B-1853 Strombeek Bever, Belgium.	Jaworska.j@pg.com			NIEHS [HHSN273201500010C]	Roger Emter generated new KeratinoSens data. Leslie Foertsch generated new DPRA data. Morihiko Hirota and Yuuki Ootsubo generated new h-CLAT data. Data generation was partially funded by Research Institute of Fragrance Materials. Yuri Dancik was involved in the early stages of data compilation. Judy Strickland was supported by NIEHS contract HHSN273201500010C in support of NICEATM.	Takenouchi O, 2013, J TOXICOL SCI, V38, P599; El Ali Z, 2013, TOXICOL SCI, V134, P39, DOI 10.1093/toxsci/kft084; Weber FC, 2010, J EXP MED, V207, P2609, DOI 10.1084/jem.20092489; Kimber I, 2003, FOOD CHEM TOXICOL, V41, P1799, DOI 10.1016/S0278-6915(03)00223-0; Goodman SN, 1999, ANN INTERN MED, V130, P1005; Bus JS, 2009, TOXICOL SCI, V112, P297, DOI 10.1093/toxsci/kfp234; Kramer NI, 2012, CHEM RES TOXICOL, V25, P436, DOI 10.1021/tx200479k; Pirone JR, 2014, ALTEX-ALTERN ANIM EX, V31, P336, DOI http://dx.doi.org/10.14573/altex.1310151; Jowsey IR, 2006, J APPL TOXICOL, V26, P341, DOI 10.1002/jat.1146; Groothuis FA, 2015, TOXICOLOGY, V332, P30, DOI 10.1016/j.tox.2013.08.012; Bauch C, 2012, REGUL TOXICOL PHARM, V63, P489, DOI 10.1016/j.yrtph.2012.05.013; Alves VM, 2015, TOXICOL APPL PHARM, V284, P273, DOI 10.1016/j.taap.2014.12.013; Miyazawa M, 2008, J TOXICOL SCI, V33, P51, DOI 10.2131/jts.33.51; Nukada Y, 2013, TOXICOL IN VITRO, V27, P609, DOI 10.1016/j.tiv.2012.11.006; Villeneuve DL, 2014, TOXICOL SCI, V142, P312, DOI 10.1093/toxsci/kfu199; Dinkova-Kostova AT, 2005, CHEM RES TOXICOL, V18, P1779, DOI 10.1021/tx050217c; Jaworska J, 2013, J APPL TOXICOL, V33, P1353, DOI 10.1002/jat.2869; Ball N, 2011, REGUL TOXICOL PHARM, V60, P389, DOI 10.1016/j.yrtph.2011.05.007; Api AM, 2008, REGUL TOXICOL PHARM, V52, P3, DOI 10.1016/j.yrtph.2007.10.008; Basketter D, 2010, J APPL TOXICOL, V30, P289, DOI 10.1002/jat.1510; Luechtefeld T, 2015, J APPL TOXICOL, V35, P1361, DOI 10.1002/jat.3172; Su B, 2009, COMPUT MATH METHOD M, V10, P9, DOI 10.1080/17486700801982713; Nukada Y, 2012, TOXICOL IN VITRO, V26, P1150, DOI 10.1016/j.tiv.2012.07.001; Bohme A, 2009, CHEM RES TOXICOL, V22, P742, DOI 10.1021/tx800492x; Gerberick GF, 2005, DERMATITIS, V16, P157, DOI 10.2310/6620.2005.05040; Maxwell G, 2008, ATLA-ALTERN LAB ANIM, V36, P521; Natsch A, 2013, J APPL TOXICOL, V33, P1337, DOI 10.1002/jat.2868; Bodin A, 2003, CHEM RES TOXICOL, V16, P575, DOI 10.1021/tx025609n; van der Veen JW, 2014, REGUL TOXICOL PHARM, V69, P371, DOI 10.1016/j.yrtph.2014.04.018; COHEN S, 1966, J AM CHEM SOC, V88, P1533, DOI 10.1021/ja00959a040; Gerberick GF, 2007, TOXICOL SCI, V97, P417, DOI 10.1093/toxsci/kfm064; Kagatani S, 2010, J INVEST DERMATOL, V130, P175, DOI 10.1038/jid.2009.229; van der Veen JW, 2013, ARCH TOXICOL, V87, P763, DOI 10.1007/s00204-012-0976-2; McKim JM, 2010, CUTAN OCUL TOXICOL, V29, P171, DOI 10.3109/15569527.2010.483869; Natsch A, 2011, CHEM RES TOXICOL, V24, P2018, DOI 10.1021/tx2003678; Villeneuve DL, 2014, TOXICOL SCI, V142, P321, DOI 10.1093/toxsci/kfu200; Adler S, 2011, ARCH TOXICOL, V85, P367, DOI 10.1007/s00204-011-0693-2; Boeniger MF, 2003, INT ARCH OCC ENV HEA, V76, P387, DOI 10.1007/s00420-002-0425-2; Dimitrov SD, 2005, INT J TOXICOL, V24, P189, DOI 10.1080/10915810591000631; Hartung T, 2013, ALTEX-ALTERN ANIM EX, V30, P3; Jaworska J, 2010, REGUL TOXICOL PHARM, V57, P157, DOI 10.1016/j.yrtph.2010.02.003; De Wever B, 2012, TOXICOL IN VITRO, V26, P526, DOI 10.1016/j.tiv.2012.01.009; Skold M, 2002, CONTACT DERMATITIS, V46, P267, DOI 10.1034/j.1600-0536.2002.460504.x; Dancik Y, 2013, ADV DRUG DELIVER REV, V65, P221, DOI 10.1016/j.addr.2012.01.006; Roberts DW, 2008, J APPL TOXICOL, V28, P377, DOI 10.1002/jat.1289; Ashikaga T, 2006, TOXICOL IN VITRO, V20, P767, DOI 10.1016/j.tiv.2005.10.012; Gerberick GF, 2001, CONTACT DERMATITIS, V45, P333, DOI 10.1034/j.1600-0536.2001.450603.x; Patlewicz G, 2014, SAR QSAR ENVIRON RES, V25, P367, DOI 10.1080/1062936X.2014.900520; Natsch A, 2010, TOXICOL SCI, V113, P284, DOI 10.1093/toxsci/kfp228; Jaworska J, 2011, ALTEX-ALTERN ANIM EX, V28, P211; Lucas PJF, 2004, ARTIF INTELL MED, V30, P201, DOI 10.1016/j.artmed.2003.11.001; Beltrani VS, 2006, ANN ALLERG ASTHMA IM, V97, pS1; Basketter DA, 2009, J APPL TOXICOL, V29, P545, DOI 10.1002/jat.1443; Emter R, 2010, TOXICOL APPL PHARM, V245, P281, DOI 10.1016/j.taap.2010.03.009; Tsujita-Inoue K, 2014, TOXICOL IN VITRO, V28, P626, DOI 10.1016/j.tiv.2014.01.003; Mehling A, 2012, ARCH TOXICOL, V86, P1273, DOI 10.1007/s00204-012-0867-6; Kimber I, 2011, TOXICOL SCI, V120, pS238, DOI 10.1093/toxsci/kfq346; Patlewicz G, 2014, REGUL TOXICOL PHARM, V69, P529, DOI 10.1016/j.yrtph.2014.06.001; Gerberick GF, 2004, TOXICOL SCI, V81, P332, DOI 10.1093/toxsci/kfh213; AP, 2014, US TODAY; Basketter David A, 2012, ALTEX, V29, P3; Brase JM, 2009, MODELING SIMULATION; De Groot AC, 1994, PATCH TESTING TEST C; Esser PR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041340; European Union, 2009, OFFICIAL J EUROPEA L, V342, P59; Hoffmann S, 2015, LLNA VARIABILITY ESS; ICCVAM, 2011, ICCVAM TEST METH EV; Jaworska Joanna, 2010, ALTEX, V27, P231; Joint Research Centre of the European Union, 2013, EURL ECVAM REC DIR P; Joint Research Centre of the European Union, 2015, EURL ECVAM REC HUM C; Joint Research Centre of the European Union, 2014, EURL ECVAM REC KERAT; Kjaerulff U.B., 2013, BAYESIAN NETWORKS IN; Middleton E, 1998, ALLERGY PRINCIPLES P; Natsch A, 2009, TOXICOL SCI, V107, P106, DOI 10.1093/toxsci/kfn204; Natsch A, 2015, TOXICOL SCI, V143, P319, DOI 10.1093/toxsci/kfu229; Natsch A, 2014, ISSUES IN TOXICOLOGY, V19, P364; NIOSH, 2012, SKIN EXP EFF WORKPL; OECD, 2015, TEST 442C CHEM SKIN; OECD, 2015, ADV OUTC PATHW MOL S; OECD, 2015, PROP NEW TE IN PRESS; OECD, 2010, TEST 429 SKIN SENSIT; OECD, 2015, TEST 442D IN VITR SK; OECD, 2012, OECD SER TEST ASS 16; Reisinger K, 2015, TOXICOL IN VITRO, V29, P259, DOI 10.1016/j.tiv.2014.10.018; Roberts DW, 2007, CHEM RES TOXICOL, V20, P1321, DOI 10.1021/tx700169w; Rovida C, 2015, ALTEX-ALTERN ANIM EX, V32, P25, DOI http://dx.doi.org/10.14573/altex.1411011; Sasseville Denis, 2008, Allergy Asthma Clin Immunol, V4, P59, DOI 10.1186/1710-1492-4-2-59; Tsujita-Inoue K, 2015, J TOXICOL SCI, V40, P193, DOI 10.2131/jts.40.193; UN, 2013, GLOB HARM SYST CLASS; UNEP, 2005, OECD SIDS PHTHAL ANH; Urbisch D, 2015, REGUL TOXICOL PHARM, V71, P337, DOI 10.1016/j.yrtph.2014.12.008	91	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0340-5761	1432-0738		ARCH TOXICOL	Arch. Toxicol.	DEC	2015	89	12					2355	2383		10.1007/s00204-015-1634-2		29	Toxicology	Toxicology	CY1GR	WOS:000366155200014		
J	Currie, T; Cloutier, R; Brittain, S; Grady, C; Burrows, A; Muto, T; Kenyon, SJ; Kuchner, MJ				Currie, Thayne; Cloutier, Ryan; Brittain, Sean; Grady, Carol; Burrows, Adam; Muto, Takayuki; Kenyon, Scott J.; Kuchner, Marc J.			RESOLVING THE HD 100546 PROTOPLANETARY SYSTEM WITH THE GEMINI PLANET IMAGER: EVIDENCE FOR MULTIPLE FORMING, ACCRETING PLANETS	ASTROPHYSICAL JOURNAL LETTERS			English	Article						planetary systems; stars: early-type; stars: individual (HD 100546)	ORBITING HR 8799; MASS COMPANION; BROWN DWARFS; DISK; CONFIRMATION; SPECTROSCOPY; HD-100546; LIGHT; DUST	We report Gemini Planet Imager H-band high-contrast imaging/integral field spectroscopy and polarimetry of the HD 100546, a 10 Myr old early-type star recently confirmed to host a thermal infrared (IR) bright (super-)Jovian protoplanet at wide separation, HD 100546 b. We resolve the inner disk cavity in polarized light, recover the thermal IR-bright arm, and identify one additional spiral arm. We easily recover HD 100546 b and show that much of its emission plausibly originates from an unresolved point source. The point-source component of HD 100546 b has extremely red IR colors compared to field brown dwarfs, qualitatively similar to young cloudy super-Jovian planets; however, these colors may instead indicate that HD 100546 b is still accreting material from a circumplanetary disk. Additionally, we identify a second point-source-like peak at r(proj) similar to 14 AU, located just interior to or at the inner disk wall consistent with being a < 10-20 M-J candidate second protoplanet-"HD 100546 c"-and lying within a weakly polarized region of the disk but along an extension of the thermal IR-bright spiral arm. Alternatively, it is equally plausible that this feature is a weakly polarized but locally bright region of the inner disk wall. Astrometric monitoring of this feature over the next 2 years and emission line measurements could confirm its status as a protoplanet, rotating disk hot spot that is possibly a signpost of a protoplanet, or a stationary emission source from within the disk.	[Cloutier, Ryan] Univ Toronto, Dept Astron & Astrophys, Toronto, ON, Canada; [Cloutier, Ryan] Univ Toronto, Ctr Planetary Sci, Toronto, ON, Canada; [Cloutier, Ryan] Univ Montreal, Inst Rech Exoplanetes, Montreal, PQ, Canada; [Brittain, Sean] Clemson Univ, Dept Phys & Astron, Clemson, SC 29634 USA; [Grady, Carol; Kuchner, Marc J.] NASA Goddard Space Flight Ctr, Exoplanets & Stellar Astrophys Lab, Greenbelt, MD USA; [Grady, Carol] Eureka Sci, Oakland, CA USA; [Burrows, Adam] Princeton Univ, Dept Astrophys Sci, Princeton, NJ 08544 USA; [Muto, Takayuki] Kogakuin Univ, Div Liberal Arts, Tokyo, Japan; [Kenyon, Scott J.] Smithsonian Astrophys Observ, Cambridge, MA USA					NASA Origins of Solar Systems program [NNG13PB64P]	We thank Gijs Mulders, Wladimir Lyra, Nienke van der Marel, and the anonymous referee for helpful comments. This work is supported through NASA Origins of Solar Systems program NNG13PB64P.	BERRIMAN GB, 1994, ASTROPHYS J, V431, pL63, DOI 10.1086/187473; Baraffe I, 2003, ASTRON ASTROPHYS, V402, P701, DOI 10.1051/0004-6361:20030252; Leggett SK, 2010, ASTROPHYS J, V710, P1627, DOI 10.1088/0004-637X/710/2/1627; Grady CA, 2005, ASTROPHYS J, V620, P470, DOI 10.1086/426887; Marois C, 2008, SCIENCE, V322, P1348, DOI 10.1126/science.1166585; Marois C, 2010, NATURE, V468, P1080, DOI 10.1038/nature09684; Allard F, 2001, ASTROPHYS J, V556, P357, DOI 10.1086/321547; Bailey V, 2013, ASTROPHYS J, V767, DOI 10.1088/0004-637X/767/1/31; Bowler BP, 2011, ASTROPHYS J, V743, DOI 10.1088/0004-637X/743/2/148; Brittain SD, 2014, ASTROPHYS J, V791, DOI 10.1088/0004-637X/791/2/136; Currie T, 2012, ASTROPHYS J LETT, V760, DOI 10.1088/2041-8205/760/2/L32; Currie T, 2014, ASTROPHYS J LETT, V780, DOI 10.1088/2041-8205/780/2/L30; Currie T, 2014, ASTROPHYS J LETT, V796, DOI 10.1088/2041-8205/796/2/L30; Currie T, 2011, ASTROPHYS J, V729, DOI 10.1088/0004-637X/729/2/128; Currie T, 2014, ASTROPHYS J, V787, DOI 10.1088/0004-637X/787/2/104; Currie T, 2015, ASTROPHYS J LETT, V807, DOI 10.1088/2041-8205/807/1/L7; Currie T, 2014, ASTROPHYS J, V795, DOI 10.1088/0004-637X/795/2/133; Currie T, 2013, ASTROPHYS J, V776, DOI 10.1088/0004-637X/776/1/15; Galicher R, 2014, ASTRON ASTROPHYS, V565, DOI 10.1051/0004-6361/201423839; Grady CA, 2001, ASTRON J, V122, P3396, DOI 10.1086/324447; Macintosh B, 2014, P NATL ACAD SCI USA, V111, P12661, DOI 10.1073/pnas.1304215111; Marois C, 2006, ASTROPHYS J, V641, P556, DOI 10.1086/500401; Mawet D, 2014, ASTROPHYS J, V792, DOI 10.1088/0004-637X/792/2/97; Mulders G., 2013, ASTRON ASTROPHYS, V557, P68, DOI DOI 10.1051/0004-6361/201220930.; Mulders G., 2011, ASTRON ASTROPHYS, V531, P93; Oppenheimer R., 2013, APJ, V768, P24; Panic O, 2014, ASTRON ASTROPHYS, V562, DOI 10.1051/0004-6361/201219223; Perrin MD, 2014, PROC SPIE, V9147, DOI 10.1117/12.2055246; Quanz S., 2011, APJ, V738, P26; Quanz SP, 2013, ASTROPHYS J LETT, V766, DOI 10.1088/2041-8205/766/1/L1; Quanz SP, 2015, ASTROPHYS J, V807, DOI 10.1088/0004-637X/807/1/64; Rameau J, 2013, ASTROPHYS J LETT, V779, DOI 10.1088/2041-8205/779/2/L26; Soummer R, 2012, ASTROPHYS J LETT, V755, DOI 10.1088/2041-8205/755/2/L28; Spiegel DS, 2012, ASTROPHYS J, V745, DOI 10.1088/0004-637X/745/2/174; Walsh C, 2014, ASTROPHYS J LETT, V791, DOI 10.1088/2041-8205/791/1/L6; Wright CM, 2015, MON NOT R ASTRON SOC, V453, P414, DOI 10.1093/mnras/stv1619; Zhu ZH, 2015, ASTROPHYS J, V799, DOI 10.1088/0004-637X/799/1/16	37	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	2041-8205	2041-8213		ASTROPHYS J LETT	Astrophys. J. Lett.	DEC 1	2015	814	2							L27	10.1088/2041-8205/814/2/L27		6	Astronomy & Astrophysics	Astronomy & Astrophysics	CY0RA	WOS:000366112000010		
J	Ito, H; Matsumoto, J; Nagataki, S; Warren, DC; Barkov, MV				Ito, Hirotaka; Matsumoto, Jin; Nagataki, Shigehiro; Warren, Donald C.; Barkov, Maxim V.			PHOTOSPHERIC EMISSION FROM COLLAPSAR JETS IN 3D RELATIVISTIC HYDRODYNAMICS	ASTROPHYSICAL JOURNAL LETTERS			English	Article						gamma-ray burst: general; radiation mechanisms: thermal; radiative transfer; scattering	GAMMA-RAY BURSTS; POLARIZATION PROPERTIES; SPECTRAL CATALOG; STRATIFIED JETS; OUTFLOWS; FERMI; PEAK; GRB; VARIABILITY; EFFICIENCY	We explore the photospheric emission from a relativistic jet breaking out from a massive stellar envelope based on relativistic hydrodynamical simulations and post-process radiation transfer calculations in three dimensions. To investigate the impact of three-dimensional (3D) dynamics on the emission, two models of injection conditions are considered for the jet at the center of the progenitor star: one with periodic precession and another without precession. We show that structures developed within the jet due to the interaction with the stellar envelope, as well as due to the precession, have a significant imprint on the resulting emission. Particularly, we find that the signature of precession activity by the central engine is not smeared out and can be directly observed in the light curve as a periodic signal. We also show that non-thermal features, which can account for observations of gamma-ray bursts, are produced in the resulting spectra even though only thermal photons are injected initially and the effect of non-thermal particles is not considered.	[Ito, Hirotaka; Matsumoto, Jin; Nagataki, Shigehiro; Warren, Donald C.; Barkov, Maxim V.] RIKEN, Astrophys Big Bang Lab, Wako, Saitama 3510198, Japan	Ito, H (reprint author), RIKEN, Astrophys Big Bang Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	hirotaka.ito@riken.jp			Japan Society for the Promotion of Science [23340069, 25610056]; Center for the Promotion of Integrated Sciences (CPIS) of Sokendai;  [26800159]	We thank A. Pozanenko and A. Mizuta for fruitful discussions. This work is supported by the Japan Society for the Promotion of Science (No. 23340069 and No. 25610056). We acknowledge the financial support of a Grant-in-Aid for Young Scientists (B:26800159). Numerical computations and data analysis were carried out on XC30 and PC cluster at Center for Computational Astrophysics, National Astronomical Observatory of Japan. This work was supported in part by the Center for the Promotion of Integrated Sciences (CPIS) of Sokendai.	Abdo AA, 2009, ASTROPHYS J LETT, V706, pL138, DOI 10.1088/0004-637X/706/1/L138; Crider A, 2006, AIP CONF PROC, V836, P64; Ghirlanda G, 2013, MON NOT R ASTRON SOC, V432, P3237, DOI 10.1093/mnras/stt681; Pe'er A, 2006, ASTROPHYS J, V642, P995, DOI 10.1086/501424; Pe'er A, 2005, ASTROPHYS J, V635, P476, DOI 10.1086/497360; Woosley SE, 2006, ASTROPHYS J, V637, P914, DOI 10.1086/498500; Lopez-Camara D, 2014, MON NOT R ASTRON SOC, V442, P2202, DOI 10.1093/mnras/stu1016; Ryde F, 2010, ASTROPHYS J LETT, V709, pL172, DOI 10.1088/2041-8205/709/2/L172; Preece RD, 1998, ASTROPHYS J, V506, pL23, DOI 10.1086/311644; Beskin G, 2010, ASTROPHYS J LETT, V719, pL10, DOI 10.1088/2041-8205/719/1/L10; Morsony BJ, 2010, ASTROPHYS J, V723, P267, DOI 10.1088/0004-637X/723/1/267; Lundman C, 2014, MON NOT R ASTRON SOC, V440, P3292, DOI 10.1093/mnras/stu457; Nava L, 2011, MON NOT R ASTRON SOC, V415, P3153, DOI 10.1111/j.1365-2966.2011.18928.x; Kaneko Y, 2006, ASTROPHYS J SUPPL S, V166, P298, DOI 10.1086/505911; Matsumoto J, 2013, ASTROPHYS J LETT, V772, DOI 10.1088/2041-8205/772/1/L1; Giannios D, 2007, ASTRON ASTROPHYS, V469, P1, DOI 10.1051/0004-6361:20066739; Asano K, 2013, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2013/09/008; Beloborodov AM, 2011, ASTROPHYS J, V737, DOI 10.1088/0004-637X/737/2/68; Beloborodov AM, 2013, ASTROPHYS J, V764, DOI 10.1088/0004-637X/764/2/157; Cuesta-Martinez C, 2015, MON NOT R ASTRON SOC, V446, P1737, DOI 10.1093/mnras/stu2109; Gruber D, 2014, ASTROPHYS J SUPPL S, V211, DOI 10.1088/0067-0049/211/1/12; Ito H, 2013, ASTROPHYS J, V777, DOI 10.1088/0004-637X/777/1/62; Ito H, 2014, ASTROPHYS J, V789, DOI 10.1088/0004-637X/789/2/159; Lazzati D, 2009, ASTROPHYS J LETT, V700, pL47, DOI 10.1088/0004-637X/700/1/L47; Matsumoto J, 2012, ASTROPHYS J, V751, DOI 10.1088/0004-637X/751/2/140; Mizuta A, 2011, ASTROPHYS J, V732, DOI 10.1088/0004-637X/732/1/26; Pe'er A, 2011, ASTROPHYS J, V732, DOI 10.1088/0004-637X/732/1/49; Pozanenko A., 2004, 35 COSPAR SCI ASS PA, P4028; Shibata S, 2014, ASTROPHYS J LETT, V787, DOI 10.1088/2041-8205/787/1/L4; Vurm I., 2015, ARXIV150601107; Vurm I, 2011, ASTROPHYS J, V738, DOI 10.1088/0004-637X/738/1/77; Vurm I, 2013, ASTROPHYS J, V764, DOI 10.1088/0004-637X/764/2/143	32	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	2041-8205	2041-8213		ASTROPHYS J LETT	Astrophys. J. Lett.	DEC 1	2015	814	2							L29	10.1088/2041-8205/814/2/L29		6	Astronomy & Astrophysics	Astronomy & Astrophysics	CY0RA	WOS:000366112000012		
J	Ito, H; Nishimura, Y				Ito, Hiroshi; Nishimura, Yuki			Stability of stochastic nonlinear systems in cascade with not necessarily unbounded decay rates	AUTOMATICA			English	Article						Stochastic systems; Nonlinear systems; Cascaded systems; Integral input-to-state stability; Lyapunov methods	TO-STATE STABILITY; UNIFORM ASYMPTOTIC STABILITY; TIME-VARYING SYSTEMS; SMALL-GAIN THEOREM; FEEDBACK STABILIZATION; STABLE SYSTEMS; INTEGRAL INPUT; ISS SYSTEMS; IISS	This paper develops tools to verify stability and robustness of cascaded nonlinear stochastic systems based on Lyapunov functions. Constituent systems are formulated in terms of integral input-to-state stability (iISS) and input-to-state stability (ISS) which are popular notions for both stochastic and deterministic systems. This paper highlights differences between the stochastic and the deterministic cases. In contrast to deterministic systems, it is demonstrated that assuming ISS systems having unbounded decay rates in dissipation inequalities is restrictive. Taking this fact into account, stability criteria are formulated without assuming unboundedness of decay rates, so that ISS systems with bounded decay rates and iISS systems which are not ISS are covered in a unified manner. Stability criteria for stochastic cascades involve the growth rate conditions at connecting channels. This paper clarifies how noise diffusion fields affect the growth rate conditions and the influence depends on definition of stochastic robustness. (C) 2015 Elsevier Ltd. All rights reserved.	[Ito, Hiroshi] Kyushu Inst Technol, Dept Syst Design & Informat, Iizuka, Fukuoka 8208502, Japan; [Nishimura, Yuki] Kagoshima Univ, Dept Mech Engn, Kagoshima 8900065, Japan	Ito, H (reprint author), Kyushu Inst Technol, Dept Syst Design & Informat, 680-4 Kawazu, Iizuka, Fukuoka 8208502, Japan.	hiroshi@ces.kyutech.ac.jp; yunishi@mech.kagoshima-u.ac.jp			JSPS KAKENHI [26420422]	This work was supported in part by JSPS KAKENHI Grant Number 26420422, The material in this paper was partially presented at the 19th IFAC World Congress, August 24-29, 2014, Cape Town, South Africa. This paper was recommended for publication in revised form by Associate Editor Valery Ugrinovskii under the direction of Editor Ian R. Petersen.	Ito H, 2012, MATH CONTROL SIGNAL, V24, P55, DOI 10.1007/s00498-012-0077-z; [Anonymous], 2013, 52 IEEE C DEC CONTR; Jiang ZP, 1996, AUTOMATICA, V32, P1211, DOI 10.1016/0005-1098(96)00051-9; Sontag ED, 1998, SYST CONTROL LETT, V34, P93, DOI 10.1016/S0167-6911(98)00003-6; Liu SJ, 2008, ACTA MATH APPL SIN-E, V24, P141, DOI 10.1007/s10255-007-7005-x; Panteley E, 2001, AUTOMATICA, V37, P453, DOI 10.1016/S0005-1098(00)00169-2; Yu X, 2010, IEEE T AUTOMAT CONTR, V55, P304, DOI 10.1109/TAC.2009.2034924; Chaillet A, 2008, SYST CONTROL LETT, V57, P519, DOI 10.1016/j.sysconle.2007.12.010; Ito H, 2009, IEEE T AUTOMAT CONTR, V54, P2389, DOI 10.1109/TAC.2009.2028980; Panteley E, 1998, SYST CONTROL LETT, V33, P131, DOI 10.1016/S0167-6911(97)00119-9; Sontag ED, 1996, IEEE T AUTOMAT CONTR, V41, P1283, DOI 10.1109/9.536498; Xie XJ, 2009, AUTOMATICA, V45, P126, DOI 10.1016/j.automatica.2008.10.006; SONTAG E, 1995, IEEE T AUTOMAT CONTR, V40, P1476, DOI 10.1109/9.402246; Yu X, 2010, AUTOMATICA, V46, P1790, DOI 10.1016/j.automatica.2010.06.042; Tang C, 2001, IEEE DECIS CONTR P, P399; Ito H, 2006, IEEE T AUTOMAT CONTR, V51, P1626, DOI 10.1109/TAC.2006.882930; Wu ZJ, 2007, AUTOMATICA, V43, P608, DOI 10.1016/j.automatica.2006.10.020; Angeli D, 2000, IEEE T AUTOMAT CONTR, V45, P1082, DOI 10.1109/9.863594; Wu ZJ, 2013, IEEE DECIS CONTR P, P1223; Arcak M, 2002, SIAM J CONTROL OPTIM, V40, P1888, DOI 10.1137/S0363012901387987; Geroliminis N, 2013, IEEE T INTELL TRANSP, V14, P348, DOI 10.1109/TITS.2012.2216877; Ferreira ASR, 2012, P AMER CONTR CONF, P6382; SONTAG ED, 1995, SYST CONTROL LETT, V24, P351, DOI 10.1016/0167-6911(94)00050-6; Nishimura Y, 2013, IEEE DECIS CONTR P, P7850, DOI 10.1109/CDC.2013.6761136; Ito H, 2010, IEEE T AUTOMAT CONTR, V55, P702, DOI 10.1109/TAC.2009.2037457; ARNOLD L, 1990, Z ANGEW MATH MECH, V70, P235, DOI 10.1002/zamm.19900700704; Daganzo CF, 2007, TRANSPORT RES B-METH, V41, P49, DOI 10.1016/j.trb.2006.03.001; Ito H., 2015, 54 IEEE C B IN PRESS; Ito H., 2014, 19 IFAC WORLD C, P8616; Ito H., 2015, IEEE T AU A IN PRESS; Khasminskii R, 2012, STOCH MOD APPL PROBA, V66, P1, DOI 10.1007/978-3-642-23280-0; Krstic M., 1998, STABILIZATION NONLIN; MAO XR, 1994, SYST CONTROL LETT, V23, P279, DOI 10.1016/0167-6911(94)90050-7; Praly L., 2010, 8 IFAC S NONL CONTR, P1075; Spillotis J, 2003, INT J ROBUST NONLIN, V13, P173, DOI 10.1002/rnc.724; Tsinias J, 1998, INT J CONTROL, V71, P907, DOI 10.1080/002071798221632	36	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0005-1098	1873-2836		AUTOMATICA	Automatica	DEC	2015	62						51	64		10.1016/j.automatica.2015.09.011		14	Automation & Control Systems; Engineering, Electrical & Electronic	Automation & Control Systems; Engineering	CY2JB	WOS:000366233700007		
J	Gotts, J; Atkinson, L; Edwards, IJ; Yanagawa, Y; Deuchars, SA; Deuchars, J				Gotts, Jittima; Atkinson, Lucy; Edwards, Ian J.; Yanagawa, Yuchio; Deuchars, Susan A.; Deuchars, Jim			Co-expression of GAD67 and choline acetyltransferase reveals a novel neuronal phenotype in the mouse medulla oblongata	AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL			English	Article						NTS; Autonomic; Reticular formation; GAD67; ChAT; Brainstem	NUCLEUS-TRACTUS-SOLITARIUS; GAMMA-AMINOBUTYRIC-ACID; RAT BRAIN-STEM; AREA-POSTREMA; CAUDAL NUCLEUS; GABAERGIC NEURONS; MECHANISMS; MOTOR; NEUROTRANSMISSION; COLOCALIZATION	GABAergic and cholinergic systems play an important part in autonomic pathways. To determine the distribution of the enzymes responsible for the production of GABA and acetylcholine in areas involved in autonomic control in the mouse brainstem, we used a transgenic mouse expressing green fluorescent protein (GFP) in glutamate decarboxylase 67 (GAD67) neurones, combined with choline acetyl transferase (ChAT) immunohistochemistty. ChAT-immunoreactive (IR) and GAD67-GFP containing neurones were observed throughout the brainstem. A small number of cells contained both ChAT-IR and GAD67-GFP. Such double labelled cells were observed in the NTS (predominantly in the intermediate and central subnudei), the area postrema, reticular formation and lateral paragigantocellular nucleus. All ChAT-IR neurones in the area postrema contained GAD67-GFP. Double labelled neurones were not observed in the dorsal vagal motor nucleus, nucleus ambiguus or hypoglossal nucleus. Double labelled ChAT-IR/GAD67-GFP cells in the NTS did not contain neuronal nitric oxide synthase (nNOS) immunoreactivity, whereas those in the reticular formation and lateral paragigantocellular nucleus did. The function of these small populations of double labelled cells is currently unknown, however their location suggests a potential role in integrating signals involved in oromotor behaviours. (C) 2015 The Authors. Published by Elsevier B.V.	[Gotts, Jittima; Atkinson, Lucy; Edwards, Ian J.; Deuchars, Susan A.; Deuchars, Jim] Univ Leeds, Fac Biol Sci, Sch Biomed Sci, Leeds LS2 9JT, W Yorkshire, England; [Yanagawa, Yuchio] Gunma Univ, Grad Sch Med, Dept Genet & Behav Neurosci, Maebashi, Gumma 3718511, Japan	Deuchars, J (reprint author), Univ Leeds, Fac Biol Sci, Sch Biomed Sci, Leeds LS2 9JT, W Yorkshire, England.	j.deuchars@leeds.ac.uk			University of Leeds; Wellcome Trust [WT093072MA]	We thank Brenda Frater for technical assistance for some of the experiments. Funding was provided by the University of Leeds (JG) and the Wellcome Trust (Grant WT093072MA to SAD, JD).	Travagli RA, 2006, ANNU REV PHYSIOL, V68, P279, DOI 10.1146/annurev.physiol.68.040504.094635; Mei L, 2003, AM J PHYSIOL-REG I, V285, pR1276, DOI 10.1152/ajpregu.00255.2003; IZZO PN, 1992, BRAIN RES, V591, P69, DOI 10.1016/0006-8993(92)90979-J; Furuya WI, 2014, EXP PHYSIOL, V99, P743, DOI 10.1113/expphysiol.2013.076794; ARMSTRONG DM, 1988, J NEUROSCI RES, V20, P279, DOI 10.1002/jnr.490200302; WANG YT, 1991, AM J PHYSIOL, V261, pR639; Kawai Y, 1999, NEUROSCIENCE, V89, P1347, DOI 10.1016/S0306-4522(98)00393-5; Okada T, 2006, BRAIN RES, V1083, P134, DOI 10.1016/j.brainres.2006.02.026; Wuchert F, 2008, J NEUROIMMUNOL, V204, P66, DOI 10.1016/j.jneuroim.2008.07.017; RUGGIERO DA, 1990, J COMP NEUROL, V292, P1, DOI 10.1002/cne.902920102; KOBAYASHI RM, 1978, BRAIN RES, V154, P13, DOI 10.1016/0006-8993(78)91047-8; HASHIM MA, 1987, BRAIN RES BULL, V18, P355, DOI 10.1016/0361-9230(87)90013-X; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Nelson AB, 2014, J NEUROSCI, V34, P8772, DOI 10.1523/JNEUROSCI.0901-14.2014; Fong AY, 2005, J COMP NEUROL, V493, P274, DOI 10.1002/cne.20758; Hayakawa T, 2001, NEUROSCI RES, V39, P221, DOI 10.1016/S0168-0102(00)00218-2; Madisen L, 2015, NEURON, V85, P942, DOI 10.1016/j.neuron.2015.02.022; DAVIDOFF MS, 1988, HISTOCHEMISTRY, V89, P25, DOI 10.1007/BF00496580; Kolisnyk B, 2013, J NEUROSCI, V33, P10427, DOI 10.1523/JNEUROSCI.0395-13.2013; Jia HG, 2003, BRAIN RES, V992, P205, DOI 10.1016/j.brainres.2003.08.062; Dong HH, 2000, GASTROENTEROLOGY, V118, P328, DOI 10.1016/S0016-5085(00)70215-0; CONTRERAS RJ, 1982, J AUTONOM NERV SYST, V6, P303, DOI 10.1016/0165-1838(82)90003-0; Nguyen LT, 2000, J COMP NEUROL, V420, P527, DOI 10.1002/(SICI)1096-9861(20000515)420:4<527::AID-CNE9>3.0.CO;2-I; ALTSCHULER SM, 1989, J COMP NEUROL, V283, P248, DOI 10.1002/cne.902830207; Bailey TW, 2008, J NEUROPHYSIOL, V99, P1712, DOI 10.1152/jn.00038.2008; VANDERKOOY D, 1983, J COMP NEUROL, V219, P328, DOI 10.1002/cne.902190307; STJOHN WM, 1986, RESP PHYSIOL, V66, P27, DOI 10.1016/0034-5687(86)90136-2; CRISCIONE L, 1983, EUR J PHARMACOL, V88, P47, DOI 10.1016/0014-2999(83)90390-4; TAGO H, 1989, BRAIN RES, V495, P271, DOI 10.1016/0006-8993(89)90221-7; KOSAKA T, 1988, EXP BRAIN RES, V70, P605; Krasteva G, 2012, HISTOCHEM CELL BIOL, V137, P483, DOI 10.1007/s00418-012-0911-x; Travers JB, 2005, J COMP NEUROL, V488, P28, DOI 10.1002/cne.20604; TSUKAMOTO K, 1994, BRAIN RES, V648, P9, DOI 10.1016/0006-8993(94)91898-8; WALBERG F, 1992, ANAT EMBRYOL, V185, P529; HELKE CJ, 1983, BRAIN RES BULL, V10, P433, DOI 10.1016/0361-9230(83)90139-9; Travers JB, 1997, NEUROSCI BIOBEHAV R, V21, P631, DOI 10.1016/S0149-7634(96)00045-0; INOUE T, 1994, J NEUROPHYSIOL, V71, P2061; SHAPIRO RE, 1985, J COMP NEUROL, V234, P344, DOI 10.1002/cne.902340306; Price CJ, 2008, NEUROSCIENTIST, V14, P182, DOI 10.1177/1073858407311100; MAQBOOL A, 1991, EUR J NEUROSCI, V3, P501, DOI 10.1111/j.1460-9568.1991.tb00837.x; SIMON JR, 1985, BRAIN RES, V344, P405, DOI 10.1016/0006-8993(85)90825-X; da Silva LG, 2008, AM J PHYSIOL-REG I, V295, pR1774, DOI 10.1152/ajpregu.00559.2007; WIEDNER EB, 1995, GASTROENTEROLOGY, V108, P367, DOI 10.1016/0016-5085(95)90062-4; Wasserman AM, 2002, AM J PHYSIOL-REG I, V283, pR1423, DOI 10.1152/ajpregu.00488.2001; Okada T, 2008, J CHEM NEUROANAT, V35, P275, DOI 10.1016/j.jchemneu.2008.02.001; Broussard Delma L., 2000, American Journal of Medicine, V108, p79S; LOEWY AD, 1990, CENTRAL REGULATION A; Nagode DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027691; Paxinos G., 1997, RAT BRAIN STEREOTAXI, P25	49	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1566-0702	1872-7484		AUTON NEUROSCI-BASIC	Auton. Neurosci-Basic Clin.	DEC	2015	193						22	30		10.1016/j.autneu.2015.05.003		9	Neurosciences	Neurosciences & Neurology	CY0DZ	WOS:000366077800004		
J	Turner, MJ; Kawada, T; Shimizu, S; Fukumitsu, M; Sugimachi, M				Turner, Michael J.; Kawada, Toru; Shimizu, Shuji; Fukumitsu, Masafumi; Sugimachi, Masaru			Open-loop characteristics of the arterial baroreflex after blockade of unmyelinated baroreceptors with resiniferatoxin	AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL			English	Article						Sympathetic nerve activity; Baroreflex; Open-loop analysis; Resiniferatoxin	RAT AORTIC BARORECEPTORS; CAROTID-SINUS; SENSORY NEURONS; BLOOD-PRESSURE; HEART-FAILURE; REFLEX; ACTIVATION; CHEMORECEPTORS; FIBERS; NERVES	Arterial baroreceptors can be divided into two categories dependent on whether their axons are myelinated (A-fiber) or unmyelinated (C-fiber). We investigated the effect of periaxonal resiniferatoxin (RTX), a blocker of C-fiber baroreceptor activity, on the open-loop static characteristics of the arterial baroreflex. The baroreceptor region of the right aortic depressor nerve was isolated, and intra-baroreceptor region pressure (BRP) was changed from 60 to 180 mm Hg in 10 anesthetized Sprague-Dawley rats. Open-loop static characteristics of the neural arc from BRP to efferent sympathetic nerve activity (SNA), peripheral arc from SNA to arterial pressure (AP), and total reflex arc from BRP to AP were estimated. Although blocking C-fiber activity with RTX resulted in a lower response range (33.7 +/- 4.6% and 49.4 +/- 4.8%, P < 0.01) and higher minimum SNA (78.0 +/- 4.7% and 53.6 +/- 5.0%, P < 0.001) of the steady-state neural arc, the peak SNA response to BRP was greater at a BRP of 160 mm Hg (37.87 +/- 5.83% and 26.28 +/- 4.90%, P = 0.01). RTX also resulted in a lower response range (27.8 +/- 5.0 mm Hg and 40.9 +/- 5.2 mm Hg, P < 0.01) and higher minimum AP (92.4 +/- 4.7 mm Hg and 79.1 +/- 4.9 mm Hg, P < 0.001) of the total reflex arc Despite these changes, the maximum slope of the neural arc and the maximum gain of the total reflex arc did not differ significantly after RTX. These data suggest that A-fiber baroreceptors can regulate AP and maintain the maximum gain when systemic AP is around the normal operating range. In contrast, C-fiber baroreceptors are critically important for reductions in SNA and AP when systemic AP is raised above the normal operating range. (C) 2015 Elsevier B.V. All rights reserved.	[Turner, Michael J.; Kawada, Toru; Shimizu, Shuji; Fukumitsu, Masafumi; Sugimachi, Masaru] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Dynam, Suita, Osaka 5658565, Japan; [Fukumitsu, Masafumi; Sugimachi, Masaru] Osaka Univ, Grad Sch Med, Fac Med, Dept Artificial Organ Med, Suita, Osaka 5650871, Japan	Turner, MJ (reprint author), Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Dynam, 5-7-1 Fujishirodai, Suita, Osaka 5658565, Japan.	michaeljturner@icloud.com			JSPS KAKENHI Grant [26750153]; Intramural Research Fund of the National Cerebral and Cardiovascular Center [26-6-21, 26-6-24]; Japan Science and Technology Agency	This study was supported partly by Support Program to break the bottlenecks at R&D System for accelerating the practical use of Health Research Outcome from Japan Science and Technology Agency, by the Grant-in-Aid for Scientific Research (JSPS KAKENHI Grant Number 26750153), and by Intramural Research Fund (26-6-21, 26-6-24) of the National Cerebral and Cardiovascular Center.	Thoren P, 1999, ACTA PHYSIOL SCAND, V166, P167; Sato T, 1999, AM J PHYSIOL-HEART C, V276, pH326; Yamamoto H, 2008, AUTON NEUROSCI-BASIC, V144, P43, DOI [10.1016/j.autneu.2008.09.002, 10.1016/autneu.2008.09.002]; Brophy S, 1999, J PHYSIOL-LONDON, V514, P821, DOI 10.1111/j.1469-7793.1999.821ad.x; Turner MJ, 2014, LIFE SCI, V106, P40, DOI 10.1016/j.lfs.2014.04.016; Doan TN, 2004, J NEUROSCI, V24, P3335, DOI 10.1523/JNEUROSCI.5156-03.2004; Sato T, 1999, AM J PHYSIOL-HEART C, V276, pH2251; Zahner MR, 2003, J PHYSIOL-LONDON, V551, P515, DOI 10.1113/jphysiol.2003.048207; Ciura S, 2006, J NEUROSCI, V26, P9069, DOI 10.1523/JNEUROSCI.0877-06.2006; Fan W, 1999, AM J PHYSIOL-REG I, V277, pR748; Sun H, 2009, J PHARMACOL EXP THER, V331, P851, DOI 10.1124/jpet.109.160473; Caterina MJ, 1999, CURR OPIN NEUROBIOL, V9, P525, DOI 10.1016/S0959-4388(99)00009-4; Kawada T, 2010, J PHYSIOL SCI, V60, P283, DOI 10.1007/s12576-010-0096-9; SEAGARD JL, 1993, CIRC RES, V72, P1011; KENT BB, 1972, CARDIOLOGY, V57, P295, DOI 10.1159/000169528; Brenneis C, 2013, J NEUROSCI, V33, P315, DOI 10.1523/JNEUROSCI.2804-12.2013; Ma QP, 2002, NEUROSCI LETT, V319, P87, DOI 10.1016/S0304-3940(01)02537-X; CHAPLEAU MW, 1989, AM J PHYSIOL, V256, pH1735; Cheng Z, 1997, J AUTONOM NERV SYST, V67, P1, DOI 10.1016/S0165-1838(97)00085-4; Fan W, 1998, AM J PHYSIOL-HEART C, V275, pH632; Glantz S.A., 2002, PRIMER BIOSTATISTICS; KARDON MB, 1975, CIRC RES, V37, P41; Kawada T, 2014, J APPL PHYSIOL, V116, P1308, DOI 10.1152/japplphysiol.00140.2014; Mohrman DE, 2010, CARDIOVASCULAR PHYSL, P246; Reynolds Patrick J, 2006, J Negat Results Biomed, V5, P6, DOI 10.1186/1477-5751-5-6	25	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1566-0702	1872-7484		AUTON NEUROSCI-BASIC	Auton. Neurosci-Basic Clin.	DEC	2015	193						38	43		10.1016/j.autneu.2015.05.008		6	Neurosciences	Neurosciences & Neurology	CY0DZ	WOS:000366077800006		
J	Uchida, S; Kagitani, F; Hotta, H				Uchida, Sae; Kagitani, Fusako; Hotta, Harumi			Afferent fibers involved in the bradykinin-induced cardiovascular reflexes from the ovary in rats	AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL			English	Article						Ovarian afferent fibers; Heart rate; Blood pressure; Reflex; Rat	CARDIAC RECEPTOR STIMULATION; FEMALE RAT; COLORECTAL DISTENSION; ANESTHETIZED RATS; BLOOD-PRESSURE; RENAL NERVE; HEART-RATE; EXTRINSIC INNERVATION; SENSORY INNERVATION; REPRODUCTIVE-ORGANS	Bleeding or rupture of the ovary often accompanies ovarian cysts and causes severe pain and autonomic responses such as hypotension. It would be expected that ovarian afferents contribute to cardiovascular responses induced by ovarian failure. The present study examined cardiovascular responses to noxious chemical stimulation of the ovary by bradykinin, an algesic substance released by tissue damage, and explored the role of ovarian afferents in the ovarian-cardiovascular responses in anesthetized rats. Non-pregnant adult rats were anesthetized with pentobarbital and artificially ventilated. The carotid artery was cannulated to monitor blood pressure and heart rate. Noxious chemical stimulation was achieved by applying a small piece of cotton soaked with bradykinin to the surface of the ovary for 30s. Application of bradykinin (10(-4) M) to the ovary decreased heart rate and blood pressure. These cardiovascular responses were not significantly influenced by severance of the vagal nerves or the superior ovarian nerve, but were abolished by severance of the ovarian nerve plexus (ONP). Application of bradykinin (10(-4) M) to the ovary evoked afferent activity of the ONP both in vivo and in vitro preparations. These results indicate that the decreases in heart rate and blood pressure following chemical noxious stimulation of the ovary with bradykinin are reflex responses, whose afferent nerve pathway is mainly through afferent fibers in the ONP. (C) 2015 Elsevier B.V. All rights reserved.	[Uchida, Sae; Kagitani, Fusako; Hotta, Harumi] Tokyo Metropolitan Inst Gerontol, Dept Auton Neurosci, Itabashi Ku, Tokyo 1730015, Japan	Uchida, S (reprint author), Tokyo Metropolitan Inst Gerontol, Dept Auton Neurosci, Itabashi Ku, 35-2 Sakaecho, Tokyo 1730015, Japan.	suchida@tmig.or.jp			Akaeda Medical Research Foundation;  [24590308]	The authors are grateful to Ms. Izumi Wantanabe for her partial participation in the experiments. This work was supported by a Grant-in Aid for Scientific Research to S.U (No. 24590308) and a grant from Akaeda Medical Research Foundation to S.U.	GORMAN AJ, 1983, AM J PHYSIOL, V244, pF659; Hisata Y, 2006, AUTON NEUROSCI-BASIC, V126, P174, DOI 10.1016/j.autneu.2006.02.008; Mizumura K, 2009, EXP BRAIN RES, V196, P53, DOI 10.1007/s00221-009-1814-5; BURDEN HW, 1983, ANAT REC, V207, P623, DOI 10.1002/ar.1092070410; LONGHURST JC, 1984, AM J PHYSIOL, V247, pR552; NESS TJ, 1988, BRAIN RES, V450, P153, DOI 10.1016/0006-8993(88)91555-7; KUMAZAWA T, 1980, J PHYSIOL-LONDON, V299, P219; Cavun S, 2004, BRAIN RES, V1019, P237, DOI 10.1016/j.brainres.2004.06.003; BALJET B, 1979, ACTA ANAT, V104, P243; SATO A, 1982, PFLUG ARCH EUR J PHY, V393, P31, DOI 10.1007/BF00582387; Li WM, 2006, J PHYSIOL SCI, V56, P153, DOI 10.2170/physiolsci.RP001106; LAWRENCE IE, 1980, ANAT REC, V196, P51, DOI 10.1002/ar.1091960106; Li WM, 2006, J PHYSIOL SCI, V56, P187, DOI 10.2170/physiolsci.SC003506; CERVERO F, 1994, PHYSIOL REV, V74, P95; Babic T, 2014, EUR J PHARMACOL, V722, P38, DOI 10.1016/j.ejphar.2013.08.047; Gerendai I, 1998, NEUROENDOCRINOLOGY, V68, P244, DOI 10.1159/000054372; BERKLEY KJ, 1988, J NEUROPHYSIOL, V59, P142; ROBBINS A, 1990, NEUROSCI LETT, V110, P82, DOI 10.1016/0304-3940(90)90791-7; PROCACCI P, 1986, PROG BRAIN RES, V67, P21; ROBBINS A, 1992, BRAIN RES, V596, P353; BALJET B, 1980, ACTA ANAT, V107, P241; BERKLEY KJ, 1990, J NEUROPHYSIOL, V63, P256; Premilovac D, 2013, CARDIOVASC RES, V98, P28, DOI 10.1093/cvr/cvt015; Veelken R, 1996, HYPERTENSION, V28, P615; Gerendai I, 2000, J AUTONOM NERV SYST, V80, P40, DOI 10.1016/S0165-1838(00)00071-0; Kruszka PS, 2010, AM FAM PHYSICIAN, V82, P141; Hanada T, 2011, AUTON NEUROSCI-BASIC, V164, P6, DOI 10.1016/j.autneu.2011.05.001; ROBBINS A, 1991, J AUTONOM NERV SYST, V33, P55, DOI 10.1016/0165-1838(91)90018-X; Klein AH, 2014, NEUROSCIENCE, V271, P45, DOI 10.1016/j.neuroscience.2014.04.019; KLEIN CM, 1988, NEUROSCI LETT, V85, P217, DOI 10.1016/0304-3940(88)90354-0; BAKER DG, 1980, J PHYSIOL-LONDON, V306, P519; Uchida S, 2008, AUTON NEUROSCI-BASIC, V143, P12, DOI 10.1016/j.autneu.2008.06.005; Kagitani F, 2008, J PHYSIOL SCI, V58, P133, DOI 10.2170/physiolsci.RP001508; NIITANI S, 1988, AM J PHYSIOL, V254, pR192; Janig W, 2006, INTEGRATIVE ACTION OF THE AUTONOMIC NERVOUS SYSTEM: NEUROBIOLOGY OF HOMEOSTASIS, P35, DOI 10.1017/CBO9780511541667.005; BERKLEY KJ, 1993, J NEUROPHYSIOL, V69, P533; UCHIDA Y, 1974, JPN HEART J, V15, P84; KAUFMAN MP, 1980, CIRC RES, V46, P476; GORMAN AJ, 1984, BASIC RES CARDIOL, V79, P142, DOI 10.1007/BF01908301; Berkley K.J., 1987, FINE AFFERENT NERVE, P128; Beyak M. J., 2005, ADV VAGAL AFFERENT N, P315; Bielefeldt K, 2013, WALL MELZACKS TXB PA, V6, P703; Burden H.W., 1985, CATECHOLAMINES HORMO, V18, P261; Gabella Giorgio, 1995, P81; Hammond R., 2008, SURGERY, V26, P467, DOI 10.1016/j.mpsur.2008.09.015; Longhurst J C, 1983, Adv Exp Med Biol, V156, P639; Papka R.E., 1993, NERVOUS CONTROL UROG, P423; Samraj George P. N., 2004, Comprehensive Therapy, V30, P173, DOI 10.1007/s12019-004-0015-1; Uchida S, 2015, AUTON NEUROSCI-BASIC, V187, P27, DOI 10.1016/j.autneu.2014.10.023	49	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1566-0702	1872-7484		AUTON NEUROSCI-BASIC	Auton. Neurosci-Basic Clin.	DEC	2015	193						57	62		10.1016/j.autneu.2015.07.006		6	Neurosciences	Neurosciences & Neurology	CY0DZ	WOS:000366077800009		
J	Sato, D; Kusunoki, M; Shinzawa, G; Feng, ZG; Nishina, A; Nakamura, T				Sato, Daisuke; Kusunoki, Masataka; Shinzawa, Go; Feng, Zhonggang; Nishina, Atsuyoshi; Nakamura, Takao			Effects of aldose reductase inhibitor on microneurographically assessed peripheral sympathetic nerve activity in rats	AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL			English	Article						Aldose reductase inhibitor; Diabetic neuropathy; Peripheral sympathetic nerve activity; Action potential	INDUCED DIABETIC-RATS; IMPAIRED GLUCOSE-TOLERANCE; AUTONOMIC NEUROPATHY; NEUROAXONAL DYSTROPHY; ANESTHETIZED RATS; SORBITOL; EPALRESTAT; INSULIN; INNERVATION; MYOINOSITOL	Autonomic neuropathy, one of the serious complications of diabetes, decreases quality of life. Aldose reductase inhibitor (ARI) blocks sorbitol production, and results in prevention of damage of nerve fibers. Beneficial effects of ARI have usually been confirmed through nerve conduction velocity tests in motor and sensory nerves. On the other hand, few reports have dealt with the effects of ARI on the small fiber activity such as sympathetic nerve one. In the present study, we administered eparlestat, ARI orally for 3 weeks, to streptozotocin-induced diabetic (STZ + ARI) rats, and then recorded peripheral sympathetic nervous signal detected with microneurographic technique. Action potentials (APs) and bursts of APs were detected from the recorded signal, and their rates and incidences ( = rates/heart rate) were compared with those in non-diabetic control (normal) and ARI-untreated streptozotocin-induced diabetic (STZ) rats. While streptozotocin and/or epalrestat did not influence burst parameters in all the three groups, AP parameters in the STZ + ART and normal groups were higher than those in the STZ group. However, response of AP parameters to the intravenous glucose administration (IVGA) was not large in the STZ + ART group, similar to that of the STZ group and different from that of the normal group in which AP parameters increased after IVGA. The results suggest that epalrestat may prevent sympathetic nerve activity (SNA) from reduction under hyperglycemic and insulin-depleted conditions, that enhancement of SNA was not induced after IVGA under that condition, and that AP parameters might be useful to assess the degree of neuropathy. (C) 2015 Elsevier B.V. All rights reserved.	[Sato, Daisuke; Shinzawa, Go; Nakamura, Takao] Yamagata Univ, Grad Sch Med Sci, Dept Biomed Informat Engn, Yamagata 9909585, Japan; [Kusunoki, Masataka] Nagoya Univ, Res Ctr Hlth, Phys Fitness & Sports, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Feng, Zhonggang] Yamagata Univ, Grad Sch Sci & Engn, Dept Biosyst Engn, Yonezawa, Yamagata 9928510, Japan; [Nishina, Atsuyoshi] Nihon Univ, Dept Mat & Appl Chem, Coll Sci & Technol, Chiyoda Ku, Tokyo 1018308, Japan	Sato, D (reprint author), 2-2-2 Iida Nishi, Yamagata 9909585, Japan.	d_sato@yz.yamagata-u.ac.jp; info@tonyo.jp; zhgfeng@yz.yamagata-u.ac.jp; nishina.atsuyoshi@nihon-u.ac.jp; task-n@yz.yamagata-u.ac.jp					Sato D, 2013, J ARTIF ORGANS, V16, P352, DOI 10.1007/s10047-013-0700-x; Fagius J, 2000, CLIN SCI, V98, P627, DOI 10.1042/CS19990330; Schemmel KE, 2010, J DIABETES COMPLICAT, V24, P354, DOI 10.1016/j.jdiacomp.2009.07.005; Fazan VPS, 2009, J PERIPHER NERV SYST, V14, P137, DOI 10.1111/j.1529-8027.2009.00223.x; Smith AG, 2001, NEUROLOGY, V57, P1701; HOFFMAN RP, 1993, DIABETES, V42, P375, DOI 10.2337/diabetes.42.3.375; Sumner CJ, 2003, NEUROLOGY, V60, P108; Nakamura T, 2003, J NEUROSCI METH, V131, P35, DOI 10.1016/S0165-0270(03)00234-6; Schmidt RE, 2005, EXP NEUROL, V192, P407, DOI 10.1016/j.expneurol.2004.12.018; FINK DJ, 1994, J NEUROCHEM, V63, P1782; Johansen NJ, 2013, AM J PHYSIOL-HEART C, V304, pH215, DOI 10.1152/ajpheart.00661.2012; Hotta N, 2008, DIABETIC MED, V25, P818, DOI 10.1111/j.1464-5491.2008.02490.x; Diedrich A, 2003, IEEE T BIO-MED ENG, V50, P41, DOI 10.1109/TBME.2002.807323; Kurata C, 1997, J NUCL MED, V38, P1677; Malik RA, 2005, DIABETOLOGIA, V48, P578, DOI 10.1007/s00125-004-1663-5; SCHMIDT RE, 1991, DIABETES, V40, P574, DOI 10.2337/diabetes.40.5.574; Price SA, 2006, J NEUROPATH EXP NEUR, V65, P722, DOI 10.1097/01.jnen.0000228199.89420.90; Schmidt RE, 1998, J NEUROPATH EXP NEUR, V57, P1175, DOI 10.1097/00005072-199812000-00010; Hotta N, 2006, DIABETES CARE, V29, P1538, DOI 10.2337/dc.05-2370; Schmidt RE, 2001, J NEUROPATH EXP NEUR, V60, P1153; Ohi T, 1998, EXP NEUROL, V151, P215, DOI 10.1006/exnr.1998.6821; YOSHIDA T, 1987, DIABETES, V36, P6, DOI 10.2337/diabetes.36.1.6; Nakayama M, 2001, DIABETES CARE, V24, P1093, DOI 10.2337/diacare.24.6.1093; SCHMIDT RE, 1989, DIABETES, V38, P569, DOI 10.2337/diabetes.38.5.569; ANDERSON EA, 1991, J CLIN INVEST, V87, P2246, DOI 10.1172/JCI115260; TERASHIMA H, 1984, J PHARMACOL EXP THER, V229, P226; Ikeda T, 1999, DIABETES RES CLIN PR, V43, P193, DOI 10.1016/S0168-8227(99)00015-7; Hoffman RP, 1998, J DIABETES COMPLICAT, V12, P307, DOI 10.1016/S1056-8727(98)00010-5; Shinzawa G, 2013, AUTON NEUROSCI-BASIC, V179, P23, DOI 10.1016/j.autneu.2013.06.005; Hu X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087096; Kiyono Yasushi, 2005, Eur J Nucl Med Mol Imaging, V32, P993, DOI 10.1007/s00259-005-1865-1; SUDO M, 1991, AM J PHYSIOL, V261, pE298; Sytze Van Dam P, 2013, EUR J PHARMACOL, V719, P180, DOI [10.1016/j.ejphar.2013.07.017, DOI 10.1016/J.EJPHAR.2013.07.017]; Yagihashi S., 2011, J DIABETES INVEST, V24, P18	34	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1566-0702	1872-7484		AUTON NEUROSCI-BASIC	Auton. Neurosci-Basic Clin.	DEC	2015	193						69	73		10.1016/j.autneu.2015.08.005		5	Neurosciences	Neurosciences & Neurology	CY0DZ	WOS:000366077800011		
J	Endo, K; Kurokawa, N; Kito, H; Nakakura, S; Fujii, M; Ohya, S				Endo, Kyoko; Kurokawa, Natsumi; Kito, Hiroaki; Nakakura, Sawa; Fujii, Masanori; Ohya, Susumu			Molecular identification of the dominant-negative, splicing isoform of the two-pore domain K+ channel K(2P)5.1 in lymphoid cells and enhancement of its expression by splicing inhibition	BIOCHEMICAL PHARMACOLOGY			English	Article						Potassium channel; Alternative splicing; Membrane trafficking; Lymphocyte	CD4(+) T-LYMPHOCYTES; POTASSIUM CHANNELS; UP-REGULATION; VOLUME REGULATION; CANCER-CELLS; TUMOR-CELLS; RNA; DISEASE; MODULATION; TASK-2	The two-pore domain background K+ channel K(2P)5.1 is expected as a possible therapeutic target for autoimmune and inflammatory disorders and cancers because it plays an important role in maintaining the resting membrane potential and regulation of Ca2+ signaling in T lymphocytes and cancer cells. However, the lack of selective K(2P)5.1 blockers has led to difficulties conducting experimental studies on this K+ channel. We identified a novel splicing isoform of K(2P)5.1, K(2P)5.1B from the mammalian spleen, which lacked the N-terminus of full-length K(2P)5.1A. A co-immunoprecipitation assay using mice spleen lysates revealed an interaction between K(2P)5.1A and K(2P)5.1B in the cytoplasmic C-terminal domain. In a heterologous HEK293 expression system, K(2P)5.1B inhibited the trafficking of K(2P)5.1A to the plasma membrane. The alkaline pHe-induced hyperpolarizing response was significantly suppressed in K(2P)5.1B-transfected human leukemia K562 cells. Enhancement in cell proliferation by the overexpression of K (2P)5.1A in K562 was significantly prevented by the transfection of K(2P)5.1B. The spliceosome inhibitor pladienolide B significantly enhanced the relative expression of K(2P)5.1B in K562, resulting in decreases in the activity of K(2P)5.1A. K(2P)5.1B suppresses the function of the K(2P)5.1 K+ channel in a dominant-negative manner, suggesting that the mRNA splicing mechanisms underlying the transcriptional regulation of K (2P)5.1B may be a new therapeutic strategy for autoimmune and inflammatory disorders and cancers. (C) 2015 Elsevier Inc. All rights reserved.	[Endo, Kyoko; Kurokawa, Natsumi; Kito, Hiroaki; Nakakura, Sawa; Fujii, Masanori; Ohya, Susumu] Kyoto Pharmaceut Univ, Dept Pharmacol, Div Pathol Sci, Kyoto 6078414, Japan	Ohya, S (reprint author), Kyoto Pharmaceut Univ, Dept Pharmacol, Div Pathol Sci, Yamashina Ku, 5 Misasagi Nakauchi, Kyoto 6078414, Japan.	ky10057@poppy.kyoto-phu.ac.jp; ky10131@poppy.kyoto-phu.ac.jp; kito@mb.kyoto-phu.ac.jp; ky09246@poppy.kyoto-phu.ac.jp; fujii@mb.kyoto-phu.ac.jp; sohya@mb.kyoto-phu.ac.jp			Japan Society for the Promotion of Science (JSPS) [25460111]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) [S1311035]; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Salt Science Research Foundation; Uehara Memorial Foundation	This work was supported by a Grant-in Aid for Scientific Research (C) (No. 25460111) from the Japan Society for the Promotion of Science (JSPS), a grant for Supported Program for the Strategic Research Foundation at Private Universities, 2013-2017 (No. S1311035) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), the Mochida Memorial Foundation for Medical and Pharmaceutical Research, the Salt Science Research Foundation, and the Uehara Memorial Foundation (to S.O.). The nucleotide sequence data reported in this manuscript has been deposited in the DDBJ, EMBL, and GenBank nucleotide sequence databases with the following accession numbers, AB743589 (human K<INF>2P</INF>5.1B) and AB743801 (mouse K<INF>2P</INF>5.1B). We thank to Ayaka Shimizu, Kazutaka Tagishi and Satomi Niwa for their technical assistance. Medical English Service (Kyoto, Japan) reviewed the manuscript prior to its submission.	Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; Kotake Y, 2007, NAT CHEM BIOL, V3, P570, DOI 10.1038/nchembio.2007.16; Clark RB, 2011, J PHYSIOL-LONDON, V589, P5071, DOI 10.1113/jphysiol.2011.210757; Lipscombe D, 2013, TRENDS NEUROSCI, V36, P598, DOI 10.1016/j.tins.2013.06.008; Niemeyer MI, 2001, J BIOL CHEM, V276, P43166, DOI 10.1074/jbc.M107192200; Reyes R, 1998, J BIOL CHEM, V273, P30863, DOI 10.1074/jbc.273.47.30863; Wulff H, 2008, CHEM REV, V108, P1744, DOI 10.1021/cr078234p; Kelemen O, 2013, GENE, V514, P1, DOI 10.1016/j.gene.2012.07.083; Andronic J, 2013, BBA-BIOMEMBRANES, V1828, P699, DOI 10.1016/j.bbamem.2012.09.028; Girard C, 2001, BIOCHEM BIOPH RES CO, V282, P249, DOI 10.1006/bbrc.2001.4562; Bonnal S, 2012, NAT REV DRUG DISCOV, V11, P847, DOI 10.1038/nrd3823; Alvarez-Baron CP, 2011, MOL ENDOCRINOL, V25, P1326, DOI 10.1210/me.2011-0045; Bittner S, 2010, ANN NEUROL, V68, P58, DOI 10.1002/ana.22010; Kirkegaard SS, 2013, CELL PHYSIOL BIOCHEM, V32, P1238, DOI 10.1159/000354522; Pal S, 2012, PHARMACOL THERAPEUT, V136, P283, DOI 10.1016/j.pharmthera.2012.08.005; Barrie ES, 2012, MOL PHARMACOL, V81, P620, DOI 10.1124/mol.111.076604; BOSTOCK CJ, 1971, EXP CELL RES, V68, P163, DOI 10.1016/0014-4827(71)90599-4; Singh RK, 2012, TRENDS MOL MED, V18, P472, DOI 10.1016/j.molmed.2012.06.006; Veale EL, 2010, J BIOL CHEM, V285, P29295, DOI 10.1074/jbc.M110.108423; Ohya S, 2011, J BIOL CHEM, V286, P16940, DOI 10.1074/jbc.M110.184192; Effenberger KA, 2014, J BIOL CHEM, V289, P1938, DOI 10.1074/jbc.M113.515536; Mirkovic K, 2011, NEUROSCIENCE, V194, P11, DOI 10.1016/j.neuroscience.2011.07.064; Bittner S, 2010, BRAIN PATHOL, V20, P999, DOI 10.1111/j.1750-3639.2010.00407.x; Rinne S, 2014, PFLUG ARCH EUR J PHY, V466, P1559, DOI 10.1007/s00424-013-1384-z; Lynch KW, 2004, NAT REV IMMUNOL, V4, P931, DOI 10.1038/nri1497; Bobak N, 2011, BBA-BIOMEMBRANES, V1808, P2036, DOI 10.1016/j.bbamem.2011.04.013; Visconte V, 2012, LEUKEMIA, V26, P2447, DOI 10.1038/leu.2012.130; Schwerk C, 2005, MOL CELL, V19, P1, DOI 10.1016/j.molcel.2005.05.026; Licatalosi DD, 2006, NEURON, V52, P93, DOI 10.1016/j.neuron.2006.09.017; Spitali P, 2012, CELL, V148, P1085, DOI 10.1016/j.cell.2012.02.014; Lara-Pezzi E, 2013, J CARDIOVASC TRANSL, V6, P945, DOI 10.1007/s12265-013-9482-z; Bittner S, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3245; Bonner TI, 2014, BRIT J PHARMACOL, V171, P1231, DOI 10.1111/bph.12526; Cid LP, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00198; Dinardo MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040235; Es-Salah-Lamoureux Z, 2010, TRENDS PHARMACOL SCI, V31, P587, DOI 10.1016/j.tips.2010.09.001; He L, 2015, CURR STEM CELL RES T, V10, P159; Kisselbach J, 2014, BRIT J PHARMACOL, V171, P5182, DOI 10.1111/bph.12596; Lorca RA, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00289; Matsuba S, 2014, J PHARMACOL EXP THER, V351, P510, DOI 10.1124/jpet.114.217315; Morimoto T, 2007, J PHARMACOL SCI, V104, P94, DOI 10.1254/jphs.SC0070032; Nam JH, 2011, AM J PHYSIOL-CELL PH, V300, pC1013, DOI 10.1152/ajpcell.00475.2010; Ohya S, 2014, AM J PHYSIOL-GASTR L, V306, pG873, DOI 10.1152/ajpgi.00156.2013; Ohya S, 2013, BRIT J PHARMACOL, V169, P1011, DOI 10.1111/bph.12215; Ouadid-Ahidouch H, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00220; Pawellek A, 2014, J BIOL CHEM, V289, P34683, DOI 10.1074/jbc.M114.590976; Schwartz S, 2009, NAT STRUCT MOL BIOL, V16, P990, DOI 10.1038/nsmb.1659; Tang JY, 2013, SCI WORLD J, DOI 10.1155/2013/703568; Williams S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074589; Wu YY, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.099499; Zhou YM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3399	51	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0006-2952	1873-2968		BIOCHEM PHARMACOL	Biochem. Pharmacol.	DEC 1	2015	98	3					440	452		10.1016/j.bcp.2015.10.002		13	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CY1ET	WOS:000366150200009		
J	Kosugi, S; Hirakawa, H; Tabata, S				Kosugi, Shunichi; Hirakawa, Hideki; Tabata, Satoshi			GMcloser: closing gaps in assemblies accurately with a likelihood-based selection of contig or long-read alignments	BIOINFORMATICS			English	Article							DE-NOVO ASSEMBLER; GENOME ASSEMBLIES; DRAFT ASSEMBLIES; SEQUENCING DATA; GENERATION; CONSENSUS; SIMULATOR; TOOL; DNA	Motivation: Genome assemblies generated with next-generation sequencing (NGS) reads usually contain a number of gaps. Several tools have recently been developed to close the gaps in these assemblies with NGS reads. Although these gap-closing tools efficiently close the gaps, they entail a high rate of misassembly at gap-closing sites. Results: We have found that the assembly error rates caused by these tools are 20-500-fold higher than the rate of errors introduced into contigs by de novo assemblers. We here describe GMcloser, a tool that accurately closes these gaps with a preassembled contig set or a long read set (i.e. error-corrected PacBio reads). GMcloser uses likelihood-based classifiers calculated from the alignment statistics between scaffolds, contigs and paired-end reads to correctly assign contigs or long reads to gap regions of scaffolds, thereby achieving accurate and efficient gap closure. We demonstrate with sequencing data from various organisms that the gap-closing accuracy of GMcloser is 3-100-fold higher than those of other available tools, with similar efficiency.	[Kosugi, Shunichi; Hirakawa, Hideki; Tabata, Satoshi] Kazusa DNA Res Inst, Dev Technol Dept, Kisarazu, Chiba 2920818, Japan	Kosugi, S (reprint author), RIKEN, Ctr Integrated Med Sci, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan.	shunichi.kosugi@riken.jp			KAKENHI from the Ministry of Education, Culture, Sports, Science and Technology of Japan [221S0002]; JSPS KAKENHI Grant [26430200]	This work was supported by KAKENHI from the Ministry of Education, Culture, Sports, Science and Technology of Japan [Grant-in-Aid for Scientific Research on Innovative Areas No. 221S0002] and by JSPS KAKENHI Grant Number 26430200.	Huang XQ, 2006, NUCLEIC ACIDS RES, V34, P201, DOI 10.1093/nar/gkj419; Hackl T, 2014, BIOINFORMATICS, V30, P3004, DOI 10.1093/bioinformatics/btu392; Howison M, 2013, BIOINFORMATICS, V29, P2959, DOI 10.1093/bioinformatics/btt525; Treangen TJ, 2012, NAT REV GENET, V13, P36, DOI 10.1038/nrg3117; Salzberg SL, 2012, GENOME RES, V22, P557, DOI 10.1101/gr.131383.111; Hu XS, 2012, BIOINFORMATICS, V28, P1533, DOI 10.1093/bioinformatics/bts187; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Noe L, 2005, NUCLEIC ACIDS RES, V33, pW540, DOI 10.1093/nar/gki478; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Yao GH, 2012, BIOINFORMATICS, V28, P13, DOI 10.1093/bioinformatics/btr588; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Li H, 2012, BIOINFORMATICS, V28, P1838, DOI 10.1093/bioinformatics/bts280; Assefa S, 2009, BIOINFORMATICS, V25, P1968, DOI 10.1093/bioinformatics/btp347; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/nmeth.2474, 10.1038/NMETH.2474]; Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174; Ono Y, 2013, BIOINFORMATICS, V29, P119, DOI 10.1093/bioinformatics/bts649; Gao S, 2011, J COMPUT BIOL, V18, P1681, DOI 10.1089/cmb.2011.0170; Li Ruiqiang, 2010, Genome Res, V20, P265, DOI 10.1101/gr.097261.109; Denisov G, 2008, BIOINFORMATICS, V24, P1035, DOI 10.1093/bioinformatics/btn074; Gordon D, 2001, GENOME RES, V11, P614, DOI 10.1101/gr.171401; Nijkamp J, 2010, BIOINFORMATICS, V26, pi433, DOI 10.1093/bioinformatics/btq366; Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086; Au KF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046679; Boetzer M, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r56; English AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047768; Gao S., 2012, LECT NOTES COMPUT SC, V7534, P314; Koren S, 2012, NAT BIOTECHNOL, V30, P692, DOI 10.1038/nbt.2280; Kosugi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075402; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lin SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060843; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Lysholm Fredrik, 2011, BMC Res Notes, V4, P449, DOI 10.1186/1756-0500-4-449; Piro Vitor C, 2014, BMC Res Notes, V7, P371, DOI 10.1186/1756-0500-7-371; Ross MG, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r51; Sommer DD, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-64; Soto-Jimenez L.M., 2013, CURR TOP MED CHEM, V14, P418; Soueidan H, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S15-S16; Tsai IJ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-4-r41; Vicedomini R, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S7-S6	41	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1367-4803	1460-2059		BIOINFORMATICS	Bioinformatics	DEC 1	2015	31	23					3733	3741		10.1093/bioinformatics/btv465		9	Biochemical Research Methods; Biotechnology & Applied Microbiology; Computer Science, Interdisciplinary Applications; Mathematical & Computational Biology; Statistics & Probability	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Computer Science; Mathematical & Computational Biology; Mathematics	CY4LA	WOS:000366378400003		
J	Yamada, T; Umeyama, S; Ohashi, M				Yamada, Toru; Umeyama, Shinji; Ohashi, Mitsuo			Removal of motion artifacts originating from optode fluctuations during functional near-infrared spectroscopy measurements	BIOMEDICAL OPTICS EXPRESS			English	Article							DIFFUSE OPTICAL TOMOGRAPHY; MOVEMENT ARTIFACTS; FNIRS; ALGORITHM	Functional near-infrared spectroscopy (fNIRS) has been increasingly utilized for detecting human cerebral activity in many disciplines because of the potential for less-restraining conditions. However, users often suffer from motion artifacts originating from optode fluctuation during task execution when the task includes motion. In such cases, the optode fluctuation induces changes both in the reflection by hair and in the transmission between the optode and scalp. If part of the reflected light is directly received by the detector optode (short-circuited light), it will contaminate the fNIRS signal. The transmittance change at the optode-scalp gap will also contaminate the signal. In this study, we proposed an optical model on the influence of optode fluctuation on the fNIRS signal and a method for removing the influence. The model revealed the following: (1) the received short-circuited light and the gap transmittance change generated a baseline change in the detected light intensity, and (2) the signal from the tissues was downscaled with increases in the receiving intensity of short-circuited light. To avoid erroneous detection of short-circuited light, we developed a method that optically eliminated hair-reflected light from the detection using linearly polarized light sources and an orthogonally polarized analyzer. The method was validated with an optical phantom possessing a haired surface. The optical absorbance change of a close source-detector (S-D) pair equipped with polarizers was very similar to that of distant S-D pairs, even though these optodes were artificially fluctuated. By combining the multidistance optode arrangement technique with the short-circuited light elimination method, the measurement could effectively eliminate motion artifacts originating from optode fluctuation. (C) 2015 Optical Society of America	[Yamada, Toru; Umeyama, Shinji] Natl Inst Adv Ind Sci & Technol, Human Informat Res Inst, Tsukuba, Ibaraki 3058568, Japan; [Ohashi, Mitsuo] Spectratech Inc, Yokohama, Kanagawa 2220033, Japan	Yamada, T (reprint author), Natl Inst Adv Ind Sci & Technol, Human Informat Res Inst, Tsukuba, Ibaraki 3058568, Japan.	toru.yamada@aist.go.jp					Orihuela-Espina F, 2010, PHYS MED BIOL, V55, P3701, DOI 10.1088/0031-9155/55/13/009; Yucel MA, 2014, J INNOV OPT HEAL SCI, V7, DOI 10.1142/S1793545813500661; Zeff BW, 2007, P NATL ACAD SCI USA, V104, P12169, DOI 10.1073/pnas.0611266104; Chiarelli AM, 2015, NEUROIMAGE, V112, P128, DOI 10.1016/j.neuroimage.2015.02.057; Molavi B, 2012, PHYSIOL MEAS, V33, P259, DOI 10.1088/0967-3334/33/2/259; Umeyama S, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.4.047003; Shimokawa T, 2012, OPT EXPRESS, V20, P20427, DOI 10.1364/OE.20.020427; Zhang Q, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2754714; Barker JW, 2013, BIOMED OPT EXPRESS, V4, P1366, DOI 10.1364/BOE.4.001366; Yamada T, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3275469; Scholkmann F, 2010, PHYSIOL MEAS, V31, P649, DOI 10.1088/0967-3334/31/5/004; Lloyd-Fox S, 2010, NEUROSCI BIOBEHAV R, V34, P269, DOI 10.1016/j.neubiorev.2009.07.008; MATCHER SJ, 1995, ANAL BIOCHEM, V227, P54, DOI 10.1006/abio.1995.1252; Kirilina E, 2012, NEUROIMAGE, V61, P70, DOI 10.1016/j.neuroimage.2012.02.074; Virtanen J, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3606576; Saager RB, 2005, J OPT SOC AM A, V22, P1874, DOI 10.1364/JOSAA.22.001874; Brigadoi S, 2014, NEUROIMAGE, V85, P181, DOI 10.1016/j.neuroimage.2013.04.082; Cooper R. J., 2015, NEUROPHOTONICS, V2; Cooper RJ, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00147; Funane T, 2014, NEUROIMAGE, V85, P150, DOI 10.1016/j.neuroimage.2013.02.026; Scholkmann F, 2014, PHYSIOL MEAS, V35, P717, DOI 10.1088/0967-3334/35/4/717; Yamada T., 2014, P SPIE INT SOC OPT E, V8928, p8928R; Yamada T, 2010, P SOC PHOTO-OPT INS, V7557, DOI 10.1117/12.841559; Yucel MA, 2014, NEUROIMAGE, V85, P192, DOI 10.1016/j.neuroimage.2013.06.054	24	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	2156-7085			BIOMED OPT EXPRESS	Biomed. Opt. Express	DEC 1	2015	6	23					4632	4649		10.1364/BOE.6.004632		18	Biochemical Research Methods; Optics; Radiology, Nuclear Medicine & Medical Imaging	Biochemistry & Molecular Biology; Optics; Radiology, Nuclear Medicine & Medical Imaging	CY0UT	WOS:000366122800002		
J	Sugiyama, S; Hong, YJ; Kasaragod, D; Makita, S; Uematsu, S; Ikuno, Y; Miura, M; Yasuno, Y				Sugiyama, Satoshi; Hong, Young-Joo; Kasaragod, Deepa; Makita, Shuichi; Uematsu, Sato; Ikuno, Yasushi; Miura, Masahiro; Yasuno, Yoshiaki			Birefringence imaging of posterior eye by multi-functional Jones matrix optical coherence tomography	BIOMEDICAL OPTICS EXPRESS			English	Article							POLARIZATION-SENSITIVE OCT; EXUDATIVE MACULAR DISEASES; NERVE-FIBER LAYER; IN-VIVO; PHASE RETARDATION; ANTERIOR SEGMENT; HIGH-SPEED; HUMAN RETINA; HUMAN CORNEA; HIGH MYOPIA	A clinical grade prototype of posterior multifunctional Jones matrix optical coherence tomography (JM-OCT) is presented. This JM-OCT visualized depth-localized birefringence in addition to conventional cumulative phase retardation imaging through local Jones matrix analysis. In addition, it simultaneously provides a sensitivity enhanced scattering OCT, a quantitative polarization uniformity contrast, and OCT-based angiography. The probe beam is at 1-mu m wavelength band. The measurement speed and the depth-resolution were 100,000 A-lines/s, and 6.6 mu m in tissue, respectively. Normal and pathologic eyes are examined and several clinical features are revealed, which includes high birefringence in the choroid and lamina cribrosa, and birefringent layered structure of the sclera. The theoretical details of the depth-localized birefringence imaging and conventional phase retardation imaging are formulated. This formulation indicates that the birefringence imaging correctly measures a depth-localized single-trip phase retardation of a tissue, while the conventional phase retardation can provide correct single-trip phase retardation only for some specific types of samples. (C) 2015 Optical Society of America	[Sugiyama, Satoshi; Hong, Young-Joo; Kasaragod, Deepa; Makita, Shuichi; Yasuno, Yoshiaki] Univ Tsukuba, Computat Opt Grp, Tsukuba, Ibaraki, Japan; [Sugiyama, Satoshi] Tomey Corp, Nagoya, Aichi, Japan; [Sugiyama, Satoshi; Hong, Young-Joo; Kasaragod, Deepa; Makita, Shuichi; Yasuno, Yoshiaki] Computat Opt & Ophthalmol Grp, Tsukuba, Ibaraki, Japan; [Uematsu, Sato; Ikuno, Yasushi] Osaka Univ Hosp, Dept Ophthalmol, Suita, Osaka, Japan; [Miura, Masahiro] Tokyo Med Univ, Ibaraki Med Ctr, Ami, Ibaraki, Japan	Sugiyama, S (reprint author), Univ Tsukuba, Computat Opt Grp, Tsukuba, Ibaraki, Japan.	yasuno@optlab2.bk.tsukuba.ac.jp			Topcon Corporation; Tomey Corporation	This research was supported in part by Topcon Corporation and Tomey Corporation. Technical advice from Masahiro Yamanari from Tomey Corporation is gratefully acknowledged.	A. N. S. Institute and L. I. of America, 2014, AM NAT STAND SAF US; Achanta R, 2012, IEEE T PATTERN ANAL, V34, P2274, DOI 10.1109/TPAMI.2012.120; Lim Y, 2011, BIOMED OPT EXPRESS, V2, P2392, DOI 10.1364/BOE.2.002892; Hong YJ, 2013, INVEST OPHTH VIS SCI, V54, P3621, DOI 10.1167/iovs.12-11184; Patel R, 2014, CANCER RES, V74, P4685, DOI 10.1158/0008-5472.CAN-13-2411; Gotzinger E, 2011, OPT EXPRESS, V19, P14568, DOI 10.1364/OE.19.014568; Braaf B, 2014, BIOMED OPT EXPRESS, V5, P2736, DOI 10.1364/BOE.5.002736; HEE MR, 1992, J OPT SOC AM B, V9, P903, DOI 10.1364/JOSAB.9.000903; Yamanari M, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2841024; Gotzinger E, 2004, J BIOMED OPT, V9, P94, DOI 10.1117/1.1629308; Rada JAS, 2006, EXP EYE RES, V82, P185, DOI 10.1016/j.exer.2005.08.009; Miura M, 2008, INVEST OPHTH VIS SCI, V49, P2661, DOI 10.1167/iovs.07-0501; Cense B, 2007, OPT EXPRESS, V15, P2421, DOI 10.1364/OE.15.002421; Gotzinger E, 2008, J BIOPHOTONICS, V1, P129, DOI 10.1002/jbio.200710009; Kim DY, 2011, BIOMED OPT EXPRESS, V2, P1504, DOI 10.1364/BOE.2.001504; Villiger M, 2013, OPT EXPRESS, V21, P16353, DOI 10.1364/OE.21.016353; Makita S, 2010, OPT EXPRESS, V18, P854, DOI 10.1364/OE.18.000854; deBoer JF, 1997, OPT LETT, V22, P934, DOI 10.1364/OL.22.000934; Makita S, 2008, OPT EXPRESS, V16, P8406, DOI 10.1364/OE.16.008406; Ju MJ, 2013, OPT EXPRESS, V21, P19412, DOI 10.1364/OE.21.019412; Yamanari M, 2008, OPT EXPRESS, V16, P5892, DOI 10.1364/OE.16.005892; Baumann B, 2012, BIOMED OPT EXPRESS, V3, P1670, DOI 10.1364/BOE.3.001670; Duan L, 2014, BIOMED OPT EXPRESS, V5, P3717, DOI 10.1364/BOE.5.003717; Lim Y, 2012, OPT LETT, V37, P1958, DOI 10.1364/OL.37.001958; Yasuno Y, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3499421; Fukuda S, 2013, INVEST OPHTH VIS SCI, V54, P1384, DOI 10.1167/iovs.12-10979; Yasuno Y, 2005, OPT EXPRESS, V13, P10652, DOI 10.1364/OPEX.13.010652; Yasuno Y, 2007, OPT EXPRESS, V15, P6121, DOI 10.1364/OE.15.006121; Makita S, 2006, OPT EXPRESS, V14, P7821, DOI 10.1364/OE.14.007821; Kasaragod D, 2014, OPT EXPRESS, V22, P16472, DOI 10.1364/OE.22.016472; vanderLoop FTL, 1997, ARTERIOSCL THROM VAS, V17, P665; Makita S, 2014, OPT LETT, V39, P6783, DOI 10.1364/OL.39.006783; Sakai S, 2008, J INVEST DERMATOL, V128, P1641, DOI 10.1038/jid.2008.8; Pierce MC, 2004, J INVEST DERMATOL, V123, P458, DOI 10.1111/j.0022-202X.2004.23404.x; Yasuno Y, 2009, OPT EXPRESS, V17, P3980, DOI 10.1364/OE.17.003980; Jia YL, 2012, OPT EXPRESS, V20, P4710, DOI 10.1364/OE.20.004710; Hitzenberger CK, 2001, OPT EXPRESS, V9, P780; Wang XJ, 1999, APPL OPTICS, V38, P2092, DOI 10.1364/AO.38.002092; Pircher M, 2004, OPT EXPRESS, V12, P5940, DOI 10.1364/OPEX.12.005940; Cense B, 2002, OPT LETT, V27, P1610, DOI 10.1364/OL.27.001610; Jonas JB, 2011, AM J OPHTHALMOL, V152, P1021, DOI 10.1016/j.ajo.2011.05.006; Nadkarni SK, 2007, J AM COLL CARDIOL, V49, P1474, DOI 10.1016/j.jacc.2006.11.040; Bhaskar U, 2014, PROC SPIE, V8930, DOI 10.1117/12.2036587; Pircher M, 2006, INVEST OPHTH VIS SCI, V47, P5487, DOI 10.1167/iovs.05-1589; Kuo WC, 2008, OPT EXPRESS, V16, P8117, DOI 10.1364/OE.16.008117; Cense B, 2013, BIOMED OPT EXPRESS, V4, P2296, DOI 10.1364/BOE.4.002296; QUIGLEY HA, 1991, BRIT J OPHTHALMOL, V75, P552, DOI 10.1136/bjo.75.9.552; Ohno-Matsui K, 2011, INVEST OPHTH VIS SCI, V52, P9644, DOI 10.1167/iovs.11-8597; Sakai S, 2011, BIOMED OPT EXPRESS, V2, P2623, DOI 10.1364/BOE.2.002623; Duan L, 2011, OPT EXPRESS, V19, P16330, DOI 10.1364/OE.19.016330; Baumann B, 2012, OPT EXPRESS, V20, DOI 10.1364/OE.20.010229; Chen Yueli, 2005, Appl Opt, V44, P2041, DOI 10.1364/AO.44.002041; CURTIN BJ, 1979, ARCH OPHTHALMOL-CHIC, V97, P912; Fukuda S, 2014, INVEST OPHTH VIS SCI, V55, P5200, DOI 10.1167/iovs.14-14474; Hong YJ, 2014, INVEST OPHTH VIS SCI, V55, P5016, DOI 10.1167/iovs.14-14005; Hong YJ, 2014, BIOMED OPT EXPRESS, V6, P225; KOMAI Y, 1991, INVEST OPHTH VIS SCI, V32, P2244; Makita S., BIOMED OPT EXP UNPUB; Makita S, 2015, INVEST OPHTH VIS SCI, V56; Nadler Z, 2014, INVEST OPHTH VIS SCI, V55, P6459, DOI 10.1167/iovs.14-15177; Nagase S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058716; Williams D. R., 2006, ADAPTIVE OPTICS VISI; Yamanari M, 2015, BIOMED OPT EXPRESS, V6, P369, DOI 10.1364/BOE.6.000369; Zotter S., 2012, INVEST OPHTH VIS SCI, V54, P72	64	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	2156-7085			BIOMED OPT EXPRESS	Biomed. Opt. Express	DEC 1	2015	6	23					4951	4974		10.1364/BOE.6.004951		24	Biochemical Research Methods; Optics; Radiology, Nuclear Medicine & Medical Imaging	Biochemistry & Molecular Biology; Optics; Radiology, Nuclear Medicine & Medical Imaging	CY0UT	WOS:000366122800027		
J	Matsuda, T; Komaki, F				Matsuda, Takeru; Komaki, Fumiyasu			Singular value shrinkage priors for Bayesian prediction	BIOMETRIKA			English	Article						Bayesian prediction; Matrix-variate normal distribution; Multivariate linear regression; Shrinkage estimator; Stein's prior	REGRESSION; MATRIX	We develop singular value shrinkage priors for the mean matrix parameters in the matrix-variate normal model with known covariance matrices. Our priors are superharmonic and put more weight on matrices with smaller singular values. They are a natural generalization of the Stein prior. Bayes estimators and Bayesian predictive densities based on our priors are minimax and dominate those based on the uniform prior in finite samples. In particular, our priors work well when the true value of the parameter has low rank.	[Matsuda, Takeru; Komaki, Fumiyasu] Univ Tokyo, Grad Sch Informat Sci & Technol, Dept Math Informat, Bunkyo Ku, Tokyo 1130033, Japan	Matsuda, T (reprint author), Univ Tokyo, Grad Sch Informat Sci & Technol, Dept Math Informat, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	Takeru_Matsuda@mist.i.u-tokyo.ac.jp; komaki@mist.i.u-tokyo.ac.jp			Japan Society for the Promotion of Science	The authors are grateful to the referees and the associate editor for valuable comments. This work was supported by the Japan Society for the Promotion of Science.	Kato K, 2009, ANN I STAT MATH, V61, P531, DOI 10.1007/s10463-007-0163-z; EFRON B, 1972, BIOMETRIKA, V59, P335, DOI 10.2307/2334578; Kobayashi K, 2008, J MULTIVARIATE ANAL, V99, P1888, DOI 10.1016/j.jmva.2008.01.014; DAWID AP, 1981, BIOMETRIKA, V68, P265; Komaki F, 2001, BIOMETRIKA, V88, P859, DOI 10.1093/biomet/88.3.859; George EI, 2008, ECONOMET THEOR, V24, P528, DOI 10.1017/S0266466608080213; George EI, 2006, ANN STAT, V34, P78, DOI 10.1214/009053606000000155; Tsukuma H, 2008, J MULTIVARIATE ANAL, V99, P2251, DOI 10.1016/j.jmva.2008.02.012; Helms LL, 2009, UNIVERSITEXT, P1; Nagar D. K., 2000, MATRIX VARIATE DISTR; Stein C., 1974, P PRAG S AS STAT, P345; Velu R. P., 1998, MULTIVARIATE REDUCED	12	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-3444	1464-3510		BIOMETRIKA	Biometrika	DEC	2015	102	4					843	854		10.1093/biomet/asv036		12	Biology; Mathematical & Computational Biology; Statistics & Probability	Life Sciences & Biomedicine - Other Topics; Mathematical & Computational Biology; Mathematics	CY4LG	WOS:000366379000007		
J	Schultz, R; Mei, SL; Pana, D; Stern, V; Gu, YJ; Kim, A; Eaton, D				Schultz, Ryan; Mei, Shilong; Pana, Dinu; Stern, Virginia; Gu, Yu Jeffrey; Kim, Ahyi; Eaton, David			The Cardston Earthquake Swarm and Hydraulic Fracturing of the Exshaw Formation (Alberta Bakken Play)	BULLETIN OF THE SEISMOLOGICAL SOCIETY OF AMERICA			English	Article							CANADA SEDIMENTARY BASIN; TREND-SURFACE ANALYSIS; WELL-LOG DATA; INDUCED SEISMICITY; FLUID-INJECTION; WESTERN CANADA; DENVER EARTHQUAKES; SHALE GAS; STRESS; TENSOR	More than 60 small earthquakes (ML 0.7-3.0) were detected from December 2011 to March 2012 north of Cardston, Alberta, an area with little evidence for previous seismic activity. The timing of these events closely correlates (>99: 7% confidence) with hydraulic fracturing completions of the Devonian-Mississippian-age Exshaw Formation at a nearby horizontal well. Unanimous waveform multiplicity within the swarm suggests that the events share a similar origin and source mechanism. This observation is corroborated by the point-like collocation of hypocenters within the crystalline basement during robust, double-difference relocations. Furthermore, the presence of a pre-existing fault is confirmed via formation-top offset mapping and interpreted to be a Late Cretaceous extensional fault. The confirmation of this fault at depth provides a plausible pathway for rapid hydraulic communication from the fracturing interval into the crystalline basement. Consistent with structural interpretations and available stress information, moment tensor inversion of the largest magnitude event (M-w 3.0) indicates reactivation of a basement fault with normal slip. We conclude that the genesis of this earthquake swarm was likely caused by increased pore pressure, within the basement fault, as a result of fracturing stimulation.	[Schultz, Ryan; Mei, Shilong; Pana, Dinu; Stern, Virginia] Alberta Geol Survey, Edmonton, AB T6B 2X3, Canada; [Gu, Yu Jeffrey] Univ Alberta, Edmonton, AB T6G 253, Canada; [Kim, Ahyi] Yokohoma City Univ, Kanazawa Ward, Yokohama, Kanagawa 2360027, Japan; [Eaton, David] Univ Calgary, Calgary, AB T2N 1N4, Canada	Schultz, R (reprint author), Alberta Geol Survey, 402 Twin Atria Bldg,4999 98 Ave, Edmonton, AB T6B 2X3, Canada.	ryan.schultz@aer.ca					Aki K, 1965, B EARTHQ RES I TOKYO, V43, P237; Zhang YP, 2013, GROUND WATER, V51, P525, DOI 10.1111/gwat.12071; Gregory KB, 2011, ELEMENTS, V7, P181, DOI 10.2113/gselements.7.3.181; Baisch S, 2008, B SEISMOL SOC AM, V98, P2806, DOI 10.1785/0120080018; HSIEH PA, 1981, J GEOPHYS RES, V86, P903, DOI 10.1029/JB086iB02p00903; SAIKIA CK, 1994, GEOPHYS J INT, V118, P142, DOI 10.1111/j.1365-246X.1994.tb04680.x; Reyes CG, 2011, SEISMOL RES LETT, V82, P104, DOI 10.1785/gssrl.82.1.104; Kim WY, 2013, J GEOPHYS RES-SOL EA, V118, P3506, DOI 10.1002/jgrb.50247; HEALY JH, 1968, SCIENCE, V161, P1301, DOI 10.1126/science.161.3848.1301; Hiebert SN, 1996, B CAN PETROL GEOL, V44, P195; Ristau J, 2007, CAN J EARTH SCI, V44, P127, DOI 10.1139/E06-057; Warpinski NR, 2012, SPE PROD OPER, V27, P240, DOI 10.2118/151597-PA; Bell JS, 2012, GEOFLUIDS, V12, P150, DOI 10.1111/j.1468-8123.2011.00349.x; Eaton DW, 2015, SEISMOL RES LETT, V86, P1078, DOI 10.1785/0220150066; Schultz R, 2015, SEISMOL RES LETT, V86, P385, DOI 10.1785/0220140203; Holland AA, 2013, B SEISMOL SOC AM, V103, P1784, DOI 10.1785/0120120109; Schaff DP, 2008, B SEISMOL SOC AM, V98, P1495, DOI 10.1785/0120060263; Telesca L, 2010, B SEISMOL SOC AM, V100, P2317, DOI 10.1785/0120090392; [Anonymous], 2000, CAN J EARTH SCI; Ross GM, 1999, B CAN PETROL GEOL, V47, P391; Davies R, 2013, MAR PETROL GEOL, V45, P171, DOI 10.1016/j.marpetgeo.2013.03.016; Schmitt DR, 2012, TECTONOPHYSICS, V580, P1, DOI 10.1016/j.tecto.2012.08.029; Schorlemmer D, 2005, NATURE, V437, P539, DOI 10.1038/nature04094; Frohlich C, 2001, GEOPHYS J INT, V144, P300, DOI 10.1046/j.1365-246x.2001.00341.x; STRUIK LC, 1988, TECTONICS, V7, P727, DOI 10.1029/TC007i004p00727; D'Alessandro A, 2012, B SEISMOL SOC AM, V102, P73, DOI 10.1785/0120100234; Gu YJ, 2011, SEISMOL RES LETT, V82, P575, DOI 10.1785/gssrl.82.4.575; Stockmal GS, 2001, B CAN PETROL GEOL, V49, P472, DOI 10.2113/49.4.472; McGarr A, 2014, J GEOPHYS RES-SOL EA, V119, P1008, DOI 10.1002/2013JB010597; Schultz R, 2015, GEOPHYS RES LETT, V42, P2750, DOI 10.1002/2015GL063455; Majer EL, 2007, GEOTHERMICS, V36, P185, DOI 10.1016/j.geothermics.2007.03.003; Clarke H, 2014, GEOPHYS RES LETT, V41, P8308, DOI 10.1002/2014GL062047; Waldhauser F, 2000, B SEISMOL SOC AM, V90, P1353, DOI 10.1785/0120000006; Skoumal RJ, 2015, B SEISMOL SOC AM, V105, P189, DOI 10.1785/0120140168; Chen Z, 2011, GEOFLUIDS, V11, P228, DOI 10.1111/j.1468-8123.2011.00334.x; Parotidis M, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018987; Davies RJ, 2012, MAR PETROL GEOL, V37, P1, DOI 10.1016/j.marpetgeo.2012.04.001; CELERIER B, 1988, TECTONICS, V7, P1257, DOI 10.1029/TC007i006p01257; Reiter K, 2014, TECTONOPHYSICS, V636, P111, DOI 10.1016/j.tecto.2014.08.006; Mei SL, 2009, CAN J EARTH SCI, V46, P41, DOI 10.1139/E09-006; SHI Y, 1982, B SEISMOL SOC AM, V72, P1677; MCKENZIE DP, 1969, B SEISMOL SOC AM, V59, P591; Lemieux S, 1999, B CAN PETROL GEOL, V47, P375; Mei SL, 2009, CAN J EARTH SCI, V46, P309, DOI 10.1139/E09-024; Schultz R, 2014, J GEOPHYS RES-SOL EA, V119, P3410, DOI 10.1002/2013JB010836; BC Oil and Gas Commission, 2012, INV OBS SEISM HORN R; BC Oil and Gas Commission, 2014, INV OBS SEISM MONTN; Beaumont C., 1993, SPEC PAP GEOL ASS CA, V39, P91; Chen YF, 2015, J GEOPHYS RES-SOL EA, V120, P6993; Davis S. D., 1993, Seismological Research Letters, V64; Downie R., 2010, SPE ANN TECHN C EXH, DOI [10.2118/134772-MS, DOI 10.2118/134772-MS]; Dreger D S., 2003, INT HDB EARTHQUAKE B, V81, P1627, DOI DOI 10.1016/S0074-6142(03)80290-5; Earthquakes Canada, 2014, NAT RES CAN; Eaton D, 2014, CSEG RECORDER, V39, P30; Efron B, 1986, STAT SCI, V1, P54, DOI DOI 10.1214/SS/1177013815; Ellsworth WL, 2013, SCIENCE, V341, P142, DOI 10.1126/science.1225942; Fischer T, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL045447; Friberg PA, 2014, SEISMOL RES LETT, V85, P1295, DOI 10.1785/0220140127; Glombick P, 2014, 201317 AERAGS; Goertz-Allmann B. P., 2012, GEOPHYSICS, V78, pKS25, DOI [10.1190/geo2012-0102.1, DOI 10.1190/GEO2012-0102.1]; Hildebrand RS, 2013, GEOL SOC AM SPEC PAP, V495, P1, DOI 10.1130/2013.2495; Horner R. B., 1994, CAN J EXPLOR GEOPHYS, V30, P39; HUBBERT MK, 1959, GEOL SOC AM BULL, V70, P115; King G. E., 2010, SPE ANN TECHN C EXH, DOI [10.2118/133456-MS, DOI 10.2118/133456-MS]; Laske G., 2013, GEOPHYS RES ABSTR, V15, P2658; Lyatsky H., 2004, LEADING EDGE, V23, P1282, DOI [10.1190/leedff.23.1282_1, DOI 10.1190/LEEDFF.23.1282_1]; Lyatsky H. V., 2005, 72 EUB ALB GEOL SURV, V72; Lyatsky H. V., 2003, CATALOGUE SELECTED R; MACQUEEN R W, 1970, Bulletin of Canadian Petroleum Geology, V18, P32; Maxwell S. C., 2011, SPE ANN TECHN C EXH, DOI [10.2118/146932-MS, DOI 10.2118/146932-MS]; Maxwell S. C., 2010, 72 EAGE C EXH BARC S; Monger J., 2002, CANADIAN SOC EXPLORA, V27, P17; Pana D. I., 2014, GEOL SOC AM BULL, DOI [10.1130/B31069.1, DOI 10.1130/B31069.1]; Price R. A., 1994, GEOLOGICAL ATLAS W C, P13; Rokosh C. D., 2012, 201206 ERCB AGS; Russel L. S., 1940, GEOLOGICAL SURVEY CA, V221, P1, DOI DOI 10.4095/101619; Rutledge J., 2013, 2013 SEG ANN M HOUST; Shapiro SA, 1997, GEOPHYS J INT, V131, pF15, DOI 10.1111/j.1365-246X.1997.tb01215.x; Stern V. H., 2013, 201315 ALB GEOL SURV; Ugalde H. A., 2008, CSEG RECORDER, V33, P1; U.S. Energy Information Administration, 2013, TECHN REC SHAL SHAL; Vavrycuk V, 2015, J SEISMOL, V19, P231, DOI 10.1007/s10950-014-9463-y; Waters G., 2009, OFFSH TECHN C HOUST, P4; WESSEL P, 1998, EOS T AGU, V0079; Wessels S. A., 2011, 1 BREAK, V29, P99; Wright G. N., 1994, GEOLOGICAL ATLAS W C, P25; Yang Y., 2013, UNC RES TECHN C DENV, DOI [10.1190/URTEC2013-056, DOI 10.1190/URTEC2013-056]; Zaitlin B., 2011, BMO TECHNICAL UPDATE; Zaitlin B., 2010, ALBERTA BAKKEN NEW U	89	0	0	SEISMOLOGICAL SOC AMER	ALBANY	400 EVELYN AVE, SUITE 201, ALBANY, CA 94706-1375 USA	0037-1106	1943-3573		B SEISMOL SOC AM	Bull. Seismol. Soc. Amer.	DEC	2015	105	6					2871	2884		10.1785/0120150131		14	Geochemistry & Geophysics	Geochemistry & Geophysics	CX7PX	WOS:000365895600004		
J	Kawase, H; Matsushima, S; Satoh, T; Sanchez-Sesma, FJ				Kawase, Hiroshi; Matsushima, Shinichi; Satoh, Toshimi; Sanchez-Sesma, Francisco J.			Applicability of Theoretical Horizontal-to-Vertical Ratio of Microtremors Based on the Diffuse Field Concept to Previously Observed Data	BULLETIN OF THE SEISMOLOGICAL SOCIETY OF AMERICA			English	Article							S-WAVE-VELOCITY; H/V SPECTRAL RATIO; SEISMIC NOISE; AMBIENT VIBRATIONS; JOINT INVERSION; EARTHQUAKE MOTIONS; PHASE-VELOCITY; LAYERED MEDIA; SENDAI BASIN; JAPAN	Horizontal-to-vertical spectral ratios of microtremors (MHVRs) have been interpreted as representing either the Rayleigh-wave ellipticity or the amplitude ratio of the sum of Rayleigh and Love waves in a horizontally layered structure. However, based on the recently established diffuse field concept, the theoretical form of MHVR has been proposed to be the square root of the ratio between the imaginary part of the horizontal Green's function on the surface and that of the vertical one. The theory assumes that the energy of a wavefield inside the earth will be equipartitioned among the various states in 3D space. In the case of microtremors, this may occur for randomly applied point-force loadings on the surface after sufficient lapse time to allow multiple scattering. Recent works on diffuse fields suggest that equipartition may arise in several ways, but understanding the emergence of equipartition in realistic settings requires further scrutiny. In the meantime, the resulting formula is quite simple, and its meaning has theoretical support from deterministic exact solutions. As references, we use observed microtremor data from several sites that were reported previously and validate the diffuse field method (DFM) as an alternative method to explain observed MHVR. We use only sites with reliable velocity structures to compare different methods quantitatively. As a result, we found that the DFM solutions with the corresponding 1D layered structures well explain the observed MHVRs for most of the sites. Thus, we believe that MHVR can be used to invert a 1D velocity structure by using DFM as a theoretical tool.	[Kawase, Hiroshi; Matsushima, Shinichi] Kyoto Univ, Disaster Prevent Res Inst, Kyoto 6110011, Japan; [Satoh, Toshimi] Shimizu Corp, Inst Technol, Tokyo 1358530, Japan; [Sanchez-Sesma, Francisco J.] Univ Nacl Autonoma Mexico, Inst Ingn, Coyoacan 04510, DF, Mexico	Kawase, H (reprint author), Kyoto Univ, Disaster Prevent Res Inst, Kyoto 6110011, Japan.	kawase@zeisei.dpri.kyoto-u.ac.jp			Monbusho (MEXT) [26242034]; AXA Research Fund; Direccion General de Asuntos del Personal Academic (DGAPA)-UNAM [IN104712]	The authors thank H. Arai of the Building Research Institute for permission to use his microtremor and velocity data and to Lic. G. Sanchez N. and her team at the Unidad de Servicios de Informacion of the Institute of Engineering, Universidad Nacional Autonoma de Mexico (UNAM) for locating useful references. We also thank the anonymous reviewers for their invaluable comments. Partial support for this work from a Monbusho (MEXT) Grant-in-Aid for Scientific Research (A) Number 26242034, 2014-2017, from the AXA Research Fund, and from Direccion General de Asuntos del Personal Academic (DGAPA)-UNAM under Project IN104712 is gratefully acknowledged.	Aki K, 1957, B EARTHQ RES I TOKYO, V25, P415; Pilz M, 2014, GEOPHYS J INT, V199, P430, DOI 10.1093/gji/ggu273; Mulargia F, 2012, J ACOUST SOC AM, V131, P2853, DOI 10.1121/1.3689551; Sanchez-Sesma FJ, 2011, GEOPHYS J INT, V186, P221, DOI 10.1111/j.1365-246X.2011.05064.x; Hennino R, 2001, PHYS REV LETT, V86, P3447, DOI 10.1103/PhysRevLett.86.3447; HORIKE M, 1985, J PHYS EARTH, V33, P59; Horike M, 2001, B SEISMOL SOC AM, V91, P1526, DOI 10.1785/0120000065; Salinas V, 2014, B SEISMOL SOC AM, V104, P995, DOI 10.1785/0120130202; Sanchez-Sesma FJ, 2011, B SEISMOL SOC AM, V101, P1704, DOI 10.1785/0120100196; LACHET C, 1994, J PHYS EARTH, V42, P377; Margerin L, 2009, GEOPHYS J INT, V177, P571, DOI 10.1111/j.1365-246X.2008.04068.x; Nagashima F, 2014, B SEISMOL SOC AM, V104, P2288, DOI 10.1785/0120130219; Castellaro S, 2009, B SEISMOL SOC AM, V99, P761, DOI 10.1785/0120080179; Kawase H, 2011, B SEISMOL SOC AM, V101, P2001, DOI 10.1785/0120100263; Arai H, 2008, EARTHQ ENG STRUCT D, V37, P845, DOI 10.1002/eqe.788; Picozzi M, 2007, GEOPHYS J INT, V169, P189, DOI 10.1111/j.1365-246X.2006.03282.x; Sanchez-Sesma FJ, 2008, WAVE MOTION, V45, P641, DOI 10.1016/j.wavemoti.2007.07.005; Arai H, 2005, B SEISMOL SOC AM, V95, P1766, DOI 10.1785/0120040243; Uebayashi H, 2012, GEOPHYS J INT, V189, P1060, DOI 10.1111/j.1365-246X.2012.05408.x; Matsushima S, 2014, B SEISMOL SOC AM, V104, P381, DOI 10.1785/0120120321; Gueguen P, 2007, PURE APPL GEOPHYS, V164, P115, DOI 10.1007/s00024-006-0151-x; Picozzi M, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022878; Malischewsky PG, 2004, WAVE MOTION, V40, P57, DOI 10.1016/j.wavemoti.2003.12.015; Arai H, 2004, B SEISMOL SOC AM, V94, P53, DOI 10.1785/0120030028; Konno K, 1998, B SEISMOL SOC AM, V88, P228; BOUCHON M, 1981, B SEISMOL SOC AM, V71, P959; Satoh T, 2001, B SEISMOL SOC AM, V91, P1267; Perton M, 2009, J ACOUST SOC AM, V126, P1125, DOI 10.1121/1.3177262; Bonnefoy-Claudet S, 2008, B SEISMOL SOC AM, V98, P288, DOI 10.1785/0120070063; Lunedei E, 2010, GEOPHYS J INT, V181, P1093, DOI 10.1111/j.1365-246X.2010.04560.x; Parolai S, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021115; Satoh T, 2001, B SEISMOL SOC AM, V91, P206, DOI 10.1785/0119990148; Satoh T, 2001, B SEISMOL SOC AM, V91, P812, DOI 10.1785/0120000086; Ducellier A, 2013, B SEISMOL SOC AM, V103, P958, DOI 10.1785/0120120214; Satoh T, 2001, B SEISMOL SOC AM, V91, P313, DOI 10.1785/0119990149; Lontsi AM, 2015, GEOPHYS J INT, V202, P298, DOI 10.1093/gji/ggv132; Albarello D, 2010, B EARTHQ ENG, V8, P519, DOI 10.1007/s10518-009-9110-0; Bard P.-Y., 1998, EFFECT SURFACE GEOLO, V2, P1251; Bonnefoy-Claudet S, 2006, EARTH-SCI REV, V79, P205, DOI 10.1016/j.earscirev.2006.07.004; Cornou C., 2004, P 13 WORLD C EARTHQ; Garcia-Jerez A., 2013, J GEOPHYS RES, V118, P1; Herak M, 2008, COMPUT GEOSCI-UK, V34, P1514, DOI 10.1016/j.cageo.2007.07.009; Horike M., 1980, Zisin. Journal of the Seismological Society of Japan, V33; Kawase H., 1998, P 2 INT S EFF SURF G, V2, P733; Kinoshita S, 1998, SEISMOL RES LETT, V69, P309; Kitagawa Y., 1994, 139 BRI, P1; LERMO J, 1994, B SEISMOL SOC AM, V84, P1350; Matsushima T., 1990, BUTSURI TANSA, V43, P21; Mulargia F, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.218501; Nakamura Y., 2000, P 12 WORLD C EARTHQ; Nakamura Y, 1989, QR RTRI, V30, P25; Okada H., 2003, GEOPHYS MONOGRAPH SE, V12; WESSEL P, 1998, EOS T AGU, V0079	53	0	0	SEISMOLOGICAL SOC AMER	ALBANY	400 EVELYN AVE, SUITE 201, ALBANY, CA 94706-1375 USA	0037-1106	1943-3573		B SEISMOL SOC AM	Bull. Seismol. Soc. Amer.	DEC	2015	105	6					3092	3103		10.1785/0120150134		12	Geochemistry & Geophysics	Geochemistry & Geophysics	CX7PX	WOS:000365895600020		
J	Katsumata, A				Katsumata, Akio			Fast Hypocenter Determination in an Inhomogeneous Velocity Structure Using a 3D Travel-Time Table	BULLETIN OF THE SEISMOLOGICAL SOCIETY OF AMERICA			English	Article							EVENT LOCATION; MODEL; EARTHQUAKE; CALIFORNIA; ALGORITHM; REGION	The computer processing time required for raytracing and hypocenter determination in a 3D inhomogeneous velocity structure is too great for the method to be used to locate a large number of hypocenters or for interactive processing. In this study, hypocenter determinations were conducted using 3D travel-time tables (3D-TTs) to reflect travel times of a 3D inhomogeneous velocity structure in event locations, and the results were compared with those achieved using the 3D raytracing method. The use of 3D-TTs reduced the calculation time by a factor of about 1800 compared with the raytracing method. Whereas minor differences between interpolated travel times and the raytracing method caused some corresponding location differences, the travel-time table was effective for correction of hypocenter locations according to an inhomogeneous velocity-structure model.	[Katsumata, Akio] Japan Meteorol Agcy, Meteorol Res Inst, Tsukuba, Ibaraki 3050052, Japan	Katsumata, A (reprint author), Japan Meteorol Agcy, Meteorol Res Inst, Nagamine 1-1, Tsukuba, Ibaraki 3050052, Japan.	akatsuma@mri-jma.go.jp					Flanagan MP, 2007, B SEISMOL SOC AM, V97, P804, DOI 10.1785/0120060079; AKI K, 1976, J GEOPHYS RES, V81, P4381, DOI 10.1029/JB081i023p04381; DOUGLAS A, 1967, NATURE, V215, P47, DOI 10.1038/215047a0; Murphy JR, 2005, B SEISMOL SOC AM, V95, P1535, DOI 10.1785/0120040087; Ritzwoller MH, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB002167; Katsumata A, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2008JB005864; Myers SC, 2010, B SEISMOL SOC AM, V100, P640, DOI 10.1785/0120090198; Waldhauser F, 2000, B SEISMOL SOC AM, V90, P1353, DOI 10.1785/0120000006; Johnson M, 2002, B SEISMOL SOC AM, V92, P2893, DOI 10.1785/0120010111; HOLE JA, 1995, GEOPHYS J INT, V121, P427, DOI 10.1111/j.1365-246X.1995.tb05723.x; Kato A, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022366; Hamada N., 1983, Q J SEISMOL, V48, P35; Hurukawa N., 1993, Zisin. Journal of the Seismological Society of Japan, V46; Ichida K., 1979, SPLINE FUNCTIONS THE; Ichikawa S., 1979, Q J SEISMOL, V43, P59; Japan Meteorological Agency, 1998, SEISM VOLC B JAP OCT; KOCH M, 1985, J GEOPHYS-Z GEOPHYS, V56, P160; Richards-Dinger KB, 2000, J GEOPHYS RES-SOL EA, V105, P10939, DOI 10.1029/2000JB900014; Ueno H., 2002, Q J SEISMOL, V65, P123; UM J, 1987, B SEISMOL SOC AM, V77, P972	20	0	0	SEISMOLOGICAL SOC AMER	ALBANY	400 EVELYN AVE, SUITE 201, ALBANY, CA 94706-1375 USA	0037-1106	1943-3573		B SEISMOL SOC AM	Bull. Seismol. Soc. Amer.	DEC	2015	105	6					3203	3208		10.1785/0120150122		6	Geochemistry & Geophysics	Geochemistry & Geophysics	CX7PX	WOS:000365895600031		
J	Maruo, T; Nagata, K; Fukuyama, Y; Nemoto, Y; Kawarai, S; Fujita, Y; Nakayama, T				Maruo, Takuya; Nagata, Koichi; Fukuyama, Yasuhiro; Nemoto, Yuki; Kawarai, Shinpei; Fujita, Yukihiro; Nakayama, Tomohiro			Intraoperative acridine orange photodynamic therapy and cribriform electron-beam irradiation for canine intranasal tumors: A pilot study	CANADIAN VETERINARY JOURNAL-REVUE VETERINAIRE CANADIENNE			English	Article							LOW-DOSE RADIATION; NASAL TUMORS; ARGON-LASER; DOGS; RADIOTHERAPY; SURVIVAL; PROGNOSIS; NEOPLASMS; SARCOMAS; SURGERY	Untreated canine intranasal tumors carry a poor prognosis. We retrospectively evaluated the efficacy of marginal tumor resection in combination with intraoperative acridine orange (AO) photodynamic therapy (PDT) and 1 fraction of 5 Gy megavoltage irradiation for canine intranasal malignant tumors. When cribriform plate invasion or turbinate destruction around the cribriform plate was present, an additional fraction of 20 Gy was delivered with an electron beam during surgery. The study included 6 dogs, 2 of which were classified as stage I, 1 as stage II, and 3 as stage IV. The median local disease-free survival time and overall survival after the treatment were 8.5 and 13 months, respectively. Recurrence was noted in 2 of the 6 dogs after 4 and 7 months. Adverse events were mild (subcutaneous emphysema in 1 case, and rhinitis in 3 cases). Combination AO therapy may increase the tumor control time of dogs with marginally resectable intranasal malignant tumors.	[Maruo, Takuya; Fukuyama, Yasuhiro; Kawarai, Shinpei; Fujita, Yukihiro] Azabu Univ, Vet Teaching Hosp, Chuo Ku, Sagamihara, Kanagawa 2525201, Japan; [Nagata, Koichi] Univ Georgia, Coll Vet Med, Athens, GA 30602 USA; [Nemoto, Yuki; Nakayama, Tomohiro] Nihon Univ, Coll Bioresource Sci, Dept Vet Med, Lab Vet Radiol, Fujisawa, Kanagawa 2520880, Japan	Maruo, T (reprint author), Azabu Univ, Vet Teaching Hosp, Chuo Ku, 1-17-71 Fuchinobe, Sagamihara, Kanagawa 2525201, Japan.	maruo@azabu-u.ac.jp					Adams WM, 2005, JAVMA-J AM VET MED A, V227, P936, DOI 10.2460/javma.2005.227.936; Buchholz J, 2013, PHOTODIAGN PHOTODYN, V10, P342, DOI 10.1016/j.pdpdt.2013.05.009; Buchholz J, 2009, VET RADIOL ULTRASOUN, V50, P679, DOI 10.1111/j.1740-8261.2009.01603.x; MCENTEE MC, 1991, VET RADIOLOGY, V32, P135; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HOEKSTRA HJ, 1989, RADIAT RES, V120, P508, DOI 10.2307/3577800; Kusuzaki K, 2005, ANTICANCER RES, V25, P1225; TOMSON SH, 1974, CANCER RES, V34, P3124; Kondo Y, 2008, J VET MED SCI, V70, P207, DOI 10.1292/jvms.70.207; Coli A, 2006, J EXP CLIN CANC RES, V25, P287; Yoon JH, 2008, RES VET SCI, V84, P140, DOI 10.1016/j.rvsc.2007.03.004; NORRIS AM, 1979, J AM ANIM HOSP ASSOC, V15, P231; Maruo T, 2012, INT J APPL RES VET M, V10, P164; Agostinis P, 2011, CA-CANCER J CLIN, V61, P250, DOI 10.3322/caac.20114; MACEWEN EG, 1977, J AM VET MED ASSOC, V170, P45; Ueda H, 2005, ANTICANCER RES, V25, P3979; Osaki T, 2009, J VET MED SCI, V71, P125, DOI 10.1292/jvms.71.125; MORRIS JS, 1994, J SMALL ANIM PRACT, V35, P567, DOI 10.1111/j.1748-5827.1994.tb03821.x; Maruo T, 2011, J VET MED SCI, V73, P193, DOI 10.1292/jvms.10-0194; LaDue TA, 1999, VET RADIOL ULTRASOUN, V40, P312, DOI 10.1111/j.1740-8261.1999.tb00367.x; Adams WM, 2009, VET RADIOL ULTRASOUN, V50, P330, DOI 10.1111/j.1740-8261.2009.01545.x; Hashiguchi S, 2002, ONCOLOGY-BASEL, V62, P85, DOI 10.1159/000048251; Nakamura T, 2008, J SURG ONCOL, V97, P523, DOI 10.1002/jso.21025; TATSUTA M, 1984, EUR J CANCER CLIN ON, V20, P543, DOI 10.1016/0277-5379(84)90241-4; Lucroy MD, 2003, J VET INTERN MED, V17, P727, DOI 10.1892/0891-6640(2003)017<0727:PTFTTO>2.3.CO;2; Henry CJ, 1998, J VET INTERN MED, V12, P436; Kusuzaki K, 2007, IN VIVO, V21, P205; LaDue T, 2001, VET RADIOL ULTRASOUN, V42, P475, DOI 10.1111/j.1740-8261.2001.tb00973.x; Farese JP, 2013, SMALL ANIMAL CLIN ON, P149; Hori H, 2014, INT J APPL RES VET M, V12, P181; Katou A., 1970, GASTROENTEROL ENDOSC, V12, P351; Lucroy MD., 2013, SMALL ANIMAL CLIN ON, P283; Matsubara T, 2013, CLIN ORTHOP RELAT R, V417, P792; Rassnick KM, 2006, JAVMA-J AM VET MED A, V229, P401, DOI 10.2460/javma.229.3.401; Theon P, 1993, J AM VET MED ASSOC, V202, P1469; Turek MM, 2008, DECISION MAKING SMAL, P239; Turek MM, 2013, SMALL ANIMAL CLIN ON, P435	37	0	0	CANADIAN VET MED ASSOC	OTTAWA	339 BOOTH ST, OTTAWA, ONTARIO K1R 7K1, CANADA	0008-5286	1928-9022		CAN VET J	Can. Vet. J.-Rev. Vet. Can.	DEC	2015	56	12					1232	1238				7	Veterinary Sciences	Veterinary Sciences	CY5HD	WOS:000366437800002		
J	Delahaye-Sourdeix, M; Urayama, KY; Gaborieau, V; Veenstra, R; Foll, M; Chabrier, A; Benavente, Y; Nieters, A; Becker, N; Foretova, L; Maynadie, M; Staines, A; Smedby, KE; Glimelius, I; Lightfoot, T; Cocco, P; Galan, P; Vatten, LJ; Duell, EJ; Kiemeney, L; Roman, E; de Sanjose, S; Lathrop, M; Melbye, M; Brennan, P; Diepstra, A; Van den Berg, A; Hjalgrim, H; Jarrett, RF; McKay, JD				Delahaye-Sourdeix, Manon; Urayama, Kevin Y.; Gaborieau, Valerie; Veenstra, Rianne; Foll, Matthieu; Chabrier, Amelie; Benavente, Yolanda; Nieters, Alexandra; Becker, Nikolaus; Foretova, Lenka; Maynadie, Marc; Staines, Anthony; Smedby, Karin Ekstrom; Glimelius, Ingrid; Lightfoot, Tracy; Cocco, Pierluigi; Galan, Pilar; Vatten, Lars J.; Duell, Eric J.; Kiemeney, Lambertus; Roman, Eve; de Sanjose, Silvia; Lathrop, Mark; Melbye, Mads; Brennan, Paul; Diepstra, Arjan; Van den Berg, Anke; Hjalgrim, Henrik; Jarrett, Ruth F.; McKay, James D.			A Novel Risk Locus at 6p21.3 for Epstein-Barr Virus-Positive Hodgkin Lymphoma	CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION			English	Article							GENOME-WIDE ASSOCIATION; INFECTIOUS-MONONUCLEOSIS; DISEASE; SUSCEPTIBILITY; SEQUENCE; SUBTYPE; EBV	Background: A proportion of the genetic variants involved in susceptibility to Hodgkin lymphoma differ by the tumor's Epstein-Barr virus (EBV) status, particularly within the MHC region. Methods: We have conducted an SNP imputation study of the MHC region, considering tumor EBV status in 1,200 classical Hodgkin lymphoma (cHL) cases and 5,726 control subjects of European origin. Notable findings were genotyped in an independent study population of 468 cHL cases and 551 controls. Results: We identified and subsequently replicated a novel association between a common genetic variant rs6457715 and cHL. Although strongly associated with EBV-positive cHL [OR, 2.33; 95% confidence interval (CI), 1.83-2.97; P = 7 x 10(-12)], there was little evidence for association between rs6457715 and the EBV-negative subgroup of cHL (OR, 1.06; 95% CI, 0.92-1.21), indicating that this association was specific to the EBV-positive subgroup (P-het < P = 10(-8)). Furthermore, the association was limited to EBV-positive cHL subgroups within mixed cell (MCHL) and nodular sclerosis subtypes (NSHL), suggesting that the association is independent of histologic subtype of cHL. Conclusions: rs6457715, located near the HLA-DPB1 gene, is associated with EBV-positive cHL and suggests this region as a novel susceptibility locus for cHL. Impact: This expands the number of genetic variants that are associated with cHL and provides additional evidence for a critical and specific role of EBV in the etiology of this disease. (C)2015 AACR.	[Delahaye-Sourdeix, Manon; Gaborieau, Valerie; Foll, Matthieu; Chabrier, Amelie; Benavente, Yolanda; Brennan, Paul; McKay, James D.] Int Agcy Res Canc, F-69372 Lyon, France; [Urayama, Kevin Y.] Tokyo Med & Dent Univ, Dept Human Genet & Dis Divers, Tokyo, Japan; [Veenstra, Rianne; Diepstra, Arjan; Van den Berg, Anke] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands; [Duell, Eric J.; de Sanjose, Silvia] Catalan Inst Oncol, IDIBELL, Canc Epidemiol Res Programme, Unit Infect & Canc, Barcelona, Spain; [Benavente, Yolanda; de Sanjose, Silvia] CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain; [Nieters, Alexandra] Univ Med Ctr Freiburg, Ctr Chron Immunodeficiency Freiburg, Freiburg, Germany; [Becker, Nikolaus] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany; [Foretova, Lenka] Masaryk Mem Canc Inst, Dept Canc Epidemiol & Genet, Brno, Czech Republic; [Maynadie, Marc] Univ Burgundy, Univ Hosp Dijon, Registry Hematol Malignancies, Dijon, France; [Staines, Anthony] Dublin City Univ, Sch Nursing, Dublin 9, Ireland; [Smedby, Karin Ekstrom] Karolinska Inst, Clin Epidemiol Unit, Dept Med Solna, Stockholm, Sweden; [Smedby, Karin Ekstrom] Karolinska Univ Hosp, Stockholm, Sweden; [Glimelius, Ingrid] Karolinska Inst, Dept Med, Clin Epidemiol Unit, Stockholm, Sweden; [Glimelius, Ingrid] Uppsala Univ, Dept Radiol Oncol & Clin Immunol, Uppsala, Sweden; [Lightfoot, Tracy; Roman, Eve] Univ York, Dept Hlth Sci, Epidemiol & Genet Unit, York YO10 5DD, N Yorkshire, England; [Cocco, Pierluigi] Univ Cagliari, Dept Publ Hlth Occupat Hlth Sect, Cagliari, Italy; [Galan, Pilar] Univ Paris 07, Univ Paris 05,Inra U1125,Cnam, Univ Paris 13,Nutr Epidemiol Res Team EREN,Inserm, Sorbonne Paris Cite Epidemiol & Biostat Res Ctr C, Bobigny, France; [Vatten, Lars J.] Norwegian Univ Sci & Technol, N-7034 Trondheim, Norway; [Kiemeney, Lambertus] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, NL-6525 ED Nijmegen, Netherlands; McGill Univ, Montreal, PQ, Canada; [Lathrop, Mark] Genome Quebec Innovat Ctr, Montreal, PQ, Canada; [Melbye, Mads; Hjalgrim, Henrik] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; [Jarrett, Ruth F.] Univ Glasgow, MRC Univ Glasgow Ctr Virus Res, Glasgow, Lanark, Scotland	McKay, JD (reprint author), Int Agcy Res Canc IARC WHO, 150 Cours Albert Thomas, F-69372 Lyon 08, France.	gcs@iarc.fr			Institut National du Cancer, France; Spanish Ministry of Health grant CIBERESP [PI11/0181008-1555, 06/02/0073]; Agencia de Gestio d'Ajuts Universitaris i de Recerca-Generalitat de Catalunya (Catalonian Government) [2014SGR756]; Ministry of Health of the Czech Republic [MZ0 MOU2005]; German Jose Carreras Leukemia Foundation [DJCLS_R04/08]; Federal Office for Radiation Protection [StSch4261, StSch4420]; EC 5th Framework Program Quality of Life [QLK4-CT-2000-00422]; EC 6th Framework Program [FP6-2003-FOOD-2-B]; La Fondation de France [1999-008471]; Compagnia di San Paolo-Programma Oncologia; Health Research Board; Leukaemia Lymphoma Research [00/73, 06001, 08031, 05045]; Kay Kendall Leukaemia Fund; U.S. NIH [R01 CA69269]; Nordic Cancer Union [16-02-D]; Plan Danmark; Danish Cancer Research Foundation [41-08]; Lundbeck Foundation [R19-A2364]; Danish Cancer Society [DP 08-155]; Swedish Cancer Society [2009/1084]; Dutch Cancer Society (KWF grants) [RUG 2000-2315, RUG 2010-4860, RUG 2014-6698]; Dutch Organization of Scientific Research (NWO-MW grant) [920-03-136]	This work was supported by Institut National du Cancer, France (to P. Galan); Spanish Ministry of Health grant CIBERESP (PI11/0181008-1555 and 06/02/0073) and Agencia de Gestio d'Ajuts Universitaris i de Recerca-Generalitat de Catalunya (Catalonian Government 2014SGR756; to Y. Benavente, E.J. Duell, and S. de Sanjose); Ministry of Health of the Czech Republic (MZ0 MOU2005; to L. Foretova); German Jose Carreras Leukemia Foundation (DJCLS_R04/08; to N. Becker); Federal Office for Radiation Protection (StSch4261 and StSch4420; to A. Nieters); EC 5th Framework Program Quality of Life (QLK4-CT-2000-00422; to Y. Benavente, A. Nieters, and S. de Sanjose); EC 6th Framework Program (FP6-2003-FOOD-2-B; to Y. Benavente, A. Nieters, and S. de Sanjose); La Fondation de France (1999-008471; to M. Maynadie); Compagnia di San Paolo-Programma Oncologia; Health Research Board (to A. Staines); Leukaemia Lymphoma Research (00/73, 06001, 08031, and 05045; to R.F. Jarrett); Kay Kendall Leukaemia Fund (to R.F. Jarrett); U.S. NIH (R01 CA69269; to M. Melbye); Nordic Cancer Union (16-02-D; to K. Ekstrom Smedby, M. Melbye, and H. Hjalgrim); Plan Danmark (to M. Melbye and H. Hjalgrim); Danish Cancer Research Foundation (41-08; to K. Ekstrom Smedby, M. Melbye, and H. Hjalgrim); Lundbeck Foundation (R19-A2364); Danish Cancer Society (DP 08-155; to K. Ekstrom Smedby, M. Melbye, and H. Hjalgrim); Swedish Cancer Society (2009/1084; to K. Ekstrom Smedby and I. Glimelius); Dutch Cancer Society (KWF grants RUG 2000-2315, RUG 2010-4860, RUG 2014-6698; to R. Veenstra, A. Diepstra, and A. van den Berg); Dutch Organization of Scientific Research (NWO-MW grant 920-03-136; to R. Veenstra, A. Diepstra, and A. van den Berg).	Hjalgrim H, 2010, P NATL ACAD SCI USA, V107, P6400, DOI 10.1073/pnas.0915054107; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Moutsianas L, 2011, BLOOD, V118, P670, DOI 10.1182/blood-2011-03-339630; Glaser SL, 1997, INT J CANCER, V70, P375; Cozen W, 2012, BLOOD, V119, P469, DOI 10.1182/blood-2011-03-343921; Kuppers R, 2009, NAT REV CANCER, V9, P15, DOI 10.1038/nrc2542; Niens M, 2007, BLOOD, V110, P3310, DOI 10.1182/blood-2007-05-086934; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Hjalgrim H, 2003, NEW ENGL J MED, V349, P1324, DOI 10.1056/NEJMoa023141; Enciso-Mora V, 2010, NAT GENET, V42, P1126, DOI 10.1038/ng.696; Diepstra A, 2005, LANCET, V365, P2216, DOI 10.1016/S0140-6736(05)66780-3; GULLEY ML, 1994, BLOOD, V83, P1595; Urayama KY, 2012, J NATL CANCER I, V104, P240, DOI 10.1093/jnci/djr516; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Taylor GM, 1996, LEUKEMIA, V10, P854; Jarrett AF, 1996, ANN ONCOL, V7, P5; Aulchenko YS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-134; Dilthey A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002877; Ferlay J, 2013, GLOBOCAN 2012 V1 0 C; Frampton M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3549; Yu K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002551	21	0	0	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	1055-9965	1538-7755		CANCER EPIDEM BIOMAR	Cancer Epidemiol. Biomarkers Prev.	DEC	2015	24	12					1838	1843		10.1158/1055-9965.EPI-15-0534		6	Oncology; Public, Environmental & Occupational Health	Oncology; Public, Environmental & Occupational Health	CY0XB	WOS:000366129100004		
J	Kong, SY; Takeuchi, M; Hyogo, H; McKeown-Eyssen, G; Yamagishi, SI; Chayama, K; O'Brien, PJ; Ferrari, P; Overvad, K; Olsen, A; Tjonneland, A; Boutron-Ruault, MC; Bastide, N; Carbonnel, F; Kuehn, T; Kaaks, R; Boeing, H; Aleksandrova, K; Trichopoulou, A; Lagiou, P; Vasilopoulou, E; Masala, G; Pala, V; De Magistris, MS; Tumino, R; Naccarati, A; Bueno-de-Mesquita, HB; Peeters, PH; Weiderpass, E; Quiros, JR; Jakszyn, P; Sanchez, MJ; Dorronsoro, M; Gavrila, D; Ardanaz, E; Rutegard, M; Nystrom, H; Wareham, NJ; Khaw, KT; Bradbury, KE; Romieu, I; Freisling, H; Stavropoulou, F; Gunter, MJ; Cross, AJ; Riboli, E; Jenab, M; Bruce, WR				Kong, So Yeon; Takeuchi, Masayoshi; Hyogo, Hideyuki; McKeown-Eyssen, Gail; Yamagishi, Sho-Ichi; Chayama, Kazuaki; O'Brien, Peter J.; Ferrari, Pietro; Overvad, Kim; Olsen, Anja; Tjonneland, Anne; Boutron-Ruault, Marie-Christine; Bastide, Nadia; Carbonnel, Franck; Kuehn, Tilman; Kaaks, Rudolf; Boeing, Heiner; Aleksandrova, Krasimira; Trichopoulou, Antonia; Lagiou, Pagona; Vasilopoulou, Effie; Masala, Giovanna; Pala, Valeria; De Magistris, Maria Santucci; Tumino, Rosario; Naccarati, Alessio; Bueno-De-Mesquita, H. B.; Peeters, Petra H.; Weiderpass, Elisabete; Quiros, J. Ramon; Jakszyn, Paula; Sanchez, Maria-Jose; Dorronsoro, Miren; Gavrila, Diana; Ardanaz, Eva; Rutegard, Martin; Nystroem, Hanna; Wareham, Nicholas J.; Khaw, Kay-Tee; Bradbury, Kathryn E.; Romieu, Isabelle; Freisling, Heinz; Stavropoulou, Faidra; Gunter, Marc J.; Cross, Amanda J.; Riboli, Elio; Jenab, Mazda; Bruce, W. Robert			The Association between Glyceraldehyde-Derived Advanced Glycation End-Products and Colorectal Cancer Risk	CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION			English	Article							SOLUBLE RECEPTOR; ALCOHOL-CONSUMPTION; METABOLIC SYNDROME; RECTAL-CANCER; DIABETIC-RATS; NUTRITION; COLON; COMPLICATIONS; INFLAMMATION; ENDPRODUCTS	Background: A large proportion of colorectal cancers are thought to be associated with unhealthy dietary and lifestyle exposures, particularly energy excess, obesity, hyperinsulinemia, and hyperglycemia. It has been suggested that these processes stimulate the production of toxic reactive carbonyls from sugars such as glyceraldehyde. Glyceraldehyde contributes to the production of a group of compounds known as glyceraldehyde-derived advanced glycation end-products (glycer-AGEs), which may promote colorectal cancer through their proinflammatory and pro-oxidative properties. The objective of this study nested within a prospective cohort was to explore the association of circulating glycer-AGEs with risk of colorectal cancer. Methods: A total of 1,055 colorectal cancer cases (colon n = 659; rectal n = 396) were matchced (1: 1) to control subjects. Circulating glycer-AGEs were measured by a competitive ELISA. Multivariable conditional logistic regression models were used to calculate ORs and 95% confidence intervals (95% CI), adjusting for potential confounding factors, including smoking, alcohol, physical activity, body mass index, and diabetes status. Results: Elevated glycer-AGEs levels were not associated with colorectal cancer risk (highest vs. lowest quartile, 1.10; 95% CI, 0.82-1.49). Subgroup analyses showed possible divergence by anatomical subsites (OR for colon cancer, 0.83; 95% CI, 0.571.22; OR for rectal cancer, 1.90; 95% CI, 1.14-3.19; Pheterogeneity = 0.14). Conclusions: In this prospective study, circulating glycer-AGEs were not associated with risk of colon cancer, but showed a positive association with the risk of rectal cancer. Impact: Further research is needed to clarify the role of toxic products of carbohydrate metabolism and energy excess in colorectal cancer development. (C) 2015 AACR.	[Kong, So Yeon; Ferrari, Pietro; Romieu, Isabelle; Freisling, Heinz; Stavropoulou, Faidra; Jenab, Mazda] Int Agcy Res Canc IARC WHO, Sect Nutr & Metab, Lyon, France; [Takeuchi, Masayoshi] Kanazawa Med Univ, Med Res Inst, Dept Adv Med, Kanazawa, Ishikawa, Japan; [Hyogo, Hideyuki; Chayama, Kazuaki] Hiroshima Univ Hosp, Dept Gastroenterol & Metab, Hiroshima, Japan; [McKeown-Eyssen, Gail] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Yamagishi, Sho-Ichi] Kurume Univ, Sch Med, Dept Pathophysiol & Therapeut Diabet Vasc Complic, Kurume, Fukuoka 830, Japan; [O'Brien, Peter J.] Univ Toronto, Dept Pharmacol, Toronto, ON, Canada; [Overvad, Kim] Aarhus Univ, Dept Publ Hlth, Sect Epidemiol, Aarhus, Denmark; [Overvad, Kim] Danish Canc Soc Res Ctr, Diet Genes & Environm, Copenhagen, Denmark; [Boutron-Ruault, Marie-Christine; Bastide, Nadia; Carbonnel, Franck] Inst Gustave Roussy, EMT, Trans Generat Integrated Epidemiol, Life Style Genes & Health, Villejuif, France; [Carbonnel, Franck] Hop Bicetre, Serv Hepatogastroenterol, Le Kremlin Bicetre, France; [Kuehn, Tilman; Kaaks, Rudolf] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany; [Boeing, Heiner; Aleksandrova, Krasimira] German Inst Human Nutr Potsdam Rehbrucke, Dept Epidemiol, Nuthetal, Germany; [Trichopoulou, Antonia] Hellen Hlth Fdn, Athens, Greece; [Trichopoulou, Antonia; Lagiou, Pagona; Vasilopoulou, Effie] Univ Athens, Sch Med, Dept Hyg Epidemiol & Med Stat, GR-11527 Athens, Greece; [Trichopoulou, Antonia; Lagiou, Pagona] Acad Athens, Bur Epidemiol Res, Athens, Greece; [Lagiou, Pagona] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Masala, Giovanna] Canc Res & Prevent Inst ISPO, Mol & Nutr Epidemiol Unit, Florence, Italy; [Pala, Valeria] Natl Canc Inst, IRCCS Fdn, Epidemiol & Prevent Unit, Milan, Italy; [De Magistris, Maria Santucci] Azienda Osped Univ AOU Federico II, Naples, Italy; [Tumino, Rosario] Civ MP Arezzo Hosp, Canc Registry & Histopathol Unit, Ragusa, Italy; [Naccarati, Alessio] Torino Mol & Genet Epidemiol Unit, Human Genet Fdn, Turin, Italy; [Bueno-De-Mesquita, H. B.] Natl Inst Publ Hlth & Environm RIVM, Dept Determinants Chron Dis DCD, Bilthoven, Netherlands; [Bueno-De-Mesquita, H. B.] Univ Med Ctr, Dept Gastroenterol & Hepatol, Utrecht, Netherlands; [Bueno-De-Mesquita, H. B.] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Bueno-De-Mesquita, H. B.] Univ Malaya, Fac Med, Dept Social & Prevent Med, Kuala Lumpur, Malaysia; [Peeters, Petra H.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Dept Epidemiol, Utrecht, Netherlands; [Peeters, Petra H.] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, MRC PHE Ctr Environm & Hlth, London, England; [Weiderpass, Elisabete] UiT Arctic Univ Norway, Fac Hlth Sci, Dept Community Med, Tromso, Norway; [Weiderpass, Elisabete] Canc Registry Norway, Oslo, Norway; [Weiderpass, Elisabete] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Weiderpass, Elisabete] Folkhalsan Res Ctr, Dept Genet Epidemiol, Helsinki, Finland; [Quiros, J. Ramon] Publ Hlth Directorate, Asturias, Spain; [Jakszyn, Paula] Catalan Inst Oncol, Canc Epidemiol Res Program, Unit Nutr Environm & Canc, Barcelona, Spain; [Sanchez, Maria-Jose; Gavrila, Diana; Ardanaz, Eva] CIBER Epidemiol & Publ Hlth CIBERESP, Madrid, Spain; [Sanchez, Maria-Jose] Univ Granada, Hosp Univ Granada, Inst Invest Biosanitaria Ibs GRANADA, Escuela Andaluza Salud Publ, Granada, Spain; [Dorronsoro, Miren] Publ Hlth Direct & CIBERESP Biodonostia Res Ins, Basque Reg Hlth Dept, San Sebastian, Spain; [Gavrila, Diana] IMIB Arrixaca, Murcia Reg Hlth Council, Dept Epidemiol, Murcia, Spain; [Ardanaz, Eva] Navarre Publ Hlth Inst, Pamplona, Spain; [Rutegard, Martin; Nystroem, Hanna] Umea Univ, Dept Surg & Perioperat Sci, Dept Surg, S-90187 Umea, Sweden; [Wareham, Nicholas J.] Addenbrookes Hosp, Inst Metab Sci, MRC Epidemiol Unit, Cambridge, England; [Khaw, Kay-Tee] Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Clin Gerontol Unit, Cambridge CB2 1TN, England; [Bradbury, Kathryn E.] Univ Oxford, Nuffield Dept Populat Hlth, Canc Epidemiol Unit, Oxford, England; [Gunter, Marc J.; Cross, Amanda J.; Riboli, Elio] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, Sch Publ Hlth, London, England; [Bruce, W. Robert] Univ Toronto, Dept Nutr Sci, Toronto, ON, Canada	Jenab, M (reprint author), Int Agcy Res Canc, 150 Cours Albert Thomas, F-69372 Lyon 08, France.	jenabm@iarc.fr; wrbruce@utoronto.ca			Wereld Kanker Onderzoek Fonds as part of the World Cancer Research Fund (WCRF) International Regular Grant Programme [2010-251]; Japan Society for the Promotion of Science [22300264]; European Commission; International Agency for Research on Cancer; Danish Cancer Society (Denmark); Ligue Contre le Cancer; Institut Gustave Roussy; Mutuelle Generale de l'Education Nationale; Institut National de la Sante et de la Recherche Medicale (INSERM) (France); Deutsche Krebshilfe, Deutsches Krebsforschungszentrum (DKFZ); Federal Ministry of Education and Research (Germany); Stavros Niarchos Foundation; Hellenic Health Foundation (Greece); Italian Association for Research on Cancer (AIRC); National Research Council; AIRE-ONLUS Ragusa, AVIS Ragusa, Sicilian Government (Italy); Dutch Ministry of Public Health, Welfare, and Sports (VWS); Netherlands Cancer Registry (NKR); LK Research Funds; Dutch Prevention Funds; Dutch ZON (Zorg Onderzoek Nederland); World Cancer Research Fund (WCRF); Statistics Netherlands (the Netherlands); European Research Council (ERC); Nordforsk; Nordic Center of Excellence Programme on Food, Nutrition, and Health (Norway); Health Research Fund (FIS); Regional Government of Andalucia; Regional Government of Asturias; Regional Government of Basque; Regional Government of Country; Regional Government of Murcia [6236]; Regional Government of Navarra; ISCIII RETIC [RD06/0020]; Catalan Institute of Oncology (Spain); Swedish Cancer Society; Swedish Scientific Council; Regional Government of Skane (Sweden); Vasterbotten (Sweden); Medical Research Council; Stroke Association; British Heart Foundation; Department of Health; Food Standards Agency; Cancer Research UK/Welcome Trust (UK)	This work was funded by Wereld Kanker Onderzoek Fonds as part of the World Cancer Research Fund (WCRF) International Regular Grant Programme (grant number 2010-251; PI: M. Jenab). This work was also supported in part by grants from the Japan Society for the Promotion of Science [Grant-in-Aid for Scientific Research (B), #22300264; M. Takeuchi]. The coordination of EPIC is financially supported by the European Commission and the International Agency for Research on Cancer. The national cohorts are supported by Danish Cancer Society (Denmark); Ligue Contre le Cancer; Institut Gustave Roussy; Mutuelle Generale de l'Education Nationale; and Institut National de la Sante et de la Recherche Medicale (INSERM) (France); Deutsche Krebshilfe, Deutsches Krebsforschungszentrum (DKFZ); and Federal Ministry of Education and Research (Germany); Stavros Niarchos Foundation; Hellenic Health Foundation (Greece); Italian Association for Research on Cancer (AIRC); National Research Council; and AIRE-ONLUS Ragusa, AVIS Ragusa, Sicilian Government (Italy); Dutch Ministry of Public Health, Welfare, and Sports (VWS); Netherlands Cancer Registry (NKR); LK Research Funds; Dutch Prevention Funds; Dutch ZON (Zorg Onderzoek Nederland); World Cancer Research Fund (WCRF); and Statistics Netherlands (the Netherlands); European Research Council (ERC) and Nordforsk; and Nordic Center of Excellence Programme on Food, Nutrition, and Health (Norway); Health Research Fund (FIS); Regional Governments of Andalucia, Asturias, Basque Country, Murcia (No. 6236) and Navarra; and ISCIII RETIC (RD06/0020) and the Catalan Institute of Oncology (Spain); Swedish Cancer Society; Swedish Scientific Council; and Regional Government of Skane and Vasterbotten (Sweden); Medical Research Council; Stroke Association; British Heart Foundation; Department of Health; Food Standards Agency; and Cancer Research UK/Welcome Trust (UK; K.E. Bradbury and K.-T. Khaw).	Li FY, 2009, J ZHEJIANG UNIV-SC B, V10, P219, DOI 10.1631/jzus.B0820273; Cai WJ, 2002, MOL MED, V8, P337; Ciccocioppo R, 2013, WORLD J GASTROENTERO, V19, P8269, DOI 10.3748/wjg.v19.i45.8269; Chen PM, 2012, DIGEST DIS SCI, V57, P48, DOI 10.1007/s10620-011-1951-0; Singh R, 2001, DIABETOLOGIA, V44, P129, DOI 10.1007/s001250051591; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Iacobini C, 2009, J PATHOL, V218, P360, DOI 10.1002/path.2536; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Giovannucci E, 2007, AM J CLIN NUTR, V86, p836S; Usui T, 2004, BIOSCI BIOTECH BIOCH, V68, P333, DOI 10.1271/bbb.68.333; Ahmed N, 2005, DIABETES RES CLIN PR, V67, P3, DOI 10.1016/j.diabres.2004.09.004; Bongaerts BWC, 2008, INT J CANCER, V123, P2411, DOI 10.1002/ijc.23774; Hyogo H, 2007, J GASTROEN HEPATOL, V22, P1112, DOI 10.1111/j.1440-1746.2006.04943.x; Van Heijst JWJ, 2005, ANN NY ACAD SCI, V1043, P725, DOI 10.1196/annals.1333.084; Usui T, 2007, BIOSCI BIOTECH BIOCH, V71, P442, DOI 10.1271/bbb.60497; Leufkens AM, 2011, CLIN GASTROENTEROL H, V9, P137, DOI 10.1016/j.cgh.2010.10.012; Grote VA, 2012, CANCER EPIDEM BIOMAR, V21, P619, DOI 10.1158/1055-9965.EPI-11-1139; Chen HB, 2014, MOL CELL ENDOCRINOL, V395, P69, DOI 10.1016/j.mce.2014.07.021; Goldberg T, 2004, J AM DIET ASSOC, V104, P1287, DOI 10.1016/j.jada.2004.05.214; Takeuchi M, 2000, MOL MED, V6, P114; Siddiqui AA, 2011, AM J MED SCI, V341, P227, DOI 10.1097/MAJ.0b013e3181df9055; Norat T, 2005, J NATL CANCER I, V97, P906, DOI 10.1093/jnci/dji164; Vazzana N, 2009, INTERN EMERG MED, V4, P389, DOI 10.1007/s11739-009-0300-1; Choei H, 2004, ACTA NEUROPATHOL, V108, P189, DOI 10.1007/s00401-004-0871-x; Aleksandrova K, 2010, AM J EPIDEMIOL, V172, P407, DOI 10.1093/aje/kwq135; Berster Jutta M., 2008, Archives of Physiology and Biochemistry, V114, P84, DOI 10.1080/13813450802008455 ; Frattini M, 2004, CLIN CANCER RES, V10, P4015, DOI 10.1158/1078-0432.CCR-04-0031; Yan SF, 2003, CIRC RES, V93, P1159, DOI 10.1161/01.RES.0000103862.26506.3D; Yamagishi S, 2005, MED HYPOTHESES, V64, P1208, DOI 10.1016/j.mehy.2005.01.015; Jiao L, 2011, CANCER EPIDEM BIOMAR, V20, P1430, DOI 10.1158/1055-9965.EPI-11-0066; Li JL, 2012, J NEUROL SCI, V317, P1, DOI 10.1016/j.jns.2012.02.018; Ebata Y, 2013, INT J VITAM NUTR RES, V83, P137, DOI 10.1024/0300-9831/a000150; Del Turco S, 2012, BIOFACTORS, V38, P266, DOI 10.1002/biof.1018; Jinno M, 2011, HUM REPROD, V26, P604, DOI 10.1093/humrep/deq388; Rinaldi S, 2008, CANCER EPIDEM BIOMAR, V17, P3108, DOI 10.1158/1055-9965.EPI-08-0495; Yamagishi S, 2003, INT J CLIN PHARM RES, V23, P129; Otani T, 2003, CANCER EPIDEM BIOMAR, V12, P1492; Jiao L, 2011, CANCER RES, V71, P3582, DOI 10.1158/0008-5472.CAN-10-2573; Kalousova M, 2004, KIDNEY BLOOD PRESS R, V27, P18, DOI 10.1159/000075533; van Duijnhoven FJB, 2009, AM J CLIN NUTR, V89, P1441, DOI 10.3945/ajcn.2008.27120; Takino J, 2010, J GASTROENTEROL, V45, P646, DOI 10.1007/s00535-009-0193-9; Goldin A, 2006, CIRCULATION, V114, P597, DOI 10.1161/CIRCULATIONAHA.106.621854; Takeuchi M, 2010, J OPHTHALMOL, DOI 10.1155/2010/170393; VLASSARA H, 1994, LAB INVEST, V70, P138; Ferrari P, 2007, INT J CANCER, V121, P2065, DOI 10.1002/ijc.22966; Takeuchi M, 2004, MED HYPOTHESES, V63, P449, DOI 10.1016/j.mehy.2004.02.042; Riboli E, 2002, PUBLIC HEALTH NUTR, V5, P1113, DOI 10.1079/PHN2002394; Goh SY, 2008, J CLIN ENDOCR METAB, V93, P1143, DOI 10.1210/jc.2007-1817; Kandarakis SA, 2014, PROG RETIN EYE RES, V42, P85, DOI 10.1016/j.preteyeres.2014.05.002; Kapiteijn E, 2001, J PATHOL, V195, P171, DOI 10.1002/path.918; Tahara N, 2012, DIABETES CARE, V35, P2618, DOI 10.2337/dc12-0087; Kitamura M, 2005, BRIT J OPHTHALMOL, V89, P1407, DOI 10.1136/bjo.2005.072678; Yamamoto Y, 2007, DIABETES RES CLIN PR, V77, pS30, DOI 10.1016/j.diabres.2007.01.030; Nicholl ID, 1998, CELL MOL BIOL, V44, P1025; Benov L., 2010, ENDOGENOUS TOXINS, P153; Dong ZY, 2014, J LEUKOCYTE BIOL, V96, P1077, DOI 10.1189/jlb.3A0513-288RRR; Durko L, 2014, CURR COLORECTAL CANC, V10, P45, DOI DOI 10.1007/S11888-013-0203-4; Gkogkolou Paraskevi, 2012, Dermatoendocrinol, V4, P259, DOI 10.4161/derm.22028; Murphy N, 2012, PLOS ONE, V7; Riboli E, 1997, INT J EPIDEMIOL, V26, pS6, DOI 10.1093/ije/26.suppl_1.S6; Steins Bisschop CN, 2014, AM J CLIN NUTR, V99, P139; World Cancer Research Fund/American Institute for Cancer Research, 2011, FOOD NUTR PHYS ACT P	62	0	0	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	1055-9965	1538-7755		CANCER EPIDEM BIOMAR	Cancer Epidemiol. Biomarkers Prev.	DEC	2015	24	12					1855	1863		10.1158/1055-9965.EPI-15-0422		9	Oncology; Public, Environmental & Occupational Health	Oncology; Public, Environmental & Occupational Health	CY0XB	WOS:000366129100007		
J	Tsukamoto, O; Asanuma, H; Kitakaze, M				Tsukamoto, Osamu; Asanuma, Hiroshi; Kitakaze, Masafumi			Targeting lysosomal Ca2+ to reduce reperfusion injury	CARDIOVASCULAR RESEARCH			English	Editorial Material									[Tsukamoto, Osamu] Osaka Univ, Grad Sch Med, Dept Med Biochem, Suita, Osaka, Japan; [Asanuma, Hiroshi] Kyoto Prefectural Univ Med, Dept Cardiovasc Med, Kyoto, Japan; [Kitakaze, Masafumi] Natl Cerebral & Cardiovasc Ctr, Dept Clin Med & Dev, Suita, Osaka 5658565, Japan	Kitakaze, M (reprint author), Natl Cerebral & Cardiovasc Ctr, Dept Clin Med & Dev, 5-7-1 Fujishirodai, Suita, Osaka 5658565, Japan.	kitakaze@zf6.so-net.ne.jp					Cung TT, 2015, NEW ENGL J MED, V373, P1021, DOI 10.1056/NEJMoa1505489; Gilbert G, 2014, CARDIOVASC RES, V103, P313, DOI 10.1093/cvr/cvu069; Schafer C, 2001, CARDIOVASC RES, V51, P241, DOI 10.1016/S0008-6363(01)00282-6; Rosen D, 2009, J BIOL CHEM, V284, P34930, DOI 10.1074/jbc.M109.016519; Halestrap AP, 2004, CARDIOVASC RES, V61, P372, DOI 10.1016/S0008-6363(03)00533-9; Bell R, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0300-6; Davidson SM, 2015, CARDIOVASC RES, V108, P357, DOI 10.1093/cvr/cvv226; FABIATO A, 1983, AM J PHYSIOL, V245, pC1	8	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0008-6363	1755-3245		CARDIOVASC RES	Cardiovasc. Res.	DEC 1	2015	108	3					321	323		10.1093/cvr/cvv242		3	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CY4OQ	WOS:000366388000003		
J	Wang, LJ; Guo, M; Sawada, K; Lin, J; Zhang, JC				Wang, Liang-Jie; Guo, Min; Sawada, Kazuhide; Lin, Jie; Zhang, Jinchi			Landslide susceptibility mapping in Mizunami City, Japan: A comparison between logistic regression, bivariate statistical analysis and multivariate adaptive regression spline models	CATENA			English	Article						Landslide susceptibility; Logistic regression (LR); Bivariate statistical analysis (BS); MARSpline; Mizunami City	ARTIFICIAL NEURAL-NETWORKS; SUPPORT VECTOR MACHINE; ANALYTICAL HIERARCHY PROCESS; FREQUENCY RATIO; DECISION-TREE; TURKEY; AREA; GIS; CATCHMENT; MOUNTAINS	Landslides are dangerous natural hazards. Because of their threat, a comprehensive landslide susceptibility map should be produced to reduce the possible damages to people and infrastructure. The quality of landslide susceptibility maps is influenced by many factors, such as the quality of input data and the selection of mathematical models. This study aimed to identify the optimal quantitative method for landslide susceptibility mapping in Mizunami City, Japan. Three mathematical methods, logistic regression (LR), bivariate statistical analysis (BS), and multivariate adaptive regression spline models (MARSplines), were used to create landslide-susceptibility maps by comparing the past landslide distribution and the conditioning factor thematic maps. A landslide inventory map with a total of 222 landslide locations was extracted from aerial photographs provided by NIED (National Research Institute for Earth Science and Disaster Prevention, Japan). Then, the landslide inventory was randomly divided into two datasets: 50% was used for training the models and the remaining 50% for validation purposes. The landslide inventory map provided by NIED and an area under the ROC curve were used to evaluate model performance. We found that the MARSpline method resulted in a better prediction rate (79%) when compared to LR (75%) and BS (77%). In addition, a higher percentage of landslide polygons were found in the high to very high classes using the MARSpline method. Therefore, we concluded that the MARSpline method was the most efficient method for landslide susceptibility mapping in this study area. (C) 2015 Elsevier B.V. All rights reserved.	[Wang, Liang-Jie; Lin, Jie; Zhang, Jinchi] Nanjing Forestry Univ, Collaborat Innovat Ctr Sustainable Forestry South, Nanjing 210037, Jiangsu, Peoples R China; [Wang, Liang-Jie; Guo, Min; Sawada, Kazuhide] Gifu Univ, Grad Sch Engn, Gifu 5011193, Japan; [Lin, Jie; Zhang, Jinchi] Nanjing Forestry Univ, Jiangsu Prov Key Lab Soil Eros & Ecol Restorat, Nanjing 210037, Jiangsu, Peoples R China	Wang, LJ (reprint author), Nanjing Forestry Univ, Collaborat Innovat Ctr Sustainable Forestry South, Nanjing 210037, Jiangsu, Peoples R China.	ljwang0811@gmail.com			High Academic Talent Foundation Nanjing Forestry University [GXL2014037]; National Basic Research Program of China [31200534]; Priority Academic Program Development of Jiangsu High Education Institutions (PAPD); Gifu University	This research was supported by High Academic Talent Foundation Nanjing Forestry University (Grant No. GXL2014037), National Basic Research Program of China (Grant No. 31200534), Priority Academic Program Development of Jiangsu High Education Institutions (PAPD) and Gifu University. The author would like to thank Prof. Dr. G. Geoff Wang (Clemson University) and two other anonymous reviewers for their constructive comments and suggestions, which significantly improved the quality of this paper.	Pradhan B, 2010, ENVIRON MODELL SOFTW, V25, P747, DOI 10.1016/j.envsoft.2009.10.016; Ayalew L, 2004, LANDSLIDES, V1, P73, DOI 10.1007/s10346-003-0006-9; Ercanoglu M, 2002, ENVIRON GEOL, V41, P720, DOI 10.1007/s00254-001-0454-2; Vahidnia MH, 2010, COMPUT GEOSCI-UK, V36, P1101, DOI 10.1016/j.cageo.2010.04.004; Pradhan B, 2013, COMPUT GEOSCI-UK, V51, P350, DOI 10.1016/j.cageo.2012.08.023; Akgun A, 2007, ENVIRON GEOL, V51, P1377, DOI 10.1007/s00254-006-0435-6; Melchiorre C, 2008, GEOMORPHOLOGY, V94, P379, DOI 10.1016/j.geomorph.2006.10.035; Das I, 2010, GEOMORPHOLOGY, V114, P627, DOI 10.1016/j.geomorph.2009.09.023; Althuwaynee OF, 2014, CATENA, V114, P21, DOI 10.1016/j.catena.2013.10.011; Pradhan B, 2009, INT J PHYS SCI, V4, P1; Atkinson PM, 2011, GEOMORPHOLOGY, V130, P55, DOI 10.1016/j.geomorph.2011.02.001; Xu C, 2012, COMPUT GEOSCI-UK, V46, P317, DOI 10.1016/j.cageo.2012.01.002; Pradhan B, 2010, LANDSLIDES, V7, P13, DOI 10.1007/s10346-009-0183-2; Oh HJ, 2011, COMPUT GEOSCI-UK, V37, P1264, DOI 10.1016/j.cageo.2010.10.012; Lee S, 2007, LANDSLIDES, V4, P33, DOI 10.1007/s10346-006-0047-y; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Bai SB, 2010, GEOMORPHOLOGY, V115, P23, DOI 10.1016/j.geomorph.2009.09.025; Regmi NR, 2010, GEOMORPHOLOGY, V115, P172, DOI 10.1016/j.geomorph.2009.10.002; Nefeslioglu HA, 2008, ENG GEOL, V97, P171, DOI 10.1016/j.enggeo.2008.01.004; Kanungo D, 2008, LANDSLIDES, V5, P407, DOI 10.1007/s10346-008-0134-3; Suzen ML, 2004, ENG GEOL, V71, P303, DOI 10.1016/S0013-7952(03)00143-1; Yao X, 2008, GEOMORPHOLOGY, V101, P572, DOI 10.1016/j.geomorph.2008.02.011; Chen CH, 2009, ENVIRON GEOL, V57, P723, DOI 10.1007/s00254-008-1350-9; Ozdemir A, 2013, J ASIAN EARTH SCI, V64, P180, DOI 10.1016/j.jseaes.2012.12.014; Nandi A, 2010, ENG GEOL, V110, P11, DOI 10.1016/j.enggeo.2009.10.001; Yesilnacar E, 2005, ENG GEOL, V79, P251, DOI 10.1016/j.enggeo.2005.02.002; Pradhan B, 2010, ENVIRON EARTH SCI, V60, P1037, DOI 10.1007/s12665-009-0245-8; Saito H, 2009, GEOMORPHOLOGY, V109, P108, DOI 10.1016/j.geomorph.2009.02.026; Oh HJ, 2009, ENVIRON GEOL, V57, P641, DOI 10.1007/s00254-008-1342-9; Lee S, 2007, ENVIRON GEOL, V52, P615, DOI 10.1007/s00254-006-0491-y; Bui DT, 2012, GEOMORPHOLOGY, V171, P12, DOI 10.1016/j.geomorph.2012.04.023; Guzzetti F, 2006, GEOMORPHOLOGY, V81, P166, DOI 10.1016/j.geomorph.2006.04.007; Shahabi H, 2014, CATENA, V115, P55, DOI 10.1016/j.catena.2013.11.014; Lee S, 2007, EARTH SURF PROC LAND, V32, P2133, DOI 10.1002/esp.1517; Poudyal CP, 2010, ENVIRON EARTH SCI, V61, P1049, DOI 10.1007/s12665-009-0426-5; Kavzoglu T, 2014, LANDSLIDES, V11, P425, DOI 10.1007/s10346-013-0391-7; Felicisimo A, 2013, LANDSLIDES, V10, P175, DOI 10.1007/s10346-012-0320-1; Tunusluoglu MC, 2008, ENVIRON GEOL, V54, P9, DOI 10.1007/s00254-007-0788-5; Wang LJ, 2013, COMPUT GEOSCI-UK, V57, P81, DOI 10.1016/j.cageo.2013.04.006; Yilmaz I, 2010, ENVIRON EARTH SCI, V61, P821, DOI 10.1007/s12665-009-0394-9; Pradhan B, 2010, J INDIAN SOC REMOT, V38, P301, DOI 10.1007/s12524-010-0020-z; Conforti M, 2014, CATENA, V113, P236, DOI [10.1016/j.catena2013.08.006, 10.1016/j.catena.2013.08.006]; Muthu K, 2008, IEEE T GEOSCI REMOTE, V46, P1253, DOI 10.1109/TGRS.2007.912441; Brabb E.E., 1984, P 4 INT S LANDSL TOR, V1, P307; Demir G., 2014, ARAB J GEOSCI; Guzzetti F, 2005, THESIS; Varnes D.J, 1978, 176 TRANSP RES BOARD, P11; Yeon Y.-IC, 2010, ENG GEOL	48	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0341-8162	1872-6887		CATENA	Catena	DEC	2015	135						271	282		10.1016/j.catena.2015.08.007		12	Geosciences, Multidisciplinary; Soil Science; Water Resources	Geology; Agriculture; Water Resources	CY2GD	WOS:000366225900028		
J	Hou, MD; Ohkama-Ohtsu, N; Suzuki, S; Tanaka, H; Schmidhalter, U; Bellingrath-Kimura, SD				Hou, Mudan; Ohkama-Ohtsu, Naoko; Suzuki, Sohzoh; Tanaka, Haruo; Schmidhalter, Urs; Bellingrath-Kimura, Sonoko Dorothea			Nitrous oxide emission from tea soil under different fertilizer managements in Japan	CATENA			English	Article						Chemical fertilizer; Chicken manure; Nitrous oxide; Tea field; Row; Canopy	AGRICULTURAL SOILS; AVAILABLE DATA; N2O; FIELD; TEMPERATURE; TRANSPORT; PLANTS; RICE; NO; PH	A field experiment was conducted to assess N2O emissions in response to different fertilizer types and amounts in a heavily fertilized tea field in Japan. Four treatments were implemented: CONT: no fertilizer, CONV: conventional fertilization, 1/2CONV, and CHEM: chemical fertilization. Gas samples were collected 5-8 times after every fertilizer application using the closed chamber method. The results revealed high seasonal variation in N2O emissions driven by soil temperature rather than the fertilizer application time. The soil temperature at a depth of 0-10 cm was significantly correlated with N2O emission (P <0.01). The highest cumulative N2O emission (73.2 kg N ha(-1) yr(-1)) was observed in the CHEM treatment, followed by the CONV treatment (65.0 kg N ha(-1) yr(-1)), the 1/2CONV treatment (18.6 kg N ha(-1) yr(-1)) and the CONT treatment (1.8 kg N ha(-1) yr(-1)). The highest N2O emission factor (7.9%) was found in the CHEM treatment, followed by the CONV treatment (7.0%) and the 1/2CONV treatment (3.7%). There were spatial differences in the soil characteristics across the tea field. Accurate estimates of the ratios of N2O emitted from the four treatments during the two crop seasons were 47.9% and 52.1% from the soil on the rows (108.6 kg N ha(-1)) and under the canopies (118.3 kg N ha(-1)), respectively. (C) 2015 Elsevier B.V. All rights reserved.	[Hou, Mudan] Tokyo Univ Agr & Technol, Dept Biol Prod Sci, Grad Sch Agr, Fuchu, Tokyo 1838509, Japan; [Ohkama-Ohtsu, Naoko; Suzuki, Sohzoh; Tanaka, Haruo] Tokyo Univ Agr & Technol, Inst Agr, Fuchu, Tokyo 1838509, Japan; [Schmidhalter, Urs] Tech Univ Munich, Sch Life Sci Weihenstephan, Inst Plant Nutr, D-85354 Freising Weihenstephan, Germany; [Bellingrath-Kimura, Sonoko Dorothea] Leibniz Ctr Agr Landscape Res, Inst Land Use Syst, D-15374 Muncheberg, Germany	Bellingrath-Kimura, SD (reprint author), Leibniz Ctr Agr Landscape Res, Inst Land Use Syst, Eberswalder Str 84, D-15374 Muncheberg, Germany.	mudan_111@yahoo.co.jp; nohtsu@cc.tuat.ac.jp; sozosan@cc.tuat.ac.jp; haruo@cc.tuat.ac.jp; schmidhalter@wzw.tum.de; belks@zalf.de					Angria L, 2012, ARPN J AGR BIOL SCI, V7, P586; Luo GJ, 2013, BIOGEOSCIENCES, V10, P3205, DOI 10.5194/bg-10-3205-2013; Ruan J, 2010, PLANT BIOLOGY, V12, P724, DOI 10.1111/j.1438-8677.2009.00288.x; Hirono Y, 2012, SOIL SCI PLANT NUTR, V58, P384, DOI 10.1080/00380768.2012.686434; MULLER MM, 1980, APPL ENVIRON MICROB, V40, P235; EICHNER MJ, 1990, J ENVIRON QUAL, V19, P272; Glinski P, 2007, INT AGROPHYS, V21, P55; Akiyama H, 2006, SOIL SCI PLANT NUTR, V52, P774, DOI 10.1111/j.1747-0765.2006.00097.x; Chen Q, 2011, J IND MICROBIOL BIOT, V38, P1305, DOI 10.1007/s10295-010-0911-6; Xue D, 2006, PLANT SOIL, V288, P319, DOI 10.1007/s11104-006-9123-2; Mosier AR, 2006, J ENVIRON QUAL, V35, P1584, DOI 10.2134/jeq2005.0232; Chadwick DR, 2000, J ENVIRON QUAL, V29, P277; Tokuda S, 2004, SOIL SCI PLANT NUTR, V50, P365; Akiyama H, 2002, NUTR CYCL AGROECOSYS, V63, P219, DOI 10.1023/A:1021102925159; MUHAMMAD S, 1974, PLANT CELL PHYSIOL, V15, P747; Oh K, 2006, PEDOSPHERE, V16, P770, DOI 10.1016/S1002-0160(06)60113-6; Kaiser BN, 1998, SCIENCE, V281, P1202, DOI 10.1126/science.281.5380.1202; Nakasone H, 2004, PADDY WATER ENVIRON, V2, P45, DOI 10.1007/s10333-004-0039-2; Kroeze C, 1999, GLOBAL BIOGEOCHEM CY, V13, P1, DOI 10.1029/1998GB900020; Signor Diana, 2013, Pesquisa Agropecuaria Tropical, V43, P322, DOI 10.1590/S1983-40632013000300014; Mu ZJ, 2009, SOIL BIOL BIOCHEM, V41, P2593, DOI 10.1016/j.soilbio.2009.09.013; Li Y, 2013, GEODERMA, V193, P1, DOI 10.1016/j.geoderma.2012.10.008; Takaya N, 2003, APPL ENVIRON MICROB, V69, P3152, DOI 10.1128/AEM.69.6.3152-3157.2003; Mishima SI, 2012, SOIL SCI PLANT NUTR, V58, P83, DOI 10.1080/00380768.2012.658581; Han WY, 2013, ENVIRON EARTH SCI, V70, P2495, DOI 10.1007/s12665-013-2292-4; Kesik M, 2006, J APPL MICROBIOL, V101, P655, DOI 10.1111/j.1365-2672.2006.02927.x; Baggs E.M., 2010, WORLD C SOIL SCI SOI; Butterbach-Bahl K., 2013, PHILOS T ROYAL SOC B; IUSS Working Group W.R.B., 2007, WORLD SOIL RESOURCES; Japan Soil Science Society (JSSS), 1996, PROM PROGR ENV PROT, P78; Jumadi Oslan, 2005, Soil Science and Plant Nutrition, V51, P693, DOI 10.1111/j.1747-0765.2005.tb00093.x; Malenga N.E.A., 1987, Q NEWSLETTER TEA FDN, V87, P7; NIES (National Institute for Environmental Studies), 2012, NAT GREENH GAS INV R; Shammas Kh.N., 1986, J WATER POLLUTION CO, V58, P52; Smith KA, 1998, NUTR CYCL AGROECOSYS, V52, P123, DOI 10.1023/A:1009781518738; Snyder C.S., 2007, GREENHOUSE GAS EMISS; Solomon S., 2007, CONTRIBUTION WORKING; Tokuda S, 2000, SOIL SCI PLANT NUTR, V46, P835; Tokunaga T., 1996, B YAMAGUCHI AGR EXP, V47, P59; Uenosono S., 2004, SOIL SCI PLANT NUTR, V75, P313; Xu S., 2014, SCI WORLD J, P1; Yamamoto A., 2014, FAO, V50, P53	42	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0341-8162	1872-6887		CATENA	Catena	DEC	2015	135						304	312		10.1016/j.catena.2015.07.014		9	Geosciences, Multidisciplinary; Soil Science; Water Resources	Geology; Agriculture; Water Resources	CY2GD	WOS:000366225900031		
J	Matsumoto, S; Kasuga, J; Taiki, N; Makino, T; Arao, T				Matsumoto, Shingo; Kasuga, Junko; Taiki, Nozomi; Makino, Tomoyuki; Arao, Tomohito			Inhibition of arsenic accumulation in Japanese rice by the application of iron and silicate materials	CATENA			English	Article						Rice; Iron oxide; Available silicate; Arsenic; Arsenic-polluted region	ORYZA-SATIVA L.; SOLUTION CULTURE; PADDY SOILS; PLAQUE; ROOTS; NUTRITION; SEEDLINGS; OXIDES; PH	There are many rice paddy fields with relatively high arsenic (As) concentrations in areas that have not been subjected to countermeasures because the As level was below the criterion value established by the Agricultural Land Soil Contamination Prevention Law in Japan. To reduce the risk of excessive As in rice paddy fields,using agronomic methods applicable to common farming practices, we examined the effect of the application of iron (Fe) and silicate materials on As uptake by rice plants in bottomless concrete frames filled with soil collected from an area surrounding a former As-polluted region. Following the application of calcium silicate slag at a rate of 0.5 kg m(-2), no significant effect was observed on the As concentration in rice grain or straw, but the available silicate in the soil was increased. The application of Fe materials at a rate of 0.5 kg m(-2) resulted in a significant reduction of the As concentration in grain and straw, as shown by an analysis of variance. The lowest concentrations of As in both grain and straw were obtained with the application of a metal Fe powder (EM), followed by that with an Fe oxide material (FB), a converter furnace slag (FM), and the control. The EM and FE applications both significantly reduced the I M HCl-soluble As concentration in soil compared to the control. The levels of both acid ammonium oxalate extractable Fe (Fe-ox) and citrate-bicarbonate-dithionite extractable Fe (Fe-COB) in the soil were significantly increased by the application of EM and that of FE compared to the FM and the control. A negative significant correlation was obtained between the amount of 1 M HCl-soluble As and two types of free Fe oxide. These results suggest that the available As in soil was strongly fixed with the Fe oxides that were increased by the application of Fe materials, and that the decrease of available As in the soil induced a decrease in the As uptake by rice plants. The application of Fe materials will thus be effective to lower or prevent the risk of the rice cultivation in paddy fields with relatively high levels of As. (C) 2015 Elsevier B.V. All rights reserved.	[Matsumoto, Shingo; Kasuga, Junko] Shimane Univ, Fac Life & Environm Sci, Educ & Res Ctr Biol Resources, Matsue, Shimane 6901102, Japan; [Taiki, Nozomi] Nihon Mikuniya Corp, Shimane Off, Izumo, Shimane 6990502, Japan; [Makino, Tomoyuki; Arao, Tomohito] Natl Inst Agroenvironm Sci, Tsukuba, Ibaraki 3058604, Japan	Matsumoto, S (reprint author), Shimane Univ, Fac Life & Environm Sci, Educ & Res Ctr Biol Resources, 2059 Kamihonjo Cho, Matsue, Shimane 6901102, Japan.	smatsu@life.shimane-u.ac.jp			Ministry of Agriculture, Forestry, and Fisheries of Japan [AC-1122]	This work was supported by a grant from the Ministry of Agriculture, Forestry, and Fisheries of Japan (research project for ensuring food safety from farm to table AC-1122).	Akinbola G.E., 2013, J EXP SCI, V4, P22; Bogdan K, 2009, ENVIRON POLLUT, V157, P2617, DOI 10.1016/j.envpol.2009.05.008; Bogdan K, 2008, ENVIRON SCI TECHNOL, V42, P7885, DOI 10.1021/es801194q; Guo W, 2007, ENVIRON POLLUT, V148, P251, DOI 10.1016/j.envpol.2006.10.021; Williams PN, 2006, ENVIRON SCI TECHNOL, V40, P4903, DOI 10.1021/es060222i; TAYLOR GJ, 1984, AM J BOT, V71, P666, DOI 10.2307/2443363; van Bodegom PM, 2003, BIOGEOCHEMISTRY, V64, P231, DOI 10.1023/A:1024935107543; Yamaguchi N, 2011, CHEMOSPHERE, V83, P925, DOI 10.1016/j.chemosphere.2011.02.044; Qu D, 2004, B ENVIRON CONTAM TOX, V72, P1172, DOI 10.1007/s00128-004-0367-3; Goldberg S, 2002, SOIL SCI SOC AM J, V66, P413; Hansel CM, 2002, ENVIRON SCI TECHNOL, V36, P1988, DOI 10.1021/es015647d; MARIN AR, 1993, PLANT SOIL, V152, P245, DOI 10.1007/BF00029094; Seyfferth AL, 2012, ENVIRON SCI TECHNOL, V46, P13176, DOI 10.1021/es3025337; Nath S, 2014, PLANT PHYSIOL BIOCH, V80, P203, DOI 10.1016/j.plaphy.2014.04.013; Arao T, 2009, ENVIRON SCI TECHNOL, V43, P9361, DOI 10.1021/es9022738; ARMSTRONG W, 1964, NATURE, V204, P801, DOI 10.1038/204801b0; Liu WJ, 2004, NEW PHYTOL, V162, P481, DOI 10.1111/j.1469-8137.2004.01035.x; Takahashi Y, 2004, ENVIRON SCI TECHNOL, V38, P1038, DOI 10.1021/es034383n; Xu XY, 2008, ENVIRON SCI TECHNOL, V42, P5574, DOI 10.1021/es800324u; Xie ZM, 2006, MANAGING ARSENIC IN THE ENVIRONMENT: FROM SOIL TO HUMAN HEALTH, P223; Guo W, 2005, PLANT SOIL, V272, P173, DOI 10.1007/s11104-004-4732-0; Inskeep WP, 2002, BOOK SOIL P, P183; Li RY, 2009, ENVIRON SCI TECHNOL, V43, P3778, DOI 10.1021/es803643v; Iimura K., 1978, B HOKURIKU NATL AGR, V21, P95; JECFA, 2010, 73 JECFA M; JECFA, 1988, SUMM EV PERF JOINT F; Maejima Y., 2008, 2008 INT S SOIL HEAV, P76; Quazi S, 2013, J HAZARD MATER, V262, P1031, DOI 10.1016/j.jhazmat.2012.10.027; SHEPPARD SC, 1992, WATER AIR SOIL POLL, V64, P539, DOI 10.1007/BF00483364; Shigezumi M., 2002, Japanese Journal of Soil Science and Plant Nutrition, V73, P383; Yamane T., 1989, B SHIMANE AGR EXP, V24, P1; Yamane T., 1976, B SHIMANE AGR EXP, V14, P1	32	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0341-8162	1872-6887		CATENA	Catena	DEC	2015	135						328	335		10.1016/j.catena.2015.07.004		8	Geosciences, Multidisciplinary; Soil Science; Water Resources	Geology; Agriculture; Water Resources	CY2GD	WOS:000366225900034		
J	Mikani, A; Watari, Y; Takeda, M				Mikani, Azam; Watari, Yasuhiko; Takeda, Makio			Brain-midgut cross-talk and autocrine metabolastat via the sNPF/CCAP negative feed-back loop in the American cockroach, Periplaneta americana	CELL AND TISSUE RESEARCH			English	Article						Short neuropeptide F; Crustacean cardioactive peptide; Locomotor activity; Metabolastat; Periplaneta americana	CRUSTACEAN CARDIOACTIVE PEPTIDE; SHORT NEUROPEPTIDE-F; PARS INTERCEREBRALIS; NEUROSECRETORY-CELLS; PROTEASE ACTIVITY; TENEBRIO-MOLITOR; ALPHA-AMYLASE; IDENTIFICATION; CCAP; MYOSUPPRESSIN	Immunohistochemical reactivities against short neuropeptide F (sNPF-ir) and crustacean cardioactive peptide (CCAP-ir) were detected in both the brain-subesophageal ganglion (Br-SOG) and midgut epithelial cells of the male American cockroach, Periplaneta americana. Four weeks of starvation increased the number of sNPF-ir cells and decreased the CCAP-ir cells in the Br-SOG, whereas refeeding reversed these effects. The contents of sNPF in the Br-SOG, midgut and hemolymph titer decreased in response to an injection of CCAP into the hemocoel of normally fed male cockroaches, while CCAP titers/contents decreased in response to an injection of sNPF. The results of a double-labeling experiment demonstrated that sNPF-ir co-existed in CCAP-ir cells in the pars intercerebralis (PI), dorsolateral region of protocerebrum (DL), deutocerebrum (De) and SOG. sNPF-ir and CCAP-ir were also colocalized in the midgut. sNPF and CCAP are neuropeptides and midgut factors that interact with each other. Since the two peptides are known to be secreted by identical cells that affect each other, this constitutes autocrine negative feedback regulation for a quick response to food accessibility/inaccessibility. These peptides not only constitute the switch in the digestive mechanism but also couple digestive adaptation with behavior. A CCAP injection suppressed locomotor activity when cockroaches were starved, whereas sNPF activated it when they were fed.	[Mikani, Azam] Tarbiat Modares Univ, Fac Agr, Dept Entomol, Tehran, Iran; [Watari, Yasuhiko] Ashiya Univ, Biotechnol Lab, Fac Educ, Ashiya, Hyogo 6598511, Japan; [Takeda, Makio] Kobe Univ, Grad Sch Agr Sci, Nada Ku, Kobe, Hyogo 6578501, Japan	Takeda, M (reprint author), Kobe Univ, Grad Sch Agr Sci, Nada Ku, 1-1 Rokkodai Cho, Kobe, Hyogo 6578501, Japan.	a.mikani@modares.ac.ir; mtakeda@kobe-u.ac.jp					Matsui T, 2009, PHYSIOL BEHAV, V96, P548, DOI 10.1016/j.physbeh.2008.12.009; Dillen S, 2014, PEPTIDES, V53, P134, DOI [10.1016/j.peptides.2013.09.018, 10.1016/j.peplides.2013.09.018]; JANKOVICHLADNI M, 1978, J INSECT PHYSIOL, V24, P61, DOI 10.1016/0022-1910(78)90012-4; Wasielewski O, 2008, J COMP PHYSIOL B, V178, P877, DOI 10.1007/s00360-008-0276-6; Brown MR, 1999, PEPTIDES, V20, P1035, DOI 10.1016/S0196-9781(99)00097-2; Matsui T, 2013, J INSECT PHYSIOL, V59, P33, DOI 10.1016/j.jinsphys.2012.06.010; Sakai T, 2004, ENDOCRINOLOGY, V145, P5671, DOI 10.1210/en.2004-0722; Fouda MMA, 2010, J INSECT PHYSIOL, V56, P1728, DOI 10.1016/j.jinsphys.2010.07.003; Hummon AB, 2006, SCIENCE, V314, P647, DOI 10.1126/science.1124128; Shao QM, 2006, J BIOL RHYTHM, V21, P118, DOI 10.1177/0748730405283660; Vehovszky A, 2005, NEUROSCI LETT, V373, P200, DOI 10.1016/j.neulet.2004.10.020; Nassel DR, 2011, PEPTIDES, V32, P1335, DOI 10.1016/j.peptides.2011.03.013; VEENSTRA JA, 1995, BIOCHEM BIOPH RES CO, V213, P519, DOI 10.1006/bbrc.1995.2162; Garczynski SF, 2006, PEPTIDES, V27, P575, DOI 10.1016/j.peptide.2005.06.029; Mikani A, 2012, PEPTIDES, V34, P135, DOI 10.1016/j.peptides.2011.10.028; Sakai T, 2006, PEPTIDES, V27, P2157, DOI 10.1016/j.peptides.2006.04.009; Shao QM, 2010, J INSECT PHYSIOL, V56, P1576, DOI 10.1016/j.jinsphys.2010.05.015; Loi PK, 2001, J EXP BIOL, V204, P2803; Schoofs L, 2001, PEPTIDES, V22, P219, DOI 10.1016/S0196-9781(00)00385-5; THOMSEN E, 1963, J EXP BIOL, V40, P301; Park MS, 2009, CELL TISSUE RES, V335, P631, DOI 10.1007/s00441-008-0737-y; Fuse M, 1999, PEPTIDES, V20, P1285, DOI 10.1016/S0196-9781(99)00133-3; Audesley N, 2009, GEN COMP ENDOCR, V162, P93; Chen ME, 2006, ARCH INSECT BIOCH PH, V61, P198; Hong SH, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002857; Ichihara N, 2000, THESIS; MURALEEDHARAN D, 1979, J INSECT PHYSIOL, V25, P237, DOI 10.1016/0022-1910(79)90049-0; Nagata Shinji, 2012, Front Endocrinol (Lausanne), V3, P3, DOI 10.3389/fendo.2012.00003; Stagier J, 1987, PNAS, V84, P575; Strand FL, 1999, GUT BRAIN NEUROPEPTI, P383; Yamanaka N, 2008, PLOS ONE, V3, P30	31	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0302-766X	1432-0878		CELL TISSUE RES	Cell Tissue Res.	DEC	2015	362	3					481	496		10.1007/s00441-015-2242-4		16	Cell Biology	Cell Biology	CY3PP	WOS:000366322300002		
J	Hayashi, H; Schrott-Fischer, A; Glueckert, R; Liu, W; Salvenmoser, W; Santi, P; Rask-Andersen, H				Hayashi, Hisamitsu; Schrott-Fischer, Annelies; Glueckert, Rudolf; Liu, Wei; Salvenmoser, Willi; Santi, Peter; Rask-Andersen, Helge			Molecular organization and fine structure of the human tectorial membrane: is it replenished?	CELL AND TISSUE RESEARCH			English	Article						Tectorial membrane; Human; Electron microscopy; alpha-tectorin	NON-SYNDROMIC DEAFNESS; HEARING IMPAIRMENT; ALPHA-TECTORIN; INTERDENTAL CELLS; BASILAR-MEMBRANE; TRAVELING-WAVES; SPIRAL GANGLION; HUMAN COCHLEA; HUMAN ORGAN; CORTI	Auditory sensitivity and frequency resolution depend on the physical properties of the basilar membrane in combination with outer hair cell-based amplification in the cochlea. The physiological role of the tectorial membrane (TM) in hair cell transduction has been controversial for decades. New insights into the TM structure and function have been gained from studies of targeted gene disruption. Several missense mutations in genes regulating the human TM structure have been described with phenotypic expressions. Here, we portray the remarkable gradient structure and molecular organization of the human TM. Ultrastructural analysis and confocal immunohistochemistry were performed in freshly fixed human cochleae obtained during surgery. Based on these findings and recent literature, we discuss the role of human TMs in hair cell activation. Moreover, the outcome proposes that the alpha-tectorin-positive amorphous layer of the human TM is replenished and partly undergoes regeneration during life.	[Hayashi, Hisamitsu; Rask-Andersen, Helge] Univ Uppsala Hosp, Dept Surg Sci Head & Neck Surg, Otolaryngol Sect, SE-75185 Uppsala, Sweden; [Hayashi, Hisamitsu] Gifu Univ, Grad Sch Med, Dept Otolaryngol, Gifu, Gifu 5011194, Japan; [Schrott-Fischer, Annelies; Glueckert, Rudolf] Med Univ Innsbruck, Dept Otolaryngol, A-6020 Innsbruck, Austria; [Liu, Wei] Univ Uppsala Hosp, Otolaryngol Sect, Dept Surg Sci, SE-75185 Uppsala, Sweden; [Salvenmoser, Willi] Univ Innsbruck, Inst Zool, A-6020 Innsbruck, Austria; [Santi, Peter] Univ Minnesota, Dept Otolaryngol, Minneapolis, MN 55455 USA	Hayashi, H (reprint author), Univ Uppsala Hosp, Dept Surg Sci Head & Neck Surg, Otolaryngol Sect, SE-75185 Uppsala, Sweden.	hisamitsu.hayashi@surgsci.uu.se; annelies.schrott@i-med.ac.at; rudolf.glueckert@i-med.ac.at; lwoo24@gmail.com; willi.salvenmoser@uibk.ac.at; psanti@umn.edu; helge.rask-andersen@akademiska.se			Uppsala University Hospital; Uppsala University; Tysta Skolan Foundation; Swedish Deafness Foundation (HRF) and Land Tirol Technologie Forderungsprogram; Forderung von Wissenschaft; Forschung und Entwicklung (Programm K-Regio Vamel); Med El, Innsbruck, Austria; European Community; NANOCI [281056]; Borje Runogard, Sweden	This study was supported by ALF grants from Uppsala University Hospital and Uppsala University and by the Tysta Skolan Foundation, Swedish Deafness Foundation (HRF) and Land Tirol Technologie Forderungsprogram, Forderung von Wissenschaft, Forschung und Entwicklung (Programm K-Regio Vamel) and Med El, Innsbruck, Austria. Our research is part of the European Community 7th Framework Programme on Research, Technological Development and Demonstration. Project acronym: NANOCI. Grant agreement no: 281056. It was also supported by kindly donated private funds from Borje Runogard, Sweden. Dr. Klaus Qvortrup is acknowledged for providing oxygenated fluorocarbon fixative for the TEM investigation.	Mustapha M, 1999, HUM MOL GENET, V8, P409, DOI 10.1093/hmg/8.3.409; RICHARDSON GP, 1987, HEARING RES, V25, P45, DOI 10.1016/0378-5955(87)90078-5; SANTI PA, 1990, J ELECTRON MICR TECH, V15, P293, DOI 10.1002/jemt.1060150308; PRIETO JJ, 1990, HEARING RES, V45, P51, DOI 10.1016/0378-5955(90)90182-O; Lukashkin AN, 2012, P NATL ACAD SCI USA, V109, P19351, DOI 10.1073/pnas.1210159109; IURATO S, 1960, Z ZELLFORSCH MIK ANA, V52, P105, DOI 10.1007/BF00344642; Richter CP, 2007, BIOPHYS J, V93, P2265, DOI 10.1529/biophysj.106.094474; Moller MN, 2013, LARYNGOSCOPE, V123, P1967, DOI 10.1002/lary.23929; TANAKA K, 1975, ANN OTO RHINOL LARYN, V84, P287; Richardson GP, 2008, CURR OPIN OTOLARYNGO, V16, P458, DOI 10.1097/MOO.0b013e32830e20c4; Russell IJ, 2007, NAT NEUROSCI, V10, P215, DOI 10.1038/nn1828; SPOENDLIN H, 1988, ACTA OTO-LARYNGOL, V105, P403, DOI 10.3109/00016488809119493; Ghaffari R, 2007, P NATL ACAD SCI USA, V104, P16510, DOI 10.1073/pnas.0703665104; Liu W, 2009, HEARING RES, V250, P55, DOI 10.1016/j.heares.2009.01.010; LIM DJ, 1990, ACTA OTO-LARYNGOL, V110, P224, DOI 10.3109/00016489009122541; KHALKHALIELLIS Z, 1987, HEARING RES, V25, P185, DOI 10.1016/0378-5955(87)90090-6; Lukashkin AN, 2004, J NEUROPHYSIOL, V91, P163, DOI 10.1152/jn.00680.2003; Sellon JB, 2014, BIOPHYS J, V106, P1406, DOI 10.1016/j.bpj.2014.02.012; HUBBARD A, 1993, SCIENCE, V259, P68, DOI 10.1126/science.8418496; HASKO JA, 1988, HEARING RES, V35, P21, DOI 10.1016/0378-5955(88)90037-8; Tylstedt S, 1997, ACTA OTO-LARYNGOL, V117, P505, DOI 10.3109/00016489709113429; Alasti F, 2008, INT J PEDIATR OTORHI, V72, P249, DOI 10.1016/j.ijporl.2007.09.023; Meaud J, 2010, J ACOUST SOC AM, V127, P1411, DOI 10.1121/1.3290995; Pfister M, 2004, CELL PHYSIOL BIOCHEM, V14, P369, DOI 10.1159/000080347; ISHIYAMA E, 1970, PRACT-OTO-RHINO-LARY, V32, P321; GILLOYZAGA P, 1985, HEARING RES, V18, P269, DOI 10.1016/0378-5955(85)90043-7; Verpy E, 2001, NAT GENET, V29, P345, DOI 10.1038/ng726; Simmler MC, 2000, NAT GENET, V24, P139, DOI 10.1038/72793; Zheng J, 2011, P NATL ACAD SCI USA, V108, P4218, DOI 10.1073/pnas.1005842108; Verhoeven K, 1998, NAT GENET, V19, P60, DOI 10.1038/ng0598-60; THORN L, 1979, ANAT EMBRYOL, V155, P303, DOI 10.1007/BF00317643; Hardesty I, 1915, AM J ANAT, V18, P1, DOI 10.1002/aja.1000180102; Rask-Andersen H, 2012, ANAT REC, V295, P1791, DOI 10.1002/ar.22599; RUBIO ME, 1994, J HISTOCHEM CYTOCHEM, V42, P405; Glueckert R, 2005, HEARING RES, V199, P40, DOI 10.1016/j.heares.2004.05.006; KAWABATA I, 1981, ACTA OTO-LARYNGOL, V91, P29, DOI 10.3109/00016488109138479; Legan PK, 2000, NEURON, V28, P273, DOI 10.1016/S0896-6273(00)00102-1; Zwaenepoel I, 2002, P NATL ACAD SCI USA, V99, P6240, DOI 10.1073/pnas.082515999; HILDING AC, 1952, ANN OTO RHINOL LARYN, V61, P354; STEEL KP, 1983, HEARING RES, V9, P327, DOI 10.1016/0378-5955(83)90035-7; KRONESTERFREI A, 1978, CELL TISSUE RES, V193, P11; Gavara N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004877; HOSHINO T, 1981, ARCH OTO-RHINO-LARYN, V232, P65, DOI 10.1007/BF00661004; HOSHINO T, 1977, ARCH OTO-RHINO-LARYN, V217, P53, DOI 10.1007/BF00453890; Kimura R S, 1966, Acta Otolaryngol, V61, P55, DOI 10.3109/00016486609127043; LIM DJ, 1972, ARCHIV OTOLARYNGOL, V96, P199; LIM DJ, 1986, HEARING RES, V22, P117, DOI 10.1016/0378-5955(86)90089-4; Lim D J, 1969, Acta Otolaryngol Suppl, V255, P1; Teudt IU, 2014, JARO-J ASSOC RES OTO, V15, P675, DOI 10.1007/s10162-014-0463-y; Voldrich L, 1967, Acta Otolaryngol, V63, P503	50	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0302-766X	1432-0878		CELL TISSUE RES	Cell Tissue Res.	DEC	2015	362	3					513	527		10.1007/s00441-015-2225-5		15	Cell Biology	Cell Biology	CY3PP	WOS:000366322300004		
J	Okano, D; Ishida, S; Ishiguro, S; Kobayashi, K				Okano, Daisuke; Ishida, Sachiko; Ishiguro, Sei-ichi; Kobayashi, Kazuya			Light and electron microscopic studies of the intestinal epithelium in Notoplana humilis (Platyhelminthes, Polycladida): the contribution of mesodermal/gastrodermal neoblasts to intestinal regeneration	CELL AND TISSUE RESEARCH			English	Article						Polyclads (Polycladida); Neoblasts; Stem cells; Chromatoid body; Intestinal regeneration	PLANARIAN DUGESIA-JAPONICA; MACROSTOMUM-LIGNANO PLATYHELMINTHES; FREE-LIVING FLATWORMS; STEM-CELLS; CHROMATOID BODIES; PATTERN-FORMATION; GENE-EXPRESSION; FINE-STRUCTURE; TURBELLARIA; RNA	Some free-living flatworms in the phylum Platyhelminthes possess strong regenerative capability that depends on putative pluripotent stem cells known as neoblasts. These neoblasts are defined based on several criteria, including their proliferative capacity and the presence of cellular components known as chromatoid bodies. Polyclads, which are marine flatworms, have the potential to be a good model system for stem cell research, yet little information is available regarding neoblasts and regeneration. In this study, transmission electron microscopy and immunostaining analyses, using antibodies against phospho-histone H3 and BrdU, were used to identify two populations of neoblasts in the polyclad Notoplana humilis: mesodermal neoblasts (located in the mesenchymal space) and gastrodermal neoblasts (located within the intestine, where granular club cells and phagocytic cells are also located). Light and electron microscopic analyses also suggested that phagocytic cells and mesodermal/gastrodermal neoblasts, but not granular club cells, migrated into blastemas and remodeled the intestine during regeneration. Therefore, we suggest that, in polyclads, intestinal regeneration is accomplished by mechanisms underlying both morphallaxis (remodeling of pre-existing tissues) and epimorphosis (de novo tissue formation derived from mesodermal/gastrodermal neoblasts). Based on the assumption that gastrodermal neoblasts, which are derived from mesodermal neoblasts, are intestinal stem cells, we propose a model to study intestinal regeneration.	[Okano, Daisuke; Ishida, Sachiko; Kobayashi, Kazuya] Hirosaki Univ, Fac Agr & Life Sci, Dept Biol, Hirosaki, Aomori 0368561, Japan; [Okano, Daisuke; Ishida, Sachiko; Kobayashi, Kazuya] Iwate Univ, United Grad Sch Agr Sci, Morioka, Iwate 0208550, Japan; [Ishiguro, Sei-ichi] Hirosaki Univ, Fac Agr & Life Sci, Dept Mol Biol, Hirosaki, Aomori 0368561, Japan	Okano, D (reprint author), Hirosaki Univ, Fac Agr & Life Sci, Dept Biol, 3 Bunkyo Cho, Hirosaki, Aomori 0368561, Japan.	okano@hirosaki-u.ac.jp					BAGUNA J, 1981, HYDROBIOLOGIA, V84, P181, DOI 10.1007/BF00026179; MORITA M, 1984, J EXP ZOOL, V229, P425, DOI 10.1002/jez.1402290310; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Forsthoefel DJ, 2012, DEV CELL, V23, P691, DOI 10.1016/j.devcel.2012.09.008; Shibata N, 2012, INT J DEV BIOL, V56, P93, DOI 10.1387/ijdb.113434ns; COWARD SJ, 1974, ANAT REC, V180, P533, DOI 10.1002/ar.1091800312; Agata K, 2003, DEV DYNAM, V226, P308, DOI 10.1002/dvdy.10249; SAKURAI T, 1995, INVERTEBR REPROD DEV, V28, P77, DOI 10.1080/07924259.1995.9672468; Nimeth KT, 2007, CELL TISSUE RES, V327, P637, DOI 10.1007/s00441-006-0299-9; Takeo M, 2008, DEV DYNAM, V237, P1284, DOI 10.1002/dvdy.21518; Drobysheva IM, 1997, DOKL AKAD NAUK+, V353, P128; Egger B, 2007, DEV GENES EVOL, V217, P89, DOI 10.1007/s00427-006-0120-5; AULADELL C, 1993, J MORPHOL, V216, P319, DOI 10.1002/jmor.1052160307; Morgan TH, 1901, SCIENCE, V14, P235, DOI 10.1126/science.14.346.235; Wang YY, 2007, P NATL ACAD SCI USA, V104, P5901, DOI 10.1073/pnas.0609708104; BOWEN ID, 1974, PROTOPLASMA, V79, P1, DOI 10.1007/BF02055779; Newmark PA, 2000, DEV BIOL, V220, P142, DOI 10.1006/dbio.2000.9645; Jiang HQ, 2011, EXP CELL RES, V317, P2780, DOI 10.1016/j.yexcr.2011.07.020; Nakamura S, 2010, SCIENCE, V328, P1561, DOI 10.1126/science.1185473; Forsthoefel DJ, 2011, DEV BIOL, V356, P445, DOI 10.1016/j.ydbio.2011.05.669; Child CM, 1910, BIOL BULL-US, V19, P333, DOI 10.2307/1535949; Ito H, 2001, DEV GENES EVOL, V211, P2, DOI 10.1007/s004270000115; Barker N, 2014, NAT REV MOL CELL BIO, V15, P19, DOI 10.1038/nrm3721; SALO E, 1985, J EMBRYOL EXP MORPH, V89, P57; BAGUNA J, 1994, ZOOL SCI, V11, P781; Liu SY, 2013, NATURE, V500, P81, DOI 10.1038/nature12414; Salo E, 2002, J EXP ZOOL, V292, P528, DOI 10.1002/jez.90001; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; HORI I, 1985, J SUBMICR CYTOL PATH, V17, P569; [Anonymous], 2005, BIOL BULL; JENNINGS JB, 1957, BIOL BULL, V112, P63, DOI 10.2307/1538879; Sikes JM, 2013, NATURE, V500, P77, DOI 10.1038/nature12403; Orii H, 2005, DEV GENES EVOL, V215, P143, DOI 10.1007/s00427-004-0460-y; Nakagawa T, 2007, DEV CELL, V12, P195, DOI 10.1016/j.devcel.2007.01.002; Apidianakis Y, 2011, DIS MODEL MECH, V4, P21, DOI 10.1242/dmm.003970; Nakagawa T, 2010, SCIENCE, V328, P62, DOI 10.1126/science.1182868; Mashanov VS, 2011, BIOL BULL-US, V221, P93; SALO E, 1989, DEVELOPMENT, V107, P69; Wagner DE, 2011, SCIENCE, V332, P811, DOI 10.1126/science.1203983; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P725, DOI 10.1146/annurev.cellbio.20.010403.095114; Shibata N, 1999, DEV BIOL, V206, P73, DOI 10.1006/dbio.1998.9130; Solana J, 2009, DEV BIOL, V328, P410, DOI 10.1016/j.ydbio.2009.01.043; HORI I, 1986, J MORPHOL, V188, P69, DOI 10.1002/jmor.1051880107; Umesono Y, 2013, NATURE, V500, P73, DOI 10.1038/nature12359; REUTER M, 1987, ACTA ZOOL-STOCKHOLM, V68, P153; HORI I, 1982, J ELECTRON MICROSC, V31, P63; Rouhana L, 2012, DEVELOPMENT, V139, P1083, DOI 10.1242/dev.076182; Bode A, 2006, CELL TISSUE RES, V325, P577, DOI 10.1007/s00441-006-0196-2; LANGE CS, 1968, INT J RADIAT BIOL RE, V14, P373, DOI 10.1080/09553006814551221; Wenemoser D, 2010, DEV BIOL, V344, P979, DOI 10.1016/j.ydbio.2010.06.017; Sato K, 2001, DEV GROWTH DIFFER, V43, P107; HORI I, 1986, HYDROBIOLOGIA, V132, P217, DOI 10.1007/BF00046251; Bogitsh BJ, 1993, T AM MICROSC SOC, V112; Brondsted HV, 1969, PLANARIAN REGENERATI; Egger B, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-41; Garcia-Arraras JE, 2011, BMC EVOLUTIONARY BIO, V11, P1; Hyman LH, 1951, THE INVERTEBRATES, VII; Ishida S, 1986, ADV BIOL TURBELLARIA, P127; KUROTAKI M, 1972, Acta Anatomica Nipponica, V47, P237; Lapraz F, 2013, EVODEVO, V4, DOI 10.1186/2041-9139-4-29; Sánchez Alvarado Alejandro, 2006, Nat Rev Genet, V7, P873; Stimpson W, 1857, P ACAD NAT SCI PHILA, V9, P19; WOLFF ETIENNE, 1948, REV SUISSE ZOOL, V55, P218; Wolff E, 1962, REGENERATION, P53; Yoshida-Kashikawa M, 2007, DEV DYNAM, V236, P3436, DOI 10.1002/dvdy.21375	65	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0302-766X	1432-0878		CELL TISSUE RES	Cell Tissue Res.	DEC	2015	362	3					529	540		10.1007/s00441-015-2221-9		12	Cell Biology	Cell Biology	CY3PP	WOS:000366322300005		
J	Sohn, WJ; Gwon, GJ; Kim, HS; Neupane, S; Cho, SJ; Lee, JH; Yamamoto, H; Choi, JY; An, CH; Lee, Y; Shin, HI; Lee, S; Kim, JY				Sohn, Wern-Joo; Gwon, Gi-Jeong; Kim, Hyeng-Soo; Neupane, Sanjiv; Cho, Sung-Jin; Lee, Jae-Hyung; Yamamoto, Hitoshi; Choi, Je-Yong; An, Chang-Hyeon; Lee, Youngkyun; Shin, Hong-In; Lee, Sanggyu; Kim, Jae-Young			Mesenchymal signaling in dorsoventral differentiation of palatal epithelium	CELL AND TISSUE RESEARCH			English	Article						Palatal development; Epithelial differentiation; Epithelial-mesenchymal interactions; Dorsal and ventral patterning; Genome-wide screening	LASER CAPTURE MICRODISSECTION; EPIDERMAL-GROWTH-FACTOR; CLEFT-PALATE; CELL-PROLIFERATION; SECONDARY PALATE; MICE; GENE; PALATOGENESIS; BMP4; SKIN	After palatal fusion, the dorsal and ventral epithelia of the palatal shelf differentiate into the nasal and oral mucosa, respectively. The tissue-specific differentiation of palatal epithelia along the dorsal-ventral axis is regulated by the signaling molecules expressed in the underlying mesenchyme. Thus, as in many other epithelial organs, differentiation relies on epithelial-mesenchymal interactions. To screen for region-specific mesenchymal signaling molecules that determine the fate of the palatal epithelia, we employed a laser microdissection (LMD) method. LMD allowed us to collect region-specific mesenchymal tissues at E13, prior to palatal fusion and the development of distinct dorsal and ventral epithelial morphology. Genome-wide screening was performed on the tissues collected using LMD to identify candidate mesenchymal signaling molecules. The microarray results were validated using real-time quantitative (qPCR) and in situ hybridization methods. The developmental role and interactions of the candidate genes were evaluated in in vitro-cultivated E13 palates using an anti-sense oligodeoxynucleotide (AS-ODN)-based loss-of-function approach. Apparent changes in the expression patterns of Runt-related transcription factor 2 (Runx2) and LIM homeobox 8 (Lhx8) were observed after knocking down each gene. Knock-down of Runx2 and Lhx8 also altered the immunolocalization pattern of cytokeratin18 (CK18), an established marker for nasal epithelium. These results were confirmed using Runx2 heterozygote mice. The mesenchymal signaling molecules Runx2 and Lhx8, which possess region-specific expression patterns along the dorsoventral axis, functionally interact to regulate the cellular and molecular characteristics of dorsal and ventral epithelia, suggesting that mesenchymal signaling molecules determine the dorsoventral fate of epithelial structures in the developing palate.	[Sohn, Wern-Joo; Gwon, Gi-Jeong; Neupane, Sanjiv; Lee, Youngkyun; Kim, Jae-Young] Kyungpook Natl Univ, Dept Biochem, Sch Dent, IHBR, Daegu 700412, South Korea; [Kim, Hyeng-Soo; Lee, Sanggyu] Kyungpook Natl Univ, Sch Life Sci & Biotechnol, Daegu 700412, South Korea; [Cho, Sung-Jin] Chungbuk Natl Univ, Coll Nat Sci, Dept Biol, Cheongju, Chungbuk, South Korea; [Lee, Jae-Hyung] Kyung Hee Univ, Dept Maxillofacial Biomed Engn, Sch Dent, Seoul, South Korea; [Yamamoto, Hitoshi] Tokyo Dent Coll, Dept Histol & Dev Biol, Tokyo, Japan; [Choi, Je-Yong] Kyungpook Natl Univ, Dept Biochem & Cell Biol, Sch Med, Cell & Matrix Res Inst,Skeletal Dis Genome Res Ct, Daegu 700412, South Korea; [An, Chang-Hyeon] Kyungpook Natl Univ, Dept Oral & Maxillofacial Radiol, Sch Dent, IHBR, Daegu 700412, South Korea; [Shin, Hong-In] Kyungpook Natl Univ, Dept Oral Pathol & Regenerat Med, Sch Dent, IHBR, Daegu 700412, South Korea	Kim, JY (reprint author), Kyungpook Natl Univ, Dept Biochem, Sch Dent, IHBR, 2177 Dalgubeol Daero, Daegu 700412, South Korea.	jykim91@knu.ac.kr			National Research Foundation of Korea (NRF) - Korean Government (MSIP) [2008-0062282]; National Research Foundation of Korea - Ministry of Education, Science and Technology, Republic of Korea [NRF-2012R1A1A2044113, NRF-2010-0004243]; Kyungpook National University Research Fund	This study was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean Government (MSIP; no. 2008-0062282) and the National Research Foundation of Korea (grant NRF-2012R1A1A2044113 and NRF-2010-0004243) funded by the Ministry of Education, Science and Technology, Republic of Korea. This research was supported by Kyungpook National University Research Fund, 2012.	Rice R, 2004, J CLIN INVEST, V113, P1692, DOI 10.1172/JCI200420384; He FL, 2010, DEV BIOL, V347, P109, DOI 10.1016/j.ydbio.2010.08.014; Alappat SR, 2005, DEV BIOL, V277, P102, DOI 10.1016/j.ydbio.2004.09.010; Sohn WJ, 2012, MECH DEVELOP, V129, P244, DOI 10.1016/j.mod.2012.07.004; Jin JZ, 2010, DEV DYNAM, V239, P2110, DOI 10.1002/dvdy.22339; Jeong JH, 2010, MOL CELL BIOL, V30, P2365, DOI 10.1128/MCB.00672-09; Chuong CM, 1998, BIOCHEM CELL BIOL, V76, P1069, DOI 10.1139/bcb-76-6-1069; Xu JX, 2010, GENESIS, V48, P390, DOI 10.1002/dvg.20626; Miettinen PJ, 1999, NAT GENET, V22, P69, DOI 10.1038/8773; Zhao YG, 1999, P NATL ACAD SCI USA, V96, P15002, DOI 10.1073/pnas.96.26.15002; Lee JM, 2007, CELL TISSUE RES, V327, P285, DOI 10.1007/s00441-006-0271-8; Bjork BC, 2010, HUM MOL GENET, V19, P774, DOI 10.1093/hmg/ddp543; Cho KW, 2006, P NATL ACAD SCI USA, V103, P16788, DOI 10.1173/pnas.0604645103; Peters H, 1998, GENE DEV, V12, P2735, DOI 10.1101/gad.12.17.2735; CARETTE MJM, 1991, DIFFERENTIATION, V47, P149, DOI 10.1111/j.1432-0436.1991.tb00233.x; Han J, 2009, DEVELOPMENT, V136, P4225, DOI 10.1242/dev.036723; Chuong CM, 1996, J INVEST DERMATOL, V107, P639; Bindea G, 2013, BIOINFORMATICS, V29, P661, DOI 10.1093/bioinformatics/btt019; TYLER MS, 1980, J EMBRYOL EXP MORPH, V58, P93; Zhang ZY, 2002, DEVELOPMENT, V129, P4135; Chai Y, 2006, DEV DYNAM, V235, P2353, DOI 10.1002/dvdy.20833; Kerman IA, 2006, J NEUROSCI METH, V153, P71, DOI 10.1016/j.jneumeth.2005.10.010; Widelitz RB, 1997, MICROSC RES TECHNIQ, V38, P452, DOI 10.1002/(SICI)1097-0029(19970815)38:4<452::AID-JEMT13>3.0.CO;2-I; Lee JM, 2008, DEV BIOL, V314, P341, DOI 10.1016/j.ydbio.2007.11.033; Wang WZ, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-69; Chokechanachaisakul U, 2010, INT J DENT, V2010; Ferguson W J, 1984, Curr Top Dev Biol, V19, P137	27	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0302-766X	1432-0878		CELL TISSUE RES	Cell Tissue Res.	DEC	2015	362	3					541	556		10.1007/s00441-015-2222-8		16	Cell Biology	Cell Biology	CY3PP	WOS:000366322300006		
J	Yokohama-Tamaki, T; Otsu, K; Harada, H; Shibata, S; Obara, N; Irie, K; Taniguchi, A; Nagasawa, T; Aoki, K; Caliari, SR; Weisgerber, DW; Harley, BAC				Yokohama-Tamaki, Tamaki; Otsu, Keishi; Harada, Hidemitsu; Shibata, Shunichi; Obara, Nobuko; Irie, Kazuharu; Taniguchi, Akiyoshi; Nagasawa, Takashi; Aoki, Kazunari; Caliari, Steven R.; Weisgerber, Daniel W.; Harley, Brendan A. C.			CXCR4/CXCL12 signaling impacts enamel progenitor cell proliferation and motility in the dental stem cell niche	CELL AND TISSUE RESEARCH			English	Article						CXCR4/CXCL12 signal; Tooth; Dental stem cell niche; Migration; Proliferation	CHEMOKINE RECEPTOR CXCR4; PRECURSOR CELLS; MICE LACKING; MIGRATION; REGENERATION; CXCL12; LYMPHOPOIESIS; MYELOPOIESIS; MAINTENANCE; CHEMOTAXIS	Dental stem cells are located at the proximal ends of rodent incisors. These stem cells reside in the dental epithelial stem cell niche, termed the apical bud. We focused on identifying critical features of a chemotactic signal in the niche. Here, we report that CXCR4/CXCL12 signaling impacts enamel progenitor cell proliferation and motility in dental stem cell niche cells. We report cells in the apical bud express CXCR4 mRNA at high levels while expression is restricted in the basal epithelium (BE) and transit-amplifying (TA) cell regions. Furthermore, the CXCL12 ligand is present in mesenchymal cells adjacent to the apical bud. We then performed gain- and loss-of-function analyses to better elucidate the role of CXCR4 and CXCL12. CXCR4-deficient mice contain epithelial cell aggregates, while cell proliferation in mutant incisors was also significantly reduced. We demonstrate in vitro that dental epithelial cells migrate toward sources of CXCL12, whereas knocking down CXCR4 impaired motility and resulted in formation of dense cell colonies. These results suggest that CXCR4 expression may be critical for activation of enamel progenitor cell division and that CXCR4/CXCL12 signaling may control movement of epithelial progenitors from the dental stem cell niche.	[Yokohama-Tamaki, Tamaki; Obara, Nobuko; Irie, Kazuharu] Hlth Sci Univ Hokkaido, Div Histol, Dept Oral Growth & Dev, Sch Dent, Sapporo, Hokkaido, Japan; [Otsu, Keishi; Harada, Hidemitsu] Iwate Med Univ, Sch Dent, Div Oral Histol & Dev Biol, Morioka, Iwate, Japan; [Yokohama-Tamaki, Tamaki; Shibata, Shunichi] Tokyo Med & Dent Univ, Grad Sch, Maxillofacial Anat, Dept Maxillofacial Biol, Tokyo, Japan; [Taniguchi, Akiyoshi] Natl Inst Mat Sci, Ctr Biomat, Ibaraki, Japan; [Nagasawa, Takashi; Aoki, Kazunari] Kyoto Univ, Dept Immunobiol & Hematol, Inst Frontier Med Sci, Kyoto, Japan; [Caliari, Steven R.; Weisgerber, Daniel W.; Harley, Brendan A. C.] Univ Illinois, Dept Biomol & Chem Engn, Urbana, IL USA	Yokohama-Tamaki, T (reprint author), Hlth Sci Univ Hokkaido, Div Histol, Dept Oral Growth & Dev, Sch Dent, Sapporo, Hokkaido, Japan.	ttamaki.mfa@tmd.ac.jp; bharley@illinois.edu			JSPS KAKENHI [19791342, 15K20358]; Chemistry-Biology Interface Training Program NIH NIGMS [T32GM070421]; Chemical and Biomolecular Engineering Dept. (BAH); Institute for Genomic Biology (BAH) at the University of Illinois at Urbana-Champaign	We are grateful to Dr. Stephanie Tsang (University of Illinois at Urbana-Champaign), Dr. Myung-Eun Shin (Duke University Medical Center), and Ms. Yanzhen Li, M.A. (University of North Carolina) for critical discussions; to Mr. Naoyuki Tamaki (IBM Global Services Japan Solution and Services Company ISOL) for technical support in generating beautiful figures; Dr. Yuko Suzuki (Health Sciences University of Hokkaido) for excellent suggestions and for providing materials. This work was supported by JSPS KAKENHI Grant Numbers 19791342, 15K20358 to Y-T. T. We are also grateful for the funding for this study provided by the Chemistry-Biology Interface Training Program NIH NIGMS T32GM070421 (SRC) as well as the Chemical and Biomolecular Engineering Dept. (BAH), and the Institute for Genomic Biology (BAH) at the University of Illinois at Urbana-Champaign.	Kawamoto T, 2003, ARCH HISTOL CYTOL, V66, P123, DOI 10.1679/aohc.66.123; Brzoska E, 2012, BIOL CELL, V104, P722, DOI 10.1111/boc.201200022; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269; Ara T, 2003, P NATL ACAD SCI USA, V100, P5319, DOI 10.1073/pnas.0730719100; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Libura J, 2002, BLOOD, V100, P2597, DOI 10.1182/blood-2002-01-0031; ATCHLEY WR, 1985, GENETICS, V111, P579; Ho TK, 2010, J VASC SURG, V51, P689, DOI 10.1016/j.jvs.2009.10.044; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Otsu K, 2011, J CELL PHYSIOL, V226, P2527, DOI 10.1002/jcp.22597; Harada H, 2004, ARCH HISTOL CYTOL, V67, P1, DOI 10.1679/aohc.67.1; Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100; Theveneau E, 2010, DEV CELL, V19, P39, DOI 10.1016/j.devcel.2010.06.012; David NB, 2002, P NATL ACAD SCI USA, V99, P16297, DOI 10.1073/pnas.252339399; Suzuki T, 2011, J DENT RES, V90, P1013, DOI 10.1177/0022034511408426; Jin J, 2013, OPHTHALMIC RES, V50, P6, DOI 10.1159/000348532; Yokohama-Tamaki T, 2011, J ANAT, V218, P517, DOI 10.1111/j.1469-7580.2011.01354.x; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Yoshida T, 2013, J CELL BIOCHEM, V114, P2138, DOI 10.1002/jcb.24564; Caliari SR, 2011, BIOMATERIALS, V32, P5330, DOI 10.1016/j.biomaterials.2011.04.021; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; Nystul T, 2007, CELL STEM CELL, V1, P277, DOI 10.1016/j.stem.2007.07.009; Thesleff I, 2007, CR BIOL, V330, P561, DOI 10.1016/j.crvi.2007.03.005; Harada H, 1999, J CELL BIOL, V147, P105, DOI 10.1083/jcb.147.1.105; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Harada H, 2002, DEVELOPMENT, V129, P1533; Ni HT, 2004, DEV BRAIN RES, V152, P159, DOI 10.1016/j.devbrainres.2004.06.015; Jiang L, 2008, J ENDODONT, V34, P939, DOI 10.1016/j.joen.2008.05.015; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Li CY, 2005, DEV BIOL, V366, P357; Maysami S, 2006, NEUROREPORT, V17, P1187, DOI 10.1097/01.wnr.0000227985.92551.9a; O' Hayre M, 2010, PLOS ONE, V22; Wang XP, 2007, PLOS BIOL, V5, P1324, DOI 10.1371/journal.pbio.0050159; Yokohama-Tamaki T., 2008, OPEN BIOTECHNOL J, V2, P111, DOI [10.2174/1874070700802020111, DOI 10.2174/1874070700802020111]	34	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0302-766X	1432-0878		CELL TISSUE RES	Cell Tissue Res.	DEC	2015	362	3					633	642		10.1007/s00441-015-2248-y		10	Cell Biology	Cell Biology	CY3PP	WOS:000366322300014		
J	Kakumura, K; Takabe, S; Takagi, W; Hasegawa, K; Konno, N; Bell, JD; Toop, T; Donald, JA; Kaneko, T; Hyodo, S				Kakumura, Keigo; Takabe, Souichirou; Takagi, Wataru; Hasegawa, Kumi; Konno, Norifumi; Bell, Justin D.; Toop, Tes; Donald, John A.; Kaneko, Toyoji; Hyodo, Susumu			Morphological and molecular investigations of the holocephalan elephant fish nephron: the existence of a countercurrent-like configuration and two separate diluting segments in the distal tubule	CELL AND TISSUE RESEARCH			English	Article						Cartilaginous fish; Kidney; Urea reabsorption; Membrane transporter; Diluting segment	DOGFISH SQUALUS-ACANTHIAS; COMPUTER-ASSISTED RECONSTRUCTION; ELASMOBRANCH RENAL TUBULE; SKATE RAJA-ERINACEA; SCYLIORHINUS-CANICULUS; CALLORHINCHUS-MILII; FINE-STRUCTURE; MARINE ELASMOBRANCHS; BANDED HOUNDSHARK; TRIAKIS SCYLLIUM	In marine cartilaginous fish, reabsorption of filtered urea by the kidney is essential for retaining a large amount of urea in their body. However, the mechanism for urea reabsorption is poorly understood due to the complexity of the kidney. To address this problem, we focused on elephant fish (Callorhinchus milii) for which a genome database is available, and conducted molecular mapping of membrane transporters along the different segments of the nephron. Basically, the nephron architecture of elephant fish was similar to that described for elasmobranch nephrons, but some unique features were observed. The late distal tubule (LDT), which corresponded to the fourth loop of the nephron, ran straight near the renal corpuscle, while it was convoluted around the tip of the loop. The ascending and descending limbs of the straight portion were closely apposed to each other and were arranged in a countercurrent fashion. The convoluted portion of LDT was tightly packed and enveloped by the larger convolution of the second loop that originated from the same renal corpuscle. In situ hybridization analysis demonstrated that co-localization of Na+,K+,2Cl(-) cotransporter 2 and Na+/K+-ATPase alpha 1 subunit was observed in the early distal tubule and the posterior part of LDT, indicating the existence of two separate diluting segments. The diluting segments most likely facilitate NaCl absorption and thereby water reabsorption to elevate urea concentration in the filtrate, and subsequently contribute to efficient urea reabsorption in the final segment of the nephron, the collecting tubule, where urea transporter-1 was intensely localized.	[Kakumura, Keigo; Takabe, Souichirou; Takagi, Wataru; Hasegawa, Kumi; Hyodo, Susumu] Univ Tokyo, Atmosphere & Ocean Res Inst, Physiol Lab, Kashiwa, Chiba 2778564, Japan; [Kakumura, Keigo; Kaneko, Toyoji] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Aquat Biosci, Lab Aquat Anim Physiol,Bunkyo Ku, Tokyo 1138657, Japan; [Konno, Norifumi] Toyama Univ, Grad Sch Sci & Engn, Dept Biol Sci, Toyama 9308555, Japan; [Bell, Justin D.] Univ Tasmania, Inst Marine & Antarctic Studies, Taroona, Tas 7053, Australia; [Toop, Tes; Donald, John A.] Deakin Univ, Sch Life & Environm Sci, Geelong, Vic 3217, Australia	Kakumura, K (reprint author), Univ Tokyo, Atmosphere & Ocean Res Inst, Physiol Lab, 5-1-5 Kashiwa No Ha, Kashiwa, Chiba 2778564, Japan.	kakumura@marine.fs.a.u-tokyo.ac.jp					HENTSCHEL H, 1993, ANAT REC, V235, P511, DOI 10.1002/ar.1092350404; HENTSCHEL H, 1987, ZOOMORPHOLOGY, V107, P115, DOI 10.1007/BF00312121; HENTSCHEL H, 1986, COMP BIOCHEM PHYS A, V84, P553, DOI 10.1016/0300-9629(86)90364-6; LACY ER, 1991, AM J ANAT, V190, P118, DOI 10.1002/aja.1001900203; Kakumura K, 2009, COMP BIOCHEM PHYS B, V154, P239, DOI 10.1016/j.cbpb.2009.06.009; SWENSON ER, 1994, AM J PHYSIOL-RENAL, V267, pF639; BOYLAN JW, 1972, COMP BIOCHEM PHYSIOL, V42, P27, DOI 10.1016/0300-9629(72)90361-1; Clarke RW, 1932, J CELL COMPAR PHYSL, V1, P131, DOI 10.1002/jcp.1030010202; Smith HW, 1936, BIOL REV CAMB PHILOS, V11, P49, DOI 10.1111/j.1469-185X.1936.tb00497.x; LACY ER, 1985, ANAT EMBRYOL, V173, P23, DOI 10.1007/BF00707301; HENTSCHEL H, 1991, AM J ANAT, V190, P309, DOI 10.1002/aja.1001900402; Morgan RL, 2003, J EXP BIOL, V206, P3293, DOI 10.1242/jeb.00555; Li SS, 2013, AM J PHYSIOL-REG I, V304, pR865, DOI 10.1152/ajpregu.00417.2012; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633; Hyodo S, 2007, J EXP BIOL, V210, P1303, DOI 10.1242/jeb.003418; EVANS DH, 1985, J EXP BIOL, V119, P375; Yamaguchi Y, 2009, J EXP ZOOL PART A, V311A, P705, DOI 10.1002/jez.558; MCMANUS JFA, 1946, NATURE, V158, P202, DOI 10.1038/158202a0; LACY ER, 1985, SCIENCE, V227, P1351, DOI 10.1126/science.3975620; Nakada T, 2010, J BIOL CHEM, V285, P2653, DOI 10.1074/jbc.M109.052068; Althoff T, 2006, AM J PHYSIOL-REG I, V290, pR1094, DOI 10.1152/ajpregu.00334.2005; PAYAN P, 1973, AM J PHYSIOL, V224, P367; GAMBA G, 1994, J BIOL CHEM, V269, P17713; LACY ER, 1991, AM J ANAT, V192, P478, DOI 10.1002/aja.1001920413; WOOD CM, 1995, J EXP BIOL, V198, P1545; Takabe S, 2012, CELL TISSUE RES, V348, P141, DOI 10.1007/s00441-012-1344-5; LACY ER, 1985, ANAT EMBRYOL, V173, P163, DOI 10.1007/BF00316299; Hentschel H, 1998, ANAT EMBRYOL, V198, P73, DOI 10.1007/s004290050166; KEMPTON RT, 1953, BIOL BULL, V104, P45, DOI 10.2307/1538690; Hyodo S, 2004, J EXP BIOL, V207, P347, DOI 10.1242/jeb.00773; Hebert SC, 2004, PFLUG ARCH EUR J PHY, V447, P580, DOI 10.1007/s00424-003-1066-3; Biemesderfer D, 1996, AM J PHYSIOL-RENAL, V270, pF927; Venkatesh B, 2014, NATURE, V505, P174, DOI 10.1038/nature12826; KOKKO JP, 1972, KIDNEY INT, V2, P214, DOI 10.1038/ki.1972.97; LACY ER, 1986, ANAT EMBRYOL, V173, P299, DOI 10.1007/BF00318913; Cutler CP, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00021; Cutler CP, 2012, FRONT PHYSIOL, V2, pCP4, DOI 10.3389/fphys.2011.00107; Deetjen P, 1970, Bull. Mt Desert Isl. biol. Lab., V10, P5; FRIEDMAN PA, 1990, AM J PHYSIOL, V258, pR398; GOLDSTEI.L, 1971, AM J PHYSIOL, V220, P742; Hwang PP, 2011, AM J PHYSIOL-REG I, V301, pR28, DOI 10.1152/ajpregu.00047.2011; Kato A, 2011, AM J PHYSIOL-REG I, V300, pR284, DOI 10.1152/ajpregu.00725.2009; Marshall W, 2006, PHYSL FISHES, V3, P177; SCHMIDTN.B, 1972, COMP BIOCHEM PHYSIOL, V42, P13, DOI 10.1016/0300-9629(72)90360-X; STEPHENS.JL, 1972, KIDNEY INT, V2, P85, DOI 10.1038/ki.1972.75; Venkatesh B, 2007, PLOS BIOL, V5, P932, DOI 10.1371/journal.pbio.0050101	46	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0302-766X	1432-0878		CELL TISSUE RES	Cell Tissue Res.	DEC	2015	362	3					677	688		10.1007/s00441-015-2234-4		12	Cell Biology	Cell Biology	CY3PP	WOS:000366322300018		
J	Hayashi, H; Schrott-Fischer, A; Glueckert, R; Liu, W; Salvenmoser, W; Santi, P; Rask-Andersen, H				Hayashi, Hisamitsu; Schrott-Fischer, Annelies; Glueckert, Rudolf; Liu, Wei; Salvenmoser, Willi; Santi, Peter; Rask-Andersen, Helge			Molecular organization and fine structure of the human tectorial membrane: is it replenished? (vol 362, pg 513, 2015)	CELL AND TISSUE RESEARCH			English	Correction									[Hayashi, Hisamitsu; Rask-Andersen, Helge] Univ Uppsala Hosp, Dept Surg Sci, Otolaryngol Sect, Head & Neck Surg, SE-75185 Uppsala, Sweden; [Hayashi, Hisamitsu] Gifu Univ, Grad Sch Med, Dept Otolaryngol, Gifu, Gifu 5011194, Japan; [Schrott-Fischer, Annelies; Glueckert, Rudolf] Med Univ Innsbruck, Dept Otolaryngol, A-6020 Innsbruck, Austria; [Liu, Wei] Univ Uppsala Hosp, Dept Surg Sci, Otolaryngol Sect, SE-75185 Uppsala, Sweden; [Salvenmoser, Willi] Univ Innsbruck, Inst Zool, A-6020 Innsbruck, Austria; [Santi, Peter] Univ Minnesota, Dept Otolaryngol, Minneapolis, MN 55455 USA	Hayashi, H (reprint author), Univ Uppsala Hosp, Dept Surg Sci, Otolaryngol Sect, Head & Neck Surg, SE-75185 Uppsala, Sweden.	hisamitsu.hayashi@surgsci.uu.se; annelies.schrott@i-med.ac.at; rudolf.glueckert@i-med.ac.at; lwoo24@gmail.com; willi.salvenmoser@uibk.ac.at; psanti@umn.edu; helge.rask-andersen@akademiska.se					Hayashi H, 2015, CELL TISSUE RES, V362, P513, DOI 10.1007/s00441-015-2225-5	1	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0302-766X	1432-0878		CELL TISSUE RES	Cell Tissue Res.	DEC	2015	362	3					689	690		10.1007/s00441-015-2284-7		2	Cell Biology	Cell Biology	CY3PP	WOS:000366322300019		
J	Shinoda, K; Ohyama, K; Hasegawa, Y; Chang, HY; Ogura, M; Sato, A; Hong, H; Hosono, T; Sharp, LZ; Scheel, DW; Graham, M; Ishihama, Y; Kajimura, S				Shinoda, Kosaku; Ohyama, Kana; Hasegawa, Yutaka; Chang, Hsin-Yi; Ogura, Mayu; Sato, Ayaka; Hong, Haemin; Hosono, Takashi; Sharp, Louis Z.; Scheel, David W.; Graham, Mark; Ishihama, Yasushi; Kajimura, Shingo			Phosphoproteomics Identifies CK2 as a Negative Regulator of Beige Adipocyte Thermogenesis and Energy Expenditure	CELL METABOLISM			English	Article							BROWN ADIPOSE-TISSUE; PROTEIN-KINASE CK2; FUNCTIONAL-CHARACTERIZATION; TRANSCRIPTIONAL COMPLEX; SIGNALING NETWORKS; INHIBITOR CX-4945; GENE-EXPRESSION; FAT DEVELOPMENT; CANCER-CELLS; PRDM16	Catecholamines promote lipolysis both in brown and white adipocytes, whereas the same stimuli preferentially activate thermogenesis in brown adipocytes. Molecular mechanisms for the adipose-selective activation of thermogenesis remain poorly understood. Here, we employed quantitative phosphoproteomics to map global and temporal phosphorylation profiles in brown, beige, and white adipocytes under beta 3-adrenenoceptor activation and identified kinases responsible for the adipose-selective phosphorylation profiles. We found that casein kinase2 (CK2) activity is preferentially higher in white adipocytes than brown/beige adipocytes. Genetic or pharmacological blockade of CK2 in white adipocytes activates the thermogenic program in response to cAMP stimuli. Such activation is largely through reduced CK2-mediated phosphorylation of class I HDACs. Notably, inhibition of CK2 promotes beige adipocyte biogenesis and leads to an increase in whole-body energy expenditure and ameliorates diet-induced obesity and insulin resistance. These results indicate that CK2 is a plausible target to rewire the beta 3-adrenenoceptor signaling cascade that promotes thermogenesis in adipocytes.	[Shinoda, Kosaku; Ohyama, Kana; Hasegawa, Yutaka; Hong, Haemin; Hosono, Takashi; Sharp, Louis Z.; Scheel, David W.; Kajimura, Shingo] Univ Calif San Francisco, UCSF Diabet Ctr, San Francisco, CA 94143 USA; [Shinoda, Kosaku; Ohyama, Kana; Hasegawa, Yutaka; Hong, Haemin; Hosono, Takashi; Sharp, Louis Z.; Scheel, David W.; Kajimura, Shingo] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA; [Chang, Hsin-Yi; Ogura, Mayu; Sato, Ayaka; Ishihama, Yasushi] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Mol & Cellular Bioanal, Kyoto 6068501, Japan; [Graham, Mark] ISIS Pharmaceut Inc, Dept Antisense Drug Discovery, Cardiovasc Grp, Carlsbad, CA 92008 USA	Kajimura, S (reprint author), Univ Calif San Francisco, UCSF Diabet Ctr, 35 Med Ctr Way, San Francisco, CA 94143 USA.	skajimura@diabetes.ucsf.edu			NIH [DK087853, DK97441]; DERC center grant [DK63720]; UCSF Liver Center [P30 DK026743]; Pew Charitable Trust; PRESTO from Japan Science and Technology Agency; Larry L. Hillblom Foundation; Manpei Suzuki Diabetes Foundation; Japan Society for the Promotion of Science	We are grateful to Dr. Patrick Seale for providing the cell line, and to Dr. Yuriy Kirichok, Dr. Christophe Paillart, Kathleen Jay, Dylan Lowe, Miranda Broz, and Svetlana Keylin for their kind support. This work was supported by grants from the NIH (DK087853 and DK97441) to S.K. We also acknowledge supports from the DERC center grant (DK63720), UCSF Liver Center (P30 DK026743), the Pew Charitable Trust, and PRESTO from Japan Science and Technology Agency (also to S.K.). K.S. is supported by a fellowship from The Larry L. Hillblom Foundation. Y.H. is supported by Manpei Suzuki Diabetes Foundation. M.G. is an employee and stock holder of Isis Pharmaceuticals. H.C. is supported by a fellowship from the Japan Society for the Promotion of Science.	Yamana R, 2013, J PROTEOME RES, V12, P214, DOI 10.1021/pr300837u; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Cao WH, 2001, J BIOL CHEM, V276, P27077, DOI 10.1074/jbc.M101049200; Duncan RE, 2007, ANNU REV NUTR, V27, P79, DOI 10.1146/annurev.nutr.27.061406.093734; Bliesath J, 2012, CANCER LETT, V322, P113, DOI 10.1016/j.canlet.2012.02.032; van der Lans AAJJ, 2013, J CLIN INVEST, V123, P3395, DOI 10.1172/JCI68993; Zheng Y, 2013, CLIN CANCER RES, V19, P6484, DOI 10.1158/1078-0432.CCR-13-0265; Kajimura S, 2009, NATURE, V460, P1154, DOI 10.1038/nature08262; Eom GH, 2011, CIRCULATION, V123, P2392, DOI 10.1161/CIRCULATIONAHA.110.003665; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Ohno H, 2013, NATURE, V504, P163, DOI 10.1038/nature12652; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Hou ZY, 2012, J MED CHEM, V55, P2899, DOI 10.1021/jm2015167; Siddiqui-Jain A, 2010, CANCER RES, V70, P10288, DOI 10.1158/0008-5472.CAN-10-1893; Cypess AM, 2013, NAT MED, V19, P635, DOI 10.1038/nm.3112; Cohen P, 2014, CELL, V156, P304, DOI 10.1016/j.cell.2013.12.021; Kajimura S, 2008, GENE DEV, V22, P1397, DOI 10.1101/gad.1666108; Valladares A, 2000, J CELL PHYSIOL, V185, P324, DOI 10.1002/1097-4652(200012)185:3<324::AID-JCP2>3.0.CO;2-Q; Fredriksson JM, 2001, BBA-MOL CELL RES, V1538, P206, DOI 10.1016/S0167-4889(01)00070-2; Montgomery RL, 2008, J CLIN INVEST, V118, P3588, DOI 10.1172/JCI35847; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Tsai SC, 2002, J BIOL CHEM, V277, P31826, DOI 10.1074/jbc.M204149200; Xue RD, 2015, NAT MED, V21, P760, DOI 10.1038/nm.3881; Lindquist JM, 1998, J BIOL CHEM, V273, P30147, DOI 10.1074/jbc.273.46.30147; Lidell ME, 2013, NAT MED, V19, P631, DOI 10.1038/nm.3017; Kruger M, 2008, P NATL ACAD SCI USA, V105, P2451, DOI 10.1073/pnas.0711713105; Ruzzene M, 2010, METHOD ENZYMOL, V484, P495, DOI [10.1016/B978-0-12-381298-8.00024-1, 10.1016/S0076-6879(10)84024-8]; Sugiyama N, 2007, MOL CELL PROTEOMICS, V6, P1103, DOI 10.1074/mcp.T600060-MCP200; Sidossis L, 2015, J CLIN INVEST, V125, P478, DOI 10.1172/JCI78362; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; ALLENDE JE, 1995, FASEB J, V9, P313; Carey AL, 2013, DIABETOLOGIA, V56, P147, DOI 10.1007/s00125-012-2748-1; Yoneshiro T, 2013, J CLIN INVEST, V123, P3404, DOI 10.1172/JCI67803; Son YH, 2013, ARCH PHARM RES, V36, P840, DOI 10.1007/s12272-013-0103-9; Ortega-Molina A, 2012, CELL METAB, V15, P382, DOI 10.1016/j.cmet.2012.02.001; Martins LR, 2014, LEUKEMIA, V28, P179, DOI 10.1038/leu.2013.232; Kajimura S, 2014, ANNU REV PHYSIOL, V76, P225, DOI 10.1146/annurev-physiol-021113-170252; Li DX, 1999, J BIOL CHEM, V274, P32988, DOI 10.1074/jbc.274.46.32988; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Blagoev B, 2004, NAT BIOTECHNOL, V22, P1139, DOI 10.1038/nbt1005; Villarroya F, 2013, CELL METAB, V17, P638, DOI 10.1016/j.cmet.2013.02.020; Amanchy R, 2007, NAT BIOTECHNOL, V25, P285, DOI 10.1038/nbt0307-285; Lee P, 2014, INT J OBESITY, V38, P170, DOI 10.1038/ijo.2013.82; Galmozzi A, 2013, DIABETES, V62, P732, DOI 10.2337/db12-0548; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Pflum MKH, 2001, J BIOL CHEM, V276, P47733, DOI 10.1074/jbc.M105590200; Villanueva CJ, 2013, CELL METAB, V17, P423, DOI 10.1016/j.cmet.2013.01.016; Shimizu Y, 1997, ENDOCRINOLOGY, V138, P248, DOI 10.1210/en.138.1.248; Ohno H, 2012, CELL METAB, V15, P395, DOI 10.1016/j.cmet.2012.01.019; Collins Sheila, 2011, Front Endocrinol (Lausanne), V2, P102, DOI 10.3389/fendo.2011.00102; Cypess AM, 2015, CELL METAB, V21, P33, DOI 10.1016/j.cmet.2014.12.009; Lee P, 2014, DIABETES, V63, P3686, DOI 10.2337/db14-0513; Sharp LZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049452; Shinoda K, 2015, NAT MED, V21, P389, DOI 10.1038/nm.3819	54	1	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1550-4131	1932-7420		CELL METAB	Cell Metab.	DEC 1	2015	22	6					997	1008		10.1016/j.cmet.2015.09.029		12	Cell Biology; Endocrinology & Metabolism	Cell Biology; Endocrinology & Metabolism	CX8ZA	WOS:000365993100008		
J	Rocha, AS; Vidal, V; Mertz, M; Kendall, TJ; Charlet, A; Okamoto, H; Schedl, A				Rocha, Ana Sofia; Vidal, Valerie; Mertz, Marjolijn; Kendall, Timothy J.; Charlet, Aurelie; Okamoto, Hitoshi; Schedl, Andreas			The Angiocrine Factor Rspondin3 Is a Key Determinant of Liver Zonation	CELL REPORTS			English	Article							MOUSE; EXPRESSION; GENE; FAMILY; REGENERATION; HEPATOCYTES; MECHANISM; PATHWAY	Liver zonation, the spatial separation of different metabolic pathways along the liver sinusoids, is fundamental for proper functioning of this organ, and its disruption can lead to the development of metabolic disorders such as hyperammonemia. Metabolic zonation involves the induction of beta-catenin signaling around the central veins, but how this patterned activity is established and maintained is unclear. Here, we show that the signaling molecule Rspondin3 is specifically expressed within the endothelial compartment of the central vein. Conditional deletion of Rspo3 in mice disrupts activation of central fate, demonstrating its crucial role in determining and maintaining beta-catenin-dependent zonation. Moreover, ectopic expression of Rspo1, a close family member of Rspo3, induces the expression of pericentral markers, demonstrating Rspondins to be sufficient to imprint a more central fate. Thus, Rspo3 is a key angiocrine factor that controls metabolic zonation of liver hepatocytes.	[Rocha, Ana Sofia; Vidal, Valerie; Mertz, Marjolijn; Charlet, Aurelie; Schedl, Andreas] Univ Nice Sophia, Inst Biol Valrose, F-06108 Nice, France; [Rocha, Ana Sofia; Vidal, Valerie; Mertz, Marjolijn; Charlet, Aurelie; Schedl, Andreas] INSERM, UMR1091, F-06108 Nice, France; [Rocha, Ana Sofia; Vidal, Valerie; Charlet, Aurelie; Schedl, Andreas] CNRS, UMR7277, F-06108 Nice, France; [Mertz, Marjolijn] Univ Nice Sophia, Inst Biol Valrose, Plateforme PRISM, F-06108 Nice, France; [Kendall, Timothy J.] Western Gen Hosp Campus, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Okamoto, Hitoshi] RIKEN, Brain Sci Inst, Wako, Saitama 3510198, Japan	Rocha, AS (reprint author), Univ Nice Sophia, Inst Biol Valrose, F-06108 Nice, France.	rocha@unice.fr; andreas.schedl@unice.fr			ARC (Association pour la Recherche sur le Cancer) [SL22020605297]; ANR [ANR-11-LABX-0028-01]; FDF (Fondation de France); ARC fellowship; Welcome Trust fellowship	We would like to thank the staff of the animal facility for their outstanding work and dedication and Agnes Loubat for expert FACS analysis; we are grateful to Christine Perret for initial input. We are indebted to Fariba Ranc for the generation of the Rspo1 gain-of-function mice and Fabio Avoglio for experimental assistance and scientific discussion. This work was supported by grants from the ARC (Association pour la Recherche sur le Cancer) (SL22020605297), ANR (ANR-ADSTEM and ANR-11-LABX-0028-01), and FDF (Fondation de France) to A.S.; A.S.R. was supported by an ARC fellowship. T.K. was supported by a Welcome Trust fellowship.	Aoki M, 2007, DEV BIOL, V301, P218, DOI 10.1016/j.ydbio.2006.08.018; Kim KA, 2008, MOL BIOL CELL, V19, P2588, DOI 10.1091/mbc.E08-02-0187; Wang B, 2015, NATURE, V524, P180, DOI 10.1038/nature14863; Monga SS, 2014, GENE EXPRESSION, V16, P51, DOI 10.3727/105221614X13919976902138; Yoon JK, 2012, CELL SIGNAL, V24, P369, DOI 10.1016/j.cellsig.2011.09.023; Burke ZD, 2009, GASTROENTEROLOGY, V136, P2316, DOI 10.1053/j.gastro.2009.02.063; Sekine S, 2006, HEPATOLOGY, V43, P817, DOI 10.1002/hep.21131; Nam JS, 2007, GENE EXPR PATTERNS, V7, P306, DOI 10.1016/j.modgep.2006.08.006; Yang J, 2014, HEPATOLOGY, V60, P964, DOI 10.1002/hep.27082; Benhamouche S, 2006, DEV CELL, V10, P759, DOI 10.1016/j.devcel.2006.03.015; Schuler M, 2004, GENESIS, V39, P167, DOI 10.1002/gene.20039; Braeuning A, 2006, FEBS J, V273, P5051, DOI 10.1111/j.1742-4658.2006.05503.x; Comai G, 2010, DEV DYNAM, V239, P1867, DOI 10.1002/dvdy.22313; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Gebhardt R, 2014, WORLD J GASTROENTERO, V20, P8491, DOI 10.3748/wjg.v20.i26.8491; Grijalva J, 2013, SEMIN PEDIATR SURG, V22, P185, DOI 10.1053/j.sempedsurg.2013.10.006; Kazanskaya O, 2008, DEVELOPMENT, V135, P3655, DOI 10.1242/dev.027284; Torre C, 2010, PROG MOL BIOL TRANSL, V97, P127, DOI 10.1016/B978-0-12-385233-5.00005-2; Torre C, 2011, INT J BIOCHEM CELL B, V43, P271, DOI 10.1016/j.biocel.2009.11.004; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Clevers H., 2014, SCIENCE, V346; Rountree C. B., 2011, JOVE-J VIS EXP, V56, P3183	22	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	2211-1247			CELL REP	Cell Reports	DEC 1	2015	13	9					1757	1764		10.1016/j.celrep.2015.10.049		8	Cell Biology	Cell Biology	CX9SY	WOS:000366047000004		
J	Sugihara, K; Nishiyama, K; Fukuhara, S; Uemura, A; Arima, S; Kobayashi, R; Kohn-Luque, A; Mochizuki, N; Suda, T; Ogawa, H; Kurihara, H				Sugihara, Kei; Nishiyama, Koichi; Fukuhara, Shigetomo; Uemura, Akiyoshi; Arima, Satoshi; Kobayashi, Ryo; Koehn-Luque, Alvaro; Mochizuki, Naoki; Suda, Toshio; Ogawa, Hisao; Kurihara, Hiroki			Autonomy and Non-autonomy of Angiogenic Cell Movements Revealed by Experiment-Driven Mathematical Modeling	CELL REPORTS			English	Article							TUMOR-INDUCED ANGIOGENESIS; ENDOTHELIAL GROWTH-FACTOR; MIGRATION; MORPHOGENESIS; NOTCH; TIP; ZEBRAFISH; ARCHITECTURE; EXPRESSION; COHESION	Angiogenesis is a multicellular phenomenon driven by morphogenetic cell movements. We recently reported morphogenetic vascular endothelial cell (EC) behaviors to be dynamic and complex. However, the principal mechanisms orchestrating individual EC movements in angiogenic morphogenesis remain largely unknown. Here we present an experiment-driven mathematical model that enables us to systematically dissect cellular mechanisms in branch elongation. We found that cell-autonomous and coordinated actions governed these multicellular behaviors, and a cell-autonomous process sufficiently illustrated essential features of the morphogenetic EC dynamics at both the single-cell and cell-population levels. Through refining our model and experimental verification, we further identified a coordinated mode of tip EC behaviors regulated via a spatial relationship between tip and follower ECs, which facilitates the forward motility of tip ECs. These findings provide insights that enhance our mechanistic understanding of not only angiogenic morphogenesis, but also other types of multicellular phenomenon.	[Sugihara, Kei; Nishiyama, Koichi; Arima, Satoshi; Kurihara, Hiroki] Univ Tokyo, Grad Sch Med, Dept Physiol Chem & Metab, Bunkyo Ku, Tokyo 1130033, Japan; [Nishiyama, Koichi; Ogawa, Hisao] Kumamoto Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Chuo Ku, Kumamoto 8608556, Japan; [Nishiyama, Koichi; Suda, Toshio] Kumamoto Univ, Int Res Ctr Med Sci, Chuo Ku, Kumamoto 8600811, Japan; [Nishiyama, Koichi; Kurihara, Hiroki] Japan Sci & Technol Agcy JST, CREST, Chiyoda Ku, Tokyo 1020076, Japan; [Fukuhara, Shigetomo; Mochizuki, Naoki] Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Cell Biol, Suita, Osaka 5658565, Japan; [Uemura, Akiyoshi] Nagoya City Univ, Grad Sch Med Sci, Dept Retinal Vasc Biol, Mizuho Ku, Nagoya, Aichi 4678601, Japan; [Kobayashi, Ryo] Hiroshima Univ, Grad Sch Sci, Dept Math & Life Sci, Higashihiroshima, Hiroshima 7398526, Japan; [Koehn-Luque, Alvaro] Tech Univ Dresden, Dept Innovat Methods Comp, Ctr Informat Serv & High Performance Comp ZIH, D-01062 Dresden, Germany; [Suda, Toshio] Natl Univ Singapore, Ctr Translat Med, Canc Inst Singapore, Singapore 117599, Singapore; [Kurihara, Hiroki] Univ Tokyo, Inst Biol & Math Dynam Cell Proc iBMath, Meguro Ku, Tokyo 1538914, Japan	Nishiyama, K (reprint author), Univ Tokyo, Grad Sch Med, Dept Physiol Chem & Metab, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	nkanako@kumamoto-u.ac.jp			Global COE Program (Integrative Life Science based on the Study of Biosignaling Mechanisms) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT); Platform for Dynamic Approaches to Living System from MEXT; CREST from the JST; MEXT [23111505, 25111705, 24249047]; Japan Society for the Promotion of Science (JSPS) [23591099]; Tokyo Society of Medical Sciences; Takeda Science Foundation; Shimabara Science Promotion Foundation; SENSHIN Medical Research Foundation; Astellas Foundation for Research on Metabolic Disorders	We thank Dr. Takashi Miura for the modeling studies. We also thank Yuriko Kondo and Akira Matsubara for excellent technical assistance. MTrackJ was developed at the Biomedical Imaging Group Rotterdam of the Erasmus MC University Medical Center Rotterdam by Erik Meijering. This work was supported in part by the Global COE Program (Integrative Life Science based on the Study of Biosignaling Mechanisms) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT); Platform for Dynamic Approaches to Living System from MEXT; CREST from the JST; grants-in-aid for scientific research from MEXT (23111505 and 25111705 to K.N. and 24249047 to H.K.); a grants-in-aid for scientific research from the Japan Society for the Promotion of Science (JSPS, 23591099 to K.N.); The Tokyo Society of Medical Sciences (to K.N.); the Takeda Science Foundation (to K.N.); The Shimabara Science Promotion Foundation (to K.N.); the SENSHIN Medical Research Foundation (to K.N.); and the Astellas Foundation for Research on Metabolic Disorders (to K.N.).	Gaengel K, 2009, ARTERIOSCL THROM VAS, V29, P630, DOI 10.1161/ATVBAHA.107.161521; Peirce S, 2008, MICROCIRCULATION, V15, P739, DOI 10.1080/10739680802220331; Bentley K, 2014, NAT CELL BIOL, V16, P309, DOI 10.1038/ncb2926; Kwon HB, 2013, DEVELOPMENT, V140, P4081, DOI 10.1242/dev.091702; Theveneau E, 2013, NAT CELL BIOL, V15, P763, DOI 10.1038/ncb2772; Holderfield MT, 2008, CIRC RES, V102, P637, DOI 10.1161/CIRCRESAHA.107.167171; Fukuhara S, 2014, DEV BIOL, V393, P10, DOI 10.1016/j.ydbio.2014.06.015; Bentley K, 2008, J THEOR BIOL, V250, P25, DOI 10.1016/j.jtbi.2007.09.015; Baish JW, 1996, MICROVASC RES, V51, P327, DOI 10.1006/mvre.1996.0031; Wimmer R, 2012, DEV CELL, V22, P158, DOI 10.1016/j.devcel.2011.11.012; Kawakami K, 2004, DEV CELL, V7, P133, DOI 10.1016/j.devcel.2004.06.005; Nicosia RF, 2009, J CELL MOL MED, V13, P4113, DOI 10.1111/j.1582-4934.2009.00891.x; Montell DJ, 2008, SCIENCE, V322, P1502, DOI 10.1126/science.1164073; Pettet GJ, 1996, MATH BIOSCI, V136, P35, DOI 10.1016/0025-5564(96)00044-2; CONNOLLY DT, 1989, J CLIN INVEST, V84, P1470, DOI 10.1172/JCI114322; Arima S, 2011, DEVELOPMENT, V138, P4763, DOI 10.1242/dev.068023; Niewiadomska P, 1999, J CELL BIOL, V144, P533, DOI 10.1083/jcb.144.3.533; Moya IM, 2012, DEV CELL, V22, P501, DOI 10.1016/j.devcel.2012.01.007; Ewald AJ, 2008, DEV CELL, V14, P570, DOI [10.1016/j.devcel.2008.03.003, 10.1016/i.devcel.2008.03.003]; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Tammela T, 2011, NAT CELL BIOL, V13, P1202, DOI 10.1038/ncb2331; Szabo A, 2008, BIOPHYS J, V95, P2702, DOI 10.1529/biophysj.108.129668; Egawa G, 2009, J INVEST DERMATOL, V129, P2386, DOI 10.1038/jid.2009.105; Daub JT, 2013, B MATH BIOL, V75, P1377, DOI 10.1007/s11538-013-9826-5; Wagner S, 2003, J NEURO-ONCOL, V62, P221, DOI 10.1023/A:1023335732264; Tyson JJ, 2007, NATURE, V445, P823, DOI 10.1038/445823a; Uemura A, 2002, J CLIN INVEST, V110, P1619, DOI 10.1172/JCI200215621; Aman A, 2008, DEV CELL, V15, P749, DOI 10.1016/j.devcel.2008.10.002; Gupta K, 1999, EXP CELL RES, V247, P495, DOI 10.1006/excr.1998.4359; Bauer AL, 2007, BIOPHYS J, V92, P3105, DOI 10.1529/biophysj.106.101501; Anderson ARA, 1998, B MATH BIOL, V60, P857, DOI 10.1006/bulm.1998.0042; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Jakobsson L, 2010, NAT CELL BIOL, V12, P943, DOI 10.1038/ncb2103; Chaplain MAJ, 2006, ANNU REV BIOMED ENG, V8, P233, DOI 10.1146/annurev.bioeng.8.061505.095807; Abedi H, 1997, J BIOL CHEM, V272, P15442, DOI 10.1074/jbc.272.24.15442; Robinson EE, 2003, J CELL SCI, V116, P377, DOI 10.1242/jcs.00231; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Scianna M, 2013, J THEOR BIOL, V333, P174, DOI 10.1016/j.jtbi.2013.04.037; Bauer AL, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000445; Bentley K, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000549; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI [10.1016/B978-0-12-391857-4.00009-4, 10.1016/13978-0-12-3918574.00009-4]; Merks RMH, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000163; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4	43	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	2211-1247			CELL REP	Cell Reports	DEC 1	2015	13	9					1814	1827		10.1016/j.celrep.2015.10.051		14	Cell Biology	Cell Biology	CX9SY	WOS:000366047000010		
J	Sadakane, O; Masamizu, Y; Watakabe, A; Terada, SI; Ohtsuka, M; Takaji, M; Mizukami, H; Ozawa, K; Kawasaki, H; Matsuzaki, M; Yamamori, T				Sadakane, Osamu; Masamizu, Yoshito; Watakabe, Akiya; Terada, Shin-Ichiro; Ohtsuka, Masanari; Takaji, Masafumi; Mizukami, Hiroaki; Ozawa, Keiya; Kawasaki, Hiroshi; Matsuzaki, Masanori; Yamamori, Tetsuo			Long-Term Two-Photon Calcium Imaging of Neuronal Populations with Subcellular Resolution in Adult Non-human Primates	CELL REPORTS			English	Article							VISUAL-CORTEX; NEURAL ACTIVITY; IN-VIVO; SIMULTANEOUS VISUALIZATION; SOMATOSENSORY CORTEX; PROJECTION NEURONS; GENE-TRANSFER; MOUSE; BRAIN; MARMOSET	Two-photon imaging with genetically encoded calcium indicators (GECIs) enables long-term observation of neuronal activity in vivo. However, there are very few studies of GECIs in primates. Here, we report a method for long-term imaging of a GECI, GCaMP6f, expressed from adeno-associated virus vectors in cortical neurons of the adult common marmoset (Callithrix jacchus), a small New World primate. We used a tetracycline-inducible expression system to robustly amplify neuronal GCaMP6f expression and up-and downregulate it for more than 100 days. We succeeded in monitoring spontaneous activity not only from hundreds of neurons three-dimensionally distributed in layers 2 and 3 but also from single dendrites and axons in layer 1. Furthermore, we detected selective activities from somata, dendrites, and axons in the somatosensory cortex responding to specific tactile stimuli. Our results provide a way to investigate the organization and plasticity of cortical microcircuits at subcellular resolution in non-human primates.	[Sadakane, Osamu; Watakabe, Akiya; Ohtsuka, Masanari; Takaji, Masafumi; Yamamori, Tetsuo] Natl Inst Nat Sci, Div Brain Biol, Okazaki, Aichi 4448585, Japan; [Sadakane, Osamu; Masamizu, Yoshito; Watakabe, Akiya; Matsuzaki, Masanori; Yamamori, Tetsuo] Grad Univ Adv Studies Sokendai, Dept Basic Biol, Okazaki, Aichi 4448585, Japan; [Sadakane, Osamu; Watakabe, Akiya; Ohtsuka, Masanari; Takaji, Masafumi; Yamamori, Tetsuo] RIKEN Brain Sci Inst, Lab Mol Anal Higher Brain Funct, Wako, Saitama 3510198, Japan; [Masamizu, Yoshito; Terada, Shin-Ichiro; Matsuzaki, Masanori] Natl Inst Nat Sci, Natl Inst Basic Biol, Div Brain Circuits, Okazaki, Aichi 4448585, Japan; [Terada, Shin-Ichiro] Kyoto Univ, Grad Sch Biostudies, Lab Cell Recognit & Pattern Format, Kyoto 6068501, Japan; [Mizukami, Hiroaki; Ozawa, Keiya] Jichi Med Univ, Ctr Mol Med, Div Genet Therapeut, Shimotsuke, Tochigi 3290498, Japan; [Kawasaki, Hiroshi] Kanazawa Univ, Dept Med Neurosci, Grad Sch Med, Kanazawa, Ishikawa 9208640, Japan	Matsuzaki, M (reprint author), Grad Univ Adv Studies Sokendai, Dept Basic Biol, Okazaki, Aichi 4448585, Japan.	mzakim@nibb.ac.jp; tetsuo.yamamori@riken.jp			JSPS [KAKENHI 40290910, 22500300]; JSPS Research Fellowship for Young Scientists; Strategic Research Program for Brain Sciences; MEXT, Japan; AMED, Japan;  [22123009];  [20240030]	We thank V. Jayaraman, R. Kerr, D. Kim, L. Looger, and K. Svoboda of the GENIE Project Janelia Farm Research Campus (HHMI) for providing rAAV2/1-SynI-GCaMP6f and pGP-CMV-GCaMP6 and K. Deisseroth of Stanford University for providing pAAV-Ef1a-DIO hChR2 (E123T/T159C)-EYFP. We thank R. Hira and Y. Isomura for the development of the custom-made marmoset chair. We thank E. Sasaki for helpful advice for handling marmosets as well as for providing two of our experimental animals. We thank S. Ohsawa and J. Wang for help with histology and Y. Takeda, R. Hirakawa, Y. Takahashi, E. Imoto, E. Iwase, and K. Kotani for animal handling. Confocal images were acquired at Spectrography and Bioimaging Facility, NIBB Core Research Facilities. The research was supported by Scientific Research on Innovative Areas to T.Y. (22123009), a grant from JSPS to A.W. (KAKENHI 40290910 and 22500300), Grants-in-Aid for Scientific Research A to T.Y. (20240030), a JSPS Research Fellowship for Young Scientists to S.-I.T., the Strategic Research Program for Brain Sciences to M.M. and T.Y., and the program for Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) from MEXT and AMED, Japan, to M.M. and T.Y.	Akerboom J, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00002; Stettler DD, 2006, NEURON, V49, P877, DOI 10.1016/j.neuron.2006.02.018; Eichhoff G, 2008, EUR J NUCL MED MOL I, V35, pS99, DOI 10.1007/s00259-007-0709-6; Sasaki E, 2009, NATURE, V459, P523, DOI 10.1038/nature08090; Ikezoe K, 2013, J NEUROSCI, V33, P16818, DOI 10.1523/JNEUROSCI.2209-13.2013; Ako R, 2011, MOL CELL NEUROSCI, V48, P246, DOI 10.1016/j.mcn.2011.08.005; Tamamaki N, 2000, NEUROSCI RES, V38, P231, DOI 10.1016/S0168-0102(00)00176-0; Diester I, 2011, NAT NEUROSCI, V14, P387, DOI 10.1038/nn.2749; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Petreanu L, 2012, NATURE, V489, P299, DOI 10.1038/nature11321; Harvey CD, 2012, NATURE, V484, P62, DOI 10.1038/nature10918; MOCHIZUKI Y, 1995, ZOOL SCI, V12, P283; Peters AJ, 2014, NATURE, V510, P263, DOI 10.1038/nature13235; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Yamazaki Y, 2011, EXP BRAIN RES, V213, P63, DOI 10.1007/s00221-011-2778-9; Watakabe A, 2015, NEUROSCI RES, V93, P144, DOI 10.1016/j.neures.2014.09.002; Xu NL, 2012, NATURE, V492, P247, DOI 10.1038/nature11601; MITZ AR, 1991, J NEUROSCI, V11, P1855; Masamizu Y, 2014, NAT NEUROSCI, V17, P987, DOI 10.1038/nn.3739; KRUBITZER LA, 1990, J NEUROSCI, V10, P952; Hofer SB, 2011, NAT NEUROSCI, V14, P1045, DOI 10.1038/nn.2876; Huber D, 2012, NATURE, V484, P473, DOI 10.1038/nature11039; Lewandoski M, 2001, NAT REV GENET, V2, P743, DOI 10.1038/35093537; Gerits A, 2013, TRENDS GENET, V29, P403, DOI 10.1016/j.tig.2013.03.004; Andermann ML, 2011, NEURON, V72, P1025, DOI 10.1016/j.neuron.2011.11.013; Chen JL, 2013, NATURE, V499, P336, DOI 10.1038/nature12236; Roberts AC, 2007, J COMP NEUROL, V502, P86, DOI 10.1002/cne.21300; HONAVAR M, 1987, MECH AGEING DEV, V41, P161, DOI 10.1016/0047-6374(87)90060-1; FLOR H, 1995, NATURE, V375, P482, DOI 10.1038/375482a0; Miller CT, 2010, AM J PRIMATOL, V72, P974, DOI 10.1002/ajp.20854; Kinoshita M, 2012, NATURE, V487, P235, DOI 10.1038/nature11206; Nauhaus I, 2012, NAT NEUROSCI, V15, P1683, DOI 10.1038/nn.3255; Hioki H, 2009, NEUROSCI RES, V63, P149, DOI 10.1016/j.neures.2008.10.010; Konishi M, 2008, J GENE MED, V10, P610, DOI 10.1002/jgm.1189; Masamizu Y, 2011, NEUROSCIENCE, V193, P249, DOI 10.1016/j.neuroscience.2011.06.080; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; O'Connor DH, 2010, NEURON, V67, P1048, DOI 10.1016/j.neuron.2010.08.026; Glickfeld LL, 2013, NAT NEUROSCI, V16, P219, DOI 10.1038/nn.3300; Takemoto A, 2011, J NEUROSCI METH, V199, P82, DOI 10.1016/j.jneumeth.2011.04.029; Liu X, 2012, NATURE, V484, P381, DOI 10.1038/nature11028; Inoue M, 2015, NAT METHODS, V12, P64, DOI [10.1038/nmeth.3185, 10.1038/NMETH.3185]; Hardman C.D., 2012, STEREOTAXIC CHEMOARC; Heider B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013829; Kawakami R, 2013, SCI REP-UK, V3, DOI 10.1038/srep01014; Khodagholy D, 2015, NAT NEUROSCI, V18, P310, DOI 10.1038/nn.3905; Lecoq J, 2014, NAT NEUROSCI, V17, P1825, DOI 10.1038/nn.3867; Lee WCA, 2006, PLOS BIOL, V4, P271, DOI 10.1371/journal.pbio.0040029; Matsui T, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00143; MERZENICH MM, 1984, J COMP NEUROL, V224, P591, DOI 10.1002/cne.902240408; Mitchell JF, 2014, J NEUROSCI, V34, P1183, DOI 10.1523/JNEUROSCI.3899-13.2014; Ohkura M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039933; Remington ED, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047895; Sooksawate T, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00162; Watakabe A, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00110; Watakabe A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046157; Yuasa S., 2010, STEREOTAXIC ATLAS MA	56	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	2211-1247			CELL REP	Cell Reports	DEC 1	2015	13	9					1989	1999		10.1016/j.celrep.2015.10.050		11	Cell Biology	Cell Biology	CX9SY	WOS:000366047000023		
J	Kuriki, I; Sun, P; Ueno, K; Tanaka, K; Cheng, K				Kuriki, Ichiro; Sun, Pei; Ueno, Kenichi; Tanaka, Keiji; Cheng, Kang			Hue Selectivity in Human Visual Cortex Revealed by Functional Magnetic Resonance Imaging	CEREBRAL CORTEX			English	Article						color vision; fMRI adaptation; functional MRI; hue selectivity; human visual cortex; population histogram	LATERAL GENICULATE-NUCLEUS; STRIATE CORTEX; CHROMATIC MECHANISMS; COLOR; MACAQUE; LUMINANCE; REPRESENTATION; ORGANIZATION; STIMULATION; ADAPTATION	The variability of color-selective neurons in human visual cortex is considered more diverse than cone-opponent mechanisms. We addressed this issue by deriving histograms of hue-selective voxels measured using fMRI with a novel stimulation paradigm, where the stimulus hue changed continuously. Despite the large between-subject difference in hue-selective histograms, individual voxels exhibited selectivity for intermediate hues, such as purple, cyan, and orange, in addition to those along cone-opponent axes. In order to rule the possibility out that the selectivity for intermediate hues emerged through spatial summation of activities of neurons selectively responding to cone-opponent signals, we further tested hue-selective adaptations in intermediate directions of cone-opponent axes, by measuring responses to 4 diagonal hues during concurrent adaptation to 1 of the 4 hues. The selective and unidirectional reduction in response to the adapted hue lends supports to our argument that cortical neurons respond selectively to intermediate hues.	[Kuriki, Ichiro] Tohoku Univ, Elect Commun Res Inst, Sendai, Miyagi 9808577, Japan; [Sun, Pei; Ueno, Kenichi; Tanaka, Keiji; Cheng, Kang] RIKEN, Brain Sci Inst, Wako, Saitama, Japan	Kuriki, I (reprint author), Tohoku Univ, Elect Commun Res Inst, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.	ikuriki@riec.tohoku.ac.jp			KAKENHI from Japan Society for Promotion of Science (JSPS) [21330165, 24330205, 25245065, 20300114, 25242079]; Japan Society for Promotion of Sciences	This study was supported in part by Grant-in-Aid for Scientific Research (KAKENHI 21330165, 24330205, and 25245065 to I.K., and 20300114 and 25242079 to K.C.) from the Japan Society for the Promotion of Science (JSPS). Funding to pay the Open Access publication charges for this article was provided by the Japan Society for the Promotion of Sciences.	Kiper DC, 1997, VISUAL NEUROSCI, V14, P1061; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; AHN SJ, 1993, VISION RES, V33, P2271, DOI 10.1016/0042-6989(93)90105-6; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.0.CO;2-W; Hansen T, 2005, J OPT SOC AM A, V22, P2081, DOI 10.1364/JOSAA.22.002081; Brouwer GJ, 2013, J NEUROSCI, V33, P15454, DOI 10.1523/JNEUROSCI.2472-13.2013; Wang Y, 2007, CEREB CORTEX, V17, P116, DOI 10.1093/cercor/bhj131; Hanazawa A, 2000, EUR J NEUROSCI, V12, P1753, DOI 10.1046/j.1460-9568.2000.00041.x; Hass CA, 2013, J NEUROPHYSIOL, V109, P2483, DOI 10.1152/jn.00671.2012; Gegenfurtner KR, 1997, J NEUROPHYSIOL, V77, P1906; Xiao YP, 2007, NEUROIMAGE, V35, P771, DOI 10.1016/j.neuroimage.2006.11.059; Mullen KT, 2007, EUR J NEUROSCI, V25, P491, DOI 10.1111/j.1460-9568.2007.05302.x; Engel S, 1997, NATURE, V388, P68, DOI 10.1038/40398; Goda N, 2001, VISION RES, V41, P2475, DOI 10.1016/S0042-6989(01)00136-5; Sun H, 2006, J NEUROPHYSIOL, V95, P837, DOI 10.1152/jn.00714.2005; Gardner JL, 2005, NEURON, V47, P607, DOI 10.1016/j.neuron.2005.07.016; Sun P, 2013, CEREB CORTEX, V23, P1618, DOI 10.1093/cercor/bhs149; Gegenfurtner KR, 2003, NAT REV NEUROSCI, V4, P563, DOI 10.1038/nrn1138; MACLEOD DIA, 1979, J OPT SOC AM, V69, P1183, DOI 10.1364/JOSA.69.001183; Brouwer GJ, 2009, J NEUROSCI, V29, P13992, DOI 10.1523/JNEUROSCI.3577-09.2009; CHAPARRO A, 1993, NATURE, V361, P348, DOI 10.1038/361348a0; KRAUSKOPF J, 1986, VISION RES, V26, P23, DOI 10.1016/0042-6989(86)90068-4; SMITH VC, 1975, VISION RES, V15, P161, DOI 10.1016/0042-6989(75)90203-5; DeValois RL, 1997, VISION RES, V37, P885, DOI 10.1016/S0042-6989(96)00234-9; Tajima S, 2010, J NEUROSCI, V30, P3264, DOI 10.1523/JNEUROSCI.4473-09.2010; Tanigawa H, 2010, NAT NEUROSCI, V13, P1542, DOI 10.1038/nn.2676; EISNER A, 1980, J OPT SOC AM, V70, P121, DOI 10.1364/JOSA.70.000121; De Valois RL, 2000, P NATL ACAD SCI USA, V97, P4997, DOI 10.1073/pnas.97.9.4997; Kuriki I, 2011, IEICE T FUND ELECTR, VE94A, P473, DOI 10.1587/transfun.E94.A.473; Lu HD, 2008, CEREB CORTEX, V18, P516, DOI 10.1093/cercor/bhm081; WEBSTER MA, 1991, NATURE, V349, P235, DOI 10.1038/349235a0; Conway BR, 2006, J NEUROSCI, V26, P10826, DOI 10.1523/JNEUROSCI.2091-06.2006; Kuriki I, 2006, VISION RES, V46, P3055, DOI 10.1016/j.visres.2006.03.012; Wachtler T, 2003, NEURON, V37, P681, DOI 10.1016/S0896-6273(03)00035-7; SAKAI K, 1995, P ROY SOC B-BIOL SCI, V261, P89, DOI 10.1098/rspb.1995.0121; WYSZECKI G, 1967, J OPT SOC AM, V57, P254, DOI 10.1364/JOSA.57.000254; Adams DL, 2007, J NEUROSCI, V27, P10391, DOI 10.1523/JNEUROSCI.2923-07.2007; Cowan W. B., 1983, Computer Graphics, V17; DERRINGTON AM, 1984, J PHYSIOL-LONDON, V357, P241; Goddard E, 2010, J VISION, V10, DOI 10.1167/10.5.25; HU XP, 1995, MAGNET RESON MED, V34, P201, DOI 10.1002/mrm.1910340211; Kuriki I, 1998, J DALTONS COLOUR VIS, P73; Kuriki I, 2007, J OPT SOC AM A, V24, P858; LENNIE P, 1990, J NEUROSCI, V10, P649; Parkes LM, 2009, J VISION, V9, DOI 10.1167/9.1.1	46	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1047-3211	1460-2199		CEREB CORTEX	Cereb. Cortex	DEC	2015	25	12					4869	4884		10.1093/cercor/bhv198		16	Neurosciences	Neurosciences & Neurology	CY5RB	WOS:000366463800020		
J	Chiken, S; Sato, A; Ohta, C; Kurokawa, M; Arai, S; Maeshima, J; Sunayama-Morita, T; Sasaoka, T; Nambu, A				Chiken, Satomi; Sato, Asako; Ohta, Chikara; Kurokawa, Makoto; Arai, Satoshi; Maeshima, Jun; Sunayama-Morita, Tomoko; Sasaoka, Toshikuni; Nambu, Atsushi			Dopamine D1 Receptor-Mediated Transmission Maintains Information Flow Through the Cortico-Striato-Entopeduncular Direct Pathway to Release Movements	CEREBRAL CORTEX			English	Article						basal ganglia; conditional knockdown; dopamine receptor; extracellular recording; mouse	PRIMATE BASAL GANGLIA; MEDIUM SPINY NEURONS; PARKINSONS-DISEASE; PALLIDAL NEURONS; SUBTHALAMIC NUCLEUS; GABAERGIC INPUTS; GENE-EXPRESSION; MESSENGER-RNA; AWAKE MONKEYS; RAT-BRAIN	In the basal ganglia (BG), dopamine plays a pivotal role in motor control, and dopamine deficiency results in severe motor dysfunctions as seen in Parkinson's disease. According to the well-accepted model of the BG, dopamine activates striatal direct pathway neurons that directly project to the output nuclei of the BG through D1 receptors (D1Rs), whereas dopamine inhibits striatal indirect pathway neurons that project to the external pallidum (GPe) through D2 receptors. To clarify the exact role of dopaminergic transmission via D1Rs in vivo, we developed novel D1R knockdown mice in which D1Rs can be conditionally and reversibly regulated. Suppression of D1R expression by doxycycline treatment decreased spontaneous motor activity and impaired motor ability in the mice. Neuronal activity in the entopeduncular nucleus (EPN), one of the output nuclei of the rodent BG, was recorded in awake conditions to examine the mechanism of motor deficits. Cortically evoked inhibition in the EPN mediated by the cortico-striato-EPN direct pathway was mostly lost during suppression of D1R expression, whereas spontaneous firing rates and patterns remained unchanged. On the other hand, GPe activity changed little. These results suggest that D1R-mediated dopaminergic transmission maintains the information flow through the direct pathway to appropriately release motor actions.	[Chiken, Satomi; Ohta, Chikara; Nambu, Atsushi] Natl Inst Physiol Sci, Div Syst Neurophysiol, Okazaki, Aichi 4448585, Japan; [Chiken, Satomi; Sasaoka, Toshikuni] SOKENDAI Grad Univ Adv Studies, Sch Life Sci, Okazaki, Aichi 4448585, Japan; [Sato, Asako; Arai, Satoshi; Maeshima, Jun; Sasaoka, Toshikuni] Kitasato Univ, Sch Med, Dept Lab Anim Sci, Sagamihara, Kanagawa 2520374, Japan; [Sato, Asako; Sasaoka, Toshikuni] Natl Inst Basic Biol, Okazaki, Aichi 4448585, Japan; [Ohta, Chikara; Kurokawa, Makoto] Tokyo Metropolitan Univ, Dept Biol Sci, Tokyo 1920397, Japan; [Sunayama-Morita, Tomoko] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo 1538902, Japan; [Sasaoka, Toshikuni] Niigata Univ, Brain Res Inst, Dept Comparat & Expt Med, Niigata 9518585, Japan	Nambu, A (reprint author), Natl Inst Physiol Sci, Div Syst Neurophysiol, 38 Nishigonaka, Okazaki, Aichi 4448585, Japan.	sasaoka@bri.niigata-u.ac.jp; sasaoka@bri.niigata-u.ac.jp			JSPS KAKENHI [23115721, 21500378, 25430021, 22500343, 26290029, 21240039, 26250009, 15H05873]; Collaborative Research Project of Brain Research Institute, Niigata University [2011-2221]; MEXT-Supported Program for Strategic Research Foundation at Private Universities; CREST; Strategic Japanese-German Cooperative Programme; Takeda Science Foundation	This study was supported by JSPS KAKENHI (#23115721, #21500378 and #25430021 to S.C.), JSPS KAKENHI (#22500343 and #26290029), the Collaborative Research Project (#2011-2221) of Brain Research Institute, Niigata University and the MEXT-Supported Program for the Strategic Research Foundation at Private Universities, 2011-2015 (to T.S.), and JSPS KAKENHI (#21240039, #26250009 and #15H05873), CREST, Strategic Japanese-German Cooperative Programme and the Takeda Science Foundation (to A.N.). Funding to pay the Open Access publication charges for this article was provided by the JSPS KAKENHI (#15H05873).	Gerfen CR, 2011, ANNU REV NEUROSCI, V34, P441, DOI 10.1146/annurev-neuro-061010-113641; Tran AH, 2008, J NEUROSCI, V28, P13390, DOI 10.1523/JNEUROSCI.2680-08.2008; Wichmann T, 2002, J NEUROPHYSIOL, V87, P1145, DOI 10.1152/jn.00427.2001; Kliem MA, 2007, J NEUROPHYSIOL, V98, P1489, DOI 10.1152/jn.00171.2007; Raz A, 2000, J NEUROSCI, V20, P8559; Boraud T, 1998, BRAIN RES, V787, P157, DOI 10.1016/S0006-8993(97)01563-1; Heimer G, 2002, J NEUROSCI, V22, P7850; HERVE D, 1995, MOL BRAIN RES, V32, P125, DOI 10.1016/0169-328X(95)00070-9; Waddington JL, 2005, PSYCHOPHARMACOLOGY, V181, P611, DOI 10.1007/s00213-005-0058-8; Mallet N, 2006, J NEUROSCI, V26, P3875, DOI 10.1523/JNEUROSCI.4439-05.2006; Joshua M, 2009, CURR OPIN NEUROBIOL, V19, P615, DOI 10.1016/j.conb.2009.10.001; Maurice N, 1999, J NEUROSCI, V19, P4674; Wichmann T, 1999, EXP BRAIN RES, V125, P397, DOI 10.1007/s002210050696; LEGENDY CR, 1985, J NEUROPHYSIOL, V53, P926; Hutchison WD, 1998, ANN NEUROL, V44, P622, DOI 10.1002/ana.410440407; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; Arbuthnott GW, 2007, TRENDS NEUROSCI, V30, P62, DOI 10.1016/j.tins.2006.12.003; ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Tachibana Y, 2011, EUR J NEUROSCI, V34, P1470, DOI 10.1111/j.1460-9568.2011.07865.x; Fujiyama F, 2011, EUR J NEUROSCI, V33, P668, DOI 10.1111/j.1460-9568.2010.07564.x; Calabresi P, 2007, TRENDS NEUROSCI, V30, P211, DOI 10.1016/j.tins.2007.03.001; Nambu A, 2000, J NEUROPHYSIOL, V84, P289; Nambu A, 2002, NEUROSCI RES, V43, P111, DOI 10.1016/S0168-0102(02)00027-5; Bergman H, 1998, TRENDS NEUROSCI, V21, P32, DOI 10.1016/S0166-2236(97)01151-X; FREMEAU RT, 1991, P NATL ACAD SCI USA, V88, P3772, DOI 10.1073/pnas.88.9.3772; Seppi K, 2011, MOVEMENT DISORD, V26, pS42, DOI 10.1002/mds.23884; STAUNTON DA, 1982, NATURE, V299, P72, DOI 10.1038/299072a0; Hirsch EC, 2000, TRENDS NEUROSCI, V23, pS78, DOI 10.1016/S1471-1931(00)00021-5; FILION M, 1991, BRAIN RES, V547, P142; WEINER DM, 1991, P NATL ACAD SCI USA, V88, P1859, DOI 10.1073/pnas.88.5.1859; Nambu A, 2007, PROG BRAIN RES, V160, P135, DOI 10.1016/S0079-6123(06)60008-3; GASPAR P, 1995, EUR J NEUROSCI, V7, P1050, DOI 10.1111/j.1460-9568.1995.tb01092.x; Surmeier DJ, 2007, TRENDS NEUROSCI, V30, P228, DOI 10.1016/j.tins.2007.03.008; Enomoto K, 2011, P NATL ACAD SCI USA, V108, P15462, DOI 10.1073/pnas.1014457108; Brown P, 2007, CURR OPIN NEUROBIOL, V17, P656, DOI 10.1016/j.conb.2007.12.001; Surmeier DJ, 1996, J NEUROSCI, V16, P6579; Kita H, 2004, J NEUROPHYSIOL, V92, P3069, DOI 10.1152/jn.00346.2004; Day M, 2008, J NEUROSCI, V28, P11603, DOI 10.1523/JNEUROSCI.1840-08.2008; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; Brown P, 2001, J NEUROSCI, V21, P1033; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Nishibayashi H, 2011, MOVEMENT DISORD, V26, P469, DOI 10.1002/mds.23502; Hikosaka O, 2000, PHYSIOL REV, V80, P953; Levesque M, 2005, P NATL ACAD SCI USA, V102, P11888, DOI 10.1073/pnas.0502710102; Chiken S, 2008, J NEUROSCI, V28, P13967, DOI 10.1523/JNEUROSCI.3834-08.2008; Smith Y, 2000, TRENDS NEUROSCI, V23, pS28, DOI 10.1016/S1471-1931(00)00023-9; Tachibana Y, 2008, EUR J NEUROSCI, V27, P238, DOI 10.1111/j.1460-9568.2007.05990.x; Fahn S, 2011, PRINCIPLES PRACTICE; Flores-Barrera Edén, 2011, Front Syst Neurosci, V5, P15, DOI 10.3389/fnsys.2011.00015; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; Graybiel AM, 2005, CURR OPIN NEUROBIOL, V15, P638, DOI 10.1016/j.conb.2005.10.006; HERSCH SM, 1995, J NEUROSCI, V15, P5222; Kita H, 2011, J NEUROSCI, V31, P10311, DOI 10.1523/JNEUROSCI.0915-11.2011; Lemberger T, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-4; Miller WC, 1987, THE BASAL GANGLIA, P415; Nagy A, 2002, MANIPULATING MOUSE E; Nakamura Toru, 2014, Front Integr Neurosci, V8, P56, DOI 10.3389/fnint.2014.00056; Planert H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057054; Sano H, 2013, J NEUROSCI, V33, P7586; Villalba RM, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00133; Yang XDW, 1997, NAT BIOTECHNOL, V15, P859, DOI 10.1038/nbt0997-859	61	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1047-3211	1460-2199		CEREB CORTEX	Cereb. Cortex	DEC	2015	25	12					4885	4897		10.1093/cercor/bhv209		13	Neurosciences	Neurosciences & Neurology	CY5RB	WOS:000366463800021		
J	Takahashi, M; Ishikawaca, Y				Takahashi, Masae; Ishikawaca, Yoichi			Terahertz vibrations of crystalline alpha-D-glucose and the spectral change in mutual transitions between the anhydride and monohydrate	CHEMICAL PHYSICS LETTERS			English	Article							DENSITY-FUNCTIONAL THEORY; FAR-INFRARED SPECTRA; IONIC LIQUIDS; NONCOVALENT INTERACTIONS; SPECTROSCOPY; TEMPERATURE; SACCHAROSE; MODES; RAMAN; FIR	We have performed dispersion-corrected first-principles calculations of crystalline a-D-glucose anhydride and the monohydrate and measured its terahertz spectrum at 4 and 300K, to reveal the terahertz vibrations and the spectral change with hydration. Dispersion-corrected first-principles calculations well reproduced the 4-K spectrum, in both the frequency values and the relative tendency of intensities. The difference from the weak-hydrogen-bonding system is that most intermolecular modes were clearly detected even at 300K. The stretching vibration of moderate hydrogen bond was mixed with one of intermolecular rotation modes. With dehydration of the monohydrate, two intermolecular translational modes appear in the THz region. (C) 2015 Elsevier B.V. All rights reserved.	[Takahashi, Masae] Tohoku Univ, Grad Sch Agr Sci, Sendai, Miyagi 9818555, Japan; [Takahashi, Masae] RIKEN Adv Sci Inst, Sendai, Miyagi 9800845, Japan; [Ishikawaca, Yoichi] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Sendai, Miyagi 9808577, Japan	Takahashi, M (reprint author), Tohoku Univ, Grad Sch Agr Sci, Sendai, Miyagi 9818555, Japan.	masae@fris.tohoku.ac.jp			Japan Society for the Promotion of Science [22550003]	The research was supported by Japan Society for the Promotion of Science (Grant No. 22550003).	Nishizawa J, 2003, J PHYS D APPL PHYS, V36, P2958, DOI 10.1088/0022-3727/36/23/015; Molteni C, 1997, CHEM PHYS LETT, V275, P409, DOI 10.1016/S0009-2614(97)00701-X; Kato T, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3583642; McIntosh AI, 2012, CHEM SOC REV, V41, P2072, DOI 10.1039/c1cs15277g; King MD, 2011, CRYST GROWTH DES, V11, P2006, DOI 10.1021/cg200211x; King MD, 2011, J PHYS CHEM A, V115, P9467, DOI 10.1021/jp111878h; HINENO M, 1970, B CHEM SOC JPN, V43, P3308, DOI 10.1246/bcsj.43.3308; Liu HB, 2006, CHEM PHYS LETT, V429, P229, DOI 10.1016/j.cplett.2006.07.100; Hakey PM, 2009, CHEMPHYSCHEM, V10, P2434, DOI 10.1002/cphc.200900293; FRANK WFX, 1979, INFRARED PHYS, V19, P481, DOI 10.1016/0020-0891(79)90063-0; MCDONALD TRR, 1952, ACTA CRYSTALLOGR, V5, P654, DOI 10.1107/S0365110X52001787; King MD, 2011, J PHYS CHEM A, V115, P14391, DOI 10.1021/jp208883t; Grimme S, 2006, J COMPUT CHEM, V27, P1787, DOI 10.1002/jcc.20495; Sponsler OL, 1931, J AM CHEM SOC, V53, P1639, DOI 10.1021/ja01356a002; SHEN DY, 1989, MACROMOLECULES, V22, P2564, DOI 10.1021/ma00196a003; CRAMER CJ, 1993, J AM CHEM SOC, V115, P5745, DOI 10.1021/ja00066a046; KILLEAN RCG, 1962, ACTA CRYSTALLOGR, V15, P911, DOI 10.1107/S0365110X62002352; Tkatchenko A, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.236402; OHSHIMA K, 1974, JPN J APPL PHYS, V13, P1959, DOI 10.1143/JJAP.13.1959; Takahashi M, 2005, CHEM PHYS LETT, V401, P475, DOI 10.1016/j.cplett.2004.11.108; Takahashi M, 2013, CHEM PHYS LETT, V576, P21, DOI 10.1016/j.cplett.2013.05.026; Tkatchenko A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.073005; Fumino K, 2008, ANGEW CHEM INT EDIT, V47, P3830, DOI 10.1002/anie.200705736; Wulf A, 2010, CHEMPHYSCHEM, V11, P349, DOI 10.1002/cphc.200900680; Yamamoto S, 2013, J PHYS CHEM B, V117, P2180, DOI 10.1021/jp309704k; Perdew JP, 1997, PHYS REV LETT, V78, P1396, DOI 10.1103/PhysRevLett.78.1396; Takahashi M, 2014, CRYSTALS, V4, P74, DOI 10.3390/cryst4020074; Takahashi M, 2009, CHEM PHYS LETT, V479, P211, DOI 10.1016/j.cplett.2009.08.017; MCDONALD TRR, 1950, ACTA CRYSTALLOGR, V3, P394, DOI 10.1107/S0365110X50001087; Takahashi M, 2012, CHEM PHYS LETT, V531, P98, DOI 10.1016/j.cplett.2012.02.034; Clark SJ, 2005, Z KRISTALLOGR, V220, P567, DOI 10.1524/zkri.220.5.567.65075; [Anonymous], 2008, NAT PHOTON; Kovacs A, 2009, J PHYS CHEM B, V113, P2151, DOI 10.1021/jp8087308; MOSTAD A, 1994, ACTA CHEM SCAND, V48, P276, DOI 10.3891/acta.chem.scand.48-0276; Marom N, 2013, ANGEW CHEM INT EDIT, V52, P6629, DOI 10.1002/anie.201301938; Civalleri B, 2008, CRYSTENGCOMM, V10, P405, DOI 10.1039/b715018k; Edward J.T., 1955, CHEM IND, P1102; HINENO M, 1973, SPECTROCHIM ACTA A, VA 29, P1575, DOI 10.1016/0584-8539(73)80107-2; HOUGH E, 1973, ACTA CRYSTALLOGR B, VB 29, P365, DOI 10.1107/S0567740873002529; Jeffrey G. A., 1997, INTRO HYDROGEN BONDI; Lemieux R.U., 1990, EXPLORATIONS SUGAR S; Moller K.D., 1971, FAR INFRARED SPECTRO; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Reilly AM, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.055701; Wulf A, 2010, ANGEW CHEM INT EDIT, V49, P449, DOI 10.1002/anie.200905437; Zheng ZP, 2014, J MOL SPECTROSC, V296, P9, DOI 10.1016/j.jms.2013.12.002	46	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0009-2614	1873-4448		CHEM PHYS LETT	Chem. Phys. Lett.	DEC 1	2015	642						29	34		10.1016/j.cplett.2015.11.003		6	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	CX9SJ	WOS:000366045300006		
J	Endo, H; Taguchi, Y; Matsumoto, J; Achiba, Y; Kodama, T; Shiromaru, H; Wakabayashi, T				Endo, H.; Taguchi, Y.; Matsumoto, J.; Achiba, Y.; Kodama, T.; Shiromaru, H.; Wakabayashi, T.			Anticorrelated formation of fullerenes and polyynes upon laser ablation of graphite under various concentrations of hydrogen sources	CHEMICAL PHYSICS LETTERS			English	Article							CARBON CLUSTERS; PLANETARY-NEBULA; C-60; BUCKMINSTERFULLERENE; VAPORIZATION; MOLECULES; GASES	Soluble fullerenes were produced with a somewhat unexpectedly high yield (10(-2) wt% of the evaporated carbons) by laser ablation of graphite in a 'room-temperature' argon gas flow. The high yield was likely due to the high temperature of the graphite after heating by the ablation laser. Laser ablation experiments using argon-diluted propane gas showed that fullerene formation was strongly inhibited by the addition of propane, while the formation of hydrogen-terminated, chain-form carbon molecules (polyynes) was enhanced. The reactivities of the fullerene precursors and chain-form carbon clusters are discussed based on the anticorrelation of the yields of fullerenes and polyynes. (C) 2015 Elsevier B.V. All rights reserved.	[Endo, H.; Taguchi, Y.; Matsumoto, J.; Achiba, Y.; Kodama, T.; Shiromaru, H.] Tokyo Metropolitan Univ, Dept Chem, Hachioji, Tokyo 1920397, Japan; [Wakabayashi, T.] Kindai Univ, Dept Chem, Higashiosaka, Osaka 5778502, Japan	Shiromaru, H (reprint author), Tokyo Metropolitan Univ, Dept Chem, Hachioji, Tokyo 1920397, Japan.				Japan Society for the Promotion of Science (JSPS) [70196632]	This work was supported partly by a Grant-in-Aid for Scientific Research (No. 70196632) from the Japan Society for the Promotion of Science (JSPS).	Iijima S, 1996, J PHYS CHEM-US, V100, P5839, DOI 10.1021/jp953400v; Kasuya D, 2001, CHEM PHYS LETT, V337, P25, DOI 10.1016/S0009-2614(01)00139-7; KROTO HW, 1985, NATURE, V318, P162, DOI 10.1038/318162a0; COX DM, 1988, J CHEM PHYS, V88, P1588, DOI 10.1063/1.454137; RUOFF RS, 1993, J PHYS CHEM-US, V97, P3379, DOI 10.1021/j100115a049; MEIJER G, 1990, J CHEM PHYS, V93, P7800, DOI 10.1063/1.459360; Kano S, 2003, CHEM PHYS LETT, V378, P474, DOI 10.1016/S0009-2614(03)01326-5; ROHLFING EA, 1990, J CHEM PHYS, V93, P7851, DOI 10.1063/1.459367; Irle S, 2006, J PHYS CHEM B, V110, P14531, DOI 10.1021/jp061173z; HEATH JR, 1987, J AM CHEM SOC, V109, P359, DOI 10.1021/ja00236a012; Kato Y, 2004, CHEM PHYS LETT, V386, P279, DOI 10.1016/j.cplett.2004.01.065; Van Orden A, 1998, CHEM REV, V98, P2313, DOI 10.1021/cr970086n; Tsuji M, 2002, CHEM PHYS LETT, V355, P101, DOI 10.1016/S0009-2614(02)00192-6; WELTNER W, 1989, CHEM REV, V89, P1713, DOI 10.1021/cr00098a005; Cami J, 2010, SCIENCE, V329, P1180, DOI 10.1126/science.1192035; Taguchi Y, 2015, CARBON, V94, P124, DOI 10.1016/j.carbon.2015.06.058; Berne O, 2012, P NATL ACAD SCI USA, V109, P401, DOI 10.1073/pnas.1114207108; Haufier E., 1991, MATER RES SOC S P, V206, P627; Inoue K., 2010, CARBON, V48, P4197; Kasuya D., 2000, THESIS; KRATSCHMER W, 1990, NATURE, V347, P354, DOI 10.1038/347354a0; Otsuka M, 2013, ASTROPHYS J, V764, DOI 10.1088/0004-637X/764/1/77; Wakabayashi T, 1997, Z PHYS D ATOM MOL CL, V40, P414, DOI 10.1007/s004600050240; Wakabayashi T., 1996, STRUCTURE DYNAMICS C, P535	24	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0009-2614	1873-4448		CHEM PHYS LETT	Chem. Phys. Lett.	DEC 1	2015	642						35	38		10.1016/j.cplett.2015.10.008		4	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	CX9SJ	WOS:000366045300007		
J	Wang, C; Wan, GH				Wang, Chen; Wan, Guanghua			Income polarization in China: Trends and changes	CHINA ECONOMIC REVIEW			English	Article						Polarization decomposition; Alienation; Identification; Income distribution; China	INEQUALITY; GROWTH; DECOMPOSITION; POVERTY; REDISTRIBUTION; DETERMINANTS; COUNTRIES; HEALTH	This paper estimates income polarization in China from 1978 to 2010 and decomposes the estimated polarization by population subgroups. In addition, a framework is proposed to disentangle a change in polarization into a growth and a redistribution component This framework is then used to quantify the contributions of various income sources to a rise in polarization in China between 2002 and 2007. The analytical results suggest that (1) income polarization exhibited a broadly increasing trend from 1978 to 2010; (2) income polarization was large and rising among rural citizens, while low and declining among urban citizens; polarization of migrants also declined; (3) geographically, income polarization rose in east and particularly central China, while west China was most polarized with little change over time; and (4) the rise in polarization between 2002 and 2007 was mainly driven by the investment income, followed by transfers. Conversely, business income is polarization-reducing, especially in rural China. To a lesser extent wage is also polarization-reducing, especially among migrants. (C) 2015 Elsevier Inc. All rights reserved.	[Wang, Chen] Shanghai Univ Finance & Econ, Sch Urban & Reg Sci, Shanghai 200433, Peoples R China; [Wang, Chen; Wan, Guanghua] Asian Dev Bank Inst, Chiyoda Ku, Tokyo 1006008, Japan; [Wan, Guanghua] Yunnan Univ Finance & Econ, Kunming 650221, Yunnan, Peoples R China	Wang, C (reprint author), Asian Dev Bank Inst, Chiyoda Ku, Kasumigaseki Bldg 8F,3-2-5, Tokyo 1006008, Japan.	winniewang2222@126.com; gwan@adbi.org			Natural Science Foundation of China [NSFC 71133004, 71063022]; Bairen Jihua (100 top scientists program) of Yunnan Province	This paper was drafted when Chen Wang undertook an internship at the Asian Development Bank (ADB). ADB refers to China by the name People's Republic of China. Earlier versions of this paper were presented at various workshops. The authors acknowledge the helpful and constructive comments of two referees. Thanks go to Shi Li and Sui Yang for providing the main data set, Xuehui Han and Iva Sebastian for computational assistance, and Natalie Chun, Xin Meng, Jacques Silber and workshop participants for suggestions and discussions. Support from the Natural Science Foundation of China (Projects NSFC 71133004, 71063022) and Bairen Jihua (100 top scientists program) of Yunnan Province are acknowledged. The usual disclaimer applies.	Alesina A, 1997, Q J ECON, V112, P1027, DOI 10.1162/003355300555411; Wan GH, 2005, REV DEV ECON, V9, P107, DOI 10.1111/j.1467-9361.2005.00266.x; Zhang Y, 2006, J COMP ECON, V34, P694, DOI 10.1016/j.jce.2006.08.008; Wang C, 2014, J ECON SURV, V28, P686, DOI 10.1111/joes.12077; Duro JA, 2005, APPL ECON LETT, V12, P759, DOI 10.1080/13504850500184298; Keefer P, 2002, PUBLIC CHOICE, V111, P127, DOI 10.1023/A:1015168000336; Duro JA, 2005, J POLICY MODEL, V27, P1001, DOI 10.1016/j.jpolmod.2005.08.001; ESTEBAN JM, 1994, ECONOMETRICA, V62, P819, DOI 10.2307/2951734; Wilkinson RG, 1997, BRIT MED J, V314, P591; ATKINSON AB, 1970, J ECON THEORY, V2, P244, DOI 10.1016/0022-0531(70)90039-6; Baye FM, 2006, J AFR ECON, V15, P543, DOI 10.1093/jae/ejk010; Ge SQ, 2014, J EUR ECON ASSOC, V12, P300, DOI 10.1111/jeea.12072; Dalton H, 1920, ECON J, V30, P348, DOI 10.2307/2223525; Duclos JY, 2004, ECONOMETRICA, V72, P1737, DOI 10.1111/j.1468-0262.2004.00552.x; Gao Q, 2008, ANN NY ACAD SCI, V1136, P342, DOI 10.1196/annals.1425.025; Perez CB, 2010, REV INCOME WEALTH, V56, P171; Foster JE, 2010, J ECON INEQUAL, V8, P247, DOI 10.1007/s10888-009-9122-7; D'Ambrosio C, 2006, INTERNATIONAL PERSPECTIVES ON HOUSEHOLD WEALTH, P394; [Anonymous], 2000, REV INCOME WEALTH SE, DOI 10.1111/j.1475-4991.2000.tb00411.x; Seshanna S, 2003, J POLICY MODEL, V25, P335, DOI 10.1016/S0161-8938(03)00009-7; Ezcurra R, 2009, REG STUD, V43, P267, DOI 10.1080/00343400701808899; DATT G, 1992, J DEV ECON, V38, P275, DOI 10.1016/0304-3878(92)90001-P; Gochoco-Bautista MS, 2013, ASIAN ECON PAP, V12, P101, DOI 10.1162/ASEP_a_00214; Zhang XB, 2001, J DEV STUD, V37, P85, DOI 10.1080/00220380412331321981; Gao Q, 2012, CHINA ECON REV, V23, P1195, DOI 10.1016/j.chieco.2012.09.002; Bonnefond C, 2012, POST-COMMUNIST ECON, V24, P15, DOI 10.1080/14631377.2012.647972; Gao Q, 2013, J SOC POLICY, V42, P743, DOI 10.1017/S0047279413000329; Araar A., 2008, DECOMPOSITION POLARI; Atkinson A.B., 1983, EC INEQUALITY; Chakravarty S.R., 2009, INEQUALITY POLARIZAT; COWELL FA, 1985, REV ECON STUD, V52, P135, DOI 10.2307/2297475; Deutsch I., 2013, ECONOMICS-KIEL, V7, P1; Deutsch M., 1971, CONFLICT RESOLUTION; FAJNZYLBER P, 2000, ECONOMIA, V0001; Foster J.E., 1992, POLARIZATION D UNPUB; Gasparini L., 2008, OXFORD DEV STUDIES, V36, P461, DOI 10.1080/13600810802457365; Gradin Carlos, 2002, J INCOME DISTRIBUTIO, V11, P34; Jain L.R., 1990, INDIAN ECON REV, P165; Kakwani N., 1990, ECON POLIT WEEKLY, pA2; Kwack Sung Yeung, 2007, Journal of Economic Development, V32, P1; Montalvo JG, 2005, AM ECON REV, V95, P796, DOI 10.1257/0002828054201468; Motiram S., 2014, OXFORD DEV STUDIES, P1; Pigou A.F., 1912, WEALTH WELFARE; Ray D., 2007, J ECON INEQUAL, V5, P1, DOI [10.1007/s10888-006-9032-x, DOI 10.1007/S10888-006-9032-X]; Sen A.K., 1973, EC INEQUALITY; Shapley L.S., 1953, CONTRIBUTIONS THEORY, P307; Shorrocks AF, 2013, J ECON INEQUAL, P1; Shorrocks A.F., 2009, ARGUMENTS BETTER WOR, VII, P414; Wan, 2008, INEQUALITY GROWTH MO; Wang Y., 2000, J PUBLIC ECON THEORY, V2, P349, DOI [10.1111/1097-3923.00042, DOI 10.1111/1097-3923.00042/PDF]; Wilkinson RG, 1998, BRIT MED J, V316, P1611; Wilkinson R.G., 1996, UNHEALTHY SOC AFFLIC; WOLFSON MC, 1994, AM ECON REV, V84, P353	53	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1043-951X	1873-7781		CHINA ECON REV	China Econ. Rev.	DEC	2015	36						58	72		10.1016/j.chieco.2015.08.007		15	Economics	Business & Economics	CY3XF	WOS:000366342500005		
J	Wunsch-Vincent, S; Kashcheeva, M; Zhou, H				Wunsch-Vincent, Sacha; Kashcheeva, Mila; Zhou, Hao			International patenting by Chinese residents: Constructing a database of Chinese foreign-oriented patent families	CHINA ECONOMIC REVIEW			English	Article						China; Innovation; Intellectual property; Patents; Patent families	INNOVATION; SURGE	This paper analyzes Chinese patenting abroad by constructing a novel database of foreign-oriented patent families (1970-2012) and by distilling stylized facts about China's international patenting strategies. Patent families are a set of related patents filed in one or more foreign jurisdictions to protect the same invention. We find that by the turn of the century China emerged as major actor in terms of international patenting. Nonetheless, the share of Chinese patents which get filed abroad is still a fraction of patents filed at home; most patents abroad also only target one foreign country. Moreover, China's foreign patents are concentrated in a few technology fields and in a few firms, mostly the information technology sector. A shift is underway however to an increased proportion of filings abroad. The paper finds that the main drivers for this change are the desire to facilitate collaboration, to license IP, and to further the firm's reputation as true innovator. (C) 2015 Elsevier Inc. All rights reserved.	[Wunsch-Vincent, Sacha; Zhou, Hao] World Intellectual Property Org, Econ & Stat Div, CH-1202 Geneva, Switzerland; [Kashcheeva, Mila] Inst Dev Econ IDE JETRO, Mihama Ku, Chiba 2618545, Japan	Wunsch-Vincent, S (reprint author), World Intellectual Property Org, Econ & Stat Div, 34 Chemin Colombettes, CH-1202 Geneva, Switzerland.	sacha.wunschvincent@wipo.int					Sun YF, 2000, REG STUD, V34, P441, DOI 10.1080/00343400050058693; Hu AG, 2009, J DEV ECON, V90, P57, DOI 10.1016/j.jdeveco.2008.11.004; Hu AGZ, 2004, CHINA ECON REV, V15, P86, DOI 10.1016/S1043-951X(03)00028-2; Li XB, 2012, RES POLICY, V41, P236, DOI 10.1016/j.respol.2011.07.003; Sun YF, 2010, TECHNOVATION, V30, P540, DOI 10.1016/j.technovation.2010.05.003; Jefferson G, 2003, CHINA ECON REV, V14, P89, DOI 10.1016/S1043-951X(03)00003-8; Hu AG, 2010, RES POLICY, V39, P985, DOI 10.1016/j.respol.2010.04.006; Awokuse TO, 2010, J COMP ECON, V38, P217, DOI 10.1016/j.jce.2009.10.001; Demis H., 2004, OECD SCI TECHNOLOGY; Eberhardt Markus, 2014, WORKING PAPER; Faust K, 1983, WORLD PATENT INFORMA, V5, P144, DOI 10.1016/0172-2190(83)90135-7; Hu, 2008, RES POLICY, V37, P65; Hu Albert Guangzhou, 2011, REV ECON STAT, V87, P780; Huang C, 2004, R&D MANAGE, V34, P367, DOI 10.1111/j.1467-9310.2004.00347.x; Kroll Henning, 2011, World Patent Information, V33, DOI 10.1016/j.wpi.2010.03.004; Lei Zhen, 2012, PAT STAT DEC MAK C 2; Martinez Catalina, 2010, 2 OECD STAT AN SCI T, V2; Motohashi Kazuyuki, 2008, World Patent Information, V30, DOI 10.1016/j.wpi.2007.10.006; Netherlands Office for Science & Technology, 2014, CHIN INS CHIN PAT FI; OECD, 2009, OECD PAT STAT MAN; Organisation for Economic Co-operation and Development (OECD), 2008, OECD REV INN POL CHI; Schaaper Martin, 2009, OECD SCI TECHNOLOGY; Schmoch Ulrich, 2008, CONCEPT TECHNOLOGY C; SIPO, 2014, CDIP13INF8 SIPO WIPO; Straus Joseph, 2008, J WORLD INTELLECTUAL, V11, P58, DOI 10.1111/j.1747-1796.2008.00334.x; Sun Y., 2003, WORLD PATENT INFORM, V25, P27, DOI 10.1016/S0172-2190(02)00086-8; van Zeebroeck N., 2007, CEB WORKING PAPERS; WIPO, 2014, WORLD INT PROP IND 2; WIPO, 2011, WIPO WORLD INT PROP; Zhang H., 2010, INT J BUSINESS MANAG, V5, pP83; Zhang P., 2011, WIPO PUBLICATION E, V1018e	31	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1043-951X	1873-7781		CHINA ECON REV	China Econ. Rev.	DEC	2015	36						198	219		10.1016/j.chieco.2015.08.004		22	Economics	Business & Economics	CY3XF	WOS:000366342500013		
J	Yano, G; Shiraishi, M				Yano, Go; Shiraishi, Maho			Trade credit and ethnicity: Case of ethnic minority area in China	CHINA ECONOMIC REVIEW			English	Article						China; Ethnic bias; Ethnic minority firms; Interfirm trust; Trade credit	RESEARCH-AND-DEVELOPMENT; FLOW SENSITIVITY; PANEL-DATA; INVESTMENT; GROWTH; PROVISION; EQUITY	Using data for trade credit practices, this work investigates interfirm trust formation by ethnic minority firms in the Xinjiang Uygur Autonomous Region, China. The main findings of this research are as follows. First, there is a general ethnic bias against ethnic minority firms in receiving trade credit Second, ethnic minority firms are less eager than Han firms to build interfirm trust with their business partners by offering trade credit, which is partly due to their financing constraints. Third, ethnic minority firms have less trust of other ethnic minority firms in offering trade credit Fourth, these trade credit practices by ethnic minority firms tend to be more pronounced in those surviving after 2005. Fifth, ethnic minority firms do not share their members' information regarding productivity within their circle of ethnic minority firms. Overall, interfirm trust is insufficiently formed, even among ethnic minority firms. (C) 2015 Elsevier Inc. All rights reserved.	[Yano, Go] Kyoto Univ, Grad Sch Econ, Sakyo Ku, Kyoto 6068501, Japan; [Shiraishi, Maho] Univ Kitakyushu, Fac Foreign Studies, Kokuraminami Ku, Kitakyushu, Fukuoka 8028577, Japan	Yano, G (reprint author), Kyoto Univ, Grad Sch Econ, Sakyo Ku, Kyoto 6068501, Japan.	rswtj922@yahoo.co.jp; mshira@kitakyu-u.ac.jp			Ministry of Education, Science, Sports, and Culture of Japan (MESSC) [26380296]; Murata Science Foundation; JSPS	We thank B-Y Kim, Chenggang Xu, Fumiharu Mieno, Mitsuo Inada, Manabu Furuta, Junfang Sun, Dongyang Zhang and anonymous referees for helpful comments. All views and errors remain our own. This work was funded by Scientific Research (C) No. 26380296 from the Ministry of Education, Science, Sports, and Culture of Japan (MESSC), the Murata Science Foundation 2012-2013, and the JSPS Asian Core Program.	Fisman R, 2003, J FINANC, V58, P353, DOI 10.1111/1540-6261.00527; Guariglia A, 2011, J DEV ECON, V96, P79, DOI 10.1016/j.jdeveco.2010.07.003; Gustafsson B, 2003, ECON DEV CULT CHANGE, V51, P805, DOI 10.1086/377191; Long C, 2011, J INT ECON, V84, P112, DOI 10.1016/j.jinteco.2011.03.002; Wu WF, 2012, J BANK FINANC, V36, P2868, DOI 10.1016/j.jbankfin.2011.04.009; Roodman D, 2009, OXFORD B ECON STAT, V71, P135, DOI 10.1111/j.1468-0084.2008.00542.x; Levinsohn J, 2003, REV ECON STUD, V70, P317, DOI 10.1111/1467-937X.00246; Gustafsson B, 2009, CHINA ECON REV, V20, P193, DOI 10.1016/j.chieco.2009.02.003; Blundell R, 1998, J ECONOMETRICS, V87, P115, DOI 10.1016/S0304-4076(98)00009-8; Johnson S, 2002, J LAW ECON ORGAN, V18, P221, DOI 10.1093/jleo/18.1.221; Brown JR, 2009, J BANK FINANC, V33, P971, DOI 10.1016/j.jbankfin.2008.10.009; Brown JR, 2009, J FINANC, V64, P151, DOI 10.1111/j.1540-6261.2008.01431.x; Wu WF, 2014, J BANK FINANC, V39, P146, DOI 10.1016/j.jbankfin.2013.11.019; Ge Y, 2007, J BANK FINANC, V31, P513, DOI 10.1016/j.jbankfin.2006.07.009; Windmeijer F, 2005, J ECONOMETRICS, V126, P25, DOI 10.1016/j.jeconom.2004.02.005; Ding S, 2013, J BANK FINANC, V37, P1490, DOI 10.1016/j.jbankfin.2012.03.025; Hovakimian A, 2009, EUR FINANC MANAG, V15, P47, DOI 10.1111/j.1468-036X.2007.00420.x; ARELLANO M, 1991, REV ECON STUD, V58, P277, DOI 10.2307/2297968; Chen M., 2013, J COMP EC; Fabbri D., 2008, 4754 WORLD BANK; Fafchamps M., 2004, MARKET I SUBSAHARAN; Fisman R, 2004, REV ECON STAT, V86, P345, DOI 10.1162/003465304323023859; McMillan J, 1999, Q J ECON, V114, P1285, DOI 10.1162/003355399556278; Petersen MA, 1997, REV FINANC STUD, V10, P661, DOI 10.1093/rfs/10.3.661; ROODMAN D., 2008, 103 CTR GLOB DEV; Sato H., 2012, CCES DISCUSSION PAPE, V46; Van Horen N., 2004, 2792 MPRA	27	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1043-951X	1873-7781		CHINA ECON REV	China Econ. Rev.	DEC	2015	36						236	260		10.1016/j.chieco.2015.09.006		25	Economics	Business & Economics	CY3XF	WOS:000366342500015		
J	Kang, B				Kang, Byeongwoo			The innovation process of Huawei and ZTE: Patent data analysis	CHINA ECONOMIC REVIEW			English	Article						China; Huawei; Patent data; Patent statistics; ZTE	RESEARCH-AND-DEVELOPMENT; TECHNOLOGICAL REGIMES; CHINESE; STATISTICS; STRATEGIES; DISCLOSURE; PATTERNS	This study compares the innovation process of Huawei and ZTE in China using their patent data. By using patent statistics and raw data, this study provides more detailed findings than what statistics alone can provide. Huawei and ZTE were selected for this study mainly because they were the only Chinese firms that ranked among the top 100 PCT applicants in 2011. This study investigates the difference in the innovation process in R&D between Huawei and ZTE by analyzing (1) domestic and international patent application patterns, (2) granted patents, (3) co-applicants and inventors, (4) knowledge accumulation inside Huawei and ZTE, and (5) knowledge spillover to domestic and foreign firms. (C) 2014 Elsevier Inc. All rights reserved.	[Kang, Byeongwoo] Inst Dev Econ IDE JETRO, Mihama Ku, Chiba 2618545, Japan; [Kang, Byeongwoo] Univ Tokyo, Bunkyo Ku, Tokyo 1138656, Japan	Kang, B (reprint author), Inst Dev Econ IDE JETRO, Mihama Ku, Wakaba 3-2-2, Chiba 2618545, Japan.	byeongwoo.kang@gmail.com					Nelson AJ, 2009, RES POLICY, V38, P994, DOI 10.1016/j.respol.2009.01.023; Verspagen B, 2007, ADV COMPLEX SYST, V10, P93, DOI 10.1142/S0219525907000945; PAKES A, 1980, ECON LETT, V5, P377, DOI 10.1016/0165-1765(80)90136-6; Baker S, 2005, J LAW ECON, V48, P173, DOI 10.1086/426879; Gao XD, 2011, RES TECHNOL MANAGE, V54, P42; SCHMOCH U, 1994, TELECOMMUN POLICY, V18, P397, DOI 10.1016/0308-5961(94)90055-8; Hagedoorn J, 2002, RES POLICY, V31, P477, DOI 10.1016/S0048-7333(01)00120-2; Ponce CJ, 2011, J ECON BEHAV ORGAN, V80, P418, DOI 10.1016/j.jebo.2011.04.005; Michel J, 2001, SCIENTOMETRICS, V51, P185, DOI 10.1023/A:1010577030871; Breschi S, 2000, ECON J, V110, P388, DOI 10.1111/1468-0297.00530; Hu AG, 2009, J DEV ECON, V90, P57, DOI 10.1016/j.jdeveco.2008.11.004; Harwit E, 2007, CHINA QUART, P311, DOI 10.1017/S030574100700121X; Li XB, 2012, RES POLICY, V41, P236, DOI 10.1016/j.respol.2011.07.003; Gnyawali DR, 2011, RES POLICY, V40, P650, DOI 10.1016/j.respol.2011.01.009; Guellec D, 2001, RES POLICY, V30, P1253, DOI 10.1016/S0048-7333(00)00149-9; Nagaoka S, 2010, HBK ECON, V2, P1083, DOI 10.1016/S0169-7218(10)02009-5; Kang B, 2014, TELECOMMUN POLICY, V38, P902, DOI 10.1016/j.telpol.2014.09.004; BASBERG BL, 1982, RES POLICY, V11, P163, DOI 10.1016/0048-7333(82)90017-8; Lee K, 2001, RES POLICY, V30, P459, DOI 10.1016/S0048-7333(00)00088-3; Child J, 1996, ORGAN SCI, V7, P60, DOI 10.1287/orsc.7.1.60; Fung MK, 2002, ECON LETT, V74, P353, DOI 10.1016/S0165-1765(01)00558-4; Fontana R., 2009, EC INNOVATION NEW TE, V18, P311; Gibbons R., 1992, GAME THEORY APPL EC; GRILICHES Z, 1990, J ECON LIT, V28, P1661; Hedge D., 2008, ECON LETT, V105, P287; Kang B., 2014, RES POLICY; Kang B., 2014, WORLD PATENT INFORM, V38, P33, DOI [10.1016/j.wpi.2014.05.001, DOI 10.1016/J.WPI.2014.05.001]; Kang B., 2013, 131 ECIS; Kang Y., 2008, CHINESE CORPORATE GO; Lee K., 2009, CHINA EC J, V2, P25; Martinelli A., 2011, RES POLICY, V41, P414; OECD & Eurostat, 2005, OSL MAN PROP GUID CO; Schmoch U, 1999, RES EVALUAT, V8, P119, DOI 10.3152/147154499781777540; TEECE DJ, 1992, J ECON BEHAV ORGAN, V18, P1, DOI 10.1016/0167-2681(92)90050-L; Trajtenberg M., 2002, PATENTS CITATIONS IN; Young S., 1995, PRIVATE BUSINESS EC; Yusuf S., 2005, NEW OWNERSHIP PRIVAT; ZIE, 2013, ZTE ANN REP 2013	38	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1043-951X	1873-7781		CHINA ECON REV	China Econ. Rev.	DEC	2015	36						378	393		10.1016/j.chieco.2014.12.003		16	Economics	Business & Economics	CY3XF	WOS:000366342500027		
J	Ran, M				Ran, Ma			Contemporary Sino-Japanese Relations on Screen: A History, 1989-2005	CHINA QUARTERLY			English	Book Review									[Ran, Ma] Nagoya Univ, Film Studies, Global Japan In Asia Cultural Studies Programme 3, Nagoya, Aichi 4648601, Japan	Ran, M (reprint author), Nagoya Univ, Film Studies, Global Japan In Asia Cultural Studies Programme 3, Nagoya, Aichi 4648601, Japan.	maran@lit.nagoya-u.ac.jp					KIRSCH G, 2015, CONT SINO JAPANESE R	1	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0305-7410	1468-2648		CHINA QUART	China Q.	DEC	2015	224						1129	1130		10.1017/S0305741015001514		2	Area Studies	Area Studies	CY1WG	WOS:000366198200033		
J	Araki, S; Haneda, M; Koya, D; Kondo, K; Tanaka, S; Arima, H; Kume, S; Nakazawa, J; Chin-Kanasaki, M; Ugi, S; Kawai, H; Araki, H; Uzu, T; Maegawa, H				Araki, Shin-ichi; Haneda, Masakazu; Koya, Daisuke; Kondo, Keiko; Tanaka, Sachiko; Arima, Hisatomi; Kume, Shinji; Nakazawa, Jun; Chin-Kanasaki, Masami; Ugi, Satoshi; Kawai, Hiromichi; Araki, Hisazumi; Uzu, Takashi; Maegawa, Hiroshi			Urinary Potassium Excretion and Renal and Cardiovascular Complications in Patients with Type 2 Diabetes and Normal Renal Function	CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY			English	Article							BLOOD-PRESSURE; KIDNEY-DISEASE; ORANGE JUICE; SODIUM; RISK; MORTALITY; HYPERTENSION; ASSOCIATION; MELLITUS; OUTCOMES	Background and objectives We investigated the association of urinary potassium and sodium excretion with the incidence of renal failure and cardiovascular disease in patients with type 2 diabetes. Design, setting, participants, & measurements A total of 623 Japanese type 2 diabetic patients with eGFR >= 60 ml/min per 1.73 m(2) were enrolled in this observational follow-up study between 1996 and 2003 and followed-up until 2013. At baseline, a 24-hour urine sample was collected to estimate urinary potassium and sodium excretion. The primary end point was renal and cardiovascular events (RRT, myocardial infarction, angina pectoris, stroke, and peripheral vascular disease). The secondary renal end points were the incidence of a 50% decline in eGFR, progression to CKD stage 4 (eGFR<30 ml/min per 1.73 m(2)), and the annual decline rate in eGFR. Results During the 11-year median follow-up period, 134 primary end points occurred. Higher urinary potassium excretion was associated with lower risk of the primary end point, whereas urinary sodium excretion was not. The adjusted hazard ratios for the primary end point in Cox proportional hazards analysis were 0.56 (95% confidence interval [95% CI], 0.33 to 0.95) in the third quartile of urinary potassium excretion (2.33-2.90 g/d) and 0.33 (95% CI, 0.18 to 0.62) in the fourth quartile (>2.90 g/d) compared with the lowest quartile (<1.72 g/d). Similar associations were observed for the secondary renal end points. The annual decline rate in eGFR in the fourth quartile of urinary potassium excretion (-1.3 ml/min per 1.73 m(2)/y; 95% CI, -1.5 to -1.0) was significantly slower than those in the first quartile (-2.2; 95% CI, -2.4 to -1.8). Conclusions Higher urinary potassium excretion was associated with the slower decline of renal function and the lower incidence of cardiovascular complications in type 2 diabetic patients with normal renal function. Interventional trials are necessary to determine whether increasing dietary potassium is beneficial.	[Araki, Shin-ichi; Kume, Shinji; Nakazawa, Jun; Chin-Kanasaki, Masami; Ugi, Satoshi; Kawai, Hiromichi; Araki, Hisazumi; Uzu, Takashi; Maegawa, Hiroshi] Shiga Univ Med Sci, Dept Med, Otsu, Shiga 5202192, Japan; [Kondo, Keiko] Shiga Univ Med Sci, Dept Publ Hlth, Otsu, Shiga 5202192, Japan; [Tanaka, Sachiko] Shiga Univ Med Sci, Dept Biostat, Otsu, Shiga 5202192, Japan; [Arima, Hisatomi] Shiga Univ Med Sci, Ctr Epidemiol Res Asia, Otsu, Shiga 5202192, Japan; [Haneda, Masakazu] Asahikawa Med Coll, Div Metab & Biosyst Sci, Dept Med, Asahikawa, Hokkaido 078, Japan; [Koya, Daisuke] Kanazawa Med Univ, Dept Med, Div Endocrinol & Metab, Kanazawa, Ishikawa, Japan	Araki, S (reprint author), Shiga Univ Med Sci, Dept Med, Otsu, Shiga 5202192, Japan.	araki@belle.shiga-med.ac.jp			Ministry of Health, Labour and Welfare of Japan; Japan Agency for Medical Research and Development; Salt Science Research Foundation [1317]; AstraZeneca; MSD K.K.	This study was supported in part by a Grant-in-Aid for Diabetic Nephropathy and Nephrosclerosis Research from the Ministry of Health, Labour and Welfare of Japan (S.A.); a Grant-in-Aid for Research on Diabetic Kidney Disease from the Japan Agency for Medical Research and Development (S.A.); the Salt Science Research Foundation, Grant No. 1317 (U.T.); and research grants from AstraZeneca and MSD K.K. (for this prospective observational follow-up study).	Aburto NJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1378; American Diabetes Association, 2014, DIABETES CARE S1, V37, pS14, DOI [DOI 10.2337/DC14-S014, 10.2337/dc14-S014]; Araki S, 2007, DIABETES, V56, P1727, DOI 10.2337/db06-1646; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Seino Y, 2010, J DIABETES INVEST, V1, P212, DOI 10.1111/j.2040-1124.2010.00074.x; O'Donnell M, 2014, NEW ENGL J MED, V371, P612, DOI 10.1056/NEJMoa1311889; Ying WZ, 2009, HYPERTENSION, V54, P1159, DOI 10.1161/HYPERTENSIONAHA.109.138255; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Ekinci EI, 2011, DIABETES CARE, V34, P703, DOI 10.2337/dc10-1723; Hidaka H, 2000, INTERNAL MED, V39, P783, DOI 10.2169/internalmedicine.39.783; He FJ, 2008, PHYSIOL PLANTARUM, V133, P725, DOI 10.1111/j.1399-3054.2007.01033.x; Cook NR, 2009, ARCH INTERN MED, V169, P32, DOI 10.1001/archinternmed.2008.523; Suckling RJ, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006763.pub2; Thomas MC, 2011, DIABETES CARE, V34, P861, DOI 10.2337/dc10-1722; Yang QH, 2011, ARCH INTERN MED, V171, P1183, DOI 10.1001/archinternmed.2011.257; Araki S, 2013, DIABETES CARE, V36, P1248, DOI 10.2337/dc12-1298; Araki SI, 2006, DIABETES CARE, V29, P864, DOI 10.2337/diacare.29.04.06.dc05-1723; Dunkler D, 2013, JAMA INTERN MED, V173, P1682, DOI 10.1001/jamainternmed.2013.9051; Stolarz-Skrzypek K, 2011, JAMA-J AM MED ASSOC, V305, P1777, DOI 10.1001/jama.2011.574; Mente A, 2014, NEW ENGL J MED, V371, P601, DOI 10.1056/NEJMoa1311989; O'Donnell MJ, 2011, JAMA-J AM MED ASSOC, V306, P2229, DOI 10.1001/jama.2011.1729; Ghanim H, 2007, DIABETES CARE, V30, P1406, DOI 10.2337/dc06-1458; Hedayati SS, 2012, CLIN J AM SOC NEPHRO, V7, P315, DOI 10.2215/CJN.02060311; Buscemi S, 2012, AM J CLIN NUTR, V95, P1089, DOI 10.3945/ajcn.111.031088; DODSON PM, 1989, BRIT MED J, V298, P227; Intersalt Cooperative Research Group, 1988, BMJ-BRIT MED J, V297, P319, DOI DOI 10.1136/BMJ.297.66; Japan Diabetes Society, TREATM GUID DIAB 201; Smyth A, 2014, KIDNEY INT, V86, P1205, DOI 10.1038/ki.2014.214; World Health Organization, 2012, GUID SOD INT AD CHIL	29	0	0	AMER SOC NEPHROLOGY	WASHINGTON	1725 I ST, NW STE 510, WASHINGTON, DC 20006 USA	1555-9041	1555-905X		CLIN J AM SOC NEPHRO	Clin. J. Am. Soc. Nephrol.	DEC	2015	10	12					2152	2158		10.2215/CJN.00980115		7	Urology & Nephrology	Urology & Nephrology	CX9EF	WOS:000366007100009		
J	Mori, K; Beppu, T; Fujisawa, Y; Onodera, M; Ogasawara, K; Sasaki, M; Ehara, S; Sakai, A; Endo, S				Mori, Kiyofumi; Beppu, Takaaki; Fujisawa, Yutaka; Onodera, Makoto; Ogasawara, Kuniaki; Sasaki, Makoto; Ehara, Shigeru; Sakai, Akio; Endo, Shigeatsu			Effect of free radical scavenger, edaravone, for patients with carbon monoxide poisoning	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Carbon monoxide poisoning; Edaravone; Free radical; Demyelination; Myelin basic protein	ISCHEMIC-STROKE; HYPERBARIC-OXYGEN; BRAIN; INTOXICATION; INFARCTION; THERAPY; MCI-186; DAMAGE; SIZE; RAT	Objective: Chronic neurological symptoms after carbon monoxide (CO) poisoning are caused by various biological processes in the damaged brain, with free radicals playing roles as mediators in establishing pathological processes leading to chronic neurological symptoms under CO poisoning. This study aimed to clarify the effects of a free radical scavenger, edaravone, in patients with CO poisoning. Methods: We retrospectively compared two groups comprising patients treated with hyperbaric oxygenation alone (Group A, n = 25) or edaravone in addition to hyperbaric oxygenation (Group B, n =25). Edaravone was administrated intravenously at 30 mg every 12 h for 7 days. Patient characteristics, general conditions on admission, and frequency of chronic neurological symptoms were compared between groups. Among patients showing chronic neurological symptoms, cognitive function and daily activity were also compared between groups. Results: No significant differences in characteristics or general conditions on admission were identified between groups. In Group B, no patients presented with marked complications caused by edaravone. Although chronic persisting symptoms were less frequent in Group B (n=1, 0.04%) than in Group A (n = 5, 20%), this difference was not significant. In the 11 patients showing chronic symptoms, scores for cognitive function and daily activity in the chronic phase were better in Group B than in Group A, but no significant differences were apparent. Conclusions: The present results suggest that edaravone represents a tolerable and feasible treatment for CO-poisoned patients. Further studies are needed to clarify whether edaravone can favorably influence chronic neurological symptoms caused by CO poisoning. (C) 2015 Elsevier B.V. All rights reserved.	[Mori, Kiyofumi; Fujisawa, Yutaka; Onodera, Makoto; Endo, Shigeatsu] Iwate Prefectural Adv Crit Care & Emergency Ctr, Morioka, Iwate, Japan; [Beppu, Takaaki; Ogasawara, Kuniaki] Iwate Med Univ, Dept Neurosurg, Morioka, Iwate 0208505, Japan; [Beppu, Takaaki] Iwate Med Univ, Div Hyperbar Med, Morioka, Iwate 0208505, Japan; [Sasaki, Makoto] Iwate Med Univ, Inst Biomed Sci, Morioka, Iwate 0208505, Japan; [Ehara, Shigeru] Iwate Med Univ, Dept Radiol, Morioka, Iwate 0208505, Japan; [Sakai, Akio] Iwate Med Univ, Dept Psychiat, Morioka, Iwate 0208505, Japan	Beppu, T (reprint author), Iwate Med Univ, Dept Neurosurg, 19-1 Uchimaru, Morioka, Iwate 0208505, Japan.	tbeppu@iwate-med.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [S1491001];  [26462764]	This study was supported in part by a Grant-in-Aid for KAKENHI (no. 26462764, 2014-2016) and the Strategic Medical Science Research (S1491001, 2014-2018) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Weaver LK, 2014, UNDERSEA HYPERBAR M, V41, P339; Chambers CA, 2008, BRAIN INJURY, V22, P387, DOI 10.1080/02699050802008075; Shinohara Y, 2009, CEREBROVASC DIS, V27, P485, DOI 10.1159/000210190; Piantadosi CA, 1997, EXP NEUROL, V147, P103, DOI 10.1006/exnr.1997.6584; Xu JJ, 2013, TOXICOL APPL PHARM, V273, P410, DOI 10.1016/j.taap.2013.09.019; Thom SR, 2010, CLIN TOXICOL, V48, P47, DOI 10.3109/15563650903468209; Alonso JR, 2003, PHARMACOL TOXICOL, V93, P142, DOI 10.1034/j.1600-0773.2003.930306.x; CHANG KH, 1992, RADIOLOGY, V184, P117; VANSWIETEN JC, 1988, STROKE, V19, P604; Weaver LK, 2002, NEW ENGL J MED, V347, P1057, DOI 10.1056/NEJMoa013121; Parkinson RB, 2002, NEUROLOGY, V58, P1525; PIANTADOSI CA, 1995, FREE RADICAL BIO MED, V18, P603, DOI 10.1016/0891-5849(95)00168-W; Weaver LK, 2009, NEW ENGL J MED, V360, P1217, DOI 10.1056/NEJMcp0808891; Porter SS, 2002, ARCH CLIN NEUROPSYCH, V17, P195, DOI 10.1016/S0887-6177(00)00110-4; Unno Y, 2010, CLIN DRUG INVEST, V30, P143, DOI 10.2165/11535500-000000000-00000; Thom SR, 2004, P NATL ACAD SCI USA, V101, P13660, DOI 10.1073/pnas.0405642101; Onogi H, 2006, CLIN EXP PHARMACOL P, V33, P1035, DOI 10.1111/j.1440-1681.2006.04483.x; Thom SR, 2006, AM J RESP CRIT CARE, V174, P1239, DOI 10.1164/rccm-200604-557OC; Peters O, 1998, J CEREBR BLOOD F MET, V18, P196; WATANABE T, 1994, J PHARMACOL EXP THER, V268, P1597; Beppu T, 2012, J NEUROL, V259, P1698, DOI 10.1007/s00415-011-6402-5; Mikawa K, 2005, ACTA ANAESTH SCAND, V49, P385, DOI 10.1111/j.1399-6576.2004.00610.x; Weaver LK, 1999, NEW ENGL J MED, V340, P1290; Beppu T, 2014, AM J NEURORADIOL, V35, P625, DOI 10.3174/ajnr.A3489; Otomo E, 2003, CEREBROVASC DIS, V15, P222, DOI 10.1159/000069318; CHOI IS, 1983, ARCH NEUROL-CHICAGO, V40, P433; Ernst A, 1998, NEW ENGL J MED, V339, P1603, DOI 10.1056/NEJM199811263392206; Feng S., 2011, COCHRANE DATABASE SY; [Anonymous], 1975, J PSYCHIATR RES, DOI DOI 10.1016/0022-3956(75)90026-6; Nakase T, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-39; Piantadosi C., 1996, CARBON MONOXIDE, P163; Qingsong Wang, 2013, Undersea Hyperb Med, V40, P223	32	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	DEC	2015	139						56	61		10.1016/j.clineuro.2015.09.003		6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CY2FG	WOS:000366223600011		
J	Ikeda, H; Ohhashi, G				Ikeda, Hidetoshi; Ohhashi, Genichiro			Demonstration of high coincidence of pituitary adenoma in patients with ruptured Rathke's cleft cyst: Results of a prospective study	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Rathke's cleft cyst; Pituitary adenoma; Chronic inflammation; MET-PET; Prospective study	STEM-CELLS; TUMORS; GLAND; LESIONS	Objective: Repeated chronic inflammation, such as under circumstances of ruptured Rathke's cleft cyst (RCC), is known as the fundamental basis of various pathological changes including neoplastic change, therefore to examine accurate incidence of pituitary adenomas is important for the preventive medicine. Materials and methods: As a prospective study, patients were initially screened by the symptoms such as periodic headache and dizziness together with the abnormal findings such as seller floor bone defect on 3D-CT. Those screened patients who showed abnormal basal pituitary hormone values were additionally examined by several loading test and 3 T magnetic resonance imaging (MRI) by three-dimensional reconstructions of Flair cube images. The presence of pituitary adenomas was evaluated by composite 3T MRI and C-11 methionine MET positron-emission tomography imaging. Immunohistochemical studies were employed for surgical biopsy specimens to demonstrate hormone production. Results: 308 cases of RCC were diagnosed by both radiologic and intraoperative findings. Pathological examination confirmed 111 pituitary adenomas in 106 patients with ruptured RCC, therefore the rate of coincidence was revealed 34%. In 78 patients with abnormalities of pituitary hormone secretion, MET uptake was observed in the pituitary gland and verified pituitary adenoma pathologically. In addition, 28 adenomas were verified without MET-PET study on pathological examination only, for a total of 106 cases. Conclusions: High coincidence (34%) of ruptured RCC and pituitary adenomas was demonstrated, which is a proof that ruptured RCC is contributed to a risk factor of pituitary adenoma. (C) 2015 Elsevier B.V. All rights reserved.	[Ikeda, Hidetoshi; Ohhashi, Genichiro] Southern Tohoku Gen Hosp, Res Inst Pituitary Dis, Koriyama, Fukushima 9638563, Japan	Ikeda, H (reprint author), Southern Tohoku Gen Hosp, Res Inst Pituitary Dis, 7-115 Yatsuyamada, Koriyama, Fukushima 9638563, Japan.	ikeda@nsg.med.tohoku.ac.jp					Kosinski M, 2003, QUAL LIFE RES, V12, P963, DOI 10.1023/A:1026119331193; Ikeda H, 2002, CLIN NEUROPATHOL, V21, P82; Davis JRE, 2001, REPRODUCTION, V121, P363; Ikeda H, 2010, J NEUROSURG, V112, P750, DOI 10.3171/2009.7.JNS09285; Voigt P, 2013, GENE DEV, V27, P1318, DOI 10.1101/gad.219626.113; Koutourousiou M, 2010, PITUITARY, V13, P8, DOI 10.1007/s11102-009-0190-2; Trifanescu R, 2012, CLIN ENDOCRINOL, V76, P151, DOI 10.1111/j.1365-2265.2011.04235.x; Ezzat S, 2004, CANCER, V101, P613, DOI 10.1002/cncr.20412; IKEDA H, 1992, ACTA NEUROPATHOL, V83, P211; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Fauquier T, 2008, P NATL ACAD SCI USA, V105, P2907, DOI 10.1073/pnas.0707886105; Castinetti F, 2011, ENDOCR REV, V32, P453, DOI 10.1210/er.2010-0011; Weiss S, 2009, CLIN NEUROPATHOL, V28, P309; Gremeaux L, 2012, STEM CELLS DEV, V21, P801, DOI 10.1089/scd.2011.0496; Buurman H, 2006, EUR J ENDOCRINOL, V154, P753, DOI 10.1530/eje.1.02107; NISHIO S, 1987, NEUROSURGERY, V21, P371; IKEDA H, 1988, ACTA NEUROPATHOL, V77, P33; Florio T, 2011, NEUROENDOCRINOLOGY, V94, P265, DOI 10.1159/000330857; Karavitaki N, 2008, PITUITARY, V11, P317, DOI 10.1007/s11102-007-0070-6; Ikeda H., 2012, J METAB SYNDR S, V2; Ikeda H., 2012, J METAB SYNDR S, V2; Ikeda H., 2011, ADV MED BIOL, V23, P185; Ikeda H., 2012, KERATIN STRUCTURE PR, P137	23	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	DEC	2015	139						144	151		10.1016/j.clineuro.2015.09.018		8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CY2FG	WOS:000366223600027		
J	Doden, T; Sato, H; Hashimoto, T				Doden, Tadashi; Sato, Hiromasa; Hashimoto, Takao			Clinical characteristics and etiology of transient myoclonic state in the elderly	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Movement disorders; Myoclonus; Asterixis; Transient myoclonic state; Polypharmacy; Clonazepam	NEGATIVE MYOCLONUS; ASTERIXIS; FEATURES; TREMOR	Objectives: To clarify clinical picture of transient myoclonic state in elderly patients. Methods: The Aizawa Hospital database was searched to identify all patients with transient myoclonic state with or without asterixis between April 2006 and June 2013. Medical records, brain images and laboratory data including electroencephalograms and electromyograms were reviewed. Results: We found 26 patients: 10 women and 16 men, and their ages ranged from 56 to 96 years (79.7 +/- 9.9 years, mean standard deviation). The affected sites of the myoclonic jerks were predominantly the lower face, neck and upper extremities. The myoclonus appeared at conscious resting condition, slightly exaggerated by posturing or action. Asterixis was observed in eight patients. Single myoclonic bursts were 1.70 +/- 0.94 s long. The interval of myoclonic bursts was 4.47 +/- 2.44 s. Single myoclonic bursts were composed of 9.5 +/- 2.5 Hz myoclonic contractions, and single myoclonic contractions were 44.4 +/- 12.3 ms in duration. Most of the patients suffered from chronic diseases, but they were basically independent in activity of daily living. Oral administration of clonazepam was effective. Conclusions: Transient myoclonic state has relatively stereotyped features. The pathophysiology may include some metabolic abnormality on a background of age-related arteriosclerotic changes. Its prognosis is benign, and prompt oral administration of clonazepam abolishes it. Further investigations will be needed to clarify its cause and pathophysiology. (C) 2015 Elsevier B.V. All rights reserved.	[Doden, Tadashi; Sato, Hiromasa; Hashimoto, Takao] Aizawa Hosp, Dept Neurol, Matsumoto, Nagano 3908510, Japan	Hashimoto, T (reprint author), Aizawa Hosp, Dept Neurol, 2-5-1 Honjo, Matsumoto, Nagano 3908510, Japan.	aidr214@ai-hosp.or.jp; knsyi33@ai-hosp.or.jp; sinke-dr@ai-hosp.or.jp					ADAMS R. D., 1949, TRANS AMER NEUROL ASSOC, V74, P217; van Rootselaar AF, 2005, MOVEMENT DISORD, V20, P665, DOI 10.1002/mds.20413; SHIBASAKI H, 1995, ADV NEUROL, V67, P199; Evidente VGH, 1999, NEUROLOGY, V52, P211; KANOSUE K, 1994, AM J PHYSIOL, V267, pR275; Hitomi T, 2011, INTERNAL MED, V50, P2303, DOI 10.2169/internalmedicine.50.5590; IKEDA A, 1990, NEUROLOGY, V40, P1561; Borg M, 2006, NEUROPHYSIOL CLIN, V36, P309, DOI 10.1016/j.neucli.2006.12.006; Hiraga A, 2014, CLIN NEUROL NEUROSUR, V117, P51, DOI 10.1016/j.clineuro.2013.11.027; Rubboli G, 2006, NEUROPHYSIOL CLIN, V36, P337, DOI 10.1016/j.neucli.2006.12.001; HASHIMOTO S, 1992, J NEUROL SCI, V109, P132, DOI 10.1016/0022-510X(92)90159-I; UGAWA Y, 1989, J NEUROL NEUROSUR PS, V52, P89, DOI 10.1136/jnnp.52.1.89; Caviness JN, 2004, LANCET NEUROL, V3, P598, DOI 10.1016/S1474-4422(04)00880-4; Fujihara K., 1995, NEUROL MED TOKYO, V43, P90; Hirata K., 1997, SHINKEI NAIKA, V46, P53; Iijima M., 1997, SHINKEI NAIKA, V46, P413; Kawakami T., 2007, SHINKEI NAIKA, V66, P117; Kohono Y., 1998, JMDD, V8, P109; Marsden C.D., 1982, MOVEMENT DISORD, P196; Mizutani T, 1986, Rinsho Shinkeigaku, V26, P1042; Negoro K, 1994, Rinsho Shinkeigaku, V34, P1153; Okuma Y., 1999, RINSHO NOUHA, V41, P780; Yamamoto A., 1997, NEUROL MED TOKYO, V47, P546; YASUDA T, 1991, Kawasaki Medical Journal, V17, P1	24	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	DEC	2015	139						192	198		10.1016/j.clineuro.2015.10.004		7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CY2FG	WOS:000366223600035		
J	Borghei-Razavi, H; Tornio, R; Fereshtehnejad, SM; Shibao, S; Schick, U; Toda, M; Kawase, T; Yoshida, K				Borghei-Razavi, Hamid; Tornio, Ryosuke; Fereshtehnejad, Seyed-Mohammad; Shibao, Shunsuke; Schick, Uta; Toda, Masahiro; Kawase, Takeshi; Yoshida, Kazunari			Anterior petrosal approach: The safety of Kawase triangle as an anatomical landmark for anterior petrosectomy in petroclival meningiomas	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Anterior petrosectomy; Kawase triangle; Petroclival meningioma	TRANSPETROSAL-TRANSTENTORIAL APPROACH; SURGICAL TECHNIQUE; SKULL-BASE; MIDDLE FOSSA; RESECTION; REGION	Object: Anterior petrosectomy through the middle fossa is a well-described option for addressing cranial base lesions of the petroclival region. To access posterior fossa through middle fossa, we quantitatively evaluate the safety of Kawase triangle as an anatomical landmark. Method: We reviewed pre- and postoperative Multi-Slice CT scan (1 mm thickness) of patients with petroclival meningioma between Jan 2009 and Sep 2013 in which anterior petrosectomy was performed to access the posterior fossa part of the tumor. The distances between drilling start and finish edge to the vital anatomical skull base structures such as internal auditory canal (IAC) and superior semicircular canal and petrous apex (petrous part of the carotid artery) were measured and analyzed. Results: Drilling entrance length is directly related with tumor size. The distances between anatomical structures and drilling points decrease with increasing tumor size, but it always remains a safe margin between drilling points and IAC, internal carotid artery (ICA), and semicircular canals in axial and coronal views. Conclusion: The Kawase triangle is shown to be a safe anatomical landmark for anterior petrosectomy. The described landmarks avoid damage to the vital anatomical structures during access to the posterior fossa through middle fossa, despite temporal bone anatomical variations and different tumor sizes. (C) 2015 Elsevier B.V. All rights reserved.	[Borghei-Razavi, Hamid; Schick, Uta] Clemens Hosp, Dept Neurosurg, Munster, Germany; [Borghei-Razavi, Hamid; Tornio, Ryosuke; Shibao, Shunsuke; Toda, Masahiro; Kawase, Takeshi; Yoshida, Kazunari] Keio Univ, Sch Med, Dept Neurosurg, Tokyo 160, Japan; [Fereshtehnejad, Seyed-Mohammad] Karolinska Inst, Dept Neurobiol Care Sci & Soc NVS, Stockholm, Sweden	Borghei-Razavi, H (reprint author), Univ Munster, Acad Hosp, Clemens Hosp, Dept Neurosurg, Duesbergweg 124, D-48153 Munster, Germany.	h.borghei-razavi@clemenshospital.de			German Society of Neurosurgery (DGNC)	Hamid Borghei-Razavi (MD) received Carl-Zeiss Scholarship from German Society of Neurosurgery (DGNC) for German/Japan exchange program. Portions of this work were presented in abstract form at the 11th European Skull Base Society Congress, June 2014; Paris, France.	Al-Mefty O., 1991, MENINGIOMAS, P517; Safavi-Abbasi S, 2007, J NEUROSURG, V107, P797, DOI 10.3171/JNS-07/10/0797; HAKUBA A, 1988, SURG NEUROL, V30, P108, DOI 10.1016/0090-3019(88)90095-X; Chopra R, 2003, SURG RADIOL ANAT, V24, P348, DOI 10.1007/s00276-002-0076-8; Samii M, 2000, J NEUROSURG, V92, P235, DOI 10.3171/jns.2000.92.2.0235; ALMEFTY O, 1988, NEUROSURGERY, V22, P510; Chang SW, 2009, NEUROSURGERY, V64, pS44, DOI 10.1227/01.NEU.0000334410.24984.DD; Ichimura S, 2012, NEUROSURG REV, V35, P609, DOI 10.1007/s10143-012-0405-2; HOUSE WF, 1976, ARCH OTOLARYNGOL, V102, P334; TEDESCHI H, 1994, SURG NEUROL, V41, P180, DOI 10.1016/0090-3019(94)90123-6; Tao J, 2014, ACTA NEUROCHIR, V156, P1085, DOI 10.1007/s00701-014-2084-y; Gupta SK, 2012, J NEUROSURG, V117, P1007, DOI 10.3171/2012.9.JNS12429; Ichimura S, 2008, ACTA NEUROCHIR, V150, P637, DOI 10.1007/s00701-008-1586-x; Roche PH, 2008, NEUROCHIRURGIE, V54, P1, DOI 10.1016/j.neuchi.2007.08.006; Shibao S, 2015, WORLD NEUROSURG, V84, P574, DOI 10.1016/j.wneu.2015.03.055; Tomio R, 2014, J NEUROSURG, V120, P1249, DOI 10.3171/2013.10.JNS132121; KAWASE T, 1994, ACTA NEUROCHIR, V129, P113, DOI 10.1007/BF01406489; Samii M, 1999, J CLIN NEUROSCI, V6, P27, DOI 10.1016/S0967-5868(99)90598-2; KHOSLA VK, 1994, SURG NEUROL, V41, P502, DOI 10.1016/0090-3019(94)90017-5; Borghei-Razavi H., 2015, J NEUROL SURG B; Borghei-Razavi H, 2014, ANAT SCI INT, V89, P112, DOI 10.1007/s12565-013-0206-x; Bozbuga Mustafa, 1998, Okajimas Folia Anatomica Japonica, V75, P33; Fukushima T., 1996, MANUAL SKULL BASE DI; Kawase T., 1991, NEUROSURGERY, V28, P875; KAWASE T, 1991, NEUROSURGERY, V28, P869; Landolfi M, 1994, Acta Otorhinolaryngol Ital, V14, P127; Mefty O. Al-, 1988, NEUROSURGERY, V22, P10; Memari F., 2009, ARCH OTORHINOLARYNGO, V266, P1373; Quinones-Hinojosa A., 2006, NEUROSURGERY S2, V58; Tomio R, 2014, ACTA NEUROCHIR, V156, P1847, DOI 10.1007/s00701-014-2162-1	30	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	DEC	2015	139						282	287		10.1016/j.clineuro.2015.10.032		6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CY2FG	WOS:000366223600054		
J	Inoue, T; Shimizu, H; Fujimura, M; Sato, K; Endo, H; Niizuma, K; Sakata, H; Tominaga, T				Inoue, Takashi; Shimizu, Hiroaki; Fujimura, Miki; Sato, Kenichi; Endo, Hidenori; Niizuma, Kuniyasu; Sakata, Hiroyuki; Tominaga, Teiji			Risk factors for meningitis after craniotomy in patients with subarachnoid hemorrhage due to anterior circulation aneurysms rupture	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Cerebral aneurysm; Clipping; Craniotomy; Meningitis; Subarachnoid hemorrhage	NEUROSURGICAL SITE INFECTIONS; ADULT NOSOCOMIAL MENINGITIS; PREVENTING SHUNT INFECTION; ANTIBIOTIC-PROPHYLAXIS; PROSPECTIVE MULTICENTER; CLINICAL ARTICLE; EFFICACY; METAANALYSIS; IRRIGATION; VASOSPASM	Objectives: Postoperative meningitis is a serious complication occurring after neurosurgical interventions. However, few investigations have focused specifically on the risk factors that predispose patients to meningitis after major craniotomy. This study identified the risk factors for postoperative meningitis after neurovascular surgery, and investigated the relationship between postoperative meningitis and clinical outcome. Patients and methods: A total of 148 consecutive patients with subarachnoid hemorrhage (SAH) who underwent clipping surgery through a pterional approach within 72 h between January 2007 and September 2011 were retrospectively analyzed. The treatment strategy of our hospital for patients with SAH was based on the findings of digital subtraction angiography in the acute phase. Coil embolization was firstly considered, and clipping through craniotomy if indicated was performed as soon as possible. Prophylactic antibiotics were administered before beginning craniotomy and for at least 3 days after. Hydrocortisone was used to prevent hyponatremia if allowed by the medical condition of the patient. Intrathecal administration of nicardipine hydrochloride was given if required for vasospasm treatment. Meningitis was clinically diagnosed from the blood samplings and cerebrospinal fluid (CSF) examinations. Data were collected from the electronic and paper charts. The status of modified Rankin scale (mRS) 0-2 at discharge was defined as favorable outcome. Results: A total of 14 patients (9.5%) had meningitis during this study period. Symptomatic vasospasm was detected in 33 patients (22.3%), and 12 patients (8.1%) had permanent neurological deficits caused by vasospasm. Overall, 109 patients (73.6%) had favorable outcome. The longer duration of drainage placement, presence of CSF leakage, and intrathecal administration of vasodilatory agent showed significantly higher incidence of postoperative meningitis in univariate analysis (p = 0.0093, 0.0017, and 0.0090, respectively). The proportion of favorable outcome patients at discharge (mRS 0-2) was significantly lower in patients with postoperative meningitis (35.7%) than in patients without it (77.6%) (p = 0.0004). The duration of in-hospital stay was significantly longer in patients with postoperative meningitis (median 58.5, range 28-115 days) than in patients without it (median 38.5, range 19-149 days) (p < 0.001). Multivariate logistic regression analysis showed that only presence of CSF leakage was associated with postoperative meningitis (p = 0.0299). Conclusion: Meningitis after surgery is still a serious complication that requires preventative intervention. The clinical outcome of patients with postoperative meningitis after neurovascular surgery is not still satisfactory. (C) 2015 Elsevier B.V. All rights reserved.	[Inoue, Takashi; Sato, Kenichi; Endo, Hidenori; Sakata, Hiroyuki] Kohnan Hosp, Dept Neurosurg, Sendai, Miyagi, Japan; [Inoue, Takashi] Sendai Med Ctr, Dept Neurosurg, Sendai, Miyagi 9838520, Japan; [Shimizu, Hiroaki; Fujimura, Miki; Niizuma, Kuniyasu; Tominaga, Teiji] Tohoku Univ, Dept Neurosurg, Grad Sch Med, Sendai, Miyagi 980, Japan	Inoue, T (reprint author), Sendai Med Ctr, Dept Neurosurg, Miyagino Ku, 2-8-8 Miyagino, Sendai, Miyagi 9838520, Japan.	tainoue@snh.go.jp					MARTIN C, 1994, INFECT CONT HOSP EP, V15, P463; Hayashi T, 2008, J NEUROS-PEDIATR, V2, P25, DOI [10.3171/PED/2008/2/7/025, 10.3777/PED/2008/2/7/025]; MOLLMAN HD, 1986, J NEUROSURG, V64, P902, DOI 10.3171/jns.1986.64.6.0902; WRIGHT RL, 1966, J NEUROSURG, V25, P125; Sarrafzadeh A, 2011, STROKE, V42, P53, DOI 10.1161/STROKEAHA.110.594705; Korinek AM, 2008, NEUROSURGERY, V62, P532, DOI [10.1227/01.neu.0000316256.44349.b1, 10.1227/01.NEU.0000220477.47323.92]; Nakagawa I, 2013, CEREBROVASC DIS, V35, P131, DOI 10.1159/000346586; Federico G, 2001, SCAND J INFECT DIS, V33, P533; Kanat A, 1998, NEUROSURGERY, V43, P189, DOI 10.1097/00006123-199807000-00133; VANEK B, 1986, J INFECTION, V12, P105, DOI 10.1016/S0163-4453(86)93483-3; BLOMSTEDT GC, 1985, ACTA NEUROCHIR, V78, P81, DOI 10.1007/BF01808684; Suzuki M, 2001, NEUROSURG REV, V24, P180, DOI 10.1007/s101430100152; [Anonymous], 1999, AM J HLTH SYST PHARM, V56, P1839; Katayama Y, 2007, STROKE, V38, P2373, DOI 10.1161/STROKEAHA.106.480038; Korinek AM, 2005, BRIT J NEUROSURG, V19, P155, DOI 10.1080/02688690500145639; Zhu XL, 2001, CLIN THER, V23, P1281, DOI 10.1016/S0149-2918(01)80107-7; Molyneux AJ, 2005, LANCET, V366, P809, DOI 10.1016/S0140-6736(05)67214-5; Bekar A, 2001, ACTA NEUROCHIR, V143, P533, DOI 10.1007/s007010170057; Hayashi T, 2010, J NEUROSURG-PEDIATR, V6, P273, DOI 10.3171/2010.5.PEDS1018; Maurice-Williams RS, 1999, BRIT J NEUROSURG, V13, P312; Kourbeti IS, 2007, NEUROSURGERY, V60, P317, DOI 10.1227/01.NEU.0000249266.26322.25; Cheng YK, 2008, J CLIN NEUROSCI, V15, P1115, DOI 10.1016/j.jocn.2007.09.022; Barker FG, 2007, NEUROSURGERY, V60, P887, DOI 10.1227/01.NEU.0000255425.31797.23; Hardy SJ, 2010, J NEUROSURG, V113, P161, DOI 10.3171/2010.2.JNS09950; Barker II F.G., 1994, NEUROSURGERY, V35, P491; BARKER FG, 1994, NEUROSURGERY, V35, P484; Kim Y S, 1994, Neurosurg Clin N Am, V5, P741; Korinek AM, 2006, NEUROSURGERY, V59, P126, DOI 10.1227/01.NEU.0000220477.47232.92; Korinek A.M., 1997, NEUROSURGERY, V41, P1079; Korinek AM, 1997, NEUROSURGERY, V41, P1073, DOI 10.1097/00006123-199711000-00010; Kourbeti I.S., 2007, NEUROSURGERY, V60; KUBOTA T, 1993, STROKE, V24, P1993; Kubota T., 1993, STROKE, V24, P2000; Narotam P.K., 1994, NEUROSURGERY, V34, P415; NAROTAM PK, 1994, NEUROSURGERY, V34, P409; Pons V.G., 1993, NEUROSURGERY, V33, P422; Pons V.G., 1993, AM J HEALTH-SYST PH, V33, P416	37	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	DEC	2015	139						302	306		10.1016/j.clineuro.2015.10.029		5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CY2FG	WOS:000366223600057		
J	Itoi, C; Hiromitsu, K; Saito, S; Yamada, R; Shinoura, N; Midorikawa, A				Itoi, Chihiro; Hiromitsu, Kentaro; Saito, Shoko; Yamada, Ryoji; Shinoura, Nobusada; Midorikawa, Akira			Predicting sleepiness during an awake craniotomy	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Awake craniotomy; Sleepiness; Cognition; COGNISTAT; Brain tumor	BRAIN-TUMORS; AWARENESS; SURGERY; CORTEX	Objective: An awake craniotomy is a safe neurological surgical technique that minimizes the risk of brain damage. During the course of this surgery, the patient is asked to perform motor or cognitive tasks, but some patients exhibit severe sleepiness. Thus, the present study investigated the predictive value of a patient's preoperative neuropsychological background in terms of sleepiness during an awake craniotomy. Methods: Thirty-seven patients with brain tumor who underwent awake craniotomy were included in this study. Prior to craniotomy, the patient evaluated cognitive status, and during the surgery, each patient's performance and attitude toward cognitive tasks were recorded by neuropsychologists. Results: The present findings showed that the construction and calculation abilities of the patients were moderately correlated with their sleepiness. Conclusion: These results indicate that the preoperative cognitive functioning of patients was related to their sleepiness during the awake craniotomy procedure and that the patients who exhibited sleepiness during an awake craniotomy had previously experienced reduced functioning in the parietal lobe. (C) 2015 Elsevier B.V. All rights reserved.	[Itoi, Chihiro; Hiromitsu, Kentaro; Saito, Shoko] Chuo Univ, Grad Sch, Dept Literature, Hachioji, Tokyo 1920393, Japan; [Yamada, Ryoji; Shinoura, Nobusada] Komagome Metropolitan Hosp, Dept Neurosurg, Bunkyo Ku, Tokyo 1138677, Japan; [Midorikawa, Akira] Chuo Univ Literature, Dept Psychol, Hachioji, Tokyo 1920393, Japan	Itoi, C (reprint author), Chuo Univ, Grad Sch, Dept Literature, 742-1 Higashi Nakano, Hachioji, Tokyo 1920393, Japan.	itoi.chihiro@gmail.com					Wahab SS, 2011, BRIT J NEUROSURG, V25, P606, DOI 10.3109/02688697.2011.568642; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; MacDonald PA, 2003, CEREB CORTEX, V13, P962, DOI 10.1093/cercor/13.9.962; Conte V, 2013, J NEUROSURG ANESTH, V25, P279, DOI 10.1097/ANA.0b013e3182913afd; Wagner AD, 2005, TRENDS COGN SCI, V9, P445, DOI 10.1016/j.tics.2005.07.001; Nossek E, 2013, J NEUROSURG, V118, P243, DOI 10.3171/2012.10.JNS12511; Ford PJ, 2007, NEUROMODULATION, V10, P329, DOI 10.1111/j.1525-1403.2007.00119.x; Shinoura N, 2011, J AFFECT DISORDERS, V133, P569, DOI [10.1016/j.jad.2011.04.029, 10.1016/j.ad.2011.04.029]; Whittle IR, 2005, ACTA NEUROCHIR, V147, P275, DOI 10.1007/s00701-004-0445-7; BERGER MS, 1989, NEUROSURGERY, V25, P786; Serletis D, 2007, J NEUROSURG, V107, P1, DOI 10.3171/JNS-07/07/0001; KIERNAN RJ, 1987, ANN INTERN MED, V107, P481; Scheibel RS, 1996, J NEURO-ONCOL, V30, P61; Blakemore SJ, 2003, CURR OPIN NEUROBIOL, V13, P219, DOI 10.1016/S0959-4388(03)00043-6; Japan Awake Surgery Conference, 2013, GUID AW CRAN; Lezak D.M., 1995, NEUROPSYCHOLOGICAL A; Matsuda O., 2004, MANUALS JAPANESE VER; Minski L, 1933, J Neurol Psychopathol, V13, P330; SIGL JC, 1994, J CLIN MONITOR, V10, P392, DOI 10.1007/BF01618421	19	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	DEC	2015	139						307	310		10.1016/j.clineuro.2015.10.033		4	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CY2FG	WOS:000366223600058		
J	Yamazaki, K; Yoshino, Y; Mori, Y; Ochi, S; Yoshida, T; Lshimaru, T; Ueno, S				Yamazaki, Kiyohiro; Yoshino, Yuta; Mori, Yoko; Ochi, Shinichiro; Yoshida, Taku; Lshimaru, Takashi; Ueno, Shu-ichi			A Case of Nasu-Hakola Disease without Fractures or Consanguinity Diagnosed Using Exome Sequencing and Treated with Sodium Valproate	CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE			English	Editorial Material						Nasu-Hakola disease; Exome sequencing; TYROBP (DAP12); TREM2; Frontal lobe symptoms; Sodium valproate	NEUROGENESIS; MUTATIONS; DEMENTIA	Nasu-Hakola disease (NHD) is a rare autosomal recessive neuropsychiatric disorder characterized by bone cysts, fractures, and cognitive impairment. Two genes are responsible for the development of NHD; TYROBP and TREM2. Although it presents with typical signs and symptoms, diagnosing this disease remains difficult, This case report describes a male with NHD with no family or past history of bone fractures who was diagnosed using exome sequencing. His frontal lobe psychiatric symptoms recovered partially following treatment with sodium valproate, but not with an antipsychotic,	[Yamazaki, Kiyohiro; Yoshino, Yuta; Mori, Yoko; Ochi, Shinichiro; Yoshida, Taku; Lshimaru, Takashi; Ueno, Shu-ichi] Ehime Univ, Grad Sch Med, Dept Neuropsychiat, Toon, Ehime 7910295, Japan	Yamazaki, K (reprint author), Ehime Univ, Grad Sch Med, Dept Neuropsychiat, Toon, Ehime 7910295, Japan.	khryamazaki5555@gmail.com					Kotani S, 2008, CHEM-BIOL INTERACT, V175, P227, DOI 10.1016/j.cbi.2008.04.004; Teer JK, 2010, HUM MOL GENET, V19, pR145, DOI 10.1093/hmg/ddq333; Paloneva J, 2000, NAT GENET, V25, P357; Biesecker LG, 2014, NEW ENGL J MED, V370, P2418, DOI 10.1056/NEJMra1312543; Paloneva J, 2002, AM J HUM GENET, V71, P656, DOI 10.1086/342259; Ishikawa R, 2014, HIPPOCAMPUS, V24, P784, DOI 10.1002/hipo.22270; Madry H, 2007, CLIN ORTHOP RELAT R, P262, DOI 10.1097/01.blo.0000229364.57985.df; Mellow A M, 1993, J Geriatr Psychiatry Neurol, V6, P205; Hakola H P, 1972, Acta Psychiatr Scand Suppl, V232, P1; Klunemann HH, 2005, NEUROLOGY, V64, P1502; Lonergan E, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003945.pub3	11	0	0	KOREAN COLL NEUROPSYCHOPHARMACOLOGY	SEOUL	RN 1003 OFFICETEL 40, 63-RO YEONGDEUNGPO-GU, SEOUL, 150-731, SOUTH KOREA	1738-1088	2093-4327		CLIN PSYCHOPHARM NEU	Clin. Psychopharmacol. Neurosci.	DEC	2015	13	3					324	326		10.9758/cpn.2015.13.3.324		3	Neurosciences; Pharmacology & Pharmacy	Neurosciences & Neurology; Pharmacology & Pharmacy	CX9DV	WOS:000366006100017		
J	Dong, C; Hashimoto, K				Dong, Chao; Hashimoto, Kenji			Early Intervention for Psychosis with N-Methyl-D-Aspartate Receptor Modulators	CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE			English	Letter							CLINICAL HIGH-RISK; D-SERINE; SCHIZOPHRENIA; INDIVIDUALS; PILOT		[Dong, Chao; Hashimoto, Kenji] Chiba Univ, Ctr Forens Mental Hlth, Div Clin Neurosci, Chiba 2608670, Japan	Hashimoto, K (reprint author), Chiba Univ, Ctr Forens Mental Hlth, Div Clin Neurosci, 1-8-1 Inohana, Chiba 2608670, Japan.	hashimoto@faculty.chiba-u.jp					Woods SW, 2013, EUR NEUROPSYCHOPHARM, V23, P931, DOI 10.1016/j.euroneuro.2012.09.008; McGorry PD, 2015, J NERV MENT DIS, V203, P310, DOI 10.1097/NMD.0000000000000284; Fusar-Poli P, 2012, ARCH GEN PSYCHIAT, V69, P562, DOI 10.1001/archgenpsychiatry.2011.1592; Seidman LJ, 2015, SCHIZOPHRENIA BULL, V41, P795, DOI 10.1093/schbul/sbv050; Hashimoto K, 2014, EXPERT OPIN THER TAR, V18, P1049, DOI 10.1517/14728222.2014.934225; Hashimoto K, 2003, ARCH GEN PSYCHIAT, V60, P572, DOI 10.1001/archpsyc.60.6.572; Yamada K, 2005, BIOL PSYCHIAT, V57, P1493, DOI 10.1016/j.biopsych.2005.03.018; Kantrowitz JT, 2015, LANCET PSYCHIAT, V2, P403, DOI 10.1016/S2215-0366(15)00098-X; Thompson E, 2015, J NERV MENT DIS, V203, P342, DOI 10.1097/NMD.0000000000000287; Hashimoto K, 2005, PROG NEURO-PSYCHOPH, V29, P767, DOI 10.1016/j.pnpbp.2005.04.023; Hagiwara H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062438; Schizophrenia Working Group of the Psychiatric Genomics C, 2014, NATURE, V511, P421, DOI DOI 10.1038/NATURE13595	12	0	0	KOREAN COLL NEUROPSYCHOPHARMACOLOGY	SEOUL	RN 1003 OFFICETEL 40, 63-RO YEONGDEUNGPO-GU, SEOUL, 150-731, SOUTH KOREA	1738-1088	2093-4327		CLIN PSYCHOPHARM NEU	Clin. Psychopharmacol. Neurosci.	DEC	2015	13	3					328	329		10.9758/cpn.2015.13.3.328		2	Neurosciences; Pharmacology & Pharmacy	Neurosciences & Neurology; Pharmacology & Pharmacy	CX9DV	WOS:000366006100019		
J	Tamura, T; Tamura, S; Tanaka, H; Ohagi, Y; Taniguchi, F; Yamanishi, H; Kohara, T; Kimura, R; Kurihara, T; Ozaki, T; Nakano, Y; Fujimoto, T				Tamura, Tadahiko; Tamura, Shinobu; Tanaka, Hironori; Ohagi, Yuko; Taniguchi, Fumitaka; Yamanishi, Hirofumi; Kohara, Toshihisa; Kimura, Ritsuko; Kurihara, Toshio; Ozaki, Takashi; Nakano, Yoshio; Fujimoto, Tokuzo			Tocilizumab for intestinal amyloidosis complicated by multi-centric Castleman's disease	CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY			English	Letter							AA AMYLOIDOSIS		[Tamura, Tadahiko; Ohagi, Yuko; Nakano, Yoshio; Fujimoto, Tokuzo] Kinan Hosp, Dept Internal Med, Wakayama, Japan; [Tamura, Shinobu] Kinan Hosp, Dept Hematol & Oncol, Wakayama, Japan; [Tanaka, Hironori] Shingu Municipal Med Ctr, Dept Internal Med, Wakayama, Japan; [Taniguchi, Fumitaka; Yamanishi, Hirofumi; Kohara, Toshihisa; Kimura, Ritsuko] Kinan Hosp, Dept Gastroenterol, Wakayama, Japan; [Kurihara, Toshio] Kinan Hosp, Dept Pharm, Wakayama, Japan; [Ozaki, Takashi] Kinan Hosp, Dept Clin Lab, Wakayama, Japan	Tamura, S (reprint author), Kinan Hosp, Dept Hematol & Oncol, 46-70 Shinjo, Tanabe City, Wakayama, Japan.	stamura@kinan-hp.tanabe.wakayama.jp					PETERSON BA, 1993, SEMIN ONCOL, V20, P636; Inoue D, 2010, CLIN RHEUMATOL, V29, P1195, DOI 10.1007/s10067-010-1422-6; Okuda Y, 2014, MOD RHEUMATOL, V24, P137, DOI 10.3109/14397595.2013.854048; Miura A, 1995, INTERNAL MED, V34, P1106, DOI 10.2169/internalmedicine.34.1106; CHAN KW, 1992, PATHOLOGY, V24, P229; PILON VA, 1982, AM J CLIN PATHOL, V78, P112; TANAKA K, 1995, INTERNAL MED, V34, P122, DOI 10.2169/internalmedicine.34.122; Morita-Hoshi Y, 2008, INT J HEMATOL, V87, P69, DOI 10.1007/s12185-007-0015-x; Hokama Akira, 2011, World J Gastrointest Endosc, V3, P157, DOI 10.4253/wjge.v3.i8.157; Pasquau Llano F, 1990, MED CLIN BARC, V94	10	0	0	ELSEVIER MASSON	MILANO	VIA PALEOCAPA 7, 20121 MILANO, ITALY	2210-7401	2210-741X		CLIN RES HEPATOL GAS	Clin. Res. Hepatol. Gastroenterol.	DEC	2015	39	6					E79	E81		10.1016/j.clinre.2015.05.003		3	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CY1IU	WOS:000366160700002		
J	Hu, S; Nozawa, J; Koizumi, H; Fujiwara, K; Uda, S				Hu, Sumeng; Nozawa, Jun; Koizumi, Haruhiko; Fujiwara, Kozo; Uda, Satoshi			Grain Boundary Segregation of Impurities During Polycrystalline Colloidal Crystallization	CRYSTAL GROWTH & DESIGN			English	Article							GROWTH-KINETICS; SURFACE-MORPHOLOGY; CRYSTAL-GROWTH; KDP CRYSTALS; SUSPENSIONS; NUCLEATION; PARTICLES; INTERFACE; MECHANISM; THICKNESS	Impurity partitioning at grain boundaries (GBs) during polycrystalline colloidal crystallization has been investigated via direct observation. Polycrystalline grains have a partitioning behavior similar to that of single colloidal crystals, which follows the Burton, Prim, and Slichter (BPS) model. We have found that impurities segregate at GBs during colloidal crystal growth, and the impurity concentration at GBs (C-GB) for various misorientation angles (theta) between adjacent grains and growth rates (V) has been investigated. C-GB was found to increase with either increasing theta or V, and also when the size of the impurity is close to that of the host colloid particle. In situ observations reveal that impurities incorporated into GBs are supplied mostly from the impurities segregated at the solid liquid interface, and C-GB and the growth rate show a BPS-like relationship.	[Hu, Sumeng; Nozawa, Jun; Koizumi, Haruhiko; Fujiwara, Kozo; Uda, Satoshi] Tohoku Univ, Inst Mat Res, Aoba Ku, Sendai, Miyagi 9808577, Japan	Nozawa, J (reprint author), Tohoku Univ, Inst Mat Res, Aoba Ku, Katahira 2-1-1, Sendai, Miyagi 9808577, Japan.	nozawa@imr.tohoku.ac.jp			JSPS KAKENHI [26870047]; China Scholarship Council (CSC)	This work was supported in part by JSPS KAKENHI Grant Number 26870047 and the China Scholarship Council (CSC). We acknowledge Professor J. Yamanaka, Nagoya City University, for helpful discussions.	Lipowsky P, 2005, NAT MATER, V4, P407, DOI 10.1038/nmat1376; Zhang TH, 2014, CHEM SOC REV, V43, P2324, DOI 10.1039/c3cs60398a; Rak M, 2005, J CRYST GROWTH, V273, P577, DOI [10.1016/j.jcrysgro.2004.09.067, 10.1016/j.jccrysgro.2004.09.067]; Ganapathy R, 2010, SCIENCE, V327, P445, DOI 10.1126/science.1179947; Xie RG, 2008, ADV FUNCT MATER, V18, P802, DOI 10.1002/adfm.200700760; Trautt ZT, 2006, SCIENCE, V314, P632, DOI 10.1126/science.1131988; Yoshizawa K, 2011, LANGMUIR, V27, P13420, DOI 10.1021/la202899v; Duscher G, 2004, NAT MATER, V3, P621, DOI 10.1038/nmat1191; Dimitrov AS, 1996, LANGMUIR, V12, P1303, DOI 10.1021/la9502251; Ghofraniha N, 2012, SOFT MATTER, V8, P6214, DOI 10.1039/c2sm25488c; de Villeneuve VWA, 2009, SOFT MATTER, V5, P2448, DOI 10.1039/b817255b; BURTON JA, 1953, J CHEM PHYS, V21, P1987, DOI 10.1063/1.1698728; Eremina TA, 2005, J CRYST GROWTH, V273, P586, DOI 10.1016/j.jcrysgro.2004.09.068; Gleiter H, 2000, ACTA MATER, V48, P1, DOI 10.1016/S1359-6454(99)00285-2; Schall P, 2006, NATURE, V440, P319, DOI 10.1038/nature04557; Cacciuto A, 2004, NATURE, V428, P404, DOI 10.1038/nature02397; de Villeneuve VWA, 2005, SCIENCE, V309, P1231, DOI 10.1126/science.1113207; Pan SH, 2000, NATURE, V403, P746; Nagamanasa KH, 2011, P NATL ACAD SCI USA, V108, P11323, DOI 10.1073/pnas.1101858108; BARY A, 1988, J APPL PHYS, V63, P435, DOI 10.1063/1.340259; Ishii M, 2007, SOFT MATTER, V3, P872, DOI 10.1039/b614593k; Nozawa J, 2013, J PHYS CHEM B, V117, P5289, DOI 10.1021/jp309550y; RANDLE V, 1986, ACTA METALL MATER, V34, P891, DOI 10.1016/0001-6160(86)90062-3; PUSEY PN, 1986, NATURE, V320, P340, DOI 10.1038/320340a0; Xie RG, 2009, J AM CHEM SOC, V131, P4976, DOI 10.1021/ja900049r; Alsayed AM, 2005, SCIENCE, V309, P1207, DOI 10.1126/science.1112399; Meng LL, 2006, NANO LETT, V6, P2249, DOI 10.1021/nl061626b; Fujiwara K, 2013, SCRIPTA MATER, V69, P266, DOI 10.1016/j.scriptamat.2013.04.015; DENKOV ND, 1993, NATURE, V361, P26, DOI 10.1038/361026a0; Land TA, 1999, NATURE, V399, P442, DOI 10.1038/20886; Callister W., 2007, MAT SCI ENG INTRO; Edwards TD, 2014, SCI REP-UK, V4, DOI 10.1038/srep06132; Gokhale S., 2012, P NATL ACAD SCI USA, V109, P20314; Gottstein G., 2010, GRAIN BOUNDARY MIGRA; Herlach DM, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/15/153101; Hirth J P, 1982, THEORY DISLOCATIONS; Howe J. M., 1997, INTERFACES MAT; Jiang P, 1999, CHEM MATER, V11, P2132, DOI 10.1021/cm990080+; Kubota N, 2001, CRYST RES TECHNOL, V36, P749, DOI 10.1002/1521-4079(200110)36:8/10<749::AID-CRAT749>3.0.CO;2-#; Lejcek P, 2010, SPRINGER SER MATER S, V136, P1, DOI 10.1007/978-3-642-12505-8; Mendelev MI, 2002, MODEL SIMUL MATER SC, V10, pR79, DOI 10.1088/0965-0393/10/6/201; Phillips R., 2001, CRYSTALS DEFECTS MIC; Skinner TOE, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.168301; Zykova-Timan T, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/46/464102	44	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1528-7483	1528-7505		CRYST GROWTH DES	Cryst. Growth Des.	DEC	2015	15	12					5685	5692		10.1021/acs.cgd.5b00646		8	Chemistry, Multidisciplinary; Crystallography; Materials Science, Multidisciplinary	Chemistry; Crystallography; Materials Science	CX8CN	WOS:000365930300009		
J	Zhang, QC; Takeda, T; Hoshino, N; Noro, S; Nakamura, T; Akutagawa, T				Zhang, Qian-Chong; Takeda, Takashi; Hoshino, Norihisa; Noro, Shin-ichiro; Nakamura, Takayoshi; Akutagawa, Tomoyuki			Liquid Crystalline Phase Induced by Molecular Rotator and Dipole Fluctuation	CRYSTAL GROWTH & DESIGN			English	Article							INTRAMOLECULAR PROTON-TRANSFER; METHYL ROTATION; HYDROGEN-BONDS; SMECTIC-A; TRANSITION; ADAMANTANE; DYNAMICS; SPECTROSCOPY; TEMPERATURE; GENERATION	The thermal properties, crystal structures, dielectric relaxations, and rotational potential energy curves were examined for new rod-like molecules 1 and 2 bearing three aromatic rings connected by two -CONH- linkage groups to clarify the dynamic molecular behavior and phase transition behavior of the molecular assemblies. The molecular structures of 1 and 2 differed in that the central aromatic ring was phenyl (-C6H4-) in 1 and pyridyl (-C5NH3-) in 2, which affected the phase transition behavior owing to the permanent dipole moment without the center of inversion in molecule 2. Although the crystal structures of 1 and 2 were isostructural, the melting point of crystal 2 was approximately 43 K lower than that of crystal 1, and a smectic A mesophase was reversibly observed in crystal 2. A broad endothermic thermal anomaly of crystal 2 was observed in the heating process on the differential scanning calorimetry chart because of thermally activated dipole fluctuation, which was consistent with the frequency- and temperature-dependent dielectric relaxations. Double- and single-minimum-type potential energy curves were observed in the rotations of -C6H4- and -C5NH3- rings, respectively, from density functional theory calculations. The difference in rotational symmetry affected the crystal lattice energy and appearance of the mesophase.	[Zhang, Qian-Chong; Takeda, Takashi; Hoshino, Norihisa; Akutagawa, Tomoyuki] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Noro, Shin-ichiro; Nakamura, Takayoshi] Hokkaido Univ, Res Inst Elect Sci, Sapporo, Hokkaido 0010020, Japan	Akutagawa, T (reprint author), Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.	akuta@tagen.tohoku.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Management Expenses Grants for National Universities of Japan; Chinese Scholarship Council	This work was supported by a Grant-in-Aid for Science Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and by Management Expenses Grants for National Universities of Japan. We thank the Chinese Scholarship Council for its support.	Akutagawa T., 2010, CHEM-ASIAN J, V5, P520; Rodriguez-Velamazan JA, 2012, J AM CHEM SOC, V134, P5083, DOI 10.1021/ja206228n; Kato T, 2006, ANGEW CHEM INT EDIT, V45, P38, DOI 10.1002/anie.200501384; CHANG SS, 1960, J PHYS CHEM-US, V64, P1547, DOI 10.1021/j100839a050; DAVID WIF, 1992, EUROPHYS LETT, V18, P219, DOI 10.1209/0295-5075/18/3/006; RUDOLPH HD, 1973, J MOL SPECTROSC, V47, P314, DOI 10.1016/0022-2852(73)90016-7; Perkowski P, 2009, OPTO-ELECTRON REV, V17, P180, DOI 10.2478/s11772-008-0062-8; Recker J, 2000, J AM CHEM SOC, V122, P10298, DOI 10.1021/ja001225c; Akutagawa T, 2009, NAT MATER, V8, P342, DOI [10.1038/nmat2377, 10.1038/NMAT2377]; LALANNE JR, 1989, PHYS REV LETT, V62, P3046, DOI 10.1103/PhysRevLett.62.3046; KATO T, 1989, J AM CHEM SOC, V111, P8533, DOI 10.1021/ja00204a044; NORDMAN CE, 1965, ACTA CRYSTALLOGR, V18, P764, DOI 10.1107/S0365110X65001755; Kato T, 2002, SCIENCE, V295, P2414, DOI 10.1126/science.1070967; Zhang QC, 2013, ANGEW CHEM INT EDIT, V52, P12602, DOI 10.1002/anie.201306193; Akutagawa T, 2010, DALTON T, V39, P8219, DOI 10.1039/c0dt00308e; Kajitani T, 2004, J MATER CHEM, V14, P3449, DOI 10.1039/b408672d; DEJEU WH, 1974, PHYS REV LETT, V32, P40, DOI 10.1103/PhysRevLett.32.40; LIBERLES A, 1972, J AM CHEM SOC, V94, P6894, DOI 10.1021/ja00775a005; Garcia-Garibay MA, 2005, P NATL ACAD SCI USA, V102, P10771, DOI 10.1073/pnas.0502816102; Devautour-Vinot S, 2012, CHEM MATER, V24, P2168, DOI 10.1021/cm300863c; Vogelsberg CS, 2012, CHEM SOC REV, V41, P1892, DOI 10.1039/c1cs15197e; JIN YM, 1992, J PHYS CHEM-US, V96, P5151, DOI 10.1021/j100191a073; ATAKE T, 1982, J CHEM PHYS, V76, P5535, DOI 10.1063/1.442909; WU PJ, 1971, J CHEM PHYS, V54, P2714, DOI 10.1063/1.1675234; GOUDA F, 1991, FERROELECTRICS, V113, P165, DOI 10.1080/00150199108014063; Kajitani T, 2004, CHEM MATER, V16, P2329, DOI 10.1021/cm049574j; LUZAR M, 1984, FERROELECTRICS, V58, P115, DOI 10.1080/00150198408237863; TRUONG TN, 1991, J AM CHEM SOC, V113, P7504, DOI 10.1021/ja00020a009; BENGUIGUI L, 1982, J PHYS-PARIS, V43, P915, DOI 10.1051/jphys:01982004306091500; TYCKO R, 1991, PHYS REV LETT, V67, P1886, DOI 10.1103/PhysRevLett.67.1886; Gilli P, 2002, J AM CHEM SOC, V124, P13554, DOI 10.1021/ja020589x; [Anonymous], 2004, CRYST STRUCT SINGL C; Hoshino N, 2014, RSC ADV, V4, P743, DOI 10.1039/c3ra44515a; Akutagawa T, 2008, INORG CHEM, V47, P5951, DOI 10.1021/ic800271m; Baldwin R. L., 2006, ADV PROTEIN CHEM, V72; Bellamy C. B. E., 1980, ADV INFRARED GROUP F, V2; Cao K. C., 2004, DIELECTRIC PHENOMENA; Chandrasekhar S, 1992, LIQUID CRYSTALS; Collings P. J., 1997, INTRO LIQUID CRYSTAL; Dolensy B, 2013, J MOL STRUCT, V1035, P124, DOI 10.1016/j.molstruc.2012.09.040; Ehuong T. V., 2006, ACCOUNTS CHEM RES, V39, P413; Frisch MJ, 2009, GAUSSIAN 09 REVISION; Greenberg A., 2003, THE AMIDE LINKAGE; Horansky RD, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.014302; Jeffrey G.A., 1991, HYDROGEN BONDING BIO; Jew W. H., 1989, J CHEM PHYS, V61, P1985; Lascombe J., 1987, DYNAMICS MOL CRYSTAL; Parsonage NG, 1978, DISORDER IN CRYSTALS; Sheldrick G. M., 1998, SHELX97 PROGRAMS CRY; Sherwood J. N., 1979, PLASTICALLY CRYSTALL; SUGA H, 1980, FARADAY DISCUSS, V69, P221, DOI 10.1039/dc9806900221; Tayi AS, 2015, NAT CHEM, V7, P281, DOI [10.1038/nchem.2206, 10.1038/NCHEM.2206]	52	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1528-7483	1528-7505		CRYST GROWTH DES	Cryst. Growth Des.	DEC	2015	15	12					5705	5711		10.1021/acs.cgd.5b00695		7	Chemistry, Multidisciplinary; Crystallography; Materials Science, Multidisciplinary	Chemistry; Crystallography; Materials Science	CX8CN	WOS:000365930300011		
J	Zeng, G; McDonald, SD; Gu, QF; Matsumura, S; Nogita, K				Zeng, Guang; McDonald, Stuart D.; Gu, Qinfen; Matsumura, Syo; Nogita, Kazuhiro			Kinetics of the beta -> alpha Transformation of Tin: Role of alpha-Tin Nucleation	CRYSTAL GROWTH & DESIGN			English	Article							SN ALLOTROPIC TRANSFORMATION; SHAPE-MEMORY ALLOYS; WHITE TIN; PHASE-TRANSFORMATION; PEST; GREY; TEMPERATURE; SOLDERS; ZN; TRANSITION	The influence of alpha-Sn nucleation on the kinetics of the beta -> alpha phase transformation are investigated, using in situ synchrotron powder X-ray diffraction (PXRD) with variable temperature control. In the entire thermal history of the alpha -> beta -> alpha transformations, the population of alpha-Sn at the onset of the beta -> alpha transformation was varied by controlling the alpha -> beta transformation under isothermal conditions. The degree of alpha-Sn nucleation is found to have a correlation with the transformation kinetics of beta -> alpha. The growth component n is determined by both temperature and transformation time (fraction). By introducing an impingement factor, the transformation curves yielded a good fit to the modified Johnson-Mehl-Avrami-Kolmogorov (JMAK) model. At the commencement of the reaction, insufficient nucleation was found in samples subject to long anneals, and additional nucleation was required, at the kinetically optimal temperature of -45 degrees C.	[Zeng, Guang; McDonald, Stuart D.; Nogita, Kazuhiro] Univ Queensland, Sch Mech & Min Engn, Nihon Super Ctr Manufacture Elect Mat NS CMEM, St Lucia, Qld 4072, Australia; [Gu, Qinfen] Australian Synchrotron, Powder Diffract Beamline, Clayton, Vic, Australia; [Matsumura, Syo] Kyushu Univ, Dept Nucl Engn & Quantum Phys, Fukuoka 8190395, Japan	Nogita, K (reprint author), Univ Queensland, Sch Mech & Min Engn, Nihon Super Ctr Manufacture Elect Mat NS CMEM, St Lucia, Qld 4072, Australia.	k.nogita@uq.edu.au			University of Queensland-Nihon Superior collaborative research program; Australian Research Council [LP140100485]; University of Queensland International (UQI) Scholarship; Graduate School International Travel Award (GSITA) of UQ; China Scholarship Council (CSC)	We gratefully acknowledge financial support from the University of Queensland-Nihon Superior collaborative research program and Australian Research Council Linkage project (LP140100485). PXRD experiments were performed at the Australian Synchrotron Powder Diffraction Beamline (AS123/PD/6371). The authors thank Dr. J. Khan of the Queensland Node of the Australian National Fabrication Facility (ANFF-Q) at UQ for use of the DSC facility. G.Z. is financially supported by a University of Queensland International (UQI) Scholarship, and Graduate School International Travel Award (GSITA) of UQ, as well as China Scholarship Council (CSC) Scholarship.	Plumbridge WJ, 2010, SOLDER SURF MT TECH, V22, P56, DOI 10.1108/09540911011015157; Zeng G, 2013, INTERMETALLICS, V43, P85, DOI 10.1016/j.intermet.2013.07.012; Skwarek A, 2011, SOLDER SURF MT TECH, V23, P184, DOI 10.1108/09540911111146944; Kariya Y, 2001, JOM-J MIN MET MAT S, V53, P39, DOI 10.1007/s11837-001-0101-0; Starink MJ, 1997, J MATER SCI, V32, P4061, DOI 10.1023/A:1018649823542; Plumbridge WJ, 2008, J ELECTRON MATER, V37, P218, DOI 10.1007/s11664-007-0165-x; Malinov S, 2001, METALL MATER TRANS A, V32, P879, DOI 10.1007/s11661-001-0345-x; RAYNOR GV, 1958, PROC R SOC LON SER-A, V244, P101, DOI 10.1098/rspa.1958.0028; LEE ES, 1990, ACTA METALL MATER, V38, P1669, DOI 10.1016/0956-7151(90)90009-6; Liu F, 2007, J MATER SCI, V42, P573, DOI 10.1007/s10853-006-1802-4; Avrami M, 1939, J CHEM PHYS, V7, P1103, DOI 10.1063/1.1750380; Plumbridge WJ, 2007, CIRCUIT WORLD, V33, P9, DOI 10.1108/03056120710723661; Leodolter-Dworak M, 2010, J ELECTRON MATER, V39, P105, DOI 10.1007/s11664-009-0958-1; Avrami M, 1941, J CHEM PHYS, V9, P177, DOI 10.1063/1.1750872; Ravelo R, 1997, PHYS REV LETT, V79, P2482, DOI 10.1103/PhysRevLett.79.2482; LEE ES, 1990, ACTA METALL MATER, V38, P1677; Gialanella S, 2009, J ALLOY COMPD, V474, P134, DOI 10.1016/j.jallcom.2008.06.103; Liu F, 2007, INT MATER REV, V52, P193, DOI 10.1179/174328007X160308; Peng WQ, 2009, MICROELECTRON RELIAB, V49, P86, DOI 10.1016/j.microrel.2008.11.001; GALLERNEAULT WMT, 1983, J APPL PHYS, V54, P4200, DOI 10.1063/1.332557; Di Maio D, 2011, MICROELECTRON ENG, V88, P117, DOI 10.1016/j.mee.2010.09.011; Plumbridge WJ, 2010, J ELECTRON MATER, V39, P433, DOI 10.1007/s11664-010-1104-9; Austin JB, 1939, T AM I MIN MET ENG, V135, P396; Zeng G, 2014, PHIL MAG LETT, V94, P53, DOI 10.1080/09500839.2013.860247; Di Maio D, 2009, J ELECTRON MATER, V38, P1874, DOI 10.1007/s11664-009-0822-3; Nogita K, 2013, PHILOS MAG, V93, P3627, DOI 10.1080/14786435.2013.820381; Semenova O, 2005, SCRIPTA MATER, V52, P89, DOI 10.1016/j.scriptamat.2004.09.025; Joo YJ, 2002, MATER LETT, V56, P793, DOI 10.1016/S0167-577X(02)00615-8; Starink MJ, 2001, J MATER SCI, V36, P4433, DOI 10.1023/A:1017974517877; Plumbridge WJ, 2007, J MATER SCI-MATER EL, V18, P307, DOI 10.1007/s10854-006-9025-3; McCusker LB, 1999, J APPL CRYSTALLOGR, V32, P36, DOI 10.1107/S0021889898009856; MITCHELL DRG, 1991, PHILOS MAG A, V63, P747; VNUK F, 1980, J CRYST GROWTH, V48, P486, DOI 10.1016/0022-0248(80)90049-4; Avrami M., 1940, Journal of Chemical Physics, V8, DOI 10.1063/1.1750631; BURGERS WG, 1957, DISCUSS FARADAY SOC, P183; Christian J. W., 2002, THEORY TRANSFORMATIO; Di Maio D, 2009, J MATER SCI-MATER EL, V20, P386, DOI 10.1007/s10854-008-9739-5; MUSGRAVE MJ, 1963, PROC R SOC LON SER-A, V272, P503, DOI 10.1098/rspa.1963.0068; Pietzka MA, 1997, J ALLOY COMPD, V247, P198, DOI 10.1016/S0925-8388(96)02608-4; TSUKEVA EA, 1989, Z KRISTALLOGR, V187, P63, DOI 10.1524/zkri.1989.187.1-2.63	40	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1528-7483	1528-7505		CRYST GROWTH DES	Cryst. Growth Des.	DEC	2015	15	12					5767	5773		10.1021/acs.cgd.5b01069		7	Chemistry, Multidisciplinary; Crystallography; Materials Science, Multidisciplinary	Chemistry; Crystallography; Materials Science	CX8CN	WOS:000365930300018		
J	Takasuga, M; Ooshima, H				Takasuga, Masahiro; Ooshima, Hiroshi			Control of Crystal Aspect Ratio and Size by Changing Solvent Composition in Oiling Out Crystallization of an Active Pharmaceutical Ingredient	CRYSTAL GROWTH & DESIGN			English	Article								Oiling out crystallization of an active pharmaceutical ingredient, API-T, was carried out under agitation using a mixed solvent (acetone/water) system, and the effects of oiling out (liquid [oily droplet phase]/liquid [continuous phase] separation) on the aspect ratio and size of crystals were investigated. Acetone composition of the oil phase and API-T distribution to the oil phase increased with a decrease in charged acetone composition, and both decreased in the continuous phase. By utilizing this relationship, API-T crystals with small aspect ratios were produced under a low charged composition of acetone, at which a high recovery of product crystals could be expected. Furthermore, large crystals were obtained in the oiling-out crystallization. Such performance was never achieved in normal single-phase crystallization, and thus an advantage of oiling out crystallization was shown.	[Takasuga, Masahiro] Takeda Pharmaceut Co Ltd, CMC Ctr, Chem Dev Labs, Yodogawa Ku, Osaka 5328686, Japan; [Takasuga, Masahiro; Ooshima, Hiroshi] Osaka City Univ, Grad Sch Engn, Dept Appl Chem & Bioengn, Sumiyoshi Ku, Osaka 5588585, Japan	Takasuga, M (reprint author), 2-17-85 Jusohonmachi,Yodogawa Ku, Osaka 5328686, Japan.	masahiro.takasuga@takeda.com					Deneau E, 2005, ORG PROCESS RES DEV, V9, P943, DOI 10.1021/op050107c; Veesler S, 2006, ORG PROCESS RES DEV, V10, P841, DOI 10.1021/op060085+; Lafferrere L, 2004, J CRYST GROWTH, V269, P550, DOI 10.1016/j.jcrysgro.2004.05.048; Vivares D, 2004, J PHYS CHEM B, V108, P6498, DOI 10.1021/jp037502u; Takasuga M, 2014, CRYST GROWTH DES, V14, P6006, DOI 10.1021/cg5011874; [Anonymous], 2007, T ICHEME A, DOI DOI 10.1205/CHERD06234; Holmback X, 1999, J CRYST GROWTH, V198, P780, DOI 10.1016/S0022-0248(98)01027-6; Galkin O, 2000, J AM CHEM SOC, V122, P156, DOI 10.1021/ja9930869; Bonnett P. E., 2003, J CHEM SOC CHEM COMM, P698	9	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1528-7483	1528-7505		CRYST GROWTH DES	Cryst. Growth Des.	DEC	2015	15	12					5834	5838		10.1021/acs.cgd.5b01192		5	Chemistry, Multidisciplinary; Crystallography; Materials Science, Multidisciplinary	Chemistry; Crystallography; Materials Science	CX8CN	WOS:000365930300025		
J	Sakata-Yanagimoto, M; Chiba, S				Sakata-Yanagimoto, Mamiko; Chiba, Shigeru			Molecular Pathogenesis of Peripheral T Cell Lymphoma	CURRENT HEMATOLOGIC MALIGNANCY REPORTS			English	Review						T cell lymphoma; Peripheral T cell lymphomas (PTCLs); B cell lymphomas	GRANULAR LYMPHOCYTIC-LEUKEMIA; EPSTEIN-BARR-VIRUS; ACUTE MYELOID-LEUKEMIA; TUMOR-SUPPRESSOR GENE; ANAPLASTIC LYMPHOMA; NPM-ALK; CLONAL HEMATOPOIESIS; STAT3 MUTATIONS; DOWN-REGULATION; ITK-SYK	Understanding the molecular pathogenesis of peripheral T cell lymphomas (PTCLs) has lagged behind that of B cell lymphomas due to disease rarity. However, novel approaches are gradually clarifying these mechanisms, and gene profiling has identified specific signaling pathways governing PTCL cell survival and growth. For example, genetic alterations have been discovered, including signal transducer and activator of transcription (STAT)3 and STAT5b mutations in several PTCLs, disease-specific ras homolog family member A (RHOA) mutations in angioimmunoblastic T cell lymphoma (AITL), and recurrent translocations at the dual specificity phosphatase 22 (DUSP22) locus in anaplastic lymphoma receptor tyrosine kinase (ALK)-negative anaplastic large cell lymphomas (ALCLs). Intriguingly, some PTCL-relevant mutations are seen in apparently normal blood cells as well as tumor cells, while others are confined to tumor cells. These data have dramatically changed our understanding of PTCL origins: once considered to originate from mature T lymphocytes, some PTCLs are now believed to emerge from immature hematopoietic progenitor cells.	[Sakata-Yanagimoto, Mamiko; Chiba, Shigeru] Univ Tsukuba, Dept Hematol, Fac Med, Tsukuba, Ibaraki 3058575, Japan	Sakata-Yanagimoto, M (reprint author), Univ Tsukuba, Dept Hematol, Fac Med, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	sakatama-tky@umin.net			Ministry of Education, Culture, Sports, Science and Technology of Japan [KAKENHI 25461407]	We appreciate Prof. Philippe Gaulard for his helpful discussions. This work is supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan (KAKENHI 25461407) to Mamiko Sakata-Yanagimoto.	Piva R, 2010, J CLIN ONCOL, V28, P1583, DOI 10.1200/JCO.2008.20.9759; Piccaluga PP, 2007, CANCER RES, V67, P10703, DOI 10.1158/0008-5472.CAN-07-1708; Ambrogio C, 2009, CANCER RES, V69, P8611, DOI 10.1158/0008-5472.CAN-09-2655; Merkel O, 2015, J PATHOL, V236, P445, DOI 10.1002/path.4539; Jager R, 2005, ANTICANCER RES, V25, P3191; Matsuyama H, 2011, BLOOD, V118, P6881, DOI 10.1182/blood-2011-05-354654; Turner SD, 2006, ANTICANCER RES, V26, P3275; YAMAGUCHI M, 1995, CANCER, V76, P2351, DOI 10.1002/1097-0142(19951201)76:11<2351::AID-CNCR2820761125>3.0.CO;2-1; Lee JH, 2006, J KOREAN MED SCI, V21, P645, DOI 10.3346/jkms.2006.21.4.645; Ohgami RS, 2013, LEUKEMIA, V27, P2244, DOI 10.1038/leu.2013.104; Karube K, 2013, CANCER LETT, V333, P47, DOI 10.1016/j.canlet.2012.12.022; Vasmatzis G, 2012, BLOOD, V120, P2280, DOI 10.1182/blood-2012-03-419937; Kucuk C, 2011, P NATL ACAD SCI USA, V108, P20119, DOI 10.1073/pnas.1115128108; Lin TC, 2013, AM J PATHOL, V182, P1865, DOI 10.1016/j.ajpath.2013.01.025; Chiarle R, 2003, BLOOD, V101, P1919, DOI 10.1182/blood-2002-05-1343; Lemonnier F, 2012, BLOOD, V120, P1466, DOI 10.1182/blood-2012-02-408542; Takakuwa T, 2002, ONCOGENE, V21, P4702, DOI 10.1038/sj.onc.1205571; Jerez A, 2012, BLOOD, V120, P3048, DOI 10.1182/blood-2012-06-435297; Bach MP, 2014, J IMMUNOL, V192, P1024, DOI 10.4049/jimmunol.1300420; de Leval L, 2007, BLOOD, V109, P4952, DOI 10.1182/blood-2006-10-055145; Sun L, 2015, ONCOL REP, V33, P2253, DOI 10.3892/or.2015.3847; Dierks C, 2010, CANCER RES, V70, P6193, DOI 10.1158/0008-5472.CAN-08-3719; Busque L, 2012, NAT GENET, V44, P1179, DOI 10.1038/ng.2413; George L, 2012, CURR HEMATOL MALIG R, V7, P276, DOI 10.1007/s11899-012-0136-z; Bustelo XR, 2007, BIOESSAYS, V29, P356, DOI 10.1002/bies.20558; Ellyard JI, 2012, BLOOD, V120, P812, DOI 10.1182/blood-2011-07-365130; Amsen D, 2009, CURR OPIN IMMUNOL, V21, P153, DOI 10.1016/j.coi.2009.03.010; Shlush LI, 2014, NATURE, V506, P328, DOI 10.1038/nature13038; Mano H, 2012, CANCER DISCOV, V2, P495, DOI 10.1158/2159-8290.CD-12-0009; Yoo HY, 2014, NAT GENET, V46, P371, DOI 10.1038/ng.2916; Couronne L, 2012, NEW ENGL J MED, V366, P95, DOI 10.1056/NEJMc1111708; Sato F, 2013, LEUKEMIA RES, V37, P21, DOI 10.1016/j.leukres.2012.09.009; Chiarle R, 2008, NAT REV CANCER, V8, P11, DOI 10.1038/nrc2291; Koskela HLM, 2012, NEW ENGL J MED, V366, P1905, DOI 10.1056/NEJMoa1114885; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; Koo GC, 2012, CANCER DISCOV, V2, P591, DOI 10.1158/2159-8290.CD-12-0028; Miething C, 2003, ONCOGENE, V22, P4642, DOI 10.1038/sj.onc.1206575; Jeon YK, 2005, LAB INVEST, V85, P874, DOI 10.1038/labinvest.3700291; Feldman AL, 2011, BLOOD, V117, P915, DOI 10.1182/blood-2010-08-303305; Quivoron C, 2011, CANCER CELL, V20, P25, DOI 10.1016/j.ccr.2011.06.003; Suzuki R, 2014, SEMIN HEMATOL, V51, P42, DOI 10.1053/j.seminhematol.2013.11.007; Abdel-Wahab O, 2013, BLOOD, V121, P3563, DOI 10.1182/blood-2013-01-451781; Cairns RA, 2012, BLOOD, V119, P1901, DOI 10.1182/blood-2011-11-391748; Iqbal J, 2010, BLOOD, V115, P1026, DOI 10.1182/blood-2009-06-227579; Merkel O, 2010, P NATL ACAD SCI USA, V107, P16228, DOI 10.1073/pnas.1009719107; Pechloff K, 2010, J EXP MED, V207, P1031, DOI 10.1084/jem.20092042; Bouchekioua A, 2014, LEUKEMIA, V28, P338, DOI 10.1038/leu.2013.157; Morito N, 2006, CANCER RES, V66, P812, DOI 10.1158/0008-5472.CAN-05-2154; Budd RC, 2006, NAT REV IMMUNOL, V6, P196, DOI 10.1038/nri1787; Pfeifer W, 1999, AM J PATHOL, V155, P1353, DOI 10.1016/S0002-9440(10)65237-6; Karube K, 2011, BLOOD, V118, P3195, DOI 10.1182/blood-2011-04-346890; Kimura H, 2014, LEUKEMIA LYMPHOMA, V55, P962, DOI 10.3109/10428194.2013.819577; Turner SD, 2003, ONCOGENE, V22, P7750, DOI 10.1038/sj.onc.1207048; Iqbal J, 2014, BLOOD, V123, P2915, DOI 10.1182/blood-2013-11-536359; Huang YL, 2009, AM J SURG PATHOL, V33, P682, DOI 10.1097/PAS.0b013e3181971591; Chiarle R, 2005, NAT MED, V11, P623, DOI 10.1038/nm1249; Dupuis J, 2006, AM J SURG PATHOL, V30, P490, DOI 10.1097/00000478-200604000-00009; Dejean E, 2011, LEUKEMIA, V25, P1882, DOI 10.1038/leu.2011.168; Laimer D, 2012, NAT MED, V18, P1699, DOI 10.1038/nm.2966; Streubel B, 2006, LEUKEMIA, V20, P313, DOI 10.1038/sj.leu.2404045; Yu D, 2007, NATURE, V450, P299, DOI 10.1038/nature06253; Genovese G, 2014, NEW ENGL J MED, V371, P2477, DOI 10.1056/NEJMoa1409405; Piccaluga PP, 2013, J CLIN ONCOL, V31, P3019, DOI 10.1200/JCO.2012.42.5611; Rajala HLM, 2013, BLOOD, V121, P4541, DOI 10.1182/blood-2012-12-474577; Zhan HQ, 2011, J CLIN PATHOL, V64, P319, DOI 10.1136/jcp.2010.084459; Ng SB, 2011, BLOOD, V118, P4919, DOI 10.1182/blood-2011-07-364224; Iqbal J, 2011, LEUKEMIA, V25, P348, DOI 10.1038/leu.2010.255; de Leval L, 2010, BRIT J HAEMATOL, V148, P673, DOI 10.1111/j.1365-2141.2009.08003.x; Lamant L, 2007, BLOOD, V109, P2156, DOI 10.1182/blood-2006-06-028969; Falini B, 2007, HAEMATOL-HEMATOL J, V92, P519, DOI 10.3324/haematol.11007; Desjobert C, 2011, BLOOD, V117, P6627, DOI 10.1182/blood-2010-09-301994; Lim MS, 2009, BLOOD, V114, P1585, DOI 10.1182/blood-2009-02-204735; Marzec M, 2007, ONCOGENE, V26, P5606, DOI 10.1038/sj.onc.1210346; Palomero T, 2014, NAT GENET, V46, P166, DOI 10.1038/ng.2873; Huang YL, 2010, BLOOD, V115, P1226, DOI 10.1182/blood-2009-05-221275; Auguste T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064536; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Jan M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004315; Kiel MJ, 2014, BLOOD, V124, P1460, DOI 10.1182/blood-2014-03-559542; Ko M, 2015, IMMUNOL REV, V263, P6, DOI 10.1111/imr.12239; Kucuk C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7025; Mehrotra M, 2014, HUM PATHOL, V45, P1995, DOI 10.1016/j.humpath.2014.06.012; Muto H, 2014, BLOOD CANCER J, V4, DOI 10.1038/bcj.2014.83; Nicolae A, 2014, LEUKEMIA, V28, P2244, DOI 10.1038/leu.2014.200; Parrilla Castellar ER, 2014, BLOOD, V124, P1473; Quintanilla-Martinez L, 2001, AM J PATHOL, V159, P2095, DOI 10.1016/S0002-9440(10)63061-1; Rodriguez-Pinilla SM, 2008, AM J SURG PATHOL, V32, P1787, DOI 10.1097/PAS.0b013e31817f123e; Sakata-Yanagimoto M, 2015, INT J HEMATOL, V102, P523, DOI 10.1007/s12185-015-1738-8; Sakata-Yanagimoto M, 2014, NAT GENET, V46, P171, DOI 10.1038/ng.2872; Sakata-Yanagimoto M, 2014, CANCER SCI, V105, P623, DOI 10.1111/cas.12408; Swerdlow SH, 2008, WHO CLASSIFICATION T; Vockerodt M, 2015, J PATHOL, V235, P312, DOI 10.1002/path.4459; Xie MC, 2014, NAT MED, V20, P1472, DOI 10.1038/nm.3733; Yang LB, 2015, NAT REV CANCER, V15, P152, DOI 10.1038/nrc3895	95	0	0	CURRENT MEDICINE GROUP	PHILADELPHIA	400 MARKET STREET, STE 700, PHILADELPHIA, PA 19106 USA	1558-8211	1558-822X		CURR HEMATOL MALIG R	Curr. Hematol. Malig. Rep.	DEC	2015	10	4					429	437		10.1007/s11899-015-0289-7		9	Oncology; Hematology	Oncology; Hematology	CY4BZ	WOS:000366354900012		
J	Baumann, Z; Fisher, NS; Gobler, CJ; Buesseler, KO; George, JA; Breier, CF; Nishikawa, J				Baumann, Z.; Fisher, N. S.; Gobler, C. J.; Buesseler, K. O.; George, J. A.; Breier, C. F.; Nishikawa, J.			Fukushima Cs-137 at the base of planktonic food webs off Japan	DEEP-SEA RESEARCH PART I-OCEANOGRAPHIC RESEARCH PAPERS			English	Article						Fukushima; Cesium; Trophic transfer; Phytoplankton; Zooplankton	TROPHIC TRANSFER; MARINE-PHYTOPLANKTON; ORGANIC-MATTER; PACIFIC-OCEAN; TRACE-METALS; BIOACCUMULATION; RADIONUCLIDES; ACCUMULATION; SEDIMENTS; ELEMENTS	The potential bioaccumulation of Cs-137 in marine food webs off Japan became a concern following the release of radioactive contaminants from the damaged Fukushima nuclear power plant into the coastal ocean. Previous studies suggest that Cs-137 activities increase with trophic level in pelagic food webs, however, the bioaccumulation of Cs-137 from seawater to primary producers, to zooplankton has not been evaluated in the field. Since phytoplankton are frequently the largest component of suspended particulate matter (SPM) we used SPM concentrations and particle-associated Cs-137 to understand bioaccumulation of Cs-137 in through trophic pathways in the field. We determined particle-associated Cs-137 for samples collected at 20 m depth from six stations off Japan three months after the initial release from the Fukushima nuclear power plant. At 20 m SPM ranged from 0.65 to 1.60 mg L-1 and rapidly declined with depth. The ratios of particulate organic carbon to chlorophyll a suggested that phytoplankton comprised much of the SPM in these samples. Cs-137 activities on particles accounted for on average 0.04% of the total Cs-137 in seawater samples, and measured concentration factors of Cs-137 on small suspended particles were comparatively low (similar to 10(2)). However, when Cs-137 in crustacean zooplankton was derived based only on modeling dietary Cs-137 uptake, we found predicted and measured Cs-137 concentrations in good agreement. We therefore postulate the possibility that the dietary route of Cs-137 bioaccumulation (i.e., phytoplankton ingestion) could be largely responsible for the measured levels in the copepod-dominated (%) zooplankton assemblages in Japanese coastal waters. Finally, our data did not support the notion that zooplankton grazing on phytoplankton results in a biomagnification of Cs-137. (C) 2015 Elsevier Ltd. All rights reserved.	[Baumann, Z.] Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA; [Baumann, Z.; Fisher, N. S.; Gobler, C. J.; George, J. A.] SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY USA; [Buesseler, K. O.; Breier, C. F.] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; [Nishikawa, J.] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba, Japan	Baumann, Z (reprint author), Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA.	zofia.baumann@uconn.edu			Gordon and Betty Moore Foundation [GBMF3007, GBMF 3423]; JSPS KAKENHI [24110005]	This project was funded by the Gordon and Betty Moore Foundation through Grants GBMF3007 and GBMF 3423, and JSPS KAKENHI Grant-in-Aid for Scientific Research on Innovative Areas Grant no. 24110005. We thank the captain and the crew of R/V Ka'imikai-O-Kanaloa. We kindly thank S.M. Pike for conducting radioanalysis and D. Hirschberg for POC and PON analyses. We also express our thanks to H. Baumann and the anonymous reviewers for their helpful comments.	Liu ZF, 2005, DEEP-SEA RES PT I, V52, P1324, DOI 10.1016/j.dsr.2005.02.005; Buesseler K, 2011, ENVIRON SCI TECHNOL, V45, P9931, DOI 10.1021/es202816c; Wakeham SG, 1997, GEOCHIM COSMOCHIM AC, V61, P5363, DOI 10.1016/S0016-7037(97)00312-8; Reinfelder JR, 1998, SCI TOTAL ENVIRON, V219, P117, DOI 10.1016/S0048-9697(98)00225-3; Mayer LM, 2007, MAR CHEM, V107, P244, DOI 10.1016/j.marchem.2007.07.007; Kaeriyama H, 2008, J ENVIRON RADIOACTIV, V99, P1838, DOI 10.1016/j.jenvrad.2008.08.006; BERGGREEN U, 1988, MAR BIOL, V99, P341, DOI 10.1007/BF02112126; SAKAGUCHI T, 1978, J FERMENT TECHNOL, V56, P561; Buesseler KO, 2014, OCEANOGRAPHY, V27, P92; FISHER NS, 1985, MAR BIOL, V87, P137, DOI 10.1007/BF00539421; Avery SV, 1996, J ENVIRON RADIOACTIV, V30, P139, DOI 10.1016/0265-931X(96)89276-9; FISHER NS, 1986, LIMNOL OCEANOGR, V31, P443; Kaeriyama H, 2015, FISHERIES SCI, V81, P139, DOI 10.1007/s12562-014-0827-6; GRAF G, 1989, NATURE, V341, P437, DOI 10.1038/341437a0; Mathews T, 2009, SCI TOTAL ENVIRON, V407, P5156, DOI 10.1016/j.scitotenv.2009.06.003; Fisher NS, 2000, MAR ECOL PROG SER, V194, P211, DOI 10.3354/meps194211; Kishi MJ, 2007, ECOL MODEL, V202, P12, DOI 10.1016/j.ecolmodel.2006.08.021; Harmelin-Vivien M, 2012, MAR POLLUT BULL, V64, P974, DOI 10.1016/j.marpolbul.2012.02.014; Charette MA, 2013, BIOGEOSCIENCES, V10, P2159, DOI 10.5194/bg-10-2159-2013; GIESY JP, 1977, APPL ENVIRON MICROB, V33, P89; Gardner WD, 2003, DEEP-SEA RES PT II, V50, P655, DOI 10.1016/S0967-0645(02)00589-1; Buesseler KO, 2012, P NATL ACAD SCI USA, V109, P5984, DOI 10.1073/pnas.1120794109; Heldal HE, 2003, J ENVIRON RADIOACTIV, V65, P177, DOI [10.1016/S0265-931X(02)00095-4, 10.1016/SO265-931X(02)00095-4]; Wang WX, 1998, LIMNOL OCEANOGR, V43, P273; Heldal HE, 2001, J ENVIRON RADIOACTIV, V57, P231, DOI 10.1016/S0265-931X(01)00020-0; MARTIN JH, 1973, GEOCHIM COSMOCHIM AC, V37, P1639, DOI 10.1016/0016-7037(73)90154-3; CABANA G, 1994, NATURE, V372, P255, DOI 10.1038/372255a0; Mathews T, 2008, ENVIRON TOXICOL CHEM, V27, P1093, DOI 10.1897/07-318.1; Honda MC, 2013, BIOGEOSCIENCES, V10, P3525, DOI 10.5194/bg-10-3525-2013; Kusakabe M, 2013, BIOGEOSCIENCES, V10, P5019, DOI 10.5194/bg-10-5019-2013; Mathews T, 2008, MAR ECOL PROG SER, V367, P23, DOI 10.3354/meps07536; REINFELDER JR, 1991, SCIENCE, V251, P794, DOI 10.1126/science.251.4995.794; Belharet M., 2015, BIOGEOSCI DISCUSS, V12, P9497; Chen C.Y., 2008, M REPORT METHYLMERCU; CUSHING C E, 1972, Northwest Science, V46, P115; CUTTER GA, 1991, GEOPH MONOG SERIES, V63, P57; Fisher N.S., 1987, OCEANIC PROCESSES MA, V2, P197; Fisher N.S., 1995, METAL SPECIATION BIO, P363; Fowler S.W., 2005, RADIOACTIVITY ENV, P167; IAEA, 2004, SED DISTR COEFF CONC, P103; Lee C, 2000, DEEP-SEA RES PT I, V47, P1535, DOI 10.1016/S0967-0637(99)00116-8; Mearns A.J., 1981, California Cooperative Oceanic Fisheries Investigations Reports, V22, P99; Nishikawa J., UNPUB; Parsons TR, 1984, MANUAL CHEM BIOL MET; Pike S. M., 2013, J RADIOANAL NUCL CHE, V296, P1; Sathyendranath S., 2009, MAR ECOL PROG SER, V383, P7; Vives i Battle J., 2015, J ENV RADIOACT; Welschmeyer N.A., 1985, LIMNOL OCEANOGR, V30	48	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0967-0637	1879-0119		DEEP-SEA RES PT I	Deep-Sea Res. Part I-Oceanogr. Res. Pap.	DEC	2015	106						9	16		10.1016/j.dsr.2015.09.006		8	Oceanography	Oceanography	CY2IX	WOS:000366233300002		
J	Kawada, T				Kawada, Tomoyuki			Incidence of Diabetes and Prediabetes and Predictors of Progression Among Asian Indians: 10-Year Follow-up of the Chennai Urban Rural Epidemiology Study (CURES). Diabetes Care 2015;38:1441-1448	DIABETES CARE			English	Letter									[Kawada, Tomoyuki] Nippon Med Sch, Dept Hyg & Publ Hlth, Tokyo 113, Japan	Kawada, T (reprint author), Nippon Med Sch, Dept Hyg & Publ Hlth, 1-1-5 Sendagi, Tokyo 113, Japan.	kawada@nms.ac.jp					Anjana RM, 2015, DIABETES CARE, V38, P1441, DOI 10.2337/dc14-2814; Koller KR, 2015, DIABETES RES CLIN PR, V108, P423, DOI 10.1016/j.diabres.2015.03.001; Qiu MY, 2015, HYPERTENSION, V65, P525, DOI 10.1161/HYPERTENSIONAHA.114.04632	3	1	1	AMER DIABETES ASSOC	ALEXANDRIA	1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA	0149-5992	1935-5548		DIABETES CARE	Diabetes Care	DEC	2015	38	12					E211	E211		10.2337/dc15-1734		1	Endocrinology & Metabolism	Endocrinology & Metabolism	CY0TK	WOS:000366118800008		
J	Uno, N; Suzuki, H; Yamakawa, H; Yamada, M; Yaguchi, Y; Notake, S; Tamai, K; Yanagisawa, H; Misawa, S; Yanagihara, K				Uno, Naoki; Suzuki, Hiromichi; Yamakawa, Hiromi; Yamada, Maiko; Yaguchi, Yuji; Notake, Shigeyuki; Tamai, Kiyoko; Yanagisawa, Hideji; Misawa, Shigeki; Yanagihara, Katsunori			Multicenter evaluation of the Verigene Gram-negative blood culture nucleic acid test for rapid detection of bacteria and resistance determinants in positive blood cultures	DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE			English	Article						Verigene; Gram-negative bacteria; Blood culture; Nucleic acid testing; Bacteremia	SPECTRUM BETA-LACTAMASES; KLEBSIELLA-PNEUMONIAE; PROTEUS-MIRABILIS; IDENTIFICATION; ORGANISMS; JAPAN; ASSAY; EMERGENCE; MARKERS; GENES	The Verigene Gram-Negative Blood Culture Nucleic Acid Test (BC-GN) is a microarray-based assay that enables rapid detection of 9 common Gram-negative bacteria and 6 resistance determinants directly from positive blood cultures. We compared the performance of BC-GN with currently used automated systems, testing 141 clinical blood cultures and 205 spiked blood cultures. For identification of BC-GN target organisms in clinical and spiked blood cultures, the BC-GN assay showed 98.5% (130/132) and 98.9% (182/184) concordance, respectively. Of 140 resistance genes positively detected in clinical and spiked blood cultures with the BC-GN test, 139 (99.3%) were confirmed by PCR, and the detection results were consistent with the resistance phenotypes observed. The BC-GN assay, thus, can potentially improve care for sepsis patients by enabling timely detection and targeted antimicrobial therapy. (C) 2015 Elsevier Inc. All rights reserved.	[Uno, Naoki; Yamakawa, Hiromi; Yamada, Maiko; Yanagihara, Katsunori] Nagasaki Univ, Grad Sch Biomed Sci, Dept Lab Med, Nagasaki 852, Japan; [Suzuki, Hiromichi] Tsukuba Med Ctr Hosp, Dept Clin Lab Med, Ibaraki, Japan; [Yaguchi, Yuji; Notake, Shigeyuki; Tamai, Kiyoko; Yanagisawa, Hideji] Miroku Med Lab Co Ltd, Nagano, Japan; [Misawa, Shigeki] Juntendo Univ Hosp, Dept Clin Lab, Tokyo, Japan	Uno, N (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Lab Med, Nagasaki 852, Japan.	nuno@nagasaki-u.ac.jp			Hitachi High-Technologies Corporation (Tokyo, Japan)	This study was supported by the Hitachi High-Technologies Corporation (Tokyo, Japan). We thank Tetsuo Miura, Sumiyo Ota, Masahide Sugiyama, and Tomoko Yoshimura for technical help.	Shibata N, 2003, J CLIN MICROBIOL, V41, P5407, DOI 10.1128/JCM.41.12.5407-5413.2003; Roh KH, 2012, DIAGN MICR INFEC DIS, V73, P239, DOI 10.1016/j.diagmicrobio.2012.03.022; KREGER BE, 1980, AM J MED, V68, P344, DOI 10.1016/0002-9343(80)90102-3; Sullivan KV, 2014, J CLIN MICROBIOL, V52, P2416, DOI 10.1128/JCM.00737-14; Kurihara Y, 2013, J INFECT CHEMOTHER, V19, P799, DOI 10.1007/s10156-013-0563-3; Poirel L, 2004, ANTIMICROB AGENTS CH, V48, P15, DOI 10.1128/AAC.48.1.15-22.2004; Shibata N, 2006, ANTIMICROB AGENTS CH, V50, P791, DOI 10.1128/AAC.50.2.791-795.2006; Matsumura Y, 2013, CLIN MICROBIOL INFEC, V19, P161, DOI 10.1111/j.1469-0691.2012.03762.x; Zarfel G, 2011, EMERG INFECT DIS, V17, P129, DOI 10.3201/eid1701.101331; Samuel LP, 2013, J CLIN MICROBIOL, V51, P1188, DOI 10.1128/JCM.02982-12; Wojewoda CM, 2013, J CLIN MICROBIOL, V51, P2072, DOI 10.1128/JCM.00831-13; Rosenblueth M, 2004, SYST APPL MICROBIOL, V27, P27, DOI 10.1078/0723-2020-00261; Harbarth S, 2003, AM J MED, V115, P529, DOI 10.1016/S0002-9343(03)00505-9; Snyder JW, 2008, J CLIN MICROBIOL, V46, P2327, DOI 10.1128/JCM.00075-08; Sidjabat H, 2011, CLIN INFECT DIS, V52, P481, DOI 10.1093/cid/ciq178; Nakamura T, 2012, AM J CLIN PATHOL, V137, P620, DOI 10.1309/AJCP48PDVKWQOXEZ; Perez KK, 2013, ARCH PATHOL LAB MED, V137, P1247, DOI 10.5858/arpa.2012-0651-OA; Bhatti MM, 2014, J CLIN MICROBIOL, V52, P3433, DOI 10.1128/JCM.01417-14; Bork JT, 2015, ANTIMICROB AGENTS CH, V59, P1593, DOI 10.1128/AAC.04259-14; Buchan BW, 2014, CLIN MICROBIOL REV, V27, P783, DOI 10.1128/CMR.00003-14; CLSI, 2014, M100S24 CLSI; Han E, 2015, DIAGN MICR INFEC DIS, V81, P153, DOI 10.1016/j.diagmicrobio.2014.10.009; Mancini N, 2014, J CLIN MICROBIOL, V52, P1242, DOI 10.1128/JCM.00142-14; Tojo M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094064; Ward C, 2014, EUR J CLIN MICROBIOL	25	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0732-8893	1879-0070		DIAGN MICR INFEC DIS	Diagn. Microbiol. Infect. Dis.	DEC	2015	83	4					344	348		10.1016/j.diagmicrobio.2015.08.004		5	Infectious Diseases; Microbiology	Infectious Diseases; Microbiology	CY1EB	WOS:000366148400005		
J	Suzuki, H; Yoshida, S; Yoshida, A; Okuzumi, K; Fukusima, A; Hishinuma, A				Suzuki, Hiromichi; Yoshida, Shiomi; Yoshida, Atsushi; Okuzumi, Katsuko; Fukusima, Atsuhito; Hishinuma, Akira			A novel cluster of Mycobacterium abscessus complex revealed by matrix-assisted laser desorption ionization-time-of-flight mass spectrometry (MALDI-TOF MS)	DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE			English	Article						MALDI-TOF MS; Mycobacterium abscessus; Mycobacterium massiliense; Mycobacterium bolletii	SUSCEPTIBILITY PATTERNS; RAPID IDENTIFICATION; M. MASSILIENSE; CULTURE-MEDIA; SP-NOV; BOLLETII; DIFFERENTIATION; INFECTIONS; PNEUMONIA; PATIENT	Mycobacterium abscessus complex is a rapidly growing mycobacterium consisting of 3 subspecies, M. abscessus, Mycobacterium massiliense, and Mycobacterium bolletii. However, rapid and accurate species identification is difficult. We first evaluated a suitable protocol of matrix-assisted laser desorption ionization-time-of-flight mass spectrometry (MALDI-TOF MS) for distinguishing these subspecies. Then, we studied spectral signals by MALDI-TOF MS in 59 M. abscessus, 42 M. massiliense, and 2 M. bolletii. Among several specific spectral signals, 4 signals clearly differentiate M. massiliense from the other 2 subspecies, M. abscessus and M. bolletii. Moreover, 6 of the 42 M. massiliense isolates showed a spectral pattern similar to M. abscessus. These isolates correspond to the distinctive class of M. massiliense (cluster D) which is closer to M. abscessus by the previous variable number tandem repeat analysis. These results indicate that MALDI-TOF MS is not only useful for the identification of 3 subspecies of M. abscessus complex but also capable of distinguishing clusters of M. massiliense. (C) 2015 Elsevier Inc. All rights reserved.	[Suzuki, Hiromichi; Yoshida, Atsushi; Fukusima, Atsuhito; Hishinuma, Akira] Dokkyo Med Univ Hosp, Clin Lab Ctr, Mibu, Tochigi 3210293, Japan; [Yoshida, Shiomi] Kinki Chuo Chest Med Ctr, Natl Hosp Org, Clin Res Ctr, Kita Ku, Sakai, Osaka 5918555, Japan; [Yoshida, Atsushi; Fukusima, Atsuhito; Hishinuma, Akira] Dokkyo Med Univ, Dept Infect Control, Mibu, Tochigi 3210293, Japan; [Yoshida, Atsushi; Fukusima, Atsuhito; Hishinuma, Akira] Dokkyo Med Univ, Clin Lab Med, Mibu, Tochigi 3210293, Japan; [Yoshida, Atsushi; Okuzumi, Katsuko; Fukusima, Atsuhito] Dokkyo Med Univ Hosp, Div Infect Control, Mibu, Tochigi 3210293, Japan	Suzuki, H (reprint author), Dokkyo Med Univ Hosp, Clin Lab Ctr, 880 Kitakobayashi, Mibu, Tochigi 3210293, Japan.	s-hiro@dokkyomed.ac.jp					Panagea T, 2015, J CLIN MICROBIOL, V53, P2355, DOI 10.1128/JCM.00494-15; Nessar R, 2012, J ANTIMICROB CHEMOTH, V67, P810, DOI 10.1093/jac/dkr578; Fangous MS, 2014, J CLIN MICROBIOL, V52, P3362, DOI 10.1128/JCM.00788-14; Koh SJ, 2010, CLIN MICROBIOL INFEC, V16, P895, DOI 10.1111/j.1469-0691.2009.03026.x; Prevots DR, 2010, AM J RESP CRIT CARE, V182, P970, DOI 10.1164/rccm.201002-0310OC; Choi GE, 2012, AM J RESP CRIT CARE, V186, P917, DOI 10.1164/rccm.201111-2005OC; Chen JHK, 2013, J CLIN MICROBIOL, V51, P3981, DOI 10.1128/JCM.01437-13; Balazova T, 2014, FEMS MICROBIOL LETT, V353, P77, DOI 10.1111/1574-6968.12408; Teng SH, 2013, J CLIN MICROBIOL, V51, P3113, DOI 10.1128/JCM.01239-13; Kim H, 2005, INT J SYST EVOL MICR, V55, P1649, DOI 10.1099/ijs.0.63553-0; Tseng SP, 2013, FUTURE MICROBIOL, V8, P1381, DOI 10.2217/fmb.13.115; Simmon KE, 2010, J CLIN MICROBIOL, V48, P3231, DOI 10.1128/JCM.00362-10; Adekambi T, 2004, J CLIN MICROBIOL, V42, P5493, DOI 10.1128/JCM.42.12.5493-5501.2004; Koh WJ, 2011, AM J RESP CRIT CARE, V183, P405, DOI 10.1164/rccm.201003-0395OC; Zelazny AM, 2009, J CLIN MICROBIOL, V47, P1985, DOI 10.1128/JCM.01688-08; Macheras E, 2014, RES MICROBIOL, V165, P82, DOI 10.1016/j.resmic.2013.12.003; Yoshida S, 2015, J MED MICROBIOL, V64, P254, DOI 10.1099/jmm.0.000016; Adekambi T, 2006, INT J SYST EVOL MICR, V56, P133, DOI 10.1099/ijs.0.63969-0; Kim HY, 2010, MICROBIOL IMMUNOL, V54, P347, DOI 10.1111/j.1348-0421.2010.00221.x; Saleeb PG, 2011, J CLIN MICROBIOL, V49, P1790, DOI 10.1128/JCM.02135-10; Kothavade RJ, 2013, EUR J CLIN MICROBIOL, V32, P161, DOI 10.1007/s10096-012-1766-8; Balada-Llasat JM, 2013, J CLIN MICROBIOL, V51, P2875, DOI 10.1128/JCM.00819-13; Bastian S, 2011, ANTIMICROB AGENTS CH, V55, P775, DOI 10.1128/AAC.00861-10; Lotz A, 2010, J CLIN MICROBIOL, V48, P4481, DOI 10.1128/JCM.01397-10; Harada T, 2012, J CLIN MICROBIOL, V50, P3556, DOI 10.1128/JCM.01175-12; Wong YL, 2012, J CLIN MICROBIOL, V50, P3084, DOI 10.1128/JCM.00753-12; Kim J, 2014, J CLIN MICROBIOL, V52, P2235, DOI 10.1128/JCM.03543-13; Nakanaga K, 2011, J CLIN MICROBIOL, V49, P613, DOI 10.1128/JCM.00817-10; Jeon SM, 2014, J MICROBIOL METH, V104, P19, DOI 10.1016/j.mimet.2014.05.024; Kim BJ, 2012, PLOS ONE, V6; Tan JL, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-879; Viana-Niero C, 2008, J CLIN MICROBIOL, V46, P850, DOI 10.1128/JCM.02052-07	32	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0732-8893	1879-0070		DIAGN MICR INFEC DIS	Diagn. Microbiol. Infect. Dis.	DEC	2015	83	4					365	370		10.1016/j.diagmicrobio.2015.08.011		6	Infectious Diseases; Microbiology	Infectious Diseases; Microbiology	CY1EB	WOS:000366148400009		
J	Matsushima, H; Kuroki, T; Kitasato, A; Adachi, T; Tanaka, T; Hirabaru, M; Hirayama, T; Kuroshima, N; Hidaka, M; Soyama, A; Takatsuki, M; Kinoshita, N; Sano, K; Nishida, N; Eguchi, S				Matsushima, Hajime; Kuroki, Tamotsu; Kitasato, Amane; Adachi, Tomohiko; Tanaka, Takayuki; Hirabaru, Masataka; Hirayama, Takanori; Kuroshima, Naoki; Hidaka, Masaaki; Soyama, Akihiko; Takatsuki, Mitsuhisa; Kinoshita, Naoe; Sano, Kazunori; Nishida, Noriyuki; Eguchi, Susumu			Sox9 expression in carcinogenesis and its clinical significance in intrahepatic cholangiocarcinoma	DIGESTIVE AND LIVER DISEASE			English	Article						Biliary intraepithelial neoplasia; Intrahepatic cholangiocarcinoma; Sox9	PANCREATIC DUCTAL ADENOCARCINOMA; TRANSCRIPTION FACTOR SOX9; GASTRIC-CARCINOMA; TUMOR PROGRESSION; CANCER; LIVER; LUNG; MAINTENANCE; MUTATIONS; MORTALITY	Background: Intrahepatic cholangiocarcinomas develop through a multi-step carcinogenesis. Precancerous lesions are defined as biliary intraepithelial neoplasia. Sex determining region Y-box9 (Sox9) is required for the normal differentiation of the biliary tract. Aims: To evaluate the Sox9 expression in carcinogenesis and its correlation with clinicopathological features in intrahepatic cholangiocarcinoma. Methods: Sox9 expression in normal epithelium, biliary intraepithelial neoplasia, and intrahepatic cholangiocarcinoma were investigated immunohistochemically using 43 specimens of intrahepatic cholangiocarcinoma. Sox9 expression in intrahepatic cholangiocarcinoma was compared with the clinicopathological features. The molecular effects of Sox9 were investigated by gene transfection to intrahepatic cholangiocarcinoma cell lines. Results: Sox9 expression was decreased from the normal epithelium to the biliary intraepithelial neoplasia in a stepwise fashion. In 51.2% (22/43) of the patients with intrahepatic cholangiocarcinoma, Sox9 expression was positive, and Sox9 expression was significantly associated with the biliary infiltration (P = 0.034) and poor overall survival (P = 0.039). Upregulation of Sox9 promoted the cell migration and invasion, and decreased the E-cadherin expression and increased the vimentin and alpha-SMA expression in cell lines. Conclusions: Decreased Sox9 expression may be related to the early stage of the carcinogenesis of intrahepatic cholangiocarcinoma. Sox9 overexpression in intrahepatic cholangiocarcinoma is related to biliary infiltration and poorer prognosis, and it promotes cell migration and invasion, via the epithelial-to-mesenchymal transition. (c) 2015 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.	[Matsushima, Hajime; Kuroki, Tamotsu; Kitasato, Amane; Adachi, Tomohiko; Tanaka, Takayuki; Hirabaru, Masataka; Hirayama, Takanori; Kuroshima, Naoki; Hidaka, Masaaki; Soyama, Akihiko; Takatsuki, Mitsuhisa; Eguchi, Susumu] Nagasaki Univ, Grad Sch Biomed Sci, Dept Surg, Nagasaki 8528501, Japan; [Kinoshita, Naoe] Nagasaki Univ Hosp, Dept Pathol, Nagasaki, Japan; [Sano, Kazunori; Nishida, Noriyuki] Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Microbiol & Immunol, Nagasaki 8528501, Japan	Eguchi, S (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Surg, 1-7-1 Sakamoto, Nagasaki 8528501, Japan.	sueguchi@nagasaki-u.ac.jp			Gastrointestinal Cancer Project - Nakayama Cancer Research Institute	This study was supported by grants from the Gastrointestinal Cancer Project funded by the Nakayama Cancer Research Institute.	Patel T, 2001, HEPATOLOGY, V33, P1353, DOI 10.1053/jhep.2001.25087; Seymour PA, 2007, P NATL ACAD SCI USA, V104, P1865, DOI 10.1073/pnas.0609217104; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Blechacz B, 2008, HEPATOLOGY, V48, P308, DOI 10.1002/hep.22310; Sano T, 2006, ANN SURG, V244, P240, DOI 10.1097/01.sla.0000217605.66519.38; Kopp JL, 2012, CANCER CELL, V22, P737, DOI 10.1016/j.ccr.2012.10.025; Akiyama H, 2008, MOD RHEUMATOL, V18, P213, DOI 10.1007/s10165-008-0048-x; BUCKLER AJ, 1991, MOL CELL BIOL, V11, P1707; Sun MH, 2012, VIRCHOWS ARCH, V460, P271, DOI 10.1007/s00428-012-1201-7; Olnes MJ, 2004, ONCOLOGY-BASEL, V66, P167, DOI 10.1159/000077991; Tannapfel A, 2000, GUT, V47, P721, DOI 10.1136/gut.47.5.721; Antoniou A, 2009, GASTROENTEROLOGY, V136, P2325, DOI 10.1053/j.gastro.2009.02.051; Mazur PK, 2012, AM J GASTROENTEROL, V107, P126, DOI 10.1038/ajg.2011.305; Maeda Y, 2007, PHYSIOL REV, V87, P219, DOI 10.1152/physrev.00028.2006; Akiyama H, 2004, P NATL ACAD SCI USA, V101, P6502, DOI 10.1073/pnas.0401711101; Chu D, 2001, J BIOL CHEM, V276, P14004; Zong YW, 2009, DEVELOPMENT, V136, P1727, DOI 10.1242/dev.029140; Tanaka T, 2013, PANCREAS, V42, P488, DOI 10.1097/MPA.0b013e318269d281; Zhao R, 2005, HEPATOLOGY, V41, P956, DOI 10.1002/hep.20691; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; Shroff S, 2014, HUM PATHOL, V45, P456, DOI 10.1016/j.humpath.2013.10.008; Capaccione KM, 2014, ONCOTARGET, V5, P3636; Pinho AV, 2011, CELL CYCLE, V10, P1312, DOI 10.4161/cc.10.8.15363; Pompolo S, 2001, BRAIN RES, V906, P143, DOI 10.1016/S0006-8993(01)02574-4; Dill MT, 2013, HEPATOLOGY, V57, P1607, DOI 10.1002/hep.26165; Kimura MS, 2011, J GASTROENTEROL, V46, P1292, DOI 10.1007/s00535-011-0443-5; Zhou CJ, 2011, DIAGN CYTOPATHOL, V39, P105, DOI 10.1002/dc.21348; Spence JR, 2009, DEV CELL, V17, P62, DOI 10.1016/j.devcel.2009.05.012; Jiang T, 2013, MOL BIOL REP, V40, P2187, DOI 10.1007/s11033-012-2279-3; Kitajima T, 2003, CARCINOGENESIS, V24, P133, DOI 10.1093/carcin/24.1.133; Lu BJ, 2008, AM J CLIN PATHOL, V130, P897, DOI 10.1309/AJCPW1W8GJBQGCNI; Song SM, 2013, CANCER RES, V73, P2159, DOI 10.1158/0008-5472.CAN-12-1962; Castellano-Megías Víctor M, 2013, World J Gastrointest Oncol, V5, P159, DOI 10.4251/wjgo.v5.i7.159; El Khatib M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077433; Fava G, 2012, INT J HEPATOLOGY, DOI DOI 10.1155/2012/630543; Furuyama K, 2011, NAT GENET, V1, P34; Guo XD, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-44; Hsu M, 2013, CANCER-AM CANCER SOC, V119, P1669, DOI 10.1002/cncr.27955; Huang XY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096860; Kim YI, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-292; Kuroki T, 2013, HEPATO-GASTROENTEROL, V60, P1573, DOI 10.5754/hge.13316; Nakanuma Yasuni, 2009, World J Hepatol, V1, P35, DOI 10.4254/wjh.v1.i1.35; O'Dell MR, 2012, CANCER RES, V72, P1557, DOI 10.1158/0008-5472.CAN-11-3596; Pinho André Costa, 2012, Int J Surg Case Rep, V3, P131, DOI 10.1016/j.ijscr.2012.01.002; Sobin L, 2009, TNM CLASSIFICATION M; Xia SH, 2015, MED ONCOL, V32, DOI 10.1007/s12032-014-0358-0; Zhou Q, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-244	47	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1590-8658	1878-3562		DIGEST LIVER DIS	Dig. Liver Dis.	DEC	2015	47	12					1067	1075		10.1016/j.dld.2015.08.003		9	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CX7XJ	WOS:000365916000013		
J	Landrein, B; Kiss, A; Sassi, M; Chauvet, A; Das, P; Cortizo, M; Laufs, P; Takeda, S; Aida, M; Traas, J; Vernoux, T; Boudaoud, A; Hamant, O				Landrein, Benoit; Kiss, Annamaria; Sassi, Massimiliano; Chauvet, Aurelie; Das, Pradeep; Cortizo, Millan; Laufs, Patrick; Takeda, Seiji; Aida, Mitsuhiro; Traas, Jan; Vernoux, Teva; Boudaoud, Arezki; Hamant, Olivier			Mechanical stress contributes to the expression of the STM homeobox gene in Arabidopsis shoot meristems	ELIFE			English	Article							POLAR AUXIN TRANSPORT; CUP-SHAPED-COTYLEDON; APICAL MERISTEM; PLANT DEVELOPMENT; REGULATORY NETWORK; SIGNALING NETWORK; ORGAN SEPARATION; CELL-GROWTH; THALIANA; KNOX	The role of mechanical signals in cell identity determination remains poorly explored in tissues. Furthermore, because mechanical stress is widespread, mechanical signals are difficult to uncouple from biochemical-based transduction pathways. Here we focus on the homeobox gene SHOOT MERISTEMLESS (STM), a master regulator and marker of meristematic identity in Arabidopsis. We found that STM expression is quantitatively correlated to curvature in the saddle-shaped boundary domain of the shoot apical meristem. As tissue folding reflects the presence of mechanical stress, we test and demonstrate that STM expression is induced after micromechanical perturbations. We also show that STM expression in the boundary domain is required for organ separation. While STM expression correlates with auxin depletion in this domain, auxin distribution and STM expression can also be uncoupled. STM expression and boundary identity are thus strengthened through a synergy between auxin depletion and an auxin-independent	[Landrein, Benoit; Kiss, Annamaria; Sassi, Massimiliano; Chauvet, Aurelie; Das, Pradeep; Traas, Jan; Vernoux, Teva; Boudaoud, Arezki; Hamant, Olivier] Univ Lyon, UCB Lyon 1, Lab Reprod & Dev Plantes, INRA,CNRS,ENS Lyon, Lyon, France; [Landrein, Benoit; Kiss, Annamaria; Chauvet, Aurelie; Das, Pradeep; Boudaoud, Arezki; Hamant, Olivier] Univ Lyon, UCB Lyon 1, Lab Joliot Curie, Lab Phys,CNRS,ENS Lyon, Lyon, France; [Cortizo, Millan; Laufs, Patrick] Saclay Plant Sci, ERL CNRS 3559, UMR 1318, INRA,Inst Jean Pierre Bourgin, Versailles, France; [Cortizo, Millan; Laufs, Patrick] Saclay Plant Sci, ERL CNRS 3559, UMR 1318, AgroParisTech,Inst Jean Pierre Bourgin, Versailles, France; [Takeda, Seiji] Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Cell & Genome Biol, Kyoto 606, Japan; [Aida, Mitsuhiro] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300101, Japan	Hamant, O (reprint author), Univ Lyon, UCB Lyon 1, Lab Reprod & Dev Plantes, INRA,CNRS,ENS Lyon, Lyon, France.	Olivier.Hamant@ens-lyon.fr			Agence Nationale de la Recherche [ANR-10-BLAN-1516, ANR-10-BLAN-1614]; European Research Council [ERC-2013-CoG-615739, ERC-2013-AdG-294397]	Agence Nationale de la Recherche ANR-10-BLAN-1516 Benoit Landrein Annamaria Kiss Jan Traas Arezki Boudaoud Olivier Hamant; European Research Council ERC-2013-CoG-615739 Olivier Hamant; Agence Nationale de la Recherche ANR-10-BLAN-1614 Milian Cortizo Patrick Laufs; European Research Council ERC-2013-AdG-294397 Massimiliano Sassi Jan Traas; The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	Hay A, 2006, DEVELOPMENT, V133, P3955, DOI 10.1242/dev.02545; Jaalouk DE, 2009, NAT REV MOL CELL BIO, V10, P63, DOI 10.1038/nrm2597; Leasure CD, 2009, PLANT J, V57, P579, DOI 10.1111/j.1365-313X.2008.03708.x; Aida M, 2006, CURR OPIN PLANT BIOL, V9, P72, DOI 10.1016/j.pbi.2005.11.011; Besnard F, 2014, NATURE, V505, P417, DOI 10.1038/nature12791; Aegerter-Wilmsen T, 2007, MECH DEVELOP, V124, P318, DOI 10.1016/j.mod.2006.12.005; Burian A, 2013, J EXP BOT, V64, P5753, DOI 10.1093/jxb/ert352; Uyttewaal M, 2012, CELL, V149, P439, DOI 10.1016/j.cell.2012.02.048; Brunoud G, 2012, NATURE, V482, P103, DOI 10.1038/nature10791; Orr AW, 2006, DEV CELL, V10, P11, DOI 10.1016/j.devcel.2005.12.006; Dumais J, 2000, J PLANT GROWTH REGUL, V19, P7; Fink J, 2011, NAT CELL BIOL, V13, P771, DOI 10.1038/ncb2269; Desprat N, 2008, DEV CELL, V15, P470, DOI 10.1016/j.devcel.2008.07.009; Houk AR, 2012, CELL, V148, P175, DOI 10.1016/j.cell.2011.10.050; Takada S, 2001, DEVELOPMENT, V128, P1127; Borghi L, 2007, PLANT CELL, V19, P1795, DOI 10.1105/tpc.106.047159; Hamant O, 2008, SCIENCE, V322, P1650, DOI 10.1126/science.1165594; Hay A, 2002, CURR BIOL, V12, P1557, DOI 10.1016/S0960-9822(02)01125-9; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Farge E, 2003, CURR BIOL, V13, P1365, DOI 10.1016/S0960-9822(03)00576-1; Wang Q, 2014, PLANT CELL, V26, P2068, DOI 10.1105/tpc.114.123059; Vernoux T, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.39; Kierzkowski D, 2012, SCIENCE, V335, P1096, DOI 10.1126/science.1213100; de Reuille PB, 2005, PLANT J, V44, P1045, DOI 10.1111/j.1365-313X.2005.02576.x; Deveaux Y, 2003, PLANT J, V36, P918, DOI 10.1046/j.1365-313X.2003.01922.x; Cary AJ, 2002, PLANT J, V32, P867, DOI 10.1046/j.1365-313X.2002.01479.x; Sassi M, 2014, CURR BIOL, V24, P2335, DOI 10.1016/j.cub.2014.08.036; Aida M, 1999, DEVELOPMENT, V126, P1563; Endrizzi K, 1996, PLANT J, V10, P967, DOI 10.1046/j.1365-313X.1996.10060967.x; Sakamoto T, 2001, GENE DEV, V15, P581, DOI 10.1101/gad.867901; Aliee M, 2012, CURR BIOL, V22, P967, DOI 10.1016/j.cub.2012.03.070; Vernoux T, 2000, DEVELOPMENT, V127, P5157; Nath U, 2003, SCIENCE, V299, P1404, DOI 10.1126/science.1079354; Chehab EW, 2012, CURR BIOL, V22, P701, DOI 10.1016/j.cub.2012.02.061; Barkoulas M, 2008, NAT GENET, V40, P1136, DOI 10.1038/ng.189; Bichet A, 2001, PLANT J, V25, P137, DOI 10.1046/j.1365-313x.2001.00946.x; Treml BS, 2005, DEVELOPMENT, V132, P4063, DOI 10.1242/dev.01969; Reinhardt D, 2003, NATURE, V426, P255, DOI 10.1038/nature02081; Laufs P, 2004, DEVELOPMENT, V131, P4311, DOI 10.1242/dev.01320; Rupp HM, 1999, PLANT J, V18, P557, DOI 10.1046/j.1365-313X.1999.00472.x; Aida M, 2002, DEVELOPMENT, V129, P3965; Chen H, 2004, PLANT J, V38, P276, DOI 10.1111/j.1365-313X.2004.02048.x; Jurkuta RJ, 2009, PLANT CELL, V21, P1957, DOI 10.1105/tpc.108.065284; Coutand C, 2009, PLANT PHYSIOL, V151, P223, DOI 10.1104/pp.109.138164; Janmey PA, 2013, DIFFERENTIATION, V86, P112, DOI 10.1016/j.diff.2013.07.004; Mousavi SAR, 2013, NATURE, V500, P422, DOI 10.1038/nature12478; Bolduc N, 2012, GENE DEV, V26, P1685, DOI 10.1101/gad.193433.112; Fernandez R, 2010, NAT METHODS, V7, P547, DOI [10.1038/nmeth.1472, 10.1038/NMETH.1472]; Hamant O, 2002, PLANT PHYSIOL, V130, P657, DOI 10.1104/pp.004564; Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222; Thery M, 2007, NATURE, V447, P493, DOI 10.1038/nature05786; Landsberg KP, 2009, CURR BIOL, V19, P1950, DOI 10.1016/j.cub.2009.10.021; Richter GL, 2009, PLANT PHYSIOL, V151, P1855, DOI 10.1104/pp.109.142448; Grandjean O, 2004, PLANT CELL, V16, P74, DOI 10.1105/tpc.017962; Yanai O, 2005, CURR BIOL, V15, P1566, DOI 10.1016/j.cub.2005.07.060; Spinelli SV, 2011, PLANT PHYSIOL, V156, P1894, DOI 10.1104/pp.111.177709; Long JA, 1998, DEVELOPMENT, V125, P3027; Kutschera U, 2007, J PLANT PHYSIOL, V164, P1395, DOI 10.1016/j.jplph.2007.08.002; Dharmasiri N, 2005, DEV CELL, V9, P109, DOI 10.1016/j.devcel.2005.05.014; Reddy GV, 2004, DEVELOPMENT, V131, P4225, DOI 10.1242/dev.01261; OKADA K, 1991, PLANT CELL, V3, P677; Kim JY, 2003, DEVELOPMENT, V130, P4351, DOI 10.1242/dev.00618; Robert HS, 2008, CURR OPIN PLANT BIOL, V11, P495, DOI 10.1016/j.pbi.2008.06.004; Kwiatkowska D, 2004, J EXP BOT, V55, P1021, DOI 10.1093/jxb/erh109; Long JA, 1996, NATURE, V379, P66, DOI 10.1038/379066a0; Scanlon MJ, 2003, PLANT PHYSIOL, V133, P597, DOI 10.1104/pp.103.026880; Nakayama N, 2012, CURR BIOL, V22, P1468, DOI 10.1016/j.cub.2012.06.050; Goncalves B, 2015, PLANT J, V83, P732, DOI 10.1111/tpj.12923; Sieber P, 2007, DEVELOPMENT, V134, P1051, DOI 10.1242/dev.02817; Belles-Boix E, 2006, PLANT CELL, V18, P1900, DOI 10.1105/tpc.106.041988; de Reuille PB, 2006, P NATL ACAD SCI USA, V103, P1627, DOI 10.1073/pnas.0510130103; Furutani M, 2004, DEVELOPMENT, V131, P5021, DOI 10.1242/dev.01388; Jasinski S, 2005, CURR BIOL, V15, P1560, DOI 10.1016/j.cub.2005.07.023; Heisler MG, 2005, CURR BIOL, V15, P1899, DOI 10.1016/j.cub.2005.09.052; Lee DK, 2009, DEVELOPMENT, V136, P2423, DOI 10.1242/dev.031971; Shraiman BI, 2005, P NATL ACAD SCI USA, V102, P3318, DOI 10.1073/pnas.0404782102; Ditengou FA, 2008, P NATL ACAD SCI USA, V105, P18818, DOI 10.1073/pnas.0807814105; Audoly B, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.086105; Besnard F., 2014, Plant Signaling and Behavior, V9, pe28788, DOI 10.4161/psb.28788; BRAAM J, 1990, CELL, V60, P357, DOI 10.1016/0092-8674(90)90587-5; Brunet T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3821; Chuck G, 1966, PLANT CELL, V8, P1277, DOI [10.1105./tpc.8.8.1277, DOI 10.1105/TPC.8.8.1277]; Creff A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7382; D'Arcy Thompson W, 1917, GROWTH FORM; Heisler MG, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000516; Kwiatkowska D, 2003, J EXP BOT, V54, P1585, DOI 10.1093/jxb/erg166; Rozier F, 2014, NAT PROTOC, V9, P2464, DOI 10.1038/nprot.2014.162; Sethian J. A., 1999, LEVEL SET METHODS FA; SMYTH DR, 1990, AUST J PLANT PHYSIOL, V17, P323; Tian CH, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145470	90	0	0	ELIFE SCIENCES PUBLICATIONS LTD	CAMBRIDGE	SHERATON HOUSE, CASTLE PARK, CAMBRIDGE, CB3 0AX, ENGLAND	2050-084X			ELIFE	eLife	DEC 1	2015	4								e0781	10.7554/eLife.07811.001		27	Biology	Life Sciences & Biomedicine - Other Topics	CX7IB	WOS:000365874300001		
J	Wu, LJ; Kobayashi, T; Li, YY; Xu, KQ				Wu, Li-Jie; Kobayashi, Takuro; Li, Yu-You; Xu, Kai-Qin			Comparison of single-stage and temperature-phased two-stage anaerobic digestion of oily food waste	ENERGY CONVERSION AND MANAGEMENT			English	Article						Food waste (FW); Anaerobic digestion; Temperature-phased anaerobic digestion (TPAD); Two-stage; Recycle; Long-chain fatty acid (LCFA)	MUNICIPAL SOLID-WASTE; HYDROGEN-PRODUCTION; METHANE PRODUCTION; ACTIVATED-SLUDGE; TRACE-ELEMENTS; THERMOPHILIC ACIDOGENESIS; FERMENTATION PROCESS; KINETIC EVALUATION; PILOT-SCALE; PERFORMANCE	Anaerobic digestion is an effective technology to recover energy from oily food waste. A single-stage system and temperature-phased two-stage systems with and without recycle for anaerobic digestion of oily food waste were constructed to compare the operation performances. The synchronous operation indicated the similar ability to produce methane in the three systems, with a methane yield of 0.44 L/g VSadded. The pH drop to less than 4.0 in the first stage of two-stage system without recycle resulted in poor hydrolysis, and methane or hydrogen was not produced in this stage. Alkalinity supplement from the second stage of two-stage system with recycle improved pH in the first stage to 5.4. Consequently, 35.3% of the particulate COD in the influent was reduced in the first stage of two-stage system with recycle according to a COD mass balance, and hydrogen was produced with a percentage of 31.7%, accordingly. Similar solids and organic matter were removed in the single-stage system and two-stage system without recycle. More lipid degradation and the conversion of long-chain fatty acids were achieved in the single-stage system. Recycling was proved to be effective in promoting the conversion of unsaturated long-chain fatty acids into saturated fatty acids in the two-stage system. (C) 2015 Elsevier Ltd. All rights reserved.	[Wu, Li-Jie; Li, Yu-You] Tohoku Univ, Grad Sch Engn, Dept Civil & Environm Engn, Aoba Ku, Sendai, Miyagi 9808579, Japan; [Kobayashi, Takuro] Natl Inst Environm Studies, Ctr Mat Cycles & Waste Management Res, Tsukuba, Ibaraki 3058506, Japan; [Li, Yu-You] Tohoku Univ, Grad Sch Environm Studies, Dept Frontier Sci Adv Environm, Aoba Ku, Sendai, Miyagi 9808579, Japan; [Xu, Kai-Qin] Shanghai Jiao Tong Univ, Sch Environm Sci & Engn, Shanghai 200240, Peoples R China	Kobayashi, T (reprint author), Natl Inst Environm Studies, Onogawa 16-2, Tsukuba, Ibaraki 3058506, Japan.	kobayashi.takuro@nies.go.jp					Gao SM, 2015, ENERG CONVERS MANAGE, V93, P166, DOI 10.1016/j.enconman.2015.01.010; Lee DY, 2010, BIORESOURCE TECHNOL, V101, pS42, DOI 10.1016/j.biortech.2009.03.037; Lee DY, 2014, INT J HYDROGEN ENERG, V39, P16863, DOI 10.1016/j.ijhydene.2014.08.022; Chu CF, 2008, INT J HYDROGEN ENERG, V33, P4739, DOI 10.1016/j.ijhydene.2008.06.060; Grimberg SJ, 2015, BIORESOURCE TECHNOL, V178, P226, DOI 10.1016/j.biortech.2014.09.001; Shin HS, 2005, BIODEGRADATION, V16, P33, DOI 10.1007/s10531-004-0377-9; Zhang L, 2012, PROCEDIA ENVIRON SCI, V16, P102, DOI 10.1016/j.proenv.2012.10.014; Han Y, 1997, WATER SCI TECHNOL, V36, P367, DOI 10.1016/S0273-1223(97)00544-1; Zhang CS, 2014, RENEW SUST ENERG REV, V38, P383, DOI 10.1016/j.rser.2014.05.038; Liu DW, 2006, WATER RES, V40, P2230, DOI 10.1016/j.watres.2006.03.029; Azbar N, 2001, J ENVIRON ENG-ASCE, V127, P240, DOI 10.1061/(ASCE)0733-9372(2001)127:3(240); Zuo Z, 2014, BIORESOURCE TECHNOL, V162, P266, DOI 10.1016/j.biortech.2014.03.156; Kobayashi T, 2012, INT J HYDROGEN ENERG, V37, P15711, DOI 10.1016/j.ijhydene.2012.05.044; Coelho NMG, 2011, WATER RES, V45, P2822, DOI 10.1016/j.watres.2011.02.032; Kosseva MR, 2011, COMPREHENSIVE BIOTECHNOLOGY, VOL 6: ENVIRONMENTAL BIOTECHNOLOGY AND SAFETY, 2ND EDITION, P557; Veeken A, 1999, BIORESOURCE TECHNOL, V69, P249, DOI 10.1016/S0960-8524(98)00188-6; Wu LJ, 2015, INT BIODETER BIODEGR, V104, P315, DOI 10.1016/j.ibiod.2015.06.020; Chipasa KB, 2006, J IND MICROBIOL BIOT, V33, P635, DOI 10.1007/s10295-006-0099-y; Pereira A, 2001, WATER ENVIRON RES, V73, P612, DOI 10.2175/106143001X143349; Appels L, 2008, PROG ENERG COMBUST, V34, P755, DOI 10.1016/j.pecs.2008.06.002; Scano EA, 2014, ENERG CONVERS MANAGE, V77, P22, DOI 10.1016/j.enconman.2013.09.004; Hwu CS, 1997, ENZYME MICROB TECH, V21, P297, DOI 10.1016/S0141-0229(97)00050-1; Zhang WQ, 2015, BIORESOURCE TECHNOL, V178, P297, DOI 10.1016/j.biortech.2014.08.046; Luo G, 2011, BIORESOURCE TECHNOL, V102, P8700, DOI 10.1016/j.biortech.2011.02.012; Halalsheh M, 2005, WATER RES, V39, P2475, DOI 10.1016/j.watres.2004.12.012; Schievano A, 2010, BIORESOURCE TECHNOL, V101, P5728, DOI 10.1016/j.biortech.2010.02.032; Schievano A, 2012, ENVIRON SCI TECHNOL, V46, P8502, DOI 10.1021/es301376n; Cuetos MJ, 2007, J POWER SOURCES, V169, P131, DOI 10.1016/j.jpowsour.2007.01.050; Wei QY, 2014, CHEMOSPHERE, V117, P477, DOI 10.1016/j.chemosphere.2014.08.060; Qiang H, 2013, CHEM ENG J, V222, P330, DOI 10.1016/j.cej.2013.02.076; Han Y, 1997, WATER ENVIRON RES, V69, P1139; Lay JJ, 1998, WATER ENVIRON RES, V70, P1075, DOI 10.2175/106143098X123426; Ariunbaatar J, 2015, WASTE MANAGE, V38, P388, DOI 10.1016/j.wasman.2014.12.001; Wu LJ, 2015, ENERGY, V87, P381, DOI 10.1016/j.energy.2015.04.110; Kobayashi T, 2012, INT J HYDROGEN ENERG, V37, P5602, DOI 10.1016/j.ijhydene.2011.12.123; Riau V, 2012, J CHEM TECHNOL BIOT, V87, P1074, DOI 10.1002/jctb.3709; Shin HS, 2004, INT J HYDROGEN ENERG, V29, P1355, DOI 10.1016/j.ijhydene.2003.09.011; Tan ST, 2015, ENERG CONVERS MANAGE, V102, P111, DOI 10.1016/j.enconman.2015.02.010; APHA- American Public Health Association, 2012, STANDARD METHODS EXA; Bou VS, 2005, WATER RES, V39, P1481; CHO JK, 1995, BIORESOURCE TECHNOL, V52, P245, DOI 10.1016/0960-8524(95)00031-9; Li RX, 2014, J RENEW SUSTAIN ENER, V6, DOI 10.1063/1.4885615; Li Y. Y., 2006, J ENV ENG MANAGE, V16, P297; Stabnikova Olena, 2005, Journal of Chemical Technology and Biotechnology, V80, P455, DOI 10.1002/jctb.1225	44	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0196-8904	1879-2227		ENERG CONVERS MANAGE	Energy Conv. Manag.	DEC	2015	106						1174	1182		10.1016/j.enconman.2015.10.059		9	Thermodynamics; Energy & Fuels; Mechanics; Physics, Nuclear	Thermodynamics; Energy & Fuels; Mechanics; Physics	CX9YU	WOS:000366063500106		
J	Namazu, T; Morikaku, T; Akamine, H; Fujii, T; Kuroda, K; Takami, Y				Namazu, Takahiro; Morikaku, Toshiyuki; Akamine, Hirokazu; Fujii, Tatsuya; Kuroda, Kazuki; Takami, Yasuhiro			Mechanical reliability of FIB-fabricated WC-Co cemented carbide nanowires evaluated by MEMS tensile testing	ENGINEERING FRACTURE MECHANICS			English	Article						WC-Co; Cemented carbide; Nanoscale tensile test; Strength; Fracture; Size effect; MEMS	THIN-FILMS; STRENGTH	In this paper, the mechanical reliability of WC-Co cemented carbide nanowires (NWs) is described. By using focused ion beam (FIB) technique, the NWs are fabricated from the bulk. Specially-developed microelectromechanical systems (MEMS) based tensile testing device is used to directly measure the fracture strength. The volume and Co area fraction of the NWs are adopted to discuss the NWs' size effect on the strength. The Weibull plot suggests that there are three different fracture mechanisms. From SEM observation results, it is found that WC-Co NWs have failed inside WC grain or Co binder under shear deformation mode. The applicability of WC-Co cemented carbide as mechanical components in MEMS is discussed. (C) 2015 Elsevier Ltd. All rights reserved.	[Namazu, Takahiro; Morikaku, Toshiyuki; Akamine, Hirokazu; Fujii, Tatsuya] Univ Hyogo, Dept Mech Engn, Himeji, Hyogo 6712201, Japan; [Kuroda, Kazuki; Takami, Yasuhiro] Silveralloy Co Ltd, Kasai, Hyogo 6752455, Japan	Namazu, T (reprint author), Univ Hyogo, Dept Mech Engn, 2167 Shosha, Himeji, Hyogo 6712201, Japan.	namazu@eng.u-hyogo.ac.jp					Tsuchiya T, 1998, J MICROELECTROMECH S, V7, P106, DOI 10.1109/84.661392; Namazu T, 2013, J MICROELECTROMECH S, V22, P625, DOI 10.1109/JMEMS.2012.2237383; Ando T, 2001, SENSOR ACTUAT A-PHYS, V93, P70, DOI 10.1016/S0924-4247(01)00623-9; Klunsner T, 2010, PROCEDIA ENGINEER, V2, P2001, DOI 10.1016/j.proeng.2010.03.215; Namazu T, 2013, J MICROELECTROMECH S, V22, P1414, DOI 10.1109/JMEMS.2013.2257985; Ogawa E, 2011, SENSOR ACTUAT A-PHYS, V169, P373, DOI 10.1016/j.sna.2011.04.014; Gaspar J, 2009, J MICROELECTROMECH S, V18, P1062, DOI 10.1109/JMEMS.2009.2029210; Namazu T, 2013, J ENG MATER-T ASME, V135, DOI 10.1115/1.4007811; Fujii T, 2013, PROC IEEE MICR ELECT, P488, DOI 10.1109/MEMSYS.2013.6474285; He JB, 2010, SMALL, V6, P1449, DOI 10.1002/smll.201000114; Fujii M, 2012, J VAC SCI TECHNOL B, V30, DOI 10.1116/1.4711040; Oh HJ, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.027201; Torres Y, 2014, MATER DESIGN, V55, P851, DOI 10.1016/j.matdes.2013.10.051; Kang W, 2010, NANOSCI NANOTECH LET, V2, P282, DOI 10.1166/nnl.2010.1107; Kamiya S, 2007, J MICROELECTROMECH S, V16, P202, DOI 10.1109/JMEMS.2007.892920; Oh HJ, 2008, IEEJ T ELECTR ELECTR, V3, P281, DOI 10.1002/tee.20268; Morikaku T, 2014, 2014 IEEE 27TH INTERNATIONAL CONFERENCE ON MICRO ELECTRO MECHANICAL SYSTEMS (MEMS), P652, DOI 10.1109/MEMSYS.2014.6765725; Tsuchiya T, 2012, J MICROELECTROMECH S, V21, P523, DOI 10.1109/JMEMS.2011.2182503; Karimpoor AA, 2003, SCRIPTA MATER, V49, P651, DOI 10.1016/S1359-6462(03)00397-X; Sharpe WN, 1997, J MICROELECTROMECH S, V6, P193, DOI 10.1109/84.623107; Jonnalagadda KN, 2010, EXP MECH, V50, P25, DOI 10.1007/s11340-008-9212-7; Fujii T, 2014, MNC2014 FUK, p7P; Fujii T, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.110118; Fujii T, 2013, J ENG MATER-T ASME, V135; Goami N, 2012, P IEEE MEMS, V2012, P404; Livescu V, 2005, MAT SCI ENG A-STRUCT, V399, P134, DOI 10.1016/j.msea.2005.02.024; Namazu T, 2012, J JPN SOC EXP MECH, V12, P8; Oh H-J, 2014, J MICROELECTROMECH S, V23, P954; Trueba M, 2013, INT J REFRACT MET H, V43, P236	29	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0013-7944	1873-7315		ENG FRACT MECH	Eng. Fract. Mech.	DEC	2015	150						126	134		10.1016/j.engfracmech.2015.07.007		9	Mechanics	Mechanics	CY3KW	WOS:000366309400009		
J	Sumigawa, T; Ashida, S; Tanaka, S; Sanada, K; Kitamura, T				Sumigawa, Takashi; Ashida, Shinsaku; Tanaka, Shuhei; Sanada, Kazunori; Kitamura, Takayuki			Fracture toughness of silicon in nanometer-scale singular stress field	ENGINEERING FRACTURE MECHANICS			English	Article						Fracture toughness; Singular stress field; Crack; Nanoscale; Silicon; Single crystal	SINGLE-CRYSTAL SILICON; MECHANICAL-PROPERTIES; STRENGTH; MICROSCOPY; FILM; AFM	The purpose of this study is to examine the size effect of a singular stress field on the fracture toughness at the nanometer scale. The cracking behavior is investigated using small single-crystal silicon specimens with different precrack lengths where the size of the singular stress field, KK, near the crack tip is 23-58 nm. The fracture toughness, KIC, is approximately 1 MPam(1/2) in all of the specimens, which is in good agreement with that of the macroscale (bulk) counterpart. This clearly indicates that the fracture toughness is independent of size while it was reported that the tensile strength without a crack showed strong dependence at the nanometer scale. (C) 2015 Elsevier Ltd. All rights reserved.	[Sumigawa, Takashi; Ashida, Shinsaku; Tanaka, Shuhei; Sanada, Kazunori; Kitamura, Takayuki] Kyoto Univ, Dept Mech Engn & Sci, Nishikyo Ku, Kyoto 6158246, Japan	Sumigawa, T (reprint author), Kyoto Univ, Dept Mech Engn & Sci, Nishikyo Ku, Kyoto 6158246, Japan.	sumigawa@cyber.kues.kyoto-u.ac.jp			Japan Society for the Promotion of Science, Japan [25000012, 24686018, 26630009]	This work was supported in part by Grants-in-Aid for Specially Promoted Research (No. 25000012), Young Scientists Research (A) (No. 24686018), and Challenging Exploratory Research (No. 26630009) of the Japan Society for the Promotion of Science, Japan.	CHEN CP, 1980, AM CERAM SOC BULL, V59, P469; Sumigawa T, 2010, MAT SCI ENG A-STRUCT, V527, P4796, DOI 10.1016/j.msea.2010.04.002; Sun QY, 2011, SCRIPTA MATER, V65, P473, DOI 10.1016/j.scriptamat.2011.05.033; WONG B, 1987, J ELECTROCHEM SOC, V134, P2254, DOI 10.1149/1.2100861; Ando T, 2005, FATIGUE FRACT ENG M, V28, P687, DOI 10.1111/j.1460-2695.2005.00920.x; Namazu T, 2000, J MICROELECTROMECH S, V9, P450, DOI 10.1109/84.896765; Kiener D, 2008, ACTA MATER, V56, P580, DOI 10.1016/j.actamat.2007.10.015; DUKINO RD, 1992, J AM CERAM SOC, V75, P3299, DOI 10.1111/j.1151-2916.1992.tb04425.x; Tanaka M, 2003, MATER TRANS, V44, P681, DOI 10.2320/matertrans.44.681; Iqbal F, 2012, ACTA MATER, V60, P1193, DOI 10.1016/j.actamat.2011.10.060; Moser B, 2007, J MATER RES, V22, P1004, DOI 10.1557/JMR.2007.0140; YASUTAKE K, 1986, J MATER SCI, V21, P2185, DOI 10.1007/BF00547968; Stan G, 2012, J MATER RES, V27, P562, DOI 10.1557/jmr.2011.354; Fitzgerald AM, 2000, SENSOR ACTUAT A-PHYS, V83, P194, DOI 10.1016/S0924-4247(99)00383-0; Greer LR, 2006, PHYS REV B, V73; He MR, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.161302; Hoffmann S, 2007, NANOTECHNOLOGY, V18; Iida S, 2000, TABLES PHYS CONSTANT; Kim JY, 2009, SCRIPTA MATER, V57, P5425; Li XP, 2005, SENSOR ACTUAT A-PHYS, V119, P229, DOI 10.1016/j.sna.2003.10.063; Sundararajan S, 2002, SENSOR ACTUAT A-PHYS, V101, P338, DOI 10.1016/S0924-4247(02)00268-6; Weertman J, 1964, ELEMENTARY DISLOCATI	22	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0013-7944	1873-7315		ENG FRACT MECH	Eng. Fract. Mech.	DEC	2015	150						161	167		10.1016/j.engfracmech.2015.05.054		7	Mechanics	Mechanics	CY3KW	WOS:000366309400013		
J	Hirakata, H; Takeuchi, K; Minoshima, K				Hirakata, Hiroyuki; Takeuchi, Kyosuke; Minoshima, Kohji			Mechanics of fracture at nanoscale stress concentrated sites in titanium doglegged nanocolumns	ENGINEERING FRACTURE MECHANICS			English	Article						Nanocolumns; Fracture; Stress concentration; Glancing angle deposition; Titanium	GLANCING ANGLE DEPOSITION; INTERFACE CRACK INITIATION; SCULPTURED THIN-FILMS; NANO-FILMS; STRENGTH; SIZE; PLASTICITY; TOUGHNESS; BEHAVIOR; BEAM	We developed a method for investigating the strength of nanocolumns against nanoscale stress concentration intentionally introduced by the control of nanocolumn shape using glancing angle deposition. We conducted fracture experiments for Ti doglegged nanocolumn arrays with controlled stress concentrated sites, which included the corner of the doglegged shape and the bottom of the column. The fracture sites were coincident with the stress concentrated sites, suggesting that the nanoscale stress concentration has a large impact on the fracture of nano-components. We discussed the dominant mechanics of fracture in the nanocolumns on the basis of stress fields by considering the plasticity of nanocolumns. (C) 2015 Elsevier Ltd. All rights reserved.	[Hirakata, Hiroyuki; Takeuchi, Kyosuke; Minoshima, Kohji] Osaka Univ, Dept Mech Engn, Suita, Osaka 5650871, Japan	Hirakata, H (reprint author), Osaka Univ, Dept Mech Engn, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.	hirakata@mech.eng.osaka-u.ac.jp			JSPS KAKENHI [26289007, 25000012]	This work was supported by JSPS KAKENHI Grant Numbers 26289007 and 25000012.	Minoshima K, 2000, FATIGUE FRACT ENG M, V23, P1033, DOI 10.1046/j.1460-2695.2000.00354.x; ROBBIE K, 1995, J VAC SCI TECHNOL A, V13, P2991, DOI 10.1116/1.579626; Keller RR, 1996, MAT SCI ENG A-STRUCT, V214, P42, DOI 10.1016/0921-5093(96)10253-7; Sumigawa T, 2010, MAT SCI ENG A-STRUCT, V527, P4796, DOI 10.1016/j.msea.2010.04.002; Hirakata H, 2007, INT J FRACTURE, V145, P261, DOI 10.1007/s10704-007-9079-0; Hawkeye MM, 2007, J VAC SCI TECHNOL A, V25, P1317, DOI 10.1116/1.2764082; Richter G, 2009, NANO LETT, V9, P3048, DOI 10.1021/nl9015107; Greer JR, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.245410; Haque MA, 2004, P NATL ACAD SCI USA, V101, P6335, DOI 10.1073/pnas.0400066101; Hirakata H, 2014, ENG FRACT MECH, V117, P71, DOI 10.1016/j.engfracmech.2014.01.008; Kiener D, 2008, ACTA MATER, V56, P580, DOI 10.1016/j.actamat.2007.10.015; Hirakata H, 2011, ENG FRACT MECH, V78, P2800, DOI 10.1016/j.engfracmech.2011.08.005; Takahashi Y, 2014, SENSOR ACTUAT A-PHYS, V206, P81, DOI 10.1016/j.sna.2013.11.037; Espinosa HD, 2005, J MICROELECTROMECH S, V14, P153, DOI 10.1109/JMEMS.2004.839013; Robbie K, 1997, J VAC SCI TECHNOL A, V15, P1460, DOI 10.1116/1.580562; Kitamura T, 2003, ENG FRACT MECH, V70, P2089, DOI 10.1016/S0013-7944(02)00254-0; Chen DZ, 2013, NANO LETT, V13, P4462, DOI 10.1021/nl402384r; Gu XW, 2013, NANO LETT, V13, P5703, DOI 10.1021/nl403453h; Hirakata H, 2011, MAT SCI ENG A-STRUCT, V528, P8120, DOI 10.1016/j.msea.2011.07.071; ASM, 1985, METALS HDB DESK EDIT; Becker TL, 1997, MECH MATER, V25, P291, DOI 10.1016/S0167-6636(97)00010-0; Kumar S, 2009, APPL PHYS LETT, P94; Magagnosc DJ, 2013, SCI REP, V3; Peng C, 2012, J APPL PHYS, V111; Suzuki M, 2001, JPN J APPL PHYS 2, V40, pL358, DOI 10.1143/JJAP.40.L358	25	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0013-7944	1873-7315		ENG FRACT MECH	Eng. Fract. Mech.	DEC	2015	150						168	183		10.1016/j.engfracmech.2015.04.007		16	Mechanics	Mechanics	CY3KW	WOS:000366309400014		
J	Wu, JY; Nagao, SJ; Zhang, ZL; He, JY				Wu, Jianyang; Nagao, Shijo; Zhang, Zhiliang; He, Jianying			Deformation and fracture of nano-sized metal-coated polymer particles: A molecular dynamics study	ENGINEERING FRACTURE MECHANICS			English	Article						Metal-coated polymer nanoparticle; Molecular dynamics simulation; Size effect; Compression strength; Burst	MECHANICAL-PROPERTIES; ATOMISTIC SIMULATION; NANOPARTICLES; POLYETHYLENE; SURFACE; INTERCONNECTION; ADHESIVES; BEHAVIOR	The mechanical behavior of Ni-coated polyethylene (PE) nanoparticles subjected to compression loading is systemically investigated by classical molecular dynamics simulation. Results show that the Ni coatings on PE nanoparticles lead to a densification of particle surface and remarkably enhance the compression strength. The particle size-effect and the coating thickness effect on the compression responses in terms of compressive strength and particle burst are observed. Burst of Ni-coated PE nanoparticles initiates at the high stress-concentrated grain-boundaries zone of polycrystalline Ni-shell, and propagates along the compression direction to the flattened contact surface, resulting in release of core PE molecules. (C) 2015 Elsevier Ltd. All rights reserved.	[Wu, Jianyang] Xiamen Univ, Res Inst Biomimet & Soft Matter, Dept Phys, Xiamen 361005, Peoples R China; [Wu, Jianyang; Nagao, Shijo; Zhang, Zhiliang; He, Jianying] Norwegian Univ Sci & Technol NTNU, Dept Struct Engn, NTNU Nanomech Lab, N-7491 Trondheim, Norway; [Nagao, Shijo] Osaka Univ, Inst Sci & Ind Res, Osaka 5670047, Japan	He, JY (reprint author), Norwegian Univ Sci & Technol NTNU, Dept Struct Engn, NTNU Nanomech Lab, N-7491 Trondheim, Norway.	jianying.he@ntnu.no			Research Council of Norway [225962, 228453]; Fundamental Research Funds for the Central Universities (Xiamen University) [20720150015]; National Natural Science Foundation of China [11502221]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry	This work is supported by the Research Council of Norway under ENERGIX Project pSiCAT (No. 225962), BIA Project Novel Particle Technology for Display Interconnect (No. 228453), the Fundamental Research Funds for the Central Universities (Xiamen University, Grant No. 20720150015), the National Natural Science Foundation of China (Grant No. 11502221) and the project sponsored by the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry. The computational resources are provided by the Norwegian Metacenter for Computational Science (NOTUR).	Ackland GJ, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.054104; Tuncel D, 2010, NANOSCALE, V2, P484, DOI 10.1039/b9nr00374f; Hildebrand FE, 2008, J MECH PHYS SOLIDS, V56, P1296, DOI 10.1016/j.jmps.2007.09.006; Zhao JH, 2010, J MATER RES, V25, P537, DOI 10.1557/JMR.2010.0061; NARKIS M, 1986, POLYM ENG SCI, V26, P139, DOI 10.1002/pen.760260205; Dou GB, 2006, ELEC COMP C, P932; He JY, 2008, POLYMER, V49, P3993, DOI 10.1016/j.polymer.2008.07.015; He JY, 2009, J APPL POLYM SCI, V113, P1398, DOI 10.1002/app.29913; Kwon WS, 2006, IEEE T COMPON PACK T, V29, P528, DOI 10.1109/TCAPT.2006.880513; Sugden MW, 2012, 2012 IEEE 62ND ELECTRONIC COMPONENTS AND TECHNOLOGY CONFERENCE (ECTC), P218, DOI 10.1109/ECTC.2012.6248831; Lee JH, 2009, CHEM MATER, V21, P5654, DOI 10.1021/cm902181n; Zhu MQ, 2006, J AM CHEM SOC, V128, P4303, DOI 10.1021/ja0567642; FOILES SM, 1986, PHYS REV B, V33, P7983, DOI 10.1103/PhysRevB.33.7983; Daoulas KC, 2005, MACROMOLECULES, V38, P5780, DOI 10.1021/ma050176r; PANT PVK, 1993, J CHEM PHYS, V99, P597, DOI 10.1063/1.465731; DAW MS, 1983, PHYS REV LETT, V50, P1285, DOI 10.1103/PhysRevLett.50.1285; Wang XT, 1998, IEEE T COMPON PACK A, V21, P248, DOI 10.1109/95.705471; Fukui K, 1999, POLYM J, V31, P664, DOI 10.1295/polymj.31.664; Zhang ZL, 2007, COMP MATER SCI, V39, P305, DOI 10.1016/j.commatsci.2006.06.009; TAKEUCHI H, 1991, J CHEM PHYS, V94, P7446, DOI 10.1063/1.460723; Chrobak D, 2011, NAT NANOTECHNOL, V6, P480, DOI [10.1038/nnano.2011.118, 10.1038/NNANO.2011.118]; Hoshino Y, 2010, J AM CHEM SOC, V132, P13648, DOI 10.1021/ja1058982; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Howes P, 2010, J AM CHEM SOC, V132, P3989, DOI 10.1021/ja1002179; Faulon JL, 2001, J COMPUT CHEM, V22, P580, DOI 10.1002/jcc.1030; He JY, 2007, INT J MATER RES, V98, P389; Siiman O, 2000, J PHYS CHEM B, V104, P9795, DOI 10.1021/jp000255z; He JY, 2013, EXPRESS POLYM LETT, V7, P365, DOI 10.3144/expresspolymlett.2013.33; Kristiansen H, 1998, IEEE T COMPON PACK A, V21, P208, DOI 10.1109/95.705466; He JY, 2012, EXPRESS POLYM LETT, V6, P198, DOI 10.3144/expresspolymlett.2012.22; Rao JP, 2011, PROG POLYM SCI, V36, P887, DOI 10.1016/j.progpolymsci.2011.01.001; Bell CA, 2006, ADV MATER, V18, P582, DOI 10.1002/adma.200501712; Guterres Sílvia S, 2007, Drug Target Insights, V2, P147; He JY, 2009, J PHYS D; MANSFIELD KF, 1990, MACROMOLECULES, V23, P4430, DOI 10.1021/ma00222a016; Natarajan Jawahar, 2012, International Journal of Health and Allied Sciences, V1, P217; Mittal V, 2010, POLYM SCI TECHNOL SE, P1; Mohanraj VJ, 2006, TROP J PHARM RES, V5, P561, DOI DOI 10.4314/TJPR.V5I1.14634; Laso M, 2006, COMPUT-AIDED CHEM EN, V22, P1; Wu JY, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-322; Wu JY, 2011, NANO LETT, P5264; Zhao JH, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-541	42	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0013-7944	1873-7315		ENG FRACT MECH	Eng. Fract. Mech.	DEC	2015	150						209	221		10.1016/j.engfracmech.2015.08.028		13	Mechanics	Mechanics	CY3KW	WOS:000366309400017		
J	Jaikaew, P; Boulange, J; Thuyet, DQ; Malhat, F; Ishihara, S; Watanabe, H				Jaikaew, Piyanuch; Boulange, Julien; Dang Quoc Thuyet; Malhat, Farag; Ishihara, Satoru; Watanabe, Hirozumi			Potential impacts of seasonal variation on atrazine and metolachlor persistence in andisol soil	ENVIRONMENTAL MONITORING AND ASSESSMENT			English	Article						Seasonal variation; Atrazine and metolachlor; Soil water balance; Persistence; Andisol soil	PERFORMANCE LIQUID-CHROMATOGRAPHY; DEGRADATION; BIODEGRADATION; FIELD; MINERALIZATION; PESTICIDES; HERBICIDES; HISTORY; CARBON; MICROORGANISMS	To estimate the potential effect of seasonal variation on the fate of herbicides in andisol soil, atrazine and metolachlor residues were investigated through the summer and winter seasons during 2013 and 2014 under field condition. The computed half-lives of atrazine and metolachlor in soil changed significantly through the two seasons of the trial. The half-lives were shorter in summer season with 16.0 and 23.5 days for atrazine and metolachlor, respectively. In contrast, the half-lives were longer during the winter season with 32.7 and 51.8 days for atrazine and metolachlor, respectively. The analysis of soil water balance suggested that more pesticide was lost in deeper soil layers through infiltration in summer than in winter. In addition, during the summer season, metolachlor was more likely to leach into deeper soil layer than atrazine possibly due to high water solubility of metolachlor.	[Jaikaew, Piyanuch; Boulange, Julien; Malhat, Farag; Watanabe, Hirozumi] Tokyo Univ Agr & Technol, Dept Agr & Environm Engn, United Grad Sch Agr, Tokyo, Japan; [Dang Quoc Thuyet] Univ Tokyo, Dept Biol & Environm Engn, Grad Sch Agr & Life Sci, Tokyo, Japan; [Malhat, Farag] Agr Res Ctr, Pesticide Residues & Environm Pollut Dept, Cent Agr Pesticide Lab, Giza 12618, Egypt; [Ishihara, Satoru] Food & Agr Mat Inspect Ctr, Agr Chem Inspect Stn, Tokyo, Japan	Watanabe, H (reprint author), Tokyo Univ Agr & Technol, Dept Agr & Environm Engn, United Grad Sch Agr, Tokyo, Japan.	pochi@cc.tuat.ac.jp			Mitsubishi International Foundation of Japan [MITSU1415]; Japan Society for the Promotion of Science (JSPS) [26.04074]	The first author was funded by the Mitsubishi International Foundation of Japan under Grant (MITSU1415). F. Malhat (26.04074) and D.Q. Thuyet are supported by Japan Society for the Promotion of Science (JSPS) as postdoctoral research fellow at Tokyo University of Agriculture and Technology and the University of Tokyo, respectively. The authors are grateful to the Food and Agricultural Materials Inspection Center (FAMIC) for their technical advices.	ALLEN RG, 1998, 56 FAO; SAXENA A, 1987, APPL ENVIRON MICROB, V53, P390; Bedos C, 2002, AGRONOMIE, V22, P21, DOI 10.1051/agro:2001003; ZELLES L, 1990, BIOL FERT SOILS, V9, P78, DOI 10.1007/BF00335866; Abdelhafid R, 2000, BIOL FERT SOILS, V30, P333, DOI 10.1007/s003740050012; WEED DAJ, 1995, J ENVIRON QUAL, V24, P68; Singh BK, 2003, APPL ENVIRON MICROB, V69, P7035, DOI 10.1128/AEM.69.12.7035-7043.2003; MANDELBAUM RT, 1995, APPL ENVIRON MICROB, V61, P1451; Azevedo AS, 2000, J AGR ENG RES, V76, P165, DOI 10.1006/jaer.2000.0543; Mueller TC, 2010, WEED SCI, V58, P478, DOI 10.1614/WS-D-09-00041.1; Vanderheyden V, 1997, PESTIC SCI, V49, P237; BARDGETT RD, 1995, BIOL FERT SOILS, V19, P148, DOI 10.1007/BF00336151; Krutz LJ, 2010, PEST MANAG SCI, V66, P461, DOI 10.1002/ps.1909; Gevao B, 2000, ENVIRON POLLUT, V108, P3, DOI 10.1016/S0269-7491(99)00197-9; Malhat F, 2011, B ENVIRON CONTAM TOX, V87, P190, DOI 10.1007/s00128-011-0336-6; Zablotowicz RM, 2006, WEED SCI, V54, P538, DOI 10.1614/WS-04-179R3.1; Ebato M, 2001, SOIL SCI PLANT NUTR, V47, P221; Wakelin SA, 2008, SOIL BIOL BIOCHEM, V40, P803, DOI 10.1016/j.soilbio.2007.10.015; Kazemi HV, 2008, J ENVIRON QUAL, V37, P1599, DOI 10.2134/jeq2007.0470; Ng HYF, 1997, SCI TOTAL ENVIRON, V193, P215, DOI 10.1016/S0048-9697(96)05342-9; Huygens D, 2005, BIOGEOSCIENCES, V2, P159; Barriuso E, 1996, SOIL BIOL BIOCHEM, V28, P1341, DOI 10.1016/S0038-0717(96)00144-7; Yassir A, 1999, PESTIC SCI, V55, P799, DOI 10.1002/ps.2780550806; Malhat FM, 2012, FOOD ANAL METHOD, V5, P1492, DOI 10.1007/s12161-012-9400-z; Shaner DL, 2007, J ENVIRON QUAL, V36, P128, DOI 10.2134/jeq2006.0160; Rebich RA, 2004, SCI TOTAL ENVIRON, V321, P189, DOI 10.1016/j.scitotenv.2003.09.006; Rosales-Conrado N, 2002, ANAL CHIM ACTA, V470, P147, DOI 10.1016/S0003-2670(02)00763-8; Perrin-Ganier C, 2001, CHEMOSPHERE, V44, P887, DOI 10.1016/S0045-6535(00)00283-6; Dusek J, 2010, PEST MANAG SCI, V66, P596, DOI 10.1002/ps.1914; Johnson AC, 2003, PEST MANAG SCI, V59, P1291, DOI 10.1002/ps.762; BLUMHORST MR, 1994, PESTIC SCI, V42, P79, DOI 10.1002/ps.2780420203; Steffens K, 2014, HYDROL EARTH SYST SC, V18, P479, DOI 10.5194/hess-18-479-2014; Moorman TB, 2001, BIOL FERT SOILS, V33, P541, DOI 10.1007/s003740100367; Miller JL, 1997, J ENVIRON QUAL, V26, P633; Andreu V, 2004, TRAC-TREND ANAL CHEM, V23, P772, DOI 10.1016/j.trac.2004.07.008; Ebato M, 2005, J PESTIC SCI, V30, P220, DOI 10.1584/jpestics.30.220; ASSAF NA, 1994, PESTIC SCI, V41, P41, DOI 10.1002/ps.2780410108; Crosson P., 1997, IMPACTS CLIMATE CHAN; Dikshith, 1991, TOXICOLOGY PESTICIDE, P31; Goux S, 2003, WATER AIR SOIL POLL, V3, P131, DOI 10.1023/A:1023998222016; Kalkhof D. W., 1997, ENVIRON SCI TECHNOL, V32, P11738; Krause A., 1985, ENVIRON TOXIC WATER, V33, P584; Palikhe B. R., 2007, J AGR ENV, V8, P83; Shaner DL, 2004, PEST MANAG SCI, V60, P17, DOI 10.1002/ps.782; Smith C. J., 1990, Environmental fate of pesticides., P47; Sparks R., 2003, ENV SOIL CHEM; Tomlin C. D. S., 2000, PESTICIDE MANUAL, p[42, 635, 678]; U.S. Geological Survey, 1999, QUAL OUR NAT WAT NUT; WAUCHOPE RD, 1978, J ENVIRON QUAL, V7, P459	49	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0167-6369	1573-2959		ENVIRON MONIT ASSESS	Environ. Monit. Assess.	DEC	2015	187	12							760	10.1007/s10661-015-4986-4		10	Environmental Sciences	Environmental Sciences & Ecology	CX7HA	WOS:000365871600035		
J	Takano, T; Okutomi, Y; Mochizuki, M; Ochiai, Y; Yamada, F; Mori, M; Ueda, F				Takano, T.; Okutomi, Y.; Mochizuki, M.; Ochiai, Y.; Yamada, F.; Mori, M.; Ueda, F.			Biological index of environmental lead pollution: accumulation of lead in liver and kidney in mice	ENVIRONMENTAL MONITORING AND ASSESSMENT			English	Article						Lead; Monitoring; Kidney; Liver; Index	AQUILA-CHRYSAETOS; HEAVY-METALS; WILD BIRDS; CADMIUM; CONTAMINATION; EXPOSURE; EAGLES	Lead (Pb) is known to be highly poisonous, and the acute poisoning of Cd causes the abdominal pains, vomiting, and shock. The digestive and nervous symptom is observed in the chronic lead poisoning. It was also known that the defect in hemoglobin synthesis by Pb produce anemia. The release of Pb into the environment presents a source of exposure for wild animals. In this study, we examined the utility of a new Pb-monitoring index in mice administered Pb. A solution containing 0.02, 0.2, 2, or 4 ppm lead chloride (PbCl2) was administered intraperitoneally to mice, and the Pb contents of the kidney and liver were determined at designated time points. The mean Pb content of both organs increased depending on the administered Pb dosage. Although the results of control was near the detection limits, the administration of 4 ppm in 4 weeks resulted in Pb levels of 260 mg ppm/wet weight and 110 ppm wet weight in the kidney and liver, respectively. However, there were no significant relationships among administered dose, duration of Pb treatment, and liver or kidney Pb content. Then, values in all mice administered control or 0.02 mg Pb were located inside the ellipse, representing the confidence area of the new index, and values in all mice administered more than 2 mg Pb were located outside the ellipse. These results confirm that animals exposed to high concentrations of Pb would be detected by this new index.	[Takano, T.; Ochiai, Y.; Yamada, F.; Ueda, F.] Nippon Vet & Life Sci Univ, Sch Vet Med, Dept Vet Prevent Med, Fac Vet Med, Musashino, Tokyo 1808602, Japan; [Okutomi, Y.; Mochizuki, M.] Nippon Vet & Life Sci Univ, Sch Vet Nursing & Technol, Dept Appl Sci, Fac Vet Sci, Musashino, Tokyo 1808602, Japan; [Yamada, F.] Saitama Inst Publ Hlth, Yochimi, Saitama 3350133, Japan; [Mori, M.] Shizuoka Univ, Dept Appl Biol Chem, Fac Agr, Shizuoka 4228529, Japan	Ueda, F (reprint author), Nippon Vet & Life Sci Univ, Sch Vet Med, Dept Vet Prevent Med, Fac Vet Med, 1-7-1 Kyonan, Musashino, Tokyo 1808602, Japan.	fueda@nvlu.ac.jp			Ministry of Education, Science, Sports, Culture, and Technology in Japan [23580430]	This study was supported by Grant-in Aid number 23580430 from the Ministry of Education, Science, Sports, Culture, and Technology in Japan.	Jumba IO, 2007, ARCH ENVIRON CON TOX, V52, P270, DOI 10.1007/s00244-005-0241-2; Larison JR, 2000, NATURE, V406, P181, DOI 10.1038/35018068; Stauber E, 2010, J AVIAN MED SURG, V24, P279, DOI 10.1647/2009-006.1; Nakade T, 2005, J WILDLIFE DIS, V41, P253; Ueda F, 2009, ENERGY ENVIRON ENG S, P176; Xie LL, 2003, BIOL TRACE ELEM RES, V93, P227, DOI 10.1385/BTER:93:1-3:227; Kenntner N, 2007, J ORNITHOL, V148, P173, DOI 10.1007/s10336-006-0115-z; Tete N, 2015, CHEMOSPHERE, V138, P940, DOI 10.1016/j.chemosphere.2014.12.031; Mochizuki M, 2008, ENVIRON MONIT ASSESS, V137, P35, DOI 10.1007/s10661-007-9727-x; Harding LE, 1998, B ENVIRON CONTAM TOX, V61, P600; Mochizuki M, 1999, ENVIRON POLLUT, V106, P249, DOI 10.1016/S0269-7491(99)00072-X; PERTTILA M, 1986, MAR ENVIRON RES, V18, P43, DOI 10.1016/0141-1136(86)90008-5; Mochizuki M, 2009, ENERGY ENVIRON ENG S, P185; Mochizuki M, 2002, ENVIRON MONIT ASSESS, V73, P229, DOI 10.1023/A:1013167321371; Mochizuki M, 2002, ENVIRON MONIT ASSESS, V77, P155, DOI 10.1023/A:1015871802566; Chemical society of Japan (CSJ), 1995, BIOL ACT TRAC MET; Mochizuki M., 2011, INT J ENERG ENV EC, V19, P535; Mochizuki M., 2013, REV AGR SCI, V1, DOI [10.7831/ras.1.65, DOI 10.7831/RAS.1.65]; NRC, 1972, LEAD AIRB LEAD PERSP; Otaki N., 1992, KANKYO HOKEN REPORTS, V59, P127; Yamada Y., 1992, KANKYO HOKEN REPORTS, V59, P127; Zechner L, 2005, EGRETTA, V47, P157	22	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0167-6369	1573-2959		ENVIRON MONIT ASSESS	Environ. Monit. Assess.	DEC	2015	187	12							744	10.1007/s10661-015-4958-8		5	Environmental Sciences	Environmental Sciences & Ecology	CX7HA	WOS:000365871600019		
J	Inubushi, K; Prikhodko, VE; Nagano, K; Manakhov, DV				Inubushi, K.; Prikhodko, V. E.; Nagano, Kh.; Manakhov, D. V.			Carbon and nitrogen compounds and emission of greenhouse gases in ancient and modern soils of the Arkaim Reserve in the Steppe Trans-Ural Region	EURASIAN SOIL SCIENCE			English	Article						chernozem; CH4; N2O; and CO2 emission; microbial nitrogen and carbon; labile nitrogen and carbon; basal respiration; parent materials; Bronze Epoch; ordinary chernozem; Phaeozem; meadow soil; solonetz	MICROBIAL BIOMASS; EURASIAN STEPPE; ORGANIC-MATTER; FLUXES; METHANE; OXIDE; COVER; N2O; RESPIRATION; GRASSLANDS	Carbon and nitrogen compounds and the emission of CO2, CH4, and N2O were studied in the ancient buried and modern background soils developed from different parent materials in the Arkaim Reserve of Chelyabinsk oblast. The studies were performed after an 18-year-long period of absence of anthropogenic loads on the local ecosystems. Element contents in the humus horizons of the chernozems of the former plowland and pastures and of the forest soil reach 28-45.6 g/kg for C-org, 2.5-4.5 g/kg for N-tot, 140-423 mg/kg for labile carbon (C-l), 32-73 mg/kg for labile nitrogen (N-l), 350-952 mg/kg for carbon of microbial biomass (C-mic), and 38-85 mg/kg for nitrogen of microbial biomass (N-mic). The contents of different forms of C and N depend on the soil type and texture and on the type of land use, including that before reservation of the territory. The emission of greenhouse gases was examined in this area for the first time. The production of CO2 by the soil buried about 4000 years ago is an order of magnitude lower than that by the modern soil. The emission and sink of N2O are small in both modern and ancient soils. The behavior of methane is clearly different in the automorphic and hydromorphic soils: the former serve as methane sinks, whereas the latter act as methane sources. The rate of the CO2 emission from the soils is controlled by many factors, including the soil type, texture, degree of hydromorphism, composition of parent materials, and type of land use.	[Inubushi, K.; Nagano, Kh.] Chiba Univ, Higher Sch Hort, Matsudo, Chiba 2718510, Japan; [Prikhodko, V. E.] Russian Acad Sci, Inst Physicochem & Biol Problems Soil Sci, Pushchino 142290, Moscow Oblast, Russia; [Manakhov, D. V.] Moscow MV Lomonosov State Univ, Fac Soil Sci, Moscow 119991, Russia	Inubushi, K (reprint author), Chiba Univ, Higher Sch Hort, Matsudo, Chiba 2718510, Japan.	inubushi@faculty.chiba-u.jp; valprikhodko@rambler.ru; demian2@yandex.ru			Russian Foundation for Basic Research [09-05-92106YaF-a, 13-05-00246a]	This study was supported by the Russian Foundation for Basic Research, project nos. 09-05-92106YaF-a and 13-05-00246a.	[Anonymous], CLIM CHEL OBL; Demkina TS, 2010, EURASIAN SOIL SCI+, V43, P1030, DOI 10.1134/S1064229310090103; ZAK DR, 1994, ECOLOGY, V75, P2333, DOI 10.2307/1940888; ANDERSON JPE, 1978, SOIL BIOL BIOCHEM, V10, P215, DOI 10.1016/0038-0717(78)90099-8; Polyanskaya LM, 1995, DOKL AKAD NAUK+, V344, P846; Kudeyarov VN, 2009, EURASIAN SOIL SCI+, V42, P953, DOI 10.1134/S1064229309090014; [Anonymous], 2006, J GEOPHYS RES-ATMOS, DOI DOI 10.1029/2005JD006058; Franzluebbers AJ, 2000, SOIL BIOL BIOCHEM, V32, P469, DOI 10.1016/S0038-0717(99)00176-5; PANIKOV NS, 1993, DOKL AKAD NAUK+, V330, P388; Prikhod'ko VE, 2012, EURASIAN SOIL SCI+, V45, P725, DOI 10.1134/S1064229312080054; Holst J, 2007, ECOSYSTEMS, V10, P623, DOI 10.1007/s10021-007-9043-x; Inubushi K, 2003, CHEMOSPHERE, V52, P603, DOI 10.1016/S0045-6535(03)00242-X; Holst J, 2008, PLANT SOIL, V308, P105, DOI 10.1007/s11104-008-9610-8; MOSIER A, 1991, NATURE, V350, P330, DOI 10.1038/350330a0; Kurganova IN, 2010, EURASIAN SOIL SCI+, V43, P919, DOI 10.1134/S1064229310080090; Pomazkina LV, 2013, EURASIAN SOIL SCI+, V46, P704, DOI 10.1134/S1064229313060070; Hanson PJ, 2000, BIOGEOCHEMISTRY, V48, P115, DOI 10.1023/A:1006244819642; Kaschuk G, 2011, PLANT SOIL, V338, P467, DOI 10.1007/s11104-010-0559-z; Hopfensperger KN, 2009, FOREST ECOL MANAG, V258, P2076, DOI 10.1016/j.foreco.2009.08.004; Ivanov IV, 1999, EURASIAN SOIL SCI+, V32, P864; Ivanov IV, 1996, EURASIAN SOIL SCI+, V29, P973; Wrage N, 2004, RAPID COMMUN MASS SP, V18, P1201, DOI 10.1002/rcm.1461; Chen WW, 2011, GLOBAL CHANGE BIOL, V17, P2803, DOI 10.1111/j.1365-2486.2011.02444.x; Kraev GN, 2013, DOKL EARTH SCI, V451, P882, DOI 10.1134/S1028334X13080291; Larionova AA, 2009, EURASIAN SOIL SCI+, V42, P1364, DOI 10.1134/S1064229309120060; Nagano H, 2012, SOIL SCI PLANT NUTR, V58, P238, DOI 10.1080/00380768.2012.661354; Kadono A, 2008, SOIL BIOL BIOCHEM, V40, P947, DOI 10.1016/j.soilbio.2007.11.015; Prikhodko VE, 2014, EURASIAN SOIL SCI+, V47, P236, DOI 10.1134/S1064229314020082; Davidson EA, 2000, GLOBAL BIOGEOCHEM CY, V14, P1035, DOI 10.1029/1999GB001223; Kudeyarov VN, 1999, EURASIAN SOIL SCI+, V32, P892; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Yevdokimov IV, 2010, EURASIAN SOIL SCI+, V43, P1373, DOI 10.1134/S1064229310120070; Bashkin V. N., 1987, AGROGEOCHEMISTRY NIT; Bazilevich N. I., 1965, GEOCHEMISTRY SODA SA; Eremchenko O. Z., 1997, NATURAL ANTHROPOGENI; Ermolaev A. M., 1999, NATURAL SYSTEMS SO U, P164; Glagolev M. V., 2007, Moscow University Soil Science Bulletin, V62, P14, DOI 10.3103/S0147687407010024; Hayashi A., 1997, Japanese Journal of Soil Science and Plant Nutrition, V68, P322; Kudeyarov V. N., 1989, NITROGEN CYCLE SOIL; Kurganova I N, 2009, Dokl Biol Sci, V426, P219, DOI 10.1134/S0012496609030089; Li X, 2015, SOIL SCI PLANT NUTR, V61, P116, DOI 10.1080/00380768.2014.978728; Moiser A. R., 1999, INT WORKSH RED N2O E; Naumov A. V., 2009, SOIL RESP COMPONENTS; Okitsu S., 2011, HORTIC RES, P97; Plekhanova L. N., 2007, EVOLUTION SOILS RIVE; Prikhod'ko VE, 2013, EURASIAN SOIL SCI+, V46, P925, DOI 10.1134/S1064229313090032; Prikhodko V. E., 2014, ARKAIM RESERVE ENFOR; Rivkina E. M., 2006, KRIOSFERA ZEMLI, V10, P23; Smagin A. V., 2005, GAS PHASE OF SOILS; Vorob'eva L. A., 1998, CHEM ANAL SOILS; Zaikov V. V., 1999, NATURAL SYSTEMS SO U, P5; Zdanovich G. B., 2007, ARKAIM RESERVE COUNT	52	0	0	MAIK NAUKA/INTERPERIODICA/SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013-1578 USA	1064-2293	1556-195X		EURASIAN SOIL SCI+	Eurasian Soil Sci.	DEC	2015	48	12					1306	1316		10.1134/S1064229315120091		11	Soil Science	Agriculture	CY1HH	WOS:000366156800004		
J	Matsumoto, M				Matsumoto, Mitsuru			Switching on the Aire conditioner	EUROPEAN JOURNAL OF IMMUNOLOGY			English	Editorial Material						Aire; Enhancer; NF-kappa B; Receptor activator of NF-kappa B; Thymic medulla	THYMIC EPITHELIAL-CELLS; REGULATORY T-CELLS; SELF-TOLERANCE; GENE-EXPRESSION; DIFFERENTIATION PROGRAM; IMMUNOLOGICAL-TOLERANCE; AUTOIMMUNE REGULATOR; MEDULLA; ESTABLISHMENT; ORGANOGENESIS	Aire has been cloned as the gene responsible for a hereditary type of organ-specific autoimmune disease. Aire controls the expression of a wide array of tissue-restricted Ags by medullary thymic epithelial cells (mTECs), thereby leading to clonal deletion and Treg-cell production, and ultimately to the establishment of self-tolerance. However, relatively little is known about the mechanism responsible for the control of Aire expression itself. In this issue of the European Journal of Immunology, Haljasorg et al. [Eur. J. Immunol. 2015. 45: 3246-3256] have reported the presence of an enhancer element for Aire that binds with NF-kappa B components downstream of the TNF receptor family member, RANK (receptor activator of NF-kappa B). The results suggest that RANK has a dual mode of action in Aire expression: one involving the promotion of mTEC differentiation and the other involving activation of the molecular switch for Aire within mature mTECs.	[Matsumoto, Mitsuru] Univ Tokushima, Inst Enzyme Res, Div Mol Immunol, Tokushima 770, Japan; [Matsumoto, Mitsuru] Japan Agcy Med Res & Dev, Core Res Evolut Sci & Technol, Tokyo, Japan	Matsumoto, M (reprint author), Univ Tokushima, Inst Enzyme Res, Div Mol Immunol, Tokushima 770, Japan.	mitsuru@tokushima-u.ac.jp					Aschenbrenner K, 2007, NAT IMMUNOL, V8, P351, DOI 10.1038/ni1444; Akiyama T, 2005, SCIENCE, V308, P248, DOI 10.1126/science.1105677; Matsumoto M, 2011, EUR J IMMUNOL, V41, P12, DOI 10.1002/eji.201041024; Yang SY, 2015, SCIENCE, V348, P589, DOI 10.1126/science.aaa7017; Hikosaka Y, 2008, IMMUNITY, V29, P438, DOI 10.1016/j.immuni.2008.06.018; Liston A, 2003, NAT IMMUNOL, V4, P350, DOI 10.1038/ni906; Rossi SW, 2007, J EXP MED, V204, P1267, DOI 10.1084/jem.20062497; Ucar O, 2013, EUR J IMMUNOL, V43, P1769, DOI 10.1002/eji.201343343; Yano M, 2008, J EXP MED, V205, P2827, DOI 10.1084/jem.20080046; Meredith M, 2015, NAT IMMUNOL, V16, P942, DOI 10.1038/ni.3247; WEIH F, 1995, CELL, V80, P331, DOI 10.1016/0092-8674(95)90416-6; Zhu MZ, 2006, J CLIN INVEST, V116, P2964, DOI 10.1172/JCI28326; Boehm T, 2003, J EXP MED, V198, P757, DOI 10.1084/jem.20030794; Gardner JM, 2008, SCIENCE, V321, P843, DOI 10.1126/science.1159407; Kinoshita D, 2006, J IMMUNOL, V176, P3995; Oftedal BE, 2015, IMMUNITY, V42, P1185, DOI 10.1016/j.immuni.2015.04.021; Abramson J, 2010, CELL, V140, P123, DOI 10.1016/j.cell.2009.12.030; Kajiura F, 2004, J IMMUNOL, V172, P2067; Alves NL, 2014, EUR J IMMUNOL, V44, P16, DOI 10.1002/eji.201344110; Metzger TC, 2013, CELL REP, V5, P166, DOI 10.1016/j.celrep.2013.08.038; Chuprin A, 2015, NAT IMMUNOL, V16, P737, DOI 10.1038/ni.3194; McCarthy NI, 2015, J IMMUNOL, V195, P2675, DOI 10.4049/jimmunol.1501226; Nishijima H, 2015, J IMMUNOL, V195, P4641, DOI 10.4049/jimmunol.1501026; Brennecke P, 2015, NAT IMMUNOL, V16, P933, DOI 10.1038/ni.3246; Malchow S, 2013, SCIENCE, V339, P1219, DOI 10.1126/science.1233913; Kong YY, 1999, NATURE, V397, P315; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Haljasorg U, 2015, EUR J IMMUNOL, V45, P3246, DOI 10.1002/eji.201545928; Hamazaki Y, 2015, EUR J IMMUNOL, V45, P2985, DOI 10.1002/eji.201545844; Kawano H., 2015, J IMMUNOL, DOI [10.4049/jimmunol.1501000, DOI 10.4049/JIMMUN0L.1501000]; Perry JSA, 2014, IMMUNITY, V41, P414, DOI 10.1016/j.immuni.2014.08.007; Sansom SN, 2014, GENOME RES, V24, P1918, DOI 10.1101/gr.171645.113	32	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0014-2980	1521-4141		EUR J IMMUNOL	Eur. J. Immunol.	DEC	2015	45	12					3237	3240		10.1002/eji.201546098		4	Immunology	Immunology	CY4TS	WOS:000366402000005		
J	Dong, H; Franklin, NA; Ritchea, SB; Yagita, H; Glennie, MJ; Bullock, TNJ				Dong, Han; Franklin, Nathan A.; Ritchea, Shane B.; Yagita, Hideo; Glennie, Martin J.; Bullock, Timothy N. J.			CD70 and IFN-1 selectively induce eomesodermin or T-bet and synergize to promote CD8(+) T-cell responses	EUROPEAN JOURNAL OF IMMUNOLOGY			English	Article						CD8(+) T cells; CD27; CD70; IFN-1; IL-12	COSTIMULATORY LIGAND CD70; DENDRITIC CELLS; IN-VIVO; CLONAL EXPANSION; TRANSCRIPTION FACTOR; PEPTIDE IMMUNIZATION; EFFECTOR FUNCTION; CD27 STIMULATION; MEMORY FORMATION; VIRAL-INFECTION	CD70-mediated stimulation of CD27 is an important cofactor of CD4(+) T-cell licensed dendritic cells (DCs). However, it is unclear how CD70-mediated stimulation of T cells is integrated with signals that emanate from signal 3 pathways, such as type-1 interferon (IFN-1) and IL-12. We find that while stimulation of CD27 in isolation drives weak Eomesodermin(hi)T-bet(lo) CD8(+) T-cell responses to OVA immunization, profound synergistic expansion is achieved by cotargeting TLR. This cooperativity can substantially boost antiviral CD8(+) T-cell responses during acute infection. Concomitant stimulation of TLR significantly increases per cell IFN-gamma production and the proportion of the population with characteristics of short-lived effector cells, yet also promotes the ability to form long-lived memory. Notably, while IFN-1 contributes to the expression of CD70 on DCs, the synergy between CD27 and TLR stimulation is dependent upon IFN-1's effect directly on CD8(+) T cells, and is associated with the increased expression of T-bet in T cells. Surprisingly, we find that IL-12 fails to synergize with CD27 stimulation to promote CD8(+) T-cell expansion, despite its capacity to drive effector CD8(+) T-cell differentiation. Together, these data identify complex interactions between signal 3 and costimulatory pathways, and identify opportunities to influence the differentiation of CD8(+) T-cell responses.	[Dong, Han; Franklin, Nathan A.; Ritchea, Shane B.; Bullock, Timothy N. J.] Univ Virginia, Dept Pathol, Charlottesville, VA 22903 USA; [Yagita, Hideo] Juntendo Univ, Sch Med, Dept Immunol, Tokyo 113, Japan; [Glennie, Martin J.] Univ Southampton, Sch Med, Gen Hosp, Canc Sci Div, Southampton, Hants, England	Bullock, TNJ (reprint author), Univ Virginia, Dept Pathol, Charlottesville, VA 22903 USA.	tbullock@virginia.edu			National Cancer Institute [CA115882, RC2CA148038]; Cancer Research Institute/Libby Bartnick Memorial Investigator Award; University of Virginia Cancer Center Support Grant [P30 CA44579]; Robert R. Wagner Fellowship from the University of Virginia	These studies were supported by National Cancer Institute (CA115882 and RC2CA148038), the Cancer Research Institute/Libby Bartnick Memorial Investigator Award, and the University of Virginia Cancer Center Support Grant P30 CA44579 (all to T.N.J.B.). H.D. was supported by a Robert R. Wagner Fellowship from the University of Virginia. We would like to thank Ms. Hillary McClintic and Mr. Drew Roberts for their technical assistance; the Beirne B. Carter Center for Immunology Research for use of flow cytometry equipment; Drs. Steven Schoenberger and Jannie Borst for providing CD27KO mice; Dr. Ross Kedl for IFN-alpha beta RKO mice and recombinant IFN-alpha; Dr. Vic Engelhard for MHC tetramers.	Keppler SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040865; Rutishauser RL, 2010, IMMUNOL REV, V235, P219, DOI 10.1111/j.0105-2896.2010.00901.x; Ahonen CL, 2004, J EXP MED, V199, P775, DOI 10.1084/jem.20031591; van Gisbergen KPJM, 2011, IMMUNITY, V35, P97, DOI 10.1016/j.immuni.2011.04.020; Taraban VY, 2004, J IMMUNOL, V173, P6542; Warger T, 2006, BLOOD, V108, P544, DOI 10.1182/blood-2005-10-4015; Obar JJ, 2010, P NATL ACAD SCI USA, V107, P193, DOI 10.1073/pnas.0909945107; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423; McWilliams JA, 2010, VACCINE, V28, P1468, DOI 10.1016/j.vaccine.2009.11.071; Taraban VY, 2013, EUR J IMMUNOL, V43, P3314, DOI 10.1002/eji.201343579; Xiao ZG, 2009, J IMMUNOL, V182, P2786, DOI 10.4049/jimmunol.0803484; Keller AM, 2009, BLOOD, V113, P5167, DOI 10.1182/blood-2008-03-148007; Dolfi DV, 2008, J IMMUNOL, V180, P2912; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Wilson DC, 2008, J IMMUNOL, V180, P5935; Wiesel M, 2012, EUR J IMMUNOL, V42, P320, DOI 10.1002/eji.201142091; Kaech SM, 2001, NAT IMMUNOL, V2, P415; Fuertes MB, 2011, J EXP MED, V208, P2005, DOI 10.1084/jem.20101159; Pipkin ME, 2010, IMMUNITY, V32, P79, DOI 10.1016/j.immuni.2009.11.012; Sanchez PJ, 2007, J IMMUNOL, V178, P1564; Arens R, 2004, J EXP MED, V199, P1595, DOI 10.1084/jem.20031111; Kalia V, 2010, IMMUNITY, V32, P91, DOI 10.1016/j.immuni.2009.11.010; Utermohlen O, 1996, J VIROL, V70, P1521; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Takemoto N, 2006, J IMMUNOL, V177, P7515; Keller AM, 2008, IMMUNITY, V29, P934, DOI 10.1016/j.immuni.2008.10.009; Peperzak V, 2010, J CLIN INVEST, V120, P168, DOI 10.1172/JCI40178; Longhi MP, 2009, J EXP MED, V206, P1589, DOI 10.1084/jem.20090247; Hendriks J, 2000, NAT IMMUNOL, V1, P433, DOI 10.1038/80877; Rowley TF, 2004, J IMMUNOL, V172, P6039; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Xu HC, 2014, IMMUNITY, V40, P949, DOI 10.1016/j.immuni.2014.05.004; Taraban VY, 2006, J IMMUNOL, V177, P2969; RUBY J, 1991, LYMPHOKINE CYTOK RES, V10, P353; Kolumam GA, 2005, J EXP MED, V202, P637, DOI 10.1084/jem.20050821; Willoughby JE, 2014, J IMMUNOL, V193, P244, DOI 10.4049/jimmunol.1301217; Wiesel M, 2011, J IMMUNOL, V186, P754, DOI 10.4049/jimmunol.1003166; Xiao YL, 2008, J IMMUNOL, V181, P1071; Sanchez PJ, 2012, VACCINE, V30, P1154, DOI 10.1016/j.vaccine.2011.12.017; Marzo AL, 2005, NAT IMMUNOL, V6, P793, DOI 10.1038/ni1227; Pearce EL, 2007, J IMMUNOL, V179, P2074; Hendriks J, 2005, J IMMUNOL, V175, P1665; Keppler SJ, 2011, EUR J IMMUNOL, V41, P3176, DOI 10.1002/eji.201141537; Bullock TNJ, 2005, J IMMUNOL, V174, P710; Agarwal P, 2009, J IMMUNOL, V183, P1695, DOI 10.4049/jimmunol.0900592; Joshi NS, 2008, J IMMUNOL, V180, P1309; Mumberg D, 1999, P NATL ACAD SCI USA, V96, P8633, DOI 10.1073/pnas.96.15.8633; Valenzuela J, 2002, J IMMUNOL, V169, P6842; Tesselaar K, 1997, J IMMUNOL, V159, P4959; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Dong H, 2012, J IMMUNOL, V188, P3829, DOI 10.4049/jimmunol.1103329; Munitic I, 2013, J IMMUNOL, V190, P1169, DOI 10.4049/jimmunol.1202353; Curtsinger JM, 2010, CURR OPIN IMMUNOL, V22, P333, DOI 10.1016/j.coi.2010.02.013; Thompson LJ, 2006, J IMMUNOL, V177, P1746; Crouse J, 2014, IMMUNITY, V40, P961, DOI 10.1016/j.immuni.2014.05.003; Schildknecht A, 2007, EUR J IMMUNOL, V37, P716, DOI 10.1002/eji.200636824; Salek-Ardakani S, 2011, J CLIN INVEST, V121, P296, DOI 10.1172/JCI42056; Slinker BK, 1998, J MOL CELL CARDIOL, V30, P723, DOI 10.1006/jmcc.1998.0655; Ochsenbein AF, 2004, J EXP MED, V200, P1407, DOI 10.1084/jem.20040717; Juedes AE, 2004, J EXP MED, V199, P1153, DOI 10.1084/jem.20031873; Angelosanto JM, 2010, IMMUNOL REV, V236, P167, DOI 10.1111/j.1600-065X.2010.00927.x; Ontiveros F, 2011, IMMUNOLOGY, V132, P549, DOI 10.1111/j.1365-2567.2010.03400.x; Curran MA, 2013, J EXP MED, V210, P743, DOI 10.1084/jem.20121190; Cho HI, 2009, CANCER RES, V69, P9012, DOI 10.1158/0008-5472.CAN-09-2019; Roberts DJ, 2010, J IMMUNOTHER, V33, P769, DOI 10.1097/CJI.0b013e3181ee238f; Feau S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1948; Hendricks J, 2003, J EXP MED, V198, P1369, DOI 10.1084/jem.20030916; Le B. A., 2006, J IMMUNOL, V176, P4682; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Starbeck-Miller GR, 2014, J EXP MED, V211, P105, DOI 10.1084/jem.20130901; Van Deusen K. E., 2009, J LEUKOCYTE BIOL, V87, P477	71	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0014-2980	1521-4141		EUR J IMMUNOL	Eur. J. Immunol.	DEC	2015	45	12					3289	3301		10.1002/eji.201445291		13	Immunology	Immunology	CY4TS	WOS:000366402000010		
J	Iijima, M; Kohda, N; Kawaguchi, K; Muguruma, T; Ohta, M; Naganishi, A; Murakami, T; Mizoguchi, I				Iijima, Masahiro; Kohda, Naohisa; Kawaguchi, Kyotaro; Muguruma, Takeshi; Ohta, Mitsuru; Naganishi, Atsuko; Murakami, Takashi; Mizoguchi, Itaru			Effects of temperature changes and stress loading on the mechanical and shape memory properties of thermoplastic materials with different glass transition behaviours and crystal structures	EUROPEAN JOURNAL OF ORTHODONTICS			English	Article							UPPER CENTRAL INCISOR; ORTHODONTIC APPLIANCES; WATER-ABSORPTION; ORAL ENVIRONMENT; INITIAL FORCES; POLYMERS	To investigate the effects of temperature changes and stress loading on the mechanical and shape memory properties of thermoplastic materials with different glass transition behaviours and crystal structures. Five thermoplastic materials, polyethylene terephthalate glycol (DuranA (R), Scheu Dental), polypropylene (HardcastA (R), Scheu Dental), and polyurethane (SMP MMA (R), SMP Technologies) with three different glass transition temperatures (T-g) were selected. The T-g and crystal structure were assessed using differential scanning calorimetry and X-ray diffraction. The deterioration of mechanical properties by thermal cycling and the orthodontic forces during stepwise temperature changes were investigated using nanoindentation testing and custom-made force-measuring system. The mechanical properties were also evaluated by three-point bending tests; shape recovery with heating was then investigated. The mechanical properties for each material were decreased significantly by 2500 cycles and great decrease was observed for Hardcast (crystal plastic) with higher T-g (155.5A degrees C) and PU 1 (crystalline or semi-crystalline plastic) with lower T-g (29.6A degrees C). The Duran, PU 2, and PU 3 with intermediate T-g (75.3A degrees C for Duran, 56.5A degrees C for PU 2, and 80.7A degrees C for PU 3) showed relatively stable mechanical properties with thermal cycling. The polyurethane polymers showed perfect shape memory effect within the range of intraoral temperature changes. The orthodontic force produced by thermoplastic appliances decreased with the stepwise temperature change for all materials. Orthodontic forces delivered by thermoplastic appliances may influence by the T-g of the materials, but not the crystal structure. Polyurethane is attractive thermoplastic materials due to their unique shape memory phenomenon, but stress relaxation with temperature changes is expected.	[Iijima, Masahiro; Kohda, Naohisa; Kawaguchi, Kyotaro; Muguruma, Takeshi; Mizoguchi, Itaru] Hlth Sci Univ Hokkaido, Sch Dent, Dept Oral Growth & Dev, Div Orthodont & Dentofacial Orthoped, Ishikari, Hokkaido 0610293, Japan; [Ohta, Mitsuru; Naganishi, Atsuko; Murakami, Takashi] Shimadzu Co Ltd, Kyoto Applicat Dev Ctr, Analyt Applicat Dept, Kyoto, Japan	Iijima, M (reprint author), Hlth Sci Univ Hokkaido, Sch Dent, Dept Oral Growth & Dev, Div Orthodont & Dentofacial Orthoped, Kanazawa 1757, Ishikari, Hokkaido 0610293, Japan.	iijima@hoku-iryo-u.ac.jp					Barbagallo LJ, 2008, ANN BIOMED ENG, V36, P335, DOI 10.1007/s10439-007-9424-5; Jeremiah HG, 2011, EUR J ORTHODONT, V33, P476, DOI 10.1093/ejo/cjq069; Airoldi G, 1997, AM J ORTHOD DENTOFAC, V112, P58, DOI 10.1016/S0889-5406(97)70274-9; Baldwin DK, 2008, AM J ORTHOD DENTOFAC, V133, P837, DOI 10.1016/j.ajodo.2006.06.025; Yang B, 2005, EUR POLYM J, V41, P1123, DOI 10.1016/j.eurpolymj.2004.11.029; Kohda N, 2013, ANGLE ORTHOD, V83, P476, DOI 10.2319/052512-432.1; Baschek G, 1999, POLYMER, V40, P3433, DOI 10.1016/S0032-3861(98)00560-6; Hahn W, 2010, ANGLE ORTHOD, V80, P239, DOI 10.2319/033009-181.1; Djeu G, 2005, AM J ORTHOD DENTOFAC, V128, P292, DOI 10.1016/j.ajodo.2005.06.002; Wei YJ, 2013, DENT MATER, V29, pE218, DOI 10.1016/j.dental.2013.05.010; Hodge RM, 1996, POLYMER, V37, P1371, DOI 10.1016/0032-3861(96)81134-7; IWAMOTO R, 1979, J POLYM SCI POL PHYS, V17, P1507, DOI 10.1002/pol.1979.180170904; Sokolowski W, 2007, BIOMED MATER, V2, pS23, DOI 10.1088/1748-6041/2/1/S04; OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564; Kwon JS, 2008, AM J ORTHOD DENTOFAC, V133, P228, DOI 10.1016/j.ajodo.2006.03.034; Behin P, 2014, DENT MATER, V30, P728, DOI 10.1016/j.dental.2014.04.002; Fang DY, 2013, DENT MATER J, V32, P946, DOI 10.4012/dmj.2013-131; Iijima M, 2012, ANGLE ORTHOD, V82, P319, DOI 10.2319/021511-112.1; Hahn W, 2009, EUR J ORTHODONT, V31, P625, DOI 10.1093/ejo/cjp047; Boyd R, 2000, J CLIN ORTHOD, V34, P13; Eliades T., 2001, ORTHODONTIC MAT SCI, P143; Hahn W, 2009, AM J ORTHOD DENTOFAC, V136; Kim Tae-Weon, 2007, World J Orthod, V8, P13; Kumcio D., 2007, ANGLE ORTHOD, V77, P864; Ryokawa H, 2006, ORTHODONTIC WAVES, V65, P64, DOI 10.1016/j.odw.2006.03.003	25	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0141-5387	1460-2210		EUR J ORTHODONT	Eur. J. Orthodont.	DEC	2015	37	6					665	670		10.1093/ejo/cjv013		6	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CY5ZI	WOS:000366486200015		
J	Tomizawa, M; Shinozaki, F; Hasegawa, R; Shirai, Y; Motoyoshi, Y; Sugiyama, T; Yamamoto, S; Ishige, N				Tomizawa, Minoru; Shinozaki, Fuminobu; Hasegawa, Rumiko; Shirai, Yoshinori; Motoyoshi, Yasufumi; Sugiyama, Takao; Yamamoto, Shigenori; Ishige, Naoki			Association between colon diverticula and hemoglobin, triglyceride and uric acid levels	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						one-way analysis of variance; receiver-operating characteristic analysis; uric acid; triglycerides	DISEASE; MANAGEMENT; RISK; EPIDEMIOLOGY; PATHOGENESIS; DIET	Colon diverticula cause bleeding and acute diverticulitis. The present study analyzed laboratory test variables, aiming to predict the presence of diverticula. Patient records from between April 2011 and March 2014 were analyzed retrospectively (1,520 patients) and a one-way analysis of variance was performed to analyze the association between the presence of diverticula and each variable. A chi(2) test was then used to assess the correlation between the prevalence of diverticula and the percentage of patients with uric acid (UA) levels >= 5.1 mg/dl. A receiver operating characteristic (ROC) analysis was performed to determine the threshold values required to predict the presence of diverticula. Hemoglobin (Hb) levels were lower in patients with diverticula than in those without diverticula (P=0.0027), and compared with patients without diverticula, UA and triglyceride (TG) levels were higher in patients with diverticula (P=0.0066 and P=0.0136, respectively). The patients were divided into two groups, as follows: Patients with UA levels >= 5.1 mg/dl (the median value) and those with UA levels <5.1 mg/dl. The prevalence of diverticula was significantly higher in patients with UA levels >=-5.1 mg/dl than in those with UA levels <5.1 mg/dl (P=0.0004). ROC analysis demonstrated that the threshold values of Hb, TG and UA were 12,400, 146 and 5.1 mg/dl, respectively. The sensitivity of the Hb and UA levels at the threshold values was 76.5 arid 71.0%, respectively. The prevalence of diverticula was associated with low Hb levels, and high TG and UA levels.	[Tomizawa, Minoru] Natl Hosp Org Shimoshizu Hosp, Dept Gastroenterol, Chiba 2840003, Japan; [Shinozaki, Fuminobu] Natl Hosp Org Shimoshizu Hosp, Dept Radiol, Chiba 2840003, Japan; [Hasegawa, Rumiko; Shirai, Yoshinori] Natl Hosp Org Shimoshizu Hosp, Dept Surg, Chiba 2840003, Japan; [Motoyoshi, Yasufumi] Natl Hosp Org Shimoshizu Hosp, Dept Neurol, Chiba 2840003, Japan; [Sugiyama, Takao] Natl Hosp Org Shimoshizu Hosp, Dept Rheumatol, Chiba 2840003, Japan; [Yamamoto, Shigenori] Natl Hosp Org Shimoshizu Hosp, Dept Pediat, Chiba 2840003, Japan; [Ishige, Naoki] Natl Hosp Org Shimoshizu Hosp, Dept Neurosurg, Chiba 2840003, Japan	Tomizawa, M (reprint author), Natl Hosp Org Shimoshizu Hosp, Dept Gastroenterol, 934-5 Shikawatashi, Chiba 2840003, Japan.	nihminor-cib@umin.ac.jp					Granlund J, 2012, ALIMENT PHARM THER, V35, P1103, DOI 10.1111/j.1365-2036.2012.05069.x; FOSTER KJ, 1978, GUT, V19, P1054, DOI 10.1136/gut.19.11.1054; Tomizawa M, 2014, EXP THER MED, V8, P759, DOI 10.3892/etm.2014.1798; Song Jung Hoon, 2010, Korean Journal of Internal Medicine, V25, P140, DOI 10.3904/kjim.2010.25.2.140; Marion Y, 2014, J VISC SURG, V151, P191, DOI 10.1016/j.jviscsurg.2014.03.008; Humes DJ, 2014, ALIMENT PHARM THER, V39, P359, DOI 10.1111/apt.12596; Jansen A, 2009, WORLD J GASTROENTERO, V15, P457, DOI 10.3748/wjg.15.457; Aldoori WH, 1998, ARCH FAM MED, V7, P255, DOI 10.1001/archfami.7.3.255; Weizman AV, 2011, CAN J GASTROENTEROL, V25, P385; Peery AF, 2012, GASTROENTEROLOGY, V142, P266, DOI 10.1053/j.gastro.2011.10.035; Afshar S, 2012, COLORECTAL DIS, V14, P135, DOI 10.1111/j.1463-1318.2011.02606.x; Heise CP, 2008, J GASTROINTEST SURG, V12, P1309, DOI 10.1007/s11605-008-0492-0; Wilkins T, 2012, AM FAM PHYSICIAN, V85, P469; Lisak M, 2013, ACTA CLIN CROAT, V52, P458; MEYERS MA, 1973, RADIOLOGY, V108, P249; Wilkins T, 2009, AM FAM PHYSICIAN, V80, P977; Tsuruoka N, 2011, J GASTROEN HEPATOL, V26, P1047, DOI 10.1111/j.1440-1746.2010.06610.x; Crowe FL, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4131; Fernández E, 1996, Rev Esp Enferm Dig, V88, P16; Kawanabe Y, 2014, BIOMED REP, V2, P633; Yamaoka K, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-138	21	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	DEC	2015	10	6					2157	2160		10.3892/etm.2015.2804		4	Medicine, Research & Experimental	Research & Experimental Medicine	CY5GJ	WOS:000366435800022		
J	Dai, YX; Takagi, A; Konishi, H; Miyazaki, T; Masuda, H; Shimada, K; Miyauchi, K; Daida, H				Dai, Yuxiang; Takagi, Atsutoshi; Konishi, Hakuoh; Miyazaki, Tetsuro; Masuda, Hiroshi; Shimada, Kazunori; Miyauchi, Katsumi; Daida, Hiroyuki			Long-term outcomes of rotational atherectomy in coronary bifurcation lesions	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						rotational atherectomy; long-term outcomes; coronary bifurcation lesion	DRUG-ELUTING STENTS; DIABETES-MELLITUS; BALLOON ANGIOPLASTY; CLINICAL-OUTCOMES; IMPLANTATION; RESTENOSIS; CLASSIFICATION; INTERVENTION; ERA; IMMEDIATE	The aim of the present study was to determine the long-term outcomes of bifurcation lesions following a rotational atherectomy (ROTA) In this retrospective study, patients that had undergone a ROTA of the bifurcation coronary lesions in Juntendo University Hospital (Tokyo, Japan) were enrolled between January 2007 and December 2009, and received follow-up for a median duration of 48 months (range, 12-84 months). A total of 337 patients were enrolled. Each patient was treated with an average of 1.2 +/- 0.4 ROTA burrs (mean size, 2.9 +/- 0.3 mm). Baseline lesion length, reference diameter, minimal lumen diameter (MLD) and percentage of diameter stenosis (%DS) prior to the procedure were comparable between the DM and non-DM patients. Furthermore, MLD, %DS and acute gain following the procedure were similar between the two groups. At follow-up, DM patients exhibited a significantly decreased MLD (1.97 +/- 0.92 vs. 2.26 +/- 0.73 mm; P=0.0038), increased %DS (27.9 +/- 21.3 vs. 20.2 +/- 13.3%; P=0.022) and late loss (0.70 +/- 0.45 vs. 0.42 +/- 0.36 mm; P=0.0047) compared with the non-DM patients. Follow-up examinations (mean duration, 52.2 +/- 19.4 months) revealed that the DM patients experienced significantly higher rates of target lesion revascularization (TLR) [28 (15.7%) vs. 8 (5.0%); P=0.0011], target lesion (TL) restenosis [46 (25.8%) vs. 20 (12.6%); P=0.0019] and major adverse cardiac events (MACE) [36 (20.2%) vs. 19 (12.0%), P=0.039] compared with the non-DM patients. Although the usage of ROTA and drug-eluting stent evidently improved long-term outcomes in patients with bifurcation lesions, DM remained an independent risk factor for TLR, TL restenosis and MACE. Therefore, the management of DM in bifurcation lesions treated with ROTA requires increased investigation in future clinical practice.	[Dai, Yuxiang; Takagi, Atsutoshi; Konishi, Hakuoh; Miyazaki, Tetsuro; Masuda, Hiroshi; Shimada, Kazunori; Miyauchi, Katsumi; Daida, Hiroyuki] Juntendo Univ Hosp, Dept Cardiol, Tokyo 1138421, Japan; [Dai, Yuxiang] Fudan Univ, Zhongshan Hosp, Shanghai Inst Cardiovasc Dis, Shanghai 200032, Peoples R China	Konishi, H (reprint author), Juntendo Univ Hosp, Dept Cardiol, 2-1-1 Hongo, Tokyo 1138421, Japan.	hakuoh_konishi@yeah.net					Medina A, 2006, REV ESP CARDIOL, V59, P183, DOI 10.1157/13084649; Ito H, 2009, J INVASIVE CARDIOL, V21, P598; KAUFMANN UP, 1995, CURR OPIN CARDIOL, V10, P412, DOI 10.1097/00001573-199507000-00011; Iijima R, 2007, AM HEART J, V154, P688, DOI 10.1016/j.ahj.2007.06.005; Zhang F, 2009, HEART, V95, P1676, DOI 10.1136/hrt.2009.168641; Kornowski R, 1997, CIRCULATION, V95, P1366; Sobel BE, 2001, CIRCULATION, V103, P1185; Bersin RM, 2003, CATHETER CARDIO INTE, V58, P485, DOI 10.1002/ccd.10459; Mauri L, 2007, NEW ENGL J MED, V356, P1020, DOI 10.1056/NEJMoa067731; Reisman M, 1996, CATHETER CARDIO DIAG, V38, P2; Nageh T, 2001, CARDIOLOGY, V95, P198, DOI 10.1159/000047372; Garot P, 2005, J AM COLL CARDIOL, V46, P606, DOI 10.1016/j.jacc.2005.01.065; RYAN TJ, 1988, CIRCULATION, V78, P486; Louvard Y, 2008, CATHETER CARDIO INTE, V71, P175, DOI 10.1002/ccd.21314; Tang Z, 2014, J GERIATR CARDIOL, V11, P44, DOI 10.3969/j.issn.1671-5411.2014.01.012; Galassi AR, 2007, CATHETER CARDIO INTE, V69, P976, DOI 10.1002/ccd.21047; Ortolani P, 2008, CIRCULATION, V117, P923, DOI 10.1161/CIRCULATIONAHA.107.730416; Chen JL, 2007, CHINESE MED J-PEKING, V120, P183; Elezi S, 1998, J AM COLL CARDIOL, V32, P1866, DOI 10.1016/S0735-1097(98)00467-7; Mehran R, 1999, CIRCULATION, V100, P1872; Dauerman HL, 1998, J AM COLL CARDIOL, V32, P1845, DOI 10.1016/S0735-1097(98)00488-4; Al Suwaidi J, 2000, J AM COLL CARDIOL, V35, P929, DOI 10.1016/S0735-1097(99)00648-8; Levey AS, 1999, ANN INTERN MED, V130, P461; Diletti R, 2013, HEART, V99, P1267, DOI 10.1136/heartjnl-2013-303778; Al Suwaidi J, 2001, AM J CARDIOL, V87, P1139, DOI 10.1016/S0002-9149(01)01482-5; Stinis CT, 2010, CATHETER CARDIO INTE, V75, P309, DOI 10.1002/ccd.22302; Liu Y, 2015, EXP THER MED, V9, P1656, DOI 10.3892/etm.2015.2366; Delhaye C, 2010, J INTERV CARDIOL, V23, P223, DOI 10.1111/j.1540-8183.2010.00546.x; Colombo Antonio, 2005, Ital Heart J, V6, P475; Dzavik V, 2005, Minerva Cardioangiol, V53, P379; Lassen JF, 2014, EUROINTERVENTION, V10, P545, DOI 10.4244/EIJV10I5A97; Levine GN, 2011, CIRCULATION, V124, P2574, DOI 10.1161/CIR.0b013e31823a5596; Melikian Narbeh, 2003, J Interv Cardiol, V16, P507, DOI 10.1046/j.1540-8183.2003.01056.x; Pan M, 2007, AM HEART J, V153, p[15, e1]; Pendyala L, 2008, Minerva Cardioangiol, V56, P89; Saland K E, 2000, Cardiol Rev, V8, P174, DOI 10.1097/00045415-200008030-00008; Sharma Samin K, 2010, Cardiol Clin, V28, P55, DOI 10.1016/j.ccl.2009.10.001; Smith Sidney C Jr, 2002, Circulation, V105, pe165, DOI 10.1161/01.CIR.0000013957.30622.05; Toutouzas K, 2015, NEW ENGL J MED, V373, P580, DOI 10.1056/NEJMc1506944#SA2; Villanueva EV, 2003, COCHRANE DB SYST REV, V4; World Health Organization, 1999, DEF DIAGN CLASS DI 1	41	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	DEC	2015	10	6					2375	2383		10.3892/etm.2015.2817		9	Medicine, Research & Experimental	Research & Experimental Medicine	CY5GJ	WOS:000366435800057		
J	Nishimoto, M; Koh, H; Hirose, A; Nakamae, M; Nakane, T; Hayashi, Y; Okamura, H; Yoshimura, T; Koh, S; Nanno, S; Nakashima, Y; Takeshita, T; Yamamoto, A; Sakai, Y; Nishida, N; Matsuoka, T; Miki, Y; Hino, M; Nakamae, H				Nishimoto, Mitsutaka; Koh, Hideo; Hirose, Asao; Nakamae, Mika; Nakane, Takahiko; Hayashi, Yoshiki; Okamura, Hiroshi; Yoshimura, Takuro; Koh, Shiro; Nanno, Satoru; Nakashima, Yasuhiro; Takeshita, Toru; Yamamoto, Akira; Sakai, Yukimasa; Nishida, Norifumi; Matsuoka, Toshiyuki; Miki, Yukio; Hino, Masayuki; Nakamae, Hirohisa			Efficacy and safety of intra-arterial steroid infusions in patients with steroid-resistant gastrointestinal acute graft-versus-host disease	EXPERIMENTAL HEMATOLOGY			English	Article							HEMATOPOIETIC-CELL TRANSPLANTATION; INFLAMMATORY-BOWEL-DISEASE; MARROW-TRANSPLANTATION; REFRACTORY ACUTE; ACUTE GVHD; RETROSPECTIVE ANALYSIS; ULCERATIVE-COLITIS; THERAPY; GLOBULIN; BLOOD	There is no established second-line treatment for steroid-resistant acute graft-versus-host disease (GVHD). We prospectively assessed the safety and efficacy of intra-arterial steroid infusions (IASIs) for steroid-resistant acute gastrointestinal (GI) GVHD and compared the outcomes with those of historical controls at our institution. Nineteen consecutive, allogeneic hematopoietic stem cell transplantation subjects aged 31-67 years (median 52) were enrolled between October, 2008, and November, 2012. Acute GVHD was confirmed by biopsy in all cases. The enrolled patients were treated with infusions of methylprednisolone into the mesenteric arteries and/or gastroduodenal and left gastric arteries. Fourteen consecutive patients who developed steroid-resistant acute GI GVHD between 2001 and 2008 were used as controls. For the primary endpoint at day 28, the overall and complete responses in the IASI group trended higher (79% vs. 42%, p = 0.066) and were significantly higher (63% vs. 21%, p = 0.033) than those in the control group. Although not statistically significant, owing to the small population, the crude day-180-nonrelapse mortality rate was about 20% lower and the day-180-overall-survival rate tended to be higher than the control (11% vs. 29%, p = 0.222; 79% vs. 50%, p = 0.109, respectively). There were no serious IASI-related complications. Our results suggest that IASI can safely provide excellent efficacy for refractory acute GI GVHD without increasing infection-related complications and may improve prognosis. Copyright (C) 2015 ISEH - International Society for Experimental Hematology. Published by Elsevier Inc.	[Nishimoto, Mitsutaka; Koh, Hideo; Hirose, Asao; Nakamae, Mika; Nakane, Takahiko; Hayashi, Yoshiki; Okamura, Hiroshi; Yoshimura, Takuro; Koh, Shiro; Nanno, Satoru; Nakashima, Yasuhiro; Hino, Masayuki; Nakamae, Hirohisa] Osaka City Univ, Grad Sch Med, Hematol, Osaka 5458585, Japan; [Takeshita, Toru; Yamamoto, Akira; Sakai, Yukimasa; Nishida, Norifumi; Matsuoka, Toshiyuki; Miki, Yukio] Osaka City Univ, Grad Sch Med, Dept Radiol, Osaka 5458585, Japan	Koh, H (reprint author), Osaka City Univ, Grad Sch Med, Hematol, Abeno Ku, 1-4-3 Asahi Machi, Osaka 5458585, Japan.	hide_koh@med.osaka-cu.ac.jp			Japan Society for the Promotion of Science KAKENHI [23591423]	This work was supported by the Japan Society for the Promotion of Science KAKENHI (grant no. 23591423).	Rogler G, 1999, EUR J CLIN INVEST, V29, P330; Gooley TA, 2010, NEW ENGL J MED, V363, P2091, DOI 10.1056/NEJMoa1004383; Martin PJ, 2012, BIOL BLOOD MARROW TR, V18, P1150, DOI 10.1016/j.bbmt.2012.04.005; Shapira MY, 2002, BRIT J HAEMATOL, V119, P760, DOI 10.1046/j.1365-2141.2002.03923.x; WEISDORF D, 1990, BLOOD, V75, P1024; HIRAMATSU K, 1976, ACTA RADIOL DIAGN, V17, P299; Klein SA, 2011, BRIT J HAEMATOL, V154, P143, DOI 10.1111/j.1365-2141.2010.08495.x; Weintraub JL, 2010, CARDIOVASC INTER RAD, V33, P509, DOI 10.1007/s00270-009-9792-3; MARTIN PJ, 1990, BLOOD, V76, P1464; Meunier M, 2014, BIOL BLOOD MARROW TR, V20, P1451, DOI 10.1016/j.bbmt.2014.05.031; Buttgereit F, 1999, BIOCHEM PHARMACOL, V58, P363, DOI 10.1016/S0006-2952(99)00090-8; Raddatz D, 2004, ALIMENT PHARM THERAP, V19, P47, DOI 10.1046/j.1365-2036.2003.01802.x; Xhaard A, 2012, BIOL BLOOD MARROW TR, V18, P406, DOI 10.1016/j.bbmt.2011.06.012; Arai S, 2002, BIOL BLOOD MARROW TR, V8, P155, DOI 10.1053/bbmt.2002.v8.pm11939605; Khoury H, 2001, BONE MARROW TRANSPL, V27, P1059, DOI 10.1038/sj.bmt.1703032; Barnes PJ, 2009, LANCET, V373, P1905, DOI 10.1016/S0140-6736(09)60326-3; Inamoto Y, 2011, BLOOD, V118, P456, DOI 10.1182/blood-2011-01-330217; MARTIN PJ, 1991, BLOOD, V77, P1821; ROY J, 1992, BONE MARROW TRANSPL, V10, P77; MacMillan ML, 2002, BIOL BLOOD MARROW TR, V8, P40, DOI 10.1053/bbmt.2002.v8.pm11858189; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Storek J, 2001, BLOOD, V97, P3380, DOI 10.1182/blood.V97.11.3380; Pidala J, 2010, BIOL BLOOD MARROW TR, V16, P1504, DOI 10.1016/j.bbmt.2010.01.007; Furlong T, 2009, BONE MARROW TRANSPL, V44, P739, DOI 10.1038/bmt.2009.76; Pidala J, 2010, BONE MARROW TRANSPL, V45, P919, DOI 10.1038/bmt.2009.252; Robin M, 2009, TRANSPLANTATION, V88, P1131, DOI 10.1097/TP.0b013e3181bc2583; Buttgereit F, 1998, ARTHRITIS RHEUM, V41, P761, DOI 10.1002/1529-0131(199805)41:5<761::AID-ART2>3.0.CO;2-M; Couriel D, 2004, BLOOD, V104, P649, DOI 10.1182/blood-2003-12-4241; Bueregler D, 2014, LEUKEMIA RES, V38, P184; MacMillan ML, 2007, BLOOD, V109, P2657, DOI 10.1182/blood-2006-08-013995	30	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	DEC	2015	43	12					995	1000		10.1016/j.exphem.2015.08.002		6	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CY1DC	WOS:000366145900003		
J	Waditee-Sirisattha, R; Kageyama, H; Fukaya, M; Rai, V; Takabe, T				Waditee-Sirisattha, Rungaroon; Kageyama, Hakuto; Fukaya, Minoru; Rai, Vandna; Takabe, Teruhiro			Nitrate and amino acid availability affects glycine betaine and mycosporine-2-glycine in response to changes of salinity in a halotolerant cyanobacterium Aphanothece halophytica	FEMS MICROBIOLOGY LETTERS			English	Article						glycine betaine; halotolerant cyanobacterium; mycosporine-2-glycine; amino acids; nitrate; salt stress	FUNCTIONAL-CHARACTERIZATION; SALT STRESS; ACCUMULATION; ASSIMILATION; PLANTS	A halotolerant cyanobacterium Aphanothece halophytica thrives in extreme salinity with accumulation of a potent osmoprotectant glycine betaine. Recently, this cyanobacterium was shown to accumulate sunscreen molecule mycosporine-2-glycine significantly at high salinity. In this study, we investigated effects of nitrate and amino acid provision on the accumulation of glycine betaine and mycosporine-2-glycine. With elevated nitrate concentrations at high salinity, intracellular levels of both metabolites were enhanced. Six-fold high nitrate concentration increased the relative amounts of glycine betaine and mycosporine-2-glycine to be 1.5 and 2.0 folds compared with control condition. Increased levels were time-and dose-dependent manner. Exogenous supply of glycine/serine at high salinity resulted in the similar trends as observed in excess nitrate experiment. Intracellular level of glycine betaine increased similar to 1.6 folds with glycine/serine supplementation. These supplementations also caused the increased level of mycosporine-2-glycine, namely 1.4 and 2 folds by glycine and serine, respectively. The transcription of glycine betaine and mycosporine-2-glycine biosynthetic genes was strongly induced under high-nitrate-salt condition. These results suggest the dependence of glycine betaine and mycosporine-2-glycine productions on substrate availability, and the effect of nitrate was possibly associated with stimulation of osmoprotectant increment in this extremophile.	[Waditee-Sirisattha, Rungaroon; Takabe, Teruhiro] Meijo Univ, Res Inst, Nagoya, Aichi 4688502, Japan; [Waditee-Sirisattha, Rungaroon] Chulalongkorn Univ, Fac Sci, Dept Microbiol, Bangkok 10330, Thailand; [Kageyama, Hakuto; Takabe, Teruhiro] Meijo Univ, Grad Sch Environm & Human Sci, Nagoya, Aichi 4688502, Japan; [Fukaya, Minoru] Meijo Univ, Fac Sci & Technol, Nagoya, Aichi 4688502, Japan; [Rai, Vandna] IARI, Natl Res Ctr Plant Biotechnol, New Delhi 110012, India	Takabe, T (reprint author), Meijo Univ, Res Inst, Tenpaku Ku, 1-501 Shiogamaguchi, Nagoya, Aichi 4688502, Japan.	takabe@meijo-u.ac.jp			Ministry of Education, Science and Culture of Japan; International Center for Green Biotechnology of Meijo University; Ratchadapisek Sompoch Endowment Fund, Chulalongkorn University [Sci-Super 2014-022]	This work was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Science and Culture of Japan and the International Center for Green Biotechnology of Meijo University to T. T. This work was in part funded by the Ratchadapisek Sompoch Endowment Fund, Chulalongkorn University (Sci-Super 2014-022) to RWS.	Kageyama H, 2011, APPL ENVIRON MICROB, V77, P5178, DOI 10.1128/AEM.00667-11; Flores E, 2005, PHOTOSYNTH RES, V83, P117, DOI 10.1007/s11120-004-5830-9; Waditee R, 2003, J BIOL CHEM, V278, P4932, DOI 10.1074/jbc.M210970200; Sakamoto T, 1999, PLANT PHYSIOL, V119, P785, DOI 10.1104/pp.119.2.785; Hu Q, 2000, APPL ENVIRON MICROB, V66, P133; Herrero A, 2001, J BACTERIOL, V183, P411, DOI 10.1128/JB.183.2.411-425.2001; Sundaralingam T, 2014, INT J PHYTOREMEDIAT, V16, P275, DOI 10.1080/15226514.2013.773279; Balskus EP, 2010, SCIENCE, V329, P1653, DOI 10.1126/science.1193637; Leigh JA, 2007, ANNU REV MICROBIOL, V61, P349, DOI 10.1146/annurev.micro.61.080706.093409; Waditee R, 2007, J BIOL CHEM, V282, P34185, DOI 10.1074/jbc.M704939200; Hibino T, 2002, J BIOL CHEM, V277, P41352, DOI 10.1074/jbc.M205965200; Ohashi Y, 2011, J EXP BOT, V62, P1411, DOI 10.1093/jxb/erq427; Waditee-Sirisattha R, 2012, FEMS MICROBIOL LETT, V2333, P46; Waditee-Sirisattha R, 2014, APPL ENVIRON MICROB, V80, P1763, DOI 10.1128/AEM.03729-13	14	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0378-1097	1574-6968		FEMS MICROBIOL LETT	FEMS Microbiol. Lett.	DEC	2015	362	23							fnv198	10.1093/femsle/fnv198		6	Microbiology	Microbiology	CY4HJ	WOS:000366368900008		
J	Yamaguchi, T; Iida, K; Shiota, S; Nakayama, H; Yoshida, S				Yamaguchi, Takayoshi; Iida, Ken-ichiro; Shiota, Susumu; Nakayama, Hiroaki; Yoshida, Shin-ichi			Elevated guanosine 5 '-diphosphate 3 '-diphosphate level inhibits bacterial growth and interferes with FtsZ assembly	FEMS MICROBIOLOGY LETTERS			English	Article						FtsZ assembly; guanosine 5 '-diphosphate 3 '-diphosphate; starved condition	DIVISION PROTEIN FTSZ; ESCHERICHIA-COLI RIBOSOMES; CELL-DIVISION; GTP HYDROLYSIS; TETRAPHOSPHATE PPGPP; Z-RING; (P)PPGPP; POLYMERIZATION; TRANSFORMATION; ASSOCIATION	FtsZ, a protein essential for prokaryotic cell division, forms a ring structure known as the Z-ring at the division site. FtsZ has a GTP binding site and is assembled into linear structures in a GTP-dependent manner in vitro. We assessed whether guanosine 5'-diphosphate 3'-diphosphate (ppGpp), a global regulator of gene expression in starved bacteria, affects cell division in Salmonella Paratyphi A. Elevation of intracellular ppGpp levels by using the relA expression vector induced repression of bacterial growth and incorrect FtsZ assembly. We found that FtsZ forms helical structures in the presence of ppGpp by using the GTP binding site; however, ppGpp levels required to form helical structures were at least 20-fold higher than the required GTP levels in vitro. Furthermore, once formed, helical structures did not change to the straight form even after GTP addition. Our data indicate that elevation of the ppGpp level leads to inhibition of bacterial growth and interferes with FtsZ assembly.	[Yamaguchi, Takayoshi; Iida, Ken-ichiro; Nakayama, Hiroaki; Yoshida, Shin-ichi] Kyushu Univ, Fac Med Sci, Dept Bacteriol, Higashi Ku, Fukuoka 8128582, Japan; [Shiota, Susumu] Kyushu Univ, Fac Med Sci, Div Oral Infect Dis & Immunol, Dept Oral Hlth Growth & Dev,Higashi Ku, Fukuoka 8128582, Japan	Yamaguchi, T (reprint author), Kyushu Univ, Fac Med Sci, Dept Bacteriol, Higashi Ku, Fukuoka 8128582, Japan.	yama_guts@yahoo.co.jp					Joseleau-Petit D, 1999, J BACTERIOL, V181, P9; OCALLAGHAN D, 1990, MOL GEN GENET, V223, P156, DOI 10.1007/BF00315809; MUKHERJEE A, 1993, P NATL ACAD SCI USA, V90, P1053, DOI 10.1073/pnas.90.3.1053; Gonzalez D, 2014, J BACTERIOL, V196, P2514, DOI 10.1128/JB.01575-14; Lutkenhaus J, 2012, CYTOSKELETON, V69, P778, DOI 10.1002/cm.21054; CASHEL M, 1974, ANAL BIOCHEM, V57, P100, DOI 10.1016/0003-2697(74)90056-6; VILLADSEN IS, 1977, J BACTERIOL, V130, P136; Schakermann M, 2013, J BACTERIOL, V195, P1912, DOI 10.1128/JB.02134-12; DEBOER P, 1992, NATURE, V359, P254, DOI 10.1038/359254a0; Peters PC, 2007, MOL MICROBIOL, V64, P487, DOI 10.1111/j.1365-2958.2007.05673.x; MEHRA RK, 1981, J GEN MICROBIOL, V123, P27; Li Y, 2013, SCIENCE, V341, P392, DOI 10.1126/science.1239248; Scheffers DJ, 2002, BIOCHEMISTRY-US, V41, P521, DOI 10.1021/bi011370i; Mukherjee A, 1998, EMBO J, V17, P462, DOI 10.1093/emboj/17.2.462; Kriel A, 2012, MOL CELL, V48, P231, DOI 10.1016/j.molcel.2012.08.009; Rivas G, 2000, J BIOL CHEM, V275, P11740, DOI 10.1074/jbc.275.16.11740; den Blaauwen T, 2001, MOL MICROBIOL, V42, P1179, DOI 10.1046/j.1365-2958.2001.02691.x; Lu CL, 2000, J BACTERIOL, V182, P164; Vicente M, 2006, J BACTERIOL, V188, P19, DOI 10.1128/JB.188.1.19-27.2006; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Magnusson LU, 2005, TRENDS MICROBIOL, V13, P236, DOI 10.1016/j.tim.2005.03.008; Romberg L, 2003, ANNU REV MICROBIOL, V57, P125, DOI 10.1146/annurev.micro.57.012903.074300; XIAO H, 1991, J BIOL CHEM, V266, P5980; KROHN M, 1995, ANAL BIOCHEM, V225, P188, DOI 10.1006/abio.1995.1138; Scheffers DJ, 2001, FEBS LETT, V506, P6, DOI 10.1016/S0014-5793(01)02855-1; Buckstein MH, 2008, J BACTERIOL, V190, P718, DOI 10.1128/JB.01020-07; Mukherjee A, 1998, P NATL ACAD SCI USA, V95, P2885, DOI 10.1073/pnas.95.6.2885; Traxler MF, 2008, MOL MICROBIOL, V68, P1128, DOI 10.1111/j.1365-2958.2008.06229.x; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; LAZZARIN.RA, 1971, J BIOL CHEM, V246, P4381; NEIDHARD.FC, 1974, J BACTERIOL, V119, P736; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2	32	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0378-1097	1574-6968		FEMS MICROBIOL LETT	FEMS Microbiol. Lett.	DEC	2015	362	23							fnv187	10.1093/femsle/fnv187		7	Microbiology	Microbiology	CY4HJ	WOS:000366368900004		
J	Fukazawa, Y; Funakoshi, M				Fukazawa, Yoshinari; Funakoshi, Mitsuaki			Onset of thermal convection and its flow patterns in a rectangular cavity	FLUID DYNAMICS RESEARCH			English	Article						thermal convection; onset; flow pattern; critical Rayleigh number	RAYLEIGH-BENARD CONVECTION; CUBICAL CAVITY; 3-DIMENSIONAL CONVECTION; NATURAL-CONVECTION; SEPARATION; STABILITY; INSTABILITY; BOXES	The onset of thermal convection of a fluid in a rectangular cavity of aspect ratios A(x) and A(y) exposed to a vertically linear temperature field is examined under the assumption that all its walls are rigid, and of perfect thermal conductance. For several A(x) and A(y) smaller than 6, the critical Rayleigh number R-c and the steady flow patterns of most unstable modes are computed by a Galerkin spectral method of high accuracy. Characteristics of flow patterns are examined by using upper-wall flow patterns based on near-wall velocity fields, distributions of vertical velocity, and trajectories of fluid particles. We find that a symmetry mode that is not the most unstable when the difference between A(x) and A(y) is large is the most unstable if both A(x) and A(y) are around 4 or around 5.5. The flow pattern of this mode is consistent with the results in a preceding experimental study. R-c increases rapidly as A(x) or A(y) decreases to zero and decreases slowly as they increase. The validity of the assumption of finite roll is found to be limited, even if the difference between A(x) and A(y) is large. The flow pattern for A(x) = A(y) = A becomes more complicated, and the number of convection cells increases as A increases. The motion of fluid particles in each cell is roughly the circulation along closed curves around an axis that is on the central horizontal plane but is not necessarily parallel to side walls. Moreover, the motion of fluid particles near side walls can be much different from that in the central part of the cavity.	[Fukazawa, Yoshinari; Funakoshi, Mitsuaki] Kyoto Univ, Dept Appl Anal & Complex Dynam Syst, Grad Sch Informat, Kyoto 6068501, Japan	Fukazawa, Y (reprint author), Hyogo Prefectural Sanda Shounkan Senior High Sch, Kobe, Hyogo 6691337, Japan.	mitsu@acs.i.kyoto-u.ac.jp			JSPS KAKENHI [25390154]	This work is partly supported by JSPS KAKENHI Grant number 25390154.	Leong WH, 1998, INT J HEAT MASS TRAN, V41, P3817, DOI 10.1016/S0017-9310(98)00095-7; Surana A, 2006, J FLUID MECH, V564, P57, DOI 10.1017/S0022112006001200; Mizushima J, 1997, J PHYS SOC JPN, V66, P2337, DOI 10.1143/JPSJ.66.2337; Puigjaner D, 2004, PHYS FLUIDS, V16, P3639, DOI 10.1063/1.1778031; Simo C, 2010, COMMUN NONLINEAR SCI, V15, P24, DOI 10.1016/j.cnsns.2008.07.012; DAVIS SH, 1967, J FLUID MECH, V30, P465, DOI 10.1017/S0022112067001545; SHERMAN M, 1966, J FLUID MECH, V24, P661, DOI 10.1017/S0022112066000909; KESSLER R, 1987, J FLUID MECH, V174, P357, DOI 10.1017/S0022112087000168; Dauby PC, 1996, J FLUID MECH, V329, P25, DOI 10.1017/S0022112096008816; Sezai I, 2000, PHYS FLUIDS, V12, P432, DOI 10.1063/1.870321; Puigjaner D, 2008, J FLUID MECH, V598, P393, DOI 10.1017/S0022112007000080; EDWARDS BF, 1988, J FLUID MECH, V191, P583, DOI 10.1017/S0022112088001727; Gelfgat AY, 1999, J COMPUT PHYS, V156, P300, DOI 10.1006/jcph.1999.6363; CHERNIKOV AA, 1992, PHYS LETT A, V169, P51, DOI 10.1016/0375-9601(92)90804-U; DANIELS PG, 1990, INT J HEAT MASS TRAN, V33, P55, DOI 10.1016/0017-9310(90)90140-P; Delery JM, 2001, ANNU REV FLUID MECH, V33, P129, DOI 10.1146/annurev.fluid.33.1.129; Hirschberg P, 1997, J NONLINEAR SCI, V7, P537, DOI 10.1007/s003329900039; Bousset F, 2008, FLUID DYN, V43, P1, DOI [10.1134/s10697-008-1001-6, 10.1134/S0015462808010018]; CATTON I, 1970, J HEAT TRANSF, V92, P186; STORK K, 1972, J FLUID MECH, V54, P599, DOI 10.1017/S0022112072000898; KIRCHARTZ KR, 1988, J FLUID MECH, V192, P249, DOI 10.1017/S0022112088001855; ARTER W, 1983, PHYS LETT A, V97, P171, DOI 10.1016/0375-9601(83)90350-X; Surana A, 2007, AIAA J, V45, P1290, DOI 10.2514/1.21464; ARTER W, 1985, J FLUID MECH, V152, P391, DOI 10.1017/S0022112085000751; Davies-Jones R P, 1970, J FLUID MECH, V44, P695, DOI 10.1017/S0022112070002094; Gershuni G Z, 1972, CONVECTIVE STABILITY; Koschmieder E L, 1993, BENARD CELLS TAYLOR; Koschmieder E L, 1966, BEITR PHYS ATMOS, V39, P1; Mizushima J, 1996, RES I APPL MATH KYOT, V970, P1; Ozoe H, 1976, ASME, V98C, P202; Ozoe H, 1979, INT CHEM ENG, V19, P454	31	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0169-5983	1873-7005		FLUID DYN RES	Fluid Dyn. Res.	DEC	2015	47	6							065505	10.1088/0169-5983/47/6/065505		33	Mechanics; Physics, Fluids & Plasmas	Mechanics; Physics	CY4LP	WOS:000366379900005		
J	Yatsuyanagi, Y; Hatori, T				Yatsuyanagi, Yuichi; Hatori, Tadatsugu			Mechanism of self-organization in point vortex system	FLUID DYNAMICS RESEARCH			English	Article						self-organization; point vortex system; negative absolute temperature	PURE ELECTRON-PLASMA; 2-DIMENSIONAL TURBULENCE; COLLISIONAL DIFFUSION; KINETIC-THEORY; 2 DIMENSIONS; VORTICES; RELAXATION; SIMULATIONS; WALLS; GAS	A mechanism of the self-organization in an unbounded two-dimensional (2D) point vortex system is discussed. A kinetic equation for the system with positive and negative vortices is derived using the Klimontovich formalism. Similar to the Fokker-Planck collision term, the obtained collision term consists of a diffusion term and a drift term. It is revealed that the mechanism for the self-organization in the 2D point vortex system at negative absolute temperature is mainly provided by the drift term. Positive and negative vortices are driven toward opposite directions respectively by the drift term. As a result, well-known, two isolated clumps with positive and negative vortices, respectively, are formed as an equilibrium distribution. Regardless of the number of species of the vortices, either single-or double-sign, it is found that the collision term has following physically good properties: (i) when the system reaches a quasi-stationary state near the thermal equilibrium state with negative absolute temperature, the sign of d omega/d Psi. is expected to be positive, where omega is the vorticity and Psi is the stream function. In this case, the diffusion term decreases the mean field energy, while the drift term increases it. As a whole, the total mean field energy is conserved. (ii) Similarly, the diffusion term increases the Boltzmann entropy, while the drift term decreases it. As a whole, the total entropy production rate is positive or zero (H theorem), which ensures that the system relaxes to the global thermal equilibrium state characterized by the zero entropy production.	[Yatsuyanagi, Yuichi] Shizuoka Univ, Fac Educ, Suruga Ku, Shizuoka 4228529, Japan; [Hatori, Tadatsugu] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan	Yatsuyanagi, Y (reprint author), Shizuoka Univ, Fac Educ, Suruga Ku, Shizuoka 4228529, Japan.	yatsuyanagi.yuichi@shizuoka.ac.jp			JSPS KAKENHI Grant [24540400]	The authors are grateful to Prof PH Chavanis for helpful comments. This work was supported by JSPS KAKENHI Grant Number 24540400.	MONTGOMERY D, 1992, PHYS FLUIDS A-FLUID, V4, P3, DOI 10.1063/1.858525; FINE KS, 1995, PHYS REV LETT, V75, P3277, DOI 10.1103/PhysRevLett.75.3277; KIDA S, 1985, J PHYS SOC JPN, V54, P2840, DOI 10.1143/JPSJ.54.2840; Dubin DHE, 2001, PHYS LETT A, V284, P112, DOI 10.1016/S0375-9601(01)00296-1; Jin DZ, 1998, PHYS REV LETT, V80, P4434, DOI 10.1103/PhysRevLett.80.4434; Yatsuyanagi Y, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.054502; POINTIN YB, 1976, PHYS FLUIDS, V19, P1459, DOI 10.1063/1.861347; Yatsuyanagi Y, 2003, PHYS PLASMAS, V10, P3188, DOI 10.1063/1.1592516; Yatsuyanagi Y, 2015, J PHYS SOC JPN, V84, DOI 10.7566/JPSJ.84.014402; ROBERT R, 1992, PHYS REV LETT, V69, P2776, DOI 10.1103/PhysRevLett.69.2776; KIDA S, 1975, J PHYS SOC JPN, V39, P1395, DOI 10.1143/JPSJ.39.1395; Li SJ, 1996, PHYS LETT A, V218, P281, DOI 10.1016/0375-9601(96)00401-X; Chavanis PH, 2008, PHYSICA A, V387, P1123, DOI 10.1016/j.physa.2007.10.022; Chavanis PH, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.026309; Eyink GL, 2006, REV MOD PHYS, V78, P87, DOI 10.1103/RevModPhys.78.87; TAYLOR JB, 1971, PHYS FLUIDS, V14, P1492, DOI 10.1063/1.1693635; Li SJ, 1997, THEOR COMP FLUID DYN, V9, P167, DOI 10.1007/s001620050038; JOYCE G, 1973, J PLASMA PHYS, V10, P107; Soga Y, 2003, PHYS PLASMAS, V10, P3922, DOI 10.1063/1.1611181; Dubin DHE, 2003, PHYS PLASMAS, V10, P1338, DOI 10.1063/1.1564596; DUBIN DHE, 1988, PHYS REV LETT, V60, P1286, DOI 10.1103/PhysRevLett.60.1286; Tabeling P, 2002, PHYS REP, V362, P1, DOI 10.1016/S0370-1573(01)00064-3; KRAICHNAN RH, 1980, REP PROG PHYS, V43, P547, DOI 10.1088/0034-4885/43/5/001; Chavanis PH, 2007, EUR PHYS J B, V59, P217, DOI 10.1140/epjb/e2007-00276-2; Chavanis PH, 1998, PHYS REV E, V58, pR1199, DOI 10.1103/PhysRevE.58.R1199; Chavanis PH, 2012, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2012/02/P02019; Newton P K, 2001, N VORTEX PROBLEM ANA; Onsager L., 1949, Supplemento al Nuovo Cimento, V6, DOI 10.1007/BF02780991; Sanpei A, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.016404; ter Haar D., 1967, STAT THEORY NONEQUIL; Yatsuyanagi Y, 2014, PAC J MATH IND, V6, P3	31	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0169-5983	1873-7005		FLUID DYN RES	Fluid Dyn. Res.	DEC	2015	47	6							065506	10.1088/0169-5983/47/6/065506		22	Mechanics; Physics, Fluids & Plasmas	Mechanics; Physics	CY4LP	WOS:000366379900006		
J	Tanaka, K; Tantasirin, C; Wiwatwittaya, D; Tanaka, N; Takahashi, HG; Yoshifuji, N; Igarashi, Y; Sato, T; Suzuki, M				Tanaka, Katsunori; Tantasirin, Chatchai; Wiwatwittaya, Decha; Tanaka, Nobuaki; Takahashi, Hiroshi G.; Yoshifuji, Natsuko; Igarashi, Yasunori; Sato, Takanori; Suzuki, Masakazu			Earlier Leaf Flush Associated with Increased Teak Defoliation	FOREST SCIENCE			English	Article						day length; leaf flush; leaf growth; soil drought; teak defoliation		The goal of this study conducted at the Mae Mo teak plantation in northern Thailand was to test the hypothesis that early teak (Tectona grandis L. f.) leaf flush results in higher levels of insect defoliation. Based on photographic evidence in both 2010 and 2012, increases in soil moisture in the root zone before the spring equinox resulted in early flushing and subsequent leaf growth and expansion. Early leaf development was observed from 2010 to 2012 in response to wind and distribution of daily rainfall during northerly surges. Adverse growing conditions of shorter day lengths and low soil moisture, in 2001, 2008, 2010, and 2012, were associated with defoliation. The insect that appears to be primarily responsible for defoliation is the teak defoliator, Hyblaea puera (Cramer 1777). In 2011, reduced ambient temperature and a lower vapor pressure deficit reduced evaporative demands during the leaf growing period, resulting in greater soil moisture retention. In 2011, these conditions induced relatively faster leaf expansion and, subsequently, limited the extent of defoliation. There is a strong probability that early leaf flush in response to an increase in premonsoon rainfall was a major factor contributing to teak leaf defoliation over a 12-year period.	[Tanaka, Katsunori] Japan Agcy Marine Earth Sci & Technol, Dept Environm Geochem Cycle Res, Yokohama, Kanagawa, Japan; [Tantasirin, Chatchai; Wiwatwittaya, Decha] Kasetsart Univ, Fac Forestry, Bangkok, Thailand; [Tanaka, Nobuaki] Univ Tokyo Forest, Ecohydrol Res Inst, Tokyo, Japan; [Takahashi, Hiroshi G.] Tokyo Metropolitan Univ, Dept Geog, Tokyo, Japan; [Yoshifuji, Natsuko] Forestry & Forest Prod Res Inst, Tsukuba, Ibaraki, Japan; [Igarashi, Yasunori] Nagoya Univ, Hydrospher Atmospher Res Ctr, Nagoya, Aichi 4648601, Japan; [Sato, Takanori; Suzuki, Masakazu] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo 1138654, Japan	Tanaka, K (reprint author), Japan Agcy Marine Earth Sci & Technol, Dept Environm Geochem Cycle Res, Yokohama, Kanagawa, Japan.	ktanaka@jamstec.go.jp; fforcct@ku.ac.th; ffordew@ku.ac.th; tanaka@ufa.u-tokyo.ac.ip; hiroshi3@tmu.ac.jp; yoshifuji@ffpri.affrc.go.jp; ya.igarashi@gmail.com; satot@uf.a.u-tokyo.ac.jp; suzuki@fr.a.u-tokyo.ac.jp			Japan Society for Promotion of Science KAKENHI [24310018]	This work was supported by Japan Society for the Promotion of Science KAKENHI Grant 24310018. We thank Nipol Pain of the Forest Industry Organization, who provided valuable comment about teak pests at the Mae Mo plantation, and Yuka Nakano, who supported visual observation. We thank the two reviewers fir their valuable comments and suggestions to improve the quality of the article. K Tanaka thanks Kenneth Childers, Mika Kowamoto, and Wattanachai Tasen for their helpful suggestions. K Tanaka gives special thanks to Kenneth Childers, his English teacher, who taught him how to effectively present the authors' work in English and helped him with this study from February to August 2014, when, unfortunately, Ken passed away. He was a good teacher, and K Tanaka respected him greatly. K Tanaka promised his wife, Izumi Childers, that he would add Ken's name to the Acknowledgments. After this work is published he will present her with a copy.		0	0	0	SOC AMER FORESTERS	BETHESDA	5400 GROSVENOR LANE, BETHESDA, MD 20814 USA	0015-749X	1938-3738		FOREST SCI	For. Sci.	DEC	2015	61	6					1009	1020		10.5849/forsci.15-004		12	Forestry	Forestry	CY1DJ	WOS:000366146600003		
J	Fukasawa, Y; Matsuoka, S				Fukasawa, Yu; Matsuoka, Shunsuke			Communities of wood-inhabiting fungi in dead pine logs along a geographical gradient in Japan	FUNGAL ECOLOGY			English	Article						Climate; Dead wood; Decay type; Fungal community; Latitude; Pine wilt disease; Pinus densiflora; Wood decay	SUBSTRATE QUALITY; DECAY; FORESTS; IDENTIFICATION; DECOMPOSITION; ECOSYSTEMS; FRACTIONS; DIVERSITY; PRIMERS; ECOLOGY	Fungi are the main agents of coarse woody debris decomposition in forest ecosystems. We examined the associations of environmental variables with fungal community structures in dead pine logs at 12 geographically distant sites using amplicon pyrosequencing of fungal ITS rDNA. A total of 575 operational taxonomic units (OTUs) were identified based on clustering at 97% similarity. Among the known fungal ecological groups, saprotrophic fungi generally showed highest frequency of occurrence and were positively associated with mean annual temperature (MAT) and log diameter. Wood decay fungi with unknown decay type were positively associated with pine wilt disease and negatively associated with log diameter. Ordination analysis of the 42 most prevalent OTUs showed that MAT and annual precipitation significantly explained the observed fungal community structure. These results suggested that climate conditions and site history differentially effect structure fungal communities in pine logs among different ecological groups. (C) 2015 Elsevier Ltd and The British Mycological Society. All rights reserved.	[Fukasawa, Yu] Tohoku Univ, Grad Sch Agr Sci, Lab Forest Ecol, Osaki, Miyagi 9896711, Japan; [Matsuoka, Shunsuke] Kyoto Univ, Ctr Ecol Res, Otsu, Shiga 5202113, Japan	Fukasawa, Y (reprint author), Tohoku Univ, Grad Sch Agr Sci, Lab Forest Ecol, Osaki, Miyagi 9896711, Japan.	fukasawayuu@gmail.com			Japan Society for the Promotion of Science (JSPS) KAKENHI Grant [23780156]	The authors are grateful for fieldwork assistance provided by Masashi Ohsawa, Masanori Kobayashi, Yumiko Kobayashi, Shin-ichi Kawakami, Masahiro Takagi, Tsutomu Enoki, Katsuyoshi Kubota, Naohiko Sagara, Masako Sagara, Yuji Kominami, Mioko Ataka, Taiki Inoue, Tsuyoshi Sato, Akiyoshi Yamada, Naoki Endo and stuffs of the botanical gardens, Tohoku University. Thanks are extended to Rikiya Endo for his advices on ecological information of yeasts, Akifumi S. Tanabe for his advices on bioinformatics, and two anonymous reviewers for valuable comments on original manuscript. This study was financially supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Number 23780156 to Y.F.	SEIFERT KA, 1983, MYCOLOGIA, V75, P1011, DOI 10.2307/3792657; Li WZ, 2012, BRIEF BIOINFORM, V13, P656, DOI 10.1093/bib/bbs035; NICOLE M, 1985, EUR J FOREST PATHOL, V15, P293; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; TANESAKA E, 1993, MYCOLOGIA, V85, P347, DOI 10.2307/3760693; Talbot JM, 2014, P NATL ACAD SCI USA, V111, P6341, DOI 10.1073/pnas.1402584111; Lindner DL, 2008, MYCOLOGIA, V100, P417, DOI 10.3852/07-124R2; Fukasawa Y, 2010, ECOL RES, V25, P959, DOI 10.1007/s11284-010-0720-4; Rajala T, 2012, FEMS MICROBIOL ECOL, V81, P494, DOI 10.1111/j.1574-6941.2012.01376.x; Hattenschwiler S, 2005, ANNU REV ECOL EVOL S, V36, P191, DOI 10.1146/annurev.ecolsys.36.112904.151932; Dickie IA, 2012, ECOL LETT, V15, P133, DOI 10.1111/j.1461-0248.2011.01722.x; Hamady M, 2008, NAT METHODS, V5, P235, DOI [10.1038/nmeth.1184, 10.1038/NMETH.1184]; Rajala T, 2011, FUNGAL ECOL, V4, P437, DOI 10.1016/j.funeco.2011.05.005; Croan SC, 1999, MYCOLOGIA, V91, P908, DOI 10.2307/3761546; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; Borcard D, 2004, ECOLOGY, V85, P1826, DOI 10.1890/03-3111; Walker JKM, 2014, BOTANY, V92, P453, DOI 10.1139/cjb-2013-0239; BODDY L, 1989, FEMS MICROBIOL ECOL, V62, P173, DOI 10.1111/j.1574-6968.1989.tb03691.x; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Fukasawa Y, 2015, FOREST ECOL MANAG, V349, P29, DOI 10.1016/j.foreco.2015.04.010; Blanchet FG, 2008, ECOLOGY, V89, P2623, DOI 10.1890/07-0986.1; Kominami Y, 2012, J FOREST RES-JPN, V17, P296, DOI 10.1007/s10310-011-0315-0; van der Wal A, 2015, ECOLOGY, V96, P124, DOI 10.1890/14-0242.1; Heilmann-Clausen J, 2004, FOREST ECOL MANAG, V201, P105, DOI 10.1016/j.foreco.2004.07.010; Kubartova A, 2012, MOL ECOL, V21, P4514, DOI 10.1111/j.1365-294X.2012.05723.x; Fukasawa Y, 2012, FOREST ECOL MANAG, V266, P232, DOI 10.1016/j.foreco.2011.11.027; Bace R, 2012, FOREST ECOL MANAG, V266, P254, DOI 10.1016/j.foreco.2011.11.025; Baldrian P, 2008, FUNGAL ECOL, V1, P4, DOI 10.1016/j.funeco.2008.02.001; Berg B., 2003, PLANT LITTER DECOMPO; Boddy L., 1988, FUNGAL DECOMPOSITION; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Enoki T., 2013, B KYUSHU U FOR, V94, P40; Fukasawa Yu, 2005, Mycoscience, V46, P209, DOI 10.1007/s10267-005-0236-x; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Green F, 2003, INT BIODETER BIODEGR, V51, P145, DOI 10.1016/S0964-8305(02)00099-9; HARMON ME, 1986, ADV ECOL RES, V15, P133, DOI 10.1016/S0065-2504(08)60121-X; Heilmann-Clausen J, 2014, J BIOGEOGR, V41, P2269, DOI 10.1111/jbi.12388; Imazeki R., 1989, COLORED ILLUSTRATION, VII; Jongman R.H.G., 1995, DATA ANAL COMMUNITY; Liyanage G. W., 1977, Journal of the Rubber Research Institute of Sri Lanka, V54, P363; Mamiya Y., 1988, NEMATOLOGY, V20, P219; Nishioka M., 1978, LITTERFALL JIBP SYNT, P231; Osono T., 2014, METAGENOMIC APPROACH, P1; Ottosson E., 2015, FEMS MICROBIOL ECOL, V91, P1; Ovaskainen O, 2010, FUNGAL ECOL, V3, P274, DOI 10.1016/j.funeco.2010.01.001; R Development Core Team, 2014, R LANG ENV STAT COMP; Schmidt O., 2006, WOOD AND TREE FUNGI; Sommer DD, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-64; Stokland JN, 2012, ECOL BIODIVERS CONS, P1, DOI 10.1017/CBO9781139025843; Tanabe AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076910; Tanabe A.S., 2013, CLAIDENT V0 1 2013 0; Tedersoo L., 2014, SCIENCE, V346; Ter Braak CJF, 2002, CANOCO REFERENCE MAN; Tokumasu Seiji, 2001, Mycoscience, V42, P575, DOI 10.1007/BF02460957; VILGALYS R, 1990, J BACTERIOL, V172, P4238; WHITE TJ, 1990, AMPLIFICATION DIRECT, P315, DOI DOI 10.1002/MRD.1080280418	58	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1754-5048	1878-0083		FUNGAL ECOL	Fungal Ecol.	DEC	2015	18						75	82		10.1016/j.funeco.2015.09.008		8	Ecology; Mycology	Environmental Sciences & Ecology; Mycology	CX9ZE	WOS:000366064500009		
J	Tanaka, M; Shintani, T; Gomi, K				Tanaka, Mizuki; Shintani, Takahiro; Gomi, Katsuya			Unfolded protein response is required for Aspergillus oryzae growth under conditions inducing secretory hydrolytic enzyme production	FUNGAL GENETICS AND BIOLOGY			English	Article						Unfolded protein response; IreA; HacA; Endoplasmic reticulum stress; Hydrolytic enzyme production	ENDOPLASMIC-RETICULUM STRESS; FILAMENTOUS FUNGI; TRANSCRIPTIONAL ACTIVATOR; NEUROSPORA-CRASSA; MESSENGER-RNAS; GENE; TRANSFORMATION; DECAY; AMYR	Unfolded protein response (UPR) is an intracellular signaling pathway for adaptation to endoplasmic reticulum (ER) stress. In yeast UPR, Ire1 cleaves the unconventional intron of HAC1 mRNA, and the functional Had protein translated from the spliced HAC1 mRNA induces the expression of ER chaperone genes and ER-associated degradation genes for the refolding or degradation of unfolded proteins. In this study, we constructed an ireA (IRE1 ortholog) conditionally expressing strain of Aspergillus oryzae, a filamentous fungus producing a large amount of amylolytic enzymes, and examined the contribution of UPR to ER stress adaptation under physiological conditions. Repression of ireA completely blocked A. oryzae growth under conditions inducing the production of hydrolytic enzymes, such as amylases and proteases. This growth defect was restored by the introduction of unconventional intronless hacA (hacA-i). Furthermore, UPR was observed to be induced by amylolytic gene expression, and the disruption of the transcriptional activator for amylolytic genes resulted in partial growth restoration of the ireA-repressing strain. In addition, a homokaryotic ireA disruption mutant was successfully generated using the strain harboring hacA-i as a parental host. These results indicated that UPR is required for A. oryzae growth to alleviate ER stress induced by excessive production of hydrolytic enzymes. (C) 2015 Elsevier Inc. All rights reserved.	[Tanaka, Mizuki; Shintani, Takahiro; Gomi, Katsuya] Tohoku Univ, Grad Sch Agr Sci, Dept Bioind Informat & Genom, Lab Bioind Genom,Aoba Ku, Sendai, Miyagi 9818555, Japan	Gomi, K (reprint author), Tohoku Univ, Grad Sch Agr Sci, Dept Bioind Informat & Genom, Lab Bioind Genom,Aoba Ku, 1-1 Tsutsumidori Amamiyamachi, Sendai, Miyagi 9818555, Japan.	gomi@biochem.tohoku.ac.jp			JSPS KAKENHI [17019001]; Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry; Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries, and Food Industry	We thank Osamu Mizutani for kindly providing the Delta ligD::loxP pyrG<SUP>-</SUP> mutant strain and Tomoko Shintani for technical assistance. This work was supported in part by JSPS KAKENHI (Grant no. 17019001), Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry, and Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries, and Food Industry.	Machida M, 2008, DNA RES, V15, P173, DOI 10.1093/dnares/dsn020; Yamada O, 1997, BIOSCI BIOTECH BIOCH, V61, P1367; Gomi K, 2000, BIOSCI BIOTECH BIOCH, V64, P816, DOI 10.1271/bbb.64.816; Joubert A, 2011, MOL MICROBIOL, V79, P1305, DOI 10.1111/j.1365-2958.2010.07522.x; Hollien J, 2009, J CELL BIOL, V186, P323, DOI 10.1083/jcb.200903014; Petersen KL, 1999, MOL GEN GENET, V262, P668, DOI 10.1007/s004380051129; Mizutani O, 2012, APPL ENVIRON MICROB, V78, P4126, DOI 10.1128/AEM.00080-12; Ichinose S, 2014, APPL MICROBIOL BIOT, V98, P335, DOI 10.1007/s00253-013-5353-4; Mulder HJ, 2009, EUKARYOT CELL, V8, P665, DOI 10.1128/EC.00131-08; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Tanaka M, 2012, APPL MICROBIOL BIOT, V96, P1275, DOI 10.1007/s00253-012-4169-y; Suzuki K, 2015, APPL MICROBIOL BIOT, V99, P1805, DOI 10.1007/s00253-014-6264-8; Mulder HJ, 2004, MOL GENET GENOMICS, V271, P130, DOI 10.1007/s00438-003-0965-5; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Saloheimo M, 2003, MOL MICROBIOL, V47, P1149, DOI 10.1046/j.1365-2958.2003.03363.x; Hiramoto T, 2015, FUNGAL GENET BIOL, V82, P136, DOI 10.1016/j.fgb.2015.05.015; Ohno A, 2011, APPL MICROBIOL BIOT, V92, P1197, DOI 10.1007/s00253-011-3487-9; GOMI K, 1987, AGR BIOL CHEM TOKYO, V51, P2549; Hasegawa S, 2010, FUNGAL GENET BIOL, V47, P1, DOI 10.1016/j.fgb.2009.10.005; Carvalho NDSP, 2010, APPL MICROBIOL BIOT, V87, P1463, DOI 10.1007/s00253-010-2588-1; Mori K, 2009, J BIOCHEM, V146, P743, DOI 10.1093/jb/mvp166; Maurel M, 2014, TRENDS BIOCHEM SCI, V39, P245, DOI 10.1016/j.tibs.2014.02.008; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Oda K, 2006, APPL ENVIRON MICROB, V72, P3448, DOI 10.1128/AEM.72.5.3448-3457.2006; Benz JP, 2014, MOL MICROBIOL, V91, P275, DOI 10.1111/mmi.12459; Fan FY, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0248-5; Feng XZ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002330; Gardner BM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013169; Heimel K, 2015, APPL MICROBIOL BIOT, V99, P121, DOI 10.1007/s00253-014-6192-7; Kimmig P, 2012, ELIFE, V1, DOI 10.7554/eLife.00048; Montenegro-Montero A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131415; Noguchi Y., 2009, APPL MICROBIOL BIOT, V85, P2236; Tam AB, 2014, CELL REP, V9, P850, DOI 10.1016/j.celrep.2014.09.016	33	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1087-1845	1096-0937		FUNGAL GENET BIOL	Fungal Genet. Biol.	DEC	2015	85						1	6		10.1016/j.fgb.2015.10.003		6	Genetics & Heredity; Mycology	Genetics & Heredity; Mycology	CY0AM	WOS:000366068300001		
J	Kobayashi, S; Saito, Y; Osawa, A; Katsumata, E; Karaki, I; Nagaoka, K; Taya, K; Watanabe, G				Kobayashi, Shohei; Saito, Yoshimichi; Osawa, Akihisa; Katsumata, Etsuko; Karaki, Isuke; Nagaoka, Kentaro; Taya, Kazuyoshi; Watanabe, Gen			Embryonic sex steroid hormones accumulate in the eggshell of loggerhead sea turtle (Caretta caretta)	GENERAL AND COMPARATIVE ENDOCRINOLOGY			English	Article						Estradiol-17 beta; Testosterone; Eggshell; Accumulation; Loggerhead sea turtle; Sex identification	HATCHLING PRODUCTION; NEST TEMPERATURES; TRACHEMYS-SCRIPTA; CHELONIA-MYDAS; CLIMATE-CHANGE; HAIR CORTISOL; TERM STRESS; FEMALE BIAS; AROMATASE; RATIOS	Steroids hormones such as estradiol-17 beta (E2) and testosterone (T) are involved in gonadal differentiation of oviparous animals with temperature-dependent sex determination (TSD), and are greatly distributed. This hypothesizes that these embryonic steroid hormones probably accumulate in the eggshell throughout blood or/and chorioallantoic fluid in sea turtle species with TSD, producing females at higher temperature. To demonstrate this hypothesis, concentrations of E2 and T in the blood plasma from the hatchling loggerhead sea turtle (Caretta caretta) and in their eggshells were measured by radioimmunoassay. In the present study we propose that both concentrations of E2 and T in the blood plasma are correlated with amounts of these sex steroids in the eggshell. Moreover, contents of E2 in the eggshell showed a significant positive correlation with mean incubation temperatures during a thermosensitive period in the experimental nests, whereas T contents in the eggshell did not. Taken together, these findings indicated that embryonic E2 and T that accumulated in the eggshell can be extracted and measured. Furthermore, the present study suggested that contents of E2 in the eggshell may differ between male and female, and monitoring of these steroids is a useful method to identify the sex of loggerhead sea turtle hatchling. (C) 2015 Elsevier Inc. All rights reserved.	[Kobayashi, Shohei] Tokyo Univ Agr & Technol, United Grad Sch Agr Sci, Dept Biol Prod Sci, Tokyo 1838509, Japan; [Saito, Yoshimichi; Osawa, Akihisa; Katsumata, Etsuko; Taya, Kazuyoshi] Kamogawa Sea World, Chiba 2960041, Japan; [Karaki, Isuke] Seiko Epson Corp, Nagano 3928502, Japan; [Nagaoka, Kentaro; Taya, Kazuyoshi; Watanabe, Gen] Tokyo Univ Agr & Technol, Inst Agr, Vet Physiol Lab, Fuchu, Tokyo 1830054, Japan	Watanabe, G (reprint author), Tokyo Univ Agr & Technol, Inst Agr, Vet Physiol Lab, 3-5-8 Saiwai Cho, Fuchu, Tokyo 1830054, Japan.	gen@cc.tuat.ac.jp			Sasakawa Scientific Research Grant from The Japan Science Society [26-430]	We are grateful to Dr. G.D. Niswender, Animal Reproduction and Biotechnology Laboratory, Colorado State University (Fort Collins, CO, USA) for providing antiserum to estradiol-17 beta (GDN244) and testosterone (GDN250). We gratefully acknowledge Kamogawa Sea World staffs for collecting the samples. We would also like to thank Dr. Katuhiko Arai, Department of Tissue Physiology, Tokyo University of Agriculture and Technology, for his valuable advise for discussion to prepare this manuscript. This study was partly supported by the Sasakawa Scientific Research Grant from The Japan Science Society (26-430).	Ackerman Ralph A., 1997, P83; Hawkes LA, 2007, GLOBAL CHANGE BIOL, V13, P923, DOI 10.1111/j.1365-2486.2007.01320.x; Cyr NE, 2008, GEN COMP ENDOCR, V158, P20, DOI 10.1016/j.ygcen.2008.05.001; WALKER LA, 1988, BIOL REPROD, V39, P1013, DOI 10.1095/biolreprod39.5.1013; MerchantLarios H, 1997, GEN COMP ENDOCR, V107, P373, DOI 10.1006/gcen.1997.6946; Laloe JO, 2014, NAT CLIM CHANGE, V4, P513, DOI 10.1038/NCLIMATE2236; YNTEMA CL, 1980, HERPETOLOGICA, V36, P33; West KL, 2000, GEN COMP ENDOCR, V117, P218, DOI 10.1006/gcen.2000.7404; Ramsey M, 2009, SEMIN CELL DEV BIOL, V20, P283, DOI 10.1016/j.semcdb.2008.10.004; Macbeth BJ, 2010, CAN J ZOOL, V88, P935, DOI 10.1139/Z10-057; Germano JM, 2009, THERIOGENOLOGY, V72, P663, DOI 10.1016/j.theriogenology.2009.04.023; Narayan EJ, 2011, GEN COMP ENDOCR, V173, P371, DOI 10.1016/j.ygcen.2011.06.015; Verkerk GA, 1998, ANIM WELFARE, V7, P77; King R, 2013, J EXP MAR BIOL ECOL, V445, P140, DOI 10.1016/j.jembe.2013.03.016; Kaska Y, 2006, NATURWISSENSCHAFTEN, V93, P338, DOI 10.1007/s00114-006-0110-5; Witt MJ, 2010, J EXP BIOL, V213, P901, DOI 10.1242/jeb.038133; DESVAGES G, 1993, GEN COMP ENDOCR, V92, P54, DOI 10.1006/gcen.1993.1142; Broderick AC, 2000, MAR ECOL PROG SER, V202, P273, DOI 10.3354/meps202273; Ramsey M, 2007, DIFFERENTIATION, V75, P978, DOI 10.1111/j.1432-0436.2007.00182.x; Marcovaldi MA, 1997, CAN J ZOOL, V75, P755, DOI 10.1139/z97-097; Ottinger MA, 2001, POULTRY SCI, V80, P795; Zbinden JA, 2006, J EXP MAR BIOL ECOL, V334, P151, DOI 10.1016/j.jembe.2006.01.021; Hirschenhauser K, 1999, GEN COMP ENDOCR, V114, P67, DOI 10.1006/gcen.1998.7236; GROSS TS, 1995, GEN COMP ENDOCR, V99, P204, DOI 10.1006/gcen.1995.1103; GAY VL, 1978, ARCH ANDROLOGY, V1, P257; Staufenbiel SM, 2013, PSYCHONEUROENDOCRINO, V38, P1220, DOI 10.1016/j.psyneuen.2012.11.015; Matsuzawa Y, 2002, MAR BIOL, V140, P639, DOI 10.1007/s00227-001-0724-2; Yang HZ, 1998, J STEROID BIOCHEM, V67, P447, DOI 10.1016/S0960-0760(98)00120-4; Godley BJ, 2001, J EXP MAR BIOL ECOL, V263, P45, DOI 10.1016/S0022-0981(01)00269-6; Zbinden Judith A., 2007, Endangered Species Research, V3, P305, DOI 10.3354/esr00058; Xia ZR, 2011, CHELONIAN CONSERV BI, V10, P117; KORENMAN SG, 1974, J CLIN ENDOCR METAB, V38, P718; CREWS D, 1994, J ENDOCRINOL, V143, P279, DOI 10.1677/joe.0.1430279; Hanson J, 1998, CAN J ZOOL, V76, P1850, DOI 10.1139/cjz-76-10-1850; CZEKALA NM, 1994, ZOO BIOL, V13, P119, DOI 10.1002/zoo.1430130204; Magiakou MA, 1997, ANN NY ACAD SCI, V816, P42, DOI 10.1111/j.1749-6632.1997.tb52128.x; Chu CT, 2008, AUST J ZOOL, V56, P57, DOI 10.1071/ZO08004; Li CW, 2001, HORM BEHAV, V40, P518, DOI 10.1006/hbeh.2001.1711; Banu TA, 2012, ACTA VET SCAND, V54, DOI 10.1186/1751-0147-54-30; Matsuzawa Y., 1998, THESIS; Merchant-Larios H., 1999, IUCN SSC MARINE TURT, V4, P130; Miller J.D., 1985, Biology of Reptilia, V14, P269; Miller Jeffrey D., 1997, P51; Nazeri S., 2014, Comparative Clinical Pathology, V23, P631, DOI 10.1007/s00580-012-1662-8; Taya K, 1985, JAPANESE J ANIMAL RE, V31, P186; Terwissen C.V., 2014, CONSERV PHYSL, V2; Viau V, 2002, J NEUROENDOCRINOL, V14, P506, DOI 10.1046/j.1365-2826.2002.00798.x; WIBBELS T, 1994, J ENDOCRINOL, V141, P295, DOI 10.1677/joe.0.1410295	48	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0016-6480	1095-6840		GEN COMP ENDOCR	Gen. Comp. Endocrinol.	DEC 1	2015	224						11	17		10.1016/j.ygcen.2015.05.013		7	Endocrinology & Metabolism	Endocrinology & Metabolism	CY5HJ	WOS:000366438400002		
J	Toyoda, F; Hasunuma, I; Nakada, T; Haraguchi, S; Tsutsui, K; Kikuyama, S				Toyoda, Fumiyo; Hasunuma, Itaru; Nakada, Tomoaki; Haraguchi, Shogo; Tsutsui, Kazuyoshi; Kikuyama, Sakae			Possible hormonal interaction for eliciting courtship behavior in the male newt, Cynops pyrrhogaster	GENERAL AND COMPARATIVE ENDOCRINOLOGY			English	Article						Newt; Courtship behavior; Hormones	ARGININE VASOTOCIN RECEPTORS; LOCOMOTOR-ACTIVITY; SEXUAL-DIMORPHISM; XENOPUS-LAEVIS; MESSENGER-RNA; BRAIN; PROLACTIN; TESTOSTERONE; NEURONS; LOCALIZATION	Reproductive behavior in amphibians, as in other vertebrate animals, is under the control of multiple hormonal substances. Prolactin (PRL), arginine vasotocin (AVT), androgen, and 7 alpha-hydroxypregnenolone (7 alpha-OH PREG), four such substances with hormonal activity, are known to be involved in the expression of the tail vibration behavior which is the initial step of courtship performed by the male newt, Cynops pyrrhogaster. As current information on the interaction(s) between these hormones in terms of eliciting tail vibration behavior is limited, we have investigated whether the decline of expression of tail vibration behavior due to suppression of the activity of any one of these hormones can be restored by supplying any one of the other three hormones exogenously. Expression of the behavior was determined in terms of incidence (% of test animals exhibiting the behavior) and frequency (number of times that the behavior was repeated during the test period). Neither PRL nor androgen restored the decline in the incidence and frequency of the tail vibration behavior caused by the suppression of the activity of any one of other three hormones. AVT completely restored both the anti-PRL antibody-induced and flutamide (an androgen receptor antagonist)-induced, but not ketoconazole (an inhibitor of the steroidogenic CYP enzymes)-induced decline in the incidence and frequency of the tail vibration behavior. The neurosteroid, 7 alpha-OH PREG, failed to restore flutamide-induced decline in the incidence and frequency of the behavior. However, it was able to restore both anti-PRL antibody-induced and AVT receptor antagonist-induced decline in the incidence, but not in the frequency of the behavior. In another experiment designed to see the activity of hormones enhancing the frequency of the tail vibration behavior, AVT was revealed to be more potent than 7 alpha-OH PREG. The role of each hormonal substance in determining the expression of the tail vibration behavior was discussed based on the results. (C) 2015 Elsevier Inc. All rights reserved.	[Toyoda, Fumiyo] Nara Med Univ, Dept Neurophysiol, Nara 6348521, Japan; [Hasunuma, Itaru; Kikuyama, Sakae] Toho Univ, Dept Biol, Fac Sci, Chiba 2748510, Japan; [Nakada, Tomoaki] Nippon Vet & Life Sci Univ, Dept Comparat & Behav Med, Tokyo 1808602, Japan; [Haraguchi, Shogo; Tsutsui, Kazuyoshi; Kikuyama, Sakae] Waseda Univ, Dept Biol, Tokyo 1628480, Japan; [Haraguchi, Shogo; Tsutsui, Kazuyoshi; Kikuyama, Sakae] Waseda Univ, Ctr Med Life Sci, Tokyo 1628480, Japan	Toyoda, F (reprint author), Nara Med Univ, Dept Neurophysiol, Shijo Chou 840, Kashihara, Nara 6348521, Japan.	tfumiyo@naramed-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [18570063, 19570061]	This study was supported by research grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan to S.K. (18570063), F.T. (19570061).	Do-Rego JL, 2006, J NEUROSCI, V26, P6749, DOI 10.1523/JNEUROSCI.4469-05.2006; Perrins R, 2002, J NEUROSCI, V22, P4229; NAKAHIRO M, 1992, NEUROSCI LETT, V138, P5, DOI 10.1016/0304-3940(92)90459-K; ZOELLER RT, 1982, HORM BEHAV, V16, P23, DOI 10.1016/0018-506X(82)90003-4; Kabelik D, 2008, BRAIN BEHAV EVOLUT, V72, P283, DOI 10.1159/000174248; Toyoda F, 2003, HORM BEHAV, V44, P346, DOI 10.1016/S0018-506X(03)00156-9; KELLEY DB, 1975, J COMP NEUROL, V164, P47, DOI 10.1002/cne.901640105; Haraguchi S, 2010, ENDOCRINOLOGY, V151, P2211, DOI 10.1210/en.2009-1229; TOYODA F, 1993, HORM BEHAV, V27, P511, DOI 10.1006/hbeh.1993.1037; Rose JD, 2002, FRONT NEUROENDOCRIN, V23, P317, DOI 10.1016/S0091-3022(02)00004-3; Kikuyama S, 2003, REPROD BIOL PHYLOGEN, V1, P275; Panzica G, 1999, BRAIN RES, V850, P55, DOI 10.1016/S0006-8993(99)02098-3; Mejia S, 2003, ENDOCRINE, V20, P155, DOI 10.1385/ENDO:20:1-2:155; MALACARNE G, 1980, MONIT ZOOL ITAL, V14, P9; ROSE JD, 1995, NEUROENDOCRINOLOGY, V62, P406, DOI 10.1159/000127030; Toyoda F, 2005, GEN COMP ENDOCR, V141, P172, DOI 10.1016/j.ygcen.2004.12.015; MOORE FL, 1979, HORM BEHAV, V13, P207, DOI 10.1016/0018-506X(79)90038-2; Moore FL, 2005, HORM BEHAV, V48, P373, DOI 10.1016/j.yhbeh.2005.05.011; Hasunuma I, 2013, INT REV CEL MOL BIO, V304, P191, DOI 10.1016/B978-0-12-407696-9.00004-X; KIKUYAMA S, 1995, SCIENCE, V267, P1643, DOI 10.1126/science.7886452; Marler CA, 1999, HORM BEHAV, V36, P53, DOI 10.1006/hbeh.1999.1524; KAN PB, 1985, J STEROID BIOCHEM, V23, P1023, DOI 10.1016/0022-4731(85)90062-7; Lalonde-Robert V, 2012, J AM ASSOC LAB ANIM, V51, P464; EIL C, 1992, HORM METAB RES, V24, P367, DOI 10.1055/s-2007-1003337; Hasunuma I, 2010, CELL TISSUE RES, V342, P437, DOI 10.1007/s00441-010-1079-0; BOYD SK, 1994, CELL TISSUE RES, V276, P593; Toyoda F, 2000, ZOOL SCI, V17, P561, DOI 10.2108/zsj.15.561; Moore FL, 2000, GEN COMP ENDOCR, V117, P281, DOI 10.1006/gcen.1999.7424; Goodson JL, 2001, BRAIN RES REV, V35, P246, DOI 10.1016/S0165-0173(01)00043-1; Thompson RR, 2000, HORM BEHAV, V38, P75, DOI 10.1006/hbeh.2000.1610; Hasunuma I, 2005, CELL TISSUE RES, V320, P477, DOI 10.1007/s00441-004-1041-0; BOYD SK, 1992, J COMP NEUROL, V325, P313, DOI 10.1002/cne.903250213; Aste N, 2013, J NEUROENDOCRINOL, V25, P811, DOI 10.1111/jne.12076; Panzica GC, 2001, BRAIN RES REV, V37, P178, DOI 10.1016/S0165-0173(01)00118-7; Matsunaga M, 2004, P NATL ACAD SCI USA, V101, P17282, DOI 10.1073/pnas.0407176101; Toyoda F, 1996, GEN COMP ENDOCR, V102, P191, DOI 10.1006/gcen.1996.0060; WADA M, 1977, HORM BEHAV, V8, P310, DOI 10.1016/0018-506X(77)90005-8; Hillsman D., 2007, SEX DEV, V1, P77; Kikuyama S., 1980, GUNMA S ENDOCRINOL, V17, P3; Korn H., 1990, HDB CHEM NEUROANATOM, P403; Moore F.L., 2002, HORMONES BRAIN BEHAV, P515; Ramlochansingh C., 2014, PLOS ONE, V9, P1; Salthe S.N., 1974, PHYSL AMPHIBIA, P329; SARKAR DK, 1988, NEUROENDOCRINOLOGY, V48, P214, DOI 10.1159/000125012; Siegel S, 1956, NONPARAMETRIC STAT B; Toyoda F., 2012, HORM BEHAV, V61, P375; Vega C., 2010, AM J PHYSIOL-REG I, V299, P1701	47	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0016-6480	1095-6840		GEN COMP ENDOCR	Gen. Comp. Endocrinol.	DEC 1	2015	224						96	103		10.1016/j.ygcen.2015.06.016		8	Endocrinology & Metabolism	Endocrinology & Metabolism	CY5HJ	WOS:000366438400008		
J	Yamaguchi, Y; Takagi, W; Kuraku, S; Moriyama, S; Bell, JD; Seale, AP; Lerner, DT; Grau, EG; Hyodo, S				Yamaguchi, Yoko; Takagi, Wataru; Kuraku, Shigehiro; Moriyama, Shunsuke; Bell, Justin D.; Seale, Andre P.; Lerner, Darren T.; Grau, E. Gordon; Hyodo, Susumu			Discovery of conventional prolactin from the holocephalan elephant fish, Callorhinchus milii	GENERAL AND COMPARATIVE ENDOCRINOLOGY			English	Article						Prolactin; GH/PRL family; Cartilaginous fish; Molecular evolution	GROWTH-HORMONE; EURYHALINE ELASMOBRANCHS; OREOCHROMIS-MOSSAMBICUS; ENVIRONMENTAL SALINITY; SIGNAL-TRANSDUCTION; FRESH-WATER; PITUITARY; RECEPTOR; SOMATOLACTIN; TILAPIA	The conventional prolactin (PRL), also known as PRL1, is an adenohypophysial hormone that critically regulates various physiological events in reproduction, metabolism, growth, osmoregulation, among others. PRL1 shares its evolutionary origin with PRL2, growth hormone (GH), somatolactin and placental lactogen, which together form the GH/PRL hormone family. Previously, several bioassays implied the existence of PRL1 in elasmobranch pituitaries. However, to date, all attempts to isolate PRL1 from chondrichthyans have been unsuccessful. Here, we cloned PRLI from the pituitary of the holocephalan elephant fish, Callorhinchus milii, as the first report of chondrichthyan PRL1. The putative mature protein of elephant fish PRL1 (cmPRL1) consists of 198 amino acids, containing two conserved disulfide bonds. The orthologous relationship of cmPRL1 to known vertebrate PRL1s was confirmed by the analyses of molecular phylogeny and gene synteny. The cmPRL1 gene was similar to teleost PRL1 genes in gene synteny, but was distinct from amniote PRL1 genes, which most likely arose in an early amphibian by duplication of the ancestral PRL1 gene. The mRNA of cmPRL1 was predominantly expressed in the pituitary, but was considerably less abundant than has been previously reported for bony fish and tetrapod PRL1s; the copy number of cmPRL1 mRNA in the pituitary was less than 1% and 0.1% of that of GH and pro-opiomelanocortin mRNAs, respectively. The cells expressing cmPRL1 mRNA were sparsely distributed in the rostral pars distalis. Our findings provide a new insight into the studies on molecular and functional evolution of PRL1 in vertebrates. (C) 2015 Elsevier Inc. All rights reserved.	[Yamaguchi, Yoko; Seale, Andre P.; Lerner, Darren T.; Grau, E. Gordon] Univ Hawaii, Hawaii Inst Marine Biol, Kaneohe, HI 96744 USA; [Takagi, Wataru; Hyodo, Susumu] Univ Tokyo, Atmosphere & Ocean Res Inst, Physiol Lab, Kashiwa, Chiba 2778564, Japan; [Kuraku, Shigehiro] RIKEN, Ctr Life Sci Technol, Phyloinformat Unit, Kobe, Hyogo 6500047, Japan; [Moriyama, Shunsuke] Kitasato Univ, Sch Marine Biosci, Sagamihara, Kanagawa 2520373, Japan; [Bell, Justin D.] Univ Tasmania, Inst Marine & Antarctic Studies, Taroona, Tas 7053, Australia; [Lerner, Darren T.; Grau, E. Gordon] Univ Hawaii Manoa, Sea Grant Coll Program, Honolulu, HI 96822 USA	Yamaguchi, Y (reprint author), Univ Hawaii, Hawaii Inst Marine Biol, Kaneohe, HI 96744 USA.	yoko7@hawaii.edu; wtakagi@aori.u-tokyo.ac.jp; shigehiro.kuraku@riken.jp; morisuke@kitasato-u.ac.jp; Justin.Bell@utas.edu.au; seale@hawaii.edu; lerner@hawaii.edu; grau@hawaii.edu; hyodo@aori.u-tokyo.ac.jp			Japan Society for the Promotion of Science [10034011-000062, 13039901-000237, 26291065, 26650110]; National Science Foundation [IOS-1119693]; National Oceanic and Atmospheric Administration - University of Hawai'i Sea Grant College Program, SOEST [NA14OAR4170071, R/SS-12]	This study was supported by Grant-in-Aid for Scientific Research (B) (Grant No. 26291065) and for Challenging Exploratory Research (Grant No. 26650110), and a Japan-Australia Research Cooperative Program (Reference Nos. 10034011-000062 and 13039901-000237) from the Japan Society for the Promotion of Science to S.H. This work was also funded by Grants from the National Science Foundation (IOS-1119693) to E.G.G. and D.T.L, and National Oceanic and Atmospheric Administration (NA14OAR4170071) which is sponsored by the University of Hawai'i Sea Grant College Program, SOEST (Project R/SS-12) to A.P.S.	ONO M, 1990, P NATL ACAD SCI USA, V87, P4330, DOI 10.1073/pnas.87.11.4330; Whittington CM, 2013, GEN COMP ENDOCR, V191, P123, DOI 10.1016/j.ygcen.2013.05.027; Kawauchi H, 2006, GEN COMP ENDOCR, V148, P3, DOI 10.1016/j.ygcen.2005.10.011; Kakumura K, 2009, COMP BIOCHEM PHYS B, V154, P239, DOI 10.1016/j.cbpb.2009.06.009; Kuraku S, 2013, NUCLEIC ACIDS RES, V41, pW22, DOI 10.1093/nar/gkt389; WOURMS JP, 1977, AM ZOOL, V17, P379; PolzonettiMagni A, 1995, ZOOL SCI, V12, P683, DOI 10.2108/zsj.12.683; HORSEMAN ND, 1995, ANNU REV NUTR, V15, P213; Schenck EJH, 2003, MOL CELL ENDOCRINOL, V204, P117, DOI 10.1016/S0303-7207(03)00123-0; Awruch CA, 2013, GEN COMP ENDOCR, V192, P60, DOI 10.1016/j.ygcen.2013.05.021; Takagi W, 2014, J EXP BIOL, V217, P1353, DOI 10.1242/jeb.094649; Kawauchi H, 2002, ENDOCRINOLOGY, V143, P4916, DOI 10.1210/en.2002-220810; CUNNINGHAM BC, 1990, SCIENCE, V250, P1709, DOI 10.1126/science.2270485; Hyodo S, 2007, J EXP BIOL, V210, P1303, DOI 10.1242/jeb.003418; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Goffin V, 1996, ENDOCR REV, V17, P385, DOI 10.1210/er.17.4.385; Yamaguchi Y, 2012, GEN COMP ENDOCR, V178, P519, DOI 10.1016/j.ygcen.2012.07.008; NOSO T, 1993, GEN COMP ENDOCR, V91, P90, DOI 10.1006/gcen.1993.1108; DORES RM, 1993, GEN COMP ENDOCR, V90, P346, DOI 10.1006/gcen.1993.1090; SOMERS W, 1994, NATURE, V372, P478, DOI 10.1038/372478a0; Near TJ, 2012, P NATL ACAD SCI USA, V109, P13698, DOI 10.1073/pnas.1206625109; Inoue JG, 2003, MOL PHYLOGENET EVOL, V26, P110, DOI 10.1016/S1055-7903(02)00331-7; RANDWEAVER M, 1991, BIOCHEMISTRY-US, V30, P1509, DOI 10.1021/bi00220a010; Bole-Feysot C, 1998, ENDOCR REV, V19, P225, DOI 10.1210/er.19.3.225; NICOLL CS, 1981, GEN COMP ENDOCR, V44, P365, DOI 10.1016/0016-6480(81)90014-9; Kopchick JJ, 2000, MOL GENET METAB, V71, P293, DOI 10.1006/mgme.2000.3068; Breves JP, 2014, GEN COMP ENDOCR, V203, P21, DOI 10.1016/j.ygcen.2013.12.014; PICKFORD GE, 1959, SCIENCE, V130, P454, DOI 10.1126/science.130.3373.454; Takabe S, 2012, CELL TISSUE RES, V348, P141, DOI 10.1007/s00441-012-1344-5; Freeman ME, 2000, PHYSIOL REV, V80, P1523; Amemiya Y, 1999, GEN COMP ENDOCR, V114, P181, DOI 10.1006/gcen.1998.7250; Shepherd BS, 1997, P NATL ACAD SCI USA, V94, P2068, DOI 10.1073/pnas.94.5.2068; CARNEVALI O, 1993, J ENDOCRINOL, V137, P383, DOI 10.1677/joe.0.1370383; Riddle O, 1933, AM J PHYSIOL, V105, P191; SINHA YN, 1995, ENDOCR REV, V16, P354, DOI 10.1210/er.16.3.354; Venkatesh B, 2014, NATURE, V505, P174, DOI 10.1038/nature12826; Manzon LA, 2002, GEN COMP ENDOCR, V125, P291, DOI 10.1006/gcen.2001.7746; Ballantyne JS, 2013, FISH PHYSIOL, V32, P125, DOI 10.1016/B978-0-12-396951-4.00004-9; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Martin RA, 2005, J MAR BIOL ASSOC UK, V85, P1049, DOI 10.1017/S0025315405012105; Magdeldin S, 2007, FISHERIES SCI, V73, P1025, DOI 10.1111/j.1444-2906.2007.01432.x; Ball J.N., 1969, FISH PHYSIOL, V2, P1; Bern H A, 1968, Recent Prog Horm Res, V24, P681; COMPAGNO LJV, 1990, ENVIRON BIOL FISH, V28, P33, DOI 10.1007/BF00751027; de Viaming V.L., 1975, COMP BIOCH PHYSL A, V52, P505; DHARMAMB.M, 1968, GEN COMP ENDOCR, V10, P409, DOI 10.1016/0016-6480(68)90051-8; Hirano T., 1986, COMP ENDOCRINOLOGY D, P53; Holmes R.L., 1974, PITUITARY GLAND COMP; Huang XG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006163; Kanda S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062776; Kikugawa K, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-3; Nelson J. S., 2006, FISHES WORLD; Nussey S.S., 2001, ENDOCRINOLOGY INTEGR; Rand-Weaver Mariann, 1993, Biochemistry and Molecular Biology of Fishes, V2, P39; Stricker P., 1928, COMPT REND SOC BIOL, V99, P1978; Takei Y., 2014, AM J PHYSIOL-REG I, V307, P778; Venkatesh B, 2007, PLOS BIOL, V5, P932, DOI 10.1371/journal.pbio.0050101	57	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0016-6480	1095-6840		GEN COMP ENDOCR	Gen. Comp. Endocrinol.	DEC 1	2015	224						216	227		10.1016/j.ygcen.2015.08.020		12	Endocrinology & Metabolism	Endocrinology & Metabolism	CY5HJ	WOS:000366438400021		
J	Fujiwara, M; Hino, T; Miyamoto, R; Inada, H; Mori, I; Koga, M; Miyahara, K; Ohshima, Y; Ishihara, T				Fujiwara, Manabi; Hino, Takahiro; Miyamoto, Ryuta; Inada, Hitoshi; Mori, Ikue; Koga, Makoto; Miyahara, Koji; Ohshima, Yasumi; Ishihara, Takeshi			The Importance of cGMP Signaling in Sensory Cilia for Body Size Regulation in Caenorhabditis elegans	GENETICS			English	Article						body size; Caenorhabditis elegans; guanylyl cyclase; cGMP-dependent protein kinase; sensory cilia	DEPENDENT PROTEIN-KINASE; NUCLEOTIDE-GATED CHANNEL; C-ELEGANS; GUANYLYL CYCLASES; CHEMOSENSORY RECEPTORS; LIFE-SPAN; NEURONS; EGL-4; EXPRESSION; MUTATIONS	The body size of Caenorhabditis elegans is thought to be controlled by sensory inputs because many mutants with sensory cilium structure defects exhibit small body size. The EGL-4 cGMP-dependent protein kinase acts in sensory neurons to reduce body size when animals fail to perceive sensory signals. In addition to body size control, EGL-4 regulates various other behavioral and developmental pathways, including those involved in the regulation of egg laying and chemotaxis behavior. Here we have identified gcy-12, which encodes a receptor-type guanylyl cyclase, as a gene involved in the sensory regulation of body size. Analyses with GFP fusion constructs showed that gcy-12 is expressed in several sensory neurons and localizes to sensory cilia. Genetic analyses indicated that GCY-12 acts upstream of EGL-4 in body size control but does not affect other EGL-4 functions. Our studies indicate that the function of the GCY-12 guanylyl cyclase is to provide cGMP to the EGL-4 cGMP-dependent kinase only for limited tasks including body size regulation. We also found that the PDE-2 cyclic nucleotide phosphodiesterase negatively regulates EGL-4 in controlling body size. Thus, the cGMP level is precisely controlled by GCY-12 and PDE-2 to determine body size through EGL-4, and the defects in the sensory cilium structure may disturb the balanced control of the cGMP level. The large number of guanylyl cyclases encoded in the C. elegans genome suggests that EGL-4 exerts pleiotropic effects by partnering with different guanylyl cyclases for different downstream functions.	[Fujiwara, Manabi; Hino, Takahiro; Miyamoto, Ryuta; Koga, Makoto; Ohshima, Yasumi; Ishihara, Takeshi] Kyushu Univ, Dept Biol, Grad Sch Sci, Fukuoka 8190395, Japan; [Inada, Hitoshi] Tohoku Univ, Grad Sch Med, Dept Dev Neurosci, Sendai, Miyagi 9808575, Japan; [Mori, Ikue] Nagoya Univ, Sch Sci, Dept Biol Sci, Nagoya, Aichi 4648602, Japan; [Miyahara, Koji] Sojo Univ, Fac Biotechnol & Life Sci, Dept Appl Life Sci, Kumamoto 8600082, Japan	Fujiwara, M (reprint author), Kyushu Univ, Dept Biol, Grad Sch Sci, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan.	fujiwara.manabi.734@m.kyushu-u.ac.jp			PRESTO, Japan Science and Technology Corporation;  [23570007];  [15770002];  [25115009];  [20115003]	We thank the C. elegans Genetics Center for worm strains, the Sanger Center for cosmids clones, Andy Fire for the various vectors, and Yuji Kohara for the cDNA clones. We also thank Isao Katsura for comments on the manuscript. This work was supported by Grants-in-Aid for Scientific Research (C) (23570007 to M.F.) and for Young Scientists (B) (15770002 to M.F.) and for Scientific Research on Innovative Areas "Memory dynamism" (25115009 to T.I.), "Molecular Ethology"(20115003 to T.I.), and "Comprehensive Brain Science Network" and PRESTO, Japan Science and Technology Corporation (to M.K.).	TRENT C, 1983, GENETICS, V104, P619; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; Murayama T, 2013, CURR BIOL, V23, P1007, DOI 10.1016/j.cub.2013.04.052; Kuhara A, 2002, NEURON, V33, P751, DOI 10.1016/S0896-6273(02)00607-4; Raizen DM, 2006, GENETICS, V173, P177, DOI 10.1534/genetics.106.057380; Lanjuin A, 2002, NEURON, V33, P369, DOI 10.1016/S0896-6273(02)00572-X; Wang D, 2013, J GEN PHYSIOL, V142, P437, DOI 10.1085/jgp.201310959; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; L'Etoile ND, 2000, NEURON, V25, P575, DOI 10.1016/S0896-6273(00)81061-2; Stansberry J, 2001, J NEUROCHEM, V76, P1177, DOI 10.1046/j.1471-4159.2001.00131.x; Fujiwara M, 2002, NEURON, V36, P1091, DOI 10.1016/S0896-6273(02)01093-0; Apfeld J, 1999, NATURE, V402, P804, DOI 10.1038/45544; MELLO CC, 1991, EMBO J, V10, P3959; STARICH TA, 1995, GENETICS, V139, P171; Ortiz CO, 2009, CURR BIOL, V19, P996, DOI 10.1016/j.cub.2009.05.043; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878; Morton DB, 2004, MOL NEUROBIOL, V29, P97, DOI 10.1385/MN:29:2:097; You YJ, 2008, CELL METAB, V7, P249, DOI 10.1016/j.cmet.2008.01.005; Hirose T, 2003, DEVELOPMENT, V130, P1089, DOI 10.1242/dev.00330; Gengyo-Ando K, 2000, BIOCHEM BIOPH RES CO, V269, P64, DOI 10.1006/bbrc.2000.2260; Ortiz CO, 2006, GENETICS, V173, P131, DOI 10.1534/genetics.106.055749; Birnby DA, 2000, GENETICS, V155, P85; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; Mak HY, 2006, NAT GENET, V38, P363, DOI 10.1038/ng1739; Charlie NK, 2006, GENETICS, V173, P111, DOI 10.1534/genetics.105.054007; Omori K, 2007, CIRC RES, V100, P309, DOI 10.1161/01.RES.0000256354.95791.f1; Silverman MA, 2009, TRENDS CELL BIOL, V19, P306, DOI 10.1016/j.tcb.2009.04.002; van der Linden AM, 2008, GENETICS, V180, P1475, DOI 10.1534/genetics.108.094771; Troemel ER, 1999, CELL, V99, P387, DOI 10.1016/S0092-8674(00)81525-1; Juang BT, 2013, CELL, V154, P1010, DOI 10.1016/j.cell.2013.08.006; Fujiwara M, 1999, DEVELOPMENT, V126, P4839; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Couto A, 2013, P NATL ACAD SCI USA, V110, pE3301, DOI 10.1073/pnas.1217428110; Alcedo J, 2004, NEURON, V41, P45, DOI 10.1016/S0896-6273(03)00816-X; L'Etoile ND, 2002, NEURON, V36, P1079, DOI 10.1016/S0896-6273(02)01066-8; Raizen DM, 2008, NATURE, V451, P569, DOI 10.1038/nature06535; Yu S, 1997, P NATL ACAD SCI USA, V94, P3384, DOI 10.1073/pnas.94.7.3384; LEWIS JA, 1977, J COMP NEUROL, V172, P489, DOI 10.1002/cne.901720306; Inada H, 2006, GENETICS, V172, P2239, DOI 10.1534/genetics.105.050013; Daniels SA, 2000, GENETICS, V156, P123; BARGMANN CI, 1991, SCIENCE, V251, P1243, DOI 10.1126/science.2006412; Nakano Y, 2004, GENES CELLS, V9, P773, DOI 10.1111/j.1365-2443.2004.00771.x; BRENNER S, 1974, GENETICS, V77, P71; Hallem EA, 2011, P NATL ACAD SCI USA, V108, P254, DOI 10.1073/pnas.1017354108; Fujiwara M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001211; Gross E, 2014, J NEUROSCI, V34, P16726, DOI 10.1523/JNEUROSCI.5368-13.2014; Hao Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002065; Hunt-Newbury R, 2007, PLOS BIOL, V5, P1981, DOI 10.1371/journal.pbio.0050237; O'Halloran D. M., 2012, PLOS ONE, V7; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; Tain LS, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-28	51	0	0	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	DEC	2015	201	4					1497	+		10.1534/genetics.115.177543		20	Genetics & Heredity	Genetics & Heredity	CY4OC	WOS:000366386500017		
J	Ooka, T; Ogura, Y; Katsura, K; Seto, K; Kobayashi, H; Kawano, K; Tokuoka, E; Furukawa, M; Harada, S; Yoshino, S; Seto, J; Ikeda, T; Yamaguchi, K; Murase, K; Gotoh, Y; Imuta, N; Nishi, J; Gomes, TA; Beutin, L; Hayashi, T				Ooka, Tadasuke; Ogura, Yoshitoshi; Katsura, Keisuke; Seto, Kazuko; Kobayashi, Hideki; Kawano, Kimiko; Tokuoka, Eisuke; Furukawa, Masato; Harada, Seiya; Yoshino, Shuji; Seto, Junji; Ikeda, Tetsuya; Yamaguchi, Keiji; Murase, Kazunori; Gotoh, Yasuhiro; Imuta, Naoko; Nishi, Junichiro; Gomes, Tania A.; Beutin, Lothar; Hayashi, Tetsuya			Defining the Genome Features of Escherichia albertii, an Emerging Enteropathogen Closely Related to Escherichia coli	GENOME BIOLOGY AND EVOLUTION			English	Article						Escherichia albertii; emerging enteropathogen; core genome; genomic comparison; interspecies horizontal gene transfer; detection system	III SECRETION SYSTEM; EVOLUTIONARY; SEQUENCE; STRAINS; CLUSTER; REVEAL; O157	Escherichia albertii is a recently recognized close relative of Escherichia coli. This emerging enteropathogen possesses a type III secretion system (T3SS) encoded by the locus of enterocyte effacement, similar to enteropathogenic and enterohemorrhagic E. coli (EPEC and EHEC). Shiga toxin-producing strains have also been identified. The genomic features of E. albertii, particularly differences from other Escherichia species, have not yet been well clarified. Here, we sequenced the genome of 29 E. albertii strains (3 complete and 26 draft sequences) isolated from multiple sources and performed intraspecies and intragenus genomic comparisons. The sizes of the E. albertii genomes range from 4.5 to 5.1 Mb, smaller than those of E. coli strains. Intraspecies genomic comparisons identified five phylogroups of E. albertii. Intragenus genomic comparison revealed that the possible core genome of E. albertii comprises 3,250 genes, whereas that of the genus Escherichia comprises 1,345 genes. Our analysis further revealed several unique or notable genetic features of E. albertii, including those responsible for known biochemical features and virulence factors and a possibly active second T3SS known as ETT2 (E. coli T3SS2) that is inactivated in E. coli. Although this organism has been observed to be nonmotile in vitro, genes for flagellar biosynthesis are fully conserved; chemotaxis-related genes have been selectively deleted. Based on these results, we have developed a nested polymerase chain reaction system to directly detect E. albertii. Our data define the genomic features of E. albertii and provide a valuable basis for future studies of this important emerging enteropathogen.	[Ooka, Tadasuke; Imuta, Naoko; Nishi, Junichiro] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Microbiol, Kagoshima 890, Japan; [Ogura, Yoshitoshi; Hayashi, Tetsuya] Kyushu Univ, Fac Med Sci, Dept Bacteriol, Fukuoka 812, Japan; [Katsura, Keisuke; Murase, Kazunori; Gotoh, Yasuhiro] Miyazaki Univ, Fac Med, Dept Infect Dis, Div Microbiol, Miyazaki, Japan; [Seto, Kazuko] Osaka Prefectural Inst Publ Hlth, Div Bacteriol, Osaka 537, Japan; [Kobayashi, Hideki] Natl Inst Anim Hlth, Ctr Anim Dis Control & Prevent, Ibaraki, Japan; [Kawano, Kimiko; Yoshino, Shuji] Miyazaki Prefectural Inst Publ Hlth & Environm, Dept Microbiol, Miyazaki, Japan; [Tokuoka, Eisuke; Furukawa, Masato; Harada, Seiya] Kumamoto Prefectural Inst Publ Hlth & Environm Sc, Div Microbiol, Kumamoto, Japan; [Seto, Junji] Yamagata Prefectural Inst Publ Hlth, Dept Microbiol, Yamagata 9900031, Japan; [Ikeda, Tetsuya; Yamaguchi, Keiji] Hokkaido Inst Publ Hlth, Dept Infect Dis Bacteriol, Sapporo, Hokkaido, Japan; [Gomes, Tania A.] Univ Fed Sao Paulo, Escola Paulista Med, Dept Microbiol Imunol & Parasitol, Sao Paulo, Brazil; [Beutin, Lothar] BfR Fed Inst Risk Assessment, Natl Reference Lab Escherichia Coil, Berlin, Germany	Hayashi, T (reprint author), Kyushu Univ, Fac Med Sci, Dept Bacteriol, Fukuoka 812, Japan.	thayash@bact.med.kyushu-u.ac.jp			JSPS KAKENHI [23790480, 25460539, 20310116]; Ministry of Education, Culture, Sports, Science and Technology of Japan [221S0002]; Kurozumi Medical Foundation; Integrated Research Project for Human and Veterinary Medicine of the University of Miyazaki	Most of this work was conducted at the University of Miyazaki. The authors thank A. Yoshida, N. Kawano, N. Sakamoto, S. Yamamoto, Y. Inoue, H. Iguchi, and M. Shinbara for providing technical assistance. This work was supported by JSPS KAKENHI Grant Numbers [23790480, 25460539 to TO., and 20310116 to T.H.], a Grant-in-Aid for Scientific Research in Innovative Areas "Genome Science" from the Ministry of Education, Culture, Sports, Science and Technology of Japan [221S0002 to T.H.], a grant from Kurozumi Medical Foundation to T.O., and the Integrated Research Project for Human and Veterinary Medicine of the University of Miyazaki.	Smati M, 2015, MICROBIOLOGYOPEN, V4, P604, DOI 10.1002/mbo3.266; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Deng WY, 2010, J BIOL CHEM, V285, P6790, DOI 10.1074/jbc.M109.086603; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; Ogura Y, 2009, P NATL ACAD SCI USA, V106, P17939, DOI 10.1073/pnas.0903585106; Sharma V, 2014, NUCLEIC ACIDS RES, V42, P7210, DOI 10.1093/nar/gku386; Ren CP, 2004, J BACTERIOL, V186, P3547, DOI 10.1128/JB.186.11.3547-3560.2004; Oaks JL, 2010, EMERG INFECT DIS, V16, P638, DOI 10.3201/eid1604.090695; Nikaido M, 2013, GENOME RES, V23, P1740, DOI 10.1101/gr.158105.113; Huys G, 2003, INT J SYST EVOL MICR, V53, P807, DOI 10.1099/ijs.0.02475-0; Murakami K, 2014, JPN J INFECT DIS, V67, P204; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Lamark T, 1996, J BACTERIOL, V178, P1655; Gordon DM, 2013, ESCHERICHIA COLI: PATHOTYPES AND PRINCIPLES OF PATHOGENESIS, 2ND EDITION, P3, DOI 10.1016/B978-0-12-397048-0.00001-2; Darmon E, 2014, MICROBIOL MOL BIOL R, V78, P1, DOI 10.1128/MMBR.00035-13; Iguchi A, 2009, J BACTERIOL, V191, P347, DOI 10.1128/JB.01238-08; Ogura Y, 2008, J BACTERIOL, V190, P6948, DOI 10.1128/JB.00625-08; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Nimri LF, 2013, DIAGN MICR INFEC DIS, V77, P91, DOI 10.1016/j.diagmicrobio.2013.06.028; Tobe T, 2006, P NATL ACAD SCI USA, V103, P14941, DOI 10.1073/pnas.0604891103; Ooka T, 2013, EMERG INFECT DIS, V19, P144, DOI 10.3201/eid1901.120646; Hyma KE, 2005, J BACTERIOL, V187, P619, DOI 10.1128/JB.187.2.619-628.2005; Ooka T, 2009, GENOME RES, V19, P1809, DOI 10.1101/gr.089615.108; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Ideses D, 2005, J BACTERIOL, V187, P8164, DOI 10.1128/JB.187.23.8164-8171.2005; Ooka T, 2012, EMERG INFECT DIS, V18, P488, DOI 10.3201/eid1803.111401; Luo CW, 2011, P NATL ACAD SCI USA, V108, P7200, DOI 10.1073/pnas.1015622108; Walk ST, 2009, APPL ENVIRON MICROB, V75, P6534, DOI 10.1128/AEM.01262-09; Wong ARC, 2011, MOL MICROBIOL, V80, P1420, DOI 10.1111/j.1365-2958.2011.07661.x; Brandal LT, 2015, J CLIN MICROBIOL, V53, P1454, DOI 10.1128/JCM.03378-14; FIedoruk K, 2014, GENOME ANNOUNC, V2; Maeda E, 2014, JPN J INFECT DIS, V67, P503, DOI 10.7883/yoken.67.503; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344	33	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1759-6653			GENOME BIOL EVOL	Genome Biol. Evol.	DEC	2015	7	12					3170	3179		10.1093/gbe/evv211		10	Evolutionary Biology; Genetics & Heredity	Evolutionary Biology; Genetics & Heredity	CY6DT	WOS:000366498700001		
J	Kuramoto, T; Nishihara, H; Watanabe, M; Okada, N				Kuramoto, Tae; Nishihara, Hidenori; Watanabe, Maiko; Okada, Norihiro			Determining the Position of Storks on the Phylogenetic Tree of Waterbirds by Retroposon Insertion Analysis	GENOME BIOLOGY AND EVOLUTION			English	Article						Aves; Ciconiiformes; chicken repeat 1; incomplete lineage sorting; next-generation sequencing	MODERN BIRDS; EVOLUTIONARY HISTORY; PLACENTAL MAMMALS; SINE INSERTIONS; ELEMENTS; SEQUENCE; CLADE; PATTERNS; WHALES; LIFE	Despite many studies on avian phylogenetics in recent decades that used morphology, mitochondrial genomes, and/or nuclear genes, the phylogenetic positions of several birds (e.g., storks) remain unsettled. In addition to the aforementioned approaches, analysis of retroposon insertions, which are nearly homoplasy-free phylogenetic markers, has also been used in avian phylogenetics. However, the first step in the analysis of retroposon insertions, that is, isolation of retroposons from genomic libraries, is a costly and timeconsuming procedure. Therefore, we developed a high-throughput and cost-effective protocol to collect retroposon insertion information based on next-generation sequencing technology, which we call here the STRONG (Screening of Transposons Obtained by Next Generation Sequencing) method, and applied it to 3 waterbird species, for which we identified 35,470 loci containing chicken repeat 1 retroposons (CR1). Our analysis of the presence/absence of 30 CR1 insertions demonstrated the intra- and interordinal phylogenetic relationships in the vvaterbird assemblage, namely 1) Loons diverged first among the waterbirds, 2) penguins (Sphenisciformes) and petrels (Procellariiformes) diverged next, and 3) among the remaining families of waterbirds traditionally classified in Ciconiiformes/Pelecaniformes, storks (Ciconiidae) diverged first. Furthermore, our genome-scale, in silico retroposon analysis based on published genome data uncovered a complex divergence history among pelican, heron, and ibis lineages, presumably involving ancient interspecies hybridization between the heron and ibis lineages. Thus, our retroposonbased waterbird phylogeny and the established phylogenetic position of storks will help to understand the evolutionary processes of aquatic adaptation and related morphological convergent evolution.	[Kuramoto, Tae; Nishihara, Hidenori; Okada, Norihiro] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 227, Japan; [Watanabe, Maiko] Natl Inst Hlth Sci, Div Microbiol, Setagaya Ku, Tokyo 1588501, Japan; [Okada, Norihiro] Fdn Adv Int Sci, Tsukuba, Ibaraki, Japan; [Okada, Norihiro] Natl Cheng Kung Univ, Dept Life Sci, Tainan 701, Taiwan	Okada, N (reprint author), Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 227, Japan.	nokada@fais.or.jp			JSPS KAKENHI [21227002, 26291075, 22770080, 26840117, 26106004, 23123504]	We thank the National Research Institute of Far Seas Fisheries, Fisheries Research Agency, the National Research Institute of Aquaculture, Fisheries Research Agency, the National Institute for Environmental Studies, the Zoorasia Yokohama Zoological Gardens, and the Ueno Zoological Gardens for providing tissue samples from the petrel and gannet, the penguin, the loon and grabe, the kagu, and all other birds, not specifically mentioned, respectively. We also thank the Biomaterial Analysis Center in Tokyo Institute of Technology for DNA sequencing. The computational analysis was conducted using the super computer system of the Institute of Statistical Mathematics. Grants from the JSPS KAKENHI (numbers 21227002 and 26291075 to N.O.) and JSPS KAKENHI (numbers 22770080, 26840117, 26106004, and 23123504 to H.N.) supported this work.	Kaiser VB, 2007, MOL BIOL EVOL, V24, P338, DOI 10.1093/molbev/msl164; Fain MG, 2004, EVOLUTION, V58, P2558; Kimball RT, 2013, MOL PHYLOGENET EVOL, V69, P1021, DOI 10.1016/j.ympev.2013.05.029; Cracraft J, 2004, ASSEMBLING THE TREE OF LIFE, P468; Okada N, 1997, GENE, V205, P229, DOI 10.1016/S0378-1119(97)00409-5; Nikaido M, 1999, P NATL ACAD SCI USA, V96, P10261, DOI 10.1073/pnas.96.18.10261; MURATA S, 1993, P NATL ACAD SCI USA, V90, P6995, DOI 10.1073/pnas.90.15.6995; Deininger PL, 2002, GENOME RES, V12, P1455, DOI 10.1101/gr.282402; Watanabe M, 2006, GENE, V365, P57, DOI 10.1016/j.gene.2005.09.042; Jarvis ED, 2014, SCIENCE, V346, P1320, DOI 10.1126/science.1253451; Watanabe M, 2006, GENE, V378, P65, DOI 10.1016/j.gene.2006.05.003; Takahashi K, 2001, MOL BIOL EVOL, V18, P2057; Nikaido M, 2006, MOL BIOL EVOL, V23, P866, DOI 10.1093/molbev/msj071; Matzke A, 2012, MOL BIOL EVOL, V29, P1497, DOI 10.1093/molbev/msr319; Suh A, 2012, MOL BIOL EVOL, V29, P2899, DOI 10.1093/molbev/mss124; Rokas A, 2000, TRENDS ECOL EVOL, V15, P454, DOI 10.1016/S0169-5347(00)01967-4; STUMPH WE, 1981, NUCLEIC ACIDS RES, V9, P5383, DOI 10.1093/nar/9.20.5383; Shedlock AM, 2004, TRENDS ECOL EVOL, V19, P545, DOI 10.1016/j.tree.2004.08.002; Platt RN, 2015, GENOME BIOL EVOL, V7, P1664, DOI 10.1093/gbe/evv099; CRACRAFT J, 1985, AUK, V102, P834; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; FEDUCCIA A, 1995, SCIENCE, V267, P637, DOI 10.1126/science.267.5198.637; Terai Y, 2003, MOL BIOL EVOL, V20, P924, DOI 10.1093/molbev/msg104; Shimamura M, 1997, NATURE, V388, P666; Nishihara H, 2009, P NATL ACAD SCI USA, V106, P5235, DOI 10.1073/pnas.0809297106; Sasaki T, 2004, MOL BIOL EVOL, V21, P705, DOI 10.1093/molbev/msh069; Livezey BC, 2007, ZOOL J LINN SOC-LOND, V149, P1, DOI 10.1111/j.1096-3642.2006.00293.x; Gregory TR, 2007, NUCLEIC ACIDS RES, V35, pD332, DOI 10.1093/nar/gkl828; Smith ND, 2012, EVOLUTION, V66, P1059, DOI 10.1111/j.1558-5646.2011.01494.x; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Nishihara H, 2006, P NATL ACAD SCI USA, V103, P9929, DOI 10.1073/pnas.0603797103; Gibb GC, 2013, MOL PHYLOGENET EVOL, V68, P229, DOI 10.1016/j.ympev.2013.03.021; BURCH JBE, 1993, P NATL ACAD SCI USA, V90, P8199, DOI 10.1073/pnas.90.17.8199; Nikaido M, 2001, P NATL ACAD SCI USA, V98, P7384, DOI 10.1073/pnas.121139198; Haddrath O, 2012, P ROY SOC B-BIOL SCI, V279, P4617, DOI 10.1098/rspb.2012.1630; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Van Tuinen M, 2001, P ROY SOC B-BIOL SCI, V268, P1345; Nishihara Hidenori, 2008, V422, P201, DOI 10.1007/978-1-59745-581-7_13; Pacheco MA, 2011, MOL BIOL EVOL, V28, P1927, DOI 10.1093/molbev/msr014; Shedlock AM, 2000, BIOESSAYS, V22, P148, DOI 10.1002/(SICI)1521-1878(200002)22:2<148::AID-BIES6>3.0.CO;2-Z; CRACRAFT J, 1981, AUK, V98, P681; VANDERGON TL, 1994, MOL BIOL EVOL, V11, P886; Mayr G, 2011, J ZOOL SYST EVOL RES, V49, P58, DOI 10.1111/j.1439-0469.2010.00586.x; Churakov G, 2009, GENOME RES, V19, P868, DOI 10.1101/gr.090647.108; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Bonaparte CL, 1954, ANN SCI NAT ZOOL, V4, P1; Doronina L, 2015, MOL BIOL EV IN PRESS; Ericson PGP, 2006, BIOL LETT-UK, V2, P543, DOI 10.1098/rsbl.2006.0523; Felice RN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089737; Garrod AH, 1874, P ZOOL SOC LOND, V42, P111; Gill F, 2015, IOC WORLD BIRD LIST, DOI [10.14344/IOC.ML.5.2, 10.143/IOC.ML.5.1]; Huxley TH, 1867, P ZOOL SOC LOND, V145, P415; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Kriegs JO, 2006, PLOS BIOL, V4, P537, DOI 10.1371/journal.pbio.0040091; Kriegs JO, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-190; Livezey Bradley C., 2006, Bulletin of Carnegie Museum of Natural History, V37, P1; Morgan-Richards M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-20; Olson SL, 1979, P COLONIAL WATERBIRD, V2, P165, DOI 10.2307/1520951; SAMBROOK J, 1989, MOL CLONING LAB MANU; Sibley CG, 1990, PHYLOGENY CLASSIFICA; Suh A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1448; Suh A, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002224; Suh A, 2014, GENOME BIOL EVOL, V7, P205; Waddell P J, 2001, Genome Inform, V12, P141; WETMORE ALEXANDER, 1960, SMITHSONIAN MISC COLL, V139, P1	65	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1759-6653			GENOME BIOL EVOL	Genome Biol. Evol.	DEC	2015	7	12					3180	3189		10.1093/gbe/evv213		10	Evolutionary Biology; Genetics & Heredity	Evolutionary Biology; Genetics & Heredity	CY6DT	WOS:000366498700002		
J	Orii, M; Hirata, K; Tanimoto, T; Ota, S; Shiono, Y; Yamano, T; Matsuo, Y; Ino, Y; Yamaguchi, T; Kubo, T; Tanaka, A; Akasaka, T				Orii, Makoto; Hirata, Kumiko; Tanimoto, Takashi; Ota, Shingo; Shiono, Yasutsugu; Yamano, Takashi; Matsuo, Yoshiki; Ino, Yasushi; Yamaguchi, Tomoyuki; Kubo, Takashi; Tanaka, Atsushi; Akasaka, Takashi			Comparison of cardiac MRI and F-18-FDG positron emission tomography manifestations and regional response to corticosteroid therapy in newly diagnosed cardiac sarcoidosis with complete heart block	HEART RHYTHM			English	Article						Cardiac sarcoidosis; Complete heart block; F-18-fluoro-2-deoxyglucose positron emission tomography; Inflammation; Magnetic resonance imaging	CARDIOVASCULAR MAGNETIC-RESONANCE; ATRIOVENTRICULAR-BLOCK; INVOLVEMENT; PATIENT; MYOCARDITIS; MANAGEMENT	BACKGROUND Complete heart block (CHB) caused by myocardial inflammation is a serious consequence of cardiac sarcoidosis (CS) that requires early diagnosis for effective anti-inflammatory treatment. OBJECTIVE This study aimed to clarify the cardiac magnetic resonance imaging (MRI) and F-18-fluoro-2-deoxyglucose positron emission tomography (F-18-FDG PET) manifestations of newly diagnosed CS with CHB and to assess whether certain imaging features could predict responders to corticosteroid therapy. METHODS Fifteen newly diagnosed CS patients with CHB and 17 without CHB were examined. We defined abnormal F-18-FDG uptake on F-18-FDG PET and increased T2-weighted signal on cardiac MRI as signs of myocardial inflammation and delayed enhancement (DE) on cardiac MRI as a sign of myocardial fibrosis. Ten CHB+ patients were then treated with corticosteroids. RESULTS The CHB+ group showed higher F-18-FDG uptake and increased T2-weighted signal in the interventricular septum, which involves the electrical pathway of atrioventricular conduction, than the CHB group (P = .001 and P < .0001, respectively), whereas there was no group difference in DE (P = .232). Six corticosteroidtreated patients recovered from CHB; all had exhibited increased T2-weighted signal, F-18-FDG uptake, and DE in the interventricular septum before therapy. In contrast, among the 4 patients without recovery, 2 showed no abnormal F-18-FDG uptake and 3 had no increased T2-weighted signal in the interventricular septum, but all showed DE. The 2 patients without recovery with abnormal F-18-FDG uptake showed wall thinning in the interventricular septum. CONCLUSION Focal inflammation in the interventricular septum was associated with CHB and might predict recovery from CHB after corticosteroids if it coexists with preserved wall thickness.	[Orii, Makoto; Hirata, Kumiko; Tanimoto, Takashi; Ota, Shingo; Shiono, Yasutsugu; Yamano, Takashi; Matsuo, Yoshiki; Ino, Yasushi; Yamaguchi, Tomoyuki; Kubo, Takashi; Tanaka, Atsushi; Akasaka, Takashi] Wakayama Med Univ, Dept Cardiovasc Med, Wakayama 6418510, Japan	Orii, M (reprint author), Wakayama Med Univ, Dept Cardiovasc Med, 811-1 Kimiidera, Wakayama 6418510, Japan.	kori931@yahoo.co.jp					Manabe O, 2013, EUR J NUCL MED MOL I, V40, P1558, DOI 10.1007/s00259-013-2460-5; Bondarenko O, 2005, J CARDIOV MAGN RESON, V7, P481, DOI 10.1081/JCMR-200053623; ROBERTS WC, 1977, AM J MED, V63, P86, DOI 10.1016/0002-9343(77)90121-8; Friedrich MG, 2009, J AM COLL CARDIOL, V53, P1475, DOI 10.1016/j.jacc.2009.02.007; Paquet N, 2004, J NUCL MED, V45, P784; Ohira H, 2008, EUR J NUCL MED MOL I, V35, P933, DOI 10.1007/s00259-007-0650-8; Mehta D, 2008, CHEST, V133, P1426, DOI 10.1378/chest.07-2784; Kim JS, 2009, AM HEART J, V157, P9, DOI 10.1016/j.ahj.2008.09.009; Tadamura E, 2006, CIRCULATION, V113, pE771, DOI 10.1161/CIRCULATIONAHA.105.594200; Tahara N, 2010, JACC-CARDIOVASC IMAG, V3, P1219, DOI 10.1016/j.jcmg.2010.09.015; Tavora F, 2009, AM J CARDIOL, V104, P571, DOI 10.1016/j.amjcard.2009.03.068; Mc Ardle BA, 2013, CIRC-CARDIOVASC IMAG, V6, P617, DOI 10.1161/CIRCIMAGING.112.000289; Tanimoto T, 2010, CIRCULATION, V122, P2281, DOI 10.1161/CIRCULATIONAHA.109.935338; Masci PG, 2010, CIRC-CARDIOVASC IMAG, V3, P482, DOI 10.1161/CIRCIMAGING.109.934638; Ishimaru S, 2005, EUR HEART J, V26, P1538, DOI 10.1093/eurheartj/ehi180; [Anonymous], 2007, JPN J SARCOIDOSIS GR, V27, P89; Smedema JP, 2005, J AM COLL CARDIOL, V45, P1683, DOI 10.1016/j.jacc.2005.01.047; Patel MR, 2009, CIRCULATION, V120, P1969, DOI 10.1161/CIRCULATIONAHA.109.851352; Koiwa H, 2010, CIRCULATION, V122, P535, DOI 10.1161/CIRCULATIONAHA.110.952184; Blankstein R, 2014, J AM COLL CARDIOL, V63, P329, DOI 10.1016/j.jacc.2013.09.022; Betensky BP, 2012, HEART RHYTHM, V9, P884, DOI 10.1016/j.hrthm.2012.02.010; Aso H, 1998, INVEST RADIOL, V33, P22, DOI 10.1097/00004424-199801000-00004; Takeda N, 2002, CIRCULATION, V105, P1144, DOI 10.1161/hc0902.103432; Moller DR, 1999, SARCOIDOSIS VASC DIF, V16, P24; Youssef G, 2012, J NUCL MED, V53, P241, DOI 10.2967/jnumed.111.090662; Uemura A, 1999, AM HEART J, V138, P299, DOI 10.1016/S0002-8703(99)70115-8; Ishibashi K, 2013, INTERNAL MED, V52, P1341, DOI 10.2169/internalmedicine.52.9364; Soejima K, 2009, J CARDIOVASC ELECTR, V20, P578, DOI 10.1111/j.1540-8167.2008.01417.x; Kandolin R, 2011, CIRC-ARRHYTHMIA ELEC, V4, P303, DOI 10.1161/CIRCEP.110.959254; Mc Ardle BA, 2013, J NUCL CARDIOL, V20, P297, DOI 10.1007/s12350-012-9668-9; Birnie David H, 2014, Heart Rhythm, V11, P1305, DOI 10.1016/j.hrthm.2014.03.043; Hiraga H, 1993, GUIDELINE DIAGNOSIS, P23; Machac Josef, 2006, J Nucl Cardiol, V13, pe121, DOI 10.1016/j.nuclcard.2006.08.009	33	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1547-5271	1556-3871		HEART RHYTHM	Heart Rhythm	DEC	2015	12	12					2477	2485		10.1016/j.hrthm.2015.06.032		9	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CY0SL	WOS:000366116200019		
J	Sobue, Y; Harada, M; Koshikawa, M; Ichikawa, T; Yamamoto, M; Okuda, K; Kato, Y; Sarai, M; Watanabe, E; Ozaki, Y				Sobue, Yoshihiro; Harada, Masahide; Koshikawa, Masayuki; Ichikawa, Tomohide; Yamamoto, Mayumi; Okuda, Kentaro; Kato, Yasuchika; Sarai, Masayoshi; Watanabe, Eiichi; Ozaki, Yukio			QRS-based assessment of myocardial damage and adverse events associated with cardiac sarcoidosis	HEART RHYTHM			English	Article						Cardiac sarcoidosis; Selvester QRS score; Cardiac magnetic resonance imaging; Myocardial scar; Electrocardiography	MAGNETIC-RESONANCE; VENTRICULAR-ARRHYTHMIAS; CARDIOMYOPATHY PATIENTS; DIAGNOSIS; HEART; SCAR; QUANTIFICATION; DEFIBRILLATORS; ABNORMALITIES; MANAGEMENT	BACKGROUND Cardiac sarcoidosis (CS) generates myocardial scar and arrhythmogenic substrate. CS diagnosis according to the Japanese Ministry of Health and Welfare guidelines relies, among others, on cardiac magnetic resonance imaging with late gadolinium enhancement (CMR-LGE). However, access to CMR-LGE is limited. The electrocardiography-based Selvester QRS score has been validated for identifying myocardial scar in ischemic/nonischemic cardiomyopathy, but its efficacy has not been tested to evaluate CS. OBJECTIVE The purpose of this study was to examine whether the QRS score can be applied to CS. METHODS CS-associated myocardial scar was assessed by both CMR-LGE and QRS scoring in patients with extra-CS (n = 59). RESULTS Of 59 patients, 35 (59%) were diagnosed with CS according to the Japanese Ministry of Health and Welfare guidelines. QRS-estimated scar mass positively correlated with that quantified by CMR-LGE (signal intensity >= 2SD above the reference; r = 0.68; P < .001). Receiver operating characteristic curves demonstrated optimal cutoffs of 9% CMR-LGE scar and 3-point QRS score to identify patients with CS. The areas under the curves of CMR-LGE and the QRS score were not significantly different (0.83 and 0.78, respectively; P =.27); both methods demonstrated similar diagnostic performance. A QRS score of >= 3 led to a higher incidence of CS-associated adverse events (death/fatal arrhythmia/ heart failure hospitalization) than did a QRS score of <3 (35 +/- 21 months of follow-up; P = .01). QRS score was an independent predictor of risk in multivariate analysis (P = .03). CONCLUSION The Selvester QRS scoring estimates CS-associated myocardial damage and identifies patients with CS equally well as CMR-LGE. A higher QRS score is also associated with an increased risk of life-threatening events in CS, indicating its potential use as a risk predictor.	[Sobue, Yoshihiro; Harada, Masahide; Koshikawa, Masayuki; Ichikawa, Tomohide; Yamamoto, Mayumi; Okuda, Kentaro; Kato, Yasuchika; Sarai, Masayoshi; Watanabe, Eiichi; Ozaki, Yukio] Fujita Hlth Univ, Dept Cardiol, Sch Med, Toyoake, Aichi 4701192, Japan	Harada, M (reprint author), Fujita Hlth Univ, Dept Cardiol, Sch Med, 1-98 Dengakugakubo,Kutsukake Cho, Toyoake, Aichi 4701192, Japan.	mharada@fujita-hu.ac.jp					ROBERTS WC, 1977, AM J MED, V63, P86, DOI 10.1016/0002-9343(77)90121-8; SEVILLA DC, 1992, AM J CARDIOL, V69, P465, DOI 10.1016/0002-9149(92)90987-A; Kron J, 2013, EUROPACE, V15, P347, DOI 10.1093/europace/eus316; Hamzeh NY, 2012, CHEST, V141, P154, DOI 10.1378/chest.11-0263; Strauss DG, 2009, J ELECTROCARDIOL, V42, P85, DOI 10.1016/j.jelectrocard.2008.07.011; SILVERMAN KJ, 1978, CIRCULATION, V58, P1204; Patel AR, 2011, EUR J HEART FAIL, V13, P1231, DOI 10.1093/eurjhf/hfr099; [Anonymous], 2007, JPN J SARCOIDOSIS GR, V27, P89; Smedema JP, 2005, J AM COLL CARDIOL, V45, P1683, DOI 10.1016/j.jacc.2005.01.047; Siddiqui AM, 2013, J ELECTROCARDIOL, V46, P256, DOI 10.1016/j.jelectrocard.2013.02.010; Patel MR, 2009, CIRCULATION, V120, P1969, DOI 10.1161/CIRCULATIONAHA.109.851352; Betensky BP, 2012, HEART RHYTHM, V9, P884, DOI 10.1016/j.hrthm.2012.02.010; Youssef G, 2011, HEART, V97, P2078, DOI 10.1136/hrt.2011.226076; Strauss DG, 2008, CIRC-ARRHYTHMIA ELEC, V1, P327, DOI 10.1161/CIRCEP.108.798660; Gao P, 2012, CIRC-CARDIOVASC IMAG, V5, P448, DOI 10.1161/CIRCIMAGING.111.971549; Perazella MA, 2009, CLIN J AM SOC NEPHRO, V4, P461, DOI 10.2215/CJN.06011108; Uemura A, 1999, AM HEART J, V138, P299, DOI 10.1016/S0002-8703(99)70115-8; Soejima K, 2009, J CARDIOVASC ELECTR, V20, P578, DOI 10.1111/j.1540-8167.2008.01417.x; Kandolin R, 2011, CIRC-ARRHYTHMIA ELEC, V4, P303, DOI 10.1161/CIRCEP.110.959254; Kribben A, 2009, J AM COLL CARDIOL, V53, P1621, DOI 10.1016/j.jacc.2008.12.061; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Sundh F, 2014, J ELECTROCARDIOL, V47, P197, DOI 10.1016/j.jelectrocard.2013.11.005; Crawford T, 2014, CIRC-ARRHYTHMIA ELEC, V7, P1109, DOI 10.1161/CIRCEP.113.000156; Smedema JP, 2005, CHEST, V128, P30, DOI 10.1378/chest.128.1.30; Mehta D, 2011, CIRC-ARRHYTHMIA ELEC, V4, P43, DOI 10.1161/CIRCEP.110.958322; Williams BR, 2006, HEART, V92, P282	26	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1547-5271	1556-3871		HEART RHYTHM	Heart Rhythm	DEC	2015	12	12					2499	2507		10.1016/j.hrthm.2015.09.008		9	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CY0SL	WOS:000366116200022		
J	Fujimaki, S; Wakabayashi, T; Takemasa, T; Asashima, M; Kuwabara, T				Fujimaki, Shin; Wakabayashi, Tamami; Takemasa, Tohru; Asashima, Makoto; Kuwabara, Tomoko			The regulation of stem cell aging by Wnt signaling	HISTOLOGY AND HISTOPATHOLOGY			English	Review						Wnt; Aging; Neural stem cells; Satellite cells; Exercise	ADULT HIPPOCAMPAL NEUROGENESIS; GROWTH-FACTOR-I; RAT SKELETAL-MUSCLE; MOUSE DENTATE GYRUS; AGE-RELATED DECLINE; GLYCOGEN-SYNTHASE KINASE-3-BETA; NECROSIS-FACTOR-ALPHA; DIFFERENT FIBER TYPES; BETA-AMYLOID FIBRILS; SATELLITE-CELL	Aging is an inevitable physiological process that leads to the dysfunction of various tissues, and these changes may contribute to certain diseases, and ultimately death. Recent research has discovered biological pathways that promote aging. This review focuses on Wnt signaling, Wnt is a highly conserved secreted signaling molecule that plays an essential role in the development and function of various tissues, and is a notable factor that regulates aging. Although Wnt signaling influences aging in various tissues, its effects are particularly prominent in neuronal tissue and skeletal muscle. In neuronal tissue, neurogenesis is attenuated by the downregulation of Wnt signaling with aging. Skeletal muscle can also become weaker with aging, in a process known as sarcopenia. A notable cause of sarcopenia is the myogenic-to-fibrogenic trans-differentiation of satellite cells by excessive upregulation of Wnt signaling with aging, resulting in the impaired regenerative capacity of aged skeletal muscle. However, exercise is very useful for preventing the age-related alterations in neuronal tissue and skeletal muscle. Upregulation of Wnt signaling is implicated in the positive effects of exercise, resulting in the activation of neurogenesis in adult neuronal tissue and myogenesis in mature skeletal muscle. Although more investigations are required to thoroughly understand age-related changes and their biological mechanisms in a variety of tissues, this review proposes exercise as a useful therapy for the elderly, to prevent the negative effects of aging and maintain their quality of life.	[Fujimaki, Shin; Wakabayashi, Tamami; Asashima, Makoto; Kuwabara, Tomoko] Natl Inst Adv Ind Sci & Technol, Biotechnol Res Inst Drug Discovery, Dept Life Sci & Biothecnol, Stem Cell Engn Res Grp, Ibaraki 3058565, Japan; [Fujimaki, Shin; Takemasa, Tohru] Univ Tsukuba, Grad Sch Comprehens Human Sci, Phys Educ Hlth & Sport Sci, Ibaraki, Japan	Kuwabara, T (reprint author), Natl Inst Adv Ind Sci & Technol, Biotechnol Res Inst Drug Discovery, Dept Life Sci & Biothecnol, Stem Cell Engn Res Grp, Cent 5,1-1-1 Higashi, Ibaraki 3058565, Japan.	t.warashina@aist.go.jp					Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Toledo EM, 2008, PROG NEUROBIOL, V86, P281, DOI 10.1016/j.pneurobio.2008.08.001; Phillips T, 2005, FASEB J, V19, P668, DOI 10.1096/fj.04-2870fje; Rosenzweig ES, 2003, PROG NEUROBIOL, V69, P143, DOI 10.1016/S0301-0082(02)00126-0; Brack AS, 2008, CELL STEM CELL, V2, P50, DOI 10.1016/j.stem.2007.10.006; Takashima A, 1998, NEUROSCI RES, V31, P317, DOI 10.1016/S0168-0102(98)00061-3; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kadi F, 1999, HISTOCHEM CELL BIOL, V111, P189, DOI 10.1007/s004180050348; Leger B, 2008, REJUV RES, V11, P163, DOI 10.1089/rej.2007.0588; Di Iorio A, 2006, INT J IMMUNOPATH PH, V19, P703; Carlson ME, 2009, AGING CELL, V8, P676, DOI 10.1111/j.1474-9726.2009.00517.x; Kronenberg G, 2006, NEUROBIOL AGING, V27, P1505, DOI 10.1016/j.neurobiolaging.2005.09.016; Liu HJ, 2007, SCIENCE, V317, P803, DOI 10.1126/science.1143578; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006; Wexler EM, 2009, STEM CELLS, V27, P1130, DOI 10.1002/stem.36; Mathews EA, 2010, J COMP NEUROL, V518, P4479, DOI 10.1002/cne.22489; Lichtenwalner RJ, 2001, NEUROSCIENCE, V107, P603, DOI 10.1016/S0306-4522(01)00378-5; MARKOWSKA AL, 1989, NEUROBIOL AGING, V10, P31, DOI 10.1016/S0197-4580(89)80008-9; BAYER SA, 1983, EXP BRAIN RES, V50, P329; Markowska AL, 1998, NEUROSCIENCE, V87, P559, DOI 10.1016/S0306-4522(98)00143-2; Verdijk LB, 2012, MED SCI SPORT EXER, V44, P2322, DOI 10.1249/MSS.0b013e3182667c2e; Kuwabara T, 2011, EMBO MOL MED, V3, P742, DOI 10.1002/emmm.201100177; Fujino H, 2009, ACTA PHYSIOL, V197, P65, DOI 10.1111/j.1748-1716.2009.01984.x; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007; Kwok JBJ, 2005, ANN NEUROL, V58, P829, DOI 10.1002/ana.20691; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Bach ME, 1999, P NATL ACAD SCI USA, V96, P5280, DOI 10.1073/pnas.96.9.5280; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; DARR KC, 1989, J APPL PHYSIOL, V67, P1827; Bergami M, 2008, P NATL ACAD SCI USA, V105, P15570, DOI 10.1073/pnas.0803702105; van Praag H, 1999, NAT NEUROSCI, V2, P266; Berwick DC, 2011, TRENDS CELL BIOL, V21, P257, DOI 10.1016/j.tcb.2011.01.001; Jin KL, 2003, AGING CELL, V2, P175, DOI 10.1046/j.1474-9728.2003.00046.x; Andersen JL, 2003, SCAND J MED SCI SPOR, V13, P40, DOI 10.1034/j.1600-0838.2003.00299.x; UMNOVA MM, 1991, INT J SPORTS MED, V12, P501, DOI 10.1055/s-2007-1024723; Gould E, 1999, P NATL ACAD SCI USA, V96, P5263, DOI 10.1073/pnas.96.9.5263; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Selkoe DJ, 2001, PHYSIOL REV, V81, P741; Katoh M, 2007, CLIN CANCER RES, V13, P4042, DOI 10.1158/1078-0432.CCR-06-2316; Arsenijevic Y, 2001, J NEUROSCI, V21, P7194; Gao ZL, 2009, NAT NEUROSCI, V12, P1090, DOI 10.1038/nn.2385; Kronenberg G, 2003, J COMP NEUROL, V467, P455, DOI 10.1002/cne.10945; Garcia-Gras E, 2006, J CLIN INVEST, V116, P2012, DOI 10.1172/JCI27751; Seri B, 2001, J NEUROSCI, V21, P7153; Kwon C, 2007, P NATL ACAD SCI USA, V104, P10894, DOI 10.1073/pnas.0704044104; Kim SK, 2007, J EXP BIOL, V210, P1607, DOI 10.1242/jeb.004887; KLITGAARD H, 1990, ACTA PHYSIOL SCAND, V140, P41, DOI 10.1111/j.1748-1716.1990.tb08974.x; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; HEAD E, 1995, BEHAV NEUROSCI, V109, P851, DOI 10.1037/0735-7044.109.5.851; BUSCIGLIO J, 1995, NEURON, V14, P879, DOI 10.1016/0896-6273(95)90232-5; Fluckey JD, 2002, ACTA PHYSIOL SCAND, V176, P293, DOI 10.1046/j.1365-201X.2002.01040.x; Brooks NE, 2009, J PHYSIOL SCI, V59, P465, DOI 10.1007/s12576-009-0058-2; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Janssen I, 2002, J AM GERIATR SOC, V50, P889, DOI 10.1046/j.1532-5415.2002.50216.x; Lai M, 2000, NEUROSCI LETT, V288, P66, DOI 10.1016/S0304-3940(00)01170-8; Olariu A, 2007, J COMP NEUROL, V501, P659, DOI 10.1002/cne.21268; Buas MF, 2010, EXP CELL RES, V316, P3028, DOI 10.1016/j.yexcr.2010.05.002; Mayhew DL, 2009, J APPL PHYSIOL, V107, P1655, DOI 10.1152/japplphysiol.91234.2008; Carleton A, 2003, NAT NEUROSCI, V6, P507, DOI 10.1038/nn1048; Pencea V, 2001, EXP NEUROL, V172, P1, DOI 10.1006/exnr.2001.7768; Han XH, 2011, J BIOL CHEM, V286, P10649, DOI 10.1074/jbc.M110.169391; Chen X, 2006, MOL CELL BIOL, V26, P4462, DOI 10.1128/MCB.02157-05; Liao P, 2010, AM J PHYSIOL-REG I, V298, pR599, DOI 10.1152/ajpregu.00480.2009; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Beccafico S, 2007, ANN NY ACAD SCI, V1100, P345, DOI 10.1196/annals.1395.037; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Barzilai N, 2012, DIABETES, V61, P1315, DOI 10.2337/db11-1300; LAI ZC, 1995, NEUROBIOL AGING, V16, P947, DOI 10.1016/0197-4580(95)02014-4; Narici MV, 2010, BRIT MED BULL, V95, P139, DOI 10.1093/bmb/ldq008; Hsieh J, 2004, J CELL BIOL, V164, P111, DOI 10.1083/jcb.200308101; Lin CH, 2010, J NEUROSCI, V30, P13138, DOI 10.1523/JNEUROSCI.1737-10.2010; Gerber J, 2009, NEUROLOGY, V73, P1026, DOI 10.1212/WNL.0b013e3181b9c892; Ghigo E, 1996, J PEDIATR ENDOCR MET, V9, P271; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; He WC, 2009, J AM SOC NEPHROL, V20, P765, DOI 10.1681/ASN.2008060566; COGGAN AR, 1992, J GERONTOL, V47, pB71; Liu WY, 2012, DEVELOPMENT, V139, P2857, DOI 10.1242/dev.079665; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; SNOW MH, 1977, CELL TISSUE RES, V185, P399; Carlson ME, 2008, NATURE, V454, P528, DOI 10.1038/nature07034; KLITGAARD H, 1990, ACTA PHYSIOL SCAND, V140, P55, DOI 10.1111/j.1748-1716.1990.tb08975.x; Ahlenius H, 2009, J NEUROSCI, V29, P4408, DOI 10.1523/JNEUROSCI.6003-08.2009; Lee J, 2002, J NEUROCHEM, V82, P1367, DOI 10.1046/j.1471-4159.2002.01085.x; Kato H, 1996, FEBS LETT, V395, P221, DOI 10.1016/0014-5793(96)01046-0; Miyazaki M, 2011, J PHYSIOL-LONDON, V589, P1831, DOI 10.1113/jphysiol.2011.205658; Burstein B, 2008, J AM COLL CARDIOL, V51, P802, DOI 10.1016/j.jacc.2007.09.064; Shefer G, 2006, DEV BIOL, V294, P50, DOI 10.1016/j.ydbio.2006.02.022; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629; Doherty TJ, 2003, J APPL PHYSIOL, V95, P1717, DOI 10.1152/japplphysiol.00347.2003; Sykova E, 2002, HIPPOCAMPUS, V12, P269, DOI 10.1002/hipo.1101; Snijders T, 2014, CLIN SCI, V126, P557, DOI 10.1042/CS20130295; Faigle R, 2013, BBA-GEN SUBJECTS, V1830, P2435, DOI 10.1016/j.bbagen.2012.09.002; Seib DRM, 2013, CELL STEM CELL, V12, P204, DOI 10.1016/j.stem.2012.11.010; von Maltzahn J, 2012, TRENDS CELL BIOL, V22, P602, DOI 10.1016/j.tcb.2012.07.008; Kempermann G, 1998, CURR BIOL, V8, P939, DOI 10.1016/S0960-9822(07)00377-6; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; NISHISHO I, 1991, SCIENCE, V253, P665, DOI 10.1126/science.1651563; Dirks AJ, 2006, J NUTR BIOCHEM, V17, P501, DOI 10.1016/j.jnutbio.2005.11.002; Kitamura T, 2006, NEUROSCI RES, V56, P45, DOI 10.1016/j.neures.2006.05.006; ALAMEDDINE HS, 1989, MUSCLE NERVE, V12, P544, DOI 10.1002/mus.880120705; Naylor AS, 2008, P NATL ACAD SCI USA, V105, P14632, DOI 10.1073/pnas.0711128105; SCHULTZ E, 1982, MECH AGEING DEV, V20, P377, DOI 10.1016/0047-6374(82)90105-1; Armstrong DD, 2005, AM J PHYSIOL-CELL PH, V289, pC853, DOI 10.1152/ajpcell.00093.2005; Moskalev AA, 2014, CELL CYCLE, V13, P1063, DOI 10.4161/cc.28433; Aberg MAI, 2000, J NEUROSCI, V20, P2896; Lang T, 2010, OSTEOPOROSIS INT, V21, P543, DOI 10.1007/s00198-009-1059-y; Smith HK, 2001, J APPL PHYSIOL, V90, P1407; Weuve J, 2004, JAMA-J AM MED ASSOC, V292, P1454, DOI 10.1001/jama.292.12.1454; Ouzounian M, 2008, NAT CLIN PRACT CARD, V5, P375, DOI 10.1038/ncpcardio1245; Baurand A, 2007, CIRC RES, V100, P1353, DOI 10.1161/01.RES.0000266605.63681.5a; Wu CW, 2008, J APPL PHYSIOL, V105, P1585, DOI 10.1152/japplphysiol.90775.2008; Janssen I, 2000, J APPL PHYSIOL, V89, P81; Qyang Y, 2007, CELL STEM CELL, V1, P165, DOI 10.1016/j.stem.2007.05.018; Tajbakhsh S, 1998, DEVELOPMENT, V125, P4155; Jessberger S, 2009, LEARN MEMORY, V16, P147, DOI 10.1101/lm.1172609; Bjornson CRR, 2012, STEM CELLS, V30, P232, DOI 10.1002/stem.773; Li HL, 2007, P NATL ACAD SCI USA, V104, P3591, DOI 10.1073/pnas.0609303104; Leuner B, 2007, P NATL ACAD SCI USA, V104, P17169, DOI 10.1073/pnas.0708228104; Lee CE, 2007, CLIN NUTR, V26, P524, DOI 10.1016/j.clnu.2007.05.005; Creer DJ, 2010, P NATL ACAD SCI USA, V107, P2367, DOI 10.1073/pnas.0911725107; LEXELL J, 1983, MUSCLE NERVE, V6, P588, DOI 10.1002/mus.880060809; McCarthy JJ, 2011, DEVELOPMENT, V138, P3657, DOI 10.1242/dev.068858; Kuwabara T, 2009, NAT NEUROSCI, V12, P1097, DOI 10.1038/nn.2360; Magarinos AM, 2011, HIPPOCAMPUS, V21, P253, DOI 10.1002/hipo.20744; Wang XD, 2006, AM J PHYSIOL-CELL PH, V290, pC981, DOI 10.1152/ajpcell.00298.2005; Hattiangady B, 2008, NEUROBIOL AGING, V29, P129, DOI 10.1016/j.neurobiolaging.2006.09.015; Kalleinen N, 2008, J CLIN ENDOCR METAB, V93, P1655, DOI 10.1210/jc.2007-2677; Rawal N, 2009, BIOCHEM BIOPH RES CO, V388, P473, DOI 10.1016/j.bbrc.2009.07.014; Brooks NE, 2010, MUSCLE NERVE, V42, P927, DOI 10.1002/mus.21780; Adachi K, 2007, STEM CELLS, V25, P2827, DOI 10.1634/stemcells.2007-0177; Brack AS, 2009, DEV BIOL, V335, P93, DOI 10.1016/j.ydbio.2009.08.014; Varela-Nallar L, 2010, BIRTH DEFECTS RES C, V90, P284, DOI 10.1002/bdrc.20193; Hasten DL, 2000, AM J PHYSIOL-ENDOC M, V278, pE620; Carmichael J, 2002, J BIOL CHEM, V277, P33791, DOI 10.1074/jbc.m204861200; Ward MT, 1999, NEUROBIOL AGING, V20, P363, DOI 10.1016/S0197-4580(99)00045-7; McKinnell IW, 2008, NAT CELL BIOL, V10, P77, DOI 10.1038/ncb1671; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; Kempermann G, 2002, J NEUROSCI, V22, P635; Haq S, 2003, P NATL ACAD SCI USA, V100, P4610, DOI 10.1073/pnas.0835895100; Della Gatta PA, 2014, BRAIN BEHAV IMMUN, V39, P80, DOI 10.1016/j.bbi.2014.01.006; Erickson KI, 2010, J NEUROSCI, V30, P5368, DOI 10.1523/JNEUROSCI.6251-09.2010; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Bunk EC, 2011, AGING CELL, V10, P28, DOI 10.1111/j.1474-9726.2010.00639.x; Shihabuddin LS, 2000, J NEUROSCI, V20, P8727; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Sonntag WE, 1999, NEUROSCIENCE, V88, P269, DOI 10.1016/S0306-4522(98)00192-4; Serrano AL, 2010, EXP CELL RES, V316, P3050, DOI 10.1016/j.yexcr.2010.05.035; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Trejo JL, 2001, J NEUROSCI, V21, P1628; Olguin HC, 2004, DEV BIOL, V275, P375, DOI 10.1016/j.ydbio.2004.08.015; He P, 2009, J NEUROSCI, V29, P6545, DOI 10.1523/JNEUROSCI.0421-09.2009; Le Grand F, 2009, CELL STEM CELL, V4, P535, DOI 10.1016/j.stem.2009.03.013; Bonaguidi MA, 2011, CELL, V145, P1142, DOI 10.1016/j.cell.2011.05.024; Naito AT, 2010, CIRC RES, V107, P1295, DOI 10.1161/CIRCRESAHA.110.223776; Degens H., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P246; Carlson ME, 2007, AGING CELL, V6, P371, DOI 10.1111/j.1474-9726.2007.00286.x; Tavernarakis N, 2008, TRENDS CELL BIOL, V18, P228, DOI 10.1016/j.tcb.2008.02.004; Kurosaka M, 2012, ACTA PHYSIOL, V205, P159, DOI 10.1111/j.1748-1716.2011.02381.x; Rutten BPF, 2003, MECH AGEING DEV, V124, P349, DOI 10.1016/S0047-6374(03)00002-2; Gines S, 2003, J BIOL CHEM, V278, P50514, DOI 10.1074/jbc.M309348200; Perrini S, 2010, J ENDOCRINOL, V205, P201, DOI 10.1677/JOE-09-0431; van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05-2005; Zwetsloot KA, 2013, CELL PROLIFERAT, V46, P45, DOI 10.1111/cpr.12007; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534; Inestrosa NC, 2010, NAT REV NEUROSCI, V11, P77, DOI 10.1038/nrn2755; Kukekov VG, 1999, EXP NEUROL, V156, P333, DOI 10.1006/exnr.1999.7028; Tropepe V, 1997, J NEUROSCI, V17, P7850; Carlson ME, 2009, EMBO MOL MED, V1, P381, DOI 10.1002/emmm.200900045; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Renault V, 2002, AGING CELL, V1, P132, DOI 10.1046/j.1474-9728.2002.00017.x; Enwere E, 2004, J NEUROSCI, V24, P8354, DOI 10.1523/JNEUROSCI.2751-04.2004; Aschenbach WG, 2006, AM J PHYSIOL-ENDOC M, V291, pE152, DOI 10.1152/ajpendo.00180.2005; Luo J, 2006, AGING CELL, V5, P139, DOI 10.1111/j.1474-9726.2006.00197.x; Wilkniss SM, 1997, PSYCHOL AGING, V12, P372, DOI 10.1037//0882-7974.12.2.372; Fujimaki S, 2014, J BIOL CHEM, V289, P7399, DOI 10.1074/jbc.M113.539247; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Goodpaster BH, 2001, J APPL PHYSIOL, V90, P2157; Fuentealba RA, 2004, BRAIN RES REV, V47, P275, DOI 10.1016/j.brainresrev.2004.07.018; Hsieh J, 2012, GENE DEV, V26, P1010, DOI 10.1101/gad.187336.112; Shetty AK, 2005, GLIA, V51, P173, DOI 10.1002/glia.20187; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Buford TW, 2010, AGEING RES REV, V9, P369, DOI 10.1016/j.arr.2010.04.004; Ortiz-Matamoros A, 2013, CURR NEUROPHARMACOL, V11, P465, DOI 10.2174/1570159X11311050001; Liu WG, 2000, NAT GENET, V26, P146, DOI 10.1038/79859; Okamoto M, 2011, FASEB J, V25, P3570, DOI 10.1096/fj.11-184697; Rapp PR, 1997, NEUROREPORT, V8, P1923, DOI 10.1097/00001756-199705260-00026; Maltais ML, 2009, J MUSCULOSKEL NEURON, V9, P186; Aberg MAI, 2003, MOL CELL NEUROSCI, V24, P23, DOI 10.1016/S1044-7431(03)00082-4; LARSSON L, 1978, ACTA PHYSIOL SCAND, V103, P31, DOI 10.1111/j.1748-1716.1978.tb06187.x; Polesskaya A, 2003, CELL, V113, P841, DOI 10.1016/S0092-8674(03)00437-9; Driscoll I, 2003, CEREB CORTEX, V13, P1344, DOI 10.1093/cercor/bhg081; Paturi S, 2010, MECH AGEING DEV, V131, P202, DOI 10.1016/j.mad.2010.01.008; Stranahan AM, 2010, NEUROBIOL AGING, V31, P1937, DOI 10.1016/j.neurobiolaging.2008.10.016; Rampalli S, 2007, NAT STRUCT MOL BIOL, V14, P1150, DOI 10.1038/nsmb1316; Ai D, 2007, P NATL ACAD SCI USA, V104, P9319, DOI 10.1073/pnas.0701212104; Sierra A, 2010, CELL STEM CELL, V7, P483, DOI 10.1016/j.stem.2010.08.014; Zammit PS, 2006, J CELL SCI, V119, P1824, DOI 10.1242/jcs.02908; Lugert S, 2010, CELL STEM CELL, V6, P445, DOI 10.1016/j.stem.2010.03.017; Sethi JK, 2010, BIOCHEM J, V427, P1, DOI 10.1042/BJ20091866; Fabel K, 2003, EUR J NEUROSCI, V18, P2803, DOI 10.1046/j.1460-9568.2003.03041.x; Maslov AY, 2004, J NEUROSCI, V24, P1726, DOI 10.1523/JNEUROSCI.4608-03.2004; Song MY, 2004, AM J CLIN NUTR, V79, P874; Kuang S, 2008, TRENDS MOL MED, V14, P82, DOI 10.1016/j.molmed.2007.12.004; De Ferrari GV, 2003, MOL PSYCHIATR, V8, P195, DOI 10.1038/sj.mp.4001208; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Gasser T, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001148; Gheusi Gilles, 2000, Proceedings of the National Academy of Sciences of the United States of America, V97, P1823, DOI 10.1073/pnas.97.4.1823; Hamada Koichiro, 2005, FASEB J, V19, P264; Hidaka R, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt201; Hikida Robert S, 2011, Curr Aging Sci, V4, P279; Hofmann JW, 2014, AGE, V36, P1033, DOI 10.1007/s11357-014-9618-3; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Jones AE, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0038-6; Kadi F, 2004, J PHYSIOL-LONDON, V558, P1005, DOI 10.1113/jphysiol.2004.065904; Kalathur RKR, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-47; Knoth R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008809; Konigshoff M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002142; LEXELL J, 1988, J NEUROL SCI, V84, P275, DOI 10.1016/0022-510X(88)90132-3; Maggio M, 2005, J Endocrinol Invest, V28, P116; Martin N. R. W., 2012, CELLULAR MOL EXERCIS, V1, P5; Nusse R., 2012, COLD SPRING HARB PER, V4; Park Dong Choon, 2013, Korean J Audiol, V17, P39, DOI 10.7874/kja.2013.17.2.39; Ramos-Rodriguez JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089229; Shefer G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013307; Song Hongjun, 2002, Nature (London), V417, P39, DOI 10.1038/417039a; Varela-Nallar L, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00100	230	0	0	F HERNANDEZ	MURCIA	PLAZA FUENSANTA 2-7 C, 30008 MURCIA, SPAIN	0213-3911	1699-5848		HISTOL HISTOPATHOL	Histol. Histopath.	DEC	2015	30	12					1411	1430				20	Cell Biology; Pathology	Cell Biology; Pathology	CY3VK	WOS:000366337800003		
J	Ochiai, H				Ochiai, Hirofumi			Philosophical Foundations of Stereochemistry	HYLE			English	Article						stereochemistry; classical model of the molecule; physical shape; absolute configuration; non-orientable space; affordances	CHEMISTRY	Stereochemistry studies molecules and molecular transformations by way of the classical model of the molecule, which envisages molecules as composed of atoms that are linked together by chemical bonds. The underlying hypothesis of this model is that molecules are entities with definite shape and structure, and behave like mechanical objects in the world of possible experience. Such a view of molecules raises questions about the legitimacy of this science because neither shape nor structure is taken any longer as a solid scaffold on which to construct philosophical or scientific arguments. Thus, questions to be addressed in this paper are whether or not it is allowed to treat molecular events, which are dynamic in nature and subject to quantum mechanical principles, by way of the classical model; whether or not the classical model is proved true by the physical measurements of molecules; and whether or not the nature of enantiomers is explicable by the classical model. An analytical tool kit for the philosophy of chemistry recently introduced by Harre (the concept of the affordance in particular) will help to prove the empirical adequacy of the classical model. Inquiries into these questions from a philosophical as well as from a chemical point of view will reveal the foundations of stereochemistry.	[Ochiai, Hirofumi] Nagoya Bunri Univ, Fundamental Learning Ctr, Inazawa, Aichi 4928520, Japan	Ochiai, H (reprint author), Nagoya Bunri Univ, Fundamental Learning Ctr, 365 Maeda,Inazawa Cho, Inazawa, Aichi 4928520, Japan.	Ochiai.hirofumi@nagoya-bunri.ac.jp					WOOLLEY RG, 1978, J AM CHEM SOC, V100, P1073, DOI 10.1021/ja00472a009; Harre R, 2014, HYLE, V20, P77; Laszlo P, 2014, HYLE, V20, P93; Cartwright N, 1983, LAWS PHYS LIE; Chakravartty Anjan, 2007, METAPHYSICS SCI REAL; Eliel E.L., 1994, STEREOCHEMISTRY ORGA; Giere R. N., 1988, EXPLAINING SCI COGNI; Hacking I., 2008, REPRESENTING INTERVE; Hendrickson J.B., 1970, ORGANIC CHEM; Le Poidevin R., 2000, MINDS MOL NEW PHILOS, P129; Nerlich G, 1994, SHAPE SPACE; Ochiai H., 2013, HYLE, V13, P139; Ramberg P.J., 2003, CHEM STRUCTURE SPATI; Ramsey J.L., 2000, MINDS MOL NEW PHILOS, P117; Rocke A.J., 2001, NATL SCI ADOLPHE WUR; Streitwieser J.A., 1976, INTRO ORGANIC CHEM; van Brakel J., 2000, PHILOS CHEM; van Brakel J., 2006, PHILOS CHEM SYNTHESI; Weininger S.J, 2000, MINDS MOL NEW PHILOS, P143	19	0	0	HYLE PUBL	KARLSRUHE	MORGENSTR 2, KARLSRUHE, D-76137, GERMANY	1433-5158	1617-4240		HYLE	HYLE	DEC	2015	21	1					1	18				18	Chemistry, Multidisciplinary; History & Philosophy Of Science	Chemistry; History & Philosophy of Science	CY3NX	WOS:000366317600001		
J	Xiao, HQ; He, Y; Wu, M; Xiao, SP; She, JH				Xiao, Hui-Qin; He, Yong; Wu, Min; Xiao, Shen-Ping; She, Jinhua			New Results on H-infinity Tracking Control Based on the T-S Fuzzy Model for Sampled-Data Networked Control System	IEEE TRANSACTIONS ON FUZZY SYSTEMS			English	Article						Augmented Lyapunov Krasovskii functional (LKF); H-infinity tracking control; linear matrix inequality (LMD; parallel distributed compensation (PDC); sampled-data networked control system (M)N CS); Takagi Sugeno (T-S) fuzzy model	TIME-DELAY SYSTEMS; FILTER DESIGN; STABILITY ANALYSIS; NONLINEAR-SYSTEMS	This study deals with the problem of H-infinity, tracking control for a sampled-data networked control system based on a Takagi Sugeno fuzzy model. An error model is established by combining the input delay and parallel distributed compensation techniques so as to transform the sampling period of a sampler, a signal transmission delay, and data packet dropouts to the refreshing interval of a zero-order hold. The method introduces a new augmented Lyapunov Krasovskii functional to derive a sufficient condition to ensure a prescribed li tracking performance with less conservativeness than others. A fuzzy controller can easily he designed using the condition. A numerical example demonstrates the validity of the method.	[Xiao, Hui-Qin] Cent S Univ, Sch Informat Sci & Engn, Changsha 410083, Hunan, Peoples R China; [Xiao, Hui-Qin; Xiao, Shen-Ping] Hunan Univ Technol, Coll Elect & Informat Engn, Zhuzhou 412008, Peoples R China; [He, Yong; Wu, Min] China Univ Geosci, Sch Automat, Wuhan 430074, Peoples R China; [She, Jinhua] Tokyo Univ Technol, Sch Engn, Tokyo 1920982, Japan	He, Y (reprint author), China Univ Geosci, Sch Automat, Wuhan 430074, Peoples R China.	xiaohq_610@126.com; heyong08@cug.edu.cn; xsph_519@163.com; she@stf.teu.ac.jp			National Natural Science Foundation of China [61125301, 61210011, 61203136]	This work was supported in part by the National Natural Science Foundation of China under Grant 61125301, Grant 61210011, and Grant 61203136.	Ahn C.K., 2013, INT J INNOV COMPUT I, V9, P2979; Zhang H, 2011, IEEE T FUZZY SYST, V19, P844, DOI 10.1109/TFUZZ.2011.2147793; Kim SH, 2004, CONTROL ENG PRACT, V12, P149, DOI 10.1016/S0967-0661(03)00016-9; Lam HK, 2014, IEEE T IND ELECTRON, V61, P956, DOI 10.1109/TIE.2013.2253064; Gao HJ, 2009, IEEE T FUZZY SYST, V17, P291, DOI 10.1109/TFUZZ.2008.924206; Wu ZG, 2012, IEEE T FUZZY SYST, V20, P22, DOI 10.1109/TFUZZ.2011.2162850; Zhao YB, 2009, IEEE T CONTR SYST T, V17, P859, DOI 10.1109/TCST.2008.2010946; Zhou Q, 2011, IEEE T FUZZY SYST, V19, P972, DOI 10.1109/TFUZZ.2011.2158652; Seuret A, 2012, AUTOMATICA, V48, P177, DOI 10.1016/j.automatica.2011.09.033; Su XJ, 2013, IEEE T IND INFORM, V9, P1739, DOI 10.1109/TII.2012.2231085; Tanaka K, 1998, IEEE T CIRCUITS-I, V45, P1021, DOI 10.1109/81.728857; Gao HJ, 2008, IEEE T AUTOMAT CONTR, V53, P655, DOI 10.1109/TAC.2008.919850; Lin C, 2008, IEEE T FUZZY SYST, V16, P739, DOI 10.1109/TFUZZ.2007.905915; Hua CC, 2012, IEEE T FUZZY SYST, V20, P9, DOI 10.1109/TFUZZ.2011.2162735; Chen B, 2012, IEEE T FUZZY SYST, V20, P1012, DOI 10.1109/TFUZZ.2012.2190048; Wu ZG, 2013, IEEE T FUZZY SYST, V21, P966, DOI 10.1109/TFUZZ.2012.2234465; Su XJ, 2012, IEEE T FUZZY SYST, V20, P1114, DOI 10.1109/TFUZZ.2012.2196522; Su XJ, 2013, IEEE T FUZZY SYST, V21, P655, DOI 10.1109/TFUZZ.2012.2226941; Zhang CK, 2013, IET CONTROL THEORY A, V7, P1219, DOI 10.1049/iet-cta.2012.0814; Lin C, 2007, IEEE T SIGNAL PROCES, V55, P2746, DOI 10.1109/TSP.2007.893761; Zhou Q, 2013, IEEE T FUZZY SYST, V21, P301, DOI 10.1109/TFUZZ.2012.2213259; Jia XC, 2009, IEEE T SYST MAN CY B, V39, P1073, DOI 10.1109/TSMCB.2008.2010524; Liao F, 2002, IEEE T CONTR SYST T, V10, P76; Wu ZG, 2013, IEEE T CYBERNETICS, V43, P1796, DOI 10.1109/TSMCB.2012.2230441; Tanaka K, 1998, IEEE T FUZZY SYST, V6, P250, DOI 10.1109/91.669023; Fridman E, 2003, IEEE T AUTOMAT CONTR, V48, P861, DOI 10.1109/TAC.2003.811269; Su XJ, 2014, IEEE T CYBERNETICS, V44, P2470, DOI 10.1109/TCYB.2014.2308983; Gao HJ, 2009, IEEE T SYST MAN CY B, V39, P306, DOI 10.1109/TSMCB.2008.2003449; Fridman E, 2010, AUTOMATICA, V46, P421, DOI 10.1016/j.automatica.2009.11.017; Hua CC, 2009, IEEE T FUZZY SYST, V17, P901, DOI 10.1109/TFUZZ.2008.924351; Wu ZG, 2014, IEEE T FUZZY SYST, V22, P153, DOI 10.1109/TFUZZ.2013.2249520; Li HY, 2009, IEEE T SYST MAN CY B, V39, P94, DOI 10.1109/TSMCB.2008.2002812; Astudillo Leslie, 2013, International Journal of Innovative Computing, Information & Control, V9; Chen Peng, 2010, IEEE Transactions on Fuzzy Systems, V18, DOI 10.1109/TFUZZ.2010.2041354; Chen Z. S., 2010, INT J AUTOM COMPUT, V7, P492, DOI 10.1007/s11633-010-0532-6; DAWSON DM, 1992, INT J CONTROL, V56, P991, DOI 10.1080/00207179208934354; Ho W.H., 2013, INT J INNOV COMPUT I, V9, P805; Li H. B., 2008, P IFAC WORLD C SEOUL, P12575; Soltanpour Mohammad Reza, 2013, International Journal of Innovative Computing, Information & Control, V9; Tanaka K., 2001, FUZZY CONTROL SYSTEM; Xiao H., 2012, IET CONTROL THEORY A, V29, P71	41	1	1	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1063-6706	1941-0034		IEEE T FUZZY SYST	IEEE Trans. Fuzzy Syst.	DEC	2015	23	6					2439	2448		10.1109/TFUZZ.2015.2410790		10	Computer Science, Artificial Intelligence; Engineering, Electrical & Electronic	Computer Science; Engineering	CX8XV	WOS:000365989300042		
J	Hattori, S; Kobayashi, K; Okada, H; Katayama, M				Hattori, Shingo; Kobayashi, Kentaro; Okada, Hiraku; Katayama, Masaaki			ON-OFF Error Control Coding Scheme for Minimizing Tracking Error in Wireless Feedback Control Systems	IEEE TRANSACTIONS ON INDUSTRIAL INFORMATICS			English	Article						Disturbance; error control coding; feedback control; networked control; packet loss; wireless control	NETWORKED CONTROL-SYSTEMS; PREDICTIVE CONTROL; TRANSMISSION	In wireless feedback control systems, reducing packet loss is critical. The use of channel codingmay decrease such packet loss; however, redundancy in channel coding also decreases the packet transmission rate although the bit rate remains the same. Thus, control systems are highly affected by disturbances. To improve control system quality, channel coding should be adaptively employed on the basis of packet loss and disturbances. Herein, an ON-OFF error control coding scheme based on the communication and control layers is proposed. In this scheme, channel coding is adaptively used to minimize tracking errors in a controlled plant. Results demonstrate that the proposed ON-OFF error control coding scheme improves the control system's reference tracking performance compared with that when using a fixed-rate coding scheme.	[Hattori, Shingo] Nagoya Univ, Grad Sch Engn, Nagoya, Aichi 4648603, Japan; [Kobayashi, Kentaro; Okada, Hiraku; Katayama, Masaaki] Nagoya Univ, Inst Mat & Syst Sustainabil, Nagoya, Aichi 4648603, Japan	Hattori, S (reprint author), Toyota Ind Corp, Aichi, Japan.	hattori@katayama.nuee.nagoya-u.ac.jp; kobayasi@nuee.nagoya-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [25870313, 15K21071]	This work was supported in part by Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Young Scientists (B) under Grant 25870313 and Grant 15K21071. Paper no. TII-14-1088.	Nagahara M, 2014, IEEE T AUTOMAT CONTR, V59, P1899, DOI 10.1109/TAC.2013.2294622; Ulusoy A, 2011, IEEE T IND INFORM, V7, P41, DOI 10.1109/TII.2010.2089059; Li HB, 2014, IEEE T IND ELECTRON, V61, P6234, DOI 10.1109/TIE.2014.2311411; Tang Y, 2014, IEEE T AUTOM SCI ENG, V11, P1056, DOI 10.1109/TASE.2013.2283304; Du SL, 2014, IEEE T AUTOM SCI ENG, V11, P740, DOI 10.1109/TASE.2014.2320322; Pang ZH, 2014, IEEE T IND ELECTRON, V61, P4867, DOI 10.1109/TIE.2013.2289890; Ding SX, 2013, IEEE T IND INFORM, V9, P462, DOI 10.1109/TII.2012.2214390; Zhang LX, 2013, IEEE T IND INFORM, V9, P403, DOI 10.1109/TII.2012.2219540; Gomez-Estern F, 2011, IEEE T AUTOMAT CONTR, V56, P129, DOI 10.1109/TAC.2010.2083370; Ellis JD, 2013, IEEE T WIREL COMMUN, V12, P6514, DOI 10.1109/TWC.2013.102813.130746; Quevedo DE, 2014, IEEE T CONTR SYST T, V22, P413, DOI 10.1109/TCST.2013.2253464; Shen W, 2014, IEEE T IND INFORM, V10, P824, DOI 10.1109/TII.2013.2280081; Du ZP, 2014, IEEE T IND INFORM, V10, P882, DOI 10.1109/TII.2013.2294114; Liu FZ, 2014, IEEE T IND ELECTRON, V61, P460, DOI 10.1109/TIE.2013.2240640; Blind R, 2012, IEEE DECIS CONTR P, P1368, DOI 10.1109/CDC.2012.6426881; You J, 2014, IEEE T IND INFORM, V10, P2216, DOI 10.1109/TII.2014.2362493; Araujo J, 2014, IEEE T IND INFORM, V10, P175, DOI 10.1109/TII.2013.2262281; Franklin G. F., 1980, DIGITAL CONTROL DYNA; Futatsugi T., 2012, P 6 INT S MED INF CO, P1; Immich R., 2014, P IEEE INT C COMM IC, P1687; Kondo T, 2012, IEICE T FUND ELECTR, VE95A, P697, DOI 10.1587/transfun.E95.A.697; Proakis J. G., 2008, DIGITAL COMMUNICATIO; RealTEC, ROT INV PEND RTC05; Singh J., 2011, PARTICIPATORY JOURNA, P1; Yin S, 2015, IEEE T IND ELECTRON, V62, P657, DOI 10.1109/TIE.2014.2308133	25	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1551-3203	1941-0050		IEEE T IND INFORM	IEEE Trans. Ind. Inform.	DEC	2015	11	6					1411	1421		10.1109/TII.2015.2489185		11	Automation & Control Systems; Computer Science, Interdisciplinary Applications; Engineering, Industrial	Automation & Control Systems; Computer Science; Engineering	CY1BI	WOS:000366141100016		
J	He, Y; Molchanov, P; Sakamoto, T; Aubry, P; Le Chevalier, F; Yarovoy, A				He, Yuan; Molchanov, Pavlo; Sakamoto, Takuya; Aubry, Pascal; Le Chevalier, Francois; Yarovoy, Alexander			Range-Doppler surface: a tool to analyse human target in ultra-wideband radar	IET RADAR SONAR AND NAVIGATION			English	Article						Doppler radar; ultra wideband radar; radar imaging; radar detection; image sequences; radar target recognition; image motion analysis; range-Doppler surface; human target analysis; ultra-wideband radar; RDS; range-Doppler imaging; RD imaging; adaptive threshold detection; isosurface extraction; Keystone-transform-based range migration compensation approach; RD video sequence; microDoppler profile; high-resolution range profile; ellipsoid-based human motion model; walking scenario	FEATURE-EXTRACTION; SIGNATURES; TRANSFORM	A novel concept, called range-Doppler surface (RDS), for human target analysis using ultra-wideband radar is proposed. The construction of RDS involves range-Doppler (RD) imaging, adaptive threshold detection and isosurface extraction. A Keystone-transform-based range migration compensation approach is proposed to allow high-quality RD imaging using ultra-wideband radar. Adaptive threshold detection is applied to detect the extended target in the RD image, and RDS is constructed by extracting an isosurface from a RD video sequence, which is defined as a sequence of RD images. In comparison with micro-Doppler profiles and high-resolution range profiles, RDS contains range, Doppler and time information simultaneously. An ellipsoid-based human motion model is designed for validation. RDSs simulated for different human activities are demonstrated and discussed. Finally, experimental results for single/two-people walking scenarios are presented to verify the simulation results. The use of the RDS opens a new area of human target analysis.	[He, Yuan; Aubry, Pascal; Le Chevalier, Francois; Yarovoy, Alexander] Delft Univ Technol, Sect Microwave Sensing Signals & Syst, Delft, Netherlands; [Molchanov, Pavlo] Tampere Univ Technol, Dept Signal Proc, FIN-33101 Tampere, Finland; [Sakamoto, Takuya] Kyoto Univ, Dept Commun & Comp Engn, Kyoto, Japan	He, Y (reprint author), Delft Univ Technol, Sect Microwave Sensing Signals & Syst, Delft, Netherlands.	eric.yuanhe@gmail.com					Andric M, 2014, RADIOENGINEERING, V23, P11; Chetty K, 2012, IEEE T GEOSCI REMOTE, V50, P1218, DOI 10.1109/TGRS.2011.2164411; He Y, 2014, IET RADAR SONAR NAV, V8, P1215, DOI 10.1049/iet-rsn.2014.0021; Thayaparan T, 2007, IET RADAR SONAR NAV, V1, P289, DOI [10.1049/iet-rsn:20060103, 10.1049/ict-rsn:20060103]; He Y, 2014, INT J MICROW WIREL T, V6, P423, DOI 10.1017/S1759078714000087; Howland PE, 2005, IEE P-RADAR SON NAV, V152, P107, DOI 10.1049/ip-rsn:20045077; Lai CP, 2008, IET RADAR SONAR NAV, V2, P244, DOI 10.1049/iet-rsn:20070140; Zabalza J, 2014, IEEE T AERO ELEC SYS, V50, P2304, DOI 10.1109/TAES.2014.130082; Thayaparan T, 2008, J FRANKLIN I, V345, P700, DOI 10.1016/j.jfranklin.2008.01.003; Smith GE, 2010, IET SIGNAL PROCESS, V4, P224, DOI 10.1049/iet-spr.2009.0058; van Dorp P, 2003, IEE P-RADAR SON NAV, V150, P356, DOI 10.1049/ip-rsn:20030568; Chen VC, 2011, ARTECH HSE RADAR LIB, P1; DRILLIS R, 1964, Artif Limbs, V8, P44; Fogle O. R., 2011, THESIS; He Y., 2014, THESIS; Mahafza B. R., 2000, RADAR SYSTEMS ANAL D; Oppenheim A. V., 1999, DISCRETE TIME SIGNAL; Richards M A, 2010, PRINCIPLES MODERN RA; Wang G, 2003, IEE P-RADAR SON NAV, V150, P292, DOI 10.1049/ip-rsn:20030700	19	0	0	INST ENGINEERING TECHNOLOGY-IET	HERTFORD	MICHAEL FARADAY HOUSE SIX HILLS WAY STEVENAGE, HERTFORD SG1 2AY, ENGLAND	1751-8784	1751-8792		IET RADAR SONAR NAV	IET Radar Sonar Navig.	DEC	2015	9	9			SI		1240	1250		10.1049/iet-rsn.2015.0065		11	Telecommunications	Telecommunications	CX7BK	WOS:000365855500014		
J	Saxena, A; Upadhyay, R; Kango, N				Saxena, Akansha; Upadhyay, Ramraj; Kango, Naveen			Isolation and identification of actinomycetes for production of novel extracellular glutaminase free L-asparaginase	INDIAN JOURNAL OF EXPERIMENTAL BIOLOGY			English	Article						Actinobacteria; Acute lymphoblastic leukemia (ALL); L-Glutaminase; Leukemia; Streptomyces	ENHANCED PRODUCTION; PURIFICATION; OPTIMIZATION; ENZYMES	Over the recent years glutaminase free L-asparaginase has gained more importance due to better therapeutic properties for treatment of acute lymphoblastic leukemia. Actinomycetes are known for L-asparaginase activity. In the current study, 80 actinomycetes were isolated from various soil habitats by serial dilution technique. Presence of L-asparaginase was investigated in a total of 240 actinomycetes by tubed agar method using modified M-9 medium. A total of 165 actinomycetes were found positive for L-asparaginase activity. Among these, 57 actinomycetes producing larger zones of L-asparagine hydrolysis were further screened for their capacity to produce glutaminase-free L-asparaginase. Four L-glutaminase-free actinomycetes were found to be potential L-asparaginase producers. These actinomycetes were identified as Streptomyces cyaneus (SAP 1287, CFS 1560), S. exfoliates (CFS 1557) and S. phaeochromogenes (GS 1573) on the basis of morphological and biochemical identification studies. Maximum L-asparaginase activity (19.2 Uml(-1)) was observed in culture filtrate of S. phaeochromogenes under submerged fermentation. Results indicate that S. phaeochromogenes could be a potential source of glutaminase free L-asparaginase for commercial purpose. To the best of our knowledge, this is the first report on production of glutaminase free L-asparaginase from S. cyaneus, S. exfoliatus and S. phaeochromogenes	[Saxena, Akansha; Upadhyay, Ramraj; Kango, Naveen] Dr Hari Singh Gour Vishwavidyalaya, Dept Appl Microbiol, Saga 470001, Japan	Saxena, A (reprint author), Dr Hari Singh Gour Vishwavidyalaya, Dept Appl Microbiol, Saga 470001, Japan.	akanksha.saxena14@gmail.com			Madhya Pradesh Biotechnology Council, Bhopal	One of the authors, AS, acknowledges Madhya Pradesh Biotechnology Council, Bhopal for providing financial support during work tenure.	Abdel-Fattah YR, 1998, EGYPT J MICROBIOL, V30, P155; Gunasekaran Suresh, 1995, Biomedical Letters, V52, P197; Muller HJ, 1998, CRIT REV ONCOL HEMAT, V28, P97, DOI 10.1016/S1040-8428(98)00015-8; DESAI AJ, 1969, J BACTERIOL, V100, P149; Peela S, 2005, WORLD J MICROB BIOT, V21, P583, DOI 10.1007/s11274-004-3493-5; Sahu MK, 2007, J ENVIRON BIOL, V28, P465; Sarquis MID, 2004, MEM I OSWALDO CRUZ, V99, P489, DOI 10.1590/S0074-02762004000500005; MANNA S, 1995, CURR MICROBIOL, V30, P291, DOI 10.1007/BF00295504; DEJONG PJ, 1972, APPL MICROBIOL, V23, P1163; Narta UK, 2007, CRIT REV ONCOL HEMAT, V61, P208, DOI 10.1016/j.critrevonc.2006.07.009; Kumar S, 2009, APPL MICROBIOL BIOT, V84, P477, DOI 10.1007/s00253-009-1973-0; Schippers A, 2002, INT J SYST EVOL MICR, V52, P2291, DOI 10.1099/ijs.0.02279-0; Velho-Pereira S, 2013, INDIAN J EXP BIOL, V51, P573; Bansal S, 2010, BIOCHEMISTRY-MOSCOW+, V75, P375, DOI 10.1134/S0006297910030144; Thomas L, 2013, INDIAN J EXP BIOL, V51, P875; Geckil H, 2004, APPL MICROBIOL BIOT, V63, P691, DOI 10.1007/s00253-003-1482-5; Amena S, 2010, BRAZ J MICROBIOL, V41, P173, DOI 10.1590/S1517-838220100001000025; Singh Y, 2013, INDIAN J EXP BIOL, V51, P322; Saxena A, 2013, J SCI IND RES INDIA, V72, P491; Prakash D, 2013, INDIAN J EXP BIOL, V51, P969; Dhevagi P., 2006, Indian Journal of Biotechnology, V5, P514; Gulati R, 1997, LETT APPL MICROBIOL, V24, P23, DOI 10.1046/j.1472-765X.1997.00331.x; Narayana KJP, 2008, INDIAN J MICROBIOL, V48, P331, DOI 10.1007/s12088-008-0018-1; Mahajan RV, 2012, BIORESOURCE TECHNOL, V125, P11, DOI 10.1016/j.biortech.2012.08.086; Chaphalkar SR, 1998, INDIAN J BIOCH BIOPH, V35; Cross T, 1989, BERGEYS MANUAL SYSTE, VV, P2340; Gallagher M P, 1989, Essays Biochem, V24, P1; Lapmak K, 2010, CHIANG MAI J SCI, V37, P160; MOSTAFA S A, 1979, Zentralblatt fuer Bakteriologie Parasitenkunde Infektionskrankheiten und Hygiene Zweite Naturwissenschaftliche Abteilung Mikrobiologie der Landwirtschaft der Technologie und des Umweltschutzes, V134, P429; Kumar V, 2012, BRAZ J MICROBIOL, V43, P205, DOI [10.1590/S1517-838220120001000022, 10.1590/S1517-83822012000100022]; Patil NN, 2014, INDIAN J EXP BIOL, V52, P1147; Savitri AN, 2003, INDIAN J BIOTECHNOL, V2, P184; SHIRLING E. B., 1966, INT J SYST BACTERIOL, V16, P313; Upadhyay R, 2012, ASIAN J PHARM CLIN R, V5, P135; Williams S. I., 1989, BERGEYS MANUAL SYSTE, P2452; Wriston JC, 1970, METHODS ENZYMOLOGY A, V17A, P732, DOI 10.1016/0076-6879(71)17273-4	36	0	0	NATL INST SCIENCE COMMUNICATION-NISCAIR	NEW DELHI	DR K S KRISHNAN MARG, PUSA CAMPUS, NEW DELHI 110 012, INDIA	0019-5189	0975-1009		INDIAN J EXP BIOL	Indian J. Exp. Biol.	DEC	2015	53	12					786	793				8	Biology	Life Sciences & Biomedicine - Other Topics	CY2FT	WOS:000366224900003		
J	Tashiro, Y; Murakami, A; Goizuka, R; Shimizu, T; Kishimoto, H; Azuma, T				Tashiro, Yasuyuki; Murakami, Akikazu; Goizuka, Ryo; Shimizu, Takeyuki; Kishimoto, Hidehiro; Azuma, Takachika			An asymmetric antibody repertoire is shaped between plasmablasts and plasma cells after secondary immunization with (4-hydroxy-3-nitrophenyl)acetyl chicken gamma-globulin	INTERNATIONAL IMMUNOLOGY			English	Article						affinity maturation; antibody; memory B cells; somatic hypermutation	PRIMARY IMMUNE-RESPONSE; CENTER B-CELLS; AFFINITY MATURATION; SOMATIC MUTATION; CYTOKINE SECRETION; HEAVY-CHAIN; MEMORY B; ANTIGEN; NP; COMPETITION	Studies on the structural basis of antibody affinity maturation have been carried out by measuring the affinity of secreted antibodies, and information on structures has often been obtained from nucleotide sequences of BCRs of memory B cells. We considered it important to establish whether the repertoire of secreted antibodies from plasma cells is really in accord with that of BCRs on memory B cells at the same time points post-immunization. We isolated plasma cells secreting antibodies specific to (4-hydroxy-3-nitrophenyl) acetyl (NP) hapten by affinity matrix technology using biotin-anti-CD138 and streptavidin-NP-allophycocyanin, to which anti-NP antibodies secreted by autologous plasma cells bound preferentially. We found that plasmablasts occupied > 90% of the antibody-secreting cell compartment in the primary response and that they secreted antibodies whose V-H regions were encoded by V186.2(+)Tyr95(+) sequences, which provided an increase in the medium level of affinity by somatic hypermutation (SHM) of heavy chains at position 33. After secondary immunization, a further increase in antibody affinity was observed, which was explained by the appearance of a number of plasma cells secreting V186.2(+)Gly95(+) antibodies that acquired high affinity by multiple SHMs as well as plasmablasts secreting V186.2(+)Tyr95(+) antibodies. However, we did not detect any plasmablasts secreting V186.2(+)Gly95(+) antibodies, showing that plasmablasts and plasma cells have a different antibody repertoire, i.e. their respective repertoires are asymmetric. On the basis of these findings, we discussed the relationship between the BCR affinity of memory B cells and plasmablasts as well as plasma cells as pertaining to their ontogeny.	[Tashiro, Yasuyuki; Goizuka, Ryo] Tokyo Univ Sci, Res Inst Biomed Sci, Div Dev & Aging, Chiba 2780022, Japan; [Tashiro, Yasuyuki; Murakami, Akikazu; Azuma, Takachika] Tokyo Univ Sci, Res Inst Biomed Sci, Div Biosignaling, Chiba 2780022, Japan; [Tashiro, Yasuyuki] Tokyo Univ Sci, Ctr Anim Dis Models, Chiba 2780022, Japan; [Murakami, Akikazu; Kishimoto, Hidehiro] Univ Ryukyus, Grad Sch Med, Dept Parasitol & Immunopathoetiol, Nishihara, Okinawa 9030215, Japan; [Shimizu, Takeyuki] Kochi Univ, Kochi Med Sch, Dept Immunol, Kochi 7838505, Japan	Azuma, T (reprint author), Tokyo Univ Sci, Res Inst Biomed Sci, Div Biosignaling, Chiba 2780022, Japan.	tazuma@rs.noda.tus.ac.jp					BOTHWELL ALM, 1981, CELL, V24, P625, DOI 10.1016/0092-8674(81)90089-1; GU H, 1991, J EXP MED, V173, P1357, DOI 10.1084/jem.173.6.1357; Manz RA, 1998, INT IMMUNOL, V10, P1703, DOI 10.1093/intimm/10.11.1703; Wiens GD, 2003, J IMMUNOL, V170, P5095; Nishimura M, 2011, INT IMMUNOL, V23, P271, DOI 10.1093/intimm/dxr002; Benedict CL, 2000, IMMUNOL REV, V175, P150, DOI 10.1111/j.1600-065X.2000.imr017518.x; Murakami A, 2010, MOL IMMUNOL, V48, P48, DOI 10.1016/j.molimm.2010.09.013; AZUMA T, 1987, MOL IMMUNOL, V24, P287; GRIFFITHS GM, 1984, NATURE, V312, P271, DOI 10.1038/312271a0; Takahashi Y, 1998, J EXP MED, V187, P885, DOI 10.1084/jem.187.6.885; BEREK C, 1985, NATURE, V316, P412, DOI 10.1038/316412a0; SIDMAN C, 1981, CELL, V23, P379, DOI 10.1016/0092-8674(81)90133-1; Phan TG, 2006, J EXP MED, V203, P2419, DOI 10.1084/jem.20061254; Furukawa K, 1999, IMMUNITY, V11, P329, DOI 10.1016/S1074-7613(00)80108-9; Brosterhus H, 1999, EUR J IMMUNOL, V29, P4053, DOI 10.1002/(SICI)1521-4141(199912)29:12<4053::AID-IMMU4053>3.0.CO;2-C; Sagawa T, 2003, MOL IMMUNOL, V39, P801, DOI 10.1016/S0161-5890(02)00282-1; Oracki SA, 2010, IMMUNOL REV, V237, P140, DOI 10.1111/j.1600-065X.2010.00940.x; MANZ R, 1995, P NATL ACAD SCI USA, V92, P1921, DOI 10.1073/pnas.92.6.1921; Kallies A, 2004, J EXP MED, V200, P967, DOI 10.1084/jcm.20040973; CUMANO A, 1986, EMBO J, V5, P2459; Smith KGC, 1997, EMBO J, V16, P2996, DOI 10.1093/emboj/16.11.2996; Guo WX, 1997, INT IMMUNOL, V9, P665, DOI 10.1093/intimm/9.5.665; Le TVL, 2008, J IMMUNOL, V181, P6027; Radbruch A, 2006, NAT REV IMMUNOL, V6, P741, DOI 10.1038/nri1886; Manz RA, 1997, NATURE, V388, P133, DOI 10.1038/40540; Yoshida T, 2010, IMMUNOL REV, V237, P117, DOI 10.1111/j.1600-065X.2010.00938.x; TORIGOE H, 1995, J BIOL CHEM, V270, P22218; Campbell JDM, 2003, METHODS, V31, P150, DOI 10.1016/S1046-2023(03)00125-7; Kabat E. A., 1991, SEQUENCES PROTEINS I	29	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0953-8178	1460-2377		INT IMMUNOL	Int. Immunol.	DEC	2015	27	12					609	620		10.1093/intimm/dxv040		12	Immunology	Immunology	CY4OY	WOS:000366389000002		
J	Morimoto, Y; Baba, T; Sasaki, T; Hiramatsu, K				Morimoto, Yuh; Baba, Tadashi; Sasaki, Takashi; Hiramatsu, Keiichi			Apigenin as an anti-quinolone-resistance antibiotic	INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS			English	Article						Apigenin; Nybomycin; Quinolone resistance; gyrA mutations; Reverse antibiotic	STAPHYLOCOCCUS-AUREUS; ANTIBACTERIAL ACTIVITY; ANTIMICROBIAL ACTIVITY; DNA GYRASE; INHIBITORS; FLAVONOIDS	We previously reported the first 'reverse antibiotic' (RA), nybomycin (NYB), which showed a unique antimicrobial activity against Staphylococcus aureus strains. NYB specifically suppressed the growth of quinolone-resistant S. aureus strains but was not effective against quinolone-susceptible strains. Although NYB was first reported in 1955, little was known about its unique antimicrobial activity because it was before the synthesis of the first quinolone ('old quinolone'), nalidixic acid, in 1962. Following our re-discovery of NYB, we looked for other RAs among natural substances that act on quinolone-resistant bacteria. Commercially available flavones were screened against S. aureus, including quinolone-resistant strains, and their minimum inhibitory concentrations (MICs) were compared using the microbroth dilution method. Some of the flavones screened showed stronger antimicrobial activity against quinolone-resistant strains than against quinolone-susceptible ones. Amongst them, apigenin (API) was the most potent in its RA activity. DNA cleavage assay showed that API inhibited DNA gyrase harbouring the quinolone resistance mutation gyrA(Ser84Leu) but did not inhibit 'wild-type' DNA gyrase that is sensitive to levofloxacin. An API-susceptible S. aureus strain Mu50 was also selected using agar plates containing 20 mg/L API. Whole-genome sequencing of selected mutant strains was performed and frequent back-mutations (reverse mutations) were found among API-resistant strains derived from the API-susceptible S. aureus strains. Here we report that API represents another molecular class of natural antibiotic having RA activity against quinolone-resistant bacteria. (C) 2015 The Authors. Published by Elsevier B.V.	[Morimoto, Yuh; Baba, Tadashi; Hiramatsu, Keiichi] Juntendo Univ, Ctr Excellence Infect Control Sci, Grad Sch Med, Bunkyo Ku, Tokyo 1138421, Japan; [Sasaki, Takashi] Juntendo Univ, Dept Bacteriol, Fac Med, Bunkyo Ku, Tokyo 1138421, Japan	Hiramatsu, K (reprint author), Juntendo Univ, Ctr Excellence Infect Control Sci, Grad Sch Med, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	khiram06@juntendo.ac.jp			MEXT (Japanese Ministry of Education, Culture, Sports, Science and Technology) [S1201013]	This study was supported in part by a Grant-in-Aid [S1201013] from MEXT (Japanese Ministry of Education, Culture, Sports, Science and Technology) Supported Program for the Strategic Research Foundation at Private University, 2012-2016.	Fukuda H, 1998, ANTIMICROB AGENTS CH, V42, P1917; Andersson MI, 2003, J ANTIMICROB CHEMOTH, V51, P1, DOI 10.1093/jac/dkg212; Lee JH, 2012, CURR MICROBIOL, V65, P726, DOI 10.1007/s00284-012-0229-x; Wu DL, 2008, INT J ANTIMICROB AG, V32, P421, DOI 10.1016/j.ijantimicag.2008.06.010; Bussmann RW, 2010, J ETHNOPHARMACOL, V132, P101, DOI 10.1016/j.jep.2010.07.048; Fisher L. Mark, 2008, V142, P11, DOI 10.1007/978-1-59745-246-5_2; Hiramatsu K, 2012, INT J ANTIMICROB AG, V39, P478, DOI 10.1016/j.ijantimicag.2012.02.007; Cushnie TPT, 2005, INT J ANTIMICROB AG, V26, P343, DOI 10.1016/j.ijantimicag.2005.09.002; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Tsuchiya H, 1996, J ETHNOPHARMACOL, V50, P27, DOI 10.1016/0378-8741(96)85514-0; Bernard FX, 1997, ANTIMICROB AGENTS CH, V41, P992; Farzaei MH, 2013, J TRADIT CHIN MED, V33, P815; STRELITZ F, 1955, P NATL ACAD SCI USA, V41, P620, DOI 10.1073/pnas.41.9.620; Sato Y, 2000, J ETHNOPHARMACOL, V72, P483, DOI 10.1016/S0378-8741(00)00265-8; Cushnie TPT, 2011, INT J ANTIMICROB AG, V38, P99, DOI 10.1016/j.ijantimicag.2011.02.014; Cheynier V, 2013, PLANT PHYSIOL BIOCH, V72, P1, DOI 10.1016/j.plaphy.2013.05.009; Hilliard JJ, 1995, ADV EXP MED BIOL, V390, P59; Bagla VP, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-383; Clinical and Laboratory Standards Institute, 2009, M07A8 CLSI; Goto T, 2015, CYTOTECHNOLOGY, V67, P357, DOI 10.1007/s10616-014-9694-3; Hiramatsu K, 2014, J INFECT CHEMOTHER, V20, P593, DOI 10.1016/j.jiac.2014.08.001; Singh Ompal, 2011, Pharmacogn Rev, V5, P82, DOI 10.4103/0973-7847.79103	22	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0924-8579	1872-7913		INT J ANTIMICROB AG	Int. J. Antimicrob. Agents	DEC	2015	46	6					666	673		10.1016/j.ijantimicag.2015.09.006		8	Infectious Diseases; Microbiology; Pharmacology & Pharmacy	Infectious Diseases; Microbiology; Pharmacology & Pharmacy	CY3AT	WOS:000366280900010		
J	Endo, S; Sasaki, T; Onishi, K; Kazebayashi, Y; Hirai, N; Minami, Y; Toyoshima, E; Yamamoto, Y; Kishino, S; Ohsaki, Y				Endo, Satoshi; Sasaki, Takaaki; Onishi, Kaori; Kazebayashi, Yoshihiro; Hirai, Noriko; Minami, Yoshinori; Toyoshima, Eri; Yamamoto, Yasushi; Kishino, Satoshi; Ohsaki, Yoshinobu			Analysis of garenoxacin distribution in the mediastinum using endobronchial ultrasound-guided transbronchial needle aspiration	INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS			English	Letter									[Endo, Satoshi; Sasaki, Takaaki; Onishi, Kaori; Kazebayashi, Yoshihiro; Hirai, Noriko; Minami, Yoshinori; Toyoshima, Eri; Yamamoto, Yasushi; Ohsaki, Yoshinobu] Asahikawa Med Univ, Resp Ctr, Asahikawa, Hokkaido 0788510, Japan; [Kishino, Satoshi] Meiji Pharmaceut Univ, Dept Medicat Use Anal & Clin Res, Tokyo, Japan	Sasaki, T (reprint author), Asahikawa Med Univ, Resp Ctr, 2-1-1-1 Midorigaoka Higashi, Asahikawa, Hokkaido 0788510, Japan.	takaaki6@asahikawa-med.ac.jp					Fung-Tomc JC, 2002, INT J ANTIMICROB AG, V20, P57, DOI 10.1016/S0924-8579(02)00109-7; Yasufuku K, 2004, CHEST, V126, P122, DOI 10.1378/chest.126.1.122; Takagi H, 2008, INT J ANTIMICROB AG, V32, P468, DOI 10.1016/j.ijantimicag.2008.06.032; Ohsaki Y, 2010, INT J ANTIMICROB AG, V35, P603, DOI 10.1016/j.ijantimicag.2010.01.020; Watanabe A, 2007, JPN J CHEMOTHER, V55, P162	5	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0924-8579	1872-7913		INT J ANTIMICROB AG	Int. J. Antimicrob. Agents	DEC	2015	46	6					721	722		10.1016/i.ijantimicag.2015.10.001		3	Infectious Diseases; Microbiology; Pharmacology & Pharmacy	Infectious Diseases; Microbiology; Pharmacology & Pharmacy	CY3AT	WOS:000366280900020		
J	Yoshida, M; Igarashi, H; Iwasaki, K; Fuse, S; Togashi, A				Yoshida, Masanori; Igarashi, Hitoshi; Iwasaki, Kento; Fuse, Sayaka; Togashi, Aya			Evaluation of Viscosity of Non-Newtonian Liquid Foods with a Flow Tube Instrument	INTERNATIONAL JOURNAL OF FOOD ENGINEERING			English	Article						liquid food; non-Newtonian; viscosity; flow tube; bubble viscometer	STAGNANT LIQUIDS; GAS-BUBBLES; TAYLOR; VELOCITY; FLUID	In a flow tube instrument modeled after a structurally simple and easy-to-use bubble viscometer, bubble ascent and liquid flow were examined to evaluate the physically defined viscosity of non-Newtonian liquid foods. For Newtonian and non-Newtonian test liquids, a dimensionless expression between the friction coefficient and Reynolds number, which was derived through analysis as an annular flow of liquid around bubble, indicated that the flow in the instrument was laminar. Prediction organized based on the empirical relation was advanced for evaluation of the non-Newtonian viscosity. The flow tube instrument was expected to be applicable to the conditions in drinking and eating, from a viewpoint of the characteristic shear rate ranging from 10 to 100 s(-1).	[Yoshida, Masanori; Igarashi, Hitoshi; Iwasaki, Kento; Fuse, Sayaka] Muroran Inst Technol, Dept Appl Sci, Muroran, Hokkaido 0508585, Japan; [Togashi, Aya] Niigata Univ, Dept Chem & Chem Engn, Niigata 9502181, Japan	Yoshida, M (reprint author), Muroran Inst Technol, Dept Appl Sci, 27-1 Mizumotocho, Muroran, Hokkaido 0508585, Japan.	myoshida@mmm.muroran-it.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	This work was partly supported by a Grant-in-Aid for Scientific Research (C) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	FARAROUI A, 1961, T SOC RHEOL, V5, P369; Briggs JL, 1996, J TEXTURE STUD, V27, P671, DOI 10.1111/j.1745-4603.1996.tb01000.x; Perona P, 2005, APPL RHEOL, V15, P218; Viana F, 2003, J FLUID MECH, V494, P379, DOI 10.1017/S0022112003006165; Bugg JD, 1998, INT J MULTIPHAS FLOW, V24, P271, DOI 10.1016/S0301-9322(97)00047-5; Tudose ET, 1999, CHEM ENG SCI, V54, P5761, DOI 10.1016/S0009-2509(99)00149-9; Araujo JDP, 2012, INT J MULTIPHAS FLOW, V43, P131, DOI 10.1016/j.ijmultiphaseflow.2012.03.007; Feng JQ, 2008, J FLUID MECH, V609, P377, DOI 10.1017/S0022112008002516; Germain I, 2006, J FOOD ENG, V73, P64, DOI 10.1016/j.jfoodeng.2005.01.006; Smith TL, 2004, J AM DIET ASSOC, V104, P969, DOI 10.1016/j.jada.2004.03.025; Nakauma M, 2011, FOOD HYDROCOLLOID, V25, P1165, DOI 10.1016/j.foodhyd.2010.11.003; Sousa RG, 2004, J FLUID MECH, V511, P217, DOI 10.1017/S0022112004009644; Bugg JD, 2002, INT J MULTIPHAS FLOW, V28, P791, DOI 10.1016/S0301-9322(02)00002-2; [Anonymous], 2013, BYK GARDNER GMBH CAT, P237; BROWN RAS, 1965, CAN J CHEM ENG, V43, P217; Barr G, 1926, PHILOS MAG SER, V7, P395; Clift R, 2005, BUBBLES DROPS PARTIC, P238; Hong SR, 2012, INT J FOOD ENG, V8, DOI 10.1515/1556-3758.2215; Logemann JA, 2000, EVALUATION TREATMENT, P12; Mezger TG, 2006, RHEOLOGY HDB, P203; Nogueira S, 2006, CHEM ENG SCI, V61, P845, DOI 10.1016/j.ces.2005.07.038; Yoshida M, 2013, J FOOD SCI ENG, V3, P411	22	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	2194-5764	1556-3758		INT J FOOD ENG	Int. J. Food Eng.	DEC	2015	11	6					815	823		10.1515/ijfe-2015-0138		9	Food Science & Technology	Food Science & Technology	CX9WX	WOS:000366058300009		
J	Kawaguchi, R; Tanase, Y; Haruta, S; Yoshida, S; Furukawa, N; Kobayashi, H				Kawaguchi, Ryuji; Tanase, Yasuhito; Haruta, Shoji; Yoshida, Shozo; Furukawa, Naoto; Kobayashi, Hiroshi			Addition of aprepitant to standard therapy for prevention of nausea and vomiting among patients with cervical cancer undergoing concurrent chemoradiotherapy	INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS			English	Editorial Material						Aprepitant; Chemoradiotherapy; Cisplatin; Nausea; Vomiting			[Kawaguchi, Ryuji; Tanase, Yasuhito; Haruta, Shoji; Yoshida, Shozo; Furukawa, Naoto; Kobayashi, Hiroshi] Nara Med Univ, Dept Obstet & Gynecol, Kashihara, Nara 6348522, Japan	Kawaguchi, R (reprint author), Nara Med Univ, Dept Obstet & Gynecol, 840 Shijo Cho, Kashihara, Nara 6348522, Japan.	kawaryu@naramed-u.ac.jp					Cohen L, 2007, SUPPORT CARE CANCER, V15, P497, DOI 10.1007/s00520-006-0173-z; RICHARDSON JL, 1988, J CLIN ONCOL, V6, P1746; Morris M, 1999, NEW ENGL J MED, V340, P1137, DOI 10.1056/NEJM199904153401501; Peters III WA, 2000, CLIN ONCOL, V18, P1606	4	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0020-7292	1879-3479		INT J GYNECOL OBSTET	Int. J. Gynecol. Obstet.	DEC	2015	131	3					312	313		10.1016/j.ijgo.2015.05.030		2	Obstetrics & Gynecology	Obstetrics & Gynecology	CY0EK	WOS:000366079000023		
J	Akoshima, M; Abe, H; Baba, T				Akoshima, M.; Abe, H.; Baba, T.			Development of Reference Materials for Thermal-Diffusivity Measurements by the Flash Method	INTERNATIONAL JOURNAL OF THERMOPHYSICS			English	Article						Certified reference materials; Flash method; Graphite; Specific heat capacity; Thermal conductivity; Thermal diffusivity	HEAT-CAPACITY; TEMPERATURE; UNCERTAINTY; STANDARD	The thermal conductivity of solid materials used for thermal simulations and thermal designs can be obtained as the product of thermal diffusivity, specific heat capacity, and bulk density in many cases. The thermal diffusivity is usually measured by the flash method, and the specific heat capacity is usually measured by differential scanning calorimetry. In order to obtain reliable thermal conductivities for strict thermal design, it is necessary to measure the thermal diffusivity using the flash method, a well-validated apparatus. Reference materials are an effective means for validation of most practical measurement apparatus. For the flash method, isotropic graphite was selected as a candidate reference material. A batch of isotropic graphite samples was prepared and characterized in detail in order to be a certified reference material for thermal-diffusivity measurement. The detailed characterization ensures the traceability of the measurement results to the international system of units (SI). A convenient reference material for thermal conductivity was also obtained by using the known thermal-diffusivity measurements, specific heat capacity, and density of the material.	[Akoshima, M.; Abe, H.] AIST, Natl Metrol Inst Japan, Thermophys Properties Sect, Tsukuba, Ibaraki 3058563, Japan; [Baba, T.] AIST, Natl Metrol Inst Japan, Tsukuba, Ibaraki 3058563, Japan	Akoshima, M (reprint author), AIST, Natl Metrol Inst Japan, Thermophys Properties Sect, Cent 3,Umezono 1-1-1, Tsukuba, Ibaraki 3058563, Japan.	m-akoshima@aist.go.jp					Abe H, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.11RG01; Akoshima M., 2004, P 24 JPN S THERM PRO, P261; PARKER WJ, 1961, J APPL PHYS, V32, P1679, DOI 10.1063/1.1728417; Ogawa M, 2001, MEAS SCI TECHNOL, V12, P2058, DOI 10.1088/0957-0233/12/12/305; [Anonymous], 2008, 9832008 ISOIEC; JOSELL D, 1995, J APPL PHYS, V78, P6867, DOI 10.1063/1.360452; Rudtsch S, 2002, THERMOCHIM ACTA, V382, P17, DOI 10.1016/S0040-6031(01)00730-4; [Anonymous], 2009, GEN REQ COMP REF MAT; Akoshima M, 2006, THERM COND, V28, P497; CAPE JA, 1963, J APPL PHYS, V34, P1909, DOI 10.1063/1.1729711; Akoshima M, 2006, INT J THERMOPHYS, V27, P1189, DOI 10.1007/s10765-006-0091-9; Baba T, 2001, MEAS SCI TECHNOL, V12, P2046, DOI 10.1088/0957-0233/12/12/304; [Anonymous], 2005, 170252005 ISOIEC; Akoshima M, 2013, INT J THERMOPHYS, V34, P778, DOI 10.1007/s10765-013-1470-7; ARCHER DG, 1993, J PHYS CHEM REF DATA, V22, P1441; Bennet S., 2007, EVOLVING NEEDS METRO; Kelly B.T., 1981, PHYS GRAPHITE; Munro R.G., 2003, SPECIAL PUBLICATION, V960-11, P6; Ziman J.M., 2001, OXFORD CLASSIC TEXTS	19	0	0	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0195-928X	1572-9567		INT J THERMOPHYS	Int. J. Thermophys.	DEC	2015	36	12			SI		3272	3287		10.1007/s10765-015-1996-y		16	Thermodynamics; Chemistry, Physical; Mechanics; Physics, Applied	Thermodynamics; Chemistry; Mechanics; Physics	CY0TZ	WOS:000366120500002		
J	Takeda, N; Oizumi, T; Tsuji, T; Akao, S; Takayanagi, K; Nakaso, N; Yamanaka, K				Takeda, N.; Oizumi, T.; Tsuji, T.; Akao, S.; Takayanagi, K.; Nakaso, N.; Yamanaka, K.			Deep Sub-micro Water-Vapor Measurement by Dual-Ball SAW Sensors for Temperature Compensation	INTERNATIONAL JOURNAL OF THERMOPHYSICS			English	Article						Dual-ball SAW sensor; Humidity; Hygrometer; Trace moisture	SURFACE-ACOUSTIC-WAVE; SPHERE	A collimated surface acoustic wave (SAW) circles around the equator of a sphere hundreds of times. Because of the long distance travel of the collimated SAW, a small change in the SAW propagation caused by the environment of the sphere can be accumulated as a measurable range in amplitude and/or in delay time. So, a spherical SAW device enables highly sensitive water-vapor measurements. In this paper, deep sub water-vapor detection by 1 mm diameter quartz crystal ball SAW sensors is described. To measure such a low water-vapor concentration in real time, it is necessary to compensate the temperature dependence of the ball SAW sensor, which is about 20 in delay time change. A dual-frequency burst analog detector was developed for the temperature compensation in real time. By using a harmonic SAW sensor, which was excited by 80 MHz and 240 MHz at the same time, it was confirmed that the delay time drift for a temperature range of became less than 0.05 ppm in delay time change. By using dual-ball SAW sensors (which included a 150 MHz sensor with a water-vapor sensitive layer and a 240 MHz sensor as a reference), water-vapor concentrations from 0.1 to were successfully measured. It appears that the delay time change is proportional to the square root of the water-vapor concentration. The detection limit determined by the electrical noise of the system was estimated at .	[Takeda, N.; Oizumi, T.; Tsuji, T.; Akao, S.; Yamanaka, K.] Tohoku Univ, Sendai, Miyagi 980, Japan; [Takayanagi, K.; Nakaso, N.] Toppan Printing Co Ltd, Saitama, Japan	Takeda, N (reprint author), Tohoku Univ, Sendai, Miyagi 980, Japan.	ntakeda@niche.tohoku.ac.jp					Abe H., 2009, SYNTHESIOLOGY, V2, P223; Abe H, 2006, SENSOR ACTUAT A-PHYS, V128, P202, DOI 10.1016/j.sna.2005.12.049; Takeda N, 2012, INT J THERMOPHYS, V33, P1642, DOI 10.1007/s10765-012-1223-z; Yamanaka K, 2000, APPL PHYS LETT, V76, P2797, DOI 10.1063/1.126481; Sim DY, 2008, JPN J APPL PHYS, V47, P4070, DOI 10.1143/JJAP.47.4070; Nakatsukasa T, 2006, JPN J APPL PHYS 1, V45, P4500, DOI 10.1143/JJAP.45.4500; Yamanaka K, 2006, IEEE T ULTRASON FERR, V53, P793, DOI 10.1109/TUFFC.2006.1621507; Ishikawa S, 2003, APPL PHYS LETT, V83, P4649, DOI 10.1063/1.1631061; Abe H, 2011, SENSOR ACTUAT A-PHYS, V165, P230, DOI 10.1016/j.sna.2010.11.005; Bell S. A., 2004, P 9 INT S TEMP THERM, P663; Hagiwara S., 2013, 3 INT S LAS ULTR ADV, P86; Tomozawa M., 2006, NEW GLASS, V21, P9	12	0	0	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0195-928X	1572-9567		INT J THERMOPHYS	Int. J. Thermophys.	DEC	2015	36	12			SI		3440	3452		10.1007/s10765-015-1967-3		13	Thermodynamics; Chemistry, Physical; Mechanics; Physics, Applied	Thermodynamics; Chemistry; Mechanics; Physics	CY0TZ	WOS:000366120500015		
J	Hamasaki, K; Hatta, S; Ishikawa, T; Yamashita, S; Dan, S; Kitada, S				Hamasaki, Katsuyuki; Hatta, Sora; Ishikawa, Takuma; Yamashita, Shota; Dan, Shigeki; Kitada, Shuichi			Emigration behavior and molting during the sea-to-land transition of terrestrial hermit crabs under laboratory conditions	INVERTEBRATE BIOLOGY			English	Article						coconut crab; land hermit crab; Birgus; Coenobita; megalopa	COENOBITA-COMPRESSUS EDWARDS,H.MILNE; PAGURUS-LONGICARPUS SAY; COCONUT CRAB; BIRGUS-LATRO; LARVAL DEVELOPMENT; SHELL PREFERENCE; MASS-PRODUCTION; WATER-BALANCE; ANOMURA; MEGALOPAE	Terrestrial hermit crabs in the family Coenobitidae (genera Coenobita and Birgus) must migrate onto land after completing a pelagic larval stage in the ocean. Better knowledge of emigration behavior would assist in the conservation and management of coenobitid populations by helping identify and protect the habitats they need to complete their life cycles. We cultured laboratory-born individuals of five coenobitid species (Coenobita cavipes, C. purpureus, C. rugosus, C. violascens, and Birgus latro) from megalopae to early juveniles (first, second, and/or third crabs) in vessels containing seawater and a hard substrate, and analyzed their behavior and molting in conjunction with our published data for C. brevimanus. Our results confirm that the coenobitids migrated from sea to land at the megalopal stage. Megalopae and early juveniles tended to select shells based on their body size. Inland-dwelling coenobitids, such as C. brevimanus, C. cavipes, and B. latro, had a longer duration from landing to first molt and had a prolonged first crab intermolt period compared with those of the beach-dwelling coenobitids C. purpureus, C. rugosus, and C. violascens, probably because of the adaptive traits for migrating to inland habitats. Little burrowing behavior was observed by megalopae of B. latro, but they had a strong tendency to be cryptic under shelters. Additionally, megalopae and early juveniles of Coenobita spp. created and utilized burrows somewhat differently. Our results suggest that coenobitids require specific microhabitats for completing their early life stages in the wild. In particular, megalopae of B. latro may need structurally complex refuges to migrate from the sea.	[Hamasaki, Katsuyuki; Hatta, Sora; Ishikawa, Takuma; Yamashita, Shota; Kitada, Shuichi] Tokyo Univ Marine Sci & Technol, Grad Sch Marine Sci & Technol, Minato Ku, Tokyo 1088477, Japan; [Dan, Shigeki] Fisheries Res Agcy, Natl Res Inst Fisheries & Environm Inland Sea, Res Ctr Marine Invertebrates, Hiroshima 7220061, Japan	Hamasaki, K (reprint author), Tokyo Univ Marine Sci & Technol, Grad Sch Marine Sci & Technol, Minato Ku, Tokyo 1088477, Japan.	hamak@kaiyodai.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [C20580198, B24310171]	We are grateful to the Okinawa Prefectural Board of Education for permission to collect and culture the land hermit crabs. We thank Bruno Pernet, Renae J. Brodie, and an anonymous reviewer for their constructive comments and suggestions, which have improved the manuscript. This study was supported by Grants-in-Aid for Scientific Research C20580198 and B24310171 from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Amesbury SS, 1980, U GUAM MARINE LAB TE, V66, P1; ANGER K., 2001, CRUSTACEAN ISS, V14, P420; SULKIN SD, 1984, MAR ECOL PROG SER, V15, P181, DOI 10.3354/meps015181; Hamasaki K, 2015, J EXP MAR BIOL ECOL, V468, P21, DOI 10.1016/j.jembe.2015.03.011; Hamasaki K, 2011, J EXP MAR BIOL ECOL, V403, P81, DOI 10.1016/j.jembe.2011.04.007; Brodie RJ, 2005, INVERTEBR BIOL, V124, P265, DOI 10.1111/j.1744-7410.2005.00024.x; Anger K, 2006, INVERTEBR REPROD DEV, V49, P175, DOI 10.1080/07924259.2006.9652207; Angel JE, 2000, J EXP MAR BIOL ECOL, V243, P169, DOI 10.1016/S0022-0981(99)00119-7; Hamasaki K, 2014, J CRUSTACEAN BIOL, V34, P309, DOI 10.1163/1937240X-00002229; Briffa M, 2005, BEHAV ECOL SOCIOBIOL, V59, P143, DOI 10.1007/s00265-005-0020-0; Sallam WS, 2008, BELG J ZOOL, V138, P13; Greenaway P, 2001, J CRUSTACEAN BIOL, V21, P317, DOI 10.1651/0278-0372(2001)021[0317:SAWBIF]2.0.CO;2; McLaughlin PA, 2010, RAFFLES B ZOOL, P5; FLETCHER WJ, 1990, J EXP MAR BIOL ECOL, V141, P63, DOI 10.1016/0022-0981(90)90158-9; Mantelatto FL, 2007, REV BIOL TROP, V55, P153; Brodie R, 2001, J CRUSTACEAN BIOL, V21, P715, DOI 10.1651/0278-0372(2001)021[0715:LDOTLH]2.0.CO;2; Turra A, 2004, MAR BIOL, V145, P251, DOI 10.1007/s00227-004-1323-9; Hamasaki K, 2009, AQUACULTURE, V292, P259, DOI 10.1016/j.aquaculture.2009.04.035; HERREID CF, 1986, J EXP BIOL, V120, P297; Osorno JL, 2005, J ZOOL, V266, P377, DOI 10.1017/S0952836905007028; HERREID CF, 1969, COMP BIOCHEM PHYSIOL, V28, P829, DOI 10.1016/0010-406X(69)92117-3; Hamasaki K, 2014, J NAT HIST, V48, P1061, DOI 10.1080/00222933.2013.861941; HARVEY AW, 1992, J CRUSTACEAN BIOL, V12, P196, DOI 10.2307/1549075; Brodie RJ, 2002, J EXP MAR BIOL ECOL, V272, P1, DOI 10.1016/S0022-0981(02)00039-4; Hamasaki K, 2013, J CRUSTACEAN BIOL, V33, P627, DOI 10.1163/1937240X-00002163; Kadiri-Jan T, 1998, ECOSCIENCE, V5, P275; Drew MM, 2010, ZOOL ANZ, V249, P45, DOI 10.1016/j.jcz.2010.03.001; REESE ES, 1968, SCIENCE, V161, P385, DOI 10.1126/science.161.3839.385; ROBERTS MH, 1971, BIOL BULL, V141, P162, DOI 10.2307/1540000; Brodie RJ, 1999, J EXP MAR BIOL ECOL, V241, P67, DOI 10.1016/S0022-0981(99)00068-4; GROSS WJ, 1964, BIOL BULL, V126, P54, DOI 10.2307/1539416; Bates D., 2014, LME4 LINEAR MIXED EF; BOOKHOUT C. G., 1964, OPHELIA, V1, P275; Brown I.W., 1991, ACIAR MONOGRAPH, V8, P1; Chemello R, 2009, ACTA OECOL, V35, P329; de Wilde PAWJ, 1973, STUD FAUNA CURACAO O, V144, P1; FLETCHER W J, 1990, Pacific Science, V44, P407; Fox J, 2011, R COMPANION APPL REG; Fujita Yoshihisa, 2008, Cancer, V17, P1; Greenaway Peter, 2003, Memoirs of Museum Victoria, V60, P13; Hamasaki Katsuyuki, 2011, Cancer, V20, P73; Hamasaki K., 2015, SEXUALITY EARLY DEV, V1, P93; Harms JW, 1938, JENAISCHE Z NATURWIS, V71, P1; Hartnoll R.G., 1988, P6, DOI 10.1017/CBO9780511753428.003; Held EE, 1965, NATURE, V200, P799; Kinzie III RA, 1968, CRUSTACEANA S, V2, P117; NAKASONE Y, 1988, ZOOL SCI, V5, P165; Nakasone Yukio, 2001, Pacific Science, V55, P157, DOI 10.1353/psc.2001.0016; Okinawa Prefectural Board of Education, 1987, AMAN REP DISTR EC LA; Pavia A, 2006, HERMIT CRAB YOUR HAP; Provenzano Jr AJ, 1965, B MAR SCI, V15, P617; R Core Team, 2014, R LANG ENV STAT COMP; REESE ERNST S., 1962, ANIMAL BEHAVIOUR, V10, P347, DOI 10.1016/0003-3472(62)90058-1; Schiller C., 1991, ACIAR MONOGRAPH, V8, P13; Thompson MT, 1903, P BOSTON SOC NAT HIS, V31, P147; Zuur A., 2009, MIXED EFFECTS MODELS	56	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1077-8306	1744-7410		INVERTEBR BIOL	Invertebr. Biol.	DEC	2015	134	4					318	331		10.1111/ivb.12107		14	Marine & Freshwater Biology; Zoology	Marine & Freshwater Biology; Zoology	CY4UB	WOS:000366403000006		
J	Iwai, S; Okano, S; Chikazawa, S; Kakizaki, T; Sakonju, I; Solomon, JA				Iwai, Satomi; Okano, Shozo; Chikazawa, Seishiro; Kakizaki, Takehiko; Sakonju, Iwao; Solomon, Jeffrey A.			Transcatheter arterial embolization for treatment of hepatocellular carcinoma in a cat	JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION			English	Article								Case Description-A 16-year-old 6.8-kg (15-lb) castrated male domestic shorthair cat was evaluated because of a 3 X 6-cm mass in the right medial lobe of the liver. Clinical Findings-The cat had a history of frequent vomiting and anorexia along with 10% weight loss over the past year. Treatment and Outcome-Transcatheter arterial embolization was selected because surgery (standard first-line treatment) was declined and only 1 vessel feeding the tumor was apparent on contrast-enhanced CT. A 4F sheath was placed in the left carotid artery, and a 3.3F guide catheter was advanced into the celiac artery. A 0.014-inch guidewire and 1.7F microcatheter were inserted into the hepatic artery through the guiding catheter and advanced into the feeding vessel. A mixture of polyvinyl alcohol particles and contrast agent was injected for embolization. A hypoechoic area in the tumor was identified on ultrasonography on posttreatment day 6, and necrotic and degenerated cells in the area were identified cytologically. By posttreatment day 71, vomiting had resolved and CT revealed decreased tumor size, but altered attenuation suggested a more solid mass on day 205. No feeding vessel for embolization was found on contrast-enhanced CT, so ultrasonic emulsification to remove the tumor was performed on day 231. No recurrence was seen on contrast-enhanced CT on day 420 or day 721.	[Iwai, Satomi; Okano, Shozo] Kitasato Univ, Sch Vet Med, Lab Small Anim Surg 2, Towada, Aomori 0348628, Japan; [Chikazawa, Seishiro] Kitasato Univ, Sch Vet Med, Lab Internal Med, Towada, Aomori 0348628, Japan; [Kakizaki, Takehiko] Kitasato Univ, Sch Vet Med, Lab Radiol, Towada, Aomori 0348628, Japan; [Sakonju, Iwao] Kitasato Univ, Sch Vet Med, Lab Small Anim Surg, Towada, Aomori 0348628, Japan; [Solomon, Jeffrey A.] Hosp Univ Penn, Sect Vasc & Intervent Radiol, Dept Radiol, Philadelphia, PA 19104 USA	Iwai, S (reprint author), Kitasato Univ, Sch Vet Med, Lab Small Anim Surg 2, 23-35-1 Higashi, Towada, Aomori 0348628, Japan.	iwai@vmas.kitasato-u.ac.jp					KNELLER SK, 1972, AM J VET RES, V33, P2111; Llovet JM, 2003, HEPATOLOGY, V37, P429, DOI 10.1053/jhep.2003.50047; Stampfl U, 2009, CARDIOVASC INTER RAD, V32, P303, DOI 10.1007/s00270-008-9495-1; LAWRENCE HJ, 1994, VET SURG, V23, P365, DOI 10.1111/j.1532-950X.1994.tb00496.x; Liptak JM, 2004, JAVMA-J AM VET MED A, V225, P1225, DOI 10.2460/javma.2004.225.1225; Siskin GP, 2003, J VASC INTERV RADIOL, V14, P89, DOI 10.1097/01.RVI.000052296.26939.4c; Hayashi M, 1999, AM J ROENTGENOL, V172, P969; Liguori G, 2010, BJU INT, V106, P500, DOI 10.1111/j.1464-410X.2009.09192.x; BEDNAROVA Z, 1986, Folia Morphologica (Prague), V34, P36; Fiore F, 2014, ENDOCRINE, V47, P177, DOI 10.1007/s12020-013-0130-9; Martin RA, 2003, TXB SMALL ANIMAL SUR, P706; Okubo H, 2004, THERAPEUTIC INTERVEN, P2; SMALLWOO.JE, 1973, AM J VET RES, V34, P955; Tacher V, 2013, JOVE-J VIS EXP, V2, P50795	14	0	0	AMER VETERINARY MEDICAL ASSOC	SCHAUMBURG	1931 N MEACHAM RD SUITE 100, SCHAUMBURG, IL 60173-4360 USA	0003-1488	1943-569X		JAVMA-J AM VET MED A	JAVMA-J. Am. Vet. Med. Assoc.	DEC 1	2015	247	11					1299	1302				4	Veterinary Sciences	Veterinary Sciences	CX3EE	WOS:000365577800035		
J	Gutierrez, M; Okano, T; Reginato, AM; Cazenave, T; Ventura-Rios, L; Bertolazzi, C; Pineda, C				Gutierrez, Marwin; Okano, Tadashi; Reginato, Anthony M.; Cazenave, Tomas; Ventura-Rios, Lucio; Bertolazzi, Chiara; Pineda, Carlos		Pan-Amer League Against Rheumatism	New Ultrasound Modalities in Rheumatology	JCR-JOURNAL OF CLINICAL RHEUMATOLOGY			English	Review						3D imaging; elastosonography; ultrasound carotid IMT; fusion imaging; rheumatology	CARPAL-TUNNEL-SYNDROME; SHEAR-WAVE ELASTOGRAPHY; INTIMA-MEDIA THICKNESS; REAL-TIME SONOELASTOGRAPHY; POWER DOPPLER SONOGRAPHY; MUSCULOSKELETAL ULTRASOUND; INTEROBSERVER RELIABILITY; DIFFERENTIAL-DIAGNOSIS; JOINT INFLAMMATION; HEALTHY-VOLUNTEERS	Over the years, ultrasound (US) has accumulated important evidence supporting its relevant role for the assessment of inflammatory processes of different rheumatologic diseases, as well as in the follow-up in assessing the response to different therapeutic approaches. This has been possible because of the increase in training, competency, and knowledge, as well as the rapid progress in the US technologies. Currently, some US machines can be equipped by sophisticated software modalities (i.e., 3-dimensional US, elastosonography, automated cardiovascular software, and fusion imaging) that can augment US traditional role as a safe, fast, and easy-to-perform modality and giving it new life and increased relevance in rheumatology. In this article, we evaluated the US developments, from conventional B-mode to more sophisticated technologies, and their potential clinical impact in the field of rheumatology. Three-dimensional US can improve the accuracy of the assessment of bone erosions and the quantification of power Doppler because of its multiplanar view including coronal, axial and sagital view. Elastosonography is still looking for its role in rheumatology. Preliminary works induce us to consider it as a promise tool for the assessment of tendon pathology and skin of patients with connective tissue disorders. The automated method for the measurement of carotid intima-media thickness permits a rapid and accurate assessment. The preliminary published data showed that it is reliable, and valid compared to the traditional method; they also support the future of rheumatologists as the direct operators in evaluating the cardiovascular risk in daily practice. Fusion imaging increases the diagnostic power of US, displaying simultaneously in the monitor, the US image, and the corresponding computed tomography/magnetic resonance imaging image. However, there are no sufficient data supporting its application in daily rheumatologic practice.	[Gutierrez, Marwin; Okano, Tadashi] Univ Politecn Marche, Clin Reumatol, Ancona, Italy; [Gutierrez, Marwin; Ventura-Rios, Lucio; Bertolazzi, Chiara; Pineda, Carlos] Inst Nacl Rehabil, Mexico City 143898, DF, Mexico; [Okano, Tadashi] Osaka City Univ, Grad Sch Med, Dept Orthoped Surg, Osaka 558, Japan; [Reginato, Anthony M.] Brown Univ, Warren Alpert Sch Med, Div Rheumatol, Providence, RI 02912 USA; [Cazenave, Tomas] Inst Rehabil Psicofis, Buenos Aires, DF, Argentina	Gutierrez, M (reprint author), Inst Nacl Rehabil, Calzada Mexico Xochimilco 289, Mexico City 143898, DF, Mexico.	dr.gmarwin@gmail.com					Leung VYF, 2013, RADIOLOGY, V269, P910, DOI 10.1148/radiol.13130128; Mauri G, 2014, IEEE ENG MED BIO, P5570, DOI 10.1109/EMBC.2014.6944889; Friedrich-Rust M, 2007, AM J ROENTGENOL, V188, P758, DOI 10.2214/AJR.06.0322; Klauser AS, 2013, RADIOLOGY, V267, P837, DOI 10.1148/radiol.13121936; Kane D, 2004, RHEUMATOLOGY, V43, P829, DOI 10.1093/rheumatology/keh215; Forzoni L, 2013, IEEE ENG MED BIO, P1394, DOI 10.1109/EMBC.2013.6609770; Naredo E, 2008, ARTHRITIS RHEUM, V58, P2248, DOI 10.1002/art.23682; Di Geso L, 2012, CLIN RHEUMATOL, V31, P881, DOI 10.1007/s10067-011-1915-y; De Zordo T, 2010, ULTRASCHALL MED, V31, P394, DOI 10.1055/s-0028-1109809; Kantarci F, 2014, EUR RADIOL, V24, P434, DOI 10.1007/s00330-013-3023-7; Pereira PL, 2000, AM J ROENTGENOL, V175, P265; de Miguel E, 2011, ANN RHEUM DIS, V70, P2008, DOI 10.1136/annrheumdis-2011-200352; Garra BS, 1997, RADIOLOGY, V202, P79; Miyamoto H, 2014, RADIOLOGY, V270, P809, DOI 10.1148/radiol.13131083; Zhang BL, 2014, ULTRASOUND MED BIOL, V40, P1400, DOI 10.1016/j.ultrasmedbio.2014.02.020; Naredo E, 2010, CLIN EXP RHEUMATOL, V28, P79; Di Mauro E, 2013, IEEE ENG MED BIO, P1406, DOI 10.1109/EMBC.2013.6609773; Naredo E, 2006, ANN RHEUM DIS, V65, P14, DOI 10.1136/ard.2005.037382; Liu J, 2012, CLIN IMAG, V36, P803, DOI 10.1016/j.clinimag.2011.10.003; Terslev L, 2003, ANN RHEUM DIS, V62, P178, DOI 10.1136/ard.62.2.178; Scheel AK, 2005, ANN RHEUM DIS, V64, P1043, DOI 10.1136/ard.2004.030387; Filippucci E, 2007, CLIN EXP RHEUMATOL, V25, P116; Klauser AS, 2009, RADIOLOGY, V250, P171, DOI 10.1148/radiol.2501080397; Naredo E, 2007, ARTHRIT RHEUM-ARTHR, V57, P116, DOI 10.1002/art.22461; Naredo E, 2011, RHEUMATOLOGY, V50, P1860, DOI 10.1093/rheumatology/ker206; Strunk J, 2006, JOINT BONE SPINE, V73, P518, DOI 10.1016/j.jbspin.2006.01.010; Downey DB, 2000, RADIOGRAPHICS, V20, P559; Sconfienza LM, 2010, CLIN EXP RHEUMATOL, V28, P144; Kane D, 2004, RHEUMATOLOGY, V43, P823, DOI 10.1093/rheumatology/keh214; Rempel D, 1998, AM J PUBLIC HEALTH, V88, P1447, DOI 10.2105/AJPH.88.10.1447; Benacerraf BR, 2005, J ULTRAS MED, V24, P1587; Grassi W, 2005, BEST PRACT RES CL RH, V19, P467, DOI 10.1016/j.berh.2005.01.002; Gutierrez M, 2009, J ULTRAS MED, V28, P1569; Filippucci E, 2006, ANN RHEUM DIS, V65, P1433, DOI 10.1136/ard.2005.044628; Hartung W, 2012, ARTHRIT CARE RES, V64, P675, DOI 10.1002/acr.21574; Dighe M, 2008, RADIOLOGY, V248, P662, DOI 10.1148/radiol.2482071758; Di Geso L, 2011, CLIN EXP RHEUMATOL, V29, P926; Cucos M, 2014, MED ULTRASON, V16, P107; Damjanov N, 2012, RHEUMATOLOGY, V51, P120, DOI 10.1093/rheumatology/ker255; Iagnocco A, 2011, RHEUMATOLOGY, V50, P1409, DOI 10.1093/rheumatology/ker111; Iagnocco A, 2010, J RHEUMATOL, V37, P1688, DOI 10.3899/jrheum.090974; Simon A, 2002, J HYPERTENS, V20, P159, DOI 10.1097/00004872-200202000-00001; Schirmer M, 2011, NAT REV RHEUMATOL, V7, P479, DOI 10.1038/nrrheum.2011.95; Wang L, 2013, SCI WORLD J, DOI 10.1155/2013/565717; Meenagh G, 2007, RHEUMATOLOGY, V46, P1736, DOI 10.1093/rheumatology/kem226; Gutierrez M, 2009, J RHEUMATOL, V36, P850, DOI 10.3899/jrheum.080739; Orman G, 2013, ULTRASOUND MED BIOL, V39, P1184, DOI 10.1016/j.ultrasmedbio.2013.02.016; Miyanaga N, 2006, INT J UROL, V13, P1514, DOI 10.1111/j.1442-2042.2006.01612.x; Iagnocco A, 2008, CLIN RHEUMATOL, V27, P491, DOI 10.1007/s10067-007-0738-3; Naredo E, 2013, RHEUMATOLOGY, V52, P376, DOI 10.1093/rheumatology/kes260; ROSENBERG JH, 1993, NEUROLOGY, V43, P2404; Thomas A, 2007, ACAD RADIOL, V14, P193, DOI 10.1016/j.acra.2006.11.010; Backhaus TM, 2013, ANN RHEUM DIS, V72, P1163, DOI 10.1136/annrheumdis-2012-201397; Lai KL, 2014, CLIN EXP RHEUMATOL, V32, P674; Lin PL, 2014, EUR RADIOL, V24, P2729, DOI 10.1007/s00330-014-3320-9; Moher D., 2009, PLOS MED, V6, DOI DOI 10.1371/J0URNAL.PMED.1000097; Reiche BE, 2014, ARTHRIT CARE RES, V66, P204, DOI 10.1002/acr.22103; Silvestri E, 2007, Clin Exp Rheumatol, V25, P796; Skoloudik D, 2015, BIOMED PAP, V159, P595, DOI 10.5507/bp.2014.064; Wells G, NEWCASTLE OTTAWA SCA	60	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1076-1608	1536-7355		JCR-J CLIN RHEUMATOL	JCR-J. Clin. Rheumatol.	DEC	2015	21	8					427	434		10.1097/RHU.0000000000000319		8	Rheumatology	Rheumatology	CX5BK	WOS:000365715400007		
J	Sumikura, H				Sumikura, Hiroyuki			When was the last time you induced general anesthesia for cesarean section?	JOURNAL OF ANESTHESIA			English	Editorial Material							OBSTETRIC ANESTHESIA; UNITED-STATES; DELIVERY		[Sumikura, Hiroyuki] Juntendo Univ, Sch Med, Dept Anesthesiol & Pain Management, Bunkyo Ku, Tokyo, Japan	Sumikura, H (reprint author), Juntendo Univ, Sch Med, Dept Anesthesiol & Pain Management, Bunkyo Ku, 3-1-3 Hongo, Tokyo, Japan.	hiroyuki.sumikura@gmail.com					Demiraran Y, 2013, J ANESTH, V27, P175, DOI 10.1007/s00540-012-1510-7; Palanisamy A, 2011, INT J OBSTET ANESTH, V20, P10, DOI 10.1016/j.ijoa.2010.07.002; Staikou C, 2014, MINERVA ANESTESIOL, V80, P347; D'Angelo R, 2014, ANESTHESIOLOGY, V120, P1505, DOI 10.1097/ALN.0000000000000253; Searle RD, 2008, INT J OBSTET ANESTH, V17, P233, DOI 10.1016/j.ijoa.2008.01.007; Eslamian L, 2012, J ANESTH, V26, P334, DOI 10.1007/s00540-012-1336-3; Hawkins JL, 2011, OBSTET GYNECOL, V117, P69, DOI 10.1097/AOG.0b013e31820093a9; Hawkins JL, 1997, ANESTHESIOLOGY, V86, P277, DOI 10.1097/00000542-199702000-00002; Yamada Yoshitsugu, 2010, Masui, V59, P290	9	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	DEC	2015	29	6					819	820		10.1007/s00540-015-1985-0		2	Anesthesiology	Anesthesiology	CY1GX	WOS:000366155800001		
J	Kakuta, N; Kume, K; Hamaguchi, E; Tsutsumi, R; Mita, N; Tanaka, K; Tsutsumi, YM				Kakuta, Nami; Kume, Katsuyoshi; Hamaguchi, Eisuke; Tsutsumi, Rie; Mita, Naoji; Tanaka, Katsuya; Tsutsumi, Yasuo M.			The effects of intravenous fosaprepitant and ondansetron in the prevention of postoperative nausea and vomiting in patients who underwent lower limb surgery: a prospective, randomized, double-blind study	JOURNAL OF ANESTHESIA			English	Article						Fosaprepitant; Neurokinin-1 receptor; Lower limb surgery; Postoperative nausea and vomiting	TOTAL JOINT ARTHROPLASTY; TOTAL KNEE; ABDOMINAL-SURGERY; TOTAL HIP; APREPITANT; ANALGESIA; TRIAL; DROPERIDOL	Purpose Postoperative nausea and vomiting (PONV) is the most common complication after surgery, and opioid administration increases its incidence. We compared the preventive effects of fosaprepitant, a neurokinin-1 (NK1) receptor antagonist, with those of ondansetron on PONV in patients who underwent lower limb surgery with postoperative epidural opioid administration. MethodsThis prospective, double-blind, randomized study included 38 patients who underwent lower limb surgery. They were randomly allocated to receive intravenous fosaprepitant 150 mg (n = 19; NK1 group) or ondansetron 4 mg (n = 19; ONS group) before general anesthesia. All patients received postoperative epidural fentanyl for pain control. The incidence of nausea and vomiting, complete response rate (no vomiting and no rescue antiemetic use), rescue antiemetic use, nausea score (0-3), and visual analog scale (VAS 0-10) score for pain were recorded at 2, 24, and 48 h after surgery. ResultsNo patient in the NK1 group experienced vomiting (0 %) during the first 24 and 48 h after surgery, while 5 of 19 (26 %) patients in the ONS group experienced this complication, indicating a significant difference between groups. There were no significant differences in the incidence of PONV, complete response rate, rescue antiemetic use, nausea score, and VAS score for pain between the NK1 and ONS groups during the study period. ConclusionsFosaprepitant was more effective than ondansetron in decreasing the incidence of vomiting after lower limb surgery with postoperative opioid administration. Meanwhile, fosaprepitant was not inferior to ondansetron in decreasing the incidence and severity of PONV.	[Kakuta, Nami; Kume, Katsuyoshi; Hamaguchi, Eisuke; Mita, Naoji; Tanaka, Katsuya; Tsutsumi, Yasuo M.] Univ Tokushima, Dept Anesthesiol, Tokushima 7708503, Japan; [Tsutsumi, Rie] Univ Tokushima, Dept Nutr, Tokushima 7708503, Japan	Tsutsumi, YM (reprint author), Univ Tokushima, Dept Anesthesiol, 3-18-15 Kuramoto, Tokushima 7708503, Japan.	tsutsumi@tokushima-u.ac.jp			JSPS KAKENHI [24791598]	This study was supported entirely by JSPS KAKENHI (Grant Number 24791598).	Dorr LD, 2007, CLIN ORTHOP RELAT R, P7, DOI 10.1097/BLO.0b013e318149296c; Vallejo MC, 2012, PLAST RECONSTR SURG, V129, P519, DOI 10.1097/PRS.0b013e31822b6932; Grunberg S, 2011, J CLIN ONCOL, V29, P1495, DOI 10.1200/JCO.2010.31.7859; GAN TJ, 1995, ANESTH ANALG, V80, P81, DOI 10.1097/00000539-199501000-00014; Kovac AL, 2000, DRUGS, V59, P213, DOI 10.2165/00003495-200059020-00005; Chen JJ, 1998, ARCH INTERN MED, V158, P2124, DOI 10.1001/archinte.158.19.2124; Diemunsch P, 2009, BRIT J ANAESTH, V103, P7, DOI 10.1093/bja/aep125; Backes JR, 2013, J ARTHROPLASTY, V28, P11, DOI 10.1016/j.arth.2013.05.041; KAUSTE A, 1986, EUR J ANAESTH, V3, P1; Gan TJ, 2014, ANESTH ANALG, V118, P85, DOI 10.1213/ANE.0000000000000002; Lasseter KC, 2007, J CLIN PHARMACOL, V47, P834, DOI 10.1177/0091270007301800; Hartrick CT, 2010, PAIN PRACT, V10, P245, DOI 10.1111/j.1533-2500.2010.00364.x; Soga T, 2015, J ANESTH, V29, P696, DOI 10.1007/s00540-015-2006-z; Gan TJ, 2007, ANESTH ANALG, V104, P1082, DOI 10.1213/01.ane.0000263277.35140.a3; Apfel CC, 1999, ANESTHESIOLOGY, V91, P693, DOI 10.1097/00000542-199909000-00022; Tsutsumi YM, 2014, BIOMED RES INT, DOI 10.1155/2014/307025; Diemunsch P, 2007, BRIT J ANAESTH, V99, P202, DOI 10.1093/bja/aem133; DiIorio TM, 2010, CLIN ORTHOP RELAT R, V468, P2405, DOI 10.1007/s11999-010-1357-x; Adam F, 2005, ANESTH ANALG, V100, P475, DOI 10.1213/01.ANE.0000142117.82241.DC; Van Laere K, 2012, CLIN PHARMACOL THER, V92, P243, DOI 10.1038/clpt.2012.62; Miyagawa Y, 2010, J CLIN PHARM THER, V35, P679, DOI 10.1111/j.1365-2710.2009.01141.x; Diemunsch Pierre, 2007, Curr Med Res Opin, V23, P2559, DOI 10.1185/030079907X233115; Kakuta Nami, 2011, J Med Invest, V58, P246	23	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	DEC	2015	29	6					836	841		10.1007/s00540-015-2054-4		6	Anesthesiology	Anesthesiology	CY1GX	WOS:000366155800004		
J	Imai, K; Kayashima, K				Imai, Keiko; Kayashima, Kenji			Evaluating the detailed position of the subclavian artery to avoid inadvertent subclavian artery puncture during right internal jugular vein catheterization	JOURNAL OF ANESTHESIA			English	Article						Subclavian artery; Jugular veins; Central venous catheter; Ultrasonography	CENTRAL VENOUS ACCESS; ULTRASOUND GUIDANCE; COMPLICATIONS; CANNULATION; PLACEMENT; NEEDLE	Purpose Central venous catheter placement is useful but is associated with complications. Inadvertent subclavian artery (SCA) puncture is a rare complication associated with internal jugular vein (IJV) catheterization. We determined the position of the SCA by ultrasonography, and propose a needle-insertion position for avoiding inadvertent SCA puncture. Methods We positioned an ultrasound probe at an angle of 60A degrees to the skin to mimic a puncture needle halfway between the clavicle and the angle of the mandible (center) and moved the probe parallel to the right IJV (RIJV) toward the clavicle until locating the SCA. We measured the distance from the clavicle to the probe 60 and from the probe to the SCA (P60-SCA) where the SCA was visible by ultrasonography. Results For 50 volunteers with a mean age of 27.3 years, the center position was, on average, 67 mm from the clavicle. The image of the SCA appeared within 65 mm of the clavicle. P60-SCA differed significantly between men and women (p = 0.0058). For 45 volunteers, P60-SCA was < 25 mm with the probe 65 mm from the clavicle on the skin. RIJVP-SCA averaged 4.4 mm. Only P60-SCA correlated well with BMI for men (r = 0.732, p = 0.0068). Conclusion Puncturing the RIJV away from the center should avoid SCA puncture; puncturing it while approaching the clavicle is more dangerous. The exact location of the SCA varies from person to person; thus, confirming SCA position by ultrasonography is recommended every time before puncturing.	[Imai, Keiko; Kayashima, Kenji] Kyushu Hosp, Japan Community Hlth Care Org, Dept Anesthesia, Yahatanishi Ku, Kitakyushu, Fukuoka 8068501, Japan	Kayashima, K (reprint author), Kyushu Hosp, Japan Community Hlth Care Org, Dept Anesthesia, Yahatanishi Ku, 1-8-1 Kishinoura, Kitakyushu, Fukuoka 8068501, Japan.	ken5ji5ka5ya5shi5ma@nifty.com					American Society of Anesthesiologists. (ASA) task force on central venous access, 2012, ANESTHESIOLOGY, V116, P539; Kayashima K, 2013, INTENS CARE MED, V39, P794, DOI 10.1007/s00134-013-2817-z; Ives C, 2012, AM SURGEON, V78, P545; HUDDY SPJ, 1989, ANAESTHESIA, V44, P588, DOI 10.1111/j.1365-2044.1989.tb11449.x; POWELL H, 1990, ANAESTHESIA, V45, P458, DOI 10.1111/j.1365-2044.1990.tb14334.x; Blaivas M, 2009, CRIT CARE MED, V37, P2345, DOI 10.1097/CCM.0b013e3181a067d4; Kayashima K, 2012, PEDIATR ANESTH, V22, P854, DOI 10.1111/j.1460-9592.2012.03816.x; Chapman GA, 2006, ANAESTHESIA, V61, P148, DOI 10.1111/j.1365-2044.2005.04475.x; GAMULIN Z, 1986, ANAESTHESIA, V41, P408, DOI 10.1111/j.1365-2044.1986.tb13229.x; Blaivas M, 2009, J ULTRAS MED, V28, P1239; Kulvatunyou N, 2002, ANESTH ANALG, V95, P564, DOI 10.1213/01.ANE.0000024001.62110.C3; Choi JI, 2012, J KOREAN MED SCI, V27, P1265, DOI 10.3346/jkms.2012.27.10.1265; Lamperti M, 2012, INTENS CARE MED, V38, P1105, DOI 10.1007/s00134-012-2597-x; Silberzweig JE, 1998, AM J ROENTGENOL, V170, P1617; Wicky S, 2002, EUR RADIOL, V12, P901, DOI 10.1007/s003300101018; Choi HJ, 2011, HONG KONG J EMERG ME, V18, P166; Lim T, 2012, CRIT CARE MED, V40, P491, DOI 10.1097/CCM.0b013e318232da48; Nadig C, 1998, NEPHROL DIAL TRANSPL, V13, P978, DOI 10.1093/ndt/13.4.978; Weiglein AH, 2005, CLIN ANAT, V18, P553, DOI 10.1002/ca.20143; Troianos CA, 2012, ANESTH ANALG, V114, P46, DOI 10.1213/ANE.0b013e3182407cd8; Kim J, 2003, ANESTH ANALG, V97, P1257, DOI 10.1213/01.ANE.0000085639.82967.81; Bowdle TA, ARTERIAL CANNULATION; Chandra M, J INTENSIVE IN PRESS; Eisen Lewis A, 2006, J Intensive Care Med, V21, P40, DOI 10.1177/0885066605280884; Gibbs FJ, 2006, HOSP PHYS, V42, P23; MANSFIELD PF, 1994, NEW ENGL J MED, V331, P1735, DOI 10.1056/NEJM199412293312602; The American College of Surgeons. (ACS) Committee on Perioperative Care, 2011, B AM COLL SURG, V96, P36	27	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	DEC	2015	29	6					850	856		10.1007/s00540-015-2061-5		7	Anesthesiology	Anesthesiology	CY1GX	WOS:000366155800006		
J	Matsumoto, Y; Shibata, SC; Maeda, A; Yoshioka, D; Kamibayashi, T; Uchiyama, A; Sawa, Y; Fujino, Y				Matsumoto, Yu; Shibata, Sho C.; Maeda, Akihiko; Yoshioka, Daisuke; Kamibayashi, Takahiko; Uchiyama, Akinori; Sawa, Yoshiki; Fujino, Yuji			Early postoperative management of heart transplant recipients with current ventricular assist device support in Japan: experience from a single center	JOURNAL OF ANESTHESIA			English	Article						Heart transplant; Japan; Ventricular assist device; Perioperative care	VON-WILLEBRAND SYNDROME; LONG-TERM SUPPORT; CONTINUOUS-FLOW; CARDIAC TRANSPLANTATION; INTERNATIONAL SOCIETY; SURGERY; COAGULOPATHY; TRANSFUSION; STERNOTOMY; MORTALITY	Purpose This study reviews our experience with the perioperative management of heart transplant (HT) recipients and explores how prior ventricular assist device (VAD) support affects the requirements for postoperative mechanical ventilation and circulatory support. Methods and results A retrospective database review was performed from 2007 to 2014. Early postoperative outcomes were compared between VAD and non-VAD groups. Forty-four patients were studied. The mean age was 38 +/- 13 years, 30 % were female, and 88 % experienced non-ischemic heart failure. Forty patients (91 %) required VAD support at the time of HT, with a mean duration of 864 +/- 351 days. The median postoperative mechanical ventilation times in the VAD and non-VAD groups were 54 [95 % confidence interval (CI) 42.9-297.3] and 15 (95 % CI 4.8-30.0; p = 0.0199) hours, respectively. The VAD group experienced increased bleeding during the first 48 h after HT (6.7 +/- 3.5 vs. 1.8 +/- A0.75 l, p = 0.004). Mechanical circulatory support with intra-aortic balloon pumping or venoarterial extracorporeal membrane oxygenation was required in 30 % of VAD group patients. Increased bleeding and primary graft failure were the main causes of prolonged mechanical ventilation. Conclusions HT recipients with VAD support required longer mechanical ventilation periods and mechanical circulatory support in the postoperative period.	[Matsumoto, Yu; Shibata, Sho C.; Maeda, Akihiko; Kamibayashi, Takahiko; Uchiyama, Akinori; Fujino, Yuji] Osaka Univ, Grad Sch Med, Dept Anesthesiol & Intens Care Med, Suita, Osaka 5650871, Japan; [Yoshioka, Daisuke; Sawa, Yoshiki] Grad Sch Med, Dept Cardiovasc Surg, Osaka, Japan	Shibata, SC (reprint author), Osaka Univ, Grad Sch Med, Dept Anesthesiol & Intens Care Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	karlshibata@pain.med.osaka-u.ac.jp					Coleman JL, 2006, AM J CARDIOL, V98, P838, DOI 10.1016/j.amjcard.2006.03.071; Saito S, 2011, J HEART LUNG TRANSPL, V30, P845, DOI 10.1016/j.healun.2011.02.004; Lund LH, 2013, J HEART LUNG TRANSPL, V32, P951, DOI 10.1016/j.healun.2013.08.006; Saito S, 2011, J HEART LUNG TRANSPL, V30, P475, DOI 10.1016/j.healun.2010.11.013; Leal-Noval SM, 2001, CHEST, V119, P1461, DOI 10.1378/chest.119.5.1461; Costanzo MR, 2010, J HEART LUNG TRANSPL, V29, P914, DOI 10.1016/j.healun.2010.05.034; Slaughter MS, 2009, NEW ENGL J MED, V361, P2241, DOI 10.1056/NEJMoa0909938; Drakos SG, 2007, ANN THORAC SURG, V83, P62, DOI 10.1016/j.athoracsur.2006.07.050; Meyer AL, 2010, CIRC-HEART FAIL, V3, P675, DOI 10.1161/CIRCHEARTFAILURE.109.877597; Miller LW, 2010, J AM COLL CARDIOL, V56, P1214, DOI 10.1016/j.jacc.2010.06.009; Eckman PM, 2012, CIRCULATION, V125, P3038, DOI 10.1161/CIRCULATIONAHA.111.040246; George TJ, 2012, ANN THORAC SURG, V94, P2025, DOI 10.1016/j.athoracsur.2012.07.039; Boyle AJ, 2014, J AM COLL CARDIOL, V63, P880, DOI 10.1016/j.jacc.2013.08.1656; Suarez J, 2011, CIRC-HEART FAIL, V4, P779, DOI 10.1161/CIRCHEARTFAILURE.111.962613; Whitson BA, 2007, J CARDIAC SURG, V22, P373, DOI 10.1111/j.1540-8191.2007.00428.x; Engoren MC, 2002, ANN THORAC SURG, V74, P1180, DOI 10.1016/S0003-4975(02)03766-9; Garatti A, 2008, EUR J CARDIO-THORAC, V34, P275, DOI 10.1016/j.ejcts.2008.02.019; Kansara P, 2014, TRANSPL P, V46, P249, DOI 10.1016/j.transproceed.2013.09.027; Steinlechner B, 2009, ANN THORAC SURG, V87, P131, DOI 10.1016/j.athoracsur.2008.10.027; Hunt SA, 2006, NEW ENGL J MED, V355, P231, DOI 10.1056/NEJMp068048; Askar FZ, 2013, TRANSPL P, V45, P1001, DOI 10.1016/j.transproceed.2013.02.069; Uriel N, 2010, J AM COLL CARDIOL, V56, P1207, DOI 10.1016/j.jacc.2010.05.016; Deo SV, 2014, HEART LUNG CIRC, V23, P224, DOI 10.1016/j.hlc.2013.07.006; Gandhi MJ, 2007, J CARDIOTHORAC SURG, V2, DOI 10.1186/1749-8090-2-32; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Kokkinos Constantinos, 2007, Heart Lung Circ, V16, P93, DOI 10.1016/j.hlc.2006.11.006; Nakatani T, 2014, CIRC J, V78, P2604, DOI 10.1253/circj.CJ-14-0970; Quinlan JJ, 2011, KAPLANS CARDIAC ANES; Song HK, 2014, J THORAC CARDIOV SUR, V147, P1036, DOI 10.1016/j.jtcvs.2013.11.020	29	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	DEC	2015	29	6					868	873		10.1007/s00540-015-2044-6		6	Anesthesiology	Anesthesiology	CY1GX	WOS:000366155800009		
J	Ohchi, F; Komasawa, N; Imagawa, K; Okamoto, K; Minami, T				Ohchi, Fumihiro; Komasawa, Nobuyasu; Imagawa, Kentaro; Okamoto, Kaori; Minami, Toshiaki			Evaluation of the efficacy of six supraglottic devices for airway management in dark conditions: a crossover randomized simulation trial	JOURNAL OF ANESTHESIA			English	Article						Supraglottic devices; Dark; Manikin; Novice doctor; Experienced doctor	RESUSCITATION COUNCIL GUIDELINES; LARYNGEAL MASK AIRWAY; MACINTOSH LARYNGOSCOPE; TRACHEAL INTUBATION; CHEST COMPRESSION; MANNEQUIN; VENTILATION; TUBE	During out-of-hospital cardiopulmonary resuscitation, several factors can render tracheal intubation more difficult, such as when rescuers must secure the airway in complete darkness or with limited illumination. The purpose of this study was to evaluate the efficacy of six supraglottic devices (SGDs), ProSeal(A (R)) (ProSeal), Classic(A (R)) (Classic), Supreme(A (R)) (Supreme), Laryngeal Tube(A (R)) (LT), air-Q(A (R)) (air-Q), and i-gel(A (R)) (i-gel), for airway management under light and dark conditions using a manikin. Seventeen novice doctors and 15 experienced doctors performed insertion of six SGDs under light and dark conditions using an adult manikin. Insertion time, successful ventilation rate, and subjective insertion difficulty on a visual analogue scale (VAS) were measured. Both novice and experienced doctors had a significantly lower ventilation success rate in the dark than in the light when ProSeal and Classic were used, but not with the other four SGDs. Novice doctors required a significantly longer insertion time in the dark than in the light with all SGDs. Experienced doctors required a significantly longer insertion time in the dark than in the light with ProSeal or Classic, but not with the other four SGDs. VAS was significantly higher for both novice and experienced doctors when ProSeal and Classic were used, as compared with the other four SGDs in the dark. Compared to ProSeal and Classic, Supreme, i-gel, LT, and air-Q are more effective for airway management in the dark. Our findings suggest that anatomically shaped SGDs may help novice doctors secure the airway under dark conditions.	[Ohchi, Fumihiro; Komasawa, Nobuyasu; Imagawa, Kentaro; Okamoto, Kaori; Minami, Toshiaki] Osaka Med Coll, Dept Anesthesiol, Takatsuki, Osaka 5698686, Japan	Komasawa, N (reprint author), Osaka Med Coll, Dept Anesthesiol, Daigaku Machi 2-7, Takatsuki, Osaka 5698686, Japan.	ane078@poh.osaka-med.ac.jp					Timmermann A, 2011, ANAESTHESIA, V66, P45, DOI 10.1111/j.1365-2044.2011.06934.x; Kohama H, 2011, J ANESTH, V25, P98, DOI 10.1007/s00540-010-1054-7; Helm M, 2006, BRIT J ANAESTH, V96, P67, DOI 10.1093/bja/aei275; Komasawa N, 2011, J ANESTH, V25, P535, DOI 10.1007/s00540-011-1145-0; Jordan GM, 2007, ANAESTHESIA, V62, P708, DOI 10.1111/j.1365-2044.2007.05069.x; Asai T, 2005, BRIT J ANAESTH, V95, P729, DOI 10.1093/bja/aei269; Deakin CD, 2010, RESUSCITATION, V81, P1305, DOI 10.1016/j.resuscitation.2010.08.017; Komasawa N, 2012, RESUSCITATION, V83, P365, DOI 10.1016/j.resuscitation.2011.08.025; Komasawa N, 2010, J ANESTH, V24, P306, DOI 10.1007/s00540-010-0874-9; Ueshima H, 2010, ANAESTHESIA, V65, P684, DOI 10.1111/j.1365-2044.2010.06366.x; Cook TM, 2003, BRIT J ANAESTH, V91, P373, DOI 10.1093/bja/aeg192; Nolan JP, 2010, RESUSCITATION, V81, P1219, DOI 10.1016/j.resuscitation.2010.08.021; Komasawa N, 2010, J ANESTH, V24, P582, DOI 10.1007/s00540-010-0950-1; Asai T, 2009, ANAESTHESIA, V64, P1114, DOI 10.1111/j.1365-2044.2009.06014.x; Theiler LG, 2009, ANESTHESIOLOGY, V111, P55, DOI 10.1097/ALN.0b013e3181a4c6b9; Apfelbaum Jeffrey L, 2013, Anesthesiology, V118, P251, DOI 10.1097/ALN.0b013e31827773b2; Asai T, 2002, ANAESTHESIA, V57, P918, DOI 10.1046/j.1365-2044.2002.02783.x; Fujiwara A, J ANESTH; Japanese Society of Anesthesiologists, 2014, J ANESTH, V28, P482; Komasawa N, 2014, J ANESTH, V28, P676, DOI 10.1007/s00540-014-1802-1; Komasawa N, 2014, J CLIN ANESTH, V26, P663, DOI 10.1016/j.jclinane.2014.08.009; Miyazaki Y, 2015, J ANESTH; Okada D, 2014, J ANESTH	23	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	DEC	2015	29	6					887	892		10.1007/s00540-015-2050-8		6	Anesthesiology	Anesthesiology	CY1GX	WOS:000366155800012		
J	Asai, T				Asai, Takashi			Airway management in patients undergoing emergency Cesarean section	JOURNAL OF ANESTHESIA			English	Review						Airway management; Difficult intubation; Obstetric anesthesia	RAPID-SEQUENCE INDUCTION; LARYNGEAL MASK AIRWAY; END-TIDAL OXYGRAPHY; CRICOID PRESSURE; TRACHEAL INTUBATION; OBSTETRIC ANESTHESIA; NEUROMUSCULAR BLOCK; MENDELSONS-SYNDROME; FAILED INTUBATION; STOMACH CONTENTS	Special care is required for airway management of patients undergoing emergency Cesarean section. Although the incidence of difficult intubation and difficult ventilation is similar between pregnant and non-pregnant women, the severity of complications in pregnant patients would be much greater than in non-pregnant patients, if tracheal intubation is found to be difficult: increased risk of pulmonary aspiration, hypoxia, airway obstruction due to laryngeal edema, and a "sleeping baby" being taken out. Rapid-sequence induction of anesthesia is generally indicated to a patient undergoing emergency Cesarean section under general anesthesia. The technique has been evolving, without losing the key premise of minimizing the period of the airway being not protected from pulmonary aspiration, and of permitting rapid wake up if tracheal intubation fails. In this review, I describe the appropriate airway management, based on the current state of knowledge, in a patient undergoing emergency Cesarean section under general anesthesia.	[Asai, Takashi] Dokkyo Med Univ, Koshigaya Hosp, Dept Anesthesiol, Koshigaya, Saitama 3438555, Japan	Asai, T (reprint author), Dokkyo Med Univ, Koshigaya Hosp, Dept Anesthesiol, 2-1-50 Minamikoshigaya, Koshigaya, Saitama 3438555, Japan.	asaita@dokkyomed.ac.jp					Abramson M, 1945, LANCET, V65, P19; ALLMAN KG, 1995, J CLIN ANESTH, V7, P197, DOI 10.1016/0952-8180(94)00048-9; Hashimoto Y, 2014, ANAESTHESIA, V69, P878, DOI 10.1111/anae.12731; Asai T, 1998, BRIT J ANAESTH, V80, P767; WARNER MA, 1993, ANESTHESIOLOGY, V78, P56, DOI 10.1097/00000542-199301000-00010; HOWELLS TH, 1983, ANAESTHESIA, V38, P457, DOI 10.1111/j.1365-2044.1983.tb12077.x; Isono S, 2008, ANESTHESIOLOGY, V108, P347, DOI 10.1097/ALN.0b013e318164cb0b; Winternitz MC, 1920, J EXP MED, V32, P199, DOI 10.1084/jem.32.2.199; Asai T, 2007, CRIT CARE MED, V35, P298, DOI 10.1097/01.CCM.0000251359.33232.1D; McClelland SH, 2008, ANAESTHESIA, V63, P264, DOI 10.1111/j.1365-2044.2007.05347.x; WHITTINGTON RM, 1979, LANCET, V2, P228; VIBYMOGENSEN J, 1980, ANESTHESIOLOGY, V53, P517, DOI 10.1097/00000542-198012000-00017; [Anonymous], 1988, REP CONF ENQ MAT DEA, P80; MURPHY DF, 1984, BRIT J ANAESTH, V56, P1113, DOI 10.1093/bja/56.10.1113; WHITE RT, 1959, OBSTET GYNECOL, V14, P111; Lee C, 2009, ANESTHESIOLOGY, V110, P1020, DOI 10.1097/ALN.0b013e31819dabb0; KALOW W, 1957, J PHARMACOL EXP THER, V120, P203; Asai T, 1996, BRIT J ANAESTH, V76, P772; WRAIGHT WJ, 1983, ANAESTHESIA, V38, P461, DOI 10.1111/j.1365-2044.1983.tb12078.x; Asai T, 2012, J ANESTH, V26, P321, DOI 10.1007/s00540-012-1375-9; MENDELSON CL, 1946, AM J OBSTET GYNECOL, V52, P191; Herman NL, 1996, ANESTH ANALG, V83, P859, DOI 10.1097/00000539-199610000-00036; Vanner RG, 1999, ANAESTHESIA, V54, P1, DOI 10.1046/j.1365-2044.1999.00756.x; Chambers D, 2010, BRIT J ANAESTH, V105, P568, DOI 10.1093/bja/aeq270; Asai T, 2009, ANESTHESIOLOGY, V110, P898, DOI 10.1097/ALN.0b013e31819c45e5; Samain E, 2000, ANAESTHESIA, V55, P841, DOI 10.1046/j.1365-2044.2000.01549.x; Bhatia PK, 1997, ANAESTHESIA, V52, P175, DOI 10.1111/j.1365-2044.1997.14-az016.x; Tao WK, 2012, J ANESTH, V26, P339, DOI 10.1007/s00540-012-1338-1; ASAI T, 1995, BRIT J ANAESTH, V74, P521, DOI 10.1093/bja/74.5.521; Asai T, 2001, ANAESTHESIA, V56, P398, DOI 10.1046/j.1365-2044.2001.01976-47.x; SELLICK BA, 1961, LANCET, V2, P404; CORMACK RS, 1984, ANAESTHESIA, V39, P1105, DOI 10.1111/j.1365-2044.1984.tb08932.x; CARP H, 1992, ANESTH ANALG, V74, P683; Cook TM, 2011, BRIT J ANAESTH, V106, P617, DOI 10.1093/bja/aer058; Kiyama S, 2003, ANAESTHESIA, V58, P571, DOI 10.1046/j.1365-2044.2003.03180.x; Asai T, 2014, J ANESTH, V28, P87, DOI 10.1007/s00540-013-1672-y; DeNormandie RL, 1938, NEW ENGL J MED, V219, P871, DOI 10.1056/NEJM193812012192202; MORGAN M, 1986, ANAESTHESIA, V41, P689, DOI 10.1111/j.1365-2044.1986.tb12832.x; Sorensen MK, 2012, BRIT J ANAESTH, V108, P682, DOI 10.1093/bja/aer503; THOMPSON DG, 1983, GUT, V24, P277, DOI 10.1136/gut.24.4.277; CRAWFORD JS, 1982, ANAESTHESIA, V37, P345, DOI 10.1111/j.1365-2044.1982.tb01119.x; BROCKUTNE JG, 1989, BRIT J ANAESTH, V62, P397, DOI 10.1093/bja/62.4.397; Vasdev GM, 2008, J ANESTH, V22, P38, DOI 10.1007/s00540-007-0577-z; HOLDSWORTH JD, 1974, BRIT J ANAESTH, V46, P526, DOI 10.1093/bja/46.7.526; Asai T, 2000, BRIT J ANAESTH, V85, P861, DOI 10.1093/bja/85.6.861; RALPH SJ, 1991, ANAESTHESIA, V46, P40, DOI 10.1111/j.1365-2044.1991.tb09314.x; TUNSTALL ME, 1989, CAN J ANAESTH, V36, P611; Bisschops MMA, 2010, ANAESTHESIA, V65, P936, DOI 10.1111/j.1365-2044.2010.06455.x; NORTON JF, 1945, AM J OBSTET GYNECOL, V49, P554; Apfelbach CW, 1937, JAMA-J AM MED ASSOC, V108, P503; Asai T., 2013, J ANESTH, V27, P1521; CAMPBELL IT, 1994, BRIT J ANAESTH, V72, P3, DOI 10.1093/bja/72.1.3; Committee on maternal mortality, 1943, NEW ENGL J MED, V228, P36; Crawford JS, 1984, PRINCIPLES PRACTICE; Hawthorne L, 1996, BRIT J ANAESTH, V76, P680; Heffernan RJ, 1938, NEW ENGL J MED, V219, P865, DOI 10.1056/NEJM193812012192201; Japanese Society of Anesthesiologists, 2014, J ANESTH, V28, P482; Liu EH, 2015, J ANESTH; MORTON H J V, 1951, Anaesthesia, V6, P190, DOI 10.1111/j.1365-2044.1951.tb01388.x; Simpson JY, 1848, LANCET, Vi, P175; SIMPSON KH, 1987, BRIT J ANAESTH, V59, P540, DOI 10.1093/bja/59.5.540; STRANG TI, 1992, ANAESTHESIA, V47, P829, DOI 10.1111/j.1365-2044.1992.tb03138.x; Tachibana N, 2015, J ANESTH, V29, P326, DOI 10.1007/s00540-014-1847-1; Vanner R G, 1992, Int J Obstet Anesth, V1, P195, DOI 10.1016/0959-289X(92)80005-D; VANNER RG, 1992, ANAESTHESIA, V47, P732, DOI 10.1111/j.1365-2044.1992.tb03248.x	65	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	DEC	2015	29	6					927	933		10.1007/s00540-015-2037-5		7	Anesthesiology	Anesthesiology	CY1GX	WOS:000366155800018		
J	Kayashima, K				Kayashima, Kenji			Factors affecting survival in pediatric cardiac tamponade caused by central venous catheters	JOURNAL OF ANESTHESIA			English	Review						Pediatric; Cardiac tamponade; Central venous catheter; Survival rate	TOTAL PARENTERAL-NUTRITION; LIFE-THREATENING COMPLICATION; BILATERAL PLEURAL EFFUSION; INSERTED CENTRAL CATHETERS; BIRTH-WEIGHT INFANT; PERICARDIAL-EFFUSION; UMBILICAL CATHETERIZATION; PREMATURE NEONATE; LINE INSERTION; NEWBORN	Pediatric central venous catheter (CVC) placement is useful but associated with complications such as cardiac tamponade. We aimed to identify risk factors for death in cardiac tamponade. Published articles on pediatric CVC-associated cardiac tamponade were obtained by searching PubMed and Google and retrospectively reviewed to analyze risk factors for death. Factors examined for their effect on mortality risk included patient age, weight, CVC size, days from CVC insertion to tamponade occurrence, substances administered, insertion site, treatment, CVC material, and initial CVC tip position. Of 110 patients reported in 62 articles, 69 survived and 41 died. Among survivors, 55 of 69 patients were treated; among deaths, only 7 of 38 (OR 537.9, 95 % CI 29.3-9,877, p < 0.0001). Multiple regression analysis in 44 cases showed that treatment (p < 0.0001) and initial CVC tip position (p = 0.020) were independent predictive factors related to improved cardiac tamponade survival. Past studies have mainly discussed how to avoid pediatric cardiac tamponade; by contrast, the present study focused on how to avoid deaths. The findings of this review suggest that cardiac tamponade survival is better when tamponade is detected early and treated promptly and might be affected by initial CVC tip position.	[Kayashima, Kenji] Kyushu Hosp, Japan Community Hlth Care Org, Dept Anesthesia, Yahatanishi Ku, Kitakyushu, Fukuoka 8068501, Japan	Kayashima, K (reprint author), Kyushu Hosp, Japan Community Hlth Care Org, Dept Anesthesia, Yahatanishi Ku, Kitakyushu 1-8-1 Kishinoura, Kitakyushu, Fukuoka 8068501, Japan.	ken5ji5ka5ya5shi5ma@nifty.com					Abdellatif M, 2012, BMJ CASE REP, V13, P2012; Agarwal R, 2001, INDIAN PEDIATR, V38, P889; Aggarwal R, 2001, Indian Pediatr, V38, P889; Al Nemri Abdulrahman M, 2006, Congenit Heart Dis, V1, P180, DOI 10.1111/j.1747-0803.2006.00031.x; Alabsi Samir, 2010, Neonatal Netw, V29, P347; Cartwright DW, 2004, ARCH DIS CHILD, V89, pF504, DOI 10.1136/adc.2004.049189; Alzaydi AM, 2005, SAUDI MED J, V26, P476; CHANG LY, 1995, J FORMOS MED ASSOC, V94, P355; Beardsall K, 2003, ARCH DIS CHILD, V88, P292; Collier PE, 1998, AM J SURG, V176, P212, DOI 10.1016/S0002-9610(98)00171-8; Sehgal A, 2007, J PERINATOL, V27, P317, DOI 10.1038/sj.jp.7211678; Haass C, 2009, J MATERN-FETAL NEO M, V22, P137, DOI 10.1080/14767050802509561; Thomson TL, 2010, PEDIATR CARDIOL, V31, P287, DOI 10.1007/s00246-009-9587-y; Leipala JA, 2001, J PAEDIATR CHILD H, V37, P168, DOI 10.1046/j.1440-1754.2001.00625.x; Nadroo AM, 2002, PEDIATRICS, V110, P131, DOI 10.1542/peds.110.1.131; AGARWAL KC, 1984, PEDIATRICS, V73, P333; Schlapbach LJ, 2009, EUR J PEDIATR, V168, P107, DOI 10.1007/s00431-008-0704-3; Ozturk E, 2014, PEDIATR INT, V56, P13, DOI 10.1111/ped.12192; Connolly B, 2006, PEDIATR RADIOL, V36, P845, DOI 10.1007/s00247-006-0172-8; Nowlen TT, 2002, PEDIATRICS, V110, P137, DOI 10.1542/peds.110.1.137; VANHAEFTEN TW, 1988, ARCH INTERN MED, V148, P1649, DOI 10.1001/archinte.148.7.1649; GOUTAILFLAUD MF, 1991, J PEDIATR SURG, V26, P645, DOI 10.1016/0022-3468(91)90001-A; van Engelenburg KCA, 1998, J PEDIATR SURG, V33, P1822, DOI 10.1016/S0022-3468(98)90296-2; CHERNG YG, 1994, ANAESTHESIA, V49, P1052, DOI 10.1111/j.1365-2044.1994.tb04354.x; LEIBOVITZ E, 1988, J PEDIATR GASTR NUTR, V7, P306, DOI 10.1097/00005176-198803000-00033; BEATTIE PG, 1993, ACTA PAEDIATR, V82, P105, DOI 10.1111/j.1651-2227.1993.tb12532.x; FISCHER G, 1973, PEDIATRICS, V52, P868; PUROHIT DM, 1977, ARCH DIS CHILD, V52, P520; BARJOSEPH G, 1983, J PEDIATR SURG, V18, P284, DOI 10.1016/S0022-3468(83)80103-1; Colomina MJ, 2005, PEDIATR ANESTH, V15, P988, DOI 10.1111/j.1460-9592.2004.01557.x; Suresh N, 2007, INDIAN PEDIATR, V44, P45; Pignotti MS, 2004, PEDIATR ANESTH, V14, P349, DOI 10.1046/j.1460-9592.2003.01225.x; AIKEN G, 1992, J PAEDIATR CHILD H, V28, P325, DOI 10.1111/j.1440-1754.1992.tb02679.x; Pesce C, 1999, EUR J PEDIATR SURG, V9, P113, DOI 10.1055/s-2008-1072224; Monteiro AJ, 2008, REV BRAS CIR CARDIOV, V23, P422, DOI 10.1590/S0102-76382008000300023; BYARD RW, 1992, ARCH PATHOL LAB MED, V116, P654; SULLIVAN CA, 1987, JPEN-PARENTER ENTER, V11, P319, DOI 10.1177/0148607187011003319; ALTMAN RP, 1971, ANN SURG, V174, P85, DOI 10.1097/00000658-197107010-00014; Megha M, 2011, INDIAN PEDIATR, V48, P404; Bagwell CE, 2000, J PEDIATR SURG, V35, P709, DOI 10.1053/jpsu.2000.6029; Booth SA, 2001, BRIT J ANAESTH, V87, P298, DOI 10.1093/bja/87.2.298; MUPANEMUNDA RH, 1992, AM J DIS CHILD, V146, P1414; Towbin R, 2008, PEDIATR RADIOL, V38, P331, DOI 10.1007/s00247-007-0674-z; ABUDALU K, 1984, Z KINDERCHIR, V39, P135; Weil BR, 2010, J PEDIATR SURG, V45, P1687, DOI 10.1016/j.jpedsurg.2009.11.006; Pezzati M, 2004, INTENS CARE MED, V30, P2253, DOI 10.1007/s00134-004-2472-5; Onal EE, 2004, PEDIATR ANESTH, V14, P953, DOI 10.1111/j.1460-9592.2004.01385.x; WIRRELL EC, 1993, AM J PERINAT, V10, P419; Traen M, 2005, ACTA PAEDIATR, V94, P626, DOI 10.1080/080352504100225492; Warren M, 2013, ANN CLIN LAB SCI, V43, P163; Arya SO, 2009, INT J PEDIAT, V2009; Askegard-Giesmann JR, 2009, SEMIN PEDIAT SURG, V18, P73, DOI 10.1053/j.sempedsurg.2009.02.003; Au Sik-Hon, 2003, Acta Paediatrica Taiwanica, V44, P235; Darling J C, 2001, J Perinatol, V21, P461, DOI 10.1038/sj.jp.7210541; Daud Danilo Felix, 2013, Radiol Bras, V46, P385, DOI 10.1590/S0100-39842013000600014; dos Santos Modelli Manoel Eugenio, 2014, Am J Forensic Med Pathol, V35, P26, DOI 10.1097/PAF.0000000000000084; Farry Paul M, 2012, Ulster Med J, V81, P50; Fioravanti J, 1998, Neonatal Netw, V17, P39; Fukuda H, 1993, Masui, V42, P280; Garg M, 1989, J Perinatol, V9, P456; GIACOIA GP, 1991, JPEN-PARENTER ENTER, V15, P110, DOI 10.1177/0148607191015001110; Hong EJ, 2006, KOREAN J PEDIAT, V49, P686; Kabra Nandkishor S., 2001, Indian Journal of Pediatrics, V68, P677, DOI 10.1007/BF02752286; Kayashima K, 1994, INT J ANESTHESIOL RE, V1, P36; Kumar N, 2013, INDIAN PEDIATR, V50, P1157, DOI 10.1007/s13312-013-0286-7; Lun KS, 2002, HONG KONG J PAEDIATR, V7, P98; Madhok AB, 2002, INTERNET J PEDIAT NE, V2, P8891; Opitz J C, 1982, Pediatrics, V70, P139; Pizzuti Alfredo, 2010, Cases J, V3, P15, DOI 10.1186/1757-1626-3-15; Rajpal MN, 2013, J PEDIAT SURG CASE R, V1, P180; ROGERS B B, 1990, Pediatric Pathology, V10, P819; Schulman Joseph, 2002, J Perinatol, V22, P679, DOI 10.1038/sj.jp.7210815; Shenoy R, 2008, INTERNET J PEDIAT NE, V10, P10207; SUTCLIFFE AG, 1995, J ROY SOC MED, V88, pP173; Yoder D, 2001, Int J Trauma Nurs, V7, P108, DOI 10.1067/mtn.2001.117434	75	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	DEC	2015	29	6					944	952		10.1007/s00540-015-2045-5		9	Anesthesiology	Anesthesiology	CY1GX	WOS:000366155800020		
J	Toyama, H; Saitoh, K; Takei, Y; Ejima, Y; Kurosawa, S; Yamauchi, M				Toyama, Hiroaki; Saitoh, Kazutomo; Takei, Yusuke; Ejima, Yutaka; Kurosawa, Shin; Yamauchi, Masanori			Two cases of bilateral lung transplantation combined with intracardiac repair and pulmonary artery replacement: perioperative managements based on the left ventricular function	JOURNAL OF ANESTHESIA			English	Article						Bilateral lung transplantation; Eisenmenger syndrome; Intracardiac repair; Pulmonary artery replacement; Left ventricular diastolic dysfunction	HYPERTENSION	We report on two patients who underwent bilateral lung transplantation (BLTx) combined with cardiac surgery. Patient 1 was a female whose pulmonary hypertension resulted from a congenital atrial septal defect (ASD) and idiopathic pulmonary arterial hypertension. She had a very small left ventricle (LV). We initiated venoarterial extracorporeal membrane oxygenation (ECMO) before induction of general anesthesia. She underwent ASD patch closure, pulmonary artery replacement, and BLTx under cardiopulmonary bypass (CPB). At the weaning from CPB, primary graft dysfunction and pulmonary edema induced by LV diastolic dysfunction was apparent. We gradually decreased the ECMO support and eventually weaned off the ECMO on the 4th postoperative day (POD) and the ventilator on the 29th POD. Patient 2 was a male with Eisenmenger syndrome, which resulted from ASD and ventricular septal defect (VSD). He had a normal LV. General anesthesia was induced smoothly without ECMO. He underwent ASD and VSD patch closure, pulmonary artery replacement, and BLTx under CPB. Weaning from CPB proceeded smoothly. These patients needed different management because of their different LV function. Especially, perioperative management of the BLTx patient with LV diastolic dysfunction was difficult. Assessment of perioperative cardiac function is very important in BLTx combined with cardiac surgery.	[Toyama, Hiroaki; Saitoh, Kazutomo; Takei, Yusuke; Ejima, Yutaka; Yamauchi, Masanori] Tohoku Univ Hosp, Dept Anesthesiol, Aoba Ku, Sendai, Miyagi 9808574, Japan; [Kurosawa, Shin] Fukushima Med Univ, Dept Anesthesiol, Fukushima 9601295, Japan	Toyama, H (reprint author), Tohoku Univ Hosp, Dept Anesthesiol, Aoba Ku, 1-1 Seiryomachi, Sendai, Miyagi 9808574, Japan.	h-toyama@umin.ac.jp					Birsan T, 1999, J HEART LUNG TRANSPL, V18, P304, DOI 10.1016/S1053-2498(98)00050-3; Feltracco P, 2007, TRANSPL P, V39, P1976, DOI 10.1016/j.transproceed.2007.05.006; Bittner HB, 2012, ANN THORAC SURG, V94, P942, DOI 10.1016/j.athoracsur.2012.05.006; Gille J, 2012, ANESTHESIOL RES PRAC, DOI [10.1155/2012/356982, DOI 10.1155/2012/356982]	4	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	DEC	2015	29	6					957	961		10.1007/s00540-015-2043-7		5	Anesthesiology	Anesthesiology	CY1GX	WOS:000366155800022		
J	Sawai, T; Nakahira, J; Minami, T				Sawai, Toshiyuki; Nakahira, Junko; Minami, Toshiaki			Usefulness of intraoperative transesophageal echocardiography for evaluation of circumflex coronary artery fistula with ruptured aneurysm draining into coronary sinus	JOURNAL OF ANESTHESIA			English	Article						Giant coronary artery aneurysm; Circumflex coronary artery aneurysm; Fistula from coronary artery aneurysm to coronary sinus; Ruptured coronary artery aneurysm	ARTERIOVENOUS-FISTULA; PULMONARY-ARTERY; CONNECTION	A coronary artery aneurysm (CAA) is defined as dilatation of a coronary artery to a diameter > 1.5 times that of the adjoining normal coronary artery. Giant CAAs with a diameter a parts per thousand yen50 mm are quite rare. Coronary artery fistulas are also uncommon, and affected patients require prompt diagnosis and treatment. Coronary angiography is the most common method of diagnosing coronary artery fistulas; however, transesophageal echocardiography (TEE) can also be a key intraoperative tool. In the present report, we describe the case of an 83-year-old man urgently admitted to our hospital with pericardial tamponade. Enhanced computed tomography and coronary angiography revealed a bulging left main and circumflex artery that was connected to a 50-mm diameter CAA. Emergency intraoperative TEE clearly showed a CAA with a surrounding hematoma, bulging circumflex artery, and a fistulous connection to the coronary sinus; the fistulous vessel contained a thrombus. Surgical repair was successful. This case demonstrates that CAA can rupture because of spontaneous closure of a thrombus-containing fistula and that intraoperative TEE could help to clearly identify the location of the CAA and fistulous connection.	[Sawai, Toshiyuki; Nakahira, Junko; Minami, Toshiaki] Osaka Med Coll, Dept Anesthesiol, Takatsuki, Osaka 5698686, Japan	Sawai, T (reprint author), Osaka Med Coll, Dept Anesthesiol, 2-7 Daigaku Machi, Takatsuki, Osaka 5698686, Japan.	ane026@poh.osaka-med.ac.jp					Abusaid GH, 2011, J CARDIOL CASES, V4, pe43; Chamberlain MH, 2001, EUR J CARDIO-THORAC, V20, P1255, DOI 10.1016/S1010-7940(01)00998-8; Alcock R, 2011, EUR HEART J, V32, P2712, DOI 10.1093/eurheartj/ehr146; Nakamura K, 2010, ANN THORAC CARDIOVAS, V16, P354; Kalangos A, 2005, J THORAC CARDIOV SUR, V130, P580, DOI 10.1016/j.jtcvs.2005.02.045; Nakamura M, 2006, CIRC J, V70, P796, DOI 10.1253/circj.70.796; Nakahira A, 2007, CIRC J, V71, P1996, DOI 10.1253/circj.71.1996; Keyser A, 2012, INTERACT CARDIOV TH, V15, P33, DOI 10.1093/icvts/ivs111; Karthik S, 2007, ANESTH ANALG, V104, P263, DOI 10.1213/01.ane.0000253070.74274.3b; Syed M, 1997, PROG CARDIOVASC DIS, V40, P77, DOI 10.1016/S0033-0620(97)80024-2; Inoue H, 2009, ANN THORAC CARDIOVAS, V15, P198; Morita H, 2012, INTERNAL MED, V51, P1361, DOI 10.2169/internalmedicine.51.7134; Mita N, 2011, J ANESTH, V25, P749, DOI 10.1007/s00540-011-1183-7; Mangukia CV, 2012, ANN THORAC SURG, V93, P2084, DOI 10.1016/j.athoracsur.2012.01.114; Crawley PD, 2014, TEX HEART I J, V41, P603, DOI 10.14503/THIJ-13-3896; Dogan A, 2006, INT J CARDIOVAS IMAG, V19, P5; Gupta V, 2008, CIRCULATION, V25, P2304; Kumar Kavita, 2002, Rev Cardiovasc Med, V3, P152; Watanabe T, 2012, J CARDIOL CASES, V5, pe96	19	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	DEC	2015	29	6					962	966		10.1007/s00540-015-2051-7		5	Anesthesiology	Anesthesiology	CY1GX	WOS:000366155800023		
J	Hashimoto, K; Iwayama, S; Sano, Y; Tatara, T; Hirose, M				Hashimoto, Kazuma; Iwayama, Sachiko; Sano, Yuka; Tatara, Tsuneo; Hirose, Munetaka			Preoperative anxiety induces no clinically relevant effect on intraoperative nociceptive levels during breast surgery under general anesthesia	JOURNAL OF ANESTHESIA			English	Article						Anxiety; Mastectomy; Nociception	PAIN; RESPONSES	Anxiety can affect acute and chronic postoperative pain after breast surgery. Nociceptive response during surgery might also be affected by preoperative anxiety even under unconscious state during general anesthesia. The aim of this retrospective study was to investigate nociceptive responses during breast surgery under general anesthesia in patients with or without preoperative anxiety. Patients (n = 45) were divided into a low-anxiety group (n = 25) and a high-anxiety group (n = 20) in accordance with preoperative scores for the State Trait Anxiety Inventory. We performed discriminant analysis to compare nociception during surgery using three intraoperative averaged values: heart rate; systolic blood pressure; and perfusion index. No significant differences in discriminant score were seen between groups (p = 0.10). Although we performed propensity score-matching to reduce the bias due to confounding variables in this retrospective study, there was also no significant difference in levels of nociceptive response between groups (p = 0.06). In conclusion, the level of nociception during breast surgery is not significantly affected by preoperative anxiety.	[Hashimoto, Kazuma; Iwayama, Sachiko; Sano, Yuka; Tatara, Tsuneo; Hirose, Munetaka] Hyogo Coll Med, Dept Anesthesiol & Pain Med, Nishinomiya, Hyogo 6638501, Japan	Hirose, M (reprint author), Hyogo Coll Med, Dept Anesthesiol & Pain Med, 1-1 Mukogawa Cho, Nishinomiya, Hyogo 6638501, Japan.	mhirose@hyo-med.ac.jp			Japan Society for the Promotion of Science [26462375]	This study was supported by a Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science (No. 26462375).	Akeju O, 2014, ELIFE, V3; Schreiber KL, 2013, PAIN, V154, P660, DOI 10.1016/j.pain.2012.11.015; Pearson S, 2005, BRIT J HEALTH PSYCH, V10, P299, DOI 10.1348/135910705X26957; Kucyi A, 2015, TRENDS NEUROSCI, V38, P86, DOI 10.1016/j.tins.2014.11.006; MANYANDE A, 1992, PSYCHOSOM MED, V54, P275; Kaunisto MA, 2013, ANESTHESIOLOGY, V119, P1410, DOI 10.1097/ALN.0000000000000012; Yalcin I, 2014, NEUROSCI BIOBEHAV R, V47, P154, DOI 10.1016/j.neubiorev.2014.08.002; Strobel C, 2014, SCI CHINA LIFE SCI, V57, P384, DOI 10.1007/s11427-014-4638-x; Deshpande G, 2010, BRAIN RES, V1318, P110, DOI 10.1016/j.brainres.2009.12.075; Coutinho JF, 2015, BRAIN IMAGING BEHAV, DOI [10.1007/s11682-015-9375-7, DOI 10.1007/S11682-015-9375-7]; Hashimoto K, 2015, HEPATO-GASTROENTEROL, V62, P34; Wang F, 2014, INT J CLIN EXP MED, V7, P331	12	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	DEC	2015	29	6					967	970		10.1007/s00540-015-2032-x		4	Anesthesiology	Anesthesiology	CY1GX	WOS:000366155800024		
J	Kuroiwa, KK; Nakazawa, M; Nishizawa, M				Kuroiwa, Kaori K.; Nakazawa, Mana; Nishizawa, Masaaki			Lanthanum carbonate hydrate causes artifacts on ultrasound	JOURNAL OF ANESTHESIA			English	Letter									[Kuroiwa, Kaori K.; Nakazawa, Mana; Nishizawa, Masaaki] Nagano Red Cross Hosp, Dept Anesthesia, Wakasato, Nagano 3808582, Japan	Kuroiwa, KK (reprint author), Nagano Red Cross Hosp, Dept Anesthesia, Wakasato, Nagano 3808582, Japan.	karyuo2001@yahoo.co.jp					Pafcugova J, 2008, NEPHROL DIAL TRANSPL, V23, P1776, DOI 10.1093/ndt/gfn015; Chung CL, 2007, KIDNEY INT, V72, P1291; Hiromitsu H, 2010, JPN J RADIOL, V28, P322	3	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	DEC	2015	29	6					974	974		10.1007/s00540-015-2034-8		1	Anesthesiology	Anesthesiology	CY1GX	WOS:000366155800026		
J	Komasawa, N; Fujiwara, S; Minami, T				Komasawa, Nobuyasu; Fujiwara, Shunsuke; Minami, Toshiaki			In reply: Videolaryngoscope for intubation during chest compression	JOURNAL OF ANESTHESIA			English	Letter									[Komasawa, Nobuyasu; Fujiwara, Shunsuke; Minami, Toshiaki] Osaka Med Coll, Dept Anesthesiol, Takatsuki, Osaka 5698686, Japan	Komasawa, N (reprint author), Osaka Med Coll, Dept Anesthesiol, Daigaku machi 2-7, Takatsuki, Osaka 5698686, Japan.	ane078@poh.osaka-med.ac.jp					Arima T, 2014, AM J EMERG MED, V32, P40, DOI 10.1016/j.ajem.2013.09.026; Okada D, 2015, J ANESTH, V29, P331, DOI 10.1007/s00540-014-1936-1; Liu KP, 2015, J ANESTH, V29, P975, DOI 10.1007/s00540-015-2039-3	3	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	DEC	2015	29	6					976	976		10.1007/s00540-015-2067-z		1	Anesthesiology	Anesthesiology	CY1GX	WOS:000366155800028		
J	Yano, T; Taniguchi, M; Tsuneyoshi, I				Yano, Takeshi; Taniguchi, Masahiko; Tsuneyoshi, Isao			Continuous rocuronium administration for tracheomalacia	JOURNAL OF ANESTHESIA			English	Letter									[Yano, Takeshi; Taniguchi, Masahiko; Tsuneyoshi, Isao] Miyazaki Univ, Dept Anesthesiol & Intens Care, Fac Med, Kiyotake, Miyazaki 8891692, Japan	Yano, T (reprint author), Miyazaki Univ, Dept Anesthesiol & Intens Care, Fac Med, 5200 Kihara, Kiyotake, Miyazaki 8891692, Japan.	yanotake@med.miyazaki-u.ac.jp					Carden KA, 2005, CHEST, V127, P984, DOI 10.1378/chest.127.3.984	1	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	DEC	2015	29	6					978	978		10.1007/s00540-015-2055-3		1	Anesthesiology	Anesthesiology	CY1GX	WOS:000366155800030		
J	Liu, Y; Xue, ZQ; Park, H; Kiyama, T; Zhang, Y; Nishizawa, O; Chae, KS				Liu, Yu; Xue, Ziqiu; Park, Hyuck; Kiyama, Tamotsu; Zhang, Yi; Nishizawa, Osamu; Chae, Kwang-seok			Measurement of electrical impedance of a Berea sandstone core during the displacement of saturated brine by oil and CO2 injections	JOURNAL OF APPLIED GEOPHYSICS			English	Article						Berea sandstone; Oil saturation; Saturation exponent; X-ray CT; Complex electrical impedance	SPECTRAL INDUCED POLARIZATION; RESISTIVITY MEASUREMENT; COMPLEX CONDUCTIVITY; SUPERCRITICAL CO2; BEARING SANDS; PERMEABILITY; IMBIBITION; RESERVOIR; NAGAOKA; MODEL	Complex electrical impedance measurements were performed on a brine-saturated Berea sandstone core while oil and CO2 were injected at different pressures and temperatures. The saturations of brine, oil, and CO2 in the core were simultaneously estimated using an X-ray computed tomography scanner. The formation factor of this Berea core and the resistivity indexes versus the brine saturations were calculated using Archie's law. The experimental results found different flow patterns of oil under different pressures and temperatures. Fingers were observed for the first experiment at 10 MPa and 40 degrees C. The fingers were restrained as the viscosity ratio of oil and water changed in the second (10 MPa and 25 degrees C) and third (5 MPa and 25 degrees C) experiments. The resistivity index showed an exponential increase with a decrease in brine saturation. The saturation exponent varied from 1.4 to 4.0 at different pressure and temperature conditions. During the oil injection procedure, the electrical impedance increased with oil saturation and was significantly affected by different oil distributions; therefore, the impedance varied whether the finger was remarkable or not, even if the oil saturation remained constant. During the CO2 injection steps, the impedance showed almost no change with CO2 saturation because the brine in the pores became immobile after the oil injection. (C) 2015 Elsevier B.V. All rights reserved.	[Liu, Yu] Dalian Univ Technol, Sch Energy & Power Engn, Dalian 116024, Peoples R China; [Xue, Ziqiu; Park, Hyuck; Kiyama, Tamotsu; Zhang, Yi; Nishizawa, Osamu] Res Inst Innovat Technol Earth RITE, Kizugawa, Kyoto 6190292, Japan; [Chae, Kwang-seok] GS Engn & Construct GRAN Seoul, Infra & Offshore Res Team, Seoul 110110, South Korea	Liu, Y (reprint author), Dalian Univ Technol, Sch Energy & Power Engn, 2 Linggong Rd, Dalian 116024, Peoples R China.	liuyu@dlut.edu.cn; xue@rite.or.jp			Ministry of Trade, Industry and Energy (MOTIE); Ministry of Economy, Trade and Industry of Japan; China Scholarship Council [201308210030]	This work was supported by a grant to the Korea Institute of Energy Technology Evaluation and Planning (KETEP) for 'The development of CO<INF>2</INF> geological storage technologies through 1,000 ton CO2-EOR pilot test," funded by the Ministry of Trade, Industry and Energy (MOTIE). A part of this study was also supported by the Ministry of Economy, Trade and Industry of Japan under a research contract for "Development of Safety Assessment Technology for Carbone Dioxide Capture and Storage." The first author was also supported by the China Scholarship Council (No. 201308210030). We also thank Mr. Seiji Shibatani for the assistance in the X-ray CT operations.	Haslam EP, 2014, J APPL GEOPHYS, V111, P384, DOI 10.1016/j.jappgeo.2014.07.017; Nakatsuka Y, 2010, INT J GREENH GAS CON, V4, P209, DOI 10.1016/j.ijggc.2010.01.001; Abousrafa EM, 2009, J PETROL SCI ENG, V65, P113, DOI 10.1016/j.petrol.2008.12.009; Georgiadis A, 2010, J SUPERCRIT FLUID, V55, P743, DOI 10.1016/j.supflu.2010.09.028; Saltas V, 2007, J HAZARD MATER, V142, P520, DOI 10.1016/j.jhazmat.2006.08.051; Skelton ADL, 1999, EARTH PLANET SC LETT, V174, P1, DOI 10.1016/S0012-821X(99)00262-9; Martinez FJ, 2012, GEOPHYSICS, V77, pWA19, DOI [10.1190/geo2011-0433.1, 10.1190/GEO2011-0433.1]; Revil A, 2010, GEOPHYS J INT, V181, P1480, DOI 10.1111/j.1365-246X.2010.04573.x; Zhang Y, 2013, ENRGY PROCED, V37, P4647, DOI 10.1016/j.egypro.2013.07.241; Schmutz M, 2010, GEOPHYS J INT, V183, P211, DOI 10.1111/j.1365-246X.2010.04751.x; Revil A, 2013, WATER RESOUR RES, V49, P306, DOI 10.1029/2012WR012700; Roberts JJ, 1997, WATER RESOUR RES, V33, P577, DOI 10.1029/96WR03905; RANDLES JEB, 1947, DISCUSS FARADAY SOC, V1, P11; Archie GE, 1942, T AM I MIN MET ENG, V146, P54; Nakajima T, 2013, INT J GREENH GAS CON, V12, P288, DOI 10.1016/j.ijggc.2012.11.002; Tong M, 2008, GEOPHYS J INT, V173, P733, DOI 10.1111/j.1365-246X.2008.03730.x; PATERSON MS, 1983, MECH MATER, V2, P345, DOI 10.1016/0167-6636(83)90025-X; Revil A, 2013, J COLLOID INTERF SCI, V398, P193, DOI 10.1016/j.jcis.2013.01.015; Revil A, 2013, GEOPHYSICS, V78, pD271, DOI 10.1190/GEO2012-0503.1; Ghorbani A, 2009, APPL CLAY SCI, V43, P493, DOI 10.1016/j.clay.2008.12.007; Nakatsuka Y, 2009, ENRGY PROCED, V1, P2211, DOI 10.1016/j.egypro.2009.01.287; Nakajima T, 2013, ENRGY PROCED, V37, P4166, DOI 10.1016/j.egypro.2013.06.318; Zhang Y, 2014, GEOPHYS J INT, V197, P1789, DOI 10.1093/gji/ggu089; Shi JQ, 2011, ENRGY PROCED, V4, P5001, DOI 10.1016/j.egypro.2011.02.471; Donaldson E.C., 1989, SPE FORMATION EVALUA; Lide D.R., 2010, HDB CHEM PHYS; Nasralla RA, 2014, J PETROL SCI ENG, V122, P384, DOI 10.1016/j.petrol.2014.07.038; Ponziani M, 2011, INT WATER TECHNOL J, V1, P14; Shi J.-Q., 2010, INT J GREENH GAS CON, V5, P75; Toumelin E., 2005, SPWLA 46 ANN LOGG S	30	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0926-9851	1879-1859		J APPL GEOPHYS	J. Appl. Geophys.	DEC	2015	123						50	62		10.1016/j.jappgeo.2015.09.024		13	Geosciences, Multidisciplinary; Mining & Mineral Processing	Geology; Mining & Mineral Processing	CY0CH	WOS:000366073400005		
J	Niki, Y; Harato, K; Nagai, K; Suda, Y; Nakamura, M; Matsumoto, M				Niki, Yasuo; Harato, Kengo; Nagai, Katsuya; Suda, Yasunori; Nakamura, Masaya; Matsumoto, Morio			Effects of Reduction Osteotomy on Gap Balancing During Total Knee Arthroplasty for Severe Varus Deformity	JOURNAL OF ARTHROPLASTY			English	Article						total knee arthroplasty; reduction osteotomy; gap balancing; component subsidence; trabecular metal	INTRAOPERATIVE JOINT GAP; POROUS TANTALUM; TIBIAL COMPONENT; IN-VITRO; BONE; REPLACEMENT; REVISION; FLEXION	This study aimed to assess the effects of down-sizing and lateralizing of the tibial component (reduction osteotomy) on gap balancing in TKA, and the clinical feasibility of an uncemented modular trabecular metal tibial tray in this technique. Reduction osteotomy was performed for 39 knees of 36 patients with knee OA with amean tibiofemoral angle of 21 degrees varus. In 20 knees, appropriate gap balance was achieved by release of the deep medial collateral ligament alone. Flexion gap imbalance could be reduced by approximately 1.7 degrees and 2.8 degrees for 4-mm osteotomy and 8-mm osteotomy, respectively. Within the first postoperative year, clinically-stable tibial component subsidence was observed in 9 knees, but it was not progressive, and the clinical results were excellent at a mean follow-up of 3.3 years. (C) 2015 Elsevier Inc. All rights reserved.	[Niki, Yasuo; Harato, Kengo; Nagai, Katsuya; Suda, Yasunori; Nakamura, Masaya; Matsumoto, Morio] Keio Univ, Dept Orthopaed Surg, Tokyo 1608582, Japan	Niki, Y (reprint author), Keio Univ, Dept Orthopaed Surg, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.						Knutson K, 2010, ACTA ORTHOP, V81, P5, DOI 10.3109/17453671003667267; Mullaji A, 2009, J ARTHROPLASTY, V24, P795, DOI 10.1016/j.arth.2008.03.018; Matsumoto T, 2006, J BIOMECH ENG-T ASME, V128, P867, DOI 10.1115/1.2354201; Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283; Dunbar MJ, 2009, J BONE JOINT SURG AM, V91A, P1578, DOI 10.2106/JBJS.H.00282; Mullaji AB, 2014, CLIN ORTHOP RELAT R, V472, P126, DOI 10.1007/s11999-013-3077-5; Young SW, 2015, J ARTHROPLASTY, V30, P813, DOI 10.1016/j.arth.2014.11.035; Matsumoto T, 2009, J BONE JOINT SURG BR, V91B, P475, DOI 10.1302/0301-620X.91B4.21862; MARKOLF KL, 1976, J BONE JOINT SURG AM, V58, P583; Wilson DAJ, 2012, ACTA ORTHOP, V83, P36, DOI 10.3109/17453674.2011.645196; Matsumoto T, 2007, KNEE SURG SPORT TR A, V15, P1013, DOI 10.1007/s00167-007-0331-y; Balla VK, 2010, ACTA BIOMATER, V6, P3349, DOI 10.1016/j.actbio.2010.01.046; Mundermann A, 2008, J ORTHOP RES, V26, P1167, DOI 10.1002/jor.20655; NIELSEN S, 1984, ACTA ORTHOP SCAND, V55, P30, DOI 10.3109/17453678408992307; Dixon MC, 2004, J ARTHROPLASTY, V19, P19, DOI 10.1016/j.arth.2003.08.001; Niki Y, 2010, J ARTHROPLASTY, V25, P381, DOI 10.1016/j.arth.2009.01.004; Levine BR, 2006, BIOMATERIALS, V27, P4671, DOI 10.1016/j.biomaterials.2006.04.041; Klein GR, 2008, J ARTHROPLASTY, V23, P619, DOI 10.1016/j.arth.2007.05.004; Matsumoto T, 2011, J ARTHROPLASTY, V26, P1291, DOI 10.1016/j.arth.2011.01.003; Unger AS, 2005, J ARTHROPLASTY, V20, P1002, DOI 10.1016/j.arth.2005.01.023; INSALL JN, 1985, CLIN ORTHOP RELAT R, P13; Tigani D, 2009, Chir Organi Mov, V93, P187, DOI 10.1007/s12306-009-0047-x	22	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	0883-5403	1532-8406		J ARTHROPLASTY	J. Arthroplast.	DEC	2015	30	12					2116	2120		10.1016/j.arth.2015.06.061		5	Orthopedics	Orthopedics	CY1JA	WOS:000366161300013		
J	Nishikawa, K; Mizu-uchi, H; Okazaki, K; Matsuda, S; Tashiro, Y; Iwamoto, Y				Nishikawa, Kazutaka; Mizu-uchi, Hideki; Okazaki, Ken; Matsuda, Shuichi; Tashiro, Yasutaka; Iwamoto, Yukihide			Accuracy of Proximal Tibial Bone Cut Using Anterior Border of Tibia as Bony Landmark in Total Knee Arthroplasty	JOURNAL OF ARTHROPLASTY			English	Article						total knee arthroplasty; coronal alignment; extramedullary alignment guide; anterior border of tibia; osteoarthritis	POSTOPERATIVE ALIGNMENT; ROTATIONAL ALIGNMENT; JAPANESE PATIENTS; REPLACEMENT; INTRAMEDULLARY; EXTRAMEDULLARY; COMPONENT; OSTEOARTHRITIS; MALALIGNMENT; SURVIVAL	The purpose of our study was to evaluate the accuracy of the tibial bone cut in total knee arthroplasty using the anterior tibial border as a guide compared to using bony and soft tissue landmarks of the ankle joint. The extramedullary alignment guide was set parallel to a line connecting the proximal and distal one-thirds of the anterior border of the tibia while the rotational direction of the distal end of the guide was adjusted to the anteroposterior axis of the proximal tibia. Significant differences were detected in the ideal coronal tibial component angles with improvements from 87.2% to 95.9%. The anterior tibial border was a reliable landmark in total knee arthroplasty in clinical practice, as shown by our previous computer simulation. (C) 2015 Elsevier Inc. All rights reserved.	[Nishikawa, Kazutaka; Mizu-uchi, Hideki; Okazaki, Ken; Tashiro, Yasutaka; Iwamoto, Yukihide] Kyushu Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Fukuoka, Fukuoka 8128582, Japan; [Matsuda, Shuichi] Kyoto Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Kyoto, Japan	Mizu-uchi, H (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Higashi Ku, 3-1-1 Maidashi, Fukuoka, Fukuoka 8128582, Japan.						Mizu-uchi H, 2009, J ARTHROPLASTY, V24, P1103, DOI 10.1016/j.arth.2008.07.007; Berger RA, 1998, CLIN ORTHOP RELAT R, P144; Green GV, 2002, J ARTHROPLASTY, V17, P1033, DOI 10.1054/arth.2002.35796; Mahaluxmivala J, 2001, J ARTHROPLASTY, V16, P635, DOI 10.1054/arth.2001.23569; Schneider M, 2007, J ARTHROPLASTY, V22, P219, DOI 10.1016/j.arth.2006.04.023; Wong J, 2011, J ORTHOP RES, V29, P347, DOI 10.1002/jor.21221; Kim YH, 2014, INT ORTHOP, V38, P379, DOI 10.1007/s00264-013-2097-9; JEFFERY RS, 1991, J BONE JOINT SURG BR, V73, P709; Sikorski JM, 2008, J BONE JOINT SURG BR, V90B, P1121, DOI 10.1302/0301-620X.90B9.20793; Mizu-Uchi H, 2008, J BONE JOINT SURG BR, V90B, P1025, DOI 10.1302/0301-620X.90B8.20265; Kalairajah Y, 2006, J BONE JOINT SURG BR, V88B, P198, DOI 10.1302/0301-620X.88B2.16906; de Kroon KE, 2012, KNEE, V19, P270, DOI 10.1016/j.knee.2011.04.007; Rodricks DJ, 2007, J BONE JOINT SURG AM, V89A, P89, DOI 10.2106/JBJS.E.00492; Kuwano T, 2005, J ORTHOP SCI, V10, P42, DOI 10.1007/s00776-004-0855-7; TEW M, 1985, J BONE JOINT SURG BR, V67, P551; Reed MR, 2002, J BONE JOINT SURG BR, V84B, P858, DOI 10.1302/0301-620X.84B6.12702; Fukagawa S, 2011, J ORTHOP RES, V29, P919, DOI 10.1002/jor.21335; Vessely MB, 2006, CLIN ORTHOP RELAT R, P28, DOI 10.1097/01.blo.0000229356.81749.11; Perillo-Marcone A, 2007, J BIOMECH ENG-T ASME, V129, P1, DOI 10.1115/1.2401177; Nagamine R, 2003, CLIN ORTHOP RELAT R, P218, DOI 10.1097/01.blo.0000053163.71678.da; Mizu-Uchi H, 2006, J BONE JOINT SURG AM, V88A, P2632, DOI 10.2106/JBJS.E.01288; Fang DM, 2009, J ARTHROPLASTY, V24, P39, DOI 10.1016/j.arth.2009.04.034; Berend ME, 2004, CLIN ORTHOP RELAT R, P26, DOI 10.1097/01.blo.0000148578.22729.0e; Matsui Y, 2005, CLIN ORTHOP RELAT R, P147, DOI 10.1097/01.blo.0000150465.29883.83; BERGER RA, 1993, CLIN ORTHOP RELAT R, P40; CAILLOUETTE JT, 1990, CLIN ORTHOP RELAT R, P198; Lombardi AV, 2011, ORTHOPEDICS, V34, pE504, DOI 10.3928/01477447-20110714-40; Petersen T L, 1988, J Arthroplasty, V3, P67, DOI 10.1016/S0883-5403(88)80054-8; Rajadhyaksha Amar D, 2009, Am J Orthop (Belle Mead NJ), V38, pE68; RITTER MA, 1994, CLIN ORTHOP RELAT R, P153; Sasanuma Hideyuki, 2014, Eur J Orthop Surg Traumatol, V24, P1525, DOI 10.1007/s00590-014-1415-2; Simmons E D Jr, 1991, J Arthroplasty, V6, P45, DOI 10.1016/S0883-5403(06)80156-7; TETER KE, 1995, CLIN ORTHOP RELAT R, P106	33	1	1	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	0883-5403	1532-8406		J ARTHROPLASTY	J. Arthroplast.	DEC	2015	30	12					2121	2124		10.1016/j.arth.2015.06.055		4	Orthopedics	Orthopedics	CY1JA	WOS:000366161300014		
J	So, K; Goto, K; Kuroda, Y; Matsuda, S				So, Kazutaka; Goto, Koji; Kuroda, Yutaka; Matsuda, Shuichi			Minimum 10-Year Wear Analysis of Highly Cross-Linked Polyethylene in Cementless Total Hip Arthroplasty	JOURNAL OF ARTHROPLASTY			English	Article						highly cross-linked polyethylene; zirconia; wear analysis; total hip arthroplasty; cementless	MOLECULAR-WEIGHT POLYETHYLENE; FOLLOW-UP; FEMORAL HEADS; IN-VITRO; CONVENTIONAL POLYETHYLENE; ZIRCONIA; REPLACEMENT; OSTEOLYSIS; ALUMINA; METAANALYSIS	Fifty-four patients (64 hips) underwent cementless total hip arthroplasty between 2000 and 2003 with a 22-mm zirconia ceramic bearing on highly cross-linked polyethylene, and were evaluated with a mean 11.9-year postoperative follow-up (range, 10-14 years). Linear wear was measured on the anteroposterior radiograph of the hip. No evidence of osteolysis and loosening was found on the final radiograph in any of the cases, and the steady-state linear wear rate was 0.017 +/- 0.018 mm/year. No significant correlation was found between the linear wear rate and age, body weight, cup inclination angle, or polyethylene thickness. Highly cross-linked polyethylene showed excellent wear resistance for >10 years when used in combination with 22-mm zirconia heads. (C) 2015 Elsevier Inc. All rights reserved.	[So, Kazutaka; Goto, Koji; Kuroda, Yutaka; Matsuda, Shuichi] Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Sakyo Ku, Kyoto, Japan	So, K (reprint author), Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Sakyo Ku, 54 Shogoin Kawaharacho, Kyoto, Japan.						Crockarell JR, 2012, J ARTHROPLASTY, V27, P37, DOI 10.1016/j.arth.2011.04.008; Rienstra W, 2013, J ARTHROPLASTY, V28, P1362, DOI 10.1016/j.arth.2012.10.004; Dowd JE, 2000, J BONE JOINT SURG AM, V82A, P1102; Kuzyk PRT, 2011, J BONE JOINT SURG BR, V93B, P593, DOI 10.1302/0301-620X.93B5.25908; Johnson AJ, 2014, CLIN ORTHOP RELAT R, V472, P624, DOI 10.1007/s11999-013-3153-x; Nakashima Y, 2013, J ORTHOP SCI, V18, P962, DOI 10.1007/s00776-013-0456-4; Muratoglu OK, 2001, J ARTHROPLASTY, V16, P24, DOI 10.1054/arth.2001.28376; Kuribayashi M, 2010, J ORTHOP SCI, V15, P452, DOI 10.1007/s00776-010-1490-0; Garcia-Rey E, 2013, BONE JOINT J, V95B, P326, DOI 10.1302/0301-620X.95B3.29456; Sychterz CJ, 1999, J BONE JOINT SURG AM, V81A, P821; Bragdon CR, 2006, CLIN ORTHOP RELAT R, P52, DOI 10.1097/01.blo.0000224018.88410.83; OONISHI H, 1992, RADIAT PHYS CHEM, V39, P495; Snir N, 2014, J ARTHROPLASTY, V29, P630, DOI 10.1016/j.arth.2013.07.034; Sochart DH, 1999, CLIN ORTHOP RELAT R, P135; Liang B, 2007, J ARTHROPLASTY, V22, P251, DOI 10.1016/j.arth.2006.03.004; So K, 2012, ACTA ORTHOP, V83, P599, DOI 10.3109/17453674.2012.736173; Hernigou P, 2003, J BONE JOINT SURG BR, V85B, P504, DOI 10.1302/0301-620X.85B4.13397; von Schewelov T, 2004, ACTA ORTHOP SCAND, V75, P691, DOI 10.1080/00016470410004058; Fernandez-Fairen M, 2007, CLIN ORTHOP RELAT R, P122, DOI 10.1097/BLO.0b013eb4c3; Akiyama H, 2013, J ORTHOP SCI, V18, P1037, DOI 10.1007/s00776-012-0255-3; Green TR, 2000, J BIOMED MATER RES, V53, P490, DOI 10.1002/1097-4636(200009)53:5<490::AID-JBM7>3.0.CO;2-7; Rieker CB, 2003, J ARTHROPLASTY, V18, P48, DOI 10.1054/S0883-5403(03)00303-6; So K, 2013, CLIN ORTHOP RELAT R, V471, P3847, DOI 10.1007/s11999-013-2945-3; Green TR, 1998, BIOMATERIALS, V19, P2297, DOI 10.1016/S0142-9612(98)00140-9; [Anonymous], 1997, CLIN ORTHOPAEDICS; Maloney WJ, 1999, CLIN ORTHOP RELAT R, P157; Gottliebsen M, 2012, HIP INT, V22, P35, DOI 10.5301/HIP.2012.9075; Engh CA, 2012, J ARTHROPLASTY, V27, P2, DOI 10.1016/j.arth.2012.03.048; Hasegawa M, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-154; Shen C, 2014, ORTHOP TRAUMATOL-SUR, V100, P745, DOI 10.1016/j.otsr.2014.07.015; Silva M, 2007, ADULT HIP, P256	31	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	0883-5403	1532-8406		J ARTHROPLASTY	J. Arthroplast.	DEC	2015	30	12					2224	2226		10.1016/j.arth.2015.06.053		3	Orthopedics	Orthopedics	CY1JA	WOS:000366161300035		
J	Miyatake, K; Jinno, T; Koga, D; Yamauchi, Y; Muneta, T; Okawa, A				Miyatake, Kazumasa; Jinno, Tetsuya; Koga, Daisuke; Yamauchi, Yuki; Muneta, Takeshi; Okawa, Atsushi			Comparison of Different Materials and Proximal Coatings Used for Femoral Components in One-Stage Bilateral Total Hip Arthroplasty	JOURNAL OF ARTHROPLASTY			English	Article						anatomical stem; grit-blasted surface; arc-deposited titanium surface; beta titanium alloy; stress shielding; bone mineral density	FOLLOW-UP; DEVELOPMENTAL DYSPLASIA; KNEE ARTHROPLASTY; COBALT-CHROME; BONE INGROWTH; UNITED-STATES; TITANIUM; REPLACEMENT; STEMS; FEMUR	To evaluate the mid-term effects of different materials and coatings used for femoral components, we prospectively performed 21 one-stage bilateral total hip arthroplasties using 2 anatomical stems which have identical geometries, randomized to side. One stem was made of Ti6Al4V alloy and had a hydroxyapatite coating on grit-blasted surface proximally, and the other was made of TMZF (TM) alloy and had a proximal coating of hydroxyapatite in addition to an arc-deposited titanium surface coating. Although we found extensions of radiopaque lines to the surface of coatings of seven grit-blasted stems whereas we found none in the case of the arc-deposited titanium stems, all hips showed excellent clinical and radiological outcomes as shown by radiographs and bone mineral density at the final follow-up, average 5.5 years postoperatively. (C) 2015 Elsevier Inc. All rights reserved.	[Miyatake, Kazumasa; Jinno, Tetsuya; Koga, Daisuke; Yamauchi, Yuki; Muneta, Takeshi; Okawa, Atsushi] Tokyo Med & Dent Univ, Dept Orthopaed Surg, Hosp Med, Tokyo 1138519, Japan	Jinno, T (reprint author), Tokyo Med & Dent Univ, Dept Orthopaed Surg, Hosp Med, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.						Nakashima Y, 1997, J BIOMED MATER RES, V35, P287; Kurtz SM, 2011, CLIN ORTHOP RELAT R, V469, P2262, DOI 10.1007/s11999-011-1872-4; Koyano G, 2015, J ARTHROPLASTY, V30, P74, DOI 10.1016/j.arth.2014.08.007; Kim YH, 2004, CLIN ORTHOP RELAT R, P148, DOI 10.1097/01.blo.0000142350.80416.84; Jinno T, 1998, J BIOMED MATER RES, V42, P20, DOI 10.1002/(SICI)1097-4636(199810)42:1<20::AID-JBM4>3.0.CO;2-Q; Harada Y, 2007, J ORTHOP SCI, V12, P127, DOI 10.1007/s00776-006-1099-5; LEWINNEK GE, 1978, J BONE JOINT SURG AM, V60, P217; BOURNE RB, 1994, J BONE JOINT SURG AM, V76A, P1464; Sluimer JC, 2006, J ARTHROPLASTY, V21, P344, DOI 10.1016/j.arth.2005.06.015; Zwartele R, 2008, INT ORTHOP, V32, P581, DOI 10.1007/s00264-007-0383-0; Bosker BH, 2012, J BONE JOINT SURG BR, V94B, P755, DOI 10.1302/0301-620X.94B6.28373; Khanuja HS, 2011, J BONE JOINT SURG AM, V93A, P500, DOI 10.2106/JBJS.J.00774; DAntonio JA, 1996, J BONE JOINT SURG AM, V78A, P1226; Kurtz S, 2005, J BONE JOINT SURG AM, V87A, P1487, DOI 10.2106/JBJS.D.02441; Svehla M, 2000, J BIOMED MATER RES, V51, P15, DOI 10.1002/(SICI)1097-4636(200007)51:1<15::AID-JBM3>3.0.CO;2-9; Yoshii T, 2009, J ORTHOP SCI, V14, P161, DOI 10.1007/s00776-008-1303-x; Rahmy AIA, 2004, OSTEOPOROSIS INT, V15, P281, DOI 10.1007/s00198-003-1546-5; ENGH CA, 1987, J BONE JOINT SURG BR, V69, P45; Sugano N, 1998, J BONE JOINT SURG BR, V80B, P711, DOI 10.1302/0301-620X.80B4.8319; Trentani L, 2002, BIOMATERIALS, V23, P2863, DOI 10.1016/S0142-9612(01)00413-6; Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222; ENGH CA, 1992, J BONE JOINT SURG AM, V74A, P1009; Healy WL, 2009, J ARTHROPLASTY, V24, P831, DOI 10.1016/j.arth.2008.06.035; Sano K, 2008, INT ORTHOP, V32, P167, DOI 10.1007/s00264-006-0298-1; Sugano N, 2009, ORTHOP CLIN N AM, V40, P365, DOI 10.1016/j.ocl.2009.04.003; Lavernia C, 2004, J ARTHROPLASTY, V19, P10, DOI 10.1016/j.arth.2004.06.023; Sinha RK, 2004, J BONE JOINT SURG AM, V86A, P1254; Kurtz SM, 2009, CLIN ORTHOP RELAT R, V467, P2606, DOI 10.1007/s11999-009-0834-6; Bugbee WD, 1997, J BONE JOINT SURG AM, V79A, P1007; Friedman RJ, 1996, J ORTHOPAED RES, V14, P455, DOI 10.1002/jor.1100140316; Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004; Capello WN, 2009, CLIN ORTHOP RELAT R, V467, P155, DOI 10.1007/s11999-008-0550-7; Owen DH, 2014, BONE JOINT J, V96B, P181, DOI 10.1302/0301-620X.96B2.32784; Yamauchi Y, 2012, J ARTHROPLASTY, V27, P1538, DOI 10.1016/j.arth.2012.01.031; Panisello JJ, 2009, J ARTHROPLASTY, V24, P56, DOI 10.1016/j.arth.2007.12.017; Brown Thomas E, 2002, J Am Acad Orthop Surg, V10, P385; Engh CA, 1990, CLIN ORTHOP RELAT RE, V107; Gehrchen P. M., 1996, Bone (New York), V18, p106S, DOI 10.1016/S8756-3282(96)80009-3; Gruen TA, 1979, CLIN ORTHOP RELAT RE, V17; Hothan A, 2011, J BIOMECH, V44; Jinno T, 2014, RECENT ADV ORTHOPEDI, P202; Kagawa Y, 2013, BONE JOINT J ORTHO S, V95, P208; Murali R, 2008, J ARTHROPLASTY, V23, P1240; Noble PC, 2003, CLIN ORTHOP RELAT R, P27, DOI 10.3097/01.blo.0000096819.67494.32; Stanat SJ, 2012, J ARTHROPLASTY, V27	45	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	0883-5403	1532-8406		J ARTHROPLASTY	J. Arthroplast.	DEC	2015	30	12					2237	2241		10.1016/j.arth.2015.06.019		5	Orthopedics	Orthopedics	CY1JA	WOS:000366161300038		
J	Nakamura, S; Morita, Y; Ito, H; Kuriyama, S; Furu, M; Matsuda, S				Nakamura, Shinichiro; Morita, Yugo; Ito, Hiromu; Kuriyama, Shinichi; Furu, Moritoshi; Matsuda, Shuichi			Morphology of the Proximal Tibia at Different Levels of Bone Resection in Japanese Knees	JOURNAL OF ARTHROPLASTY			English	Article						morphology; proximal tibia; revision total knee arthroplasty; computed tomography; rotational alignment	ARTHROPLASTY; VARIABILITY; POPULATION; PROSTHESIS; COMPONENT; ROTATION; DESIGN	The purpose was to measure the morphology of the proximal tibia at different levels for consideration of tibial tray design and placement. The morphology was analysed in 51 knees at 10, 15,20, and 25 mm below the centre of the lateral tibial plateau. Surface rotation was measured by fitting an ellipse on the resection surface. The anteroposterior (AP), mediolateral (ML), medial AP (MAP) and lateral AP (LAP) dimensions were also measured. The resection surface showed internal rotation of 22.9 degrees from the 10 mm level to the 25 mm level. More distally, the ML AP and MAP/LAP ratios showed significant changes. Surgeons should pay attention to morphological changes for patients with gross tibial bone defects in primary and revision total knee arthroplasty. (C) 2015 Elsevier Inc. All rights reserved.	[Nakamura, Shinichiro; Morita, Yugo; Ito, Hiromu; Kuriyama, Shinichi; Furu, Moritoshi; Matsuda, Shuichi] Kyoto Univ, Grad Sch Med, Dept Orthoped Surg, Kyoto, Japan	Nakamura, S (reprint author), Kyoto Univ, Grad Sch Med, Dept Orthoped Surg, Sakyo Ku, 54 Shogoin Kawaharacho, Kyoto, Japan.						Akagi M, 2004, CLIN ORTHOP RELAT R, P213, DOI 10.1097/01.blo.0000118442.93383.16; Akagi M, 2005, CLIN ORTHOP RELAT R, P172, DOI 10.1097/01.blo.0000160027.52481.32; Berger RA, 1998, CLIN ORTHOP RELAT R, P144; Backstein D, 2006, CLIN ORTHOP RELAT R, P104, DOI 10.1097/01.blo.0000214426.52206.2c; Barnett SL, 2014, J ARTHROPLASTY, V6, P1219; Barrack RL, 2001, CLIN ORTHOP RELAT R, P46; Bedard M, 2011, CLIN ORTHOP RELAT R, V8, P2346; Chun CH, 2014, KNEE, V2, P420; Daines BK, 2012, J BONE JOINT SURG AM, V12, P1131; Graw BP, 2010, CLIN ORTHOP RELAT R, V10, P2734; Hartel MJ, 2009, KNEE, V6, P452; Hartel MJ, 2014, KNEE, V2, P415; Kuriyama S., 2014, J ORTHOP RES, V12, P1658; Kwak DS, 2007, KNEE, V14, P295, DOI 10.1016/j.knee.2007.05.004; Mahfouz M, 2012, CLIN ORTHOP RELAT R, V1, P172; Matsuda S, 2001, Am J Knee Surg, V14, P152; Nakamura S., 2010, KNEE, V4, P274; Nakamura S., 2014, INT ORTHOP, V4, P761; Nicoll D, 2010, J BONE JOINT SURG BR, V9, P1238; Siston RA, 2006, CLIN ORTHOP RELAT R, P65, DOI 10.1097/01.blo.0000229335.36900.a0; Springer BD, 2001, CLIN ORTHOP RELAT R, P283; Uehara K, 2002, J ARTHROPLASTY, V17, P1028, DOI 10.1054/arth.2002.35790; Westrich GH, 1995, J ARTHROPLASTY, V1, P47	23	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	0883-5403	1532-8406		J ARTHROPLASTY	J. Arthroplast.	DEC	2015	30	12					2323	2327		10.1016/j.arth.2015.05.056		5	Orthopedics	Orthopedics	CY1JA	WOS:000366161300056		
